data_6yi3_residue ############################ # Computer software used # ############################ save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 6yi3 _Structure_validation_residue.Date_analyzed 2020-04-03 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.502 0 CA-C-O 121.568 0.699 . . . . 0.0 111.186 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 12.3 p -59.92 142.69 53.21 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.225 -0.898 . . . . 0.0 109.98 177.053 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . 0.419 ' CD2' ' HD3' ' A' ' 109' ' ' ARG . 12.4 m95 -67.3 -21.86 65.66 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 114.648 1.351 . . . . 0.0 114.648 -178.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -121.48 163.36 18.92 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 113.992 1.108 . . . . 0.0 113.992 -170.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 65.6 p -70.96 168.39 17.07 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.304 -1.317 . . . . 0.0 108.258 178.087 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -78.34 149.4 33.44 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 114.182 1.178 . . . . 0.0 114.182 -175.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 13.9 mt -92.3 143.75 26.08 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 102.439 -3.171 . . . . 0.0 102.439 166.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 44.2 m -124.58 131.83 53.46 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 -178.494 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 4.0 tp-100 -95.59 139.19 32.21 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.616 0.599 . . . . 0.0 112.616 -178.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 64.2 t60 -136.08 99.5 4.15 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 105.352 -2.092 . . . . 0.0 105.352 170.171 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 166.39 -160.02 33.47 Favored Glycine 0 C--O 1.227 -0.309 0 N-CA-C 110.294 -1.123 . . . . 0.0 110.294 -176.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -104.32 -23.69 13.18 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 112.809 0.67 . . . . 0.0 112.809 179.302 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 52.7 mm-40 -75.07 168.04 20.75 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 177.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -95.81 -62.84 1.22 Allowed 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 177.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 51.9 tp 173.76 136.04 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 125.761 1.624 . . . . 0.0 106.887 173.459 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 54.7 tptt -155.48 139.75 16.64 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 107.934 -1.135 . . . . 0.0 107.934 172.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 14.4 m-85 -117.84 142.82 31.4 Favored Pre-proline 0 C--O 1.241 0.655 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 176.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -64.6 165.89 19.27 Favored 'Trans proline' 0 CA--C 1.54 0.825 0 C-N-CA 122.209 1.939 . . . . 0.0 114.696 176.037 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 17.1 tpt180 -62.47 133.59 55.21 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.888 -178.347 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 77.53 15.81 80.98 Favored Glycine 0 C--O 1.223 -0.542 0 CA-C-N 115.894 -0.593 . . . . 0.0 112.651 175.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -148.37 167.66 24.67 Favored 'General case' 0 N--CA 1.442 -0.862 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 -174.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 111.58 -23.49 17.58 Favored Glycine 0 CA--C 1.497 -1.08 0 C-N-CA 121.809 -0.234 . . . . 0.0 113.36 173.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 93.1 t -65.67 127.12 92.8 Favored Pre-proline 0 C--N 1.318 -0.762 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 178.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -75.21 170.03 21.25 Favored 'Trans proline' 0 N--CA 1.461 -0.425 0 O-C-N 122.102 0.527 . . . . 0.0 111.429 178.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 97.6 mt -67.95 109.57 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-O 121.931 0.872 . . . . 0.0 109.109 179.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 73.2 m-80 -99.97 87.43 3.49 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 114.756 -1.111 . . . . 0.0 109.223 -179.052 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 72.5 p -67.82 -16.35 64.06 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 -178.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 11.4 p30 -108.19 22.9 15.3 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.318 -0.856 . . . . 0.0 112.843 -177.03 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 15.3 m -138.94 152.05 47.4 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 114.729 1.381 . . . . 0.0 114.729 -175.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 67.5 m -74.86 164.97 57.74 Favored Pre-proline 0 CA--C 1.537 0.469 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.479 177.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -65.48 -24.85 56.14 Favored 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 115.341 -2.64 . . . . 0.0 114.538 -178.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.422 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 6.1 p-10 -76.45 -26.09 55.06 Favored 'General case' 0 C--N 1.324 -0.539 0 O-C-N 121.625 -0.672 . . . . 0.0 110.906 177.026 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.487 ' HA ' ' HE3' ' A' ' 103' ' ' LYS . 15.2 m-20 -75.76 -10.75 59.69 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.198 0.999 . . . . 0.0 112.952 -175.809 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 96.8 mm-40 -58.55 -29.07 66.08 Favored 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 114.782 1.401 . . . . 0.0 114.782 -176.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 11.9 tt -59.5 140.22 18.0 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.874 0 CA-C-O 122.287 1.042 . . . . 0.0 112.843 -178.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -179.34 -155.63 15.47 Favored Glycine 0 CA--C 1.506 -0.482 0 C-N-CA 120.406 -0.902 . . . . 0.0 112.49 -178.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 50.3 p90 -154.99 171.7 19.31 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 179.021 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 19.3 m-85 -112.89 140.06 48.01 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 173.304 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 69.4 ttt-85 -111.33 124.66 52.68 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.979 -177.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 37.7 ttt-85 -65.05 141.1 58.86 Favored 'General case' 0 C--N 1.322 -0.625 0 O-C-N 123.557 0.536 . . . . 0.0 109.764 177.164 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -151.03 150.42 30.72 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.997 0.427 . . . . 0.0 110.605 179.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 34.0 p -145.89 168.41 20.89 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 103.621 -2.733 . . . . 0.0 103.621 174.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 14.5 tpt180 -149.08 131.08 15.28 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.604 0.716 . . . . 0.0 111.664 175.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 37.6 mtt180 -140.98 165.82 26.5 Favored 'General case' 0 CA--C 1.493 -1.241 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 178.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -132.33 175.93 10.19 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 N-CA-C 104.24 -2.504 . . . . 0.0 104.24 -179.186 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 3.5 tmt_? -120.69 99.38 6.5 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 178.232 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -76.09 150.36 38.95 Favored Glycine 0 N--CA 1.45 -0.43 0 N-CA-C 105.627 -2.989 . . . . 0.0 105.627 173.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -63.64 -36.1 92.9 Favored Glycine 0 C--O 1.217 -0.964 0 CA-C-N 118.669 1.235 . . . . 0.0 111.718 -179.422 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.409 ' HB3' ' HE2' ' A' ' 60' ' ' LYS . 27.2 t0 -89.08 17.15 6.12 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-O 122.328 1.061 . . . . 0.0 111.433 179.586 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 85.47 14.79 67.58 Favored Glycine 0 C--O 1.223 -0.578 0 CA-C-N 115.505 -0.77 . . . . 0.0 113.575 173.239 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.409 ' HE2' ' HB3' ' A' ' 58' ' ' ASP . 49.9 mmtt -69.61 133.67 47.86 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.58 0.705 . . . . 0.0 110.59 -176.451 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 4.0 mmt -113.11 155.3 25.18 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 114.225 -1.352 . . . . 0.0 111.101 -176.322 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 1.2 mmtp -96.28 -41.95 8.41 Favored 'General case' 0 CA--C 1.5 -0.979 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 173.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 11.3 t0 45.61 57.3 5.09 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 111.206 -2.724 . . . . 0.0 115.796 176.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 64.4 mt -68.58 138.68 55.28 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 177.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -58.67 161.81 7.68 Favored Pre-proline 0 C--O 1.242 0.698 0 CA-C-N 115.316 -0.856 . . . . 0.0 112.931 -177.587 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -62.22 134.85 51.07 Favored 'Trans proline' 0 C--N 1.354 0.864 0 C-N-CA 116.814 -1.657 . . . . 0.0 112.119 179.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 20.9 mtt-85 -132.15 161.12 34.12 Favored 'General case' 0 CA--C 1.503 -0.83 0 CA-C-N 114.338 -1.301 . . . . 0.0 109.805 -175.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 70.2 m95 -134.52 143.42 47.43 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 177.24 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 70.7 m-85 -126.38 148.61 49.57 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 106.334 -1.728 . . . . 0.0 106.334 178.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 86.8 t80 -94.71 138.12 32.95 Favored 'General case' 0 CA--C 1.506 -0.727 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 -176.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 11.2 m-85 -138.86 142.19 38.61 Favored 'General case' 0 N--CA 1.438 -1.072 0 N-CA-C 106.53 -1.656 . . . . 0.0 106.53 -174.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 88.5 m-85 -80.89 159.52 24.98 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.437 0.161 . . . . 0.0 110.845 -175.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -56.12 126.69 27.13 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.9 0.381 . . . . 0.0 110.79 -177.722 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 69.29 38.63 81.74 Favored Glycine 0 C--O 1.218 -0.88 0 CA-C-O 119.106 -0.83 . . . . 0.0 114.75 176.179 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.326 -0.444 0 N-CA-C 105.623 -1.992 . . . . 0.0 105.623 177.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 17.3 mt . . . . . 0 N--CA 1.446 -0.657 0 N-CA-C 114.39 1.256 . . . . 0.0 114.39 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -78.58 164.49 25.92 Favored 'Trans proline' 0 C--O 1.235 0.374 0 C-N-CA 121.963 1.775 . . . . 0.0 108.318 169.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 57.9 t80 -61.79 132.03 51.8 Favored 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 120.396 -0.522 . . . . 0.0 110.085 -179.462 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 91.64 -5.98 79.99 Favored Glycine 0 CA--C 1.518 0.258 0 CA-C-O 119.417 -0.657 . . . . 0.0 114.493 178.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -63.5 131.24 47.49 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 118.369 1.085 . . . . 0.0 111.453 179.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 36.1 t-20 -77.87 127.3 32.16 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.496 -178.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 28.7 ttmt -156.2 151.26 26.38 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 105.508 -2.034 . . . . 0.0 105.508 178.03 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -64.66 132.14 48.89 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.085 0.469 . . . . 0.0 110.666 -178.044 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 68.29 27.31 73.8 Favored Glycine 0 N--CA 1.449 -0.439 0 CA-C-N 115.719 -0.673 . . . . 0.0 114.256 178.156 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 45.8 mm -124.84 123.42 65.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 117.419 0.609 . . . . 0.0 110.669 179.375 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.1 pt -127.16 111.94 27.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 CA-C-O 121.953 0.882 . . . . 0.0 111.762 177.051 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 95.1 m95 -77.36 136.83 38.47 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 112.983 0.734 . . . . 0.0 112.983 -177.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 17.3 m -138.86 151.61 23.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 C-N-CA 123.481 0.712 . . . . 0.0 109.824 179.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -157.01 166.59 32.93 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 105.877 -1.898 . . . . 0.0 105.877 179.494 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 14.5 t -130.34 176.34 8.21 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 105.521 -2.029 . . . . 0.0 105.521 178.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -67.58 135.07 52.35 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.162 0.506 . . . . 0.0 110.169 -179.253 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 93.19 -10.79 73.02 Favored Glycine 0 C--O 1.229 -0.182 0 CA-C-N 115.938 -0.574 . . . . 0.0 113.302 178.253 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.422 ' HA ' ' HA ' ' A' ' 41' ' ' ASP . . . -73.9 136.76 43.38 Favored 'General case' 0 CA--C 1.543 0.687 0 O-C-N 122.543 -0.387 . . . . 0.0 110.617 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 36.7 mt -95.72 139.57 31.76 Favored 'General case' 0 C--O 1.218 -0.601 0 N-CA-C 113.725 1.009 . . . . 0.0 113.725 -176.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 57.3 t30 -84.4 73.91 10.43 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.497 0.665 . . . . 0.0 110.52 179.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -146.41 159.25 45.56 Favored Pre-proline 0 C--N 1.321 -0.659 0 N-CA-C 103.024 -2.954 . . . . 0.0 103.024 179.445 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -73.27 149.95 46.38 Favored 'Trans proline' 0 CA--C 1.537 0.644 0 N-CA-C 114.061 0.754 . . . . 0.0 114.061 177.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.487 ' HE3' ' HA ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -142.29 58.69 1.46 Allowed 'General case' 0 N--CA 1.475 0.823 0 CA-C-O 122.799 1.285 . . . . 0.0 109.402 176.835 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -63.12 -23.77 67.59 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.263 -1.335 . . . . 0.0 110.963 178.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 17.9 p80 -55.87 -17.94 7.62 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 114.516 1.302 . . . . 0.0 114.516 -178.439 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 22.5 mt -88.81 -38.33 11.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 121.393 0.616 . . . . 0.0 109.842 -179.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -76.15 14.66 6.12 Favored Glycine 0 C--O 1.22 -0.767 0 N-CA-C 116.748 1.459 . . . . 0.0 116.748 -174.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 13.4 t -83.14 15.97 2.61 Favored 'General case' 0 CA--C 1.545 0.777 0 CA-C-N 117.985 0.893 . . . . 0.0 111.427 179.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.419 ' HD3' ' CD2' ' A' ' 12' ' ' TRP . 59.8 ttp85 -62.73 138.7 58.58 Favored 'General case' 0 C--N 1.327 -0.397 0 O-C-N 122.02 -0.425 . . . . 0.0 111.002 -178.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -110.28 123.64 35.41 Favored Pre-proline 0 C--O 1.236 0.342 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 177.122 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -75.06 -10.85 21.29 Favored 'Trans proline' 0 C--O 1.219 -0.453 0 N-CA-C 113.324 0.471 . . . . 0.0 113.324 -176.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -77.76 -24.96 48.83 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.045 178.012 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 75.2 m-20 -104.12 -25.56 12.9 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 113.989 1.107 . . . . 0.0 113.989 -173.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -142.67 154.55 44.44 Favored 'General case' 0 N--CA 1.433 -1.307 0 CA-C-O 121.261 0.553 . . . . 0.0 109.71 -176.301 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -92.93 142.7 27.01 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.197 -0.911 . . . . 0.0 110.206 179.321 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -68.74 147.11 52.28 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.239 0.543 . . . . 0.0 110.761 179.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 25.3 mt -81.77 138.38 19.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 -178.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 82.7 t -60.91 123.69 14.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 175.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 6.0 tt -67.66 128.82 37.87 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 -178.161 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -134.96 157.86 45.82 Favored 'General case' 0 CA--C 1.508 -0.653 0 N-CA-C 107.273 -1.38 . . . . 0.0 107.273 -177.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 13.8 mt -113.2 150.38 42.91 Favored Pre-proline 0 C--N 1.32 -0.699 0 N-CA-C 105.747 -1.946 . . . . 0.0 105.747 175.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -70.42 168.2 23.1 Favored 'Trans proline' 0 C--N 1.342 0.22 0 N-CA-C 114.143 0.786 . . . . 0.0 114.143 -176.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 49.7 tt0 -55.23 133.43 49.25 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.273 -178.032 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 89.61 -13.77 63.21 Favored Glycine 0 C--O 1.228 -0.28 0 CA-C-N 115.964 -0.562 . . . . 0.0 112.659 -179.343 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 18.6 m -106.92 128.38 54.26 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 117.356 0.578 . . . . 0.0 110.511 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 13.7 p -121.71 148.32 44.76 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.316 0.579 . . . . 0.0 112.483 -177.227 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 86.0 mt -68.52 156.26 90.99 Favored Pre-proline 0 C--N 1.326 -0.435 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 177.267 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -74.25 164.86 33.23 Favored 'Trans proline' 0 N--CA 1.461 -0.394 0 C-N-CA 117.655 -1.096 . . . . 0.0 110.941 178.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -60.13 130.46 46.77 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.174 -177.185 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 95.08 -3.93 67.28 Favored Glycine 0 C--O 1.225 -0.447 0 N-CA-C 114.823 0.689 . . . . 0.0 114.823 179.357 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -106.78 141.97 37.16 Favored 'General case' 0 CA--C 1.507 -0.703 0 CA-C-N 117.874 0.837 . . . . 0.0 110.743 179.306 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 43.7 p90 -142.53 161.29 38.44 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 114.382 -1.281 . . . . 0.0 107.983 175.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -104.86 146.98 28.25 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.652 0.739 . . . . 0.0 111.496 -177.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -74.23 127.52 33.18 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 179.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 87.94 -5.66 84.57 Favored Glycine 0 C--O 1.224 -0.523 0 CA-C-N 116.091 -0.504 . . . . 0.0 113.076 -178.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 33.7 t . . . . . 0 C--N 1.326 -0.447 0 CA-C-O 121.411 0.624 . . . . 0.0 109.379 179.572 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.239 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 41.3 t -61.13 140.9 57.79 Favored 'General case' 0 CA--C 1.513 -0.476 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 178.244 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 7.5 m95 -68.41 -21.93 64.65 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.486 178.373 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 29.8 m-85 -121.4 163.02 19.39 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 115.872 -0.604 . . . . 0.0 112.559 -171.36 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.422 ' HB ' ' HB3' ' A' ' 134' ' ' GLU . 71.7 p -71.55 163.07 28.42 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.495 -0.775 . . . . 0.0 108.926 178.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -76.81 138.05 39.62 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -176.44 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 13.8 mt -82.74 145.03 29.79 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 104.45 -2.426 . . . . 0.0 104.45 171.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 20.0 m -127.47 133.27 49.91 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 118.331 0.514 . . . . 0.0 110.597 -178.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 4.0 tp-100 -89.52 150.74 22.31 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.869 179.27 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 73.5 t60 -136.38 99.25 4.04 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 103.189 -2.893 . . . . 0.0 103.189 166.383 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 162.79 -173.07 38.97 Favored Glycine 0 N--CA 1.451 -0.328 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 -175.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 55.3 mtmt -93.34 -29.44 15.63 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 114.962 1.467 . . . . 0.0 114.962 -176.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -87.39 157.31 19.27 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 106.906 -1.516 . . . . 0.0 106.906 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -83.52 -62.75 1.5 Allowed 'General case' 0 C--O 1.218 -0.566 0 N-CA-C 115.405 1.631 . . . . 0.0 115.405 -174.881 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 56.8 tp 179.1 143.3 0.13 Allowed 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 124.356 1.062 . . . . 0.0 108.154 178.06 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 13.6 tptm -158.86 141.23 14.05 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 173.333 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 7.9 m-85 -123.56 140.57 34.42 Favored Pre-proline 0 C--N 1.324 -0.524 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 176.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -61.54 155.52 52.57 Favored 'Trans proline' 0 CA--C 1.538 0.71 0 C-N-CA 120.283 0.656 . . . . 0.0 113.206 175.343 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 16.9 tpt180 -63.68 135.66 56.89 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.604 -177.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 83.9 10.31 81.2 Favored Glycine 0 C--O 1.225 -0.452 0 C-N-CA 121.368 -0.444 . . . . 0.0 112.348 178.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -148.14 168.64 21.9 Favored 'General case' 0 N--CA 1.443 -0.792 0 N-CA-C 106.975 -1.491 . . . . 0.0 106.975 -176.504 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 110.69 -19.89 25.45 Favored Glycine 0 CA--C 1.499 -0.946 0 CA-C-O 121.14 0.3 . . . . 0.0 113.643 172.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 99.2 t -65.41 128.16 93.56 Favored Pre-proline 0 C--N 1.319 -0.756 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 178.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -74.19 170.99 18.9 Favored 'Trans proline' 0 N--CA 1.46 -0.448 0 O-C-N 122.116 0.535 . . . . 0.0 111.327 178.02 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 89.9 mt -69.34 107.32 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-O 122.155 0.978 . . . . 0.0 108.656 179.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 -98.94 84.56 3.1 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 114.278 -1.328 . . . . 0.0 109.444 -177.326 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 70.4 p -66.56 -15.03 63.11 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.687 0.756 . . . . 0.0 112.895 -178.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 20.7 p30 -109.11 20.69 18.08 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 114.93 -1.032 . . . . 0.0 112.986 -177.128 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 27.9 m -139.02 147.95 42.77 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 113.693 0.997 . . . . 0.0 113.693 -176.46 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -72.21 167.14 34.84 Favored Pre-proline 0 C--N 1.327 -0.399 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 176.292 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -64.49 -28.18 62.03 Favored 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 115.185 -2.744 . . . . 0.0 111.958 178.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -62.31 -29.21 70.28 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 123.626 0.77 . . . . 0.0 111.422 176.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.55 ' HA ' ' HE3' ' A' ' 103' ' ' LYS . 62.1 m-20 -95.28 -0.3 53.06 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 114.584 1.328 . . . . 0.0 114.584 -171.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 94.7 mm-40 -60.7 -30.89 70.23 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 114.097 1.147 . . . . 0.0 114.097 178.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 20.6 tt -59.28 140.4 17.58 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.745 0 CA-C-O 122.385 1.088 . . . . 0.0 113.64 -177.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 179.88 -154.98 14.39 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.629 -178.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 50.4 p90 -155.02 171.13 20.25 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 178.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 17.8 m-85 -113.99 142.8 45.71 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 172.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 57.9 ttt180 -112.11 129.2 56.31 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.435 -179.005 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 27.5 ttt180 -67.22 136.27 54.72 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 123.452 0.701 . . . . 0.0 110.042 177.252 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -151.31 142.67 23.39 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.733 0.301 . . . . 0.0 110.606 178.44 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 9.3 t -148.42 151.24 34.9 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 176.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 8.3 tpt180 -164.84 124.97 1.94 Allowed 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 -178.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 15.1 ptt85 -106.93 158.92 16.66 Favored 'General case' 0 CA--C 1.508 -0.652 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 175.446 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -144.4 -179.57 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.913 0 N-CA-C 104.626 -2.361 . . . . 0.0 104.626 -175.321 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 5.6 mtt-85 -138.65 124.84 20.25 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 175.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -86.14 170.88 43.7 Favored Glycine 0 C--O 1.225 -0.412 0 N-CA-C 107.82 -2.112 . . . . 0.0 107.82 175.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -79.06 -28.59 53.68 Favored Glycine 0 C--O 1.216 -1.014 0 N-CA-C 108.194 -1.963 . . . . 0.0 108.194 179.459 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.443 ' CG ' ' HZ3' ' A' ' 60' ' ' LYS . 43.2 t0 -76.22 -5.03 45.0 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-N 113.069 -1.566 . . . . 0.0 108.627 176.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 90.48 -11.72 70.54 Favored Glycine 0 CA--C 1.51 -0.277 0 CA-C-N 114.721 -1.127 . . . . 0.0 113.787 176.406 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.443 ' HZ3' ' CG ' ' A' ' 58' ' ' ASP . 0.3 OUTLIER -71.8 138.26 48.22 Favored 'General case' 0 CA--C 1.507 -0.692 0 CA-C-O 121.939 0.876 . . . . 0.0 109.868 -177.322 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 28.2 ptm -133.18 167.57 20.11 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 114.152 -1.385 . . . . 0.0 110.049 -178.398 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 29.0 mttp -75.67 -56.54 4.59 Favored 'General case' 0 C--O 1.219 -0.551 0 N-CA-C 113.814 1.042 . . . . 0.0 113.814 -177.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.6 t70 54.45 -140.13 0.96 Allowed 'General case' 0 CA--C 1.541 0.613 0 O-C-N 124.79 1.306 . . . . 0.0 110.065 -178.046 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 8.8 mt 61.11 173.84 0.11 Allowed 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 116.911 2.189 . . . . 0.0 116.911 177.463 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 36.6 m -67.52 160.79 70.35 Favored Pre-proline 0 C--O 1.238 0.497 0 CA-C-N 114.654 -1.157 . . . . 0.0 110.064 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -63.15 162.07 27.8 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 117.821 -0.986 . . . . 0.0 114.548 -179.507 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 18.5 mtp180 -108.01 160.29 15.9 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 106.801 -1.555 . . . . 0.0 106.801 -179.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 50.1 m95 -127.05 133.98 50.37 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 54.4 m-85 -114.71 141.23 48.11 Favored 'General case' 0 C--O 1.216 -0.699 0 N-CA-C 107.961 -1.125 . . . . 0.0 107.961 -177.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 88.2 t80 -89.97 134.7 34.08 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 118.474 0.579 . . . . 0.0 109.847 -177.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -137.71 147.27 44.65 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 -177.404 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -82.4 159.46 22.99 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 -173.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 16.9 tp -59.43 128.8 38.86 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.383 0.611 . . . . 0.0 109.595 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 78.23 26.66 59.32 Favored Glycine 0 C--O 1.217 -0.964 0 N-CA-C 115.704 1.042 . . . . 0.0 115.704 177.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 2.4 p . . . . . 0 C--N 1.326 -0.451 0 CA-C-N 119.093 1.447 . . . . 0.0 109.286 178.854 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 24.2 mt . . . . . 0 N--CA 1.448 -0.573 0 N-CA-C 115.212 1.56 . . . . 0.0 115.212 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -77.22 164.76 28.81 Favored 'Trans proline' 0 N--CA 1.459 -0.506 0 N-CA-C 108.002 -1.576 . . . . 0.0 108.002 170.05 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 70.0 t80 -62.62 128.57 36.6 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 120.478 -0.489 . . . . 0.0 110.584 -178.22 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 94.07 -5.5 72.03 Favored Glycine 0 CA--C 1.52 0.404 0 N-CA-C 114.851 0.7 . . . . 0.0 114.851 179.427 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -65.39 128.78 37.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 118.43 1.115 . . . . 0.0 112.314 179.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 72.2 m-20 -71.15 128.09 34.77 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 114.766 -1.107 . . . . 0.0 111.142 -178.345 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 25.2 ttmt -156.03 153.03 28.82 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 105.884 -1.895 . . . . 0.0 105.884 177.236 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 20.0 t0 -68.46 135.38 51.58 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.081 0.467 . . . . 0.0 110.12 -178.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 68.8 25.7 75.03 Favored Glycine 0 N--CA 1.447 -0.63 0 CA-C-N 115.735 -0.666 . . . . 0.0 114.133 177.488 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 42.8 mm -125.52 127.68 71.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 117.427 0.614 . . . . 0.0 109.989 179.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -129.39 115.91 37.17 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 CA-C-O 121.61 0.719 . . . . 0.0 110.202 176.64 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 97.7 m95 -82.38 134.79 35.26 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 113.773 1.027 . . . . 0.0 113.773 -175.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 20.8 m -136.6 149.81 27.01 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 CA-C-O 121.529 0.68 . . . . 0.0 110.537 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -157.03 166.56 32.98 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 103.93 -2.618 . . . . 0.0 103.93 -179.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 13.4 t -136.59 174.05 11.04 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 105.14 -2.17 . . . . 0.0 105.14 178.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -64.92 134.44 53.98 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.01 0.434 . . . . 0.0 109.971 -179.456 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 95.42 -5.86 67.87 Favored Glycine 0 C--O 1.225 -0.436 0 CA-C-N 115.992 -0.549 . . . . 0.0 113.769 178.459 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -83.15 138.25 33.73 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 122.262 -0.552 . . . . 0.0 110.46 -179.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 56.0 mt -88.79 141.11 28.77 Favored 'General case' 0 C--O 1.22 -0.485 0 CA-C-O 121.149 0.499 . . . . 0.0 111.559 -178.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -83.57 58.8 4.77 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.358 0.599 . . . . 0.0 110.98 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -139.02 158.31 69.87 Favored Pre-proline 0 C--N 1.325 -0.484 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 -177.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -73.09 158.89 48.68 Favored 'Trans proline' 0 CA--C 1.537 0.633 0 N-CA-C 115.272 1.22 . . . . 0.0 115.272 179.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.55 ' HE3' ' HA ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -154.42 57.93 0.7 Allowed 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 122.813 1.292 . . . . 0.0 109.572 177.137 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -59.04 -30.39 68.0 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.103 -1.408 . . . . 0.0 112.177 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 17.5 p80 -58.72 -11.2 2.89 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 115.091 1.515 . . . . 0.0 115.091 -177.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 33.3 mt -91.82 -32.28 5.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 178.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -71.75 -3.39 54.89 Favored Glycine 0 C--O 1.224 -0.479 0 N-CA-C 116.082 1.193 . . . . 0.0 116.082 -175.468 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 15.0 t -83.16 26.56 0.62 Allowed 'General case' 0 CA--C 1.549 0.92 0 N-CA-C 113.67 0.989 . . . . 0.0 113.67 -177.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 70.8 ttp85 -57.27 122.99 13.83 Favored 'General case' 0 N--CA 1.472 0.667 0 O-C-N 121.398 -0.814 . . . . 0.0 109.039 178.35 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 60.2 m-20 -90.0 119.08 69.35 Favored Pre-proline 0 C--N 1.324 -0.504 0 N-CA-C 107.208 -1.405 . . . . 0.0 107.208 -179.4 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -70.84 -15.93 33.02 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 117.898 -0.934 . . . . 0.0 114.117 -177.089 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -77.41 -25.76 51.05 Favored 'General case' 0 C--O 1.219 -0.503 0 CA-C-O 120.87 0.367 . . . . 0.0 110.391 178.191 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -102.8 -24.55 13.7 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 113.183 0.808 . . . . 0.0 113.183 -174.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 18.8 t30 -149.12 146.54 27.74 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -177.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -88.35 151.14 22.8 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-O 121.575 0.702 . . . . 0.0 112.356 -179.444 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -75.01 149.72 39.18 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.412 177.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 7.9 mt -90.26 139.91 16.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 -178.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 85.4 t -60.58 124.24 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 N-CA-C 106.245 -1.761 . . . . 0.0 106.245 175.339 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 6.6 tt -67.23 130.84 44.38 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.148 0.499 . . . . 0.0 110.223 -176.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -134.09 158.22 44.17 Favored 'General case' 0 CA--C 1.509 -0.605 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 -178.342 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 13.7 mt -112.49 149.77 41.6 Favored Pre-proline 0 C--N 1.322 -0.626 0 N-CA-C 105.915 -1.883 . . . . 0.0 105.915 175.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_endo -70.35 168.83 21.2 Favored 'Trans proline' 0 C--N 1.342 0.213 0 N-CA-C 114.531 0.935 . . . . 0.0 114.531 -176.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 39.4 tt0 -54.52 130.85 41.33 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.758 -178.333 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 89.97 -11.79 69.58 Favored Glycine 0 C--O 1.226 -0.357 0 CA-C-N 115.786 -0.643 . . . . 0.0 112.87 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 18.1 m -106.99 126.64 52.59 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 117.37 0.585 . . . . 0.0 110.535 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 22.8 p -118.05 148.35 42.35 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 113.261 0.837 . . . . 0.0 113.261 -177.34 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 86.2 mt -68.74 155.91 92.15 Favored Pre-proline 0 C--N 1.324 -0.504 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 176.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -75.23 166.3 29.2 Favored 'Trans proline' 0 N--CA 1.462 -0.372 0 C-N-CA 117.44 -1.24 . . . . 0.0 110.315 177.258 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -58.94 130.96 49.52 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.061 -176.383 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 95.13 -9.88 69.93 Favored Glycine 0 C--O 1.224 -0.474 0 N-CA-C 115.137 0.815 . . . . 0.0 115.137 178.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -94.4 143.4 26.43 Favored 'General case' 0 N--CA 1.439 -1.002 0 CA-C-O 122.498 1.142 . . . . 0.0 111.717 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 39.9 p90 -142.32 163.78 31.91 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 113.231 -1.804 . . . . 0.0 107.654 175.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -106.46 144.17 33.51 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.1 0.476 . . . . 0.0 111.454 -177.344 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.422 ' HB3' ' HB ' ' A' ' 14' ' ' THR . 1.6 tp10 -69.62 129.95 41.06 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 106.544 -1.65 . . . . 0.0 106.544 177.446 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 93.1 -6.3 75.95 Favored Glycine 0 C--O 1.225 -0.446 0 C-N-CA 121.325 -0.464 . . . . 0.0 113.235 -179.281 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 35.3 t . . . . . 0 C--N 1.326 -0.436 0 N-CA-C 109.125 -0.695 . . . . 0.0 109.125 177.779 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.861 0 CA-C-O 121.98 0.895 . . . . 0.0 112.388 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.8 t -54.83 137.57 44.73 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 114.325 -1.307 . . . . 0.0 108.962 174.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 15.6 m95 -64.54 -21.89 66.82 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 178.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 46.5 m-85 -121.5 159.56 26.05 Favored 'General case' 0 C--O 1.241 0.612 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 -172.087 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.433 ' HB ' ' HB3' ' A' ' 134' ' ' GLU . 76.0 p -69.12 163.6 24.44 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 114.949 -1.023 . . . . 0.0 108.861 178.831 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -81.47 141.23 34.06 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 -176.417 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 27.5 mt -78.78 148.85 32.79 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 104.64 -2.356 . . . . 0.0 104.64 170.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 30.6 m -112.95 128.59 56.53 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 179.243 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 2.6 tm0? -93.24 134.82 35.04 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.025 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 78.0 t60 -139.41 99.45 3.74 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 106.172 -1.788 . . . . 0.0 106.172 168.313 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 169.49 -166.14 39.43 Favored Glycine 0 C--O 1.226 -0.373 0 C-N-CA 120.156 -1.021 . . . . 0.0 112.574 -177.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -101.79 -24.58 14.04 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -179.447 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -91.78 153.32 19.68 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 179.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -72.4 -62.85 1.29 Allowed 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -174.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 43.0 tp 174.6 145.77 0.06 Allowed 'General case' 0 N--CA 1.483 1.212 0 N-CA-C 105.949 -1.871 . . . . 0.0 105.949 175.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 54.0 tptt -156.03 138.7 15.1 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 175.138 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 16.8 m-85 -124.88 152.68 70.27 Favored Pre-proline 0 C--O 1.243 0.752 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 174.428 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -70.31 161.47 45.9 Favored 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 120.201 0.6 . . . . 0.0 112.672 178.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 20.9 tpt180 -69.07 135.25 50.5 Favored 'General case' 0 C--O 1.216 -0.66 0 O-C-N 122.147 -0.346 . . . . 0.0 110.105 -177.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 82.34 11.49 82.05 Favored Glycine 0 C--O 1.223 -0.576 0 N-CA-C 111.785 -0.526 . . . . 0.0 111.785 179.017 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 10.6 mt-30 -150.7 170.5 19.05 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 -175.218 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 107.37 -16.28 38.2 Favored Glycine 0 CA--C 1.503 -0.69 0 C-N-CA 121.429 -0.415 . . . . 0.0 113.204 175.217 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 57.4 t -67.91 129.19 93.31 Favored Pre-proline 0 C--N 1.319 -0.739 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 177.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -74.22 163.13 37.22 Favored 'Trans proline' 0 N--CA 1.459 -0.517 0 O-C-N 122.193 0.575 . . . . 0.0 111.967 178.375 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 93.7 mt -66.49 122.95 18.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.612 -177.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.449 ' ND2' ' HH ' ' A' ' 72' ' ' TYR . 44.8 t-20 -124.74 93.43 3.89 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.693 0.758 . . . . 0.0 110.373 179.342 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 82.6 p -75.98 -16.63 59.95 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 112.953 0.723 . . . . 0.0 112.953 -175.272 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 65.5 m-80 -104.33 32.77 3.83 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.631 -174.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 82.4 p -144.88 -179.08 6.37 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 114.735 1.383 . . . . 0.0 114.735 -176.354 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 56.8 m -105.05 165.93 12.33 Favored Pre-proline 0 CA--C 1.544 0.718 0 CA-C-N 114.947 -1.024 . . . . 0.0 108.942 178.449 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_endo -68.84 -18.96 41.3 Favored 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 116.405 -1.93 . . . . 0.0 114.983 -178.292 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.421 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 5.5 p-10 -75.03 -21.38 59.1 Favored 'General case' 0 C--N 1.324 -0.526 0 O-C-N 121.728 -0.608 . . . . 0.0 111.907 179.516 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -74.18 -23.09 59.18 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 114.183 1.179 . . . . 0.0 114.183 -174.362 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 93.7 mm-40 -53.61 -26.2 20.93 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 115.57 1.692 . . . . 0.0 115.57 -171.218 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 9.1 tt -64.43 136.5 26.41 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 CA-C-O 122.553 1.168 . . . . 0.0 112.203 -179.469 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 175.49 -156.89 22.95 Favored Glycine 0 CA--C 1.502 -0.72 0 C-N-CA 120.156 -1.021 . . . . 0.0 111.863 -178.447 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 47.1 p90 -155.1 170.45 21.76 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 -179.492 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 21.9 m-85 -109.53 139.49 44.47 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 106.538 -1.652 . . . . 0.0 106.538 174.084 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 58.4 ttt-85 -113.43 120.84 42.45 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 123.698 0.799 . . . . 0.0 111.253 -176.199 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 37.9 ttp85 -69.41 140.21 54.12 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.959 0.409 . . . . 0.0 109.933 177.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -144.28 149.41 36.23 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 122.979 0.511 . . . . 0.0 110.111 179.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 15.3 t -154.29 167.01 31.37 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 176.285 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 15.7 tpt180 -147.98 129.63 15.05 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 178.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 6.1 tpp180 -133.58 138.85 46.21 Favored 'General case' 0 CA--C 1.499 -1.01 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 -178.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -138.76 174.23 10.39 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 -178.284 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 1.7 ttt-85 -122.37 118.57 28.74 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 104.894 -2.262 . . . . 0.0 104.894 175.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -71.74 172.36 46.1 Favored Glycine 0 C--O 1.221 -0.71 0 N-CA-C 109.132 -1.587 . . . . 0.0 109.132 177.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -68.89 -37.69 84.05 Favored Glycine 0 C--O 1.222 -0.647 0 N-CA-C 110.303 -1.119 . . . . 0.0 110.303 -179.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -74.53 -12.27 60.43 Favored 'General case' 0 C--O 1.214 -0.799 0 CA-C-O 122.131 0.967 . . . . 0.0 109.582 177.143 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 104.54 -7.9 46.9 Favored Glycine 0 CA--C 1.505 -0.562 0 CA-C-N 115.685 -0.689 . . . . 0.0 113.14 173.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.95 139.5 58.25 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 122.143 0.973 . . . . 0.0 112.211 -177.048 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 91.1 mmm -93.84 166.16 12.32 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 113.845 -1.525 . . . . 0.0 110.615 -177.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 10.5 tttt -79.69 -49.01 12.73 Favored 'General case' 0 C--O 1.213 -0.862 0 N-CA-C 112.978 0.732 . . . . 0.0 112.978 177.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 44.88 24.02 0.1 Allowed 'General case' 0 N--CA 1.481 1.124 0 N-CA-C 117.815 2.524 . . . . 0.0 117.815 -178.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.4 mp -76.88 152.65 35.33 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 121.451 -0.781 . . . . 0.0 110.329 177.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -59.15 150.79 60.77 Favored Pre-proline 0 C--O 1.245 0.851 0 CA-C-N 115.188 -0.914 . . . . 0.0 113.391 -178.219 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -72.53 158.66 50.63 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 117.364 -1.291 . . . . 0.0 111.166 177.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 17.1 mtp180 -125.5 162.55 24.64 Favored 'General case' 0 CA--C 1.508 -0.648 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 -178.417 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 69.6 m95 -126.31 131.98 51.73 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 178.411 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 63.0 m-85 -111.4 150.23 30.08 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 106.113 -1.81 . . . . 0.0 106.113 178.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 79.1 t80 -94.1 134.91 36.02 Favored 'General case' 0 CA--C 1.507 -0.707 0 N-CA-C 106.44 -1.689 . . . . 0.0 106.44 179.226 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 8.8 m-85 -137.59 130.08 29.63 Favored 'General case' 0 N--CA 1.439 -0.984 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 -176.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.449 ' HH ' ' ND2' ' A' ' 35' ' ' ASN . 66.5 m-85 -66.08 159.56 25.79 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 114.581 -1.19 . . . . 0.0 111.745 -176.833 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -52.54 129.12 28.13 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.009 0.433 . . . . 0.0 111.229 -179.422 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 72.94 25.87 72.62 Favored Glycine 0 C--O 1.224 -0.511 0 N-CA-C 116.189 1.236 . . . . 0.0 116.189 177.038 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 63.2 p . . . . . 0 N--CA 1.469 0.479 0 CA-C-N 118.647 1.223 . . . . 0.0 111.361 178.264 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 18.7 mt . . . . . 0 C--O 1.238 0.489 0 N-CA-C 116.314 1.968 . . . . 0.0 116.314 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -79.35 163.65 24.61 Favored 'Trans proline' 0 CA--C 1.53 0.305 0 C-N-CA 122.42 2.08 . . . . 0.0 108.296 168.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 75.0 t80 -61.51 130.86 48.01 Favored 'General case' 0 C--N 1.323 -0.555 0 O-C-N 121.88 -0.512 . . . . 0.0 111.283 -176.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 90.89 -5.95 81.95 Favored Glycine 0 C--O 1.227 -0.307 0 CA-C-O 119.286 -0.73 . . . . 0.0 114.519 178.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -64.22 130.44 43.91 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 118.438 1.119 . . . . 0.0 111.256 179.416 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 56.9 t30 -79.96 127.0 31.74 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.522 -178.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 29.8 ttmt -156.25 152.68 28.06 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 179.417 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 15.0 t0 -66.34 135.91 55.04 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 110.248 -0.279 . . . . 0.0 110.248 -179.492 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 67.14 27.18 73.4 Favored Glycine 0 N--CA 1.45 -0.403 0 CA-C-O 119.671 -0.516 . . . . 0.0 113.617 178.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 44.5 mm -129.31 128.44 66.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 121.168 0.509 . . . . 0.0 109.977 179.556 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -133.58 116.95 25.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 CA-C-O 121.359 0.6 . . . . 0.0 111.404 177.429 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 96.1 m95 -81.84 136.69 35.36 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 113.57 0.952 . . . . 0.0 113.57 -177.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 17.7 m -136.84 156.04 34.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 178.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -164.0 166.56 21.42 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 103.297 -2.853 . . . . 0.0 103.297 -179.335 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 10.8 t -137.59 -179.62 5.85 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 106.148 -1.797 . . . . 0.0 106.148 177.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -65.15 134.72 54.36 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.217 0.532 . . . . 0.0 110.56 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 92.7 -9.32 75.87 Favored Glycine 0 N--CA 1.458 0.136 0 CA-C-N 115.918 -0.583 . . . . 0.0 114.128 177.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.421 ' HA ' ' HA ' ' A' ' 41' ' ' ASP . . . -72.22 133.61 45.18 Favored 'General case' 0 CA--C 1.544 0.735 0 O-C-N 122.441 -0.446 . . . . 0.0 111.395 -179.44 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 25.6 mt -93.23 136.86 33.1 Favored 'General case' 0 CA--C 1.507 -0.711 0 CA-C-O 120.931 0.396 . . . . 0.0 111.601 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 62.8 t30 -80.58 69.47 7.09 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.215 -179.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 2.0 t -144.57 156.25 56.62 Favored Pre-proline 0 CA--C 1.541 0.599 0 N-CA-C 106.932 -1.507 . . . . 0.0 106.932 179.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -63.68 153.21 76.59 Favored 'Trans proline' 0 C--N 1.348 0.518 0 N-CA-C 114.629 0.973 . . . . 0.0 114.629 -179.121 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -125.22 41.19 3.57 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 123.289 0.636 . . . . 0.0 110.02 -179.426 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 15.5 p-10 -53.11 -43.59 67.0 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.717 -0.674 . . . . 0.0 112.314 -177.363 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 17.7 p80 -70.33 -6.56 36.06 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 114.45 1.278 . . . . 0.0 114.45 -178.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 32.0 mt -96.35 -44.88 12.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 118.075 0.398 . . . . 0.0 109.938 178.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -71.35 14.68 1.68 Allowed Glycine 0 C--O 1.223 -0.592 0 N-CA-C 116.357 1.303 . . . . 0.0 116.357 -177.22 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 15.3 t -94.3 25.71 3.71 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 -177.487 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 65.2 ttp85 -58.13 121.07 9.79 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 178.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -88.8 126.68 58.75 Favored Pre-proline 0 C--N 1.322 -0.598 0 N-CA-C 106.588 -1.634 . . . . 0.0 106.588 -177.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -73.23 -14.36 25.68 Favored 'Trans proline' 0 C--O 1.218 -0.488 0 C-N-CA 117.629 -1.114 . . . . 0.0 114.019 -177.295 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -81.56 -24.46 36.54 Favored 'General case' 0 C--O 1.22 -0.462 0 CA-C-O 121.124 0.487 . . . . 0.0 110.098 178.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 74.9 m-20 -101.82 -24.84 13.99 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 113.343 0.868 . . . . 0.0 113.343 -174.13 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 30.7 t30 -151.35 149.95 29.92 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 113.001 0.741 . . . . 0.0 113.001 -177.432 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -89.44 148.15 23.62 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-O 121.538 0.685 . . . . 0.0 111.867 179.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -71.25 147.23 48.4 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.186 178.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 18.8 mt -86.47 139.56 17.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 -179.357 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 75.0 t -62.0 123.64 15.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 N-CA-C 106.564 -1.643 . . . . 0.0 106.564 175.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 6.8 tt -67.01 127.41 32.47 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.017 0.436 . . . . 0.0 109.994 -177.37 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 33.3 mt-30 -132.76 157.16 45.64 Favored 'General case' 0 CA--C 1.511 -0.557 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 -179.254 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 13.3 mt -112.04 147.74 37.55 Favored Pre-proline 0 C--N 1.322 -0.612 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 177.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -73.04 164.63 34.98 Favored 'Trans proline' 0 C--O 1.236 0.387 0 O-C-N 122.272 0.617 . . . . 0.0 112.529 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 51.8 tt0 -55.35 133.74 49.82 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 100.34 -22.86 38.15 Favored Glycine 0 C--O 1.227 -0.337 0 CA-C-N 116.128 -0.487 . . . . 0.0 112.631 -178.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 5.0 m -107.02 128.4 54.33 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 117.961 0.88 . . . . 0.0 110.293 178.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 8.1 p -120.69 148.34 44.07 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.776 -178.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 88.4 mt -73.48 153.37 89.88 Favored Pre-proline 0 C--N 1.324 -0.517 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 177.284 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -76.51 171.2 18.49 Favored 'Trans proline' 0 C--O 1.234 0.281 0 C-N-CA 118.566 -0.489 . . . . 0.0 111.225 178.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 24.2 tptm -60.58 129.23 40.51 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 -179.301 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 91.03 18.4 47.05 Favored Glycine 0 C--O 1.223 -0.548 0 C-N-CA 120.931 -0.652 . . . . 0.0 114.655 178.262 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -127.21 141.71 51.67 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 117.596 0.698 . . . . 0.0 111.509 177.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 45.3 p90 -150.04 162.98 39.33 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 176.263 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -100.99 147.73 25.84 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.246 0.546 . . . . 0.0 111.844 -177.404 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.433 ' HB3' ' HB ' ' A' ' 14' ' ' THR . 0.9 OUTLIER -69.74 128.93 38.13 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 177.372 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 89.82 -7.31 82.0 Favored Glycine 0 C--O 1.225 -0.465 0 CA-C-N 116.315 -0.402 . . . . 0.0 113.54 179.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 34.5 t . . . . . 0 C--N 1.324 -0.516 0 CA-C-O 121.402 0.62 . . . . 0.0 110.869 179.476 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.456 -0.131 0 CA-C-O 121.379 0.609 . . . . 0.0 111.286 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 40.9 t -64.71 145.14 56.64 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 177.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 11.7 m95 -67.27 -21.91 65.69 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 122.799 0.44 . . . . 0.0 111.999 177.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 40.1 m-85 -121.4 165.56 15.38 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 114.136 1.161 . . . . 0.0 114.136 -170.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 73.6 p -71.85 163.13 28.37 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 114.63 -1.168 . . . . 0.0 108.662 177.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -74.43 141.66 45.01 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -176.434 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 11.8 mt -85.94 143.84 27.96 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 102.962 -2.977 . . . . 0.0 102.962 169.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 21.5 m -124.54 137.39 54.41 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 -177.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . 0.418 ' HB2' ' CZ ' ' A' ' 131' ' ' PHE . 4.7 tp60 -114.36 140.19 48.86 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 113.505 0.928 . . . . 0.0 113.505 -176.405 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 72.0 t60 -134.59 99.67 4.41 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 105.112 -2.181 . . . . 0.0 105.112 169.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 177.33 -169.2 41.31 Favored Glycine 0 N--CA 1.451 -0.334 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 -176.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 65.4 mttp -99.58 -26.95 13.92 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 117.398 0.599 . . . . 0.0 112.544 -179.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -85.74 158.01 20.13 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 178.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -82.46 -62.72 1.54 Allowed 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 120.786 -0.366 . . . . 0.0 111.782 -177.485 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 39.0 tp 179.62 142.55 0.14 Allowed 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 106.843 -1.54 . . . . 0.0 106.843 174.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -157.52 139.25 14.03 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 174.244 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 13.3 m-85 -123.22 151.57 62.42 Favored Pre-proline 0 C--O 1.239 0.537 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 176.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -74.28 165.55 31.58 Favored 'Trans proline' 0 CA--C 1.539 0.746 0 C-N-CA 120.058 0.505 . . . . 0.0 113.028 178.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 21.7 tpt180 -66.95 135.23 53.47 Favored 'General case' 0 C--O 1.216 -0.687 0 O-C-N 122.145 -0.347 . . . . 0.0 110.977 -177.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 82.95 4.24 90.1 Favored Glycine 0 C--O 1.223 -0.582 0 N-CA-C 111.935 -0.466 . . . . 0.0 111.935 178.156 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 40.0 mt-30 -141.79 170.6 15.4 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 123.206 0.602 . . . . 0.0 109.844 -174.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 105.61 -23.1 30.71 Favored Glycine 0 CA--C 1.498 -0.989 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.906 175.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 95.7 t -65.1 126.44 91.28 Favored Pre-proline 0 C--N 1.32 -0.694 0 N-CA-C 105.963 -1.866 . . . . 0.0 105.963 176.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -74.41 169.06 23.36 Favored 'Trans proline' 0 N--CA 1.459 -0.522 0 O-C-N 122.221 0.59 . . . . 0.0 110.912 179.168 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 92.8 mt -68.28 108.94 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 -179.435 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 75.0 m-80 -99.25 87.1 3.56 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 114.759 -1.109 . . . . 0.0 110.307 -177.243 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 73.7 p -68.73 -14.76 63.23 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.772 0.796 . . . . 0.0 112.243 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 10.8 p30 -107.34 18.8 21.15 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.861 -1.063 . . . . 0.0 113.357 -176.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 12.9 m -137.8 152.62 49.32 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 114.999 1.481 . . . . 0.0 114.999 -175.199 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.7 m -72.04 164.96 54.65 Favored Pre-proline 0 C--N 1.325 -0.482 0 CA-C-N 115.138 -0.937 . . . . 0.0 109.39 177.303 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -66.28 -27.3 48.24 Favored 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 114.858 -2.961 . . . . 0.0 113.861 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.433 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 2.1 p-10 -75.39 -22.32 57.56 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 121.57 -0.706 . . . . 0.0 110.916 177.01 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 56.4 m-20 -81.73 -7.18 59.57 Favored 'General case' 0 C--O 1.221 -0.406 0 N-CA-C 113.654 0.983 . . . . 0.0 113.654 -175.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 96.4 mm-40 -58.61 -28.18 65.38 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 113.797 1.036 . . . . 0.0 113.797 -178.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 9.8 tt -58.71 139.53 18.27 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.877 0 CA-C-O 122.302 1.049 . . . . 0.0 113.251 -179.214 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -179.88 -157.7 20.58 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.457 -0.878 . . . . 0.0 112.742 -179.509 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 41.6 p90 -155.06 171.75 19.25 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 179.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 20.2 m-85 -113.3 138.65 49.71 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 173.585 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 50.7 ttt180 -109.3 127.14 54.06 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.006 -178.3 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 40.8 ttt-85 -66.78 140.66 57.85 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 177.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -147.05 146.61 30.07 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.51 0.672 . . . . 0.0 111.361 179.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 21.2 p -144.31 157.65 44.16 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 104.235 -2.506 . . . . 0.0 104.235 175.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 19.0 tpp85 -147.3 125.68 12.34 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 118.296 0.498 . . . . 0.0 110.282 178.18 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 6.0 tmm_? -147.36 139.23 24.21 Favored 'General case' 0 CA--C 1.492 -1.282 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 179.431 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -132.56 179.1 4.71 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 N-CA-C 105.461 -2.052 . . . . 0.0 105.461 -178.529 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 56.1 ttp180 -120.96 113.61 20.35 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 106.855 -1.535 . . . . 0.0 106.855 172.479 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -95.98 147.36 18.62 Favored Glycine 0 C--N 1.317 -0.488 0 N-CA-C 106.114 -2.794 . . . . 0.0 106.114 177.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -63.92 -33.33 86.94 Favored Glycine 0 C--O 1.216 -0.969 0 CA-C-N 118.459 1.13 . . . . 0.0 111.584 -179.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 38.5 t0 -89.95 17.04 7.22 Favored 'General case' 0 CA--C 1.549 0.918 0 CA-C-O 122.263 1.03 . . . . 0.0 111.308 179.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 81.04 22.91 60.23 Favored Glycine 0 C--O 1.226 -0.404 0 CA-C-O 121.798 0.666 . . . . 0.0 113.823 172.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 21.9 mmtt -85.74 149.4 25.31 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.745 0.783 . . . . 0.0 112.26 -174.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 15.6 mtp -115.38 -179.89 3.77 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 113.824 -1.535 . . . . 0.0 110.886 -177.141 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -119.86 -65.4 1.16 Allowed 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 113.626 0.973 . . . . 0.0 113.626 -177.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -130.18 159.21 37.52 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 103.525 -2.768 . . . . 0.0 103.525 177.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 93.5 mt -121.22 -70.7 0.77 Allowed 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 120.769 0.318 . . . . 0.0 111.306 -179.49 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 16.0 m -67.73 152.72 96.07 Favored Pre-proline 0 C--O 1.239 0.55 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.13 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -68.2 148.15 74.12 Favored 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 116.99 -1.54 . . . . 0.0 111.858 178.146 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 34.6 mtt180 -128.7 164.13 23.61 Favored 'General case' 0 CA--C 1.508 -0.641 0 CA-C-N 115.923 -0.581 . . . . 0.0 112.477 -178.2 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 73.0 m95 -134.58 145.94 49.16 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 178.134 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 22.1 m-85 -128.24 141.95 51.3 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 106.327 -1.731 . . . . 0.0 106.327 179.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 76.4 t80 -88.8 136.68 32.88 Favored 'General case' 0 CA--C 1.507 -0.702 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 -177.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -140.52 135.73 32.18 Favored 'General case' 0 N--CA 1.439 -1.0 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 -175.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 84.8 m-85 -73.26 159.5 33.33 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.425 -174.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -54.38 126.1 22.01 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.121 0.486 . . . . 0.0 111.545 -177.253 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 68.38 36.01 83.36 Favored Glycine 0 N--CA 1.448 -0.544 0 CA-C-O 119.048 -0.862 . . . . 0.0 114.326 176.45 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.3 p . . . . . 0 C--N 1.325 -0.46 0 N-CA-C 106.619 -1.622 . . . . 0.0 106.619 176.145 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 14.4 mt . . . . . 0 N--CA 1.443 -0.814 0 N-CA-C 115.076 1.509 . . . . 0.0 115.076 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -79.01 163.27 25.77 Favored 'Trans proline' 0 N--CA 1.462 -0.359 0 C-N-CA 122.352 2.035 . . . . 0.0 107.706 167.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 58.4 t80 -61.8 132.03 51.77 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 120.329 -0.549 . . . . 0.0 110.352 -178.027 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 90.94 -5.71 81.91 Favored Glycine 0 C--O 1.226 -0.362 0 CA-C-O 119.37 -0.683 . . . . 0.0 114.408 178.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -66.35 130.33 42.84 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 118.582 1.191 . . . . 0.0 111.117 179.126 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 57.5 t30 -77.11 128.07 33.78 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.24 -179.252 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 30.1 ttmt -156.17 151.78 27.07 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 179.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 29.4 t0 -64.81 132.38 49.34 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.933 0.397 . . . . 0.0 110.36 -178.398 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 68.1 28.83 73.24 Favored Glycine 0 N--CA 1.451 -0.351 0 CA-C-O 119.447 -0.64 . . . . 0.0 114.281 178.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 44.7 mm -128.3 127.56 67.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 117.465 0.632 . . . . 0.0 110.61 179.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -131.29 118.83 41.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.997 176.193 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 95.9 m95 -84.99 137.25 33.2 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 113.499 0.925 . . . . 0.0 113.499 -176.584 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 15.9 m -137.79 149.71 25.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.43 0.633 . . . . 0.0 109.856 179.488 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -157.81 166.43 32.74 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 105.43 -2.063 . . . . 0.0 105.43 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 14.7 t -131.34 179.84 5.78 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 105.94 -1.874 . . . . 0.0 105.94 178.492 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -67.54 135.38 52.89 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.231 0.539 . . . . 0.0 110.436 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 90.72 -9.33 78.01 Favored Glycine 0 C--O 1.23 -0.133 0 CA-C-N 115.932 -0.576 . . . . 0.0 113.513 177.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.433 ' HA ' ' HA ' ' A' ' 41' ' ' ASP . . . -73.15 131.43 42.03 Favored 'General case' 0 CA--C 1.544 0.733 0 O-C-N 122.525 -0.397 . . . . 0.0 110.646 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 26.7 mt -91.58 139.24 30.89 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 113.117 0.784 . . . . 0.0 113.117 -177.485 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 53.4 t30 -84.01 73.09 10.4 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.361 -179.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 1.3 t -142.23 152.33 60.81 Favored Pre-proline 0 C--N 1.323 -0.566 0 N-CA-C 107.551 -1.278 . . . . 0.0 107.551 179.131 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -66.45 149.18 84.68 Favored 'Trans proline' 0 CA--C 1.528 0.221 0 N-CA-C 114.278 0.838 . . . . 0.0 114.278 177.05 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -148.97 57.55 1.03 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.852 0.834 . . . . 0.0 112.733 179.124 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 32.0 t0 -60.51 -20.3 59.7 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.577 176.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 15.6 p80 -59.94 -10.98 4.67 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 113.543 0.942 . . . . 0.0 113.543 179.135 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 41.3 mt -96.21 -30.14 3.92 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 CA-C-O 120.698 0.285 . . . . 0.0 110.78 179.153 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -75.13 4.8 37.5 Favored Glycine 0 N--CA 1.462 0.413 0 N-CA-C 115.375 0.91 . . . . 0.0 115.375 -176.122 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 14.6 t -83.1 15.83 2.65 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 113.991 1.108 . . . . 0.0 113.991 -177.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 62.6 ttp85 -63.84 126.84 28.91 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 177.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -108.56 134.59 20.21 Favored Pre-proline 0 C--N 1.323 -0.551 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_endo -69.05 -18.22 40.47 Favored 'Trans proline' 0 C--O 1.218 -0.49 0 N-CA-C 114.934 1.09 . . . . 0.0 114.934 -175.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -77.03 -24.15 52.09 Favored 'General case' 0 C--O 1.221 -0.41 0 CA-C-O 121.106 0.479 . . . . 0.0 110.085 178.31 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -99.32 -28.48 13.28 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.64 -0.709 . . . . 0.0 112.848 -175.188 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 21.9 t30 -155.68 147.26 22.93 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 -178.343 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -84.1 145.55 28.38 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-O 121.44 0.638 . . . . 0.0 111.638 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -69.54 145.54 52.54 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.208 0.527 . . . . 0.0 110.525 178.389 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 18.3 mt -86.54 138.22 19.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 -178.445 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 92.5 t -61.24 124.03 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 N-CA-C 105.912 -1.885 . . . . 0.0 105.912 175.235 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 6.3 tt -66.4 128.78 37.5 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.155 0.502 . . . . 0.0 110.038 -176.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 -132.84 156.02 47.93 Favored 'General case' 0 CA--C 1.508 -0.659 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 -178.606 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 13.2 mt -111.75 148.87 39.83 Favored Pre-proline 0 C--N 1.322 -0.629 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 177.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -72.96 164.26 36.06 Favored 'Trans proline' 0 N--CA 1.462 -0.361 0 C-N-CA 118.079 -0.814 . . . . 0.0 112.575 -179.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -55.17 130.98 44.16 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 104.31 -23.77 30.84 Favored Glycine 0 C--O 1.226 -0.402 0 CA-C-N 116.01 -0.541 . . . . 0.0 112.538 -178.524 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 7.7 m -108.4 129.71 55.25 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 118.137 0.968 . . . . 0.0 111.23 178.308 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 4.7 p -119.73 148.33 43.53 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.572 179.067 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 80.4 mt -69.75 154.81 94.42 Favored Pre-proline 0 C--N 1.324 -0.539 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 178.115 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -76.78 168.77 22.98 Favored 'Trans proline' 0 C--O 1.233 0.232 0 C-N-CA 117.775 -1.017 . . . . 0.0 110.5 176.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 7.5 tmtm? -57.74 130.56 46.96 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.967 0.413 . . . . 0.0 111.863 -175.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 95.14 -6.99 69.32 Favored Glycine 0 C--O 1.235 0.204 0 CA-C-N 115.461 -0.791 . . . . 0.0 114.907 177.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.418 ' CZ ' ' HB2' ' A' ' 18' ' ' GLN . 2.5 m-85 -95.99 138.6 33.39 Favored 'General case' 0 CA--C 1.502 -0.877 0 CA-C-O 122.086 0.946 . . . . 0.0 111.126 179.818 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 38.6 p90 -142.64 160.28 40.6 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 113.583 -1.644 . . . . 0.0 107.867 175.106 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -102.5 144.89 30.36 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.121 0.486 . . . . 0.0 111.189 -177.445 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -71.87 136.14 46.85 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 106.63 -1.619 . . . . 0.0 106.63 177.567 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 86.13 -2.63 87.6 Favored Glycine 0 C--O 1.227 -0.333 0 C-N-CA 121.211 -0.519 . . . . 0.0 112.545 -177.201 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 8.2 t . . . . . 0 C--N 1.326 -0.425 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 177.722 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.456 -0.151 0 CA-C-O 120.885 0.374 . . . . 0.0 110.974 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 26.6 t -60.32 137.03 58.2 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 176.393 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 9.8 m95 -70.83 -23.19 62.3 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.963 0.411 . . . . 0.0 111.18 178.451 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 24.8 m-85 -121.4 158.39 28.41 Favored 'General case' 0 C--O 1.241 0.634 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -171.128 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.423 ' HB ' ' HB3' ' A' ' 134' ' ' GLU . 72.0 p -69.06 163.34 24.93 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.012 -0.994 . . . . 0.0 109.189 179.153 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -74.78 145.27 43.07 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 113.333 0.864 . . . . 0.0 113.333 -175.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 16.5 mt -85.74 148.9 25.64 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 103.754 -2.684 . . . . 0.0 103.754 169.349 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 31.0 m -124.86 128.97 49.49 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 178.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -82.42 137.26 34.75 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.018 179.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 72.0 t60 -139.32 94.93 2.85 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 104.085 -2.561 . . . . 0.0 104.085 168.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 163.74 -143.04 8.26 Favored Glycine 0 C--O 1.225 -0.437 0 C-N-CA 120.628 -0.796 . . . . 0.0 111.975 -175.561 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 54.7 mtpt -120.39 -25.56 5.59 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 116.98 2.215 . . . . 0.0 116.98 -175.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -94.41 159.37 15.14 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 117.861 0.3 . . . . 0.0 110.736 -176.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -63.07 -62.85 1.43 Allowed 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 111.999 0.37 . . . . 0.0 111.999 -178.217 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 51.3 tp 165.28 141.94 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.111 0 N-CA-C 103.849 -2.648 . . . . 0.0 103.849 178.51 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 23.3 tptm -156.76 140.66 16.2 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 118.242 0.474 . . . . 0.0 109.813 176.034 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 26.1 m-85 -126.89 150.43 71.66 Favored Pre-proline 0 C--N 1.324 -0.538 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 175.435 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -77.2 165.79 27.38 Favored 'Trans proline' 0 CA--C 1.538 0.697 0 C-N-CA 120.395 0.73 . . . . 0.0 112.571 177.382 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 75.7 ttt180 -66.81 136.37 55.34 Favored 'General case' 0 N--CA 1.472 0.649 0 O-C-N 122.107 -0.37 . . . . 0.0 110.318 -179.201 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 85.56 6.38 83.45 Favored Glycine 0 C--O 1.222 -0.596 0 N-CA-C 111.498 -0.641 . . . . 0.0 111.498 178.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.529 HE22 HG21 ' A' ' 125' ' ' THR . 23.3 mt-30 -146.25 170.55 16.53 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 -175.354 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 103.28 -21.64 38.89 Favored Glycine 0 CA--C 1.499 -0.952 0 CA-C-N 115.772 -0.649 . . . . 0.0 114.017 173.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 92.7 t -65.71 128.52 93.87 Favored Pre-proline 0 C--N 1.319 -0.739 0 N-CA-C 106.468 -1.679 . . . . 0.0 106.468 177.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -71.91 171.7 16.06 Favored 'Trans proline' 0 C--O 1.22 -0.384 0 O-C-N 122.183 0.57 . . . . 0.0 111.221 177.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 92.1 mt -71.09 106.36 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 179.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -96.44 84.2 3.67 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 114.399 -1.273 . . . . 0.0 109.318 -176.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 67.8 p -66.97 -14.72 63.14 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.69 0.757 . . . . 0.0 112.749 -178.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 10.6 p30 -106.18 20.32 19.14 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 114.906 -1.043 . . . . 0.0 112.441 -177.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 15.1 m -139.91 151.23 45.43 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 114.886 1.439 . . . . 0.0 114.886 -175.259 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 2.2 m -72.24 166.33 42.37 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.314 176.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -66.27 -25.97 49.34 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 114.964 -2.891 . . . . 0.0 114.19 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.446 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 3.3 p-10 -77.53 -21.43 52.64 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 121.51 -0.744 . . . . 0.0 110.83 177.491 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 70.7 m-20 -81.39 -7.14 59.53 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 113.69 0.996 . . . . 0.0 113.69 -175.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 96.1 mm-40 -58.6 -26.5 63.74 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 114.262 1.208 . . . . 0.0 114.262 -178.44 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 9.9 tt -58.66 138.31 19.86 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.958 0 N-CA-C 113.87 1.063 . . . . 0.0 113.87 -178.246 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -179.72 -156.98 19.12 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.746 -0.74 . . . . 0.0 111.903 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 42.8 p90 -155.16 171.06 20.41 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 178.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 23.5 m-85 -113.96 142.22 46.42 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 106.924 -1.51 . . . . 0.0 106.924 173.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 52.7 ttt180 -115.06 126.9 55.24 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.668 -178.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 10.1 ttp85 -70.05 133.06 46.8 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 176.22 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -115.51 123.55 48.82 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 176.267 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -153.2 144.31 23.01 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 114.974 -1.012 . . . . 0.0 108.546 -179.339 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 22.7 tpp180 -153.98 123.82 6.77 Favored 'General case' 0 C--O 1.217 -0.646 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 175.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.56 145.63 48.16 Favored 'General case' 0 CA--C 1.49 -1.334 0 CA-C-O 121.684 0.754 . . . . 0.0 110.895 179.356 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -142.79 176.41 3.48 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.959 0 N-CA-C 104.389 -2.448 . . . . 0.0 104.389 178.537 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 5.5 tmm_? -128.07 99.21 5.39 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 106.238 -1.764 . . . . 0.0 106.238 175.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -70.04 146.93 43.79 Favored Glycine 0 N--CA 1.451 -0.364 0 N-CA-C 108.878 -1.689 . . . . 0.0 108.878 178.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -63.06 -33.43 87.22 Favored Glycine 0 C--O 1.215 -1.048 0 C-N-CA 120.453 -0.88 . . . . 0.0 110.981 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 27.2 t0 -90.06 17.63 6.71 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-O 121.936 0.874 . . . . 0.0 111.598 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 86.6 -7.0 81.21 Favored Glycine 0 N--CA 1.462 0.391 0 N-CA-C 116.326 1.291 . . . . 0.0 116.326 174.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.71 128.44 36.29 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 114.211 1.189 . . . . 0.0 114.211 -178.159 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 98.3 mmm -96.56 177.95 5.5 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 106.503 -1.666 . . . . 0.0 106.503 176.304 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 6.6 tmtt? -103.63 -57.23 2.07 Favored 'General case' 0 CA--C 1.507 -0.675 0 CA-C-O 121.474 0.654 . . . . 0.0 110.49 177.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 25.4 p30 -133.8 170.34 15.72 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 178.395 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -125.02 -53.58 1.63 Allowed 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 179.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 25.9 t -108.09 147.43 35.51 Favored Pre-proline 0 C--O 1.24 0.558 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 178.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -72.93 155.13 53.35 Favored 'Trans proline' 0 C--O 1.24 0.612 0 N-CA-C 115.376 1.26 . . . . 0.0 115.376 -178.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 25.5 mtp180 -115.45 161.57 18.39 Favored 'General case' 0 CA--C 1.509 -0.604 0 N-CA-C 106.651 -1.611 . . . . 0.0 106.651 173.304 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 61.0 m95 -129.81 142.76 50.63 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 178.196 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 53.8 m-85 -123.89 144.37 49.8 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 179.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 86.1 t80 -93.55 138.02 32.24 Favored 'General case' 0 CA--C 1.511 -0.54 0 N-CA-C 108.415 -0.958 . . . . 0.0 108.415 -177.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -141.49 143.14 33.67 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 -177.522 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -76.66 159.48 30.2 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.794 -0.639 . . . . 0.0 112.23 -176.05 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -55.08 131.22 44.53 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.571 -179.391 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 77.53 25.03 63.95 Favored Glycine 0 C--O 1.22 -0.719 0 N-CA-C 115.921 1.128 . . . . 0.0 115.921 176.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 7.4 p . . . . . 0 C--N 1.325 -0.467 0 CA-C-N 118.46 1.13 . . . . 0.0 109.364 179.01 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 21.2 mt . . . . . 0 C--O 1.237 0.425 0 N-CA-C 115.319 1.6 . . . . 0.0 115.319 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -77.06 164.22 29.82 Favored 'Trans proline' 0 N--CA 1.461 -0.43 0 N-CA-C 108.213 -1.495 . . . . 0.0 108.213 169.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 57.1 t80 -61.19 132.43 53.67 Favored 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 120.594 -0.442 . . . . 0.0 110.074 -179.073 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 91.63 -7.65 79.46 Favored Glycine 0 CA--C 1.52 0.349 0 N-CA-C 114.683 0.633 . . . . 0.0 114.683 178.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -64.89 131.74 47.52 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 118.267 1.034 . . . . 0.0 111.682 179.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 34.3 t-20 -77.27 128.56 34.55 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.764 -177.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 20.5 ttmt -156.14 150.93 26.09 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 106.41 -1.7 . . . . 0.0 106.41 177.398 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -65.09 133.64 52.06 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.823 0.344 . . . . 0.0 110.168 -179.363 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 69.87 24.98 76.1 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 121.018 -0.611 . . . . 0.0 114.181 177.463 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 39.1 mm -126.31 127.4 70.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 117.335 0.568 . . . . 0.0 109.682 178.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.1 pt -131.32 116.73 33.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 CA-C-O 121.752 0.787 . . . . 0.0 110.268 176.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 94.8 m95 -82.52 137.12 34.7 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.081 -0.509 . . . . 0.0 112.355 -177.01 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 16.4 m -137.83 149.7 25.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.646 0.736 . . . . 0.0 110.186 179.39 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -157.91 165.59 34.81 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 104.093 -2.558 . . . . 0.0 104.093 179.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 14.3 t -130.18 178.85 6.25 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 105.467 -2.049 . . . . 0.0 105.467 179.018 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -67.39 134.98 52.47 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.178 0.513 . . . . 0.0 109.849 -179.555 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 92.89 -12.38 70.04 Favored Glycine 0 C--O 1.227 -0.284 0 CA-C-N 115.92 -0.582 . . . . 0.0 113.255 178.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.446 ' HA ' ' HA ' ' A' ' 41' ' ' ASP . . . -70.16 130.7 42.79 Favored 'General case' 0 CA--C 1.542 0.668 0 O-C-N 122.56 -0.376 . . . . 0.0 110.644 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 24.4 mt -90.33 140.4 29.74 Favored 'General case' 0 C--O 1.219 -0.518 0 CA-C-O 121.392 0.615 . . . . 0.0 112.137 -178.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 58.6 t30 -84.14 70.12 10.48 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.681 -179.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 1.1 t -140.78 153.39 67.67 Favored Pre-proline 0 C--N 1.323 -0.559 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 179.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -68.0 152.35 76.87 Favored 'Trans proline' 0 C--N 1.343 0.26 0 N-CA-C 114.249 0.827 . . . . 0.0 114.249 177.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -152.08 55.15 0.82 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 122.904 1.335 . . . . 0.0 110.896 178.232 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 15.0 p-10 -58.67 -32.51 69.18 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 113.635 -1.62 . . . . 0.0 110.695 177.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 30.9 p-80 -58.94 -16.67 18.91 Favored 'General case' 0 C--O 1.218 -0.591 0 N-CA-C 114.429 1.27 . . . . 0.0 114.429 -179.043 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 75.0 mt -79.93 -33.39 14.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 178.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -76.97 11.21 15.87 Favored Glycine 0 C--O 1.225 -0.422 0 N-CA-C 116.006 1.163 . . . . 0.0 116.006 -176.216 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 15.2 t -83.06 25.19 0.71 Allowed 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 118.224 1.012 . . . . 0.0 112.021 -177.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.421 ' HD2' ' OD1' ' A' ' 114' ' ' ASN . 66.1 ttp85 -62.35 125.28 23.36 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 121.736 -0.602 . . . . 0.0 111.301 -178.549 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 7.8 m120 -88.38 115.63 63.84 Favored Pre-proline 0 C--N 1.326 -0.427 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 179.01 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -73.1 -11.22 25.14 Favored 'Trans proline' 0 C--O 1.218 -0.496 0 C-N-CA 117.963 -0.891 . . . . 0.0 114.233 -177.569 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -81.49 -24.47 36.69 Favored 'General case' 0 C--O 1.22 -0.46 0 CA-C-O 121.002 0.43 . . . . 0.0 110.086 177.341 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -99.84 -30.37 12.08 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.779 -0.646 . . . . 0.0 112.383 -175.239 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . 0.421 ' OD1' ' HD2' ' A' ' 109' ' ' ARG . 0.5 OUTLIER -131.97 151.08 51.95 Favored 'General case' 0 N--CA 1.437 -1.075 0 CA-C-O 121.338 0.59 . . . . 0.0 111.623 -178.31 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -94.82 137.55 33.75 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.084 -0.962 . . . . 0.0 108.852 176.421 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -63.66 146.14 54.37 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.405 0.621 . . . . 0.0 111.208 -179.392 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 24.1 mt -82.04 134.2 27.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.155 -178.009 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 67.7 t -60.1 123.28 12.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 N-CA-C 105.879 -1.897 . . . . 0.0 105.879 174.435 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 6.3 tt -66.26 127.58 32.78 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.488 0.661 . . . . 0.0 110.28 -176.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 34.5 mt-30 -132.71 162.12 32.25 Favored 'General case' 0 CA--C 1.511 -0.527 0 N-CA-C 106.277 -1.749 . . . . 0.0 106.277 -178.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 17.2 mt -117.51 147.67 41.24 Favored Pre-proline 0 C--N 1.321 -0.633 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 178.174 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -73.75 173.37 14.07 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 120.662 0.908 . . . . 0.0 114.156 -177.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 56.5 tt0 -54.22 133.15 44.51 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.152 -179.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 88.25 -15.23 56.97 Favored Glycine 0 C--O 1.227 -0.295 0 CA-C-N 116.045 -0.525 . . . . 0.0 113.651 179.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.529 HG21 HE22 ' A' ' 30' ' ' GLN . 12.6 m -108.6 126.1 52.58 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 117.886 0.843 . . . . 0.0 110.445 -179.437 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 9.3 p -123.46 148.33 46.3 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.995 -178.178 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 91.9 mt -66.49 153.41 93.13 Favored Pre-proline 0 C--N 1.326 -0.452 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 177.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -76.03 169.53 21.91 Favored 'Trans proline' 0 N--CA 1.461 -0.396 0 C-N-CA 118.154 -0.764 . . . . 0.0 111.074 -179.205 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 58.7 tttp -59.7 126.75 28.82 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 179.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 89.36 30.76 12.96 Favored Glycine 0 C--O 1.225 -0.42 0 N-CA-C 115.947 1.139 . . . . 0.0 115.947 178.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -140.57 149.15 42.03 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 117.811 0.806 . . . . 0.0 111.35 177.113 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 46.2 p90 -149.42 164.51 34.78 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 107.216 -1.402 . . . . 0.0 107.216 175.485 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -106.72 149.97 26.75 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.228 0.537 . . . . 0.0 110.926 -178.562 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.423 ' HB3' ' HB ' ' A' ' 14' ' ' THR . 0.9 OUTLIER -71.67 131.32 42.99 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 108.293 -1.002 . . . . 0.0 108.293 179.462 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 81.88 2.29 90.51 Favored Glycine 0 C--O 1.225 -0.455 0 C-N-CA 121.23 -0.51 . . . . 0.0 112.708 -179.379 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 6.9 t . . . . . 0 C--N 1.325 -0.483 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 179.383 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 0.227 0 CA-C-O 121.252 0.548 . . . . 0.0 109.549 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 42.1 t -59.22 142.29 52.16 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.57 177.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 14.9 m95 -64.85 -23.33 67.2 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 113.132 0.79 . . . . 0.0 113.132 178.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 43.3 m-85 -121.48 164.16 17.63 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 113.284 0.846 . . . . 0.0 113.284 -170.132 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 66.9 p -70.16 163.63 25.91 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 108.199 -1.038 . . . . 0.0 108.199 178.457 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -73.8 149.96 41.35 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.425 0.631 . . . . 0.0 111.569 -176.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 12.2 mt -89.86 137.82 32.01 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 102.859 -3.015 . . . . 0.0 102.859 168.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 49.4 m -113.82 126.72 55.52 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -77.57 136.4 38.28 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 178.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 32.3 t60 -139.23 94.87 2.85 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 104.786 -2.302 . . . . 0.0 104.786 170.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 152.26 -134.69 4.65 Favored Glycine 0 C--O 1.227 -0.293 0 C-N-CA 120.245 -0.979 . . . . 0.0 112.671 -175.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -126.73 -24.77 3.49 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 116.963 2.208 . . . . 0.0 116.963 -176.275 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -73.44 156.45 38.25 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 178.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -77.24 -58.31 3.35 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 178.396 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 62.4 tp 167.52 137.37 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.177 0 N-CA-C 104.772 -2.307 . . . . 0.0 104.772 173.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 22.9 tptm -157.64 142.53 16.68 Favored 'General case' 0 C--O 1.221 -0.44 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 176.11 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 27.9 m-85 -127.67 151.26 75.03 Favored Pre-proline 0 C--O 1.24 0.577 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 176.128 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -72.2 156.8 54.94 Favored 'Trans proline' 0 C--N 1.351 0.686 0 O-C-N 122.107 0.53 . . . . 0.0 111.996 176.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.67 134.34 52.06 Favored 'General case' 0 N--CA 1.472 0.637 0 O-C-N 121.986 -0.446 . . . . 0.0 110.487 -178.161 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 90.67 1.85 73.43 Favored Glycine 0 N--CA 1.46 0.295 0 N-CA-C 111.174 -0.77 . . . . 0.0 111.174 179.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 30.7 mt-30 -144.33 170.49 15.91 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 123.846 0.858 . . . . 0.0 108.902 -175.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 107.3 -17.42 37.26 Favored Glycine 0 CA--C 1.498 -0.981 0 CA-C-N 116.059 -0.518 . . . . 0.0 113.369 173.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 57.2 t -67.39 129.17 93.73 Favored Pre-proline 0 C--N 1.319 -0.722 0 N-CA-C 105.767 -1.938 . . . . 0.0 105.767 176.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -71.73 171.01 17.31 Favored 'Trans proline' 0 N--CA 1.459 -0.505 0 O-C-N 122.196 0.577 . . . . 0.0 111.2 178.146 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 95.0 mt -71.09 107.44 2.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 179.529 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 -93.11 84.33 4.83 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 114.175 -1.375 . . . . 0.0 109.354 -177.386 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 81.0 p -66.9 -15.06 63.41 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 114.003 1.112 . . . . 0.0 114.003 -177.101 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -111.39 17.28 20.29 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.282 -0.872 . . . . 0.0 112.846 -176.42 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -140.73 169.78 16.99 Favored 'General case' 0 CA--C 1.543 0.673 0 N-CA-C 115.891 1.812 . . . . 0.0 115.891 -171.855 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 35.4 m -94.41 161.35 29.48 Favored Pre-proline 0 C--O 1.218 -0.597 0 C-N-CA 124.343 1.057 . . . . 0.0 112.592 -174.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -65.24 -24.71 58.1 Favored 'Trans proline' 0 CA--C 1.535 0.557 0 C-N-CA 115.474 -2.551 . . . . 0.0 115.572 -178.249 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -75.16 -24.42 57.91 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 121.551 -0.718 . . . . 0.0 111.921 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 15.5 p30 -95.07 1.0 54.94 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 115.021 1.489 . . . . 0.0 115.021 -171.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 82.7 mm-40 -56.96 -24.09 50.44 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.591 -0.731 . . . . 0.0 112.8 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 11.3 tt -61.14 136.98 24.14 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.805 0 CA-C-O 122.533 1.158 . . . . 0.0 112.652 179.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 178.23 -156.35 19.11 Favored Glycine 0 N--CA 1.448 -0.527 0 N-CA-C 111.187 -0.765 . . . . 0.0 111.187 -178.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 45.3 p90 -155.15 172.11 18.69 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 179.278 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 14.3 m-85 -113.14 138.75 49.48 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 173.12 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 54.4 ttt-85 -108.12 124.69 50.62 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.549 -178.055 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 43.8 ttt180 -63.75 135.98 57.09 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 176.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -135.67 127.03 28.45 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.5 0.667 . . . . 0.0 111.928 -179.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 11.3 p -137.21 131.16 32.05 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 176.505 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 10.5 tpp180 -167.38 135.71 2.54 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 178.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 45.2 mtt180 -121.13 165.81 14.82 Favored 'General case' 0 CA--C 1.497 -1.071 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 177.277 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -134.79 173.97 13.68 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 N-CA-C 104.707 -2.331 . . . . 0.0 104.707 -179.844 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.31 109.03 7.5 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 175.421 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -77.73 159.64 48.09 Favored Glycine 0 C--O 1.228 -0.228 0 N-CA-C 107.263 -2.335 . . . . 0.0 107.263 176.353 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -58.12 -42.05 94.97 Favored Glycine 0 C--O 1.224 -0.527 0 CA-C-N 118.464 1.132 . . . . 0.0 112.082 -178.366 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.7 t0 -80.07 17.16 1.04 Allowed 'General case' 0 CA--C 1.548 0.881 0 CA-C-O 122.278 1.037 . . . . 0.0 112.658 -179.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 85.03 14.94 68.27 Favored Glycine 0 CA--C 1.504 -0.605 0 CA-C-N 115.417 -0.811 . . . . 0.0 113.179 171.314 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 33.3 mmtt -76.34 128.26 34.5 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.128 0.49 . . . . 0.0 110.374 -175.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 93.6 mmm -116.52 157.99 24.35 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 108.002 -1.111 . . . . 0.0 108.002 -178.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 14.0 tppt? -84.51 -43.46 14.54 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 106.638 -1.615 . . . . 0.0 106.638 176.274 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.5 t70 53.26 -145.53 0.59 Allowed 'General case' 0 C--O 1.241 0.623 0 CA-C-N 114.616 -1.174 . . . . 0.0 111.076 177.395 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.2 mm? 67.17 173.93 0.26 Allowed 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 116.062 1.875 . . . . 0.0 116.062 175.353 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -67.97 169.28 10.13 Favored Pre-proline 0 C--O 1.24 0.574 0 CA-C-N 113.962 -1.472 . . . . 0.0 113.91 -176.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -67.49 155.86 68.53 Favored 'Trans proline' 0 C--N 1.354 0.846 0 C-N-CA 116.107 -2.128 . . . . 0.0 112.659 177.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.31 160.1 21.65 Favored 'General case' 0 CA--C 1.505 -0.764 0 N-CA-C 105.377 -2.083 . . . . 0.0 105.377 178.051 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 53.1 m95 -131.47 146.53 52.29 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 178.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -126.75 142.32 51.58 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 179.343 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 81.3 t80 -88.79 136.88 32.77 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 108.59 -0.892 . . . . 0.0 108.59 -178.22 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -140.4 139.52 35.3 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 -176.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 75.2 m-85 -74.35 159.48 32.33 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.762 -0.653 . . . . 0.0 111.527 -175.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -55.91 131.12 46.27 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.194 0.521 . . . . 0.0 112.373 -178.131 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 75.5 26.8 64.71 Favored Glycine 0 C--O 1.218 -0.882 0 N-CA-C 115.842 1.097 . . . . 0.0 115.842 175.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 2.8 p . . . . . 0 C--N 1.323 -0.548 0 CA-C-N 118.606 1.203 . . . . 0.0 108.472 178.674 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 16.3 mt . . . . . 0 N--CA 1.445 -0.692 0 N-CA-C 114.768 1.395 . . . . 0.0 114.768 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -78.33 164.89 26.15 Favored 'Trans proline' 0 N--CA 1.461 -0.409 0 N-CA-C 107.97 -1.588 . . . . 0.0 107.97 169.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.415 ' CE1' ' HB3' ' A' ' 92' ' ' TRP . 66.7 t80 -61.25 133.08 55.53 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 120.353 -0.539 . . . . 0.0 110.148 -179.535 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 90.73 -7.03 81.87 Favored Glycine 0 CA--C 1.519 0.325 0 N-CA-C 114.797 0.679 . . . . 0.0 114.797 178.442 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -65.02 129.18 38.74 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 118.469 1.135 . . . . 0.0 111.546 179.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 60.0 t30 -76.62 127.54 32.99 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.694 -178.052 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 27.7 ttmt -156.14 152.14 27.56 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 106.686 -1.598 . . . . 0.0 106.686 179.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 17.6 t0 -63.79 129.48 40.27 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.14 0.495 . . . . 0.0 110.167 -178.18 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 70.18 26.69 73.9 Favored Glycine 0 N--CA 1.443 -0.835 0 CA-C-N 115.723 -0.671 . . . . 0.0 114.672 176.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 47.2 mm -125.41 123.52 65.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 178.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -126.88 115.43 41.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.514 -0.767 . . . . 0.0 110.163 176.853 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . 0.415 ' HB3' ' CE1' ' A' ' 83' ' ' TYR . 96.2 m95 -82.02 137.29 35.12 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 112.697 0.629 . . . . 0.0 112.697 -176.577 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 17.3 m -136.93 149.73 26.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 178.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -158.97 166.59 31.43 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 103.465 -2.791 . . . . 0.0 103.465 -178.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 6.6 t -134.76 -179.03 5.35 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 106.311 -1.737 . . . . 0.0 106.311 177.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -67.53 134.13 50.72 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.235 0.54 . . . . 0.0 110.688 -178.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 92.06 -10.05 75.21 Favored Glycine 0 C--O 1.229 -0.174 0 CA-C-N 115.915 -0.584 . . . . 0.0 113.662 177.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -70.83 134.9 47.73 Favored 'General case' 0 CA--C 1.544 0.728 0 O-C-N 122.523 -0.399 . . . . 0.0 111.247 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 29.3 mt -93.39 135.77 34.3 Favored 'General case' 0 CA--C 1.511 -0.552 0 N-CA-C 112.997 0.74 . . . . 0.0 112.997 -178.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 52.1 t30 -85.09 76.62 10.21 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.57 -178.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 1.2 t -146.42 155.66 49.67 Favored Pre-proline 0 C--N 1.322 -0.616 0 N-CA-C 105.607 -1.997 . . . . 0.0 105.607 179.47 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -69.01 149.96 72.24 Favored 'Trans proline' 0 CA--C 1.531 0.338 0 N-CA-C 113.729 0.627 . . . . 0.0 113.729 177.068 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 4.7 ptpt -152.8 56.67 0.79 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 122.78 1.276 . . . . 0.0 110.184 178.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -58.85 -31.31 68.4 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.08 -1.418 . . . . 0.0 112.586 -179.202 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 16.2 p80 -61.0 -9.09 3.78 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 114.589 1.329 . . . . 0.0 114.589 -177.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 50.4 mt -91.08 -37.92 9.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 178.194 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -75.48 14.64 5.21 Favored Glycine 0 CA--C 1.52 0.396 0 N-CA-C 115.428 0.931 . . . . 0.0 115.428 -177.073 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 11.6 t -95.61 24.24 5.43 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -177.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 62.5 ttp85 -59.37 130.91 49.24 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 177.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -101.98 135.42 19.69 Favored Pre-proline 0 C--N 1.323 -0.586 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 179.563 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -73.47 -18.33 22.95 Favored 'Trans proline' 0 C--O 1.219 -0.427 0 C-N-CA 118.387 -0.609 . . . . 0.0 113.017 -178.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -77.42 -25.05 50.36 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.894 0.378 . . . . 0.0 110.369 178.37 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 95.2 m-20 -101.1 -21.4 14.99 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 114.062 1.134 . . . . 0.0 114.062 -175.389 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 29.8 t30 -158.26 151.99 23.63 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 -178.277 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -88.78 145.64 25.48 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-O 121.436 0.636 . . . . 0.0 111.711 178.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -70.18 147.51 49.76 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.18 0.514 . . . . 0.0 111.144 178.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 12.1 mt -88.61 138.29 19.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.095 -178.696 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 71.7 t -59.65 122.39 9.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 N-CA-C 106.908 -1.515 . . . . 0.0 106.908 175.148 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 6.4 tt -67.71 128.22 35.66 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.251 0.548 . . . . 0.0 109.695 -177.387 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -134.27 160.26 38.45 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 106.359 -1.719 . . . . 0.0 106.359 -179.273 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 13.6 mt -113.91 147.65 38.19 Favored Pre-proline 0 C--N 1.322 -0.629 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 177.197 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -72.7 164.93 34.18 Favored 'Trans proline' 0 C--O 1.236 0.396 0 O-C-N 122.26 0.611 . . . . 0.0 112.574 -179.338 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -55.42 131.48 46.0 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.289 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 101.98 -22.3 38.68 Favored Glycine 0 C--O 1.226 -0.35 0 CA-C-N 115.945 -0.571 . . . . 0.0 112.505 -178.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 9.5 m -108.58 130.79 55.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 117.992 0.896 . . . . 0.0 110.98 178.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 6.1 p -122.05 148.35 44.95 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.651 -179.492 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 84.5 mt -66.53 156.14 86.81 Favored Pre-proline 0 C--N 1.324 -0.515 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 178.246 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -74.22 173.99 13.23 Favored 'Trans proline' 0 C--O 1.238 0.486 0 N-CA-C 110.453 -0.634 . . . . 0.0 110.453 -179.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -62.73 123.46 18.48 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.643 0.735 . . . . 0.0 110.269 -176.413 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 85.95 45.9 5.54 Favored Glycine 0 N--CA 1.449 -0.491 0 N-CA-C 115.854 1.102 . . . . 0.0 115.854 179.021 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -145.6 149.18 34.06 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 117.534 0.667 . . . . 0.0 111.726 177.565 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 47.1 p90 -148.14 165.32 31.22 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 174.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -105.63 145.43 31.03 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.754 0.311 . . . . 0.0 110.186 -178.326 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -68.87 131.44 45.12 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 -179.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 86.73 -15.15 53.71 Favored Glycine 0 CA--C 1.521 0.455 0 CA-C-N 115.971 -0.558 . . . . 0.0 114.11 -177.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 32.9 t . . . . . 0 C--N 1.326 -0.44 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 179.749 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 -0.183 0 CA-C-O 121.7 0.762 . . . . 0.0 111.894 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.67 143.77 55.82 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 114.773 -1.103 . . . . 0.0 108.249 177.536 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . 0.445 ' CD2' ' HD3' ' A' ' 109' ' ' ARG . 16.2 m95 -68.45 -21.86 64.61 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 113.627 0.973 . . . . 0.0 113.627 179.417 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 25.4 m-85 -121.37 161.1 22.7 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 114.226 1.195 . . . . 0.0 114.226 -171.144 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.402 ' HB ' ' HB3' ' A' ' 134' ' ' GLU . 72.9 p -68.34 163.29 23.38 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 114.43 -1.259 . . . . 0.0 111.247 -178.566 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -75.99 134.11 40.24 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 113.563 0.949 . . . . 0.0 113.563 -175.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.9 mp -84.8 146.67 27.23 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 105.388 -2.078 . . . . 0.0 105.388 170.286 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 69.8 m -126.24 131.03 52.02 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 -177.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . 0.424 ' HB2' ' CZ ' ' A' ' 131' ' ' PHE . 4.1 tp60 -97.79 138.58 34.95 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.912 -0.586 . . . . 0.0 112.11 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 52.6 t60 -128.55 99.22 5.29 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 104.722 -2.325 . . . . 0.0 104.722 168.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 168.46 -166.18 39.38 Favored Glycine 0 N--CA 1.451 -0.334 0 N-CA-C 109.14 -1.584 . . . . 0.0 109.14 -176.293 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -103.45 -26.9 12.7 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 113.404 0.89 . . . . 0.0 113.404 -178.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -80.87 160.17 24.83 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 106.981 -1.488 . . . . 0.0 106.981 177.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -85.86 -62.9 1.42 Allowed 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 113.051 0.759 . . . . 0.0 113.051 -177.734 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 51.2 tp -177.79 142.79 0.31 Allowed 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 106.892 -1.522 . . . . 0.0 106.892 175.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.1 tmtp? -158.11 138.41 12.59 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 175.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 14.9 m-85 -121.87 153.36 60.38 Favored Pre-proline 0 C--O 1.239 0.534 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 176.205 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -70.48 158.76 55.06 Favored 'Trans proline' 0 C--N 1.351 0.67 0 O-C-N 121.957 0.451 . . . . 0.0 112.468 177.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 9.7 tpp85 -64.29 135.59 56.36 Favored 'General case' 0 C--O 1.217 -0.651 0 CA-C-N 116.572 -0.286 . . . . 0.0 111.251 -178.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 78.94 13.63 82.88 Favored Glycine 0 C--O 1.224 -0.487 0 C-N-CA 121.268 -0.491 . . . . 0.0 112.259 178.188 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 8.4 mt-30 -150.24 170.49 18.86 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 -175.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 106.96 -18.69 36.49 Favored Glycine 0 CA--C 1.503 -0.681 0 CA-C-N 116.278 -0.419 . . . . 0.0 113.16 175.115 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 99.1 t -65.6 128.4 93.78 Favored Pre-proline 0 C--N 1.321 -0.669 0 N-CA-C 106.962 -1.495 . . . . 0.0 106.962 177.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -75.17 170.02 21.27 Favored 'Trans proline' 0 N--CA 1.461 -0.438 0 O-C-N 122.217 0.588 . . . . 0.0 111.84 179.296 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 91.2 mt -69.36 109.03 2.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 178.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 78.1 m-20 -99.25 85.69 3.25 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 114.506 -1.224 . . . . 0.0 109.924 -177.294 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 72.9 p -67.79 -15.1 63.47 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.524 0.678 . . . . 0.0 112.542 -178.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 11.6 p30 -108.17 19.61 19.71 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 114.977 -1.011 . . . . 0.0 113.287 -177.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 7.6 m -137.94 152.85 49.36 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 114.689 1.366 . . . . 0.0 114.689 -175.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 58.9 m -73.78 164.14 63.31 Favored Pre-proline 0 CA--C 1.537 0.476 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.65 177.341 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -66.21 -25.18 50.47 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 115.362 -2.625 . . . . 0.0 114.499 -178.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.438 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 6.4 p-10 -75.23 -26.45 58.92 Favored 'General case' 0 C--N 1.323 -0.569 0 O-C-N 121.616 -0.677 . . . . 0.0 110.579 177.152 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.479 ' HA ' ' HE3' ' A' ' 103' ' ' LYS . 32.6 m-20 -76.69 -8.11 56.62 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.485 1.114 . . . . 0.0 113.674 -175.801 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 95.0 mm-40 -59.64 -31.24 69.33 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 114.667 1.358 . . . . 0.0 114.667 -177.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 14.8 tt -60.17 140.04 18.78 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.81 0 CA-C-O 122.223 1.011 . . . . 0.0 112.567 -179.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 179.35 -155.36 15.69 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.494 -0.86 . . . . 0.0 111.678 -178.18 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 49.9 p90 -155.13 173.38 16.69 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 179.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 20.0 m-85 -113.33 140.39 48.05 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 106.927 -1.509 . . . . 0.0 106.927 173.381 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 66.7 ttt-85 -112.4 130.68 55.89 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.981 -177.535 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 29.2 ttt-85 -68.96 142.49 54.67 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 176.001 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -142.23 133.17 25.82 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.799 0.333 . . . . 0.0 110.109 177.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -156.74 131.8 9.06 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 177.072 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -129.1 123.98 33.62 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 108.253 -1.018 . . . . 0.0 108.253 174.079 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.55 137.24 54.82 Favored 'General case' 0 CA--C 1.488 -1.421 0 CA-C-O 121.493 0.663 . . . . 0.0 110.206 -177.44 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -127.49 176.91 6.48 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 N-CA-C 106.636 -1.616 . . . . 0.0 106.636 179.212 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 56.1 ttp180 -127.85 116.87 20.82 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 174.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -85.06 161.56 36.16 Favored Glycine 0 C--O 1.224 -0.474 0 N-CA-C 106.233 -2.747 . . . . 0.0 106.233 176.129 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -64.91 -35.93 92.49 Favored Glycine 0 C--O 1.216 -0.998 0 CA-C-N 118.671 1.235 . . . . 0.0 110.345 179.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 32.1 t0 -91.26 17.17 8.65 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-O 122.374 1.083 . . . . 0.0 110.62 178.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 84.16 -7.06 73.05 Favored Glycine 0 N--CA 1.46 0.27 0 N-CA-C 117.25 1.66 . . . . 0.0 117.25 172.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.56 150.53 31.33 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 122.586 1.184 . . . . 0.0 112.914 -177.883 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 73.1 mtp -119.95 -174.49 2.77 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 112.775 -2.011 . . . . 0.0 112.871 -174.535 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 25.4 mmtt -123.23 -72.99 0.66 Allowed 'General case' 0 C--O 1.219 -0.535 0 C-N-CA 122.917 0.487 . . . . 0.0 109.701 179.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -93.7 147.63 22.85 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 106.935 -1.506 . . . . 0.0 106.935 177.06 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -124.74 -63.57 1.17 Allowed 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 106.194 -1.78 . . . . 0.0 106.194 178.347 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -82.02 152.49 68.58 Favored Pre-proline 0 C--O 1.241 0.657 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 176.392 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -75.39 149.28 34.93 Favored 'Trans proline' 0 C--O 1.238 0.491 0 C-N-CA 115.632 -2.445 . . . . 0.0 112.701 179.068 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 94.8 mtt-85 -103.89 152.18 22.25 Favored 'General case' 0 CA--C 1.506 -0.745 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 177.206 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 71.7 m95 -132.44 137.67 47.35 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 175.313 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 78.1 m-85 -127.63 147.39 50.36 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 -179.35 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 74.1 t80 -90.76 137.0 32.7 Favored 'General case' 0 CA--C 1.507 -0.68 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -139.25 140.3 37.65 Favored 'General case' 0 N--CA 1.439 -1.007 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 -175.501 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -79.87 159.51 26.4 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.428 -174.485 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -53.39 124.12 13.87 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.97 0.414 . . . . 0.0 111.608 -178.082 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 82.86 13.51 77.58 Favored Glycine 0 C--O 1.222 -0.595 0 N-CA-C 116.514 1.366 . . . . 0.0 116.514 178.012 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 23.7 p . . . . . 0 N--CA 1.47 0.561 0 CA-C-N 119.032 1.416 . . . . 0.0 111.224 179.733 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 15.9 mt . . . . . 0 N--CA 1.448 -0.535 0 N-CA-C 115.94 1.83 . . . . 0.0 115.94 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -77.8 161.66 30.25 Favored 'Trans proline' 0 N--CA 1.461 -0.384 0 N-CA-C 107.416 -1.802 . . . . 0.0 107.416 168.238 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 58.1 t80 -61.41 133.22 55.55 Favored 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 120.277 -0.569 . . . . 0.0 110.848 -177.289 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 90.99 -9.02 78.99 Favored Glycine 0 CA--C 1.519 0.31 0 CA-C-O 119.445 -0.642 . . . . 0.0 114.366 179.279 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -65.37 130.8 44.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 118.343 1.072 . . . . 0.0 111.154 179.461 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 58.4 t30 -79.01 130.17 35.24 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.389 -179.244 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 28.4 ttmt -156.14 152.0 27.39 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 107.675 -1.232 . . . . 0.0 107.675 179.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 38.2 t0 -62.58 129.79 42.16 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.883 0.373 . . . . 0.0 110.421 -179.117 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 69.57 27.52 73.32 Favored Glycine 0 N--CA 1.45 -0.404 0 CA-C-O 119.324 -0.709 . . . . 0.0 114.696 178.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 40.8 mm -127.5 128.82 70.2 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 CA-C-N 117.643 0.722 . . . . 0.0 110.918 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -132.81 117.15 29.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 CA-C-O 121.465 0.65 . . . . 0.0 111.352 177.049 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 97.4 m95 -81.52 138.26 35.48 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 114.063 1.134 . . . . 0.0 114.063 -176.444 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 16.3 m -139.32 151.15 22.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.626 -0.716 . . . . 0.0 109.153 178.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -158.8 166.54 31.7 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 105.87 -1.9 . . . . 0.0 105.87 -179.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 14.5 t -133.95 169.45 17.09 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 105.361 -2.088 . . . . 0.0 105.361 178.126 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -65.89 136.26 55.89 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.263 0.554 . . . . 0.0 109.954 -179.105 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 96.21 -12.17 66.89 Favored Glycine 0 C--O 1.229 -0.182 0 CA-C-N 115.768 -0.651 . . . . 0.0 113.044 178.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.438 ' HA ' ' HA ' ' A' ' 41' ' ' ASP . . . -76.66 139.95 40.75 Favored 'General case' 0 CA--C 1.542 0.635 0 O-C-N 122.458 -0.436 . . . . 0.0 110.22 179.109 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 39.7 mt -98.32 137.79 36.52 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 113.771 1.026 . . . . 0.0 113.771 -177.126 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 56.9 t30 -82.95 76.43 9.78 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.544 0.687 . . . . 0.0 110.299 179.388 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 1.2 t -146.26 160.69 41.75 Favored Pre-proline 0 C--N 1.321 -0.67 0 N-CA-C 102.218 -3.253 . . . . 0.0 102.218 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -72.59 148.91 48.39 Favored 'Trans proline' 0 CA--C 1.538 0.678 0 N-CA-C 114.172 0.797 . . . . 0.0 114.172 176.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.479 ' HE3' ' HA ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -143.91 54.88 1.31 Allowed 'General case' 0 N--CA 1.474 0.727 0 CA-C-O 123.406 1.574 . . . . 0.0 108.485 176.835 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 14.6 p-10 -64.56 -25.39 67.96 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 113.244 -1.798 . . . . 0.0 110.721 178.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 20.6 p-80 -56.33 -19.64 15.4 Favored 'General case' 0 C--O 1.221 -0.415 0 N-CA-C 114.205 1.187 . . . . 0.0 114.205 -179.026 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 20.5 mt -82.69 -28.15 8.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-O 121.371 0.605 . . . . 0.0 109.735 -179.243 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -77.28 5.13 52.32 Favored Glycine 0 CA--C 1.519 0.317 0 N-CA-C 115.84 1.096 . . . . 0.0 115.84 -175.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 12.0 t -83.17 11.18 6.81 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 117.323 0.562 . . . . 0.0 112.321 -178.356 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.445 ' HD3' ' CD2' ' A' ' 12' ' ' TRP . 63.5 ttp85 -58.38 130.16 45.42 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 178.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -97.63 128.91 32.85 Favored Pre-proline 0 C--N 1.326 -0.454 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 178.102 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -75.69 -13.08 20.13 Favored 'Trans proline' 0 C--O 1.219 -0.451 0 N-CA-C 113.197 0.422 . . . . 0.0 113.197 -178.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -81.12 -24.09 37.92 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.092 0.472 . . . . 0.0 109.888 178.392 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -101.01 -27.41 13.29 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 113.293 0.849 . . . . 0.0 113.293 -174.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . 0.432 ' OD1' ' HD2' ' A' ' 109' ' ' ARG . 0.4 OUTLIER -139.39 152.43 47.11 Favored 'General case' 0 N--CA 1.437 -1.108 0 CA-C-O 121.263 0.554 . . . . 0.0 111.263 -177.595 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -95.73 137.31 34.98 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 115.199 -0.909 . . . . 0.0 108.94 176.19 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -65.32 148.6 51.42 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.435 0.636 . . . . 0.0 111.966 -178.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 16.8 mt -83.24 136.69 22.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.127 -178.459 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 88.7 t -61.64 122.77 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 N-CA-C 106.376 -1.713 . . . . 0.0 106.376 175.287 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 7.3 tt -66.76 131.32 45.69 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.237 0.542 . . . . 0.0 110.718 -176.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -130.96 154.48 48.1 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 106.452 -1.684 . . . . 0.0 106.452 179.416 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 13.3 mt -110.85 149.02 39.79 Favored Pre-proline 0 C--N 1.322 -0.603 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 178.059 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -73.83 167.06 28.16 Favored 'Trans proline' 0 C--N 1.345 0.343 0 O-C-N 122.2 0.579 . . . . 0.0 112.856 -179.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 55.7 tt0 -55.07 132.0 46.27 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.672 -0.694 . . . . 0.0 109.402 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 98.75 -20.98 48.19 Favored Glycine 0 C--O 1.226 -0.374 0 CA-C-N 115.981 -0.554 . . . . 0.0 113.065 -179.487 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 7.0 m -108.0 129.29 55.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 118.127 0.964 . . . . 0.0 110.688 178.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 4.8 p -122.34 148.44 45.05 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.245 -179.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 87.6 mt -70.64 153.42 94.95 Favored Pre-proline 0 C--N 1.325 -0.488 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 176.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -75.63 169.07 23.08 Favored 'Trans proline' 0 N--CA 1.463 -0.307 0 C-N-CA 117.949 -0.901 . . . . 0.0 110.913 178.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 39.8 tptt -60.13 131.83 52.05 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.125 -176.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 95.12 -6.06 68.78 Favored Glycine 0 C--O 1.228 -0.265 0 N-CA-C 115.006 0.762 . . . . 0.0 115.006 178.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.424 ' CZ ' ' HB2' ' A' ' 18' ' ' GLN . 1.3 m-85 -102.61 143.92 31.67 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-O 122.177 0.989 . . . . 0.0 111.752 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 45.2 p90 -146.45 165.61 28.87 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 113.6 -1.636 . . . . 0.0 107.342 173.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -108.56 148.07 30.85 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.949 0.405 . . . . 0.0 110.556 -178.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.402 ' HB3' ' HB ' ' A' ' 14' ' ' THR . 6.4 tp10 -70.43 136.51 49.6 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 178.769 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 81.22 -0.24 87.88 Favored Glycine 0 CA--C 1.52 0.385 0 C-N-CA 121.356 -0.449 . . . . 0.0 112.322 -176.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 4.3 t . . . . . 0 C--N 1.327 -0.407 0 CA-C-O 121.253 0.549 . . . . 0.0 110.22 179.998 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.177 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 29.1 p -66.36 144.69 56.39 Favored 'General case' 0 CA--C 1.508 -0.661 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 177.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 12.1 m95 -69.65 -21.9 63.5 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 120.859 0.361 . . . . 0.0 111.695 178.439 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -121.4 164.1 17.64 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -173.315 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 67.2 p -70.35 168.99 14.81 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.45 -1.25 . . . . 0.0 108.476 178.392 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -73.87 156.7 37.44 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 122.309 1.052 . . . . 0.0 113.523 -176.306 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 11.5 mt -101.42 137.78 39.3 Favored 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 101.81 -3.404 . . . . 0.0 101.81 166.359 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 34.3 m -115.88 136.45 53.04 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 -177.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . 0.436 ' HB2' ' CZ ' ' A' ' 131' ' ' PHE . 4.2 tp60 -114.0 137.58 51.51 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 113.959 1.096 . . . . 0.0 113.959 -176.091 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 6.5 t-160 -131.78 99.37 4.75 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 104.644 -2.354 . . . . 0.0 104.644 169.48 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 174.78 -168.35 40.95 Favored Glycine 0 C--O 1.225 -0.467 0 N-CA-C 110.562 -1.015 . . . . 0.0 110.562 -177.014 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -102.11 -25.18 13.82 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 112.832 0.678 . . . . 0.0 112.832 -179.177 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -82.86 158.23 22.8 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.316 -0.402 . . . . 0.0 109.999 -179.356 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -74.59 -62.93 1.36 Allowed 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.307 -178.462 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 28.6 tp 173.71 144.55 0.05 OUTLIER 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 103.333 -2.84 . . . . 0.0 103.333 177.338 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 11.0 tmtt? -155.45 134.26 12.02 Favored 'General case' 0 C--O 1.221 -0.442 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 176.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 9.6 m-85 -122.13 155.74 60.92 Favored Pre-proline 0 C--O 1.243 0.739 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 177.061 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -72.72 168.24 25.06 Favored 'Trans proline' 0 C--N 1.352 0.745 0 N-CA-C 113.409 0.503 . . . . 0.0 113.409 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 20.8 tpt180 -72.8 135.78 45.3 Favored 'General case' 0 C--O 1.215 -0.725 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 -178.244 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 83.86 7.32 85.86 Favored Glycine 0 C--O 1.223 -0.576 0 C-N-CA 121.236 -0.507 . . . . 0.0 112.893 177.527 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -150.19 168.42 24.04 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 -177.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 131.15 -30.29 3.35 Favored Glycine 0 CA--C 1.483 -1.927 0 N-CA-C 109.188 -1.565 . . . . 0.0 109.188 166.317 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 33.9 m -65.67 141.2 97.72 Favored Pre-proline 0 N--CA 1.433 -1.279 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 177.288 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_endo -74.01 176.48 9.45 Favored 'Trans proline' 0 N--CA 1.456 -0.691 0 C-N-CA 121.745 1.63 . . . . 0.0 110.821 178.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 91.3 mt -73.09 114.99 13.33 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 178.038 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 29.5 m-80 -109.14 82.86 1.66 Allowed 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 -179.412 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 60.9 p -67.28 -21.99 65.67 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 113.018 0.747 . . . . 0.0 113.018 -176.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 69.1 m-80 -106.1 35.74 2.82 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.054 -176.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 17.4 m -145.51 152.48 39.82 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 -179.217 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 4.6 m -73.08 164.79 58.33 Favored Pre-proline 0 C--N 1.324 -0.513 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 178.017 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -64.59 -26.24 61.75 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 114.748 -3.035 . . . . 0.0 111.14 177.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -62.18 -27.47 68.99 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 123.862 0.865 . . . . 0.0 111.573 175.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 77.3 m-20 -96.44 -4.9 40.86 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 115.225 1.565 . . . . 0.0 115.225 -171.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 90.6 mm-40 -59.6 -28.41 67.15 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 113.599 0.962 . . . . 0.0 113.599 -177.574 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 13.8 tt -57.45 141.52 14.34 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 N-CA-C 114.46 1.281 . . . . 0.0 114.46 -178.195 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -179.53 -153.47 11.87 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.071 179.318 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 49.5 p90 -155.03 169.51 23.94 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 177.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 19.3 m-85 -111.63 143.01 43.22 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 173.244 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 17.4 ttt180 -116.18 125.88 52.9 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.698 -178.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 18.2 ttp85 -68.67 135.93 52.15 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 107.956 -1.128 . . . . 0.0 107.956 176.56 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -127.52 125.32 40.19 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.401 0.619 . . . . 0.0 109.719 179.552 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -146.19 117.55 7.94 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.142 -0.935 . . . . 0.0 108.954 179.406 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 6.7 tpp85 -147.78 127.57 13.46 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 178.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 29.1 mtt85 -130.89 165.92 22.03 Favored 'General case' 0 CA--C 1.495 -1.153 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 177.39 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -141.06 179.4 2.34 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 -177.553 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 19.1 ttm180 -115.05 104.96 12.4 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 106.182 -1.785 . . . . 0.0 106.182 174.194 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -84.18 143.25 21.04 Favored Glycine 0 C--O 1.226 -0.392 0 N-CA-C 107.275 -2.33 . . . . 0.0 107.275 178.041 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -64.7 -38.5 95.71 Favored Glycine 0 C--O 1.219 -0.83 0 CA-C-N 118.404 1.102 . . . . 0.0 112.339 -177.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -85.76 11.58 10.77 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.7 0.762 . . . . 0.0 112.083 -179.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 84.7 20.33 58.34 Favored Glycine 0 C--O 1.226 -0.399 0 CA-C-N 115.235 -0.893 . . . . 0.0 112.467 176.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 21.6 mmtt -88.21 130.85 34.96 Favored 'General case' 0 C--N 1.324 -0.542 0 O-C-N 122.21 -0.582 . . . . 0.0 110.872 -175.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 86.8 mmm -100.98 159.9 14.82 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.156 -0.929 . . . . 0.0 109.128 -178.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 16.5 tppt? -83.22 -48.68 10.22 Favored 'General case' 0 C--O 1.219 -0.526 0 N-CA-C 108.401 -0.962 . . . . 0.0 108.401 177.526 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 21.3 t0 -162.82 163.53 26.53 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 105.327 -2.101 . . . . 0.0 105.327 177.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -117.28 -34.24 4.39 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 177.38 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 20.9 m -85.33 148.53 50.01 Favored Pre-proline 0 C--N 1.326 -0.425 0 N-CA-C 113.753 1.02 . . . . 0.0 113.753 -176.058 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -77.59 145.57 23.42 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 117.97 -0.887 . . . . 0.0 112.187 174.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 47.8 mtt180 -119.1 165.09 14.59 Favored 'General case' 0 CA--C 1.508 -0.656 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.864 179.049 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 64.9 m95 -134.25 144.32 48.32 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 106.588 -1.634 . . . . 0.0 106.588 172.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 71.5 m-85 -130.16 148.51 52.01 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 178.144 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 76.1 t80 -92.59 134.73 34.71 Favored 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 -177.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -137.11 140.19 41.75 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 -176.493 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -77.87 159.51 28.88 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.167 -177.194 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -53.33 138.94 31.45 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 -179.233 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 70.51 38.27 69.03 Favored Glycine 0 C--O 1.225 -0.454 0 N-CA-C 115.726 1.05 . . . . 0.0 115.726 175.22 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 12.7 p . . . . . 0 C--N 1.325 -0.483 0 CA-C-N 117.804 0.802 . . . . 0.0 111.238 178.832 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 47.2 mt . . . . . 0 C--O 1.239 0.528 0 N-CA-C 114.892 1.442 . . . . 0.0 114.892 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -77.87 167.68 23.38 Favored 'Trans proline' 0 C--O 1.237 0.451 0 N-CA-C 108.725 -1.298 . . . . 0.0 108.725 170.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 62.8 t80 -62.42 131.46 49.3 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 179.161 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 92.97 -5.94 76.21 Favored Glycine 0 CA--C 1.52 0.344 0 N-CA-C 114.967 0.747 . . . . 0.0 114.967 178.577 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -64.49 129.18 38.88 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 118.296 1.048 . . . . 0.0 112.085 179.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 43.3 t-20 -75.24 126.6 31.35 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.912 -177.406 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 9.9 ttmm -156.18 150.85 25.93 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 177.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -63.58 134.05 54.82 Favored 'General case' 0 C--N 1.324 -0.529 0 O-C-N 123.176 0.298 . . . . 0.0 110.526 179.416 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 68.51 26.9 74.11 Favored Glycine 0 N--CA 1.45 -0.387 0 CA-C-O 119.496 -0.613 . . . . 0.0 114.081 177.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 34.0 mm -130.18 130.81 65.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 117.417 0.608 . . . . 0.0 109.831 179.277 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.1 pt -132.5 113.49 21.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 CA-C-O 121.5 0.667 . . . . 0.0 110.815 175.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 95.1 m95 -80.98 131.85 35.35 Favored 'General case' 0 C--N 1.321 -0.662 0 O-C-N 121.893 -0.505 . . . . 0.0 111.492 -177.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 2.8 m -139.96 150.86 21.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.819 -177.269 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -156.71 166.57 33.02 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 106.071 -1.826 . . . . 0.0 106.071 -178.553 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 14.8 t -125.9 167.48 15.2 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 105.072 -2.195 . . . . 0.0 105.072 176.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -66.45 136.6 55.94 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 -179.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 96.09 -10.87 67.81 Favored Glycine 0 C--O 1.225 -0.432 0 CA-C-N 115.966 -0.561 . . . . 0.0 113.114 178.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -78.44 141.43 38.28 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 122.308 -0.525 . . . . 0.0 110.744 179.378 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 33.9 mt -91.79 135.64 33.76 Favored 'General case' 0 CA--C 1.51 -0.57 0 CA-C-O 121.429 0.633 . . . . 0.0 112.561 -178.577 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 58.5 t30 -82.32 70.05 9.19 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.601 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 2.0 t -142.48 157.55 62.3 Favored Pre-proline 0 CA--C 1.54 0.578 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 -178.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_exo -61.86 149.21 91.04 Favored 'Trans proline' 0 C--N 1.348 0.539 0 N-CA-C 114.407 0.887 . . . . 0.0 114.407 -179.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -124.79 41.13 3.58 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 122.017 0.913 . . . . 0.0 108.73 -178.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 16.7 p-10 -50.36 -46.55 55.91 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 114.583 -1.189 . . . . 0.0 112.855 -178.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 48.2 p-80 -69.78 -9.15 53.51 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 113.577 0.955 . . . . 0.0 113.577 -177.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 40.8 mt -95.31 -40.13 10.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 178.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -72.14 1.31 34.11 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 115.804 1.081 . . . . 0.0 115.804 -178.149 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 6.2 t -83.03 19.22 1.45 Allowed 'General case' 0 CA--C 1.549 0.934 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 -178.261 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.429 ' HD2' HD22 ' A' ' 114' ' ' ASN . 66.5 ttp85 -59.24 130.67 48.06 Favored 'General case' 0 N--CA 1.47 0.55 0 O-C-N 121.101 -1.0 . . . . 0.0 109.142 179.478 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -103.88 127.03 30.23 Favored Pre-proline 0 C--N 1.323 -0.567 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 178.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -72.7 -14.76 27.18 Favored 'Trans proline' 0 C--O 1.22 -0.411 0 C-N-CA 118.098 -0.801 . . . . 0.0 113.234 -178.171 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -74.32 -27.09 60.54 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.919 0.39 . . . . 0.0 110.497 178.201 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 79.7 m-20 -104.27 -23.05 13.27 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 113.908 1.077 . . . . 0.0 113.908 -174.109 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . 0.429 HD22 ' HD2' ' A' ' 109' ' ' ARG . 26.1 t30 -148.37 151.91 36.12 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -177.325 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -91.52 148.83 22.01 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-O 121.384 0.611 . . . . 0.0 111.943 179.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -74.65 150.12 39.71 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.441 178.114 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 6.9 mt -92.22 140.34 16.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 -178.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 95.2 t -61.49 124.78 16.58 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 N-CA-C 107.162 -1.422 . . . . 0.0 107.162 175.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 5.3 tt -67.4 129.15 39.0 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.137 0.494 . . . . 0.0 111.108 -176.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 29.2 mt-30 -133.01 154.51 50.45 Favored 'General case' 0 C--O 1.219 -0.531 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 -179.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 12.8 mt -110.9 147.92 37.53 Favored Pre-proline 0 C--N 1.322 -0.622 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 177.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -73.33 166.84 28.84 Favored 'Trans proline' 0 C--N 1.346 0.444 0 O-C-N 122.197 0.577 . . . . 0.0 113.196 179.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 39.3 tt0 -54.08 133.03 43.83 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.779 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 97.02 -20.55 50.41 Favored Glycine 0 C--O 1.227 -0.337 0 CA-C-N 115.941 -0.572 . . . . 0.0 112.93 -179.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 1.5 m -104.95 127.38 52.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 117.916 0.858 . . . . 0.0 110.569 178.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 6.9 p -122.79 148.29 45.54 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.739 -179.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 85.2 mt -71.86 150.52 92.95 Favored Pre-proline 0 C--N 1.324 -0.538 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 179.181 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -78.74 179.79 6.16 Favored 'Trans proline' 0 C--O 1.236 0.387 0 O-C-N 121.99 0.468 . . . . 0.0 111.341 178.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 8.1 tmtt? -57.11 126.93 29.42 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 -175.306 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 89.56 -0.03 79.83 Favored Glycine 0 CA--C 1.51 -0.26 0 N-CA-C 116.233 1.253 . . . . 0.0 116.233 173.533 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.436 ' CZ ' ' HB2' ' A' ' 18' ' ' GLN . 4.0 m-85 -99.53 137.9 37.38 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-O 121.881 0.848 . . . . 0.0 111.762 -179.113 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 40.0 p90 -145.43 161.75 38.95 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 114.166 -1.379 . . . . 0.0 107.741 174.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -99.68 142.86 30.6 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.573 0.701 . . . . 0.0 112.468 -175.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -70.4 129.77 40.17 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 107.367 -1.345 . . . . 0.0 107.367 178.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 95.21 -21.51 43.75 Favored Glycine 0 C--O 1.227 -0.331 0 CA-C-N 116.15 -0.477 . . . . 0.0 112.761 -178.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 20.0 t . . . . . 0 C--N 1.326 -0.422 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 179.181 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.642 0 CA-C-O 121.592 0.71 . . . . 0.0 110.403 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 37.2 p -62.94 142.29 58.39 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 114.994 -1.003 . . . . 0.0 108.883 177.108 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . 0.414 ' CD2' ' HD3' ' A' ' 109' ' ' ARG . 7.4 m95 -66.23 -21.87 66.31 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 177.754 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -121.41 161.51 22.04 Favored 'General case' 0 CA--C 1.509 -0.619 0 N-CA-C 113.944 1.09 . . . . 0.0 113.944 -172.102 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 77.4 p -72.55 172.69 10.08 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 113.692 -1.594 . . . . 0.0 109.136 177.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -77.67 142.6 38.73 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 -176.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 11.8 mt -90.48 133.59 34.94 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 102.299 -3.223 . . . . 0.0 102.299 167.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 64.5 m -118.37 138.59 52.32 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 118.143 0.429 . . . . 0.0 110.264 -176.103 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . 0.414 ' HB2' ' CZ ' ' A' ' 131' ' ' PHE . 4.0 tp60 -105.84 139.89 39.72 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 113.596 0.962 . . . . 0.0 113.596 -177.823 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 59.7 t60 -128.74 99.71 5.44 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 104.476 -2.416 . . . . 0.0 104.476 168.241 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 160.78 -162.38 33.47 Favored Glycine 0 C--O 1.226 -0.375 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 -176.333 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 54.0 mttp -110.04 -15.79 13.96 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 113.508 0.929 . . . . 0.0 113.508 -179.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -74.05 153.52 39.62 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 179.395 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 63.0 m-20 -79.82 -62.85 1.56 Allowed 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 120.566 0.222 . . . . 0.0 110.975 -178.133 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 48.3 tp 165.69 137.38 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 102.763 -3.051 . . . . 0.0 102.763 177.418 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -155.43 135.78 13.19 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 177.007 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -124.47 157.84 63.7 Favored Pre-proline 0 C--N 1.322 -0.599 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 177.467 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -69.33 174.39 9.21 Favored 'Trans proline' 0 CA--C 1.539 0.762 0 C-N-CA 121.704 1.602 . . . . 0.0 114.933 -178.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 17.3 tpt180 -78.25 129.54 35.19 Favored 'General case' 0 C--O 1.216 -0.681 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 178.367 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 75.42 12.29 83.73 Favored Glycine 0 C--O 1.225 -0.411 0 N-CA-C 114.99 0.756 . . . . 0.0 114.99 175.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 33.6 tt0 -157.29 145.16 19.04 Favored 'General case' 0 C--O 1.219 -0.523 0 N-CA-C 106.378 -1.712 . . . . 0.0 106.378 -178.489 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 138.66 -14.39 3.4 Favored Glycine 0 CA--C 1.506 -0.504 0 C-N-CA 120.038 -1.077 . . . . 0.0 113.707 177.42 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 30.8 m -72.56 145.31 87.31 Favored Pre-proline 0 C--N 1.319 -0.729 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 177.044 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -75.69 166.28 28.66 Favored 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 122.104 1.869 . . . . 0.0 113.775 179.386 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 97.6 mt -73.3 124.84 31.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.34 -0.846 . . . . 0.0 110.568 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.429 ' ND2' ' HH ' ' A' ' 72' ' ' TYR . 16.3 t-20 -125.41 122.76 37.65 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.861 0.362 . . . . 0.0 110.921 174.64 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 72.7 p -91.04 -15.91 28.77 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 113.837 1.051 . . . . 0.0 113.837 -177.195 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 11.8 p30 -112.96 25.37 11.47 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.637 -0.711 . . . . 0.0 112.385 -176.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 68.3 m -136.36 153.34 51.15 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 178.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 2.9 m -68.62 162.9 59.24 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.527 -178.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -66.47 -28.61 45.77 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 114.493 -3.204 . . . . 0.0 113.638 179.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.515 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 5.1 p-10 -75.23 -23.08 57.5 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 121.621 -0.674 . . . . 0.0 111.608 177.151 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.438 ' HA ' ' HE3' ' A' ' 103' ' ' LYS . 18.8 m-20 -73.25 -13.15 61.08 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.712 0.805 . . . . 0.0 112.901 -176.406 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 93.1 mm-40 -62.44 -24.53 67.47 Favored 'General case' 0 C--O 1.219 -0.547 0 N-CA-C 114.492 1.293 . . . . 0.0 114.492 -177.092 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 12.9 tt -57.16 140.15 15.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 CA-C-O 122.303 1.049 . . . . 0.0 112.952 179.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 178.35 -151.78 10.89 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.122 -1.037 . . . . 0.0 113.14 -179.116 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 48.7 p90 -154.71 168.71 25.91 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 179.074 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -108.67 138.4 45.04 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 173.151 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.96 126.01 51.68 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 123.821 0.849 . . . . 0.0 108.758 -179.379 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 34.1 ttt180 -70.78 144.16 50.94 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 122.339 0.256 . . . . 0.0 111.404 177.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -149.16 160.22 43.55 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.709 0.766 . . . . 0.0 111.679 178.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 8.4 t -169.13 176.28 5.35 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 102.09 -3.3 . . . . 0.0 102.09 174.485 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 12.9 tpt180 -128.41 123.86 34.85 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 177.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 3.3 tmt_? -134.95 142.22 46.45 Favored 'General case' 0 CA--C 1.5 -0.974 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 -177.505 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -141.88 179.75 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 -177.605 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 24.9 tpt85 -134.96 104.52 5.99 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 105.669 -1.975 . . . . 0.0 105.669 171.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -77.54 152.54 39.5 Favored Glycine 0 N--CA 1.45 -0.385 0 N-CA-C 105.078 -3.209 . . . . 0.0 105.078 176.258 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -59.76 -38.21 93.57 Favored Glycine 0 C--O 1.222 -0.617 0 CA-C-N 118.9 1.35 . . . . 0.0 112.147 -178.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 37.5 t0 -81.83 15.73 2.11 Favored 'General case' 0 CA--C 1.551 0.993 0 CA-C-O 122.345 1.069 . . . . 0.0 112.057 -179.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 85.13 15.46 66.95 Favored Glycine 0 C--O 1.222 -0.64 0 CA-C-N 115.664 -0.698 . . . . 0.0 113.294 171.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 21.1 mmtt -82.34 140.55 33.47 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.399 0.619 . . . . 0.0 109.855 -175.384 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 61.7 mtp -125.51 -178.37 4.22 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 114.418 -1.265 . . . . 0.0 110.451 -176.297 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 34.6 mmtt -136.88 -57.95 0.72 Allowed 'General case' 0 CA--C 1.504 -0.817 0 CA-C-O 121.33 0.586 . . . . 0.0 109.441 -177.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 34.47 64.04 0.41 Allowed 'General case' 0 C--N 1.322 -0.63 0 O-C-N 126.172 2.17 . . . . 0.0 112.897 173.528 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 75.9 mt -61.74 159.33 13.77 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 113.669 -1.605 . . . . 0.0 112.258 -176.376 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 54.1 p -55.61 142.77 60.96 Favored Pre-proline 0 C--O 1.252 1.187 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.368 179.327 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -66.46 142.06 63.9 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 116.7 -1.733 . . . . 0.0 112.554 -176.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 6.9 ptp180 -139.26 162.81 34.09 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 114.477 -1.238 . . . . 0.0 108.198 -179.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 53.1 m95 -132.65 148.92 52.36 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 -177.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 45.1 m-85 -125.09 150.46 46.81 Favored 'General case' 0 C--O 1.215 -0.763 0 N-CA-C 106.17 -1.789 . . . . 0.0 106.17 179.433 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 86.3 t80 -97.06 139.01 33.71 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 118.818 0.735 . . . . 0.0 109.756 -175.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -140.99 152.28 44.8 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 -175.171 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.429 ' HH ' ' ND2' ' A' ' 35' ' ' ASN . 65.9 m-85 -85.53 159.47 19.9 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -175.045 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -54.2 126.61 23.62 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.127 178.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 72.92 30.79 62.92 Favored Glycine 0 C--O 1.22 -0.737 0 N-CA-C 116.105 1.202 . . . . 0.0 116.105 177.226 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.2 p . . . . . 0 C--N 1.327 -0.374 0 CA-C-N 119.133 1.467 . . . . 0.0 108.154 178.922 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 15.0 mt . . . . . 0 N--CA 1.446 -0.662 0 N-CA-C 115.401 1.63 . . . . 0.0 115.401 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -79.48 163.99 24.06 Favored 'Trans proline' 0 N--CA 1.46 -0.47 0 C-N-CA 122.421 2.08 . . . . 0.0 107.846 167.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 48.6 t80 -61.51 131.01 48.75 Favored 'General case' 0 C--N 1.319 -0.733 0 C-N-CA 120.467 -0.493 . . . . 0.0 110.214 -178.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 92.89 -7.65 76.7 Favored Glycine 0 CA--C 1.52 0.368 0 CA-C-O 119.349 -0.695 . . . . 0.0 114.778 178.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -66.88 130.59 43.65 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 118.58 1.19 . . . . 0.0 111.655 179.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 56.4 t30 -76.44 129.7 36.92 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.606 -179.328 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 22.0 ttmt -156.07 153.13 28.91 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 179.304 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 35.0 t0 -60.2 125.23 22.88 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.312 0.577 . . . . 0.0 111.48 -178.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 69.66 30.92 70.49 Favored Glycine 0 N--CA 1.449 -0.472 0 CA-C-O 118.908 -0.94 . . . . 0.0 114.484 177.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 42.8 mm -126.0 129.86 72.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 117.844 0.822 . . . . 0.0 111.445 179.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -130.82 117.88 39.9 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.662 175.25 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 96.4 m95 -82.99 136.68 34.43 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 113.81 1.041 . . . . 0.0 113.81 -176.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -144.77 155.37 14.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.611 -179.121 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -155.81 166.6 33.01 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 104.729 -2.323 . . . . 0.0 104.729 -178.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 15.1 t -116.28 170.04 8.83 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 104.892 -2.262 . . . . 0.0 104.892 173.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -66.13 135.1 54.1 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 178.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 91.3 -7.52 80.34 Favored Glycine 0 CA--C 1.517 0.188 0 CA-C-N 116.143 -0.481 . . . . 0.0 113.169 179.48 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.515 ' HA ' ' HA ' ' A' ' 41' ' ' ASP . . . -72.16 134.34 45.66 Favored 'General case' 0 CA--C 1.539 0.542 0 O-C-N 122.322 -0.516 . . . . 0.0 110.337 178.81 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 31.8 mt -85.96 138.19 32.18 Favored 'General case' 0 CA--C 1.511 -0.532 0 CA-C-O 121.48 0.657 . . . . 0.0 112.591 -177.163 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 60.0 t30 -85.43 69.73 10.72 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.277 -179.542 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -145.1 158.52 51.83 Favored Pre-proline 0 C--N 1.321 -0.657 0 N-CA-C 104.237 -2.505 . . . . 0.0 104.237 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -73.08 149.9 47.25 Favored 'Trans proline' 0 CA--C 1.534 0.515 0 N-CA-C 113.938 0.707 . . . . 0.0 113.938 177.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.438 ' HE3' ' HA ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -146.83 56.84 1.15 Allowed 'General case' 0 N--CA 1.477 0.883 0 CA-C-O 122.702 1.239 . . . . 0.0 109.205 176.444 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -65.14 -21.38 66.78 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.291 -1.322 . . . . 0.0 111.519 179.382 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 19.0 p80 -56.83 -19.67 18.61 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 114.307 1.225 . . . . 0.0 114.307 -179.13 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 11.7 mt -83.58 -27.91 7.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 121.698 0.761 . . . . 0.0 109.017 -179.413 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -78.2 14.66 10.72 Favored Glycine 0 C--O 1.219 -0.798 0 CA-C-N 115.715 -0.675 . . . . 0.0 114.416 -176.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 7.8 t -83.05 15.42 2.81 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-O 122.079 0.942 . . . . 0.0 110.467 -179.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.414 ' HD3' ' CD2' ' A' ' 12' ' ' TRP . 57.8 ttp85 -63.46 131.3 47.72 Favored 'General case' 0 C--N 1.327 -0.41 0 O-C-N 121.851 -0.531 . . . . 0.0 110.212 -179.512 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 66.4 m-20 -106.65 120.18 49.19 Favored Pre-proline 0 C--N 1.327 -0.404 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 179.289 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -70.71 -13.92 32.67 Favored 'Trans proline' 0 C--N 1.347 0.489 0 N-CA-C 113.808 0.657 . . . . 0.0 113.808 -176.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -72.61 -26.04 61.54 Favored 'General case' 0 C--O 1.22 -0.46 0 CA-C-O 120.717 0.294 . . . . 0.0 110.825 177.09 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 -104.05 -24.82 13.17 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 114.273 1.212 . . . . 0.0 114.273 -174.196 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . 0.401 ' OD1' ' HD2' ' A' ' 109' ' ' ARG . 0.1 OUTLIER -143.26 154.98 44.37 Favored 'General case' 0 N--CA 1.434 -1.238 0 CA-C-O 121.284 0.564 . . . . 0.0 110.308 -176.211 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -94.99 144.1 25.95 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.462 178.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -70.3 148.23 48.74 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.197 0.522 . . . . 0.0 110.958 179.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 15.0 mt -84.45 136.98 21.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 -178.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -62.67 125.92 20.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 106.776 -1.564 . . . . 0.0 106.776 175.628 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 4.2 tt -66.08 128.39 35.89 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.163 0.506 . . . . 0.0 111.005 -177.398 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -132.03 156.86 45.52 Favored 'General case' 0 CA--C 1.509 -0.612 0 N-CA-C 106.946 -1.502 . . . . 0.0 106.946 -179.58 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 14.3 mt -115.3 147.49 38.71 Favored Pre-proline 0 C--N 1.32 -0.679 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 179.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -73.29 169.38 22.42 Favored 'Trans proline' 0 C--N 1.346 0.421 0 O-C-N 122.361 0.664 . . . . 0.0 113.754 -178.579 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 39.7 tt0 -53.6 131.85 39.49 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.426 -0.806 . . . . 0.0 109.899 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 94.26 -18.05 57.67 Favored Glycine 0 C--O 1.228 -0.248 0 CA-C-N 115.904 -0.589 . . . . 0.0 113.395 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 3.3 m -104.66 126.77 52.06 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 118.108 0.954 . . . . 0.0 111.261 178.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 5.5 p -119.87 148.27 43.68 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.964 -179.348 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 88.7 mt -69.86 152.8 95.9 Favored Pre-proline 0 C--N 1.324 -0.535 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 178.204 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -76.58 175.37 11.45 Favored 'Trans proline' 0 N--CA 1.462 -0.375 0 C-N-CA 118.524 -0.517 . . . . 0.0 111.077 178.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 62.6 tttm -56.9 126.62 27.89 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 113.431 0.9 . . . . 0.0 113.431 -174.552 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 89.56 -6.42 83.17 Favored Glycine 0 CA--C 1.517 0.197 0 N-CA-C 116.106 1.202 . . . . 0.0 116.106 175.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.414 ' CZ ' ' HB2' ' A' ' 18' ' ' GLN . 2.7 m-85 -91.68 145.68 24.39 Favored 'General case' 0 N--CA 1.434 -1.26 0 CA-C-O 122.653 1.216 . . . . 0.0 111.681 -178.685 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 50.2 p90 -145.34 162.5 37.08 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 112.902 -1.953 . . . . 0.0 107.896 175.162 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -105.48 136.53 44.87 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.162 0.506 . . . . 0.0 111.913 -176.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -67.56 133.73 49.97 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.356 -0.838 . . . . 0.0 108.92 177.584 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 91.88 -27.51 9.92 Favored Glycine 0 CA--C 1.522 0.513 0 N-CA-C 113.663 0.225 . . . . 0.0 113.663 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 4.9 t . . . . . 0 C--N 1.323 -0.552 0 CA-C-O 121.306 0.574 . . . . 0.0 111.248 178.139 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.464 0 N-CA-C 113.318 0.858 . . . . 0.0 113.318 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 16.2 t -66.2 141.86 57.91 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.78 178.431 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 27.3 m95 -68.35 -23.21 64.66 Favored 'General case' 0 CA--C 1.509 -0.634 0 O-C-N 123.372 0.42 . . . . 0.0 111.457 177.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 36.7 m-85 -121.38 158.26 28.69 Favored 'General case' 0 CA--C 1.506 -0.714 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.83 -173.396 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.42 ' HB ' ' HB3' ' A' ' 134' ' ' GLU . 69.8 p -65.67 160.43 22.74 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.235 -0.893 . . . . 0.0 109.838 -179.65 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -80.25 139.34 36.73 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.147 -0.933 . . . . 0.0 112.166 -174.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.8 mp -83.15 148.9 27.19 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 172.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 64.7 m -124.49 138.76 54.32 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 179.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . 0.4 ' HB2' ' CZ ' ' A' ' 131' ' ' PHE . 4.3 tp60 -111.85 136.44 51.14 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 -178.023 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 56.0 t60 -131.22 94.97 3.68 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 104.318 -2.475 . . . . 0.0 104.318 169.152 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 178.61 -166.32 36.06 Favored Glycine 0 C--O 1.224 -0.475 0 N-CA-C 110.802 -0.919 . . . . 0.0 110.802 -176.3 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 91.9 mttt -101.11 -21.79 14.88 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 114.442 1.275 . . . . 0.0 114.442 -177.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -94.03 161.53 14.25 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 179.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -77.76 -62.92 1.51 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.517 -179.012 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 45.0 tp 179.44 140.7 0.12 Allowed 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 105.387 -2.079 . . . . 0.0 105.387 175.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 23.7 tptm -155.67 134.84 12.21 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 118.051 0.387 . . . . 0.0 110.49 174.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 20.1 m-85 -121.24 151.69 56.19 Favored Pre-proline 0 C--O 1.242 0.66 0 N-CA-C 107.178 -1.416 . . . . 0.0 107.178 174.062 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -73.97 160.63 42.74 Favored 'Trans proline' 0 CA--C 1.535 0.541 0 O-C-N 122.058 0.504 . . . . 0.0 111.946 177.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 3.8 tmt_? -64.3 132.02 48.99 Favored 'General case' 0 N--CA 1.47 0.539 0 O-C-N 122.169 -0.332 . . . . 0.0 110.35 -178.102 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 83.23 15.38 72.04 Favored Glycine 0 C--O 1.223 -0.557 0 C-N-CA 121.249 -0.501 . . . . 0.0 112.375 177.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.533 HE22 HG22 ' A' ' 125' ' ' THR . 0.8 OUTLIER -150.92 170.54 19.07 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 -176.668 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 100.32 -10.83 59.89 Favored Glycine 0 CA--C 1.508 -0.384 0 N-CA-C 115.183 0.833 . . . . 0.0 115.183 174.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 90.3 t -68.91 130.07 91.85 Favored Pre-proline 0 C--N 1.321 -0.669 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 177.342 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -73.18 171.75 16.98 Favored 'Trans proline' 0 C--O 1.221 -0.357 0 O-C-N 122.183 0.57 . . . . 0.0 112.351 178.343 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 92.6 mt -71.57 106.44 2.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 179.304 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 -96.17 86.55 4.28 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 114.33 -1.305 . . . . 0.0 109.755 -176.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 77.5 p -67.65 -14.89 63.33 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.543 -0.753 . . . . 0.0 112.816 -178.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -108.35 21.04 17.88 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.158 -0.928 . . . . 0.0 112.022 -177.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.404 ' HB3' ' HB2' ' A' ' 42' ' ' ASP . 2.0 m -143.17 149.84 38.58 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 114.333 1.234 . . . . 0.0 114.333 -175.824 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.2 m -76.8 168.41 28.32 Favored Pre-proline 0 N--CA 1.471 0.595 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 177.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -64.39 -27.44 62.94 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 114.731 -3.046 . . . . 0.0 112.095 178.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -62.84 -23.97 67.55 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 124.104 0.962 . . . . 0.0 112.322 176.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.447 ' HA ' ' HE3' ' A' ' 103' ' ' LYS . 68.7 m-20 -99.28 -1.98 37.66 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 114.106 1.151 . . . . 0.0 114.106 -171.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 91.8 mm-40 -61.89 -26.01 67.9 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 114.002 1.112 . . . . 0.0 114.002 -177.433 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 8.5 tt -59.04 137.26 21.72 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.83 0 CA-C-O 122.242 1.02 . . . . 0.0 112.977 -179.281 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -179.33 -159.18 22.97 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.437 -0.887 . . . . 0.0 112.505 -178.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 42.7 p90 -155.02 168.12 28.08 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 179.468 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 31.9 m-85 -109.37 140.77 42.66 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 175.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 66.0 ttt-85 -116.85 120.77 39.54 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.892 -175.054 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 50.1 ttp180 -70.73 143.7 51.19 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 110.244 -0.28 . . . . 0.0 110.244 177.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -144.32 141.26 29.65 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 122.734 0.414 . . . . 0.0 110.327 178.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 25.4 p -144.49 151.5 39.25 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 178.192 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 13.3 tpt180 -149.14 130.52 14.72 Favored 'General case' 0 N--CA 1.469 0.517 0 O-C-N 122.176 -0.328 . . . . 0.0 111.3 176.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 4.2 tmm_? -144.07 138.83 28.57 Favored 'General case' 0 CA--C 1.5 -0.96 0 CA-C-O 121.157 0.503 . . . . 0.0 109.793 179.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -131.81 179.2 4.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 -179.658 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 5.0 ttt85 -115.36 99.16 7.18 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 174.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -77.91 157.69 45.58 Favored Glycine 0 C--O 1.223 -0.551 0 N-CA-C 107.359 -2.296 . . . . 0.0 107.359 176.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -66.04 -41.9 94.91 Favored Glycine 0 C--O 1.217 -0.953 0 CA-C-N 118.427 1.114 . . . . 0.0 111.899 179.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -85.35 -11.05 55.5 Favored 'General case' 0 C--O 1.215 -0.719 0 CA-C-O 122.137 0.97 . . . . 0.0 110.328 178.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 103.57 9.7 37.48 Favored Glycine 0 C--O 1.226 -0.398 0 CA-C-N 115.288 -0.869 . . . . 0.0 112.781 177.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 59.5 mmtt -61.12 132.36 53.48 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.274 0.559 . . . . 0.0 110.59 -179.391 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 95.8 mmm -86.19 167.62 14.72 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 114.781 -1.099 . . . . 0.0 111.185 179.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 16.2 tppt? -108.61 -39.42 5.39 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 176.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 15.2 t0 -141.77 164.98 28.72 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 105.253 -2.129 . . . . 0.0 105.253 178.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -121.2 -94.27 0.5 Allowed 'General case' 0 C--N 1.325 -0.469 0 O-C-N 123.502 0.501 . . . . 0.0 110.597 -176.334 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -72.45 159.4 85.48 Favored Pre-proline 0 C--N 1.326 -0.43 0 C-N-CA 122.717 0.407 . . . . 0.0 109.976 179.667 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -68.79 140.86 47.62 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 115.116 -2.789 . . . . 0.0 111.377 177.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 53.5 mtt180 -104.2 155.65 18.54 Favored 'General case' 0 CA--C 1.504 -0.798 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.067 179.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 66.0 m95 -127.53 125.85 41.13 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 174.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 69.6 m-85 -110.32 160.22 16.75 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 106.605 -1.628 . . . . 0.0 106.605 -178.615 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -103.55 132.8 49.49 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 179.378 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -131.65 145.69 51.8 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 -176.081 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 58.8 m-85 -87.26 161.59 17.9 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 120.755 0.312 . . . . 0.0 110.289 -176.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -53.42 132.46 39.69 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 120.747 0.308 . . . . 0.0 111.379 -178.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 70.37 27.98 71.95 Favored Glycine 0 C--O 1.224 -0.508 0 N-CA-C 116.264 1.266 . . . . 0.0 116.264 176.529 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 69.9 p . . . . . 0 N--CA 1.467 0.422 0 CA-C-N 118.278 1.039 . . . . 0.0 111.286 178.891 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 27.4 mt . . . . . 0 C--O 1.238 0.482 0 N-CA-C 117.348 2.351 . . . . 0.0 117.348 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -77.88 164.36 27.69 Favored 'Trans proline' 0 C--O 1.234 0.303 0 C-N-CA 121.787 1.658 . . . . 0.0 108.011 167.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 53.5 t80 -62.43 133.1 54.55 Favored 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 120.493 -0.483 . . . . 0.0 111.191 -176.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 89.52 -7.6 81.59 Favored Glycine 0 CA--C 1.517 0.202 0 CA-C-O 119.6 -0.556 . . . . 0.0 114.373 178.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -63.5 131.61 48.68 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 118.134 0.967 . . . . 0.0 111.084 179.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -78.25 130.13 35.9 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.242 -179.277 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 24.8 ttmt -156.2 150.97 26.04 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 105.37 -2.085 . . . . 0.0 105.37 176.501 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 42.4 t0 -70.88 135.85 48.28 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.827 -0.435 . . . . 0.0 109.827 -177.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 71.95 24.5 76.48 Favored Glycine 0 N--CA 1.453 -0.222 0 C-N-CA 121.158 -0.544 . . . . 0.0 113.937 -179.373 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 41.6 mm -129.36 129.61 67.27 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 CA-C-N 117.198 0.499 . . . . 0.0 110.593 -179.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.1 pt -132.91 125.22 51.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 CA-C-O 121.17 0.51 . . . . 0.0 110.591 176.472 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 95.9 m95 -88.63 138.96 30.95 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 113.62 0.97 . . . . 0.0 113.62 -176.023 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 16.6 m -137.78 152.21 26.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 108.982 -0.748 . . . . 0.0 108.982 178.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -160.62 166.6 28.63 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 103.368 -2.827 . . . . 0.0 103.368 -179.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 12.4 t -138.63 177.24 8.03 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 106.059 -1.83 . . . . 0.0 106.059 178.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -67.5 135.71 53.47 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.983 0.421 . . . . 0.0 109.972 -179.415 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 96.16 -8.52 67.36 Favored Glycine 0 C--O 1.224 -0.514 0 CA-C-N 115.952 -0.567 . . . . 0.0 113.506 178.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -80.92 138.76 36.13 Favored 'General case' 0 CA--C 1.538 0.491 0 O-C-N 122.37 -0.488 . . . . 0.0 111.678 -179.534 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 91.9 mt -88.05 154.93 20.09 Favored 'General case' 0 C--O 1.214 -0.808 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 178.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 57.8 t30 -96.99 64.88 2.02 Favored 'General case' 0 C--N 1.323 -0.572 0 O-C-N 122.14 -0.35 . . . . 0.0 110.516 178.237 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -138.24 154.51 73.95 Favored Pre-proline 0 CA--C 1.538 0.518 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 -179.119 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -68.02 154.17 73.32 Favored 'Trans proline' 0 C--N 1.349 0.602 0 N-CA-C 114.332 0.859 . . . . 0.0 114.332 -179.222 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.447 ' HE3' ' HA ' ' A' ' 42' ' ' ASP . 70.9 mmtt -128.67 54.35 1.78 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.552 0.691 . . . . 0.0 109.627 -178.364 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 12.7 p-10 -60.48 -37.23 80.36 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.573 -177.017 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 10.6 p80 -65.56 -15.18 62.46 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 113.205 0.817 . . . . 0.0 113.205 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 25.1 mt -91.21 -38.19 10.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 178.276 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -75.74 2.75 53.18 Favored Glycine 0 CA--C 1.521 0.438 0 N-CA-C 116.013 1.165 . . . . 0.0 116.013 -177.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 6.2 t -91.17 22.45 3.78 Favored 'General case' 0 CA--C 1.548 0.876 0 CA-C-O 121.98 0.895 . . . . 0.0 111.728 -178.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.423 ' HD2' ' OD1' ' A' ' 114' ' ' ASN . 61.1 ttp85 -59.11 131.41 50.96 Favored 'General case' 0 N--CA 1.468 0.464 0 O-C-N 121.507 -0.745 . . . . 0.0 110.918 -179.625 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 71.1 m-20 -104.38 121.41 47.42 Favored Pre-proline 0 C--N 1.327 -0.394 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_endo -70.09 -14.72 35.37 Favored 'Trans proline' 0 C--N 1.348 0.516 0 N-CA-C 113.994 0.729 . . . . 0.0 113.994 -178.101 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -73.79 -25.61 60.21 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 120.665 0.269 . . . . 0.0 110.899 177.06 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 -101.89 -25.41 13.8 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 113.325 0.861 . . . . 0.0 113.325 -175.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . 0.423 ' OD1' ' HD2' ' A' ' 109' ' ' ARG . 0.4 OUTLIER -141.8 151.92 43.26 Favored 'General case' 0 N--CA 1.439 -1.013 0 CA-C-O 121.196 0.522 . . . . 0.0 111.451 -176.782 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -97.24 140.47 31.67 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 115.382 -0.826 . . . . 0.0 109.594 177.395 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -68.88 151.99 45.87 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.275 0.56 . . . . 0.0 111.459 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 5.3 mt -95.4 139.43 18.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.066 -178.018 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 71.8 t -62.07 125.9 19.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 N-CA-C 106.391 -1.707 . . . . 0.0 106.391 175.389 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 7.6 tt -66.85 128.14 35.17 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.225 0.536 . . . . 0.0 109.58 -177.392 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 29.5 mt-30 -129.45 158.26 39.68 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 105.417 -2.068 . . . . 0.0 105.417 179.391 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 21.3 mt -115.02 148.28 40.2 Favored Pre-proline 0 C--N 1.321 -0.662 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 179.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -72.65 170.33 19.76 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 120.49 0.793 . . . . 0.0 113.636 -177.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 4.1 tp-100 -53.84 129.08 32.43 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.391 -179.371 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 89.66 -10.97 71.7 Favored Glycine 0 CA--C 1.519 0.34 0 CA-C-N 115.999 -0.546 . . . . 0.0 114.385 179.399 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.533 HG22 HE22 ' A' ' 30' ' ' GLN . 25.7 m -108.67 127.05 53.64 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 117.955 0.877 . . . . 0.0 110.002 179.052 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 12.7 p -125.07 152.52 44.23 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 123.054 0.541 . . . . 0.0 110.83 -178.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 83.7 mt -69.62 153.27 95.82 Favored Pre-proline 0 C--N 1.328 -0.362 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 179.398 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -77.96 176.48 9.94 Favored 'Trans proline' 0 C--N 1.345 0.377 0 O-C-N 121.946 0.445 . . . . 0.0 111.283 178.401 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -59.48 125.59 24.24 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 113.85 1.056 . . . . 0.0 113.85 -174.572 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 91.51 -4.0 79.39 Favored Glycine 0 C--N 1.33 0.2 0 N-CA-C 115.748 1.059 . . . . 0.0 115.748 175.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.4 ' CZ ' ' HB2' ' A' ' 18' ' ' GLN . 2.4 m-85 -96.58 142.51 28.55 Favored 'General case' 0 N--CA 1.44 -0.964 0 CA-C-O 122.09 0.947 . . . . 0.0 113.055 -177.696 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 52.8 p90 -146.04 161.62 39.72 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 113.66 -1.609 . . . . 0.0 107.568 173.201 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -104.83 151.31 23.96 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 -178.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.42 ' HB3' ' HB ' ' A' ' 14' ' ' THR . 4.9 tp10 -70.92 134.94 47.65 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 178.488 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 84.56 -4.45 84.34 Favored Glycine 0 CA--C 1.521 0.438 0 C-N-CA 121.537 -0.364 . . . . 0.0 113.72 -177.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 18.2 t . . . . . 0 C--N 1.326 -0.431 0 CA-C-O 121.636 0.731 . . . . 0.0 109.292 178.87 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.173 0 CA-C-O 121.545 0.688 . . . . 0.0 112.101 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -59.17 142.48 51.54 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.184 -0.916 . . . . 0.0 110.305 177.934 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 21.4 m95 -67.19 -21.92 65.76 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 114.066 1.135 . . . . 0.0 114.066 -179.191 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 39.2 m-85 -121.48 162.21 20.91 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 114.336 1.236 . . . . 0.0 114.336 -170.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 53.8 p -68.87 164.58 21.72 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.377 -1.283 . . . . 0.0 110.811 -179.64 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -85.59 131.56 34.33 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.261 -0.881 . . . . 0.0 112.388 -176.731 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -81.61 148.85 28.87 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 105.466 -2.05 . . . . 0.0 105.466 173.793 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 57.1 m -118.21 139.66 50.95 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 179.441 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 4.1 tp60 -110.03 136.91 48.55 Favored 'General case' 0 C--N 1.328 -0.345 0 O-C-N 123.426 0.454 . . . . 0.0 111.338 -179.079 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 42.8 t60 -128.09 99.38 5.45 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 105.402 -2.073 . . . . 0.0 105.402 171.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 169.7 -167.57 40.62 Favored Glycine 0 C--O 1.225 -0.432 0 N-CA-C 109.289 -1.524 . . . . 0.0 109.289 -176.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 64.8 mttp -103.77 -23.32 13.42 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 179.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -82.51 158.85 23.01 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 -179.504 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -76.75 -62.86 1.5 Allowed 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 -179.369 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 32.7 tp 172.62 144.8 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 104.228 -2.508 . . . . 0.0 104.228 179.347 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 22.2 tptm -155.59 141.08 17.8 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 174.284 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -126.08 157.91 67.99 Favored Pre-proline 0 C--O 1.241 0.634 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 177.043 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -70.77 176.15 7.93 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 121.307 1.338 . . . . 0.0 114.678 -178.449 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 77.5 ttt180 -74.86 126.41 30.88 Favored 'General case' 0 C--O 1.217 -0.633 0 O-C-N 121.803 -0.56 . . . . 0.0 110.443 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 76.79 13.08 83.94 Favored Glycine 0 C--O 1.223 -0.54 0 N-CA-C 115.483 0.953 . . . . 0.0 115.483 175.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.492 HE22 HG21 ' A' ' 125' ' ' THR . 34.1 tt0 -157.01 142.5 17.47 Favored 'General case' 0 C--O 1.22 -0.458 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 -177.722 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 141.29 -18.06 2.69 Favored Glycine 0 CA--C 1.506 -0.503 0 C-N-CA 120.308 -0.949 . . . . 0.0 113.391 179.108 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 31.6 m -69.49 145.45 95.38 Favored Pre-proline 0 C--N 1.323 -0.566 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 176.381 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -75.9 172.45 16.25 Favored 'Trans proline' 0 CA--C 1.511 -0.64 0 C-N-CA 121.211 1.274 . . . . 0.0 112.582 -179.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 97.9 mt -71.8 109.97 4.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 176.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 69.6 m-80 -101.1 85.59 2.86 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 114.681 -1.145 . . . . 0.0 108.986 -177.812 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 73.7 p -66.16 -15.85 63.48 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 113.021 0.749 . . . . 0.0 113.021 -177.589 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 10.4 p30 -105.65 21.89 16.46 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.253 -0.885 . . . . 0.0 111.315 -178.276 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 14.2 m -141.44 150.95 42.98 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 113.306 0.854 . . . . 0.0 113.306 -176.624 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -73.72 166.57 43.01 Favored Pre-proline 0 C--N 1.326 -0.441 0 N-CA-C 108.396 -0.965 . . . . 0.0 108.396 176.761 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -64.22 -27.92 64.38 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 115.12 -2.787 . . . . 0.0 111.715 178.737 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -61.25 -28.68 69.34 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 123.778 0.831 . . . . 0.0 111.31 176.051 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 75.3 m-20 -98.51 -0.37 43.47 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 115.242 1.571 . . . . 0.0 115.242 -171.35 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 92.7 mm-40 -61.39 -25.63 67.31 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 113.554 0.946 . . . . 0.0 113.554 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 12.3 tt -58.78 141.08 16.22 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 N-CA-C 113.917 1.081 . . . . 0.0 113.917 -178.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 179.54 -152.59 11.15 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.422 -0.894 . . . . 0.0 112.294 179.388 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 48.7 p90 -155.07 165.67 35.99 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 108.312 -0.995 . . . . 0.0 108.312 178.475 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 24.9 m-85 -105.98 142.07 36.31 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 107.413 -1.328 . . . . 0.0 107.413 174.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 69.3 ttt-85 -116.77 123.56 47.44 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 123.597 0.759 . . . . 0.0 112.048 -176.155 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 50.4 ttp180 -71.53 144.46 49.58 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.024 177.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -144.82 143.3 30.56 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 175.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 35.3 p -138.67 171.35 14.48 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 103.379 -2.823 . . . . 0.0 103.379 175.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 23.5 tpt180 -135.7 122.61 21.25 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.253 -0.579 . . . . 0.0 109.941 174.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.76 144.44 25.12 Favored 'General case' 0 CA--C 1.498 -1.024 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 179.684 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -144.22 178.5 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 N-CA-C 104.123 -2.547 . . . . 0.0 104.123 -178.101 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.77 112.0 15.54 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 105.878 -1.897 . . . . 0.0 105.878 174.175 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -74.17 167.36 54.62 Favored Glycine 0 C--O 1.224 -0.483 0 N-CA-C 108.097 -2.001 . . . . 0.0 108.097 177.661 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -62.56 -48.23 83.36 Favored Glycine 0 C--O 1.224 -0.501 0 N-CA-C 109.677 -1.369 . . . . 0.0 109.677 -177.572 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -85.32 17.2 3.2 Favored 'General case' 0 C--O 1.217 -0.61 0 CA-C-O 122.432 1.11 . . . . 0.0 110.758 178.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 87.81 -19.43 33.59 Favored Glycine 0 C--O 1.228 -0.225 0 N-CA-C 115.699 1.039 . . . . 0.0 115.699 174.031 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -56.74 131.1 48.21 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.799 0.809 . . . . 0.0 110.548 -178.333 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 22.4 ptm -127.34 -163.21 1.23 Allowed 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 114.391 -1.277 . . . . 0.0 113.865 -171.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 10.8 mptt -126.14 -57.82 1.39 Allowed 'General case' 0 C--O 1.211 -0.942 0 C-N-CA 123.502 0.721 . . . . 0.0 111.624 -175.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 50.47 51.12 17.48 Favored 'General case' 0 N--CA 1.477 0.918 0 O-C-N 124.695 1.247 . . . . 0.0 113.587 178.325 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -66.37 138.69 57.77 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.632 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -57.42 157.71 12.5 Favored Pre-proline 0 C--O 1.242 0.677 0 CA-C-N 114.803 -1.089 . . . . 0.0 112.71 -179.355 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -68.11 135.85 35.92 Favored 'Trans proline' 0 C--O 1.24 0.592 0 C-N-CA 116.6 -1.8 . . . . 0.0 114.974 -177.665 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 30.0 mtp180 -119.76 158.13 27.16 Favored 'General case' 0 CA--C 1.507 -0.695 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 174.585 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 59.7 m95 -128.3 129.72 46.74 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.186 0.517 . . . . 0.0 109.974 178.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 70.4 m-85 -110.58 163.13 14.03 Favored 'General case' 0 C--O 1.213 -0.858 0 N-CA-C 105.505 -2.035 . . . . 0.0 105.505 179.251 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 89.6 t80 -109.88 136.71 48.74 Favored 'General case' 0 CA--C 1.511 -0.55 0 N-CA-C 107.305 -1.368 . . . . 0.0 107.305 177.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 9.8 m-85 -136.57 148.92 47.79 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 -176.477 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -82.46 159.42 22.92 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.484 -175.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -54.61 129.62 37.14 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.812 -178.262 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 66.85 39.73 93.5 Favored Glycine 0 C--O 1.222 -0.599 0 CA-C-O 119.187 -0.785 . . . . 0.0 114.863 176.196 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.326 -0.441 0 CA-C-N 118.187 0.993 . . . . 0.0 108.351 177.507 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 26.6 mt . . . . . 0 C--O 1.238 0.469 0 N-CA-C 114.7 1.37 . . . . 0.0 114.7 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -78.2 167.86 22.63 Favored 'Trans proline' 0 N--CA 1.461 -0.389 0 C-N-CA 121.671 1.58 . . . . 0.0 108.972 170.812 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 61.0 t80 -63.06 133.54 54.67 Favored 'General case' 0 C--N 1.32 -0.701 0 O-C-N 121.986 -0.446 . . . . 0.0 110.135 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 89.23 -3.19 84.1 Favored Glycine 0 CA--C 1.519 0.296 0 N-CA-C 114.437 0.535 . . . . 0.0 114.437 178.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -63.56 128.79 37.4 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 117.843 0.821 . . . . 0.0 112.873 -179.397 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 44.8 t30 -68.26 118.74 11.76 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.882 -179.436 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 16.1 ttmm -152.92 145.96 24.59 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 176.364 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 33.0 t0 -67.37 132.97 48.72 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.277 -0.874 . . . . 0.0 109.919 -179.272 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 71.81 24.67 76.33 Favored Glycine 0 C--O 1.24 0.498 0 CA-C-O 119.505 -0.608 . . . . 0.0 114.612 179.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 36.9 mm -131.66 132.6 62.11 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 CA-C-N 117.286 0.543 . . . . 0.0 110.495 -179.506 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.1 pt -131.44 117.14 34.62 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 CA-C-O 121.551 0.691 . . . . 0.0 110.572 175.5 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 96.1 m95 -82.53 134.74 35.2 Favored 'General case' 0 C--N 1.321 -0.645 0 O-C-N 121.966 -0.458 . . . . 0.0 111.996 -177.552 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -142.9 150.53 17.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 121.522 0.677 . . . . 0.0 109.788 -178.275 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -155.0 166.57 33.16 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 105.333 -2.099 . . . . 0.0 105.333 -178.756 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 14.7 t -128.1 167.9 16.11 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 105.186 -2.153 . . . . 0.0 105.186 176.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -65.04 137.0 57.43 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 95.68 -8.0 68.33 Favored Glycine 0 C--O 1.225 -0.417 0 CA-C-N 115.919 -0.582 . . . . 0.0 113.204 179.247 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -82.35 142.8 31.72 Favored 'General case' 0 CA--C 1.541 0.597 0 O-C-N 122.26 -0.553 . . . . 0.0 111.473 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 34.9 mt -90.98 135.55 33.66 Favored 'General case' 0 CA--C 1.513 -0.471 0 CA-C-O 121.386 0.612 . . . . 0.0 112.456 -179.242 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 55.3 t30 -84.69 72.27 10.72 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.526 -178.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -146.39 153.25 47.73 Favored Pre-proline 0 C--N 1.324 -0.531 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 -179.583 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -68.65 150.37 74.52 Favored 'Trans proline' 0 C--N 1.344 0.291 0 N-CA-C 114.103 0.77 . . . . 0.0 114.103 178.227 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 3.3 ptpt -151.78 56.82 0.86 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.791 0.805 . . . . 0.0 112.906 -179.432 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -56.76 -28.16 60.75 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 115.557 -0.747 . . . . 0.0 112.146 177.521 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 12.2 p80 -59.76 -10.82 4.16 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 114.363 1.246 . . . . 0.0 114.363 -178.775 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 55.7 mt -93.19 -42.16 13.01 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.496 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 178.118 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -72.06 14.65 2.12 Favored Glycine 0 N--CA 1.464 0.534 0 N-CA-C 116.559 1.384 . . . . 0.0 116.559 -176.007 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 15.2 t -90.45 23.73 2.87 Favored 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 112.768 0.655 . . . . 0.0 112.768 -178.132 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 62.0 ttp85 -55.39 130.19 41.6 Favored 'General case' 0 N--CA 1.475 0.788 0 O-C-N 121.58 -0.7 . . . . 0.0 109.62 -179.514 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 36.3 m120 -95.47 122.92 58.1 Favored Pre-proline 0 C--N 1.322 -0.608 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 -179.404 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -68.44 -20.17 42.22 Favored 'Trans proline' 0 C--O 1.219 -0.443 0 C-N-CA 117.159 -1.427 . . . . 0.0 113.133 179.624 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -73.26 -29.26 62.63 Favored 'General case' 0 C--O 1.22 -0.498 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.427 178.228 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 -100.63 -25.81 14.03 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -175.414 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 26.7 t30 -151.61 144.44 24.42 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 113.448 0.907 . . . . 0.0 113.448 -178.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -83.84 146.92 27.84 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.113 179.549 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -66.34 139.99 58.07 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.209 0.528 . . . . 0.0 110.274 178.676 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 14.3 mt -82.38 138.74 18.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 -177.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -61.15 125.71 17.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 175.328 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 7.8 tt -67.08 128.78 37.66 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 -178.018 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 29.6 mt-30 -128.65 153.35 47.37 Favored 'General case' 0 CA--C 1.507 -0.7 0 N-CA-C 106.088 -1.819 . . . . 0.0 106.088 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 17.0 mt -113.31 149.51 41.6 Favored Pre-proline 0 C--N 1.321 -0.661 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 178.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -72.15 170.65 18.55 Favored 'Trans proline' 0 C--N 1.343 0.278 0 N-CA-C 113.888 0.688 . . . . 0.0 113.888 -177.562 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -54.45 130.86 41.03 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.219 -179.349 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 90.13 -12.21 68.49 Favored Glycine 0 C--O 1.227 -0.325 0 CA-C-N 115.931 -0.577 . . . . 0.0 113.363 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.492 HG21 HE22 ' A' ' 30' ' ' GLN . 8.8 m -108.56 125.63 52.04 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 117.659 0.73 . . . . 0.0 110.271 179.145 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 10.3 p -126.21 150.43 48.36 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.929 -177.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 83.0 mt -69.53 153.79 95.42 Favored Pre-proline 0 C--N 1.325 -0.488 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 176.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -76.03 169.55 21.89 Favored 'Trans proline' 0 N--CA 1.464 -0.251 0 C-N-CA 118.349 -0.634 . . . . 0.0 111.23 178.491 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 60.0 tttm -61.3 130.72 47.55 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 122.144 -0.348 . . . . 0.0 110.507 -177.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 95.29 -3.57 66.47 Favored Glycine 0 C--O 1.226 -0.354 0 CA-C-N 115.923 -0.58 . . . . 0.0 114.106 178.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -106.47 137.83 43.75 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 179.506 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 51.1 p90 -141.53 160.04 40.97 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 175.157 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -107.14 139.74 41.1 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.594 0.59 . . . . 0.0 112.594 -175.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -73.68 143.8 46.08 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 177.183 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 96.51 -37.58 3.39 Favored Glycine 0 C--O 1.224 -0.506 0 N-CA-C 111.208 -0.757 . . . . 0.0 111.208 -178.449 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 36.9 t . . . . . 0 C--N 1.323 -0.559 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 176.419 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 0.227 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -60.16 142.28 54.57 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.053 178.688 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 19.0 m95 -69.75 -23.98 63.46 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 113.816 1.043 . . . . 0.0 113.816 -179.089 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 52.7 m-85 -121.54 162.68 20.15 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 113.343 0.868 . . . . 0.0 113.343 -171.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 66.3 p -68.42 164.48 20.93 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.787 -1.097 . . . . 0.0 108.959 178.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -75.87 145.57 40.44 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 113.242 0.83 . . . . 0.0 113.242 -176.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 15.7 mt -87.4 140.3 29.67 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 102.175 -3.269 . . . . 0.0 102.175 167.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 63.7 m -116.7 128.5 55.4 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 -179.501 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -82.72 138.79 33.96 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.909 179.512 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 9.5 t-160 -139.46 94.74 2.82 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 103.589 -2.745 . . . . 0.0 103.589 167.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 163.13 -143.04 8.31 Favored Glycine 0 C--O 1.226 -0.386 0 C-N-CA 120.432 -0.889 . . . . 0.0 112.267 -175.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -121.19 -27.35 4.91 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 116.179 1.918 . . . . 0.0 116.179 -176.596 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -78.75 158.05 28.35 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 179.467 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -72.35 -62.87 1.28 Allowed 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.416 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 53.3 tp 175.54 143.93 0.06 Allowed 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 104.216 -2.512 . . . . 0.0 104.216 173.407 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.9 tppp? -158.13 141.23 14.99 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 108.855 -0.795 . . . . 0.0 108.855 176.669 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -126.01 153.12 73.86 Favored Pre-proline 0 C--N 1.325 -0.49 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 175.745 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -68.77 162.23 42.17 Favored 'Trans proline' 0 C--N 1.352 0.717 0 O-C-N 122.151 0.553 . . . . 0.0 113.09 179.481 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 18.0 tpt180 -64.02 131.88 48.92 Favored 'General case' 0 C--O 1.216 -0.678 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.895 -177.279 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 76.18 17.37 80.04 Favored Glycine 0 C--O 1.224 -0.486 0 C-N-CA 121.319 -0.467 . . . . 0.0 112.911 178.234 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 8.8 mt-30 -150.35 170.49 18.91 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 -175.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 109.2 -14.87 33.4 Favored Glycine 0 CA--C 1.502 -0.735 0 C-N-CA 121.455 -0.402 . . . . 0.0 113.345 175.275 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 89.2 t -66.13 129.6 94.24 Favored Pre-proline 0 C--N 1.319 -0.741 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 177.338 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_endo -74.21 169.55 22.21 Favored 'Trans proline' 0 N--CA 1.46 -0.481 0 O-C-N 122.143 0.549 . . . . 0.0 111.492 178.11 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 89.1 mt -70.33 107.73 2.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-O 122.084 0.945 . . . . 0.0 108.69 -179.643 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 76.1 m-20 -98.85 85.22 3.24 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 114.34 -1.3 . . . . 0.0 108.837 -178.213 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 70.1 p -66.29 -15.85 63.56 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 113.761 1.023 . . . . 0.0 113.761 -176.674 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 20.0 p30 -110.01 23.72 13.98 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.297 -0.865 . . . . 0.0 112.204 -177.398 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 15.9 m -138.55 149.25 45.12 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 113.227 0.825 . . . . 0.0 113.227 -175.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -73.77 166.71 41.83 Favored Pre-proline 0 C--O 1.236 0.379 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 177.751 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -64.66 -27.35 60.79 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 114.936 -2.909 . . . . 0.0 111.661 178.443 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -61.87 -27.67 68.96 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 123.69 0.796 . . . . 0.0 111.7 176.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 77.3 m-20 -94.87 -4.17 47.47 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 114.696 1.369 . . . . 0.0 114.696 -171.123 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 96.2 mm-40 -59.78 -28.94 67.85 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 114.465 1.283 . . . . 0.0 114.465 -177.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 11.4 tt -58.54 138.19 19.89 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.884 0 CA-C-O 122.308 1.051 . . . . 0.0 113.804 -177.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -178.82 -156.9 18.27 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.616 -0.802 . . . . 0.0 113.004 -178.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 46.6 p90 -155.14 170.54 21.59 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 179.389 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 20.0 m-85 -111.35 140.26 46.07 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 173.363 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -109.55 120.3 42.06 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 124.122 0.969 . . . . 0.0 109.933 -177.694 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 40.2 ttp180 -68.08 136.19 53.39 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 175.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -144.83 147.24 32.62 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 123.054 0.542 . . . . 0.0 110.817 -177.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -153.39 129.03 10.04 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.082 176.254 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 15.0 tpp180 -90.04 123.73 34.17 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 105.048 -2.205 . . . . 0.0 105.048 174.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 4.3 tmt_? -145.51 130.85 18.6 Favored 'General case' 0 CA--C 1.489 -1.371 0 CA-C-O 122.351 1.072 . . . . 0.0 111.029 -178.067 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -140.04 -179.94 2.36 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 CA-C-N 112.685 -2.052 . . . . 0.0 106.661 -177.884 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 3.3 tmt_? -129.32 103.77 7.12 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 105.677 -1.971 . . . . 0.0 105.677 172.027 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -72.83 158.35 53.05 Favored Glycine 0 N--CA 1.452 -0.241 0 N-CA-C 107.708 -2.157 . . . . 0.0 107.708 177.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -60.7 -37.07 92.93 Favored Glycine 0 C--O 1.222 -0.649 0 CA-C-N 118.173 0.986 . . . . 0.0 111.998 -179.371 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 39.5 t0 -86.96 13.98 8.16 Favored 'General case' 0 CA--C 1.55 0.951 0 CA-C-O 122.731 1.253 . . . . 0.0 111.248 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 86.85 6.37 79.79 Favored Glycine 0 C--O 1.224 -0.47 0 CA-C-N 115.393 -0.821 . . . . 0.0 113.543 171.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 20.9 mmtt -74.62 151.15 39.38 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-O 121.812 0.815 . . . . 0.0 111.463 -174.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 83.2 mtp -118.17 -173.94 2.56 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 114.059 -1.428 . . . . 0.0 109.576 -179.145 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 16.0 mmtt -119.94 -75.96 0.58 Allowed 'General case' 0 C--O 1.22 -0.478 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 179.774 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 52.3 m-20 -95.18 149.72 20.99 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 104.628 -2.36 . . . . 0.0 104.628 176.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 84.5 mt -118.96 -57.24 2.04 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 106.327 -1.731 . . . . 0.0 106.327 177.072 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -78.96 141.28 58.65 Favored Pre-proline 0 C--O 1.245 0.824 0 CA-C-N 115.058 -0.973 . . . . 0.0 108.929 175.468 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -73.06 155.88 52.2 Favored 'Trans proline' 0 C--O 1.239 0.531 0 C-N-CA 116.808 -1.661 . . . . 0.0 112.273 178.691 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 29.6 mtt85 -123.94 159.93 28.67 Favored 'General case' 0 CA--C 1.507 -0.685 0 CA-C-N 115.958 -0.564 . . . . 0.0 109.779 -178.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 54.4 m95 -134.01 140.9 47.01 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 177.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 61.6 m-85 -120.56 154.62 35.12 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 106.567 -1.642 . . . . 0.0 106.567 178.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 86.1 t80 -98.27 137.88 36.35 Favored 'General case' 0 CA--C 1.507 -0.696 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 -179.165 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -137.67 144.05 41.63 Favored 'General case' 0 N--CA 1.44 -0.925 0 N-CA-C 106.838 -1.542 . . . . 0.0 106.838 -176.599 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 55.5 m-85 -81.84 159.47 23.73 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.137 -176.37 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -53.86 132.16 41.19 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 112.473 0.546 . . . . 0.0 112.473 -177.499 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 65.56 29.88 76.18 Favored Glycine 0 C--O 1.224 -0.492 0 N-CA-C 115.83 1.092 . . . . 0.0 115.83 173.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 13.6 p . . . . . 0 C--N 1.322 -0.592 0 CA-C-N 117.958 0.879 . . . . 0.0 108.881 177.978 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 17.5 mt . . . . . 0 N--CA 1.446 -0.633 0 N-CA-C 114.31 1.226 . . . . 0.0 114.31 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -78.57 165.2 25.3 Favored 'Trans proline' 0 C--O 1.237 0.445 0 C-N-CA 121.625 1.55 . . . . 0.0 108.147 169.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 68.0 t80 -61.85 131.43 49.76 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 120.343 -0.543 . . . . 0.0 110.216 -179.363 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 92.21 -6.64 78.58 Favored Glycine 0 CA--C 1.52 0.372 0 N-CA-C 115.101 0.8 . . . . 0.0 115.101 178.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -64.42 129.02 38.28 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 118.431 1.115 . . . . 0.0 112.36 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 58.0 t30 -75.09 127.95 34.39 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.287 -178.318 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 1.2 ttmp? -156.18 153.2 28.87 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 179.33 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -62.11 129.06 39.09 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.812 0.339 . . . . 0.0 111.766 -179.434 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 66.39 31.38 78.73 Favored Glycine 0 N--CA 1.451 -0.301 0 CA-C-O 119.457 -0.635 . . . . 0.0 114.238 178.041 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 43.8 mm -128.61 129.95 68.79 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 CA-C-N 117.419 0.61 . . . . 0.0 109.942 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.1 pt -132.86 120.33 40.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.204 176.025 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 96.0 m95 -85.98 136.81 33.11 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 -176.678 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 16.3 m -138.15 149.74 24.66 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 CA-C-O 121.525 0.679 . . . . 0.0 109.623 179.523 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -155.97 166.62 32.93 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 104.43 -2.433 . . . . 0.0 104.43 -179.359 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 12.6 t -137.93 175.14 9.85 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 105.936 -1.876 . . . . 0.0 105.936 179.311 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -64.96 135.48 55.71 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.162 0.506 . . . . 0.0 110.549 -179.409 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 94.39 -7.9 71.93 Favored Glycine 0 C--O 1.224 -0.526 0 CA-C-N 115.881 -0.599 . . . . 0.0 113.755 177.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -79.35 138.84 37.84 Favored 'General case' 0 CA--C 1.538 0.505 0 O-C-N 122.443 -0.445 . . . . 0.0 111.92 -179.449 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 34.7 mt -95.08 137.08 34.62 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-O 121.007 0.432 . . . . 0.0 111.993 -179.455 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 58.9 t30 -82.0 69.54 8.73 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.11 0.481 . . . . 0.0 110.764 -179.437 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -141.26 155.65 67.85 Favored Pre-proline 0 C--N 1.323 -0.562 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 -178.626 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -64.62 150.53 88.04 Favored 'Trans proline' 0 C--N 1.344 0.338 0 N-CA-C 115.262 1.216 . . . . 0.0 115.262 179.649 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -124.8 37.75 4.34 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 114.609 -1.178 . . . . 0.0 109.054 -177.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 16.6 p-10 -48.89 -45.96 41.95 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 114.742 -1.117 . . . . 0.0 112.869 -179.647 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 48.8 p-80 -70.05 -9.5 55.56 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 124.38 1.072 . . . . 0.0 113.747 -177.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 48.8 mt -94.9 -48.04 13.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 179.055 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -74.99 14.66 4.53 Favored Glycine 0 C--O 1.224 -0.502 0 N-CA-C 116.397 1.319 . . . . 0.0 116.397 -177.122 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 13.6 t -92.95 24.56 3.62 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 117.41 0.605 . . . . 0.0 111.099 179.478 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.449 ' HD2' HD22 ' A' ' 114' ' ' ASN . 65.9 ttp85 -57.8 136.28 56.93 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 178.918 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -109.09 132.22 21.34 Favored Pre-proline 0 C--N 1.324 -0.51 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -72.6 -15.35 27.37 Favored 'Trans proline' 0 C--O 1.219 -0.447 0 C-N-CA 117.877 -0.949 . . . . 0.0 113.52 -178.177 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -75.62 -25.62 57.07 Favored 'General case' 0 C--O 1.22 -0.481 0 CA-C-O 120.942 0.401 . . . . 0.0 110.303 178.401 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 82.7 m-20 -102.6 -23.31 13.88 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 113.745 1.017 . . . . 0.0 113.745 -174.339 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . 0.449 HD22 ' HD2' ' A' ' 109' ' ' ARG . 35.7 t30 -153.98 152.36 30.45 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.62 0.6 . . . . 0.0 112.62 -176.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -94.27 146.9 23.69 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-O 121.184 0.516 . . . . 0.0 110.749 178.402 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -71.38 148.47 46.95 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.005 0.431 . . . . 0.0 110.833 178.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 3.4 mt -92.41 142.33 13.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 -178.322 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -59.47 126.19 16.76 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 175.825 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 6.0 tt -68.55 128.88 38.2 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.956 -177.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 30.2 mt-30 -132.36 157.93 43.23 Favored 'General case' 0 CA--C 1.511 -0.544 0 N-CA-C 106.677 -1.601 . . . . 0.0 106.677 -179.122 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 13.7 mt -113.69 147.56 37.89 Favored Pre-proline 0 C--N 1.322 -0.62 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 177.6 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -73.32 167.0 28.44 Favored 'Trans proline' 0 C--N 1.346 0.397 0 O-C-N 122.223 0.591 . . . . 0.0 112.928 -179.342 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 43.6 tt0 -54.88 131.39 44.2 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.604 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 97.89 -19.45 54.54 Favored Glycine 0 C--O 1.227 -0.303 0 CA-C-N 116.004 -0.543 . . . . 0.0 113.256 -179.511 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 6.9 m -106.71 127.57 53.48 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 118.148 0.974 . . . . 0.0 110.576 178.713 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 17.2 p -120.24 148.36 43.79 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.541 -179.535 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 91.7 mt -67.24 154.87 91.96 Favored Pre-proline 0 C--N 1.324 -0.526 0 N-CA-C 107.953 -1.128 . . . . 0.0 107.953 178.082 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -75.16 170.47 20.3 Favored 'Trans proline' 0 N--CA 1.461 -0.385 0 C-N-CA 118.208 -0.728 . . . . 0.0 110.854 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 23.8 tptm -60.9 120.66 10.61 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 -178.094 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 91.13 41.53 5.21 Favored Glycine 0 C--O 1.227 -0.331 0 N-CA-C 115.297 0.879 . . . . 0.0 115.297 178.736 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -145.19 148.53 33.65 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 117.384 0.592 . . . . 0.0 110.403 177.557 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 54.8 p90 -147.73 165.05 31.68 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.212 -1.032 . . . . 0.0 108.212 176.106 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -105.99 139.81 39.95 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.01 0.433 . . . . 0.0 111.851 -176.703 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -74.09 143.56 45.34 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 178.236 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 95.59 -38.14 3.21 Favored Glycine 0 CA--C 1.518 0.25 0 C-N-CA 121.687 -0.292 . . . . 0.0 113.486 179.373 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 32.2 t . . . . . 0 C--N 1.324 -0.518 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 177.101 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.598 0 CA-C-O 122.464 1.126 . . . . 0.0 113.72 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 30.9 t -58.98 142.21 51.72 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 113.986 -1.461 . . . . 0.0 109.974 175.21 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 17.1 m95 -64.33 -21.94 66.78 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 114.104 1.15 . . . . 0.0 114.104 178.545 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -121.41 162.96 19.49 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 114.312 1.227 . . . . 0.0 114.312 -169.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 68.3 p -70.76 162.66 28.72 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 114.575 -1.193 . . . . 0.0 107.855 176.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -75.72 141.98 42.54 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 113.243 0.831 . . . . 0.0 113.243 -175.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 12.4 mt -85.66 142.46 29.04 Favored 'General case' 0 C--O 1.213 -0.868 0 N-CA-C 102.678 -3.082 . . . . 0.0 102.678 169.257 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 40.9 m -123.84 135.77 53.96 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 118.638 0.654 . . . . 0.0 110.267 -177.603 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . 0.419 ' HB2' ' CZ ' ' A' ' 131' ' ' PHE . 4.1 tp60 -100.7 139.25 36.65 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.493 -0.776 . . . . 0.0 112.005 -178.133 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 16.1 t-160 -126.58 99.6 5.87 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 103.775 -2.676 . . . . 0.0 103.775 168.674 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 157.17 -173.54 34.72 Favored Glycine 0 C--O 1.225 -0.417 0 N-CA-C 109.098 -1.601 . . . . 0.0 109.098 -176.629 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -97.68 -21.86 16.78 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 114.629 1.344 . . . . 0.0 114.629 -177.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -71.4 157.18 38.52 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.723 0.297 . . . . 0.0 110.351 -178.471 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -74.98 -63.0 1.36 Allowed 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.837 -0.345 . . . . 0.0 111.292 -178.092 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 36.0 tp 161.03 141.78 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.203 0 N-CA-C 102.299 -3.223 . . . . 0.0 102.299 179.094 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 13.8 tmtt? -156.71 131.07 8.63 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 176.625 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 -114.77 142.43 28.32 Favored Pre-proline 0 CA--C 1.54 0.592 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 176.491 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -62.88 154.12 68.52 Favored 'Trans proline' 0 CA--C 1.541 0.869 0 CA-C-O 121.325 0.469 . . . . 0.0 112.958 173.347 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 4.1 tmt_? -63.66 134.14 54.89 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.943 -177.701 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 87.96 6.85 75.09 Favored Glycine 0 C--O 1.226 -0.347 0 O-C-N 123.4 0.438 . . . . 0.0 112.381 178.381 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -145.72 167.78 22.31 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 -176.108 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 112.59 -19.38 21.73 Favored Glycine 0 CA--C 1.5 -0.846 0 C-N-CA 121.716 -0.278 . . . . 0.0 113.638 173.449 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 95.8 t -67.33 127.82 93.55 Favored Pre-proline 0 C--N 1.32 -0.712 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 178.473 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -74.93 164.03 34.25 Favored 'Trans proline' 0 N--CA 1.459 -0.504 0 O-C-N 122.124 0.539 . . . . 0.0 111.801 178.12 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 97.9 mt -66.84 123.44 19.9 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 -178.573 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.42 ' ND2' ' HH ' ' A' ' 72' ' ' TYR . 46.1 t-20 -125.61 113.83 17.91 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 177.239 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 67.0 p -90.68 -14.83 31.47 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 -175.509 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -111.51 28.99 8.23 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 113.408 0.892 . . . . 0.0 113.408 -175.65 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 99.3 p -141.58 164.88 29.02 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.713 0.292 . . . . 0.0 110.998 -179.412 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 4.2 m -77.13 164.95 55.73 Favored Pre-proline 0 C--N 1.321 -0.642 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.85 -178.294 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -68.31 -25.03 36.7 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 115.068 -2.821 . . . . 0.0 113.425 178.03 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.5 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 3.4 p-10 -76.64 -19.06 58.21 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 121.375 -0.828 . . . . 0.0 111.563 176.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 78.1 m-20 -78.57 -6.92 56.86 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 113.469 0.914 . . . . 0.0 113.469 -176.695 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 95.7 mm-40 -62.16 -24.91 67.46 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 113.595 0.961 . . . . 0.0 113.595 -177.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 7.9 tt -60.93 137.9 22.61 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.811 0 CA-C-O 122.205 1.003 . . . . 0.0 112.761 179.47 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 179.15 -156.9 19.7 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.465 -0.874 . . . . 0.0 112.382 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 45.3 p90 -155.02 170.45 21.74 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 179.1 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 19.5 m-85 -112.59 141.75 45.99 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 107.219 -1.401 . . . . 0.0 107.219 173.559 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 67.8 ttt-85 -112.24 130.24 55.99 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.971 -0.558 . . . . 0.0 111.237 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 44.8 ttt85 -71.67 145.35 48.95 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.472 0.653 . . . . 0.0 112.249 179.222 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -152.2 170.07 20.9 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 105.501 -2.037 . . . . 0.0 105.501 177.479 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 12.1 t -156.6 166.65 32.8 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 176.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 34.8 tpt85 -130.25 127.5 39.7 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 173.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 2.9 tmt_? -151.04 152.05 32.9 Favored 'General case' 0 CA--C 1.495 -1.147 0 N-CA-C 105.229 -2.137 . . . . 0.0 105.229 -178.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -125.99 174.17 10.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 26.8 tpt180 -141.99 122.31 13.96 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 106.106 -1.813 . . . . 0.0 106.106 177.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -82.65 174.56 53.14 Favored Glycine 0 C--O 1.224 -0.505 0 N-CA-C 109.24 -1.544 . . . . 0.0 109.24 178.003 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -72.26 -40.24 55.98 Favored Glycine 0 C--O 1.216 -1.023 0 N-CA-C 111.241 -0.744 . . . . 0.0 111.241 -177.485 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 27.3 t0 -71.93 -20.67 61.72 Favored 'General case' 0 C--O 1.217 -0.65 0 CA-C-O 122.635 1.207 . . . . 0.0 108.4 177.577 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 116.55 -12.39 15.82 Favored Glycine 0 CA--C 1.501 -0.803 0 CA-C-N 114.74 -1.118 . . . . 0.0 111.051 172.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 4.0 pttt -67.69 140.68 56.79 Favored 'General case' 0 CA--C 1.505 -0.755 0 CA-C-O 121.974 0.892 . . . . 0.0 110.495 -177.613 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 16.9 ptm -136.34 -177.47 4.73 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 114.027 -1.442 . . . . 0.0 112.155 -174.327 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 58.4 mmtt -90.58 -125.21 0.07 Allowed 'General case' 0 C--O 1.216 -0.663 0 N-CA-C 104.16 -2.533 . . . . 0.0 104.16 175.305 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 38.2 t0 -143.92 177.2 8.71 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 103.882 -2.636 . . . . 0.0 103.882 177.182 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -80.92 136.98 36.13 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 178.292 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.1 p -112.23 89.92 13.03 Favored Pre-proline 0 C--N 1.322 -0.593 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 173.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -69.13 131.82 22.99 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 115.632 -2.445 . . . . 0.0 112.107 -178.356 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 33.5 ptt180 -141.46 157.99 44.44 Favored 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 179.182 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 57.3 m95 -129.57 148.07 51.44 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 120.668 0.271 . . . . 0.0 111.306 -175.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 48.1 m-85 -124.68 146.09 49.32 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 106.499 -1.667 . . . . 0.0 106.499 -179.433 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 75.1 t80 -95.74 131.5 41.94 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 -175.411 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -133.87 159.81 39.56 Favored 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 107.096 -1.446 . . . . 0.0 107.096 -175.201 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.42 ' HH ' ' ND2' ' A' ' 35' ' ' ASN . 71.5 m-85 -99.95 159.56 14.98 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 111.713 0.264 . . . . 0.0 111.713 -171.637 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -54.51 129.69 37.01 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.688 -178.759 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 68.72 34.48 78.13 Favored Glycine 0 C--O 1.221 -0.665 0 CA-C-O 118.804 -0.998 . . . . 0.0 115.57 176.666 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.327 -0.391 0 CA-C-N 118.633 1.216 . . . . 0.0 109.225 177.623 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 53.0 mt . . . . . 0 N--CA 1.447 -0.624 0 N-CA-C 115.015 1.487 . . . . 0.0 115.015 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -77.32 167.87 23.91 Favored 'Trans proline' 0 C--O 1.237 0.432 0 N-CA-C 108.749 -1.289 . . . . 0.0 108.749 170.454 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 66.7 t80 -62.77 134.0 55.62 Favored 'General case' 0 C--N 1.321 -0.658 0 O-C-N 121.957 -0.465 . . . . 0.0 110.019 179.431 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 89.64 -3.25 83.31 Favored Glycine 0 CA--C 1.519 0.327 0 N-CA-C 114.505 0.562 . . . . 0.0 114.505 178.236 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -63.14 130.13 43.3 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 117.812 0.806 . . . . 0.0 112.061 179.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 50.1 t-20 -76.6 124.67 27.98 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.692 -178.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 23.3 tttt -155.33 152.15 28.82 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 178.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -64.12 130.49 44.15 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.962 -178.117 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 65.62 30.27 77.01 Favored Glycine 0 N--CA 1.45 -0.395 0 CA-C-O 119.597 -0.557 . . . . 0.0 114.238 179.057 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 37.1 mm -129.83 128.71 65.56 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 CA-C-N 117.362 0.581 . . . . 0.0 110.154 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -133.16 118.27 31.78 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 CA-C-O 121.425 0.631 . . . . 0.0 110.747 177.175 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 92.8 m95 -84.98 137.27 33.19 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 113.395 0.887 . . . . 0.0 113.395 -175.675 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 18.6 m -137.85 149.7 25.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.66 0.743 . . . . 0.0 110.016 179.653 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -159.63 166.64 30.24 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 104.049 -2.575 . . . . 0.0 104.049 -179.404 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 10.6 t -131.73 173.92 10.66 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 104.956 -2.239 . . . . 0.0 104.956 177.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -67.69 135.14 52.3 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 -178.293 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 95.84 -11.14 68.22 Favored Glycine 0 CA--C 1.518 0.231 0 CA-C-N 115.883 -0.598 . . . . 0.0 112.945 -179.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.5 ' HA ' ' HA ' ' A' ' 41' ' ' ASP . . . -74.24 133.01 42.65 Favored 'General case' 0 CA--C 1.541 0.609 0 O-C-N 122.413 -0.463 . . . . 0.0 109.864 178.847 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 27.8 mt -88.53 140.39 29.51 Favored 'General case' 0 CA--C 1.513 -0.473 0 CA-C-O 121.367 0.603 . . . . 0.0 111.917 -178.148 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 58.0 t30 -84.43 68.08 10.13 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.371 -179.263 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -138.41 151.95 70.28 Favored Pre-proline 0 C--O 1.24 0.594 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -68.14 150.89 77.39 Favored 'Trans proline' 0 C--N 1.343 0.256 0 N-CA-C 114.62 0.969 . . . . 0.0 114.62 177.304 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 1.6 ptpt -150.99 58.45 0.91 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.987 0.898 . . . . 0.0 111.863 178.496 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -56.47 -28.47 59.8 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 115.037 -0.983 . . . . 0.0 111.225 177.061 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 14.2 p80 -59.24 -10.38 2.89 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 114.544 1.312 . . . . 0.0 114.544 -178.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 37.9 mt -96.31 -36.3 6.33 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.577 0 CA-C-N 117.92 0.327 . . . . 0.0 110.165 178.128 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -74.11 14.44 3.86 Favored Glycine 0 N--CA 1.464 0.538 0 N-CA-C 116.023 1.169 . . . . 0.0 116.023 -176.314 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 15.2 t -96.5 23.29 6.96 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 -177.179 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 57.8 ttp85 -63.05 126.63 27.97 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 106.943 -1.503 . . . . 0.0 106.943 177.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 18.3 m-20 -110.84 131.96 21.87 Favored Pre-proline 0 C--N 1.32 -0.684 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 -178.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -67.64 -21.45 45.56 Favored 'Trans proline' 0 C--N 1.349 0.589 0 N-CA-C 114.728 1.011 . . . . 0.0 114.728 -175.072 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -71.99 -25.0 61.67 Favored 'General case' 0 C--O 1.219 -0.526 0 CA-C-O 120.784 0.326 . . . . 0.0 110.266 177.559 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 -101.81 -28.54 12.38 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 113.486 0.921 . . . . 0.0 113.486 -175.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 18.9 t30 -159.36 148.91 18.53 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -178.117 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -85.28 149.62 25.35 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-O 121.675 0.75 . . . . 0.0 112.862 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -70.73 147.39 49.08 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.762 178.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 23.5 mt -86.8 139.31 17.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.387 -179.141 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 73.1 t -61.87 122.02 11.56 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 174.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 5.8 tt -67.79 129.38 39.73 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.957 0.408 . . . . 0.0 110.123 -177.433 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -134.79 158.1 45.04 Favored 'General case' 0 CA--C 1.513 -0.472 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 -178.581 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 14.9 mt -114.45 149.2 41.78 Favored Pre-proline 0 C--N 1.322 -0.618 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 176.346 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_endo -70.56 168.81 21.52 Favored 'Trans proline' 0 C--N 1.343 0.27 0 N-CA-C 114.377 0.876 . . . . 0.0 114.377 -177.042 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -55.5 133.82 50.34 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.415 -178.242 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 88.27 -12.16 65.45 Favored Glycine 0 C--O 1.227 -0.333 0 CA-C-N 115.854 -0.612 . . . . 0.0 112.619 -179.688 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 16.2 m -107.38 125.9 51.79 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.113 0.483 . . . . 0.0 110.28 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 17.7 p -121.48 148.26 44.67 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 113.027 0.751 . . . . 0.0 113.027 -176.572 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 89.3 mt -69.79 156.28 92.0 Favored Pre-proline 0 C--N 1.326 -0.439 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 177.147 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -75.49 168.16 25.07 Favored 'Trans proline' 0 C--O 1.235 0.334 0 C-N-CA 118.42 -0.587 . . . . 0.0 111.252 178.506 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 1.8 tmtp? -58.72 128.79 38.97 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.702 -177.609 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 95.0 -5.57 68.76 Favored Glycine 0 C--O 1.225 -0.421 0 N-CA-C 114.664 0.625 . . . . 0.0 114.664 177.627 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.419 ' CZ ' ' HB2' ' A' ' 18' ' ' GLN . 1.4 m-85 -104.27 140.24 38.15 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-O 121.873 0.844 . . . . 0.0 111.199 -179.521 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 46.1 p90 -142.19 165.67 26.8 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 114.174 -1.376 . . . . 0.0 107.461 176.092 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -106.98 144.61 33.35 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.927 0.394 . . . . 0.0 111.358 -177.37 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -72.67 136.94 45.73 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 178.747 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 89.64 -30.0 5.97 Favored Glycine 0 CA--C 1.518 0.241 0 CA-C-N 116.139 -0.482 . . . . 0.0 112.786 -177.242 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 22.7 t . . . . . 0 C--N 1.325 -0.476 0 CA-C-N 117.386 0.593 . . . . 0.0 110.635 -179.942 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.836 0 CA-C-O 121.703 0.763 . . . . 0.0 112.724 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 51.2 p -60.66 144.84 51.12 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 114.908 -1.042 . . . . 0.0 110.293 178.652 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 22.3 m95 -70.8 -24.36 62.55 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 114.727 1.38 . . . . 0.0 114.727 -178.369 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 26.3 m-85 -121.49 162.47 20.46 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 -171.645 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 73.0 p -70.25 162.68 27.99 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 179.195 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -79.42 149.17 31.68 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.953 0.882 . . . . 0.0 112.991 -177.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 37.1 mt -89.52 148.95 23.12 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 102.77 -3.048 . . . . 0.0 102.77 168.637 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 33.6 m -122.83 138.51 54.63 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . 0.426 ' HB2' ' CZ ' ' A' ' 131' ' ' PHE . 4.1 tp60 -110.66 135.08 51.81 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.246 0.546 . . . . 0.0 112.3 -176.785 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 7.7 t-160 -130.9 94.68 3.66 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 104.055 -2.572 . . . . 0.0 104.055 170.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -178.76 -171.21 41.76 Favored Glycine 0 C--O 1.224 -0.494 0 N-CA-C 110.19 -1.164 . . . . 0.0 110.19 -176.622 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -97.69 -26.45 14.74 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 113.844 1.053 . . . . 0.0 113.844 -177.646 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 25.6 pt-20 -92.23 166.41 12.63 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 179.024 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -79.22 -62.93 1.54 Allowed 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 120.704 -0.398 . . . . 0.0 111.753 -177.255 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 36.8 tp 171.61 144.18 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 105.822 -1.918 . . . . 0.0 105.822 178.059 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 55.0 tttm -156.03 142.69 18.7 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 171.434 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 15.5 m-85 -119.66 157.9 50.86 Favored Pre-proline 0 C--O 1.247 0.955 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 176.175 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -64.99 163.78 27.26 Favored 'Trans proline' 0 C--N 1.352 0.745 0 C-N-CA 121.355 1.37 . . . . 0.0 112.755 175.64 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 25.9 tpt180 -78.14 132.63 37.73 Favored 'General case' 0 C--O 1.216 -0.696 0 O-C-N 121.845 -0.534 . . . . 0.0 110.743 -177.435 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 77.95 17.81 77.88 Favored Glycine 0 C--O 1.223 -0.571 0 O-C-N 123.386 0.429 . . . . 0.0 112.315 177.21 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 49.3 tt0 -157.33 170.47 22.39 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 104.451 -2.425 . . . . 0.0 104.451 -175.497 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 105.73 -8.74 43.55 Favored Glycine 0 N--CA 1.462 0.41 0 CA-C-N 118.525 0.602 . . . . 0.0 113.811 177.399 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 76.2 t -70.9 133.8 86.03 Favored Pre-proline 0 C--N 1.321 -0.665 0 N-CA-C 106.791 -1.559 . . . . 0.0 106.791 176.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -69.98 171.87 13.9 Favored 'Trans proline' 0 N--CA 1.464 -0.246 0 C-N-CA 120.588 0.858 . . . . 0.0 112.967 178.113 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 83.7 mt -74.85 112.05 11.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 179.113 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 64.7 m-20 -109.6 80.74 1.35 Allowed 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 114.842 -1.072 . . . . 0.0 109.865 -175.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 76.2 p -69.87 -17.71 63.37 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 114.124 1.157 . . . . 0.0 114.124 -176.255 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 70.3 m-80 -112.54 35.46 3.82 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.701 -178.116 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.7 m -146.54 165.69 28.7 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 111.716 0.265 . . . . 0.0 111.716 -177.579 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 47.0 m -93.15 158.78 36.72 Favored Pre-proline 0 CA--C 1.536 0.439 0 C-N-CA 123.219 0.608 . . . . 0.0 111.718 -176.041 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -65.91 -23.92 54.1 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 115.71 -2.393 . . . . 0.0 115.253 -177.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -76.84 -20.23 56.59 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 121.68 -0.638 . . . . 0.0 112.675 179.051 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 12.4 p30 -96.41 0.99 51.28 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 114.643 1.349 . . . . 0.0 114.643 -174.565 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 86.4 mm-40 -57.36 -22.32 41.67 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.667 0.746 . . . . 0.0 112.675 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 8.2 tt -62.73 135.66 26.85 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.741 0 CA-C-O 122.366 1.079 . . . . 0.0 111.752 177.769 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 179.3 -156.81 19.36 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.212 -0.994 . . . . 0.0 112.232 -178.164 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 39.9 p90 -155.12 166.98 31.88 Favored 'General case' 0 C--N 1.318 -0.803 0 O-C-N 122.564 -0.374 . . . . 0.0 110.263 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 32.4 m-85 -108.22 140.68 41.1 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 175.556 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 48.5 ttt180 -115.85 120.21 38.5 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 124.1 0.96 . . . . 0.0 112.56 -175.215 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 36.7 ttt180 -66.32 141.21 58.07 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 123.785 0.834 . . . . 0.0 111.427 178.675 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -149.88 143.2 25.15 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 122.609 0.364 . . . . 0.0 111.116 176.752 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 14.6 t -161.0 165.86 29.18 Favored 'General case' 0 C--O 1.239 0.544 0 N-CA-C 106.078 -1.823 . . . . 0.0 106.078 174.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 3.9 tpt180 -144.9 127.97 16.58 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.78 0.324 . . . . 0.0 110.392 178.078 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 7.5 tmm_? -139.39 131.62 28.21 Favored 'General case' 0 CA--C 1.498 -1.023 0 CA-C-O 121.54 0.686 . . . . 0.0 109.698 178.369 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -139.85 179.28 2.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 N-CA-C 105.775 -1.935 . . . . 0.0 105.775 -178.564 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 17.4 tpp180 -124.9 103.51 8.09 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 106.244 -1.762 . . . . 0.0 106.244 173.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -75.57 159.04 50.89 Favored Glycine 0 C--O 1.227 -0.304 0 N-CA-C 106.945 -2.462 . . . . 0.0 106.945 176.067 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -60.51 -38.23 94.55 Favored Glycine 0 C--O 1.22 -0.765 0 CA-C-N 118.277 1.038 . . . . 0.0 113.698 -178.011 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -86.03 7.09 25.92 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.691 0.758 . . . . 0.0 111.593 179.731 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 96.62 -2.21 62.34 Favored Glycine 0 C--N 1.321 -0.29 0 CA-C-N 115.241 -0.89 . . . . 0.0 113.711 177.617 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 18.3 mttt -59.55 140.25 56.46 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.852 0.834 . . . . 0.0 112.703 -178.51 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 84.1 mtp -111.81 -169.97 1.56 Allowed 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 113.974 -1.466 . . . . 0.0 109.562 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 8.4 mmtt -121.28 -69.0 0.86 Allowed 'General case' 0 C--O 1.217 -0.636 0 N-CA-C 111.801 0.297 . . . . 0.0 111.801 -179.126 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 70.4 m-20 -126.46 158.71 35.33 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 -179.446 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 95.2 mt -122.4 -68.74 0.87 Allowed 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 177.231 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -71.17 135.25 84.82 Favored Pre-proline 0 C--N 1.323 -0.561 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.682 177.566 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -75.06 155.5 42.64 Favored 'Trans proline' 0 C--O 1.236 0.4 0 C-N-CA 117.048 -1.501 . . . . 0.0 113.165 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 75.6 mtt85 -111.59 160.02 17.6 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.234 178.33 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 71.2 m95 -132.64 127.4 34.82 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 175.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 65.7 m-85 -110.29 167.1 10.45 Favored 'General case' 0 C--O 1.21 -0.993 0 N-CA-C 104.758 -2.312 . . . . 0.0 104.758 -179.59 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 85.2 t80 -114.88 139.73 49.54 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 119.339 0.972 . . . . 0.0 109.118 -179.05 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 -138.61 148.69 44.42 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.515 -176.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 71.5 m-85 -82.2 159.49 23.25 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.423 -177.48 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -54.12 129.46 34.76 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-O 121.234 0.54 . . . . 0.0 112.407 -177.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 73.9 28.34 64.97 Favored Glycine 0 C--O 1.219 -0.837 0 N-CA-C 115.804 1.081 . . . . 0.0 115.804 175.714 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 2.3 p . . . . . 0 C--N 1.323 -0.545 0 CA-C-N 118.675 1.238 . . . . 0.0 108.56 179.39 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 74.7 mt . . . . . 0 N--CA 1.449 -0.488 0 N-CA-C 114.935 1.457 . . . . 0.0 114.935 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -76.57 166.96 26.41 Favored 'Trans proline' 0 C--O 1.238 0.482 0 N-CA-C 109.078 -1.162 . . . . 0.0 109.078 170.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.404 ' CE1' ' HB3' ' A' ' 92' ' ' TRP . 83.3 t80 -61.04 128.89 38.67 Favored 'General case' 0 C--N 1.323 -0.557 0 O-C-N 121.989 -0.444 . . . . 0.0 110.898 -179.747 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 93.89 -4.92 72.29 Favored Glycine 0 CA--C 1.518 0.277 0 N-CA-C 114.977 0.751 . . . . 0.0 114.977 178.228 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -63.81 133.2 52.99 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 118.027 0.913 . . . . 0.0 111.935 179.376 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 -77.95 130.31 36.38 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.096 -179.108 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 39.2 tttm -156.07 150.29 25.52 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 176.123 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -63.36 131.65 48.94 Favored 'General case' 0 C--O 1.24 0.573 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 178.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 72.33 23.33 78.11 Favored Glycine 0 N--CA 1.445 -0.757 0 N-CA-C 114.894 0.718 . . . . 0.0 114.894 177.439 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 42.7 mm -130.45 127.46 62.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 117.146 0.473 . . . . 0.0 109.946 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -133.17 123.56 47.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.929 176.678 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . 0.404 ' HB3' ' CE1' ' A' ' 83' ' ' TYR . 92.9 m95 -89.55 137.41 32.36 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 113.225 0.824 . . . . 0.0 113.225 -175.453 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 15.8 m -136.74 153.06 29.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 178.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -157.5 166.53 32.71 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 102.863 -3.014 . . . . 0.0 102.863 -179.51 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 11.4 t -136.05 175.26 9.76 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 106.215 -1.772 . . . . 0.0 106.215 179.33 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -64.02 133.55 53.33 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.011 0.434 . . . . 0.0 110.226 -179.666 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 93.85 -9.4 73.21 Favored Glycine 0 N--CA 1.46 0.237 0 CA-C-N 116.061 -0.518 . . . . 0.0 114.116 178.108 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -74.58 139.38 43.66 Favored 'General case' 0 CA--C 1.54 0.576 0 O-C-N 122.484 -0.421 . . . . 0.0 111.425 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 18.5 mt -82.13 162.48 22.47 Favored 'General case' 0 C--O 1.213 -0.86 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 177.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 59.4 t30 -114.87 69.53 0.72 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.075 0.464 . . . . 0.0 110.405 178.409 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -143.1 152.54 58.45 Favored Pre-proline 0 C--O 1.241 0.616 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -67.44 150.94 80.72 Favored 'Trans proline' 0 C--N 1.345 0.355 0 N-CA-C 113.511 0.543 . . . . 0.0 113.511 177.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 4.9 ptpt -151.6 59.11 0.88 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 122.777 1.275 . . . . 0.0 109.128 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -60.39 -30.6 69.69 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 113.846 -1.524 . . . . 0.0 113.028 -178.307 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 48.5 p-80 -60.84 -22.92 64.7 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 113.095 0.776 . . . . 0.0 113.095 -178.02 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 67.4 mt -71.45 -31.83 44.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 178.586 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -74.93 14.64 4.49 Favored Glycine 0 CA--C 1.524 0.596 0 N-CA-C 115.638 1.015 . . . . 0.0 115.638 -178.082 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 9.5 t -83.27 16.19 2.58 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 113.773 1.027 . . . . 0.0 113.773 -178.395 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 65.3 ttp85 -59.17 130.02 44.96 Favored 'General case' 0 N--CA 1.47 0.552 0 O-C-N 121.225 -0.922 . . . . 0.0 108.861 -178.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -107.93 130.18 23.14 Favored Pre-proline 0 C--N 1.322 -0.606 0 N-CA-C 106.408 -1.701 . . . . 0.0 106.408 179.475 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -69.61 -17.78 38.08 Favored 'Trans proline' 0 C--O 1.219 -0.461 0 C-N-CA 117.826 -0.982 . . . . 0.0 113.667 -177.652 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -74.14 -26.14 60.15 Favored 'General case' 0 C--O 1.22 -0.47 0 CA-C-O 120.838 0.352 . . . . 0.0 110.657 178.191 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 77.9 m-20 -102.23 -25.07 13.82 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 113.195 0.813 . . . . 0.0 113.195 -174.481 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 30.9 t30 -156.04 147.15 22.33 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.623 0.601 . . . . 0.0 112.623 -178.603 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -89.5 146.99 24.24 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.706 179.368 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -70.71 147.43 49.07 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.928 0.394 . . . . 0.0 109.969 178.129 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 2.0 mt -91.36 142.65 12.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 -178.129 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 87.8 t -59.14 123.08 10.72 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 N-CA-C 107.883 -1.155 . . . . 0.0 107.883 177.077 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 7.3 tt -70.46 127.89 34.28 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 -178.499 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 36.5 mt-30 -132.77 162.74 30.67 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 -178.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 15.4 mt -114.81 145.55 34.19 Favored Pre-proline 0 C--N 1.323 -0.584 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 179.268 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -72.93 170.34 19.97 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 120.329 0.686 . . . . 0.0 113.84 -177.567 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -54.61 133.36 46.53 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.738 -179.645 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 92.6 -17.43 57.67 Favored Glycine 0 C--O 1.227 -0.331 0 CA-C-N 116.001 -0.545 . . . . 0.0 113.191 -179.383 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 3.8 m -108.62 126.22 52.72 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 117.773 0.786 . . . . 0.0 110.303 178.689 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 14.5 p -123.4 152.19 41.83 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.057 -0.52 . . . . 0.0 109.922 -178.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 90.4 mt -72.34 151.47 92.05 Favored Pre-proline 0 C--N 1.324 -0.527 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 178.299 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -77.81 173.08 14.62 Favored 'Trans proline' 0 N--CA 1.462 -0.34 0 O-C-N 121.966 0.456 . . . . 0.0 111.06 178.418 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 66.3 tttp -59.78 127.89 34.2 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 122.074 -0.392 . . . . 0.0 111.519 -177.631 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 95.17 -1.48 64.87 Favored Glycine 0 C--O 1.227 -0.292 0 N-CA-C 115.142 0.817 . . . . 0.0 115.142 176.696 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.426 ' CZ ' ' HB2' ' A' ' 18' ' ' GLN . 1.2 m-85 -103.75 141.69 35.65 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-O 121.601 0.715 . . . . 0.0 111.632 -179.25 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 47.2 p90 -146.13 166.07 27.25 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 114.572 -1.194 . . . . 0.0 107.833 175.415 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -106.47 145.57 31.64 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 112.446 0.536 . . . . 0.0 112.446 -176.31 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -72.81 139.35 46.97 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 177.489 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 90.69 -36.85 3.48 Favored Glycine 0 CA--C 1.515 0.079 0 CA-C-N 116.177 -0.465 . . . . 0.0 112.821 -178.613 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 31.3 t . . . . . 0 C--N 1.325 -0.488 0 N-CA-C 109.541 -0.541 . . . . 0.0 109.541 -179.445 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.311 0 CA-C-O 121.134 0.492 . . . . 0.0 110.714 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 5.3 m -61.14 145.86 49.54 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.877 176.523 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 18.7 m95 -67.04 -22.83 65.86 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 113.452 0.908 . . . . 0.0 113.452 179.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -121.43 162.32 20.65 Favored 'General case' 0 CA--C 1.507 -0.688 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.974 -172.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 76.5 p -70.5 161.97 29.64 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 177.473 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -83.58 144.76 29.26 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.9 -0.591 . . . . 0.0 112.392 -175.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 66.2 mt -76.32 148.85 37.21 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 104.798 -2.297 . . . . 0.0 104.798 171.525 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 31.3 m -128.14 148.58 50.6 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 105.24 -2.133 . . . . 0.0 105.24 179.12 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -138.47 163.12 32.77 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 114.925 1.454 . . . . 0.0 114.925 -178.336 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 52.9 t60 -89.71 99.5 12.5 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 100.705 -3.813 . . . . 0.0 100.705 168.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -42.07 103.05 0.03 OUTLIER Glycine 0 N--CA 1.461 0.313 0 N-CA-C 118.538 2.175 . . . . 0.0 118.538 -173.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 82.4 mttt -142.97 -44.93 0.3 Allowed 'General case' 0 C--O 1.221 -0.401 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 177.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -120.67 169.61 10.22 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 -179.393 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -106.01 32.74 4.19 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 122.967 1.365 . . . . 0.0 110.045 178.873 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 32.6 tp 64.23 141.49 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 111.283 -2.689 . . . . 0.0 114.619 176.798 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 43.1 tptt -153.68 138.22 16.84 Favored 'General case' 0 C--N 1.324 -0.532 0 O-C-N 121.31 -0.869 . . . . 0.0 110.529 171.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -122.66 149.14 55.14 Favored Pre-proline 0 C--N 1.321 -0.633 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 176.073 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -70.25 159.44 53.04 Favored 'Trans proline' 0 C--N 1.349 0.576 0 O-C-N 122.188 0.573 . . . . 0.0 112.7 179.149 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 16.0 tpt180 -67.04 136.15 54.79 Favored 'General case' 0 C--O 1.218 -0.598 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 -178.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 85.94 6.96 81.63 Favored Glycine 0 C--O 1.222 -0.621 0 N-CA-C 111.241 -0.744 . . . . 0.0 111.241 179.606 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 20.3 mt-30 -147.77 172.68 13.74 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 123.27 0.628 . . . . 0.0 109.433 -175.356 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 104.23 -20.47 40.22 Favored Glycine 0 CA--C 1.501 -0.816 0 CA-C-N 115.883 -0.599 . . . . 0.0 113.558 174.424 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 57.6 t -67.28 128.22 93.66 Favored Pre-proline 0 C--N 1.32 -0.706 0 N-CA-C 106.76 -1.57 . . . . 0.0 106.76 177.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -71.59 171.61 15.98 Favored 'Trans proline' 0 C--O 1.223 -0.265 0 O-C-N 122.161 0.558 . . . . 0.0 111.329 177.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 87.6 mt -70.01 106.57 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-O 121.96 0.886 . . . . 0.0 108.791 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 -98.1 83.67 3.15 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 114.663 -1.153 . . . . 0.0 110.616 -176.55 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 73.1 p -68.02 -14.21 62.79 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.707 0.765 . . . . 0.0 112.725 -179.51 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 11.1 p30 -108.84 21.61 17.01 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.008 -0.997 . . . . 0.0 112.724 -177.216 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 5.8 m -142.83 151.47 41.16 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 113.366 0.876 . . . . 0.0 113.366 -176.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 52.8 m -78.32 166.53 42.37 Favored Pre-proline 0 C--N 1.327 -0.407 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 177.224 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -63.94 -26.67 66.63 Favored 'Trans proline' 0 C--N 1.353 0.77 0 C-N-CA 115.24 -2.707 . . . . 0.0 112.86 179.65 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -60.81 -32.82 72.17 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.663 0.744 . . . . 0.0 110.78 177.192 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 68.8 m-20 -88.7 -6.15 57.64 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 115.416 1.636 . . . . 0.0 115.416 -172.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 96.5 mm-40 -58.33 -29.25 65.77 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 114.295 1.22 . . . . 0.0 114.295 -176.248 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 11.2 tt -59.5 136.69 22.85 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-O 122.408 1.099 . . . . 0.0 112.244 -179.299 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -179.04 -157.9 20.4 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.495 -0.86 . . . . 0.0 111.996 -177.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 47.7 p90 -155.01 171.41 19.79 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 179.438 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 19.1 m-85 -112.71 141.05 46.95 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 106.551 -1.648 . . . . 0.0 106.551 173.548 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 69.4 ttt-85 -114.18 124.79 52.92 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.758 -177.144 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 15.2 ttt-85 -63.22 137.82 58.34 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 175.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -149.27 140.87 23.45 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.776 0.798 . . . . 0.0 112.708 179.477 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 12.2 p -133.26 142.64 48.63 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 104.602 -2.37 . . . . 0.0 104.602 174.34 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 11.8 tpt180 -160.68 128.23 4.38 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 112.959 0.726 . . . . 0.0 112.959 -179.81 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.5 tpp180 -116.68 142.7 46.56 Favored 'General case' 0 CA--C 1.507 -0.69 0 N-CA-C 105.734 -1.951 . . . . 0.0 105.734 173.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -138.37 177.1 5.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 -177.043 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.93 117.41 19.2 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 104.434 -2.432 . . . . 0.0 104.434 172.65 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -82.79 163.41 42.04 Favored Glycine 0 C--O 1.224 -0.511 0 N-CA-C 107.57 -2.212 . . . . 0.0 107.57 176.681 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -64.35 -32.58 84.68 Favored Glycine 0 C--O 1.214 -1.112 0 CA-C-N 118.121 0.96 . . . . 0.0 111.609 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -90.86 17.91 7.22 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-O 122.147 0.975 . . . . 0.0 110.551 178.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 85.36 -6.25 80.51 Favored Glycine 0 N--CA 1.46 0.247 0 N-CA-C 116.338 1.295 . . . . 0.0 116.338 173.54 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.42 128.69 37.54 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.807 0.813 . . . . 0.0 112.634 -178.069 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 97.8 mmm -99.32 -174.73 2.81 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 114.323 -1.308 . . . . 0.0 108.051 178.466 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 6.3 tttp -117.02 -62.0 1.64 Allowed 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 175.34 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.1 t0 54.74 -152.82 0.33 Allowed 'General case' 0 C--O 1.24 0.59 0 O-C-N 124.771 1.294 . . . . 0.0 110.955 178.346 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.9 mm? 67.16 -179.47 0.22 Allowed 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 115.372 1.619 . . . . 0.0 115.372 174.069 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -58.26 156.34 21.89 Favored Pre-proline 0 C--O 1.24 0.585 0 N-CA-C 116.804 2.15 . . . . 0.0 116.804 -174.874 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -66.41 156.57 64.62 Favored 'Trans proline' 0 C--N 1.354 0.838 0 CA-C-O 121.3 0.458 . . . . 0.0 111.817 177.431 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 42.2 mtt-85 -128.69 163.31 25.38 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.622 -175.326 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 61.8 m95 -127.42 129.97 48.48 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 179.122 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 24.2 m-85 -111.27 149.08 31.56 Favored 'General case' 0 C--O 1.213 -0.838 0 N-CA-C 106.949 -1.5 . . . . 0.0 106.949 -178.38 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 86.8 t80 -98.1 139.97 33.12 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.909 -0.775 . . . . 0.0 108.909 -178.224 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -142.36 153.13 43.56 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 -179.052 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 69.1 m-85 -88.12 159.51 18.18 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.87 -174.502 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -54.43 131.01 41.5 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.77 0.319 . . . . 0.0 110.686 -179.487 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 69.67 32.98 71.0 Favored Glycine 0 C--O 1.223 -0.578 0 N-CA-C 115.345 0.898 . . . . 0.0 115.345 176.37 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.4 p . . . . . 0 C--N 1.325 -0.463 0 CA-C-N 118.108 0.954 . . . . 0.0 109.312 177.268 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 52.2 mt . . . . . 0 C--O 1.238 0.491 0 N-CA-C 115.65 1.722 . . . . 0.0 115.65 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -78.15 168.0 22.49 Favored 'Trans proline' 0 CA--C 1.53 0.32 0 C-N-CA 120.954 1.103 . . . . 0.0 109.442 170.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.418 ' CE2' ' HB3' ' A' ' 92' ' ' TRP . 73.2 t80 -62.26 131.96 51.09 Favored 'General case' 0 C--N 1.323 -0.575 0 O-C-N 121.883 -0.511 . . . . 0.0 110.309 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 90.55 -3.6 81.72 Favored Glycine 0 C--O 1.228 -0.265 0 N-CA-C 114.585 0.594 . . . . 0.0 114.585 177.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -63.09 131.0 47.08 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 118.016 0.908 . . . . 0.0 111.403 179.392 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 53.7 t30 -77.84 124.92 28.58 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.181 -178.641 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 12.1 tttp -156.15 151.74 27.05 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 178.322 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 20.3 t0 -66.41 133.79 51.18 Favored 'General case' 0 C--N 1.322 -0.623 0 O-C-N 123.395 0.435 . . . . 0.0 110.068 -179.197 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 67.31 27.56 73.53 Favored Glycine 0 N--CA 1.45 -0.431 0 N-CA-C 114.749 0.66 . . . . 0.0 114.749 178.529 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 41.7 mm -129.27 125.84 62.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 117.266 0.533 . . . . 0.0 110.655 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.1 pt -129.78 116.16 36.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 CA-C-O 121.909 0.861 . . . . 0.0 112.536 176.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . 0.418 ' HB3' ' CE2' ' A' ' 83' ' ' TYR . 94.8 m95 -80.52 135.28 36.07 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 113.533 0.938 . . . . 0.0 113.533 -176.921 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 17.1 m -135.13 151.99 31.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 179.427 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -160.6 166.5 28.84 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 104.683 -2.34 . . . . 0.0 104.683 -178.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 13.5 t -136.39 178.78 6.8 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 105.151 -2.166 . . . . 0.0 105.151 177.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -66.99 136.48 55.38 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.318 0.58 . . . . 0.0 110.693 -179.257 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 92.24 -14.32 64.88 Favored Glycine 0 C--O 1.226 -0.374 0 CA-C-N 115.715 -0.675 . . . . 0.0 113.563 177.256 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -69.96 126.71 30.48 Favored 'General case' 0 C--N 1.322 -0.624 0 O-C-N 122.43 -0.453 . . . . 0.0 110.975 -179.492 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 43.6 mt -83.49 138.37 33.47 Favored 'General case' 0 CA--C 1.515 -0.392 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 -177.224 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 61.5 t30 -82.08 65.11 7.06 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.527 0.68 . . . . 0.0 110.729 179.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -140.11 155.18 70.71 Favored Pre-proline 0 C--N 1.322 -0.619 0 N-CA-C 105.639 -1.985 . . . . 0.0 105.639 179.591 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_endo -73.33 155.83 50.94 Favored 'Trans proline' 0 CA--C 1.532 0.377 0 N-CA-C 115.016 1.122 . . . . 0.0 115.016 179.438 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.79 58.02 1.05 Allowed 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 121.852 0.834 . . . . 0.0 112.055 176.338 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -56.98 -26.94 60.94 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.117 178.115 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 17.1 p80 -58.84 -11.52 3.36 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 114.521 1.304 . . . . 0.0 114.521 -178.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 23.2 mt -96.35 -36.14 6.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 122.175 -0.328 . . . . 0.0 110.836 178.22 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -73.83 14.51 3.55 Favored Glycine 0 CA--C 1.522 0.495 0 N-CA-C 116.189 1.235 . . . . 0.0 116.189 -175.334 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 9.7 t -107.33 29.26 7.3 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-O 121.057 0.456 . . . . 0.0 111.971 -177.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.427 ' HD2' HD22 ' A' ' 114' ' ' ASN . 64.2 ttp85 -54.73 134.36 47.44 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 177.513 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 41.6 m-20 -102.06 122.73 46.01 Favored Pre-proline 0 C--N 1.325 -0.497 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 -178.129 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -68.74 -18.6 42.02 Favored 'Trans proline' 0 C--O 1.217 -0.531 0 N-CA-C 114.425 0.894 . . . . 0.0 114.425 -176.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -75.69 -25.92 57.15 Favored 'General case' 0 C--O 1.22 -0.477 0 CA-C-O 120.842 0.353 . . . . 0.0 110.657 178.121 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 83.0 m-20 -100.75 -23.84 14.53 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 -175.39 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . 0.427 HD22 ' HD2' ' A' ' 109' ' ' ARG . 31.4 t30 -154.98 147.91 24.6 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.764 0.654 . . . . 0.0 112.764 -178.879 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -88.37 148.57 24.18 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-O 121.454 0.645 . . . . 0.0 111.404 179.493 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -68.97 142.45 54.67 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.226 0.536 . . . . 0.0 110.183 178.378 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 18.9 mt -84.8 136.56 22.5 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 -179.038 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 74.4 t -60.49 124.69 15.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 N-CA-C 105.295 -2.113 . . . . 0.0 105.295 174.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 7.6 tt -66.18 127.93 34.1 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.199 0.523 . . . . 0.0 109.968 -176.65 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 30.1 mt-30 -129.68 156.35 44.4 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 106.169 -1.789 . . . . 0.0 106.169 -179.483 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 13.6 mt -112.37 148.02 38.27 Favored Pre-proline 0 C--N 1.321 -0.661 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 177.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -72.43 165.37 32.88 Favored 'Trans proline' 0 C--O 1.236 0.38 0 O-C-N 122.293 0.628 . . . . 0.0 112.454 -179.354 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 65.1 tt0 -54.86 130.41 41.06 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.491 -179.471 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 99.47 -19.8 52.27 Favored Glycine 0 C--O 1.226 -0.39 0 CA-C-N 115.873 -0.603 . . . . 0.0 113.601 -179.278 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 11.2 m -105.76 130.91 53.66 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 118.251 1.025 . . . . 0.0 110.684 178.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 16.9 p -124.54 152.11 43.88 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.614 -178.035 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 90.3 mt -78.67 155.3 78.45 Favored Pre-proline 0 C--N 1.326 -0.432 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 177.287 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -75.19 170.25 20.77 Favored 'Trans proline' 0 C--O 1.237 0.44 0 CA-C-O 121.55 0.562 . . . . 0.0 111.367 177.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 48.1 tptt -63.5 122.49 16.4 Favored 'General case' 0 C--O 1.218 -0.579 0 CA-C-O 121.006 0.432 . . . . 0.0 111.234 -175.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 95.21 7.36 59.54 Favored Glycine 0 C--O 1.228 -0.263 0 N-CA-C 115.236 0.854 . . . . 0.0 115.236 178.331 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -110.48 143.48 40.74 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 107.332 -1.358 . . . . 0.0 107.332 176.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 35.2 p90 -147.56 163.95 34.99 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 177.263 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -99.55 145.6 27.34 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.894 0.378 . . . . 0.0 110.625 -178.393 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -72.07 135.84 46.42 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 178.28 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 86.41 -10.47 66.68 Favored Glycine 0 C--O 1.226 -0.396 0 CA-C-N 116.28 -0.418 . . . . 0.0 113.464 -178.641 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 32.2 t . . . . . 0 C--N 1.326 -0.429 0 CA-C-N 117.535 0.668 . . . . 0.0 110.089 179.482 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.623 0 CA-C-O 121.486 0.66 . . . . 0.0 109.667 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -58.37 140.28 53.88 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.608 177.674 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 35.7 m95 -65.82 -22.0 66.52 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 114.283 1.216 . . . . 0.0 114.283 -178.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 82.6 m-85 -121.37 161.84 21.4 Favored 'General case' 0 CA--C 1.506 -0.714 0 N-CA-C 114.453 1.279 . . . . 0.0 114.453 -171.086 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.42 ' HB ' ' HB3' ' A' ' 134' ' ' GLU . 73.1 p -69.89 163.59 25.62 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 114.045 -1.434 . . . . 0.0 108.468 177.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -77.43 139.3 39.64 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 -175.224 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 12.8 mt -84.49 145.62 28.02 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 103.927 -2.619 . . . . 0.0 103.927 170.8 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 21.9 m -129.31 133.2 47.33 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 118.13 0.423 . . . . 0.0 109.96 -179.4 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . 0.4 ' HB2' ' CZ ' ' A' ' 131' ' ' PHE . 3.8 tp60 -95.34 143.33 26.79 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 123.615 0.572 . . . . 0.0 111.577 -179.568 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 23.1 t-160 -138.97 96.5 3.13 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 102.609 -3.108 . . . . 0.0 102.609 165.57 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 172.57 -161.22 32.67 Favored Glycine 0 C--O 1.226 -0.399 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 -173.531 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 49.6 mtmt -104.54 -27.89 11.61 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 116.332 1.975 . . . . 0.0 116.332 -176.634 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -85.58 162.44 18.86 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 179.231 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -76.03 -62.9 1.44 Allowed 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 -178.519 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 36.4 tp -178.32 138.14 0.18 Allowed 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 104.799 -2.297 . . . . 0.0 104.799 172.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 11.0 tmtt? -149.28 133.33 17.18 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 176.606 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -121.05 159.8 47.78 Favored Pre-proline 0 C--O 1.243 0.748 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 177.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -65.39 171.52 9.16 Favored 'Trans proline' 0 CA--C 1.539 0.746 0 C-N-CA 121.004 1.136 . . . . 0.0 114.706 -179.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 25.5 tpt180 -78.4 128.0 33.0 Favored 'General case' 0 C--O 1.215 -0.758 0 O-C-N 121.561 -0.712 . . . . 0.0 109.289 179.448 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 72.12 18.68 78.06 Favored Glycine 0 C--O 1.225 -0.459 0 N-CA-C 114.552 0.581 . . . . 0.0 114.552 176.583 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 43.1 tt0 -159.32 149.59 19.17 Favored 'General case' 0 C--O 1.22 -0.46 0 N-CA-C 105.652 -1.981 . . . . 0.0 105.652 -178.437 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 136.05 -14.74 4.05 Favored Glycine 0 CA--C 1.505 -0.548 0 C-N-CA 120.323 -0.941 . . . . 0.0 113.225 176.524 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 27.6 m -71.6 145.93 90.6 Favored Pre-proline 0 C--N 1.32 -0.698 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 177.382 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -77.17 173.03 15.03 Favored 'Trans proline' 0 N--CA 1.46 -0.491 0 C-N-CA 121.507 1.471 . . . . 0.0 112.578 178.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 91.5 mt -79.3 116.74 23.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.129 -179.379 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.431 ' HB2' HE21 ' A' ' 43' ' ' GLN . 22.4 m-20 -100.95 86.13 3.0 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 176.664 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 69.8 p -60.39 -27.06 67.14 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 115.661 1.726 . . . . 0.0 115.661 -173.69 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 19.7 p30 -108.18 21.38 17.43 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 -177.37 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 15.1 m -130.19 169.32 15.52 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 112.165 0.432 . . . . 0.0 112.165 -175.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 68.8 m -83.7 158.39 62.64 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.295 -176.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -67.42 -21.53 46.77 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 116.882 -1.612 . . . . 0.0 114.751 -177.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.455 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 4.1 p-10 -74.65 -17.04 60.75 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 121.927 -0.483 . . . . 0.0 110.856 178.814 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.424 ' HA ' ' HE3' ' A' ' 103' ' ' LYS . 0.0 OUTLIER -87.04 -16.32 35.99 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 114.925 1.454 . . . . 0.0 114.925 -174.269 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . 0.431 HE21 ' HB2' ' A' ' 35' ' ' ASN . 84.0 mm-40 -57.81 -20.63 37.21 Favored 'General case' 0 C--O 1.218 -0.582 0 N-CA-C 114.093 1.145 . . . . 0.0 114.093 -172.154 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 20.6 tt -58.8 139.93 17.83 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 CA-C-O 122.401 1.095 . . . . 0.0 113.076 178.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 177.86 -153.61 13.54 Favored Glycine 0 N--CA 1.444 -0.792 0 C-N-CA 119.924 -1.131 . . . . 0.0 112.653 178.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 51.6 p90 -155.1 167.75 29.31 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 178.361 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 38.2 m-85 -108.74 140.28 42.38 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 106.435 -1.691 . . . . 0.0 106.435 174.419 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 65.3 ttt-85 -113.33 122.73 48.28 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.923 -177.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 49.0 ttp85 -68.62 136.89 53.71 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 177.008 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -134.85 136.41 42.43 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 179.041 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 14.8 t -152.9 159.19 42.98 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 106.697 -1.594 . . . . 0.0 106.697 176.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 21.6 tpt180 -157.74 142.27 16.33 Favored 'General case' 0 C--O 1.216 -0.663 0 N-CA-C 105.955 -1.869 . . . . 0.0 105.955 179.618 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -129.05 130.64 46.82 Favored 'General case' 0 CA--C 1.493 -1.223 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 176.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -128.89 173.05 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.003 0 N-CA-C 105.664 -1.976 . . . . 0.0 105.664 -179.14 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 6.6 tmm_? -140.33 112.76 7.9 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 106.024 -1.843 . . . . 0.0 106.024 175.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -74.04 164.24 54.7 Favored Glycine 0 C--O 1.226 -0.376 0 N-CA-C 110.448 -1.061 . . . . 0.0 110.448 -179.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -65.93 -33.8 86.7 Favored Glycine 0 C--O 1.217 -0.935 0 N-CA-C 110.522 -1.031 . . . . 0.0 110.522 -179.269 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.0 t0 -85.2 16.96 3.23 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-O 122.157 0.98 . . . . 0.0 110.968 179.352 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 84.77 -4.81 84.17 Favored Glycine 0 CA--C 1.509 -0.298 0 N-CA-C 116.071 1.188 . . . . 0.0 116.071 172.277 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.59 123.16 20.1 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.488 0.661 . . . . 0.0 111.785 -177.394 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 93.4 mmm -88.84 169.49 11.55 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.01 -0.996 . . . . 0.0 108.663 178.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 5.4 tmtt? -74.99 -52.74 10.37 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 177.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 58.37 -174.27 0.09 Allowed 'General case' 0 C--O 1.243 0.713 0 N-CA-C 115.547 1.684 . . . . 0.0 115.547 178.941 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.5 mm? 64.79 169.77 0.19 Allowed 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 115.018 1.488 . . . . 0.0 115.018 -179.461 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -70.62 163.25 65.35 Favored Pre-proline 0 C--O 1.243 0.723 0 CA-C-N 114.603 -1.181 . . . . 0.0 114.181 -176.331 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -72.12 166.8 28.58 Favored 'Trans proline' 0 C--N 1.351 0.666 0 CA-C-O 121.562 0.568 . . . . 0.0 112.736 177.748 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 22.9 mtp180 -117.91 166.3 12.65 Favored 'General case' 0 CA--C 1.512 -0.497 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 178.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 62.8 m95 -127.45 143.4 51.2 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 177.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 60.7 m-85 -124.02 147.49 47.78 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 178.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 86.5 t80 -95.79 139.24 32.31 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 -177.356 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -142.44 140.6 32.01 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 -176.471 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 74.9 m-85 -68.1 159.44 30.91 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -179.313 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 19.1 tp -59.44 134.72 57.27 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 175.147 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 75.66 35.28 46.76 Favored Glycine 0 C--O 1.222 -0.638 0 N-CA-C 115.881 1.112 . . . . 0.0 115.881 177.22 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 21.7 p . . . . . 0 C--N 1.325 -0.459 0 CA-C-N 118.288 1.044 . . . . 0.0 109.832 177.867 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 75.2 mt . . . . . 0 C--O 1.238 0.48 0 N-CA-C 114.874 1.435 . . . . 0.0 114.874 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -76.85 166.75 26.44 Favored 'Trans proline' 0 N--CA 1.461 -0.41 0 N-CA-C 109.231 -1.103 . . . . 0.0 109.231 171.253 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 62.1 t80 -62.95 131.26 48.08 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 120.708 -0.397 . . . . 0.0 110.29 -179.219 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 92.39 -3.48 75.72 Favored Glycine 0 CA--C 1.52 0.396 0 N-CA-C 114.524 0.569 . . . . 0.0 114.524 179.156 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -63.03 130.94 46.89 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 117.863 0.832 . . . . 0.0 112.104 179.406 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 32.7 t-20 -78.3 125.85 29.95 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.568 -178.466 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 14.7 ttmm -155.55 150.47 26.53 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 176.743 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -63.36 131.36 48.01 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.245 179.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 70.66 25.88 74.98 Favored Glycine 0 N--CA 1.45 -0.418 0 CA-C-O 119.375 -0.681 . . . . 0.0 114.184 177.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 39.7 mm -128.83 128.14 67.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 117.515 0.658 . . . . 0.0 109.963 179.339 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.1 pt -130.13 115.26 32.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 CA-C-O 121.422 0.63 . . . . 0.0 110.891 176.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 97.4 m95 -82.07 132.22 35.25 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 112.941 0.719 . . . . 0.0 112.941 -176.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 1.1 m -142.05 152.95 18.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.187 -178.127 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -155.12 166.53 33.28 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 103.371 -2.826 . . . . 0.0 103.371 -178.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 14.5 t -122.76 169.13 11.39 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 104.206 -2.516 . . . . 0.0 104.206 174.481 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -65.37 137.16 57.32 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.193 0.52 . . . . 0.0 109.922 -179.495 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 91.19 -5.79 81.29 Favored Glycine 0 CA--C 1.516 0.119 0 CA-C-N 115.749 -0.659 . . . . 0.0 113.4 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.455 ' HA ' ' HA ' ' A' ' 41' ' ' ASP . . . -77.81 135.48 37.96 Favored 'General case' 0 CA--C 1.537 0.478 0 O-C-N 122.307 -0.525 . . . . 0.0 109.647 179.2 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 28.8 mt -88.25 136.37 33.01 Favored 'General case' 0 CA--C 1.509 -0.615 0 CA-C-O 121.601 0.715 . . . . 0.0 111.979 -178.249 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 54.4 t30 -82.59 67.95 8.84 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.978 -1.01 . . . . 0.0 110.588 -178.683 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -142.77 155.63 63.0 Favored Pre-proline 0 C--N 1.323 -0.57 0 N-CA-C 106.382 -1.711 . . . . 0.0 106.382 -179.102 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -66.83 150.6 83.23 Favored 'Trans proline' 0 CA--C 1.53 0.292 0 N-CA-C 114.78 1.031 . . . . 0.0 114.78 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.424 ' HE3' ' HA ' ' A' ' 42' ' ' ASP . 71.1 mmtt -126.89 36.88 4.38 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.152 179.758 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 14.0 p-10 -49.55 -42.77 45.04 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.268 0.556 . . . . 0.0 112.003 -177.796 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 15.4 p80 -67.5 -10.3 50.36 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 115.121 1.526 . . . . 0.0 115.121 -178.589 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 38.8 mt -91.93 -31.95 5.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 179.535 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -74.12 14.6 3.76 Favored Glycine 0 C--O 1.222 -0.597 0 N-CA-C 115.488 0.955 . . . . 0.0 115.488 -177.79 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 15.1 t -83.17 24.44 0.79 Allowed 'General case' 0 CA--C 1.547 0.862 0 N-CA-C 113.814 1.042 . . . . 0.0 113.814 -177.145 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 69.9 ttp85 -62.17 124.92 22.16 Favored 'General case' 0 N--CA 1.471 0.584 0 O-C-N 121.033 -1.042 . . . . 0.0 108.691 179.604 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 11.4 m-20 -99.56 125.34 41.17 Favored Pre-proline 0 C--N 1.323 -0.563 0 N-CA-C 106.307 -1.738 . . . . 0.0 106.307 179.381 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -68.85 -18.5 41.4 Favored 'Trans proline' 0 C--O 1.22 -0.421 0 C-N-CA 117.98 -0.88 . . . . 0.0 114.315 -176.126 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -75.41 -26.19 58.19 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.854 0.359 . . . . 0.0 110.621 178.04 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 -100.58 -25.86 14.03 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 -174.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 27.7 t30 -152.11 145.6 24.87 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 -179.423 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -86.7 149.39 24.92 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.402 179.69 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -66.8 142.34 57.39 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.295 0.569 . . . . 0.0 110.381 178.668 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 22.8 mt -84.15 139.26 17.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.312 -0.858 . . . . 0.0 108.689 -178.152 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 91.6 t -61.67 124.52 16.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 105.789 -1.93 . . . . 0.0 105.789 175.134 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 6.1 tt -66.51 128.74 37.37 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.098 0.475 . . . . 0.0 109.906 -177.257 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -129.88 151.8 50.05 Favored 'General case' 0 CA--C 1.507 -0.696 0 N-CA-C 106.285 -1.746 . . . . 0.0 106.285 -179.31 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 13.0 mt -110.16 148.32 38.1 Favored Pre-proline 0 C--N 1.321 -0.655 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 178.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -71.59 164.26 36.28 Favored 'Trans proline' 0 C--N 1.345 0.349 0 O-C-N 122.228 0.594 . . . . 0.0 112.999 -178.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 54.8 tt0 -54.25 131.12 40.93 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.628 -0.714 . . . . 0.0 109.685 -179.412 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 98.93 -17.7 57.84 Favored Glycine 0 C--O 1.228 -0.262 0 CA-C-N 115.829 -0.623 . . . . 0.0 112.494 -178.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 1.8 m -108.62 128.94 55.28 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 117.716 0.758 . . . . 0.0 110.587 178.052 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 6.0 p -124.91 151.05 45.88 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 179.37 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 72.6 mt -67.33 153.28 95.07 Favored Pre-proline 0 C--N 1.324 -0.525 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 -179.705 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -75.06 168.08 25.58 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 117.938 -0.908 . . . . 0.0 110.406 178.461 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -57.0 124.52 18.96 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 112.92 0.711 . . . . 0.0 112.92 -174.074 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 95.2 -6.06 68.55 Favored Glycine 0 C--O 1.229 -0.201 0 N-CA-C 115.818 1.087 . . . . 0.0 115.818 177.402 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.4 ' CZ ' ' HB2' ' A' ' 18' ' ' GLN . 1.7 m-85 -93.13 146.32 23.75 Favored 'General case' 0 N--CA 1.439 -1.013 0 CA-C-O 122.096 0.95 . . . . 0.0 110.416 179.362 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 46.8 p90 -144.75 160.58 41.0 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 113.793 -1.549 . . . . 0.0 108.12 174.438 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -102.56 142.84 33.07 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.092 0.472 . . . . 0.0 111.02 -177.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.42 ' HB3' ' HB ' ' A' ' 14' ' ' THR . 3.5 tp10 -70.12 131.61 44.56 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 177.779 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 92.29 -10.98 73.22 Favored Glycine 0 C--O 1.227 -0.298 0 C-N-CA 121.359 -0.448 . . . . 0.0 112.944 -178.526 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 41.9 t . . . . . 0 C--N 1.327 -0.395 0 N-CA-C 106.957 -1.497 . . . . 0.0 106.957 176.84 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.095 0 CA-C-O 121.462 0.649 . . . . 0.0 111.73 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 35.7 t -63.16 144.0 57.3 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.144 177.775 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 18.1 m95 -67.34 -21.83 65.63 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 112.824 0.675 . . . . 0.0 112.824 178.025 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 39.8 m-85 -121.55 165.6 15.43 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 114.663 1.357 . . . . 0.0 114.663 -170.437 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 76.1 p -71.44 166.45 21.69 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 114.459 -1.246 . . . . 0.0 107.758 176.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -78.01 157.51 29.62 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 113.54 0.941 . . . . 0.0 113.54 -175.554 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 12.9 mt -102.05 137.1 40.77 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 105.288 -2.116 . . . . 0.0 105.288 171.114 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 37.0 m -122.19 145.4 48.23 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 -177.278 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . 0.405 ' HB2' ' CZ ' ' A' ' 131' ' ' PHE . 4.2 tp60 -112.51 142.89 44.54 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 114.664 1.357 . . . . 0.0 114.664 -175.172 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 72.4 t60 -131.98 99.46 4.75 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 104.663 -2.347 . . . . 0.0 104.663 166.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 171.04 -152.97 19.74 Favored Glycine 0 C--O 1.227 -0.309 0 N-CA-C 109.954 -1.258 . . . . 0.0 109.954 -175.374 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -117.39 -21.97 8.43 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-O 121.44 0.638 . . . . 0.0 110.865 179.455 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -72.65 151.0 42.5 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.311 -179.646 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 16.8 t0 -76.61 -62.59 1.58 Allowed 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 178.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 43.1 tp 179.64 143.35 0.15 Allowed 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 103.478 -2.786 . . . . 0.0 103.478 171.299 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 56.8 tptt -154.56 134.57 13.06 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 118.047 0.385 . . . . 0.0 110.188 176.001 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 12.0 m-85 -125.0 157.27 67.42 Favored Pre-proline 0 C--O 1.244 0.811 0 N-CA-C 106.291 -1.744 . . . . 0.0 106.291 175.363 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -72.2 175.02 10.51 Favored 'Trans proline' 0 CA--C 1.536 0.611 0 C-N-CA 121.174 1.249 . . . . 0.0 114.527 -178.526 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 46.7 tpt85 -78.33 127.45 32.24 Favored 'General case' 0 C--O 1.214 -0.815 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 178.351 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 80.17 10.5 85.41 Favored Glycine 0 C--O 1.223 -0.567 0 N-CA-C 115.417 0.927 . . . . 0.0 115.417 175.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.53 HE22 HG21 ' A' ' 125' ' ' THR . 22.3 tt0 -157.71 145.5 18.71 Favored 'General case' 0 C--O 1.219 -0.521 0 N-CA-C 106.264 -1.754 . . . . 0.0 106.264 -179.537 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 138.5 -14.61 3.43 Favored Glycine 0 CA--C 1.504 -0.607 0 C-N-CA 120.042 -1.075 . . . . 0.0 113.523 177.298 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 27.8 m -70.06 144.72 93.14 Favored Pre-proline 0 C--N 1.322 -0.595 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 176.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -76.16 174.28 13.09 Favored 'Trans proline' 0 N--CA 1.46 -0.496 0 C-N-CA 121.483 1.455 . . . . 0.0 111.773 178.523 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 92.4 mt -71.86 118.47 16.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 178.404 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 45.1 m-80 -111.29 87.08 2.46 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 179.515 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 82.1 p -66.84 -21.94 66.01 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 112.769 0.655 . . . . 0.0 112.769 -177.091 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 71.6 m-80 -105.62 34.71 3.15 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.875 -177.249 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 20.6 m -145.84 150.41 36.11 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.745 0.307 . . . . 0.0 111.603 -179.4 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 25.3 m -71.31 164.19 59.39 Favored Pre-proline 0 C--N 1.325 -0.484 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 176.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -64.57 -26.8 61.66 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 114.926 -2.916 . . . . 0.0 111.598 177.721 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 51.2 m-20 -63.03 -27.39 69.38 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.827 177.001 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.434 ' HA ' ' HE3' ' A' ' 103' ' ' LYS . 67.9 m-20 -93.41 -6.62 46.68 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 115.569 1.692 . . . . 0.0 115.569 -171.878 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 92.0 mm-40 -60.43 -33.12 72.06 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 115.097 1.517 . . . . 0.0 115.097 -176.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 14.5 tt -60.1 140.62 17.86 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 CA-C-O 122.137 0.97 . . . . 0.0 113.117 -178.686 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 179.85 -149.34 8.53 Favored Glycine 0 C--O 1.227 -0.325 0 CA-C-N 115.623 -0.717 . . . . 0.0 112.455 -176.675 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 50.7 p90 -155.08 171.98 18.89 Favored 'General case' 0 C--N 1.319 -0.72 0 O-C-N 122.187 -0.596 . . . . 0.0 109.959 179.164 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 28.7 m-85 -114.25 142.99 45.57 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 173.222 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 68.5 ttt180 -115.22 125.88 53.89 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 123.739 0.815 . . . . 0.0 110.628 -178.329 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 6.3 ttp85 -71.26 135.52 47.49 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 107.675 -1.231 . . . . 0.0 107.675 176.317 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -135.35 129.64 33.73 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 123.218 0.607 . . . . 0.0 111.212 -178.732 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 15.0 t -159.96 155.43 25.45 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 174.271 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 20.3 tpt180 -161.26 139.18 9.33 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 105.319 -2.104 . . . . 0.0 105.319 178.021 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -88.44 135.38 33.5 Favored 'General case' 0 CA--C 1.505 -0.761 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 179.532 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -127.87 173.56 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.766 0 N-CA-C 106.826 -1.546 . . . . 0.0 106.826 -178.854 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.15 117.15 15.29 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 178.611 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -73.87 157.25 51.32 Favored Glycine 0 C--O 1.23 -0.125 0 N-CA-C 107.273 -2.331 . . . . 0.0 107.273 176.09 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -58.49 -35.7 81.19 Favored Glycine 0 N--CA 1.461 0.347 0 CA-C-N 119.017 1.408 . . . . 0.0 112.184 -177.038 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -73.43 0.8 11.25 Favored 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 124.64 1.176 . . . . 0.0 113.553 -179.376 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 93.44 14.54 53.32 Favored Glycine 0 C--N 1.317 -0.505 0 CA-C-N 114.38 -1.282 . . . . 0.0 113.027 174.239 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 16.4 mmtt -79.02 130.6 35.7 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.393 0.616 . . . . 0.0 110.635 -175.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 1.4 mmt -86.08 161.06 19.09 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.008 -0.997 . . . . 0.0 110.47 179.613 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 22.6 tptp -64.45 -52.52 57.6 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.383 176.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.4 t70 45.33 -149.89 0.07 Allowed 'General case' 0 CA--C 1.549 0.905 0 O-C-N 124.842 1.339 . . . . 0.0 112.315 -176.424 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 62.0 mt 52.94 178.73 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.814 0 N-CA-C 118.407 2.743 . . . . 0.0 118.407 174.335 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 2.1 p -74.2 159.51 83.66 Favored Pre-proline 0 C--O 1.245 0.853 0 CA-C-N 115.124 -0.943 . . . . 0.0 112.904 -177.721 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -77.05 175.89 10.82 Favored 'Trans proline' 0 C--N 1.352 0.722 0 N-CA-C 110.796 -0.502 . . . . 0.0 110.796 174.088 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 33.3 ptt-85 -132.13 163.32 28.77 Favored 'General case' 0 C--O 1.218 -0.56 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 177.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 56.3 m95 -122.93 150.2 43.25 Favored 'General case' 0 C--O 1.212 -0.882 0 C-N-CA 122.468 0.307 . . . . 0.0 111.224 -177.186 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 56.1 m-85 -128.12 147.29 50.54 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 177.72 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 88.7 t80 -94.43 135.46 35.83 Favored 'General case' 0 CA--C 1.506 -0.747 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 -177.274 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -136.99 131.98 33.68 Favored 'General case' 0 N--CA 1.437 -1.096 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 -175.657 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 74.2 m-85 -70.89 159.57 34.41 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.037 -176.134 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -53.07 125.46 17.41 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.829 -178.218 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 71.57 23.32 78.18 Favored Glycine 0 C--O 1.224 -0.474 0 N-CA-C 116.309 1.284 . . . . 0.0 116.309 177.056 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 18.3 p . . . . . 0 C--N 1.326 -0.453 0 CA-C-N 119.056 1.428 . . . . 0.0 108.842 177.402 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 14.7 mt . . . . . 0 N--CA 1.444 -0.767 0 N-CA-C 115.503 1.668 . . . . 0.0 115.503 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -79.08 161.89 26.29 Favored 'Trans proline' 0 N--CA 1.463 -0.313 0 C-N-CA 122.517 2.145 . . . . 0.0 107.683 167.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 57.1 t80 -60.86 131.21 49.96 Favored 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 120.373 -0.531 . . . . 0.0 110.579 -177.411 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 92.33 -7.51 78.02 Favored Glycine 0 C--O 1.228 -0.269 0 CA-C-O 119.349 -0.695 . . . . 0.0 114.65 179.11 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -66.62 131.12 45.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 118.649 1.224 . . . . 0.0 111.336 179.503 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 56.7 t30 -78.73 129.18 34.38 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.627 -179.388 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 30.0 ttmt -156.17 153.27 28.99 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 106.492 -1.67 . . . . 0.0 106.492 179.29 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -63.48 130.82 46.01 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.051 0.453 . . . . 0.0 111.165 -178.105 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 68.5 27.64 73.68 Favored Glycine 0 N--CA 1.449 -0.483 0 CA-C-O 119.263 -0.743 . . . . 0.0 113.994 177.652 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 45.9 mm -123.28 125.57 72.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 117.487 0.644 . . . . 0.0 110.303 179.331 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -127.85 115.25 38.56 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 CA-C-O 121.575 0.702 . . . . 0.0 111.296 177.061 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 97.7 m95 -80.45 137.45 36.49 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -177.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -142.61 154.34 17.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 -178.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -157.27 166.64 32.6 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 105.695 -1.965 . . . . 0.0 105.695 -177.096 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 14.7 t -125.84 166.49 16.75 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 104.03 -2.582 . . . . 0.0 104.03 173.205 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 77.7 tt0 -67.68 137.67 55.72 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 121.108 0.48 . . . . 0.0 109.879 -178.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 95.45 -19.23 55.25 Favored Glycine 0 C--O 1.224 -0.521 0 CA-C-N 115.705 -0.68 . . . . 0.0 112.973 178.042 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -67.81 137.93 55.75 Favored 'General case' 0 CA--C 1.542 0.661 0 O-C-N 122.542 -0.387 . . . . 0.0 110.753 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 47.0 mt -92.21 136.55 33.1 Favored 'General case' 0 CA--C 1.514 -0.425 0 N-CA-C 113.771 1.026 . . . . 0.0 113.771 -176.349 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 63.6 t30 -80.39 61.34 4.12 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.21 -0.905 . . . . 0.0 110.939 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 2.6 t -133.12 160.93 66.73 Favored Pre-proline 0 C--N 1.322 -0.588 0 N-CA-C 104.452 -2.425 . . . . 0.0 104.452 -179.133 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_exo -64.58 152.06 83.24 Favored 'Trans proline' 0 CA--C 1.534 0.475 0 N-CA-C 116.669 1.757 . . . . 0.0 116.669 -177.298 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.434 ' HE3' ' HA ' ' A' ' 42' ' ' ASP . 0.4 OUTLIER -127.19 31.93 5.15 Favored 'General case' 0 CA--C 1.515 -0.388 0 C-N-CA 124.545 1.138 . . . . 0.0 109.416 176.784 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 15.2 p-10 -55.22 -36.89 66.46 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.285 -0.871 . . . . 0.0 109.84 179.284 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 16.7 p80 -60.8 -13.65 16.63 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 114.832 1.419 . . . . 0.0 114.832 179.377 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 10.8 mt -96.27 -23.71 4.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 121.14 0.495 . . . . 0.0 110.787 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -76.19 1.25 60.74 Favored Glycine 0 C--O 1.227 -0.303 0 N-CA-C 115.559 0.984 . . . . 0.0 115.559 -175.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 14.6 t -83.08 16.06 2.53 Favored 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 113.848 1.055 . . . . 0.0 113.848 -177.514 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 63.1 ttp85 -66.26 129.75 40.89 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 177.781 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -111.73 134.19 21.36 Favored Pre-proline 0 C--N 1.325 -0.491 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 179.429 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_endo -69.76 -21.55 33.31 Favored 'Trans proline' 0 C--O 1.217 -0.535 0 N-CA-C 115.314 1.236 . . . . 0.0 115.314 -174.447 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -74.81 -24.09 58.58 Favored 'General case' 0 C--O 1.22 -0.49 0 CA-C-O 121.094 0.473 . . . . 0.0 110.478 178.391 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 83.5 m-20 -97.72 -22.49 16.41 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 113.302 0.853 . . . . 0.0 113.302 -175.068 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 19.6 t30 -157.99 150.03 21.99 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 112.0 0.371 . . . . 0.0 112.0 -178.356 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -87.27 147.47 25.52 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-O 121.575 0.702 . . . . 0.0 112.182 179.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -72.73 147.92 45.15 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.27 178.13 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 15.0 mt -91.42 139.43 17.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.226 -178.156 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 73.9 t -60.13 125.41 16.2 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 N-CA-C 106.572 -1.64 . . . . 0.0 106.572 175.084 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 6.4 tt -66.6 129.19 39.04 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.101 0.477 . . . . 0.0 110.168 -177.324 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 31.0 mt-30 -131.26 156.66 45.03 Favored 'General case' 0 CA--C 1.511 -0.534 0 N-CA-C 107.062 -1.459 . . . . 0.0 107.062 -178.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 14.4 mt -113.25 148.07 38.75 Favored Pre-proline 0 C--N 1.321 -0.631 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 178.438 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -72.06 167.5 26.58 Favored 'Trans proline' 0 C--N 1.345 0.392 0 O-C-N 122.229 0.594 . . . . 0.0 112.969 -179.335 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -55.56 133.48 50.35 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.814 -179.498 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 91.91 -14.75 63.48 Favored Glycine 0 C--O 1.227 -0.332 0 CA-C-N 116.05 -0.523 . . . . 0.0 113.368 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.53 HG21 HE22 ' A' ' 30' ' ' GLN . 16.7 m -105.95 126.94 52.79 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 117.841 0.82 . . . . 0.0 110.309 179.012 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 6.9 p -118.51 148.24 42.83 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.78 -178.268 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 84.9 mt -69.94 153.61 95.31 Favored Pre-proline 0 C--N 1.325 -0.472 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 177.661 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -76.15 173.48 14.42 Favored 'Trans proline' 0 C--O 1.235 0.345 0 N-CA-C 110.531 -0.604 . . . . 0.0 110.531 178.624 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 8.2 tmtt? -53.83 126.61 22.84 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.21 0.528 . . . . 0.0 112.224 -175.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 85.29 -1.55 88.52 Favored Glycine 0 N--CA 1.454 -0.144 0 N-CA-C 116.861 1.504 . . . . 0.0 116.861 173.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.405 ' CZ ' ' HB2' ' A' ' 18' ' ' GLN . 1.5 m-85 -94.71 141.26 28.82 Favored 'General case' 0 N--CA 1.436 -1.167 0 CA-C-O 122.069 0.938 . . . . 0.0 110.436 -179.209 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 42.8 p90 -142.08 161.47 37.92 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 113.639 -1.618 . . . . 0.0 108.351 176.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -103.0 143.74 32.18 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.345 0.593 . . . . 0.0 111.705 -176.842 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -70.68 135.3 48.22 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 179.693 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 81.89 -9.69 55.43 Favored Glycine 0 CA--C 1.52 0.365 0 CA-C-N 116.118 -0.492 . . . . 0.0 114.095 -178.75 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 28.8 t . . . . . 0 C--N 1.326 -0.439 0 CA-C-N 117.926 0.863 . . . . 0.0 110.51 -179.534 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.44 -0.943 0 CA-C-O 121.876 0.846 . . . . 0.0 113.157 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 32.9 p -62.21 140.91 58.44 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 114.853 -1.067 . . . . 0.0 109.982 178.803 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 17.4 m95 -67.62 -21.81 65.37 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 113.795 1.035 . . . . 0.0 113.795 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 36.8 m-85 -121.55 160.87 23.39 Favored 'General case' 0 CA--C 1.509 -0.621 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 -172.598 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 67.7 p -69.47 162.03 28.26 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 178.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -78.31 147.12 34.38 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 114.084 1.142 . . . . 0.0 114.084 -175.726 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 27.1 mt -89.02 148.88 23.52 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 105.149 -2.167 . . . . 0.0 105.149 170.634 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.6 m -122.97 144.85 48.97 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 179.473 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 3.8 tp60 -109.99 154.79 22.67 Favored 'General case' 0 C--N 1.328 -0.339 0 O-C-N 123.762 0.664 . . . . 0.0 110.742 -176.283 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 67.9 t60 -139.34 99.51 3.76 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 105.588 -2.004 . . . . 0.0 105.588 170.086 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 163.09 -171.63 38.9 Favored Glycine 0 N--CA 1.452 -0.239 0 N-CA-C 110.653 -0.979 . . . . 0.0 110.653 -177.778 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -99.56 -22.52 15.43 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 112.477 0.547 . . . . 0.0 112.477 179.672 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -83.44 161.99 21.12 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.963 -178.168 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -75.55 -62.94 1.4 Allowed 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 114.539 1.311 . . . . 0.0 114.539 -175.894 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 32.2 tp 157.23 144.84 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.283 0 N-CA-C 104.935 -2.246 . . . . 0.0 104.935 -175.56 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 56.1 tptt -156.02 141.39 17.61 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 108.779 -0.822 . . . . 0.0 108.779 173.009 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 15.1 m-85 -122.97 150.7 59.77 Favored Pre-proline 0 C--O 1.242 0.699 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 175.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -74.22 163.21 37.04 Favored 'Trans proline' 0 C--N 1.352 0.752 0 C-N-CA 120.88 1.053 . . . . 0.0 113.383 179.467 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 4.1 tmt_? -65.36 133.71 51.95 Favored 'General case' 0 N--CA 1.473 0.707 0 O-C-N 122.045 -0.409 . . . . 0.0 110.493 -178.484 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 88.12 1.34 82.0 Favored Glycine 0 C--O 1.228 -0.235 0 N-CA-C 111.912 -0.475 . . . . 0.0 111.912 178.614 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 33.0 mt-30 -141.83 171.65 13.77 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 123.455 0.702 . . . . 0.0 110.4 -174.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 107.06 -25.26 22.78 Favored Glycine 0 CA--C 1.497 -1.049 0 CA-C-N 115.54 -0.754 . . . . 0.0 111.937 175.176 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 95.7 t -63.72 127.4 91.47 Favored Pre-proline 0 C--N 1.318 -0.779 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 177.736 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -73.46 171.58 17.42 Favored 'Trans proline' 0 N--CA 1.462 -0.351 0 O-C-N 122.142 0.548 . . . . 0.0 111.385 178.189 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 86.1 mt -69.81 107.02 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-O 121.963 0.887 . . . . 0.0 108.892 -179.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 75.3 m-20 -99.96 84.82 2.94 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 114.626 -1.17 . . . . 0.0 109.9 -177.36 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 69.6 p -67.06 -15.74 63.91 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 112.94 0.719 . . . . 0.0 112.94 -178.631 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 12.3 p30 -107.13 22.77 15.47 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.375 -0.83 . . . . 0.0 112.382 -177.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 15.0 m -140.5 148.89 41.77 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 113.787 1.032 . . . . 0.0 113.787 -176.525 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -74.37 167.35 36.73 Favored Pre-proline 0 N--CA 1.468 0.447 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 177.194 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -64.93 -28.48 58.27 Favored 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 114.663 -3.091 . . . . 0.0 111.827 178.309 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -62.11 -24.31 67.06 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 123.883 0.873 . . . . 0.0 111.658 176.743 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 71.6 m-20 -98.41 -2.57 38.81 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 114.957 1.466 . . . . 0.0 114.957 -172.183 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 94.5 mm-40 -60.77 -28.94 69.11 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 114.543 1.312 . . . . 0.0 114.543 -178.21 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 12.9 tt -60.07 139.31 19.78 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.846 0 CA-C-O 122.358 1.075 . . . . 0.0 113.339 -177.677 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -177.94 -155.96 15.38 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.84 -0.695 . . . . 0.0 111.903 -178.478 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 49.8 p90 -155.05 168.59 26.51 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 178.665 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 22.5 m-85 -108.99 141.35 41.22 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 172.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 51.7 ttt180 -115.0 120.54 40.23 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 114.917 -1.038 . . . . 0.0 111.919 -174.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 38.9 ttp180 -68.47 134.7 50.52 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 176.159 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -150.79 151.11 31.85 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.159 0.504 . . . . 0.0 111.494 -178.393 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 14.3 t -158.9 164.98 35.18 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 174.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 14.3 tpt180 -149.83 123.83 9.38 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 105.367 -2.086 . . . . 0.0 105.367 177.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 4.6 tmm_? -88.9 128.01 35.66 Favored 'General case' 0 CA--C 1.498 -1.054 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 -179.21 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -128.6 169.83 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.107 0 N-CA-C 105.725 -1.954 . . . . 0.0 105.725 179.032 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 1.1 ttt-85 -144.04 110.72 5.62 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 176.131 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -71.17 160.88 54.13 Favored Glycine 0 N--CA 1.449 -0.443 0 N-CA-C 107.891 -2.084 . . . . 0.0 107.891 176.492 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -69.94 -33.8 70.61 Favored Glycine 0 C--O 1.222 -0.596 0 N-CA-C 109.899 -1.28 . . . . 0.0 109.899 -178.106 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.2 t0 -73.12 3.54 5.45 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 114.133 -1.033 . . . . 0.0 111.831 179.422 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 96.6 -9.12 66.53 Favored Glycine 0 C--O 1.226 -0.353 0 CA-C-N 115.725 -0.67 . . . . 0.0 114.5 175.48 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.49 106.7 4.68 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.759 0.79 . . . . 0.0 111.751 -178.185 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 18.6 mtp -88.8 -179.98 6.1 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 114.783 -1.099 . . . . 0.0 109.124 179.313 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 23.9 tptp -73.88 -59.5 2.69 Favored 'General case' 0 CA--C 1.51 -0.58 0 C-N-CA 120.603 -0.439 . . . . 0.0 111.409 -179.609 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 47.02 -161.53 0.03 OUTLIER 'General case' 0 C--O 1.25 1.082 0 O-C-N 125.358 1.661 . . . . 0.0 115.256 -179.339 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 82.2 mt 53.48 -176.66 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 116.489 2.033 . . . . 0.0 116.489 178.711 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 24.3 m -65.04 154.01 87.65 Favored Pre-proline 0 C--O 1.24 0.596 0 CA-C-N 115.182 -0.917 . . . . 0.0 112.336 -177.303 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -73.8 175.5 10.69 Favored 'Trans proline' 0 C--N 1.348 0.506 0 CA-C-O 122.015 0.756 . . . . 0.0 113.72 -179.353 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 1.2 mmt180 -106.55 159.99 15.76 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 114.897 -1.047 . . . . 0.0 108.294 -178.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 73.2 m95 -128.3 125.02 37.96 Favored 'General case' 0 C--O 1.215 -0.748 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 176.252 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 33.9 m-85 -110.99 156.54 21.09 Favored 'General case' 0 C--O 1.213 -0.849 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 -178.727 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 81.2 t80 -101.76 135.31 43.5 Favored 'General case' 0 CA--C 1.51 -0.596 0 CA-C-N 119.204 0.911 . . . . 0.0 108.94 -179.297 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -136.92 147.46 46.41 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 -176.583 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 84.3 m-85 -82.5 159.43 22.86 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.069 -176.709 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -54.67 130.26 39.71 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.991 0.424 . . . . 0.0 111.066 -179.28 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 73.54 26.23 70.41 Favored Glycine 0 C--O 1.219 -0.837 0 N-CA-C 116.107 1.203 . . . . 0.0 116.107 176.63 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 5.3 p . . . . . 0 C--N 1.326 -0.433 0 CA-C-N 118.775 1.287 . . . . 0.0 109.724 178.13 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 42.9 mt . . . . . 0 C--O 1.238 0.452 0 N-CA-C 115.318 1.599 . . . . 0.0 115.318 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -76.97 166.14 27.25 Favored 'Trans proline' 0 C--O 1.237 0.427 0 N-CA-C 108.669 -1.32 . . . . 0.0 108.669 170.144 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.405 ' CE1' ' HB3' ' A' ' 92' ' ' TRP . 62.5 t80 -62.8 133.68 55.12 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 120.491 -0.484 . . . . 0.0 110.069 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 90.37 -5.45 82.7 Favored Glycine 0 CA--C 1.519 0.317 0 N-CA-C 114.489 0.556 . . . . 0.0 114.489 178.815 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -63.08 132.33 51.54 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 117.901 0.85 . . . . 0.0 112.22 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 51.5 t30 -74.52 126.26 30.39 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.903 -0.59 . . . . 0.0 112.094 -178.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 15.2 ttmm -156.14 149.86 24.96 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 176.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -63.63 132.79 52.26 Favored 'General case' 0 C--N 1.321 -0.64 0 O-C-N 123.251 0.345 . . . . 0.0 110.802 -179.646 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 66.87 28.41 73.77 Favored Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 121.037 -0.602 . . . . 0.0 114.481 177.328 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 40.9 mm -127.5 126.43 67.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 117.302 0.551 . . . . 0.0 109.993 179.41 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.1 pt -128.13 115.15 37.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 121.812 0.815 . . . . 0.0 110.889 176.307 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . 0.405 ' HB3' ' CE1' ' A' ' 83' ' ' TYR . 95.8 m95 -79.03 135.73 36.97 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.983 -0.553 . . . . 0.0 112.34 -177.886 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 17.0 m -137.3 149.72 25.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.566 0.698 . . . . 0.0 109.534 179.72 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -157.59 166.6 32.44 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 104.333 -2.469 . . . . 0.0 104.333 -178.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 6.6 t -138.21 177.04 8.17 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 106.037 -1.838 . . . . 0.0 106.037 177.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -67.61 135.08 52.32 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.056 0.455 . . . . 0.0 110.51 -178.255 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 96.02 -8.29 67.59 Favored Glycine 0 C--O 1.224 -0.52 0 CA-C-N 115.938 -0.574 . . . . 0.0 113.514 178.688 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -81.22 139.23 35.62 Favored 'General case' 0 C--N 1.324 -0.541 0 O-C-N 122.443 -0.446 . . . . 0.0 111.456 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 47.3 mt -90.04 138.7 31.29 Favored 'General case' 0 CA--C 1.512 -0.495 0 CA-C-O 120.805 0.336 . . . . 0.0 111.284 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 62.4 t30 -83.42 68.13 9.6 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.992 0.425 . . . . 0.0 110.743 179.806 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 1.1 t -141.67 151.71 60.96 Favored Pre-proline 0 C--O 1.24 0.566 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 -178.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -66.24 153.15 79.18 Favored 'Trans proline' 0 C--N 1.345 0.39 0 N-CA-C 113.645 0.594 . . . . 0.0 113.645 176.597 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 1.4 ptpm? -152.25 56.49 0.83 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 122.502 1.144 . . . . 0.0 110.809 -179.235 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -59.66 -27.13 66.12 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 114.535 -1.211 . . . . 0.0 111.443 179.35 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 12.7 p80 -59.71 -12.4 6.97 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 114.029 1.122 . . . . 0.0 114.029 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 55.3 mt -91.94 -43.07 13.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 177.367 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -77.12 11.45 15.92 Favored Glycine 0 C--O 1.224 -0.495 0 N-CA-C 114.825 0.69 . . . . 0.0 114.825 -177.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 6.6 t -83.2 17.84 1.91 Allowed 'General case' 0 CA--C 1.545 0.778 0 CA-C-O 122.214 1.007 . . . . 0.0 110.416 178.782 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.429 ' HD2' ' OD1' ' A' ' 114' ' ' ASN . 62.7 ttp85 -59.32 131.46 51.06 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.786 -179.912 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 10.2 m-20 -100.22 122.04 51.58 Favored Pre-proline 0 C--N 1.326 -0.444 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -71.06 -15.06 32.3 Favored 'Trans proline' 0 C--O 1.218 -0.485 0 N-CA-C 113.672 0.604 . . . . 0.0 113.672 -177.74 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -76.16 -24.38 54.82 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.853 0.359 . . . . 0.0 110.912 177.628 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -101.47 -26.09 13.69 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 113.499 0.926 . . . . 0.0 113.499 -175.5 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . 0.429 ' OD1' ' HD2' ' A' ' 109' ' ' ARG . 0.4 OUTLIER -142.77 153.64 43.46 Favored 'General case' 0 N--CA 1.437 -1.119 0 CA-C-O 121.031 0.443 . . . . 0.0 111.428 -176.694 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -99.23 142.22 30.99 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.626 177.082 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -69.23 150.07 47.85 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.403 0.62 . . . . 0.0 112.17 -179.08 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 6.8 mt -86.14 138.42 19.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.382 -0.826 . . . . 0.0 109.23 -178.591 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 97.1 t -60.73 124.08 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 N-CA-C 106.754 -1.573 . . . . 0.0 106.754 176.064 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 6.7 tt -66.5 130.6 43.74 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.226 0.536 . . . . 0.0 111.372 -175.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 28.7 mt-30 -131.82 156.77 45.46 Favored 'General case' 0 CA--C 1.514 -0.43 0 N-CA-C 106.827 -1.545 . . . . 0.0 106.827 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 13.9 mt -113.12 147.4 37.21 Favored Pre-proline 0 C--N 1.323 -0.559 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 178.151 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -74.76 169.67 22.06 Favored 'Trans proline' 0 C--N 1.345 0.374 0 O-C-N 122.224 0.592 . . . . 0.0 113.465 -179.384 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 36.8 tt0 -54.25 131.34 41.39 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.317 178.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 99.78 -22.47 40.23 Favored Glycine 0 C--O 1.227 -0.321 0 CA-C-O 119.439 -0.645 . . . . 0.0 113.474 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 5.7 m -108.75 129.29 55.37 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 118.461 1.13 . . . . 0.0 111.179 179.071 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 7.1 p -123.34 149.16 45.24 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.793 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 96.7 mt -71.48 151.09 93.93 Favored Pre-proline 0 C--N 1.324 -0.522 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 178.448 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -79.11 178.25 7.72 Favored 'Trans proline' 0 CA--C 1.531 0.361 0 C-N-CA 120.33 0.686 . . . . 0.0 112.296 179.31 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 64.4 tttp -57.17 129.95 44.02 Favored 'General case' 0 C--O 1.219 -0.504 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.224 -178.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 87.18 -1.98 86.61 Favored Glycine 0 C--O 1.226 -0.379 0 N-CA-C 115.425 0.93 . . . . 0.0 115.425 175.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -101.1 137.11 39.9 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-O 121.883 0.849 . . . . 0.0 112.433 -178.136 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 48.4 p90 -145.4 164.44 31.51 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 114.343 -1.299 . . . . 0.0 108.735 176.564 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -104.84 144.89 31.15 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 -176.246 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -71.62 136.23 47.27 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 177.804 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 94.06 -8.96 73.0 Favored Glycine 0 C--O 1.225 -0.445 0 C-N-CA 121.425 -0.417 . . . . 0.0 112.297 178.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 32.8 t . . . . . 0 C--N 1.325 -0.496 0 N-CA-C 110.305 -0.257 . . . . 0.0 110.305 178.018 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.119 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 34.7 p -66.84 141.74 57.57 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 -178.291 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 20.6 m95 -67.07 -26.95 66.99 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 178.597 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 24.9 m-85 -121.38 164.89 16.35 Favored 'General case' 0 C--O 1.241 0.633 0 N-CA-C 113.74 1.015 . . . . 0.0 113.74 -171.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 56.1 p -68.23 167.97 13.23 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 114.609 -1.178 . . . . 0.0 110.204 179.045 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -81.61 142.35 32.86 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 114.531 1.308 . . . . 0.0 114.531 -174.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 25.3 mt -84.42 146.8 27.46 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 102.55 -3.13 . . . . 0.0 102.55 167.554 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 29.8 m -130.12 141.28 50.7 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 -178.182 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 4.3 tp60 -109.64 140.42 43.5 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 -176.181 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 53.6 t60 -131.07 99.93 5.05 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 104.054 -2.573 . . . . 0.0 104.054 168.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 163.97 -162.93 35.57 Favored Glycine 0 C--O 1.227 -0.301 0 N-CA-C 108.252 -1.939 . . . . 0.0 108.252 -175.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 90.2 mttt -111.36 -22.17 11.47 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 115.207 1.558 . . . . 0.0 115.207 -178.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -75.2 158.95 32.17 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 106.602 -1.629 . . . . 0.0 106.602 174.757 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -83.59 -62.12 1.66 Allowed 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 120.545 -0.462 . . . . 0.0 110.851 -178.726 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 41.5 tp -175.08 150.83 1.23 Allowed 'General case' 0 N--CA 1.481 1.094 0 N-CA-C 105.637 -1.986 . . . . 0.0 105.637 173.53 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -158.11 134.61 9.59 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 178.113 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -129.35 148.65 70.09 Favored Pre-proline 0 C--N 1.323 -0.551 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 173.693 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -72.63 155.74 54.21 Favored 'Trans proline' 0 C--N 1.35 0.654 0 O-C-N 122.194 0.576 . . . . 0.0 112.703 178.082 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 17.3 tpt180 -67.56 137.76 55.96 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 -179.23 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 89.26 0.67 79.88 Favored Glycine 0 C--O 1.222 -0.612 0 N-CA-C 110.684 -0.967 . . . . 0.0 110.684 179.501 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 -146.71 -179.62 6.91 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 -174.793 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 99.96 -27.06 22.06 Favored Glycine 0 CA--C 1.5 -0.906 0 CA-C-N 116.241 -0.436 . . . . 0.0 112.219 175.325 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 71.9 t -63.32 128.52 92.58 Favored Pre-proline 0 C--N 1.319 -0.736 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 177.062 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -74.74 168.39 24.94 Favored 'Trans proline' 0 N--CA 1.458 -0.575 0 O-C-N 122.165 0.56 . . . . 0.0 110.86 178.557 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 97.4 mt -68.01 116.92 8.83 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 69.2 m-80 -105.06 98.38 8.1 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.448 -179.455 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 67.6 p -73.4 -22.18 60.31 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.19 0.519 . . . . 0.0 111.683 -179.192 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 71.2 m-80 -111.12 36.85 3.02 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.496 -0.774 . . . . 0.0 112.682 -177.64 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 17.5 m -144.59 146.96 32.59 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 179.313 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -72.26 166.39 41.89 Favored Pre-proline 0 C--N 1.327 -0.405 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 176.943 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -64.79 -27.03 59.76 Favored 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 115.198 -2.735 . . . . 0.0 111.86 178.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -62.22 -29.07 70.13 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.662 0.744 . . . . 0.0 111.17 176.377 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 76.6 m-20 -96.29 0.8 51.34 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 115.288 1.588 . . . . 0.0 115.288 -170.628 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 94.7 mm-40 -61.58 -27.12 68.41 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 121.345 0.593 . . . . 0.0 112.478 178.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 19.5 tt -57.52 138.67 18.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-O 122.236 1.017 . . . . 0.0 113.712 -179.325 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -177.82 -158.74 21.39 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.274 -0.965 . . . . 0.0 113.158 -179.47 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 38.2 p90 -155.04 169.12 24.84 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 107.721 -1.214 . . . . 0.0 107.721 179.291 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 29.1 m-85 -113.63 141.42 47.23 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 106.784 -1.562 . . . . 0.0 106.784 173.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 44.4 ttt-85 -112.21 131.71 55.33 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.826 -0.624 . . . . 0.0 112.231 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 39.2 ttt-85 -65.39 142.44 58.2 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.437 176.134 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -147.98 166.13 28.66 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 177.52 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 6.3 t -152.37 162.46 41.14 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 -177.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 10.1 ttm180 -90.72 123.88 34.66 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 104.619 -2.363 . . . . 0.0 104.619 176.032 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 8.3 tmm_? -148.25 144.65 27.8 Favored 'General case' 0 CA--C 1.508 -0.665 0 CA-C-O 121.105 0.479 . . . . 0.0 111.633 -172.321 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -126.68 -179.68 2.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 -178.61 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -117.37 104.32 11.0 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 171.598 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -71.84 165.02 54.07 Favored Glycine 0 C--O 1.222 -0.625 0 N-CA-C 108.189 -1.964 . . . . 0.0 108.189 178.68 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -61.15 -42.45 99.79 Favored Glycine 0 C--O 1.217 -0.935 0 CA-C-N 118.483 1.142 . . . . 0.0 112.131 -179.256 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 41.2 t0 -95.67 16.94 15.99 Favored 'General case' 0 CA--C 1.549 0.923 0 CA-C-O 122.912 1.339 . . . . 0.0 110.39 179.434 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 86.01 6.86 81.55 Favored Glycine 0 C--O 1.226 -0.384 0 CA-C-N 114.769 -1.105 . . . . 0.0 113.833 172.759 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 23.9 mmtt -69.49 142.48 53.72 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 122.235 1.017 . . . . 0.0 112.472 -173.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 5.1 mmt -93.82 172.42 8.26 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 113.135 -1.848 . . . . 0.0 113.961 -175.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 12.2 tptt -124.34 -41.74 2.16 Favored 'General case' 0 CA--C 1.491 -1.311 0 CA-C-N 114.811 -1.086 . . . . 0.0 108.896 173.351 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 26.56 86.27 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.872 0 O-C-N 126.814 2.571 . . . . 0.0 116.315 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -75.89 173.01 11.74 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 114.141 -1.39 . . . . 0.0 108.904 -179.695 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 5.7 m -46.13 140.07 5.29 Favored Pre-proline 0 C--O 1.244 0.814 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 -179.141 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -68.14 148.36 74.89 Favored 'Trans proline' 0 C--O 1.24 0.598 0 C-N-CA 116.73 -1.713 . . . . 0.0 114.191 -175.687 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 26.0 mtp180 -124.96 162.15 25.1 Favored 'General case' 0 CA--C 1.501 -0.941 0 N-CA-C 106.692 -1.595 . . . . 0.0 106.692 177.401 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 62.4 m95 -132.72 133.51 43.59 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 179.256 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 80.5 m-85 -116.59 146.42 42.68 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 -178.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 82.9 t80 -94.85 134.04 37.93 Favored 'General case' 0 CA--C 1.509 -0.628 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 -175.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 11.5 m-85 -137.33 152.96 50.29 Favored 'General case' 0 N--CA 1.439 -0.988 0 N-CA-C 106.674 -1.602 . . . . 0.0 106.674 -175.69 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -91.96 159.38 15.77 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 112.338 0.495 . . . . 0.0 112.338 -173.709 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 15.2 tp -57.13 127.13 30.41 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.38 0.61 . . . . 0.0 110.088 179.749 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 71.04 28.66 70.04 Favored Glycine 0 N--CA 1.45 -0.422 0 N-CA-C 116.848 1.499 . . . . 0.0 116.848 175.435 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.4 ' HA ' ' HA ' ' A' ' 104' ' ' ASP . 24.0 p . . . . . 0 CA--C 1.508 -0.635 0 CA-C-N 119.487 1.644 . . . . 0.0 109.079 175.379 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 12.4 mt . . . . . 0 N--CA 1.436 -1.139 0 N-CA-C 114.404 1.261 . . . . 0.0 114.404 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -78.29 161.7 28.74 Favored 'Trans proline' 0 N--CA 1.461 -0.404 0 C-N-CA 122.168 1.912 . . . . 0.0 107.3 167.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 55.0 t80 -61.19 131.93 52.04 Favored 'General case' 0 C--N 1.32 -0.678 0 C-N-CA 120.274 -0.57 . . . . 0.0 110.257 -177.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 91.6 -6.73 80.18 Favored Glycine 0 C--O 1.227 -0.298 0 CA-C-O 119.407 -0.663 . . . . 0.0 114.622 179.277 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -68.6 130.76 43.8 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 118.647 1.224 . . . . 0.0 111.714 179.731 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 56.0 t30 -78.17 130.99 37.0 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.337 179.675 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 26.1 ttmt -156.18 155.81 33.11 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 106.983 -1.488 . . . . 0.0 106.983 -179.28 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 15.2 t0 -56.41 121.37 9.43 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.261 0.553 . . . . 0.0 111.719 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 68.58 33.4 76.44 Favored Glycine 0 N--CA 1.448 -0.536 0 CA-C-O 118.975 -0.903 . . . . 0.0 114.971 177.157 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 41.3 mm -125.66 129.46 72.68 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 CA-C-N 118.079 0.939 . . . . 0.0 112.091 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -130.34 125.24 59.19 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.841 174.277 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 96.9 m95 -90.94 138.28 31.72 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 113.631 0.975 . . . . 0.0 113.631 -176.353 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 13.9 m -138.87 149.66 23.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.547 0.689 . . . . 0.0 109.445 178.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -160.82 164.75 31.17 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 105.058 -2.201 . . . . 0.0 105.058 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 14.8 t -130.35 168.9 16.19 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 105.091 -2.188 . . . . 0.0 105.091 178.197 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -67.4 137.49 55.98 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 -179.284 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 97.76 -12.73 64.3 Favored Glycine 0 C--O 1.225 -0.416 0 CA-C-N 115.832 -0.622 . . . . 0.0 112.145 179.352 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -79.65 136.77 36.9 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 178.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 44.1 mt -87.15 138.05 31.82 Favored 'General case' 0 CA--C 1.512 -0.512 0 CA-C-O 121.43 0.633 . . . . 0.0 112.288 -177.279 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 60.3 t30 -84.46 66.95 9.72 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.849 -179.462 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -142.46 156.45 63.69 Favored Pre-proline 0 C--N 1.322 -0.629 0 N-CA-C 107.078 -1.453 . . . . 0.0 107.078 -178.316 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -70.93 153.69 63.42 Favored 'Trans proline' 0 CA--C 1.531 0.329 0 N-CA-C 114.227 0.818 . . . . 0.0 114.227 178.401 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -145.92 60.66 1.25 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 123.103 1.43 . . . . 0.0 111.356 178.877 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . 0.4 ' HA ' ' HA ' ' A' ' 75' ' ' THR . 16.7 p-10 -53.38 -39.48 64.25 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 113.229 -1.805 . . . . 0.0 112.789 178.024 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 48.2 p-80 -62.22 -8.21 5.34 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 115.071 1.508 . . . . 0.0 115.071 -178.116 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 57.9 mt -95.77 -45.32 13.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 177.683 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -74.19 -1.17 59.5 Favored Glycine 0 C--O 1.223 -0.543 0 N-CA-C 115.53 0.972 . . . . 0.0 115.53 -177.193 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 13.3 t -83.29 21.13 1.17 Allowed 'General case' 0 CA--C 1.542 0.672 0 CA-C-O 121.757 0.789 . . . . 0.0 111.542 -178.597 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.423 ' HD2' ' OD1' ' A' ' 114' ' ' ASN . 65.4 ttp85 -52.77 131.92 35.76 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.145 178.658 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 36.4 m120 -88.37 117.44 68.39 Favored Pre-proline 0 C--N 1.323 -0.549 0 N-CA-C 107.718 -1.215 . . . . 0.0 107.718 179.631 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -72.4 -13.39 27.84 Favored 'Trans proline' 0 C--O 1.216 -0.583 0 C-N-CA 117.243 -1.372 . . . . 0.0 112.817 -179.051 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -78.49 -26.93 46.12 Favored 'General case' 0 C--O 1.219 -0.506 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.638 177.3 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 -102.21 -24.86 13.87 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 113.203 0.816 . . . . 0.0 113.203 -174.795 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . 0.423 ' OD1' ' HD2' ' A' ' 109' ' ' ARG . 5.6 t-20 -128.7 147.2 50.74 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 113.508 0.929 . . . . 0.0 113.508 -178.229 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -95.93 129.92 43.05 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 107.686 -1.228 . . . . 0.0 107.686 173.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -64.65 151.51 44.7 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.441 -0.8 . . . . 0.0 112.28 -178.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 4.0 mt -89.83 144.11 9.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.288 -0.869 . . . . 0.0 109.692 -177.508 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 72.5 t -60.8 124.54 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 175.111 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 6.7 tt -69.07 128.07 35.36 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.181 0.515 . . . . 0.0 109.736 -178.577 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 33.0 mt-30 -133.4 157.87 44.46 Favored 'General case' 0 CA--C 1.511 -0.526 0 N-CA-C 106.785 -1.561 . . . . 0.0 106.785 -178.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 13.4 mt -112.88 148.05 38.52 Favored Pre-proline 0 C--N 1.32 -0.688 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 178.022 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -73.97 167.54 26.97 Favored 'Trans proline' 0 C--O 1.237 0.459 0 O-C-N 122.291 0.627 . . . . 0.0 112.837 179.376 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 60.8 tt0 -54.46 134.04 45.94 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.265 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 100.42 -28.19 16.94 Favored Glycine 0 C--O 1.227 -0.315 0 CA-C-N 115.944 -0.571 . . . . 0.0 112.867 -179.297 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 4.1 m -100.04 128.87 46.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 118.4 1.1 . . . . 0.0 112.116 179.451 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 3.2 p -120.35 148.11 44.17 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.188 178.695 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 90.3 mt -71.5 153.18 93.83 Favored Pre-proline 0 C--N 1.323 -0.559 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 178.408 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -75.19 168.72 24.09 Favored 'Trans proline' 0 N--CA 1.463 -0.299 0 C-N-CA 118.508 -0.528 . . . . 0.0 111.005 178.599 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 53.0 tptt -59.59 130.23 45.83 Favored 'General case' 0 C--N 1.324 -0.539 0 O-C-N 122.199 -0.313 . . . . 0.0 111.018 -176.564 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 95.15 -10.64 69.74 Favored Glycine 0 C--O 1.23 -0.124 0 CA-C-N 115.547 -0.752 . . . . 0.0 114.846 178.33 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -95.41 144.41 25.95 Favored 'General case' 0 N--CA 1.436 -1.168 0 CA-C-O 122.39 1.091 . . . . 0.0 110.53 179.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 38.1 p90 -143.13 164.76 29.27 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 113.168 -1.833 . . . . 0.0 107.892 175.484 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -108.22 153.53 23.06 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.08 0.466 . . . . 0.0 110.446 -176.648 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -90.12 132.22 35.55 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.322 -178.813 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 97.2 -33.76 5.57 Favored Glycine 0 C--O 1.225 -0.414 0 CA-C-N 116.044 -0.525 . . . . 0.0 113.102 179.082 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.442 -0.848 0 CA-C-O 121.798 0.808 . . . . 0.0 111.121 179.402 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.822 0 CA-C-O 121.822 0.82 . . . . 0.0 111.473 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -58.59 140.6 54.12 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 114.635 -1.166 . . . . 0.0 110.808 178.67 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 26.5 m95 -73.05 -21.95 60.7 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 114.906 1.447 . . . . 0.0 114.906 -178.217 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -121.47 156.15 33.39 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-O 121.015 0.436 . . . . 0.0 111.867 -174.454 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 75.9 p -68.6 162.99 24.68 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.745 -1.116 . . . . 0.0 110.078 -179.647 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -79.61 126.62 31.14 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 116.299 1.963 . . . . 0.0 116.299 -174.481 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -74.32 121.28 21.1 Favored 'General case' 0 N--CA 1.438 -1.029 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 170.272 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 56.7 m -87.19 126.92 35.11 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 -176.309 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 3.2 tm0? -88.27 135.02 33.65 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 -179.685 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 37.8 t60 -139.36 99.49 3.75 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 169.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 162.34 -161.37 33.5 Favored Glycine 0 C--O 1.226 -0.355 0 C-N-CA 120.008 -1.091 . . . . 0.0 113.371 -179.481 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -105.59 -24.09 12.65 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -85.68 153.55 22.27 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 178.612 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -78.22 -62.81 1.56 Allowed 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 120.598 -0.441 . . . . 0.0 110.964 -176.315 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 58.2 tp 173.66 145.62 0.05 OUTLIER 'General case' 0 N--CA 1.485 1.316 0 N-CA-C 106.104 -1.813 . . . . 0.0 106.104 174.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 2.5 tppp? -158.92 140.87 13.67 Favored 'General case' 0 C--O 1.223 -0.336 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 175.325 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 20.9 m-85 -127.24 151.49 74.64 Favored Pre-proline 0 C--N 1.325 -0.499 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 174.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -73.7 162.68 39.08 Favored 'Trans proline' 0 C--N 1.349 0.574 0 O-C-N 122.183 0.57 . . . . 0.0 113.269 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 16.6 tpt180 -64.59 133.3 52.0 Favored 'General case' 0 C--O 1.218 -0.605 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.647 -178.344 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 79.83 15.66 78.79 Favored Glycine 0 C--O 1.221 -0.671 0 CA-C-N 116.252 -0.431 . . . . 0.0 112.248 178.543 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.564 HE22 HG22 ' A' ' 125' ' ' THR . 0.9 OUTLIER -151.86 170.59 19.44 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 -175.094 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 99.53 -8.61 60.28 Favored Glycine 0 C--O 1.222 -0.656 0 N-CA-C 114.501 0.561 . . . . 0.0 114.501 174.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 96.4 t -69.21 130.92 90.75 Favored Pre-proline 0 C--N 1.319 -0.729 0 N-CA-C 106.471 -1.677 . . . . 0.0 106.471 176.747 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -70.11 174.5 9.71 Favored 'Trans proline' 0 C--O 1.223 -0.228 0 O-C-N 122.314 0.639 . . . . 0.0 113.22 178.659 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 74.2 mt -75.65 105.64 4.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 122.3 1.048 . . . . 0.0 108.485 179.765 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 50.8 m-20 -100.6 79.64 2.11 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 113.96 -1.473 . . . . 0.0 109.027 -176.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 69.7 p -66.65 -22.43 66.1 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 114.797 1.406 . . . . 0.0 114.797 -175.039 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 10.5 p30 -120.87 30.28 6.96 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 -176.022 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -128.59 157.24 41.81 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 179.134 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.6 p -74.18 162.22 74.84 Favored Pre-proline 0 C--N 1.321 -0.64 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 -179.426 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -65.89 -20.54 58.1 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 115.78 -2.346 . . . . 0.0 112.561 177.222 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.408 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 3.3 p-10 -75.19 -21.89 58.38 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 119.636 -0.825 . . . . 0.0 110.747 179.785 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 31.3 t0 -89.92 0.82 56.85 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 114.147 1.166 . . . . 0.0 114.147 -175.401 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 91.4 mm-40 -63.21 -28.11 69.82 Favored 'General case' 0 C--N 1.318 -0.786 0 O-C-N 121.047 -1.033 . . . . 0.0 111.634 -179.787 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 12.8 tt -66.58 137.84 24.09 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-O 122.259 1.028 . . . . 0.0 111.531 178.08 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 178.4 -158.08 22.44 Favored Glycine 0 CA--C 1.505 -0.581 0 C-N-CA 120.443 -0.884 . . . . 0.0 111.456 -178.255 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 43.9 p90 -155.09 167.61 29.78 Favored 'General case' 0 C--N 1.319 -0.738 0 O-C-N 122.627 -0.337 . . . . 0.0 110.574 179.598 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 16.2 m-85 -109.16 141.9 40.72 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 176.356 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 62.4 ttt-85 -120.39 117.99 29.19 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 124.112 0.965 . . . . 0.0 112.346 -174.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 28.5 ttp85 -69.78 136.48 50.92 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 177.386 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -146.26 138.53 25.18 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.341 0.656 . . . . 0.0 110.281 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 14.1 t -160.21 153.1 21.42 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.082 0.468 . . . . 0.0 110.142 174.77 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 22.4 tpt180 -151.37 123.81 8.38 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 175.212 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 4.5 tmt_? -134.03 139.04 45.76 Favored 'General case' 0 CA--C 1.501 -0.928 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -141.53 179.2 2.26 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 N-CA-C 105.939 -1.874 . . . . 0.0 105.939 -176.55 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 8.1 ttm180 -131.32 111.99 12.36 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 175.726 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -77.67 169.51 54.73 Favored Glycine 0 C--O 1.229 -0.216 0 N-CA-C 108.699 -1.76 . . . . 0.0 108.699 176.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -65.44 -42.29 95.95 Favored Glycine 0 C--O 1.219 -0.826 0 C-N-CA 120.613 -0.804 . . . . 0.0 112.36 -177.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -90.57 14.45 13.18 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 122.617 1.199 . . . . 0.0 111.764 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 90.86 -12.37 69.09 Favored Glycine 0 C--N 1.314 -0.664 0 CA-C-N 113.958 -1.474 . . . . 0.0 115.979 175.697 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 4.4 mppt? -57.79 132.63 53.89 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.586 0.708 . . . . 0.0 109.409 179.358 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 26.1 ptm -132.43 -171.49 2.66 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 114.747 -1.115 . . . . 0.0 112.358 -176.147 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 60.9 mmtt -112.71 -119.72 0.3 Allowed 'General case' 0 C--O 1.219 -0.519 0 C-N-CA 123.477 0.711 . . . . 0.0 109.282 -178.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 57.8 m-20 -66.97 141.46 57.59 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 111.729 0.27 . . . . 0.0 111.729 -174.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 55.8 mt -87.94 -61.65 1.67 Allowed 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 177.318 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 71.0 p -112.35 166.12 11.61 Favored Pre-proline 0 C--O 1.243 0.724 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 178.231 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -73.31 163.81 36.88 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 116.3 -2.0 . . . . 0.0 112.416 177.168 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.44 160.83 39.13 Favored 'General case' 0 C--N 1.326 -0.423 0 O-C-N 122.148 -0.345 . . . . 0.0 110.847 179.037 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 67.0 m95 -117.74 133.98 55.38 Favored 'General case' 0 C--O 1.214 -0.777 0 C-N-CA 122.871 0.468 . . . . 0.0 111.067 -178.138 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 52.1 m-85 -110.39 163.29 13.82 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 106.438 -1.69 . . . . 0.0 106.438 179.041 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 81.0 t80 -110.81 138.25 47.44 Favored 'General case' 0 CA--C 1.51 -0.589 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 -179.066 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -137.6 136.47 37.56 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.114 -0.948 . . . . 0.0 108.548 -176.274 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 34.2 m-85 -70.66 159.52 34.28 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.012 178.469 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -53.56 127.72 26.36 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 113.106 0.78 . . . . 0.0 113.106 -177.181 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 64.47 33.45 87.27 Favored Glycine 0 C--O 1.224 -0.506 0 N-CA-C 115.434 0.934 . . . . 0.0 115.434 174.02 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 4.1 p . . . . . 0 C--N 1.323 -0.555 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 177.79 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 19.1 mt . . . . . 0 C--O 1.238 0.472 0 N-CA-C 114.117 1.155 . . . . 0.0 114.117 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -76.77 165.64 28.33 Favored 'Trans proline' 0 N--CA 1.462 -0.345 0 C-N-CA 121.12 1.213 . . . . 0.0 109.171 172.656 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.41 ' CE1' ' HB3' ' A' ' 92' ' ' TRP . 74.4 t80 -62.37 131.88 50.75 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 120.398 -0.521 . . . . 0.0 110.359 -179.485 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 90.07 -1.33 80.11 Favored Glycine 0 CA--C 1.518 0.235 0 CA-C-O 119.834 -0.426 . . . . 0.0 113.903 178.36 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -61.73 130.26 44.94 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 117.667 0.733 . . . . 0.0 111.348 178.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 54.3 t30 -79.42 120.63 24.1 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.452 -178.639 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 50.4 tttm -153.71 149.95 28.03 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 179.396 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -66.03 134.95 53.96 Favored 'General case' 0 C--O 1.238 0.49 0 CA-C-O 120.809 0.338 . . . . 0.0 110.405 179.179 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 70.65 23.57 77.63 Favored Glycine 0 N--CA 1.45 -0.397 0 CA-C-O 119.419 -0.656 . . . . 0.0 113.637 178.616 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 42.2 mm -129.59 130.83 67.2 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 CA-C-N 117.385 0.592 . . . . 0.0 110.401 -179.51 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.1 pt -135.59 120.18 27.03 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 CA-C-O 121.387 0.613 . . . . 0.0 110.251 176.196 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . 0.41 ' HB3' ' CE1' ' A' ' 83' ' ' TYR . 93.6 m95 -87.8 137.61 32.19 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 113.087 0.773 . . . . 0.0 113.087 -176.087 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 18.9 m -137.04 154.41 31.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 179.108 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -160.33 166.58 29.17 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 106.465 -1.68 . . . . 0.0 106.465 -178.368 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 11.3 t -138.8 174.73 10.22 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 105.618 -1.993 . . . . 0.0 105.618 177.278 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 59.8 tt0 -67.45 137.43 55.86 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.324 0.583 . . . . 0.0 110.861 -179.011 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 95.26 -11.85 68.63 Favored Glycine 0 N--CA 1.46 0.268 0 CA-C-N 115.756 -0.657 . . . . 0.0 113.3 178.053 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.408 ' HA ' ' HA ' ' A' ' 41' ' ' ASP . . . -76.57 143.05 40.54 Favored 'General case' 0 C--N 1.322 -0.592 0 O-C-N 122.598 -0.354 . . . . 0.0 110.541 179.441 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 46.2 mt -105.4 134.37 48.63 Favored 'General case' 0 CA--C 1.513 -0.459 0 N-CA-C 113.855 1.057 . . . . 0.0 113.855 -178.14 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -79.24 65.58 4.45 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.223 -0.899 . . . . 0.0 111.142 -178.548 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.414 HG23 ' HZ3' ' A' ' 103' ' ' LYS . 1.2 t -134.77 156.18 78.79 Favored Pre-proline 0 C--N 1.322 -0.629 0 N-CA-C 105.359 -2.089 . . . . 0.0 105.359 -179.408 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -65.93 153.11 79.48 Favored 'Trans proline' 0 C--N 1.344 0.322 0 N-CA-C 115.05 1.135 . . . . 0.0 115.05 179.34 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.414 ' HZ3' HG23 ' A' ' 101' ' ' THR . 72.0 mmtt -122.94 32.46 5.7 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.201 -0.909 . . . . 0.0 109.149 -178.619 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 15.4 p-10 -50.92 -44.24 60.08 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.989 -177.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 16.0 p80 -69.78 -8.92 52.28 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 114.015 1.117 . . . . 0.0 114.015 -178.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 33.8 mt -96.15 -41.7 11.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 O-C-N 122.186 -0.321 . . . . 0.0 110.214 179.186 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -68.44 14.75 0.66 Allowed Glycine 0 N--CA 1.466 0.67 0 N-CA-C 117.995 1.958 . . . . 0.0 117.995 -176.224 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 8.9 t -90.27 28.77 1.36 Allowed 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 123.695 0.798 . . . . 0.0 111.976 -178.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 73.9 ttp85 -57.75 121.4 10.36 Favored 'General case' 0 N--CA 1.474 0.737 0 O-C-N 121.451 -0.781 . . . . 0.0 109.956 -179.684 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 63.3 m-20 -90.57 118.09 68.46 Favored Pre-proline 0 C--N 1.322 -0.591 0 N-CA-C 106.174 -1.788 . . . . 0.0 106.174 179.618 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -71.09 -14.79 32.11 Favored 'Trans proline' 0 C--O 1.218 -0.523 0 C-N-CA 117.902 -0.932 . . . . 0.0 113.384 -177.052 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -75.53 -26.8 58.37 Favored 'General case' 0 C--O 1.22 -0.484 0 CA-C-O 120.858 0.361 . . . . 0.0 110.41 177.565 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 -104.33 -26.51 12.43 Favored 'General case' 0 C--O 1.222 -0.358 0 N-CA-C 113.284 0.846 . . . . 0.0 113.284 -174.314 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 25.5 t30 -146.0 143.99 29.81 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 -178.062 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -87.29 149.71 24.36 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.731 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -68.71 146.76 52.68 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 177.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 9.0 mt -78.61 134.58 27.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 -178.642 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 98.8 t -63.14 118.96 5.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 106.423 -1.695 . . . . 0.0 106.423 176.404 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 5.0 tt -67.02 125.31 25.61 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.398 0.618 . . . . 0.0 110.796 -176.303 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -132.7 161.02 35.06 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 105.6 -2.0 . . . . 0.0 105.6 179.452 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 20.1 mt -117.2 146.33 37.91 Favored Pre-proline 0 C--N 1.322 -0.594 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 179.435 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -73.14 171.58 17.29 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 121.183 1.256 . . . . 0.0 114.522 -175.463 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 39.6 tt0 -53.41 129.99 33.93 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.874 -179.311 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 90.99 -16.03 59.52 Favored Glycine 0 C--O 1.226 -0.357 0 CA-C-N 115.963 -0.562 . . . . 0.0 113.229 -179.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.564 HG22 HE22 ' A' ' 30' ' ' GLN . 19.2 m -108.61 127.15 53.71 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 179.501 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 4.8 p -125.28 148.28 48.75 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.754 0.312 . . . . 0.0 110.668 -176.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 84.8 mt -66.41 152.23 94.88 Favored Pre-proline 0 C--N 1.327 -0.406 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 177.197 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -76.83 168.1 24.11 Favored 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 117.747 -1.035 . . . . 0.0 110.859 -179.571 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -59.44 126.73 28.79 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 91.58 27.96 15.84 Favored Glycine 0 C--O 1.224 -0.5 0 N-CA-C 114.938 0.735 . . . . 0.0 114.938 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -139.07 147.42 41.99 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 117.701 0.75 . . . . 0.0 111.369 177.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 54.0 p90 -153.93 165.22 36.8 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 176.401 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -100.25 142.03 32.28 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 114.146 1.165 . . . . 0.0 114.146 -175.375 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -67.96 140.63 56.42 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 107.181 -1.415 . . . . 0.0 107.181 175.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 90.7 -34.79 4.07 Favored Glycine 0 C--O 1.23 -0.151 0 C-N-CA 121.457 -0.401 . . . . 0.0 112.327 -179.055 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 22.9 t . . . . . 0 C--N 1.327 -0.407 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 179.671 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.431 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 58.3 p -61.62 145.18 52.98 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.752 178.633 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 15.8 m95 -67.93 -24.13 65.16 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 112.609 0.596 . . . . 0.0 112.609 179.392 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 25.8 m-85 -121.48 163.35 18.94 Favored 'General case' 0 CA--C 1.505 -0.754 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -172.156 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 70.1 p -70.64 164.17 25.51 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 176.528 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -80.5 152.04 28.91 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.449 0.642 . . . . 0.0 112.656 -176.871 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 21.8 mt -85.02 146.37 27.22 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 102.753 -3.055 . . . . 0.0 102.753 168.605 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 52.4 m -119.64 129.51 54.63 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 179.528 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -85.34 133.25 34.15 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.648 -179.412 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 21.9 t-160 -139.16 94.94 2.86 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 103.533 -2.766 . . . . 0.0 103.533 168.591 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 166.46 -131.26 2.32 Favored Glycine 0 C--O 1.226 -0.379 0 C-N-CA 120.184 -1.008 . . . . 0.0 113.119 -174.902 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 64.1 mttm -130.96 -38.5 1.25 Allowed 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 116.973 2.212 . . . . 0.0 116.973 -176.327 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -75.62 163.32 27.45 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 179.513 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -72.22 -62.66 1.35 Allowed 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 178.284 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 48.4 tp 174.47 134.2 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 104.843 -2.28 . . . . 0.0 104.843 173.256 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 11.1 tmtt? -148.24 127.51 13.0 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 118.403 0.547 . . . . 0.0 111.386 178.266 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 16.0 m-85 -113.22 153.16 45.54 Favored Pre-proline 0 C--O 1.243 0.716 0 CA-C-O 120.562 0.22 . . . . 0.0 111.306 176.811 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.42 162.57 41.38 Favored 'Trans proline' 0 C--N 1.353 0.765 0 C-N-CA 120.02 0.48 . . . . 0.0 112.541 177.594 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 16.9 tpt180 -69.93 134.63 48.6 Favored 'General case' 0 C--O 1.216 -0.704 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 -176.837 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 78.92 15.1 81.21 Favored Glycine 0 C--O 1.224 -0.506 0 C-N-CA 121.136 -0.554 . . . . 0.0 111.908 178.859 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 8.9 mt-30 -151.63 170.49 19.57 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 -175.291 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 108.09 -16.73 35.6 Favored Glycine 0 CA--C 1.501 -0.805 0 CA-C-N 116.236 -0.438 . . . . 0.0 112.676 175.373 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 95.0 t -65.7 129.29 94.3 Favored Pre-proline 0 C--N 1.319 -0.718 0 N-CA-C 106.968 -1.494 . . . . 0.0 106.968 177.41 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -73.29 170.33 20.14 Favored 'Trans proline' 0 N--CA 1.461 -0.422 0 O-C-N 122.17 0.563 . . . . 0.0 111.297 177.869 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 91.6 mt -69.39 107.63 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 179.829 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 -97.67 84.75 3.44 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 114.409 -1.269 . . . . 0.0 109.857 -176.817 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 69.8 p -66.59 -15.65 63.59 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.647 -0.706 . . . . 0.0 112.699 -178.869 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -107.32 22.62 15.7 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.152 -0.931 . . . . 0.0 112.162 -177.917 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 14.3 m -141.92 148.06 38.06 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 114.518 1.303 . . . . 0.0 114.518 -176.233 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -74.65 168.35 27.9 Favored Pre-proline 0 N--CA 1.468 0.46 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 176.424 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -64.65 -28.98 60.6 Favored 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 114.807 -2.996 . . . . 0.0 112.3 178.756 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -62.92 -24.07 67.67 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 123.74 0.816 . . . . 0.0 111.667 176.289 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 70.3 m-20 -98.93 -1.49 39.86 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 114.865 1.431 . . . . 0.0 114.865 -172.354 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 93.7 mm-40 -60.36 -29.26 68.8 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 114.459 1.281 . . . . 0.0 114.459 -178.888 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 20.8 tt -58.61 139.65 18.0 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.882 0 CA-C-O 122.32 1.057 . . . . 0.0 113.774 -177.296 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -179.18 -156.65 17.91 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.434 -178.738 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 46.6 p90 -155.12 171.52 19.65 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 178.653 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 19.9 m-85 -113.15 139.45 48.74 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 106.365 -1.717 . . . . 0.0 106.365 173.131 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 55.8 ttt180 -110.33 119.71 40.09 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.033 -176.951 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 11.8 ttp180 -65.92 137.92 57.49 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 177.431 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -143.8 142.67 31.0 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.772 0.796 . . . . 0.0 111.266 -179.976 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 41.4 p -142.99 172.49 12.63 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 102.284 -3.228 . . . . 0.0 102.284 174.995 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 17.9 tpt180 -140.62 125.98 18.79 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 120.345 -0.542 . . . . 0.0 111.025 176.557 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.26 148.11 33.12 Favored 'General case' 0 CA--C 1.488 -1.436 0 CA-C-O 121.611 0.719 . . . . 0.0 109.537 179.604 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -144.61 179.61 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.055 0 N-CA-C 102.123 -3.288 . . . . 0.0 102.123 178.804 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 79.2 ttt180 -132.7 121.16 22.68 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 175.295 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -97.33 147.07 18.53 Favored Glycine 0 N--CA 1.448 -0.547 0 N-CA-C 106.582 -2.607 . . . . 0.0 106.582 175.543 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -68.73 -30.94 72.72 Favored Glycine 0 C--O 1.216 -1.016 0 N-CA-C 109.798 -1.321 . . . . 0.0 109.798 179.507 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 30.7 t0 -87.26 17.02 4.62 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-O 122.016 0.912 . . . . 0.0 111.394 179.99 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 84.93 -6.49 78.63 Favored Glycine 0 C--O 1.223 -0.55 0 N-CA-C 116.462 1.345 . . . . 0.0 116.462 174.196 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.13 132.11 47.16 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.959 0.885 . . . . 0.0 112.509 -179.277 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 91.6 mmm -121.79 179.38 4.51 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 113.81 -1.541 . . . . 0.0 108.485 -177.917 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 13.6 mmtt -111.41 -54.35 2.62 Favored 'General case' 0 C--O 1.215 -0.761 0 CA-C-O 120.857 0.36 . . . . 0.0 110.155 178.268 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 49.58 50.0 18.99 Favored 'General case' 0 C--N 1.323 -0.579 0 O-C-N 124.993 1.433 . . . . 0.0 113.867 174.972 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 63.9 mt -70.97 142.08 51.02 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 107.143 -1.429 . . . . 0.0 107.143 176.453 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 72.6 p -58.92 153.59 42.93 Favored Pre-proline 0 C--O 1.239 0.515 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -176.423 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -65.84 128.99 21.0 Favored 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 117.898 -0.935 . . . . 0.0 112.406 -178.918 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 18.1 mtt-85 -134.7 160.83 36.91 Favored 'General case' 0 CA--C 1.51 -0.592 0 CA-C-N 115.249 -0.887 . . . . 0.0 111.214 -176.499 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 57.6 m95 -129.49 129.19 44.25 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 178.152 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 40.4 m-85 -111.43 139.35 46.92 Favored 'General case' 0 C--O 1.217 -0.627 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 -178.491 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 92.0 t80 -86.9 136.64 32.88 Favored 'General case' 0 CA--C 1.509 -0.604 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 -177.973 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -141.77 144.91 34.22 Favored 'General case' 0 N--CA 1.441 -0.905 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 -175.434 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 -80.76 159.38 25.2 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 112.276 0.472 . . . . 0.0 112.276 -174.726 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 15.8 tp -58.1 126.95 29.7 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 121.363 0.602 . . . . 0.0 110.177 -179.423 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 85.21 16.73 64.11 Favored Glycine 0 C--O 1.221 -0.704 0 N-CA-C 116.086 1.195 . . . . 0.0 116.086 178.468 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 19.4 p . . . . . 0 N--CA 1.469 0.477 0 CA-C-N 118.971 1.385 . . . . 0.0 111.187 179.941 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 43.9 mt . . . . . 0 N--CA 1.449 -0.483 0 N-CA-C 115.525 1.676 . . . . 0.0 115.525 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -77.52 166.02 26.41 Favored 'Trans proline' 0 N--CA 1.461 -0.407 0 N-CA-C 108.388 -1.428 . . . . 0.0 108.388 169.274 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 64.1 t80 -63.14 132.51 52.05 Favored 'General case' 0 C--N 1.322 -0.602 0 O-C-N 121.947 -0.471 . . . . 0.0 109.958 -179.677 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 91.39 -4.91 80.6 Favored Glycine 0 CA--C 1.52 0.353 0 N-CA-C 114.637 0.615 . . . . 0.0 114.637 178.868 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -65.14 132.3 48.8 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 118.038 0.919 . . . . 0.0 112.357 179.781 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 50.1 t30 -74.96 125.9 29.87 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.863 -178.807 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 26.9 ttmt -156.26 151.6 26.7 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 107.178 -1.416 . . . . 0.0 107.178 177.321 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 15.6 t0 -61.97 129.63 41.82 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.013 0.435 . . . . 0.0 110.853 179.423 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 69.19 27.85 73.35 Favored Glycine 0 N--CA 1.447 -0.609 0 CA-C-N 115.82 -0.627 . . . . 0.0 114.319 176.032 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 45.1 mm -125.11 120.77 59.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 117.365 0.583 . . . . 0.0 110.062 178.764 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.1 pt -123.68 113.79 38.75 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 CA-C-O 121.896 0.855 . . . . 0.0 110.592 176.972 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 96.5 m95 -80.51 132.67 35.72 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.763 -0.653 . . . . 0.0 112.601 -176.978 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 17.0 m -135.59 149.7 28.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.795 0.807 . . . . 0.0 109.492 179.599 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -156.28 166.57 33.06 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 103.531 -2.766 . . . . 0.0 103.531 -179.282 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 14.5 t -131.53 168.94 16.8 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 104.221 -2.511 . . . . 0.0 104.221 177.522 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -65.41 134.17 52.91 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 -178.681 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 95.75 -7.06 67.75 Favored Glycine 0 C--O 1.226 -0.369 0 CA-C-N 116.004 -0.544 . . . . 0.0 113.529 179.4 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -80.51 135.42 36.11 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 122.096 -0.649 . . . . 0.0 109.823 179.029 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 37.0 mt -81.86 136.25 35.38 Favored 'General case' 0 CA--C 1.511 -0.529 0 CA-C-O 121.161 0.505 . . . . 0.0 111.479 -178.878 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 63.4 t30 -84.08 65.22 8.62 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.633 -179.664 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -140.1 153.75 69.55 Favored Pre-proline 0 C--N 1.324 -0.519 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 -178.553 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -66.85 149.89 83.23 Favored 'Trans proline' 0 C--N 1.344 0.319 0 N-CA-C 113.977 0.722 . . . . 0.0 113.977 177.252 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 1.5 ptpm? -149.15 55.51 0.99 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 123.036 1.398 . . . . 0.0 109.571 179.759 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 13.6 p-10 -54.92 -35.1 63.83 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 113.451 -1.704 . . . . 0.0 112.344 179.52 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 37.5 p-80 -60.3 -14.6 19.09 Favored 'General case' 0 C--O 1.219 -0.549 0 N-CA-C 114.728 1.381 . . . . 0.0 114.728 -177.839 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 62.8 mt -84.42 -39.16 14.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 178.515 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -74.16 14.6 3.8 Favored Glycine 0 C--O 1.221 -0.678 0 N-CA-C 116.126 1.211 . . . . 0.0 116.126 -176.558 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 11.5 t -94.29 23.11 5.35 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 117.968 0.884 . . . . 0.0 112.667 -178.038 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 65.3 ttp85 -55.91 133.65 51.56 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.387 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 15.1 m-20 -104.28 125.18 34.97 Favored Pre-proline 0 C--N 1.324 -0.523 0 N-CA-C 106.854 -1.536 . . . . 0.0 106.854 -179.389 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_endo -69.59 -18.51 37.75 Favored 'Trans proline' 0 C--O 1.217 -0.527 0 N-CA-C 114.037 0.745 . . . . 0.0 114.037 -177.903 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -73.63 -26.28 60.7 Favored 'General case' 0 C--O 1.22 -0.498 0 CA-C-O 120.877 0.37 . . . . 0.0 110.675 178.1 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -102.11 -23.93 14.0 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 113.142 0.793 . . . . 0.0 113.142 -174.978 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 26.8 t30 -154.55 148.37 25.52 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 112.578 0.584 . . . . 0.0 112.578 -178.361 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -88.94 149.1 23.46 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-O 121.432 0.634 . . . . 0.0 111.702 179.575 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -70.08 145.18 51.83 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.221 0.534 . . . . 0.0 110.446 178.369 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 14.4 mt -86.3 138.8 18.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 115.393 -0.821 . . . . 0.0 108.815 -178.601 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 75.6 t -61.16 123.9 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 N-CA-C 106.077 -1.823 . . . . 0.0 106.077 174.848 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 7.1 tt -66.84 130.11 42.07 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.134 0.492 . . . . 0.0 110.379 -177.021 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 30.2 mt-30 -132.72 157.94 43.62 Favored 'General case' 0 CA--C 1.511 -0.551 0 N-CA-C 106.615 -1.624 . . . . 0.0 106.615 -179.445 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 13.3 mt -112.31 148.18 38.59 Favored Pre-proline 0 C--N 1.322 -0.588 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 177.12 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -73.2 166.17 30.68 Favored 'Trans proline' 0 N--CA 1.462 -0.371 0 O-C-N 122.325 0.645 . . . . 0.0 112.933 -179.501 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 60.2 tp60 -54.27 130.37 38.56 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.887 -179.879 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 97.15 -17.12 59.73 Favored Glycine 0 C--O 1.227 -0.3 0 CA-C-N 115.907 -0.588 . . . . 0.0 113.611 -179.926 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 9.5 m -106.71 127.01 53.02 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 118.149 0.975 . . . . 0.0 109.984 178.288 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 17.3 p -120.02 148.32 43.71 Favored 'General case' 0 CA--C 1.511 -0.534 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.845 -179.132 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 88.8 mt -70.4 156.1 92.41 Favored Pre-proline 0 C--N 1.323 -0.561 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 177.559 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -74.55 169.11 23.26 Favored 'Trans proline' 0 C--O 1.236 0.406 0 C-N-CA 117.749 -1.034 . . . . 0.0 110.343 178.302 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 12.4 tmtt? -63.72 120.67 12.29 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 -176.823 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 95.18 37.94 4.98 Favored Glycine 0 N--CA 1.452 -0.257 0 N-CA-C 114.943 0.737 . . . . 0.0 114.943 178.942 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -142.31 146.15 34.73 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 176.85 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 48.6 p90 -147.11 162.38 38.94 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 176.627 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -97.68 143.26 28.53 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.042 0.449 . . . . 0.0 110.547 -178.345 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -71.34 135.84 47.54 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 178.812 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 87.87 -13.53 60.84 Favored Glycine 0 C--O 1.227 -0.299 0 CA-C-N 116.109 -0.496 . . . . 0.0 113.147 -178.24 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 35.2 t . . . . . 0 C--N 1.326 -0.43 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 178.733 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.456 -0.128 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 62.5 p -63.06 141.07 58.9 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 178.865 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 10.9 m95 -67.95 -27.21 66.4 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.038 0.447 . . . . 0.0 111.772 178.716 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 20.1 m-85 -121.53 163.97 17.99 Favored 'General case' 0 C--O 1.242 0.68 0 CA-C-N 115.517 -0.765 . . . . 0.0 112.537 -171.349 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 63.7 p -70.19 166.5 19.87 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 177.096 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -83.58 148.17 27.32 Favored 'General case' 0 N--CA 1.443 -0.785 0 N-CA-C 113.529 0.937 . . . . 0.0 113.529 -175.371 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 15.6 mt -81.88 144.92 30.65 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 103.768 -2.679 . . . . 0.0 103.768 170.902 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 26.4 m -123.28 131.03 53.52 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.108 0.48 . . . . 0.0 110.052 -178.008 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -83.39 141.93 31.38 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.34 -0.845 . . . . 0.0 111.94 -178.627 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 23.0 t-160 -139.11 99.71 3.83 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 105.83 -1.915 . . . . 0.0 105.83 168.477 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 151.02 -134.59 4.76 Favored Glycine 0 C--N 1.322 -0.242 0 N-CA-C 111.134 -0.786 . . . . 0.0 111.134 -176.841 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 51.6 mttp -132.7 -16.1 2.65 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 114.993 1.479 . . . . 0.0 114.993 -179.351 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 59.7 mt-10 -73.98 155.49 38.55 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 107.1 -1.444 . . . . 0.0 107.1 178.027 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -82.17 -62.6 1.58 Allowed 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 120.458 -0.497 . . . . 0.0 109.791 -178.685 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 56.5 tp 168.58 136.7 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 103.661 -2.718 . . . . 0.0 103.661 175.411 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -157.01 138.87 14.3 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 176.511 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 25.6 m-85 -127.55 151.38 75.01 Favored Pre-proline 0 C--N 1.324 -0.531 0 O-C-N 123.307 0.379 . . . . 0.0 110.212 176.804 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -79.72 165.89 22.08 Favored 'Trans proline' 0 CA--C 1.541 0.83 0 C-N-CA 120.568 0.845 . . . . 0.0 113.03 176.755 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 2.2 tmt_? -67.3 138.33 56.75 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 116.548 -0.296 . . . . 0.0 110.257 -179.384 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 86.66 2.73 84.39 Favored Glycine 0 C--O 1.224 -0.503 0 N-CA-C 110.894 -0.883 . . . . 0.0 110.894 178.008 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.533 HE22 HG22 ' A' ' 125' ' ' THR . 27.6 mt-30 -143.86 -179.62 6.58 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 -175.14 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 95.54 -28.97 10.4 Favored Glycine 0 CA--C 1.5 -0.896 0 CA-C-N 115.794 -0.639 . . . . 0.0 113.555 174.716 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 91.6 t -64.14 127.3 91.78 Favored Pre-proline 0 C--N 1.319 -0.721 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 177.486 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -72.91 171.72 16.88 Favored 'Trans proline' 0 N--CA 1.461 -0.433 0 C-N-CA 120.128 0.552 . . . . 0.0 111.717 178.409 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 85.6 mt -69.21 107.89 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-O 122.299 1.047 . . . . 0.0 108.539 179.415 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 84.7 m-20 -98.45 86.33 3.58 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 114.122 -1.399 . . . . 0.0 109.874 -176.614 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 67.0 p -67.56 -15.79 63.84 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.525 -0.761 . . . . 0.0 112.627 -178.848 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 11.2 p30 -107.11 21.09 18.08 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 114.9 -1.046 . . . . 0.0 113.014 -177.31 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 9.9 m -140.16 150.38 44.15 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 115.741 1.756 . . . . 0.0 115.741 -174.817 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 4.6 m -72.49 166.28 43.49 Favored Pre-proline 0 N--CA 1.468 0.464 0 CA-C-N 115.415 -0.812 . . . . 0.0 109.553 176.22 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -66.03 -27.98 49.75 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 114.533 -3.178 . . . . 0.0 113.944 -179.805 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.404 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 5.6 p-10 -75.06 -21.55 58.92 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 121.66 -0.65 . . . . 0.0 111.213 177.113 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 75.0 m-20 -81.36 -10.53 59.52 Favored 'General case' 0 C--O 1.221 -0.415 0 N-CA-C 113.453 0.908 . . . . 0.0 113.453 -176.034 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 96.6 mm-40 -56.69 -27.29 58.65 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 115.155 1.539 . . . . 0.0 115.155 -176.59 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 19.7 tt -55.31 138.46 15.57 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.941 0 N-CA-C 114.418 1.266 . . . . 0.0 114.418 -178.077 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -176.88 -159.95 23.09 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.416 -0.897 . . . . 0.0 114.353 -179.406 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 44.8 p90 -154.92 170.47 21.63 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 179.242 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 17.6 m-85 -114.39 141.46 47.62 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 172.905 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 58.3 ttt180 -113.56 117.24 31.1 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 124.415 1.086 . . . . 0.0 110.992 -175.428 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 46.6 ttp180 -65.6 137.52 57.41 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 178.356 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -150.41 150.06 30.87 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.854 0.359 . . . . 0.0 111.149 -178.029 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 21.6 p -141.94 140.13 32.69 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.826 176.282 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 14.0 tpt180 -142.74 123.87 14.53 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 174.742 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.52 133.84 52.22 Favored 'General case' 0 CA--C 1.494 -1.187 0 CA-C-O 121.584 0.706 . . . . 0.0 110.963 -176.508 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -129.17 179.1 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.883 0 N-CA-C 105.472 -2.047 . . . . 0.0 105.472 178.238 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 27.8 tpt180 -139.57 107.93 5.83 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 106.803 -1.554 . . . . 0.0 106.803 172.502 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -74.17 156.61 50.36 Favored Glycine 0 N--CA 1.447 -0.568 0 N-CA-C 107.681 -2.168 . . . . 0.0 107.681 176.608 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -69.34 -33.23 72.66 Favored Glycine 0 C--O 1.216 -0.983 0 N-CA-C 108.62 -1.792 . . . . 0.0 108.62 179.373 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.1 t0 -84.75 16.61 3.19 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-O 122.55 1.167 . . . . 0.0 109.689 177.715 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 85.03 -14.6 48.35 Favored Glycine 0 N--CA 1.455 -0.086 0 N-CA-C 116.961 1.544 . . . . 0.0 116.961 173.457 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -55.91 142.01 37.15 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 114.968 1.469 . . . . 0.0 114.968 -176.74 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 95.3 mmm -116.48 177.98 4.5 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 112.543 -2.117 . . . . 0.0 109.475 -177.095 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 13.7 tppt? -126.28 -53.76 1.49 Allowed 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 178.208 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 -120.43 149.42 42.4 Favored 'General case' 0 CA--C 1.506 -0.716 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 178.499 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -133.49 -44.18 0.83 Allowed 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 104.306 -2.479 . . . . 0.0 104.306 176.256 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 33.3 t -112.02 153.27 44.63 Favored Pre-proline 0 C--O 1.243 0.748 0 N-CA-C 105.42 -2.066 . . . . 0.0 105.42 175.954 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -68.75 156.74 64.48 Favored 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 117.06 -1.494 . . . . 0.0 114.983 -179.381 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 94.0 mtt-85 -113.98 165.46 12.58 Favored 'General case' 0 CA--C 1.509 -0.6 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.523 178.015 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 49.8 m95 -132.03 129.47 40.11 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 176.247 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 17.0 m-85 -110.77 141.34 44.23 Favored 'General case' 0 C--O 1.216 -0.658 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 -176.863 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -88.7 136.87 32.78 Favored 'General case' 0 CA--C 1.506 -0.732 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 -176.527 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -141.36 143.44 33.99 Favored 'General case' 0 N--CA 1.438 -1.032 0 N-CA-C 106.976 -1.491 . . . . 0.0 106.976 -175.888 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 66.8 m-85 -82.94 159.35 22.29 Favored 'General case' 0 C--N 1.317 -0.842 0 O-C-N 122.21 -0.306 . . . . 0.0 110.94 -175.342 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 15.4 tp -54.59 131.49 43.16 Favored 'General case' 0 C--O 1.218 -0.583 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 179.452 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 74.54 25.43 70.22 Favored Glycine 0 C--O 1.225 -0.466 0 N-CA-C 115.8 1.08 . . . . 0.0 115.8 177.633 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 49.8 p . . . . . 0 N--CA 1.466 0.353 0 CA-C-N 118.421 1.11 . . . . 0.0 110.279 176.167 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 15.4 mt . . . . . 0 N--CA 1.442 -0.858 0 N-CA-C 115.291 1.589 . . . . 0.0 115.291 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -78.59 161.83 27.77 Favored 'Trans proline' 0 N--CA 1.461 -0.393 0 C-N-CA 122.516 2.144 . . . . 0.0 107.229 167.596 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 49.7 t80 -61.46 133.54 55.87 Favored 'General case' 0 C--N 1.319 -0.718 0 C-N-CA 120.425 -0.51 . . . . 0.0 110.283 -177.331 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 90.68 -8.62 79.53 Favored Glycine 0 CA--C 1.518 0.278 0 CA-C-O 119.518 -0.601 . . . . 0.0 114.394 179.599 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -66.3 130.3 42.76 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 118.569 1.184 . . . . 0.0 111.624 179.669 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 48.8 t-20 -80.25 130.33 35.13 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.479 -179.441 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 28.0 ttmt -156.1 154.56 31.12 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 106.865 -1.531 . . . . 0.0 106.865 -179.844 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -58.78 124.04 18.43 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.914 0.388 . . . . 0.0 110.868 -179.164 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 69.31 31.48 71.59 Favored Glycine 0 N--CA 1.449 -0.446 0 CA-C-O 119.044 -0.864 . . . . 0.0 115.029 177.556 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 43.2 mm -124.71 127.67 72.89 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 CA-C-N 118.045 0.922 . . . . 0.0 110.992 179.534 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -129.49 123.51 57.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.4 176.357 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 98.7 m95 -88.34 138.14 31.7 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 114.05 1.13 . . . . 0.0 114.05 -176.241 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 16.2 m -139.0 149.8 23.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 121.693 0.759 . . . . 0.0 110.053 178.936 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -159.22 161.12 36.04 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 103.915 -2.624 . . . . 0.0 103.915 178.405 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 13.9 t -118.23 172.78 7.2 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 105.227 -2.138 . . . . 0.0 105.227 178.559 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -66.43 131.95 47.19 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.811 0.339 . . . . 0.0 110.238 -178.624 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 90.98 -4.1 81.28 Favored Glycine 0 CA--C 1.519 0.283 0 C-N-CA 121.359 -0.448 . . . . 0.0 113.746 178.806 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.404 ' HA ' ' HA ' ' A' ' 41' ' ' ASP . . . -73.83 136.06 43.48 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 178.44 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 30.3 mt -89.22 140.55 29.36 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.51 0.671 . . . . 0.0 112.195 -177.071 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 61.9 t30 -83.98 64.95 8.42 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.193 -179.304 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -137.46 155.84 75.29 Favored Pre-proline 0 C--N 1.322 -0.593 0 N-CA-C 106.438 -1.69 . . . . 0.0 106.438 -178.956 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -66.48 151.43 83.05 Favored 'Trans proline' 0 C--N 1.342 0.223 0 N-CA-C 115.359 1.253 . . . . 0.0 115.359 179.993 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -123.02 41.19 3.53 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 114.44 -1.254 . . . . 0.0 108.909 -178.757 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 18.3 p-10 -51.22 -43.4 61.43 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 114.235 -1.348 . . . . 0.0 111.329 178.848 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 46.5 p-80 -66.45 -10.94 49.19 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 124.567 1.147 . . . . 0.0 113.953 -178.839 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 50.4 mt -96.11 -38.22 8.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 179.806 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -74.58 1.74 50.63 Favored Glycine 0 C--O 1.225 -0.453 0 N-CA-C 115.59 0.996 . . . . 0.0 115.59 -177.759 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 14.7 t -83.39 18.8 1.69 Allowed 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 117.869 0.835 . . . . 0.0 112.753 -176.635 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.424 ' HD2' ' OD1' ' A' ' 114' ' ' ASN . 64.2 ttp85 -57.03 130.57 46.69 Favored 'General case' 0 N--CA 1.467 0.391 0 O-C-N 121.998 -0.439 . . . . 0.0 110.129 178.862 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 35.8 m120 -88.49 117.63 68.56 Favored Pre-proline 0 C--N 1.323 -0.546 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 179.843 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -72.76 -13.2 26.87 Favored 'Trans proline' 0 C--O 1.217 -0.531 0 C-N-CA 117.128 -1.448 . . . . 0.0 112.835 -179.528 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -78.4 -27.18 46.66 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.568 177.413 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 -102.06 -25.69 13.65 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 113.237 0.829 . . . . 0.0 113.237 -174.795 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . 0.424 ' OD1' ' HD2' ' A' ' 109' ' ' ARG . 5.0 t-20 -128.7 147.61 50.77 Favored 'General case' 0 N--CA 1.442 -0.829 0 N-CA-C 113.149 0.796 . . . . 0.0 113.149 -177.905 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -95.28 129.23 42.49 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 173.808 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -62.16 148.15 45.4 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.448 -0.796 . . . . 0.0 112.371 -178.236 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 9.8 mt -80.72 138.99 18.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 114.89 -1.05 . . . . 0.0 109.432 -177.832 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 79.5 t -63.11 123.38 15.76 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 N-CA-C 106.12 -1.807 . . . . 0.0 106.12 174.516 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 6.6 tt -65.63 130.48 43.46 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.258 0.552 . . . . 0.0 111.045 -176.876 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 31.0 mt-30 -132.99 159.02 41.21 Favored 'General case' 0 CA--C 1.513 -0.461 0 N-CA-C 106.729 -1.582 . . . . 0.0 106.729 -179.553 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 13.5 mt -112.97 146.73 35.72 Favored Pre-proline 0 C--N 1.323 -0.559 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 177.836 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -73.11 166.78 29.09 Favored 'Trans proline' 0 C--N 1.345 0.348 0 O-C-N 122.272 0.617 . . . . 0.0 113.038 -179.367 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 39.9 tt0 -54.89 131.53 44.53 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.902 179.998 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 95.8 -17.06 60.0 Favored Glycine 0 C--O 1.226 -0.371 0 CA-C-N 115.903 -0.589 . . . . 0.0 113.311 179.944 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.533 HG22 HE22 ' A' ' 30' ' ' GLN . 16.0 m -103.72 128.85 51.04 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 118.073 0.937 . . . . 0.0 111.032 178.811 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 5.8 p -117.23 148.26 41.79 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.795 -179.416 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 83.4 mt -71.23 157.8 89.41 Favored Pre-proline 0 C--N 1.324 -0.504 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 176.989 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -75.55 174.15 13.3 Favored 'Trans proline' 0 C--O 1.237 0.451 0 C-N-CA 117.514 -1.191 . . . . 0.0 109.866 178.367 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 64.1 tttm -62.06 125.94 25.61 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.437 0.636 . . . . 0.0 110.454 -177.141 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 82.31 45.44 6.99 Favored Glycine 0 C--O 1.226 -0.378 0 N-CA-C 115.275 0.87 . . . . 0.0 115.275 178.3 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -141.54 150.87 42.7 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 117.856 0.828 . . . . 0.0 111.476 177.852 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 42.6 p90 -149.95 165.61 32.12 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 176.65 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -101.92 145.32 29.4 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.155 0.502 . . . . 0.0 111.468 -177.993 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -72.69 127.83 33.73 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 179.964 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 92.21 -15.04 63.04 Favored Glycine 0 C--O 1.228 -0.224 0 CA-C-N 115.948 -0.569 . . . . 0.0 113.574 179.506 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 33.5 t . . . . . 0 C--N 1.325 -0.489 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 179.978 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.265 0 CA-C-O 121.3 0.571 . . . . 0.0 111.137 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 17.1 t -65.73 139.96 58.41 Favored 'General case' 0 CA--C 1.512 -0.513 0 N-CA-C 106.954 -1.499 . . . . 0.0 106.954 176.825 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 6.9 m95 -69.62 -21.91 63.53 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.136 0.493 . . . . 0.0 110.276 177.939 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 17.5 m-85 -121.42 161.91 21.35 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.393 -0.821 . . . . 0.0 112.452 -172.223 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.411 ' HB ' ' HB3' ' A' ' 134' ' ' GLU . 67.8 p -69.13 164.77 21.8 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 179.079 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -81.1 140.26 35.16 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 113.06 0.763 . . . . 0.0 113.06 -176.592 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 20.1 mt -78.82 148.22 32.95 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 103.576 -2.75 . . . . 0.0 103.576 170.614 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 16.2 m -130.12 134.76 47.56 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 118.189 0.45 . . . . 0.0 110.605 -178.005 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . 0.405 ' HB2' ' CZ ' ' A' ' 131' ' ' PHE . 4.1 tp60 -100.87 141.56 33.58 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 -177.804 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 52.1 t60 -128.56 99.66 5.46 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 104.636 -2.357 . . . . 0.0 104.636 169.126 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 164.43 -158.76 31.54 Favored Glycine 0 N--CA 1.452 -0.251 0 N-CA-C 108.239 -1.945 . . . . 0.0 108.239 -175.892 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -115.59 -20.9 9.98 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 117.688 0.744 . . . . 0.0 111.127 179.18 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -72.11 153.69 41.53 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.201 -0.909 . . . . 0.0 109.121 178.701 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -82.23 -62.89 1.5 Allowed 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 113.905 1.076 . . . . 0.0 113.905 -176.832 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 50.1 tp 165.33 142.18 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.268 0 N-CA-C 105.815 -1.92 . . . . 0.0 105.815 179.025 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 51.8 tptt -157.25 139.6 14.67 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 173.46 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 16.3 m-85 -122.47 151.92 60.48 Favored Pre-proline 0 C--O 1.241 0.636 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 175.865 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -70.4 161.32 46.43 Favored 'Trans proline' 0 C--N 1.351 0.659 0 O-C-N 122.261 0.611 . . . . 0.0 112.496 178.625 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 22.7 tpt180 -67.83 135.55 52.75 Favored 'General case' 0 C--O 1.216 -0.673 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 -178.249 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 82.55 10.78 82.91 Favored Glycine 0 C--O 1.223 -0.565 0 C-N-CA 121.218 -0.515 . . . . 0.0 111.87 178.87 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 10.2 mt-30 -150.37 170.5 18.89 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 -175.116 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 105.68 -16.56 43.83 Favored Glycine 0 CA--C 1.503 -0.711 0 CA-C-N 116.289 -0.414 . . . . 0.0 113.393 174.887 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 94.1 t -65.75 130.03 94.43 Favored Pre-proline 0 C--N 1.319 -0.726 0 N-CA-C 106.273 -1.751 . . . . 0.0 106.273 177.027 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -72.64 171.17 17.76 Favored 'Trans proline' 0 N--CA 1.46 -0.468 0 O-C-N 122.194 0.576 . . . . 0.0 111.23 178.084 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 87.9 mt -71.01 107.06 2.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 179.801 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 -99.55 84.82 3.02 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.523 -1.217 . . . . 0.0 110.55 -176.329 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 75.7 p -67.97 -14.96 63.38 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.644 -0.707 . . . . 0.0 112.568 -179.204 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 12.5 p30 -108.48 21.71 16.93 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.15 -0.932 . . . . 0.0 112.871 -177.646 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 11.8 m -140.71 148.09 40.21 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 113.454 0.909 . . . . 0.0 113.454 -177.14 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -72.0 166.08 44.09 Favored Pre-proline 0 C--N 1.326 -0.418 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 177.068 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -64.8 -27.22 59.7 Favored 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 115.376 -2.616 . . . . 0.0 111.793 178.69 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -62.26 -28.77 69.94 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.786 0.803 . . . . 0.0 111.132 176.451 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -96.6 1.02 50.82 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 115.348 1.611 . . . . 0.0 115.348 -171.042 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 94.9 mm-40 -61.4 -30.1 70.34 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 113.841 1.052 . . . . 0.0 113.841 179.641 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 14.6 tt -61.22 138.0 22.65 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.789 0 CA-C-O 122.322 1.058 . . . . 0.0 113.346 -177.937 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 179.17 -155.55 16.29 Favored Glycine 0 N--CA 1.449 -0.447 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.468 -177.976 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 46.8 p90 -155.07 171.14 20.25 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 179.786 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 22.4 m-85 -111.56 138.92 47.46 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 173.813 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 40.4 ttt-85 -110.96 120.16 41.45 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 124.034 0.934 . . . . 0.0 110.298 -177.229 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 52.0 ttp180 -68.26 140.92 56.02 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 178.183 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -142.77 148.73 37.66 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.223 0.535 . . . . 0.0 110.344 179.231 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -158.14 154.22 27.08 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 104.387 -2.449 . . . . 0.0 104.387 176.252 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 20.9 tpt85 -150.81 133.02 15.39 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 177.462 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 72.4 ttt180 -143.38 153.2 42.46 Favored 'General case' 0 CA--C 1.496 -1.131 0 CA-C-O 121.835 0.826 . . . . 0.0 110.528 178.281 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -148.13 -179.68 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 N-CA-C 103.463 -2.791 . . . . 0.0 103.463 179.971 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.64 99.23 6.2 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 174.305 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -71.54 159.63 53.87 Favored Glycine 0 C--O 1.227 -0.308 0 N-CA-C 106.894 -2.482 . . . . 0.0 106.894 176.84 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -60.72 -42.49 99.41 Favored Glycine 0 C--O 1.222 -0.65 0 CA-C-N 118.867 1.333 . . . . 0.0 111.832 -179.486 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -92.82 17.02 11.14 Favored 'General case' 0 CA--C 1.546 0.825 0 CA-C-O 122.895 1.331 . . . . 0.0 110.782 178.822 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 90.06 -1.24 80.01 Favored Glycine 0 N--CA 1.462 0.402 0 N-CA-C 118.163 2.025 . . . . 0.0 118.163 169.145 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 2.1 mptp? -59.27 139.66 56.76 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.999 0.904 . . . . 0.0 111.992 -178.023 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 63.4 mtp -97.23 -178.26 4.11 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 113.419 -1.719 . . . . 0.0 109.475 178.041 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 5.4 tmtt? -109.94 -55.71 2.41 Favored 'General case' 0 CA--C 1.508 -0.64 0 CA-C-O 121.538 0.685 . . . . 0.0 110.836 -178.782 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -125.07 165.05 18.88 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 103.307 -2.849 . . . . 0.0 103.307 177.105 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 94.3 mt -119.57 -99.68 0.44 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 117.888 0.313 . . . . 0.0 111.228 -176.715 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.21 156.38 88.25 Favored Pre-proline 0 C--N 1.325 -0.476 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 179.018 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -68.43 142.59 54.77 Favored 'Trans proline' 0 C--O 1.241 0.674 0 C-N-CA 114.777 -3.015 . . . . 0.0 112.628 -179.775 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 13.4 mtp180 -119.79 160.47 22.56 Favored 'General case' 0 CA--C 1.511 -0.539 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.662 -178.944 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 55.7 m95 -131.29 128.63 40.19 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.445 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 50.0 m-85 -110.45 144.87 38.59 Favored 'General case' 0 C--O 1.217 -0.622 0 N-CA-C 107.505 -1.295 . . . . 0.0 107.505 -177.773 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -89.84 129.97 36.15 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 118.801 0.728 . . . . 0.0 109.254 -178.297 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -132.35 133.07 43.54 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 -175.799 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -71.65 159.49 34.31 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.705 -0.68 . . . . 0.0 112.552 -176.13 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -53.99 129.26 33.57 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-O 121.069 0.461 . . . . 0.0 111.916 -179.448 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 73.26 26.66 69.9 Favored Glycine 0 C--O 1.22 -0.75 0 N-CA-C 115.887 1.115 . . . . 0.0 115.887 176.971 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 2.9 p . . . . . 0 C--N 1.325 -0.466 0 CA-C-N 118.601 1.201 . . . . 0.0 109.336 178.904 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 15.1 mt . . . . . 0 N--CA 1.446 -0.653 0 N-CA-C 115.112 1.523 . . . . 0.0 115.112 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -78.79 163.72 26.02 Favored 'Trans proline' 0 N--CA 1.461 -0.427 0 C-N-CA 121.939 1.759 . . . . 0.0 107.994 168.531 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 74.9 t80 -61.5 130.58 46.68 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 120.305 -0.558 . . . . 0.0 111.085 -177.729 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 92.19 -7.74 78.16 Favored Glycine 0 CA--C 1.519 0.305 0 CA-C-O 119.326 -0.708 . . . . 0.0 114.704 178.699 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -64.0 131.81 48.72 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 118.391 1.096 . . . . 0.0 111.656 179.948 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 47.1 t-20 -77.83 128.12 33.48 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.647 -179.465 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 26.4 ttmt -155.46 150.37 26.54 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 106.567 -1.642 . . . . 0.0 106.567 179.269 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -64.24 129.05 38.44 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.902 0.382 . . . . 0.0 110.968 -177.219 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 71.04 26.45 73.85 Favored Glycine 0 CA--C 1.52 0.346 0 CA-C-O 119.348 -0.696 . . . . 0.0 114.767 179.764 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 41.8 mm -126.83 129.25 71.41 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 CA-C-N 117.572 0.686 . . . . 0.0 111.007 -179.965 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.1 pt -132.02 119.34 40.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 CA-C-O 121.542 0.687 . . . . 0.0 111.186 176.133 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 95.3 m95 -84.68 138.92 32.39 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 113.651 0.982 . . . . 0.0 113.651 -176.9 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 16.5 m -138.03 151.28 25.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 179.03 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -159.89 166.62 29.85 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 105.497 -2.038 . . . . 0.0 105.497 -178.502 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 12.0 t -136.51 175.61 9.45 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 105.657 -1.979 . . . . 0.0 105.657 177.15 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -66.26 136.81 56.38 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.155 0.502 . . . . 0.0 110.783 -179.466 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 92.76 -10.53 73.83 Favored Glycine 0 C--O 1.224 -0.513 0 CA-C-N 115.839 -0.619 . . . . 0.0 113.566 177.311 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -74.24 134.34 42.68 Favored 'General case' 0 C--N 1.323 -0.586 0 O-C-N 122.409 -0.465 . . . . 0.0 111.227 -179.849 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 38.3 mt -91.73 133.36 35.67 Favored 'General case' 0 CA--C 1.513 -0.48 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 -177.804 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 55.6 t30 -81.27 70.43 8.11 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.188 -0.914 . . . . 0.0 110.838 -178.977 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 1.3 t -139.19 155.29 72.55 Favored Pre-proline 0 C--N 1.322 -0.629 0 N-CA-C 106.1 -1.815 . . . . 0.0 106.1 -179.392 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -67.32 148.46 79.96 Favored 'Trans proline' 0 CA--C 1.53 0.32 0 C-N-CA 118.114 -0.791 . . . . 0.0 113.176 176.418 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -148.64 52.55 0.99 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 122.788 1.28 . . . . 0.0 110.435 179.243 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 13.0 p-10 -60.28 -30.48 69.49 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 114.047 -1.433 . . . . 0.0 110.829 179.268 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 16.0 p80 -59.15 -12.59 5.33 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 114.578 1.325 . . . . 0.0 114.578 -179.149 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 54.0 mt -86.5 -32.08 6.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 178.721 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -75.33 12.96 6.55 Favored Glycine 0 CA--C 1.522 0.479 0 N-CA-C 114.764 0.666 . . . . 0.0 114.764 -177.462 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 11.8 t -83.13 13.4 4.15 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 113.103 0.779 . . . . 0.0 113.103 -178.471 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 66.7 ttp85 -58.66 122.55 13.74 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 178.369 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -97.79 129.59 30.95 Favored Pre-proline 0 C--N 1.321 -0.669 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 -178.872 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -69.68 -15.4 37.38 Favored 'Trans proline' 0 C--O 1.219 -0.462 0 O-C-N 122.072 0.511 . . . . 0.0 113.087 -179.193 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -75.94 -26.58 57.02 Favored 'General case' 0 C--O 1.221 -0.425 0 CA-C-O 120.847 0.356 . . . . 0.0 110.404 177.738 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 76.1 m-20 -104.13 -27.23 12.2 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 113.724 1.009 . . . . 0.0 113.724 -174.727 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 29.7 t30 -152.15 149.04 28.34 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 113.078 0.77 . . . . 0.0 113.078 -177.283 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -90.44 150.45 21.82 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-O 121.457 0.646 . . . . 0.0 111.476 179.325 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -70.18 145.23 51.62 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.248 0.547 . . . . 0.0 111.284 178.867 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 17.9 mt -82.86 139.33 17.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 -179.029 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 99.2 t -59.58 122.9 10.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 N-CA-C 106.642 -1.614 . . . . 0.0 106.642 175.299 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 7.2 tt -68.18 129.04 38.74 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.139 0.495 . . . . 0.0 110.112 -176.703 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 31.5 mt-30 -131.12 158.74 39.63 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 -179.162 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 13.7 mt -113.27 147.57 37.67 Favored Pre-proline 0 C--N 1.322 -0.623 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 177.822 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -74.37 168.9 23.72 Favored 'Trans proline' 0 C--O 1.235 0.366 0 O-C-N 122.224 0.592 . . . . 0.0 113.276 -179.313 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 38.6 tt0 -54.14 131.95 42.1 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.518 -0.765 . . . . 0.0 109.415 179.411 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 99.01 -22.58 40.28 Favored Glycine 0 C--O 1.227 -0.282 0 CA-C-O 119.542 -0.588 . . . . 0.0 113.193 -179.779 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 4.1 m -106.63 127.58 53.46 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 118.361 1.081 . . . . 0.0 111.203 178.887 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 7.1 p -121.14 148.38 44.28 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.951 -179.562 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 92.7 mt -70.5 151.28 95.6 Favored Pre-proline 0 C--N 1.324 -0.513 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 178.874 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -78.6 172.92 14.43 Favored 'Trans proline' 0 N--CA 1.463 -0.303 0 O-C-N 122.0 0.473 . . . . 0.0 111.385 178.796 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 1.7 tmmt? -54.44 130.05 38.06 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.78 -177.847 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 91.53 -7.43 79.92 Favored Glycine 0 C--O 1.229 -0.19 0 N-CA-C 115.794 1.078 . . . . 0.0 115.794 175.655 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.405 ' CZ ' ' HB2' ' A' ' 18' ' ' GLN . 2.3 m-85 -97.84 142.54 29.48 Favored 'General case' 0 N--CA 1.441 -0.888 0 CA-C-O 122.311 1.053 . . . . 0.0 112.859 -177.818 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 47.0 p90 -141.73 165.1 28.41 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 113.473 -1.694 . . . . 0.0 106.961 173.974 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -102.51 143.75 31.82 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.731 0.3 . . . . 0.0 110.274 -178.583 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.411 ' HB3' ' HB ' ' A' ' 14' ' ' THR . 6.5 tp10 -71.55 135.7 47.16 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 106.762 -1.57 . . . . 0.0 106.762 177.84 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 93.33 -7.82 75.33 Favored Glycine 0 C--O 1.225 -0.412 0 C-N-CA 121.369 -0.443 . . . . 0.0 113.497 -177.626 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 34.6 t . . . . . 0 N--CA 1.468 0.433 0 CA-C-N 117.842 0.821 . . . . 0.0 111.221 177.194 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.456 -0.126 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 39.3 p -65.47 142.77 58.04 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.806 -0.812 . . . . 0.0 108.806 177.93 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . 0.423 ' CD2' ' HD3' ' A' ' 109' ' ' ARG . 14.8 m95 -67.69 -21.85 65.31 Favored 'General case' 0 CA--C 1.511 -0.557 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 178.066 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 44.4 m-85 -121.42 160.87 23.23 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 113.8 1.037 . . . . 0.0 113.8 -170.518 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 59.0 p -71.85 166.99 20.95 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 113.891 -1.504 . . . . 0.0 109.637 179.243 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -80.29 131.11 35.6 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 -177.136 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 13.8 mt -74.51 146.43 42.71 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 103.278 -2.86 . . . . 0.0 103.278 170.1 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 24.8 m -126.8 136.65 52.67 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 -177.207 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . 0.434 ' HB2' ' CZ ' ' A' ' 131' ' ' PHE . 4.7 tp60 -111.9 139.97 46.95 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 114.036 1.125 . . . . 0.0 114.036 -175.328 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 57.7 t60 -130.32 99.48 5.04 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 106.541 -1.652 . . . . 0.0 106.541 170.496 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 173.95 -170.57 43.71 Favored Glycine 0 C--O 1.227 -0.293 0 N-CA-C 109.014 -1.634 . . . . 0.0 109.014 -177.973 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -97.97 -24.25 15.45 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 117.523 0.662 . . . . 0.0 111.694 178.963 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -83.5 157.45 22.39 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 106.111 -1.811 . . . . 0.0 106.111 174.816 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -93.18 -62.76 1.31 Allowed 'General case' 0 C--O 1.215 -0.73 0 C-N-CA 120.123 -0.631 . . . . 0.0 112.637 -176.838 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 42.5 tp -169.83 138.62 1.82 Allowed 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 175.291 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 10.8 tmtt? -153.89 128.59 9.38 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 176.303 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -117.91 159.35 43.06 Favored Pre-proline 0 CA--C 1.547 0.835 0 N-CA-C 110.378 -0.23 . . . . 0.0 110.378 178.096 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -69.12 173.92 9.7 Favored 'Trans proline' 0 C--N 1.354 0.821 0 C-N-CA 121.687 1.591 . . . . 0.0 115.015 -179.574 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -78.37 132.74 37.51 Favored 'General case' 0 C--O 1.216 -0.699 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 178.116 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 69.42 14.21 68.96 Favored Glycine 0 C--O 1.225 -0.415 0 N-CA-C 115.089 0.796 . . . . 0.0 115.089 175.732 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 39.1 tt0 -157.77 148.11 20.65 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 105.758 -1.942 . . . . 0.0 105.758 -178.079 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 136.04 -17.12 3.89 Favored Glycine 0 CA--C 1.502 -0.72 0 C-N-CA 120.187 -1.006 . . . . 0.0 112.723 175.648 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 30.3 m -70.46 145.21 92.65 Favored Pre-proline 0 C--N 1.321 -0.666 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 177.042 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -76.76 167.53 25.19 Favored 'Trans proline' 0 N--CA 1.461 -0.395 0 C-N-CA 122.187 1.925 . . . . 0.0 113.74 179.695 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 97.9 mt -69.68 128.11 32.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 178.696 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 51.4 t-20 -125.49 122.17 35.85 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.889 -0.411 . . . . 0.0 109.889 175.998 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 74.2 p -92.74 -15.49 26.58 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 113.668 0.988 . . . . 0.0 113.668 -177.189 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 20.0 p30 -109.27 21.49 17.04 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 115.259 1.577 . . . . 0.0 115.259 -174.009 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 37.8 m -147.42 164.88 31.94 Favored 'General case' 0 N--CA 1.468 0.437 0 O-C-N 121.918 -0.489 . . . . 0.0 111.538 -179.875 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 32.6 m -75.27 164.44 61.11 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.703 -178.632 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -65.16 -24.81 58.52 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 115.529 -2.514 . . . . 0.0 111.769 177.362 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -59.75 -33.78 72.11 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 122.051 0.929 . . . . 0.0 110.613 176.559 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -83.35 -7.65 59.54 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 114.954 1.465 . . . . 0.0 114.954 -173.903 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 93.0 mm-40 -65.85 -31.64 72.71 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 114.521 1.304 . . . . 0.0 114.521 -174.806 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 14.7 tt -58.9 138.75 19.56 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 CA-C-O 122.076 0.941 . . . . 0.0 112.078 179.314 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 179.0 -148.36 8.21 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.124 -175.556 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 46.1 p90 -154.96 166.87 32.19 Favored 'General case' 0 C--N 1.32 -0.711 0 O-C-N 122.438 -0.448 . . . . 0.0 110.263 179.786 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 40.3 m-85 -107.51 141.97 38.11 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 174.116 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 58.6 ttt-85 -114.22 120.53 40.76 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 123.454 0.702 . . . . 0.0 112.028 -175.926 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 62.8 ttt-85 -64.43 141.4 58.79 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 122.789 0.436 . . . . 0.0 110.165 177.697 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -150.67 132.94 15.45 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.173 0.511 . . . . 0.0 112.249 178.624 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 7.0 p -149.48 139.74 22.26 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 107.259 -1.386 . . . . 0.0 107.259 175.818 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 25.0 tpt180 -147.1 123.98 11.29 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 175.385 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.53 145.34 47.41 Favored 'General case' 0 CA--C 1.484 -1.592 0 CA-C-O 122.313 1.054 . . . . 0.0 112.434 -178.951 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -142.32 176.32 3.89 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 N-CA-C 104.686 -2.338 . . . . 0.0 104.686 176.23 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 4.1 tmt_? -129.2 101.62 6.09 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 105.192 -2.151 . . . . 0.0 105.192 176.472 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -69.01 154.7 53.46 Favored Glycine 0 C--O 1.221 -0.697 0 N-CA-C 109.903 -1.279 . . . . 0.0 109.903 -178.434 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -64.93 -37.95 94.9 Favored Glycine 0 C--O 1.222 -0.637 0 N-CA-C 110.095 -1.202 . . . . 0.0 110.095 -178.219 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 27.5 t0 -89.79 16.95 7.16 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-O 122.339 1.066 . . . . 0.0 110.269 179.208 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 86.93 -15.66 51.71 Favored Glycine 0 C--O 1.227 -0.33 0 N-CA-C 115.818 1.087 . . . . 0.0 115.818 174.087 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -62.1 135.78 57.66 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 122.189 0.995 . . . . 0.0 112.705 -177.911 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 87.5 mtp -108.32 -174.21 2.46 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 113.704 -1.589 . . . . 0.0 109.821 -178.431 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 11.4 mmtt -105.56 -61.83 1.44 Allowed 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 120.979 0.418 . . . . 0.0 110.963 -179.077 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 19.8 p30 -132.74 168.28 18.61 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 176.734 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -128.99 -60.99 1.06 Allowed 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 -179.267 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -81.35 151.31 69.01 Favored Pre-proline 0 C--N 1.32 -0.714 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 176.395 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -70.58 152.02 64.77 Favored 'Trans proline' 0 C--O 1.239 0.569 0 C-N-CA 116.551 -1.833 . . . . 0.0 111.397 177.672 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 7.4 mtp180 -125.07 158.57 33.48 Favored 'General case' 0 CA--C 1.515 -0.4 0 C-N-CA 121.09 -0.244 . . . . 0.0 110.7 -179.786 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 48.2 m95 -131.75 136.4 47.56 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 178.312 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 48.1 m-85 -110.37 172.95 6.56 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 104.804 -2.295 . . . . 0.0 104.804 -179.91 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 92.4 t80 -124.03 136.72 54.46 Favored 'General case' 0 CA--C 1.51 -0.595 0 CA-C-N 119.526 1.057 . . . . 0.0 108.597 -178.721 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 34.6 m-85 -137.51 148.89 46.35 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 -176.246 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 44.0 m-85 -84.05 159.52 21.15 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.359 -176.152 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -54.93 132.04 45.83 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.203 178.054 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 67.29 38.37 91.51 Favored Glycine 0 C--O 1.225 -0.436 0 N-CA-C 115.206 0.842 . . . . 0.0 115.206 177.124 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.2 p . . . . . 0 C--N 1.327 -0.392 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 175.757 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 14.7 mt . . . . . 0 N--CA 1.444 -0.76 0 N-CA-C 114.874 1.435 . . . . 0.0 114.874 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -79.73 164.69 23.01 Favored 'Trans proline' 0 C--O 1.235 0.36 0 C-N-CA 122.783 2.322 . . . . 0.0 107.78 167.455 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 60.6 t80 -62.32 131.67 50.09 Favored 'General case' 0 C--N 1.321 -0.666 0 C-N-CA 120.367 -0.533 . . . . 0.0 110.338 -178.066 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 91.14 -5.65 81.44 Favored Glycine 0 C--O 1.228 -0.273 0 N-CA-C 114.901 0.72 . . . . 0.0 114.901 179.031 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -66.77 130.49 43.33 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 118.649 1.225 . . . . 0.0 111.608 179.499 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 57.0 t30 -74.92 128.37 35.41 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.892 -179.186 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 26.4 ttmt -156.01 152.01 27.59 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 106.354 -1.721 . . . . 0.0 106.354 178.476 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -65.61 132.7 49.48 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.069 0.461 . . . . 0.0 110.615 -178.059 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 69.31 25.92 75.04 Favored Glycine 0 N--CA 1.449 -0.495 0 CA-C-N 115.714 -0.675 . . . . 0.0 114.239 177.97 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 47.7 mm -124.82 126.63 71.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 117.345 0.572 . . . . 0.0 110.842 179.945 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -127.08 116.98 46.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.356 176.243 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 96.9 m95 -82.22 135.66 35.21 Favored 'General case' 0 C--N 1.319 -0.72 0 O-C-N 121.864 -0.522 . . . . 0.0 112.227 -177.676 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -142.22 154.97 18.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 -178.113 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -154.92 166.52 33.28 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 106.193 -1.78 . . . . 0.0 106.193 -176.635 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 14.7 t -121.79 164.63 17.13 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 103.211 -2.885 . . . . 0.0 103.211 171.53 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -67.56 136.08 53.95 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 -179.099 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 92.84 -9.67 75.14 Favored Glycine 0 C--O 1.224 -0.501 0 CA-C-N 115.986 -0.552 . . . . 0.0 113.833 178.504 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -74.16 143.08 45.41 Favored 'General case' 0 CA--C 1.545 0.756 0 O-C-N 122.339 -0.506 . . . . 0.0 110.429 179.143 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 40.2 mt -93.17 133.48 36.32 Favored 'General case' 0 CA--C 1.516 -0.347 0 N-CA-C 115.004 1.483 . . . . 0.0 115.004 -175.496 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 61.6 t30 -79.67 64.68 4.61 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 114.683 -1.144 . . . . 0.0 110.966 -178.256 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -135.85 157.41 76.07 Favored Pre-proline 0 C--N 1.322 -0.588 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 -178.152 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -73.27 148.24 43.45 Favored 'Trans proline' 0 CA--C 1.534 0.493 0 N-CA-C 114.496 0.921 . . . . 0.0 114.496 175.338 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.54 58.85 1.07 Allowed 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 177.595 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -64.01 -14.37 53.68 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.275 176.449 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 18.0 p-80 -61.53 -14.46 29.78 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 179.396 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 23.4 mt -92.81 -26.7 4.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 121.329 0.585 . . . . 0.0 109.616 179.456 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -81.3 10.34 49.83 Favored Glycine 0 N--CA 1.459 0.232 0 O-C-N 122.007 -0.433 . . . . 0.0 113.63 -178.128 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 12.4 t -83.22 6.48 19.33 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 122.295 -0.532 . . . . 0.0 111.262 -178.4 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.423 ' HD3' ' CD2' ' A' ' 12' ' ' TRP . 63.5 ttp85 -54.51 133.61 46.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.509 179.908 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 35.0 m120 -96.97 115.82 65.85 Favored Pre-proline 0 C--N 1.326 -0.455 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 178.8 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -73.23 -11.53 25.03 Favored 'Trans proline' 0 C--O 1.219 -0.473 0 C-N-CA 117.45 -1.233 . . . . 0.0 113.351 -178.155 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -80.54 -25.45 38.63 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.215 177.436 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 -101.99 -25.44 13.76 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 113.543 0.942 . . . . 0.0 113.543 -174.334 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -140.42 154.27 46.6 Favored 'General case' 0 N--CA 1.434 -1.226 0 CA-C-O 121.497 0.665 . . . . 0.0 109.45 -177.59 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -93.36 144.45 25.31 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 114.938 -1.028 . . . . 0.0 110.837 -179.531 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -68.83 145.44 53.73 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.37 0.605 . . . . 0.0 110.561 178.853 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 27.8 mt -81.59 137.44 21.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 -178.723 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 1.2 p -62.08 125.99 19.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 176.324 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 6.4 tt -67.11 127.52 32.91 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.01 0.434 . . . . 0.0 110.116 -177.013 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 29.7 mt-30 -130.86 155.84 46.04 Favored 'General case' 0 CA--C 1.512 -0.488 0 N-CA-C 107.251 -1.388 . . . . 0.0 107.251 -179.132 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 13.5 mt -111.97 148.6 39.35 Favored Pre-proline 0 C--N 1.322 -0.616 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 179.029 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -71.5 164.52 35.45 Favored 'Trans proline' 0 C--N 1.346 0.403 0 O-C-N 122.278 0.62 . . . . 0.0 112.814 -179.037 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 65.1 tt0 -55.12 132.51 47.59 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.422 -179.649 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 96.57 -16.48 60.95 Favored Glycine 0 C--O 1.227 -0.32 0 CA-C-N 116.039 -0.528 . . . . 0.0 112.945 -179.002 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 6.1 m -107.59 126.77 52.96 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 117.907 0.853 . . . . 0.0 110.559 178.329 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 14.8 p -117.0 148.14 41.72 Favored 'General case' 0 CA--C 1.509 -0.605 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.534 -179.454 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 82.7 mt -68.37 152.37 96.62 Favored Pre-proline 0 C--N 1.321 -0.636 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 178.036 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -76.83 173.01 15.16 Favored 'Trans proline' 0 N--CA 1.462 -0.342 0 C-N-CA 117.87 -0.953 . . . . 0.0 110.43 177.989 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 84.4 tttt -57.27 128.42 36.9 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 113.485 0.92 . . . . 0.0 113.485 -174.12 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 95.12 -6.02 68.74 Favored Glycine 0 CA--C 1.518 0.227 0 N-CA-C 115.854 1.101 . . . . 0.0 115.854 176.15 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.434 ' CZ ' ' HB2' ' A' ' 18' ' ' GLN . 4.6 m-85 -92.38 147.09 23.18 Favored 'General case' 0 N--CA 1.437 -1.092 0 CA-C-O 122.962 1.363 . . . . 0.0 114.004 -178.194 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 48.5 p90 -146.76 163.51 35.76 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 112.29 -2.232 . . . . 0.0 107.274 172.94 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -105.31 143.69 33.12 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 112.762 0.653 . . . . 0.0 112.762 -177.398 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -76.78 147.95 36.96 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 175.368 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 95.02 -33.66 5.26 Favored Glycine 0 C--O 1.227 -0.333 0 C-N-CA 121.428 -0.415 . . . . 0.0 113.964 178.184 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.323 -0.548 0 CA-C-O 121.201 0.524 . . . . 0.0 111.658 177.113 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -0.898 0 CA-C-O 121.871 0.843 . . . . 0.0 112.296 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -61.8 143.65 55.98 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 114.767 -1.106 . . . . 0.0 110.287 177.785 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 21.1 m95 -69.38 -23.64 63.77 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 114.864 1.431 . . . . 0.0 114.864 -178.514 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 86.2 m-85 -121.52 161.07 22.95 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.186 0.517 . . . . 0.0 112.384 -172.747 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 74.6 p -70.31 161.58 30.12 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 177.013 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -74.83 153.79 38.57 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.902 0.858 . . . . 0.0 113.191 -175.995 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 22.6 mt -90.94 148.79 22.2 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 102.497 -3.149 . . . . 0.0 102.497 168.171 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 51.9 m -123.85 139.59 53.82 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 179.893 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . 0.434 ' HB2' ' CZ ' ' A' ' 131' ' ' PHE . 4.3 tp60 -110.41 138.98 46.08 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-O 121.527 0.679 . . . . 0.0 112.298 -178.531 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 73.0 t60 -134.14 99.44 4.41 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 103.391 -2.818 . . . . 0.0 103.391 169.773 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 173.13 -165.97 38.34 Favored Glycine 0 C--O 1.225 -0.452 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 -176.055 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 37.9 mtmm -102.18 -25.09 13.83 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 113.956 1.095 . . . . 0.0 113.956 -178.221 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -89.21 162.1 16.08 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.056 -179.154 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -77.62 -62.95 1.5 Allowed 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.203 -176.916 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 34.6 tp 172.99 142.66 0.04 OUTLIER 'General case' 0 N--CA 1.482 1.133 0 N-CA-C 105.545 -2.02 . . . . 0.0 105.545 176.409 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 12.0 tmtt? -154.95 125.45 6.89 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 175.459 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -106.81 152.46 40.87 Favored Pre-proline 0 C--O 1.242 0.676 0 CA-C-O 120.457 0.17 . . . . 0.0 110.711 177.842 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -68.71 161.48 45.17 Favored 'Trans proline' 0 C--N 1.352 0.724 0 CA-C-O 121.226 0.427 . . . . 0.0 112.799 178.455 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 71.6 ttt180 -69.86 132.37 45.91 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 122.182 -0.324 . . . . 0.0 111.361 -175.846 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 79.35 13.6 82.53 Favored Glycine 0 C--O 1.222 -0.612 0 N-CA-C 111.697 -0.561 . . . . 0.0 111.697 179.254 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 31.0 mt-30 -148.23 171.74 15.45 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.18 -1.045 . . . . 0.0 108.18 -175.327 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 107.71 -10.22 38.11 Favored Glycine 0 CA--C 1.501 -0.786 0 CA-C-N 116.159 -0.473 . . . . 0.0 112.803 175.851 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 57.4 t -74.37 130.89 81.29 Favored Pre-proline 0 C--N 1.32 -0.685 0 N-CA-C 106.437 -1.69 . . . . 0.0 106.437 176.739 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -71.62 172.84 13.56 Favored 'Trans proline' 0 C--O 1.221 -0.34 0 O-C-N 122.179 0.568 . . . . 0.0 112.505 177.658 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 64.8 mt -75.85 106.3 5.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 122.228 1.013 . . . . 0.0 110.341 -179.111 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.499 ' HB2' HE21 ' A' ' 43' ' ' GLN . 38.8 m-20 -97.67 77.89 2.59 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 114.184 -1.371 . . . . 0.0 108.407 -179.425 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 80.7 p -63.88 -25.56 68.21 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 115.289 1.588 . . . . 0.0 115.289 -174.677 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -116.19 32.23 6.24 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 -176.369 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 5.9 m -133.06 166.87 21.42 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.678 0.275 . . . . 0.0 111.356 -178.903 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 25.0 m -77.57 155.92 81.0 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-N 116.583 -0.281 . . . . 0.0 111.657 -177.527 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -68.95 -20.91 38.08 Favored 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 116.804 -1.664 . . . . 0.0 114.378 -179.809 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.405 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 1.9 p-10 -76.95 -23.19 52.39 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 121.434 -0.791 . . . . 0.0 110.978 177.203 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -76.69 -13.08 60.07 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 114.715 1.376 . . . . 0.0 114.715 -170.924 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . 0.499 HE21 ' HB2' ' A' ' 35' ' ' ASN . 94.8 mm-40 -55.01 -28.15 49.78 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 113.934 1.086 . . . . 0.0 113.934 -175.025 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 13.6 tt -64.63 135.82 27.51 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.784 0 CA-C-O 122.316 1.055 . . . . 0.0 111.981 178.643 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 179.36 -155.91 17.06 Favored Glycine 0 N--CA 1.45 -0.432 0 N-CA-C 110.755 -0.938 . . . . 0.0 110.755 -177.54 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 33.2 p90 -155.1 168.34 27.35 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.882 0.341 . . . . 0.0 110.554 179.826 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.412 ' HH ' HD21 ' A' ' 119' ' ' LEU . 29.1 m-85 -112.79 141.2 46.87 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 175.345 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 73.7 ttt-85 -116.77 125.04 51.05 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.661 -0.7 . . . . 0.0 112.675 -177.969 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 50.4 ttp85 -69.15 141.05 54.71 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 121.084 0.468 . . . . 0.0 111.092 177.518 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -152.05 157.54 41.8 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 179.104 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 68.1 p -129.43 166.29 19.87 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 104.058 -2.571 . . . . 0.0 104.058 172.571 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 21.5 tpt180 -96.09 118.96 33.72 Favored 'General case' 0 C--O 1.218 -0.584 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 178.667 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 6.7 tmm_? -139.59 139.1 36.7 Favored 'General case' 0 CA--C 1.502 -0.88 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 -178.951 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -137.29 -179.6 2.93 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 114.802 -1.09 . . . . 0.0 108.245 -175.982 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 13.1 tpp85 -129.14 125.14 36.42 Favored 'General case' 0 C--O 1.221 -0.431 0 N-CA-C 105.02 -2.215 . . . . 0.0 105.02 174.339 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -156.02 144.03 10.43 Favored Glycine 0 C--O 1.224 -0.489 0 N-CA-C 107.524 -2.23 . . . . 0.0 107.524 177.325 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -65.87 -60.65 6.28 Favored Glycine 0 C--O 1.227 -0.319 0 CA-C-N 117.883 0.842 . . . . 0.0 112.391 -177.958 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -107.34 8.39 29.69 Favored 'General case' 0 C--O 1.215 -0.744 0 CA-C-O 121.967 0.889 . . . . 0.0 110.838 178.715 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -95.95 -11.59 54.49 Favored Glycine 0 CA--C 1.504 -0.653 0 N-CA-C 105.542 -3.023 . . . . 0.0 105.542 179.318 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 53.7 mmtt 52.93 -161.59 0.11 Allowed 'General case' 0 N--CA 1.442 -0.846 0 CA-C-N 112.95 -1.625 . . . . 0.0 111.723 176.79 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 70.1 mtp -90.43 -179.02 5.49 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 114.516 -1.22 . . . . 0.0 109.865 176.875 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 18.5 mmtm -134.8 -69.53 0.51 Allowed 'General case' 0 C--O 1.211 -0.941 0 CA-C-O 120.897 0.38 . . . . 0.0 110.503 179.497 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.7 t0 52.1 51.41 16.44 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 114.318 -1.31 . . . . 0.0 111.923 178.918 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -61.97 162.59 8.92 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 114.116 -1.402 . . . . 0.0 111.969 -179.687 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -45.76 146.18 2.01 Favored Pre-proline 0 C--O 1.25 1.08 0 CA-C-N 115.047 -0.979 . . . . 0.0 113.495 -177.335 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -61.86 142.54 93.73 Favored 'Trans proline' 0 C--N 1.349 0.601 0 CA-C-O 122.768 1.07 . . . . 0.0 114.209 -174.895 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 22.6 mtt85 -128.95 155.77 44.8 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-N 113.2 -1.818 . . . . 0.0 108.054 -178.629 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 66.5 m95 -127.8 131.63 49.57 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 179.711 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 70.9 m-85 -111.41 148.23 33.52 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 107.289 -1.375 . . . . 0.0 107.289 179.064 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 68.1 t80 -95.79 131.35 42.18 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 -177.778 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -134.36 146.52 50.0 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 -178.263 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -83.34 159.51 21.85 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 113.016 0.747 . . . . 0.0 113.016 -174.956 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -55.53 132.91 49.74 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.391 179.489 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 72.56 33.96 60.5 Favored Glycine 0 C--O 1.221 -0.696 0 N-CA-C 115.469 0.947 . . . . 0.0 115.469 176.629 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 9.2 p . . . . . 0 C--N 1.325 -0.468 0 N-CA-C 108.226 -1.028 . . . . 0.0 108.226 177.818 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 21.3 mt . . . . . 0 C--O 1.238 0.468 0 N-CA-C 114.273 1.212 . . . . 0.0 114.273 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -78.5 167.19 23.12 Favored 'Trans proline' 0 N--CA 1.461 -0.436 0 N-CA-C 108.439 -1.408 . . . . 0.0 108.439 170.895 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.413 ' CE1' ' HB3' ' A' ' 92' ' ' TRP . 77.9 t80 -61.24 132.47 53.74 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 120.357 -0.537 . . . . 0.0 110.254 179.979 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 90.43 -4.9 82.71 Favored Glycine 0 CA--C 1.518 0.276 0 N-CA-C 115.065 0.786 . . . . 0.0 115.065 178.03 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -65.38 128.09 34.47 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 118.463 1.132 . . . . 0.0 111.472 179.407 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 45.9 t-20 -78.05 128.01 33.2 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.322 -176.576 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 16.7 ttmm -156.08 152.09 27.57 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 179.54 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -62.73 132.76 53.34 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.744 0.307 . . . . 0.0 110.441 179.447 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 68.86 24.41 75.64 Favored Glycine 0 N--CA 1.449 -0.44 0 CA-C-O 119.477 -0.624 . . . . 0.0 113.734 178.033 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 38.6 mm -129.32 128.51 66.57 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.304 0 CA-C-N 117.362 0.581 . . . . 0.0 110.077 179.866 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.1 pt -134.56 123.71 42.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.573 176.036 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . 0.413 ' HB3' ' CE1' ' A' ' 83' ' ' TYR . 90.0 m95 -89.37 139.42 30.53 Favored 'General case' 0 C--N 1.321 -0.671 0 O-C-N 121.908 -0.495 . . . . 0.0 111.617 -176.933 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 17.8 m -135.09 153.77 34.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 179.903 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -162.03 166.56 25.77 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 105.812 -1.921 . . . . 0.0 105.812 -178.63 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 13.5 t -130.41 169.29 15.69 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 104.628 -2.36 . . . . 0.0 104.628 176.137 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -66.22 135.07 53.97 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.225 0.536 . . . . 0.0 110.218 -178.601 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 93.81 -12.73 68.86 Favored Glycine 0 CA--C 1.517 0.195 0 CA-C-N 115.982 -0.554 . . . . 0.0 113.998 178.395 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.405 ' HA ' ' HA ' ' A' ' 41' ' ' ASP . . . -68.16 135.97 52.92 Favored 'General case' 0 CA--C 1.542 0.667 0 O-C-N 122.33 -0.512 . . . . 0.0 110.133 179.088 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 32.4 mt -89.34 130.31 35.73 Favored 'General case' 0 CA--C 1.507 -0.681 0 N-CA-C 113.416 0.895 . . . . 0.0 113.416 -177.145 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 53.5 t30 -81.17 73.8 8.2 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 114.526 -1.215 . . . . 0.0 110.564 -178.718 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 1.5 t -142.97 153.83 61.12 Favored Pre-proline 0 C--N 1.321 -0.631 0 N-CA-C 106.427 -1.694 . . . . 0.0 106.427 179.723 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -67.65 147.74 76.63 Favored 'Trans proline' 0 CA--C 1.528 0.213 0 C-N-CA 117.824 -0.984 . . . . 0.0 113.089 176.018 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 6.6 ptpt -145.73 56.95 1.22 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 122.722 1.248 . . . . 0.0 110.593 179.066 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -58.54 -31.05 67.58 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.149 -1.387 . . . . 0.0 111.9 179.304 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 18.3 p80 -62.62 -7.41 4.72 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 113.944 1.09 . . . . 0.0 113.944 -179.34 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 29.1 mt -96.24 -45.29 13.02 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.53 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 177.148 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -69.92 14.66 1.1 Allowed Glycine 0 CA--C 1.524 0.609 0 N-CA-C 116.436 1.334 . . . . 0.0 116.436 -177.798 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 15.2 t -95.77 26.51 3.99 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.328 0.651 . . . . 0.0 112.111 -178.841 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 67.7 ttp85 -59.29 125.94 25.65 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 178.429 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -101.26 128.02 30.34 Favored Pre-proline 0 C--N 1.322 -0.615 0 N-CA-C 106.671 -1.603 . . . . 0.0 106.671 -178.28 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -68.53 -20.3 41.48 Favored 'Trans proline' 0 C--O 1.219 -0.468 0 N-CA-C 114.605 0.964 . . . . 0.0 114.605 -176.81 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -74.17 -24.62 59.41 Favored 'General case' 0 C--O 1.221 -0.428 0 CA-C-O 120.861 0.362 . . . . 0.0 110.619 178.269 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 84.7 m-20 -100.94 -24.32 14.37 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 -175.714 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 33.0 t30 -158.23 149.74 21.27 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 113.364 0.876 . . . . 0.0 113.364 -177.634 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -91.61 150.52 21.13 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-O 121.428 0.632 . . . . 0.0 111.787 179.512 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -69.96 146.62 50.99 Favored 'General case' 0 C--N 1.323 -0.543 0 CA-C-O 121.261 0.553 . . . . 0.0 111.451 178.996 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 15.6 mt -86.68 136.45 22.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.828 -178.714 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 70.0 t -62.94 120.89 10.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 N-CA-C 106.179 -1.785 . . . . 0.0 106.179 175.109 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.412 HD21 ' HH ' ' A' ' 47' ' ' TYR . 6.0 tt -68.47 134.43 50.11 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -175.58 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 50.8 mt-30 -135.19 161.91 34.03 Favored 'General case' 0 CA--C 1.513 -0.452 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 178.328 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 13.3 mt -114.63 146.3 35.68 Favored Pre-proline 0 C--N 1.323 -0.58 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 175.646 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -71.71 165.91 31.07 Favored 'Trans proline' 0 C--N 1.345 0.384 0 O-C-N 122.243 0.601 . . . . 0.0 113.619 -177.64 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 41.3 tt0 -53.26 128.83 29.53 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.238 -179.421 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 97.68 -17.32 59.08 Favored Glycine 0 C--O 1.227 -0.299 0 CA-C-N 115.886 -0.597 . . . . 0.0 113.058 -179.279 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 5.8 m -108.73 125.96 52.48 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 117.721 0.76 . . . . 0.0 109.263 178.083 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 5.8 p -124.8 148.23 48.27 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 -179.176 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 81.6 mt -69.56 155.04 94.24 Favored Pre-proline 0 C--N 1.325 -0.493 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 179.876 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_endo -74.44 169.06 23.35 Favored 'Trans proline' 0 N--CA 1.463 -0.299 0 C-N-CA 118.235 -0.71 . . . . 0.0 110.846 178.026 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -61.73 130.42 45.72 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.269 -176.191 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 95.2 -5.7 68.32 Favored Glycine 0 CA--C 1.518 0.224 0 CA-C-N 115.762 -0.653 . . . . 0.0 114.584 179.103 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.434 ' CZ ' ' HB2' ' A' ' 18' ' ' GLN . 1.2 m-85 -101.2 142.49 32.55 Favored 'General case' 0 N--CA 1.445 -0.725 0 CA-C-O 121.712 0.767 . . . . 0.0 110.678 179.441 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 45.6 p90 -145.22 164.19 32.1 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 114.478 -1.237 . . . . 0.0 108.019 175.194 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -100.77 145.78 28.08 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.094 0.474 . . . . 0.0 110.708 -177.949 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -70.58 129.01 38.07 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 -179.86 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 91.55 -32.02 5.5 Favored Glycine 0 CA--C 1.52 0.357 0 CA-C-N 116.159 -0.473 . . . . 0.0 113.967 -179.965 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 34.3 t . . . . . 0 C--N 1.323 -0.547 0 CA-C-N 117.577 0.688 . . . . 0.0 110.177 -178.949 . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.679 0 CA-C-O 121.57 0.7 . . . . 0.0 110.499 . . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -57.48 138.4 55.15 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.018 -0.992 . . . . 0.0 109.65 177.245 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 38.1 m95 -67.39 -21.83 65.58 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 114.127 1.158 . . . . 0.0 114.127 -178.437 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -121.46 159.31 26.52 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.435 0.636 . . . . 0.0 112.433 -174.09 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 56.7 p -67.93 165.07 18.49 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.457 -1.247 . . . . 0.0 108.318 178.185 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -83.37 148.6 27.22 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 113.716 1.006 . . . . 0.0 113.716 -175.006 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 85.0 mt -84.95 148.88 25.99 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 102.627 -3.101 . . . . 0.0 102.627 166.975 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 81.7 m -106.85 125.04 50.49 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 178.366 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -88.95 105.64 17.9 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 179.09 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 73.5 t60 -113.48 97.52 6.51 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 104.18 -2.526 . . . . 0.0 104.18 173.107 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 148.99 -168.01 29.43 Favored Glycine 0 N--CA 1.45 -0.41 0 N-CA-C 108.828 -1.709 . . . . 0.0 108.828 -176.128 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -104.4 -22.3 13.35 Favored 'General case' 0 C--O 1.215 -0.738 0 N-CA-C 115.369 1.618 . . . . 0.0 115.369 -176.487 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -71.12 146.36 49.25 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.6 0.714 . . . . 0.0 112.638 -176.357 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -95.58 33.29 1.65 Allowed 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 122.691 1.234 . . . . 0.0 111.918 -176.605 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 31.4 tp 62.52 146.29 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.99 0 CA-C-N 112.791 -2.004 . . . . 0.0 115.305 176.219 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 51.9 tptt -158.16 140.39 14.23 Favored 'General case' 0 CA--C 1.514 -0.433 0 O-C-N 121.118 -0.989 . . . . 0.0 109.869 174.58 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 -125.51 151.36 70.16 Favored Pre-proline 0 C--O 1.241 0.655 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 175.411 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -74.66 165.68 31.02 Favored 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 120.674 0.916 . . . . 0.0 113.863 -179.906 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 16.7 tpt180 -65.07 133.97 52.78 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.885 -178.211 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 83.96 2.32 89.59 Favored Glycine 0 C--O 1.227 -0.293 0 CA-C-O 121.305 0.392 . . . . 0.0 112.351 177.959 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 30.2 mt-30 -141.29 171.14 14.47 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 123.674 0.79 . . . . 0.0 109.803 -173.74 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 105.1 -19.58 40.2 Favored Glycine 0 CA--C 1.497 -1.062 0 N-CA-C 111.254 -0.738 . . . . 0.0 111.254 175.987 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 84.8 t -65.74 127.81 93.34 Favored Pre-proline 0 C--N 1.317 -0.818 0 N-CA-C 105.813 -1.921 . . . . 0.0 105.813 176.311 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -71.62 172.96 13.31 Favored 'Trans proline' 0 N--CA 1.46 -0.485 0 O-C-N 122.292 0.627 . . . . 0.0 111.295 178.141 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 78.4 mt -74.29 108.97 6.31 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 -179.324 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 30.4 m-20 -110.11 74.43 0.88 Allowed 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.648 -1.16 . . . . 0.0 110.454 -175.455 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 65.8 p -66.08 -23.0 66.44 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 115.588 1.699 . . . . 0.0 115.588 -174.298 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -110.76 31.3 6.1 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 112.259 0.466 . . . . 0.0 112.259 -176.474 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 73.8 p -132.9 167.56 20.0 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 178.988 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 44.6 m -84.26 162.45 51.41 Favored Pre-proline 0 C--N 1.321 -0.672 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.417 -178.59 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -67.64 -21.79 45.01 Favored 'Trans proline' 0 C--N 1.351 0.69 0 C-N-CA 116.526 -1.849 . . . . 0.0 114.668 -178.836 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.401 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 6.3 p-10 -75.19 -18.15 60.22 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 121.73 -0.606 . . . . 0.0 109.858 177.785 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.478 ' HA ' ' HZ3' ' A' ' 103' ' ' LYS . 26.1 t0 -90.42 2.11 55.96 Favored 'General case' 0 C--O 1.219 -0.525 0 N-CA-C 114.32 1.23 . . . . 0.0 114.32 -175.016 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 93.0 mm-40 -65.26 -23.76 67.14 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-O 121.624 0.726 . . . . 0.0 109.99 176.789 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 9.0 tt -66.59 141.09 18.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 122.044 0.926 . . . . 0.0 111.083 177.964 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 175.18 -160.98 30.04 Favored Glycine 0 CA--C 1.504 -0.626 0 C-N-CA 120.2 -1.0 . . . . 0.0 110.636 179.364 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 44.3 p90 -155.1 170.73 21.11 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 178.832 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -112.8 140.24 47.76 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 106.522 -1.658 . . . . 0.0 106.522 175.213 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 63.9 ttt180 -115.49 121.97 44.3 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 123.831 0.852 . . . . 0.0 112.152 -175.59 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 32.3 ttp85 -68.65 138.66 55.18 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 176.977 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -143.64 138.73 29.19 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 123.217 0.607 . . . . 0.0 109.597 179.954 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.8 t -161.38 155.08 21.88 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 105.076 -2.194 . . . . 0.0 105.076 176.721 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 11.6 tpt180 -141.42 123.81 15.77 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 107.243 -1.392 . . . . 0.0 107.243 176.495 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 7.7 tmm_? -132.77 129.7 38.95 Favored 'General case' 0 CA--C 1.49 -1.341 0 CA-C-O 121.983 0.897 . . . . 0.0 110.221 179.931 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -139.68 176.82 5.17 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 N-CA-C 104.853 -2.277 . . . . 0.0 104.853 -178.75 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 30.2 ttt85 -127.42 115.91 19.65 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 105.847 -1.909 . . . . 0.0 105.847 175.172 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -82.35 156.83 35.92 Favored Glycine 0 N--CA 1.448 -0.502 0 N-CA-C 108.092 -2.003 . . . . 0.0 108.092 177.802 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -75.45 -31.66 56.39 Favored Glycine 0 C--O 1.215 -1.055 0 N-CA-C 108.808 -1.717 . . . . 0.0 108.808 178.964 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -71.76 -20.69 61.85 Favored 'General case' 0 C--O 1.217 -0.627 0 CA-C-N 114.17 -1.015 . . . . 0.0 109.718 178.211 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 115.65 -9.89 19.17 Favored Glycine 0 CA--C 1.506 -0.48 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.869 173.841 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 5.0 pttt -79.13 154.06 29.62 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 122.085 0.945 . . . . 0.0 113.354 -176.822 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 94.4 mtp -122.48 -160.24 0.87 Allowed 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 113.89 -1.504 . . . . 0.0 110.053 -176.865 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 18.7 mmtt -118.75 -70.0 0.82 Allowed 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 122.199 0.2 . . . . 0.0 111.103 -179.397 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -141.13 160.43 40.12 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 177.269 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -121.17 -28.23 4.76 Favored 'General case' 0 N--CA 1.469 0.5 0 O-C-N 123.892 0.745 . . . . 0.0 110.792 -177.664 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -110.03 130.83 22.4 Favored Pre-proline 0 C--O 1.238 0.469 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 -179.22 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -65.23 162.61 32.46 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 117.386 -1.276 . . . . 0.0 113.439 179.492 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 29.2 mtt-85 -123.31 156.74 34.72 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 178.654 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 54.6 m95 -129.78 125.14 35.08 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 177.215 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 -112.22 147.5 36.08 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 -178.582 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 79.2 t80 -91.0 136.9 32.76 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 -179.335 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -140.53 140.68 35.28 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.338 -0.847 . . . . 0.0 109.364 -173.93 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 34.7 m-85 -74.44 159.53 32.17 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.173 0.511 . . . . 0.0 111.373 -179.605 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -54.74 124.95 18.06 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.76 -0.654 . . . . 0.0 112.105 -177.994 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 81.18 16.73 73.63 Favored Glycine 0 C--O 1.221 -0.7 0 N-CA-C 117.012 1.565 . . . . 0.0 117.012 176.868 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 19.4 p . . . . . 0 N--CA 1.47 0.536 0 CA-C-N 119.173 1.486 . . . . 0.0 111.704 -179.88 . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 16.9 mt . . . . . 0 N--CA 1.449 -0.514 0 N-CA-C 115.486 1.662 . . . . 0.0 115.486 . . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -78.51 163.16 27.19 Favored 'Trans proline' 0 N--CA 1.461 -0.406 0 N-CA-C 107.698 -1.693 . . . . 0.0 107.698 168.269 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 55.0 t80 -61.62 133.61 55.84 Favored 'General case' 0 C--N 1.321 -0.668 0 C-N-CA 120.466 -0.493 . . . . 0.0 110.372 -178.305 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 90.7 -7.84 80.69 Favored Glycine 0 CA--C 1.517 0.206 0 CA-C-O 119.548 -0.584 . . . . 0.0 114.346 178.841 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -65.48 130.81 44.62 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 118.386 1.093 . . . . 0.0 111.03 179.098 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 59.1 t30 -79.71 129.21 34.28 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.381 -179.421 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 30.7 ttmt -156.07 152.96 28.66 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 106.571 -1.641 . . . . 0.0 106.571 179.451 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -60.95 127.47 31.71 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 -179.645 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 70.22 28.65 71.19 Favored Glycine 0 N--CA 1.449 -0.485 0 CA-C-O 119.382 -0.677 . . . . 0.0 114.677 176.593 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 43.5 mm -126.69 122.43 60.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 117.601 0.7 . . . . 0.0 110.842 179.406 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.1 pt -127.49 116.41 43.55 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 CA-C-O 121.762 0.792 . . . . 0.0 111.828 176.612 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 95.2 m95 -81.68 137.84 35.36 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 113.223 0.823 . . . . 0.0 113.223 -177.597 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 18.2 m -137.2 152.43 27.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 178.305 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -163.01 165.99 24.25 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 104.754 -2.313 . . . . 0.0 104.754 -179.999 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 6.5 t -140.2 -178.94 5.7 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 105.938 -1.875 . . . . 0.0 105.938 177.583 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -67.63 136.32 54.22 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.338 0.589 . . . . 0.0 110.614 -178.675 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 96.65 -13.69 65.04 Favored Glycine 0 N--CA 1.459 0.215 0 CA-C-N 115.668 -0.696 . . . . 0.0 112.967 178.48 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.401 ' HA ' ' HA ' ' A' ' 41' ' ' ASP . . . -75.59 140.02 42.42 Favored 'General case' 0 C--N 1.322 -0.608 0 O-C-N 122.716 -0.285 . . . . 0.0 110.573 179.997 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 36.4 mt -96.53 139.89 31.96 Favored 'General case' 0 C--O 1.218 -0.555 0 CA-C-O 121.259 0.552 . . . . 0.0 111.69 -179.373 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 58.9 t30 -86.16 68.77 10.38 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.711 179.473 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 1.1 t -140.67 150.77 61.33 Favored Pre-proline 0 C--N 1.325 -0.489 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 179.12 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -67.74 149.57 78.76 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 118.345 -0.636 . . . . 0.0 113.544 176.908 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.478 ' HZ3' ' HA ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -146.64 47.12 1.19 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 122.732 1.253 . . . . 0.0 110.839 179.061 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 16.0 p-10 -47.73 -39.34 17.47 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 113.44 -1.709 . . . . 0.0 113.34 178.752 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 50.1 p-80 -60.74 -17.1 46.53 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 115.336 1.606 . . . . 0.0 115.336 -177.814 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 68.9 mt -81.55 -29.16 10.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 178.896 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -72.06 14.65 2.12 Favored Glycine 0 CA--C 1.522 0.525 0 N-CA-C 115.771 1.068 . . . . 0.0 115.771 -177.622 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 15.2 t -83.29 28.16 0.55 Allowed 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 123.54 0.736 . . . . 0.0 112.981 -177.711 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 72.9 ttp85 -61.61 116.38 4.7 Favored 'General case' 0 N--CA 1.469 0.514 0 O-C-N 121.221 -0.924 . . . . 0.0 108.647 178.443 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 14.5 m-20 -82.88 118.39 71.61 Favored Pre-proline 0 C--N 1.323 -0.554 0 N-CA-C 105.351 -2.092 . . . . 0.0 105.351 179.279 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -71.66 -13.61 29.88 Favored 'Trans proline' 0 C--O 1.219 -0.46 0 C-N-CA 117.312 -1.326 . . . . 0.0 113.891 -176.418 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -81.25 -24.91 37.01 Favored 'General case' 0 C--O 1.22 -0.465 0 CA-C-O 120.892 0.377 . . . . 0.0 110.241 178.252 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 81.2 m-20 -102.86 -24.78 13.67 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 113.521 0.934 . . . . 0.0 113.521 -175.315 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 30.7 t30 -145.97 145.42 30.64 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 -178.349 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -89.23 149.68 22.99 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.368 -179.927 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -70.24 148.31 48.72 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.305 0.574 . . . . 0.0 110.61 178.129 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 8.0 mt -83.43 139.33 17.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 -179.178 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 89.7 t -62.55 121.43 11.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 176.069 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 5.5 tt -68.07 126.92 31.01 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.244 0.545 . . . . 0.0 109.996 -177.798 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 30.8 mt-30 -132.96 154.23 50.67 Favored 'General case' 0 CA--C 1.509 -0.628 0 N-CA-C 106.656 -1.609 . . . . 0.0 106.656 -179.85 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 12.8 mt -110.73 147.45 36.48 Favored Pre-proline 0 C--N 1.321 -0.657 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 176.779 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -72.96 162.18 41.67 Favored 'Trans proline' 0 C--O 1.236 0.376 0 O-C-N 122.265 0.613 . . . . 0.0 112.491 -179.718 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 56.8 tt0 -55.15 131.27 44.82 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 -179.797 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 104.27 -22.8 33.65 Favored Glycine 0 C--O 1.226 -0.359 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.842 -178.267 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 3.8 m -108.72 126.98 53.59 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 117.641 0.72 . . . . 0.0 109.791 177.778 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 15.5 p -121.64 148.41 44.6 Favored 'General case' 0 CA--C 1.508 -0.635 0 CA-C-O 121.029 0.442 . . . . 0.0 110.25 179.912 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 83.0 mt -71.79 152.92 93.31 Favored Pre-proline 0 C--N 1.321 -0.634 0 N-CA-C 107.305 -1.369 . . . . 0.0 107.305 178.011 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -77.63 172.58 15.54 Favored 'Trans proline' 0 C--O 1.237 0.439 0 CA-C-O 121.384 0.493 . . . . 0.0 111.252 179.022 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 65.2 tttm -57.61 127.51 32.4 Favored 'General case' 0 C--O 1.219 -0.519 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.778 -178.047 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 91.82 7.84 64.15 Favored Glycine 0 C--O 1.226 -0.406 0 N-CA-C 115.625 1.01 . . . . 0.0 115.625 177.678 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 34.5 m-85 -118.86 136.87 53.81 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 118.064 0.932 . . . . 0.0 109.927 177.774 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 55.2 p90 -144.93 161.8 38.46 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 176.683 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -99.45 146.27 26.52 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.617 0.722 . . . . 0.0 112.893 -175.665 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -75.39 132.02 40.61 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 178.658 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 88.6 -6.85 83.18 Favored Glycine 0 C--O 1.225 -0.412 0 C-N-CA 121.323 -0.465 . . . . 0.0 112.959 -179.032 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 31.6 t . . . . . 0 C--N 1.328 -0.363 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 178.848 . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.245 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 . . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 34.0 p -64.21 145.65 55.63 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 178.351 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 13.1 m95 -64.73 -24.35 67.54 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.955 0.407 . . . . 0.0 112.086 179.5 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -121.38 163.93 17.91 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.578 -0.737 . . . . 0.0 112.416 -172.269 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 47.0 p -70.43 165.96 21.4 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 177.093 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -79.34 146.56 32.83 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.715 0.769 . . . . 0.0 112.472 -176.507 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 12.1 mt -83.32 146.73 28.35 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 102.931 -2.989 . . . . 0.0 102.931 169.151 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 29.9 m -129.78 138.75 51.23 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 -178.686 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . 0.42 ' HB2' ' CZ ' ' A' ' 131' ' ' PHE . 4.0 tp60 -106.67 136.91 45.66 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.837 0.68 . . . . 0.0 112.837 -176.93 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 5.7 t60 -130.75 94.77 3.69 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 103.014 -2.958 . . . . 0.0 103.014 168.612 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 173.33 -157.33 26.01 Favored Glycine 0 C--O 1.223 -0.541 0 N-CA-C 110.957 -0.857 . . . . 0.0 110.957 -174.302 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 29.8 mtpp -112.32 -24.86 9.55 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 115.321 1.601 . . . . 0.0 115.321 -177.436 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 88.3 mt-10 -80.5 158.29 25.89 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 177.759 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -79.91 -62.8 1.57 Allowed 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 177.667 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 44.3 tp -179.25 141.09 0.16 Allowed 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 172.56 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 23.8 tptm -156.07 140.45 16.7 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 174.188 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 15.3 m-85 -125.02 152.1 69.92 Favored Pre-proline 0 C--O 1.242 0.68 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 175.817 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -72.69 160.41 46.43 Favored 'Trans proline' 0 CA--C 1.54 0.778 0 C-N-CA 120.658 0.905 . . . . 0.0 112.859 178.292 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.02 131.91 47.32 Favored 'General case' 0 C--O 1.216 -0.665 0 O-C-N 122.172 -0.33 . . . . 0.0 110.813 -178.033 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 85.45 7.27 82.64 Favored Glycine 0 N--CA 1.46 0.292 0 C-N-CA 121.445 -0.407 . . . . 0.0 112.181 179.195 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.407 HE22 HG23 ' A' ' 125' ' ' THR . 16.9 mt-30 -145.95 170.53 16.42 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 123.19 0.596 . . . . 0.0 109.983 -174.991 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 105.41 -16.88 44.36 Favored Glycine 0 CA--C 1.501 -0.819 0 CA-C-N 116.1 -0.5 . . . . 0.0 113.139 174.881 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 93.9 t -65.78 129.08 94.24 Favored Pre-proline 0 C--N 1.32 -0.704 0 N-CA-C 106.52 -1.659 . . . . 0.0 106.52 176.988 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -73.27 170.77 19.08 Favored 'Trans proline' 0 C--O 1.219 -0.433 0 O-C-N 122.148 0.552 . . . . 0.0 111.052 177.764 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 86.1 mt -70.55 106.56 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-O 122.009 0.909 . . . . 0.0 108.693 -179.601 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -98.14 84.1 3.21 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 114.514 -1.221 . . . . 0.0 110.017 -176.915 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 77.3 p -68.3 -14.08 62.73 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.775 0.798 . . . . 0.0 112.48 -179.313 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 11.5 p30 -106.69 22.98 15.02 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 114.82 -1.082 . . . . 0.0 111.718 -177.776 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 19.0 m -141.15 150.97 43.48 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 113.745 1.016 . . . . 0.0 113.745 -176.424 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.1 m -72.28 166.88 37.38 Favored Pre-proline 0 C--N 1.326 -0.441 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 176.415 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -66.4 -25.62 48.65 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 114.792 -3.005 . . . . 0.0 114.112 -179.714 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.466 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 4.5 p-10 -78.66 -20.63 49.82 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.586 0.708 . . . . 0.0 110.891 177.546 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 -81.64 -6.68 59.24 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 -176.086 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 96.0 mm-40 -57.7 -26.81 62.26 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 114.124 1.157 . . . . 0.0 114.124 -178.481 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 8.5 tt -59.31 138.35 20.49 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.939 0 N-CA-C 113.872 1.064 . . . . 0.0 113.872 -178.367 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -178.34 -158.2 20.57 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.389 -179.376 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 36.4 p90 -154.95 168.14 27.97 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 179.427 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 29.1 m-85 -112.77 141.74 46.22 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 174.634 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 69.2 ttt-85 -115.14 124.15 50.75 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 123.423 0.689 . . . . 0.0 112.514 -178.353 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 50.0 ttt180 -64.64 136.33 56.87 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 122.784 0.434 . . . . 0.0 110.12 177.3 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -152.13 150.92 30.42 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.713 0.634 . . . . 0.0 112.713 -179.791 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 6.4 p -144.15 147.88 34.29 Favored 'General case' 0 C--O 1.238 0.494 0 N-CA-C 105.488 -2.041 . . . . 0.0 105.488 172.704 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 16.1 tpt180 -166.22 123.86 1.42 Allowed 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 177.698 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 7.8 tmm_? -94.35 124.03 38.12 Favored 'General case' 0 CA--C 1.485 -1.553 0 CA-C-O 122.375 1.083 . . . . 0.0 111.0 177.973 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -126.74 174.64 10.2 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.076 0 CA-C-N 112.841 -1.981 . . . . 0.0 106.596 176.273 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 78.6 ttt180 -122.94 121.44 36.16 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 105.46 -2.052 . . . . 0.0 105.46 175.289 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -90.42 157.64 25.86 Favored Glycine 0 N--CA 1.448 -0.511 0 N-CA-C 106.969 -2.452 . . . . 0.0 106.969 177.955 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -72.21 -34.27 61.33 Favored Glycine 0 C--O 1.217 -0.966 0 N-CA-C 107.588 -2.205 . . . . 0.0 107.588 178.141 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 30.8 t0 -93.62 14.82 17.79 Favored 'General case' 0 C--O 1.217 -0.642 0 CA-C-O 122.529 1.157 . . . . 0.0 109.497 178.409 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 83.66 -17.21 26.8 Favored Glycine 0 C--O 1.227 -0.295 0 N-CA-C 117.101 1.601 . . . . 0.0 117.101 172.794 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.74 125.96 22.14 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 114.026 1.121 . . . . 0.0 114.026 -176.853 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 78.5 mtp -104.24 -179.32 3.91 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 114.37 -1.286 . . . . 0.0 112.239 -177.971 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 10.5 mptt -131.85 -47.25 0.95 Allowed 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.893 0.877 . . . . 0.0 111.331 -179.913 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -66.3 -172.07 0.14 Allowed 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 113.158 -1.837 . . . . 0.0 114.405 -179.512 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 79.52 -54.43 0.41 Allowed 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 126.855 2.062 . . . . 0.0 109.14 -177.967 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 22.3 p -92.14 131.84 33.9 Favored Pre-proline 0 C--N 1.32 -0.712 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 174.965 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -70.48 149.64 62.58 Favored 'Trans proline' 0 C--O 1.24 0.615 0 C-N-CA 115.513 -2.524 . . . . 0.0 111.112 178.734 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.411 HH12 ' CD ' ' A' ' 134' ' ' GLU . 0.1 OUTLIER -123.78 158.96 30.54 Favored 'General case' 0 CA--C 1.504 -0.803 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.096 -176.75 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 65.9 m95 -133.47 128.08 34.65 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 177.163 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 43.4 m-85 -110.92 143.26 41.83 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 106.669 -1.604 . . . . 0.0 106.669 -178.796 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 92.1 t80 -94.72 135.09 36.61 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 -175.844 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -137.92 155.55 48.81 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 108.072 -1.085 . . . . 0.0 108.072 -177.747 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 80.9 m-85 -89.39 159.47 17.3 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 112.06 0.393 . . . . 0.0 112.06 -174.362 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -55.05 128.95 36.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.01 -177.958 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 68.13 39.18 88.62 Favored Glycine 0 C--O 1.217 -0.91 0 CA-C-O 119.201 -0.777 . . . . 0.0 114.822 175.672 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.325 -0.486 0 N-CA-C 106.408 -1.701 . . . . 0.0 106.408 177.719 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 17.5 mt . . . . . 0 N--CA 1.445 -0.72 0 N-CA-C 113.501 0.926 . . . . 0.0 113.501 . . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -78.29 166.61 24.21 Favored 'Trans proline' 0 N--CA 1.46 -0.471 0 C-N-CA 121.54 1.494 . . . . 0.0 108.323 170.655 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 70.6 t80 -61.74 131.16 48.98 Favored 'General case' 0 C--N 1.321 -0.63 0 C-N-CA 120.371 -0.532 . . . . 0.0 109.978 -179.978 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 92.34 -7.07 78.31 Favored Glycine 0 CA--C 1.52 0.354 0 N-CA-C 114.943 0.737 . . . . 0.0 114.943 178.093 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -64.19 129.51 40.27 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 118.433 1.117 . . . . 0.0 111.866 -179.991 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -75.53 130.15 38.39 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.492 -177.778 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 28.1 ttmt -156.17 151.75 27.04 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 105.58 -2.007 . . . . 0.0 105.58 177.43 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 31.1 t0 -66.2 133.62 51.01 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.017 0.436 . . . . 0.0 110.423 -177.89 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 69.03 25.6 75.3 Favored Glycine 0 N--CA 1.449 -0.442 0 CA-C-O 119.46 -0.633 . . . . 0.0 114.089 179.234 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 41.3 mm -127.15 128.75 70.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 117.504 0.652 . . . . 0.0 110.484 179.898 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.1 pt -131.52 122.48 50.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 CA-C-N 115.782 -0.644 . . . . 0.0 109.719 175.312 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 94.0 m95 -88.35 138.75 31.16 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 -176.975 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 16.2 m -137.56 149.73 25.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 121.687 0.756 . . . . 0.0 109.635 178.806 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -158.5 166.6 31.77 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 102.684 -3.08 . . . . 0.0 102.684 -179.494 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 8.4 t -134.34 177.19 7.95 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 105.52 -2.03 . . . . 0.0 105.52 178.267 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 64.4 tt0 -67.46 134.46 51.41 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.142 0.496 . . . . 0.0 109.9 -178.547 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 96.01 -13.75 65.59 Favored Glycine 0 C--O 1.229 -0.19 0 CA-C-N 115.92 -0.582 . . . . 0.0 112.942 -179.804 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.466 ' HA ' ' HA ' ' A' ' 41' ' ' ASP . . . -73.42 138.17 45.06 Favored 'General case' 0 CA--C 1.54 0.575 0 O-C-N 122.498 -0.413 . . . . 0.0 110.288 178.964 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 31.7 mt -97.02 139.33 33.2 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 121.269 0.557 . . . . 0.0 112.398 -179.441 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -83.0 62.87 6.79 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.804 -178.872 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 1.2 t -131.98 152.89 81.04 Favored Pre-proline 0 C--N 1.324 -0.54 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 178.99 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -67.51 152.34 78.63 Favored 'Trans proline' 0 C--N 1.344 0.292 0 N-CA-C 114.489 0.919 . . . . 0.0 114.489 178.304 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 1.3 ptpt -151.87 59.07 0.86 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 122.879 1.324 . . . . 0.0 111.124 178.466 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 15.0 p-10 -56.33 -36.04 68.27 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 113.628 -1.624 . . . . 0.0 111.556 177.803 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 38.0 p-80 -60.58 -10.82 5.66 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 114.891 1.441 . . . . 0.0 114.891 -177.868 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 55.0 mt -92.36 -43.72 13.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 178.117 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -72.97 14.65 2.67 Favored Glycine 0 CA--C 1.523 0.541 0 N-CA-C 116.256 1.262 . . . . 0.0 116.256 -176.339 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 14.4 t -95.73 25.52 4.56 Favored 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 -177.382 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 62.4 ttp85 -55.62 129.98 41.21 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 179.629 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 6.5 m-20 -99.72 126.1 38.28 Favored Pre-proline 0 C--N 1.323 -0.57 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 -178.528 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -69.9 -17.88 36.69 Favored 'Trans proline' 0 C--O 1.219 -0.444 0 C-N-CA 118.041 -0.839 . . . . 0.0 113.465 -178.127 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -73.3 -28.67 62.23 Favored 'General case' 0 C--O 1.22 -0.463 0 CA-C-O 120.96 0.409 . . . . 0.0 110.681 178.239 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 76.1 m-20 -102.3 -24.72 13.85 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 -174.107 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 31.9 t30 -153.2 149.51 28.06 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 113.176 0.806 . . . . 0.0 113.176 -178.209 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -89.15 148.21 23.78 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-O 121.382 0.61 . . . . 0.0 111.497 179.392 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -68.49 143.47 54.97 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.374 0.606 . . . . 0.0 110.968 178.808 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 19.4 mt -85.28 139.87 16.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 -179.164 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 91.5 t -63.3 123.31 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 N-CA-C 106.105 -1.813 . . . . 0.0 106.105 175.271 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 6.8 tt -66.0 130.32 42.84 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.151 0.5 . . . . 0.0 110.598 -176.705 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 32.7 mt-30 -132.61 159.81 38.46 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 106.892 -1.521 . . . . 0.0 106.892 -179.376 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 13.7 mt -113.59 147.85 38.46 Favored Pre-proline 0 C--N 1.322 -0.589 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 177.256 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -72.82 169.51 21.87 Favored 'Trans proline' 0 C--N 1.344 0.34 0 O-C-N 122.254 0.607 . . . . 0.0 113.356 -178.6 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 60.3 tt0 -54.7 131.76 44.2 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.715 -179.638 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 93.13 -16.76 59.76 Favored Glycine 0 C--O 1.227 -0.339 0 CA-C-O 119.654 -0.525 . . . . 0.0 114.168 179.767 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.407 HG23 HE22 ' A' ' 30' ' ' GLN . 15.1 m -106.36 127.78 53.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 118.396 1.098 . . . . 0.0 110.547 178.864 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 10.4 p -121.23 148.7 43.92 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.593 -178.82 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 79.0 mt -71.05 153.52 94.54 Favored Pre-proline 0 C--N 1.324 -0.534 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 178.937 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -75.09 170.34 20.61 Favored 'Trans proline' 0 C--O 1.236 0.398 0 N-CA-C 110.363 -0.668 . . . . 0.0 110.363 178.089 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 13.9 tmtt? -54.74 121.4 8.45 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 113.314 0.857 . . . . 0.0 113.314 -174.093 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 95.24 -6.01 68.43 Favored Glycine 0 C--N 1.328 0.106 0 N-CA-C 116.719 1.448 . . . . 0.0 116.719 174.684 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.42 ' CZ ' ' HB2' ' A' ' 18' ' ' GLN . 1.5 m-85 -87.51 145.69 26.13 Favored 'General case' 0 N--CA 1.436 -1.16 0 CA-C-O 122.192 0.996 . . . . 0.0 110.342 178.813 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 37.4 p90 -145.4 163.11 35.6 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 113.458 -1.701 . . . . 0.0 107.625 175.326 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -102.98 145.39 29.94 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.081 0.467 . . . . 0.0 110.659 -177.787 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.411 ' CD ' HH12 ' A' ' 67' ' ' ARG . 33.7 tt0 -73.56 132.28 42.65 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 107.081 -1.452 . . . . 0.0 107.081 178.303 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 92.92 -2.4 72.28 Favored Glycine 0 C--O 1.223 -0.539 0 N-CA-C 111.125 -0.79 . . . . 0.0 111.125 -177.636 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 8.9 t . . . . . 0 C--N 1.325 -0.469 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 177.496 . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.415 0 CA-C-O 121.352 0.596 . . . . 0.0 110.912 . . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 54.0 p -63.27 144.99 56.47 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.02 178.478 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 42.8 m95 -68.78 -23.44 64.3 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 113.69 0.996 . . . . 0.0 113.69 179.987 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -116.84 160.09 21.37 Favored 'General case' 0 C--O 1.242 0.668 0 CA-C-O 121.239 0.542 . . . . 0.0 111.69 -174.898 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.463 ' HB ' ' HB3' ' A' ' 134' ' ' GLU . 75.9 p -70.13 163.1 27.02 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.694 -1.139 . . . . 0.0 109.482 178.999 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -82.65 135.87 34.92 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 113.478 0.918 . . . . 0.0 113.478 -175.809 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.0 mp -80.19 146.83 31.55 Favored 'General case' 0 CA--C 1.503 -0.854 0 N-CA-C 106.466 -1.679 . . . . 0.0 106.466 173.419 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 25.2 m -106.08 136.2 46.19 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 178.01 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 -110.78 128.2 55.66 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.265 0.555 . . . . 0.0 111.198 -178.359 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 40.7 t60 -129.12 99.47 5.27 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 106.229 -1.767 . . . . 0.0 106.229 175.18 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 165.79 -173.13 41.4 Favored Glycine 0 N--CA 1.451 -0.347 0 N-CA-C 110.418 -1.073 . . . . 0.0 110.418 -178.502 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -98.01 -16.94 19.44 Favored 'General case' 0 C--O 1.218 -0.566 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 -179.387 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 84.0 mt-10 -71.04 169.16 15.55 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 113.49 0.922 . . . . 0.0 113.49 -176.29 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 70.0 m-20 -116.17 24.33 11.49 Favored 'General case' 0 C--O 1.221 -0.428 0 CA-C-O 122.013 0.911 . . . . 0.0 111.797 178.895 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 62.2 tp 66.54 144.19 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 126.598 1.959 . . . . 0.0 113.597 179.987 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 49.3 tptt -157.74 138.15 12.79 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 176.234 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -123.56 136.27 27.04 Favored Pre-proline 0 C--O 1.242 0.699 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 173.535 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -64.04 162.34 29.79 Favored 'Trans proline' 0 CA--C 1.539 0.74 0 C-N-CA 121.205 1.27 . . . . 0.0 113.344 175.349 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -67.13 143.2 56.77 Favored 'General case' 0 C--O 1.22 -0.495 0 O-C-N 122.017 -0.427 . . . . 0.0 112.007 -179.278 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 78.29 13.65 83.06 Favored Glycine 0 C--O 1.222 -0.62 0 N-CA-C 111.115 -0.794 . . . . 0.0 111.115 178.951 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -152.52 168.6 25.0 Favored 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 -173.938 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 104.2 -19.87 41.96 Favored Glycine 0 CA--C 1.499 -0.951 0 CA-C-O 121.015 0.231 . . . . 0.0 112.881 173.809 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 58.3 t -72.01 127.25 90.8 Favored Pre-proline 0 C--N 1.319 -0.749 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 177.911 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -68.64 175.23 7.39 Favored 'Trans proline' 0 CA--C 1.531 0.36 0 N-CA-C 113.7 0.616 . . . . 0.0 113.7 177.404 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 88.0 mt -75.56 110.41 10.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 121.882 0.848 . . . . 0.0 109.174 178.616 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -108.35 83.26 1.75 Allowed 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 114.674 -1.148 . . . . 0.0 109.637 -178.406 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 80.9 p -69.71 -18.37 63.53 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 113.704 1.001 . . . . 0.0 113.704 -176.783 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -119.64 32.11 6.23 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 -175.916 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.4 m -136.35 157.38 46.93 Favored 'General case' 0 C--N 1.327 -0.394 0 O-C-N 122.045 -0.409 . . . . 0.0 111.456 179.214 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 15.0 m -72.68 159.35 85.57 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.017 -179.979 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -65.42 -24.92 56.47 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 116.127 -2.115 . . . . 0.0 111.331 176.833 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -62.14 -29.79 70.59 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.444 176.578 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 35.4 t0 -88.25 -6.38 57.83 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 113.737 1.014 . . . . 0.0 113.737 -172.536 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 95.1 mm-40 -62.03 -31.84 72.27 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 112.95 0.722 . . . . 0.0 112.95 -177.177 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 13.6 tt -62.42 137.86 23.54 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 CA-C-O 122.135 0.969 . . . . 0.0 110.753 177.902 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -179.25 -159.55 23.54 Favored Glycine 0 CA--C 1.504 -0.638 0 C-N-CA 120.1 -1.048 . . . . 0.0 111.51 -178.247 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 38.2 p90 -155.09 168.52 26.73 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 109.838 -0.431 . . . . 0.0 109.838 179.408 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 14.2 m-85 -110.34 137.32 48.21 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 175.615 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 47.6 ttt-85 -112.03 125.3 53.93 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 124.12 0.968 . . . . 0.0 109.936 -176.941 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 9.1 ttt180 -72.77 145.96 46.7 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 122.051 0.929 . . . . 0.0 109.339 179.343 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -75.91 170.8 15.55 Favored 'General case' 0 N--CA 1.432 -1.337 0 CA-C-N 114.165 -1.379 . . . . 0.0 109.895 178.472 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 8.5 t -61.7 147.82 44.78 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 122.222 1.011 . . . . 0.0 110.615 -178.747 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 10.2 tpt180 -72.46 147.42 46.11 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.687 -1.142 . . . . 0.0 111.661 -175.938 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 3.2 tmt_? -88.44 129.06 35.52 Favored 'General case' 0 CA--C 1.504 -0.799 0 N-CA-C 106.113 -1.81 . . . . 0.0 106.113 175.919 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -132.43 176.87 8.04 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-N 114.381 -1.282 . . . . 0.0 111.397 -172.639 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 18.8 ttm180 -112.68 117.03 31.12 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 103.92 -2.622 . . . . 0.0 103.92 174.783 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -92.79 142.41 15.97 Favored Glycine 0 C--O 1.222 -0.596 0 N-CA-C 109.301 -1.52 . . . . 0.0 109.301 179.45 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -70.9 -27.19 72.66 Favored Glycine 0 C--O 1.214 -1.125 0 C-N-CA 121.02 -0.61 . . . . 0.0 114.0 -177.337 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -83.55 -2.34 55.78 Favored 'General case' 0 C--O 1.218 -0.581 0 CA-C-O 121.516 0.674 . . . . 0.0 112.551 -178.319 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 102.94 12.14 32.72 Favored Glycine 0 CA--C 1.504 -0.624 0 CA-C-O 121.557 0.532 . . . . 0.0 112.267 172.037 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 2.6 pttt -130.22 149.23 52.01 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 111.875 0.324 . . . . 0.0 111.875 -177.895 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 23.1 ptm -147.8 176.92 9.74 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 114.594 1.331 . . . . 0.0 114.594 -170.282 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 13.4 mptt -82.35 -45.42 14.91 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.399 178.696 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 8.2 t0 62.45 -169.66 0.18 Allowed 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 112.129 -2.305 . . . . 0.0 113.657 -177.344 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER 66.53 165.16 0.2 Allowed 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 115.23 1.567 . . . . 0.0 115.23 -179.681 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -79.76 157.35 74.39 Favored Pre-proline 0 C--O 1.238 0.494 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 177.909 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -67.43 143.74 64.65 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 114.969 -2.887 . . . . 0.0 112.088 178.805 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 25.6 mtp180 -118.82 166.02 13.31 Favored 'General case' 0 CA--C 1.511 -0.531 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 179.396 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 71.3 m95 -131.09 132.05 44.6 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 178.031 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 61.1 m-85 -112.68 152.1 29.42 Favored 'General case' 0 C--O 1.214 -0.79 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 -178.792 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 77.8 t80 -102.03 136.67 41.46 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 119.35 0.977 . . . . 0.0 109.804 -177.816 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -141.03 146.6 37.44 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.981 -175.288 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 30.5 m-85 -77.82 159.48 28.95 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.128 0.49 . . . . 0.0 111.884 -178.62 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -55.31 131.76 46.37 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.015 179.436 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 72.09 27.82 69.54 Favored Glycine 0 C--O 1.219 -0.816 0 N-CA-C 116.095 1.198 . . . . 0.0 116.095 176.542 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 3.7 p . . . . . 0 C--N 1.325 -0.462 0 CA-C-N 118.575 1.187 . . . . 0.0 108.527 177.734 . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 16.7 mt . . . . . 0 N--CA 1.449 -0.508 0 N-CA-C 114.637 1.347 . . . . 0.0 114.637 . . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -78.34 165.61 25.31 Favored 'Trans proline' 0 N--CA 1.462 -0.362 0 C-N-CA 121.525 1.484 . . . . 0.0 108.653 169.865 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 88.2 t80 -61.39 128.47 36.47 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.983 0.42 . . . . 0.0 110.505 -179.222 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 93.25 -6.83 75.74 Favored Glycine 0 CA--C 1.521 0.409 0 N-CA-C 115.364 0.905 . . . . 0.0 115.364 178.676 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -63.32 133.6 54.39 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 118.433 1.117 . . . . 0.0 112.417 -179.961 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -78.02 125.87 29.99 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.415 -179.246 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 29.6 ttmt -156.22 151.32 26.41 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 107.046 -1.464 . . . . 0.0 107.046 178.145 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -66.44 133.04 49.61 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 -178.204 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 70.44 24.04 77.06 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.889 -0.672 . . . . 0.0 114.019 178.022 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 43.5 mm -127.3 125.67 66.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 117.241 0.52 . . . . 0.0 109.918 179.229 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.1 pt -131.21 122.07 50.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 121.6 0.714 . . . . 0.0 110.5 177.055 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 94.0 m95 -88.25 138.28 31.58 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 -176.261 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 23.4 m -135.95 155.46 35.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 178.916 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -162.93 166.09 24.31 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 105.412 -2.07 . . . . 0.0 105.412 -179.843 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 11.9 t -135.98 173.66 11.47 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 105.37 -2.085 . . . . 0.0 105.37 178.38 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -67.6 136.72 54.89 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.161 0.505 . . . . 0.0 110.443 -178.646 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 92.51 -6.71 77.83 Favored Glycine 0 C--O 1.227 -0.289 0 CA-C-N 115.943 -0.572 . . . . 0.0 114.266 177.571 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -78.05 148.26 34.39 Favored 'General case' 0 C--N 1.322 -0.596 0 O-C-N 122.439 -0.448 . . . . 0.0 110.696 179.228 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 70.5 mt -81.21 170.78 15.68 Favored 'General case' 0 C--O 1.208 -1.095 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 178.015 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -112.96 28.84 8.46 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 121.239 0.542 . . . . 0.0 109.898 177.709 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -109.94 151.74 42.6 Favored Pre-proline 0 CA--C 1.546 0.825 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 -174.36 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -71.01 151.07 61.62 Favored 'Trans proline' 0 C--N 1.352 0.744 0 C-N-CA 120.481 0.787 . . . . 0.0 113.569 177.391 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 6.6 pttp -154.33 57.44 0.7 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 122.548 1.166 . . . . 0.0 111.423 -177.631 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -57.24 -31.99 66.11 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 114.518 -1.219 . . . . 0.0 112.511 179.813 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 11.9 p80 -60.67 -11.32 7.01 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 114.929 1.455 . . . . 0.0 114.929 -177.991 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 45.8 mt -92.31 -43.4 13.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 177.495 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -70.85 14.68 1.42 Allowed Glycine 0 CA--C 1.523 0.558 0 N-CA-C 117.296 1.678 . . . . 0.0 117.296 -175.556 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 12.3 t -90.31 30.24 1.15 Allowed 'General case' 0 CA--C 1.548 0.876 0 N-CA-C 112.527 0.566 . . . . 0.0 112.527 -178.108 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 68.8 ttp85 -56.19 131.25 47.3 Favored 'General case' 0 N--CA 1.475 0.808 0 O-C-N 121.426 -0.796 . . . . 0.0 109.846 179.398 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 37.1 m-20 -100.52 119.57 58.42 Favored Pre-proline 0 C--N 1.325 -0.465 0 N-CA-C 105.125 -2.176 . . . . 0.0 105.125 178.698 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -71.05 -17.34 31.84 Favored 'Trans proline' 0 C--N 1.347 0.469 0 N-CA-C 114.793 1.036 . . . . 0.0 114.793 -174.824 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -75.0 -25.37 58.76 Favored 'General case' 0 C--O 1.22 -0.48 0 CA-C-O 120.946 0.403 . . . . 0.0 110.064 177.631 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 -100.55 -24.67 14.4 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 113.296 0.85 . . . . 0.0 113.296 -175.519 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 23.5 t30 -149.56 145.44 26.82 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.933 0.716 . . . . 0.0 112.933 -179.446 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -83.66 147.54 27.63 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-O 121.617 0.722 . . . . 0.0 112.305 -179.914 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -72.33 147.46 46.29 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.669 178.315 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 9.9 mt -83.71 133.76 28.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 -179.255 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 74.0 t -62.73 120.93 10.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 N-CA-C 105.853 -1.906 . . . . 0.0 105.853 175.534 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 6.7 tt -68.44 128.95 38.44 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.21 0.529 . . . . 0.0 110.483 -176.919 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 29.8 mt-30 -132.14 156.51 46.26 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 105.835 -1.913 . . . . 0.0 105.835 179.065 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 14.1 mt -112.25 149.8 41.54 Favored Pre-proline 0 C--N 1.321 -0.631 0 N-CA-C 105.93 -1.878 . . . . 0.0 105.93 177.744 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -69.9 171.01 15.41 Favored 'Trans proline' 0 C--N 1.344 0.302 0 N-CA-C 115.136 1.168 . . . . 0.0 115.136 -175.061 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -54.9 130.94 43.19 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.835 -178.116 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 88.12 -10.68 69.92 Favored Glycine 0 C--O 1.227 -0.315 0 CA-C-N 115.89 -0.595 . . . . 0.0 112.648 -179.99 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 27.9 m -108.66 127.68 54.18 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.146 0.498 . . . . 0.0 110.662 -179.854 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 19.2 p -124.22 152.99 42.28 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.301 0.572 . . . . 0.0 112.309 -177.532 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 71.4 mt -70.36 155.45 93.41 Favored Pre-proline 0 C--N 1.326 -0.433 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 176.833 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -76.86 172.77 15.59 Favored 'Trans proline' 0 N--CA 1.463 -0.265 0 O-C-N 121.933 0.438 . . . . 0.0 111.038 179.085 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 48.5 tptt -60.78 132.57 54.3 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 -178.341 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 86.81 22.53 45.76 Favored Glycine 0 CA--C 1.518 0.247 0 N-CA-C 114.844 0.698 . . . . 0.0 114.844 177.816 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -131.91 143.43 50.13 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 117.35 0.575 . . . . 0.0 112.258 178.553 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 49.2 p90 -148.94 158.71 44.38 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 106.267 -1.753 . . . . 0.0 106.267 172.507 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -100.43 148.47 24.71 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.816 0.341 . . . . 0.0 110.279 -178.412 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.463 ' HB3' ' HB ' ' A' ' 14' ' ' THR . 8.7 tp10 -67.39 134.33 51.26 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.204 -1.035 . . . . 0.0 108.204 177.593 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 85.78 -7.89 75.08 Favored Glycine 0 C--O 1.227 -0.33 0 CA-C-N 116.058 -0.519 . . . . 0.0 112.941 -177.9 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 20.8 t . . . . . 0 C--N 1.325 -0.488 0 CA-C-O 121.459 0.647 . . . . 0.0 109.86 179.95 . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.241 0 CA-C-O 121.387 0.613 . . . . 0.0 112.273 . . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.7 t -58.53 139.81 55.13 Favored 'General case' 0 CA--C 1.508 -0.647 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 174.902 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 22.1 m95 -64.27 -21.82 66.73 Favored 'General case' 0 C--N 1.323 -0.564 0 O-C-N 123.188 0.305 . . . . 0.0 111.323 177.855 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 51.6 m-85 -121.5 163.17 19.26 Favored 'General case' 0 C--O 1.241 0.628 0 N-CA-C 114.259 1.207 . . . . 0.0 114.259 -172.727 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 57.4 p -68.51 164.7 20.62 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 114.562 -1.199 . . . . 0.0 110.476 179.513 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -80.73 137.92 36.3 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 -176.34 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -90.21 147.3 23.64 Favored 'General case' 0 CA--C 1.502 -0.883 0 N-CA-C 105.767 -1.938 . . . . 0.0 105.767 171.883 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 91.8 m -123.7 141.71 51.76 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 -178.538 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 4.3 tp60 -111.23 136.14 50.74 Favored 'General case' 0 C--N 1.329 -0.295 0 O-C-N 123.629 0.581 . . . . 0.0 112.543 -177.783 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 46.0 t60 -133.32 99.44 4.53 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 103.813 -2.662 . . . . 0.0 103.813 169.551 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 179.12 -158.78 23.13 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.537 -0.839 . . . . 0.0 111.028 -175.204 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 35.3 mmtp -108.52 -28.09 9.52 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 113.958 1.096 . . . . 0.0 113.958 -178.225 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -90.94 167.45 12.41 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 176.231 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -81.81 -62.62 1.59 Allowed 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 -178.855 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 36.5 tp -174.39 142.79 0.8 Allowed 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 105.51 -2.033 . . . . 0.0 105.51 174.043 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 79.5 tttt -151.48 146.18 25.73 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 174.946 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -135.7 157.62 75.84 Favored Pre-proline 0 C--N 1.323 -0.562 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 176.939 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -71.78 172.82 13.73 Favored 'Trans proline' 0 CA--C 1.536 0.614 0 C-N-CA 120.718 0.945 . . . . 0.0 114.002 -179.429 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 25.3 tpt180 -78.41 130.97 36.72 Favored 'General case' 0 C--O 1.216 -0.675 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 177.798 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 81.07 7.15 88.86 Favored Glycine 0 C--O 1.225 -0.461 0 N-CA-C 115.279 0.871 . . . . 0.0 115.279 175.886 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.487 HE22 HG22 ' A' ' 125' ' ' THR . 25.2 tt0 -158.52 146.48 18.24 Favored 'General case' 0 C--O 1.217 -0.654 0 N-CA-C 106.457 -1.682 . . . . 0.0 106.457 -177.854 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 136.65 -17.21 3.73 Favored Glycine 0 CA--C 1.503 -0.676 0 C-N-CA 120.344 -0.932 . . . . 0.0 112.556 177.7 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 33.1 m -71.27 146.52 92.25 Favored Pre-proline 0 C--N 1.321 -0.637 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 176.922 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_endo -76.1 173.49 14.39 Favored 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 121.121 1.214 . . . . 0.0 112.606 178.65 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 93.3 mt -76.09 113.06 14.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 N-CA-C 108.042 -1.095 . . . . 0.0 108.042 178.517 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 45.0 m-20 -104.67 83.91 2.09 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 -178.801 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 69.0 p -64.26 -22.2 66.86 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 115.352 1.612 . . . . 0.0 115.352 -174.422 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 11.1 p30 -106.02 18.28 22.31 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.293 -177.384 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 9.4 m -125.55 157.88 35.96 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -175.152 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -74.29 162.26 74.62 Favored Pre-proline 0 C--N 1.323 -0.56 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 178.23 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -66.11 -23.03 53.67 Favored 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 115.159 -2.76 . . . . 0.0 112.015 177.542 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.459 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 0.0 OUTLIER -72.37 -13.56 61.5 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.278 0.561 . . . . 0.0 111.128 178.824 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -104.83 1.06 28.7 Favored 'General case' 0 C--O 1.219 -0.528 0 N-CA-C 114.541 1.311 . . . . 0.0 114.541 -175.063 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 86.6 mm-40 -62.54 -21.64 65.71 Favored 'General case' 0 CA--C 1.548 0.881 0 O-C-N 120.633 -1.292 . . . . 0.0 110.749 178.193 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 14.3 tt -62.69 143.26 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 CA-C-O 121.96 0.886 . . . . 0.0 112.827 178.413 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 177.14 -153.77 14.4 Favored Glycine 0 N--CA 1.446 -0.668 0 N-CA-C 110.774 -0.93 . . . . 0.0 110.774 178.565 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 43.2 p90 -154.95 168.48 26.82 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 178.242 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 40.1 m-85 -111.31 140.96 45.45 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 106.66 -1.607 . . . . 0.0 106.66 175.186 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 34.4 ttt180 -114.59 125.73 54.1 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 123.273 0.629 . . . . 0.0 111.913 -178.203 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 27.8 ttt180 -67.5 139.0 56.99 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 176.28 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -136.72 129.75 31.01 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.058 0.456 . . . . 0.0 110.855 179.339 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 27.3 p -145.54 154.41 42.15 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 106.533 -1.654 . . . . 0.0 106.533 176.322 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 15.8 tpt180 -163.33 121.69 1.99 Allowed 'General case' 0 CA--C 1.513 -0.443 0 N-CA-C 106.561 -1.644 . . . . 0.0 106.561 173.323 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 3.3 tmt_? -132.07 144.78 50.99 Favored 'General case' 0 CA--C 1.495 -1.136 0 CA-C-O 121.448 0.642 . . . . 0.0 109.81 -176.684 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -140.92 178.25 3.14 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 N-CA-C 105.378 -2.082 . . . . 0.0 105.378 -178.378 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 6.8 tmm_? -137.25 105.74 5.8 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 175.134 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -72.38 163.22 54.67 Favored Glycine 0 N--CA 1.448 -0.503 0 N-CA-C 108.853 -1.699 . . . . 0.0 108.853 178.305 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -71.24 -32.29 65.52 Favored Glycine 0 C--O 1.214 -1.11 0 N-CA-C 108.689 -1.764 . . . . 0.0 108.689 179.331 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 30.6 t0 -89.43 17.07 6.58 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 122.4 1.095 . . . . 0.0 109.478 178.47 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 84.16 -16.2 34.8 Favored Glycine 0 N--CA 1.46 0.259 0 N-CA-C 116.228 1.251 . . . . 0.0 116.228 173.302 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -56.52 134.37 54.11 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 113.886 1.069 . . . . 0.0 113.886 -176.976 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 47.1 mtp -112.83 -168.84 1.38 Allowed 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 113.536 -1.665 . . . . 0.0 110.29 -179.978 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 15.7 mmtt -122.75 -57.94 1.7 Allowed 'General case' 0 C--O 1.217 -0.61 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -178.689 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 58.0 p30 -135.55 174.72 10.3 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.433 -0.803 . . . . 0.0 112.062 -179.076 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 80.4 mt -136.17 -66.2 0.55 Allowed 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 177.681 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 20.0 m -79.98 150.87 72.6 Favored Pre-proline 0 C--O 1.244 0.771 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.036 178.857 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -75.04 157.56 42.53 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 117.111 -1.46 . . . . 0.0 111.417 176.233 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 7.6 ptt-85 -131.64 162.5 30.24 Favored 'General case' 0 CA--C 1.51 -0.569 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 177.128 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 64.3 m95 -129.57 147.67 51.39 Favored 'General case' 0 C--N 1.318 -0.769 0 O-C-N 123.458 0.474 . . . . 0.0 110.114 -178.316 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 72.9 m-85 -127.47 150.46 49.65 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 178.728 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 87.6 t80 -96.55 135.8 37.96 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 -179.621 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -136.07 140.75 44.02 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 121.822 0.82 . . . . 0.0 109.314 -176.949 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 78.2 m-85 -74.62 159.43 32.13 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 114.602 -1.181 . . . . 0.0 110.651 -176.624 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -57.16 135.81 56.4 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 114.088 1.144 . . . . 0.0 114.088 -176.619 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 65.54 29.17 74.56 Favored Glycine 0 C--O 1.224 -0.511 0 N-CA-C 115.869 1.108 . . . . 0.0 115.869 175.036 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 16.8 p . . . . . 0 C--N 1.324 -0.502 0 CA-C-N 118.001 0.9 . . . . 0.0 110.19 179.739 . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 52.1 mt . . . . . 0 N--CA 1.447 -0.606 0 N-CA-C 115.278 1.584 . . . . 0.0 115.278 . . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -78.58 167.65 22.35 Favored 'Trans proline' 0 C--O 1.238 0.501 0 N-CA-C 108.832 -1.257 . . . . 0.0 108.832 170.51 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 68.2 t80 -61.59 130.35 45.49 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 120.558 -0.457 . . . . 0.0 110.321 179.458 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 93.47 -5.48 74.19 Favored Glycine 0 CA--C 1.519 0.283 0 N-CA-C 115.013 0.765 . . . . 0.0 115.013 178.212 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -66.2 129.42 39.75 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 118.459 1.129 . . . . 0.0 112.381 179.977 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 54.7 t30 -75.8 128.1 34.42 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.772 -0.649 . . . . 0.0 112.104 -177.758 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 22.2 ttmt -156.23 152.98 28.45 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 106.978 -1.489 . . . . 0.0 106.978 178.116 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 22.4 t0 -64.86 133.09 51.14 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 -179.19 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 68.75 28.23 73.26 Favored Glycine 0 N--CA 1.448 -0.547 0 CA-C-O 119.557 -0.579 . . . . 0.0 114.308 178.14 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 40.2 mm -129.39 129.22 67.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 117.376 0.588 . . . . 0.0 110.17 179.418 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -131.64 117.75 36.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 CA-C-O 121.446 0.641 . . . . 0.0 110.517 176.172 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 95.9 m95 -86.26 133.07 33.85 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 112.23 0.456 . . . . 0.0 112.23 -177.269 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 1.2 m -140.87 151.12 20.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 -177.571 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -155.64 166.43 33.54 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 105.776 -1.935 . . . . 0.0 105.776 -177.908 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 11.4 t -127.18 171.29 11.56 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 105.621 -1.992 . . . . 0.0 105.621 175.21 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -64.76 136.28 56.75 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.327 0.584 . . . . 0.0 110.578 -179.544 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 94.2 -9.72 72.11 Favored Glycine 0 C--O 1.23 -0.117 0 CA-C-N 115.75 -0.659 . . . . 0.0 113.047 177.92 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.459 ' HA ' ' HA ' ' A' ' 41' ' ' ASP . . . -79.83 139.56 37.15 Favored 'General case' 0 CA--C 1.543 0.692 0 O-C-N 122.543 -0.386 . . . . 0.0 110.846 179.971 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 42.2 mt -102.03 137.67 40.01 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 114.65 1.352 . . . . 0.0 114.65 -176.437 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 50.3 t30 -81.18 75.39 8.15 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.101 -0.954 . . . . 0.0 110.252 179.29 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 2.0 t -139.24 157.55 70.74 Favored Pre-proline 0 CA--C 1.541 0.619 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 -179.373 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -64.35 145.01 87.56 Favored 'Trans proline' 0 C--N 1.348 0.512 0 N-CA-C 114.328 0.857 . . . . 0.0 114.328 -179.108 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 67.4 mmtt -126.41 33.55 4.98 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.664 0.745 . . . . 0.0 109.738 -178.11 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -51.45 -45.52 62.72 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.379 -0.828 . . . . 0.0 112.815 -177.189 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 17.8 p80 -72.93 -4.26 30.96 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 114.353 1.242 . . . . 0.0 114.353 -178.273 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 31.7 mt -96.35 -44.08 12.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 122.191 -0.318 . . . . 0.0 110.496 -179.154 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -74.06 12.11 5.62 Favored Glycine 0 CA--C 1.522 0.514 0 N-CA-C 115.205 0.842 . . . . 0.0 115.205 -178.306 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 13.4 t -83.29 19.72 1.44 Allowed 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 113.812 1.042 . . . . 0.0 113.812 -177.147 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 69.3 ttp85 -56.83 126.13 25.59 Favored 'General case' 0 N--CA 1.471 0.593 0 O-C-N 121.488 -0.757 . . . . 0.0 109.905 -179.3 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 34.4 m120 -93.56 124.21 57.82 Favored Pre-proline 0 C--N 1.322 -0.597 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 179.134 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -70.4 -17.73 34.48 Favored 'Trans proline' 0 C--O 1.219 -0.463 0 C-N-CA 117.021 -1.519 . . . . 0.0 113.15 -179.38 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -76.37 -26.86 56.08 Favored 'General case' 0 C--O 1.22 -0.454 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.247 178.021 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 84.1 m-20 -101.65 -23.69 14.22 Favored 'General case' 0 C--O 1.223 -0.33 0 N-CA-C 113.49 0.922 . . . . 0.0 113.49 -174.991 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 24.2 t30 -149.74 150.64 32.37 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 -178.373 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -88.21 149.02 24.09 Favored 'General case' 0 CA--C 1.545 0.779 0 CA-C-O 121.711 0.767 . . . . 0.0 112.559 179.639 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -72.74 149.86 43.35 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.905 178.364 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 16.7 mt -91.44 139.5 17.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 -179.26 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 93.2 t -62.73 123.79 16.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 N-CA-C 106.021 -1.844 . . . . 0.0 106.021 174.992 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 7.1 tt -66.11 131.25 45.74 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.129 0.49 . . . . 0.0 110.096 -177.215 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 28.3 mt-30 -129.31 152.17 49.16 Favored 'General case' 0 CA--C 1.508 -0.666 0 N-CA-C 106.227 -1.768 . . . . 0.0 106.227 179.838 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 14.3 mt -111.5 148.52 39.01 Favored Pre-proline 0 C--N 1.32 -0.682 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 178.891 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -71.07 165.61 31.82 Favored 'Trans proline' 0 C--N 1.345 0.38 0 O-C-N 122.231 0.595 . . . . 0.0 112.886 -178.546 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 59.5 tt0 -54.65 130.71 41.28 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.504 -177.8 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 94.12 -16.74 60.3 Favored Glycine 0 C--O 1.228 -0.276 0 CA-C-N 115.901 -0.591 . . . . 0.0 113.093 -179.4 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.487 HG22 HE22 ' A' ' 30' ' ' GLN . 10.5 m -102.64 129.51 49.25 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 117.652 0.726 . . . . 0.0 109.765 179.366 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 2.7 p -127.39 148.33 50.27 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.671 -177.788 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 72.9 mt -68.76 154.14 95.1 Favored Pre-proline 0 C--N 1.327 -0.378 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 177.719 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -74.92 170.7 19.81 Favored 'Trans proline' 0 C--O 1.233 0.256 0 C-N-CA 117.724 -1.051 . . . . 0.0 110.681 178.674 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 1.3 tptm -60.78 130.59 47.26 Favored 'General case' 0 C--N 1.324 -0.543 0 O-C-N 122.085 -0.384 . . . . 0.0 111.32 -176.13 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 95.19 -2.63 65.9 Favored Glycine 0 CA--C 1.518 0.225 0 N-CA-C 115.111 0.804 . . . . 0.0 115.111 178.256 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -102.37 144.31 31.02 Favored 'General case' 0 N--CA 1.441 -0.903 0 CA-C-O 122.106 0.955 . . . . 0.0 111.23 -179.964 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 47.6 p90 -146.32 163.33 35.88 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 114.022 -1.444 . . . . 0.0 108.305 174.492 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -111.35 146.44 37.08 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.775 0.322 . . . . 0.0 111.158 -177.429 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -73.29 138.12 45.27 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 178.837 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 84.75 -4.23 85.28 Favored Glycine 0 C--O 1.228 -0.28 0 CA-C-N 116.217 -0.447 . . . . 0.0 112.121 -176.787 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 7.5 t . . . . . 0 C--O 1.238 0.452 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 179.816 . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.288 0 CA-C-O 121.171 0.51 . . . . 0.0 110.26 . . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 43.1 t -55.63 137.12 49.84 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 177.173 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 7.9 m95 -66.14 -21.93 66.36 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 178.798 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 44.2 m-85 -121.48 163.04 19.46 Favored 'General case' 0 CA--C 1.509 -0.598 0 N-CA-C 113.261 0.837 . . . . 0.0 113.261 -171.023 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 73.6 p -72.28 164.28 26.54 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.079 -0.964 . . . . 0.0 109.175 178.765 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -82.81 131.33 35.2 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 112.715 0.635 . . . . 0.0 112.715 -176.039 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 17.1 mt -72.06 148.04 46.19 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 174.134 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 6.2 m -117.58 140.3 49.82 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 -179.406 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 3.8 tp60 -109.72 128.18 55.1 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 123.557 0.536 . . . . 0.0 111.088 179.112 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 41.5 t60 -116.61 99.51 7.19 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 103.615 -2.735 . . . . 0.0 103.615 171.043 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 160.37 -159.2 30.62 Favored Glycine 0 N--CA 1.45 -0.391 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 -175.643 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 69.1 mttm -118.77 -23.43 7.01 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 114.106 1.15 . . . . 0.0 114.106 -178.304 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -74.35 159.75 31.97 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.763 -177.991 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -71.66 -62.95 1.23 Allowed 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 112.976 0.732 . . . . 0.0 112.976 -177.815 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 40.8 tp 153.73 143.43 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.306 0 N-CA-C 103.759 -2.682 . . . . 0.0 103.759 -176.183 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 50.0 tptt -156.44 141.02 16.87 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 175.477 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -125.38 149.91 65.9 Favored Pre-proline 0 C--O 1.241 0.634 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 175.908 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -71.75 161.3 45.56 Favored 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 120.651 0.901 . . . . 0.0 112.793 178.664 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 40.0 tpt85 -66.73 133.29 49.87 Favored 'General case' 0 C--O 1.216 -0.695 0 O-C-N 122.059 -0.401 . . . . 0.0 109.964 -178.437 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 86.02 7.0 81.35 Favored Glycine 0 C--O 1.223 -0.566 0 N-CA-C 111.66 -0.576 . . . . 0.0 111.66 178.839 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 18.4 mt-30 -146.42 170.57 16.56 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 -175.031 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 103.63 -15.08 53.36 Favored Glycine 0 CA--C 1.501 -0.84 0 CA-C-N 116.122 -0.49 . . . . 0.0 113.434 174.78 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 92.4 t -67.61 128.92 93.6 Favored Pre-proline 0 C--N 1.317 -0.81 0 N-CA-C 106.241 -1.763 . . . . 0.0 106.241 176.726 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -72.87 170.69 19.07 Favored 'Trans proline' 0 N--CA 1.459 -0.502 0 O-C-N 122.26 0.611 . . . . 0.0 111.214 178.22 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 90.6 mt -70.73 107.31 2.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-O 122.075 0.94 . . . . 0.0 108.715 -179.345 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 71.3 m-20 -101.46 84.98 2.69 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 114.357 -1.292 . . . . 0.0 109.417 -177.299 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 72.6 p -68.5 -15.03 63.4 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.722 0.772 . . . . 0.0 112.527 -178.704 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 21.0 p30 -106.0 21.96 16.44 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 114.845 -1.071 . . . . 0.0 112.062 -177.22 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 50.5 m -139.51 150.05 44.67 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 113.577 0.954 . . . . 0.0 113.577 -176.044 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 2.5 m -71.65 166.61 38.08 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.448 176.675 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -66.22 -25.9 49.81 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 114.811 -2.993 . . . . 0.0 114.159 -179.775 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.453 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 3.4 p-10 -78.06 -21.01 51.25 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.551 0.691 . . . . 0.0 110.922 177.194 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 62.0 m-20 -81.35 -8.29 59.71 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 113.214 0.82 . . . . 0.0 113.214 -175.34 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 97.1 mm-40 -57.83 -25.95 61.35 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 114.495 1.295 . . . . 0.0 114.495 -178.876 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 9.6 tt -58.38 138.92 18.75 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.971 0 CA-C-O 122.179 0.99 . . . . 0.0 113.638 -178.676 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 179.04 -159.67 24.69 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.411 -179.36 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 43.5 p90 -155.05 170.79 20.96 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 178.958 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 14.5 m-85 -113.1 140.07 48.19 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 173.764 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -110.26 121.66 45.82 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 123.938 0.895 . . . . 0.0 110.436 -178.579 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 40.2 ttp180 -70.84 130.84 42.72 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 174.535 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -142.5 146.6 34.88 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.177 0.513 . . . . 0.0 111.605 -178.737 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 10.2 t -155.4 162.47 40.78 Favored 'General case' 0 C--O 1.245 0.84 0 N-CA-C 104.021 -2.585 . . . . 0.0 104.021 174.186 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 10.1 tpp85 -169.68 139.7 2.04 Favored 'General case' 0 C--O 1.215 -0.733 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 -179.423 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 7.0 ttm180 -121.21 131.15 54.06 Favored 'General case' 0 CA--C 1.497 -1.068 0 N-CA-C 106.39 -1.707 . . . . 0.0 106.39 172.635 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -140.62 178.05 3.46 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 CA-C-N 114.684 -1.144 . . . . 0.0 107.961 -175.396 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.66 99.4 5.97 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 104.813 -2.291 . . . . 0.0 104.813 171.801 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -69.91 161.48 52.95 Favored Glycine 0 C--O 1.227 -0.319 0 N-CA-C 108.755 -1.738 . . . . 0.0 108.755 179.416 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -58.26 -41.41 94.91 Favored Glycine 0 C--O 1.223 -0.592 0 CA-C-N 118.036 0.918 . . . . 0.0 113.566 -178.039 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 32.2 t0 -89.12 15.67 8.41 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-O 122.343 1.068 . . . . 0.0 111.759 -179.584 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 87.45 9.11 73.05 Favored Glycine 0 C--O 1.221 -0.66 0 CA-C-N 115.326 -0.852 . . . . 0.0 113.191 172.865 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 21.8 mmtt -79.6 139.7 37.38 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.184 0.516 . . . . 0.0 109.697 -175.56 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 84.2 mtp -114.75 -167.36 1.21 Allowed 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.794 -177.91 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 57.3 mmtt -144.27 -73.76 0.26 Allowed 'General case' 0 C--O 1.213 -0.819 0 C-N-CA 123.14 0.576 . . . . 0.0 109.476 -177.806 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 30.74 -121.65 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.64 0 O-C-N 125.18 1.55 . . . . 0.0 114.606 179.102 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 59.47 -168.45 0.15 Allowed 'General case' 0 C--N 1.318 -0.766 0 O-C-N 124.772 1.295 . . . . 0.0 112.371 -179.487 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 18.9 m -62.09 153.73 72.77 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.744 179.411 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -65.74 148.57 86.89 Favored 'Trans proline' 0 C--O 1.237 0.447 0 C-N-CA 115.845 -2.303 . . . . 0.0 111.733 178.709 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 31.8 mtp180 -118.61 158.13 26.05 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 -177.653 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 64.2 m95 -120.13 129.58 54.22 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 120.852 0.358 . . . . 0.0 110.436 -179.054 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 24.1 m-85 -110.35 142.21 42.32 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 -178.778 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 85.4 t80 -94.22 136.76 34.16 Favored 'General case' 0 CA--C 1.511 -0.536 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 -178.182 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -139.63 146.56 39.9 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 -177.056 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -81.58 159.51 24.06 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.135 -175.703 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -54.59 131.53 43.22 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.921 0.391 . . . . 0.0 111.786 -179.277 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 71.38 33.71 64.21 Favored Glycine 0 C--O 1.222 -0.618 0 N-CA-C 115.583 0.993 . . . . 0.0 115.583 176.375 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 4.2 p . . . . . 0 C--N 1.326 -0.426 0 CA-C-N 118.135 0.967 . . . . 0.0 110.384 178.64 . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 13.7 mt . . . . . 0 N--CA 1.441 -0.886 0 N-CA-C 114.136 1.162 . . . . 0.0 114.136 . . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -78.63 161.52 27.82 Favored 'Trans proline' 0 N--CA 1.461 -0.398 0 N-CA-C 107.444 -1.791 . . . . 0.0 107.444 167.956 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 58.2 t80 -60.21 132.55 54.28 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 120.187 -0.605 . . . . 0.0 110.226 -178.313 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 91.84 -8.52 78.19 Favored Glycine 0 N--CA 1.452 -0.27 0 CA-C-O 119.193 -0.782 . . . . 0.0 114.712 178.873 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -66.03 129.63 40.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 118.788 1.294 . . . . 0.0 111.171 179.889 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 46.7 t-20 -79.32 128.72 33.69 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.421 -178.542 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 30.5 ttmt -156.18 153.19 28.85 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 107.483 -1.302 . . . . 0.0 107.483 -178.699 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -59.58 125.12 22.38 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.853 0.359 . . . . 0.0 111.807 -178.561 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 68.2 31.39 74.58 Favored Glycine 0 N--CA 1.448 -0.551 0 CA-C-O 119.286 -0.73 . . . . 0.0 113.9 178.262 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 43.4 mm -126.53 128.09 70.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 117.535 0.668 . . . . 0.0 109.954 178.442 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.1 pt -132.75 116.26 26.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 121.53 0.681 . . . . 0.0 110.599 176.555 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 94.8 m95 -82.94 138.45 33.82 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 112.216 0.45 . . . . 0.0 112.216 -177.86 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 16.0 m -137.69 150.91 25.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 178.816 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -160.3 165.33 31.54 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 103.523 -2.769 . . . . 0.0 103.523 179.837 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 14.8 t -125.07 175.82 7.1 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 104.941 -2.244 . . . . 0.0 104.941 178.114 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 -67.52 134.85 52.06 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 -179.826 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 91.49 -8.46 78.88 Favored Glycine 0 C--O 1.228 -0.244 0 CA-C-N 116.123 -0.49 . . . . 0.0 113.536 179.156 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.453 ' HA ' ' HA ' ' A' ' 41' ' ' ASP . . . -71.99 131.9 43.56 Favored 'General case' 0 CA--C 1.542 0.666 0 O-C-N 122.393 -0.475 . . . . 0.0 110.345 179.403 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 23.4 mt -88.91 138.89 31.0 Favored 'General case' 0 CA--C 1.51 -0.569 0 N-CA-C 112.995 0.739 . . . . 0.0 112.995 -177.433 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 56.9 t30 -83.94 72.11 10.45 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.353 -0.839 . . . . 0.0 111.046 179.475 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 2.3 t -143.4 155.38 60.94 Favored Pre-proline 0 C--N 1.324 -0.503 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 178.754 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_exo -67.61 153.25 76.74 Favored 'Trans proline' 0 CA--C 1.514 -0.495 0 CA-C-N 118.454 0.483 . . . . 0.0 113.183 179.175 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -152.02 52.73 0.8 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.928 0.871 . . . . 0.0 111.144 176.59 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -57.55 -26.54 61.57 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 114.918 -1.037 . . . . 0.0 109.972 175.194 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 9.6 p80 -57.18 -12.59 2.35 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 114.643 1.349 . . . . 0.0 114.643 179.198 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 64.2 mt -92.72 -45.19 14.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 178.372 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -70.59 14.72 1.32 Allowed Glycine 0 C--O 1.211 -1.298 0 N-CA-C 117.205 1.642 . . . . 0.0 117.205 -175.414 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 30.8 p -83.04 3.79 28.84 Favored 'General case' 0 CA--C 1.506 -0.718 0 C-N-CA 124.015 0.926 . . . . 0.0 113.249 -174.08 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 67.0 ttp85 -44.36 121.0 2.38 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 114.056 -1.429 . . . . 0.0 110.666 179.655 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 36.5 m120 -90.02 126.09 58.39 Favored Pre-proline 0 C--N 1.322 -0.624 0 N-CA-C 107.675 -1.232 . . . . 0.0 107.675 -179.579 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -69.89 -18.27 36.5 Favored 'Trans proline' 0 C--O 1.219 -0.473 0 C-N-CA 117.015 -1.524 . . . . 0.0 113.045 179.273 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -75.74 -27.95 58.32 Favored 'General case' 0 C--O 1.219 -0.536 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.308 178.125 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 -101.88 -23.96 14.09 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 113.283 0.846 . . . . 0.0 113.283 -175.244 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 26.8 t30 -150.63 148.63 28.86 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.941 0.719 . . . . 0.0 112.941 -178.201 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -87.86 147.33 25.16 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-O 121.521 0.677 . . . . 0.0 111.32 179.419 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -70.02 145.05 52.04 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.554 178.576 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 13.7 mt -83.18 139.06 18.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 -178.744 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 1.4 p -62.05 126.08 19.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 175.721 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 5.7 tt -65.91 128.57 36.56 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.156 0.503 . . . . 0.0 110.3 -176.748 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -132.33 157.55 44.17 Favored 'General case' 0 CA--C 1.509 -0.633 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 -178.73 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 13.7 mt -113.58 148.76 40.42 Favored Pre-proline 0 C--N 1.322 -0.622 0 N-CA-C 108.091 -1.078 . . . . 0.0 108.091 177.059 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -73.43 165.52 32.28 Favored 'Trans proline' 0 N--CA 1.463 -0.314 0 O-C-N 122.227 0.593 . . . . 0.0 112.867 -178.846 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 40.6 tt0 -54.69 130.35 40.15 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.655 -179.682 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 101.38 -22.45 38.91 Favored Glycine 0 C--O 1.224 -0.509 0 CA-C-N 116.043 -0.526 . . . . 0.0 112.838 -179.056 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 9.8 m -108.63 127.26 53.81 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 117.795 0.798 . . . . 0.0 109.456 178.167 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 16.5 p -119.69 148.33 43.51 Favored 'General case' 0 CA--C 1.51 -0.575 0 CA-C-O 121.035 0.445 . . . . 0.0 110.837 -179.398 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 91.8 mt -69.07 152.29 96.82 Favored Pre-proline 0 C--N 1.324 -0.529 0 N-CA-C 107.108 -1.441 . . . . 0.0 107.108 177.678 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -77.67 174.08 13.17 Favored 'Trans proline' 0 N--CA 1.462 -0.37 0 CA-C-O 121.425 0.51 . . . . 0.0 111.782 179.834 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -56.19 129.25 39.37 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.23 -178.487 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 91.65 -4.92 79.78 Favored Glycine 0 C--O 1.226 -0.353 0 N-CA-C 115.601 1.001 . . . . 0.0 115.601 177.063 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -102.39 136.75 41.66 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 117.937 0.868 . . . . 0.0 112.465 -178.068 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 41.5 p90 -143.46 163.14 33.94 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 114.213 -1.358 . . . . 0.0 108.269 174.895 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -103.82 138.0 41.04 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 -176.351 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -66.28 141.83 57.88 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.237 -0.892 . . . . 0.0 108.976 176.288 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 94.81 -32.79 5.79 Favored Glycine 0 N--CA 1.458 0.142 0 C-N-CA 121.604 -0.331 . . . . 0.0 113.366 179.756 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 32.7 t . . . . . 0 C--N 1.325 -0.494 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 177.249 . . . . . . . . 0 0 . 1 . 031 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 0.344 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 . . . . . . . . . 0 0 . 1 . 031 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.432 ' HB3' ' CE1' ' A' ' 71' ' ' TYR . 11.6 p -60.22 139.22 57.7 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.389 178.568 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 47.5 m95 -71.3 -21.93 62.01 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 114.95 1.463 . . . . 0.0 114.95 -178.762 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -121.49 162.07 21.16 Favored 'General case' 0 C--O 1.24 0.562 0 N-CA-C 113.734 1.013 . . . . 0.0 113.734 -173.329 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 77.8 p -68.68 163.39 23.97 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 114.548 -1.206 . . . . 0.0 109.849 179.418 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -86.08 145.57 26.99 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 113.486 0.921 . . . . 0.0 113.486 -175.722 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -94.67 137.77 33.35 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 108.245 -1.021 . . . . 0.0 108.245 173.731 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 62.4 m -87.56 129.28 35.15 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 -179.924 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 16.6 tm0? -91.07 128.32 36.85 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 177.98 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 58.7 t60 -139.25 99.53 3.77 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 172.11 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 173.0 -170.91 44.06 Favored Glycine 0 C--O 1.229 -0.213 0 C-N-CA 120.496 -0.859 . . . . 0.0 111.445 179.511 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -97.66 -25.64 15.04 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 120.686 0.279 . . . . 0.0 110.529 178.631 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -96.5 163.23 13.13 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 105.594 -2.002 . . . . 0.0 105.594 174.631 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -88.62 -62.89 1.39 Allowed 'General case' 0 C--O 1.216 -0.691 0 N-CA-C 115.187 1.551 . . . . 0.0 115.187 -173.926 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 53.4 tp -176.87 142.93 0.41 Allowed 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 178.11 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 23.5 tptm -157.49 141.02 15.65 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 174.226 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 13.7 m-85 -123.92 152.49 66.5 Favored Pre-proline 0 C--O 1.24 0.595 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 175.53 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -70.41 159.09 54.1 Favored 'Trans proline' 0 CA--C 1.538 0.71 0 C-N-CA 120.449 0.766 . . . . 0.0 112.331 177.427 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 15.8 tpt180 -69.27 137.29 52.95 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 -178.377 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 83.85 8.64 84.02 Favored Glycine 0 C--O 1.222 -0.614 0 N-CA-C 111.345 -0.702 . . . . 0.0 111.345 179.082 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 9.1 mt-30 -150.92 170.95 18.06 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 -173.886 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 102.94 -16.67 54.08 Favored Glycine 0 CA--C 1.499 -0.928 0 CA-C-N 116.219 -0.446 . . . . 0.0 112.031 175.756 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 77.9 t -66.07 128.68 93.98 Favored Pre-proline 0 C--N 1.319 -0.759 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 177.144 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -73.46 170.11 20.7 Favored 'Trans proline' 0 N--CA 1.461 -0.435 0 O-C-N 122.201 0.579 . . . . 0.0 112.373 178.404 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 78.5 mt -73.01 112.38 9.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 -179.851 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 48.9 m-20 -109.89 77.29 1.04 Allowed 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 114.622 -1.172 . . . . 0.0 109.406 -177.189 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 71.5 p -65.11 -20.96 66.72 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 115.586 1.698 . . . . 0.0 115.586 -173.658 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 5.5 p30 -113.64 31.05 6.78 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.976 -176.175 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 78.0 p -134.42 166.57 22.55 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.011 0.434 . . . . 0.0 110.839 179.63 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 28.1 m -81.58 160.32 64.72 Favored Pre-proline 0 C--N 1.322 -0.612 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.75 -179.219 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -67.81 -24.23 40.69 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 116.453 -1.898 . . . . 0.0 114.033 -179.461 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -75.52 -12.62 60.26 Favored 'General case' 0 C--N 1.322 -0.592 0 O-C-N 121.562 -0.711 . . . . 0.0 111.264 177.241 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 27.3 t0 -94.84 1.05 55.32 Favored 'General case' 0 C--O 1.214 -0.798 0 N-CA-C 113.328 0.862 . . . . 0.0 113.328 -177.371 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 93.1 mm-40 -62.34 -20.2 64.12 Favored 'General case' 0 CA--C 1.548 0.89 0 O-C-N 121.074 -1.016 . . . . 0.0 111.711 178.965 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 17.5 tt -63.98 140.46 19.65 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-O 122.118 0.961 . . . . 0.0 112.293 177.701 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 178.49 -161.17 27.62 Favored Glycine 0 CA--C 1.502 -0.737 0 C-N-CA 119.794 -1.193 . . . . 0.0 112.781 178.328 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 46.1 p90 -155.24 165.68 35.92 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 178.642 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 19.0 m-85 -106.87 139.68 40.9 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 106.771 -1.566 . . . . 0.0 106.771 175.986 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 42.5 ttt180 -113.47 118.23 33.93 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.08 -174.869 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 26.3 ttt180 -66.47 137.72 57.03 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 176.655 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -137.3 125.65 23.32 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.733 0.777 . . . . 0.0 111.465 179.923 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 37.7 p -136.74 154.28 50.63 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 106.079 -1.823 . . . . 0.0 106.079 177.128 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 65.1 ttt180 -159.73 124.04 3.85 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 121.06 -0.256 . . . . 0.0 110.486 177.399 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.35 144.33 51.32 Favored 'General case' 0 CA--C 1.484 -1.581 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 175.647 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -142.47 175.23 4.77 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.132 0 N-CA-C 105.854 -1.906 . . . . 0.0 105.854 179.023 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 78.0 ttt180 -119.67 128.89 54.25 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 102.466 -3.161 . . . . 0.0 102.466 171.14 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -80.89 -176.8 51.03 Favored Glycine 0 C--O 1.221 -0.667 0 N-CA-C 110.796 -0.922 . . . . 0.0 110.796 -179.784 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -78.75 -34.29 35.21 Favored Glycine 0 C--O 1.216 -1.005 0 N-CA-C 107.886 -2.086 . . . . 0.0 107.886 179.385 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -71.38 -20.69 62.11 Favored 'General case' 0 C--O 1.217 -0.655 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 175.184 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 108.43 -15.52 35.42 Favored Glycine 0 CA--C 1.503 -0.696 0 N-CA-C 110.351 -1.1 . . . . 0.0 110.351 172.593 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.8 144.57 57.16 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-O 122.394 1.092 . . . . 0.0 112.294 -177.96 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 5.4 mtp -87.8 175.08 8.0 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 114.01 -1.45 . . . . 0.0 112.57 -177.184 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 1.6 tmtm? -78.4 -46.04 20.87 Favored 'General case' 0 C--O 1.217 -0.642 0 CA-C-O 121.949 0.881 . . . . 0.0 109.797 176.915 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.2 t0 47.39 24.85 0.51 Allowed 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 119.054 2.983 . . . . 0.0 119.054 178.573 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.6 mp -83.45 149.01 26.93 Favored 'General case' 0 C--O 1.239 0.528 0 O-C-N 121.397 -0.814 . . . . 0.0 111.752 178.543 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -66.71 158.42 79.65 Favored Pre-proline 0 C--O 1.243 0.738 0 CA-C-N 115.395 -0.82 . . . . 0.0 111.909 178.834 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -71.44 147.21 51.87 Favored 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 118.126 -0.782 . . . . 0.0 112.582 177.585 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 1.2 mtt180 -134.14 165.81 24.22 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.998 176.228 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 62.5 m95 -121.89 135.03 54.86 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 176.328 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -112.83 171.77 7.33 Favored 'General case' 0 C--O 1.215 -0.738 0 N-CA-C 105.891 -1.892 . . . . 0.0 105.891 178.142 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -118.4 139.47 51.34 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 178.673 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.432 ' CE1' ' HB3' ' A' ' 11' ' ' SER . 14.2 m-85 -139.06 139.33 37.74 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 -176.545 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 45.3 m-85 -68.67 159.51 32.0 Favored 'General case' 0 C--O 1.24 0.585 0 N-CA-C 110.013 -0.366 . . . . 0.0 110.013 177.14 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 19.7 tp -53.4 130.56 35.74 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 121.18 0.514 . . . . 0.0 112.229 -178.515 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 67.49 28.41 73.6 Favored Glycine 0 C--O 1.223 -0.573 0 N-CA-C 116.269 1.268 . . . . 0.0 116.269 174.636 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 16.2 p . . . . . 0 C--N 1.324 -0.528 0 CA-C-N 118.262 1.031 . . . . 0.0 110.409 177.927 . . . . . . . . 0 0 . 1 . 031 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 18.1 mt . . . . . 0 N--CA 1.448 -0.543 0 N-CA-C 115.939 1.829 . . . . 0.0 115.939 . . . . . . . . . 0 0 . 1 . 031 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -78.76 164.01 25.87 Favored 'Trans proline' 0 N--CA 1.462 -0.344 0 C-N-CA 122.42 2.08 . . . . 0.0 108.176 168.274 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 56.2 t80 -62.08 132.29 52.38 Favored 'General case' 0 C--N 1.321 -0.642 0 O-C-N 121.947 -0.471 . . . . 0.0 110.627 -177.698 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 90.4 -6.17 82.43 Favored Glycine 0 C--O 1.227 -0.29 0 N-CA-C 114.528 0.571 . . . . 0.0 114.528 179.131 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -65.15 132.04 48.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 118.242 1.021 . . . . 0.0 111.821 179.677 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 50.5 t30 -78.68 127.31 31.92 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.523 179.403 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 28.2 ttmt -156.19 152.14 27.48 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 106.266 -1.753 . . . . 0.0 106.266 178.578 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 19.1 t0 -64.55 131.83 48.14 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 -179.249 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 69.66 28.84 71.71 Favored Glycine 0 N--CA 1.446 -0.655 0 N-CA-C 114.958 0.743 . . . . 0.0 114.958 177.116 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 42.7 mm -127.89 128.15 68.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 117.401 0.6 . . . . 0.0 109.985 179.044 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.1 pt -131.58 123.62 52.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.351 176.98 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 97.8 m95 -88.39 135.57 33.4 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 114.149 1.166 . . . . 0.0 114.149 -175.304 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 17.8 m -136.16 152.03 29.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 178.778 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -163.97 166.6 21.44 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 103.514 -2.773 . . . . 0.0 103.514 -179.969 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 13.3 t -134.53 174.72 10.24 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 104.78 -2.304 . . . . 0.0 104.78 177.675 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 78.2 tt0 -66.71 135.21 53.67 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.185 0.516 . . . . 0.0 109.999 -178.955 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 95.75 -9.72 68.56 Favored Glycine 0 C--O 1.228 -0.234 0 CA-C-N 115.93 -0.577 . . . . 0.0 113.623 178.635 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -76.78 137.95 39.6 Favored 'General case' 0 CA--C 1.54 0.571 0 O-C-N 122.323 -0.516 . . . . 0.0 109.859 179.457 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 32.3 mt -92.56 140.29 29.7 Favored 'General case' 0 C--O 1.22 -0.471 0 CA-C-O 121.555 0.693 . . . . 0.0 112.324 -178.236 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 61.3 t30 -85.04 66.59 9.83 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.498 -0.773 . . . . 0.0 110.518 -179.037 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -136.37 152.84 75.73 Favored Pre-proline 0 C--N 1.324 -0.502 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 -179.527 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -68.45 150.87 75.94 Favored 'Trans proline' 0 C--N 1.344 0.326 0 N-CA-C 115.249 1.211 . . . . 0.0 115.249 178.779 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 67.5 mmtt -127.12 31.61 5.22 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.189 -0.914 . . . . 0.0 113.32 -176.339 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 18.1 t0 -60.98 -27.56 68.37 Favored 'General case' 0 N--CA 1.475 0.789 0 O-C-N 121.287 -0.883 . . . . 0.0 111.616 -178.135 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 47.2 p-80 -67.95 -16.78 64.22 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.806 177.853 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 66.3 mt -94.25 -38.56 9.45 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 176.078 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -72.96 6.73 11.72 Favored Glycine 0 C--O 1.225 -0.429 0 N-CA-C 115.668 1.027 . . . . 0.0 115.668 -178.214 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 14.5 t -83.05 25.44 0.69 Allowed 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 117.785 0.792 . . . . 0.0 111.684 -178.862 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.401 ' HD2' ' OD1' ' A' ' 114' ' ' ASN . 65.3 ttp85 -57.45 131.82 51.29 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.949 -179.42 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 55.1 m-20 -99.65 115.1 65.89 Favored Pre-proline 0 C--N 1.326 -0.423 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 178.804 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -72.8 -12.54 26.47 Favored 'Trans proline' 0 C--O 1.218 -0.518 0 N-CA-C 114.089 0.765 . . . . 0.0 114.089 -177.352 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -74.87 -24.56 58.58 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 176.042 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 -102.19 -30.78 10.92 Favored 'General case' 0 C--O 1.222 -0.344 0 N-CA-C 113.012 0.745 . . . . 0.0 113.012 -176.036 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . 0.401 ' OD1' ' HD2' ' A' ' 109' ' ' ARG . 0.9 OUTLIER -132.07 150.26 52.2 Favored 'General case' 0 N--CA 1.44 -0.937 0 CA-C-O 121.279 0.561 . . . . 0.0 112.265 -177.186 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -100.65 138.4 37.75 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 175.701 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -66.33 150.01 49.51 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.303 0.573 . . . . 0.0 111.722 -179.191 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 3.1 mt -87.96 141.48 14.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.669 -177.323 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 1.3 p -62.22 125.92 19.47 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 176.211 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 7.0 tt -70.07 129.62 39.92 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.25 -178.055 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 25.6 mt-30 -131.71 159.49 38.25 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 106.47 -1.678 . . . . 0.0 106.47 179.378 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 14.2 mt -114.37 146.09 35.12 Favored Pre-proline 0 C--N 1.323 -0.561 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 177.98 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -74.63 172.07 16.94 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 120.228 0.619 . . . . 0.0 113.678 -178.547 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 6.0 tp-100 -53.65 137.07 38.13 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.753 179.42 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 89.82 -20.71 34.04 Favored Glycine 0 N--CA 1.453 -0.229 0 CA-C-N 115.927 -0.579 . . . . 0.0 113.733 -179.11 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 3.9 m -108.56 129.81 55.3 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 118.274 1.037 . . . . 0.0 111.143 -179.995 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 2.3 p -125.87 148.27 49.23 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 -178.951 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 91.0 mt -68.93 154.57 94.82 Favored Pre-proline 0 C--N 1.327 -0.38 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 178.357 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -75.57 170.55 20.0 Favored 'Trans proline' 0 N--CA 1.463 -0.296 0 C-N-CA 118.342 -0.639 . . . . 0.0 111.48 -179.615 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -60.2 129.16 40.34 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 179.253 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 89.73 21.34 40.34 Favored Glycine 0 C--O 1.225 -0.444 0 C-N-CA 120.904 -0.665 . . . . 0.0 114.734 178.835 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -131.15 141.76 50.14 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 117.472 0.636 . . . . 0.0 111.651 178.115 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 51.8 p90 -150.47 163.79 37.53 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 175.508 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -107.35 147.25 30.56 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 113.396 0.887 . . . . 0.0 113.396 -175.826 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -73.52 142.7 46.72 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.091 -0.959 . . . . 0.0 109.666 177.206 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 93.38 -39.56 2.93 Favored Glycine 0 CA--C 1.519 0.298 0 N-CA-C 114.169 0.428 . . . . 0.0 114.169 178.665 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.445 -0.698 0 CA-C-O 121.854 0.835 . . . . 0.0 111.425 178.514 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.849 0 CA-C-O 121.422 0.629 . . . . 0.0 109.668 . . . . . . . . . 0 0 . 1 . 032 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 61.6 p -58.14 141.53 50.05 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.213 -0.903 . . . . 0.0 109.882 179.108 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . 0.432 ' CD2' ' HD3' ' A' ' 109' ' ' ARG . 23.9 m95 -65.65 -26.44 67.8 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.769 178.213 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 78.0 m-85 -121.74 162.87 20.04 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.302 0.572 . . . . 0.0 112.379 -174.235 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 73.1 p -71.44 164.86 24.99 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 176.529 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -77.74 157.04 30.23 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.855 0.836 . . . . 0.0 113.219 -177.672 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 25.0 mt -92.39 148.91 21.74 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 102.919 -2.993 . . . . 0.0 102.919 168.005 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 33.2 m -121.36 128.5 52.31 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 120.897 0.379 . . . . 0.0 110.396 -178.03 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 1.9 tm0? -90.42 130.03 36.54 Favored 'General case' 0 CA--C 1.512 -0.501 0 CA-C-N 115.567 -0.742 . . . . 0.0 112.82 -177.554 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 52.9 t60 -138.76 99.9 3.92 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 106.354 -1.721 . . . . 0.0 106.354 167.217 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 159.58 -140.86 7.09 Favored Glycine 0 C--N 1.323 -0.181 0 C-N-CA 119.589 -1.291 . . . . 0.0 113.813 -176.969 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -115.71 -27.18 7.15 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 114.875 1.435 . . . . 0.0 114.875 -177.692 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -78.46 151.96 32.37 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 177.403 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -79.13 -57.55 3.67 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 179.197 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 41.9 tp 175.96 135.16 0.05 OUTLIER 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 101.254 -3.61 . . . . 0.0 101.254 171.103 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 11.2 tmtt? -154.22 133.23 12.43 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 179.448 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 21.8 m-85 -122.33 153.3 61.89 Favored Pre-proline 0 C--O 1.241 0.636 0 O-C-N 123.023 0.202 . . . . 0.0 111.44 176.726 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -74.51 159.91 42.3 Favored 'Trans proline' 0 CA--C 1.538 0.702 0 CA-C-O 120.935 0.306 . . . . 0.0 111.768 175.727 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 17.0 tpt180 -70.71 139.75 51.25 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 -178.411 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 87.05 2.11 84.0 Favored Glycine 0 C--O 1.221 -0.687 0 N-CA-C 110.707 -0.957 . . . . 0.0 110.707 179.524 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 30.6 mt-30 -146.69 -179.66 6.94 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 -174.797 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 99.36 -20.26 50.54 Favored Glycine 0 CA--C 1.498 -0.987 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.714 176.232 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 86.8 t -67.92 126.87 93.16 Favored Pre-proline 0 C--N 1.317 -0.818 0 N-CA-C 106.703 -1.592 . . . . 0.0 106.703 177.295 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -73.28 167.53 27.08 Favored 'Trans proline' 0 N--CA 1.46 -0.485 0 C-N-CA 120.111 0.541 . . . . 0.0 112.494 178.649 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 85.6 mt -67.25 111.74 2.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 122.023 0.916 . . . . 0.0 109.352 -178.869 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 26.6 m-20 -94.82 100.79 12.62 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 114.394 -1.276 . . . . 0.0 110.157 -177.973 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 80.7 p -80.52 -20.32 43.8 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 113.912 1.078 . . . . 0.0 113.912 -176.901 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -117.45 3.66 12.49 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 115.411 1.634 . . . . 0.0 115.411 -174.486 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -110.77 157.27 19.97 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 115.756 1.761 . . . . 0.0 115.756 -171.926 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 47.6 m -79.23 162.77 62.76 Favored Pre-proline 0 C--N 1.318 -0.783 0 CA-C-N 113.896 -1.502 . . . . 0.0 108.845 177.937 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -67.48 -20.66 47.56 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 116.986 -1.543 . . . . 0.0 114.878 -177.46 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.406 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 6.2 p-10 -75.21 -20.39 59.3 Favored 'General case' 0 C--N 1.321 -0.637 0 O-C-N 121.74 -0.6 . . . . 0.0 111.075 178.359 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -88.79 0.87 56.1 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 114.394 1.257 . . . . 0.0 114.394 -174.746 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 94.4 mm-40 -62.45 -29.03 70.23 Favored 'General case' 0 C--N 1.316 -0.876 0 O-C-N 121.062 -1.024 . . . . 0.0 111.526 -179.382 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 13.3 tt -64.93 139.04 22.07 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.771 0 CA-C-O 122.009 0.909 . . . . 0.0 112.112 178.419 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 176.46 -158.97 25.65 Favored Glycine 0 CA--C 1.509 -0.305 0 C-N-CA 120.401 -0.904 . . . . 0.0 111.969 -177.722 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 42.8 p90 -155.04 169.97 22.86 Favored 'General case' 0 C--N 1.32 -0.715 0 O-C-N 122.458 -0.436 . . . . 0.0 109.996 -179.788 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 10.6 m-85 -112.73 138.04 50.13 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 173.43 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.06 119.12 38.38 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 123.896 0.878 . . . . 0.0 109.733 -179.26 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 49.5 ttp180 -65.7 134.28 52.88 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 174.765 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -143.74 147.82 34.75 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.844 0.354 . . . . 0.0 110.814 -178.072 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 5.8 p -148.36 139.83 23.52 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 175.623 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 12.4 tpt180 -130.34 133.69 46.62 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 173.55 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 2.7 tpp180 -147.32 148.31 31.26 Favored 'General case' 0 CA--C 1.487 -1.463 0 CA-C-O 121.51 0.671 . . . . 0.0 110.77 -176.169 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -138.4 177.14 5.56 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.922 0 N-CA-C 103.715 -2.698 . . . . 0.0 103.715 178.9 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 48.1 ttp180 -138.77 117.09 11.92 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 177.578 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -100.48 155.8 19.43 Favored Glycine 0 C--O 1.222 -0.656 0 N-CA-C 108.146 -1.982 . . . . 0.0 108.146 177.787 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -75.27 -24.55 70.78 Favored Glycine 0 C--O 1.22 -0.731 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 178.458 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.4 p30 -83.28 -20.36 34.6 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 114.469 -0.865 . . . . 0.0 110.235 177.334 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 110.12 8.46 25.53 Favored Glycine 0 C--O 1.227 -0.307 0 N-CA-C 114.78 0.672 . . . . 0.0 114.78 173.136 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 10.6 pttt -66.01 137.23 56.97 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 122.319 1.057 . . . . 0.0 111.83 179.399 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 99.1 mmm -118.9 172.29 7.64 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 113.234 -1.803 . . . . 0.0 108.844 -178.929 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 14.2 tppt? -116.35 -66.56 1.07 Allowed 'General case' 0 C--O 1.219 -0.552 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 177.636 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -107.09 147.64 29.76 Favored 'General case' 0 CA--C 1.506 -0.722 0 N-CA-C 105.552 -2.018 . . . . 0.0 105.552 176.201 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -113.45 -47.07 3.02 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 105.657 -1.979 . . . . 0.0 105.657 175.616 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -102.38 151.82 38.23 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-N 114.867 -1.061 . . . . 0.0 110.378 179.205 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -64.07 150.73 87.74 Favored 'Trans proline' 0 C--N 1.35 0.658 0 O-C-N 122.033 0.491 . . . . 0.0 113.079 176.441 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 90.6 mtt-85 -116.7 159.21 22.59 Favored 'General case' 0 C--O 1.222 -0.394 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 178.748 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 53.7 m95 -137.33 125.38 22.86 Favored 'General case' 0 C--O 1.214 -0.765 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 174.77 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 59.9 m-85 -110.43 142.67 41.83 Favored 'General case' 0 C--O 1.216 -0.671 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 -177.08 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 81.1 t80 -93.01 135.95 33.72 Favored 'General case' 0 CA--C 1.507 -0.708 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 -176.142 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -139.01 137.72 36.58 Favored 'General case' 0 N--CA 1.441 -0.911 0 CA-C-N 114.739 -1.119 . . . . 0.0 109.195 -175.246 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 27.3 m-85 -67.74 159.39 30.27 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.71 179.065 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -50.46 122.53 7.19 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 113.743 1.016 . . . . 0.0 113.743 -177.258 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 68.53 22.13 74.88 Favored Glycine 0 C--O 1.226 -0.351 0 N-CA-C 116.193 1.237 . . . . 0.0 116.193 176.028 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 33.8 p . . . . . 0 C--N 1.325 -0.495 0 CA-C-N 118.351 1.075 . . . . 0.0 111.017 179.306 . . . . . . . . 0 0 . 1 . 032 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 16.4 mt . . . . . 0 N--CA 1.442 -0.839 0 N-CA-C 116.289 1.959 . . . . 0.0 116.289 . . . . . . . . . 0 0 . 1 . 032 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -78.46 160.81 28.67 Favored 'Trans proline' 0 C--O 1.233 0.227 0 C-N-CA 122.337 2.025 . . . . 0.0 107.417 167.949 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 60.3 t80 -60.85 132.76 54.89 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 120.291 -0.564 . . . . 0.0 110.957 -176.855 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 90.04 -6.53 82.65 Favored Glycine 0 N--CA 1.453 -0.215 0 CA-C-O 119.484 -0.62 . . . . 0.0 114.177 179.452 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -66.17 130.52 43.51 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 118.533 1.167 . . . . 0.0 111.332 179.459 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 52.5 t30 -80.86 128.54 33.79 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.332 -0.849 . . . . 0.0 109.091 179.431 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 27.7 ttmt -156.21 158.9 38.39 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 107.375 -1.343 . . . . 0.0 107.375 -178.921 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -54.67 122.34 10.43 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.053 0.39 . . . . 0.0 112.053 179.33 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 64.49 35.66 92.22 Favored Glycine 0 N--CA 1.448 -0.527 0 CA-C-O 119.189 -0.784 . . . . 0.0 114.376 174.436 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 49.4 mm -121.06 126.0 74.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 117.631 0.715 . . . . 0.0 110.939 179.225 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -126.92 117.73 48.56 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.706 176.254 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 97.5 m95 -85.38 136.3 33.52 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 -177.72 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 16.5 m -134.77 155.17 38.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 178.8 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -165.68 165.32 18.75 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 -178.373 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 12.3 t -130.42 168.32 17.18 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 104.969 -2.234 . . . . 0.0 104.969 174.107 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 76.6 tt0 -67.39 137.82 56.24 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.342 0.592 . . . . 0.0 110.88 -178.777 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 94.91 -10.58 70.21 Favored Glycine 0 C--O 1.229 -0.162 0 CA-C-N 115.662 -0.699 . . . . 0.0 113.093 177.578 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.406 ' HA ' ' HA ' ' A' ' 41' ' ' ASP . . . -78.75 118.4 20.78 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-O 120.974 0.416 . . . . 0.0 111.149 -179.938 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -68.6 133.42 48.47 Favored 'General case' 0 CA--C 1.51 -0.593 0 N-CA-C 114.101 1.148 . . . . 0.0 114.101 -177.628 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 46.9 t30 -83.26 76.23 9.9 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 113.825 -1.534 . . . . 0.0 109.062 178.776 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 1.4 t -146.44 155.36 49.61 Favored Pre-proline 0 C--N 1.322 -0.615 0 N-CA-C 106.053 -1.832 . . . . 0.0 106.053 -177.88 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -61.56 150.16 86.6 Favored 'Trans proline' 0 C--N 1.345 0.346 0 N-CA-C 115.446 1.287 . . . . 0.0 115.446 178.475 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 71.9 mmtt -123.29 30.47 6.3 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.748 -179.983 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 15.4 p-10 -51.34 -42.91 61.58 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.897 -0.592 . . . . 0.0 112.174 -176.914 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 15.6 p80 -68.5 -11.38 59.76 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 113.962 1.097 . . . . 0.0 113.962 -179.652 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 28.1 mt -95.54 -43.28 12.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 121.7 0.762 . . . . 0.0 110.488 178.826 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -72.8 4.03 24.38 Favored Glycine 0 C--O 1.221 -0.717 0 N-CA-C 116.119 1.208 . . . . 0.0 116.119 -176.543 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 13.1 t -83.38 25.78 0.71 Allowed 'General case' 0 CA--C 1.543 0.711 0 CA-C-O 121.492 0.663 . . . . 0.0 111.497 179.57 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.438 ' HD2' HD22 ' A' ' 114' ' ' ASN . 63.6 ttp85 -58.51 129.19 40.88 Favored 'General case' 0 CA--C 1.517 -0.319 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 -179.786 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 34.2 m120 -89.71 121.77 68.74 Favored Pre-proline 0 C--N 1.322 -0.617 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 -177.397 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -72.89 -15.22 26.5 Favored 'Trans proline' 0 C--O 1.218 -0.492 0 C-N-CA 116.789 -1.674 . . . . 0.0 112.188 178.95 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -77.03 -28.98 55.09 Favored 'General case' 0 C--O 1.221 -0.447 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.182 178.199 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 84.7 m-20 -102.69 -22.63 13.92 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 113.673 0.99 . . . . 0.0 113.673 -175.12 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . 0.438 HD22 ' HD2' ' A' ' 109' ' ' ARG . 37.6 t30 -140.23 153.48 46.57 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 -177.852 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -95.55 143.73 26.61 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-O 121.264 0.554 . . . . 0.0 110.358 178.298 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -72.88 149.25 43.65 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.315 0.578 . . . . 0.0 110.9 178.893 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 8.9 mt -84.69 136.93 21.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.213 -178.817 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 78.7 t -62.27 121.97 11.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 N-CA-C 106.037 -1.838 . . . . 0.0 106.037 174.927 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 5.9 tt -67.04 130.27 42.58 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.095 0.474 . . . . 0.0 111.338 -176.145 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 31.5 mt-30 -134.48 158.56 43.62 Favored 'General case' 0 CA--C 1.513 -0.475 0 N-CA-C 106.751 -1.574 . . . . 0.0 106.751 -179.607 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 13.2 mt -112.24 147.15 36.36 Favored Pre-proline 0 C--N 1.322 -0.592 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 177.637 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -73.96 165.64 31.59 Favored 'Trans proline' 0 C--N 1.346 0.408 0 O-C-N 122.168 0.562 . . . . 0.0 113.059 -179.92 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 58.3 tp60 -53.85 130.18 36.23 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.296 -0.865 . . . . 0.0 109.453 179.381 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 103.4 -24.2 30.78 Favored Glycine 0 C--O 1.226 -0.355 0 CA-C-N 115.618 -0.719 . . . . 0.0 112.767 -179.376 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 4.7 m -103.54 129.7 50.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 118.307 1.053 . . . . 0.0 111.958 178.844 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 3.7 p -117.37 148.12 42.03 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.309 -0.859 . . . . 0.0 109.569 179.126 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 82.5 mt -70.52 157.38 90.2 Favored Pre-proline 0 C--N 1.323 -0.545 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 177.566 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -73.06 173.09 14.2 Favored 'Trans proline' 0 C--O 1.236 0.42 0 N-CA-C 110.111 -0.765 . . . . 0.0 110.111 178.395 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -68.71 122.83 19.35 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 119.704 -0.798 . . . . 0.0 111.192 -173.605 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 90.08 45.85 4.34 Favored Glycine 0 N--CA 1.452 -0.279 0 CA-C-N 115.1 -0.954 . . . . 0.0 113.877 -179.886 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -141.93 150.0 40.89 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 117.265 0.532 . . . . 0.0 111.765 179.016 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 42.3 p90 -150.69 166.11 31.36 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 175.718 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -100.63 147.03 26.43 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.031 0.443 . . . . 0.0 111.137 -178.481 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -70.51 136.8 49.67 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 179.296 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 86.52 -30.93 4.34 Favored Glycine 0 C--O 1.227 -0.295 0 CA-C-N 116.21 -0.45 . . . . 0.0 112.777 -177.699 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 19.6 t . . . . . 0 C--N 1.325 -0.486 0 O-C-N 122.117 -0.637 . . . . 0.0 110.404 -179.132 . . . . . . . . 0 0 . 1 . 033 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 0.243 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 . . . . . . . . . 0 0 . 1 . 033 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 54.2 p -59.54 144.3 47.75 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 178.876 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 24.8 m95 -65.56 -21.9 66.65 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.574 0.583 . . . . 0.0 112.574 178.809 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 12.7 m-85 -121.43 163.33 18.92 Favored 'General case' 0 CA--C 1.507 -0.673 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 -170.562 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 72.0 p -70.47 165.36 22.74 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 114.517 -1.219 . . . . 0.0 107.794 177.35 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -80.04 149.57 30.66 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.561 0.696 . . . . 0.0 112.004 -177.853 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 13.9 mt -85.83 145.07 27.37 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 102.416 -3.179 . . . . 0.0 102.416 169.362 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 65.0 m -120.46 141.28 50.33 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 -179.256 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . 0.439 ' HB2' ' CZ ' ' A' ' 131' ' ' PHE . 4.4 tp60 -111.04 136.03 50.65 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -177.091 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 60.1 t60 -132.06 99.47 4.74 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 103.42 -2.807 . . . . 0.0 103.42 168.612 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 171.79 -167.03 40.04 Favored Glycine 0 N--CA 1.451 -0.328 0 N-CA-C 110.254 -1.138 . . . . 0.0 110.254 -175.479 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 49.8 mtpt -102.61 -27.25 12.85 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 115.126 1.528 . . . . 0.0 115.126 -177.454 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -85.71 166.28 16.26 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 -179.982 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -77.19 -62.91 1.5 Allowed 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.698 -178.708 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 29.3 tp 178.64 140.01 0.1 Allowed 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 104.864 -2.273 . . . . 0.0 104.864 175.474 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 44.0 tptt -148.18 135.31 20.3 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.064 0.459 . . . . 0.0 110.825 175.282 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -125.3 155.08 71.99 Favored Pre-proline 0 C--O 1.243 0.739 0 N-CA-C 105.594 -2.002 . . . . 0.0 105.594 174.852 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -71.58 173.13 13.0 Favored 'Trans proline' 0 C--N 1.347 0.485 0 CA-C-O 121.88 0.7 . . . . 0.0 113.652 -179.067 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 52.9 tpt85 -77.48 123.87 27.15 Favored 'General case' 0 C--O 1.217 -0.651 0 O-C-N 121.377 -0.827 . . . . 0.0 109.703 179.886 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 85.51 10.64 76.49 Favored Glycine 0 C--O 1.223 -0.569 0 CA-C-N 115.122 -0.945 . . . . 0.0 115.264 176.346 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.534 HE22 HG21 ' A' ' 125' ' ' THR . 18.9 tt0 -157.54 143.35 17.43 Favored 'General case' 0 C--O 1.219 -0.545 0 N-CA-C 106.747 -1.575 . . . . 0.0 106.747 -179.418 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 139.37 -13.32 3.25 Favored Glycine 0 CA--C 1.507 -0.428 0 C-N-CA 120.274 -0.965 . . . . 0.0 113.652 178.205 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 34.6 m -71.8 144.96 88.86 Favored Pre-proline 0 C--N 1.322 -0.616 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 177.898 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -76.92 171.62 17.66 Favored 'Trans proline' 0 N--CA 1.46 -0.441 0 C-N-CA 121.621 1.548 . . . . 0.0 113.203 179.685 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 94.8 mt -75.05 115.75 16.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 121.578 0.704 . . . . 0.0 109.369 178.893 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -94.63 85.01 4.38 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 107.243 -1.391 . . . . 0.0 107.243 178.113 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 73.4 p -61.64 -21.82 64.73 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 115.971 1.841 . . . . 0.0 115.971 -173.79 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -114.25 16.31 17.98 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 113.376 0.88 . . . . 0.0 113.376 -176.556 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.4 m -132.55 172.55 12.36 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 115.94 1.83 . . . . 0.0 115.94 -174.857 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 42.0 m -82.0 159.18 66.2 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 115.218 -0.901 . . . . 0.0 112.525 -176.273 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -67.28 -19.69 49.86 Favored 'Trans proline' 0 C--N 1.351 0.675 0 C-N-CA 117.219 -1.388 . . . . 0.0 114.279 -179.548 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.3 -24.15 62.09 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 121.746 -0.596 . . . . 0.0 110.776 177.898 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -85.11 -10.73 56.47 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 116.021 1.86 . . . . 0.0 116.021 -170.939 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 85.0 mm-40 -56.93 -26.59 59.75 Favored 'General case' 0 C--O 1.217 -0.631 0 N-CA-C 113.807 1.039 . . . . 0.0 113.807 -173.151 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 14.0 tt -62.12 139.42 20.88 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 CA-C-O 122.313 1.054 . . . . 0.0 112.875 178.539 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 177.68 -152.66 12.1 Favored Glycine 0 CA--C 1.505 -0.563 0 C-N-CA 120.402 -0.904 . . . . 0.0 110.994 -178.975 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 51.3 p90 -155.06 169.38 24.25 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 178.685 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 35.9 m-85 -111.34 143.4 42.19 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 106.764 -1.569 . . . . 0.0 106.764 173.983 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 71.7 ttt-85 -117.48 124.4 48.68 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 123.744 0.817 . . . . 0.0 111.595 -177.694 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 2.1 ptm180 -71.03 146.2 49.5 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.203 0.525 . . . . 0.0 110.525 179.412 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -146.24 144.86 30.15 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.419 0.628 . . . . 0.0 110.736 179.108 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 41.1 p -142.99 171.61 13.82 Favored 'General case' 0 C--O 1.249 1.034 0 N-CA-C 104.364 -2.458 . . . . 0.0 104.364 175.451 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -140.65 123.9 16.7 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 122.004 -0.435 . . . . 0.0 111.55 176.25 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 4.6 tmt_? -140.78 137.01 33.05 Favored 'General case' 0 CA--C 1.496 -1.109 0 CA-C-O 121.611 0.72 . . . . 0.0 110.562 -178.568 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -140.24 -179.38 2.0 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 N-CA-C 105.949 -1.871 . . . . 0.0 105.949 -179.453 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 6.3 ttm180 -128.94 119.25 24.02 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 175.216 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -80.72 -179.87 53.14 Favored Glycine 0 C--O 1.224 -0.476 0 N-CA-C 108.481 -1.847 . . . . 0.0 108.481 176.243 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -63.63 -46.96 90.93 Favored Glycine 0 C--O 1.219 -0.827 0 CA-C-N 118.343 1.072 . . . . 0.0 112.625 -178.463 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -75.8 -8.41 56.8 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 121.724 0.774 . . . . 0.0 110.11 178.995 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 104.43 -13.77 51.05 Favored Glycine 0 CA--C 1.51 -0.269 0 CA-C-N 115.32 -0.855 . . . . 0.0 111.501 178.875 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 12.0 pttt -56.37 136.59 53.54 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-O 122.112 0.958 . . . . 0.0 110.795 -178.877 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 15.0 ptm -132.05 165.76 23.26 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 114.375 -1.284 . . . . 0.0 114.127 -173.698 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 40.2 mttt -77.08 -60.13 2.49 Favored 'General case' 0 C--O 1.212 -0.903 0 N-CA-C 114.623 1.342 . . . . 0.0 114.623 -176.182 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 52.97 48.04 23.3 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 113.785 1.031 . . . . 0.0 113.785 178.509 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.4 mp -60.97 141.97 56.88 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.389 179.951 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 59.3 p -55.39 148.97 30.11 Favored Pre-proline 0 C--O 1.25 1.086 0 CA-C-N 115.071 -0.968 . . . . 0.0 111.753 -176.903 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -65.22 138.71 57.2 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 117.529 -1.18 . . . . 0.0 112.813 -176.979 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 5.4 ptp180 -141.38 155.78 45.88 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.425 -1.261 . . . . 0.0 108.517 -178.834 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 48.0 m95 -123.64 137.9 54.64 Favored 'General case' 0 C--N 1.318 -0.777 0 C-N-CA 122.671 0.389 . . . . 0.0 110.494 -176.16 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 29.5 m-85 -114.84 139.4 49.79 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 -179.464 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 88.5 t80 -88.49 135.94 33.24 Favored 'General case' 0 CA--C 1.505 -0.77 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 -178.825 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -139.73 139.13 36.45 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 -176.054 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 64.6 m-85 -71.21 159.47 34.59 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.351 -0.84 . . . . 0.0 112.326 -175.117 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -54.84 126.76 25.59 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.843 -179.624 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 68.61 38.21 85.88 Favored Glycine 0 C--O 1.218 -0.85 0 N-CA-C 115.482 0.953 . . . . 0.0 115.482 176.59 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.327 -0.411 0 CA-C-N 118.927 1.364 . . . . 0.0 107.985 178.058 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 17.8 mt . . . . . 0 N--CA 1.447 -0.623 0 N-CA-C 114.249 1.203 . . . . 0.0 114.249 . . . . . . . . . 0 0 . 1 . 033 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -78.86 165.16 24.7 Favored 'Trans proline' 0 C--O 1.237 0.431 0 C-N-CA 121.817 1.678 . . . . 0.0 108.414 170.239 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 61.4 t80 -61.6 131.17 49.16 Favored 'General case' 0 C--N 1.321 -0.654 0 C-N-CA 120.445 -0.502 . . . . 0.0 109.855 -179.958 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 92.45 -5.31 77.45 Favored Glycine 0 C--O 1.227 -0.315 0 N-CA-C 114.775 0.67 . . . . 0.0 114.775 178.806 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -65.57 126.76 29.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 118.412 1.106 . . . . 0.0 111.966 179.127 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 70.3 m-20 -71.97 126.79 30.64 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 114.624 -1.171 . . . . 0.0 110.335 -178.579 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 13.7 ttmm -156.12 151.35 26.62 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 178.564 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -62.55 131.05 47.8 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.274 178.931 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 68.46 27.86 73.55 Favored Glycine 0 N--CA 1.452 -0.275 0 N-CA-C 115.395 0.918 . . . . 0.0 115.395 177.809 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 39.3 mm -129.33 131.35 67.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 117.35 0.575 . . . . 0.0 110.494 -179.999 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.1 pt -131.48 114.85 26.67 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 CA-C-O 121.495 0.665 . . . . 0.0 110.774 175.643 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 95.7 m95 -82.24 135.13 35.29 Favored 'General case' 0 C--N 1.321 -0.662 0 O-C-N 121.831 -0.543 . . . . 0.0 112.227 -177.604 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -142.1 152.02 18.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.824 -0.626 . . . . 0.0 109.312 -178.525 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -155.98 166.59 33.02 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 105.646 -1.983 . . . . 0.0 105.646 -177.826 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 11.6 t -134.38 173.83 11.19 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 105.973 -1.862 . . . . 0.0 105.973 176.263 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -66.57 138.02 57.18 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.343 0.592 . . . . 0.0 110.925 -179.603 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 95.05 -14.66 64.91 Favored Glycine 0 N--CA 1.458 0.146 0 CA-C-N 115.568 -0.742 . . . . 0.0 112.836 177.652 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -75.06 136.08 41.2 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-O 120.738 0.304 . . . . 0.0 111.311 -179.633 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 30.2 mt -93.75 134.16 36.37 Favored 'General case' 0 CA--C 1.51 -0.58 0 N-CA-C 113.072 0.767 . . . . 0.0 113.072 -178.923 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 55.5 t30 -81.45 71.73 8.47 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 114.878 -1.055 . . . . 0.0 110.838 -178.391 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 1.3 t -142.17 154.79 64.94 Favored Pre-proline 0 C--N 1.322 -0.601 0 N-CA-C 106.129 -1.804 . . . . 0.0 106.129 179.784 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -68.78 148.71 71.88 Favored 'Trans proline' 0 CA--C 1.531 0.362 0 C-N-CA 118.347 -0.635 . . . . 0.0 113.537 176.34 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 5.8 ptpt -149.19 56.12 0.99 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 122.522 1.153 . . . . 0.0 111.169 178.384 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -57.46 -33.23 67.75 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.434 -1.257 . . . . 0.0 112.39 179.703 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 16.9 p80 -62.72 -7.66 5.3 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 115.015 1.487 . . . . 0.0 115.015 -177.862 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 44.7 mt -93.58 -39.25 10.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 177.857 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -72.81 14.65 2.57 Favored Glycine 0 C--O 1.218 -0.88 0 N-CA-C 115.612 1.005 . . . . 0.0 115.612 -178.409 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 14.3 t -99.67 27.98 5.0 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 113.322 0.86 . . . . 0.0 113.322 -176.928 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 62.4 ttp85 -51.52 133.08 30.4 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 177.477 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -90.45 117.88 68.33 Favored Pre-proline 0 C--N 1.326 -0.434 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 -179.538 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -71.45 -15.17 31.06 Favored 'Trans proline' 0 C--O 1.219 -0.462 0 C-N-CA 117.569 -1.154 . . . . 0.0 114.651 -177.086 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -81.1 -24.86 37.42 Favored 'General case' 0 C--O 1.22 -0.485 0 CA-C-O 121.052 0.453 . . . . 0.0 110.277 178.779 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 -100.89 -25.54 14.06 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 -175.02 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 27.3 t30 -147.96 144.37 27.96 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 113.284 0.846 . . . . 0.0 113.284 -178.404 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -84.27 146.46 27.75 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.13 179.823 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -67.77 143.67 55.74 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.405 0.622 . . . . 0.0 110.434 178.587 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 20.6 mt -83.84 139.43 17.64 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 -178.807 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 71.3 t -58.89 126.81 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 N-CA-C 106.393 -1.706 . . . . 0.0 106.393 175.252 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 7.7 tt -67.29 129.31 39.49 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 -178.933 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -130.34 156.61 44.41 Favored 'General case' 0 CA--C 1.511 -0.534 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 -178.474 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 14.8 mt -113.56 147.72 38.16 Favored Pre-proline 0 C--N 1.323 -0.582 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 178.879 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -71.94 166.77 28.56 Favored 'Trans proline' 0 C--N 1.345 0.382 0 O-C-N 122.338 0.652 . . . . 0.0 113.262 -178.721 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 34.0 tt0 -54.86 129.78 38.66 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.284 -179.409 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 93.71 -13.24 67.92 Favored Glycine 0 C--O 1.226 -0.363 0 CA-C-N 115.985 -0.552 . . . . 0.0 113.552 179.976 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.534 HG21 HE22 ' A' ' 30' ' ' GLN . 23.0 m -103.92 126.69 51.23 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 117.904 0.852 . . . . 0.0 110.265 179.035 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 11.6 p -121.67 148.4 44.63 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.934 -177.227 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 77.4 mt -74.13 154.08 88.49 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.301 178.286 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -76.86 173.87 13.77 Favored 'Trans proline' 0 C--N 1.345 0.393 0 N-CA-C 110.471 -0.627 . . . . 0.0 110.471 177.103 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 4.8 tmtt? -61.04 123.28 17.19 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.785 0.661 . . . . 0.0 112.785 -174.687 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 95.23 0.8 63.06 Favored Glycine 0 C--N 1.328 0.122 0 N-CA-C 115.141 0.817 . . . . 0.0 115.141 175.201 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.439 ' CZ ' ' HB2' ' A' ' 18' ' ' GLN . 1.2 m-85 -100.87 135.33 42.48 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-O 121.777 0.799 . . . . 0.0 110.538 -179.64 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 37.8 p90 -140.46 160.5 39.86 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 114.531 -1.213 . . . . 0.0 108.762 177.469 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -96.59 139.37 32.78 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.14 0.495 . . . . 0.0 111.454 -177.292 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -70.15 135.91 49.59 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 177.966 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 93.9 -9.01 73.44 Favored Glycine 0 CA--C 1.519 0.328 0 N-CA-C 114.716 0.646 . . . . 0.0 114.716 179.601 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 8.4 t . . . . . 0 C--N 1.326 -0.426 0 CA-C-N 117.803 0.801 . . . . 0.0 110.781 178.44 . . . . . . . . 0 0 . 1 . 034 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.163 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 . . . . . . . . . 0 0 . 1 . 034 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 31.3 t -61.36 136.92 58.21 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.448 178.368 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 4.3 m95 -68.91 -26.26 65.01 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-O 121.24 0.543 . . . . 0.0 111.005 177.126 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -121.58 162.68 20.19 Favored 'General case' 0 CA--C 1.51 -0.592 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.385 -171.191 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 64.1 p -68.05 163.31 22.67 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 178.454 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -75.08 152.36 38.59 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.839 0.828 . . . . 0.0 113.166 -176.26 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 12.7 mt -91.35 148.68 22.15 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 102.882 -3.007 . . . . 0.0 102.882 169.458 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 25.9 m -127.76 140.36 52.1 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 -178.38 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . 0.437 ' HB2' ' CZ ' ' A' ' 131' ' ' PHE . 4.6 tp60 -119.34 139.59 51.73 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 114.313 1.227 . . . . 0.0 114.313 -175.668 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 34.7 t60 -136.17 99.57 4.16 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 104.045 -2.576 . . . . 0.0 104.045 168.047 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 177.04 -158.56 24.35 Favored Glycine 0 C--O 1.228 -0.277 0 N-CA-C 110.801 -0.92 . . . . 0.0 110.801 -175.165 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 60.8 mttp -114.16 -22.32 10.05 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 114.16 1.17 . . . . 0.0 114.16 -178.579 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -84.76 157.38 21.04 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 107.883 -1.155 . . . . 0.0 107.883 177.785 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -76.67 -62.68 1.55 Allowed 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 -177.758 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 41.1 tp 177.23 145.14 0.1 Allowed 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 104.084 -2.561 . . . . 0.0 104.084 173.279 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 79.7 tttt -157.77 145.29 18.47 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 175.115 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 17.3 m-85 -134.53 151.21 75.65 Favored Pre-proline 0 C--N 1.323 -0.546 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 175.572 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -77.68 162.29 30.15 Favored 'Trans proline' 0 CA--C 1.538 0.716 0 O-C-N 122.02 0.484 . . . . 0.0 113.106 178.558 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 17.7 tpt180 -64.7 136.5 57.01 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.466 -178.862 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 90.26 -5.7 82.76 Favored Glycine 0 C--N 1.329 0.181 0 N-CA-C 111.397 -0.681 . . . . 0.0 111.397 178.132 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 -138.48 -179.68 5.95 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 123.714 0.805 . . . . 0.0 109.354 -174.665 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 100.22 -27.29 21.03 Favored Glycine 0 CA--C 1.497 -1.058 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.516 176.046 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 92.3 t -65.45 126.17 90.97 Favored Pre-proline 0 N--CA 1.444 -0.772 0 N-CA-C 106.207 -1.775 . . . . 0.0 106.207 176.288 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -72.44 164.26 36.16 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 O-C-N 122.175 0.566 . . . . 0.0 111.248 178.624 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 87.3 mt -63.85 115.58 2.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-O 121.658 0.742 . . . . 0.0 109.695 -176.692 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 6.7 m-80 -95.91 108.05 20.38 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.18 -0.918 . . . . 0.0 111.914 -177.026 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 70.3 p -91.3 -12.73 34.2 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.909 0.861 . . . . 0.0 110.827 177.662 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 12.5 p30 -110.27 9.01 23.74 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 116.993 2.219 . . . . 0.0 116.993 -173.247 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 87.6 p -154.08 165.57 35.78 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 115.19 1.552 . . . . 0.0 115.19 -175.23 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 25.4 m -78.65 167.56 34.22 Favored Pre-proline 0 N--CA 1.472 0.637 0 C-N-CA 124.311 1.044 . . . . 0.0 112.624 -176.42 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -64.54 -24.69 63.13 Favored 'Trans proline' 0 C--N 1.354 0.845 0 C-N-CA 115.62 -2.453 . . . . 0.0 112.843 177.575 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -63.0 -25.93 68.62 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.506 0.67 . . . . 0.0 111.211 176.168 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -97.3 -1.45 44.64 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 115.06 1.504 . . . . 0.0 115.06 -170.877 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 94.5 mm-40 -60.74 -26.12 66.96 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 113.243 0.831 . . . . 0.0 113.243 -177.614 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 19.0 tt -58.61 137.7 20.63 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 CA-C-O 122.384 1.087 . . . . 0.0 113.683 -177.994 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 178.9 -161.01 27.05 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.473 -0.87 . . . . 0.0 113.43 -178.787 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 44.7 p90 -154.76 169.09 24.76 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 179.357 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 13.6 m-85 -112.17 139.93 47.29 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 172.369 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.14 129.78 54.15 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 179.407 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 17.6 ttm105 -73.25 132.94 43.74 Favored 'General case' 0 CA--C 1.5 -0.971 0 N-CA-C 104.873 -2.269 . . . . 0.0 104.873 175.496 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -69.86 165.93 20.52 Favored 'General case' 0 N--CA 1.426 -1.648 0 CA-C-O 122.654 1.216 . . . . 0.0 111.89 -177.14 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 77.2 p -71.11 160.63 32.54 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 113.672 -1.603 . . . . 0.0 112.826 -176.27 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 6.0 tpt180 -65.71 154.07 39.97 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 114.555 -1.202 . . . . 0.0 111.657 -177.913 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.416 ' HG3' ' H ' ' A' ' 63' ' ' ASP . 10.0 ttm180 -88.68 136.97 32.73 Favored 'General case' 0 CA--C 1.504 -0.82 0 N-CA-C 108.266 -1.012 . . . . 0.0 108.266 177.367 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -143.04 175.11 4.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 N-CA-C 105.988 -1.856 . . . . 0.0 105.988 -176.355 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 14.9 tpt180 -92.88 116.4 29.0 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 106.27 -1.752 . . . . 0.0 106.27 176.137 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -79.65 137.64 19.12 Favored Glycine 0 N--CA 1.446 -0.645 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 177.917 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -72.01 -18.93 78.08 Favored Glycine 0 C--O 1.219 -0.841 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 178.733 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -64.37 -12.01 38.41 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 124.286 1.034 . . . . 0.0 110.11 176.234 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 109.26 15.92 11.93 Favored Glycine 0 CA--C 1.5 -0.862 0 CA-C-N 115.933 -0.576 . . . . 0.0 112.663 169.521 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.4 167.89 24.91 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 116.19 1.922 . . . . 0.0 116.19 -173.353 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -84.92 156.02 21.41 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.873 179.66 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -80.51 -55.15 5.07 Favored 'General case' 0 C--O 1.216 -0.693 0 CA-C-O 121.959 0.885 . . . . 0.0 112.717 -179.953 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.416 ' H ' ' HG3' ' A' ' 53' ' ' ARG . 1.0 OUTLIER -150.06 179.28 8.2 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 114.44 -1.254 . . . . 0.0 111.403 -174.259 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 95.6 mt -112.28 -83.73 0.58 Allowed 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 175.643 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -88.85 162.8 37.3 Favored Pre-proline 0 C--N 1.323 -0.564 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 177.849 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -69.52 142.98 50.5 Favored 'Trans proline' 0 C--N 1.348 0.503 0 C-N-CA 115.708 -2.395 . . . . 0.0 112.235 176.841 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 93.5 mtt-85 -121.59 166.25 14.49 Favored 'General case' 0 CA--C 1.513 -0.455 0 N-CA-C 112.99 0.737 . . . . 0.0 112.99 179.701 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 57.9 m95 -131.94 145.83 51.73 Favored 'General case' 0 C--O 1.216 -0.672 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 175.349 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 29.8 m-85 -125.88 154.1 43.21 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 105.661 -1.977 . . . . 0.0 105.661 -178.891 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 90.8 t80 -105.9 135.96 46.39 Favored 'General case' 0 CA--C 1.508 -0.672 0 CA-C-N 119.006 0.821 . . . . 0.0 109.54 -174.586 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 21.2 m-85 -140.91 144.81 35.42 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 107.259 -1.386 . . . . 0.0 107.259 -175.989 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 53.7 m-85 -84.83 159.52 20.39 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.453 -174.465 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 16.8 tp -53.29 129.98 33.44 Favored 'General case' 0 C--O 1.216 -0.677 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 179.884 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 70.81 22.26 78.18 Favored Glycine 0 C--O 1.223 -0.577 0 N-CA-C 116.375 1.31 . . . . 0.0 116.375 176.831 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 18.9 p . . . . . 0 CA--C 1.511 -0.522 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 175.658 . . . . . . . . 0 0 . 1 . 034 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 12.9 mt . . . . . 0 N--CA 1.438 -1.061 0 N-CA-C 114.075 1.139 . . . . 0.0 114.075 . . . . . . . . . 0 0 . 1 . 034 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -78.84 161.5 27.19 Favored 'Trans proline' 0 N--CA 1.462 -0.368 0 C-N-CA 122.268 1.978 . . . . 0.0 107.192 167.819 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 56.0 t80 -61.09 132.85 55.1 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 120.226 -0.589 . . . . 0.0 110.063 -177.704 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 91.1 -7.15 81.27 Favored Glycine 0 CA--C 1.519 0.337 0 CA-C-O 119.333 -0.704 . . . . 0.0 114.541 179.407 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -67.68 129.73 40.81 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 118.804 1.302 . . . . 0.0 111.808 179.909 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 51.1 t30 -79.04 128.76 33.68 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.042 -179.893 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 28.7 ttmt -155.94 157.9 37.04 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 106.964 -1.495 . . . . 0.0 106.964 -178.774 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -54.87 120.2 6.49 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.473 0.546 . . . . 0.0 112.473 -179.696 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 66.12 35.6 90.73 Favored Glycine 0 CA--C 1.507 -0.467 0 CA-C-O 118.989 -0.895 . . . . 0.0 114.022 175.176 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 49.6 mm -122.47 126.29 73.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 117.452 0.626 . . . . 0.0 110.856 178.904 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -126.84 121.17 57.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.892 175.666 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 98.7 m95 -87.57 135.67 33.26 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 113.602 0.964 . . . . 0.0 113.602 -176.71 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 15.8 m -137.2 149.78 26.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 121.638 0.733 . . . . 0.0 109.069 178.618 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -162.46 161.97 27.37 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 103.363 -2.829 . . . . 0.0 103.363 179.416 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 6.0 t -126.43 173.85 9.06 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 105.098 -2.186 . . . . 0.0 105.098 178.151 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -67.26 134.42 51.59 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.054 0.454 . . . . 0.0 109.957 -178.303 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 96.0 -9.65 67.98 Favored Glycine 0 C--O 1.226 -0.396 0 CA-C-N 115.97 -0.559 . . . . 0.0 113.05 179.318 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -76.37 134.02 39.78 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 178.891 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 65.9 mt -87.75 140.96 28.98 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.174 0.511 . . . . 0.0 112.147 -176.743 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 63.4 t30 -84.29 61.98 6.89 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.968 -179.599 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -135.91 156.47 77.17 Favored Pre-proline 0 C--N 1.322 -0.617 0 N-CA-C 106.159 -1.793 . . . . 0.0 106.159 -178.592 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -67.73 152.8 77.3 Favored 'Trans proline' 0 C--N 1.343 0.272 0 N-CA-C 114.793 1.036 . . . . 0.0 114.793 -179.889 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -126.07 37.9 4.25 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 114.648 -1.16 . . . . 0.0 110.079 -177.111 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 15.9 p-10 -53.32 -41.22 65.49 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.168 -179.051 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 16.3 p80 -66.21 -8.88 27.14 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 114.359 1.244 . . . . 0.0 114.359 179.99 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 31.3 mt -95.27 -44.64 13.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 178.727 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -70.66 3.04 13.24 Favored Glycine 0 C--O 1.221 -0.673 0 N-CA-C 115.661 1.024 . . . . 0.0 115.661 -177.537 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 14.6 t -83.15 15.13 3.0 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 117.637 0.719 . . . . 0.0 112.28 -177.868 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 57.6 ttp85 -58.72 130.83 48.75 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 176.629 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -98.6 137.62 20.66 Favored Pre-proline 0 C--N 1.323 -0.585 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 178.399 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -74.96 -19.84 17.53 Favored 'Trans proline' 0 C--O 1.219 -0.434 0 N-CA-C 113.863 0.678 . . . . 0.0 113.863 179.424 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -81.36 -25.14 36.57 Favored 'General case' 0 C--O 1.221 -0.437 0 CA-C-O 121.163 0.506 . . . . 0.0 110.226 179.293 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 -97.76 -21.54 16.91 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 113.437 0.903 . . . . 0.0 113.437 -175.128 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 29.5 t30 -150.31 153.24 35.76 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 111.884 0.328 . . . . 0.0 111.884 -178.77 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -89.45 140.92 29.05 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-O 121.246 0.546 . . . . 0.0 110.586 178.4 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -70.99 147.64 48.44 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.136 0.494 . . . . 0.0 110.355 178.667 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 11.7 mt -81.89 136.47 22.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.473 -178.494 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 77.0 t -58.78 121.9 7.47 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 N-CA-C 106.43 -1.693 . . . . 0.0 106.43 174.601 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 6.1 tt -67.35 127.54 33.05 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.297 0.57 . . . . 0.0 110.328 -176.662 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 -133.98 155.08 50.59 Favored 'General case' 0 CA--C 1.508 -0.661 0 N-CA-C 106.489 -1.671 . . . . 0.0 106.489 -179.233 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 12.9 mt -111.08 147.96 37.66 Favored Pre-proline 0 C--N 1.319 -0.724 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 177.738 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -73.3 163.5 37.71 Favored 'Trans proline' 0 C--O 1.237 0.439 0 C-N-CA 118.016 -0.856 . . . . 0.0 112.626 -179.934 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 40.1 tt0 -54.47 130.65 40.34 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.06 179.963 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 105.94 -26.25 21.4 Favored Glycine 0 C--O 1.227 -0.309 0 CA-C-N 115.871 -0.604 . . . . 0.0 112.251 -178.656 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 4.6 m -102.36 129.91 48.95 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 118.276 1.038 . . . . 0.0 112.131 178.586 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 3.1 p -116.61 147.86 41.49 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.274 178.625 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 82.8 mt -72.11 153.79 92.48 Favored Pre-proline 0 C--N 1.323 -0.559 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 177.911 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -75.54 175.53 11.16 Favored 'Trans proline' 0 C--O 1.235 0.334 0 N-CA-C 110.576 -0.586 . . . . 0.0 110.576 177.901 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 76.1 tttt -64.55 124.51 22.04 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 114.023 1.12 . . . . 0.0 114.023 -170.811 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 95.19 -1.86 65.18 Favored Glycine 0 CA--C 1.518 0.243 0 CA-C-N 114.891 -1.05 . . . . 0.0 115.342 177.101 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.437 ' CZ ' ' HB2' ' A' ' 18' ' ' GLN . 3.5 m-85 -94.81 143.12 26.71 Favored 'General case' 0 N--CA 1.436 -1.14 0 CA-C-O 122.465 1.126 . . . . 0.0 111.619 -179.328 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 43.7 p90 -144.19 164.46 30.64 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 113.053 -1.885 . . . . 0.0 107.375 173.992 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -105.18 148.55 26.79 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.253 0.549 . . . . 0.0 111.465 -176.759 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -79.05 139.8 38.05 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 179.397 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 81.98 -0.21 88.79 Favored Glycine 0 C--O 1.226 -0.369 0 C-N-CA 121.161 -0.543 . . . . 0.0 112.241 -178.283 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 8.3 t . . . . . 0 C--N 1.324 -0.515 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 178.288 . . . . . . . . 0 0 . 1 . 035 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.537 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 . . . . . . . . . 0 0 . 1 . 035 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 69.6 p -63.18 144.02 57.28 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 178.259 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 14.8 m95 -70.9 -22.82 62.22 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 111.923 0.342 . . . . 0.0 111.923 179.225 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 33.9 m-85 -121.48 162.53 20.33 Favored 'General case' 0 C--O 1.243 0.736 0 N-CA-C 113.239 0.829 . . . . 0.0 113.239 -172.353 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.428 ' HB ' ' HB3' ' A' ' 134' ' ' GLU . 70.5 p -71.13 165.0 24.5 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 114.806 -1.088 . . . . 0.0 108.245 178.149 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -83.4 145.13 29.17 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 113.803 1.038 . . . . 0.0 113.803 -176.401 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 22.9 mt -78.0 148.91 34.17 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 103.942 -2.614 . . . . 0.0 103.942 168.832 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 26.8 m -126.96 140.42 52.33 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 107.432 -1.321 . . . . 0.0 107.432 179.392 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 56.7 tt0 -116.44 148.69 40.47 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 114.936 1.458 . . . . 0.0 114.936 -174.172 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 63.3 t60 -134.52 99.62 4.41 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 105.375 -2.083 . . . . 0.0 105.375 169.967 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -178.95 -163.01 29.34 Favored Glycine 0 CA--C 1.522 0.494 0 C-N-CA 121.006 -0.616 . . . . 0.0 113.233 -176.621 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 68.9 mmtt -116.27 -31.7 5.55 Favored 'General case' 0 N--CA 1.48 1.062 0 N-CA-C 113.919 1.081 . . . . 0.0 113.919 -178.899 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -84.23 -166.67 1.5 Allowed 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 178.61 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 13.7 p-10 -105.74 -66.08 1.01 Allowed 'General case' 0 CA--C 1.556 1.187 0 N-CA-C 117.699 2.481 . . . . 0.0 117.699 -177.614 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 49.3 tp 172.7 141.62 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 179.777 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -154.26 145.36 22.77 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 107.062 -1.459 . . . . 0.0 107.062 -178.732 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -134.51 148.44 67.48 Favored Pre-proline 0 C--N 1.322 -0.589 0 N-CA-C 105.779 -1.934 . . . . 0.0 105.779 176.23 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -69.98 150.22 66.6 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 117.875 -0.95 . . . . 0.0 111.71 179.433 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 16.8 tpt180 -65.98 134.98 54.07 Favored 'General case' 0 C--O 1.217 -0.651 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 -178.369 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 98.84 -3.6 58.9 Favored Glycine 0 C--O 1.222 -0.608 0 N-CA-C 110.335 -1.106 . . . . 0.0 110.335 -179.377 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -146.57 170.51 16.76 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 -179.372 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 128.88 -31.41 3.52 Favored Glycine 0 CA--C 1.48 -2.096 0 N-CA-C 108.774 -1.731 . . . . 0.0 108.774 165.142 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 35.7 m -66.47 139.63 96.23 Favored Pre-proline 0 N--CA 1.43 -1.458 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 177.378 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -72.77 174.01 12.5 Favored 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 121.785 1.657 . . . . 0.0 111.6 177.049 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 90.9 mt -72.1 113.46 9.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 N-CA-C 107.656 -1.239 . . . . 0.0 107.656 178.083 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.536 HD22 ' HA ' ' A' ' 43' ' ' GLN . 37.8 m-20 -109.75 82.16 1.55 Allowed 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.431 -0.804 . . . . 0.0 108.947 -178.31 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 67.7 p -64.87 -24.41 67.53 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.46 -0.791 . . . . 0.0 112.972 -177.044 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 72.7 m-80 -100.72 35.75 2.09 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.647 -178.191 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 21.1 m -147.88 151.7 36.33 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.6 -0.273 . . . . 0.0 110.596 -179.269 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 18.4 m -72.17 165.45 50.4 Favored Pre-proline 0 C--N 1.324 -0.507 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 176.877 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -64.68 -27.79 60.53 Favored 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 114.94 -2.907 . . . . 0.0 111.62 177.813 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -60.84 -30.8 70.32 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 122.121 0.963 . . . . 0.0 110.629 175.784 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 92.6 m-20 -95.58 -0.16 52.26 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 114.931 1.456 . . . . 0.0 114.931 -170.552 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . 0.536 ' HA ' HD22 ' A' ' 35' ' ' ASN . 91.4 mm-40 -60.89 -25.56 66.8 Favored 'General case' 0 C--O 1.219 -0.509 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 178.653 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 21.5 tt -55.79 142.56 10.41 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 N-CA-C 115.209 1.559 . . . . 0.0 115.209 -178.621 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 179.22 -155.23 15.43 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.089 178.079 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 43.0 p90 -155.11 168.03 28.38 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 178.254 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 33.6 m-85 -109.28 137.68 46.79 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 174.722 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 60.9 ttt180 -111.9 119.32 38.14 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.474 -0.784 . . . . 0.0 110.827 -177.776 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 1.1 ttp-105 -65.5 134.33 53.17 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 106.78 -1.563 . . . . 0.0 106.78 175.871 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -135.59 153.4 51.68 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.052 0.453 . . . . 0.0 110.541 -177.487 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.448 ' HB ' HD23 ' A' ' 64' ' ' LEU . 32.7 p -133.4 159.01 41.58 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.272 -177.639 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 63.4 ttt180 -158.34 129.71 6.55 Favored 'General case' 0 N--CA 1.477 0.92 0 O-C-N 122.235 -0.291 . . . . 0.0 111.27 177.471 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.81 142.16 24.24 Favored 'General case' 0 CA--C 1.498 -1.039 0 N-CA-C 104.224 -2.51 . . . . 0.0 104.224 -179.933 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -132.1 173.94 13.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 -177.076 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.08 107.39 17.69 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 -179.39 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -74.38 151.82 44.0 Favored Glycine 0 N--CA 1.452 -0.24 0 N-CA-C 107.059 -2.417 . . . . 0.0 107.059 177.201 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -63.38 -42.79 99.02 Favored Glycine 0 C--O 1.223 -0.578 0 CA-C-N 118.559 1.18 . . . . 0.0 111.907 -178.643 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -76.2 -3.22 35.15 Favored 'General case' 0 C--O 1.218 -0.572 0 CA-C-O 121.518 0.675 . . . . 0.0 111.967 179.594 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 96.72 -1.1 61.41 Favored Glycine 0 C--O 1.227 -0.313 0 CA-C-N 115.855 -0.612 . . . . 0.0 112.617 177.395 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 12.8 pttt -63.82 133.66 53.82 Favored 'General case' 0 C--O 1.24 0.581 0 CA-C-O 122.147 0.975 . . . . 0.0 112.587 -178.089 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 13.8 mmt -90.78 145.44 24.78 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 114.171 -1.377 . . . . 0.0 113.022 -179.619 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 2.1 tmtm? -102.11 -23.43 14.06 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.048 -0.978 . . . . 0.0 109.814 176.259 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 13.3 t0 63.7 164.37 0.12 Allowed 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 115.998 1.851 . . . . 0.0 115.998 178.338 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.448 HD23 ' HB ' ' A' ' 51' ' ' THR . 57.4 mt -88.61 131.12 35.1 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.331 0.586 . . . . 0.0 111.304 -176.538 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 4.8 p -112.31 131.29 22.65 Favored Pre-proline 0 C--N 1.319 -0.722 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 176.215 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -74.95 98.14 1.13 Allowed 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 117.35 -1.3 . . . . 0.0 112.065 178.044 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 11.7 mtp180 -110.34 152.81 25.76 Favored 'General case' 0 CA--C 1.507 -0.69 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 178.018 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 64.0 m95 -127.69 126.37 41.78 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 179.666 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 58.7 m-85 -110.35 141.17 43.74 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 -178.592 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 86.1 t80 -87.73 135.87 33.19 Favored 'General case' 0 CA--C 1.506 -0.732 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 -178.581 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -139.42 143.49 37.66 Favored 'General case' 0 N--CA 1.439 -0.995 0 CA-C-N 115.076 -0.965 . . . . 0.0 108.434 -175.376 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -77.01 159.45 29.9 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.089 0.471 . . . . 0.0 110.743 -176.847 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 15.8 tp -59.62 128.17 35.67 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.855 -0.612 . . . . 0.0 110.819 -178.455 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 80.73 24.73 57.81 Favored Glycine 0 C--O 1.218 -0.856 0 N-CA-C 116.342 1.297 . . . . 0.0 116.342 177.603 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 3.7 p . . . . . 0 N--CA 1.467 0.408 0 CA-C-N 118.873 1.336 . . . . 0.0 110.67 -179.609 . . . . . . . . 0 0 . 1 . 035 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 27.6 mt . . . . . 0 C--O 1.238 0.492 0 N-CA-C 115.103 1.519 . . . . 0.0 115.103 . . . . . . . . . 0 0 . 1 . 035 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -78.25 169.19 20.58 Favored 'Trans proline' 0 C--O 1.235 0.352 0 C-N-CA 121.815 1.676 . . . . 0.0 109.483 171.566 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 51.3 t80 -63.49 130.5 44.63 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 179.564 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 92.13 -3.98 77.21 Favored Glycine 0 C--O 1.225 -0.409 0 N-CA-C 114.754 0.662 . . . . 0.0 114.754 178.691 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -68.44 123.69 21.5 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 118.63 1.215 . . . . 0.0 111.471 178.747 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 74.6 m-20 -71.66 126.05 28.69 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 114.799 -1.091 . . . . 0.0 111.839 -176.805 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 29.2 ttmt -156.13 151.5 26.77 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 106.927 -1.509 . . . . 0.0 106.927 177.153 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 18.5 t0 -66.82 133.4 50.02 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.904 0.383 . . . . 0.0 110.032 -178.892 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 72.46 21.42 79.46 Favored Glycine 0 CA--C 1.507 -0.467 0 C-N-CA 120.938 -0.649 . . . . 0.0 113.962 177.731 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 44.0 mm -125.31 124.21 66.7 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.421 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 178.864 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.1 pt -127.68 114.47 35.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.725 176.63 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 95.8 m95 -81.09 128.77 34.1 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.371 -177.704 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 2.8 m -136.7 149.74 26.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 121.483 0.659 . . . . 0.0 109.572 -177.347 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -157.51 164.63 37.18 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 105.134 -2.173 . . . . 0.0 105.134 -178.696 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 14.5 t -122.96 174.83 6.93 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 105.705 -1.961 . . . . 0.0 105.705 177.985 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -64.97 133.81 52.55 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.197 0.523 . . . . 0.0 109.812 -179.679 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 92.07 -9.22 76.92 Favored Glycine 0 C--O 1.225 -0.445 0 CA-C-N 115.886 -0.597 . . . . 0.0 113.232 178.482 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -77.74 137.73 38.63 Favored 'General case' 0 C--N 1.324 -0.534 0 O-C-N 122.249 -0.56 . . . . 0.0 109.523 179.434 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 51.7 mt -92.82 134.18 35.33 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 113.523 0.935 . . . . 0.0 113.523 -176.64 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 71.6 m-20 -79.47 56.16 2.1 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.411 -179.196 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -130.85 152.34 80.42 Favored Pre-proline 0 C--N 1.323 -0.549 0 N-CA-C 107.953 -1.128 . . . . 0.0 107.953 -179.595 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -66.76 149.9 83.5 Favored 'Trans proline' 0 C--N 1.343 0.256 0 N-CA-C 114.281 0.839 . . . . 0.0 114.281 178.364 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 4.5 ptpt -151.18 56.13 0.88 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 122.71 1.243 . . . . 0.0 110.467 178.955 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -57.81 -30.71 65.92 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 113.852 -1.522 . . . . 0.0 111.411 178.338 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 29.5 p-80 -59.67 -16.62 27.83 Favored 'General case' 0 C--O 1.218 -0.602 0 N-CA-C 114.205 1.187 . . . . 0.0 114.205 -178.901 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 64.0 mt -81.41 -32.63 12.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 178.305 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -73.86 14.8 3.39 Favored Glycine 0 CA--C 1.522 0.479 0 N-CA-C 115.023 0.769 . . . . 0.0 115.023 -178.337 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 11.6 t -83.1 17.65 1.93 Allowed 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 112.846 0.684 . . . . 0.0 112.846 -177.718 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 73.3 ttp85 -58.83 130.27 46.14 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 178.838 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -101.77 125.44 37.13 Favored Pre-proline 0 C--N 1.322 -0.625 0 N-CA-C 105.778 -1.934 . . . . 0.0 105.778 179.352 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -68.69 -17.35 42.66 Favored 'Trans proline' 0 C--O 1.218 -0.525 0 C-N-CA 117.766 -1.023 . . . . 0.0 114.397 -176.705 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -78.77 -24.3 44.77 Favored 'General case' 0 C--O 1.22 -0.468 0 CA-C-O 120.932 0.396 . . . . 0.0 110.516 178.339 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 -100.11 -23.04 14.97 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 -174.923 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 28.2 t30 -158.2 149.13 20.77 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.473 0.545 . . . . 0.0 112.473 -178.706 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -92.64 154.16 18.54 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-O 121.518 0.675 . . . . 0.0 111.825 179.606 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -69.39 144.26 53.45 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.216 0.531 . . . . 0.0 111.031 178.87 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 15.3 mt -85.77 139.94 16.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.303 -178.287 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 92.5 t -60.77 124.77 15.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 175.918 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 6.9 tt -67.29 129.0 38.5 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.966 -177.093 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 29.5 mt-30 -132.14 156.64 46.03 Favored 'General case' 0 C--O 1.219 -0.513 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 -179.467 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 13.4 mt -112.29 148.04 38.28 Favored Pre-proline 0 C--N 1.323 -0.578 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 178.449 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -72.65 168.54 24.2 Favored 'Trans proline' 0 C--N 1.346 0.409 0 O-C-N 122.219 0.589 . . . . 0.0 113.615 -179.128 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 39.1 tt0 -53.82 131.87 40.49 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.309 -0.86 . . . . 0.0 109.553 179.554 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 96.38 -18.94 56.57 Favored Glycine 0 C--O 1.226 -0.403 0 CA-C-N 115.919 -0.582 . . . . 0.0 113.452 179.991 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 4.1 m -108.43 128.48 54.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 118.227 1.014 . . . . 0.0 111.375 179.239 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 10.0 p -122.46 150.77 42.05 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.278 179.172 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 87.8 mt -70.79 151.88 95.19 Favored Pre-proline 0 C--N 1.324 -0.533 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 179.076 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -76.03 166.17 28.42 Favored 'Trans proline' 0 C--O 1.236 0.383 0 C-N-CA 117.775 -1.016 . . . . 0.0 110.973 178.864 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 14.7 tmtt? -59.04 127.02 30.11 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.121 -177.293 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 95.1 15.59 44.31 Favored Glycine 0 C--O 1.227 -0.344 0 N-CA-C 114.865 0.706 . . . . 0.0 114.865 178.785 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -125.52 149.17 48.53 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 117.688 0.744 . . . . 0.0 110.637 177.873 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 43.6 p90 -150.37 161.97 41.46 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 174.43 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -99.92 147.01 26.01 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.825 0.345 . . . . 0.0 110.412 -179.017 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.428 ' HB3' ' HB ' ' A' ' 14' ' ' THR . 3.6 tp10 -72.18 133.76 45.31 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 106.65 -1.611 . . . . 0.0 106.65 177.81 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 89.48 -3.17 83.6 Favored Glycine 0 C--O 1.224 -0.5 0 N-CA-C 111.254 -0.738 . . . . 0.0 111.254 -177.144 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 9.7 t . . . . . 0 C--N 1.325 -0.471 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 177.42 . . . . . . . . 0 0 . 1 . 036 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.667 0 CA-C-O 121.475 0.655 . . . . 0.0 109.262 . . . . . . . . . 0 0 . 1 . 036 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 54.3 p -59.72 143.72 50.05 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.254 -0.884 . . . . 0.0 109.231 177.907 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 13.4 m95 -65.87 -26.75 67.78 Favored 'General case' 0 CA--C 1.512 -0.485 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 179.26 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 27.4 m-85 -121.46 164.79 16.59 Favored 'General case' 0 CA--C 1.503 -0.831 0 CA-C-N 115.784 -0.644 . . . . 0.0 112.109 -172.201 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.464 ' HB ' ' HB3' ' A' ' 134' ' ' GLU . 67.1 p -70.35 166.41 20.31 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 114.614 -1.175 . . . . 0.0 108.629 177.642 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -87.23 149.92 24.27 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 113.306 0.854 . . . . 0.0 113.306 -176.507 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 53.0 mt -85.54 148.81 25.77 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 173.18 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 24.2 m -125.19 131.98 53.1 Favored 'General case' 0 C--N 1.32 -0.716 0 C-N-CA 122.515 0.326 . . . . 0.0 110.698 -179.822 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 3.9 tp-100 -95.6 141.67 28.83 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 179.129 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 41.5 t60 -135.35 100.04 4.41 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 102.54 -3.133 . . . . 0.0 102.54 166.598 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 167.77 -143.9 8.53 Favored Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 120.286 -0.959 . . . . 0.0 111.545 -175.027 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -124.74 -32.3 3.1 Favored 'General case' 0 C--O 1.221 -0.405 0 N-CA-C 115.449 1.648 . . . . 0.0 115.449 -177.811 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -77.69 165.77 23.82 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 178.57 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -79.66 -62.89 1.55 Allowed 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 -179.249 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 48.0 tp 173.88 141.04 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.221 0 N-CA-C 106.114 -1.81 . . . . 0.0 106.114 176.057 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 56.2 tptt -153.71 139.46 17.99 Favored 'General case' 0 C--O 1.222 -0.371 0 CA-C-N 118.077 0.399 . . . . 0.0 110.539 173.983 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 20.5 m-85 -126.27 151.49 72.32 Favored Pre-proline 0 C--O 1.24 0.59 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 175.189 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -78.98 166.95 22.64 Favored 'Trans proline' 0 C--N 1.353 0.813 0 C-N-CA 120.934 1.089 . . . . 0.0 113.535 178.347 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 2.0 tmt_? -66.86 137.07 56.32 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.821 -178.732 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 86.67 -0.21 86.52 Favored Glycine 0 C--O 1.223 -0.536 0 N-CA-C 111.302 -0.719 . . . . 0.0 111.302 177.169 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -140.65 -179.69 6.18 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 -175.176 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.52 -28.28 13.98 Favored Glycine 0 CA--C 1.498 -1.025 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.87 176.104 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 76.2 t -64.44 126.45 90.61 Favored Pre-proline 0 C--N 1.32 -0.705 0 N-CA-C 106.177 -1.786 . . . . 0.0 106.177 176.559 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -73.66 168.87 23.69 Favored 'Trans proline' 0 N--CA 1.459 -0.513 0 O-C-N 122.225 0.592 . . . . 0.0 111.446 179.134 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 87.6 mt -66.71 110.1 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-O 122.06 0.934 . . . . 0.0 109.177 -179.761 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 71.6 m-80 -97.94 91.45 5.33 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 114.636 -1.165 . . . . 0.0 110.734 -177.493 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 75.7 p -71.38 -14.89 62.32 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.744 0.783 . . . . 0.0 111.469 178.667 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 10.7 p30 -111.14 20.52 17.32 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 114.915 1.45 . . . . 0.0 114.915 -175.893 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 6.1 m -138.91 152.32 47.66 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 115.938 1.829 . . . . 0.0 115.938 -175.728 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 2.0 m -70.22 164.7 50.81 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 115.085 -0.962 . . . . 0.0 109.936 176.219 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -66.36 -28.38 46.84 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 114.758 -3.028 . . . . 0.0 113.915 -179.823 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.415 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 4.2 p-10 -75.3 -21.59 58.35 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.657 0.741 . . . . 0.0 110.688 177.319 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -83.28 -5.76 59.24 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 114.063 1.134 . . . . 0.0 114.063 -174.776 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 93.6 mm-40 -58.89 -26.52 64.36 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 113.248 0.833 . . . . 0.0 113.248 -179.427 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 20.1 tt -57.66 138.86 18.03 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.726 0 N-CA-C 114.402 1.26 . . . . 0.0 114.402 -178.744 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -177.07 -159.35 22.18 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.57 -0.824 . . . . 0.0 111.977 178.806 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 51.5 p90 -155.05 172.7 17.68 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 177.907 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 16.9 m-85 -113.49 138.89 49.47 Favored 'General case' 0 C--N 1.319 -0.761 0 N-CA-C 106.125 -1.806 . . . . 0.0 106.125 173.869 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 36.2 ttt180 -108.23 120.01 41.14 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 114.991 -1.004 . . . . 0.0 110.387 -176.728 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 13.1 ttt180 -64.33 131.7 48.04 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 176.316 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -142.18 129.77 21.44 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.544 0.688 . . . . 0.0 110.882 -179.693 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 15.3 t -156.8 155.46 31.59 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 175.183 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 15.0 tpt85 -154.88 135.12 13.18 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 104.865 -2.272 . . . . 0.0 104.865 178.11 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -127.82 136.37 51.35 Favored 'General case' 0 CA--C 1.495 -1.138 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 -179.423 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.401 ' H ' ' HB2' ' A' ' 62' ' ' LYS . 0.1 OUTLIER -132.67 172.4 16.49 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 -177.38 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 5.5 tmm_? -116.08 112.3 21.54 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 105.439 -2.06 . . . . 0.0 105.439 176.71 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -75.76 150.07 39.1 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 121.008 -0.615 . . . . 0.0 112.368 -177.512 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -70.89 -22.16 78.26 Favored Glycine 0 C--O 1.218 -0.896 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.44 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 41.1 t0 -65.16 -12.9 56.0 Favored 'General case' 0 CA--C 1.548 0.903 0 CA-C-N 114.236 -0.982 . . . . 0.0 110.363 176.951 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 108.07 18.46 9.86 Favored Glycine 0 CA--C 1.501 -0.827 0 CA-C-N 116.105 -0.498 . . . . 0.0 112.818 169.338 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.66 160.28 42.86 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 116.583 2.068 . . . . 0.0 116.583 -174.155 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 93.9 mmm -85.03 160.25 20.05 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.589 -0.732 . . . . 0.0 112.873 -176.398 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.401 ' HB2' ' H ' ' A' ' 54' ' ' ILE . 13.3 tmtt? -63.86 -42.91 97.43 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 122.316 1.055 . . . . 0.0 112.412 176.64 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 13.1 t70 56.15 -139.85 0.92 Allowed 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 112.444 -2.162 . . . . 0.0 109.988 -174.916 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER 66.9 156.23 0.11 Allowed 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 116.001 1.852 . . . . 0.0 116.001 178.777 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 14.1 p -81.26 162.59 58.44 Favored Pre-proline 0 C--O 1.242 0.675 0 CA-C-N 114.462 -1.245 . . . . 0.0 110.678 -179.949 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -71.6 156.5 57.61 Favored 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 116.434 -1.911 . . . . 0.0 111.293 175.563 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 11.7 mtt180 -116.7 161.46 19.19 Favored 'General case' 0 CA--C 1.506 -0.737 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 178.251 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 62.3 m95 -123.18 125.98 46.13 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 179.919 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 11.3 m-85 -110.37 138.06 47.26 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 107.278 -1.378 . . . . 0.0 107.278 -176.742 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 79.7 t80 -85.25 133.8 34.16 Favored 'General case' 0 CA--C 1.509 -0.629 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 -177.248 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -141.47 135.49 30.31 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 -175.254 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 86.3 m-85 -73.73 159.54 32.82 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 -175.652 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 11.3 tp -57.02 126.55 27.68 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.312 0.577 . . . . 0.0 109.615 179.849 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 82.03 18.68 66.8 Favored Glycine 0 C--O 1.22 -0.751 0 N-CA-C 116.49 1.356 . . . . 0.0 116.49 178.041 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 16.7 p . . . . . 0 N--CA 1.469 0.478 0 CA-C-N 119.331 1.566 . . . . 0.0 110.228 178.622 . . . . . . . . 0 0 . 1 . 036 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 15.0 mt . . . . . 0 N--CA 1.44 -0.968 0 N-CA-C 116.027 1.862 . . . . 0.0 116.027 . . . . . . . . . 0 0 . 1 . 036 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -78.47 162.21 27.9 Favored 'Trans proline' 0 N--CA 1.462 -0.357 0 C-N-CA 122.684 2.256 . . . . 0.0 107.165 166.962 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 59.1 t80 -61.44 132.56 53.86 Favored 'General case' 0 C--N 1.32 -0.712 0 C-N-CA 120.239 -0.584 . . . . 0.0 110.35 -177.499 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 91.4 -8.98 78.45 Favored Glycine 0 CA--C 1.519 0.324 0 N-CA-C 114.953 0.741 . . . . 0.0 114.953 179.296 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -66.35 131.54 46.33 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 118.676 1.238 . . . . 0.0 111.711 179.84 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 56.9 t30 -78.81 131.31 36.45 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.287 -179.724 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 32.7 tttt -156.22 156.77 34.7 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 106.807 -1.553 . . . . 0.0 106.807 -179.568 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -64.56 127.76 32.87 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.719 -0.475 . . . . 0.0 109.719 -178.129 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 67.41 33.02 80.74 Favored Glycine 0 N--CA 1.444 -0.778 0 N-CA-C 115.171 0.829 . . . . 0.0 115.171 176.8 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 41.0 mm -126.34 125.44 67.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 117.404 0.602 . . . . 0.0 110.132 179.067 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -127.41 112.45 28.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.202 177.278 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 98.6 m95 -78.02 137.29 38.19 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 113.371 0.878 . . . . 0.0 113.371 -177.681 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 14.0 m -139.45 149.75 22.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 177.843 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -160.7 164.17 31.87 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 104.299 -2.482 . . . . 0.0 104.299 179.385 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 14.1 t -124.08 174.58 7.53 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 105.668 -1.975 . . . . 0.0 105.668 178.48 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -65.99 132.28 48.21 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.992 0.425 . . . . 0.0 110.438 -178.752 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 92.59 -6.72 77.6 Favored Glycine 0 C--O 1.23 -0.154 0 CA-C-N 116.103 -0.498 . . . . 0.0 113.543 178.997 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.415 ' HA ' ' HA ' ' A' ' 41' ' ' ASP . . . -74.8 138.88 42.9 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 178.681 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 40.2 mt -94.6 139.01 31.76 Favored 'General case' 0 C--O 1.222 -0.39 0 N-CA-C 113.442 0.905 . . . . 0.0 113.442 -177.053 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 74.0 m-20 -83.18 62.08 6.44 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.869 -178.782 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -135.39 154.33 78.49 Favored Pre-proline 0 C--N 1.32 -0.692 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 -179.495 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -68.39 150.68 76.06 Favored 'Trans proline' 0 C--N 1.342 0.191 0 N-CA-C 114.476 0.914 . . . . 0.0 114.476 178.699 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -149.27 59.39 1.03 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 122.94 1.352 . . . . 0.0 110.988 178.006 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 14.0 p-10 -58.61 -30.43 67.24 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 113.694 -1.594 . . . . 0.0 110.206 176.894 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 23.0 p-80 -59.77 -14.66 15.54 Favored 'General case' 0 C--O 1.222 -0.366 0 N-CA-C 114.214 1.19 . . . . 0.0 114.214 -179.272 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 51.9 mt -90.33 -48.51 14.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 177.846 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -71.69 14.37 1.99 Allowed Glycine 0 C--O 1.219 -0.823 0 N-CA-C 116.094 1.197 . . . . 0.0 116.094 -176.271 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 13.8 t -90.95 19.88 5.28 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 117.596 0.698 . . . . 0.0 111.947 179.987 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 65.6 ttp85 -57.47 135.11 56.57 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 178.988 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -105.11 136.21 19.21 Favored Pre-proline 0 C--N 1.323 -0.559 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 178.515 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -73.96 -17.96 21.93 Favored 'Trans proline' 0 C--O 1.219 -0.464 0 O-C-N 121.967 0.456 . . . . 0.0 113.148 -179.885 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -80.07 -24.61 40.52 Favored 'General case' 0 C--O 1.221 -0.409 0 CA-C-O 121.148 0.499 . . . . 0.0 110.271 178.938 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 88.4 m-20 -99.4 -22.37 15.57 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 113.464 0.913 . . . . 0.0 113.464 -175.32 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 20.4 t30 -158.7 149.72 20.4 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.135 0.42 . . . . 0.0 112.135 -178.659 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -85.34 145.29 27.57 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-O 121.427 0.632 . . . . 0.0 111.872 179.68 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -69.6 148.1 49.82 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.17 0.51 . . . . 0.0 110.544 178.361 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 17.4 mt -89.42 138.99 18.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 -179.045 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 79.7 t -62.81 124.92 18.3 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 N-CA-C 106.088 -1.819 . . . . 0.0 106.088 174.259 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 7.2 tt -67.55 130.61 43.59 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 -177.782 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -135.0 154.11 51.85 Favored 'General case' 0 CA--C 1.51 -0.591 0 N-CA-C 106.135 -1.802 . . . . 0.0 106.135 -179.152 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 13.1 mt -108.56 147.34 35.54 Favored Pre-proline 0 C--N 1.321 -0.673 0 CA-C-O 120.574 0.226 . . . . 0.0 110.732 177.15 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -73.34 163.91 36.58 Favored 'Trans proline' 0 C--O 1.236 0.401 0 C-N-CA 118.371 -0.62 . . . . 0.0 113.378 -179.873 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 39.4 tt0 -53.87 129.22 33.04 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.274 -0.876 . . . . 0.0 109.09 178.999 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 108.65 -26.89 14.65 Favored Glycine 0 C--O 1.225 -0.408 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.911 -178.681 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 5.0 m -108.56 132.28 54.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 118.012 0.906 . . . . 0.0 111.545 178.499 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 2.8 p -121.14 148.18 44.56 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 177.3 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 75.9 mt -70.02 153.59 95.27 Favored Pre-proline 0 C--N 1.323 -0.566 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 177.739 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -74.1 168.82 23.88 Favored 'Trans proline' 0 C--O 1.235 0.354 0 N-CA-C 110.714 -0.533 . . . . 0.0 110.714 179.176 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -60.17 125.81 25.09 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.988 0.423 . . . . 0.0 111.49 -175.268 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 94.95 -2.9 66.73 Favored Glycine 0 C--O 1.227 -0.307 0 N-CA-C 115.131 0.813 . . . . 0.0 115.131 178.444 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -102.89 138.91 39.15 Favored 'General case' 0 N--CA 1.441 -0.911 0 CA-C-O 122.175 0.988 . . . . 0.0 110.39 -179.899 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 45.9 p90 -141.81 159.88 41.32 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 113.989 -1.46 . . . . 0.0 107.656 175.846 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -98.89 150.65 21.69 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 -179.505 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.464 ' HB3' ' HB ' ' A' ' 14' ' ' THR . 2.9 tp10 -73.17 129.03 37.16 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 106.77 -1.567 . . . . 0.0 106.77 179.74 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 89.03 -2.92 84.41 Favored Glycine 0 C--O 1.227 -0.318 0 C-N-CA 121.341 -0.457 . . . . 0.0 112.183 -177.615 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 46.4 t . . . . . 0 C--N 1.326 -0.422 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 178.218 . . . . . . . . 0 0 . 1 . 037 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.255 0 CA-C-O 121.252 0.549 . . . . 0.0 109.664 . . . . . . . . . 0 0 . 1 . 037 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 53.2 p -64.97 144.27 57.4 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 178.303 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 6.3 m95 -66.31 -26.3 67.25 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 111.959 0.355 . . . . 0.0 111.959 177.86 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 32.1 m-85 -121.72 159.15 27.19 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.361 -171.851 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 45.4 p -68.22 166.75 15.68 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.266 -0.879 . . . . 0.0 111.271 -178.246 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -85.38 127.2 34.28 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 113.695 0.998 . . . . 0.0 113.695 -175.513 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 22.6 mt -67.76 147.93 51.93 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 105.332 -2.099 . . . . 0.0 105.332 172.763 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 34.6 m -123.69 133.0 53.96 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 -178.733 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -94.48 140.94 29.18 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 114.266 1.21 . . . . 0.0 114.266 -176.43 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 57.3 t60 -138.82 100.1 3.97 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 105.673 -1.973 . . . . 0.0 105.673 166.04 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 166.3 -153.83 23.95 Favored Glycine 0 C--O 1.224 -0.503 0 C-N-CA 120.844 -0.693 . . . . 0.0 111.537 -177.756 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 40.2 mtpt -117.43 -21.73 8.52 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 113.556 0.947 . . . . 0.0 113.556 -179.42 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -76.1 156.74 33.57 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 178.369 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -73.75 -62.41 1.5 Allowed 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 179.776 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 35.4 tp 171.3 142.24 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 103.418 -2.808 . . . . 0.0 103.418 174.169 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 52.7 tptt -151.78 134.72 15.71 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 118.424 0.556 . . . . 0.0 111.281 174.823 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -123.02 149.13 56.14 Favored Pre-proline 0 C--O 1.243 0.74 0 N-CA-C 108.42 -0.955 . . . . 0.0 108.42 174.152 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -77.39 167.68 24.12 Favored 'Trans proline' 0 CA--C 1.537 0.653 0 C-N-CA 120.906 1.071 . . . . 0.0 113.671 179.268 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 71.3 ttt180 -67.96 137.65 55.32 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.759 -178.871 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 85.93 -0.11 87.61 Favored Glycine 0 C--O 1.224 -0.487 0 N-CA-C 111.562 -0.615 . . . . 0.0 111.562 178.336 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 -140.52 -179.48 6.04 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 -176.288 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 101.15 -29.14 13.15 Favored Glycine 0 CA--C 1.501 -0.842 0 CA-C-N 115.732 -0.667 . . . . 0.0 112.866 175.613 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 98.5 t -66.1 127.39 93.17 Favored Pre-proline 0 C--N 1.322 -0.621 0 N-CA-C 105.456 -2.053 . . . . 0.0 105.456 176.867 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -71.46 167.4 26.45 Favored 'Trans proline' 0 N--CA 1.461 -0.44 0 C-N-CA 120.329 0.686 . . . . 0.0 111.955 179.543 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 95.7 mt -63.36 121.32 12.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 106.227 -1.768 . . . . 0.0 106.227 179.481 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 43.3 t-20 -116.93 122.65 44.89 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.287 -0.87 . . . . 0.0 110.881 -173.913 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 73.4 p -103.03 -11.88 17.83 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.393 -0.821 . . . . 0.0 112.716 -177.475 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 17.5 p30 -114.24 15.99 18.04 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 116.324 1.972 . . . . 0.0 116.324 -173.063 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 29.0 m -141.83 154.31 45.09 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 113.742 1.015 . . . . 0.0 113.742 -177.694 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 18.6 m -72.44 164.45 59.6 Favored Pre-proline 0 C--O 1.238 0.464 0 CA-C-N 115.331 -0.85 . . . . 0.0 109.014 176.696 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -64.3 -28.44 63.68 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 115.4 -2.6 . . . . 0.0 112.46 178.918 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -62.65 -24.21 67.5 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 123.735 0.814 . . . . 0.0 111.613 177.643 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 33.4 m-20 -99.81 -2.49 34.92 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 114.75 1.389 . . . . 0.0 114.75 -171.622 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 96.9 mm-40 -60.46 -37.79 82.11 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 115.937 1.828 . . . . 0.0 115.937 -179.992 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 15.7 tt -59.33 138.3 20.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-O 122.313 1.054 . . . . 0.0 112.59 -176.965 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -178.77 -152.34 10.36 Favored Glycine 0 C--O 1.226 -0.383 0 CA-C-N 115.338 -0.847 . . . . 0.0 111.964 -174.862 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 47.8 p90 -154.7 173.59 16.18 Favored 'General case' 0 C--N 1.321 -0.636 0 O-C-N 122.379 -0.483 . . . . 0.0 110.448 -179.33 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -113.98 140.12 48.68 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 171.29 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -105.73 119.33 38.86 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 124.192 0.997 . . . . 0.0 109.69 -178.348 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -70.89 133.18 46.24 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 175.556 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -143.93 154.79 43.68 Favored 'General case' 0 C--N 1.321 -0.654 0 C-N-CA 122.814 0.445 . . . . 0.0 110.175 -177.441 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 15.2 t -156.68 166.98 31.84 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 174.975 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.7 tpt85 -160.29 153.81 22.33 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 103.421 -2.807 . . . . 0.0 103.421 179.475 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 21.8 ttm180 -131.37 146.07 52.12 Favored 'General case' 0 CA--C 1.495 -1.168 0 CA-C-N 118.804 0.729 . . . . 0.0 111.908 179.387 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -142.67 177.71 2.65 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 N-CA-C 104.823 -2.288 . . . . 0.0 104.823 179.205 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 7.1 tmm_? -128.09 103.05 7.0 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 104.999 -2.223 . . . . 0.0 104.999 174.852 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -70.49 154.89 52.76 Favored Glycine 0 C--O 1.22 -0.776 0 N-CA-C 110.731 -0.947 . . . . 0.0 110.731 -176.55 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -67.45 -34.8 85.69 Favored Glycine 0 C--O 1.215 -1.051 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 -179.817 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.1 t0 -94.24 16.91 13.71 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-O 122.483 1.135 . . . . 0.0 109.532 178.416 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 86.42 -17.53 38.35 Favored Glycine 0 C--O 1.225 -0.41 0 N-CA-C 116.225 1.25 . . . . 0.0 116.225 173.801 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -58.9 135.51 57.58 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 122.286 1.041 . . . . 0.0 113.319 -177.314 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 79.3 mtp -113.63 -175.76 2.75 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 113.472 -1.695 . . . . 0.0 111.728 -177.416 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 12.2 mptt -130.29 -41.98 1.22 Allowed 'General case' 0 N--CA 1.476 0.831 0 CA-C-O 122.641 1.21 . . . . 0.0 111.674 -178.984 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 15.7 t0 -61.02 -177.6 0.08 Allowed 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 111.657 -2.52 . . . . 0.0 113.456 179.014 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER 81.02 -52.41 0.3 Allowed 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 126.952 2.101 . . . . 0.0 110.162 -179.206 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 37.9 t -83.81 113.71 49.24 Favored Pre-proline 0 C--N 1.321 -0.662 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 175.459 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -73.45 150.01 45.53 Favored 'Trans proline' 0 C--O 1.239 0.565 0 C-N-CA 114.803 -2.998 . . . . 0.0 111.062 177.94 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 36.6 mtp180 -120.08 157.79 28.21 Favored 'General case' 0 CA--C 1.503 -0.855 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 -179.45 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 77.3 m95 -128.78 126.8 40.69 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 120.77 0.319 . . . . 0.0 110.874 -179.088 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 13.2 m-85 -110.52 134.25 52.54 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 106.769 -1.567 . . . . 0.0 106.769 -177.501 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 88.4 t80 -83.66 134.21 34.79 Favored 'General case' 0 CA--C 1.508 -0.661 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 -178.139 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -139.67 145.49 38.48 Favored 'General case' 0 N--CA 1.44 -0.935 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 -175.899 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 76.9 m-85 -83.12 159.55 22.06 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.937 -172.971 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -56.48 126.63 27.33 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 179.462 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 78.96 26.8 57.63 Favored Glycine 0 C--O 1.223 -0.559 0 N-CA-C 115.908 1.123 . . . . 0.0 115.908 178.224 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 22.2 p . . . . . 0 N--CA 1.469 0.515 0 CA-C-N 118.829 1.314 . . . . 0.0 109.746 177.201 . . . . . . . . 0 0 . 1 . 037 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 18.5 mt . . . . . 0 N--CA 1.447 -0.588 0 N-CA-C 116.628 2.084 . . . . 0.0 116.628 . . . . . . . . . 0 0 . 1 . 037 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -78.63 163.1 26.94 Favored 'Trans proline' 0 N--CA 1.461 -0.386 0 C-N-CA 122.305 2.004 . . . . 0.0 107.732 167.898 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 65.9 t80 -61.9 132.06 51.78 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 120.307 -0.557 . . . . 0.0 110.651 -177.005 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 92.1 -9.21 76.91 Favored Glycine 0 C--O 1.228 -0.277 0 CA-C-O 119.595 -0.559 . . . . 0.0 114.359 179.092 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -65.01 130.71 44.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 118.256 1.028 . . . . 0.0 111.39 179.403 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 57.0 t30 -79.36 130.75 35.74 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.413 -179.246 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 26.9 ttmt -154.84 150.71 27.77 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 178.454 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 32.1 t0 -64.4 120.78 12.89 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.284 0.564 . . . . 0.0 110.402 -178.047 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 78.41 29.76 51.92 Favored Glycine 0 N--CA 1.451 -0.309 0 CA-C-N 115.437 -0.802 . . . . 0.0 114.506 179.471 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 41.6 mm -127.06 126.38 68.09 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 CA-C-N 117.612 0.706 . . . . 0.0 110.712 179.099 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -127.16 116.04 42.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 CA-C-O 121.478 0.656 . . . . 0.0 111.381 176.337 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 96.7 m95 -79.91 138.48 37.14 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -178.326 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 16.1 m -138.29 153.23 26.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 179.15 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -160.1 165.92 30.84 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 107.073 -1.454 . . . . 0.0 107.073 -178.407 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 14.0 t -133.05 165.97 23.49 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 105.007 -2.22 . . . . 0.0 105.007 176.205 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 61.0 tt0 -67.41 138.18 56.5 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.096 0.474 . . . . 0.0 110.163 -179.06 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 94.97 -8.53 70.33 Favored Glycine 0 C--O 1.225 -0.432 0 CA-C-N 115.853 -0.612 . . . . 0.0 112.999 178.756 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -81.3 143.0 32.55 Favored 'General case' 0 C--N 1.323 -0.543 0 O-C-N 122.543 -0.386 . . . . 0.0 110.364 178.878 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 38.7 mt -100.53 134.76 43.0 Favored 'General case' 0 CA--C 1.514 -0.404 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -178.409 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -78.55 48.07 0.76 Allowed 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 115.184 -0.916 . . . . 0.0 112.049 -177.248 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 1.4 t -114.91 154.85 46.98 Favored Pre-proline 0 C--N 1.32 -0.717 0 N-CA-C 105.366 -2.087 . . . . 0.0 105.366 -179.98 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -64.97 149.01 90.03 Favored 'Trans proline' 0 C--N 1.342 0.197 0 N-CA-C 113.636 0.591 . . . . 0.0 113.636 176.802 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.99 54.96 1.3 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 123.551 1.644 . . . . 0.0 109.603 178.616 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -58.32 -30.66 66.86 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 113.128 -1.851 . . . . 0.0 111.456 178.501 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 29.4 p-80 -57.08 -16.65 7.89 Favored 'General case' 0 C--O 1.222 -0.389 0 N-CA-C 115.026 1.491 . . . . 0.0 115.026 -178.422 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 4.4 mt -92.02 -21.01 6.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 121.256 0.55 . . . . 0.0 110.515 -179.946 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -77.11 3.0 59.32 Favored Glycine 0 C--O 1.225 -0.413 0 C-N-CA 120.806 -0.711 . . . . 0.0 113.81 -177.692 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 9.9 t -83.34 11.33 6.9 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 114.235 1.198 . . . . 0.0 114.235 -176.588 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 66.9 ttp85 -59.69 126.09 26.22 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 107.794 -1.188 . . . . 0.0 107.794 178.417 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -97.45 137.38 21.1 Favored Pre-proline 0 C--N 1.322 -0.623 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 178.574 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -74.68 -20.27 17.84 Favored 'Trans proline' 0 C--O 1.219 -0.458 0 N-CA-C 113.815 0.66 . . . . 0.0 113.815 179.999 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -81.6 -24.87 36.18 Favored 'General case' 0 C--O 1.221 -0.408 0 CA-C-O 121.116 0.484 . . . . 0.0 110.145 179.919 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 87.4 m-20 -97.32 -22.27 16.74 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 113.503 0.927 . . . . 0.0 113.503 -175.266 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 24.4 t30 -157.22 151.35 24.82 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 112.315 0.487 . . . . 0.0 112.315 -178.005 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -89.08 146.19 24.98 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-O 121.433 0.635 . . . . 0.0 111.435 179.196 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -70.75 149.06 47.29 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.348 0.594 . . . . 0.0 110.923 178.713 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 22.7 mt -81.21 137.88 20.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 179.864 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 87.7 t -61.35 121.09 8.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 106.679 -1.6 . . . . 0.0 106.679 175.109 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 6.1 tt -67.39 125.53 26.41 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.074 0.464 . . . . 0.0 110.075 -176.985 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -134.46 159.12 42.09 Favored 'General case' 0 CA--C 1.508 -0.643 0 N-CA-C 106.491 -1.67 . . . . 0.0 106.491 -179.169 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 13.6 mt -112.97 148.31 39.12 Favored Pre-proline 0 C--N 1.32 -0.713 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 178.501 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -73.17 163.75 37.23 Favored 'Trans proline' 0 C--O 1.236 0.425 0 C-N-CA 118.254 -0.698 . . . . 0.0 112.836 -179.933 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 39.0 tt0 -54.6 129.55 36.82 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 179.403 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 108.83 -27.82 12.45 Favored Glycine 0 C--O 1.225 -0.416 0 CA-C-N 115.853 -0.612 . . . . 0.0 112.08 -178.461 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 4.3 m -105.6 129.29 53.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 118.128 0.964 . . . . 0.0 111.507 178.54 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 3.3 p -116.97 148.28 41.56 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.809 179.35 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 89.5 mt -73.2 151.43 90.16 Favored Pre-proline 0 C--N 1.323 -0.552 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 177.987 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -78.49 -172.04 1.4 Allowed 'Trans proline' 0 C--O 1.238 0.52 0 C-N-CA 121.061 1.174 . . . . 0.0 112.346 179.396 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 7.8 tmtt? -55.15 120.71 7.41 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 114.235 1.198 . . . . 0.0 114.235 -171.893 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 66.36 22.79 71.41 Favored Glycine 0 C--O 1.224 -0.494 0 CA-C-N 114.888 -1.051 . . . . 0.0 115.522 173.703 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -99.84 134.41 42.78 Favored 'General case' 0 N--CA 1.439 -0.977 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 177.774 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 42.5 p90 -139.8 161.27 37.97 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.051 -0.977 . . . . 0.0 108.711 178.392 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -98.08 144.93 27.05 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.727 0.775 . . . . 0.0 112.508 -176.716 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -78.29 139.24 38.87 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 106.566 -1.642 . . . . 0.0 106.566 176.212 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 91.75 -5.04 79.55 Favored Glycine 0 C--O 1.224 -0.471 0 C-N-CA 120.956 -0.64 . . . . 0.0 111.887 -178.355 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 21.9 t . . . . . 0 N--CA 1.449 -0.487 0 N-CA-C 105.635 -1.987 . . . . 0.0 105.635 175.948 . . . . . . . . 0 0 . 1 . 038 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 0.237 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 . . . . . . . . . 0 0 . 1 . 038 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -61.24 137.41 58.24 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 178.246 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 9.8 m95 -68.81 -27.01 65.47 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 113.151 0.797 . . . . 0.0 113.151 -179.851 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 54.5 m-85 -121.65 163.4 19.05 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 113.342 0.868 . . . . 0.0 113.342 -170.321 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 59.7 p -68.25 167.29 14.64 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 114.51 -1.223 . . . . 0.0 108.327 177.49 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -78.53 152.53 31.91 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 122.346 1.069 . . . . 0.0 112.803 -177.207 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 14.9 mt -91.98 142.26 27.73 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 102.383 -3.191 . . . . 0.0 102.383 167.527 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 33.1 m -124.71 140.01 53.33 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 -176.806 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . 0.445 ' HB2' ' CZ ' ' A' ' 131' ' ' PHE . 4.9 tp60 -120.76 146.0 46.95 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 116.095 1.887 . . . . 0.0 116.095 -172.725 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 78.2 t60 -133.14 99.47 4.56 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 106.811 -1.551 . . . . 0.0 106.811 169.706 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 178.03 -164.58 33.51 Favored Glycine 0 C--O 1.227 -0.294 0 N-CA-C 109.008 -1.637 . . . . 0.0 109.008 -177.722 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -99.79 -25.0 14.51 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 177.905 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -77.52 152.39 34.12 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 114.279 -1.328 . . . . 0.0 109.617 -179.897 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -88.97 -62.44 1.48 Allowed 'General case' 0 C--O 1.212 -0.891 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 178.095 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 45.0 tp -174.93 141.29 0.59 Allowed 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 174.699 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 9.8 tmtt? -156.94 131.58 8.74 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 176.193 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -120.73 153.63 56.94 Favored Pre-proline 0 CA--C 1.543 0.69 0 N-CA-C 111.517 0.191 . . . . 0.0 111.517 177.171 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_endo -78.39 164.18 26.65 Favored 'Trans proline' 0 CA--C 1.542 0.91 0 C-N-CA 120.695 0.93 . . . . 0.0 112.965 176.571 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 1.6 tmt_? -70.75 139.15 51.01 Favored 'General case' 0 N--CA 1.475 0.786 0 O-C-N 122.261 -0.275 . . . . 0.0 110.424 -178.753 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 85.31 4.27 86.33 Favored Glycine 0 C--O 1.223 -0.551 0 N-CA-C 110.851 -0.9 . . . . 0.0 110.851 177.66 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 38.5 mt-30 -147.16 -179.86 7.12 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 -174.257 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 97.48 -28.35 14.57 Favored Glycine 0 CA--C 1.499 -0.943 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.816 175.543 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 94.6 t -64.4 127.9 92.71 Favored Pre-proline 0 C--N 1.321 -0.642 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 177.1 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -73.76 170.72 19.37 Favored 'Trans proline' 0 N--CA 1.461 -0.431 0 O-C-N 122.236 0.598 . . . . 0.0 111.793 178.902 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 94.6 mt -68.07 112.7 3.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 178.784 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 80.5 m-20 -104.12 93.42 4.83 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 114.68 -1.145 . . . . 0.0 110.303 -176.855 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 67.4 p -69.39 -16.79 63.59 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.584 -0.734 . . . . 0.0 112.281 -179.032 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 10.9 p30 -106.92 22.76 15.46 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.057 -0.974 . . . . 0.0 113.227 -177.006 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 16.3 m -139.5 147.02 40.7 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 116.742 2.127 . . . . 0.0 116.742 -175.242 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 2.0 m -71.34 166.55 37.87 Favored Pre-proline 0 N--CA 1.468 0.431 0 CA-C-N 114.706 -1.133 . . . . 0.0 109.658 175.228 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -66.65 -27.97 44.89 Favored 'Trans proline' 0 CA--C 1.536 0.613 0 C-N-CA 114.238 -3.375 . . . . 0.0 113.922 -179.796 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.453 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 3.1 p-10 -75.28 -20.64 59.03 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.871 0.843 . . . . 0.0 110.944 178.057 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -83.49 -11.43 57.48 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 114.09 1.144 . . . . 0.0 114.09 -173.747 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 97.5 mm-40 -56.69 -29.79 62.75 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 115.512 1.671 . . . . 0.0 115.512 -177.03 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 12.0 tt -56.79 139.57 16.13 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.007 0 N-CA-C 114.385 1.254 . . . . 0.0 114.385 -176.948 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -177.31 -157.4 18.18 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.619 -0.8 . . . . 0.0 113.428 -178.413 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 41.4 p90 -154.66 170.53 21.33 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 179.766 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 23.5 m-85 -113.68 142.03 46.51 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 173.546 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 59.8 ttt180 -113.57 120.02 39.51 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 114.96 -1.018 . . . . 0.0 110.888 -175.455 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 3.6 ttt180 -63.06 140.95 58.93 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 123.184 0.594 . . . . 0.0 109.488 176.985 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -144.48 128.96 18.01 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.804 0.335 . . . . 0.0 110.173 177.442 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -158.79 134.17 8.58 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.129 178.574 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 18.5 tpt180 -145.94 123.74 11.94 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.479 0.657 . . . . 0.0 110.929 174.438 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 9.2 ttp180 -113.08 141.44 46.88 Favored 'General case' 0 CA--C 1.489 -1.394 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.423 178.495 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -131.56 177.77 6.53 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 N-CA-C 106.442 -1.688 . . . . 0.0 106.442 178.111 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 17.0 ttt85 -138.39 112.28 8.42 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 106.193 -1.781 . . . . 0.0 106.193 178.505 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -150.78 175.5 29.74 Favored Glycine 0 N--CA 1.444 -0.772 0 N-CA-C 107.145 -2.382 . . . . 0.0 107.145 178.395 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -75.25 -59.31 3.64 Favored Glycine 0 C--O 1.222 -0.624 0 N-CA-C 108.238 -1.945 . . . . 0.0 108.238 178.251 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.52 ' C ' ' H ' ' A' ' 60' ' ' LYS . 0.7 OUTLIER -94.26 -3.19 51.09 Favored 'General case' 0 C--O 1.217 -0.634 0 N-CA-C 105.207 -2.146 . . . . 0.0 105.207 174.266 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -89.53 33.89 4.21 Favored Glycine 0 N--CA 1.451 -0.314 0 N-CA-C 106.088 -2.805 . . . . 0.0 106.088 173.243 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.52 ' H ' ' C ' ' A' ' 58' ' ' ASP . 1.3 pttt -50.67 167.55 0.06 Allowed 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 113.415 -1.393 . . . . 0.0 111.028 172.268 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -46.69 129.59 11.31 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 113.926 -1.488 . . . . 0.0 113.698 -175.745 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -98.52 -73.99 0.6 Allowed 'General case' 0 C--O 1.219 -0.543 0 CA-C-N 113.666 -1.606 . . . . 0.0 114.044 -174.866 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 73.6 m-20 -95.06 96.66 9.4 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 179.349 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -74.58 -40.85 61.37 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 179.147 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 4.5 p -112.23 152.82 44.73 Favored Pre-proline 0 C--O 1.24 0.6 0 CA-C-N 114.962 -1.017 . . . . 0.0 108.985 179.723 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -74.34 156.68 45.96 Favored 'Trans proline' 0 C--O 1.238 0.497 0 C-N-CA 117.108 -1.461 . . . . 0.0 112.6 178.174 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 58.1 mtt-85 -124.58 149.87 46.55 Favored 'General case' 0 CA--C 1.513 -0.449 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.677 -179.657 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 35.0 m95 -134.75 129.82 35.24 Favored 'General case' 0 C--O 1.216 -0.662 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 175.565 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 60.0 m-85 -110.48 156.38 20.94 Favored 'General case' 0 C--O 1.212 -0.91 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 -178.96 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -97.97 136.91 37.57 Favored 'General case' 0 CA--C 1.509 -0.608 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 -179.84 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -139.12 130.31 26.73 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 107.097 -1.446 . . . . 0.0 107.097 -175.846 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 86.1 m-85 -70.69 159.47 34.4 Favored 'General case' 0 C--N 1.319 -0.756 0 O-C-N 122.191 -0.318 . . . . 0.0 111.063 -178.009 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -49.01 121.59 4.93 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 113.496 0.925 . . . . 0.0 113.496 -175.973 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 70.32 21.53 77.36 Favored Glycine 0 C--O 1.224 -0.529 0 N-CA-C 116.44 1.336 . . . . 0.0 116.44 176.009 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 34.2 p . . . . . 0 C--O 1.236 0.387 0 CA-C-N 118.604 1.202 . . . . 0.0 111.648 -179.742 . . . . . . . . 0 0 . 1 . 038 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 14.7 mt . . . . . 0 N--CA 1.444 -0.775 0 N-CA-C 115.412 1.634 . . . . 0.0 115.412 . . . . . . . . . 0 0 . 1 . 038 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -77.62 161.77 30.72 Favored 'Trans proline' 0 N--CA 1.461 -0.401 0 C-N-CA 122.061 1.84 . . . . 0.0 107.404 168.501 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 57.6 t80 -61.12 131.86 51.87 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 120.379 -0.529 . . . . 0.0 110.395 -177.177 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 92.98 -11.97 70.94 Favored Glycine 0 C--O 1.225 -0.432 0 CA-C-O 119.399 -0.667 . . . . 0.0 114.41 179.409 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -65.1 130.37 43.09 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 118.497 1.149 . . . . 0.0 112.071 -179.51 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 30.9 m120 -77.72 132.64 38.24 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 114.563 -1.199 . . . . 0.0 110.146 179.724 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 30.6 ttmt -156.21 155.35 32.26 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 104.148 -2.538 . . . . 0.0 104.148 177.795 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -65.75 133.22 50.57 Favored 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 120.273 -0.571 . . . . 0.0 109.672 -179.03 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 69.06 28.53 72.85 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.772 -0.728 . . . . 0.0 114.794 177.572 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 46.4 mm -126.01 126.6 70.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 117.476 0.638 . . . . 0.0 110.548 179.725 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -129.24 123.11 57.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.565 177.023 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 96.9 m95 -87.78 138.7 31.23 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 -176.758 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 13.7 m -138.02 151.49 25.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 179.102 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -160.29 165.86 30.57 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 104.833 -2.284 . . . . 0.0 104.833 -179.973 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 14.1 t -127.09 170.78 11.99 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 105.237 -2.135 . . . . 0.0 105.237 178.479 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -66.07 133.55 50.99 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.088 0.471 . . . . 0.0 110.651 -178.635 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 92.69 -7.5 77.21 Favored Glycine 0 N--CA 1.459 0.172 0 CA-C-N 116.017 -0.538 . . . . 0.0 113.422 178.749 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.453 ' HA ' ' HA ' ' A' ' 41' ' ' ASP . . . -74.63 140.49 44.33 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 178.504 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 39.6 mt -99.27 138.03 36.95 Favored 'General case' 0 CA--C 1.515 -0.385 0 N-CA-C 113.398 0.888 . . . . 0.0 113.398 -177.763 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -81.4 66.55 6.99 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.438 -178.751 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 1.2 t -133.11 155.36 81.1 Favored Pre-proline 0 C--N 1.32 -0.697 0 N-CA-C 105.327 -2.101 . . . . 0.0 105.327 -179.5 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -61.17 147.82 94.57 Favored 'Trans proline' 0 C--N 1.343 0.253 0 N-CA-C 114.614 0.967 . . . . 0.0 114.614 -179.603 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -121.39 38.17 4.16 Favored 'General case' 0 CA--C 1.508 -0.643 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.332 -179.402 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 16.7 p-10 -59.9 -33.62 72.1 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 176.514 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 7.9 p80 -62.79 -16.19 56.94 Favored 'General case' 0 C--O 1.221 -0.411 0 N-CA-C 113.158 0.799 . . . . 0.0 113.158 177.973 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 60.2 mt -95.93 -49.96 11.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 120.977 0.418 . . . . 0.0 110.896 178.281 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -71.02 14.19 1.63 Allowed Glycine 0 C--O 1.22 -0.741 0 N-CA-C 117.53 1.772 . . . . 0.0 117.53 -174.124 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 9.0 t -83.59 26.43 0.68 Allowed 'General case' 0 CA--C 1.551 0.988 0 CA-C-O 121.671 0.748 . . . . 0.0 111.744 -179.31 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 64.8 ttp85 -68.32 119.43 12.84 Favored 'General case' 0 N--CA 1.465 0.325 0 O-C-N 121.271 -0.893 . . . . 0.0 109.978 178.66 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -86.54 122.17 71.95 Favored Pre-proline 0 C--N 1.323 -0.569 0 N-CA-C 105.103 -2.184 . . . . 0.0 105.103 176.571 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -72.78 -15.43 26.79 Favored 'Trans proline' 0 C--O 1.218 -0.494 0 C-N-CA 116.907 -1.595 . . . . 0.0 114.374 -177.174 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -81.57 -24.56 36.43 Favored 'General case' 0 C--O 1.221 -0.422 0 CA-C-O 120.963 0.411 . . . . 0.0 110.479 178.745 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 -100.15 -22.98 14.97 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 -174.504 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 15.5 t30 -145.72 148.69 33.28 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -178.314 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -86.37 148.44 25.58 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-O 121.654 0.74 . . . . 0.0 112.536 -179.776 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -73.74 151.02 40.79 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.635 178.132 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 14.2 mt -90.73 139.62 17.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.565 -178.738 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 73.1 t -62.83 121.82 12.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 174.588 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 5.2 tt -67.18 129.45 39.95 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.189 0.519 . . . . 0.0 111.088 -176.923 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 34.5 mt-30 -135.88 158.41 44.47 Favored 'General case' 0 C--O 1.218 -0.562 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 -179.226 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 13.4 mt -112.18 148.0 38.16 Favored Pre-proline 0 C--N 1.322 -0.598 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 177.577 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -73.59 163.02 38.52 Favored 'Trans proline' 0 C--O 1.237 0.457 0 O-C-N 122.195 0.576 . . . . 0.0 112.546 179.179 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 53.9 tt0 -55.24 132.0 46.74 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 179.508 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 106.57 -27.06 17.9 Favored Glycine 0 C--O 1.226 -0.37 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.983 -178.515 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 8.9 m -105.44 129.33 53.77 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 118.04 0.92 . . . . 0.0 111.198 178.395 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 3.0 p -115.65 148.21 39.94 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.15 178.44 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 86.2 mt -71.4 152.94 94.09 Favored Pre-proline 0 C--N 1.323 -0.587 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 177.647 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -76.53 175.02 11.89 Favored 'Trans proline' 0 CA--C 1.531 0.325 0 N-CA-C 110.615 -0.571 . . . . 0.0 110.615 178.529 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 12.0 tmtt? -53.49 128.65 29.66 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 -175.571 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 88.43 -3.54 85.29 Favored Glycine 0 C--O 1.23 -0.151 0 N-CA-C 116.74 1.456 . . . . 0.0 116.74 173.497 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.445 ' CZ ' ' HB2' ' A' ' 18' ' ' GLN . 1.8 m-85 -93.18 144.09 25.62 Favored 'General case' 0 N--CA 1.433 -1.316 0 CA-C-O 122.718 1.247 . . . . 0.0 112.072 -178.464 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 34.6 p90 -144.52 164.47 30.79 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-N 112.636 -2.074 . . . . 0.0 106.773 174.193 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -106.35 147.06 29.65 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.243 0.545 . . . . 0.0 110.736 -177.381 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -75.8 129.91 37.77 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 -179.59 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 87.63 -0.32 84.78 Favored Glycine 0 C--O 1.225 -0.464 0 C-N-CA 121.161 -0.542 . . . . 0.0 112.55 -178.093 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 24.9 t . . . . . 0 C--N 1.327 -0.386 0 O-C-N 122.433 -0.451 . . . . 0.0 110.106 178.491 . . . . . . . . 0 0 . 1 . 039 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.217 0 N-CA-C 113.379 0.881 . . . . 0.0 113.379 . . . . . . . . . 0 0 . 1 . 039 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 28.4 t -58.88 134.97 57.39 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 114.548 -1.205 . . . . 0.0 108.63 174.591 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 3.1 m95 -67.55 -26.87 66.52 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 178.058 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -121.73 161.34 22.75 Favored 'General case' 0 CA--C 1.507 -0.676 0 CA-C-O 121.192 0.52 . . . . 0.0 110.312 -171.375 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 64.8 p -67.33 161.26 25.46 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 122.195 0.997 . . . . 0.0 109.561 179.622 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -92.14 120.71 33.0 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 114.686 -1.143 . . . . 0.0 112.474 -174.156 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -68.59 148.81 49.96 Favored 'General case' 0 CA--C 1.505 -0.768 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 179.96 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 17.4 m -93.26 136.62 33.35 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 176.947 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 20.0 tm0? -107.28 117.5 34.24 Favored 'General case' 0 CA--C 1.509 -0.621 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 177.144 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 22.7 t-160 -139.32 99.88 3.85 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 172.728 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 173.53 -166.12 38.33 Favored Glycine 0 C--N 1.319 -0.407 0 N-CA-C 110.521 -1.032 . . . . 0.0 110.521 -178.977 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 89.0 mttt -92.53 -24.8 18.64 Favored 'General case' 0 CA--C 1.512 -0.516 0 CA-C-O 121.993 0.901 . . . . 0.0 109.635 179.449 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -90.6 152.11 21.02 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 114.175 -1.375 . . . . 0.0 108.384 179.311 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -87.57 -62.4 1.51 Allowed 'General case' 0 C--O 1.21 -0.977 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.062 -177.421 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 49.6 tp 172.34 141.71 0.03 OUTLIER 'General case' 0 CA--C 1.506 -0.75 0 N-CA-C 104.572 -2.381 . . . . 0.0 104.572 176.824 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 23.3 tptt -161.94 143.38 10.99 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 106.606 -1.627 . . . . 0.0 106.606 178.185 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 16.6 m-85 -132.62 150.0 74.6 Favored Pre-proline 0 C--N 1.323 -0.558 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 177.398 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -76.56 166.87 26.56 Favored 'Trans proline' 0 C--N 1.351 0.702 0 C-N-CA 120.159 0.573 . . . . 0.0 113.402 179.593 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 21.3 tpt180 -64.14 136.11 56.95 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.587 -178.647 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 86.32 -1.91 87.48 Favored Glycine 0 N--CA 1.46 0.24 0 CA-C-O 121.395 0.442 . . . . 0.0 112.145 177.751 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -138.67 170.52 15.86 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 123.408 0.683 . . . . 0.0 110.433 -174.144 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 107.06 -26.82 17.88 Favored Glycine 0 CA--C 1.496 -1.103 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.67 175.249 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 85.1 t -65.27 125.49 89.51 Favored Pre-proline 0 C--N 1.32 -0.699 0 N-CA-C 105.498 -2.038 . . . . 0.0 105.498 176.372 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -71.6 164.52 35.44 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 N-CA-C 110.579 -0.585 . . . . 0.0 110.579 178.422 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 84.8 mt -61.99 115.0 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 -177.237 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -116.98 74.84 0.93 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 122.667 1.223 . . . . 0.0 112.307 -170.377 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 72.7 p -69.73 -19.51 63.54 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 114.371 -1.286 . . . . 0.0 113.506 -175.53 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 52.9 m-80 -106.38 29.04 7.19 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.644 -0.707 . . . . 0.0 112.165 -174.195 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 97.8 p -146.46 160.73 41.72 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.919 0.39 . . . . 0.0 111.032 179.786 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.3 m -71.67 163.83 63.14 Favored Pre-proline 0 C--N 1.323 -0.546 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.67 -178.313 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -67.34 -28.39 39.56 Favored 'Trans proline' 0 C--N 1.351 0.658 0 C-N-CA 115.167 -2.755 . . . . 0.0 113.669 179.041 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.43 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 1.6 p-10 -75.13 -19.84 59.71 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 121.525 -0.734 . . . . 0.0 110.518 176.714 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 34.6 m-20 -84.45 -6.9 59.42 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 113.955 1.094 . . . . 0.0 113.955 -173.335 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 97.6 mm-40 -57.54 -32.53 67.17 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 114.144 1.165 . . . . 0.0 114.144 -179.113 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 10.4 tt -58.43 139.24 18.38 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 CA-C-O 122.382 1.087 . . . . 0.0 113.49 -176.904 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -176.26 -159.65 22.26 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.277 -0.964 . . . . 0.0 112.899 -178.166 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 38.3 p90 -154.82 166.6 32.97 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 179.511 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 13.3 m-85 -109.27 142.9 39.46 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 174.472 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 62.9 ttt180 -116.15 125.45 52.34 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 123.182 0.593 . . . . 0.0 111.044 -176.89 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 47.8 ttp180 -74.06 134.19 42.95 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 109.592 -0.522 . . . . 0.0 109.592 177.329 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -152.0 170.0 20.95 Favored 'General case' 0 C--O 1.213 -0.846 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 -179.072 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 8.9 t -136.82 142.41 42.89 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 119.161 0.891 . . . . 0.0 110.574 172.106 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 14.7 tpt180 -166.79 128.66 1.73 Allowed 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 179.226 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 21.9 mmt180 -147.63 -179.42 6.86 Favored 'General case' 0 CA--C 1.48 -1.72 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 -179.01 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -117.25 170.92 6.19 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.97 0 CA-C-N 113.686 -1.597 . . . . 0.0 107.043 -177.105 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 8.7 ttm-85 -143.44 129.69 19.83 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 175.886 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -82.01 178.99 53.45 Favored Glycine 0 C--O 1.221 -0.703 0 N-CA-C 109.882 -1.287 . . . . 0.0 109.882 178.583 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -67.59 -36.34 87.89 Favored Glycine 0 C--O 1.217 -0.951 0 C-N-CA 121.008 -0.615 . . . . 0.0 114.116 -176.425 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -80.3 -16.59 54.28 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 122.143 0.973 . . . . 0.0 109.054 178.787 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 114.37 -6.37 23.03 Favored Glycine 0 N--CA 1.452 -0.293 0 CA-C-N 114.496 -1.229 . . . . 0.0 114.584 179.587 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.414 ' H ' ' HD2' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -61.33 150.47 34.91 Favored 'General case' 0 CA--C 1.506 -0.725 0 CA-C-N 118.334 1.067 . . . . 0.0 111.242 -178.404 . . . . . . . . 3 3 . 1 . 039 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 89.7 mtp -126.88 164.2 21.94 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 113.978 -1.464 . . . . 0.0 112.249 -176.647 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 2.0 tppt? -77.87 -37.43 48.2 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.298 -179.031 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 60.2 t0 -175.53 167.1 3.27 Favored 'General case' 0 C--N 1.318 -0.778 1 N-CA-C 99.283 -4.34 . . . . 0.0 99.283 -177.242 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -109.95 -31.83 7.25 Favored 'General case' 0 N--CA 1.435 -1.205 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 176.72 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.5 m -55.91 156.55 9.64 Favored Pre-proline 0 C--O 1.245 0.853 0 N-CA-C 116.342 1.979 . . . . 0.0 116.342 -174.949 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -75.62 -176.68 3.1 Favored 'Trans proline' 0 C--N 1.354 0.822 0 C-N-CA 121.039 1.16 . . . . 0.0 114.276 -179.275 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 81.0 mtt-85 -133.75 166.36 22.83 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.488 -177.836 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 50.9 m95 -125.39 131.72 52.9 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 173.751 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 24.1 m-85 -110.55 166.86 10.66 Favored 'General case' 0 C--O 1.216 -0.683 0 N-CA-C 105.45 -2.055 . . . . 0.0 105.45 -177.595 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 93.4 t80 -117.92 134.91 54.49 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-N 119.287 0.948 . . . . 0.0 109.721 -178.949 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 16.7 m-85 -136.36 158.88 43.38 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 -177.316 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 63.3 m-85 -98.63 159.34 15.02 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 -174.794 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -53.83 127.71 27.06 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.986 0.422 . . . . 0.0 111.039 -178.167 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 68.17 31.78 75.29 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.439 -0.886 . . . . 0.0 114.84 176.76 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 2.3 p . . . . . 0 C--N 1.327 -0.37 0 N-CA-C 105.181 -2.155 . . . . 0.0 105.181 174.16 . . . . . . . . 0 0 . 1 . 039 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 13.2 mt . . . . . 0 N--CA 1.44 -0.972 0 N-CA-C 115.039 1.496 . . . . 0.0 115.039 . . . . . . . . . 0 0 . 1 . 039 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -78.4 161.61 28.45 Favored 'Trans proline' 0 N--CA 1.461 -0.424 0 C-N-CA 122.226 1.951 . . . . 0.0 107.304 167.772 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 57.7 t80 -61.11 130.66 47.44 Favored 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 120.315 -0.554 . . . . 0.0 110.44 -177.576 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 93.27 -8.51 75.32 Favored Glycine 0 CA--C 1.52 0.351 0 CA-C-O 119.35 -0.694 . . . . 0.0 114.352 178.956 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -67.12 131.73 46.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 118.607 1.203 . . . . 0.0 111.247 179.754 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 57.0 t30 -78.93 132.13 36.62 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.734 -0.667 . . . . 0.0 110.167 179.895 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 29.0 ttmt -155.97 154.38 31.02 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 106.146 -1.798 . . . . 0.0 106.146 179.28 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -61.4 129.32 40.64 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.081 0.467 . . . . 0.0 111.136 -178.648 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 67.86 30.08 74.11 Favored Glycine 0 N--CA 1.449 -0.474 0 CA-C-O 119.175 -0.792 . . . . 0.0 114.185 177.624 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 43.3 mm -126.04 131.86 71.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 117.845 0.822 . . . . 0.0 111.286 179.632 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -134.93 122.64 38.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.776 175.636 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 95.8 m95 -87.18 137.97 31.89 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 113.167 0.803 . . . . 0.0 113.167 -176.913 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 17.7 m -137.48 150.67 25.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.607 179.326 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -160.39 166.03 30.06 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 105.03 -2.211 . . . . 0.0 105.03 179.907 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 7.1 t -134.41 176.63 8.43 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 105.305 -2.109 . . . . 0.0 105.305 177.849 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -67.56 135.24 52.64 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.302 0.572 . . . . 0.0 110.702 -178.473 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 96.57 -12.7 66.1 Favored Glycine 0 C--O 1.228 -0.269 0 CA-C-N 115.703 -0.68 . . . . 0.0 112.911 178.341 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.43 ' HA ' ' HA ' ' A' ' 41' ' ' ASP . . . -77.16 137.09 38.67 Favored 'General case' 0 CA--C 1.543 0.676 0 O-C-N 122.694 -0.297 . . . . 0.0 110.622 179.982 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 40.6 mt -98.78 138.55 35.76 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 -177.884 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -80.11 63.8 4.73 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.165 -179.023 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 1.4 t -132.27 154.96 81.8 Favored Pre-proline 0 C--N 1.323 -0.581 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 -179.399 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -66.52 148.23 83.38 Favored 'Trans proline' 0 CA--C 1.53 0.319 0 N-CA-C 114.48 0.915 . . . . 0.0 114.48 175.974 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -148.83 57.9 1.04 Allowed 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 113.571 0.952 . . . . 0.0 113.571 179.212 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 12.5 t0 -64.56 -11.34 33.51 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 121.28 0.562 . . . . 0.0 110.658 175.782 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 12.5 p-80 -62.45 -13.42 29.88 Favored 'General case' 0 N--CA 1.468 0.473 0 O-C-N 122.038 -0.414 . . . . 0.0 111.679 177.412 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 20.6 mt -96.09 -28.75 3.91 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 CA-C-O 120.819 0.342 . . . . 0.0 111.023 179.079 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -73.46 3.74 31.05 Favored Glycine 0 N--CA 1.462 0.387 0 N-CA-C 115.09 0.796 . . . . 0.0 115.09 -176.117 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 14.4 t -83.22 19.03 1.56 Allowed 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 113.515 0.931 . . . . 0.0 113.515 -177.694 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 67.1 ttp85 -64.39 114.95 4.63 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 177.664 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 58.8 m-20 -91.12 121.36 67.93 Favored Pre-proline 0 C--N 1.318 -0.78 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 -178.596 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -68.93 -18.74 40.85 Favored 'Trans proline' 0 C--N 1.347 0.493 0 N-CA-C 114.343 0.863 . . . . 0.0 114.343 -176.176 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -73.77 -26.01 60.43 Favored 'General case' 0 C--O 1.22 -0.469 0 CA-C-O 120.734 0.302 . . . . 0.0 110.548 177.365 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 76.5 m-20 -103.49 -27.1 12.58 Favored 'General case' 0 C--O 1.222 -0.361 0 N-CA-C 113.421 0.897 . . . . 0.0 113.421 -174.95 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 19.0 t30 -147.35 145.04 29.17 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.818 0.673 . . . . 0.0 112.818 -178.751 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -83.19 146.16 28.76 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-O 121.517 0.675 . . . . 0.0 111.911 -179.79 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -70.38 144.13 51.69 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 177.325 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 12.0 mt -76.9 135.63 26.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 -178.406 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 72.9 t -63.75 118.33 5.8 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 N-CA-C 103.633 -2.729 . . . . 0.0 103.633 172.859 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 6.8 tt -63.18 130.99 46.96 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.38 0.609 . . . . 0.0 112.072 -174.061 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 30.8 mt-30 -130.58 150.46 51.77 Favored 'General case' 0 CA--C 1.508 -0.671 0 N-CA-C 106.084 -1.821 . . . . 0.0 106.084 179.089 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 12.5 mt -110.37 148.3 38.13 Favored Pre-proline 0 C--N 1.319 -0.76 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 177.773 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -73.71 166.07 30.69 Favored 'Trans proline' 0 C--O 1.236 0.416 0 C-N-CA 118.239 -0.707 . . . . 0.0 112.659 -179.605 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 40.5 tt0 -54.04 131.88 41.52 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.073 179.425 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 104.1 -27.35 19.77 Favored Glycine 0 C--O 1.226 -0.356 0 CA-C-N 115.91 -0.587 . . . . 0.0 112.288 -178.598 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 2.7 m -105.98 129.34 54.12 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 118.207 1.004 . . . . 0.0 112.205 178.759 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 9.4 p -119.8 148.24 43.68 Favored 'General case' 0 CA--C 1.509 -0.607 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.899 178.423 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 93.1 mt -68.07 154.31 94.06 Favored Pre-proline 0 C--N 1.323 -0.571 0 N-CA-C 106.935 -1.506 . . . . 0.0 106.935 177.2 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -76.77 177.6 8.65 Favored 'Trans proline' 0 N--CA 1.464 -0.214 0 CA-C-O 121.446 0.519 . . . . 0.0 112.442 -178.795 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 3.0 ttpm? -59.77 130.65 47.85 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.118 -0.492 . . . . 0.0 109.701 179.072 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 84.26 23.21 52.36 Favored Glycine 0 N--CA 1.454 -0.138 0 N-CA-C 115.44 0.936 . . . . 0.0 115.44 176.876 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -124.73 141.72 51.91 Favored 'General case' 0 CA--C 1.51 -0.568 0 CA-C-O 121.426 0.631 . . . . 0.0 112.152 179.382 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 45.4 p90 -145.6 153.21 40.81 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 107.259 -1.386 . . . . 0.0 107.259 172.584 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -89.18 139.21 30.71 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.186 0.517 . . . . 0.0 111.025 -177.577 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -71.38 137.87 48.72 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 176.325 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 89.34 -2.34 83.15 Favored Glycine 0 C--O 1.224 -0.53 0 N-CA-C 111.653 -0.579 . . . . 0.0 111.653 -178.215 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 9.6 t . . . . . 0 C--N 1.327 -0.409 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 177.46 . . . . . . . . 0 0 . 1 . 040 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.228 -0.078 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 . . . . . . . . . 0 0 . 1 . 040 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 46.6 t -64.01 141.83 58.63 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 177.973 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 17.8 m95 -68.44 -21.72 64.63 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 111.944 0.35 . . . . 0.0 111.944 178.284 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 64.8 m-85 -121.53 164.38 17.32 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 -172.366 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 73.8 p -70.01 161.53 29.9 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 178.97 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -76.22 149.74 37.18 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 113.743 1.016 . . . . 0.0 113.743 -175.425 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 13.9 mt -91.99 148.87 21.87 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 103.818 -2.66 . . . . 0.0 103.818 170.425 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 19.6 m -122.33 137.63 54.79 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 -179.186 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . 0.42 ' HB2' ' CZ ' ' A' ' 131' ' ' PHE . 4.4 tp60 -112.05 133.11 54.41 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 -177.669 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 8.7 t60 -126.9 99.43 5.73 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 105.178 -2.156 . . . . 0.0 105.178 171.18 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 175.25 -172.77 45.78 Favored Glycine 0 C--O 1.227 -0.286 0 N-CA-C 110.212 -1.155 . . . . 0.0 110.212 -177.626 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -99.21 -27.29 13.87 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 121.048 0.451 . . . . 0.0 111.27 179.496 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -80.93 166.7 20.62 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 107.038 -1.467 . . . . 0.0 107.038 177.06 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -94.48 -62.78 1.27 Allowed 'General case' 0 CA--C 1.548 0.888 0 CA-C-O 118.443 -0.789 . . . . 0.0 112.156 -176.662 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 33.7 tp -175.08 140.95 0.54 Allowed 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 124.044 0.938 . . . . 0.0 109.413 172.821 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 50.2 tptt -151.77 138.85 19.14 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 172.67 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -122.25 153.71 61.78 Favored Pre-proline 0 C--O 1.242 0.671 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 176.533 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -70.33 158.15 57.1 Favored 'Trans proline' 0 C--N 1.353 0.795 0 O-C-N 122.079 0.515 . . . . 0.0 112.727 179.458 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 70.9 ttt180 -70.16 134.36 48.05 Favored 'General case' 0 C--O 1.216 -0.688 0 O-C-N 121.848 -0.533 . . . . 0.0 111.072 -177.725 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 90.13 1.16 76.25 Favored Glycine 0 N--CA 1.462 0.409 0 CA-C-O 121.649 0.583 . . . . 0.0 112.035 179.262 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -146.77 170.45 16.97 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 107.497 -1.298 . . . . 0.0 107.497 -176.941 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 127.09 -28.39 4.6 Favored Glycine 0 CA--C 1.483 -1.948 0 N-CA-C 108.46 -1.856 . . . . 0.0 108.46 165.79 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 32.8 m -67.72 140.69 94.45 Favored Pre-proline 0 N--CA 1.429 -1.477 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 177.462 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -74.37 173.93 13.39 Favored 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 121.226 1.284 . . . . 0.0 111.91 178.918 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 92.7 mt -73.72 115.03 14.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 N-CA-C 107.494 -1.298 . . . . 0.0 107.494 177.823 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 31.6 m-20 -111.79 80.33 1.31 Allowed 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.423 -177.791 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 81.2 p -67.76 -16.2 64.01 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 113.835 1.05 . . . . 0.0 113.835 -176.877 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -106.83 21.31 17.72 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.375 -177.15 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 5.3 m -134.97 157.79 45.99 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.78 0.324 . . . . 0.0 111.483 -176.47 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 20.0 m -72.85 161.36 79.74 Favored Pre-proline 0 C--N 1.323 -0.549 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 178.615 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -65.19 -26.62 56.96 Favored 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 114.93 -2.913 . . . . 0.0 110.49 176.021 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -61.75 -19.32 62.32 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 124.578 1.151 . . . . 0.0 111.652 175.713 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -107.92 1.0 22.34 Favored 'General case' 0 C--O 1.217 -0.618 0 N-CA-C 115.027 1.491 . . . . 0.0 115.027 -172.617 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 85.7 mm-40 -61.45 -27.57 68.66 Favored 'General case' 0 C--O 1.216 -0.694 0 O-C-N 121.045 -1.034 . . . . 0.0 111.068 178.995 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 13.0 tt -60.35 144.05 13.65 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 N-CA-C 113.797 1.036 . . . . 0.0 113.797 179.209 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 178.85 -152.57 11.41 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.527 -0.844 . . . . 0.0 111.21 178.543 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 47.1 p90 -155.08 168.88 25.54 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 177.22 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 25.4 m-85 -113.34 141.07 47.48 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 106.648 -1.612 . . . . 0.0 106.648 174.071 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 38.6 ttt180 -111.05 127.6 55.6 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.37 -178.695 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 28.4 ttm180 -68.04 134.54 50.81 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 106.353 -1.721 . . . . 0.0 106.353 176.602 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -139.57 127.89 22.7 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 -176.734 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 6.8 p -139.62 131.95 28.37 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 174.773 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 11.2 tpt180 -160.73 123.83 3.34 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 178.621 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 2.5 tpp180 -97.17 137.42 36.23 Favored 'General case' 0 CA--C 1.501 -0.935 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 179.801 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -124.87 171.44 13.73 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 -179.201 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 8.1 tmm_? -134.66 114.03 12.32 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 106.324 -1.732 . . . . 0.0 106.324 177.745 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -74.5 165.07 54.75 Favored Glycine 0 N--CA 1.449 -0.497 0 N-CA-C 110.733 -0.947 . . . . 0.0 110.733 179.489 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -75.3 -27.42 63.84 Favored Glycine 0 C--O 1.217 -0.954 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 -179.562 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -89.77 14.61 11.45 Favored 'General case' 0 C--O 1.219 -0.523 0 CA-C-O 122.256 1.027 . . . . 0.0 109.706 179.077 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 86.21 -12.81 59.39 Favored Glycine 0 C--O 1.227 -0.288 0 N-CA-C 115.897 1.119 . . . . 0.0 115.897 173.706 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -64.5 130.49 43.9 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.699 0.762 . . . . 0.0 111.614 -178.609 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 94.8 mmm -91.86 -170.65 2.62 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 114.527 -1.215 . . . . 0.0 110.399 -178.489 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 18.4 tptp -92.79 -53.95 3.96 Favored 'General case' 0 CA--C 1.515 -0.395 0 N-CA-C 114.085 1.142 . . . . 0.0 114.085 179.436 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 38.45 -140.78 0.04 OUTLIER 'General case' 0 C--O 1.245 0.861 0 O-C-N 125.135 1.522 . . . . 0.0 113.025 -175.571 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 61.29 170.8 0.11 Allowed 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.694 1.198 . . . . 0.0 113.999 -176.232 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -74.69 165.35 54.46 Favored Pre-proline 0 C--O 1.24 0.589 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.71 -179.655 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -66.18 152.16 81.84 Favored 'Trans proline' 0 C--N 1.355 0.87 0 C-N-CA 117.818 -0.988 . . . . 0.0 112.053 178.67 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 30.7 mtt180 -124.02 166.3 15.97 Favored 'General case' 0 CA--C 1.51 -0.57 0 N-CA-C 114.779 1.4 . . . . 0.0 114.779 -175.958 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 67.4 m95 -130.43 146.84 52.06 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 177.922 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 25.5 m-85 -130.64 144.11 51.2 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 -178.799 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 77.4 t80 -89.91 136.42 33.05 Favored 'General case' 0 CA--C 1.512 -0.485 0 N-CA-C 109.001 -0.741 . . . . 0.0 109.001 -177.218 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -139.64 143.23 37.09 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 108.812 -0.811 . . . . 0.0 108.812 -176.333 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -74.23 159.43 32.51 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.67 -175.993 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.1 tt -55.89 129.54 40.0 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 -176.137 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 69.0 34.54 76.79 Favored Glycine 0 C--O 1.222 -0.649 0 N-CA-C 115.487 0.955 . . . . 0.0 115.487 175.498 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.326 -0.432 0 CA-C-N 118.28 1.04 . . . . 0.0 111.334 -179.989 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 20.2 mt . . . . . 0 N--CA 1.448 -0.551 0 N-CA-C 115.683 1.734 . . . . 0.0 115.683 . . . . . . . . . 0 0 . 1 . 040 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -78.89 166.27 23.5 Favored 'Trans proline' 0 N--CA 1.46 -0.458 0 C-N-CA 121.826 1.684 . . . . 0.0 108.034 168.707 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 54.2 t80 -62.2 132.34 52.44 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 120.622 -0.431 . . . . 0.0 109.935 -179.96 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 92.06 -8.25 78.01 Favored Glycine 0 CA--C 1.52 0.358 0 N-CA-C 115.085 0.794 . . . . 0.0 115.085 178.794 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -64.35 131.48 47.38 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 118.321 1.06 . . . . 0.0 112.007 -179.963 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 33.4 t-20 -73.98 127.16 32.15 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.595 -178.517 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 26.4 ttmt -156.18 150.1 25.15 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 104.992 -2.225 . . . . 0.0 104.992 175.74 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -71.13 136.05 47.97 Favored 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 120.198 -0.601 . . . . 0.0 109.723 -177.376 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 73.58 21.09 79.81 Favored Glycine 0 N--CA 1.447 -0.59 0 CA-C-O 119.19 -0.783 . . . . 0.0 113.353 178.665 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 44.3 mm -124.87 121.83 62.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 117.542 0.671 . . . . 0.0 110.376 179.402 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -122.75 112.52 34.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 CA-C-O 121.862 0.839 . . . . 0.0 110.793 175.749 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 96.4 m95 -78.44 133.21 37.51 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.126 -178.814 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 1.7 m -140.81 149.73 20.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 -178.689 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -157.98 166.05 33.57 Favored 'General case' 0 CA--C 1.507 -0.696 0 N-CA-C 106.491 -1.67 . . . . 0.0 106.491 -178.404 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 5.9 t -132.44 171.5 13.68 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 105.94 -1.874 . . . . 0.0 105.94 174.897 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -67.65 138.86 56.67 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.258 0.551 . . . . 0.0 110.81 -178.142 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 96.46 -7.67 66.2 Favored Glycine 0 C--O 1.226 -0.386 0 CA-C-N 115.705 -0.68 . . . . 0.0 113.143 178.943 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -85.6 147.23 26.5 Favored 'General case' 0 CA--C 1.544 0.74 0 O-C-N 122.632 -0.334 . . . . 0.0 111.489 179.982 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 45.2 mt -92.02 139.7 30.38 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -178.274 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 60.8 t30 -90.45 66.61 6.43 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.057 0.456 . . . . 0.0 110.83 -179.463 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -141.31 155.88 67.62 Favored Pre-proline 0 C--N 1.323 -0.57 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 179.889 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -73.77 152.4 47.32 Favored 'Trans proline' 0 CA--C 1.535 0.565 0 N-CA-C 114.955 1.098 . . . . 0.0 114.955 178.313 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.54 57.96 1.12 Allowed 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 121.827 0.823 . . . . 0.0 111.125 179.171 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -57.9 -31.6 66.93 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.609 179.071 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 42.7 p-80 -63.12 -13.95 42.77 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 114.273 1.212 . . . . 0.0 114.273 -178.162 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 94.8 mt -87.92 -29.06 5.46 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 177.617 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -75.58 4.2 44.6 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 115.239 0.856 . . . . 0.0 115.239 -177.304 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 12.7 t -83.09 21.06 1.12 Allowed 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 -178.134 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 69.2 ttp85 -56.25 126.61 26.94 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 179.25 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -95.93 127.36 41.28 Favored Pre-proline 0 C--N 1.322 -0.619 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 -179.623 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -74.19 -15.14 23.04 Favored 'Trans proline' 0 C--O 1.219 -0.425 0 O-C-N 121.898 0.42 . . . . 0.0 112.717 -178.452 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -77.87 -25.34 48.57 Favored 'General case' 0 C--O 1.222 -0.394 0 CA-C-O 120.863 0.363 . . . . 0.0 110.239 178.188 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 -104.3 -25.63 12.79 Favored 'General case' 0 C--O 1.223 -0.341 0 N-CA-C 113.977 1.103 . . . . 0.0 113.977 -174.867 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 30.4 t30 -147.2 150.18 34.4 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 -177.26 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -92.49 147.1 23.16 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 121.238 0.542 . . . . 0.0 111.206 179.405 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -74.11 153.39 39.6 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.239 177.931 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 2.5 mt -96.76 142.13 14.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 -178.132 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 87.0 t -58.05 125.04 13.42 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 176.87 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 6.4 tt -68.75 128.01 35.11 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.085 -177.848 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 29.8 mt-30 -132.36 154.42 49.79 Favored 'General case' 0 CA--C 1.508 -0.635 0 N-CA-C 107.119 -1.437 . . . . 0.0 107.119 -178.942 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 12.6 mt -109.44 148.93 39.07 Favored Pre-proline 0 C--N 1.321 -0.651 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 176.955 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -70.9 160.89 47.93 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 118.057 -0.829 . . . . 0.0 112.21 179.767 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -55.37 136.12 49.61 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 -179.249 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 95.11 -16.78 60.62 Favored Glycine 0 C--O 1.226 -0.374 0 CA-C-N 116.005 -0.543 . . . . 0.0 112.81 -177.566 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 6.2 m -108.63 128.3 54.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 117.827 0.814 . . . . 0.0 109.834 178.003 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 8.2 p -120.48 148.37 43.92 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.848 -178.522 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 85.7 mt -72.37 153.41 92.08 Favored Pre-proline 0 C--N 1.324 -0.515 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 177.776 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -76.32 170.89 19.1 Favored 'Trans proline' 0 N--CA 1.462 -0.352 0 C-N-CA 118.334 -0.644 . . . . 0.0 110.711 178.513 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -60.82 130.88 48.66 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.569 -177.44 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 95.1 -2.48 65.96 Favored Glycine 0 CA--C 1.517 0.189 0 N-CA-C 114.774 0.67 . . . . 0.0 114.774 178.209 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.42 ' CZ ' ' HB2' ' A' ' 18' ' ' GLN . 2.6 m-85 -106.43 140.07 39.92 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-O 121.732 0.777 . . . . 0.0 111.973 -179.376 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 52.6 p90 -145.52 164.34 31.93 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 114.423 -1.262 . . . . 0.0 108.069 174.515 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -105.38 147.18 28.48 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 112.481 0.549 . . . . 0.0 112.481 -176.465 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -74.97 134.88 41.41 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 178.645 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 86.03 -0.74 87.71 Favored Glycine 0 C--O 1.227 -0.321 0 C-N-CA 121.094 -0.574 . . . . 0.0 112.717 -179.959 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 8.7 t . . . . . 0 C--N 1.325 -0.465 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 178.03 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.683 0 CA-C-O 118.978 -0.901 . . . . 0.0 111.269 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -76.59 161.06 28.89 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 177.422 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 77.3 mtm -133.55 130.03 37.88 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 104.921 -2.251 . . . . 0.0 104.921 178.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -149.25 49.47 0.57 Allowed Glycine 0 C--O 1.225 -0.466 0 O-C-N 123.485 0.49 . . . . 0.0 112.414 -177.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 10.9 mp -64.56 145.15 98.66 Favored Pre-proline 0 CA--C 1.539 0.521 0 N-CA-C 108.031 -1.099 . . . . 0.0 108.031 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -77.15 50.59 3.18 Favored 'Trans proline' 0 CA--C 1.543 0.956 0 C-N-CA 121.71 1.607 . . . . 0.0 114.952 -177.13 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 -123.8 92.24 3.64 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 -179.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 17.9 t-20 -71.48 -55.59 7.58 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 116.107 -0.497 . . . . 0.0 112.221 -177.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 18.6 p 35.11 77.09 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 116.322 1.971 . . . . 0.0 116.322 178.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -95.76 140.8 30.03 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.186 -178.226 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 12.3 p -59.92 142.69 53.21 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.225 -0.898 . . . . 0.0 109.98 177.053 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . 0.419 ' CD2' ' HD3' ' A' ' 109' ' ' ARG . 12.4 m95 -67.3 -21.86 65.66 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 114.648 1.351 . . . . 0.0 114.648 -178.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -121.48 163.36 18.92 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 113.992 1.108 . . . . 0.0 113.992 -170.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 65.6 p -70.96 168.39 17.07 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.304 -1.317 . . . . 0.0 108.258 178.087 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -78.34 149.4 33.44 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 114.182 1.178 . . . . 0.0 114.182 -175.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 13.9 mt -92.3 143.75 26.08 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 102.439 -3.171 . . . . 0.0 102.439 166.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 44.2 m -124.58 131.83 53.46 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 -178.494 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 4.0 tp-100 -95.59 139.19 32.21 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.616 0.599 . . . . 0.0 112.616 -178.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 64.2 t60 -136.08 99.5 4.15 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 105.352 -2.092 . . . . 0.0 105.352 170.171 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 166.39 -160.02 33.47 Favored Glycine 0 C--O 1.227 -0.309 0 N-CA-C 110.294 -1.123 . . . . 0.0 110.294 -176.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -104.32 -23.69 13.18 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 112.809 0.67 . . . . 0.0 112.809 179.302 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 52.7 mm-40 -75.07 168.04 20.75 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 177.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -95.81 -62.84 1.22 Allowed 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 177.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 51.9 tp 173.76 136.04 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 125.761 1.624 . . . . 0.0 106.887 173.459 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 54.7 tptt -155.48 139.75 16.64 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 107.934 -1.135 . . . . 0.0 107.934 172.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 14.4 m-85 -117.84 142.82 31.4 Favored Pre-proline 0 C--O 1.241 0.655 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 176.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -64.6 165.89 19.27 Favored 'Trans proline' 0 CA--C 1.54 0.825 0 C-N-CA 122.209 1.939 . . . . 0.0 114.696 176.037 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 17.1 tpt180 -62.47 133.59 55.21 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.888 -178.347 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 77.53 15.81 80.98 Favored Glycine 0 C--O 1.223 -0.542 0 CA-C-N 115.894 -0.593 . . . . 0.0 112.651 175.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -148.37 167.66 24.67 Favored 'General case' 0 N--CA 1.442 -0.862 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 -174.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 111.58 -23.49 17.58 Favored Glycine 0 CA--C 1.497 -1.08 0 C-N-CA 121.809 -0.234 . . . . 0.0 113.36 173.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 93.1 t -65.67 127.12 92.8 Favored Pre-proline 0 C--N 1.318 -0.762 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 178.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -75.21 170.03 21.25 Favored 'Trans proline' 0 N--CA 1.461 -0.425 0 O-C-N 122.102 0.527 . . . . 0.0 111.429 178.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 97.6 mt -67.95 109.57 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-O 121.931 0.872 . . . . 0.0 109.109 179.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 73.2 m-80 -99.97 87.43 3.49 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 114.756 -1.111 . . . . 0.0 109.223 -179.052 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 72.5 p -67.82 -16.35 64.06 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 -178.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 11.4 p30 -108.19 22.9 15.3 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.318 -0.856 . . . . 0.0 112.843 -177.03 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 15.3 m -138.94 152.05 47.4 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 114.729 1.381 . . . . 0.0 114.729 -175.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 67.5 m -74.86 164.97 57.74 Favored Pre-proline 0 CA--C 1.537 0.469 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.479 177.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -65.48 -24.85 56.14 Favored 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 115.341 -2.64 . . . . 0.0 114.538 -178.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.422 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 6.1 p-10 -76.45 -26.09 55.06 Favored 'General case' 0 C--N 1.324 -0.539 0 O-C-N 121.625 -0.672 . . . . 0.0 110.906 177.026 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.487 ' HA ' ' HE3' ' A' ' 103' ' ' LYS . 15.2 m-20 -75.76 -10.75 59.69 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.198 0.999 . . . . 0.0 112.952 -175.809 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 96.8 mm-40 -58.55 -29.07 66.08 Favored 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 114.782 1.401 . . . . 0.0 114.782 -176.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 11.9 tt -59.5 140.22 18.0 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.874 0 CA-C-O 122.287 1.042 . . . . 0.0 112.843 -178.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -179.34 -155.63 15.47 Favored Glycine 0 CA--C 1.506 -0.482 0 C-N-CA 120.406 -0.902 . . . . 0.0 112.49 -178.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 50.3 p90 -154.99 171.7 19.31 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 179.021 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 19.3 m-85 -112.89 140.06 48.01 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 173.304 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 69.4 ttt-85 -111.33 124.66 52.68 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.979 -177.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 37.7 ttt-85 -65.05 141.1 58.86 Favored 'General case' 0 C--N 1.322 -0.625 0 O-C-N 123.557 0.536 . . . . 0.0 109.764 177.164 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -151.03 150.42 30.72 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.997 0.427 . . . . 0.0 110.605 179.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 34.0 p -145.89 168.41 20.89 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 103.621 -2.733 . . . . 0.0 103.621 174.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 14.5 tpt180 -149.08 131.08 15.28 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.604 0.716 . . . . 0.0 111.664 175.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 37.6 mtt180 -140.98 165.82 26.5 Favored 'General case' 0 CA--C 1.493 -1.241 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 178.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -132.33 175.93 10.19 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 N-CA-C 104.24 -2.504 . . . . 0.0 104.24 -179.186 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 3.5 tmt_? -120.69 99.38 6.5 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 178.232 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -76.09 150.36 38.95 Favored Glycine 0 N--CA 1.45 -0.43 0 N-CA-C 105.627 -2.989 . . . . 0.0 105.627 173.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -63.64 -36.1 92.9 Favored Glycine 0 C--O 1.217 -0.964 0 CA-C-N 118.669 1.235 . . . . 0.0 111.718 -179.422 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.409 ' HB3' ' HE2' ' A' ' 60' ' ' LYS . 27.2 t0 -89.08 17.15 6.12 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-O 122.328 1.061 . . . . 0.0 111.433 179.586 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 85.47 14.79 67.58 Favored Glycine 0 C--O 1.223 -0.578 0 CA-C-N 115.505 -0.77 . . . . 0.0 113.575 173.239 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.409 ' HE2' ' HB3' ' A' ' 58' ' ' ASP . 49.9 mmtt -69.61 133.67 47.86 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.58 0.705 . . . . 0.0 110.59 -176.451 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 4.0 mmt -113.11 155.3 25.18 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 114.225 -1.352 . . . . 0.0 111.101 -176.322 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 1.2 mmtp -96.28 -41.95 8.41 Favored 'General case' 0 CA--C 1.5 -0.979 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 173.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 11.3 t0 45.61 57.3 5.09 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 111.206 -2.724 . . . . 0.0 115.796 176.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 64.4 mt -68.58 138.68 55.28 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 177.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -58.67 161.81 7.68 Favored Pre-proline 0 C--O 1.242 0.698 0 CA-C-N 115.316 -0.856 . . . . 0.0 112.931 -177.587 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -62.22 134.85 51.07 Favored 'Trans proline' 0 C--N 1.354 0.864 0 C-N-CA 116.814 -1.657 . . . . 0.0 112.119 179.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 20.9 mtt-85 -132.15 161.12 34.12 Favored 'General case' 0 CA--C 1.503 -0.83 0 CA-C-N 114.338 -1.301 . . . . 0.0 109.805 -175.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 70.2 m95 -134.52 143.42 47.43 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 177.24 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 70.7 m-85 -126.38 148.61 49.57 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 106.334 -1.728 . . . . 0.0 106.334 178.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 86.8 t80 -94.71 138.12 32.95 Favored 'General case' 0 CA--C 1.506 -0.727 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 -176.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 11.2 m-85 -138.86 142.19 38.61 Favored 'General case' 0 N--CA 1.438 -1.072 0 N-CA-C 106.53 -1.656 . . . . 0.0 106.53 -174.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 88.5 m-85 -80.89 159.52 24.98 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.437 0.161 . . . . 0.0 110.845 -175.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -56.12 126.69 27.13 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.9 0.381 . . . . 0.0 110.79 -177.722 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 69.29 38.63 81.74 Favored Glycine 0 C--O 1.218 -0.88 0 CA-C-O 119.106 -0.83 . . . . 0.0 114.75 176.179 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -89.17 146.1 25.0 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 105.623 -1.992 . . . . 0.0 105.623 177.591 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 92.2 131.47 5.48 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 106.4 -2.68 . . . . 0.0 106.4 -171.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -68.13 -39.32 10.73 Favored 'Trans proline' 0 C--N 1.346 0.42 0 CA-C-N 120.102 1.951 . . . . 0.0 116.127 -172.216 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -114.93 35.57 4.25 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.894 0.854 . . . . 0.0 108.897 -176.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -65.31 -29.1 69.82 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.769 -178.197 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 61.18 28.69 69.5 Favored Glycine 0 C--O 1.227 -0.283 0 N-CA-C 114.733 0.653 . . . . 0.0 114.733 178.041 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 17.3 mt -117.48 103.83 50.57 Favored Pre-proline 0 N--CA 1.446 -0.657 0 N-CA-C 114.39 1.256 . . . . 0.0 114.39 -177.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -78.58 164.49 25.92 Favored 'Trans proline' 0 C--O 1.235 0.374 0 C-N-CA 121.963 1.775 . . . . 0.0 108.318 169.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 57.9 t80 -61.79 132.03 51.8 Favored 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 120.396 -0.522 . . . . 0.0 110.085 -179.462 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 91.64 -5.98 79.99 Favored Glycine 0 CA--C 1.518 0.258 0 CA-C-O 119.417 -0.657 . . . . 0.0 114.493 178.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -63.5 131.24 47.49 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 118.369 1.085 . . . . 0.0 111.453 179.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 36.1 t-20 -77.87 127.3 32.16 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.496 -178.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 28.7 ttmt -156.2 151.26 26.38 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 105.508 -2.034 . . . . 0.0 105.508 178.03 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -64.66 132.14 48.89 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.085 0.469 . . . . 0.0 110.666 -178.044 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 68.29 27.31 73.8 Favored Glycine 0 N--CA 1.449 -0.439 0 CA-C-N 115.719 -0.673 . . . . 0.0 114.256 178.156 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 45.8 mm -124.84 123.42 65.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 117.419 0.609 . . . . 0.0 110.669 179.375 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.1 pt -127.16 111.94 27.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 CA-C-O 121.953 0.882 . . . . 0.0 111.762 177.051 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 95.1 m95 -77.36 136.83 38.47 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 112.983 0.734 . . . . 0.0 112.983 -177.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 17.3 m -138.86 151.61 23.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 C-N-CA 123.481 0.712 . . . . 0.0 109.824 179.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -157.01 166.59 32.93 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 105.877 -1.898 . . . . 0.0 105.877 179.494 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 14.5 t -130.34 176.34 8.21 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 105.521 -2.029 . . . . 0.0 105.521 178.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -67.58 135.07 52.35 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.162 0.506 . . . . 0.0 110.169 -179.253 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 93.19 -10.79 73.02 Favored Glycine 0 C--O 1.229 -0.182 0 CA-C-N 115.938 -0.574 . . . . 0.0 113.302 178.253 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.422 ' HA ' ' HA ' ' A' ' 41' ' ' ASP . . . -73.9 136.76 43.38 Favored 'General case' 0 CA--C 1.543 0.687 0 O-C-N 122.543 -0.387 . . . . 0.0 110.617 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 36.7 mt -95.72 139.57 31.76 Favored 'General case' 0 C--O 1.218 -0.601 0 N-CA-C 113.725 1.009 . . . . 0.0 113.725 -176.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 57.3 t30 -84.4 73.91 10.43 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.497 0.665 . . . . 0.0 110.52 179.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -146.41 159.25 45.56 Favored Pre-proline 0 C--N 1.321 -0.659 0 N-CA-C 103.024 -2.954 . . . . 0.0 103.024 179.445 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -73.27 149.95 46.38 Favored 'Trans proline' 0 CA--C 1.537 0.644 0 N-CA-C 114.061 0.754 . . . . 0.0 114.061 177.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.487 ' HE3' ' HA ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -142.29 58.69 1.46 Allowed 'General case' 0 N--CA 1.475 0.823 0 CA-C-O 122.799 1.285 . . . . 0.0 109.402 176.835 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -63.12 -23.77 67.59 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.263 -1.335 . . . . 0.0 110.963 178.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 17.9 p80 -55.87 -17.94 7.62 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 114.516 1.302 . . . . 0.0 114.516 -178.439 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 22.5 mt -88.81 -38.33 11.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 121.393 0.616 . . . . 0.0 109.842 -179.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -76.15 14.66 6.12 Favored Glycine 0 C--O 1.22 -0.767 0 N-CA-C 116.748 1.459 . . . . 0.0 116.748 -174.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 13.4 t -83.14 15.97 2.61 Favored 'General case' 0 CA--C 1.545 0.777 0 CA-C-N 117.985 0.893 . . . . 0.0 111.427 179.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.419 ' HD3' ' CD2' ' A' ' 12' ' ' TRP . 59.8 ttp85 -62.73 138.7 58.58 Favored 'General case' 0 C--N 1.327 -0.397 0 O-C-N 122.02 -0.425 . . . . 0.0 111.002 -178.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -110.28 123.64 35.41 Favored Pre-proline 0 C--O 1.236 0.342 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 177.122 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -75.06 -10.85 21.29 Favored 'Trans proline' 0 C--O 1.219 -0.453 0 N-CA-C 113.324 0.471 . . . . 0.0 113.324 -176.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -77.76 -24.96 48.83 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.045 178.012 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 75.2 m-20 -104.12 -25.56 12.9 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 113.989 1.107 . . . . 0.0 113.989 -173.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -142.67 154.55 44.44 Favored 'General case' 0 N--CA 1.433 -1.307 0 CA-C-O 121.261 0.553 . . . . 0.0 109.71 -176.301 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -92.93 142.7 27.01 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.197 -0.911 . . . . 0.0 110.206 179.321 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -68.74 147.11 52.28 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.239 0.543 . . . . 0.0 110.761 179.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 25.3 mt -81.77 138.38 19.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 -178.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 82.7 t -60.91 123.69 14.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 175.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 6.0 tt -67.66 128.82 37.87 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 -178.161 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -134.96 157.86 45.82 Favored 'General case' 0 CA--C 1.508 -0.653 0 N-CA-C 107.273 -1.38 . . . . 0.0 107.273 -177.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 13.8 mt -113.2 150.38 42.91 Favored Pre-proline 0 C--N 1.32 -0.699 0 N-CA-C 105.747 -1.946 . . . . 0.0 105.747 175.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -70.42 168.2 23.1 Favored 'Trans proline' 0 C--N 1.342 0.22 0 N-CA-C 114.143 0.786 . . . . 0.0 114.143 -176.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 49.7 tt0 -55.23 133.43 49.25 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.273 -178.032 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 89.61 -13.77 63.21 Favored Glycine 0 C--O 1.228 -0.28 0 CA-C-N 115.964 -0.562 . . . . 0.0 112.659 -179.343 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 18.6 m -106.92 128.38 54.26 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 117.356 0.578 . . . . 0.0 110.511 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 13.7 p -121.71 148.32 44.76 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.316 0.579 . . . . 0.0 112.483 -177.227 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 86.0 mt -68.52 156.26 90.99 Favored Pre-proline 0 C--N 1.326 -0.435 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 177.267 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -74.25 164.86 33.23 Favored 'Trans proline' 0 N--CA 1.461 -0.394 0 C-N-CA 117.655 -1.096 . . . . 0.0 110.941 178.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -60.13 130.46 46.77 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.174 -177.185 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 95.08 -3.93 67.28 Favored Glycine 0 C--O 1.225 -0.447 0 N-CA-C 114.823 0.689 . . . . 0.0 114.823 179.357 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -106.78 141.97 37.16 Favored 'General case' 0 CA--C 1.507 -0.703 0 CA-C-N 117.874 0.837 . . . . 0.0 110.743 179.306 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 43.7 p90 -142.53 161.29 38.44 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 114.382 -1.281 . . . . 0.0 107.983 175.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -104.86 146.98 28.25 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.652 0.739 . . . . 0.0 111.496 -177.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -74.23 127.52 33.18 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 179.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 87.94 -5.66 84.57 Favored Glycine 0 C--O 1.224 -0.523 0 CA-C-N 116.091 -0.504 . . . . 0.0 113.076 -178.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 33.7 t -96.17 148.57 22.57 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.411 0.624 . . . . 0.0 109.379 179.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 25.5 mmt85 -144.43 164.49 30.7 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 105.285 -2.117 . . . . 0.0 105.285 177.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -118.57 161.58 13.58 Favored Glycine 0 C--N 1.322 -0.231 0 N-CA-C 107.225 -2.35 . . . . 0.0 107.225 176.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 84.28 -160.09 36.1 Favored Glycine 0 N--CA 1.453 -0.196 0 N-CA-C 108.783 -1.727 . . . . 0.0 108.783 -177.328 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 7.2 m . . . . . 0 C--O 1.247 0.953 0 C-N-CA 123.751 0.82 . . . . 0.0 111.127 -177.71 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.79 0 CA-C-O 118.377 -1.235 . . . . 0.0 111.025 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -153.36 172.1 17.59 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 105.956 -1.868 . . . . 0.0 105.956 -178.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 59.6 mtt 54.07 46.0 26.36 Favored 'General case' 0 N--CA 1.474 0.74 0 O-C-N 124.231 0.957 . . . . 0.0 113.158 177.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -81.78 49.17 4.02 Favored Glycine 0 N--CA 1.461 0.337 0 N-CA-C 111.752 -0.539 . . . . 0.0 111.752 178.168 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 91.1 mt -75.13 155.32 86.33 Favored Pre-proline 0 C--N 1.322 -0.59 0 C-N-CA 123.019 0.528 . . . . 0.0 110.617 -177.364 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -68.75 158.03 59.46 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 117.471 -1.219 . . . . 0.0 111.665 177.61 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 -144.69 -61.93 0.37 Allowed 'General case' 0 C--O 1.217 -0.646 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.533 -177.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 9.0 t30 57.36 50.44 11.44 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 113.794 1.035 . . . . 0.0 113.794 177.171 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 33.5 p -134.32 136.3 43.38 Favored 'General case' 0 N--CA 1.437 -1.099 0 N-CA-C 103.51 -2.774 . . . . 0.0 103.51 177.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -141.12 141.25 34.2 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 115.024 -0.989 . . . . 0.0 108.657 179.076 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 41.3 t -61.13 140.9 57.79 Favored 'General case' 0 CA--C 1.513 -0.476 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 178.244 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 7.5 m95 -68.41 -21.93 64.65 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.486 178.373 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 29.8 m-85 -121.4 163.02 19.39 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 115.872 -0.604 . . . . 0.0 112.559 -171.36 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.422 ' HB ' ' HB3' ' A' ' 134' ' ' GLU . 71.7 p -71.55 163.07 28.42 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.495 -0.775 . . . . 0.0 108.926 178.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -76.81 138.05 39.62 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -176.44 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 13.8 mt -82.74 145.03 29.79 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 104.45 -2.426 . . . . 0.0 104.45 171.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 20.0 m -127.47 133.27 49.91 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 118.331 0.514 . . . . 0.0 110.597 -178.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 4.0 tp-100 -89.52 150.74 22.31 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.869 179.27 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 73.5 t60 -136.38 99.25 4.04 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 103.189 -2.893 . . . . 0.0 103.189 166.383 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 162.79 -173.07 38.97 Favored Glycine 0 N--CA 1.451 -0.328 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 -175.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 55.3 mtmt -93.34 -29.44 15.63 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 114.962 1.467 . . . . 0.0 114.962 -176.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -87.39 157.31 19.27 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 106.906 -1.516 . . . . 0.0 106.906 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -83.52 -62.75 1.5 Allowed 'General case' 0 C--O 1.218 -0.566 0 N-CA-C 115.405 1.631 . . . . 0.0 115.405 -174.881 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 56.8 tp 179.1 143.3 0.13 Allowed 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 124.356 1.062 . . . . 0.0 108.154 178.06 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 13.6 tptm -158.86 141.23 14.05 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 173.333 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 7.9 m-85 -123.56 140.57 34.42 Favored Pre-proline 0 C--N 1.324 -0.524 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 176.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -61.54 155.52 52.57 Favored 'Trans proline' 0 CA--C 1.538 0.71 0 C-N-CA 120.283 0.656 . . . . 0.0 113.206 175.343 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 16.9 tpt180 -63.68 135.66 56.89 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.604 -177.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 83.9 10.31 81.2 Favored Glycine 0 C--O 1.225 -0.452 0 C-N-CA 121.368 -0.444 . . . . 0.0 112.348 178.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -148.14 168.64 21.9 Favored 'General case' 0 N--CA 1.443 -0.792 0 N-CA-C 106.975 -1.491 . . . . 0.0 106.975 -176.504 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 110.69 -19.89 25.45 Favored Glycine 0 CA--C 1.499 -0.946 0 CA-C-O 121.14 0.3 . . . . 0.0 113.643 172.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 99.2 t -65.41 128.16 93.56 Favored Pre-proline 0 C--N 1.319 -0.756 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 178.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -74.19 170.99 18.9 Favored 'Trans proline' 0 N--CA 1.46 -0.448 0 O-C-N 122.116 0.535 . . . . 0.0 111.327 178.02 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 89.9 mt -69.34 107.32 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-O 122.155 0.978 . . . . 0.0 108.656 179.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 -98.94 84.56 3.1 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 114.278 -1.328 . . . . 0.0 109.444 -177.326 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 70.4 p -66.56 -15.03 63.11 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.687 0.756 . . . . 0.0 112.895 -178.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 20.7 p30 -109.11 20.69 18.08 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 114.93 -1.032 . . . . 0.0 112.986 -177.128 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 27.9 m -139.02 147.95 42.77 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 113.693 0.997 . . . . 0.0 113.693 -176.46 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -72.21 167.14 34.84 Favored Pre-proline 0 C--N 1.327 -0.399 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 176.292 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -64.49 -28.18 62.03 Favored 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 115.185 -2.744 . . . . 0.0 111.958 178.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -62.31 -29.21 70.28 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 123.626 0.77 . . . . 0.0 111.422 176.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.55 ' HA ' ' HE3' ' A' ' 103' ' ' LYS . 62.1 m-20 -95.28 -0.3 53.06 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 114.584 1.328 . . . . 0.0 114.584 -171.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 94.7 mm-40 -60.7 -30.89 70.23 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 114.097 1.147 . . . . 0.0 114.097 178.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 20.6 tt -59.28 140.4 17.58 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.745 0 CA-C-O 122.385 1.088 . . . . 0.0 113.64 -177.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 179.88 -154.98 14.39 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.629 -178.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 50.4 p90 -155.02 171.13 20.25 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 178.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 17.8 m-85 -113.99 142.8 45.71 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 172.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 57.9 ttt180 -112.11 129.2 56.31 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.435 -179.005 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 27.5 ttt180 -67.22 136.27 54.72 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 123.452 0.701 . . . . 0.0 110.042 177.252 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -151.31 142.67 23.39 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.733 0.301 . . . . 0.0 110.606 178.44 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 9.3 t -148.42 151.24 34.9 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 176.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 8.3 tpt180 -164.84 124.97 1.94 Allowed 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 -178.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 15.1 ptt85 -106.93 158.92 16.66 Favored 'General case' 0 CA--C 1.508 -0.652 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 175.446 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -144.4 -179.57 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.913 0 N-CA-C 104.626 -2.361 . . . . 0.0 104.626 -175.321 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 5.6 mtt-85 -138.65 124.84 20.25 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 175.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -86.14 170.88 43.7 Favored Glycine 0 C--O 1.225 -0.412 0 N-CA-C 107.82 -2.112 . . . . 0.0 107.82 175.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -79.06 -28.59 53.68 Favored Glycine 0 C--O 1.216 -1.014 0 N-CA-C 108.194 -1.963 . . . . 0.0 108.194 179.459 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.443 ' CG ' ' HZ3' ' A' ' 60' ' ' LYS . 43.2 t0 -76.22 -5.03 45.0 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-N 113.069 -1.566 . . . . 0.0 108.627 176.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 90.48 -11.72 70.54 Favored Glycine 0 CA--C 1.51 -0.277 0 CA-C-N 114.721 -1.127 . . . . 0.0 113.787 176.406 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.443 ' HZ3' ' CG ' ' A' ' 58' ' ' ASP . 0.3 OUTLIER -71.8 138.26 48.22 Favored 'General case' 0 CA--C 1.507 -0.692 0 CA-C-O 121.939 0.876 . . . . 0.0 109.868 -177.322 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 28.2 ptm -133.18 167.57 20.11 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 114.152 -1.385 . . . . 0.0 110.049 -178.398 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 29.0 mttp -75.67 -56.54 4.59 Favored 'General case' 0 C--O 1.219 -0.551 0 N-CA-C 113.814 1.042 . . . . 0.0 113.814 -177.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.6 t70 54.45 -140.13 0.96 Allowed 'General case' 0 CA--C 1.541 0.613 0 O-C-N 124.79 1.306 . . . . 0.0 110.065 -178.046 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 8.8 mt 61.11 173.84 0.11 Allowed 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 116.911 2.189 . . . . 0.0 116.911 177.463 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 36.6 m -67.52 160.79 70.35 Favored Pre-proline 0 C--O 1.238 0.497 0 CA-C-N 114.654 -1.157 . . . . 0.0 110.064 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -63.15 162.07 27.8 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 117.821 -0.986 . . . . 0.0 114.548 -179.507 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 18.5 mtp180 -108.01 160.29 15.9 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 106.801 -1.555 . . . . 0.0 106.801 -179.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 50.1 m95 -127.05 133.98 50.37 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 54.4 m-85 -114.71 141.23 48.11 Favored 'General case' 0 C--O 1.216 -0.699 0 N-CA-C 107.961 -1.125 . . . . 0.0 107.961 -177.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 88.2 t80 -89.97 134.7 34.08 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 118.474 0.579 . . . . 0.0 109.847 -177.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -137.71 147.27 44.65 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 -177.404 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -82.4 159.46 22.99 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 -173.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 16.9 tp -59.43 128.8 38.86 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.383 0.611 . . . . 0.0 109.595 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 78.23 26.66 59.32 Favored Glycine 0 C--O 1.217 -0.964 0 N-CA-C 115.704 1.042 . . . . 0.0 115.704 177.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 2.4 p -89.4 146.06 24.92 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 119.093 1.447 . . . . 0.0 109.286 178.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 101.04 139.01 10.51 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 108.901 -1.68 . . . . 0.0 108.901 -176.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -68.36 -43.45 4.33 Favored 'Trans proline' 0 C--N 1.348 0.523 0 CA-C-N 119.787 1.794 . . . . 0.0 115.987 -173.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -112.79 36.64 3.38 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 -177.507 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -64.58 -43.33 94.2 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.678 -177.447 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 57.62 30.01 61.81 Favored Glycine 0 C--O 1.226 -0.396 0 CA-C-N 115.82 -0.627 . . . . 0.0 113.512 179.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 24.2 mt -111.47 103.83 55.46 Favored Pre-proline 0 N--CA 1.448 -0.573 0 N-CA-C 115.212 1.56 . . . . 0.0 115.212 -175.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -77.22 164.76 28.81 Favored 'Trans proline' 0 N--CA 1.459 -0.506 0 N-CA-C 108.002 -1.576 . . . . 0.0 108.002 170.05 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 70.0 t80 -62.62 128.57 36.6 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 120.478 -0.489 . . . . 0.0 110.584 -178.22 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 94.07 -5.5 72.03 Favored Glycine 0 CA--C 1.52 0.404 0 N-CA-C 114.851 0.7 . . . . 0.0 114.851 179.427 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -65.39 128.78 37.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 118.43 1.115 . . . . 0.0 112.314 179.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 72.2 m-20 -71.15 128.09 34.77 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 114.766 -1.107 . . . . 0.0 111.142 -178.345 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 25.2 ttmt -156.03 153.03 28.82 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 105.884 -1.895 . . . . 0.0 105.884 177.236 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 20.0 t0 -68.46 135.38 51.58 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.081 0.467 . . . . 0.0 110.12 -178.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 68.8 25.7 75.03 Favored Glycine 0 N--CA 1.447 -0.63 0 CA-C-N 115.735 -0.666 . . . . 0.0 114.133 177.488 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 42.8 mm -125.52 127.68 71.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 117.427 0.614 . . . . 0.0 109.989 179.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -129.39 115.91 37.17 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 CA-C-O 121.61 0.719 . . . . 0.0 110.202 176.64 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 97.7 m95 -82.38 134.79 35.26 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 113.773 1.027 . . . . 0.0 113.773 -175.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 20.8 m -136.6 149.81 27.01 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 CA-C-O 121.529 0.68 . . . . 0.0 110.537 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -157.03 166.56 32.98 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 103.93 -2.618 . . . . 0.0 103.93 -179.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 13.4 t -136.59 174.05 11.04 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 105.14 -2.17 . . . . 0.0 105.14 178.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -64.92 134.44 53.98 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.01 0.434 . . . . 0.0 109.971 -179.456 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 95.42 -5.86 67.87 Favored Glycine 0 C--O 1.225 -0.436 0 CA-C-N 115.992 -0.549 . . . . 0.0 113.769 178.459 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -83.15 138.25 33.73 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 122.262 -0.552 . . . . 0.0 110.46 -179.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 56.0 mt -88.79 141.11 28.77 Favored 'General case' 0 C--O 1.22 -0.485 0 CA-C-O 121.149 0.499 . . . . 0.0 111.559 -178.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -83.57 58.8 4.77 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.358 0.599 . . . . 0.0 110.98 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -139.02 158.31 69.87 Favored Pre-proline 0 C--N 1.325 -0.484 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 -177.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -73.09 158.89 48.68 Favored 'Trans proline' 0 CA--C 1.537 0.633 0 N-CA-C 115.272 1.22 . . . . 0.0 115.272 179.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.55 ' HE3' ' HA ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -154.42 57.93 0.7 Allowed 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 122.813 1.292 . . . . 0.0 109.572 177.137 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -59.04 -30.39 68.0 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.103 -1.408 . . . . 0.0 112.177 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 17.5 p80 -58.72 -11.2 2.89 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 115.091 1.515 . . . . 0.0 115.091 -177.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 33.3 mt -91.82 -32.28 5.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 178.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -71.75 -3.39 54.89 Favored Glycine 0 C--O 1.224 -0.479 0 N-CA-C 116.082 1.193 . . . . 0.0 116.082 -175.468 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 15.0 t -83.16 26.56 0.62 Allowed 'General case' 0 CA--C 1.549 0.92 0 N-CA-C 113.67 0.989 . . . . 0.0 113.67 -177.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 70.8 ttp85 -57.27 122.99 13.83 Favored 'General case' 0 N--CA 1.472 0.667 0 O-C-N 121.398 -0.814 . . . . 0.0 109.039 178.35 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 60.2 m-20 -90.0 119.08 69.35 Favored Pre-proline 0 C--N 1.324 -0.504 0 N-CA-C 107.208 -1.405 . . . . 0.0 107.208 -179.4 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -70.84 -15.93 33.02 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 117.898 -0.934 . . . . 0.0 114.117 -177.089 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -77.41 -25.76 51.05 Favored 'General case' 0 C--O 1.219 -0.503 0 CA-C-O 120.87 0.367 . . . . 0.0 110.391 178.191 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -102.8 -24.55 13.7 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 113.183 0.808 . . . . 0.0 113.183 -174.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 18.8 t30 -149.12 146.54 27.74 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -177.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -88.35 151.14 22.8 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-O 121.575 0.702 . . . . 0.0 112.356 -179.444 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -75.01 149.72 39.18 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.412 177.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 7.9 mt -90.26 139.91 16.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 -178.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 85.4 t -60.58 124.24 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 N-CA-C 106.245 -1.761 . . . . 0.0 106.245 175.339 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 6.6 tt -67.23 130.84 44.38 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.148 0.499 . . . . 0.0 110.223 -176.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -134.09 158.22 44.17 Favored 'General case' 0 CA--C 1.509 -0.605 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 -178.342 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 13.7 mt -112.49 149.77 41.6 Favored Pre-proline 0 C--N 1.322 -0.626 0 N-CA-C 105.915 -1.883 . . . . 0.0 105.915 175.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_endo -70.35 168.83 21.2 Favored 'Trans proline' 0 C--N 1.342 0.213 0 N-CA-C 114.531 0.935 . . . . 0.0 114.531 -176.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 39.4 tt0 -54.52 130.85 41.33 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.758 -178.333 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 89.97 -11.79 69.58 Favored Glycine 0 C--O 1.226 -0.357 0 CA-C-N 115.786 -0.643 . . . . 0.0 112.87 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 18.1 m -106.99 126.64 52.59 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 117.37 0.585 . . . . 0.0 110.535 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 22.8 p -118.05 148.35 42.35 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 113.261 0.837 . . . . 0.0 113.261 -177.34 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 86.2 mt -68.74 155.91 92.15 Favored Pre-proline 0 C--N 1.324 -0.504 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 176.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -75.23 166.3 29.2 Favored 'Trans proline' 0 N--CA 1.462 -0.372 0 C-N-CA 117.44 -1.24 . . . . 0.0 110.315 177.258 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -58.94 130.96 49.52 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.061 -176.383 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 95.13 -9.88 69.93 Favored Glycine 0 C--O 1.224 -0.474 0 N-CA-C 115.137 0.815 . . . . 0.0 115.137 178.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -94.4 143.4 26.43 Favored 'General case' 0 N--CA 1.439 -1.002 0 CA-C-O 122.498 1.142 . . . . 0.0 111.717 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 39.9 p90 -142.32 163.78 31.91 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 113.231 -1.804 . . . . 0.0 107.654 175.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -106.46 144.17 33.51 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.1 0.476 . . . . 0.0 111.454 -177.344 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.422 ' HB3' ' HB ' ' A' ' 14' ' ' THR . 1.6 tp10 -69.62 129.95 41.06 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 106.544 -1.65 . . . . 0.0 106.544 177.446 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 93.1 -6.3 75.95 Favored Glycine 0 C--O 1.225 -0.446 0 C-N-CA 121.325 -0.464 . . . . 0.0 113.235 -179.281 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 35.3 t -111.17 137.0 49.4 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.125 -0.695 . . . . 0.0 109.125 177.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -145.63 116.3 7.67 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 110.501 -0.185 . . . . 0.0 110.501 -179.076 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -76.95 149.12 35.71 Favored Glycine 0 CA--C 1.516 0.132 0 N-CA-C 108.575 -1.81 . . . . 0.0 108.575 176.084 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -142.6 42.69 1.1 Allowed Glycine 0 C--O 1.225 -0.432 0 CA-C-N 117.949 0.875 . . . . 0.0 112.525 -177.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 18.9 m . . . . . 0 C--O 1.24 0.581 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 -179.287 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.57 0 CA-C-O 119.068 -0.851 . . . . 0.0 111.361 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -69.08 157.18 37.34 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 117.723 0.762 . . . . 0.0 109.266 179.253 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 20.6 ptp -155.95 158.51 38.04 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 103.722 -2.696 . . . . 0.0 103.722 178.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 78.78 30.19 49.02 Favored Glycine 0 C--O 1.223 -0.573 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.97 178.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 10.5 mp -60.98 140.54 93.88 Favored Pre-proline 0 C--O 1.24 0.567 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 -179.127 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -73.43 154.19 50.48 Favored 'Trans proline' 0 C--N 1.345 0.364 0 O-C-N 122.053 0.502 . . . . 0.0 112.923 -178.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 30.5 t-20 -158.64 114.55 2.66 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 178.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 11.7 p-10 -104.32 -6.93 20.37 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 111.881 0.326 . . . . 0.0 111.881 179.329 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 24.7 p -87.57 83.7 7.21 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 -178.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -93.18 147.55 22.79 Favored 'General case' 0 N--CA 1.442 -0.861 0 CA-C-N 115.169 -0.923 . . . . 0.0 112.388 -174.543 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.8 t -54.83 137.57 44.73 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 114.325 -1.307 . . . . 0.0 108.962 174.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 15.6 m95 -64.54 -21.89 66.82 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 178.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 46.5 m-85 -121.5 159.56 26.05 Favored 'General case' 0 C--O 1.241 0.612 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 -172.087 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.433 ' HB ' ' HB3' ' A' ' 134' ' ' GLU . 76.0 p -69.12 163.6 24.44 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 114.949 -1.023 . . . . 0.0 108.861 178.831 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -81.47 141.23 34.06 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 -176.417 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 27.5 mt -78.78 148.85 32.79 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 104.64 -2.356 . . . . 0.0 104.64 170.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 30.6 m -112.95 128.59 56.53 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 179.243 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 2.6 tm0? -93.24 134.82 35.04 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.025 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 78.0 t60 -139.41 99.45 3.74 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 106.172 -1.788 . . . . 0.0 106.172 168.313 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 169.49 -166.14 39.43 Favored Glycine 0 C--O 1.226 -0.373 0 C-N-CA 120.156 -1.021 . . . . 0.0 112.574 -177.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -101.79 -24.58 14.04 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -179.447 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -91.78 153.32 19.68 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 179.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -72.4 -62.85 1.29 Allowed 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -174.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 43.0 tp 174.6 145.77 0.06 Allowed 'General case' 0 N--CA 1.483 1.212 0 N-CA-C 105.949 -1.871 . . . . 0.0 105.949 175.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 54.0 tptt -156.03 138.7 15.1 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 175.138 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 16.8 m-85 -124.88 152.68 70.27 Favored Pre-proline 0 C--O 1.243 0.752 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 174.428 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -70.31 161.47 45.9 Favored 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 120.201 0.6 . . . . 0.0 112.672 178.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 20.9 tpt180 -69.07 135.25 50.5 Favored 'General case' 0 C--O 1.216 -0.66 0 O-C-N 122.147 -0.346 . . . . 0.0 110.105 -177.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 82.34 11.49 82.05 Favored Glycine 0 C--O 1.223 -0.576 0 N-CA-C 111.785 -0.526 . . . . 0.0 111.785 179.017 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 10.6 mt-30 -150.7 170.5 19.05 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 -175.218 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 107.37 -16.28 38.2 Favored Glycine 0 CA--C 1.503 -0.69 0 C-N-CA 121.429 -0.415 . . . . 0.0 113.204 175.217 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 57.4 t -67.91 129.19 93.31 Favored Pre-proline 0 C--N 1.319 -0.739 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 177.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -74.22 163.13 37.22 Favored 'Trans proline' 0 N--CA 1.459 -0.517 0 O-C-N 122.193 0.575 . . . . 0.0 111.967 178.375 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 93.7 mt -66.49 122.95 18.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.612 -177.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.449 ' ND2' ' HH ' ' A' ' 72' ' ' TYR . 44.8 t-20 -124.74 93.43 3.89 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.693 0.758 . . . . 0.0 110.373 179.342 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 82.6 p -75.98 -16.63 59.95 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 112.953 0.723 . . . . 0.0 112.953 -175.272 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 65.5 m-80 -104.33 32.77 3.83 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.631 -174.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 82.4 p -144.88 -179.08 6.37 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 114.735 1.383 . . . . 0.0 114.735 -176.354 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 56.8 m -105.05 165.93 12.33 Favored Pre-proline 0 CA--C 1.544 0.718 0 CA-C-N 114.947 -1.024 . . . . 0.0 108.942 178.449 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_endo -68.84 -18.96 41.3 Favored 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 116.405 -1.93 . . . . 0.0 114.983 -178.292 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.421 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 5.5 p-10 -75.03 -21.38 59.1 Favored 'General case' 0 C--N 1.324 -0.526 0 O-C-N 121.728 -0.608 . . . . 0.0 111.907 179.516 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -74.18 -23.09 59.18 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 114.183 1.179 . . . . 0.0 114.183 -174.362 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 93.7 mm-40 -53.61 -26.2 20.93 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 115.57 1.692 . . . . 0.0 115.57 -171.218 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 9.1 tt -64.43 136.5 26.41 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 CA-C-O 122.553 1.168 . . . . 0.0 112.203 -179.469 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 175.49 -156.89 22.95 Favored Glycine 0 CA--C 1.502 -0.72 0 C-N-CA 120.156 -1.021 . . . . 0.0 111.863 -178.447 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 47.1 p90 -155.1 170.45 21.76 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 -179.492 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 21.9 m-85 -109.53 139.49 44.47 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 106.538 -1.652 . . . . 0.0 106.538 174.084 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 58.4 ttt-85 -113.43 120.84 42.45 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 123.698 0.799 . . . . 0.0 111.253 -176.199 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 37.9 ttp85 -69.41 140.21 54.12 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.959 0.409 . . . . 0.0 109.933 177.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -144.28 149.41 36.23 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 122.979 0.511 . . . . 0.0 110.111 179.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 15.3 t -154.29 167.01 31.37 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 176.285 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 15.7 tpt180 -147.98 129.63 15.05 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 178.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 6.1 tpp180 -133.58 138.85 46.21 Favored 'General case' 0 CA--C 1.499 -1.01 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 -178.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -138.76 174.23 10.39 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 -178.284 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 1.7 ttt-85 -122.37 118.57 28.74 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 104.894 -2.262 . . . . 0.0 104.894 175.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -71.74 172.36 46.1 Favored Glycine 0 C--O 1.221 -0.71 0 N-CA-C 109.132 -1.587 . . . . 0.0 109.132 177.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -68.89 -37.69 84.05 Favored Glycine 0 C--O 1.222 -0.647 0 N-CA-C 110.303 -1.119 . . . . 0.0 110.303 -179.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -74.53 -12.27 60.43 Favored 'General case' 0 C--O 1.214 -0.799 0 CA-C-O 122.131 0.967 . . . . 0.0 109.582 177.143 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 104.54 -7.9 46.9 Favored Glycine 0 CA--C 1.505 -0.562 0 CA-C-N 115.685 -0.689 . . . . 0.0 113.14 173.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.95 139.5 58.25 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 122.143 0.973 . . . . 0.0 112.211 -177.048 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 91.1 mmm -93.84 166.16 12.32 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 113.845 -1.525 . . . . 0.0 110.615 -177.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 10.5 tttt -79.69 -49.01 12.73 Favored 'General case' 0 C--O 1.213 -0.862 0 N-CA-C 112.978 0.732 . . . . 0.0 112.978 177.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 44.88 24.02 0.1 Allowed 'General case' 0 N--CA 1.481 1.124 0 N-CA-C 117.815 2.524 . . . . 0.0 117.815 -178.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.4 mp -76.88 152.65 35.33 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 121.451 -0.781 . . . . 0.0 110.329 177.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -59.15 150.79 60.77 Favored Pre-proline 0 C--O 1.245 0.851 0 CA-C-N 115.188 -0.914 . . . . 0.0 113.391 -178.219 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -72.53 158.66 50.63 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 117.364 -1.291 . . . . 0.0 111.166 177.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 17.1 mtp180 -125.5 162.55 24.64 Favored 'General case' 0 CA--C 1.508 -0.648 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 -178.417 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 69.6 m95 -126.31 131.98 51.73 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 178.411 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 63.0 m-85 -111.4 150.23 30.08 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 106.113 -1.81 . . . . 0.0 106.113 178.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 79.1 t80 -94.1 134.91 36.02 Favored 'General case' 0 CA--C 1.507 -0.707 0 N-CA-C 106.44 -1.689 . . . . 0.0 106.44 179.226 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 8.8 m-85 -137.59 130.08 29.63 Favored 'General case' 0 N--CA 1.439 -0.984 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 -176.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.449 ' HH ' ' ND2' ' A' ' 35' ' ' ASN . 66.5 m-85 -66.08 159.56 25.79 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 114.581 -1.19 . . . . 0.0 111.745 -176.833 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -52.54 129.12 28.13 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.009 0.433 . . . . 0.0 111.229 -179.422 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 72.94 25.87 72.62 Favored Glycine 0 C--O 1.224 -0.511 0 N-CA-C 116.189 1.236 . . . . 0.0 116.189 177.038 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 63.2 p -108.19 148.87 29.3 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 118.647 1.223 . . . . 0.0 111.361 178.264 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 117.18 140.51 6.68 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 108.416 -1.873 . . . . 0.0 108.416 -177.205 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -68.16 -41.97 6.5 Favored 'Trans proline' 0 C--N 1.347 0.499 0 CA-C-N 120.044 1.922 . . . . 0.0 115.744 -173.298 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -111.6 23.65 13.67 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.757 0.789 . . . . 0.0 109.371 -178.351 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -62.4 -55.6 26.33 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.998 -176.009 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 56.18 35.95 66.73 Favored Glycine 0 C--O 1.226 -0.386 0 N-CA-C 111.561 -0.615 . . . . 0.0 111.561 -178.162 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 18.7 mt -113.73 103.86 55.27 Favored Pre-proline 0 C--O 1.238 0.489 0 N-CA-C 116.314 1.968 . . . . 0.0 116.314 -173.629 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -79.35 163.65 24.61 Favored 'Trans proline' 0 CA--C 1.53 0.305 0 C-N-CA 122.42 2.08 . . . . 0.0 108.296 168.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 75.0 t80 -61.51 130.86 48.01 Favored 'General case' 0 C--N 1.323 -0.555 0 O-C-N 121.88 -0.512 . . . . 0.0 111.283 -176.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 90.89 -5.95 81.95 Favored Glycine 0 C--O 1.227 -0.307 0 CA-C-O 119.286 -0.73 . . . . 0.0 114.519 178.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -64.22 130.44 43.91 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 118.438 1.119 . . . . 0.0 111.256 179.416 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 56.9 t30 -79.96 127.0 31.74 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.522 -178.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 29.8 ttmt -156.25 152.68 28.06 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 179.417 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 15.0 t0 -66.34 135.91 55.04 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 110.248 -0.279 . . . . 0.0 110.248 -179.492 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 67.14 27.18 73.4 Favored Glycine 0 N--CA 1.45 -0.403 0 CA-C-O 119.671 -0.516 . . . . 0.0 113.617 178.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 44.5 mm -129.31 128.44 66.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 121.168 0.509 . . . . 0.0 109.977 179.556 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -133.58 116.95 25.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 CA-C-O 121.359 0.6 . . . . 0.0 111.404 177.429 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 96.1 m95 -81.84 136.69 35.36 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 113.57 0.952 . . . . 0.0 113.57 -177.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 17.7 m -136.84 156.04 34.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 178.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -164.0 166.56 21.42 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 103.297 -2.853 . . . . 0.0 103.297 -179.335 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 10.8 t -137.59 -179.62 5.85 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 106.148 -1.797 . . . . 0.0 106.148 177.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -65.15 134.72 54.36 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.217 0.532 . . . . 0.0 110.56 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 92.7 -9.32 75.87 Favored Glycine 0 N--CA 1.458 0.136 0 CA-C-N 115.918 -0.583 . . . . 0.0 114.128 177.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.421 ' HA ' ' HA ' ' A' ' 41' ' ' ASP . . . -72.22 133.61 45.18 Favored 'General case' 0 CA--C 1.544 0.735 0 O-C-N 122.441 -0.446 . . . . 0.0 111.395 -179.44 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 25.6 mt -93.23 136.86 33.1 Favored 'General case' 0 CA--C 1.507 -0.711 0 CA-C-O 120.931 0.396 . . . . 0.0 111.601 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 62.8 t30 -80.58 69.47 7.09 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.215 -179.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 2.0 t -144.57 156.25 56.62 Favored Pre-proline 0 CA--C 1.541 0.599 0 N-CA-C 106.932 -1.507 . . . . 0.0 106.932 179.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -63.68 153.21 76.59 Favored 'Trans proline' 0 C--N 1.348 0.518 0 N-CA-C 114.629 0.973 . . . . 0.0 114.629 -179.121 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -125.22 41.19 3.57 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 123.289 0.636 . . . . 0.0 110.02 -179.426 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 15.5 p-10 -53.11 -43.59 67.0 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.717 -0.674 . . . . 0.0 112.314 -177.363 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 17.7 p80 -70.33 -6.56 36.06 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 114.45 1.278 . . . . 0.0 114.45 -178.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 32.0 mt -96.35 -44.88 12.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 118.075 0.398 . . . . 0.0 109.938 178.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -71.35 14.68 1.68 Allowed Glycine 0 C--O 1.223 -0.592 0 N-CA-C 116.357 1.303 . . . . 0.0 116.357 -177.22 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 15.3 t -94.3 25.71 3.71 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 -177.487 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 65.2 ttp85 -58.13 121.07 9.79 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 178.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -88.8 126.68 58.75 Favored Pre-proline 0 C--N 1.322 -0.598 0 N-CA-C 106.588 -1.634 . . . . 0.0 106.588 -177.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -73.23 -14.36 25.68 Favored 'Trans proline' 0 C--O 1.218 -0.488 0 C-N-CA 117.629 -1.114 . . . . 0.0 114.019 -177.295 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -81.56 -24.46 36.54 Favored 'General case' 0 C--O 1.22 -0.462 0 CA-C-O 121.124 0.487 . . . . 0.0 110.098 178.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 74.9 m-20 -101.82 -24.84 13.99 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 113.343 0.868 . . . . 0.0 113.343 -174.13 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 30.7 t30 -151.35 149.95 29.92 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 113.001 0.741 . . . . 0.0 113.001 -177.432 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -89.44 148.15 23.62 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-O 121.538 0.685 . . . . 0.0 111.867 179.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -71.25 147.23 48.4 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.186 178.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 18.8 mt -86.47 139.56 17.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 -179.357 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 75.0 t -62.0 123.64 15.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 N-CA-C 106.564 -1.643 . . . . 0.0 106.564 175.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 6.8 tt -67.01 127.41 32.47 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.017 0.436 . . . . 0.0 109.994 -177.37 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 33.3 mt-30 -132.76 157.16 45.64 Favored 'General case' 0 CA--C 1.511 -0.557 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 -179.254 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 13.3 mt -112.04 147.74 37.55 Favored Pre-proline 0 C--N 1.322 -0.612 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 177.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -73.04 164.63 34.98 Favored 'Trans proline' 0 C--O 1.236 0.387 0 O-C-N 122.272 0.617 . . . . 0.0 112.529 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 51.8 tt0 -55.35 133.74 49.82 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 100.34 -22.86 38.15 Favored Glycine 0 C--O 1.227 -0.337 0 CA-C-N 116.128 -0.487 . . . . 0.0 112.631 -178.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 5.0 m -107.02 128.4 54.33 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 117.961 0.88 . . . . 0.0 110.293 178.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 8.1 p -120.69 148.34 44.07 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.776 -178.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 88.4 mt -73.48 153.37 89.88 Favored Pre-proline 0 C--N 1.324 -0.517 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 177.284 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -76.51 171.2 18.49 Favored 'Trans proline' 0 C--O 1.234 0.281 0 C-N-CA 118.566 -0.489 . . . . 0.0 111.225 178.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 24.2 tptm -60.58 129.23 40.51 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 -179.301 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 91.03 18.4 47.05 Favored Glycine 0 C--O 1.223 -0.548 0 C-N-CA 120.931 -0.652 . . . . 0.0 114.655 178.262 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -127.21 141.71 51.67 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 117.596 0.698 . . . . 0.0 111.509 177.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 45.3 p90 -150.04 162.98 39.33 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 176.263 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -100.99 147.73 25.84 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.246 0.546 . . . . 0.0 111.844 -177.404 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.433 ' HB3' ' HB ' ' A' ' 14' ' ' THR . 0.9 OUTLIER -69.74 128.93 38.13 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 177.372 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 89.82 -7.31 82.0 Favored Glycine 0 C--O 1.225 -0.465 0 CA-C-N 116.315 -0.402 . . . . 0.0 113.54 179.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 34.5 t -79.34 127.21 31.79 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.402 0.62 . . . . 0.0 110.869 179.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 30.3 mmt180 -143.91 148.64 35.69 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 106.136 -1.802 . . . . 0.0 106.136 176.007 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 144.51 -172.78 25.38 Favored Glycine 0 CA--C 1.509 -0.292 0 N-CA-C 105.082 -3.207 . . . . 0.0 105.082 -178.161 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 74.58 49.84 10.52 Favored Glycine 0 C--O 1.229 -0.199 0 CA-C-N 118.553 1.177 . . . . 0.0 112.074 178.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 37.8 m . . . . . 0 C--O 1.253 1.278 0 CA-C-O 115.324 -2.274 . . . . 0.0 105.09 179.945 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.082 0 CA-C-O 118.703 -1.054 . . . . 0.0 111.273 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -70.97 125.08 25.88 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 118.611 1.206 . . . . 0.0 109.989 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 65.7 mtt -129.96 42.02 3.34 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 179.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -79.72 65.36 3.72 Favored Glycine 0 N--CA 1.459 0.205 0 CA-C-N 115.522 -0.763 . . . . 0.0 113.973 -177.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 10.8 mp -71.22 145.62 91.2 Favored Pre-proline 0 C--N 1.322 -0.628 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 178.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_endo -77.1 164.94 28.85 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 118.759 -0.36 . . . . 0.0 112.056 178.03 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 38.3 m-80 -141.7 -153.63 0.47 Allowed 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 101.377 -3.564 . . . . 0.0 101.377 177.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -97.59 44.18 1.05 Allowed 'General case' 0 C--N 1.313 -1.01 0 CA-C-O 121.969 0.89 . . . . 0.0 109.368 -176.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 24.0 p -142.44 129.45 20.75 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 103.822 -2.658 . . . . 0.0 103.822 -179.2 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -145.51 149.7 35.11 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.379 0.609 . . . . 0.0 111.286 -178.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 40.9 t -64.71 145.14 56.64 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 177.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 11.7 m95 -67.27 -21.91 65.69 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 122.799 0.44 . . . . 0.0 111.999 177.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 40.1 m-85 -121.4 165.56 15.38 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 114.136 1.161 . . . . 0.0 114.136 -170.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 73.6 p -71.85 163.13 28.37 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 114.63 -1.168 . . . . 0.0 108.662 177.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -74.43 141.66 45.01 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -176.434 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 11.8 mt -85.94 143.84 27.96 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 102.962 -2.977 . . . . 0.0 102.962 169.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 21.5 m -124.54 137.39 54.41 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 -177.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.418 ' HB2' ' CZ ' ' A' ' 131' ' ' PHE . 4.7 tp60 -114.36 140.19 48.86 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 113.505 0.928 . . . . 0.0 113.505 -176.405 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 72.0 t60 -134.59 99.67 4.41 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 105.112 -2.181 . . . . 0.0 105.112 169.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 177.33 -169.2 41.31 Favored Glycine 0 N--CA 1.451 -0.334 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 -176.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 65.4 mttp -99.58 -26.95 13.92 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 117.398 0.599 . . . . 0.0 112.544 -179.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -85.74 158.01 20.13 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 178.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -82.46 -62.72 1.54 Allowed 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 120.786 -0.366 . . . . 0.0 111.782 -177.485 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 39.0 tp 179.62 142.55 0.14 Allowed 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 106.843 -1.54 . . . . 0.0 106.843 174.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -157.52 139.25 14.03 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 174.244 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 13.3 m-85 -123.22 151.57 62.42 Favored Pre-proline 0 C--O 1.239 0.537 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 176.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -74.28 165.55 31.58 Favored 'Trans proline' 0 CA--C 1.539 0.746 0 C-N-CA 120.058 0.505 . . . . 0.0 113.028 178.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 21.7 tpt180 -66.95 135.23 53.47 Favored 'General case' 0 C--O 1.216 -0.687 0 O-C-N 122.145 -0.347 . . . . 0.0 110.977 -177.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 82.95 4.24 90.1 Favored Glycine 0 C--O 1.223 -0.582 0 N-CA-C 111.935 -0.466 . . . . 0.0 111.935 178.156 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 40.0 mt-30 -141.79 170.6 15.4 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 123.206 0.602 . . . . 0.0 109.844 -174.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 105.61 -23.1 30.71 Favored Glycine 0 CA--C 1.498 -0.989 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.906 175.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 95.7 t -65.1 126.44 91.28 Favored Pre-proline 0 C--N 1.32 -0.694 0 N-CA-C 105.963 -1.866 . . . . 0.0 105.963 176.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -74.41 169.06 23.36 Favored 'Trans proline' 0 N--CA 1.459 -0.522 0 O-C-N 122.221 0.59 . . . . 0.0 110.912 179.168 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 92.8 mt -68.28 108.94 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 -179.435 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 75.0 m-80 -99.25 87.1 3.56 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 114.759 -1.109 . . . . 0.0 110.307 -177.243 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 73.7 p -68.73 -14.76 63.23 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.772 0.796 . . . . 0.0 112.243 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 10.8 p30 -107.34 18.8 21.15 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.861 -1.063 . . . . 0.0 113.357 -176.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 12.9 m -137.8 152.62 49.32 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 114.999 1.481 . . . . 0.0 114.999 -175.199 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.7 m -72.04 164.96 54.65 Favored Pre-proline 0 C--N 1.325 -0.482 0 CA-C-N 115.138 -0.937 . . . . 0.0 109.39 177.303 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -66.28 -27.3 48.24 Favored 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 114.858 -2.961 . . . . 0.0 113.861 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.433 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 2.1 p-10 -75.39 -22.32 57.56 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 121.57 -0.706 . . . . 0.0 110.916 177.01 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 56.4 m-20 -81.73 -7.18 59.57 Favored 'General case' 0 C--O 1.221 -0.406 0 N-CA-C 113.654 0.983 . . . . 0.0 113.654 -175.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 96.4 mm-40 -58.61 -28.18 65.38 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 113.797 1.036 . . . . 0.0 113.797 -178.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 9.8 tt -58.71 139.53 18.27 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.877 0 CA-C-O 122.302 1.049 . . . . 0.0 113.251 -179.214 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -179.88 -157.7 20.58 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.457 -0.878 . . . . 0.0 112.742 -179.509 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 41.6 p90 -155.06 171.75 19.25 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 179.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 20.2 m-85 -113.3 138.65 49.71 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 173.585 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 50.7 ttt180 -109.3 127.14 54.06 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.006 -178.3 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 40.8 ttt-85 -66.78 140.66 57.85 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 177.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -147.05 146.61 30.07 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.51 0.672 . . . . 0.0 111.361 179.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 21.2 p -144.31 157.65 44.16 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 104.235 -2.506 . . . . 0.0 104.235 175.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 19.0 tpp85 -147.3 125.68 12.34 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 118.296 0.498 . . . . 0.0 110.282 178.18 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 6.0 tmm_? -147.36 139.23 24.21 Favored 'General case' 0 CA--C 1.492 -1.282 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 179.431 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -132.56 179.1 4.71 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 N-CA-C 105.461 -2.052 . . . . 0.0 105.461 -178.529 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 56.1 ttp180 -120.96 113.61 20.35 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 106.855 -1.535 . . . . 0.0 106.855 172.479 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -95.98 147.36 18.62 Favored Glycine 0 C--N 1.317 -0.488 0 N-CA-C 106.114 -2.794 . . . . 0.0 106.114 177.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -63.92 -33.33 86.94 Favored Glycine 0 C--O 1.216 -0.969 0 CA-C-N 118.459 1.13 . . . . 0.0 111.584 -179.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 38.5 t0 -89.95 17.04 7.22 Favored 'General case' 0 CA--C 1.549 0.918 0 CA-C-O 122.263 1.03 . . . . 0.0 111.308 179.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 81.04 22.91 60.23 Favored Glycine 0 C--O 1.226 -0.404 0 CA-C-O 121.798 0.666 . . . . 0.0 113.823 172.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 21.9 mmtt -85.74 149.4 25.31 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.745 0.783 . . . . 0.0 112.26 -174.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 15.6 mtp -115.38 -179.89 3.77 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 113.824 -1.535 . . . . 0.0 110.886 -177.141 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -119.86 -65.4 1.16 Allowed 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 113.626 0.973 . . . . 0.0 113.626 -177.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -130.18 159.21 37.52 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 103.525 -2.768 . . . . 0.0 103.525 177.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 93.5 mt -121.22 -70.7 0.77 Allowed 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 120.769 0.318 . . . . 0.0 111.306 -179.49 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 16.0 m -67.73 152.72 96.07 Favored Pre-proline 0 C--O 1.239 0.55 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.13 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -68.2 148.15 74.12 Favored 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 116.99 -1.54 . . . . 0.0 111.858 178.146 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 34.6 mtt180 -128.7 164.13 23.61 Favored 'General case' 0 CA--C 1.508 -0.641 0 CA-C-N 115.923 -0.581 . . . . 0.0 112.477 -178.2 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 73.0 m95 -134.58 145.94 49.16 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 178.134 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 22.1 m-85 -128.24 141.95 51.3 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 106.327 -1.731 . . . . 0.0 106.327 179.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 76.4 t80 -88.8 136.68 32.88 Favored 'General case' 0 CA--C 1.507 -0.702 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 -177.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -140.52 135.73 32.18 Favored 'General case' 0 N--CA 1.439 -1.0 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 -175.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 84.8 m-85 -73.26 159.5 33.33 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.425 -174.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -54.38 126.1 22.01 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.121 0.486 . . . . 0.0 111.545 -177.253 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 68.38 36.01 83.36 Favored Glycine 0 N--CA 1.448 -0.544 0 CA-C-O 119.048 -0.862 . . . . 0.0 114.326 176.45 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.3 p -89.2 146.04 25.02 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 106.619 -1.622 . . . . 0.0 106.619 176.145 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 89.69 129.67 3.85 Favored Glycine 0 CA--C 1.528 0.86 0 N-CA-C 108.977 -1.649 . . . . 0.0 108.977 -174.206 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -68.6 -36.99 13.45 Favored 'Trans proline' 0 C--N 1.346 0.417 0 CA-C-N 119.6 1.7 . . . . 0.0 116.437 -174.31 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 57.5 mt-10 -104.79 24.09 12.4 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 -175.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -63.04 -36.85 84.96 Favored 'General case' 0 C--O 1.24 0.553 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.568 -175.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 60.17 33.0 78.03 Favored Glycine 0 C--O 1.229 -0.193 0 CA-C-N 115.544 -0.753 . . . . 0.0 113.486 178.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 14.4 mt -124.66 103.91 31.17 Favored Pre-proline 0 N--CA 1.443 -0.814 0 N-CA-C 115.076 1.509 . . . . 0.0 115.076 -177.346 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -79.01 163.27 25.77 Favored 'Trans proline' 0 N--CA 1.462 -0.359 0 C-N-CA 122.352 2.035 . . . . 0.0 107.706 167.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 58.4 t80 -61.8 132.03 51.77 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 120.329 -0.549 . . . . 0.0 110.352 -178.027 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 90.94 -5.71 81.91 Favored Glycine 0 C--O 1.226 -0.362 0 CA-C-O 119.37 -0.683 . . . . 0.0 114.408 178.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -66.35 130.33 42.84 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 118.582 1.191 . . . . 0.0 111.117 179.126 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 57.5 t30 -77.11 128.07 33.78 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.24 -179.252 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 30.1 ttmt -156.17 151.78 27.07 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 179.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 29.4 t0 -64.81 132.38 49.34 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.933 0.397 . . . . 0.0 110.36 -178.398 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 68.1 28.83 73.24 Favored Glycine 0 N--CA 1.451 -0.351 0 CA-C-O 119.447 -0.64 . . . . 0.0 114.281 178.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 44.7 mm -128.3 127.56 67.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 117.465 0.632 . . . . 0.0 110.61 179.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -131.29 118.83 41.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.997 176.193 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 95.9 m95 -84.99 137.25 33.2 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 113.499 0.925 . . . . 0.0 113.499 -176.584 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 15.9 m -137.79 149.71 25.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.43 0.633 . . . . 0.0 109.856 179.488 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -157.81 166.43 32.74 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 105.43 -2.063 . . . . 0.0 105.43 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 14.7 t -131.34 179.84 5.78 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 105.94 -1.874 . . . . 0.0 105.94 178.492 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -67.54 135.38 52.89 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.231 0.539 . . . . 0.0 110.436 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 90.72 -9.33 78.01 Favored Glycine 0 C--O 1.23 -0.133 0 CA-C-N 115.932 -0.576 . . . . 0.0 113.513 177.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.433 ' HA ' ' HA ' ' A' ' 41' ' ' ASP . . . -73.15 131.43 42.03 Favored 'General case' 0 CA--C 1.544 0.733 0 O-C-N 122.525 -0.397 . . . . 0.0 110.646 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 26.7 mt -91.58 139.24 30.89 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 113.117 0.784 . . . . 0.0 113.117 -177.485 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 53.4 t30 -84.01 73.09 10.4 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.361 -179.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 1.3 t -142.23 152.33 60.81 Favored Pre-proline 0 C--N 1.323 -0.566 0 N-CA-C 107.551 -1.278 . . . . 0.0 107.551 179.131 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -66.45 149.18 84.68 Favored 'Trans proline' 0 CA--C 1.528 0.221 0 N-CA-C 114.278 0.838 . . . . 0.0 114.278 177.05 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -148.97 57.55 1.03 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.852 0.834 . . . . 0.0 112.733 179.124 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 32.0 t0 -60.51 -20.3 59.7 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.577 176.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 15.6 p80 -59.94 -10.98 4.67 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 113.543 0.942 . . . . 0.0 113.543 179.135 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 41.3 mt -96.21 -30.14 3.92 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 CA-C-O 120.698 0.285 . . . . 0.0 110.78 179.153 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -75.13 4.8 37.5 Favored Glycine 0 N--CA 1.462 0.413 0 N-CA-C 115.375 0.91 . . . . 0.0 115.375 -176.122 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 14.6 t -83.1 15.83 2.65 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 113.991 1.108 . . . . 0.0 113.991 -177.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 62.6 ttp85 -63.84 126.84 28.91 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 177.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -108.56 134.59 20.21 Favored Pre-proline 0 C--N 1.323 -0.551 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_endo -69.05 -18.22 40.47 Favored 'Trans proline' 0 C--O 1.218 -0.49 0 N-CA-C 114.934 1.09 . . . . 0.0 114.934 -175.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -77.03 -24.15 52.09 Favored 'General case' 0 C--O 1.221 -0.41 0 CA-C-O 121.106 0.479 . . . . 0.0 110.085 178.31 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -99.32 -28.48 13.28 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.64 -0.709 . . . . 0.0 112.848 -175.188 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 21.9 t30 -155.68 147.26 22.93 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 -178.343 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -84.1 145.55 28.38 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-O 121.44 0.638 . . . . 0.0 111.638 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -69.54 145.54 52.54 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.208 0.527 . . . . 0.0 110.525 178.389 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 18.3 mt -86.54 138.22 19.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 -178.445 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 92.5 t -61.24 124.03 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 N-CA-C 105.912 -1.885 . . . . 0.0 105.912 175.235 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 6.3 tt -66.4 128.78 37.5 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.155 0.502 . . . . 0.0 110.038 -176.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 -132.84 156.02 47.93 Favored 'General case' 0 CA--C 1.508 -0.659 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 -178.606 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 13.2 mt -111.75 148.87 39.83 Favored Pre-proline 0 C--N 1.322 -0.629 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 177.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -72.96 164.26 36.06 Favored 'Trans proline' 0 N--CA 1.462 -0.361 0 C-N-CA 118.079 -0.814 . . . . 0.0 112.575 -179.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -55.17 130.98 44.16 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 104.31 -23.77 30.84 Favored Glycine 0 C--O 1.226 -0.402 0 CA-C-N 116.01 -0.541 . . . . 0.0 112.538 -178.524 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 7.7 m -108.4 129.71 55.25 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 118.137 0.968 . . . . 0.0 111.23 178.308 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 4.7 p -119.73 148.33 43.53 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.572 179.067 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 80.4 mt -69.75 154.81 94.42 Favored Pre-proline 0 C--N 1.324 -0.539 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 178.115 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -76.78 168.77 22.98 Favored 'Trans proline' 0 C--O 1.233 0.232 0 C-N-CA 117.775 -1.017 . . . . 0.0 110.5 176.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 7.5 tmtm? -57.74 130.56 46.96 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.967 0.413 . . . . 0.0 111.863 -175.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 95.14 -6.99 69.32 Favored Glycine 0 C--O 1.235 0.204 0 CA-C-N 115.461 -0.791 . . . . 0.0 114.907 177.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.418 ' CZ ' ' HB2' ' A' ' 18' ' ' GLN . 2.5 m-85 -95.99 138.6 33.39 Favored 'General case' 0 CA--C 1.502 -0.877 0 CA-C-O 122.086 0.946 . . . . 0.0 111.126 179.818 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 38.6 p90 -142.64 160.28 40.6 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 113.583 -1.644 . . . . 0.0 107.867 175.106 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -102.5 144.89 30.36 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.121 0.486 . . . . 0.0 111.189 -177.445 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -71.87 136.14 46.85 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 106.63 -1.619 . . . . 0.0 106.63 177.567 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 86.13 -2.63 87.6 Favored Glycine 0 C--O 1.227 -0.333 0 C-N-CA 121.211 -0.519 . . . . 0.0 112.545 -177.201 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 8.2 t -118.28 -176.9 3.16 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 177.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 24.7 tpt180 -141.05 138.83 33.9 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 92.95 168.79 39.46 Favored Glycine 0 C--O 1.226 -0.349 0 N-CA-C 110.01 -1.236 . . . . 0.0 110.01 -178.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -174.25 173.31 45.93 Favored Glycine 0 N--CA 1.45 -0.372 0 N-CA-C 107.095 -2.402 . . . . 0.0 107.095 -178.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 19.3 m . . . . . 0 C--O 1.244 0.796 0 CA-C-O 117.694 -1.146 . . . . 0.0 112.986 -177.361 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.734 0 CA-C-O 118.846 -0.974 . . . . 0.0 111.329 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -97.76 158.4 15.53 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 177.469 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 2.8 mpt? -126.34 114.79 18.7 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 178.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -175.22 78.15 0.08 OUTLIER Glycine 0 C--O 1.225 -0.416 0 C-N-CA 120.975 -0.631 . . . . 0.0 112.496 -178.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 96.1 mt -72.54 149.28 90.89 Favored Pre-proline 0 C--N 1.323 -0.563 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 178.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -69.45 138.79 39.66 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 115.991 -2.206 . . . . 0.0 111.216 178.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 32.9 t30 -143.92 -8.69 0.71 Allowed 'General case' 0 C--O 1.216 -0.677 0 N-CA-C 113.221 0.823 . . . . 0.0 113.221 -179.354 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 53.5 t30 56.59 43.37 25.74 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.064 0.946 . . . . 0.0 112.045 -179.458 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 41.6 p -116.68 111.89 20.45 Favored 'General case' 0 CA--C 1.509 -0.633 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 -179.355 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -131.46 142.84 50.07 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 114.969 -1.014 . . . . 0.0 110.974 -178.207 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 26.6 t -60.32 137.03 58.2 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 176.393 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 9.8 m95 -70.83 -23.19 62.3 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.963 0.411 . . . . 0.0 111.18 178.451 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 24.8 m-85 -121.4 158.39 28.41 Favored 'General case' 0 C--O 1.241 0.634 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -171.128 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.423 ' HB ' ' HB3' ' A' ' 134' ' ' GLU . 72.0 p -69.06 163.34 24.93 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.012 -0.994 . . . . 0.0 109.189 179.153 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -74.78 145.27 43.07 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 113.333 0.864 . . . . 0.0 113.333 -175.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 16.5 mt -85.74 148.9 25.64 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 103.754 -2.684 . . . . 0.0 103.754 169.349 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 31.0 m -124.86 128.97 49.49 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 178.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -82.42 137.26 34.75 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.018 179.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 72.0 t60 -139.32 94.93 2.85 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 104.085 -2.561 . . . . 0.0 104.085 168.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 163.74 -143.04 8.26 Favored Glycine 0 C--O 1.225 -0.437 0 C-N-CA 120.628 -0.796 . . . . 0.0 111.975 -175.561 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 54.7 mtpt -120.39 -25.56 5.59 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 116.98 2.215 . . . . 0.0 116.98 -175.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -94.41 159.37 15.14 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 117.861 0.3 . . . . 0.0 110.736 -176.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -63.07 -62.85 1.43 Allowed 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 111.999 0.37 . . . . 0.0 111.999 -178.217 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 51.3 tp 165.28 141.94 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.111 0 N-CA-C 103.849 -2.648 . . . . 0.0 103.849 178.51 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 23.3 tptm -156.76 140.66 16.2 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 118.242 0.474 . . . . 0.0 109.813 176.034 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 26.1 m-85 -126.89 150.43 71.66 Favored Pre-proline 0 C--N 1.324 -0.538 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 175.435 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -77.2 165.79 27.38 Favored 'Trans proline' 0 CA--C 1.538 0.697 0 C-N-CA 120.395 0.73 . . . . 0.0 112.571 177.382 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 75.7 ttt180 -66.81 136.37 55.34 Favored 'General case' 0 N--CA 1.472 0.649 0 O-C-N 122.107 -0.37 . . . . 0.0 110.318 -179.201 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 85.56 6.38 83.45 Favored Glycine 0 C--O 1.222 -0.596 0 N-CA-C 111.498 -0.641 . . . . 0.0 111.498 178.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.529 HE22 HG21 ' A' ' 125' ' ' THR . 23.3 mt-30 -146.25 170.55 16.53 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 -175.354 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 103.28 -21.64 38.89 Favored Glycine 0 CA--C 1.499 -0.952 0 CA-C-N 115.772 -0.649 . . . . 0.0 114.017 173.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 92.7 t -65.71 128.52 93.87 Favored Pre-proline 0 C--N 1.319 -0.739 0 N-CA-C 106.468 -1.679 . . . . 0.0 106.468 177.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -71.91 171.7 16.06 Favored 'Trans proline' 0 C--O 1.22 -0.384 0 O-C-N 122.183 0.57 . . . . 0.0 111.221 177.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 92.1 mt -71.09 106.36 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 179.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -96.44 84.2 3.67 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 114.399 -1.273 . . . . 0.0 109.318 -176.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 67.8 p -66.97 -14.72 63.14 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.69 0.757 . . . . 0.0 112.749 -178.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 10.6 p30 -106.18 20.32 19.14 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 114.906 -1.043 . . . . 0.0 112.441 -177.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 15.1 m -139.91 151.23 45.43 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 114.886 1.439 . . . . 0.0 114.886 -175.259 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 2.2 m -72.24 166.33 42.37 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.314 176.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -66.27 -25.97 49.34 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 114.964 -2.891 . . . . 0.0 114.19 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.446 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 3.3 p-10 -77.53 -21.43 52.64 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 121.51 -0.744 . . . . 0.0 110.83 177.491 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 70.7 m-20 -81.39 -7.14 59.53 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 113.69 0.996 . . . . 0.0 113.69 -175.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 96.1 mm-40 -58.6 -26.5 63.74 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 114.262 1.208 . . . . 0.0 114.262 -178.44 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 9.9 tt -58.66 138.31 19.86 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.958 0 N-CA-C 113.87 1.063 . . . . 0.0 113.87 -178.246 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -179.72 -156.98 19.12 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.746 -0.74 . . . . 0.0 111.903 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 42.8 p90 -155.16 171.06 20.41 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 178.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 23.5 m-85 -113.96 142.22 46.42 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 106.924 -1.51 . . . . 0.0 106.924 173.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 52.7 ttt180 -115.06 126.9 55.24 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.668 -178.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 10.1 ttp85 -70.05 133.06 46.8 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 176.22 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -115.51 123.55 48.82 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 176.267 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -153.2 144.31 23.01 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 114.974 -1.012 . . . . 0.0 108.546 -179.339 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 22.7 tpp180 -153.98 123.82 6.77 Favored 'General case' 0 C--O 1.217 -0.646 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 175.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.56 145.63 48.16 Favored 'General case' 0 CA--C 1.49 -1.334 0 CA-C-O 121.684 0.754 . . . . 0.0 110.895 179.356 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -142.79 176.41 3.48 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.959 0 N-CA-C 104.389 -2.448 . . . . 0.0 104.389 178.537 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 5.5 tmm_? -128.07 99.21 5.39 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 106.238 -1.764 . . . . 0.0 106.238 175.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -70.04 146.93 43.79 Favored Glycine 0 N--CA 1.451 -0.364 0 N-CA-C 108.878 -1.689 . . . . 0.0 108.878 178.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -63.06 -33.43 87.22 Favored Glycine 0 C--O 1.215 -1.048 0 C-N-CA 120.453 -0.88 . . . . 0.0 110.981 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 27.2 t0 -90.06 17.63 6.71 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-O 121.936 0.874 . . . . 0.0 111.598 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 86.6 -7.0 81.21 Favored Glycine 0 N--CA 1.462 0.391 0 N-CA-C 116.326 1.291 . . . . 0.0 116.326 174.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.71 128.44 36.29 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 114.211 1.189 . . . . 0.0 114.211 -178.159 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 98.3 mmm -96.56 177.95 5.5 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 106.503 -1.666 . . . . 0.0 106.503 176.304 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 6.6 tmtt? -103.63 -57.23 2.07 Favored 'General case' 0 CA--C 1.507 -0.675 0 CA-C-O 121.474 0.654 . . . . 0.0 110.49 177.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 25.4 p30 -133.8 170.34 15.72 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 178.395 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -125.02 -53.58 1.63 Allowed 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 179.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 25.9 t -108.09 147.43 35.51 Favored Pre-proline 0 C--O 1.24 0.558 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 178.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -72.93 155.13 53.35 Favored 'Trans proline' 0 C--O 1.24 0.612 0 N-CA-C 115.376 1.26 . . . . 0.0 115.376 -178.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 25.5 mtp180 -115.45 161.57 18.39 Favored 'General case' 0 CA--C 1.509 -0.604 0 N-CA-C 106.651 -1.611 . . . . 0.0 106.651 173.304 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 61.0 m95 -129.81 142.76 50.63 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 178.196 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 53.8 m-85 -123.89 144.37 49.8 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 179.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 86.1 t80 -93.55 138.02 32.24 Favored 'General case' 0 CA--C 1.511 -0.54 0 N-CA-C 108.415 -0.958 . . . . 0.0 108.415 -177.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -141.49 143.14 33.67 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 -177.522 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -76.66 159.48 30.2 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.794 -0.639 . . . . 0.0 112.23 -176.05 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -55.08 131.22 44.53 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.571 -179.391 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 77.53 25.03 63.95 Favored Glycine 0 C--O 1.22 -0.719 0 N-CA-C 115.921 1.128 . . . . 0.0 115.921 176.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 7.4 p -92.53 146.1 23.94 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 118.46 1.13 . . . . 0.0 109.364 179.01 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 101.26 132.73 7.86 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 -177.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -69.59 -38.34 8.31 Favored 'Trans proline' 0 C--N 1.347 0.464 0 CA-C-N 119.706 1.753 . . . . 0.0 115.575 -174.338 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -107.84 30.0 6.73 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 -177.127 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -64.66 -51.02 64.75 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.831 -176.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 57.9 26.75 58.48 Favored Glycine 0 C--O 1.226 -0.393 0 CA-C-N 115.858 -0.61 . . . . 0.0 113.001 -179.329 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 21.2 mt -111.33 105.36 56.88 Favored Pre-proline 0 C--O 1.237 0.425 0 N-CA-C 115.319 1.6 . . . . 0.0 115.319 -174.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -77.06 164.22 29.82 Favored 'Trans proline' 0 N--CA 1.461 -0.43 0 N-CA-C 108.213 -1.495 . . . . 0.0 108.213 169.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 57.1 t80 -61.19 132.43 53.67 Favored 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 120.594 -0.442 . . . . 0.0 110.074 -179.073 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 91.63 -7.65 79.46 Favored Glycine 0 CA--C 1.52 0.349 0 N-CA-C 114.683 0.633 . . . . 0.0 114.683 178.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -64.89 131.74 47.52 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 118.267 1.034 . . . . 0.0 111.682 179.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 34.3 t-20 -77.27 128.56 34.55 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.764 -177.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 20.5 ttmt -156.14 150.93 26.09 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 106.41 -1.7 . . . . 0.0 106.41 177.398 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -65.09 133.64 52.06 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.823 0.344 . . . . 0.0 110.168 -179.363 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 69.87 24.98 76.1 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 121.018 -0.611 . . . . 0.0 114.181 177.463 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 39.1 mm -126.31 127.4 70.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 117.335 0.568 . . . . 0.0 109.682 178.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.1 pt -131.32 116.73 33.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 CA-C-O 121.752 0.787 . . . . 0.0 110.268 176.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 94.8 m95 -82.52 137.12 34.7 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.081 -0.509 . . . . 0.0 112.355 -177.01 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 16.4 m -137.83 149.7 25.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.646 0.736 . . . . 0.0 110.186 179.39 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -157.91 165.59 34.81 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 104.093 -2.558 . . . . 0.0 104.093 179.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 14.3 t -130.18 178.85 6.25 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 105.467 -2.049 . . . . 0.0 105.467 179.018 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -67.39 134.98 52.47 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.178 0.513 . . . . 0.0 109.849 -179.555 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 92.89 -12.38 70.04 Favored Glycine 0 C--O 1.227 -0.284 0 CA-C-N 115.92 -0.582 . . . . 0.0 113.255 178.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.446 ' HA ' ' HA ' ' A' ' 41' ' ' ASP . . . -70.16 130.7 42.79 Favored 'General case' 0 CA--C 1.542 0.668 0 O-C-N 122.56 -0.376 . . . . 0.0 110.644 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 24.4 mt -90.33 140.4 29.74 Favored 'General case' 0 C--O 1.219 -0.518 0 CA-C-O 121.392 0.615 . . . . 0.0 112.137 -178.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 58.6 t30 -84.14 70.12 10.48 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.681 -179.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 1.1 t -140.78 153.39 67.67 Favored Pre-proline 0 C--N 1.323 -0.559 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 179.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -68.0 152.35 76.87 Favored 'Trans proline' 0 C--N 1.343 0.26 0 N-CA-C 114.249 0.827 . . . . 0.0 114.249 177.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -152.08 55.15 0.82 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 122.904 1.335 . . . . 0.0 110.896 178.232 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 15.0 p-10 -58.67 -32.51 69.18 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 113.635 -1.62 . . . . 0.0 110.695 177.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 30.9 p-80 -58.94 -16.67 18.91 Favored 'General case' 0 C--O 1.218 -0.591 0 N-CA-C 114.429 1.27 . . . . 0.0 114.429 -179.043 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 75.0 mt -79.93 -33.39 14.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 178.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -76.97 11.21 15.87 Favored Glycine 0 C--O 1.225 -0.422 0 N-CA-C 116.006 1.163 . . . . 0.0 116.006 -176.216 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 15.2 t -83.06 25.19 0.71 Allowed 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 118.224 1.012 . . . . 0.0 112.021 -177.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.421 ' HD2' ' OD1' ' A' ' 114' ' ' ASN . 66.1 ttp85 -62.35 125.28 23.36 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 121.736 -0.602 . . . . 0.0 111.301 -178.549 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 7.8 m120 -88.38 115.63 63.84 Favored Pre-proline 0 C--N 1.326 -0.427 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 179.01 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -73.1 -11.22 25.14 Favored 'Trans proline' 0 C--O 1.218 -0.496 0 C-N-CA 117.963 -0.891 . . . . 0.0 114.233 -177.569 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -81.49 -24.47 36.69 Favored 'General case' 0 C--O 1.22 -0.46 0 CA-C-O 121.002 0.43 . . . . 0.0 110.086 177.341 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -99.84 -30.37 12.08 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.779 -0.646 . . . . 0.0 112.383 -175.239 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . 0.421 ' OD1' ' HD2' ' A' ' 109' ' ' ARG . 0.5 OUTLIER -131.97 151.08 51.95 Favored 'General case' 0 N--CA 1.437 -1.075 0 CA-C-O 121.338 0.59 . . . . 0.0 111.623 -178.31 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -94.82 137.55 33.75 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.084 -0.962 . . . . 0.0 108.852 176.421 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -63.66 146.14 54.37 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.405 0.621 . . . . 0.0 111.208 -179.392 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 24.1 mt -82.04 134.2 27.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.155 -178.009 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 67.7 t -60.1 123.28 12.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 N-CA-C 105.879 -1.897 . . . . 0.0 105.879 174.435 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 6.3 tt -66.26 127.58 32.78 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.488 0.661 . . . . 0.0 110.28 -176.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 34.5 mt-30 -132.71 162.12 32.25 Favored 'General case' 0 CA--C 1.511 -0.527 0 N-CA-C 106.277 -1.749 . . . . 0.0 106.277 -178.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 17.2 mt -117.51 147.67 41.24 Favored Pre-proline 0 C--N 1.321 -0.633 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 178.174 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -73.75 173.37 14.07 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 120.662 0.908 . . . . 0.0 114.156 -177.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 56.5 tt0 -54.22 133.15 44.51 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.152 -179.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 88.25 -15.23 56.97 Favored Glycine 0 C--O 1.227 -0.295 0 CA-C-N 116.045 -0.525 . . . . 0.0 113.651 179.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.529 HG21 HE22 ' A' ' 30' ' ' GLN . 12.6 m -108.6 126.1 52.58 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 117.886 0.843 . . . . 0.0 110.445 -179.437 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 9.3 p -123.46 148.33 46.3 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.995 -178.178 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 91.9 mt -66.49 153.41 93.13 Favored Pre-proline 0 C--N 1.326 -0.452 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 177.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -76.03 169.53 21.91 Favored 'Trans proline' 0 N--CA 1.461 -0.396 0 C-N-CA 118.154 -0.764 . . . . 0.0 111.074 -179.205 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 58.7 tttp -59.7 126.75 28.82 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 179.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 89.36 30.76 12.96 Favored Glycine 0 C--O 1.225 -0.42 0 N-CA-C 115.947 1.139 . . . . 0.0 115.947 178.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -140.57 149.15 42.03 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 117.811 0.806 . . . . 0.0 111.35 177.113 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 46.2 p90 -149.42 164.51 34.78 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 107.216 -1.402 . . . . 0.0 107.216 175.485 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -106.72 149.97 26.75 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.228 0.537 . . . . 0.0 110.926 -178.562 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.423 ' HB3' ' HB ' ' A' ' 14' ' ' THR . 0.9 OUTLIER -71.67 131.32 42.99 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 108.293 -1.002 . . . . 0.0 108.293 179.462 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 81.88 2.29 90.51 Favored Glycine 0 C--O 1.225 -0.455 0 C-N-CA 121.23 -0.51 . . . . 0.0 112.708 -179.379 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 6.9 t -109.6 -173.74 2.33 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 179.383 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 61.35 25.66 15.59 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.724 0.81 . . . . 0.0 112.757 178.787 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -71.04 -24.39 77.15 Favored Glycine 0 C--O 1.22 -0.746 0 C-N-CA 121.173 -0.537 . . . . 0.0 113.339 179.221 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 107.21 -42.78 1.84 Allowed Glycine 0 C--O 1.228 -0.252 0 N-CA-C 111.732 -0.547 . . . . 0.0 111.732 179.474 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 42.8 m . . . . . 0 C--O 1.248 0.982 0 CA-C-O 117.557 -1.211 . . . . 0.0 112.27 179.021 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.873 0 CA-C-O 118.77 -1.016 . . . . 0.0 111.655 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 61.92 154.21 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 116.989 2.218 . . . . 0.0 116.989 178.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 2.1 mpt? -84.66 87.73 7.31 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.679 -1.146 . . . . 0.0 109.554 -178.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -83.15 61.79 4.72 Favored Glycine 0 C--O 1.228 -0.239 0 CA-C-N 116.145 -0.479 . . . . 0.0 113.189 -179.222 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 95.8 mt -86.33 150.59 52.12 Favored Pre-proline 0 C--N 1.324 -0.509 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -74.04 155.62 47.61 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 117.821 -0.986 . . . . 0.0 112.548 178.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 26.4 p30 -144.02 -144.82 0.16 Allowed 'General case' 0 N--CA 1.434 -1.269 0 N-CA-C 105.796 -1.927 . . . . 0.0 105.796 179.022 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 -94.49 -1.27 53.79 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 114.158 1.17 . . . . 0.0 114.158 -175.387 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 41.0 p -117.89 90.78 3.41 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.662 0.615 . . . . 0.0 112.662 -175.16 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -106.46 149.47 27.03 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.252 0.548 . . . . 0.0 109.549 179.083 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 42.1 t -59.22 142.29 52.16 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.57 177.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 14.9 m95 -64.85 -23.33 67.2 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 113.132 0.79 . . . . 0.0 113.132 178.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 43.3 m-85 -121.48 164.16 17.63 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 113.284 0.846 . . . . 0.0 113.284 -170.132 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 66.9 p -70.16 163.63 25.91 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 108.199 -1.038 . . . . 0.0 108.199 178.457 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -73.8 149.96 41.35 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.425 0.631 . . . . 0.0 111.569 -176.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 12.2 mt -89.86 137.82 32.01 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 102.859 -3.015 . . . . 0.0 102.859 168.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 49.4 m -113.82 126.72 55.52 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -77.57 136.4 38.28 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 178.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 32.3 t60 -139.23 94.87 2.85 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 104.786 -2.302 . . . . 0.0 104.786 170.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 152.26 -134.69 4.65 Favored Glycine 0 C--O 1.227 -0.293 0 C-N-CA 120.245 -0.979 . . . . 0.0 112.671 -175.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -126.73 -24.77 3.49 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 116.963 2.208 . . . . 0.0 116.963 -176.275 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -73.44 156.45 38.25 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 178.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -77.24 -58.31 3.35 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 178.396 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 62.4 tp 167.52 137.37 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.177 0 N-CA-C 104.772 -2.307 . . . . 0.0 104.772 173.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 22.9 tptm -157.64 142.53 16.68 Favored 'General case' 0 C--O 1.221 -0.44 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 176.11 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 27.9 m-85 -127.67 151.26 75.03 Favored Pre-proline 0 C--O 1.24 0.577 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 176.128 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -72.2 156.8 54.94 Favored 'Trans proline' 0 C--N 1.351 0.686 0 O-C-N 122.107 0.53 . . . . 0.0 111.996 176.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.67 134.34 52.06 Favored 'General case' 0 N--CA 1.472 0.637 0 O-C-N 121.986 -0.446 . . . . 0.0 110.487 -178.161 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 90.67 1.85 73.43 Favored Glycine 0 N--CA 1.46 0.295 0 N-CA-C 111.174 -0.77 . . . . 0.0 111.174 179.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 30.7 mt-30 -144.33 170.49 15.91 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 123.846 0.858 . . . . 0.0 108.902 -175.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 107.3 -17.42 37.26 Favored Glycine 0 CA--C 1.498 -0.981 0 CA-C-N 116.059 -0.518 . . . . 0.0 113.369 173.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 57.2 t -67.39 129.17 93.73 Favored Pre-proline 0 C--N 1.319 -0.722 0 N-CA-C 105.767 -1.938 . . . . 0.0 105.767 176.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -71.73 171.01 17.31 Favored 'Trans proline' 0 N--CA 1.459 -0.505 0 O-C-N 122.196 0.577 . . . . 0.0 111.2 178.146 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 95.0 mt -71.09 107.44 2.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 179.529 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 -93.11 84.33 4.83 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 114.175 -1.375 . . . . 0.0 109.354 -177.386 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 81.0 p -66.9 -15.06 63.41 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 114.003 1.112 . . . . 0.0 114.003 -177.101 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -111.39 17.28 20.29 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.282 -0.872 . . . . 0.0 112.846 -176.42 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -140.73 169.78 16.99 Favored 'General case' 0 CA--C 1.543 0.673 0 N-CA-C 115.891 1.812 . . . . 0.0 115.891 -171.855 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 35.4 m -94.41 161.35 29.48 Favored Pre-proline 0 C--O 1.218 -0.597 0 C-N-CA 124.343 1.057 . . . . 0.0 112.592 -174.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -65.24 -24.71 58.1 Favored 'Trans proline' 0 CA--C 1.535 0.557 0 C-N-CA 115.474 -2.551 . . . . 0.0 115.572 -178.249 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -75.16 -24.42 57.91 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 121.551 -0.718 . . . . 0.0 111.921 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 15.5 p30 -95.07 1.0 54.94 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 115.021 1.489 . . . . 0.0 115.021 -171.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 82.7 mm-40 -56.96 -24.09 50.44 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.591 -0.731 . . . . 0.0 112.8 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 11.3 tt -61.14 136.98 24.14 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.805 0 CA-C-O 122.533 1.158 . . . . 0.0 112.652 179.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 178.23 -156.35 19.11 Favored Glycine 0 N--CA 1.448 -0.527 0 N-CA-C 111.187 -0.765 . . . . 0.0 111.187 -178.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 45.3 p90 -155.15 172.11 18.69 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 179.278 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 14.3 m-85 -113.14 138.75 49.48 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 173.12 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 54.4 ttt-85 -108.12 124.69 50.62 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.549 -178.055 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 43.8 ttt180 -63.75 135.98 57.09 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 176.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -135.67 127.03 28.45 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.5 0.667 . . . . 0.0 111.928 -179.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 11.3 p -137.21 131.16 32.05 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 176.505 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 10.5 tpp180 -167.38 135.71 2.54 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 178.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 45.2 mtt180 -121.13 165.81 14.82 Favored 'General case' 0 CA--C 1.497 -1.071 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 177.277 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -134.79 173.97 13.68 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 N-CA-C 104.707 -2.331 . . . . 0.0 104.707 -179.844 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.31 109.03 7.5 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 175.421 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -77.73 159.64 48.09 Favored Glycine 0 C--O 1.228 -0.228 0 N-CA-C 107.263 -2.335 . . . . 0.0 107.263 176.353 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -58.12 -42.05 94.97 Favored Glycine 0 C--O 1.224 -0.527 0 CA-C-N 118.464 1.132 . . . . 0.0 112.082 -178.366 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.7 t0 -80.07 17.16 1.04 Allowed 'General case' 0 CA--C 1.548 0.881 0 CA-C-O 122.278 1.037 . . . . 0.0 112.658 -179.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 85.03 14.94 68.27 Favored Glycine 0 CA--C 1.504 -0.605 0 CA-C-N 115.417 -0.811 . . . . 0.0 113.179 171.314 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 33.3 mmtt -76.34 128.26 34.5 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.128 0.49 . . . . 0.0 110.374 -175.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 93.6 mmm -116.52 157.99 24.35 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 108.002 -1.111 . . . . 0.0 108.002 -178.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 14.0 tppt? -84.51 -43.46 14.54 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 106.638 -1.615 . . . . 0.0 106.638 176.274 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.5 t70 53.26 -145.53 0.59 Allowed 'General case' 0 C--O 1.241 0.623 0 CA-C-N 114.616 -1.174 . . . . 0.0 111.076 177.395 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.2 mm? 67.17 173.93 0.26 Allowed 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 116.062 1.875 . . . . 0.0 116.062 175.353 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -67.97 169.28 10.13 Favored Pre-proline 0 C--O 1.24 0.574 0 CA-C-N 113.962 -1.472 . . . . 0.0 113.91 -176.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -67.49 155.86 68.53 Favored 'Trans proline' 0 C--N 1.354 0.846 0 C-N-CA 116.107 -2.128 . . . . 0.0 112.659 177.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.31 160.1 21.65 Favored 'General case' 0 CA--C 1.505 -0.764 0 N-CA-C 105.377 -2.083 . . . . 0.0 105.377 178.051 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 53.1 m95 -131.47 146.53 52.29 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 178.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -126.75 142.32 51.58 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 179.343 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 81.3 t80 -88.79 136.88 32.77 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 108.59 -0.892 . . . . 0.0 108.59 -178.22 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -140.4 139.52 35.3 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 -176.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 75.2 m-85 -74.35 159.48 32.33 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.762 -0.653 . . . . 0.0 111.527 -175.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -55.91 131.12 46.27 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.194 0.521 . . . . 0.0 112.373 -178.131 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 75.5 26.8 64.71 Favored Glycine 0 C--O 1.218 -0.882 0 N-CA-C 115.842 1.097 . . . . 0.0 115.842 175.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 2.8 p -88.9 145.98 25.21 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 118.606 1.203 . . . . 0.0 108.472 178.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 100.32 138.45 10.28 Favored Glycine 0 CA--C 1.527 0.799 0 N-CA-C 109.953 -1.259 . . . . 0.0 109.953 -176.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -70.33 -40.25 4.61 Favored 'Trans proline' 0 C--N 1.348 0.519 0 CA-C-N 119.778 1.789 . . . . 0.0 115.74 -174.332 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -112.31 37.0 3.15 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 -177.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -62.99 -46.31 88.29 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.597 -177.132 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 57.29 30.54 61.42 Favored Glycine 0 C--N 1.33 0.228 0 CA-C-N 115.897 -0.592 . . . . 0.0 112.679 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 16.3 mt -118.78 103.72 47.99 Favored Pre-proline 0 N--CA 1.445 -0.692 0 N-CA-C 114.768 1.395 . . . . 0.0 114.768 -175.53 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -78.33 164.89 26.15 Favored 'Trans proline' 0 N--CA 1.461 -0.409 0 N-CA-C 107.97 -1.588 . . . . 0.0 107.97 169.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.415 ' CE1' ' HB3' ' A' ' 92' ' ' TRP . 66.7 t80 -61.25 133.08 55.53 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 120.353 -0.539 . . . . 0.0 110.148 -179.535 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 90.73 -7.03 81.87 Favored Glycine 0 CA--C 1.519 0.325 0 N-CA-C 114.797 0.679 . . . . 0.0 114.797 178.442 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -65.02 129.18 38.74 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 118.469 1.135 . . . . 0.0 111.546 179.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 60.0 t30 -76.62 127.54 32.99 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.694 -178.052 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 27.7 ttmt -156.14 152.14 27.56 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 106.686 -1.598 . . . . 0.0 106.686 179.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 17.6 t0 -63.79 129.48 40.27 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.14 0.495 . . . . 0.0 110.167 -178.18 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 70.18 26.69 73.9 Favored Glycine 0 N--CA 1.443 -0.835 0 CA-C-N 115.723 -0.671 . . . . 0.0 114.672 176.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 47.2 mm -125.41 123.52 65.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 178.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -126.88 115.43 41.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.514 -0.767 . . . . 0.0 110.163 176.853 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . 0.415 ' HB3' ' CE1' ' A' ' 83' ' ' TYR . 96.2 m95 -82.02 137.29 35.12 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 112.697 0.629 . . . . 0.0 112.697 -176.577 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 17.3 m -136.93 149.73 26.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 178.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -158.97 166.59 31.43 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 103.465 -2.791 . . . . 0.0 103.465 -178.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 6.6 t -134.76 -179.03 5.35 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 106.311 -1.737 . . . . 0.0 106.311 177.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -67.53 134.13 50.72 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.235 0.54 . . . . 0.0 110.688 -178.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 92.06 -10.05 75.21 Favored Glycine 0 C--O 1.229 -0.174 0 CA-C-N 115.915 -0.584 . . . . 0.0 113.662 177.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -70.83 134.9 47.73 Favored 'General case' 0 CA--C 1.544 0.728 0 O-C-N 122.523 -0.399 . . . . 0.0 111.247 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 29.3 mt -93.39 135.77 34.3 Favored 'General case' 0 CA--C 1.511 -0.552 0 N-CA-C 112.997 0.74 . . . . 0.0 112.997 -178.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 52.1 t30 -85.09 76.62 10.21 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.57 -178.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 1.2 t -146.42 155.66 49.67 Favored Pre-proline 0 C--N 1.322 -0.616 0 N-CA-C 105.607 -1.997 . . . . 0.0 105.607 179.47 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -69.01 149.96 72.24 Favored 'Trans proline' 0 CA--C 1.531 0.338 0 N-CA-C 113.729 0.627 . . . . 0.0 113.729 177.068 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 4.7 ptpt -152.8 56.67 0.79 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 122.78 1.276 . . . . 0.0 110.184 178.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -58.85 -31.31 68.4 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.08 -1.418 . . . . 0.0 112.586 -179.202 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 16.2 p80 -61.0 -9.09 3.78 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 114.589 1.329 . . . . 0.0 114.589 -177.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 50.4 mt -91.08 -37.92 9.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 178.194 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -75.48 14.64 5.21 Favored Glycine 0 CA--C 1.52 0.396 0 N-CA-C 115.428 0.931 . . . . 0.0 115.428 -177.073 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 11.6 t -95.61 24.24 5.43 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -177.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 62.5 ttp85 -59.37 130.91 49.24 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 177.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -101.98 135.42 19.69 Favored Pre-proline 0 C--N 1.323 -0.586 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 179.563 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -73.47 -18.33 22.95 Favored 'Trans proline' 0 C--O 1.219 -0.427 0 C-N-CA 118.387 -0.609 . . . . 0.0 113.017 -178.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -77.42 -25.05 50.36 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.894 0.378 . . . . 0.0 110.369 178.37 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 95.2 m-20 -101.1 -21.4 14.99 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 114.062 1.134 . . . . 0.0 114.062 -175.389 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 29.8 t30 -158.26 151.99 23.63 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 -178.277 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -88.78 145.64 25.48 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-O 121.436 0.636 . . . . 0.0 111.711 178.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -70.18 147.51 49.76 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.18 0.514 . . . . 0.0 111.144 178.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 12.1 mt -88.61 138.29 19.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.095 -178.696 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 71.7 t -59.65 122.39 9.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 N-CA-C 106.908 -1.515 . . . . 0.0 106.908 175.148 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 6.4 tt -67.71 128.22 35.66 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.251 0.548 . . . . 0.0 109.695 -177.387 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -134.27 160.26 38.45 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 106.359 -1.719 . . . . 0.0 106.359 -179.273 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 13.6 mt -113.91 147.65 38.19 Favored Pre-proline 0 C--N 1.322 -0.629 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 177.197 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -72.7 164.93 34.18 Favored 'Trans proline' 0 C--O 1.236 0.396 0 O-C-N 122.26 0.611 . . . . 0.0 112.574 -179.338 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -55.42 131.48 46.0 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.289 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 101.98 -22.3 38.68 Favored Glycine 0 C--O 1.226 -0.35 0 CA-C-N 115.945 -0.571 . . . . 0.0 112.505 -178.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 9.5 m -108.58 130.79 55.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 117.992 0.896 . . . . 0.0 110.98 178.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 6.1 p -122.05 148.35 44.95 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.651 -179.492 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 84.5 mt -66.53 156.14 86.81 Favored Pre-proline 0 C--N 1.324 -0.515 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 178.246 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -74.22 173.99 13.23 Favored 'Trans proline' 0 C--O 1.238 0.486 0 N-CA-C 110.453 -0.634 . . . . 0.0 110.453 -179.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -62.73 123.46 18.48 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.643 0.735 . . . . 0.0 110.269 -176.413 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 85.95 45.9 5.54 Favored Glycine 0 N--CA 1.449 -0.491 0 N-CA-C 115.854 1.102 . . . . 0.0 115.854 179.021 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -145.6 149.18 34.06 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 117.534 0.667 . . . . 0.0 111.726 177.565 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 47.1 p90 -148.14 165.32 31.22 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 174.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -105.63 145.43 31.03 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.754 0.311 . . . . 0.0 110.186 -178.326 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -68.87 131.44 45.12 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 -179.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 86.73 -15.15 53.71 Favored Glycine 0 CA--C 1.521 0.455 0 CA-C-N 115.971 -0.558 . . . . 0.0 114.11 -177.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 32.9 t -82.62 123.59 29.38 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 179.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 6.0 tpt180 51.83 44.77 29.11 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 121.488 0.661 . . . . 0.0 110.535 -177.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -62.93 145.58 50.09 Favored Glycine 0 CA--C 1.517 0.216 0 N-CA-C 110.405 -1.078 . . . . 0.0 110.405 178.438 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 179.61 -161.57 27.59 Favored Glycine 0 N--CA 1.45 -0.388 0 N-CA-C 107.168 -2.373 . . . . 0.0 107.168 -178.175 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 21.1 m . . . . . 0 C--O 1.246 0.889 0 CA-C-O 118.27 -0.871 . . . . 0.0 109.77 178.122 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.881 0 CA-C-O 118.925 -0.931 . . . . 0.0 111.354 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -78.3 126.33 30.63 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 177.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 15.2 mmt -81.99 51.7 1.81 Allowed 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 112.511 0.56 . . . . 0.0 112.511 -177.311 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -87.47 43.0 3.16 Favored Glycine 0 C--O 1.226 -0.377 0 N-CA-C 111.353 -0.699 . . . . 0.0 111.353 -179.412 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 61.7 mt -61.75 147.66 88.7 Favored Pre-proline 0 C--O 1.243 0.727 0 C-N-CA 123.358 0.663 . . . . 0.0 112.607 -174.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -71.39 153.55 61.07 Favored 'Trans proline' 0 C--N 1.349 0.566 0 N-CA-C 113.851 0.673 . . . . 0.0 113.851 -179.431 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 48.0 t30 -147.97 95.18 2.45 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.516 -0.765 . . . . 0.0 109.417 178.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 44.9 t30 -108.18 41.09 1.62 Allowed 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 121.873 0.844 . . . . 0.0 108.989 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -146.24 159.32 43.49 Favored 'General case' 0 N--CA 1.438 -1.07 1 N-CA-C 98.025 -4.805 . . . . 0.0 98.025 -178.226 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -139.66 139.16 36.59 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-O 121.7 0.762 . . . . 0.0 111.894 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.67 143.77 55.82 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 114.773 -1.103 . . . . 0.0 108.249 177.536 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . 0.445 ' CD2' ' HD3' ' A' ' 109' ' ' ARG . 16.2 m95 -68.45 -21.86 64.61 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 113.627 0.973 . . . . 0.0 113.627 179.417 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 25.4 m-85 -121.37 161.1 22.7 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 114.226 1.195 . . . . 0.0 114.226 -171.144 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.402 ' HB ' ' HB3' ' A' ' 134' ' ' GLU . 72.9 p -68.34 163.29 23.38 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 114.43 -1.259 . . . . 0.0 111.247 -178.566 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -75.99 134.11 40.24 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 113.563 0.949 . . . . 0.0 113.563 -175.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.9 mp -84.8 146.67 27.23 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 105.388 -2.078 . . . . 0.0 105.388 170.286 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 69.8 m -126.24 131.03 52.02 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 -177.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.424 ' HB2' ' CZ ' ' A' ' 131' ' ' PHE . 4.1 tp60 -97.79 138.58 34.95 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.912 -0.586 . . . . 0.0 112.11 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 52.6 t60 -128.55 99.22 5.29 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 104.722 -2.325 . . . . 0.0 104.722 168.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 168.46 -166.18 39.38 Favored Glycine 0 N--CA 1.451 -0.334 0 N-CA-C 109.14 -1.584 . . . . 0.0 109.14 -176.293 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -103.45 -26.9 12.7 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 113.404 0.89 . . . . 0.0 113.404 -178.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -80.87 160.17 24.83 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 106.981 -1.488 . . . . 0.0 106.981 177.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -85.86 -62.9 1.42 Allowed 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 113.051 0.759 . . . . 0.0 113.051 -177.734 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 51.2 tp -177.79 142.79 0.31 Allowed 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 106.892 -1.522 . . . . 0.0 106.892 175.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.1 tmtp? -158.11 138.41 12.59 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 175.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 14.9 m-85 -121.87 153.36 60.38 Favored Pre-proline 0 C--O 1.239 0.534 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 176.205 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -70.48 158.76 55.06 Favored 'Trans proline' 0 C--N 1.351 0.67 0 O-C-N 121.957 0.451 . . . . 0.0 112.468 177.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 9.7 tpp85 -64.29 135.59 56.36 Favored 'General case' 0 C--O 1.217 -0.651 0 CA-C-N 116.572 -0.286 . . . . 0.0 111.251 -178.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 78.94 13.63 82.88 Favored Glycine 0 C--O 1.224 -0.487 0 C-N-CA 121.268 -0.491 . . . . 0.0 112.259 178.188 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 8.4 mt-30 -150.24 170.49 18.86 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 -175.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 106.96 -18.69 36.49 Favored Glycine 0 CA--C 1.503 -0.681 0 CA-C-N 116.278 -0.419 . . . . 0.0 113.16 175.115 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 99.1 t -65.6 128.4 93.78 Favored Pre-proline 0 C--N 1.321 -0.669 0 N-CA-C 106.962 -1.495 . . . . 0.0 106.962 177.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -75.17 170.02 21.27 Favored 'Trans proline' 0 N--CA 1.461 -0.438 0 O-C-N 122.217 0.588 . . . . 0.0 111.84 179.296 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 91.2 mt -69.36 109.03 2.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 178.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 78.1 m-20 -99.25 85.69 3.25 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 114.506 -1.224 . . . . 0.0 109.924 -177.294 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 72.9 p -67.79 -15.1 63.47 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.524 0.678 . . . . 0.0 112.542 -178.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 11.6 p30 -108.17 19.61 19.71 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 114.977 -1.011 . . . . 0.0 113.287 -177.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 7.6 m -137.94 152.85 49.36 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 114.689 1.366 . . . . 0.0 114.689 -175.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 58.9 m -73.78 164.14 63.31 Favored Pre-proline 0 CA--C 1.537 0.476 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.65 177.341 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -66.21 -25.18 50.47 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 115.362 -2.625 . . . . 0.0 114.499 -178.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.438 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 6.4 p-10 -75.23 -26.45 58.92 Favored 'General case' 0 C--N 1.323 -0.569 0 O-C-N 121.616 -0.677 . . . . 0.0 110.579 177.152 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.479 ' HA ' ' HE3' ' A' ' 103' ' ' LYS . 32.6 m-20 -76.69 -8.11 56.62 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.485 1.114 . . . . 0.0 113.674 -175.801 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 95.0 mm-40 -59.64 -31.24 69.33 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 114.667 1.358 . . . . 0.0 114.667 -177.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 14.8 tt -60.17 140.04 18.78 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.81 0 CA-C-O 122.223 1.011 . . . . 0.0 112.567 -179.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 179.35 -155.36 15.69 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.494 -0.86 . . . . 0.0 111.678 -178.18 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 49.9 p90 -155.13 173.38 16.69 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 179.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 20.0 m-85 -113.33 140.39 48.05 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 106.927 -1.509 . . . . 0.0 106.927 173.381 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 66.7 ttt-85 -112.4 130.68 55.89 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.981 -177.535 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 29.2 ttt-85 -68.96 142.49 54.67 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 176.001 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -142.23 133.17 25.82 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.799 0.333 . . . . 0.0 110.109 177.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -156.74 131.8 9.06 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 177.072 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -129.1 123.98 33.62 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 108.253 -1.018 . . . . 0.0 108.253 174.079 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.55 137.24 54.82 Favored 'General case' 0 CA--C 1.488 -1.421 0 CA-C-O 121.493 0.663 . . . . 0.0 110.206 -177.44 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -127.49 176.91 6.48 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 N-CA-C 106.636 -1.616 . . . . 0.0 106.636 179.212 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 56.1 ttp180 -127.85 116.87 20.82 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 174.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -85.06 161.56 36.16 Favored Glycine 0 C--O 1.224 -0.474 0 N-CA-C 106.233 -2.747 . . . . 0.0 106.233 176.129 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -64.91 -35.93 92.49 Favored Glycine 0 C--O 1.216 -0.998 0 CA-C-N 118.671 1.235 . . . . 0.0 110.345 179.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 32.1 t0 -91.26 17.17 8.65 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-O 122.374 1.083 . . . . 0.0 110.62 178.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 84.16 -7.06 73.05 Favored Glycine 0 N--CA 1.46 0.27 0 N-CA-C 117.25 1.66 . . . . 0.0 117.25 172.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.56 150.53 31.33 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 122.586 1.184 . . . . 0.0 112.914 -177.883 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 73.1 mtp -119.95 -174.49 2.77 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 112.775 -2.011 . . . . 0.0 112.871 -174.535 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 25.4 mmtt -123.23 -72.99 0.66 Allowed 'General case' 0 C--O 1.219 -0.535 0 C-N-CA 122.917 0.487 . . . . 0.0 109.701 179.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -93.7 147.63 22.85 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 106.935 -1.506 . . . . 0.0 106.935 177.06 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -124.74 -63.57 1.17 Allowed 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 106.194 -1.78 . . . . 0.0 106.194 178.347 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -82.02 152.49 68.58 Favored Pre-proline 0 C--O 1.241 0.657 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 176.392 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -75.39 149.28 34.93 Favored 'Trans proline' 0 C--O 1.238 0.491 0 C-N-CA 115.632 -2.445 . . . . 0.0 112.701 179.068 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 94.8 mtt-85 -103.89 152.18 22.25 Favored 'General case' 0 CA--C 1.506 -0.745 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 177.206 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 71.7 m95 -132.44 137.67 47.35 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 175.313 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 78.1 m-85 -127.63 147.39 50.36 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 -179.35 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 74.1 t80 -90.76 137.0 32.7 Favored 'General case' 0 CA--C 1.507 -0.68 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -139.25 140.3 37.65 Favored 'General case' 0 N--CA 1.439 -1.007 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 -175.501 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -79.87 159.51 26.4 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.428 -174.485 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -53.39 124.12 13.87 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.97 0.414 . . . . 0.0 111.608 -178.082 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 82.86 13.51 77.58 Favored Glycine 0 C--O 1.222 -0.595 0 N-CA-C 116.514 1.366 . . . . 0.0 116.514 178.012 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 23.7 p -89.2 146.26 24.88 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 119.032 1.416 . . . . 0.0 111.224 179.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 111.35 141.86 8.73 Favored Glycine 0 CA--C 1.523 0.551 0 N-CA-C 110.094 -1.203 . . . . 0.0 110.094 -179.201 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -68.86 -39.55 8.19 Favored 'Trans proline' 0 C--N 1.348 0.528 0 CA-C-N 119.602 1.701 . . . . 0.0 115.755 -174.213 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -109.44 25.14 12.14 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.853 -178.208 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -57.88 -55.67 31.92 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.071 -0.513 . . . . 0.0 112.305 -174.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 54.47 33.83 54.23 Favored Glycine 0 CA--C 1.522 0.472 0 C-N-CA 121.071 -0.585 . . . . 0.0 112.31 179.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 15.9 mt -117.24 103.93 50.94 Favored Pre-proline 0 N--CA 1.448 -0.535 0 N-CA-C 115.94 1.83 . . . . 0.0 115.94 -172.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -77.8 161.66 30.25 Favored 'Trans proline' 0 N--CA 1.461 -0.384 0 N-CA-C 107.416 -1.802 . . . . 0.0 107.416 168.238 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 58.1 t80 -61.41 133.22 55.55 Favored 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 120.277 -0.569 . . . . 0.0 110.848 -177.289 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 90.99 -9.02 78.99 Favored Glycine 0 CA--C 1.519 0.31 0 CA-C-O 119.445 -0.642 . . . . 0.0 114.366 179.279 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -65.37 130.8 44.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 118.343 1.072 . . . . 0.0 111.154 179.461 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 58.4 t30 -79.01 130.17 35.24 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.389 -179.244 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 28.4 ttmt -156.14 152.0 27.39 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 107.675 -1.232 . . . . 0.0 107.675 179.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 38.2 t0 -62.58 129.79 42.16 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.883 0.373 . . . . 0.0 110.421 -179.117 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 69.57 27.52 73.32 Favored Glycine 0 N--CA 1.45 -0.404 0 CA-C-O 119.324 -0.709 . . . . 0.0 114.696 178.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 40.8 mm -127.5 128.82 70.2 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 CA-C-N 117.643 0.722 . . . . 0.0 110.918 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -132.81 117.15 29.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 CA-C-O 121.465 0.65 . . . . 0.0 111.352 177.049 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 97.4 m95 -81.52 138.26 35.48 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 114.063 1.134 . . . . 0.0 114.063 -176.444 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 16.3 m -139.32 151.15 22.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.626 -0.716 . . . . 0.0 109.153 178.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -158.8 166.54 31.7 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 105.87 -1.9 . . . . 0.0 105.87 -179.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 14.5 t -133.95 169.45 17.09 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 105.361 -2.088 . . . . 0.0 105.361 178.126 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -65.89 136.26 55.89 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.263 0.554 . . . . 0.0 109.954 -179.105 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 96.21 -12.17 66.89 Favored Glycine 0 C--O 1.229 -0.182 0 CA-C-N 115.768 -0.651 . . . . 0.0 113.044 178.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.438 ' HA ' ' HA ' ' A' ' 41' ' ' ASP . . . -76.66 139.95 40.75 Favored 'General case' 0 CA--C 1.542 0.635 0 O-C-N 122.458 -0.436 . . . . 0.0 110.22 179.109 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 39.7 mt -98.32 137.79 36.52 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 113.771 1.026 . . . . 0.0 113.771 -177.126 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 56.9 t30 -82.95 76.43 9.78 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.544 0.687 . . . . 0.0 110.299 179.388 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 1.2 t -146.26 160.69 41.75 Favored Pre-proline 0 C--N 1.321 -0.67 0 N-CA-C 102.218 -3.253 . . . . 0.0 102.218 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -72.59 148.91 48.39 Favored 'Trans proline' 0 CA--C 1.538 0.678 0 N-CA-C 114.172 0.797 . . . . 0.0 114.172 176.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.479 ' HE3' ' HA ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -143.91 54.88 1.31 Allowed 'General case' 0 N--CA 1.474 0.727 0 CA-C-O 123.406 1.574 . . . . 0.0 108.485 176.835 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 14.6 p-10 -64.56 -25.39 67.96 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 113.244 -1.798 . . . . 0.0 110.721 178.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 20.6 p-80 -56.33 -19.64 15.4 Favored 'General case' 0 C--O 1.221 -0.415 0 N-CA-C 114.205 1.187 . . . . 0.0 114.205 -179.026 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 20.5 mt -82.69 -28.15 8.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-O 121.371 0.605 . . . . 0.0 109.735 -179.243 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -77.28 5.13 52.32 Favored Glycine 0 CA--C 1.519 0.317 0 N-CA-C 115.84 1.096 . . . . 0.0 115.84 -175.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 12.0 t -83.17 11.18 6.81 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 117.323 0.562 . . . . 0.0 112.321 -178.356 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.445 ' HD3' ' CD2' ' A' ' 12' ' ' TRP . 63.5 ttp85 -58.38 130.16 45.42 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 178.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -97.63 128.91 32.85 Favored Pre-proline 0 C--N 1.326 -0.454 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 178.102 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -75.69 -13.08 20.13 Favored 'Trans proline' 0 C--O 1.219 -0.451 0 N-CA-C 113.197 0.422 . . . . 0.0 113.197 -178.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -81.12 -24.09 37.92 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.092 0.472 . . . . 0.0 109.888 178.392 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -101.01 -27.41 13.29 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 113.293 0.849 . . . . 0.0 113.293 -174.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . 0.432 ' OD1' ' HD2' ' A' ' 109' ' ' ARG . 0.4 OUTLIER -139.39 152.43 47.11 Favored 'General case' 0 N--CA 1.437 -1.108 0 CA-C-O 121.263 0.554 . . . . 0.0 111.263 -177.595 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -95.73 137.31 34.98 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 115.199 -0.909 . . . . 0.0 108.94 176.19 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -65.32 148.6 51.42 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.435 0.636 . . . . 0.0 111.966 -178.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 16.8 mt -83.24 136.69 22.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.127 -178.459 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 88.7 t -61.64 122.77 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 N-CA-C 106.376 -1.713 . . . . 0.0 106.376 175.287 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 7.3 tt -66.76 131.32 45.69 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.237 0.542 . . . . 0.0 110.718 -176.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -130.96 154.48 48.1 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 106.452 -1.684 . . . . 0.0 106.452 179.416 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 13.3 mt -110.85 149.02 39.79 Favored Pre-proline 0 C--N 1.322 -0.603 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 178.059 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -73.83 167.06 28.16 Favored 'Trans proline' 0 C--N 1.345 0.343 0 O-C-N 122.2 0.579 . . . . 0.0 112.856 -179.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 55.7 tt0 -55.07 132.0 46.27 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.672 -0.694 . . . . 0.0 109.402 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 98.75 -20.98 48.19 Favored Glycine 0 C--O 1.226 -0.374 0 CA-C-N 115.981 -0.554 . . . . 0.0 113.065 -179.487 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 7.0 m -108.0 129.29 55.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 118.127 0.964 . . . . 0.0 110.688 178.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 4.8 p -122.34 148.44 45.05 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.245 -179.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 87.6 mt -70.64 153.42 94.95 Favored Pre-proline 0 C--N 1.325 -0.488 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 176.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -75.63 169.07 23.08 Favored 'Trans proline' 0 N--CA 1.463 -0.307 0 C-N-CA 117.949 -0.901 . . . . 0.0 110.913 178.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 39.8 tptt -60.13 131.83 52.05 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.125 -176.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 95.12 -6.06 68.78 Favored Glycine 0 C--O 1.228 -0.265 0 N-CA-C 115.006 0.762 . . . . 0.0 115.006 178.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.424 ' CZ ' ' HB2' ' A' ' 18' ' ' GLN . 1.3 m-85 -102.61 143.92 31.67 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-O 122.177 0.989 . . . . 0.0 111.752 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 45.2 p90 -146.45 165.61 28.87 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 113.6 -1.636 . . . . 0.0 107.342 173.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -108.56 148.07 30.85 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.949 0.405 . . . . 0.0 110.556 -178.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.402 ' HB3' ' HB ' ' A' ' 14' ' ' THR . 6.4 tp10 -70.43 136.51 49.6 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 178.769 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 81.22 -0.24 87.88 Favored Glycine 0 CA--C 1.52 0.385 0 C-N-CA 121.356 -0.449 . . . . 0.0 112.322 -176.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 4.3 t -122.07 -166.83 1.45 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.253 0.549 . . . . 0.0 110.22 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 37.1 mmt180 -138.25 170.79 15.42 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 105.564 -2.013 . . . . 0.0 105.564 178.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -152.03 174.67 30.99 Favored Glycine 0 C--N 1.317 -0.524 0 N-CA-C 105.633 -2.987 . . . . 0.0 105.633 178.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -162.75 -173.3 31.28 Favored Glycine 0 C--O 1.237 0.293 0 N-CA-C 109.23 -1.548 . . . . 0.0 109.23 -178.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 16.0 m . . . . . 0 C--O 1.247 0.93 0 CA-C-O 116.144 -1.884 . . . . 0.0 106.193 -179.447 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.288 0 CA-C-O 119.034 -0.87 . . . . 0.0 111.548 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -78.31 69.98 4.59 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 118.206 1.003 . . . . 0.0 112.687 -177.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 18.5 ptt? -136.27 48.33 2.16 Favored 'General case' 0 C--O 1.218 -0.554 0 CA-C-O 121.821 0.82 . . . . 0.0 109.542 179.412 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -166.27 -34.67 0.02 OUTLIER Glycine 0 C--O 1.222 -0.634 0 CA-C-N 115.342 -0.845 . . . . 0.0 112.444 -178.519 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 95.2 mt -62.47 135.79 95.58 Favored Pre-proline 0 C--O 1.241 0.634 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 177.082 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -79.37 173.79 12.76 Favored 'Trans proline' 0 C--N 1.347 0.492 0 O-C-N 122.21 0.584 . . . . 0.0 112.953 -179.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 33.9 t30 -147.58 108.31 4.17 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 177.117 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 25.4 t30 -109.38 39.61 2.04 Favored 'General case' 0 C--N 1.323 -0.578 0 O-C-N 123.396 0.435 . . . . 0.0 111.192 -178.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 81.0 p -146.08 155.72 42.96 Favored 'General case' 0 N--CA 1.441 -0.88 0 N-CA-C 101.901 -3.37 . . . . 0.0 101.901 179.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -145.56 146.58 31.45 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 177.158 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 29.1 p -66.36 144.69 56.39 Favored 'General case' 0 CA--C 1.508 -0.661 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 177.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 12.1 m95 -69.65 -21.9 63.5 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 120.859 0.361 . . . . 0.0 111.695 178.439 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -121.4 164.1 17.64 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -173.315 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 67.2 p -70.35 168.99 14.81 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.45 -1.25 . . . . 0.0 108.476 178.392 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -73.87 156.7 37.44 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 122.309 1.052 . . . . 0.0 113.523 -176.306 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 11.5 mt -101.42 137.78 39.3 Favored 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 101.81 -3.404 . . . . 0.0 101.81 166.359 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 34.3 m -115.88 136.45 53.04 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 -177.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.436 ' HB2' ' CZ ' ' A' ' 131' ' ' PHE . 4.2 tp60 -114.0 137.58 51.51 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 113.959 1.096 . . . . 0.0 113.959 -176.091 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 6.5 t-160 -131.78 99.37 4.75 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 104.644 -2.354 . . . . 0.0 104.644 169.48 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 174.78 -168.35 40.95 Favored Glycine 0 C--O 1.225 -0.467 0 N-CA-C 110.562 -1.015 . . . . 0.0 110.562 -177.014 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -102.11 -25.18 13.82 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 112.832 0.678 . . . . 0.0 112.832 -179.177 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -82.86 158.23 22.8 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.316 -0.402 . . . . 0.0 109.999 -179.356 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -74.59 -62.93 1.36 Allowed 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.307 -178.462 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 28.6 tp 173.71 144.55 0.05 OUTLIER 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 103.333 -2.84 . . . . 0.0 103.333 177.338 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 11.0 tmtt? -155.45 134.26 12.02 Favored 'General case' 0 C--O 1.221 -0.442 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 176.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 9.6 m-85 -122.13 155.74 60.92 Favored Pre-proline 0 C--O 1.243 0.739 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 177.061 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -72.72 168.24 25.06 Favored 'Trans proline' 0 C--N 1.352 0.745 0 N-CA-C 113.409 0.503 . . . . 0.0 113.409 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 20.8 tpt180 -72.8 135.78 45.3 Favored 'General case' 0 C--O 1.215 -0.725 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 -178.244 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 83.86 7.32 85.86 Favored Glycine 0 C--O 1.223 -0.576 0 C-N-CA 121.236 -0.507 . . . . 0.0 112.893 177.527 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -150.19 168.42 24.04 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 -177.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 131.15 -30.29 3.35 Favored Glycine 0 CA--C 1.483 -1.927 0 N-CA-C 109.188 -1.565 . . . . 0.0 109.188 166.317 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 33.9 m -65.67 141.2 97.72 Favored Pre-proline 0 N--CA 1.433 -1.279 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 177.288 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_endo -74.01 176.48 9.45 Favored 'Trans proline' 0 N--CA 1.456 -0.691 0 C-N-CA 121.745 1.63 . . . . 0.0 110.821 178.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 91.3 mt -73.09 114.99 13.33 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 178.038 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 29.5 m-80 -109.14 82.86 1.66 Allowed 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 -179.412 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 60.9 p -67.28 -21.99 65.67 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 113.018 0.747 . . . . 0.0 113.018 -176.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 69.1 m-80 -106.1 35.74 2.82 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.054 -176.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 17.4 m -145.51 152.48 39.82 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 -179.217 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 4.6 m -73.08 164.79 58.33 Favored Pre-proline 0 C--N 1.324 -0.513 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 178.017 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -64.59 -26.24 61.75 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 114.748 -3.035 . . . . 0.0 111.14 177.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -62.18 -27.47 68.99 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 123.862 0.865 . . . . 0.0 111.573 175.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 77.3 m-20 -96.44 -4.9 40.86 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 115.225 1.565 . . . . 0.0 115.225 -171.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 90.6 mm-40 -59.6 -28.41 67.15 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 113.599 0.962 . . . . 0.0 113.599 -177.574 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 13.8 tt -57.45 141.52 14.34 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 N-CA-C 114.46 1.281 . . . . 0.0 114.46 -178.195 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -179.53 -153.47 11.87 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.071 179.318 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 49.5 p90 -155.03 169.51 23.94 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 177.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 19.3 m-85 -111.63 143.01 43.22 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 173.244 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 17.4 ttt180 -116.18 125.88 52.9 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.698 -178.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 18.2 ttp85 -68.67 135.93 52.15 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 107.956 -1.128 . . . . 0.0 107.956 176.56 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -127.52 125.32 40.19 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.401 0.619 . . . . 0.0 109.719 179.552 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -146.19 117.55 7.94 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.142 -0.935 . . . . 0.0 108.954 179.406 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 6.7 tpp85 -147.78 127.57 13.46 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 178.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 29.1 mtt85 -130.89 165.92 22.03 Favored 'General case' 0 CA--C 1.495 -1.153 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 177.39 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -141.06 179.4 2.34 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 -177.553 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 19.1 ttm180 -115.05 104.96 12.4 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 106.182 -1.785 . . . . 0.0 106.182 174.194 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -84.18 143.25 21.04 Favored Glycine 0 C--O 1.226 -0.392 0 N-CA-C 107.275 -2.33 . . . . 0.0 107.275 178.041 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -64.7 -38.5 95.71 Favored Glycine 0 C--O 1.219 -0.83 0 CA-C-N 118.404 1.102 . . . . 0.0 112.339 -177.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -85.76 11.58 10.77 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.7 0.762 . . . . 0.0 112.083 -179.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 84.7 20.33 58.34 Favored Glycine 0 C--O 1.226 -0.399 0 CA-C-N 115.235 -0.893 . . . . 0.0 112.467 176.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 21.6 mmtt -88.21 130.85 34.96 Favored 'General case' 0 C--N 1.324 -0.542 0 O-C-N 122.21 -0.582 . . . . 0.0 110.872 -175.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 86.8 mmm -100.98 159.9 14.82 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.156 -0.929 . . . . 0.0 109.128 -178.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 16.5 tppt? -83.22 -48.68 10.22 Favored 'General case' 0 C--O 1.219 -0.526 0 N-CA-C 108.401 -0.962 . . . . 0.0 108.401 177.526 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 21.3 t0 -162.82 163.53 26.53 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 105.327 -2.101 . . . . 0.0 105.327 177.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -117.28 -34.24 4.39 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 177.38 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 20.9 m -85.33 148.53 50.01 Favored Pre-proline 0 C--N 1.326 -0.425 0 N-CA-C 113.753 1.02 . . . . 0.0 113.753 -176.058 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -77.59 145.57 23.42 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 117.97 -0.887 . . . . 0.0 112.187 174.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 47.8 mtt180 -119.1 165.09 14.59 Favored 'General case' 0 CA--C 1.508 -0.656 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.864 179.049 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 64.9 m95 -134.25 144.32 48.32 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 106.588 -1.634 . . . . 0.0 106.588 172.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 71.5 m-85 -130.16 148.51 52.01 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 178.144 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 76.1 t80 -92.59 134.73 34.71 Favored 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 -177.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -137.11 140.19 41.75 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 -176.493 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -77.87 159.51 28.88 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.167 -177.194 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -53.33 138.94 31.45 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 -179.233 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 70.51 38.27 69.03 Favored Glycine 0 C--O 1.225 -0.454 0 N-CA-C 115.726 1.05 . . . . 0.0 115.726 175.22 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 12.7 p -109.49 146.09 35.16 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 117.804 0.802 . . . . 0.0 111.238 178.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 112.01 145.39 9.81 Favored Glycine 0 C--O 1.223 -0.548 0 N-CA-C 108.141 -1.984 . . . . 0.0 108.141 -176.501 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -67.59 -48.42 1.58 Allowed 'Trans proline' 0 C--N 1.348 0.514 0 CA-C-N 119.907 1.853 . . . . 0.0 115.702 -173.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -121.63 40.49 3.6 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 -179.397 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -65.53 -43.96 88.37 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.652 -178.066 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 57.62 24.84 54.19 Favored Glycine 0 C--O 1.224 -0.482 0 CA-C-N 115.992 -0.549 . . . . 0.0 113.972 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 47.2 mt -101.12 109.65 59.07 Favored Pre-proline 0 C--O 1.239 0.528 0 N-CA-C 114.892 1.442 . . . . 0.0 114.892 -175.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -77.87 167.68 23.38 Favored 'Trans proline' 0 C--O 1.237 0.451 0 N-CA-C 108.725 -1.298 . . . . 0.0 108.725 170.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 62.8 t80 -62.42 131.46 49.3 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 179.161 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 92.97 -5.94 76.21 Favored Glycine 0 CA--C 1.52 0.344 0 N-CA-C 114.967 0.747 . . . . 0.0 114.967 178.577 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -64.49 129.18 38.88 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 118.296 1.048 . . . . 0.0 112.085 179.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 43.3 t-20 -75.24 126.6 31.35 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.912 -177.406 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 9.9 ttmm -156.18 150.85 25.93 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 177.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -63.58 134.05 54.82 Favored 'General case' 0 C--N 1.324 -0.529 0 O-C-N 123.176 0.298 . . . . 0.0 110.526 179.416 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 68.51 26.9 74.11 Favored Glycine 0 N--CA 1.45 -0.387 0 CA-C-O 119.496 -0.613 . . . . 0.0 114.081 177.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 34.0 mm -130.18 130.81 65.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 117.417 0.608 . . . . 0.0 109.831 179.277 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.1 pt -132.5 113.49 21.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 CA-C-O 121.5 0.667 . . . . 0.0 110.815 175.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 95.1 m95 -80.98 131.85 35.35 Favored 'General case' 0 C--N 1.321 -0.662 0 O-C-N 121.893 -0.505 . . . . 0.0 111.492 -177.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 2.8 m -139.96 150.86 21.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.819 -177.269 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -156.71 166.57 33.02 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 106.071 -1.826 . . . . 0.0 106.071 -178.553 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 14.8 t -125.9 167.48 15.2 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 105.072 -2.195 . . . . 0.0 105.072 176.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -66.45 136.6 55.94 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 -179.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 96.09 -10.87 67.81 Favored Glycine 0 C--O 1.225 -0.432 0 CA-C-N 115.966 -0.561 . . . . 0.0 113.114 178.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -78.44 141.43 38.28 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 122.308 -0.525 . . . . 0.0 110.744 179.378 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 33.9 mt -91.79 135.64 33.76 Favored 'General case' 0 CA--C 1.51 -0.57 0 CA-C-O 121.429 0.633 . . . . 0.0 112.561 -178.577 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 58.5 t30 -82.32 70.05 9.19 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.601 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 2.0 t -142.48 157.55 62.3 Favored Pre-proline 0 CA--C 1.54 0.578 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 -178.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_exo -61.86 149.21 91.04 Favored 'Trans proline' 0 C--N 1.348 0.539 0 N-CA-C 114.407 0.887 . . . . 0.0 114.407 -179.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -124.79 41.13 3.58 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 122.017 0.913 . . . . 0.0 108.73 -178.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 16.7 p-10 -50.36 -46.55 55.91 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 114.583 -1.189 . . . . 0.0 112.855 -178.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 48.2 p-80 -69.78 -9.15 53.51 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 113.577 0.955 . . . . 0.0 113.577 -177.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 40.8 mt -95.31 -40.13 10.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 178.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -72.14 1.31 34.11 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 115.804 1.081 . . . . 0.0 115.804 -178.149 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 6.2 t -83.03 19.22 1.45 Allowed 'General case' 0 CA--C 1.549 0.934 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 -178.261 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.429 ' HD2' HD22 ' A' ' 114' ' ' ASN . 66.5 ttp85 -59.24 130.67 48.06 Favored 'General case' 0 N--CA 1.47 0.55 0 O-C-N 121.101 -1.0 . . . . 0.0 109.142 179.478 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -103.88 127.03 30.23 Favored Pre-proline 0 C--N 1.323 -0.567 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 178.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -72.7 -14.76 27.18 Favored 'Trans proline' 0 C--O 1.22 -0.411 0 C-N-CA 118.098 -0.801 . . . . 0.0 113.234 -178.171 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -74.32 -27.09 60.54 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.919 0.39 . . . . 0.0 110.497 178.201 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 79.7 m-20 -104.27 -23.05 13.27 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 113.908 1.077 . . . . 0.0 113.908 -174.109 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . 0.429 HD22 ' HD2' ' A' ' 109' ' ' ARG . 26.1 t30 -148.37 151.91 36.12 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -177.325 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -91.52 148.83 22.01 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-O 121.384 0.611 . . . . 0.0 111.943 179.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -74.65 150.12 39.71 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.441 178.114 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 6.9 mt -92.22 140.34 16.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 -178.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 95.2 t -61.49 124.78 16.58 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 N-CA-C 107.162 -1.422 . . . . 0.0 107.162 175.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 5.3 tt -67.4 129.15 39.0 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.137 0.494 . . . . 0.0 111.108 -176.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 29.2 mt-30 -133.01 154.51 50.45 Favored 'General case' 0 C--O 1.219 -0.531 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 -179.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 12.8 mt -110.9 147.92 37.53 Favored Pre-proline 0 C--N 1.322 -0.622 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 177.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -73.33 166.84 28.84 Favored 'Trans proline' 0 C--N 1.346 0.444 0 O-C-N 122.197 0.577 . . . . 0.0 113.196 179.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 39.3 tt0 -54.08 133.03 43.83 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.779 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 97.02 -20.55 50.41 Favored Glycine 0 C--O 1.227 -0.337 0 CA-C-N 115.941 -0.572 . . . . 0.0 112.93 -179.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 1.5 m -104.95 127.38 52.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 117.916 0.858 . . . . 0.0 110.569 178.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 6.9 p -122.79 148.29 45.54 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.739 -179.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 85.2 mt -71.86 150.52 92.95 Favored Pre-proline 0 C--N 1.324 -0.538 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 179.181 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -78.74 179.79 6.16 Favored 'Trans proline' 0 C--O 1.236 0.387 0 O-C-N 121.99 0.468 . . . . 0.0 111.341 178.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 8.1 tmtt? -57.11 126.93 29.42 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 -175.306 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 89.56 -0.03 79.83 Favored Glycine 0 CA--C 1.51 -0.26 0 N-CA-C 116.233 1.253 . . . . 0.0 116.233 173.533 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.436 ' CZ ' ' HB2' ' A' ' 18' ' ' GLN . 4.0 m-85 -99.53 137.9 37.38 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-O 121.881 0.848 . . . . 0.0 111.762 -179.113 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 40.0 p90 -145.43 161.75 38.95 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 114.166 -1.379 . . . . 0.0 107.741 174.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -99.68 142.86 30.6 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.573 0.701 . . . . 0.0 112.468 -175.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -70.4 129.77 40.17 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 107.367 -1.345 . . . . 0.0 107.367 178.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 95.21 -21.51 43.75 Favored Glycine 0 C--O 1.227 -0.331 0 CA-C-N 116.15 -0.477 . . . . 0.0 112.761 -178.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 20.0 t -89.96 89.45 7.72 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 179.181 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 47.3 ttp180 60.3 93.05 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 124.38 1.072 . . . . 0.0 112.193 -177.027 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -87.33 -144.97 9.27 Favored Glycine 0 C--O 1.225 -0.438 0 CA-C-N 115.384 -0.825 . . . . 0.0 111.195 -178.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -85.08 18.54 26.95 Favored Glycine 0 CA--C 1.519 0.284 0 N-CA-C 111.444 -0.662 . . . . 0.0 111.444 178.153 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 40.1 t . . . . . 0 C--O 1.26 1.653 0 N-CA-C 103.491 -2.781 . . . . 0.0 103.491 -179.895 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.766 0 CA-C-O 118.251 -1.305 . . . . 0.0 111.184 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -154.95 173.52 16.42 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 -179.024 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 67.6 ttp -138.74 132.86 31.4 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 103.908 -2.627 . . . . 0.0 103.908 178.251 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 151.9 128.65 1.43 Allowed Glycine 0 N--CA 1.446 -0.645 0 N-CA-C 106.721 -2.552 . . . . 0.0 106.721 -176.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 96.7 mt -126.9 146.28 56.88 Favored Pre-proline 0 C--N 1.319 -0.726 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 -179.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -75.82 161.69 36.01 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 117.749 -1.034 . . . . 0.0 111.885 177.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 58.3 t30 -65.74 -32.0 73.3 Favored 'General case' 0 C--O 1.22 -0.458 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 179.479 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 -158.59 -98.28 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 177.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 34.6 p 39.87 73.19 0.12 Allowed 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 114.651 1.352 . . . . 0.0 114.651 -179.055 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -96.89 145.87 25.47 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 114.926 -1.034 . . . . 0.0 110.403 -176.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 37.2 p -62.94 142.29 58.39 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 114.994 -1.003 . . . . 0.0 108.883 177.108 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . 0.414 ' CD2' ' HD3' ' A' ' 109' ' ' ARG . 7.4 m95 -66.23 -21.87 66.31 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 177.754 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -121.41 161.51 22.04 Favored 'General case' 0 CA--C 1.509 -0.619 0 N-CA-C 113.944 1.09 . . . . 0.0 113.944 -172.102 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 77.4 p -72.55 172.69 10.08 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 113.692 -1.594 . . . . 0.0 109.136 177.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -77.67 142.6 38.73 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 -176.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 11.8 mt -90.48 133.59 34.94 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 102.299 -3.223 . . . . 0.0 102.299 167.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 64.5 m -118.37 138.59 52.32 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 118.143 0.429 . . . . 0.0 110.264 -176.103 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.414 ' HB2' ' CZ ' ' A' ' 131' ' ' PHE . 4.0 tp60 -105.84 139.89 39.72 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 113.596 0.962 . . . . 0.0 113.596 -177.823 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 59.7 t60 -128.74 99.71 5.44 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 104.476 -2.416 . . . . 0.0 104.476 168.241 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 160.78 -162.38 33.47 Favored Glycine 0 C--O 1.226 -0.375 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 -176.333 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 54.0 mttp -110.04 -15.79 13.96 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 113.508 0.929 . . . . 0.0 113.508 -179.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -74.05 153.52 39.62 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 179.395 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 63.0 m-20 -79.82 -62.85 1.56 Allowed 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 120.566 0.222 . . . . 0.0 110.975 -178.133 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 48.3 tp 165.69 137.38 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 102.763 -3.051 . . . . 0.0 102.763 177.418 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -155.43 135.78 13.19 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 177.007 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -124.47 157.84 63.7 Favored Pre-proline 0 C--N 1.322 -0.599 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 177.467 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -69.33 174.39 9.21 Favored 'Trans proline' 0 CA--C 1.539 0.762 0 C-N-CA 121.704 1.602 . . . . 0.0 114.933 -178.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 17.3 tpt180 -78.25 129.54 35.19 Favored 'General case' 0 C--O 1.216 -0.681 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 178.367 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 75.42 12.29 83.73 Favored Glycine 0 C--O 1.225 -0.411 0 N-CA-C 114.99 0.756 . . . . 0.0 114.99 175.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 33.6 tt0 -157.29 145.16 19.04 Favored 'General case' 0 C--O 1.219 -0.523 0 N-CA-C 106.378 -1.712 . . . . 0.0 106.378 -178.489 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 138.66 -14.39 3.4 Favored Glycine 0 CA--C 1.506 -0.504 0 C-N-CA 120.038 -1.077 . . . . 0.0 113.707 177.42 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 30.8 m -72.56 145.31 87.31 Favored Pre-proline 0 C--N 1.319 -0.729 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 177.044 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -75.69 166.28 28.66 Favored 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 122.104 1.869 . . . . 0.0 113.775 179.386 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 97.6 mt -73.3 124.84 31.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.34 -0.846 . . . . 0.0 110.568 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.429 ' ND2' ' HH ' ' A' ' 72' ' ' TYR . 16.3 t-20 -125.41 122.76 37.65 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.861 0.362 . . . . 0.0 110.921 174.64 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 72.7 p -91.04 -15.91 28.77 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 113.837 1.051 . . . . 0.0 113.837 -177.195 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 11.8 p30 -112.96 25.37 11.47 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.637 -0.711 . . . . 0.0 112.385 -176.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 68.3 m -136.36 153.34 51.15 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 178.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 2.9 m -68.62 162.9 59.24 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.527 -178.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -66.47 -28.61 45.77 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 114.493 -3.204 . . . . 0.0 113.638 179.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.515 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 5.1 p-10 -75.23 -23.08 57.5 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 121.621 -0.674 . . . . 0.0 111.608 177.151 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.438 ' HA ' ' HE3' ' A' ' 103' ' ' LYS . 18.8 m-20 -73.25 -13.15 61.08 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.712 0.805 . . . . 0.0 112.901 -176.406 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 93.1 mm-40 -62.44 -24.53 67.47 Favored 'General case' 0 C--O 1.219 -0.547 0 N-CA-C 114.492 1.293 . . . . 0.0 114.492 -177.092 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 12.9 tt -57.16 140.15 15.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 CA-C-O 122.303 1.049 . . . . 0.0 112.952 179.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 178.35 -151.78 10.89 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.122 -1.037 . . . . 0.0 113.14 -179.116 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 48.7 p90 -154.71 168.71 25.91 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 179.074 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -108.67 138.4 45.04 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 173.151 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.96 126.01 51.68 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 123.821 0.849 . . . . 0.0 108.758 -179.379 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 34.1 ttt180 -70.78 144.16 50.94 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 122.339 0.256 . . . . 0.0 111.404 177.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -149.16 160.22 43.55 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.709 0.766 . . . . 0.0 111.679 178.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 8.4 t -169.13 176.28 5.35 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 102.09 -3.3 . . . . 0.0 102.09 174.485 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 12.9 tpt180 -128.41 123.86 34.85 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 177.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 3.3 tmt_? -134.95 142.22 46.45 Favored 'General case' 0 CA--C 1.5 -0.974 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 -177.505 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -141.88 179.75 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 -177.605 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 24.9 tpt85 -134.96 104.52 5.99 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 105.669 -1.975 . . . . 0.0 105.669 171.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -77.54 152.54 39.5 Favored Glycine 0 N--CA 1.45 -0.385 0 N-CA-C 105.078 -3.209 . . . . 0.0 105.078 176.258 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -59.76 -38.21 93.57 Favored Glycine 0 C--O 1.222 -0.617 0 CA-C-N 118.9 1.35 . . . . 0.0 112.147 -178.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 37.5 t0 -81.83 15.73 2.11 Favored 'General case' 0 CA--C 1.551 0.993 0 CA-C-O 122.345 1.069 . . . . 0.0 112.057 -179.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 85.13 15.46 66.95 Favored Glycine 0 C--O 1.222 -0.64 0 CA-C-N 115.664 -0.698 . . . . 0.0 113.294 171.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 21.1 mmtt -82.34 140.55 33.47 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.399 0.619 . . . . 0.0 109.855 -175.384 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 61.7 mtp -125.51 -178.37 4.22 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 114.418 -1.265 . . . . 0.0 110.451 -176.297 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 34.6 mmtt -136.88 -57.95 0.72 Allowed 'General case' 0 CA--C 1.504 -0.817 0 CA-C-O 121.33 0.586 . . . . 0.0 109.441 -177.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 34.47 64.04 0.41 Allowed 'General case' 0 C--N 1.322 -0.63 0 O-C-N 126.172 2.17 . . . . 0.0 112.897 173.528 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 75.9 mt -61.74 159.33 13.77 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 113.669 -1.605 . . . . 0.0 112.258 -176.376 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 54.1 p -55.61 142.77 60.96 Favored Pre-proline 0 C--O 1.252 1.187 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.368 179.327 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -66.46 142.06 63.9 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 116.7 -1.733 . . . . 0.0 112.554 -176.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 6.9 ptp180 -139.26 162.81 34.09 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 114.477 -1.238 . . . . 0.0 108.198 -179.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 53.1 m95 -132.65 148.92 52.36 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 -177.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 45.1 m-85 -125.09 150.46 46.81 Favored 'General case' 0 C--O 1.215 -0.763 0 N-CA-C 106.17 -1.789 . . . . 0.0 106.17 179.433 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 86.3 t80 -97.06 139.01 33.71 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 118.818 0.735 . . . . 0.0 109.756 -175.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -140.99 152.28 44.8 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 -175.171 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.429 ' HH ' ' ND2' ' A' ' 35' ' ' ASN . 65.9 m-85 -85.53 159.47 19.9 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -175.045 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -54.2 126.61 23.62 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.127 178.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 72.92 30.79 62.92 Favored Glycine 0 C--O 1.22 -0.737 0 N-CA-C 116.105 1.202 . . . . 0.0 116.105 177.226 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.2 p -89.31 146.21 24.86 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 119.133 1.467 . . . . 0.0 108.154 178.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 98.01 133.09 7.8 Favored Glycine 0 CA--C 1.527 0.786 0 N-CA-C 109.186 -1.565 . . . . 0.0 109.186 -176.51 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -70.41 -36.45 9.06 Favored 'Trans proline' 0 C--N 1.346 0.433 0 CA-C-N 119.716 1.758 . . . . 0.0 116.036 -173.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -105.24 15.16 27.86 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 114.983 -1.008 . . . . 0.0 108.884 -176.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -60.3 -43.07 96.63 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.349 -175.291 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 56.48 35.13 65.16 Favored Glycine 0 C--O 1.228 -0.242 0 CA-C-N 115.871 -0.604 . . . . 0.0 112.687 179.434 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 15.0 mt -113.28 103.91 55.57 Favored Pre-proline 0 N--CA 1.446 -0.662 0 N-CA-C 115.401 1.63 . . . . 0.0 115.401 -175.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -79.48 163.99 24.06 Favored 'Trans proline' 0 N--CA 1.46 -0.47 0 C-N-CA 122.421 2.08 . . . . 0.0 107.846 167.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 48.6 t80 -61.51 131.01 48.75 Favored 'General case' 0 C--N 1.319 -0.733 0 C-N-CA 120.467 -0.493 . . . . 0.0 110.214 -178.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 92.89 -7.65 76.7 Favored Glycine 0 CA--C 1.52 0.368 0 CA-C-O 119.349 -0.695 . . . . 0.0 114.778 178.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -66.88 130.59 43.65 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 118.58 1.19 . . . . 0.0 111.655 179.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 56.4 t30 -76.44 129.7 36.92 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.606 -179.328 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 22.0 ttmt -156.07 153.13 28.91 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 179.304 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 35.0 t0 -60.2 125.23 22.88 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.312 0.577 . . . . 0.0 111.48 -178.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 69.66 30.92 70.49 Favored Glycine 0 N--CA 1.449 -0.472 0 CA-C-O 118.908 -0.94 . . . . 0.0 114.484 177.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 42.8 mm -126.0 129.86 72.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 117.844 0.822 . . . . 0.0 111.445 179.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -130.82 117.88 39.9 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.662 175.25 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 96.4 m95 -82.99 136.68 34.43 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 113.81 1.041 . . . . 0.0 113.81 -176.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -144.77 155.37 14.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.611 -179.121 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -155.81 166.6 33.01 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 104.729 -2.323 . . . . 0.0 104.729 -178.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 15.1 t -116.28 170.04 8.83 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 104.892 -2.262 . . . . 0.0 104.892 173.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -66.13 135.1 54.1 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 178.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 91.3 -7.52 80.34 Favored Glycine 0 CA--C 1.517 0.188 0 CA-C-N 116.143 -0.481 . . . . 0.0 113.169 179.48 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.515 ' HA ' ' HA ' ' A' ' 41' ' ' ASP . . . -72.16 134.34 45.66 Favored 'General case' 0 CA--C 1.539 0.542 0 O-C-N 122.322 -0.516 . . . . 0.0 110.337 178.81 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 31.8 mt -85.96 138.19 32.18 Favored 'General case' 0 CA--C 1.511 -0.532 0 CA-C-O 121.48 0.657 . . . . 0.0 112.591 -177.163 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 60.0 t30 -85.43 69.73 10.72 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.277 -179.542 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -145.1 158.52 51.83 Favored Pre-proline 0 C--N 1.321 -0.657 0 N-CA-C 104.237 -2.505 . . . . 0.0 104.237 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -73.08 149.9 47.25 Favored 'Trans proline' 0 CA--C 1.534 0.515 0 N-CA-C 113.938 0.707 . . . . 0.0 113.938 177.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.438 ' HE3' ' HA ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -146.83 56.84 1.15 Allowed 'General case' 0 N--CA 1.477 0.883 0 CA-C-O 122.702 1.239 . . . . 0.0 109.205 176.444 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -65.14 -21.38 66.78 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.291 -1.322 . . . . 0.0 111.519 179.382 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 19.0 p80 -56.83 -19.67 18.61 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 114.307 1.225 . . . . 0.0 114.307 -179.13 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 11.7 mt -83.58 -27.91 7.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 121.698 0.761 . . . . 0.0 109.017 -179.413 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -78.2 14.66 10.72 Favored Glycine 0 C--O 1.219 -0.798 0 CA-C-N 115.715 -0.675 . . . . 0.0 114.416 -176.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 7.8 t -83.05 15.42 2.81 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-O 122.079 0.942 . . . . 0.0 110.467 -179.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.414 ' HD3' ' CD2' ' A' ' 12' ' ' TRP . 57.8 ttp85 -63.46 131.3 47.72 Favored 'General case' 0 C--N 1.327 -0.41 0 O-C-N 121.851 -0.531 . . . . 0.0 110.212 -179.512 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 66.4 m-20 -106.65 120.18 49.19 Favored Pre-proline 0 C--N 1.327 -0.404 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 179.289 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -70.71 -13.92 32.67 Favored 'Trans proline' 0 C--N 1.347 0.489 0 N-CA-C 113.808 0.657 . . . . 0.0 113.808 -176.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -72.61 -26.04 61.54 Favored 'General case' 0 C--O 1.22 -0.46 0 CA-C-O 120.717 0.294 . . . . 0.0 110.825 177.09 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 -104.05 -24.82 13.17 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 114.273 1.212 . . . . 0.0 114.273 -174.196 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . 0.401 ' OD1' ' HD2' ' A' ' 109' ' ' ARG . 0.1 OUTLIER -143.26 154.98 44.37 Favored 'General case' 0 N--CA 1.434 -1.238 0 CA-C-O 121.284 0.564 . . . . 0.0 110.308 -176.211 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -94.99 144.1 25.95 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.462 178.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -70.3 148.23 48.74 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.197 0.522 . . . . 0.0 110.958 179.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 15.0 mt -84.45 136.98 21.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 -178.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -62.67 125.92 20.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 106.776 -1.564 . . . . 0.0 106.776 175.628 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 4.2 tt -66.08 128.39 35.89 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.163 0.506 . . . . 0.0 111.005 -177.398 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -132.03 156.86 45.52 Favored 'General case' 0 CA--C 1.509 -0.612 0 N-CA-C 106.946 -1.502 . . . . 0.0 106.946 -179.58 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 14.3 mt -115.3 147.49 38.71 Favored Pre-proline 0 C--N 1.32 -0.679 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 179.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -73.29 169.38 22.42 Favored 'Trans proline' 0 C--N 1.346 0.421 0 O-C-N 122.361 0.664 . . . . 0.0 113.754 -178.579 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 39.7 tt0 -53.6 131.85 39.49 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.426 -0.806 . . . . 0.0 109.899 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 94.26 -18.05 57.67 Favored Glycine 0 C--O 1.228 -0.248 0 CA-C-N 115.904 -0.589 . . . . 0.0 113.395 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 3.3 m -104.66 126.77 52.06 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 118.108 0.954 . . . . 0.0 111.261 178.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 5.5 p -119.87 148.27 43.68 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.964 -179.348 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 88.7 mt -69.86 152.8 95.9 Favored Pre-proline 0 C--N 1.324 -0.535 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 178.204 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -76.58 175.37 11.45 Favored 'Trans proline' 0 N--CA 1.462 -0.375 0 C-N-CA 118.524 -0.517 . . . . 0.0 111.077 178.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 62.6 tttm -56.9 126.62 27.89 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 113.431 0.9 . . . . 0.0 113.431 -174.552 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 89.56 -6.42 83.17 Favored Glycine 0 CA--C 1.517 0.197 0 N-CA-C 116.106 1.202 . . . . 0.0 116.106 175.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.414 ' CZ ' ' HB2' ' A' ' 18' ' ' GLN . 2.7 m-85 -91.68 145.68 24.39 Favored 'General case' 0 N--CA 1.434 -1.26 0 CA-C-O 122.653 1.216 . . . . 0.0 111.681 -178.685 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 50.2 p90 -145.34 162.5 37.08 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 112.902 -1.953 . . . . 0.0 107.896 175.162 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -105.48 136.53 44.87 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.162 0.506 . . . . 0.0 111.913 -176.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -67.56 133.73 49.97 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.356 -0.838 . . . . 0.0 108.92 177.584 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 91.88 -27.51 9.92 Favored Glycine 0 CA--C 1.522 0.513 0 N-CA-C 113.663 0.225 . . . . 0.0 113.663 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 4.9 t -71.41 177.84 3.75 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.306 0.574 . . . . 0.0 111.248 178.139 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 42.7 ttt180 65.0 0.46 1.23 Allowed 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 124.985 1.314 . . . . 0.0 114.42 -179.268 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -68.27 161.03 50.62 Favored Glycine 0 CA--C 1.52 0.351 0 N-CA-C 109.776 -1.329 . . . . 0.0 109.776 174.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -127.55 35.04 2.88 Favored Glycine 0 N--CA 1.457 0.093 0 N-CA-C 112.077 -0.409 . . . . 0.0 112.077 -178.384 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 50.1 m . . . . . 0 C--O 1.252 1.199 0 CA-C-O 115.619 -2.134 . . . . 0.0 105.869 -179.396 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.91 0 CA-C-O 118.311 -1.272 . . . . 0.0 111.167 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -69.73 151.65 45.57 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 118.678 1.239 . . . . 0.0 107.867 177.586 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 26.6 mmt -80.62 52.38 1.66 Allowed 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -178.383 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 61.14 28.76 69.55 Favored Glycine 0 C--O 1.224 -0.522 0 CA-C-O 121.492 0.496 . . . . 0.0 113.78 179.448 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 80.2 mt -65.96 141.52 97.6 Favored Pre-proline 0 C--N 1.323 -0.556 0 CA-C-N 115.683 -0.258 . . . . 0.0 110.922 -176.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -74.03 89.79 1.01 Allowed 'Trans proline' 0 C--N 1.352 0.723 0 CA-C-O 122.224 0.843 . . . . 0.0 112.903 179.193 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 14.0 p-10 -81.91 28.61 0.42 Allowed 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 115.222 1.564 . . . . 0.0 115.222 -175.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -70.38 -31.86 69.28 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 178.462 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 26.8 p -17.75 97.41 0.01 OUTLIER 'General case' 0 C--O 1.24 0.571 0 C-N-CA 127.092 2.157 . . . . 0.0 115.569 178.351 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -128.6 140.26 51.86 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 114.527 -1.215 . . . . 0.0 113.318 -175.608 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 16.2 t -66.2 141.86 57.91 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.78 178.431 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 27.3 m95 -68.35 -23.21 64.66 Favored 'General case' 0 CA--C 1.509 -0.634 0 O-C-N 123.372 0.42 . . . . 0.0 111.457 177.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 36.7 m-85 -121.38 158.26 28.69 Favored 'General case' 0 CA--C 1.506 -0.714 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.83 -173.396 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.42 ' HB ' ' HB3' ' A' ' 134' ' ' GLU . 69.8 p -65.67 160.43 22.74 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.235 -0.893 . . . . 0.0 109.838 -179.65 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -80.25 139.34 36.73 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.147 -0.933 . . . . 0.0 112.166 -174.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.8 mp -83.15 148.9 27.19 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 172.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 64.7 m -124.49 138.76 54.32 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 179.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.4 ' HB2' ' CZ ' ' A' ' 131' ' ' PHE . 4.3 tp60 -111.85 136.44 51.14 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 -178.023 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 56.0 t60 -131.22 94.97 3.68 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 104.318 -2.475 . . . . 0.0 104.318 169.152 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 178.61 -166.32 36.06 Favored Glycine 0 C--O 1.224 -0.475 0 N-CA-C 110.802 -0.919 . . . . 0.0 110.802 -176.3 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 91.9 mttt -101.11 -21.79 14.88 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 114.442 1.275 . . . . 0.0 114.442 -177.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -94.03 161.53 14.25 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 179.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -77.76 -62.92 1.51 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.517 -179.012 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 45.0 tp 179.44 140.7 0.12 Allowed 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 105.387 -2.079 . . . . 0.0 105.387 175.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 23.7 tptm -155.67 134.84 12.21 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 118.051 0.387 . . . . 0.0 110.49 174.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 20.1 m-85 -121.24 151.69 56.19 Favored Pre-proline 0 C--O 1.242 0.66 0 N-CA-C 107.178 -1.416 . . . . 0.0 107.178 174.062 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -73.97 160.63 42.74 Favored 'Trans proline' 0 CA--C 1.535 0.541 0 O-C-N 122.058 0.504 . . . . 0.0 111.946 177.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 3.8 tmt_? -64.3 132.02 48.99 Favored 'General case' 0 N--CA 1.47 0.539 0 O-C-N 122.169 -0.332 . . . . 0.0 110.35 -178.102 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 83.23 15.38 72.04 Favored Glycine 0 C--O 1.223 -0.557 0 C-N-CA 121.249 -0.501 . . . . 0.0 112.375 177.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.533 HE22 HG22 ' A' ' 125' ' ' THR . 0.8 OUTLIER -150.92 170.54 19.07 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 -176.668 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 100.32 -10.83 59.89 Favored Glycine 0 CA--C 1.508 -0.384 0 N-CA-C 115.183 0.833 . . . . 0.0 115.183 174.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 90.3 t -68.91 130.07 91.85 Favored Pre-proline 0 C--N 1.321 -0.669 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 177.342 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -73.18 171.75 16.98 Favored 'Trans proline' 0 C--O 1.221 -0.357 0 O-C-N 122.183 0.57 . . . . 0.0 112.351 178.343 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 92.6 mt -71.57 106.44 2.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 179.304 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 -96.17 86.55 4.28 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 114.33 -1.305 . . . . 0.0 109.755 -176.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 77.5 p -67.65 -14.89 63.33 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.543 -0.753 . . . . 0.0 112.816 -178.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -108.35 21.04 17.88 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.158 -0.928 . . . . 0.0 112.022 -177.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.404 ' HB3' ' HB2' ' A' ' 42' ' ' ASP . 2.0 m -143.17 149.84 38.58 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 114.333 1.234 . . . . 0.0 114.333 -175.824 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.2 m -76.8 168.41 28.32 Favored Pre-proline 0 N--CA 1.471 0.595 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 177.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -64.39 -27.44 62.94 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 114.731 -3.046 . . . . 0.0 112.095 178.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -62.84 -23.97 67.55 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 124.104 0.962 . . . . 0.0 112.322 176.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.447 ' HA ' ' HE3' ' A' ' 103' ' ' LYS . 68.7 m-20 -99.28 -1.98 37.66 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 114.106 1.151 . . . . 0.0 114.106 -171.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 91.8 mm-40 -61.89 -26.01 67.9 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 114.002 1.112 . . . . 0.0 114.002 -177.433 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 8.5 tt -59.04 137.26 21.72 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.83 0 CA-C-O 122.242 1.02 . . . . 0.0 112.977 -179.281 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -179.33 -159.18 22.97 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.437 -0.887 . . . . 0.0 112.505 -178.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 42.7 p90 -155.02 168.12 28.08 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 179.468 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 31.9 m-85 -109.37 140.77 42.66 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 175.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 66.0 ttt-85 -116.85 120.77 39.54 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.892 -175.054 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 50.1 ttp180 -70.73 143.7 51.19 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 110.244 -0.28 . . . . 0.0 110.244 177.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -144.32 141.26 29.65 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 122.734 0.414 . . . . 0.0 110.327 178.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 25.4 p -144.49 151.5 39.25 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 178.192 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 13.3 tpt180 -149.14 130.52 14.72 Favored 'General case' 0 N--CA 1.469 0.517 0 O-C-N 122.176 -0.328 . . . . 0.0 111.3 176.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 4.2 tmm_? -144.07 138.83 28.57 Favored 'General case' 0 CA--C 1.5 -0.96 0 CA-C-O 121.157 0.503 . . . . 0.0 109.793 179.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -131.81 179.2 4.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 -179.658 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 5.0 ttt85 -115.36 99.16 7.18 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 174.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -77.91 157.69 45.58 Favored Glycine 0 C--O 1.223 -0.551 0 N-CA-C 107.359 -2.296 . . . . 0.0 107.359 176.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -66.04 -41.9 94.91 Favored Glycine 0 C--O 1.217 -0.953 0 CA-C-N 118.427 1.114 . . . . 0.0 111.899 179.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -85.35 -11.05 55.5 Favored 'General case' 0 C--O 1.215 -0.719 0 CA-C-O 122.137 0.97 . . . . 0.0 110.328 178.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 103.57 9.7 37.48 Favored Glycine 0 C--O 1.226 -0.398 0 CA-C-N 115.288 -0.869 . . . . 0.0 112.781 177.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 59.5 mmtt -61.12 132.36 53.48 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.274 0.559 . . . . 0.0 110.59 -179.391 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 95.8 mmm -86.19 167.62 14.72 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 114.781 -1.099 . . . . 0.0 111.185 179.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 16.2 tppt? -108.61 -39.42 5.39 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 176.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 15.2 t0 -141.77 164.98 28.72 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 105.253 -2.129 . . . . 0.0 105.253 178.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -121.2 -94.27 0.5 Allowed 'General case' 0 C--N 1.325 -0.469 0 O-C-N 123.502 0.501 . . . . 0.0 110.597 -176.334 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -72.45 159.4 85.48 Favored Pre-proline 0 C--N 1.326 -0.43 0 C-N-CA 122.717 0.407 . . . . 0.0 109.976 179.667 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -68.79 140.86 47.62 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 115.116 -2.789 . . . . 0.0 111.377 177.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 53.5 mtt180 -104.2 155.65 18.54 Favored 'General case' 0 CA--C 1.504 -0.798 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.067 179.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 66.0 m95 -127.53 125.85 41.13 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 174.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 69.6 m-85 -110.32 160.22 16.75 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 106.605 -1.628 . . . . 0.0 106.605 -178.615 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -103.55 132.8 49.49 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 179.378 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -131.65 145.69 51.8 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 -176.081 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 58.8 m-85 -87.26 161.59 17.9 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 120.755 0.312 . . . . 0.0 110.289 -176.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -53.42 132.46 39.69 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 120.747 0.308 . . . . 0.0 111.379 -178.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 70.37 27.98 71.95 Favored Glycine 0 C--O 1.224 -0.508 0 N-CA-C 116.264 1.266 . . . . 0.0 116.264 176.529 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 69.9 p -110.27 154.96 22.7 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 118.278 1.039 . . . . 0.0 111.286 178.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 111.48 146.21 10.34 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.387 -1.085 . . . . 0.0 110.387 -178.201 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -70.41 -40.4 4.34 Favored 'Trans proline' 0 C--N 1.348 0.545 0 CA-C-N 119.588 1.694 . . . . 0.0 116.4 -173.448 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -117.92 23.74 11.47 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.972 0.892 . . . . 0.0 109.649 -178.003 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -66.75 -55.64 14.09 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.855 -0.612 . . . . 0.0 111.554 -176.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 55.77 35.28 62.49 Favored Glycine 0 C--O 1.223 -0.552 0 N-CA-C 111.398 -0.681 . . . . 0.0 111.398 -177.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 27.4 mt -106.39 104.73 51.69 Favored Pre-proline 0 C--O 1.238 0.482 0 N-CA-C 117.348 2.351 . . . . 0.0 117.348 -172.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -77.88 164.36 27.69 Favored 'Trans proline' 0 C--O 1.234 0.303 0 C-N-CA 121.787 1.658 . . . . 0.0 108.011 167.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 53.5 t80 -62.43 133.1 54.55 Favored 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 120.493 -0.483 . . . . 0.0 111.191 -176.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 89.52 -7.6 81.59 Favored Glycine 0 CA--C 1.517 0.202 0 CA-C-O 119.6 -0.556 . . . . 0.0 114.373 178.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -63.5 131.61 48.68 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 118.134 0.967 . . . . 0.0 111.084 179.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -78.25 130.13 35.9 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.242 -179.277 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 24.8 ttmt -156.2 150.97 26.04 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 105.37 -2.085 . . . . 0.0 105.37 176.501 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 42.4 t0 -70.88 135.85 48.28 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.827 -0.435 . . . . 0.0 109.827 -177.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 71.95 24.5 76.48 Favored Glycine 0 N--CA 1.453 -0.222 0 C-N-CA 121.158 -0.544 . . . . 0.0 113.937 -179.373 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 41.6 mm -129.36 129.61 67.27 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 CA-C-N 117.198 0.499 . . . . 0.0 110.593 -179.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.1 pt -132.91 125.22 51.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 CA-C-O 121.17 0.51 . . . . 0.0 110.591 176.472 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 95.9 m95 -88.63 138.96 30.95 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 113.62 0.97 . . . . 0.0 113.62 -176.023 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 16.6 m -137.78 152.21 26.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 108.982 -0.748 . . . . 0.0 108.982 178.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -160.62 166.6 28.63 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 103.368 -2.827 . . . . 0.0 103.368 -179.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 12.4 t -138.63 177.24 8.03 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 106.059 -1.83 . . . . 0.0 106.059 178.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -67.5 135.71 53.47 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.983 0.421 . . . . 0.0 109.972 -179.415 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 96.16 -8.52 67.36 Favored Glycine 0 C--O 1.224 -0.514 0 CA-C-N 115.952 -0.567 . . . . 0.0 113.506 178.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -80.92 138.76 36.13 Favored 'General case' 0 CA--C 1.538 0.491 0 O-C-N 122.37 -0.488 . . . . 0.0 111.678 -179.534 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 91.9 mt -88.05 154.93 20.09 Favored 'General case' 0 C--O 1.214 -0.808 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 178.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 57.8 t30 -96.99 64.88 2.02 Favored 'General case' 0 C--N 1.323 -0.572 0 O-C-N 122.14 -0.35 . . . . 0.0 110.516 178.237 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -138.24 154.51 73.95 Favored Pre-proline 0 CA--C 1.538 0.518 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 -179.119 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -68.02 154.17 73.32 Favored 'Trans proline' 0 C--N 1.349 0.602 0 N-CA-C 114.332 0.859 . . . . 0.0 114.332 -179.222 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.447 ' HE3' ' HA ' ' A' ' 42' ' ' ASP . 70.9 mmtt -128.67 54.35 1.78 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.552 0.691 . . . . 0.0 109.627 -178.364 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 12.7 p-10 -60.48 -37.23 80.36 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.573 -177.017 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 10.6 p80 -65.56 -15.18 62.46 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 113.205 0.817 . . . . 0.0 113.205 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 25.1 mt -91.21 -38.19 10.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 178.276 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -75.74 2.75 53.18 Favored Glycine 0 CA--C 1.521 0.438 0 N-CA-C 116.013 1.165 . . . . 0.0 116.013 -177.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 6.2 t -91.17 22.45 3.78 Favored 'General case' 0 CA--C 1.548 0.876 0 CA-C-O 121.98 0.895 . . . . 0.0 111.728 -178.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.423 ' HD2' ' OD1' ' A' ' 114' ' ' ASN . 61.1 ttp85 -59.11 131.41 50.96 Favored 'General case' 0 N--CA 1.468 0.464 0 O-C-N 121.507 -0.745 . . . . 0.0 110.918 -179.625 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 71.1 m-20 -104.38 121.41 47.42 Favored Pre-proline 0 C--N 1.327 -0.394 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_endo -70.09 -14.72 35.37 Favored 'Trans proline' 0 C--N 1.348 0.516 0 N-CA-C 113.994 0.729 . . . . 0.0 113.994 -178.101 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -73.79 -25.61 60.21 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 120.665 0.269 . . . . 0.0 110.899 177.06 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 -101.89 -25.41 13.8 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 113.325 0.861 . . . . 0.0 113.325 -175.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . 0.423 ' OD1' ' HD2' ' A' ' 109' ' ' ARG . 0.4 OUTLIER -141.8 151.92 43.26 Favored 'General case' 0 N--CA 1.439 -1.013 0 CA-C-O 121.196 0.522 . . . . 0.0 111.451 -176.782 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -97.24 140.47 31.67 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 115.382 -0.826 . . . . 0.0 109.594 177.395 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -68.88 151.99 45.87 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.275 0.56 . . . . 0.0 111.459 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 5.3 mt -95.4 139.43 18.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.066 -178.018 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 71.8 t -62.07 125.9 19.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 N-CA-C 106.391 -1.707 . . . . 0.0 106.391 175.389 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 7.6 tt -66.85 128.14 35.17 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.225 0.536 . . . . 0.0 109.58 -177.392 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 29.5 mt-30 -129.45 158.26 39.68 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 105.417 -2.068 . . . . 0.0 105.417 179.391 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 21.3 mt -115.02 148.28 40.2 Favored Pre-proline 0 C--N 1.321 -0.662 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 179.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -72.65 170.33 19.76 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 120.49 0.793 . . . . 0.0 113.636 -177.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 4.1 tp-100 -53.84 129.08 32.43 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.391 -179.371 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 89.66 -10.97 71.7 Favored Glycine 0 CA--C 1.519 0.34 0 CA-C-N 115.999 -0.546 . . . . 0.0 114.385 179.399 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.533 HG22 HE22 ' A' ' 30' ' ' GLN . 25.7 m -108.67 127.05 53.64 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 117.955 0.877 . . . . 0.0 110.002 179.052 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 12.7 p -125.07 152.52 44.23 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 123.054 0.541 . . . . 0.0 110.83 -178.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 83.7 mt -69.62 153.27 95.82 Favored Pre-proline 0 C--N 1.328 -0.362 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 179.398 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -77.96 176.48 9.94 Favored 'Trans proline' 0 C--N 1.345 0.377 0 O-C-N 121.946 0.445 . . . . 0.0 111.283 178.401 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -59.48 125.59 24.24 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 113.85 1.056 . . . . 0.0 113.85 -174.572 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 91.51 -4.0 79.39 Favored Glycine 0 C--N 1.33 0.2 0 N-CA-C 115.748 1.059 . . . . 0.0 115.748 175.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.4 ' CZ ' ' HB2' ' A' ' 18' ' ' GLN . 2.4 m-85 -96.58 142.51 28.55 Favored 'General case' 0 N--CA 1.44 -0.964 0 CA-C-O 122.09 0.947 . . . . 0.0 113.055 -177.696 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 52.8 p90 -146.04 161.62 39.72 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 113.66 -1.609 . . . . 0.0 107.568 173.201 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -104.83 151.31 23.96 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 -178.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.42 ' HB3' ' HB ' ' A' ' 14' ' ' THR . 4.9 tp10 -70.92 134.94 47.65 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 178.488 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 84.56 -4.45 84.34 Favored Glycine 0 CA--C 1.521 0.438 0 C-N-CA 121.537 -0.364 . . . . 0.0 113.72 -177.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 18.2 t -85.89 173.06 10.25 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.636 0.731 . . . . 0.0 109.292 178.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 56.2 mmm-85 -130.63 173.08 11.24 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 105.534 -2.025 . . . . 0.0 105.534 177.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -164.43 -172.92 32.49 Favored Glycine 0 C--N 1.316 -0.557 0 N-CA-C 105.839 -2.904 . . . . 0.0 105.839 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -145.59 -173.54 16.95 Favored Glycine 0 N--CA 1.452 -0.244 0 N-CA-C 107.972 -2.051 . . . . 0.0 107.972 179.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 25.7 m . . . . . 0 C--O 1.249 1.032 0 CA-C-O 117.317 -1.325 . . . . 0.0 109.868 178.938 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.758 0 CA-C-O 118.499 -1.167 . . . . 0.0 111.44 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 54.22 28.74 9.52 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 115.353 1.612 . . . . 0.0 115.353 177.692 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 3.3 tmm? -156.8 130.29 8.1 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 178.485 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -174.18 -79.02 0.05 OUTLIER Glycine 0 C--O 1.229 -0.18 0 C-N-CA 120.797 -0.715 . . . . 0.0 113.344 179.153 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 91.1 mt -118.58 153.95 52.29 Favored Pre-proline 0 C--N 1.327 -0.41 0 N-CA-C 110.094 -0.336 . . . . 0.0 110.094 -177.32 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -78.84 173.11 14.02 Favored 'Trans proline' 0 C--N 1.349 0.562 0 O-C-N 122.061 0.506 . . . . 0.0 111.345 176.251 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 79.3 m-20 -115.72 -142.38 0.38 Allowed 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 105.659 -1.978 . . . . 0.0 105.659 178.101 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 66.6 t30 -103.91 50.49 0.8 Allowed 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.295 0.569 . . . . 0.0 111.33 -176.494 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 22.3 p -139.4 149.49 44.16 Favored 'General case' 0 N--CA 1.439 -1.023 0 N-CA-C 100.285 -3.969 . . . . 0.0 100.285 -179.698 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -146.8 147.53 30.98 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-O 121.545 0.688 . . . . 0.0 112.101 -177.11 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -59.17 142.48 51.54 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.184 -0.916 . . . . 0.0 110.305 177.934 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 21.4 m95 -67.19 -21.92 65.76 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 114.066 1.135 . . . . 0.0 114.066 -179.191 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 39.2 m-85 -121.48 162.21 20.91 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 114.336 1.236 . . . . 0.0 114.336 -170.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 53.8 p -68.87 164.58 21.72 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.377 -1.283 . . . . 0.0 110.811 -179.64 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -85.59 131.56 34.33 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.261 -0.881 . . . . 0.0 112.388 -176.731 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -81.61 148.85 28.87 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 105.466 -2.05 . . . . 0.0 105.466 173.793 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 57.1 m -118.21 139.66 50.95 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 179.441 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 4.1 tp60 -110.03 136.91 48.55 Favored 'General case' 0 C--N 1.328 -0.345 0 O-C-N 123.426 0.454 . . . . 0.0 111.338 -179.079 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 42.8 t60 -128.09 99.38 5.45 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 105.402 -2.073 . . . . 0.0 105.402 171.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 169.7 -167.57 40.62 Favored Glycine 0 C--O 1.225 -0.432 0 N-CA-C 109.289 -1.524 . . . . 0.0 109.289 -176.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 64.8 mttp -103.77 -23.32 13.42 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 179.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -82.51 158.85 23.01 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 -179.504 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -76.75 -62.86 1.5 Allowed 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 -179.369 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 32.7 tp 172.62 144.8 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 104.228 -2.508 . . . . 0.0 104.228 179.347 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 22.2 tptm -155.59 141.08 17.8 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 174.284 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -126.08 157.91 67.99 Favored Pre-proline 0 C--O 1.241 0.634 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 177.043 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -70.77 176.15 7.93 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 121.307 1.338 . . . . 0.0 114.678 -178.449 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 77.5 ttt180 -74.86 126.41 30.88 Favored 'General case' 0 C--O 1.217 -0.633 0 O-C-N 121.803 -0.56 . . . . 0.0 110.443 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 76.79 13.08 83.94 Favored Glycine 0 C--O 1.223 -0.54 0 N-CA-C 115.483 0.953 . . . . 0.0 115.483 175.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.492 HE22 HG21 ' A' ' 125' ' ' THR . 34.1 tt0 -157.01 142.5 17.47 Favored 'General case' 0 C--O 1.22 -0.458 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 -177.722 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 141.29 -18.06 2.69 Favored Glycine 0 CA--C 1.506 -0.503 0 C-N-CA 120.308 -0.949 . . . . 0.0 113.391 179.108 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 31.6 m -69.49 145.45 95.38 Favored Pre-proline 0 C--N 1.323 -0.566 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 176.381 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -75.9 172.45 16.25 Favored 'Trans proline' 0 CA--C 1.511 -0.64 0 C-N-CA 121.211 1.274 . . . . 0.0 112.582 -179.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 97.9 mt -71.8 109.97 4.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 176.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 69.6 m-80 -101.1 85.59 2.86 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 114.681 -1.145 . . . . 0.0 108.986 -177.812 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 73.7 p -66.16 -15.85 63.48 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 113.021 0.749 . . . . 0.0 113.021 -177.589 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 10.4 p30 -105.65 21.89 16.46 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.253 -0.885 . . . . 0.0 111.315 -178.276 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 14.2 m -141.44 150.95 42.98 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 113.306 0.854 . . . . 0.0 113.306 -176.624 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -73.72 166.57 43.01 Favored Pre-proline 0 C--N 1.326 -0.441 0 N-CA-C 108.396 -0.965 . . . . 0.0 108.396 176.761 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -64.22 -27.92 64.38 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 115.12 -2.787 . . . . 0.0 111.715 178.737 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -61.25 -28.68 69.34 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 123.778 0.831 . . . . 0.0 111.31 176.051 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 75.3 m-20 -98.51 -0.37 43.47 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 115.242 1.571 . . . . 0.0 115.242 -171.35 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 92.7 mm-40 -61.39 -25.63 67.31 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 113.554 0.946 . . . . 0.0 113.554 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 12.3 tt -58.78 141.08 16.22 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 N-CA-C 113.917 1.081 . . . . 0.0 113.917 -178.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 179.54 -152.59 11.15 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.422 -0.894 . . . . 0.0 112.294 179.388 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 48.7 p90 -155.07 165.67 35.99 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 108.312 -0.995 . . . . 0.0 108.312 178.475 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 24.9 m-85 -105.98 142.07 36.31 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 107.413 -1.328 . . . . 0.0 107.413 174.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 69.3 ttt-85 -116.77 123.56 47.44 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 123.597 0.759 . . . . 0.0 112.048 -176.155 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 50.4 ttp180 -71.53 144.46 49.58 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.024 177.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -144.82 143.3 30.56 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 175.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 35.3 p -138.67 171.35 14.48 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 103.379 -2.823 . . . . 0.0 103.379 175.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 23.5 tpt180 -135.7 122.61 21.25 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.253 -0.579 . . . . 0.0 109.941 174.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.76 144.44 25.12 Favored 'General case' 0 CA--C 1.498 -1.024 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 179.684 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -144.22 178.5 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 N-CA-C 104.123 -2.547 . . . . 0.0 104.123 -178.101 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.77 112.0 15.54 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 105.878 -1.897 . . . . 0.0 105.878 174.175 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -74.17 167.36 54.62 Favored Glycine 0 C--O 1.224 -0.483 0 N-CA-C 108.097 -2.001 . . . . 0.0 108.097 177.661 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -62.56 -48.23 83.36 Favored Glycine 0 C--O 1.224 -0.501 0 N-CA-C 109.677 -1.369 . . . . 0.0 109.677 -177.572 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -85.32 17.2 3.2 Favored 'General case' 0 C--O 1.217 -0.61 0 CA-C-O 122.432 1.11 . . . . 0.0 110.758 178.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 87.81 -19.43 33.59 Favored Glycine 0 C--O 1.228 -0.225 0 N-CA-C 115.699 1.039 . . . . 0.0 115.699 174.031 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -56.74 131.1 48.21 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.799 0.809 . . . . 0.0 110.548 -178.333 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 22.4 ptm -127.34 -163.21 1.23 Allowed 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 114.391 -1.277 . . . . 0.0 113.865 -171.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 10.8 mptt -126.14 -57.82 1.39 Allowed 'General case' 0 C--O 1.211 -0.942 0 C-N-CA 123.502 0.721 . . . . 0.0 111.624 -175.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 50.47 51.12 17.48 Favored 'General case' 0 N--CA 1.477 0.918 0 O-C-N 124.695 1.247 . . . . 0.0 113.587 178.325 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -66.37 138.69 57.77 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.632 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -57.42 157.71 12.5 Favored Pre-proline 0 C--O 1.242 0.677 0 CA-C-N 114.803 -1.089 . . . . 0.0 112.71 -179.355 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -68.11 135.85 35.92 Favored 'Trans proline' 0 C--O 1.24 0.592 0 C-N-CA 116.6 -1.8 . . . . 0.0 114.974 -177.665 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 30.0 mtp180 -119.76 158.13 27.16 Favored 'General case' 0 CA--C 1.507 -0.695 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 174.585 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 59.7 m95 -128.3 129.72 46.74 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.186 0.517 . . . . 0.0 109.974 178.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 70.4 m-85 -110.58 163.13 14.03 Favored 'General case' 0 C--O 1.213 -0.858 0 N-CA-C 105.505 -2.035 . . . . 0.0 105.505 179.251 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 89.6 t80 -109.88 136.71 48.74 Favored 'General case' 0 CA--C 1.511 -0.55 0 N-CA-C 107.305 -1.368 . . . . 0.0 107.305 177.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 9.8 m-85 -136.57 148.92 47.79 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 -176.477 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -82.46 159.42 22.92 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.484 -175.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -54.61 129.62 37.14 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.812 -178.262 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 66.85 39.73 93.5 Favored Glycine 0 C--O 1.222 -0.599 0 CA-C-O 119.187 -0.785 . . . . 0.0 114.863 176.196 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -89.01 146.11 25.07 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 118.187 0.993 . . . . 0.0 108.351 177.507 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 98.18 145.18 18.38 Favored Glycine 0 CA--C 1.527 0.834 0 N-CA-C 110.36 -1.096 . . . . 0.0 110.36 -176.528 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -69.27 -44.9 2.11 Favored 'Trans proline' 0 C--N 1.35 0.62 0 N-CA-C 116.804 1.809 . . . . 0.0 116.804 -173.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -114.74 33.21 5.5 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.527 0.679 . . . . 0.0 109.25 -177.434 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -62.78 -40.76 98.31 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.767 -178.017 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 58.83 28.86 63.81 Favored Glycine 0 C--O 1.226 -0.355 0 CA-C-N 115.886 -0.597 . . . . 0.0 113.47 179.286 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 26.6 mt -109.09 103.89 53.51 Favored Pre-proline 0 C--O 1.238 0.469 0 N-CA-C 114.7 1.37 . . . . 0.0 114.7 -176.606 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -78.2 167.86 22.63 Favored 'Trans proline' 0 N--CA 1.461 -0.389 0 C-N-CA 121.671 1.58 . . . . 0.0 108.972 170.812 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 61.0 t80 -63.06 133.54 54.67 Favored 'General case' 0 C--N 1.32 -0.701 0 O-C-N 121.986 -0.446 . . . . 0.0 110.135 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 89.23 -3.19 84.1 Favored Glycine 0 CA--C 1.519 0.296 0 N-CA-C 114.437 0.535 . . . . 0.0 114.437 178.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -63.56 128.79 37.4 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 117.843 0.821 . . . . 0.0 112.873 -179.397 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 44.8 t30 -68.26 118.74 11.76 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.882 -179.436 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 16.1 ttmm -152.92 145.96 24.59 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 176.364 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 33.0 t0 -67.37 132.97 48.72 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.277 -0.874 . . . . 0.0 109.919 -179.272 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 71.81 24.67 76.33 Favored Glycine 0 C--O 1.24 0.498 0 CA-C-O 119.505 -0.608 . . . . 0.0 114.612 179.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 36.9 mm -131.66 132.6 62.11 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 CA-C-N 117.286 0.543 . . . . 0.0 110.495 -179.506 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.1 pt -131.44 117.14 34.62 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 CA-C-O 121.551 0.691 . . . . 0.0 110.572 175.5 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 96.1 m95 -82.53 134.74 35.2 Favored 'General case' 0 C--N 1.321 -0.645 0 O-C-N 121.966 -0.458 . . . . 0.0 111.996 -177.552 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -142.9 150.53 17.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 121.522 0.677 . . . . 0.0 109.788 -178.275 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -155.0 166.57 33.16 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 105.333 -2.099 . . . . 0.0 105.333 -178.756 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 14.7 t -128.1 167.9 16.11 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 105.186 -2.153 . . . . 0.0 105.186 176.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -65.04 137.0 57.43 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 95.68 -8.0 68.33 Favored Glycine 0 C--O 1.225 -0.417 0 CA-C-N 115.919 -0.582 . . . . 0.0 113.204 179.247 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -82.35 142.8 31.72 Favored 'General case' 0 CA--C 1.541 0.597 0 O-C-N 122.26 -0.553 . . . . 0.0 111.473 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 34.9 mt -90.98 135.55 33.66 Favored 'General case' 0 CA--C 1.513 -0.471 0 CA-C-O 121.386 0.612 . . . . 0.0 112.456 -179.242 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 55.3 t30 -84.69 72.27 10.72 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.526 -178.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -146.39 153.25 47.73 Favored Pre-proline 0 C--N 1.324 -0.531 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 -179.583 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -68.65 150.37 74.52 Favored 'Trans proline' 0 C--N 1.344 0.291 0 N-CA-C 114.103 0.77 . . . . 0.0 114.103 178.227 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 3.3 ptpt -151.78 56.82 0.86 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.791 0.805 . . . . 0.0 112.906 -179.432 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -56.76 -28.16 60.75 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 115.557 -0.747 . . . . 0.0 112.146 177.521 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 12.2 p80 -59.76 -10.82 4.16 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 114.363 1.246 . . . . 0.0 114.363 -178.775 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 55.7 mt -93.19 -42.16 13.01 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.496 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 178.118 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -72.06 14.65 2.12 Favored Glycine 0 N--CA 1.464 0.534 0 N-CA-C 116.559 1.384 . . . . 0.0 116.559 -176.007 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 15.2 t -90.45 23.73 2.87 Favored 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 112.768 0.655 . . . . 0.0 112.768 -178.132 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 62.0 ttp85 -55.39 130.19 41.6 Favored 'General case' 0 N--CA 1.475 0.788 0 O-C-N 121.58 -0.7 . . . . 0.0 109.62 -179.514 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 36.3 m120 -95.47 122.92 58.1 Favored Pre-proline 0 C--N 1.322 -0.608 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 -179.404 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -68.44 -20.17 42.22 Favored 'Trans proline' 0 C--O 1.219 -0.443 0 C-N-CA 117.159 -1.427 . . . . 0.0 113.133 179.624 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -73.26 -29.26 62.63 Favored 'General case' 0 C--O 1.22 -0.498 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.427 178.228 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 -100.63 -25.81 14.03 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -175.414 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 26.7 t30 -151.61 144.44 24.42 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 113.448 0.907 . . . . 0.0 113.448 -178.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -83.84 146.92 27.84 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.113 179.549 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -66.34 139.99 58.07 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.209 0.528 . . . . 0.0 110.274 178.676 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 14.3 mt -82.38 138.74 18.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 -177.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -61.15 125.71 17.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 175.328 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 7.8 tt -67.08 128.78 37.66 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 -178.018 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 29.6 mt-30 -128.65 153.35 47.37 Favored 'General case' 0 CA--C 1.507 -0.7 0 N-CA-C 106.088 -1.819 . . . . 0.0 106.088 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 17.0 mt -113.31 149.51 41.6 Favored Pre-proline 0 C--N 1.321 -0.661 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 178.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -72.15 170.65 18.55 Favored 'Trans proline' 0 C--N 1.343 0.278 0 N-CA-C 113.888 0.688 . . . . 0.0 113.888 -177.562 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -54.45 130.86 41.03 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.219 -179.349 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 90.13 -12.21 68.49 Favored Glycine 0 C--O 1.227 -0.325 0 CA-C-N 115.931 -0.577 . . . . 0.0 113.363 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.492 HG21 HE22 ' A' ' 30' ' ' GLN . 8.8 m -108.56 125.63 52.04 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 117.659 0.73 . . . . 0.0 110.271 179.145 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 10.3 p -126.21 150.43 48.36 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.929 -177.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 83.0 mt -69.53 153.79 95.42 Favored Pre-proline 0 C--N 1.325 -0.488 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 176.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -76.03 169.55 21.89 Favored 'Trans proline' 0 N--CA 1.464 -0.251 0 C-N-CA 118.349 -0.634 . . . . 0.0 111.23 178.491 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 60.0 tttm -61.3 130.72 47.55 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 122.144 -0.348 . . . . 0.0 110.507 -177.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 95.29 -3.57 66.47 Favored Glycine 0 C--O 1.226 -0.354 0 CA-C-N 115.923 -0.58 . . . . 0.0 114.106 178.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -106.47 137.83 43.75 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 179.506 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 51.1 p90 -141.53 160.04 40.97 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 175.157 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -107.14 139.74 41.1 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.594 0.59 . . . . 0.0 112.594 -175.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -73.68 143.8 46.08 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 177.183 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 96.51 -37.58 3.39 Favored Glycine 0 C--O 1.224 -0.506 0 N-CA-C 111.208 -0.757 . . . . 0.0 111.208 -178.449 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 36.9 t -75.87 140.75 42.37 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 176.419 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? -146.64 163.29 36.34 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 103.218 -2.882 . . . . 0.0 103.218 178.476 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 87.2 27.96 26.64 Favored Glycine 0 C--O 1.224 -0.49 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.845 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -117.08 -177.43 17.75 Favored Glycine 0 C--N 1.323 -0.139 0 N-CA-C 107.736 -2.146 . . . . 0.0 107.736 177.71 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 24.0 m . . . . . 0 C--O 1.25 1.106 0 CA-C-O 116.367 -1.778 . . . . 0.0 108.053 -178.837 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.902 0 CA-C-O 118.641 -1.088 . . . . 0.0 111.145 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -70.7 148.64 47.79 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 105.69 -1.967 . . . . 0.0 105.69 175.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 70.6 mtm -126.91 34.32 4.79 Favored 'General case' 0 C--O 1.218 -0.583 0 N-CA-C 108.482 -0.932 . . . . 0.0 108.482 -178.281 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 147.53 131.26 2.11 Favored Glycine 0 N--CA 1.444 -0.831 0 N-CA-C 106.081 -2.807 . . . . 0.0 106.081 -176.393 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 9.1 mp -113.45 141.68 26.29 Favored Pre-proline 0 C--N 1.318 -0.763 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 178.774 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -73.56 154.62 50.06 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 117.529 -1.181 . . . . 0.0 110.709 177.257 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 57.3 t30 -123.08 -60.6 1.49 Allowed 'General case' 0 C--O 1.22 -0.456 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -179.027 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 15.9 p-10 -105.27 12.79 31.4 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 113.29 0.848 . . . . 0.0 113.29 -176.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 37.6 p -119.67 90.01 3.24 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 113.313 0.857 . . . . 0.0 113.313 -174.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -105.52 142.75 34.72 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 177.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -60.16 142.28 54.57 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.053 178.688 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 19.0 m95 -69.75 -23.98 63.46 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 113.816 1.043 . . . . 0.0 113.816 -179.089 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 52.7 m-85 -121.54 162.68 20.15 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 113.343 0.868 . . . . 0.0 113.343 -171.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 66.3 p -68.42 164.48 20.93 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.787 -1.097 . . . . 0.0 108.959 178.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -75.87 145.57 40.44 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 113.242 0.83 . . . . 0.0 113.242 -176.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 15.7 mt -87.4 140.3 29.67 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 102.175 -3.269 . . . . 0.0 102.175 167.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 63.7 m -116.7 128.5 55.4 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 -179.501 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -82.72 138.79 33.96 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.909 179.512 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 9.5 t-160 -139.46 94.74 2.82 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 103.589 -2.745 . . . . 0.0 103.589 167.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 163.13 -143.04 8.31 Favored Glycine 0 C--O 1.226 -0.386 0 C-N-CA 120.432 -0.889 . . . . 0.0 112.267 -175.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -121.19 -27.35 4.91 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 116.179 1.918 . . . . 0.0 116.179 -176.596 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -78.75 158.05 28.35 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 179.467 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -72.35 -62.87 1.28 Allowed 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.416 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 53.3 tp 175.54 143.93 0.06 Allowed 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 104.216 -2.512 . . . . 0.0 104.216 173.407 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.9 tppp? -158.13 141.23 14.99 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 108.855 -0.795 . . . . 0.0 108.855 176.669 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -126.01 153.12 73.86 Favored Pre-proline 0 C--N 1.325 -0.49 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 175.745 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -68.77 162.23 42.17 Favored 'Trans proline' 0 C--N 1.352 0.717 0 O-C-N 122.151 0.553 . . . . 0.0 113.09 179.481 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 18.0 tpt180 -64.02 131.88 48.92 Favored 'General case' 0 C--O 1.216 -0.678 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.895 -177.279 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 76.18 17.37 80.04 Favored Glycine 0 C--O 1.224 -0.486 0 C-N-CA 121.319 -0.467 . . . . 0.0 112.911 178.234 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 8.8 mt-30 -150.35 170.49 18.91 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 -175.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 109.2 -14.87 33.4 Favored Glycine 0 CA--C 1.502 -0.735 0 C-N-CA 121.455 -0.402 . . . . 0.0 113.345 175.275 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 89.2 t -66.13 129.6 94.24 Favored Pre-proline 0 C--N 1.319 -0.741 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 177.338 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_endo -74.21 169.55 22.21 Favored 'Trans proline' 0 N--CA 1.46 -0.481 0 O-C-N 122.143 0.549 . . . . 0.0 111.492 178.11 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 89.1 mt -70.33 107.73 2.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-O 122.084 0.945 . . . . 0.0 108.69 -179.643 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 76.1 m-20 -98.85 85.22 3.24 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 114.34 -1.3 . . . . 0.0 108.837 -178.213 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 70.1 p -66.29 -15.85 63.56 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 113.761 1.023 . . . . 0.0 113.761 -176.674 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 20.0 p30 -110.01 23.72 13.98 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.297 -0.865 . . . . 0.0 112.204 -177.398 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 15.9 m -138.55 149.25 45.12 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 113.227 0.825 . . . . 0.0 113.227 -175.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -73.77 166.71 41.83 Favored Pre-proline 0 C--O 1.236 0.379 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 177.751 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -64.66 -27.35 60.79 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 114.936 -2.909 . . . . 0.0 111.661 178.443 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -61.87 -27.67 68.96 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 123.69 0.796 . . . . 0.0 111.7 176.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 77.3 m-20 -94.87 -4.17 47.47 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 114.696 1.369 . . . . 0.0 114.696 -171.123 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 96.2 mm-40 -59.78 -28.94 67.85 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 114.465 1.283 . . . . 0.0 114.465 -177.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 11.4 tt -58.54 138.19 19.89 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.884 0 CA-C-O 122.308 1.051 . . . . 0.0 113.804 -177.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -178.82 -156.9 18.27 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.616 -0.802 . . . . 0.0 113.004 -178.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 46.6 p90 -155.14 170.54 21.59 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 179.389 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 20.0 m-85 -111.35 140.26 46.07 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 173.363 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -109.55 120.3 42.06 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 124.122 0.969 . . . . 0.0 109.933 -177.694 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 40.2 ttp180 -68.08 136.19 53.39 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 175.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -144.83 147.24 32.62 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 123.054 0.542 . . . . 0.0 110.817 -177.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -153.39 129.03 10.04 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.082 176.254 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 15.0 tpp180 -90.04 123.73 34.17 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 105.048 -2.205 . . . . 0.0 105.048 174.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 4.3 tmt_? -145.51 130.85 18.6 Favored 'General case' 0 CA--C 1.489 -1.371 0 CA-C-O 122.351 1.072 . . . . 0.0 111.029 -178.067 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -140.04 -179.94 2.36 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 CA-C-N 112.685 -2.052 . . . . 0.0 106.661 -177.884 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 3.3 tmt_? -129.32 103.77 7.12 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 105.677 -1.971 . . . . 0.0 105.677 172.027 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -72.83 158.35 53.05 Favored Glycine 0 N--CA 1.452 -0.241 0 N-CA-C 107.708 -2.157 . . . . 0.0 107.708 177.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -60.7 -37.07 92.93 Favored Glycine 0 C--O 1.222 -0.649 0 CA-C-N 118.173 0.986 . . . . 0.0 111.998 -179.371 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 39.5 t0 -86.96 13.98 8.16 Favored 'General case' 0 CA--C 1.55 0.951 0 CA-C-O 122.731 1.253 . . . . 0.0 111.248 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 86.85 6.37 79.79 Favored Glycine 0 C--O 1.224 -0.47 0 CA-C-N 115.393 -0.821 . . . . 0.0 113.543 171.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 20.9 mmtt -74.62 151.15 39.38 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-O 121.812 0.815 . . . . 0.0 111.463 -174.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 83.2 mtp -118.17 -173.94 2.56 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 114.059 -1.428 . . . . 0.0 109.576 -179.145 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 16.0 mmtt -119.94 -75.96 0.58 Allowed 'General case' 0 C--O 1.22 -0.478 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 179.774 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 52.3 m-20 -95.18 149.72 20.99 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 104.628 -2.36 . . . . 0.0 104.628 176.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 84.5 mt -118.96 -57.24 2.04 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 106.327 -1.731 . . . . 0.0 106.327 177.072 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -78.96 141.28 58.65 Favored Pre-proline 0 C--O 1.245 0.824 0 CA-C-N 115.058 -0.973 . . . . 0.0 108.929 175.468 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -73.06 155.88 52.2 Favored 'Trans proline' 0 C--O 1.239 0.531 0 C-N-CA 116.808 -1.661 . . . . 0.0 112.273 178.691 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 29.6 mtt85 -123.94 159.93 28.67 Favored 'General case' 0 CA--C 1.507 -0.685 0 CA-C-N 115.958 -0.564 . . . . 0.0 109.779 -178.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 54.4 m95 -134.01 140.9 47.01 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 177.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 61.6 m-85 -120.56 154.62 35.12 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 106.567 -1.642 . . . . 0.0 106.567 178.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 86.1 t80 -98.27 137.88 36.35 Favored 'General case' 0 CA--C 1.507 -0.696 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 -179.165 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -137.67 144.05 41.63 Favored 'General case' 0 N--CA 1.44 -0.925 0 N-CA-C 106.838 -1.542 . . . . 0.0 106.838 -176.599 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 55.5 m-85 -81.84 159.47 23.73 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.137 -176.37 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -53.86 132.16 41.19 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 112.473 0.546 . . . . 0.0 112.473 -177.499 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 65.56 29.88 76.18 Favored Glycine 0 C--O 1.224 -0.492 0 N-CA-C 115.83 1.092 . . . . 0.0 115.83 173.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 13.6 p -89.0 146.1 25.08 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 117.958 0.879 . . . . 0.0 108.881 177.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 105.92 145.99 13.65 Favored Glycine 0 CA--C 1.522 0.486 0 N-CA-C 108.038 -2.025 . . . . 0.0 108.038 -175.546 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -68.83 -44.25 2.95 Favored 'Trans proline' 0 C--N 1.346 0.426 0 CA-C-N 119.687 1.743 . . . . 0.0 116.132 -173.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -119.94 40.73 3.35 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 -177.234 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -62.84 -40.62 98.02 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.513 -177.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 57.99 29.22 61.92 Favored Glycine 0 C--O 1.228 -0.245 0 CA-C-N 116.168 -0.469 . . . . 0.0 113.645 179.424 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 17.5 mt -114.41 103.8 54.83 Favored Pre-proline 0 N--CA 1.446 -0.633 0 N-CA-C 114.31 1.226 . . . . 0.0 114.31 -176.604 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -78.57 165.2 25.3 Favored 'Trans proline' 0 C--O 1.237 0.445 0 C-N-CA 121.625 1.55 . . . . 0.0 108.147 169.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 68.0 t80 -61.85 131.43 49.76 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 120.343 -0.543 . . . . 0.0 110.216 -179.363 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 92.21 -6.64 78.58 Favored Glycine 0 CA--C 1.52 0.372 0 N-CA-C 115.101 0.8 . . . . 0.0 115.101 178.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -64.42 129.02 38.28 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 118.431 1.115 . . . . 0.0 112.36 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 58.0 t30 -75.09 127.95 34.39 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.287 -178.318 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 1.2 ttmp? -156.18 153.2 28.87 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 179.33 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -62.11 129.06 39.09 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.812 0.339 . . . . 0.0 111.766 -179.434 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 66.39 31.38 78.73 Favored Glycine 0 N--CA 1.451 -0.301 0 CA-C-O 119.457 -0.635 . . . . 0.0 114.238 178.041 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 43.8 mm -128.61 129.95 68.79 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 CA-C-N 117.419 0.61 . . . . 0.0 109.942 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.1 pt -132.86 120.33 40.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.204 176.025 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 96.0 m95 -85.98 136.81 33.11 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 -176.678 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 16.3 m -138.15 149.74 24.66 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 CA-C-O 121.525 0.679 . . . . 0.0 109.623 179.523 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -155.97 166.62 32.93 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 104.43 -2.433 . . . . 0.0 104.43 -179.359 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 12.6 t -137.93 175.14 9.85 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 105.936 -1.876 . . . . 0.0 105.936 179.311 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -64.96 135.48 55.71 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.162 0.506 . . . . 0.0 110.549 -179.409 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 94.39 -7.9 71.93 Favored Glycine 0 C--O 1.224 -0.526 0 CA-C-N 115.881 -0.599 . . . . 0.0 113.755 177.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -79.35 138.84 37.84 Favored 'General case' 0 CA--C 1.538 0.505 0 O-C-N 122.443 -0.445 . . . . 0.0 111.92 -179.449 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 34.7 mt -95.08 137.08 34.62 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-O 121.007 0.432 . . . . 0.0 111.993 -179.455 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 58.9 t30 -82.0 69.54 8.73 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.11 0.481 . . . . 0.0 110.764 -179.437 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -141.26 155.65 67.85 Favored Pre-proline 0 C--N 1.323 -0.562 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 -178.626 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -64.62 150.53 88.04 Favored 'Trans proline' 0 C--N 1.344 0.338 0 N-CA-C 115.262 1.216 . . . . 0.0 115.262 179.649 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -124.8 37.75 4.34 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 114.609 -1.178 . . . . 0.0 109.054 -177.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 16.6 p-10 -48.89 -45.96 41.95 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 114.742 -1.117 . . . . 0.0 112.869 -179.647 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 48.8 p-80 -70.05 -9.5 55.56 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 124.38 1.072 . . . . 0.0 113.747 -177.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 48.8 mt -94.9 -48.04 13.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 179.055 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -74.99 14.66 4.53 Favored Glycine 0 C--O 1.224 -0.502 0 N-CA-C 116.397 1.319 . . . . 0.0 116.397 -177.122 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 13.6 t -92.95 24.56 3.62 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 117.41 0.605 . . . . 0.0 111.099 179.478 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.449 ' HD2' HD22 ' A' ' 114' ' ' ASN . 65.9 ttp85 -57.8 136.28 56.93 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 178.918 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -109.09 132.22 21.34 Favored Pre-proline 0 C--N 1.324 -0.51 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -72.6 -15.35 27.37 Favored 'Trans proline' 0 C--O 1.219 -0.447 0 C-N-CA 117.877 -0.949 . . . . 0.0 113.52 -178.177 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -75.62 -25.62 57.07 Favored 'General case' 0 C--O 1.22 -0.481 0 CA-C-O 120.942 0.401 . . . . 0.0 110.303 178.401 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 82.7 m-20 -102.6 -23.31 13.88 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 113.745 1.017 . . . . 0.0 113.745 -174.339 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . 0.449 HD22 ' HD2' ' A' ' 109' ' ' ARG . 35.7 t30 -153.98 152.36 30.45 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.62 0.6 . . . . 0.0 112.62 -176.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -94.27 146.9 23.69 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-O 121.184 0.516 . . . . 0.0 110.749 178.402 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -71.38 148.47 46.95 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.005 0.431 . . . . 0.0 110.833 178.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 3.4 mt -92.41 142.33 13.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 -178.322 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -59.47 126.19 16.76 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 175.825 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 6.0 tt -68.55 128.88 38.2 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.956 -177.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 30.2 mt-30 -132.36 157.93 43.23 Favored 'General case' 0 CA--C 1.511 -0.544 0 N-CA-C 106.677 -1.601 . . . . 0.0 106.677 -179.122 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 13.7 mt -113.69 147.56 37.89 Favored Pre-proline 0 C--N 1.322 -0.62 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 177.6 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -73.32 167.0 28.44 Favored 'Trans proline' 0 C--N 1.346 0.397 0 O-C-N 122.223 0.591 . . . . 0.0 112.928 -179.342 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 43.6 tt0 -54.88 131.39 44.2 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.604 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 97.89 -19.45 54.54 Favored Glycine 0 C--O 1.227 -0.303 0 CA-C-N 116.004 -0.543 . . . . 0.0 113.256 -179.511 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 6.9 m -106.71 127.57 53.48 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 118.148 0.974 . . . . 0.0 110.576 178.713 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 17.2 p -120.24 148.36 43.79 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.541 -179.535 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 91.7 mt -67.24 154.87 91.96 Favored Pre-proline 0 C--N 1.324 -0.526 0 N-CA-C 107.953 -1.128 . . . . 0.0 107.953 178.082 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -75.16 170.47 20.3 Favored 'Trans proline' 0 N--CA 1.461 -0.385 0 C-N-CA 118.208 -0.728 . . . . 0.0 110.854 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 23.8 tptm -60.9 120.66 10.61 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 -178.094 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 91.13 41.53 5.21 Favored Glycine 0 C--O 1.227 -0.331 0 N-CA-C 115.297 0.879 . . . . 0.0 115.297 178.736 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -145.19 148.53 33.65 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 117.384 0.592 . . . . 0.0 110.403 177.557 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 54.8 p90 -147.73 165.05 31.68 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.212 -1.032 . . . . 0.0 108.212 176.106 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -105.99 139.81 39.95 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.01 0.433 . . . . 0.0 111.851 -176.703 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -74.09 143.56 45.34 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 178.236 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 95.59 -38.14 3.21 Favored Glycine 0 CA--C 1.518 0.25 0 C-N-CA 121.687 -0.292 . . . . 0.0 113.486 179.373 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 32.2 t -72.13 117.91 14.35 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 177.101 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 12.6 mmm-85 -93.68 -44.21 8.28 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 -179.349 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 76.64 -63.2 3.09 Favored Glycine 0 CA--C 1.521 0.462 0 N-CA-C 114.526 0.57 . . . . 0.0 114.526 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -130.57 -159.46 9.66 Favored Glycine 0 C--O 1.24 0.517 0 CA-C-N 116.944 0.372 . . . . 0.0 113.231 -177.751 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 34.8 t . . . . . 0 C--O 1.243 0.712 0 CA-C-O 118.202 -0.904 . . . . 0.0 109.71 179.486 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.498 -0.974 0 N-CA-C 110.993 -0.843 . . . . 0.0 110.993 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -61.19 140.76 57.86 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 114.186 1.18 . . . . 0.0 114.186 -176.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 27.3 ttt -143.19 138.41 29.7 Favored 'General case' 0 C--O 1.214 -0.791 1 N-CA-C 99.866 -4.124 . . . . 0.0 99.866 173.223 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 81.34 42.86 8.97 Favored Glycine 0 CA--C 1.519 0.304 0 N-CA-C 109.097 -1.601 . . . . 0.0 109.097 -174.051 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 9.1 mp -61.98 142.73 95.12 Favored Pre-proline 0 C--O 1.236 0.345 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 -179.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -69.2 133.77 27.44 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 116.047 -2.168 . . . . 0.0 113.579 -176.206 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 54.7 t-20 -137.88 65.98 1.46 Allowed 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 104.367 -2.457 . . . . 0.0 104.367 178.192 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 75.23 -51.62 0.66 Allowed 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 126.156 1.782 . . . . 0.0 109.755 -172.636 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 15.4 p 28.31 81.13 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 115.568 1.692 . . . . 0.0 115.568 172.271 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -105.7 158.25 16.85 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 122.464 1.126 . . . . 0.0 113.72 -173.619 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 30.9 t -58.98 142.21 51.72 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 113.986 -1.461 . . . . 0.0 109.974 175.21 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 17.1 m95 -64.33 -21.94 66.78 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 114.104 1.15 . . . . 0.0 114.104 178.545 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -121.41 162.96 19.49 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 114.312 1.227 . . . . 0.0 114.312 -169.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 68.3 p -70.76 162.66 28.72 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 114.575 -1.193 . . . . 0.0 107.855 176.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -75.72 141.98 42.54 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 113.243 0.831 . . . . 0.0 113.243 -175.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 12.4 mt -85.66 142.46 29.04 Favored 'General case' 0 C--O 1.213 -0.868 0 N-CA-C 102.678 -3.082 . . . . 0.0 102.678 169.257 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 40.9 m -123.84 135.77 53.96 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 118.638 0.654 . . . . 0.0 110.267 -177.603 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.419 ' HB2' ' CZ ' ' A' ' 131' ' ' PHE . 4.1 tp60 -100.7 139.25 36.65 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.493 -0.776 . . . . 0.0 112.005 -178.133 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 16.1 t-160 -126.58 99.6 5.87 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 103.775 -2.676 . . . . 0.0 103.775 168.674 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 157.17 -173.54 34.72 Favored Glycine 0 C--O 1.225 -0.417 0 N-CA-C 109.098 -1.601 . . . . 0.0 109.098 -176.629 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -97.68 -21.86 16.78 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 114.629 1.344 . . . . 0.0 114.629 -177.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -71.4 157.18 38.52 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.723 0.297 . . . . 0.0 110.351 -178.471 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -74.98 -63.0 1.36 Allowed 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.837 -0.345 . . . . 0.0 111.292 -178.092 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 36.0 tp 161.03 141.78 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.203 0 N-CA-C 102.299 -3.223 . . . . 0.0 102.299 179.094 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 13.8 tmtt? -156.71 131.07 8.63 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 176.625 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 -114.77 142.43 28.32 Favored Pre-proline 0 CA--C 1.54 0.592 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 176.491 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -62.88 154.12 68.52 Favored 'Trans proline' 0 CA--C 1.541 0.869 0 CA-C-O 121.325 0.469 . . . . 0.0 112.958 173.347 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 4.1 tmt_? -63.66 134.14 54.89 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.943 -177.701 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 87.96 6.85 75.09 Favored Glycine 0 C--O 1.226 -0.347 0 O-C-N 123.4 0.438 . . . . 0.0 112.381 178.381 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -145.72 167.78 22.31 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 -176.108 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 112.59 -19.38 21.73 Favored Glycine 0 CA--C 1.5 -0.846 0 C-N-CA 121.716 -0.278 . . . . 0.0 113.638 173.449 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 95.8 t -67.33 127.82 93.55 Favored Pre-proline 0 C--N 1.32 -0.712 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 178.473 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -74.93 164.03 34.25 Favored 'Trans proline' 0 N--CA 1.459 -0.504 0 O-C-N 122.124 0.539 . . . . 0.0 111.801 178.12 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 97.9 mt -66.84 123.44 19.9 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 -178.573 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.42 ' ND2' ' HH ' ' A' ' 72' ' ' TYR . 46.1 t-20 -125.61 113.83 17.91 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 177.239 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 67.0 p -90.68 -14.83 31.47 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 -175.509 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -111.51 28.99 8.23 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 113.408 0.892 . . . . 0.0 113.408 -175.65 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 99.3 p -141.58 164.88 29.02 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.713 0.292 . . . . 0.0 110.998 -179.412 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 4.2 m -77.13 164.95 55.73 Favored Pre-proline 0 C--N 1.321 -0.642 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.85 -178.294 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -68.31 -25.03 36.7 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 115.068 -2.821 . . . . 0.0 113.425 178.03 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.5 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 3.4 p-10 -76.64 -19.06 58.21 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 121.375 -0.828 . . . . 0.0 111.563 176.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 78.1 m-20 -78.57 -6.92 56.86 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 113.469 0.914 . . . . 0.0 113.469 -176.695 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 95.7 mm-40 -62.16 -24.91 67.46 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 113.595 0.961 . . . . 0.0 113.595 -177.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 7.9 tt -60.93 137.9 22.61 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.811 0 CA-C-O 122.205 1.003 . . . . 0.0 112.761 179.47 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 179.15 -156.9 19.7 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.465 -0.874 . . . . 0.0 112.382 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 45.3 p90 -155.02 170.45 21.74 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 179.1 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 19.5 m-85 -112.59 141.75 45.99 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 107.219 -1.401 . . . . 0.0 107.219 173.559 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 67.8 ttt-85 -112.24 130.24 55.99 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.971 -0.558 . . . . 0.0 111.237 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 44.8 ttt85 -71.67 145.35 48.95 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.472 0.653 . . . . 0.0 112.249 179.222 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -152.2 170.07 20.9 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 105.501 -2.037 . . . . 0.0 105.501 177.479 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 12.1 t -156.6 166.65 32.8 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 176.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 34.8 tpt85 -130.25 127.5 39.7 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 173.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 2.9 tmt_? -151.04 152.05 32.9 Favored 'General case' 0 CA--C 1.495 -1.147 0 N-CA-C 105.229 -2.137 . . . . 0.0 105.229 -178.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -125.99 174.17 10.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 26.8 tpt180 -141.99 122.31 13.96 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 106.106 -1.813 . . . . 0.0 106.106 177.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -82.65 174.56 53.14 Favored Glycine 0 C--O 1.224 -0.505 0 N-CA-C 109.24 -1.544 . . . . 0.0 109.24 178.003 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -72.26 -40.24 55.98 Favored Glycine 0 C--O 1.216 -1.023 0 N-CA-C 111.241 -0.744 . . . . 0.0 111.241 -177.485 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 27.3 t0 -71.93 -20.67 61.72 Favored 'General case' 0 C--O 1.217 -0.65 0 CA-C-O 122.635 1.207 . . . . 0.0 108.4 177.577 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 116.55 -12.39 15.82 Favored Glycine 0 CA--C 1.501 -0.803 0 CA-C-N 114.74 -1.118 . . . . 0.0 111.051 172.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 4.0 pttt -67.69 140.68 56.79 Favored 'General case' 0 CA--C 1.505 -0.755 0 CA-C-O 121.974 0.892 . . . . 0.0 110.495 -177.613 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 16.9 ptm -136.34 -177.47 4.73 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 114.027 -1.442 . . . . 0.0 112.155 -174.327 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 58.4 mmtt -90.58 -125.21 0.07 Allowed 'General case' 0 C--O 1.216 -0.663 0 N-CA-C 104.16 -2.533 . . . . 0.0 104.16 175.305 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 38.2 t0 -143.92 177.2 8.71 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 103.882 -2.636 . . . . 0.0 103.882 177.182 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -80.92 136.98 36.13 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 178.292 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.1 p -112.23 89.92 13.03 Favored Pre-proline 0 C--N 1.322 -0.593 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 173.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -69.13 131.82 22.99 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 115.632 -2.445 . . . . 0.0 112.107 -178.356 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 33.5 ptt180 -141.46 157.99 44.44 Favored 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 179.182 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 57.3 m95 -129.57 148.07 51.44 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 120.668 0.271 . . . . 0.0 111.306 -175.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 48.1 m-85 -124.68 146.09 49.32 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 106.499 -1.667 . . . . 0.0 106.499 -179.433 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 75.1 t80 -95.74 131.5 41.94 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 -175.411 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -133.87 159.81 39.56 Favored 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 107.096 -1.446 . . . . 0.0 107.096 -175.201 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.42 ' HH ' ' ND2' ' A' ' 35' ' ' ASN . 71.5 m-85 -99.95 159.56 14.98 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 111.713 0.264 . . . . 0.0 111.713 -171.637 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -54.51 129.69 37.01 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.688 -178.759 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 68.72 34.48 78.13 Favored Glycine 0 C--O 1.221 -0.665 0 CA-C-O 118.804 -0.998 . . . . 0.0 115.57 176.666 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -89.35 146.08 24.93 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 118.633 1.216 . . . . 0.0 109.225 177.623 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 105.52 158.85 22.86 Favored Glycine 0 CA--C 1.522 0.524 0 CA-C-N 116.27 -0.423 . . . . 0.0 112.475 179.531 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -63.97 -50.3 3.15 Favored 'Trans proline' 0 C--N 1.346 0.427 0 N-CA-C 117.349 2.019 . . . . 0.0 117.349 -172.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 64.4 mt-10 -138.12 44.67 2.14 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 106.827 -1.545 . . . . 0.0 106.827 -179.369 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -60.28 -39.37 86.66 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.006 -178.249 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 62.3 22.44 63.22 Favored Glycine 0 C--O 1.223 -0.545 0 N-CA-C 115.53 0.972 . . . . 0.0 115.53 177.097 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 53.0 mt -102.31 110.95 63.93 Favored Pre-proline 0 N--CA 1.447 -0.624 0 N-CA-C 115.015 1.487 . . . . 0.0 115.015 -177.258 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -77.32 167.87 23.91 Favored 'Trans proline' 0 C--O 1.237 0.432 0 N-CA-C 108.749 -1.289 . . . . 0.0 108.749 170.454 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 66.7 t80 -62.77 134.0 55.62 Favored 'General case' 0 C--N 1.321 -0.658 0 O-C-N 121.957 -0.465 . . . . 0.0 110.019 179.431 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 89.64 -3.25 83.31 Favored Glycine 0 CA--C 1.519 0.327 0 N-CA-C 114.505 0.562 . . . . 0.0 114.505 178.236 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -63.14 130.13 43.3 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 117.812 0.806 . . . . 0.0 112.061 179.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 50.1 t-20 -76.6 124.67 27.98 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.692 -178.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 23.3 tttt -155.33 152.15 28.82 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 178.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -64.12 130.49 44.15 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.962 -178.117 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 65.62 30.27 77.01 Favored Glycine 0 N--CA 1.45 -0.395 0 CA-C-O 119.597 -0.557 . . . . 0.0 114.238 179.057 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 37.1 mm -129.83 128.71 65.56 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 CA-C-N 117.362 0.581 . . . . 0.0 110.154 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -133.16 118.27 31.78 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 CA-C-O 121.425 0.631 . . . . 0.0 110.747 177.175 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 92.8 m95 -84.98 137.27 33.19 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 113.395 0.887 . . . . 0.0 113.395 -175.675 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 18.6 m -137.85 149.7 25.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.66 0.743 . . . . 0.0 110.016 179.653 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -159.63 166.64 30.24 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 104.049 -2.575 . . . . 0.0 104.049 -179.404 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 10.6 t -131.73 173.92 10.66 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 104.956 -2.239 . . . . 0.0 104.956 177.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -67.69 135.14 52.3 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 -178.293 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 95.84 -11.14 68.22 Favored Glycine 0 CA--C 1.518 0.231 0 CA-C-N 115.883 -0.598 . . . . 0.0 112.945 -179.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.5 ' HA ' ' HA ' ' A' ' 41' ' ' ASP . . . -74.24 133.01 42.65 Favored 'General case' 0 CA--C 1.541 0.609 0 O-C-N 122.413 -0.463 . . . . 0.0 109.864 178.847 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 27.8 mt -88.53 140.39 29.51 Favored 'General case' 0 CA--C 1.513 -0.473 0 CA-C-O 121.367 0.603 . . . . 0.0 111.917 -178.148 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 58.0 t30 -84.43 68.08 10.13 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.371 -179.263 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -138.41 151.95 70.28 Favored Pre-proline 0 C--O 1.24 0.594 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -68.14 150.89 77.39 Favored 'Trans proline' 0 C--N 1.343 0.256 0 N-CA-C 114.62 0.969 . . . . 0.0 114.62 177.304 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 1.6 ptpt -150.99 58.45 0.91 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.987 0.898 . . . . 0.0 111.863 178.496 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -56.47 -28.47 59.8 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 115.037 -0.983 . . . . 0.0 111.225 177.061 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 14.2 p80 -59.24 -10.38 2.89 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 114.544 1.312 . . . . 0.0 114.544 -178.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 37.9 mt -96.31 -36.3 6.33 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.577 0 CA-C-N 117.92 0.327 . . . . 0.0 110.165 178.128 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -74.11 14.44 3.86 Favored Glycine 0 N--CA 1.464 0.538 0 N-CA-C 116.023 1.169 . . . . 0.0 116.023 -176.314 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 15.2 t -96.5 23.29 6.96 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 -177.179 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 57.8 ttp85 -63.05 126.63 27.97 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 106.943 -1.503 . . . . 0.0 106.943 177.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 18.3 m-20 -110.84 131.96 21.87 Favored Pre-proline 0 C--N 1.32 -0.684 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 -178.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -67.64 -21.45 45.56 Favored 'Trans proline' 0 C--N 1.349 0.589 0 N-CA-C 114.728 1.011 . . . . 0.0 114.728 -175.072 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -71.99 -25.0 61.67 Favored 'General case' 0 C--O 1.219 -0.526 0 CA-C-O 120.784 0.326 . . . . 0.0 110.266 177.559 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 -101.81 -28.54 12.38 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 113.486 0.921 . . . . 0.0 113.486 -175.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 18.9 t30 -159.36 148.91 18.53 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -178.117 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -85.28 149.62 25.35 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-O 121.675 0.75 . . . . 0.0 112.862 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -70.73 147.39 49.08 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.762 178.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 23.5 mt -86.8 139.31 17.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.387 -179.141 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 73.1 t -61.87 122.02 11.56 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 174.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 5.8 tt -67.79 129.38 39.73 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.957 0.408 . . . . 0.0 110.123 -177.433 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -134.79 158.1 45.04 Favored 'General case' 0 CA--C 1.513 -0.472 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 -178.581 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 14.9 mt -114.45 149.2 41.78 Favored Pre-proline 0 C--N 1.322 -0.618 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 176.346 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_endo -70.56 168.81 21.52 Favored 'Trans proline' 0 C--N 1.343 0.27 0 N-CA-C 114.377 0.876 . . . . 0.0 114.377 -177.042 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -55.5 133.82 50.34 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.415 -178.242 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 88.27 -12.16 65.45 Favored Glycine 0 C--O 1.227 -0.333 0 CA-C-N 115.854 -0.612 . . . . 0.0 112.619 -179.688 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 16.2 m -107.38 125.9 51.79 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.113 0.483 . . . . 0.0 110.28 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 17.7 p -121.48 148.26 44.67 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 113.027 0.751 . . . . 0.0 113.027 -176.572 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 89.3 mt -69.79 156.28 92.0 Favored Pre-proline 0 C--N 1.326 -0.439 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 177.147 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -75.49 168.16 25.07 Favored 'Trans proline' 0 C--O 1.235 0.334 0 C-N-CA 118.42 -0.587 . . . . 0.0 111.252 178.506 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 1.8 tmtp? -58.72 128.79 38.97 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.702 -177.609 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 95.0 -5.57 68.76 Favored Glycine 0 C--O 1.225 -0.421 0 N-CA-C 114.664 0.625 . . . . 0.0 114.664 177.627 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.419 ' CZ ' ' HB2' ' A' ' 18' ' ' GLN . 1.4 m-85 -104.27 140.24 38.15 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-O 121.873 0.844 . . . . 0.0 111.199 -179.521 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 46.1 p90 -142.19 165.67 26.8 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 114.174 -1.376 . . . . 0.0 107.461 176.092 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -106.98 144.61 33.35 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.927 0.394 . . . . 0.0 111.358 -177.37 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -72.67 136.94 45.73 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 178.747 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 89.64 -30.0 5.97 Favored Glycine 0 CA--C 1.518 0.241 0 CA-C-N 116.139 -0.482 . . . . 0.0 112.786 -177.242 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 22.7 t -86.07 100.2 12.01 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 117.386 0.593 . . . . 0.0 110.635 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 3.0 mpt_? -96.47 71.37 2.7 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 179.579 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -85.95 136.44 14.25 Favored Glycine 0 C--O 1.228 -0.258 0 N-CA-C 109.879 -1.288 . . . . 0.0 109.879 178.556 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 167.82 -177.32 42.18 Favored Glycine 0 N--CA 1.451 -0.358 0 N-CA-C 107.926 -2.07 . . . . 0.0 107.926 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 57.1 p . . . . . 0 C--O 1.253 1.26 0 CA-C-O 115.19 -2.338 . . . . 0.0 104.991 178.847 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.811 0 CA-C-O 118.553 -1.137 . . . . 0.0 111.281 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -138.66 103.41 4.84 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 118.319 1.059 . . . . 0.0 109.433 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 98.1 mtp -132.94 70.97 1.46 Allowed 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 -179.341 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -126.19 84.62 0.34 Allowed Glycine 0 C--O 1.227 -0.321 0 CA-C-N 115.969 -0.56 . . . . 0.0 113.055 -176.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -76.33 150.89 83.08 Favored Pre-proline 0 C--N 1.323 -0.578 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 178.084 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -68.37 -27.58 33.89 Favored 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 117.055 -1.497 . . . . 0.0 115.265 -177.491 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 64.1 t30 45.95 53.02 9.45 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 114.376 1.25 . . . . 0.0 114.376 175.618 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 84.7 m-20 -61.49 -43.7 98.4 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 115.501 1.667 . . . . 0.0 115.501 -174.589 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 23.1 p 10.21 83.83 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 125.945 1.698 . . . . 0.0 115.243 178.343 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -93.39 140.81 29.15 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-O 121.703 0.763 . . . . 0.0 112.724 -171.668 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 51.2 p -60.66 144.84 51.12 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 114.908 -1.042 . . . . 0.0 110.293 178.652 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 22.3 m95 -70.8 -24.36 62.55 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 114.727 1.38 . . . . 0.0 114.727 -178.369 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 26.3 m-85 -121.49 162.47 20.46 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 -171.645 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 73.0 p -70.25 162.68 27.99 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 179.195 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -79.42 149.17 31.68 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.953 0.882 . . . . 0.0 112.991 -177.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 37.1 mt -89.52 148.95 23.12 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 102.77 -3.048 . . . . 0.0 102.77 168.637 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 33.6 m -122.83 138.51 54.63 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.426 ' HB2' ' CZ ' ' A' ' 131' ' ' PHE . 4.1 tp60 -110.66 135.08 51.81 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.246 0.546 . . . . 0.0 112.3 -176.785 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 7.7 t-160 -130.9 94.68 3.66 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 104.055 -2.572 . . . . 0.0 104.055 170.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -178.76 -171.21 41.76 Favored Glycine 0 C--O 1.224 -0.494 0 N-CA-C 110.19 -1.164 . . . . 0.0 110.19 -176.622 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -97.69 -26.45 14.74 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 113.844 1.053 . . . . 0.0 113.844 -177.646 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 25.6 pt-20 -92.23 166.41 12.63 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 179.024 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -79.22 -62.93 1.54 Allowed 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 120.704 -0.398 . . . . 0.0 111.753 -177.255 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 36.8 tp 171.61 144.18 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 105.822 -1.918 . . . . 0.0 105.822 178.059 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 55.0 tttm -156.03 142.69 18.7 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 171.434 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 15.5 m-85 -119.66 157.9 50.86 Favored Pre-proline 0 C--O 1.247 0.955 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 176.175 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -64.99 163.78 27.26 Favored 'Trans proline' 0 C--N 1.352 0.745 0 C-N-CA 121.355 1.37 . . . . 0.0 112.755 175.64 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 25.9 tpt180 -78.14 132.63 37.73 Favored 'General case' 0 C--O 1.216 -0.696 0 O-C-N 121.845 -0.534 . . . . 0.0 110.743 -177.435 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 77.95 17.81 77.88 Favored Glycine 0 C--O 1.223 -0.571 0 O-C-N 123.386 0.429 . . . . 0.0 112.315 177.21 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 49.3 tt0 -157.33 170.47 22.39 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 104.451 -2.425 . . . . 0.0 104.451 -175.497 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 105.73 -8.74 43.55 Favored Glycine 0 N--CA 1.462 0.41 0 CA-C-N 118.525 0.602 . . . . 0.0 113.811 177.399 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 76.2 t -70.9 133.8 86.03 Favored Pre-proline 0 C--N 1.321 -0.665 0 N-CA-C 106.791 -1.559 . . . . 0.0 106.791 176.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -69.98 171.87 13.9 Favored 'Trans proline' 0 N--CA 1.464 -0.246 0 C-N-CA 120.588 0.858 . . . . 0.0 112.967 178.113 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 83.7 mt -74.85 112.05 11.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 179.113 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 64.7 m-20 -109.6 80.74 1.35 Allowed 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 114.842 -1.072 . . . . 0.0 109.865 -175.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 76.2 p -69.87 -17.71 63.37 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 114.124 1.157 . . . . 0.0 114.124 -176.255 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 70.3 m-80 -112.54 35.46 3.82 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.701 -178.116 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.7 m -146.54 165.69 28.7 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 111.716 0.265 . . . . 0.0 111.716 -177.579 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 47.0 m -93.15 158.78 36.72 Favored Pre-proline 0 CA--C 1.536 0.439 0 C-N-CA 123.219 0.608 . . . . 0.0 111.718 -176.041 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -65.91 -23.92 54.1 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 115.71 -2.393 . . . . 0.0 115.253 -177.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -76.84 -20.23 56.59 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 121.68 -0.638 . . . . 0.0 112.675 179.051 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 12.4 p30 -96.41 0.99 51.28 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 114.643 1.349 . . . . 0.0 114.643 -174.565 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 86.4 mm-40 -57.36 -22.32 41.67 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.667 0.746 . . . . 0.0 112.675 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 8.2 tt -62.73 135.66 26.85 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.741 0 CA-C-O 122.366 1.079 . . . . 0.0 111.752 177.769 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 179.3 -156.81 19.36 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.212 -0.994 . . . . 0.0 112.232 -178.164 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 39.9 p90 -155.12 166.98 31.88 Favored 'General case' 0 C--N 1.318 -0.803 0 O-C-N 122.564 -0.374 . . . . 0.0 110.263 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 32.4 m-85 -108.22 140.68 41.1 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 175.556 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 48.5 ttt180 -115.85 120.21 38.5 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 124.1 0.96 . . . . 0.0 112.56 -175.215 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 36.7 ttt180 -66.32 141.21 58.07 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 123.785 0.834 . . . . 0.0 111.427 178.675 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -149.88 143.2 25.15 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 122.609 0.364 . . . . 0.0 111.116 176.752 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 14.6 t -161.0 165.86 29.18 Favored 'General case' 0 C--O 1.239 0.544 0 N-CA-C 106.078 -1.823 . . . . 0.0 106.078 174.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 3.9 tpt180 -144.9 127.97 16.58 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.78 0.324 . . . . 0.0 110.392 178.078 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 7.5 tmm_? -139.39 131.62 28.21 Favored 'General case' 0 CA--C 1.498 -1.023 0 CA-C-O 121.54 0.686 . . . . 0.0 109.698 178.369 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -139.85 179.28 2.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 N-CA-C 105.775 -1.935 . . . . 0.0 105.775 -178.564 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 17.4 tpp180 -124.9 103.51 8.09 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 106.244 -1.762 . . . . 0.0 106.244 173.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -75.57 159.04 50.89 Favored Glycine 0 C--O 1.227 -0.304 0 N-CA-C 106.945 -2.462 . . . . 0.0 106.945 176.067 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -60.51 -38.23 94.55 Favored Glycine 0 C--O 1.22 -0.765 0 CA-C-N 118.277 1.038 . . . . 0.0 113.698 -178.011 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -86.03 7.09 25.92 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.691 0.758 . . . . 0.0 111.593 179.731 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 96.62 -2.21 62.34 Favored Glycine 0 C--N 1.321 -0.29 0 CA-C-N 115.241 -0.89 . . . . 0.0 113.711 177.617 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 18.3 mttt -59.55 140.25 56.46 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.852 0.834 . . . . 0.0 112.703 -178.51 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 84.1 mtp -111.81 -169.97 1.56 Allowed 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 113.974 -1.466 . . . . 0.0 109.562 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 8.4 mmtt -121.28 -69.0 0.86 Allowed 'General case' 0 C--O 1.217 -0.636 0 N-CA-C 111.801 0.297 . . . . 0.0 111.801 -179.126 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 70.4 m-20 -126.46 158.71 35.33 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 -179.446 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 95.2 mt -122.4 -68.74 0.87 Allowed 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 177.231 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -71.17 135.25 84.82 Favored Pre-proline 0 C--N 1.323 -0.561 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.682 177.566 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -75.06 155.5 42.64 Favored 'Trans proline' 0 C--O 1.236 0.4 0 C-N-CA 117.048 -1.501 . . . . 0.0 113.165 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 75.6 mtt85 -111.59 160.02 17.6 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.234 178.33 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 71.2 m95 -132.64 127.4 34.82 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 175.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 65.7 m-85 -110.29 167.1 10.45 Favored 'General case' 0 C--O 1.21 -0.993 0 N-CA-C 104.758 -2.312 . . . . 0.0 104.758 -179.59 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 85.2 t80 -114.88 139.73 49.54 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 119.339 0.972 . . . . 0.0 109.118 -179.05 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 -138.61 148.69 44.42 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.515 -176.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 71.5 m-85 -82.2 159.49 23.25 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.423 -177.48 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -54.12 129.46 34.76 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-O 121.234 0.54 . . . . 0.0 112.407 -177.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 73.9 28.34 64.97 Favored Glycine 0 C--O 1.219 -0.837 0 N-CA-C 115.804 1.081 . . . . 0.0 115.804 175.714 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 2.3 p -89.0 145.88 25.21 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 118.675 1.238 . . . . 0.0 108.56 179.39 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 102.86 131.67 7.4 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 108.191 -1.963 . . . . 0.0 108.191 -175.494 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -68.23 -36.0 17.63 Favored 'Trans proline' 0 CA--C 1.516 -0.393 0 CA-C-N 119.676 1.738 . . . . 0.0 115.671 -172.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -114.19 32.07 6.15 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 -177.551 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -68.52 -49.75 57.26 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.823 -179.414 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 60.64 18.38 51.86 Favored Glycine 0 C--O 1.226 -0.403 0 N-CA-C 114.942 0.737 . . . . 0.0 114.942 179.172 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 74.7 mt -99.81 113.4 65.08 Favored Pre-proline 0 N--CA 1.449 -0.488 0 N-CA-C 114.935 1.457 . . . . 0.0 114.935 -176.048 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -76.57 166.96 26.41 Favored 'Trans proline' 0 C--O 1.238 0.482 0 N-CA-C 109.078 -1.162 . . . . 0.0 109.078 170.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.404 ' CE1' ' HB3' ' A' ' 92' ' ' TRP . 83.3 t80 -61.04 128.89 38.67 Favored 'General case' 0 C--N 1.323 -0.557 0 O-C-N 121.989 -0.444 . . . . 0.0 110.898 -179.747 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 93.89 -4.92 72.29 Favored Glycine 0 CA--C 1.518 0.277 0 N-CA-C 114.977 0.751 . . . . 0.0 114.977 178.228 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -63.81 133.2 52.99 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 118.027 0.913 . . . . 0.0 111.935 179.376 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 -77.95 130.31 36.38 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.096 -179.108 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 39.2 tttm -156.07 150.29 25.52 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 176.123 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -63.36 131.65 48.94 Favored 'General case' 0 C--O 1.24 0.573 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 178.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 72.33 23.33 78.11 Favored Glycine 0 N--CA 1.445 -0.757 0 N-CA-C 114.894 0.718 . . . . 0.0 114.894 177.439 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 42.7 mm -130.45 127.46 62.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 117.146 0.473 . . . . 0.0 109.946 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -133.17 123.56 47.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.929 176.678 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . 0.404 ' HB3' ' CE1' ' A' ' 83' ' ' TYR . 92.9 m95 -89.55 137.41 32.36 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 113.225 0.824 . . . . 0.0 113.225 -175.453 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 15.8 m -136.74 153.06 29.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 178.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -157.5 166.53 32.71 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 102.863 -3.014 . . . . 0.0 102.863 -179.51 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 11.4 t -136.05 175.26 9.76 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 106.215 -1.772 . . . . 0.0 106.215 179.33 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -64.02 133.55 53.33 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.011 0.434 . . . . 0.0 110.226 -179.666 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 93.85 -9.4 73.21 Favored Glycine 0 N--CA 1.46 0.237 0 CA-C-N 116.061 -0.518 . . . . 0.0 114.116 178.108 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -74.58 139.38 43.66 Favored 'General case' 0 CA--C 1.54 0.576 0 O-C-N 122.484 -0.421 . . . . 0.0 111.425 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 18.5 mt -82.13 162.48 22.47 Favored 'General case' 0 C--O 1.213 -0.86 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 177.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 59.4 t30 -114.87 69.53 0.72 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.075 0.464 . . . . 0.0 110.405 178.409 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -143.1 152.54 58.45 Favored Pre-proline 0 C--O 1.241 0.616 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -67.44 150.94 80.72 Favored 'Trans proline' 0 C--N 1.345 0.355 0 N-CA-C 113.511 0.543 . . . . 0.0 113.511 177.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 4.9 ptpt -151.6 59.11 0.88 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 122.777 1.275 . . . . 0.0 109.128 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -60.39 -30.6 69.69 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 113.846 -1.524 . . . . 0.0 113.028 -178.307 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 48.5 p-80 -60.84 -22.92 64.7 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 113.095 0.776 . . . . 0.0 113.095 -178.02 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 67.4 mt -71.45 -31.83 44.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 178.586 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -74.93 14.64 4.49 Favored Glycine 0 CA--C 1.524 0.596 0 N-CA-C 115.638 1.015 . . . . 0.0 115.638 -178.082 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 9.5 t -83.27 16.19 2.58 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 113.773 1.027 . . . . 0.0 113.773 -178.395 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 65.3 ttp85 -59.17 130.02 44.96 Favored 'General case' 0 N--CA 1.47 0.552 0 O-C-N 121.225 -0.922 . . . . 0.0 108.861 -178.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -107.93 130.18 23.14 Favored Pre-proline 0 C--N 1.322 -0.606 0 N-CA-C 106.408 -1.701 . . . . 0.0 106.408 179.475 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -69.61 -17.78 38.08 Favored 'Trans proline' 0 C--O 1.219 -0.461 0 C-N-CA 117.826 -0.982 . . . . 0.0 113.667 -177.652 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -74.14 -26.14 60.15 Favored 'General case' 0 C--O 1.22 -0.47 0 CA-C-O 120.838 0.352 . . . . 0.0 110.657 178.191 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 77.9 m-20 -102.23 -25.07 13.82 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 113.195 0.813 . . . . 0.0 113.195 -174.481 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 30.9 t30 -156.04 147.15 22.33 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.623 0.601 . . . . 0.0 112.623 -178.603 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -89.5 146.99 24.24 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.706 179.368 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -70.71 147.43 49.07 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.928 0.394 . . . . 0.0 109.969 178.129 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 2.0 mt -91.36 142.65 12.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 -178.129 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 87.8 t -59.14 123.08 10.72 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 N-CA-C 107.883 -1.155 . . . . 0.0 107.883 177.077 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 7.3 tt -70.46 127.89 34.28 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 -178.499 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 36.5 mt-30 -132.77 162.74 30.67 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 -178.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 15.4 mt -114.81 145.55 34.19 Favored Pre-proline 0 C--N 1.323 -0.584 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 179.268 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -72.93 170.34 19.97 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 120.329 0.686 . . . . 0.0 113.84 -177.567 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -54.61 133.36 46.53 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.738 -179.645 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 92.6 -17.43 57.67 Favored Glycine 0 C--O 1.227 -0.331 0 CA-C-N 116.001 -0.545 . . . . 0.0 113.191 -179.383 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 3.8 m -108.62 126.22 52.72 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 117.773 0.786 . . . . 0.0 110.303 178.689 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 14.5 p -123.4 152.19 41.83 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.057 -0.52 . . . . 0.0 109.922 -178.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 90.4 mt -72.34 151.47 92.05 Favored Pre-proline 0 C--N 1.324 -0.527 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 178.299 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -77.81 173.08 14.62 Favored 'Trans proline' 0 N--CA 1.462 -0.34 0 O-C-N 121.966 0.456 . . . . 0.0 111.06 178.418 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 66.3 tttp -59.78 127.89 34.2 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 122.074 -0.392 . . . . 0.0 111.519 -177.631 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 95.17 -1.48 64.87 Favored Glycine 0 C--O 1.227 -0.292 0 N-CA-C 115.142 0.817 . . . . 0.0 115.142 176.696 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.426 ' CZ ' ' HB2' ' A' ' 18' ' ' GLN . 1.2 m-85 -103.75 141.69 35.65 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-O 121.601 0.715 . . . . 0.0 111.632 -179.25 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 47.2 p90 -146.13 166.07 27.25 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 114.572 -1.194 . . . . 0.0 107.833 175.415 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -106.47 145.57 31.64 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 112.446 0.536 . . . . 0.0 112.446 -176.31 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -72.81 139.35 46.97 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 177.489 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 90.69 -36.85 3.48 Favored Glycine 0 CA--C 1.515 0.079 0 CA-C-N 116.177 -0.465 . . . . 0.0 112.821 -178.613 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 31.3 t -77.26 131.64 38.28 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.541 -0.541 . . . . 0.0 109.541 -179.445 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 1.2 mpp_? -140.69 144.65 35.75 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 107.297 -1.371 . . . . 0.0 107.297 178.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 149.46 177.52 23.63 Favored Glycine 0 C--O 1.227 -0.342 0 N-CA-C 106.639 -2.584 . . . . 0.0 106.639 179.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 93.32 -146.64 18.21 Favored Glycine 0 N--CA 1.454 -0.115 0 CA-C-N 118.102 0.951 . . . . 0.0 110.738 -178.503 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 67.0 p . . . . . 0 C--O 1.243 0.724 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 -179.51 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.671 0 CA-C-O 118.588 -1.118 . . . . 0.0 111.148 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -70.92 152.05 44.05 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 178.022 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 53.6 ttp -148.31 142.23 25.82 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 104.798 -2.297 . . . . 0.0 104.798 179.406 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -172.99 -117.06 0.44 Allowed Glycine 0 C--O 1.222 -0.615 0 N-CA-C 110.933 -0.867 . . . . 0.0 110.933 -179.238 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 86.4 mt -77.9 145.78 70.77 Favored Pre-proline 0 C--N 1.322 -0.589 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 -179.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -73.89 167.0 28.28 Favored 'Trans proline' 0 C--N 1.345 0.365 0 O-C-N 122.138 0.546 . . . . 0.0 111.392 176.658 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 24.3 t30 -63.4 -33.3 75.23 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 114.058 1.132 . . . . 0.0 114.058 -177.229 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 33.5 m120 -144.42 -104.1 0.11 Allowed 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 119.722 -0.18 . . . . 0.0 111.403 -177.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 41.4 p 40.55 79.64 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 115.101 1.519 . . . . 0.0 115.101 -179.562 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -110.9 148.78 31.71 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.714 -178.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 5.3 m -61.14 145.86 49.54 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.877 176.523 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 18.7 m95 -67.04 -22.83 65.86 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 113.452 0.908 . . . . 0.0 113.452 179.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -121.43 162.32 20.65 Favored 'General case' 0 CA--C 1.507 -0.688 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.974 -172.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 76.5 p -70.5 161.97 29.64 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 177.473 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -83.58 144.76 29.26 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.9 -0.591 . . . . 0.0 112.392 -175.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 66.2 mt -76.32 148.85 37.21 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 104.798 -2.297 . . . . 0.0 104.798 171.525 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 31.3 m -128.14 148.58 50.6 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 105.24 -2.133 . . . . 0.0 105.24 179.12 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -138.47 163.12 32.77 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 114.925 1.454 . . . . 0.0 114.925 -178.336 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 52.9 t60 -89.71 99.5 12.5 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 100.705 -3.813 . . . . 0.0 100.705 168.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -42.07 103.05 0.03 OUTLIER Glycine 0 N--CA 1.461 0.313 0 N-CA-C 118.538 2.175 . . . . 0.0 118.538 -173.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 82.4 mttt -142.97 -44.93 0.3 Allowed 'General case' 0 C--O 1.221 -0.401 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 177.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -120.67 169.61 10.22 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 -179.393 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -106.01 32.74 4.19 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 122.967 1.365 . . . . 0.0 110.045 178.873 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 32.6 tp 64.23 141.49 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 111.283 -2.689 . . . . 0.0 114.619 176.798 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 43.1 tptt -153.68 138.22 16.84 Favored 'General case' 0 C--N 1.324 -0.532 0 O-C-N 121.31 -0.869 . . . . 0.0 110.529 171.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -122.66 149.14 55.14 Favored Pre-proline 0 C--N 1.321 -0.633 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 176.073 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -70.25 159.44 53.04 Favored 'Trans proline' 0 C--N 1.349 0.576 0 O-C-N 122.188 0.573 . . . . 0.0 112.7 179.149 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 16.0 tpt180 -67.04 136.15 54.79 Favored 'General case' 0 C--O 1.218 -0.598 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 -178.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 85.94 6.96 81.63 Favored Glycine 0 C--O 1.222 -0.621 0 N-CA-C 111.241 -0.744 . . . . 0.0 111.241 179.606 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 20.3 mt-30 -147.77 172.68 13.74 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 123.27 0.628 . . . . 0.0 109.433 -175.356 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 104.23 -20.47 40.22 Favored Glycine 0 CA--C 1.501 -0.816 0 CA-C-N 115.883 -0.599 . . . . 0.0 113.558 174.424 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 57.6 t -67.28 128.22 93.66 Favored Pre-proline 0 C--N 1.32 -0.706 0 N-CA-C 106.76 -1.57 . . . . 0.0 106.76 177.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -71.59 171.61 15.98 Favored 'Trans proline' 0 C--O 1.223 -0.265 0 O-C-N 122.161 0.558 . . . . 0.0 111.329 177.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 87.6 mt -70.01 106.57 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-O 121.96 0.886 . . . . 0.0 108.791 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 -98.1 83.67 3.15 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 114.663 -1.153 . . . . 0.0 110.616 -176.55 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 73.1 p -68.02 -14.21 62.79 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.707 0.765 . . . . 0.0 112.725 -179.51 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 11.1 p30 -108.84 21.61 17.01 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.008 -0.997 . . . . 0.0 112.724 -177.216 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 5.8 m -142.83 151.47 41.16 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 113.366 0.876 . . . . 0.0 113.366 -176.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 52.8 m -78.32 166.53 42.37 Favored Pre-proline 0 C--N 1.327 -0.407 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 177.224 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -63.94 -26.67 66.63 Favored 'Trans proline' 0 C--N 1.353 0.77 0 C-N-CA 115.24 -2.707 . . . . 0.0 112.86 179.65 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -60.81 -32.82 72.17 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.663 0.744 . . . . 0.0 110.78 177.192 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 68.8 m-20 -88.7 -6.15 57.64 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 115.416 1.636 . . . . 0.0 115.416 -172.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 96.5 mm-40 -58.33 -29.25 65.77 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 114.295 1.22 . . . . 0.0 114.295 -176.248 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 11.2 tt -59.5 136.69 22.85 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-O 122.408 1.099 . . . . 0.0 112.244 -179.299 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -179.04 -157.9 20.4 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.495 -0.86 . . . . 0.0 111.996 -177.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 47.7 p90 -155.01 171.41 19.79 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 179.438 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 19.1 m-85 -112.71 141.05 46.95 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 106.551 -1.648 . . . . 0.0 106.551 173.548 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 69.4 ttt-85 -114.18 124.79 52.92 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.758 -177.144 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 15.2 ttt-85 -63.22 137.82 58.34 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 175.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -149.27 140.87 23.45 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.776 0.798 . . . . 0.0 112.708 179.477 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 12.2 p -133.26 142.64 48.63 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 104.602 -2.37 . . . . 0.0 104.602 174.34 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 11.8 tpt180 -160.68 128.23 4.38 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 112.959 0.726 . . . . 0.0 112.959 -179.81 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.5 tpp180 -116.68 142.7 46.56 Favored 'General case' 0 CA--C 1.507 -0.69 0 N-CA-C 105.734 -1.951 . . . . 0.0 105.734 173.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -138.37 177.1 5.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 -177.043 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.93 117.41 19.2 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 104.434 -2.432 . . . . 0.0 104.434 172.65 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -82.79 163.41 42.04 Favored Glycine 0 C--O 1.224 -0.511 0 N-CA-C 107.57 -2.212 . . . . 0.0 107.57 176.681 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -64.35 -32.58 84.68 Favored Glycine 0 C--O 1.214 -1.112 0 CA-C-N 118.121 0.96 . . . . 0.0 111.609 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -90.86 17.91 7.22 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-O 122.147 0.975 . . . . 0.0 110.551 178.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 85.36 -6.25 80.51 Favored Glycine 0 N--CA 1.46 0.247 0 N-CA-C 116.338 1.295 . . . . 0.0 116.338 173.54 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.42 128.69 37.54 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.807 0.813 . . . . 0.0 112.634 -178.069 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 97.8 mmm -99.32 -174.73 2.81 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 114.323 -1.308 . . . . 0.0 108.051 178.466 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 6.3 tttp -117.02 -62.0 1.64 Allowed 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 175.34 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.1 t0 54.74 -152.82 0.33 Allowed 'General case' 0 C--O 1.24 0.59 0 O-C-N 124.771 1.294 . . . . 0.0 110.955 178.346 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.9 mm? 67.16 -179.47 0.22 Allowed 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 115.372 1.619 . . . . 0.0 115.372 174.069 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -58.26 156.34 21.89 Favored Pre-proline 0 C--O 1.24 0.585 0 N-CA-C 116.804 2.15 . . . . 0.0 116.804 -174.874 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -66.41 156.57 64.62 Favored 'Trans proline' 0 C--N 1.354 0.838 0 CA-C-O 121.3 0.458 . . . . 0.0 111.817 177.431 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 42.2 mtt-85 -128.69 163.31 25.38 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.622 -175.326 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 61.8 m95 -127.42 129.97 48.48 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 179.122 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 24.2 m-85 -111.27 149.08 31.56 Favored 'General case' 0 C--O 1.213 -0.838 0 N-CA-C 106.949 -1.5 . . . . 0.0 106.949 -178.38 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 86.8 t80 -98.1 139.97 33.12 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.909 -0.775 . . . . 0.0 108.909 -178.224 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -142.36 153.13 43.56 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 -179.052 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 69.1 m-85 -88.12 159.51 18.18 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.87 -174.502 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -54.43 131.01 41.5 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.77 0.319 . . . . 0.0 110.686 -179.487 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 69.67 32.98 71.0 Favored Glycine 0 C--O 1.223 -0.578 0 N-CA-C 115.345 0.898 . . . . 0.0 115.345 176.37 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.4 p -89.92 146.16 24.6 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 118.108 0.954 . . . . 0.0 109.312 177.268 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 99.09 147.08 21.41 Favored Glycine 0 CA--C 1.523 0.576 0 N-CA-C 111.637 -0.585 . . . . 0.0 111.637 -179.725 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -71.21 -40.13 3.44 Favored 'Trans proline' 0 C--N 1.347 0.492 0 N-CA-C 116.775 1.798 . . . . 0.0 116.775 -173.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 19.0 pt-20 -116.68 19.37 14.57 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.397 0.617 . . . . 0.0 110.825 -176.058 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -61.9 -44.87 95.9 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.52 -0.472 . . . . 0.0 110.752 -177.195 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 56.43 24.05 44.51 Favored Glycine 0 C--O 1.226 -0.371 0 N-CA-C 115.628 1.011 . . . . 0.0 115.628 178.348 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 52.2 mt -99.87 110.99 61.02 Favored Pre-proline 0 C--O 1.238 0.491 0 N-CA-C 115.65 1.722 . . . . 0.0 115.65 -176.121 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -78.15 168.0 22.49 Favored 'Trans proline' 0 CA--C 1.53 0.32 0 C-N-CA 120.954 1.103 . . . . 0.0 109.442 170.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.418 ' CE2' ' HB3' ' A' ' 92' ' ' TRP . 73.2 t80 -62.26 131.96 51.09 Favored 'General case' 0 C--N 1.323 -0.575 0 O-C-N 121.883 -0.511 . . . . 0.0 110.309 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 90.55 -3.6 81.72 Favored Glycine 0 C--O 1.228 -0.265 0 N-CA-C 114.585 0.594 . . . . 0.0 114.585 177.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -63.09 131.0 47.08 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 118.016 0.908 . . . . 0.0 111.403 179.392 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 53.7 t30 -77.84 124.92 28.58 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.181 -178.641 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 12.1 tttp -156.15 151.74 27.05 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 178.322 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 20.3 t0 -66.41 133.79 51.18 Favored 'General case' 0 C--N 1.322 -0.623 0 O-C-N 123.395 0.435 . . . . 0.0 110.068 -179.197 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 67.31 27.56 73.53 Favored Glycine 0 N--CA 1.45 -0.431 0 N-CA-C 114.749 0.66 . . . . 0.0 114.749 178.529 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 41.7 mm -129.27 125.84 62.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 117.266 0.533 . . . . 0.0 110.655 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.1 pt -129.78 116.16 36.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 CA-C-O 121.909 0.861 . . . . 0.0 112.536 176.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . 0.418 ' HB3' ' CE2' ' A' ' 83' ' ' TYR . 94.8 m95 -80.52 135.28 36.07 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 113.533 0.938 . . . . 0.0 113.533 -176.921 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 17.1 m -135.13 151.99 31.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 179.427 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -160.6 166.5 28.84 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 104.683 -2.34 . . . . 0.0 104.683 -178.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 13.5 t -136.39 178.78 6.8 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 105.151 -2.166 . . . . 0.0 105.151 177.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -66.99 136.48 55.38 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.318 0.58 . . . . 0.0 110.693 -179.257 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 92.24 -14.32 64.88 Favored Glycine 0 C--O 1.226 -0.374 0 CA-C-N 115.715 -0.675 . . . . 0.0 113.563 177.256 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -69.96 126.71 30.48 Favored 'General case' 0 C--N 1.322 -0.624 0 O-C-N 122.43 -0.453 . . . . 0.0 110.975 -179.492 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 43.6 mt -83.49 138.37 33.47 Favored 'General case' 0 CA--C 1.515 -0.392 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 -177.224 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 61.5 t30 -82.08 65.11 7.06 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.527 0.68 . . . . 0.0 110.729 179.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -140.11 155.18 70.71 Favored Pre-proline 0 C--N 1.322 -0.619 0 N-CA-C 105.639 -1.985 . . . . 0.0 105.639 179.591 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_endo -73.33 155.83 50.94 Favored 'Trans proline' 0 CA--C 1.532 0.377 0 N-CA-C 115.016 1.122 . . . . 0.0 115.016 179.438 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.79 58.02 1.05 Allowed 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 121.852 0.834 . . . . 0.0 112.055 176.338 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -56.98 -26.94 60.94 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.117 178.115 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 17.1 p80 -58.84 -11.52 3.36 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 114.521 1.304 . . . . 0.0 114.521 -178.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 23.2 mt -96.35 -36.14 6.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 122.175 -0.328 . . . . 0.0 110.836 178.22 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -73.83 14.51 3.55 Favored Glycine 0 CA--C 1.522 0.495 0 N-CA-C 116.189 1.235 . . . . 0.0 116.189 -175.334 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 9.7 t -107.33 29.26 7.3 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-O 121.057 0.456 . . . . 0.0 111.971 -177.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.427 ' HD2' HD22 ' A' ' 114' ' ' ASN . 64.2 ttp85 -54.73 134.36 47.44 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 177.513 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 41.6 m-20 -102.06 122.73 46.01 Favored Pre-proline 0 C--N 1.325 -0.497 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 -178.129 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -68.74 -18.6 42.02 Favored 'Trans proline' 0 C--O 1.217 -0.531 0 N-CA-C 114.425 0.894 . . . . 0.0 114.425 -176.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -75.69 -25.92 57.15 Favored 'General case' 0 C--O 1.22 -0.477 0 CA-C-O 120.842 0.353 . . . . 0.0 110.657 178.121 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 83.0 m-20 -100.75 -23.84 14.53 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 -175.39 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . 0.427 HD22 ' HD2' ' A' ' 109' ' ' ARG . 31.4 t30 -154.98 147.91 24.6 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.764 0.654 . . . . 0.0 112.764 -178.879 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -88.37 148.57 24.18 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-O 121.454 0.645 . . . . 0.0 111.404 179.493 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -68.97 142.45 54.67 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.226 0.536 . . . . 0.0 110.183 178.378 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 18.9 mt -84.8 136.56 22.5 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 -179.038 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 74.4 t -60.49 124.69 15.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 N-CA-C 105.295 -2.113 . . . . 0.0 105.295 174.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 7.6 tt -66.18 127.93 34.1 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.199 0.523 . . . . 0.0 109.968 -176.65 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 30.1 mt-30 -129.68 156.35 44.4 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 106.169 -1.789 . . . . 0.0 106.169 -179.483 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 13.6 mt -112.37 148.02 38.27 Favored Pre-proline 0 C--N 1.321 -0.661 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 177.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -72.43 165.37 32.88 Favored 'Trans proline' 0 C--O 1.236 0.38 0 O-C-N 122.293 0.628 . . . . 0.0 112.454 -179.354 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 65.1 tt0 -54.86 130.41 41.06 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.491 -179.471 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 99.47 -19.8 52.27 Favored Glycine 0 C--O 1.226 -0.39 0 CA-C-N 115.873 -0.603 . . . . 0.0 113.601 -179.278 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 11.2 m -105.76 130.91 53.66 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 118.251 1.025 . . . . 0.0 110.684 178.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 16.9 p -124.54 152.11 43.88 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.614 -178.035 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 90.3 mt -78.67 155.3 78.45 Favored Pre-proline 0 C--N 1.326 -0.432 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 177.287 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -75.19 170.25 20.77 Favored 'Trans proline' 0 C--O 1.237 0.44 0 CA-C-O 121.55 0.562 . . . . 0.0 111.367 177.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 48.1 tptt -63.5 122.49 16.4 Favored 'General case' 0 C--O 1.218 -0.579 0 CA-C-O 121.006 0.432 . . . . 0.0 111.234 -175.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 95.21 7.36 59.54 Favored Glycine 0 C--O 1.228 -0.263 0 N-CA-C 115.236 0.854 . . . . 0.0 115.236 178.331 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -110.48 143.48 40.74 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 107.332 -1.358 . . . . 0.0 107.332 176.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 35.2 p90 -147.56 163.95 34.99 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 177.263 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -99.55 145.6 27.34 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.894 0.378 . . . . 0.0 110.625 -178.393 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -72.07 135.84 46.42 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 178.28 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 86.41 -10.47 66.68 Favored Glycine 0 C--O 1.226 -0.396 0 CA-C-N 116.28 -0.418 . . . . 0.0 113.464 -178.641 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 32.2 t -85.08 118.44 24.64 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 117.535 0.668 . . . . 0.0 110.089 179.482 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 1.8 mmm180 -152.91 162.38 41.38 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 105.24 -2.133 . . . . 0.0 105.24 179.382 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 103.69 -168.71 17.49 Favored Glycine 0 C--O 1.229 -0.196 0 N-CA-C 111.654 -0.578 . . . . 0.0 111.654 178.573 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 136.74 -24.88 3.13 Favored Glycine 0 C--O 1.228 -0.24 0 N-CA-C 107.348 -2.301 . . . . 0.0 107.348 -177.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 61.4 m . . . . . 0 C--O 1.26 1.649 0 N-CA-C 101.73 -3.433 . . . . 0.0 101.73 175.924 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.612 0 CA-C-O 118.746 -1.03 . . . . 0.0 111.141 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -70.42 152.71 43.77 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 118.069 0.935 . . . . 0.0 110.839 -179.608 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 28.1 ttt -149.01 143.97 26.44 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 102.033 -3.321 . . . . 0.0 102.033 178.247 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 80.29 35.24 27.17 Favored Glycine 0 C--O 1.224 -0.514 0 C-N-CA 120.266 -0.969 . . . . 0.0 111.243 -177.663 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 8.9 mp -59.69 145.67 82.68 Favored Pre-proline 0 C--O 1.239 0.534 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 -179.173 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -69.01 152.08 73.25 Favored 'Trans proline' 0 C--N 1.347 0.499 0 N-CA-C 114.286 0.841 . . . . 0.0 114.286 -176.5 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 35.2 t30 -144.38 89.73 2.03 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.429 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 17.5 t30 -125.21 14.09 8.35 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 121.421 0.629 . . . . 0.0 110.276 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 22.6 p -133.48 89.48 2.6 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 -178.118 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -90.58 141.28 28.93 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-O 121.486 0.66 . . . . 0.0 109.667 -177.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -58.37 140.28 53.88 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.608 177.674 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 35.7 m95 -65.82 -22.0 66.52 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 114.283 1.216 . . . . 0.0 114.283 -178.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 82.6 m-85 -121.37 161.84 21.4 Favored 'General case' 0 CA--C 1.506 -0.714 0 N-CA-C 114.453 1.279 . . . . 0.0 114.453 -171.086 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.42 ' HB ' ' HB3' ' A' ' 134' ' ' GLU . 73.1 p -69.89 163.59 25.62 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 114.045 -1.434 . . . . 0.0 108.468 177.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -77.43 139.3 39.64 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 -175.224 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 12.8 mt -84.49 145.62 28.02 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 103.927 -2.619 . . . . 0.0 103.927 170.8 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 21.9 m -129.31 133.2 47.33 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 118.13 0.423 . . . . 0.0 109.96 -179.4 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.4 ' HB2' ' CZ ' ' A' ' 131' ' ' PHE . 3.8 tp60 -95.34 143.33 26.79 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 123.615 0.572 . . . . 0.0 111.577 -179.568 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 23.1 t-160 -138.97 96.5 3.13 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 102.609 -3.108 . . . . 0.0 102.609 165.57 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 172.57 -161.22 32.67 Favored Glycine 0 C--O 1.226 -0.399 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 -173.531 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 49.6 mtmt -104.54 -27.89 11.61 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 116.332 1.975 . . . . 0.0 116.332 -176.634 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -85.58 162.44 18.86 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 179.231 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -76.03 -62.9 1.44 Allowed 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 -178.519 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 36.4 tp -178.32 138.14 0.18 Allowed 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 104.799 -2.297 . . . . 0.0 104.799 172.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 11.0 tmtt? -149.28 133.33 17.18 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 176.606 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -121.05 159.8 47.78 Favored Pre-proline 0 C--O 1.243 0.748 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 177.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -65.39 171.52 9.16 Favored 'Trans proline' 0 CA--C 1.539 0.746 0 C-N-CA 121.004 1.136 . . . . 0.0 114.706 -179.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 25.5 tpt180 -78.4 128.0 33.0 Favored 'General case' 0 C--O 1.215 -0.758 0 O-C-N 121.561 -0.712 . . . . 0.0 109.289 179.448 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 72.12 18.68 78.06 Favored Glycine 0 C--O 1.225 -0.459 0 N-CA-C 114.552 0.581 . . . . 0.0 114.552 176.583 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 43.1 tt0 -159.32 149.59 19.17 Favored 'General case' 0 C--O 1.22 -0.46 0 N-CA-C 105.652 -1.981 . . . . 0.0 105.652 -178.437 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 136.05 -14.74 4.05 Favored Glycine 0 CA--C 1.505 -0.548 0 C-N-CA 120.323 -0.941 . . . . 0.0 113.225 176.524 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 27.6 m -71.6 145.93 90.6 Favored Pre-proline 0 C--N 1.32 -0.698 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 177.382 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -77.17 173.03 15.03 Favored 'Trans proline' 0 N--CA 1.46 -0.491 0 C-N-CA 121.507 1.471 . . . . 0.0 112.578 178.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 91.5 mt -79.3 116.74 23.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.129 -179.379 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.431 ' HB2' HE21 ' A' ' 43' ' ' GLN . 22.4 m-20 -100.95 86.13 3.0 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 176.664 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 69.8 p -60.39 -27.06 67.14 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 115.661 1.726 . . . . 0.0 115.661 -173.69 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 19.7 p30 -108.18 21.38 17.43 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 -177.37 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 15.1 m -130.19 169.32 15.52 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 112.165 0.432 . . . . 0.0 112.165 -175.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 68.8 m -83.7 158.39 62.64 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.295 -176.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -67.42 -21.53 46.77 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 116.882 -1.612 . . . . 0.0 114.751 -177.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.455 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 4.1 p-10 -74.65 -17.04 60.75 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 121.927 -0.483 . . . . 0.0 110.856 178.814 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.424 ' HA ' ' HE3' ' A' ' 103' ' ' LYS . 0.0 OUTLIER -87.04 -16.32 35.99 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 114.925 1.454 . . . . 0.0 114.925 -174.269 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . 0.431 HE21 ' HB2' ' A' ' 35' ' ' ASN . 84.0 mm-40 -57.81 -20.63 37.21 Favored 'General case' 0 C--O 1.218 -0.582 0 N-CA-C 114.093 1.145 . . . . 0.0 114.093 -172.154 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 20.6 tt -58.8 139.93 17.83 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 CA-C-O 122.401 1.095 . . . . 0.0 113.076 178.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 177.86 -153.61 13.54 Favored Glycine 0 N--CA 1.444 -0.792 0 C-N-CA 119.924 -1.131 . . . . 0.0 112.653 178.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 51.6 p90 -155.1 167.75 29.31 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 178.361 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 38.2 m-85 -108.74 140.28 42.38 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 106.435 -1.691 . . . . 0.0 106.435 174.419 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 65.3 ttt-85 -113.33 122.73 48.28 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.923 -177.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 49.0 ttp85 -68.62 136.89 53.71 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 177.008 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -134.85 136.41 42.43 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 179.041 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 14.8 t -152.9 159.19 42.98 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 106.697 -1.594 . . . . 0.0 106.697 176.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 21.6 tpt180 -157.74 142.27 16.33 Favored 'General case' 0 C--O 1.216 -0.663 0 N-CA-C 105.955 -1.869 . . . . 0.0 105.955 179.618 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -129.05 130.64 46.82 Favored 'General case' 0 CA--C 1.493 -1.223 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 176.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -128.89 173.05 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.003 0 N-CA-C 105.664 -1.976 . . . . 0.0 105.664 -179.14 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 6.6 tmm_? -140.33 112.76 7.9 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 106.024 -1.843 . . . . 0.0 106.024 175.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -74.04 164.24 54.7 Favored Glycine 0 C--O 1.226 -0.376 0 N-CA-C 110.448 -1.061 . . . . 0.0 110.448 -179.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -65.93 -33.8 86.7 Favored Glycine 0 C--O 1.217 -0.935 0 N-CA-C 110.522 -1.031 . . . . 0.0 110.522 -179.269 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.0 t0 -85.2 16.96 3.23 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-O 122.157 0.98 . . . . 0.0 110.968 179.352 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 84.77 -4.81 84.17 Favored Glycine 0 CA--C 1.509 -0.298 0 N-CA-C 116.071 1.188 . . . . 0.0 116.071 172.277 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.59 123.16 20.1 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.488 0.661 . . . . 0.0 111.785 -177.394 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 93.4 mmm -88.84 169.49 11.55 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.01 -0.996 . . . . 0.0 108.663 178.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 5.4 tmtt? -74.99 -52.74 10.37 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 177.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 58.37 -174.27 0.09 Allowed 'General case' 0 C--O 1.243 0.713 0 N-CA-C 115.547 1.684 . . . . 0.0 115.547 178.941 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.5 mm? 64.79 169.77 0.19 Allowed 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 115.018 1.488 . . . . 0.0 115.018 -179.461 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -70.62 163.25 65.35 Favored Pre-proline 0 C--O 1.243 0.723 0 CA-C-N 114.603 -1.181 . . . . 0.0 114.181 -176.331 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -72.12 166.8 28.58 Favored 'Trans proline' 0 C--N 1.351 0.666 0 CA-C-O 121.562 0.568 . . . . 0.0 112.736 177.748 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 22.9 mtp180 -117.91 166.3 12.65 Favored 'General case' 0 CA--C 1.512 -0.497 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 178.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 62.8 m95 -127.45 143.4 51.2 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 177.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 60.7 m-85 -124.02 147.49 47.78 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 178.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 86.5 t80 -95.79 139.24 32.31 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 -177.356 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -142.44 140.6 32.01 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 -176.471 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 74.9 m-85 -68.1 159.44 30.91 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -179.313 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 19.1 tp -59.44 134.72 57.27 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 175.147 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 75.66 35.28 46.76 Favored Glycine 0 C--O 1.222 -0.638 0 N-CA-C 115.881 1.112 . . . . 0.0 115.881 177.22 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 21.7 p -110.13 153.08 25.2 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 118.288 1.044 . . . . 0.0 109.832 177.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 106.04 143.06 11.3 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 -177.528 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -71.11 -39.26 4.16 Favored 'Trans proline' 0 C--N 1.348 0.529 0 CA-C-N 119.651 1.725 . . . . 0.0 116.215 -173.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -117.09 17.56 14.82 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.436 -176.721 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -64.75 -52.04 59.12 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.882 -176.155 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 55.72 27.38 49.34 Favored Glycine 0 C--O 1.225 -0.458 0 N-CA-C 114.691 0.636 . . . . 0.0 114.691 179.179 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 75.2 mt -95.05 114.53 63.89 Favored Pre-proline 0 C--O 1.238 0.48 0 N-CA-C 114.874 1.435 . . . . 0.0 114.874 -175.449 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -76.85 166.75 26.44 Favored 'Trans proline' 0 N--CA 1.461 -0.41 0 N-CA-C 109.231 -1.103 . . . . 0.0 109.231 171.253 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 62.1 t80 -62.95 131.26 48.08 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 120.708 -0.397 . . . . 0.0 110.29 -179.219 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 92.39 -3.48 75.72 Favored Glycine 0 CA--C 1.52 0.396 0 N-CA-C 114.524 0.569 . . . . 0.0 114.524 179.156 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -63.03 130.94 46.89 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 117.863 0.832 . . . . 0.0 112.104 179.406 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 32.7 t-20 -78.3 125.85 29.95 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.568 -178.466 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 14.7 ttmm -155.55 150.47 26.53 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 176.743 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -63.36 131.36 48.01 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.245 179.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 70.66 25.88 74.98 Favored Glycine 0 N--CA 1.45 -0.418 0 CA-C-O 119.375 -0.681 . . . . 0.0 114.184 177.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 39.7 mm -128.83 128.14 67.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 117.515 0.658 . . . . 0.0 109.963 179.339 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.1 pt -130.13 115.26 32.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 CA-C-O 121.422 0.63 . . . . 0.0 110.891 176.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 97.4 m95 -82.07 132.22 35.25 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 112.941 0.719 . . . . 0.0 112.941 -176.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 1.1 m -142.05 152.95 18.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.187 -178.127 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -155.12 166.53 33.28 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 103.371 -2.826 . . . . 0.0 103.371 -178.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 14.5 t -122.76 169.13 11.39 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 104.206 -2.516 . . . . 0.0 104.206 174.481 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -65.37 137.16 57.32 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.193 0.52 . . . . 0.0 109.922 -179.495 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 91.19 -5.79 81.29 Favored Glycine 0 CA--C 1.516 0.119 0 CA-C-N 115.749 -0.659 . . . . 0.0 113.4 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.455 ' HA ' ' HA ' ' A' ' 41' ' ' ASP . . . -77.81 135.48 37.96 Favored 'General case' 0 CA--C 1.537 0.478 0 O-C-N 122.307 -0.525 . . . . 0.0 109.647 179.2 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 28.8 mt -88.25 136.37 33.01 Favored 'General case' 0 CA--C 1.509 -0.615 0 CA-C-O 121.601 0.715 . . . . 0.0 111.979 -178.249 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 54.4 t30 -82.59 67.95 8.84 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.978 -1.01 . . . . 0.0 110.588 -178.683 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -142.77 155.63 63.0 Favored Pre-proline 0 C--N 1.323 -0.57 0 N-CA-C 106.382 -1.711 . . . . 0.0 106.382 -179.102 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -66.83 150.6 83.23 Favored 'Trans proline' 0 CA--C 1.53 0.292 0 N-CA-C 114.78 1.031 . . . . 0.0 114.78 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.424 ' HE3' ' HA ' ' A' ' 42' ' ' ASP . 71.1 mmtt -126.89 36.88 4.38 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.152 179.758 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 14.0 p-10 -49.55 -42.77 45.04 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.268 0.556 . . . . 0.0 112.003 -177.796 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 15.4 p80 -67.5 -10.3 50.36 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 115.121 1.526 . . . . 0.0 115.121 -178.589 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 38.8 mt -91.93 -31.95 5.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 179.535 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -74.12 14.6 3.76 Favored Glycine 0 C--O 1.222 -0.597 0 N-CA-C 115.488 0.955 . . . . 0.0 115.488 -177.79 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 15.1 t -83.17 24.44 0.79 Allowed 'General case' 0 CA--C 1.547 0.862 0 N-CA-C 113.814 1.042 . . . . 0.0 113.814 -177.145 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 69.9 ttp85 -62.17 124.92 22.16 Favored 'General case' 0 N--CA 1.471 0.584 0 O-C-N 121.033 -1.042 . . . . 0.0 108.691 179.604 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 11.4 m-20 -99.56 125.34 41.17 Favored Pre-proline 0 C--N 1.323 -0.563 0 N-CA-C 106.307 -1.738 . . . . 0.0 106.307 179.381 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -68.85 -18.5 41.4 Favored 'Trans proline' 0 C--O 1.22 -0.421 0 C-N-CA 117.98 -0.88 . . . . 0.0 114.315 -176.126 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -75.41 -26.19 58.19 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.854 0.359 . . . . 0.0 110.621 178.04 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 -100.58 -25.86 14.03 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 -174.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 27.7 t30 -152.11 145.6 24.87 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 -179.423 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -86.7 149.39 24.92 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.402 179.69 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -66.8 142.34 57.39 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.295 0.569 . . . . 0.0 110.381 178.668 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 22.8 mt -84.15 139.26 17.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.312 -0.858 . . . . 0.0 108.689 -178.152 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 91.6 t -61.67 124.52 16.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 105.789 -1.93 . . . . 0.0 105.789 175.134 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 6.1 tt -66.51 128.74 37.37 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.098 0.475 . . . . 0.0 109.906 -177.257 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -129.88 151.8 50.05 Favored 'General case' 0 CA--C 1.507 -0.696 0 N-CA-C 106.285 -1.746 . . . . 0.0 106.285 -179.31 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 13.0 mt -110.16 148.32 38.1 Favored Pre-proline 0 C--N 1.321 -0.655 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 178.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -71.59 164.26 36.28 Favored 'Trans proline' 0 C--N 1.345 0.349 0 O-C-N 122.228 0.594 . . . . 0.0 112.999 -178.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 54.8 tt0 -54.25 131.12 40.93 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.628 -0.714 . . . . 0.0 109.685 -179.412 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 98.93 -17.7 57.84 Favored Glycine 0 C--O 1.228 -0.262 0 CA-C-N 115.829 -0.623 . . . . 0.0 112.494 -178.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 1.8 m -108.62 128.94 55.28 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 117.716 0.758 . . . . 0.0 110.587 178.052 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 6.0 p -124.91 151.05 45.88 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 179.37 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 72.6 mt -67.33 153.28 95.07 Favored Pre-proline 0 C--N 1.324 -0.525 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 -179.705 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -75.06 168.08 25.58 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 117.938 -0.908 . . . . 0.0 110.406 178.461 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -57.0 124.52 18.96 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 112.92 0.711 . . . . 0.0 112.92 -174.074 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 95.2 -6.06 68.55 Favored Glycine 0 C--O 1.229 -0.201 0 N-CA-C 115.818 1.087 . . . . 0.0 115.818 177.402 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.4 ' CZ ' ' HB2' ' A' ' 18' ' ' GLN . 1.7 m-85 -93.13 146.32 23.75 Favored 'General case' 0 N--CA 1.439 -1.013 0 CA-C-O 122.096 0.95 . . . . 0.0 110.416 179.362 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 46.8 p90 -144.75 160.58 41.0 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 113.793 -1.549 . . . . 0.0 108.12 174.438 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -102.56 142.84 33.07 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.092 0.472 . . . . 0.0 111.02 -177.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.42 ' HB3' ' HB ' ' A' ' 14' ' ' THR . 3.5 tp10 -70.12 131.61 44.56 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 177.779 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 92.29 -10.98 73.22 Favored Glycine 0 C--O 1.227 -0.298 0 C-N-CA 121.359 -0.448 . . . . 0.0 112.944 -178.526 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 41.9 t -91.69 144.02 25.95 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 106.957 -1.497 . . . . 0.0 106.957 176.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 2.9 tmt_? -78.0 -20.55 52.34 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.558 178.368 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 126.29 176.53 14.53 Favored Glycine 0 C--O 1.227 -0.306 0 N-CA-C 107.272 -2.331 . . . . 0.0 107.272 -177.335 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 80.28 42.79 10.13 Favored Glycine 0 C--O 1.226 -0.377 0 N-CA-C 110.246 -1.142 . . . . 0.0 110.246 -178.016 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 6.7 m . . . . . 0 C--O 1.25 1.083 0 N-CA-C 106.944 -1.502 . . . . 0.0 106.944 -178.149 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.762 0 CA-C-O 118.883 -0.954 . . . . 0.0 111.331 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -61.93 147.48 46.72 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 118.034 0.917 . . . . 0.0 108.691 178.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 65.2 mtm 59.7 16.79 5.75 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 113.596 0.961 . . . . 0.0 113.596 -179.207 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -84.26 60.18 4.86 Favored Glycine 0 C--O 1.227 -0.339 0 N-CA-C 112.124 -0.39 . . . . 0.0 112.124 178.639 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 10.3 mp -65.96 140.89 97.31 Favored Pre-proline 0 C--N 1.325 -0.488 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 -178.426 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -74.21 -22.28 16.87 Favored 'Trans proline' 0 C--N 1.349 0.567 0 N-CA-C 113.862 0.678 . . . . 0.0 113.862 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 26.7 t30 48.91 43.35 21.59 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 114.073 1.138 . . . . 0.0 114.073 178.134 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 15.4 t30 -83.13 46.63 1.14 Allowed 'General case' 0 N--CA 1.474 0.753 0 CA-C-O 121.421 0.629 . . . . 0.0 111.213 -179.154 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 17.4 p -148.1 129.27 14.61 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 104.078 -2.564 . . . . 0.0 104.078 179.124 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -139.19 146.39 40.49 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.462 0.649 . . . . 0.0 111.73 -179.057 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 35.7 t -63.16 144.0 57.3 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.144 177.775 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 18.1 m95 -67.34 -21.83 65.63 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 112.824 0.675 . . . . 0.0 112.824 178.025 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 39.8 m-85 -121.55 165.6 15.43 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 114.663 1.357 . . . . 0.0 114.663 -170.437 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 76.1 p -71.44 166.45 21.69 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 114.459 -1.246 . . . . 0.0 107.758 176.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -78.01 157.51 29.62 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 113.54 0.941 . . . . 0.0 113.54 -175.554 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 12.9 mt -102.05 137.1 40.77 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 105.288 -2.116 . . . . 0.0 105.288 171.114 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 37.0 m -122.19 145.4 48.23 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 -177.278 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.405 ' HB2' ' CZ ' ' A' ' 131' ' ' PHE . 4.2 tp60 -112.51 142.89 44.54 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 114.664 1.357 . . . . 0.0 114.664 -175.172 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 72.4 t60 -131.98 99.46 4.75 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 104.663 -2.347 . . . . 0.0 104.663 166.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 171.04 -152.97 19.74 Favored Glycine 0 C--O 1.227 -0.309 0 N-CA-C 109.954 -1.258 . . . . 0.0 109.954 -175.374 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -117.39 -21.97 8.43 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-O 121.44 0.638 . . . . 0.0 110.865 179.455 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -72.65 151.0 42.5 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.311 -179.646 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 16.8 t0 -76.61 -62.59 1.58 Allowed 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 178.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 43.1 tp 179.64 143.35 0.15 Allowed 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 103.478 -2.786 . . . . 0.0 103.478 171.299 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 56.8 tptt -154.56 134.57 13.06 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 118.047 0.385 . . . . 0.0 110.188 176.001 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 12.0 m-85 -125.0 157.27 67.42 Favored Pre-proline 0 C--O 1.244 0.811 0 N-CA-C 106.291 -1.744 . . . . 0.0 106.291 175.363 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -72.2 175.02 10.51 Favored 'Trans proline' 0 CA--C 1.536 0.611 0 C-N-CA 121.174 1.249 . . . . 0.0 114.527 -178.526 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 46.7 tpt85 -78.33 127.45 32.24 Favored 'General case' 0 C--O 1.214 -0.815 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 178.351 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 80.17 10.5 85.41 Favored Glycine 0 C--O 1.223 -0.567 0 N-CA-C 115.417 0.927 . . . . 0.0 115.417 175.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.53 HE22 HG21 ' A' ' 125' ' ' THR . 22.3 tt0 -157.71 145.5 18.71 Favored 'General case' 0 C--O 1.219 -0.521 0 N-CA-C 106.264 -1.754 . . . . 0.0 106.264 -179.537 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 138.5 -14.61 3.43 Favored Glycine 0 CA--C 1.504 -0.607 0 C-N-CA 120.042 -1.075 . . . . 0.0 113.523 177.298 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 27.8 m -70.06 144.72 93.14 Favored Pre-proline 0 C--N 1.322 -0.595 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 176.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -76.16 174.28 13.09 Favored 'Trans proline' 0 N--CA 1.46 -0.496 0 C-N-CA 121.483 1.455 . . . . 0.0 111.773 178.523 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 92.4 mt -71.86 118.47 16.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 178.404 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 45.1 m-80 -111.29 87.08 2.46 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 179.515 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 82.1 p -66.84 -21.94 66.01 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 112.769 0.655 . . . . 0.0 112.769 -177.091 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 71.6 m-80 -105.62 34.71 3.15 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.875 -177.249 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 20.6 m -145.84 150.41 36.11 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.745 0.307 . . . . 0.0 111.603 -179.4 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 25.3 m -71.31 164.19 59.39 Favored Pre-proline 0 C--N 1.325 -0.484 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 176.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -64.57 -26.8 61.66 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 114.926 -2.916 . . . . 0.0 111.598 177.721 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 51.2 m-20 -63.03 -27.39 69.38 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.827 177.001 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.434 ' HA ' ' HE3' ' A' ' 103' ' ' LYS . 67.9 m-20 -93.41 -6.62 46.68 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 115.569 1.692 . . . . 0.0 115.569 -171.878 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 92.0 mm-40 -60.43 -33.12 72.06 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 115.097 1.517 . . . . 0.0 115.097 -176.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 14.5 tt -60.1 140.62 17.86 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 CA-C-O 122.137 0.97 . . . . 0.0 113.117 -178.686 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 179.85 -149.34 8.53 Favored Glycine 0 C--O 1.227 -0.325 0 CA-C-N 115.623 -0.717 . . . . 0.0 112.455 -176.675 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 50.7 p90 -155.08 171.98 18.89 Favored 'General case' 0 C--N 1.319 -0.72 0 O-C-N 122.187 -0.596 . . . . 0.0 109.959 179.164 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 28.7 m-85 -114.25 142.99 45.57 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 173.222 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 68.5 ttt180 -115.22 125.88 53.89 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 123.739 0.815 . . . . 0.0 110.628 -178.329 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 6.3 ttp85 -71.26 135.52 47.49 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 107.675 -1.231 . . . . 0.0 107.675 176.317 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -135.35 129.64 33.73 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 123.218 0.607 . . . . 0.0 111.212 -178.732 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 15.0 t -159.96 155.43 25.45 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 174.271 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 20.3 tpt180 -161.26 139.18 9.33 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 105.319 -2.104 . . . . 0.0 105.319 178.021 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -88.44 135.38 33.5 Favored 'General case' 0 CA--C 1.505 -0.761 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 179.532 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -127.87 173.56 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.766 0 N-CA-C 106.826 -1.546 . . . . 0.0 106.826 -178.854 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.15 117.15 15.29 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 178.611 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -73.87 157.25 51.32 Favored Glycine 0 C--O 1.23 -0.125 0 N-CA-C 107.273 -2.331 . . . . 0.0 107.273 176.09 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -58.49 -35.7 81.19 Favored Glycine 0 N--CA 1.461 0.347 0 CA-C-N 119.017 1.408 . . . . 0.0 112.184 -177.038 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -73.43 0.8 11.25 Favored 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 124.64 1.176 . . . . 0.0 113.553 -179.376 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 93.44 14.54 53.32 Favored Glycine 0 C--N 1.317 -0.505 0 CA-C-N 114.38 -1.282 . . . . 0.0 113.027 174.239 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 16.4 mmtt -79.02 130.6 35.7 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.393 0.616 . . . . 0.0 110.635 -175.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 1.4 mmt -86.08 161.06 19.09 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.008 -0.997 . . . . 0.0 110.47 179.613 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 22.6 tptp -64.45 -52.52 57.6 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.383 176.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.4 t70 45.33 -149.89 0.07 Allowed 'General case' 0 CA--C 1.549 0.905 0 O-C-N 124.842 1.339 . . . . 0.0 112.315 -176.424 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 62.0 mt 52.94 178.73 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.814 0 N-CA-C 118.407 2.743 . . . . 0.0 118.407 174.335 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 2.1 p -74.2 159.51 83.66 Favored Pre-proline 0 C--O 1.245 0.853 0 CA-C-N 115.124 -0.943 . . . . 0.0 112.904 -177.721 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -77.05 175.89 10.82 Favored 'Trans proline' 0 C--N 1.352 0.722 0 N-CA-C 110.796 -0.502 . . . . 0.0 110.796 174.088 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 33.3 ptt-85 -132.13 163.32 28.77 Favored 'General case' 0 C--O 1.218 -0.56 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 177.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 56.3 m95 -122.93 150.2 43.25 Favored 'General case' 0 C--O 1.212 -0.882 0 C-N-CA 122.468 0.307 . . . . 0.0 111.224 -177.186 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 56.1 m-85 -128.12 147.29 50.54 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 177.72 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 88.7 t80 -94.43 135.46 35.83 Favored 'General case' 0 CA--C 1.506 -0.747 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 -177.274 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -136.99 131.98 33.68 Favored 'General case' 0 N--CA 1.437 -1.096 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 -175.657 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 74.2 m-85 -70.89 159.57 34.41 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.037 -176.134 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -53.07 125.46 17.41 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.829 -178.218 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 71.57 23.32 78.18 Favored Glycine 0 C--O 1.224 -0.474 0 N-CA-C 116.309 1.284 . . . . 0.0 116.309 177.056 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 18.3 p -89.27 146.09 24.96 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 119.056 1.428 . . . . 0.0 108.842 177.402 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 99.32 133.05 7.94 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 110.167 -1.173 . . . . 0.0 110.167 -177.821 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -72.3 -31.48 11.59 Favored 'Trans proline' 0 CA--C 1.516 -0.419 0 CA-C-N 119.524 1.662 . . . . 0.0 115.389 -175.133 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -102.77 12.13 36.66 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 114.133 -1.394 . . . . 0.0 108.93 -175.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -60.79 -48.15 83.09 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.577 -173.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 55.66 36.77 65.92 Favored Glycine 0 C--N 1.33 0.21 0 CA-C-N 116.043 -0.526 . . . . 0.0 112.718 179.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 14.7 mt -124.78 103.92 30.79 Favored Pre-proline 0 N--CA 1.444 -0.767 0 N-CA-C 115.503 1.668 . . . . 0.0 115.503 -175.471 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -79.08 161.89 26.29 Favored 'Trans proline' 0 N--CA 1.463 -0.313 0 C-N-CA 122.517 2.145 . . . . 0.0 107.683 167.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 57.1 t80 -60.86 131.21 49.96 Favored 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 120.373 -0.531 . . . . 0.0 110.579 -177.411 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 92.33 -7.51 78.02 Favored Glycine 0 C--O 1.228 -0.269 0 CA-C-O 119.349 -0.695 . . . . 0.0 114.65 179.11 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -66.62 131.12 45.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 118.649 1.224 . . . . 0.0 111.336 179.503 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 56.7 t30 -78.73 129.18 34.38 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.627 -179.388 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 30.0 ttmt -156.17 153.27 28.99 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 106.492 -1.67 . . . . 0.0 106.492 179.29 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -63.48 130.82 46.01 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.051 0.453 . . . . 0.0 111.165 -178.105 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 68.5 27.64 73.68 Favored Glycine 0 N--CA 1.449 -0.483 0 CA-C-O 119.263 -0.743 . . . . 0.0 113.994 177.652 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 45.9 mm -123.28 125.57 72.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 117.487 0.644 . . . . 0.0 110.303 179.331 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -127.85 115.25 38.56 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 CA-C-O 121.575 0.702 . . . . 0.0 111.296 177.061 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 97.7 m95 -80.45 137.45 36.49 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -177.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -142.61 154.34 17.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 -178.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -157.27 166.64 32.6 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 105.695 -1.965 . . . . 0.0 105.695 -177.096 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 14.7 t -125.84 166.49 16.75 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 104.03 -2.582 . . . . 0.0 104.03 173.205 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 77.7 tt0 -67.68 137.67 55.72 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 121.108 0.48 . . . . 0.0 109.879 -178.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 95.45 -19.23 55.25 Favored Glycine 0 C--O 1.224 -0.521 0 CA-C-N 115.705 -0.68 . . . . 0.0 112.973 178.042 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -67.81 137.93 55.75 Favored 'General case' 0 CA--C 1.542 0.661 0 O-C-N 122.542 -0.387 . . . . 0.0 110.753 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 47.0 mt -92.21 136.55 33.1 Favored 'General case' 0 CA--C 1.514 -0.425 0 N-CA-C 113.771 1.026 . . . . 0.0 113.771 -176.349 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 63.6 t30 -80.39 61.34 4.12 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.21 -0.905 . . . . 0.0 110.939 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 2.6 t -133.12 160.93 66.73 Favored Pre-proline 0 C--N 1.322 -0.588 0 N-CA-C 104.452 -2.425 . . . . 0.0 104.452 -179.133 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_exo -64.58 152.06 83.24 Favored 'Trans proline' 0 CA--C 1.534 0.475 0 N-CA-C 116.669 1.757 . . . . 0.0 116.669 -177.298 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.434 ' HE3' ' HA ' ' A' ' 42' ' ' ASP . 0.4 OUTLIER -127.19 31.93 5.15 Favored 'General case' 0 CA--C 1.515 -0.388 0 C-N-CA 124.545 1.138 . . . . 0.0 109.416 176.784 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 15.2 p-10 -55.22 -36.89 66.46 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.285 -0.871 . . . . 0.0 109.84 179.284 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 16.7 p80 -60.8 -13.65 16.63 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 114.832 1.419 . . . . 0.0 114.832 179.377 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 10.8 mt -96.27 -23.71 4.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 121.14 0.495 . . . . 0.0 110.787 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -76.19 1.25 60.74 Favored Glycine 0 C--O 1.227 -0.303 0 N-CA-C 115.559 0.984 . . . . 0.0 115.559 -175.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 14.6 t -83.08 16.06 2.53 Favored 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 113.848 1.055 . . . . 0.0 113.848 -177.514 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 63.1 ttp85 -66.26 129.75 40.89 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 177.781 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -111.73 134.19 21.36 Favored Pre-proline 0 C--N 1.325 -0.491 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 179.429 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_endo -69.76 -21.55 33.31 Favored 'Trans proline' 0 C--O 1.217 -0.535 0 N-CA-C 115.314 1.236 . . . . 0.0 115.314 -174.447 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -74.81 -24.09 58.58 Favored 'General case' 0 C--O 1.22 -0.49 0 CA-C-O 121.094 0.473 . . . . 0.0 110.478 178.391 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 83.5 m-20 -97.72 -22.49 16.41 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 113.302 0.853 . . . . 0.0 113.302 -175.068 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 19.6 t30 -157.99 150.03 21.99 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 112.0 0.371 . . . . 0.0 112.0 -178.356 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -87.27 147.47 25.52 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-O 121.575 0.702 . . . . 0.0 112.182 179.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -72.73 147.92 45.15 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.27 178.13 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 15.0 mt -91.42 139.43 17.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.226 -178.156 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 73.9 t -60.13 125.41 16.2 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 N-CA-C 106.572 -1.64 . . . . 0.0 106.572 175.084 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 6.4 tt -66.6 129.19 39.04 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.101 0.477 . . . . 0.0 110.168 -177.324 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 31.0 mt-30 -131.26 156.66 45.03 Favored 'General case' 0 CA--C 1.511 -0.534 0 N-CA-C 107.062 -1.459 . . . . 0.0 107.062 -178.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 14.4 mt -113.25 148.07 38.75 Favored Pre-proline 0 C--N 1.321 -0.631 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 178.438 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -72.06 167.5 26.58 Favored 'Trans proline' 0 C--N 1.345 0.392 0 O-C-N 122.229 0.594 . . . . 0.0 112.969 -179.335 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -55.56 133.48 50.35 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.814 -179.498 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 91.91 -14.75 63.48 Favored Glycine 0 C--O 1.227 -0.332 0 CA-C-N 116.05 -0.523 . . . . 0.0 113.368 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.53 HG21 HE22 ' A' ' 30' ' ' GLN . 16.7 m -105.95 126.94 52.79 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 117.841 0.82 . . . . 0.0 110.309 179.012 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 6.9 p -118.51 148.24 42.83 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.78 -178.268 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 84.9 mt -69.94 153.61 95.31 Favored Pre-proline 0 C--N 1.325 -0.472 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 177.661 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -76.15 173.48 14.42 Favored 'Trans proline' 0 C--O 1.235 0.345 0 N-CA-C 110.531 -0.604 . . . . 0.0 110.531 178.624 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 8.2 tmtt? -53.83 126.61 22.84 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.21 0.528 . . . . 0.0 112.224 -175.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 85.29 -1.55 88.52 Favored Glycine 0 N--CA 1.454 -0.144 0 N-CA-C 116.861 1.504 . . . . 0.0 116.861 173.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.405 ' CZ ' ' HB2' ' A' ' 18' ' ' GLN . 1.5 m-85 -94.71 141.26 28.82 Favored 'General case' 0 N--CA 1.436 -1.167 0 CA-C-O 122.069 0.938 . . . . 0.0 110.436 -179.209 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 42.8 p90 -142.08 161.47 37.92 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 113.639 -1.618 . . . . 0.0 108.351 176.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -103.0 143.74 32.18 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.345 0.593 . . . . 0.0 111.705 -176.842 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -70.68 135.3 48.22 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 179.693 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 81.89 -9.69 55.43 Favored Glycine 0 CA--C 1.52 0.365 0 CA-C-N 116.118 -0.492 . . . . 0.0 114.095 -178.75 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 28.8 t -86.66 122.46 30.6 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 117.926 0.863 . . . . 0.0 110.51 -179.534 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 26.2 mmt180 -96.85 -21.46 17.49 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.767 177.355 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 81.18 -44.68 3.08 Favored Glycine 0 C--O 1.225 -0.449 0 C-N-CA 121.71 -0.281 . . . . 0.0 112.974 -178.125 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -168.0 -167.86 29.27 Favored Glycine 0 N--CA 1.451 -0.34 0 N-CA-C 107.487 -2.245 . . . . 0.0 107.487 179.299 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 47.2 t . . . . . 0 C--O 1.245 0.827 0 N-CA-C 105.097 -2.186 . . . . 0.0 105.097 179.01 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.177 0 CA-C-O 118.265 -1.297 . . . . 0.0 111.299 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 50.76 36.5 14.51 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 115.771 1.767 . . . . 0.0 115.771 176.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 26.9 ptt? -81.79 15.43 2.2 Favored 'General case' 0 N--CA 1.473 0.69 0 O-C-N 121.74 -0.6 . . . . 0.0 112.507 -179.409 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -115.71 43.14 1.73 Allowed Glycine 0 C--O 1.223 -0.538 0 N-CA-C 111.708 -0.557 . . . . 0.0 111.708 -178.362 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 89.6 mt -64.17 147.41 96.81 Favored Pre-proline 0 CA--C 1.539 0.539 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 -179.755 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -76.24 51.22 3.12 Favored 'Trans proline' 0 CA--C 1.546 1.104 0 C-N-CA 122.454 2.102 . . . . 0.0 114.712 -177.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 44.2 t30 -102.54 87.02 2.9 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.478 0.656 . . . . 0.0 109.857 -178.463 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 16.9 m-80 -67.15 -23.43 65.79 Favored 'General case' 0 C--O 1.216 -0.666 0 N-CA-C 116.581 2.067 . . . . 0.0 116.581 -178.788 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 40.6 p -37.24 94.88 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 125.809 1.644 . . . . 0.0 114.827 -174.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -109.27 146.18 34.7 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 113.114 -1.857 . . . . 0.0 113.157 -173.523 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 32.9 p -62.21 140.91 58.44 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 114.853 -1.067 . . . . 0.0 109.982 178.803 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 17.4 m95 -67.62 -21.81 65.37 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 113.795 1.035 . . . . 0.0 113.795 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 36.8 m-85 -121.55 160.87 23.39 Favored 'General case' 0 CA--C 1.509 -0.621 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 -172.598 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 67.7 p -69.47 162.03 28.26 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 178.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -78.31 147.12 34.38 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 114.084 1.142 . . . . 0.0 114.084 -175.726 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 27.1 mt -89.02 148.88 23.52 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 105.149 -2.167 . . . . 0.0 105.149 170.634 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.6 m -122.97 144.85 48.97 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 179.473 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 3.8 tp60 -109.99 154.79 22.67 Favored 'General case' 0 C--N 1.328 -0.339 0 O-C-N 123.762 0.664 . . . . 0.0 110.742 -176.283 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 67.9 t60 -139.34 99.51 3.76 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 105.588 -2.004 . . . . 0.0 105.588 170.086 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 163.09 -171.63 38.9 Favored Glycine 0 N--CA 1.452 -0.239 0 N-CA-C 110.653 -0.979 . . . . 0.0 110.653 -177.778 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -99.56 -22.52 15.43 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 112.477 0.547 . . . . 0.0 112.477 179.672 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -83.44 161.99 21.12 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.963 -178.168 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -75.55 -62.94 1.4 Allowed 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 114.539 1.311 . . . . 0.0 114.539 -175.894 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 32.2 tp 157.23 144.84 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.283 0 N-CA-C 104.935 -2.246 . . . . 0.0 104.935 -175.56 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 56.1 tptt -156.02 141.39 17.61 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 108.779 -0.822 . . . . 0.0 108.779 173.009 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 15.1 m-85 -122.97 150.7 59.77 Favored Pre-proline 0 C--O 1.242 0.699 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 175.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -74.22 163.21 37.04 Favored 'Trans proline' 0 C--N 1.352 0.752 0 C-N-CA 120.88 1.053 . . . . 0.0 113.383 179.467 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 4.1 tmt_? -65.36 133.71 51.95 Favored 'General case' 0 N--CA 1.473 0.707 0 O-C-N 122.045 -0.409 . . . . 0.0 110.493 -178.484 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 88.12 1.34 82.0 Favored Glycine 0 C--O 1.228 -0.235 0 N-CA-C 111.912 -0.475 . . . . 0.0 111.912 178.614 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 33.0 mt-30 -141.83 171.65 13.77 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 123.455 0.702 . . . . 0.0 110.4 -174.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 107.06 -25.26 22.78 Favored Glycine 0 CA--C 1.497 -1.049 0 CA-C-N 115.54 -0.754 . . . . 0.0 111.937 175.176 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 95.7 t -63.72 127.4 91.47 Favored Pre-proline 0 C--N 1.318 -0.779 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 177.736 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -73.46 171.58 17.42 Favored 'Trans proline' 0 N--CA 1.462 -0.351 0 O-C-N 122.142 0.548 . . . . 0.0 111.385 178.189 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 86.1 mt -69.81 107.02 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-O 121.963 0.887 . . . . 0.0 108.892 -179.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 75.3 m-20 -99.96 84.82 2.94 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 114.626 -1.17 . . . . 0.0 109.9 -177.36 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 69.6 p -67.06 -15.74 63.91 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 112.94 0.719 . . . . 0.0 112.94 -178.631 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 12.3 p30 -107.13 22.77 15.47 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.375 -0.83 . . . . 0.0 112.382 -177.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 15.0 m -140.5 148.89 41.77 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 113.787 1.032 . . . . 0.0 113.787 -176.525 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -74.37 167.35 36.73 Favored Pre-proline 0 N--CA 1.468 0.447 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 177.194 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -64.93 -28.48 58.27 Favored 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 114.663 -3.091 . . . . 0.0 111.827 178.309 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -62.11 -24.31 67.06 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 123.883 0.873 . . . . 0.0 111.658 176.743 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 71.6 m-20 -98.41 -2.57 38.81 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 114.957 1.466 . . . . 0.0 114.957 -172.183 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 94.5 mm-40 -60.77 -28.94 69.11 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 114.543 1.312 . . . . 0.0 114.543 -178.21 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 12.9 tt -60.07 139.31 19.78 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.846 0 CA-C-O 122.358 1.075 . . . . 0.0 113.339 -177.677 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -177.94 -155.96 15.38 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.84 -0.695 . . . . 0.0 111.903 -178.478 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 49.8 p90 -155.05 168.59 26.51 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 178.665 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 22.5 m-85 -108.99 141.35 41.22 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 172.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 51.7 ttt180 -115.0 120.54 40.23 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 114.917 -1.038 . . . . 0.0 111.919 -174.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 38.9 ttp180 -68.47 134.7 50.52 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 176.159 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -150.79 151.11 31.85 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.159 0.504 . . . . 0.0 111.494 -178.393 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 14.3 t -158.9 164.98 35.18 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 174.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 14.3 tpt180 -149.83 123.83 9.38 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 105.367 -2.086 . . . . 0.0 105.367 177.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 4.6 tmm_? -88.9 128.01 35.66 Favored 'General case' 0 CA--C 1.498 -1.054 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 -179.21 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -128.6 169.83 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.107 0 N-CA-C 105.725 -1.954 . . . . 0.0 105.725 179.032 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 1.1 ttt-85 -144.04 110.72 5.62 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 176.131 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -71.17 160.88 54.13 Favored Glycine 0 N--CA 1.449 -0.443 0 N-CA-C 107.891 -2.084 . . . . 0.0 107.891 176.492 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -69.94 -33.8 70.61 Favored Glycine 0 C--O 1.222 -0.596 0 N-CA-C 109.899 -1.28 . . . . 0.0 109.899 -178.106 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.2 t0 -73.12 3.54 5.45 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 114.133 -1.033 . . . . 0.0 111.831 179.422 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 96.6 -9.12 66.53 Favored Glycine 0 C--O 1.226 -0.353 0 CA-C-N 115.725 -0.67 . . . . 0.0 114.5 175.48 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.49 106.7 4.68 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.759 0.79 . . . . 0.0 111.751 -178.185 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 18.6 mtp -88.8 -179.98 6.1 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 114.783 -1.099 . . . . 0.0 109.124 179.313 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 23.9 tptp -73.88 -59.5 2.69 Favored 'General case' 0 CA--C 1.51 -0.58 0 C-N-CA 120.603 -0.439 . . . . 0.0 111.409 -179.609 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 47.02 -161.53 0.03 OUTLIER 'General case' 0 C--O 1.25 1.082 0 O-C-N 125.358 1.661 . . . . 0.0 115.256 -179.339 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 82.2 mt 53.48 -176.66 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 116.489 2.033 . . . . 0.0 116.489 178.711 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 24.3 m -65.04 154.01 87.65 Favored Pre-proline 0 C--O 1.24 0.596 0 CA-C-N 115.182 -0.917 . . . . 0.0 112.336 -177.303 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -73.8 175.5 10.69 Favored 'Trans proline' 0 C--N 1.348 0.506 0 CA-C-O 122.015 0.756 . . . . 0.0 113.72 -179.353 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 1.2 mmt180 -106.55 159.99 15.76 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 114.897 -1.047 . . . . 0.0 108.294 -178.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 73.2 m95 -128.3 125.02 37.96 Favored 'General case' 0 C--O 1.215 -0.748 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 176.252 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 33.9 m-85 -110.99 156.54 21.09 Favored 'General case' 0 C--O 1.213 -0.849 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 -178.727 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 81.2 t80 -101.76 135.31 43.5 Favored 'General case' 0 CA--C 1.51 -0.596 0 CA-C-N 119.204 0.911 . . . . 0.0 108.94 -179.297 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -136.92 147.46 46.41 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 -176.583 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 84.3 m-85 -82.5 159.43 22.86 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.069 -176.709 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -54.67 130.26 39.71 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.991 0.424 . . . . 0.0 111.066 -179.28 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 73.54 26.23 70.41 Favored Glycine 0 C--O 1.219 -0.837 0 N-CA-C 116.107 1.203 . . . . 0.0 116.107 176.63 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 5.3 p -89.14 146.16 24.97 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 118.775 1.287 . . . . 0.0 109.724 178.13 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 105.89 139.73 9.75 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 107.395 -2.282 . . . . 0.0 107.395 -175.489 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -67.24 -42.91 6.93 Favored 'Trans proline' 0 C--N 1.346 0.424 0 CA-C-N 119.915 1.858 . . . . 0.0 116.126 -172.724 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -114.78 39.1 2.94 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 -177.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -66.83 -47.38 72.17 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.967 -178.055 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 57.52 23.93 50.76 Favored Glycine 0 CA--C 1.521 0.464 0 N-CA-C 114.439 0.536 . . . . 0.0 114.439 179.377 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 42.9 mt -102.57 109.72 61.43 Favored Pre-proline 0 C--O 1.238 0.452 0 N-CA-C 115.318 1.599 . . . . 0.0 115.318 -175.6 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -76.97 166.14 27.25 Favored 'Trans proline' 0 C--O 1.237 0.427 0 N-CA-C 108.669 -1.32 . . . . 0.0 108.669 170.144 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.405 ' CE1' ' HB3' ' A' ' 92' ' ' TRP . 62.5 t80 -62.8 133.68 55.12 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 120.491 -0.484 . . . . 0.0 110.069 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 90.37 -5.45 82.7 Favored Glycine 0 CA--C 1.519 0.317 0 N-CA-C 114.489 0.556 . . . . 0.0 114.489 178.815 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -63.08 132.33 51.54 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 117.901 0.85 . . . . 0.0 112.22 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 51.5 t30 -74.52 126.26 30.39 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.903 -0.59 . . . . 0.0 112.094 -178.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 15.2 ttmm -156.14 149.86 24.96 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 176.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -63.63 132.79 52.26 Favored 'General case' 0 C--N 1.321 -0.64 0 O-C-N 123.251 0.345 . . . . 0.0 110.802 -179.646 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 66.87 28.41 73.77 Favored Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 121.037 -0.602 . . . . 0.0 114.481 177.328 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 40.9 mm -127.5 126.43 67.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 117.302 0.551 . . . . 0.0 109.993 179.41 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.1 pt -128.13 115.15 37.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 121.812 0.815 . . . . 0.0 110.889 176.307 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . 0.405 ' HB3' ' CE1' ' A' ' 83' ' ' TYR . 95.8 m95 -79.03 135.73 36.97 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.983 -0.553 . . . . 0.0 112.34 -177.886 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 17.0 m -137.3 149.72 25.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.566 0.698 . . . . 0.0 109.534 179.72 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -157.59 166.6 32.44 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 104.333 -2.469 . . . . 0.0 104.333 -178.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 6.6 t -138.21 177.04 8.17 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 106.037 -1.838 . . . . 0.0 106.037 177.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -67.61 135.08 52.32 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.056 0.455 . . . . 0.0 110.51 -178.255 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 96.02 -8.29 67.59 Favored Glycine 0 C--O 1.224 -0.52 0 CA-C-N 115.938 -0.574 . . . . 0.0 113.514 178.688 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -81.22 139.23 35.62 Favored 'General case' 0 C--N 1.324 -0.541 0 O-C-N 122.443 -0.446 . . . . 0.0 111.456 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 47.3 mt -90.04 138.7 31.29 Favored 'General case' 0 CA--C 1.512 -0.495 0 CA-C-O 120.805 0.336 . . . . 0.0 111.284 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 62.4 t30 -83.42 68.13 9.6 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.992 0.425 . . . . 0.0 110.743 179.806 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 1.1 t -141.67 151.71 60.96 Favored Pre-proline 0 C--O 1.24 0.566 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 -178.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -66.24 153.15 79.18 Favored 'Trans proline' 0 C--N 1.345 0.39 0 N-CA-C 113.645 0.594 . . . . 0.0 113.645 176.597 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 1.4 ptpm? -152.25 56.49 0.83 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 122.502 1.144 . . . . 0.0 110.809 -179.235 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -59.66 -27.13 66.12 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 114.535 -1.211 . . . . 0.0 111.443 179.35 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 12.7 p80 -59.71 -12.4 6.97 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 114.029 1.122 . . . . 0.0 114.029 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 55.3 mt -91.94 -43.07 13.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 177.367 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -77.12 11.45 15.92 Favored Glycine 0 C--O 1.224 -0.495 0 N-CA-C 114.825 0.69 . . . . 0.0 114.825 -177.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 6.6 t -83.2 17.84 1.91 Allowed 'General case' 0 CA--C 1.545 0.778 0 CA-C-O 122.214 1.007 . . . . 0.0 110.416 178.782 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.429 ' HD2' ' OD1' ' A' ' 114' ' ' ASN . 62.7 ttp85 -59.32 131.46 51.06 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.786 -179.912 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 10.2 m-20 -100.22 122.04 51.58 Favored Pre-proline 0 C--N 1.326 -0.444 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -71.06 -15.06 32.3 Favored 'Trans proline' 0 C--O 1.218 -0.485 0 N-CA-C 113.672 0.604 . . . . 0.0 113.672 -177.74 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -76.16 -24.38 54.82 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.853 0.359 . . . . 0.0 110.912 177.628 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -101.47 -26.09 13.69 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 113.499 0.926 . . . . 0.0 113.499 -175.5 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . 0.429 ' OD1' ' HD2' ' A' ' 109' ' ' ARG . 0.4 OUTLIER -142.77 153.64 43.46 Favored 'General case' 0 N--CA 1.437 -1.119 0 CA-C-O 121.031 0.443 . . . . 0.0 111.428 -176.694 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -99.23 142.22 30.99 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.626 177.082 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -69.23 150.07 47.85 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.403 0.62 . . . . 0.0 112.17 -179.08 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 6.8 mt -86.14 138.42 19.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.382 -0.826 . . . . 0.0 109.23 -178.591 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 97.1 t -60.73 124.08 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 N-CA-C 106.754 -1.573 . . . . 0.0 106.754 176.064 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 6.7 tt -66.5 130.6 43.74 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.226 0.536 . . . . 0.0 111.372 -175.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 28.7 mt-30 -131.82 156.77 45.46 Favored 'General case' 0 CA--C 1.514 -0.43 0 N-CA-C 106.827 -1.545 . . . . 0.0 106.827 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 13.9 mt -113.12 147.4 37.21 Favored Pre-proline 0 C--N 1.323 -0.559 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 178.151 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -74.76 169.67 22.06 Favored 'Trans proline' 0 C--N 1.345 0.374 0 O-C-N 122.224 0.592 . . . . 0.0 113.465 -179.384 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 36.8 tt0 -54.25 131.34 41.39 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.317 178.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 99.78 -22.47 40.23 Favored Glycine 0 C--O 1.227 -0.321 0 CA-C-O 119.439 -0.645 . . . . 0.0 113.474 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 5.7 m -108.75 129.29 55.37 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 118.461 1.13 . . . . 0.0 111.179 179.071 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 7.1 p -123.34 149.16 45.24 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.793 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 96.7 mt -71.48 151.09 93.93 Favored Pre-proline 0 C--N 1.324 -0.522 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 178.448 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -79.11 178.25 7.72 Favored 'Trans proline' 0 CA--C 1.531 0.361 0 C-N-CA 120.33 0.686 . . . . 0.0 112.296 179.31 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 64.4 tttp -57.17 129.95 44.02 Favored 'General case' 0 C--O 1.219 -0.504 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.224 -178.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 87.18 -1.98 86.61 Favored Glycine 0 C--O 1.226 -0.379 0 N-CA-C 115.425 0.93 . . . . 0.0 115.425 175.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -101.1 137.11 39.9 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-O 121.883 0.849 . . . . 0.0 112.433 -178.136 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 48.4 p90 -145.4 164.44 31.51 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 114.343 -1.299 . . . . 0.0 108.735 176.564 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -104.84 144.89 31.15 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 -176.246 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -71.62 136.23 47.27 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 177.804 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 94.06 -8.96 73.0 Favored Glycine 0 C--O 1.225 -0.445 0 C-N-CA 121.425 -0.417 . . . . 0.0 112.297 178.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 32.8 t -112.29 142.93 44.19 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 110.305 -0.257 . . . . 0.0 110.305 178.018 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER 52.29 63.84 2.08 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 113.722 1.008 . . . . 0.0 113.722 176.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -162.56 171.46 38.41 Favored Glycine 0 C--O 1.225 -0.442 0 N-CA-C 107.012 -2.435 . . . . 0.0 107.012 177.276 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 80.02 34.11 31.16 Favored Glycine 0 C--O 1.227 -0.298 0 CA-C-N 118.266 1.033 . . . . 0.0 112.636 179.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 78.7 p . . . . . 0 C--O 1.256 1.412 0 CA-C-O 115.273 -2.299 . . . . 0.0 106.433 -178.997 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.706 0 CA-C-O 118.693 -1.059 . . . . 0.0 111.122 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -68.75 147.7 51.41 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 117.989 0.894 . . . . 0.0 110.945 -179.406 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 26.6 ttt -157.17 138.74 13.98 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 105.217 -2.142 . . . . 0.0 105.217 177.041 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 136.27 -66.57 0.55 Allowed Glycine 0 C--O 1.227 -0.325 0 C-N-CA 121.199 -0.524 . . . . 0.0 112.958 178.227 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 9.5 mp -67.74 139.21 93.54 Favored Pre-proline 0 C--N 1.326 -0.447 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 -178.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -79.79 138.3 13.21 Favored 'Trans proline' 0 CA--C 1.533 0.441 0 C-N-CA 118.446 -0.569 . . . . 0.0 112.317 176.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 49.1 t30 -79.8 -20.53 45.93 Favored 'General case' 0 C--O 1.219 -0.514 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 175.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 59.7 t30 60.4 49.38 6.93 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.94 1.296 . . . . 0.0 112.058 178.131 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 69.0 p -140.12 131.09 26.15 Favored 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 -177.539 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -134.07 135.75 43.5 Favored 'General case' 0 C--N 1.312 -1.038 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 174.735 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 34.7 p -66.84 141.74 57.57 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 -178.291 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 20.6 m95 -67.07 -26.95 66.99 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 178.597 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 24.9 m-85 -121.38 164.89 16.35 Favored 'General case' 0 C--O 1.241 0.633 0 N-CA-C 113.74 1.015 . . . . 0.0 113.74 -171.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 56.1 p -68.23 167.97 13.23 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 114.609 -1.178 . . . . 0.0 110.204 179.045 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -81.61 142.35 32.86 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 114.531 1.308 . . . . 0.0 114.531 -174.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 25.3 mt -84.42 146.8 27.46 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 102.55 -3.13 . . . . 0.0 102.55 167.554 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 29.8 m -130.12 141.28 50.7 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 -178.182 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 4.3 tp60 -109.64 140.42 43.5 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 -176.181 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 53.6 t60 -131.07 99.93 5.05 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 104.054 -2.573 . . . . 0.0 104.054 168.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 163.97 -162.93 35.57 Favored Glycine 0 C--O 1.227 -0.301 0 N-CA-C 108.252 -1.939 . . . . 0.0 108.252 -175.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 90.2 mttt -111.36 -22.17 11.47 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 115.207 1.558 . . . . 0.0 115.207 -178.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -75.2 158.95 32.17 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 106.602 -1.629 . . . . 0.0 106.602 174.757 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -83.59 -62.12 1.66 Allowed 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 120.545 -0.462 . . . . 0.0 110.851 -178.726 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 41.5 tp -175.08 150.83 1.23 Allowed 'General case' 0 N--CA 1.481 1.094 0 N-CA-C 105.637 -1.986 . . . . 0.0 105.637 173.53 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -158.11 134.61 9.59 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 178.113 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -129.35 148.65 70.09 Favored Pre-proline 0 C--N 1.323 -0.551 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 173.693 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -72.63 155.74 54.21 Favored 'Trans proline' 0 C--N 1.35 0.654 0 O-C-N 122.194 0.576 . . . . 0.0 112.703 178.082 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 17.3 tpt180 -67.56 137.76 55.96 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 -179.23 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 89.26 0.67 79.88 Favored Glycine 0 C--O 1.222 -0.612 0 N-CA-C 110.684 -0.967 . . . . 0.0 110.684 179.501 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 -146.71 -179.62 6.91 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 -174.793 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 99.96 -27.06 22.06 Favored Glycine 0 CA--C 1.5 -0.906 0 CA-C-N 116.241 -0.436 . . . . 0.0 112.219 175.325 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 71.9 t -63.32 128.52 92.58 Favored Pre-proline 0 C--N 1.319 -0.736 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 177.062 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -74.74 168.39 24.94 Favored 'Trans proline' 0 N--CA 1.458 -0.575 0 O-C-N 122.165 0.56 . . . . 0.0 110.86 178.557 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 97.4 mt -68.01 116.92 8.83 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 69.2 m-80 -105.06 98.38 8.1 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.448 -179.455 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 67.6 p -73.4 -22.18 60.31 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.19 0.519 . . . . 0.0 111.683 -179.192 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 71.2 m-80 -111.12 36.85 3.02 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.496 -0.774 . . . . 0.0 112.682 -177.64 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 17.5 m -144.59 146.96 32.59 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 179.313 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -72.26 166.39 41.89 Favored Pre-proline 0 C--N 1.327 -0.405 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 176.943 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -64.79 -27.03 59.76 Favored 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 115.198 -2.735 . . . . 0.0 111.86 178.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -62.22 -29.07 70.13 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.662 0.744 . . . . 0.0 111.17 176.377 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 76.6 m-20 -96.29 0.8 51.34 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 115.288 1.588 . . . . 0.0 115.288 -170.628 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 94.7 mm-40 -61.58 -27.12 68.41 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 121.345 0.593 . . . . 0.0 112.478 178.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 19.5 tt -57.52 138.67 18.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-O 122.236 1.017 . . . . 0.0 113.712 -179.325 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -177.82 -158.74 21.39 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.274 -0.965 . . . . 0.0 113.158 -179.47 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 38.2 p90 -155.04 169.12 24.84 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 107.721 -1.214 . . . . 0.0 107.721 179.291 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 29.1 m-85 -113.63 141.42 47.23 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 106.784 -1.562 . . . . 0.0 106.784 173.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 44.4 ttt-85 -112.21 131.71 55.33 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.826 -0.624 . . . . 0.0 112.231 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 39.2 ttt-85 -65.39 142.44 58.2 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.437 176.134 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -147.98 166.13 28.66 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 177.52 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 6.3 t -152.37 162.46 41.14 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 -177.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 10.1 ttm180 -90.72 123.88 34.66 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 104.619 -2.363 . . . . 0.0 104.619 176.032 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 8.3 tmm_? -148.25 144.65 27.8 Favored 'General case' 0 CA--C 1.508 -0.665 0 CA-C-O 121.105 0.479 . . . . 0.0 111.633 -172.321 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -126.68 -179.68 2.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 -178.61 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -117.37 104.32 11.0 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 171.598 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -71.84 165.02 54.07 Favored Glycine 0 C--O 1.222 -0.625 0 N-CA-C 108.189 -1.964 . . . . 0.0 108.189 178.68 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -61.15 -42.45 99.79 Favored Glycine 0 C--O 1.217 -0.935 0 CA-C-N 118.483 1.142 . . . . 0.0 112.131 -179.256 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 41.2 t0 -95.67 16.94 15.99 Favored 'General case' 0 CA--C 1.549 0.923 0 CA-C-O 122.912 1.339 . . . . 0.0 110.39 179.434 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 86.01 6.86 81.55 Favored Glycine 0 C--O 1.226 -0.384 0 CA-C-N 114.769 -1.105 . . . . 0.0 113.833 172.759 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 23.9 mmtt -69.49 142.48 53.72 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 122.235 1.017 . . . . 0.0 112.472 -173.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 5.1 mmt -93.82 172.42 8.26 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 113.135 -1.848 . . . . 0.0 113.961 -175.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 12.2 tptt -124.34 -41.74 2.16 Favored 'General case' 0 CA--C 1.491 -1.311 0 CA-C-N 114.811 -1.086 . . . . 0.0 108.896 173.351 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 26.56 86.27 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.872 0 O-C-N 126.814 2.571 . . . . 0.0 116.315 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -75.89 173.01 11.74 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 114.141 -1.39 . . . . 0.0 108.904 -179.695 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 5.7 m -46.13 140.07 5.29 Favored Pre-proline 0 C--O 1.244 0.814 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 -179.141 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -68.14 148.36 74.89 Favored 'Trans proline' 0 C--O 1.24 0.598 0 C-N-CA 116.73 -1.713 . . . . 0.0 114.191 -175.687 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 26.0 mtp180 -124.96 162.15 25.1 Favored 'General case' 0 CA--C 1.501 -0.941 0 N-CA-C 106.692 -1.595 . . . . 0.0 106.692 177.401 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 62.4 m95 -132.72 133.51 43.59 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 179.256 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 80.5 m-85 -116.59 146.42 42.68 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 -178.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 82.9 t80 -94.85 134.04 37.93 Favored 'General case' 0 CA--C 1.509 -0.628 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 -175.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 11.5 m-85 -137.33 152.96 50.29 Favored 'General case' 0 N--CA 1.439 -0.988 0 N-CA-C 106.674 -1.602 . . . . 0.0 106.674 -175.69 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -91.96 159.38 15.77 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 112.338 0.495 . . . . 0.0 112.338 -173.709 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 15.2 tp -57.13 127.13 30.41 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.38 0.61 . . . . 0.0 110.088 179.749 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 71.04 28.66 70.04 Favored Glycine 0 N--CA 1.45 -0.422 0 N-CA-C 116.848 1.499 . . . . 0.0 116.848 175.435 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.4 ' HA ' ' HA ' ' A' ' 104' ' ' ASP . 24.0 p -89.42 146.12 24.87 Favored 'General case' 0 CA--C 1.508 -0.635 0 CA-C-N 119.487 1.644 . . . . 0.0 109.079 175.379 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 89.32 138.56 6.82 Favored Glycine 0 CA--C 1.527 0.812 0 O-C-N 123.822 0.701 . . . . 0.0 112.295 -178.306 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -70.87 -38.65 5.12 Favored 'Trans proline' 0 C--N 1.346 0.415 0 N-CA-C 116.977 1.876 . . . . 0.0 116.977 -176.007 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -102.3 17.77 22.63 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 -174.293 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -61.19 -41.53 96.99 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 115.375 -0.829 . . . . 0.0 111.776 -175.289 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 55.1 43.57 83.43 Favored Glycine 0 CA--C 1.518 0.219 0 CA-C-N 115.552 -0.749 . . . . 0.0 114.492 178.291 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 12.4 mt -132.66 103.88 13.27 Favored Pre-proline 0 N--CA 1.436 -1.139 0 N-CA-C 114.404 1.261 . . . . 0.0 114.404 -178.537 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -78.29 161.7 28.74 Favored 'Trans proline' 0 N--CA 1.461 -0.404 0 C-N-CA 122.168 1.912 . . . . 0.0 107.3 167.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 55.0 t80 -61.19 131.93 52.04 Favored 'General case' 0 C--N 1.32 -0.678 0 C-N-CA 120.274 -0.57 . . . . 0.0 110.257 -177.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 91.6 -6.73 80.18 Favored Glycine 0 C--O 1.227 -0.298 0 CA-C-O 119.407 -0.663 . . . . 0.0 114.622 179.277 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -68.6 130.76 43.8 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 118.647 1.224 . . . . 0.0 111.714 179.731 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 56.0 t30 -78.17 130.99 37.0 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.337 179.675 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 26.1 ttmt -156.18 155.81 33.11 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 106.983 -1.488 . . . . 0.0 106.983 -179.28 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 15.2 t0 -56.41 121.37 9.43 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.261 0.553 . . . . 0.0 111.719 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 68.58 33.4 76.44 Favored Glycine 0 N--CA 1.448 -0.536 0 CA-C-O 118.975 -0.903 . . . . 0.0 114.971 177.157 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 41.3 mm -125.66 129.46 72.68 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 CA-C-N 118.079 0.939 . . . . 0.0 112.091 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -130.34 125.24 59.19 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.841 174.277 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 96.9 m95 -90.94 138.28 31.72 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 113.631 0.975 . . . . 0.0 113.631 -176.353 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 13.9 m -138.87 149.66 23.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.547 0.689 . . . . 0.0 109.445 178.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -160.82 164.75 31.17 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 105.058 -2.201 . . . . 0.0 105.058 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 14.8 t -130.35 168.9 16.19 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 105.091 -2.188 . . . . 0.0 105.091 178.197 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -67.4 137.49 55.98 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 -179.284 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 97.76 -12.73 64.3 Favored Glycine 0 C--O 1.225 -0.416 0 CA-C-N 115.832 -0.622 . . . . 0.0 112.145 179.352 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -79.65 136.77 36.9 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 178.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 44.1 mt -87.15 138.05 31.82 Favored 'General case' 0 CA--C 1.512 -0.512 0 CA-C-O 121.43 0.633 . . . . 0.0 112.288 -177.279 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 60.3 t30 -84.46 66.95 9.72 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.849 -179.462 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -142.46 156.45 63.69 Favored Pre-proline 0 C--N 1.322 -0.629 0 N-CA-C 107.078 -1.453 . . . . 0.0 107.078 -178.316 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -70.93 153.69 63.42 Favored 'Trans proline' 0 CA--C 1.531 0.329 0 N-CA-C 114.227 0.818 . . . . 0.0 114.227 178.401 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -145.92 60.66 1.25 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 123.103 1.43 . . . . 0.0 111.356 178.877 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . 0.4 ' HA ' ' HA ' ' A' ' 75' ' ' THR . 16.7 p-10 -53.38 -39.48 64.25 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 113.229 -1.805 . . . . 0.0 112.789 178.024 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 48.2 p-80 -62.22 -8.21 5.34 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 115.071 1.508 . . . . 0.0 115.071 -178.116 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 57.9 mt -95.77 -45.32 13.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 177.683 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -74.19 -1.17 59.5 Favored Glycine 0 C--O 1.223 -0.543 0 N-CA-C 115.53 0.972 . . . . 0.0 115.53 -177.193 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 13.3 t -83.29 21.13 1.17 Allowed 'General case' 0 CA--C 1.542 0.672 0 CA-C-O 121.757 0.789 . . . . 0.0 111.542 -178.597 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.423 ' HD2' ' OD1' ' A' ' 114' ' ' ASN . 65.4 ttp85 -52.77 131.92 35.76 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.145 178.658 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 36.4 m120 -88.37 117.44 68.39 Favored Pre-proline 0 C--N 1.323 -0.549 0 N-CA-C 107.718 -1.215 . . . . 0.0 107.718 179.631 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -72.4 -13.39 27.84 Favored 'Trans proline' 0 C--O 1.216 -0.583 0 C-N-CA 117.243 -1.372 . . . . 0.0 112.817 -179.051 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -78.49 -26.93 46.12 Favored 'General case' 0 C--O 1.219 -0.506 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.638 177.3 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 -102.21 -24.86 13.87 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 113.203 0.816 . . . . 0.0 113.203 -174.795 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . 0.423 ' OD1' ' HD2' ' A' ' 109' ' ' ARG . 5.6 t-20 -128.7 147.2 50.74 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 113.508 0.929 . . . . 0.0 113.508 -178.229 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -95.93 129.92 43.05 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 107.686 -1.228 . . . . 0.0 107.686 173.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -64.65 151.51 44.7 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.441 -0.8 . . . . 0.0 112.28 -178.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 4.0 mt -89.83 144.11 9.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.288 -0.869 . . . . 0.0 109.692 -177.508 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 72.5 t -60.8 124.54 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 175.111 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 6.7 tt -69.07 128.07 35.36 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.181 0.515 . . . . 0.0 109.736 -178.577 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 33.0 mt-30 -133.4 157.87 44.46 Favored 'General case' 0 CA--C 1.511 -0.526 0 N-CA-C 106.785 -1.561 . . . . 0.0 106.785 -178.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 13.4 mt -112.88 148.05 38.52 Favored Pre-proline 0 C--N 1.32 -0.688 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 178.022 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -73.97 167.54 26.97 Favored 'Trans proline' 0 C--O 1.237 0.459 0 O-C-N 122.291 0.627 . . . . 0.0 112.837 179.376 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 60.8 tt0 -54.46 134.04 45.94 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.265 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 100.42 -28.19 16.94 Favored Glycine 0 C--O 1.227 -0.315 0 CA-C-N 115.944 -0.571 . . . . 0.0 112.867 -179.297 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 4.1 m -100.04 128.87 46.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 118.4 1.1 . . . . 0.0 112.116 179.451 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 3.2 p -120.35 148.11 44.17 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.188 178.695 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 90.3 mt -71.5 153.18 93.83 Favored Pre-proline 0 C--N 1.323 -0.559 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 178.408 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -75.19 168.72 24.09 Favored 'Trans proline' 0 N--CA 1.463 -0.299 0 C-N-CA 118.508 -0.528 . . . . 0.0 111.005 178.599 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 53.0 tptt -59.59 130.23 45.83 Favored 'General case' 0 C--N 1.324 -0.539 0 O-C-N 122.199 -0.313 . . . . 0.0 111.018 -176.564 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 95.15 -10.64 69.74 Favored Glycine 0 C--O 1.23 -0.124 0 CA-C-N 115.547 -0.752 . . . . 0.0 114.846 178.33 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -95.41 144.41 25.95 Favored 'General case' 0 N--CA 1.436 -1.168 0 CA-C-O 122.39 1.091 . . . . 0.0 110.53 179.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 38.1 p90 -143.13 164.76 29.27 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 113.168 -1.833 . . . . 0.0 107.892 175.484 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -108.22 153.53 23.06 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.08 0.466 . . . . 0.0 110.446 -176.648 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -90.12 132.22 35.55 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.322 -178.813 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 97.2 -33.76 5.57 Favored Glycine 0 C--O 1.225 -0.414 0 CA-C-N 116.044 -0.525 . . . . 0.0 113.102 179.082 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -74.02 130.19 39.34 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-O 121.798 0.808 . . . . 0.0 111.121 179.402 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 25.8 tpt180 -143.54 153.12 42.25 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 105.233 -2.136 . . . . 0.0 105.233 178.526 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -129.34 -71.76 0.13 Allowed Glycine 0 C--O 1.224 -0.516 0 N-CA-C 109.067 -1.613 . . . . 0.0 109.067 179.548 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -79.9 163.62 47.75 Favored Glycine 0 N--CA 1.452 -0.253 0 N-CA-C 105.835 -2.906 . . . . 0.0 105.835 173.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 32.4 t . . . . . 0 C--O 1.246 0.888 0 CA-C-N 118.088 0.944 . . . . 0.0 110.292 -178.736 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.701 0 CA-C-O 118.495 -1.169 . . . . 0.0 111.109 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -71.22 135.79 47.7 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 177.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 96.4 mtp -136.31 54.76 1.88 Allowed 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 -179.245 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -93.46 -91.1 1.58 Allowed Glycine 0 C--O 1.224 -0.528 0 CA-C-N 115.839 -0.619 . . . . 0.0 113.108 -178.677 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 99.1 mt -128.52 146.15 58.82 Favored Pre-proline 0 C--N 1.327 -0.372 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 179.353 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -75.54 -20.37 15.9 Favored 'Trans proline' 0 C--N 1.347 0.467 0 N-CA-C 114.18 0.8 . . . . 0.0 114.18 -179.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -104.97 -46.73 4.2 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 109.762 -0.458 . . . . 0.0 109.762 179.091 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 21.5 t30 56.35 32.14 19.95 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.112 0.965 . . . . 0.0 113.599 174.54 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 36.0 p -85.62 87.59 7.42 Favored 'General case' 0 C--O 1.24 0.584 0 CA-C-O 122.008 0.909 . . . . 0.0 108.613 -178.011 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -92.62 141.54 28.37 Favored 'General case' 0 N--CA 1.443 -0.822 0 CA-C-N 115.094 -0.957 . . . . 0.0 111.473 -175.562 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -58.59 140.6 54.12 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 114.635 -1.166 . . . . 0.0 110.808 178.67 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 26.5 m95 -73.05 -21.95 60.7 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 114.906 1.447 . . . . 0.0 114.906 -178.217 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -121.47 156.15 33.39 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-O 121.015 0.436 . . . . 0.0 111.867 -174.454 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 75.9 p -68.6 162.99 24.68 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.745 -1.116 . . . . 0.0 110.078 -179.647 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -79.61 126.62 31.14 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 116.299 1.963 . . . . 0.0 116.299 -174.481 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -74.32 121.28 21.1 Favored 'General case' 0 N--CA 1.438 -1.029 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 170.272 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 56.7 m -87.19 126.92 35.11 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 -176.309 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 3.2 tm0? -88.27 135.02 33.65 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 -179.685 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 37.8 t60 -139.36 99.49 3.75 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 169.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 162.34 -161.37 33.5 Favored Glycine 0 C--O 1.226 -0.355 0 C-N-CA 120.008 -1.091 . . . . 0.0 113.371 -179.481 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -105.59 -24.09 12.65 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -85.68 153.55 22.27 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 178.612 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -78.22 -62.81 1.56 Allowed 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 120.598 -0.441 . . . . 0.0 110.964 -176.315 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 58.2 tp 173.66 145.62 0.05 OUTLIER 'General case' 0 N--CA 1.485 1.316 0 N-CA-C 106.104 -1.813 . . . . 0.0 106.104 174.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 2.5 tppp? -158.92 140.87 13.67 Favored 'General case' 0 C--O 1.223 -0.336 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 175.325 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 20.9 m-85 -127.24 151.49 74.64 Favored Pre-proline 0 C--N 1.325 -0.499 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 174.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -73.7 162.68 39.08 Favored 'Trans proline' 0 C--N 1.349 0.574 0 O-C-N 122.183 0.57 . . . . 0.0 113.269 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 16.6 tpt180 -64.59 133.3 52.0 Favored 'General case' 0 C--O 1.218 -0.605 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.647 -178.344 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 79.83 15.66 78.79 Favored Glycine 0 C--O 1.221 -0.671 0 CA-C-N 116.252 -0.431 . . . . 0.0 112.248 178.543 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.564 HE22 HG22 ' A' ' 125' ' ' THR . 0.9 OUTLIER -151.86 170.59 19.44 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 -175.094 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 99.53 -8.61 60.28 Favored Glycine 0 C--O 1.222 -0.656 0 N-CA-C 114.501 0.561 . . . . 0.0 114.501 174.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 96.4 t -69.21 130.92 90.75 Favored Pre-proline 0 C--N 1.319 -0.729 0 N-CA-C 106.471 -1.677 . . . . 0.0 106.471 176.747 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -70.11 174.5 9.71 Favored 'Trans proline' 0 C--O 1.223 -0.228 0 O-C-N 122.314 0.639 . . . . 0.0 113.22 178.659 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 74.2 mt -75.65 105.64 4.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 122.3 1.048 . . . . 0.0 108.485 179.765 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 50.8 m-20 -100.6 79.64 2.11 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 113.96 -1.473 . . . . 0.0 109.027 -176.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 69.7 p -66.65 -22.43 66.1 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 114.797 1.406 . . . . 0.0 114.797 -175.039 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 10.5 p30 -120.87 30.28 6.96 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 -176.022 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -128.59 157.24 41.81 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 179.134 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.6 p -74.18 162.22 74.84 Favored Pre-proline 0 C--N 1.321 -0.64 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 -179.426 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -65.89 -20.54 58.1 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 115.78 -2.346 . . . . 0.0 112.561 177.222 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.408 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 3.3 p-10 -75.19 -21.89 58.38 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 119.636 -0.825 . . . . 0.0 110.747 179.785 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 31.3 t0 -89.92 0.82 56.85 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 114.147 1.166 . . . . 0.0 114.147 -175.401 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 91.4 mm-40 -63.21 -28.11 69.82 Favored 'General case' 0 C--N 1.318 -0.786 0 O-C-N 121.047 -1.033 . . . . 0.0 111.634 -179.787 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 12.8 tt -66.58 137.84 24.09 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-O 122.259 1.028 . . . . 0.0 111.531 178.08 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 178.4 -158.08 22.44 Favored Glycine 0 CA--C 1.505 -0.581 0 C-N-CA 120.443 -0.884 . . . . 0.0 111.456 -178.255 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 43.9 p90 -155.09 167.61 29.78 Favored 'General case' 0 C--N 1.319 -0.738 0 O-C-N 122.627 -0.337 . . . . 0.0 110.574 179.598 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 16.2 m-85 -109.16 141.9 40.72 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 176.356 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 62.4 ttt-85 -120.39 117.99 29.19 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 124.112 0.965 . . . . 0.0 112.346 -174.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 28.5 ttp85 -69.78 136.48 50.92 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 177.386 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -146.26 138.53 25.18 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.341 0.656 . . . . 0.0 110.281 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 14.1 t -160.21 153.1 21.42 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.082 0.468 . . . . 0.0 110.142 174.77 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 22.4 tpt180 -151.37 123.81 8.38 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 175.212 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 4.5 tmt_? -134.03 139.04 45.76 Favored 'General case' 0 CA--C 1.501 -0.928 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -141.53 179.2 2.26 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 N-CA-C 105.939 -1.874 . . . . 0.0 105.939 -176.55 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 8.1 ttm180 -131.32 111.99 12.36 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 175.726 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -77.67 169.51 54.73 Favored Glycine 0 C--O 1.229 -0.216 0 N-CA-C 108.699 -1.76 . . . . 0.0 108.699 176.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -65.44 -42.29 95.95 Favored Glycine 0 C--O 1.219 -0.826 0 C-N-CA 120.613 -0.804 . . . . 0.0 112.36 -177.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -90.57 14.45 13.18 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 122.617 1.199 . . . . 0.0 111.764 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 90.86 -12.37 69.09 Favored Glycine 0 C--N 1.314 -0.664 0 CA-C-N 113.958 -1.474 . . . . 0.0 115.979 175.697 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 4.4 mppt? -57.79 132.63 53.89 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.586 0.708 . . . . 0.0 109.409 179.358 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 26.1 ptm -132.43 -171.49 2.66 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 114.747 -1.115 . . . . 0.0 112.358 -176.147 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 60.9 mmtt -112.71 -119.72 0.3 Allowed 'General case' 0 C--O 1.219 -0.519 0 C-N-CA 123.477 0.711 . . . . 0.0 109.282 -178.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 57.8 m-20 -66.97 141.46 57.59 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 111.729 0.27 . . . . 0.0 111.729 -174.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 55.8 mt -87.94 -61.65 1.67 Allowed 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 177.318 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 71.0 p -112.35 166.12 11.61 Favored Pre-proline 0 C--O 1.243 0.724 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 178.231 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -73.31 163.81 36.88 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 116.3 -2.0 . . . . 0.0 112.416 177.168 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.44 160.83 39.13 Favored 'General case' 0 C--N 1.326 -0.423 0 O-C-N 122.148 -0.345 . . . . 0.0 110.847 179.037 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 67.0 m95 -117.74 133.98 55.38 Favored 'General case' 0 C--O 1.214 -0.777 0 C-N-CA 122.871 0.468 . . . . 0.0 111.067 -178.138 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 52.1 m-85 -110.39 163.29 13.82 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 106.438 -1.69 . . . . 0.0 106.438 179.041 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 81.0 t80 -110.81 138.25 47.44 Favored 'General case' 0 CA--C 1.51 -0.589 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 -179.066 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -137.6 136.47 37.56 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.114 -0.948 . . . . 0.0 108.548 -176.274 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 34.2 m-85 -70.66 159.52 34.28 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.012 178.469 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -53.56 127.72 26.36 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 113.106 0.78 . . . . 0.0 113.106 -177.181 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 64.47 33.45 87.27 Favored Glycine 0 C--O 1.224 -0.506 0 N-CA-C 115.434 0.934 . . . . 0.0 115.434 174.02 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 4.1 p -89.2 146.12 24.97 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 177.79 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 106.77 144.35 11.74 Favored Glycine 0 CA--C 1.521 0.455 0 N-CA-C 108.12 -1.992 . . . . 0.0 108.12 -175.463 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -70.0 -40.21 5.2 Favored 'Trans proline' 0 C--N 1.346 0.4 0 CA-C-N 119.652 1.726 . . . . 0.0 116.12 -173.733 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -113.81 24.33 12.2 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.69 -0.687 . . . . 0.0 110.662 -176.637 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -57.86 -44.28 86.49 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 113.052 0.76 . . . . 0.0 113.052 -176.055 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 57.26 22.99 46.04 Favored Glycine 0 CA--C 1.522 0.484 0 N-CA-C 115.59 0.996 . . . . 0.0 115.59 178.706 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 19.1 mt -105.9 103.96 46.84 Favored Pre-proline 0 C--O 1.238 0.472 0 N-CA-C 114.117 1.155 . . . . 0.0 114.117 -176.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -76.77 165.64 28.33 Favored 'Trans proline' 0 N--CA 1.462 -0.345 0 C-N-CA 121.12 1.213 . . . . 0.0 109.171 172.656 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.41 ' CE1' ' HB3' ' A' ' 92' ' ' TRP . 74.4 t80 -62.37 131.88 50.75 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 120.398 -0.521 . . . . 0.0 110.359 -179.485 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 90.07 -1.33 80.11 Favored Glycine 0 CA--C 1.518 0.235 0 CA-C-O 119.834 -0.426 . . . . 0.0 113.903 178.36 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -61.73 130.26 44.94 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 117.667 0.733 . . . . 0.0 111.348 178.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 54.3 t30 -79.42 120.63 24.1 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.452 -178.639 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 50.4 tttm -153.71 149.95 28.03 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 179.396 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -66.03 134.95 53.96 Favored 'General case' 0 C--O 1.238 0.49 0 CA-C-O 120.809 0.338 . . . . 0.0 110.405 179.179 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 70.65 23.57 77.63 Favored Glycine 0 N--CA 1.45 -0.397 0 CA-C-O 119.419 -0.656 . . . . 0.0 113.637 178.616 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 42.2 mm -129.59 130.83 67.2 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 CA-C-N 117.385 0.592 . . . . 0.0 110.401 -179.51 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.1 pt -135.59 120.18 27.03 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 CA-C-O 121.387 0.613 . . . . 0.0 110.251 176.196 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . 0.41 ' HB3' ' CE1' ' A' ' 83' ' ' TYR . 93.6 m95 -87.8 137.61 32.19 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 113.087 0.773 . . . . 0.0 113.087 -176.087 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 18.9 m -137.04 154.41 31.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 179.108 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -160.33 166.58 29.17 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 106.465 -1.68 . . . . 0.0 106.465 -178.368 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 11.3 t -138.8 174.73 10.22 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 105.618 -1.993 . . . . 0.0 105.618 177.278 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 59.8 tt0 -67.45 137.43 55.86 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.324 0.583 . . . . 0.0 110.861 -179.011 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 95.26 -11.85 68.63 Favored Glycine 0 N--CA 1.46 0.268 0 CA-C-N 115.756 -0.657 . . . . 0.0 113.3 178.053 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.408 ' HA ' ' HA ' ' A' ' 41' ' ' ASP . . . -76.57 143.05 40.54 Favored 'General case' 0 C--N 1.322 -0.592 0 O-C-N 122.598 -0.354 . . . . 0.0 110.541 179.441 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 46.2 mt -105.4 134.37 48.63 Favored 'General case' 0 CA--C 1.513 -0.459 0 N-CA-C 113.855 1.057 . . . . 0.0 113.855 -178.14 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -79.24 65.58 4.45 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.223 -0.899 . . . . 0.0 111.142 -178.548 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.414 HG23 ' HZ3' ' A' ' 103' ' ' LYS . 1.2 t -134.77 156.18 78.79 Favored Pre-proline 0 C--N 1.322 -0.629 0 N-CA-C 105.359 -2.089 . . . . 0.0 105.359 -179.408 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -65.93 153.11 79.48 Favored 'Trans proline' 0 C--N 1.344 0.322 0 N-CA-C 115.05 1.135 . . . . 0.0 115.05 179.34 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.414 ' HZ3' HG23 ' A' ' 101' ' ' THR . 72.0 mmtt -122.94 32.46 5.7 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.201 -0.909 . . . . 0.0 109.149 -178.619 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 15.4 p-10 -50.92 -44.24 60.08 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.989 -177.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 16.0 p80 -69.78 -8.92 52.28 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 114.015 1.117 . . . . 0.0 114.015 -178.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 33.8 mt -96.15 -41.7 11.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 O-C-N 122.186 -0.321 . . . . 0.0 110.214 179.186 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -68.44 14.75 0.66 Allowed Glycine 0 N--CA 1.466 0.67 0 N-CA-C 117.995 1.958 . . . . 0.0 117.995 -176.224 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 8.9 t -90.27 28.77 1.36 Allowed 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 123.695 0.798 . . . . 0.0 111.976 -178.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 73.9 ttp85 -57.75 121.4 10.36 Favored 'General case' 0 N--CA 1.474 0.737 0 O-C-N 121.451 -0.781 . . . . 0.0 109.956 -179.684 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 63.3 m-20 -90.57 118.09 68.46 Favored Pre-proline 0 C--N 1.322 -0.591 0 N-CA-C 106.174 -1.788 . . . . 0.0 106.174 179.618 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -71.09 -14.79 32.11 Favored 'Trans proline' 0 C--O 1.218 -0.523 0 C-N-CA 117.902 -0.932 . . . . 0.0 113.384 -177.052 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -75.53 -26.8 58.37 Favored 'General case' 0 C--O 1.22 -0.484 0 CA-C-O 120.858 0.361 . . . . 0.0 110.41 177.565 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 -104.33 -26.51 12.43 Favored 'General case' 0 C--O 1.222 -0.358 0 N-CA-C 113.284 0.846 . . . . 0.0 113.284 -174.314 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 25.5 t30 -146.0 143.99 29.81 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 -178.062 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -87.29 149.71 24.36 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.731 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -68.71 146.76 52.68 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 177.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 9.0 mt -78.61 134.58 27.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 -178.642 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 98.8 t -63.14 118.96 5.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 106.423 -1.695 . . . . 0.0 106.423 176.404 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 5.0 tt -67.02 125.31 25.61 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.398 0.618 . . . . 0.0 110.796 -176.303 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -132.7 161.02 35.06 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 105.6 -2.0 . . . . 0.0 105.6 179.452 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 20.1 mt -117.2 146.33 37.91 Favored Pre-proline 0 C--N 1.322 -0.594 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 179.435 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -73.14 171.58 17.29 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 121.183 1.256 . . . . 0.0 114.522 -175.463 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 39.6 tt0 -53.41 129.99 33.93 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.874 -179.311 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 90.99 -16.03 59.52 Favored Glycine 0 C--O 1.226 -0.357 0 CA-C-N 115.963 -0.562 . . . . 0.0 113.229 -179.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.564 HG22 HE22 ' A' ' 30' ' ' GLN . 19.2 m -108.61 127.15 53.71 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 179.501 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 4.8 p -125.28 148.28 48.75 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.754 0.312 . . . . 0.0 110.668 -176.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 84.8 mt -66.41 152.23 94.88 Favored Pre-proline 0 C--N 1.327 -0.406 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 177.197 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -76.83 168.1 24.11 Favored 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 117.747 -1.035 . . . . 0.0 110.859 -179.571 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -59.44 126.73 28.79 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 91.58 27.96 15.84 Favored Glycine 0 C--O 1.224 -0.5 0 N-CA-C 114.938 0.735 . . . . 0.0 114.938 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -139.07 147.42 41.99 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 117.701 0.75 . . . . 0.0 111.369 177.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 54.0 p90 -153.93 165.22 36.8 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 176.401 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -100.25 142.03 32.28 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 114.146 1.165 . . . . 0.0 114.146 -175.375 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -67.96 140.63 56.42 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 107.181 -1.415 . . . . 0.0 107.181 175.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 90.7 -34.79 4.07 Favored Glycine 0 C--O 1.23 -0.151 0 C-N-CA 121.457 -0.401 . . . . 0.0 112.327 -179.055 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 22.9 t -71.89 102.64 2.95 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 179.671 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 52.01 46.94 25.74 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 122.39 1.09 . . . . 0.0 110.037 -177.2 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -89.64 -39.79 6.16 Favored Glycine 0 C--O 1.225 -0.415 0 CA-C-N 114.7 -1.136 . . . . 0.0 112.9 -179.391 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -132.97 -167.86 11.81 Favored Glycine 0 C--O 1.235 0.2 0 N-CA-C 109.998 -1.241 . . . . 0.0 109.998 -178.818 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 46.8 t . . . . . 0 C--O 1.251 1.161 0 N-CA-C 104.888 -2.264 . . . . 0.0 104.888 179.474 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.827 0 CA-C-O 118.476 -1.18 . . . . 0.0 111.018 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -74.16 150.3 40.49 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 105.273 -2.121 . . . . 0.0 105.273 175.605 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 22.0 ptt? -127.27 8.36 6.58 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.886 0.851 . . . . 0.0 110.962 -178.846 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -175.84 124.78 1.01 Allowed Glycine 0 N--CA 1.437 -1.256 0 N-CA-C 104.54 -3.424 . . . . 0.0 104.54 -175.154 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 80.4 mt -131.07 141.82 43.34 Favored Pre-proline 0 C--N 1.314 -0.95 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 177.986 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -77.4 163.89 29.37 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 118.133 -0.778 . . . . 0.0 111.488 177.161 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 58.9 t30 -63.73 -34.86 78.83 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.026 0.441 . . . . 0.0 109.834 176.541 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 -168.23 -73.69 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.036 175.838 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 66.0 p 41.71 77.5 0.06 Allowed 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 116.573 2.064 . . . . 0.0 116.573 179.355 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -101.2 145.0 29.38 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.105 178.8 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 58.3 p -61.62 145.18 52.98 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.752 178.633 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 15.8 m95 -67.93 -24.13 65.16 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 112.609 0.596 . . . . 0.0 112.609 179.392 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 25.8 m-85 -121.48 163.35 18.94 Favored 'General case' 0 CA--C 1.505 -0.754 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -172.156 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 70.1 p -70.64 164.17 25.51 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 176.528 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -80.5 152.04 28.91 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.449 0.642 . . . . 0.0 112.656 -176.871 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 21.8 mt -85.02 146.37 27.22 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 102.753 -3.055 . . . . 0.0 102.753 168.605 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 52.4 m -119.64 129.51 54.63 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 179.528 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -85.34 133.25 34.15 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.648 -179.412 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 21.9 t-160 -139.16 94.94 2.86 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 103.533 -2.766 . . . . 0.0 103.533 168.591 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 166.46 -131.26 2.32 Favored Glycine 0 C--O 1.226 -0.379 0 C-N-CA 120.184 -1.008 . . . . 0.0 113.119 -174.902 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 64.1 mttm -130.96 -38.5 1.25 Allowed 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 116.973 2.212 . . . . 0.0 116.973 -176.327 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -75.62 163.32 27.45 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 179.513 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -72.22 -62.66 1.35 Allowed 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 178.284 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 48.4 tp 174.47 134.2 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 104.843 -2.28 . . . . 0.0 104.843 173.256 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 11.1 tmtt? -148.24 127.51 13.0 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 118.403 0.547 . . . . 0.0 111.386 178.266 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 16.0 m-85 -113.22 153.16 45.54 Favored Pre-proline 0 C--O 1.243 0.716 0 CA-C-O 120.562 0.22 . . . . 0.0 111.306 176.811 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.42 162.57 41.38 Favored 'Trans proline' 0 C--N 1.353 0.765 0 C-N-CA 120.02 0.48 . . . . 0.0 112.541 177.594 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 16.9 tpt180 -69.93 134.63 48.6 Favored 'General case' 0 C--O 1.216 -0.704 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 -176.837 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 78.92 15.1 81.21 Favored Glycine 0 C--O 1.224 -0.506 0 C-N-CA 121.136 -0.554 . . . . 0.0 111.908 178.859 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 8.9 mt-30 -151.63 170.49 19.57 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 -175.291 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 108.09 -16.73 35.6 Favored Glycine 0 CA--C 1.501 -0.805 0 CA-C-N 116.236 -0.438 . . . . 0.0 112.676 175.373 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 95.0 t -65.7 129.29 94.3 Favored Pre-proline 0 C--N 1.319 -0.718 0 N-CA-C 106.968 -1.494 . . . . 0.0 106.968 177.41 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -73.29 170.33 20.14 Favored 'Trans proline' 0 N--CA 1.461 -0.422 0 O-C-N 122.17 0.563 . . . . 0.0 111.297 177.869 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 91.6 mt -69.39 107.63 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 179.829 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 -97.67 84.75 3.44 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 114.409 -1.269 . . . . 0.0 109.857 -176.817 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 69.8 p -66.59 -15.65 63.59 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.647 -0.706 . . . . 0.0 112.699 -178.869 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -107.32 22.62 15.7 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.152 -0.931 . . . . 0.0 112.162 -177.917 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 14.3 m -141.92 148.06 38.06 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 114.518 1.303 . . . . 0.0 114.518 -176.233 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -74.65 168.35 27.9 Favored Pre-proline 0 N--CA 1.468 0.46 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 176.424 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -64.65 -28.98 60.6 Favored 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 114.807 -2.996 . . . . 0.0 112.3 178.756 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -62.92 -24.07 67.67 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 123.74 0.816 . . . . 0.0 111.667 176.289 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 70.3 m-20 -98.93 -1.49 39.86 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 114.865 1.431 . . . . 0.0 114.865 -172.354 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 93.7 mm-40 -60.36 -29.26 68.8 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 114.459 1.281 . . . . 0.0 114.459 -178.888 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 20.8 tt -58.61 139.65 18.0 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.882 0 CA-C-O 122.32 1.057 . . . . 0.0 113.774 -177.296 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -179.18 -156.65 17.91 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.434 -178.738 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 46.6 p90 -155.12 171.52 19.65 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 178.653 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 19.9 m-85 -113.15 139.45 48.74 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 106.365 -1.717 . . . . 0.0 106.365 173.131 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 55.8 ttt180 -110.33 119.71 40.09 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.033 -176.951 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 11.8 ttp180 -65.92 137.92 57.49 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 177.431 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -143.8 142.67 31.0 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.772 0.796 . . . . 0.0 111.266 -179.976 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 41.4 p -142.99 172.49 12.63 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 102.284 -3.228 . . . . 0.0 102.284 174.995 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 17.9 tpt180 -140.62 125.98 18.79 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 120.345 -0.542 . . . . 0.0 111.025 176.557 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.26 148.11 33.12 Favored 'General case' 0 CA--C 1.488 -1.436 0 CA-C-O 121.611 0.719 . . . . 0.0 109.537 179.604 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -144.61 179.61 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.055 0 N-CA-C 102.123 -3.288 . . . . 0.0 102.123 178.804 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 79.2 ttt180 -132.7 121.16 22.68 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 175.295 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -97.33 147.07 18.53 Favored Glycine 0 N--CA 1.448 -0.547 0 N-CA-C 106.582 -2.607 . . . . 0.0 106.582 175.543 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -68.73 -30.94 72.72 Favored Glycine 0 C--O 1.216 -1.016 0 N-CA-C 109.798 -1.321 . . . . 0.0 109.798 179.507 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 30.7 t0 -87.26 17.02 4.62 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-O 122.016 0.912 . . . . 0.0 111.394 179.99 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 84.93 -6.49 78.63 Favored Glycine 0 C--O 1.223 -0.55 0 N-CA-C 116.462 1.345 . . . . 0.0 116.462 174.196 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.13 132.11 47.16 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.959 0.885 . . . . 0.0 112.509 -179.277 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 91.6 mmm -121.79 179.38 4.51 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 113.81 -1.541 . . . . 0.0 108.485 -177.917 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 13.6 mmtt -111.41 -54.35 2.62 Favored 'General case' 0 C--O 1.215 -0.761 0 CA-C-O 120.857 0.36 . . . . 0.0 110.155 178.268 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 49.58 50.0 18.99 Favored 'General case' 0 C--N 1.323 -0.579 0 O-C-N 124.993 1.433 . . . . 0.0 113.867 174.972 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 63.9 mt -70.97 142.08 51.02 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 107.143 -1.429 . . . . 0.0 107.143 176.453 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 72.6 p -58.92 153.59 42.93 Favored Pre-proline 0 C--O 1.239 0.515 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -176.423 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -65.84 128.99 21.0 Favored 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 117.898 -0.935 . . . . 0.0 112.406 -178.918 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 18.1 mtt-85 -134.7 160.83 36.91 Favored 'General case' 0 CA--C 1.51 -0.592 0 CA-C-N 115.249 -0.887 . . . . 0.0 111.214 -176.499 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 57.6 m95 -129.49 129.19 44.25 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 178.152 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 40.4 m-85 -111.43 139.35 46.92 Favored 'General case' 0 C--O 1.217 -0.627 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 -178.491 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 92.0 t80 -86.9 136.64 32.88 Favored 'General case' 0 CA--C 1.509 -0.604 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 -177.973 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -141.77 144.91 34.22 Favored 'General case' 0 N--CA 1.441 -0.905 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 -175.434 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 -80.76 159.38 25.2 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 112.276 0.472 . . . . 0.0 112.276 -174.726 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 15.8 tp -58.1 126.95 29.7 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 121.363 0.602 . . . . 0.0 110.177 -179.423 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 85.21 16.73 64.11 Favored Glycine 0 C--O 1.221 -0.704 0 N-CA-C 116.086 1.195 . . . . 0.0 116.086 178.468 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 19.4 p -90.65 146.11 24.29 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 118.971 1.385 . . . . 0.0 111.187 179.941 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 113.98 143.86 8.55 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 -178.673 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -71.75 -39.13 3.63 Favored 'Trans proline' 0 C--N 1.347 0.496 0 CA-C-N 119.776 1.788 . . . . 0.0 114.978 -174.402 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -115.2 32.42 6.06 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 -178.766 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -60.81 -55.45 32.89 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.811 -0.631 . . . . 0.0 112.014 -176.177 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 56.54 23.88 44.68 Favored Glycine 0 CA--C 1.523 0.555 0 CA-C-N 116.277 -0.42 . . . . 0.0 114.09 -178.989 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 43.9 mt -105.59 111.18 64.81 Favored Pre-proline 0 N--CA 1.449 -0.483 0 N-CA-C 115.525 1.676 . . . . 0.0 115.525 -174.989 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -77.52 166.02 26.41 Favored 'Trans proline' 0 N--CA 1.461 -0.407 0 N-CA-C 108.388 -1.428 . . . . 0.0 108.388 169.274 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 64.1 t80 -63.14 132.51 52.05 Favored 'General case' 0 C--N 1.322 -0.602 0 O-C-N 121.947 -0.471 . . . . 0.0 109.958 -179.677 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 91.39 -4.91 80.6 Favored Glycine 0 CA--C 1.52 0.353 0 N-CA-C 114.637 0.615 . . . . 0.0 114.637 178.868 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -65.14 132.3 48.8 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 118.038 0.919 . . . . 0.0 112.357 179.781 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 50.1 t30 -74.96 125.9 29.87 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.863 -178.807 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 26.9 ttmt -156.26 151.6 26.7 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 107.178 -1.416 . . . . 0.0 107.178 177.321 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 15.6 t0 -61.97 129.63 41.82 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.013 0.435 . . . . 0.0 110.853 179.423 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 69.19 27.85 73.35 Favored Glycine 0 N--CA 1.447 -0.609 0 CA-C-N 115.82 -0.627 . . . . 0.0 114.319 176.032 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 45.1 mm -125.11 120.77 59.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 117.365 0.583 . . . . 0.0 110.062 178.764 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.1 pt -123.68 113.79 38.75 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 CA-C-O 121.896 0.855 . . . . 0.0 110.592 176.972 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 96.5 m95 -80.51 132.67 35.72 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.763 -0.653 . . . . 0.0 112.601 -176.978 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 17.0 m -135.59 149.7 28.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.795 0.807 . . . . 0.0 109.492 179.599 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -156.28 166.57 33.06 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 103.531 -2.766 . . . . 0.0 103.531 -179.282 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 14.5 t -131.53 168.94 16.8 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 104.221 -2.511 . . . . 0.0 104.221 177.522 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -65.41 134.17 52.91 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 -178.681 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 95.75 -7.06 67.75 Favored Glycine 0 C--O 1.226 -0.369 0 CA-C-N 116.004 -0.544 . . . . 0.0 113.529 179.4 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -80.51 135.42 36.11 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 122.096 -0.649 . . . . 0.0 109.823 179.029 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 37.0 mt -81.86 136.25 35.38 Favored 'General case' 0 CA--C 1.511 -0.529 0 CA-C-O 121.161 0.505 . . . . 0.0 111.479 -178.878 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 63.4 t30 -84.08 65.22 8.62 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.633 -179.664 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -140.1 153.75 69.55 Favored Pre-proline 0 C--N 1.324 -0.519 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 -178.553 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -66.85 149.89 83.23 Favored 'Trans proline' 0 C--N 1.344 0.319 0 N-CA-C 113.977 0.722 . . . . 0.0 113.977 177.252 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 1.5 ptpm? -149.15 55.51 0.99 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 123.036 1.398 . . . . 0.0 109.571 179.759 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 13.6 p-10 -54.92 -35.1 63.83 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 113.451 -1.704 . . . . 0.0 112.344 179.52 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 37.5 p-80 -60.3 -14.6 19.09 Favored 'General case' 0 C--O 1.219 -0.549 0 N-CA-C 114.728 1.381 . . . . 0.0 114.728 -177.839 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 62.8 mt -84.42 -39.16 14.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 178.515 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -74.16 14.6 3.8 Favored Glycine 0 C--O 1.221 -0.678 0 N-CA-C 116.126 1.211 . . . . 0.0 116.126 -176.558 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 11.5 t -94.29 23.11 5.35 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 117.968 0.884 . . . . 0.0 112.667 -178.038 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 65.3 ttp85 -55.91 133.65 51.56 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.387 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 15.1 m-20 -104.28 125.18 34.97 Favored Pre-proline 0 C--N 1.324 -0.523 0 N-CA-C 106.854 -1.536 . . . . 0.0 106.854 -179.389 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_endo -69.59 -18.51 37.75 Favored 'Trans proline' 0 C--O 1.217 -0.527 0 N-CA-C 114.037 0.745 . . . . 0.0 114.037 -177.903 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -73.63 -26.28 60.7 Favored 'General case' 0 C--O 1.22 -0.498 0 CA-C-O 120.877 0.37 . . . . 0.0 110.675 178.1 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -102.11 -23.93 14.0 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 113.142 0.793 . . . . 0.0 113.142 -174.978 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 26.8 t30 -154.55 148.37 25.52 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 112.578 0.584 . . . . 0.0 112.578 -178.361 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -88.94 149.1 23.46 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-O 121.432 0.634 . . . . 0.0 111.702 179.575 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -70.08 145.18 51.83 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.221 0.534 . . . . 0.0 110.446 178.369 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 14.4 mt -86.3 138.8 18.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 115.393 -0.821 . . . . 0.0 108.815 -178.601 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 75.6 t -61.16 123.9 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 N-CA-C 106.077 -1.823 . . . . 0.0 106.077 174.848 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 7.1 tt -66.84 130.11 42.07 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.134 0.492 . . . . 0.0 110.379 -177.021 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 30.2 mt-30 -132.72 157.94 43.62 Favored 'General case' 0 CA--C 1.511 -0.551 0 N-CA-C 106.615 -1.624 . . . . 0.0 106.615 -179.445 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 13.3 mt -112.31 148.18 38.59 Favored Pre-proline 0 C--N 1.322 -0.588 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 177.12 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -73.2 166.17 30.68 Favored 'Trans proline' 0 N--CA 1.462 -0.371 0 O-C-N 122.325 0.645 . . . . 0.0 112.933 -179.501 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 60.2 tp60 -54.27 130.37 38.56 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.887 -179.879 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 97.15 -17.12 59.73 Favored Glycine 0 C--O 1.227 -0.3 0 CA-C-N 115.907 -0.588 . . . . 0.0 113.611 -179.926 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 9.5 m -106.71 127.01 53.02 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 118.149 0.975 . . . . 0.0 109.984 178.288 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 17.3 p -120.02 148.32 43.71 Favored 'General case' 0 CA--C 1.511 -0.534 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.845 -179.132 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 88.8 mt -70.4 156.1 92.41 Favored Pre-proline 0 C--N 1.323 -0.561 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 177.559 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -74.55 169.11 23.26 Favored 'Trans proline' 0 C--O 1.236 0.406 0 C-N-CA 117.749 -1.034 . . . . 0.0 110.343 178.302 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 12.4 tmtt? -63.72 120.67 12.29 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 -176.823 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 95.18 37.94 4.98 Favored Glycine 0 N--CA 1.452 -0.257 0 N-CA-C 114.943 0.737 . . . . 0.0 114.943 178.942 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -142.31 146.15 34.73 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 176.85 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 48.6 p90 -147.11 162.38 38.94 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 176.627 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -97.68 143.26 28.53 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.042 0.449 . . . . 0.0 110.547 -178.345 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -71.34 135.84 47.54 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 178.812 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 87.87 -13.53 60.84 Favored Glycine 0 C--O 1.227 -0.299 0 CA-C-N 116.109 -0.496 . . . . 0.0 113.147 -178.24 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 35.2 t -89.51 124.7 34.75 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 178.733 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 6.0 tpt180 -141.88 34.4 1.58 Allowed 'General case' 0 C--O 1.219 -0.504 0 CA-C-O 121.347 0.594 . . . . 0.0 112.143 179.143 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -72.22 -18.39 78.02 Favored Glycine 0 C--O 1.224 -0.49 0 CA-C-O 122.315 0.953 . . . . 0.0 111.41 178.363 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -168.86 177.18 42.81 Favored Glycine 0 C--O 1.241 0.541 0 N-CA-C 104.378 -3.489 . . . . 0.0 104.378 178.345 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 43.6 t . . . . . 0 C--O 1.247 0.972 0 CA-C-O 116.209 -1.853 . . . . 0.0 106.139 179.962 . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.108 0 CA-C-O 118.766 -1.019 . . . . 0.0 111.328 . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -65.68 148.65 51.41 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 177.598 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 75.5 mtp -124.88 15.31 8.6 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -177.836 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -109.53 28.47 10.75 Favored Glycine 0 C--O 1.219 -0.792 0 CA-C-N 116.286 -0.416 . . . . 0.0 112.875 -178.326 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -71.12 142.33 87.29 Favored Pre-proline 0 C--N 1.32 -0.689 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 -178.654 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -68.08 151.01 77.74 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 117.238 -1.375 . . . . 0.0 111.504 178.079 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 66.9 t30 -140.82 72.06 1.38 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.578 0.704 . . . . 0.0 110.188 -176.988 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -77.24 23.38 0.2 Allowed 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 115.13 -0.941 . . . . 0.0 112.005 -177.615 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 16.9 p -140.89 129.69 23.0 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 104.67 -2.345 . . . . 0.0 104.67 -177.862 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -106.44 139.74 40.45 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 -179.78 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 62.5 p -63.06 141.07 58.9 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 178.865 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 10.9 m95 -67.95 -27.21 66.4 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.038 0.447 . . . . 0.0 111.772 178.716 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 20.1 m-85 -121.53 163.97 17.99 Favored 'General case' 0 C--O 1.242 0.68 0 CA-C-N 115.517 -0.765 . . . . 0.0 112.537 -171.349 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 63.7 p -70.19 166.5 19.87 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 177.096 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -83.58 148.17 27.32 Favored 'General case' 0 N--CA 1.443 -0.785 0 N-CA-C 113.529 0.937 . . . . 0.0 113.529 -175.371 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 15.6 mt -81.88 144.92 30.65 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 103.768 -2.679 . . . . 0.0 103.768 170.902 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 26.4 m -123.28 131.03 53.52 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.108 0.48 . . . . 0.0 110.052 -178.008 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -83.39 141.93 31.38 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.34 -0.845 . . . . 0.0 111.94 -178.627 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 23.0 t-160 -139.11 99.71 3.83 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 105.83 -1.915 . . . . 0.0 105.83 168.477 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 151.02 -134.59 4.76 Favored Glycine 0 C--N 1.322 -0.242 0 N-CA-C 111.134 -0.786 . . . . 0.0 111.134 -176.841 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 51.6 mttp -132.7 -16.1 2.65 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 114.993 1.479 . . . . 0.0 114.993 -179.351 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 59.7 mt-10 -73.98 155.49 38.55 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 107.1 -1.444 . . . . 0.0 107.1 178.027 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -82.17 -62.6 1.58 Allowed 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 120.458 -0.497 . . . . 0.0 109.791 -178.685 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 56.5 tp 168.58 136.7 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 103.661 -2.718 . . . . 0.0 103.661 175.411 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -157.01 138.87 14.3 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 176.511 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 25.6 m-85 -127.55 151.38 75.01 Favored Pre-proline 0 C--N 1.324 -0.531 0 O-C-N 123.307 0.379 . . . . 0.0 110.212 176.804 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -79.72 165.89 22.08 Favored 'Trans proline' 0 CA--C 1.541 0.83 0 C-N-CA 120.568 0.845 . . . . 0.0 113.03 176.755 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 2.2 tmt_? -67.3 138.33 56.75 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 116.548 -0.296 . . . . 0.0 110.257 -179.384 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 86.66 2.73 84.39 Favored Glycine 0 C--O 1.224 -0.503 0 N-CA-C 110.894 -0.883 . . . . 0.0 110.894 178.008 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.533 HE22 HG22 ' A' ' 125' ' ' THR . 27.6 mt-30 -143.86 -179.62 6.58 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 -175.14 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 95.54 -28.97 10.4 Favored Glycine 0 CA--C 1.5 -0.896 0 CA-C-N 115.794 -0.639 . . . . 0.0 113.555 174.716 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 91.6 t -64.14 127.3 91.78 Favored Pre-proline 0 C--N 1.319 -0.721 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 177.486 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -72.91 171.72 16.88 Favored 'Trans proline' 0 N--CA 1.461 -0.433 0 C-N-CA 120.128 0.552 . . . . 0.0 111.717 178.409 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 85.6 mt -69.21 107.89 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-O 122.299 1.047 . . . . 0.0 108.539 179.415 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 84.7 m-20 -98.45 86.33 3.58 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 114.122 -1.399 . . . . 0.0 109.874 -176.614 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 67.0 p -67.56 -15.79 63.84 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.525 -0.761 . . . . 0.0 112.627 -178.848 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 11.2 p30 -107.11 21.09 18.08 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 114.9 -1.046 . . . . 0.0 113.014 -177.31 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 9.9 m -140.16 150.38 44.15 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 115.741 1.756 . . . . 0.0 115.741 -174.817 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 4.6 m -72.49 166.28 43.49 Favored Pre-proline 0 N--CA 1.468 0.464 0 CA-C-N 115.415 -0.812 . . . . 0.0 109.553 176.22 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -66.03 -27.98 49.75 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 114.533 -3.178 . . . . 0.0 113.944 -179.805 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.404 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 5.6 p-10 -75.06 -21.55 58.92 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 121.66 -0.65 . . . . 0.0 111.213 177.113 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 75.0 m-20 -81.36 -10.53 59.52 Favored 'General case' 0 C--O 1.221 -0.415 0 N-CA-C 113.453 0.908 . . . . 0.0 113.453 -176.034 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 96.6 mm-40 -56.69 -27.29 58.65 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 115.155 1.539 . . . . 0.0 115.155 -176.59 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 19.7 tt -55.31 138.46 15.57 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.941 0 N-CA-C 114.418 1.266 . . . . 0.0 114.418 -178.077 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -176.88 -159.95 23.09 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.416 -0.897 . . . . 0.0 114.353 -179.406 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 44.8 p90 -154.92 170.47 21.63 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 179.242 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 17.6 m-85 -114.39 141.46 47.62 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 172.905 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 58.3 ttt180 -113.56 117.24 31.1 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 124.415 1.086 . . . . 0.0 110.992 -175.428 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 46.6 ttp180 -65.6 137.52 57.41 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 178.356 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -150.41 150.06 30.87 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.854 0.359 . . . . 0.0 111.149 -178.029 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 21.6 p -141.94 140.13 32.69 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.826 176.282 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 14.0 tpt180 -142.74 123.87 14.53 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 174.742 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.52 133.84 52.22 Favored 'General case' 0 CA--C 1.494 -1.187 0 CA-C-O 121.584 0.706 . . . . 0.0 110.963 -176.508 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -129.17 179.1 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.883 0 N-CA-C 105.472 -2.047 . . . . 0.0 105.472 178.238 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 27.8 tpt180 -139.57 107.93 5.83 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 106.803 -1.554 . . . . 0.0 106.803 172.502 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -74.17 156.61 50.36 Favored Glycine 0 N--CA 1.447 -0.568 0 N-CA-C 107.681 -2.168 . . . . 0.0 107.681 176.608 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -69.34 -33.23 72.66 Favored Glycine 0 C--O 1.216 -0.983 0 N-CA-C 108.62 -1.792 . . . . 0.0 108.62 179.373 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.1 t0 -84.75 16.61 3.19 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-O 122.55 1.167 . . . . 0.0 109.689 177.715 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 85.03 -14.6 48.35 Favored Glycine 0 N--CA 1.455 -0.086 0 N-CA-C 116.961 1.544 . . . . 0.0 116.961 173.457 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -55.91 142.01 37.15 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 114.968 1.469 . . . . 0.0 114.968 -176.74 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 95.3 mmm -116.48 177.98 4.5 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 112.543 -2.117 . . . . 0.0 109.475 -177.095 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 13.7 tppt? -126.28 -53.76 1.49 Allowed 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 178.208 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 -120.43 149.42 42.4 Favored 'General case' 0 CA--C 1.506 -0.716 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 178.499 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -133.49 -44.18 0.83 Allowed 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 104.306 -2.479 . . . . 0.0 104.306 176.256 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 33.3 t -112.02 153.27 44.63 Favored Pre-proline 0 C--O 1.243 0.748 0 N-CA-C 105.42 -2.066 . . . . 0.0 105.42 175.954 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -68.75 156.74 64.48 Favored 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 117.06 -1.494 . . . . 0.0 114.983 -179.381 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 94.0 mtt-85 -113.98 165.46 12.58 Favored 'General case' 0 CA--C 1.509 -0.6 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.523 178.015 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 49.8 m95 -132.03 129.47 40.11 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 176.247 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 17.0 m-85 -110.77 141.34 44.23 Favored 'General case' 0 C--O 1.216 -0.658 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 -176.863 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -88.7 136.87 32.78 Favored 'General case' 0 CA--C 1.506 -0.732 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 -176.527 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -141.36 143.44 33.99 Favored 'General case' 0 N--CA 1.438 -1.032 0 N-CA-C 106.976 -1.491 . . . . 0.0 106.976 -175.888 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 66.8 m-85 -82.94 159.35 22.29 Favored 'General case' 0 C--N 1.317 -0.842 0 O-C-N 122.21 -0.306 . . . . 0.0 110.94 -175.342 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 15.4 tp -54.59 131.49 43.16 Favored 'General case' 0 C--O 1.218 -0.583 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 179.452 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 74.54 25.43 70.22 Favored Glycine 0 C--O 1.225 -0.466 0 N-CA-C 115.8 1.08 . . . . 0.0 115.8 177.633 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 49.8 p -108.78 146.17 34.02 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 118.421 1.11 . . . . 0.0 110.279 176.167 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 110.04 132.62 6.37 Favored Glycine 0 CA--C 1.522 0.495 0 N-CA-C 108.722 -1.751 . . . . 0.0 108.722 -176.677 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -66.61 -43.2 7.96 Favored 'Trans proline' 0 C--N 1.347 0.485 0 CA-C-N 119.776 1.788 . . . . 0.0 115.184 -174.457 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 90.9 mt-10 -110.07 31.13 6.11 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 -179.442 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -66.04 -48.32 71.49 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.553 -178.396 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 54.56 41.6 73.9 Favored Glycine 0 N--CA 1.46 0.279 0 C-N-CA 121.288 -0.482 . . . . 0.0 112.19 179.744 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 15.4 mt -124.61 104.32 31.02 Favored Pre-proline 0 N--CA 1.442 -0.858 0 N-CA-C 115.291 1.589 . . . . 0.0 115.291 -175.218 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -78.59 161.83 27.77 Favored 'Trans proline' 0 N--CA 1.461 -0.393 0 C-N-CA 122.516 2.144 . . . . 0.0 107.229 167.596 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 49.7 t80 -61.46 133.54 55.87 Favored 'General case' 0 C--N 1.319 -0.718 0 C-N-CA 120.425 -0.51 . . . . 0.0 110.283 -177.331 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 90.68 -8.62 79.53 Favored Glycine 0 CA--C 1.518 0.278 0 CA-C-O 119.518 -0.601 . . . . 0.0 114.394 179.599 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -66.3 130.3 42.76 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 118.569 1.184 . . . . 0.0 111.624 179.669 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 48.8 t-20 -80.25 130.33 35.13 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.479 -179.441 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 28.0 ttmt -156.1 154.56 31.12 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 106.865 -1.531 . . . . 0.0 106.865 -179.844 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -58.78 124.04 18.43 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.914 0.388 . . . . 0.0 110.868 -179.164 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 69.31 31.48 71.59 Favored Glycine 0 N--CA 1.449 -0.446 0 CA-C-O 119.044 -0.864 . . . . 0.0 115.029 177.556 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 43.2 mm -124.71 127.67 72.89 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 CA-C-N 118.045 0.922 . . . . 0.0 110.992 179.534 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -129.49 123.51 57.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.4 176.357 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 98.7 m95 -88.34 138.14 31.7 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 114.05 1.13 . . . . 0.0 114.05 -176.241 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 16.2 m -139.0 149.8 23.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 121.693 0.759 . . . . 0.0 110.053 178.936 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -159.22 161.12 36.04 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 103.915 -2.624 . . . . 0.0 103.915 178.405 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 13.9 t -118.23 172.78 7.2 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 105.227 -2.138 . . . . 0.0 105.227 178.559 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -66.43 131.95 47.19 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.811 0.339 . . . . 0.0 110.238 -178.624 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 90.98 -4.1 81.28 Favored Glycine 0 CA--C 1.519 0.283 0 C-N-CA 121.359 -0.448 . . . . 0.0 113.746 178.806 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.404 ' HA ' ' HA ' ' A' ' 41' ' ' ASP . . . -73.83 136.06 43.48 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 178.44 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 30.3 mt -89.22 140.55 29.36 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.51 0.671 . . . . 0.0 112.195 -177.071 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 61.9 t30 -83.98 64.95 8.42 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.193 -179.304 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -137.46 155.84 75.29 Favored Pre-proline 0 C--N 1.322 -0.593 0 N-CA-C 106.438 -1.69 . . . . 0.0 106.438 -178.956 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -66.48 151.43 83.05 Favored 'Trans proline' 0 C--N 1.342 0.223 0 N-CA-C 115.359 1.253 . . . . 0.0 115.359 179.993 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -123.02 41.19 3.53 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 114.44 -1.254 . . . . 0.0 108.909 -178.757 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 18.3 p-10 -51.22 -43.4 61.43 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 114.235 -1.348 . . . . 0.0 111.329 178.848 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 46.5 p-80 -66.45 -10.94 49.19 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 124.567 1.147 . . . . 0.0 113.953 -178.839 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 50.4 mt -96.11 -38.22 8.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 179.806 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -74.58 1.74 50.63 Favored Glycine 0 C--O 1.225 -0.453 0 N-CA-C 115.59 0.996 . . . . 0.0 115.59 -177.759 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 14.7 t -83.39 18.8 1.69 Allowed 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 117.869 0.835 . . . . 0.0 112.753 -176.635 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.424 ' HD2' ' OD1' ' A' ' 114' ' ' ASN . 64.2 ttp85 -57.03 130.57 46.69 Favored 'General case' 0 N--CA 1.467 0.391 0 O-C-N 121.998 -0.439 . . . . 0.0 110.129 178.862 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 35.8 m120 -88.49 117.63 68.56 Favored Pre-proline 0 C--N 1.323 -0.546 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 179.843 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -72.76 -13.2 26.87 Favored 'Trans proline' 0 C--O 1.217 -0.531 0 C-N-CA 117.128 -1.448 . . . . 0.0 112.835 -179.528 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -78.4 -27.18 46.66 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.568 177.413 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 -102.06 -25.69 13.65 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 113.237 0.829 . . . . 0.0 113.237 -174.795 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . 0.424 ' OD1' ' HD2' ' A' ' 109' ' ' ARG . 5.0 t-20 -128.7 147.61 50.77 Favored 'General case' 0 N--CA 1.442 -0.829 0 N-CA-C 113.149 0.796 . . . . 0.0 113.149 -177.905 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -95.28 129.23 42.49 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 173.808 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -62.16 148.15 45.4 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.448 -0.796 . . . . 0.0 112.371 -178.236 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 9.8 mt -80.72 138.99 18.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 114.89 -1.05 . . . . 0.0 109.432 -177.832 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 79.5 t -63.11 123.38 15.76 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 N-CA-C 106.12 -1.807 . . . . 0.0 106.12 174.516 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 6.6 tt -65.63 130.48 43.46 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.258 0.552 . . . . 0.0 111.045 -176.876 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 31.0 mt-30 -132.99 159.02 41.21 Favored 'General case' 0 CA--C 1.513 -0.461 0 N-CA-C 106.729 -1.582 . . . . 0.0 106.729 -179.553 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 13.5 mt -112.97 146.73 35.72 Favored Pre-proline 0 C--N 1.323 -0.559 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 177.836 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -73.11 166.78 29.09 Favored 'Trans proline' 0 C--N 1.345 0.348 0 O-C-N 122.272 0.617 . . . . 0.0 113.038 -179.367 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 39.9 tt0 -54.89 131.53 44.53 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.902 179.998 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 95.8 -17.06 60.0 Favored Glycine 0 C--O 1.226 -0.371 0 CA-C-N 115.903 -0.589 . . . . 0.0 113.311 179.944 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.533 HG22 HE22 ' A' ' 30' ' ' GLN . 16.0 m -103.72 128.85 51.04 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 118.073 0.937 . . . . 0.0 111.032 178.811 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 5.8 p -117.23 148.26 41.79 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.795 -179.416 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 83.4 mt -71.23 157.8 89.41 Favored Pre-proline 0 C--N 1.324 -0.504 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 176.989 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -75.55 174.15 13.3 Favored 'Trans proline' 0 C--O 1.237 0.451 0 C-N-CA 117.514 -1.191 . . . . 0.0 109.866 178.367 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 64.1 tttm -62.06 125.94 25.61 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.437 0.636 . . . . 0.0 110.454 -177.141 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 82.31 45.44 6.99 Favored Glycine 0 C--O 1.226 -0.378 0 N-CA-C 115.275 0.87 . . . . 0.0 115.275 178.3 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -141.54 150.87 42.7 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 117.856 0.828 . . . . 0.0 111.476 177.852 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 42.6 p90 -149.95 165.61 32.12 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 176.65 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -101.92 145.32 29.4 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.155 0.502 . . . . 0.0 111.468 -177.993 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -72.69 127.83 33.73 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 179.964 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 92.21 -15.04 63.04 Favored Glycine 0 C--O 1.228 -0.224 0 CA-C-N 115.948 -0.569 . . . . 0.0 113.574 179.506 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 33.5 t -78.79 126.97 31.43 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 179.978 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 72.3 mtm-85 -144.82 157.99 43.96 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 179.584 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -93.65 -177.3 39.85 Favored Glycine 0 C--N 1.321 -0.299 0 N-CA-C 107.587 -2.205 . . . . 0.0 107.587 173.306 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -173.82 169.67 42.74 Favored Glycine 0 N--CA 1.45 -0.395 0 N-CA-C 107.076 -2.41 . . . . 0.0 107.076 178.737 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 14.4 m . . . . . 0 C--O 1.246 0.893 0 O-C-N 124.924 1.014 . . . . 0.0 110.579 -176.7 . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.215 0 CA-C-O 118.109 -1.384 . . . . 0.0 111.043 . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -103.14 14.77 31.0 Favored 'General case' 0 C--O 1.211 -0.926 0 N-CA-C 114.975 1.472 . . . . 0.0 114.975 -175.695 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 41.1 mtm 61.68 -9.44 0.08 Allowed 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 119.119 3.007 . . . . 0.0 119.119 178.47 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -79.02 65.64 3.53 Favored Glycine 0 C--N 1.309 -0.96 0 CA-C-N 114.932 -1.031 . . . . 0.0 114.066 -176.933 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 89.6 mt -83.74 134.13 45.12 Favored Pre-proline 0 C--N 1.32 -0.7 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 178.783 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -76.3 110.34 3.05 Favored 'Trans proline' 0 CA--C 1.534 0.5 0 C-N-CA 118.653 -0.432 . . . . 0.0 111.885 177.868 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 88.8 m-20 -87.41 -33.18 19.19 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 114.299 1.222 . . . . 0.0 114.299 -176.903 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -145.57 39.12 1.15 Allowed 'General case' 0 C--O 1.218 -0.602 0 CA-C-O 121.672 0.748 . . . . 0.0 111.661 -179.428 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 25.3 p -138.9 137.83 36.85 Favored 'General case' 0 CA--C 1.504 -0.803 0 N-CA-C 100.825 -3.768 . . . . 0.0 100.825 179.121 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -141.1 145.96 36.46 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-O 121.3 0.571 . . . . 0.0 111.137 -179.284 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 17.1 t -65.73 139.96 58.41 Favored 'General case' 0 CA--C 1.512 -0.513 0 N-CA-C 106.954 -1.499 . . . . 0.0 106.954 176.825 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 6.9 m95 -69.62 -21.91 63.53 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.136 0.493 . . . . 0.0 110.276 177.939 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 17.5 m-85 -121.42 161.91 21.35 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.393 -0.821 . . . . 0.0 112.452 -172.223 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.411 ' HB ' ' HB3' ' A' ' 134' ' ' GLU . 67.8 p -69.13 164.77 21.8 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 179.079 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -81.1 140.26 35.16 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 113.06 0.763 . . . . 0.0 113.06 -176.592 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 20.1 mt -78.82 148.22 32.95 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 103.576 -2.75 . . . . 0.0 103.576 170.614 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 16.2 m -130.12 134.76 47.56 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 118.189 0.45 . . . . 0.0 110.605 -178.005 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.405 ' HB2' ' CZ ' ' A' ' 131' ' ' PHE . 4.1 tp60 -100.87 141.56 33.58 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 -177.804 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 52.1 t60 -128.56 99.66 5.46 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 104.636 -2.357 . . . . 0.0 104.636 169.126 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 164.43 -158.76 31.54 Favored Glycine 0 N--CA 1.452 -0.251 0 N-CA-C 108.239 -1.945 . . . . 0.0 108.239 -175.892 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -115.59 -20.9 9.98 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 117.688 0.744 . . . . 0.0 111.127 179.18 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -72.11 153.69 41.53 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.201 -0.909 . . . . 0.0 109.121 178.701 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -82.23 -62.89 1.5 Allowed 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 113.905 1.076 . . . . 0.0 113.905 -176.832 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 50.1 tp 165.33 142.18 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.268 0 N-CA-C 105.815 -1.92 . . . . 0.0 105.815 179.025 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 51.8 tptt -157.25 139.6 14.67 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 173.46 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 16.3 m-85 -122.47 151.92 60.48 Favored Pre-proline 0 C--O 1.241 0.636 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 175.865 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -70.4 161.32 46.43 Favored 'Trans proline' 0 C--N 1.351 0.659 0 O-C-N 122.261 0.611 . . . . 0.0 112.496 178.625 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 22.7 tpt180 -67.83 135.55 52.75 Favored 'General case' 0 C--O 1.216 -0.673 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 -178.249 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 82.55 10.78 82.91 Favored Glycine 0 C--O 1.223 -0.565 0 C-N-CA 121.218 -0.515 . . . . 0.0 111.87 178.87 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 10.2 mt-30 -150.37 170.5 18.89 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 -175.116 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 105.68 -16.56 43.83 Favored Glycine 0 CA--C 1.503 -0.711 0 CA-C-N 116.289 -0.414 . . . . 0.0 113.393 174.887 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 94.1 t -65.75 130.03 94.43 Favored Pre-proline 0 C--N 1.319 -0.726 0 N-CA-C 106.273 -1.751 . . . . 0.0 106.273 177.027 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -72.64 171.17 17.76 Favored 'Trans proline' 0 N--CA 1.46 -0.468 0 O-C-N 122.194 0.576 . . . . 0.0 111.23 178.084 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 87.9 mt -71.01 107.06 2.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 179.801 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 -99.55 84.82 3.02 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.523 -1.217 . . . . 0.0 110.55 -176.329 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 75.7 p -67.97 -14.96 63.38 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.644 -0.707 . . . . 0.0 112.568 -179.204 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 12.5 p30 -108.48 21.71 16.93 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.15 -0.932 . . . . 0.0 112.871 -177.646 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 11.8 m -140.71 148.09 40.21 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 113.454 0.909 . . . . 0.0 113.454 -177.14 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -72.0 166.08 44.09 Favored Pre-proline 0 C--N 1.326 -0.418 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 177.068 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -64.8 -27.22 59.7 Favored 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 115.376 -2.616 . . . . 0.0 111.793 178.69 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -62.26 -28.77 69.94 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.786 0.803 . . . . 0.0 111.132 176.451 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -96.6 1.02 50.82 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 115.348 1.611 . . . . 0.0 115.348 -171.042 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 94.9 mm-40 -61.4 -30.1 70.34 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 113.841 1.052 . . . . 0.0 113.841 179.641 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 14.6 tt -61.22 138.0 22.65 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.789 0 CA-C-O 122.322 1.058 . . . . 0.0 113.346 -177.937 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 179.17 -155.55 16.29 Favored Glycine 0 N--CA 1.449 -0.447 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.468 -177.976 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 46.8 p90 -155.07 171.14 20.25 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 179.786 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 22.4 m-85 -111.56 138.92 47.46 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 173.813 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 40.4 ttt-85 -110.96 120.16 41.45 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 124.034 0.934 . . . . 0.0 110.298 -177.229 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 52.0 ttp180 -68.26 140.92 56.02 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 178.183 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -142.77 148.73 37.66 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.223 0.535 . . . . 0.0 110.344 179.231 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -158.14 154.22 27.08 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 104.387 -2.449 . . . . 0.0 104.387 176.252 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 20.9 tpt85 -150.81 133.02 15.39 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 177.462 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 72.4 ttt180 -143.38 153.2 42.46 Favored 'General case' 0 CA--C 1.496 -1.131 0 CA-C-O 121.835 0.826 . . . . 0.0 110.528 178.281 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -148.13 -179.68 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 N-CA-C 103.463 -2.791 . . . . 0.0 103.463 179.971 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.64 99.23 6.2 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 174.305 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -71.54 159.63 53.87 Favored Glycine 0 C--O 1.227 -0.308 0 N-CA-C 106.894 -2.482 . . . . 0.0 106.894 176.84 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -60.72 -42.49 99.41 Favored Glycine 0 C--O 1.222 -0.65 0 CA-C-N 118.867 1.333 . . . . 0.0 111.832 -179.486 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -92.82 17.02 11.14 Favored 'General case' 0 CA--C 1.546 0.825 0 CA-C-O 122.895 1.331 . . . . 0.0 110.782 178.822 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 90.06 -1.24 80.01 Favored Glycine 0 N--CA 1.462 0.402 0 N-CA-C 118.163 2.025 . . . . 0.0 118.163 169.145 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 2.1 mptp? -59.27 139.66 56.76 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.999 0.904 . . . . 0.0 111.992 -178.023 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 63.4 mtp -97.23 -178.26 4.11 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 113.419 -1.719 . . . . 0.0 109.475 178.041 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 5.4 tmtt? -109.94 -55.71 2.41 Favored 'General case' 0 CA--C 1.508 -0.64 0 CA-C-O 121.538 0.685 . . . . 0.0 110.836 -178.782 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -125.07 165.05 18.88 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 103.307 -2.849 . . . . 0.0 103.307 177.105 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 94.3 mt -119.57 -99.68 0.44 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 117.888 0.313 . . . . 0.0 111.228 -176.715 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.21 156.38 88.25 Favored Pre-proline 0 C--N 1.325 -0.476 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 179.018 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -68.43 142.59 54.77 Favored 'Trans proline' 0 C--O 1.241 0.674 0 C-N-CA 114.777 -3.015 . . . . 0.0 112.628 -179.775 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 13.4 mtp180 -119.79 160.47 22.56 Favored 'General case' 0 CA--C 1.511 -0.539 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.662 -178.944 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 55.7 m95 -131.29 128.63 40.19 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.445 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 50.0 m-85 -110.45 144.87 38.59 Favored 'General case' 0 C--O 1.217 -0.622 0 N-CA-C 107.505 -1.295 . . . . 0.0 107.505 -177.773 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -89.84 129.97 36.15 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 118.801 0.728 . . . . 0.0 109.254 -178.297 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -132.35 133.07 43.54 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 -175.799 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -71.65 159.49 34.31 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.705 -0.68 . . . . 0.0 112.552 -176.13 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -53.99 129.26 33.57 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-O 121.069 0.461 . . . . 0.0 111.916 -179.448 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 73.26 26.66 69.9 Favored Glycine 0 C--O 1.22 -0.75 0 N-CA-C 115.887 1.115 . . . . 0.0 115.887 176.971 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 2.9 p -90.63 146.07 24.34 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 118.601 1.201 . . . . 0.0 109.336 178.904 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 100.32 136.1 9.2 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 110.126 -1.19 . . . . 0.0 110.126 -178.737 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -69.33 -41.63 4.63 Favored 'Trans proline' 0 C--N 1.349 0.556 0 CA-C-N 119.628 1.714 . . . . 0.0 116.068 -174.122 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -107.03 23.09 14.97 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 121.725 0.774 . . . . 0.0 108.921 -177.574 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -58.51 -45.23 89.22 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.736 -0.666 . . . . 0.0 111.27 -176.337 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 56.16 35.01 63.36 Favored Glycine 0 C--O 1.228 -0.256 0 CA-C-N 116.021 -0.536 . . . . 0.0 112.571 179.447 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 15.1 mt -119.04 103.85 47.27 Favored Pre-proline 0 N--CA 1.446 -0.653 0 N-CA-C 115.112 1.523 . . . . 0.0 115.112 -175.477 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -78.79 163.72 26.02 Favored 'Trans proline' 0 N--CA 1.461 -0.427 0 C-N-CA 121.939 1.759 . . . . 0.0 107.994 168.531 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 74.9 t80 -61.5 130.58 46.68 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 120.305 -0.558 . . . . 0.0 111.085 -177.729 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 92.19 -7.74 78.16 Favored Glycine 0 CA--C 1.519 0.305 0 CA-C-O 119.326 -0.708 . . . . 0.0 114.704 178.699 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -64.0 131.81 48.72 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 118.391 1.096 . . . . 0.0 111.656 179.948 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 47.1 t-20 -77.83 128.12 33.48 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.647 -179.465 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 26.4 ttmt -155.46 150.37 26.54 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 106.567 -1.642 . . . . 0.0 106.567 179.269 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -64.24 129.05 38.44 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.902 0.382 . . . . 0.0 110.968 -177.219 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 71.04 26.45 73.85 Favored Glycine 0 CA--C 1.52 0.346 0 CA-C-O 119.348 -0.696 . . . . 0.0 114.767 179.764 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 41.8 mm -126.83 129.25 71.41 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 CA-C-N 117.572 0.686 . . . . 0.0 111.007 -179.965 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.1 pt -132.02 119.34 40.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 CA-C-O 121.542 0.687 . . . . 0.0 111.186 176.133 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 95.3 m95 -84.68 138.92 32.39 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 113.651 0.982 . . . . 0.0 113.651 -176.9 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 16.5 m -138.03 151.28 25.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 179.03 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -159.89 166.62 29.85 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 105.497 -2.038 . . . . 0.0 105.497 -178.502 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 12.0 t -136.51 175.61 9.45 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 105.657 -1.979 . . . . 0.0 105.657 177.15 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -66.26 136.81 56.38 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.155 0.502 . . . . 0.0 110.783 -179.466 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 92.76 -10.53 73.83 Favored Glycine 0 C--O 1.224 -0.513 0 CA-C-N 115.839 -0.619 . . . . 0.0 113.566 177.311 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -74.24 134.34 42.68 Favored 'General case' 0 C--N 1.323 -0.586 0 O-C-N 122.409 -0.465 . . . . 0.0 111.227 -179.849 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 38.3 mt -91.73 133.36 35.67 Favored 'General case' 0 CA--C 1.513 -0.48 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 -177.804 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 55.6 t30 -81.27 70.43 8.11 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.188 -0.914 . . . . 0.0 110.838 -178.977 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 1.3 t -139.19 155.29 72.55 Favored Pre-proline 0 C--N 1.322 -0.629 0 N-CA-C 106.1 -1.815 . . . . 0.0 106.1 -179.392 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -67.32 148.46 79.96 Favored 'Trans proline' 0 CA--C 1.53 0.32 0 C-N-CA 118.114 -0.791 . . . . 0.0 113.176 176.418 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -148.64 52.55 0.99 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 122.788 1.28 . . . . 0.0 110.435 179.243 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 13.0 p-10 -60.28 -30.48 69.49 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 114.047 -1.433 . . . . 0.0 110.829 179.268 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 16.0 p80 -59.15 -12.59 5.33 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 114.578 1.325 . . . . 0.0 114.578 -179.149 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 54.0 mt -86.5 -32.08 6.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 178.721 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -75.33 12.96 6.55 Favored Glycine 0 CA--C 1.522 0.479 0 N-CA-C 114.764 0.666 . . . . 0.0 114.764 -177.462 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 11.8 t -83.13 13.4 4.15 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 113.103 0.779 . . . . 0.0 113.103 -178.471 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 66.7 ttp85 -58.66 122.55 13.74 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 178.369 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -97.79 129.59 30.95 Favored Pre-proline 0 C--N 1.321 -0.669 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 -178.872 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -69.68 -15.4 37.38 Favored 'Trans proline' 0 C--O 1.219 -0.462 0 O-C-N 122.072 0.511 . . . . 0.0 113.087 -179.193 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -75.94 -26.58 57.02 Favored 'General case' 0 C--O 1.221 -0.425 0 CA-C-O 120.847 0.356 . . . . 0.0 110.404 177.738 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 76.1 m-20 -104.13 -27.23 12.2 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 113.724 1.009 . . . . 0.0 113.724 -174.727 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 29.7 t30 -152.15 149.04 28.34 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 113.078 0.77 . . . . 0.0 113.078 -177.283 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -90.44 150.45 21.82 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-O 121.457 0.646 . . . . 0.0 111.476 179.325 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -70.18 145.23 51.62 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.248 0.547 . . . . 0.0 111.284 178.867 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 17.9 mt -82.86 139.33 17.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 -179.029 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 99.2 t -59.58 122.9 10.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 N-CA-C 106.642 -1.614 . . . . 0.0 106.642 175.299 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 7.2 tt -68.18 129.04 38.74 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.139 0.495 . . . . 0.0 110.112 -176.703 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 31.5 mt-30 -131.12 158.74 39.63 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 -179.162 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 13.7 mt -113.27 147.57 37.67 Favored Pre-proline 0 C--N 1.322 -0.623 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 177.822 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -74.37 168.9 23.72 Favored 'Trans proline' 0 C--O 1.235 0.366 0 O-C-N 122.224 0.592 . . . . 0.0 113.276 -179.313 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 38.6 tt0 -54.14 131.95 42.1 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.518 -0.765 . . . . 0.0 109.415 179.411 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 99.01 -22.58 40.28 Favored Glycine 0 C--O 1.227 -0.282 0 CA-C-O 119.542 -0.588 . . . . 0.0 113.193 -179.779 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 4.1 m -106.63 127.58 53.46 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 118.361 1.081 . . . . 0.0 111.203 178.887 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 7.1 p -121.14 148.38 44.28 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.951 -179.562 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 92.7 mt -70.5 151.28 95.6 Favored Pre-proline 0 C--N 1.324 -0.513 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 178.874 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -78.6 172.92 14.43 Favored 'Trans proline' 0 N--CA 1.463 -0.303 0 O-C-N 122.0 0.473 . . . . 0.0 111.385 178.796 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 1.7 tmmt? -54.44 130.05 38.06 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.78 -177.847 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 91.53 -7.43 79.92 Favored Glycine 0 C--O 1.229 -0.19 0 N-CA-C 115.794 1.078 . . . . 0.0 115.794 175.655 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.405 ' CZ ' ' HB2' ' A' ' 18' ' ' GLN . 2.3 m-85 -97.84 142.54 29.48 Favored 'General case' 0 N--CA 1.441 -0.888 0 CA-C-O 122.311 1.053 . . . . 0.0 112.859 -177.818 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 47.0 p90 -141.73 165.1 28.41 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 113.473 -1.694 . . . . 0.0 106.961 173.974 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -102.51 143.75 31.82 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.731 0.3 . . . . 0.0 110.274 -178.583 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.411 ' HB3' ' HB ' ' A' ' 14' ' ' THR . 6.5 tp10 -71.55 135.7 47.16 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 106.762 -1.57 . . . . 0.0 106.762 177.84 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 93.33 -7.82 75.33 Favored Glycine 0 C--O 1.225 -0.412 0 C-N-CA 121.369 -0.443 . . . . 0.0 113.497 -177.626 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 34.6 t -136.12 131.79 35.21 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 117.842 0.821 . . . . 0.0 111.221 177.194 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 16.9 mmt85 -143.32 -44.92 0.29 Allowed 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 113.521 0.934 . . . . 0.0 113.521 -179.962 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 84.38 -176.87 51.56 Favored Glycine 0 N--CA 1.453 -0.199 0 N-CA-C 108.668 -1.773 . . . . 0.0 108.668 -176.031 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 166.84 -163.58 37.16 Favored Glycine 0 N--CA 1.451 -0.35 0 N-CA-C 106.875 -2.49 . . . . 0.0 106.875 -178.42 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 54.8 p . . . . . 0 C--O 1.241 0.62 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 177.794 . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.763 0 CA-C-O 118.553 -1.137 . . . . 0.0 111.088 . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -86.55 49.07 1.73 Allowed 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 118.344 1.072 . . . . 0.0 108.899 177.959 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -162.95 176.06 10.54 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 102.742 -3.059 . . . . 0.0 102.742 -175.235 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 152.24 -29.38 0.88 Allowed Glycine 0 C--N 1.319 -0.389 0 CA-C-O 121.543 0.524 . . . . 0.0 112.019 -178.689 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 94.7 mt -110.42 136.4 20.58 Favored Pre-proline 0 C--N 1.322 -0.592 0 N-CA-C 107.478 -1.305 . . . . 0.0 107.478 177.752 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -73.99 155.42 47.93 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 117.276 -1.349 . . . . 0.0 112.976 -178.452 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 10.0 m120 -68.25 -32.99 73.55 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.315 179.659 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 31.7 t30 -164.67 -80.58 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 178.1 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 44.4 p 36.3 75.86 0.06 Allowed 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 115.148 1.536 . . . . 0.0 115.148 -179.911 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -102.28 131.65 48.73 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.382 -0.826 . . . . 0.0 109.813 -178.726 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 39.3 p -65.47 142.77 58.04 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.806 -0.812 . . . . 0.0 108.806 177.93 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . 0.423 ' CD2' ' HD3' ' A' ' 109' ' ' ARG . 14.8 m95 -67.69 -21.85 65.31 Favored 'General case' 0 CA--C 1.511 -0.557 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 178.066 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 44.4 m-85 -121.42 160.87 23.23 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 113.8 1.037 . . . . 0.0 113.8 -170.518 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 59.0 p -71.85 166.99 20.95 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 113.891 -1.504 . . . . 0.0 109.637 179.243 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -80.29 131.11 35.6 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 -177.136 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 13.8 mt -74.51 146.43 42.71 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 103.278 -2.86 . . . . 0.0 103.278 170.1 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 24.8 m -126.8 136.65 52.67 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 -177.207 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.434 ' HB2' ' CZ ' ' A' ' 131' ' ' PHE . 4.7 tp60 -111.9 139.97 46.95 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 114.036 1.125 . . . . 0.0 114.036 -175.328 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 57.7 t60 -130.32 99.48 5.04 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 106.541 -1.652 . . . . 0.0 106.541 170.496 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 173.95 -170.57 43.71 Favored Glycine 0 C--O 1.227 -0.293 0 N-CA-C 109.014 -1.634 . . . . 0.0 109.014 -177.973 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -97.97 -24.25 15.45 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 117.523 0.662 . . . . 0.0 111.694 178.963 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -83.5 157.45 22.39 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 106.111 -1.811 . . . . 0.0 106.111 174.816 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -93.18 -62.76 1.31 Allowed 'General case' 0 C--O 1.215 -0.73 0 C-N-CA 120.123 -0.631 . . . . 0.0 112.637 -176.838 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 42.5 tp -169.83 138.62 1.82 Allowed 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 175.291 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 10.8 tmtt? -153.89 128.59 9.38 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 176.303 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -117.91 159.35 43.06 Favored Pre-proline 0 CA--C 1.547 0.835 0 N-CA-C 110.378 -0.23 . . . . 0.0 110.378 178.096 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -69.12 173.92 9.7 Favored 'Trans proline' 0 C--N 1.354 0.821 0 C-N-CA 121.687 1.591 . . . . 0.0 115.015 -179.574 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -78.37 132.74 37.51 Favored 'General case' 0 C--O 1.216 -0.699 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 178.116 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 69.42 14.21 68.96 Favored Glycine 0 C--O 1.225 -0.415 0 N-CA-C 115.089 0.796 . . . . 0.0 115.089 175.732 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 39.1 tt0 -157.77 148.11 20.65 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 105.758 -1.942 . . . . 0.0 105.758 -178.079 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 136.04 -17.12 3.89 Favored Glycine 0 CA--C 1.502 -0.72 0 C-N-CA 120.187 -1.006 . . . . 0.0 112.723 175.648 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 30.3 m -70.46 145.21 92.65 Favored Pre-proline 0 C--N 1.321 -0.666 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 177.042 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -76.76 167.53 25.19 Favored 'Trans proline' 0 N--CA 1.461 -0.395 0 C-N-CA 122.187 1.925 . . . . 0.0 113.74 179.695 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 97.9 mt -69.68 128.11 32.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 178.696 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 51.4 t-20 -125.49 122.17 35.85 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.889 -0.411 . . . . 0.0 109.889 175.998 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 74.2 p -92.74 -15.49 26.58 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 113.668 0.988 . . . . 0.0 113.668 -177.189 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 20.0 p30 -109.27 21.49 17.04 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 115.259 1.577 . . . . 0.0 115.259 -174.009 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 37.8 m -147.42 164.88 31.94 Favored 'General case' 0 N--CA 1.468 0.437 0 O-C-N 121.918 -0.489 . . . . 0.0 111.538 -179.875 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 32.6 m -75.27 164.44 61.11 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.703 -178.632 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -65.16 -24.81 58.52 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 115.529 -2.514 . . . . 0.0 111.769 177.362 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -59.75 -33.78 72.11 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 122.051 0.929 . . . . 0.0 110.613 176.559 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -83.35 -7.65 59.54 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 114.954 1.465 . . . . 0.0 114.954 -173.903 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 93.0 mm-40 -65.85 -31.64 72.71 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 114.521 1.304 . . . . 0.0 114.521 -174.806 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 14.7 tt -58.9 138.75 19.56 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 CA-C-O 122.076 0.941 . . . . 0.0 112.078 179.314 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 179.0 -148.36 8.21 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.124 -175.556 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 46.1 p90 -154.96 166.87 32.19 Favored 'General case' 0 C--N 1.32 -0.711 0 O-C-N 122.438 -0.448 . . . . 0.0 110.263 179.786 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 40.3 m-85 -107.51 141.97 38.11 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 174.116 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 58.6 ttt-85 -114.22 120.53 40.76 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 123.454 0.702 . . . . 0.0 112.028 -175.926 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 62.8 ttt-85 -64.43 141.4 58.79 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 122.789 0.436 . . . . 0.0 110.165 177.697 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -150.67 132.94 15.45 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.173 0.511 . . . . 0.0 112.249 178.624 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 7.0 p -149.48 139.74 22.26 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 107.259 -1.386 . . . . 0.0 107.259 175.818 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 25.0 tpt180 -147.1 123.98 11.29 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 175.385 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.53 145.34 47.41 Favored 'General case' 0 CA--C 1.484 -1.592 0 CA-C-O 122.313 1.054 . . . . 0.0 112.434 -178.951 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -142.32 176.32 3.89 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 N-CA-C 104.686 -2.338 . . . . 0.0 104.686 176.23 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 4.1 tmt_? -129.2 101.62 6.09 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 105.192 -2.151 . . . . 0.0 105.192 176.472 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -69.01 154.7 53.46 Favored Glycine 0 C--O 1.221 -0.697 0 N-CA-C 109.903 -1.279 . . . . 0.0 109.903 -178.434 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -64.93 -37.95 94.9 Favored Glycine 0 C--O 1.222 -0.637 0 N-CA-C 110.095 -1.202 . . . . 0.0 110.095 -178.219 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 27.5 t0 -89.79 16.95 7.16 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-O 122.339 1.066 . . . . 0.0 110.269 179.208 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 86.93 -15.66 51.71 Favored Glycine 0 C--O 1.227 -0.33 0 N-CA-C 115.818 1.087 . . . . 0.0 115.818 174.087 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -62.1 135.78 57.66 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 122.189 0.995 . . . . 0.0 112.705 -177.911 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 87.5 mtp -108.32 -174.21 2.46 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 113.704 -1.589 . . . . 0.0 109.821 -178.431 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 11.4 mmtt -105.56 -61.83 1.44 Allowed 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 120.979 0.418 . . . . 0.0 110.963 -179.077 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 19.8 p30 -132.74 168.28 18.61 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 176.734 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -128.99 -60.99 1.06 Allowed 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 -179.267 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -81.35 151.31 69.01 Favored Pre-proline 0 C--N 1.32 -0.714 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 176.395 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -70.58 152.02 64.77 Favored 'Trans proline' 0 C--O 1.239 0.569 0 C-N-CA 116.551 -1.833 . . . . 0.0 111.397 177.672 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 7.4 mtp180 -125.07 158.57 33.48 Favored 'General case' 0 CA--C 1.515 -0.4 0 C-N-CA 121.09 -0.244 . . . . 0.0 110.7 -179.786 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 48.2 m95 -131.75 136.4 47.56 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 178.312 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 48.1 m-85 -110.37 172.95 6.56 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 104.804 -2.295 . . . . 0.0 104.804 -179.91 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 92.4 t80 -124.03 136.72 54.46 Favored 'General case' 0 CA--C 1.51 -0.595 0 CA-C-N 119.526 1.057 . . . . 0.0 108.597 -178.721 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 34.6 m-85 -137.51 148.89 46.35 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 -176.246 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 44.0 m-85 -84.05 159.52 21.15 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.359 -176.152 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -54.93 132.04 45.83 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.203 178.054 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 67.29 38.37 91.51 Favored Glycine 0 C--O 1.225 -0.436 0 N-CA-C 115.206 0.842 . . . . 0.0 115.206 177.124 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.2 p -94.05 146.16 24.15 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 175.757 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 90.5 136.0 6.37 Favored Glycine 0 CA--C 1.525 0.686 0 CA-C-O 119.699 -0.5 . . . . 0.0 112.289 -178.033 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -68.86 -41.73 5.23 Favored 'Trans proline' 0 C--N 1.348 0.539 0 N-CA-C 116.257 1.599 . . . . 0.0 116.257 -175.513 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -113.02 23.41 13.4 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.445 0.64 . . . . 0.0 109.717 -177.855 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -61.48 -32.86 72.89 Favored 'General case' 0 C--O 1.239 0.509 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.432 -177.563 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 59.02 33.03 72.29 Favored Glycine 0 C--O 1.227 -0.295 0 CA-C-N 115.406 -0.815 . . . . 0.0 114.184 176.681 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 14.7 mt -118.28 103.65 49.13 Favored Pre-proline 0 N--CA 1.444 -0.76 0 N-CA-C 114.874 1.435 . . . . 0.0 114.874 -177.704 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -79.73 164.69 23.01 Favored 'Trans proline' 0 C--O 1.235 0.36 0 C-N-CA 122.783 2.322 . . . . 0.0 107.78 167.455 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 60.6 t80 -62.32 131.67 50.09 Favored 'General case' 0 C--N 1.321 -0.666 0 C-N-CA 120.367 -0.533 . . . . 0.0 110.338 -178.066 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 91.14 -5.65 81.44 Favored Glycine 0 C--O 1.228 -0.273 0 N-CA-C 114.901 0.72 . . . . 0.0 114.901 179.031 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -66.77 130.49 43.33 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 118.649 1.225 . . . . 0.0 111.608 179.499 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 57.0 t30 -74.92 128.37 35.41 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.892 -179.186 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 26.4 ttmt -156.01 152.01 27.59 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 106.354 -1.721 . . . . 0.0 106.354 178.476 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -65.61 132.7 49.48 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.069 0.461 . . . . 0.0 110.615 -178.059 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 69.31 25.92 75.04 Favored Glycine 0 N--CA 1.449 -0.495 0 CA-C-N 115.714 -0.675 . . . . 0.0 114.239 177.97 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 47.7 mm -124.82 126.63 71.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 117.345 0.572 . . . . 0.0 110.842 179.945 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -127.08 116.98 46.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.356 176.243 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 96.9 m95 -82.22 135.66 35.21 Favored 'General case' 0 C--N 1.319 -0.72 0 O-C-N 121.864 -0.522 . . . . 0.0 112.227 -177.676 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -142.22 154.97 18.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 -178.113 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -154.92 166.52 33.28 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 106.193 -1.78 . . . . 0.0 106.193 -176.635 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 14.7 t -121.79 164.63 17.13 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 103.211 -2.885 . . . . 0.0 103.211 171.53 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -67.56 136.08 53.95 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 -179.099 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 92.84 -9.67 75.14 Favored Glycine 0 C--O 1.224 -0.501 0 CA-C-N 115.986 -0.552 . . . . 0.0 113.833 178.504 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -74.16 143.08 45.41 Favored 'General case' 0 CA--C 1.545 0.756 0 O-C-N 122.339 -0.506 . . . . 0.0 110.429 179.143 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 40.2 mt -93.17 133.48 36.32 Favored 'General case' 0 CA--C 1.516 -0.347 0 N-CA-C 115.004 1.483 . . . . 0.0 115.004 -175.496 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 61.6 t30 -79.67 64.68 4.61 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 114.683 -1.144 . . . . 0.0 110.966 -178.256 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -135.85 157.41 76.07 Favored Pre-proline 0 C--N 1.322 -0.588 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 -178.152 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -73.27 148.24 43.45 Favored 'Trans proline' 0 CA--C 1.534 0.493 0 N-CA-C 114.496 0.921 . . . . 0.0 114.496 175.338 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.54 58.85 1.07 Allowed 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 177.595 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -64.01 -14.37 53.68 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.275 176.449 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 18.0 p-80 -61.53 -14.46 29.78 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 179.396 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 23.4 mt -92.81 -26.7 4.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 121.329 0.585 . . . . 0.0 109.616 179.456 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -81.3 10.34 49.83 Favored Glycine 0 N--CA 1.459 0.232 0 O-C-N 122.007 -0.433 . . . . 0.0 113.63 -178.128 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 12.4 t -83.22 6.48 19.33 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 122.295 -0.532 . . . . 0.0 111.262 -178.4 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.423 ' HD3' ' CD2' ' A' ' 12' ' ' TRP . 63.5 ttp85 -54.51 133.61 46.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.509 179.908 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 35.0 m120 -96.97 115.82 65.85 Favored Pre-proline 0 C--N 1.326 -0.455 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 178.8 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -73.23 -11.53 25.03 Favored 'Trans proline' 0 C--O 1.219 -0.473 0 C-N-CA 117.45 -1.233 . . . . 0.0 113.351 -178.155 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -80.54 -25.45 38.63 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.215 177.436 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 -101.99 -25.44 13.76 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 113.543 0.942 . . . . 0.0 113.543 -174.334 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -140.42 154.27 46.6 Favored 'General case' 0 N--CA 1.434 -1.226 0 CA-C-O 121.497 0.665 . . . . 0.0 109.45 -177.59 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -93.36 144.45 25.31 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 114.938 -1.028 . . . . 0.0 110.837 -179.531 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -68.83 145.44 53.73 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.37 0.605 . . . . 0.0 110.561 178.853 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 27.8 mt -81.59 137.44 21.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 -178.723 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 1.2 p -62.08 125.99 19.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 176.324 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 6.4 tt -67.11 127.52 32.91 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.01 0.434 . . . . 0.0 110.116 -177.013 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 29.7 mt-30 -130.86 155.84 46.04 Favored 'General case' 0 CA--C 1.512 -0.488 0 N-CA-C 107.251 -1.388 . . . . 0.0 107.251 -179.132 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 13.5 mt -111.97 148.6 39.35 Favored Pre-proline 0 C--N 1.322 -0.616 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 179.029 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -71.5 164.52 35.45 Favored 'Trans proline' 0 C--N 1.346 0.403 0 O-C-N 122.278 0.62 . . . . 0.0 112.814 -179.037 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 65.1 tt0 -55.12 132.51 47.59 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.422 -179.649 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 96.57 -16.48 60.95 Favored Glycine 0 C--O 1.227 -0.32 0 CA-C-N 116.039 -0.528 . . . . 0.0 112.945 -179.002 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 6.1 m -107.59 126.77 52.96 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 117.907 0.853 . . . . 0.0 110.559 178.329 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 14.8 p -117.0 148.14 41.72 Favored 'General case' 0 CA--C 1.509 -0.605 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.534 -179.454 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 82.7 mt -68.37 152.37 96.62 Favored Pre-proline 0 C--N 1.321 -0.636 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 178.036 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -76.83 173.01 15.16 Favored 'Trans proline' 0 N--CA 1.462 -0.342 0 C-N-CA 117.87 -0.953 . . . . 0.0 110.43 177.989 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 84.4 tttt -57.27 128.42 36.9 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 113.485 0.92 . . . . 0.0 113.485 -174.12 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 95.12 -6.02 68.74 Favored Glycine 0 CA--C 1.518 0.227 0 N-CA-C 115.854 1.101 . . . . 0.0 115.854 176.15 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.434 ' CZ ' ' HB2' ' A' ' 18' ' ' GLN . 4.6 m-85 -92.38 147.09 23.18 Favored 'General case' 0 N--CA 1.437 -1.092 0 CA-C-O 122.962 1.363 . . . . 0.0 114.004 -178.194 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 48.5 p90 -146.76 163.51 35.76 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 112.29 -2.232 . . . . 0.0 107.274 172.94 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -105.31 143.69 33.12 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 112.762 0.653 . . . . 0.0 112.762 -177.398 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -76.78 147.95 36.96 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 175.368 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 95.02 -33.66 5.26 Favored Glycine 0 C--O 1.227 -0.333 0 C-N-CA 121.428 -0.415 . . . . 0.0 113.964 178.184 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -61.27 123.02 16.56 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.201 0.524 . . . . 0.0 111.658 177.113 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 28.9 mmm180 -124.72 16.19 8.73 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.541 179.08 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -67.51 143.99 43.31 Favored Glycine 0 C--N 1.319 -0.392 0 N-CA-C 108.44 -1.864 . . . . 0.0 108.44 177.362 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 165.94 -157.06 29.37 Favored Glycine 0 N--CA 1.451 -0.356 0 N-CA-C 108.224 -1.95 . . . . 0.0 108.224 -177.675 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 56.4 p . . . . . 0 C--O 1.253 1.244 0 CA-C-O 115.477 -2.201 . . . . 0.0 105.485 179.316 . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.484 0 CA-C-O 118.769 -1.017 . . . . 0.0 111.318 . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -101.37 131.89 47.23 Favored 'General case' 0 C--O 1.22 -0.45 0 CA-C-N 118.457 1.128 . . . . 0.0 111.932 -177.302 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 5.5 ttt 53.02 14.48 0.47 Allowed 'General case' 0 N--CA 1.483 1.211 0 N-CA-C 117.637 2.458 . . . . 0.0 117.637 174.969 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -82.85 -33.75 23.46 Favored Glycine 0 C--O 1.225 -0.454 0 N-CA-C 115.794 1.078 . . . . 0.0 115.794 -177.797 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 96.3 mt -101.74 141.02 21.72 Favored Pre-proline 0 C--N 1.324 -0.535 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 -178.489 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -73.4 -17.94 23.49 Favored 'Trans proline' 0 C--N 1.351 0.661 0 N-CA-C 114.133 0.782 . . . . 0.0 114.133 -179.122 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 50.48 43.33 27.15 Favored 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 114.525 1.306 . . . . 0.0 114.525 175.808 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -93.62 23.33 4.74 Favored 'General case' 0 N--CA 1.471 0.616 0 O-C-N 121.593 -0.692 . . . . 0.0 110.902 -179.67 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 20.1 p -73.98 88.68 1.88 Allowed 'General case' 0 C--O 1.239 0.522 0 C-N-CA 124.285 1.034 . . . . 0.0 111.115 -174.75 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -101.48 152.17 21.08 Favored 'General case' 0 N--CA 1.441 -0.898 0 CA-C-N 114.979 -1.009 . . . . 0.0 112.296 -175.634 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -61.8 143.65 55.98 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 114.767 -1.106 . . . . 0.0 110.287 177.785 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 21.1 m95 -69.38 -23.64 63.77 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 114.864 1.431 . . . . 0.0 114.864 -178.514 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 86.2 m-85 -121.52 161.07 22.95 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.186 0.517 . . . . 0.0 112.384 -172.747 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 74.6 p -70.31 161.58 30.12 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 177.013 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -74.83 153.79 38.57 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.902 0.858 . . . . 0.0 113.191 -175.995 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 22.6 mt -90.94 148.79 22.2 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 102.497 -3.149 . . . . 0.0 102.497 168.171 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 51.9 m -123.85 139.59 53.82 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 179.893 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.434 ' HB2' ' CZ ' ' A' ' 131' ' ' PHE . 4.3 tp60 -110.41 138.98 46.08 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-O 121.527 0.679 . . . . 0.0 112.298 -178.531 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 73.0 t60 -134.14 99.44 4.41 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 103.391 -2.818 . . . . 0.0 103.391 169.773 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 173.13 -165.97 38.34 Favored Glycine 0 C--O 1.225 -0.452 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 -176.055 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 37.9 mtmm -102.18 -25.09 13.83 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 113.956 1.095 . . . . 0.0 113.956 -178.221 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -89.21 162.1 16.08 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.056 -179.154 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -77.62 -62.95 1.5 Allowed 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.203 -176.916 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 34.6 tp 172.99 142.66 0.04 OUTLIER 'General case' 0 N--CA 1.482 1.133 0 N-CA-C 105.545 -2.02 . . . . 0.0 105.545 176.409 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 12.0 tmtt? -154.95 125.45 6.89 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 175.459 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -106.81 152.46 40.87 Favored Pre-proline 0 C--O 1.242 0.676 0 CA-C-O 120.457 0.17 . . . . 0.0 110.711 177.842 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -68.71 161.48 45.17 Favored 'Trans proline' 0 C--N 1.352 0.724 0 CA-C-O 121.226 0.427 . . . . 0.0 112.799 178.455 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 71.6 ttt180 -69.86 132.37 45.91 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 122.182 -0.324 . . . . 0.0 111.361 -175.846 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 79.35 13.6 82.53 Favored Glycine 0 C--O 1.222 -0.612 0 N-CA-C 111.697 -0.561 . . . . 0.0 111.697 179.254 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 31.0 mt-30 -148.23 171.74 15.45 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.18 -1.045 . . . . 0.0 108.18 -175.327 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 107.71 -10.22 38.11 Favored Glycine 0 CA--C 1.501 -0.786 0 CA-C-N 116.159 -0.473 . . . . 0.0 112.803 175.851 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 57.4 t -74.37 130.89 81.29 Favored Pre-proline 0 C--N 1.32 -0.685 0 N-CA-C 106.437 -1.69 . . . . 0.0 106.437 176.739 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -71.62 172.84 13.56 Favored 'Trans proline' 0 C--O 1.221 -0.34 0 O-C-N 122.179 0.568 . . . . 0.0 112.505 177.658 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 64.8 mt -75.85 106.3 5.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 122.228 1.013 . . . . 0.0 110.341 -179.111 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.499 ' HB2' HE21 ' A' ' 43' ' ' GLN . 38.8 m-20 -97.67 77.89 2.59 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 114.184 -1.371 . . . . 0.0 108.407 -179.425 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 80.7 p -63.88 -25.56 68.21 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 115.289 1.588 . . . . 0.0 115.289 -174.677 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -116.19 32.23 6.24 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 -176.369 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 5.9 m -133.06 166.87 21.42 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.678 0.275 . . . . 0.0 111.356 -178.903 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 25.0 m -77.57 155.92 81.0 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-N 116.583 -0.281 . . . . 0.0 111.657 -177.527 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -68.95 -20.91 38.08 Favored 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 116.804 -1.664 . . . . 0.0 114.378 -179.809 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.405 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 1.9 p-10 -76.95 -23.19 52.39 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 121.434 -0.791 . . . . 0.0 110.978 177.203 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -76.69 -13.08 60.07 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 114.715 1.376 . . . . 0.0 114.715 -170.924 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . 0.499 HE21 ' HB2' ' A' ' 35' ' ' ASN . 94.8 mm-40 -55.01 -28.15 49.78 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 113.934 1.086 . . . . 0.0 113.934 -175.025 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 13.6 tt -64.63 135.82 27.51 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.784 0 CA-C-O 122.316 1.055 . . . . 0.0 111.981 178.643 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 179.36 -155.91 17.06 Favored Glycine 0 N--CA 1.45 -0.432 0 N-CA-C 110.755 -0.938 . . . . 0.0 110.755 -177.54 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 33.2 p90 -155.1 168.34 27.35 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.882 0.341 . . . . 0.0 110.554 179.826 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.412 ' HH ' HD21 ' A' ' 119' ' ' LEU . 29.1 m-85 -112.79 141.2 46.87 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 175.345 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 73.7 ttt-85 -116.77 125.04 51.05 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.661 -0.7 . . . . 0.0 112.675 -177.969 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 50.4 ttp85 -69.15 141.05 54.71 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 121.084 0.468 . . . . 0.0 111.092 177.518 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -152.05 157.54 41.8 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 179.104 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 68.1 p -129.43 166.29 19.87 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 104.058 -2.571 . . . . 0.0 104.058 172.571 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 21.5 tpt180 -96.09 118.96 33.72 Favored 'General case' 0 C--O 1.218 -0.584 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 178.667 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 6.7 tmm_? -139.59 139.1 36.7 Favored 'General case' 0 CA--C 1.502 -0.88 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 -178.951 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -137.29 -179.6 2.93 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 114.802 -1.09 . . . . 0.0 108.245 -175.982 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 13.1 tpp85 -129.14 125.14 36.42 Favored 'General case' 0 C--O 1.221 -0.431 0 N-CA-C 105.02 -2.215 . . . . 0.0 105.02 174.339 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -156.02 144.03 10.43 Favored Glycine 0 C--O 1.224 -0.489 0 N-CA-C 107.524 -2.23 . . . . 0.0 107.524 177.325 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -65.87 -60.65 6.28 Favored Glycine 0 C--O 1.227 -0.319 0 CA-C-N 117.883 0.842 . . . . 0.0 112.391 -177.958 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -107.34 8.39 29.69 Favored 'General case' 0 C--O 1.215 -0.744 0 CA-C-O 121.967 0.889 . . . . 0.0 110.838 178.715 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -95.95 -11.59 54.49 Favored Glycine 0 CA--C 1.504 -0.653 0 N-CA-C 105.542 -3.023 . . . . 0.0 105.542 179.318 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 53.7 mmtt 52.93 -161.59 0.11 Allowed 'General case' 0 N--CA 1.442 -0.846 0 CA-C-N 112.95 -1.625 . . . . 0.0 111.723 176.79 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 70.1 mtp -90.43 -179.02 5.49 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 114.516 -1.22 . . . . 0.0 109.865 176.875 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 18.5 mmtm -134.8 -69.53 0.51 Allowed 'General case' 0 C--O 1.211 -0.941 0 CA-C-O 120.897 0.38 . . . . 0.0 110.503 179.497 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.7 t0 52.1 51.41 16.44 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 114.318 -1.31 . . . . 0.0 111.923 178.918 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -61.97 162.59 8.92 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 114.116 -1.402 . . . . 0.0 111.969 -179.687 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -45.76 146.18 2.01 Favored Pre-proline 0 C--O 1.25 1.08 0 CA-C-N 115.047 -0.979 . . . . 0.0 113.495 -177.335 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -61.86 142.54 93.73 Favored 'Trans proline' 0 C--N 1.349 0.601 0 CA-C-O 122.768 1.07 . . . . 0.0 114.209 -174.895 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 22.6 mtt85 -128.95 155.77 44.8 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-N 113.2 -1.818 . . . . 0.0 108.054 -178.629 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 66.5 m95 -127.8 131.63 49.57 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 179.711 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 70.9 m-85 -111.41 148.23 33.52 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 107.289 -1.375 . . . . 0.0 107.289 179.064 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 68.1 t80 -95.79 131.35 42.18 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 -177.778 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -134.36 146.52 50.0 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 -178.263 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -83.34 159.51 21.85 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 113.016 0.747 . . . . 0.0 113.016 -174.956 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -55.53 132.91 49.74 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.391 179.489 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 72.56 33.96 60.5 Favored Glycine 0 C--O 1.221 -0.696 0 N-CA-C 115.469 0.947 . . . . 0.0 115.469 176.629 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 9.2 p -99.97 146.09 27.1 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.226 -1.028 . . . . 0.0 108.226 177.818 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 103.21 138.62 9.98 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 108.572 -1.811 . . . . 0.0 108.572 -176.619 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -70.51 -40.43 4.16 Favored 'Trans proline' 0 C--N 1.347 0.458 0 CA-C-N 119.748 1.774 . . . . 0.0 115.577 -173.494 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -123.18 39.14 4.03 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 -177.538 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -64.95 -41.78 95.19 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.529 -0.76 . . . . 0.0 111.621 -177.818 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 61.23 24.56 63.51 Favored Glycine 0 C--O 1.226 -0.385 0 CA-C-N 116.127 -0.488 . . . . 0.0 113.654 179.854 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 21.3 mt -109.47 103.89 53.91 Favored Pre-proline 0 C--O 1.238 0.468 0 N-CA-C 114.273 1.212 . . . . 0.0 114.273 -176.719 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -78.5 167.19 23.12 Favored 'Trans proline' 0 N--CA 1.461 -0.436 0 N-CA-C 108.439 -1.408 . . . . 0.0 108.439 170.895 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.413 ' CE1' ' HB3' ' A' ' 92' ' ' TRP . 77.9 t80 -61.24 132.47 53.74 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 120.357 -0.537 . . . . 0.0 110.254 179.979 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 90.43 -4.9 82.71 Favored Glycine 0 CA--C 1.518 0.276 0 N-CA-C 115.065 0.786 . . . . 0.0 115.065 178.03 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -65.38 128.09 34.47 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 118.463 1.132 . . . . 0.0 111.472 179.407 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 45.9 t-20 -78.05 128.01 33.2 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.322 -176.576 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 16.7 ttmm -156.08 152.09 27.57 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 179.54 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -62.73 132.76 53.34 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.744 0.307 . . . . 0.0 110.441 179.447 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 68.86 24.41 75.64 Favored Glycine 0 N--CA 1.449 -0.44 0 CA-C-O 119.477 -0.624 . . . . 0.0 113.734 178.033 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 38.6 mm -129.32 128.51 66.57 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.304 0 CA-C-N 117.362 0.581 . . . . 0.0 110.077 179.866 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.1 pt -134.56 123.71 42.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.573 176.036 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . 0.413 ' HB3' ' CE1' ' A' ' 83' ' ' TYR . 90.0 m95 -89.37 139.42 30.53 Favored 'General case' 0 C--N 1.321 -0.671 0 O-C-N 121.908 -0.495 . . . . 0.0 111.617 -176.933 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 17.8 m -135.09 153.77 34.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 179.903 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -162.03 166.56 25.77 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 105.812 -1.921 . . . . 0.0 105.812 -178.63 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 13.5 t -130.41 169.29 15.69 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 104.628 -2.36 . . . . 0.0 104.628 176.137 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -66.22 135.07 53.97 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.225 0.536 . . . . 0.0 110.218 -178.601 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 93.81 -12.73 68.86 Favored Glycine 0 CA--C 1.517 0.195 0 CA-C-N 115.982 -0.554 . . . . 0.0 113.998 178.395 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.405 ' HA ' ' HA ' ' A' ' 41' ' ' ASP . . . -68.16 135.97 52.92 Favored 'General case' 0 CA--C 1.542 0.667 0 O-C-N 122.33 -0.512 . . . . 0.0 110.133 179.088 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 32.4 mt -89.34 130.31 35.73 Favored 'General case' 0 CA--C 1.507 -0.681 0 N-CA-C 113.416 0.895 . . . . 0.0 113.416 -177.145 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 53.5 t30 -81.17 73.8 8.2 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 114.526 -1.215 . . . . 0.0 110.564 -178.718 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 1.5 t -142.97 153.83 61.12 Favored Pre-proline 0 C--N 1.321 -0.631 0 N-CA-C 106.427 -1.694 . . . . 0.0 106.427 179.723 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -67.65 147.74 76.63 Favored 'Trans proline' 0 CA--C 1.528 0.213 0 C-N-CA 117.824 -0.984 . . . . 0.0 113.089 176.018 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 6.6 ptpt -145.73 56.95 1.22 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 122.722 1.248 . . . . 0.0 110.593 179.066 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -58.54 -31.05 67.58 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.149 -1.387 . . . . 0.0 111.9 179.304 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 18.3 p80 -62.62 -7.41 4.72 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 113.944 1.09 . . . . 0.0 113.944 -179.34 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 29.1 mt -96.24 -45.29 13.02 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.53 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 177.148 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -69.92 14.66 1.1 Allowed Glycine 0 CA--C 1.524 0.609 0 N-CA-C 116.436 1.334 . . . . 0.0 116.436 -177.798 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 15.2 t -95.77 26.51 3.99 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.328 0.651 . . . . 0.0 112.111 -178.841 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 67.7 ttp85 -59.29 125.94 25.65 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 178.429 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -101.26 128.02 30.34 Favored Pre-proline 0 C--N 1.322 -0.615 0 N-CA-C 106.671 -1.603 . . . . 0.0 106.671 -178.28 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -68.53 -20.3 41.48 Favored 'Trans proline' 0 C--O 1.219 -0.468 0 N-CA-C 114.605 0.964 . . . . 0.0 114.605 -176.81 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -74.17 -24.62 59.41 Favored 'General case' 0 C--O 1.221 -0.428 0 CA-C-O 120.861 0.362 . . . . 0.0 110.619 178.269 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 84.7 m-20 -100.94 -24.32 14.37 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 -175.714 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 33.0 t30 -158.23 149.74 21.27 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 113.364 0.876 . . . . 0.0 113.364 -177.634 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -91.61 150.52 21.13 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-O 121.428 0.632 . . . . 0.0 111.787 179.512 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -69.96 146.62 50.99 Favored 'General case' 0 C--N 1.323 -0.543 0 CA-C-O 121.261 0.553 . . . . 0.0 111.451 178.996 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 15.6 mt -86.68 136.45 22.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.828 -178.714 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 70.0 t -62.94 120.89 10.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 N-CA-C 106.179 -1.785 . . . . 0.0 106.179 175.109 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.412 HD21 ' HH ' ' A' ' 47' ' ' TYR . 6.0 tt -68.47 134.43 50.11 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -175.58 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 50.8 mt-30 -135.19 161.91 34.03 Favored 'General case' 0 CA--C 1.513 -0.452 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 178.328 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 13.3 mt -114.63 146.3 35.68 Favored Pre-proline 0 C--N 1.323 -0.58 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 175.646 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -71.71 165.91 31.07 Favored 'Trans proline' 0 C--N 1.345 0.384 0 O-C-N 122.243 0.601 . . . . 0.0 113.619 -177.64 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 41.3 tt0 -53.26 128.83 29.53 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.238 -179.421 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 97.68 -17.32 59.08 Favored Glycine 0 C--O 1.227 -0.299 0 CA-C-N 115.886 -0.597 . . . . 0.0 113.058 -179.279 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 5.8 m -108.73 125.96 52.48 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 117.721 0.76 . . . . 0.0 109.263 178.083 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 5.8 p -124.8 148.23 48.27 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 -179.176 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 81.6 mt -69.56 155.04 94.24 Favored Pre-proline 0 C--N 1.325 -0.493 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 179.876 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_endo -74.44 169.06 23.35 Favored 'Trans proline' 0 N--CA 1.463 -0.299 0 C-N-CA 118.235 -0.71 . . . . 0.0 110.846 178.026 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -61.73 130.42 45.72 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.269 -176.191 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 95.2 -5.7 68.32 Favored Glycine 0 CA--C 1.518 0.224 0 CA-C-N 115.762 -0.653 . . . . 0.0 114.584 179.103 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.434 ' CZ ' ' HB2' ' A' ' 18' ' ' GLN . 1.2 m-85 -101.2 142.49 32.55 Favored 'General case' 0 N--CA 1.445 -0.725 0 CA-C-O 121.712 0.767 . . . . 0.0 110.678 179.441 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 45.6 p90 -145.22 164.19 32.1 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 114.478 -1.237 . . . . 0.0 108.019 175.194 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -100.77 145.78 28.08 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.094 0.474 . . . . 0.0 110.708 -177.949 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -70.58 129.01 38.07 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 -179.86 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 91.55 -32.02 5.5 Favored Glycine 0 CA--C 1.52 0.357 0 CA-C-N 116.159 -0.473 . . . . 0.0 113.967 -179.965 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 34.3 t -80.77 138.96 36.3 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 117.577 0.688 . . . . 0.0 110.177 -178.949 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? -100.9 -5.68 25.71 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.058 -0.974 . . . . 0.0 110.103 176.594 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 85.13 174.8 50.41 Favored Glycine 0 N--CA 1.452 -0.245 0 N-CA-C 107.478 -2.249 . . . . 0.0 107.478 -173.448 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 139.36 -154.76 23.68 Favored Glycine 0 CA--C 1.511 -0.21 0 N-CA-C 109.272 -1.531 . . . . 0.0 109.272 -178.553 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 61.8 p . . . . . 0 C--O 1.241 0.631 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 178.532 . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.704 0 CA-C-O 119.015 -0.881 . . . . 0.0 111.369 . . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -152.61 166.44 32.06 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 105.219 -2.141 . . . . 0.0 105.219 179.466 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -128.48 112.65 14.58 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-O 121.578 0.704 . . . . 0.0 110.299 -179.828 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 135.68 127.21 2.65 Favored Glycine 0 C--O 1.228 -0.261 0 N-CA-C 107.122 -2.391 . . . . 0.0 107.122 -177.031 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 10.5 mp -72.73 142.25 83.26 Favored Pre-proline 0 C--N 1.324 -0.543 0 CA-C-N 117.38 0.59 . . . . 0.0 110.46 -177.745 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -78.92 159.5 27.46 Favored 'Trans proline' 0 C--N 1.344 0.341 0 CA-C-O 121.343 0.476 . . . . 0.0 112.972 178.075 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 -143.86 -29.39 0.5 Allowed 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 175.557 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 43.1 t30 67.26 30.54 7.08 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.87 1.268 . . . . 0.0 112.268 174.217 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 35.3 p -108.83 89.01 2.86 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 106.937 -1.505 . . . . 0.0 106.937 178.745 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -92.56 138.25 31.67 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.499 -175.096 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -57.48 138.4 55.15 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.018 -0.992 . . . . 0.0 109.65 177.245 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 38.1 m95 -67.39 -21.83 65.58 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 114.127 1.158 . . . . 0.0 114.127 -178.437 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -121.46 159.31 26.52 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.435 0.636 . . . . 0.0 112.433 -174.09 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 56.7 p -67.93 165.07 18.49 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.457 -1.247 . . . . 0.0 108.318 178.185 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -83.37 148.6 27.22 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 113.716 1.006 . . . . 0.0 113.716 -175.006 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 85.0 mt -84.95 148.88 25.99 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 102.627 -3.101 . . . . 0.0 102.627 166.975 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 81.7 m -106.85 125.04 50.49 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 178.366 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -88.95 105.64 17.9 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 179.09 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 73.5 t60 -113.48 97.52 6.51 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 104.18 -2.526 . . . . 0.0 104.18 173.107 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 148.99 -168.01 29.43 Favored Glycine 0 N--CA 1.45 -0.41 0 N-CA-C 108.828 -1.709 . . . . 0.0 108.828 -176.128 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -104.4 -22.3 13.35 Favored 'General case' 0 C--O 1.215 -0.738 0 N-CA-C 115.369 1.618 . . . . 0.0 115.369 -176.487 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -71.12 146.36 49.25 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.6 0.714 . . . . 0.0 112.638 -176.357 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -95.58 33.29 1.65 Allowed 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 122.691 1.234 . . . . 0.0 111.918 -176.605 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 31.4 tp 62.52 146.29 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.99 0 CA-C-N 112.791 -2.004 . . . . 0.0 115.305 176.219 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 51.9 tptt -158.16 140.39 14.23 Favored 'General case' 0 CA--C 1.514 -0.433 0 O-C-N 121.118 -0.989 . . . . 0.0 109.869 174.58 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 -125.51 151.36 70.16 Favored Pre-proline 0 C--O 1.241 0.655 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 175.411 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -74.66 165.68 31.02 Favored 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 120.674 0.916 . . . . 0.0 113.863 -179.906 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 16.7 tpt180 -65.07 133.97 52.78 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.885 -178.211 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 83.96 2.32 89.59 Favored Glycine 0 C--O 1.227 -0.293 0 CA-C-O 121.305 0.392 . . . . 0.0 112.351 177.959 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 30.2 mt-30 -141.29 171.14 14.47 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 123.674 0.79 . . . . 0.0 109.803 -173.74 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 105.1 -19.58 40.2 Favored Glycine 0 CA--C 1.497 -1.062 0 N-CA-C 111.254 -0.738 . . . . 0.0 111.254 175.987 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 84.8 t -65.74 127.81 93.34 Favored Pre-proline 0 C--N 1.317 -0.818 0 N-CA-C 105.813 -1.921 . . . . 0.0 105.813 176.311 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -71.62 172.96 13.31 Favored 'Trans proline' 0 N--CA 1.46 -0.485 0 O-C-N 122.292 0.627 . . . . 0.0 111.295 178.141 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 78.4 mt -74.29 108.97 6.31 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 -179.324 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 30.4 m-20 -110.11 74.43 0.88 Allowed 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.648 -1.16 . . . . 0.0 110.454 -175.455 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 65.8 p -66.08 -23.0 66.44 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 115.588 1.699 . . . . 0.0 115.588 -174.298 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -110.76 31.3 6.1 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 112.259 0.466 . . . . 0.0 112.259 -176.474 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 73.8 p -132.9 167.56 20.0 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 178.988 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 44.6 m -84.26 162.45 51.41 Favored Pre-proline 0 C--N 1.321 -0.672 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.417 -178.59 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -67.64 -21.79 45.01 Favored 'Trans proline' 0 C--N 1.351 0.69 0 C-N-CA 116.526 -1.849 . . . . 0.0 114.668 -178.836 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.401 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 6.3 p-10 -75.19 -18.15 60.22 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 121.73 -0.606 . . . . 0.0 109.858 177.785 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.478 ' HA ' ' HZ3' ' A' ' 103' ' ' LYS . 26.1 t0 -90.42 2.11 55.96 Favored 'General case' 0 C--O 1.219 -0.525 0 N-CA-C 114.32 1.23 . . . . 0.0 114.32 -175.016 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 93.0 mm-40 -65.26 -23.76 67.14 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-O 121.624 0.726 . . . . 0.0 109.99 176.789 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 9.0 tt -66.59 141.09 18.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 122.044 0.926 . . . . 0.0 111.083 177.964 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 175.18 -160.98 30.04 Favored Glycine 0 CA--C 1.504 -0.626 0 C-N-CA 120.2 -1.0 . . . . 0.0 110.636 179.364 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 44.3 p90 -155.1 170.73 21.11 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 178.832 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -112.8 140.24 47.76 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 106.522 -1.658 . . . . 0.0 106.522 175.213 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 63.9 ttt180 -115.49 121.97 44.3 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 123.831 0.852 . . . . 0.0 112.152 -175.59 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 32.3 ttp85 -68.65 138.66 55.18 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 176.977 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -143.64 138.73 29.19 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 123.217 0.607 . . . . 0.0 109.597 179.954 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.8 t -161.38 155.08 21.88 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 105.076 -2.194 . . . . 0.0 105.076 176.721 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 11.6 tpt180 -141.42 123.81 15.77 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 107.243 -1.392 . . . . 0.0 107.243 176.495 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 7.7 tmm_? -132.77 129.7 38.95 Favored 'General case' 0 CA--C 1.49 -1.341 0 CA-C-O 121.983 0.897 . . . . 0.0 110.221 179.931 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -139.68 176.82 5.17 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 N-CA-C 104.853 -2.277 . . . . 0.0 104.853 -178.75 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 30.2 ttt85 -127.42 115.91 19.65 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 105.847 -1.909 . . . . 0.0 105.847 175.172 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -82.35 156.83 35.92 Favored Glycine 0 N--CA 1.448 -0.502 0 N-CA-C 108.092 -2.003 . . . . 0.0 108.092 177.802 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -75.45 -31.66 56.39 Favored Glycine 0 C--O 1.215 -1.055 0 N-CA-C 108.808 -1.717 . . . . 0.0 108.808 178.964 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -71.76 -20.69 61.85 Favored 'General case' 0 C--O 1.217 -0.627 0 CA-C-N 114.17 -1.015 . . . . 0.0 109.718 178.211 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 115.65 -9.89 19.17 Favored Glycine 0 CA--C 1.506 -0.48 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.869 173.841 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 5.0 pttt -79.13 154.06 29.62 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 122.085 0.945 . . . . 0.0 113.354 -176.822 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 94.4 mtp -122.48 -160.24 0.87 Allowed 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 113.89 -1.504 . . . . 0.0 110.053 -176.865 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 18.7 mmtt -118.75 -70.0 0.82 Allowed 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 122.199 0.2 . . . . 0.0 111.103 -179.397 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -141.13 160.43 40.12 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 177.269 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -121.17 -28.23 4.76 Favored 'General case' 0 N--CA 1.469 0.5 0 O-C-N 123.892 0.745 . . . . 0.0 110.792 -177.664 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -110.03 130.83 22.4 Favored Pre-proline 0 C--O 1.238 0.469 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 -179.22 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -65.23 162.61 32.46 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 117.386 -1.276 . . . . 0.0 113.439 179.492 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 29.2 mtt-85 -123.31 156.74 34.72 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 178.654 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 54.6 m95 -129.78 125.14 35.08 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 177.215 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 -112.22 147.5 36.08 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 -178.582 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 79.2 t80 -91.0 136.9 32.76 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 -179.335 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -140.53 140.68 35.28 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.338 -0.847 . . . . 0.0 109.364 -173.93 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 34.7 m-85 -74.44 159.53 32.17 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.173 0.511 . . . . 0.0 111.373 -179.605 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -54.74 124.95 18.06 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.76 -0.654 . . . . 0.0 112.105 -177.994 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 81.18 16.73 73.63 Favored Glycine 0 C--O 1.221 -0.7 0 N-CA-C 117.012 1.565 . . . . 0.0 117.012 176.868 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 19.4 p -88.98 146.05 25.12 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 119.173 1.486 . . . . 0.0 111.704 -179.88 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 122.65 154.82 9.18 Favored Glycine 0 CA--C 1.523 0.536 0 N-CA-C 109.841 -1.304 . . . . 0.0 109.841 -179.137 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -70.92 -39.86 3.96 Favored 'Trans proline' 0 C--O 1.22 -0.423 0 CA-C-N 119.315 1.557 . . . . 0.0 115.204 -175.714 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -127.53 35.81 4.47 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 108.002 -1.111 . . . . 0.0 108.002 -177.859 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -55.13 -55.55 29.82 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.17 -0.923 . . . . 0.0 112.405 -175.628 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 55.73 32.21 58.53 Favored Glycine 0 C--O 1.227 -0.336 0 C-N-CA 121.264 -0.493 . . . . 0.0 112.474 -179.236 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 16.9 mt -114.83 103.9 54.5 Favored Pre-proline 0 N--CA 1.449 -0.514 0 N-CA-C 115.486 1.662 . . . . 0.0 115.486 -174.783 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -78.51 163.16 27.19 Favored 'Trans proline' 0 N--CA 1.461 -0.406 0 N-CA-C 107.698 -1.693 . . . . 0.0 107.698 168.269 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 55.0 t80 -61.62 133.61 55.84 Favored 'General case' 0 C--N 1.321 -0.668 0 C-N-CA 120.466 -0.493 . . . . 0.0 110.372 -178.305 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 90.7 -7.84 80.69 Favored Glycine 0 CA--C 1.517 0.206 0 CA-C-O 119.548 -0.584 . . . . 0.0 114.346 178.841 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -65.48 130.81 44.62 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 118.386 1.093 . . . . 0.0 111.03 179.098 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 59.1 t30 -79.71 129.21 34.28 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.381 -179.421 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 30.7 ttmt -156.07 152.96 28.66 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 106.571 -1.641 . . . . 0.0 106.571 179.451 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -60.95 127.47 31.71 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 -179.645 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 70.22 28.65 71.19 Favored Glycine 0 N--CA 1.449 -0.485 0 CA-C-O 119.382 -0.677 . . . . 0.0 114.677 176.593 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 43.5 mm -126.69 122.43 60.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 117.601 0.7 . . . . 0.0 110.842 179.406 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.1 pt -127.49 116.41 43.55 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 CA-C-O 121.762 0.792 . . . . 0.0 111.828 176.612 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 95.2 m95 -81.68 137.84 35.36 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 113.223 0.823 . . . . 0.0 113.223 -177.597 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 18.2 m -137.2 152.43 27.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 178.305 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -163.01 165.99 24.25 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 104.754 -2.313 . . . . 0.0 104.754 -179.999 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 6.5 t -140.2 -178.94 5.7 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 105.938 -1.875 . . . . 0.0 105.938 177.583 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -67.63 136.32 54.22 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.338 0.589 . . . . 0.0 110.614 -178.675 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 96.65 -13.69 65.04 Favored Glycine 0 N--CA 1.459 0.215 0 CA-C-N 115.668 -0.696 . . . . 0.0 112.967 178.48 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.401 ' HA ' ' HA ' ' A' ' 41' ' ' ASP . . . -75.59 140.02 42.42 Favored 'General case' 0 C--N 1.322 -0.608 0 O-C-N 122.716 -0.285 . . . . 0.0 110.573 179.997 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 36.4 mt -96.53 139.89 31.96 Favored 'General case' 0 C--O 1.218 -0.555 0 CA-C-O 121.259 0.552 . . . . 0.0 111.69 -179.373 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 58.9 t30 -86.16 68.77 10.38 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.711 179.473 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 1.1 t -140.67 150.77 61.33 Favored Pre-proline 0 C--N 1.325 -0.489 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 179.12 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -67.74 149.57 78.76 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 118.345 -0.636 . . . . 0.0 113.544 176.908 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.478 ' HZ3' ' HA ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -146.64 47.12 1.19 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 122.732 1.253 . . . . 0.0 110.839 179.061 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 16.0 p-10 -47.73 -39.34 17.47 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 113.44 -1.709 . . . . 0.0 113.34 178.752 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 50.1 p-80 -60.74 -17.1 46.53 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 115.336 1.606 . . . . 0.0 115.336 -177.814 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 68.9 mt -81.55 -29.16 10.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 178.896 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -72.06 14.65 2.12 Favored Glycine 0 CA--C 1.522 0.525 0 N-CA-C 115.771 1.068 . . . . 0.0 115.771 -177.622 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 15.2 t -83.29 28.16 0.55 Allowed 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 123.54 0.736 . . . . 0.0 112.981 -177.711 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 72.9 ttp85 -61.61 116.38 4.7 Favored 'General case' 0 N--CA 1.469 0.514 0 O-C-N 121.221 -0.924 . . . . 0.0 108.647 178.443 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 14.5 m-20 -82.88 118.39 71.61 Favored Pre-proline 0 C--N 1.323 -0.554 0 N-CA-C 105.351 -2.092 . . . . 0.0 105.351 179.279 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -71.66 -13.61 29.88 Favored 'Trans proline' 0 C--O 1.219 -0.46 0 C-N-CA 117.312 -1.326 . . . . 0.0 113.891 -176.418 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -81.25 -24.91 37.01 Favored 'General case' 0 C--O 1.22 -0.465 0 CA-C-O 120.892 0.377 . . . . 0.0 110.241 178.252 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 81.2 m-20 -102.86 -24.78 13.67 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 113.521 0.934 . . . . 0.0 113.521 -175.315 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 30.7 t30 -145.97 145.42 30.64 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 -178.349 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -89.23 149.68 22.99 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.368 -179.927 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -70.24 148.31 48.72 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.305 0.574 . . . . 0.0 110.61 178.129 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 8.0 mt -83.43 139.33 17.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 -179.178 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 89.7 t -62.55 121.43 11.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 176.069 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 5.5 tt -68.07 126.92 31.01 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.244 0.545 . . . . 0.0 109.996 -177.798 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 30.8 mt-30 -132.96 154.23 50.67 Favored 'General case' 0 CA--C 1.509 -0.628 0 N-CA-C 106.656 -1.609 . . . . 0.0 106.656 -179.85 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 12.8 mt -110.73 147.45 36.48 Favored Pre-proline 0 C--N 1.321 -0.657 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 176.779 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -72.96 162.18 41.67 Favored 'Trans proline' 0 C--O 1.236 0.376 0 O-C-N 122.265 0.613 . . . . 0.0 112.491 -179.718 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 56.8 tt0 -55.15 131.27 44.82 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 -179.797 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 104.27 -22.8 33.65 Favored Glycine 0 C--O 1.226 -0.359 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.842 -178.267 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 3.8 m -108.72 126.98 53.59 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 117.641 0.72 . . . . 0.0 109.791 177.778 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 15.5 p -121.64 148.41 44.6 Favored 'General case' 0 CA--C 1.508 -0.635 0 CA-C-O 121.029 0.442 . . . . 0.0 110.25 179.912 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 83.0 mt -71.79 152.92 93.31 Favored Pre-proline 0 C--N 1.321 -0.634 0 N-CA-C 107.305 -1.369 . . . . 0.0 107.305 178.011 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -77.63 172.58 15.54 Favored 'Trans proline' 0 C--O 1.237 0.439 0 CA-C-O 121.384 0.493 . . . . 0.0 111.252 179.022 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 65.2 tttm -57.61 127.51 32.4 Favored 'General case' 0 C--O 1.219 -0.519 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.778 -178.047 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 91.82 7.84 64.15 Favored Glycine 0 C--O 1.226 -0.406 0 N-CA-C 115.625 1.01 . . . . 0.0 115.625 177.678 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 34.5 m-85 -118.86 136.87 53.81 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 118.064 0.932 . . . . 0.0 109.927 177.774 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 55.2 p90 -144.93 161.8 38.46 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 176.683 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -99.45 146.27 26.52 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.617 0.722 . . . . 0.0 112.893 -175.665 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -75.39 132.02 40.61 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 178.658 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 88.6 -6.85 83.18 Favored Glycine 0 C--O 1.225 -0.412 0 C-N-CA 121.323 -0.465 . . . . 0.0 112.959 -179.032 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 31.6 t -107.5 122.41 46.6 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 178.848 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 2.8 tmt_? 47.66 56.31 7.27 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-O 121.979 0.895 . . . . 0.0 111.724 -179.413 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -73.14 145.04 35.64 Favored Glycine 0 N--CA 1.451 -0.326 0 N-CA-C 107.175 -2.37 . . . . 0.0 107.175 175.633 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 81.03 -147.59 27.69 Favored Glycine 0 C--O 1.236 0.254 0 N-CA-C 110.223 -1.151 . . . . 0.0 110.223 -178.098 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 75.3 m . . . . . 0 C--O 1.245 0.858 0 CA-C-O 116.541 -1.695 . . . . 0.0 108.085 178.827 . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.125 0 CA-C-O 118.123 -1.376 . . . . 0.0 111.501 . . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 62.01 -23.19 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.279 0 N-CA-C 120.149 3.388 . . . . 0.0 120.149 177.504 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 77.2 mtm -76.09 90.24 3.06 Favored 'General case' 0 C--N 1.308 -1.226 0 C-N-CA 123.17 0.588 . . . . 0.0 110.714 -179.594 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -90.15 43.07 2.93 Favored Glycine 0 C--O 1.228 -0.242 0 CA-C-N 116.121 -0.49 . . . . 0.0 113.95 -179.584 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 10.2 mp -66.04 144.69 98.88 Favored Pre-proline 0 C--N 1.326 -0.454 0 CA-C-N 117.126 0.463 . . . . 0.0 109.949 -178.641 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -74.55 148.02 36.88 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 117.696 -1.069 . . . . 0.0 112.735 179.405 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 49.3 t30 -90.69 -27.94 18.67 Favored 'General case' 0 C--O 1.215 -0.761 0 CA-C-O 121.36 0.6 . . . . 0.0 109.494 177.879 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 30.1 t30 65.18 32.13 10.33 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 125.495 1.518 . . . . 0.0 112.536 178.442 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 44.7 p -146.15 167.39 23.56 Favored 'General case' 0 N--CA 1.435 -1.204 0 N-CA-C 101.376 -3.565 . . . . 0.0 101.376 -179.329 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -148.33 151.32 35.15 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 116.004 -0.544 . . . . 0.0 109.574 178.58 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 34.0 p -64.21 145.65 55.63 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 178.351 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 13.1 m95 -64.73 -24.35 67.54 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.955 0.407 . . . . 0.0 112.086 179.5 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -121.38 163.93 17.91 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.578 -0.737 . . . . 0.0 112.416 -172.269 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 47.0 p -70.43 165.96 21.4 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 177.093 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -79.34 146.56 32.83 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.715 0.769 . . . . 0.0 112.472 -176.507 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 12.1 mt -83.32 146.73 28.35 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 102.931 -2.989 . . . . 0.0 102.931 169.151 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 29.9 m -129.78 138.75 51.23 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 -178.686 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.42 ' HB2' ' CZ ' ' A' ' 131' ' ' PHE . 4.0 tp60 -106.67 136.91 45.66 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.837 0.68 . . . . 0.0 112.837 -176.93 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 5.7 t60 -130.75 94.77 3.69 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 103.014 -2.958 . . . . 0.0 103.014 168.612 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 173.33 -157.33 26.01 Favored Glycine 0 C--O 1.223 -0.541 0 N-CA-C 110.957 -0.857 . . . . 0.0 110.957 -174.302 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 29.8 mtpp -112.32 -24.86 9.55 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 115.321 1.601 . . . . 0.0 115.321 -177.436 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 88.3 mt-10 -80.5 158.29 25.89 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 177.759 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -79.91 -62.8 1.57 Allowed 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 177.667 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 44.3 tp -179.25 141.09 0.16 Allowed 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 172.56 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 23.8 tptm -156.07 140.45 16.7 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 174.188 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 15.3 m-85 -125.02 152.1 69.92 Favored Pre-proline 0 C--O 1.242 0.68 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 175.817 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -72.69 160.41 46.43 Favored 'Trans proline' 0 CA--C 1.54 0.778 0 C-N-CA 120.658 0.905 . . . . 0.0 112.859 178.292 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.02 131.91 47.32 Favored 'General case' 0 C--O 1.216 -0.665 0 O-C-N 122.172 -0.33 . . . . 0.0 110.813 -178.033 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 85.45 7.27 82.64 Favored Glycine 0 N--CA 1.46 0.292 0 C-N-CA 121.445 -0.407 . . . . 0.0 112.181 179.195 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.407 HE22 HG23 ' A' ' 125' ' ' THR . 16.9 mt-30 -145.95 170.53 16.42 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 123.19 0.596 . . . . 0.0 109.983 -174.991 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 105.41 -16.88 44.36 Favored Glycine 0 CA--C 1.501 -0.819 0 CA-C-N 116.1 -0.5 . . . . 0.0 113.139 174.881 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 93.9 t -65.78 129.08 94.24 Favored Pre-proline 0 C--N 1.32 -0.704 0 N-CA-C 106.52 -1.659 . . . . 0.0 106.52 176.988 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -73.27 170.77 19.08 Favored 'Trans proline' 0 C--O 1.219 -0.433 0 O-C-N 122.148 0.552 . . . . 0.0 111.052 177.764 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 86.1 mt -70.55 106.56 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-O 122.009 0.909 . . . . 0.0 108.693 -179.601 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -98.14 84.1 3.21 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 114.514 -1.221 . . . . 0.0 110.017 -176.915 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 77.3 p -68.3 -14.08 62.73 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.775 0.798 . . . . 0.0 112.48 -179.313 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 11.5 p30 -106.69 22.98 15.02 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 114.82 -1.082 . . . . 0.0 111.718 -177.776 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 19.0 m -141.15 150.97 43.48 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 113.745 1.016 . . . . 0.0 113.745 -176.424 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.1 m -72.28 166.88 37.38 Favored Pre-proline 0 C--N 1.326 -0.441 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 176.415 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -66.4 -25.62 48.65 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 114.792 -3.005 . . . . 0.0 114.112 -179.714 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.466 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 4.5 p-10 -78.66 -20.63 49.82 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.586 0.708 . . . . 0.0 110.891 177.546 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 -81.64 -6.68 59.24 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 -176.086 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 96.0 mm-40 -57.7 -26.81 62.26 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 114.124 1.157 . . . . 0.0 114.124 -178.481 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 8.5 tt -59.31 138.35 20.49 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.939 0 N-CA-C 113.872 1.064 . . . . 0.0 113.872 -178.367 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -178.34 -158.2 20.57 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.389 -179.376 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 36.4 p90 -154.95 168.14 27.97 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 179.427 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 29.1 m-85 -112.77 141.74 46.22 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 174.634 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 69.2 ttt-85 -115.14 124.15 50.75 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 123.423 0.689 . . . . 0.0 112.514 -178.353 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 50.0 ttt180 -64.64 136.33 56.87 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 122.784 0.434 . . . . 0.0 110.12 177.3 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -152.13 150.92 30.42 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.713 0.634 . . . . 0.0 112.713 -179.791 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 6.4 p -144.15 147.88 34.29 Favored 'General case' 0 C--O 1.238 0.494 0 N-CA-C 105.488 -2.041 . . . . 0.0 105.488 172.704 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 16.1 tpt180 -166.22 123.86 1.42 Allowed 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 177.698 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 7.8 tmm_? -94.35 124.03 38.12 Favored 'General case' 0 CA--C 1.485 -1.553 0 CA-C-O 122.375 1.083 . . . . 0.0 111.0 177.973 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -126.74 174.64 10.2 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.076 0 CA-C-N 112.841 -1.981 . . . . 0.0 106.596 176.273 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 78.6 ttt180 -122.94 121.44 36.16 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 105.46 -2.052 . . . . 0.0 105.46 175.289 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -90.42 157.64 25.86 Favored Glycine 0 N--CA 1.448 -0.511 0 N-CA-C 106.969 -2.452 . . . . 0.0 106.969 177.955 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -72.21 -34.27 61.33 Favored Glycine 0 C--O 1.217 -0.966 0 N-CA-C 107.588 -2.205 . . . . 0.0 107.588 178.141 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 30.8 t0 -93.62 14.82 17.79 Favored 'General case' 0 C--O 1.217 -0.642 0 CA-C-O 122.529 1.157 . . . . 0.0 109.497 178.409 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 83.66 -17.21 26.8 Favored Glycine 0 C--O 1.227 -0.295 0 N-CA-C 117.101 1.601 . . . . 0.0 117.101 172.794 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.74 125.96 22.14 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 114.026 1.121 . . . . 0.0 114.026 -176.853 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 78.5 mtp -104.24 -179.32 3.91 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 114.37 -1.286 . . . . 0.0 112.239 -177.971 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 10.5 mptt -131.85 -47.25 0.95 Allowed 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.893 0.877 . . . . 0.0 111.331 -179.913 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -66.3 -172.07 0.14 Allowed 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 113.158 -1.837 . . . . 0.0 114.405 -179.512 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 79.52 -54.43 0.41 Allowed 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 126.855 2.062 . . . . 0.0 109.14 -177.967 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 22.3 p -92.14 131.84 33.9 Favored Pre-proline 0 C--N 1.32 -0.712 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 174.965 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -70.48 149.64 62.58 Favored 'Trans proline' 0 C--O 1.24 0.615 0 C-N-CA 115.513 -2.524 . . . . 0.0 111.112 178.734 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.411 HH12 ' CD ' ' A' ' 134' ' ' GLU . 0.1 OUTLIER -123.78 158.96 30.54 Favored 'General case' 0 CA--C 1.504 -0.803 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.096 -176.75 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 65.9 m95 -133.47 128.08 34.65 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 177.163 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 43.4 m-85 -110.92 143.26 41.83 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 106.669 -1.604 . . . . 0.0 106.669 -178.796 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 92.1 t80 -94.72 135.09 36.61 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 -175.844 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -137.92 155.55 48.81 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 108.072 -1.085 . . . . 0.0 108.072 -177.747 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 80.9 m-85 -89.39 159.47 17.3 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 112.06 0.393 . . . . 0.0 112.06 -174.362 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -55.05 128.95 36.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.01 -177.958 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 68.13 39.18 88.62 Favored Glycine 0 C--O 1.217 -0.91 0 CA-C-O 119.201 -0.777 . . . . 0.0 114.822 175.672 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -89.03 142.24 27.8 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 106.408 -1.701 . . . . 0.0 106.408 177.719 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 96.93 139.15 10.46 Favored Glycine 0 CA--C 1.527 0.822 0 N-CA-C 107.239 -2.344 . . . . 0.0 107.239 -173.25 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -68.26 -43.2 4.75 Favored 'Trans proline' 0 C--N 1.346 0.447 0 CA-C-N 120.033 1.917 . . . . 0.0 116.338 -172.733 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -117.13 42.07 2.62 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 -177.617 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -63.23 -30.51 71.64 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.0 -1.0 . . . . 0.0 111.923 -178.147 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 59.52 27.75 64.0 Favored Glycine 0 C--O 1.229 -0.195 0 CA-C-N 115.902 -0.59 . . . . 0.0 114.248 178.243 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 17.5 mt -118.66 103.84 48.09 Favored Pre-proline 0 N--CA 1.445 -0.72 0 N-CA-C 113.501 0.926 . . . . 0.0 113.501 -177.709 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -78.29 166.61 24.21 Favored 'Trans proline' 0 N--CA 1.46 -0.471 0 C-N-CA 121.54 1.494 . . . . 0.0 108.323 170.655 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 70.6 t80 -61.74 131.16 48.98 Favored 'General case' 0 C--N 1.321 -0.63 0 C-N-CA 120.371 -0.532 . . . . 0.0 109.978 -179.978 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 92.34 -7.07 78.31 Favored Glycine 0 CA--C 1.52 0.354 0 N-CA-C 114.943 0.737 . . . . 0.0 114.943 178.093 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -64.19 129.51 40.27 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 118.433 1.117 . . . . 0.0 111.866 -179.991 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -75.53 130.15 38.39 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.492 -177.778 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 28.1 ttmt -156.17 151.75 27.04 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 105.58 -2.007 . . . . 0.0 105.58 177.43 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 31.1 t0 -66.2 133.62 51.01 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.017 0.436 . . . . 0.0 110.423 -177.89 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 69.03 25.6 75.3 Favored Glycine 0 N--CA 1.449 -0.442 0 CA-C-O 119.46 -0.633 . . . . 0.0 114.089 179.234 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 41.3 mm -127.15 128.75 70.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 117.504 0.652 . . . . 0.0 110.484 179.898 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.1 pt -131.52 122.48 50.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 CA-C-N 115.782 -0.644 . . . . 0.0 109.719 175.312 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 94.0 m95 -88.35 138.75 31.16 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 -176.975 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 16.2 m -137.56 149.73 25.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 121.687 0.756 . . . . 0.0 109.635 178.806 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -158.5 166.6 31.77 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 102.684 -3.08 . . . . 0.0 102.684 -179.494 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 8.4 t -134.34 177.19 7.95 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 105.52 -2.03 . . . . 0.0 105.52 178.267 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 64.4 tt0 -67.46 134.46 51.41 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.142 0.496 . . . . 0.0 109.9 -178.547 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 96.01 -13.75 65.59 Favored Glycine 0 C--O 1.229 -0.19 0 CA-C-N 115.92 -0.582 . . . . 0.0 112.942 -179.804 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.466 ' HA ' ' HA ' ' A' ' 41' ' ' ASP . . . -73.42 138.17 45.06 Favored 'General case' 0 CA--C 1.54 0.575 0 O-C-N 122.498 -0.413 . . . . 0.0 110.288 178.964 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 31.7 mt -97.02 139.33 33.2 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 121.269 0.557 . . . . 0.0 112.398 -179.441 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -83.0 62.87 6.79 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.804 -178.872 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 1.2 t -131.98 152.89 81.04 Favored Pre-proline 0 C--N 1.324 -0.54 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 178.99 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -67.51 152.34 78.63 Favored 'Trans proline' 0 C--N 1.344 0.292 0 N-CA-C 114.489 0.919 . . . . 0.0 114.489 178.304 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 1.3 ptpt -151.87 59.07 0.86 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 122.879 1.324 . . . . 0.0 111.124 178.466 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 15.0 p-10 -56.33 -36.04 68.27 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 113.628 -1.624 . . . . 0.0 111.556 177.803 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 38.0 p-80 -60.58 -10.82 5.66 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 114.891 1.441 . . . . 0.0 114.891 -177.868 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 55.0 mt -92.36 -43.72 13.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 178.117 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -72.97 14.65 2.67 Favored Glycine 0 CA--C 1.523 0.541 0 N-CA-C 116.256 1.262 . . . . 0.0 116.256 -176.339 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 14.4 t -95.73 25.52 4.56 Favored 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 -177.382 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 62.4 ttp85 -55.62 129.98 41.21 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 179.629 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 6.5 m-20 -99.72 126.1 38.28 Favored Pre-proline 0 C--N 1.323 -0.57 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 -178.528 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -69.9 -17.88 36.69 Favored 'Trans proline' 0 C--O 1.219 -0.444 0 C-N-CA 118.041 -0.839 . . . . 0.0 113.465 -178.127 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -73.3 -28.67 62.23 Favored 'General case' 0 C--O 1.22 -0.463 0 CA-C-O 120.96 0.409 . . . . 0.0 110.681 178.239 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 76.1 m-20 -102.3 -24.72 13.85 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 -174.107 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 31.9 t30 -153.2 149.51 28.06 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 113.176 0.806 . . . . 0.0 113.176 -178.209 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -89.15 148.21 23.78 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-O 121.382 0.61 . . . . 0.0 111.497 179.392 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -68.49 143.47 54.97 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.374 0.606 . . . . 0.0 110.968 178.808 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 19.4 mt -85.28 139.87 16.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 -179.164 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 91.5 t -63.3 123.31 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 N-CA-C 106.105 -1.813 . . . . 0.0 106.105 175.271 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 6.8 tt -66.0 130.32 42.84 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.151 0.5 . . . . 0.0 110.598 -176.705 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 32.7 mt-30 -132.61 159.81 38.46 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 106.892 -1.521 . . . . 0.0 106.892 -179.376 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 13.7 mt -113.59 147.85 38.46 Favored Pre-proline 0 C--N 1.322 -0.589 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 177.256 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -72.82 169.51 21.87 Favored 'Trans proline' 0 C--N 1.344 0.34 0 O-C-N 122.254 0.607 . . . . 0.0 113.356 -178.6 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 60.3 tt0 -54.7 131.76 44.2 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.715 -179.638 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 93.13 -16.76 59.76 Favored Glycine 0 C--O 1.227 -0.339 0 CA-C-O 119.654 -0.525 . . . . 0.0 114.168 179.767 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.407 HG23 HE22 ' A' ' 30' ' ' GLN . 15.1 m -106.36 127.78 53.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 118.396 1.098 . . . . 0.0 110.547 178.864 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 10.4 p -121.23 148.7 43.92 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.593 -178.82 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 79.0 mt -71.05 153.52 94.54 Favored Pre-proline 0 C--N 1.324 -0.534 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 178.937 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -75.09 170.34 20.61 Favored 'Trans proline' 0 C--O 1.236 0.398 0 N-CA-C 110.363 -0.668 . . . . 0.0 110.363 178.089 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 13.9 tmtt? -54.74 121.4 8.45 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 113.314 0.857 . . . . 0.0 113.314 -174.093 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 95.24 -6.01 68.43 Favored Glycine 0 C--N 1.328 0.106 0 N-CA-C 116.719 1.448 . . . . 0.0 116.719 174.684 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.42 ' CZ ' ' HB2' ' A' ' 18' ' ' GLN . 1.5 m-85 -87.51 145.69 26.13 Favored 'General case' 0 N--CA 1.436 -1.16 0 CA-C-O 122.192 0.996 . . . . 0.0 110.342 178.813 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 37.4 p90 -145.4 163.11 35.6 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 113.458 -1.701 . . . . 0.0 107.625 175.326 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -102.98 145.39 29.94 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.081 0.467 . . . . 0.0 110.659 -177.787 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.411 ' CD ' HH12 ' A' ' 67' ' ' ARG . 33.7 tt0 -73.56 132.28 42.65 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 107.081 -1.452 . . . . 0.0 107.081 178.303 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 92.92 -2.4 72.28 Favored Glycine 0 C--O 1.223 -0.539 0 N-CA-C 111.125 -0.79 . . . . 0.0 111.125 -177.636 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 8.9 t -130.01 -177.22 4.21 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 177.496 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 4.3 tmt_? 65.06 -48.53 0.35 Allowed 'General case' 0 N--CA 1.484 1.252 0 N-CA-C 115.996 1.85 . . . . 0.0 115.996 179.33 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 72.99 -156.56 51.77 Favored Glycine 0 CA--C 1.518 0.263 0 CA-C-N 118.636 0.653 . . . . 0.0 111.97 179.789 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 145.25 -162.28 28.17 Favored Glycine 0 CA--C 1.508 -0.382 0 N-CA-C 110.17 -1.172 . . . . 0.0 110.17 179.465 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 22.1 m . . . . . 0 C--O 1.241 0.616 0 N-CA-C 106.279 -1.748 . . . . 0.0 106.279 176.97 . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.916 0 CA-C-O 118.099 -1.389 . . . . 0.0 111.315 . . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 54.87 45.28 26.89 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 117.849 0.825 . . . . 0.0 111.594 -177.614 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 11.6 mtp -132.11 103.18 6.13 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 105.476 -2.046 . . . . 0.0 105.476 179.839 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -176.88 122.52 0.85 Allowed Glycine 0 N--CA 1.443 -0.894 0 N-CA-C 107.843 -2.103 . . . . 0.0 107.843 -176.433 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 96.2 mt -128.32 153.2 78.95 Favored Pre-proline 0 C--N 1.315 -0.897 0 N-CA-C 105.552 -2.018 . . . . 0.0 105.552 177.185 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -72.63 -22.69 20.51 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 117.829 -0.981 . . . . 0.0 114.585 -177.979 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 15.0 t-20 -164.99 -157.22 0.34 Allowed 'General case' 0 N--CA 1.437 -1.085 1 N-CA-C 96.655 -5.313 . . . . 0.0 96.655 178.494 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -71.23 -39.9 71.4 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 118.58 0.627 . . . . 0.0 110.013 179.121 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 16.8 p 24.55 78.76 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.076 0 N-CA-C 116.769 2.137 . . . . 0.0 116.769 177.395 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -109.88 153.09 24.94 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.912 -177.655 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 54.0 p -63.27 144.99 56.47 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.02 178.478 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 42.8 m95 -68.78 -23.44 64.3 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 113.69 0.996 . . . . 0.0 113.69 179.987 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -116.84 160.09 21.37 Favored 'General case' 0 C--O 1.242 0.668 0 CA-C-O 121.239 0.542 . . . . 0.0 111.69 -174.898 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.463 ' HB ' ' HB3' ' A' ' 134' ' ' GLU . 75.9 p -70.13 163.1 27.02 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.694 -1.139 . . . . 0.0 109.482 178.999 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -82.65 135.87 34.92 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 113.478 0.918 . . . . 0.0 113.478 -175.809 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.0 mp -80.19 146.83 31.55 Favored 'General case' 0 CA--C 1.503 -0.854 0 N-CA-C 106.466 -1.679 . . . . 0.0 106.466 173.419 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 25.2 m -106.08 136.2 46.19 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 178.01 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 -110.78 128.2 55.66 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.265 0.555 . . . . 0.0 111.198 -178.359 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 40.7 t60 -129.12 99.47 5.27 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 106.229 -1.767 . . . . 0.0 106.229 175.18 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 165.79 -173.13 41.4 Favored Glycine 0 N--CA 1.451 -0.347 0 N-CA-C 110.418 -1.073 . . . . 0.0 110.418 -178.502 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -98.01 -16.94 19.44 Favored 'General case' 0 C--O 1.218 -0.566 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 -179.387 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 84.0 mt-10 -71.04 169.16 15.55 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 113.49 0.922 . . . . 0.0 113.49 -176.29 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 70.0 m-20 -116.17 24.33 11.49 Favored 'General case' 0 C--O 1.221 -0.428 0 CA-C-O 122.013 0.911 . . . . 0.0 111.797 178.895 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 62.2 tp 66.54 144.19 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 126.598 1.959 . . . . 0.0 113.597 179.987 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 49.3 tptt -157.74 138.15 12.79 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 176.234 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -123.56 136.27 27.04 Favored Pre-proline 0 C--O 1.242 0.699 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 173.535 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -64.04 162.34 29.79 Favored 'Trans proline' 0 CA--C 1.539 0.74 0 C-N-CA 121.205 1.27 . . . . 0.0 113.344 175.349 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -67.13 143.2 56.77 Favored 'General case' 0 C--O 1.22 -0.495 0 O-C-N 122.017 -0.427 . . . . 0.0 112.007 -179.278 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 78.29 13.65 83.06 Favored Glycine 0 C--O 1.222 -0.62 0 N-CA-C 111.115 -0.794 . . . . 0.0 111.115 178.951 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -152.52 168.6 25.0 Favored 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 -173.938 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 104.2 -19.87 41.96 Favored Glycine 0 CA--C 1.499 -0.951 0 CA-C-O 121.015 0.231 . . . . 0.0 112.881 173.809 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 58.3 t -72.01 127.25 90.8 Favored Pre-proline 0 C--N 1.319 -0.749 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 177.911 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -68.64 175.23 7.39 Favored 'Trans proline' 0 CA--C 1.531 0.36 0 N-CA-C 113.7 0.616 . . . . 0.0 113.7 177.404 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 88.0 mt -75.56 110.41 10.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 121.882 0.848 . . . . 0.0 109.174 178.616 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -108.35 83.26 1.75 Allowed 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 114.674 -1.148 . . . . 0.0 109.637 -178.406 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 80.9 p -69.71 -18.37 63.53 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 113.704 1.001 . . . . 0.0 113.704 -176.783 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -119.64 32.11 6.23 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 -175.916 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.4 m -136.35 157.38 46.93 Favored 'General case' 0 C--N 1.327 -0.394 0 O-C-N 122.045 -0.409 . . . . 0.0 111.456 179.214 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 15.0 m -72.68 159.35 85.57 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.017 -179.979 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -65.42 -24.92 56.47 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 116.127 -2.115 . . . . 0.0 111.331 176.833 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -62.14 -29.79 70.59 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.444 176.578 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 35.4 t0 -88.25 -6.38 57.83 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 113.737 1.014 . . . . 0.0 113.737 -172.536 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 95.1 mm-40 -62.03 -31.84 72.27 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 112.95 0.722 . . . . 0.0 112.95 -177.177 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 13.6 tt -62.42 137.86 23.54 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 CA-C-O 122.135 0.969 . . . . 0.0 110.753 177.902 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -179.25 -159.55 23.54 Favored Glycine 0 CA--C 1.504 -0.638 0 C-N-CA 120.1 -1.048 . . . . 0.0 111.51 -178.247 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 38.2 p90 -155.09 168.52 26.73 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 109.838 -0.431 . . . . 0.0 109.838 179.408 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 14.2 m-85 -110.34 137.32 48.21 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 175.615 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 47.6 ttt-85 -112.03 125.3 53.93 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 124.12 0.968 . . . . 0.0 109.936 -176.941 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 9.1 ttt180 -72.77 145.96 46.7 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 122.051 0.929 . . . . 0.0 109.339 179.343 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -75.91 170.8 15.55 Favored 'General case' 0 N--CA 1.432 -1.337 0 CA-C-N 114.165 -1.379 . . . . 0.0 109.895 178.472 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 8.5 t -61.7 147.82 44.78 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 122.222 1.011 . . . . 0.0 110.615 -178.747 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 10.2 tpt180 -72.46 147.42 46.11 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.687 -1.142 . . . . 0.0 111.661 -175.938 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 3.2 tmt_? -88.44 129.06 35.52 Favored 'General case' 0 CA--C 1.504 -0.799 0 N-CA-C 106.113 -1.81 . . . . 0.0 106.113 175.919 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -132.43 176.87 8.04 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-N 114.381 -1.282 . . . . 0.0 111.397 -172.639 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 18.8 ttm180 -112.68 117.03 31.12 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 103.92 -2.622 . . . . 0.0 103.92 174.783 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -92.79 142.41 15.97 Favored Glycine 0 C--O 1.222 -0.596 0 N-CA-C 109.301 -1.52 . . . . 0.0 109.301 179.45 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -70.9 -27.19 72.66 Favored Glycine 0 C--O 1.214 -1.125 0 C-N-CA 121.02 -0.61 . . . . 0.0 114.0 -177.337 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -83.55 -2.34 55.78 Favored 'General case' 0 C--O 1.218 -0.581 0 CA-C-O 121.516 0.674 . . . . 0.0 112.551 -178.319 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 102.94 12.14 32.72 Favored Glycine 0 CA--C 1.504 -0.624 0 CA-C-O 121.557 0.532 . . . . 0.0 112.267 172.037 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 2.6 pttt -130.22 149.23 52.01 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 111.875 0.324 . . . . 0.0 111.875 -177.895 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 23.1 ptm -147.8 176.92 9.74 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 114.594 1.331 . . . . 0.0 114.594 -170.282 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 13.4 mptt -82.35 -45.42 14.91 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.399 178.696 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 8.2 t0 62.45 -169.66 0.18 Allowed 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 112.129 -2.305 . . . . 0.0 113.657 -177.344 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER 66.53 165.16 0.2 Allowed 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 115.23 1.567 . . . . 0.0 115.23 -179.681 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -79.76 157.35 74.39 Favored Pre-proline 0 C--O 1.238 0.494 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 177.909 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -67.43 143.74 64.65 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 114.969 -2.887 . . . . 0.0 112.088 178.805 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 25.6 mtp180 -118.82 166.02 13.31 Favored 'General case' 0 CA--C 1.511 -0.531 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 179.396 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 71.3 m95 -131.09 132.05 44.6 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 178.031 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 61.1 m-85 -112.68 152.1 29.42 Favored 'General case' 0 C--O 1.214 -0.79 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 -178.792 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 77.8 t80 -102.03 136.67 41.46 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 119.35 0.977 . . . . 0.0 109.804 -177.816 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -141.03 146.6 37.44 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.981 -175.288 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 30.5 m-85 -77.82 159.48 28.95 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.128 0.49 . . . . 0.0 111.884 -178.62 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -55.31 131.76 46.37 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.015 179.436 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 72.09 27.82 69.54 Favored Glycine 0 C--O 1.219 -0.816 0 N-CA-C 116.095 1.198 . . . . 0.0 116.095 176.542 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 3.7 p -88.97 146.06 25.12 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 118.575 1.187 . . . . 0.0 108.527 177.734 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 104.67 143.76 12.45 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 109.656 -1.378 . . . . 0.0 109.656 -177.995 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -71.7 -40.22 2.96 Favored 'Trans proline' 0 C--N 1.347 0.448 0 CA-C-N 119.612 1.706 . . . . 0.0 115.553 -173.473 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -119.57 30.17 7.22 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.865 0.841 . . . . 0.0 109.743 -177.768 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -56.0 -43.51 77.75 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.94 -177.009 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 57.99 30.07 63.02 Favored Glycine 0 C--O 1.228 -0.274 0 CA-C-N 115.95 -0.568 . . . . 0.0 112.608 179.375 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 16.7 mt -114.72 103.75 54.67 Favored Pre-proline 0 N--CA 1.449 -0.508 0 N-CA-C 114.637 1.347 . . . . 0.0 114.637 -175.597 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -78.34 165.61 25.31 Favored 'Trans proline' 0 N--CA 1.462 -0.362 0 C-N-CA 121.525 1.484 . . . . 0.0 108.653 169.865 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 88.2 t80 -61.39 128.47 36.47 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.983 0.42 . . . . 0.0 110.505 -179.222 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 93.25 -6.83 75.74 Favored Glycine 0 CA--C 1.521 0.409 0 N-CA-C 115.364 0.905 . . . . 0.0 115.364 178.676 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -63.32 133.6 54.39 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 118.433 1.117 . . . . 0.0 112.417 -179.961 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -78.02 125.87 29.99 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.415 -179.246 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 29.6 ttmt -156.22 151.32 26.41 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 107.046 -1.464 . . . . 0.0 107.046 178.145 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -66.44 133.04 49.61 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 -178.204 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 70.44 24.04 77.06 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.889 -0.672 . . . . 0.0 114.019 178.022 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 43.5 mm -127.3 125.67 66.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 117.241 0.52 . . . . 0.0 109.918 179.229 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.1 pt -131.21 122.07 50.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 121.6 0.714 . . . . 0.0 110.5 177.055 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 94.0 m95 -88.25 138.28 31.58 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 -176.261 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 23.4 m -135.95 155.46 35.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 178.916 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -162.93 166.09 24.31 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 105.412 -2.07 . . . . 0.0 105.412 -179.843 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 11.9 t -135.98 173.66 11.47 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 105.37 -2.085 . . . . 0.0 105.37 178.38 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -67.6 136.72 54.89 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.161 0.505 . . . . 0.0 110.443 -178.646 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 92.51 -6.71 77.83 Favored Glycine 0 C--O 1.227 -0.289 0 CA-C-N 115.943 -0.572 . . . . 0.0 114.266 177.571 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -78.05 148.26 34.39 Favored 'General case' 0 C--N 1.322 -0.596 0 O-C-N 122.439 -0.448 . . . . 0.0 110.696 179.228 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 70.5 mt -81.21 170.78 15.68 Favored 'General case' 0 C--O 1.208 -1.095 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 178.015 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -112.96 28.84 8.46 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 121.239 0.542 . . . . 0.0 109.898 177.709 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -109.94 151.74 42.6 Favored Pre-proline 0 CA--C 1.546 0.825 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 -174.36 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -71.01 151.07 61.62 Favored 'Trans proline' 0 C--N 1.352 0.744 0 C-N-CA 120.481 0.787 . . . . 0.0 113.569 177.391 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 6.6 pttp -154.33 57.44 0.7 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 122.548 1.166 . . . . 0.0 111.423 -177.631 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -57.24 -31.99 66.11 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 114.518 -1.219 . . . . 0.0 112.511 179.813 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 11.9 p80 -60.67 -11.32 7.01 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 114.929 1.455 . . . . 0.0 114.929 -177.991 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 45.8 mt -92.31 -43.4 13.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 177.495 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -70.85 14.68 1.42 Allowed Glycine 0 CA--C 1.523 0.558 0 N-CA-C 117.296 1.678 . . . . 0.0 117.296 -175.556 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 12.3 t -90.31 30.24 1.15 Allowed 'General case' 0 CA--C 1.548 0.876 0 N-CA-C 112.527 0.566 . . . . 0.0 112.527 -178.108 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 68.8 ttp85 -56.19 131.25 47.3 Favored 'General case' 0 N--CA 1.475 0.808 0 O-C-N 121.426 -0.796 . . . . 0.0 109.846 179.398 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 37.1 m-20 -100.52 119.57 58.42 Favored Pre-proline 0 C--N 1.325 -0.465 0 N-CA-C 105.125 -2.176 . . . . 0.0 105.125 178.698 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -71.05 -17.34 31.84 Favored 'Trans proline' 0 C--N 1.347 0.469 0 N-CA-C 114.793 1.036 . . . . 0.0 114.793 -174.824 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -75.0 -25.37 58.76 Favored 'General case' 0 C--O 1.22 -0.48 0 CA-C-O 120.946 0.403 . . . . 0.0 110.064 177.631 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 -100.55 -24.67 14.4 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 113.296 0.85 . . . . 0.0 113.296 -175.519 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 23.5 t30 -149.56 145.44 26.82 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.933 0.716 . . . . 0.0 112.933 -179.446 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -83.66 147.54 27.63 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-O 121.617 0.722 . . . . 0.0 112.305 -179.914 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -72.33 147.46 46.29 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.669 178.315 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 9.9 mt -83.71 133.76 28.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 -179.255 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 74.0 t -62.73 120.93 10.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 N-CA-C 105.853 -1.906 . . . . 0.0 105.853 175.534 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 6.7 tt -68.44 128.95 38.44 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.21 0.529 . . . . 0.0 110.483 -176.919 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 29.8 mt-30 -132.14 156.51 46.26 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 105.835 -1.913 . . . . 0.0 105.835 179.065 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 14.1 mt -112.25 149.8 41.54 Favored Pre-proline 0 C--N 1.321 -0.631 0 N-CA-C 105.93 -1.878 . . . . 0.0 105.93 177.744 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -69.9 171.01 15.41 Favored 'Trans proline' 0 C--N 1.344 0.302 0 N-CA-C 115.136 1.168 . . . . 0.0 115.136 -175.061 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -54.9 130.94 43.19 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.835 -178.116 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 88.12 -10.68 69.92 Favored Glycine 0 C--O 1.227 -0.315 0 CA-C-N 115.89 -0.595 . . . . 0.0 112.648 -179.99 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 27.9 m -108.66 127.68 54.18 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.146 0.498 . . . . 0.0 110.662 -179.854 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 19.2 p -124.22 152.99 42.28 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.301 0.572 . . . . 0.0 112.309 -177.532 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 71.4 mt -70.36 155.45 93.41 Favored Pre-proline 0 C--N 1.326 -0.433 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 176.833 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -76.86 172.77 15.59 Favored 'Trans proline' 0 N--CA 1.463 -0.265 0 O-C-N 121.933 0.438 . . . . 0.0 111.038 179.085 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 48.5 tptt -60.78 132.57 54.3 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 -178.341 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 86.81 22.53 45.76 Favored Glycine 0 CA--C 1.518 0.247 0 N-CA-C 114.844 0.698 . . . . 0.0 114.844 177.816 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -131.91 143.43 50.13 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 117.35 0.575 . . . . 0.0 112.258 178.553 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 49.2 p90 -148.94 158.71 44.38 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 106.267 -1.753 . . . . 0.0 106.267 172.507 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -100.43 148.47 24.71 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.816 0.341 . . . . 0.0 110.279 -178.412 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.463 ' HB3' ' HB ' ' A' ' 14' ' ' THR . 8.7 tp10 -67.39 134.33 51.26 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.204 -1.035 . . . . 0.0 108.204 177.593 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 85.78 -7.89 75.08 Favored Glycine 0 C--O 1.227 -0.33 0 CA-C-N 116.058 -0.519 . . . . 0.0 112.941 -177.9 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 20.8 t -100.91 152.74 20.18 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.459 0.647 . . . . 0.0 109.86 179.95 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 41.3 mmt180 -140.38 -171.52 3.23 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 105.578 -2.008 . . . . 0.0 105.578 -178.924 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 101.51 34.5 4.42 Favored Glycine 0 C--O 1.223 -0.537 0 C-N-CA 120.916 -0.659 . . . . 0.0 113.042 179.812 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -158.41 175.78 35.47 Favored Glycine 0 N--CA 1.45 -0.424 0 N-CA-C 107.039 -2.425 . . . . 0.0 107.039 178.823 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 59.0 p . . . . . 0 C--O 1.253 1.288 0 CA-C-O 115.786 -2.054 . . . . 0.0 106.169 -179.215 . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.735 0 CA-C-O 119.269 -0.739 . . . . 0.0 111.452 . . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -73.63 153.77 40.02 Favored 'General case' 0 C--O 1.222 -0.392 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 178.323 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 87.9 mtp -120.89 34.31 5.26 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 121.296 0.57 . . . . 0.0 109.529 -179.953 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -91.25 42.44 2.84 Favored Glycine 0 C--O 1.22 -0.72 0 CA-C-N 116.018 -0.537 . . . . 0.0 114.073 -177.522 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -66.08 138.21 96.09 Favored Pre-proline 0 C--O 1.239 0.526 0 CA-C-N 117.297 0.548 . . . . 0.0 110.111 -177.923 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -74.84 152.81 42.07 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 118.327 -0.649 . . . . 0.0 111.783 177.412 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 59.4 t30 -155.94 98.06 1.86 Allowed 'General case' 0 C--N 1.327 -0.382 0 O-C-N 122.343 -0.223 . . . . 0.0 111.444 179.96 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -104.79 30.43 5.48 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-O 121.657 0.741 . . . . 0.0 110.438 179.966 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 22.6 p -140.93 162.54 35.22 Favored 'General case' 0 N--CA 1.433 -1.276 1 N-CA-C 98.539 -4.615 . . . . 0.0 98.539 -179.135 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -152.73 152.05 31.24 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-O 121.387 0.613 . . . . 0.0 112.273 -178.261 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.7 t -58.53 139.81 55.13 Favored 'General case' 0 CA--C 1.508 -0.647 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 174.902 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 22.1 m95 -64.27 -21.82 66.73 Favored 'General case' 0 C--N 1.323 -0.564 0 O-C-N 123.188 0.305 . . . . 0.0 111.323 177.855 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 51.6 m-85 -121.5 163.17 19.26 Favored 'General case' 0 C--O 1.241 0.628 0 N-CA-C 114.259 1.207 . . . . 0.0 114.259 -172.727 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 57.4 p -68.51 164.7 20.62 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 114.562 -1.199 . . . . 0.0 110.476 179.513 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -80.73 137.92 36.3 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 -176.34 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -90.21 147.3 23.64 Favored 'General case' 0 CA--C 1.502 -0.883 0 N-CA-C 105.767 -1.938 . . . . 0.0 105.767 171.883 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 91.8 m -123.7 141.71 51.76 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 -178.538 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 4.3 tp60 -111.23 136.14 50.74 Favored 'General case' 0 C--N 1.329 -0.295 0 O-C-N 123.629 0.581 . . . . 0.0 112.543 -177.783 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 46.0 t60 -133.32 99.44 4.53 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 103.813 -2.662 . . . . 0.0 103.813 169.551 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 179.12 -158.78 23.13 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.537 -0.839 . . . . 0.0 111.028 -175.204 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 35.3 mmtp -108.52 -28.09 9.52 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 113.958 1.096 . . . . 0.0 113.958 -178.225 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -90.94 167.45 12.41 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 176.231 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -81.81 -62.62 1.59 Allowed 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 -178.855 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 36.5 tp -174.39 142.79 0.8 Allowed 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 105.51 -2.033 . . . . 0.0 105.51 174.043 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 79.5 tttt -151.48 146.18 25.73 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 174.946 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -135.7 157.62 75.84 Favored Pre-proline 0 C--N 1.323 -0.562 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 176.939 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -71.78 172.82 13.73 Favored 'Trans proline' 0 CA--C 1.536 0.614 0 C-N-CA 120.718 0.945 . . . . 0.0 114.002 -179.429 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 25.3 tpt180 -78.41 130.97 36.72 Favored 'General case' 0 C--O 1.216 -0.675 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 177.798 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 81.07 7.15 88.86 Favored Glycine 0 C--O 1.225 -0.461 0 N-CA-C 115.279 0.871 . . . . 0.0 115.279 175.886 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.487 HE22 HG22 ' A' ' 125' ' ' THR . 25.2 tt0 -158.52 146.48 18.24 Favored 'General case' 0 C--O 1.217 -0.654 0 N-CA-C 106.457 -1.682 . . . . 0.0 106.457 -177.854 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 136.65 -17.21 3.73 Favored Glycine 0 CA--C 1.503 -0.676 0 C-N-CA 120.344 -0.932 . . . . 0.0 112.556 177.7 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 33.1 m -71.27 146.52 92.25 Favored Pre-proline 0 C--N 1.321 -0.637 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 176.922 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_endo -76.1 173.49 14.39 Favored 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 121.121 1.214 . . . . 0.0 112.606 178.65 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 93.3 mt -76.09 113.06 14.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 N-CA-C 108.042 -1.095 . . . . 0.0 108.042 178.517 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 45.0 m-20 -104.67 83.91 2.09 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 -178.801 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 69.0 p -64.26 -22.2 66.86 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 115.352 1.612 . . . . 0.0 115.352 -174.422 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 11.1 p30 -106.02 18.28 22.31 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.293 -177.384 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 9.4 m -125.55 157.88 35.96 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -175.152 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -74.29 162.26 74.62 Favored Pre-proline 0 C--N 1.323 -0.56 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 178.23 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -66.11 -23.03 53.67 Favored 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 115.159 -2.76 . . . . 0.0 112.015 177.542 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.459 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 0.0 OUTLIER -72.37 -13.56 61.5 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.278 0.561 . . . . 0.0 111.128 178.824 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -104.83 1.06 28.7 Favored 'General case' 0 C--O 1.219 -0.528 0 N-CA-C 114.541 1.311 . . . . 0.0 114.541 -175.063 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 86.6 mm-40 -62.54 -21.64 65.71 Favored 'General case' 0 CA--C 1.548 0.881 0 O-C-N 120.633 -1.292 . . . . 0.0 110.749 178.193 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 14.3 tt -62.69 143.26 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 CA-C-O 121.96 0.886 . . . . 0.0 112.827 178.413 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 177.14 -153.77 14.4 Favored Glycine 0 N--CA 1.446 -0.668 0 N-CA-C 110.774 -0.93 . . . . 0.0 110.774 178.565 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 43.2 p90 -154.95 168.48 26.82 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 178.242 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 40.1 m-85 -111.31 140.96 45.45 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 106.66 -1.607 . . . . 0.0 106.66 175.186 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 34.4 ttt180 -114.59 125.73 54.1 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 123.273 0.629 . . . . 0.0 111.913 -178.203 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 27.8 ttt180 -67.5 139.0 56.99 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 176.28 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -136.72 129.75 31.01 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.058 0.456 . . . . 0.0 110.855 179.339 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 27.3 p -145.54 154.41 42.15 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 106.533 -1.654 . . . . 0.0 106.533 176.322 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 15.8 tpt180 -163.33 121.69 1.99 Allowed 'General case' 0 CA--C 1.513 -0.443 0 N-CA-C 106.561 -1.644 . . . . 0.0 106.561 173.323 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 3.3 tmt_? -132.07 144.78 50.99 Favored 'General case' 0 CA--C 1.495 -1.136 0 CA-C-O 121.448 0.642 . . . . 0.0 109.81 -176.684 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -140.92 178.25 3.14 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 N-CA-C 105.378 -2.082 . . . . 0.0 105.378 -178.378 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 6.8 tmm_? -137.25 105.74 5.8 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 175.134 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -72.38 163.22 54.67 Favored Glycine 0 N--CA 1.448 -0.503 0 N-CA-C 108.853 -1.699 . . . . 0.0 108.853 178.305 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -71.24 -32.29 65.52 Favored Glycine 0 C--O 1.214 -1.11 0 N-CA-C 108.689 -1.764 . . . . 0.0 108.689 179.331 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 30.6 t0 -89.43 17.07 6.58 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 122.4 1.095 . . . . 0.0 109.478 178.47 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 84.16 -16.2 34.8 Favored Glycine 0 N--CA 1.46 0.259 0 N-CA-C 116.228 1.251 . . . . 0.0 116.228 173.302 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -56.52 134.37 54.11 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 113.886 1.069 . . . . 0.0 113.886 -176.976 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 47.1 mtp -112.83 -168.84 1.38 Allowed 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 113.536 -1.665 . . . . 0.0 110.29 -179.978 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 15.7 mmtt -122.75 -57.94 1.7 Allowed 'General case' 0 C--O 1.217 -0.61 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -178.689 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 58.0 p30 -135.55 174.72 10.3 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.433 -0.803 . . . . 0.0 112.062 -179.076 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 80.4 mt -136.17 -66.2 0.55 Allowed 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 177.681 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 20.0 m -79.98 150.87 72.6 Favored Pre-proline 0 C--O 1.244 0.771 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.036 178.857 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -75.04 157.56 42.53 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 117.111 -1.46 . . . . 0.0 111.417 176.233 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 7.6 ptt-85 -131.64 162.5 30.24 Favored 'General case' 0 CA--C 1.51 -0.569 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 177.128 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 64.3 m95 -129.57 147.67 51.39 Favored 'General case' 0 C--N 1.318 -0.769 0 O-C-N 123.458 0.474 . . . . 0.0 110.114 -178.316 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 72.9 m-85 -127.47 150.46 49.65 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 178.728 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 87.6 t80 -96.55 135.8 37.96 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 -179.621 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -136.07 140.75 44.02 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 121.822 0.82 . . . . 0.0 109.314 -176.949 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 78.2 m-85 -74.62 159.43 32.13 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 114.602 -1.181 . . . . 0.0 110.651 -176.624 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -57.16 135.81 56.4 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 114.088 1.144 . . . . 0.0 114.088 -176.619 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 65.54 29.17 74.56 Favored Glycine 0 C--O 1.224 -0.511 0 N-CA-C 115.869 1.108 . . . . 0.0 115.869 175.036 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 16.8 p -94.54 146.1 24.35 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 118.001 0.9 . . . . 0.0 110.19 179.739 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 108.21 141.56 9.74 Favored Glycine 0 CA--C 1.523 0.569 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 -177.57 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -69.59 -41.8 4.17 Favored 'Trans proline' 0 C--N 1.347 0.486 0 CA-C-N 119.824 1.812 . . . . 0.0 116.257 -173.337 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -109.34 19.58 19.22 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.522 0.677 . . . . 0.0 109.428 -177.351 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -60.54 -51.61 68.71 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.252 -175.794 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 56.45 26.98 53.02 Favored Glycine 0 C--O 1.224 -0.472 0 CA-C-N 115.857 -0.61 . . . . 0.0 114.386 179.45 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 52.1 mt -103.54 110.85 64.59 Favored Pre-proline 0 N--CA 1.447 -0.606 0 N-CA-C 115.278 1.584 . . . . 0.0 115.278 -175.465 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -78.58 167.65 22.35 Favored 'Trans proline' 0 C--O 1.238 0.501 0 N-CA-C 108.832 -1.257 . . . . 0.0 108.832 170.51 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 68.2 t80 -61.59 130.35 45.49 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 120.558 -0.457 . . . . 0.0 110.321 179.458 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 93.47 -5.48 74.19 Favored Glycine 0 CA--C 1.519 0.283 0 N-CA-C 115.013 0.765 . . . . 0.0 115.013 178.212 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -66.2 129.42 39.75 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 118.459 1.129 . . . . 0.0 112.381 179.977 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 54.7 t30 -75.8 128.1 34.42 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.772 -0.649 . . . . 0.0 112.104 -177.758 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 22.2 ttmt -156.23 152.98 28.45 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 106.978 -1.489 . . . . 0.0 106.978 178.116 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 22.4 t0 -64.86 133.09 51.14 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 -179.19 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 68.75 28.23 73.26 Favored Glycine 0 N--CA 1.448 -0.547 0 CA-C-O 119.557 -0.579 . . . . 0.0 114.308 178.14 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 40.2 mm -129.39 129.22 67.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 117.376 0.588 . . . . 0.0 110.17 179.418 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -131.64 117.75 36.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 CA-C-O 121.446 0.641 . . . . 0.0 110.517 176.172 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 95.9 m95 -86.26 133.07 33.85 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 112.23 0.456 . . . . 0.0 112.23 -177.269 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 1.2 m -140.87 151.12 20.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 -177.571 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -155.64 166.43 33.54 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 105.776 -1.935 . . . . 0.0 105.776 -177.908 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 11.4 t -127.18 171.29 11.56 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 105.621 -1.992 . . . . 0.0 105.621 175.21 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -64.76 136.28 56.75 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.327 0.584 . . . . 0.0 110.578 -179.544 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 94.2 -9.72 72.11 Favored Glycine 0 C--O 1.23 -0.117 0 CA-C-N 115.75 -0.659 . . . . 0.0 113.047 177.92 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.459 ' HA ' ' HA ' ' A' ' 41' ' ' ASP . . . -79.83 139.56 37.15 Favored 'General case' 0 CA--C 1.543 0.692 0 O-C-N 122.543 -0.386 . . . . 0.0 110.846 179.971 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 42.2 mt -102.03 137.67 40.01 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 114.65 1.352 . . . . 0.0 114.65 -176.437 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 50.3 t30 -81.18 75.39 8.15 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.101 -0.954 . . . . 0.0 110.252 179.29 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 2.0 t -139.24 157.55 70.74 Favored Pre-proline 0 CA--C 1.541 0.619 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 -179.373 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -64.35 145.01 87.56 Favored 'Trans proline' 0 C--N 1.348 0.512 0 N-CA-C 114.328 0.857 . . . . 0.0 114.328 -179.108 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 67.4 mmtt -126.41 33.55 4.98 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.664 0.745 . . . . 0.0 109.738 -178.11 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -51.45 -45.52 62.72 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.379 -0.828 . . . . 0.0 112.815 -177.189 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 17.8 p80 -72.93 -4.26 30.96 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 114.353 1.242 . . . . 0.0 114.353 -178.273 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 31.7 mt -96.35 -44.08 12.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 122.191 -0.318 . . . . 0.0 110.496 -179.154 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -74.06 12.11 5.62 Favored Glycine 0 CA--C 1.522 0.514 0 N-CA-C 115.205 0.842 . . . . 0.0 115.205 -178.306 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 13.4 t -83.29 19.72 1.44 Allowed 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 113.812 1.042 . . . . 0.0 113.812 -177.147 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 69.3 ttp85 -56.83 126.13 25.59 Favored 'General case' 0 N--CA 1.471 0.593 0 O-C-N 121.488 -0.757 . . . . 0.0 109.905 -179.3 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 34.4 m120 -93.56 124.21 57.82 Favored Pre-proline 0 C--N 1.322 -0.597 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 179.134 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -70.4 -17.73 34.48 Favored 'Trans proline' 0 C--O 1.219 -0.463 0 C-N-CA 117.021 -1.519 . . . . 0.0 113.15 -179.38 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -76.37 -26.86 56.08 Favored 'General case' 0 C--O 1.22 -0.454 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.247 178.021 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 84.1 m-20 -101.65 -23.69 14.22 Favored 'General case' 0 C--O 1.223 -0.33 0 N-CA-C 113.49 0.922 . . . . 0.0 113.49 -174.991 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 24.2 t30 -149.74 150.64 32.37 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 -178.373 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -88.21 149.02 24.09 Favored 'General case' 0 CA--C 1.545 0.779 0 CA-C-O 121.711 0.767 . . . . 0.0 112.559 179.639 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -72.74 149.86 43.35 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.905 178.364 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 16.7 mt -91.44 139.5 17.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 -179.26 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 93.2 t -62.73 123.79 16.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 N-CA-C 106.021 -1.844 . . . . 0.0 106.021 174.992 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 7.1 tt -66.11 131.25 45.74 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.129 0.49 . . . . 0.0 110.096 -177.215 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 28.3 mt-30 -129.31 152.17 49.16 Favored 'General case' 0 CA--C 1.508 -0.666 0 N-CA-C 106.227 -1.768 . . . . 0.0 106.227 179.838 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 14.3 mt -111.5 148.52 39.01 Favored Pre-proline 0 C--N 1.32 -0.682 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 178.891 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -71.07 165.61 31.82 Favored 'Trans proline' 0 C--N 1.345 0.38 0 O-C-N 122.231 0.595 . . . . 0.0 112.886 -178.546 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 59.5 tt0 -54.65 130.71 41.28 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.504 -177.8 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 94.12 -16.74 60.3 Favored Glycine 0 C--O 1.228 -0.276 0 CA-C-N 115.901 -0.591 . . . . 0.0 113.093 -179.4 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.487 HG22 HE22 ' A' ' 30' ' ' GLN . 10.5 m -102.64 129.51 49.25 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 117.652 0.726 . . . . 0.0 109.765 179.366 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 2.7 p -127.39 148.33 50.27 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.671 -177.788 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 72.9 mt -68.76 154.14 95.1 Favored Pre-proline 0 C--N 1.327 -0.378 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 177.719 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -74.92 170.7 19.81 Favored 'Trans proline' 0 C--O 1.233 0.256 0 C-N-CA 117.724 -1.051 . . . . 0.0 110.681 178.674 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 1.3 tptm -60.78 130.59 47.26 Favored 'General case' 0 C--N 1.324 -0.543 0 O-C-N 122.085 -0.384 . . . . 0.0 111.32 -176.13 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 95.19 -2.63 65.9 Favored Glycine 0 CA--C 1.518 0.225 0 N-CA-C 115.111 0.804 . . . . 0.0 115.111 178.256 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -102.37 144.31 31.02 Favored 'General case' 0 N--CA 1.441 -0.903 0 CA-C-O 122.106 0.955 . . . . 0.0 111.23 -179.964 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 47.6 p90 -146.32 163.33 35.88 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 114.022 -1.444 . . . . 0.0 108.305 174.492 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -111.35 146.44 37.08 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.775 0.322 . . . . 0.0 111.158 -177.429 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -73.29 138.12 45.27 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 178.837 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 84.75 -4.23 85.28 Favored Glycine 0 C--O 1.228 -0.28 0 CA-C-N 116.217 -0.447 . . . . 0.0 112.121 -176.787 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 7.5 t -119.04 -151.92 0.49 Allowed 'General case' 0 C--O 1.238 0.452 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 179.816 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 87.9 mmt-85 -137.95 162.01 35.19 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 105.624 -1.991 . . . . 0.0 105.624 178.048 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -127.09 179.84 16.16 Favored Glycine 0 C--N 1.319 -0.395 0 N-CA-C 108.514 -1.834 . . . . 0.0 108.514 178.756 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -124.08 167.73 16.34 Favored Glycine 0 N--CA 1.454 -0.14 0 N-CA-C 109.948 -1.261 . . . . 0.0 109.948 179.219 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 18.0 m . . . . . 0 C--O 1.247 0.966 0 CA-C-O 118.021 -0.99 . . . . 0.0 110.728 179.443 . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 2.807 0 CA-C-O 118.911 -0.938 . . . . 0.0 111.571 . . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -155.34 151.51 28.03 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 179.47 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -160.83 176.42 11.48 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 100.668 -3.827 . . . . 0.0 100.668 178.878 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 58.7 46.34 93.51 Favored Glycine 0 CA--C 1.507 -0.43 0 N-CA-C 115.662 1.025 . . . . 0.0 115.662 177.496 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 92.6 mt -62.86 130.83 94.22 Favored Pre-proline 0 C--N 1.325 -0.468 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 -179.592 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -74.46 146.32 34.88 Favored 'Trans proline' 0 N--CA 1.462 -0.362 0 C-N-CA 118.17 -0.753 . . . . 0.0 113.241 -177.413 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 51.5 t30 -104.81 -44.85 4.73 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.261 0.553 . . . . 0.0 111.792 178.879 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 15.9 p-10 -111.21 -1.39 16.15 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 113.677 0.991 . . . . 0.0 113.677 -176.787 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 40.6 p -115.75 99.52 7.37 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.588 0.709 . . . . 0.0 112.006 -177.45 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -105.84 145.87 30.65 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.26 -178.672 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 43.1 t -55.63 137.12 49.84 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 177.173 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 7.9 m95 -66.14 -21.93 66.36 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 178.798 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 44.2 m-85 -121.48 163.04 19.46 Favored 'General case' 0 CA--C 1.509 -0.598 0 N-CA-C 113.261 0.837 . . . . 0.0 113.261 -171.023 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 73.6 p -72.28 164.28 26.54 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.079 -0.964 . . . . 0.0 109.175 178.765 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -82.81 131.33 35.2 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 112.715 0.635 . . . . 0.0 112.715 -176.039 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 17.1 mt -72.06 148.04 46.19 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 174.134 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 6.2 m -117.58 140.3 49.82 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 -179.406 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 3.8 tp60 -109.72 128.18 55.1 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 123.557 0.536 . . . . 0.0 111.088 179.112 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 41.5 t60 -116.61 99.51 7.19 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 103.615 -2.735 . . . . 0.0 103.615 171.043 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 160.37 -159.2 30.62 Favored Glycine 0 N--CA 1.45 -0.391 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 -175.643 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 69.1 mttm -118.77 -23.43 7.01 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 114.106 1.15 . . . . 0.0 114.106 -178.304 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -74.35 159.75 31.97 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.763 -177.991 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -71.66 -62.95 1.23 Allowed 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 112.976 0.732 . . . . 0.0 112.976 -177.815 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 40.8 tp 153.73 143.43 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.306 0 N-CA-C 103.759 -2.682 . . . . 0.0 103.759 -176.183 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 50.0 tptt -156.44 141.02 16.87 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 175.477 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -125.38 149.91 65.9 Favored Pre-proline 0 C--O 1.241 0.634 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 175.908 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -71.75 161.3 45.56 Favored 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 120.651 0.901 . . . . 0.0 112.793 178.664 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 40.0 tpt85 -66.73 133.29 49.87 Favored 'General case' 0 C--O 1.216 -0.695 0 O-C-N 122.059 -0.401 . . . . 0.0 109.964 -178.437 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 86.02 7.0 81.35 Favored Glycine 0 C--O 1.223 -0.566 0 N-CA-C 111.66 -0.576 . . . . 0.0 111.66 178.839 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 18.4 mt-30 -146.42 170.57 16.56 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 -175.031 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 103.63 -15.08 53.36 Favored Glycine 0 CA--C 1.501 -0.84 0 CA-C-N 116.122 -0.49 . . . . 0.0 113.434 174.78 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 92.4 t -67.61 128.92 93.6 Favored Pre-proline 0 C--N 1.317 -0.81 0 N-CA-C 106.241 -1.763 . . . . 0.0 106.241 176.726 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -72.87 170.69 19.07 Favored 'Trans proline' 0 N--CA 1.459 -0.502 0 O-C-N 122.26 0.611 . . . . 0.0 111.214 178.22 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 90.6 mt -70.73 107.31 2.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-O 122.075 0.94 . . . . 0.0 108.715 -179.345 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 71.3 m-20 -101.46 84.98 2.69 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 114.357 -1.292 . . . . 0.0 109.417 -177.299 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 72.6 p -68.5 -15.03 63.4 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.722 0.772 . . . . 0.0 112.527 -178.704 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 21.0 p30 -106.0 21.96 16.44 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 114.845 -1.071 . . . . 0.0 112.062 -177.22 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 50.5 m -139.51 150.05 44.67 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 113.577 0.954 . . . . 0.0 113.577 -176.044 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 2.5 m -71.65 166.61 38.08 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.448 176.675 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -66.22 -25.9 49.81 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 114.811 -2.993 . . . . 0.0 114.159 -179.775 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.453 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 3.4 p-10 -78.06 -21.01 51.25 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.551 0.691 . . . . 0.0 110.922 177.194 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 62.0 m-20 -81.35 -8.29 59.71 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 113.214 0.82 . . . . 0.0 113.214 -175.34 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 97.1 mm-40 -57.83 -25.95 61.35 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 114.495 1.295 . . . . 0.0 114.495 -178.876 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 9.6 tt -58.38 138.92 18.75 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.971 0 CA-C-O 122.179 0.99 . . . . 0.0 113.638 -178.676 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 179.04 -159.67 24.69 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.411 -179.36 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 43.5 p90 -155.05 170.79 20.96 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 178.958 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 14.5 m-85 -113.1 140.07 48.19 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 173.764 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -110.26 121.66 45.82 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 123.938 0.895 . . . . 0.0 110.436 -178.579 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 40.2 ttp180 -70.84 130.84 42.72 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 174.535 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -142.5 146.6 34.88 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.177 0.513 . . . . 0.0 111.605 -178.737 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 10.2 t -155.4 162.47 40.78 Favored 'General case' 0 C--O 1.245 0.84 0 N-CA-C 104.021 -2.585 . . . . 0.0 104.021 174.186 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 10.1 tpp85 -169.68 139.7 2.04 Favored 'General case' 0 C--O 1.215 -0.733 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 -179.423 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 7.0 ttm180 -121.21 131.15 54.06 Favored 'General case' 0 CA--C 1.497 -1.068 0 N-CA-C 106.39 -1.707 . . . . 0.0 106.39 172.635 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -140.62 178.05 3.46 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 CA-C-N 114.684 -1.144 . . . . 0.0 107.961 -175.396 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.66 99.4 5.97 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 104.813 -2.291 . . . . 0.0 104.813 171.801 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -69.91 161.48 52.95 Favored Glycine 0 C--O 1.227 -0.319 0 N-CA-C 108.755 -1.738 . . . . 0.0 108.755 179.416 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -58.26 -41.41 94.91 Favored Glycine 0 C--O 1.223 -0.592 0 CA-C-N 118.036 0.918 . . . . 0.0 113.566 -178.039 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 32.2 t0 -89.12 15.67 8.41 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-O 122.343 1.068 . . . . 0.0 111.759 -179.584 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 87.45 9.11 73.05 Favored Glycine 0 C--O 1.221 -0.66 0 CA-C-N 115.326 -0.852 . . . . 0.0 113.191 172.865 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 21.8 mmtt -79.6 139.7 37.38 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.184 0.516 . . . . 0.0 109.697 -175.56 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 84.2 mtp -114.75 -167.36 1.21 Allowed 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.794 -177.91 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 57.3 mmtt -144.27 -73.76 0.26 Allowed 'General case' 0 C--O 1.213 -0.819 0 C-N-CA 123.14 0.576 . . . . 0.0 109.476 -177.806 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 30.74 -121.65 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.64 0 O-C-N 125.18 1.55 . . . . 0.0 114.606 179.102 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 59.47 -168.45 0.15 Allowed 'General case' 0 C--N 1.318 -0.766 0 O-C-N 124.772 1.295 . . . . 0.0 112.371 -179.487 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 18.9 m -62.09 153.73 72.77 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.744 179.411 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -65.74 148.57 86.89 Favored 'Trans proline' 0 C--O 1.237 0.447 0 C-N-CA 115.845 -2.303 . . . . 0.0 111.733 178.709 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 31.8 mtp180 -118.61 158.13 26.05 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 -177.653 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 64.2 m95 -120.13 129.58 54.22 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 120.852 0.358 . . . . 0.0 110.436 -179.054 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 24.1 m-85 -110.35 142.21 42.32 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 -178.778 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 85.4 t80 -94.22 136.76 34.16 Favored 'General case' 0 CA--C 1.511 -0.536 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 -178.182 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -139.63 146.56 39.9 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 -177.056 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -81.58 159.51 24.06 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.135 -175.703 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -54.59 131.53 43.22 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.921 0.391 . . . . 0.0 111.786 -179.277 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 71.38 33.71 64.21 Favored Glycine 0 C--O 1.222 -0.618 0 N-CA-C 115.583 0.993 . . . . 0.0 115.583 176.375 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 4.2 p -97.75 146.12 25.69 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 118.135 0.967 . . . . 0.0 110.384 178.64 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 98.61 147.86 22.68 Favored Glycine 0 CA--C 1.525 0.66 0 CA-C-O 119.769 -0.462 . . . . 0.0 112.743 178.968 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -69.14 -48.26 0.89 Allowed 'Trans proline' 0 C--N 1.35 0.614 0 N-CA-C 117.063 1.909 . . . . 0.0 117.063 -173.593 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -119.04 32.72 5.98 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.963 0.887 . . . . 0.0 108.718 -178.075 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -56.91 -40.67 76.75 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.4 -178.865 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 56.21 42.01 87.43 Favored Glycine 0 C--N 1.33 0.226 0 CA-C-N 115.839 -0.619 . . . . 0.0 112.391 178.006 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 13.7 mt -128.26 103.75 20.31 Favored Pre-proline 0 N--CA 1.441 -0.886 0 N-CA-C 114.136 1.162 . . . . 0.0 114.136 -177.175 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -78.63 161.52 27.82 Favored 'Trans proline' 0 N--CA 1.461 -0.398 0 N-CA-C 107.444 -1.791 . . . . 0.0 107.444 167.956 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 58.2 t80 -60.21 132.55 54.28 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 120.187 -0.605 . . . . 0.0 110.226 -178.313 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 91.84 -8.52 78.19 Favored Glycine 0 N--CA 1.452 -0.27 0 CA-C-O 119.193 -0.782 . . . . 0.0 114.712 178.873 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -66.03 129.63 40.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 118.788 1.294 . . . . 0.0 111.171 179.889 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 46.7 t-20 -79.32 128.72 33.69 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.421 -178.542 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 30.5 ttmt -156.18 153.19 28.85 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 107.483 -1.302 . . . . 0.0 107.483 -178.699 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -59.58 125.12 22.38 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.853 0.359 . . . . 0.0 111.807 -178.561 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 68.2 31.39 74.58 Favored Glycine 0 N--CA 1.448 -0.551 0 CA-C-O 119.286 -0.73 . . . . 0.0 113.9 178.262 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 43.4 mm -126.53 128.09 70.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 117.535 0.668 . . . . 0.0 109.954 178.442 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.1 pt -132.75 116.26 26.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 121.53 0.681 . . . . 0.0 110.599 176.555 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 94.8 m95 -82.94 138.45 33.82 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 112.216 0.45 . . . . 0.0 112.216 -177.86 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 16.0 m -137.69 150.91 25.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 178.816 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -160.3 165.33 31.54 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 103.523 -2.769 . . . . 0.0 103.523 179.837 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 14.8 t -125.07 175.82 7.1 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 104.941 -2.244 . . . . 0.0 104.941 178.114 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 -67.52 134.85 52.06 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 -179.826 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 91.49 -8.46 78.88 Favored Glycine 0 C--O 1.228 -0.244 0 CA-C-N 116.123 -0.49 . . . . 0.0 113.536 179.156 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.453 ' HA ' ' HA ' ' A' ' 41' ' ' ASP . . . -71.99 131.9 43.56 Favored 'General case' 0 CA--C 1.542 0.666 0 O-C-N 122.393 -0.475 . . . . 0.0 110.345 179.403 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 23.4 mt -88.91 138.89 31.0 Favored 'General case' 0 CA--C 1.51 -0.569 0 N-CA-C 112.995 0.739 . . . . 0.0 112.995 -177.433 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 56.9 t30 -83.94 72.11 10.45 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.353 -0.839 . . . . 0.0 111.046 179.475 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 2.3 t -143.4 155.38 60.94 Favored Pre-proline 0 C--N 1.324 -0.503 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 178.754 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_exo -67.61 153.25 76.74 Favored 'Trans proline' 0 CA--C 1.514 -0.495 0 CA-C-N 118.454 0.483 . . . . 0.0 113.183 179.175 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -152.02 52.73 0.8 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.928 0.871 . . . . 0.0 111.144 176.59 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -57.55 -26.54 61.57 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 114.918 -1.037 . . . . 0.0 109.972 175.194 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 9.6 p80 -57.18 -12.59 2.35 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 114.643 1.349 . . . . 0.0 114.643 179.198 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 64.2 mt -92.72 -45.19 14.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 178.372 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -70.59 14.72 1.32 Allowed Glycine 0 C--O 1.211 -1.298 0 N-CA-C 117.205 1.642 . . . . 0.0 117.205 -175.414 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 30.8 p -83.04 3.79 28.84 Favored 'General case' 0 CA--C 1.506 -0.718 0 C-N-CA 124.015 0.926 . . . . 0.0 113.249 -174.08 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 67.0 ttp85 -44.36 121.0 2.38 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 114.056 -1.429 . . . . 0.0 110.666 179.655 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 36.5 m120 -90.02 126.09 58.39 Favored Pre-proline 0 C--N 1.322 -0.624 0 N-CA-C 107.675 -1.232 . . . . 0.0 107.675 -179.579 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -69.89 -18.27 36.5 Favored 'Trans proline' 0 C--O 1.219 -0.473 0 C-N-CA 117.015 -1.524 . . . . 0.0 113.045 179.273 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -75.74 -27.95 58.32 Favored 'General case' 0 C--O 1.219 -0.536 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.308 178.125 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 -101.88 -23.96 14.09 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 113.283 0.846 . . . . 0.0 113.283 -175.244 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 26.8 t30 -150.63 148.63 28.86 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.941 0.719 . . . . 0.0 112.941 -178.201 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -87.86 147.33 25.16 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-O 121.521 0.677 . . . . 0.0 111.32 179.419 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -70.02 145.05 52.04 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.554 178.576 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 13.7 mt -83.18 139.06 18.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 -178.744 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 1.4 p -62.05 126.08 19.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 175.721 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 5.7 tt -65.91 128.57 36.56 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.156 0.503 . . . . 0.0 110.3 -176.748 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -132.33 157.55 44.17 Favored 'General case' 0 CA--C 1.509 -0.633 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 -178.73 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 13.7 mt -113.58 148.76 40.42 Favored Pre-proline 0 C--N 1.322 -0.622 0 N-CA-C 108.091 -1.078 . . . . 0.0 108.091 177.059 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -73.43 165.52 32.28 Favored 'Trans proline' 0 N--CA 1.463 -0.314 0 O-C-N 122.227 0.593 . . . . 0.0 112.867 -178.846 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 40.6 tt0 -54.69 130.35 40.15 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.655 -179.682 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 101.38 -22.45 38.91 Favored Glycine 0 C--O 1.224 -0.509 0 CA-C-N 116.043 -0.526 . . . . 0.0 112.838 -179.056 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 9.8 m -108.63 127.26 53.81 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 117.795 0.798 . . . . 0.0 109.456 178.167 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 16.5 p -119.69 148.33 43.51 Favored 'General case' 0 CA--C 1.51 -0.575 0 CA-C-O 121.035 0.445 . . . . 0.0 110.837 -179.398 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 91.8 mt -69.07 152.29 96.82 Favored Pre-proline 0 C--N 1.324 -0.529 0 N-CA-C 107.108 -1.441 . . . . 0.0 107.108 177.678 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -77.67 174.08 13.17 Favored 'Trans proline' 0 N--CA 1.462 -0.37 0 CA-C-O 121.425 0.51 . . . . 0.0 111.782 179.834 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -56.19 129.25 39.37 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.23 -178.487 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 91.65 -4.92 79.78 Favored Glycine 0 C--O 1.226 -0.353 0 N-CA-C 115.601 1.001 . . . . 0.0 115.601 177.063 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -102.39 136.75 41.66 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 117.937 0.868 . . . . 0.0 112.465 -178.068 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 41.5 p90 -143.46 163.14 33.94 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 114.213 -1.358 . . . . 0.0 108.269 174.895 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -103.82 138.0 41.04 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 -176.351 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -66.28 141.83 57.88 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.237 -0.892 . . . . 0.0 108.976 176.288 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 94.81 -32.79 5.79 Favored Glycine 0 N--CA 1.458 0.142 0 C-N-CA 121.604 -0.331 . . . . 0.0 113.366 179.756 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 32.7 t -68.7 123.59 21.33 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 177.249 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 64.1 ttp85 53.2 79.12 0.13 Allowed 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 114.057 1.132 . . . . 0.0 114.057 -178.982 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -70.62 168.63 48.93 Favored Glycine 0 CA--C 1.52 0.356 0 N-CA-C 110.539 -1.024 . . . . 0.0 110.539 176.916 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -175.88 -166.75 33.79 Favored Glycine 0 N--CA 1.451 -0.346 0 N-CA-C 107.708 -2.157 . . . . 0.0 107.708 -179.08 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 22.1 m . . . . . 0 C--O 1.25 1.101 0 CA-C-O 117.423 -1.275 . . . . 0.0 109.834 178.206 . . . . . . . . 0 0 . 1 . 031 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.589 0 CA-C-O 118.447 -1.196 . . . . 0.0 111.054 . . . . . . . . . 0 0 . 1 . 031 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -61.34 145.2 52.3 Favored 'General case' 0 C--O 1.239 0.509 0 N-CA-C 113.662 0.986 . . . . 0.0 113.662 -176.79 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 5.0 ppp? -165.0 169.39 16.42 Favored 'General case' 0 C--N 1.322 -0.619 1 N-CA-C 99.995 -4.076 . . . . 0.0 99.995 176.932 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 79.9 33.15 34.26 Favored Glycine 0 C--O 1.225 -0.441 0 C-N-CA 119.943 -1.122 . . . . 0.0 112.495 179.448 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -64.51 148.09 96.84 Favored Pre-proline 0 CA--C 1.539 0.548 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 179.536 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -73.02 -12.29 25.83 Favored 'Trans proline' 0 C--N 1.35 0.634 0 N-CA-C 113.361 0.485 . . . . 0.0 113.361 -179.534 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -149.58 -143.06 0.13 Allowed 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 101.364 -3.569 . . . . 0.0 101.364 176.79 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 12.6 m-80 -101.05 -34.35 9.77 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 112.813 0.671 . . . . 0.0 112.813 -179.467 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 40.5 p 35.69 78.9 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 115.7 1.741 . . . . 0.0 115.7 179.506 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -124.4 147.24 48.38 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 -174.737 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.432 ' HB3' ' CE1' ' A' ' 71' ' ' TYR . 11.6 p -60.22 139.22 57.7 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.389 178.568 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 47.5 m95 -71.3 -21.93 62.01 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 114.95 1.463 . . . . 0.0 114.95 -178.762 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -121.49 162.07 21.16 Favored 'General case' 0 C--O 1.24 0.562 0 N-CA-C 113.734 1.013 . . . . 0.0 113.734 -173.329 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 77.8 p -68.68 163.39 23.97 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 114.548 -1.206 . . . . 0.0 109.849 179.418 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -86.08 145.57 26.99 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 113.486 0.921 . . . . 0.0 113.486 -175.722 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -94.67 137.77 33.35 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 108.245 -1.021 . . . . 0.0 108.245 173.731 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 62.4 m -87.56 129.28 35.15 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 -179.924 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 16.6 tm0? -91.07 128.32 36.85 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 177.98 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 58.7 t60 -139.25 99.53 3.77 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 172.11 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 173.0 -170.91 44.06 Favored Glycine 0 C--O 1.229 -0.213 0 C-N-CA 120.496 -0.859 . . . . 0.0 111.445 179.511 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -97.66 -25.64 15.04 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 120.686 0.279 . . . . 0.0 110.529 178.631 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -96.5 163.23 13.13 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 105.594 -2.002 . . . . 0.0 105.594 174.631 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -88.62 -62.89 1.39 Allowed 'General case' 0 C--O 1.216 -0.691 0 N-CA-C 115.187 1.551 . . . . 0.0 115.187 -173.926 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 53.4 tp -176.87 142.93 0.41 Allowed 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 178.11 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 23.5 tptm -157.49 141.02 15.65 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 174.226 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 13.7 m-85 -123.92 152.49 66.5 Favored Pre-proline 0 C--O 1.24 0.595 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 175.53 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -70.41 159.09 54.1 Favored 'Trans proline' 0 CA--C 1.538 0.71 0 C-N-CA 120.449 0.766 . . . . 0.0 112.331 177.427 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 15.8 tpt180 -69.27 137.29 52.95 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 -178.377 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 83.85 8.64 84.02 Favored Glycine 0 C--O 1.222 -0.614 0 N-CA-C 111.345 -0.702 . . . . 0.0 111.345 179.082 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 9.1 mt-30 -150.92 170.95 18.06 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 -173.886 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 102.94 -16.67 54.08 Favored Glycine 0 CA--C 1.499 -0.928 0 CA-C-N 116.219 -0.446 . . . . 0.0 112.031 175.756 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 77.9 t -66.07 128.68 93.98 Favored Pre-proline 0 C--N 1.319 -0.759 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 177.144 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -73.46 170.11 20.7 Favored 'Trans proline' 0 N--CA 1.461 -0.435 0 O-C-N 122.201 0.579 . . . . 0.0 112.373 178.404 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 78.5 mt -73.01 112.38 9.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 -179.851 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 48.9 m-20 -109.89 77.29 1.04 Allowed 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 114.622 -1.172 . . . . 0.0 109.406 -177.189 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 71.5 p -65.11 -20.96 66.72 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 115.586 1.698 . . . . 0.0 115.586 -173.658 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 5.5 p30 -113.64 31.05 6.78 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.976 -176.175 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 78.0 p -134.42 166.57 22.55 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.011 0.434 . . . . 0.0 110.839 179.63 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 28.1 m -81.58 160.32 64.72 Favored Pre-proline 0 C--N 1.322 -0.612 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.75 -179.219 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -67.81 -24.23 40.69 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 116.453 -1.898 . . . . 0.0 114.033 -179.461 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -75.52 -12.62 60.26 Favored 'General case' 0 C--N 1.322 -0.592 0 O-C-N 121.562 -0.711 . . . . 0.0 111.264 177.241 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 27.3 t0 -94.84 1.05 55.32 Favored 'General case' 0 C--O 1.214 -0.798 0 N-CA-C 113.328 0.862 . . . . 0.0 113.328 -177.371 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 93.1 mm-40 -62.34 -20.2 64.12 Favored 'General case' 0 CA--C 1.548 0.89 0 O-C-N 121.074 -1.016 . . . . 0.0 111.711 178.965 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 17.5 tt -63.98 140.46 19.65 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-O 122.118 0.961 . . . . 0.0 112.293 177.701 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 178.49 -161.17 27.62 Favored Glycine 0 CA--C 1.502 -0.737 0 C-N-CA 119.794 -1.193 . . . . 0.0 112.781 178.328 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 46.1 p90 -155.24 165.68 35.92 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 178.642 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 19.0 m-85 -106.87 139.68 40.9 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 106.771 -1.566 . . . . 0.0 106.771 175.986 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 42.5 ttt180 -113.47 118.23 33.93 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.08 -174.869 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 26.3 ttt180 -66.47 137.72 57.03 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 176.655 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -137.3 125.65 23.32 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.733 0.777 . . . . 0.0 111.465 179.923 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 37.7 p -136.74 154.28 50.63 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 106.079 -1.823 . . . . 0.0 106.079 177.128 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 65.1 ttt180 -159.73 124.04 3.85 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 121.06 -0.256 . . . . 0.0 110.486 177.399 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.35 144.33 51.32 Favored 'General case' 0 CA--C 1.484 -1.581 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 175.647 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -142.47 175.23 4.77 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.132 0 N-CA-C 105.854 -1.906 . . . . 0.0 105.854 179.023 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 78.0 ttt180 -119.67 128.89 54.25 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 102.466 -3.161 . . . . 0.0 102.466 171.14 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -80.89 -176.8 51.03 Favored Glycine 0 C--O 1.221 -0.667 0 N-CA-C 110.796 -0.922 . . . . 0.0 110.796 -179.784 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -78.75 -34.29 35.21 Favored Glycine 0 C--O 1.216 -1.005 0 N-CA-C 107.886 -2.086 . . . . 0.0 107.886 179.385 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -71.38 -20.69 62.11 Favored 'General case' 0 C--O 1.217 -0.655 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 175.184 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 108.43 -15.52 35.42 Favored Glycine 0 CA--C 1.503 -0.696 0 N-CA-C 110.351 -1.1 . . . . 0.0 110.351 172.593 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.8 144.57 57.16 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-O 122.394 1.092 . . . . 0.0 112.294 -177.96 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 5.4 mtp -87.8 175.08 8.0 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 114.01 -1.45 . . . . 0.0 112.57 -177.184 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 1.6 tmtm? -78.4 -46.04 20.87 Favored 'General case' 0 C--O 1.217 -0.642 0 CA-C-O 121.949 0.881 . . . . 0.0 109.797 176.915 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.2 t0 47.39 24.85 0.51 Allowed 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 119.054 2.983 . . . . 0.0 119.054 178.573 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.6 mp -83.45 149.01 26.93 Favored 'General case' 0 C--O 1.239 0.528 0 O-C-N 121.397 -0.814 . . . . 0.0 111.752 178.543 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -66.71 158.42 79.65 Favored Pre-proline 0 C--O 1.243 0.738 0 CA-C-N 115.395 -0.82 . . . . 0.0 111.909 178.834 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -71.44 147.21 51.87 Favored 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 118.126 -0.782 . . . . 0.0 112.582 177.585 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 1.2 mtt180 -134.14 165.81 24.22 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.998 176.228 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 62.5 m95 -121.89 135.03 54.86 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 176.328 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -112.83 171.77 7.33 Favored 'General case' 0 C--O 1.215 -0.738 0 N-CA-C 105.891 -1.892 . . . . 0.0 105.891 178.142 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -118.4 139.47 51.34 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 178.673 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.432 ' CE1' ' HB3' ' A' ' 11' ' ' SER . 14.2 m-85 -139.06 139.33 37.74 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 -176.545 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 45.3 m-85 -68.67 159.51 32.0 Favored 'General case' 0 C--O 1.24 0.585 0 N-CA-C 110.013 -0.366 . . . . 0.0 110.013 177.14 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 19.7 tp -53.4 130.56 35.74 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 121.18 0.514 . . . . 0.0 112.229 -178.515 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 67.49 28.41 73.6 Favored Glycine 0 C--O 1.223 -0.573 0 N-CA-C 116.269 1.268 . . . . 0.0 116.269 174.636 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 16.2 p -92.17 146.02 24.05 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 118.262 1.031 . . . . 0.0 110.409 177.927 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 104.15 137.69 9.36 Favored Glycine 0 CA--C 1.527 0.829 0 N-CA-C 110.701 -0.96 . . . . 0.0 110.701 -178.913 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -69.96 -36.65 9.91 Favored 'Trans proline' 0 C--N 1.348 0.516 0 N-CA-C 116.272 1.605 . . . . 0.0 116.272 -174.506 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -103.44 15.15 29.76 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 -176.838 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -63.68 -50.95 67.22 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 120.217 -0.593 . . . . 0.0 111.547 -174.438 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 55.97 34.55 61.93 Favored Glycine 0 CA--C 1.519 0.325 0 CA-C-N 116.186 -0.461 . . . . 0.0 113.059 -179.979 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 18.1 mt -116.83 103.79 51.86 Favored Pre-proline 0 N--CA 1.448 -0.543 0 N-CA-C 115.939 1.829 . . . . 0.0 115.939 -175.394 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -78.76 164.01 25.87 Favored 'Trans proline' 0 N--CA 1.462 -0.344 0 C-N-CA 122.42 2.08 . . . . 0.0 108.176 168.274 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 56.2 t80 -62.08 132.29 52.38 Favored 'General case' 0 C--N 1.321 -0.642 0 O-C-N 121.947 -0.471 . . . . 0.0 110.627 -177.698 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 90.4 -6.17 82.43 Favored Glycine 0 C--O 1.227 -0.29 0 N-CA-C 114.528 0.571 . . . . 0.0 114.528 179.131 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -65.15 132.04 48.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 118.242 1.021 . . . . 0.0 111.821 179.677 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 50.5 t30 -78.68 127.31 31.92 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.523 179.403 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 28.2 ttmt -156.19 152.14 27.48 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 106.266 -1.753 . . . . 0.0 106.266 178.578 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 19.1 t0 -64.55 131.83 48.14 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 -179.249 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 69.66 28.84 71.71 Favored Glycine 0 N--CA 1.446 -0.655 0 N-CA-C 114.958 0.743 . . . . 0.0 114.958 177.116 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 42.7 mm -127.89 128.15 68.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 117.401 0.6 . . . . 0.0 109.985 179.044 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.1 pt -131.58 123.62 52.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.351 176.98 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 97.8 m95 -88.39 135.57 33.4 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 114.149 1.166 . . . . 0.0 114.149 -175.304 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 17.8 m -136.16 152.03 29.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 178.778 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -163.97 166.6 21.44 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 103.514 -2.773 . . . . 0.0 103.514 -179.969 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 13.3 t -134.53 174.72 10.24 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 104.78 -2.304 . . . . 0.0 104.78 177.675 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 78.2 tt0 -66.71 135.21 53.67 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.185 0.516 . . . . 0.0 109.999 -178.955 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 95.75 -9.72 68.56 Favored Glycine 0 C--O 1.228 -0.234 0 CA-C-N 115.93 -0.577 . . . . 0.0 113.623 178.635 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -76.78 137.95 39.6 Favored 'General case' 0 CA--C 1.54 0.571 0 O-C-N 122.323 -0.516 . . . . 0.0 109.859 179.457 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 32.3 mt -92.56 140.29 29.7 Favored 'General case' 0 C--O 1.22 -0.471 0 CA-C-O 121.555 0.693 . . . . 0.0 112.324 -178.236 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 61.3 t30 -85.04 66.59 9.83 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.498 -0.773 . . . . 0.0 110.518 -179.037 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -136.37 152.84 75.73 Favored Pre-proline 0 C--N 1.324 -0.502 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 -179.527 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -68.45 150.87 75.94 Favored 'Trans proline' 0 C--N 1.344 0.326 0 N-CA-C 115.249 1.211 . . . . 0.0 115.249 178.779 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 67.5 mmtt -127.12 31.61 5.22 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.189 -0.914 . . . . 0.0 113.32 -176.339 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 18.1 t0 -60.98 -27.56 68.37 Favored 'General case' 0 N--CA 1.475 0.789 0 O-C-N 121.287 -0.883 . . . . 0.0 111.616 -178.135 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 47.2 p-80 -67.95 -16.78 64.22 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.806 177.853 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 66.3 mt -94.25 -38.56 9.45 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 176.078 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -72.96 6.73 11.72 Favored Glycine 0 C--O 1.225 -0.429 0 N-CA-C 115.668 1.027 . . . . 0.0 115.668 -178.214 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 14.5 t -83.05 25.44 0.69 Allowed 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 117.785 0.792 . . . . 0.0 111.684 -178.862 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.401 ' HD2' ' OD1' ' A' ' 114' ' ' ASN . 65.3 ttp85 -57.45 131.82 51.29 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.949 -179.42 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 55.1 m-20 -99.65 115.1 65.89 Favored Pre-proline 0 C--N 1.326 -0.423 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 178.804 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -72.8 -12.54 26.47 Favored 'Trans proline' 0 C--O 1.218 -0.518 0 N-CA-C 114.089 0.765 . . . . 0.0 114.089 -177.352 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -74.87 -24.56 58.58 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 176.042 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 -102.19 -30.78 10.92 Favored 'General case' 0 C--O 1.222 -0.344 0 N-CA-C 113.012 0.745 . . . . 0.0 113.012 -176.036 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . 0.401 ' OD1' ' HD2' ' A' ' 109' ' ' ARG . 0.9 OUTLIER -132.07 150.26 52.2 Favored 'General case' 0 N--CA 1.44 -0.937 0 CA-C-O 121.279 0.561 . . . . 0.0 112.265 -177.186 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -100.65 138.4 37.75 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 175.701 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -66.33 150.01 49.51 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.303 0.573 . . . . 0.0 111.722 -179.191 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 3.1 mt -87.96 141.48 14.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.669 -177.323 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 1.3 p -62.22 125.92 19.47 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 176.211 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 7.0 tt -70.07 129.62 39.92 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.25 -178.055 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 25.6 mt-30 -131.71 159.49 38.25 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 106.47 -1.678 . . . . 0.0 106.47 179.378 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 14.2 mt -114.37 146.09 35.12 Favored Pre-proline 0 C--N 1.323 -0.561 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 177.98 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -74.63 172.07 16.94 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 120.228 0.619 . . . . 0.0 113.678 -178.547 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 6.0 tp-100 -53.65 137.07 38.13 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.753 179.42 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 89.82 -20.71 34.04 Favored Glycine 0 N--CA 1.453 -0.229 0 CA-C-N 115.927 -0.579 . . . . 0.0 113.733 -179.11 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 3.9 m -108.56 129.81 55.3 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 118.274 1.037 . . . . 0.0 111.143 -179.995 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 2.3 p -125.87 148.27 49.23 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 -178.951 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 91.0 mt -68.93 154.57 94.82 Favored Pre-proline 0 C--N 1.327 -0.38 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 178.357 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -75.57 170.55 20.0 Favored 'Trans proline' 0 N--CA 1.463 -0.296 0 C-N-CA 118.342 -0.639 . . . . 0.0 111.48 -179.615 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -60.2 129.16 40.34 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 179.253 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 89.73 21.34 40.34 Favored Glycine 0 C--O 1.225 -0.444 0 C-N-CA 120.904 -0.665 . . . . 0.0 114.734 178.835 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -131.15 141.76 50.14 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 117.472 0.636 . . . . 0.0 111.651 178.115 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 51.8 p90 -150.47 163.79 37.53 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 175.508 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -107.35 147.25 30.56 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 113.396 0.887 . . . . 0.0 113.396 -175.826 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -73.52 142.7 46.72 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.091 -0.959 . . . . 0.0 109.666 177.206 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 93.38 -39.56 2.93 Favored Glycine 0 CA--C 1.519 0.298 0 N-CA-C 114.169 0.428 . . . . 0.0 114.169 178.665 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -66.31 137.47 56.94 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-O 121.854 0.835 . . . . 0.0 111.425 178.514 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 16.2 mtm105 -127.86 137.37 52.32 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 105.734 -1.95 . . . . 0.0 105.734 176.368 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -79.11 -25.29 59.92 Favored Glycine 0 C--O 1.224 -0.487 0 CA-C-O 121.697 0.609 . . . . 0.0 114.076 -177.944 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 167.88 -164.74 38.2 Favored Glycine 0 C--N 1.319 -0.391 0 N-CA-C 107.433 -2.267 . . . . 0.0 107.433 -178.658 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 15.7 m . . . . . 0 C--O 1.245 0.842 0 O-C-N 124.805 0.944 . . . . 0.0 111.042 -179.195 . . . . . . . . 0 0 . 1 . 032 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.577 0 CA-C-O 117.909 -1.495 . . . . 0.0 111.044 . . . . . . . . . 0 0 . 1 . 032 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 54.9 -158.22 0.2 Allowed 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 117.695 0.747 . . . . 0.0 110.061 -176.168 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 67.0 mtm 54.69 35.36 23.69 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.257 0.623 . . . . 0.0 112.037 179.474 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -173.42 116.48 0.6 Allowed Glycine 0 N--CA 1.445 -0.736 0 N-CA-C 107.09 -2.404 . . . . 0.0 107.09 -178.035 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 91.5 mt -110.61 153.11 43.73 Favored Pre-proline 0 C--N 1.319 -0.74 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 179.414 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -69.18 142.82 51.58 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 116.495 -1.87 . . . . 0.0 113.439 -178.114 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 32.4 t-20 -89.06 81.21 6.85 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 122.05 0.929 . . . . 0.0 110.098 -179.227 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -109.8 24.4 13.09 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 106.611 -1.626 . . . . 0.0 106.611 174.136 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 8.4 p -95.74 90.21 5.59 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 -176.769 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -95.52 142.61 27.66 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-O 121.422 0.629 . . . . 0.0 109.668 -177.924 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 61.6 p -58.14 141.53 50.05 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.213 -0.903 . . . . 0.0 109.882 179.108 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . 0.432 ' CD2' ' HD3' ' A' ' 109' ' ' ARG . 23.9 m95 -65.65 -26.44 67.8 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.769 178.213 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 78.0 m-85 -121.74 162.87 20.04 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.302 0.572 . . . . 0.0 112.379 -174.235 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 73.1 p -71.44 164.86 24.99 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 176.529 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -77.74 157.04 30.23 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.855 0.836 . . . . 0.0 113.219 -177.672 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 25.0 mt -92.39 148.91 21.74 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 102.919 -2.993 . . . . 0.0 102.919 168.005 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 33.2 m -121.36 128.5 52.31 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 120.897 0.379 . . . . 0.0 110.396 -178.03 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 1.9 tm0? -90.42 130.03 36.54 Favored 'General case' 0 CA--C 1.512 -0.501 0 CA-C-N 115.567 -0.742 . . . . 0.0 112.82 -177.554 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 52.9 t60 -138.76 99.9 3.92 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 106.354 -1.721 . . . . 0.0 106.354 167.217 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 159.58 -140.86 7.09 Favored Glycine 0 C--N 1.323 -0.181 0 C-N-CA 119.589 -1.291 . . . . 0.0 113.813 -176.969 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -115.71 -27.18 7.15 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 114.875 1.435 . . . . 0.0 114.875 -177.692 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -78.46 151.96 32.37 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 177.403 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -79.13 -57.55 3.67 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 179.197 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 41.9 tp 175.96 135.16 0.05 OUTLIER 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 101.254 -3.61 . . . . 0.0 101.254 171.103 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 11.2 tmtt? -154.22 133.23 12.43 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 179.448 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 21.8 m-85 -122.33 153.3 61.89 Favored Pre-proline 0 C--O 1.241 0.636 0 O-C-N 123.023 0.202 . . . . 0.0 111.44 176.726 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -74.51 159.91 42.3 Favored 'Trans proline' 0 CA--C 1.538 0.702 0 CA-C-O 120.935 0.306 . . . . 0.0 111.768 175.727 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 17.0 tpt180 -70.71 139.75 51.25 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 -178.411 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 87.05 2.11 84.0 Favored Glycine 0 C--O 1.221 -0.687 0 N-CA-C 110.707 -0.957 . . . . 0.0 110.707 179.524 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 30.6 mt-30 -146.69 -179.66 6.94 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 -174.797 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 99.36 -20.26 50.54 Favored Glycine 0 CA--C 1.498 -0.987 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.714 176.232 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 86.8 t -67.92 126.87 93.16 Favored Pre-proline 0 C--N 1.317 -0.818 0 N-CA-C 106.703 -1.592 . . . . 0.0 106.703 177.295 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -73.28 167.53 27.08 Favored 'Trans proline' 0 N--CA 1.46 -0.485 0 C-N-CA 120.111 0.541 . . . . 0.0 112.494 178.649 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 85.6 mt -67.25 111.74 2.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 122.023 0.916 . . . . 0.0 109.352 -178.869 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 26.6 m-20 -94.82 100.79 12.62 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 114.394 -1.276 . . . . 0.0 110.157 -177.973 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 80.7 p -80.52 -20.32 43.8 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 113.912 1.078 . . . . 0.0 113.912 -176.901 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -117.45 3.66 12.49 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 115.411 1.634 . . . . 0.0 115.411 -174.486 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -110.77 157.27 19.97 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 115.756 1.761 . . . . 0.0 115.756 -171.926 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 47.6 m -79.23 162.77 62.76 Favored Pre-proline 0 C--N 1.318 -0.783 0 CA-C-N 113.896 -1.502 . . . . 0.0 108.845 177.937 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -67.48 -20.66 47.56 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 116.986 -1.543 . . . . 0.0 114.878 -177.46 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.406 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 6.2 p-10 -75.21 -20.39 59.3 Favored 'General case' 0 C--N 1.321 -0.637 0 O-C-N 121.74 -0.6 . . . . 0.0 111.075 178.359 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -88.79 0.87 56.1 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 114.394 1.257 . . . . 0.0 114.394 -174.746 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 94.4 mm-40 -62.45 -29.03 70.23 Favored 'General case' 0 C--N 1.316 -0.876 0 O-C-N 121.062 -1.024 . . . . 0.0 111.526 -179.382 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 13.3 tt -64.93 139.04 22.07 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.771 0 CA-C-O 122.009 0.909 . . . . 0.0 112.112 178.419 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 176.46 -158.97 25.65 Favored Glycine 0 CA--C 1.509 -0.305 0 C-N-CA 120.401 -0.904 . . . . 0.0 111.969 -177.722 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 42.8 p90 -155.04 169.97 22.86 Favored 'General case' 0 C--N 1.32 -0.715 0 O-C-N 122.458 -0.436 . . . . 0.0 109.996 -179.788 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 10.6 m-85 -112.73 138.04 50.13 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 173.43 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.06 119.12 38.38 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 123.896 0.878 . . . . 0.0 109.733 -179.26 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 49.5 ttp180 -65.7 134.28 52.88 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 174.765 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -143.74 147.82 34.75 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.844 0.354 . . . . 0.0 110.814 -178.072 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 5.8 p -148.36 139.83 23.52 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 175.623 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 12.4 tpt180 -130.34 133.69 46.62 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 173.55 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 2.7 tpp180 -147.32 148.31 31.26 Favored 'General case' 0 CA--C 1.487 -1.463 0 CA-C-O 121.51 0.671 . . . . 0.0 110.77 -176.169 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -138.4 177.14 5.56 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.922 0 N-CA-C 103.715 -2.698 . . . . 0.0 103.715 178.9 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 48.1 ttp180 -138.77 117.09 11.92 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 177.578 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -100.48 155.8 19.43 Favored Glycine 0 C--O 1.222 -0.656 0 N-CA-C 108.146 -1.982 . . . . 0.0 108.146 177.787 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -75.27 -24.55 70.78 Favored Glycine 0 C--O 1.22 -0.731 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 178.458 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.4 p30 -83.28 -20.36 34.6 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 114.469 -0.865 . . . . 0.0 110.235 177.334 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 110.12 8.46 25.53 Favored Glycine 0 C--O 1.227 -0.307 0 N-CA-C 114.78 0.672 . . . . 0.0 114.78 173.136 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 10.6 pttt -66.01 137.23 56.97 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 122.319 1.057 . . . . 0.0 111.83 179.399 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 99.1 mmm -118.9 172.29 7.64 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 113.234 -1.803 . . . . 0.0 108.844 -178.929 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 14.2 tppt? -116.35 -66.56 1.07 Allowed 'General case' 0 C--O 1.219 -0.552 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 177.636 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -107.09 147.64 29.76 Favored 'General case' 0 CA--C 1.506 -0.722 0 N-CA-C 105.552 -2.018 . . . . 0.0 105.552 176.201 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -113.45 -47.07 3.02 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 105.657 -1.979 . . . . 0.0 105.657 175.616 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -102.38 151.82 38.23 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-N 114.867 -1.061 . . . . 0.0 110.378 179.205 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -64.07 150.73 87.74 Favored 'Trans proline' 0 C--N 1.35 0.658 0 O-C-N 122.033 0.491 . . . . 0.0 113.079 176.441 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 90.6 mtt-85 -116.7 159.21 22.59 Favored 'General case' 0 C--O 1.222 -0.394 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 178.748 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 53.7 m95 -137.33 125.38 22.86 Favored 'General case' 0 C--O 1.214 -0.765 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 174.77 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 59.9 m-85 -110.43 142.67 41.83 Favored 'General case' 0 C--O 1.216 -0.671 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 -177.08 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 81.1 t80 -93.01 135.95 33.72 Favored 'General case' 0 CA--C 1.507 -0.708 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 -176.142 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -139.01 137.72 36.58 Favored 'General case' 0 N--CA 1.441 -0.911 0 CA-C-N 114.739 -1.119 . . . . 0.0 109.195 -175.246 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 27.3 m-85 -67.74 159.39 30.27 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.71 179.065 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -50.46 122.53 7.19 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 113.743 1.016 . . . . 0.0 113.743 -177.258 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 68.53 22.13 74.88 Favored Glycine 0 C--O 1.226 -0.351 0 N-CA-C 116.193 1.237 . . . . 0.0 116.193 176.028 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 33.8 p -90.16 146.76 24.03 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 118.351 1.075 . . . . 0.0 111.017 179.306 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 110.33 137.03 7.48 Favored Glycine 0 CA--C 1.522 0.471 0 N-CA-C 109.236 -1.546 . . . . 0.0 109.236 -177.431 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -72.67 -30.79 11.44 Favored 'Trans proline' 0 CA--C 1.513 -0.557 0 CA-C-N 119.433 1.617 . . . . 0.0 115.225 -175.704 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -102.09 11.16 38.81 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 114.257 -1.338 . . . . 0.0 108.256 -176.967 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -64.23 -54.91 25.97 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -172.727 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 54.21 44.86 74.87 Favored Glycine 0 CA--C 1.52 0.383 0 C-N-CA 121.258 -0.496 . . . . 0.0 112.884 -179.128 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 16.4 mt -128.51 103.9 19.67 Favored Pre-proline 0 N--CA 1.442 -0.839 0 N-CA-C 116.289 1.959 . . . . 0.0 116.289 -175.272 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -78.46 160.81 28.67 Favored 'Trans proline' 0 C--O 1.233 0.227 0 C-N-CA 122.337 2.025 . . . . 0.0 107.417 167.949 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 60.3 t80 -60.85 132.76 54.89 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 120.291 -0.564 . . . . 0.0 110.957 -176.855 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 90.04 -6.53 82.65 Favored Glycine 0 N--CA 1.453 -0.215 0 CA-C-O 119.484 -0.62 . . . . 0.0 114.177 179.452 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -66.17 130.52 43.51 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 118.533 1.167 . . . . 0.0 111.332 179.459 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 52.5 t30 -80.86 128.54 33.79 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.332 -0.849 . . . . 0.0 109.091 179.431 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 27.7 ttmt -156.21 158.9 38.39 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 107.375 -1.343 . . . . 0.0 107.375 -178.921 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -54.67 122.34 10.43 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.053 0.39 . . . . 0.0 112.053 179.33 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 64.49 35.66 92.22 Favored Glycine 0 N--CA 1.448 -0.527 0 CA-C-O 119.189 -0.784 . . . . 0.0 114.376 174.436 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 49.4 mm -121.06 126.0 74.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 117.631 0.715 . . . . 0.0 110.939 179.225 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -126.92 117.73 48.56 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.706 176.254 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 97.5 m95 -85.38 136.3 33.52 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 -177.72 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 16.5 m -134.77 155.17 38.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 178.8 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -165.68 165.32 18.75 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 -178.373 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 12.3 t -130.42 168.32 17.18 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 104.969 -2.234 . . . . 0.0 104.969 174.107 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 76.6 tt0 -67.39 137.82 56.24 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.342 0.592 . . . . 0.0 110.88 -178.777 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 94.91 -10.58 70.21 Favored Glycine 0 C--O 1.229 -0.162 0 CA-C-N 115.662 -0.699 . . . . 0.0 113.093 177.578 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.406 ' HA ' ' HA ' ' A' ' 41' ' ' ASP . . . -78.75 118.4 20.78 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-O 120.974 0.416 . . . . 0.0 111.149 -179.938 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -68.6 133.42 48.47 Favored 'General case' 0 CA--C 1.51 -0.593 0 N-CA-C 114.101 1.148 . . . . 0.0 114.101 -177.628 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 46.9 t30 -83.26 76.23 9.9 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 113.825 -1.534 . . . . 0.0 109.062 178.776 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 1.4 t -146.44 155.36 49.61 Favored Pre-proline 0 C--N 1.322 -0.615 0 N-CA-C 106.053 -1.832 . . . . 0.0 106.053 -177.88 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -61.56 150.16 86.6 Favored 'Trans proline' 0 C--N 1.345 0.346 0 N-CA-C 115.446 1.287 . . . . 0.0 115.446 178.475 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 71.9 mmtt -123.29 30.47 6.3 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.748 -179.983 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 15.4 p-10 -51.34 -42.91 61.58 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.897 -0.592 . . . . 0.0 112.174 -176.914 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 15.6 p80 -68.5 -11.38 59.76 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 113.962 1.097 . . . . 0.0 113.962 -179.652 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 28.1 mt -95.54 -43.28 12.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 121.7 0.762 . . . . 0.0 110.488 178.826 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -72.8 4.03 24.38 Favored Glycine 0 C--O 1.221 -0.717 0 N-CA-C 116.119 1.208 . . . . 0.0 116.119 -176.543 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 13.1 t -83.38 25.78 0.71 Allowed 'General case' 0 CA--C 1.543 0.711 0 CA-C-O 121.492 0.663 . . . . 0.0 111.497 179.57 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.438 ' HD2' HD22 ' A' ' 114' ' ' ASN . 63.6 ttp85 -58.51 129.19 40.88 Favored 'General case' 0 CA--C 1.517 -0.319 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 -179.786 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 34.2 m120 -89.71 121.77 68.74 Favored Pre-proline 0 C--N 1.322 -0.617 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 -177.397 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -72.89 -15.22 26.5 Favored 'Trans proline' 0 C--O 1.218 -0.492 0 C-N-CA 116.789 -1.674 . . . . 0.0 112.188 178.95 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -77.03 -28.98 55.09 Favored 'General case' 0 C--O 1.221 -0.447 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.182 178.199 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 84.7 m-20 -102.69 -22.63 13.92 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 113.673 0.99 . . . . 0.0 113.673 -175.12 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . 0.438 HD22 ' HD2' ' A' ' 109' ' ' ARG . 37.6 t30 -140.23 153.48 46.57 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 -177.852 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -95.55 143.73 26.61 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-O 121.264 0.554 . . . . 0.0 110.358 178.298 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -72.88 149.25 43.65 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.315 0.578 . . . . 0.0 110.9 178.893 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 8.9 mt -84.69 136.93 21.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.213 -178.817 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 78.7 t -62.27 121.97 11.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 N-CA-C 106.037 -1.838 . . . . 0.0 106.037 174.927 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 5.9 tt -67.04 130.27 42.58 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.095 0.474 . . . . 0.0 111.338 -176.145 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 31.5 mt-30 -134.48 158.56 43.62 Favored 'General case' 0 CA--C 1.513 -0.475 0 N-CA-C 106.751 -1.574 . . . . 0.0 106.751 -179.607 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 13.2 mt -112.24 147.15 36.36 Favored Pre-proline 0 C--N 1.322 -0.592 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 177.637 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -73.96 165.64 31.59 Favored 'Trans proline' 0 C--N 1.346 0.408 0 O-C-N 122.168 0.562 . . . . 0.0 113.059 -179.92 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 58.3 tp60 -53.85 130.18 36.23 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.296 -0.865 . . . . 0.0 109.453 179.381 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 103.4 -24.2 30.78 Favored Glycine 0 C--O 1.226 -0.355 0 CA-C-N 115.618 -0.719 . . . . 0.0 112.767 -179.376 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 4.7 m -103.54 129.7 50.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 118.307 1.053 . . . . 0.0 111.958 178.844 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 3.7 p -117.37 148.12 42.03 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.309 -0.859 . . . . 0.0 109.569 179.126 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 82.5 mt -70.52 157.38 90.2 Favored Pre-proline 0 C--N 1.323 -0.545 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 177.566 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -73.06 173.09 14.2 Favored 'Trans proline' 0 C--O 1.236 0.42 0 N-CA-C 110.111 -0.765 . . . . 0.0 110.111 178.395 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -68.71 122.83 19.35 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 119.704 -0.798 . . . . 0.0 111.192 -173.605 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 90.08 45.85 4.34 Favored Glycine 0 N--CA 1.452 -0.279 0 CA-C-N 115.1 -0.954 . . . . 0.0 113.877 -179.886 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -141.93 150.0 40.89 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 117.265 0.532 . . . . 0.0 111.765 179.016 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 42.3 p90 -150.69 166.11 31.36 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 175.718 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -100.63 147.03 26.43 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.031 0.443 . . . . 0.0 111.137 -178.481 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -70.51 136.8 49.67 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 179.296 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 86.52 -30.93 4.34 Favored Glycine 0 C--O 1.227 -0.295 0 CA-C-N 116.21 -0.45 . . . . 0.0 112.777 -177.699 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 19.6 t -76.97 95.45 4.15 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 122.117 -0.637 . . . . 0.0 110.404 -179.132 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 1.4 tmt_? 57.51 30.16 18.25 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 115.252 -0.886 . . . . 0.0 110.946 -179.694 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -74.24 -21.02 79.52 Favored Glycine 0 C--O 1.225 -0.426 0 CA-C-O 122.468 1.038 . . . . 0.0 111.744 179.351 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -166.33 -165.06 23.07 Favored Glycine 0 C--N 1.317 -0.479 0 N-CA-C 107.147 -2.381 . . . . 0.0 107.147 179.947 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 59.3 p . . . . . 0 C--O 1.242 0.693 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 178.785 . . . . . . . . 0 0 . 1 . 033 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.948 0 CA-C-O 118.457 -1.19 . . . . 0.0 111.106 . . . . . . . . . 0 0 . 1 . 033 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -78.17 129.57 35.29 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 106.222 -1.77 . . . . 0.0 106.222 177.172 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 16.3 mmt -127.53 70.53 1.32 Allowed 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 -178.167 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 109.64 135.48 7.22 Favored Glycine 0 N--CA 1.44 -1.043 0 N-CA-C 107.248 -2.341 . . . . 0.0 107.248 -175.298 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 96.3 mt -115.27 148.9 41.76 Favored Pre-proline 0 C--N 1.315 -0.922 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 177.182 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -72.2 156.61 55.14 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 116.742 -1.705 . . . . 0.0 112.172 179.473 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 54.8 t30 -65.85 -26.89 67.86 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 112.732 0.642 . . . . 0.0 112.732 -179.585 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 52.3 t30 -156.08 -102.48 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 179.897 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 39.1 p 40.51 74.34 0.1 Allowed 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 115.788 1.773 . . . . 0.0 115.788 -179.175 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -105.11 137.77 42.35 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.239 -0.891 . . . . 0.0 109.5 179.429 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 54.2 p -59.54 144.3 47.75 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 178.876 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 24.8 m95 -65.56 -21.9 66.65 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.574 0.583 . . . . 0.0 112.574 178.809 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 12.7 m-85 -121.43 163.33 18.92 Favored 'General case' 0 CA--C 1.507 -0.673 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 -170.562 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 72.0 p -70.47 165.36 22.74 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 114.517 -1.219 . . . . 0.0 107.794 177.35 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -80.04 149.57 30.66 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.561 0.696 . . . . 0.0 112.004 -177.853 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 13.9 mt -85.83 145.07 27.37 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 102.416 -3.179 . . . . 0.0 102.416 169.362 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 65.0 m -120.46 141.28 50.33 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 -179.256 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.439 ' HB2' ' CZ ' ' A' ' 131' ' ' PHE . 4.4 tp60 -111.04 136.03 50.65 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -177.091 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 60.1 t60 -132.06 99.47 4.74 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 103.42 -2.807 . . . . 0.0 103.42 168.612 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 171.79 -167.03 40.04 Favored Glycine 0 N--CA 1.451 -0.328 0 N-CA-C 110.254 -1.138 . . . . 0.0 110.254 -175.479 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 49.8 mtpt -102.61 -27.25 12.85 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 115.126 1.528 . . . . 0.0 115.126 -177.454 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -85.71 166.28 16.26 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 -179.982 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -77.19 -62.91 1.5 Allowed 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.698 -178.708 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 29.3 tp 178.64 140.01 0.1 Allowed 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 104.864 -2.273 . . . . 0.0 104.864 175.474 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 44.0 tptt -148.18 135.31 20.3 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.064 0.459 . . . . 0.0 110.825 175.282 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -125.3 155.08 71.99 Favored Pre-proline 0 C--O 1.243 0.739 0 N-CA-C 105.594 -2.002 . . . . 0.0 105.594 174.852 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -71.58 173.13 13.0 Favored 'Trans proline' 0 C--N 1.347 0.485 0 CA-C-O 121.88 0.7 . . . . 0.0 113.652 -179.067 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 52.9 tpt85 -77.48 123.87 27.15 Favored 'General case' 0 C--O 1.217 -0.651 0 O-C-N 121.377 -0.827 . . . . 0.0 109.703 179.886 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 85.51 10.64 76.49 Favored Glycine 0 C--O 1.223 -0.569 0 CA-C-N 115.122 -0.945 . . . . 0.0 115.264 176.346 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.534 HE22 HG21 ' A' ' 125' ' ' THR . 18.9 tt0 -157.54 143.35 17.43 Favored 'General case' 0 C--O 1.219 -0.545 0 N-CA-C 106.747 -1.575 . . . . 0.0 106.747 -179.418 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 139.37 -13.32 3.25 Favored Glycine 0 CA--C 1.507 -0.428 0 C-N-CA 120.274 -0.965 . . . . 0.0 113.652 178.205 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 34.6 m -71.8 144.96 88.86 Favored Pre-proline 0 C--N 1.322 -0.616 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 177.898 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -76.92 171.62 17.66 Favored 'Trans proline' 0 N--CA 1.46 -0.441 0 C-N-CA 121.621 1.548 . . . . 0.0 113.203 179.685 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 94.8 mt -75.05 115.75 16.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 121.578 0.704 . . . . 0.0 109.369 178.893 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -94.63 85.01 4.38 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 107.243 -1.391 . . . . 0.0 107.243 178.113 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 73.4 p -61.64 -21.82 64.73 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 115.971 1.841 . . . . 0.0 115.971 -173.79 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -114.25 16.31 17.98 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 113.376 0.88 . . . . 0.0 113.376 -176.556 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.4 m -132.55 172.55 12.36 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 115.94 1.83 . . . . 0.0 115.94 -174.857 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 42.0 m -82.0 159.18 66.2 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 115.218 -0.901 . . . . 0.0 112.525 -176.273 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -67.28 -19.69 49.86 Favored 'Trans proline' 0 C--N 1.351 0.675 0 C-N-CA 117.219 -1.388 . . . . 0.0 114.279 -179.548 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.3 -24.15 62.09 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 121.746 -0.596 . . . . 0.0 110.776 177.898 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -85.11 -10.73 56.47 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 116.021 1.86 . . . . 0.0 116.021 -170.939 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 85.0 mm-40 -56.93 -26.59 59.75 Favored 'General case' 0 C--O 1.217 -0.631 0 N-CA-C 113.807 1.039 . . . . 0.0 113.807 -173.151 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 14.0 tt -62.12 139.42 20.88 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 CA-C-O 122.313 1.054 . . . . 0.0 112.875 178.539 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 177.68 -152.66 12.1 Favored Glycine 0 CA--C 1.505 -0.563 0 C-N-CA 120.402 -0.904 . . . . 0.0 110.994 -178.975 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 51.3 p90 -155.06 169.38 24.25 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 178.685 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 35.9 m-85 -111.34 143.4 42.19 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 106.764 -1.569 . . . . 0.0 106.764 173.983 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 71.7 ttt-85 -117.48 124.4 48.68 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 123.744 0.817 . . . . 0.0 111.595 -177.694 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 2.1 ptm180 -71.03 146.2 49.5 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.203 0.525 . . . . 0.0 110.525 179.412 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -146.24 144.86 30.15 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.419 0.628 . . . . 0.0 110.736 179.108 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 41.1 p -142.99 171.61 13.82 Favored 'General case' 0 C--O 1.249 1.034 0 N-CA-C 104.364 -2.458 . . . . 0.0 104.364 175.451 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -140.65 123.9 16.7 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 122.004 -0.435 . . . . 0.0 111.55 176.25 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 4.6 tmt_? -140.78 137.01 33.05 Favored 'General case' 0 CA--C 1.496 -1.109 0 CA-C-O 121.611 0.72 . . . . 0.0 110.562 -178.568 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -140.24 -179.38 2.0 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 N-CA-C 105.949 -1.871 . . . . 0.0 105.949 -179.453 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 6.3 ttm180 -128.94 119.25 24.02 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 175.216 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -80.72 -179.87 53.14 Favored Glycine 0 C--O 1.224 -0.476 0 N-CA-C 108.481 -1.847 . . . . 0.0 108.481 176.243 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -63.63 -46.96 90.93 Favored Glycine 0 C--O 1.219 -0.827 0 CA-C-N 118.343 1.072 . . . . 0.0 112.625 -178.463 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -75.8 -8.41 56.8 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 121.724 0.774 . . . . 0.0 110.11 178.995 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 104.43 -13.77 51.05 Favored Glycine 0 CA--C 1.51 -0.269 0 CA-C-N 115.32 -0.855 . . . . 0.0 111.501 178.875 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 12.0 pttt -56.37 136.59 53.54 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-O 122.112 0.958 . . . . 0.0 110.795 -178.877 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 15.0 ptm -132.05 165.76 23.26 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 114.375 -1.284 . . . . 0.0 114.127 -173.698 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 40.2 mttt -77.08 -60.13 2.49 Favored 'General case' 0 C--O 1.212 -0.903 0 N-CA-C 114.623 1.342 . . . . 0.0 114.623 -176.182 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 52.97 48.04 23.3 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 113.785 1.031 . . . . 0.0 113.785 178.509 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.4 mp -60.97 141.97 56.88 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.389 179.951 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 59.3 p -55.39 148.97 30.11 Favored Pre-proline 0 C--O 1.25 1.086 0 CA-C-N 115.071 -0.968 . . . . 0.0 111.753 -176.903 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -65.22 138.71 57.2 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 117.529 -1.18 . . . . 0.0 112.813 -176.979 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 5.4 ptp180 -141.38 155.78 45.88 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.425 -1.261 . . . . 0.0 108.517 -178.834 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 48.0 m95 -123.64 137.9 54.64 Favored 'General case' 0 C--N 1.318 -0.777 0 C-N-CA 122.671 0.389 . . . . 0.0 110.494 -176.16 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 29.5 m-85 -114.84 139.4 49.79 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 -179.464 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 88.5 t80 -88.49 135.94 33.24 Favored 'General case' 0 CA--C 1.505 -0.77 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 -178.825 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -139.73 139.13 36.45 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 -176.054 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 64.6 m-85 -71.21 159.47 34.59 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.351 -0.84 . . . . 0.0 112.326 -175.117 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -54.84 126.76 25.59 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.843 -179.624 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 68.61 38.21 85.88 Favored Glycine 0 C--O 1.218 -0.85 0 N-CA-C 115.482 0.953 . . . . 0.0 115.482 176.59 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -89.17 145.98 25.08 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 118.927 1.364 . . . . 0.0 107.985 178.058 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 97.98 141.8 12.64 Favored Glycine 0 CA--C 1.526 0.773 0 N-CA-C 108.72 -1.752 . . . . 0.0 108.72 -175.353 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -70.03 -42.42 3.14 Favored 'Trans proline' 0 C--N 1.347 0.479 0 CA-C-N 119.799 1.799 . . . . 0.0 116.222 -173.753 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -114.61 39.62 2.78 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 -177.346 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -64.1 -40.63 96.63 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.053 -0.976 . . . . 0.0 111.511 -177.962 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 60.21 26.07 63.26 Favored Glycine 0 C--O 1.228 -0.257 0 CA-C-N 115.916 -0.584 . . . . 0.0 113.832 179.305 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 17.8 mt -114.46 103.81 54.8 Favored Pre-proline 0 N--CA 1.447 -0.623 0 N-CA-C 114.249 1.203 . . . . 0.0 114.249 -176.964 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -78.86 165.16 24.7 Favored 'Trans proline' 0 C--O 1.237 0.431 0 C-N-CA 121.817 1.678 . . . . 0.0 108.414 170.239 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 61.4 t80 -61.6 131.17 49.16 Favored 'General case' 0 C--N 1.321 -0.654 0 C-N-CA 120.445 -0.502 . . . . 0.0 109.855 -179.958 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 92.45 -5.31 77.45 Favored Glycine 0 C--O 1.227 -0.315 0 N-CA-C 114.775 0.67 . . . . 0.0 114.775 178.806 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -65.57 126.76 29.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 118.412 1.106 . . . . 0.0 111.966 179.127 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 70.3 m-20 -71.97 126.79 30.64 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 114.624 -1.171 . . . . 0.0 110.335 -178.579 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 13.7 ttmm -156.12 151.35 26.62 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 178.564 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -62.55 131.05 47.8 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.274 178.931 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 68.46 27.86 73.55 Favored Glycine 0 N--CA 1.452 -0.275 0 N-CA-C 115.395 0.918 . . . . 0.0 115.395 177.809 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 39.3 mm -129.33 131.35 67.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 117.35 0.575 . . . . 0.0 110.494 -179.999 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.1 pt -131.48 114.85 26.67 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 CA-C-O 121.495 0.665 . . . . 0.0 110.774 175.643 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 95.7 m95 -82.24 135.13 35.29 Favored 'General case' 0 C--N 1.321 -0.662 0 O-C-N 121.831 -0.543 . . . . 0.0 112.227 -177.604 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -142.1 152.02 18.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.824 -0.626 . . . . 0.0 109.312 -178.525 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -155.98 166.59 33.02 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 105.646 -1.983 . . . . 0.0 105.646 -177.826 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 11.6 t -134.38 173.83 11.19 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 105.973 -1.862 . . . . 0.0 105.973 176.263 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -66.57 138.02 57.18 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.343 0.592 . . . . 0.0 110.925 -179.603 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 95.05 -14.66 64.91 Favored Glycine 0 N--CA 1.458 0.146 0 CA-C-N 115.568 -0.742 . . . . 0.0 112.836 177.652 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -75.06 136.08 41.2 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-O 120.738 0.304 . . . . 0.0 111.311 -179.633 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 30.2 mt -93.75 134.16 36.37 Favored 'General case' 0 CA--C 1.51 -0.58 0 N-CA-C 113.072 0.767 . . . . 0.0 113.072 -178.923 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 55.5 t30 -81.45 71.73 8.47 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 114.878 -1.055 . . . . 0.0 110.838 -178.391 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 1.3 t -142.17 154.79 64.94 Favored Pre-proline 0 C--N 1.322 -0.601 0 N-CA-C 106.129 -1.804 . . . . 0.0 106.129 179.784 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -68.78 148.71 71.88 Favored 'Trans proline' 0 CA--C 1.531 0.362 0 C-N-CA 118.347 -0.635 . . . . 0.0 113.537 176.34 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 5.8 ptpt -149.19 56.12 0.99 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 122.522 1.153 . . . . 0.0 111.169 178.384 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -57.46 -33.23 67.75 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.434 -1.257 . . . . 0.0 112.39 179.703 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 16.9 p80 -62.72 -7.66 5.3 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 115.015 1.487 . . . . 0.0 115.015 -177.862 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 44.7 mt -93.58 -39.25 10.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 177.857 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -72.81 14.65 2.57 Favored Glycine 0 C--O 1.218 -0.88 0 N-CA-C 115.612 1.005 . . . . 0.0 115.612 -178.409 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 14.3 t -99.67 27.98 5.0 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 113.322 0.86 . . . . 0.0 113.322 -176.928 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 62.4 ttp85 -51.52 133.08 30.4 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 177.477 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -90.45 117.88 68.33 Favored Pre-proline 0 C--N 1.326 -0.434 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 -179.538 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -71.45 -15.17 31.06 Favored 'Trans proline' 0 C--O 1.219 -0.462 0 C-N-CA 117.569 -1.154 . . . . 0.0 114.651 -177.086 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -81.1 -24.86 37.42 Favored 'General case' 0 C--O 1.22 -0.485 0 CA-C-O 121.052 0.453 . . . . 0.0 110.277 178.779 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 -100.89 -25.54 14.06 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 -175.02 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 27.3 t30 -147.96 144.37 27.96 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 113.284 0.846 . . . . 0.0 113.284 -178.404 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -84.27 146.46 27.75 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.13 179.823 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -67.77 143.67 55.74 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.405 0.622 . . . . 0.0 110.434 178.587 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 20.6 mt -83.84 139.43 17.64 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 -178.807 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 71.3 t -58.89 126.81 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 N-CA-C 106.393 -1.706 . . . . 0.0 106.393 175.252 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 7.7 tt -67.29 129.31 39.49 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 -178.933 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -130.34 156.61 44.41 Favored 'General case' 0 CA--C 1.511 -0.534 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 -178.474 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 14.8 mt -113.56 147.72 38.16 Favored Pre-proline 0 C--N 1.323 -0.582 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 178.879 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -71.94 166.77 28.56 Favored 'Trans proline' 0 C--N 1.345 0.382 0 O-C-N 122.338 0.652 . . . . 0.0 113.262 -178.721 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 34.0 tt0 -54.86 129.78 38.66 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.284 -179.409 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 93.71 -13.24 67.92 Favored Glycine 0 C--O 1.226 -0.363 0 CA-C-N 115.985 -0.552 . . . . 0.0 113.552 179.976 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.534 HG21 HE22 ' A' ' 30' ' ' GLN . 23.0 m -103.92 126.69 51.23 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 117.904 0.852 . . . . 0.0 110.265 179.035 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 11.6 p -121.67 148.4 44.63 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.934 -177.227 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 77.4 mt -74.13 154.08 88.49 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.301 178.286 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -76.86 173.87 13.77 Favored 'Trans proline' 0 C--N 1.345 0.393 0 N-CA-C 110.471 -0.627 . . . . 0.0 110.471 177.103 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 4.8 tmtt? -61.04 123.28 17.19 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.785 0.661 . . . . 0.0 112.785 -174.687 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 95.23 0.8 63.06 Favored Glycine 0 C--N 1.328 0.122 0 N-CA-C 115.141 0.817 . . . . 0.0 115.141 175.201 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.439 ' CZ ' ' HB2' ' A' ' 18' ' ' GLN . 1.2 m-85 -100.87 135.33 42.48 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-O 121.777 0.799 . . . . 0.0 110.538 -179.64 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 37.8 p90 -140.46 160.5 39.86 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 114.531 -1.213 . . . . 0.0 108.762 177.469 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -96.59 139.37 32.78 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.14 0.495 . . . . 0.0 111.454 -177.292 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -70.15 135.91 49.59 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 177.966 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 93.9 -9.01 73.44 Favored Glycine 0 CA--C 1.519 0.328 0 N-CA-C 114.716 0.646 . . . . 0.0 114.716 179.601 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 8.4 t -145.02 -176.15 4.98 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 117.803 0.801 . . . . 0.0 110.781 178.44 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 11.9 mpt_? -99.31 118.97 37.16 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 106.752 -1.573 . . . . 0.0 106.752 179.738 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -86.28 -173.89 49.33 Favored Glycine 0 C--N 1.318 -0.456 0 N-CA-C 108.671 -1.772 . . . . 0.0 108.671 176.439 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -117.72 -161.29 11.98 Favored Glycine 0 N--CA 1.452 -0.243 0 N-CA-C 108.867 -1.693 . . . . 0.0 108.867 178.598 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 28.6 t . . . . . 0 C--O 1.263 1.772 0 C-N-CA 123.644 0.778 . . . . 0.0 112.874 178.312 . . . . . . . . 0 0 . 1 . 034 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.612 0 CA-C-O 118.881 -0.955 . . . . 0.0 110.996 . . . . . . . . . 0 0 . 1 . 034 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -80.25 137.64 36.67 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 104.325 -2.472 . . . . 0.0 104.325 174.759 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -154.25 168.37 26.79 Favored 'General case' 0 N--CA 1.445 -0.72 0 N-CA-C 101.617 -3.475 . . . . 0.0 101.617 -177.781 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 99.76 77.07 1.28 Allowed Glycine 0 C--N 1.318 -0.451 0 N-CA-C 110.843 -0.903 . . . . 0.0 110.843 -178.884 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 96.2 mt -59.13 136.9 88.18 Favored Pre-proline 0 C--O 1.242 0.66 0 CA-C-O 120.997 0.427 . . . . 0.0 111.142 -179.169 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -73.79 158.19 46.97 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 118.19 -0.74 . . . . 0.0 113.629 -177.531 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 29.8 t30 58.07 23.91 10.6 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 114.059 1.133 . . . . 0.0 114.059 177.846 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -91.3 -21.8 20.87 Favored 'General case' 0 C--O 1.221 -0.409 0 N-CA-C 104.765 -2.309 . . . . 0.0 104.765 174.57 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 75.6 p -151.13 160.56 43.8 Favored 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 100.3 -3.963 . . . . 0.0 100.3 -177.932 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -151.47 151.98 32.39 Favored 'General case' 0 C--N 1.313 -1.002 0 O-C-N 123.685 0.615 . . . . 0.0 109.776 177.122 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 31.3 t -61.36 136.92 58.21 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.448 178.368 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 4.3 m95 -68.91 -26.26 65.01 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-O 121.24 0.543 . . . . 0.0 111.005 177.126 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -121.58 162.68 20.19 Favored 'General case' 0 CA--C 1.51 -0.592 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.385 -171.191 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 64.1 p -68.05 163.31 22.67 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 178.454 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -75.08 152.36 38.59 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.839 0.828 . . . . 0.0 113.166 -176.26 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 12.7 mt -91.35 148.68 22.15 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 102.882 -3.007 . . . . 0.0 102.882 169.458 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 25.9 m -127.76 140.36 52.1 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 -178.38 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.437 ' HB2' ' CZ ' ' A' ' 131' ' ' PHE . 4.6 tp60 -119.34 139.59 51.73 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 114.313 1.227 . . . . 0.0 114.313 -175.668 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 34.7 t60 -136.17 99.57 4.16 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 104.045 -2.576 . . . . 0.0 104.045 168.047 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 177.04 -158.56 24.35 Favored Glycine 0 C--O 1.228 -0.277 0 N-CA-C 110.801 -0.92 . . . . 0.0 110.801 -175.165 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 60.8 mttp -114.16 -22.32 10.05 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 114.16 1.17 . . . . 0.0 114.16 -178.579 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -84.76 157.38 21.04 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 107.883 -1.155 . . . . 0.0 107.883 177.785 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -76.67 -62.68 1.55 Allowed 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 -177.758 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 41.1 tp 177.23 145.14 0.1 Allowed 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 104.084 -2.561 . . . . 0.0 104.084 173.279 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 79.7 tttt -157.77 145.29 18.47 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 175.115 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 17.3 m-85 -134.53 151.21 75.65 Favored Pre-proline 0 C--N 1.323 -0.546 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 175.572 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -77.68 162.29 30.15 Favored 'Trans proline' 0 CA--C 1.538 0.716 0 O-C-N 122.02 0.484 . . . . 0.0 113.106 178.558 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 17.7 tpt180 -64.7 136.5 57.01 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.466 -178.862 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 90.26 -5.7 82.76 Favored Glycine 0 C--N 1.329 0.181 0 N-CA-C 111.397 -0.681 . . . . 0.0 111.397 178.132 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 -138.48 -179.68 5.95 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 123.714 0.805 . . . . 0.0 109.354 -174.665 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 100.22 -27.29 21.03 Favored Glycine 0 CA--C 1.497 -1.058 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.516 176.046 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 92.3 t -65.45 126.17 90.97 Favored Pre-proline 0 N--CA 1.444 -0.772 0 N-CA-C 106.207 -1.775 . . . . 0.0 106.207 176.288 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -72.44 164.26 36.16 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 O-C-N 122.175 0.566 . . . . 0.0 111.248 178.624 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 87.3 mt -63.85 115.58 2.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-O 121.658 0.742 . . . . 0.0 109.695 -176.692 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 6.7 m-80 -95.91 108.05 20.38 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.18 -0.918 . . . . 0.0 111.914 -177.026 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 70.3 p -91.3 -12.73 34.2 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.909 0.861 . . . . 0.0 110.827 177.662 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 12.5 p30 -110.27 9.01 23.74 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 116.993 2.219 . . . . 0.0 116.993 -173.247 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 87.6 p -154.08 165.57 35.78 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 115.19 1.552 . . . . 0.0 115.19 -175.23 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 25.4 m -78.65 167.56 34.22 Favored Pre-proline 0 N--CA 1.472 0.637 0 C-N-CA 124.311 1.044 . . . . 0.0 112.624 -176.42 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -64.54 -24.69 63.13 Favored 'Trans proline' 0 C--N 1.354 0.845 0 C-N-CA 115.62 -2.453 . . . . 0.0 112.843 177.575 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -63.0 -25.93 68.62 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.506 0.67 . . . . 0.0 111.211 176.168 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -97.3 -1.45 44.64 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 115.06 1.504 . . . . 0.0 115.06 -170.877 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 94.5 mm-40 -60.74 -26.12 66.96 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 113.243 0.831 . . . . 0.0 113.243 -177.614 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 19.0 tt -58.61 137.7 20.63 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 CA-C-O 122.384 1.087 . . . . 0.0 113.683 -177.994 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 178.9 -161.01 27.05 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.473 -0.87 . . . . 0.0 113.43 -178.787 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 44.7 p90 -154.76 169.09 24.76 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 179.357 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 13.6 m-85 -112.17 139.93 47.29 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 172.369 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.14 129.78 54.15 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 179.407 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 17.6 ttm105 -73.25 132.94 43.74 Favored 'General case' 0 CA--C 1.5 -0.971 0 N-CA-C 104.873 -2.269 . . . . 0.0 104.873 175.496 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -69.86 165.93 20.52 Favored 'General case' 0 N--CA 1.426 -1.648 0 CA-C-O 122.654 1.216 . . . . 0.0 111.89 -177.14 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 77.2 p -71.11 160.63 32.54 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 113.672 -1.603 . . . . 0.0 112.826 -176.27 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 6.0 tpt180 -65.71 154.07 39.97 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 114.555 -1.202 . . . . 0.0 111.657 -177.913 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.416 ' HG3' ' H ' ' A' ' 63' ' ' ASP . 10.0 ttm180 -88.68 136.97 32.73 Favored 'General case' 0 CA--C 1.504 -0.82 0 N-CA-C 108.266 -1.012 . . . . 0.0 108.266 177.367 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -143.04 175.11 4.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 N-CA-C 105.988 -1.856 . . . . 0.0 105.988 -176.355 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 14.9 tpt180 -92.88 116.4 29.0 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 106.27 -1.752 . . . . 0.0 106.27 176.137 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -79.65 137.64 19.12 Favored Glycine 0 N--CA 1.446 -0.645 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 177.917 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -72.01 -18.93 78.08 Favored Glycine 0 C--O 1.219 -0.841 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 178.733 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -64.37 -12.01 38.41 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 124.286 1.034 . . . . 0.0 110.11 176.234 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 109.26 15.92 11.93 Favored Glycine 0 CA--C 1.5 -0.862 0 CA-C-N 115.933 -0.576 . . . . 0.0 112.663 169.521 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.4 167.89 24.91 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 116.19 1.922 . . . . 0.0 116.19 -173.353 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -84.92 156.02 21.41 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.873 179.66 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -80.51 -55.15 5.07 Favored 'General case' 0 C--O 1.216 -0.693 0 CA-C-O 121.959 0.885 . . . . 0.0 112.717 -179.953 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.416 ' H ' ' HG3' ' A' ' 53' ' ' ARG . 1.0 OUTLIER -150.06 179.28 8.2 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 114.44 -1.254 . . . . 0.0 111.403 -174.259 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 95.6 mt -112.28 -83.73 0.58 Allowed 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 175.643 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -88.85 162.8 37.3 Favored Pre-proline 0 C--N 1.323 -0.564 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 177.849 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -69.52 142.98 50.5 Favored 'Trans proline' 0 C--N 1.348 0.503 0 C-N-CA 115.708 -2.395 . . . . 0.0 112.235 176.841 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 93.5 mtt-85 -121.59 166.25 14.49 Favored 'General case' 0 CA--C 1.513 -0.455 0 N-CA-C 112.99 0.737 . . . . 0.0 112.99 179.701 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 57.9 m95 -131.94 145.83 51.73 Favored 'General case' 0 C--O 1.216 -0.672 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 175.349 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 29.8 m-85 -125.88 154.1 43.21 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 105.661 -1.977 . . . . 0.0 105.661 -178.891 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 90.8 t80 -105.9 135.96 46.39 Favored 'General case' 0 CA--C 1.508 -0.672 0 CA-C-N 119.006 0.821 . . . . 0.0 109.54 -174.586 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 21.2 m-85 -140.91 144.81 35.42 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 107.259 -1.386 . . . . 0.0 107.259 -175.989 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 53.7 m-85 -84.83 159.52 20.39 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.453 -174.465 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 16.8 tp -53.29 129.98 33.44 Favored 'General case' 0 C--O 1.216 -0.677 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 179.884 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 70.81 22.26 78.18 Favored Glycine 0 C--O 1.223 -0.577 0 N-CA-C 116.375 1.31 . . . . 0.0 116.375 176.831 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 18.9 p -90.9 146.15 24.14 Favored 'General case' 0 CA--C 1.511 -0.522 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 175.658 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 97.76 129.12 6.23 Favored Glycine 0 CA--C 1.523 0.576 0 N-CA-C 108.845 -1.702 . . . . 0.0 108.845 -176.971 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -67.89 -35.92 19.55 Favored 'Trans proline' 0 CA--C 1.516 -0.406 0 CA-C-N 119.575 1.687 . . . . 0.0 115.421 -174.22 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -108.37 21.02 17.9 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 114.637 -1.165 . . . . 0.0 109.395 -176.031 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -61.02 -42.07 97.75 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.695 -175.32 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 55.94 43.91 87.73 Favored Glycine 0 CA--C 1.516 0.117 0 CA-C-N 115.894 -0.594 . . . . 0.0 113.198 178.862 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 12.9 mt -130.82 104.23 15.65 Favored Pre-proline 0 N--CA 1.438 -1.061 0 N-CA-C 114.075 1.139 . . . . 0.0 114.075 -177.999 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -78.84 161.5 27.19 Favored 'Trans proline' 0 N--CA 1.462 -0.368 0 C-N-CA 122.268 1.978 . . . . 0.0 107.192 167.819 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 56.0 t80 -61.09 132.85 55.1 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 120.226 -0.589 . . . . 0.0 110.063 -177.704 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 91.1 -7.15 81.27 Favored Glycine 0 CA--C 1.519 0.337 0 CA-C-O 119.333 -0.704 . . . . 0.0 114.541 179.407 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -67.68 129.73 40.81 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 118.804 1.302 . . . . 0.0 111.808 179.909 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 51.1 t30 -79.04 128.76 33.68 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.042 -179.893 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 28.7 ttmt -155.94 157.9 37.04 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 106.964 -1.495 . . . . 0.0 106.964 -178.774 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -54.87 120.2 6.49 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.473 0.546 . . . . 0.0 112.473 -179.696 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 66.12 35.6 90.73 Favored Glycine 0 CA--C 1.507 -0.467 0 CA-C-O 118.989 -0.895 . . . . 0.0 114.022 175.176 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 49.6 mm -122.47 126.29 73.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 117.452 0.626 . . . . 0.0 110.856 178.904 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -126.84 121.17 57.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.892 175.666 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 98.7 m95 -87.57 135.67 33.26 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 113.602 0.964 . . . . 0.0 113.602 -176.71 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 15.8 m -137.2 149.78 26.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 121.638 0.733 . . . . 0.0 109.069 178.618 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -162.46 161.97 27.37 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 103.363 -2.829 . . . . 0.0 103.363 179.416 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 6.0 t -126.43 173.85 9.06 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 105.098 -2.186 . . . . 0.0 105.098 178.151 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -67.26 134.42 51.59 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.054 0.454 . . . . 0.0 109.957 -178.303 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 96.0 -9.65 67.98 Favored Glycine 0 C--O 1.226 -0.396 0 CA-C-N 115.97 -0.559 . . . . 0.0 113.05 179.318 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -76.37 134.02 39.78 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 178.891 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 65.9 mt -87.75 140.96 28.98 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.174 0.511 . . . . 0.0 112.147 -176.743 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 63.4 t30 -84.29 61.98 6.89 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.968 -179.599 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -135.91 156.47 77.17 Favored Pre-proline 0 C--N 1.322 -0.617 0 N-CA-C 106.159 -1.793 . . . . 0.0 106.159 -178.592 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -67.73 152.8 77.3 Favored 'Trans proline' 0 C--N 1.343 0.272 0 N-CA-C 114.793 1.036 . . . . 0.0 114.793 -179.889 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -126.07 37.9 4.25 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 114.648 -1.16 . . . . 0.0 110.079 -177.111 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 15.9 p-10 -53.32 -41.22 65.49 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.168 -179.051 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 16.3 p80 -66.21 -8.88 27.14 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 114.359 1.244 . . . . 0.0 114.359 179.99 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 31.3 mt -95.27 -44.64 13.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 178.727 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -70.66 3.04 13.24 Favored Glycine 0 C--O 1.221 -0.673 0 N-CA-C 115.661 1.024 . . . . 0.0 115.661 -177.537 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 14.6 t -83.15 15.13 3.0 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 117.637 0.719 . . . . 0.0 112.28 -177.868 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 57.6 ttp85 -58.72 130.83 48.75 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 176.629 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -98.6 137.62 20.66 Favored Pre-proline 0 C--N 1.323 -0.585 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 178.399 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -74.96 -19.84 17.53 Favored 'Trans proline' 0 C--O 1.219 -0.434 0 N-CA-C 113.863 0.678 . . . . 0.0 113.863 179.424 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -81.36 -25.14 36.57 Favored 'General case' 0 C--O 1.221 -0.437 0 CA-C-O 121.163 0.506 . . . . 0.0 110.226 179.293 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 -97.76 -21.54 16.91 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 113.437 0.903 . . . . 0.0 113.437 -175.128 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 29.5 t30 -150.31 153.24 35.76 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 111.884 0.328 . . . . 0.0 111.884 -178.77 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -89.45 140.92 29.05 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-O 121.246 0.546 . . . . 0.0 110.586 178.4 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -70.99 147.64 48.44 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.136 0.494 . . . . 0.0 110.355 178.667 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 11.7 mt -81.89 136.47 22.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.473 -178.494 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 77.0 t -58.78 121.9 7.47 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 N-CA-C 106.43 -1.693 . . . . 0.0 106.43 174.601 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 6.1 tt -67.35 127.54 33.05 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.297 0.57 . . . . 0.0 110.328 -176.662 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 -133.98 155.08 50.59 Favored 'General case' 0 CA--C 1.508 -0.661 0 N-CA-C 106.489 -1.671 . . . . 0.0 106.489 -179.233 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 12.9 mt -111.08 147.96 37.66 Favored Pre-proline 0 C--N 1.319 -0.724 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 177.738 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -73.3 163.5 37.71 Favored 'Trans proline' 0 C--O 1.237 0.439 0 C-N-CA 118.016 -0.856 . . . . 0.0 112.626 -179.934 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 40.1 tt0 -54.47 130.65 40.34 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.06 179.963 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 105.94 -26.25 21.4 Favored Glycine 0 C--O 1.227 -0.309 0 CA-C-N 115.871 -0.604 . . . . 0.0 112.251 -178.656 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 4.6 m -102.36 129.91 48.95 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 118.276 1.038 . . . . 0.0 112.131 178.586 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 3.1 p -116.61 147.86 41.49 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.274 178.625 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 82.8 mt -72.11 153.79 92.48 Favored Pre-proline 0 C--N 1.323 -0.559 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 177.911 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -75.54 175.53 11.16 Favored 'Trans proline' 0 C--O 1.235 0.334 0 N-CA-C 110.576 -0.586 . . . . 0.0 110.576 177.901 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 76.1 tttt -64.55 124.51 22.04 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 114.023 1.12 . . . . 0.0 114.023 -170.811 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 95.19 -1.86 65.18 Favored Glycine 0 CA--C 1.518 0.243 0 CA-C-N 114.891 -1.05 . . . . 0.0 115.342 177.101 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.437 ' CZ ' ' HB2' ' A' ' 18' ' ' GLN . 3.5 m-85 -94.81 143.12 26.71 Favored 'General case' 0 N--CA 1.436 -1.14 0 CA-C-O 122.465 1.126 . . . . 0.0 111.619 -179.328 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 43.7 p90 -144.19 164.46 30.64 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 113.053 -1.885 . . . . 0.0 107.375 173.992 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -105.18 148.55 26.79 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.253 0.549 . . . . 0.0 111.465 -176.759 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -79.05 139.8 38.05 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 179.397 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 81.98 -0.21 88.79 Favored Glycine 0 C--O 1.226 -0.369 0 C-N-CA 121.161 -0.543 . . . . 0.0 112.241 -178.283 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 8.3 t -98.24 -151.4 0.38 Allowed 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 178.288 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 1.5 tmm_? -66.1 97.67 0.39 Allowed 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 177.421 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -88.74 174.55 42.9 Favored Glycine 0 N--CA 1.452 -0.245 0 CA-C-N 116.115 -0.493 . . . . 0.0 112.077 179.984 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 93.74 -178.7 38.08 Favored Glycine 0 C--O 1.229 -0.188 0 N-CA-C 108.987 -1.645 . . . . 0.0 108.987 -178.19 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 30.2 t . . . . . 0 C--O 1.241 0.657 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 179.049 . . . . . . . . 0 0 . 1 . 035 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.876 0 CA-C-O 117.316 -1.825 . . . . 0.0 110.966 . . . . . . . . . 0 0 . 1 . 035 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 53.36 51.65 14.99 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 118.345 1.073 . . . . 0.0 112.536 179.004 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -153.55 176.68 11.77 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 103.759 -2.682 . . . . 0.0 103.759 -178.12 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 153.3 -71.87 0.28 Allowed Glycine 0 CA--C 1.521 0.414 0 N-CA-C 117.176 1.63 . . . . 0.0 117.176 177.593 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 96.0 mt -101.6 144.96 29.6 Favored Pre-proline 0 N--CA 1.468 0.438 0 CA-C-N 117.486 0.643 . . . . 0.0 111.662 -176.416 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -76.5 159.82 35.63 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 118.285 -0.676 . . . . 0.0 112.015 177.359 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 90.1 m-20 -65.04 -31.6 72.9 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 112.438 0.533 . . . . 0.0 112.438 -179.861 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 30.5 t30 -158.43 -91.8 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 177.734 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 27.8 p 41.59 75.98 0.08 Allowed 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.981 0.912 . . . . 0.0 112.685 -176.456 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -91.27 135.17 33.99 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.446 -0.797 . . . . 0.0 108.885 -177.939 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 69.6 p -63.18 144.02 57.28 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 178.259 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 14.8 m95 -70.9 -22.82 62.22 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 111.923 0.342 . . . . 0.0 111.923 179.225 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 33.9 m-85 -121.48 162.53 20.33 Favored 'General case' 0 C--O 1.243 0.736 0 N-CA-C 113.239 0.829 . . . . 0.0 113.239 -172.353 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.428 ' HB ' ' HB3' ' A' ' 134' ' ' GLU . 70.5 p -71.13 165.0 24.5 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 114.806 -1.088 . . . . 0.0 108.245 178.149 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -83.4 145.13 29.17 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 113.803 1.038 . . . . 0.0 113.803 -176.401 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 22.9 mt -78.0 148.91 34.17 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 103.942 -2.614 . . . . 0.0 103.942 168.832 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 26.8 m -126.96 140.42 52.33 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 107.432 -1.321 . . . . 0.0 107.432 179.392 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 56.7 tt0 -116.44 148.69 40.47 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 114.936 1.458 . . . . 0.0 114.936 -174.172 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 63.3 t60 -134.52 99.62 4.41 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 105.375 -2.083 . . . . 0.0 105.375 169.967 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -178.95 -163.01 29.34 Favored Glycine 0 CA--C 1.522 0.494 0 C-N-CA 121.006 -0.616 . . . . 0.0 113.233 -176.621 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 68.9 mmtt -116.27 -31.7 5.55 Favored 'General case' 0 N--CA 1.48 1.062 0 N-CA-C 113.919 1.081 . . . . 0.0 113.919 -178.899 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -84.23 -166.67 1.5 Allowed 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 178.61 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 13.7 p-10 -105.74 -66.08 1.01 Allowed 'General case' 0 CA--C 1.556 1.187 0 N-CA-C 117.699 2.481 . . . . 0.0 117.699 -177.614 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 49.3 tp 172.7 141.62 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 179.777 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -154.26 145.36 22.77 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 107.062 -1.459 . . . . 0.0 107.062 -178.732 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -134.51 148.44 67.48 Favored Pre-proline 0 C--N 1.322 -0.589 0 N-CA-C 105.779 -1.934 . . . . 0.0 105.779 176.23 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -69.98 150.22 66.6 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 117.875 -0.95 . . . . 0.0 111.71 179.433 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 16.8 tpt180 -65.98 134.98 54.07 Favored 'General case' 0 C--O 1.217 -0.651 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 -178.369 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 98.84 -3.6 58.9 Favored Glycine 0 C--O 1.222 -0.608 0 N-CA-C 110.335 -1.106 . . . . 0.0 110.335 -179.377 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -146.57 170.51 16.76 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 -179.372 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 128.88 -31.41 3.52 Favored Glycine 0 CA--C 1.48 -2.096 0 N-CA-C 108.774 -1.731 . . . . 0.0 108.774 165.142 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 35.7 m -66.47 139.63 96.23 Favored Pre-proline 0 N--CA 1.43 -1.458 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 177.378 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -72.77 174.01 12.5 Favored 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 121.785 1.657 . . . . 0.0 111.6 177.049 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 90.9 mt -72.1 113.46 9.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 N-CA-C 107.656 -1.239 . . . . 0.0 107.656 178.083 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.536 HD22 ' HA ' ' A' ' 43' ' ' GLN . 37.8 m-20 -109.75 82.16 1.55 Allowed 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.431 -0.804 . . . . 0.0 108.947 -178.31 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 67.7 p -64.87 -24.41 67.53 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.46 -0.791 . . . . 0.0 112.972 -177.044 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 72.7 m-80 -100.72 35.75 2.09 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.647 -178.191 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 21.1 m -147.88 151.7 36.33 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.6 -0.273 . . . . 0.0 110.596 -179.269 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 18.4 m -72.17 165.45 50.4 Favored Pre-proline 0 C--N 1.324 -0.507 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 176.877 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -64.68 -27.79 60.53 Favored 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 114.94 -2.907 . . . . 0.0 111.62 177.813 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -60.84 -30.8 70.32 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 122.121 0.963 . . . . 0.0 110.629 175.784 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 92.6 m-20 -95.58 -0.16 52.26 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 114.931 1.456 . . . . 0.0 114.931 -170.552 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . 0.536 ' HA ' HD22 ' A' ' 35' ' ' ASN . 91.4 mm-40 -60.89 -25.56 66.8 Favored 'General case' 0 C--O 1.219 -0.509 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 178.653 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 21.5 tt -55.79 142.56 10.41 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 N-CA-C 115.209 1.559 . . . . 0.0 115.209 -178.621 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 179.22 -155.23 15.43 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.089 178.079 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 43.0 p90 -155.11 168.03 28.38 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 178.254 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 33.6 m-85 -109.28 137.68 46.79 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 174.722 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 60.9 ttt180 -111.9 119.32 38.14 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.474 -0.784 . . . . 0.0 110.827 -177.776 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 1.1 ttp-105 -65.5 134.33 53.17 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 106.78 -1.563 . . . . 0.0 106.78 175.871 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -135.59 153.4 51.68 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.052 0.453 . . . . 0.0 110.541 -177.487 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.448 ' HB ' HD23 ' A' ' 64' ' ' LEU . 32.7 p -133.4 159.01 41.58 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.272 -177.639 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 63.4 ttt180 -158.34 129.71 6.55 Favored 'General case' 0 N--CA 1.477 0.92 0 O-C-N 122.235 -0.291 . . . . 0.0 111.27 177.471 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.81 142.16 24.24 Favored 'General case' 0 CA--C 1.498 -1.039 0 N-CA-C 104.224 -2.51 . . . . 0.0 104.224 -179.933 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -132.1 173.94 13.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 -177.076 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.08 107.39 17.69 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 -179.39 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -74.38 151.82 44.0 Favored Glycine 0 N--CA 1.452 -0.24 0 N-CA-C 107.059 -2.417 . . . . 0.0 107.059 177.201 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -63.38 -42.79 99.02 Favored Glycine 0 C--O 1.223 -0.578 0 CA-C-N 118.559 1.18 . . . . 0.0 111.907 -178.643 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -76.2 -3.22 35.15 Favored 'General case' 0 C--O 1.218 -0.572 0 CA-C-O 121.518 0.675 . . . . 0.0 111.967 179.594 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 96.72 -1.1 61.41 Favored Glycine 0 C--O 1.227 -0.313 0 CA-C-N 115.855 -0.612 . . . . 0.0 112.617 177.395 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 12.8 pttt -63.82 133.66 53.82 Favored 'General case' 0 C--O 1.24 0.581 0 CA-C-O 122.147 0.975 . . . . 0.0 112.587 -178.089 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 13.8 mmt -90.78 145.44 24.78 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 114.171 -1.377 . . . . 0.0 113.022 -179.619 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 2.1 tmtm? -102.11 -23.43 14.06 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.048 -0.978 . . . . 0.0 109.814 176.259 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 13.3 t0 63.7 164.37 0.12 Allowed 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 115.998 1.851 . . . . 0.0 115.998 178.338 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.448 HD23 ' HB ' ' A' ' 51' ' ' THR . 57.4 mt -88.61 131.12 35.1 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.331 0.586 . . . . 0.0 111.304 -176.538 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 4.8 p -112.31 131.29 22.65 Favored Pre-proline 0 C--N 1.319 -0.722 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 176.215 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -74.95 98.14 1.13 Allowed 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 117.35 -1.3 . . . . 0.0 112.065 178.044 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 11.7 mtp180 -110.34 152.81 25.76 Favored 'General case' 0 CA--C 1.507 -0.69 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 178.018 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 64.0 m95 -127.69 126.37 41.78 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 179.666 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 58.7 m-85 -110.35 141.17 43.74 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 -178.592 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 86.1 t80 -87.73 135.87 33.19 Favored 'General case' 0 CA--C 1.506 -0.732 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 -178.581 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -139.42 143.49 37.66 Favored 'General case' 0 N--CA 1.439 -0.995 0 CA-C-N 115.076 -0.965 . . . . 0.0 108.434 -175.376 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -77.01 159.45 29.9 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.089 0.471 . . . . 0.0 110.743 -176.847 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 15.8 tp -59.62 128.17 35.67 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.855 -0.612 . . . . 0.0 110.819 -178.455 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 80.73 24.73 57.81 Favored Glycine 0 C--O 1.218 -0.856 0 N-CA-C 116.342 1.297 . . . . 0.0 116.342 177.603 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 3.7 p -89.12 146.13 25.0 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 118.873 1.336 . . . . 0.0 110.67 -179.609 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 108.19 143.6 10.68 Favored Glycine 0 CA--C 1.523 0.538 0 N-CA-C 109.274 -1.53 . . . . 0.0 109.274 -177.778 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -69.23 -41.71 4.68 Favored 'Trans proline' 0 C--N 1.348 0.512 0 CA-C-N 119.94 1.87 . . . . 0.0 115.958 -173.463 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -116.5 27.57 9.12 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.748 0.785 . . . . 0.0 109.841 -178.21 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -60.43 -46.43 90.06 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.782 -177.032 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 56.7 27.54 55.44 Favored Glycine 0 C--O 1.223 -0.547 0 O-C-N 123.5 0.5 . . . . 0.0 113.942 179.468 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 27.6 mt -105.88 105.32 52.87 Favored Pre-proline 0 C--O 1.238 0.492 0 N-CA-C 115.103 1.519 . . . . 0.0 115.103 -175.422 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -78.25 169.19 20.58 Favored 'Trans proline' 0 C--O 1.235 0.352 0 C-N-CA 121.815 1.676 . . . . 0.0 109.483 171.566 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 51.3 t80 -63.49 130.5 44.63 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 179.564 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 92.13 -3.98 77.21 Favored Glycine 0 C--O 1.225 -0.409 0 N-CA-C 114.754 0.662 . . . . 0.0 114.754 178.691 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -68.44 123.69 21.5 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 118.63 1.215 . . . . 0.0 111.471 178.747 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 74.6 m-20 -71.66 126.05 28.69 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 114.799 -1.091 . . . . 0.0 111.839 -176.805 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 29.2 ttmt -156.13 151.5 26.77 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 106.927 -1.509 . . . . 0.0 106.927 177.153 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 18.5 t0 -66.82 133.4 50.02 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.904 0.383 . . . . 0.0 110.032 -178.892 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 72.46 21.42 79.46 Favored Glycine 0 CA--C 1.507 -0.467 0 C-N-CA 120.938 -0.649 . . . . 0.0 113.962 177.731 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 44.0 mm -125.31 124.21 66.7 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.421 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 178.864 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.1 pt -127.68 114.47 35.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.725 176.63 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 95.8 m95 -81.09 128.77 34.1 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.371 -177.704 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 2.8 m -136.7 149.74 26.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 121.483 0.659 . . . . 0.0 109.572 -177.347 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -157.51 164.63 37.18 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 105.134 -2.173 . . . . 0.0 105.134 -178.696 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 14.5 t -122.96 174.83 6.93 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 105.705 -1.961 . . . . 0.0 105.705 177.985 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -64.97 133.81 52.55 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.197 0.523 . . . . 0.0 109.812 -179.679 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 92.07 -9.22 76.92 Favored Glycine 0 C--O 1.225 -0.445 0 CA-C-N 115.886 -0.597 . . . . 0.0 113.232 178.482 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -77.74 137.73 38.63 Favored 'General case' 0 C--N 1.324 -0.534 0 O-C-N 122.249 -0.56 . . . . 0.0 109.523 179.434 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 51.7 mt -92.82 134.18 35.33 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 113.523 0.935 . . . . 0.0 113.523 -176.64 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 71.6 m-20 -79.47 56.16 2.1 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.411 -179.196 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -130.85 152.34 80.42 Favored Pre-proline 0 C--N 1.323 -0.549 0 N-CA-C 107.953 -1.128 . . . . 0.0 107.953 -179.595 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -66.76 149.9 83.5 Favored 'Trans proline' 0 C--N 1.343 0.256 0 N-CA-C 114.281 0.839 . . . . 0.0 114.281 178.364 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 4.5 ptpt -151.18 56.13 0.88 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 122.71 1.243 . . . . 0.0 110.467 178.955 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -57.81 -30.71 65.92 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 113.852 -1.522 . . . . 0.0 111.411 178.338 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 29.5 p-80 -59.67 -16.62 27.83 Favored 'General case' 0 C--O 1.218 -0.602 0 N-CA-C 114.205 1.187 . . . . 0.0 114.205 -178.901 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 64.0 mt -81.41 -32.63 12.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 178.305 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -73.86 14.8 3.39 Favored Glycine 0 CA--C 1.522 0.479 0 N-CA-C 115.023 0.769 . . . . 0.0 115.023 -178.337 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 11.6 t -83.1 17.65 1.93 Allowed 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 112.846 0.684 . . . . 0.0 112.846 -177.718 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 73.3 ttp85 -58.83 130.27 46.14 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 178.838 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -101.77 125.44 37.13 Favored Pre-proline 0 C--N 1.322 -0.625 0 N-CA-C 105.778 -1.934 . . . . 0.0 105.778 179.352 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -68.69 -17.35 42.66 Favored 'Trans proline' 0 C--O 1.218 -0.525 0 C-N-CA 117.766 -1.023 . . . . 0.0 114.397 -176.705 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -78.77 -24.3 44.77 Favored 'General case' 0 C--O 1.22 -0.468 0 CA-C-O 120.932 0.396 . . . . 0.0 110.516 178.339 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 -100.11 -23.04 14.97 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 -174.923 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 28.2 t30 -158.2 149.13 20.77 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.473 0.545 . . . . 0.0 112.473 -178.706 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -92.64 154.16 18.54 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-O 121.518 0.675 . . . . 0.0 111.825 179.606 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -69.39 144.26 53.45 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.216 0.531 . . . . 0.0 111.031 178.87 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 15.3 mt -85.77 139.94 16.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.303 -178.287 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 92.5 t -60.77 124.77 15.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 175.918 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 6.9 tt -67.29 129.0 38.5 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.966 -177.093 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 29.5 mt-30 -132.14 156.64 46.03 Favored 'General case' 0 C--O 1.219 -0.513 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 -179.467 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 13.4 mt -112.29 148.04 38.28 Favored Pre-proline 0 C--N 1.323 -0.578 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 178.449 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -72.65 168.54 24.2 Favored 'Trans proline' 0 C--N 1.346 0.409 0 O-C-N 122.219 0.589 . . . . 0.0 113.615 -179.128 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 39.1 tt0 -53.82 131.87 40.49 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.309 -0.86 . . . . 0.0 109.553 179.554 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 96.38 -18.94 56.57 Favored Glycine 0 C--O 1.226 -0.403 0 CA-C-N 115.919 -0.582 . . . . 0.0 113.452 179.991 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 4.1 m -108.43 128.48 54.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 118.227 1.014 . . . . 0.0 111.375 179.239 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 10.0 p -122.46 150.77 42.05 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.278 179.172 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 87.8 mt -70.79 151.88 95.19 Favored Pre-proline 0 C--N 1.324 -0.533 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 179.076 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -76.03 166.17 28.42 Favored 'Trans proline' 0 C--O 1.236 0.383 0 C-N-CA 117.775 -1.016 . . . . 0.0 110.973 178.864 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 14.7 tmtt? -59.04 127.02 30.11 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.121 -177.293 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 95.1 15.59 44.31 Favored Glycine 0 C--O 1.227 -0.344 0 N-CA-C 114.865 0.706 . . . . 0.0 114.865 178.785 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -125.52 149.17 48.53 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 117.688 0.744 . . . . 0.0 110.637 177.873 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 43.6 p90 -150.37 161.97 41.46 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 174.43 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -99.92 147.01 26.01 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.825 0.345 . . . . 0.0 110.412 -179.017 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.428 ' HB3' ' HB ' ' A' ' 14' ' ' THR . 3.6 tp10 -72.18 133.76 45.31 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 106.65 -1.611 . . . . 0.0 106.65 177.81 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 89.48 -3.17 83.6 Favored Glycine 0 C--O 1.224 -0.5 0 N-CA-C 111.254 -0.738 . . . . 0.0 111.254 -177.144 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 9.7 t -129.11 -175.89 3.7 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 177.42 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -131.6 135.69 47.18 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 -178.775 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -114.68 165.1 12.03 Favored Glycine 0 C--O 1.235 0.194 0 N-CA-C 108.587 -1.805 . . . . 0.0 108.587 176.763 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 118.66 -149.31 18.29 Favored Glycine 0 CA--C 1.509 -0.333 0 N-CA-C 106.493 -2.643 . . . . 0.0 106.493 -176.939 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 11.8 t . . . . . 0 C--O 1.248 0.998 0 O-C-N 125.023 1.072 . . . . 0.0 109.304 -178.177 . . . . . . . . 0 0 . 1 . 036 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.783 0 CA-C-O 118.261 -1.299 . . . . 0.0 110.991 . . . . . . . . . 0 0 . 1 . 036 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -67.93 144.18 55.34 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 118.628 1.214 . . . . 0.0 108.558 178.582 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 87.3 mtp -135.32 -135.62 0.16 Allowed 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 -179.498 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 81.62 26.91 49.16 Favored Glycine 0 CA--C 1.501 -0.827 0 N-CA-C 115.288 0.875 . . . . 0.0 115.288 177.669 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -72.01 134.34 83.31 Favored Pre-proline 0 C--N 1.316 -0.856 0 N-CA-C 105.891 -1.892 . . . . 0.0 105.891 178.32 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -78.3 157.26 29.53 Favored 'Trans proline' 0 N--CA 1.463 -0.312 0 C-N-CA 117.79 -1.007 . . . . 0.0 111.985 179.144 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 -68.33 -31.38 70.75 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 176.113 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 -163.13 -86.77 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.843 177.215 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 82.8 p 39.43 79.03 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 116.34 1.978 . . . . 0.0 116.34 178.476 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -96.69 147.83 23.5 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.262 -179.383 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 54.3 p -59.72 143.72 50.05 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.254 -0.884 . . . . 0.0 109.231 177.907 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 13.4 m95 -65.87 -26.75 67.78 Favored 'General case' 0 CA--C 1.512 -0.485 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 179.26 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 27.4 m-85 -121.46 164.79 16.59 Favored 'General case' 0 CA--C 1.503 -0.831 0 CA-C-N 115.784 -0.644 . . . . 0.0 112.109 -172.201 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.464 ' HB ' ' HB3' ' A' ' 134' ' ' GLU . 67.1 p -70.35 166.41 20.31 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 114.614 -1.175 . . . . 0.0 108.629 177.642 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -87.23 149.92 24.27 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 113.306 0.854 . . . . 0.0 113.306 -176.507 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 53.0 mt -85.54 148.81 25.77 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 173.18 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 24.2 m -125.19 131.98 53.1 Favored 'General case' 0 C--N 1.32 -0.716 0 C-N-CA 122.515 0.326 . . . . 0.0 110.698 -179.822 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 3.9 tp-100 -95.6 141.67 28.83 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 179.129 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 41.5 t60 -135.35 100.04 4.41 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 102.54 -3.133 . . . . 0.0 102.54 166.598 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 167.77 -143.9 8.53 Favored Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 120.286 -0.959 . . . . 0.0 111.545 -175.027 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -124.74 -32.3 3.1 Favored 'General case' 0 C--O 1.221 -0.405 0 N-CA-C 115.449 1.648 . . . . 0.0 115.449 -177.811 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -77.69 165.77 23.82 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 178.57 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -79.66 -62.89 1.55 Allowed 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 -179.249 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 48.0 tp 173.88 141.04 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.221 0 N-CA-C 106.114 -1.81 . . . . 0.0 106.114 176.057 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 56.2 tptt -153.71 139.46 17.99 Favored 'General case' 0 C--O 1.222 -0.371 0 CA-C-N 118.077 0.399 . . . . 0.0 110.539 173.983 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 20.5 m-85 -126.27 151.49 72.32 Favored Pre-proline 0 C--O 1.24 0.59 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 175.189 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -78.98 166.95 22.64 Favored 'Trans proline' 0 C--N 1.353 0.813 0 C-N-CA 120.934 1.089 . . . . 0.0 113.535 178.347 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 2.0 tmt_? -66.86 137.07 56.32 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.821 -178.732 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 86.67 -0.21 86.52 Favored Glycine 0 C--O 1.223 -0.536 0 N-CA-C 111.302 -0.719 . . . . 0.0 111.302 177.169 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -140.65 -179.69 6.18 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 -175.176 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.52 -28.28 13.98 Favored Glycine 0 CA--C 1.498 -1.025 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.87 176.104 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 76.2 t -64.44 126.45 90.61 Favored Pre-proline 0 C--N 1.32 -0.705 0 N-CA-C 106.177 -1.786 . . . . 0.0 106.177 176.559 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -73.66 168.87 23.69 Favored 'Trans proline' 0 N--CA 1.459 -0.513 0 O-C-N 122.225 0.592 . . . . 0.0 111.446 179.134 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 87.6 mt -66.71 110.1 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-O 122.06 0.934 . . . . 0.0 109.177 -179.761 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 71.6 m-80 -97.94 91.45 5.33 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 114.636 -1.165 . . . . 0.0 110.734 -177.493 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 75.7 p -71.38 -14.89 62.32 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.744 0.783 . . . . 0.0 111.469 178.667 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 10.7 p30 -111.14 20.52 17.32 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 114.915 1.45 . . . . 0.0 114.915 -175.893 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 6.1 m -138.91 152.32 47.66 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 115.938 1.829 . . . . 0.0 115.938 -175.728 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 2.0 m -70.22 164.7 50.81 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 115.085 -0.962 . . . . 0.0 109.936 176.219 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -66.36 -28.38 46.84 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 114.758 -3.028 . . . . 0.0 113.915 -179.823 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.415 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 4.2 p-10 -75.3 -21.59 58.35 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.657 0.741 . . . . 0.0 110.688 177.319 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -83.28 -5.76 59.24 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 114.063 1.134 . . . . 0.0 114.063 -174.776 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 93.6 mm-40 -58.89 -26.52 64.36 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 113.248 0.833 . . . . 0.0 113.248 -179.427 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 20.1 tt -57.66 138.86 18.03 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.726 0 N-CA-C 114.402 1.26 . . . . 0.0 114.402 -178.744 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -177.07 -159.35 22.18 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.57 -0.824 . . . . 0.0 111.977 178.806 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 51.5 p90 -155.05 172.7 17.68 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 177.907 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 16.9 m-85 -113.49 138.89 49.47 Favored 'General case' 0 C--N 1.319 -0.761 0 N-CA-C 106.125 -1.806 . . . . 0.0 106.125 173.869 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 36.2 ttt180 -108.23 120.01 41.14 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 114.991 -1.004 . . . . 0.0 110.387 -176.728 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 13.1 ttt180 -64.33 131.7 48.04 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 176.316 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -142.18 129.77 21.44 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.544 0.688 . . . . 0.0 110.882 -179.693 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 15.3 t -156.8 155.46 31.59 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 175.183 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 15.0 tpt85 -154.88 135.12 13.18 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 104.865 -2.272 . . . . 0.0 104.865 178.11 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -127.82 136.37 51.35 Favored 'General case' 0 CA--C 1.495 -1.138 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 -179.423 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.401 ' H ' ' HB2' ' A' ' 62' ' ' LYS . 0.1 OUTLIER -132.67 172.4 16.49 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 -177.38 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 5.5 tmm_? -116.08 112.3 21.54 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 105.439 -2.06 . . . . 0.0 105.439 176.71 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -75.76 150.07 39.1 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 121.008 -0.615 . . . . 0.0 112.368 -177.512 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -70.89 -22.16 78.26 Favored Glycine 0 C--O 1.218 -0.896 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.44 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 41.1 t0 -65.16 -12.9 56.0 Favored 'General case' 0 CA--C 1.548 0.903 0 CA-C-N 114.236 -0.982 . . . . 0.0 110.363 176.951 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 108.07 18.46 9.86 Favored Glycine 0 CA--C 1.501 -0.827 0 CA-C-N 116.105 -0.498 . . . . 0.0 112.818 169.338 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.66 160.28 42.86 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 116.583 2.068 . . . . 0.0 116.583 -174.155 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 93.9 mmm -85.03 160.25 20.05 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.589 -0.732 . . . . 0.0 112.873 -176.398 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.401 ' HB2' ' H ' ' A' ' 54' ' ' ILE . 13.3 tmtt? -63.86 -42.91 97.43 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 122.316 1.055 . . . . 0.0 112.412 176.64 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 13.1 t70 56.15 -139.85 0.92 Allowed 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 112.444 -2.162 . . . . 0.0 109.988 -174.916 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER 66.9 156.23 0.11 Allowed 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 116.001 1.852 . . . . 0.0 116.001 178.777 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 14.1 p -81.26 162.59 58.44 Favored Pre-proline 0 C--O 1.242 0.675 0 CA-C-N 114.462 -1.245 . . . . 0.0 110.678 -179.949 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -71.6 156.5 57.61 Favored 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 116.434 -1.911 . . . . 0.0 111.293 175.563 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 11.7 mtt180 -116.7 161.46 19.19 Favored 'General case' 0 CA--C 1.506 -0.737 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 178.251 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 62.3 m95 -123.18 125.98 46.13 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 179.919 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 11.3 m-85 -110.37 138.06 47.26 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 107.278 -1.378 . . . . 0.0 107.278 -176.742 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 79.7 t80 -85.25 133.8 34.16 Favored 'General case' 0 CA--C 1.509 -0.629 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 -177.248 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -141.47 135.49 30.31 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 -175.254 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 86.3 m-85 -73.73 159.54 32.82 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 -175.652 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 11.3 tp -57.02 126.55 27.68 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.312 0.577 . . . . 0.0 109.615 179.849 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 82.03 18.68 66.8 Favored Glycine 0 C--O 1.22 -0.751 0 N-CA-C 116.49 1.356 . . . . 0.0 116.49 178.041 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 16.7 p -89.72 146.07 24.76 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 119.331 1.566 . . . . 0.0 110.228 178.622 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 97.13 142.85 13.83 Favored Glycine 0 CA--C 1.528 0.891 0 N-CA-C 110.716 -0.953 . . . . 0.0 110.716 -177.461 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -71.34 -46.62 0.63 Allowed 'Trans proline' 0 C--N 1.35 0.614 0 CA-C-N 119.844 1.822 . . . . 0.0 116.481 -174.908 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 68.1 mt-10 -107.56 39.33 1.93 Allowed 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 106.269 -1.752 . . . . 0.0 106.269 -178.265 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -65.25 -43.52 91.07 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.499 -1.228 . . . . 0.0 109.603 -178.702 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 57.24 33.27 64.84 Favored Glycine 0 C--O 1.226 -0.375 0 CA-C-N 115.724 -0.671 . . . . 0.0 114.136 177.666 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 15.0 mt -124.21 103.84 32.56 Favored Pre-proline 0 N--CA 1.44 -0.968 0 N-CA-C 116.027 1.862 . . . . 0.0 116.027 -175.311 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -78.47 162.21 27.9 Favored 'Trans proline' 0 N--CA 1.462 -0.357 0 C-N-CA 122.684 2.256 . . . . 0.0 107.165 166.962 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 59.1 t80 -61.44 132.56 53.86 Favored 'General case' 0 C--N 1.32 -0.712 0 C-N-CA 120.239 -0.584 . . . . 0.0 110.35 -177.499 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 91.4 -8.98 78.45 Favored Glycine 0 CA--C 1.519 0.324 0 N-CA-C 114.953 0.741 . . . . 0.0 114.953 179.296 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -66.35 131.54 46.33 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 118.676 1.238 . . . . 0.0 111.711 179.84 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 56.9 t30 -78.81 131.31 36.45 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.287 -179.724 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 32.7 tttt -156.22 156.77 34.7 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 106.807 -1.553 . . . . 0.0 106.807 -179.568 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -64.56 127.76 32.87 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.719 -0.475 . . . . 0.0 109.719 -178.129 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 67.41 33.02 80.74 Favored Glycine 0 N--CA 1.444 -0.778 0 N-CA-C 115.171 0.829 . . . . 0.0 115.171 176.8 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 41.0 mm -126.34 125.44 67.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 117.404 0.602 . . . . 0.0 110.132 179.067 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -127.41 112.45 28.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.202 177.278 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 98.6 m95 -78.02 137.29 38.19 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 113.371 0.878 . . . . 0.0 113.371 -177.681 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 14.0 m -139.45 149.75 22.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 177.843 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -160.7 164.17 31.87 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 104.299 -2.482 . . . . 0.0 104.299 179.385 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 14.1 t -124.08 174.58 7.53 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 105.668 -1.975 . . . . 0.0 105.668 178.48 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -65.99 132.28 48.21 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.992 0.425 . . . . 0.0 110.438 -178.752 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 92.59 -6.72 77.6 Favored Glycine 0 C--O 1.23 -0.154 0 CA-C-N 116.103 -0.498 . . . . 0.0 113.543 178.997 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.415 ' HA ' ' HA ' ' A' ' 41' ' ' ASP . . . -74.8 138.88 42.9 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 178.681 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 40.2 mt -94.6 139.01 31.76 Favored 'General case' 0 C--O 1.222 -0.39 0 N-CA-C 113.442 0.905 . . . . 0.0 113.442 -177.053 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 74.0 m-20 -83.18 62.08 6.44 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.869 -178.782 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -135.39 154.33 78.49 Favored Pre-proline 0 C--N 1.32 -0.692 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 -179.495 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -68.39 150.68 76.06 Favored 'Trans proline' 0 C--N 1.342 0.191 0 N-CA-C 114.476 0.914 . . . . 0.0 114.476 178.699 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -149.27 59.39 1.03 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 122.94 1.352 . . . . 0.0 110.988 178.006 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 14.0 p-10 -58.61 -30.43 67.24 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 113.694 -1.594 . . . . 0.0 110.206 176.894 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 23.0 p-80 -59.77 -14.66 15.54 Favored 'General case' 0 C--O 1.222 -0.366 0 N-CA-C 114.214 1.19 . . . . 0.0 114.214 -179.272 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 51.9 mt -90.33 -48.51 14.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 177.846 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -71.69 14.37 1.99 Allowed Glycine 0 C--O 1.219 -0.823 0 N-CA-C 116.094 1.197 . . . . 0.0 116.094 -176.271 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 13.8 t -90.95 19.88 5.28 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 117.596 0.698 . . . . 0.0 111.947 179.987 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 65.6 ttp85 -57.47 135.11 56.57 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 178.988 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -105.11 136.21 19.21 Favored Pre-proline 0 C--N 1.323 -0.559 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 178.515 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -73.96 -17.96 21.93 Favored 'Trans proline' 0 C--O 1.219 -0.464 0 O-C-N 121.967 0.456 . . . . 0.0 113.148 -179.885 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -80.07 -24.61 40.52 Favored 'General case' 0 C--O 1.221 -0.409 0 CA-C-O 121.148 0.499 . . . . 0.0 110.271 178.938 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 88.4 m-20 -99.4 -22.37 15.57 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 113.464 0.913 . . . . 0.0 113.464 -175.32 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 20.4 t30 -158.7 149.72 20.4 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.135 0.42 . . . . 0.0 112.135 -178.659 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -85.34 145.29 27.57 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-O 121.427 0.632 . . . . 0.0 111.872 179.68 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -69.6 148.1 49.82 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.17 0.51 . . . . 0.0 110.544 178.361 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 17.4 mt -89.42 138.99 18.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 -179.045 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 79.7 t -62.81 124.92 18.3 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 N-CA-C 106.088 -1.819 . . . . 0.0 106.088 174.259 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 7.2 tt -67.55 130.61 43.59 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 -177.782 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -135.0 154.11 51.85 Favored 'General case' 0 CA--C 1.51 -0.591 0 N-CA-C 106.135 -1.802 . . . . 0.0 106.135 -179.152 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 13.1 mt -108.56 147.34 35.54 Favored Pre-proline 0 C--N 1.321 -0.673 0 CA-C-O 120.574 0.226 . . . . 0.0 110.732 177.15 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -73.34 163.91 36.58 Favored 'Trans proline' 0 C--O 1.236 0.401 0 C-N-CA 118.371 -0.62 . . . . 0.0 113.378 -179.873 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 39.4 tt0 -53.87 129.22 33.04 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.274 -0.876 . . . . 0.0 109.09 178.999 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 108.65 -26.89 14.65 Favored Glycine 0 C--O 1.225 -0.408 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.911 -178.681 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 5.0 m -108.56 132.28 54.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 118.012 0.906 . . . . 0.0 111.545 178.499 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 2.8 p -121.14 148.18 44.56 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 177.3 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 75.9 mt -70.02 153.59 95.27 Favored Pre-proline 0 C--N 1.323 -0.566 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 177.739 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -74.1 168.82 23.88 Favored 'Trans proline' 0 C--O 1.235 0.354 0 N-CA-C 110.714 -0.533 . . . . 0.0 110.714 179.176 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -60.17 125.81 25.09 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.988 0.423 . . . . 0.0 111.49 -175.268 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 94.95 -2.9 66.73 Favored Glycine 0 C--O 1.227 -0.307 0 N-CA-C 115.131 0.813 . . . . 0.0 115.131 178.444 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -102.89 138.91 39.15 Favored 'General case' 0 N--CA 1.441 -0.911 0 CA-C-O 122.175 0.988 . . . . 0.0 110.39 -179.899 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 45.9 p90 -141.81 159.88 41.32 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 113.989 -1.46 . . . . 0.0 107.656 175.846 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -98.89 150.65 21.69 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 -179.505 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.464 ' HB3' ' HB ' ' A' ' 14' ' ' THR . 2.9 tp10 -73.17 129.03 37.16 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 106.77 -1.567 . . . . 0.0 106.77 179.74 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 89.03 -2.92 84.41 Favored Glycine 0 C--O 1.227 -0.318 0 C-N-CA 121.341 -0.457 . . . . 0.0 112.183 -177.615 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 46.4 t -118.0 165.65 13.48 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 178.218 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 49.4 mtm180 -84.97 -16.86 39.48 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.498 0.666 . . . . 0.0 109.478 177.584 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 104.04 175.18 25.52 Favored Glycine 0 C--N 1.319 -0.413 0 N-CA-C 107.153 -2.379 . . . . 0.0 107.153 -176.179 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 81.03 50.07 5.32 Favored Glycine 0 C--O 1.228 -0.271 0 N-CA-C 109.326 -1.51 . . . . 0.0 109.326 -176.025 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 62.5 m . . . . . 0 N--CA 1.48 1.06 0 C-N-CA 125.977 1.711 . . . . 0.0 110.845 -177.45 . . . . . . . . 0 0 . 1 . 037 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.46 0 CA-C-O 119.016 -0.88 . . . . 0.0 111.193 . . . . . . . . . 0 0 . 1 . 037 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -143.67 162.82 34.96 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 117.979 0.889 . . . . 0.0 109.816 -177.301 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 21.7 ttt -141.23 172.34 12.81 Favored 'General case' 0 C--N 1.321 -0.645 1 N-CA-C 98.627 -4.583 . . . . 0.0 98.627 177.989 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 90.41 67.02 1.2 Allowed Glycine 0 C--N 1.316 -0.57 0 C-N-CA 120.734 -0.746 . . . . 0.0 111.855 -175.08 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 10.2 mp -97.68 142.05 23.95 Favored Pre-proline 0 C--N 1.325 -0.46 0 N-CA-C 106.784 -1.561 . . . . 0.0 106.784 179.178 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -74.5 152.24 43.21 Favored 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 117.664 -1.091 . . . . 0.0 113.418 -179.233 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 36.4 t30 -151.6 -59.33 0.16 Allowed 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.653 177.691 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -88.26 -3.61 58.83 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 120.983 0.421 . . . . 0.0 111.375 -177.914 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 16.8 p -133.48 118.51 18.42 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 106.102 -1.814 . . . . 0.0 106.102 -178.311 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -108.55 146.69 32.88 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.252 0.549 . . . . 0.0 109.664 -178.398 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 53.2 p -64.97 144.27 57.4 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 178.303 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 6.3 m95 -66.31 -26.3 67.25 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 111.959 0.355 . . . . 0.0 111.959 177.86 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 32.1 m-85 -121.72 159.15 27.19 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.361 -171.851 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 45.4 p -68.22 166.75 15.68 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.266 -0.879 . . . . 0.0 111.271 -178.246 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -85.38 127.2 34.28 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 113.695 0.998 . . . . 0.0 113.695 -175.513 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 22.6 mt -67.76 147.93 51.93 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 105.332 -2.099 . . . . 0.0 105.332 172.763 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 34.6 m -123.69 133.0 53.96 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 -178.733 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -94.48 140.94 29.18 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 114.266 1.21 . . . . 0.0 114.266 -176.43 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 57.3 t60 -138.82 100.1 3.97 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 105.673 -1.973 . . . . 0.0 105.673 166.04 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 166.3 -153.83 23.95 Favored Glycine 0 C--O 1.224 -0.503 0 C-N-CA 120.844 -0.693 . . . . 0.0 111.537 -177.756 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 40.2 mtpt -117.43 -21.73 8.52 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 113.556 0.947 . . . . 0.0 113.556 -179.42 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -76.1 156.74 33.57 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 178.369 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -73.75 -62.41 1.5 Allowed 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 179.776 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 35.4 tp 171.3 142.24 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 103.418 -2.808 . . . . 0.0 103.418 174.169 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 52.7 tptt -151.78 134.72 15.71 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 118.424 0.556 . . . . 0.0 111.281 174.823 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -123.02 149.13 56.14 Favored Pre-proline 0 C--O 1.243 0.74 0 N-CA-C 108.42 -0.955 . . . . 0.0 108.42 174.152 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -77.39 167.68 24.12 Favored 'Trans proline' 0 CA--C 1.537 0.653 0 C-N-CA 120.906 1.071 . . . . 0.0 113.671 179.268 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 71.3 ttt180 -67.96 137.65 55.32 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.759 -178.871 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 85.93 -0.11 87.61 Favored Glycine 0 C--O 1.224 -0.487 0 N-CA-C 111.562 -0.615 . . . . 0.0 111.562 178.336 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 -140.52 -179.48 6.04 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 -176.288 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 101.15 -29.14 13.15 Favored Glycine 0 CA--C 1.501 -0.842 0 CA-C-N 115.732 -0.667 . . . . 0.0 112.866 175.613 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 98.5 t -66.1 127.39 93.17 Favored Pre-proline 0 C--N 1.322 -0.621 0 N-CA-C 105.456 -2.053 . . . . 0.0 105.456 176.867 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -71.46 167.4 26.45 Favored 'Trans proline' 0 N--CA 1.461 -0.44 0 C-N-CA 120.329 0.686 . . . . 0.0 111.955 179.543 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 95.7 mt -63.36 121.32 12.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 106.227 -1.768 . . . . 0.0 106.227 179.481 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 43.3 t-20 -116.93 122.65 44.89 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.287 -0.87 . . . . 0.0 110.881 -173.913 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 73.4 p -103.03 -11.88 17.83 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.393 -0.821 . . . . 0.0 112.716 -177.475 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 17.5 p30 -114.24 15.99 18.04 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 116.324 1.972 . . . . 0.0 116.324 -173.063 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 29.0 m -141.83 154.31 45.09 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 113.742 1.015 . . . . 0.0 113.742 -177.694 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 18.6 m -72.44 164.45 59.6 Favored Pre-proline 0 C--O 1.238 0.464 0 CA-C-N 115.331 -0.85 . . . . 0.0 109.014 176.696 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -64.3 -28.44 63.68 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 115.4 -2.6 . . . . 0.0 112.46 178.918 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -62.65 -24.21 67.5 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 123.735 0.814 . . . . 0.0 111.613 177.643 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 33.4 m-20 -99.81 -2.49 34.92 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 114.75 1.389 . . . . 0.0 114.75 -171.622 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 96.9 mm-40 -60.46 -37.79 82.11 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 115.937 1.828 . . . . 0.0 115.937 -179.992 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 15.7 tt -59.33 138.3 20.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-O 122.313 1.054 . . . . 0.0 112.59 -176.965 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -178.77 -152.34 10.36 Favored Glycine 0 C--O 1.226 -0.383 0 CA-C-N 115.338 -0.847 . . . . 0.0 111.964 -174.862 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 47.8 p90 -154.7 173.59 16.18 Favored 'General case' 0 C--N 1.321 -0.636 0 O-C-N 122.379 -0.483 . . . . 0.0 110.448 -179.33 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -113.98 140.12 48.68 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 171.29 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -105.73 119.33 38.86 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 124.192 0.997 . . . . 0.0 109.69 -178.348 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -70.89 133.18 46.24 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 175.556 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -143.93 154.79 43.68 Favored 'General case' 0 C--N 1.321 -0.654 0 C-N-CA 122.814 0.445 . . . . 0.0 110.175 -177.441 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 15.2 t -156.68 166.98 31.84 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 174.975 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.7 tpt85 -160.29 153.81 22.33 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 103.421 -2.807 . . . . 0.0 103.421 179.475 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 21.8 ttm180 -131.37 146.07 52.12 Favored 'General case' 0 CA--C 1.495 -1.168 0 CA-C-N 118.804 0.729 . . . . 0.0 111.908 179.387 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -142.67 177.71 2.65 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 N-CA-C 104.823 -2.288 . . . . 0.0 104.823 179.205 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 7.1 tmm_? -128.09 103.05 7.0 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 104.999 -2.223 . . . . 0.0 104.999 174.852 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -70.49 154.89 52.76 Favored Glycine 0 C--O 1.22 -0.776 0 N-CA-C 110.731 -0.947 . . . . 0.0 110.731 -176.55 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -67.45 -34.8 85.69 Favored Glycine 0 C--O 1.215 -1.051 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 -179.817 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.1 t0 -94.24 16.91 13.71 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-O 122.483 1.135 . . . . 0.0 109.532 178.416 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 86.42 -17.53 38.35 Favored Glycine 0 C--O 1.225 -0.41 0 N-CA-C 116.225 1.25 . . . . 0.0 116.225 173.801 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -58.9 135.51 57.58 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 122.286 1.041 . . . . 0.0 113.319 -177.314 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 79.3 mtp -113.63 -175.76 2.75 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 113.472 -1.695 . . . . 0.0 111.728 -177.416 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 12.2 mptt -130.29 -41.98 1.22 Allowed 'General case' 0 N--CA 1.476 0.831 0 CA-C-O 122.641 1.21 . . . . 0.0 111.674 -178.984 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 15.7 t0 -61.02 -177.6 0.08 Allowed 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 111.657 -2.52 . . . . 0.0 113.456 179.014 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER 81.02 -52.41 0.3 Allowed 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 126.952 2.101 . . . . 0.0 110.162 -179.206 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 37.9 t -83.81 113.71 49.24 Favored Pre-proline 0 C--N 1.321 -0.662 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 175.459 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -73.45 150.01 45.53 Favored 'Trans proline' 0 C--O 1.239 0.565 0 C-N-CA 114.803 -2.998 . . . . 0.0 111.062 177.94 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 36.6 mtp180 -120.08 157.79 28.21 Favored 'General case' 0 CA--C 1.503 -0.855 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 -179.45 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 77.3 m95 -128.78 126.8 40.69 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 120.77 0.319 . . . . 0.0 110.874 -179.088 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 13.2 m-85 -110.52 134.25 52.54 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 106.769 -1.567 . . . . 0.0 106.769 -177.501 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 88.4 t80 -83.66 134.21 34.79 Favored 'General case' 0 CA--C 1.508 -0.661 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 -178.139 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -139.67 145.49 38.48 Favored 'General case' 0 N--CA 1.44 -0.935 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 -175.899 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 76.9 m-85 -83.12 159.55 22.06 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.937 -172.971 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -56.48 126.63 27.33 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 179.462 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 78.96 26.8 57.63 Favored Glycine 0 C--O 1.223 -0.559 0 N-CA-C 115.908 1.123 . . . . 0.0 115.908 178.224 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 22.2 p -102.82 146.21 28.62 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 118.829 1.314 . . . . 0.0 109.746 177.201 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 103.78 137.62 9.42 Favored Glycine 0 CA--C 1.527 0.821 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.824 -179.912 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -73.1 -38.4 2.82 Favored 'Trans proline' 0 C--N 1.349 0.586 0 CA-C-N 119.446 1.623 . . . . 0.0 116.229 -175.117 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -103.82 17.57 23.82 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 -176.968 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -65.28 -55.47 18.14 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.204 -176.241 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 55.94 34.06 61.19 Favored Glycine 0 C--O 1.225 -0.449 0 C-N-CA 121.302 -0.475 . . . . 0.0 112.32 -179.402 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 18.5 mt -112.61 103.83 55.68 Favored Pre-proline 0 N--CA 1.447 -0.588 0 N-CA-C 116.628 2.084 . . . . 0.0 116.628 -174.002 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -78.63 163.1 26.94 Favored 'Trans proline' 0 N--CA 1.461 -0.386 0 C-N-CA 122.305 2.004 . . . . 0.0 107.732 167.898 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 65.9 t80 -61.9 132.06 51.78 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 120.307 -0.557 . . . . 0.0 110.651 -177.005 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 92.1 -9.21 76.91 Favored Glycine 0 C--O 1.228 -0.277 0 CA-C-O 119.595 -0.559 . . . . 0.0 114.359 179.092 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -65.01 130.71 44.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 118.256 1.028 . . . . 0.0 111.39 179.403 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 57.0 t30 -79.36 130.75 35.74 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.413 -179.246 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 26.9 ttmt -154.84 150.71 27.77 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 178.454 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 32.1 t0 -64.4 120.78 12.89 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.284 0.564 . . . . 0.0 110.402 -178.047 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 78.41 29.76 51.92 Favored Glycine 0 N--CA 1.451 -0.309 0 CA-C-N 115.437 -0.802 . . . . 0.0 114.506 179.471 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 41.6 mm -127.06 126.38 68.09 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 CA-C-N 117.612 0.706 . . . . 0.0 110.712 179.099 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -127.16 116.04 42.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 CA-C-O 121.478 0.656 . . . . 0.0 111.381 176.337 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 96.7 m95 -79.91 138.48 37.14 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -178.326 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 16.1 m -138.29 153.23 26.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 179.15 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -160.1 165.92 30.84 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 107.073 -1.454 . . . . 0.0 107.073 -178.407 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 14.0 t -133.05 165.97 23.49 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 105.007 -2.22 . . . . 0.0 105.007 176.205 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 61.0 tt0 -67.41 138.18 56.5 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.096 0.474 . . . . 0.0 110.163 -179.06 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 94.97 -8.53 70.33 Favored Glycine 0 C--O 1.225 -0.432 0 CA-C-N 115.853 -0.612 . . . . 0.0 112.999 178.756 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -81.3 143.0 32.55 Favored 'General case' 0 C--N 1.323 -0.543 0 O-C-N 122.543 -0.386 . . . . 0.0 110.364 178.878 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 38.7 mt -100.53 134.76 43.0 Favored 'General case' 0 CA--C 1.514 -0.404 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -178.409 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -78.55 48.07 0.76 Allowed 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 115.184 -0.916 . . . . 0.0 112.049 -177.248 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 1.4 t -114.91 154.85 46.98 Favored Pre-proline 0 C--N 1.32 -0.717 0 N-CA-C 105.366 -2.087 . . . . 0.0 105.366 -179.98 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -64.97 149.01 90.03 Favored 'Trans proline' 0 C--N 1.342 0.197 0 N-CA-C 113.636 0.591 . . . . 0.0 113.636 176.802 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.99 54.96 1.3 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 123.551 1.644 . . . . 0.0 109.603 178.616 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -58.32 -30.66 66.86 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 113.128 -1.851 . . . . 0.0 111.456 178.501 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 29.4 p-80 -57.08 -16.65 7.89 Favored 'General case' 0 C--O 1.222 -0.389 0 N-CA-C 115.026 1.491 . . . . 0.0 115.026 -178.422 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 4.4 mt -92.02 -21.01 6.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 121.256 0.55 . . . . 0.0 110.515 -179.946 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -77.11 3.0 59.32 Favored Glycine 0 C--O 1.225 -0.413 0 C-N-CA 120.806 -0.711 . . . . 0.0 113.81 -177.692 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 9.9 t -83.34 11.33 6.9 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 114.235 1.198 . . . . 0.0 114.235 -176.588 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 66.9 ttp85 -59.69 126.09 26.22 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 107.794 -1.188 . . . . 0.0 107.794 178.417 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -97.45 137.38 21.1 Favored Pre-proline 0 C--N 1.322 -0.623 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 178.574 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -74.68 -20.27 17.84 Favored 'Trans proline' 0 C--O 1.219 -0.458 0 N-CA-C 113.815 0.66 . . . . 0.0 113.815 179.999 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -81.6 -24.87 36.18 Favored 'General case' 0 C--O 1.221 -0.408 0 CA-C-O 121.116 0.484 . . . . 0.0 110.145 179.919 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 87.4 m-20 -97.32 -22.27 16.74 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 113.503 0.927 . . . . 0.0 113.503 -175.266 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 24.4 t30 -157.22 151.35 24.82 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 112.315 0.487 . . . . 0.0 112.315 -178.005 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -89.08 146.19 24.98 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-O 121.433 0.635 . . . . 0.0 111.435 179.196 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -70.75 149.06 47.29 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.348 0.594 . . . . 0.0 110.923 178.713 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 22.7 mt -81.21 137.88 20.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 179.864 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 87.7 t -61.35 121.09 8.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 106.679 -1.6 . . . . 0.0 106.679 175.109 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 6.1 tt -67.39 125.53 26.41 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.074 0.464 . . . . 0.0 110.075 -176.985 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -134.46 159.12 42.09 Favored 'General case' 0 CA--C 1.508 -0.643 0 N-CA-C 106.491 -1.67 . . . . 0.0 106.491 -179.169 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 13.6 mt -112.97 148.31 39.12 Favored Pre-proline 0 C--N 1.32 -0.713 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 178.501 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -73.17 163.75 37.23 Favored 'Trans proline' 0 C--O 1.236 0.425 0 C-N-CA 118.254 -0.698 . . . . 0.0 112.836 -179.933 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 39.0 tt0 -54.6 129.55 36.82 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 179.403 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 108.83 -27.82 12.45 Favored Glycine 0 C--O 1.225 -0.416 0 CA-C-N 115.853 -0.612 . . . . 0.0 112.08 -178.461 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 4.3 m -105.6 129.29 53.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 118.128 0.964 . . . . 0.0 111.507 178.54 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 3.3 p -116.97 148.28 41.56 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.809 179.35 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 89.5 mt -73.2 151.43 90.16 Favored Pre-proline 0 C--N 1.323 -0.552 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 177.987 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -78.49 -172.04 1.4 Allowed 'Trans proline' 0 C--O 1.238 0.52 0 C-N-CA 121.061 1.174 . . . . 0.0 112.346 179.396 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 7.8 tmtt? -55.15 120.71 7.41 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 114.235 1.198 . . . . 0.0 114.235 -171.893 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 66.36 22.79 71.41 Favored Glycine 0 C--O 1.224 -0.494 0 CA-C-N 114.888 -1.051 . . . . 0.0 115.522 173.703 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -99.84 134.41 42.78 Favored 'General case' 0 N--CA 1.439 -0.977 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 177.774 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 42.5 p90 -139.8 161.27 37.97 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.051 -0.977 . . . . 0.0 108.711 178.392 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -98.08 144.93 27.05 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.727 0.775 . . . . 0.0 112.508 -176.716 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -78.29 139.24 38.87 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 106.566 -1.642 . . . . 0.0 106.566 176.212 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 91.75 -5.04 79.55 Favored Glycine 0 C--O 1.224 -0.471 0 C-N-CA 120.956 -0.64 . . . . 0.0 111.887 -178.355 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 21.9 t -82.51 174.81 10.73 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 105.635 -1.987 . . . . 0.0 105.635 175.948 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.02 100.42 1.99 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.135 0.493 . . . . 0.0 110.676 -178.264 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -167.24 -179.52 40.23 Favored Glycine 0 N--CA 1.45 -0.373 0 N-CA-C 107.649 -2.181 . . . . 0.0 107.649 179.679 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 71.18 16.99 75.49 Favored Glycine 0 C--O 1.227 -0.313 0 N-CA-C 110.875 -0.89 . . . . 0.0 110.875 -179.234 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 4.7 p . . . . . 0 C--O 1.257 1.477 0 N-CA-C 102.411 -3.181 . . . . 0.0 102.411 -177.39 . . . . . . . . 0 0 . 1 . 038 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 2.017 0 CA-C-O 119.028 -0.873 . . . . 0.0 111.469 . . . . . . . . . 0 0 . 1 . 038 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -62.38 135.54 57.5 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 177.596 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 86.9 mtp 57.39 10.72 0.99 Allowed 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 114.057 1.132 . . . . 0.0 114.057 -177.46 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -130.45 59.46 0.69 Allowed Glycine 0 CA--C 1.509 -0.313 0 N-CA-C 107.766 -2.133 . . . . 0.0 107.766 -179.032 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 10.7 mp -85.06 158.56 58.41 Favored Pre-proline 0 C--N 1.32 -0.679 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 -177.817 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -67.23 -15.58 46.41 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 117.184 -1.411 . . . . 0.0 111.79 176.214 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 9.2 m120 -72.91 1.9 7.86 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 123.53 0.732 . . . . 0.0 112.121 178.622 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 9.6 m-20 -81.43 11.01 4.85 Favored 'General case' 0 C--O 1.217 -0.609 0 C-N-CA 122.448 0.299 . . . . 0.0 110.321 177.774 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 58.8 p -120.75 114.87 22.26 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-O 122.272 1.034 . . . . 0.0 108.467 -177.973 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -143.26 155.06 44.4 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 114.227 -1.351 . . . . 0.0 110.017 -179.828 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -61.24 137.41 58.24 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 178.246 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 9.8 m95 -68.81 -27.01 65.47 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 113.151 0.797 . . . . 0.0 113.151 -179.851 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 54.5 m-85 -121.65 163.4 19.05 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 113.342 0.868 . . . . 0.0 113.342 -170.321 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 59.7 p -68.25 167.29 14.64 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 114.51 -1.223 . . . . 0.0 108.327 177.49 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -78.53 152.53 31.91 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 122.346 1.069 . . . . 0.0 112.803 -177.207 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 14.9 mt -91.98 142.26 27.73 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 102.383 -3.191 . . . . 0.0 102.383 167.527 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 33.1 m -124.71 140.01 53.33 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 -176.806 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.445 ' HB2' ' CZ ' ' A' ' 131' ' ' PHE . 4.9 tp60 -120.76 146.0 46.95 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 116.095 1.887 . . . . 0.0 116.095 -172.725 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 78.2 t60 -133.14 99.47 4.56 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 106.811 -1.551 . . . . 0.0 106.811 169.706 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 178.03 -164.58 33.51 Favored Glycine 0 C--O 1.227 -0.294 0 N-CA-C 109.008 -1.637 . . . . 0.0 109.008 -177.722 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -99.79 -25.0 14.51 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 177.905 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -77.52 152.39 34.12 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 114.279 -1.328 . . . . 0.0 109.617 -179.897 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -88.97 -62.44 1.48 Allowed 'General case' 0 C--O 1.212 -0.891 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 178.095 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 45.0 tp -174.93 141.29 0.59 Allowed 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 174.699 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 9.8 tmtt? -156.94 131.58 8.74 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 176.193 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -120.73 153.63 56.94 Favored Pre-proline 0 CA--C 1.543 0.69 0 N-CA-C 111.517 0.191 . . . . 0.0 111.517 177.171 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_endo -78.39 164.18 26.65 Favored 'Trans proline' 0 CA--C 1.542 0.91 0 C-N-CA 120.695 0.93 . . . . 0.0 112.965 176.571 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 1.6 tmt_? -70.75 139.15 51.01 Favored 'General case' 0 N--CA 1.475 0.786 0 O-C-N 122.261 -0.275 . . . . 0.0 110.424 -178.753 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 85.31 4.27 86.33 Favored Glycine 0 C--O 1.223 -0.551 0 N-CA-C 110.851 -0.9 . . . . 0.0 110.851 177.66 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 38.5 mt-30 -147.16 -179.86 7.12 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 -174.257 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 97.48 -28.35 14.57 Favored Glycine 0 CA--C 1.499 -0.943 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.816 175.543 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 94.6 t -64.4 127.9 92.71 Favored Pre-proline 0 C--N 1.321 -0.642 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 177.1 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -73.76 170.72 19.37 Favored 'Trans proline' 0 N--CA 1.461 -0.431 0 O-C-N 122.236 0.598 . . . . 0.0 111.793 178.902 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 94.6 mt -68.07 112.7 3.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 178.784 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 80.5 m-20 -104.12 93.42 4.83 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 114.68 -1.145 . . . . 0.0 110.303 -176.855 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 67.4 p -69.39 -16.79 63.59 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.584 -0.734 . . . . 0.0 112.281 -179.032 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 10.9 p30 -106.92 22.76 15.46 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.057 -0.974 . . . . 0.0 113.227 -177.006 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 16.3 m -139.5 147.02 40.7 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 116.742 2.127 . . . . 0.0 116.742 -175.242 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 2.0 m -71.34 166.55 37.87 Favored Pre-proline 0 N--CA 1.468 0.431 0 CA-C-N 114.706 -1.133 . . . . 0.0 109.658 175.228 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -66.65 -27.97 44.89 Favored 'Trans proline' 0 CA--C 1.536 0.613 0 C-N-CA 114.238 -3.375 . . . . 0.0 113.922 -179.796 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.453 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 3.1 p-10 -75.28 -20.64 59.03 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.871 0.843 . . . . 0.0 110.944 178.057 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -83.49 -11.43 57.48 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 114.09 1.144 . . . . 0.0 114.09 -173.747 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 97.5 mm-40 -56.69 -29.79 62.75 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 115.512 1.671 . . . . 0.0 115.512 -177.03 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 12.0 tt -56.79 139.57 16.13 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.007 0 N-CA-C 114.385 1.254 . . . . 0.0 114.385 -176.948 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -177.31 -157.4 18.18 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.619 -0.8 . . . . 0.0 113.428 -178.413 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 41.4 p90 -154.66 170.53 21.33 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 179.766 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 23.5 m-85 -113.68 142.03 46.51 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 173.546 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 59.8 ttt180 -113.57 120.02 39.51 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 114.96 -1.018 . . . . 0.0 110.888 -175.455 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 3.6 ttt180 -63.06 140.95 58.93 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 123.184 0.594 . . . . 0.0 109.488 176.985 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -144.48 128.96 18.01 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.804 0.335 . . . . 0.0 110.173 177.442 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -158.79 134.17 8.58 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.129 178.574 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 18.5 tpt180 -145.94 123.74 11.94 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.479 0.657 . . . . 0.0 110.929 174.438 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 9.2 ttp180 -113.08 141.44 46.88 Favored 'General case' 0 CA--C 1.489 -1.394 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.423 178.495 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -131.56 177.77 6.53 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 N-CA-C 106.442 -1.688 . . . . 0.0 106.442 178.111 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 17.0 ttt85 -138.39 112.28 8.42 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 106.193 -1.781 . . . . 0.0 106.193 178.505 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -150.78 175.5 29.74 Favored Glycine 0 N--CA 1.444 -0.772 0 N-CA-C 107.145 -2.382 . . . . 0.0 107.145 178.395 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -75.25 -59.31 3.64 Favored Glycine 0 C--O 1.222 -0.624 0 N-CA-C 108.238 -1.945 . . . . 0.0 108.238 178.251 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.52 ' C ' ' H ' ' A' ' 60' ' ' LYS . 0.7 OUTLIER -94.26 -3.19 51.09 Favored 'General case' 0 C--O 1.217 -0.634 0 N-CA-C 105.207 -2.146 . . . . 0.0 105.207 174.266 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -89.53 33.89 4.21 Favored Glycine 0 N--CA 1.451 -0.314 0 N-CA-C 106.088 -2.805 . . . . 0.0 106.088 173.243 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.52 ' H ' ' C ' ' A' ' 58' ' ' ASP . 1.3 pttt -50.67 167.55 0.06 Allowed 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 113.415 -1.393 . . . . 0.0 111.028 172.268 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -46.69 129.59 11.31 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 113.926 -1.488 . . . . 0.0 113.698 -175.745 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -98.52 -73.99 0.6 Allowed 'General case' 0 C--O 1.219 -0.543 0 CA-C-N 113.666 -1.606 . . . . 0.0 114.044 -174.866 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 73.6 m-20 -95.06 96.66 9.4 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 179.349 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -74.58 -40.85 61.37 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 179.147 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 4.5 p -112.23 152.82 44.73 Favored Pre-proline 0 C--O 1.24 0.6 0 CA-C-N 114.962 -1.017 . . . . 0.0 108.985 179.723 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -74.34 156.68 45.96 Favored 'Trans proline' 0 C--O 1.238 0.497 0 C-N-CA 117.108 -1.461 . . . . 0.0 112.6 178.174 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 58.1 mtt-85 -124.58 149.87 46.55 Favored 'General case' 0 CA--C 1.513 -0.449 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.677 -179.657 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 35.0 m95 -134.75 129.82 35.24 Favored 'General case' 0 C--O 1.216 -0.662 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 175.565 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 60.0 m-85 -110.48 156.38 20.94 Favored 'General case' 0 C--O 1.212 -0.91 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 -178.96 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -97.97 136.91 37.57 Favored 'General case' 0 CA--C 1.509 -0.608 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 -179.84 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -139.12 130.31 26.73 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 107.097 -1.446 . . . . 0.0 107.097 -175.846 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 86.1 m-85 -70.69 159.47 34.4 Favored 'General case' 0 C--N 1.319 -0.756 0 O-C-N 122.191 -0.318 . . . . 0.0 111.063 -178.009 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -49.01 121.59 4.93 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 113.496 0.925 . . . . 0.0 113.496 -175.973 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 70.32 21.53 77.36 Favored Glycine 0 C--O 1.224 -0.529 0 N-CA-C 116.44 1.336 . . . . 0.0 116.44 176.009 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 34.2 p -89.37 146.38 24.72 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 118.604 1.202 . . . . 0.0 111.648 -179.742 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 108.68 144.53 10.93 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 108.296 -1.922 . . . . 0.0 108.296 -176.163 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -73.15 -34.51 6.14 Favored 'Trans proline' 0 CA--C 1.518 -0.307 0 CA-C-N 119.792 1.796 . . . . 0.0 115.164 -175.731 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -97.78 14.0 28.51 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 114.771 -1.104 . . . . 0.0 109.435 -177.216 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -54.17 -55.48 27.45 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 -171.03 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 54.66 33.86 55.44 Favored Glycine 0 C--O 1.226 -0.357 0 C-N-CA 121.194 -0.527 . . . . 0.0 113.044 178.898 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 14.7 mt -126.68 103.86 24.37 Favored Pre-proline 0 N--CA 1.444 -0.775 0 N-CA-C 115.412 1.634 . . . . 0.0 115.412 -174.225 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -77.62 161.77 30.72 Favored 'Trans proline' 0 N--CA 1.461 -0.401 0 C-N-CA 122.061 1.84 . . . . 0.0 107.404 168.501 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 57.6 t80 -61.12 131.86 51.87 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 120.379 -0.529 . . . . 0.0 110.395 -177.177 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 92.98 -11.97 70.94 Favored Glycine 0 C--O 1.225 -0.432 0 CA-C-O 119.399 -0.667 . . . . 0.0 114.41 179.409 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -65.1 130.37 43.09 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 118.497 1.149 . . . . 0.0 112.071 -179.51 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 30.9 m120 -77.72 132.64 38.24 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 114.563 -1.199 . . . . 0.0 110.146 179.724 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 30.6 ttmt -156.21 155.35 32.26 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 104.148 -2.538 . . . . 0.0 104.148 177.795 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -65.75 133.22 50.57 Favored 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 120.273 -0.571 . . . . 0.0 109.672 -179.03 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 69.06 28.53 72.85 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.772 -0.728 . . . . 0.0 114.794 177.572 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 46.4 mm -126.01 126.6 70.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 117.476 0.638 . . . . 0.0 110.548 179.725 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -129.24 123.11 57.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.565 177.023 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 96.9 m95 -87.78 138.7 31.23 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 -176.758 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 13.7 m -138.02 151.49 25.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 179.102 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -160.29 165.86 30.57 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 104.833 -2.284 . . . . 0.0 104.833 -179.973 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 14.1 t -127.09 170.78 11.99 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 105.237 -2.135 . . . . 0.0 105.237 178.479 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -66.07 133.55 50.99 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.088 0.471 . . . . 0.0 110.651 -178.635 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 92.69 -7.5 77.21 Favored Glycine 0 N--CA 1.459 0.172 0 CA-C-N 116.017 -0.538 . . . . 0.0 113.422 178.749 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.453 ' HA ' ' HA ' ' A' ' 41' ' ' ASP . . . -74.63 140.49 44.33 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 178.504 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 39.6 mt -99.27 138.03 36.95 Favored 'General case' 0 CA--C 1.515 -0.385 0 N-CA-C 113.398 0.888 . . . . 0.0 113.398 -177.763 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -81.4 66.55 6.99 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.438 -178.751 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 1.2 t -133.11 155.36 81.1 Favored Pre-proline 0 C--N 1.32 -0.697 0 N-CA-C 105.327 -2.101 . . . . 0.0 105.327 -179.5 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -61.17 147.82 94.57 Favored 'Trans proline' 0 C--N 1.343 0.253 0 N-CA-C 114.614 0.967 . . . . 0.0 114.614 -179.603 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -121.39 38.17 4.16 Favored 'General case' 0 CA--C 1.508 -0.643 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.332 -179.402 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 16.7 p-10 -59.9 -33.62 72.1 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 176.514 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 7.9 p80 -62.79 -16.19 56.94 Favored 'General case' 0 C--O 1.221 -0.411 0 N-CA-C 113.158 0.799 . . . . 0.0 113.158 177.973 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 60.2 mt -95.93 -49.96 11.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 120.977 0.418 . . . . 0.0 110.896 178.281 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -71.02 14.19 1.63 Allowed Glycine 0 C--O 1.22 -0.741 0 N-CA-C 117.53 1.772 . . . . 0.0 117.53 -174.124 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 9.0 t -83.59 26.43 0.68 Allowed 'General case' 0 CA--C 1.551 0.988 0 CA-C-O 121.671 0.748 . . . . 0.0 111.744 -179.31 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 64.8 ttp85 -68.32 119.43 12.84 Favored 'General case' 0 N--CA 1.465 0.325 0 O-C-N 121.271 -0.893 . . . . 0.0 109.978 178.66 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -86.54 122.17 71.95 Favored Pre-proline 0 C--N 1.323 -0.569 0 N-CA-C 105.103 -2.184 . . . . 0.0 105.103 176.571 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -72.78 -15.43 26.79 Favored 'Trans proline' 0 C--O 1.218 -0.494 0 C-N-CA 116.907 -1.595 . . . . 0.0 114.374 -177.174 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -81.57 -24.56 36.43 Favored 'General case' 0 C--O 1.221 -0.422 0 CA-C-O 120.963 0.411 . . . . 0.0 110.479 178.745 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 -100.15 -22.98 14.97 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 -174.504 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 15.5 t30 -145.72 148.69 33.28 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -178.314 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -86.37 148.44 25.58 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-O 121.654 0.74 . . . . 0.0 112.536 -179.776 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -73.74 151.02 40.79 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.635 178.132 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 14.2 mt -90.73 139.62 17.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.565 -178.738 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 73.1 t -62.83 121.82 12.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 174.588 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 5.2 tt -67.18 129.45 39.95 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.189 0.519 . . . . 0.0 111.088 -176.923 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 34.5 mt-30 -135.88 158.41 44.47 Favored 'General case' 0 C--O 1.218 -0.562 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 -179.226 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 13.4 mt -112.18 148.0 38.16 Favored Pre-proline 0 C--N 1.322 -0.598 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 177.577 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -73.59 163.02 38.52 Favored 'Trans proline' 0 C--O 1.237 0.457 0 O-C-N 122.195 0.576 . . . . 0.0 112.546 179.179 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 53.9 tt0 -55.24 132.0 46.74 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 179.508 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 106.57 -27.06 17.9 Favored Glycine 0 C--O 1.226 -0.37 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.983 -178.515 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 8.9 m -105.44 129.33 53.77 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 118.04 0.92 . . . . 0.0 111.198 178.395 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 3.0 p -115.65 148.21 39.94 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.15 178.44 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 86.2 mt -71.4 152.94 94.09 Favored Pre-proline 0 C--N 1.323 -0.587 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 177.647 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -76.53 175.02 11.89 Favored 'Trans proline' 0 CA--C 1.531 0.325 0 N-CA-C 110.615 -0.571 . . . . 0.0 110.615 178.529 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 12.0 tmtt? -53.49 128.65 29.66 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 -175.571 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 88.43 -3.54 85.29 Favored Glycine 0 C--O 1.23 -0.151 0 N-CA-C 116.74 1.456 . . . . 0.0 116.74 173.497 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.445 ' CZ ' ' HB2' ' A' ' 18' ' ' GLN . 1.8 m-85 -93.18 144.09 25.62 Favored 'General case' 0 N--CA 1.433 -1.316 0 CA-C-O 122.718 1.247 . . . . 0.0 112.072 -178.464 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 34.6 p90 -144.52 164.47 30.79 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-N 112.636 -2.074 . . . . 0.0 106.773 174.193 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -106.35 147.06 29.65 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.243 0.545 . . . . 0.0 110.736 -177.381 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -75.8 129.91 37.77 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 -179.59 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 87.63 -0.32 84.78 Favored Glycine 0 C--O 1.225 -0.464 0 C-N-CA 121.161 -0.542 . . . . 0.0 112.55 -178.093 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 24.9 t -117.77 145.61 44.38 Favored 'General case' 0 C--N 1.327 -0.386 0 O-C-N 122.433 -0.451 . . . . 0.0 110.106 178.491 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 9.9 tpt180 52.15 36.17 18.46 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 113.478 0.918 . . . . 0.0 113.478 178.639 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -155.66 166.81 32.96 Favored Glycine 0 N--CA 1.449 -0.483 0 N-CA-C 104.56 -3.416 . . . . 0.0 104.56 177.699 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 82.54 -156.46 35.12 Favored Glycine 0 CA--C 1.517 0.189 0 N-CA-C 109.022 -1.631 . . . . 0.0 109.022 -176.918 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 41.2 t . . . . . 0 C--O 1.251 1.139 0 N-CA-C 105.394 -2.076 . . . . 0.0 105.394 179.509 . . . . . . . . 0 0 . 1 . 039 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.664 0 CA-C-O 118.658 -1.079 . . . . 0.0 111.231 . . . . . . . . . 0 0 . 1 . 039 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -70.28 141.0 52.45 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 117.992 0.896 . . . . 0.0 109.58 179.888 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 21.5 ptp -165.91 33.55 0.05 Allowed 'General case' 0 N--CA 1.474 0.768 0 CA-C-O 121.866 0.841 . . . . 0.0 109.024 -179.258 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -106.29 80.2 0.28 Allowed Glycine 0 N--CA 1.449 -0.459 0 N-CA-C 111.007 -0.837 . . . . 0.0 111.007 -174.651 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 94.0 mt -59.09 140.35 87.31 Favored Pre-proline 0 C--N 1.322 -0.621 0 N-CA-C 106.88 -1.526 . . . . 0.0 106.88 176.13 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -74.28 -21.79 17.22 Favored 'Trans proline' 0 C--N 1.345 0.379 0 N-CA-C 116.079 1.53 . . . . 0.0 116.079 -172.488 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -168.74 -55.34 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.305 0.574 . . . . 0.0 110.707 -178.397 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 11.0 t30 -144.74 -69.04 0.3 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.421 -177.392 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.2 p 41.65 77.15 0.06 Allowed 'General case' 0 N--CA 1.477 0.917 0 CA-C-O 122.006 0.908 . . . . 0.0 112.996 -178.133 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -103.67 143.7 32.42 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.17 -0.923 . . . . 0.0 113.379 -173.138 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 28.4 t -58.88 134.97 57.39 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 114.548 -1.205 . . . . 0.0 108.63 174.591 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 3.1 m95 -67.55 -26.87 66.52 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 178.058 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -121.73 161.34 22.75 Favored 'General case' 0 CA--C 1.507 -0.676 0 CA-C-O 121.192 0.52 . . . . 0.0 110.312 -171.375 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 64.8 p -67.33 161.26 25.46 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 122.195 0.997 . . . . 0.0 109.561 179.622 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -92.14 120.71 33.0 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 114.686 -1.143 . . . . 0.0 112.474 -174.156 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -68.59 148.81 49.96 Favored 'General case' 0 CA--C 1.505 -0.768 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 179.96 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 17.4 m -93.26 136.62 33.35 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 176.947 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 20.0 tm0? -107.28 117.5 34.24 Favored 'General case' 0 CA--C 1.509 -0.621 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 177.144 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 22.7 t-160 -139.32 99.88 3.85 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 172.728 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 173.53 -166.12 38.33 Favored Glycine 0 C--N 1.319 -0.407 0 N-CA-C 110.521 -1.032 . . . . 0.0 110.521 -178.977 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 89.0 mttt -92.53 -24.8 18.64 Favored 'General case' 0 CA--C 1.512 -0.516 0 CA-C-O 121.993 0.901 . . . . 0.0 109.635 179.449 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -90.6 152.11 21.02 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 114.175 -1.375 . . . . 0.0 108.384 179.311 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -87.57 -62.4 1.51 Allowed 'General case' 0 C--O 1.21 -0.977 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.062 -177.421 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 49.6 tp 172.34 141.71 0.03 OUTLIER 'General case' 0 CA--C 1.506 -0.75 0 N-CA-C 104.572 -2.381 . . . . 0.0 104.572 176.824 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 23.3 tptt -161.94 143.38 10.99 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 106.606 -1.627 . . . . 0.0 106.606 178.185 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 16.6 m-85 -132.62 150.0 74.6 Favored Pre-proline 0 C--N 1.323 -0.558 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 177.398 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -76.56 166.87 26.56 Favored 'Trans proline' 0 C--N 1.351 0.702 0 C-N-CA 120.159 0.573 . . . . 0.0 113.402 179.593 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 21.3 tpt180 -64.14 136.11 56.95 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.587 -178.647 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 86.32 -1.91 87.48 Favored Glycine 0 N--CA 1.46 0.24 0 CA-C-O 121.395 0.442 . . . . 0.0 112.145 177.751 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -138.67 170.52 15.86 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 123.408 0.683 . . . . 0.0 110.433 -174.144 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 107.06 -26.82 17.88 Favored Glycine 0 CA--C 1.496 -1.103 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.67 175.249 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 85.1 t -65.27 125.49 89.51 Favored Pre-proline 0 C--N 1.32 -0.699 0 N-CA-C 105.498 -2.038 . . . . 0.0 105.498 176.372 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -71.6 164.52 35.44 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 N-CA-C 110.579 -0.585 . . . . 0.0 110.579 178.422 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 84.8 mt -61.99 115.0 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 -177.237 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -116.98 74.84 0.93 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 122.667 1.223 . . . . 0.0 112.307 -170.377 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 72.7 p -69.73 -19.51 63.54 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 114.371 -1.286 . . . . 0.0 113.506 -175.53 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 52.9 m-80 -106.38 29.04 7.19 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.644 -0.707 . . . . 0.0 112.165 -174.195 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 97.8 p -146.46 160.73 41.72 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.919 0.39 . . . . 0.0 111.032 179.786 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.3 m -71.67 163.83 63.14 Favored Pre-proline 0 C--N 1.323 -0.546 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.67 -178.313 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -67.34 -28.39 39.56 Favored 'Trans proline' 0 C--N 1.351 0.658 0 C-N-CA 115.167 -2.755 . . . . 0.0 113.669 179.041 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.43 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 1.6 p-10 -75.13 -19.84 59.71 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 121.525 -0.734 . . . . 0.0 110.518 176.714 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 34.6 m-20 -84.45 -6.9 59.42 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 113.955 1.094 . . . . 0.0 113.955 -173.335 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 97.6 mm-40 -57.54 -32.53 67.17 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 114.144 1.165 . . . . 0.0 114.144 -179.113 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 10.4 tt -58.43 139.24 18.38 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 CA-C-O 122.382 1.087 . . . . 0.0 113.49 -176.904 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -176.26 -159.65 22.26 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.277 -0.964 . . . . 0.0 112.899 -178.166 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 38.3 p90 -154.82 166.6 32.97 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 179.511 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 13.3 m-85 -109.27 142.9 39.46 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 174.472 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 62.9 ttt180 -116.15 125.45 52.34 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 123.182 0.593 . . . . 0.0 111.044 -176.89 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 47.8 ttp180 -74.06 134.19 42.95 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 109.592 -0.522 . . . . 0.0 109.592 177.329 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -152.0 170.0 20.95 Favored 'General case' 0 C--O 1.213 -0.846 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 -179.072 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 8.9 t -136.82 142.41 42.89 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 119.161 0.891 . . . . 0.0 110.574 172.106 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 14.7 tpt180 -166.79 128.66 1.73 Allowed 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 179.226 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 21.9 mmt180 -147.63 -179.42 6.86 Favored 'General case' 0 CA--C 1.48 -1.72 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 -179.01 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -117.25 170.92 6.19 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.97 0 CA-C-N 113.686 -1.597 . . . . 0.0 107.043 -177.105 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 8.7 ttm-85 -143.44 129.69 19.83 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 175.886 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -82.01 178.99 53.45 Favored Glycine 0 C--O 1.221 -0.703 0 N-CA-C 109.882 -1.287 . . . . 0.0 109.882 178.583 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -67.59 -36.34 87.89 Favored Glycine 0 C--O 1.217 -0.951 0 C-N-CA 121.008 -0.615 . . . . 0.0 114.116 -176.425 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -80.3 -16.59 54.28 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 122.143 0.973 . . . . 0.0 109.054 178.787 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 114.37 -6.37 23.03 Favored Glycine 0 N--CA 1.452 -0.293 0 CA-C-N 114.496 -1.229 . . . . 0.0 114.584 179.587 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.414 ' H ' ' HD2' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -61.33 150.47 34.91 Favored 'General case' 0 CA--C 1.506 -0.725 0 CA-C-N 118.334 1.067 . . . . 0.0 111.242 -178.404 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 89.7 mtp -126.88 164.2 21.94 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 113.978 -1.464 . . . . 0.0 112.249 -176.647 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 2.0 tppt? -77.87 -37.43 48.2 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.298 -179.031 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 60.2 t0 -175.53 167.1 3.27 Favored 'General case' 0 C--N 1.318 -0.778 1 N-CA-C 99.283 -4.34 . . . . 0.0 99.283 -177.242 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -109.95 -31.83 7.25 Favored 'General case' 0 N--CA 1.435 -1.205 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 176.72 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.5 m -55.91 156.55 9.64 Favored Pre-proline 0 C--O 1.245 0.853 0 N-CA-C 116.342 1.979 . . . . 0.0 116.342 -174.949 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -75.62 -176.68 3.1 Favored 'Trans proline' 0 C--N 1.354 0.822 0 C-N-CA 121.039 1.16 . . . . 0.0 114.276 -179.275 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 81.0 mtt-85 -133.75 166.36 22.83 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.488 -177.836 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 50.9 m95 -125.39 131.72 52.9 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 173.751 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 24.1 m-85 -110.55 166.86 10.66 Favored 'General case' 0 C--O 1.216 -0.683 0 N-CA-C 105.45 -2.055 . . . . 0.0 105.45 -177.595 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 93.4 t80 -117.92 134.91 54.49 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-N 119.287 0.948 . . . . 0.0 109.721 -178.949 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 16.7 m-85 -136.36 158.88 43.38 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 -177.316 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 63.3 m-85 -98.63 159.34 15.02 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 -174.794 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -53.83 127.71 27.06 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.986 0.422 . . . . 0.0 111.039 -178.167 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 68.17 31.78 75.29 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.439 -0.886 . . . . 0.0 114.84 176.76 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 2.3 p -89.39 146.28 24.77 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 105.181 -2.155 . . . . 0.0 105.181 174.16 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 83.96 130.87 1.93 Allowed Glycine 0 CA--C 1.532 1.145 0 C-N-CA 121.462 -0.399 . . . . 0.0 112.294 -178.316 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -75.42 -27.88 8.98 Favored 'Trans proline' 0 CA--C 1.512 -0.613 0 CA-C-N 119.182 1.491 . . . . 0.0 115.317 -177.33 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -97.02 5.83 49.71 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 113.592 -1.64 . . . . 0.0 108.08 -174.88 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -60.6 -42.6 97.08 Favored 'General case' 0 N--CA 1.436 -1.125 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.976 -172.866 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 56.68 37.47 76.79 Favored Glycine 0 C--N 1.331 0.275 0 CA-C-N 115.67 -0.695 . . . . 0.0 112.241 179.165 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 13.2 mt -129.06 103.87 18.42 Favored Pre-proline 0 N--CA 1.44 -0.972 0 N-CA-C 115.039 1.496 . . . . 0.0 115.039 -176.073 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -78.4 161.61 28.45 Favored 'Trans proline' 0 N--CA 1.461 -0.424 0 C-N-CA 122.226 1.951 . . . . 0.0 107.304 167.772 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 57.7 t80 -61.11 130.66 47.44 Favored 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 120.315 -0.554 . . . . 0.0 110.44 -177.576 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 93.27 -8.51 75.32 Favored Glycine 0 CA--C 1.52 0.351 0 CA-C-O 119.35 -0.694 . . . . 0.0 114.352 178.956 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -67.12 131.73 46.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 118.607 1.203 . . . . 0.0 111.247 179.754 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 57.0 t30 -78.93 132.13 36.62 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.734 -0.667 . . . . 0.0 110.167 179.895 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 29.0 ttmt -155.97 154.38 31.02 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 106.146 -1.798 . . . . 0.0 106.146 179.28 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -61.4 129.32 40.64 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.081 0.467 . . . . 0.0 111.136 -178.648 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 67.86 30.08 74.11 Favored Glycine 0 N--CA 1.449 -0.474 0 CA-C-O 119.175 -0.792 . . . . 0.0 114.185 177.624 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 43.3 mm -126.04 131.86 71.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 117.845 0.822 . . . . 0.0 111.286 179.632 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -134.93 122.64 38.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.776 175.636 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 95.8 m95 -87.18 137.97 31.89 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 113.167 0.803 . . . . 0.0 113.167 -176.913 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 17.7 m -137.48 150.67 25.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.607 179.326 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -160.39 166.03 30.06 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 105.03 -2.211 . . . . 0.0 105.03 179.907 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 7.1 t -134.41 176.63 8.43 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 105.305 -2.109 . . . . 0.0 105.305 177.849 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -67.56 135.24 52.64 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.302 0.572 . . . . 0.0 110.702 -178.473 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 96.57 -12.7 66.1 Favored Glycine 0 C--O 1.228 -0.269 0 CA-C-N 115.703 -0.68 . . . . 0.0 112.911 178.341 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.43 ' HA ' ' HA ' ' A' ' 41' ' ' ASP . . . -77.16 137.09 38.67 Favored 'General case' 0 CA--C 1.543 0.676 0 O-C-N 122.694 -0.297 . . . . 0.0 110.622 179.982 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 40.6 mt -98.78 138.55 35.76 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 -177.884 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -80.11 63.8 4.73 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.165 -179.023 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 1.4 t -132.27 154.96 81.8 Favored Pre-proline 0 C--N 1.323 -0.581 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 -179.399 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -66.52 148.23 83.38 Favored 'Trans proline' 0 CA--C 1.53 0.319 0 N-CA-C 114.48 0.915 . . . . 0.0 114.48 175.974 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -148.83 57.9 1.04 Allowed 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 113.571 0.952 . . . . 0.0 113.571 179.212 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 12.5 t0 -64.56 -11.34 33.51 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 121.28 0.562 . . . . 0.0 110.658 175.782 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 12.5 p-80 -62.45 -13.42 29.88 Favored 'General case' 0 N--CA 1.468 0.473 0 O-C-N 122.038 -0.414 . . . . 0.0 111.679 177.412 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 20.6 mt -96.09 -28.75 3.91 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 CA-C-O 120.819 0.342 . . . . 0.0 111.023 179.079 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -73.46 3.74 31.05 Favored Glycine 0 N--CA 1.462 0.387 0 N-CA-C 115.09 0.796 . . . . 0.0 115.09 -176.117 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 14.4 t -83.22 19.03 1.56 Allowed 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 113.515 0.931 . . . . 0.0 113.515 -177.694 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 67.1 ttp85 -64.39 114.95 4.63 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 177.664 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 58.8 m-20 -91.12 121.36 67.93 Favored Pre-proline 0 C--N 1.318 -0.78 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 -178.596 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -68.93 -18.74 40.85 Favored 'Trans proline' 0 C--N 1.347 0.493 0 N-CA-C 114.343 0.863 . . . . 0.0 114.343 -176.176 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -73.77 -26.01 60.43 Favored 'General case' 0 C--O 1.22 -0.469 0 CA-C-O 120.734 0.302 . . . . 0.0 110.548 177.365 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 76.5 m-20 -103.49 -27.1 12.58 Favored 'General case' 0 C--O 1.222 -0.361 0 N-CA-C 113.421 0.897 . . . . 0.0 113.421 -174.95 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 19.0 t30 -147.35 145.04 29.17 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.818 0.673 . . . . 0.0 112.818 -178.751 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -83.19 146.16 28.76 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-O 121.517 0.675 . . . . 0.0 111.911 -179.79 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -70.38 144.13 51.69 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 177.325 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 12.0 mt -76.9 135.63 26.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 -178.406 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 72.9 t -63.75 118.33 5.8 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 N-CA-C 103.633 -2.729 . . . . 0.0 103.633 172.859 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 6.8 tt -63.18 130.99 46.96 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.38 0.609 . . . . 0.0 112.072 -174.061 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 30.8 mt-30 -130.58 150.46 51.77 Favored 'General case' 0 CA--C 1.508 -0.671 0 N-CA-C 106.084 -1.821 . . . . 0.0 106.084 179.089 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 12.5 mt -110.37 148.3 38.13 Favored Pre-proline 0 C--N 1.319 -0.76 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 177.773 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -73.71 166.07 30.69 Favored 'Trans proline' 0 C--O 1.236 0.416 0 C-N-CA 118.239 -0.707 . . . . 0.0 112.659 -179.605 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 40.5 tt0 -54.04 131.88 41.52 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.073 179.425 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 104.1 -27.35 19.77 Favored Glycine 0 C--O 1.226 -0.356 0 CA-C-N 115.91 -0.587 . . . . 0.0 112.288 -178.598 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 2.7 m -105.98 129.34 54.12 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 118.207 1.004 . . . . 0.0 112.205 178.759 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 9.4 p -119.8 148.24 43.68 Favored 'General case' 0 CA--C 1.509 -0.607 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.899 178.423 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 93.1 mt -68.07 154.31 94.06 Favored Pre-proline 0 C--N 1.323 -0.571 0 N-CA-C 106.935 -1.506 . . . . 0.0 106.935 177.2 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -76.77 177.6 8.65 Favored 'Trans proline' 0 N--CA 1.464 -0.214 0 CA-C-O 121.446 0.519 . . . . 0.0 112.442 -178.795 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 3.0 ttpm? -59.77 130.65 47.85 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.118 -0.492 . . . . 0.0 109.701 179.072 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 84.26 23.21 52.36 Favored Glycine 0 N--CA 1.454 -0.138 0 N-CA-C 115.44 0.936 . . . . 0.0 115.44 176.876 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -124.73 141.72 51.91 Favored 'General case' 0 CA--C 1.51 -0.568 0 CA-C-O 121.426 0.631 . . . . 0.0 112.152 179.382 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 45.4 p90 -145.6 153.21 40.81 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 107.259 -1.386 . . . . 0.0 107.259 172.584 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -89.18 139.21 30.71 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.186 0.517 . . . . 0.0 111.025 -177.577 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -71.38 137.87 48.72 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 176.325 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 89.34 -2.34 83.15 Favored Glycine 0 C--O 1.224 -0.53 0 N-CA-C 111.653 -0.579 . . . . 0.0 111.653 -178.215 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 9.6 t -114.25 171.89 7.34 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 177.46 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 7.8 tpt180 51.69 58.0 5.95 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 121.993 0.901 . . . . 0.0 112.871 -178.395 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -89.98 -147.06 16.34 Favored Glycine 0 N--CA 1.452 -0.245 0 N-CA-C 108.51 -1.836 . . . . 0.0 108.51 175.731 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -101.57 155.16 18.93 Favored Glycine 0 N--CA 1.453 -0.214 0 N-CA-C 107.34 -2.304 . . . . 0.0 107.34 176.71 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 11.3 t . . . . . 0 C--O 1.252 1.208 0 CA-C-O 117.146 -1.407 . . . . 0.0 110.419 -177.477 . . . . . . . . 0 0 . 1 . 040 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.224 0 CA-C-O 119.128 -0.818 . . . . 0.0 111.379 . . . . . . . . . 0 0 . 1 . 040 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 51.93 42.43 30.2 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 117.51 0.655 . . . . 0.0 112.762 178.866 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 33.2 tpp -78.29 55.95 1.63 Allowed 'General case' 0 CA--C 1.544 0.715 0 CA-C-O 122.034 0.921 . . . . 0.0 112.423 -178.274 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -95.49 -22.32 22.04 Favored Glycine 0 C--O 1.229 -0.167 0 N-CA-C 109.322 -1.511 . . . . 0.0 109.322 176.363 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -72.9 153.4 91.07 Favored Pre-proline 0 C--N 1.322 -0.608 0 CA-C-N 114.224 -0.988 . . . . 0.0 108.823 179.935 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -69.08 145.07 59.9 Favored 'Trans proline' 0 C--N 1.345 0.395 0 C-N-CA 115.966 -2.223 . . . . 0.0 110.884 176.786 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 26.0 p30 -86.44 -13.27 46.7 Favored 'General case' 0 C--O 1.218 -0.553 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -178.323 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 36.4 t30 60.28 42.99 14.24 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.193 0.997 . . . . 0.0 112.538 178.957 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 58.6 p -137.68 152.89 49.76 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 102.718 -3.068 . . . . 0.0 102.718 179.991 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -148.78 142.82 25.89 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.476 177.227 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 46.6 t -64.01 141.83 58.63 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 177.973 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 17.8 m95 -68.44 -21.72 64.63 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 111.944 0.35 . . . . 0.0 111.944 178.284 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 64.8 m-85 -121.53 164.38 17.32 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 -172.366 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 73.8 p -70.01 161.53 29.9 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 178.97 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -76.22 149.74 37.18 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 113.743 1.016 . . . . 0.0 113.743 -175.425 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 13.9 mt -91.99 148.87 21.87 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 103.818 -2.66 . . . . 0.0 103.818 170.425 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 19.6 m -122.33 137.63 54.79 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 -179.186 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.42 ' HB2' ' CZ ' ' A' ' 131' ' ' PHE . 4.4 tp60 -112.05 133.11 54.41 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 -177.669 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 8.7 t60 -126.9 99.43 5.73 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 105.178 -2.156 . . . . 0.0 105.178 171.18 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 175.25 -172.77 45.78 Favored Glycine 0 C--O 1.227 -0.286 0 N-CA-C 110.212 -1.155 . . . . 0.0 110.212 -177.626 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -99.21 -27.29 13.87 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 121.048 0.451 . . . . 0.0 111.27 179.496 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -80.93 166.7 20.62 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 107.038 -1.467 . . . . 0.0 107.038 177.06 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -94.48 -62.78 1.27 Allowed 'General case' 0 CA--C 1.548 0.888 0 CA-C-O 118.443 -0.789 . . . . 0.0 112.156 -176.662 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 33.7 tp -175.08 140.95 0.54 Allowed 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 124.044 0.938 . . . . 0.0 109.413 172.821 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 50.2 tptt -151.77 138.85 19.14 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 172.67 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -122.25 153.71 61.78 Favored Pre-proline 0 C--O 1.242 0.671 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 176.533 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -70.33 158.15 57.1 Favored 'Trans proline' 0 C--N 1.353 0.795 0 O-C-N 122.079 0.515 . . . . 0.0 112.727 179.458 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 70.9 ttt180 -70.16 134.36 48.05 Favored 'General case' 0 C--O 1.216 -0.688 0 O-C-N 121.848 -0.533 . . . . 0.0 111.072 -177.725 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 90.13 1.16 76.25 Favored Glycine 0 N--CA 1.462 0.409 0 CA-C-O 121.649 0.583 . . . . 0.0 112.035 179.262 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -146.77 170.45 16.97 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 107.497 -1.298 . . . . 0.0 107.497 -176.941 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 127.09 -28.39 4.6 Favored Glycine 0 CA--C 1.483 -1.948 0 N-CA-C 108.46 -1.856 . . . . 0.0 108.46 165.79 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 32.8 m -67.72 140.69 94.45 Favored Pre-proline 0 N--CA 1.429 -1.477 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 177.462 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -74.37 173.93 13.39 Favored 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 121.226 1.284 . . . . 0.0 111.91 178.918 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 92.7 mt -73.72 115.03 14.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 N-CA-C 107.494 -1.298 . . . . 0.0 107.494 177.823 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 31.6 m-20 -111.79 80.33 1.31 Allowed 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.423 -177.791 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 81.2 p -67.76 -16.2 64.01 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 113.835 1.05 . . . . 0.0 113.835 -176.877 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -106.83 21.31 17.72 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.375 -177.15 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 5.3 m -134.97 157.79 45.99 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.78 0.324 . . . . 0.0 111.483 -176.47 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 20.0 m -72.85 161.36 79.74 Favored Pre-proline 0 C--N 1.323 -0.549 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 178.615 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -65.19 -26.62 56.96 Favored 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 114.93 -2.913 . . . . 0.0 110.49 176.021 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -61.75 -19.32 62.32 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 124.578 1.151 . . . . 0.0 111.652 175.713 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -107.92 1.0 22.34 Favored 'General case' 0 C--O 1.217 -0.618 0 N-CA-C 115.027 1.491 . . . . 0.0 115.027 -172.617 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 85.7 mm-40 -61.45 -27.57 68.66 Favored 'General case' 0 C--O 1.216 -0.694 0 O-C-N 121.045 -1.034 . . . . 0.0 111.068 178.995 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 13.0 tt -60.35 144.05 13.65 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 N-CA-C 113.797 1.036 . . . . 0.0 113.797 179.209 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 178.85 -152.57 11.41 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.527 -0.844 . . . . 0.0 111.21 178.543 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 47.1 p90 -155.08 168.88 25.54 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 177.22 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 25.4 m-85 -113.34 141.07 47.48 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 106.648 -1.612 . . . . 0.0 106.648 174.071 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 38.6 ttt180 -111.05 127.6 55.6 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.37 -178.695 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 28.4 ttm180 -68.04 134.54 50.81 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 106.353 -1.721 . . . . 0.0 106.353 176.602 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -139.57 127.89 22.7 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 -176.734 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 6.8 p -139.62 131.95 28.37 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 174.773 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 11.2 tpt180 -160.73 123.83 3.34 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 178.621 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 2.5 tpp180 -97.17 137.42 36.23 Favored 'General case' 0 CA--C 1.501 -0.935 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 179.801 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -124.87 171.44 13.73 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 -179.201 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 8.1 tmm_? -134.66 114.03 12.32 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 106.324 -1.732 . . . . 0.0 106.324 177.745 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -74.5 165.07 54.75 Favored Glycine 0 N--CA 1.449 -0.497 0 N-CA-C 110.733 -0.947 . . . . 0.0 110.733 179.489 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -75.3 -27.42 63.84 Favored Glycine 0 C--O 1.217 -0.954 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 -179.562 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -89.77 14.61 11.45 Favored 'General case' 0 C--O 1.219 -0.523 0 CA-C-O 122.256 1.027 . . . . 0.0 109.706 179.077 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 86.21 -12.81 59.39 Favored Glycine 0 C--O 1.227 -0.288 0 N-CA-C 115.897 1.119 . . . . 0.0 115.897 173.706 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -64.5 130.49 43.9 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.699 0.762 . . . . 0.0 111.614 -178.609 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 94.8 mmm -91.86 -170.65 2.62 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 114.527 -1.215 . . . . 0.0 110.399 -178.489 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 18.4 tptp -92.79 -53.95 3.96 Favored 'General case' 0 CA--C 1.515 -0.395 0 N-CA-C 114.085 1.142 . . . . 0.0 114.085 179.436 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 38.45 -140.78 0.04 OUTLIER 'General case' 0 C--O 1.245 0.861 0 O-C-N 125.135 1.522 . . . . 0.0 113.025 -175.571 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 61.29 170.8 0.11 Allowed 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.694 1.198 . . . . 0.0 113.999 -176.232 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -74.69 165.35 54.46 Favored Pre-proline 0 C--O 1.24 0.589 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.71 -179.655 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -66.18 152.16 81.84 Favored 'Trans proline' 0 C--N 1.355 0.87 0 C-N-CA 117.818 -0.988 . . . . 0.0 112.053 178.67 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 30.7 mtt180 -124.02 166.3 15.97 Favored 'General case' 0 CA--C 1.51 -0.57 0 N-CA-C 114.779 1.4 . . . . 0.0 114.779 -175.958 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 67.4 m95 -130.43 146.84 52.06 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 177.922 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 25.5 m-85 -130.64 144.11 51.2 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 -178.799 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 77.4 t80 -89.91 136.42 33.05 Favored 'General case' 0 CA--C 1.512 -0.485 0 N-CA-C 109.001 -0.741 . . . . 0.0 109.001 -177.218 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -139.64 143.23 37.09 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 108.812 -0.811 . . . . 0.0 108.812 -176.333 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -74.23 159.43 32.51 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.67 -175.993 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.1 tt -55.89 129.54 40.0 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 -176.137 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 69.0 34.54 76.79 Favored Glycine 0 C--O 1.222 -0.649 0 N-CA-C 115.487 0.955 . . . . 0.0 115.487 175.498 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -89.11 145.99 25.1 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 118.28 1.04 . . . . 0.0 111.334 -179.989 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 105.2 142.25 11.19 Favored Glycine 0 CA--C 1.529 0.909 0 N-CA-C 111.046 -0.822 . . . . 0.0 111.046 -177.905 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -66.01 -44.07 8.08 Favored 'Trans proline' 0 C--N 1.35 0.64 0 N-CA-C 116.928 1.857 . . . . 0.0 116.928 -173.31 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 -109.2 27.29 9.68 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.674 0.749 . . . . 0.0 109.232 -178.846 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -58.88 -48.35 81.7 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.381 -176.685 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 57.48 32.23 64.26 Favored Glycine 0 C--O 1.225 -0.438 0 O-C-N 123.71 0.631 . . . . 0.0 112.012 -179.447 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 20.2 mt -111.57 103.88 55.53 Favored Pre-proline 0 N--CA 1.448 -0.551 0 N-CA-C 115.683 1.734 . . . . 0.0 115.683 -174.728 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -78.89 166.27 23.5 Favored 'Trans proline' 0 N--CA 1.46 -0.458 0 C-N-CA 121.826 1.684 . . . . 0.0 108.034 168.707 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 54.2 t80 -62.2 132.34 52.44 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 120.622 -0.431 . . . . 0.0 109.935 -179.96 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 92.06 -8.25 78.01 Favored Glycine 0 CA--C 1.52 0.358 0 N-CA-C 115.085 0.794 . . . . 0.0 115.085 178.794 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -64.35 131.48 47.38 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 118.321 1.06 . . . . 0.0 112.007 -179.963 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 33.4 t-20 -73.98 127.16 32.15 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.595 -178.517 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 26.4 ttmt -156.18 150.1 25.15 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 104.992 -2.225 . . . . 0.0 104.992 175.74 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -71.13 136.05 47.97 Favored 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 120.198 -0.601 . . . . 0.0 109.723 -177.376 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 73.58 21.09 79.81 Favored Glycine 0 N--CA 1.447 -0.59 0 CA-C-O 119.19 -0.783 . . . . 0.0 113.353 178.665 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 44.3 mm -124.87 121.83 62.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 117.542 0.671 . . . . 0.0 110.376 179.402 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -122.75 112.52 34.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 CA-C-O 121.862 0.839 . . . . 0.0 110.793 175.749 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 96.4 m95 -78.44 133.21 37.51 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.126 -178.814 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 1.7 m -140.81 149.73 20.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 -178.689 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -157.98 166.05 33.57 Favored 'General case' 0 CA--C 1.507 -0.696 0 N-CA-C 106.491 -1.67 . . . . 0.0 106.491 -178.404 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 5.9 t -132.44 171.5 13.68 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 105.94 -1.874 . . . . 0.0 105.94 174.897 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -67.65 138.86 56.67 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.258 0.551 . . . . 0.0 110.81 -178.142 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 96.46 -7.67 66.2 Favored Glycine 0 C--O 1.226 -0.386 0 CA-C-N 115.705 -0.68 . . . . 0.0 113.143 178.943 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -85.6 147.23 26.5 Favored 'General case' 0 CA--C 1.544 0.74 0 O-C-N 122.632 -0.334 . . . . 0.0 111.489 179.982 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 45.2 mt -92.02 139.7 30.38 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -178.274 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 60.8 t30 -90.45 66.61 6.43 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.057 0.456 . . . . 0.0 110.83 -179.463 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -141.31 155.88 67.62 Favored Pre-proline 0 C--N 1.323 -0.57 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 179.889 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -73.77 152.4 47.32 Favored 'Trans proline' 0 CA--C 1.535 0.565 0 N-CA-C 114.955 1.098 . . . . 0.0 114.955 178.313 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.54 57.96 1.12 Allowed 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 121.827 0.823 . . . . 0.0 111.125 179.171 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -57.9 -31.6 66.93 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.609 179.071 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 42.7 p-80 -63.12 -13.95 42.77 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 114.273 1.212 . . . . 0.0 114.273 -178.162 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 94.8 mt -87.92 -29.06 5.46 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 177.617 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -75.58 4.2 44.6 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 115.239 0.856 . . . . 0.0 115.239 -177.304 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 12.7 t -83.09 21.06 1.12 Allowed 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 -178.134 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 69.2 ttp85 -56.25 126.61 26.94 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 179.25 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -95.93 127.36 41.28 Favored Pre-proline 0 C--N 1.322 -0.619 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 -179.623 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -74.19 -15.14 23.04 Favored 'Trans proline' 0 C--O 1.219 -0.425 0 O-C-N 121.898 0.42 . . . . 0.0 112.717 -178.452 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -77.87 -25.34 48.57 Favored 'General case' 0 C--O 1.222 -0.394 0 CA-C-O 120.863 0.363 . . . . 0.0 110.239 178.188 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 -104.3 -25.63 12.79 Favored 'General case' 0 C--O 1.223 -0.341 0 N-CA-C 113.977 1.103 . . . . 0.0 113.977 -174.867 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 30.4 t30 -147.2 150.18 34.4 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 -177.26 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -92.49 147.1 23.16 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 121.238 0.542 . . . . 0.0 111.206 179.405 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -74.11 153.39 39.6 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.239 177.931 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 2.5 mt -96.76 142.13 14.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 -178.132 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 87.0 t -58.05 125.04 13.42 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 176.87 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 6.4 tt -68.75 128.01 35.11 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.085 -177.848 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 29.8 mt-30 -132.36 154.42 49.79 Favored 'General case' 0 CA--C 1.508 -0.635 0 N-CA-C 107.119 -1.437 . . . . 0.0 107.119 -178.942 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 12.6 mt -109.44 148.93 39.07 Favored Pre-proline 0 C--N 1.321 -0.651 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 176.955 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -70.9 160.89 47.93 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 118.057 -0.829 . . . . 0.0 112.21 179.767 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -55.37 136.12 49.61 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 -179.249 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 95.11 -16.78 60.62 Favored Glycine 0 C--O 1.226 -0.374 0 CA-C-N 116.005 -0.543 . . . . 0.0 112.81 -177.566 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 6.2 m -108.63 128.3 54.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 117.827 0.814 . . . . 0.0 109.834 178.003 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 8.2 p -120.48 148.37 43.92 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.848 -178.522 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 85.7 mt -72.37 153.41 92.08 Favored Pre-proline 0 C--N 1.324 -0.515 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 177.776 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -76.32 170.89 19.1 Favored 'Trans proline' 0 N--CA 1.462 -0.352 0 C-N-CA 118.334 -0.644 . . . . 0.0 110.711 178.513 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -60.82 130.88 48.66 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.569 -177.44 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 95.1 -2.48 65.96 Favored Glycine 0 CA--C 1.517 0.189 0 N-CA-C 114.774 0.67 . . . . 0.0 114.774 178.209 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.42 ' CZ ' ' HB2' ' A' ' 18' ' ' GLN . 2.6 m-85 -106.43 140.07 39.92 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-O 121.732 0.777 . . . . 0.0 111.973 -179.376 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 52.6 p90 -145.52 164.34 31.93 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 114.423 -1.262 . . . . 0.0 108.069 174.515 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -105.38 147.18 28.48 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 112.481 0.549 . . . . 0.0 112.481 -176.465 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -74.97 134.88 41.41 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 178.645 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 86.03 -0.74 87.71 Favored Glycine 0 C--O 1.227 -0.321 0 C-N-CA 121.094 -0.574 . . . . 0.0 112.717 -179.959 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 8.7 t -106.41 -179.52 3.96 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 178.03 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 1.5 mmm180 -146.14 150.12 35.3 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 106.236 -1.764 . . . . 0.0 106.236 -179.84 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . 0.423 ' C ' ' H ' ' A' ' 140' ' ' SER . . . 142.23 131.39 2.6 Favored Glycine 0 C--O 1.224 -0.504 0 N-CA-C 108.149 -1.98 . . . . 0.0 108.149 -177.979 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 86.06 -35.03 3.31 Favored Glycine 0 N--CA 1.462 0.396 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 -175.623 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 140' ' ' SER . . . . . 0.423 ' H ' ' C ' ' A' ' 138' ' ' GLY . 68.6 m . . . . . 0 C--O 1.243 0.738 0 N-CA-C 103.139 -2.912 . . . . 0.0 103.139 176.056 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.502 0 CA-C-O 121.568 0.699 . . . . 0.0 111.186 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 12.3 p -59.92 142.69 53.21 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.225 -0.898 . . . . 0.0 109.98 177.053 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' TRP . . . . . 0.437 ' CD2' ' HD3' ' A' ' 109' ' ' ARG . 12.4 m95 -67.3 -21.86 65.66 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 114.648 1.351 . . . . 0.0 114.648 -178.986 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -121.48 163.36 18.92 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 113.992 1.108 . . . . 0.0 113.992 -170.734 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 65.6 p -70.96 168.39 17.07 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.304 -1.317 . . . . 0.0 108.258 178.087 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.581 ' HB2' ' CZ ' ' A' ' 69' ' ' TYR . . . -78.34 149.4 33.44 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 114.182 1.178 . . . . 0.0 114.182 -175.515 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 13.9 mt -92.3 143.75 26.08 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 102.439 -3.171 . . . . 0.0 102.439 166.782 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 44.2 m -124.58 131.83 53.46 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 -178.494 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.403 ' HB2' ' CZ ' ' A' ' 131' ' ' PHE . 4.0 tp-100 -95.59 139.19 32.21 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.616 0.599 . . . . 0.0 112.616 -178.0 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 64.2 t60 -136.08 99.5 4.15 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 105.352 -2.092 . . . . 0.0 105.352 170.171 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 166.39 -160.02 33.47 Favored Glycine 0 C--O 1.227 -0.309 0 N-CA-C 110.294 -1.123 . . . . 0.0 110.294 -176.642 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -104.32 -23.69 13.18 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 112.809 0.67 . . . . 0.0 112.809 179.302 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 52.7 mm-40 -75.07 168.04 20.75 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 177.292 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -95.81 -62.84 1.22 Allowed 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 177.74 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 51.9 tp 173.76 136.04 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 125.761 1.624 . . . . 0.0 106.887 173.459 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 54.7 tptt -155.48 139.75 16.64 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 107.934 -1.135 . . . . 0.0 107.934 172.443 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 14.4 m-85 -117.84 142.82 31.4 Favored Pre-proline 0 C--O 1.241 0.655 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 176.755 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -64.6 165.89 19.27 Favored 'Trans proline' 0 CA--C 1.54 0.825 0 C-N-CA 122.209 1.939 . . . . 0.0 114.696 176.037 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 17.1 tpt180 -62.47 133.59 55.21 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.888 -178.347 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 77.53 15.81 80.98 Favored Glycine 0 C--O 1.223 -0.542 0 CA-C-N 115.894 -0.593 . . . . 0.0 112.651 175.961 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -148.37 167.66 24.67 Favored 'General case' 0 N--CA 1.442 -0.862 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 -174.632 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 111.58 -23.49 17.58 Favored Glycine 0 CA--C 1.497 -1.08 0 C-N-CA 121.809 -0.234 . . . . 0.0 113.36 173.616 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 93.1 t -65.67 127.12 92.8 Favored Pre-proline 0 C--N 1.318 -0.762 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 178.796 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -75.21 170.03 21.25 Favored 'Trans proline' 0 N--CA 1.461 -0.425 0 O-C-N 122.102 0.527 . . . . 0.0 111.429 178.634 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 97.6 mt -67.95 109.57 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-O 121.931 0.872 . . . . 0.0 109.109 179.778 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 73.2 m-80 -99.97 87.43 3.49 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 114.756 -1.111 . . . . 0.0 109.223 -179.052 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 72.5 p -67.82 -16.35 64.06 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 -178.592 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 11.4 p30 -108.19 22.9 15.3 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.318 -0.856 . . . . 0.0 112.843 -177.03 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 15.3 m -138.94 152.05 47.4 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 114.729 1.381 . . . . 0.0 114.729 -175.839 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 67.5 m -74.86 164.97 57.74 Favored Pre-proline 0 CA--C 1.537 0.469 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.479 177.492 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -65.48 -24.85 56.14 Favored 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 115.341 -2.64 . . . . 0.0 114.538 -178.481 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.436 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 6.1 p-10 -76.45 -26.09 55.06 Favored 'General case' 0 C--N 1.324 -0.539 0 O-C-N 121.625 -0.672 . . . . 0.0 110.906 177.026 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.555 ' HA ' ' HE3' ' A' ' 103' ' ' LYS . 15.2 m-20 -75.76 -10.75 59.69 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.198 0.999 . . . . 0.0 112.952 -175.809 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 96.8 mm-40 -58.55 -29.07 66.08 Favored 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 114.782 1.401 . . . . 0.0 114.782 -176.453 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.493 ' HB ' ' HB1' ' A' ' 98' ' ' ALA . 11.9 tt -59.5 140.22 18.0 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.874 0 CA-C-O 122.287 1.042 . . . . 0.0 112.843 -178.868 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -179.34 -155.63 15.47 Favored Glycine 0 CA--C 1.506 -0.482 0 C-N-CA 120.406 -0.902 . . . . 0.0 112.49 -178.701 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 50.3 p90 -154.99 171.7 19.31 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 179.021 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 19.3 m-85 -112.89 140.06 48.01 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 173.304 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 69.4 ttt-85 -111.33 124.66 52.68 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.979 -177.897 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 37.7 ttt-85 -65.05 141.1 58.86 Favored 'General case' 0 C--N 1.322 -0.625 0 O-C-N 123.557 0.536 . . . . 0.0 109.764 177.164 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -151.03 150.42 30.72 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.997 0.427 . . . . 0.0 110.605 179.781 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 34.0 p -145.89 168.41 20.89 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 103.621 -2.733 . . . . 0.0 103.621 174.912 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 14.5 tpt180 -149.08 131.08 15.28 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.604 0.716 . . . . 0.0 111.664 175.866 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 37.6 mtt180 -140.98 165.82 26.5 Favored 'General case' 0 CA--C 1.493 -1.241 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 178.626 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -132.33 175.93 10.19 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 N-CA-C 104.24 -2.504 . . . . 0.0 104.24 -179.186 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 3.5 tmt_? -120.69 99.38 6.5 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 178.232 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -76.09 150.36 38.95 Favored Glycine 0 N--CA 1.45 -0.43 0 N-CA-C 105.627 -2.989 . . . . 0.0 105.627 173.71 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -63.64 -36.1 92.9 Favored Glycine 0 C--O 1.217 -0.964 0 CA-C-N 118.669 1.235 . . . . 0.0 111.718 -179.422 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 27.2 t0 -89.08 17.15 6.12 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-O 122.328 1.061 . . . . 0.0 111.433 179.586 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 85.47 14.79 67.58 Favored Glycine 0 C--O 1.223 -0.578 0 CA-C-N 115.505 -0.77 . . . . 0.0 113.575 173.239 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 49.9 mmtt -69.61 133.67 47.86 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.58 0.705 . . . . 0.0 110.59 -176.451 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 4.0 mmt -113.11 155.3 25.18 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 114.225 -1.352 . . . . 0.0 111.101 -176.322 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 1.2 mmtp -96.28 -41.95 8.41 Favored 'General case' 0 CA--C 1.5 -0.979 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 173.848 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 11.3 t0 45.61 57.3 5.09 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 111.206 -2.724 . . . . 0.0 115.796 176.754 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 64.4 mt -68.58 138.68 55.28 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 177.849 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -58.67 161.81 7.68 Favored Pre-proline 0 C--O 1.242 0.698 0 CA-C-N 115.316 -0.856 . . . . 0.0 112.931 -177.587 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -62.22 134.85 51.07 Favored 'Trans proline' 0 C--N 1.354 0.864 0 C-N-CA 116.814 -1.657 . . . . 0.0 112.119 179.381 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 20.9 mtt-85 -132.15 161.12 34.12 Favored 'General case' 0 CA--C 1.503 -0.83 0 CA-C-N 114.338 -1.301 . . . . 0.0 109.805 -175.485 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 70.2 m95 -134.52 143.42 47.43 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 177.24 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.581 ' CZ ' ' HB2' ' A' ' 15' ' ' ALA . 70.7 m-85 -126.38 148.61 49.57 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 106.334 -1.728 . . . . 0.0 106.334 178.592 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 86.8 t80 -94.71 138.12 32.95 Favored 'General case' 0 CA--C 1.506 -0.727 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 -176.835 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 11.2 m-85 -138.86 142.19 38.61 Favored 'General case' 0 N--CA 1.438 -1.072 0 N-CA-C 106.53 -1.656 . . . . 0.0 106.53 -174.692 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 88.5 m-85 -80.89 159.52 24.98 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.437 0.161 . . . . 0.0 110.845 -175.632 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -56.12 126.69 27.13 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.9 0.381 . . . . 0.0 110.79 -177.722 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 69.29 38.63 81.74 Favored Glycine 0 C--O 1.218 -0.88 0 CA-C-O 119.106 -0.83 . . . . 0.0 114.75 176.179 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.326 -0.444 0 N-CA-C 105.623 -1.992 . . . . 0.0 105.623 177.591 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 17.3 mt . . . . . 0 N--CA 1.446 -0.657 0 N-CA-C 114.39 1.256 . . . . 0.0 114.39 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -78.58 164.49 25.92 Favored 'Trans proline' 0 C--O 1.235 0.374 0 C-N-CA 121.963 1.775 . . . . 0.0 108.318 169.823 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 57.9 t80 -61.79 132.03 51.8 Favored 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 120.396 -0.522 . . . . 0.0 110.085 -179.462 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 91.64 -5.98 79.99 Favored Glycine 0 CA--C 1.518 0.258 0 CA-C-O 119.417 -0.657 . . . . 0.0 114.493 178.916 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -63.5 131.24 47.49 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 118.369 1.085 . . . . 0.0 111.453 179.447 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 36.1 t-20 -77.87 127.3 32.16 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.496 -178.755 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 28.7 ttmt -156.2 151.26 26.38 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 105.508 -2.034 . . . . 0.0 105.508 178.03 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -64.66 132.14 48.89 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.085 0.469 . . . . 0.0 110.666 -178.044 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 68.29 27.31 73.8 Favored Glycine 0 N--CA 1.449 -0.439 0 CA-C-N 115.719 -0.673 . . . . 0.0 114.256 178.156 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 45.8 mm -124.84 123.42 65.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 117.419 0.609 . . . . 0.0 110.669 179.375 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.1 pt -127.16 111.94 27.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 CA-C-O 121.953 0.882 . . . . 0.0 111.762 177.051 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 95.1 m95 -77.36 136.83 38.47 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 112.983 0.734 . . . . 0.0 112.983 -177.941 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 17.3 m -138.86 151.61 23.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 C-N-CA 123.481 0.712 . . . . 0.0 109.824 179.796 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -157.01 166.59 32.93 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 105.877 -1.898 . . . . 0.0 105.877 179.494 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 14.5 t -130.34 176.34 8.21 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 105.521 -2.029 . . . . 0.0 105.521 178.73 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -67.58 135.07 52.35 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.162 0.506 . . . . 0.0 110.169 -179.253 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 93.19 -10.79 73.02 Favored Glycine 0 C--O 1.229 -0.182 0 CA-C-N 115.938 -0.574 . . . . 0.0 113.302 178.253 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.493 ' HB1' ' HB ' ' A' ' 44' ' ' ILE . . . -73.9 136.76 43.38 Favored 'General case' 0 CA--C 1.543 0.687 0 O-C-N 122.543 -0.387 . . . . 0.0 110.617 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 36.7 mt -95.72 139.57 31.76 Favored 'General case' 0 C--O 1.218 -0.601 0 N-CA-C 113.725 1.009 . . . . 0.0 113.725 -176.926 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 57.3 t30 -84.4 73.91 10.43 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.497 0.665 . . . . 0.0 110.52 179.515 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -146.41 159.25 45.56 Favored Pre-proline 0 C--N 1.321 -0.659 0 N-CA-C 103.024 -2.954 . . . . 0.0 103.024 179.445 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -73.27 149.95 46.38 Favored 'Trans proline' 0 CA--C 1.537 0.644 0 N-CA-C 114.061 0.754 . . . . 0.0 114.061 177.489 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.555 ' HE3' ' HA ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -142.29 58.69 1.46 Allowed 'General case' 0 N--CA 1.475 0.823 0 CA-C-O 122.799 1.285 . . . . 0.0 109.402 176.835 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -63.12 -23.77 67.59 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.263 -1.335 . . . . 0.0 110.963 178.235 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 17.9 p80 -55.87 -17.94 7.62 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 114.516 1.302 . . . . 0.0 114.516 -178.439 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 22.5 mt -88.81 -38.33 11.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 121.393 0.616 . . . . 0.0 109.842 -179.756 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -76.15 14.66 6.12 Favored Glycine 0 C--O 1.22 -0.767 0 N-CA-C 116.748 1.459 . . . . 0.0 116.748 -174.758 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 13.4 t -83.14 15.97 2.61 Favored 'General case' 0 CA--C 1.545 0.777 0 CA-C-N 117.985 0.893 . . . . 0.0 111.427 179.734 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.437 ' HD3' ' CD2' ' A' ' 12' ' ' TRP . 59.8 ttp85 -62.73 138.7 58.58 Favored 'General case' 0 C--N 1.327 -0.397 0 O-C-N 122.02 -0.425 . . . . 0.0 111.002 -178.89 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -110.28 123.64 35.41 Favored Pre-proline 0 C--O 1.236 0.342 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 177.122 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -75.06 -10.85 21.29 Favored 'Trans proline' 0 C--O 1.219 -0.453 0 N-CA-C 113.324 0.471 . . . . 0.0 113.324 -176.859 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -77.76 -24.96 48.83 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.045 178.012 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 75.2 m-20 -104.12 -25.56 12.9 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 113.989 1.107 . . . . 0.0 113.989 -173.334 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -142.67 154.55 44.44 Favored 'General case' 0 N--CA 1.433 -1.307 0 CA-C-O 121.261 0.553 . . . . 0.0 109.71 -176.301 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -92.93 142.7 27.01 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.197 -0.911 . . . . 0.0 110.206 179.321 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -68.74 147.11 52.28 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.239 0.543 . . . . 0.0 110.761 179.447 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 25.3 mt -81.77 138.38 19.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 -178.756 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 82.7 t -60.91 123.69 14.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 175.938 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 6.0 tt -67.66 128.82 37.87 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 -178.161 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -134.96 157.86 45.82 Favored 'General case' 0 CA--C 1.508 -0.653 0 N-CA-C 107.273 -1.38 . . . . 0.0 107.273 -177.844 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 13.8 mt -113.2 150.38 42.91 Favored Pre-proline 0 C--N 1.32 -0.699 0 N-CA-C 105.747 -1.946 . . . . 0.0 105.747 175.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -70.42 168.2 23.1 Favored 'Trans proline' 0 C--N 1.342 0.22 0 N-CA-C 114.143 0.786 . . . . 0.0 114.143 -176.515 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 49.7 tt0 -55.23 133.43 49.25 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.273 -178.032 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 89.61 -13.77 63.21 Favored Glycine 0 C--O 1.228 -0.28 0 CA-C-N 115.964 -0.562 . . . . 0.0 112.659 -179.343 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 18.6 m -106.92 128.38 54.26 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 117.356 0.578 . . . . 0.0 110.511 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 13.7 p -121.71 148.32 44.76 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.316 0.579 . . . . 0.0 112.483 -177.227 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 86.0 mt -68.52 156.26 90.99 Favored Pre-proline 0 C--N 1.326 -0.435 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 177.267 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -74.25 164.86 33.23 Favored 'Trans proline' 0 N--CA 1.461 -0.394 0 C-N-CA 117.655 -1.096 . . . . 0.0 110.941 178.431 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -60.13 130.46 46.77 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.174 -177.185 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 95.08 -3.93 67.28 Favored Glycine 0 C--O 1.225 -0.447 0 N-CA-C 114.823 0.689 . . . . 0.0 114.823 179.357 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.403 ' CZ ' ' HB2' ' A' ' 18' ' ' GLN . 0.8 OUTLIER -106.78 141.97 37.16 Favored 'General case' 0 CA--C 1.507 -0.703 0 CA-C-N 117.874 0.837 . . . . 0.0 110.743 179.306 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 43.7 p90 -142.53 161.29 38.44 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 114.382 -1.281 . . . . 0.0 107.983 175.849 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -104.86 146.98 28.25 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.652 0.739 . . . . 0.0 111.496 -177.501 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -74.23 127.52 33.18 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 179.644 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 87.94 -5.66 84.57 Favored Glycine 0 C--O 1.224 -0.523 0 CA-C-N 116.091 -0.504 . . . . 0.0 113.076 -178.979 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 33.7 t . . . . . 0 C--N 1.326 -0.447 0 CA-C-O 121.411 0.624 . . . . 0.0 109.379 179.572 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.239 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 41.3 t -61.13 140.9 57.79 Favored 'General case' 0 CA--C 1.513 -0.476 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 178.244 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 7.5 m95 -68.41 -21.93 64.65 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.486 178.373 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 29.8 m-85 -121.4 163.02 19.39 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 115.872 -0.604 . . . . 0.0 112.559 -171.36 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.418 ' HB ' ' HB3' ' A' ' 134' ' ' GLU . 71.7 p -71.55 163.07 28.42 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.495 -0.775 . . . . 0.0 108.926 178.911 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.445 ' HB2' ' CZ ' ' A' ' 69' ' ' TYR . . . -76.81 138.05 39.62 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -176.44 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 13.8 mt -82.74 145.03 29.79 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 104.45 -2.426 . . . . 0.0 104.45 171.486 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 20.0 m -127.47 133.27 49.91 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 118.331 0.514 . . . . 0.0 110.597 -178.908 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 4.0 tp-100 -89.52 150.74 22.31 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.869 179.27 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 73.5 t60 -136.38 99.25 4.04 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 103.189 -2.893 . . . . 0.0 103.189 166.383 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 162.79 -173.07 38.97 Favored Glycine 0 N--CA 1.451 -0.328 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 -175.692 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 55.3 mtmt -93.34 -29.44 15.63 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 114.962 1.467 . . . . 0.0 114.962 -176.938 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -87.39 157.31 19.27 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 106.906 -1.516 . . . . 0.0 106.906 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -83.52 -62.75 1.5 Allowed 'General case' 0 C--O 1.218 -0.566 0 N-CA-C 115.405 1.631 . . . . 0.0 115.405 -174.881 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 56.8 tp 179.1 143.3 0.13 Allowed 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 124.356 1.062 . . . . 0.0 108.154 178.06 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 13.6 tptm -158.86 141.23 14.05 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 173.333 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 7.9 m-85 -123.56 140.57 34.42 Favored Pre-proline 0 C--N 1.324 -0.524 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 176.885 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -61.54 155.52 52.57 Favored 'Trans proline' 0 CA--C 1.538 0.71 0 C-N-CA 120.283 0.656 . . . . 0.0 113.206 175.343 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 16.9 tpt180 -63.68 135.66 56.89 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.604 -177.764 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 83.9 10.31 81.2 Favored Glycine 0 C--O 1.225 -0.452 0 C-N-CA 121.368 -0.444 . . . . 0.0 112.348 178.435 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -148.14 168.64 21.9 Favored 'General case' 0 N--CA 1.443 -0.792 0 N-CA-C 106.975 -1.491 . . . . 0.0 106.975 -176.504 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 110.69 -19.89 25.45 Favored Glycine 0 CA--C 1.499 -0.946 0 CA-C-O 121.14 0.3 . . . . 0.0 113.643 172.927 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 99.2 t -65.41 128.16 93.56 Favored Pre-proline 0 C--N 1.319 -0.756 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 178.617 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -74.19 170.99 18.9 Favored 'Trans proline' 0 N--CA 1.46 -0.448 0 O-C-N 122.116 0.535 . . . . 0.0 111.327 178.02 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 89.9 mt -69.34 107.32 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-O 122.155 0.978 . . . . 0.0 108.656 179.379 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 -98.94 84.56 3.1 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 114.278 -1.328 . . . . 0.0 109.444 -177.326 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 70.4 p -66.56 -15.03 63.11 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.687 0.756 . . . . 0.0 112.895 -178.6 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 20.7 p30 -109.11 20.69 18.08 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 114.93 -1.032 . . . . 0.0 112.986 -177.128 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 27.9 m -139.02 147.95 42.77 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 113.693 0.997 . . . . 0.0 113.693 -176.46 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -72.21 167.14 34.84 Favored Pre-proline 0 C--N 1.327 -0.399 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 176.292 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -64.49 -28.18 62.03 Favored 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 115.185 -2.744 . . . . 0.0 111.958 178.919 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -62.31 -29.21 70.28 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 123.626 0.77 . . . . 0.0 111.422 176.928 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.598 ' HA ' ' HE3' ' A' ' 103' ' ' LYS . 62.1 m-20 -95.28 -0.3 53.06 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 114.584 1.328 . . . . 0.0 114.584 -171.974 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 94.7 mm-40 -60.7 -30.89 70.23 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 114.097 1.147 . . . . 0.0 114.097 178.92 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.43 ' HB ' ' HB1' ' A' ' 98' ' ' ALA . 20.6 tt -59.28 140.4 17.58 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.745 0 CA-C-O 122.385 1.088 . . . . 0.0 113.64 -177.674 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 179.88 -154.98 14.39 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.629 -178.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 50.4 p90 -155.02 171.13 20.25 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 178.736 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 17.8 m-85 -113.99 142.8 45.71 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 172.449 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 57.9 ttt180 -112.11 129.2 56.31 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.435 -179.005 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 27.5 ttt180 -67.22 136.27 54.72 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 123.452 0.701 . . . . 0.0 110.042 177.252 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -151.31 142.67 23.39 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.733 0.301 . . . . 0.0 110.606 178.44 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 9.3 t -148.42 151.24 34.9 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 176.585 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 8.3 tpt180 -164.84 124.97 1.94 Allowed 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 -178.959 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 15.1 ptt85 -106.93 158.92 16.66 Favored 'General case' 0 CA--C 1.508 -0.652 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 175.446 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -144.4 -179.57 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.913 0 N-CA-C 104.626 -2.361 . . . . 0.0 104.626 -175.321 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 5.6 mtt-85 -138.65 124.84 20.25 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 175.711 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -86.14 170.88 43.7 Favored Glycine 0 C--O 1.225 -0.412 0 N-CA-C 107.82 -2.112 . . . . 0.0 107.82 175.867 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -79.06 -28.59 53.68 Favored Glycine 0 C--O 1.216 -1.014 0 N-CA-C 108.194 -1.963 . . . . 0.0 108.194 179.459 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 43.2 t0 -76.22 -5.03 45.0 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-N 113.069 -1.566 . . . . 0.0 108.627 176.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 90.48 -11.72 70.54 Favored Glycine 0 CA--C 1.51 -0.277 0 CA-C-N 114.721 -1.127 . . . . 0.0 113.787 176.406 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -71.8 138.26 48.22 Favored 'General case' 0 CA--C 1.507 -0.692 0 CA-C-O 121.939 0.876 . . . . 0.0 109.868 -177.322 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 28.2 ptm -133.18 167.57 20.11 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 114.152 -1.385 . . . . 0.0 110.049 -178.398 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 29.0 mttp -75.67 -56.54 4.59 Favored 'General case' 0 C--O 1.219 -0.551 0 N-CA-C 113.814 1.042 . . . . 0.0 113.814 -177.821 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.6 t70 54.45 -140.13 0.96 Allowed 'General case' 0 CA--C 1.541 0.613 0 O-C-N 124.79 1.306 . . . . 0.0 110.065 -178.046 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 8.8 mt 61.11 173.84 0.11 Allowed 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 116.911 2.189 . . . . 0.0 116.911 177.463 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 36.6 m -67.52 160.79 70.35 Favored Pre-proline 0 C--O 1.238 0.497 0 CA-C-N 114.654 -1.157 . . . . 0.0 110.064 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -63.15 162.07 27.8 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 117.821 -0.986 . . . . 0.0 114.548 -179.507 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 18.5 mtp180 -108.01 160.29 15.9 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 106.801 -1.555 . . . . 0.0 106.801 -179.414 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 50.1 m95 -127.05 133.98 50.37 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.445 ' CZ ' ' HB2' ' A' ' 15' ' ' ALA . 54.4 m-85 -114.71 141.23 48.11 Favored 'General case' 0 C--O 1.216 -0.699 0 N-CA-C 107.961 -1.125 . . . . 0.0 107.961 -177.812 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 88.2 t80 -89.97 134.7 34.08 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 118.474 0.579 . . . . 0.0 109.847 -177.552 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -137.71 147.27 44.65 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 -177.404 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -82.4 159.46 22.99 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 -173.981 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 16.9 tp -59.43 128.8 38.86 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.383 0.611 . . . . 0.0 109.595 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 78.23 26.66 59.32 Favored Glycine 0 C--O 1.217 -0.964 0 N-CA-C 115.704 1.042 . . . . 0.0 115.704 177.999 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 2.4 p . . . . . 0 C--N 1.326 -0.451 0 CA-C-N 119.093 1.447 . . . . 0.0 109.286 178.854 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 24.2 mt . . . . . 0 N--CA 1.448 -0.573 0 N-CA-C 115.212 1.56 . . . . 0.0 115.212 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -77.22 164.76 28.81 Favored 'Trans proline' 0 N--CA 1.459 -0.506 0 N-CA-C 108.002 -1.576 . . . . 0.0 108.002 170.05 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 70.0 t80 -62.62 128.57 36.6 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 120.478 -0.489 . . . . 0.0 110.584 -178.22 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 94.07 -5.5 72.03 Favored Glycine 0 CA--C 1.52 0.404 0 N-CA-C 114.851 0.7 . . . . 0.0 114.851 179.427 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -65.39 128.78 37.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 118.43 1.115 . . . . 0.0 112.314 179.506 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 72.2 m-20 -71.15 128.09 34.77 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 114.766 -1.107 . . . . 0.0 111.142 -178.345 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 25.2 ttmt -156.03 153.03 28.82 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 105.884 -1.895 . . . . 0.0 105.884 177.236 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 20.0 t0 -68.46 135.38 51.58 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.081 0.467 . . . . 0.0 110.12 -178.75 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 68.8 25.7 75.03 Favored Glycine 0 N--CA 1.447 -0.63 0 CA-C-N 115.735 -0.666 . . . . 0.0 114.133 177.488 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 42.8 mm -125.52 127.68 71.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 117.427 0.614 . . . . 0.0 109.989 179.669 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -129.39 115.91 37.17 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 CA-C-O 121.61 0.719 . . . . 0.0 110.202 176.64 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 97.7 m95 -82.38 134.79 35.26 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 113.773 1.027 . . . . 0.0 113.773 -175.611 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 20.8 m -136.6 149.81 27.01 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 CA-C-O 121.529 0.68 . . . . 0.0 110.537 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -157.03 166.56 32.98 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 103.93 -2.618 . . . . 0.0 103.93 -179.472 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 13.4 t -136.59 174.05 11.04 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 105.14 -2.17 . . . . 0.0 105.14 178.586 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -64.92 134.44 53.98 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.01 0.434 . . . . 0.0 109.971 -179.456 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 95.42 -5.86 67.87 Favored Glycine 0 C--O 1.225 -0.436 0 CA-C-N 115.992 -0.549 . . . . 0.0 113.769 178.459 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.43 ' HB1' ' HB ' ' A' ' 44' ' ' ILE . . . -83.15 138.25 33.73 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 122.262 -0.552 . . . . 0.0 110.46 -179.767 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 56.0 mt -88.79 141.11 28.77 Favored 'General case' 0 C--O 1.22 -0.485 0 CA-C-O 121.149 0.499 . . . . 0.0 111.559 -178.581 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -83.57 58.8 4.77 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.358 0.599 . . . . 0.0 110.98 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -139.02 158.31 69.87 Favored Pre-proline 0 C--N 1.325 -0.484 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 -177.907 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -73.09 158.89 48.68 Favored 'Trans proline' 0 CA--C 1.537 0.633 0 N-CA-C 115.272 1.22 . . . . 0.0 115.272 179.308 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.598 ' HE3' ' HA ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -154.42 57.93 0.7 Allowed 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 122.813 1.292 . . . . 0.0 109.572 177.137 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -59.04 -30.39 68.0 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.103 -1.408 . . . . 0.0 112.177 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 17.5 p80 -58.72 -11.2 2.89 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 115.091 1.515 . . . . 0.0 115.091 -177.859 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 33.3 mt -91.82 -32.28 5.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 178.731 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -71.75 -3.39 54.89 Favored Glycine 0 C--O 1.224 -0.479 0 N-CA-C 116.082 1.193 . . . . 0.0 116.082 -175.468 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 15.0 t -83.16 26.56 0.62 Allowed 'General case' 0 CA--C 1.549 0.92 0 N-CA-C 113.67 0.989 . . . . 0.0 113.67 -177.961 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 70.8 ttp85 -57.27 122.99 13.83 Favored 'General case' 0 N--CA 1.472 0.667 0 O-C-N 121.398 -0.814 . . . . 0.0 109.039 178.35 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 60.2 m-20 -90.0 119.08 69.35 Favored Pre-proline 0 C--N 1.324 -0.504 0 N-CA-C 107.208 -1.405 . . . . 0.0 107.208 -179.4 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -70.84 -15.93 33.02 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 117.898 -0.934 . . . . 0.0 114.117 -177.089 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -77.41 -25.76 51.05 Favored 'General case' 0 C--O 1.219 -0.503 0 CA-C-O 120.87 0.367 . . . . 0.0 110.391 178.191 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -102.8 -24.55 13.7 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 113.183 0.808 . . . . 0.0 113.183 -174.968 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 19.7 t-20 -149.12 146.54 27.74 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -177.828 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -88.35 151.14 22.8 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-O 121.575 0.702 . . . . 0.0 112.356 -179.444 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -75.01 149.72 39.18 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.412 177.872 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 7.9 mt -90.26 139.91 16.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 -178.797 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 85.4 t -60.58 124.24 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 N-CA-C 106.245 -1.761 . . . . 0.0 106.245 175.339 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 6.6 tt -67.23 130.84 44.38 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.148 0.499 . . . . 0.0 110.223 -176.867 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -134.09 158.22 44.17 Favored 'General case' 0 CA--C 1.509 -0.605 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 -178.342 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 13.7 mt -112.49 149.77 41.6 Favored Pre-proline 0 C--N 1.322 -0.626 0 N-CA-C 105.915 -1.883 . . . . 0.0 105.915 175.984 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_endo -70.35 168.83 21.2 Favored 'Trans proline' 0 C--N 1.342 0.213 0 N-CA-C 114.531 0.935 . . . . 0.0 114.531 -176.466 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 39.4 tt0 -54.52 130.85 41.33 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.758 -178.333 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 89.97 -11.79 69.58 Favored Glycine 0 C--O 1.226 -0.357 0 CA-C-N 115.786 -0.643 . . . . 0.0 112.87 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 18.1 m -106.99 126.64 52.59 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 117.37 0.585 . . . . 0.0 110.535 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 22.8 p -118.05 148.35 42.35 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 113.261 0.837 . . . . 0.0 113.261 -177.34 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 86.2 mt -68.74 155.91 92.15 Favored Pre-proline 0 C--N 1.324 -0.504 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 176.806 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -75.23 166.3 29.2 Favored 'Trans proline' 0 N--CA 1.462 -0.372 0 C-N-CA 117.44 -1.24 . . . . 0.0 110.315 177.258 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -58.94 130.96 49.52 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.061 -176.383 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 95.13 -9.88 69.93 Favored Glycine 0 C--O 1.224 -0.474 0 N-CA-C 115.137 0.815 . . . . 0.0 115.137 178.711 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -94.4 143.4 26.43 Favored 'General case' 0 N--CA 1.439 -1.002 0 CA-C-O 122.498 1.142 . . . . 0.0 111.717 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 39.9 p90 -142.32 163.78 31.91 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 113.231 -1.804 . . . . 0.0 107.654 175.757 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -106.46 144.17 33.51 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.1 0.476 . . . . 0.0 111.454 -177.344 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.418 ' HB3' ' HB ' ' A' ' 14' ' ' THR . 1.6 tp10 -69.62 129.95 41.06 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 106.544 -1.65 . . . . 0.0 106.544 177.446 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 93.1 -6.3 75.95 Favored Glycine 0 C--O 1.225 -0.446 0 C-N-CA 121.325 -0.464 . . . . 0.0 113.235 -179.281 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 35.3 t . . . . . 0 C--N 1.326 -0.436 0 N-CA-C 109.125 -0.695 . . . . 0.0 109.125 177.779 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.861 0 CA-C-O 121.98 0.895 . . . . 0.0 112.388 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.8 t -54.83 137.57 44.73 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 114.325 -1.307 . . . . 0.0 108.962 174.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 15.6 m95 -64.54 -21.89 66.82 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 178.671 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 46.5 m-85 -121.5 159.56 26.05 Favored 'General case' 0 C--O 1.241 0.612 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 -172.087 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.432 ' HB ' ' HB3' ' A' ' 134' ' ' GLU . 76.0 p -69.12 163.6 24.44 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 114.949 -1.023 . . . . 0.0 108.861 178.831 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -81.47 141.23 34.06 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 -176.417 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 27.5 mt -78.78 148.85 32.79 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 104.64 -2.356 . . . . 0.0 104.64 170.664 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 30.6 m -112.95 128.59 56.53 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 179.243 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 2.6 tm0? -93.24 134.82 35.04 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.025 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 78.0 t60 -139.41 99.45 3.74 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 106.172 -1.788 . . . . 0.0 106.172 168.313 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 169.49 -166.14 39.43 Favored Glycine 0 C--O 1.226 -0.373 0 C-N-CA 120.156 -1.021 . . . . 0.0 112.574 -177.992 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -101.79 -24.58 14.04 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -179.447 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -91.78 153.32 19.68 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 179.65 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -72.4 -62.85 1.29 Allowed 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -174.939 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 43.0 tp 174.6 145.77 0.06 Allowed 'General case' 0 N--CA 1.483 1.212 0 N-CA-C 105.949 -1.871 . . . . 0.0 105.949 175.628 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 54.0 tptt -156.03 138.7 15.1 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 175.138 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 16.8 m-85 -124.88 152.68 70.27 Favored Pre-proline 0 C--O 1.243 0.752 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 174.428 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -70.31 161.47 45.9 Favored 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 120.201 0.6 . . . . 0.0 112.672 178.856 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 20.9 tpt180 -69.07 135.25 50.5 Favored 'General case' 0 C--O 1.216 -0.66 0 O-C-N 122.147 -0.346 . . . . 0.0 110.105 -177.793 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 82.34 11.49 82.05 Favored Glycine 0 C--O 1.223 -0.576 0 N-CA-C 111.785 -0.526 . . . . 0.0 111.785 179.017 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 10.6 mt-30 -150.7 170.5 19.05 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 -175.218 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 107.37 -16.28 38.2 Favored Glycine 0 CA--C 1.503 -0.69 0 C-N-CA 121.429 -0.415 . . . . 0.0 113.204 175.217 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 57.4 t -67.91 129.19 93.31 Favored Pre-proline 0 C--N 1.319 -0.739 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 177.896 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -74.22 163.13 37.22 Favored 'Trans proline' 0 N--CA 1.459 -0.517 0 O-C-N 122.193 0.575 . . . . 0.0 111.967 178.375 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 93.7 mt -66.49 122.95 18.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.612 -177.55 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 44.8 t-20 -124.74 93.43 3.89 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.693 0.758 . . . . 0.0 110.373 179.342 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 82.6 p -75.98 -16.63 59.95 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 112.953 0.723 . . . . 0.0 112.953 -175.272 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 65.5 m-80 -104.33 32.77 3.83 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.631 -174.772 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 82.4 p -144.88 -179.08 6.37 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 114.735 1.383 . . . . 0.0 114.735 -176.354 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 56.8 m -105.05 165.93 12.33 Favored Pre-proline 0 CA--C 1.544 0.718 0 CA-C-N 114.947 -1.024 . . . . 0.0 108.942 178.449 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_endo -68.84 -18.96 41.3 Favored 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 116.405 -1.93 . . . . 0.0 114.983 -178.292 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.449 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 5.5 p-10 -75.03 -21.38 59.1 Favored 'General case' 0 C--N 1.324 -0.526 0 O-C-N 121.728 -0.608 . . . . 0.0 111.907 179.516 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -74.18 -23.09 59.18 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 114.183 1.179 . . . . 0.0 114.183 -174.362 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 93.7 mm-40 -53.61 -26.2 20.93 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 115.57 1.692 . . . . 0.0 115.57 -171.218 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.444 ' HB ' ' HB1' ' A' ' 98' ' ' ALA . 9.1 tt -64.43 136.5 26.41 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 CA-C-O 122.553 1.168 . . . . 0.0 112.203 -179.469 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 175.49 -156.89 22.95 Favored Glycine 0 CA--C 1.502 -0.72 0 C-N-CA 120.156 -1.021 . . . . 0.0 111.863 -178.447 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 47.1 p90 -155.1 170.45 21.76 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 -179.492 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 21.9 m-85 -109.53 139.49 44.47 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 106.538 -1.652 . . . . 0.0 106.538 174.084 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 58.4 ttt-85 -113.43 120.84 42.45 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 123.698 0.799 . . . . 0.0 111.253 -176.199 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 37.9 ttp85 -69.41 140.21 54.12 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.959 0.409 . . . . 0.0 109.933 177.806 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -144.28 149.41 36.23 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 122.979 0.511 . . . . 0.0 110.111 179.434 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 15.3 t -154.29 167.01 31.37 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 176.285 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 15.7 tpt180 -147.98 129.63 15.05 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 178.882 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 6.1 tpp180 -133.58 138.85 46.21 Favored 'General case' 0 CA--C 1.499 -1.01 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 -178.627 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -138.76 174.23 10.39 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 -178.284 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 1.7 ttt-85 -122.37 118.57 28.74 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 104.894 -2.262 . . . . 0.0 104.894 175.778 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -71.74 172.36 46.1 Favored Glycine 0 C--O 1.221 -0.71 0 N-CA-C 109.132 -1.587 . . . . 0.0 109.132 177.973 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -68.89 -37.69 84.05 Favored Glycine 0 C--O 1.222 -0.647 0 N-CA-C 110.303 -1.119 . . . . 0.0 110.303 -179.521 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -74.53 -12.27 60.43 Favored 'General case' 0 C--O 1.214 -0.799 0 CA-C-O 122.131 0.967 . . . . 0.0 109.582 177.143 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 104.54 -7.9 46.9 Favored Glycine 0 CA--C 1.505 -0.562 0 CA-C-N 115.685 -0.689 . . . . 0.0 113.14 173.939 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.95 139.5 58.25 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 122.143 0.973 . . . . 0.0 112.211 -177.048 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 91.1 mmm -93.84 166.16 12.32 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 113.845 -1.525 . . . . 0.0 110.615 -177.652 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 10.5 tttt -79.69 -49.01 12.73 Favored 'General case' 0 C--O 1.213 -0.862 0 N-CA-C 112.978 0.732 . . . . 0.0 112.978 177.895 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 44.88 24.02 0.1 Allowed 'General case' 0 N--CA 1.481 1.124 0 N-CA-C 117.815 2.524 . . . . 0.0 117.815 -178.972 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.4 mp -76.88 152.65 35.33 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 121.451 -0.781 . . . . 0.0 110.329 177.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -59.15 150.79 60.77 Favored Pre-proline 0 C--O 1.245 0.851 0 CA-C-N 115.188 -0.914 . . . . 0.0 113.391 -178.219 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -72.53 158.66 50.63 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 117.364 -1.291 . . . . 0.0 111.166 177.733 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 17.1 mtp180 -125.5 162.55 24.64 Favored 'General case' 0 CA--C 1.508 -0.648 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 -178.417 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 69.6 m95 -126.31 131.98 51.73 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 178.411 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 63.0 m-85 -111.4 150.23 30.08 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 106.113 -1.81 . . . . 0.0 106.113 178.682 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 79.1 t80 -94.1 134.91 36.02 Favored 'General case' 0 CA--C 1.507 -0.707 0 N-CA-C 106.44 -1.689 . . . . 0.0 106.44 179.226 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 8.8 m-85 -137.59 130.08 29.63 Favored 'General case' 0 N--CA 1.439 -0.984 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 -176.897 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.415 ' HB3' ' HB2' ' A' ' 103' ' ' LYS . 66.5 m-85 -66.08 159.56 25.79 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 114.581 -1.19 . . . . 0.0 111.745 -176.833 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -52.54 129.12 28.13 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.009 0.433 . . . . 0.0 111.229 -179.422 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 72.94 25.87 72.62 Favored Glycine 0 C--O 1.224 -0.511 0 N-CA-C 116.189 1.236 . . . . 0.0 116.189 177.038 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 63.2 p . . . . . 0 N--CA 1.469 0.479 0 CA-C-N 118.647 1.223 . . . . 0.0 111.361 178.264 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 18.7 mt . . . . . 0 C--O 1.238 0.489 0 N-CA-C 116.314 1.968 . . . . 0.0 116.314 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -79.35 163.65 24.61 Favored 'Trans proline' 0 CA--C 1.53 0.305 0 C-N-CA 122.42 2.08 . . . . 0.0 108.296 168.829 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 75.0 t80 -61.51 130.86 48.01 Favored 'General case' 0 C--N 1.323 -0.555 0 O-C-N 121.88 -0.512 . . . . 0.0 111.283 -176.697 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 90.89 -5.95 81.95 Favored Glycine 0 C--O 1.227 -0.307 0 CA-C-O 119.286 -0.73 . . . . 0.0 114.519 178.765 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -64.22 130.44 43.91 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 118.438 1.119 . . . . 0.0 111.256 179.416 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 56.9 t30 -79.96 127.0 31.74 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.522 -178.879 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 29.8 ttmt -156.25 152.68 28.06 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 179.417 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 15.0 t0 -66.34 135.91 55.04 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 110.248 -0.279 . . . . 0.0 110.248 -179.492 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 67.14 27.18 73.4 Favored Glycine 0 N--CA 1.45 -0.403 0 CA-C-O 119.671 -0.516 . . . . 0.0 113.617 178.755 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 44.5 mm -129.31 128.44 66.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 121.168 0.509 . . . . 0.0 109.977 179.556 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -133.58 116.95 25.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 CA-C-O 121.359 0.6 . . . . 0.0 111.404 177.429 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 96.1 m95 -81.84 136.69 35.36 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 113.57 0.952 . . . . 0.0 113.57 -177.414 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 17.7 m -136.84 156.04 34.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 178.83 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -164.0 166.56 21.42 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 103.297 -2.853 . . . . 0.0 103.297 -179.335 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 10.8 t -137.59 -179.62 5.85 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 106.148 -1.797 . . . . 0.0 106.148 177.909 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -65.15 134.72 54.36 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.217 0.532 . . . . 0.0 110.56 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 92.7 -9.32 75.87 Favored Glycine 0 N--CA 1.458 0.136 0 CA-C-N 115.918 -0.583 . . . . 0.0 114.128 177.753 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.449 ' HA ' ' HA ' ' A' ' 41' ' ' ASP . . . -72.22 133.61 45.18 Favored 'General case' 0 CA--C 1.544 0.735 0 O-C-N 122.441 -0.446 . . . . 0.0 111.395 -179.44 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 25.6 mt -93.23 136.86 33.1 Favored 'General case' 0 CA--C 1.507 -0.711 0 CA-C-O 120.931 0.396 . . . . 0.0 111.601 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 62.8 t30 -80.58 69.47 7.09 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.215 -179.826 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 2.0 t -144.57 156.25 56.62 Favored Pre-proline 0 CA--C 1.541 0.599 0 N-CA-C 106.932 -1.507 . . . . 0.0 106.932 179.533 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -63.68 153.21 76.59 Favored 'Trans proline' 0 C--N 1.348 0.518 0 N-CA-C 114.629 0.973 . . . . 0.0 114.629 -179.121 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.503 ' HB3' HD12 ' A' ' 106' ' ' ILE . 73.5 mmtt -125.22 41.19 3.57 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 123.289 0.636 . . . . 0.0 110.02 -179.426 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 15.5 p-10 -53.11 -43.59 67.0 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.717 -0.674 . . . . 0.0 112.314 -177.363 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 17.7 p80 -70.33 -6.56 36.06 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 114.45 1.278 . . . . 0.0 114.45 -178.509 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.503 HD12 ' HB3' ' A' ' 103' ' ' LYS . 32.0 mt -96.35 -44.88 12.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 118.075 0.398 . . . . 0.0 109.938 178.909 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -71.35 14.68 1.68 Allowed Glycine 0 C--O 1.223 -0.592 0 N-CA-C 116.357 1.303 . . . . 0.0 116.357 -177.22 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 15.3 t -94.3 25.71 3.71 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 -177.487 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 65.2 ttp85 -58.13 121.07 9.79 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 178.454 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -88.8 126.68 58.75 Favored Pre-proline 0 C--N 1.322 -0.598 0 N-CA-C 106.588 -1.634 . . . . 0.0 106.588 -177.917 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -73.23 -14.36 25.68 Favored 'Trans proline' 0 C--O 1.218 -0.488 0 C-N-CA 117.629 -1.114 . . . . 0.0 114.019 -177.295 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -81.56 -24.46 36.54 Favored 'General case' 0 C--O 1.22 -0.462 0 CA-C-O 121.124 0.487 . . . . 0.0 110.098 178.786 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 74.9 m-20 -101.82 -24.84 13.99 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 113.343 0.868 . . . . 0.0 113.343 -174.13 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 19.8 t-20 -151.35 149.95 29.92 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 113.001 0.741 . . . . 0.0 113.001 -177.432 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -89.44 148.15 23.62 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-O 121.538 0.685 . . . . 0.0 111.867 179.508 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -71.25 147.23 48.4 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.186 178.645 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 18.8 mt -86.47 139.56 17.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 -179.357 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 75.0 t -62.0 123.64 15.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 N-CA-C 106.564 -1.643 . . . . 0.0 106.564 175.645 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 6.8 tt -67.01 127.41 32.47 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.017 0.436 . . . . 0.0 109.994 -177.37 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 33.3 mt-30 -132.76 157.16 45.64 Favored 'General case' 0 CA--C 1.511 -0.557 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 -179.254 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 13.3 mt -112.04 147.74 37.55 Favored Pre-proline 0 C--N 1.322 -0.612 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 177.789 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -73.04 164.63 34.98 Favored 'Trans proline' 0 C--O 1.236 0.387 0 O-C-N 122.272 0.617 . . . . 0.0 112.529 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 51.8 tt0 -55.35 133.74 49.82 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 100.34 -22.86 38.15 Favored Glycine 0 C--O 1.227 -0.337 0 CA-C-N 116.128 -0.487 . . . . 0.0 112.631 -178.607 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 5.0 m -107.02 128.4 54.33 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 117.961 0.88 . . . . 0.0 110.293 178.458 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 8.1 p -120.69 148.34 44.07 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.776 -178.782 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 88.4 mt -73.48 153.37 89.88 Favored Pre-proline 0 C--N 1.324 -0.517 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 177.284 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -76.51 171.2 18.49 Favored 'Trans proline' 0 C--O 1.234 0.281 0 C-N-CA 118.566 -0.489 . . . . 0.0 111.225 178.784 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 24.2 tptm -60.58 129.23 40.51 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 -179.301 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 91.03 18.4 47.05 Favored Glycine 0 C--O 1.223 -0.548 0 C-N-CA 120.931 -0.652 . . . . 0.0 114.655 178.262 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -127.21 141.71 51.67 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 117.596 0.698 . . . . 0.0 111.509 177.968 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 45.3 p90 -150.04 162.98 39.33 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 176.263 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -100.99 147.73 25.84 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.246 0.546 . . . . 0.0 111.844 -177.404 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.432 ' HB3' ' HB ' ' A' ' 14' ' ' THR . 0.9 OUTLIER -69.74 128.93 38.13 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 177.372 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 89.82 -7.31 82.0 Favored Glycine 0 C--O 1.225 -0.465 0 CA-C-N 116.315 -0.402 . . . . 0.0 113.54 179.422 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 34.5 t . . . . . 0 C--N 1.324 -0.516 0 CA-C-O 121.402 0.62 . . . . 0.0 110.869 179.476 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.456 -0.131 0 CA-C-O 121.379 0.609 . . . . 0.0 111.286 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 40.9 t -64.71 145.14 56.64 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 177.572 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 11.7 m95 -67.27 -21.91 65.69 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 122.799 0.44 . . . . 0.0 111.999 177.582 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 40.1 m-85 -121.4 165.56 15.38 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 114.136 1.161 . . . . 0.0 114.136 -170.458 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 73.6 p -71.85 163.13 28.37 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 114.63 -1.168 . . . . 0.0 108.662 177.956 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.46 ' HB2' ' CZ ' ' A' ' 69' ' ' TYR . . . -74.43 141.66 45.01 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -176.434 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.401 HD23 ' HA ' ' A' ' 16' ' ' LEU . 11.8 mt -85.94 143.84 27.96 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 102.962 -2.977 . . . . 0.0 102.962 169.837 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 21.5 m -124.54 137.39 54.41 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 -177.847 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.434 ' HB2' ' CZ ' ' A' ' 131' ' ' PHE . 4.7 tp60 -114.36 140.19 48.86 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 113.505 0.928 . . . . 0.0 113.505 -176.405 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 72.0 t60 -134.59 99.67 4.41 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 105.112 -2.181 . . . . 0.0 105.112 169.62 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 177.33 -169.2 41.31 Favored Glycine 0 N--CA 1.451 -0.334 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 -176.855 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 65.4 mttp -99.58 -26.95 13.92 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 117.398 0.599 . . . . 0.0 112.544 -179.7 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -85.74 158.01 20.13 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 178.614 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -82.46 -62.72 1.54 Allowed 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 120.786 -0.366 . . . . 0.0 111.782 -177.485 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 39.0 tp 179.62 142.55 0.14 Allowed 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 106.843 -1.54 . . . . 0.0 106.843 174.893 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -157.52 139.25 14.03 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 174.244 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 13.3 m-85 -123.22 151.57 62.42 Favored Pre-proline 0 C--O 1.239 0.537 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 176.717 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -74.28 165.55 31.58 Favored 'Trans proline' 0 CA--C 1.539 0.746 0 C-N-CA 120.058 0.505 . . . . 0.0 113.028 178.601 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 21.7 tpt180 -66.95 135.23 53.47 Favored 'General case' 0 C--O 1.216 -0.687 0 O-C-N 122.145 -0.347 . . . . 0.0 110.977 -177.664 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 82.95 4.24 90.1 Favored Glycine 0 C--O 1.223 -0.582 0 N-CA-C 111.935 -0.466 . . . . 0.0 111.935 178.156 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 40.0 mt-30 -141.79 170.6 15.4 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 123.206 0.602 . . . . 0.0 109.844 -174.465 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 105.61 -23.1 30.71 Favored Glycine 0 CA--C 1.498 -0.989 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.906 175.503 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 95.7 t -65.1 126.44 91.28 Favored Pre-proline 0 C--N 1.32 -0.694 0 N-CA-C 105.963 -1.866 . . . . 0.0 105.963 176.712 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -74.41 169.06 23.36 Favored 'Trans proline' 0 N--CA 1.459 -0.522 0 O-C-N 122.221 0.59 . . . . 0.0 110.912 179.168 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 92.8 mt -68.28 108.94 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 -179.435 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 75.0 m-80 -99.25 87.1 3.56 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 114.759 -1.109 . . . . 0.0 110.307 -177.243 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 73.7 p -68.73 -14.76 63.23 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.772 0.796 . . . . 0.0 112.243 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -107.34 18.8 21.15 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.861 -1.063 . . . . 0.0 113.357 -176.771 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 12.9 m -137.8 152.62 49.32 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 114.999 1.481 . . . . 0.0 114.999 -175.199 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.7 m -72.04 164.96 54.65 Favored Pre-proline 0 C--N 1.325 -0.482 0 CA-C-N 115.138 -0.937 . . . . 0.0 109.39 177.303 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -66.28 -27.3 48.24 Favored 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 114.858 -2.961 . . . . 0.0 113.861 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.448 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 2.1 p-10 -75.39 -22.32 57.56 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 121.57 -0.706 . . . . 0.0 110.916 177.01 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 56.4 m-20 -81.73 -7.18 59.57 Favored 'General case' 0 C--O 1.221 -0.406 0 N-CA-C 113.654 0.983 . . . . 0.0 113.654 -175.739 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 96.4 mm-40 -58.61 -28.18 65.38 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 113.797 1.036 . . . . 0.0 113.797 -178.819 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.528 ' HB ' ' HB1' ' A' ' 98' ' ' ALA . 9.8 tt -58.71 139.53 18.27 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.877 0 CA-C-O 122.302 1.049 . . . . 0.0 113.251 -179.214 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -179.88 -157.7 20.58 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.457 -0.878 . . . . 0.0 112.742 -179.509 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 41.6 p90 -155.06 171.75 19.25 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 179.441 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 20.2 m-85 -113.3 138.65 49.71 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 173.585 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 50.7 ttt180 -109.3 127.14 54.06 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.006 -178.3 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 40.8 ttt-85 -66.78 140.66 57.85 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 177.714 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -147.05 146.61 30.07 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.51 0.672 . . . . 0.0 111.361 179.656 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 21.2 p -144.31 157.65 44.16 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 104.235 -2.506 . . . . 0.0 104.235 175.59 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 19.0 tpp85 -147.3 125.68 12.34 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 118.296 0.498 . . . . 0.0 110.282 178.18 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 6.0 tmm_? -147.36 139.23 24.21 Favored 'General case' 0 CA--C 1.492 -1.282 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 179.431 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -132.56 179.1 4.71 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 N-CA-C 105.461 -2.052 . . . . 0.0 105.461 -178.529 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 56.1 ttp180 -120.96 113.61 20.35 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 106.855 -1.535 . . . . 0.0 106.855 172.479 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -95.98 147.36 18.62 Favored Glycine 0 C--N 1.317 -0.488 0 N-CA-C 106.114 -2.794 . . . . 0.0 106.114 177.877 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -63.92 -33.33 86.94 Favored Glycine 0 C--O 1.216 -0.969 0 CA-C-N 118.459 1.13 . . . . 0.0 111.584 -179.752 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 38.5 t0 -89.95 17.04 7.22 Favored 'General case' 0 CA--C 1.549 0.918 0 CA-C-O 122.263 1.03 . . . . 0.0 111.308 179.763 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 81.04 22.91 60.23 Favored Glycine 0 C--O 1.226 -0.404 0 CA-C-O 121.798 0.666 . . . . 0.0 113.823 172.953 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 21.9 mmtt -85.74 149.4 25.31 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.745 0.783 . . . . 0.0 112.26 -174.508 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 15.6 mtp -115.38 -179.89 3.77 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 113.824 -1.535 . . . . 0.0 110.886 -177.141 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -119.86 -65.4 1.16 Allowed 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 113.626 0.973 . . . . 0.0 113.626 -177.963 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -130.18 159.21 37.52 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 103.525 -2.768 . . . . 0.0 103.525 177.958 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 93.5 mt -121.22 -70.7 0.77 Allowed 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 120.769 0.318 . . . . 0.0 111.306 -179.49 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 16.0 m -67.73 152.72 96.07 Favored Pre-proline 0 C--O 1.239 0.55 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.13 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -68.2 148.15 74.12 Favored 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 116.99 -1.54 . . . . 0.0 111.858 178.146 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 34.6 mtt180 -128.7 164.13 23.61 Favored 'General case' 0 CA--C 1.508 -0.641 0 CA-C-N 115.923 -0.581 . . . . 0.0 112.477 -178.2 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 73.0 m95 -134.58 145.94 49.16 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 178.134 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.46 ' CZ ' ' HB2' ' A' ' 15' ' ' ALA . 22.1 m-85 -128.24 141.95 51.3 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 106.327 -1.731 . . . . 0.0 106.327 179.38 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 76.4 t80 -88.8 136.68 32.88 Favored 'General case' 0 CA--C 1.507 -0.702 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 -177.743 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -140.52 135.73 32.18 Favored 'General case' 0 N--CA 1.439 -1.0 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 -175.898 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 84.8 m-85 -73.26 159.5 33.33 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.425 -174.992 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -54.38 126.1 22.01 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.121 0.486 . . . . 0.0 111.545 -177.253 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 68.38 36.01 83.36 Favored Glycine 0 N--CA 1.448 -0.544 0 CA-C-O 119.048 -0.862 . . . . 0.0 114.326 176.45 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.3 p . . . . . 0 C--N 1.325 -0.46 0 N-CA-C 106.619 -1.622 . . . . 0.0 106.619 176.145 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 14.4 mt . . . . . 0 N--CA 1.443 -0.814 0 N-CA-C 115.076 1.509 . . . . 0.0 115.076 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -79.01 163.27 25.77 Favored 'Trans proline' 0 N--CA 1.462 -0.359 0 C-N-CA 122.352 2.035 . . . . 0.0 107.706 167.998 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 58.4 t80 -61.8 132.03 51.77 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 120.329 -0.549 . . . . 0.0 110.352 -178.027 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 90.94 -5.71 81.91 Favored Glycine 0 C--O 1.226 -0.362 0 CA-C-O 119.37 -0.683 . . . . 0.0 114.408 178.864 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -66.35 130.33 42.84 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 118.582 1.191 . . . . 0.0 111.117 179.126 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 57.5 t30 -77.11 128.07 33.78 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.24 -179.252 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 30.1 ttmt -156.17 151.78 27.07 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 179.499 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 29.4 t0 -64.81 132.38 49.34 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.933 0.397 . . . . 0.0 110.36 -178.398 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 68.1 28.83 73.24 Favored Glycine 0 N--CA 1.451 -0.351 0 CA-C-O 119.447 -0.64 . . . . 0.0 114.281 178.988 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 44.7 mm -128.3 127.56 67.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 117.465 0.632 . . . . 0.0 110.61 179.675 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -131.29 118.83 41.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.997 176.193 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 95.9 m95 -84.99 137.25 33.2 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 113.499 0.925 . . . . 0.0 113.499 -176.584 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 15.9 m -137.79 149.71 25.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.43 0.633 . . . . 0.0 109.856 179.488 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -157.81 166.43 32.74 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 105.43 -2.063 . . . . 0.0 105.43 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 14.7 t -131.34 179.84 5.78 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 105.94 -1.874 . . . . 0.0 105.94 178.492 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -67.54 135.38 52.89 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.231 0.539 . . . . 0.0 110.436 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 90.72 -9.33 78.01 Favored Glycine 0 C--O 1.23 -0.133 0 CA-C-N 115.932 -0.576 . . . . 0.0 113.513 177.586 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.528 ' HB1' ' HB ' ' A' ' 44' ' ' ILE . . . -73.15 131.43 42.03 Favored 'General case' 0 CA--C 1.544 0.733 0 O-C-N 122.525 -0.397 . . . . 0.0 110.646 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 26.7 mt -91.58 139.24 30.89 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 113.117 0.784 . . . . 0.0 113.117 -177.485 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 53.4 t30 -84.01 73.09 10.4 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.361 -179.613 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 1.3 t -142.23 152.33 60.81 Favored Pre-proline 0 C--N 1.323 -0.566 0 N-CA-C 107.551 -1.278 . . . . 0.0 107.551 179.131 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -66.45 149.18 84.68 Favored 'Trans proline' 0 CA--C 1.528 0.221 0 N-CA-C 114.278 0.838 . . . . 0.0 114.278 177.05 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -148.97 57.55 1.03 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.852 0.834 . . . . 0.0 112.733 179.124 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 32.0 t0 -60.51 -20.3 59.7 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.577 176.512 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 15.6 p80 -59.94 -10.98 4.67 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 113.543 0.942 . . . . 0.0 113.543 179.135 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 41.3 mt -96.21 -30.14 3.92 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 CA-C-O 120.698 0.285 . . . . 0.0 110.78 179.153 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -75.13 4.8 37.5 Favored Glycine 0 N--CA 1.462 0.413 0 N-CA-C 115.375 0.91 . . . . 0.0 115.375 -176.122 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 14.6 t -83.1 15.83 2.65 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 113.991 1.108 . . . . 0.0 113.991 -177.878 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 62.6 ttp85 -63.84 126.84 28.91 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 177.713 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -108.56 134.59 20.21 Favored Pre-proline 0 C--N 1.323 -0.551 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_endo -69.05 -18.22 40.47 Favored 'Trans proline' 0 C--O 1.218 -0.49 0 N-CA-C 114.934 1.09 . . . . 0.0 114.934 -175.904 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -77.03 -24.15 52.09 Favored 'General case' 0 C--O 1.221 -0.41 0 CA-C-O 121.106 0.479 . . . . 0.0 110.085 178.31 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -99.32 -28.48 13.28 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.64 -0.709 . . . . 0.0 112.848 -175.188 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 -155.68 147.26 22.93 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 -178.343 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -84.1 145.55 28.38 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-O 121.44 0.638 . . . . 0.0 111.638 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -69.54 145.54 52.54 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.208 0.527 . . . . 0.0 110.525 178.389 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 18.3 mt -86.54 138.22 19.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 -178.445 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 92.5 t -61.24 124.03 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 N-CA-C 105.912 -1.885 . . . . 0.0 105.912 175.235 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 6.3 tt -66.4 128.78 37.5 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.155 0.502 . . . . 0.0 110.038 -176.654 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 -132.84 156.02 47.93 Favored 'General case' 0 CA--C 1.508 -0.659 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 -178.606 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 13.2 mt -111.75 148.87 39.83 Favored Pre-proline 0 C--N 1.322 -0.629 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 177.399 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -72.96 164.26 36.06 Favored 'Trans proline' 0 N--CA 1.462 -0.361 0 C-N-CA 118.079 -0.814 . . . . 0.0 112.575 -179.502 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -55.17 130.98 44.16 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 104.31 -23.77 30.84 Favored Glycine 0 C--O 1.226 -0.402 0 CA-C-N 116.01 -0.541 . . . . 0.0 112.538 -178.524 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 7.7 m -108.4 129.71 55.25 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 118.137 0.968 . . . . 0.0 111.23 178.308 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 4.7 p -119.73 148.33 43.53 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.572 179.067 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 80.4 mt -69.75 154.81 94.42 Favored Pre-proline 0 C--N 1.324 -0.539 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 178.115 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -76.78 168.77 22.98 Favored 'Trans proline' 0 C--O 1.233 0.232 0 C-N-CA 117.775 -1.017 . . . . 0.0 110.5 176.833 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 7.5 tmtm? -57.74 130.56 46.96 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.967 0.413 . . . . 0.0 111.863 -175.763 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 95.14 -6.99 69.32 Favored Glycine 0 C--O 1.235 0.204 0 CA-C-N 115.461 -0.791 . . . . 0.0 114.907 177.382 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.434 ' CZ ' ' HB2' ' A' ' 18' ' ' GLN . 2.5 m-85 -95.99 138.6 33.39 Favored 'General case' 0 CA--C 1.502 -0.877 0 CA-C-O 122.086 0.946 . . . . 0.0 111.126 179.818 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 38.6 p90 -142.64 160.28 40.6 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 113.583 -1.644 . . . . 0.0 107.867 175.106 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -102.5 144.89 30.36 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.121 0.486 . . . . 0.0 111.189 -177.445 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -71.87 136.14 46.85 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 106.63 -1.619 . . . . 0.0 106.63 177.567 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 86.13 -2.63 87.6 Favored Glycine 0 C--O 1.227 -0.333 0 C-N-CA 121.211 -0.519 . . . . 0.0 112.545 -177.201 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 8.2 t . . . . . 0 C--N 1.326 -0.425 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 177.722 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.456 -0.151 0 CA-C-O 120.885 0.374 . . . . 0.0 110.974 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 26.6 t -60.32 137.03 58.2 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 176.393 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' TRP . . . . . 0.4 ' HA ' ' HD3' ' A' ' 109' ' ' ARG . 9.8 m95 -70.83 -23.19 62.3 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.963 0.411 . . . . 0.0 111.18 178.451 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 24.8 m-85 -121.4 158.39 28.41 Favored 'General case' 0 C--O 1.241 0.634 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -171.128 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.424 ' HB ' ' HB3' ' A' ' 134' ' ' GLU . 72.0 p -69.06 163.34 24.93 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.012 -0.994 . . . . 0.0 109.189 179.153 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.426 ' HB2' ' CZ ' ' A' ' 69' ' ' TYR . . . -74.78 145.27 43.07 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 113.333 0.864 . . . . 0.0 113.333 -175.792 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 16.5 mt -85.74 148.9 25.64 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 103.754 -2.684 . . . . 0.0 103.754 169.349 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 31.0 m -124.86 128.97 49.49 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 178.96 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -82.42 137.26 34.75 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.018 179.52 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 72.0 t60 -139.32 94.93 2.85 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 104.085 -2.561 . . . . 0.0 104.085 168.466 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 163.74 -143.04 8.26 Favored Glycine 0 C--O 1.225 -0.437 0 C-N-CA 120.628 -0.796 . . . . 0.0 111.975 -175.561 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 54.7 mtpt -120.39 -25.56 5.59 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 116.98 2.215 . . . . 0.0 116.98 -175.984 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -94.41 159.37 15.14 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 117.861 0.3 . . . . 0.0 110.736 -176.755 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -63.07 -62.85 1.43 Allowed 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 111.999 0.37 . . . . 0.0 111.999 -178.217 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 51.3 tp 165.28 141.94 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.111 0 N-CA-C 103.849 -2.648 . . . . 0.0 103.849 178.51 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 23.3 tptm -156.76 140.66 16.2 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 118.242 0.474 . . . . 0.0 109.813 176.034 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 26.1 m-85 -126.89 150.43 71.66 Favored Pre-proline 0 C--N 1.324 -0.538 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 175.435 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -77.2 165.79 27.38 Favored 'Trans proline' 0 CA--C 1.538 0.697 0 C-N-CA 120.395 0.73 . . . . 0.0 112.571 177.382 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 75.7 ttt180 -66.81 136.37 55.34 Favored 'General case' 0 N--CA 1.472 0.649 0 O-C-N 122.107 -0.37 . . . . 0.0 110.318 -179.201 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 85.56 6.38 83.45 Favored Glycine 0 C--O 1.222 -0.596 0 N-CA-C 111.498 -0.641 . . . . 0.0 111.498 178.746 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 28.5 mt-30 -146.25 170.55 16.53 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 -175.354 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.416 ' H ' HG21 ' A' ' 125' ' ' THR . . . 103.28 -21.64 38.89 Favored Glycine 0 CA--C 1.499 -0.952 0 CA-C-N 115.772 -0.649 . . . . 0.0 114.017 173.877 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 92.7 t -65.71 128.52 93.87 Favored Pre-proline 0 C--N 1.319 -0.739 0 N-CA-C 106.468 -1.679 . . . . 0.0 106.468 177.531 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -71.91 171.7 16.06 Favored 'Trans proline' 0 C--O 1.22 -0.384 0 O-C-N 122.183 0.57 . . . . 0.0 111.221 177.848 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 92.1 mt -71.09 106.36 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 179.584 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -96.44 84.2 3.67 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 114.399 -1.273 . . . . 0.0 109.318 -176.87 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 67.8 p -66.97 -14.72 63.14 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.69 0.757 . . . . 0.0 112.749 -178.884 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -106.18 20.32 19.14 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 114.906 -1.043 . . . . 0.0 112.441 -177.675 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 15.1 m -139.91 151.23 45.43 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 114.886 1.439 . . . . 0.0 114.886 -175.259 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 2.2 m -72.24 166.33 42.37 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.314 176.612 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -66.27 -25.97 49.34 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 114.964 -2.891 . . . . 0.0 114.19 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.451 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 3.3 p-10 -77.53 -21.43 52.64 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 121.51 -0.744 . . . . 0.0 110.83 177.491 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 70.7 m-20 -81.39 -7.14 59.53 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 113.69 0.996 . . . . 0.0 113.69 -175.841 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 96.1 mm-40 -58.6 -26.5 63.74 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 114.262 1.208 . . . . 0.0 114.262 -178.44 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.425 ' HB ' ' HB1' ' A' ' 98' ' ' ALA . 9.9 tt -58.66 138.31 19.86 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.958 0 N-CA-C 113.87 1.063 . . . . 0.0 113.87 -178.246 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -179.72 -156.98 19.12 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.746 -0.74 . . . . 0.0 111.903 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 42.8 p90 -155.16 171.06 20.41 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 178.852 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 23.5 m-85 -113.96 142.22 46.42 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 106.924 -1.51 . . . . 0.0 106.924 173.466 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 52.7 ttt180 -115.06 126.9 55.24 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.668 -178.774 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 10.1 ttp85 -70.05 133.06 46.8 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 176.22 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -115.51 123.55 48.82 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 176.267 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -153.2 144.31 23.01 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 114.974 -1.012 . . . . 0.0 108.546 -179.339 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 22.7 tpp180 -153.98 123.82 6.77 Favored 'General case' 0 C--O 1.217 -0.646 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 175.87 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.56 145.63 48.16 Favored 'General case' 0 CA--C 1.49 -1.334 0 CA-C-O 121.684 0.754 . . . . 0.0 110.895 179.356 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -142.79 176.41 3.48 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.959 0 N-CA-C 104.389 -2.448 . . . . 0.0 104.389 178.537 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 5.5 tmm_? -128.07 99.21 5.39 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 106.238 -1.764 . . . . 0.0 106.238 175.683 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -70.04 146.93 43.79 Favored Glycine 0 N--CA 1.451 -0.364 0 N-CA-C 108.878 -1.689 . . . . 0.0 108.878 178.895 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -63.06 -33.43 87.22 Favored Glycine 0 C--O 1.215 -1.048 0 C-N-CA 120.453 -0.88 . . . . 0.0 110.981 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 27.2 t0 -90.06 17.63 6.71 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-O 121.936 0.874 . . . . 0.0 111.598 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 86.6 -7.0 81.21 Favored Glycine 0 N--CA 1.462 0.391 0 N-CA-C 116.326 1.291 . . . . 0.0 116.326 174.649 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.71 128.44 36.29 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 114.211 1.189 . . . . 0.0 114.211 -178.159 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 98.3 mmm -96.56 177.95 5.5 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 106.503 -1.666 . . . . 0.0 106.503 176.304 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 6.6 tmtt? -103.63 -57.23 2.07 Favored 'General case' 0 CA--C 1.507 -0.675 0 CA-C-O 121.474 0.654 . . . . 0.0 110.49 177.805 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 25.4 p30 -133.8 170.34 15.72 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 178.395 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -125.02 -53.58 1.63 Allowed 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 179.736 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 25.9 t -108.09 147.43 35.51 Favored Pre-proline 0 C--O 1.24 0.558 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 178.877 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -72.93 155.13 53.35 Favored 'Trans proline' 0 C--O 1.24 0.612 0 N-CA-C 115.376 1.26 . . . . 0.0 115.376 -178.585 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 25.5 mtp180 -115.45 161.57 18.39 Favored 'General case' 0 CA--C 1.509 -0.604 0 N-CA-C 106.651 -1.611 . . . . 0.0 106.651 173.304 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 61.0 m95 -129.81 142.76 50.63 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 178.196 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.426 ' CZ ' ' HB2' ' A' ' 15' ' ' ALA . 53.8 m-85 -123.89 144.37 49.8 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 179.467 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 86.1 t80 -93.55 138.02 32.24 Favored 'General case' 0 CA--C 1.511 -0.54 0 N-CA-C 108.415 -0.958 . . . . 0.0 108.415 -177.724 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -141.49 143.14 33.67 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 -177.522 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -76.66 159.48 30.2 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.794 -0.639 . . . . 0.0 112.23 -176.05 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -55.08 131.22 44.53 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.571 -179.391 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 77.53 25.03 63.95 Favored Glycine 0 C--O 1.22 -0.719 0 N-CA-C 115.921 1.128 . . . . 0.0 115.921 176.796 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 7.4 p . . . . . 0 C--N 1.325 -0.467 0 CA-C-N 118.46 1.13 . . . . 0.0 109.364 179.01 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 21.2 mt . . . . . 0 C--O 1.237 0.425 0 N-CA-C 115.319 1.6 . . . . 0.0 115.319 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -77.06 164.22 29.82 Favored 'Trans proline' 0 N--CA 1.461 -0.43 0 N-CA-C 108.213 -1.495 . . . . 0.0 108.213 169.906 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 57.1 t80 -61.19 132.43 53.67 Favored 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 120.594 -0.442 . . . . 0.0 110.074 -179.073 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 91.63 -7.65 79.46 Favored Glycine 0 CA--C 1.52 0.349 0 N-CA-C 114.683 0.633 . . . . 0.0 114.683 178.895 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -64.89 131.74 47.52 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 118.267 1.034 . . . . 0.0 111.682 179.558 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 34.3 t-20 -77.27 128.56 34.55 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.764 -177.638 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 20.5 ttmt -156.14 150.93 26.09 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 106.41 -1.7 . . . . 0.0 106.41 177.398 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -65.09 133.64 52.06 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.823 0.344 . . . . 0.0 110.168 -179.363 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 69.87 24.98 76.1 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 121.018 -0.611 . . . . 0.0 114.181 177.463 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 39.1 mm -126.31 127.4 70.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 117.335 0.568 . . . . 0.0 109.682 178.716 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.1 pt -131.32 116.73 33.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 CA-C-O 121.752 0.787 . . . . 0.0 110.268 176.549 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 94.8 m95 -82.52 137.12 34.7 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.081 -0.509 . . . . 0.0 112.355 -177.01 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 16.4 m -137.83 149.7 25.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.646 0.736 . . . . 0.0 110.186 179.39 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -157.91 165.59 34.81 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 104.093 -2.558 . . . . 0.0 104.093 179.58 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 14.3 t -130.18 178.85 6.25 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 105.467 -2.049 . . . . 0.0 105.467 179.018 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -67.39 134.98 52.47 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.178 0.513 . . . . 0.0 109.849 -179.555 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 92.89 -12.38 70.04 Favored Glycine 0 C--O 1.227 -0.284 0 CA-C-N 115.92 -0.582 . . . . 0.0 113.255 178.841 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.451 ' HA ' ' HA ' ' A' ' 41' ' ' ASP . . . -70.16 130.7 42.79 Favored 'General case' 0 CA--C 1.542 0.668 0 O-C-N 122.56 -0.376 . . . . 0.0 110.644 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 24.4 mt -90.33 140.4 29.74 Favored 'General case' 0 C--O 1.219 -0.518 0 CA-C-O 121.392 0.615 . . . . 0.0 112.137 -178.695 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 58.6 t30 -84.14 70.12 10.48 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.681 -179.52 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 1.1 t -140.78 153.39 67.67 Favored Pre-proline 0 C--N 1.323 -0.559 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 179.434 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -68.0 152.35 76.87 Favored 'Trans proline' 0 C--N 1.343 0.26 0 N-CA-C 114.249 0.827 . . . . 0.0 114.249 177.525 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -152.08 55.15 0.82 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 122.904 1.335 . . . . 0.0 110.896 178.232 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 15.0 p-10 -58.67 -32.51 69.18 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 113.635 -1.62 . . . . 0.0 110.695 177.703 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 30.9 p-80 -58.94 -16.67 18.91 Favored 'General case' 0 C--O 1.218 -0.591 0 N-CA-C 114.429 1.27 . . . . 0.0 114.429 -179.043 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 75.0 mt -79.93 -33.39 14.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 178.743 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -76.97 11.21 15.87 Favored Glycine 0 C--O 1.225 -0.422 0 N-CA-C 116.006 1.163 . . . . 0.0 116.006 -176.216 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 15.2 t -83.06 25.19 0.71 Allowed 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 118.224 1.012 . . . . 0.0 112.021 -177.513 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.434 ' HD2' ' OD1' ' A' ' 114' ' ' ASN . 66.1 ttp85 -62.35 125.28 23.36 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 121.736 -0.602 . . . . 0.0 111.301 -178.549 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 7.8 m120 -88.38 115.63 63.84 Favored Pre-proline 0 C--N 1.326 -0.427 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 179.01 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -73.1 -11.22 25.14 Favored 'Trans proline' 0 C--O 1.218 -0.496 0 C-N-CA 117.963 -0.891 . . . . 0.0 114.233 -177.569 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -81.49 -24.47 36.69 Favored 'General case' 0 C--O 1.22 -0.46 0 CA-C-O 121.002 0.43 . . . . 0.0 110.086 177.341 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -99.84 -30.37 12.08 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.779 -0.646 . . . . 0.0 112.383 -175.239 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' ASN . . . . . 0.434 ' OD1' ' HD2' ' A' ' 109' ' ' ARG . 0.5 OUTLIER -131.97 151.08 51.95 Favored 'General case' 0 N--CA 1.437 -1.075 0 CA-C-O 121.338 0.59 . . . . 0.0 111.623 -178.31 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -94.82 137.55 33.75 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.084 -0.962 . . . . 0.0 108.852 176.421 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -63.66 146.14 54.37 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.405 0.621 . . . . 0.0 111.208 -179.392 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 24.1 mt -82.04 134.2 27.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.155 -178.009 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 67.7 t -60.1 123.28 12.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 N-CA-C 105.879 -1.897 . . . . 0.0 105.879 174.435 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 6.3 tt -66.26 127.58 32.78 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.488 0.661 . . . . 0.0 110.28 -176.652 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 34.5 mt-30 -132.71 162.12 32.25 Favored 'General case' 0 CA--C 1.511 -0.527 0 N-CA-C 106.277 -1.749 . . . . 0.0 106.277 -178.703 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 17.2 mt -117.51 147.67 41.24 Favored Pre-proline 0 C--N 1.321 -0.633 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 178.174 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -73.75 173.37 14.07 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 120.662 0.908 . . . . 0.0 114.156 -177.5 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 56.5 tt0 -54.22 133.15 44.51 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.152 -179.698 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 88.25 -15.23 56.97 Favored Glycine 0 C--O 1.227 -0.295 0 CA-C-N 116.045 -0.525 . . . . 0.0 113.651 179.489 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.416 HG21 ' H ' ' A' ' 31' ' ' GLY . 12.6 m -108.6 126.1 52.58 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 117.886 0.843 . . . . 0.0 110.445 -179.437 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 9.3 p -123.46 148.33 46.3 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.995 -178.178 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 91.9 mt -66.49 153.41 93.13 Favored Pre-proline 0 C--N 1.326 -0.452 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 177.929 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -76.03 169.53 21.91 Favored 'Trans proline' 0 N--CA 1.461 -0.396 0 C-N-CA 118.154 -0.764 . . . . 0.0 111.074 -179.205 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 58.7 tttp -59.7 126.75 28.82 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 179.705 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 89.36 30.76 12.96 Favored Glycine 0 C--O 1.225 -0.42 0 N-CA-C 115.947 1.139 . . . . 0.0 115.947 178.802 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -140.57 149.15 42.03 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 117.811 0.806 . . . . 0.0 111.35 177.113 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 46.2 p90 -149.42 164.51 34.78 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 107.216 -1.402 . . . . 0.0 107.216 175.485 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -106.72 149.97 26.75 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.228 0.537 . . . . 0.0 110.926 -178.562 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.424 ' HB3' ' HB ' ' A' ' 14' ' ' THR . 0.9 OUTLIER -71.67 131.32 42.99 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 108.293 -1.002 . . . . 0.0 108.293 179.462 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 81.88 2.29 90.51 Favored Glycine 0 C--O 1.225 -0.455 0 C-N-CA 121.23 -0.51 . . . . 0.0 112.708 -179.379 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 6.9 t . . . . . 0 C--N 1.325 -0.483 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 179.383 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 0.227 0 CA-C-O 121.252 0.548 . . . . 0.0 109.549 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 42.1 t -59.22 142.29 52.16 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.57 177.641 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 14.9 m95 -64.85 -23.33 67.2 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 113.132 0.79 . . . . 0.0 113.132 178.761 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 43.3 m-85 -121.48 164.16 17.63 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 113.284 0.846 . . . . 0.0 113.284 -170.132 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 66.9 p -70.16 163.63 25.91 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 108.199 -1.038 . . . . 0.0 108.199 178.457 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -73.8 149.96 41.35 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.425 0.631 . . . . 0.0 111.569 -176.682 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.408 HD23 ' HA ' ' A' ' 16' ' ' LEU . 12.2 mt -89.86 137.82 32.01 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 102.859 -3.015 . . . . 0.0 102.859 168.66 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 49.4 m -113.82 126.72 55.52 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -77.57 136.4 38.28 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 178.624 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 32.3 t60 -139.23 94.87 2.85 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 104.786 -2.302 . . . . 0.0 104.786 170.604 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 152.26 -134.69 4.65 Favored Glycine 0 C--O 1.227 -0.293 0 C-N-CA 120.245 -0.979 . . . . 0.0 112.671 -175.742 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -126.73 -24.77 3.49 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 116.963 2.208 . . . . 0.0 116.963 -176.275 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -73.44 156.45 38.25 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 178.687 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -77.24 -58.31 3.35 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 178.396 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 62.4 tp 167.52 137.37 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.177 0 N-CA-C 104.772 -2.307 . . . . 0.0 104.772 173.945 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 22.9 tptm -157.64 142.53 16.68 Favored 'General case' 0 C--O 1.221 -0.44 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 176.11 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 27.9 m-85 -127.67 151.26 75.03 Favored Pre-proline 0 C--O 1.24 0.577 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 176.128 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -72.2 156.8 54.94 Favored 'Trans proline' 0 C--N 1.351 0.686 0 O-C-N 122.107 0.53 . . . . 0.0 111.996 176.901 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.67 134.34 52.06 Favored 'General case' 0 N--CA 1.472 0.637 0 O-C-N 121.986 -0.446 . . . . 0.0 110.487 -178.161 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 90.67 1.85 73.43 Favored Glycine 0 N--CA 1.46 0.295 0 N-CA-C 111.174 -0.77 . . . . 0.0 111.174 179.624 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 31.5 mt-30 -144.33 170.49 15.91 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 123.846 0.858 . . . . 0.0 108.902 -175.731 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 107.3 -17.42 37.26 Favored Glycine 0 CA--C 1.498 -0.981 0 CA-C-N 116.059 -0.518 . . . . 0.0 113.369 173.954 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.413 HG11 ' HB3' ' A' ' 43' ' ' GLN . 57.2 t -67.39 129.17 93.73 Favored Pre-proline 0 C--N 1.319 -0.722 0 N-CA-C 105.767 -1.938 . . . . 0.0 105.767 176.919 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -71.73 171.01 17.31 Favored 'Trans proline' 0 N--CA 1.459 -0.505 0 O-C-N 122.196 0.577 . . . . 0.0 111.2 178.146 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 95.0 mt -71.09 107.44 2.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 179.529 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.418 ' HB2' HE22 ' A' ' 43' ' ' GLN . 90.7 m-20 -93.11 84.33 4.83 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 114.175 -1.375 . . . . 0.0 109.354 -177.386 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 81.0 p -66.9 -15.06 63.41 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 114.003 1.112 . . . . 0.0 114.003 -177.101 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -111.39 17.28 20.29 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.282 -0.872 . . . . 0.0 112.846 -176.42 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -140.73 169.78 16.99 Favored 'General case' 0 CA--C 1.543 0.673 0 N-CA-C 115.891 1.812 . . . . 0.0 115.891 -171.855 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 35.4 m -94.41 161.35 29.48 Favored Pre-proline 0 C--O 1.218 -0.597 0 C-N-CA 124.343 1.057 . . . . 0.0 112.592 -174.919 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -65.24 -24.71 58.1 Favored 'Trans proline' 0 CA--C 1.535 0.557 0 C-N-CA 115.474 -2.551 . . . . 0.0 115.572 -178.249 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -75.16 -24.42 57.91 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 121.551 -0.718 . . . . 0.0 111.921 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 15.5 p30 -95.07 1.0 54.94 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 115.021 1.489 . . . . 0.0 115.021 -171.895 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.418 HE22 ' HB2' ' A' ' 35' ' ' ASN . 82.7 mm-40 -56.96 -24.09 50.44 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.591 -0.731 . . . . 0.0 112.8 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 11.3 tt -61.14 136.98 24.14 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.805 0 CA-C-O 122.533 1.158 . . . . 0.0 112.652 179.448 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 178.23 -156.35 19.11 Favored Glycine 0 N--CA 1.448 -0.527 0 N-CA-C 111.187 -0.765 . . . . 0.0 111.187 -178.165 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 45.3 p90 -155.15 172.11 18.69 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 179.278 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 14.3 m-85 -113.14 138.75 49.48 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 173.12 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 54.4 ttt-85 -108.12 124.69 50.62 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.549 -178.055 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 43.8 ttt180 -63.75 135.98 57.09 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 176.804 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -135.67 127.03 28.45 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.5 0.667 . . . . 0.0 111.928 -179.472 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 11.3 p -137.21 131.16 32.05 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 176.505 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 10.5 tpp180 -167.38 135.71 2.54 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 178.806 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 45.2 mtt180 -121.13 165.81 14.82 Favored 'General case' 0 CA--C 1.497 -1.071 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 177.277 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -134.79 173.97 13.68 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 N-CA-C 104.707 -2.331 . . . . 0.0 104.707 -179.844 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.31 109.03 7.5 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 175.421 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -77.73 159.64 48.09 Favored Glycine 0 C--O 1.228 -0.228 0 N-CA-C 107.263 -2.335 . . . . 0.0 107.263 176.353 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -58.12 -42.05 94.97 Favored Glycine 0 C--O 1.224 -0.527 0 CA-C-N 118.464 1.132 . . . . 0.0 112.082 -178.366 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.7 t0 -80.07 17.16 1.04 Allowed 'General case' 0 CA--C 1.548 0.881 0 CA-C-O 122.278 1.037 . . . . 0.0 112.658 -179.618 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 85.03 14.94 68.27 Favored Glycine 0 CA--C 1.504 -0.605 0 CA-C-N 115.417 -0.811 . . . . 0.0 113.179 171.314 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 33.3 mmtt -76.34 128.26 34.5 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.128 0.49 . . . . 0.0 110.374 -175.959 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 93.6 mmm -116.52 157.99 24.35 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 108.002 -1.111 . . . . 0.0 108.002 -178.905 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 14.0 tppt? -84.51 -43.46 14.54 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 106.638 -1.615 . . . . 0.0 106.638 176.274 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.5 t70 53.26 -145.53 0.59 Allowed 'General case' 0 C--O 1.241 0.623 0 CA-C-N 114.616 -1.174 . . . . 0.0 111.076 177.395 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.2 mm? 67.17 173.93 0.26 Allowed 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 116.062 1.875 . . . . 0.0 116.062 175.353 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -67.97 169.28 10.13 Favored Pre-proline 0 C--O 1.24 0.574 0 CA-C-N 113.962 -1.472 . . . . 0.0 113.91 -176.889 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -67.49 155.86 68.53 Favored 'Trans proline' 0 C--N 1.354 0.846 0 C-N-CA 116.107 -2.128 . . . . 0.0 112.659 177.88 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.31 160.1 21.65 Favored 'General case' 0 CA--C 1.505 -0.764 0 N-CA-C 105.377 -2.083 . . . . 0.0 105.377 178.051 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 53.1 m95 -131.47 146.53 52.29 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 178.855 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -126.75 142.32 51.58 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 179.343 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 81.3 t80 -88.79 136.88 32.77 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 108.59 -0.892 . . . . 0.0 108.59 -178.22 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -140.4 139.52 35.3 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 -176.939 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 75.2 m-85 -74.35 159.48 32.33 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.762 -0.653 . . . . 0.0 111.527 -175.735 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -55.91 131.12 46.27 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.194 0.521 . . . . 0.0 112.373 -178.131 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 75.5 26.8 64.71 Favored Glycine 0 C--O 1.218 -0.882 0 N-CA-C 115.842 1.097 . . . . 0.0 115.842 175.799 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 2.8 p . . . . . 0 C--N 1.323 -0.548 0 CA-C-N 118.606 1.203 . . . . 0.0 108.472 178.674 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 16.3 mt . . . . . 0 N--CA 1.445 -0.692 0 N-CA-C 114.768 1.395 . . . . 0.0 114.768 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -78.33 164.89 26.15 Favored 'Trans proline' 0 N--CA 1.461 -0.409 0 N-CA-C 107.97 -1.588 . . . . 0.0 107.97 169.32 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.429 ' CE1' ' HB3' ' A' ' 92' ' ' TRP . 66.7 t80 -61.25 133.08 55.53 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 120.353 -0.539 . . . . 0.0 110.148 -179.535 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 90.73 -7.03 81.87 Favored Glycine 0 CA--C 1.519 0.325 0 N-CA-C 114.797 0.679 . . . . 0.0 114.797 178.442 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -65.02 129.18 38.74 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 118.469 1.135 . . . . 0.0 111.546 179.597 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 60.0 t30 -76.62 127.54 32.99 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.694 -178.052 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 27.7 ttmt -156.14 152.14 27.56 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 106.686 -1.598 . . . . 0.0 106.686 179.687 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 17.6 t0 -63.79 129.48 40.27 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.14 0.495 . . . . 0.0 110.167 -178.18 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 70.18 26.69 73.9 Favored Glycine 0 N--CA 1.443 -0.835 0 CA-C-N 115.723 -0.671 . . . . 0.0 114.672 176.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 47.2 mm -125.41 123.52 65.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 178.59 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -126.88 115.43 41.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.514 -0.767 . . . . 0.0 110.163 176.853 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' TRP . . . . . 0.429 ' HB3' ' CE1' ' A' ' 83' ' ' TYR . 96.2 m95 -82.02 137.29 35.12 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 112.697 0.629 . . . . 0.0 112.697 -176.577 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 17.3 m -136.93 149.73 26.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 178.936 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -158.97 166.59 31.43 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 103.465 -2.791 . . . . 0.0 103.465 -178.621 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 6.6 t -134.76 -179.03 5.35 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 106.311 -1.737 . . . . 0.0 106.311 177.685 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -67.53 134.13 50.72 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.235 0.54 . . . . 0.0 110.688 -178.634 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 92.06 -10.05 75.21 Favored Glycine 0 C--O 1.229 -0.174 0 CA-C-N 115.915 -0.584 . . . . 0.0 113.662 177.765 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -70.83 134.9 47.73 Favored 'General case' 0 CA--C 1.544 0.728 0 O-C-N 122.523 -0.399 . . . . 0.0 111.247 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 29.3 mt -93.39 135.77 34.3 Favored 'General case' 0 CA--C 1.511 -0.552 0 N-CA-C 112.997 0.74 . . . . 0.0 112.997 -178.667 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 52.1 t30 -85.09 76.62 10.21 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.57 -178.772 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 1.2 t -146.42 155.66 49.67 Favored Pre-proline 0 C--N 1.322 -0.616 0 N-CA-C 105.607 -1.997 . . . . 0.0 105.607 179.47 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -69.01 149.96 72.24 Favored 'Trans proline' 0 CA--C 1.531 0.338 0 N-CA-C 113.729 0.627 . . . . 0.0 113.729 177.068 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 4.7 ptpt -152.8 56.67 0.79 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 122.78 1.276 . . . . 0.0 110.184 178.526 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -58.85 -31.31 68.4 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.08 -1.418 . . . . 0.0 112.586 -179.202 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 16.2 p80 -61.0 -9.09 3.78 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 114.589 1.329 . . . . 0.0 114.589 -177.763 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 50.4 mt -91.08 -37.92 9.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 178.194 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -75.48 14.64 5.21 Favored Glycine 0 CA--C 1.52 0.396 0 N-CA-C 115.428 0.931 . . . . 0.0 115.428 -177.073 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 11.6 t -95.61 24.24 5.43 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -177.658 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 62.5 ttp85 -59.37 130.91 49.24 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 177.853 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -101.98 135.42 19.69 Favored Pre-proline 0 C--N 1.323 -0.586 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 179.563 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -73.47 -18.33 22.95 Favored 'Trans proline' 0 C--O 1.219 -0.427 0 C-N-CA 118.387 -0.609 . . . . 0.0 113.017 -178.929 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -77.42 -25.05 50.36 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.894 0.378 . . . . 0.0 110.369 178.37 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 95.2 m-20 -101.1 -21.4 14.99 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 114.062 1.134 . . . . 0.0 114.062 -175.389 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 18.5 t-20 -158.26 151.99 23.63 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 -178.277 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -88.78 145.64 25.48 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-O 121.436 0.636 . . . . 0.0 111.711 178.895 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -70.18 147.51 49.76 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.18 0.514 . . . . 0.0 111.144 178.859 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 12.1 mt -88.61 138.29 19.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.095 -178.696 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 71.7 t -59.65 122.39 9.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 N-CA-C 106.908 -1.515 . . . . 0.0 106.908 175.148 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 6.4 tt -67.71 128.22 35.66 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.251 0.548 . . . . 0.0 109.695 -177.387 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -134.27 160.26 38.45 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 106.359 -1.719 . . . . 0.0 106.359 -179.273 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 13.6 mt -113.91 147.65 38.19 Favored Pre-proline 0 C--N 1.322 -0.629 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 177.197 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -72.7 164.93 34.18 Favored 'Trans proline' 0 C--O 1.236 0.396 0 O-C-N 122.26 0.611 . . . . 0.0 112.574 -179.338 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -55.42 131.48 46.0 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.289 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 101.98 -22.3 38.68 Favored Glycine 0 C--O 1.226 -0.35 0 CA-C-N 115.945 -0.571 . . . . 0.0 112.505 -178.839 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 9.5 m -108.58 130.79 55.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 117.992 0.896 . . . . 0.0 110.98 178.498 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 6.1 p -122.05 148.35 44.95 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.651 -179.492 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 84.5 mt -66.53 156.14 86.81 Favored Pre-proline 0 C--N 1.324 -0.515 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 178.246 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -74.22 173.99 13.23 Favored 'Trans proline' 0 C--O 1.238 0.486 0 N-CA-C 110.453 -0.634 . . . . 0.0 110.453 -179.767 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -62.73 123.46 18.48 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.643 0.735 . . . . 0.0 110.269 -176.413 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 85.95 45.9 5.54 Favored Glycine 0 N--CA 1.449 -0.491 0 N-CA-C 115.854 1.102 . . . . 0.0 115.854 179.021 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -145.6 149.18 34.06 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 117.534 0.667 . . . . 0.0 111.726 177.565 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 47.1 p90 -148.14 165.32 31.22 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 174.78 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -105.63 145.43 31.03 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.754 0.311 . . . . 0.0 110.186 -178.326 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -68.87 131.44 45.12 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 -179.455 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 86.73 -15.15 53.71 Favored Glycine 0 CA--C 1.521 0.455 0 CA-C-N 115.971 -0.558 . . . . 0.0 114.11 -177.807 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 32.9 t . . . . . 0 C--N 1.326 -0.44 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 179.749 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 -0.183 0 CA-C-O 121.7 0.762 . . . . 0.0 111.894 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.67 143.77 55.82 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 114.773 -1.103 . . . . 0.0 108.249 177.536 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' TRP . . . . . 0.467 ' CD2' ' HD3' ' A' ' 109' ' ' ARG . 16.2 m95 -68.45 -21.86 64.61 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 113.627 0.973 . . . . 0.0 113.627 179.417 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 25.4 m-85 -121.37 161.1 22.7 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 114.226 1.195 . . . . 0.0 114.226 -171.144 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.403 ' HB ' ' HB3' ' A' ' 134' ' ' GLU . 72.9 p -68.34 163.29 23.38 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 114.43 -1.259 . . . . 0.0 111.247 -178.566 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.545 ' HB2' ' CZ ' ' A' ' 69' ' ' TYR . . . -75.99 134.11 40.24 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 113.563 0.949 . . . . 0.0 113.563 -175.801 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.433 HD13 HD13 ' A' ' 119' ' ' LEU . 1.9 mp -84.8 146.67 27.23 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 105.388 -2.078 . . . . 0.0 105.388 170.286 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 69.8 m -126.24 131.03 52.02 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 -177.912 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.441 ' HB2' ' CZ ' ' A' ' 131' ' ' PHE . 4.1 tp60 -97.79 138.58 34.95 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.912 -0.586 . . . . 0.0 112.11 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 52.6 t60 -128.55 99.22 5.29 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 104.722 -2.325 . . . . 0.0 104.722 168.921 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 168.46 -166.18 39.38 Favored Glycine 0 N--CA 1.451 -0.334 0 N-CA-C 109.14 -1.584 . . . . 0.0 109.14 -176.293 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -103.45 -26.9 12.7 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 113.404 0.89 . . . . 0.0 113.404 -178.927 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -80.87 160.17 24.83 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 106.981 -1.488 . . . . 0.0 106.981 177.737 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -85.86 -62.9 1.42 Allowed 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 113.051 0.759 . . . . 0.0 113.051 -177.734 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 51.2 tp -177.79 142.79 0.31 Allowed 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 106.892 -1.522 . . . . 0.0 106.892 175.862 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.1 tmtp? -158.11 138.41 12.59 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 175.593 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 14.9 m-85 -121.87 153.36 60.38 Favored Pre-proline 0 C--O 1.239 0.534 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 176.205 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -70.48 158.76 55.06 Favored 'Trans proline' 0 C--N 1.351 0.67 0 O-C-N 121.957 0.451 . . . . 0.0 112.468 177.936 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 9.7 tpp85 -64.29 135.59 56.36 Favored 'General case' 0 C--O 1.217 -0.651 0 CA-C-N 116.572 -0.286 . . . . 0.0 111.251 -178.541 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 78.94 13.63 82.88 Favored Glycine 0 C--O 1.224 -0.487 0 C-N-CA 121.268 -0.491 . . . . 0.0 112.259 178.188 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 5.6 mt-30 -150.24 170.49 18.86 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 -175.541 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 106.96 -18.69 36.49 Favored Glycine 0 CA--C 1.503 -0.681 0 CA-C-N 116.278 -0.419 . . . . 0.0 113.16 175.115 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 99.1 t -65.6 128.4 93.78 Favored Pre-proline 0 C--N 1.321 -0.669 0 N-CA-C 106.962 -1.495 . . . . 0.0 106.962 177.655 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.415 ' HB3' HD21 ' A' ' 119' ' ' LEU . 84.2 Cg_endo -75.17 170.02 21.27 Favored 'Trans proline' 0 N--CA 1.461 -0.438 0 O-C-N 122.217 0.588 . . . . 0.0 111.84 179.296 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 91.2 mt -69.36 109.03 2.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 178.781 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 78.1 m-20 -99.25 85.69 3.25 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 114.506 -1.224 . . . . 0.0 109.924 -177.294 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 72.9 p -67.79 -15.1 63.47 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.524 0.678 . . . . 0.0 112.542 -178.955 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 11.6 p30 -108.17 19.61 19.71 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 114.977 -1.011 . . . . 0.0 113.287 -177.224 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 7.6 m -137.94 152.85 49.36 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 114.689 1.366 . . . . 0.0 114.689 -175.759 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 58.9 m -73.78 164.14 63.31 Favored Pre-proline 0 CA--C 1.537 0.476 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.65 177.341 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -66.21 -25.18 50.47 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 115.362 -2.625 . . . . 0.0 114.499 -178.475 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.443 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 6.4 p-10 -75.23 -26.45 58.92 Favored 'General case' 0 C--N 1.323 -0.569 0 O-C-N 121.616 -0.677 . . . . 0.0 110.579 177.152 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.547 ' HA ' ' HE3' ' A' ' 103' ' ' LYS . 32.6 m-20 -76.69 -8.11 56.62 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.485 1.114 . . . . 0.0 113.674 -175.801 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 95.0 mm-40 -59.64 -31.24 69.33 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 114.667 1.358 . . . . 0.0 114.667 -177.456 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.419 ' HB ' ' HB1' ' A' ' 98' ' ' ALA . 14.8 tt -60.17 140.04 18.78 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.81 0 CA-C-O 122.223 1.011 . . . . 0.0 112.567 -179.729 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 179.35 -155.36 15.69 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.494 -0.86 . . . . 0.0 111.678 -178.18 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 49.9 p90 -155.13 173.38 16.69 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 179.449 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 20.0 m-85 -113.33 140.39 48.05 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 106.927 -1.509 . . . . 0.0 106.927 173.381 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 66.7 ttt-85 -112.4 130.68 55.89 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.981 -177.535 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 29.2 ttt-85 -68.96 142.49 54.67 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 176.001 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -142.23 133.17 25.82 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.799 0.333 . . . . 0.0 110.109 177.957 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -156.74 131.8 9.06 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 177.072 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -129.1 123.98 33.62 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 108.253 -1.018 . . . . 0.0 108.253 174.079 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.55 137.24 54.82 Favored 'General case' 0 CA--C 1.488 -1.421 0 CA-C-O 121.493 0.663 . . . . 0.0 110.206 -177.44 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -127.49 176.91 6.48 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 N-CA-C 106.636 -1.616 . . . . 0.0 106.636 179.212 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 56.1 ttp180 -127.85 116.87 20.82 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 174.936 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -85.06 161.56 36.16 Favored Glycine 0 C--O 1.224 -0.474 0 N-CA-C 106.233 -2.747 . . . . 0.0 106.233 176.129 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -64.91 -35.93 92.49 Favored Glycine 0 C--O 1.216 -0.998 0 CA-C-N 118.671 1.235 . . . . 0.0 110.345 179.441 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 32.1 t0 -91.26 17.17 8.65 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-O 122.374 1.083 . . . . 0.0 110.62 178.793 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 84.16 -7.06 73.05 Favored Glycine 0 N--CA 1.46 0.27 0 N-CA-C 117.25 1.66 . . . . 0.0 117.25 172.579 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.56 150.53 31.33 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 122.586 1.184 . . . . 0.0 112.914 -177.883 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 73.1 mtp -119.95 -174.49 2.77 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 112.775 -2.011 . . . . 0.0 112.871 -174.535 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 25.4 mmtt -123.23 -72.99 0.66 Allowed 'General case' 0 C--O 1.219 -0.535 0 C-N-CA 122.917 0.487 . . . . 0.0 109.701 179.511 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -93.7 147.63 22.85 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 106.935 -1.506 . . . . 0.0 106.935 177.06 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -124.74 -63.57 1.17 Allowed 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 106.194 -1.78 . . . . 0.0 106.194 178.347 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -82.02 152.49 68.58 Favored Pre-proline 0 C--O 1.241 0.657 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 176.392 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -75.39 149.28 34.93 Favored 'Trans proline' 0 C--O 1.238 0.491 0 C-N-CA 115.632 -2.445 . . . . 0.0 112.701 179.068 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 94.8 mtt-85 -103.89 152.18 22.25 Favored 'General case' 0 CA--C 1.506 -0.745 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 177.206 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 71.7 m95 -132.44 137.67 47.35 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 175.313 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.545 ' CZ ' ' HB2' ' A' ' 15' ' ' ALA . 78.1 m-85 -127.63 147.39 50.36 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 -179.35 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 74.1 t80 -90.76 137.0 32.7 Favored 'General case' 0 CA--C 1.507 -0.68 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -139.25 140.3 37.65 Favored 'General case' 0 N--CA 1.439 -1.007 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 -175.501 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -79.87 159.51 26.4 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.428 -174.485 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -53.39 124.12 13.87 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.97 0.414 . . . . 0.0 111.608 -178.082 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 82.86 13.51 77.58 Favored Glycine 0 C--O 1.222 -0.595 0 N-CA-C 116.514 1.366 . . . . 0.0 116.514 178.012 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 23.7 p . . . . . 0 N--CA 1.47 0.561 0 CA-C-N 119.032 1.416 . . . . 0.0 111.224 179.733 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 15.9 mt . . . . . 0 N--CA 1.448 -0.535 0 N-CA-C 115.94 1.83 . . . . 0.0 115.94 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -77.8 161.66 30.25 Favored 'Trans proline' 0 N--CA 1.461 -0.384 0 N-CA-C 107.416 -1.802 . . . . 0.0 107.416 168.238 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 58.1 t80 -61.41 133.22 55.55 Favored 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 120.277 -0.569 . . . . 0.0 110.848 -177.289 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 90.99 -9.02 78.99 Favored Glycine 0 CA--C 1.519 0.31 0 CA-C-O 119.445 -0.642 . . . . 0.0 114.366 179.279 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -65.37 130.8 44.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 118.343 1.072 . . . . 0.0 111.154 179.461 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 58.4 t30 -79.01 130.17 35.24 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.389 -179.244 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 28.4 ttmt -156.14 152.0 27.39 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 107.675 -1.232 . . . . 0.0 107.675 179.358 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 38.2 t0 -62.58 129.79 42.16 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.883 0.373 . . . . 0.0 110.421 -179.117 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 69.57 27.52 73.32 Favored Glycine 0 N--CA 1.45 -0.404 0 CA-C-O 119.324 -0.709 . . . . 0.0 114.696 178.755 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 40.8 mm -127.5 128.82 70.2 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 CA-C-N 117.643 0.722 . . . . 0.0 110.918 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -132.81 117.15 29.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 CA-C-O 121.465 0.65 . . . . 0.0 111.352 177.049 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 97.4 m95 -81.52 138.26 35.48 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 114.063 1.134 . . . . 0.0 114.063 -176.444 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 16.3 m -139.32 151.15 22.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.626 -0.716 . . . . 0.0 109.153 178.835 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -158.8 166.54 31.7 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 105.87 -1.9 . . . . 0.0 105.87 -179.709 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 14.5 t -133.95 169.45 17.09 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 105.361 -2.088 . . . . 0.0 105.361 178.126 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -65.89 136.26 55.89 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.263 0.554 . . . . 0.0 109.954 -179.105 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 96.21 -12.17 66.89 Favored Glycine 0 C--O 1.229 -0.182 0 CA-C-N 115.768 -0.651 . . . . 0.0 113.044 178.795 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.443 ' HA ' ' HA ' ' A' ' 41' ' ' ASP . . . -76.66 139.95 40.75 Favored 'General case' 0 CA--C 1.542 0.635 0 O-C-N 122.458 -0.436 . . . . 0.0 110.22 179.109 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 39.7 mt -98.32 137.79 36.52 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 113.771 1.026 . . . . 0.0 113.771 -177.126 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 56.9 t30 -82.95 76.43 9.78 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.544 0.687 . . . . 0.0 110.299 179.388 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 1.2 t -146.26 160.69 41.75 Favored Pre-proline 0 C--N 1.321 -0.67 0 N-CA-C 102.218 -3.253 . . . . 0.0 102.218 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -72.59 148.91 48.39 Favored 'Trans proline' 0 CA--C 1.538 0.678 0 N-CA-C 114.172 0.797 . . . . 0.0 114.172 176.749 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.547 ' HE3' ' HA ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -143.91 54.88 1.31 Allowed 'General case' 0 N--CA 1.474 0.727 0 CA-C-O 123.406 1.574 . . . . 0.0 108.485 176.835 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 14.6 p-10 -64.56 -25.39 67.96 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 113.244 -1.798 . . . . 0.0 110.721 178.71 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 20.6 p-80 -56.33 -19.64 15.4 Favored 'General case' 0 C--O 1.221 -0.415 0 N-CA-C 114.205 1.187 . . . . 0.0 114.205 -179.026 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.421 HD11 ' CG ' ' A' ' 42' ' ' ASP . 20.5 mt -82.69 -28.15 8.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-O 121.371 0.605 . . . . 0.0 109.735 -179.243 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -77.28 5.13 52.32 Favored Glycine 0 CA--C 1.519 0.317 0 N-CA-C 115.84 1.096 . . . . 0.0 115.84 -175.934 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 12.0 t -83.17 11.18 6.81 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 117.323 0.562 . . . . 0.0 112.321 -178.356 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.467 ' HD3' ' CD2' ' A' ' 12' ' ' TRP . 63.5 ttp85 -58.38 130.16 45.42 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 178.945 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -97.63 128.91 32.85 Favored Pre-proline 0 C--N 1.326 -0.454 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 178.102 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -75.69 -13.08 20.13 Favored 'Trans proline' 0 C--O 1.219 -0.451 0 N-CA-C 113.197 0.422 . . . . 0.0 113.197 -178.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -81.12 -24.09 37.92 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.092 0.472 . . . . 0.0 109.888 178.392 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -101.01 -27.41 13.29 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 113.293 0.849 . . . . 0.0 113.293 -174.93 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' ASN . . . . . 0.446 ' OD1' ' HD2' ' A' ' 109' ' ' ARG . 0.4 OUTLIER -139.39 152.43 47.11 Favored 'General case' 0 N--CA 1.437 -1.108 0 CA-C-O 121.263 0.554 . . . . 0.0 111.263 -177.595 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -95.73 137.31 34.98 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 115.199 -0.909 . . . . 0.0 108.94 176.19 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -65.32 148.6 51.42 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.435 0.636 . . . . 0.0 111.966 -178.762 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 16.8 mt -83.24 136.69 22.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.127 -178.459 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 88.7 t -61.64 122.77 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 N-CA-C 106.376 -1.713 . . . . 0.0 106.376 175.287 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.433 HD13 HD13 ' A' ' 16' ' ' LEU . 7.3 tt -66.76 131.32 45.69 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.237 0.542 . . . . 0.0 110.718 -176.414 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -130.96 154.48 48.1 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 106.452 -1.684 . . . . 0.0 106.452 179.416 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 13.3 mt -110.85 149.02 39.79 Favored Pre-proline 0 C--N 1.322 -0.603 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 178.059 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -73.83 167.06 28.16 Favored 'Trans proline' 0 C--N 1.345 0.343 0 O-C-N 122.2 0.579 . . . . 0.0 112.856 -179.497 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 55.7 tt0 -55.07 132.0 46.27 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.672 -0.694 . . . . 0.0 109.402 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 98.75 -20.98 48.19 Favored Glycine 0 C--O 1.226 -0.374 0 CA-C-N 115.981 -0.554 . . . . 0.0 113.065 -179.487 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 7.0 m -108.0 129.29 55.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 118.127 0.964 . . . . 0.0 110.688 178.761 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 4.8 p -122.34 148.44 45.05 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.245 -179.432 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 87.6 mt -70.64 153.42 94.95 Favored Pre-proline 0 C--N 1.325 -0.488 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 176.919 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -75.63 169.07 23.08 Favored 'Trans proline' 0 N--CA 1.463 -0.307 0 C-N-CA 117.949 -0.901 . . . . 0.0 110.913 178.876 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 39.8 tptt -60.13 131.83 52.05 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.125 -176.865 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 95.12 -6.06 68.78 Favored Glycine 0 C--O 1.228 -0.265 0 N-CA-C 115.006 0.762 . . . . 0.0 115.006 178.894 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.441 ' CZ ' ' HB2' ' A' ' 18' ' ' GLN . 1.3 m-85 -102.61 143.92 31.67 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-O 122.177 0.989 . . . . 0.0 111.752 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 45.2 p90 -146.45 165.61 28.87 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 113.6 -1.636 . . . . 0.0 107.342 173.933 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -108.56 148.07 30.85 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.949 0.405 . . . . 0.0 110.556 -178.838 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.403 ' HB3' ' HB ' ' A' ' 14' ' ' THR . 6.4 tp10 -70.43 136.51 49.6 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 178.769 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 81.22 -0.24 87.88 Favored Glycine 0 CA--C 1.52 0.385 0 C-N-CA 121.356 -0.449 . . . . 0.0 112.322 -176.849 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 4.3 t . . . . . 0 C--N 1.327 -0.407 0 CA-C-O 121.253 0.549 . . . . 0.0 110.22 179.998 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.177 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 29.1 p -66.36 144.69 56.39 Favored 'General case' 0 CA--C 1.508 -0.661 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 177.906 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 12.1 m95 -69.65 -21.9 63.5 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 120.859 0.361 . . . . 0.0 111.695 178.439 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -121.4 164.1 17.64 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -173.315 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 67.2 p -70.35 168.99 14.81 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.45 -1.25 . . . . 0.0 108.476 178.392 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.588 ' HB2' ' CZ ' ' A' ' 69' ' ' TYR . . . -73.87 156.7 37.44 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 122.309 1.052 . . . . 0.0 113.523 -176.306 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 11.5 mt -101.42 137.78 39.3 Favored 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 101.81 -3.404 . . . . 0.0 101.81 166.359 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 34.3 m -115.88 136.45 53.04 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 -177.647 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.454 ' HB2' ' CZ ' ' A' ' 131' ' ' PHE . 4.2 tp60 -114.0 137.58 51.51 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 113.959 1.096 . . . . 0.0 113.959 -176.091 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -131.78 99.37 4.75 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 104.644 -2.354 . . . . 0.0 104.644 169.48 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 174.78 -168.35 40.95 Favored Glycine 0 C--O 1.225 -0.467 0 N-CA-C 110.562 -1.015 . . . . 0.0 110.562 -177.014 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -102.11 -25.18 13.82 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 112.832 0.678 . . . . 0.0 112.832 -179.177 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -82.86 158.23 22.8 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.316 -0.402 . . . . 0.0 109.999 -179.356 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -74.59 -62.93 1.36 Allowed 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.307 -178.462 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 28.6 tp 173.71 144.55 0.05 OUTLIER 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 103.333 -2.84 . . . . 0.0 103.333 177.338 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 11.0 tmtt? -155.45 134.26 12.02 Favored 'General case' 0 C--O 1.221 -0.442 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 176.95 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 9.6 m-85 -122.13 155.74 60.92 Favored Pre-proline 0 C--O 1.243 0.739 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 177.061 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -72.72 168.24 25.06 Favored 'Trans proline' 0 C--N 1.352 0.745 0 N-CA-C 113.409 0.503 . . . . 0.0 113.409 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 20.8 tpt180 -72.8 135.78 45.3 Favored 'General case' 0 C--O 1.215 -0.725 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 -178.244 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 83.86 7.32 85.86 Favored Glycine 0 C--O 1.223 -0.576 0 C-N-CA 121.236 -0.507 . . . . 0.0 112.893 177.527 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -150.19 168.42 24.04 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 -177.64 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 131.15 -30.29 3.35 Favored Glycine 0 CA--C 1.483 -1.927 0 N-CA-C 109.188 -1.565 . . . . 0.0 109.188 166.317 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 33.9 m -65.67 141.2 97.72 Favored Pre-proline 0 N--CA 1.433 -1.279 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 177.288 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_endo -74.01 176.48 9.45 Favored 'Trans proline' 0 N--CA 1.456 -0.691 0 C-N-CA 121.745 1.63 . . . . 0.0 110.821 178.854 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 91.3 mt -73.09 114.99 13.33 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 178.038 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 29.5 m-80 -109.14 82.86 1.66 Allowed 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 -179.412 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 60.9 p -67.28 -21.99 65.67 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 113.018 0.747 . . . . 0.0 113.018 -176.776 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 69.1 m-80 -106.1 35.74 2.82 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.054 -176.633 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 17.4 m -145.51 152.48 39.82 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 -179.217 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 4.6 m -73.08 164.79 58.33 Favored Pre-proline 0 C--N 1.324 -0.513 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 178.017 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -64.59 -26.24 61.75 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 114.748 -3.035 . . . . 0.0 111.14 177.624 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -62.18 -27.47 68.99 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 123.862 0.865 . . . . 0.0 111.573 175.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 77.3 m-20 -96.44 -4.9 40.86 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 115.225 1.565 . . . . 0.0 115.225 -171.418 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 90.6 mm-40 -59.6 -28.41 67.15 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 113.599 0.962 . . . . 0.0 113.599 -177.574 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 13.8 tt -57.45 141.52 14.34 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 N-CA-C 114.46 1.281 . . . . 0.0 114.46 -178.195 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -179.53 -153.47 11.87 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.071 179.318 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 49.5 p90 -155.03 169.51 23.94 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 177.998 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 19.3 m-85 -111.63 143.01 43.22 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 173.244 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 17.4 ttt180 -116.18 125.88 52.9 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.698 -178.727 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 18.2 ttp85 -68.67 135.93 52.15 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 107.956 -1.128 . . . . 0.0 107.956 176.56 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -127.52 125.32 40.19 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.401 0.619 . . . . 0.0 109.719 179.552 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -146.19 117.55 7.94 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.142 -0.935 . . . . 0.0 108.954 179.406 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 6.7 tpp85 -147.78 127.57 13.46 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 178.889 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 29.1 mtt85 -130.89 165.92 22.03 Favored 'General case' 0 CA--C 1.495 -1.153 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 177.39 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -141.06 179.4 2.34 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 -177.553 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 19.1 ttm180 -115.05 104.96 12.4 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 106.182 -1.785 . . . . 0.0 106.182 174.194 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -84.18 143.25 21.04 Favored Glycine 0 C--O 1.226 -0.392 0 N-CA-C 107.275 -2.33 . . . . 0.0 107.275 178.041 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -64.7 -38.5 95.71 Favored Glycine 0 C--O 1.219 -0.83 0 CA-C-N 118.404 1.102 . . . . 0.0 112.339 -177.684 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -85.76 11.58 10.77 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.7 0.762 . . . . 0.0 112.083 -179.61 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 84.7 20.33 58.34 Favored Glycine 0 C--O 1.226 -0.399 0 CA-C-N 115.235 -0.893 . . . . 0.0 112.467 176.657 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 21.6 mmtt -88.21 130.85 34.96 Favored 'General case' 0 C--N 1.324 -0.542 0 O-C-N 122.21 -0.582 . . . . 0.0 110.872 -175.848 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 86.8 mmm -100.98 159.9 14.82 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.156 -0.929 . . . . 0.0 109.128 -178.954 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 16.5 tppt? -83.22 -48.68 10.22 Favored 'General case' 0 C--O 1.219 -0.526 0 N-CA-C 108.401 -0.962 . . . . 0.0 108.401 177.526 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 21.3 t0 -162.82 163.53 26.53 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 105.327 -2.101 . . . . 0.0 105.327 177.829 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -117.28 -34.24 4.39 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 177.38 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 20.9 m -85.33 148.53 50.01 Favored Pre-proline 0 C--N 1.326 -0.425 0 N-CA-C 113.753 1.02 . . . . 0.0 113.753 -176.058 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -77.59 145.57 23.42 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 117.97 -0.887 . . . . 0.0 112.187 174.769 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 47.8 mtt180 -119.1 165.09 14.59 Favored 'General case' 0 CA--C 1.508 -0.656 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.864 179.049 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 64.9 m95 -134.25 144.32 48.32 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 106.588 -1.634 . . . . 0.0 106.588 172.689 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.588 ' CZ ' ' HB2' ' A' ' 15' ' ' ALA . 71.5 m-85 -130.16 148.51 52.01 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 178.144 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 76.1 t80 -92.59 134.73 34.71 Favored 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 -177.748 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -137.11 140.19 41.75 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 -176.493 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -77.87 159.51 28.88 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.167 -177.194 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -53.33 138.94 31.45 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 -179.233 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 70.51 38.27 69.03 Favored Glycine 0 C--O 1.225 -0.454 0 N-CA-C 115.726 1.05 . . . . 0.0 115.726 175.22 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 12.7 p . . . . . 0 C--N 1.325 -0.483 0 CA-C-N 117.804 0.802 . . . . 0.0 111.238 178.832 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 47.2 mt . . . . . 0 C--O 1.239 0.528 0 N-CA-C 114.892 1.442 . . . . 0.0 114.892 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -77.87 167.68 23.38 Favored 'Trans proline' 0 C--O 1.237 0.451 0 N-CA-C 108.725 -1.298 . . . . 0.0 108.725 170.846 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 62.8 t80 -62.42 131.46 49.3 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 179.161 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 92.97 -5.94 76.21 Favored Glycine 0 CA--C 1.52 0.344 0 N-CA-C 114.967 0.747 . . . . 0.0 114.967 178.577 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -64.49 129.18 38.88 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 118.296 1.048 . . . . 0.0 112.085 179.688 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 43.3 t-20 -75.24 126.6 31.35 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.912 -177.406 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 9.9 ttmm -156.18 150.85 25.93 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 177.92 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -63.58 134.05 54.82 Favored 'General case' 0 C--N 1.324 -0.529 0 O-C-N 123.176 0.298 . . . . 0.0 110.526 179.416 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 68.51 26.9 74.11 Favored Glycine 0 N--CA 1.45 -0.387 0 CA-C-O 119.496 -0.613 . . . . 0.0 114.081 177.621 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 34.0 mm -130.18 130.81 65.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 117.417 0.608 . . . . 0.0 109.831 179.277 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.1 pt -132.5 113.49 21.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 CA-C-O 121.5 0.667 . . . . 0.0 110.815 175.623 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 95.1 m95 -80.98 131.85 35.35 Favored 'General case' 0 C--N 1.321 -0.662 0 O-C-N 121.893 -0.505 . . . . 0.0 111.492 -177.845 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 2.8 m -139.96 150.86 21.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.819 -177.269 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -156.71 166.57 33.02 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 106.071 -1.826 . . . . 0.0 106.071 -178.553 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 14.8 t -125.9 167.48 15.2 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 105.072 -2.195 . . . . 0.0 105.072 176.85 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -66.45 136.6 55.94 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 -179.491 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 96.09 -10.87 67.81 Favored Glycine 0 C--O 1.225 -0.432 0 CA-C-N 115.966 -0.561 . . . . 0.0 113.114 178.863 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -78.44 141.43 38.28 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 122.308 -0.525 . . . . 0.0 110.744 179.378 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 33.9 mt -91.79 135.64 33.76 Favored 'General case' 0 CA--C 1.51 -0.57 0 CA-C-O 121.429 0.633 . . . . 0.0 112.561 -178.577 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 58.5 t30 -82.32 70.05 9.19 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.601 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 2.0 t -142.48 157.55 62.3 Favored Pre-proline 0 CA--C 1.54 0.578 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 -178.822 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_exo -61.86 149.21 91.04 Favored 'Trans proline' 0 C--N 1.348 0.539 0 N-CA-C 114.407 0.887 . . . . 0.0 114.407 -179.779 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.478 ' HB3' HD12 ' A' ' 106' ' ' ILE . 74.7 mmtt -124.79 41.13 3.58 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 122.017 0.913 . . . . 0.0 108.73 -178.579 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 16.7 p-10 -50.36 -46.55 55.91 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 114.583 -1.189 . . . . 0.0 112.855 -178.531 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 48.2 p-80 -69.78 -9.15 53.51 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 113.577 0.955 . . . . 0.0 113.577 -177.674 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.478 HD12 ' HB3' ' A' ' 103' ' ' LYS . 40.8 mt -95.31 -40.13 10.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 178.972 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -72.14 1.31 34.11 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 115.804 1.081 . . . . 0.0 115.804 -178.149 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 6.2 t -83.03 19.22 1.45 Allowed 'General case' 0 CA--C 1.549 0.934 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 -178.261 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 66.5 ttp85 -59.24 130.67 48.06 Favored 'General case' 0 N--CA 1.47 0.55 0 O-C-N 121.101 -1.0 . . . . 0.0 109.142 179.478 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -103.88 127.03 30.23 Favored Pre-proline 0 C--N 1.323 -0.567 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 178.976 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -72.7 -14.76 27.18 Favored 'Trans proline' 0 C--O 1.22 -0.411 0 C-N-CA 118.098 -0.801 . . . . 0.0 113.234 -178.171 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -74.32 -27.09 60.54 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.919 0.39 . . . . 0.0 110.497 178.201 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 79.7 m-20 -104.27 -23.05 13.27 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 113.908 1.077 . . . . 0.0 113.908 -174.109 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 19.0 t-20 -148.37 151.91 36.12 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -177.325 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -91.52 148.83 22.01 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-O 121.384 0.611 . . . . 0.0 111.943 179.438 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -74.65 150.12 39.71 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.441 178.114 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 6.9 mt -92.22 140.34 16.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 -178.67 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 95.2 t -61.49 124.78 16.58 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 N-CA-C 107.162 -1.422 . . . . 0.0 107.162 175.944 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 5.3 tt -67.4 129.15 39.0 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.137 0.494 . . . . 0.0 111.108 -176.962 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 29.2 mt-30 -133.01 154.51 50.45 Favored 'General case' 0 C--O 1.219 -0.531 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 -179.484 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 12.8 mt -110.9 147.92 37.53 Favored Pre-proline 0 C--N 1.322 -0.622 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 177.763 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -73.33 166.84 28.84 Favored 'Trans proline' 0 C--N 1.346 0.444 0 O-C-N 122.197 0.577 . . . . 0.0 113.196 179.559 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 39.3 tt0 -54.08 133.03 43.83 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.779 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 97.02 -20.55 50.41 Favored Glycine 0 C--O 1.227 -0.337 0 CA-C-N 115.941 -0.572 . . . . 0.0 112.93 -179.477 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 1.5 m -104.95 127.38 52.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 117.916 0.858 . . . . 0.0 110.569 178.779 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 6.9 p -122.79 148.29 45.54 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.739 -179.674 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 85.2 mt -71.86 150.52 92.95 Favored Pre-proline 0 C--N 1.324 -0.538 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 179.181 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -78.74 179.79 6.16 Favored 'Trans proline' 0 C--O 1.236 0.387 0 O-C-N 121.99 0.468 . . . . 0.0 111.341 178.711 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 8.1 tmtt? -57.11 126.93 29.42 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 -175.306 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 89.56 -0.03 79.83 Favored Glycine 0 CA--C 1.51 -0.26 0 N-CA-C 116.233 1.253 . . . . 0.0 116.233 173.533 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.454 ' CZ ' ' HB2' ' A' ' 18' ' ' GLN . 4.0 m-85 -99.53 137.9 37.38 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-O 121.881 0.848 . . . . 0.0 111.762 -179.113 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 40.0 p90 -145.43 161.75 38.95 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 114.166 -1.379 . . . . 0.0 107.741 174.879 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -99.68 142.86 30.6 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.573 0.701 . . . . 0.0 112.468 -175.841 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -70.4 129.77 40.17 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 107.367 -1.345 . . . . 0.0 107.367 178.69 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 95.21 -21.51 43.75 Favored Glycine 0 C--O 1.227 -0.331 0 CA-C-N 116.15 -0.477 . . . . 0.0 112.761 -178.698 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 20.0 t . . . . . 0 C--N 1.326 -0.422 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 179.181 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.642 0 CA-C-O 121.592 0.71 . . . . 0.0 110.403 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 37.2 p -62.94 142.29 58.39 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 114.994 -1.003 . . . . 0.0 108.883 177.108 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' TRP . . . . . 0.43 ' CD2' ' HD3' ' A' ' 109' ' ' ARG . 7.4 m95 -66.23 -21.87 66.31 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 177.754 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -121.41 161.51 22.04 Favored 'General case' 0 CA--C 1.509 -0.619 0 N-CA-C 113.944 1.09 . . . . 0.0 113.944 -172.102 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 77.4 p -72.55 172.69 10.08 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 113.692 -1.594 . . . . 0.0 109.136 177.863 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.591 ' HB2' ' CZ ' ' A' ' 69' ' ' TYR . . . -77.67 142.6 38.73 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 -176.598 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.405 HD23 ' HA ' ' A' ' 16' ' ' LEU . 11.8 mt -90.48 133.59 34.94 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 102.299 -3.223 . . . . 0.0 102.299 167.882 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 64.5 m -118.37 138.59 52.32 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 118.143 0.429 . . . . 0.0 110.264 -176.103 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.429 ' HB2' ' CZ ' ' A' ' 131' ' ' PHE . 4.0 tp60 -105.84 139.89 39.72 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 113.596 0.962 . . . . 0.0 113.596 -177.823 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 59.7 t60 -128.74 99.71 5.44 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 104.476 -2.416 . . . . 0.0 104.476 168.241 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 160.78 -162.38 33.47 Favored Glycine 0 C--O 1.226 -0.375 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 -176.333 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 54.0 mttp -110.04 -15.79 13.96 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 113.508 0.929 . . . . 0.0 113.508 -179.632 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -74.05 153.52 39.62 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 179.395 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 63.0 m-20 -79.82 -62.85 1.56 Allowed 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 120.566 0.222 . . . . 0.0 110.975 -178.133 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 48.3 tp 165.69 137.38 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 102.763 -3.051 . . . . 0.0 102.763 177.418 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -155.43 135.78 13.19 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 177.007 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -124.47 157.84 63.7 Favored Pre-proline 0 C--N 1.322 -0.599 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 177.467 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -69.33 174.39 9.21 Favored 'Trans proline' 0 CA--C 1.539 0.762 0 C-N-CA 121.704 1.602 . . . . 0.0 114.933 -178.695 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 17.3 tpt180 -78.25 129.54 35.19 Favored 'General case' 0 C--O 1.216 -0.681 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 178.367 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 75.42 12.29 83.73 Favored Glycine 0 C--O 1.225 -0.411 0 N-CA-C 114.99 0.756 . . . . 0.0 114.99 175.855 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -157.29 145.16 19.04 Favored 'General case' 0 C--O 1.219 -0.523 0 N-CA-C 106.378 -1.712 . . . . 0.0 106.378 -178.489 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 138.66 -14.39 3.4 Favored Glycine 0 CA--C 1.506 -0.504 0 C-N-CA 120.038 -1.077 . . . . 0.0 113.707 177.42 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 30.8 m -72.56 145.31 87.31 Favored Pre-proline 0 C--N 1.319 -0.729 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 177.044 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -75.69 166.28 28.66 Favored 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 122.104 1.869 . . . . 0.0 113.775 179.386 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 97.6 mt -73.3 124.84 31.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.34 -0.846 . . . . 0.0 110.568 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 16.3 t-20 -125.41 122.76 37.65 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.861 0.362 . . . . 0.0 110.921 174.64 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 72.7 p -91.04 -15.91 28.77 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 113.837 1.051 . . . . 0.0 113.837 -177.195 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 11.8 p30 -112.96 25.37 11.47 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.637 -0.711 . . . . 0.0 112.385 -176.915 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 68.3 m -136.36 153.34 51.15 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 178.898 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 2.9 m -68.62 162.9 59.24 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.527 -178.787 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -66.47 -28.61 45.77 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 114.493 -3.204 . . . . 0.0 113.638 179.785 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.53 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 5.1 p-10 -75.23 -23.08 57.5 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 121.621 -0.674 . . . . 0.0 111.608 177.151 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.482 ' HA ' ' HE3' ' A' ' 103' ' ' LYS . 18.8 m-20 -73.25 -13.15 61.08 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.712 0.805 . . . . 0.0 112.901 -176.406 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 93.1 mm-40 -62.44 -24.53 67.47 Favored 'General case' 0 C--O 1.219 -0.547 0 N-CA-C 114.492 1.293 . . . . 0.0 114.492 -177.092 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.567 ' HB ' ' HB1' ' A' ' 98' ' ' ALA . 12.9 tt -57.16 140.15 15.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 CA-C-O 122.303 1.049 . . . . 0.0 112.952 179.473 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 178.35 -151.78 10.89 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.122 -1.037 . . . . 0.0 113.14 -179.116 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 48.7 p90 -154.71 168.71 25.91 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 179.074 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -108.67 138.4 45.04 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 173.151 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.96 126.01 51.68 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 123.821 0.849 . . . . 0.0 108.758 -179.379 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 34.1 ttt180 -70.78 144.16 50.94 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 122.339 0.256 . . . . 0.0 111.404 177.937 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -149.16 160.22 43.55 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.709 0.766 . . . . 0.0 111.679 178.746 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 8.4 t -169.13 176.28 5.35 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 102.09 -3.3 . . . . 0.0 102.09 174.485 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 12.9 tpt180 -128.41 123.86 34.85 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 177.665 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 3.3 tmt_? -134.95 142.22 46.45 Favored 'General case' 0 CA--C 1.5 -0.974 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 -177.505 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -141.88 179.75 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 -177.605 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 24.9 tpt85 -134.96 104.52 5.99 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 105.669 -1.975 . . . . 0.0 105.669 171.97 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -77.54 152.54 39.5 Favored Glycine 0 N--CA 1.45 -0.385 0 N-CA-C 105.078 -3.209 . . . . 0.0 105.078 176.258 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -59.76 -38.21 93.57 Favored Glycine 0 C--O 1.222 -0.617 0 CA-C-N 118.9 1.35 . . . . 0.0 112.147 -178.357 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 37.5 t0 -81.83 15.73 2.11 Favored 'General case' 0 CA--C 1.551 0.993 0 CA-C-O 122.345 1.069 . . . . 0.0 112.057 -179.557 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 85.13 15.46 66.95 Favored Glycine 0 C--O 1.222 -0.64 0 CA-C-N 115.664 -0.698 . . . . 0.0 113.294 171.814 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 21.1 mmtt -82.34 140.55 33.47 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.399 0.619 . . . . 0.0 109.855 -175.384 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 61.7 mtp -125.51 -178.37 4.22 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 114.418 -1.265 . . . . 0.0 110.451 -176.297 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 34.6 mmtt -136.88 -57.95 0.72 Allowed 'General case' 0 CA--C 1.504 -0.817 0 CA-C-O 121.33 0.586 . . . . 0.0 109.441 -177.867 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 34.47 64.04 0.41 Allowed 'General case' 0 C--N 1.322 -0.63 0 O-C-N 126.172 2.17 . . . . 0.0 112.897 173.528 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 75.9 mt -61.74 159.33 13.77 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 113.669 -1.605 . . . . 0.0 112.258 -176.376 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 54.1 p -55.61 142.77 60.96 Favored Pre-proline 0 C--O 1.252 1.187 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.368 179.327 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -66.46 142.06 63.9 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 116.7 -1.733 . . . . 0.0 112.554 -176.464 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.445 ' HB2' ' HB1' ' A' ' 15' ' ' ALA . 6.9 ptp180 -139.26 162.81 34.09 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 114.477 -1.238 . . . . 0.0 108.198 -179.739 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 53.1 m95 -132.65 148.92 52.36 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 -177.663 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.591 ' CZ ' ' HB2' ' A' ' 15' ' ' ALA . 45.1 m-85 -125.09 150.46 46.81 Favored 'General case' 0 C--O 1.215 -0.763 0 N-CA-C 106.17 -1.789 . . . . 0.0 106.17 179.433 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 86.3 t80 -97.06 139.01 33.71 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 118.818 0.735 . . . . 0.0 109.756 -175.808 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -140.99 152.28 44.8 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 -175.171 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 65.9 m-85 -85.53 159.47 19.9 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -175.045 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -54.2 126.61 23.62 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.127 178.993 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 72.92 30.79 62.92 Favored Glycine 0 C--O 1.22 -0.737 0 N-CA-C 116.105 1.202 . . . . 0.0 116.105 177.226 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.2 p . . . . . 0 C--N 1.327 -0.374 0 CA-C-N 119.133 1.467 . . . . 0.0 108.154 178.922 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 15.0 mt . . . . . 0 N--CA 1.446 -0.662 0 N-CA-C 115.401 1.63 . . . . 0.0 115.401 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -79.48 163.99 24.06 Favored 'Trans proline' 0 N--CA 1.46 -0.47 0 C-N-CA 122.421 2.08 . . . . 0.0 107.846 167.938 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 48.6 t80 -61.51 131.01 48.75 Favored 'General case' 0 C--N 1.319 -0.733 0 C-N-CA 120.467 -0.493 . . . . 0.0 110.214 -178.614 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 92.89 -7.65 76.7 Favored Glycine 0 CA--C 1.52 0.368 0 CA-C-O 119.349 -0.695 . . . . 0.0 114.778 178.93 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -66.88 130.59 43.65 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 118.58 1.19 . . . . 0.0 111.655 179.446 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 56.4 t30 -76.44 129.7 36.92 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.606 -179.328 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 22.0 ttmt -156.07 153.13 28.91 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 179.304 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 35.0 t0 -60.2 125.23 22.88 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.312 0.577 . . . . 0.0 111.48 -178.866 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 69.66 30.92 70.49 Favored Glycine 0 N--CA 1.449 -0.472 0 CA-C-O 118.908 -0.94 . . . . 0.0 114.484 177.57 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 42.8 mm -126.0 129.86 72.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 117.844 0.822 . . . . 0.0 111.445 179.755 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -130.82 117.88 39.9 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.662 175.25 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 96.4 m95 -82.99 136.68 34.43 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 113.81 1.041 . . . . 0.0 113.81 -176.665 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -144.77 155.37 14.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.611 -179.121 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -155.81 166.6 33.01 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 104.729 -2.323 . . . . 0.0 104.729 -178.896 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 15.1 t -116.28 170.04 8.83 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 104.892 -2.262 . . . . 0.0 104.892 173.711 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -66.13 135.1 54.1 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 178.839 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 91.3 -7.52 80.34 Favored Glycine 0 CA--C 1.517 0.188 0 CA-C-N 116.143 -0.481 . . . . 0.0 113.169 179.48 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.567 ' HB1' ' HB ' ' A' ' 44' ' ' ILE . . . -72.16 134.34 45.66 Favored 'General case' 0 CA--C 1.539 0.542 0 O-C-N 122.322 -0.516 . . . . 0.0 110.337 178.81 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 31.8 mt -85.96 138.19 32.18 Favored 'General case' 0 CA--C 1.511 -0.532 0 CA-C-O 121.48 0.657 . . . . 0.0 112.591 -177.163 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 60.0 t30 -85.43 69.73 10.72 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.277 -179.542 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -145.1 158.52 51.83 Favored Pre-proline 0 C--N 1.321 -0.657 0 N-CA-C 104.237 -2.505 . . . . 0.0 104.237 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -73.08 149.9 47.25 Favored 'Trans proline' 0 CA--C 1.534 0.515 0 N-CA-C 113.938 0.707 . . . . 0.0 113.938 177.921 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.482 ' HE3' ' HA ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -146.83 56.84 1.15 Allowed 'General case' 0 N--CA 1.477 0.883 0 CA-C-O 122.702 1.239 . . . . 0.0 109.205 176.444 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -65.14 -21.38 66.78 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.291 -1.322 . . . . 0.0 111.519 179.382 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 19.0 p80 -56.83 -19.67 18.61 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 114.307 1.225 . . . . 0.0 114.307 -179.13 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 11.7 mt -83.58 -27.91 7.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 121.698 0.761 . . . . 0.0 109.017 -179.413 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -78.2 14.66 10.72 Favored Glycine 0 C--O 1.219 -0.798 0 CA-C-N 115.715 -0.675 . . . . 0.0 114.416 -176.975 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 7.8 t -83.05 15.42 2.81 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-O 122.079 0.942 . . . . 0.0 110.467 -179.652 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.43 ' HD3' ' CD2' ' A' ' 12' ' ' TRP . 57.8 ttp85 -63.46 131.3 47.72 Favored 'General case' 0 C--N 1.327 -0.41 0 O-C-N 121.851 -0.531 . . . . 0.0 110.212 -179.512 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 66.4 m-20 -106.65 120.18 49.19 Favored Pre-proline 0 C--N 1.327 -0.404 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 179.289 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -70.71 -13.92 32.67 Favored 'Trans proline' 0 C--N 1.347 0.489 0 N-CA-C 113.808 0.657 . . . . 0.0 113.808 -176.631 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -72.61 -26.04 61.54 Favored 'General case' 0 C--O 1.22 -0.46 0 CA-C-O 120.717 0.294 . . . . 0.0 110.825 177.09 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 -104.05 -24.82 13.17 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 114.273 1.212 . . . . 0.0 114.273 -174.196 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' ASN . . . . . 0.404 ' OD1' ' HD2' ' A' ' 109' ' ' ARG . 0.1 OUTLIER -143.26 154.98 44.37 Favored 'General case' 0 N--CA 1.434 -1.238 0 CA-C-O 121.284 0.564 . . . . 0.0 110.308 -176.211 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -94.99 144.1 25.95 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.462 178.71 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -70.3 148.23 48.74 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.197 0.522 . . . . 0.0 110.958 179.501 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 15.0 mt -84.45 136.98 21.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 -178.815 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -62.67 125.92 20.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 106.776 -1.564 . . . . 0.0 106.776 175.628 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 4.2 tt -66.08 128.39 35.89 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.163 0.506 . . . . 0.0 111.005 -177.398 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -132.03 156.86 45.52 Favored 'General case' 0 CA--C 1.509 -0.612 0 N-CA-C 106.946 -1.502 . . . . 0.0 106.946 -179.58 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.4 HD13 HG22 ' A' ' 125' ' ' THR . 14.3 mt -115.3 147.49 38.71 Favored Pre-proline 0 C--N 1.32 -0.679 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 179.688 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -73.29 169.38 22.42 Favored 'Trans proline' 0 C--N 1.346 0.421 0 O-C-N 122.361 0.664 . . . . 0.0 113.754 -178.579 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 39.7 tt0 -53.6 131.85 39.49 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.426 -0.806 . . . . 0.0 109.899 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 94.26 -18.05 57.67 Favored Glycine 0 C--O 1.228 -0.248 0 CA-C-N 115.904 -0.589 . . . . 0.0 113.395 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.4 HG22 HD13 ' A' ' 121' ' ' LEU . 3.3 m -104.66 126.77 52.06 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 118.108 0.954 . . . . 0.0 111.261 178.979 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 5.5 p -119.87 148.27 43.68 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.964 -179.348 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 88.7 mt -69.86 152.8 95.9 Favored Pre-proline 0 C--N 1.324 -0.535 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 178.204 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -76.58 175.37 11.45 Favored 'Trans proline' 0 N--CA 1.462 -0.375 0 C-N-CA 118.524 -0.517 . . . . 0.0 111.077 178.805 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 62.6 tttm -56.9 126.62 27.89 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 113.431 0.9 . . . . 0.0 113.431 -174.552 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 89.56 -6.42 83.17 Favored Glycine 0 CA--C 1.517 0.197 0 N-CA-C 116.106 1.202 . . . . 0.0 116.106 175.945 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.429 ' CZ ' ' HB2' ' A' ' 18' ' ' GLN . 2.7 m-85 -91.68 145.68 24.39 Favored 'General case' 0 N--CA 1.434 -1.26 0 CA-C-O 122.653 1.216 . . . . 0.0 111.681 -178.685 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 50.2 p90 -145.34 162.5 37.08 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 112.902 -1.953 . . . . 0.0 107.896 175.162 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -105.48 136.53 44.87 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.162 0.506 . . . . 0.0 111.913 -176.938 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -67.56 133.73 49.97 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.356 -0.838 . . . . 0.0 108.92 177.584 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 91.88 -27.51 9.92 Favored Glycine 0 CA--C 1.522 0.513 0 N-CA-C 113.663 0.225 . . . . 0.0 113.663 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 4.9 t . . . . . 0 C--N 1.323 -0.552 0 CA-C-O 121.306 0.574 . . . . 0.0 111.248 178.139 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.464 0 N-CA-C 113.318 0.858 . . . . 0.0 113.318 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 16.2 t -66.2 141.86 57.91 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.78 178.431 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 27.3 m95 -68.35 -23.21 64.66 Favored 'General case' 0 CA--C 1.509 -0.634 0 O-C-N 123.372 0.42 . . . . 0.0 111.457 177.743 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 36.7 m-85 -121.38 158.26 28.69 Favored 'General case' 0 CA--C 1.506 -0.714 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.83 -173.396 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.419 ' HB ' ' HB3' ' A' ' 134' ' ' GLU . 69.8 p -65.67 160.43 22.74 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.235 -0.893 . . . . 0.0 109.838 -179.65 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.434 ' HB2' ' CE1' ' A' ' 69' ' ' TYR . . . -80.25 139.34 36.73 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.147 -0.933 . . . . 0.0 112.166 -174.844 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.464 HD11 HD22 ' A' ' 119' ' ' LEU . 3.8 mp -83.15 148.9 27.19 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 172.995 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 64.7 m -124.49 138.76 54.32 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 179.835 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.415 ' HB2' ' CZ ' ' A' ' 131' ' ' PHE . 4.3 tp60 -111.85 136.44 51.14 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 -178.023 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 56.0 t60 -131.22 94.97 3.68 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 104.318 -2.475 . . . . 0.0 104.318 169.152 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 178.61 -166.32 36.06 Favored Glycine 0 C--O 1.224 -0.475 0 N-CA-C 110.802 -0.919 . . . . 0.0 110.802 -176.3 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 91.9 mttt -101.11 -21.79 14.88 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 114.442 1.275 . . . . 0.0 114.442 -177.956 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -94.03 161.53 14.25 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 179.6 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -77.76 -62.92 1.51 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.517 -179.012 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 45.0 tp 179.44 140.7 0.12 Allowed 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 105.387 -2.079 . . . . 0.0 105.387 175.619 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 23.7 tptm -155.67 134.84 12.21 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 118.051 0.387 . . . . 0.0 110.49 174.981 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 20.1 m-85 -121.24 151.69 56.19 Favored Pre-proline 0 C--O 1.242 0.66 0 N-CA-C 107.178 -1.416 . . . . 0.0 107.178 174.062 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -73.97 160.63 42.74 Favored 'Trans proline' 0 CA--C 1.535 0.541 0 O-C-N 122.058 0.504 . . . . 0.0 111.946 177.866 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 3.8 tmt_? -64.3 132.02 48.99 Favored 'General case' 0 N--CA 1.47 0.539 0 O-C-N 122.169 -0.332 . . . . 0.0 110.35 -178.102 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 83.23 15.38 72.04 Favored Glycine 0 C--O 1.223 -0.557 0 C-N-CA 121.249 -0.501 . . . . 0.0 112.375 177.99 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -150.92 170.54 19.07 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 -176.668 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 100.32 -10.83 59.89 Favored Glycine 0 CA--C 1.508 -0.384 0 N-CA-C 115.183 0.833 . . . . 0.0 115.183 174.643 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 90.3 t -68.91 130.07 91.85 Favored Pre-proline 0 C--N 1.321 -0.669 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 177.342 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -73.18 171.75 16.98 Favored 'Trans proline' 0 C--O 1.221 -0.357 0 O-C-N 122.183 0.57 . . . . 0.0 112.351 178.343 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 92.6 mt -71.57 106.44 2.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 179.304 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 -96.17 86.55 4.28 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 114.33 -1.305 . . . . 0.0 109.755 -176.852 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 77.5 p -67.65 -14.89 63.33 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.543 -0.753 . . . . 0.0 112.816 -178.691 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -108.35 21.04 17.88 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.158 -0.928 . . . . 0.0 112.022 -177.861 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.475 ' HB3' ' HB2' ' A' ' 42' ' ' ASP . 2.0 m -143.17 149.84 38.58 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 114.333 1.234 . . . . 0.0 114.333 -175.824 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.2 m -76.8 168.41 28.32 Favored Pre-proline 0 N--CA 1.471 0.595 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 177.762 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -64.39 -27.44 62.94 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 114.731 -3.046 . . . . 0.0 112.095 178.634 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -62.84 -23.97 67.55 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 124.104 0.962 . . . . 0.0 112.322 176.242 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.475 ' HB2' ' HB3' ' A' ' 38' ' ' SER . 68.7 m-20 -99.28 -1.98 37.66 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 114.106 1.151 . . . . 0.0 114.106 -171.986 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 91.8 mm-40 -61.89 -26.01 67.9 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 114.002 1.112 . . . . 0.0 114.002 -177.433 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 8.5 tt -59.04 137.26 21.72 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.83 0 CA-C-O 122.242 1.02 . . . . 0.0 112.977 -179.281 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -179.33 -159.18 22.97 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.437 -0.887 . . . . 0.0 112.505 -178.637 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.414 ' CE2' HD12 ' A' ' 90' ' ' ILE . 42.7 p90 -155.02 168.12 28.08 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 179.468 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 31.9 m-85 -109.37 140.77 42.66 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 175.314 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 66.0 ttt-85 -116.85 120.77 39.54 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.892 -175.054 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 50.1 ttp180 -70.73 143.7 51.19 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 110.244 -0.28 . . . . 0.0 110.244 177.899 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -144.32 141.26 29.65 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 122.734 0.414 . . . . 0.0 110.327 178.807 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 25.4 p -144.49 151.5 39.25 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 178.192 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 13.3 tpt180 -149.14 130.52 14.72 Favored 'General case' 0 N--CA 1.469 0.517 0 O-C-N 122.176 -0.328 . . . . 0.0 111.3 176.674 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 4.2 tmm_? -144.07 138.83 28.57 Favored 'General case' 0 CA--C 1.5 -0.96 0 CA-C-O 121.157 0.503 . . . . 0.0 109.793 179.654 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -131.81 179.2 4.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 -179.658 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 5.0 ttt85 -115.36 99.16 7.18 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 174.827 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -77.91 157.69 45.58 Favored Glycine 0 C--O 1.223 -0.551 0 N-CA-C 107.359 -2.296 . . . . 0.0 107.359 176.914 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -66.04 -41.9 94.91 Favored Glycine 0 C--O 1.217 -0.953 0 CA-C-N 118.427 1.114 . . . . 0.0 111.899 179.641 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -85.35 -11.05 55.5 Favored 'General case' 0 C--O 1.215 -0.719 0 CA-C-O 122.137 0.97 . . . . 0.0 110.328 178.551 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 103.57 9.7 37.48 Favored Glycine 0 C--O 1.226 -0.398 0 CA-C-N 115.288 -0.869 . . . . 0.0 112.781 177.84 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 59.5 mmtt -61.12 132.36 53.48 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.274 0.559 . . . . 0.0 110.59 -179.391 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 95.8 mmm -86.19 167.62 14.72 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 114.781 -1.099 . . . . 0.0 111.185 179.705 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 16.2 tppt? -108.61 -39.42 5.39 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 176.985 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 15.2 t0 -141.77 164.98 28.72 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 105.253 -2.129 . . . . 0.0 105.253 178.531 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -121.2 -94.27 0.5 Allowed 'General case' 0 C--N 1.325 -0.469 0 O-C-N 123.502 0.501 . . . . 0.0 110.597 -176.334 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -72.45 159.4 85.48 Favored Pre-proline 0 C--N 1.326 -0.43 0 C-N-CA 122.717 0.407 . . . . 0.0 109.976 179.667 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -68.79 140.86 47.62 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 115.116 -2.789 . . . . 0.0 111.377 177.649 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 53.5 mtt180 -104.2 155.65 18.54 Favored 'General case' 0 CA--C 1.504 -0.798 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.067 179.479 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 66.0 m95 -127.53 125.85 41.13 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 174.916 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.434 ' CE1' ' HB2' ' A' ' 15' ' ' ALA . 69.6 m-85 -110.32 160.22 16.75 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 106.605 -1.628 . . . . 0.0 106.605 -178.615 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -103.55 132.8 49.49 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 179.378 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -131.65 145.69 51.8 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 -176.081 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 58.8 m-85 -87.26 161.59 17.9 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 120.755 0.312 . . . . 0.0 110.289 -176.954 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -53.42 132.46 39.69 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 120.747 0.308 . . . . 0.0 111.379 -178.908 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 70.37 27.98 71.95 Favored Glycine 0 C--O 1.224 -0.508 0 N-CA-C 116.264 1.266 . . . . 0.0 116.264 176.529 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 69.9 p . . . . . 0 N--CA 1.467 0.422 0 CA-C-N 118.278 1.039 . . . . 0.0 111.286 178.891 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 27.4 mt . . . . . 0 C--O 1.238 0.482 0 N-CA-C 117.348 2.351 . . . . 0.0 117.348 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -77.88 164.36 27.69 Favored 'Trans proline' 0 C--O 1.234 0.303 0 C-N-CA 121.787 1.658 . . . . 0.0 108.011 167.789 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 53.5 t80 -62.43 133.1 54.55 Favored 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 120.493 -0.483 . . . . 0.0 111.191 -176.785 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 89.52 -7.6 81.59 Favored Glycine 0 CA--C 1.517 0.202 0 CA-C-O 119.6 -0.556 . . . . 0.0 114.373 178.867 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -63.5 131.61 48.68 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 118.134 0.967 . . . . 0.0 111.084 179.62 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -78.25 130.13 35.9 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.242 -179.277 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 24.8 ttmt -156.2 150.97 26.04 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 105.37 -2.085 . . . . 0.0 105.37 176.501 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 42.4 t0 -70.88 135.85 48.28 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.827 -0.435 . . . . 0.0 109.827 -177.853 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 71.95 24.5 76.48 Favored Glycine 0 N--CA 1.453 -0.222 0 C-N-CA 121.158 -0.544 . . . . 0.0 113.937 -179.373 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.414 HD12 ' CE2' ' A' ' 46' ' ' TYR . 41.6 mm -129.36 129.61 67.27 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 CA-C-N 117.198 0.499 . . . . 0.0 110.593 -179.712 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.1 pt -132.91 125.22 51.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 CA-C-O 121.17 0.51 . . . . 0.0 110.591 176.472 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 95.9 m95 -88.63 138.96 30.95 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 113.62 0.97 . . . . 0.0 113.62 -176.023 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 16.6 m -137.78 152.21 26.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 108.982 -0.748 . . . . 0.0 108.982 178.775 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -160.62 166.6 28.63 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 103.368 -2.827 . . . . 0.0 103.368 -179.831 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 12.4 t -138.63 177.24 8.03 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 106.059 -1.83 . . . . 0.0 106.059 178.968 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -67.5 135.71 53.47 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.983 0.421 . . . . 0.0 109.972 -179.415 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 96.16 -8.52 67.36 Favored Glycine 0 C--O 1.224 -0.514 0 CA-C-N 115.952 -0.567 . . . . 0.0 113.506 178.803 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -80.92 138.76 36.13 Favored 'General case' 0 CA--C 1.538 0.491 0 O-C-N 122.37 -0.488 . . . . 0.0 111.678 -179.534 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 91.9 mt -88.05 154.93 20.09 Favored 'General case' 0 C--O 1.214 -0.808 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 178.785 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 57.8 t30 -96.99 64.88 2.02 Favored 'General case' 0 C--N 1.323 -0.572 0 O-C-N 122.14 -0.35 . . . . 0.0 110.516 178.237 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -138.24 154.51 73.95 Favored Pre-proline 0 CA--C 1.538 0.518 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 -179.119 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -68.02 154.17 73.32 Favored 'Trans proline' 0 C--N 1.349 0.602 0 N-CA-C 114.332 0.859 . . . . 0.0 114.332 -179.222 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.441 ' HE3' ' HA ' ' A' ' 42' ' ' ASP . 70.9 mmtt -128.67 54.35 1.78 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.552 0.691 . . . . 0.0 109.627 -178.364 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 12.7 p-10 -60.48 -37.23 80.36 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.573 -177.017 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 10.6 p80 -65.56 -15.18 62.46 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 113.205 0.817 . . . . 0.0 113.205 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.411 HD12 ' HB3' ' A' ' 103' ' ' LYS . 25.1 mt -91.21 -38.19 10.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 178.276 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -75.74 2.75 53.18 Favored Glycine 0 CA--C 1.521 0.438 0 N-CA-C 116.013 1.165 . . . . 0.0 116.013 -177.851 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 6.2 t -91.17 22.45 3.78 Favored 'General case' 0 CA--C 1.548 0.876 0 CA-C-O 121.98 0.895 . . . . 0.0 111.728 -178.852 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.437 ' HD2' ' OD1' ' A' ' 114' ' ' ASN . 61.1 ttp85 -59.11 131.41 50.96 Favored 'General case' 0 N--CA 1.468 0.464 0 O-C-N 121.507 -0.745 . . . . 0.0 110.918 -179.625 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 71.1 m-20 -104.38 121.41 47.42 Favored Pre-proline 0 C--N 1.327 -0.394 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_endo -70.09 -14.72 35.37 Favored 'Trans proline' 0 C--N 1.348 0.516 0 N-CA-C 113.994 0.729 . . . . 0.0 113.994 -178.101 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -73.79 -25.61 60.21 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 120.665 0.269 . . . . 0.0 110.899 177.06 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 -101.89 -25.41 13.8 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 113.325 0.861 . . . . 0.0 113.325 -175.713 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' ASN . . . . . 0.437 ' OD1' ' HD2' ' A' ' 109' ' ' ARG . 0.4 OUTLIER -141.8 151.92 43.26 Favored 'General case' 0 N--CA 1.439 -1.013 0 CA-C-O 121.196 0.522 . . . . 0.0 111.451 -176.782 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -97.24 140.47 31.67 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 115.382 -0.826 . . . . 0.0 109.594 177.395 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -68.88 151.99 45.87 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.275 0.56 . . . . 0.0 111.459 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 5.3 mt -95.4 139.43 18.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.066 -178.018 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 71.8 t -62.07 125.9 19.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 N-CA-C 106.391 -1.707 . . . . 0.0 106.391 175.389 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.464 HD22 HD11 ' A' ' 16' ' ' LEU . 7.6 tt -66.85 128.14 35.17 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.225 0.536 . . . . 0.0 109.58 -177.392 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 29.5 mt-30 -129.45 158.26 39.68 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 105.417 -2.068 . . . . 0.0 105.417 179.391 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 21.3 mt -115.02 148.28 40.2 Favored Pre-proline 0 C--N 1.321 -0.662 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 179.588 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -72.65 170.33 19.76 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 120.49 0.793 . . . . 0.0 113.636 -177.673 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 4.1 tp-100 -53.84 129.08 32.43 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.391 -179.371 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 89.66 -10.97 71.7 Favored Glycine 0 CA--C 1.519 0.34 0 CA-C-N 115.999 -0.546 . . . . 0.0 114.385 179.399 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 25.7 m -108.67 127.05 53.64 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 117.955 0.877 . . . . 0.0 110.002 179.052 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 12.7 p -125.07 152.52 44.23 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 123.054 0.541 . . . . 0.0 110.83 -178.661 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 83.7 mt -69.62 153.27 95.82 Favored Pre-proline 0 C--N 1.328 -0.362 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 179.398 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -77.96 176.48 9.94 Favored 'Trans proline' 0 C--N 1.345 0.377 0 O-C-N 121.946 0.445 . . . . 0.0 111.283 178.401 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -59.48 125.59 24.24 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 113.85 1.056 . . . . 0.0 113.85 -174.572 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 91.51 -4.0 79.39 Favored Glycine 0 C--N 1.33 0.2 0 N-CA-C 115.748 1.059 . . . . 0.0 115.748 175.683 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.415 ' CZ ' ' HB2' ' A' ' 18' ' ' GLN . 2.4 m-85 -96.58 142.51 28.55 Favored 'General case' 0 N--CA 1.44 -0.964 0 CA-C-O 122.09 0.947 . . . . 0.0 113.055 -177.696 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 52.8 p90 -146.04 161.62 39.72 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 113.66 -1.609 . . . . 0.0 107.568 173.201 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -104.83 151.31 23.96 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 -178.904 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.419 ' HB3' ' HB ' ' A' ' 14' ' ' THR . 4.9 tp10 -70.92 134.94 47.65 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 178.488 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 84.56 -4.45 84.34 Favored Glycine 0 CA--C 1.521 0.438 0 C-N-CA 121.537 -0.364 . . . . 0.0 113.72 -177.675 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 18.2 t . . . . . 0 C--N 1.326 -0.431 0 CA-C-O 121.636 0.731 . . . . 0.0 109.292 178.87 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.173 0 CA-C-O 121.545 0.688 . . . . 0.0 112.101 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -59.17 142.48 51.54 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.184 -0.916 . . . . 0.0 110.305 177.934 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 21.4 m95 -67.19 -21.92 65.76 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 114.066 1.135 . . . . 0.0 114.066 -179.191 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 39.2 m-85 -121.48 162.21 20.91 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 114.336 1.236 . . . . 0.0 114.336 -170.714 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 53.8 p -68.87 164.58 21.72 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.377 -1.283 . . . . 0.0 110.811 -179.64 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.462 ' HB2' ' CZ ' ' A' ' 69' ' ' TYR . . . -85.59 131.56 34.33 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.261 -0.881 . . . . 0.0 112.388 -176.731 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -81.61 148.85 28.87 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 105.466 -2.05 . . . . 0.0 105.466 173.793 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 57.1 m -118.21 139.66 50.95 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 179.441 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 4.1 tp60 -110.03 136.91 48.55 Favored 'General case' 0 C--N 1.328 -0.345 0 O-C-N 123.426 0.454 . . . . 0.0 111.338 -179.079 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 42.8 t60 -128.09 99.38 5.45 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 105.402 -2.073 . . . . 0.0 105.402 171.674 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 169.7 -167.57 40.62 Favored Glycine 0 C--O 1.225 -0.432 0 N-CA-C 109.289 -1.524 . . . . 0.0 109.289 -176.781 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 64.8 mttp -103.77 -23.32 13.42 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 179.853 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -82.51 158.85 23.01 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 -179.504 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -76.75 -62.86 1.5 Allowed 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 -179.369 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 32.7 tp 172.62 144.8 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 104.228 -2.508 . . . . 0.0 104.228 179.347 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 22.2 tptm -155.59 141.08 17.8 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 174.284 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -126.08 157.91 67.99 Favored Pre-proline 0 C--O 1.241 0.634 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 177.043 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -70.77 176.15 7.93 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 121.307 1.338 . . . . 0.0 114.678 -178.449 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 77.5 ttt180 -74.86 126.41 30.88 Favored 'General case' 0 C--O 1.217 -0.633 0 O-C-N 121.803 -0.56 . . . . 0.0 110.443 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 76.79 13.08 83.94 Favored Glycine 0 C--O 1.223 -0.54 0 N-CA-C 115.483 0.953 . . . . 0.0 115.483 175.91 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -157.01 142.5 17.47 Favored 'General case' 0 C--O 1.22 -0.458 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 -177.722 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 141.29 -18.06 2.69 Favored Glycine 0 CA--C 1.506 -0.503 0 C-N-CA 120.308 -0.949 . . . . 0.0 113.391 179.108 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 31.6 m -69.49 145.45 95.38 Favored Pre-proline 0 C--N 1.323 -0.566 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 176.381 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -75.9 172.45 16.25 Favored 'Trans proline' 0 CA--C 1.511 -0.64 0 C-N-CA 121.211 1.274 . . . . 0.0 112.582 -179.739 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 97.9 mt -71.8 109.97 4.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 176.842 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 69.6 m-80 -101.1 85.59 2.86 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 114.681 -1.145 . . . . 0.0 108.986 -177.812 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 73.7 p -66.16 -15.85 63.48 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 113.021 0.749 . . . . 0.0 113.021 -177.589 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 10.4 p30 -105.65 21.89 16.46 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.253 -0.885 . . . . 0.0 111.315 -178.276 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 14.2 m -141.44 150.95 42.98 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 113.306 0.854 . . . . 0.0 113.306 -176.624 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -73.72 166.57 43.01 Favored Pre-proline 0 C--N 1.326 -0.441 0 N-CA-C 108.396 -0.965 . . . . 0.0 108.396 176.761 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -64.22 -27.92 64.38 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 115.12 -2.787 . . . . 0.0 111.715 178.737 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -61.25 -28.68 69.34 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 123.778 0.831 . . . . 0.0 111.31 176.051 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 75.3 m-20 -98.51 -0.37 43.47 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 115.242 1.571 . . . . 0.0 115.242 -171.35 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 92.7 mm-40 -61.39 -25.63 67.31 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 113.554 0.946 . . . . 0.0 113.554 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 12.3 tt -58.78 141.08 16.22 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 N-CA-C 113.917 1.081 . . . . 0.0 113.917 -178.81 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 179.54 -152.59 11.15 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.422 -0.894 . . . . 0.0 112.294 179.388 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 48.7 p90 -155.07 165.67 35.99 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 108.312 -0.995 . . . . 0.0 108.312 178.475 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 24.9 m-85 -105.98 142.07 36.31 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 107.413 -1.328 . . . . 0.0 107.413 174.814 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 69.3 ttt-85 -116.77 123.56 47.44 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 123.597 0.759 . . . . 0.0 112.048 -176.155 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 50.4 ttp180 -71.53 144.46 49.58 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.024 177.971 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -144.82 143.3 30.56 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 175.819 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 35.3 p -138.67 171.35 14.48 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 103.379 -2.823 . . . . 0.0 103.379 175.815 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 23.5 tpt180 -135.7 122.61 21.25 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.253 -0.579 . . . . 0.0 109.941 174.628 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.76 144.44 25.12 Favored 'General case' 0 CA--C 1.498 -1.024 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 179.684 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -144.22 178.5 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 N-CA-C 104.123 -2.547 . . . . 0.0 104.123 -178.101 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.77 112.0 15.54 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 105.878 -1.897 . . . . 0.0 105.878 174.175 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -74.17 167.36 54.62 Favored Glycine 0 C--O 1.224 -0.483 0 N-CA-C 108.097 -2.001 . . . . 0.0 108.097 177.661 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -62.56 -48.23 83.36 Favored Glycine 0 C--O 1.224 -0.501 0 N-CA-C 109.677 -1.369 . . . . 0.0 109.677 -177.572 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -85.32 17.2 3.2 Favored 'General case' 0 C--O 1.217 -0.61 0 CA-C-O 122.432 1.11 . . . . 0.0 110.758 178.989 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 87.81 -19.43 33.59 Favored Glycine 0 C--O 1.228 -0.225 0 N-CA-C 115.699 1.039 . . . . 0.0 115.699 174.031 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -56.74 131.1 48.21 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.799 0.809 . . . . 0.0 110.548 -178.333 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 22.4 ptm -127.34 -163.21 1.23 Allowed 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 114.391 -1.277 . . . . 0.0 113.865 -171.889 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 10.8 mptt -126.14 -57.82 1.39 Allowed 'General case' 0 C--O 1.211 -0.942 0 C-N-CA 123.502 0.721 . . . . 0.0 111.624 -175.922 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 50.47 51.12 17.48 Favored 'General case' 0 N--CA 1.477 0.918 0 O-C-N 124.695 1.247 . . . . 0.0 113.587 178.325 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -66.37 138.69 57.77 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.632 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -57.42 157.71 12.5 Favored Pre-proline 0 C--O 1.242 0.677 0 CA-C-N 114.803 -1.089 . . . . 0.0 112.71 -179.355 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -68.11 135.85 35.92 Favored 'Trans proline' 0 C--O 1.24 0.592 0 C-N-CA 116.6 -1.8 . . . . 0.0 114.974 -177.665 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 30.0 mtp180 -119.76 158.13 27.16 Favored 'General case' 0 CA--C 1.507 -0.695 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 174.585 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 59.7 m95 -128.3 129.72 46.74 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.186 0.517 . . . . 0.0 109.974 178.921 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.462 ' CZ ' ' HB2' ' A' ' 15' ' ' ALA . 70.4 m-85 -110.58 163.13 14.03 Favored 'General case' 0 C--O 1.213 -0.858 0 N-CA-C 105.505 -2.035 . . . . 0.0 105.505 179.251 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 89.6 t80 -109.88 136.71 48.74 Favored 'General case' 0 CA--C 1.511 -0.55 0 N-CA-C 107.305 -1.368 . . . . 0.0 107.305 177.979 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 9.8 m-85 -136.57 148.92 47.79 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 -176.477 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -82.46 159.42 22.92 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.484 -175.761 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -54.61 129.62 37.14 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.812 -178.262 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 66.85 39.73 93.5 Favored Glycine 0 C--O 1.222 -0.599 0 CA-C-O 119.187 -0.785 . . . . 0.0 114.863 176.196 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.326 -0.441 0 CA-C-N 118.187 0.993 . . . . 0.0 108.351 177.507 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 26.6 mt . . . . . 0 C--O 1.238 0.469 0 N-CA-C 114.7 1.37 . . . . 0.0 114.7 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -78.2 167.86 22.63 Favored 'Trans proline' 0 N--CA 1.461 -0.389 0 C-N-CA 121.671 1.58 . . . . 0.0 108.972 170.812 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 61.0 t80 -63.06 133.54 54.67 Favored 'General case' 0 C--N 1.32 -0.701 0 O-C-N 121.986 -0.446 . . . . 0.0 110.135 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 89.23 -3.19 84.1 Favored Glycine 0 CA--C 1.519 0.296 0 N-CA-C 114.437 0.535 . . . . 0.0 114.437 178.854 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -63.56 128.79 37.4 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 117.843 0.821 . . . . 0.0 112.873 -179.397 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 44.8 t30 -68.26 118.74 11.76 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.882 -179.436 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 16.1 ttmm -152.92 145.96 24.59 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 176.364 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 33.0 t0 -67.37 132.97 48.72 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.277 -0.874 . . . . 0.0 109.919 -179.272 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 71.81 24.67 76.33 Favored Glycine 0 C--O 1.24 0.498 0 CA-C-O 119.505 -0.608 . . . . 0.0 114.612 179.789 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 36.9 mm -131.66 132.6 62.11 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 CA-C-N 117.286 0.543 . . . . 0.0 110.495 -179.506 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.1 pt -131.44 117.14 34.62 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 CA-C-O 121.551 0.691 . . . . 0.0 110.572 175.5 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 96.1 m95 -82.53 134.74 35.2 Favored 'General case' 0 C--N 1.321 -0.645 0 O-C-N 121.966 -0.458 . . . . 0.0 111.996 -177.552 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -142.9 150.53 17.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 121.522 0.677 . . . . 0.0 109.788 -178.275 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -155.0 166.57 33.16 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 105.333 -2.099 . . . . 0.0 105.333 -178.756 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 14.7 t -128.1 167.9 16.11 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 105.186 -2.153 . . . . 0.0 105.186 176.703 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -65.04 137.0 57.43 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 95.68 -8.0 68.33 Favored Glycine 0 C--O 1.225 -0.417 0 CA-C-N 115.919 -0.582 . . . . 0.0 113.204 179.247 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -82.35 142.8 31.72 Favored 'General case' 0 CA--C 1.541 0.597 0 O-C-N 122.26 -0.553 . . . . 0.0 111.473 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 34.9 mt -90.98 135.55 33.66 Favored 'General case' 0 CA--C 1.513 -0.471 0 CA-C-O 121.386 0.612 . . . . 0.0 112.456 -179.242 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 55.3 t30 -84.69 72.27 10.72 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.526 -178.988 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -146.39 153.25 47.73 Favored Pre-proline 0 C--N 1.324 -0.531 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 -179.583 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -68.65 150.37 74.52 Favored 'Trans proline' 0 C--N 1.344 0.291 0 N-CA-C 114.103 0.77 . . . . 0.0 114.103 178.227 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 3.3 ptpt -151.78 56.82 0.86 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.791 0.805 . . . . 0.0 112.906 -179.432 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -56.76 -28.16 60.75 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 115.557 -0.747 . . . . 0.0 112.146 177.521 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 12.2 p80 -59.76 -10.82 4.16 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 114.363 1.246 . . . . 0.0 114.363 -178.775 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 55.7 mt -93.19 -42.16 13.01 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.496 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 178.118 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -72.06 14.65 2.12 Favored Glycine 0 N--CA 1.464 0.534 0 N-CA-C 116.559 1.384 . . . . 0.0 116.559 -176.007 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 15.2 t -90.45 23.73 2.87 Favored 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 112.768 0.655 . . . . 0.0 112.768 -178.132 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 62.0 ttp85 -55.39 130.19 41.6 Favored 'General case' 0 N--CA 1.475 0.788 0 O-C-N 121.58 -0.7 . . . . 0.0 109.62 -179.514 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 36.3 m120 -95.47 122.92 58.1 Favored Pre-proline 0 C--N 1.322 -0.608 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 -179.404 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -68.44 -20.17 42.22 Favored 'Trans proline' 0 C--O 1.219 -0.443 0 C-N-CA 117.159 -1.427 . . . . 0.0 113.133 179.624 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -73.26 -29.26 62.63 Favored 'General case' 0 C--O 1.22 -0.498 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.427 178.228 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 -100.63 -25.81 14.03 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -175.414 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 19.0 t-20 -151.61 144.44 24.42 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 113.448 0.907 . . . . 0.0 113.448 -178.871 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -83.84 146.92 27.84 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.113 179.549 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -66.34 139.99 58.07 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.209 0.528 . . . . 0.0 110.274 178.676 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 14.3 mt -82.38 138.74 18.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 -177.992 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -61.15 125.71 17.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 175.328 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 7.8 tt -67.08 128.78 37.66 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 -178.018 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 29.6 mt-30 -128.65 153.35 47.37 Favored 'General case' 0 CA--C 1.507 -0.7 0 N-CA-C 106.088 -1.819 . . . . 0.0 106.088 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 17.0 mt -113.31 149.51 41.6 Favored Pre-proline 0 C--N 1.321 -0.661 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 178.983 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -72.15 170.65 18.55 Favored 'Trans proline' 0 C--N 1.343 0.278 0 N-CA-C 113.888 0.688 . . . . 0.0 113.888 -177.562 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -54.45 130.86 41.03 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.219 -179.349 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 90.13 -12.21 68.49 Favored Glycine 0 C--O 1.227 -0.325 0 CA-C-N 115.931 -0.577 . . . . 0.0 113.363 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 8.8 m -108.56 125.63 52.04 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 117.659 0.73 . . . . 0.0 110.271 179.145 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 10.3 p -126.21 150.43 48.36 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.929 -177.738 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 83.0 mt -69.53 153.79 95.42 Favored Pre-proline 0 C--N 1.325 -0.488 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 176.993 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -76.03 169.55 21.89 Favored 'Trans proline' 0 N--CA 1.464 -0.251 0 C-N-CA 118.349 -0.634 . . . . 0.0 111.23 178.491 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 60.0 tttm -61.3 130.72 47.55 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 122.144 -0.348 . . . . 0.0 110.507 -177.927 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 95.29 -3.57 66.47 Favored Glycine 0 C--O 1.226 -0.354 0 CA-C-N 115.923 -0.58 . . . . 0.0 114.106 178.681 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -106.47 137.83 43.75 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 179.506 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 51.1 p90 -141.53 160.04 40.97 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 175.157 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -107.14 139.74 41.1 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.594 0.59 . . . . 0.0 112.594 -175.958 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -73.68 143.8 46.08 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 177.183 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 96.51 -37.58 3.39 Favored Glycine 0 C--O 1.224 -0.506 0 N-CA-C 111.208 -0.757 . . . . 0.0 111.208 -178.449 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 36.9 t . . . . . 0 C--N 1.323 -0.559 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 176.419 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 0.227 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -60.16 142.28 54.57 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.053 178.688 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 19.0 m95 -69.75 -23.98 63.46 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 113.816 1.043 . . . . 0.0 113.816 -179.089 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 52.7 m-85 -121.54 162.68 20.15 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 113.343 0.868 . . . . 0.0 113.343 -171.752 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 66.3 p -68.42 164.48 20.93 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.787 -1.097 . . . . 0.0 108.959 178.932 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.447 ' HB2' ' CZ ' ' A' ' 69' ' ' TYR . . . -75.87 145.57 40.44 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 113.242 0.83 . . . . 0.0 113.242 -176.84 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 15.7 mt -87.4 140.3 29.67 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 102.175 -3.269 . . . . 0.0 102.175 167.844 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 63.7 m -116.7 128.5 55.4 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 -179.501 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -82.72 138.79 33.96 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.909 179.512 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 9.5 t-160 -139.46 94.74 2.82 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 103.589 -2.745 . . . . 0.0 103.589 167.983 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 163.13 -143.04 8.31 Favored Glycine 0 C--O 1.226 -0.386 0 C-N-CA 120.432 -0.889 . . . . 0.0 112.267 -175.914 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -121.19 -27.35 4.91 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 116.179 1.918 . . . . 0.0 116.179 -176.596 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -78.75 158.05 28.35 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 179.467 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -72.35 -62.87 1.28 Allowed 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.416 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 53.3 tp 175.54 143.93 0.06 Allowed 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 104.216 -2.512 . . . . 0.0 104.216 173.407 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.9 tppp? -158.13 141.23 14.99 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 108.855 -0.795 . . . . 0.0 108.855 176.669 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -126.01 153.12 73.86 Favored Pre-proline 0 C--N 1.325 -0.49 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 175.745 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -68.77 162.23 42.17 Favored 'Trans proline' 0 C--N 1.352 0.717 0 O-C-N 122.151 0.553 . . . . 0.0 113.09 179.481 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 18.0 tpt180 -64.02 131.88 48.92 Favored 'General case' 0 C--O 1.216 -0.678 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.895 -177.279 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 76.18 17.37 80.04 Favored Glycine 0 C--O 1.224 -0.486 0 C-N-CA 121.319 -0.467 . . . . 0.0 112.911 178.234 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 5.3 mt-30 -150.35 170.49 18.91 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 -175.977 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 109.2 -14.87 33.4 Favored Glycine 0 CA--C 1.502 -0.735 0 C-N-CA 121.455 -0.402 . . . . 0.0 113.345 175.275 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 89.2 t -66.13 129.6 94.24 Favored Pre-proline 0 C--N 1.319 -0.741 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 177.338 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_endo -74.21 169.55 22.21 Favored 'Trans proline' 0 N--CA 1.46 -0.481 0 O-C-N 122.143 0.549 . . . . 0.0 111.492 178.11 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 89.1 mt -70.33 107.73 2.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-O 122.084 0.945 . . . . 0.0 108.69 -179.643 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 76.1 m-20 -98.85 85.22 3.24 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 114.34 -1.3 . . . . 0.0 108.837 -178.213 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 70.1 p -66.29 -15.85 63.56 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 113.761 1.023 . . . . 0.0 113.761 -176.674 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 20.0 p30 -110.01 23.72 13.98 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.297 -0.865 . . . . 0.0 112.204 -177.398 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.41 ' HB3' ' HB2' ' A' ' 42' ' ' ASP . 15.9 m -138.55 149.25 45.12 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 113.227 0.825 . . . . 0.0 113.227 -175.926 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -73.77 166.71 41.83 Favored Pre-proline 0 C--O 1.236 0.379 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 177.751 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -64.66 -27.35 60.79 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 114.936 -2.909 . . . . 0.0 111.661 178.443 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -61.87 -27.67 68.96 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 123.69 0.796 . . . . 0.0 111.7 176.776 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.41 ' HB2' ' HB3' ' A' ' 38' ' ' SER . 77.3 m-20 -94.87 -4.17 47.47 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 114.696 1.369 . . . . 0.0 114.696 -171.123 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 96.2 mm-40 -59.78 -28.94 67.85 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 114.465 1.283 . . . . 0.0 114.465 -177.923 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 11.4 tt -58.54 138.19 19.89 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.884 0 CA-C-O 122.308 1.051 . . . . 0.0 113.804 -177.88 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -178.82 -156.9 18.27 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.616 -0.802 . . . . 0.0 113.004 -178.837 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 46.6 p90 -155.14 170.54 21.59 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 179.389 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 20.0 m-85 -111.35 140.26 46.07 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 173.363 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -109.55 120.3 42.06 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 124.122 0.969 . . . . 0.0 109.933 -177.694 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 40.2 ttp180 -68.08 136.19 53.39 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 175.982 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -144.83 147.24 32.62 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 123.054 0.542 . . . . 0.0 110.817 -177.898 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.415 HG23 ' HA ' ' A' ' 66' ' ' PRO . 0.1 OUTLIER -153.39 129.03 10.04 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.082 176.254 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 15.0 tpp180 -90.04 123.73 34.17 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 105.048 -2.205 . . . . 0.0 105.048 174.913 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 4.3 tmt_? -145.51 130.85 18.6 Favored 'General case' 0 CA--C 1.489 -1.371 0 CA-C-O 122.351 1.072 . . . . 0.0 111.029 -178.067 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -140.04 -179.94 2.36 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 CA-C-N 112.685 -2.052 . . . . 0.0 106.661 -177.884 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 3.3 tmt_? -129.32 103.77 7.12 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 105.677 -1.971 . . . . 0.0 105.677 172.027 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -72.83 158.35 53.05 Favored Glycine 0 N--CA 1.452 -0.241 0 N-CA-C 107.708 -2.157 . . . . 0.0 107.708 177.919 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -60.7 -37.07 92.93 Favored Glycine 0 C--O 1.222 -0.649 0 CA-C-N 118.173 0.986 . . . . 0.0 111.998 -179.371 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 39.5 t0 -86.96 13.98 8.16 Favored 'General case' 0 CA--C 1.55 0.951 0 CA-C-O 122.731 1.253 . . . . 0.0 111.248 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 86.85 6.37 79.79 Favored Glycine 0 C--O 1.224 -0.47 0 CA-C-N 115.393 -0.821 . . . . 0.0 113.543 171.948 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 20.9 mmtt -74.62 151.15 39.38 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-O 121.812 0.815 . . . . 0.0 111.463 -174.862 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 83.2 mtp -118.17 -173.94 2.56 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 114.059 -1.428 . . . . 0.0 109.576 -179.145 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 16.0 mmtt -119.94 -75.96 0.58 Allowed 'General case' 0 C--O 1.22 -0.478 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 179.774 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 52.3 m-20 -95.18 149.72 20.99 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 104.628 -2.36 . . . . 0.0 104.628 176.71 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 84.5 mt -118.96 -57.24 2.04 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 106.327 -1.731 . . . . 0.0 106.327 177.072 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -78.96 141.28 58.65 Favored Pre-proline 0 C--O 1.245 0.824 0 CA-C-N 115.058 -0.973 . . . . 0.0 108.929 175.468 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.415 ' HA ' HG23 ' A' ' 51' ' ' THR . 97.5 Cg_endo -73.06 155.88 52.2 Favored 'Trans proline' 0 C--O 1.239 0.531 0 C-N-CA 116.808 -1.661 . . . . 0.0 112.273 178.691 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 29.6 mtt85 -123.94 159.93 28.67 Favored 'General case' 0 CA--C 1.507 -0.685 0 CA-C-N 115.958 -0.564 . . . . 0.0 109.779 -178.742 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 54.4 m95 -134.01 140.9 47.01 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 177.779 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.447 ' CZ ' ' HB2' ' A' ' 15' ' ' ALA . 61.6 m-85 -120.56 154.62 35.12 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 106.567 -1.642 . . . . 0.0 106.567 178.791 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 86.1 t80 -98.27 137.88 36.35 Favored 'General case' 0 CA--C 1.507 -0.696 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 -179.165 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -137.67 144.05 41.63 Favored 'General case' 0 N--CA 1.44 -0.925 0 N-CA-C 106.838 -1.542 . . . . 0.0 106.838 -176.599 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 55.5 m-85 -81.84 159.47 23.73 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.137 -176.37 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -53.86 132.16 41.19 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 112.473 0.546 . . . . 0.0 112.473 -177.499 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 65.56 29.88 76.18 Favored Glycine 0 C--O 1.224 -0.492 0 N-CA-C 115.83 1.092 . . . . 0.0 115.83 173.785 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 13.6 p . . . . . 0 C--N 1.322 -0.592 0 CA-C-N 117.958 0.879 . . . . 0.0 108.881 177.978 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 17.5 mt . . . . . 0 N--CA 1.446 -0.633 0 N-CA-C 114.31 1.226 . . . . 0.0 114.31 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -78.57 165.2 25.3 Favored 'Trans proline' 0 C--O 1.237 0.445 0 C-N-CA 121.625 1.55 . . . . 0.0 108.147 169.854 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 68.0 t80 -61.85 131.43 49.76 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 120.343 -0.543 . . . . 0.0 110.216 -179.363 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 92.21 -6.64 78.58 Favored Glycine 0 CA--C 1.52 0.372 0 N-CA-C 115.101 0.8 . . . . 0.0 115.101 178.861 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -64.42 129.02 38.28 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 118.431 1.115 . . . . 0.0 112.36 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 58.0 t30 -75.09 127.95 34.39 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.287 -178.318 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 1.2 ttmp? -156.18 153.2 28.87 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 179.33 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -62.11 129.06 39.09 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.812 0.339 . . . . 0.0 111.766 -179.434 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 66.39 31.38 78.73 Favored Glycine 0 N--CA 1.451 -0.301 0 CA-C-O 119.457 -0.635 . . . . 0.0 114.238 178.041 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 43.8 mm -128.61 129.95 68.79 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 CA-C-N 117.419 0.61 . . . . 0.0 109.942 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.1 pt -132.86 120.33 40.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.204 176.025 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 96.0 m95 -85.98 136.81 33.11 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 -176.678 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 16.3 m -138.15 149.74 24.66 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 CA-C-O 121.525 0.679 . . . . 0.0 109.623 179.523 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -155.97 166.62 32.93 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 104.43 -2.433 . . . . 0.0 104.43 -179.359 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 12.6 t -137.93 175.14 9.85 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 105.936 -1.876 . . . . 0.0 105.936 179.311 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -64.96 135.48 55.71 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.162 0.506 . . . . 0.0 110.549 -179.409 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 94.39 -7.9 71.93 Favored Glycine 0 C--O 1.224 -0.526 0 CA-C-N 115.881 -0.599 . . . . 0.0 113.755 177.879 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -79.35 138.84 37.84 Favored 'General case' 0 CA--C 1.538 0.505 0 O-C-N 122.443 -0.445 . . . . 0.0 111.92 -179.449 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 34.7 mt -95.08 137.08 34.62 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-O 121.007 0.432 . . . . 0.0 111.993 -179.455 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 58.9 t30 -82.0 69.54 8.73 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.11 0.481 . . . . 0.0 110.764 -179.437 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -141.26 155.65 67.85 Favored Pre-proline 0 C--N 1.323 -0.562 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 -178.626 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -64.62 150.53 88.04 Favored 'Trans proline' 0 C--N 1.344 0.338 0 N-CA-C 115.262 1.216 . . . . 0.0 115.262 179.649 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.478 ' HB3' HD12 ' A' ' 106' ' ' ILE . 74.1 mmtt -124.8 37.75 4.34 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 114.609 -1.178 . . . . 0.0 109.054 -177.644 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 16.6 p-10 -48.89 -45.96 41.95 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 114.742 -1.117 . . . . 0.0 112.869 -179.647 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 48.8 p-80 -70.05 -9.5 55.56 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 124.38 1.072 . . . . 0.0 113.747 -177.801 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.478 HD12 ' HB3' ' A' ' 103' ' ' LYS . 48.8 mt -94.9 -48.04 13.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 179.055 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -74.99 14.66 4.53 Favored Glycine 0 C--O 1.224 -0.502 0 N-CA-C 116.397 1.319 . . . . 0.0 116.397 -177.122 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 13.6 t -92.95 24.56 3.62 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 117.41 0.605 . . . . 0.0 111.099 179.478 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 65.9 ttp85 -57.8 136.28 56.93 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 178.918 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -109.09 132.22 21.34 Favored Pre-proline 0 C--N 1.324 -0.51 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -72.6 -15.35 27.37 Favored 'Trans proline' 0 C--O 1.219 -0.447 0 C-N-CA 117.877 -0.949 . . . . 0.0 113.52 -178.177 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -75.62 -25.62 57.07 Favored 'General case' 0 C--O 1.22 -0.481 0 CA-C-O 120.942 0.401 . . . . 0.0 110.303 178.401 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 82.7 m-20 -102.6 -23.31 13.88 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 113.745 1.017 . . . . 0.0 113.745 -174.339 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 -153.98 152.36 30.45 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.62 0.6 . . . . 0.0 112.62 -176.982 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -94.27 146.9 23.69 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-O 121.184 0.516 . . . . 0.0 110.749 178.402 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -71.38 148.47 46.95 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.005 0.431 . . . . 0.0 110.833 178.759 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 3.4 mt -92.41 142.33 13.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 -178.322 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -59.47 126.19 16.76 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 175.825 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 6.0 tt -68.55 128.88 38.2 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.956 -177.892 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 30.2 mt-30 -132.36 157.93 43.23 Favored 'General case' 0 CA--C 1.511 -0.544 0 N-CA-C 106.677 -1.601 . . . . 0.0 106.677 -179.122 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 13.7 mt -113.69 147.56 37.89 Favored Pre-proline 0 C--N 1.322 -0.62 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 177.6 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -73.32 167.0 28.44 Favored 'Trans proline' 0 C--N 1.346 0.397 0 O-C-N 122.223 0.591 . . . . 0.0 112.928 -179.342 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 43.6 tt0 -54.88 131.39 44.2 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.604 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 97.89 -19.45 54.54 Favored Glycine 0 C--O 1.227 -0.303 0 CA-C-N 116.004 -0.543 . . . . 0.0 113.256 -179.511 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 6.9 m -106.71 127.57 53.48 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 118.148 0.974 . . . . 0.0 110.576 178.713 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 17.2 p -120.24 148.36 43.79 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.541 -179.535 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 91.7 mt -67.24 154.87 91.96 Favored Pre-proline 0 C--N 1.324 -0.526 0 N-CA-C 107.953 -1.128 . . . . 0.0 107.953 178.082 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -75.16 170.47 20.3 Favored 'Trans proline' 0 N--CA 1.461 -0.385 0 C-N-CA 118.208 -0.728 . . . . 0.0 110.854 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 23.8 tptm -60.9 120.66 10.61 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 -178.094 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 91.13 41.53 5.21 Favored Glycine 0 C--O 1.227 -0.331 0 N-CA-C 115.297 0.879 . . . . 0.0 115.297 178.736 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -145.19 148.53 33.65 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 117.384 0.592 . . . . 0.0 110.403 177.557 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 54.8 p90 -147.73 165.05 31.68 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.212 -1.032 . . . . 0.0 108.212 176.106 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -105.99 139.81 39.95 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.01 0.433 . . . . 0.0 111.851 -176.703 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -74.09 143.56 45.34 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 178.236 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 95.59 -38.14 3.21 Favored Glycine 0 CA--C 1.518 0.25 0 C-N-CA 121.687 -0.292 . . . . 0.0 113.486 179.373 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 32.2 t . . . . . 0 C--N 1.324 -0.518 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 177.101 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.598 0 CA-C-O 122.464 1.126 . . . . 0.0 113.72 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 30.9 t -58.98 142.21 51.72 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 113.986 -1.461 . . . . 0.0 109.974 175.21 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 17.1 m95 -64.33 -21.94 66.78 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 114.104 1.15 . . . . 0.0 114.104 178.545 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -121.41 162.96 19.49 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 114.312 1.227 . . . . 0.0 114.312 -169.806 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 68.3 p -70.76 162.66 28.72 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 114.575 -1.193 . . . . 0.0 107.855 176.978 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.471 ' HB2' ' CZ ' ' A' ' 69' ' ' TYR . . . -75.72 141.98 42.54 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 113.243 0.831 . . . . 0.0 113.243 -175.97 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.419 HD23 ' HA ' ' A' ' 16' ' ' LEU . 12.4 mt -85.66 142.46 29.04 Favored 'General case' 0 C--O 1.213 -0.868 0 N-CA-C 102.678 -3.082 . . . . 0.0 102.678 169.257 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 40.9 m -123.84 135.77 53.96 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 118.638 0.654 . . . . 0.0 110.267 -177.603 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.438 ' HB2' ' CZ ' ' A' ' 131' ' ' PHE . 4.1 tp60 -100.7 139.25 36.65 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.493 -0.776 . . . . 0.0 112.005 -178.133 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 16.1 t-160 -126.58 99.6 5.87 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 103.775 -2.676 . . . . 0.0 103.775 168.674 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 157.17 -173.54 34.72 Favored Glycine 0 C--O 1.225 -0.417 0 N-CA-C 109.098 -1.601 . . . . 0.0 109.098 -176.629 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -97.68 -21.86 16.78 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 114.629 1.344 . . . . 0.0 114.629 -177.996 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -71.4 157.18 38.52 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.723 0.297 . . . . 0.0 110.351 -178.471 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -74.98 -63.0 1.36 Allowed 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.837 -0.345 . . . . 0.0 111.292 -178.092 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 36.0 tp 161.03 141.78 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.203 0 N-CA-C 102.299 -3.223 . . . . 0.0 102.299 179.094 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 13.8 tmtt? -156.71 131.07 8.63 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 176.625 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 -114.77 142.43 28.32 Favored Pre-proline 0 CA--C 1.54 0.592 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 176.491 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -62.88 154.12 68.52 Favored 'Trans proline' 0 CA--C 1.541 0.869 0 CA-C-O 121.325 0.469 . . . . 0.0 112.958 173.347 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 4.1 tmt_? -63.66 134.14 54.89 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.943 -177.701 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 87.96 6.85 75.09 Favored Glycine 0 C--O 1.226 -0.347 0 O-C-N 123.4 0.438 . . . . 0.0 112.381 178.381 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -145.72 167.78 22.31 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 -176.108 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 112.59 -19.38 21.73 Favored Glycine 0 CA--C 1.5 -0.846 0 C-N-CA 121.716 -0.278 . . . . 0.0 113.638 173.449 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.417 HG11 ' HB3' ' A' ' 43' ' ' GLN . 95.8 t -67.33 127.82 93.55 Favored Pre-proline 0 C--N 1.32 -0.712 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 178.473 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -74.93 164.03 34.25 Favored 'Trans proline' 0 N--CA 1.459 -0.504 0 O-C-N 122.124 0.539 . . . . 0.0 111.801 178.12 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 97.9 mt -66.84 123.44 19.9 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 -178.573 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 46.1 t-20 -125.61 113.83 17.91 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 177.239 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 67.0 p -90.68 -14.83 31.47 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 -175.509 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -111.51 28.99 8.23 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 113.408 0.892 . . . . 0.0 113.408 -175.65 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 99.3 p -141.58 164.88 29.02 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.713 0.292 . . . . 0.0 110.998 -179.412 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 4.2 m -77.13 164.95 55.73 Favored Pre-proline 0 C--N 1.321 -0.642 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.85 -178.294 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -68.31 -25.03 36.7 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 115.068 -2.821 . . . . 0.0 113.425 178.03 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.52 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 3.4 p-10 -76.64 -19.06 58.21 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 121.375 -0.828 . . . . 0.0 111.563 176.992 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 78.1 m-20 -78.57 -6.92 56.86 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 113.469 0.914 . . . . 0.0 113.469 -176.695 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.417 ' HB3' HG11 ' A' ' 32' ' ' VAL . 95.7 mm-40 -62.16 -24.91 67.46 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 113.595 0.961 . . . . 0.0 113.595 -177.997 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.449 ' HB ' ' HB1' ' A' ' 98' ' ' ALA . 7.9 tt -60.93 137.9 22.61 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.811 0 CA-C-O 122.205 1.003 . . . . 0.0 112.761 179.47 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 179.15 -156.9 19.7 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.465 -0.874 . . . . 0.0 112.382 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 45.3 p90 -155.02 170.45 21.74 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 179.1 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 19.5 m-85 -112.59 141.75 45.99 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 107.219 -1.401 . . . . 0.0 107.219 173.559 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 67.8 ttt-85 -112.24 130.24 55.99 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.971 -0.558 . . . . 0.0 111.237 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 44.8 ttt85 -71.67 145.35 48.95 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.472 0.653 . . . . 0.0 112.249 179.222 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -152.2 170.07 20.9 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 105.501 -2.037 . . . . 0.0 105.501 177.479 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 12.1 t -156.6 166.65 32.8 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 176.848 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 34.8 tpt85 -130.25 127.5 39.7 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 173.872 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 2.9 tmt_? -151.04 152.05 32.9 Favored 'General case' 0 CA--C 1.495 -1.147 0 N-CA-C 105.229 -2.137 . . . . 0.0 105.229 -178.68 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -125.99 174.17 10.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 26.8 tpt180 -141.99 122.31 13.96 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 106.106 -1.813 . . . . 0.0 106.106 177.905 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -82.65 174.56 53.14 Favored Glycine 0 C--O 1.224 -0.505 0 N-CA-C 109.24 -1.544 . . . . 0.0 109.24 178.003 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -72.26 -40.24 55.98 Favored Glycine 0 C--O 1.216 -1.023 0 N-CA-C 111.241 -0.744 . . . . 0.0 111.241 -177.485 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 27.3 t0 -71.93 -20.67 61.72 Favored 'General case' 0 C--O 1.217 -0.65 0 CA-C-O 122.635 1.207 . . . . 0.0 108.4 177.577 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 116.55 -12.39 15.82 Favored Glycine 0 CA--C 1.501 -0.803 0 CA-C-N 114.74 -1.118 . . . . 0.0 111.051 172.877 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 4.0 pttt -67.69 140.68 56.79 Favored 'General case' 0 CA--C 1.505 -0.755 0 CA-C-O 121.974 0.892 . . . . 0.0 110.495 -177.613 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 16.9 ptm -136.34 -177.47 4.73 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 114.027 -1.442 . . . . 0.0 112.155 -174.327 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 58.4 mmtt -90.58 -125.21 0.07 Allowed 'General case' 0 C--O 1.216 -0.663 0 N-CA-C 104.16 -2.533 . . . . 0.0 104.16 175.305 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 38.2 t0 -143.92 177.2 8.71 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 103.882 -2.636 . . . . 0.0 103.882 177.182 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -80.92 136.98 36.13 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 178.292 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.1 p -112.23 89.92 13.03 Favored Pre-proline 0 C--N 1.322 -0.593 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 173.739 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -69.13 131.82 22.99 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 115.632 -2.445 . . . . 0.0 112.107 -178.356 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 33.5 ptt180 -141.46 157.99 44.44 Favored 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 179.182 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 57.3 m95 -129.57 148.07 51.44 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 120.668 0.271 . . . . 0.0 111.306 -175.962 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.471 ' CZ ' ' HB2' ' A' ' 15' ' ' ALA . 48.1 m-85 -124.68 146.09 49.32 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 106.499 -1.667 . . . . 0.0 106.499 -179.433 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 75.1 t80 -95.74 131.5 41.94 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 -175.411 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -133.87 159.81 39.56 Favored 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 107.096 -1.446 . . . . 0.0 107.096 -175.201 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 71.5 m-85 -99.95 159.56 14.98 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 111.713 0.264 . . . . 0.0 111.713 -171.637 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -54.51 129.69 37.01 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.688 -178.759 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 68.72 34.48 78.13 Favored Glycine 0 C--O 1.221 -0.665 0 CA-C-O 118.804 -0.998 . . . . 0.0 115.57 176.666 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.327 -0.391 0 CA-C-N 118.633 1.216 . . . . 0.0 109.225 177.623 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 53.0 mt . . . . . 0 N--CA 1.447 -0.624 0 N-CA-C 115.015 1.487 . . . . 0.0 115.015 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -77.32 167.87 23.91 Favored 'Trans proline' 0 C--O 1.237 0.432 0 N-CA-C 108.749 -1.289 . . . . 0.0 108.749 170.454 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 66.7 t80 -62.77 134.0 55.62 Favored 'General case' 0 C--N 1.321 -0.658 0 O-C-N 121.957 -0.465 . . . . 0.0 110.019 179.431 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 89.64 -3.25 83.31 Favored Glycine 0 CA--C 1.519 0.327 0 N-CA-C 114.505 0.562 . . . . 0.0 114.505 178.236 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -63.14 130.13 43.3 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 117.812 0.806 . . . . 0.0 112.061 179.71 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 50.1 t-20 -76.6 124.67 27.98 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.692 -178.88 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 23.3 tttt -155.33 152.15 28.82 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 178.998 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -64.12 130.49 44.15 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.962 -178.117 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 65.62 30.27 77.01 Favored Glycine 0 N--CA 1.45 -0.395 0 CA-C-O 119.597 -0.557 . . . . 0.0 114.238 179.057 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 37.1 mm -129.83 128.71 65.56 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 CA-C-N 117.362 0.581 . . . . 0.0 110.154 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -133.16 118.27 31.78 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 CA-C-O 121.425 0.631 . . . . 0.0 110.747 177.175 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 92.8 m95 -84.98 137.27 33.19 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 113.395 0.887 . . . . 0.0 113.395 -175.675 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 18.6 m -137.85 149.7 25.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.66 0.743 . . . . 0.0 110.016 179.653 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -159.63 166.64 30.24 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 104.049 -2.575 . . . . 0.0 104.049 -179.404 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 10.6 t -131.73 173.92 10.66 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 104.956 -2.239 . . . . 0.0 104.956 177.918 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -67.69 135.14 52.3 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 -178.293 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 95.84 -11.14 68.22 Favored Glycine 0 CA--C 1.518 0.231 0 CA-C-N 115.883 -0.598 . . . . 0.0 112.945 -179.792 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.52 ' HA ' ' HA ' ' A' ' 41' ' ' ASP . . . -74.24 133.01 42.65 Favored 'General case' 0 CA--C 1.541 0.609 0 O-C-N 122.413 -0.463 . . . . 0.0 109.864 178.847 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 27.8 mt -88.53 140.39 29.51 Favored 'General case' 0 CA--C 1.513 -0.473 0 CA-C-O 121.367 0.603 . . . . 0.0 111.917 -178.148 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 58.0 t30 -84.43 68.08 10.13 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.371 -179.263 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -138.41 151.95 70.28 Favored Pre-proline 0 C--O 1.24 0.594 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -68.14 150.89 77.39 Favored 'Trans proline' 0 C--N 1.343 0.256 0 N-CA-C 114.62 0.969 . . . . 0.0 114.62 177.304 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 1.6 ptpt -150.99 58.45 0.91 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.987 0.898 . . . . 0.0 111.863 178.496 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -56.47 -28.47 59.8 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 115.037 -0.983 . . . . 0.0 111.225 177.061 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 14.2 p80 -59.24 -10.38 2.89 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 114.544 1.312 . . . . 0.0 114.544 -178.982 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 37.9 mt -96.31 -36.3 6.33 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.577 0 CA-C-N 117.92 0.327 . . . . 0.0 110.165 178.128 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -74.11 14.44 3.86 Favored Glycine 0 N--CA 1.464 0.538 0 N-CA-C 116.023 1.169 . . . . 0.0 116.023 -176.314 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 15.2 t -96.5 23.29 6.96 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 -177.179 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 57.8 ttp85 -63.05 126.63 27.97 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 106.943 -1.503 . . . . 0.0 106.943 177.817 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 18.3 m-20 -110.84 131.96 21.87 Favored Pre-proline 0 C--N 1.32 -0.684 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 -178.829 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -67.64 -21.45 45.56 Favored 'Trans proline' 0 C--N 1.349 0.589 0 N-CA-C 114.728 1.011 . . . . 0.0 114.728 -175.072 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -71.99 -25.0 61.67 Favored 'General case' 0 C--O 1.219 -0.526 0 CA-C-O 120.784 0.326 . . . . 0.0 110.266 177.559 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 -101.81 -28.54 12.38 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 113.486 0.921 . . . . 0.0 113.486 -175.822 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 -159.36 148.91 18.53 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -178.117 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -85.28 149.62 25.35 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-O 121.675 0.75 . . . . 0.0 112.862 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -70.73 147.39 49.08 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.762 178.797 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 23.5 mt -86.8 139.31 17.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.387 -179.141 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 73.1 t -61.87 122.02 11.56 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 174.874 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 5.8 tt -67.79 129.38 39.73 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.957 0.408 . . . . 0.0 110.123 -177.433 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -134.79 158.1 45.04 Favored 'General case' 0 CA--C 1.513 -0.472 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 -178.581 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 14.9 mt -114.45 149.2 41.78 Favored Pre-proline 0 C--N 1.322 -0.618 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 176.346 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_endo -70.56 168.81 21.52 Favored 'Trans proline' 0 C--N 1.343 0.27 0 N-CA-C 114.377 0.876 . . . . 0.0 114.377 -177.042 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -55.5 133.82 50.34 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.415 -178.242 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 88.27 -12.16 65.45 Favored Glycine 0 C--O 1.227 -0.333 0 CA-C-N 115.854 -0.612 . . . . 0.0 112.619 -179.688 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 16.2 m -107.38 125.9 51.79 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.113 0.483 . . . . 0.0 110.28 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 17.7 p -121.48 148.26 44.67 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 113.027 0.751 . . . . 0.0 113.027 -176.572 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 89.3 mt -69.79 156.28 92.0 Favored Pre-proline 0 C--N 1.326 -0.439 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 177.147 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -75.49 168.16 25.07 Favored 'Trans proline' 0 C--O 1.235 0.334 0 C-N-CA 118.42 -0.587 . . . . 0.0 111.252 178.506 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 1.8 tmtp? -58.72 128.79 38.97 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.702 -177.609 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 95.0 -5.57 68.76 Favored Glycine 0 C--O 1.225 -0.421 0 N-CA-C 114.664 0.625 . . . . 0.0 114.664 177.627 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.438 ' CZ ' ' HB2' ' A' ' 18' ' ' GLN . 1.4 m-85 -104.27 140.24 38.15 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-O 121.873 0.844 . . . . 0.0 111.199 -179.521 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 46.1 p90 -142.19 165.67 26.8 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 114.174 -1.376 . . . . 0.0 107.461 176.092 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -106.98 144.61 33.35 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.927 0.394 . . . . 0.0 111.358 -177.37 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -72.67 136.94 45.73 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 178.747 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 89.64 -30.0 5.97 Favored Glycine 0 CA--C 1.518 0.241 0 CA-C-N 116.139 -0.482 . . . . 0.0 112.786 -177.242 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 22.7 t . . . . . 0 C--N 1.325 -0.476 0 CA-C-N 117.386 0.593 . . . . 0.0 110.635 -179.942 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.836 0 CA-C-O 121.703 0.763 . . . . 0.0 112.724 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 51.2 p -60.66 144.84 51.12 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 114.908 -1.042 . . . . 0.0 110.293 178.652 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 22.3 m95 -70.8 -24.36 62.55 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 114.727 1.38 . . . . 0.0 114.727 -178.369 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 26.3 m-85 -121.49 162.47 20.46 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 -171.645 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 73.0 p -70.25 162.68 27.99 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 179.195 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -79.42 149.17 31.68 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.953 0.882 . . . . 0.0 112.991 -177.782 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 37.1 mt -89.52 148.95 23.12 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 102.77 -3.048 . . . . 0.0 102.77 168.637 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 33.6 m -122.83 138.51 54.63 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.444 ' HB2' ' CZ ' ' A' ' 131' ' ' PHE . 4.1 tp60 -110.66 135.08 51.81 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.246 0.546 . . . . 0.0 112.3 -176.785 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 7.7 t-160 -130.9 94.68 3.66 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 104.055 -2.572 . . . . 0.0 104.055 170.751 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -178.76 -171.21 41.76 Favored Glycine 0 C--O 1.224 -0.494 0 N-CA-C 110.19 -1.164 . . . . 0.0 110.19 -176.622 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -97.69 -26.45 14.74 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 113.844 1.053 . . . . 0.0 113.844 -177.646 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 25.6 pt-20 -92.23 166.41 12.63 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 179.024 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -79.22 -62.93 1.54 Allowed 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 120.704 -0.398 . . . . 0.0 111.753 -177.255 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 36.8 tp 171.61 144.18 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 105.822 -1.918 . . . . 0.0 105.822 178.059 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 55.0 tttm -156.03 142.69 18.7 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 171.434 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 15.5 m-85 -119.66 157.9 50.86 Favored Pre-proline 0 C--O 1.247 0.955 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 176.175 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.415 ' HG2' ' HB3' ' A' ' 30' ' ' GLN . 50.0 Cg_endo -64.99 163.78 27.26 Favored 'Trans proline' 0 C--N 1.352 0.745 0 C-N-CA 121.355 1.37 . . . . 0.0 112.755 175.64 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 25.9 tpt180 -78.14 132.63 37.73 Favored 'General case' 0 C--O 1.216 -0.696 0 O-C-N 121.845 -0.534 . . . . 0.0 110.743 -177.435 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 77.95 17.81 77.88 Favored Glycine 0 C--O 1.223 -0.571 0 O-C-N 123.386 0.429 . . . . 0.0 112.315 177.21 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.415 ' HB3' ' HG2' ' A' ' 27' ' ' PRO . 49.3 tt0 -157.33 170.47 22.39 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 104.451 -2.425 . . . . 0.0 104.451 -175.497 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 105.73 -8.74 43.55 Favored Glycine 0 N--CA 1.462 0.41 0 CA-C-N 118.525 0.602 . . . . 0.0 113.811 177.399 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 76.2 t -70.9 133.8 86.03 Favored Pre-proline 0 C--N 1.321 -0.665 0 N-CA-C 106.791 -1.559 . . . . 0.0 106.791 176.984 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -69.98 171.87 13.9 Favored 'Trans proline' 0 N--CA 1.464 -0.246 0 C-N-CA 120.588 0.858 . . . . 0.0 112.967 178.113 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 83.7 mt -74.85 112.05 11.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 179.113 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 64.7 m-20 -109.6 80.74 1.35 Allowed 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 114.842 -1.072 . . . . 0.0 109.865 -175.97 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 76.2 p -69.87 -17.71 63.37 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 114.124 1.157 . . . . 0.0 114.124 -176.255 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 70.3 m-80 -112.54 35.46 3.82 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.701 -178.116 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.7 m -146.54 165.69 28.7 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 111.716 0.265 . . . . 0.0 111.716 -177.579 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 47.0 m -93.15 158.78 36.72 Favored Pre-proline 0 CA--C 1.536 0.439 0 C-N-CA 123.219 0.608 . . . . 0.0 111.718 -176.041 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -65.91 -23.92 54.1 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 115.71 -2.393 . . . . 0.0 115.253 -177.768 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -76.84 -20.23 56.59 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 121.68 -0.638 . . . . 0.0 112.675 179.051 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 12.4 p30 -96.41 0.99 51.28 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 114.643 1.349 . . . . 0.0 114.643 -174.565 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 86.4 mm-40 -57.36 -22.32 41.67 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.667 0.746 . . . . 0.0 112.675 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 8.2 tt -62.73 135.66 26.85 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.741 0 CA-C-O 122.366 1.079 . . . . 0.0 111.752 177.769 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 179.3 -156.81 19.36 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.212 -0.994 . . . . 0.0 112.232 -178.164 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 39.9 p90 -155.12 166.98 31.88 Favored 'General case' 0 C--N 1.318 -0.803 0 O-C-N 122.564 -0.374 . . . . 0.0 110.263 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 32.4 m-85 -108.22 140.68 41.1 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 175.556 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 48.5 ttt180 -115.85 120.21 38.5 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 124.1 0.96 . . . . 0.0 112.56 -175.215 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 36.7 ttt180 -66.32 141.21 58.07 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 123.785 0.834 . . . . 0.0 111.427 178.675 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -149.88 143.2 25.15 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 122.609 0.364 . . . . 0.0 111.116 176.752 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 14.6 t -161.0 165.86 29.18 Favored 'General case' 0 C--O 1.239 0.544 0 N-CA-C 106.078 -1.823 . . . . 0.0 106.078 174.852 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 3.9 tpt180 -144.9 127.97 16.58 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.78 0.324 . . . . 0.0 110.392 178.078 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 7.5 tmm_? -139.39 131.62 28.21 Favored 'General case' 0 CA--C 1.498 -1.023 0 CA-C-O 121.54 0.686 . . . . 0.0 109.698 178.369 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -139.85 179.28 2.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 N-CA-C 105.775 -1.935 . . . . 0.0 105.775 -178.564 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 17.4 tpp180 -124.9 103.51 8.09 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 106.244 -1.762 . . . . 0.0 106.244 173.808 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -75.57 159.04 50.89 Favored Glycine 0 C--O 1.227 -0.304 0 N-CA-C 106.945 -2.462 . . . . 0.0 106.945 176.067 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -60.51 -38.23 94.55 Favored Glycine 0 C--O 1.22 -0.765 0 CA-C-N 118.277 1.038 . . . . 0.0 113.698 -178.011 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -86.03 7.09 25.92 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.691 0.758 . . . . 0.0 111.593 179.731 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 96.62 -2.21 62.34 Favored Glycine 0 C--N 1.321 -0.29 0 CA-C-N 115.241 -0.89 . . . . 0.0 113.711 177.617 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 18.3 mttt -59.55 140.25 56.46 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.852 0.834 . . . . 0.0 112.703 -178.51 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 84.1 mtp -111.81 -169.97 1.56 Allowed 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 113.974 -1.466 . . . . 0.0 109.562 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 8.4 mmtt -121.28 -69.0 0.86 Allowed 'General case' 0 C--O 1.217 -0.636 0 N-CA-C 111.801 0.297 . . . . 0.0 111.801 -179.126 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 70.4 m-20 -126.46 158.71 35.33 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 -179.446 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 95.2 mt -122.4 -68.74 0.87 Allowed 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 177.231 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -71.17 135.25 84.82 Favored Pre-proline 0 C--N 1.323 -0.561 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.682 177.566 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -75.06 155.5 42.64 Favored 'Trans proline' 0 C--O 1.236 0.4 0 C-N-CA 117.048 -1.501 . . . . 0.0 113.165 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 75.6 mtt85 -111.59 160.02 17.6 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.234 178.33 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 71.2 m95 -132.64 127.4 34.82 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 175.891 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 65.7 m-85 -110.29 167.1 10.45 Favored 'General case' 0 C--O 1.21 -0.993 0 N-CA-C 104.758 -2.312 . . . . 0.0 104.758 -179.59 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 85.2 t80 -114.88 139.73 49.54 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 119.339 0.972 . . . . 0.0 109.118 -179.05 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 -138.61 148.69 44.42 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.515 -176.866 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 71.5 m-85 -82.2 159.49 23.25 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.423 -177.48 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -54.12 129.46 34.76 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-O 121.234 0.54 . . . . 0.0 112.407 -177.934 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 73.9 28.34 64.97 Favored Glycine 0 C--O 1.219 -0.837 0 N-CA-C 115.804 1.081 . . . . 0.0 115.804 175.714 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 2.3 p . . . . . 0 C--N 1.323 -0.545 0 CA-C-N 118.675 1.238 . . . . 0.0 108.56 179.39 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 74.7 mt . . . . . 0 N--CA 1.449 -0.488 0 N-CA-C 114.935 1.457 . . . . 0.0 114.935 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -76.57 166.96 26.41 Favored 'Trans proline' 0 C--O 1.238 0.482 0 N-CA-C 109.078 -1.162 . . . . 0.0 109.078 170.976 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.415 ' CE1' ' HB3' ' A' ' 92' ' ' TRP . 83.3 t80 -61.04 128.89 38.67 Favored 'General case' 0 C--N 1.323 -0.557 0 O-C-N 121.989 -0.444 . . . . 0.0 110.898 -179.747 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 93.89 -4.92 72.29 Favored Glycine 0 CA--C 1.518 0.277 0 N-CA-C 114.977 0.751 . . . . 0.0 114.977 178.228 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -63.81 133.2 52.99 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 118.027 0.913 . . . . 0.0 111.935 179.376 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 -77.95 130.31 36.38 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.096 -179.108 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 39.2 tttm -156.07 150.29 25.52 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 176.123 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -63.36 131.65 48.94 Favored 'General case' 0 C--O 1.24 0.573 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 178.965 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 72.33 23.33 78.11 Favored Glycine 0 N--CA 1.445 -0.757 0 N-CA-C 114.894 0.718 . . . . 0.0 114.894 177.439 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 42.7 mm -130.45 127.46 62.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 117.146 0.473 . . . . 0.0 109.946 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -133.17 123.56 47.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.929 176.678 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' TRP . . . . . 0.415 ' HB3' ' CE1' ' A' ' 83' ' ' TYR . 92.9 m95 -89.55 137.41 32.36 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 113.225 0.824 . . . . 0.0 113.225 -175.453 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 15.8 m -136.74 153.06 29.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 178.839 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -157.5 166.53 32.71 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 102.863 -3.014 . . . . 0.0 102.863 -179.51 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 11.4 t -136.05 175.26 9.76 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 106.215 -1.772 . . . . 0.0 106.215 179.33 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -64.02 133.55 53.33 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.011 0.434 . . . . 0.0 110.226 -179.666 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 93.85 -9.4 73.21 Favored Glycine 0 N--CA 1.46 0.237 0 CA-C-N 116.061 -0.518 . . . . 0.0 114.116 178.108 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -74.58 139.38 43.66 Favored 'General case' 0 CA--C 1.54 0.576 0 O-C-N 122.484 -0.421 . . . . 0.0 111.425 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 18.5 mt -82.13 162.48 22.47 Favored 'General case' 0 C--O 1.213 -0.86 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 177.844 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 59.4 t30 -114.87 69.53 0.72 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.075 0.464 . . . . 0.0 110.405 178.409 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -143.1 152.54 58.45 Favored Pre-proline 0 C--O 1.241 0.616 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -67.44 150.94 80.72 Favored 'Trans proline' 0 C--N 1.345 0.355 0 N-CA-C 113.511 0.543 . . . . 0.0 113.511 177.77 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 4.9 ptpt -151.6 59.11 0.88 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 122.777 1.275 . . . . 0.0 109.128 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -60.39 -30.6 69.69 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 113.846 -1.524 . . . . 0.0 113.028 -178.307 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 48.5 p-80 -60.84 -22.92 64.7 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 113.095 0.776 . . . . 0.0 113.095 -178.02 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 67.4 mt -71.45 -31.83 44.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 178.586 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -74.93 14.64 4.49 Favored Glycine 0 CA--C 1.524 0.596 0 N-CA-C 115.638 1.015 . . . . 0.0 115.638 -178.082 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 9.5 t -83.27 16.19 2.58 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 113.773 1.027 . . . . 0.0 113.773 -178.395 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 65.3 ttp85 -59.17 130.02 44.96 Favored 'General case' 0 N--CA 1.47 0.552 0 O-C-N 121.225 -0.922 . . . . 0.0 108.861 -178.79 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -107.93 130.18 23.14 Favored Pre-proline 0 C--N 1.322 -0.606 0 N-CA-C 106.408 -1.701 . . . . 0.0 106.408 179.475 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -69.61 -17.78 38.08 Favored 'Trans proline' 0 C--O 1.219 -0.461 0 C-N-CA 117.826 -0.982 . . . . 0.0 113.667 -177.652 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -74.14 -26.14 60.15 Favored 'General case' 0 C--O 1.22 -0.47 0 CA-C-O 120.838 0.352 . . . . 0.0 110.657 178.191 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 77.9 m-20 -102.23 -25.07 13.82 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 113.195 0.813 . . . . 0.0 113.195 -174.481 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 17.9 t-20 -156.04 147.15 22.33 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.623 0.601 . . . . 0.0 112.623 -178.603 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -89.5 146.99 24.24 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.706 179.368 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -70.71 147.43 49.07 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.928 0.394 . . . . 0.0 109.969 178.129 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 2.0 mt -91.36 142.65 12.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 -178.129 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 87.8 t -59.14 123.08 10.72 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 N-CA-C 107.883 -1.155 . . . . 0.0 107.883 177.077 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 7.3 tt -70.46 127.89 34.28 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 -178.499 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 36.5 mt-30 -132.77 162.74 30.67 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 -178.76 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 15.4 mt -114.81 145.55 34.19 Favored Pre-proline 0 C--N 1.323 -0.584 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 179.268 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -72.93 170.34 19.97 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 120.329 0.686 . . . . 0.0 113.84 -177.567 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -54.61 133.36 46.53 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.738 -179.645 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 92.6 -17.43 57.67 Favored Glycine 0 C--O 1.227 -0.331 0 CA-C-N 116.001 -0.545 . . . . 0.0 113.191 -179.383 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 3.8 m -108.62 126.22 52.72 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 117.773 0.786 . . . . 0.0 110.303 178.689 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 14.5 p -123.4 152.19 41.83 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.057 -0.52 . . . . 0.0 109.922 -178.868 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 90.4 mt -72.34 151.47 92.05 Favored Pre-proline 0 C--N 1.324 -0.527 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 178.299 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -77.81 173.08 14.62 Favored 'Trans proline' 0 N--CA 1.462 -0.34 0 O-C-N 121.966 0.456 . . . . 0.0 111.06 178.418 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 66.3 tttp -59.78 127.89 34.2 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 122.074 -0.392 . . . . 0.0 111.519 -177.631 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 95.17 -1.48 64.87 Favored Glycine 0 C--O 1.227 -0.292 0 N-CA-C 115.142 0.817 . . . . 0.0 115.142 176.696 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.444 ' CZ ' ' HB2' ' A' ' 18' ' ' GLN . 1.2 m-85 -103.75 141.69 35.65 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-O 121.601 0.715 . . . . 0.0 111.632 -179.25 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 47.2 p90 -146.13 166.07 27.25 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 114.572 -1.194 . . . . 0.0 107.833 175.415 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -106.47 145.57 31.64 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 112.446 0.536 . . . . 0.0 112.446 -176.31 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -72.81 139.35 46.97 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 177.489 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 90.69 -36.85 3.48 Favored Glycine 0 CA--C 1.515 0.079 0 CA-C-N 116.177 -0.465 . . . . 0.0 112.821 -178.613 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 31.3 t . . . . . 0 C--N 1.325 -0.488 0 N-CA-C 109.541 -0.541 . . . . 0.0 109.541 -179.445 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.311 0 CA-C-O 121.134 0.492 . . . . 0.0 110.714 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 5.3 m -61.14 145.86 49.54 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.877 176.523 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 18.7 m95 -67.04 -22.83 65.86 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 113.452 0.908 . . . . 0.0 113.452 179.804 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -121.43 162.32 20.65 Favored 'General case' 0 CA--C 1.507 -0.688 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.974 -172.896 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 76.5 p -70.5 161.97 29.64 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 177.473 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -83.58 144.76 29.26 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.9 -0.591 . . . . 0.0 112.392 -175.82 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.41 HD21 HD22 ' A' ' 119' ' ' LEU . 66.2 mt -76.32 148.85 37.21 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 104.798 -2.297 . . . . 0.0 104.798 171.525 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 31.3 m -128.14 148.58 50.6 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 105.24 -2.133 . . . . 0.0 105.24 179.12 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -138.47 163.12 32.77 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 114.925 1.454 . . . . 0.0 114.925 -178.336 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 52.9 t60 -89.71 99.5 12.5 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 100.705 -3.813 . . . . 0.0 100.705 168.811 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -42.07 103.05 0.03 OUTLIER Glycine 0 N--CA 1.461 0.313 0 N-CA-C 118.538 2.175 . . . . 0.0 118.538 -173.803 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 82.4 mttt -142.97 -44.93 0.3 Allowed 'General case' 0 C--O 1.221 -0.401 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 177.862 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -120.67 169.61 10.22 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 -179.393 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -106.01 32.74 4.19 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 122.967 1.365 . . . . 0.0 110.045 178.873 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 32.6 tp 64.23 141.49 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 111.283 -2.689 . . . . 0.0 114.619 176.798 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 43.1 tptt -153.68 138.22 16.84 Favored 'General case' 0 C--N 1.324 -0.532 0 O-C-N 121.31 -0.869 . . . . 0.0 110.529 171.879 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -122.66 149.14 55.14 Favored Pre-proline 0 C--N 1.321 -0.633 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 176.073 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -70.25 159.44 53.04 Favored 'Trans proline' 0 C--N 1.349 0.576 0 O-C-N 122.188 0.573 . . . . 0.0 112.7 179.149 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 16.0 tpt180 -67.04 136.15 54.79 Favored 'General case' 0 C--O 1.218 -0.598 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 -178.826 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 85.94 6.96 81.63 Favored Glycine 0 C--O 1.222 -0.621 0 N-CA-C 111.241 -0.744 . . . . 0.0 111.241 179.606 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 17.4 mt-30 -147.77 172.68 13.74 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 123.27 0.628 . . . . 0.0 109.433 -175.356 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 104.23 -20.47 40.22 Favored Glycine 0 CA--C 1.501 -0.816 0 CA-C-N 115.883 -0.599 . . . . 0.0 113.558 174.424 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 57.6 t -67.28 128.22 93.66 Favored Pre-proline 0 C--N 1.32 -0.706 0 N-CA-C 106.76 -1.57 . . . . 0.0 106.76 177.87 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -71.59 171.61 15.98 Favored 'Trans proline' 0 C--O 1.223 -0.265 0 O-C-N 122.161 0.558 . . . . 0.0 111.329 177.843 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 87.6 mt -70.01 106.57 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-O 121.96 0.886 . . . . 0.0 108.791 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 -98.1 83.67 3.15 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 114.663 -1.153 . . . . 0.0 110.616 -176.55 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 73.1 p -68.02 -14.21 62.79 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.707 0.765 . . . . 0.0 112.725 -179.51 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 11.1 p30 -108.84 21.61 17.01 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.008 -0.997 . . . . 0.0 112.724 -177.216 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 5.8 m -142.83 151.47 41.16 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 113.366 0.876 . . . . 0.0 113.366 -176.844 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 52.8 m -78.32 166.53 42.37 Favored Pre-proline 0 C--N 1.327 -0.407 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 177.224 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.418 ' HA ' ' HG2' ' A' ' 43' ' ' GLN . 60.6 Cg_endo -63.94 -26.67 66.63 Favored 'Trans proline' 0 C--N 1.353 0.77 0 C-N-CA 115.24 -2.707 . . . . 0.0 112.86 179.65 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -60.81 -32.82 72.17 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.663 0.744 . . . . 0.0 110.78 177.192 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 68.8 m-20 -88.7 -6.15 57.64 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 115.416 1.636 . . . . 0.0 115.416 -172.88 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.418 ' HG2' ' HA ' ' A' ' 40' ' ' PRO . 96.5 mm-40 -58.33 -29.25 65.77 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 114.295 1.22 . . . . 0.0 114.295 -176.248 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.43 ' HB ' ' HB1' ' A' ' 98' ' ' ALA . 11.2 tt -59.5 136.69 22.85 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-O 122.408 1.099 . . . . 0.0 112.244 -179.299 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -179.04 -157.9 20.4 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.495 -0.86 . . . . 0.0 111.996 -177.57 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 47.7 p90 -155.01 171.41 19.79 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 179.438 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 19.1 m-85 -112.71 141.05 46.95 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 106.551 -1.648 . . . . 0.0 106.551 173.548 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 69.4 ttt-85 -114.18 124.79 52.92 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.758 -177.144 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 15.2 ttt-85 -63.22 137.82 58.34 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 175.971 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -149.27 140.87 23.45 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.776 0.798 . . . . 0.0 112.708 179.477 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 12.2 p -133.26 142.64 48.63 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 104.602 -2.37 . . . . 0.0 104.602 174.34 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 11.8 tpt180 -160.68 128.23 4.38 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 112.959 0.726 . . . . 0.0 112.959 -179.81 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.5 tpp180 -116.68 142.7 46.56 Favored 'General case' 0 CA--C 1.507 -0.69 0 N-CA-C 105.734 -1.951 . . . . 0.0 105.734 173.777 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -138.37 177.1 5.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 -177.043 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.93 117.41 19.2 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 104.434 -2.432 . . . . 0.0 104.434 172.65 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -82.79 163.41 42.04 Favored Glycine 0 C--O 1.224 -0.511 0 N-CA-C 107.57 -2.212 . . . . 0.0 107.57 176.681 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -64.35 -32.58 84.68 Favored Glycine 0 C--O 1.214 -1.112 0 CA-C-N 118.121 0.96 . . . . 0.0 111.609 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -90.86 17.91 7.22 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-O 122.147 0.975 . . . . 0.0 110.551 178.89 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 85.36 -6.25 80.51 Favored Glycine 0 N--CA 1.46 0.247 0 N-CA-C 116.338 1.295 . . . . 0.0 116.338 173.54 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.42 128.69 37.54 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.807 0.813 . . . . 0.0 112.634 -178.069 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 97.8 mmm -99.32 -174.73 2.81 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 114.323 -1.308 . . . . 0.0 108.051 178.466 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 6.3 tttp -117.02 -62.0 1.64 Allowed 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 175.34 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.1 t0 54.74 -152.82 0.33 Allowed 'General case' 0 C--O 1.24 0.59 0 O-C-N 124.771 1.294 . . . . 0.0 110.955 178.346 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.9 mm? 67.16 -179.47 0.22 Allowed 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 115.372 1.619 . . . . 0.0 115.372 174.069 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -58.26 156.34 21.89 Favored Pre-proline 0 C--O 1.24 0.585 0 N-CA-C 116.804 2.15 . . . . 0.0 116.804 -174.874 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -66.41 156.57 64.62 Favored 'Trans proline' 0 C--N 1.354 0.838 0 CA-C-O 121.3 0.458 . . . . 0.0 111.817 177.431 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 42.2 mtt-85 -128.69 163.31 25.38 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.622 -175.326 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 61.8 m95 -127.42 129.97 48.48 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 179.122 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 24.2 m-85 -111.27 149.08 31.56 Favored 'General case' 0 C--O 1.213 -0.838 0 N-CA-C 106.949 -1.5 . . . . 0.0 106.949 -178.38 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 86.8 t80 -98.1 139.97 33.12 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.909 -0.775 . . . . 0.0 108.909 -178.224 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -142.36 153.13 43.56 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 -179.052 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 69.1 m-85 -88.12 159.51 18.18 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.87 -174.502 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -54.43 131.01 41.5 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.77 0.319 . . . . 0.0 110.686 -179.487 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 69.67 32.98 71.0 Favored Glycine 0 C--O 1.223 -0.578 0 N-CA-C 115.345 0.898 . . . . 0.0 115.345 176.37 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.433 HG22 ' HA ' ' A' ' 104' ' ' ASP . 1.4 p . . . . . 0 C--N 1.325 -0.463 0 CA-C-N 118.108 0.954 . . . . 0.0 109.312 177.268 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 52.2 mt . . . . . 0 C--O 1.238 0.491 0 N-CA-C 115.65 1.722 . . . . 0.0 115.65 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -78.15 168.0 22.49 Favored 'Trans proline' 0 CA--C 1.53 0.32 0 C-N-CA 120.954 1.103 . . . . 0.0 109.442 170.783 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.432 ' CE2' ' HB3' ' A' ' 92' ' ' TRP . 73.2 t80 -62.26 131.96 51.09 Favored 'General case' 0 C--N 1.323 -0.575 0 O-C-N 121.883 -0.511 . . . . 0.0 110.309 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 90.55 -3.6 81.72 Favored Glycine 0 C--O 1.228 -0.265 0 N-CA-C 114.585 0.594 . . . . 0.0 114.585 177.998 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -63.09 131.0 47.08 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 118.016 0.908 . . . . 0.0 111.403 179.392 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 53.7 t30 -77.84 124.92 28.58 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.181 -178.641 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 12.1 tttp -156.15 151.74 27.05 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 178.322 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 20.3 t0 -66.41 133.79 51.18 Favored 'General case' 0 C--N 1.322 -0.623 0 O-C-N 123.395 0.435 . . . . 0.0 110.068 -179.197 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 67.31 27.56 73.53 Favored Glycine 0 N--CA 1.45 -0.431 0 N-CA-C 114.749 0.66 . . . . 0.0 114.749 178.529 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 41.7 mm -129.27 125.84 62.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 117.266 0.533 . . . . 0.0 110.655 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.1 pt -129.78 116.16 36.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 CA-C-O 121.909 0.861 . . . . 0.0 112.536 176.782 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' TRP . . . . . 0.432 ' HB3' ' CE2' ' A' ' 83' ' ' TYR . 94.8 m95 -80.52 135.28 36.07 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 113.533 0.938 . . . . 0.0 113.533 -176.921 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 17.1 m -135.13 151.99 31.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 179.427 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -160.6 166.5 28.84 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 104.683 -2.34 . . . . 0.0 104.683 -178.801 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 13.5 t -136.39 178.78 6.8 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 105.151 -2.166 . . . . 0.0 105.151 177.958 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -66.99 136.48 55.38 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.318 0.58 . . . . 0.0 110.693 -179.257 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 92.24 -14.32 64.88 Favored Glycine 0 C--O 1.226 -0.374 0 CA-C-N 115.715 -0.675 . . . . 0.0 113.563 177.256 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.43 ' HB1' ' HB ' ' A' ' 44' ' ' ILE . . . -69.96 126.71 30.48 Favored 'General case' 0 C--N 1.322 -0.624 0 O-C-N 122.43 -0.453 . . . . 0.0 110.975 -179.492 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 43.6 mt -83.49 138.37 33.47 Favored 'General case' 0 CA--C 1.515 -0.392 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 -177.224 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 61.5 t30 -82.08 65.11 7.06 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.527 0.68 . . . . 0.0 110.729 179.816 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -140.11 155.18 70.71 Favored Pre-proline 0 C--N 1.322 -0.619 0 N-CA-C 105.639 -1.985 . . . . 0.0 105.639 179.591 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_endo -73.33 155.83 50.94 Favored 'Trans proline' 0 CA--C 1.532 0.377 0 N-CA-C 115.016 1.122 . . . . 0.0 115.016 179.438 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.79 58.02 1.05 Allowed 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 121.852 0.834 . . . . 0.0 112.055 176.338 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' ASP . . . . . 0.433 ' HA ' HG22 ' A' ' 75' ' ' THR . 33.7 t70 -56.98 -26.94 60.94 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.117 178.115 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 17.1 p80 -58.84 -11.52 3.36 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 114.521 1.304 . . . . 0.0 114.521 -178.886 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 23.2 mt -96.35 -36.14 6.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 122.175 -0.328 . . . . 0.0 110.836 178.22 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -73.83 14.51 3.55 Favored Glycine 0 CA--C 1.522 0.495 0 N-CA-C 116.189 1.235 . . . . 0.0 116.189 -175.334 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 9.7 t -107.33 29.26 7.3 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-O 121.057 0.456 . . . . 0.0 111.971 -177.872 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 64.2 ttp85 -54.73 134.36 47.44 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 177.513 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 41.6 m-20 -102.06 122.73 46.01 Favored Pre-proline 0 C--N 1.325 -0.497 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 -178.129 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -68.74 -18.6 42.02 Favored 'Trans proline' 0 C--O 1.217 -0.531 0 N-CA-C 114.425 0.894 . . . . 0.0 114.425 -176.838 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -75.69 -25.92 57.15 Favored 'General case' 0 C--O 1.22 -0.477 0 CA-C-O 120.842 0.353 . . . . 0.0 110.657 178.121 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 83.0 m-20 -100.75 -23.84 14.53 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 -175.39 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 -154.98 147.91 24.6 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.764 0.654 . . . . 0.0 112.764 -178.879 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -88.37 148.57 24.18 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-O 121.454 0.645 . . . . 0.0 111.404 179.493 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -68.97 142.45 54.67 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.226 0.536 . . . . 0.0 110.183 178.378 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 18.9 mt -84.8 136.56 22.5 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 -179.038 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 74.4 t -60.49 124.69 15.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 N-CA-C 105.295 -2.113 . . . . 0.0 105.295 174.984 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.41 HD22 HD21 ' A' ' 16' ' ' LEU . 7.6 tt -66.18 127.93 34.1 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.199 0.523 . . . . 0.0 109.968 -176.65 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 30.1 mt-30 -129.68 156.35 44.4 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 106.169 -1.789 . . . . 0.0 106.169 -179.483 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 13.6 mt -112.37 148.02 38.27 Favored Pre-proline 0 C--N 1.321 -0.661 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 177.849 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -72.43 165.37 32.88 Favored 'Trans proline' 0 C--O 1.236 0.38 0 O-C-N 122.293 0.628 . . . . 0.0 112.454 -179.354 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 65.1 tt0 -54.86 130.41 41.06 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.491 -179.471 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 99.47 -19.8 52.27 Favored Glycine 0 C--O 1.226 -0.39 0 CA-C-N 115.873 -0.603 . . . . 0.0 113.601 -179.278 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 11.2 m -105.76 130.91 53.66 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 118.251 1.025 . . . . 0.0 110.684 178.827 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 16.9 p -124.54 152.11 43.88 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.614 -178.035 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 90.3 mt -78.67 155.3 78.45 Favored Pre-proline 0 C--N 1.326 -0.432 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 177.287 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -75.19 170.25 20.77 Favored 'Trans proline' 0 C--O 1.237 0.44 0 CA-C-O 121.55 0.562 . . . . 0.0 111.367 177.993 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 48.1 tptt -63.5 122.49 16.4 Favored 'General case' 0 C--O 1.218 -0.579 0 CA-C-O 121.006 0.432 . . . . 0.0 111.234 -175.863 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 95.21 7.36 59.54 Favored Glycine 0 C--O 1.228 -0.263 0 N-CA-C 115.236 0.854 . . . . 0.0 115.236 178.331 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -110.48 143.48 40.74 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 107.332 -1.358 . . . . 0.0 107.332 176.788 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 35.2 p90 -147.56 163.95 34.99 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 177.263 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -99.55 145.6 27.34 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.894 0.378 . . . . 0.0 110.625 -178.393 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -72.07 135.84 46.42 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 178.28 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 86.41 -10.47 66.68 Favored Glycine 0 C--O 1.226 -0.396 0 CA-C-N 116.28 -0.418 . . . . 0.0 113.464 -178.641 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 32.2 t . . . . . 0 C--N 1.326 -0.429 0 CA-C-N 117.535 0.668 . . . . 0.0 110.089 179.482 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.623 0 CA-C-O 121.486 0.66 . . . . 0.0 109.667 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -58.37 140.28 53.88 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.608 177.674 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 35.7 m95 -65.82 -22.0 66.52 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 114.283 1.216 . . . . 0.0 114.283 -178.769 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 82.6 m-85 -121.37 161.84 21.4 Favored 'General case' 0 CA--C 1.506 -0.714 0 N-CA-C 114.453 1.279 . . . . 0.0 114.453 -171.086 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.423 ' HB ' ' HB3' ' A' ' 134' ' ' GLU . 73.1 p -69.89 163.59 25.62 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 114.045 -1.434 . . . . 0.0 108.468 177.956 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.468 ' HB2' ' CZ ' ' A' ' 69' ' ' TYR . . . -77.43 139.3 39.64 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 -175.224 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 12.8 mt -84.49 145.62 28.02 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 103.927 -2.619 . . . . 0.0 103.927 170.8 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 21.9 m -129.31 133.2 47.33 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 118.13 0.423 . . . . 0.0 109.96 -179.4 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.414 ' HB2' ' CZ ' ' A' ' 131' ' ' PHE . 3.8 tp60 -95.34 143.33 26.79 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 123.615 0.572 . . . . 0.0 111.577 -179.568 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 23.1 t-160 -138.97 96.5 3.13 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 102.609 -3.108 . . . . 0.0 102.609 165.57 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 172.57 -161.22 32.67 Favored Glycine 0 C--O 1.226 -0.399 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 -173.531 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 49.6 mtmt -104.54 -27.89 11.61 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 116.332 1.975 . . . . 0.0 116.332 -176.634 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -85.58 162.44 18.86 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 179.231 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -76.03 -62.9 1.44 Allowed 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 -178.519 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 36.4 tp -178.32 138.14 0.18 Allowed 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 104.799 -2.297 . . . . 0.0 104.799 172.958 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 11.0 tmtt? -149.28 133.33 17.18 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 176.606 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -121.05 159.8 47.78 Favored Pre-proline 0 C--O 1.243 0.748 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 177.887 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -65.39 171.52 9.16 Favored 'Trans proline' 0 CA--C 1.539 0.746 0 C-N-CA 121.004 1.136 . . . . 0.0 114.706 -179.82 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 25.5 tpt180 -78.4 128.0 33.0 Favored 'General case' 0 C--O 1.215 -0.758 0 O-C-N 121.561 -0.712 . . . . 0.0 109.289 179.448 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 72.12 18.68 78.06 Favored Glycine 0 C--O 1.225 -0.459 0 N-CA-C 114.552 0.581 . . . . 0.0 114.552 176.583 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 43.1 tt0 -159.32 149.59 19.17 Favored 'General case' 0 C--O 1.22 -0.46 0 N-CA-C 105.652 -1.981 . . . . 0.0 105.652 -178.437 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 136.05 -14.74 4.05 Favored Glycine 0 CA--C 1.505 -0.548 0 C-N-CA 120.323 -0.941 . . . . 0.0 113.225 176.524 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 27.6 m -71.6 145.93 90.6 Favored Pre-proline 0 C--N 1.32 -0.698 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 177.382 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -77.17 173.03 15.03 Favored 'Trans proline' 0 N--CA 1.46 -0.491 0 C-N-CA 121.507 1.471 . . . . 0.0 112.578 178.992 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 91.5 mt -79.3 116.74 23.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.129 -179.379 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.456 ' HB2' HE22 ' A' ' 43' ' ' GLN . 22.4 m-20 -100.95 86.13 3.0 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 176.664 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 69.8 p -60.39 -27.06 67.14 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 115.661 1.726 . . . . 0.0 115.661 -173.69 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 19.7 p30 -108.18 21.38 17.43 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 -177.37 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 15.1 m -130.19 169.32 15.52 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 112.165 0.432 . . . . 0.0 112.165 -175.948 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 68.8 m -83.7 158.39 62.64 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.295 -176.952 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -67.42 -21.53 46.77 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 116.882 -1.612 . . . . 0.0 114.751 -177.909 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.464 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 4.1 p-10 -74.65 -17.04 60.75 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 121.927 -0.483 . . . . 0.0 110.856 178.814 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.446 ' HA ' ' HE3' ' A' ' 103' ' ' LYS . 0.0 OUTLIER -87.04 -16.32 35.99 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 114.925 1.454 . . . . 0.0 114.925 -174.269 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.456 HE22 ' HB2' ' A' ' 35' ' ' ASN . 84.0 mm-40 -57.81 -20.63 37.21 Favored 'General case' 0 C--O 1.218 -0.582 0 N-CA-C 114.093 1.145 . . . . 0.0 114.093 -172.154 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.412 ' HB ' ' HB1' ' A' ' 98' ' ' ALA . 20.6 tt -58.8 139.93 17.83 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 CA-C-O 122.401 1.095 . . . . 0.0 113.076 178.918 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 177.86 -153.61 13.54 Favored Glycine 0 N--CA 1.444 -0.792 0 C-N-CA 119.924 -1.131 . . . . 0.0 112.653 178.851 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 51.6 p90 -155.1 167.75 29.31 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 178.361 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 38.2 m-85 -108.74 140.28 42.38 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 106.435 -1.691 . . . . 0.0 106.435 174.419 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 65.3 ttt-85 -113.33 122.73 48.28 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.923 -177.82 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 49.0 ttp85 -68.62 136.89 53.71 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 177.008 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -134.85 136.41 42.43 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 179.041 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 14.8 t -152.9 159.19 42.98 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 106.697 -1.594 . . . . 0.0 106.697 176.84 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 21.6 tpt180 -157.74 142.27 16.33 Favored 'General case' 0 C--O 1.216 -0.663 0 N-CA-C 105.955 -1.869 . . . . 0.0 105.955 179.618 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -129.05 130.64 46.82 Favored 'General case' 0 CA--C 1.493 -1.223 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 176.996 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -128.89 173.05 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.003 0 N-CA-C 105.664 -1.976 . . . . 0.0 105.664 -179.14 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 6.6 tmm_? -140.33 112.76 7.9 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 106.024 -1.843 . . . . 0.0 106.024 175.811 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -74.04 164.24 54.7 Favored Glycine 0 C--O 1.226 -0.376 0 N-CA-C 110.448 -1.061 . . . . 0.0 110.448 -179.808 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -65.93 -33.8 86.7 Favored Glycine 0 C--O 1.217 -0.935 0 N-CA-C 110.522 -1.031 . . . . 0.0 110.522 -179.269 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.0 t0 -85.2 16.96 3.23 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-O 122.157 0.98 . . . . 0.0 110.968 179.352 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 84.77 -4.81 84.17 Favored Glycine 0 CA--C 1.509 -0.298 0 N-CA-C 116.071 1.188 . . . . 0.0 116.071 172.277 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.59 123.16 20.1 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.488 0.661 . . . . 0.0 111.785 -177.394 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 93.4 mmm -88.84 169.49 11.55 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.01 -0.996 . . . . 0.0 108.663 178.86 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 5.4 tmtt? -74.99 -52.74 10.37 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 177.895 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 58.37 -174.27 0.09 Allowed 'General case' 0 C--O 1.243 0.713 0 N-CA-C 115.547 1.684 . . . . 0.0 115.547 178.941 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.5 mm? 64.79 169.77 0.19 Allowed 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 115.018 1.488 . . . . 0.0 115.018 -179.461 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -70.62 163.25 65.35 Favored Pre-proline 0 C--O 1.243 0.723 0 CA-C-N 114.603 -1.181 . . . . 0.0 114.181 -176.331 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -72.12 166.8 28.58 Favored 'Trans proline' 0 C--N 1.351 0.666 0 CA-C-O 121.562 0.568 . . . . 0.0 112.736 177.748 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 22.9 mtp180 -117.91 166.3 12.65 Favored 'General case' 0 CA--C 1.512 -0.497 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 178.795 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 62.8 m95 -127.45 143.4 51.2 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 177.986 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.468 ' CZ ' ' HB2' ' A' ' 15' ' ' ALA . 60.7 m-85 -124.02 147.49 47.78 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 178.889 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 86.5 t80 -95.79 139.24 32.31 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 -177.356 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -142.44 140.6 32.01 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 -176.471 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.407 ' HB3' ' HB2' ' A' ' 103' ' ' LYS . 74.9 m-85 -68.1 159.44 30.91 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -179.313 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 19.1 tp -59.44 134.72 57.27 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 175.147 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 75.66 35.28 46.76 Favored Glycine 0 C--O 1.222 -0.638 0 N-CA-C 115.881 1.112 . . . . 0.0 115.881 177.22 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 21.7 p . . . . . 0 C--N 1.325 -0.459 0 CA-C-N 118.288 1.044 . . . . 0.0 109.832 177.867 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 75.2 mt . . . . . 0 C--O 1.238 0.48 0 N-CA-C 114.874 1.435 . . . . 0.0 114.874 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -76.85 166.75 26.44 Favored 'Trans proline' 0 N--CA 1.461 -0.41 0 N-CA-C 109.231 -1.103 . . . . 0.0 109.231 171.253 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 62.1 t80 -62.95 131.26 48.08 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 120.708 -0.397 . . . . 0.0 110.29 -179.219 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 92.39 -3.48 75.72 Favored Glycine 0 CA--C 1.52 0.396 0 N-CA-C 114.524 0.569 . . . . 0.0 114.524 179.156 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -63.03 130.94 46.89 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 117.863 0.832 . . . . 0.0 112.104 179.406 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 32.7 t-20 -78.3 125.85 29.95 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.568 -178.466 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 14.7 ttmm -155.55 150.47 26.53 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 176.743 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -63.36 131.36 48.01 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.245 179.585 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 70.66 25.88 74.98 Favored Glycine 0 N--CA 1.45 -0.418 0 CA-C-O 119.375 -0.681 . . . . 0.0 114.184 177.935 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 39.7 mm -128.83 128.14 67.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 117.515 0.658 . . . . 0.0 109.963 179.339 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.1 pt -130.13 115.26 32.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 CA-C-O 121.422 0.63 . . . . 0.0 110.891 176.952 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 97.4 m95 -82.07 132.22 35.25 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 112.941 0.719 . . . . 0.0 112.941 -176.871 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 1.1 m -142.05 152.95 18.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.187 -178.127 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -155.12 166.53 33.28 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 103.371 -2.826 . . . . 0.0 103.371 -178.824 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 14.5 t -122.76 169.13 11.39 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 104.206 -2.516 . . . . 0.0 104.206 174.481 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -65.37 137.16 57.32 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.193 0.52 . . . . 0.0 109.922 -179.495 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 91.19 -5.79 81.29 Favored Glycine 0 CA--C 1.516 0.119 0 CA-C-N 115.749 -0.659 . . . . 0.0 113.4 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.464 ' HA ' ' HA ' ' A' ' 41' ' ' ASP . . . -77.81 135.48 37.96 Favored 'General case' 0 CA--C 1.537 0.478 0 O-C-N 122.307 -0.525 . . . . 0.0 109.647 179.2 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 28.8 mt -88.25 136.37 33.01 Favored 'General case' 0 CA--C 1.509 -0.615 0 CA-C-O 121.601 0.715 . . . . 0.0 111.979 -178.249 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 54.4 t30 -82.59 67.95 8.84 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.978 -1.01 . . . . 0.0 110.588 -178.683 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -142.77 155.63 63.0 Favored Pre-proline 0 C--N 1.323 -0.57 0 N-CA-C 106.382 -1.711 . . . . 0.0 106.382 -179.102 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -66.83 150.6 83.23 Favored 'Trans proline' 0 CA--C 1.53 0.292 0 N-CA-C 114.78 1.031 . . . . 0.0 114.78 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.581 ' HB3' HD12 ' A' ' 106' ' ' ILE . 71.1 mmtt -126.89 36.88 4.38 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.152 179.758 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 14.0 p-10 -49.55 -42.77 45.04 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.268 0.556 . . . . 0.0 112.003 -177.796 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 15.4 p80 -67.5 -10.3 50.36 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 115.121 1.526 . . . . 0.0 115.121 -178.589 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.581 HD12 ' HB3' ' A' ' 103' ' ' LYS . 38.8 mt -91.93 -31.95 5.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 179.535 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -74.12 14.6 3.76 Favored Glycine 0 C--O 1.222 -0.597 0 N-CA-C 115.488 0.955 . . . . 0.0 115.488 -177.79 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 15.1 t -83.17 24.44 0.79 Allowed 'General case' 0 CA--C 1.547 0.862 0 N-CA-C 113.814 1.042 . . . . 0.0 113.814 -177.145 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 69.9 ttp85 -62.17 124.92 22.16 Favored 'General case' 0 N--CA 1.471 0.584 0 O-C-N 121.033 -1.042 . . . . 0.0 108.691 179.604 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 11.4 m-20 -99.56 125.34 41.17 Favored Pre-proline 0 C--N 1.323 -0.563 0 N-CA-C 106.307 -1.738 . . . . 0.0 106.307 179.381 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -68.85 -18.5 41.4 Favored 'Trans proline' 0 C--O 1.22 -0.421 0 C-N-CA 117.98 -0.88 . . . . 0.0 114.315 -176.126 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -75.41 -26.19 58.19 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.854 0.359 . . . . 0.0 110.621 178.04 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 -100.58 -25.86 14.03 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 -174.85 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 19.5 t-20 -152.11 145.6 24.87 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 -179.423 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -86.7 149.39 24.92 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.402 179.69 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -66.8 142.34 57.39 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.295 0.569 . . . . 0.0 110.381 178.668 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 22.8 mt -84.15 139.26 17.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.312 -0.858 . . . . 0.0 108.689 -178.152 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 91.6 t -61.67 124.52 16.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 105.789 -1.93 . . . . 0.0 105.789 175.134 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 6.1 tt -66.51 128.74 37.37 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.098 0.475 . . . . 0.0 109.906 -177.257 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -129.88 151.8 50.05 Favored 'General case' 0 CA--C 1.507 -0.696 0 N-CA-C 106.285 -1.746 . . . . 0.0 106.285 -179.31 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 13.0 mt -110.16 148.32 38.1 Favored Pre-proline 0 C--N 1.321 -0.655 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 178.897 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -71.59 164.26 36.28 Favored 'Trans proline' 0 C--N 1.345 0.349 0 O-C-N 122.228 0.594 . . . . 0.0 112.999 -178.932 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 54.8 tt0 -54.25 131.12 40.93 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.628 -0.714 . . . . 0.0 109.685 -179.412 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 98.93 -17.7 57.84 Favored Glycine 0 C--O 1.228 -0.262 0 CA-C-N 115.829 -0.623 . . . . 0.0 112.494 -178.822 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 1.8 m -108.62 128.94 55.28 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 117.716 0.758 . . . . 0.0 110.587 178.052 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 6.0 p -124.91 151.05 45.88 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 179.37 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 72.6 mt -67.33 153.28 95.07 Favored Pre-proline 0 C--N 1.324 -0.525 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 -179.705 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -75.06 168.08 25.58 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 117.938 -0.908 . . . . 0.0 110.406 178.461 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -57.0 124.52 18.96 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 112.92 0.711 . . . . 0.0 112.92 -174.074 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 95.2 -6.06 68.55 Favored Glycine 0 C--O 1.229 -0.201 0 N-CA-C 115.818 1.087 . . . . 0.0 115.818 177.402 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.414 ' CZ ' ' HB2' ' A' ' 18' ' ' GLN . 1.7 m-85 -93.13 146.32 23.75 Favored 'General case' 0 N--CA 1.439 -1.013 0 CA-C-O 122.096 0.95 . . . . 0.0 110.416 179.362 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 46.8 p90 -144.75 160.58 41.0 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 113.793 -1.549 . . . . 0.0 108.12 174.438 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -102.56 142.84 33.07 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.092 0.472 . . . . 0.0 111.02 -177.981 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.423 ' HB3' ' HB ' ' A' ' 14' ' ' THR . 3.5 tp10 -70.12 131.61 44.56 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 177.779 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 92.29 -10.98 73.22 Favored Glycine 0 C--O 1.227 -0.298 0 C-N-CA 121.359 -0.448 . . . . 0.0 112.944 -178.526 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 41.9 t . . . . . 0 C--N 1.327 -0.395 0 N-CA-C 106.957 -1.497 . . . . 0.0 106.957 176.84 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.095 0 CA-C-O 121.462 0.649 . . . . 0.0 111.73 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 35.7 t -63.16 144.0 57.3 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.144 177.775 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 18.1 m95 -67.34 -21.83 65.63 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 112.824 0.675 . . . . 0.0 112.824 178.025 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 39.8 m-85 -121.55 165.6 15.43 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 114.663 1.357 . . . . 0.0 114.663 -170.437 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 76.1 p -71.44 166.45 21.69 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 114.459 -1.246 . . . . 0.0 107.758 176.977 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.495 ' HB2' ' CZ ' ' A' ' 69' ' ' TYR . . . -78.01 157.51 29.62 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 113.54 0.941 . . . . 0.0 113.54 -175.554 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 12.9 mt -102.05 137.1 40.77 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 105.288 -2.116 . . . . 0.0 105.288 171.114 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 37.0 m -122.19 145.4 48.23 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 -177.278 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.419 ' HB2' ' CZ ' ' A' ' 131' ' ' PHE . 4.2 tp60 -112.51 142.89 44.54 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 114.664 1.357 . . . . 0.0 114.664 -175.172 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 72.4 t60 -131.98 99.46 4.75 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 104.663 -2.347 . . . . 0.0 104.663 166.954 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 171.04 -152.97 19.74 Favored Glycine 0 C--O 1.227 -0.309 0 N-CA-C 109.954 -1.258 . . . . 0.0 109.954 -175.374 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -117.39 -21.97 8.43 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-O 121.44 0.638 . . . . 0.0 110.865 179.455 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -72.65 151.0 42.5 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.311 -179.646 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 16.8 t0 -76.61 -62.59 1.58 Allowed 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 178.921 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 43.1 tp 179.64 143.35 0.15 Allowed 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 103.478 -2.786 . . . . 0.0 103.478 171.299 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 56.8 tptt -154.56 134.57 13.06 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 118.047 0.385 . . . . 0.0 110.188 176.001 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 12.0 m-85 -125.0 157.27 67.42 Favored Pre-proline 0 C--O 1.244 0.811 0 N-CA-C 106.291 -1.744 . . . . 0.0 106.291 175.363 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -72.2 175.02 10.51 Favored 'Trans proline' 0 CA--C 1.536 0.611 0 C-N-CA 121.174 1.249 . . . . 0.0 114.527 -178.526 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 46.7 tpt85 -78.33 127.45 32.24 Favored 'General case' 0 C--O 1.214 -0.815 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 178.351 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 80.17 10.5 85.41 Favored Glycine 0 C--O 1.223 -0.567 0 N-CA-C 115.417 0.927 . . . . 0.0 115.417 175.854 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -157.71 145.5 18.71 Favored 'General case' 0 C--O 1.219 -0.521 0 N-CA-C 106.264 -1.754 . . . . 0.0 106.264 -179.537 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 138.5 -14.61 3.43 Favored Glycine 0 CA--C 1.504 -0.607 0 C-N-CA 120.042 -1.075 . . . . 0.0 113.523 177.298 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 27.8 m -70.06 144.72 93.14 Favored Pre-proline 0 C--N 1.322 -0.595 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 176.984 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -76.16 174.28 13.09 Favored 'Trans proline' 0 N--CA 1.46 -0.496 0 C-N-CA 121.483 1.455 . . . . 0.0 111.773 178.523 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 92.4 mt -71.86 118.47 16.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 178.404 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 45.1 m-80 -111.29 87.08 2.46 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 179.515 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 82.1 p -66.84 -21.94 66.01 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 112.769 0.655 . . . . 0.0 112.769 -177.091 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 71.6 m-80 -105.62 34.71 3.15 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.875 -177.249 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 20.6 m -145.84 150.41 36.11 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.745 0.307 . . . . 0.0 111.603 -179.4 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 25.3 m -71.31 164.19 59.39 Favored Pre-proline 0 C--N 1.325 -0.484 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 176.947 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -64.57 -26.8 61.66 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 114.926 -2.916 . . . . 0.0 111.598 177.721 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 51.2 m-20 -63.03 -27.39 69.38 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.827 177.001 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.491 ' HA ' ' HE3' ' A' ' 103' ' ' LYS . 67.9 m-20 -93.41 -6.62 46.68 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 115.569 1.692 . . . . 0.0 115.569 -171.878 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 92.0 mm-40 -60.43 -33.12 72.06 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 115.097 1.517 . . . . 0.0 115.097 -176.955 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 14.5 tt -60.1 140.62 17.86 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 CA-C-O 122.137 0.97 . . . . 0.0 113.117 -178.686 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 179.85 -149.34 8.53 Favored Glycine 0 C--O 1.227 -0.325 0 CA-C-N 115.623 -0.717 . . . . 0.0 112.455 -176.675 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 50.7 p90 -155.08 171.98 18.89 Favored 'General case' 0 C--N 1.319 -0.72 0 O-C-N 122.187 -0.596 . . . . 0.0 109.959 179.164 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 28.7 m-85 -114.25 142.99 45.57 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 173.222 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 68.5 ttt180 -115.22 125.88 53.89 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 123.739 0.815 . . . . 0.0 110.628 -178.329 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 6.3 ttp85 -71.26 135.52 47.49 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 107.675 -1.231 . . . . 0.0 107.675 176.317 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -135.35 129.64 33.73 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 123.218 0.607 . . . . 0.0 111.212 -178.732 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 15.0 t -159.96 155.43 25.45 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 174.271 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 20.3 tpt180 -161.26 139.18 9.33 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 105.319 -2.104 . . . . 0.0 105.319 178.021 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -88.44 135.38 33.5 Favored 'General case' 0 CA--C 1.505 -0.761 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 179.532 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -127.87 173.56 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.766 0 N-CA-C 106.826 -1.546 . . . . 0.0 106.826 -178.854 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.15 117.15 15.29 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 178.611 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -73.87 157.25 51.32 Favored Glycine 0 C--O 1.23 -0.125 0 N-CA-C 107.273 -2.331 . . . . 0.0 107.273 176.09 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -58.49 -35.7 81.19 Favored Glycine 0 N--CA 1.461 0.347 0 CA-C-N 119.017 1.408 . . . . 0.0 112.184 -177.038 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -73.43 0.8 11.25 Favored 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 124.64 1.176 . . . . 0.0 113.553 -179.376 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 93.44 14.54 53.32 Favored Glycine 0 C--N 1.317 -0.505 0 CA-C-N 114.38 -1.282 . . . . 0.0 113.027 174.239 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 16.4 mmtt -79.02 130.6 35.7 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.393 0.616 . . . . 0.0 110.635 -175.924 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 1.4 mmt -86.08 161.06 19.09 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.008 -0.997 . . . . 0.0 110.47 179.613 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 22.6 tptp -64.45 -52.52 57.6 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.383 176.771 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.4 t70 45.33 -149.89 0.07 Allowed 'General case' 0 CA--C 1.549 0.905 0 O-C-N 124.842 1.339 . . . . 0.0 112.315 -176.424 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 62.0 mt 52.94 178.73 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.814 0 N-CA-C 118.407 2.743 . . . . 0.0 118.407 174.335 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 2.1 p -74.2 159.51 83.66 Favored Pre-proline 0 C--O 1.245 0.853 0 CA-C-N 115.124 -0.943 . . . . 0.0 112.904 -177.721 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -77.05 175.89 10.82 Favored 'Trans proline' 0 C--N 1.352 0.722 0 N-CA-C 110.796 -0.502 . . . . 0.0 110.796 174.088 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 33.3 ptt-85 -132.13 163.32 28.77 Favored 'General case' 0 C--O 1.218 -0.56 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 177.99 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 56.3 m95 -122.93 150.2 43.25 Favored 'General case' 0 C--O 1.212 -0.882 0 C-N-CA 122.468 0.307 . . . . 0.0 111.224 -177.186 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.495 ' CZ ' ' HB2' ' A' ' 15' ' ' ALA . 56.1 m-85 -128.12 147.29 50.54 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 177.72 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 88.7 t80 -94.43 135.46 35.83 Favored 'General case' 0 CA--C 1.506 -0.747 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 -177.274 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -136.99 131.98 33.68 Favored 'General case' 0 N--CA 1.437 -1.096 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 -175.657 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 74.2 m-85 -70.89 159.57 34.41 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.037 -176.134 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -53.07 125.46 17.41 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.829 -178.218 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 71.57 23.32 78.18 Favored Glycine 0 C--O 1.224 -0.474 0 N-CA-C 116.309 1.284 . . . . 0.0 116.309 177.056 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 18.3 p . . . . . 0 C--N 1.326 -0.453 0 CA-C-N 119.056 1.428 . . . . 0.0 108.842 177.402 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 14.7 mt . . . . . 0 N--CA 1.444 -0.767 0 N-CA-C 115.503 1.668 . . . . 0.0 115.503 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -79.08 161.89 26.29 Favored 'Trans proline' 0 N--CA 1.463 -0.313 0 C-N-CA 122.517 2.145 . . . . 0.0 107.683 167.899 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 57.1 t80 -60.86 131.21 49.96 Favored 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 120.373 -0.531 . . . . 0.0 110.579 -177.411 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 92.33 -7.51 78.02 Favored Glycine 0 C--O 1.228 -0.269 0 CA-C-O 119.349 -0.695 . . . . 0.0 114.65 179.11 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -66.62 131.12 45.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 118.649 1.224 . . . . 0.0 111.336 179.503 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 56.7 t30 -78.73 129.18 34.38 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.627 -179.388 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 30.0 ttmt -156.17 153.27 28.99 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 106.492 -1.67 . . . . 0.0 106.492 179.29 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -63.48 130.82 46.01 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.051 0.453 . . . . 0.0 111.165 -178.105 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 68.5 27.64 73.68 Favored Glycine 0 N--CA 1.449 -0.483 0 CA-C-O 119.263 -0.743 . . . . 0.0 113.994 177.652 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 45.9 mm -123.28 125.57 72.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 117.487 0.644 . . . . 0.0 110.303 179.331 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -127.85 115.25 38.56 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 CA-C-O 121.575 0.702 . . . . 0.0 111.296 177.061 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 97.7 m95 -80.45 137.45 36.49 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -177.794 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -142.61 154.34 17.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 -178.962 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -157.27 166.64 32.6 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 105.695 -1.965 . . . . 0.0 105.695 -177.096 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 14.7 t -125.84 166.49 16.75 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 104.03 -2.582 . . . . 0.0 104.03 173.205 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 77.7 tt0 -67.68 137.67 55.72 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 121.108 0.48 . . . . 0.0 109.879 -178.957 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 95.45 -19.23 55.25 Favored Glycine 0 C--O 1.224 -0.521 0 CA-C-N 115.705 -0.68 . . . . 0.0 112.973 178.042 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -67.81 137.93 55.75 Favored 'General case' 0 CA--C 1.542 0.661 0 O-C-N 122.542 -0.387 . . . . 0.0 110.753 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 47.0 mt -92.21 136.55 33.1 Favored 'General case' 0 CA--C 1.514 -0.425 0 N-CA-C 113.771 1.026 . . . . 0.0 113.771 -176.349 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 63.6 t30 -80.39 61.34 4.12 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.21 -0.905 . . . . 0.0 110.939 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 2.6 t -133.12 160.93 66.73 Favored Pre-proline 0 C--N 1.322 -0.588 0 N-CA-C 104.452 -2.425 . . . . 0.0 104.452 -179.133 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_exo -64.58 152.06 83.24 Favored 'Trans proline' 0 CA--C 1.534 0.475 0 N-CA-C 116.669 1.757 . . . . 0.0 116.669 -177.298 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.491 ' HE3' ' HA ' ' A' ' 42' ' ' ASP . 0.4 OUTLIER -127.19 31.93 5.15 Favored 'General case' 0 CA--C 1.515 -0.388 0 C-N-CA 124.545 1.138 . . . . 0.0 109.416 176.784 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 15.2 p-10 -55.22 -36.89 66.46 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.285 -0.871 . . . . 0.0 109.84 179.284 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 16.7 p80 -60.8 -13.65 16.63 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 114.832 1.419 . . . . 0.0 114.832 179.377 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 10.8 mt -96.27 -23.71 4.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 121.14 0.495 . . . . 0.0 110.787 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -76.19 1.25 60.74 Favored Glycine 0 C--O 1.227 -0.303 0 N-CA-C 115.559 0.984 . . . . 0.0 115.559 -175.783 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 14.6 t -83.08 16.06 2.53 Favored 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 113.848 1.055 . . . . 0.0 113.848 -177.514 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 63.1 ttp85 -66.26 129.75 40.89 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 177.781 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -111.73 134.19 21.36 Favored Pre-proline 0 C--N 1.325 -0.491 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 179.429 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_endo -69.76 -21.55 33.31 Favored 'Trans proline' 0 C--O 1.217 -0.535 0 N-CA-C 115.314 1.236 . . . . 0.0 115.314 -174.447 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -74.81 -24.09 58.58 Favored 'General case' 0 C--O 1.22 -0.49 0 CA-C-O 121.094 0.473 . . . . 0.0 110.478 178.391 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 83.5 m-20 -97.72 -22.49 16.41 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 113.302 0.853 . . . . 0.0 113.302 -175.068 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 -157.99 150.03 21.99 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 112.0 0.371 . . . . 0.0 112.0 -178.356 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -87.27 147.47 25.52 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-O 121.575 0.702 . . . . 0.0 112.182 179.751 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -72.73 147.92 45.15 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.27 178.13 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 15.0 mt -91.42 139.43 17.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.226 -178.156 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 73.9 t -60.13 125.41 16.2 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 N-CA-C 106.572 -1.64 . . . . 0.0 106.572 175.084 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 6.4 tt -66.6 129.19 39.04 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.101 0.477 . . . . 0.0 110.168 -177.324 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 31.0 mt-30 -131.26 156.66 45.03 Favored 'General case' 0 CA--C 1.511 -0.534 0 N-CA-C 107.062 -1.459 . . . . 0.0 107.062 -178.886 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.426 HD13 HG22 ' A' ' 125' ' ' THR . 14.4 mt -113.25 148.07 38.75 Favored Pre-proline 0 C--N 1.321 -0.631 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 178.438 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -72.06 167.5 26.58 Favored 'Trans proline' 0 C--N 1.345 0.392 0 O-C-N 122.229 0.594 . . . . 0.0 112.969 -179.335 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -55.56 133.48 50.35 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.814 -179.498 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 91.91 -14.75 63.48 Favored Glycine 0 C--O 1.227 -0.332 0 CA-C-N 116.05 -0.523 . . . . 0.0 113.368 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.426 HG22 HD13 ' A' ' 121' ' ' LEU . 16.7 m -105.95 126.94 52.79 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 117.841 0.82 . . . . 0.0 110.309 179.012 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 6.9 p -118.51 148.24 42.83 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.78 -178.268 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 84.9 mt -69.94 153.61 95.31 Favored Pre-proline 0 C--N 1.325 -0.472 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 177.661 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -76.15 173.48 14.42 Favored 'Trans proline' 0 C--O 1.235 0.345 0 N-CA-C 110.531 -0.604 . . . . 0.0 110.531 178.624 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 8.2 tmtt? -53.83 126.61 22.84 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.21 0.528 . . . . 0.0 112.224 -175.988 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 85.29 -1.55 88.52 Favored Glycine 0 N--CA 1.454 -0.144 0 N-CA-C 116.861 1.504 . . . . 0.0 116.861 173.743 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.419 ' CZ ' ' HB2' ' A' ' 18' ' ' GLN . 1.5 m-85 -94.71 141.26 28.82 Favored 'General case' 0 N--CA 1.436 -1.167 0 CA-C-O 122.069 0.938 . . . . 0.0 110.436 -179.209 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 42.8 p90 -142.08 161.47 37.92 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 113.639 -1.618 . . . . 0.0 108.351 176.923 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -103.0 143.74 32.18 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.345 0.593 . . . . 0.0 111.705 -176.842 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -70.68 135.3 48.22 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 179.693 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 81.89 -9.69 55.43 Favored Glycine 0 CA--C 1.52 0.365 0 CA-C-N 116.118 -0.492 . . . . 0.0 114.095 -178.75 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 28.8 t . . . . . 0 C--N 1.326 -0.439 0 CA-C-N 117.926 0.863 . . . . 0.0 110.51 -179.534 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.44 -0.943 0 CA-C-O 121.876 0.846 . . . . 0.0 113.157 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 32.9 p -62.21 140.91 58.44 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 114.853 -1.067 . . . . 0.0 109.982 178.803 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' TRP . . . . . 0.405 ' CD2' ' HD3' ' A' ' 109' ' ' ARG . 17.4 m95 -67.62 -21.81 65.37 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 113.795 1.035 . . . . 0.0 113.795 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 36.8 m-85 -121.55 160.87 23.39 Favored 'General case' 0 CA--C 1.509 -0.621 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 -172.598 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 67.7 p -69.47 162.03 28.26 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 178.836 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.445 ' HB2' ' CZ ' ' A' ' 69' ' ' TYR . . . -78.31 147.12 34.38 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 114.084 1.142 . . . . 0.0 114.084 -175.726 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 27.1 mt -89.02 148.88 23.52 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 105.149 -2.167 . . . . 0.0 105.149 170.634 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.6 m -122.97 144.85 48.97 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 179.473 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 3.8 tp60 -109.99 154.79 22.67 Favored 'General case' 0 C--N 1.328 -0.339 0 O-C-N 123.762 0.664 . . . . 0.0 110.742 -176.283 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 67.9 t60 -139.34 99.51 3.76 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 105.588 -2.004 . . . . 0.0 105.588 170.086 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 163.09 -171.63 38.9 Favored Glycine 0 N--CA 1.452 -0.239 0 N-CA-C 110.653 -0.979 . . . . 0.0 110.653 -177.778 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -99.56 -22.52 15.43 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 112.477 0.547 . . . . 0.0 112.477 179.672 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -83.44 161.99 21.12 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.963 -178.168 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -75.55 -62.94 1.4 Allowed 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 114.539 1.311 . . . . 0.0 114.539 -175.894 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 32.2 tp 157.23 144.84 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.283 0 N-CA-C 104.935 -2.246 . . . . 0.0 104.935 -175.56 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 56.1 tptt -156.02 141.39 17.61 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 108.779 -0.822 . . . . 0.0 108.779 173.009 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 15.1 m-85 -122.97 150.7 59.77 Favored Pre-proline 0 C--O 1.242 0.699 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 175.923 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -74.22 163.21 37.04 Favored 'Trans proline' 0 C--N 1.352 0.752 0 C-N-CA 120.88 1.053 . . . . 0.0 113.383 179.467 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 4.1 tmt_? -65.36 133.71 51.95 Favored 'General case' 0 N--CA 1.473 0.707 0 O-C-N 122.045 -0.409 . . . . 0.0 110.493 -178.484 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 88.12 1.34 82.0 Favored Glycine 0 C--O 1.228 -0.235 0 N-CA-C 111.912 -0.475 . . . . 0.0 111.912 178.614 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 38.0 mt-30 -141.83 171.65 13.77 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 123.455 0.702 . . . . 0.0 110.4 -174.981 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 107.06 -25.26 22.78 Favored Glycine 0 CA--C 1.497 -1.049 0 CA-C-N 115.54 -0.754 . . . . 0.0 111.937 175.176 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 95.7 t -63.72 127.4 91.47 Favored Pre-proline 0 C--N 1.318 -0.779 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 177.736 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -73.46 171.58 17.42 Favored 'Trans proline' 0 N--CA 1.462 -0.351 0 O-C-N 122.142 0.548 . . . . 0.0 111.385 178.189 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 86.1 mt -69.81 107.02 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-O 121.963 0.887 . . . . 0.0 108.892 -179.874 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 75.3 m-20 -99.96 84.82 2.94 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 114.626 -1.17 . . . . 0.0 109.9 -177.36 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 69.6 p -67.06 -15.74 63.91 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 112.94 0.719 . . . . 0.0 112.94 -178.631 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 12.3 p30 -107.13 22.77 15.47 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.375 -0.83 . . . . 0.0 112.382 -177.833 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 15.0 m -140.5 148.89 41.77 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 113.787 1.032 . . . . 0.0 113.787 -176.525 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -74.37 167.35 36.73 Favored Pre-proline 0 N--CA 1.468 0.447 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 177.194 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -64.93 -28.48 58.27 Favored 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 114.663 -3.091 . . . . 0.0 111.827 178.309 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -62.11 -24.31 67.06 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 123.883 0.873 . . . . 0.0 111.658 176.743 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 71.6 m-20 -98.41 -2.57 38.81 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 114.957 1.466 . . . . 0.0 114.957 -172.183 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 94.5 mm-40 -60.77 -28.94 69.11 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 114.543 1.312 . . . . 0.0 114.543 -178.21 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 12.9 tt -60.07 139.31 19.78 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.846 0 CA-C-O 122.358 1.075 . . . . 0.0 113.339 -177.677 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -177.94 -155.96 15.38 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.84 -0.695 . . . . 0.0 111.903 -178.478 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 49.8 p90 -155.05 168.59 26.51 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 178.665 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 22.5 m-85 -108.99 141.35 41.22 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 172.992 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 51.7 ttt180 -115.0 120.54 40.23 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 114.917 -1.038 . . . . 0.0 111.919 -174.902 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 38.9 ttp180 -68.47 134.7 50.52 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 176.159 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -150.79 151.11 31.85 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.159 0.504 . . . . 0.0 111.494 -178.393 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 14.3 t -158.9 164.98 35.18 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 174.982 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 14.3 tpt180 -149.83 123.83 9.38 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 105.367 -2.086 . . . . 0.0 105.367 177.921 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 4.6 tmm_? -88.9 128.01 35.66 Favored 'General case' 0 CA--C 1.498 -1.054 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 -179.21 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -128.6 169.83 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.107 0 N-CA-C 105.725 -1.954 . . . . 0.0 105.725 179.032 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 1.1 ttt-85 -144.04 110.72 5.62 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 176.131 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -71.17 160.88 54.13 Favored Glycine 0 N--CA 1.449 -0.443 0 N-CA-C 107.891 -2.084 . . . . 0.0 107.891 176.492 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -69.94 -33.8 70.61 Favored Glycine 0 C--O 1.222 -0.596 0 N-CA-C 109.899 -1.28 . . . . 0.0 109.899 -178.106 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.2 t0 -73.12 3.54 5.45 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 114.133 -1.033 . . . . 0.0 111.831 179.422 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 96.6 -9.12 66.53 Favored Glycine 0 C--O 1.226 -0.353 0 CA-C-N 115.725 -0.67 . . . . 0.0 114.5 175.48 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.49 106.7 4.68 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.759 0.79 . . . . 0.0 111.751 -178.185 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 18.6 mtp -88.8 -179.98 6.1 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 114.783 -1.099 . . . . 0.0 109.124 179.313 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 23.9 tptp -73.88 -59.5 2.69 Favored 'General case' 0 CA--C 1.51 -0.58 0 C-N-CA 120.603 -0.439 . . . . 0.0 111.409 -179.609 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 47.02 -161.53 0.03 OUTLIER 'General case' 0 C--O 1.25 1.082 0 O-C-N 125.358 1.661 . . . . 0.0 115.256 -179.339 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 82.2 mt 53.48 -176.66 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 116.489 2.033 . . . . 0.0 116.489 178.711 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 24.3 m -65.04 154.01 87.65 Favored Pre-proline 0 C--O 1.24 0.596 0 CA-C-N 115.182 -0.917 . . . . 0.0 112.336 -177.303 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -73.8 175.5 10.69 Favored 'Trans proline' 0 C--N 1.348 0.506 0 CA-C-O 122.015 0.756 . . . . 0.0 113.72 -179.353 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 1.2 mmt180 -106.55 159.99 15.76 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 114.897 -1.047 . . . . 0.0 108.294 -178.817 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 73.2 m95 -128.3 125.02 37.96 Favored 'General case' 0 C--O 1.215 -0.748 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 176.252 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.445 ' CZ ' ' HB2' ' A' ' 15' ' ' ALA . 33.9 m-85 -110.99 156.54 21.09 Favored 'General case' 0 C--O 1.213 -0.849 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 -178.727 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 81.2 t80 -101.76 135.31 43.5 Favored 'General case' 0 CA--C 1.51 -0.596 0 CA-C-N 119.204 0.911 . . . . 0.0 108.94 -179.297 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -136.92 147.46 46.41 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 -176.583 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 84.3 m-85 -82.5 159.43 22.86 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.069 -176.709 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -54.67 130.26 39.71 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.991 0.424 . . . . 0.0 111.066 -179.28 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 73.54 26.23 70.41 Favored Glycine 0 C--O 1.219 -0.837 0 N-CA-C 116.107 1.203 . . . . 0.0 116.107 176.63 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 5.3 p . . . . . 0 C--N 1.326 -0.433 0 CA-C-N 118.775 1.287 . . . . 0.0 109.724 178.13 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 42.9 mt . . . . . 0 C--O 1.238 0.452 0 N-CA-C 115.318 1.599 . . . . 0.0 115.318 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -76.97 166.14 27.25 Favored 'Trans proline' 0 C--O 1.237 0.427 0 N-CA-C 108.669 -1.32 . . . . 0.0 108.669 170.144 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.417 ' CE1' ' HB3' ' A' ' 92' ' ' TRP . 62.5 t80 -62.8 133.68 55.12 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 120.491 -0.484 . . . . 0.0 110.069 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 90.37 -5.45 82.7 Favored Glycine 0 CA--C 1.519 0.317 0 N-CA-C 114.489 0.556 . . . . 0.0 114.489 178.815 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -63.08 132.33 51.54 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 117.901 0.85 . . . . 0.0 112.22 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 51.5 t30 -74.52 126.26 30.39 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.903 -0.59 . . . . 0.0 112.094 -178.809 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 15.2 ttmm -156.14 149.86 24.96 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 176.799 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -63.63 132.79 52.26 Favored 'General case' 0 C--N 1.321 -0.64 0 O-C-N 123.251 0.345 . . . . 0.0 110.802 -179.646 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 66.87 28.41 73.77 Favored Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 121.037 -0.602 . . . . 0.0 114.481 177.328 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 40.9 mm -127.5 126.43 67.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 117.302 0.551 . . . . 0.0 109.993 179.41 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.1 pt -128.13 115.15 37.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 121.812 0.815 . . . . 0.0 110.889 176.307 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' TRP . . . . . 0.417 ' HB3' ' CE1' ' A' ' 83' ' ' TYR . 95.8 m95 -79.03 135.73 36.97 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.983 -0.553 . . . . 0.0 112.34 -177.886 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 17.0 m -137.3 149.72 25.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.566 0.698 . . . . 0.0 109.534 179.72 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -157.59 166.6 32.44 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 104.333 -2.469 . . . . 0.0 104.333 -178.863 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 6.6 t -138.21 177.04 8.17 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 106.037 -1.838 . . . . 0.0 106.037 177.971 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -67.61 135.08 52.32 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.056 0.455 . . . . 0.0 110.51 -178.255 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 96.02 -8.29 67.59 Favored Glycine 0 C--O 1.224 -0.52 0 CA-C-N 115.938 -0.574 . . . . 0.0 113.514 178.688 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -81.22 139.23 35.62 Favored 'General case' 0 C--N 1.324 -0.541 0 O-C-N 122.443 -0.446 . . . . 0.0 111.456 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 47.3 mt -90.04 138.7 31.29 Favored 'General case' 0 CA--C 1.512 -0.495 0 CA-C-O 120.805 0.336 . . . . 0.0 111.284 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 62.4 t30 -83.42 68.13 9.6 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.992 0.425 . . . . 0.0 110.743 179.806 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 1.1 t -141.67 151.71 60.96 Favored Pre-proline 0 C--O 1.24 0.566 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 -178.937 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -66.24 153.15 79.18 Favored 'Trans proline' 0 C--N 1.345 0.39 0 N-CA-C 113.645 0.594 . . . . 0.0 113.645 176.597 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 1.4 ptpm? -152.25 56.49 0.83 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 122.502 1.144 . . . . 0.0 110.809 -179.235 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -59.66 -27.13 66.12 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 114.535 -1.211 . . . . 0.0 111.443 179.35 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 12.7 p80 -59.71 -12.4 6.97 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 114.029 1.122 . . . . 0.0 114.029 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 55.3 mt -91.94 -43.07 13.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 177.367 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -77.12 11.45 15.92 Favored Glycine 0 C--O 1.224 -0.495 0 N-CA-C 114.825 0.69 . . . . 0.0 114.825 -177.934 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 6.6 t -83.2 17.84 1.91 Allowed 'General case' 0 CA--C 1.545 0.778 0 CA-C-O 122.214 1.007 . . . . 0.0 110.416 178.782 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.442 ' HD2' ' OD1' ' A' ' 114' ' ' ASN . 62.7 ttp85 -59.32 131.46 51.06 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.786 -179.912 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 10.2 m-20 -100.22 122.04 51.58 Favored Pre-proline 0 C--N 1.326 -0.444 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -71.06 -15.06 32.3 Favored 'Trans proline' 0 C--O 1.218 -0.485 0 N-CA-C 113.672 0.604 . . . . 0.0 113.672 -177.74 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -76.16 -24.38 54.82 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.853 0.359 . . . . 0.0 110.912 177.628 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -101.47 -26.09 13.69 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 113.499 0.926 . . . . 0.0 113.499 -175.5 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' ASN . . . . . 0.442 ' OD1' ' HD2' ' A' ' 109' ' ' ARG . 0.4 OUTLIER -142.77 153.64 43.46 Favored 'General case' 0 N--CA 1.437 -1.119 0 CA-C-O 121.031 0.443 . . . . 0.0 111.428 -176.694 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -99.23 142.22 30.99 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.626 177.082 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -69.23 150.07 47.85 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.403 0.62 . . . . 0.0 112.17 -179.08 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 6.8 mt -86.14 138.42 19.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.382 -0.826 . . . . 0.0 109.23 -178.591 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 97.1 t -60.73 124.08 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 N-CA-C 106.754 -1.573 . . . . 0.0 106.754 176.064 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 6.7 tt -66.5 130.6 43.74 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.226 0.536 . . . . 0.0 111.372 -175.993 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 28.7 mt-30 -131.82 156.77 45.46 Favored 'General case' 0 CA--C 1.514 -0.43 0 N-CA-C 106.827 -1.545 . . . . 0.0 106.827 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 13.9 mt -113.12 147.4 37.21 Favored Pre-proline 0 C--N 1.323 -0.559 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 178.151 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -74.76 169.67 22.06 Favored 'Trans proline' 0 C--N 1.345 0.374 0 O-C-N 122.224 0.592 . . . . 0.0 113.465 -179.384 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 36.8 tt0 -54.25 131.34 41.39 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.317 178.857 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 99.78 -22.47 40.23 Favored Glycine 0 C--O 1.227 -0.321 0 CA-C-O 119.439 -0.645 . . . . 0.0 113.474 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 5.7 m -108.75 129.29 55.37 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 118.461 1.13 . . . . 0.0 111.179 179.071 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 7.1 p -123.34 149.16 45.24 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.793 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 96.7 mt -71.48 151.09 93.93 Favored Pre-proline 0 C--N 1.324 -0.522 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 178.448 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -79.11 178.25 7.72 Favored 'Trans proline' 0 CA--C 1.531 0.361 0 C-N-CA 120.33 0.686 . . . . 0.0 112.296 179.31 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 64.4 tttp -57.17 129.95 44.02 Favored 'General case' 0 C--O 1.219 -0.504 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.224 -178.933 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 87.18 -1.98 86.61 Favored Glycine 0 C--O 1.226 -0.379 0 N-CA-C 115.425 0.93 . . . . 0.0 115.425 175.76 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -101.1 137.11 39.9 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-O 121.883 0.849 . . . . 0.0 112.433 -178.136 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 48.4 p90 -145.4 164.44 31.51 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 114.343 -1.299 . . . . 0.0 108.735 176.564 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -104.84 144.89 31.15 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 -176.246 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -71.62 136.23 47.27 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 177.804 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 94.06 -8.96 73.0 Favored Glycine 0 C--O 1.225 -0.445 0 C-N-CA 121.425 -0.417 . . . . 0.0 112.297 178.859 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 32.8 t . . . . . 0 C--N 1.325 -0.496 0 N-CA-C 110.305 -0.257 . . . . 0.0 110.305 178.018 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.119 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 34.7 p -66.84 141.74 57.57 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 -178.291 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' TRP . . . . . 0.407 ' CD2' ' HD3' ' A' ' 109' ' ' ARG . 20.6 m95 -67.07 -26.95 66.99 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 178.597 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 24.9 m-85 -121.38 164.89 16.35 Favored 'General case' 0 C--O 1.241 0.633 0 N-CA-C 113.74 1.015 . . . . 0.0 113.74 -171.837 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 56.1 p -68.23 167.97 13.23 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 114.609 -1.178 . . . . 0.0 110.204 179.045 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.489 ' HB2' ' CZ ' ' A' ' 69' ' ' TYR . . . -81.61 142.35 32.86 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 114.531 1.308 . . . . 0.0 114.531 -174.845 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 25.3 mt -84.42 146.8 27.46 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 102.55 -3.13 . . . . 0.0 102.55 167.554 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 29.8 m -130.12 141.28 50.7 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 -178.182 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.402 ' HB2' ' CZ ' ' A' ' 131' ' ' PHE . 4.3 tp60 -109.64 140.42 43.5 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 -176.181 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 53.6 t60 -131.07 99.93 5.05 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 104.054 -2.573 . . . . 0.0 104.054 168.846 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 163.97 -162.93 35.57 Favored Glycine 0 C--O 1.227 -0.301 0 N-CA-C 108.252 -1.939 . . . . 0.0 108.252 -175.907 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 90.2 mttt -111.36 -22.17 11.47 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 115.207 1.558 . . . . 0.0 115.207 -178.986 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -75.2 158.95 32.17 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 106.602 -1.629 . . . . 0.0 106.602 174.757 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -83.59 -62.12 1.66 Allowed 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 120.545 -0.462 . . . . 0.0 110.851 -178.726 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 41.5 tp -175.08 150.83 1.23 Allowed 'General case' 0 N--CA 1.481 1.094 0 N-CA-C 105.637 -1.986 . . . . 0.0 105.637 173.53 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -158.11 134.61 9.59 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 178.113 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -129.35 148.65 70.09 Favored Pre-proline 0 C--N 1.323 -0.551 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 173.693 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -72.63 155.74 54.21 Favored 'Trans proline' 0 C--N 1.35 0.654 0 O-C-N 122.194 0.576 . . . . 0.0 112.703 178.082 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 17.3 tpt180 -67.56 137.76 55.96 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 -179.23 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 89.26 0.67 79.88 Favored Glycine 0 C--O 1.222 -0.612 0 N-CA-C 110.684 -0.967 . . . . 0.0 110.684 179.501 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 30.8 mt-30 -146.71 -179.62 6.91 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 -174.793 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 99.96 -27.06 22.06 Favored Glycine 0 CA--C 1.5 -0.906 0 CA-C-N 116.241 -0.436 . . . . 0.0 112.219 175.325 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 71.9 t -63.32 128.52 92.58 Favored Pre-proline 0 C--N 1.319 -0.736 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 177.062 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -74.74 168.39 24.94 Favored 'Trans proline' 0 N--CA 1.458 -0.575 0 O-C-N 122.165 0.56 . . . . 0.0 110.86 178.557 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 97.4 mt -68.01 116.92 8.83 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 69.2 m-80 -105.06 98.38 8.1 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.448 -179.455 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 67.6 p -73.4 -22.18 60.31 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.19 0.519 . . . . 0.0 111.683 -179.192 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 71.2 m-80 -111.12 36.85 3.02 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.496 -0.774 . . . . 0.0 112.682 -177.64 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 17.5 m -144.59 146.96 32.59 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 179.313 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -72.26 166.39 41.89 Favored Pre-proline 0 C--N 1.327 -0.405 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 176.943 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -64.79 -27.03 59.76 Favored 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 115.198 -2.735 . . . . 0.0 111.86 178.756 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -62.22 -29.07 70.13 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.662 0.744 . . . . 0.0 111.17 176.377 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 76.6 m-20 -96.29 0.8 51.34 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 115.288 1.588 . . . . 0.0 115.288 -170.628 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 94.7 mm-40 -61.58 -27.12 68.41 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 121.345 0.593 . . . . 0.0 112.478 178.845 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.402 ' HB ' ' HB1' ' A' ' 98' ' ' ALA . 19.5 tt -57.52 138.67 18.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-O 122.236 1.017 . . . . 0.0 113.712 -179.325 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -177.82 -158.74 21.39 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.274 -0.965 . . . . 0.0 113.158 -179.47 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 38.2 p90 -155.04 169.12 24.84 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 107.721 -1.214 . . . . 0.0 107.721 179.291 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 29.1 m-85 -113.63 141.42 47.23 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 106.784 -1.562 . . . . 0.0 106.784 173.879 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 44.4 ttt-85 -112.21 131.71 55.33 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.826 -0.624 . . . . 0.0 112.231 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 39.2 ttt-85 -65.39 142.44 58.2 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.437 176.134 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -147.98 166.13 28.66 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 177.52 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 6.3 t -152.37 162.46 41.14 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 -177.942 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 10.1 ttm180 -90.72 123.88 34.66 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 104.619 -2.363 . . . . 0.0 104.619 176.032 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 8.3 tmm_? -148.25 144.65 27.8 Favored 'General case' 0 CA--C 1.508 -0.665 0 CA-C-O 121.105 0.479 . . . . 0.0 111.633 -172.321 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.463 HD12 ' HB2' ' A' ' 62' ' ' LYS . 0.0 OUTLIER -126.68 -179.68 2.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 -178.61 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -117.37 104.32 11.0 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 171.598 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -71.84 165.02 54.07 Favored Glycine 0 C--O 1.222 -0.625 0 N-CA-C 108.189 -1.964 . . . . 0.0 108.189 178.68 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -61.15 -42.45 99.79 Favored Glycine 0 C--O 1.217 -0.935 0 CA-C-N 118.483 1.142 . . . . 0.0 112.131 -179.256 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 41.2 t0 -95.67 16.94 15.99 Favored 'General case' 0 CA--C 1.549 0.923 0 CA-C-O 122.912 1.339 . . . . 0.0 110.39 179.434 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 86.01 6.86 81.55 Favored Glycine 0 C--O 1.226 -0.384 0 CA-C-N 114.769 -1.105 . . . . 0.0 113.833 172.759 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 23.9 mmtt -69.49 142.48 53.72 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 122.235 1.017 . . . . 0.0 112.472 -173.969 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 5.1 mmt -93.82 172.42 8.26 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 113.135 -1.848 . . . . 0.0 113.961 -175.748 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.463 ' HB2' HD12 ' A' ' 54' ' ' ILE . 12.2 tptt -124.34 -41.74 2.16 Favored 'General case' 0 CA--C 1.491 -1.311 0 CA-C-N 114.811 -1.086 . . . . 0.0 108.896 173.351 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 26.56 86.27 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.872 0 O-C-N 126.814 2.571 . . . . 0.0 116.315 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -75.89 173.01 11.74 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 114.141 -1.39 . . . . 0.0 108.904 -179.695 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 5.7 m -46.13 140.07 5.29 Favored Pre-proline 0 C--O 1.244 0.814 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 -179.141 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -68.14 148.36 74.89 Favored 'Trans proline' 0 C--O 1.24 0.598 0 C-N-CA 116.73 -1.713 . . . . 0.0 114.191 -175.687 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 26.0 mtp180 -124.96 162.15 25.1 Favored 'General case' 0 CA--C 1.501 -0.941 0 N-CA-C 106.692 -1.595 . . . . 0.0 106.692 177.401 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 62.4 m95 -132.72 133.51 43.59 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 179.256 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.489 ' CZ ' ' HB2' ' A' ' 15' ' ' ALA . 80.5 m-85 -116.59 146.42 42.68 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 -178.872 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 82.9 t80 -94.85 134.04 37.93 Favored 'General case' 0 CA--C 1.509 -0.628 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 -175.929 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 11.5 m-85 -137.33 152.96 50.29 Favored 'General case' 0 N--CA 1.439 -0.988 0 N-CA-C 106.674 -1.602 . . . . 0.0 106.674 -175.69 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -91.96 159.38 15.77 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 112.338 0.495 . . . . 0.0 112.338 -173.709 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 15.2 tp -57.13 127.13 30.41 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.38 0.61 . . . . 0.0 110.088 179.749 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 71.04 28.66 70.04 Favored Glycine 0 N--CA 1.45 -0.422 0 N-CA-C 116.848 1.499 . . . . 0.0 116.848 175.435 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.421 ' HA ' ' HA ' ' A' ' 104' ' ' ASP . 24.0 p . . . . . 0 CA--C 1.508 -0.635 0 CA-C-N 119.487 1.644 . . . . 0.0 109.079 175.379 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 12.4 mt . . . . . 0 N--CA 1.436 -1.139 0 N-CA-C 114.404 1.261 . . . . 0.0 114.404 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -78.29 161.7 28.74 Favored 'Trans proline' 0 N--CA 1.461 -0.404 0 C-N-CA 122.168 1.912 . . . . 0.0 107.3 167.978 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 55.0 t80 -61.19 131.93 52.04 Favored 'General case' 0 C--N 1.32 -0.678 0 C-N-CA 120.274 -0.57 . . . . 0.0 110.257 -177.926 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 91.6 -6.73 80.18 Favored Glycine 0 C--O 1.227 -0.298 0 CA-C-O 119.407 -0.663 . . . . 0.0 114.622 179.277 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -68.6 130.76 43.8 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 118.647 1.224 . . . . 0.0 111.714 179.731 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 56.0 t30 -78.17 130.99 37.0 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.337 179.675 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 26.1 ttmt -156.18 155.81 33.11 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 106.983 -1.488 . . . . 0.0 106.983 -179.28 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 15.2 t0 -56.41 121.37 9.43 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.261 0.553 . . . . 0.0 111.719 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 68.58 33.4 76.44 Favored Glycine 0 N--CA 1.448 -0.536 0 CA-C-O 118.975 -0.903 . . . . 0.0 114.971 177.157 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 41.3 mm -125.66 129.46 72.68 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 CA-C-N 118.079 0.939 . . . . 0.0 112.091 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -130.34 125.24 59.19 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.841 174.277 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 96.9 m95 -90.94 138.28 31.72 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 113.631 0.975 . . . . 0.0 113.631 -176.353 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 13.9 m -138.87 149.66 23.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.547 0.689 . . . . 0.0 109.445 178.844 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -160.82 164.75 31.17 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 105.058 -2.201 . . . . 0.0 105.058 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 14.8 t -130.35 168.9 16.19 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 105.091 -2.188 . . . . 0.0 105.091 178.197 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -67.4 137.49 55.98 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 -179.284 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 97.76 -12.73 64.3 Favored Glycine 0 C--O 1.225 -0.416 0 CA-C-N 115.832 -0.622 . . . . 0.0 112.145 179.352 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.402 ' HB1' ' HB ' ' A' ' 44' ' ' ILE . . . -79.65 136.77 36.9 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 178.839 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 44.1 mt -87.15 138.05 31.82 Favored 'General case' 0 CA--C 1.512 -0.512 0 CA-C-O 121.43 0.633 . . . . 0.0 112.288 -177.279 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 60.3 t30 -84.46 66.95 9.72 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.849 -179.462 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -142.46 156.45 63.69 Favored Pre-proline 0 C--N 1.322 -0.629 0 N-CA-C 107.078 -1.453 . . . . 0.0 107.078 -178.316 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -70.93 153.69 63.42 Favored 'Trans proline' 0 CA--C 1.531 0.329 0 N-CA-C 114.227 0.818 . . . . 0.0 114.227 178.401 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -145.92 60.66 1.25 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 123.103 1.43 . . . . 0.0 111.356 178.877 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 104' ' ' ASP . . . . . 0.421 ' HA ' ' HA ' ' A' ' 75' ' ' THR . 16.7 p-10 -53.38 -39.48 64.25 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 113.229 -1.805 . . . . 0.0 112.789 178.024 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 48.2 p-80 -62.22 -8.21 5.34 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 115.071 1.508 . . . . 0.0 115.071 -178.116 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 57.9 mt -95.77 -45.32 13.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 177.683 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -74.19 -1.17 59.5 Favored Glycine 0 C--O 1.223 -0.543 0 N-CA-C 115.53 0.972 . . . . 0.0 115.53 -177.193 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 13.3 t -83.29 21.13 1.17 Allowed 'General case' 0 CA--C 1.542 0.672 0 CA-C-O 121.757 0.789 . . . . 0.0 111.542 -178.597 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.441 ' HD2' ' OD1' ' A' ' 114' ' ' ASN . 65.4 ttp85 -52.77 131.92 35.76 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.145 178.658 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 36.4 m120 -88.37 117.44 68.39 Favored Pre-proline 0 C--N 1.323 -0.549 0 N-CA-C 107.718 -1.215 . . . . 0.0 107.718 179.631 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -72.4 -13.39 27.84 Favored 'Trans proline' 0 C--O 1.216 -0.583 0 C-N-CA 117.243 -1.372 . . . . 0.0 112.817 -179.051 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -78.49 -26.93 46.12 Favored 'General case' 0 C--O 1.219 -0.506 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.638 177.3 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 -102.21 -24.86 13.87 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 113.203 0.816 . . . . 0.0 113.203 -174.795 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' ASN . . . . . 0.441 ' OD1' ' HD2' ' A' ' 109' ' ' ARG . 5.6 t-20 -128.7 147.2 50.74 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 113.508 0.929 . . . . 0.0 113.508 -178.229 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -95.93 129.92 43.05 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 107.686 -1.228 . . . . 0.0 107.686 173.896 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -64.65 151.51 44.7 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.441 -0.8 . . . . 0.0 112.28 -178.9 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 4.0 mt -89.83 144.11 9.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.288 -0.869 . . . . 0.0 109.692 -177.508 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 72.5 t -60.8 124.54 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 175.111 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 6.7 tt -69.07 128.07 35.36 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.181 0.515 . . . . 0.0 109.736 -178.577 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 33.0 mt-30 -133.4 157.87 44.46 Favored 'General case' 0 CA--C 1.511 -0.526 0 N-CA-C 106.785 -1.561 . . . . 0.0 106.785 -178.992 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 13.4 mt -112.88 148.05 38.52 Favored Pre-proline 0 C--N 1.32 -0.688 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 178.022 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -73.97 167.54 26.97 Favored 'Trans proline' 0 C--O 1.237 0.459 0 O-C-N 122.291 0.627 . . . . 0.0 112.837 179.376 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 60.8 tt0 -54.46 134.04 45.94 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.265 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 100.42 -28.19 16.94 Favored Glycine 0 C--O 1.227 -0.315 0 CA-C-N 115.944 -0.571 . . . . 0.0 112.867 -179.297 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 4.1 m -100.04 128.87 46.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 118.4 1.1 . . . . 0.0 112.116 179.451 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 3.2 p -120.35 148.11 44.17 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.188 178.695 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 90.3 mt -71.5 153.18 93.83 Favored Pre-proline 0 C--N 1.323 -0.559 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 178.408 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -75.19 168.72 24.09 Favored 'Trans proline' 0 N--CA 1.463 -0.299 0 C-N-CA 118.508 -0.528 . . . . 0.0 111.005 178.599 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 53.0 tptt -59.59 130.23 45.83 Favored 'General case' 0 C--N 1.324 -0.539 0 O-C-N 122.199 -0.313 . . . . 0.0 111.018 -176.564 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 95.15 -10.64 69.74 Favored Glycine 0 C--O 1.23 -0.124 0 CA-C-N 115.547 -0.752 . . . . 0.0 114.846 178.33 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.402 ' CZ ' ' HB2' ' A' ' 18' ' ' GLN . 1.3 m-85 -95.41 144.41 25.95 Favored 'General case' 0 N--CA 1.436 -1.168 0 CA-C-O 122.39 1.091 . . . . 0.0 110.53 179.888 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 38.1 p90 -143.13 164.76 29.27 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 113.168 -1.833 . . . . 0.0 107.892 175.484 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -108.22 153.53 23.06 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.08 0.466 . . . . 0.0 110.446 -176.648 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -90.12 132.22 35.55 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.322 -178.813 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 97.2 -33.76 5.57 Favored Glycine 0 C--O 1.225 -0.414 0 CA-C-N 116.044 -0.525 . . . . 0.0 113.102 179.082 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.442 -0.848 0 CA-C-O 121.798 0.808 . . . . 0.0 111.121 179.402 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.822 0 CA-C-O 121.822 0.82 . . . . 0.0 111.473 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -58.59 140.6 54.12 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 114.635 -1.166 . . . . 0.0 110.808 178.67 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 26.5 m95 -73.05 -21.95 60.7 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 114.906 1.447 . . . . 0.0 114.906 -178.217 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -121.47 156.15 33.39 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-O 121.015 0.436 . . . . 0.0 111.867 -174.454 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 75.9 p -68.6 162.99 24.68 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.745 -1.116 . . . . 0.0 110.078 -179.647 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.595 ' HB1' ' HB2' ' A' ' 67' ' ' ARG . . . -79.61 126.62 31.14 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 116.299 1.963 . . . . 0.0 116.299 -174.481 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.484 HD13 HD13 ' A' ' 119' ' ' LEU . 0.0 OUTLIER -74.32 121.28 21.1 Favored 'General case' 0 N--CA 1.438 -1.029 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 170.272 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 56.7 m -87.19 126.92 35.11 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 -176.309 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 3.2 tm0? -88.27 135.02 33.65 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 -179.685 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 37.8 t60 -139.36 99.49 3.75 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 169.99 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 162.34 -161.37 33.5 Favored Glycine 0 C--O 1.226 -0.355 0 C-N-CA 120.008 -1.091 . . . . 0.0 113.371 -179.481 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -105.59 -24.09 12.65 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -85.68 153.55 22.27 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 178.612 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -78.22 -62.81 1.56 Allowed 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 120.598 -0.441 . . . . 0.0 110.964 -176.315 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 58.2 tp 173.66 145.62 0.05 OUTLIER 'General case' 0 N--CA 1.485 1.316 0 N-CA-C 106.104 -1.813 . . . . 0.0 106.104 174.886 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 2.5 tppp? -158.92 140.87 13.67 Favored 'General case' 0 C--O 1.223 -0.336 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 175.325 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 20.9 m-85 -127.24 151.49 74.64 Favored Pre-proline 0 C--N 1.325 -0.499 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 174.826 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -73.7 162.68 39.08 Favored 'Trans proline' 0 C--N 1.349 0.574 0 O-C-N 122.183 0.57 . . . . 0.0 113.269 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 16.6 tpt180 -64.59 133.3 52.0 Favored 'General case' 0 C--O 1.218 -0.605 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.647 -178.344 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 79.83 15.66 78.79 Favored Glycine 0 C--O 1.221 -0.671 0 CA-C-N 116.252 -0.431 . . . . 0.0 112.248 178.543 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -151.86 170.59 19.44 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 -175.094 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 99.53 -8.61 60.28 Favored Glycine 0 C--O 1.222 -0.656 0 N-CA-C 114.501 0.561 . . . . 0.0 114.501 174.982 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 96.4 t -69.21 130.92 90.75 Favored Pre-proline 0 C--N 1.319 -0.729 0 N-CA-C 106.471 -1.677 . . . . 0.0 106.471 176.747 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -70.11 174.5 9.71 Favored 'Trans proline' 0 C--O 1.223 -0.228 0 O-C-N 122.314 0.639 . . . . 0.0 113.22 178.659 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 74.2 mt -75.65 105.64 4.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 122.3 1.048 . . . . 0.0 108.485 179.765 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 50.8 m-20 -100.6 79.64 2.11 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 113.96 -1.473 . . . . 0.0 109.027 -176.986 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 69.7 p -66.65 -22.43 66.1 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 114.797 1.406 . . . . 0.0 114.797 -175.039 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -120.87 30.28 6.96 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 -176.022 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -128.59 157.24 41.81 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 179.134 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.6 p -74.18 162.22 74.84 Favored Pre-proline 0 C--N 1.321 -0.64 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 -179.426 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -65.89 -20.54 58.1 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 115.78 -2.346 . . . . 0.0 112.561 177.222 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.421 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 3.3 p-10 -75.19 -21.89 58.38 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 119.636 -0.825 . . . . 0.0 110.747 179.785 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 31.3 t0 -89.92 0.82 56.85 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 114.147 1.166 . . . . 0.0 114.147 -175.401 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 91.4 mm-40 -63.21 -28.11 69.82 Favored 'General case' 0 C--N 1.318 -0.786 0 O-C-N 121.047 -1.033 . . . . 0.0 111.634 -179.787 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 12.8 tt -66.58 137.84 24.09 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-O 122.259 1.028 . . . . 0.0 111.531 178.08 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 178.4 -158.08 22.44 Favored Glycine 0 CA--C 1.505 -0.581 0 C-N-CA 120.443 -0.884 . . . . 0.0 111.456 -178.255 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 43.9 p90 -155.09 167.61 29.78 Favored 'General case' 0 C--N 1.319 -0.738 0 O-C-N 122.627 -0.337 . . . . 0.0 110.574 179.598 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 16.2 m-85 -109.16 141.9 40.72 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 176.356 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 62.4 ttt-85 -120.39 117.99 29.19 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 124.112 0.965 . . . . 0.0 112.346 -174.992 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 28.5 ttp85 -69.78 136.48 50.92 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 177.386 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -146.26 138.53 25.18 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.341 0.656 . . . . 0.0 110.281 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 14.1 t -160.21 153.1 21.42 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.082 0.468 . . . . 0.0 110.142 174.77 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 22.4 tpt180 -151.37 123.81 8.38 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 175.212 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 4.5 tmt_? -134.03 139.04 45.76 Favored 'General case' 0 CA--C 1.501 -0.928 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -141.53 179.2 2.26 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 N-CA-C 105.939 -1.874 . . . . 0.0 105.939 -176.55 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 8.1 ttm180 -131.32 111.99 12.36 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 175.726 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -77.67 169.51 54.73 Favored Glycine 0 C--O 1.229 -0.216 0 N-CA-C 108.699 -1.76 . . . . 0.0 108.699 176.972 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -65.44 -42.29 95.95 Favored Glycine 0 C--O 1.219 -0.826 0 C-N-CA 120.613 -0.804 . . . . 0.0 112.36 -177.939 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -90.57 14.45 13.18 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 122.617 1.199 . . . . 0.0 111.764 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 90.86 -12.37 69.09 Favored Glycine 0 C--N 1.314 -0.664 0 CA-C-N 113.958 -1.474 . . . . 0.0 115.979 175.697 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 4.4 mppt? -57.79 132.63 53.89 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.586 0.708 . . . . 0.0 109.409 179.358 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 26.1 ptm -132.43 -171.49 2.66 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 114.747 -1.115 . . . . 0.0 112.358 -176.147 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 60.9 mmtt -112.71 -119.72 0.3 Allowed 'General case' 0 C--O 1.219 -0.519 0 C-N-CA 123.477 0.711 . . . . 0.0 109.282 -178.958 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 57.8 m-20 -66.97 141.46 57.59 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 111.729 0.27 . . . . 0.0 111.729 -174.918 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 55.8 mt -87.94 -61.65 1.67 Allowed 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 177.318 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 71.0 p -112.35 166.12 11.61 Favored Pre-proline 0 C--O 1.243 0.724 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 178.231 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -73.31 163.81 36.88 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 116.3 -2.0 . . . . 0.0 112.416 177.168 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.595 ' HB2' ' HB1' ' A' ' 15' ' ' ALA . 0.0 OUTLIER -140.44 160.83 39.13 Favored 'General case' 0 C--N 1.326 -0.423 0 O-C-N 122.148 -0.345 . . . . 0.0 110.847 179.037 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 67.0 m95 -117.74 133.98 55.38 Favored 'General case' 0 C--O 1.214 -0.777 0 C-N-CA 122.871 0.468 . . . . 0.0 111.067 -178.138 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.558 ' CZ ' ' HB2' ' A' ' 15' ' ' ALA . 52.1 m-85 -110.39 163.29 13.82 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 106.438 -1.69 . . . . 0.0 106.438 179.041 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 81.0 t80 -110.81 138.25 47.44 Favored 'General case' 0 CA--C 1.51 -0.589 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 -179.066 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -137.6 136.47 37.56 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.114 -0.948 . . . . 0.0 108.548 -176.274 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 34.2 m-85 -70.66 159.52 34.28 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.012 178.469 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -53.56 127.72 26.36 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 113.106 0.78 . . . . 0.0 113.106 -177.181 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 64.47 33.45 87.27 Favored Glycine 0 C--O 1.224 -0.506 0 N-CA-C 115.434 0.934 . . . . 0.0 115.434 174.02 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 4.1 p . . . . . 0 C--N 1.323 -0.555 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 177.79 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 19.1 mt . . . . . 0 C--O 1.238 0.472 0 N-CA-C 114.117 1.155 . . . . 0.0 114.117 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -76.77 165.64 28.33 Favored 'Trans proline' 0 N--CA 1.462 -0.345 0 C-N-CA 121.12 1.213 . . . . 0.0 109.171 172.656 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.425 ' CE1' ' HB3' ' A' ' 92' ' ' TRP . 74.4 t80 -62.37 131.88 50.75 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 120.398 -0.521 . . . . 0.0 110.359 -179.485 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 90.07 -1.33 80.11 Favored Glycine 0 CA--C 1.518 0.235 0 CA-C-O 119.834 -0.426 . . . . 0.0 113.903 178.36 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -61.73 130.26 44.94 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 117.667 0.733 . . . . 0.0 111.348 178.985 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 54.3 t30 -79.42 120.63 24.1 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.452 -178.639 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 50.4 tttm -153.71 149.95 28.03 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 179.396 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -66.03 134.95 53.96 Favored 'General case' 0 C--O 1.238 0.49 0 CA-C-O 120.809 0.338 . . . . 0.0 110.405 179.179 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 70.65 23.57 77.63 Favored Glycine 0 N--CA 1.45 -0.397 0 CA-C-O 119.419 -0.656 . . . . 0.0 113.637 178.616 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 42.2 mm -129.59 130.83 67.2 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 CA-C-N 117.385 0.592 . . . . 0.0 110.401 -179.51 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.1 pt -135.59 120.18 27.03 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 CA-C-O 121.387 0.613 . . . . 0.0 110.251 176.196 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' TRP . . . . . 0.425 ' HB3' ' CE1' ' A' ' 83' ' ' TYR . 93.6 m95 -87.8 137.61 32.19 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 113.087 0.773 . . . . 0.0 113.087 -176.087 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 18.9 m -137.04 154.41 31.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 179.108 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -160.33 166.58 29.17 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 106.465 -1.68 . . . . 0.0 106.465 -178.368 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 11.3 t -138.8 174.73 10.22 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 105.618 -1.993 . . . . 0.0 105.618 177.278 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 59.8 tt0 -67.45 137.43 55.86 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.324 0.583 . . . . 0.0 110.861 -179.011 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 95.26 -11.85 68.63 Favored Glycine 0 N--CA 1.46 0.268 0 CA-C-N 115.756 -0.657 . . . . 0.0 113.3 178.053 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.421 ' HA ' ' HA ' ' A' ' 41' ' ' ASP . . . -76.57 143.05 40.54 Favored 'General case' 0 C--N 1.322 -0.592 0 O-C-N 122.598 -0.354 . . . . 0.0 110.541 179.441 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 46.2 mt -105.4 134.37 48.63 Favored 'General case' 0 CA--C 1.513 -0.459 0 N-CA-C 113.855 1.057 . . . . 0.0 113.855 -178.14 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -79.24 65.58 4.45 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.223 -0.899 . . . . 0.0 111.142 -178.548 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 1.2 t -134.77 156.18 78.79 Favored Pre-proline 0 C--N 1.322 -0.629 0 N-CA-C 105.359 -2.089 . . . . 0.0 105.359 -179.408 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -65.93 153.11 79.48 Favored 'Trans proline' 0 C--N 1.344 0.322 0 N-CA-C 115.05 1.135 . . . . 0.0 115.05 179.34 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.475 ' HB3' HD12 ' A' ' 106' ' ' ILE . 72.0 mmtt -122.94 32.46 5.7 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.201 -0.909 . . . . 0.0 109.149 -178.619 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 15.4 p-10 -50.92 -44.24 60.08 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.989 -177.907 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 16.0 p80 -69.78 -8.92 52.28 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 114.015 1.117 . . . . 0.0 114.015 -178.9 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.475 HD12 ' HB3' ' A' ' 103' ' ' LYS . 33.8 mt -96.15 -41.7 11.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 O-C-N 122.186 -0.321 . . . . 0.0 110.214 179.186 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -68.44 14.75 0.66 Allowed Glycine 0 N--CA 1.466 0.67 0 N-CA-C 117.995 1.958 . . . . 0.0 117.995 -176.224 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 8.9 t -90.27 28.77 1.36 Allowed 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 123.695 0.798 . . . . 0.0 111.976 -178.902 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 73.9 ttp85 -57.75 121.4 10.36 Favored 'General case' 0 N--CA 1.474 0.737 0 O-C-N 121.451 -0.781 . . . . 0.0 109.956 -179.684 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 63.3 m-20 -90.57 118.09 68.46 Favored Pre-proline 0 C--N 1.322 -0.591 0 N-CA-C 106.174 -1.788 . . . . 0.0 106.174 179.618 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -71.09 -14.79 32.11 Favored 'Trans proline' 0 C--O 1.218 -0.523 0 C-N-CA 117.902 -0.932 . . . . 0.0 113.384 -177.052 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -75.53 -26.8 58.37 Favored 'General case' 0 C--O 1.22 -0.484 0 CA-C-O 120.858 0.361 . . . . 0.0 110.41 177.565 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 -104.33 -26.51 12.43 Favored 'General case' 0 C--O 1.222 -0.358 0 N-CA-C 113.284 0.846 . . . . 0.0 113.284 -174.314 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 18.9 t-20 -146.0 143.99 29.81 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 -178.062 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -87.29 149.71 24.36 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.731 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -68.71 146.76 52.68 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 177.943 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 9.0 mt -78.61 134.58 27.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 -178.642 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 98.8 t -63.14 118.96 5.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 106.423 -1.695 . . . . 0.0 106.423 176.404 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.484 HD13 HD13 ' A' ' 16' ' ' LEU . 5.0 tt -67.02 125.31 25.61 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.398 0.618 . . . . 0.0 110.796 -176.303 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -132.7 161.02 35.06 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 105.6 -2.0 . . . . 0.0 105.6 179.452 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 20.1 mt -117.2 146.33 37.91 Favored Pre-proline 0 C--N 1.322 -0.594 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 179.435 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -73.14 171.58 17.29 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 121.183 1.256 . . . . 0.0 114.522 -175.463 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 39.6 tt0 -53.41 129.99 33.93 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.874 -179.311 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 90.99 -16.03 59.52 Favored Glycine 0 C--O 1.226 -0.357 0 CA-C-N 115.963 -0.562 . . . . 0.0 113.229 -179.884 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 19.2 m -108.61 127.15 53.71 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 179.501 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 4.8 p -125.28 148.28 48.75 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.754 0.312 . . . . 0.0 110.668 -176.983 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 84.8 mt -66.41 152.23 94.88 Favored Pre-proline 0 C--N 1.327 -0.406 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 177.197 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -76.83 168.1 24.11 Favored 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 117.747 -1.035 . . . . 0.0 110.859 -179.571 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -59.44 126.73 28.79 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 91.58 27.96 15.84 Favored Glycine 0 C--O 1.224 -0.5 0 N-CA-C 114.938 0.735 . . . . 0.0 114.938 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -139.07 147.42 41.99 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 117.701 0.75 . . . . 0.0 111.369 177.883 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 54.0 p90 -153.93 165.22 36.8 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 176.401 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -100.25 142.03 32.28 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 114.146 1.165 . . . . 0.0 114.146 -175.375 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -67.96 140.63 56.42 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 107.181 -1.415 . . . . 0.0 107.181 175.926 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 90.7 -34.79 4.07 Favored Glycine 0 C--O 1.23 -0.151 0 C-N-CA 121.457 -0.401 . . . . 0.0 112.327 -179.055 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 22.9 t . . . . . 0 C--N 1.327 -0.407 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 179.671 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.431 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 58.3 p -61.62 145.18 52.98 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.752 178.633 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 15.8 m95 -67.93 -24.13 65.16 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 112.609 0.596 . . . . 0.0 112.609 179.392 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 25.8 m-85 -121.48 163.35 18.94 Favored 'General case' 0 CA--C 1.505 -0.754 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -172.156 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 70.1 p -70.64 164.17 25.51 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 176.528 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -80.5 152.04 28.91 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.449 0.642 . . . . 0.0 112.656 -176.871 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 21.8 mt -85.02 146.37 27.22 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 102.753 -3.055 . . . . 0.0 102.753 168.605 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 52.4 m -119.64 129.51 54.63 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 179.528 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -85.34 133.25 34.15 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.648 -179.412 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 21.9 t-160 -139.16 94.94 2.86 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 103.533 -2.766 . . . . 0.0 103.533 168.591 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 166.46 -131.26 2.32 Favored Glycine 0 C--O 1.226 -0.379 0 C-N-CA 120.184 -1.008 . . . . 0.0 113.119 -174.902 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 64.1 mttm -130.96 -38.5 1.25 Allowed 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 116.973 2.212 . . . . 0.0 116.973 -176.327 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -75.62 163.32 27.45 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 179.513 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -72.22 -62.66 1.35 Allowed 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 178.284 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 48.4 tp 174.47 134.2 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 104.843 -2.28 . . . . 0.0 104.843 173.256 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 11.1 tmtt? -148.24 127.51 13.0 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 118.403 0.547 . . . . 0.0 111.386 178.266 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 16.0 m-85 -113.22 153.16 45.54 Favored Pre-proline 0 C--O 1.243 0.716 0 CA-C-O 120.562 0.22 . . . . 0.0 111.306 176.811 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.42 162.57 41.38 Favored 'Trans proline' 0 C--N 1.353 0.765 0 C-N-CA 120.02 0.48 . . . . 0.0 112.541 177.594 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 16.9 tpt180 -69.93 134.63 48.6 Favored 'General case' 0 C--O 1.216 -0.704 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 -176.837 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 78.92 15.1 81.21 Favored Glycine 0 C--O 1.224 -0.506 0 C-N-CA 121.136 -0.554 . . . . 0.0 111.908 178.859 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 4.7 mt-30 -151.63 170.49 19.57 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 -175.291 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 108.09 -16.73 35.6 Favored Glycine 0 CA--C 1.501 -0.805 0 CA-C-N 116.236 -0.438 . . . . 0.0 112.676 175.373 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 95.0 t -65.7 129.29 94.3 Favored Pre-proline 0 C--N 1.319 -0.718 0 N-CA-C 106.968 -1.494 . . . . 0.0 106.968 177.41 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -73.29 170.33 20.14 Favored 'Trans proline' 0 N--CA 1.461 -0.422 0 O-C-N 122.17 0.563 . . . . 0.0 111.297 177.869 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 91.6 mt -69.39 107.63 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 179.829 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -97.67 84.75 3.44 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 114.409 -1.269 . . . . 0.0 109.857 -176.817 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 69.8 p -66.59 -15.65 63.59 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.647 -0.706 . . . . 0.0 112.699 -178.869 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -107.32 22.62 15.7 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.152 -0.931 . . . . 0.0 112.162 -177.917 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 14.3 m -141.92 148.06 38.06 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 114.518 1.303 . . . . 0.0 114.518 -176.233 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -74.65 168.35 27.9 Favored Pre-proline 0 N--CA 1.468 0.46 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 176.424 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -64.65 -28.98 60.6 Favored 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 114.807 -2.996 . . . . 0.0 112.3 178.756 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -62.92 -24.07 67.67 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 123.74 0.816 . . . . 0.0 111.667 176.289 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 70.3 m-20 -98.93 -1.49 39.86 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 114.865 1.431 . . . . 0.0 114.865 -172.354 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 93.7 mm-40 -60.36 -29.26 68.8 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 114.459 1.281 . . . . 0.0 114.459 -178.888 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 20.8 tt -58.61 139.65 18.0 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.882 0 CA-C-O 122.32 1.057 . . . . 0.0 113.774 -177.296 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -179.18 -156.65 17.91 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.434 -178.738 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 46.6 p90 -155.12 171.52 19.65 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 178.653 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 19.9 m-85 -113.15 139.45 48.74 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 106.365 -1.717 . . . . 0.0 106.365 173.131 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 55.8 ttt180 -110.33 119.71 40.09 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.033 -176.951 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 11.8 ttp180 -65.92 137.92 57.49 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 177.431 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -143.8 142.67 31.0 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.772 0.796 . . . . 0.0 111.266 -179.976 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 41.4 p -142.99 172.49 12.63 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 102.284 -3.228 . . . . 0.0 102.284 174.995 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 17.9 tpt180 -140.62 125.98 18.79 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 120.345 -0.542 . . . . 0.0 111.025 176.557 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.26 148.11 33.12 Favored 'General case' 0 CA--C 1.488 -1.436 0 CA-C-O 121.611 0.719 . . . . 0.0 109.537 179.604 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -144.61 179.61 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.055 0 N-CA-C 102.123 -3.288 . . . . 0.0 102.123 178.804 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 79.2 ttt180 -132.7 121.16 22.68 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 175.295 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -97.33 147.07 18.53 Favored Glycine 0 N--CA 1.448 -0.547 0 N-CA-C 106.582 -2.607 . . . . 0.0 106.582 175.543 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -68.73 -30.94 72.72 Favored Glycine 0 C--O 1.216 -1.016 0 N-CA-C 109.798 -1.321 . . . . 0.0 109.798 179.507 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 30.7 t0 -87.26 17.02 4.62 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-O 122.016 0.912 . . . . 0.0 111.394 179.99 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 84.93 -6.49 78.63 Favored Glycine 0 C--O 1.223 -0.55 0 N-CA-C 116.462 1.345 . . . . 0.0 116.462 174.196 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.13 132.11 47.16 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.959 0.885 . . . . 0.0 112.509 -179.277 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 91.6 mmm -121.79 179.38 4.51 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 113.81 -1.541 . . . . 0.0 108.485 -177.917 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 13.6 mmtt -111.41 -54.35 2.62 Favored 'General case' 0 C--O 1.215 -0.761 0 CA-C-O 120.857 0.36 . . . . 0.0 110.155 178.268 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 49.58 50.0 18.99 Favored 'General case' 0 C--N 1.323 -0.579 0 O-C-N 124.993 1.433 . . . . 0.0 113.867 174.972 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 63.9 mt -70.97 142.08 51.02 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 107.143 -1.429 . . . . 0.0 107.143 176.453 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 72.6 p -58.92 153.59 42.93 Favored Pre-proline 0 C--O 1.239 0.515 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -176.423 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -65.84 128.99 21.0 Favored 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 117.898 -0.935 . . . . 0.0 112.406 -178.918 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 18.1 mtt-85 -134.7 160.83 36.91 Favored 'General case' 0 CA--C 1.51 -0.592 0 CA-C-N 115.249 -0.887 . . . . 0.0 111.214 -176.499 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 57.6 m95 -129.49 129.19 44.25 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 178.152 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 40.4 m-85 -111.43 139.35 46.92 Favored 'General case' 0 C--O 1.217 -0.627 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 -178.491 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 92.0 t80 -86.9 136.64 32.88 Favored 'General case' 0 CA--C 1.509 -0.604 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 -177.973 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -141.77 144.91 34.22 Favored 'General case' 0 N--CA 1.441 -0.905 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 -175.434 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 -80.76 159.38 25.2 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 112.276 0.472 . . . . 0.0 112.276 -174.726 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 15.8 tp -58.1 126.95 29.7 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 121.363 0.602 . . . . 0.0 110.177 -179.423 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 85.21 16.73 64.11 Favored Glycine 0 C--O 1.221 -0.704 0 N-CA-C 116.086 1.195 . . . . 0.0 116.086 178.468 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 19.4 p . . . . . 0 N--CA 1.469 0.477 0 CA-C-N 118.971 1.385 . . . . 0.0 111.187 179.941 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 43.9 mt . . . . . 0 N--CA 1.449 -0.483 0 N-CA-C 115.525 1.676 . . . . 0.0 115.525 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -77.52 166.02 26.41 Favored 'Trans proline' 0 N--CA 1.461 -0.407 0 N-CA-C 108.388 -1.428 . . . . 0.0 108.388 169.274 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 64.1 t80 -63.14 132.51 52.05 Favored 'General case' 0 C--N 1.322 -0.602 0 O-C-N 121.947 -0.471 . . . . 0.0 109.958 -179.677 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 91.39 -4.91 80.6 Favored Glycine 0 CA--C 1.52 0.353 0 N-CA-C 114.637 0.615 . . . . 0.0 114.637 178.868 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -65.14 132.3 48.8 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 118.038 0.919 . . . . 0.0 112.357 179.781 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 50.1 t30 -74.96 125.9 29.87 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.863 -178.807 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 26.9 ttmt -156.26 151.6 26.7 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 107.178 -1.416 . . . . 0.0 107.178 177.321 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 15.6 t0 -61.97 129.63 41.82 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.013 0.435 . . . . 0.0 110.853 179.423 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 69.19 27.85 73.35 Favored Glycine 0 N--CA 1.447 -0.609 0 CA-C-N 115.82 -0.627 . . . . 0.0 114.319 176.032 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 45.1 mm -125.11 120.77 59.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 117.365 0.583 . . . . 0.0 110.062 178.764 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.1 pt -123.68 113.79 38.75 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 CA-C-O 121.896 0.855 . . . . 0.0 110.592 176.972 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 96.5 m95 -80.51 132.67 35.72 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.763 -0.653 . . . . 0.0 112.601 -176.978 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 17.0 m -135.59 149.7 28.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.795 0.807 . . . . 0.0 109.492 179.599 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -156.28 166.57 33.06 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 103.531 -2.766 . . . . 0.0 103.531 -179.282 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 14.5 t -131.53 168.94 16.8 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 104.221 -2.511 . . . . 0.0 104.221 177.522 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -65.41 134.17 52.91 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 -178.681 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 95.75 -7.06 67.75 Favored Glycine 0 C--O 1.226 -0.369 0 CA-C-N 116.004 -0.544 . . . . 0.0 113.529 179.4 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -80.51 135.42 36.11 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 122.096 -0.649 . . . . 0.0 109.823 179.029 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 37.0 mt -81.86 136.25 35.38 Favored 'General case' 0 CA--C 1.511 -0.529 0 CA-C-O 121.161 0.505 . . . . 0.0 111.479 -178.878 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 63.4 t30 -84.08 65.22 8.62 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.633 -179.664 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -140.1 153.75 69.55 Favored Pre-proline 0 C--N 1.324 -0.519 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 -178.553 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -66.85 149.89 83.23 Favored 'Trans proline' 0 C--N 1.344 0.319 0 N-CA-C 113.977 0.722 . . . . 0.0 113.977 177.252 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 1.5 ptpm? -149.15 55.51 0.99 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 123.036 1.398 . . . . 0.0 109.571 179.759 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 13.6 p-10 -54.92 -35.1 63.83 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 113.451 -1.704 . . . . 0.0 112.344 179.52 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 37.5 p-80 -60.3 -14.6 19.09 Favored 'General case' 0 C--O 1.219 -0.549 0 N-CA-C 114.728 1.381 . . . . 0.0 114.728 -177.839 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 62.8 mt -84.42 -39.16 14.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 178.515 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -74.16 14.6 3.8 Favored Glycine 0 C--O 1.221 -0.678 0 N-CA-C 116.126 1.211 . . . . 0.0 116.126 -176.558 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 11.5 t -94.29 23.11 5.35 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 117.968 0.884 . . . . 0.0 112.667 -178.038 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 65.3 ttp85 -55.91 133.65 51.56 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.387 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 15.1 m-20 -104.28 125.18 34.97 Favored Pre-proline 0 C--N 1.324 -0.523 0 N-CA-C 106.854 -1.536 . . . . 0.0 106.854 -179.389 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_endo -69.59 -18.51 37.75 Favored 'Trans proline' 0 C--O 1.217 -0.527 0 N-CA-C 114.037 0.745 . . . . 0.0 114.037 -177.903 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -73.63 -26.28 60.7 Favored 'General case' 0 C--O 1.22 -0.498 0 CA-C-O 120.877 0.37 . . . . 0.0 110.675 178.1 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -102.11 -23.93 14.0 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 113.142 0.793 . . . . 0.0 113.142 -174.978 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 -154.55 148.37 25.52 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 112.578 0.584 . . . . 0.0 112.578 -178.361 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -88.94 149.1 23.46 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-O 121.432 0.634 . . . . 0.0 111.702 179.575 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -70.08 145.18 51.83 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.221 0.534 . . . . 0.0 110.446 178.369 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 14.4 mt -86.3 138.8 18.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 115.393 -0.821 . . . . 0.0 108.815 -178.601 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 75.6 t -61.16 123.9 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 N-CA-C 106.077 -1.823 . . . . 0.0 106.077 174.848 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 7.1 tt -66.84 130.11 42.07 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.134 0.492 . . . . 0.0 110.379 -177.021 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 30.2 mt-30 -132.72 157.94 43.62 Favored 'General case' 0 CA--C 1.511 -0.551 0 N-CA-C 106.615 -1.624 . . . . 0.0 106.615 -179.445 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 13.3 mt -112.31 148.18 38.59 Favored Pre-proline 0 C--N 1.322 -0.588 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 177.12 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -73.2 166.17 30.68 Favored 'Trans proline' 0 N--CA 1.462 -0.371 0 O-C-N 122.325 0.645 . . . . 0.0 112.933 -179.501 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 60.2 tp60 -54.27 130.37 38.56 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.887 -179.879 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 97.15 -17.12 59.73 Favored Glycine 0 C--O 1.227 -0.3 0 CA-C-N 115.907 -0.588 . . . . 0.0 113.611 -179.926 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 9.5 m -106.71 127.01 53.02 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 118.149 0.975 . . . . 0.0 109.984 178.288 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 17.3 p -120.02 148.32 43.71 Favored 'General case' 0 CA--C 1.511 -0.534 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.845 -179.132 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 88.8 mt -70.4 156.1 92.41 Favored Pre-proline 0 C--N 1.323 -0.561 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 177.559 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -74.55 169.11 23.26 Favored 'Trans proline' 0 C--O 1.236 0.406 0 C-N-CA 117.749 -1.034 . . . . 0.0 110.343 178.302 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 12.4 tmtt? -63.72 120.67 12.29 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 -176.823 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 95.18 37.94 4.98 Favored Glycine 0 N--CA 1.452 -0.257 0 N-CA-C 114.943 0.737 . . . . 0.0 114.943 178.942 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -142.31 146.15 34.73 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 176.85 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 48.6 p90 -147.11 162.38 38.94 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 176.627 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -97.68 143.26 28.53 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.042 0.449 . . . . 0.0 110.547 -178.345 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -71.34 135.84 47.54 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 178.812 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 87.87 -13.53 60.84 Favored Glycine 0 C--O 1.227 -0.299 0 CA-C-N 116.109 -0.496 . . . . 0.0 113.147 -178.24 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 35.2 t . . . . . 0 C--N 1.326 -0.43 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 178.733 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.456 -0.128 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 62.5 p -63.06 141.07 58.9 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 178.865 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 12' ' ' TRP . . . . . 0.415 ' CD2' ' HD3' ' A' ' 109' ' ' ARG . 10.9 m95 -67.95 -27.21 66.4 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.038 0.447 . . . . 0.0 111.772 178.716 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 20.1 m-85 -121.53 163.97 17.99 Favored 'General case' 0 C--O 1.242 0.68 0 CA-C-N 115.517 -0.765 . . . . 0.0 112.537 -171.349 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 63.7 p -70.19 166.5 19.87 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 177.096 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.433 ' HB1' ' HB3' ' A' ' 67' ' ' ARG . . . -83.58 148.17 27.32 Favored 'General case' 0 N--CA 1.443 -0.785 0 N-CA-C 113.529 0.937 . . . . 0.0 113.529 -175.371 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 15.6 mt -81.88 144.92 30.65 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 103.768 -2.679 . . . . 0.0 103.768 170.902 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 26.4 m -123.28 131.03 53.52 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.108 0.48 . . . . 0.0 110.052 -178.008 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -83.39 141.93 31.38 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.34 -0.845 . . . . 0.0 111.94 -178.627 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 23.0 t-160 -139.11 99.71 3.83 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 105.83 -1.915 . . . . 0.0 105.83 168.477 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 151.02 -134.59 4.76 Favored Glycine 0 C--N 1.322 -0.242 0 N-CA-C 111.134 -0.786 . . . . 0.0 111.134 -176.841 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 51.6 mttp -132.7 -16.1 2.65 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 114.993 1.479 . . . . 0.0 114.993 -179.351 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 59.7 mt-10 -73.98 155.49 38.55 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 107.1 -1.444 . . . . 0.0 107.1 178.027 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -82.17 -62.6 1.58 Allowed 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 120.458 -0.497 . . . . 0.0 109.791 -178.685 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 56.5 tp 168.58 136.7 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 103.661 -2.718 . . . . 0.0 103.661 175.411 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -157.01 138.87 14.3 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 176.511 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 25.6 m-85 -127.55 151.38 75.01 Favored Pre-proline 0 C--N 1.324 -0.531 0 O-C-N 123.307 0.379 . . . . 0.0 110.212 176.804 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -79.72 165.89 22.08 Favored 'Trans proline' 0 CA--C 1.541 0.83 0 C-N-CA 120.568 0.845 . . . . 0.0 113.03 176.755 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 2.2 tmt_? -67.3 138.33 56.75 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 116.548 -0.296 . . . . 0.0 110.257 -179.384 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 86.66 2.73 84.39 Favored Glycine 0 C--O 1.224 -0.503 0 N-CA-C 110.894 -0.883 . . . . 0.0 110.894 178.008 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -143.86 -179.62 6.58 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 -175.14 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.448 ' H ' HG21 ' A' ' 125' ' ' THR . . . 95.54 -28.97 10.4 Favored Glycine 0 CA--C 1.5 -0.896 0 CA-C-N 115.794 -0.639 . . . . 0.0 113.555 174.716 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 91.6 t -64.14 127.3 91.78 Favored Pre-proline 0 C--N 1.319 -0.721 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 177.486 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -72.91 171.72 16.88 Favored 'Trans proline' 0 N--CA 1.461 -0.433 0 C-N-CA 120.128 0.552 . . . . 0.0 111.717 178.409 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 85.6 mt -69.21 107.89 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-O 122.299 1.047 . . . . 0.0 108.539 179.415 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -98.45 86.33 3.58 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 114.122 -1.399 . . . . 0.0 109.874 -176.614 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 67.0 p -67.56 -15.79 63.84 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.525 -0.761 . . . . 0.0 112.627 -178.848 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -107.11 21.09 18.08 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 114.9 -1.046 . . . . 0.0 113.014 -177.31 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 9.9 m -140.16 150.38 44.15 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 115.741 1.756 . . . . 0.0 115.741 -174.817 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 4.6 m -72.49 166.28 43.49 Favored Pre-proline 0 N--CA 1.468 0.464 0 CA-C-N 115.415 -0.812 . . . . 0.0 109.553 176.22 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -66.03 -27.98 49.75 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 114.533 -3.178 . . . . 0.0 113.944 -179.805 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.402 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 5.6 p-10 -75.06 -21.55 58.92 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 121.66 -0.65 . . . . 0.0 111.213 177.113 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 75.0 m-20 -81.36 -10.53 59.52 Favored 'General case' 0 C--O 1.221 -0.415 0 N-CA-C 113.453 0.908 . . . . 0.0 113.453 -176.034 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 96.6 mm-40 -56.69 -27.29 58.65 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 115.155 1.539 . . . . 0.0 115.155 -176.59 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 19.7 tt -55.31 138.46 15.57 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.941 0 N-CA-C 114.418 1.266 . . . . 0.0 114.418 -178.077 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -176.88 -159.95 23.09 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.416 -0.897 . . . . 0.0 114.353 -179.406 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 44.8 p90 -154.92 170.47 21.63 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 179.242 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 17.6 m-85 -114.39 141.46 47.62 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 172.905 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 58.3 ttt180 -113.56 117.24 31.1 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 124.415 1.086 . . . . 0.0 110.992 -175.428 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 46.6 ttp180 -65.6 137.52 57.41 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 178.356 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -150.41 150.06 30.87 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.854 0.359 . . . . 0.0 111.149 -178.029 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 21.6 p -141.94 140.13 32.69 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.826 176.282 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 14.0 tpt180 -142.74 123.87 14.53 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 174.742 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.52 133.84 52.22 Favored 'General case' 0 CA--C 1.494 -1.187 0 CA-C-O 121.584 0.706 . . . . 0.0 110.963 -176.508 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -129.17 179.1 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.883 0 N-CA-C 105.472 -2.047 . . . . 0.0 105.472 178.238 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 27.8 tpt180 -139.57 107.93 5.83 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 106.803 -1.554 . . . . 0.0 106.803 172.502 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -74.17 156.61 50.36 Favored Glycine 0 N--CA 1.447 -0.568 0 N-CA-C 107.681 -2.168 . . . . 0.0 107.681 176.608 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -69.34 -33.23 72.66 Favored Glycine 0 C--O 1.216 -0.983 0 N-CA-C 108.62 -1.792 . . . . 0.0 108.62 179.373 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.1 t0 -84.75 16.61 3.19 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-O 122.55 1.167 . . . . 0.0 109.689 177.715 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 85.03 -14.6 48.35 Favored Glycine 0 N--CA 1.455 -0.086 0 N-CA-C 116.961 1.544 . . . . 0.0 116.961 173.457 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -55.91 142.01 37.15 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 114.968 1.469 . . . . 0.0 114.968 -176.74 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 95.3 mmm -116.48 177.98 4.5 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 112.543 -2.117 . . . . 0.0 109.475 -177.095 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 13.7 tppt? -126.28 -53.76 1.49 Allowed 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 178.208 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 -120.43 149.42 42.4 Favored 'General case' 0 CA--C 1.506 -0.716 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 178.499 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -133.49 -44.18 0.83 Allowed 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 104.306 -2.479 . . . . 0.0 104.306 176.256 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 33.3 t -112.02 153.27 44.63 Favored Pre-proline 0 C--O 1.243 0.748 0 N-CA-C 105.42 -2.066 . . . . 0.0 105.42 175.954 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -68.75 156.74 64.48 Favored 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 117.06 -1.494 . . . . 0.0 114.983 -179.381 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.433 ' HB3' ' HB1' ' A' ' 15' ' ' ALA . 94.0 mtt-85 -113.98 165.46 12.58 Favored 'General case' 0 CA--C 1.509 -0.6 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.523 178.015 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 49.8 m95 -132.03 129.47 40.11 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 176.247 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 17.0 m-85 -110.77 141.34 44.23 Favored 'General case' 0 C--O 1.216 -0.658 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 -176.863 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -88.7 136.87 32.78 Favored 'General case' 0 CA--C 1.506 -0.732 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 -176.527 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -141.36 143.44 33.99 Favored 'General case' 0 N--CA 1.438 -1.032 0 N-CA-C 106.976 -1.491 . . . . 0.0 106.976 -175.888 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 66.8 m-85 -82.94 159.35 22.29 Favored 'General case' 0 C--N 1.317 -0.842 0 O-C-N 122.21 -0.306 . . . . 0.0 110.94 -175.342 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 15.4 tp -54.59 131.49 43.16 Favored 'General case' 0 C--O 1.218 -0.583 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 179.452 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 74.54 25.43 70.22 Favored Glycine 0 C--O 1.225 -0.466 0 N-CA-C 115.8 1.08 . . . . 0.0 115.8 177.633 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 49.8 p . . . . . 0 N--CA 1.466 0.353 0 CA-C-N 118.421 1.11 . . . . 0.0 110.279 176.167 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 15.4 mt . . . . . 0 N--CA 1.442 -0.858 0 N-CA-C 115.291 1.589 . . . . 0.0 115.291 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -78.59 161.83 27.77 Favored 'Trans proline' 0 N--CA 1.461 -0.393 0 C-N-CA 122.516 2.144 . . . . 0.0 107.229 167.596 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 49.7 t80 -61.46 133.54 55.87 Favored 'General case' 0 C--N 1.319 -0.718 0 C-N-CA 120.425 -0.51 . . . . 0.0 110.283 -177.331 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 90.68 -8.62 79.53 Favored Glycine 0 CA--C 1.518 0.278 0 CA-C-O 119.518 -0.601 . . . . 0.0 114.394 179.599 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -66.3 130.3 42.76 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 118.569 1.184 . . . . 0.0 111.624 179.669 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 48.8 t-20 -80.25 130.33 35.13 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.479 -179.441 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 28.0 ttmt -156.1 154.56 31.12 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 106.865 -1.531 . . . . 0.0 106.865 -179.844 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -58.78 124.04 18.43 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.914 0.388 . . . . 0.0 110.868 -179.164 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 69.31 31.48 71.59 Favored Glycine 0 N--CA 1.449 -0.446 0 CA-C-O 119.044 -0.864 . . . . 0.0 115.029 177.556 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 43.2 mm -124.71 127.67 72.89 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 CA-C-N 118.045 0.922 . . . . 0.0 110.992 179.534 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -129.49 123.51 57.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.4 176.357 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 98.7 m95 -88.34 138.14 31.7 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 114.05 1.13 . . . . 0.0 114.05 -176.241 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 16.2 m -139.0 149.8 23.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 121.693 0.759 . . . . 0.0 110.053 178.936 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -159.22 161.12 36.04 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 103.915 -2.624 . . . . 0.0 103.915 178.405 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 13.9 t -118.23 172.78 7.2 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 105.227 -2.138 . . . . 0.0 105.227 178.559 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -66.43 131.95 47.19 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.811 0.339 . . . . 0.0 110.238 -178.624 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 90.98 -4.1 81.28 Favored Glycine 0 CA--C 1.519 0.283 0 C-N-CA 121.359 -0.448 . . . . 0.0 113.746 178.806 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.402 ' HA ' ' HA ' ' A' ' 41' ' ' ASP . . . -73.83 136.06 43.48 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 178.44 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 30.3 mt -89.22 140.55 29.36 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.51 0.671 . . . . 0.0 112.195 -177.071 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 61.9 t30 -83.98 64.95 8.42 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.193 -179.304 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -137.46 155.84 75.29 Favored Pre-proline 0 C--N 1.322 -0.593 0 N-CA-C 106.438 -1.69 . . . . 0.0 106.438 -178.956 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -66.48 151.43 83.05 Favored 'Trans proline' 0 C--N 1.342 0.223 0 N-CA-C 115.359 1.253 . . . . 0.0 115.359 179.993 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.557 ' HB3' HD12 ' A' ' 106' ' ' ILE . 73.3 mmtt -123.02 41.19 3.53 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 114.44 -1.254 . . . . 0.0 108.909 -178.757 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 18.3 p-10 -51.22 -43.4 61.43 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 114.235 -1.348 . . . . 0.0 111.329 178.848 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 46.5 p-80 -66.45 -10.94 49.19 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 124.567 1.147 . . . . 0.0 113.953 -178.839 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.557 HD12 ' HB3' ' A' ' 103' ' ' LYS . 50.4 mt -96.11 -38.22 8.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 179.806 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -74.58 1.74 50.63 Favored Glycine 0 C--O 1.225 -0.453 0 N-CA-C 115.59 0.996 . . . . 0.0 115.59 -177.759 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 14.7 t -83.39 18.8 1.69 Allowed 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 117.869 0.835 . . . . 0.0 112.753 -176.635 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.442 ' HD2' ' OD1' ' A' ' 114' ' ' ASN . 64.2 ttp85 -57.03 130.57 46.69 Favored 'General case' 0 N--CA 1.467 0.391 0 O-C-N 121.998 -0.439 . . . . 0.0 110.129 178.862 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 35.8 m120 -88.49 117.63 68.56 Favored Pre-proline 0 C--N 1.323 -0.546 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 179.843 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -72.76 -13.2 26.87 Favored 'Trans proline' 0 C--O 1.217 -0.531 0 C-N-CA 117.128 -1.448 . . . . 0.0 112.835 -179.528 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -78.4 -27.18 46.66 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.568 177.413 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 -102.06 -25.69 13.65 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 113.237 0.829 . . . . 0.0 113.237 -174.795 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 114' ' ' ASN . . . . . 0.442 ' OD1' ' HD2' ' A' ' 109' ' ' ARG . 5.0 t-20 -128.7 147.61 50.77 Favored 'General case' 0 N--CA 1.442 -0.829 0 N-CA-C 113.149 0.796 . . . . 0.0 113.149 -177.905 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -95.28 129.23 42.49 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 173.808 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -62.16 148.15 45.4 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.448 -0.796 . . . . 0.0 112.371 -178.236 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 9.8 mt -80.72 138.99 18.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 114.89 -1.05 . . . . 0.0 109.432 -177.832 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 79.5 t -63.11 123.38 15.76 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 N-CA-C 106.12 -1.807 . . . . 0.0 106.12 174.516 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 6.6 tt -65.63 130.48 43.46 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.258 0.552 . . . . 0.0 111.045 -176.876 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 31.0 mt-30 -132.99 159.02 41.21 Favored 'General case' 0 CA--C 1.513 -0.461 0 N-CA-C 106.729 -1.582 . . . . 0.0 106.729 -179.553 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 13.5 mt -112.97 146.73 35.72 Favored Pre-proline 0 C--N 1.323 -0.559 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 177.836 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -73.11 166.78 29.09 Favored 'Trans proline' 0 C--N 1.345 0.348 0 O-C-N 122.272 0.617 . . . . 0.0 113.038 -179.367 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 39.9 tt0 -54.89 131.53 44.53 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.902 179.998 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 95.8 -17.06 60.0 Favored Glycine 0 C--O 1.226 -0.371 0 CA-C-N 115.903 -0.589 . . . . 0.0 113.311 179.944 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.448 HG21 ' H ' ' A' ' 31' ' ' GLY . 16.0 m -103.72 128.85 51.04 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 118.073 0.937 . . . . 0.0 111.032 178.811 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 5.8 p -117.23 148.26 41.79 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.795 -179.416 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 83.4 mt -71.23 157.8 89.41 Favored Pre-proline 0 C--N 1.324 -0.504 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 176.989 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -75.55 174.15 13.3 Favored 'Trans proline' 0 C--O 1.237 0.451 0 C-N-CA 117.514 -1.191 . . . . 0.0 109.866 178.367 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 64.1 tttm -62.06 125.94 25.61 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.437 0.636 . . . . 0.0 110.454 -177.141 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 82.31 45.44 6.99 Favored Glycine 0 C--O 1.226 -0.378 0 N-CA-C 115.275 0.87 . . . . 0.0 115.275 178.3 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -141.54 150.87 42.7 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 117.856 0.828 . . . . 0.0 111.476 177.852 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 42.6 p90 -149.95 165.61 32.12 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 176.65 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -101.92 145.32 29.4 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.155 0.502 . . . . 0.0 111.468 -177.993 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -72.69 127.83 33.73 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 179.964 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 92.21 -15.04 63.04 Favored Glycine 0 C--O 1.228 -0.224 0 CA-C-N 115.948 -0.569 . . . . 0.0 113.574 179.506 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 33.5 t . . . . . 0 C--N 1.325 -0.489 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 179.978 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.265 0 CA-C-O 121.3 0.571 . . . . 0.0 111.137 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 17.1 t -65.73 139.96 58.41 Favored 'General case' 0 CA--C 1.512 -0.513 0 N-CA-C 106.954 -1.499 . . . . 0.0 106.954 176.825 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 6.9 m95 -69.62 -21.91 63.53 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.136 0.493 . . . . 0.0 110.276 177.939 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 17.5 m-85 -121.42 161.91 21.35 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.393 -0.821 . . . . 0.0 112.452 -172.223 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.418 ' HB ' ' HB3' ' A' ' 134' ' ' GLU . 67.8 p -69.13 164.77 21.8 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 179.079 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -81.1 140.26 35.16 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 113.06 0.763 . . . . 0.0 113.06 -176.592 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 20.1 mt -78.82 148.22 32.95 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 103.576 -2.75 . . . . 0.0 103.576 170.614 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 16.2 m -130.12 134.76 47.56 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 118.189 0.45 . . . . 0.0 110.605 -178.005 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.42 ' HB2' ' CZ ' ' A' ' 131' ' ' PHE . 4.1 tp60 -100.87 141.56 33.58 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 -177.804 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 52.1 t60 -128.56 99.66 5.46 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 104.636 -2.357 . . . . 0.0 104.636 169.126 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 164.43 -158.76 31.54 Favored Glycine 0 N--CA 1.452 -0.251 0 N-CA-C 108.239 -1.945 . . . . 0.0 108.239 -175.892 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -115.59 -20.9 9.98 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 117.688 0.744 . . . . 0.0 111.127 179.18 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -72.11 153.69 41.53 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.201 -0.909 . . . . 0.0 109.121 178.701 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -82.23 -62.89 1.5 Allowed 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 113.905 1.076 . . . . 0.0 113.905 -176.832 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 50.1 tp 165.33 142.18 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.268 0 N-CA-C 105.815 -1.92 . . . . 0.0 105.815 179.025 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 51.8 tptt -157.25 139.6 14.67 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 173.46 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 16.3 m-85 -122.47 151.92 60.48 Favored Pre-proline 0 C--O 1.241 0.636 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 175.865 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -70.4 161.32 46.43 Favored 'Trans proline' 0 C--N 1.351 0.659 0 O-C-N 122.261 0.611 . . . . 0.0 112.496 178.625 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 22.7 tpt180 -67.83 135.55 52.75 Favored 'General case' 0 C--O 1.216 -0.673 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 -178.249 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 82.55 10.78 82.91 Favored Glycine 0 C--O 1.223 -0.565 0 C-N-CA 121.218 -0.515 . . . . 0.0 111.87 178.87 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 10.2 mt-30 -150.37 170.5 18.89 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 -175.116 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 105.68 -16.56 43.83 Favored Glycine 0 CA--C 1.503 -0.711 0 CA-C-N 116.289 -0.414 . . . . 0.0 113.393 174.887 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 94.1 t -65.75 130.03 94.43 Favored Pre-proline 0 C--N 1.319 -0.726 0 N-CA-C 106.273 -1.751 . . . . 0.0 106.273 177.027 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -72.64 171.17 17.76 Favored 'Trans proline' 0 N--CA 1.46 -0.468 0 O-C-N 122.194 0.576 . . . . 0.0 111.23 178.084 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 87.9 mt -71.01 107.06 2.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 179.801 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 -99.55 84.82 3.02 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.523 -1.217 . . . . 0.0 110.55 -176.329 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 75.7 p -67.97 -14.96 63.38 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.644 -0.707 . . . . 0.0 112.568 -179.204 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -108.48 21.71 16.93 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.15 -0.932 . . . . 0.0 112.871 -177.646 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 11.8 m -140.71 148.09 40.21 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 113.454 0.909 . . . . 0.0 113.454 -177.14 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -72.0 166.08 44.09 Favored Pre-proline 0 C--N 1.326 -0.418 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 177.068 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -64.8 -27.22 59.7 Favored 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 115.376 -2.616 . . . . 0.0 111.793 178.69 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -62.26 -28.77 69.94 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.786 0.803 . . . . 0.0 111.132 176.451 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -96.6 1.02 50.82 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 115.348 1.611 . . . . 0.0 115.348 -171.042 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 94.9 mm-40 -61.4 -30.1 70.34 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 113.841 1.052 . . . . 0.0 113.841 179.641 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 14.6 tt -61.22 138.0 22.65 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.789 0 CA-C-O 122.322 1.058 . . . . 0.0 113.346 -177.937 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 179.17 -155.55 16.29 Favored Glycine 0 N--CA 1.449 -0.447 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.468 -177.976 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 46.8 p90 -155.07 171.14 20.25 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 179.786 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 22.4 m-85 -111.56 138.92 47.46 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 173.813 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 40.4 ttt-85 -110.96 120.16 41.45 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 124.034 0.934 . . . . 0.0 110.298 -177.229 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 52.0 ttp180 -68.26 140.92 56.02 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 178.183 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -142.77 148.73 37.66 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.223 0.535 . . . . 0.0 110.344 179.231 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -158.14 154.22 27.08 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 104.387 -2.449 . . . . 0.0 104.387 176.252 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 20.9 tpt85 -150.81 133.02 15.39 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 177.462 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 72.4 ttt180 -143.38 153.2 42.46 Favored 'General case' 0 CA--C 1.496 -1.131 0 CA-C-O 121.835 0.826 . . . . 0.0 110.528 178.281 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -148.13 -179.68 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 N-CA-C 103.463 -2.791 . . . . 0.0 103.463 179.971 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.64 99.23 6.2 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 174.305 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -71.54 159.63 53.87 Favored Glycine 0 C--O 1.227 -0.308 0 N-CA-C 106.894 -2.482 . . . . 0.0 106.894 176.84 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -60.72 -42.49 99.41 Favored Glycine 0 C--O 1.222 -0.65 0 CA-C-N 118.867 1.333 . . . . 0.0 111.832 -179.486 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -92.82 17.02 11.14 Favored 'General case' 0 CA--C 1.546 0.825 0 CA-C-O 122.895 1.331 . . . . 0.0 110.782 178.822 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 90.06 -1.24 80.01 Favored Glycine 0 N--CA 1.462 0.402 0 N-CA-C 118.163 2.025 . . . . 0.0 118.163 169.145 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.408 ' H ' ' HD2' ' A' ' 60' ' ' LYS . 2.1 mptp? -59.27 139.66 56.76 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.999 0.904 . . . . 0.0 111.992 -178.023 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 63.4 mtp -97.23 -178.26 4.11 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 113.419 -1.719 . . . . 0.0 109.475 178.041 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 5.4 tmtt? -109.94 -55.71 2.41 Favored 'General case' 0 CA--C 1.508 -0.64 0 CA-C-O 121.538 0.685 . . . . 0.0 110.836 -178.782 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -125.07 165.05 18.88 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 103.307 -2.849 . . . . 0.0 103.307 177.105 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 94.3 mt -119.57 -99.68 0.44 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 117.888 0.313 . . . . 0.0 111.228 -176.715 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.21 156.38 88.25 Favored Pre-proline 0 C--N 1.325 -0.476 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 179.018 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -68.43 142.59 54.77 Favored 'Trans proline' 0 C--O 1.241 0.674 0 C-N-CA 114.777 -3.015 . . . . 0.0 112.628 -179.775 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 13.4 mtp180 -119.79 160.47 22.56 Favored 'General case' 0 CA--C 1.511 -0.539 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.662 -178.944 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 55.7 m95 -131.29 128.63 40.19 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.445 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 50.0 m-85 -110.45 144.87 38.59 Favored 'General case' 0 C--O 1.217 -0.622 0 N-CA-C 107.505 -1.295 . . . . 0.0 107.505 -177.773 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -89.84 129.97 36.15 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 118.801 0.728 . . . . 0.0 109.254 -178.297 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -132.35 133.07 43.54 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 -175.799 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -71.65 159.49 34.31 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.705 -0.68 . . . . 0.0 112.552 -176.13 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -53.99 129.26 33.57 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-O 121.069 0.461 . . . . 0.0 111.916 -179.448 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 73.26 26.66 69.9 Favored Glycine 0 C--O 1.22 -0.75 0 N-CA-C 115.887 1.115 . . . . 0.0 115.887 176.971 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 2.9 p . . . . . 0 C--N 1.325 -0.466 0 CA-C-N 118.601 1.201 . . . . 0.0 109.336 178.904 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 15.1 mt . . . . . 0 N--CA 1.446 -0.653 0 N-CA-C 115.112 1.523 . . . . 0.0 115.112 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -78.79 163.72 26.02 Favored 'Trans proline' 0 N--CA 1.461 -0.427 0 C-N-CA 121.939 1.759 . . . . 0.0 107.994 168.531 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.407 ' CE1' ' HB3' ' A' ' 92' ' ' TRP . 74.9 t80 -61.5 130.58 46.68 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 120.305 -0.558 . . . . 0.0 111.085 -177.729 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 92.19 -7.74 78.16 Favored Glycine 0 CA--C 1.519 0.305 0 CA-C-O 119.326 -0.708 . . . . 0.0 114.704 178.699 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -64.0 131.81 48.72 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 118.391 1.096 . . . . 0.0 111.656 179.948 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 47.1 t-20 -77.83 128.12 33.48 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.647 -179.465 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 26.4 ttmt -155.46 150.37 26.54 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 106.567 -1.642 . . . . 0.0 106.567 179.269 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -64.24 129.05 38.44 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.902 0.382 . . . . 0.0 110.968 -177.219 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 71.04 26.45 73.85 Favored Glycine 0 CA--C 1.52 0.346 0 CA-C-O 119.348 -0.696 . . . . 0.0 114.767 179.764 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 41.8 mm -126.83 129.25 71.41 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 CA-C-N 117.572 0.686 . . . . 0.0 111.007 -179.965 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.1 pt -132.02 119.34 40.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 CA-C-O 121.542 0.687 . . . . 0.0 111.186 176.133 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 92' ' ' TRP . . . . . 0.407 ' HB3' ' CE1' ' A' ' 83' ' ' TYR . 95.3 m95 -84.68 138.92 32.39 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 113.651 0.982 . . . . 0.0 113.651 -176.9 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 16.5 m -138.03 151.28 25.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 179.03 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -159.89 166.62 29.85 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 105.497 -2.038 . . . . 0.0 105.497 -178.502 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 12.0 t -136.51 175.61 9.45 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 105.657 -1.979 . . . . 0.0 105.657 177.15 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -66.26 136.81 56.38 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.155 0.502 . . . . 0.0 110.783 -179.466 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 92.76 -10.53 73.83 Favored Glycine 0 C--O 1.224 -0.513 0 CA-C-N 115.839 -0.619 . . . . 0.0 113.566 177.311 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -74.24 134.34 42.68 Favored 'General case' 0 C--N 1.323 -0.586 0 O-C-N 122.409 -0.465 . . . . 0.0 111.227 -179.849 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 38.3 mt -91.73 133.36 35.67 Favored 'General case' 0 CA--C 1.513 -0.48 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 -177.804 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 55.6 t30 -81.27 70.43 8.11 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.188 -0.914 . . . . 0.0 110.838 -178.977 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 1.3 t -139.19 155.29 72.55 Favored Pre-proline 0 C--N 1.322 -0.629 0 N-CA-C 106.1 -1.815 . . . . 0.0 106.1 -179.392 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -67.32 148.46 79.96 Favored 'Trans proline' 0 CA--C 1.53 0.32 0 C-N-CA 118.114 -0.791 . . . . 0.0 113.176 176.418 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -148.64 52.55 0.99 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 122.788 1.28 . . . . 0.0 110.435 179.243 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 13.0 p-10 -60.28 -30.48 69.49 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 114.047 -1.433 . . . . 0.0 110.829 179.268 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 16.0 p80 -59.15 -12.59 5.33 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 114.578 1.325 . . . . 0.0 114.578 -179.149 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 54.0 mt -86.5 -32.08 6.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 178.721 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -75.33 12.96 6.55 Favored Glycine 0 CA--C 1.522 0.479 0 N-CA-C 114.764 0.666 . . . . 0.0 114.764 -177.462 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 11.8 t -83.13 13.4 4.15 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 113.103 0.779 . . . . 0.0 113.103 -178.471 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 66.7 ttp85 -58.66 122.55 13.74 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 178.369 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -97.79 129.59 30.95 Favored Pre-proline 0 C--N 1.321 -0.669 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 -178.872 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -69.68 -15.4 37.38 Favored 'Trans proline' 0 C--O 1.219 -0.462 0 O-C-N 122.072 0.511 . . . . 0.0 113.087 -179.193 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -75.94 -26.58 57.02 Favored 'General case' 0 C--O 1.221 -0.425 0 CA-C-O 120.847 0.356 . . . . 0.0 110.404 177.738 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 76.1 m-20 -104.13 -27.23 12.2 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 113.724 1.009 . . . . 0.0 113.724 -174.727 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 -152.15 149.04 28.34 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 113.078 0.77 . . . . 0.0 113.078 -177.283 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -90.44 150.45 21.82 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-O 121.457 0.646 . . . . 0.0 111.476 179.325 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -70.18 145.23 51.62 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.248 0.547 . . . . 0.0 111.284 178.867 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 17.9 mt -82.86 139.33 17.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 -179.029 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 99.2 t -59.58 122.9 10.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 N-CA-C 106.642 -1.614 . . . . 0.0 106.642 175.299 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 7.2 tt -68.18 129.04 38.74 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.139 0.495 . . . . 0.0 110.112 -176.703 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 31.5 mt-30 -131.12 158.74 39.63 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 -179.162 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 13.7 mt -113.27 147.57 37.67 Favored Pre-proline 0 C--N 1.322 -0.623 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 177.822 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -74.37 168.9 23.72 Favored 'Trans proline' 0 C--O 1.235 0.366 0 O-C-N 122.224 0.592 . . . . 0.0 113.276 -179.313 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 38.6 tt0 -54.14 131.95 42.1 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.518 -0.765 . . . . 0.0 109.415 179.411 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 99.01 -22.58 40.28 Favored Glycine 0 C--O 1.227 -0.282 0 CA-C-O 119.542 -0.588 . . . . 0.0 113.193 -179.779 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 4.1 m -106.63 127.58 53.46 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 118.361 1.081 . . . . 0.0 111.203 178.887 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 7.1 p -121.14 148.38 44.28 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.951 -179.562 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 92.7 mt -70.5 151.28 95.6 Favored Pre-proline 0 C--N 1.324 -0.513 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 178.874 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -78.6 172.92 14.43 Favored 'Trans proline' 0 N--CA 1.463 -0.303 0 O-C-N 122.0 0.473 . . . . 0.0 111.385 178.796 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 1.7 tmmt? -54.44 130.05 38.06 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.78 -177.847 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 91.53 -7.43 79.92 Favored Glycine 0 C--O 1.229 -0.19 0 N-CA-C 115.794 1.078 . . . . 0.0 115.794 175.655 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.42 ' CZ ' ' HB2' ' A' ' 18' ' ' GLN . 2.3 m-85 -97.84 142.54 29.48 Favored 'General case' 0 N--CA 1.441 -0.888 0 CA-C-O 122.311 1.053 . . . . 0.0 112.859 -177.818 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 47.0 p90 -141.73 165.1 28.41 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 113.473 -1.694 . . . . 0.0 106.961 173.974 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -102.51 143.75 31.82 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.731 0.3 . . . . 0.0 110.274 -178.583 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.418 ' HB3' ' HB ' ' A' ' 14' ' ' THR . 6.5 tp10 -71.55 135.7 47.16 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 106.762 -1.57 . . . . 0.0 106.762 177.84 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 93.33 -7.82 75.33 Favored Glycine 0 C--O 1.225 -0.412 0 C-N-CA 121.369 -0.443 . . . . 0.0 113.497 -177.626 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 34.6 t . . . . . 0 N--CA 1.468 0.433 0 CA-C-N 117.842 0.821 . . . . 0.0 111.221 177.194 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.456 -0.126 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 39.3 p -65.47 142.77 58.04 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.806 -0.812 . . . . 0.0 108.806 177.93 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 12' ' ' TRP . . . . . 0.44 ' CD2' ' HD3' ' A' ' 109' ' ' ARG . 14.8 m95 -67.69 -21.85 65.31 Favored 'General case' 0 CA--C 1.511 -0.557 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 178.066 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 44.4 m-85 -121.42 160.87 23.23 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 113.8 1.037 . . . . 0.0 113.8 -170.518 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 59.0 p -71.85 166.99 20.95 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 113.891 -1.504 . . . . 0.0 109.637 179.243 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.431 ' HB2' ' CZ ' ' A' ' 69' ' ' TYR . . . -80.29 131.11 35.6 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 -177.136 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 13.8 mt -74.51 146.43 42.71 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 103.278 -2.86 . . . . 0.0 103.278 170.1 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 24.8 m -126.8 136.65 52.67 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 -177.207 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.452 ' HB2' ' CZ ' ' A' ' 131' ' ' PHE . 4.7 tp60 -111.9 139.97 46.95 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 114.036 1.125 . . . . 0.0 114.036 -175.328 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 57.7 t60 -130.32 99.48 5.04 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 106.541 -1.652 . . . . 0.0 106.541 170.496 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 173.95 -170.57 43.71 Favored Glycine 0 C--O 1.227 -0.293 0 N-CA-C 109.014 -1.634 . . . . 0.0 109.014 -177.973 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -97.97 -24.25 15.45 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 117.523 0.662 . . . . 0.0 111.694 178.963 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -83.5 157.45 22.39 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 106.111 -1.811 . . . . 0.0 106.111 174.816 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -93.18 -62.76 1.31 Allowed 'General case' 0 C--O 1.215 -0.73 0 C-N-CA 120.123 -0.631 . . . . 0.0 112.637 -176.838 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 42.5 tp -169.83 138.62 1.82 Allowed 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 175.291 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 10.8 tmtt? -153.89 128.59 9.38 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 176.303 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -117.91 159.35 43.06 Favored Pre-proline 0 CA--C 1.547 0.835 0 N-CA-C 110.378 -0.23 . . . . 0.0 110.378 178.096 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -69.12 173.92 9.7 Favored 'Trans proline' 0 C--N 1.354 0.821 0 C-N-CA 121.687 1.591 . . . . 0.0 115.015 -179.574 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -78.37 132.74 37.51 Favored 'General case' 0 C--O 1.216 -0.699 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 178.116 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 69.42 14.21 68.96 Favored Glycine 0 C--O 1.225 -0.415 0 N-CA-C 115.089 0.796 . . . . 0.0 115.089 175.732 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 4.8 tt0 -157.77 148.11 20.65 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 105.758 -1.942 . . . . 0.0 105.758 -178.079 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 136.04 -17.12 3.89 Favored Glycine 0 CA--C 1.502 -0.72 0 C-N-CA 120.187 -1.006 . . . . 0.0 112.723 175.648 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 30.3 m -70.46 145.21 92.65 Favored Pre-proline 0 C--N 1.321 -0.666 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 177.042 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -76.76 167.53 25.19 Favored 'Trans proline' 0 N--CA 1.461 -0.395 0 C-N-CA 122.187 1.925 . . . . 0.0 113.74 179.695 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 97.9 mt -69.68 128.11 32.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 178.696 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 51.4 t-20 -125.49 122.17 35.85 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.889 -0.411 . . . . 0.0 109.889 175.998 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 74.2 p -92.74 -15.49 26.58 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 113.668 0.988 . . . . 0.0 113.668 -177.189 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 20.0 p30 -109.27 21.49 17.04 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 115.259 1.577 . . . . 0.0 115.259 -174.009 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 37.8 m -147.42 164.88 31.94 Favored 'General case' 0 N--CA 1.468 0.437 0 O-C-N 121.918 -0.489 . . . . 0.0 111.538 -179.875 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 32.6 m -75.27 164.44 61.11 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.703 -178.632 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -65.16 -24.81 58.52 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 115.529 -2.514 . . . . 0.0 111.769 177.362 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -59.75 -33.78 72.11 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 122.051 0.929 . . . . 0.0 110.613 176.559 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -83.35 -7.65 59.54 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 114.954 1.465 . . . . 0.0 114.954 -173.903 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 93.0 mm-40 -65.85 -31.64 72.71 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 114.521 1.304 . . . . 0.0 114.521 -174.806 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 14.7 tt -58.9 138.75 19.56 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 CA-C-O 122.076 0.941 . . . . 0.0 112.078 179.314 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 179.0 -148.36 8.21 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.124 -175.556 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.412 ' CE1' HD12 ' A' ' 90' ' ' ILE . 46.1 p90 -154.96 166.87 32.19 Favored 'General case' 0 C--N 1.32 -0.711 0 O-C-N 122.438 -0.448 . . . . 0.0 110.263 179.786 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 40.3 m-85 -107.51 141.97 38.11 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 174.116 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 58.6 ttt-85 -114.22 120.53 40.76 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 123.454 0.702 . . . . 0.0 112.028 -175.926 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 62.8 ttt-85 -64.43 141.4 58.79 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 122.789 0.436 . . . . 0.0 110.165 177.697 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -150.67 132.94 15.45 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.173 0.511 . . . . 0.0 112.249 178.624 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 7.0 p -149.48 139.74 22.26 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 107.259 -1.386 . . . . 0.0 107.259 175.818 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 25.0 tpt180 -147.1 123.98 11.29 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 175.385 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.53 145.34 47.41 Favored 'General case' 0 CA--C 1.484 -1.592 0 CA-C-O 122.313 1.054 . . . . 0.0 112.434 -178.951 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -142.32 176.32 3.89 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 N-CA-C 104.686 -2.338 . . . . 0.0 104.686 176.23 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 4.1 tmt_? -129.2 101.62 6.09 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 105.192 -2.151 . . . . 0.0 105.192 176.472 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -69.01 154.7 53.46 Favored Glycine 0 C--O 1.221 -0.697 0 N-CA-C 109.903 -1.279 . . . . 0.0 109.903 -178.434 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -64.93 -37.95 94.9 Favored Glycine 0 C--O 1.222 -0.637 0 N-CA-C 110.095 -1.202 . . . . 0.0 110.095 -178.219 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 27.5 t0 -89.79 16.95 7.16 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-O 122.339 1.066 . . . . 0.0 110.269 179.208 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 86.93 -15.66 51.71 Favored Glycine 0 C--O 1.227 -0.33 0 N-CA-C 115.818 1.087 . . . . 0.0 115.818 174.087 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -62.1 135.78 57.66 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 122.189 0.995 . . . . 0.0 112.705 -177.911 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 87.5 mtp -108.32 -174.21 2.46 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 113.704 -1.589 . . . . 0.0 109.821 -178.431 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 11.4 mmtt -105.56 -61.83 1.44 Allowed 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 120.979 0.418 . . . . 0.0 110.963 -179.077 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 19.8 p30 -132.74 168.28 18.61 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 176.734 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -128.99 -60.99 1.06 Allowed 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 -179.267 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -81.35 151.31 69.01 Favored Pre-proline 0 C--N 1.32 -0.714 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 176.395 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -70.58 152.02 64.77 Favored 'Trans proline' 0 C--O 1.239 0.569 0 C-N-CA 116.551 -1.833 . . . . 0.0 111.397 177.672 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 7.4 mtp180 -125.07 158.57 33.48 Favored 'General case' 0 CA--C 1.515 -0.4 0 C-N-CA 121.09 -0.244 . . . . 0.0 110.7 -179.786 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 48.2 m95 -131.75 136.4 47.56 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 178.312 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.431 ' CZ ' ' HB2' ' A' ' 15' ' ' ALA . 48.1 m-85 -110.37 172.95 6.56 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 104.804 -2.295 . . . . 0.0 104.804 -179.91 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 92.4 t80 -124.03 136.72 54.46 Favored 'General case' 0 CA--C 1.51 -0.595 0 CA-C-N 119.526 1.057 . . . . 0.0 108.597 -178.721 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 34.6 m-85 -137.51 148.89 46.35 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 -176.246 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 44.0 m-85 -84.05 159.52 21.15 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.359 -176.152 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -54.93 132.04 45.83 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.203 178.054 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 67.29 38.37 91.51 Favored Glycine 0 C--O 1.225 -0.436 0 N-CA-C 115.206 0.842 . . . . 0.0 115.206 177.124 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.2 p . . . . . 0 C--N 1.327 -0.392 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 175.757 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 14.7 mt . . . . . 0 N--CA 1.444 -0.76 0 N-CA-C 114.874 1.435 . . . . 0.0 114.874 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -79.73 164.69 23.01 Favored 'Trans proline' 0 C--O 1.235 0.36 0 C-N-CA 122.783 2.322 . . . . 0.0 107.78 167.455 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 60.6 t80 -62.32 131.67 50.09 Favored 'General case' 0 C--N 1.321 -0.666 0 C-N-CA 120.367 -0.533 . . . . 0.0 110.338 -178.066 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 91.14 -5.65 81.44 Favored Glycine 0 C--O 1.228 -0.273 0 N-CA-C 114.901 0.72 . . . . 0.0 114.901 179.031 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -66.77 130.49 43.33 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 118.649 1.225 . . . . 0.0 111.608 179.499 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 57.0 t30 -74.92 128.37 35.41 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.892 -179.186 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 26.4 ttmt -156.01 152.01 27.59 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 106.354 -1.721 . . . . 0.0 106.354 178.476 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -65.61 132.7 49.48 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.069 0.461 . . . . 0.0 110.615 -178.059 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 69.31 25.92 75.04 Favored Glycine 0 N--CA 1.449 -0.495 0 CA-C-N 115.714 -0.675 . . . . 0.0 114.239 177.97 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.412 HD12 ' CE1' ' A' ' 46' ' ' TYR . 47.7 mm -124.82 126.63 71.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 117.345 0.572 . . . . 0.0 110.842 179.945 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -127.08 116.98 46.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.356 176.243 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 96.9 m95 -82.22 135.66 35.21 Favored 'General case' 0 C--N 1.319 -0.72 0 O-C-N 121.864 -0.522 . . . . 0.0 112.227 -177.676 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -142.22 154.97 18.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 -178.113 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -154.92 166.52 33.28 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 106.193 -1.78 . . . . 0.0 106.193 -176.635 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 14.7 t -121.79 164.63 17.13 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 103.211 -2.885 . . . . 0.0 103.211 171.53 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -67.56 136.08 53.95 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 -179.099 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 92.84 -9.67 75.14 Favored Glycine 0 C--O 1.224 -0.501 0 CA-C-N 115.986 -0.552 . . . . 0.0 113.833 178.504 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -74.16 143.08 45.41 Favored 'General case' 0 CA--C 1.545 0.756 0 O-C-N 122.339 -0.506 . . . . 0.0 110.429 179.143 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 40.2 mt -93.17 133.48 36.32 Favored 'General case' 0 CA--C 1.516 -0.347 0 N-CA-C 115.004 1.483 . . . . 0.0 115.004 -175.496 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 61.6 t30 -79.67 64.68 4.61 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 114.683 -1.144 . . . . 0.0 110.966 -178.256 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -135.85 157.41 76.07 Favored Pre-proline 0 C--N 1.322 -0.588 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 -178.152 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -73.27 148.24 43.45 Favored 'Trans proline' 0 CA--C 1.534 0.493 0 N-CA-C 114.496 0.921 . . . . 0.0 114.496 175.338 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.54 58.85 1.07 Allowed 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 177.595 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -64.01 -14.37 53.68 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.275 176.449 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 18.0 p-80 -61.53 -14.46 29.78 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 179.396 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 23.4 mt -92.81 -26.7 4.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 121.329 0.585 . . . . 0.0 109.616 179.456 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -81.3 10.34 49.83 Favored Glycine 0 N--CA 1.459 0.232 0 O-C-N 122.007 -0.433 . . . . 0.0 113.63 -178.128 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 12.4 t -83.22 6.48 19.33 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 122.295 -0.532 . . . . 0.0 111.262 -178.4 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.44 ' HD3' ' CD2' ' A' ' 12' ' ' TRP . 63.5 ttp85 -54.51 133.61 46.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.509 179.908 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 35.0 m120 -96.97 115.82 65.85 Favored Pre-proline 0 C--N 1.326 -0.455 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 178.8 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -73.23 -11.53 25.03 Favored 'Trans proline' 0 C--O 1.219 -0.473 0 C-N-CA 117.45 -1.233 . . . . 0.0 113.351 -178.155 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -80.54 -25.45 38.63 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.215 177.436 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 -101.99 -25.44 13.76 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 113.543 0.942 . . . . 0.0 113.543 -174.334 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -140.42 154.27 46.6 Favored 'General case' 0 N--CA 1.434 -1.226 0 CA-C-O 121.497 0.665 . . . . 0.0 109.45 -177.59 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -93.36 144.45 25.31 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 114.938 -1.028 . . . . 0.0 110.837 -179.531 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -68.83 145.44 53.73 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.37 0.605 . . . . 0.0 110.561 178.853 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 27.8 mt -81.59 137.44 21.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 -178.723 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 1.2 p -62.08 125.99 19.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 176.324 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 6.4 tt -67.11 127.52 32.91 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.01 0.434 . . . . 0.0 110.116 -177.013 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 29.7 mt-30 -130.86 155.84 46.04 Favored 'General case' 0 CA--C 1.512 -0.488 0 N-CA-C 107.251 -1.388 . . . . 0.0 107.251 -179.132 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 13.5 mt -111.97 148.6 39.35 Favored Pre-proline 0 C--N 1.322 -0.616 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 179.029 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -71.5 164.52 35.45 Favored 'Trans proline' 0 C--N 1.346 0.403 0 O-C-N 122.278 0.62 . . . . 0.0 112.814 -179.037 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 65.1 tt0 -55.12 132.51 47.59 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.422 -179.649 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 96.57 -16.48 60.95 Favored Glycine 0 C--O 1.227 -0.32 0 CA-C-N 116.039 -0.528 . . . . 0.0 112.945 -179.002 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 6.1 m -107.59 126.77 52.96 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 117.907 0.853 . . . . 0.0 110.559 178.329 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 14.8 p -117.0 148.14 41.72 Favored 'General case' 0 CA--C 1.509 -0.605 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.534 -179.454 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 82.7 mt -68.37 152.37 96.62 Favored Pre-proline 0 C--N 1.321 -0.636 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 178.036 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -76.83 173.01 15.16 Favored 'Trans proline' 0 N--CA 1.462 -0.342 0 C-N-CA 117.87 -0.953 . . . . 0.0 110.43 177.989 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 84.4 tttt -57.27 128.42 36.9 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 113.485 0.92 . . . . 0.0 113.485 -174.12 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 95.12 -6.02 68.74 Favored Glycine 0 CA--C 1.518 0.227 0 N-CA-C 115.854 1.101 . . . . 0.0 115.854 176.15 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.452 ' CZ ' ' HB2' ' A' ' 18' ' ' GLN . 4.6 m-85 -92.38 147.09 23.18 Favored 'General case' 0 N--CA 1.437 -1.092 0 CA-C-O 122.962 1.363 . . . . 0.0 114.004 -178.194 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 48.5 p90 -146.76 163.51 35.76 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 112.29 -2.232 . . . . 0.0 107.274 172.94 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -105.31 143.69 33.12 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 112.762 0.653 . . . . 0.0 112.762 -177.398 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -76.78 147.95 36.96 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 175.368 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 95.02 -33.66 5.26 Favored Glycine 0 C--O 1.227 -0.333 0 C-N-CA 121.428 -0.415 . . . . 0.0 113.964 178.184 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.323 -0.548 0 CA-C-O 121.201 0.524 . . . . 0.0 111.658 177.113 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -0.898 0 CA-C-O 121.871 0.843 . . . . 0.0 112.296 . . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -61.8 143.65 55.98 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 114.767 -1.106 . . . . 0.0 110.287 177.785 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 21.1 m95 -69.38 -23.64 63.77 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 114.864 1.431 . . . . 0.0 114.864 -178.514 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 86.2 m-85 -121.52 161.07 22.95 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.186 0.517 . . . . 0.0 112.384 -172.747 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 74.6 p -70.31 161.58 30.12 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 177.013 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -74.83 153.79 38.57 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.902 0.858 . . . . 0.0 113.191 -175.995 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 22.6 mt -90.94 148.79 22.2 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 102.497 -3.149 . . . . 0.0 102.497 168.171 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 51.9 m -123.85 139.59 53.82 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 179.893 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.449 ' HB2' ' CZ ' ' A' ' 131' ' ' PHE . 4.3 tp60 -110.41 138.98 46.08 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-O 121.527 0.679 . . . . 0.0 112.298 -178.531 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 73.0 t60 -134.14 99.44 4.41 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 103.391 -2.818 . . . . 0.0 103.391 169.773 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 173.13 -165.97 38.34 Favored Glycine 0 C--O 1.225 -0.452 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 -176.055 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 37.9 mtmm -102.18 -25.09 13.83 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 113.956 1.095 . . . . 0.0 113.956 -178.221 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -89.21 162.1 16.08 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.056 -179.154 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -77.62 -62.95 1.5 Allowed 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.203 -176.916 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 34.6 tp 172.99 142.66 0.04 OUTLIER 'General case' 0 N--CA 1.482 1.133 0 N-CA-C 105.545 -2.02 . . . . 0.0 105.545 176.409 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 12.0 tmtt? -154.95 125.45 6.89 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 175.459 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -106.81 152.46 40.87 Favored Pre-proline 0 C--O 1.242 0.676 0 CA-C-O 120.457 0.17 . . . . 0.0 110.711 177.842 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -68.71 161.48 45.17 Favored 'Trans proline' 0 C--N 1.352 0.724 0 CA-C-O 121.226 0.427 . . . . 0.0 112.799 178.455 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 71.6 ttt180 -69.86 132.37 45.91 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 122.182 -0.324 . . . . 0.0 111.361 -175.846 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 79.35 13.6 82.53 Favored Glycine 0 C--O 1.222 -0.612 0 N-CA-C 111.697 -0.561 . . . . 0.0 111.697 179.254 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 31.0 mt-30 -148.23 171.74 15.45 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.18 -1.045 . . . . 0.0 108.18 -175.327 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 107.71 -10.22 38.11 Favored Glycine 0 CA--C 1.501 -0.786 0 CA-C-N 116.159 -0.473 . . . . 0.0 112.803 175.851 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.408 HG11 ' HB3' ' A' ' 43' ' ' GLN . 57.4 t -74.37 130.89 81.29 Favored Pre-proline 0 C--N 1.32 -0.685 0 N-CA-C 106.437 -1.69 . . . . 0.0 106.437 176.739 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -71.62 172.84 13.56 Favored 'Trans proline' 0 C--O 1.221 -0.34 0 O-C-N 122.179 0.568 . . . . 0.0 112.505 177.658 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 64.8 mt -75.85 106.3 5.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 122.228 1.013 . . . . 0.0 110.341 -179.111 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 38.8 m-20 -97.67 77.89 2.59 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 114.184 -1.371 . . . . 0.0 108.407 -179.425 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 80.7 p -63.88 -25.56 68.21 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 115.289 1.588 . . . . 0.0 115.289 -174.677 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -116.19 32.23 6.24 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 -176.369 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 5.9 m -133.06 166.87 21.42 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.678 0.275 . . . . 0.0 111.356 -178.903 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 25.0 m -77.57 155.92 81.0 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-N 116.583 -0.281 . . . . 0.0 111.657 -177.527 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -68.95 -20.91 38.08 Favored 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 116.804 -1.664 . . . . 0.0 114.378 -179.809 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.408 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 1.9 p-10 -76.95 -23.19 52.39 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 121.434 -0.791 . . . . 0.0 110.978 177.203 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -76.69 -13.08 60.07 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 114.715 1.376 . . . . 0.0 114.715 -170.924 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.408 ' HB3' HG11 ' A' ' 32' ' ' VAL . 29.2 mm100 -55.01 -28.15 49.78 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 113.934 1.086 . . . . 0.0 113.934 -175.025 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 13.6 tt -64.63 135.82 27.51 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.784 0 CA-C-O 122.316 1.055 . . . . 0.0 111.981 178.643 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 179.36 -155.91 17.06 Favored Glycine 0 N--CA 1.45 -0.432 0 N-CA-C 110.755 -0.938 . . . . 0.0 110.755 -177.54 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 33.2 p90 -155.1 168.34 27.35 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.882 0.341 . . . . 0.0 110.554 179.826 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 29.1 m-85 -112.79 141.2 46.87 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 175.345 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 73.7 ttt-85 -116.77 125.04 51.05 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.661 -0.7 . . . . 0.0 112.675 -177.969 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 50.4 ttp85 -69.15 141.05 54.71 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 121.084 0.468 . . . . 0.0 111.092 177.518 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -152.05 157.54 41.8 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 179.104 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 68.1 p -129.43 166.29 19.87 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 104.058 -2.571 . . . . 0.0 104.058 172.571 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 21.5 tpt180 -96.09 118.96 33.72 Favored 'General case' 0 C--O 1.218 -0.584 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 178.667 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 6.7 tmm_? -139.59 139.1 36.7 Favored 'General case' 0 CA--C 1.502 -0.88 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 -178.951 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -137.29 -179.6 2.93 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 114.802 -1.09 . . . . 0.0 108.245 -175.982 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 13.1 tpp85 -129.14 125.14 36.42 Favored 'General case' 0 C--O 1.221 -0.431 0 N-CA-C 105.02 -2.215 . . . . 0.0 105.02 174.339 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -156.02 144.03 10.43 Favored Glycine 0 C--O 1.224 -0.489 0 N-CA-C 107.524 -2.23 . . . . 0.0 107.524 177.325 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -65.87 -60.65 6.28 Favored Glycine 0 C--O 1.227 -0.319 0 CA-C-N 117.883 0.842 . . . . 0.0 112.391 -177.958 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -107.34 8.39 29.69 Favored 'General case' 0 C--O 1.215 -0.744 0 CA-C-O 121.967 0.889 . . . . 0.0 110.838 178.715 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -95.95 -11.59 54.49 Favored Glycine 0 CA--C 1.504 -0.653 0 N-CA-C 105.542 -3.023 . . . . 0.0 105.542 179.318 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 53.7 mmtt 52.93 -161.59 0.11 Allowed 'General case' 0 N--CA 1.442 -0.846 0 CA-C-N 112.95 -1.625 . . . . 0.0 111.723 176.79 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 70.1 mtp -90.43 -179.02 5.49 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 114.516 -1.22 . . . . 0.0 109.865 176.875 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 18.5 mmtm -134.8 -69.53 0.51 Allowed 'General case' 0 C--O 1.211 -0.941 0 CA-C-O 120.897 0.38 . . . . 0.0 110.503 179.497 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.7 t0 52.1 51.41 16.44 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 114.318 -1.31 . . . . 0.0 111.923 178.918 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -61.97 162.59 8.92 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 114.116 -1.402 . . . . 0.0 111.969 -179.687 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -45.76 146.18 2.01 Favored Pre-proline 0 C--O 1.25 1.08 0 CA-C-N 115.047 -0.979 . . . . 0.0 113.495 -177.335 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -61.86 142.54 93.73 Favored 'Trans proline' 0 C--N 1.349 0.601 0 CA-C-O 122.768 1.07 . . . . 0.0 114.209 -174.895 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 22.6 mtt85 -128.95 155.77 44.8 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-N 113.2 -1.818 . . . . 0.0 108.054 -178.629 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 66.5 m95 -127.8 131.63 49.57 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 179.711 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 70.9 m-85 -111.41 148.23 33.52 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 107.289 -1.375 . . . . 0.0 107.289 179.064 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 68.1 t80 -95.79 131.35 42.18 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 -177.778 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -134.36 146.52 50.0 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 -178.263 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -83.34 159.51 21.85 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 113.016 0.747 . . . . 0.0 113.016 -174.956 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -55.53 132.91 49.74 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.391 179.489 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 72.56 33.96 60.5 Favored Glycine 0 C--O 1.221 -0.696 0 N-CA-C 115.469 0.947 . . . . 0.0 115.469 176.629 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 9.2 p . . . . . 0 C--N 1.325 -0.468 0 N-CA-C 108.226 -1.028 . . . . 0.0 108.226 177.818 . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 21.3 mt . . . . . 0 C--O 1.238 0.468 0 N-CA-C 114.273 1.212 . . . . 0.0 114.273 . . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -78.5 167.19 23.12 Favored 'Trans proline' 0 N--CA 1.461 -0.436 0 N-CA-C 108.439 -1.408 . . . . 0.0 108.439 170.895 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.43 ' CE1' ' HB3' ' A' ' 92' ' ' TRP . 77.9 t80 -61.24 132.47 53.74 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 120.357 -0.537 . . . . 0.0 110.254 179.979 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 90.43 -4.9 82.71 Favored Glycine 0 CA--C 1.518 0.276 0 N-CA-C 115.065 0.786 . . . . 0.0 115.065 178.03 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -65.38 128.09 34.47 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 118.463 1.132 . . . . 0.0 111.472 179.407 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 45.9 t-20 -78.05 128.01 33.2 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.322 -176.576 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 16.7 ttmm -156.08 152.09 27.57 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 179.54 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -62.73 132.76 53.34 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.744 0.307 . . . . 0.0 110.441 179.447 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 68.86 24.41 75.64 Favored Glycine 0 N--CA 1.449 -0.44 0 CA-C-O 119.477 -0.624 . . . . 0.0 113.734 178.033 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 38.6 mm -129.32 128.51 66.57 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.304 0 CA-C-N 117.362 0.581 . . . . 0.0 110.077 179.866 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.1 pt -134.56 123.71 42.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.573 176.036 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 92' ' ' TRP . . . . . 0.43 ' HB3' ' CE1' ' A' ' 83' ' ' TYR . 90.0 m95 -89.37 139.42 30.53 Favored 'General case' 0 C--N 1.321 -0.671 0 O-C-N 121.908 -0.495 . . . . 0.0 111.617 -176.933 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 17.8 m -135.09 153.77 34.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 179.903 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -162.03 166.56 25.77 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 105.812 -1.921 . . . . 0.0 105.812 -178.63 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 13.5 t -130.41 169.29 15.69 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 104.628 -2.36 . . . . 0.0 104.628 176.137 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -66.22 135.07 53.97 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.225 0.536 . . . . 0.0 110.218 -178.601 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 93.81 -12.73 68.86 Favored Glycine 0 CA--C 1.517 0.195 0 CA-C-N 115.982 -0.554 . . . . 0.0 113.998 178.395 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.408 ' HA ' ' HA ' ' A' ' 41' ' ' ASP . . . -68.16 135.97 52.92 Favored 'General case' 0 CA--C 1.542 0.667 0 O-C-N 122.33 -0.512 . . . . 0.0 110.133 179.088 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 32.4 mt -89.34 130.31 35.73 Favored 'General case' 0 CA--C 1.507 -0.681 0 N-CA-C 113.416 0.895 . . . . 0.0 113.416 -177.145 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 53.5 t30 -81.17 73.8 8.2 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 114.526 -1.215 . . . . 0.0 110.564 -178.718 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 1.5 t -142.97 153.83 61.12 Favored Pre-proline 0 C--N 1.321 -0.631 0 N-CA-C 106.427 -1.694 . . . . 0.0 106.427 179.723 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -67.65 147.74 76.63 Favored 'Trans proline' 0 CA--C 1.528 0.213 0 C-N-CA 117.824 -0.984 . . . . 0.0 113.089 176.018 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 6.6 ptpt -145.73 56.95 1.22 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 122.722 1.248 . . . . 0.0 110.593 179.066 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -58.54 -31.05 67.58 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.149 -1.387 . . . . 0.0 111.9 179.304 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 18.3 p80 -62.62 -7.41 4.72 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 113.944 1.09 . . . . 0.0 113.944 -179.34 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 29.1 mt -96.24 -45.29 13.02 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.53 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 177.148 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -69.92 14.66 1.1 Allowed Glycine 0 CA--C 1.524 0.609 0 N-CA-C 116.436 1.334 . . . . 0.0 116.436 -177.798 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 15.2 t -95.77 26.51 3.99 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.328 0.651 . . . . 0.0 112.111 -178.841 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 67.7 ttp85 -59.29 125.94 25.65 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 178.429 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -101.26 128.02 30.34 Favored Pre-proline 0 C--N 1.322 -0.615 0 N-CA-C 106.671 -1.603 . . . . 0.0 106.671 -178.28 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -68.53 -20.3 41.48 Favored 'Trans proline' 0 C--O 1.219 -0.468 0 N-CA-C 114.605 0.964 . . . . 0.0 114.605 -176.81 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -74.17 -24.62 59.41 Favored 'General case' 0 C--O 1.221 -0.428 0 CA-C-O 120.861 0.362 . . . . 0.0 110.619 178.269 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 84.7 m-20 -100.94 -24.32 14.37 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 -175.714 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -158.23 149.74 21.27 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 113.364 0.876 . . . . 0.0 113.364 -177.634 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -91.61 150.52 21.13 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-O 121.428 0.632 . . . . 0.0 111.787 179.512 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -69.96 146.62 50.99 Favored 'General case' 0 C--N 1.323 -0.543 0 CA-C-O 121.261 0.553 . . . . 0.0 111.451 178.996 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 15.6 mt -86.68 136.45 22.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.828 -178.714 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 70.0 t -62.94 120.89 10.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 N-CA-C 106.179 -1.785 . . . . 0.0 106.179 175.109 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 6.0 tt -68.47 134.43 50.11 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -175.58 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 50.8 mt-30 -135.19 161.91 34.03 Favored 'General case' 0 CA--C 1.513 -0.452 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 178.328 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.44 HD13 HG22 ' A' ' 125' ' ' THR . 13.3 mt -114.63 146.3 35.68 Favored Pre-proline 0 C--N 1.323 -0.58 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 175.646 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -71.71 165.91 31.07 Favored 'Trans proline' 0 C--N 1.345 0.384 0 O-C-N 122.243 0.601 . . . . 0.0 113.619 -177.64 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 41.3 tt0 -53.26 128.83 29.53 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.238 -179.421 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 97.68 -17.32 59.08 Favored Glycine 0 C--O 1.227 -0.299 0 CA-C-N 115.886 -0.597 . . . . 0.0 113.058 -179.279 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.44 HG22 HD13 ' A' ' 121' ' ' LEU . 5.8 m -108.73 125.96 52.48 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 117.721 0.76 . . . . 0.0 109.263 178.083 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 5.8 p -124.8 148.23 48.27 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 -179.176 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 81.6 mt -69.56 155.04 94.24 Favored Pre-proline 0 C--N 1.325 -0.493 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 179.876 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_endo -74.44 169.06 23.35 Favored 'Trans proline' 0 N--CA 1.463 -0.299 0 C-N-CA 118.235 -0.71 . . . . 0.0 110.846 178.026 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -61.73 130.42 45.72 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.269 -176.191 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 95.2 -5.7 68.32 Favored Glycine 0 CA--C 1.518 0.224 0 CA-C-N 115.762 -0.653 . . . . 0.0 114.584 179.103 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.449 ' CZ ' ' HB2' ' A' ' 18' ' ' GLN . 1.2 m-85 -101.2 142.49 32.55 Favored 'General case' 0 N--CA 1.445 -0.725 0 CA-C-O 121.712 0.767 . . . . 0.0 110.678 179.441 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 45.6 p90 -145.22 164.19 32.1 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 114.478 -1.237 . . . . 0.0 108.019 175.194 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -100.77 145.78 28.08 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.094 0.474 . . . . 0.0 110.708 -177.949 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -70.58 129.01 38.07 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 -179.86 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 91.55 -32.02 5.5 Favored Glycine 0 CA--C 1.52 0.357 0 CA-C-N 116.159 -0.473 . . . . 0.0 113.967 -179.965 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 34.3 t . . . . . 0 C--N 1.323 -0.547 0 CA-C-N 117.577 0.688 . . . . 0.0 110.177 -178.949 . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.679 0 CA-C-O 121.57 0.7 . . . . 0.0 110.499 . . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -57.48 138.4 55.15 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.018 -0.992 . . . . 0.0 109.65 177.245 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 38.1 m95 -67.39 -21.83 65.58 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 114.127 1.158 . . . . 0.0 114.127 -178.437 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -121.46 159.31 26.52 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.435 0.636 . . . . 0.0 112.433 -174.09 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 56.7 p -67.93 165.07 18.49 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.457 -1.247 . . . . 0.0 108.318 178.185 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.431 ' HB2' ' CE2' ' A' ' 69' ' ' TYR . . . -83.37 148.6 27.22 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 113.716 1.006 . . . . 0.0 113.716 -175.006 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 85.0 mt -84.95 148.88 25.99 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 102.627 -3.101 . . . . 0.0 102.627 166.975 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 81.7 m -106.85 125.04 50.49 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 178.366 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -88.95 105.64 17.9 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 179.09 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 73.5 t60 -113.48 97.52 6.51 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 104.18 -2.526 . . . . 0.0 104.18 173.107 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 148.99 -168.01 29.43 Favored Glycine 0 N--CA 1.45 -0.41 0 N-CA-C 108.828 -1.709 . . . . 0.0 108.828 -176.128 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -104.4 -22.3 13.35 Favored 'General case' 0 C--O 1.215 -0.738 0 N-CA-C 115.369 1.618 . . . . 0.0 115.369 -176.487 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -71.12 146.36 49.25 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.6 0.714 . . . . 0.0 112.638 -176.357 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -95.58 33.29 1.65 Allowed 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 122.691 1.234 . . . . 0.0 111.918 -176.605 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 31.4 tp 62.52 146.29 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.99 0 CA-C-N 112.791 -2.004 . . . . 0.0 115.305 176.219 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 51.9 tptt -158.16 140.39 14.23 Favored 'General case' 0 CA--C 1.514 -0.433 0 O-C-N 121.118 -0.989 . . . . 0.0 109.869 174.58 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 -125.51 151.36 70.16 Favored Pre-proline 0 C--O 1.241 0.655 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 175.411 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -74.66 165.68 31.02 Favored 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 120.674 0.916 . . . . 0.0 113.863 -179.906 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 16.7 tpt180 -65.07 133.97 52.78 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.885 -178.211 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 83.96 2.32 89.59 Favored Glycine 0 C--O 1.227 -0.293 0 CA-C-O 121.305 0.392 . . . . 0.0 112.351 177.959 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 30.2 mt-30 -141.29 171.14 14.47 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 123.674 0.79 . . . . 0.0 109.803 -173.74 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 105.1 -19.58 40.2 Favored Glycine 0 CA--C 1.497 -1.062 0 N-CA-C 111.254 -0.738 . . . . 0.0 111.254 175.987 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 84.8 t -65.74 127.81 93.34 Favored Pre-proline 0 C--N 1.317 -0.818 0 N-CA-C 105.813 -1.921 . . . . 0.0 105.813 176.311 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -71.62 172.96 13.31 Favored 'Trans proline' 0 N--CA 1.46 -0.485 0 O-C-N 122.292 0.627 . . . . 0.0 111.295 178.141 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 78.4 mt -74.29 108.97 6.31 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 -179.324 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 30.4 m-20 -110.11 74.43 0.88 Allowed 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.648 -1.16 . . . . 0.0 110.454 -175.455 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 65.8 p -66.08 -23.0 66.44 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 115.588 1.699 . . . . 0.0 115.588 -174.298 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -110.76 31.3 6.1 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 112.259 0.466 . . . . 0.0 112.259 -176.474 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 73.8 p -132.9 167.56 20.0 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 178.988 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 44.6 m -84.26 162.45 51.41 Favored Pre-proline 0 C--N 1.321 -0.672 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.417 -178.59 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -67.64 -21.79 45.01 Favored 'Trans proline' 0 C--N 1.351 0.69 0 C-N-CA 116.526 -1.849 . . . . 0.0 114.668 -178.836 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.42 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 6.3 p-10 -75.19 -18.15 60.22 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 121.73 -0.606 . . . . 0.0 109.858 177.785 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -90.42 2.11 55.96 Favored 'General case' 0 C--O 1.219 -0.525 0 N-CA-C 114.32 1.23 . . . . 0.0 114.32 -175.016 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 93.0 mm-40 -65.26 -23.76 67.14 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-O 121.624 0.726 . . . . 0.0 109.99 176.789 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.499 ' HB ' ' HB1' ' A' ' 98' ' ' ALA . 9.0 tt -66.59 141.09 18.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 122.044 0.926 . . . . 0.0 111.083 177.964 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 175.18 -160.98 30.04 Favored Glycine 0 CA--C 1.504 -0.626 0 C-N-CA 120.2 -1.0 . . . . 0.0 110.636 179.364 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 44.3 p90 -155.1 170.73 21.11 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 178.832 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -112.8 140.24 47.76 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 106.522 -1.658 . . . . 0.0 106.522 175.213 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 63.9 ttt180 -115.49 121.97 44.3 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 123.831 0.852 . . . . 0.0 112.152 -175.59 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 32.3 ttp85 -68.65 138.66 55.18 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 176.977 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -143.64 138.73 29.19 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 123.217 0.607 . . . . 0.0 109.597 179.954 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.8 t -161.38 155.08 21.88 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 105.076 -2.194 . . . . 0.0 105.076 176.721 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 11.6 tpt180 -141.42 123.81 15.77 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 107.243 -1.392 . . . . 0.0 107.243 176.495 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 7.7 tmm_? -132.77 129.7 38.95 Favored 'General case' 0 CA--C 1.49 -1.341 0 CA-C-O 121.983 0.897 . . . . 0.0 110.221 179.931 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -139.68 176.82 5.17 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 N-CA-C 104.853 -2.277 . . . . 0.0 104.853 -178.75 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 30.2 ttt85 -127.42 115.91 19.65 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 105.847 -1.909 . . . . 0.0 105.847 175.172 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -82.35 156.83 35.92 Favored Glycine 0 N--CA 1.448 -0.502 0 N-CA-C 108.092 -2.003 . . . . 0.0 108.092 177.802 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -75.45 -31.66 56.39 Favored Glycine 0 C--O 1.215 -1.055 0 N-CA-C 108.808 -1.717 . . . . 0.0 108.808 178.964 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -71.76 -20.69 61.85 Favored 'General case' 0 C--O 1.217 -0.627 0 CA-C-N 114.17 -1.015 . . . . 0.0 109.718 178.211 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 115.65 -9.89 19.17 Favored Glycine 0 CA--C 1.506 -0.48 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.869 173.841 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 5.0 pttt -79.13 154.06 29.62 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 122.085 0.945 . . . . 0.0 113.354 -176.822 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 94.4 mtp -122.48 -160.24 0.87 Allowed 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 113.89 -1.504 . . . . 0.0 110.053 -176.865 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 18.7 mmtt -118.75 -70.0 0.82 Allowed 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 122.199 0.2 . . . . 0.0 111.103 -179.397 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -141.13 160.43 40.12 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 177.269 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -121.17 -28.23 4.76 Favored 'General case' 0 N--CA 1.469 0.5 0 O-C-N 123.892 0.745 . . . . 0.0 110.792 -177.664 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -110.03 130.83 22.4 Favored Pre-proline 0 C--O 1.238 0.469 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 -179.22 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -65.23 162.61 32.46 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 117.386 -1.276 . . . . 0.0 113.439 179.492 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 29.2 mtt-85 -123.31 156.74 34.72 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 178.654 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 54.6 m95 -129.78 125.14 35.08 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 177.215 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.431 ' CE2' ' HB2' ' A' ' 15' ' ' ALA . 88.4 m-85 -112.22 147.5 36.08 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 -178.582 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 79.2 t80 -91.0 136.9 32.76 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 -179.335 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -140.53 140.68 35.28 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.338 -0.847 . . . . 0.0 109.364 -173.93 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 34.7 m-85 -74.44 159.53 32.17 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.173 0.511 . . . . 0.0 111.373 -179.605 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -54.74 124.95 18.06 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.76 -0.654 . . . . 0.0 112.105 -177.994 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 81.18 16.73 73.63 Favored Glycine 0 C--O 1.221 -0.7 0 N-CA-C 117.012 1.565 . . . . 0.0 117.012 176.868 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 19.4 p . . . . . 0 N--CA 1.47 0.536 0 CA-C-N 119.173 1.486 . . . . 0.0 111.704 -179.88 . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 16.9 mt . . . . . 0 N--CA 1.449 -0.514 0 N-CA-C 115.486 1.662 . . . . 0.0 115.486 . . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -78.51 163.16 27.19 Favored 'Trans proline' 0 N--CA 1.461 -0.406 0 N-CA-C 107.698 -1.693 . . . . 0.0 107.698 168.269 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 55.0 t80 -61.62 133.61 55.84 Favored 'General case' 0 C--N 1.321 -0.668 0 C-N-CA 120.466 -0.493 . . . . 0.0 110.372 -178.305 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 90.7 -7.84 80.69 Favored Glycine 0 CA--C 1.517 0.206 0 CA-C-O 119.548 -0.584 . . . . 0.0 114.346 178.841 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -65.48 130.81 44.62 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 118.386 1.093 . . . . 0.0 111.03 179.098 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 59.1 t30 -79.71 129.21 34.28 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.381 -179.421 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 30.7 ttmt -156.07 152.96 28.66 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 106.571 -1.641 . . . . 0.0 106.571 179.451 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -60.95 127.47 31.71 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 -179.645 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 70.22 28.65 71.19 Favored Glycine 0 N--CA 1.449 -0.485 0 CA-C-O 119.382 -0.677 . . . . 0.0 114.677 176.593 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 43.5 mm -126.69 122.43 60.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 117.601 0.7 . . . . 0.0 110.842 179.406 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.1 pt -127.49 116.41 43.55 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 CA-C-O 121.762 0.792 . . . . 0.0 111.828 176.612 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 95.2 m95 -81.68 137.84 35.36 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 113.223 0.823 . . . . 0.0 113.223 -177.597 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 18.2 m -137.2 152.43 27.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 178.305 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -163.01 165.99 24.25 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 104.754 -2.313 . . . . 0.0 104.754 -179.999 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 6.5 t -140.2 -178.94 5.7 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 105.938 -1.875 . . . . 0.0 105.938 177.583 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -67.63 136.32 54.22 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.338 0.589 . . . . 0.0 110.614 -178.675 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 96.65 -13.69 65.04 Favored Glycine 0 N--CA 1.459 0.215 0 CA-C-N 115.668 -0.696 . . . . 0.0 112.967 178.48 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.499 ' HB1' ' HB ' ' A' ' 44' ' ' ILE . . . -75.59 140.02 42.42 Favored 'General case' 0 C--N 1.322 -0.608 0 O-C-N 122.716 -0.285 . . . . 0.0 110.573 179.997 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 36.4 mt -96.53 139.89 31.96 Favored 'General case' 0 C--O 1.218 -0.555 0 CA-C-O 121.259 0.552 . . . . 0.0 111.69 -179.373 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 58.9 t30 -86.16 68.77 10.38 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.711 179.473 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 1.1 t -140.67 150.77 61.33 Favored Pre-proline 0 C--N 1.325 -0.489 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 179.12 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -67.74 149.57 78.76 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 118.345 -0.636 . . . . 0.0 113.544 176.908 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.64 47.12 1.19 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 122.732 1.253 . . . . 0.0 110.839 179.061 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 16.0 p-10 -47.73 -39.34 17.47 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 113.44 -1.709 . . . . 0.0 113.34 178.752 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 50.1 p-80 -60.74 -17.1 46.53 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 115.336 1.606 . . . . 0.0 115.336 -177.814 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 68.9 mt -81.55 -29.16 10.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 178.896 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -72.06 14.65 2.12 Favored Glycine 0 CA--C 1.522 0.525 0 N-CA-C 115.771 1.068 . . . . 0.0 115.771 -177.622 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 15.2 t -83.29 28.16 0.55 Allowed 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 123.54 0.736 . . . . 0.0 112.981 -177.711 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 72.9 ttp85 -61.61 116.38 4.7 Favored 'General case' 0 N--CA 1.469 0.514 0 O-C-N 121.221 -0.924 . . . . 0.0 108.647 178.443 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 14.5 m-20 -82.88 118.39 71.61 Favored Pre-proline 0 C--N 1.323 -0.554 0 N-CA-C 105.351 -2.092 . . . . 0.0 105.351 179.279 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -71.66 -13.61 29.88 Favored 'Trans proline' 0 C--O 1.219 -0.46 0 C-N-CA 117.312 -1.326 . . . . 0.0 113.891 -176.418 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -81.25 -24.91 37.01 Favored 'General case' 0 C--O 1.22 -0.465 0 CA-C-O 120.892 0.377 . . . . 0.0 110.241 178.252 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 81.2 m-20 -102.86 -24.78 13.67 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 113.521 0.934 . . . . 0.0 113.521 -175.315 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -145.97 145.42 30.64 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 -178.349 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -89.23 149.68 22.99 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.368 -179.927 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -70.24 148.31 48.72 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.305 0.574 . . . . 0.0 110.61 178.129 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 8.0 mt -83.43 139.33 17.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 -179.178 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 89.7 t -62.55 121.43 11.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 176.069 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 5.5 tt -68.07 126.92 31.01 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.244 0.545 . . . . 0.0 109.996 -177.798 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 30.8 mt-30 -132.96 154.23 50.67 Favored 'General case' 0 CA--C 1.509 -0.628 0 N-CA-C 106.656 -1.609 . . . . 0.0 106.656 -179.85 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 12.8 mt -110.73 147.45 36.48 Favored Pre-proline 0 C--N 1.321 -0.657 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 176.779 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -72.96 162.18 41.67 Favored 'Trans proline' 0 C--O 1.236 0.376 0 O-C-N 122.265 0.613 . . . . 0.0 112.491 -179.718 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 56.8 tt0 -55.15 131.27 44.82 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 -179.797 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 104.27 -22.8 33.65 Favored Glycine 0 C--O 1.226 -0.359 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.842 -178.267 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 3.8 m -108.72 126.98 53.59 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 117.641 0.72 . . . . 0.0 109.791 177.778 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 15.5 p -121.64 148.41 44.6 Favored 'General case' 0 CA--C 1.508 -0.635 0 CA-C-O 121.029 0.442 . . . . 0.0 110.25 179.912 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 83.0 mt -71.79 152.92 93.31 Favored Pre-proline 0 C--N 1.321 -0.634 0 N-CA-C 107.305 -1.369 . . . . 0.0 107.305 178.011 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -77.63 172.58 15.54 Favored 'Trans proline' 0 C--O 1.237 0.439 0 CA-C-O 121.384 0.493 . . . . 0.0 111.252 179.022 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 65.2 tttm -57.61 127.51 32.4 Favored 'General case' 0 C--O 1.219 -0.519 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.778 -178.047 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 91.82 7.84 64.15 Favored Glycine 0 C--O 1.226 -0.406 0 N-CA-C 115.625 1.01 . . . . 0.0 115.625 177.678 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 34.5 m-85 -118.86 136.87 53.81 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 118.064 0.932 . . . . 0.0 109.927 177.774 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 55.2 p90 -144.93 161.8 38.46 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 176.683 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -99.45 146.27 26.52 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.617 0.722 . . . . 0.0 112.893 -175.665 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -75.39 132.02 40.61 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 178.658 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 88.6 -6.85 83.18 Favored Glycine 0 C--O 1.225 -0.412 0 C-N-CA 121.323 -0.465 . . . . 0.0 112.959 -179.032 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 31.6 t . . . . . 0 C--N 1.328 -0.363 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 178.848 . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.245 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 . . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 34.0 p -64.21 145.65 55.63 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 178.351 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 13.1 m95 -64.73 -24.35 67.54 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.955 0.407 . . . . 0.0 112.086 179.5 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -121.38 163.93 17.91 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.578 -0.737 . . . . 0.0 112.416 -172.269 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 47.0 p -70.43 165.96 21.4 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 177.093 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -79.34 146.56 32.83 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.715 0.769 . . . . 0.0 112.472 -176.507 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.407 HD23 ' HA ' ' A' ' 16' ' ' LEU . 12.1 mt -83.32 146.73 28.35 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 102.931 -2.989 . . . . 0.0 102.931 169.151 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 29.9 m -129.78 138.75 51.23 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 -178.686 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.438 ' HB2' ' CZ ' ' A' ' 131' ' ' PHE . 4.0 tp60 -106.67 136.91 45.66 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.837 0.68 . . . . 0.0 112.837 -176.93 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 5.7 t60 -130.75 94.77 3.69 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 103.014 -2.958 . . . . 0.0 103.014 168.612 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 173.33 -157.33 26.01 Favored Glycine 0 C--O 1.223 -0.541 0 N-CA-C 110.957 -0.857 . . . . 0.0 110.957 -174.302 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 29.8 mtpp -112.32 -24.86 9.55 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 115.321 1.601 . . . . 0.0 115.321 -177.436 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 88.3 mt-10 -80.5 158.29 25.89 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 177.759 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -79.91 -62.8 1.57 Allowed 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 177.667 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 44.3 tp -179.25 141.09 0.16 Allowed 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 172.56 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 23.8 tptm -156.07 140.45 16.7 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 174.188 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 15.3 m-85 -125.02 152.1 69.92 Favored Pre-proline 0 C--O 1.242 0.68 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 175.817 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -72.69 160.41 46.43 Favored 'Trans proline' 0 CA--C 1.54 0.778 0 C-N-CA 120.658 0.905 . . . . 0.0 112.859 178.292 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.02 131.91 47.32 Favored 'General case' 0 C--O 1.216 -0.665 0 O-C-N 122.172 -0.33 . . . . 0.0 110.813 -178.033 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 85.45 7.27 82.64 Favored Glycine 0 N--CA 1.46 0.292 0 C-N-CA 121.445 -0.407 . . . . 0.0 112.181 179.195 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 13.1 mt-30 -145.95 170.53 16.42 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 123.19 0.596 . . . . 0.0 109.983 -174.991 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 105.41 -16.88 44.36 Favored Glycine 0 CA--C 1.501 -0.819 0 CA-C-N 116.1 -0.5 . . . . 0.0 113.139 174.881 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 93.9 t -65.78 129.08 94.24 Favored Pre-proline 0 C--N 1.32 -0.704 0 N-CA-C 106.52 -1.659 . . . . 0.0 106.52 176.988 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -73.27 170.77 19.08 Favored 'Trans proline' 0 C--O 1.219 -0.433 0 O-C-N 122.148 0.552 . . . . 0.0 111.052 177.764 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 86.1 mt -70.55 106.56 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-O 122.009 0.909 . . . . 0.0 108.693 -179.601 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -98.14 84.1 3.21 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 114.514 -1.221 . . . . 0.0 110.017 -176.915 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 77.3 p -68.3 -14.08 62.73 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.775 0.798 . . . . 0.0 112.48 -179.313 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 11.5 p30 -106.69 22.98 15.02 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 114.82 -1.082 . . . . 0.0 111.718 -177.776 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 19.0 m -141.15 150.97 43.48 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 113.745 1.016 . . . . 0.0 113.745 -176.424 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.1 m -72.28 166.88 37.38 Favored Pre-proline 0 C--N 1.326 -0.441 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 176.415 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -66.4 -25.62 48.65 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 114.792 -3.005 . . . . 0.0 114.112 -179.714 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.472 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 4.5 p-10 -78.66 -20.63 49.82 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.586 0.708 . . . . 0.0 110.891 177.546 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 -81.64 -6.68 59.24 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 -176.086 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 96.0 mm-40 -57.7 -26.81 62.26 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 114.124 1.157 . . . . 0.0 114.124 -178.481 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.423 ' HB ' ' HB1' ' A' ' 98' ' ' ALA . 8.5 tt -59.31 138.35 20.49 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.939 0 N-CA-C 113.872 1.064 . . . . 0.0 113.872 -178.367 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -178.34 -158.2 20.57 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.389 -179.376 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 36.4 p90 -154.95 168.14 27.97 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 179.427 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 29.1 m-85 -112.77 141.74 46.22 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 174.634 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 69.2 ttt-85 -115.14 124.15 50.75 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 123.423 0.689 . . . . 0.0 112.514 -178.353 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 50.0 ttt180 -64.64 136.33 56.87 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 122.784 0.434 . . . . 0.0 110.12 177.3 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -152.13 150.92 30.42 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.713 0.634 . . . . 0.0 112.713 -179.791 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 6.4 p -144.15 147.88 34.29 Favored 'General case' 0 C--O 1.238 0.494 0 N-CA-C 105.488 -2.041 . . . . 0.0 105.488 172.704 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 16.1 tpt180 -166.22 123.86 1.42 Allowed 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 177.698 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 7.8 tmm_? -94.35 124.03 38.12 Favored 'General case' 0 CA--C 1.485 -1.553 0 CA-C-O 122.375 1.083 . . . . 0.0 111.0 177.973 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -126.74 174.64 10.2 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.076 0 CA-C-N 112.841 -1.981 . . . . 0.0 106.596 176.273 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 78.6 ttt180 -122.94 121.44 36.16 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 105.46 -2.052 . . . . 0.0 105.46 175.289 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -90.42 157.64 25.86 Favored Glycine 0 N--CA 1.448 -0.511 0 N-CA-C 106.969 -2.452 . . . . 0.0 106.969 177.955 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -72.21 -34.27 61.33 Favored Glycine 0 C--O 1.217 -0.966 0 N-CA-C 107.588 -2.205 . . . . 0.0 107.588 178.141 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 30.8 t0 -93.62 14.82 17.79 Favored 'General case' 0 C--O 1.217 -0.642 0 CA-C-O 122.529 1.157 . . . . 0.0 109.497 178.409 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 83.66 -17.21 26.8 Favored Glycine 0 C--O 1.227 -0.295 0 N-CA-C 117.101 1.601 . . . . 0.0 117.101 172.794 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.74 125.96 22.14 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 114.026 1.121 . . . . 0.0 114.026 -176.853 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 78.5 mtp -104.24 -179.32 3.91 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 114.37 -1.286 . . . . 0.0 112.239 -177.971 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 10.5 mptt -131.85 -47.25 0.95 Allowed 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.893 0.877 . . . . 0.0 111.331 -179.913 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -66.3 -172.07 0.14 Allowed 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 113.158 -1.837 . . . . 0.0 114.405 -179.512 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 79.52 -54.43 0.41 Allowed 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 126.855 2.062 . . . . 0.0 109.14 -177.967 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 22.3 p -92.14 131.84 33.9 Favored Pre-proline 0 C--N 1.32 -0.712 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 174.965 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -70.48 149.64 62.58 Favored 'Trans proline' 0 C--O 1.24 0.615 0 C-N-CA 115.513 -2.524 . . . . 0.0 111.112 178.734 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.409 HH12 ' CD ' ' A' ' 134' ' ' GLU . 0.1 OUTLIER -123.78 158.96 30.54 Favored 'General case' 0 CA--C 1.504 -0.803 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.096 -176.75 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 65.9 m95 -133.47 128.08 34.65 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 177.163 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 43.4 m-85 -110.92 143.26 41.83 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 106.669 -1.604 . . . . 0.0 106.669 -178.796 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 92.1 t80 -94.72 135.09 36.61 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 -175.844 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -137.92 155.55 48.81 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 108.072 -1.085 . . . . 0.0 108.072 -177.747 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 80.9 m-85 -89.39 159.47 17.3 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 112.06 0.393 . . . . 0.0 112.06 -174.362 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -55.05 128.95 36.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.01 -177.958 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 68.13 39.18 88.62 Favored Glycine 0 C--O 1.217 -0.91 0 CA-C-O 119.201 -0.777 . . . . 0.0 114.822 175.672 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.325 -0.486 0 N-CA-C 106.408 -1.701 . . . . 0.0 106.408 177.719 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 17.5 mt . . . . . 0 N--CA 1.445 -0.72 0 N-CA-C 113.501 0.926 . . . . 0.0 113.501 . . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -78.29 166.61 24.21 Favored 'Trans proline' 0 N--CA 1.46 -0.471 0 C-N-CA 121.54 1.494 . . . . 0.0 108.323 170.655 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.402 ' CE1' ' HB3' ' A' ' 92' ' ' TRP . 70.6 t80 -61.74 131.16 48.98 Favored 'General case' 0 C--N 1.321 -0.63 0 C-N-CA 120.371 -0.532 . . . . 0.0 109.978 -179.978 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 92.34 -7.07 78.31 Favored Glycine 0 CA--C 1.52 0.354 0 N-CA-C 114.943 0.737 . . . . 0.0 114.943 178.093 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -64.19 129.51 40.27 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 118.433 1.117 . . . . 0.0 111.866 -179.991 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -75.53 130.15 38.39 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.492 -177.778 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 28.1 ttmt -156.17 151.75 27.04 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 105.58 -2.007 . . . . 0.0 105.58 177.43 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 31.1 t0 -66.2 133.62 51.01 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.017 0.436 . . . . 0.0 110.423 -177.89 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 69.03 25.6 75.3 Favored Glycine 0 N--CA 1.449 -0.442 0 CA-C-O 119.46 -0.633 . . . . 0.0 114.089 179.234 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 41.3 mm -127.15 128.75 70.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 117.504 0.652 . . . . 0.0 110.484 179.898 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.1 pt -131.52 122.48 50.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 CA-C-N 115.782 -0.644 . . . . 0.0 109.719 175.312 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 92' ' ' TRP . . . . . 0.402 ' HB3' ' CE1' ' A' ' 83' ' ' TYR . 94.0 m95 -88.35 138.75 31.16 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 -176.975 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 16.2 m -137.56 149.73 25.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 121.687 0.756 . . . . 0.0 109.635 178.806 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -158.5 166.6 31.77 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 102.684 -3.08 . . . . 0.0 102.684 -179.494 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 8.4 t -134.34 177.19 7.95 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 105.52 -2.03 . . . . 0.0 105.52 178.267 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 64.4 tt0 -67.46 134.46 51.41 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.142 0.496 . . . . 0.0 109.9 -178.547 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 96.01 -13.75 65.59 Favored Glycine 0 C--O 1.229 -0.19 0 CA-C-N 115.92 -0.582 . . . . 0.0 112.942 -179.804 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.472 ' HA ' ' HA ' ' A' ' 41' ' ' ASP . . . -73.42 138.17 45.06 Favored 'General case' 0 CA--C 1.54 0.575 0 O-C-N 122.498 -0.413 . . . . 0.0 110.288 178.964 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 31.7 mt -97.02 139.33 33.2 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 121.269 0.557 . . . . 0.0 112.398 -179.441 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -83.0 62.87 6.79 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.804 -178.872 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 1.2 t -131.98 152.89 81.04 Favored Pre-proline 0 C--N 1.324 -0.54 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 178.99 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -67.51 152.34 78.63 Favored 'Trans proline' 0 C--N 1.344 0.292 0 N-CA-C 114.489 0.919 . . . . 0.0 114.489 178.304 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 1.3 ptpt -151.87 59.07 0.86 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 122.879 1.324 . . . . 0.0 111.124 178.466 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 15.0 p-10 -56.33 -36.04 68.27 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 113.628 -1.624 . . . . 0.0 111.556 177.803 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 38.0 p-80 -60.58 -10.82 5.66 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 114.891 1.441 . . . . 0.0 114.891 -177.868 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 55.0 mt -92.36 -43.72 13.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 178.117 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -72.97 14.65 2.67 Favored Glycine 0 CA--C 1.523 0.541 0 N-CA-C 116.256 1.262 . . . . 0.0 116.256 -176.339 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 14.4 t -95.73 25.52 4.56 Favored 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 -177.382 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 62.4 ttp85 -55.62 129.98 41.21 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 179.629 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 6.5 m-20 -99.72 126.1 38.28 Favored Pre-proline 0 C--N 1.323 -0.57 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 -178.528 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -69.9 -17.88 36.69 Favored 'Trans proline' 0 C--O 1.219 -0.444 0 C-N-CA 118.041 -0.839 . . . . 0.0 113.465 -178.127 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -73.3 -28.67 62.23 Favored 'General case' 0 C--O 1.22 -0.463 0 CA-C-O 120.96 0.409 . . . . 0.0 110.681 178.239 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 76.1 m-20 -102.3 -24.72 13.85 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 -174.107 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 -153.2 149.51 28.06 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 113.176 0.806 . . . . 0.0 113.176 -178.209 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -89.15 148.21 23.78 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-O 121.382 0.61 . . . . 0.0 111.497 179.392 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -68.49 143.47 54.97 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.374 0.606 . . . . 0.0 110.968 178.808 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 19.4 mt -85.28 139.87 16.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 -179.164 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 91.5 t -63.3 123.31 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 N-CA-C 106.105 -1.813 . . . . 0.0 106.105 175.271 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 6.8 tt -66.0 130.32 42.84 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.151 0.5 . . . . 0.0 110.598 -176.705 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 32.7 mt-30 -132.61 159.81 38.46 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 106.892 -1.521 . . . . 0.0 106.892 -179.376 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 13.7 mt -113.59 147.85 38.46 Favored Pre-proline 0 C--N 1.322 -0.589 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 177.256 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -72.82 169.51 21.87 Favored 'Trans proline' 0 C--N 1.344 0.34 0 O-C-N 122.254 0.607 . . . . 0.0 113.356 -178.6 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 60.3 tt0 -54.7 131.76 44.2 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.715 -179.638 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 93.13 -16.76 59.76 Favored Glycine 0 C--O 1.227 -0.339 0 CA-C-O 119.654 -0.525 . . . . 0.0 114.168 179.767 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 15.1 m -106.36 127.78 53.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 118.396 1.098 . . . . 0.0 110.547 178.864 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 10.4 p -121.23 148.7 43.92 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.593 -178.82 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 79.0 mt -71.05 153.52 94.54 Favored Pre-proline 0 C--N 1.324 -0.534 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 178.937 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -75.09 170.34 20.61 Favored 'Trans proline' 0 C--O 1.236 0.398 0 N-CA-C 110.363 -0.668 . . . . 0.0 110.363 178.089 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 13.9 tmtt? -54.74 121.4 8.45 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 113.314 0.857 . . . . 0.0 113.314 -174.093 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 95.24 -6.01 68.43 Favored Glycine 0 C--N 1.328 0.106 0 N-CA-C 116.719 1.448 . . . . 0.0 116.719 174.684 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.438 ' CZ ' ' HB2' ' A' ' 18' ' ' GLN . 1.5 m-85 -87.51 145.69 26.13 Favored 'General case' 0 N--CA 1.436 -1.16 0 CA-C-O 122.192 0.996 . . . . 0.0 110.342 178.813 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 37.4 p90 -145.4 163.11 35.6 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 113.458 -1.701 . . . . 0.0 107.625 175.326 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -102.98 145.39 29.94 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.081 0.467 . . . . 0.0 110.659 -177.787 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.409 ' CD ' HH12 ' A' ' 67' ' ' ARG . 33.7 tt0 -73.56 132.28 42.65 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 107.081 -1.452 . . . . 0.0 107.081 178.303 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 92.92 -2.4 72.28 Favored Glycine 0 C--O 1.223 -0.539 0 N-CA-C 111.125 -0.79 . . . . 0.0 111.125 -177.636 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 8.9 t . . . . . 0 C--N 1.325 -0.469 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 177.496 . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.415 0 CA-C-O 121.352 0.596 . . . . 0.0 110.912 . . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 54.0 p -63.27 144.99 56.47 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.02 178.478 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 42.8 m95 -68.78 -23.44 64.3 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 113.69 0.996 . . . . 0.0 113.69 179.987 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -116.84 160.09 21.37 Favored 'General case' 0 C--O 1.242 0.668 0 CA-C-O 121.239 0.542 . . . . 0.0 111.69 -174.898 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.474 ' HB ' ' HB3' ' A' ' 134' ' ' GLU . 75.9 p -70.13 163.1 27.02 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.694 -1.139 . . . . 0.0 109.482 178.999 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -82.65 135.87 34.92 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 113.478 0.918 . . . . 0.0 113.478 -175.809 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.452 HD11 HD22 ' A' ' 119' ' ' LEU . 3.0 mp -80.19 146.83 31.55 Favored 'General case' 0 CA--C 1.503 -0.854 0 N-CA-C 106.466 -1.679 . . . . 0.0 106.466 173.419 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 25.2 m -106.08 136.2 46.19 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 178.01 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 -110.78 128.2 55.66 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.265 0.555 . . . . 0.0 111.198 -178.359 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 40.7 t60 -129.12 99.47 5.27 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 106.229 -1.767 . . . . 0.0 106.229 175.18 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 165.79 -173.13 41.4 Favored Glycine 0 N--CA 1.451 -0.347 0 N-CA-C 110.418 -1.073 . . . . 0.0 110.418 -178.502 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -98.01 -16.94 19.44 Favored 'General case' 0 C--O 1.218 -0.566 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 -179.387 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 84.0 mt-10 -71.04 169.16 15.55 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 113.49 0.922 . . . . 0.0 113.49 -176.29 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 70.0 m-20 -116.17 24.33 11.49 Favored 'General case' 0 C--O 1.221 -0.428 0 CA-C-O 122.013 0.911 . . . . 0.0 111.797 178.895 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 62.2 tp 66.54 144.19 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 126.598 1.959 . . . . 0.0 113.597 179.987 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 49.3 tptt -157.74 138.15 12.79 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 176.234 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -123.56 136.27 27.04 Favored Pre-proline 0 C--O 1.242 0.699 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 173.535 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -64.04 162.34 29.79 Favored 'Trans proline' 0 CA--C 1.539 0.74 0 C-N-CA 121.205 1.27 . . . . 0.0 113.344 175.349 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -67.13 143.2 56.77 Favored 'General case' 0 C--O 1.22 -0.495 0 O-C-N 122.017 -0.427 . . . . 0.0 112.007 -179.278 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 78.29 13.65 83.06 Favored Glycine 0 C--O 1.222 -0.62 0 N-CA-C 111.115 -0.794 . . . . 0.0 111.115 178.951 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -152.52 168.6 25.0 Favored 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 -173.938 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 104.2 -19.87 41.96 Favored Glycine 0 CA--C 1.499 -0.951 0 CA-C-O 121.015 0.231 . . . . 0.0 112.881 173.809 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 58.3 t -72.01 127.25 90.8 Favored Pre-proline 0 C--N 1.319 -0.749 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 177.911 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -68.64 175.23 7.39 Favored 'Trans proline' 0 CA--C 1.531 0.36 0 N-CA-C 113.7 0.616 . . . . 0.0 113.7 177.404 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 88.0 mt -75.56 110.41 10.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 121.882 0.848 . . . . 0.0 109.174 178.616 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -108.35 83.26 1.75 Allowed 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 114.674 -1.148 . . . . 0.0 109.637 -178.406 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 80.9 p -69.71 -18.37 63.53 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 113.704 1.001 . . . . 0.0 113.704 -176.783 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -119.64 32.11 6.23 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 -175.916 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.4 m -136.35 157.38 46.93 Favored 'General case' 0 C--N 1.327 -0.394 0 O-C-N 122.045 -0.409 . . . . 0.0 111.456 179.214 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 15.0 m -72.68 159.35 85.57 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.017 -179.979 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -65.42 -24.92 56.47 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 116.127 -2.115 . . . . 0.0 111.331 176.833 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -62.14 -29.79 70.59 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.444 176.578 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 35.4 t0 -88.25 -6.38 57.83 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 113.737 1.014 . . . . 0.0 113.737 -172.536 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 95.1 mm-40 -62.03 -31.84 72.27 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 112.95 0.722 . . . . 0.0 112.95 -177.177 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 13.6 tt -62.42 137.86 23.54 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 CA-C-O 122.135 0.969 . . . . 0.0 110.753 177.902 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -179.25 -159.55 23.54 Favored Glycine 0 CA--C 1.504 -0.638 0 C-N-CA 120.1 -1.048 . . . . 0.0 111.51 -178.247 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 38.2 p90 -155.09 168.52 26.73 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 109.838 -0.431 . . . . 0.0 109.838 179.408 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 14.2 m-85 -110.34 137.32 48.21 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 175.615 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 47.6 ttt-85 -112.03 125.3 53.93 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 124.12 0.968 . . . . 0.0 109.936 -176.941 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 9.1 ttt180 -72.77 145.96 46.7 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 122.051 0.929 . . . . 0.0 109.339 179.343 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -75.91 170.8 15.55 Favored 'General case' 0 N--CA 1.432 -1.337 0 CA-C-N 114.165 -1.379 . . . . 0.0 109.895 178.472 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 8.5 t -61.7 147.82 44.78 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 122.222 1.011 . . . . 0.0 110.615 -178.747 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 10.2 tpt180 -72.46 147.42 46.11 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.687 -1.142 . . . . 0.0 111.661 -175.938 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 3.2 tmt_? -88.44 129.06 35.52 Favored 'General case' 0 CA--C 1.504 -0.799 0 N-CA-C 106.113 -1.81 . . . . 0.0 106.113 175.919 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -132.43 176.87 8.04 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-N 114.381 -1.282 . . . . 0.0 111.397 -172.639 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 18.8 ttm180 -112.68 117.03 31.12 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 103.92 -2.622 . . . . 0.0 103.92 174.783 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -92.79 142.41 15.97 Favored Glycine 0 C--O 1.222 -0.596 0 N-CA-C 109.301 -1.52 . . . . 0.0 109.301 179.45 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -70.9 -27.19 72.66 Favored Glycine 0 C--O 1.214 -1.125 0 C-N-CA 121.02 -0.61 . . . . 0.0 114.0 -177.337 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -83.55 -2.34 55.78 Favored 'General case' 0 C--O 1.218 -0.581 0 CA-C-O 121.516 0.674 . . . . 0.0 112.551 -178.319 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 102.94 12.14 32.72 Favored Glycine 0 CA--C 1.504 -0.624 0 CA-C-O 121.557 0.532 . . . . 0.0 112.267 172.037 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 2.6 pttt -130.22 149.23 52.01 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 111.875 0.324 . . . . 0.0 111.875 -177.895 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 23.1 ptm -147.8 176.92 9.74 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 114.594 1.331 . . . . 0.0 114.594 -170.282 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 13.4 mptt -82.35 -45.42 14.91 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.399 178.696 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 8.2 t0 62.45 -169.66 0.18 Allowed 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 112.129 -2.305 . . . . 0.0 113.657 -177.344 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER 66.53 165.16 0.2 Allowed 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 115.23 1.567 . . . . 0.0 115.23 -179.681 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -79.76 157.35 74.39 Favored Pre-proline 0 C--O 1.238 0.494 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 177.909 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -67.43 143.74 64.65 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 114.969 -2.887 . . . . 0.0 112.088 178.805 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 25.6 mtp180 -118.82 166.02 13.31 Favored 'General case' 0 CA--C 1.511 -0.531 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 179.396 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 71.3 m95 -131.09 132.05 44.6 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 178.031 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 61.1 m-85 -112.68 152.1 29.42 Favored 'General case' 0 C--O 1.214 -0.79 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 -178.792 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 77.8 t80 -102.03 136.67 41.46 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 119.35 0.977 . . . . 0.0 109.804 -177.816 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -141.03 146.6 37.44 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.981 -175.288 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 30.5 m-85 -77.82 159.48 28.95 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.128 0.49 . . . . 0.0 111.884 -178.62 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -55.31 131.76 46.37 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.015 179.436 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 72.09 27.82 69.54 Favored Glycine 0 C--O 1.219 -0.816 0 N-CA-C 116.095 1.198 . . . . 0.0 116.095 176.542 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 3.7 p . . . . . 0 C--N 1.325 -0.462 0 CA-C-N 118.575 1.187 . . . . 0.0 108.527 177.734 . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 16.7 mt . . . . . 0 N--CA 1.449 -0.508 0 N-CA-C 114.637 1.347 . . . . 0.0 114.637 . . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -78.34 165.61 25.31 Favored 'Trans proline' 0 N--CA 1.462 -0.362 0 C-N-CA 121.525 1.484 . . . . 0.0 108.653 169.865 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 88.2 t80 -61.39 128.47 36.47 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.983 0.42 . . . . 0.0 110.505 -179.222 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 93.25 -6.83 75.74 Favored Glycine 0 CA--C 1.521 0.409 0 N-CA-C 115.364 0.905 . . . . 0.0 115.364 178.676 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -63.32 133.6 54.39 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 118.433 1.117 . . . . 0.0 112.417 -179.961 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -78.02 125.87 29.99 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.415 -179.246 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 29.6 ttmt -156.22 151.32 26.41 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 107.046 -1.464 . . . . 0.0 107.046 178.145 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -66.44 133.04 49.61 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 -178.204 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 70.44 24.04 77.06 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.889 -0.672 . . . . 0.0 114.019 178.022 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 43.5 mm -127.3 125.67 66.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 117.241 0.52 . . . . 0.0 109.918 179.229 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.1 pt -131.21 122.07 50.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 121.6 0.714 . . . . 0.0 110.5 177.055 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 94.0 m95 -88.25 138.28 31.58 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 -176.261 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 23.4 m -135.95 155.46 35.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 178.916 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -162.93 166.09 24.31 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 105.412 -2.07 . . . . 0.0 105.412 -179.843 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 11.9 t -135.98 173.66 11.47 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 105.37 -2.085 . . . . 0.0 105.37 178.38 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -67.6 136.72 54.89 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.161 0.505 . . . . 0.0 110.443 -178.646 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 92.51 -6.71 77.83 Favored Glycine 0 C--O 1.227 -0.289 0 CA-C-N 115.943 -0.572 . . . . 0.0 114.266 177.571 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -78.05 148.26 34.39 Favored 'General case' 0 C--N 1.322 -0.596 0 O-C-N 122.439 -0.448 . . . . 0.0 110.696 179.228 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 70.5 mt -81.21 170.78 15.68 Favored 'General case' 0 C--O 1.208 -1.095 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 178.015 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -112.96 28.84 8.46 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 121.239 0.542 . . . . 0.0 109.898 177.709 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -109.94 151.74 42.6 Favored Pre-proline 0 CA--C 1.546 0.825 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 -174.36 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -71.01 151.07 61.62 Favored 'Trans proline' 0 C--N 1.352 0.744 0 C-N-CA 120.481 0.787 . . . . 0.0 113.569 177.391 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 6.6 pttp -154.33 57.44 0.7 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 122.548 1.166 . . . . 0.0 111.423 -177.631 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -57.24 -31.99 66.11 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 114.518 -1.219 . . . . 0.0 112.511 179.813 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 11.9 p80 -60.67 -11.32 7.01 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 114.929 1.455 . . . . 0.0 114.929 -177.991 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 45.8 mt -92.31 -43.4 13.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 177.495 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -70.85 14.68 1.42 Allowed Glycine 0 CA--C 1.523 0.558 0 N-CA-C 117.296 1.678 . . . . 0.0 117.296 -175.556 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 12.3 t -90.31 30.24 1.15 Allowed 'General case' 0 CA--C 1.548 0.876 0 N-CA-C 112.527 0.566 . . . . 0.0 112.527 -178.108 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 68.8 ttp85 -56.19 131.25 47.3 Favored 'General case' 0 N--CA 1.475 0.808 0 O-C-N 121.426 -0.796 . . . . 0.0 109.846 179.398 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 37.1 m-20 -100.52 119.57 58.42 Favored Pre-proline 0 C--N 1.325 -0.465 0 N-CA-C 105.125 -2.176 . . . . 0.0 105.125 178.698 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -71.05 -17.34 31.84 Favored 'Trans proline' 0 C--N 1.347 0.469 0 N-CA-C 114.793 1.036 . . . . 0.0 114.793 -174.824 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -75.0 -25.37 58.76 Favored 'General case' 0 C--O 1.22 -0.48 0 CA-C-O 120.946 0.403 . . . . 0.0 110.064 177.631 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 -100.55 -24.67 14.4 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 113.296 0.85 . . . . 0.0 113.296 -175.519 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -149.56 145.44 26.82 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.933 0.716 . . . . 0.0 112.933 -179.446 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -83.66 147.54 27.63 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-O 121.617 0.722 . . . . 0.0 112.305 -179.914 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -72.33 147.46 46.29 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.669 178.315 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 9.9 mt -83.71 133.76 28.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 -179.255 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 74.0 t -62.73 120.93 10.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 N-CA-C 105.853 -1.906 . . . . 0.0 105.853 175.534 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.452 HD22 HD11 ' A' ' 16' ' ' LEU . 6.7 tt -68.44 128.95 38.44 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.21 0.529 . . . . 0.0 110.483 -176.919 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 29.8 mt-30 -132.14 156.51 46.26 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 105.835 -1.913 . . . . 0.0 105.835 179.065 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 14.1 mt -112.25 149.8 41.54 Favored Pre-proline 0 C--N 1.321 -0.631 0 N-CA-C 105.93 -1.878 . . . . 0.0 105.93 177.744 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -69.9 171.01 15.41 Favored 'Trans proline' 0 C--N 1.344 0.302 0 N-CA-C 115.136 1.168 . . . . 0.0 115.136 -175.061 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -54.9 130.94 43.19 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.835 -178.116 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 88.12 -10.68 69.92 Favored Glycine 0 C--O 1.227 -0.315 0 CA-C-N 115.89 -0.595 . . . . 0.0 112.648 -179.99 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 27.9 m -108.66 127.68 54.18 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.146 0.498 . . . . 0.0 110.662 -179.854 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 19.2 p -124.22 152.99 42.28 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.301 0.572 . . . . 0.0 112.309 -177.532 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 71.4 mt -70.36 155.45 93.41 Favored Pre-proline 0 C--N 1.326 -0.433 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 176.833 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -76.86 172.77 15.59 Favored 'Trans proline' 0 N--CA 1.463 -0.265 0 O-C-N 121.933 0.438 . . . . 0.0 111.038 179.085 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 48.5 tptt -60.78 132.57 54.3 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 -178.341 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 86.81 22.53 45.76 Favored Glycine 0 CA--C 1.518 0.247 0 N-CA-C 114.844 0.698 . . . . 0.0 114.844 177.816 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -131.91 143.43 50.13 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 117.35 0.575 . . . . 0.0 112.258 178.553 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 49.2 p90 -148.94 158.71 44.38 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 106.267 -1.753 . . . . 0.0 106.267 172.507 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -100.43 148.47 24.71 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.816 0.341 . . . . 0.0 110.279 -178.412 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.474 ' HB3' ' HB ' ' A' ' 14' ' ' THR . 8.7 tp10 -67.39 134.33 51.26 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.204 -1.035 . . . . 0.0 108.204 177.593 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 85.78 -7.89 75.08 Favored Glycine 0 C--O 1.227 -0.33 0 CA-C-N 116.058 -0.519 . . . . 0.0 112.941 -177.9 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 20.8 t . . . . . 0 C--N 1.325 -0.488 0 CA-C-O 121.459 0.647 . . . . 0.0 109.86 179.95 . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.241 0 CA-C-O 121.387 0.613 . . . . 0.0 112.273 . . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.7 t -58.53 139.81 55.13 Favored 'General case' 0 CA--C 1.508 -0.647 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 174.902 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 22.1 m95 -64.27 -21.82 66.73 Favored 'General case' 0 C--N 1.323 -0.564 0 O-C-N 123.188 0.305 . . . . 0.0 111.323 177.855 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 51.6 m-85 -121.5 163.17 19.26 Favored 'General case' 0 C--O 1.241 0.628 0 N-CA-C 114.259 1.207 . . . . 0.0 114.259 -172.727 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 57.4 p -68.51 164.7 20.62 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 114.562 -1.199 . . . . 0.0 110.476 179.513 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.499 ' HB2' ' CZ ' ' A' ' 69' ' ' TYR . . . -80.73 137.92 36.3 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 -176.34 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -90.21 147.3 23.64 Favored 'General case' 0 CA--C 1.502 -0.883 0 N-CA-C 105.767 -1.938 . . . . 0.0 105.767 171.883 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 91.8 m -123.7 141.71 51.76 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 -178.538 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.411 ' HB2' ' CZ ' ' A' ' 131' ' ' PHE . 4.3 tp60 -111.23 136.14 50.74 Favored 'General case' 0 C--N 1.329 -0.295 0 O-C-N 123.629 0.581 . . . . 0.0 112.543 -177.783 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 46.0 t60 -133.32 99.44 4.53 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 103.813 -2.662 . . . . 0.0 103.813 169.551 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 179.12 -158.78 23.13 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.537 -0.839 . . . . 0.0 111.028 -175.204 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 35.3 mmtp -108.52 -28.09 9.52 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 113.958 1.096 . . . . 0.0 113.958 -178.225 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -90.94 167.45 12.41 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 176.231 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -81.81 -62.62 1.59 Allowed 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 -178.855 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 36.5 tp -174.39 142.79 0.8 Allowed 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 105.51 -2.033 . . . . 0.0 105.51 174.043 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 79.5 tttt -151.48 146.18 25.73 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 174.946 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -135.7 157.62 75.84 Favored Pre-proline 0 C--N 1.323 -0.562 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 176.939 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -71.78 172.82 13.73 Favored 'Trans proline' 0 CA--C 1.536 0.614 0 C-N-CA 120.718 0.945 . . . . 0.0 114.002 -179.429 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 25.3 tpt180 -78.41 130.97 36.72 Favored 'General case' 0 C--O 1.216 -0.675 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 177.798 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 81.07 7.15 88.86 Favored Glycine 0 C--O 1.225 -0.461 0 N-CA-C 115.279 0.871 . . . . 0.0 115.279 175.886 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 4.8 tt0 -158.52 146.48 18.24 Favored 'General case' 0 C--O 1.217 -0.654 0 N-CA-C 106.457 -1.682 . . . . 0.0 106.457 -177.854 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 136.65 -17.21 3.73 Favored Glycine 0 CA--C 1.503 -0.676 0 C-N-CA 120.344 -0.932 . . . . 0.0 112.556 177.7 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 33.1 m -71.27 146.52 92.25 Favored Pre-proline 0 C--N 1.321 -0.637 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 176.922 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_endo -76.1 173.49 14.39 Favored 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 121.121 1.214 . . . . 0.0 112.606 178.65 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 93.3 mt -76.09 113.06 14.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 N-CA-C 108.042 -1.095 . . . . 0.0 108.042 178.517 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 45.0 m-20 -104.67 83.91 2.09 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 -178.801 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 69.0 p -64.26 -22.2 66.86 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 115.352 1.612 . . . . 0.0 115.352 -174.422 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 11.1 p30 -106.02 18.28 22.31 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.293 -177.384 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 9.4 m -125.55 157.88 35.96 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -175.152 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -74.29 162.26 74.62 Favored Pre-proline 0 C--N 1.323 -0.56 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 178.23 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -66.11 -23.03 53.67 Favored 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 115.159 -2.76 . . . . 0.0 112.015 177.542 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.496 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 0.0 OUTLIER -72.37 -13.56 61.5 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.278 0.561 . . . . 0.0 111.128 178.824 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -104.83 1.06 28.7 Favored 'General case' 0 C--O 1.219 -0.528 0 N-CA-C 114.541 1.311 . . . . 0.0 114.541 -175.063 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 86.6 mm-40 -62.54 -21.64 65.71 Favored 'General case' 0 CA--C 1.548 0.881 0 O-C-N 120.633 -1.292 . . . . 0.0 110.749 178.193 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.506 ' HB ' ' HB1' ' A' ' 98' ' ' ALA . 14.3 tt -62.69 143.26 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 CA-C-O 121.96 0.886 . . . . 0.0 112.827 178.413 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 177.14 -153.77 14.4 Favored Glycine 0 N--CA 1.446 -0.668 0 N-CA-C 110.774 -0.93 . . . . 0.0 110.774 178.565 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 43.2 p90 -154.95 168.48 26.82 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 178.242 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 40.1 m-85 -111.31 140.96 45.45 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 106.66 -1.607 . . . . 0.0 106.66 175.186 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 34.4 ttt180 -114.59 125.73 54.1 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 123.273 0.629 . . . . 0.0 111.913 -178.203 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 27.8 ttt180 -67.5 139.0 56.99 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 176.28 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -136.72 129.75 31.01 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.058 0.456 . . . . 0.0 110.855 179.339 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 27.3 p -145.54 154.41 42.15 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 106.533 -1.654 . . . . 0.0 106.533 176.322 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 15.8 tpt180 -163.33 121.69 1.99 Allowed 'General case' 0 CA--C 1.513 -0.443 0 N-CA-C 106.561 -1.644 . . . . 0.0 106.561 173.323 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 3.3 tmt_? -132.07 144.78 50.99 Favored 'General case' 0 CA--C 1.495 -1.136 0 CA-C-O 121.448 0.642 . . . . 0.0 109.81 -176.684 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -140.92 178.25 3.14 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 N-CA-C 105.378 -2.082 . . . . 0.0 105.378 -178.378 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 6.8 tmm_? -137.25 105.74 5.8 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 175.134 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -72.38 163.22 54.67 Favored Glycine 0 N--CA 1.448 -0.503 0 N-CA-C 108.853 -1.699 . . . . 0.0 108.853 178.305 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -71.24 -32.29 65.52 Favored Glycine 0 C--O 1.214 -1.11 0 N-CA-C 108.689 -1.764 . . . . 0.0 108.689 179.331 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 30.6 t0 -89.43 17.07 6.58 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 122.4 1.095 . . . . 0.0 109.478 178.47 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 84.16 -16.2 34.8 Favored Glycine 0 N--CA 1.46 0.259 0 N-CA-C 116.228 1.251 . . . . 0.0 116.228 173.302 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -56.52 134.37 54.11 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 113.886 1.069 . . . . 0.0 113.886 -176.976 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 47.1 mtp -112.83 -168.84 1.38 Allowed 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 113.536 -1.665 . . . . 0.0 110.29 -179.978 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 15.7 mmtt -122.75 -57.94 1.7 Allowed 'General case' 0 C--O 1.217 -0.61 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -178.689 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 58.0 p30 -135.55 174.72 10.3 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.433 -0.803 . . . . 0.0 112.062 -179.076 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 80.4 mt -136.17 -66.2 0.55 Allowed 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 177.681 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 20.0 m -79.98 150.87 72.6 Favored Pre-proline 0 C--O 1.244 0.771 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.036 178.857 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -75.04 157.56 42.53 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 117.111 -1.46 . . . . 0.0 111.417 176.233 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 7.6 ptt-85 -131.64 162.5 30.24 Favored 'General case' 0 CA--C 1.51 -0.569 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 177.128 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 64.3 m95 -129.57 147.67 51.39 Favored 'General case' 0 C--N 1.318 -0.769 0 O-C-N 123.458 0.474 . . . . 0.0 110.114 -178.316 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.499 ' CZ ' ' HB2' ' A' ' 15' ' ' ALA . 72.9 m-85 -127.47 150.46 49.65 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 178.728 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 87.6 t80 -96.55 135.8 37.96 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 -179.621 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -136.07 140.75 44.02 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 121.822 0.82 . . . . 0.0 109.314 -176.949 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 78.2 m-85 -74.62 159.43 32.13 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 114.602 -1.181 . . . . 0.0 110.651 -176.624 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -57.16 135.81 56.4 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 114.088 1.144 . . . . 0.0 114.088 -176.619 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 65.54 29.17 74.56 Favored Glycine 0 C--O 1.224 -0.511 0 N-CA-C 115.869 1.108 . . . . 0.0 115.869 175.036 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 16.8 p . . . . . 0 C--N 1.324 -0.502 0 CA-C-N 118.001 0.9 . . . . 0.0 110.19 179.739 . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 52.1 mt . . . . . 0 N--CA 1.447 -0.606 0 N-CA-C 115.278 1.584 . . . . 0.0 115.278 . . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -78.58 167.65 22.35 Favored 'Trans proline' 0 C--O 1.238 0.501 0 N-CA-C 108.832 -1.257 . . . . 0.0 108.832 170.51 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 68.2 t80 -61.59 130.35 45.49 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 120.558 -0.457 . . . . 0.0 110.321 179.458 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 93.47 -5.48 74.19 Favored Glycine 0 CA--C 1.519 0.283 0 N-CA-C 115.013 0.765 . . . . 0.0 115.013 178.212 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -66.2 129.42 39.75 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 118.459 1.129 . . . . 0.0 112.381 179.977 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 54.7 t30 -75.8 128.1 34.42 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.772 -0.649 . . . . 0.0 112.104 -177.758 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 22.2 ttmt -156.23 152.98 28.45 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 106.978 -1.489 . . . . 0.0 106.978 178.116 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 22.4 t0 -64.86 133.09 51.14 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 -179.19 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 68.75 28.23 73.26 Favored Glycine 0 N--CA 1.448 -0.547 0 CA-C-O 119.557 -0.579 . . . . 0.0 114.308 178.14 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 40.2 mm -129.39 129.22 67.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 117.376 0.588 . . . . 0.0 110.17 179.418 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -131.64 117.75 36.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 CA-C-O 121.446 0.641 . . . . 0.0 110.517 176.172 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 95.9 m95 -86.26 133.07 33.85 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 112.23 0.456 . . . . 0.0 112.23 -177.269 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 1.2 m -140.87 151.12 20.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 -177.571 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -155.64 166.43 33.54 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 105.776 -1.935 . . . . 0.0 105.776 -177.908 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 11.4 t -127.18 171.29 11.56 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 105.621 -1.992 . . . . 0.0 105.621 175.21 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -64.76 136.28 56.75 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.327 0.584 . . . . 0.0 110.578 -179.544 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 94.2 -9.72 72.11 Favored Glycine 0 C--O 1.23 -0.117 0 CA-C-N 115.75 -0.659 . . . . 0.0 113.047 177.92 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.506 ' HB1' ' HB ' ' A' ' 44' ' ' ILE . . . -79.83 139.56 37.15 Favored 'General case' 0 CA--C 1.543 0.692 0 O-C-N 122.543 -0.386 . . . . 0.0 110.846 179.971 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 42.2 mt -102.03 137.67 40.01 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 114.65 1.352 . . . . 0.0 114.65 -176.437 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 50.3 t30 -81.18 75.39 8.15 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.101 -0.954 . . . . 0.0 110.252 179.29 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 2.0 t -139.24 157.55 70.74 Favored Pre-proline 0 CA--C 1.541 0.619 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 -179.373 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -64.35 145.01 87.56 Favored 'Trans proline' 0 C--N 1.348 0.512 0 N-CA-C 114.328 0.857 . . . . 0.0 114.328 -179.108 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 67.4 mmtt -126.41 33.55 4.98 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.664 0.745 . . . . 0.0 109.738 -178.11 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -51.45 -45.52 62.72 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.379 -0.828 . . . . 0.0 112.815 -177.189 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 17.8 p80 -72.93 -4.26 30.96 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 114.353 1.242 . . . . 0.0 114.353 -178.273 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 31.7 mt -96.35 -44.08 12.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 122.191 -0.318 . . . . 0.0 110.496 -179.154 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -74.06 12.11 5.62 Favored Glycine 0 CA--C 1.522 0.514 0 N-CA-C 115.205 0.842 . . . . 0.0 115.205 -178.306 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 13.4 t -83.29 19.72 1.44 Allowed 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 113.812 1.042 . . . . 0.0 113.812 -177.147 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 69.3 ttp85 -56.83 126.13 25.59 Favored 'General case' 0 N--CA 1.471 0.593 0 O-C-N 121.488 -0.757 . . . . 0.0 109.905 -179.3 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 34.4 m120 -93.56 124.21 57.82 Favored Pre-proline 0 C--N 1.322 -0.597 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 179.134 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -70.4 -17.73 34.48 Favored 'Trans proline' 0 C--O 1.219 -0.463 0 C-N-CA 117.021 -1.519 . . . . 0.0 113.15 -179.38 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -76.37 -26.86 56.08 Favored 'General case' 0 C--O 1.22 -0.454 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.247 178.021 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 84.1 m-20 -101.65 -23.69 14.22 Favored 'General case' 0 C--O 1.223 -0.33 0 N-CA-C 113.49 0.922 . . . . 0.0 113.49 -174.991 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -149.74 150.64 32.37 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 -178.373 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -88.21 149.02 24.09 Favored 'General case' 0 CA--C 1.545 0.779 0 CA-C-O 121.711 0.767 . . . . 0.0 112.559 179.639 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -72.74 149.86 43.35 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.905 178.364 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 16.7 mt -91.44 139.5 17.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 -179.26 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 93.2 t -62.73 123.79 16.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 N-CA-C 106.021 -1.844 . . . . 0.0 106.021 174.992 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 7.1 tt -66.11 131.25 45.74 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.129 0.49 . . . . 0.0 110.096 -177.215 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 28.3 mt-30 -129.31 152.17 49.16 Favored 'General case' 0 CA--C 1.508 -0.666 0 N-CA-C 106.227 -1.768 . . . . 0.0 106.227 179.838 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 14.3 mt -111.5 148.52 39.01 Favored Pre-proline 0 C--N 1.32 -0.682 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 178.891 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -71.07 165.61 31.82 Favored 'Trans proline' 0 C--N 1.345 0.38 0 O-C-N 122.231 0.595 . . . . 0.0 112.886 -178.546 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 59.5 tt0 -54.65 130.71 41.28 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.504 -177.8 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 94.12 -16.74 60.3 Favored Glycine 0 C--O 1.228 -0.276 0 CA-C-N 115.901 -0.591 . . . . 0.0 113.093 -179.4 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 10.5 m -102.64 129.51 49.25 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 117.652 0.726 . . . . 0.0 109.765 179.366 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 2.7 p -127.39 148.33 50.27 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.671 -177.788 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 72.9 mt -68.76 154.14 95.1 Favored Pre-proline 0 C--N 1.327 -0.378 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 177.719 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -74.92 170.7 19.81 Favored 'Trans proline' 0 C--O 1.233 0.256 0 C-N-CA 117.724 -1.051 . . . . 0.0 110.681 178.674 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 1.3 tptm -60.78 130.59 47.26 Favored 'General case' 0 C--N 1.324 -0.543 0 O-C-N 122.085 -0.384 . . . . 0.0 111.32 -176.13 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 95.19 -2.63 65.9 Favored Glycine 0 CA--C 1.518 0.225 0 N-CA-C 115.111 0.804 . . . . 0.0 115.111 178.256 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.411 ' CZ ' ' HB2' ' A' ' 18' ' ' GLN . 1.2 m-85 -102.37 144.31 31.02 Favored 'General case' 0 N--CA 1.441 -0.903 0 CA-C-O 122.106 0.955 . . . . 0.0 111.23 -179.964 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 47.6 p90 -146.32 163.33 35.88 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 114.022 -1.444 . . . . 0.0 108.305 174.492 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -111.35 146.44 37.08 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.775 0.322 . . . . 0.0 111.158 -177.429 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -73.29 138.12 45.27 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 178.837 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 84.75 -4.23 85.28 Favored Glycine 0 C--O 1.228 -0.28 0 CA-C-N 116.217 -0.447 . . . . 0.0 112.121 -176.787 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 7.5 t . . . . . 0 C--O 1.238 0.452 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 179.816 . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.288 0 CA-C-O 121.171 0.51 . . . . 0.0 110.26 . . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 43.1 t -55.63 137.12 49.84 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 177.173 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 7.9 m95 -66.14 -21.93 66.36 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 178.798 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 44.2 m-85 -121.48 163.04 19.46 Favored 'General case' 0 CA--C 1.509 -0.598 0 N-CA-C 113.261 0.837 . . . . 0.0 113.261 -171.023 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 73.6 p -72.28 164.28 26.54 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.079 -0.964 . . . . 0.0 109.175 178.765 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -82.81 131.33 35.2 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 112.715 0.635 . . . . 0.0 112.715 -176.039 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 17.1 mt -72.06 148.04 46.19 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 174.134 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 6.2 m -117.58 140.3 49.82 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 -179.406 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 3.8 tp60 -109.72 128.18 55.1 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 123.557 0.536 . . . . 0.0 111.088 179.112 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 41.5 t60 -116.61 99.51 7.19 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 103.615 -2.735 . . . . 0.0 103.615 171.043 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 160.37 -159.2 30.62 Favored Glycine 0 N--CA 1.45 -0.391 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 -175.643 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 69.1 mttm -118.77 -23.43 7.01 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 114.106 1.15 . . . . 0.0 114.106 -178.304 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -74.35 159.75 31.97 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.763 -177.991 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -71.66 -62.95 1.23 Allowed 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 112.976 0.732 . . . . 0.0 112.976 -177.815 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 40.8 tp 153.73 143.43 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.306 0 N-CA-C 103.759 -2.682 . . . . 0.0 103.759 -176.183 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 50.0 tptt -156.44 141.02 16.87 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 175.477 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -125.38 149.91 65.9 Favored Pre-proline 0 C--O 1.241 0.634 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 175.908 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -71.75 161.3 45.56 Favored 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 120.651 0.901 . . . . 0.0 112.793 178.664 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 40.0 tpt85 -66.73 133.29 49.87 Favored 'General case' 0 C--O 1.216 -0.695 0 O-C-N 122.059 -0.401 . . . . 0.0 109.964 -178.437 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 86.02 7.0 81.35 Favored Glycine 0 C--O 1.223 -0.566 0 N-CA-C 111.66 -0.576 . . . . 0.0 111.66 178.839 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 15.5 mt-30 -146.42 170.57 16.56 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 -175.031 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 103.63 -15.08 53.36 Favored Glycine 0 CA--C 1.501 -0.84 0 CA-C-N 116.122 -0.49 . . . . 0.0 113.434 174.78 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.417 HG11 ' HB3' ' A' ' 43' ' ' GLN . 92.4 t -67.61 128.92 93.6 Favored Pre-proline 0 C--N 1.317 -0.81 0 N-CA-C 106.241 -1.763 . . . . 0.0 106.241 176.726 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -72.87 170.69 19.07 Favored 'Trans proline' 0 N--CA 1.459 -0.502 0 O-C-N 122.26 0.611 . . . . 0.0 111.214 178.22 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 90.6 mt -70.73 107.31 2.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-O 122.075 0.94 . . . . 0.0 108.715 -179.345 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 71.3 m-20 -101.46 84.98 2.69 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 114.357 -1.292 . . . . 0.0 109.417 -177.299 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 72.6 p -68.5 -15.03 63.4 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.722 0.772 . . . . 0.0 112.527 -178.704 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 21.0 p30 -106.0 21.96 16.44 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 114.845 -1.071 . . . . 0.0 112.062 -177.22 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 50.5 m -139.51 150.05 44.67 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 113.577 0.954 . . . . 0.0 113.577 -176.044 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 2.5 m -71.65 166.61 38.08 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.448 176.675 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -66.22 -25.9 49.81 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 114.811 -2.993 . . . . 0.0 114.159 -179.775 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.471 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 3.4 p-10 -78.06 -21.01 51.25 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.551 0.691 . . . . 0.0 110.922 177.194 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 62.0 m-20 -81.35 -8.29 59.71 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 113.214 0.82 . . . . 0.0 113.214 -175.34 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.417 ' HB3' HG11 ' A' ' 32' ' ' VAL . 97.1 mm-40 -57.83 -25.95 61.35 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 114.495 1.295 . . . . 0.0 114.495 -178.876 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.438 ' HB ' ' HB1' ' A' ' 98' ' ' ALA . 9.6 tt -58.38 138.92 18.75 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.971 0 CA-C-O 122.179 0.99 . . . . 0.0 113.638 -178.676 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 179.04 -159.67 24.69 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.411 -179.36 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 43.5 p90 -155.05 170.79 20.96 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 178.958 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 14.5 m-85 -113.1 140.07 48.19 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 173.764 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -110.26 121.66 45.82 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 123.938 0.895 . . . . 0.0 110.436 -178.579 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 40.2 ttp180 -70.84 130.84 42.72 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 174.535 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -142.5 146.6 34.88 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.177 0.513 . . . . 0.0 111.605 -178.737 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 10.2 t -155.4 162.47 40.78 Favored 'General case' 0 C--O 1.245 0.84 0 N-CA-C 104.021 -2.585 . . . . 0.0 104.021 174.186 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 10.1 tpp85 -169.68 139.7 2.04 Favored 'General case' 0 C--O 1.215 -0.733 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 -179.423 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 7.0 ttm180 -121.21 131.15 54.06 Favored 'General case' 0 CA--C 1.497 -1.068 0 N-CA-C 106.39 -1.707 . . . . 0.0 106.39 172.635 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -140.62 178.05 3.46 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 CA-C-N 114.684 -1.144 . . . . 0.0 107.961 -175.396 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.66 99.4 5.97 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 104.813 -2.291 . . . . 0.0 104.813 171.801 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -69.91 161.48 52.95 Favored Glycine 0 C--O 1.227 -0.319 0 N-CA-C 108.755 -1.738 . . . . 0.0 108.755 179.416 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -58.26 -41.41 94.91 Favored Glycine 0 C--O 1.223 -0.592 0 CA-C-N 118.036 0.918 . . . . 0.0 113.566 -178.039 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 32.2 t0 -89.12 15.67 8.41 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-O 122.343 1.068 . . . . 0.0 111.759 -179.584 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 87.45 9.11 73.05 Favored Glycine 0 C--O 1.221 -0.66 0 CA-C-N 115.326 -0.852 . . . . 0.0 113.191 172.865 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 21.8 mmtt -79.6 139.7 37.38 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.184 0.516 . . . . 0.0 109.697 -175.56 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 84.2 mtp -114.75 -167.36 1.21 Allowed 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.794 -177.91 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 57.3 mmtt -144.27 -73.76 0.26 Allowed 'General case' 0 C--O 1.213 -0.819 0 C-N-CA 123.14 0.576 . . . . 0.0 109.476 -177.806 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 30.74 -121.65 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.64 0 O-C-N 125.18 1.55 . . . . 0.0 114.606 179.102 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 59.47 -168.45 0.15 Allowed 'General case' 0 C--N 1.318 -0.766 0 O-C-N 124.772 1.295 . . . . 0.0 112.371 -179.487 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 18.9 m -62.09 153.73 72.77 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.744 179.411 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -65.74 148.57 86.89 Favored 'Trans proline' 0 C--O 1.237 0.447 0 C-N-CA 115.845 -2.303 . . . . 0.0 111.733 178.709 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 31.8 mtp180 -118.61 158.13 26.05 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 -177.653 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 64.2 m95 -120.13 129.58 54.22 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 120.852 0.358 . . . . 0.0 110.436 -179.054 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 24.1 m-85 -110.35 142.21 42.32 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 -178.778 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 85.4 t80 -94.22 136.76 34.16 Favored 'General case' 0 CA--C 1.511 -0.536 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 -178.182 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -139.63 146.56 39.9 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 -177.056 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -81.58 159.51 24.06 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.135 -175.703 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -54.59 131.53 43.22 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.921 0.391 . . . . 0.0 111.786 -179.277 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 71.38 33.71 64.21 Favored Glycine 0 C--O 1.222 -0.618 0 N-CA-C 115.583 0.993 . . . . 0.0 115.583 176.375 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 4.2 p . . . . . 0 C--N 1.326 -0.426 0 CA-C-N 118.135 0.967 . . . . 0.0 110.384 178.64 . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 13.7 mt . . . . . 0 N--CA 1.441 -0.886 0 N-CA-C 114.136 1.162 . . . . 0.0 114.136 . . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -78.63 161.52 27.82 Favored 'Trans proline' 0 N--CA 1.461 -0.398 0 N-CA-C 107.444 -1.791 . . . . 0.0 107.444 167.956 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 58.2 t80 -60.21 132.55 54.28 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 120.187 -0.605 . . . . 0.0 110.226 -178.313 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 91.84 -8.52 78.19 Favored Glycine 0 N--CA 1.452 -0.27 0 CA-C-O 119.193 -0.782 . . . . 0.0 114.712 178.873 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -66.03 129.63 40.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 118.788 1.294 . . . . 0.0 111.171 179.889 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 46.7 t-20 -79.32 128.72 33.69 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.421 -178.542 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 30.5 ttmt -156.18 153.19 28.85 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 107.483 -1.302 . . . . 0.0 107.483 -178.699 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -59.58 125.12 22.38 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.853 0.359 . . . . 0.0 111.807 -178.561 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 68.2 31.39 74.58 Favored Glycine 0 N--CA 1.448 -0.551 0 CA-C-O 119.286 -0.73 . . . . 0.0 113.9 178.262 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 43.4 mm -126.53 128.09 70.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 117.535 0.668 . . . . 0.0 109.954 178.442 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.1 pt -132.75 116.26 26.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 121.53 0.681 . . . . 0.0 110.599 176.555 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 94.8 m95 -82.94 138.45 33.82 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 112.216 0.45 . . . . 0.0 112.216 -177.86 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 16.0 m -137.69 150.91 25.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 178.816 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -160.3 165.33 31.54 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 103.523 -2.769 . . . . 0.0 103.523 179.837 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 14.8 t -125.07 175.82 7.1 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 104.941 -2.244 . . . . 0.0 104.941 178.114 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 -67.52 134.85 52.06 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 -179.826 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 91.49 -8.46 78.88 Favored Glycine 0 C--O 1.228 -0.244 0 CA-C-N 116.123 -0.49 . . . . 0.0 113.536 179.156 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.471 ' HA ' ' HA ' ' A' ' 41' ' ' ASP . . . -71.99 131.9 43.56 Favored 'General case' 0 CA--C 1.542 0.666 0 O-C-N 122.393 -0.475 . . . . 0.0 110.345 179.403 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 23.4 mt -88.91 138.89 31.0 Favored 'General case' 0 CA--C 1.51 -0.569 0 N-CA-C 112.995 0.739 . . . . 0.0 112.995 -177.433 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 56.9 t30 -83.94 72.11 10.45 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.353 -0.839 . . . . 0.0 111.046 179.475 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 2.3 t -143.4 155.38 60.94 Favored Pre-proline 0 C--N 1.324 -0.503 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 178.754 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_exo -67.61 153.25 76.74 Favored 'Trans proline' 0 CA--C 1.514 -0.495 0 CA-C-N 118.454 0.483 . . . . 0.0 113.183 179.175 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -152.02 52.73 0.8 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.928 0.871 . . . . 0.0 111.144 176.59 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -57.55 -26.54 61.57 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 114.918 -1.037 . . . . 0.0 109.972 175.194 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 9.6 p80 -57.18 -12.59 2.35 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 114.643 1.349 . . . . 0.0 114.643 179.198 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 64.2 mt -92.72 -45.19 14.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 178.372 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -70.59 14.72 1.32 Allowed Glycine 0 C--O 1.211 -1.298 0 N-CA-C 117.205 1.642 . . . . 0.0 117.205 -175.414 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 30.8 p -83.04 3.79 28.84 Favored 'General case' 0 CA--C 1.506 -0.718 0 C-N-CA 124.015 0.926 . . . . 0.0 113.249 -174.08 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 67.0 ttp85 -44.36 121.0 2.38 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 114.056 -1.429 . . . . 0.0 110.666 179.655 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 36.5 m120 -90.02 126.09 58.39 Favored Pre-proline 0 C--N 1.322 -0.624 0 N-CA-C 107.675 -1.232 . . . . 0.0 107.675 -179.579 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -69.89 -18.27 36.5 Favored 'Trans proline' 0 C--O 1.219 -0.473 0 C-N-CA 117.015 -1.524 . . . . 0.0 113.045 179.273 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -75.74 -27.95 58.32 Favored 'General case' 0 C--O 1.219 -0.536 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.308 178.125 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 -101.88 -23.96 14.09 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 113.283 0.846 . . . . 0.0 113.283 -175.244 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 18.6 t-20 -150.63 148.63 28.86 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.941 0.719 . . . . 0.0 112.941 -178.201 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -87.86 147.33 25.16 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-O 121.521 0.677 . . . . 0.0 111.32 179.419 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -70.02 145.05 52.04 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.554 178.576 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 13.7 mt -83.18 139.06 18.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 -178.744 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 1.4 p -62.05 126.08 19.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 175.721 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 5.7 tt -65.91 128.57 36.56 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.156 0.503 . . . . 0.0 110.3 -176.748 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -132.33 157.55 44.17 Favored 'General case' 0 CA--C 1.509 -0.633 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 -178.73 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.429 HD13 HG22 ' A' ' 125' ' ' THR . 13.7 mt -113.58 148.76 40.42 Favored Pre-proline 0 C--N 1.322 -0.622 0 N-CA-C 108.091 -1.078 . . . . 0.0 108.091 177.059 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -73.43 165.52 32.28 Favored 'Trans proline' 0 N--CA 1.463 -0.314 0 O-C-N 122.227 0.593 . . . . 0.0 112.867 -178.846 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 40.6 tt0 -54.69 130.35 40.15 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.655 -179.682 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 101.38 -22.45 38.91 Favored Glycine 0 C--O 1.224 -0.509 0 CA-C-N 116.043 -0.526 . . . . 0.0 112.838 -179.056 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.429 HG22 HD13 ' A' ' 121' ' ' LEU . 9.8 m -108.63 127.26 53.81 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 117.795 0.798 . . . . 0.0 109.456 178.167 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 16.5 p -119.69 148.33 43.51 Favored 'General case' 0 CA--C 1.51 -0.575 0 CA-C-O 121.035 0.445 . . . . 0.0 110.837 -179.398 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 91.8 mt -69.07 152.29 96.82 Favored Pre-proline 0 C--N 1.324 -0.529 0 N-CA-C 107.108 -1.441 . . . . 0.0 107.108 177.678 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -77.67 174.08 13.17 Favored 'Trans proline' 0 N--CA 1.462 -0.37 0 CA-C-O 121.425 0.51 . . . . 0.0 111.782 179.834 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -56.19 129.25 39.37 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.23 -178.487 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 91.65 -4.92 79.78 Favored Glycine 0 C--O 1.226 -0.353 0 N-CA-C 115.601 1.001 . . . . 0.0 115.601 177.063 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -102.39 136.75 41.66 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 117.937 0.868 . . . . 0.0 112.465 -178.068 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 41.5 p90 -143.46 163.14 33.94 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 114.213 -1.358 . . . . 0.0 108.269 174.895 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -103.82 138.0 41.04 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 -176.351 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -66.28 141.83 57.88 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.237 -0.892 . . . . 0.0 108.976 176.288 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 94.81 -32.79 5.79 Favored Glycine 0 N--CA 1.458 0.142 0 C-N-CA 121.604 -0.331 . . . . 0.0 113.366 179.756 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 32.7 t . . . . . 0 C--N 1.325 -0.494 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 177.249 . . . . . . . . 0 0 . 1 . 031 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 0.344 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 . . . . . . . . . 0 0 . 1 . 031 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.431 ' HB3' ' CE1' ' A' ' 71' ' ' TYR . 11.6 p -60.22 139.22 57.7 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.389 178.568 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 12' ' ' TRP . . . . . 0.412 ' CD2' ' HD3' ' A' ' 109' ' ' ARG . 47.5 m95 -71.3 -21.93 62.01 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 114.95 1.463 . . . . 0.0 114.95 -178.762 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -121.49 162.07 21.16 Favored 'General case' 0 C--O 1.24 0.562 0 N-CA-C 113.734 1.013 . . . . 0.0 113.734 -173.329 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 77.8 p -68.68 163.39 23.97 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 114.548 -1.206 . . . . 0.0 109.849 179.418 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.401 ' HB2' ' CZ ' ' A' ' 69' ' ' TYR . . . -86.08 145.57 26.99 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 113.486 0.921 . . . . 0.0 113.486 -175.722 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -94.67 137.77 33.35 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 108.245 -1.021 . . . . 0.0 108.245 173.731 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 62.4 m -87.56 129.28 35.15 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 -179.924 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 16.6 tm0? -91.07 128.32 36.85 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 177.98 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 58.7 t60 -139.25 99.53 3.77 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 172.11 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 173.0 -170.91 44.06 Favored Glycine 0 C--O 1.229 -0.213 0 C-N-CA 120.496 -0.859 . . . . 0.0 111.445 179.511 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -97.66 -25.64 15.04 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 120.686 0.279 . . . . 0.0 110.529 178.631 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -96.5 163.23 13.13 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 105.594 -2.002 . . . . 0.0 105.594 174.631 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -88.62 -62.89 1.39 Allowed 'General case' 0 C--O 1.216 -0.691 0 N-CA-C 115.187 1.551 . . . . 0.0 115.187 -173.926 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 53.4 tp -176.87 142.93 0.41 Allowed 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 178.11 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 23.5 tptm -157.49 141.02 15.65 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 174.226 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 13.7 m-85 -123.92 152.49 66.5 Favored Pre-proline 0 C--O 1.24 0.595 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 175.53 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -70.41 159.09 54.1 Favored 'Trans proline' 0 CA--C 1.538 0.71 0 C-N-CA 120.449 0.766 . . . . 0.0 112.331 177.427 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 15.8 tpt180 -69.27 137.29 52.95 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 -178.377 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 83.85 8.64 84.02 Favored Glycine 0 C--O 1.222 -0.614 0 N-CA-C 111.345 -0.702 . . . . 0.0 111.345 179.082 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 6.6 mt-30 -150.92 170.95 18.06 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 -173.886 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 102.94 -16.67 54.08 Favored Glycine 0 CA--C 1.499 -0.928 0 CA-C-N 116.219 -0.446 . . . . 0.0 112.031 175.756 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 77.9 t -66.07 128.68 93.98 Favored Pre-proline 0 C--N 1.319 -0.759 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 177.144 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -73.46 170.11 20.7 Favored 'Trans proline' 0 N--CA 1.461 -0.435 0 O-C-N 122.201 0.579 . . . . 0.0 112.373 178.404 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 78.5 mt -73.01 112.38 9.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 -179.851 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 48.9 m-20 -109.89 77.29 1.04 Allowed 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 114.622 -1.172 . . . . 0.0 109.406 -177.189 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 71.5 p -65.11 -20.96 66.72 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 115.586 1.698 . . . . 0.0 115.586 -173.658 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -113.64 31.05 6.78 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.976 -176.175 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 78.0 p -134.42 166.57 22.55 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.011 0.434 . . . . 0.0 110.839 179.63 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 28.1 m -81.58 160.32 64.72 Favored Pre-proline 0 C--N 1.322 -0.612 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.75 -179.219 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -67.81 -24.23 40.69 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 116.453 -1.898 . . . . 0.0 114.033 -179.461 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.402 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 8.4 p-10 -75.52 -12.62 60.26 Favored 'General case' 0 C--N 1.322 -0.592 0 O-C-N 121.562 -0.711 . . . . 0.0 111.264 177.241 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 27.3 t0 -94.84 1.05 55.32 Favored 'General case' 0 C--O 1.214 -0.798 0 N-CA-C 113.328 0.862 . . . . 0.0 113.328 -177.371 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 93.1 mm-40 -62.34 -20.2 64.12 Favored 'General case' 0 CA--C 1.548 0.89 0 O-C-N 121.074 -1.016 . . . . 0.0 111.711 178.965 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.456 ' HB ' ' HB1' ' A' ' 98' ' ' ALA . 17.5 tt -63.98 140.46 19.65 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-O 122.118 0.961 . . . . 0.0 112.293 177.701 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 178.49 -161.17 27.62 Favored Glycine 0 CA--C 1.502 -0.737 0 C-N-CA 119.794 -1.193 . . . . 0.0 112.781 178.328 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.4 ' HB3' ' CE3' ' A' ' 92' ' ' TRP . 46.1 p90 -155.24 165.68 35.92 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 178.642 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 19.0 m-85 -106.87 139.68 40.9 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 106.771 -1.566 . . . . 0.0 106.771 175.986 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 42.5 ttt180 -113.47 118.23 33.93 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.08 -174.869 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 26.3 ttt180 -66.47 137.72 57.03 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 176.655 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -137.3 125.65 23.32 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.733 0.777 . . . . 0.0 111.465 179.923 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 37.7 p -136.74 154.28 50.63 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 106.079 -1.823 . . . . 0.0 106.079 177.128 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 65.1 ttt180 -159.73 124.04 3.85 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 121.06 -0.256 . . . . 0.0 110.486 177.399 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.35 144.33 51.32 Favored 'General case' 0 CA--C 1.484 -1.581 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 175.647 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -142.47 175.23 4.77 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.132 0 N-CA-C 105.854 -1.906 . . . . 0.0 105.854 179.023 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 78.0 ttt180 -119.67 128.89 54.25 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 102.466 -3.161 . . . . 0.0 102.466 171.14 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -80.89 -176.8 51.03 Favored Glycine 0 C--O 1.221 -0.667 0 N-CA-C 110.796 -0.922 . . . . 0.0 110.796 -179.784 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -78.75 -34.29 35.21 Favored Glycine 0 C--O 1.216 -1.005 0 N-CA-C 107.886 -2.086 . . . . 0.0 107.886 179.385 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -71.38 -20.69 62.11 Favored 'General case' 0 C--O 1.217 -0.655 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 175.184 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 108.43 -15.52 35.42 Favored Glycine 0 CA--C 1.503 -0.696 0 N-CA-C 110.351 -1.1 . . . . 0.0 110.351 172.593 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.8 144.57 57.16 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-O 122.394 1.092 . . . . 0.0 112.294 -177.96 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 5.4 mtp -87.8 175.08 8.0 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 114.01 -1.45 . . . . 0.0 112.57 -177.184 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 1.6 tmtm? -78.4 -46.04 20.87 Favored 'General case' 0 C--O 1.217 -0.642 0 CA-C-O 121.949 0.881 . . . . 0.0 109.797 176.915 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.2 t0 47.39 24.85 0.51 Allowed 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 119.054 2.983 . . . . 0.0 119.054 178.573 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.6 mp -83.45 149.01 26.93 Favored 'General case' 0 C--O 1.239 0.528 0 O-C-N 121.397 -0.814 . . . . 0.0 111.752 178.543 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -66.71 158.42 79.65 Favored Pre-proline 0 C--O 1.243 0.738 0 CA-C-N 115.395 -0.82 . . . . 0.0 111.909 178.834 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -71.44 147.21 51.87 Favored 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 118.126 -0.782 . . . . 0.0 112.582 177.585 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 1.2 mtt180 -134.14 165.81 24.22 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.998 176.228 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 62.5 m95 -121.89 135.03 54.86 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 176.328 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.401 ' CZ ' ' HB2' ' A' ' 15' ' ' ALA . 68.6 m-85 -112.83 171.77 7.33 Favored 'General case' 0 C--O 1.215 -0.738 0 N-CA-C 105.891 -1.892 . . . . 0.0 105.891 178.142 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -118.4 139.47 51.34 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 178.673 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.431 ' CE1' ' HB3' ' A' ' 11' ' ' SER . 14.2 m-85 -139.06 139.33 37.74 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 -176.545 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 45.3 m-85 -68.67 159.51 32.0 Favored 'General case' 0 C--O 1.24 0.585 0 N-CA-C 110.013 -0.366 . . . . 0.0 110.013 177.14 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 19.7 tp -53.4 130.56 35.74 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 121.18 0.514 . . . . 0.0 112.229 -178.515 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 67.49 28.41 73.6 Favored Glycine 0 C--O 1.223 -0.573 0 N-CA-C 116.269 1.268 . . . . 0.0 116.269 174.636 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 16.2 p . . . . . 0 C--N 1.324 -0.528 0 CA-C-N 118.262 1.031 . . . . 0.0 110.409 177.927 . . . . . . . . 0 0 . 1 . 031 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 18.1 mt . . . . . 0 N--CA 1.448 -0.543 0 N-CA-C 115.939 1.829 . . . . 0.0 115.939 . . . . . . . . . 0 0 . 1 . 031 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -78.76 164.01 25.87 Favored 'Trans proline' 0 N--CA 1.462 -0.344 0 C-N-CA 122.42 2.08 . . . . 0.0 108.176 168.274 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 56.2 t80 -62.08 132.29 52.38 Favored 'General case' 0 C--N 1.321 -0.642 0 O-C-N 121.947 -0.471 . . . . 0.0 110.627 -177.698 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 90.4 -6.17 82.43 Favored Glycine 0 C--O 1.227 -0.29 0 N-CA-C 114.528 0.571 . . . . 0.0 114.528 179.131 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -65.15 132.04 48.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 118.242 1.021 . . . . 0.0 111.821 179.677 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 50.5 t30 -78.68 127.31 31.92 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.523 179.403 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 28.2 ttmt -156.19 152.14 27.48 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 106.266 -1.753 . . . . 0.0 106.266 178.578 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 19.1 t0 -64.55 131.83 48.14 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 -179.249 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 69.66 28.84 71.71 Favored Glycine 0 N--CA 1.446 -0.655 0 N-CA-C 114.958 0.743 . . . . 0.0 114.958 177.116 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 42.7 mm -127.89 128.15 68.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 117.401 0.6 . . . . 0.0 109.985 179.044 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.1 pt -131.58 123.62 52.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.351 176.98 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 92' ' ' TRP . . . . . 0.4 ' CE3' ' HB3' ' A' ' 46' ' ' TYR . 97.8 m95 -88.39 135.57 33.4 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 114.149 1.166 . . . . 0.0 114.149 -175.304 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 17.8 m -136.16 152.03 29.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 178.778 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -163.97 166.6 21.44 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 103.514 -2.773 . . . . 0.0 103.514 -179.969 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 13.3 t -134.53 174.72 10.24 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 104.78 -2.304 . . . . 0.0 104.78 177.675 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 78.2 tt0 -66.71 135.21 53.67 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.185 0.516 . . . . 0.0 109.999 -178.955 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 95.75 -9.72 68.56 Favored Glycine 0 C--O 1.228 -0.234 0 CA-C-N 115.93 -0.577 . . . . 0.0 113.623 178.635 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.456 ' HB1' ' HB ' ' A' ' 44' ' ' ILE . . . -76.78 137.95 39.6 Favored 'General case' 0 CA--C 1.54 0.571 0 O-C-N 122.323 -0.516 . . . . 0.0 109.859 179.457 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 32.3 mt -92.56 140.29 29.7 Favored 'General case' 0 C--O 1.22 -0.471 0 CA-C-O 121.555 0.693 . . . . 0.0 112.324 -178.236 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 61.3 t30 -85.04 66.59 9.83 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.498 -0.773 . . . . 0.0 110.518 -179.037 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -136.37 152.84 75.73 Favored Pre-proline 0 C--N 1.324 -0.502 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 -179.527 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -68.45 150.87 75.94 Favored 'Trans proline' 0 C--N 1.344 0.326 0 N-CA-C 115.249 1.211 . . . . 0.0 115.249 178.779 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.492 ' HB3' HD12 ' A' ' 106' ' ' ILE . 67.5 mmtt -127.12 31.61 5.22 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.189 -0.914 . . . . 0.0 113.32 -176.339 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 18.1 t0 -60.98 -27.56 68.37 Favored 'General case' 0 N--CA 1.475 0.789 0 O-C-N 121.287 -0.883 . . . . 0.0 111.616 -178.135 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 47.2 p-80 -67.95 -16.78 64.22 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.806 177.853 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.492 HD12 ' HB3' ' A' ' 103' ' ' LYS . 66.3 mt -94.25 -38.56 9.45 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 176.078 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -72.96 6.73 11.72 Favored Glycine 0 C--O 1.225 -0.429 0 N-CA-C 115.668 1.027 . . . . 0.0 115.668 -178.214 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 14.5 t -83.05 25.44 0.69 Allowed 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 117.785 0.792 . . . . 0.0 111.684 -178.862 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.413 ' HD2' ' OD1' ' A' ' 114' ' ' ASN . 65.3 ttp85 -57.45 131.82 51.29 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.949 -179.42 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 55.1 m-20 -99.65 115.1 65.89 Favored Pre-proline 0 C--N 1.326 -0.423 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 178.804 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -72.8 -12.54 26.47 Favored 'Trans proline' 0 C--O 1.218 -0.518 0 N-CA-C 114.089 0.765 . . . . 0.0 114.089 -177.352 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -74.87 -24.56 58.58 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 176.042 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 -102.19 -30.78 10.92 Favored 'General case' 0 C--O 1.222 -0.344 0 N-CA-C 113.012 0.745 . . . . 0.0 113.012 -176.036 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 114' ' ' ASN . . . . . 0.413 ' OD1' ' HD2' ' A' ' 109' ' ' ARG . 0.9 OUTLIER -132.07 150.26 52.2 Favored 'General case' 0 N--CA 1.44 -0.937 0 CA-C-O 121.279 0.561 . . . . 0.0 112.265 -177.186 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -100.65 138.4 37.75 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 175.701 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -66.33 150.01 49.51 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.303 0.573 . . . . 0.0 111.722 -179.191 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 3.1 mt -87.96 141.48 14.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.669 -177.323 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 1.3 p -62.22 125.92 19.47 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 176.211 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 7.0 tt -70.07 129.62 39.92 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.25 -178.055 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 25.6 mt-30 -131.71 159.49 38.25 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 106.47 -1.678 . . . . 0.0 106.47 179.378 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 14.2 mt -114.37 146.09 35.12 Favored Pre-proline 0 C--N 1.323 -0.561 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 177.98 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -74.63 172.07 16.94 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 120.228 0.619 . . . . 0.0 113.678 -178.547 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 6.0 tp-100 -53.65 137.07 38.13 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.753 179.42 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 89.82 -20.71 34.04 Favored Glycine 0 N--CA 1.453 -0.229 0 CA-C-N 115.927 -0.579 . . . . 0.0 113.733 -179.11 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 3.9 m -108.56 129.81 55.3 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 118.274 1.037 . . . . 0.0 111.143 -179.995 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 2.3 p -125.87 148.27 49.23 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 -178.951 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 91.0 mt -68.93 154.57 94.82 Favored Pre-proline 0 C--N 1.327 -0.38 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 178.357 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -75.57 170.55 20.0 Favored 'Trans proline' 0 N--CA 1.463 -0.296 0 C-N-CA 118.342 -0.639 . . . . 0.0 111.48 -179.615 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -60.2 129.16 40.34 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 179.253 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 89.73 21.34 40.34 Favored Glycine 0 C--O 1.225 -0.444 0 C-N-CA 120.904 -0.665 . . . . 0.0 114.734 178.835 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -131.15 141.76 50.14 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 117.472 0.636 . . . . 0.0 111.651 178.115 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 51.8 p90 -150.47 163.79 37.53 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 175.508 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -107.35 147.25 30.56 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 113.396 0.887 . . . . 0.0 113.396 -175.826 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -73.52 142.7 46.72 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.091 -0.959 . . . . 0.0 109.666 177.206 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 93.38 -39.56 2.93 Favored Glycine 0 CA--C 1.519 0.298 0 N-CA-C 114.169 0.428 . . . . 0.0 114.169 178.665 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.445 -0.698 0 CA-C-O 121.854 0.835 . . . . 0.0 111.425 178.514 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.849 0 CA-C-O 121.422 0.629 . . . . 0.0 109.668 . . . . . . . . . 0 0 . 1 . 032 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 61.6 p -58.14 141.53 50.05 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.213 -0.903 . . . . 0.0 109.882 179.108 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 12' ' ' TRP . . . . . 0.444 ' CD2' ' HD3' ' A' ' 109' ' ' ARG . 23.9 m95 -65.65 -26.44 67.8 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.769 178.213 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 78.0 m-85 -121.74 162.87 20.04 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.302 0.572 . . . . 0.0 112.379 -174.235 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 73.1 p -71.44 164.86 24.99 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 176.529 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -77.74 157.04 30.23 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.855 0.836 . . . . 0.0 113.219 -177.672 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 25.0 mt -92.39 148.91 21.74 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 102.919 -2.993 . . . . 0.0 102.919 168.005 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 33.2 m -121.36 128.5 52.31 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 120.897 0.379 . . . . 0.0 110.396 -178.03 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 1.9 tm0? -90.42 130.03 36.54 Favored 'General case' 0 CA--C 1.512 -0.501 0 CA-C-N 115.567 -0.742 . . . . 0.0 112.82 -177.554 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 52.9 t60 -138.76 99.9 3.92 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 106.354 -1.721 . . . . 0.0 106.354 167.217 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 159.58 -140.86 7.09 Favored Glycine 0 C--N 1.323 -0.181 0 C-N-CA 119.589 -1.291 . . . . 0.0 113.813 -176.969 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -115.71 -27.18 7.15 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 114.875 1.435 . . . . 0.0 114.875 -177.692 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -78.46 151.96 32.37 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 177.403 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -79.13 -57.55 3.67 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 179.197 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 41.9 tp 175.96 135.16 0.05 OUTLIER 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 101.254 -3.61 . . . . 0.0 101.254 171.103 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 11.2 tmtt? -154.22 133.23 12.43 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 179.448 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 21.8 m-85 -122.33 153.3 61.89 Favored Pre-proline 0 C--O 1.241 0.636 0 O-C-N 123.023 0.202 . . . . 0.0 111.44 176.726 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -74.51 159.91 42.3 Favored 'Trans proline' 0 CA--C 1.538 0.702 0 CA-C-O 120.935 0.306 . . . . 0.0 111.768 175.727 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 17.0 tpt180 -70.71 139.75 51.25 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 -178.411 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 87.05 2.11 84.0 Favored Glycine 0 C--O 1.221 -0.687 0 N-CA-C 110.707 -0.957 . . . . 0.0 110.707 179.524 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 31.2 mt-30 -146.69 -179.66 6.94 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 -174.797 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 99.36 -20.26 50.54 Favored Glycine 0 CA--C 1.498 -0.987 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.714 176.232 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 86.8 t -67.92 126.87 93.16 Favored Pre-proline 0 C--N 1.317 -0.818 0 N-CA-C 106.703 -1.592 . . . . 0.0 106.703 177.295 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -73.28 167.53 27.08 Favored 'Trans proline' 0 N--CA 1.46 -0.485 0 C-N-CA 120.111 0.541 . . . . 0.0 112.494 178.649 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 85.6 mt -67.25 111.74 2.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 122.023 0.916 . . . . 0.0 109.352 -178.869 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 26.6 m-20 -94.82 100.79 12.62 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 114.394 -1.276 . . . . 0.0 110.157 -177.973 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 80.7 p -80.52 -20.32 43.8 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 113.912 1.078 . . . . 0.0 113.912 -176.901 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -117.45 3.66 12.49 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 115.411 1.634 . . . . 0.0 115.411 -174.486 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -110.77 157.27 19.97 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 115.756 1.761 . . . . 0.0 115.756 -171.926 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 47.6 m -79.23 162.77 62.76 Favored Pre-proline 0 C--N 1.318 -0.783 0 CA-C-N 113.896 -1.502 . . . . 0.0 108.845 177.937 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -67.48 -20.66 47.56 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 116.986 -1.543 . . . . 0.0 114.878 -177.46 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.417 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 6.2 p-10 -75.21 -20.39 59.3 Favored 'General case' 0 C--N 1.321 -0.637 0 O-C-N 121.74 -0.6 . . . . 0.0 111.075 178.359 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -88.79 0.87 56.1 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 114.394 1.257 . . . . 0.0 114.394 -174.746 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 94.4 mm-40 -62.45 -29.03 70.23 Favored 'General case' 0 C--N 1.316 -0.876 0 O-C-N 121.062 -1.024 . . . . 0.0 111.526 -179.382 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 13.3 tt -64.93 139.04 22.07 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.771 0 CA-C-O 122.009 0.909 . . . . 0.0 112.112 178.419 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 176.46 -158.97 25.65 Favored Glycine 0 CA--C 1.509 -0.305 0 C-N-CA 120.401 -0.904 . . . . 0.0 111.969 -177.722 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 42.8 p90 -155.04 169.97 22.86 Favored 'General case' 0 C--N 1.32 -0.715 0 O-C-N 122.458 -0.436 . . . . 0.0 109.996 -179.788 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 10.6 m-85 -112.73 138.04 50.13 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 173.43 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.06 119.12 38.38 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 123.896 0.878 . . . . 0.0 109.733 -179.26 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 49.5 ttp180 -65.7 134.28 52.88 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 174.765 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -143.74 147.82 34.75 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.844 0.354 . . . . 0.0 110.814 -178.072 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 5.8 p -148.36 139.83 23.52 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 175.623 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 12.4 tpt180 -130.34 133.69 46.62 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 173.55 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 2.7 tpp180 -147.32 148.31 31.26 Favored 'General case' 0 CA--C 1.487 -1.463 0 CA-C-O 121.51 0.671 . . . . 0.0 110.77 -176.169 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -138.4 177.14 5.56 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.922 0 N-CA-C 103.715 -2.698 . . . . 0.0 103.715 178.9 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 48.1 ttp180 -138.77 117.09 11.92 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 177.578 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -100.48 155.8 19.43 Favored Glycine 0 C--O 1.222 -0.656 0 N-CA-C 108.146 -1.982 . . . . 0.0 108.146 177.787 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -75.27 -24.55 70.78 Favored Glycine 0 C--O 1.22 -0.731 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 178.458 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.4 p30 -83.28 -20.36 34.6 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 114.469 -0.865 . . . . 0.0 110.235 177.334 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 110.12 8.46 25.53 Favored Glycine 0 C--O 1.227 -0.307 0 N-CA-C 114.78 0.672 . . . . 0.0 114.78 173.136 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 10.6 pttt -66.01 137.23 56.97 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 122.319 1.057 . . . . 0.0 111.83 179.399 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 99.1 mmm -118.9 172.29 7.64 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 113.234 -1.803 . . . . 0.0 108.844 -178.929 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 14.2 tppt? -116.35 -66.56 1.07 Allowed 'General case' 0 C--O 1.219 -0.552 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 177.636 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -107.09 147.64 29.76 Favored 'General case' 0 CA--C 1.506 -0.722 0 N-CA-C 105.552 -2.018 . . . . 0.0 105.552 176.201 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -113.45 -47.07 3.02 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 105.657 -1.979 . . . . 0.0 105.657 175.616 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -102.38 151.82 38.23 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-N 114.867 -1.061 . . . . 0.0 110.378 179.205 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -64.07 150.73 87.74 Favored 'Trans proline' 0 C--N 1.35 0.658 0 O-C-N 122.033 0.491 . . . . 0.0 113.079 176.441 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 90.6 mtt-85 -116.7 159.21 22.59 Favored 'General case' 0 C--O 1.222 -0.394 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 178.748 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 53.7 m95 -137.33 125.38 22.86 Favored 'General case' 0 C--O 1.214 -0.765 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 174.77 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 59.9 m-85 -110.43 142.67 41.83 Favored 'General case' 0 C--O 1.216 -0.671 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 -177.08 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 81.1 t80 -93.01 135.95 33.72 Favored 'General case' 0 CA--C 1.507 -0.708 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 -176.142 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -139.01 137.72 36.58 Favored 'General case' 0 N--CA 1.441 -0.911 0 CA-C-N 114.739 -1.119 . . . . 0.0 109.195 -175.246 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 27.3 m-85 -67.74 159.39 30.27 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.71 179.065 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -50.46 122.53 7.19 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 113.743 1.016 . . . . 0.0 113.743 -177.258 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 68.53 22.13 74.88 Favored Glycine 0 C--O 1.226 -0.351 0 N-CA-C 116.193 1.237 . . . . 0.0 116.193 176.028 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 33.8 p . . . . . 0 C--N 1.325 -0.495 0 CA-C-N 118.351 1.075 . . . . 0.0 111.017 179.306 . . . . . . . . 0 0 . 1 . 032 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 16.4 mt . . . . . 0 N--CA 1.442 -0.839 0 N-CA-C 116.289 1.959 . . . . 0.0 116.289 . . . . . . . . . 0 0 . 1 . 032 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -78.46 160.81 28.67 Favored 'Trans proline' 0 C--O 1.233 0.227 0 C-N-CA 122.337 2.025 . . . . 0.0 107.417 167.949 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 60.3 t80 -60.85 132.76 54.89 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 120.291 -0.564 . . . . 0.0 110.957 -176.855 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 90.04 -6.53 82.65 Favored Glycine 0 N--CA 1.453 -0.215 0 CA-C-O 119.484 -0.62 . . . . 0.0 114.177 179.452 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -66.17 130.52 43.51 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 118.533 1.167 . . . . 0.0 111.332 179.459 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 52.5 t30 -80.86 128.54 33.79 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.332 -0.849 . . . . 0.0 109.091 179.431 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.429 ' HB3' HG13 ' A' ' 90' ' ' ILE . 27.7 ttmt -156.21 158.9 38.39 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 107.375 -1.343 . . . . 0.0 107.375 -178.921 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -54.67 122.34 10.43 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.053 0.39 . . . . 0.0 112.053 179.33 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 64.49 35.66 92.22 Favored Glycine 0 N--CA 1.448 -0.527 0 CA-C-O 119.189 -0.784 . . . . 0.0 114.376 174.436 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.429 HG13 ' HB3' ' A' ' 87' ' ' LYS . 49.4 mm -121.06 126.0 74.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 117.631 0.715 . . . . 0.0 110.939 179.225 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -126.92 117.73 48.56 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.706 176.254 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 97.5 m95 -85.38 136.3 33.52 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 -177.72 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 16.5 m -134.77 155.17 38.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 178.8 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -165.68 165.32 18.75 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 -178.373 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 12.3 t -130.42 168.32 17.18 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 104.969 -2.234 . . . . 0.0 104.969 174.107 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 76.6 tt0 -67.39 137.82 56.24 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.342 0.592 . . . . 0.0 110.88 -178.777 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 94.91 -10.58 70.21 Favored Glycine 0 C--O 1.229 -0.162 0 CA-C-N 115.662 -0.699 . . . . 0.0 113.093 177.578 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.417 ' HA ' ' HA ' ' A' ' 41' ' ' ASP . . . -78.75 118.4 20.78 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-O 120.974 0.416 . . . . 0.0 111.149 -179.938 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -68.6 133.42 48.47 Favored 'General case' 0 CA--C 1.51 -0.593 0 N-CA-C 114.101 1.148 . . . . 0.0 114.101 -177.628 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 46.9 t30 -83.26 76.23 9.9 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 113.825 -1.534 . . . . 0.0 109.062 178.776 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 1.4 t -146.44 155.36 49.61 Favored Pre-proline 0 C--N 1.322 -0.615 0 N-CA-C 106.053 -1.832 . . . . 0.0 106.053 -177.88 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -61.56 150.16 86.6 Favored 'Trans proline' 0 C--N 1.345 0.346 0 N-CA-C 115.446 1.287 . . . . 0.0 115.446 178.475 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.511 ' HB3' HD12 ' A' ' 106' ' ' ILE . 71.9 mmtt -123.29 30.47 6.3 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.748 -179.983 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 15.4 p-10 -51.34 -42.91 61.58 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.897 -0.592 . . . . 0.0 112.174 -176.914 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 15.6 p80 -68.5 -11.38 59.76 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 113.962 1.097 . . . . 0.0 113.962 -179.652 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.511 HD12 ' HB3' ' A' ' 103' ' ' LYS . 28.1 mt -95.54 -43.28 12.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 121.7 0.762 . . . . 0.0 110.488 178.826 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -72.8 4.03 24.38 Favored Glycine 0 C--O 1.221 -0.717 0 N-CA-C 116.119 1.208 . . . . 0.0 116.119 -176.543 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 13.1 t -83.38 25.78 0.71 Allowed 'General case' 0 CA--C 1.543 0.711 0 CA-C-O 121.492 0.663 . . . . 0.0 111.497 179.57 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.444 ' HD3' ' CD2' ' A' ' 12' ' ' TRP . 63.6 ttp85 -58.51 129.19 40.88 Favored 'General case' 0 CA--C 1.517 -0.319 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 -179.786 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 34.2 m120 -89.71 121.77 68.74 Favored Pre-proline 0 C--N 1.322 -0.617 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 -177.397 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -72.89 -15.22 26.5 Favored 'Trans proline' 0 C--O 1.218 -0.492 0 C-N-CA 116.789 -1.674 . . . . 0.0 112.188 178.95 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -77.03 -28.98 55.09 Favored 'General case' 0 C--O 1.221 -0.447 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.182 178.199 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 84.7 m-20 -102.69 -22.63 13.92 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 113.673 0.99 . . . . 0.0 113.673 -175.12 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -140.23 153.48 46.57 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 -177.852 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -95.55 143.73 26.61 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-O 121.264 0.554 . . . . 0.0 110.358 178.298 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -72.88 149.25 43.65 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.315 0.578 . . . . 0.0 110.9 178.893 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 8.9 mt -84.69 136.93 21.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.213 -178.817 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 78.7 t -62.27 121.97 11.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 N-CA-C 106.037 -1.838 . . . . 0.0 106.037 174.927 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 5.9 tt -67.04 130.27 42.58 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.095 0.474 . . . . 0.0 111.338 -176.145 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 31.5 mt-30 -134.48 158.56 43.62 Favored 'General case' 0 CA--C 1.513 -0.475 0 N-CA-C 106.751 -1.574 . . . . 0.0 106.751 -179.607 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 13.2 mt -112.24 147.15 36.36 Favored Pre-proline 0 C--N 1.322 -0.592 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 177.637 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -73.96 165.64 31.59 Favored 'Trans proline' 0 C--N 1.346 0.408 0 O-C-N 122.168 0.562 . . . . 0.0 113.059 -179.92 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 58.3 tp60 -53.85 130.18 36.23 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.296 -0.865 . . . . 0.0 109.453 179.381 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 103.4 -24.2 30.78 Favored Glycine 0 C--O 1.226 -0.355 0 CA-C-N 115.618 -0.719 . . . . 0.0 112.767 -179.376 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 4.7 m -103.54 129.7 50.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 118.307 1.053 . . . . 0.0 111.958 178.844 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 3.7 p -117.37 148.12 42.03 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.309 -0.859 . . . . 0.0 109.569 179.126 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 82.5 mt -70.52 157.38 90.2 Favored Pre-proline 0 C--N 1.323 -0.545 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 177.566 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -73.06 173.09 14.2 Favored 'Trans proline' 0 C--O 1.236 0.42 0 N-CA-C 110.111 -0.765 . . . . 0.0 110.111 178.395 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -68.71 122.83 19.35 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 119.704 -0.798 . . . . 0.0 111.192 -173.605 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 90.08 45.85 4.34 Favored Glycine 0 N--CA 1.452 -0.279 0 CA-C-N 115.1 -0.954 . . . . 0.0 113.877 -179.886 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -141.93 150.0 40.89 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 117.265 0.532 . . . . 0.0 111.765 179.016 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 42.3 p90 -150.69 166.11 31.36 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 175.718 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -100.63 147.03 26.43 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.031 0.443 . . . . 0.0 111.137 -178.481 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -70.51 136.8 49.67 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 179.296 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 86.52 -30.93 4.34 Favored Glycine 0 C--O 1.227 -0.295 0 CA-C-N 116.21 -0.45 . . . . 0.0 112.777 -177.699 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 19.6 t . . . . . 0 C--N 1.325 -0.486 0 O-C-N 122.117 -0.637 . . . . 0.0 110.404 -179.132 . . . . . . . . 0 0 . 1 . 033 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 0.243 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 . . . . . . . . . 0 0 . 1 . 033 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 54.2 p -59.54 144.3 47.75 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 178.876 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 24.8 m95 -65.56 -21.9 66.65 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.574 0.583 . . . . 0.0 112.574 178.809 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 12.7 m-85 -121.43 163.33 18.92 Favored 'General case' 0 CA--C 1.507 -0.673 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 -170.562 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 72.0 p -70.47 165.36 22.74 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 114.517 -1.219 . . . . 0.0 107.794 177.35 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -80.04 149.57 30.66 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.561 0.696 . . . . 0.0 112.004 -177.853 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 13.9 mt -85.83 145.07 27.37 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 102.416 -3.179 . . . . 0.0 102.416 169.362 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 65.0 m -120.46 141.28 50.33 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 -179.256 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.455 ' HB2' ' CZ ' ' A' ' 131' ' ' PHE . 4.4 tp60 -111.04 136.03 50.65 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -177.091 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 60.1 t60 -132.06 99.47 4.74 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 103.42 -2.807 . . . . 0.0 103.42 168.612 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 171.79 -167.03 40.04 Favored Glycine 0 N--CA 1.451 -0.328 0 N-CA-C 110.254 -1.138 . . . . 0.0 110.254 -175.479 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 49.8 mtpt -102.61 -27.25 12.85 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 115.126 1.528 . . . . 0.0 115.126 -177.454 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -85.71 166.28 16.26 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 -179.982 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -77.19 -62.91 1.5 Allowed 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.698 -178.708 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 29.3 tp 178.64 140.01 0.1 Allowed 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 104.864 -2.273 . . . . 0.0 104.864 175.474 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 44.0 tptt -148.18 135.31 20.3 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.064 0.459 . . . . 0.0 110.825 175.282 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -125.3 155.08 71.99 Favored Pre-proline 0 C--O 1.243 0.739 0 N-CA-C 105.594 -2.002 . . . . 0.0 105.594 174.852 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -71.58 173.13 13.0 Favored 'Trans proline' 0 C--N 1.347 0.485 0 CA-C-O 121.88 0.7 . . . . 0.0 113.652 -179.067 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 52.9 tpt85 -77.48 123.87 27.15 Favored 'General case' 0 C--O 1.217 -0.651 0 O-C-N 121.377 -0.827 . . . . 0.0 109.703 179.886 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 85.51 10.64 76.49 Favored Glycine 0 C--O 1.223 -0.569 0 CA-C-N 115.122 -0.945 . . . . 0.0 115.264 176.346 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -157.54 143.35 17.43 Favored 'General case' 0 C--O 1.219 -0.545 0 N-CA-C 106.747 -1.575 . . . . 0.0 106.747 -179.418 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 139.37 -13.32 3.25 Favored Glycine 0 CA--C 1.507 -0.428 0 C-N-CA 120.274 -0.965 . . . . 0.0 113.652 178.205 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 34.6 m -71.8 144.96 88.86 Favored Pre-proline 0 C--N 1.322 -0.616 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 177.898 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -76.92 171.62 17.66 Favored 'Trans proline' 0 N--CA 1.46 -0.441 0 C-N-CA 121.621 1.548 . . . . 0.0 113.203 179.685 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 94.8 mt -75.05 115.75 16.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 121.578 0.704 . . . . 0.0 109.369 178.893 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.413 ' HB2' HE22 ' A' ' 43' ' ' GLN . 76.8 m-20 -94.63 85.01 4.38 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 107.243 -1.391 . . . . 0.0 107.243 178.113 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 73.4 p -61.64 -21.82 64.73 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 115.971 1.841 . . . . 0.0 115.971 -173.79 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -114.25 16.31 17.98 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 113.376 0.88 . . . . 0.0 113.376 -176.556 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.4 m -132.55 172.55 12.36 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 115.94 1.83 . . . . 0.0 115.94 -174.857 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 42.0 m -82.0 159.18 66.2 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 115.218 -0.901 . . . . 0.0 112.525 -176.273 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -67.28 -19.69 49.86 Favored 'Trans proline' 0 C--N 1.351 0.675 0 C-N-CA 117.219 -1.388 . . . . 0.0 114.279 -179.548 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.411 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 0.4 OUTLIER -71.3 -24.15 62.09 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 121.746 -0.596 . . . . 0.0 110.776 177.898 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -85.11 -10.73 56.47 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 116.021 1.86 . . . . 0.0 116.021 -170.939 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.413 HE22 ' HB2' ' A' ' 35' ' ' ASN . 85.0 mm-40 -56.93 -26.59 59.75 Favored 'General case' 0 C--O 1.217 -0.631 0 N-CA-C 113.807 1.039 . . . . 0.0 113.807 -173.151 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 14.0 tt -62.12 139.42 20.88 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 CA-C-O 122.313 1.054 . . . . 0.0 112.875 178.539 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 177.68 -152.66 12.1 Favored Glycine 0 CA--C 1.505 -0.563 0 C-N-CA 120.402 -0.904 . . . . 0.0 110.994 -178.975 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 51.3 p90 -155.06 169.38 24.25 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 178.685 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 35.9 m-85 -111.34 143.4 42.19 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 106.764 -1.569 . . . . 0.0 106.764 173.983 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 71.7 ttt-85 -117.48 124.4 48.68 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 123.744 0.817 . . . . 0.0 111.595 -177.694 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 2.1 ptm180 -71.03 146.2 49.5 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.203 0.525 . . . . 0.0 110.525 179.412 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -146.24 144.86 30.15 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.419 0.628 . . . . 0.0 110.736 179.108 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 41.1 p -142.99 171.61 13.82 Favored 'General case' 0 C--O 1.249 1.034 0 N-CA-C 104.364 -2.458 . . . . 0.0 104.364 175.451 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -140.65 123.9 16.7 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 122.004 -0.435 . . . . 0.0 111.55 176.25 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 4.6 tmt_? -140.78 137.01 33.05 Favored 'General case' 0 CA--C 1.496 -1.109 0 CA-C-O 121.611 0.72 . . . . 0.0 110.562 -178.568 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -140.24 -179.38 2.0 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 N-CA-C 105.949 -1.871 . . . . 0.0 105.949 -179.453 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 6.3 ttm180 -128.94 119.25 24.02 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 175.216 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -80.72 -179.87 53.14 Favored Glycine 0 C--O 1.224 -0.476 0 N-CA-C 108.481 -1.847 . . . . 0.0 108.481 176.243 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -63.63 -46.96 90.93 Favored Glycine 0 C--O 1.219 -0.827 0 CA-C-N 118.343 1.072 . . . . 0.0 112.625 -178.463 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -75.8 -8.41 56.8 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 121.724 0.774 . . . . 0.0 110.11 178.995 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 104.43 -13.77 51.05 Favored Glycine 0 CA--C 1.51 -0.269 0 CA-C-N 115.32 -0.855 . . . . 0.0 111.501 178.875 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 12.0 pttt -56.37 136.59 53.54 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-O 122.112 0.958 . . . . 0.0 110.795 -178.877 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 15.0 ptm -132.05 165.76 23.26 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 114.375 -1.284 . . . . 0.0 114.127 -173.698 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 40.2 mttt -77.08 -60.13 2.49 Favored 'General case' 0 C--O 1.212 -0.903 0 N-CA-C 114.623 1.342 . . . . 0.0 114.623 -176.182 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 52.97 48.04 23.3 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 113.785 1.031 . . . . 0.0 113.785 178.509 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.4 mp -60.97 141.97 56.88 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.389 179.951 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 59.3 p -55.39 148.97 30.11 Favored Pre-proline 0 C--O 1.25 1.086 0 CA-C-N 115.071 -0.968 . . . . 0.0 111.753 -176.903 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -65.22 138.71 57.2 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 117.529 -1.18 . . . . 0.0 112.813 -176.979 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 5.4 ptp180 -141.38 155.78 45.88 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.425 -1.261 . . . . 0.0 108.517 -178.834 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 48.0 m95 -123.64 137.9 54.64 Favored 'General case' 0 C--N 1.318 -0.777 0 C-N-CA 122.671 0.389 . . . . 0.0 110.494 -176.16 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 29.5 m-85 -114.84 139.4 49.79 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 -179.464 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 88.5 t80 -88.49 135.94 33.24 Favored 'General case' 0 CA--C 1.505 -0.77 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 -178.825 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -139.73 139.13 36.45 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 -176.054 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 64.6 m-85 -71.21 159.47 34.59 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.351 -0.84 . . . . 0.0 112.326 -175.117 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -54.84 126.76 25.59 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.843 -179.624 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 68.61 38.21 85.88 Favored Glycine 0 C--O 1.218 -0.85 0 N-CA-C 115.482 0.953 . . . . 0.0 115.482 176.59 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.327 -0.411 0 CA-C-N 118.927 1.364 . . . . 0.0 107.985 178.058 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 17.8 mt . . . . . 0 N--CA 1.447 -0.623 0 N-CA-C 114.249 1.203 . . . . 0.0 114.249 . . . . . . . . . 0 0 . 1 . 033 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -78.86 165.16 24.7 Favored 'Trans proline' 0 C--O 1.237 0.431 0 C-N-CA 121.817 1.678 . . . . 0.0 108.414 170.239 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 61.4 t80 -61.6 131.17 49.16 Favored 'General case' 0 C--N 1.321 -0.654 0 C-N-CA 120.445 -0.502 . . . . 0.0 109.855 -179.958 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 92.45 -5.31 77.45 Favored Glycine 0 C--O 1.227 -0.315 0 N-CA-C 114.775 0.67 . . . . 0.0 114.775 178.806 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -65.57 126.76 29.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 118.412 1.106 . . . . 0.0 111.966 179.127 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 70.3 m-20 -71.97 126.79 30.64 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 114.624 -1.171 . . . . 0.0 110.335 -178.579 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 13.7 ttmm -156.12 151.35 26.62 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 178.564 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -62.55 131.05 47.8 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.274 178.931 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 68.46 27.86 73.55 Favored Glycine 0 N--CA 1.452 -0.275 0 N-CA-C 115.395 0.918 . . . . 0.0 115.395 177.809 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 39.3 mm -129.33 131.35 67.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 117.35 0.575 . . . . 0.0 110.494 -179.999 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.1 pt -131.48 114.85 26.67 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 CA-C-O 121.495 0.665 . . . . 0.0 110.774 175.643 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 95.7 m95 -82.24 135.13 35.29 Favored 'General case' 0 C--N 1.321 -0.662 0 O-C-N 121.831 -0.543 . . . . 0.0 112.227 -177.604 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -142.1 152.02 18.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.824 -0.626 . . . . 0.0 109.312 -178.525 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -155.98 166.59 33.02 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 105.646 -1.983 . . . . 0.0 105.646 -177.826 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 11.6 t -134.38 173.83 11.19 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 105.973 -1.862 . . . . 0.0 105.973 176.263 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -66.57 138.02 57.18 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.343 0.592 . . . . 0.0 110.925 -179.603 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 95.05 -14.66 64.91 Favored Glycine 0 N--CA 1.458 0.146 0 CA-C-N 115.568 -0.742 . . . . 0.0 112.836 177.652 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.411 ' HA ' ' HA ' ' A' ' 41' ' ' ASP . . . -75.06 136.08 41.2 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-O 120.738 0.304 . . . . 0.0 111.311 -179.633 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 30.2 mt -93.75 134.16 36.37 Favored 'General case' 0 CA--C 1.51 -0.58 0 N-CA-C 113.072 0.767 . . . . 0.0 113.072 -178.923 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 55.5 t30 -81.45 71.73 8.47 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 114.878 -1.055 . . . . 0.0 110.838 -178.391 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 1.3 t -142.17 154.79 64.94 Favored Pre-proline 0 C--N 1.322 -0.601 0 N-CA-C 106.129 -1.804 . . . . 0.0 106.129 179.784 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -68.78 148.71 71.88 Favored 'Trans proline' 0 CA--C 1.531 0.362 0 C-N-CA 118.347 -0.635 . . . . 0.0 113.537 176.34 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 5.8 ptpt -149.19 56.12 0.99 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 122.522 1.153 . . . . 0.0 111.169 178.384 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -57.46 -33.23 67.75 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.434 -1.257 . . . . 0.0 112.39 179.703 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 16.9 p80 -62.72 -7.66 5.3 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 115.015 1.487 . . . . 0.0 115.015 -177.862 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 44.7 mt -93.58 -39.25 10.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 177.857 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -72.81 14.65 2.57 Favored Glycine 0 C--O 1.218 -0.88 0 N-CA-C 115.612 1.005 . . . . 0.0 115.612 -178.409 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 14.3 t -99.67 27.98 5.0 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 113.322 0.86 . . . . 0.0 113.322 -176.928 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 62.4 ttp85 -51.52 133.08 30.4 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 177.477 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -90.45 117.88 68.33 Favored Pre-proline 0 C--N 1.326 -0.434 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 -179.538 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -71.45 -15.17 31.06 Favored 'Trans proline' 0 C--O 1.219 -0.462 0 C-N-CA 117.569 -1.154 . . . . 0.0 114.651 -177.086 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -81.1 -24.86 37.42 Favored 'General case' 0 C--O 1.22 -0.485 0 CA-C-O 121.052 0.453 . . . . 0.0 110.277 178.779 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 -100.89 -25.54 14.06 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 -175.02 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 19.9 t-20 -147.96 144.37 27.96 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 113.284 0.846 . . . . 0.0 113.284 -178.404 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -84.27 146.46 27.75 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.13 179.823 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -67.77 143.67 55.74 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.405 0.622 . . . . 0.0 110.434 178.587 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 20.6 mt -83.84 139.43 17.64 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 -178.807 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.48 HG11 ' HB2' ' A' ' 136' ' ' SER . 71.3 t -58.89 126.81 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 N-CA-C 106.393 -1.706 . . . . 0.0 106.393 175.252 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 7.7 tt -67.29 129.31 39.49 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 -178.933 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -130.34 156.61 44.41 Favored 'General case' 0 CA--C 1.511 -0.534 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 -178.474 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.415 HD13 HG22 ' A' ' 125' ' ' THR . 14.8 mt -113.56 147.72 38.16 Favored Pre-proline 0 C--N 1.323 -0.582 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 178.879 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -71.94 166.77 28.56 Favored 'Trans proline' 0 C--N 1.345 0.382 0 O-C-N 122.338 0.652 . . . . 0.0 113.262 -178.721 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 34.0 tt0 -54.86 129.78 38.66 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.284 -179.409 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 93.71 -13.24 67.92 Favored Glycine 0 C--O 1.226 -0.363 0 CA-C-N 115.985 -0.552 . . . . 0.0 113.552 179.976 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.415 HG22 HD13 ' A' ' 121' ' ' LEU . 23.0 m -103.92 126.69 51.23 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 117.904 0.852 . . . . 0.0 110.265 179.035 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 11.6 p -121.67 148.4 44.63 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.934 -177.227 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 77.4 mt -74.13 154.08 88.49 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.301 178.286 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -76.86 173.87 13.77 Favored 'Trans proline' 0 C--N 1.345 0.393 0 N-CA-C 110.471 -0.627 . . . . 0.0 110.471 177.103 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 4.8 tmtt? -61.04 123.28 17.19 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.785 0.661 . . . . 0.0 112.785 -174.687 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 95.23 0.8 63.06 Favored Glycine 0 C--N 1.328 0.122 0 N-CA-C 115.141 0.817 . . . . 0.0 115.141 175.201 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.455 ' CZ ' ' HB2' ' A' ' 18' ' ' GLN . 1.2 m-85 -100.87 135.33 42.48 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-O 121.777 0.799 . . . . 0.0 110.538 -179.64 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 37.8 p90 -140.46 160.5 39.86 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 114.531 -1.213 . . . . 0.0 108.762 177.469 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -96.59 139.37 32.78 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.14 0.495 . . . . 0.0 111.454 -177.292 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -70.15 135.91 49.59 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 177.966 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 93.9 -9.01 73.44 Favored Glycine 0 CA--C 1.519 0.328 0 N-CA-C 114.716 0.646 . . . . 0.0 114.716 179.601 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 136' ' ' SER . . . . . 0.48 ' HB2' HG11 ' A' ' 118' ' ' VAL . 8.4 t . . . . . 0 C--N 1.326 -0.426 0 CA-C-N 117.803 0.801 . . . . 0.0 110.781 178.44 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.163 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 . . . . . . . . . 0 0 . 1 . 034 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 31.3 t -61.36 136.92 58.21 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.448 178.368 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 12' ' ' TRP . . . . . 0.408 ' CD2' ' HD3' ' A' ' 109' ' ' ARG . 4.3 m95 -68.91 -26.26 65.01 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-O 121.24 0.543 . . . . 0.0 111.005 177.126 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -121.58 162.68 20.19 Favored 'General case' 0 CA--C 1.51 -0.592 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.385 -171.191 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 64.1 p -68.05 163.31 22.67 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 178.454 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -75.08 152.36 38.59 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.839 0.828 . . . . 0.0 113.166 -176.26 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 12.7 mt -91.35 148.68 22.15 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 102.882 -3.007 . . . . 0.0 102.882 169.458 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 25.9 m -127.76 140.36 52.1 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 -178.38 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.455 ' HB2' ' CZ ' ' A' ' 131' ' ' PHE . 4.6 tp60 -119.34 139.59 51.73 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 114.313 1.227 . . . . 0.0 114.313 -175.668 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 34.7 t60 -136.17 99.57 4.16 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 104.045 -2.576 . . . . 0.0 104.045 168.047 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 177.04 -158.56 24.35 Favored Glycine 0 C--O 1.228 -0.277 0 N-CA-C 110.801 -0.92 . . . . 0.0 110.801 -175.165 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 60.8 mttp -114.16 -22.32 10.05 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 114.16 1.17 . . . . 0.0 114.16 -178.579 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -84.76 157.38 21.04 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 107.883 -1.155 . . . . 0.0 107.883 177.785 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -76.67 -62.68 1.55 Allowed 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 -177.758 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 41.1 tp 177.23 145.14 0.1 Allowed 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 104.084 -2.561 . . . . 0.0 104.084 173.279 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 79.7 tttt -157.77 145.29 18.47 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 175.115 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 17.3 m-85 -134.53 151.21 75.65 Favored Pre-proline 0 C--N 1.323 -0.546 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 175.572 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -77.68 162.29 30.15 Favored 'Trans proline' 0 CA--C 1.538 0.716 0 O-C-N 122.02 0.484 . . . . 0.0 113.106 178.558 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 17.7 tpt180 -64.7 136.5 57.01 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.466 -178.862 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 90.26 -5.7 82.76 Favored Glycine 0 C--N 1.329 0.181 0 N-CA-C 111.397 -0.681 . . . . 0.0 111.397 178.132 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 55.0 mt-30 -138.48 -179.68 5.95 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 123.714 0.805 . . . . 0.0 109.354 -174.665 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 100.22 -27.29 21.03 Favored Glycine 0 CA--C 1.497 -1.058 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.516 176.046 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 92.3 t -65.45 126.17 90.97 Favored Pre-proline 0 N--CA 1.444 -0.772 0 N-CA-C 106.207 -1.775 . . . . 0.0 106.207 176.288 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -72.44 164.26 36.16 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 O-C-N 122.175 0.566 . . . . 0.0 111.248 178.624 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 87.3 mt -63.85 115.58 2.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-O 121.658 0.742 . . . . 0.0 109.695 -176.692 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 6.7 m-80 -95.91 108.05 20.38 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.18 -0.918 . . . . 0.0 111.914 -177.026 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 70.3 p -91.3 -12.73 34.2 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.909 0.861 . . . . 0.0 110.827 177.662 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 12.5 p30 -110.27 9.01 23.74 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 116.993 2.219 . . . . 0.0 116.993 -173.247 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 87.6 p -154.08 165.57 35.78 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 115.19 1.552 . . . . 0.0 115.19 -175.23 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 25.4 m -78.65 167.56 34.22 Favored Pre-proline 0 N--CA 1.472 0.637 0 C-N-CA 124.311 1.044 . . . . 0.0 112.624 -176.42 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -64.54 -24.69 63.13 Favored 'Trans proline' 0 C--N 1.354 0.845 0 C-N-CA 115.62 -2.453 . . . . 0.0 112.843 177.575 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -63.0 -25.93 68.62 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.506 0.67 . . . . 0.0 111.211 176.168 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -97.3 -1.45 44.64 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 115.06 1.504 . . . . 0.0 115.06 -170.877 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 94.5 mm-40 -60.74 -26.12 66.96 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 113.243 0.831 . . . . 0.0 113.243 -177.614 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.411 ' HB ' ' HB1' ' A' ' 98' ' ' ALA . 19.0 tt -58.61 137.7 20.63 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 CA-C-O 122.384 1.087 . . . . 0.0 113.683 -177.994 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 178.9 -161.01 27.05 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.473 -0.87 . . . . 0.0 113.43 -178.787 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 44.7 p90 -154.76 169.09 24.76 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 179.357 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 13.6 m-85 -112.17 139.93 47.29 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 172.369 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.14 129.78 54.15 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 179.407 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 17.6 ttm105 -73.25 132.94 43.74 Favored 'General case' 0 CA--C 1.5 -0.971 0 N-CA-C 104.873 -2.269 . . . . 0.0 104.873 175.496 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -69.86 165.93 20.52 Favored 'General case' 0 N--CA 1.426 -1.648 0 CA-C-O 122.654 1.216 . . . . 0.0 111.89 -177.14 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 77.2 p -71.11 160.63 32.54 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 113.672 -1.603 . . . . 0.0 112.826 -176.27 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 6.0 tpt180 -65.71 154.07 39.97 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 114.555 -1.202 . . . . 0.0 111.657 -177.913 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.476 ' HG3' ' H ' ' A' ' 63' ' ' ASP . 10.0 ttm180 -88.68 136.97 32.73 Favored 'General case' 0 CA--C 1.504 -0.82 0 N-CA-C 108.266 -1.012 . . . . 0.0 108.266 177.367 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -143.04 175.11 4.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 N-CA-C 105.988 -1.856 . . . . 0.0 105.988 -176.355 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 14.9 tpt180 -92.88 116.4 29.0 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 106.27 -1.752 . . . . 0.0 106.27 176.137 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -79.65 137.64 19.12 Favored Glycine 0 N--CA 1.446 -0.645 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 177.917 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -72.01 -18.93 78.08 Favored Glycine 0 C--O 1.219 -0.841 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 178.733 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -64.37 -12.01 38.41 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 124.286 1.034 . . . . 0.0 110.11 176.234 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 109.26 15.92 11.93 Favored Glycine 0 CA--C 1.5 -0.862 0 CA-C-N 115.933 -0.576 . . . . 0.0 112.663 169.521 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.4 167.89 24.91 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 116.19 1.922 . . . . 0.0 116.19 -173.353 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -84.92 156.02 21.41 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.873 179.66 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -80.51 -55.15 5.07 Favored 'General case' 0 C--O 1.216 -0.693 0 CA-C-O 121.959 0.885 . . . . 0.0 112.717 -179.953 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.476 ' H ' ' HG3' ' A' ' 53' ' ' ARG . 1.0 OUTLIER -150.06 179.28 8.2 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 114.44 -1.254 . . . . 0.0 111.403 -174.259 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 95.6 mt -112.28 -83.73 0.58 Allowed 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 175.643 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -88.85 162.8 37.3 Favored Pre-proline 0 C--N 1.323 -0.564 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 177.849 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -69.52 142.98 50.5 Favored 'Trans proline' 0 C--N 1.348 0.503 0 C-N-CA 115.708 -2.395 . . . . 0.0 112.235 176.841 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 93.5 mtt-85 -121.59 166.25 14.49 Favored 'General case' 0 CA--C 1.513 -0.455 0 N-CA-C 112.99 0.737 . . . . 0.0 112.99 179.701 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 57.9 m95 -131.94 145.83 51.73 Favored 'General case' 0 C--O 1.216 -0.672 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 175.349 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 29.8 m-85 -125.88 154.1 43.21 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 105.661 -1.977 . . . . 0.0 105.661 -178.891 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 90.8 t80 -105.9 135.96 46.39 Favored 'General case' 0 CA--C 1.508 -0.672 0 CA-C-N 119.006 0.821 . . . . 0.0 109.54 -174.586 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 21.2 m-85 -140.91 144.81 35.42 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 107.259 -1.386 . . . . 0.0 107.259 -175.989 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 53.7 m-85 -84.83 159.52 20.39 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.453 -174.465 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 16.8 tp -53.29 129.98 33.44 Favored 'General case' 0 C--O 1.216 -0.677 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 179.884 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 70.81 22.26 78.18 Favored Glycine 0 C--O 1.223 -0.577 0 N-CA-C 116.375 1.31 . . . . 0.0 116.375 176.831 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 18.9 p . . . . . 0 CA--C 1.511 -0.522 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 175.658 . . . . . . . . 0 0 . 1 . 034 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 12.9 mt . . . . . 0 N--CA 1.438 -1.061 0 N-CA-C 114.075 1.139 . . . . 0.0 114.075 . . . . . . . . . 0 0 . 1 . 034 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -78.84 161.5 27.19 Favored 'Trans proline' 0 N--CA 1.462 -0.368 0 C-N-CA 122.268 1.978 . . . . 0.0 107.192 167.819 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 56.0 t80 -61.09 132.85 55.1 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 120.226 -0.589 . . . . 0.0 110.063 -177.704 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 91.1 -7.15 81.27 Favored Glycine 0 CA--C 1.519 0.337 0 CA-C-O 119.333 -0.704 . . . . 0.0 114.541 179.407 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -67.68 129.73 40.81 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 118.804 1.302 . . . . 0.0 111.808 179.909 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 51.1 t30 -79.04 128.76 33.68 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.042 -179.893 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.4 ' HB3' HG13 ' A' ' 90' ' ' ILE . 28.7 ttmt -155.94 157.9 37.04 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 106.964 -1.495 . . . . 0.0 106.964 -178.774 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -54.87 120.2 6.49 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.473 0.546 . . . . 0.0 112.473 -179.696 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 66.12 35.6 90.73 Favored Glycine 0 CA--C 1.507 -0.467 0 CA-C-O 118.989 -0.895 . . . . 0.0 114.022 175.176 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.4 HG13 ' HB3' ' A' ' 87' ' ' LYS . 49.6 mm -122.47 126.29 73.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 117.452 0.626 . . . . 0.0 110.856 178.904 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -126.84 121.17 57.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.892 175.666 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 98.7 m95 -87.57 135.67 33.26 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 113.602 0.964 . . . . 0.0 113.602 -176.71 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 15.8 m -137.2 149.78 26.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 121.638 0.733 . . . . 0.0 109.069 178.618 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -162.46 161.97 27.37 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 103.363 -2.829 . . . . 0.0 103.363 179.416 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 6.0 t -126.43 173.85 9.06 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 105.098 -2.186 . . . . 0.0 105.098 178.151 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -67.26 134.42 51.59 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.054 0.454 . . . . 0.0 109.957 -178.303 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 96.0 -9.65 67.98 Favored Glycine 0 C--O 1.226 -0.396 0 CA-C-N 115.97 -0.559 . . . . 0.0 113.05 179.318 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.411 ' HB1' ' HB ' ' A' ' 44' ' ' ILE . . . -76.37 134.02 39.78 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 178.891 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 65.9 mt -87.75 140.96 28.98 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.174 0.511 . . . . 0.0 112.147 -176.743 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 63.4 t30 -84.29 61.98 6.89 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.968 -179.599 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -135.91 156.47 77.17 Favored Pre-proline 0 C--N 1.322 -0.617 0 N-CA-C 106.159 -1.793 . . . . 0.0 106.159 -178.592 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -67.73 152.8 77.3 Favored 'Trans proline' 0 C--N 1.343 0.272 0 N-CA-C 114.793 1.036 . . . . 0.0 114.793 -179.889 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.507 ' HB3' HD12 ' A' ' 106' ' ' ILE . 73.8 mmtt -126.07 37.9 4.25 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 114.648 -1.16 . . . . 0.0 110.079 -177.111 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 15.9 p-10 -53.32 -41.22 65.49 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.168 -179.051 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 16.3 p80 -66.21 -8.88 27.14 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 114.359 1.244 . . . . 0.0 114.359 179.99 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.507 HD12 ' HB3' ' A' ' 103' ' ' LYS . 31.3 mt -95.27 -44.64 13.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 178.727 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -70.66 3.04 13.24 Favored Glycine 0 C--O 1.221 -0.673 0 N-CA-C 115.661 1.024 . . . . 0.0 115.661 -177.537 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 14.6 t -83.15 15.13 3.0 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 117.637 0.719 . . . . 0.0 112.28 -177.868 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.408 ' HD3' ' CD2' ' A' ' 12' ' ' TRP . 57.6 ttp85 -58.72 130.83 48.75 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 176.629 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -98.6 137.62 20.66 Favored Pre-proline 0 C--N 1.323 -0.585 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 178.399 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -74.96 -19.84 17.53 Favored 'Trans proline' 0 C--O 1.219 -0.434 0 N-CA-C 113.863 0.678 . . . . 0.0 113.863 179.424 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -81.36 -25.14 36.57 Favored 'General case' 0 C--O 1.221 -0.437 0 CA-C-O 121.163 0.506 . . . . 0.0 110.226 179.293 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 -97.76 -21.54 16.91 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 113.437 0.903 . . . . 0.0 113.437 -175.128 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 -150.31 153.24 35.76 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 111.884 0.328 . . . . 0.0 111.884 -178.77 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -89.45 140.92 29.05 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-O 121.246 0.546 . . . . 0.0 110.586 178.4 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -70.99 147.64 48.44 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.136 0.494 . . . . 0.0 110.355 178.667 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 11.7 mt -81.89 136.47 22.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.473 -178.494 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 77.0 t -58.78 121.9 7.47 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 N-CA-C 106.43 -1.693 . . . . 0.0 106.43 174.601 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 6.1 tt -67.35 127.54 33.05 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.297 0.57 . . . . 0.0 110.328 -176.662 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 -133.98 155.08 50.59 Favored 'General case' 0 CA--C 1.508 -0.661 0 N-CA-C 106.489 -1.671 . . . . 0.0 106.489 -179.233 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 12.9 mt -111.08 147.96 37.66 Favored Pre-proline 0 C--N 1.319 -0.724 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 177.738 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -73.3 163.5 37.71 Favored 'Trans proline' 0 C--O 1.237 0.439 0 C-N-CA 118.016 -0.856 . . . . 0.0 112.626 -179.934 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 40.1 tt0 -54.47 130.65 40.34 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.06 179.963 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 105.94 -26.25 21.4 Favored Glycine 0 C--O 1.227 -0.309 0 CA-C-N 115.871 -0.604 . . . . 0.0 112.251 -178.656 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 4.6 m -102.36 129.91 48.95 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 118.276 1.038 . . . . 0.0 112.131 178.586 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 3.1 p -116.61 147.86 41.49 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.274 178.625 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 82.8 mt -72.11 153.79 92.48 Favored Pre-proline 0 C--N 1.323 -0.559 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 177.911 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -75.54 175.53 11.16 Favored 'Trans proline' 0 C--O 1.235 0.334 0 N-CA-C 110.576 -0.586 . . . . 0.0 110.576 177.901 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 76.1 tttt -64.55 124.51 22.04 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 114.023 1.12 . . . . 0.0 114.023 -170.811 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 95.19 -1.86 65.18 Favored Glycine 0 CA--C 1.518 0.243 0 CA-C-N 114.891 -1.05 . . . . 0.0 115.342 177.101 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.455 ' CZ ' ' HB2' ' A' ' 18' ' ' GLN . 3.5 m-85 -94.81 143.12 26.71 Favored 'General case' 0 N--CA 1.436 -1.14 0 CA-C-O 122.465 1.126 . . . . 0.0 111.619 -179.328 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 43.7 p90 -144.19 164.46 30.64 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 113.053 -1.885 . . . . 0.0 107.375 173.992 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -105.18 148.55 26.79 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.253 0.549 . . . . 0.0 111.465 -176.759 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -79.05 139.8 38.05 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 179.397 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 81.98 -0.21 88.79 Favored Glycine 0 C--O 1.226 -0.369 0 C-N-CA 121.161 -0.543 . . . . 0.0 112.241 -178.283 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 8.3 t . . . . . 0 C--N 1.324 -0.515 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 178.288 . . . . . . . . 0 0 . 1 . 035 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.537 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 . . . . . . . . . 0 0 . 1 . 035 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 69.6 p -63.18 144.02 57.28 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 178.259 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 14.8 m95 -70.9 -22.82 62.22 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 111.923 0.342 . . . . 0.0 111.923 179.225 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 33.9 m-85 -121.48 162.53 20.33 Favored 'General case' 0 C--O 1.243 0.736 0 N-CA-C 113.239 0.829 . . . . 0.0 113.239 -172.353 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.43 ' HB ' ' HB3' ' A' ' 134' ' ' GLU . 70.5 p -71.13 165.0 24.5 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 114.806 -1.088 . . . . 0.0 108.245 178.149 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -83.4 145.13 29.17 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 113.803 1.038 . . . . 0.0 113.803 -176.401 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 22.9 mt -78.0 148.91 34.17 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 103.942 -2.614 . . . . 0.0 103.942 168.832 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 26.8 m -126.96 140.42 52.33 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 107.432 -1.321 . . . . 0.0 107.432 179.392 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 56.7 tt0 -116.44 148.69 40.47 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 114.936 1.458 . . . . 0.0 114.936 -174.172 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 63.3 t60 -134.52 99.62 4.41 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 105.375 -2.083 . . . . 0.0 105.375 169.967 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -178.95 -163.01 29.34 Favored Glycine 0 CA--C 1.522 0.494 0 C-N-CA 121.006 -0.616 . . . . 0.0 113.233 -176.621 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 68.9 mmtt -116.27 -31.7 5.55 Favored 'General case' 0 N--CA 1.48 1.062 0 N-CA-C 113.919 1.081 . . . . 0.0 113.919 -178.899 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -84.23 -166.67 1.5 Allowed 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 178.61 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 13.7 p-10 -105.74 -66.08 1.01 Allowed 'General case' 0 CA--C 1.556 1.187 0 N-CA-C 117.699 2.481 . . . . 0.0 117.699 -177.614 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 49.3 tp 172.7 141.62 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 179.777 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -154.26 145.36 22.77 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 107.062 -1.459 . . . . 0.0 107.062 -178.732 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -134.51 148.44 67.48 Favored Pre-proline 0 C--N 1.322 -0.589 0 N-CA-C 105.779 -1.934 . . . . 0.0 105.779 176.23 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -69.98 150.22 66.6 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 117.875 -0.95 . . . . 0.0 111.71 179.433 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 16.8 tpt180 -65.98 134.98 54.07 Favored 'General case' 0 C--O 1.217 -0.651 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 -178.369 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 98.84 -3.6 58.9 Favored Glycine 0 C--O 1.222 -0.608 0 N-CA-C 110.335 -1.106 . . . . 0.0 110.335 -179.377 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -146.57 170.51 16.76 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 -179.372 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 128.88 -31.41 3.52 Favored Glycine 0 CA--C 1.48 -2.096 0 N-CA-C 108.774 -1.731 . . . . 0.0 108.774 165.142 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 35.7 m -66.47 139.63 96.23 Favored Pre-proline 0 N--CA 1.43 -1.458 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 177.378 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -72.77 174.01 12.5 Favored 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 121.785 1.657 . . . . 0.0 111.6 177.049 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 90.9 mt -72.1 113.46 9.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 N-CA-C 107.656 -1.239 . . . . 0.0 107.656 178.083 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.557 HD22 ' HA ' ' A' ' 43' ' ' GLN . 37.8 m-20 -109.75 82.16 1.55 Allowed 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.431 -0.804 . . . . 0.0 108.947 -178.31 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 67.7 p -64.87 -24.41 67.53 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.46 -0.791 . . . . 0.0 112.972 -177.044 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 72.7 m-80 -100.72 35.75 2.09 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.647 -178.191 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 21.1 m -147.88 151.7 36.33 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.6 -0.273 . . . . 0.0 110.596 -179.269 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 18.4 m -72.17 165.45 50.4 Favored Pre-proline 0 C--N 1.324 -0.507 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 176.877 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -64.68 -27.79 60.53 Favored 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 114.94 -2.907 . . . . 0.0 111.62 177.813 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -60.84 -30.8 70.32 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 122.121 0.963 . . . . 0.0 110.629 175.784 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 92.6 m-20 -95.58 -0.16 52.26 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 114.931 1.456 . . . . 0.0 114.931 -170.552 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.557 ' HA ' HD22 ' A' ' 35' ' ' ASN . 91.4 mm-40 -60.89 -25.56 66.8 Favored 'General case' 0 C--O 1.219 -0.509 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 178.653 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.494 ' HB ' ' HB1' ' A' ' 98' ' ' ALA . 21.5 tt -55.79 142.56 10.41 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 N-CA-C 115.209 1.559 . . . . 0.0 115.209 -178.621 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 179.22 -155.23 15.43 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.089 178.079 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 43.0 p90 -155.11 168.03 28.38 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 178.254 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 33.6 m-85 -109.28 137.68 46.79 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 174.722 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 60.9 ttt180 -111.9 119.32 38.14 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.474 -0.784 . . . . 0.0 110.827 -177.776 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 1.1 ttp-105 -65.5 134.33 53.17 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 106.78 -1.563 . . . . 0.0 106.78 175.871 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -135.59 153.4 51.68 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.052 0.453 . . . . 0.0 110.541 -177.487 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.477 ' HB ' HD22 ' A' ' 64' ' ' LEU . 32.7 p -133.4 159.01 41.58 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.272 -177.639 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 63.4 ttt180 -158.34 129.71 6.55 Favored 'General case' 0 N--CA 1.477 0.92 0 O-C-N 122.235 -0.291 . . . . 0.0 111.27 177.471 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.81 142.16 24.24 Favored 'General case' 0 CA--C 1.498 -1.039 0 N-CA-C 104.224 -2.51 . . . . 0.0 104.224 -179.933 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -132.1 173.94 13.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 -177.076 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.08 107.39 17.69 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 -179.39 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -74.38 151.82 44.0 Favored Glycine 0 N--CA 1.452 -0.24 0 N-CA-C 107.059 -2.417 . . . . 0.0 107.059 177.201 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -63.38 -42.79 99.02 Favored Glycine 0 C--O 1.223 -0.578 0 CA-C-N 118.559 1.18 . . . . 0.0 111.907 -178.643 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -76.2 -3.22 35.15 Favored 'General case' 0 C--O 1.218 -0.572 0 CA-C-O 121.518 0.675 . . . . 0.0 111.967 179.594 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 96.72 -1.1 61.41 Favored Glycine 0 C--O 1.227 -0.313 0 CA-C-N 115.855 -0.612 . . . . 0.0 112.617 177.395 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 12.8 pttt -63.82 133.66 53.82 Favored 'General case' 0 C--O 1.24 0.581 0 CA-C-O 122.147 0.975 . . . . 0.0 112.587 -178.089 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 13.8 mmt -90.78 145.44 24.78 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 114.171 -1.377 . . . . 0.0 113.022 -179.619 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 2.1 tmtm? -102.11 -23.43 14.06 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.048 -0.978 . . . . 0.0 109.814 176.259 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 13.3 t0 63.7 164.37 0.12 Allowed 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 115.998 1.851 . . . . 0.0 115.998 178.338 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.477 HD22 ' HB ' ' A' ' 51' ' ' THR . 57.4 mt -88.61 131.12 35.1 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.331 0.586 . . . . 0.0 111.304 -176.538 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 4.8 p -112.31 131.29 22.65 Favored Pre-proline 0 C--N 1.319 -0.722 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 176.215 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -74.95 98.14 1.13 Allowed 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 117.35 -1.3 . . . . 0.0 112.065 178.044 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.4 HH22 ' CD ' ' A' ' 134' ' ' GLU . 11.7 mtp180 -110.34 152.81 25.76 Favored 'General case' 0 CA--C 1.507 -0.69 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 178.018 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 64.0 m95 -127.69 126.37 41.78 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 179.666 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 58.7 m-85 -110.35 141.17 43.74 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 -178.592 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 86.1 t80 -87.73 135.87 33.19 Favored 'General case' 0 CA--C 1.506 -0.732 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 -178.581 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -139.42 143.49 37.66 Favored 'General case' 0 N--CA 1.439 -0.995 0 CA-C-N 115.076 -0.965 . . . . 0.0 108.434 -175.376 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -77.01 159.45 29.9 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.089 0.471 . . . . 0.0 110.743 -176.847 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 15.8 tp -59.62 128.17 35.67 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.855 -0.612 . . . . 0.0 110.819 -178.455 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 80.73 24.73 57.81 Favored Glycine 0 C--O 1.218 -0.856 0 N-CA-C 116.342 1.297 . . . . 0.0 116.342 177.603 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 3.7 p . . . . . 0 N--CA 1.467 0.408 0 CA-C-N 118.873 1.336 . . . . 0.0 110.67 -179.609 . . . . . . . . 0 0 . 1 . 035 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 27.6 mt . . . . . 0 C--O 1.238 0.492 0 N-CA-C 115.103 1.519 . . . . 0.0 115.103 . . . . . . . . . 0 0 . 1 . 035 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -78.25 169.19 20.58 Favored 'Trans proline' 0 C--O 1.235 0.352 0 C-N-CA 121.815 1.676 . . . . 0.0 109.483 171.566 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 51.3 t80 -63.49 130.5 44.63 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 179.564 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 92.13 -3.98 77.21 Favored Glycine 0 C--O 1.225 -0.409 0 N-CA-C 114.754 0.662 . . . . 0.0 114.754 178.691 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -68.44 123.69 21.5 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 118.63 1.215 . . . . 0.0 111.471 178.747 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 74.6 m-20 -71.66 126.05 28.69 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 114.799 -1.091 . . . . 0.0 111.839 -176.805 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 29.2 ttmt -156.13 151.5 26.77 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 106.927 -1.509 . . . . 0.0 106.927 177.153 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 18.5 t0 -66.82 133.4 50.02 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.904 0.383 . . . . 0.0 110.032 -178.892 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 72.46 21.42 79.46 Favored Glycine 0 CA--C 1.507 -0.467 0 C-N-CA 120.938 -0.649 . . . . 0.0 113.962 177.731 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 44.0 mm -125.31 124.21 66.7 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.421 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 178.864 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.1 pt -127.68 114.47 35.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.725 176.63 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 95.8 m95 -81.09 128.77 34.1 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.371 -177.704 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 2.8 m -136.7 149.74 26.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 121.483 0.659 . . . . 0.0 109.572 -177.347 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -157.51 164.63 37.18 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 105.134 -2.173 . . . . 0.0 105.134 -178.696 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 14.5 t -122.96 174.83 6.93 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 105.705 -1.961 . . . . 0.0 105.705 177.985 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -64.97 133.81 52.55 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.197 0.523 . . . . 0.0 109.812 -179.679 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 92.07 -9.22 76.92 Favored Glycine 0 C--O 1.225 -0.445 0 CA-C-N 115.886 -0.597 . . . . 0.0 113.232 178.482 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.494 ' HB1' ' HB ' ' A' ' 44' ' ' ILE . . . -77.74 137.73 38.63 Favored 'General case' 0 C--N 1.324 -0.534 0 O-C-N 122.249 -0.56 . . . . 0.0 109.523 179.434 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 51.7 mt -92.82 134.18 35.33 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 113.523 0.935 . . . . 0.0 113.523 -176.64 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 71.6 m-20 -79.47 56.16 2.1 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.411 -179.196 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -130.85 152.34 80.42 Favored Pre-proline 0 C--N 1.323 -0.549 0 N-CA-C 107.953 -1.128 . . . . 0.0 107.953 -179.595 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -66.76 149.9 83.5 Favored 'Trans proline' 0 C--N 1.343 0.256 0 N-CA-C 114.281 0.839 . . . . 0.0 114.281 178.364 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 4.5 ptpt -151.18 56.13 0.88 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 122.71 1.243 . . . . 0.0 110.467 178.955 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -57.81 -30.71 65.92 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 113.852 -1.522 . . . . 0.0 111.411 178.338 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 29.5 p-80 -59.67 -16.62 27.83 Favored 'General case' 0 C--O 1.218 -0.602 0 N-CA-C 114.205 1.187 . . . . 0.0 114.205 -178.901 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 64.0 mt -81.41 -32.63 12.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 178.305 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -73.86 14.8 3.39 Favored Glycine 0 CA--C 1.522 0.479 0 N-CA-C 115.023 0.769 . . . . 0.0 115.023 -178.337 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 11.6 t -83.1 17.65 1.93 Allowed 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 112.846 0.684 . . . . 0.0 112.846 -177.718 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 73.3 ttp85 -58.83 130.27 46.14 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 178.838 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -101.77 125.44 37.13 Favored Pre-proline 0 C--N 1.322 -0.625 0 N-CA-C 105.778 -1.934 . . . . 0.0 105.778 179.352 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -68.69 -17.35 42.66 Favored 'Trans proline' 0 C--O 1.218 -0.525 0 C-N-CA 117.766 -1.023 . . . . 0.0 114.397 -176.705 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -78.77 -24.3 44.77 Favored 'General case' 0 C--O 1.22 -0.468 0 CA-C-O 120.932 0.396 . . . . 0.0 110.516 178.339 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 -100.11 -23.04 14.97 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 -174.923 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 -158.2 149.13 20.77 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.473 0.545 . . . . 0.0 112.473 -178.706 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -92.64 154.16 18.54 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-O 121.518 0.675 . . . . 0.0 111.825 179.606 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -69.39 144.26 53.45 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.216 0.531 . . . . 0.0 111.031 178.87 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 15.3 mt -85.77 139.94 16.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.303 -178.287 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 92.5 t -60.77 124.77 15.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 175.918 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 6.9 tt -67.29 129.0 38.5 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.966 -177.093 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 29.5 mt-30 -132.14 156.64 46.03 Favored 'General case' 0 C--O 1.219 -0.513 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 -179.467 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 13.4 mt -112.29 148.04 38.28 Favored Pre-proline 0 C--N 1.323 -0.578 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 178.449 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -72.65 168.54 24.2 Favored 'Trans proline' 0 C--N 1.346 0.409 0 O-C-N 122.219 0.589 . . . . 0.0 113.615 -179.128 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 39.1 tt0 -53.82 131.87 40.49 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.309 -0.86 . . . . 0.0 109.553 179.554 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 96.38 -18.94 56.57 Favored Glycine 0 C--O 1.226 -0.403 0 CA-C-N 115.919 -0.582 . . . . 0.0 113.452 179.991 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 4.1 m -108.43 128.48 54.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 118.227 1.014 . . . . 0.0 111.375 179.239 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 10.0 p -122.46 150.77 42.05 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.278 179.172 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 87.8 mt -70.79 151.88 95.19 Favored Pre-proline 0 C--N 1.324 -0.533 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 179.076 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -76.03 166.17 28.42 Favored 'Trans proline' 0 C--O 1.236 0.383 0 C-N-CA 117.775 -1.016 . . . . 0.0 110.973 178.864 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 14.7 tmtt? -59.04 127.02 30.11 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.121 -177.293 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 95.1 15.59 44.31 Favored Glycine 0 C--O 1.227 -0.344 0 N-CA-C 114.865 0.706 . . . . 0.0 114.865 178.785 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -125.52 149.17 48.53 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 117.688 0.744 . . . . 0.0 110.637 177.873 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 43.6 p90 -150.37 161.97 41.46 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 174.43 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -99.92 147.01 26.01 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.825 0.345 . . . . 0.0 110.412 -179.017 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.43 ' HB3' ' HB ' ' A' ' 14' ' ' THR . 3.6 tp10 -72.18 133.76 45.31 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 106.65 -1.611 . . . . 0.0 106.65 177.81 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 89.48 -3.17 83.6 Favored Glycine 0 C--O 1.224 -0.5 0 N-CA-C 111.254 -0.738 . . . . 0.0 111.254 -177.144 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 9.7 t . . . . . 0 C--N 1.325 -0.471 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 177.42 . . . . . . . . 0 0 . 1 . 036 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.667 0 CA-C-O 121.475 0.655 . . . . 0.0 109.262 . . . . . . . . . 0 0 . 1 . 036 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 54.3 p -59.72 143.72 50.05 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.254 -0.884 . . . . 0.0 109.231 177.907 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 13.4 m95 -65.87 -26.75 67.78 Favored 'General case' 0 CA--C 1.512 -0.485 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 179.26 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 27.4 m-85 -121.46 164.79 16.59 Favored 'General case' 0 CA--C 1.503 -0.831 0 CA-C-N 115.784 -0.644 . . . . 0.0 112.109 -172.201 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.466 ' HB ' ' HB3' ' A' ' 134' ' ' GLU . 67.1 p -70.35 166.41 20.31 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 114.614 -1.175 . . . . 0.0 108.629 177.642 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -87.23 149.92 24.27 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 113.306 0.854 . . . . 0.0 113.306 -176.507 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.466 HD21 HD22 ' A' ' 119' ' ' LEU . 53.0 mt -85.54 148.81 25.77 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 173.18 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 24.2 m -125.19 131.98 53.1 Favored 'General case' 0 C--N 1.32 -0.716 0 C-N-CA 122.515 0.326 . . . . 0.0 110.698 -179.822 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 3.9 tp-100 -95.6 141.67 28.83 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 179.129 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 41.5 t60 -135.35 100.04 4.41 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 102.54 -3.133 . . . . 0.0 102.54 166.598 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 167.77 -143.9 8.53 Favored Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 120.286 -0.959 . . . . 0.0 111.545 -175.027 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -124.74 -32.3 3.1 Favored 'General case' 0 C--O 1.221 -0.405 0 N-CA-C 115.449 1.648 . . . . 0.0 115.449 -177.811 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -77.69 165.77 23.82 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 178.57 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -79.66 -62.89 1.55 Allowed 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 -179.249 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 48.0 tp 173.88 141.04 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.221 0 N-CA-C 106.114 -1.81 . . . . 0.0 106.114 176.057 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 56.2 tptt -153.71 139.46 17.99 Favored 'General case' 0 C--O 1.222 -0.371 0 CA-C-N 118.077 0.399 . . . . 0.0 110.539 173.983 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 20.5 m-85 -126.27 151.49 72.32 Favored Pre-proline 0 C--O 1.24 0.59 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 175.189 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -78.98 166.95 22.64 Favored 'Trans proline' 0 C--N 1.353 0.813 0 C-N-CA 120.934 1.089 . . . . 0.0 113.535 178.347 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 2.0 tmt_? -66.86 137.07 56.32 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.821 -178.732 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 86.67 -0.21 86.52 Favored Glycine 0 C--O 1.223 -0.536 0 N-CA-C 111.302 -0.719 . . . . 0.0 111.302 177.169 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 58.5 mt-30 -140.65 -179.69 6.18 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 -175.176 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.52 -28.28 13.98 Favored Glycine 0 CA--C 1.498 -1.025 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.87 176.104 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 76.2 t -64.44 126.45 90.61 Favored Pre-proline 0 C--N 1.32 -0.705 0 N-CA-C 106.177 -1.786 . . . . 0.0 106.177 176.559 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -73.66 168.87 23.69 Favored 'Trans proline' 0 N--CA 1.459 -0.513 0 O-C-N 122.225 0.592 . . . . 0.0 111.446 179.134 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 87.6 mt -66.71 110.1 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-O 122.06 0.934 . . . . 0.0 109.177 -179.761 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 71.6 m-80 -97.94 91.45 5.33 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 114.636 -1.165 . . . . 0.0 110.734 -177.493 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 75.7 p -71.38 -14.89 62.32 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.744 0.783 . . . . 0.0 111.469 178.667 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 10.7 p30 -111.14 20.52 17.32 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 114.915 1.45 . . . . 0.0 114.915 -175.893 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 6.1 m -138.91 152.32 47.66 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 115.938 1.829 . . . . 0.0 115.938 -175.728 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 2.0 m -70.22 164.7 50.81 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 115.085 -0.962 . . . . 0.0 109.936 176.219 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -66.36 -28.38 46.84 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 114.758 -3.028 . . . . 0.0 113.915 -179.823 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.41 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 4.2 p-10 -75.3 -21.59 58.35 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.657 0.741 . . . . 0.0 110.688 177.319 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -83.28 -5.76 59.24 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 114.063 1.134 . . . . 0.0 114.063 -174.776 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 93.6 mm-40 -58.89 -26.52 64.36 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 113.248 0.833 . . . . 0.0 113.248 -179.427 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.453 ' HB ' ' HB1' ' A' ' 98' ' ' ALA . 20.1 tt -57.66 138.86 18.03 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.726 0 N-CA-C 114.402 1.26 . . . . 0.0 114.402 -178.744 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -177.07 -159.35 22.18 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.57 -0.824 . . . . 0.0 111.977 178.806 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 51.5 p90 -155.05 172.7 17.68 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 177.907 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 16.9 m-85 -113.49 138.89 49.47 Favored 'General case' 0 C--N 1.319 -0.761 0 N-CA-C 106.125 -1.806 . . . . 0.0 106.125 173.869 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 36.2 ttt180 -108.23 120.01 41.14 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 114.991 -1.004 . . . . 0.0 110.387 -176.728 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 13.1 ttt180 -64.33 131.7 48.04 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 176.316 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -142.18 129.77 21.44 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.544 0.688 . . . . 0.0 110.882 -179.693 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 15.3 t -156.8 155.46 31.59 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 175.183 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 15.0 tpt85 -154.88 135.12 13.18 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 104.865 -2.272 . . . . 0.0 104.865 178.11 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -127.82 136.37 51.35 Favored 'General case' 0 CA--C 1.495 -1.138 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 -179.423 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.447 HD13 ' HB2' ' A' ' 62' ' ' LYS . 0.1 OUTLIER -132.67 172.4 16.49 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 -177.38 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 5.5 tmm_? -116.08 112.3 21.54 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 105.439 -2.06 . . . . 0.0 105.439 176.71 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -75.76 150.07 39.1 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 121.008 -0.615 . . . . 0.0 112.368 -177.512 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -70.89 -22.16 78.26 Favored Glycine 0 C--O 1.218 -0.896 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.44 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 41.1 t0 -65.16 -12.9 56.0 Favored 'General case' 0 CA--C 1.548 0.903 0 CA-C-N 114.236 -0.982 . . . . 0.0 110.363 176.951 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 108.07 18.46 9.86 Favored Glycine 0 CA--C 1.501 -0.827 0 CA-C-N 116.105 -0.498 . . . . 0.0 112.818 169.338 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.66 160.28 42.86 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 116.583 2.068 . . . . 0.0 116.583 -174.155 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 93.9 mmm -85.03 160.25 20.05 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.589 -0.732 . . . . 0.0 112.873 -176.398 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.447 ' HB2' HD13 ' A' ' 54' ' ' ILE . 13.3 tmtt? -63.86 -42.91 97.43 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 122.316 1.055 . . . . 0.0 112.412 176.64 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 13.1 t70 56.15 -139.85 0.92 Allowed 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 112.444 -2.162 . . . . 0.0 109.988 -174.916 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER 66.9 156.23 0.11 Allowed 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 116.001 1.852 . . . . 0.0 116.001 178.777 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 14.1 p -81.26 162.59 58.44 Favored Pre-proline 0 C--O 1.242 0.675 0 CA-C-N 114.462 -1.245 . . . . 0.0 110.678 -179.949 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -71.6 156.5 57.61 Favored 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 116.434 -1.911 . . . . 0.0 111.293 175.563 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 11.7 mtt180 -116.7 161.46 19.19 Favored 'General case' 0 CA--C 1.506 -0.737 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 178.251 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 62.3 m95 -123.18 125.98 46.13 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 179.919 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 11.3 m-85 -110.37 138.06 47.26 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 107.278 -1.378 . . . . 0.0 107.278 -176.742 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 79.7 t80 -85.25 133.8 34.16 Favored 'General case' 0 CA--C 1.509 -0.629 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 -177.248 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -141.47 135.49 30.31 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 -175.254 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 86.3 m-85 -73.73 159.54 32.82 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 -175.652 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 11.3 tp -57.02 126.55 27.68 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.312 0.577 . . . . 0.0 109.615 179.849 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 82.03 18.68 66.8 Favored Glycine 0 C--O 1.22 -0.751 0 N-CA-C 116.49 1.356 . . . . 0.0 116.49 178.041 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 16.7 p . . . . . 0 N--CA 1.469 0.478 0 CA-C-N 119.331 1.566 . . . . 0.0 110.228 178.622 . . . . . . . . 0 0 . 1 . 036 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.406 ' HA ' ' HD2' ' A' ' 82' ' ' PRO . 15.0 mt . . . . . 0 N--CA 1.44 -0.968 0 N-CA-C 116.027 1.862 . . . . 0.0 116.027 . . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.406 ' HD2' ' HA ' ' A' ' 81' ' ' LEU . 90.8 Cg_endo -78.47 162.21 27.9 Favored 'Trans proline' 0 N--CA 1.462 -0.357 0 C-N-CA 122.684 2.256 . . . . 0.0 107.165 166.962 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 59.1 t80 -61.44 132.56 53.86 Favored 'General case' 0 C--N 1.32 -0.712 0 C-N-CA 120.239 -0.584 . . . . 0.0 110.35 -177.499 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 91.4 -8.98 78.45 Favored Glycine 0 CA--C 1.519 0.324 0 N-CA-C 114.953 0.741 . . . . 0.0 114.953 179.296 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -66.35 131.54 46.33 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 118.676 1.238 . . . . 0.0 111.711 179.84 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 56.9 t30 -78.81 131.31 36.45 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.287 -179.724 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 32.7 tttt -156.22 156.77 34.7 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 106.807 -1.553 . . . . 0.0 106.807 -179.568 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -64.56 127.76 32.87 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.719 -0.475 . . . . 0.0 109.719 -178.129 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 67.41 33.02 80.74 Favored Glycine 0 N--CA 1.444 -0.778 0 N-CA-C 115.171 0.829 . . . . 0.0 115.171 176.8 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 41.0 mm -126.34 125.44 67.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 117.404 0.602 . . . . 0.0 110.132 179.067 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -127.41 112.45 28.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.202 177.278 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 98.6 m95 -78.02 137.29 38.19 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 113.371 0.878 . . . . 0.0 113.371 -177.681 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 14.0 m -139.45 149.75 22.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 177.843 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -160.7 164.17 31.87 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 104.299 -2.482 . . . . 0.0 104.299 179.385 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 14.1 t -124.08 174.58 7.53 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 105.668 -1.975 . . . . 0.0 105.668 178.48 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -65.99 132.28 48.21 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.992 0.425 . . . . 0.0 110.438 -178.752 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 92.59 -6.72 77.6 Favored Glycine 0 C--O 1.23 -0.154 0 CA-C-N 116.103 -0.498 . . . . 0.0 113.543 178.997 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.453 ' HB1' ' HB ' ' A' ' 44' ' ' ILE . . . -74.8 138.88 42.9 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 178.681 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 40.2 mt -94.6 139.01 31.76 Favored 'General case' 0 C--O 1.222 -0.39 0 N-CA-C 113.442 0.905 . . . . 0.0 113.442 -177.053 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 74.0 m-20 -83.18 62.08 6.44 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.869 -178.782 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -135.39 154.33 78.49 Favored Pre-proline 0 C--N 1.32 -0.692 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 -179.495 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -68.39 150.68 76.06 Favored 'Trans proline' 0 C--N 1.342 0.191 0 N-CA-C 114.476 0.914 . . . . 0.0 114.476 178.699 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -149.27 59.39 1.03 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 122.94 1.352 . . . . 0.0 110.988 178.006 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 14.0 p-10 -58.61 -30.43 67.24 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 113.694 -1.594 . . . . 0.0 110.206 176.894 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 23.0 p-80 -59.77 -14.66 15.54 Favored 'General case' 0 C--O 1.222 -0.366 0 N-CA-C 114.214 1.19 . . . . 0.0 114.214 -179.272 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 51.9 mt -90.33 -48.51 14.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 177.846 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -71.69 14.37 1.99 Allowed Glycine 0 C--O 1.219 -0.823 0 N-CA-C 116.094 1.197 . . . . 0.0 116.094 -176.271 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 13.8 t -90.95 19.88 5.28 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 117.596 0.698 . . . . 0.0 111.947 179.987 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 65.6 ttp85 -57.47 135.11 56.57 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 178.988 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -105.11 136.21 19.21 Favored Pre-proline 0 C--N 1.323 -0.559 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 178.515 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -73.96 -17.96 21.93 Favored 'Trans proline' 0 C--O 1.219 -0.464 0 O-C-N 121.967 0.456 . . . . 0.0 113.148 -179.885 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -80.07 -24.61 40.52 Favored 'General case' 0 C--O 1.221 -0.409 0 CA-C-O 121.148 0.499 . . . . 0.0 110.271 178.938 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 88.4 m-20 -99.4 -22.37 15.57 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 113.464 0.913 . . . . 0.0 113.464 -175.32 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 -158.7 149.72 20.4 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.135 0.42 . . . . 0.0 112.135 -178.659 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -85.34 145.29 27.57 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-O 121.427 0.632 . . . . 0.0 111.872 179.68 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -69.6 148.1 49.82 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.17 0.51 . . . . 0.0 110.544 178.361 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 17.4 mt -89.42 138.99 18.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 -179.045 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 79.7 t -62.81 124.92 18.3 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 N-CA-C 106.088 -1.819 . . . . 0.0 106.088 174.259 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.466 HD22 HD21 ' A' ' 16' ' ' LEU . 7.2 tt -67.55 130.61 43.59 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 -177.782 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -135.0 154.11 51.85 Favored 'General case' 0 CA--C 1.51 -0.591 0 N-CA-C 106.135 -1.802 . . . . 0.0 106.135 -179.152 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 13.1 mt -108.56 147.34 35.54 Favored Pre-proline 0 C--N 1.321 -0.673 0 CA-C-O 120.574 0.226 . . . . 0.0 110.732 177.15 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -73.34 163.91 36.58 Favored 'Trans proline' 0 C--O 1.236 0.401 0 C-N-CA 118.371 -0.62 . . . . 0.0 113.378 -179.873 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 39.4 tt0 -53.87 129.22 33.04 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.274 -0.876 . . . . 0.0 109.09 178.999 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 108.65 -26.89 14.65 Favored Glycine 0 C--O 1.225 -0.408 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.911 -178.681 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 5.0 m -108.56 132.28 54.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 118.012 0.906 . . . . 0.0 111.545 178.499 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 2.8 p -121.14 148.18 44.56 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 177.3 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 75.9 mt -70.02 153.59 95.27 Favored Pre-proline 0 C--N 1.323 -0.566 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 177.739 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -74.1 168.82 23.88 Favored 'Trans proline' 0 C--O 1.235 0.354 0 N-CA-C 110.714 -0.533 . . . . 0.0 110.714 179.176 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -60.17 125.81 25.09 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.988 0.423 . . . . 0.0 111.49 -175.268 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 94.95 -2.9 66.73 Favored Glycine 0 C--O 1.227 -0.307 0 N-CA-C 115.131 0.813 . . . . 0.0 115.131 178.444 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -102.89 138.91 39.15 Favored 'General case' 0 N--CA 1.441 -0.911 0 CA-C-O 122.175 0.988 . . . . 0.0 110.39 -179.899 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 45.9 p90 -141.81 159.88 41.32 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 113.989 -1.46 . . . . 0.0 107.656 175.846 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -98.89 150.65 21.69 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 -179.505 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.466 ' HB3' ' HB ' ' A' ' 14' ' ' THR . 2.9 tp10 -73.17 129.03 37.16 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 106.77 -1.567 . . . . 0.0 106.77 179.74 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 89.03 -2.92 84.41 Favored Glycine 0 C--O 1.227 -0.318 0 C-N-CA 121.341 -0.457 . . . . 0.0 112.183 -177.615 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 46.4 t . . . . . 0 C--N 1.326 -0.422 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 178.218 . . . . . . . . 0 0 . 1 . 037 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.255 0 CA-C-O 121.252 0.549 . . . . 0.0 109.664 . . . . . . . . . 0 0 . 1 . 037 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 53.2 p -64.97 144.27 57.4 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 178.303 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 6.3 m95 -66.31 -26.3 67.25 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 111.959 0.355 . . . . 0.0 111.959 177.86 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 32.1 m-85 -121.72 159.15 27.19 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.361 -171.851 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 45.4 p -68.22 166.75 15.68 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.266 -0.879 . . . . 0.0 111.271 -178.246 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -85.38 127.2 34.28 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 113.695 0.998 . . . . 0.0 113.695 -175.513 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 22.6 mt -67.76 147.93 51.93 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 105.332 -2.099 . . . . 0.0 105.332 172.763 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 34.6 m -123.69 133.0 53.96 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 -178.733 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -94.48 140.94 29.18 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 114.266 1.21 . . . . 0.0 114.266 -176.43 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 57.3 t60 -138.82 100.1 3.97 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 105.673 -1.973 . . . . 0.0 105.673 166.04 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 166.3 -153.83 23.95 Favored Glycine 0 C--O 1.224 -0.503 0 C-N-CA 120.844 -0.693 . . . . 0.0 111.537 -177.756 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 40.2 mtpt -117.43 -21.73 8.52 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 113.556 0.947 . . . . 0.0 113.556 -179.42 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -76.1 156.74 33.57 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 178.369 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -73.75 -62.41 1.5 Allowed 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 179.776 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 35.4 tp 171.3 142.24 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 103.418 -2.808 . . . . 0.0 103.418 174.169 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 52.7 tptt -151.78 134.72 15.71 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 118.424 0.556 . . . . 0.0 111.281 174.823 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -123.02 149.13 56.14 Favored Pre-proline 0 C--O 1.243 0.74 0 N-CA-C 108.42 -0.955 . . . . 0.0 108.42 174.152 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -77.39 167.68 24.12 Favored 'Trans proline' 0 CA--C 1.537 0.653 0 C-N-CA 120.906 1.071 . . . . 0.0 113.671 179.268 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 71.3 ttt180 -67.96 137.65 55.32 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.759 -178.871 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 85.93 -0.11 87.61 Favored Glycine 0 C--O 1.224 -0.487 0 N-CA-C 111.562 -0.615 . . . . 0.0 111.562 178.336 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 -140.52 -179.48 6.04 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 -176.288 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 101.15 -29.14 13.15 Favored Glycine 0 CA--C 1.501 -0.842 0 CA-C-N 115.732 -0.667 . . . . 0.0 112.866 175.613 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 98.5 t -66.1 127.39 93.17 Favored Pre-proline 0 C--N 1.322 -0.621 0 N-CA-C 105.456 -2.053 . . . . 0.0 105.456 176.867 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -71.46 167.4 26.45 Favored 'Trans proline' 0 N--CA 1.461 -0.44 0 C-N-CA 120.329 0.686 . . . . 0.0 111.955 179.543 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 95.7 mt -63.36 121.32 12.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 106.227 -1.768 . . . . 0.0 106.227 179.481 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 43.3 t-20 -116.93 122.65 44.89 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.287 -0.87 . . . . 0.0 110.881 -173.913 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 73.4 p -103.03 -11.88 17.83 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.393 -0.821 . . . . 0.0 112.716 -177.475 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 17.5 p30 -114.24 15.99 18.04 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 116.324 1.972 . . . . 0.0 116.324 -173.063 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 29.0 m -141.83 154.31 45.09 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 113.742 1.015 . . . . 0.0 113.742 -177.694 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 18.6 m -72.44 164.45 59.6 Favored Pre-proline 0 C--O 1.238 0.464 0 CA-C-N 115.331 -0.85 . . . . 0.0 109.014 176.696 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -64.3 -28.44 63.68 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 115.4 -2.6 . . . . 0.0 112.46 178.918 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -62.65 -24.21 67.5 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 123.735 0.814 . . . . 0.0 111.613 177.643 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.445 ' HA ' ' HE3' ' A' ' 103' ' ' LYS . 33.4 m-20 -99.81 -2.49 34.92 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 114.75 1.389 . . . . 0.0 114.75 -171.622 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 96.9 mm-40 -60.46 -37.79 82.11 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 115.937 1.828 . . . . 0.0 115.937 -179.992 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 15.7 tt -59.33 138.3 20.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-O 122.313 1.054 . . . . 0.0 112.59 -176.965 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -178.77 -152.34 10.36 Favored Glycine 0 C--O 1.226 -0.383 0 CA-C-N 115.338 -0.847 . . . . 0.0 111.964 -174.862 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 47.8 p90 -154.7 173.59 16.18 Favored 'General case' 0 C--N 1.321 -0.636 0 O-C-N 122.379 -0.483 . . . . 0.0 110.448 -179.33 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -113.98 140.12 48.68 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 171.29 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -105.73 119.33 38.86 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 124.192 0.997 . . . . 0.0 109.69 -178.348 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -70.89 133.18 46.24 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 175.556 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -143.93 154.79 43.68 Favored 'General case' 0 C--N 1.321 -0.654 0 C-N-CA 122.814 0.445 . . . . 0.0 110.175 -177.441 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 15.2 t -156.68 166.98 31.84 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 174.975 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.7 tpt85 -160.29 153.81 22.33 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 103.421 -2.807 . . . . 0.0 103.421 179.475 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 21.8 ttm180 -131.37 146.07 52.12 Favored 'General case' 0 CA--C 1.495 -1.168 0 CA-C-N 118.804 0.729 . . . . 0.0 111.908 179.387 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -142.67 177.71 2.65 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 N-CA-C 104.823 -2.288 . . . . 0.0 104.823 179.205 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 7.1 tmm_? -128.09 103.05 7.0 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 104.999 -2.223 . . . . 0.0 104.999 174.852 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -70.49 154.89 52.76 Favored Glycine 0 C--O 1.22 -0.776 0 N-CA-C 110.731 -0.947 . . . . 0.0 110.731 -176.55 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -67.45 -34.8 85.69 Favored Glycine 0 C--O 1.215 -1.051 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 -179.817 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.1 t0 -94.24 16.91 13.71 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-O 122.483 1.135 . . . . 0.0 109.532 178.416 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 86.42 -17.53 38.35 Favored Glycine 0 C--O 1.225 -0.41 0 N-CA-C 116.225 1.25 . . . . 0.0 116.225 173.801 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -58.9 135.51 57.58 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 122.286 1.041 . . . . 0.0 113.319 -177.314 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 79.3 mtp -113.63 -175.76 2.75 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 113.472 -1.695 . . . . 0.0 111.728 -177.416 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 12.2 mptt -130.29 -41.98 1.22 Allowed 'General case' 0 N--CA 1.476 0.831 0 CA-C-O 122.641 1.21 . . . . 0.0 111.674 -178.984 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 15.7 t0 -61.02 -177.6 0.08 Allowed 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 111.657 -2.52 . . . . 0.0 113.456 179.014 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER 81.02 -52.41 0.3 Allowed 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 126.952 2.101 . . . . 0.0 110.162 -179.206 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 37.9 t -83.81 113.71 49.24 Favored Pre-proline 0 C--N 1.321 -0.662 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 175.459 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -73.45 150.01 45.53 Favored 'Trans proline' 0 C--O 1.239 0.565 0 C-N-CA 114.803 -2.998 . . . . 0.0 111.062 177.94 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 36.6 mtp180 -120.08 157.79 28.21 Favored 'General case' 0 CA--C 1.503 -0.855 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 -179.45 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 77.3 m95 -128.78 126.8 40.69 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 120.77 0.319 . . . . 0.0 110.874 -179.088 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 13.2 m-85 -110.52 134.25 52.54 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 106.769 -1.567 . . . . 0.0 106.769 -177.501 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 88.4 t80 -83.66 134.21 34.79 Favored 'General case' 0 CA--C 1.508 -0.661 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 -178.139 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -139.67 145.49 38.48 Favored 'General case' 0 N--CA 1.44 -0.935 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 -175.899 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 76.9 m-85 -83.12 159.55 22.06 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.937 -172.971 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -56.48 126.63 27.33 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 179.462 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 78.96 26.8 57.63 Favored Glycine 0 C--O 1.223 -0.559 0 N-CA-C 115.908 1.123 . . . . 0.0 115.908 178.224 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 22.2 p . . . . . 0 N--CA 1.469 0.515 0 CA-C-N 118.829 1.314 . . . . 0.0 109.746 177.201 . . . . . . . . 0 0 . 1 . 037 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 18.5 mt . . . . . 0 N--CA 1.447 -0.588 0 N-CA-C 116.628 2.084 . . . . 0.0 116.628 . . . . . . . . . 0 0 . 1 . 037 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -78.63 163.1 26.94 Favored 'Trans proline' 0 N--CA 1.461 -0.386 0 C-N-CA 122.305 2.004 . . . . 0.0 107.732 167.898 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.407 ' CE1' ' HB3' ' A' ' 92' ' ' TRP . 65.9 t80 -61.9 132.06 51.78 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 120.307 -0.557 . . . . 0.0 110.651 -177.005 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 92.1 -9.21 76.91 Favored Glycine 0 C--O 1.228 -0.277 0 CA-C-O 119.595 -0.559 . . . . 0.0 114.359 179.092 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -65.01 130.71 44.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 118.256 1.028 . . . . 0.0 111.39 179.403 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 57.0 t30 -79.36 130.75 35.74 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.413 -179.246 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 26.9 ttmt -154.84 150.71 27.77 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 178.454 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 32.1 t0 -64.4 120.78 12.89 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.284 0.564 . . . . 0.0 110.402 -178.047 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 78.41 29.76 51.92 Favored Glycine 0 N--CA 1.451 -0.309 0 CA-C-N 115.437 -0.802 . . . . 0.0 114.506 179.471 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 41.6 mm -127.06 126.38 68.09 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 CA-C-N 117.612 0.706 . . . . 0.0 110.712 179.099 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -127.16 116.04 42.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 CA-C-O 121.478 0.656 . . . . 0.0 111.381 176.337 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 92' ' ' TRP . . . . . 0.407 ' HB3' ' CE1' ' A' ' 83' ' ' TYR . 96.7 m95 -79.91 138.48 37.14 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -178.326 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 16.1 m -138.29 153.23 26.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 179.15 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -160.1 165.92 30.84 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 107.073 -1.454 . . . . 0.0 107.073 -178.407 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 14.0 t -133.05 165.97 23.49 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 105.007 -2.22 . . . . 0.0 105.007 176.205 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 61.0 tt0 -67.41 138.18 56.5 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.096 0.474 . . . . 0.0 110.163 -179.06 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 94.97 -8.53 70.33 Favored Glycine 0 C--O 1.225 -0.432 0 CA-C-N 115.853 -0.612 . . . . 0.0 112.999 178.756 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -81.3 143.0 32.55 Favored 'General case' 0 C--N 1.323 -0.543 0 O-C-N 122.543 -0.386 . . . . 0.0 110.364 178.878 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 38.7 mt -100.53 134.76 43.0 Favored 'General case' 0 CA--C 1.514 -0.404 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -178.409 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -78.55 48.07 0.76 Allowed 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 115.184 -0.916 . . . . 0.0 112.049 -177.248 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 1.4 t -114.91 154.85 46.98 Favored Pre-proline 0 C--N 1.32 -0.717 0 N-CA-C 105.366 -2.087 . . . . 0.0 105.366 -179.98 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -64.97 149.01 90.03 Favored 'Trans proline' 0 C--N 1.342 0.197 0 N-CA-C 113.636 0.591 . . . . 0.0 113.636 176.802 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.445 ' HE3' ' HA ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -143.99 54.96 1.3 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 123.551 1.644 . . . . 0.0 109.603 178.616 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -58.32 -30.66 66.86 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 113.128 -1.851 . . . . 0.0 111.456 178.501 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 29.4 p-80 -57.08 -16.65 7.89 Favored 'General case' 0 C--O 1.222 -0.389 0 N-CA-C 115.026 1.491 . . . . 0.0 115.026 -178.422 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 4.4 mt -92.02 -21.01 6.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 121.256 0.55 . . . . 0.0 110.515 -179.946 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -77.11 3.0 59.32 Favored Glycine 0 C--O 1.225 -0.413 0 C-N-CA 120.806 -0.711 . . . . 0.0 113.81 -177.692 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 9.9 t -83.34 11.33 6.9 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 114.235 1.198 . . . . 0.0 114.235 -176.588 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 66.9 ttp85 -59.69 126.09 26.22 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 107.794 -1.188 . . . . 0.0 107.794 178.417 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -97.45 137.38 21.1 Favored Pre-proline 0 C--N 1.322 -0.623 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 178.574 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -74.68 -20.27 17.84 Favored 'Trans proline' 0 C--O 1.219 -0.458 0 N-CA-C 113.815 0.66 . . . . 0.0 113.815 179.999 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -81.6 -24.87 36.18 Favored 'General case' 0 C--O 1.221 -0.408 0 CA-C-O 121.116 0.484 . . . . 0.0 110.145 179.919 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 87.4 m-20 -97.32 -22.27 16.74 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 113.503 0.927 . . . . 0.0 113.503 -175.266 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 -157.22 151.35 24.82 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 112.315 0.487 . . . . 0.0 112.315 -178.005 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -89.08 146.19 24.98 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-O 121.433 0.635 . . . . 0.0 111.435 179.196 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -70.75 149.06 47.29 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.348 0.594 . . . . 0.0 110.923 178.713 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 22.7 mt -81.21 137.88 20.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 179.864 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 87.7 t -61.35 121.09 8.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 106.679 -1.6 . . . . 0.0 106.679 175.109 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 6.1 tt -67.39 125.53 26.41 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.074 0.464 . . . . 0.0 110.075 -176.985 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -134.46 159.12 42.09 Favored 'General case' 0 CA--C 1.508 -0.643 0 N-CA-C 106.491 -1.67 . . . . 0.0 106.491 -179.169 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 13.6 mt -112.97 148.31 39.12 Favored Pre-proline 0 C--N 1.32 -0.713 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 178.501 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -73.17 163.75 37.23 Favored 'Trans proline' 0 C--O 1.236 0.425 0 C-N-CA 118.254 -0.698 . . . . 0.0 112.836 -179.933 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 39.0 tt0 -54.6 129.55 36.82 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 179.403 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 108.83 -27.82 12.45 Favored Glycine 0 C--O 1.225 -0.416 0 CA-C-N 115.853 -0.612 . . . . 0.0 112.08 -178.461 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 4.3 m -105.6 129.29 53.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 118.128 0.964 . . . . 0.0 111.507 178.54 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 3.3 p -116.97 148.28 41.56 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.809 179.35 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 89.5 mt -73.2 151.43 90.16 Favored Pre-proline 0 C--N 1.323 -0.552 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 177.987 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -78.49 -172.04 1.4 Allowed 'Trans proline' 0 C--O 1.238 0.52 0 C-N-CA 121.061 1.174 . . . . 0.0 112.346 179.396 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 7.8 tmtt? -55.15 120.71 7.41 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 114.235 1.198 . . . . 0.0 114.235 -171.893 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 66.36 22.79 71.41 Favored Glycine 0 C--O 1.224 -0.494 0 CA-C-N 114.888 -1.051 . . . . 0.0 115.522 173.703 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -99.84 134.41 42.78 Favored 'General case' 0 N--CA 1.439 -0.977 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 177.774 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 42.5 p90 -139.8 161.27 37.97 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.051 -0.977 . . . . 0.0 108.711 178.392 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -98.08 144.93 27.05 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.727 0.775 . . . . 0.0 112.508 -176.716 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -78.29 139.24 38.87 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 106.566 -1.642 . . . . 0.0 106.566 176.212 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 91.75 -5.04 79.55 Favored Glycine 0 C--O 1.224 -0.471 0 C-N-CA 120.956 -0.64 . . . . 0.0 111.887 -178.355 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 21.9 t . . . . . 0 N--CA 1.449 -0.487 0 N-CA-C 105.635 -1.987 . . . . 0.0 105.635 175.948 . . . . . . . . 0 0 . 1 . 038 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 0.237 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 . . . . . . . . . 0 0 . 1 . 038 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -61.24 137.41 58.24 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 178.246 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 9.8 m95 -68.81 -27.01 65.47 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 113.151 0.797 . . . . 0.0 113.151 -179.851 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 54.5 m-85 -121.65 163.4 19.05 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 113.342 0.868 . . . . 0.0 113.342 -170.321 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 59.7 p -68.25 167.29 14.64 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 114.51 -1.223 . . . . 0.0 108.327 177.49 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -78.53 152.53 31.91 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 122.346 1.069 . . . . 0.0 112.803 -177.207 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.42 HD23 ' HA ' ' A' ' 16' ' ' LEU . 14.9 mt -91.98 142.26 27.73 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 102.383 -3.191 . . . . 0.0 102.383 167.527 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 33.1 m -124.71 140.01 53.33 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 -176.806 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.461 ' HB2' ' CZ ' ' A' ' 131' ' ' PHE . 4.9 tp60 -120.76 146.0 46.95 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 116.095 1.887 . . . . 0.0 116.095 -172.725 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 78.2 t60 -133.14 99.47 4.56 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 106.811 -1.551 . . . . 0.0 106.811 169.706 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 178.03 -164.58 33.51 Favored Glycine 0 C--O 1.227 -0.294 0 N-CA-C 109.008 -1.637 . . . . 0.0 109.008 -177.722 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -99.79 -25.0 14.51 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 177.905 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -77.52 152.39 34.12 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 114.279 -1.328 . . . . 0.0 109.617 -179.897 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -88.97 -62.44 1.48 Allowed 'General case' 0 C--O 1.212 -0.891 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 178.095 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 45.0 tp -174.93 141.29 0.59 Allowed 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 174.699 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 9.8 tmtt? -156.94 131.58 8.74 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 176.193 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -120.73 153.63 56.94 Favored Pre-proline 0 CA--C 1.543 0.69 0 N-CA-C 111.517 0.191 . . . . 0.0 111.517 177.171 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_endo -78.39 164.18 26.65 Favored 'Trans proline' 0 CA--C 1.542 0.91 0 C-N-CA 120.695 0.93 . . . . 0.0 112.965 176.571 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 1.6 tmt_? -70.75 139.15 51.01 Favored 'General case' 0 N--CA 1.475 0.786 0 O-C-N 122.261 -0.275 . . . . 0.0 110.424 -178.753 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 85.31 4.27 86.33 Favored Glycine 0 C--O 1.223 -0.551 0 N-CA-C 110.851 -0.9 . . . . 0.0 110.851 177.66 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 -147.16 -179.86 7.12 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 -174.257 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 97.48 -28.35 14.57 Favored Glycine 0 CA--C 1.499 -0.943 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.816 175.543 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 94.6 t -64.4 127.9 92.71 Favored Pre-proline 0 C--N 1.321 -0.642 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 177.1 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -73.76 170.72 19.37 Favored 'Trans proline' 0 N--CA 1.461 -0.431 0 O-C-N 122.236 0.598 . . . . 0.0 111.793 178.902 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 94.6 mt -68.07 112.7 3.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 178.784 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 80.5 m-20 -104.12 93.42 4.83 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 114.68 -1.145 . . . . 0.0 110.303 -176.855 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 67.4 p -69.39 -16.79 63.59 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.584 -0.734 . . . . 0.0 112.281 -179.032 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 10.9 p30 -106.92 22.76 15.46 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.057 -0.974 . . . . 0.0 113.227 -177.006 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 16.3 m -139.5 147.02 40.7 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 116.742 2.127 . . . . 0.0 116.742 -175.242 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 2.0 m -71.34 166.55 37.87 Favored Pre-proline 0 N--CA 1.468 0.431 0 CA-C-N 114.706 -1.133 . . . . 0.0 109.658 175.228 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -66.65 -27.97 44.89 Favored 'Trans proline' 0 CA--C 1.536 0.613 0 C-N-CA 114.238 -3.375 . . . . 0.0 113.922 -179.796 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.458 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 3.1 p-10 -75.28 -20.64 59.03 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.871 0.843 . . . . 0.0 110.944 178.057 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -83.49 -11.43 57.48 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 114.09 1.144 . . . . 0.0 114.09 -173.747 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 97.5 mm-40 -56.69 -29.79 62.75 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 115.512 1.671 . . . . 0.0 115.512 -177.03 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 12.0 tt -56.79 139.57 16.13 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.007 0 N-CA-C 114.385 1.254 . . . . 0.0 114.385 -176.948 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -177.31 -157.4 18.18 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.619 -0.8 . . . . 0.0 113.428 -178.413 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 41.4 p90 -154.66 170.53 21.33 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 179.766 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 23.5 m-85 -113.68 142.03 46.51 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 173.546 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 59.8 ttt180 -113.57 120.02 39.51 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 114.96 -1.018 . . . . 0.0 110.888 -175.455 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 3.6 ttt180 -63.06 140.95 58.93 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 123.184 0.594 . . . . 0.0 109.488 176.985 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -144.48 128.96 18.01 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.804 0.335 . . . . 0.0 110.173 177.442 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -158.79 134.17 8.58 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.129 178.574 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 18.5 tpt180 -145.94 123.74 11.94 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.479 0.657 . . . . 0.0 110.929 174.438 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 9.2 ttp180 -113.08 141.44 46.88 Favored 'General case' 0 CA--C 1.489 -1.394 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.423 178.495 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -131.56 177.77 6.53 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 N-CA-C 106.442 -1.688 . . . . 0.0 106.442 178.111 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 17.0 ttt85 -138.39 112.28 8.42 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 106.193 -1.781 . . . . 0.0 106.193 178.505 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -150.78 175.5 29.74 Favored Glycine 0 N--CA 1.444 -0.772 0 N-CA-C 107.145 -2.382 . . . . 0.0 107.145 178.395 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -75.25 -59.31 3.64 Favored Glycine 0 C--O 1.222 -0.624 0 N-CA-C 108.238 -1.945 . . . . 0.0 108.238 178.251 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.501 ' C ' ' H ' ' A' ' 60' ' ' LYS . 0.7 OUTLIER -94.26 -3.19 51.09 Favored 'General case' 0 C--O 1.217 -0.634 0 N-CA-C 105.207 -2.146 . . . . 0.0 105.207 174.266 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -89.53 33.89 4.21 Favored Glycine 0 N--CA 1.451 -0.314 0 N-CA-C 106.088 -2.805 . . . . 0.0 106.088 173.243 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.501 ' H ' ' C ' ' A' ' 58' ' ' ASP . 1.3 pttt -50.67 167.55 0.06 Allowed 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 113.415 -1.393 . . . . 0.0 111.028 172.268 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -46.69 129.59 11.31 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 113.926 -1.488 . . . . 0.0 113.698 -175.745 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -98.52 -73.99 0.6 Allowed 'General case' 0 C--O 1.219 -0.543 0 CA-C-N 113.666 -1.606 . . . . 0.0 114.044 -174.866 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 73.6 m-20 -95.06 96.66 9.4 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 179.349 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -74.58 -40.85 61.37 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 179.147 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 4.5 p -112.23 152.82 44.73 Favored Pre-proline 0 C--O 1.24 0.6 0 CA-C-N 114.962 -1.017 . . . . 0.0 108.985 179.723 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -74.34 156.68 45.96 Favored 'Trans proline' 0 C--O 1.238 0.497 0 C-N-CA 117.108 -1.461 . . . . 0.0 112.6 178.174 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 58.1 mtt-85 -124.58 149.87 46.55 Favored 'General case' 0 CA--C 1.513 -0.449 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.677 -179.657 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 35.0 m95 -134.75 129.82 35.24 Favored 'General case' 0 C--O 1.216 -0.662 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 175.565 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 60.0 m-85 -110.48 156.38 20.94 Favored 'General case' 0 C--O 1.212 -0.91 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 -178.96 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -97.97 136.91 37.57 Favored 'General case' 0 CA--C 1.509 -0.608 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 -179.84 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -139.12 130.31 26.73 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 107.097 -1.446 . . . . 0.0 107.097 -175.846 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 86.1 m-85 -70.69 159.47 34.4 Favored 'General case' 0 C--N 1.319 -0.756 0 O-C-N 122.191 -0.318 . . . . 0.0 111.063 -178.009 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -49.01 121.59 4.93 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 113.496 0.925 . . . . 0.0 113.496 -175.973 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 70.32 21.53 77.36 Favored Glycine 0 C--O 1.224 -0.529 0 N-CA-C 116.44 1.336 . . . . 0.0 116.44 176.009 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 34.2 p . . . . . 0 C--O 1.236 0.387 0 CA-C-N 118.604 1.202 . . . . 0.0 111.648 -179.742 . . . . . . . . 0 0 . 1 . 038 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 14.7 mt . . . . . 0 N--CA 1.444 -0.775 0 N-CA-C 115.412 1.634 . . . . 0.0 115.412 . . . . . . . . . 0 0 . 1 . 038 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -77.62 161.77 30.72 Favored 'Trans proline' 0 N--CA 1.461 -0.401 0 C-N-CA 122.061 1.84 . . . . 0.0 107.404 168.501 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 57.6 t80 -61.12 131.86 51.87 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 120.379 -0.529 . . . . 0.0 110.395 -177.177 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 92.98 -11.97 70.94 Favored Glycine 0 C--O 1.225 -0.432 0 CA-C-O 119.399 -0.667 . . . . 0.0 114.41 179.409 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -65.1 130.37 43.09 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 118.497 1.149 . . . . 0.0 112.071 -179.51 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 30.9 m120 -77.72 132.64 38.24 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 114.563 -1.199 . . . . 0.0 110.146 179.724 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 30.6 ttmt -156.21 155.35 32.26 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 104.148 -2.538 . . . . 0.0 104.148 177.795 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -65.75 133.22 50.57 Favored 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 120.273 -0.571 . . . . 0.0 109.672 -179.03 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 69.06 28.53 72.85 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.772 -0.728 . . . . 0.0 114.794 177.572 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 46.4 mm -126.01 126.6 70.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 117.476 0.638 . . . . 0.0 110.548 179.725 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -129.24 123.11 57.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.565 177.023 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 96.9 m95 -87.78 138.7 31.23 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 -176.758 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 13.7 m -138.02 151.49 25.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 179.102 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -160.29 165.86 30.57 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 104.833 -2.284 . . . . 0.0 104.833 -179.973 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 14.1 t -127.09 170.78 11.99 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 105.237 -2.135 . . . . 0.0 105.237 178.479 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -66.07 133.55 50.99 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.088 0.471 . . . . 0.0 110.651 -178.635 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 92.69 -7.5 77.21 Favored Glycine 0 N--CA 1.459 0.172 0 CA-C-N 116.017 -0.538 . . . . 0.0 113.422 178.749 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.458 ' HA ' ' HA ' ' A' ' 41' ' ' ASP . . . -74.63 140.49 44.33 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 178.504 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 39.6 mt -99.27 138.03 36.95 Favored 'General case' 0 CA--C 1.515 -0.385 0 N-CA-C 113.398 0.888 . . . . 0.0 113.398 -177.763 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -81.4 66.55 6.99 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.438 -178.751 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 1.2 t -133.11 155.36 81.1 Favored Pre-proline 0 C--N 1.32 -0.697 0 N-CA-C 105.327 -2.101 . . . . 0.0 105.327 -179.5 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -61.17 147.82 94.57 Favored 'Trans proline' 0 C--N 1.343 0.253 0 N-CA-C 114.614 0.967 . . . . 0.0 114.614 -179.603 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.522 ' HB3' HD12 ' A' ' 106' ' ' ILE . 74.1 mmtt -121.39 38.17 4.16 Favored 'General case' 0 CA--C 1.508 -0.643 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.332 -179.402 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 16.7 p-10 -59.9 -33.62 72.1 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 176.514 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 7.9 p80 -62.79 -16.19 56.94 Favored 'General case' 0 C--O 1.221 -0.411 0 N-CA-C 113.158 0.799 . . . . 0.0 113.158 177.973 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.522 HD12 ' HB3' ' A' ' 103' ' ' LYS . 60.2 mt -95.93 -49.96 11.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 120.977 0.418 . . . . 0.0 110.896 178.281 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -71.02 14.19 1.63 Allowed Glycine 0 C--O 1.22 -0.741 0 N-CA-C 117.53 1.772 . . . . 0.0 117.53 -174.124 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 9.0 t -83.59 26.43 0.68 Allowed 'General case' 0 CA--C 1.551 0.988 0 CA-C-O 121.671 0.748 . . . . 0.0 111.744 -179.31 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 64.8 ttp85 -68.32 119.43 12.84 Favored 'General case' 0 N--CA 1.465 0.325 0 O-C-N 121.271 -0.893 . . . . 0.0 109.978 178.66 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -86.54 122.17 71.95 Favored Pre-proline 0 C--N 1.323 -0.569 0 N-CA-C 105.103 -2.184 . . . . 0.0 105.103 176.571 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -72.78 -15.43 26.79 Favored 'Trans proline' 0 C--O 1.218 -0.494 0 C-N-CA 116.907 -1.595 . . . . 0.0 114.374 -177.174 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -81.57 -24.56 36.43 Favored 'General case' 0 C--O 1.221 -0.422 0 CA-C-O 120.963 0.411 . . . . 0.0 110.479 178.745 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 -100.15 -22.98 14.97 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 -174.504 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 18.2 t-20 -145.72 148.69 33.28 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -178.314 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -86.37 148.44 25.58 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-O 121.654 0.74 . . . . 0.0 112.536 -179.776 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -73.74 151.02 40.79 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.635 178.132 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 14.2 mt -90.73 139.62 17.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.565 -178.738 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 73.1 t -62.83 121.82 12.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 174.588 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 5.2 tt -67.18 129.45 39.95 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.189 0.519 . . . . 0.0 111.088 -176.923 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 34.5 mt-30 -135.88 158.41 44.47 Favored 'General case' 0 C--O 1.218 -0.562 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 -179.226 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 13.4 mt -112.18 148.0 38.16 Favored Pre-proline 0 C--N 1.322 -0.598 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 177.577 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -73.59 163.02 38.52 Favored 'Trans proline' 0 C--O 1.237 0.457 0 O-C-N 122.195 0.576 . . . . 0.0 112.546 179.179 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 53.9 tt0 -55.24 132.0 46.74 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 179.508 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 106.57 -27.06 17.9 Favored Glycine 0 C--O 1.226 -0.37 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.983 -178.515 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 8.9 m -105.44 129.33 53.77 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 118.04 0.92 . . . . 0.0 111.198 178.395 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 3.0 p -115.65 148.21 39.94 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.15 178.44 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 86.2 mt -71.4 152.94 94.09 Favored Pre-proline 0 C--N 1.323 -0.587 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 177.647 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -76.53 175.02 11.89 Favored 'Trans proline' 0 CA--C 1.531 0.325 0 N-CA-C 110.615 -0.571 . . . . 0.0 110.615 178.529 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 12.0 tmtt? -53.49 128.65 29.66 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 -175.571 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 88.43 -3.54 85.29 Favored Glycine 0 C--O 1.23 -0.151 0 N-CA-C 116.74 1.456 . . . . 0.0 116.74 173.497 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.461 ' CZ ' ' HB2' ' A' ' 18' ' ' GLN . 1.8 m-85 -93.18 144.09 25.62 Favored 'General case' 0 N--CA 1.433 -1.316 0 CA-C-O 122.718 1.247 . . . . 0.0 112.072 -178.464 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 34.6 p90 -144.52 164.47 30.79 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-N 112.636 -2.074 . . . . 0.0 106.773 174.193 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -106.35 147.06 29.65 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.243 0.545 . . . . 0.0 110.736 -177.381 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -75.8 129.91 37.77 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 -179.59 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 87.63 -0.32 84.78 Favored Glycine 0 C--O 1.225 -0.464 0 C-N-CA 121.161 -0.542 . . . . 0.0 112.55 -178.093 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 24.9 t . . . . . 0 C--N 1.327 -0.386 0 O-C-N 122.433 -0.451 . . . . 0.0 110.106 178.491 . . . . . . . . 0 0 . 1 . 039 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.217 0 N-CA-C 113.379 0.881 . . . . 0.0 113.379 . . . . . . . . . 0 0 . 1 . 039 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 28.4 t -58.88 134.97 57.39 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 114.548 -1.205 . . . . 0.0 108.63 174.591 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 3.1 m95 -67.55 -26.87 66.52 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 178.058 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -121.73 161.34 22.75 Favored 'General case' 0 CA--C 1.507 -0.676 0 CA-C-O 121.192 0.52 . . . . 0.0 110.312 -171.375 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 64.8 p -67.33 161.26 25.46 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 122.195 0.997 . . . . 0.0 109.561 179.622 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -92.14 120.71 33.0 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 114.686 -1.143 . . . . 0.0 112.474 -174.156 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -68.59 148.81 49.96 Favored 'General case' 0 CA--C 1.505 -0.768 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 179.96 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.487 HG23 HH22 ' A' ' 53' ' ' ARG . 17.4 m -93.26 136.62 33.35 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 176.947 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 20.0 tm0? -107.28 117.5 34.24 Favored 'General case' 0 CA--C 1.509 -0.621 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 177.144 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 22.7 t-160 -139.32 99.88 3.85 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 172.728 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 173.53 -166.12 38.33 Favored Glycine 0 C--N 1.319 -0.407 0 N-CA-C 110.521 -1.032 . . . . 0.0 110.521 -178.977 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 89.0 mttt -92.53 -24.8 18.64 Favored 'General case' 0 CA--C 1.512 -0.516 0 CA-C-O 121.993 0.901 . . . . 0.0 109.635 179.449 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -90.6 152.11 21.02 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 114.175 -1.375 . . . . 0.0 108.384 179.311 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -87.57 -62.4 1.51 Allowed 'General case' 0 C--O 1.21 -0.977 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.062 -177.421 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 49.6 tp 172.34 141.71 0.03 OUTLIER 'General case' 0 CA--C 1.506 -0.75 0 N-CA-C 104.572 -2.381 . . . . 0.0 104.572 176.824 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 23.3 tptt -161.94 143.38 10.99 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 106.606 -1.627 . . . . 0.0 106.606 178.185 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 16.6 m-85 -132.62 150.0 74.6 Favored Pre-proline 0 C--N 1.323 -0.558 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 177.398 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -76.56 166.87 26.56 Favored 'Trans proline' 0 C--N 1.351 0.702 0 C-N-CA 120.159 0.573 . . . . 0.0 113.402 179.593 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 21.3 tpt180 -64.14 136.11 56.95 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.587 -178.647 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 86.32 -1.91 87.48 Favored Glycine 0 N--CA 1.46 0.24 0 CA-C-O 121.395 0.442 . . . . 0.0 112.145 177.751 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 54.9 mt-30 -138.67 170.52 15.86 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 123.408 0.683 . . . . 0.0 110.433 -174.144 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 107.06 -26.82 17.88 Favored Glycine 0 CA--C 1.496 -1.103 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.67 175.249 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 85.1 t -65.27 125.49 89.51 Favored Pre-proline 0 C--N 1.32 -0.699 0 N-CA-C 105.498 -2.038 . . . . 0.0 105.498 176.372 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -71.6 164.52 35.44 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 N-CA-C 110.579 -0.585 . . . . 0.0 110.579 178.422 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 84.8 mt -61.99 115.0 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 -177.237 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -116.98 74.84 0.93 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 122.667 1.223 . . . . 0.0 112.307 -170.377 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 72.7 p -69.73 -19.51 63.54 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 114.371 -1.286 . . . . 0.0 113.506 -175.53 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 23.6 m120 -106.38 29.04 7.19 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.644 -0.707 . . . . 0.0 112.165 -174.195 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 97.8 p -146.46 160.73 41.72 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.919 0.39 . . . . 0.0 111.032 179.786 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.3 m -71.67 163.83 63.14 Favored Pre-proline 0 C--N 1.323 -0.546 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.67 -178.313 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -67.34 -28.39 39.56 Favored 'Trans proline' 0 C--N 1.351 0.658 0 C-N-CA 115.167 -2.755 . . . . 0.0 113.669 179.041 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.448 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 1.6 p-10 -75.13 -19.84 59.71 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 121.525 -0.734 . . . . 0.0 110.518 176.714 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.416 ' CG ' HD11 ' A' ' 106' ' ' ILE . 34.6 m-20 -84.45 -6.9 59.42 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 113.955 1.094 . . . . 0.0 113.955 -173.335 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 97.6 mm-40 -57.54 -32.53 67.17 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 114.144 1.165 . . . . 0.0 114.144 -179.113 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.488 ' HB ' ' HB1' ' A' ' 98' ' ' ALA . 10.4 tt -58.43 139.24 18.38 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 CA-C-O 122.382 1.087 . . . . 0.0 113.49 -176.904 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -176.26 -159.65 22.26 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.277 -0.964 . . . . 0.0 112.899 -178.166 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 38.3 p90 -154.82 166.6 32.97 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 179.511 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 13.3 m-85 -109.27 142.9 39.46 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 174.472 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 62.9 ttt180 -116.15 125.45 52.34 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 123.182 0.593 . . . . 0.0 111.044 -176.89 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 47.8 ttp180 -74.06 134.19 42.95 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 109.592 -0.522 . . . . 0.0 109.592 177.329 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -152.0 170.0 20.95 Favored 'General case' 0 C--O 1.213 -0.846 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 -179.072 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 8.9 t -136.82 142.41 42.89 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 119.161 0.891 . . . . 0.0 110.574 172.106 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 14.7 tpt180 -166.79 128.66 1.73 Allowed 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 179.226 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.487 HH22 HG23 ' A' ' 17' ' ' THR . 21.9 mmt180 -147.63 -179.42 6.86 Favored 'General case' 0 CA--C 1.48 -1.72 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 -179.01 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -117.25 170.92 6.19 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.97 0 CA-C-N 113.686 -1.597 . . . . 0.0 107.043 -177.105 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 8.7 ttm-85 -143.44 129.69 19.83 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 175.886 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -82.01 178.99 53.45 Favored Glycine 0 C--O 1.221 -0.703 0 N-CA-C 109.882 -1.287 . . . . 0.0 109.882 178.583 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -67.59 -36.34 87.89 Favored Glycine 0 C--O 1.217 -0.951 0 C-N-CA 121.008 -0.615 . . . . 0.0 114.116 -176.425 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -80.3 -16.59 54.28 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 122.143 0.973 . . . . 0.0 109.054 178.787 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 114.37 -6.37 23.03 Favored Glycine 0 N--CA 1.452 -0.293 0 CA-C-N 114.496 -1.229 . . . . 0.0 114.584 179.587 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.429 ' H ' ' HD2' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -61.33 150.47 34.91 Favored 'General case' 0 CA--C 1.506 -0.725 0 CA-C-N 118.334 1.067 . . . . 0.0 111.242 -178.404 . . . . . . . . 3 3 . 1 . 039 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 89.7 mtp -126.88 164.2 21.94 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 113.978 -1.464 . . . . 0.0 112.249 -176.647 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 2.0 tppt? -77.87 -37.43 48.2 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.298 -179.031 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 60.2 t0 -175.53 167.1 3.27 Favored 'General case' 0 C--N 1.318 -0.778 1 N-CA-C 99.283 -4.34 . . . . 0.0 99.283 -177.242 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -109.95 -31.83 7.25 Favored 'General case' 0 N--CA 1.435 -1.205 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 176.72 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.5 m -55.91 156.55 9.64 Favored Pre-proline 0 C--O 1.245 0.853 0 N-CA-C 116.342 1.979 . . . . 0.0 116.342 -174.949 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -75.62 -176.68 3.1 Favored 'Trans proline' 0 C--N 1.354 0.822 0 C-N-CA 121.039 1.16 . . . . 0.0 114.276 -179.275 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 81.0 mtt-85 -133.75 166.36 22.83 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.488 -177.836 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 50.9 m95 -125.39 131.72 52.9 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 173.751 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 24.1 m-85 -110.55 166.86 10.66 Favored 'General case' 0 C--O 1.216 -0.683 0 N-CA-C 105.45 -2.055 . . . . 0.0 105.45 -177.595 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 93.4 t80 -117.92 134.91 54.49 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-N 119.287 0.948 . . . . 0.0 109.721 -178.949 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 16.7 m-85 -136.36 158.88 43.38 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 -177.316 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 63.3 m-85 -98.63 159.34 15.02 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 -174.794 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -53.83 127.71 27.06 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.986 0.422 . . . . 0.0 111.039 -178.167 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 68.17 31.78 75.29 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.439 -0.886 . . . . 0.0 114.84 176.76 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.478 HG22 ' HA ' ' A' ' 104' ' ' ASP . 2.3 p . . . . . 0 C--N 1.327 -0.37 0 N-CA-C 105.181 -2.155 . . . . 0.0 105.181 174.16 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 13.2 mt . . . . . 0 N--CA 1.44 -0.972 0 N-CA-C 115.039 1.496 . . . . 0.0 115.039 . . . . . . . . . 0 0 . 1 . 039 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -78.4 161.61 28.45 Favored 'Trans proline' 0 N--CA 1.461 -0.424 0 C-N-CA 122.226 1.951 . . . . 0.0 107.304 167.772 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 57.7 t80 -61.11 130.66 47.44 Favored 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 120.315 -0.554 . . . . 0.0 110.44 -177.576 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 93.27 -8.51 75.32 Favored Glycine 0 CA--C 1.52 0.351 0 CA-C-O 119.35 -0.694 . . . . 0.0 114.352 178.956 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -67.12 131.73 46.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 118.607 1.203 . . . . 0.0 111.247 179.754 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 57.0 t30 -78.93 132.13 36.62 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.734 -0.667 . . . . 0.0 110.167 179.895 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 29.0 ttmt -155.97 154.38 31.02 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 106.146 -1.798 . . . . 0.0 106.146 179.28 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -61.4 129.32 40.64 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.081 0.467 . . . . 0.0 111.136 -178.648 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 67.86 30.08 74.11 Favored Glycine 0 N--CA 1.449 -0.474 0 CA-C-O 119.175 -0.792 . . . . 0.0 114.185 177.624 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 43.3 mm -126.04 131.86 71.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 117.845 0.822 . . . . 0.0 111.286 179.632 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -134.93 122.64 38.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.776 175.636 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 95.8 m95 -87.18 137.97 31.89 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 113.167 0.803 . . . . 0.0 113.167 -176.913 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 17.7 m -137.48 150.67 25.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.607 179.326 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -160.39 166.03 30.06 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 105.03 -2.211 . . . . 0.0 105.03 179.907 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 7.1 t -134.41 176.63 8.43 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 105.305 -2.109 . . . . 0.0 105.305 177.849 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -67.56 135.24 52.64 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.302 0.572 . . . . 0.0 110.702 -178.473 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 96.57 -12.7 66.1 Favored Glycine 0 C--O 1.228 -0.269 0 CA-C-N 115.703 -0.68 . . . . 0.0 112.911 178.341 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.488 ' HB1' ' HB ' ' A' ' 44' ' ' ILE . . . -77.16 137.09 38.67 Favored 'General case' 0 CA--C 1.543 0.676 0 O-C-N 122.694 -0.297 . . . . 0.0 110.622 179.982 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 40.6 mt -98.78 138.55 35.76 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 -177.884 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -80.11 63.8 4.73 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.165 -179.023 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 1.4 t -132.27 154.96 81.8 Favored Pre-proline 0 C--N 1.323 -0.581 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 -179.399 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -66.52 148.23 83.38 Favored 'Trans proline' 0 CA--C 1.53 0.319 0 N-CA-C 114.48 0.915 . . . . 0.0 114.48 175.974 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -148.83 57.9 1.04 Allowed 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 113.571 0.952 . . . . 0.0 113.571 179.212 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 104' ' ' ASP . . . . . 0.478 ' HA ' HG22 ' A' ' 75' ' ' THR . 12.5 t0 -64.56 -11.34 33.51 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 121.28 0.562 . . . . 0.0 110.658 175.782 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 12.5 p-80 -62.45 -13.42 29.88 Favored 'General case' 0 N--CA 1.468 0.473 0 O-C-N 122.038 -0.414 . . . . 0.0 111.679 177.412 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.416 HD11 ' CG ' ' A' ' 42' ' ' ASP . 20.6 mt -96.09 -28.75 3.91 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 CA-C-O 120.819 0.342 . . . . 0.0 111.023 179.079 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -73.46 3.74 31.05 Favored Glycine 0 N--CA 1.462 0.387 0 N-CA-C 115.09 0.796 . . . . 0.0 115.09 -176.117 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 14.4 t -83.22 19.03 1.56 Allowed 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 113.515 0.931 . . . . 0.0 113.515 -177.694 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 67.1 ttp85 -64.39 114.95 4.63 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 177.664 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 58.8 m-20 -91.12 121.36 67.93 Favored Pre-proline 0 C--N 1.318 -0.78 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 -178.596 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -68.93 -18.74 40.85 Favored 'Trans proline' 0 C--N 1.347 0.493 0 N-CA-C 114.343 0.863 . . . . 0.0 114.343 -176.176 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -73.77 -26.01 60.43 Favored 'General case' 0 C--O 1.22 -0.469 0 CA-C-O 120.734 0.302 . . . . 0.0 110.548 177.365 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 76.5 m-20 -103.49 -27.1 12.58 Favored 'General case' 0 C--O 1.222 -0.361 0 N-CA-C 113.421 0.897 . . . . 0.0 113.421 -174.95 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 18.6 t-20 -147.35 145.04 29.17 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.818 0.673 . . . . 0.0 112.818 -178.751 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -83.19 146.16 28.76 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-O 121.517 0.675 . . . . 0.0 111.911 -179.79 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -70.38 144.13 51.69 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 177.325 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 12.0 mt -76.9 135.63 26.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 -178.406 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 72.9 t -63.75 118.33 5.8 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 N-CA-C 103.633 -2.729 . . . . 0.0 103.633 172.859 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 6.8 tt -63.18 130.99 46.96 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.38 0.609 . . . . 0.0 112.072 -174.061 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 30.8 mt-30 -130.58 150.46 51.77 Favored 'General case' 0 CA--C 1.508 -0.671 0 N-CA-C 106.084 -1.821 . . . . 0.0 106.084 179.089 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 12.5 mt -110.37 148.3 38.13 Favored Pre-proline 0 C--N 1.319 -0.76 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 177.773 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -73.71 166.07 30.69 Favored 'Trans proline' 0 C--O 1.236 0.416 0 C-N-CA 118.239 -0.707 . . . . 0.0 112.659 -179.605 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 40.5 tt0 -54.04 131.88 41.52 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.073 179.425 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 104.1 -27.35 19.77 Favored Glycine 0 C--O 1.226 -0.356 0 CA-C-N 115.91 -0.587 . . . . 0.0 112.288 -178.598 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 2.7 m -105.98 129.34 54.12 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 118.207 1.004 . . . . 0.0 112.205 178.759 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 9.4 p -119.8 148.24 43.68 Favored 'General case' 0 CA--C 1.509 -0.607 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.899 178.423 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 93.1 mt -68.07 154.31 94.06 Favored Pre-proline 0 C--N 1.323 -0.571 0 N-CA-C 106.935 -1.506 . . . . 0.0 106.935 177.2 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -76.77 177.6 8.65 Favored 'Trans proline' 0 N--CA 1.464 -0.214 0 CA-C-O 121.446 0.519 . . . . 0.0 112.442 -178.795 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 3.0 ttpm? -59.77 130.65 47.85 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.118 -0.492 . . . . 0.0 109.701 179.072 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 84.26 23.21 52.36 Favored Glycine 0 N--CA 1.454 -0.138 0 N-CA-C 115.44 0.936 . . . . 0.0 115.44 176.876 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -124.73 141.72 51.91 Favored 'General case' 0 CA--C 1.51 -0.568 0 CA-C-O 121.426 0.631 . . . . 0.0 112.152 179.382 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 45.4 p90 -145.6 153.21 40.81 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 107.259 -1.386 . . . . 0.0 107.259 172.584 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -89.18 139.21 30.71 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.186 0.517 . . . . 0.0 111.025 -177.577 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -71.38 137.87 48.72 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 176.325 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 89.34 -2.34 83.15 Favored Glycine 0 C--O 1.224 -0.53 0 N-CA-C 111.653 -0.579 . . . . 0.0 111.653 -178.215 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 9.6 t . . . . . 0 C--N 1.327 -0.409 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 177.46 . . . . . . . . 0 0 . 1 . 040 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.228 -0.078 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 . . . . . . . . . 0 0 . 1 . 040 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 46.6 t -64.01 141.83 58.63 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 177.973 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 17.8 m95 -68.44 -21.72 64.63 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 111.944 0.35 . . . . 0.0 111.944 178.284 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 64.8 m-85 -121.53 164.38 17.32 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 -172.366 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 73.8 p -70.01 161.53 29.9 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 178.97 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.452 ' HB2' ' CZ ' ' A' ' 69' ' ' TYR . . . -76.22 149.74 37.18 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 113.743 1.016 . . . . 0.0 113.743 -175.425 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 13.9 mt -91.99 148.87 21.87 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 103.818 -2.66 . . . . 0.0 103.818 170.425 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 19.6 m -122.33 137.63 54.79 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 -179.186 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.435 ' HB2' ' CZ ' ' A' ' 131' ' ' PHE . 4.4 tp60 -112.05 133.11 54.41 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 -177.669 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 8.7 t60 -126.9 99.43 5.73 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 105.178 -2.156 . . . . 0.0 105.178 171.18 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 175.25 -172.77 45.78 Favored Glycine 0 C--O 1.227 -0.286 0 N-CA-C 110.212 -1.155 . . . . 0.0 110.212 -177.626 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -99.21 -27.29 13.87 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 121.048 0.451 . . . . 0.0 111.27 179.496 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -80.93 166.7 20.62 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 107.038 -1.467 . . . . 0.0 107.038 177.06 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -94.48 -62.78 1.27 Allowed 'General case' 0 CA--C 1.548 0.888 0 CA-C-O 118.443 -0.789 . . . . 0.0 112.156 -176.662 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.426 HD13 ' CZ ' ' A' ' 131' ' ' PHE . 33.7 tp -175.08 140.95 0.54 Allowed 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 124.044 0.938 . . . . 0.0 109.413 172.821 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 50.2 tptt -151.77 138.85 19.14 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 172.67 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -122.25 153.71 61.78 Favored Pre-proline 0 C--O 1.242 0.671 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 176.533 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -70.33 158.15 57.1 Favored 'Trans proline' 0 C--N 1.353 0.795 0 O-C-N 122.079 0.515 . . . . 0.0 112.727 179.458 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 70.9 ttt180 -70.16 134.36 48.05 Favored 'General case' 0 C--O 1.216 -0.688 0 O-C-N 121.848 -0.533 . . . . 0.0 111.072 -177.725 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 90.13 1.16 76.25 Favored Glycine 0 N--CA 1.462 0.409 0 CA-C-O 121.649 0.583 . . . . 0.0 112.035 179.262 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -146.77 170.45 16.97 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 107.497 -1.298 . . . . 0.0 107.497 -176.941 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 127.09 -28.39 4.6 Favored Glycine 0 CA--C 1.483 -1.948 0 N-CA-C 108.46 -1.856 . . . . 0.0 108.46 165.79 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 32.8 m -67.72 140.69 94.45 Favored Pre-proline 0 N--CA 1.429 -1.477 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 177.462 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -74.37 173.93 13.39 Favored 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 121.226 1.284 . . . . 0.0 111.91 178.918 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 92.7 mt -73.72 115.03 14.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 N-CA-C 107.494 -1.298 . . . . 0.0 107.494 177.823 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 31.6 m-20 -111.79 80.33 1.31 Allowed 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.423 -177.791 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 81.2 p -67.76 -16.2 64.01 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 113.835 1.05 . . . . 0.0 113.835 -176.877 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -106.83 21.31 17.72 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.375 -177.15 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 5.3 m -134.97 157.79 45.99 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.78 0.324 . . . . 0.0 111.483 -176.47 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 20.0 m -72.85 161.36 79.74 Favored Pre-proline 0 C--N 1.323 -0.549 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 178.615 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -65.19 -26.62 56.96 Favored 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 114.93 -2.913 . . . . 0.0 110.49 176.021 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -61.75 -19.32 62.32 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 124.578 1.151 . . . . 0.0 111.652 175.713 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -107.92 1.0 22.34 Favored 'General case' 0 C--O 1.217 -0.618 0 N-CA-C 115.027 1.491 . . . . 0.0 115.027 -172.617 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 85.7 mm-40 -61.45 -27.57 68.66 Favored 'General case' 0 C--O 1.216 -0.694 0 O-C-N 121.045 -1.034 . . . . 0.0 111.068 178.995 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 13.0 tt -60.35 144.05 13.65 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 N-CA-C 113.797 1.036 . . . . 0.0 113.797 179.209 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 178.85 -152.57 11.41 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.527 -0.844 . . . . 0.0 111.21 178.543 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 47.1 p90 -155.08 168.88 25.54 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 177.22 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 25.4 m-85 -113.34 141.07 47.48 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 106.648 -1.612 . . . . 0.0 106.648 174.071 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 38.6 ttt180 -111.05 127.6 55.6 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.37 -178.695 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 28.4 ttm180 -68.04 134.54 50.81 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 106.353 -1.721 . . . . 0.0 106.353 176.602 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -139.57 127.89 22.7 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 -176.734 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 6.8 p -139.62 131.95 28.37 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 174.773 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 11.2 tpt180 -160.73 123.83 3.34 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 178.621 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 2.5 tpp180 -97.17 137.42 36.23 Favored 'General case' 0 CA--C 1.501 -0.935 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 179.801 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -124.87 171.44 13.73 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 -179.201 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 8.1 tmm_? -134.66 114.03 12.32 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 106.324 -1.732 . . . . 0.0 106.324 177.745 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -74.5 165.07 54.75 Favored Glycine 0 N--CA 1.449 -0.497 0 N-CA-C 110.733 -0.947 . . . . 0.0 110.733 179.489 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -75.3 -27.42 63.84 Favored Glycine 0 C--O 1.217 -0.954 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 -179.562 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -89.77 14.61 11.45 Favored 'General case' 0 C--O 1.219 -0.523 0 CA-C-O 122.256 1.027 . . . . 0.0 109.706 179.077 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 86.21 -12.81 59.39 Favored Glycine 0 C--O 1.227 -0.288 0 N-CA-C 115.897 1.119 . . . . 0.0 115.897 173.706 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -64.5 130.49 43.9 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.699 0.762 . . . . 0.0 111.614 -178.609 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 94.8 mmm -91.86 -170.65 2.62 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 114.527 -1.215 . . . . 0.0 110.399 -178.489 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 18.4 tptp -92.79 -53.95 3.96 Favored 'General case' 0 CA--C 1.515 -0.395 0 N-CA-C 114.085 1.142 . . . . 0.0 114.085 179.436 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 38.45 -140.78 0.04 OUTLIER 'General case' 0 C--O 1.245 0.861 0 O-C-N 125.135 1.522 . . . . 0.0 113.025 -175.571 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 61.29 170.8 0.11 Allowed 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.694 1.198 . . . . 0.0 113.999 -176.232 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -74.69 165.35 54.46 Favored Pre-proline 0 C--O 1.24 0.589 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.71 -179.655 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -66.18 152.16 81.84 Favored 'Trans proline' 0 C--N 1.355 0.87 0 C-N-CA 117.818 -0.988 . . . . 0.0 112.053 178.67 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 30.7 mtt180 -124.02 166.3 15.97 Favored 'General case' 0 CA--C 1.51 -0.57 0 N-CA-C 114.779 1.4 . . . . 0.0 114.779 -175.958 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 67.4 m95 -130.43 146.84 52.06 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 177.922 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.452 ' CZ ' ' HB2' ' A' ' 15' ' ' ALA . 25.5 m-85 -130.64 144.11 51.2 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 -178.799 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 77.4 t80 -89.91 136.42 33.05 Favored 'General case' 0 CA--C 1.512 -0.485 0 N-CA-C 109.001 -0.741 . . . . 0.0 109.001 -177.218 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -139.64 143.23 37.09 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 108.812 -0.811 . . . . 0.0 108.812 -176.333 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -74.23 159.43 32.51 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.67 -175.993 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.1 tt -55.89 129.54 40.0 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 -176.137 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 69.0 34.54 76.79 Favored Glycine 0 C--O 1.222 -0.649 0 N-CA-C 115.487 0.955 . . . . 0.0 115.487 175.498 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.326 -0.432 0 CA-C-N 118.28 1.04 . . . . 0.0 111.334 -179.989 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 20.2 mt . . . . . 0 N--CA 1.448 -0.551 0 N-CA-C 115.683 1.734 . . . . 0.0 115.683 . . . . . . . . . 0 0 . 1 . 040 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -78.89 166.27 23.5 Favored 'Trans proline' 0 N--CA 1.46 -0.458 0 C-N-CA 121.826 1.684 . . . . 0.0 108.034 168.707 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 54.2 t80 -62.2 132.34 52.44 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 120.622 -0.431 . . . . 0.0 109.935 -179.96 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 92.06 -8.25 78.01 Favored Glycine 0 CA--C 1.52 0.358 0 N-CA-C 115.085 0.794 . . . . 0.0 115.085 178.794 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -64.35 131.48 47.38 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 118.321 1.06 . . . . 0.0 112.007 -179.963 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 33.4 t-20 -73.98 127.16 32.15 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.595 -178.517 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 26.4 ttmt -156.18 150.1 25.15 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 104.992 -2.225 . . . . 0.0 104.992 175.74 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -71.13 136.05 47.97 Favored 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 120.198 -0.601 . . . . 0.0 109.723 -177.376 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 73.58 21.09 79.81 Favored Glycine 0 N--CA 1.447 -0.59 0 CA-C-O 119.19 -0.783 . . . . 0.0 113.353 178.665 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 44.3 mm -124.87 121.83 62.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 117.542 0.671 . . . . 0.0 110.376 179.402 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -122.75 112.52 34.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 CA-C-O 121.862 0.839 . . . . 0.0 110.793 175.749 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 96.4 m95 -78.44 133.21 37.51 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.126 -178.814 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 1.7 m -140.81 149.73 20.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 -178.689 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -157.98 166.05 33.57 Favored 'General case' 0 CA--C 1.507 -0.696 0 N-CA-C 106.491 -1.67 . . . . 0.0 106.491 -178.404 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 5.9 t -132.44 171.5 13.68 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 105.94 -1.874 . . . . 0.0 105.94 174.897 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -67.65 138.86 56.67 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.258 0.551 . . . . 0.0 110.81 -178.142 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 96.46 -7.67 66.2 Favored Glycine 0 C--O 1.226 -0.386 0 CA-C-N 115.705 -0.68 . . . . 0.0 113.143 178.943 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -85.6 147.23 26.5 Favored 'General case' 0 CA--C 1.544 0.74 0 O-C-N 122.632 -0.334 . . . . 0.0 111.489 179.982 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 45.2 mt -92.02 139.7 30.38 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -178.274 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 60.8 t30 -90.45 66.61 6.43 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.057 0.456 . . . . 0.0 110.83 -179.463 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -141.31 155.88 67.62 Favored Pre-proline 0 C--N 1.323 -0.57 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 179.889 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -73.77 152.4 47.32 Favored 'Trans proline' 0 CA--C 1.535 0.565 0 N-CA-C 114.955 1.098 . . . . 0.0 114.955 178.313 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.54 57.96 1.12 Allowed 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 121.827 0.823 . . . . 0.0 111.125 179.171 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -57.9 -31.6 66.93 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.609 179.071 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 42.7 p-80 -63.12 -13.95 42.77 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 114.273 1.212 . . . . 0.0 114.273 -178.162 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 94.8 mt -87.92 -29.06 5.46 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 177.617 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -75.58 4.2 44.6 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 115.239 0.856 . . . . 0.0 115.239 -177.304 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 12.7 t -83.09 21.06 1.12 Allowed 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 -178.134 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 69.2 ttp85 -56.25 126.61 26.94 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 179.25 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -95.93 127.36 41.28 Favored Pre-proline 0 C--N 1.322 -0.619 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 -179.623 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -74.19 -15.14 23.04 Favored 'Trans proline' 0 C--O 1.219 -0.425 0 O-C-N 121.898 0.42 . . . . 0.0 112.717 -178.452 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -77.87 -25.34 48.57 Favored 'General case' 0 C--O 1.222 -0.394 0 CA-C-O 120.863 0.363 . . . . 0.0 110.239 178.188 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 -104.3 -25.63 12.79 Favored 'General case' 0 C--O 1.223 -0.341 0 N-CA-C 113.977 1.103 . . . . 0.0 113.977 -174.867 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 -147.2 150.18 34.4 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 -177.26 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -92.49 147.1 23.16 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 121.238 0.542 . . . . 0.0 111.206 179.405 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -74.11 153.39 39.6 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.239 177.931 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 2.5 mt -96.76 142.13 14.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 -178.132 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 87.0 t -58.05 125.04 13.42 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 176.87 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 6.4 tt -68.75 128.01 35.11 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.085 -177.848 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 29.8 mt-30 -132.36 154.42 49.79 Favored 'General case' 0 CA--C 1.508 -0.635 0 N-CA-C 107.119 -1.437 . . . . 0.0 107.119 -178.942 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 12.6 mt -109.44 148.93 39.07 Favored Pre-proline 0 C--N 1.321 -0.651 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 176.955 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -70.9 160.89 47.93 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 118.057 -0.829 . . . . 0.0 112.21 179.767 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -55.37 136.12 49.61 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 -179.249 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 95.11 -16.78 60.62 Favored Glycine 0 C--O 1.226 -0.374 0 CA-C-N 116.005 -0.543 . . . . 0.0 112.81 -177.566 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 6.2 m -108.63 128.3 54.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 117.827 0.814 . . . . 0.0 109.834 178.003 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 8.2 p -120.48 148.37 43.92 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.848 -178.522 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 85.7 mt -72.37 153.41 92.08 Favored Pre-proline 0 C--N 1.324 -0.515 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 177.776 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -76.32 170.89 19.1 Favored 'Trans proline' 0 N--CA 1.462 -0.352 0 C-N-CA 118.334 -0.644 . . . . 0.0 110.711 178.513 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -60.82 130.88 48.66 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.569 -177.44 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 95.1 -2.48 65.96 Favored Glycine 0 CA--C 1.517 0.189 0 N-CA-C 114.774 0.67 . . . . 0.0 114.774 178.209 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.435 ' CZ ' ' HB2' ' A' ' 18' ' ' GLN . 2.6 m-85 -106.43 140.07 39.92 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-O 121.732 0.777 . . . . 0.0 111.973 -179.376 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 52.6 p90 -145.52 164.34 31.93 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 114.423 -1.262 . . . . 0.0 108.069 174.515 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -105.38 147.18 28.48 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 112.481 0.549 . . . . 0.0 112.481 -176.465 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -74.97 134.88 41.41 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 178.645 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 86.03 -0.74 87.71 Favored Glycine 0 C--O 1.227 -0.321 0 C-N-CA 121.094 -0.574 . . . . 0.0 112.717 -179.959 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 8.7 t . . . . . 0 C--N 1.325 -0.465 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 178.03 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.683 0 CA-C-O 118.978 -0.901 . . . . 0.0 111.269 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -76.59 161.06 28.89 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 177.422 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 77.3 mtm -133.55 130.03 37.88 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 104.921 -2.251 . . . . 0.0 104.921 178.762 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -149.25 49.47 0.57 Allowed Glycine 0 C--O 1.225 -0.466 0 O-C-N 123.485 0.49 . . . . 0.0 112.414 -177.614 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 10.9 mp -64.56 145.15 98.66 Favored Pre-proline 0 CA--C 1.539 0.521 0 N-CA-C 108.031 -1.099 . . . . 0.0 108.031 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -77.15 50.59 3.18 Favored 'Trans proline' 0 CA--C 1.543 0.956 0 C-N-CA 121.71 1.607 . . . . 0.0 114.952 -177.13 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 -123.8 92.24 3.64 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 -179.554 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 17.9 t-20 -71.48 -55.59 7.58 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 116.107 -0.497 . . . . 0.0 112.221 -177.579 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 18.6 p 35.11 77.09 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 116.322 1.971 . . . . 0.0 116.322 178.849 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -95.76 140.8 30.03 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.186 -178.226 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 12.3 p -59.92 142.69 53.21 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.225 -0.898 . . . . 0.0 109.98 177.053 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' TRP . . . . . 0.437 ' CD2' ' HD3' ' A' ' 109' ' ' ARG . 12.4 m95 -67.3 -21.86 65.66 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 114.648 1.351 . . . . 0.0 114.648 -178.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -121.48 163.36 18.92 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 113.992 1.108 . . . . 0.0 113.992 -170.734 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 65.6 p -70.96 168.39 17.07 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.304 -1.317 . . . . 0.0 108.258 178.087 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.581 ' HB2' ' CZ ' ' A' ' 69' ' ' TYR . . . -78.34 149.4 33.44 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 114.182 1.178 . . . . 0.0 114.182 -175.515 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 13.9 mt -92.3 143.75 26.08 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 102.439 -3.171 . . . . 0.0 102.439 166.782 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 44.2 m -124.58 131.83 53.46 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 -178.494 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.403 ' HB2' ' CZ ' ' A' ' 131' ' ' PHE . 4.0 tp-100 -95.59 139.19 32.21 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.616 0.599 . . . . 0.0 112.616 -178.0 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 64.2 t60 -136.08 99.5 4.15 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 105.352 -2.092 . . . . 0.0 105.352 170.171 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 166.39 -160.02 33.47 Favored Glycine 0 C--O 1.227 -0.309 0 N-CA-C 110.294 -1.123 . . . . 0.0 110.294 -176.642 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -104.32 -23.69 13.18 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 112.809 0.67 . . . . 0.0 112.809 179.302 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 52.7 mm-40 -75.07 168.04 20.75 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 177.292 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -95.81 -62.84 1.22 Allowed 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 177.74 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 51.9 tp 173.76 136.04 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 125.761 1.624 . . . . 0.0 106.887 173.459 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 54.7 tptt -155.48 139.75 16.64 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 107.934 -1.135 . . . . 0.0 107.934 172.443 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 14.4 m-85 -117.84 142.82 31.4 Favored Pre-proline 0 C--O 1.241 0.655 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 176.755 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -64.6 165.89 19.27 Favored 'Trans proline' 0 CA--C 1.54 0.825 0 C-N-CA 122.209 1.939 . . . . 0.0 114.696 176.037 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 17.1 tpt180 -62.47 133.59 55.21 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.888 -178.347 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 77.53 15.81 80.98 Favored Glycine 0 C--O 1.223 -0.542 0 CA-C-N 115.894 -0.593 . . . . 0.0 112.651 175.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -148.37 167.66 24.67 Favored 'General case' 0 N--CA 1.442 -0.862 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 -174.632 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 111.58 -23.49 17.58 Favored Glycine 0 CA--C 1.497 -1.08 0 C-N-CA 121.809 -0.234 . . . . 0.0 113.36 173.616 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 93.1 t -65.67 127.12 92.8 Favored Pre-proline 0 C--N 1.318 -0.762 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 178.796 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -75.21 170.03 21.25 Favored 'Trans proline' 0 N--CA 1.461 -0.425 0 O-C-N 122.102 0.527 . . . . 0.0 111.429 178.634 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 97.6 mt -67.95 109.57 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-O 121.931 0.872 . . . . 0.0 109.109 179.778 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 73.2 m-80 -99.97 87.43 3.49 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 114.756 -1.111 . . . . 0.0 109.223 -179.052 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 72.5 p -67.82 -16.35 64.06 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 -178.592 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 11.4 p30 -108.19 22.9 15.3 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.318 -0.856 . . . . 0.0 112.843 -177.03 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 15.3 m -138.94 152.05 47.4 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 114.729 1.381 . . . . 0.0 114.729 -175.839 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 67.5 m -74.86 164.97 57.74 Favored Pre-proline 0 CA--C 1.537 0.469 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.479 177.492 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -65.48 -24.85 56.14 Favored 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 115.341 -2.64 . . . . 0.0 114.538 -178.481 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.436 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 6.1 p-10 -76.45 -26.09 55.06 Favored 'General case' 0 C--N 1.324 -0.539 0 O-C-N 121.625 -0.672 . . . . 0.0 110.906 177.026 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.555 ' HA ' ' HE3' ' A' ' 103' ' ' LYS . 15.2 m-20 -75.76 -10.75 59.69 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.198 0.999 . . . . 0.0 112.952 -175.809 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 96.8 mm-40 -58.55 -29.07 66.08 Favored 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 114.782 1.401 . . . . 0.0 114.782 -176.453 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.493 ' HB ' ' HB1' ' A' ' 98' ' ' ALA . 11.9 tt -59.5 140.22 18.0 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.874 0 CA-C-O 122.287 1.042 . . . . 0.0 112.843 -178.868 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -179.34 -155.63 15.47 Favored Glycine 0 CA--C 1.506 -0.482 0 C-N-CA 120.406 -0.902 . . . . 0.0 112.49 -178.701 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 50.3 p90 -154.99 171.7 19.31 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 179.021 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 19.3 m-85 -112.89 140.06 48.01 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 173.304 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 69.4 ttt-85 -111.33 124.66 52.68 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.979 -177.897 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 37.7 ttt-85 -65.05 141.1 58.86 Favored 'General case' 0 C--N 1.322 -0.625 0 O-C-N 123.557 0.536 . . . . 0.0 109.764 177.164 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -151.03 150.42 30.72 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.997 0.427 . . . . 0.0 110.605 179.781 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 34.0 p -145.89 168.41 20.89 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 103.621 -2.733 . . . . 0.0 103.621 174.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 14.5 tpt180 -149.08 131.08 15.28 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.604 0.716 . . . . 0.0 111.664 175.866 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 37.6 mtt180 -140.98 165.82 26.5 Favored 'General case' 0 CA--C 1.493 -1.241 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 178.626 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -132.33 175.93 10.19 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 N-CA-C 104.24 -2.504 . . . . 0.0 104.24 -179.186 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 3.5 tmt_? -120.69 99.38 6.5 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 178.232 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -76.09 150.36 38.95 Favored Glycine 0 N--CA 1.45 -0.43 0 N-CA-C 105.627 -2.989 . . . . 0.0 105.627 173.71 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -63.64 -36.1 92.9 Favored Glycine 0 C--O 1.217 -0.964 0 CA-C-N 118.669 1.235 . . . . 0.0 111.718 -179.422 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 27.2 t0 -89.08 17.15 6.12 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-O 122.328 1.061 . . . . 0.0 111.433 179.586 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 85.47 14.79 67.58 Favored Glycine 0 C--O 1.223 -0.578 0 CA-C-N 115.505 -0.77 . . . . 0.0 113.575 173.239 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 49.9 mmtt -69.61 133.67 47.86 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.58 0.705 . . . . 0.0 110.59 -176.451 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 4.0 mmt -113.11 155.3 25.18 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 114.225 -1.352 . . . . 0.0 111.101 -176.322 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 1.2 mmtp -96.28 -41.95 8.41 Favored 'General case' 0 CA--C 1.5 -0.979 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 173.848 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 11.3 t0 45.61 57.3 5.09 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 111.206 -2.724 . . . . 0.0 115.796 176.754 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 64.4 mt -68.58 138.68 55.28 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 177.849 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -58.67 161.81 7.68 Favored Pre-proline 0 C--O 1.242 0.698 0 CA-C-N 115.316 -0.856 . . . . 0.0 112.931 -177.587 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -62.22 134.85 51.07 Favored 'Trans proline' 0 C--N 1.354 0.864 0 C-N-CA 116.814 -1.657 . . . . 0.0 112.119 179.381 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 20.9 mtt-85 -132.15 161.12 34.12 Favored 'General case' 0 CA--C 1.503 -0.83 0 CA-C-N 114.338 -1.301 . . . . 0.0 109.805 -175.485 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 70.2 m95 -134.52 143.42 47.43 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 177.24 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.581 ' CZ ' ' HB2' ' A' ' 15' ' ' ALA . 70.7 m-85 -126.38 148.61 49.57 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 106.334 -1.728 . . . . 0.0 106.334 178.592 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 86.8 t80 -94.71 138.12 32.95 Favored 'General case' 0 CA--C 1.506 -0.727 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 -176.835 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 11.2 m-85 -138.86 142.19 38.61 Favored 'General case' 0 N--CA 1.438 -1.072 0 N-CA-C 106.53 -1.656 . . . . 0.0 106.53 -174.692 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 88.5 m-85 -80.89 159.52 24.98 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.437 0.161 . . . . 0.0 110.845 -175.632 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -56.12 126.69 27.13 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.9 0.381 . . . . 0.0 110.79 -177.722 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 69.29 38.63 81.74 Favored Glycine 0 C--O 1.218 -0.88 0 CA-C-O 119.106 -0.83 . . . . 0.0 114.75 176.179 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -89.17 146.1 25.0 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 105.623 -1.992 . . . . 0.0 105.623 177.591 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 92.2 131.47 5.48 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 106.4 -2.68 . . . . 0.0 106.4 -171.877 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -68.13 -39.32 10.73 Favored 'Trans proline' 0 C--N 1.346 0.42 0 CA-C-N 120.102 1.951 . . . . 0.0 116.127 -172.216 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -114.93 35.57 4.25 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.894 0.854 . . . . 0.0 108.897 -176.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -65.31 -29.1 69.82 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.769 -178.197 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 61.18 28.69 69.5 Favored Glycine 0 C--O 1.227 -0.283 0 N-CA-C 114.733 0.653 . . . . 0.0 114.733 178.041 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 17.3 mt -117.48 103.83 50.57 Favored Pre-proline 0 N--CA 1.446 -0.657 0 N-CA-C 114.39 1.256 . . . . 0.0 114.39 -177.836 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -78.58 164.49 25.92 Favored 'Trans proline' 0 C--O 1.235 0.374 0 C-N-CA 121.963 1.775 . . . . 0.0 108.318 169.823 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 57.9 t80 -61.79 132.03 51.8 Favored 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 120.396 -0.522 . . . . 0.0 110.085 -179.462 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 91.64 -5.98 79.99 Favored Glycine 0 CA--C 1.518 0.258 0 CA-C-O 119.417 -0.657 . . . . 0.0 114.493 178.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -63.5 131.24 47.49 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 118.369 1.085 . . . . 0.0 111.453 179.447 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 36.1 t-20 -77.87 127.3 32.16 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.496 -178.755 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 28.7 ttmt -156.2 151.26 26.38 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 105.508 -2.034 . . . . 0.0 105.508 178.03 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -64.66 132.14 48.89 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.085 0.469 . . . . 0.0 110.666 -178.044 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 68.29 27.31 73.8 Favored Glycine 0 N--CA 1.449 -0.439 0 CA-C-N 115.719 -0.673 . . . . 0.0 114.256 178.156 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 45.8 mm -124.84 123.42 65.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 117.419 0.609 . . . . 0.0 110.669 179.375 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.1 pt -127.16 111.94 27.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 CA-C-O 121.953 0.882 . . . . 0.0 111.762 177.051 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 95.1 m95 -77.36 136.83 38.47 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 112.983 0.734 . . . . 0.0 112.983 -177.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 17.3 m -138.86 151.61 23.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 C-N-CA 123.481 0.712 . . . . 0.0 109.824 179.796 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -157.01 166.59 32.93 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 105.877 -1.898 . . . . 0.0 105.877 179.494 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 14.5 t -130.34 176.34 8.21 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 105.521 -2.029 . . . . 0.0 105.521 178.73 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -67.58 135.07 52.35 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.162 0.506 . . . . 0.0 110.169 -179.253 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 93.19 -10.79 73.02 Favored Glycine 0 C--O 1.229 -0.182 0 CA-C-N 115.938 -0.574 . . . . 0.0 113.302 178.253 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.493 ' HB1' ' HB ' ' A' ' 44' ' ' ILE . . . -73.9 136.76 43.38 Favored 'General case' 0 CA--C 1.543 0.687 0 O-C-N 122.543 -0.387 . . . . 0.0 110.617 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 36.7 mt -95.72 139.57 31.76 Favored 'General case' 0 C--O 1.218 -0.601 0 N-CA-C 113.725 1.009 . . . . 0.0 113.725 -176.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 57.3 t30 -84.4 73.91 10.43 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.497 0.665 . . . . 0.0 110.52 179.515 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -146.41 159.25 45.56 Favored Pre-proline 0 C--N 1.321 -0.659 0 N-CA-C 103.024 -2.954 . . . . 0.0 103.024 179.445 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -73.27 149.95 46.38 Favored 'Trans proline' 0 CA--C 1.537 0.644 0 N-CA-C 114.061 0.754 . . . . 0.0 114.061 177.489 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.555 ' HE3' ' HA ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -142.29 58.69 1.46 Allowed 'General case' 0 N--CA 1.475 0.823 0 CA-C-O 122.799 1.285 . . . . 0.0 109.402 176.835 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -63.12 -23.77 67.59 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.263 -1.335 . . . . 0.0 110.963 178.235 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 17.9 p80 -55.87 -17.94 7.62 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 114.516 1.302 . . . . 0.0 114.516 -178.439 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 22.5 mt -88.81 -38.33 11.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 121.393 0.616 . . . . 0.0 109.842 -179.756 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -76.15 14.66 6.12 Favored Glycine 0 C--O 1.22 -0.767 0 N-CA-C 116.748 1.459 . . . . 0.0 116.748 -174.758 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 13.4 t -83.14 15.97 2.61 Favored 'General case' 0 CA--C 1.545 0.777 0 CA-C-N 117.985 0.893 . . . . 0.0 111.427 179.734 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.437 ' HD3' ' CD2' ' A' ' 12' ' ' TRP . 59.8 ttp85 -62.73 138.7 58.58 Favored 'General case' 0 C--N 1.327 -0.397 0 O-C-N 122.02 -0.425 . . . . 0.0 111.002 -178.89 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -110.28 123.64 35.41 Favored Pre-proline 0 C--O 1.236 0.342 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 177.122 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -75.06 -10.85 21.29 Favored 'Trans proline' 0 C--O 1.219 -0.453 0 N-CA-C 113.324 0.471 . . . . 0.0 113.324 -176.859 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -77.76 -24.96 48.83 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.045 178.012 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 75.2 m-20 -104.12 -25.56 12.9 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 113.989 1.107 . . . . 0.0 113.989 -173.334 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -142.67 154.55 44.44 Favored 'General case' 0 N--CA 1.433 -1.307 0 CA-C-O 121.261 0.553 . . . . 0.0 109.71 -176.301 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -92.93 142.7 27.01 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.197 -0.911 . . . . 0.0 110.206 179.321 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -68.74 147.11 52.28 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.239 0.543 . . . . 0.0 110.761 179.447 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 25.3 mt -81.77 138.38 19.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 -178.756 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 82.7 t -60.91 123.69 14.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 175.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 6.0 tt -67.66 128.82 37.87 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 -178.161 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -134.96 157.86 45.82 Favored 'General case' 0 CA--C 1.508 -0.653 0 N-CA-C 107.273 -1.38 . . . . 0.0 107.273 -177.844 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 13.8 mt -113.2 150.38 42.91 Favored Pre-proline 0 C--N 1.32 -0.699 0 N-CA-C 105.747 -1.946 . . . . 0.0 105.747 175.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -70.42 168.2 23.1 Favored 'Trans proline' 0 C--N 1.342 0.22 0 N-CA-C 114.143 0.786 . . . . 0.0 114.143 -176.515 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 49.7 tt0 -55.23 133.43 49.25 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.273 -178.032 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 89.61 -13.77 63.21 Favored Glycine 0 C--O 1.228 -0.28 0 CA-C-N 115.964 -0.562 . . . . 0.0 112.659 -179.343 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 18.6 m -106.92 128.38 54.26 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 117.356 0.578 . . . . 0.0 110.511 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 13.7 p -121.71 148.32 44.76 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.316 0.579 . . . . 0.0 112.483 -177.227 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 86.0 mt -68.52 156.26 90.99 Favored Pre-proline 0 C--N 1.326 -0.435 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 177.267 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -74.25 164.86 33.23 Favored 'Trans proline' 0 N--CA 1.461 -0.394 0 C-N-CA 117.655 -1.096 . . . . 0.0 110.941 178.431 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -60.13 130.46 46.77 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.174 -177.185 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 95.08 -3.93 67.28 Favored Glycine 0 C--O 1.225 -0.447 0 N-CA-C 114.823 0.689 . . . . 0.0 114.823 179.357 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.403 ' CZ ' ' HB2' ' A' ' 18' ' ' GLN . 0.8 OUTLIER -106.78 141.97 37.16 Favored 'General case' 0 CA--C 1.507 -0.703 0 CA-C-N 117.874 0.837 . . . . 0.0 110.743 179.306 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 43.7 p90 -142.53 161.29 38.44 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 114.382 -1.281 . . . . 0.0 107.983 175.849 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -104.86 146.98 28.25 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.652 0.739 . . . . 0.0 111.496 -177.501 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -74.23 127.52 33.18 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 179.644 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 87.94 -5.66 84.57 Favored Glycine 0 C--O 1.224 -0.523 0 CA-C-N 116.091 -0.504 . . . . 0.0 113.076 -178.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 33.7 t -96.17 148.57 22.57 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.411 0.624 . . . . 0.0 109.379 179.572 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 25.5 mmt85 -144.43 164.49 30.7 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 105.285 -2.117 . . . . 0.0 105.285 177.863 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -118.57 161.58 13.58 Favored Glycine 0 C--N 1.322 -0.231 0 N-CA-C 107.225 -2.35 . . . . 0.0 107.225 176.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 84.28 -160.09 36.1 Favored Glycine 0 N--CA 1.453 -0.196 0 N-CA-C 108.783 -1.727 . . . . 0.0 108.783 -177.328 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 7.2 m . . . . . 0 C--O 1.247 0.953 0 C-N-CA 123.751 0.82 . . . . 0.0 111.127 -177.71 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.79 0 CA-C-O 118.377 -1.235 . . . . 0.0 111.025 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -153.36 172.1 17.59 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 105.956 -1.868 . . . . 0.0 105.956 -178.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 59.6 mtt 54.07 46.0 26.36 Favored 'General case' 0 N--CA 1.474 0.74 0 O-C-N 124.231 0.957 . . . . 0.0 113.158 177.72 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -81.78 49.17 4.02 Favored Glycine 0 N--CA 1.461 0.337 0 N-CA-C 111.752 -0.539 . . . . 0.0 111.752 178.168 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 91.1 mt -75.13 155.32 86.33 Favored Pre-proline 0 C--N 1.322 -0.59 0 C-N-CA 123.019 0.528 . . . . 0.0 110.617 -177.364 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -68.75 158.03 59.46 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 117.471 -1.219 . . . . 0.0 111.665 177.61 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 -144.69 -61.93 0.37 Allowed 'General case' 0 C--O 1.217 -0.646 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.533 -177.648 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 9.0 t30 57.36 50.44 11.44 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 113.794 1.035 . . . . 0.0 113.794 177.171 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 33.5 p -134.32 136.3 43.38 Favored 'General case' 0 N--CA 1.437 -1.099 0 N-CA-C 103.51 -2.774 . . . . 0.0 103.51 177.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -141.12 141.25 34.2 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 115.024 -0.989 . . . . 0.0 108.657 179.076 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 41.3 t -61.13 140.9 57.79 Favored 'General case' 0 CA--C 1.513 -0.476 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 178.244 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 7.5 m95 -68.41 -21.93 64.65 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.486 178.373 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 29.8 m-85 -121.4 163.02 19.39 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 115.872 -0.604 . . . . 0.0 112.559 -171.36 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.418 ' HB ' ' HB3' ' A' ' 134' ' ' GLU . 71.7 p -71.55 163.07 28.42 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.495 -0.775 . . . . 0.0 108.926 178.911 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.445 ' HB2' ' CZ ' ' A' ' 69' ' ' TYR . . . -76.81 138.05 39.62 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -176.44 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 13.8 mt -82.74 145.03 29.79 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 104.45 -2.426 . . . . 0.0 104.45 171.486 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 20.0 m -127.47 133.27 49.91 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 118.331 0.514 . . . . 0.0 110.597 -178.908 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 4.0 tp-100 -89.52 150.74 22.31 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.869 179.27 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 73.5 t60 -136.38 99.25 4.04 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 103.189 -2.893 . . . . 0.0 103.189 166.383 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 162.79 -173.07 38.97 Favored Glycine 0 N--CA 1.451 -0.328 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 -175.692 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 55.3 mtmt -93.34 -29.44 15.63 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 114.962 1.467 . . . . 0.0 114.962 -176.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -87.39 157.31 19.27 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 106.906 -1.516 . . . . 0.0 106.906 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -83.52 -62.75 1.5 Allowed 'General case' 0 C--O 1.218 -0.566 0 N-CA-C 115.405 1.631 . . . . 0.0 115.405 -174.881 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 56.8 tp 179.1 143.3 0.13 Allowed 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 124.356 1.062 . . . . 0.0 108.154 178.06 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 13.6 tptm -158.86 141.23 14.05 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 173.333 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 7.9 m-85 -123.56 140.57 34.42 Favored Pre-proline 0 C--N 1.324 -0.524 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 176.885 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -61.54 155.52 52.57 Favored 'Trans proline' 0 CA--C 1.538 0.71 0 C-N-CA 120.283 0.656 . . . . 0.0 113.206 175.343 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 16.9 tpt180 -63.68 135.66 56.89 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.604 -177.764 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 83.9 10.31 81.2 Favored Glycine 0 C--O 1.225 -0.452 0 C-N-CA 121.368 -0.444 . . . . 0.0 112.348 178.435 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -148.14 168.64 21.9 Favored 'General case' 0 N--CA 1.443 -0.792 0 N-CA-C 106.975 -1.491 . . . . 0.0 106.975 -176.504 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 110.69 -19.89 25.45 Favored Glycine 0 CA--C 1.499 -0.946 0 CA-C-O 121.14 0.3 . . . . 0.0 113.643 172.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 99.2 t -65.41 128.16 93.56 Favored Pre-proline 0 C--N 1.319 -0.756 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 178.617 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -74.19 170.99 18.9 Favored 'Trans proline' 0 N--CA 1.46 -0.448 0 O-C-N 122.116 0.535 . . . . 0.0 111.327 178.02 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 89.9 mt -69.34 107.32 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-O 122.155 0.978 . . . . 0.0 108.656 179.379 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 -98.94 84.56 3.1 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 114.278 -1.328 . . . . 0.0 109.444 -177.326 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 70.4 p -66.56 -15.03 63.11 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.687 0.756 . . . . 0.0 112.895 -178.6 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 20.7 p30 -109.11 20.69 18.08 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 114.93 -1.032 . . . . 0.0 112.986 -177.128 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 27.9 m -139.02 147.95 42.77 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 113.693 0.997 . . . . 0.0 113.693 -176.46 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -72.21 167.14 34.84 Favored Pre-proline 0 C--N 1.327 -0.399 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 176.292 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -64.49 -28.18 62.03 Favored 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 115.185 -2.744 . . . . 0.0 111.958 178.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -62.31 -29.21 70.28 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 123.626 0.77 . . . . 0.0 111.422 176.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.598 ' HA ' ' HE3' ' A' ' 103' ' ' LYS . 62.1 m-20 -95.28 -0.3 53.06 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 114.584 1.328 . . . . 0.0 114.584 -171.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 94.7 mm-40 -60.7 -30.89 70.23 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 114.097 1.147 . . . . 0.0 114.097 178.92 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.43 ' HB ' ' HB1' ' A' ' 98' ' ' ALA . 20.6 tt -59.28 140.4 17.58 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.745 0 CA-C-O 122.385 1.088 . . . . 0.0 113.64 -177.674 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 179.88 -154.98 14.39 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.629 -178.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 50.4 p90 -155.02 171.13 20.25 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 178.736 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 17.8 m-85 -113.99 142.8 45.71 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 172.449 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 57.9 ttt180 -112.11 129.2 56.31 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.435 -179.005 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 27.5 ttt180 -67.22 136.27 54.72 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 123.452 0.701 . . . . 0.0 110.042 177.252 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -151.31 142.67 23.39 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.733 0.301 . . . . 0.0 110.606 178.44 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 9.3 t -148.42 151.24 34.9 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 176.585 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 8.3 tpt180 -164.84 124.97 1.94 Allowed 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 -178.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 15.1 ptt85 -106.93 158.92 16.66 Favored 'General case' 0 CA--C 1.508 -0.652 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 175.446 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -144.4 -179.57 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.913 0 N-CA-C 104.626 -2.361 . . . . 0.0 104.626 -175.321 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 5.6 mtt-85 -138.65 124.84 20.25 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 175.711 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -86.14 170.88 43.7 Favored Glycine 0 C--O 1.225 -0.412 0 N-CA-C 107.82 -2.112 . . . . 0.0 107.82 175.867 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -79.06 -28.59 53.68 Favored Glycine 0 C--O 1.216 -1.014 0 N-CA-C 108.194 -1.963 . . . . 0.0 108.194 179.459 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 43.2 t0 -76.22 -5.03 45.0 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-N 113.069 -1.566 . . . . 0.0 108.627 176.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 90.48 -11.72 70.54 Favored Glycine 0 CA--C 1.51 -0.277 0 CA-C-N 114.721 -1.127 . . . . 0.0 113.787 176.406 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -71.8 138.26 48.22 Favored 'General case' 0 CA--C 1.507 -0.692 0 CA-C-O 121.939 0.876 . . . . 0.0 109.868 -177.322 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 28.2 ptm -133.18 167.57 20.11 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 114.152 -1.385 . . . . 0.0 110.049 -178.398 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 29.0 mttp -75.67 -56.54 4.59 Favored 'General case' 0 C--O 1.219 -0.551 0 N-CA-C 113.814 1.042 . . . . 0.0 113.814 -177.821 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.6 t70 54.45 -140.13 0.96 Allowed 'General case' 0 CA--C 1.541 0.613 0 O-C-N 124.79 1.306 . . . . 0.0 110.065 -178.046 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 8.8 mt 61.11 173.84 0.11 Allowed 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 116.911 2.189 . . . . 0.0 116.911 177.463 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 36.6 m -67.52 160.79 70.35 Favored Pre-proline 0 C--O 1.238 0.497 0 CA-C-N 114.654 -1.157 . . . . 0.0 110.064 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -63.15 162.07 27.8 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 117.821 -0.986 . . . . 0.0 114.548 -179.507 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 18.5 mtp180 -108.01 160.29 15.9 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 106.801 -1.555 . . . . 0.0 106.801 -179.414 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 50.1 m95 -127.05 133.98 50.37 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.445 ' CZ ' ' HB2' ' A' ' 15' ' ' ALA . 54.4 m-85 -114.71 141.23 48.11 Favored 'General case' 0 C--O 1.216 -0.699 0 N-CA-C 107.961 -1.125 . . . . 0.0 107.961 -177.812 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 88.2 t80 -89.97 134.7 34.08 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 118.474 0.579 . . . . 0.0 109.847 -177.552 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -137.71 147.27 44.65 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 -177.404 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -82.4 159.46 22.99 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 -173.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 16.9 tp -59.43 128.8 38.86 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.383 0.611 . . . . 0.0 109.595 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 78.23 26.66 59.32 Favored Glycine 0 C--O 1.217 -0.964 0 N-CA-C 115.704 1.042 . . . . 0.0 115.704 177.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 2.4 p -89.4 146.06 24.92 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 119.093 1.447 . . . . 0.0 109.286 178.854 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 101.04 139.01 10.51 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 108.901 -1.68 . . . . 0.0 108.901 -176.716 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -68.36 -43.45 4.33 Favored 'Trans proline' 0 C--N 1.348 0.523 0 CA-C-N 119.787 1.794 . . . . 0.0 115.987 -173.652 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -112.79 36.64 3.38 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 -177.507 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -64.58 -43.33 94.2 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.678 -177.447 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 57.62 30.01 61.81 Favored Glycine 0 C--O 1.226 -0.396 0 CA-C-N 115.82 -0.627 . . . . 0.0 113.512 179.697 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 24.2 mt -111.47 103.83 55.46 Favored Pre-proline 0 N--CA 1.448 -0.573 0 N-CA-C 115.212 1.56 . . . . 0.0 115.212 -175.888 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -77.22 164.76 28.81 Favored 'Trans proline' 0 N--CA 1.459 -0.506 0 N-CA-C 108.002 -1.576 . . . . 0.0 108.002 170.05 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 70.0 t80 -62.62 128.57 36.6 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 120.478 -0.489 . . . . 0.0 110.584 -178.22 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 94.07 -5.5 72.03 Favored Glycine 0 CA--C 1.52 0.404 0 N-CA-C 114.851 0.7 . . . . 0.0 114.851 179.427 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -65.39 128.78 37.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 118.43 1.115 . . . . 0.0 112.314 179.506 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 72.2 m-20 -71.15 128.09 34.77 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 114.766 -1.107 . . . . 0.0 111.142 -178.345 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 25.2 ttmt -156.03 153.03 28.82 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 105.884 -1.895 . . . . 0.0 105.884 177.236 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 20.0 t0 -68.46 135.38 51.58 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.081 0.467 . . . . 0.0 110.12 -178.75 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 68.8 25.7 75.03 Favored Glycine 0 N--CA 1.447 -0.63 0 CA-C-N 115.735 -0.666 . . . . 0.0 114.133 177.488 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 42.8 mm -125.52 127.68 71.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 117.427 0.614 . . . . 0.0 109.989 179.669 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -129.39 115.91 37.17 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 CA-C-O 121.61 0.719 . . . . 0.0 110.202 176.64 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 97.7 m95 -82.38 134.79 35.26 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 113.773 1.027 . . . . 0.0 113.773 -175.611 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 20.8 m -136.6 149.81 27.01 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 CA-C-O 121.529 0.68 . . . . 0.0 110.537 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -157.03 166.56 32.98 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 103.93 -2.618 . . . . 0.0 103.93 -179.472 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 13.4 t -136.59 174.05 11.04 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 105.14 -2.17 . . . . 0.0 105.14 178.586 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -64.92 134.44 53.98 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.01 0.434 . . . . 0.0 109.971 -179.456 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 95.42 -5.86 67.87 Favored Glycine 0 C--O 1.225 -0.436 0 CA-C-N 115.992 -0.549 . . . . 0.0 113.769 178.459 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.43 ' HB1' ' HB ' ' A' ' 44' ' ' ILE . . . -83.15 138.25 33.73 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 122.262 -0.552 . . . . 0.0 110.46 -179.767 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 56.0 mt -88.79 141.11 28.77 Favored 'General case' 0 C--O 1.22 -0.485 0 CA-C-O 121.149 0.499 . . . . 0.0 111.559 -178.581 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -83.57 58.8 4.77 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.358 0.599 . . . . 0.0 110.98 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -139.02 158.31 69.87 Favored Pre-proline 0 C--N 1.325 -0.484 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 -177.907 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -73.09 158.89 48.68 Favored 'Trans proline' 0 CA--C 1.537 0.633 0 N-CA-C 115.272 1.22 . . . . 0.0 115.272 179.308 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.598 ' HE3' ' HA ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -154.42 57.93 0.7 Allowed 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 122.813 1.292 . . . . 0.0 109.572 177.137 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -59.04 -30.39 68.0 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.103 -1.408 . . . . 0.0 112.177 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 17.5 p80 -58.72 -11.2 2.89 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 115.091 1.515 . . . . 0.0 115.091 -177.859 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 33.3 mt -91.82 -32.28 5.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 178.731 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -71.75 -3.39 54.89 Favored Glycine 0 C--O 1.224 -0.479 0 N-CA-C 116.082 1.193 . . . . 0.0 116.082 -175.468 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 15.0 t -83.16 26.56 0.62 Allowed 'General case' 0 CA--C 1.549 0.92 0 N-CA-C 113.67 0.989 . . . . 0.0 113.67 -177.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 70.8 ttp85 -57.27 122.99 13.83 Favored 'General case' 0 N--CA 1.472 0.667 0 O-C-N 121.398 -0.814 . . . . 0.0 109.039 178.35 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 60.2 m-20 -90.0 119.08 69.35 Favored Pre-proline 0 C--N 1.324 -0.504 0 N-CA-C 107.208 -1.405 . . . . 0.0 107.208 -179.4 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -70.84 -15.93 33.02 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 117.898 -0.934 . . . . 0.0 114.117 -177.089 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -77.41 -25.76 51.05 Favored 'General case' 0 C--O 1.219 -0.503 0 CA-C-O 120.87 0.367 . . . . 0.0 110.391 178.191 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -102.8 -24.55 13.7 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 113.183 0.808 . . . . 0.0 113.183 -174.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 19.7 t-20 -149.12 146.54 27.74 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -177.828 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -88.35 151.14 22.8 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-O 121.575 0.702 . . . . 0.0 112.356 -179.444 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -75.01 149.72 39.18 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.412 177.872 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 7.9 mt -90.26 139.91 16.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 -178.797 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 85.4 t -60.58 124.24 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 N-CA-C 106.245 -1.761 . . . . 0.0 106.245 175.339 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 6.6 tt -67.23 130.84 44.38 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.148 0.499 . . . . 0.0 110.223 -176.867 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -134.09 158.22 44.17 Favored 'General case' 0 CA--C 1.509 -0.605 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 -178.342 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 13.7 mt -112.49 149.77 41.6 Favored Pre-proline 0 C--N 1.322 -0.626 0 N-CA-C 105.915 -1.883 . . . . 0.0 105.915 175.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_endo -70.35 168.83 21.2 Favored 'Trans proline' 0 C--N 1.342 0.213 0 N-CA-C 114.531 0.935 . . . . 0.0 114.531 -176.466 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 39.4 tt0 -54.52 130.85 41.33 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.758 -178.333 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 89.97 -11.79 69.58 Favored Glycine 0 C--O 1.226 -0.357 0 CA-C-N 115.786 -0.643 . . . . 0.0 112.87 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 18.1 m -106.99 126.64 52.59 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 117.37 0.585 . . . . 0.0 110.535 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 22.8 p -118.05 148.35 42.35 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 113.261 0.837 . . . . 0.0 113.261 -177.34 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 86.2 mt -68.74 155.91 92.15 Favored Pre-proline 0 C--N 1.324 -0.504 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 176.806 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -75.23 166.3 29.2 Favored 'Trans proline' 0 N--CA 1.462 -0.372 0 C-N-CA 117.44 -1.24 . . . . 0.0 110.315 177.258 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -58.94 130.96 49.52 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.061 -176.383 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 95.13 -9.88 69.93 Favored Glycine 0 C--O 1.224 -0.474 0 N-CA-C 115.137 0.815 . . . . 0.0 115.137 178.711 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -94.4 143.4 26.43 Favored 'General case' 0 N--CA 1.439 -1.002 0 CA-C-O 122.498 1.142 . . . . 0.0 111.717 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 39.9 p90 -142.32 163.78 31.91 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 113.231 -1.804 . . . . 0.0 107.654 175.757 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -106.46 144.17 33.51 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.1 0.476 . . . . 0.0 111.454 -177.344 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.418 ' HB3' ' HB ' ' A' ' 14' ' ' THR . 1.6 tp10 -69.62 129.95 41.06 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 106.544 -1.65 . . . . 0.0 106.544 177.446 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 93.1 -6.3 75.95 Favored Glycine 0 C--O 1.225 -0.446 0 C-N-CA 121.325 -0.464 . . . . 0.0 113.235 -179.281 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 35.3 t -111.17 137.0 49.4 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.125 -0.695 . . . . 0.0 109.125 177.779 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -145.63 116.3 7.67 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 110.501 -0.185 . . . . 0.0 110.501 -179.076 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -76.95 149.12 35.71 Favored Glycine 0 CA--C 1.516 0.132 0 N-CA-C 108.575 -1.81 . . . . 0.0 108.575 176.084 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -142.6 42.69 1.1 Allowed Glycine 0 C--O 1.225 -0.432 0 CA-C-N 117.949 0.875 . . . . 0.0 112.525 -177.735 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 18.9 m . . . . . 0 C--O 1.24 0.581 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 -179.287 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.57 0 CA-C-O 119.068 -0.851 . . . . 0.0 111.361 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -69.08 157.18 37.34 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 117.723 0.762 . . . . 0.0 109.266 179.253 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 20.6 ptp -155.95 158.51 38.04 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 103.722 -2.696 . . . . 0.0 103.722 178.904 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 78.78 30.19 49.02 Favored Glycine 0 C--O 1.223 -0.573 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.97 178.689 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 10.5 mp -60.98 140.54 93.88 Favored Pre-proline 0 C--O 1.24 0.567 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 -179.127 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -73.43 154.19 50.48 Favored 'Trans proline' 0 C--N 1.345 0.364 0 O-C-N 122.053 0.502 . . . . 0.0 112.923 -178.412 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 30.5 t-20 -158.64 114.55 2.66 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 178.879 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 11.7 p-10 -104.32 -6.93 20.37 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 111.881 0.326 . . . . 0.0 111.881 179.329 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 24.7 p -87.57 83.7 7.21 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 -178.601 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -93.18 147.55 22.79 Favored 'General case' 0 N--CA 1.442 -0.861 0 CA-C-N 115.169 -0.923 . . . . 0.0 112.388 -174.543 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.8 t -54.83 137.57 44.73 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 114.325 -1.307 . . . . 0.0 108.962 174.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 15.6 m95 -64.54 -21.89 66.82 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 178.671 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 46.5 m-85 -121.5 159.56 26.05 Favored 'General case' 0 C--O 1.241 0.612 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 -172.087 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.432 ' HB ' ' HB3' ' A' ' 134' ' ' GLU . 76.0 p -69.12 163.6 24.44 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 114.949 -1.023 . . . . 0.0 108.861 178.831 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -81.47 141.23 34.06 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 -176.417 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 27.5 mt -78.78 148.85 32.79 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 104.64 -2.356 . . . . 0.0 104.64 170.664 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 30.6 m -112.95 128.59 56.53 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 179.243 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 2.6 tm0? -93.24 134.82 35.04 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.025 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 78.0 t60 -139.41 99.45 3.74 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 106.172 -1.788 . . . . 0.0 106.172 168.313 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 169.49 -166.14 39.43 Favored Glycine 0 C--O 1.226 -0.373 0 C-N-CA 120.156 -1.021 . . . . 0.0 112.574 -177.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -101.79 -24.58 14.04 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -179.447 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -91.78 153.32 19.68 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 179.65 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -72.4 -62.85 1.29 Allowed 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -174.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 43.0 tp 174.6 145.77 0.06 Allowed 'General case' 0 N--CA 1.483 1.212 0 N-CA-C 105.949 -1.871 . . . . 0.0 105.949 175.628 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 54.0 tptt -156.03 138.7 15.1 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 175.138 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 16.8 m-85 -124.88 152.68 70.27 Favored Pre-proline 0 C--O 1.243 0.752 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 174.428 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -70.31 161.47 45.9 Favored 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 120.201 0.6 . . . . 0.0 112.672 178.856 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 20.9 tpt180 -69.07 135.25 50.5 Favored 'General case' 0 C--O 1.216 -0.66 0 O-C-N 122.147 -0.346 . . . . 0.0 110.105 -177.793 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 82.34 11.49 82.05 Favored Glycine 0 C--O 1.223 -0.576 0 N-CA-C 111.785 -0.526 . . . . 0.0 111.785 179.017 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 10.6 mt-30 -150.7 170.5 19.05 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 -175.218 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 107.37 -16.28 38.2 Favored Glycine 0 CA--C 1.503 -0.69 0 C-N-CA 121.429 -0.415 . . . . 0.0 113.204 175.217 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 57.4 t -67.91 129.19 93.31 Favored Pre-proline 0 C--N 1.319 -0.739 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 177.896 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -74.22 163.13 37.22 Favored 'Trans proline' 0 N--CA 1.459 -0.517 0 O-C-N 122.193 0.575 . . . . 0.0 111.967 178.375 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 93.7 mt -66.49 122.95 18.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.612 -177.55 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 44.8 t-20 -124.74 93.43 3.89 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.693 0.758 . . . . 0.0 110.373 179.342 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 82.6 p -75.98 -16.63 59.95 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 112.953 0.723 . . . . 0.0 112.953 -175.272 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 65.5 m-80 -104.33 32.77 3.83 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.631 -174.772 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 82.4 p -144.88 -179.08 6.37 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 114.735 1.383 . . . . 0.0 114.735 -176.354 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 56.8 m -105.05 165.93 12.33 Favored Pre-proline 0 CA--C 1.544 0.718 0 CA-C-N 114.947 -1.024 . . . . 0.0 108.942 178.449 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_endo -68.84 -18.96 41.3 Favored 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 116.405 -1.93 . . . . 0.0 114.983 -178.292 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.449 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 5.5 p-10 -75.03 -21.38 59.1 Favored 'General case' 0 C--N 1.324 -0.526 0 O-C-N 121.728 -0.608 . . . . 0.0 111.907 179.516 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -74.18 -23.09 59.18 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 114.183 1.179 . . . . 0.0 114.183 -174.362 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 93.7 mm-40 -53.61 -26.2 20.93 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 115.57 1.692 . . . . 0.0 115.57 -171.218 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.444 ' HB ' ' HB1' ' A' ' 98' ' ' ALA . 9.1 tt -64.43 136.5 26.41 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 CA-C-O 122.553 1.168 . . . . 0.0 112.203 -179.469 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 175.49 -156.89 22.95 Favored Glycine 0 CA--C 1.502 -0.72 0 C-N-CA 120.156 -1.021 . . . . 0.0 111.863 -178.447 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 47.1 p90 -155.1 170.45 21.76 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 -179.492 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 21.9 m-85 -109.53 139.49 44.47 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 106.538 -1.652 . . . . 0.0 106.538 174.084 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 58.4 ttt-85 -113.43 120.84 42.45 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 123.698 0.799 . . . . 0.0 111.253 -176.199 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 37.9 ttp85 -69.41 140.21 54.12 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.959 0.409 . . . . 0.0 109.933 177.806 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -144.28 149.41 36.23 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 122.979 0.511 . . . . 0.0 110.111 179.434 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 15.3 t -154.29 167.01 31.37 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 176.285 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 15.7 tpt180 -147.98 129.63 15.05 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 178.882 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 6.1 tpp180 -133.58 138.85 46.21 Favored 'General case' 0 CA--C 1.499 -1.01 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 -178.627 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -138.76 174.23 10.39 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 -178.284 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 1.7 ttt-85 -122.37 118.57 28.74 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 104.894 -2.262 . . . . 0.0 104.894 175.778 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -71.74 172.36 46.1 Favored Glycine 0 C--O 1.221 -0.71 0 N-CA-C 109.132 -1.587 . . . . 0.0 109.132 177.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -68.89 -37.69 84.05 Favored Glycine 0 C--O 1.222 -0.647 0 N-CA-C 110.303 -1.119 . . . . 0.0 110.303 -179.521 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -74.53 -12.27 60.43 Favored 'General case' 0 C--O 1.214 -0.799 0 CA-C-O 122.131 0.967 . . . . 0.0 109.582 177.143 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 104.54 -7.9 46.9 Favored Glycine 0 CA--C 1.505 -0.562 0 CA-C-N 115.685 -0.689 . . . . 0.0 113.14 173.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.95 139.5 58.25 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 122.143 0.973 . . . . 0.0 112.211 -177.048 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 91.1 mmm -93.84 166.16 12.32 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 113.845 -1.525 . . . . 0.0 110.615 -177.652 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 10.5 tttt -79.69 -49.01 12.73 Favored 'General case' 0 C--O 1.213 -0.862 0 N-CA-C 112.978 0.732 . . . . 0.0 112.978 177.895 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 44.88 24.02 0.1 Allowed 'General case' 0 N--CA 1.481 1.124 0 N-CA-C 117.815 2.524 . . . . 0.0 117.815 -178.972 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.4 mp -76.88 152.65 35.33 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 121.451 -0.781 . . . . 0.0 110.329 177.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -59.15 150.79 60.77 Favored Pre-proline 0 C--O 1.245 0.851 0 CA-C-N 115.188 -0.914 . . . . 0.0 113.391 -178.219 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -72.53 158.66 50.63 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 117.364 -1.291 . . . . 0.0 111.166 177.733 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 17.1 mtp180 -125.5 162.55 24.64 Favored 'General case' 0 CA--C 1.508 -0.648 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 -178.417 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 69.6 m95 -126.31 131.98 51.73 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 178.411 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 63.0 m-85 -111.4 150.23 30.08 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 106.113 -1.81 . . . . 0.0 106.113 178.682 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 79.1 t80 -94.1 134.91 36.02 Favored 'General case' 0 CA--C 1.507 -0.707 0 N-CA-C 106.44 -1.689 . . . . 0.0 106.44 179.226 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 8.8 m-85 -137.59 130.08 29.63 Favored 'General case' 0 N--CA 1.439 -0.984 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 -176.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.415 ' HB3' ' HB2' ' A' ' 103' ' ' LYS . 66.5 m-85 -66.08 159.56 25.79 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 114.581 -1.19 . . . . 0.0 111.745 -176.833 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -52.54 129.12 28.13 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.009 0.433 . . . . 0.0 111.229 -179.422 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 72.94 25.87 72.62 Favored Glycine 0 C--O 1.224 -0.511 0 N-CA-C 116.189 1.236 . . . . 0.0 116.189 177.038 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 63.2 p -108.19 148.87 29.3 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 118.647 1.223 . . . . 0.0 111.361 178.264 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 117.18 140.51 6.68 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 108.416 -1.873 . . . . 0.0 108.416 -177.205 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -68.16 -41.97 6.5 Favored 'Trans proline' 0 C--N 1.347 0.499 0 CA-C-N 120.044 1.922 . . . . 0.0 115.744 -173.298 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -111.6 23.65 13.67 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.757 0.789 . . . . 0.0 109.371 -178.351 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -62.4 -55.6 26.33 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.998 -176.009 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 56.18 35.95 66.73 Favored Glycine 0 C--O 1.226 -0.386 0 N-CA-C 111.561 -0.615 . . . . 0.0 111.561 -178.162 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 18.7 mt -113.73 103.86 55.27 Favored Pre-proline 0 C--O 1.238 0.489 0 N-CA-C 116.314 1.968 . . . . 0.0 116.314 -173.629 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -79.35 163.65 24.61 Favored 'Trans proline' 0 CA--C 1.53 0.305 0 C-N-CA 122.42 2.08 . . . . 0.0 108.296 168.829 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 75.0 t80 -61.51 130.86 48.01 Favored 'General case' 0 C--N 1.323 -0.555 0 O-C-N 121.88 -0.512 . . . . 0.0 111.283 -176.697 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 90.89 -5.95 81.95 Favored Glycine 0 C--O 1.227 -0.307 0 CA-C-O 119.286 -0.73 . . . . 0.0 114.519 178.765 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -64.22 130.44 43.91 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 118.438 1.119 . . . . 0.0 111.256 179.416 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 56.9 t30 -79.96 127.0 31.74 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.522 -178.879 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 29.8 ttmt -156.25 152.68 28.06 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 179.417 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 15.0 t0 -66.34 135.91 55.04 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 110.248 -0.279 . . . . 0.0 110.248 -179.492 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 67.14 27.18 73.4 Favored Glycine 0 N--CA 1.45 -0.403 0 CA-C-O 119.671 -0.516 . . . . 0.0 113.617 178.755 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 44.5 mm -129.31 128.44 66.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 121.168 0.509 . . . . 0.0 109.977 179.556 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -133.58 116.95 25.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 CA-C-O 121.359 0.6 . . . . 0.0 111.404 177.429 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 96.1 m95 -81.84 136.69 35.36 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 113.57 0.952 . . . . 0.0 113.57 -177.414 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 17.7 m -136.84 156.04 34.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 178.83 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -164.0 166.56 21.42 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 103.297 -2.853 . . . . 0.0 103.297 -179.335 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 10.8 t -137.59 -179.62 5.85 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 106.148 -1.797 . . . . 0.0 106.148 177.909 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -65.15 134.72 54.36 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.217 0.532 . . . . 0.0 110.56 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 92.7 -9.32 75.87 Favored Glycine 0 N--CA 1.458 0.136 0 CA-C-N 115.918 -0.583 . . . . 0.0 114.128 177.753 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.449 ' HA ' ' HA ' ' A' ' 41' ' ' ASP . . . -72.22 133.61 45.18 Favored 'General case' 0 CA--C 1.544 0.735 0 O-C-N 122.441 -0.446 . . . . 0.0 111.395 -179.44 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 25.6 mt -93.23 136.86 33.1 Favored 'General case' 0 CA--C 1.507 -0.711 0 CA-C-O 120.931 0.396 . . . . 0.0 111.601 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 62.8 t30 -80.58 69.47 7.09 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.215 -179.826 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 2.0 t -144.57 156.25 56.62 Favored Pre-proline 0 CA--C 1.541 0.599 0 N-CA-C 106.932 -1.507 . . . . 0.0 106.932 179.533 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -63.68 153.21 76.59 Favored 'Trans proline' 0 C--N 1.348 0.518 0 N-CA-C 114.629 0.973 . . . . 0.0 114.629 -179.121 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.503 ' HB3' HD12 ' A' ' 106' ' ' ILE . 73.5 mmtt -125.22 41.19 3.57 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 123.289 0.636 . . . . 0.0 110.02 -179.426 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 15.5 p-10 -53.11 -43.59 67.0 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.717 -0.674 . . . . 0.0 112.314 -177.363 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 17.7 p80 -70.33 -6.56 36.06 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 114.45 1.278 . . . . 0.0 114.45 -178.509 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.503 HD12 ' HB3' ' A' ' 103' ' ' LYS . 32.0 mt -96.35 -44.88 12.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 118.075 0.398 . . . . 0.0 109.938 178.909 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -71.35 14.68 1.68 Allowed Glycine 0 C--O 1.223 -0.592 0 N-CA-C 116.357 1.303 . . . . 0.0 116.357 -177.22 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 15.3 t -94.3 25.71 3.71 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 -177.487 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 65.2 ttp85 -58.13 121.07 9.79 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 178.454 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -88.8 126.68 58.75 Favored Pre-proline 0 C--N 1.322 -0.598 0 N-CA-C 106.588 -1.634 . . . . 0.0 106.588 -177.917 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -73.23 -14.36 25.68 Favored 'Trans proline' 0 C--O 1.218 -0.488 0 C-N-CA 117.629 -1.114 . . . . 0.0 114.019 -177.295 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -81.56 -24.46 36.54 Favored 'General case' 0 C--O 1.22 -0.462 0 CA-C-O 121.124 0.487 . . . . 0.0 110.098 178.786 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 74.9 m-20 -101.82 -24.84 13.99 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 113.343 0.868 . . . . 0.0 113.343 -174.13 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 19.8 t-20 -151.35 149.95 29.92 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 113.001 0.741 . . . . 0.0 113.001 -177.432 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -89.44 148.15 23.62 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-O 121.538 0.685 . . . . 0.0 111.867 179.508 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -71.25 147.23 48.4 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.186 178.645 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 18.8 mt -86.47 139.56 17.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 -179.357 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 75.0 t -62.0 123.64 15.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 N-CA-C 106.564 -1.643 . . . . 0.0 106.564 175.645 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 6.8 tt -67.01 127.41 32.47 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.017 0.436 . . . . 0.0 109.994 -177.37 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 33.3 mt-30 -132.76 157.16 45.64 Favored 'General case' 0 CA--C 1.511 -0.557 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 -179.254 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 13.3 mt -112.04 147.74 37.55 Favored Pre-proline 0 C--N 1.322 -0.612 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 177.789 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -73.04 164.63 34.98 Favored 'Trans proline' 0 C--O 1.236 0.387 0 O-C-N 122.272 0.617 . . . . 0.0 112.529 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 51.8 tt0 -55.35 133.74 49.82 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 100.34 -22.86 38.15 Favored Glycine 0 C--O 1.227 -0.337 0 CA-C-N 116.128 -0.487 . . . . 0.0 112.631 -178.607 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 5.0 m -107.02 128.4 54.33 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 117.961 0.88 . . . . 0.0 110.293 178.458 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 8.1 p -120.69 148.34 44.07 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.776 -178.782 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 88.4 mt -73.48 153.37 89.88 Favored Pre-proline 0 C--N 1.324 -0.517 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 177.284 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -76.51 171.2 18.49 Favored 'Trans proline' 0 C--O 1.234 0.281 0 C-N-CA 118.566 -0.489 . . . . 0.0 111.225 178.784 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 24.2 tptm -60.58 129.23 40.51 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 -179.301 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 91.03 18.4 47.05 Favored Glycine 0 C--O 1.223 -0.548 0 C-N-CA 120.931 -0.652 . . . . 0.0 114.655 178.262 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -127.21 141.71 51.67 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 117.596 0.698 . . . . 0.0 111.509 177.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 45.3 p90 -150.04 162.98 39.33 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 176.263 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -100.99 147.73 25.84 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.246 0.546 . . . . 0.0 111.844 -177.404 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.432 ' HB3' ' HB ' ' A' ' 14' ' ' THR . 0.9 OUTLIER -69.74 128.93 38.13 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 177.372 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 89.82 -7.31 82.0 Favored Glycine 0 C--O 1.225 -0.465 0 CA-C-N 116.315 -0.402 . . . . 0.0 113.54 179.422 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 34.5 t -79.34 127.21 31.79 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.402 0.62 . . . . 0.0 110.869 179.476 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 30.3 mmt180 -143.91 148.64 35.69 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 106.136 -1.802 . . . . 0.0 106.136 176.007 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 144.51 -172.78 25.38 Favored Glycine 0 CA--C 1.509 -0.292 0 N-CA-C 105.082 -3.207 . . . . 0.0 105.082 -178.161 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 74.58 49.84 10.52 Favored Glycine 0 C--O 1.229 -0.199 0 CA-C-N 118.553 1.177 . . . . 0.0 112.074 178.828 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 37.8 m . . . . . 0 C--O 1.253 1.278 0 CA-C-O 115.324 -2.274 . . . . 0.0 105.09 179.945 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.082 0 CA-C-O 118.703 -1.054 . . . . 0.0 111.273 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -70.97 125.08 25.88 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 118.611 1.206 . . . . 0.0 109.989 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 65.7 mtt -129.96 42.02 3.34 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 179.714 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -79.72 65.36 3.72 Favored Glycine 0 N--CA 1.459 0.205 0 CA-C-N 115.522 -0.763 . . . . 0.0 113.973 -177.64 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 10.8 mp -71.22 145.62 91.2 Favored Pre-proline 0 C--N 1.322 -0.628 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 178.85 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_endo -77.1 164.94 28.85 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 118.759 -0.36 . . . . 0.0 112.056 178.03 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 38.3 m-80 -141.7 -153.63 0.47 Allowed 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 101.377 -3.564 . . . . 0.0 101.377 177.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -97.59 44.18 1.05 Allowed 'General case' 0 C--N 1.313 -1.01 0 CA-C-O 121.969 0.89 . . . . 0.0 109.368 -176.727 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 24.0 p -142.44 129.45 20.75 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 103.822 -2.658 . . . . 0.0 103.822 -179.2 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -145.51 149.7 35.11 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.379 0.609 . . . . 0.0 111.286 -178.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 40.9 t -64.71 145.14 56.64 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 177.572 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 11.7 m95 -67.27 -21.91 65.69 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 122.799 0.44 . . . . 0.0 111.999 177.582 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 40.1 m-85 -121.4 165.56 15.38 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 114.136 1.161 . . . . 0.0 114.136 -170.458 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 73.6 p -71.85 163.13 28.37 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 114.63 -1.168 . . . . 0.0 108.662 177.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.46 ' HB2' ' CZ ' ' A' ' 69' ' ' TYR . . . -74.43 141.66 45.01 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -176.434 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.401 HD23 ' HA ' ' A' ' 16' ' ' LEU . 11.8 mt -85.94 143.84 27.96 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 102.962 -2.977 . . . . 0.0 102.962 169.837 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 21.5 m -124.54 137.39 54.41 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 -177.847 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.434 ' HB2' ' CZ ' ' A' ' 131' ' ' PHE . 4.7 tp60 -114.36 140.19 48.86 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 113.505 0.928 . . . . 0.0 113.505 -176.405 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 72.0 t60 -134.59 99.67 4.41 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 105.112 -2.181 . . . . 0.0 105.112 169.62 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 177.33 -169.2 41.31 Favored Glycine 0 N--CA 1.451 -0.334 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 -176.855 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 65.4 mttp -99.58 -26.95 13.92 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 117.398 0.599 . . . . 0.0 112.544 -179.7 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -85.74 158.01 20.13 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 178.614 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -82.46 -62.72 1.54 Allowed 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 120.786 -0.366 . . . . 0.0 111.782 -177.485 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 39.0 tp 179.62 142.55 0.14 Allowed 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 106.843 -1.54 . . . . 0.0 106.843 174.893 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -157.52 139.25 14.03 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 174.244 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 13.3 m-85 -123.22 151.57 62.42 Favored Pre-proline 0 C--O 1.239 0.537 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 176.717 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -74.28 165.55 31.58 Favored 'Trans proline' 0 CA--C 1.539 0.746 0 C-N-CA 120.058 0.505 . . . . 0.0 113.028 178.601 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 21.7 tpt180 -66.95 135.23 53.47 Favored 'General case' 0 C--O 1.216 -0.687 0 O-C-N 122.145 -0.347 . . . . 0.0 110.977 -177.664 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 82.95 4.24 90.1 Favored Glycine 0 C--O 1.223 -0.582 0 N-CA-C 111.935 -0.466 . . . . 0.0 111.935 178.156 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 40.0 mt-30 -141.79 170.6 15.4 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 123.206 0.602 . . . . 0.0 109.844 -174.465 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 105.61 -23.1 30.71 Favored Glycine 0 CA--C 1.498 -0.989 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.906 175.503 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 95.7 t -65.1 126.44 91.28 Favored Pre-proline 0 C--N 1.32 -0.694 0 N-CA-C 105.963 -1.866 . . . . 0.0 105.963 176.712 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -74.41 169.06 23.36 Favored 'Trans proline' 0 N--CA 1.459 -0.522 0 O-C-N 122.221 0.59 . . . . 0.0 110.912 179.168 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 92.8 mt -68.28 108.94 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 -179.435 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 75.0 m-80 -99.25 87.1 3.56 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 114.759 -1.109 . . . . 0.0 110.307 -177.243 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 73.7 p -68.73 -14.76 63.23 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.772 0.796 . . . . 0.0 112.243 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -107.34 18.8 21.15 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.861 -1.063 . . . . 0.0 113.357 -176.771 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 12.9 m -137.8 152.62 49.32 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 114.999 1.481 . . . . 0.0 114.999 -175.199 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.7 m -72.04 164.96 54.65 Favored Pre-proline 0 C--N 1.325 -0.482 0 CA-C-N 115.138 -0.937 . . . . 0.0 109.39 177.303 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -66.28 -27.3 48.24 Favored 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 114.858 -2.961 . . . . 0.0 113.861 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.448 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 2.1 p-10 -75.39 -22.32 57.56 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 121.57 -0.706 . . . . 0.0 110.916 177.01 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 56.4 m-20 -81.73 -7.18 59.57 Favored 'General case' 0 C--O 1.221 -0.406 0 N-CA-C 113.654 0.983 . . . . 0.0 113.654 -175.739 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 96.4 mm-40 -58.61 -28.18 65.38 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 113.797 1.036 . . . . 0.0 113.797 -178.819 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.528 ' HB ' ' HB1' ' A' ' 98' ' ' ALA . 9.8 tt -58.71 139.53 18.27 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.877 0 CA-C-O 122.302 1.049 . . . . 0.0 113.251 -179.214 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -179.88 -157.7 20.58 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.457 -0.878 . . . . 0.0 112.742 -179.509 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 41.6 p90 -155.06 171.75 19.25 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 179.441 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 20.2 m-85 -113.3 138.65 49.71 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 173.585 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 50.7 ttt180 -109.3 127.14 54.06 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.006 -178.3 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 40.8 ttt-85 -66.78 140.66 57.85 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 177.714 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -147.05 146.61 30.07 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.51 0.672 . . . . 0.0 111.361 179.656 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 21.2 p -144.31 157.65 44.16 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 104.235 -2.506 . . . . 0.0 104.235 175.59 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 19.0 tpp85 -147.3 125.68 12.34 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 118.296 0.498 . . . . 0.0 110.282 178.18 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 6.0 tmm_? -147.36 139.23 24.21 Favored 'General case' 0 CA--C 1.492 -1.282 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 179.431 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -132.56 179.1 4.71 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 N-CA-C 105.461 -2.052 . . . . 0.0 105.461 -178.529 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 56.1 ttp180 -120.96 113.61 20.35 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 106.855 -1.535 . . . . 0.0 106.855 172.479 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -95.98 147.36 18.62 Favored Glycine 0 C--N 1.317 -0.488 0 N-CA-C 106.114 -2.794 . . . . 0.0 106.114 177.877 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -63.92 -33.33 86.94 Favored Glycine 0 C--O 1.216 -0.969 0 CA-C-N 118.459 1.13 . . . . 0.0 111.584 -179.752 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 38.5 t0 -89.95 17.04 7.22 Favored 'General case' 0 CA--C 1.549 0.918 0 CA-C-O 122.263 1.03 . . . . 0.0 111.308 179.763 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 81.04 22.91 60.23 Favored Glycine 0 C--O 1.226 -0.404 0 CA-C-O 121.798 0.666 . . . . 0.0 113.823 172.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 21.9 mmtt -85.74 149.4 25.31 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.745 0.783 . . . . 0.0 112.26 -174.508 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 15.6 mtp -115.38 -179.89 3.77 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 113.824 -1.535 . . . . 0.0 110.886 -177.141 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -119.86 -65.4 1.16 Allowed 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 113.626 0.973 . . . . 0.0 113.626 -177.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -130.18 159.21 37.52 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 103.525 -2.768 . . . . 0.0 103.525 177.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 93.5 mt -121.22 -70.7 0.77 Allowed 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 120.769 0.318 . . . . 0.0 111.306 -179.49 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 16.0 m -67.73 152.72 96.07 Favored Pre-proline 0 C--O 1.239 0.55 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.13 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -68.2 148.15 74.12 Favored 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 116.99 -1.54 . . . . 0.0 111.858 178.146 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 34.6 mtt180 -128.7 164.13 23.61 Favored 'General case' 0 CA--C 1.508 -0.641 0 CA-C-N 115.923 -0.581 . . . . 0.0 112.477 -178.2 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 73.0 m95 -134.58 145.94 49.16 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 178.134 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.46 ' CZ ' ' HB2' ' A' ' 15' ' ' ALA . 22.1 m-85 -128.24 141.95 51.3 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 106.327 -1.731 . . . . 0.0 106.327 179.38 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 76.4 t80 -88.8 136.68 32.88 Favored 'General case' 0 CA--C 1.507 -0.702 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 -177.743 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -140.52 135.73 32.18 Favored 'General case' 0 N--CA 1.439 -1.0 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 -175.898 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 84.8 m-85 -73.26 159.5 33.33 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.425 -174.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -54.38 126.1 22.01 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.121 0.486 . . . . 0.0 111.545 -177.253 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 68.38 36.01 83.36 Favored Glycine 0 N--CA 1.448 -0.544 0 CA-C-O 119.048 -0.862 . . . . 0.0 114.326 176.45 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.3 p -89.2 146.04 25.02 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 106.619 -1.622 . . . . 0.0 106.619 176.145 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 89.69 129.67 3.85 Favored Glycine 0 CA--C 1.528 0.86 0 N-CA-C 108.977 -1.649 . . . . 0.0 108.977 -174.206 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -68.6 -36.99 13.45 Favored 'Trans proline' 0 C--N 1.346 0.417 0 CA-C-N 119.6 1.7 . . . . 0.0 116.437 -174.31 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 57.5 mt-10 -104.79 24.09 12.4 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 -175.79 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -63.04 -36.85 84.96 Favored 'General case' 0 C--O 1.24 0.553 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.568 -175.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 60.17 33.0 78.03 Favored Glycine 0 C--O 1.229 -0.193 0 CA-C-N 115.544 -0.753 . . . . 0.0 113.486 178.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 14.4 mt -124.66 103.91 31.17 Favored Pre-proline 0 N--CA 1.443 -0.814 0 N-CA-C 115.076 1.509 . . . . 0.0 115.076 -177.346 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -79.01 163.27 25.77 Favored 'Trans proline' 0 N--CA 1.462 -0.359 0 C-N-CA 122.352 2.035 . . . . 0.0 107.706 167.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 58.4 t80 -61.8 132.03 51.77 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 120.329 -0.549 . . . . 0.0 110.352 -178.027 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 90.94 -5.71 81.91 Favored Glycine 0 C--O 1.226 -0.362 0 CA-C-O 119.37 -0.683 . . . . 0.0 114.408 178.864 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -66.35 130.33 42.84 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 118.582 1.191 . . . . 0.0 111.117 179.126 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 57.5 t30 -77.11 128.07 33.78 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.24 -179.252 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 30.1 ttmt -156.17 151.78 27.07 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 179.499 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 29.4 t0 -64.81 132.38 49.34 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.933 0.397 . . . . 0.0 110.36 -178.398 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 68.1 28.83 73.24 Favored Glycine 0 N--CA 1.451 -0.351 0 CA-C-O 119.447 -0.64 . . . . 0.0 114.281 178.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 44.7 mm -128.3 127.56 67.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 117.465 0.632 . . . . 0.0 110.61 179.675 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -131.29 118.83 41.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.997 176.193 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 95.9 m95 -84.99 137.25 33.2 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 113.499 0.925 . . . . 0.0 113.499 -176.584 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 15.9 m -137.79 149.71 25.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.43 0.633 . . . . 0.0 109.856 179.488 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -157.81 166.43 32.74 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 105.43 -2.063 . . . . 0.0 105.43 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 14.7 t -131.34 179.84 5.78 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 105.94 -1.874 . . . . 0.0 105.94 178.492 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -67.54 135.38 52.89 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.231 0.539 . . . . 0.0 110.436 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 90.72 -9.33 78.01 Favored Glycine 0 C--O 1.23 -0.133 0 CA-C-N 115.932 -0.576 . . . . 0.0 113.513 177.586 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.528 ' HB1' ' HB ' ' A' ' 44' ' ' ILE . . . -73.15 131.43 42.03 Favored 'General case' 0 CA--C 1.544 0.733 0 O-C-N 122.525 -0.397 . . . . 0.0 110.646 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 26.7 mt -91.58 139.24 30.89 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 113.117 0.784 . . . . 0.0 113.117 -177.485 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 53.4 t30 -84.01 73.09 10.4 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.361 -179.613 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 1.3 t -142.23 152.33 60.81 Favored Pre-proline 0 C--N 1.323 -0.566 0 N-CA-C 107.551 -1.278 . . . . 0.0 107.551 179.131 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -66.45 149.18 84.68 Favored 'Trans proline' 0 CA--C 1.528 0.221 0 N-CA-C 114.278 0.838 . . . . 0.0 114.278 177.05 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -148.97 57.55 1.03 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.852 0.834 . . . . 0.0 112.733 179.124 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 32.0 t0 -60.51 -20.3 59.7 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.577 176.512 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 15.6 p80 -59.94 -10.98 4.67 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 113.543 0.942 . . . . 0.0 113.543 179.135 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 41.3 mt -96.21 -30.14 3.92 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 CA-C-O 120.698 0.285 . . . . 0.0 110.78 179.153 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -75.13 4.8 37.5 Favored Glycine 0 N--CA 1.462 0.413 0 N-CA-C 115.375 0.91 . . . . 0.0 115.375 -176.122 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 14.6 t -83.1 15.83 2.65 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 113.991 1.108 . . . . 0.0 113.991 -177.878 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 62.6 ttp85 -63.84 126.84 28.91 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 177.713 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -108.56 134.59 20.21 Favored Pre-proline 0 C--N 1.323 -0.551 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_endo -69.05 -18.22 40.47 Favored 'Trans proline' 0 C--O 1.218 -0.49 0 N-CA-C 114.934 1.09 . . . . 0.0 114.934 -175.904 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -77.03 -24.15 52.09 Favored 'General case' 0 C--O 1.221 -0.41 0 CA-C-O 121.106 0.479 . . . . 0.0 110.085 178.31 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -99.32 -28.48 13.28 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.64 -0.709 . . . . 0.0 112.848 -175.188 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 -155.68 147.26 22.93 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 -178.343 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -84.1 145.55 28.38 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-O 121.44 0.638 . . . . 0.0 111.638 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -69.54 145.54 52.54 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.208 0.527 . . . . 0.0 110.525 178.389 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 18.3 mt -86.54 138.22 19.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 -178.445 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 92.5 t -61.24 124.03 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 N-CA-C 105.912 -1.885 . . . . 0.0 105.912 175.235 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 6.3 tt -66.4 128.78 37.5 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.155 0.502 . . . . 0.0 110.038 -176.654 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 -132.84 156.02 47.93 Favored 'General case' 0 CA--C 1.508 -0.659 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 -178.606 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 13.2 mt -111.75 148.87 39.83 Favored Pre-proline 0 C--N 1.322 -0.629 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 177.399 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -72.96 164.26 36.06 Favored 'Trans proline' 0 N--CA 1.462 -0.361 0 C-N-CA 118.079 -0.814 . . . . 0.0 112.575 -179.502 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -55.17 130.98 44.16 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 104.31 -23.77 30.84 Favored Glycine 0 C--O 1.226 -0.402 0 CA-C-N 116.01 -0.541 . . . . 0.0 112.538 -178.524 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 7.7 m -108.4 129.71 55.25 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 118.137 0.968 . . . . 0.0 111.23 178.308 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 4.7 p -119.73 148.33 43.53 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.572 179.067 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 80.4 mt -69.75 154.81 94.42 Favored Pre-proline 0 C--N 1.324 -0.539 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 178.115 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -76.78 168.77 22.98 Favored 'Trans proline' 0 C--O 1.233 0.232 0 C-N-CA 117.775 -1.017 . . . . 0.0 110.5 176.833 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 7.5 tmtm? -57.74 130.56 46.96 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.967 0.413 . . . . 0.0 111.863 -175.763 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 95.14 -6.99 69.32 Favored Glycine 0 C--O 1.235 0.204 0 CA-C-N 115.461 -0.791 . . . . 0.0 114.907 177.382 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.434 ' CZ ' ' HB2' ' A' ' 18' ' ' GLN . 2.5 m-85 -95.99 138.6 33.39 Favored 'General case' 0 CA--C 1.502 -0.877 0 CA-C-O 122.086 0.946 . . . . 0.0 111.126 179.818 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 38.6 p90 -142.64 160.28 40.6 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 113.583 -1.644 . . . . 0.0 107.867 175.106 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -102.5 144.89 30.36 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.121 0.486 . . . . 0.0 111.189 -177.445 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -71.87 136.14 46.85 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 106.63 -1.619 . . . . 0.0 106.63 177.567 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 86.13 -2.63 87.6 Favored Glycine 0 C--O 1.227 -0.333 0 C-N-CA 121.211 -0.519 . . . . 0.0 112.545 -177.201 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 8.2 t -118.28 -176.9 3.16 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 177.722 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 24.7 tpt180 -141.05 138.83 33.9 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 92.95 168.79 39.46 Favored Glycine 0 C--O 1.226 -0.349 0 N-CA-C 110.01 -1.236 . . . . 0.0 110.01 -178.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -174.25 173.31 45.93 Favored Glycine 0 N--CA 1.45 -0.372 0 N-CA-C 107.095 -2.402 . . . . 0.0 107.095 -178.737 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 19.3 m . . . . . 0 C--O 1.244 0.796 0 CA-C-O 117.694 -1.146 . . . . 0.0 112.986 -177.361 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.734 0 CA-C-O 118.846 -0.974 . . . . 0.0 111.329 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -97.76 158.4 15.53 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 177.469 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 2.8 mpt? -126.34 114.79 18.7 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 178.595 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -175.22 78.15 0.08 OUTLIER Glycine 0 C--O 1.225 -0.416 0 C-N-CA 120.975 -0.631 . . . . 0.0 112.496 -178.666 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 96.1 mt -72.54 149.28 90.89 Favored Pre-proline 0 C--N 1.323 -0.563 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 178.902 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -69.45 138.79 39.66 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 115.991 -2.206 . . . . 0.0 111.216 178.55 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 32.9 t30 -143.92 -8.69 0.71 Allowed 'General case' 0 C--O 1.216 -0.677 0 N-CA-C 113.221 0.823 . . . . 0.0 113.221 -179.354 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 53.5 t30 56.59 43.37 25.74 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.064 0.946 . . . . 0.0 112.045 -179.458 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 41.6 p -116.68 111.89 20.45 Favored 'General case' 0 CA--C 1.509 -0.633 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 -179.355 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -131.46 142.84 50.07 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 114.969 -1.014 . . . . 0.0 110.974 -178.207 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 26.6 t -60.32 137.03 58.2 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 176.393 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' TRP . . . . . 0.4 ' HA ' ' HD3' ' A' ' 109' ' ' ARG . 9.8 m95 -70.83 -23.19 62.3 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.963 0.411 . . . . 0.0 111.18 178.451 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 24.8 m-85 -121.4 158.39 28.41 Favored 'General case' 0 C--O 1.241 0.634 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -171.128 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.424 ' HB ' ' HB3' ' A' ' 134' ' ' GLU . 72.0 p -69.06 163.34 24.93 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.012 -0.994 . . . . 0.0 109.189 179.153 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.426 ' HB2' ' CZ ' ' A' ' 69' ' ' TYR . . . -74.78 145.27 43.07 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 113.333 0.864 . . . . 0.0 113.333 -175.792 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 16.5 mt -85.74 148.9 25.64 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 103.754 -2.684 . . . . 0.0 103.754 169.349 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 31.0 m -124.86 128.97 49.49 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 178.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -82.42 137.26 34.75 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.018 179.52 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 72.0 t60 -139.32 94.93 2.85 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 104.085 -2.561 . . . . 0.0 104.085 168.466 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 163.74 -143.04 8.26 Favored Glycine 0 C--O 1.225 -0.437 0 C-N-CA 120.628 -0.796 . . . . 0.0 111.975 -175.561 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 54.7 mtpt -120.39 -25.56 5.59 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 116.98 2.215 . . . . 0.0 116.98 -175.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -94.41 159.37 15.14 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 117.861 0.3 . . . . 0.0 110.736 -176.755 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -63.07 -62.85 1.43 Allowed 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 111.999 0.37 . . . . 0.0 111.999 -178.217 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 51.3 tp 165.28 141.94 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.111 0 N-CA-C 103.849 -2.648 . . . . 0.0 103.849 178.51 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 23.3 tptm -156.76 140.66 16.2 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 118.242 0.474 . . . . 0.0 109.813 176.034 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 26.1 m-85 -126.89 150.43 71.66 Favored Pre-proline 0 C--N 1.324 -0.538 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 175.435 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -77.2 165.79 27.38 Favored 'Trans proline' 0 CA--C 1.538 0.697 0 C-N-CA 120.395 0.73 . . . . 0.0 112.571 177.382 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 75.7 ttt180 -66.81 136.37 55.34 Favored 'General case' 0 N--CA 1.472 0.649 0 O-C-N 122.107 -0.37 . . . . 0.0 110.318 -179.201 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 85.56 6.38 83.45 Favored Glycine 0 C--O 1.222 -0.596 0 N-CA-C 111.498 -0.641 . . . . 0.0 111.498 178.746 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 28.5 mt-30 -146.25 170.55 16.53 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 -175.354 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.416 ' H ' HG21 ' A' ' 125' ' ' THR . . . 103.28 -21.64 38.89 Favored Glycine 0 CA--C 1.499 -0.952 0 CA-C-N 115.772 -0.649 . . . . 0.0 114.017 173.877 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 92.7 t -65.71 128.52 93.87 Favored Pre-proline 0 C--N 1.319 -0.739 0 N-CA-C 106.468 -1.679 . . . . 0.0 106.468 177.531 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -71.91 171.7 16.06 Favored 'Trans proline' 0 C--O 1.22 -0.384 0 O-C-N 122.183 0.57 . . . . 0.0 111.221 177.848 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 92.1 mt -71.09 106.36 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 179.584 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -96.44 84.2 3.67 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 114.399 -1.273 . . . . 0.0 109.318 -176.87 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 67.8 p -66.97 -14.72 63.14 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.69 0.757 . . . . 0.0 112.749 -178.884 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -106.18 20.32 19.14 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 114.906 -1.043 . . . . 0.0 112.441 -177.675 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 15.1 m -139.91 151.23 45.43 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 114.886 1.439 . . . . 0.0 114.886 -175.259 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 2.2 m -72.24 166.33 42.37 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.314 176.612 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -66.27 -25.97 49.34 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 114.964 -2.891 . . . . 0.0 114.19 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.451 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 3.3 p-10 -77.53 -21.43 52.64 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 121.51 -0.744 . . . . 0.0 110.83 177.491 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 70.7 m-20 -81.39 -7.14 59.53 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 113.69 0.996 . . . . 0.0 113.69 -175.841 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 96.1 mm-40 -58.6 -26.5 63.74 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 114.262 1.208 . . . . 0.0 114.262 -178.44 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.425 ' HB ' ' HB1' ' A' ' 98' ' ' ALA . 9.9 tt -58.66 138.31 19.86 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.958 0 N-CA-C 113.87 1.063 . . . . 0.0 113.87 -178.246 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -179.72 -156.98 19.12 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.746 -0.74 . . . . 0.0 111.903 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 42.8 p90 -155.16 171.06 20.41 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 178.852 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 23.5 m-85 -113.96 142.22 46.42 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 106.924 -1.51 . . . . 0.0 106.924 173.466 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 52.7 ttt180 -115.06 126.9 55.24 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.668 -178.774 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 10.1 ttp85 -70.05 133.06 46.8 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 176.22 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -115.51 123.55 48.82 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 176.267 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -153.2 144.31 23.01 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 114.974 -1.012 . . . . 0.0 108.546 -179.339 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 22.7 tpp180 -153.98 123.82 6.77 Favored 'General case' 0 C--O 1.217 -0.646 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 175.87 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.56 145.63 48.16 Favored 'General case' 0 CA--C 1.49 -1.334 0 CA-C-O 121.684 0.754 . . . . 0.0 110.895 179.356 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -142.79 176.41 3.48 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.959 0 N-CA-C 104.389 -2.448 . . . . 0.0 104.389 178.537 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 5.5 tmm_? -128.07 99.21 5.39 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 106.238 -1.764 . . . . 0.0 106.238 175.683 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -70.04 146.93 43.79 Favored Glycine 0 N--CA 1.451 -0.364 0 N-CA-C 108.878 -1.689 . . . . 0.0 108.878 178.895 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -63.06 -33.43 87.22 Favored Glycine 0 C--O 1.215 -1.048 0 C-N-CA 120.453 -0.88 . . . . 0.0 110.981 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 27.2 t0 -90.06 17.63 6.71 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-O 121.936 0.874 . . . . 0.0 111.598 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 86.6 -7.0 81.21 Favored Glycine 0 N--CA 1.462 0.391 0 N-CA-C 116.326 1.291 . . . . 0.0 116.326 174.649 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.71 128.44 36.29 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 114.211 1.189 . . . . 0.0 114.211 -178.159 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 98.3 mmm -96.56 177.95 5.5 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 106.503 -1.666 . . . . 0.0 106.503 176.304 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 6.6 tmtt? -103.63 -57.23 2.07 Favored 'General case' 0 CA--C 1.507 -0.675 0 CA-C-O 121.474 0.654 . . . . 0.0 110.49 177.805 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 25.4 p30 -133.8 170.34 15.72 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 178.395 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -125.02 -53.58 1.63 Allowed 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 179.736 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 25.9 t -108.09 147.43 35.51 Favored Pre-proline 0 C--O 1.24 0.558 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 178.877 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -72.93 155.13 53.35 Favored 'Trans proline' 0 C--O 1.24 0.612 0 N-CA-C 115.376 1.26 . . . . 0.0 115.376 -178.585 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 25.5 mtp180 -115.45 161.57 18.39 Favored 'General case' 0 CA--C 1.509 -0.604 0 N-CA-C 106.651 -1.611 . . . . 0.0 106.651 173.304 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 61.0 m95 -129.81 142.76 50.63 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 178.196 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.426 ' CZ ' ' HB2' ' A' ' 15' ' ' ALA . 53.8 m-85 -123.89 144.37 49.8 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 179.467 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 86.1 t80 -93.55 138.02 32.24 Favored 'General case' 0 CA--C 1.511 -0.54 0 N-CA-C 108.415 -0.958 . . . . 0.0 108.415 -177.724 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -141.49 143.14 33.67 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 -177.522 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -76.66 159.48 30.2 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.794 -0.639 . . . . 0.0 112.23 -176.05 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -55.08 131.22 44.53 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.571 -179.391 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 77.53 25.03 63.95 Favored Glycine 0 C--O 1.22 -0.719 0 N-CA-C 115.921 1.128 . . . . 0.0 115.921 176.796 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 7.4 p -92.53 146.1 23.94 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 118.46 1.13 . . . . 0.0 109.364 179.01 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 101.26 132.73 7.86 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 -177.346 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -69.59 -38.34 8.31 Favored 'Trans proline' 0 C--N 1.347 0.464 0 CA-C-N 119.706 1.753 . . . . 0.0 115.575 -174.338 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -107.84 30.0 6.73 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 -177.127 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -64.66 -51.02 64.75 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.831 -176.73 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 57.9 26.75 58.48 Favored Glycine 0 C--O 1.226 -0.393 0 CA-C-N 115.858 -0.61 . . . . 0.0 113.001 -179.329 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 21.2 mt -111.33 105.36 56.88 Favored Pre-proline 0 C--O 1.237 0.425 0 N-CA-C 115.319 1.6 . . . . 0.0 115.319 -174.759 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -77.06 164.22 29.82 Favored 'Trans proline' 0 N--CA 1.461 -0.43 0 N-CA-C 108.213 -1.495 . . . . 0.0 108.213 169.906 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 57.1 t80 -61.19 132.43 53.67 Favored 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 120.594 -0.442 . . . . 0.0 110.074 -179.073 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 91.63 -7.65 79.46 Favored Glycine 0 CA--C 1.52 0.349 0 N-CA-C 114.683 0.633 . . . . 0.0 114.683 178.895 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -64.89 131.74 47.52 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 118.267 1.034 . . . . 0.0 111.682 179.558 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 34.3 t-20 -77.27 128.56 34.55 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.764 -177.638 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 20.5 ttmt -156.14 150.93 26.09 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 106.41 -1.7 . . . . 0.0 106.41 177.398 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -65.09 133.64 52.06 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.823 0.344 . . . . 0.0 110.168 -179.363 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 69.87 24.98 76.1 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 121.018 -0.611 . . . . 0.0 114.181 177.463 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 39.1 mm -126.31 127.4 70.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 117.335 0.568 . . . . 0.0 109.682 178.716 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.1 pt -131.32 116.73 33.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 CA-C-O 121.752 0.787 . . . . 0.0 110.268 176.549 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 94.8 m95 -82.52 137.12 34.7 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.081 -0.509 . . . . 0.0 112.355 -177.01 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 16.4 m -137.83 149.7 25.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.646 0.736 . . . . 0.0 110.186 179.39 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -157.91 165.59 34.81 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 104.093 -2.558 . . . . 0.0 104.093 179.58 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 14.3 t -130.18 178.85 6.25 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 105.467 -2.049 . . . . 0.0 105.467 179.018 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -67.39 134.98 52.47 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.178 0.513 . . . . 0.0 109.849 -179.555 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 92.89 -12.38 70.04 Favored Glycine 0 C--O 1.227 -0.284 0 CA-C-N 115.92 -0.582 . . . . 0.0 113.255 178.841 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.451 ' HA ' ' HA ' ' A' ' 41' ' ' ASP . . . -70.16 130.7 42.79 Favored 'General case' 0 CA--C 1.542 0.668 0 O-C-N 122.56 -0.376 . . . . 0.0 110.644 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 24.4 mt -90.33 140.4 29.74 Favored 'General case' 0 C--O 1.219 -0.518 0 CA-C-O 121.392 0.615 . . . . 0.0 112.137 -178.695 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 58.6 t30 -84.14 70.12 10.48 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.681 -179.52 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 1.1 t -140.78 153.39 67.67 Favored Pre-proline 0 C--N 1.323 -0.559 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 179.434 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -68.0 152.35 76.87 Favored 'Trans proline' 0 C--N 1.343 0.26 0 N-CA-C 114.249 0.827 . . . . 0.0 114.249 177.525 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -152.08 55.15 0.82 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 122.904 1.335 . . . . 0.0 110.896 178.232 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 15.0 p-10 -58.67 -32.51 69.18 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 113.635 -1.62 . . . . 0.0 110.695 177.703 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 30.9 p-80 -58.94 -16.67 18.91 Favored 'General case' 0 C--O 1.218 -0.591 0 N-CA-C 114.429 1.27 . . . . 0.0 114.429 -179.043 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 75.0 mt -79.93 -33.39 14.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 178.743 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -76.97 11.21 15.87 Favored Glycine 0 C--O 1.225 -0.422 0 N-CA-C 116.006 1.163 . . . . 0.0 116.006 -176.216 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 15.2 t -83.06 25.19 0.71 Allowed 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 118.224 1.012 . . . . 0.0 112.021 -177.513 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.434 ' HD2' ' OD1' ' A' ' 114' ' ' ASN . 66.1 ttp85 -62.35 125.28 23.36 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 121.736 -0.602 . . . . 0.0 111.301 -178.549 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 7.8 m120 -88.38 115.63 63.84 Favored Pre-proline 0 C--N 1.326 -0.427 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 179.01 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -73.1 -11.22 25.14 Favored 'Trans proline' 0 C--O 1.218 -0.496 0 C-N-CA 117.963 -0.891 . . . . 0.0 114.233 -177.569 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -81.49 -24.47 36.69 Favored 'General case' 0 C--O 1.22 -0.46 0 CA-C-O 121.002 0.43 . . . . 0.0 110.086 177.341 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -99.84 -30.37 12.08 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.779 -0.646 . . . . 0.0 112.383 -175.239 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ASN . . . . . 0.434 ' OD1' ' HD2' ' A' ' 109' ' ' ARG . 0.5 OUTLIER -131.97 151.08 51.95 Favored 'General case' 0 N--CA 1.437 -1.075 0 CA-C-O 121.338 0.59 . . . . 0.0 111.623 -178.31 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -94.82 137.55 33.75 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.084 -0.962 . . . . 0.0 108.852 176.421 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -63.66 146.14 54.37 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.405 0.621 . . . . 0.0 111.208 -179.392 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 24.1 mt -82.04 134.2 27.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.155 -178.009 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 67.7 t -60.1 123.28 12.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 N-CA-C 105.879 -1.897 . . . . 0.0 105.879 174.435 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 6.3 tt -66.26 127.58 32.78 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.488 0.661 . . . . 0.0 110.28 -176.652 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 34.5 mt-30 -132.71 162.12 32.25 Favored 'General case' 0 CA--C 1.511 -0.527 0 N-CA-C 106.277 -1.749 . . . . 0.0 106.277 -178.703 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 17.2 mt -117.51 147.67 41.24 Favored Pre-proline 0 C--N 1.321 -0.633 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 178.174 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -73.75 173.37 14.07 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 120.662 0.908 . . . . 0.0 114.156 -177.5 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 56.5 tt0 -54.22 133.15 44.51 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.152 -179.698 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 88.25 -15.23 56.97 Favored Glycine 0 C--O 1.227 -0.295 0 CA-C-N 116.045 -0.525 . . . . 0.0 113.651 179.489 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.416 HG21 ' H ' ' A' ' 31' ' ' GLY . 12.6 m -108.6 126.1 52.58 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 117.886 0.843 . . . . 0.0 110.445 -179.437 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 9.3 p -123.46 148.33 46.3 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.995 -178.178 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 91.9 mt -66.49 153.41 93.13 Favored Pre-proline 0 C--N 1.326 -0.452 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 177.929 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -76.03 169.53 21.91 Favored 'Trans proline' 0 N--CA 1.461 -0.396 0 C-N-CA 118.154 -0.764 . . . . 0.0 111.074 -179.205 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 58.7 tttp -59.7 126.75 28.82 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 179.705 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 89.36 30.76 12.96 Favored Glycine 0 C--O 1.225 -0.42 0 N-CA-C 115.947 1.139 . . . . 0.0 115.947 178.802 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -140.57 149.15 42.03 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 117.811 0.806 . . . . 0.0 111.35 177.113 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 46.2 p90 -149.42 164.51 34.78 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 107.216 -1.402 . . . . 0.0 107.216 175.485 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -106.72 149.97 26.75 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.228 0.537 . . . . 0.0 110.926 -178.562 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.424 ' HB3' ' HB ' ' A' ' 14' ' ' THR . 0.9 OUTLIER -71.67 131.32 42.99 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 108.293 -1.002 . . . . 0.0 108.293 179.462 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 81.88 2.29 90.51 Favored Glycine 0 C--O 1.225 -0.455 0 C-N-CA 121.23 -0.51 . . . . 0.0 112.708 -179.379 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 6.9 t -109.6 -173.74 2.33 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 179.383 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 61.35 25.66 15.59 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.724 0.81 . . . . 0.0 112.757 178.787 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -71.04 -24.39 77.15 Favored Glycine 0 C--O 1.22 -0.746 0 C-N-CA 121.173 -0.537 . . . . 0.0 113.339 179.221 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 107.21 -42.78 1.84 Allowed Glycine 0 C--O 1.228 -0.252 0 N-CA-C 111.732 -0.547 . . . . 0.0 111.732 179.474 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 42.8 m . . . . . 0 C--O 1.248 0.982 0 CA-C-O 117.557 -1.211 . . . . 0.0 112.27 179.021 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.873 0 CA-C-O 118.77 -1.016 . . . . 0.0 111.655 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 61.92 154.21 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 116.989 2.218 . . . . 0.0 116.989 178.734 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 2.1 mpt? -84.66 87.73 7.31 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.679 -1.146 . . . . 0.0 109.554 -178.854 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -83.15 61.79 4.72 Favored Glycine 0 C--O 1.228 -0.239 0 CA-C-N 116.145 -0.479 . . . . 0.0 113.189 -179.222 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 95.8 mt -86.33 150.59 52.12 Favored Pre-proline 0 C--N 1.324 -0.509 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -74.04 155.62 47.61 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 117.821 -0.986 . . . . 0.0 112.548 178.892 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 26.4 p30 -144.02 -144.82 0.16 Allowed 'General case' 0 N--CA 1.434 -1.269 0 N-CA-C 105.796 -1.927 . . . . 0.0 105.796 179.022 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 -94.49 -1.27 53.79 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 114.158 1.17 . . . . 0.0 114.158 -175.387 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 41.0 p -117.89 90.78 3.41 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.662 0.615 . . . . 0.0 112.662 -175.16 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -106.46 149.47 27.03 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.252 0.548 . . . . 0.0 109.549 179.083 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 42.1 t -59.22 142.29 52.16 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.57 177.641 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 14.9 m95 -64.85 -23.33 67.2 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 113.132 0.79 . . . . 0.0 113.132 178.761 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 43.3 m-85 -121.48 164.16 17.63 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 113.284 0.846 . . . . 0.0 113.284 -170.132 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 66.9 p -70.16 163.63 25.91 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 108.199 -1.038 . . . . 0.0 108.199 178.457 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -73.8 149.96 41.35 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.425 0.631 . . . . 0.0 111.569 -176.682 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.408 HD23 ' HA ' ' A' ' 16' ' ' LEU . 12.2 mt -89.86 137.82 32.01 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 102.859 -3.015 . . . . 0.0 102.859 168.66 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 49.4 m -113.82 126.72 55.52 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -77.57 136.4 38.28 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 178.624 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 32.3 t60 -139.23 94.87 2.85 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 104.786 -2.302 . . . . 0.0 104.786 170.604 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 152.26 -134.69 4.65 Favored Glycine 0 C--O 1.227 -0.293 0 C-N-CA 120.245 -0.979 . . . . 0.0 112.671 -175.742 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -126.73 -24.77 3.49 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 116.963 2.208 . . . . 0.0 116.963 -176.275 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -73.44 156.45 38.25 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 178.687 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -77.24 -58.31 3.35 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 178.396 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 62.4 tp 167.52 137.37 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.177 0 N-CA-C 104.772 -2.307 . . . . 0.0 104.772 173.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 22.9 tptm -157.64 142.53 16.68 Favored 'General case' 0 C--O 1.221 -0.44 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 176.11 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 27.9 m-85 -127.67 151.26 75.03 Favored Pre-proline 0 C--O 1.24 0.577 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 176.128 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -72.2 156.8 54.94 Favored 'Trans proline' 0 C--N 1.351 0.686 0 O-C-N 122.107 0.53 . . . . 0.0 111.996 176.901 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.67 134.34 52.06 Favored 'General case' 0 N--CA 1.472 0.637 0 O-C-N 121.986 -0.446 . . . . 0.0 110.487 -178.161 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 90.67 1.85 73.43 Favored Glycine 0 N--CA 1.46 0.295 0 N-CA-C 111.174 -0.77 . . . . 0.0 111.174 179.624 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 31.5 mt-30 -144.33 170.49 15.91 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 123.846 0.858 . . . . 0.0 108.902 -175.731 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 107.3 -17.42 37.26 Favored Glycine 0 CA--C 1.498 -0.981 0 CA-C-N 116.059 -0.518 . . . . 0.0 113.369 173.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.413 HG11 ' HB3' ' A' ' 43' ' ' GLN . 57.2 t -67.39 129.17 93.73 Favored Pre-proline 0 C--N 1.319 -0.722 0 N-CA-C 105.767 -1.938 . . . . 0.0 105.767 176.919 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -71.73 171.01 17.31 Favored 'Trans proline' 0 N--CA 1.459 -0.505 0 O-C-N 122.196 0.577 . . . . 0.0 111.2 178.146 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 95.0 mt -71.09 107.44 2.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 179.529 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.418 ' HB2' HE22 ' A' ' 43' ' ' GLN . 90.7 m-20 -93.11 84.33 4.83 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 114.175 -1.375 . . . . 0.0 109.354 -177.386 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 81.0 p -66.9 -15.06 63.41 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 114.003 1.112 . . . . 0.0 114.003 -177.101 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -111.39 17.28 20.29 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.282 -0.872 . . . . 0.0 112.846 -176.42 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -140.73 169.78 16.99 Favored 'General case' 0 CA--C 1.543 0.673 0 N-CA-C 115.891 1.812 . . . . 0.0 115.891 -171.855 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 35.4 m -94.41 161.35 29.48 Favored Pre-proline 0 C--O 1.218 -0.597 0 C-N-CA 124.343 1.057 . . . . 0.0 112.592 -174.919 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -65.24 -24.71 58.1 Favored 'Trans proline' 0 CA--C 1.535 0.557 0 C-N-CA 115.474 -2.551 . . . . 0.0 115.572 -178.249 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -75.16 -24.42 57.91 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 121.551 -0.718 . . . . 0.0 111.921 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 15.5 p30 -95.07 1.0 54.94 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 115.021 1.489 . . . . 0.0 115.021 -171.895 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.418 HE22 ' HB2' ' A' ' 35' ' ' ASN . 82.7 mm-40 -56.96 -24.09 50.44 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.591 -0.731 . . . . 0.0 112.8 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 11.3 tt -61.14 136.98 24.14 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.805 0 CA-C-O 122.533 1.158 . . . . 0.0 112.652 179.448 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 178.23 -156.35 19.11 Favored Glycine 0 N--CA 1.448 -0.527 0 N-CA-C 111.187 -0.765 . . . . 0.0 111.187 -178.165 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 45.3 p90 -155.15 172.11 18.69 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 179.278 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 14.3 m-85 -113.14 138.75 49.48 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 173.12 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 54.4 ttt-85 -108.12 124.69 50.62 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.549 -178.055 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 43.8 ttt180 -63.75 135.98 57.09 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 176.804 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -135.67 127.03 28.45 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.5 0.667 . . . . 0.0 111.928 -179.472 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 11.3 p -137.21 131.16 32.05 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 176.505 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 10.5 tpp180 -167.38 135.71 2.54 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 178.806 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 45.2 mtt180 -121.13 165.81 14.82 Favored 'General case' 0 CA--C 1.497 -1.071 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 177.277 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -134.79 173.97 13.68 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 N-CA-C 104.707 -2.331 . . . . 0.0 104.707 -179.844 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.31 109.03 7.5 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 175.421 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -77.73 159.64 48.09 Favored Glycine 0 C--O 1.228 -0.228 0 N-CA-C 107.263 -2.335 . . . . 0.0 107.263 176.353 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -58.12 -42.05 94.97 Favored Glycine 0 C--O 1.224 -0.527 0 CA-C-N 118.464 1.132 . . . . 0.0 112.082 -178.366 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.7 t0 -80.07 17.16 1.04 Allowed 'General case' 0 CA--C 1.548 0.881 0 CA-C-O 122.278 1.037 . . . . 0.0 112.658 -179.618 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 85.03 14.94 68.27 Favored Glycine 0 CA--C 1.504 -0.605 0 CA-C-N 115.417 -0.811 . . . . 0.0 113.179 171.314 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 33.3 mmtt -76.34 128.26 34.5 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.128 0.49 . . . . 0.0 110.374 -175.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 93.6 mmm -116.52 157.99 24.35 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 108.002 -1.111 . . . . 0.0 108.002 -178.905 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 14.0 tppt? -84.51 -43.46 14.54 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 106.638 -1.615 . . . . 0.0 106.638 176.274 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.5 t70 53.26 -145.53 0.59 Allowed 'General case' 0 C--O 1.241 0.623 0 CA-C-N 114.616 -1.174 . . . . 0.0 111.076 177.395 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.2 mm? 67.17 173.93 0.26 Allowed 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 116.062 1.875 . . . . 0.0 116.062 175.353 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -67.97 169.28 10.13 Favored Pre-proline 0 C--O 1.24 0.574 0 CA-C-N 113.962 -1.472 . . . . 0.0 113.91 -176.889 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -67.49 155.86 68.53 Favored 'Trans proline' 0 C--N 1.354 0.846 0 C-N-CA 116.107 -2.128 . . . . 0.0 112.659 177.88 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.31 160.1 21.65 Favored 'General case' 0 CA--C 1.505 -0.764 0 N-CA-C 105.377 -2.083 . . . . 0.0 105.377 178.051 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 53.1 m95 -131.47 146.53 52.29 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 178.855 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -126.75 142.32 51.58 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 179.343 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 81.3 t80 -88.79 136.88 32.77 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 108.59 -0.892 . . . . 0.0 108.59 -178.22 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -140.4 139.52 35.3 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 -176.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 75.2 m-85 -74.35 159.48 32.33 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.762 -0.653 . . . . 0.0 111.527 -175.735 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -55.91 131.12 46.27 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.194 0.521 . . . . 0.0 112.373 -178.131 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 75.5 26.8 64.71 Favored Glycine 0 C--O 1.218 -0.882 0 N-CA-C 115.842 1.097 . . . . 0.0 115.842 175.799 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 2.8 p -88.9 145.98 25.21 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 118.606 1.203 . . . . 0.0 108.472 178.674 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 100.32 138.45 10.28 Favored Glycine 0 CA--C 1.527 0.799 0 N-CA-C 109.953 -1.259 . . . . 0.0 109.953 -176.839 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -70.33 -40.25 4.61 Favored 'Trans proline' 0 C--N 1.348 0.519 0 CA-C-N 119.778 1.789 . . . . 0.0 115.74 -174.332 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -112.31 37.0 3.15 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 -177.51 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -62.99 -46.31 88.29 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.597 -177.132 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 57.29 30.54 61.42 Favored Glycine 0 C--N 1.33 0.228 0 CA-C-N 115.897 -0.592 . . . . 0.0 112.679 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 16.3 mt -118.78 103.72 47.99 Favored Pre-proline 0 N--CA 1.445 -0.692 0 N-CA-C 114.768 1.395 . . . . 0.0 114.768 -175.53 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -78.33 164.89 26.15 Favored 'Trans proline' 0 N--CA 1.461 -0.409 0 N-CA-C 107.97 -1.588 . . . . 0.0 107.97 169.32 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.429 ' CE1' ' HB3' ' A' ' 92' ' ' TRP . 66.7 t80 -61.25 133.08 55.53 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 120.353 -0.539 . . . . 0.0 110.148 -179.535 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 90.73 -7.03 81.87 Favored Glycine 0 CA--C 1.519 0.325 0 N-CA-C 114.797 0.679 . . . . 0.0 114.797 178.442 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -65.02 129.18 38.74 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 118.469 1.135 . . . . 0.0 111.546 179.597 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 60.0 t30 -76.62 127.54 32.99 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.694 -178.052 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 27.7 ttmt -156.14 152.14 27.56 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 106.686 -1.598 . . . . 0.0 106.686 179.687 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 17.6 t0 -63.79 129.48 40.27 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.14 0.495 . . . . 0.0 110.167 -178.18 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 70.18 26.69 73.9 Favored Glycine 0 N--CA 1.443 -0.835 0 CA-C-N 115.723 -0.671 . . . . 0.0 114.672 176.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 47.2 mm -125.41 123.52 65.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 178.59 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -126.88 115.43 41.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.514 -0.767 . . . . 0.0 110.163 176.853 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' TRP . . . . . 0.429 ' HB3' ' CE1' ' A' ' 83' ' ' TYR . 96.2 m95 -82.02 137.29 35.12 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 112.697 0.629 . . . . 0.0 112.697 -176.577 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 17.3 m -136.93 149.73 26.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 178.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -158.97 166.59 31.43 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 103.465 -2.791 . . . . 0.0 103.465 -178.621 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 6.6 t -134.76 -179.03 5.35 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 106.311 -1.737 . . . . 0.0 106.311 177.685 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -67.53 134.13 50.72 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.235 0.54 . . . . 0.0 110.688 -178.634 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 92.06 -10.05 75.21 Favored Glycine 0 C--O 1.229 -0.174 0 CA-C-N 115.915 -0.584 . . . . 0.0 113.662 177.765 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -70.83 134.9 47.73 Favored 'General case' 0 CA--C 1.544 0.728 0 O-C-N 122.523 -0.399 . . . . 0.0 111.247 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 29.3 mt -93.39 135.77 34.3 Favored 'General case' 0 CA--C 1.511 -0.552 0 N-CA-C 112.997 0.74 . . . . 0.0 112.997 -178.667 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 52.1 t30 -85.09 76.62 10.21 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.57 -178.772 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 1.2 t -146.42 155.66 49.67 Favored Pre-proline 0 C--N 1.322 -0.616 0 N-CA-C 105.607 -1.997 . . . . 0.0 105.607 179.47 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -69.01 149.96 72.24 Favored 'Trans proline' 0 CA--C 1.531 0.338 0 N-CA-C 113.729 0.627 . . . . 0.0 113.729 177.068 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 4.7 ptpt -152.8 56.67 0.79 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 122.78 1.276 . . . . 0.0 110.184 178.526 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -58.85 -31.31 68.4 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.08 -1.418 . . . . 0.0 112.586 -179.202 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 16.2 p80 -61.0 -9.09 3.78 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 114.589 1.329 . . . . 0.0 114.589 -177.763 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 50.4 mt -91.08 -37.92 9.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 178.194 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -75.48 14.64 5.21 Favored Glycine 0 CA--C 1.52 0.396 0 N-CA-C 115.428 0.931 . . . . 0.0 115.428 -177.073 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 11.6 t -95.61 24.24 5.43 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -177.658 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 62.5 ttp85 -59.37 130.91 49.24 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 177.853 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -101.98 135.42 19.69 Favored Pre-proline 0 C--N 1.323 -0.586 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 179.563 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -73.47 -18.33 22.95 Favored 'Trans proline' 0 C--O 1.219 -0.427 0 C-N-CA 118.387 -0.609 . . . . 0.0 113.017 -178.929 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -77.42 -25.05 50.36 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.894 0.378 . . . . 0.0 110.369 178.37 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 95.2 m-20 -101.1 -21.4 14.99 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 114.062 1.134 . . . . 0.0 114.062 -175.389 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 18.5 t-20 -158.26 151.99 23.63 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 -178.277 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -88.78 145.64 25.48 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-O 121.436 0.636 . . . . 0.0 111.711 178.895 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -70.18 147.51 49.76 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.18 0.514 . . . . 0.0 111.144 178.859 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 12.1 mt -88.61 138.29 19.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.095 -178.696 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 71.7 t -59.65 122.39 9.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 N-CA-C 106.908 -1.515 . . . . 0.0 106.908 175.148 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 6.4 tt -67.71 128.22 35.66 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.251 0.548 . . . . 0.0 109.695 -177.387 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -134.27 160.26 38.45 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 106.359 -1.719 . . . . 0.0 106.359 -179.273 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 13.6 mt -113.91 147.65 38.19 Favored Pre-proline 0 C--N 1.322 -0.629 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 177.197 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -72.7 164.93 34.18 Favored 'Trans proline' 0 C--O 1.236 0.396 0 O-C-N 122.26 0.611 . . . . 0.0 112.574 -179.338 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -55.42 131.48 46.0 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.289 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 101.98 -22.3 38.68 Favored Glycine 0 C--O 1.226 -0.35 0 CA-C-N 115.945 -0.571 . . . . 0.0 112.505 -178.839 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 9.5 m -108.58 130.79 55.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 117.992 0.896 . . . . 0.0 110.98 178.498 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 6.1 p -122.05 148.35 44.95 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.651 -179.492 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 84.5 mt -66.53 156.14 86.81 Favored Pre-proline 0 C--N 1.324 -0.515 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 178.246 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -74.22 173.99 13.23 Favored 'Trans proline' 0 C--O 1.238 0.486 0 N-CA-C 110.453 -0.634 . . . . 0.0 110.453 -179.767 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -62.73 123.46 18.48 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.643 0.735 . . . . 0.0 110.269 -176.413 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 85.95 45.9 5.54 Favored Glycine 0 N--CA 1.449 -0.491 0 N-CA-C 115.854 1.102 . . . . 0.0 115.854 179.021 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -145.6 149.18 34.06 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 117.534 0.667 . . . . 0.0 111.726 177.565 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 47.1 p90 -148.14 165.32 31.22 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 174.78 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -105.63 145.43 31.03 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.754 0.311 . . . . 0.0 110.186 -178.326 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -68.87 131.44 45.12 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 -179.455 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 86.73 -15.15 53.71 Favored Glycine 0 CA--C 1.521 0.455 0 CA-C-N 115.971 -0.558 . . . . 0.0 114.11 -177.807 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 32.9 t -82.62 123.59 29.38 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 179.749 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 6.0 tpt180 51.83 44.77 29.11 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 121.488 0.661 . . . . 0.0 110.535 -177.594 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -62.93 145.58 50.09 Favored Glycine 0 CA--C 1.517 0.216 0 N-CA-C 110.405 -1.078 . . . . 0.0 110.405 178.438 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 179.61 -161.57 27.59 Favored Glycine 0 N--CA 1.45 -0.388 0 N-CA-C 107.168 -2.373 . . . . 0.0 107.168 -178.175 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 21.1 m . . . . . 0 C--O 1.246 0.889 0 CA-C-O 118.27 -0.871 . . . . 0.0 109.77 178.122 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.881 0 CA-C-O 118.925 -0.931 . . . . 0.0 111.354 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -78.3 126.33 30.63 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 177.868 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 15.2 mmt -81.99 51.7 1.81 Allowed 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 112.511 0.56 . . . . 0.0 112.511 -177.311 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -87.47 43.0 3.16 Favored Glycine 0 C--O 1.226 -0.377 0 N-CA-C 111.353 -0.699 . . . . 0.0 111.353 -179.412 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 61.7 mt -61.75 147.66 88.7 Favored Pre-proline 0 C--O 1.243 0.727 0 C-N-CA 123.358 0.663 . . . . 0.0 112.607 -174.737 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -71.39 153.55 61.07 Favored 'Trans proline' 0 C--N 1.349 0.566 0 N-CA-C 113.851 0.673 . . . . 0.0 113.851 -179.431 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 48.0 t30 -147.97 95.18 2.45 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.516 -0.765 . . . . 0.0 109.417 178.722 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 44.9 t30 -108.18 41.09 1.62 Allowed 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 121.873 0.844 . . . . 0.0 108.989 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -146.24 159.32 43.49 Favored 'General case' 0 N--CA 1.438 -1.07 1 N-CA-C 98.025 -4.805 . . . . 0.0 98.025 -178.226 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -139.66 139.16 36.59 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-O 121.7 0.762 . . . . 0.0 111.894 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.67 143.77 55.82 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 114.773 -1.103 . . . . 0.0 108.249 177.536 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' TRP . . . . . 0.467 ' CD2' ' HD3' ' A' ' 109' ' ' ARG . 16.2 m95 -68.45 -21.86 64.61 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 113.627 0.973 . . . . 0.0 113.627 179.417 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 25.4 m-85 -121.37 161.1 22.7 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 114.226 1.195 . . . . 0.0 114.226 -171.144 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.403 ' HB ' ' HB3' ' A' ' 134' ' ' GLU . 72.9 p -68.34 163.29 23.38 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 114.43 -1.259 . . . . 0.0 111.247 -178.566 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.545 ' HB2' ' CZ ' ' A' ' 69' ' ' TYR . . . -75.99 134.11 40.24 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 113.563 0.949 . . . . 0.0 113.563 -175.801 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.433 HD13 HD13 ' A' ' 119' ' ' LEU . 1.9 mp -84.8 146.67 27.23 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 105.388 -2.078 . . . . 0.0 105.388 170.286 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 69.8 m -126.24 131.03 52.02 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 -177.912 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.441 ' HB2' ' CZ ' ' A' ' 131' ' ' PHE . 4.1 tp60 -97.79 138.58 34.95 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.912 -0.586 . . . . 0.0 112.11 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 52.6 t60 -128.55 99.22 5.29 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 104.722 -2.325 . . . . 0.0 104.722 168.921 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 168.46 -166.18 39.38 Favored Glycine 0 N--CA 1.451 -0.334 0 N-CA-C 109.14 -1.584 . . . . 0.0 109.14 -176.293 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -103.45 -26.9 12.7 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 113.404 0.89 . . . . 0.0 113.404 -178.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -80.87 160.17 24.83 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 106.981 -1.488 . . . . 0.0 106.981 177.737 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -85.86 -62.9 1.42 Allowed 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 113.051 0.759 . . . . 0.0 113.051 -177.734 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 51.2 tp -177.79 142.79 0.31 Allowed 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 106.892 -1.522 . . . . 0.0 106.892 175.862 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.1 tmtp? -158.11 138.41 12.59 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 175.593 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 14.9 m-85 -121.87 153.36 60.38 Favored Pre-proline 0 C--O 1.239 0.534 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 176.205 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -70.48 158.76 55.06 Favored 'Trans proline' 0 C--N 1.351 0.67 0 O-C-N 121.957 0.451 . . . . 0.0 112.468 177.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 9.7 tpp85 -64.29 135.59 56.36 Favored 'General case' 0 C--O 1.217 -0.651 0 CA-C-N 116.572 -0.286 . . . . 0.0 111.251 -178.541 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 78.94 13.63 82.88 Favored Glycine 0 C--O 1.224 -0.487 0 C-N-CA 121.268 -0.491 . . . . 0.0 112.259 178.188 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 5.6 mt-30 -150.24 170.49 18.86 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 -175.541 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 106.96 -18.69 36.49 Favored Glycine 0 CA--C 1.503 -0.681 0 CA-C-N 116.278 -0.419 . . . . 0.0 113.16 175.115 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 99.1 t -65.6 128.4 93.78 Favored Pre-proline 0 C--N 1.321 -0.669 0 N-CA-C 106.962 -1.495 . . . . 0.0 106.962 177.655 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.415 ' HB3' HD21 ' A' ' 119' ' ' LEU . 84.2 Cg_endo -75.17 170.02 21.27 Favored 'Trans proline' 0 N--CA 1.461 -0.438 0 O-C-N 122.217 0.588 . . . . 0.0 111.84 179.296 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 91.2 mt -69.36 109.03 2.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 178.781 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 78.1 m-20 -99.25 85.69 3.25 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 114.506 -1.224 . . . . 0.0 109.924 -177.294 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 72.9 p -67.79 -15.1 63.47 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.524 0.678 . . . . 0.0 112.542 -178.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 11.6 p30 -108.17 19.61 19.71 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 114.977 -1.011 . . . . 0.0 113.287 -177.224 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 7.6 m -137.94 152.85 49.36 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 114.689 1.366 . . . . 0.0 114.689 -175.759 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 58.9 m -73.78 164.14 63.31 Favored Pre-proline 0 CA--C 1.537 0.476 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.65 177.341 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -66.21 -25.18 50.47 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 115.362 -2.625 . . . . 0.0 114.499 -178.475 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.443 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 6.4 p-10 -75.23 -26.45 58.92 Favored 'General case' 0 C--N 1.323 -0.569 0 O-C-N 121.616 -0.677 . . . . 0.0 110.579 177.152 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.547 ' HA ' ' HE3' ' A' ' 103' ' ' LYS . 32.6 m-20 -76.69 -8.11 56.62 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.485 1.114 . . . . 0.0 113.674 -175.801 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 95.0 mm-40 -59.64 -31.24 69.33 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 114.667 1.358 . . . . 0.0 114.667 -177.456 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.419 ' HB ' ' HB1' ' A' ' 98' ' ' ALA . 14.8 tt -60.17 140.04 18.78 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.81 0 CA-C-O 122.223 1.011 . . . . 0.0 112.567 -179.729 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 179.35 -155.36 15.69 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.494 -0.86 . . . . 0.0 111.678 -178.18 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 49.9 p90 -155.13 173.38 16.69 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 179.449 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 20.0 m-85 -113.33 140.39 48.05 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 106.927 -1.509 . . . . 0.0 106.927 173.381 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 66.7 ttt-85 -112.4 130.68 55.89 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.981 -177.535 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 29.2 ttt-85 -68.96 142.49 54.67 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 176.001 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -142.23 133.17 25.82 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.799 0.333 . . . . 0.0 110.109 177.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -156.74 131.8 9.06 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 177.072 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -129.1 123.98 33.62 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 108.253 -1.018 . . . . 0.0 108.253 174.079 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.55 137.24 54.82 Favored 'General case' 0 CA--C 1.488 -1.421 0 CA-C-O 121.493 0.663 . . . . 0.0 110.206 -177.44 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -127.49 176.91 6.48 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 N-CA-C 106.636 -1.616 . . . . 0.0 106.636 179.212 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 56.1 ttp180 -127.85 116.87 20.82 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 174.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -85.06 161.56 36.16 Favored Glycine 0 C--O 1.224 -0.474 0 N-CA-C 106.233 -2.747 . . . . 0.0 106.233 176.129 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -64.91 -35.93 92.49 Favored Glycine 0 C--O 1.216 -0.998 0 CA-C-N 118.671 1.235 . . . . 0.0 110.345 179.441 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 32.1 t0 -91.26 17.17 8.65 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-O 122.374 1.083 . . . . 0.0 110.62 178.793 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 84.16 -7.06 73.05 Favored Glycine 0 N--CA 1.46 0.27 0 N-CA-C 117.25 1.66 . . . . 0.0 117.25 172.579 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.56 150.53 31.33 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 122.586 1.184 . . . . 0.0 112.914 -177.883 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 73.1 mtp -119.95 -174.49 2.77 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 112.775 -2.011 . . . . 0.0 112.871 -174.535 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 25.4 mmtt -123.23 -72.99 0.66 Allowed 'General case' 0 C--O 1.219 -0.535 0 C-N-CA 122.917 0.487 . . . . 0.0 109.701 179.511 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -93.7 147.63 22.85 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 106.935 -1.506 . . . . 0.0 106.935 177.06 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -124.74 -63.57 1.17 Allowed 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 106.194 -1.78 . . . . 0.0 106.194 178.347 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -82.02 152.49 68.58 Favored Pre-proline 0 C--O 1.241 0.657 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 176.392 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -75.39 149.28 34.93 Favored 'Trans proline' 0 C--O 1.238 0.491 0 C-N-CA 115.632 -2.445 . . . . 0.0 112.701 179.068 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 94.8 mtt-85 -103.89 152.18 22.25 Favored 'General case' 0 CA--C 1.506 -0.745 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 177.206 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 71.7 m95 -132.44 137.67 47.35 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 175.313 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.545 ' CZ ' ' HB2' ' A' ' 15' ' ' ALA . 78.1 m-85 -127.63 147.39 50.36 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 -179.35 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 74.1 t80 -90.76 137.0 32.7 Favored 'General case' 0 CA--C 1.507 -0.68 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -139.25 140.3 37.65 Favored 'General case' 0 N--CA 1.439 -1.007 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 -175.501 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -79.87 159.51 26.4 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.428 -174.485 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -53.39 124.12 13.87 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.97 0.414 . . . . 0.0 111.608 -178.082 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 82.86 13.51 77.58 Favored Glycine 0 C--O 1.222 -0.595 0 N-CA-C 116.514 1.366 . . . . 0.0 116.514 178.012 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 23.7 p -89.2 146.26 24.88 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 119.032 1.416 . . . . 0.0 111.224 179.733 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 111.35 141.86 8.73 Favored Glycine 0 CA--C 1.523 0.551 0 N-CA-C 110.094 -1.203 . . . . 0.0 110.094 -179.201 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -68.86 -39.55 8.19 Favored 'Trans proline' 0 C--N 1.348 0.528 0 CA-C-N 119.602 1.701 . . . . 0.0 115.755 -174.213 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -109.44 25.14 12.14 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.853 -178.208 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -57.88 -55.67 31.92 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.071 -0.513 . . . . 0.0 112.305 -174.836 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 54.47 33.83 54.23 Favored Glycine 0 CA--C 1.522 0.472 0 C-N-CA 121.071 -0.585 . . . . 0.0 112.31 179.669 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 15.9 mt -117.24 103.93 50.94 Favored Pre-proline 0 N--CA 1.448 -0.535 0 N-CA-C 115.94 1.83 . . . . 0.0 115.94 -172.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -77.8 161.66 30.25 Favored 'Trans proline' 0 N--CA 1.461 -0.384 0 N-CA-C 107.416 -1.802 . . . . 0.0 107.416 168.238 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 58.1 t80 -61.41 133.22 55.55 Favored 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 120.277 -0.569 . . . . 0.0 110.848 -177.289 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 90.99 -9.02 78.99 Favored Glycine 0 CA--C 1.519 0.31 0 CA-C-O 119.445 -0.642 . . . . 0.0 114.366 179.279 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -65.37 130.8 44.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 118.343 1.072 . . . . 0.0 111.154 179.461 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 58.4 t30 -79.01 130.17 35.24 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.389 -179.244 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 28.4 ttmt -156.14 152.0 27.39 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 107.675 -1.232 . . . . 0.0 107.675 179.358 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 38.2 t0 -62.58 129.79 42.16 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.883 0.373 . . . . 0.0 110.421 -179.117 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 69.57 27.52 73.32 Favored Glycine 0 N--CA 1.45 -0.404 0 CA-C-O 119.324 -0.709 . . . . 0.0 114.696 178.755 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 40.8 mm -127.5 128.82 70.2 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 CA-C-N 117.643 0.722 . . . . 0.0 110.918 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -132.81 117.15 29.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 CA-C-O 121.465 0.65 . . . . 0.0 111.352 177.049 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 97.4 m95 -81.52 138.26 35.48 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 114.063 1.134 . . . . 0.0 114.063 -176.444 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 16.3 m -139.32 151.15 22.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.626 -0.716 . . . . 0.0 109.153 178.835 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -158.8 166.54 31.7 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 105.87 -1.9 . . . . 0.0 105.87 -179.709 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 14.5 t -133.95 169.45 17.09 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 105.361 -2.088 . . . . 0.0 105.361 178.126 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -65.89 136.26 55.89 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.263 0.554 . . . . 0.0 109.954 -179.105 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 96.21 -12.17 66.89 Favored Glycine 0 C--O 1.229 -0.182 0 CA-C-N 115.768 -0.651 . . . . 0.0 113.044 178.795 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.443 ' HA ' ' HA ' ' A' ' 41' ' ' ASP . . . -76.66 139.95 40.75 Favored 'General case' 0 CA--C 1.542 0.635 0 O-C-N 122.458 -0.436 . . . . 0.0 110.22 179.109 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 39.7 mt -98.32 137.79 36.52 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 113.771 1.026 . . . . 0.0 113.771 -177.126 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 56.9 t30 -82.95 76.43 9.78 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.544 0.687 . . . . 0.0 110.299 179.388 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 1.2 t -146.26 160.69 41.75 Favored Pre-proline 0 C--N 1.321 -0.67 0 N-CA-C 102.218 -3.253 . . . . 0.0 102.218 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -72.59 148.91 48.39 Favored 'Trans proline' 0 CA--C 1.538 0.678 0 N-CA-C 114.172 0.797 . . . . 0.0 114.172 176.749 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.547 ' HE3' ' HA ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -143.91 54.88 1.31 Allowed 'General case' 0 N--CA 1.474 0.727 0 CA-C-O 123.406 1.574 . . . . 0.0 108.485 176.835 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 14.6 p-10 -64.56 -25.39 67.96 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 113.244 -1.798 . . . . 0.0 110.721 178.71 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 20.6 p-80 -56.33 -19.64 15.4 Favored 'General case' 0 C--O 1.221 -0.415 0 N-CA-C 114.205 1.187 . . . . 0.0 114.205 -179.026 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.421 HD11 ' CG ' ' A' ' 42' ' ' ASP . 20.5 mt -82.69 -28.15 8.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-O 121.371 0.605 . . . . 0.0 109.735 -179.243 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -77.28 5.13 52.32 Favored Glycine 0 CA--C 1.519 0.317 0 N-CA-C 115.84 1.096 . . . . 0.0 115.84 -175.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 12.0 t -83.17 11.18 6.81 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 117.323 0.562 . . . . 0.0 112.321 -178.356 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.467 ' HD3' ' CD2' ' A' ' 12' ' ' TRP . 63.5 ttp85 -58.38 130.16 45.42 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 178.945 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -97.63 128.91 32.85 Favored Pre-proline 0 C--N 1.326 -0.454 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 178.102 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -75.69 -13.08 20.13 Favored 'Trans proline' 0 C--O 1.219 -0.451 0 N-CA-C 113.197 0.422 . . . . 0.0 113.197 -178.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -81.12 -24.09 37.92 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.092 0.472 . . . . 0.0 109.888 178.392 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -101.01 -27.41 13.29 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 113.293 0.849 . . . . 0.0 113.293 -174.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ASN . . . . . 0.446 ' OD1' ' HD2' ' A' ' 109' ' ' ARG . 0.4 OUTLIER -139.39 152.43 47.11 Favored 'General case' 0 N--CA 1.437 -1.108 0 CA-C-O 121.263 0.554 . . . . 0.0 111.263 -177.595 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -95.73 137.31 34.98 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 115.199 -0.909 . . . . 0.0 108.94 176.19 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -65.32 148.6 51.42 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.435 0.636 . . . . 0.0 111.966 -178.762 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 16.8 mt -83.24 136.69 22.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.127 -178.459 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 88.7 t -61.64 122.77 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 N-CA-C 106.376 -1.713 . . . . 0.0 106.376 175.287 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.433 HD13 HD13 ' A' ' 16' ' ' LEU . 7.3 tt -66.76 131.32 45.69 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.237 0.542 . . . . 0.0 110.718 -176.414 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -130.96 154.48 48.1 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 106.452 -1.684 . . . . 0.0 106.452 179.416 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 13.3 mt -110.85 149.02 39.79 Favored Pre-proline 0 C--N 1.322 -0.603 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 178.059 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -73.83 167.06 28.16 Favored 'Trans proline' 0 C--N 1.345 0.343 0 O-C-N 122.2 0.579 . . . . 0.0 112.856 -179.497 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 55.7 tt0 -55.07 132.0 46.27 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.672 -0.694 . . . . 0.0 109.402 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 98.75 -20.98 48.19 Favored Glycine 0 C--O 1.226 -0.374 0 CA-C-N 115.981 -0.554 . . . . 0.0 113.065 -179.487 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 7.0 m -108.0 129.29 55.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 118.127 0.964 . . . . 0.0 110.688 178.761 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 4.8 p -122.34 148.44 45.05 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.245 -179.432 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 87.6 mt -70.64 153.42 94.95 Favored Pre-proline 0 C--N 1.325 -0.488 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 176.919 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -75.63 169.07 23.08 Favored 'Trans proline' 0 N--CA 1.463 -0.307 0 C-N-CA 117.949 -0.901 . . . . 0.0 110.913 178.876 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 39.8 tptt -60.13 131.83 52.05 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.125 -176.865 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 95.12 -6.06 68.78 Favored Glycine 0 C--O 1.228 -0.265 0 N-CA-C 115.006 0.762 . . . . 0.0 115.006 178.894 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.441 ' CZ ' ' HB2' ' A' ' 18' ' ' GLN . 1.3 m-85 -102.61 143.92 31.67 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-O 122.177 0.989 . . . . 0.0 111.752 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 45.2 p90 -146.45 165.61 28.87 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 113.6 -1.636 . . . . 0.0 107.342 173.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -108.56 148.07 30.85 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.949 0.405 . . . . 0.0 110.556 -178.838 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.403 ' HB3' ' HB ' ' A' ' 14' ' ' THR . 6.4 tp10 -70.43 136.51 49.6 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 178.769 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 81.22 -0.24 87.88 Favored Glycine 0 CA--C 1.52 0.385 0 C-N-CA 121.356 -0.449 . . . . 0.0 112.322 -176.849 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 4.3 t -122.07 -166.83 1.45 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.253 0.549 . . . . 0.0 110.22 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 37.1 mmt180 -138.25 170.79 15.42 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 105.564 -2.013 . . . . 0.0 105.564 178.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -152.03 174.67 30.99 Favored Glycine 0 C--N 1.317 -0.524 0 N-CA-C 105.633 -2.987 . . . . 0.0 105.633 178.783 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -162.75 -173.3 31.28 Favored Glycine 0 C--O 1.237 0.293 0 N-CA-C 109.23 -1.548 . . . . 0.0 109.23 -178.652 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 16.0 m . . . . . 0 C--O 1.247 0.93 0 CA-C-O 116.144 -1.884 . . . . 0.0 106.193 -179.447 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.288 0 CA-C-O 119.034 -0.87 . . . . 0.0 111.548 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -78.31 69.98 4.59 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 118.206 1.003 . . . . 0.0 112.687 -177.795 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 18.5 ptt? -136.27 48.33 2.16 Favored 'General case' 0 C--O 1.218 -0.554 0 CA-C-O 121.821 0.82 . . . . 0.0 109.542 179.412 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -166.27 -34.67 0.02 OUTLIER Glycine 0 C--O 1.222 -0.634 0 CA-C-N 115.342 -0.845 . . . . 0.0 112.444 -178.519 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 95.2 mt -62.47 135.79 95.58 Favored Pre-proline 0 C--O 1.241 0.634 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 177.082 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -79.37 173.79 12.76 Favored 'Trans proline' 0 C--N 1.347 0.492 0 O-C-N 122.21 0.584 . . . . 0.0 112.953 -179.678 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 33.9 t30 -147.58 108.31 4.17 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 177.117 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 25.4 t30 -109.38 39.61 2.04 Favored 'General case' 0 C--N 1.323 -0.578 0 O-C-N 123.396 0.435 . . . . 0.0 111.192 -178.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 81.0 p -146.08 155.72 42.96 Favored 'General case' 0 N--CA 1.441 -0.88 0 N-CA-C 101.901 -3.37 . . . . 0.0 101.901 179.799 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -145.56 146.58 31.45 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 177.158 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 29.1 p -66.36 144.69 56.39 Favored 'General case' 0 CA--C 1.508 -0.661 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 177.906 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 12.1 m95 -69.65 -21.9 63.5 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 120.859 0.361 . . . . 0.0 111.695 178.439 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -121.4 164.1 17.64 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -173.315 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 67.2 p -70.35 168.99 14.81 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.45 -1.25 . . . . 0.0 108.476 178.392 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.588 ' HB2' ' CZ ' ' A' ' 69' ' ' TYR . . . -73.87 156.7 37.44 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 122.309 1.052 . . . . 0.0 113.523 -176.306 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 11.5 mt -101.42 137.78 39.3 Favored 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 101.81 -3.404 . . . . 0.0 101.81 166.359 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 34.3 m -115.88 136.45 53.04 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 -177.647 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.454 ' HB2' ' CZ ' ' A' ' 131' ' ' PHE . 4.2 tp60 -114.0 137.58 51.51 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 113.959 1.096 . . . . 0.0 113.959 -176.091 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -131.78 99.37 4.75 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 104.644 -2.354 . . . . 0.0 104.644 169.48 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 174.78 -168.35 40.95 Favored Glycine 0 C--O 1.225 -0.467 0 N-CA-C 110.562 -1.015 . . . . 0.0 110.562 -177.014 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -102.11 -25.18 13.82 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 112.832 0.678 . . . . 0.0 112.832 -179.177 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -82.86 158.23 22.8 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.316 -0.402 . . . . 0.0 109.999 -179.356 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -74.59 -62.93 1.36 Allowed 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.307 -178.462 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 28.6 tp 173.71 144.55 0.05 OUTLIER 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 103.333 -2.84 . . . . 0.0 103.333 177.338 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 11.0 tmtt? -155.45 134.26 12.02 Favored 'General case' 0 C--O 1.221 -0.442 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 176.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 9.6 m-85 -122.13 155.74 60.92 Favored Pre-proline 0 C--O 1.243 0.739 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 177.061 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -72.72 168.24 25.06 Favored 'Trans proline' 0 C--N 1.352 0.745 0 N-CA-C 113.409 0.503 . . . . 0.0 113.409 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 20.8 tpt180 -72.8 135.78 45.3 Favored 'General case' 0 C--O 1.215 -0.725 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 -178.244 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 83.86 7.32 85.86 Favored Glycine 0 C--O 1.223 -0.576 0 C-N-CA 121.236 -0.507 . . . . 0.0 112.893 177.527 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -150.19 168.42 24.04 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 -177.64 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 131.15 -30.29 3.35 Favored Glycine 0 CA--C 1.483 -1.927 0 N-CA-C 109.188 -1.565 . . . . 0.0 109.188 166.317 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 33.9 m -65.67 141.2 97.72 Favored Pre-proline 0 N--CA 1.433 -1.279 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 177.288 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_endo -74.01 176.48 9.45 Favored 'Trans proline' 0 N--CA 1.456 -0.691 0 C-N-CA 121.745 1.63 . . . . 0.0 110.821 178.854 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 91.3 mt -73.09 114.99 13.33 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 178.038 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 29.5 m-80 -109.14 82.86 1.66 Allowed 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 -179.412 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 60.9 p -67.28 -21.99 65.67 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 113.018 0.747 . . . . 0.0 113.018 -176.776 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 69.1 m-80 -106.1 35.74 2.82 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.054 -176.633 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 17.4 m -145.51 152.48 39.82 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 -179.217 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 4.6 m -73.08 164.79 58.33 Favored Pre-proline 0 C--N 1.324 -0.513 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 178.017 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -64.59 -26.24 61.75 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 114.748 -3.035 . . . . 0.0 111.14 177.624 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -62.18 -27.47 68.99 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 123.862 0.865 . . . . 0.0 111.573 175.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 77.3 m-20 -96.44 -4.9 40.86 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 115.225 1.565 . . . . 0.0 115.225 -171.418 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 90.6 mm-40 -59.6 -28.41 67.15 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 113.599 0.962 . . . . 0.0 113.599 -177.574 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 13.8 tt -57.45 141.52 14.34 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 N-CA-C 114.46 1.281 . . . . 0.0 114.46 -178.195 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -179.53 -153.47 11.87 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.071 179.318 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 49.5 p90 -155.03 169.51 23.94 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 177.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 19.3 m-85 -111.63 143.01 43.22 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 173.244 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 17.4 ttt180 -116.18 125.88 52.9 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.698 -178.727 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 18.2 ttp85 -68.67 135.93 52.15 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 107.956 -1.128 . . . . 0.0 107.956 176.56 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -127.52 125.32 40.19 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.401 0.619 . . . . 0.0 109.719 179.552 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -146.19 117.55 7.94 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.142 -0.935 . . . . 0.0 108.954 179.406 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 6.7 tpp85 -147.78 127.57 13.46 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 178.889 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 29.1 mtt85 -130.89 165.92 22.03 Favored 'General case' 0 CA--C 1.495 -1.153 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 177.39 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -141.06 179.4 2.34 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 -177.553 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 19.1 ttm180 -115.05 104.96 12.4 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 106.182 -1.785 . . . . 0.0 106.182 174.194 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -84.18 143.25 21.04 Favored Glycine 0 C--O 1.226 -0.392 0 N-CA-C 107.275 -2.33 . . . . 0.0 107.275 178.041 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -64.7 -38.5 95.71 Favored Glycine 0 C--O 1.219 -0.83 0 CA-C-N 118.404 1.102 . . . . 0.0 112.339 -177.684 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -85.76 11.58 10.77 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.7 0.762 . . . . 0.0 112.083 -179.61 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 84.7 20.33 58.34 Favored Glycine 0 C--O 1.226 -0.399 0 CA-C-N 115.235 -0.893 . . . . 0.0 112.467 176.657 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 21.6 mmtt -88.21 130.85 34.96 Favored 'General case' 0 C--N 1.324 -0.542 0 O-C-N 122.21 -0.582 . . . . 0.0 110.872 -175.848 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 86.8 mmm -100.98 159.9 14.82 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.156 -0.929 . . . . 0.0 109.128 -178.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 16.5 tppt? -83.22 -48.68 10.22 Favored 'General case' 0 C--O 1.219 -0.526 0 N-CA-C 108.401 -0.962 . . . . 0.0 108.401 177.526 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 21.3 t0 -162.82 163.53 26.53 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 105.327 -2.101 . . . . 0.0 105.327 177.829 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -117.28 -34.24 4.39 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 177.38 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 20.9 m -85.33 148.53 50.01 Favored Pre-proline 0 C--N 1.326 -0.425 0 N-CA-C 113.753 1.02 . . . . 0.0 113.753 -176.058 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -77.59 145.57 23.42 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 117.97 -0.887 . . . . 0.0 112.187 174.769 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 47.8 mtt180 -119.1 165.09 14.59 Favored 'General case' 0 CA--C 1.508 -0.656 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.864 179.049 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 64.9 m95 -134.25 144.32 48.32 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 106.588 -1.634 . . . . 0.0 106.588 172.689 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.588 ' CZ ' ' HB2' ' A' ' 15' ' ' ALA . 71.5 m-85 -130.16 148.51 52.01 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 178.144 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 76.1 t80 -92.59 134.73 34.71 Favored 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 -177.748 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -137.11 140.19 41.75 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 -176.493 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -77.87 159.51 28.88 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.167 -177.194 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -53.33 138.94 31.45 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 -179.233 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 70.51 38.27 69.03 Favored Glycine 0 C--O 1.225 -0.454 0 N-CA-C 115.726 1.05 . . . . 0.0 115.726 175.22 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 12.7 p -109.49 146.09 35.16 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 117.804 0.802 . . . . 0.0 111.238 178.832 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 112.01 145.39 9.81 Favored Glycine 0 C--O 1.223 -0.548 0 N-CA-C 108.141 -1.984 . . . . 0.0 108.141 -176.501 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -67.59 -48.42 1.58 Allowed 'Trans proline' 0 C--N 1.348 0.514 0 CA-C-N 119.907 1.853 . . . . 0.0 115.702 -173.732 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -121.63 40.49 3.6 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 -179.397 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -65.53 -43.96 88.37 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.652 -178.066 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 57.62 24.84 54.19 Favored Glycine 0 C--O 1.224 -0.482 0 CA-C-N 115.992 -0.549 . . . . 0.0 113.972 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 47.2 mt -101.12 109.65 59.07 Favored Pre-proline 0 C--O 1.239 0.528 0 N-CA-C 114.892 1.442 . . . . 0.0 114.892 -175.832 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -77.87 167.68 23.38 Favored 'Trans proline' 0 C--O 1.237 0.451 0 N-CA-C 108.725 -1.298 . . . . 0.0 108.725 170.846 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 62.8 t80 -62.42 131.46 49.3 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 179.161 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 92.97 -5.94 76.21 Favored Glycine 0 CA--C 1.52 0.344 0 N-CA-C 114.967 0.747 . . . . 0.0 114.967 178.577 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -64.49 129.18 38.88 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 118.296 1.048 . . . . 0.0 112.085 179.688 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 43.3 t-20 -75.24 126.6 31.35 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.912 -177.406 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 9.9 ttmm -156.18 150.85 25.93 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 177.92 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -63.58 134.05 54.82 Favored 'General case' 0 C--N 1.324 -0.529 0 O-C-N 123.176 0.298 . . . . 0.0 110.526 179.416 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 68.51 26.9 74.11 Favored Glycine 0 N--CA 1.45 -0.387 0 CA-C-O 119.496 -0.613 . . . . 0.0 114.081 177.621 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 34.0 mm -130.18 130.81 65.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 117.417 0.608 . . . . 0.0 109.831 179.277 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.1 pt -132.5 113.49 21.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 CA-C-O 121.5 0.667 . . . . 0.0 110.815 175.623 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 95.1 m95 -80.98 131.85 35.35 Favored 'General case' 0 C--N 1.321 -0.662 0 O-C-N 121.893 -0.505 . . . . 0.0 111.492 -177.845 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 2.8 m -139.96 150.86 21.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.819 -177.269 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -156.71 166.57 33.02 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 106.071 -1.826 . . . . 0.0 106.071 -178.553 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 14.8 t -125.9 167.48 15.2 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 105.072 -2.195 . . . . 0.0 105.072 176.85 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -66.45 136.6 55.94 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 -179.491 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 96.09 -10.87 67.81 Favored Glycine 0 C--O 1.225 -0.432 0 CA-C-N 115.966 -0.561 . . . . 0.0 113.114 178.863 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -78.44 141.43 38.28 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 122.308 -0.525 . . . . 0.0 110.744 179.378 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 33.9 mt -91.79 135.64 33.76 Favored 'General case' 0 CA--C 1.51 -0.57 0 CA-C-O 121.429 0.633 . . . . 0.0 112.561 -178.577 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 58.5 t30 -82.32 70.05 9.19 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.601 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 2.0 t -142.48 157.55 62.3 Favored Pre-proline 0 CA--C 1.54 0.578 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 -178.822 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_exo -61.86 149.21 91.04 Favored 'Trans proline' 0 C--N 1.348 0.539 0 N-CA-C 114.407 0.887 . . . . 0.0 114.407 -179.779 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.478 ' HB3' HD12 ' A' ' 106' ' ' ILE . 74.7 mmtt -124.79 41.13 3.58 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 122.017 0.913 . . . . 0.0 108.73 -178.579 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 16.7 p-10 -50.36 -46.55 55.91 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 114.583 -1.189 . . . . 0.0 112.855 -178.531 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 48.2 p-80 -69.78 -9.15 53.51 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 113.577 0.955 . . . . 0.0 113.577 -177.674 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.478 HD12 ' HB3' ' A' ' 103' ' ' LYS . 40.8 mt -95.31 -40.13 10.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 178.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -72.14 1.31 34.11 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 115.804 1.081 . . . . 0.0 115.804 -178.149 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 6.2 t -83.03 19.22 1.45 Allowed 'General case' 0 CA--C 1.549 0.934 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 -178.261 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 66.5 ttp85 -59.24 130.67 48.06 Favored 'General case' 0 N--CA 1.47 0.55 0 O-C-N 121.101 -1.0 . . . . 0.0 109.142 179.478 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -103.88 127.03 30.23 Favored Pre-proline 0 C--N 1.323 -0.567 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 178.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -72.7 -14.76 27.18 Favored 'Trans proline' 0 C--O 1.22 -0.411 0 C-N-CA 118.098 -0.801 . . . . 0.0 113.234 -178.171 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -74.32 -27.09 60.54 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.919 0.39 . . . . 0.0 110.497 178.201 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 79.7 m-20 -104.27 -23.05 13.27 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 113.908 1.077 . . . . 0.0 113.908 -174.109 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 19.0 t-20 -148.37 151.91 36.12 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -177.325 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -91.52 148.83 22.01 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-O 121.384 0.611 . . . . 0.0 111.943 179.438 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -74.65 150.12 39.71 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.441 178.114 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 6.9 mt -92.22 140.34 16.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 -178.67 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 95.2 t -61.49 124.78 16.58 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 N-CA-C 107.162 -1.422 . . . . 0.0 107.162 175.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 5.3 tt -67.4 129.15 39.0 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.137 0.494 . . . . 0.0 111.108 -176.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 29.2 mt-30 -133.01 154.51 50.45 Favored 'General case' 0 C--O 1.219 -0.531 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 -179.484 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 12.8 mt -110.9 147.92 37.53 Favored Pre-proline 0 C--N 1.322 -0.622 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 177.763 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -73.33 166.84 28.84 Favored 'Trans proline' 0 C--N 1.346 0.444 0 O-C-N 122.197 0.577 . . . . 0.0 113.196 179.559 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 39.3 tt0 -54.08 133.03 43.83 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.779 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 97.02 -20.55 50.41 Favored Glycine 0 C--O 1.227 -0.337 0 CA-C-N 115.941 -0.572 . . . . 0.0 112.93 -179.477 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 1.5 m -104.95 127.38 52.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 117.916 0.858 . . . . 0.0 110.569 178.779 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 6.9 p -122.79 148.29 45.54 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.739 -179.674 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 85.2 mt -71.86 150.52 92.95 Favored Pre-proline 0 C--N 1.324 -0.538 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 179.181 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -78.74 179.79 6.16 Favored 'Trans proline' 0 C--O 1.236 0.387 0 O-C-N 121.99 0.468 . . . . 0.0 111.341 178.711 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 8.1 tmtt? -57.11 126.93 29.42 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 -175.306 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 89.56 -0.03 79.83 Favored Glycine 0 CA--C 1.51 -0.26 0 N-CA-C 116.233 1.253 . . . . 0.0 116.233 173.533 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.454 ' CZ ' ' HB2' ' A' ' 18' ' ' GLN . 4.0 m-85 -99.53 137.9 37.38 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-O 121.881 0.848 . . . . 0.0 111.762 -179.113 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 40.0 p90 -145.43 161.75 38.95 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 114.166 -1.379 . . . . 0.0 107.741 174.879 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -99.68 142.86 30.6 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.573 0.701 . . . . 0.0 112.468 -175.841 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -70.4 129.77 40.17 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 107.367 -1.345 . . . . 0.0 107.367 178.69 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 95.21 -21.51 43.75 Favored Glycine 0 C--O 1.227 -0.331 0 CA-C-N 116.15 -0.477 . . . . 0.0 112.761 -178.698 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 20.0 t -89.96 89.45 7.72 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 179.181 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 47.3 ttp180 60.3 93.05 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 124.38 1.072 . . . . 0.0 112.193 -177.027 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -87.33 -144.97 9.27 Favored Glycine 0 C--O 1.225 -0.438 0 CA-C-N 115.384 -0.825 . . . . 0.0 111.195 -178.811 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -85.08 18.54 26.95 Favored Glycine 0 CA--C 1.519 0.284 0 N-CA-C 111.444 -0.662 . . . . 0.0 111.444 178.153 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 40.1 t . . . . . 0 C--O 1.26 1.653 0 N-CA-C 103.491 -2.781 . . . . 0.0 103.491 -179.895 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.766 0 CA-C-O 118.251 -1.305 . . . . 0.0 111.184 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -154.95 173.52 16.42 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 -179.024 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 67.6 ttp -138.74 132.86 31.4 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 103.908 -2.627 . . . . 0.0 103.908 178.251 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 151.9 128.65 1.43 Allowed Glycine 0 N--CA 1.446 -0.645 0 N-CA-C 106.721 -2.552 . . . . 0.0 106.721 -176.9 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 96.7 mt -126.9 146.28 56.88 Favored Pre-proline 0 C--N 1.319 -0.726 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 -179.814 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -75.82 161.69 36.01 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 117.749 -1.034 . . . . 0.0 111.885 177.724 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 58.3 t30 -65.74 -32.0 73.3 Favored 'General case' 0 C--O 1.22 -0.458 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 179.479 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 -158.59 -98.28 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 177.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 34.6 p 39.87 73.19 0.12 Allowed 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 114.651 1.352 . . . . 0.0 114.651 -179.055 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -96.89 145.87 25.47 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 114.926 -1.034 . . . . 0.0 110.403 -176.705 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 37.2 p -62.94 142.29 58.39 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 114.994 -1.003 . . . . 0.0 108.883 177.108 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' TRP . . . . . 0.43 ' CD2' ' HD3' ' A' ' 109' ' ' ARG . 7.4 m95 -66.23 -21.87 66.31 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 177.754 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -121.41 161.51 22.04 Favored 'General case' 0 CA--C 1.509 -0.619 0 N-CA-C 113.944 1.09 . . . . 0.0 113.944 -172.102 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 77.4 p -72.55 172.69 10.08 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 113.692 -1.594 . . . . 0.0 109.136 177.863 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.591 ' HB2' ' CZ ' ' A' ' 69' ' ' TYR . . . -77.67 142.6 38.73 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 -176.598 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.405 HD23 ' HA ' ' A' ' 16' ' ' LEU . 11.8 mt -90.48 133.59 34.94 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 102.299 -3.223 . . . . 0.0 102.299 167.882 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 64.5 m -118.37 138.59 52.32 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 118.143 0.429 . . . . 0.0 110.264 -176.103 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.429 ' HB2' ' CZ ' ' A' ' 131' ' ' PHE . 4.0 tp60 -105.84 139.89 39.72 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 113.596 0.962 . . . . 0.0 113.596 -177.823 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 59.7 t60 -128.74 99.71 5.44 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 104.476 -2.416 . . . . 0.0 104.476 168.241 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 160.78 -162.38 33.47 Favored Glycine 0 C--O 1.226 -0.375 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 -176.333 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 54.0 mttp -110.04 -15.79 13.96 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 113.508 0.929 . . . . 0.0 113.508 -179.632 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -74.05 153.52 39.62 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 179.395 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 63.0 m-20 -79.82 -62.85 1.56 Allowed 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 120.566 0.222 . . . . 0.0 110.975 -178.133 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 48.3 tp 165.69 137.38 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 102.763 -3.051 . . . . 0.0 102.763 177.418 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -155.43 135.78 13.19 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 177.007 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -124.47 157.84 63.7 Favored Pre-proline 0 C--N 1.322 -0.599 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 177.467 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -69.33 174.39 9.21 Favored 'Trans proline' 0 CA--C 1.539 0.762 0 C-N-CA 121.704 1.602 . . . . 0.0 114.933 -178.695 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 17.3 tpt180 -78.25 129.54 35.19 Favored 'General case' 0 C--O 1.216 -0.681 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 178.367 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 75.42 12.29 83.73 Favored Glycine 0 C--O 1.225 -0.411 0 N-CA-C 114.99 0.756 . . . . 0.0 114.99 175.855 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -157.29 145.16 19.04 Favored 'General case' 0 C--O 1.219 -0.523 0 N-CA-C 106.378 -1.712 . . . . 0.0 106.378 -178.489 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 138.66 -14.39 3.4 Favored Glycine 0 CA--C 1.506 -0.504 0 C-N-CA 120.038 -1.077 . . . . 0.0 113.707 177.42 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 30.8 m -72.56 145.31 87.31 Favored Pre-proline 0 C--N 1.319 -0.729 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 177.044 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -75.69 166.28 28.66 Favored 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 122.104 1.869 . . . . 0.0 113.775 179.386 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 97.6 mt -73.3 124.84 31.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.34 -0.846 . . . . 0.0 110.568 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 16.3 t-20 -125.41 122.76 37.65 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.861 0.362 . . . . 0.0 110.921 174.64 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 72.7 p -91.04 -15.91 28.77 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 113.837 1.051 . . . . 0.0 113.837 -177.195 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 11.8 p30 -112.96 25.37 11.47 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.637 -0.711 . . . . 0.0 112.385 -176.915 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 68.3 m -136.36 153.34 51.15 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 178.898 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 2.9 m -68.62 162.9 59.24 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.527 -178.787 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -66.47 -28.61 45.77 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 114.493 -3.204 . . . . 0.0 113.638 179.785 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.53 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 5.1 p-10 -75.23 -23.08 57.5 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 121.621 -0.674 . . . . 0.0 111.608 177.151 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.482 ' HA ' ' HE3' ' A' ' 103' ' ' LYS . 18.8 m-20 -73.25 -13.15 61.08 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.712 0.805 . . . . 0.0 112.901 -176.406 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 93.1 mm-40 -62.44 -24.53 67.47 Favored 'General case' 0 C--O 1.219 -0.547 0 N-CA-C 114.492 1.293 . . . . 0.0 114.492 -177.092 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.567 ' HB ' ' HB1' ' A' ' 98' ' ' ALA . 12.9 tt -57.16 140.15 15.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 CA-C-O 122.303 1.049 . . . . 0.0 112.952 179.473 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 178.35 -151.78 10.89 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.122 -1.037 . . . . 0.0 113.14 -179.116 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 48.7 p90 -154.71 168.71 25.91 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 179.074 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -108.67 138.4 45.04 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 173.151 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.96 126.01 51.68 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 123.821 0.849 . . . . 0.0 108.758 -179.379 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 34.1 ttt180 -70.78 144.16 50.94 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 122.339 0.256 . . . . 0.0 111.404 177.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -149.16 160.22 43.55 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.709 0.766 . . . . 0.0 111.679 178.746 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 8.4 t -169.13 176.28 5.35 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 102.09 -3.3 . . . . 0.0 102.09 174.485 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 12.9 tpt180 -128.41 123.86 34.85 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 177.665 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 3.3 tmt_? -134.95 142.22 46.45 Favored 'General case' 0 CA--C 1.5 -0.974 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 -177.505 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -141.88 179.75 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 -177.605 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 24.9 tpt85 -134.96 104.52 5.99 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 105.669 -1.975 . . . . 0.0 105.669 171.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -77.54 152.54 39.5 Favored Glycine 0 N--CA 1.45 -0.385 0 N-CA-C 105.078 -3.209 . . . . 0.0 105.078 176.258 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -59.76 -38.21 93.57 Favored Glycine 0 C--O 1.222 -0.617 0 CA-C-N 118.9 1.35 . . . . 0.0 112.147 -178.357 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 37.5 t0 -81.83 15.73 2.11 Favored 'General case' 0 CA--C 1.551 0.993 0 CA-C-O 122.345 1.069 . . . . 0.0 112.057 -179.557 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 85.13 15.46 66.95 Favored Glycine 0 C--O 1.222 -0.64 0 CA-C-N 115.664 -0.698 . . . . 0.0 113.294 171.814 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 21.1 mmtt -82.34 140.55 33.47 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.399 0.619 . . . . 0.0 109.855 -175.384 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 61.7 mtp -125.51 -178.37 4.22 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 114.418 -1.265 . . . . 0.0 110.451 -176.297 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 34.6 mmtt -136.88 -57.95 0.72 Allowed 'General case' 0 CA--C 1.504 -0.817 0 CA-C-O 121.33 0.586 . . . . 0.0 109.441 -177.867 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 34.47 64.04 0.41 Allowed 'General case' 0 C--N 1.322 -0.63 0 O-C-N 126.172 2.17 . . . . 0.0 112.897 173.528 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 75.9 mt -61.74 159.33 13.77 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 113.669 -1.605 . . . . 0.0 112.258 -176.376 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 54.1 p -55.61 142.77 60.96 Favored Pre-proline 0 C--O 1.252 1.187 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.368 179.327 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -66.46 142.06 63.9 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 116.7 -1.733 . . . . 0.0 112.554 -176.464 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.445 ' HB2' ' HB1' ' A' ' 15' ' ' ALA . 6.9 ptp180 -139.26 162.81 34.09 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 114.477 -1.238 . . . . 0.0 108.198 -179.739 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 53.1 m95 -132.65 148.92 52.36 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 -177.663 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.591 ' CZ ' ' HB2' ' A' ' 15' ' ' ALA . 45.1 m-85 -125.09 150.46 46.81 Favored 'General case' 0 C--O 1.215 -0.763 0 N-CA-C 106.17 -1.789 . . . . 0.0 106.17 179.433 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 86.3 t80 -97.06 139.01 33.71 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 118.818 0.735 . . . . 0.0 109.756 -175.808 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -140.99 152.28 44.8 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 -175.171 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 65.9 m-85 -85.53 159.47 19.9 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -175.045 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -54.2 126.61 23.62 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.127 178.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 72.92 30.79 62.92 Favored Glycine 0 C--O 1.22 -0.737 0 N-CA-C 116.105 1.202 . . . . 0.0 116.105 177.226 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.2 p -89.31 146.21 24.86 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 119.133 1.467 . . . . 0.0 108.154 178.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 98.01 133.09 7.8 Favored Glycine 0 CA--C 1.527 0.786 0 N-CA-C 109.186 -1.565 . . . . 0.0 109.186 -176.51 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -70.41 -36.45 9.06 Favored 'Trans proline' 0 C--N 1.346 0.433 0 CA-C-N 119.716 1.758 . . . . 0.0 116.036 -173.883 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -105.24 15.16 27.86 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 114.983 -1.008 . . . . 0.0 108.884 -176.62 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -60.3 -43.07 96.63 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.349 -175.291 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 56.48 35.13 65.16 Favored Glycine 0 C--O 1.228 -0.242 0 CA-C-N 115.871 -0.604 . . . . 0.0 112.687 179.434 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 15.0 mt -113.28 103.91 55.57 Favored Pre-proline 0 N--CA 1.446 -0.662 0 N-CA-C 115.401 1.63 . . . . 0.0 115.401 -175.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -79.48 163.99 24.06 Favored 'Trans proline' 0 N--CA 1.46 -0.47 0 C-N-CA 122.421 2.08 . . . . 0.0 107.846 167.938 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 48.6 t80 -61.51 131.01 48.75 Favored 'General case' 0 C--N 1.319 -0.733 0 C-N-CA 120.467 -0.493 . . . . 0.0 110.214 -178.614 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 92.89 -7.65 76.7 Favored Glycine 0 CA--C 1.52 0.368 0 CA-C-O 119.349 -0.695 . . . . 0.0 114.778 178.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -66.88 130.59 43.65 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 118.58 1.19 . . . . 0.0 111.655 179.446 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 56.4 t30 -76.44 129.7 36.92 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.606 -179.328 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 22.0 ttmt -156.07 153.13 28.91 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 179.304 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 35.0 t0 -60.2 125.23 22.88 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.312 0.577 . . . . 0.0 111.48 -178.866 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 69.66 30.92 70.49 Favored Glycine 0 N--CA 1.449 -0.472 0 CA-C-O 118.908 -0.94 . . . . 0.0 114.484 177.57 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 42.8 mm -126.0 129.86 72.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 117.844 0.822 . . . . 0.0 111.445 179.755 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -130.82 117.88 39.9 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.662 175.25 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 96.4 m95 -82.99 136.68 34.43 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 113.81 1.041 . . . . 0.0 113.81 -176.665 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -144.77 155.37 14.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.611 -179.121 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -155.81 166.6 33.01 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 104.729 -2.323 . . . . 0.0 104.729 -178.896 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 15.1 t -116.28 170.04 8.83 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 104.892 -2.262 . . . . 0.0 104.892 173.711 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -66.13 135.1 54.1 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 178.839 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 91.3 -7.52 80.34 Favored Glycine 0 CA--C 1.517 0.188 0 CA-C-N 116.143 -0.481 . . . . 0.0 113.169 179.48 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.567 ' HB1' ' HB ' ' A' ' 44' ' ' ILE . . . -72.16 134.34 45.66 Favored 'General case' 0 CA--C 1.539 0.542 0 O-C-N 122.322 -0.516 . . . . 0.0 110.337 178.81 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 31.8 mt -85.96 138.19 32.18 Favored 'General case' 0 CA--C 1.511 -0.532 0 CA-C-O 121.48 0.657 . . . . 0.0 112.591 -177.163 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 60.0 t30 -85.43 69.73 10.72 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.277 -179.542 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -145.1 158.52 51.83 Favored Pre-proline 0 C--N 1.321 -0.657 0 N-CA-C 104.237 -2.505 . . . . 0.0 104.237 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -73.08 149.9 47.25 Favored 'Trans proline' 0 CA--C 1.534 0.515 0 N-CA-C 113.938 0.707 . . . . 0.0 113.938 177.921 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.482 ' HE3' ' HA ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -146.83 56.84 1.15 Allowed 'General case' 0 N--CA 1.477 0.883 0 CA-C-O 122.702 1.239 . . . . 0.0 109.205 176.444 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -65.14 -21.38 66.78 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.291 -1.322 . . . . 0.0 111.519 179.382 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 19.0 p80 -56.83 -19.67 18.61 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 114.307 1.225 . . . . 0.0 114.307 -179.13 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 11.7 mt -83.58 -27.91 7.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 121.698 0.761 . . . . 0.0 109.017 -179.413 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -78.2 14.66 10.72 Favored Glycine 0 C--O 1.219 -0.798 0 CA-C-N 115.715 -0.675 . . . . 0.0 114.416 -176.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 7.8 t -83.05 15.42 2.81 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-O 122.079 0.942 . . . . 0.0 110.467 -179.652 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.43 ' HD3' ' CD2' ' A' ' 12' ' ' TRP . 57.8 ttp85 -63.46 131.3 47.72 Favored 'General case' 0 C--N 1.327 -0.41 0 O-C-N 121.851 -0.531 . . . . 0.0 110.212 -179.512 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 66.4 m-20 -106.65 120.18 49.19 Favored Pre-proline 0 C--N 1.327 -0.404 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 179.289 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -70.71 -13.92 32.67 Favored 'Trans proline' 0 C--N 1.347 0.489 0 N-CA-C 113.808 0.657 . . . . 0.0 113.808 -176.631 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -72.61 -26.04 61.54 Favored 'General case' 0 C--O 1.22 -0.46 0 CA-C-O 120.717 0.294 . . . . 0.0 110.825 177.09 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 -104.05 -24.82 13.17 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 114.273 1.212 . . . . 0.0 114.273 -174.196 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ASN . . . . . 0.404 ' OD1' ' HD2' ' A' ' 109' ' ' ARG . 0.1 OUTLIER -143.26 154.98 44.37 Favored 'General case' 0 N--CA 1.434 -1.238 0 CA-C-O 121.284 0.564 . . . . 0.0 110.308 -176.211 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -94.99 144.1 25.95 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.462 178.71 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -70.3 148.23 48.74 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.197 0.522 . . . . 0.0 110.958 179.501 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 15.0 mt -84.45 136.98 21.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 -178.815 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -62.67 125.92 20.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 106.776 -1.564 . . . . 0.0 106.776 175.628 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 4.2 tt -66.08 128.39 35.89 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.163 0.506 . . . . 0.0 111.005 -177.398 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -132.03 156.86 45.52 Favored 'General case' 0 CA--C 1.509 -0.612 0 N-CA-C 106.946 -1.502 . . . . 0.0 106.946 -179.58 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.4 HD13 HG22 ' A' ' 125' ' ' THR . 14.3 mt -115.3 147.49 38.71 Favored Pre-proline 0 C--N 1.32 -0.679 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 179.688 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -73.29 169.38 22.42 Favored 'Trans proline' 0 C--N 1.346 0.421 0 O-C-N 122.361 0.664 . . . . 0.0 113.754 -178.579 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 39.7 tt0 -53.6 131.85 39.49 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.426 -0.806 . . . . 0.0 109.899 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 94.26 -18.05 57.67 Favored Glycine 0 C--O 1.228 -0.248 0 CA-C-N 115.904 -0.589 . . . . 0.0 113.395 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.4 HG22 HD13 ' A' ' 121' ' ' LEU . 3.3 m -104.66 126.77 52.06 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 118.108 0.954 . . . . 0.0 111.261 178.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 5.5 p -119.87 148.27 43.68 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.964 -179.348 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 88.7 mt -69.86 152.8 95.9 Favored Pre-proline 0 C--N 1.324 -0.535 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 178.204 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -76.58 175.37 11.45 Favored 'Trans proline' 0 N--CA 1.462 -0.375 0 C-N-CA 118.524 -0.517 . . . . 0.0 111.077 178.805 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 62.6 tttm -56.9 126.62 27.89 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 113.431 0.9 . . . . 0.0 113.431 -174.552 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 89.56 -6.42 83.17 Favored Glycine 0 CA--C 1.517 0.197 0 N-CA-C 116.106 1.202 . . . . 0.0 116.106 175.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.429 ' CZ ' ' HB2' ' A' ' 18' ' ' GLN . 2.7 m-85 -91.68 145.68 24.39 Favored 'General case' 0 N--CA 1.434 -1.26 0 CA-C-O 122.653 1.216 . . . . 0.0 111.681 -178.685 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 50.2 p90 -145.34 162.5 37.08 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 112.902 -1.953 . . . . 0.0 107.896 175.162 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -105.48 136.53 44.87 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.162 0.506 . . . . 0.0 111.913 -176.938 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -67.56 133.73 49.97 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.356 -0.838 . . . . 0.0 108.92 177.584 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 91.88 -27.51 9.92 Favored Glycine 0 CA--C 1.522 0.513 0 N-CA-C 113.663 0.225 . . . . 0.0 113.663 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 4.9 t -71.41 177.84 3.75 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.306 0.574 . . . . 0.0 111.248 178.139 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 42.7 ttt180 65.0 0.46 1.23 Allowed 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 124.985 1.314 . . . . 0.0 114.42 -179.268 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -68.27 161.03 50.62 Favored Glycine 0 CA--C 1.52 0.351 0 N-CA-C 109.776 -1.329 . . . . 0.0 109.776 174.872 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -127.55 35.04 2.88 Favored Glycine 0 N--CA 1.457 0.093 0 N-CA-C 112.077 -0.409 . . . . 0.0 112.077 -178.384 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 50.1 m . . . . . 0 C--O 1.252 1.199 0 CA-C-O 115.619 -2.134 . . . . 0.0 105.869 -179.396 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.91 0 CA-C-O 118.311 -1.272 . . . . 0.0 111.167 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -69.73 151.65 45.57 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 118.678 1.239 . . . . 0.0 107.867 177.586 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 26.6 mmt -80.62 52.38 1.66 Allowed 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -178.383 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 61.14 28.76 69.55 Favored Glycine 0 C--O 1.224 -0.522 0 CA-C-O 121.492 0.496 . . . . 0.0 113.78 179.448 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 80.2 mt -65.96 141.52 97.6 Favored Pre-proline 0 C--N 1.323 -0.556 0 CA-C-N 115.683 -0.258 . . . . 0.0 110.922 -176.758 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -74.03 89.79 1.01 Allowed 'Trans proline' 0 C--N 1.352 0.723 0 CA-C-O 122.224 0.843 . . . . 0.0 112.903 179.193 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 14.0 p-10 -81.91 28.61 0.42 Allowed 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 115.222 1.564 . . . . 0.0 115.222 -175.686 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -70.38 -31.86 69.28 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 178.462 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 26.8 p -17.75 97.41 0.01 OUTLIER 'General case' 0 C--O 1.24 0.571 0 C-N-CA 127.092 2.157 . . . . 0.0 115.569 178.351 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -128.6 140.26 51.86 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 114.527 -1.215 . . . . 0.0 113.318 -175.608 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 16.2 t -66.2 141.86 57.91 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.78 178.431 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 27.3 m95 -68.35 -23.21 64.66 Favored 'General case' 0 CA--C 1.509 -0.634 0 O-C-N 123.372 0.42 . . . . 0.0 111.457 177.743 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 36.7 m-85 -121.38 158.26 28.69 Favored 'General case' 0 CA--C 1.506 -0.714 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.83 -173.396 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.419 ' HB ' ' HB3' ' A' ' 134' ' ' GLU . 69.8 p -65.67 160.43 22.74 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.235 -0.893 . . . . 0.0 109.838 -179.65 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.434 ' HB2' ' CE1' ' A' ' 69' ' ' TYR . . . -80.25 139.34 36.73 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.147 -0.933 . . . . 0.0 112.166 -174.844 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.464 HD11 HD22 ' A' ' 119' ' ' LEU . 3.8 mp -83.15 148.9 27.19 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 172.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 64.7 m -124.49 138.76 54.32 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 179.835 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.415 ' HB2' ' CZ ' ' A' ' 131' ' ' PHE . 4.3 tp60 -111.85 136.44 51.14 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 -178.023 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 56.0 t60 -131.22 94.97 3.68 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 104.318 -2.475 . . . . 0.0 104.318 169.152 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 178.61 -166.32 36.06 Favored Glycine 0 C--O 1.224 -0.475 0 N-CA-C 110.802 -0.919 . . . . 0.0 110.802 -176.3 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 91.9 mttt -101.11 -21.79 14.88 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 114.442 1.275 . . . . 0.0 114.442 -177.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -94.03 161.53 14.25 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 179.6 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -77.76 -62.92 1.51 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.517 -179.012 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 45.0 tp 179.44 140.7 0.12 Allowed 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 105.387 -2.079 . . . . 0.0 105.387 175.619 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 23.7 tptm -155.67 134.84 12.21 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 118.051 0.387 . . . . 0.0 110.49 174.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 20.1 m-85 -121.24 151.69 56.19 Favored Pre-proline 0 C--O 1.242 0.66 0 N-CA-C 107.178 -1.416 . . . . 0.0 107.178 174.062 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -73.97 160.63 42.74 Favored 'Trans proline' 0 CA--C 1.535 0.541 0 O-C-N 122.058 0.504 . . . . 0.0 111.946 177.866 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 3.8 tmt_? -64.3 132.02 48.99 Favored 'General case' 0 N--CA 1.47 0.539 0 O-C-N 122.169 -0.332 . . . . 0.0 110.35 -178.102 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 83.23 15.38 72.04 Favored Glycine 0 C--O 1.223 -0.557 0 C-N-CA 121.249 -0.501 . . . . 0.0 112.375 177.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -150.92 170.54 19.07 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 -176.668 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 100.32 -10.83 59.89 Favored Glycine 0 CA--C 1.508 -0.384 0 N-CA-C 115.183 0.833 . . . . 0.0 115.183 174.643 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 90.3 t -68.91 130.07 91.85 Favored Pre-proline 0 C--N 1.321 -0.669 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 177.342 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -73.18 171.75 16.98 Favored 'Trans proline' 0 C--O 1.221 -0.357 0 O-C-N 122.183 0.57 . . . . 0.0 112.351 178.343 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 92.6 mt -71.57 106.44 2.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 179.304 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 -96.17 86.55 4.28 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 114.33 -1.305 . . . . 0.0 109.755 -176.852 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 77.5 p -67.65 -14.89 63.33 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.543 -0.753 . . . . 0.0 112.816 -178.691 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -108.35 21.04 17.88 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.158 -0.928 . . . . 0.0 112.022 -177.861 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.475 ' HB3' ' HB2' ' A' ' 42' ' ' ASP . 2.0 m -143.17 149.84 38.58 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 114.333 1.234 . . . . 0.0 114.333 -175.824 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.2 m -76.8 168.41 28.32 Favored Pre-proline 0 N--CA 1.471 0.595 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 177.762 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -64.39 -27.44 62.94 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 114.731 -3.046 . . . . 0.0 112.095 178.634 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -62.84 -23.97 67.55 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 124.104 0.962 . . . . 0.0 112.322 176.242 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.475 ' HB2' ' HB3' ' A' ' 38' ' ' SER . 68.7 m-20 -99.28 -1.98 37.66 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 114.106 1.151 . . . . 0.0 114.106 -171.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 91.8 mm-40 -61.89 -26.01 67.9 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 114.002 1.112 . . . . 0.0 114.002 -177.433 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 8.5 tt -59.04 137.26 21.72 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.83 0 CA-C-O 122.242 1.02 . . . . 0.0 112.977 -179.281 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -179.33 -159.18 22.97 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.437 -0.887 . . . . 0.0 112.505 -178.637 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.414 ' CE2' HD12 ' A' ' 90' ' ' ILE . 42.7 p90 -155.02 168.12 28.08 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 179.468 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 31.9 m-85 -109.37 140.77 42.66 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 175.314 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 66.0 ttt-85 -116.85 120.77 39.54 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.892 -175.054 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 50.1 ttp180 -70.73 143.7 51.19 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 110.244 -0.28 . . . . 0.0 110.244 177.899 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -144.32 141.26 29.65 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 122.734 0.414 . . . . 0.0 110.327 178.807 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 25.4 p -144.49 151.5 39.25 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 178.192 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 13.3 tpt180 -149.14 130.52 14.72 Favored 'General case' 0 N--CA 1.469 0.517 0 O-C-N 122.176 -0.328 . . . . 0.0 111.3 176.674 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 4.2 tmm_? -144.07 138.83 28.57 Favored 'General case' 0 CA--C 1.5 -0.96 0 CA-C-O 121.157 0.503 . . . . 0.0 109.793 179.654 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -131.81 179.2 4.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 -179.658 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 5.0 ttt85 -115.36 99.16 7.18 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 174.827 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -77.91 157.69 45.58 Favored Glycine 0 C--O 1.223 -0.551 0 N-CA-C 107.359 -2.296 . . . . 0.0 107.359 176.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -66.04 -41.9 94.91 Favored Glycine 0 C--O 1.217 -0.953 0 CA-C-N 118.427 1.114 . . . . 0.0 111.899 179.641 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -85.35 -11.05 55.5 Favored 'General case' 0 C--O 1.215 -0.719 0 CA-C-O 122.137 0.97 . . . . 0.0 110.328 178.551 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 103.57 9.7 37.48 Favored Glycine 0 C--O 1.226 -0.398 0 CA-C-N 115.288 -0.869 . . . . 0.0 112.781 177.84 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 59.5 mmtt -61.12 132.36 53.48 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.274 0.559 . . . . 0.0 110.59 -179.391 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 95.8 mmm -86.19 167.62 14.72 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 114.781 -1.099 . . . . 0.0 111.185 179.705 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 16.2 tppt? -108.61 -39.42 5.39 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 176.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 15.2 t0 -141.77 164.98 28.72 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 105.253 -2.129 . . . . 0.0 105.253 178.531 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -121.2 -94.27 0.5 Allowed 'General case' 0 C--N 1.325 -0.469 0 O-C-N 123.502 0.501 . . . . 0.0 110.597 -176.334 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -72.45 159.4 85.48 Favored Pre-proline 0 C--N 1.326 -0.43 0 C-N-CA 122.717 0.407 . . . . 0.0 109.976 179.667 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -68.79 140.86 47.62 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 115.116 -2.789 . . . . 0.0 111.377 177.649 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 53.5 mtt180 -104.2 155.65 18.54 Favored 'General case' 0 CA--C 1.504 -0.798 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.067 179.479 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 66.0 m95 -127.53 125.85 41.13 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 174.916 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.434 ' CE1' ' HB2' ' A' ' 15' ' ' ALA . 69.6 m-85 -110.32 160.22 16.75 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 106.605 -1.628 . . . . 0.0 106.605 -178.615 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -103.55 132.8 49.49 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 179.378 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -131.65 145.69 51.8 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 -176.081 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 58.8 m-85 -87.26 161.59 17.9 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 120.755 0.312 . . . . 0.0 110.289 -176.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -53.42 132.46 39.69 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 120.747 0.308 . . . . 0.0 111.379 -178.908 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 70.37 27.98 71.95 Favored Glycine 0 C--O 1.224 -0.508 0 N-CA-C 116.264 1.266 . . . . 0.0 116.264 176.529 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 69.9 p -110.27 154.96 22.7 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 118.278 1.039 . . . . 0.0 111.286 178.891 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 111.48 146.21 10.34 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.387 -1.085 . . . . 0.0 110.387 -178.201 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -70.41 -40.4 4.34 Favored 'Trans proline' 0 C--N 1.348 0.545 0 CA-C-N 119.588 1.694 . . . . 0.0 116.4 -173.448 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -117.92 23.74 11.47 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.972 0.892 . . . . 0.0 109.649 -178.003 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -66.75 -55.64 14.09 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.855 -0.612 . . . . 0.0 111.554 -176.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 55.77 35.28 62.49 Favored Glycine 0 C--O 1.223 -0.552 0 N-CA-C 111.398 -0.681 . . . . 0.0 111.398 -177.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 27.4 mt -106.39 104.73 51.69 Favored Pre-proline 0 C--O 1.238 0.482 0 N-CA-C 117.348 2.351 . . . . 0.0 117.348 -172.765 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -77.88 164.36 27.69 Favored 'Trans proline' 0 C--O 1.234 0.303 0 C-N-CA 121.787 1.658 . . . . 0.0 108.011 167.789 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 53.5 t80 -62.43 133.1 54.55 Favored 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 120.493 -0.483 . . . . 0.0 111.191 -176.785 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 89.52 -7.6 81.59 Favored Glycine 0 CA--C 1.517 0.202 0 CA-C-O 119.6 -0.556 . . . . 0.0 114.373 178.867 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -63.5 131.61 48.68 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 118.134 0.967 . . . . 0.0 111.084 179.62 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -78.25 130.13 35.9 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.242 -179.277 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 24.8 ttmt -156.2 150.97 26.04 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 105.37 -2.085 . . . . 0.0 105.37 176.501 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 42.4 t0 -70.88 135.85 48.28 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.827 -0.435 . . . . 0.0 109.827 -177.853 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 71.95 24.5 76.48 Favored Glycine 0 N--CA 1.453 -0.222 0 C-N-CA 121.158 -0.544 . . . . 0.0 113.937 -179.373 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.414 HD12 ' CE2' ' A' ' 46' ' ' TYR . 41.6 mm -129.36 129.61 67.27 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 CA-C-N 117.198 0.499 . . . . 0.0 110.593 -179.712 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.1 pt -132.91 125.22 51.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 CA-C-O 121.17 0.51 . . . . 0.0 110.591 176.472 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 95.9 m95 -88.63 138.96 30.95 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 113.62 0.97 . . . . 0.0 113.62 -176.023 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 16.6 m -137.78 152.21 26.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 108.982 -0.748 . . . . 0.0 108.982 178.775 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -160.62 166.6 28.63 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 103.368 -2.827 . . . . 0.0 103.368 -179.831 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 12.4 t -138.63 177.24 8.03 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 106.059 -1.83 . . . . 0.0 106.059 178.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -67.5 135.71 53.47 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.983 0.421 . . . . 0.0 109.972 -179.415 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 96.16 -8.52 67.36 Favored Glycine 0 C--O 1.224 -0.514 0 CA-C-N 115.952 -0.567 . . . . 0.0 113.506 178.803 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -80.92 138.76 36.13 Favored 'General case' 0 CA--C 1.538 0.491 0 O-C-N 122.37 -0.488 . . . . 0.0 111.678 -179.534 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 91.9 mt -88.05 154.93 20.09 Favored 'General case' 0 C--O 1.214 -0.808 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 178.785 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 57.8 t30 -96.99 64.88 2.02 Favored 'General case' 0 C--N 1.323 -0.572 0 O-C-N 122.14 -0.35 . . . . 0.0 110.516 178.237 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -138.24 154.51 73.95 Favored Pre-proline 0 CA--C 1.538 0.518 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 -179.119 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -68.02 154.17 73.32 Favored 'Trans proline' 0 C--N 1.349 0.602 0 N-CA-C 114.332 0.859 . . . . 0.0 114.332 -179.222 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.441 ' HE3' ' HA ' ' A' ' 42' ' ' ASP . 70.9 mmtt -128.67 54.35 1.78 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.552 0.691 . . . . 0.0 109.627 -178.364 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 12.7 p-10 -60.48 -37.23 80.36 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.573 -177.017 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 10.6 p80 -65.56 -15.18 62.46 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 113.205 0.817 . . . . 0.0 113.205 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.411 HD12 ' HB3' ' A' ' 103' ' ' LYS . 25.1 mt -91.21 -38.19 10.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 178.276 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -75.74 2.75 53.18 Favored Glycine 0 CA--C 1.521 0.438 0 N-CA-C 116.013 1.165 . . . . 0.0 116.013 -177.851 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 6.2 t -91.17 22.45 3.78 Favored 'General case' 0 CA--C 1.548 0.876 0 CA-C-O 121.98 0.895 . . . . 0.0 111.728 -178.852 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.437 ' HD2' ' OD1' ' A' ' 114' ' ' ASN . 61.1 ttp85 -59.11 131.41 50.96 Favored 'General case' 0 N--CA 1.468 0.464 0 O-C-N 121.507 -0.745 . . . . 0.0 110.918 -179.625 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 71.1 m-20 -104.38 121.41 47.42 Favored Pre-proline 0 C--N 1.327 -0.394 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_endo -70.09 -14.72 35.37 Favored 'Trans proline' 0 C--N 1.348 0.516 0 N-CA-C 113.994 0.729 . . . . 0.0 113.994 -178.101 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -73.79 -25.61 60.21 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 120.665 0.269 . . . . 0.0 110.899 177.06 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 -101.89 -25.41 13.8 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 113.325 0.861 . . . . 0.0 113.325 -175.713 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ASN . . . . . 0.437 ' OD1' ' HD2' ' A' ' 109' ' ' ARG . 0.4 OUTLIER -141.8 151.92 43.26 Favored 'General case' 0 N--CA 1.439 -1.013 0 CA-C-O 121.196 0.522 . . . . 0.0 111.451 -176.782 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -97.24 140.47 31.67 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 115.382 -0.826 . . . . 0.0 109.594 177.395 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -68.88 151.99 45.87 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.275 0.56 . . . . 0.0 111.459 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 5.3 mt -95.4 139.43 18.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.066 -178.018 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 71.8 t -62.07 125.9 19.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 N-CA-C 106.391 -1.707 . . . . 0.0 106.391 175.389 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.464 HD22 HD11 ' A' ' 16' ' ' LEU . 7.6 tt -66.85 128.14 35.17 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.225 0.536 . . . . 0.0 109.58 -177.392 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 29.5 mt-30 -129.45 158.26 39.68 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 105.417 -2.068 . . . . 0.0 105.417 179.391 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 21.3 mt -115.02 148.28 40.2 Favored Pre-proline 0 C--N 1.321 -0.662 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 179.588 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -72.65 170.33 19.76 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 120.49 0.793 . . . . 0.0 113.636 -177.673 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 4.1 tp-100 -53.84 129.08 32.43 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.391 -179.371 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 89.66 -10.97 71.7 Favored Glycine 0 CA--C 1.519 0.34 0 CA-C-N 115.999 -0.546 . . . . 0.0 114.385 179.399 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 25.7 m -108.67 127.05 53.64 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 117.955 0.877 . . . . 0.0 110.002 179.052 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 12.7 p -125.07 152.52 44.23 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 123.054 0.541 . . . . 0.0 110.83 -178.661 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 83.7 mt -69.62 153.27 95.82 Favored Pre-proline 0 C--N 1.328 -0.362 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 179.398 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -77.96 176.48 9.94 Favored 'Trans proline' 0 C--N 1.345 0.377 0 O-C-N 121.946 0.445 . . . . 0.0 111.283 178.401 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -59.48 125.59 24.24 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 113.85 1.056 . . . . 0.0 113.85 -174.572 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 91.51 -4.0 79.39 Favored Glycine 0 C--N 1.33 0.2 0 N-CA-C 115.748 1.059 . . . . 0.0 115.748 175.683 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.415 ' CZ ' ' HB2' ' A' ' 18' ' ' GLN . 2.4 m-85 -96.58 142.51 28.55 Favored 'General case' 0 N--CA 1.44 -0.964 0 CA-C-O 122.09 0.947 . . . . 0.0 113.055 -177.696 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 52.8 p90 -146.04 161.62 39.72 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 113.66 -1.609 . . . . 0.0 107.568 173.201 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -104.83 151.31 23.96 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 -178.904 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.419 ' HB3' ' HB ' ' A' ' 14' ' ' THR . 4.9 tp10 -70.92 134.94 47.65 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 178.488 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 84.56 -4.45 84.34 Favored Glycine 0 CA--C 1.521 0.438 0 C-N-CA 121.537 -0.364 . . . . 0.0 113.72 -177.675 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 18.2 t -85.89 173.06 10.25 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.636 0.731 . . . . 0.0 109.292 178.87 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 56.2 mmm-85 -130.63 173.08 11.24 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 105.534 -2.025 . . . . 0.0 105.534 177.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -164.43 -172.92 32.49 Favored Glycine 0 C--N 1.316 -0.557 0 N-CA-C 105.839 -2.904 . . . . 0.0 105.839 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -145.59 -173.54 16.95 Favored Glycine 0 N--CA 1.452 -0.244 0 N-CA-C 107.972 -2.051 . . . . 0.0 107.972 179.508 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 25.7 m . . . . . 0 C--O 1.249 1.032 0 CA-C-O 117.317 -1.325 . . . . 0.0 109.868 178.938 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.758 0 CA-C-O 118.499 -1.167 . . . . 0.0 111.44 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 54.22 28.74 9.52 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 115.353 1.612 . . . . 0.0 115.353 177.692 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 3.3 tmm? -156.8 130.29 8.1 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 178.485 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -174.18 -79.02 0.05 OUTLIER Glycine 0 C--O 1.229 -0.18 0 C-N-CA 120.797 -0.715 . . . . 0.0 113.344 179.153 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 91.1 mt -118.58 153.95 52.29 Favored Pre-proline 0 C--N 1.327 -0.41 0 N-CA-C 110.094 -0.336 . . . . 0.0 110.094 -177.32 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -78.84 173.11 14.02 Favored 'Trans proline' 0 C--N 1.349 0.562 0 O-C-N 122.061 0.506 . . . . 0.0 111.345 176.251 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 79.3 m-20 -115.72 -142.38 0.38 Allowed 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 105.659 -1.978 . . . . 0.0 105.659 178.101 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 66.6 t30 -103.91 50.49 0.8 Allowed 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.295 0.569 . . . . 0.0 111.33 -176.494 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 22.3 p -139.4 149.49 44.16 Favored 'General case' 0 N--CA 1.439 -1.023 0 N-CA-C 100.285 -3.969 . . . . 0.0 100.285 -179.698 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -146.8 147.53 30.98 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-O 121.545 0.688 . . . . 0.0 112.101 -177.11 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -59.17 142.48 51.54 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.184 -0.916 . . . . 0.0 110.305 177.934 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 21.4 m95 -67.19 -21.92 65.76 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 114.066 1.135 . . . . 0.0 114.066 -179.191 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 39.2 m-85 -121.48 162.21 20.91 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 114.336 1.236 . . . . 0.0 114.336 -170.714 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 53.8 p -68.87 164.58 21.72 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.377 -1.283 . . . . 0.0 110.811 -179.64 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.462 ' HB2' ' CZ ' ' A' ' 69' ' ' TYR . . . -85.59 131.56 34.33 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.261 -0.881 . . . . 0.0 112.388 -176.731 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -81.61 148.85 28.87 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 105.466 -2.05 . . . . 0.0 105.466 173.793 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 57.1 m -118.21 139.66 50.95 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 179.441 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 4.1 tp60 -110.03 136.91 48.55 Favored 'General case' 0 C--N 1.328 -0.345 0 O-C-N 123.426 0.454 . . . . 0.0 111.338 -179.079 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 42.8 t60 -128.09 99.38 5.45 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 105.402 -2.073 . . . . 0.0 105.402 171.674 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 169.7 -167.57 40.62 Favored Glycine 0 C--O 1.225 -0.432 0 N-CA-C 109.289 -1.524 . . . . 0.0 109.289 -176.781 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 64.8 mttp -103.77 -23.32 13.42 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 179.853 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -82.51 158.85 23.01 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 -179.504 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -76.75 -62.86 1.5 Allowed 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 -179.369 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 32.7 tp 172.62 144.8 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 104.228 -2.508 . . . . 0.0 104.228 179.347 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 22.2 tptm -155.59 141.08 17.8 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 174.284 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -126.08 157.91 67.99 Favored Pre-proline 0 C--O 1.241 0.634 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 177.043 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -70.77 176.15 7.93 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 121.307 1.338 . . . . 0.0 114.678 -178.449 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 77.5 ttt180 -74.86 126.41 30.88 Favored 'General case' 0 C--O 1.217 -0.633 0 O-C-N 121.803 -0.56 . . . . 0.0 110.443 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 76.79 13.08 83.94 Favored Glycine 0 C--O 1.223 -0.54 0 N-CA-C 115.483 0.953 . . . . 0.0 115.483 175.91 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -157.01 142.5 17.47 Favored 'General case' 0 C--O 1.22 -0.458 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 -177.722 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 141.29 -18.06 2.69 Favored Glycine 0 CA--C 1.506 -0.503 0 C-N-CA 120.308 -0.949 . . . . 0.0 113.391 179.108 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 31.6 m -69.49 145.45 95.38 Favored Pre-proline 0 C--N 1.323 -0.566 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 176.381 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -75.9 172.45 16.25 Favored 'Trans proline' 0 CA--C 1.511 -0.64 0 C-N-CA 121.211 1.274 . . . . 0.0 112.582 -179.739 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 97.9 mt -71.8 109.97 4.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 176.842 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 69.6 m-80 -101.1 85.59 2.86 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 114.681 -1.145 . . . . 0.0 108.986 -177.812 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 73.7 p -66.16 -15.85 63.48 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 113.021 0.749 . . . . 0.0 113.021 -177.589 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 10.4 p30 -105.65 21.89 16.46 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.253 -0.885 . . . . 0.0 111.315 -178.276 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 14.2 m -141.44 150.95 42.98 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 113.306 0.854 . . . . 0.0 113.306 -176.624 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -73.72 166.57 43.01 Favored Pre-proline 0 C--N 1.326 -0.441 0 N-CA-C 108.396 -0.965 . . . . 0.0 108.396 176.761 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -64.22 -27.92 64.38 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 115.12 -2.787 . . . . 0.0 111.715 178.737 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -61.25 -28.68 69.34 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 123.778 0.831 . . . . 0.0 111.31 176.051 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 75.3 m-20 -98.51 -0.37 43.47 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 115.242 1.571 . . . . 0.0 115.242 -171.35 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 92.7 mm-40 -61.39 -25.63 67.31 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 113.554 0.946 . . . . 0.0 113.554 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 12.3 tt -58.78 141.08 16.22 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 N-CA-C 113.917 1.081 . . . . 0.0 113.917 -178.81 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 179.54 -152.59 11.15 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.422 -0.894 . . . . 0.0 112.294 179.388 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 48.7 p90 -155.07 165.67 35.99 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 108.312 -0.995 . . . . 0.0 108.312 178.475 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 24.9 m-85 -105.98 142.07 36.31 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 107.413 -1.328 . . . . 0.0 107.413 174.814 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 69.3 ttt-85 -116.77 123.56 47.44 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 123.597 0.759 . . . . 0.0 112.048 -176.155 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 50.4 ttp180 -71.53 144.46 49.58 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.024 177.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -144.82 143.3 30.56 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 175.819 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 35.3 p -138.67 171.35 14.48 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 103.379 -2.823 . . . . 0.0 103.379 175.815 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 23.5 tpt180 -135.7 122.61 21.25 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.253 -0.579 . . . . 0.0 109.941 174.628 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.76 144.44 25.12 Favored 'General case' 0 CA--C 1.498 -1.024 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 179.684 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -144.22 178.5 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 N-CA-C 104.123 -2.547 . . . . 0.0 104.123 -178.101 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.77 112.0 15.54 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 105.878 -1.897 . . . . 0.0 105.878 174.175 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -74.17 167.36 54.62 Favored Glycine 0 C--O 1.224 -0.483 0 N-CA-C 108.097 -2.001 . . . . 0.0 108.097 177.661 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -62.56 -48.23 83.36 Favored Glycine 0 C--O 1.224 -0.501 0 N-CA-C 109.677 -1.369 . . . . 0.0 109.677 -177.572 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -85.32 17.2 3.2 Favored 'General case' 0 C--O 1.217 -0.61 0 CA-C-O 122.432 1.11 . . . . 0.0 110.758 178.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 87.81 -19.43 33.59 Favored Glycine 0 C--O 1.228 -0.225 0 N-CA-C 115.699 1.039 . . . . 0.0 115.699 174.031 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -56.74 131.1 48.21 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.799 0.809 . . . . 0.0 110.548 -178.333 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 22.4 ptm -127.34 -163.21 1.23 Allowed 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 114.391 -1.277 . . . . 0.0 113.865 -171.889 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 10.8 mptt -126.14 -57.82 1.39 Allowed 'General case' 0 C--O 1.211 -0.942 0 C-N-CA 123.502 0.721 . . . . 0.0 111.624 -175.922 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 50.47 51.12 17.48 Favored 'General case' 0 N--CA 1.477 0.918 0 O-C-N 124.695 1.247 . . . . 0.0 113.587 178.325 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -66.37 138.69 57.77 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.632 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -57.42 157.71 12.5 Favored Pre-proline 0 C--O 1.242 0.677 0 CA-C-N 114.803 -1.089 . . . . 0.0 112.71 -179.355 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -68.11 135.85 35.92 Favored 'Trans proline' 0 C--O 1.24 0.592 0 C-N-CA 116.6 -1.8 . . . . 0.0 114.974 -177.665 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 30.0 mtp180 -119.76 158.13 27.16 Favored 'General case' 0 CA--C 1.507 -0.695 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 174.585 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 59.7 m95 -128.3 129.72 46.74 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.186 0.517 . . . . 0.0 109.974 178.921 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.462 ' CZ ' ' HB2' ' A' ' 15' ' ' ALA . 70.4 m-85 -110.58 163.13 14.03 Favored 'General case' 0 C--O 1.213 -0.858 0 N-CA-C 105.505 -2.035 . . . . 0.0 105.505 179.251 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 89.6 t80 -109.88 136.71 48.74 Favored 'General case' 0 CA--C 1.511 -0.55 0 N-CA-C 107.305 -1.368 . . . . 0.0 107.305 177.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 9.8 m-85 -136.57 148.92 47.79 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 -176.477 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -82.46 159.42 22.92 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.484 -175.761 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -54.61 129.62 37.14 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.812 -178.262 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 66.85 39.73 93.5 Favored Glycine 0 C--O 1.222 -0.599 0 CA-C-O 119.187 -0.785 . . . . 0.0 114.863 176.196 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -89.01 146.11 25.07 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 118.187 0.993 . . . . 0.0 108.351 177.507 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 98.18 145.18 18.38 Favored Glycine 0 CA--C 1.527 0.834 0 N-CA-C 110.36 -1.096 . . . . 0.0 110.36 -176.528 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -69.27 -44.9 2.11 Favored 'Trans proline' 0 C--N 1.35 0.62 0 N-CA-C 116.804 1.809 . . . . 0.0 116.804 -173.904 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -114.74 33.21 5.5 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.527 0.679 . . . . 0.0 109.25 -177.434 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -62.78 -40.76 98.31 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.767 -178.017 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 58.83 28.86 63.81 Favored Glycine 0 C--O 1.226 -0.355 0 CA-C-N 115.886 -0.597 . . . . 0.0 113.47 179.286 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 26.6 mt -109.09 103.89 53.51 Favored Pre-proline 0 C--O 1.238 0.469 0 N-CA-C 114.7 1.37 . . . . 0.0 114.7 -176.606 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -78.2 167.86 22.63 Favored 'Trans proline' 0 N--CA 1.461 -0.389 0 C-N-CA 121.671 1.58 . . . . 0.0 108.972 170.812 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 61.0 t80 -63.06 133.54 54.67 Favored 'General case' 0 C--N 1.32 -0.701 0 O-C-N 121.986 -0.446 . . . . 0.0 110.135 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 89.23 -3.19 84.1 Favored Glycine 0 CA--C 1.519 0.296 0 N-CA-C 114.437 0.535 . . . . 0.0 114.437 178.854 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -63.56 128.79 37.4 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 117.843 0.821 . . . . 0.0 112.873 -179.397 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 44.8 t30 -68.26 118.74 11.76 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.882 -179.436 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 16.1 ttmm -152.92 145.96 24.59 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 176.364 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 33.0 t0 -67.37 132.97 48.72 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.277 -0.874 . . . . 0.0 109.919 -179.272 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 71.81 24.67 76.33 Favored Glycine 0 C--O 1.24 0.498 0 CA-C-O 119.505 -0.608 . . . . 0.0 114.612 179.789 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 36.9 mm -131.66 132.6 62.11 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 CA-C-N 117.286 0.543 . . . . 0.0 110.495 -179.506 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.1 pt -131.44 117.14 34.62 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 CA-C-O 121.551 0.691 . . . . 0.0 110.572 175.5 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 96.1 m95 -82.53 134.74 35.2 Favored 'General case' 0 C--N 1.321 -0.645 0 O-C-N 121.966 -0.458 . . . . 0.0 111.996 -177.552 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -142.9 150.53 17.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 121.522 0.677 . . . . 0.0 109.788 -178.275 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -155.0 166.57 33.16 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 105.333 -2.099 . . . . 0.0 105.333 -178.756 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 14.7 t -128.1 167.9 16.11 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 105.186 -2.153 . . . . 0.0 105.186 176.703 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -65.04 137.0 57.43 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 95.68 -8.0 68.33 Favored Glycine 0 C--O 1.225 -0.417 0 CA-C-N 115.919 -0.582 . . . . 0.0 113.204 179.247 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -82.35 142.8 31.72 Favored 'General case' 0 CA--C 1.541 0.597 0 O-C-N 122.26 -0.553 . . . . 0.0 111.473 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 34.9 mt -90.98 135.55 33.66 Favored 'General case' 0 CA--C 1.513 -0.471 0 CA-C-O 121.386 0.612 . . . . 0.0 112.456 -179.242 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 55.3 t30 -84.69 72.27 10.72 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.526 -178.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -146.39 153.25 47.73 Favored Pre-proline 0 C--N 1.324 -0.531 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 -179.583 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -68.65 150.37 74.52 Favored 'Trans proline' 0 C--N 1.344 0.291 0 N-CA-C 114.103 0.77 . . . . 0.0 114.103 178.227 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 3.3 ptpt -151.78 56.82 0.86 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.791 0.805 . . . . 0.0 112.906 -179.432 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -56.76 -28.16 60.75 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 115.557 -0.747 . . . . 0.0 112.146 177.521 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 12.2 p80 -59.76 -10.82 4.16 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 114.363 1.246 . . . . 0.0 114.363 -178.775 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 55.7 mt -93.19 -42.16 13.01 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.496 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 178.118 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -72.06 14.65 2.12 Favored Glycine 0 N--CA 1.464 0.534 0 N-CA-C 116.559 1.384 . . . . 0.0 116.559 -176.007 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 15.2 t -90.45 23.73 2.87 Favored 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 112.768 0.655 . . . . 0.0 112.768 -178.132 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 62.0 ttp85 -55.39 130.19 41.6 Favored 'General case' 0 N--CA 1.475 0.788 0 O-C-N 121.58 -0.7 . . . . 0.0 109.62 -179.514 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 36.3 m120 -95.47 122.92 58.1 Favored Pre-proline 0 C--N 1.322 -0.608 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 -179.404 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -68.44 -20.17 42.22 Favored 'Trans proline' 0 C--O 1.219 -0.443 0 C-N-CA 117.159 -1.427 . . . . 0.0 113.133 179.624 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -73.26 -29.26 62.63 Favored 'General case' 0 C--O 1.22 -0.498 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.427 178.228 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 -100.63 -25.81 14.03 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -175.414 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 19.0 t-20 -151.61 144.44 24.42 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 113.448 0.907 . . . . 0.0 113.448 -178.871 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -83.84 146.92 27.84 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.113 179.549 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -66.34 139.99 58.07 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.209 0.528 . . . . 0.0 110.274 178.676 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 14.3 mt -82.38 138.74 18.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 -177.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -61.15 125.71 17.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 175.328 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 7.8 tt -67.08 128.78 37.66 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 -178.018 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 29.6 mt-30 -128.65 153.35 47.37 Favored 'General case' 0 CA--C 1.507 -0.7 0 N-CA-C 106.088 -1.819 . . . . 0.0 106.088 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 17.0 mt -113.31 149.51 41.6 Favored Pre-proline 0 C--N 1.321 -0.661 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 178.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -72.15 170.65 18.55 Favored 'Trans proline' 0 C--N 1.343 0.278 0 N-CA-C 113.888 0.688 . . . . 0.0 113.888 -177.562 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -54.45 130.86 41.03 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.219 -179.349 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 90.13 -12.21 68.49 Favored Glycine 0 C--O 1.227 -0.325 0 CA-C-N 115.931 -0.577 . . . . 0.0 113.363 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 8.8 m -108.56 125.63 52.04 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 117.659 0.73 . . . . 0.0 110.271 179.145 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 10.3 p -126.21 150.43 48.36 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.929 -177.738 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 83.0 mt -69.53 153.79 95.42 Favored Pre-proline 0 C--N 1.325 -0.488 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 176.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -76.03 169.55 21.89 Favored 'Trans proline' 0 N--CA 1.464 -0.251 0 C-N-CA 118.349 -0.634 . . . . 0.0 111.23 178.491 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 60.0 tttm -61.3 130.72 47.55 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 122.144 -0.348 . . . . 0.0 110.507 -177.927 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 95.29 -3.57 66.47 Favored Glycine 0 C--O 1.226 -0.354 0 CA-C-N 115.923 -0.58 . . . . 0.0 114.106 178.681 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -106.47 137.83 43.75 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 179.506 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 51.1 p90 -141.53 160.04 40.97 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 175.157 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -107.14 139.74 41.1 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.594 0.59 . . . . 0.0 112.594 -175.958 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -73.68 143.8 46.08 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 177.183 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 96.51 -37.58 3.39 Favored Glycine 0 C--O 1.224 -0.506 0 N-CA-C 111.208 -0.757 . . . . 0.0 111.208 -178.449 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 36.9 t -75.87 140.75 42.37 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 176.419 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? -146.64 163.29 36.34 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 103.218 -2.882 . . . . 0.0 103.218 178.476 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 87.2 27.96 26.64 Favored Glycine 0 C--O 1.224 -0.49 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.845 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -117.08 -177.43 17.75 Favored Glycine 0 C--N 1.323 -0.139 0 N-CA-C 107.736 -2.146 . . . . 0.0 107.736 177.71 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 24.0 m . . . . . 0 C--O 1.25 1.106 0 CA-C-O 116.367 -1.778 . . . . 0.0 108.053 -178.837 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.902 0 CA-C-O 118.641 -1.088 . . . . 0.0 111.145 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -70.7 148.64 47.79 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 105.69 -1.967 . . . . 0.0 105.69 175.845 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 70.6 mtm -126.91 34.32 4.79 Favored 'General case' 0 C--O 1.218 -0.583 0 N-CA-C 108.482 -0.932 . . . . 0.0 108.482 -178.281 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 147.53 131.26 2.11 Favored Glycine 0 N--CA 1.444 -0.831 0 N-CA-C 106.081 -2.807 . . . . 0.0 106.081 -176.393 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 9.1 mp -113.45 141.68 26.29 Favored Pre-proline 0 C--N 1.318 -0.763 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 178.774 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -73.56 154.62 50.06 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 117.529 -1.181 . . . . 0.0 110.709 177.257 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 57.3 t30 -123.08 -60.6 1.49 Allowed 'General case' 0 C--O 1.22 -0.456 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -179.027 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 15.9 p-10 -105.27 12.79 31.4 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 113.29 0.848 . . . . 0.0 113.29 -176.941 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 37.6 p -119.67 90.01 3.24 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 113.313 0.857 . . . . 0.0 113.313 -174.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -105.52 142.75 34.72 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 177.82 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -60.16 142.28 54.57 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.053 178.688 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 19.0 m95 -69.75 -23.98 63.46 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 113.816 1.043 . . . . 0.0 113.816 -179.089 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 52.7 m-85 -121.54 162.68 20.15 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 113.343 0.868 . . . . 0.0 113.343 -171.752 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 66.3 p -68.42 164.48 20.93 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.787 -1.097 . . . . 0.0 108.959 178.932 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.447 ' HB2' ' CZ ' ' A' ' 69' ' ' TYR . . . -75.87 145.57 40.44 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 113.242 0.83 . . . . 0.0 113.242 -176.84 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 15.7 mt -87.4 140.3 29.67 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 102.175 -3.269 . . . . 0.0 102.175 167.844 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 63.7 m -116.7 128.5 55.4 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 -179.501 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -82.72 138.79 33.96 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.909 179.512 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 9.5 t-160 -139.46 94.74 2.82 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 103.589 -2.745 . . . . 0.0 103.589 167.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 163.13 -143.04 8.31 Favored Glycine 0 C--O 1.226 -0.386 0 C-N-CA 120.432 -0.889 . . . . 0.0 112.267 -175.914 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -121.19 -27.35 4.91 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 116.179 1.918 . . . . 0.0 116.179 -176.596 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -78.75 158.05 28.35 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 179.467 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -72.35 -62.87 1.28 Allowed 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.416 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 53.3 tp 175.54 143.93 0.06 Allowed 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 104.216 -2.512 . . . . 0.0 104.216 173.407 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.9 tppp? -158.13 141.23 14.99 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 108.855 -0.795 . . . . 0.0 108.855 176.669 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -126.01 153.12 73.86 Favored Pre-proline 0 C--N 1.325 -0.49 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 175.745 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -68.77 162.23 42.17 Favored 'Trans proline' 0 C--N 1.352 0.717 0 O-C-N 122.151 0.553 . . . . 0.0 113.09 179.481 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 18.0 tpt180 -64.02 131.88 48.92 Favored 'General case' 0 C--O 1.216 -0.678 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.895 -177.279 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 76.18 17.37 80.04 Favored Glycine 0 C--O 1.224 -0.486 0 C-N-CA 121.319 -0.467 . . . . 0.0 112.911 178.234 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 5.3 mt-30 -150.35 170.49 18.91 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 -175.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 109.2 -14.87 33.4 Favored Glycine 0 CA--C 1.502 -0.735 0 C-N-CA 121.455 -0.402 . . . . 0.0 113.345 175.275 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 89.2 t -66.13 129.6 94.24 Favored Pre-proline 0 C--N 1.319 -0.741 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 177.338 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_endo -74.21 169.55 22.21 Favored 'Trans proline' 0 N--CA 1.46 -0.481 0 O-C-N 122.143 0.549 . . . . 0.0 111.492 178.11 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 89.1 mt -70.33 107.73 2.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-O 122.084 0.945 . . . . 0.0 108.69 -179.643 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 76.1 m-20 -98.85 85.22 3.24 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 114.34 -1.3 . . . . 0.0 108.837 -178.213 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 70.1 p -66.29 -15.85 63.56 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 113.761 1.023 . . . . 0.0 113.761 -176.674 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 20.0 p30 -110.01 23.72 13.98 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.297 -0.865 . . . . 0.0 112.204 -177.398 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.41 ' HB3' ' HB2' ' A' ' 42' ' ' ASP . 15.9 m -138.55 149.25 45.12 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 113.227 0.825 . . . . 0.0 113.227 -175.926 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -73.77 166.71 41.83 Favored Pre-proline 0 C--O 1.236 0.379 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 177.751 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -64.66 -27.35 60.79 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 114.936 -2.909 . . . . 0.0 111.661 178.443 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -61.87 -27.67 68.96 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 123.69 0.796 . . . . 0.0 111.7 176.776 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.41 ' HB2' ' HB3' ' A' ' 38' ' ' SER . 77.3 m-20 -94.87 -4.17 47.47 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 114.696 1.369 . . . . 0.0 114.696 -171.123 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 96.2 mm-40 -59.78 -28.94 67.85 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 114.465 1.283 . . . . 0.0 114.465 -177.923 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 11.4 tt -58.54 138.19 19.89 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.884 0 CA-C-O 122.308 1.051 . . . . 0.0 113.804 -177.88 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -178.82 -156.9 18.27 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.616 -0.802 . . . . 0.0 113.004 -178.837 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 46.6 p90 -155.14 170.54 21.59 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 179.389 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 20.0 m-85 -111.35 140.26 46.07 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 173.363 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -109.55 120.3 42.06 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 124.122 0.969 . . . . 0.0 109.933 -177.694 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 40.2 ttp180 -68.08 136.19 53.39 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 175.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -144.83 147.24 32.62 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 123.054 0.542 . . . . 0.0 110.817 -177.898 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.415 HG23 ' HA ' ' A' ' 66' ' ' PRO . 0.1 OUTLIER -153.39 129.03 10.04 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.082 176.254 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 15.0 tpp180 -90.04 123.73 34.17 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 105.048 -2.205 . . . . 0.0 105.048 174.913 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 4.3 tmt_? -145.51 130.85 18.6 Favored 'General case' 0 CA--C 1.489 -1.371 0 CA-C-O 122.351 1.072 . . . . 0.0 111.029 -178.067 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -140.04 -179.94 2.36 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 CA-C-N 112.685 -2.052 . . . . 0.0 106.661 -177.884 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 3.3 tmt_? -129.32 103.77 7.12 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 105.677 -1.971 . . . . 0.0 105.677 172.027 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -72.83 158.35 53.05 Favored Glycine 0 N--CA 1.452 -0.241 0 N-CA-C 107.708 -2.157 . . . . 0.0 107.708 177.919 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -60.7 -37.07 92.93 Favored Glycine 0 C--O 1.222 -0.649 0 CA-C-N 118.173 0.986 . . . . 0.0 111.998 -179.371 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 39.5 t0 -86.96 13.98 8.16 Favored 'General case' 0 CA--C 1.55 0.951 0 CA-C-O 122.731 1.253 . . . . 0.0 111.248 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 86.85 6.37 79.79 Favored Glycine 0 C--O 1.224 -0.47 0 CA-C-N 115.393 -0.821 . . . . 0.0 113.543 171.948 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 20.9 mmtt -74.62 151.15 39.38 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-O 121.812 0.815 . . . . 0.0 111.463 -174.862 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 83.2 mtp -118.17 -173.94 2.56 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 114.059 -1.428 . . . . 0.0 109.576 -179.145 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 16.0 mmtt -119.94 -75.96 0.58 Allowed 'General case' 0 C--O 1.22 -0.478 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 179.774 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 52.3 m-20 -95.18 149.72 20.99 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 104.628 -2.36 . . . . 0.0 104.628 176.71 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 84.5 mt -118.96 -57.24 2.04 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 106.327 -1.731 . . . . 0.0 106.327 177.072 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -78.96 141.28 58.65 Favored Pre-proline 0 C--O 1.245 0.824 0 CA-C-N 115.058 -0.973 . . . . 0.0 108.929 175.468 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.415 ' HA ' HG23 ' A' ' 51' ' ' THR . 97.5 Cg_endo -73.06 155.88 52.2 Favored 'Trans proline' 0 C--O 1.239 0.531 0 C-N-CA 116.808 -1.661 . . . . 0.0 112.273 178.691 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 29.6 mtt85 -123.94 159.93 28.67 Favored 'General case' 0 CA--C 1.507 -0.685 0 CA-C-N 115.958 -0.564 . . . . 0.0 109.779 -178.742 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 54.4 m95 -134.01 140.9 47.01 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 177.779 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.447 ' CZ ' ' HB2' ' A' ' 15' ' ' ALA . 61.6 m-85 -120.56 154.62 35.12 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 106.567 -1.642 . . . . 0.0 106.567 178.791 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 86.1 t80 -98.27 137.88 36.35 Favored 'General case' 0 CA--C 1.507 -0.696 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 -179.165 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -137.67 144.05 41.63 Favored 'General case' 0 N--CA 1.44 -0.925 0 N-CA-C 106.838 -1.542 . . . . 0.0 106.838 -176.599 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 55.5 m-85 -81.84 159.47 23.73 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.137 -176.37 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -53.86 132.16 41.19 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 112.473 0.546 . . . . 0.0 112.473 -177.499 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 65.56 29.88 76.18 Favored Glycine 0 C--O 1.224 -0.492 0 N-CA-C 115.83 1.092 . . . . 0.0 115.83 173.785 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 13.6 p -89.0 146.1 25.08 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 117.958 0.879 . . . . 0.0 108.881 177.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 105.92 145.99 13.65 Favored Glycine 0 CA--C 1.522 0.486 0 N-CA-C 108.038 -2.025 . . . . 0.0 108.038 -175.546 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -68.83 -44.25 2.95 Favored 'Trans proline' 0 C--N 1.346 0.426 0 CA-C-N 119.687 1.743 . . . . 0.0 116.132 -173.776 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -119.94 40.73 3.35 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 -177.234 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -62.84 -40.62 98.02 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.513 -177.835 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 57.99 29.22 61.92 Favored Glycine 0 C--O 1.228 -0.245 0 CA-C-N 116.168 -0.469 . . . . 0.0 113.645 179.424 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 17.5 mt -114.41 103.8 54.83 Favored Pre-proline 0 N--CA 1.446 -0.633 0 N-CA-C 114.31 1.226 . . . . 0.0 114.31 -176.604 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -78.57 165.2 25.3 Favored 'Trans proline' 0 C--O 1.237 0.445 0 C-N-CA 121.625 1.55 . . . . 0.0 108.147 169.854 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 68.0 t80 -61.85 131.43 49.76 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 120.343 -0.543 . . . . 0.0 110.216 -179.363 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 92.21 -6.64 78.58 Favored Glycine 0 CA--C 1.52 0.372 0 N-CA-C 115.101 0.8 . . . . 0.0 115.101 178.861 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -64.42 129.02 38.28 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 118.431 1.115 . . . . 0.0 112.36 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 58.0 t30 -75.09 127.95 34.39 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.287 -178.318 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 1.2 ttmp? -156.18 153.2 28.87 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 179.33 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -62.11 129.06 39.09 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.812 0.339 . . . . 0.0 111.766 -179.434 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 66.39 31.38 78.73 Favored Glycine 0 N--CA 1.451 -0.301 0 CA-C-O 119.457 -0.635 . . . . 0.0 114.238 178.041 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 43.8 mm -128.61 129.95 68.79 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 CA-C-N 117.419 0.61 . . . . 0.0 109.942 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.1 pt -132.86 120.33 40.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.204 176.025 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 96.0 m95 -85.98 136.81 33.11 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 -176.678 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 16.3 m -138.15 149.74 24.66 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 CA-C-O 121.525 0.679 . . . . 0.0 109.623 179.523 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -155.97 166.62 32.93 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 104.43 -2.433 . . . . 0.0 104.43 -179.359 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 12.6 t -137.93 175.14 9.85 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 105.936 -1.876 . . . . 0.0 105.936 179.311 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -64.96 135.48 55.71 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.162 0.506 . . . . 0.0 110.549 -179.409 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 94.39 -7.9 71.93 Favored Glycine 0 C--O 1.224 -0.526 0 CA-C-N 115.881 -0.599 . . . . 0.0 113.755 177.879 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -79.35 138.84 37.84 Favored 'General case' 0 CA--C 1.538 0.505 0 O-C-N 122.443 -0.445 . . . . 0.0 111.92 -179.449 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 34.7 mt -95.08 137.08 34.62 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-O 121.007 0.432 . . . . 0.0 111.993 -179.455 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 58.9 t30 -82.0 69.54 8.73 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.11 0.481 . . . . 0.0 110.764 -179.437 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -141.26 155.65 67.85 Favored Pre-proline 0 C--N 1.323 -0.562 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 -178.626 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -64.62 150.53 88.04 Favored 'Trans proline' 0 C--N 1.344 0.338 0 N-CA-C 115.262 1.216 . . . . 0.0 115.262 179.649 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.478 ' HB3' HD12 ' A' ' 106' ' ' ILE . 74.1 mmtt -124.8 37.75 4.34 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 114.609 -1.178 . . . . 0.0 109.054 -177.644 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 16.6 p-10 -48.89 -45.96 41.95 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 114.742 -1.117 . . . . 0.0 112.869 -179.647 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 48.8 p-80 -70.05 -9.5 55.56 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 124.38 1.072 . . . . 0.0 113.747 -177.801 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.478 HD12 ' HB3' ' A' ' 103' ' ' LYS . 48.8 mt -94.9 -48.04 13.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 179.055 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -74.99 14.66 4.53 Favored Glycine 0 C--O 1.224 -0.502 0 N-CA-C 116.397 1.319 . . . . 0.0 116.397 -177.122 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 13.6 t -92.95 24.56 3.62 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 117.41 0.605 . . . . 0.0 111.099 179.478 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 65.9 ttp85 -57.8 136.28 56.93 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 178.918 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -109.09 132.22 21.34 Favored Pre-proline 0 C--N 1.324 -0.51 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -72.6 -15.35 27.37 Favored 'Trans proline' 0 C--O 1.219 -0.447 0 C-N-CA 117.877 -0.949 . . . . 0.0 113.52 -178.177 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -75.62 -25.62 57.07 Favored 'General case' 0 C--O 1.22 -0.481 0 CA-C-O 120.942 0.401 . . . . 0.0 110.303 178.401 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 82.7 m-20 -102.6 -23.31 13.88 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 113.745 1.017 . . . . 0.0 113.745 -174.339 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 -153.98 152.36 30.45 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.62 0.6 . . . . 0.0 112.62 -176.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -94.27 146.9 23.69 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-O 121.184 0.516 . . . . 0.0 110.749 178.402 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -71.38 148.47 46.95 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.005 0.431 . . . . 0.0 110.833 178.759 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 3.4 mt -92.41 142.33 13.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 -178.322 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -59.47 126.19 16.76 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 175.825 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 6.0 tt -68.55 128.88 38.2 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.956 -177.892 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 30.2 mt-30 -132.36 157.93 43.23 Favored 'General case' 0 CA--C 1.511 -0.544 0 N-CA-C 106.677 -1.601 . . . . 0.0 106.677 -179.122 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 13.7 mt -113.69 147.56 37.89 Favored Pre-proline 0 C--N 1.322 -0.62 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 177.6 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -73.32 167.0 28.44 Favored 'Trans proline' 0 C--N 1.346 0.397 0 O-C-N 122.223 0.591 . . . . 0.0 112.928 -179.342 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 43.6 tt0 -54.88 131.39 44.2 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.604 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 97.89 -19.45 54.54 Favored Glycine 0 C--O 1.227 -0.303 0 CA-C-N 116.004 -0.543 . . . . 0.0 113.256 -179.511 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 6.9 m -106.71 127.57 53.48 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 118.148 0.974 . . . . 0.0 110.576 178.713 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 17.2 p -120.24 148.36 43.79 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.541 -179.535 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 91.7 mt -67.24 154.87 91.96 Favored Pre-proline 0 C--N 1.324 -0.526 0 N-CA-C 107.953 -1.128 . . . . 0.0 107.953 178.082 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -75.16 170.47 20.3 Favored 'Trans proline' 0 N--CA 1.461 -0.385 0 C-N-CA 118.208 -0.728 . . . . 0.0 110.854 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 23.8 tptm -60.9 120.66 10.61 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 -178.094 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 91.13 41.53 5.21 Favored Glycine 0 C--O 1.227 -0.331 0 N-CA-C 115.297 0.879 . . . . 0.0 115.297 178.736 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -145.19 148.53 33.65 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 117.384 0.592 . . . . 0.0 110.403 177.557 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 54.8 p90 -147.73 165.05 31.68 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.212 -1.032 . . . . 0.0 108.212 176.106 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -105.99 139.81 39.95 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.01 0.433 . . . . 0.0 111.851 -176.703 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -74.09 143.56 45.34 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 178.236 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 95.59 -38.14 3.21 Favored Glycine 0 CA--C 1.518 0.25 0 C-N-CA 121.687 -0.292 . . . . 0.0 113.486 179.373 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 32.2 t -72.13 117.91 14.35 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 177.101 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 12.6 mmm-85 -93.68 -44.21 8.28 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 -179.349 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 76.64 -63.2 3.09 Favored Glycine 0 CA--C 1.521 0.462 0 N-CA-C 114.526 0.57 . . . . 0.0 114.526 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -130.57 -159.46 9.66 Favored Glycine 0 C--O 1.24 0.517 0 CA-C-N 116.944 0.372 . . . . 0.0 113.231 -177.751 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 34.8 t . . . . . 0 C--O 1.243 0.712 0 CA-C-O 118.202 -0.904 . . . . 0.0 109.71 179.486 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.498 -0.974 0 N-CA-C 110.993 -0.843 . . . . 0.0 110.993 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -61.19 140.76 57.86 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 114.186 1.18 . . . . 0.0 114.186 -176.883 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 27.3 ttt -143.19 138.41 29.7 Favored 'General case' 0 C--O 1.214 -0.791 1 N-CA-C 99.866 -4.124 . . . . 0.0 99.866 173.223 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 81.34 42.86 8.97 Favored Glycine 0 CA--C 1.519 0.304 0 N-CA-C 109.097 -1.601 . . . . 0.0 109.097 -174.051 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 9.1 mp -61.98 142.73 95.12 Favored Pre-proline 0 C--O 1.236 0.345 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 -179.796 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -69.2 133.77 27.44 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 116.047 -2.168 . . . . 0.0 113.579 -176.206 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.411 ' H ' HG23 ' A' ' 9' ' ' THR . 54.7 t-20 -137.88 65.98 1.46 Allowed 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 104.367 -2.457 . . . . 0.0 104.367 178.192 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 75.23 -51.62 0.66 Allowed 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 126.156 1.782 . . . . 0.0 109.755 -172.636 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.411 HG23 ' H ' ' A' ' 7' ' ' ASN . 15.4 p 28.31 81.13 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 115.568 1.692 . . . . 0.0 115.568 172.271 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -105.7 158.25 16.85 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 122.464 1.126 . . . . 0.0 113.72 -173.619 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 30.9 t -58.98 142.21 51.72 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 113.986 -1.461 . . . . 0.0 109.974 175.21 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 17.1 m95 -64.33 -21.94 66.78 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 114.104 1.15 . . . . 0.0 114.104 178.545 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -121.41 162.96 19.49 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 114.312 1.227 . . . . 0.0 114.312 -169.806 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 68.3 p -70.76 162.66 28.72 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 114.575 -1.193 . . . . 0.0 107.855 176.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.471 ' HB2' ' CZ ' ' A' ' 69' ' ' TYR . . . -75.72 141.98 42.54 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 113.243 0.831 . . . . 0.0 113.243 -175.97 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.419 HD23 ' HA ' ' A' ' 16' ' ' LEU . 12.4 mt -85.66 142.46 29.04 Favored 'General case' 0 C--O 1.213 -0.868 0 N-CA-C 102.678 -3.082 . . . . 0.0 102.678 169.257 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 40.9 m -123.84 135.77 53.96 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 118.638 0.654 . . . . 0.0 110.267 -177.603 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.438 ' HB2' ' CZ ' ' A' ' 131' ' ' PHE . 4.1 tp60 -100.7 139.25 36.65 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.493 -0.776 . . . . 0.0 112.005 -178.133 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 16.1 t-160 -126.58 99.6 5.87 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 103.775 -2.676 . . . . 0.0 103.775 168.674 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 157.17 -173.54 34.72 Favored Glycine 0 C--O 1.225 -0.417 0 N-CA-C 109.098 -1.601 . . . . 0.0 109.098 -176.629 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -97.68 -21.86 16.78 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 114.629 1.344 . . . . 0.0 114.629 -177.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -71.4 157.18 38.52 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.723 0.297 . . . . 0.0 110.351 -178.471 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -74.98 -63.0 1.36 Allowed 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.837 -0.345 . . . . 0.0 111.292 -178.092 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 36.0 tp 161.03 141.78 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.203 0 N-CA-C 102.299 -3.223 . . . . 0.0 102.299 179.094 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 13.8 tmtt? -156.71 131.07 8.63 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 176.625 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 -114.77 142.43 28.32 Favored Pre-proline 0 CA--C 1.54 0.592 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 176.491 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -62.88 154.12 68.52 Favored 'Trans proline' 0 CA--C 1.541 0.869 0 CA-C-O 121.325 0.469 . . . . 0.0 112.958 173.347 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 4.1 tmt_? -63.66 134.14 54.89 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.943 -177.701 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 87.96 6.85 75.09 Favored Glycine 0 C--O 1.226 -0.347 0 O-C-N 123.4 0.438 . . . . 0.0 112.381 178.381 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -145.72 167.78 22.31 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 -176.108 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 112.59 -19.38 21.73 Favored Glycine 0 CA--C 1.5 -0.846 0 C-N-CA 121.716 -0.278 . . . . 0.0 113.638 173.449 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.417 HG11 ' HB3' ' A' ' 43' ' ' GLN . 95.8 t -67.33 127.82 93.55 Favored Pre-proline 0 C--N 1.32 -0.712 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 178.473 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -74.93 164.03 34.25 Favored 'Trans proline' 0 N--CA 1.459 -0.504 0 O-C-N 122.124 0.539 . . . . 0.0 111.801 178.12 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 97.9 mt -66.84 123.44 19.9 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 -178.573 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 46.1 t-20 -125.61 113.83 17.91 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 177.239 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 67.0 p -90.68 -14.83 31.47 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 -175.509 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -111.51 28.99 8.23 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 113.408 0.892 . . . . 0.0 113.408 -175.65 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 99.3 p -141.58 164.88 29.02 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.713 0.292 . . . . 0.0 110.998 -179.412 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 4.2 m -77.13 164.95 55.73 Favored Pre-proline 0 C--N 1.321 -0.642 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.85 -178.294 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -68.31 -25.03 36.7 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 115.068 -2.821 . . . . 0.0 113.425 178.03 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.52 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 3.4 p-10 -76.64 -19.06 58.21 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 121.375 -0.828 . . . . 0.0 111.563 176.992 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 78.1 m-20 -78.57 -6.92 56.86 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 113.469 0.914 . . . . 0.0 113.469 -176.695 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.417 ' HB3' HG11 ' A' ' 32' ' ' VAL . 95.7 mm-40 -62.16 -24.91 67.46 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 113.595 0.961 . . . . 0.0 113.595 -177.997 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.449 ' HB ' ' HB1' ' A' ' 98' ' ' ALA . 7.9 tt -60.93 137.9 22.61 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.811 0 CA-C-O 122.205 1.003 . . . . 0.0 112.761 179.47 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 179.15 -156.9 19.7 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.465 -0.874 . . . . 0.0 112.382 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 45.3 p90 -155.02 170.45 21.74 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 179.1 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 19.5 m-85 -112.59 141.75 45.99 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 107.219 -1.401 . . . . 0.0 107.219 173.559 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 67.8 ttt-85 -112.24 130.24 55.99 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.971 -0.558 . . . . 0.0 111.237 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 44.8 ttt85 -71.67 145.35 48.95 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.472 0.653 . . . . 0.0 112.249 179.222 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -152.2 170.07 20.9 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 105.501 -2.037 . . . . 0.0 105.501 177.479 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 12.1 t -156.6 166.65 32.8 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 176.848 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 34.8 tpt85 -130.25 127.5 39.7 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 173.872 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 2.9 tmt_? -151.04 152.05 32.9 Favored 'General case' 0 CA--C 1.495 -1.147 0 N-CA-C 105.229 -2.137 . . . . 0.0 105.229 -178.68 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -125.99 174.17 10.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 26.8 tpt180 -141.99 122.31 13.96 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 106.106 -1.813 . . . . 0.0 106.106 177.905 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -82.65 174.56 53.14 Favored Glycine 0 C--O 1.224 -0.505 0 N-CA-C 109.24 -1.544 . . . . 0.0 109.24 178.003 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -72.26 -40.24 55.98 Favored Glycine 0 C--O 1.216 -1.023 0 N-CA-C 111.241 -0.744 . . . . 0.0 111.241 -177.485 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 27.3 t0 -71.93 -20.67 61.72 Favored 'General case' 0 C--O 1.217 -0.65 0 CA-C-O 122.635 1.207 . . . . 0.0 108.4 177.577 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 116.55 -12.39 15.82 Favored Glycine 0 CA--C 1.501 -0.803 0 CA-C-N 114.74 -1.118 . . . . 0.0 111.051 172.877 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 4.0 pttt -67.69 140.68 56.79 Favored 'General case' 0 CA--C 1.505 -0.755 0 CA-C-O 121.974 0.892 . . . . 0.0 110.495 -177.613 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 16.9 ptm -136.34 -177.47 4.73 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 114.027 -1.442 . . . . 0.0 112.155 -174.327 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 58.4 mmtt -90.58 -125.21 0.07 Allowed 'General case' 0 C--O 1.216 -0.663 0 N-CA-C 104.16 -2.533 . . . . 0.0 104.16 175.305 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 38.2 t0 -143.92 177.2 8.71 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 103.882 -2.636 . . . . 0.0 103.882 177.182 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -80.92 136.98 36.13 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 178.292 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.1 p -112.23 89.92 13.03 Favored Pre-proline 0 C--N 1.322 -0.593 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 173.739 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -69.13 131.82 22.99 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 115.632 -2.445 . . . . 0.0 112.107 -178.356 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 33.5 ptt180 -141.46 157.99 44.44 Favored 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 179.182 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 57.3 m95 -129.57 148.07 51.44 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 120.668 0.271 . . . . 0.0 111.306 -175.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.471 ' CZ ' ' HB2' ' A' ' 15' ' ' ALA . 48.1 m-85 -124.68 146.09 49.32 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 106.499 -1.667 . . . . 0.0 106.499 -179.433 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 75.1 t80 -95.74 131.5 41.94 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 -175.411 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -133.87 159.81 39.56 Favored 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 107.096 -1.446 . . . . 0.0 107.096 -175.201 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 71.5 m-85 -99.95 159.56 14.98 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 111.713 0.264 . . . . 0.0 111.713 -171.637 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -54.51 129.69 37.01 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.688 -178.759 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 68.72 34.48 78.13 Favored Glycine 0 C--O 1.221 -0.665 0 CA-C-O 118.804 -0.998 . . . . 0.0 115.57 176.666 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -89.35 146.08 24.93 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 118.633 1.216 . . . . 0.0 109.225 177.623 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 105.52 158.85 22.86 Favored Glycine 0 CA--C 1.522 0.524 0 CA-C-N 116.27 -0.423 . . . . 0.0 112.475 179.531 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -63.97 -50.3 3.15 Favored 'Trans proline' 0 C--N 1.346 0.427 0 N-CA-C 117.349 2.019 . . . . 0.0 117.349 -172.821 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 64.4 mt-10 -138.12 44.67 2.14 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 106.827 -1.545 . . . . 0.0 106.827 -179.369 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -60.28 -39.37 86.66 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.006 -178.249 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 62.3 22.44 63.22 Favored Glycine 0 C--O 1.223 -0.545 0 N-CA-C 115.53 0.972 . . . . 0.0 115.53 177.097 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 53.0 mt -102.31 110.95 63.93 Favored Pre-proline 0 N--CA 1.447 -0.624 0 N-CA-C 115.015 1.487 . . . . 0.0 115.015 -177.258 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -77.32 167.87 23.91 Favored 'Trans proline' 0 C--O 1.237 0.432 0 N-CA-C 108.749 -1.289 . . . . 0.0 108.749 170.454 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 66.7 t80 -62.77 134.0 55.62 Favored 'General case' 0 C--N 1.321 -0.658 0 O-C-N 121.957 -0.465 . . . . 0.0 110.019 179.431 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 89.64 -3.25 83.31 Favored Glycine 0 CA--C 1.519 0.327 0 N-CA-C 114.505 0.562 . . . . 0.0 114.505 178.236 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -63.14 130.13 43.3 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 117.812 0.806 . . . . 0.0 112.061 179.71 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 50.1 t-20 -76.6 124.67 27.98 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.692 -178.88 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 23.3 tttt -155.33 152.15 28.82 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 178.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -64.12 130.49 44.15 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.962 -178.117 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 65.62 30.27 77.01 Favored Glycine 0 N--CA 1.45 -0.395 0 CA-C-O 119.597 -0.557 . . . . 0.0 114.238 179.057 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 37.1 mm -129.83 128.71 65.56 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 CA-C-N 117.362 0.581 . . . . 0.0 110.154 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -133.16 118.27 31.78 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 CA-C-O 121.425 0.631 . . . . 0.0 110.747 177.175 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 92.8 m95 -84.98 137.27 33.19 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 113.395 0.887 . . . . 0.0 113.395 -175.675 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 18.6 m -137.85 149.7 25.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.66 0.743 . . . . 0.0 110.016 179.653 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -159.63 166.64 30.24 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 104.049 -2.575 . . . . 0.0 104.049 -179.404 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 10.6 t -131.73 173.92 10.66 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 104.956 -2.239 . . . . 0.0 104.956 177.918 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -67.69 135.14 52.3 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 -178.293 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 95.84 -11.14 68.22 Favored Glycine 0 CA--C 1.518 0.231 0 CA-C-N 115.883 -0.598 . . . . 0.0 112.945 -179.792 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.52 ' HA ' ' HA ' ' A' ' 41' ' ' ASP . . . -74.24 133.01 42.65 Favored 'General case' 0 CA--C 1.541 0.609 0 O-C-N 122.413 -0.463 . . . . 0.0 109.864 178.847 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 27.8 mt -88.53 140.39 29.51 Favored 'General case' 0 CA--C 1.513 -0.473 0 CA-C-O 121.367 0.603 . . . . 0.0 111.917 -178.148 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 58.0 t30 -84.43 68.08 10.13 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.371 -179.263 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -138.41 151.95 70.28 Favored Pre-proline 0 C--O 1.24 0.594 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -68.14 150.89 77.39 Favored 'Trans proline' 0 C--N 1.343 0.256 0 N-CA-C 114.62 0.969 . . . . 0.0 114.62 177.304 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 1.6 ptpt -150.99 58.45 0.91 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.987 0.898 . . . . 0.0 111.863 178.496 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -56.47 -28.47 59.8 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 115.037 -0.983 . . . . 0.0 111.225 177.061 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 14.2 p80 -59.24 -10.38 2.89 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 114.544 1.312 . . . . 0.0 114.544 -178.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 37.9 mt -96.31 -36.3 6.33 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.577 0 CA-C-N 117.92 0.327 . . . . 0.0 110.165 178.128 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -74.11 14.44 3.86 Favored Glycine 0 N--CA 1.464 0.538 0 N-CA-C 116.023 1.169 . . . . 0.0 116.023 -176.314 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 15.2 t -96.5 23.29 6.96 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 -177.179 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 57.8 ttp85 -63.05 126.63 27.97 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 106.943 -1.503 . . . . 0.0 106.943 177.817 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 18.3 m-20 -110.84 131.96 21.87 Favored Pre-proline 0 C--N 1.32 -0.684 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 -178.829 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -67.64 -21.45 45.56 Favored 'Trans proline' 0 C--N 1.349 0.589 0 N-CA-C 114.728 1.011 . . . . 0.0 114.728 -175.072 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -71.99 -25.0 61.67 Favored 'General case' 0 C--O 1.219 -0.526 0 CA-C-O 120.784 0.326 . . . . 0.0 110.266 177.559 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 -101.81 -28.54 12.38 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 113.486 0.921 . . . . 0.0 113.486 -175.822 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 -159.36 148.91 18.53 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -178.117 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -85.28 149.62 25.35 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-O 121.675 0.75 . . . . 0.0 112.862 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -70.73 147.39 49.08 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.762 178.797 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 23.5 mt -86.8 139.31 17.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.387 -179.141 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 73.1 t -61.87 122.02 11.56 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 174.874 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 5.8 tt -67.79 129.38 39.73 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.957 0.408 . . . . 0.0 110.123 -177.433 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -134.79 158.1 45.04 Favored 'General case' 0 CA--C 1.513 -0.472 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 -178.581 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 14.9 mt -114.45 149.2 41.78 Favored Pre-proline 0 C--N 1.322 -0.618 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 176.346 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_endo -70.56 168.81 21.52 Favored 'Trans proline' 0 C--N 1.343 0.27 0 N-CA-C 114.377 0.876 . . . . 0.0 114.377 -177.042 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -55.5 133.82 50.34 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.415 -178.242 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 88.27 -12.16 65.45 Favored Glycine 0 C--O 1.227 -0.333 0 CA-C-N 115.854 -0.612 . . . . 0.0 112.619 -179.688 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 16.2 m -107.38 125.9 51.79 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.113 0.483 . . . . 0.0 110.28 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 17.7 p -121.48 148.26 44.67 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 113.027 0.751 . . . . 0.0 113.027 -176.572 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 89.3 mt -69.79 156.28 92.0 Favored Pre-proline 0 C--N 1.326 -0.439 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 177.147 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -75.49 168.16 25.07 Favored 'Trans proline' 0 C--O 1.235 0.334 0 C-N-CA 118.42 -0.587 . . . . 0.0 111.252 178.506 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 1.8 tmtp? -58.72 128.79 38.97 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.702 -177.609 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 95.0 -5.57 68.76 Favored Glycine 0 C--O 1.225 -0.421 0 N-CA-C 114.664 0.625 . . . . 0.0 114.664 177.627 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.438 ' CZ ' ' HB2' ' A' ' 18' ' ' GLN . 1.4 m-85 -104.27 140.24 38.15 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-O 121.873 0.844 . . . . 0.0 111.199 -179.521 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 46.1 p90 -142.19 165.67 26.8 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 114.174 -1.376 . . . . 0.0 107.461 176.092 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -106.98 144.61 33.35 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.927 0.394 . . . . 0.0 111.358 -177.37 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -72.67 136.94 45.73 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 178.747 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 89.64 -30.0 5.97 Favored Glycine 0 CA--C 1.518 0.241 0 CA-C-N 116.139 -0.482 . . . . 0.0 112.786 -177.242 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 22.7 t -86.07 100.2 12.01 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 117.386 0.593 . . . . 0.0 110.635 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 3.0 mpt_? -96.47 71.37 2.7 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 179.579 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -85.95 136.44 14.25 Favored Glycine 0 C--O 1.228 -0.258 0 N-CA-C 109.879 -1.288 . . . . 0.0 109.879 178.556 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 167.82 -177.32 42.18 Favored Glycine 0 N--CA 1.451 -0.358 0 N-CA-C 107.926 -2.07 . . . . 0.0 107.926 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 57.1 p . . . . . 0 C--O 1.253 1.26 0 CA-C-O 115.19 -2.338 . . . . 0.0 104.991 178.847 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.811 0 CA-C-O 118.553 -1.137 . . . . 0.0 111.281 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -138.66 103.41 4.84 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 118.319 1.059 . . . . 0.0 109.433 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 98.1 mtp -132.94 70.97 1.46 Allowed 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 -179.341 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -126.19 84.62 0.34 Allowed Glycine 0 C--O 1.227 -0.321 0 CA-C-N 115.969 -0.56 . . . . 0.0 113.055 -176.782 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -76.33 150.89 83.08 Favored Pre-proline 0 C--N 1.323 -0.578 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 178.084 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -68.37 -27.58 33.89 Favored 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 117.055 -1.497 . . . . 0.0 115.265 -177.491 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 64.1 t30 45.95 53.02 9.45 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 114.376 1.25 . . . . 0.0 114.376 175.618 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 84.7 m-20 -61.49 -43.7 98.4 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 115.501 1.667 . . . . 0.0 115.501 -174.589 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 23.1 p 10.21 83.83 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 125.945 1.698 . . . . 0.0 115.243 178.343 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -93.39 140.81 29.15 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-O 121.703 0.763 . . . . 0.0 112.724 -171.668 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 51.2 p -60.66 144.84 51.12 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 114.908 -1.042 . . . . 0.0 110.293 178.652 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 22.3 m95 -70.8 -24.36 62.55 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 114.727 1.38 . . . . 0.0 114.727 -178.369 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 26.3 m-85 -121.49 162.47 20.46 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 -171.645 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 73.0 p -70.25 162.68 27.99 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 179.195 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -79.42 149.17 31.68 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.953 0.882 . . . . 0.0 112.991 -177.782 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 37.1 mt -89.52 148.95 23.12 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 102.77 -3.048 . . . . 0.0 102.77 168.637 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 33.6 m -122.83 138.51 54.63 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.444 ' HB2' ' CZ ' ' A' ' 131' ' ' PHE . 4.1 tp60 -110.66 135.08 51.81 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.246 0.546 . . . . 0.0 112.3 -176.785 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 7.7 t-160 -130.9 94.68 3.66 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 104.055 -2.572 . . . . 0.0 104.055 170.751 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -178.76 -171.21 41.76 Favored Glycine 0 C--O 1.224 -0.494 0 N-CA-C 110.19 -1.164 . . . . 0.0 110.19 -176.622 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -97.69 -26.45 14.74 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 113.844 1.053 . . . . 0.0 113.844 -177.646 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 25.6 pt-20 -92.23 166.41 12.63 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 179.024 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -79.22 -62.93 1.54 Allowed 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 120.704 -0.398 . . . . 0.0 111.753 -177.255 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 36.8 tp 171.61 144.18 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 105.822 -1.918 . . . . 0.0 105.822 178.059 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 55.0 tttm -156.03 142.69 18.7 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 171.434 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 15.5 m-85 -119.66 157.9 50.86 Favored Pre-proline 0 C--O 1.247 0.955 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 176.175 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.415 ' HG2' ' HB3' ' A' ' 30' ' ' GLN . 50.0 Cg_endo -64.99 163.78 27.26 Favored 'Trans proline' 0 C--N 1.352 0.745 0 C-N-CA 121.355 1.37 . . . . 0.0 112.755 175.64 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 25.9 tpt180 -78.14 132.63 37.73 Favored 'General case' 0 C--O 1.216 -0.696 0 O-C-N 121.845 -0.534 . . . . 0.0 110.743 -177.435 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 77.95 17.81 77.88 Favored Glycine 0 C--O 1.223 -0.571 0 O-C-N 123.386 0.429 . . . . 0.0 112.315 177.21 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.415 ' HB3' ' HG2' ' A' ' 27' ' ' PRO . 49.3 tt0 -157.33 170.47 22.39 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 104.451 -2.425 . . . . 0.0 104.451 -175.497 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 105.73 -8.74 43.55 Favored Glycine 0 N--CA 1.462 0.41 0 CA-C-N 118.525 0.602 . . . . 0.0 113.811 177.399 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 76.2 t -70.9 133.8 86.03 Favored Pre-proline 0 C--N 1.321 -0.665 0 N-CA-C 106.791 -1.559 . . . . 0.0 106.791 176.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -69.98 171.87 13.9 Favored 'Trans proline' 0 N--CA 1.464 -0.246 0 C-N-CA 120.588 0.858 . . . . 0.0 112.967 178.113 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 83.7 mt -74.85 112.05 11.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 179.113 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 64.7 m-20 -109.6 80.74 1.35 Allowed 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 114.842 -1.072 . . . . 0.0 109.865 -175.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 76.2 p -69.87 -17.71 63.37 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 114.124 1.157 . . . . 0.0 114.124 -176.255 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 70.3 m-80 -112.54 35.46 3.82 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.701 -178.116 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.7 m -146.54 165.69 28.7 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 111.716 0.265 . . . . 0.0 111.716 -177.579 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 47.0 m -93.15 158.78 36.72 Favored Pre-proline 0 CA--C 1.536 0.439 0 C-N-CA 123.219 0.608 . . . . 0.0 111.718 -176.041 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -65.91 -23.92 54.1 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 115.71 -2.393 . . . . 0.0 115.253 -177.768 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -76.84 -20.23 56.59 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 121.68 -0.638 . . . . 0.0 112.675 179.051 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 12.4 p30 -96.41 0.99 51.28 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 114.643 1.349 . . . . 0.0 114.643 -174.565 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 86.4 mm-40 -57.36 -22.32 41.67 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.667 0.746 . . . . 0.0 112.675 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 8.2 tt -62.73 135.66 26.85 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.741 0 CA-C-O 122.366 1.079 . . . . 0.0 111.752 177.769 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 179.3 -156.81 19.36 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.212 -0.994 . . . . 0.0 112.232 -178.164 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 39.9 p90 -155.12 166.98 31.88 Favored 'General case' 0 C--N 1.318 -0.803 0 O-C-N 122.564 -0.374 . . . . 0.0 110.263 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 32.4 m-85 -108.22 140.68 41.1 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 175.556 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 48.5 ttt180 -115.85 120.21 38.5 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 124.1 0.96 . . . . 0.0 112.56 -175.215 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 36.7 ttt180 -66.32 141.21 58.07 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 123.785 0.834 . . . . 0.0 111.427 178.675 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -149.88 143.2 25.15 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 122.609 0.364 . . . . 0.0 111.116 176.752 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 14.6 t -161.0 165.86 29.18 Favored 'General case' 0 C--O 1.239 0.544 0 N-CA-C 106.078 -1.823 . . . . 0.0 106.078 174.852 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 3.9 tpt180 -144.9 127.97 16.58 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.78 0.324 . . . . 0.0 110.392 178.078 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 7.5 tmm_? -139.39 131.62 28.21 Favored 'General case' 0 CA--C 1.498 -1.023 0 CA-C-O 121.54 0.686 . . . . 0.0 109.698 178.369 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -139.85 179.28 2.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 N-CA-C 105.775 -1.935 . . . . 0.0 105.775 -178.564 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 17.4 tpp180 -124.9 103.51 8.09 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 106.244 -1.762 . . . . 0.0 106.244 173.808 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -75.57 159.04 50.89 Favored Glycine 0 C--O 1.227 -0.304 0 N-CA-C 106.945 -2.462 . . . . 0.0 106.945 176.067 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -60.51 -38.23 94.55 Favored Glycine 0 C--O 1.22 -0.765 0 CA-C-N 118.277 1.038 . . . . 0.0 113.698 -178.011 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -86.03 7.09 25.92 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.691 0.758 . . . . 0.0 111.593 179.731 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 96.62 -2.21 62.34 Favored Glycine 0 C--N 1.321 -0.29 0 CA-C-N 115.241 -0.89 . . . . 0.0 113.711 177.617 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 18.3 mttt -59.55 140.25 56.46 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.852 0.834 . . . . 0.0 112.703 -178.51 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 84.1 mtp -111.81 -169.97 1.56 Allowed 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 113.974 -1.466 . . . . 0.0 109.562 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 8.4 mmtt -121.28 -69.0 0.86 Allowed 'General case' 0 C--O 1.217 -0.636 0 N-CA-C 111.801 0.297 . . . . 0.0 111.801 -179.126 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 70.4 m-20 -126.46 158.71 35.33 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 -179.446 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 95.2 mt -122.4 -68.74 0.87 Allowed 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 177.231 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -71.17 135.25 84.82 Favored Pre-proline 0 C--N 1.323 -0.561 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.682 177.566 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -75.06 155.5 42.64 Favored 'Trans proline' 0 C--O 1.236 0.4 0 C-N-CA 117.048 -1.501 . . . . 0.0 113.165 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 75.6 mtt85 -111.59 160.02 17.6 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.234 178.33 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 71.2 m95 -132.64 127.4 34.82 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 175.891 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 65.7 m-85 -110.29 167.1 10.45 Favored 'General case' 0 C--O 1.21 -0.993 0 N-CA-C 104.758 -2.312 . . . . 0.0 104.758 -179.59 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 85.2 t80 -114.88 139.73 49.54 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 119.339 0.972 . . . . 0.0 109.118 -179.05 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 -138.61 148.69 44.42 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.515 -176.866 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 71.5 m-85 -82.2 159.49 23.25 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.423 -177.48 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -54.12 129.46 34.76 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-O 121.234 0.54 . . . . 0.0 112.407 -177.934 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 73.9 28.34 64.97 Favored Glycine 0 C--O 1.219 -0.837 0 N-CA-C 115.804 1.081 . . . . 0.0 115.804 175.714 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 2.3 p -89.0 145.88 25.21 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 118.675 1.238 . . . . 0.0 108.56 179.39 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 102.86 131.67 7.4 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 108.191 -1.963 . . . . 0.0 108.191 -175.494 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -68.23 -36.0 17.63 Favored 'Trans proline' 0 CA--C 1.516 -0.393 0 CA-C-N 119.676 1.738 . . . . 0.0 115.671 -172.806 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -114.19 32.07 6.15 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 -177.551 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -68.52 -49.75 57.26 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.823 -179.414 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 60.64 18.38 51.86 Favored Glycine 0 C--O 1.226 -0.403 0 N-CA-C 114.942 0.737 . . . . 0.0 114.942 179.172 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 74.7 mt -99.81 113.4 65.08 Favored Pre-proline 0 N--CA 1.449 -0.488 0 N-CA-C 114.935 1.457 . . . . 0.0 114.935 -176.048 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -76.57 166.96 26.41 Favored 'Trans proline' 0 C--O 1.238 0.482 0 N-CA-C 109.078 -1.162 . . . . 0.0 109.078 170.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.415 ' CE1' ' HB3' ' A' ' 92' ' ' TRP . 83.3 t80 -61.04 128.89 38.67 Favored 'General case' 0 C--N 1.323 -0.557 0 O-C-N 121.989 -0.444 . . . . 0.0 110.898 -179.747 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 93.89 -4.92 72.29 Favored Glycine 0 CA--C 1.518 0.277 0 N-CA-C 114.977 0.751 . . . . 0.0 114.977 178.228 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -63.81 133.2 52.99 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 118.027 0.913 . . . . 0.0 111.935 179.376 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 -77.95 130.31 36.38 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.096 -179.108 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 39.2 tttm -156.07 150.29 25.52 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 176.123 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -63.36 131.65 48.94 Favored 'General case' 0 C--O 1.24 0.573 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 178.965 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 72.33 23.33 78.11 Favored Glycine 0 N--CA 1.445 -0.757 0 N-CA-C 114.894 0.718 . . . . 0.0 114.894 177.439 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 42.7 mm -130.45 127.46 62.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 117.146 0.473 . . . . 0.0 109.946 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -133.17 123.56 47.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.929 176.678 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' TRP . . . . . 0.415 ' HB3' ' CE1' ' A' ' 83' ' ' TYR . 92.9 m95 -89.55 137.41 32.36 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 113.225 0.824 . . . . 0.0 113.225 -175.453 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 15.8 m -136.74 153.06 29.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 178.839 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -157.5 166.53 32.71 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 102.863 -3.014 . . . . 0.0 102.863 -179.51 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 11.4 t -136.05 175.26 9.76 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 106.215 -1.772 . . . . 0.0 106.215 179.33 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -64.02 133.55 53.33 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.011 0.434 . . . . 0.0 110.226 -179.666 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 93.85 -9.4 73.21 Favored Glycine 0 N--CA 1.46 0.237 0 CA-C-N 116.061 -0.518 . . . . 0.0 114.116 178.108 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -74.58 139.38 43.66 Favored 'General case' 0 CA--C 1.54 0.576 0 O-C-N 122.484 -0.421 . . . . 0.0 111.425 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 18.5 mt -82.13 162.48 22.47 Favored 'General case' 0 C--O 1.213 -0.86 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 177.844 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 59.4 t30 -114.87 69.53 0.72 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.075 0.464 . . . . 0.0 110.405 178.409 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -143.1 152.54 58.45 Favored Pre-proline 0 C--O 1.241 0.616 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -67.44 150.94 80.72 Favored 'Trans proline' 0 C--N 1.345 0.355 0 N-CA-C 113.511 0.543 . . . . 0.0 113.511 177.77 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 4.9 ptpt -151.6 59.11 0.88 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 122.777 1.275 . . . . 0.0 109.128 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -60.39 -30.6 69.69 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 113.846 -1.524 . . . . 0.0 113.028 -178.307 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 48.5 p-80 -60.84 -22.92 64.7 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 113.095 0.776 . . . . 0.0 113.095 -178.02 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 67.4 mt -71.45 -31.83 44.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 178.586 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -74.93 14.64 4.49 Favored Glycine 0 CA--C 1.524 0.596 0 N-CA-C 115.638 1.015 . . . . 0.0 115.638 -178.082 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 9.5 t -83.27 16.19 2.58 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 113.773 1.027 . . . . 0.0 113.773 -178.395 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 65.3 ttp85 -59.17 130.02 44.96 Favored 'General case' 0 N--CA 1.47 0.552 0 O-C-N 121.225 -0.922 . . . . 0.0 108.861 -178.79 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -107.93 130.18 23.14 Favored Pre-proline 0 C--N 1.322 -0.606 0 N-CA-C 106.408 -1.701 . . . . 0.0 106.408 179.475 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -69.61 -17.78 38.08 Favored 'Trans proline' 0 C--O 1.219 -0.461 0 C-N-CA 117.826 -0.982 . . . . 0.0 113.667 -177.652 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -74.14 -26.14 60.15 Favored 'General case' 0 C--O 1.22 -0.47 0 CA-C-O 120.838 0.352 . . . . 0.0 110.657 178.191 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 77.9 m-20 -102.23 -25.07 13.82 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 113.195 0.813 . . . . 0.0 113.195 -174.481 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 17.9 t-20 -156.04 147.15 22.33 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.623 0.601 . . . . 0.0 112.623 -178.603 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -89.5 146.99 24.24 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.706 179.368 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -70.71 147.43 49.07 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.928 0.394 . . . . 0.0 109.969 178.129 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 2.0 mt -91.36 142.65 12.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 -178.129 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 87.8 t -59.14 123.08 10.72 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 N-CA-C 107.883 -1.155 . . . . 0.0 107.883 177.077 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 7.3 tt -70.46 127.89 34.28 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 -178.499 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 36.5 mt-30 -132.77 162.74 30.67 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 -178.76 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 15.4 mt -114.81 145.55 34.19 Favored Pre-proline 0 C--N 1.323 -0.584 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 179.268 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -72.93 170.34 19.97 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 120.329 0.686 . . . . 0.0 113.84 -177.567 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -54.61 133.36 46.53 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.738 -179.645 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 92.6 -17.43 57.67 Favored Glycine 0 C--O 1.227 -0.331 0 CA-C-N 116.001 -0.545 . . . . 0.0 113.191 -179.383 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 3.8 m -108.62 126.22 52.72 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 117.773 0.786 . . . . 0.0 110.303 178.689 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 14.5 p -123.4 152.19 41.83 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.057 -0.52 . . . . 0.0 109.922 -178.868 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 90.4 mt -72.34 151.47 92.05 Favored Pre-proline 0 C--N 1.324 -0.527 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 178.299 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -77.81 173.08 14.62 Favored 'Trans proline' 0 N--CA 1.462 -0.34 0 O-C-N 121.966 0.456 . . . . 0.0 111.06 178.418 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 66.3 tttp -59.78 127.89 34.2 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 122.074 -0.392 . . . . 0.0 111.519 -177.631 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 95.17 -1.48 64.87 Favored Glycine 0 C--O 1.227 -0.292 0 N-CA-C 115.142 0.817 . . . . 0.0 115.142 176.696 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.444 ' CZ ' ' HB2' ' A' ' 18' ' ' GLN . 1.2 m-85 -103.75 141.69 35.65 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-O 121.601 0.715 . . . . 0.0 111.632 -179.25 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 47.2 p90 -146.13 166.07 27.25 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 114.572 -1.194 . . . . 0.0 107.833 175.415 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -106.47 145.57 31.64 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 112.446 0.536 . . . . 0.0 112.446 -176.31 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -72.81 139.35 46.97 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 177.489 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 90.69 -36.85 3.48 Favored Glycine 0 CA--C 1.515 0.079 0 CA-C-N 116.177 -0.465 . . . . 0.0 112.821 -178.613 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 31.3 t -77.26 131.64 38.28 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.541 -0.541 . . . . 0.0 109.541 -179.445 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 1.2 mpp_? -140.69 144.65 35.75 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 107.297 -1.371 . . . . 0.0 107.297 178.905 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 149.46 177.52 23.63 Favored Glycine 0 C--O 1.227 -0.342 0 N-CA-C 106.639 -2.584 . . . . 0.0 106.639 179.831 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 93.32 -146.64 18.21 Favored Glycine 0 N--CA 1.454 -0.115 0 CA-C-N 118.102 0.951 . . . . 0.0 110.738 -178.503 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 67.0 p . . . . . 0 C--O 1.243 0.724 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 -179.51 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.671 0 CA-C-O 118.588 -1.118 . . . . 0.0 111.148 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -70.92 152.05 44.05 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 178.022 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 53.6 ttp -148.31 142.23 25.82 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 104.798 -2.297 . . . . 0.0 104.798 179.406 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -172.99 -117.06 0.44 Allowed Glycine 0 C--O 1.222 -0.615 0 N-CA-C 110.933 -0.867 . . . . 0.0 110.933 -179.238 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 86.4 mt -77.9 145.78 70.77 Favored Pre-proline 0 C--N 1.322 -0.589 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 -179.834 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -73.89 167.0 28.28 Favored 'Trans proline' 0 C--N 1.345 0.365 0 O-C-N 122.138 0.546 . . . . 0.0 111.392 176.658 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 24.3 t30 -63.4 -33.3 75.23 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 114.058 1.132 . . . . 0.0 114.058 -177.229 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 33.5 m120 -144.42 -104.1 0.11 Allowed 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 119.722 -0.18 . . . . 0.0 111.403 -177.946 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 41.4 p 40.55 79.64 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 115.101 1.519 . . . . 0.0 115.101 -179.562 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -110.9 148.78 31.71 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.714 -178.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 5.3 m -61.14 145.86 49.54 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.877 176.523 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 18.7 m95 -67.04 -22.83 65.86 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 113.452 0.908 . . . . 0.0 113.452 179.804 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -121.43 162.32 20.65 Favored 'General case' 0 CA--C 1.507 -0.688 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.974 -172.896 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 76.5 p -70.5 161.97 29.64 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 177.473 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -83.58 144.76 29.26 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.9 -0.591 . . . . 0.0 112.392 -175.82 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.41 HD21 HD22 ' A' ' 119' ' ' LEU . 66.2 mt -76.32 148.85 37.21 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 104.798 -2.297 . . . . 0.0 104.798 171.525 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 31.3 m -128.14 148.58 50.6 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 105.24 -2.133 . . . . 0.0 105.24 179.12 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -138.47 163.12 32.77 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 114.925 1.454 . . . . 0.0 114.925 -178.336 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 52.9 t60 -89.71 99.5 12.5 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 100.705 -3.813 . . . . 0.0 100.705 168.811 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -42.07 103.05 0.03 OUTLIER Glycine 0 N--CA 1.461 0.313 0 N-CA-C 118.538 2.175 . . . . 0.0 118.538 -173.803 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 82.4 mttt -142.97 -44.93 0.3 Allowed 'General case' 0 C--O 1.221 -0.401 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 177.862 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -120.67 169.61 10.22 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 -179.393 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -106.01 32.74 4.19 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 122.967 1.365 . . . . 0.0 110.045 178.873 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 32.6 tp 64.23 141.49 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 111.283 -2.689 . . . . 0.0 114.619 176.798 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 43.1 tptt -153.68 138.22 16.84 Favored 'General case' 0 C--N 1.324 -0.532 0 O-C-N 121.31 -0.869 . . . . 0.0 110.529 171.879 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -122.66 149.14 55.14 Favored Pre-proline 0 C--N 1.321 -0.633 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 176.073 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -70.25 159.44 53.04 Favored 'Trans proline' 0 C--N 1.349 0.576 0 O-C-N 122.188 0.573 . . . . 0.0 112.7 179.149 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 16.0 tpt180 -67.04 136.15 54.79 Favored 'General case' 0 C--O 1.218 -0.598 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 -178.826 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 85.94 6.96 81.63 Favored Glycine 0 C--O 1.222 -0.621 0 N-CA-C 111.241 -0.744 . . . . 0.0 111.241 179.606 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 17.4 mt-30 -147.77 172.68 13.74 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 123.27 0.628 . . . . 0.0 109.433 -175.356 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 104.23 -20.47 40.22 Favored Glycine 0 CA--C 1.501 -0.816 0 CA-C-N 115.883 -0.599 . . . . 0.0 113.558 174.424 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 57.6 t -67.28 128.22 93.66 Favored Pre-proline 0 C--N 1.32 -0.706 0 N-CA-C 106.76 -1.57 . . . . 0.0 106.76 177.87 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -71.59 171.61 15.98 Favored 'Trans proline' 0 C--O 1.223 -0.265 0 O-C-N 122.161 0.558 . . . . 0.0 111.329 177.843 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 87.6 mt -70.01 106.57 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-O 121.96 0.886 . . . . 0.0 108.791 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 -98.1 83.67 3.15 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 114.663 -1.153 . . . . 0.0 110.616 -176.55 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 73.1 p -68.02 -14.21 62.79 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.707 0.765 . . . . 0.0 112.725 -179.51 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 11.1 p30 -108.84 21.61 17.01 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.008 -0.997 . . . . 0.0 112.724 -177.216 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 5.8 m -142.83 151.47 41.16 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 113.366 0.876 . . . . 0.0 113.366 -176.844 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 52.8 m -78.32 166.53 42.37 Favored Pre-proline 0 C--N 1.327 -0.407 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 177.224 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.418 ' HA ' ' HG2' ' A' ' 43' ' ' GLN . 60.6 Cg_endo -63.94 -26.67 66.63 Favored 'Trans proline' 0 C--N 1.353 0.77 0 C-N-CA 115.24 -2.707 . . . . 0.0 112.86 179.65 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -60.81 -32.82 72.17 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.663 0.744 . . . . 0.0 110.78 177.192 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 68.8 m-20 -88.7 -6.15 57.64 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 115.416 1.636 . . . . 0.0 115.416 -172.88 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.418 ' HG2' ' HA ' ' A' ' 40' ' ' PRO . 96.5 mm-40 -58.33 -29.25 65.77 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 114.295 1.22 . . . . 0.0 114.295 -176.248 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.43 ' HB ' ' HB1' ' A' ' 98' ' ' ALA . 11.2 tt -59.5 136.69 22.85 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-O 122.408 1.099 . . . . 0.0 112.244 -179.299 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -179.04 -157.9 20.4 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.495 -0.86 . . . . 0.0 111.996 -177.57 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 47.7 p90 -155.01 171.41 19.79 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 179.438 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 19.1 m-85 -112.71 141.05 46.95 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 106.551 -1.648 . . . . 0.0 106.551 173.548 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 69.4 ttt-85 -114.18 124.79 52.92 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.758 -177.144 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 15.2 ttt-85 -63.22 137.82 58.34 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 175.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -149.27 140.87 23.45 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.776 0.798 . . . . 0.0 112.708 179.477 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 12.2 p -133.26 142.64 48.63 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 104.602 -2.37 . . . . 0.0 104.602 174.34 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 11.8 tpt180 -160.68 128.23 4.38 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 112.959 0.726 . . . . 0.0 112.959 -179.81 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.5 tpp180 -116.68 142.7 46.56 Favored 'General case' 0 CA--C 1.507 -0.69 0 N-CA-C 105.734 -1.951 . . . . 0.0 105.734 173.777 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -138.37 177.1 5.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 -177.043 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.93 117.41 19.2 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 104.434 -2.432 . . . . 0.0 104.434 172.65 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -82.79 163.41 42.04 Favored Glycine 0 C--O 1.224 -0.511 0 N-CA-C 107.57 -2.212 . . . . 0.0 107.57 176.681 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -64.35 -32.58 84.68 Favored Glycine 0 C--O 1.214 -1.112 0 CA-C-N 118.121 0.96 . . . . 0.0 111.609 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -90.86 17.91 7.22 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-O 122.147 0.975 . . . . 0.0 110.551 178.89 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 85.36 -6.25 80.51 Favored Glycine 0 N--CA 1.46 0.247 0 N-CA-C 116.338 1.295 . . . . 0.0 116.338 173.54 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.42 128.69 37.54 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.807 0.813 . . . . 0.0 112.634 -178.069 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 97.8 mmm -99.32 -174.73 2.81 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 114.323 -1.308 . . . . 0.0 108.051 178.466 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 6.3 tttp -117.02 -62.0 1.64 Allowed 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 175.34 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.1 t0 54.74 -152.82 0.33 Allowed 'General case' 0 C--O 1.24 0.59 0 O-C-N 124.771 1.294 . . . . 0.0 110.955 178.346 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.9 mm? 67.16 -179.47 0.22 Allowed 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 115.372 1.619 . . . . 0.0 115.372 174.069 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -58.26 156.34 21.89 Favored Pre-proline 0 C--O 1.24 0.585 0 N-CA-C 116.804 2.15 . . . . 0.0 116.804 -174.874 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -66.41 156.57 64.62 Favored 'Trans proline' 0 C--N 1.354 0.838 0 CA-C-O 121.3 0.458 . . . . 0.0 111.817 177.431 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 42.2 mtt-85 -128.69 163.31 25.38 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.622 -175.326 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 61.8 m95 -127.42 129.97 48.48 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 179.122 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 24.2 m-85 -111.27 149.08 31.56 Favored 'General case' 0 C--O 1.213 -0.838 0 N-CA-C 106.949 -1.5 . . . . 0.0 106.949 -178.38 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 86.8 t80 -98.1 139.97 33.12 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.909 -0.775 . . . . 0.0 108.909 -178.224 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -142.36 153.13 43.56 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 -179.052 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 69.1 m-85 -88.12 159.51 18.18 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.87 -174.502 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -54.43 131.01 41.5 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.77 0.319 . . . . 0.0 110.686 -179.487 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 69.67 32.98 71.0 Favored Glycine 0 C--O 1.223 -0.578 0 N-CA-C 115.345 0.898 . . . . 0.0 115.345 176.37 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.433 HG22 ' HA ' ' A' ' 104' ' ' ASP . 1.4 p -89.92 146.16 24.6 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 118.108 0.954 . . . . 0.0 109.312 177.268 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 99.09 147.08 21.41 Favored Glycine 0 CA--C 1.523 0.576 0 N-CA-C 111.637 -0.585 . . . . 0.0 111.637 -179.725 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -71.21 -40.13 3.44 Favored 'Trans proline' 0 C--N 1.347 0.492 0 N-CA-C 116.775 1.798 . . . . 0.0 116.775 -173.959 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 19.0 pt-20 -116.68 19.37 14.57 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.397 0.617 . . . . 0.0 110.825 -176.058 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -61.9 -44.87 95.9 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.52 -0.472 . . . . 0.0 110.752 -177.195 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 56.43 24.05 44.51 Favored Glycine 0 C--O 1.226 -0.371 0 N-CA-C 115.628 1.011 . . . . 0.0 115.628 178.348 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 52.2 mt -99.87 110.99 61.02 Favored Pre-proline 0 C--O 1.238 0.491 0 N-CA-C 115.65 1.722 . . . . 0.0 115.65 -176.121 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -78.15 168.0 22.49 Favored 'Trans proline' 0 CA--C 1.53 0.32 0 C-N-CA 120.954 1.103 . . . . 0.0 109.442 170.783 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.432 ' CE2' ' HB3' ' A' ' 92' ' ' TRP . 73.2 t80 -62.26 131.96 51.09 Favored 'General case' 0 C--N 1.323 -0.575 0 O-C-N 121.883 -0.511 . . . . 0.0 110.309 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 90.55 -3.6 81.72 Favored Glycine 0 C--O 1.228 -0.265 0 N-CA-C 114.585 0.594 . . . . 0.0 114.585 177.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -63.09 131.0 47.08 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 118.016 0.908 . . . . 0.0 111.403 179.392 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 53.7 t30 -77.84 124.92 28.58 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.181 -178.641 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 12.1 tttp -156.15 151.74 27.05 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 178.322 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 20.3 t0 -66.41 133.79 51.18 Favored 'General case' 0 C--N 1.322 -0.623 0 O-C-N 123.395 0.435 . . . . 0.0 110.068 -179.197 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 67.31 27.56 73.53 Favored Glycine 0 N--CA 1.45 -0.431 0 N-CA-C 114.749 0.66 . . . . 0.0 114.749 178.529 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 41.7 mm -129.27 125.84 62.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 117.266 0.533 . . . . 0.0 110.655 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.1 pt -129.78 116.16 36.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 CA-C-O 121.909 0.861 . . . . 0.0 112.536 176.782 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' TRP . . . . . 0.432 ' HB3' ' CE2' ' A' ' 83' ' ' TYR . 94.8 m95 -80.52 135.28 36.07 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 113.533 0.938 . . . . 0.0 113.533 -176.921 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 17.1 m -135.13 151.99 31.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 179.427 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -160.6 166.5 28.84 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 104.683 -2.34 . . . . 0.0 104.683 -178.801 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 13.5 t -136.39 178.78 6.8 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 105.151 -2.166 . . . . 0.0 105.151 177.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -66.99 136.48 55.38 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.318 0.58 . . . . 0.0 110.693 -179.257 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 92.24 -14.32 64.88 Favored Glycine 0 C--O 1.226 -0.374 0 CA-C-N 115.715 -0.675 . . . . 0.0 113.563 177.256 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.43 ' HB1' ' HB ' ' A' ' 44' ' ' ILE . . . -69.96 126.71 30.48 Favored 'General case' 0 C--N 1.322 -0.624 0 O-C-N 122.43 -0.453 . . . . 0.0 110.975 -179.492 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 43.6 mt -83.49 138.37 33.47 Favored 'General case' 0 CA--C 1.515 -0.392 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 -177.224 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 61.5 t30 -82.08 65.11 7.06 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.527 0.68 . . . . 0.0 110.729 179.816 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -140.11 155.18 70.71 Favored Pre-proline 0 C--N 1.322 -0.619 0 N-CA-C 105.639 -1.985 . . . . 0.0 105.639 179.591 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_endo -73.33 155.83 50.94 Favored 'Trans proline' 0 CA--C 1.532 0.377 0 N-CA-C 115.016 1.122 . . . . 0.0 115.016 179.438 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.79 58.02 1.05 Allowed 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 121.852 0.834 . . . . 0.0 112.055 176.338 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' ASP . . . . . 0.433 ' HA ' HG22 ' A' ' 75' ' ' THR . 33.7 t70 -56.98 -26.94 60.94 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.117 178.115 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 17.1 p80 -58.84 -11.52 3.36 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 114.521 1.304 . . . . 0.0 114.521 -178.886 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 23.2 mt -96.35 -36.14 6.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 122.175 -0.328 . . . . 0.0 110.836 178.22 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -73.83 14.51 3.55 Favored Glycine 0 CA--C 1.522 0.495 0 N-CA-C 116.189 1.235 . . . . 0.0 116.189 -175.334 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 9.7 t -107.33 29.26 7.3 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-O 121.057 0.456 . . . . 0.0 111.971 -177.872 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 64.2 ttp85 -54.73 134.36 47.44 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 177.513 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 41.6 m-20 -102.06 122.73 46.01 Favored Pre-proline 0 C--N 1.325 -0.497 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 -178.129 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -68.74 -18.6 42.02 Favored 'Trans proline' 0 C--O 1.217 -0.531 0 N-CA-C 114.425 0.894 . . . . 0.0 114.425 -176.838 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -75.69 -25.92 57.15 Favored 'General case' 0 C--O 1.22 -0.477 0 CA-C-O 120.842 0.353 . . . . 0.0 110.657 178.121 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 83.0 m-20 -100.75 -23.84 14.53 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 -175.39 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 -154.98 147.91 24.6 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.764 0.654 . . . . 0.0 112.764 -178.879 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -88.37 148.57 24.18 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-O 121.454 0.645 . . . . 0.0 111.404 179.493 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -68.97 142.45 54.67 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.226 0.536 . . . . 0.0 110.183 178.378 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 18.9 mt -84.8 136.56 22.5 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 -179.038 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 74.4 t -60.49 124.69 15.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 N-CA-C 105.295 -2.113 . . . . 0.0 105.295 174.984 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.41 HD22 HD21 ' A' ' 16' ' ' LEU . 7.6 tt -66.18 127.93 34.1 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.199 0.523 . . . . 0.0 109.968 -176.65 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 30.1 mt-30 -129.68 156.35 44.4 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 106.169 -1.789 . . . . 0.0 106.169 -179.483 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 13.6 mt -112.37 148.02 38.27 Favored Pre-proline 0 C--N 1.321 -0.661 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 177.849 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -72.43 165.37 32.88 Favored 'Trans proline' 0 C--O 1.236 0.38 0 O-C-N 122.293 0.628 . . . . 0.0 112.454 -179.354 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 65.1 tt0 -54.86 130.41 41.06 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.491 -179.471 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 99.47 -19.8 52.27 Favored Glycine 0 C--O 1.226 -0.39 0 CA-C-N 115.873 -0.603 . . . . 0.0 113.601 -179.278 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 11.2 m -105.76 130.91 53.66 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 118.251 1.025 . . . . 0.0 110.684 178.827 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 16.9 p -124.54 152.11 43.88 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.614 -178.035 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 90.3 mt -78.67 155.3 78.45 Favored Pre-proline 0 C--N 1.326 -0.432 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 177.287 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -75.19 170.25 20.77 Favored 'Trans proline' 0 C--O 1.237 0.44 0 CA-C-O 121.55 0.562 . . . . 0.0 111.367 177.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 48.1 tptt -63.5 122.49 16.4 Favored 'General case' 0 C--O 1.218 -0.579 0 CA-C-O 121.006 0.432 . . . . 0.0 111.234 -175.863 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 95.21 7.36 59.54 Favored Glycine 0 C--O 1.228 -0.263 0 N-CA-C 115.236 0.854 . . . . 0.0 115.236 178.331 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -110.48 143.48 40.74 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 107.332 -1.358 . . . . 0.0 107.332 176.788 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 35.2 p90 -147.56 163.95 34.99 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 177.263 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -99.55 145.6 27.34 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.894 0.378 . . . . 0.0 110.625 -178.393 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -72.07 135.84 46.42 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 178.28 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 86.41 -10.47 66.68 Favored Glycine 0 C--O 1.226 -0.396 0 CA-C-N 116.28 -0.418 . . . . 0.0 113.464 -178.641 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 32.2 t -85.08 118.44 24.64 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 117.535 0.668 . . . . 0.0 110.089 179.482 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 1.8 mmm180 -152.91 162.38 41.38 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 105.24 -2.133 . . . . 0.0 105.24 179.382 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 103.69 -168.71 17.49 Favored Glycine 0 C--O 1.229 -0.196 0 N-CA-C 111.654 -0.578 . . . . 0.0 111.654 178.573 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 136.74 -24.88 3.13 Favored Glycine 0 C--O 1.228 -0.24 0 N-CA-C 107.348 -2.301 . . . . 0.0 107.348 -177.783 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 61.4 m . . . . . 0 C--O 1.26 1.649 0 N-CA-C 101.73 -3.433 . . . . 0.0 101.73 175.924 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.612 0 CA-C-O 118.746 -1.03 . . . . 0.0 111.141 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -70.42 152.71 43.77 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 118.069 0.935 . . . . 0.0 110.839 -179.608 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 28.1 ttt -149.01 143.97 26.44 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 102.033 -3.321 . . . . 0.0 102.033 178.247 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 80.29 35.24 27.17 Favored Glycine 0 C--O 1.224 -0.514 0 C-N-CA 120.266 -0.969 . . . . 0.0 111.243 -177.663 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 8.9 mp -59.69 145.67 82.68 Favored Pre-proline 0 C--O 1.239 0.534 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 -179.173 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -69.01 152.08 73.25 Favored 'Trans proline' 0 C--N 1.347 0.499 0 N-CA-C 114.286 0.841 . . . . 0.0 114.286 -176.5 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 35.2 t30 -144.38 89.73 2.03 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.429 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 17.5 t30 -125.21 14.09 8.35 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 121.421 0.629 . . . . 0.0 110.276 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 22.6 p -133.48 89.48 2.6 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 -178.118 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -90.58 141.28 28.93 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-O 121.486 0.66 . . . . 0.0 109.667 -177.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -58.37 140.28 53.88 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.608 177.674 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 35.7 m95 -65.82 -22.0 66.52 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 114.283 1.216 . . . . 0.0 114.283 -178.769 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 82.6 m-85 -121.37 161.84 21.4 Favored 'General case' 0 CA--C 1.506 -0.714 0 N-CA-C 114.453 1.279 . . . . 0.0 114.453 -171.086 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.423 ' HB ' ' HB3' ' A' ' 134' ' ' GLU . 73.1 p -69.89 163.59 25.62 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 114.045 -1.434 . . . . 0.0 108.468 177.956 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.468 ' HB2' ' CZ ' ' A' ' 69' ' ' TYR . . . -77.43 139.3 39.64 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 -175.224 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 12.8 mt -84.49 145.62 28.02 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 103.927 -2.619 . . . . 0.0 103.927 170.8 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 21.9 m -129.31 133.2 47.33 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 118.13 0.423 . . . . 0.0 109.96 -179.4 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.414 ' HB2' ' CZ ' ' A' ' 131' ' ' PHE . 3.8 tp60 -95.34 143.33 26.79 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 123.615 0.572 . . . . 0.0 111.577 -179.568 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 23.1 t-160 -138.97 96.5 3.13 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 102.609 -3.108 . . . . 0.0 102.609 165.57 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 172.57 -161.22 32.67 Favored Glycine 0 C--O 1.226 -0.399 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 -173.531 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 49.6 mtmt -104.54 -27.89 11.61 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 116.332 1.975 . . . . 0.0 116.332 -176.634 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -85.58 162.44 18.86 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 179.231 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -76.03 -62.9 1.44 Allowed 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 -178.519 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 36.4 tp -178.32 138.14 0.18 Allowed 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 104.799 -2.297 . . . . 0.0 104.799 172.958 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 11.0 tmtt? -149.28 133.33 17.18 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 176.606 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -121.05 159.8 47.78 Favored Pre-proline 0 C--O 1.243 0.748 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 177.887 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -65.39 171.52 9.16 Favored 'Trans proline' 0 CA--C 1.539 0.746 0 C-N-CA 121.004 1.136 . . . . 0.0 114.706 -179.82 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 25.5 tpt180 -78.4 128.0 33.0 Favored 'General case' 0 C--O 1.215 -0.758 0 O-C-N 121.561 -0.712 . . . . 0.0 109.289 179.448 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 72.12 18.68 78.06 Favored Glycine 0 C--O 1.225 -0.459 0 N-CA-C 114.552 0.581 . . . . 0.0 114.552 176.583 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 43.1 tt0 -159.32 149.59 19.17 Favored 'General case' 0 C--O 1.22 -0.46 0 N-CA-C 105.652 -1.981 . . . . 0.0 105.652 -178.437 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 136.05 -14.74 4.05 Favored Glycine 0 CA--C 1.505 -0.548 0 C-N-CA 120.323 -0.941 . . . . 0.0 113.225 176.524 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 27.6 m -71.6 145.93 90.6 Favored Pre-proline 0 C--N 1.32 -0.698 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 177.382 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -77.17 173.03 15.03 Favored 'Trans proline' 0 N--CA 1.46 -0.491 0 C-N-CA 121.507 1.471 . . . . 0.0 112.578 178.992 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 91.5 mt -79.3 116.74 23.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.129 -179.379 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.456 ' HB2' HE22 ' A' ' 43' ' ' GLN . 22.4 m-20 -100.95 86.13 3.0 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 176.664 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 69.8 p -60.39 -27.06 67.14 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 115.661 1.726 . . . . 0.0 115.661 -173.69 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 19.7 p30 -108.18 21.38 17.43 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 -177.37 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 15.1 m -130.19 169.32 15.52 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 112.165 0.432 . . . . 0.0 112.165 -175.948 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 68.8 m -83.7 158.39 62.64 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.295 -176.952 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -67.42 -21.53 46.77 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 116.882 -1.612 . . . . 0.0 114.751 -177.909 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.464 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 4.1 p-10 -74.65 -17.04 60.75 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 121.927 -0.483 . . . . 0.0 110.856 178.814 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.446 ' HA ' ' HE3' ' A' ' 103' ' ' LYS . 0.0 OUTLIER -87.04 -16.32 35.99 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 114.925 1.454 . . . . 0.0 114.925 -174.269 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.456 HE22 ' HB2' ' A' ' 35' ' ' ASN . 84.0 mm-40 -57.81 -20.63 37.21 Favored 'General case' 0 C--O 1.218 -0.582 0 N-CA-C 114.093 1.145 . . . . 0.0 114.093 -172.154 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.412 ' HB ' ' HB1' ' A' ' 98' ' ' ALA . 20.6 tt -58.8 139.93 17.83 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 CA-C-O 122.401 1.095 . . . . 0.0 113.076 178.918 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 177.86 -153.61 13.54 Favored Glycine 0 N--CA 1.444 -0.792 0 C-N-CA 119.924 -1.131 . . . . 0.0 112.653 178.851 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 51.6 p90 -155.1 167.75 29.31 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 178.361 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 38.2 m-85 -108.74 140.28 42.38 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 106.435 -1.691 . . . . 0.0 106.435 174.419 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 65.3 ttt-85 -113.33 122.73 48.28 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.923 -177.82 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 49.0 ttp85 -68.62 136.89 53.71 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 177.008 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -134.85 136.41 42.43 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 179.041 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 14.8 t -152.9 159.19 42.98 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 106.697 -1.594 . . . . 0.0 106.697 176.84 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 21.6 tpt180 -157.74 142.27 16.33 Favored 'General case' 0 C--O 1.216 -0.663 0 N-CA-C 105.955 -1.869 . . . . 0.0 105.955 179.618 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -129.05 130.64 46.82 Favored 'General case' 0 CA--C 1.493 -1.223 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 176.996 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -128.89 173.05 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.003 0 N-CA-C 105.664 -1.976 . . . . 0.0 105.664 -179.14 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 6.6 tmm_? -140.33 112.76 7.9 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 106.024 -1.843 . . . . 0.0 106.024 175.811 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -74.04 164.24 54.7 Favored Glycine 0 C--O 1.226 -0.376 0 N-CA-C 110.448 -1.061 . . . . 0.0 110.448 -179.808 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -65.93 -33.8 86.7 Favored Glycine 0 C--O 1.217 -0.935 0 N-CA-C 110.522 -1.031 . . . . 0.0 110.522 -179.269 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.0 t0 -85.2 16.96 3.23 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-O 122.157 0.98 . . . . 0.0 110.968 179.352 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 84.77 -4.81 84.17 Favored Glycine 0 CA--C 1.509 -0.298 0 N-CA-C 116.071 1.188 . . . . 0.0 116.071 172.277 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.59 123.16 20.1 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.488 0.661 . . . . 0.0 111.785 -177.394 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 93.4 mmm -88.84 169.49 11.55 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.01 -0.996 . . . . 0.0 108.663 178.86 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 5.4 tmtt? -74.99 -52.74 10.37 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 177.895 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 58.37 -174.27 0.09 Allowed 'General case' 0 C--O 1.243 0.713 0 N-CA-C 115.547 1.684 . . . . 0.0 115.547 178.941 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.5 mm? 64.79 169.77 0.19 Allowed 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 115.018 1.488 . . . . 0.0 115.018 -179.461 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -70.62 163.25 65.35 Favored Pre-proline 0 C--O 1.243 0.723 0 CA-C-N 114.603 -1.181 . . . . 0.0 114.181 -176.331 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -72.12 166.8 28.58 Favored 'Trans proline' 0 C--N 1.351 0.666 0 CA-C-O 121.562 0.568 . . . . 0.0 112.736 177.748 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 22.9 mtp180 -117.91 166.3 12.65 Favored 'General case' 0 CA--C 1.512 -0.497 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 178.795 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 62.8 m95 -127.45 143.4 51.2 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 177.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.468 ' CZ ' ' HB2' ' A' ' 15' ' ' ALA . 60.7 m-85 -124.02 147.49 47.78 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 178.889 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 86.5 t80 -95.79 139.24 32.31 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 -177.356 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -142.44 140.6 32.01 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 -176.471 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.407 ' HB3' ' HB2' ' A' ' 103' ' ' LYS . 74.9 m-85 -68.1 159.44 30.91 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -179.313 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 19.1 tp -59.44 134.72 57.27 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 175.147 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 75.66 35.28 46.76 Favored Glycine 0 C--O 1.222 -0.638 0 N-CA-C 115.881 1.112 . . . . 0.0 115.881 177.22 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 21.7 p -110.13 153.08 25.2 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 118.288 1.044 . . . . 0.0 109.832 177.867 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 106.04 143.06 11.3 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 -177.528 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -71.11 -39.26 4.16 Favored 'Trans proline' 0 C--N 1.348 0.529 0 CA-C-N 119.651 1.725 . . . . 0.0 116.215 -173.939 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -117.09 17.56 14.82 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.436 -176.721 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -64.75 -52.04 59.12 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.882 -176.155 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 55.72 27.38 49.34 Favored Glycine 0 C--O 1.225 -0.458 0 N-CA-C 114.691 0.636 . . . . 0.0 114.691 179.179 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 75.2 mt -95.05 114.53 63.89 Favored Pre-proline 0 C--O 1.238 0.48 0 N-CA-C 114.874 1.435 . . . . 0.0 114.874 -175.449 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -76.85 166.75 26.44 Favored 'Trans proline' 0 N--CA 1.461 -0.41 0 N-CA-C 109.231 -1.103 . . . . 0.0 109.231 171.253 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 62.1 t80 -62.95 131.26 48.08 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 120.708 -0.397 . . . . 0.0 110.29 -179.219 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 92.39 -3.48 75.72 Favored Glycine 0 CA--C 1.52 0.396 0 N-CA-C 114.524 0.569 . . . . 0.0 114.524 179.156 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -63.03 130.94 46.89 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 117.863 0.832 . . . . 0.0 112.104 179.406 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 32.7 t-20 -78.3 125.85 29.95 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.568 -178.466 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 14.7 ttmm -155.55 150.47 26.53 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 176.743 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -63.36 131.36 48.01 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.245 179.585 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 70.66 25.88 74.98 Favored Glycine 0 N--CA 1.45 -0.418 0 CA-C-O 119.375 -0.681 . . . . 0.0 114.184 177.935 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 39.7 mm -128.83 128.14 67.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 117.515 0.658 . . . . 0.0 109.963 179.339 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.1 pt -130.13 115.26 32.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 CA-C-O 121.422 0.63 . . . . 0.0 110.891 176.952 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 97.4 m95 -82.07 132.22 35.25 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 112.941 0.719 . . . . 0.0 112.941 -176.871 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 1.1 m -142.05 152.95 18.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.187 -178.127 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -155.12 166.53 33.28 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 103.371 -2.826 . . . . 0.0 103.371 -178.824 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 14.5 t -122.76 169.13 11.39 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 104.206 -2.516 . . . . 0.0 104.206 174.481 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -65.37 137.16 57.32 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.193 0.52 . . . . 0.0 109.922 -179.495 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 91.19 -5.79 81.29 Favored Glycine 0 CA--C 1.516 0.119 0 CA-C-N 115.749 -0.659 . . . . 0.0 113.4 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.464 ' HA ' ' HA ' ' A' ' 41' ' ' ASP . . . -77.81 135.48 37.96 Favored 'General case' 0 CA--C 1.537 0.478 0 O-C-N 122.307 -0.525 . . . . 0.0 109.647 179.2 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 28.8 mt -88.25 136.37 33.01 Favored 'General case' 0 CA--C 1.509 -0.615 0 CA-C-O 121.601 0.715 . . . . 0.0 111.979 -178.249 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 54.4 t30 -82.59 67.95 8.84 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.978 -1.01 . . . . 0.0 110.588 -178.683 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -142.77 155.63 63.0 Favored Pre-proline 0 C--N 1.323 -0.57 0 N-CA-C 106.382 -1.711 . . . . 0.0 106.382 -179.102 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -66.83 150.6 83.23 Favored 'Trans proline' 0 CA--C 1.53 0.292 0 N-CA-C 114.78 1.031 . . . . 0.0 114.78 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.581 ' HB3' HD12 ' A' ' 106' ' ' ILE . 71.1 mmtt -126.89 36.88 4.38 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.152 179.758 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 14.0 p-10 -49.55 -42.77 45.04 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.268 0.556 . . . . 0.0 112.003 -177.796 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 15.4 p80 -67.5 -10.3 50.36 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 115.121 1.526 . . . . 0.0 115.121 -178.589 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.581 HD12 ' HB3' ' A' ' 103' ' ' LYS . 38.8 mt -91.93 -31.95 5.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 179.535 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -74.12 14.6 3.76 Favored Glycine 0 C--O 1.222 -0.597 0 N-CA-C 115.488 0.955 . . . . 0.0 115.488 -177.79 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 15.1 t -83.17 24.44 0.79 Allowed 'General case' 0 CA--C 1.547 0.862 0 N-CA-C 113.814 1.042 . . . . 0.0 113.814 -177.145 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 69.9 ttp85 -62.17 124.92 22.16 Favored 'General case' 0 N--CA 1.471 0.584 0 O-C-N 121.033 -1.042 . . . . 0.0 108.691 179.604 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 11.4 m-20 -99.56 125.34 41.17 Favored Pre-proline 0 C--N 1.323 -0.563 0 N-CA-C 106.307 -1.738 . . . . 0.0 106.307 179.381 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -68.85 -18.5 41.4 Favored 'Trans proline' 0 C--O 1.22 -0.421 0 C-N-CA 117.98 -0.88 . . . . 0.0 114.315 -176.126 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -75.41 -26.19 58.19 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.854 0.359 . . . . 0.0 110.621 178.04 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 -100.58 -25.86 14.03 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 -174.85 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 19.5 t-20 -152.11 145.6 24.87 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 -179.423 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -86.7 149.39 24.92 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.402 179.69 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -66.8 142.34 57.39 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.295 0.569 . . . . 0.0 110.381 178.668 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 22.8 mt -84.15 139.26 17.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.312 -0.858 . . . . 0.0 108.689 -178.152 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 91.6 t -61.67 124.52 16.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 105.789 -1.93 . . . . 0.0 105.789 175.134 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 6.1 tt -66.51 128.74 37.37 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.098 0.475 . . . . 0.0 109.906 -177.257 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -129.88 151.8 50.05 Favored 'General case' 0 CA--C 1.507 -0.696 0 N-CA-C 106.285 -1.746 . . . . 0.0 106.285 -179.31 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 13.0 mt -110.16 148.32 38.1 Favored Pre-proline 0 C--N 1.321 -0.655 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 178.897 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -71.59 164.26 36.28 Favored 'Trans proline' 0 C--N 1.345 0.349 0 O-C-N 122.228 0.594 . . . . 0.0 112.999 -178.932 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 54.8 tt0 -54.25 131.12 40.93 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.628 -0.714 . . . . 0.0 109.685 -179.412 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 98.93 -17.7 57.84 Favored Glycine 0 C--O 1.228 -0.262 0 CA-C-N 115.829 -0.623 . . . . 0.0 112.494 -178.822 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 1.8 m -108.62 128.94 55.28 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 117.716 0.758 . . . . 0.0 110.587 178.052 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 6.0 p -124.91 151.05 45.88 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 179.37 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 72.6 mt -67.33 153.28 95.07 Favored Pre-proline 0 C--N 1.324 -0.525 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 -179.705 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -75.06 168.08 25.58 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 117.938 -0.908 . . . . 0.0 110.406 178.461 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -57.0 124.52 18.96 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 112.92 0.711 . . . . 0.0 112.92 -174.074 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 95.2 -6.06 68.55 Favored Glycine 0 C--O 1.229 -0.201 0 N-CA-C 115.818 1.087 . . . . 0.0 115.818 177.402 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.414 ' CZ ' ' HB2' ' A' ' 18' ' ' GLN . 1.7 m-85 -93.13 146.32 23.75 Favored 'General case' 0 N--CA 1.439 -1.013 0 CA-C-O 122.096 0.95 . . . . 0.0 110.416 179.362 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 46.8 p90 -144.75 160.58 41.0 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 113.793 -1.549 . . . . 0.0 108.12 174.438 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -102.56 142.84 33.07 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.092 0.472 . . . . 0.0 111.02 -177.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.423 ' HB3' ' HB ' ' A' ' 14' ' ' THR . 3.5 tp10 -70.12 131.61 44.56 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 177.779 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 92.29 -10.98 73.22 Favored Glycine 0 C--O 1.227 -0.298 0 C-N-CA 121.359 -0.448 . . . . 0.0 112.944 -178.526 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 41.9 t -91.69 144.02 25.95 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 106.957 -1.497 . . . . 0.0 106.957 176.84 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 2.9 tmt_? -78.0 -20.55 52.34 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.558 178.368 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 126.29 176.53 14.53 Favored Glycine 0 C--O 1.227 -0.306 0 N-CA-C 107.272 -2.331 . . . . 0.0 107.272 -177.335 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 80.28 42.79 10.13 Favored Glycine 0 C--O 1.226 -0.377 0 N-CA-C 110.246 -1.142 . . . . 0.0 110.246 -178.016 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 6.7 m . . . . . 0 C--O 1.25 1.083 0 N-CA-C 106.944 -1.502 . . . . 0.0 106.944 -178.149 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.762 0 CA-C-O 118.883 -0.954 . . . . 0.0 111.331 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -61.93 147.48 46.72 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 118.034 0.917 . . . . 0.0 108.691 178.867 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 65.2 mtm 59.7 16.79 5.75 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 113.596 0.961 . . . . 0.0 113.596 -179.207 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -84.26 60.18 4.86 Favored Glycine 0 C--O 1.227 -0.339 0 N-CA-C 112.124 -0.39 . . . . 0.0 112.124 178.639 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 10.3 mp -65.96 140.89 97.31 Favored Pre-proline 0 C--N 1.325 -0.488 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 -178.426 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -74.21 -22.28 16.87 Favored 'Trans proline' 0 C--N 1.349 0.567 0 N-CA-C 113.862 0.678 . . . . 0.0 113.862 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 26.7 t30 48.91 43.35 21.59 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 114.073 1.138 . . . . 0.0 114.073 178.134 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 15.4 t30 -83.13 46.63 1.14 Allowed 'General case' 0 N--CA 1.474 0.753 0 CA-C-O 121.421 0.629 . . . . 0.0 111.213 -179.154 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 17.4 p -148.1 129.27 14.61 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 104.078 -2.564 . . . . 0.0 104.078 179.124 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -139.19 146.39 40.49 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.462 0.649 . . . . 0.0 111.73 -179.057 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 35.7 t -63.16 144.0 57.3 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.144 177.775 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 18.1 m95 -67.34 -21.83 65.63 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 112.824 0.675 . . . . 0.0 112.824 178.025 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 39.8 m-85 -121.55 165.6 15.43 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 114.663 1.357 . . . . 0.0 114.663 -170.437 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 76.1 p -71.44 166.45 21.69 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 114.459 -1.246 . . . . 0.0 107.758 176.977 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.495 ' HB2' ' CZ ' ' A' ' 69' ' ' TYR . . . -78.01 157.51 29.62 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 113.54 0.941 . . . . 0.0 113.54 -175.554 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 12.9 mt -102.05 137.1 40.77 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 105.288 -2.116 . . . . 0.0 105.288 171.114 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 37.0 m -122.19 145.4 48.23 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 -177.278 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.419 ' HB2' ' CZ ' ' A' ' 131' ' ' PHE . 4.2 tp60 -112.51 142.89 44.54 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 114.664 1.357 . . . . 0.0 114.664 -175.172 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 72.4 t60 -131.98 99.46 4.75 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 104.663 -2.347 . . . . 0.0 104.663 166.954 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 171.04 -152.97 19.74 Favored Glycine 0 C--O 1.227 -0.309 0 N-CA-C 109.954 -1.258 . . . . 0.0 109.954 -175.374 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -117.39 -21.97 8.43 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-O 121.44 0.638 . . . . 0.0 110.865 179.455 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -72.65 151.0 42.5 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.311 -179.646 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 16.8 t0 -76.61 -62.59 1.58 Allowed 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 178.921 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 43.1 tp 179.64 143.35 0.15 Allowed 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 103.478 -2.786 . . . . 0.0 103.478 171.299 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 56.8 tptt -154.56 134.57 13.06 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 118.047 0.385 . . . . 0.0 110.188 176.001 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 12.0 m-85 -125.0 157.27 67.42 Favored Pre-proline 0 C--O 1.244 0.811 0 N-CA-C 106.291 -1.744 . . . . 0.0 106.291 175.363 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -72.2 175.02 10.51 Favored 'Trans proline' 0 CA--C 1.536 0.611 0 C-N-CA 121.174 1.249 . . . . 0.0 114.527 -178.526 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 46.7 tpt85 -78.33 127.45 32.24 Favored 'General case' 0 C--O 1.214 -0.815 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 178.351 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 80.17 10.5 85.41 Favored Glycine 0 C--O 1.223 -0.567 0 N-CA-C 115.417 0.927 . . . . 0.0 115.417 175.854 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -157.71 145.5 18.71 Favored 'General case' 0 C--O 1.219 -0.521 0 N-CA-C 106.264 -1.754 . . . . 0.0 106.264 -179.537 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 138.5 -14.61 3.43 Favored Glycine 0 CA--C 1.504 -0.607 0 C-N-CA 120.042 -1.075 . . . . 0.0 113.523 177.298 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 27.8 m -70.06 144.72 93.14 Favored Pre-proline 0 C--N 1.322 -0.595 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 176.984 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -76.16 174.28 13.09 Favored 'Trans proline' 0 N--CA 1.46 -0.496 0 C-N-CA 121.483 1.455 . . . . 0.0 111.773 178.523 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 92.4 mt -71.86 118.47 16.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 178.404 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 45.1 m-80 -111.29 87.08 2.46 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 179.515 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 82.1 p -66.84 -21.94 66.01 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 112.769 0.655 . . . . 0.0 112.769 -177.091 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 71.6 m-80 -105.62 34.71 3.15 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.875 -177.249 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 20.6 m -145.84 150.41 36.11 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.745 0.307 . . . . 0.0 111.603 -179.4 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 25.3 m -71.31 164.19 59.39 Favored Pre-proline 0 C--N 1.325 -0.484 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 176.947 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -64.57 -26.8 61.66 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 114.926 -2.916 . . . . 0.0 111.598 177.721 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 51.2 m-20 -63.03 -27.39 69.38 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.827 177.001 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.491 ' HA ' ' HE3' ' A' ' 103' ' ' LYS . 67.9 m-20 -93.41 -6.62 46.68 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 115.569 1.692 . . . . 0.0 115.569 -171.878 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 92.0 mm-40 -60.43 -33.12 72.06 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 115.097 1.517 . . . . 0.0 115.097 -176.955 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 14.5 tt -60.1 140.62 17.86 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 CA-C-O 122.137 0.97 . . . . 0.0 113.117 -178.686 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 179.85 -149.34 8.53 Favored Glycine 0 C--O 1.227 -0.325 0 CA-C-N 115.623 -0.717 . . . . 0.0 112.455 -176.675 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 50.7 p90 -155.08 171.98 18.89 Favored 'General case' 0 C--N 1.319 -0.72 0 O-C-N 122.187 -0.596 . . . . 0.0 109.959 179.164 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 28.7 m-85 -114.25 142.99 45.57 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 173.222 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 68.5 ttt180 -115.22 125.88 53.89 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 123.739 0.815 . . . . 0.0 110.628 -178.329 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 6.3 ttp85 -71.26 135.52 47.49 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 107.675 -1.231 . . . . 0.0 107.675 176.317 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -135.35 129.64 33.73 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 123.218 0.607 . . . . 0.0 111.212 -178.732 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 15.0 t -159.96 155.43 25.45 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 174.271 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 20.3 tpt180 -161.26 139.18 9.33 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 105.319 -2.104 . . . . 0.0 105.319 178.021 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -88.44 135.38 33.5 Favored 'General case' 0 CA--C 1.505 -0.761 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 179.532 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -127.87 173.56 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.766 0 N-CA-C 106.826 -1.546 . . . . 0.0 106.826 -178.854 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.15 117.15 15.29 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 178.611 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -73.87 157.25 51.32 Favored Glycine 0 C--O 1.23 -0.125 0 N-CA-C 107.273 -2.331 . . . . 0.0 107.273 176.09 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -58.49 -35.7 81.19 Favored Glycine 0 N--CA 1.461 0.347 0 CA-C-N 119.017 1.408 . . . . 0.0 112.184 -177.038 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -73.43 0.8 11.25 Favored 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 124.64 1.176 . . . . 0.0 113.553 -179.376 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 93.44 14.54 53.32 Favored Glycine 0 C--N 1.317 -0.505 0 CA-C-N 114.38 -1.282 . . . . 0.0 113.027 174.239 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 16.4 mmtt -79.02 130.6 35.7 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.393 0.616 . . . . 0.0 110.635 -175.924 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 1.4 mmt -86.08 161.06 19.09 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.008 -0.997 . . . . 0.0 110.47 179.613 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 22.6 tptp -64.45 -52.52 57.6 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.383 176.771 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.4 t70 45.33 -149.89 0.07 Allowed 'General case' 0 CA--C 1.549 0.905 0 O-C-N 124.842 1.339 . . . . 0.0 112.315 -176.424 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 62.0 mt 52.94 178.73 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.814 0 N-CA-C 118.407 2.743 . . . . 0.0 118.407 174.335 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 2.1 p -74.2 159.51 83.66 Favored Pre-proline 0 C--O 1.245 0.853 0 CA-C-N 115.124 -0.943 . . . . 0.0 112.904 -177.721 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -77.05 175.89 10.82 Favored 'Trans proline' 0 C--N 1.352 0.722 0 N-CA-C 110.796 -0.502 . . . . 0.0 110.796 174.088 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 33.3 ptt-85 -132.13 163.32 28.77 Favored 'General case' 0 C--O 1.218 -0.56 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 177.99 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 56.3 m95 -122.93 150.2 43.25 Favored 'General case' 0 C--O 1.212 -0.882 0 C-N-CA 122.468 0.307 . . . . 0.0 111.224 -177.186 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.495 ' CZ ' ' HB2' ' A' ' 15' ' ' ALA . 56.1 m-85 -128.12 147.29 50.54 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 177.72 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 88.7 t80 -94.43 135.46 35.83 Favored 'General case' 0 CA--C 1.506 -0.747 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 -177.274 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -136.99 131.98 33.68 Favored 'General case' 0 N--CA 1.437 -1.096 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 -175.657 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 74.2 m-85 -70.89 159.57 34.41 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.037 -176.134 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -53.07 125.46 17.41 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.829 -178.218 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 71.57 23.32 78.18 Favored Glycine 0 C--O 1.224 -0.474 0 N-CA-C 116.309 1.284 . . . . 0.0 116.309 177.056 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 18.3 p -89.27 146.09 24.96 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 119.056 1.428 . . . . 0.0 108.842 177.402 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 99.32 133.05 7.94 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 110.167 -1.173 . . . . 0.0 110.167 -177.821 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -72.3 -31.48 11.59 Favored 'Trans proline' 0 CA--C 1.516 -0.419 0 CA-C-N 119.524 1.662 . . . . 0.0 115.389 -175.133 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -102.77 12.13 36.66 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 114.133 -1.394 . . . . 0.0 108.93 -175.869 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -60.79 -48.15 83.09 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.577 -173.966 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 55.66 36.77 65.92 Favored Glycine 0 C--N 1.33 0.21 0 CA-C-N 116.043 -0.526 . . . . 0.0 112.718 179.835 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 14.7 mt -124.78 103.92 30.79 Favored Pre-proline 0 N--CA 1.444 -0.767 0 N-CA-C 115.503 1.668 . . . . 0.0 115.503 -175.471 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -79.08 161.89 26.29 Favored 'Trans proline' 0 N--CA 1.463 -0.313 0 C-N-CA 122.517 2.145 . . . . 0.0 107.683 167.899 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 57.1 t80 -60.86 131.21 49.96 Favored 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 120.373 -0.531 . . . . 0.0 110.579 -177.411 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 92.33 -7.51 78.02 Favored Glycine 0 C--O 1.228 -0.269 0 CA-C-O 119.349 -0.695 . . . . 0.0 114.65 179.11 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -66.62 131.12 45.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 118.649 1.224 . . . . 0.0 111.336 179.503 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 56.7 t30 -78.73 129.18 34.38 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.627 -179.388 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 30.0 ttmt -156.17 153.27 28.99 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 106.492 -1.67 . . . . 0.0 106.492 179.29 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -63.48 130.82 46.01 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.051 0.453 . . . . 0.0 111.165 -178.105 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 68.5 27.64 73.68 Favored Glycine 0 N--CA 1.449 -0.483 0 CA-C-O 119.263 -0.743 . . . . 0.0 113.994 177.652 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 45.9 mm -123.28 125.57 72.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 117.487 0.644 . . . . 0.0 110.303 179.331 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -127.85 115.25 38.56 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 CA-C-O 121.575 0.702 . . . . 0.0 111.296 177.061 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 97.7 m95 -80.45 137.45 36.49 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -177.794 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -142.61 154.34 17.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 -178.962 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -157.27 166.64 32.6 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 105.695 -1.965 . . . . 0.0 105.695 -177.096 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 14.7 t -125.84 166.49 16.75 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 104.03 -2.582 . . . . 0.0 104.03 173.205 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 77.7 tt0 -67.68 137.67 55.72 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 121.108 0.48 . . . . 0.0 109.879 -178.957 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 95.45 -19.23 55.25 Favored Glycine 0 C--O 1.224 -0.521 0 CA-C-N 115.705 -0.68 . . . . 0.0 112.973 178.042 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -67.81 137.93 55.75 Favored 'General case' 0 CA--C 1.542 0.661 0 O-C-N 122.542 -0.387 . . . . 0.0 110.753 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 47.0 mt -92.21 136.55 33.1 Favored 'General case' 0 CA--C 1.514 -0.425 0 N-CA-C 113.771 1.026 . . . . 0.0 113.771 -176.349 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 63.6 t30 -80.39 61.34 4.12 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.21 -0.905 . . . . 0.0 110.939 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 2.6 t -133.12 160.93 66.73 Favored Pre-proline 0 C--N 1.322 -0.588 0 N-CA-C 104.452 -2.425 . . . . 0.0 104.452 -179.133 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_exo -64.58 152.06 83.24 Favored 'Trans proline' 0 CA--C 1.534 0.475 0 N-CA-C 116.669 1.757 . . . . 0.0 116.669 -177.298 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.491 ' HE3' ' HA ' ' A' ' 42' ' ' ASP . 0.4 OUTLIER -127.19 31.93 5.15 Favored 'General case' 0 CA--C 1.515 -0.388 0 C-N-CA 124.545 1.138 . . . . 0.0 109.416 176.784 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 15.2 p-10 -55.22 -36.89 66.46 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.285 -0.871 . . . . 0.0 109.84 179.284 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 16.7 p80 -60.8 -13.65 16.63 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 114.832 1.419 . . . . 0.0 114.832 179.377 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 10.8 mt -96.27 -23.71 4.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 121.14 0.495 . . . . 0.0 110.787 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -76.19 1.25 60.74 Favored Glycine 0 C--O 1.227 -0.303 0 N-CA-C 115.559 0.984 . . . . 0.0 115.559 -175.783 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 14.6 t -83.08 16.06 2.53 Favored 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 113.848 1.055 . . . . 0.0 113.848 -177.514 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 63.1 ttp85 -66.26 129.75 40.89 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 177.781 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -111.73 134.19 21.36 Favored Pre-proline 0 C--N 1.325 -0.491 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 179.429 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_endo -69.76 -21.55 33.31 Favored 'Trans proline' 0 C--O 1.217 -0.535 0 N-CA-C 115.314 1.236 . . . . 0.0 115.314 -174.447 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -74.81 -24.09 58.58 Favored 'General case' 0 C--O 1.22 -0.49 0 CA-C-O 121.094 0.473 . . . . 0.0 110.478 178.391 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 83.5 m-20 -97.72 -22.49 16.41 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 113.302 0.853 . . . . 0.0 113.302 -175.068 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 -157.99 150.03 21.99 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 112.0 0.371 . . . . 0.0 112.0 -178.356 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -87.27 147.47 25.52 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-O 121.575 0.702 . . . . 0.0 112.182 179.751 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -72.73 147.92 45.15 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.27 178.13 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 15.0 mt -91.42 139.43 17.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.226 -178.156 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 73.9 t -60.13 125.41 16.2 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 N-CA-C 106.572 -1.64 . . . . 0.0 106.572 175.084 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 6.4 tt -66.6 129.19 39.04 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.101 0.477 . . . . 0.0 110.168 -177.324 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 31.0 mt-30 -131.26 156.66 45.03 Favored 'General case' 0 CA--C 1.511 -0.534 0 N-CA-C 107.062 -1.459 . . . . 0.0 107.062 -178.886 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.426 HD13 HG22 ' A' ' 125' ' ' THR . 14.4 mt -113.25 148.07 38.75 Favored Pre-proline 0 C--N 1.321 -0.631 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 178.438 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -72.06 167.5 26.58 Favored 'Trans proline' 0 C--N 1.345 0.392 0 O-C-N 122.229 0.594 . . . . 0.0 112.969 -179.335 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -55.56 133.48 50.35 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.814 -179.498 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 91.91 -14.75 63.48 Favored Glycine 0 C--O 1.227 -0.332 0 CA-C-N 116.05 -0.523 . . . . 0.0 113.368 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.426 HG22 HD13 ' A' ' 121' ' ' LEU . 16.7 m -105.95 126.94 52.79 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 117.841 0.82 . . . . 0.0 110.309 179.012 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 6.9 p -118.51 148.24 42.83 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.78 -178.268 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 84.9 mt -69.94 153.61 95.31 Favored Pre-proline 0 C--N 1.325 -0.472 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 177.661 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -76.15 173.48 14.42 Favored 'Trans proline' 0 C--O 1.235 0.345 0 N-CA-C 110.531 -0.604 . . . . 0.0 110.531 178.624 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 8.2 tmtt? -53.83 126.61 22.84 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.21 0.528 . . . . 0.0 112.224 -175.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 85.29 -1.55 88.52 Favored Glycine 0 N--CA 1.454 -0.144 0 N-CA-C 116.861 1.504 . . . . 0.0 116.861 173.743 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.419 ' CZ ' ' HB2' ' A' ' 18' ' ' GLN . 1.5 m-85 -94.71 141.26 28.82 Favored 'General case' 0 N--CA 1.436 -1.167 0 CA-C-O 122.069 0.938 . . . . 0.0 110.436 -179.209 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 42.8 p90 -142.08 161.47 37.92 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 113.639 -1.618 . . . . 0.0 108.351 176.923 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -103.0 143.74 32.18 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.345 0.593 . . . . 0.0 111.705 -176.842 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -70.68 135.3 48.22 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 179.693 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 81.89 -9.69 55.43 Favored Glycine 0 CA--C 1.52 0.365 0 CA-C-N 116.118 -0.492 . . . . 0.0 114.095 -178.75 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 28.8 t -86.66 122.46 30.6 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 117.926 0.863 . . . . 0.0 110.51 -179.534 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 26.2 mmt180 -96.85 -21.46 17.49 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.767 177.355 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 81.18 -44.68 3.08 Favored Glycine 0 C--O 1.225 -0.449 0 C-N-CA 121.71 -0.281 . . . . 0.0 112.974 -178.125 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -168.0 -167.86 29.27 Favored Glycine 0 N--CA 1.451 -0.34 0 N-CA-C 107.487 -2.245 . . . . 0.0 107.487 179.299 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 47.2 t . . . . . 0 C--O 1.245 0.827 0 N-CA-C 105.097 -2.186 . . . . 0.0 105.097 179.01 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.177 0 CA-C-O 118.265 -1.297 . . . . 0.0 111.299 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 50.76 36.5 14.51 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 115.771 1.767 . . . . 0.0 115.771 176.901 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 26.9 ptt? -81.79 15.43 2.2 Favored 'General case' 0 N--CA 1.473 0.69 0 O-C-N 121.74 -0.6 . . . . 0.0 112.507 -179.409 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -115.71 43.14 1.73 Allowed Glycine 0 C--O 1.223 -0.538 0 N-CA-C 111.708 -0.557 . . . . 0.0 111.708 -178.362 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 89.6 mt -64.17 147.41 96.81 Favored Pre-proline 0 CA--C 1.539 0.539 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 -179.755 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -76.24 51.22 3.12 Favored 'Trans proline' 0 CA--C 1.546 1.104 0 C-N-CA 122.454 2.102 . . . . 0.0 114.712 -177.961 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 44.2 t30 -102.54 87.02 2.9 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.478 0.656 . . . . 0.0 109.857 -178.463 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 16.9 m-80 -67.15 -23.43 65.79 Favored 'General case' 0 C--O 1.216 -0.666 0 N-CA-C 116.581 2.067 . . . . 0.0 116.581 -178.788 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 40.6 p -37.24 94.88 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 125.809 1.644 . . . . 0.0 114.827 -174.938 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -109.27 146.18 34.7 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 113.114 -1.857 . . . . 0.0 113.157 -173.523 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 32.9 p -62.21 140.91 58.44 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 114.853 -1.067 . . . . 0.0 109.982 178.803 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' TRP . . . . . 0.405 ' CD2' ' HD3' ' A' ' 109' ' ' ARG . 17.4 m95 -67.62 -21.81 65.37 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 113.795 1.035 . . . . 0.0 113.795 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 36.8 m-85 -121.55 160.87 23.39 Favored 'General case' 0 CA--C 1.509 -0.621 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 -172.598 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 67.7 p -69.47 162.03 28.26 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 178.836 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.445 ' HB2' ' CZ ' ' A' ' 69' ' ' TYR . . . -78.31 147.12 34.38 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 114.084 1.142 . . . . 0.0 114.084 -175.726 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 27.1 mt -89.02 148.88 23.52 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 105.149 -2.167 . . . . 0.0 105.149 170.634 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.6 m -122.97 144.85 48.97 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 179.473 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 3.8 tp60 -109.99 154.79 22.67 Favored 'General case' 0 C--N 1.328 -0.339 0 O-C-N 123.762 0.664 . . . . 0.0 110.742 -176.283 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 67.9 t60 -139.34 99.51 3.76 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 105.588 -2.004 . . . . 0.0 105.588 170.086 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 163.09 -171.63 38.9 Favored Glycine 0 N--CA 1.452 -0.239 0 N-CA-C 110.653 -0.979 . . . . 0.0 110.653 -177.778 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -99.56 -22.52 15.43 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 112.477 0.547 . . . . 0.0 112.477 179.672 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -83.44 161.99 21.12 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.963 -178.168 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -75.55 -62.94 1.4 Allowed 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 114.539 1.311 . . . . 0.0 114.539 -175.894 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 32.2 tp 157.23 144.84 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.283 0 N-CA-C 104.935 -2.246 . . . . 0.0 104.935 -175.56 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 56.1 tptt -156.02 141.39 17.61 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 108.779 -0.822 . . . . 0.0 108.779 173.009 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 15.1 m-85 -122.97 150.7 59.77 Favored Pre-proline 0 C--O 1.242 0.699 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 175.923 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -74.22 163.21 37.04 Favored 'Trans proline' 0 C--N 1.352 0.752 0 C-N-CA 120.88 1.053 . . . . 0.0 113.383 179.467 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 4.1 tmt_? -65.36 133.71 51.95 Favored 'General case' 0 N--CA 1.473 0.707 0 O-C-N 122.045 -0.409 . . . . 0.0 110.493 -178.484 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 88.12 1.34 82.0 Favored Glycine 0 C--O 1.228 -0.235 0 N-CA-C 111.912 -0.475 . . . . 0.0 111.912 178.614 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 38.0 mt-30 -141.83 171.65 13.77 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 123.455 0.702 . . . . 0.0 110.4 -174.981 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 107.06 -25.26 22.78 Favored Glycine 0 CA--C 1.497 -1.049 0 CA-C-N 115.54 -0.754 . . . . 0.0 111.937 175.176 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 95.7 t -63.72 127.4 91.47 Favored Pre-proline 0 C--N 1.318 -0.779 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 177.736 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -73.46 171.58 17.42 Favored 'Trans proline' 0 N--CA 1.462 -0.351 0 O-C-N 122.142 0.548 . . . . 0.0 111.385 178.189 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 86.1 mt -69.81 107.02 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-O 121.963 0.887 . . . . 0.0 108.892 -179.874 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 75.3 m-20 -99.96 84.82 2.94 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 114.626 -1.17 . . . . 0.0 109.9 -177.36 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 69.6 p -67.06 -15.74 63.91 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 112.94 0.719 . . . . 0.0 112.94 -178.631 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 12.3 p30 -107.13 22.77 15.47 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.375 -0.83 . . . . 0.0 112.382 -177.833 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 15.0 m -140.5 148.89 41.77 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 113.787 1.032 . . . . 0.0 113.787 -176.525 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -74.37 167.35 36.73 Favored Pre-proline 0 N--CA 1.468 0.447 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 177.194 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -64.93 -28.48 58.27 Favored 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 114.663 -3.091 . . . . 0.0 111.827 178.309 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -62.11 -24.31 67.06 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 123.883 0.873 . . . . 0.0 111.658 176.743 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 71.6 m-20 -98.41 -2.57 38.81 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 114.957 1.466 . . . . 0.0 114.957 -172.183 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 94.5 mm-40 -60.77 -28.94 69.11 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 114.543 1.312 . . . . 0.0 114.543 -178.21 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 12.9 tt -60.07 139.31 19.78 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.846 0 CA-C-O 122.358 1.075 . . . . 0.0 113.339 -177.677 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -177.94 -155.96 15.38 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.84 -0.695 . . . . 0.0 111.903 -178.478 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 49.8 p90 -155.05 168.59 26.51 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 178.665 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 22.5 m-85 -108.99 141.35 41.22 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 172.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 51.7 ttt180 -115.0 120.54 40.23 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 114.917 -1.038 . . . . 0.0 111.919 -174.902 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 38.9 ttp180 -68.47 134.7 50.52 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 176.159 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -150.79 151.11 31.85 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.159 0.504 . . . . 0.0 111.494 -178.393 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 14.3 t -158.9 164.98 35.18 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 174.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 14.3 tpt180 -149.83 123.83 9.38 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 105.367 -2.086 . . . . 0.0 105.367 177.921 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 4.6 tmm_? -88.9 128.01 35.66 Favored 'General case' 0 CA--C 1.498 -1.054 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 -179.21 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -128.6 169.83 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.107 0 N-CA-C 105.725 -1.954 . . . . 0.0 105.725 179.032 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 1.1 ttt-85 -144.04 110.72 5.62 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 176.131 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -71.17 160.88 54.13 Favored Glycine 0 N--CA 1.449 -0.443 0 N-CA-C 107.891 -2.084 . . . . 0.0 107.891 176.492 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -69.94 -33.8 70.61 Favored Glycine 0 C--O 1.222 -0.596 0 N-CA-C 109.899 -1.28 . . . . 0.0 109.899 -178.106 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.2 t0 -73.12 3.54 5.45 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 114.133 -1.033 . . . . 0.0 111.831 179.422 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 96.6 -9.12 66.53 Favored Glycine 0 C--O 1.226 -0.353 0 CA-C-N 115.725 -0.67 . . . . 0.0 114.5 175.48 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.49 106.7 4.68 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.759 0.79 . . . . 0.0 111.751 -178.185 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 18.6 mtp -88.8 -179.98 6.1 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 114.783 -1.099 . . . . 0.0 109.124 179.313 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 23.9 tptp -73.88 -59.5 2.69 Favored 'General case' 0 CA--C 1.51 -0.58 0 C-N-CA 120.603 -0.439 . . . . 0.0 111.409 -179.609 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 47.02 -161.53 0.03 OUTLIER 'General case' 0 C--O 1.25 1.082 0 O-C-N 125.358 1.661 . . . . 0.0 115.256 -179.339 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 82.2 mt 53.48 -176.66 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 116.489 2.033 . . . . 0.0 116.489 178.711 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 24.3 m -65.04 154.01 87.65 Favored Pre-proline 0 C--O 1.24 0.596 0 CA-C-N 115.182 -0.917 . . . . 0.0 112.336 -177.303 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -73.8 175.5 10.69 Favored 'Trans proline' 0 C--N 1.348 0.506 0 CA-C-O 122.015 0.756 . . . . 0.0 113.72 -179.353 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 1.2 mmt180 -106.55 159.99 15.76 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 114.897 -1.047 . . . . 0.0 108.294 -178.817 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 73.2 m95 -128.3 125.02 37.96 Favored 'General case' 0 C--O 1.215 -0.748 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 176.252 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.445 ' CZ ' ' HB2' ' A' ' 15' ' ' ALA . 33.9 m-85 -110.99 156.54 21.09 Favored 'General case' 0 C--O 1.213 -0.849 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 -178.727 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 81.2 t80 -101.76 135.31 43.5 Favored 'General case' 0 CA--C 1.51 -0.596 0 CA-C-N 119.204 0.911 . . . . 0.0 108.94 -179.297 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -136.92 147.46 46.41 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 -176.583 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 84.3 m-85 -82.5 159.43 22.86 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.069 -176.709 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -54.67 130.26 39.71 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.991 0.424 . . . . 0.0 111.066 -179.28 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 73.54 26.23 70.41 Favored Glycine 0 C--O 1.219 -0.837 0 N-CA-C 116.107 1.203 . . . . 0.0 116.107 176.63 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 5.3 p -89.14 146.16 24.97 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 118.775 1.287 . . . . 0.0 109.724 178.13 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 105.89 139.73 9.75 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 107.395 -2.282 . . . . 0.0 107.395 -175.489 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -67.24 -42.91 6.93 Favored 'Trans proline' 0 C--N 1.346 0.424 0 CA-C-N 119.915 1.858 . . . . 0.0 116.126 -172.724 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -114.78 39.1 2.94 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 -177.827 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -66.83 -47.38 72.17 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.967 -178.055 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 57.52 23.93 50.76 Favored Glycine 0 CA--C 1.521 0.464 0 N-CA-C 114.439 0.536 . . . . 0.0 114.439 179.377 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 42.9 mt -102.57 109.72 61.43 Favored Pre-proline 0 C--O 1.238 0.452 0 N-CA-C 115.318 1.599 . . . . 0.0 115.318 -175.6 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -76.97 166.14 27.25 Favored 'Trans proline' 0 C--O 1.237 0.427 0 N-CA-C 108.669 -1.32 . . . . 0.0 108.669 170.144 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.417 ' CE1' ' HB3' ' A' ' 92' ' ' TRP . 62.5 t80 -62.8 133.68 55.12 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 120.491 -0.484 . . . . 0.0 110.069 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 90.37 -5.45 82.7 Favored Glycine 0 CA--C 1.519 0.317 0 N-CA-C 114.489 0.556 . . . . 0.0 114.489 178.815 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -63.08 132.33 51.54 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 117.901 0.85 . . . . 0.0 112.22 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 51.5 t30 -74.52 126.26 30.39 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.903 -0.59 . . . . 0.0 112.094 -178.809 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 15.2 ttmm -156.14 149.86 24.96 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 176.799 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -63.63 132.79 52.26 Favored 'General case' 0 C--N 1.321 -0.64 0 O-C-N 123.251 0.345 . . . . 0.0 110.802 -179.646 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 66.87 28.41 73.77 Favored Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 121.037 -0.602 . . . . 0.0 114.481 177.328 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 40.9 mm -127.5 126.43 67.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 117.302 0.551 . . . . 0.0 109.993 179.41 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.1 pt -128.13 115.15 37.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 121.812 0.815 . . . . 0.0 110.889 176.307 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' TRP . . . . . 0.417 ' HB3' ' CE1' ' A' ' 83' ' ' TYR . 95.8 m95 -79.03 135.73 36.97 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.983 -0.553 . . . . 0.0 112.34 -177.886 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 17.0 m -137.3 149.72 25.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.566 0.698 . . . . 0.0 109.534 179.72 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -157.59 166.6 32.44 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 104.333 -2.469 . . . . 0.0 104.333 -178.863 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 6.6 t -138.21 177.04 8.17 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 106.037 -1.838 . . . . 0.0 106.037 177.971 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -67.61 135.08 52.32 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.056 0.455 . . . . 0.0 110.51 -178.255 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 96.02 -8.29 67.59 Favored Glycine 0 C--O 1.224 -0.52 0 CA-C-N 115.938 -0.574 . . . . 0.0 113.514 178.688 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -81.22 139.23 35.62 Favored 'General case' 0 C--N 1.324 -0.541 0 O-C-N 122.443 -0.446 . . . . 0.0 111.456 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 47.3 mt -90.04 138.7 31.29 Favored 'General case' 0 CA--C 1.512 -0.495 0 CA-C-O 120.805 0.336 . . . . 0.0 111.284 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 62.4 t30 -83.42 68.13 9.6 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.992 0.425 . . . . 0.0 110.743 179.806 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 1.1 t -141.67 151.71 60.96 Favored Pre-proline 0 C--O 1.24 0.566 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 -178.937 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -66.24 153.15 79.18 Favored 'Trans proline' 0 C--N 1.345 0.39 0 N-CA-C 113.645 0.594 . . . . 0.0 113.645 176.597 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 1.4 ptpm? -152.25 56.49 0.83 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 122.502 1.144 . . . . 0.0 110.809 -179.235 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -59.66 -27.13 66.12 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 114.535 -1.211 . . . . 0.0 111.443 179.35 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 12.7 p80 -59.71 -12.4 6.97 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 114.029 1.122 . . . . 0.0 114.029 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 55.3 mt -91.94 -43.07 13.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 177.367 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -77.12 11.45 15.92 Favored Glycine 0 C--O 1.224 -0.495 0 N-CA-C 114.825 0.69 . . . . 0.0 114.825 -177.934 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 6.6 t -83.2 17.84 1.91 Allowed 'General case' 0 CA--C 1.545 0.778 0 CA-C-O 122.214 1.007 . . . . 0.0 110.416 178.782 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.442 ' HD2' ' OD1' ' A' ' 114' ' ' ASN . 62.7 ttp85 -59.32 131.46 51.06 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.786 -179.912 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 10.2 m-20 -100.22 122.04 51.58 Favored Pre-proline 0 C--N 1.326 -0.444 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -71.06 -15.06 32.3 Favored 'Trans proline' 0 C--O 1.218 -0.485 0 N-CA-C 113.672 0.604 . . . . 0.0 113.672 -177.74 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -76.16 -24.38 54.82 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.853 0.359 . . . . 0.0 110.912 177.628 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -101.47 -26.09 13.69 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 113.499 0.926 . . . . 0.0 113.499 -175.5 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' ASN . . . . . 0.442 ' OD1' ' HD2' ' A' ' 109' ' ' ARG . 0.4 OUTLIER -142.77 153.64 43.46 Favored 'General case' 0 N--CA 1.437 -1.119 0 CA-C-O 121.031 0.443 . . . . 0.0 111.428 -176.694 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -99.23 142.22 30.99 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.626 177.082 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -69.23 150.07 47.85 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.403 0.62 . . . . 0.0 112.17 -179.08 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 6.8 mt -86.14 138.42 19.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.382 -0.826 . . . . 0.0 109.23 -178.591 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 97.1 t -60.73 124.08 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 N-CA-C 106.754 -1.573 . . . . 0.0 106.754 176.064 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 6.7 tt -66.5 130.6 43.74 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.226 0.536 . . . . 0.0 111.372 -175.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 28.7 mt-30 -131.82 156.77 45.46 Favored 'General case' 0 CA--C 1.514 -0.43 0 N-CA-C 106.827 -1.545 . . . . 0.0 106.827 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 13.9 mt -113.12 147.4 37.21 Favored Pre-proline 0 C--N 1.323 -0.559 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 178.151 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -74.76 169.67 22.06 Favored 'Trans proline' 0 C--N 1.345 0.374 0 O-C-N 122.224 0.592 . . . . 0.0 113.465 -179.384 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 36.8 tt0 -54.25 131.34 41.39 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.317 178.857 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 99.78 -22.47 40.23 Favored Glycine 0 C--O 1.227 -0.321 0 CA-C-O 119.439 -0.645 . . . . 0.0 113.474 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 5.7 m -108.75 129.29 55.37 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 118.461 1.13 . . . . 0.0 111.179 179.071 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 7.1 p -123.34 149.16 45.24 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.793 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 96.7 mt -71.48 151.09 93.93 Favored Pre-proline 0 C--N 1.324 -0.522 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 178.448 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -79.11 178.25 7.72 Favored 'Trans proline' 0 CA--C 1.531 0.361 0 C-N-CA 120.33 0.686 . . . . 0.0 112.296 179.31 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 64.4 tttp -57.17 129.95 44.02 Favored 'General case' 0 C--O 1.219 -0.504 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.224 -178.933 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 87.18 -1.98 86.61 Favored Glycine 0 C--O 1.226 -0.379 0 N-CA-C 115.425 0.93 . . . . 0.0 115.425 175.76 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -101.1 137.11 39.9 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-O 121.883 0.849 . . . . 0.0 112.433 -178.136 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 48.4 p90 -145.4 164.44 31.51 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 114.343 -1.299 . . . . 0.0 108.735 176.564 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -104.84 144.89 31.15 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 -176.246 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -71.62 136.23 47.27 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 177.804 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 94.06 -8.96 73.0 Favored Glycine 0 C--O 1.225 -0.445 0 C-N-CA 121.425 -0.417 . . . . 0.0 112.297 178.859 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 32.8 t -112.29 142.93 44.19 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 110.305 -0.257 . . . . 0.0 110.305 178.018 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER 52.29 63.84 2.08 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 113.722 1.008 . . . . 0.0 113.722 176.982 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -162.56 171.46 38.41 Favored Glycine 0 C--O 1.225 -0.442 0 N-CA-C 107.012 -2.435 . . . . 0.0 107.012 177.276 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 80.02 34.11 31.16 Favored Glycine 0 C--O 1.227 -0.298 0 CA-C-N 118.266 1.033 . . . . 0.0 112.636 179.864 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 78.7 p . . . . . 0 C--O 1.256 1.412 0 CA-C-O 115.273 -2.299 . . . . 0.0 106.433 -178.997 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.706 0 CA-C-O 118.693 -1.059 . . . . 0.0 111.122 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -68.75 147.7 51.41 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 117.989 0.894 . . . . 0.0 110.945 -179.406 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 26.6 ttt -157.17 138.74 13.98 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 105.217 -2.142 . . . . 0.0 105.217 177.041 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 136.27 -66.57 0.55 Allowed Glycine 0 C--O 1.227 -0.325 0 C-N-CA 121.199 -0.524 . . . . 0.0 112.958 178.227 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 9.5 mp -67.74 139.21 93.54 Favored Pre-proline 0 C--N 1.326 -0.447 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 -178.867 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -79.79 138.3 13.21 Favored 'Trans proline' 0 CA--C 1.533 0.441 0 C-N-CA 118.446 -0.569 . . . . 0.0 112.317 176.873 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 49.1 t30 -79.8 -20.53 45.93 Favored 'General case' 0 C--O 1.219 -0.514 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 175.884 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 59.7 t30 60.4 49.38 6.93 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.94 1.296 . . . . 0.0 112.058 178.131 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 69.0 p -140.12 131.09 26.15 Favored 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 -177.539 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -134.07 135.75 43.5 Favored 'General case' 0 C--N 1.312 -1.038 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 174.735 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 34.7 p -66.84 141.74 57.57 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 -178.291 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' TRP . . . . . 0.407 ' CD2' ' HD3' ' A' ' 109' ' ' ARG . 20.6 m95 -67.07 -26.95 66.99 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 178.597 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 24.9 m-85 -121.38 164.89 16.35 Favored 'General case' 0 C--O 1.241 0.633 0 N-CA-C 113.74 1.015 . . . . 0.0 113.74 -171.837 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 56.1 p -68.23 167.97 13.23 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 114.609 -1.178 . . . . 0.0 110.204 179.045 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.489 ' HB2' ' CZ ' ' A' ' 69' ' ' TYR . . . -81.61 142.35 32.86 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 114.531 1.308 . . . . 0.0 114.531 -174.845 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 25.3 mt -84.42 146.8 27.46 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 102.55 -3.13 . . . . 0.0 102.55 167.554 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 29.8 m -130.12 141.28 50.7 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 -178.182 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.402 ' HB2' ' CZ ' ' A' ' 131' ' ' PHE . 4.3 tp60 -109.64 140.42 43.5 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 -176.181 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 53.6 t60 -131.07 99.93 5.05 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 104.054 -2.573 . . . . 0.0 104.054 168.846 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 163.97 -162.93 35.57 Favored Glycine 0 C--O 1.227 -0.301 0 N-CA-C 108.252 -1.939 . . . . 0.0 108.252 -175.907 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 90.2 mttt -111.36 -22.17 11.47 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 115.207 1.558 . . . . 0.0 115.207 -178.986 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -75.2 158.95 32.17 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 106.602 -1.629 . . . . 0.0 106.602 174.757 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -83.59 -62.12 1.66 Allowed 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 120.545 -0.462 . . . . 0.0 110.851 -178.726 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 41.5 tp -175.08 150.83 1.23 Allowed 'General case' 0 N--CA 1.481 1.094 0 N-CA-C 105.637 -1.986 . . . . 0.0 105.637 173.53 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -158.11 134.61 9.59 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 178.113 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -129.35 148.65 70.09 Favored Pre-proline 0 C--N 1.323 -0.551 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 173.693 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -72.63 155.74 54.21 Favored 'Trans proline' 0 C--N 1.35 0.654 0 O-C-N 122.194 0.576 . . . . 0.0 112.703 178.082 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 17.3 tpt180 -67.56 137.76 55.96 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 -179.23 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 89.26 0.67 79.88 Favored Glycine 0 C--O 1.222 -0.612 0 N-CA-C 110.684 -0.967 . . . . 0.0 110.684 179.501 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 30.8 mt-30 -146.71 -179.62 6.91 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 -174.793 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 99.96 -27.06 22.06 Favored Glycine 0 CA--C 1.5 -0.906 0 CA-C-N 116.241 -0.436 . . . . 0.0 112.219 175.325 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 71.9 t -63.32 128.52 92.58 Favored Pre-proline 0 C--N 1.319 -0.736 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 177.062 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -74.74 168.39 24.94 Favored 'Trans proline' 0 N--CA 1.458 -0.575 0 O-C-N 122.165 0.56 . . . . 0.0 110.86 178.557 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 97.4 mt -68.01 116.92 8.83 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 69.2 m-80 -105.06 98.38 8.1 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.448 -179.455 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 67.6 p -73.4 -22.18 60.31 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.19 0.519 . . . . 0.0 111.683 -179.192 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 71.2 m-80 -111.12 36.85 3.02 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.496 -0.774 . . . . 0.0 112.682 -177.64 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 17.5 m -144.59 146.96 32.59 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 179.313 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -72.26 166.39 41.89 Favored Pre-proline 0 C--N 1.327 -0.405 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 176.943 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -64.79 -27.03 59.76 Favored 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 115.198 -2.735 . . . . 0.0 111.86 178.756 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -62.22 -29.07 70.13 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.662 0.744 . . . . 0.0 111.17 176.377 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 76.6 m-20 -96.29 0.8 51.34 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 115.288 1.588 . . . . 0.0 115.288 -170.628 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 94.7 mm-40 -61.58 -27.12 68.41 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 121.345 0.593 . . . . 0.0 112.478 178.845 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.402 ' HB ' ' HB1' ' A' ' 98' ' ' ALA . 19.5 tt -57.52 138.67 18.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-O 122.236 1.017 . . . . 0.0 113.712 -179.325 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -177.82 -158.74 21.39 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.274 -0.965 . . . . 0.0 113.158 -179.47 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 38.2 p90 -155.04 169.12 24.84 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 107.721 -1.214 . . . . 0.0 107.721 179.291 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 29.1 m-85 -113.63 141.42 47.23 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 106.784 -1.562 . . . . 0.0 106.784 173.879 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 44.4 ttt-85 -112.21 131.71 55.33 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.826 -0.624 . . . . 0.0 112.231 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 39.2 ttt-85 -65.39 142.44 58.2 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.437 176.134 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -147.98 166.13 28.66 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 177.52 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 6.3 t -152.37 162.46 41.14 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 -177.942 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 10.1 ttm180 -90.72 123.88 34.66 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 104.619 -2.363 . . . . 0.0 104.619 176.032 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 8.3 tmm_? -148.25 144.65 27.8 Favored 'General case' 0 CA--C 1.508 -0.665 0 CA-C-O 121.105 0.479 . . . . 0.0 111.633 -172.321 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.463 HD12 ' HB2' ' A' ' 62' ' ' LYS . 0.0 OUTLIER -126.68 -179.68 2.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 -178.61 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -117.37 104.32 11.0 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 171.598 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -71.84 165.02 54.07 Favored Glycine 0 C--O 1.222 -0.625 0 N-CA-C 108.189 -1.964 . . . . 0.0 108.189 178.68 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -61.15 -42.45 99.79 Favored Glycine 0 C--O 1.217 -0.935 0 CA-C-N 118.483 1.142 . . . . 0.0 112.131 -179.256 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 41.2 t0 -95.67 16.94 15.99 Favored 'General case' 0 CA--C 1.549 0.923 0 CA-C-O 122.912 1.339 . . . . 0.0 110.39 179.434 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 86.01 6.86 81.55 Favored Glycine 0 C--O 1.226 -0.384 0 CA-C-N 114.769 -1.105 . . . . 0.0 113.833 172.759 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 23.9 mmtt -69.49 142.48 53.72 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 122.235 1.017 . . . . 0.0 112.472 -173.969 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 5.1 mmt -93.82 172.42 8.26 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 113.135 -1.848 . . . . 0.0 113.961 -175.748 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.463 ' HB2' HD12 ' A' ' 54' ' ' ILE . 12.2 tptt -124.34 -41.74 2.16 Favored 'General case' 0 CA--C 1.491 -1.311 0 CA-C-N 114.811 -1.086 . . . . 0.0 108.896 173.351 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 26.56 86.27 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.872 0 O-C-N 126.814 2.571 . . . . 0.0 116.315 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -75.89 173.01 11.74 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 114.141 -1.39 . . . . 0.0 108.904 -179.695 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 5.7 m -46.13 140.07 5.29 Favored Pre-proline 0 C--O 1.244 0.814 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 -179.141 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -68.14 148.36 74.89 Favored 'Trans proline' 0 C--O 1.24 0.598 0 C-N-CA 116.73 -1.713 . . . . 0.0 114.191 -175.687 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 26.0 mtp180 -124.96 162.15 25.1 Favored 'General case' 0 CA--C 1.501 -0.941 0 N-CA-C 106.692 -1.595 . . . . 0.0 106.692 177.401 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 62.4 m95 -132.72 133.51 43.59 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 179.256 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.489 ' CZ ' ' HB2' ' A' ' 15' ' ' ALA . 80.5 m-85 -116.59 146.42 42.68 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 -178.872 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 82.9 t80 -94.85 134.04 37.93 Favored 'General case' 0 CA--C 1.509 -0.628 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 -175.929 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 11.5 m-85 -137.33 152.96 50.29 Favored 'General case' 0 N--CA 1.439 -0.988 0 N-CA-C 106.674 -1.602 . . . . 0.0 106.674 -175.69 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -91.96 159.38 15.77 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 112.338 0.495 . . . . 0.0 112.338 -173.709 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 15.2 tp -57.13 127.13 30.41 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.38 0.61 . . . . 0.0 110.088 179.749 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 71.04 28.66 70.04 Favored Glycine 0 N--CA 1.45 -0.422 0 N-CA-C 116.848 1.499 . . . . 0.0 116.848 175.435 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.421 ' HA ' ' HA ' ' A' ' 104' ' ' ASP . 24.0 p -89.42 146.12 24.87 Favored 'General case' 0 CA--C 1.508 -0.635 0 CA-C-N 119.487 1.644 . . . . 0.0 109.079 175.379 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 89.32 138.56 6.82 Favored Glycine 0 CA--C 1.527 0.812 0 O-C-N 123.822 0.701 . . . . 0.0 112.295 -178.306 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -70.87 -38.65 5.12 Favored 'Trans proline' 0 C--N 1.346 0.415 0 N-CA-C 116.977 1.876 . . . . 0.0 116.977 -176.007 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -102.3 17.77 22.63 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 -174.293 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -61.19 -41.53 96.99 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 115.375 -0.829 . . . . 0.0 111.776 -175.289 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 55.1 43.57 83.43 Favored Glycine 0 CA--C 1.518 0.219 0 CA-C-N 115.552 -0.749 . . . . 0.0 114.492 178.291 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 12.4 mt -132.66 103.88 13.27 Favored Pre-proline 0 N--CA 1.436 -1.139 0 N-CA-C 114.404 1.261 . . . . 0.0 114.404 -178.537 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -78.29 161.7 28.74 Favored 'Trans proline' 0 N--CA 1.461 -0.404 0 C-N-CA 122.168 1.912 . . . . 0.0 107.3 167.978 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 55.0 t80 -61.19 131.93 52.04 Favored 'General case' 0 C--N 1.32 -0.678 0 C-N-CA 120.274 -0.57 . . . . 0.0 110.257 -177.926 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 91.6 -6.73 80.18 Favored Glycine 0 C--O 1.227 -0.298 0 CA-C-O 119.407 -0.663 . . . . 0.0 114.622 179.277 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -68.6 130.76 43.8 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 118.647 1.224 . . . . 0.0 111.714 179.731 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 56.0 t30 -78.17 130.99 37.0 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.337 179.675 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 26.1 ttmt -156.18 155.81 33.11 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 106.983 -1.488 . . . . 0.0 106.983 -179.28 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 15.2 t0 -56.41 121.37 9.43 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.261 0.553 . . . . 0.0 111.719 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 68.58 33.4 76.44 Favored Glycine 0 N--CA 1.448 -0.536 0 CA-C-O 118.975 -0.903 . . . . 0.0 114.971 177.157 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 41.3 mm -125.66 129.46 72.68 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 CA-C-N 118.079 0.939 . . . . 0.0 112.091 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -130.34 125.24 59.19 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.841 174.277 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 96.9 m95 -90.94 138.28 31.72 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 113.631 0.975 . . . . 0.0 113.631 -176.353 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 13.9 m -138.87 149.66 23.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.547 0.689 . . . . 0.0 109.445 178.844 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -160.82 164.75 31.17 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 105.058 -2.201 . . . . 0.0 105.058 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 14.8 t -130.35 168.9 16.19 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 105.091 -2.188 . . . . 0.0 105.091 178.197 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -67.4 137.49 55.98 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 -179.284 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 97.76 -12.73 64.3 Favored Glycine 0 C--O 1.225 -0.416 0 CA-C-N 115.832 -0.622 . . . . 0.0 112.145 179.352 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.402 ' HB1' ' HB ' ' A' ' 44' ' ' ILE . . . -79.65 136.77 36.9 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 178.839 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 44.1 mt -87.15 138.05 31.82 Favored 'General case' 0 CA--C 1.512 -0.512 0 CA-C-O 121.43 0.633 . . . . 0.0 112.288 -177.279 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 60.3 t30 -84.46 66.95 9.72 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.849 -179.462 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -142.46 156.45 63.69 Favored Pre-proline 0 C--N 1.322 -0.629 0 N-CA-C 107.078 -1.453 . . . . 0.0 107.078 -178.316 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -70.93 153.69 63.42 Favored 'Trans proline' 0 CA--C 1.531 0.329 0 N-CA-C 114.227 0.818 . . . . 0.0 114.227 178.401 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -145.92 60.66 1.25 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 123.103 1.43 . . . . 0.0 111.356 178.877 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' ASP . . . . . 0.421 ' HA ' ' HA ' ' A' ' 75' ' ' THR . 16.7 p-10 -53.38 -39.48 64.25 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 113.229 -1.805 . . . . 0.0 112.789 178.024 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 48.2 p-80 -62.22 -8.21 5.34 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 115.071 1.508 . . . . 0.0 115.071 -178.116 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 57.9 mt -95.77 -45.32 13.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 177.683 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -74.19 -1.17 59.5 Favored Glycine 0 C--O 1.223 -0.543 0 N-CA-C 115.53 0.972 . . . . 0.0 115.53 -177.193 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 13.3 t -83.29 21.13 1.17 Allowed 'General case' 0 CA--C 1.542 0.672 0 CA-C-O 121.757 0.789 . . . . 0.0 111.542 -178.597 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.441 ' HD2' ' OD1' ' A' ' 114' ' ' ASN . 65.4 ttp85 -52.77 131.92 35.76 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.145 178.658 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 36.4 m120 -88.37 117.44 68.39 Favored Pre-proline 0 C--N 1.323 -0.549 0 N-CA-C 107.718 -1.215 . . . . 0.0 107.718 179.631 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -72.4 -13.39 27.84 Favored 'Trans proline' 0 C--O 1.216 -0.583 0 C-N-CA 117.243 -1.372 . . . . 0.0 112.817 -179.051 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -78.49 -26.93 46.12 Favored 'General case' 0 C--O 1.219 -0.506 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.638 177.3 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 -102.21 -24.86 13.87 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 113.203 0.816 . . . . 0.0 113.203 -174.795 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' ASN . . . . . 0.441 ' OD1' ' HD2' ' A' ' 109' ' ' ARG . 5.6 t-20 -128.7 147.2 50.74 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 113.508 0.929 . . . . 0.0 113.508 -178.229 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -95.93 129.92 43.05 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 107.686 -1.228 . . . . 0.0 107.686 173.896 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -64.65 151.51 44.7 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.441 -0.8 . . . . 0.0 112.28 -178.9 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 4.0 mt -89.83 144.11 9.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.288 -0.869 . . . . 0.0 109.692 -177.508 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 72.5 t -60.8 124.54 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 175.111 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 6.7 tt -69.07 128.07 35.36 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.181 0.515 . . . . 0.0 109.736 -178.577 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 33.0 mt-30 -133.4 157.87 44.46 Favored 'General case' 0 CA--C 1.511 -0.526 0 N-CA-C 106.785 -1.561 . . . . 0.0 106.785 -178.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 13.4 mt -112.88 148.05 38.52 Favored Pre-proline 0 C--N 1.32 -0.688 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 178.022 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -73.97 167.54 26.97 Favored 'Trans proline' 0 C--O 1.237 0.459 0 O-C-N 122.291 0.627 . . . . 0.0 112.837 179.376 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 60.8 tt0 -54.46 134.04 45.94 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.265 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 100.42 -28.19 16.94 Favored Glycine 0 C--O 1.227 -0.315 0 CA-C-N 115.944 -0.571 . . . . 0.0 112.867 -179.297 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 4.1 m -100.04 128.87 46.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 118.4 1.1 . . . . 0.0 112.116 179.451 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 3.2 p -120.35 148.11 44.17 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.188 178.695 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 90.3 mt -71.5 153.18 93.83 Favored Pre-proline 0 C--N 1.323 -0.559 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 178.408 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -75.19 168.72 24.09 Favored 'Trans proline' 0 N--CA 1.463 -0.299 0 C-N-CA 118.508 -0.528 . . . . 0.0 111.005 178.599 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 53.0 tptt -59.59 130.23 45.83 Favored 'General case' 0 C--N 1.324 -0.539 0 O-C-N 122.199 -0.313 . . . . 0.0 111.018 -176.564 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 95.15 -10.64 69.74 Favored Glycine 0 C--O 1.23 -0.124 0 CA-C-N 115.547 -0.752 . . . . 0.0 114.846 178.33 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.402 ' CZ ' ' HB2' ' A' ' 18' ' ' GLN . 1.3 m-85 -95.41 144.41 25.95 Favored 'General case' 0 N--CA 1.436 -1.168 0 CA-C-O 122.39 1.091 . . . . 0.0 110.53 179.888 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 38.1 p90 -143.13 164.76 29.27 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 113.168 -1.833 . . . . 0.0 107.892 175.484 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -108.22 153.53 23.06 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.08 0.466 . . . . 0.0 110.446 -176.648 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -90.12 132.22 35.55 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.322 -178.813 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 97.2 -33.76 5.57 Favored Glycine 0 C--O 1.225 -0.414 0 CA-C-N 116.044 -0.525 . . . . 0.0 113.102 179.082 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -74.02 130.19 39.34 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-O 121.798 0.808 . . . . 0.0 111.121 179.402 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 25.8 tpt180 -143.54 153.12 42.25 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 105.233 -2.136 . . . . 0.0 105.233 178.526 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -129.34 -71.76 0.13 Allowed Glycine 0 C--O 1.224 -0.516 0 N-CA-C 109.067 -1.613 . . . . 0.0 109.067 179.548 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -79.9 163.62 47.75 Favored Glycine 0 N--CA 1.452 -0.253 0 N-CA-C 105.835 -2.906 . . . . 0.0 105.835 173.943 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 32.4 t . . . . . 0 C--O 1.246 0.888 0 CA-C-N 118.088 0.944 . . . . 0.0 110.292 -178.736 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.701 0 CA-C-O 118.495 -1.169 . . . . 0.0 111.109 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -71.22 135.79 47.7 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 177.925 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 96.4 mtp -136.31 54.76 1.88 Allowed 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 -179.245 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -93.46 -91.1 1.58 Allowed Glycine 0 C--O 1.224 -0.528 0 CA-C-N 115.839 -0.619 . . . . 0.0 113.108 -178.677 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 99.1 mt -128.52 146.15 58.82 Favored Pre-proline 0 C--N 1.327 -0.372 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 179.353 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -75.54 -20.37 15.9 Favored 'Trans proline' 0 C--N 1.347 0.467 0 N-CA-C 114.18 0.8 . . . . 0.0 114.18 -179.884 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -104.97 -46.73 4.2 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 109.762 -0.458 . . . . 0.0 109.762 179.091 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.403 HD21 ' HD2' ' A' ' 111' ' ' PRO . 21.5 t30 56.35 32.14 19.95 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.112 0.965 . . . . 0.0 113.599 174.54 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 36.0 p -85.62 87.59 7.42 Favored 'General case' 0 C--O 1.24 0.584 0 CA-C-O 122.008 0.909 . . . . 0.0 108.613 -178.011 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -92.62 141.54 28.37 Favored 'General case' 0 N--CA 1.443 -0.822 0 CA-C-N 115.094 -0.957 . . . . 0.0 111.473 -175.562 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -58.59 140.6 54.12 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 114.635 -1.166 . . . . 0.0 110.808 178.67 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 26.5 m95 -73.05 -21.95 60.7 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 114.906 1.447 . . . . 0.0 114.906 -178.217 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -121.47 156.15 33.39 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-O 121.015 0.436 . . . . 0.0 111.867 -174.454 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 75.9 p -68.6 162.99 24.68 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.745 -1.116 . . . . 0.0 110.078 -179.647 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.595 ' HB1' ' HB2' ' A' ' 67' ' ' ARG . . . -79.61 126.62 31.14 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 116.299 1.963 . . . . 0.0 116.299 -174.481 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.484 HD13 HD13 ' A' ' 119' ' ' LEU . 0.0 OUTLIER -74.32 121.28 21.1 Favored 'General case' 0 N--CA 1.438 -1.029 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 170.272 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 56.7 m -87.19 126.92 35.11 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 -176.309 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 3.2 tm0? -88.27 135.02 33.65 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 -179.685 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 37.8 t60 -139.36 99.49 3.75 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 169.99 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 162.34 -161.37 33.5 Favored Glycine 0 C--O 1.226 -0.355 0 C-N-CA 120.008 -1.091 . . . . 0.0 113.371 -179.481 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -105.59 -24.09 12.65 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -85.68 153.55 22.27 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 178.612 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -78.22 -62.81 1.56 Allowed 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 120.598 -0.441 . . . . 0.0 110.964 -176.315 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 58.2 tp 173.66 145.62 0.05 OUTLIER 'General case' 0 N--CA 1.485 1.316 0 N-CA-C 106.104 -1.813 . . . . 0.0 106.104 174.886 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 2.5 tppp? -158.92 140.87 13.67 Favored 'General case' 0 C--O 1.223 -0.336 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 175.325 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 20.9 m-85 -127.24 151.49 74.64 Favored Pre-proline 0 C--N 1.325 -0.499 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 174.826 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -73.7 162.68 39.08 Favored 'Trans proline' 0 C--N 1.349 0.574 0 O-C-N 122.183 0.57 . . . . 0.0 113.269 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 16.6 tpt180 -64.59 133.3 52.0 Favored 'General case' 0 C--O 1.218 -0.605 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.647 -178.344 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 79.83 15.66 78.79 Favored Glycine 0 C--O 1.221 -0.671 0 CA-C-N 116.252 -0.431 . . . . 0.0 112.248 178.543 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -151.86 170.59 19.44 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 -175.094 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 99.53 -8.61 60.28 Favored Glycine 0 C--O 1.222 -0.656 0 N-CA-C 114.501 0.561 . . . . 0.0 114.501 174.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 96.4 t -69.21 130.92 90.75 Favored Pre-proline 0 C--N 1.319 -0.729 0 N-CA-C 106.471 -1.677 . . . . 0.0 106.471 176.747 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -70.11 174.5 9.71 Favored 'Trans proline' 0 C--O 1.223 -0.228 0 O-C-N 122.314 0.639 . . . . 0.0 113.22 178.659 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 74.2 mt -75.65 105.64 4.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 122.3 1.048 . . . . 0.0 108.485 179.765 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 50.8 m-20 -100.6 79.64 2.11 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 113.96 -1.473 . . . . 0.0 109.027 -176.986 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 69.7 p -66.65 -22.43 66.1 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 114.797 1.406 . . . . 0.0 114.797 -175.039 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -120.87 30.28 6.96 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 -176.022 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -128.59 157.24 41.81 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 179.134 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.6 p -74.18 162.22 74.84 Favored Pre-proline 0 C--N 1.321 -0.64 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 -179.426 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -65.89 -20.54 58.1 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 115.78 -2.346 . . . . 0.0 112.561 177.222 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.421 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 3.3 p-10 -75.19 -21.89 58.38 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 119.636 -0.825 . . . . 0.0 110.747 179.785 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 31.3 t0 -89.92 0.82 56.85 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 114.147 1.166 . . . . 0.0 114.147 -175.401 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 91.4 mm-40 -63.21 -28.11 69.82 Favored 'General case' 0 C--N 1.318 -0.786 0 O-C-N 121.047 -1.033 . . . . 0.0 111.634 -179.787 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 12.8 tt -66.58 137.84 24.09 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-O 122.259 1.028 . . . . 0.0 111.531 178.08 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 178.4 -158.08 22.44 Favored Glycine 0 CA--C 1.505 -0.581 0 C-N-CA 120.443 -0.884 . . . . 0.0 111.456 -178.255 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 43.9 p90 -155.09 167.61 29.78 Favored 'General case' 0 C--N 1.319 -0.738 0 O-C-N 122.627 -0.337 . . . . 0.0 110.574 179.598 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 16.2 m-85 -109.16 141.9 40.72 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 176.356 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 62.4 ttt-85 -120.39 117.99 29.19 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 124.112 0.965 . . . . 0.0 112.346 -174.992 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 28.5 ttp85 -69.78 136.48 50.92 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 177.386 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -146.26 138.53 25.18 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.341 0.656 . . . . 0.0 110.281 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 14.1 t -160.21 153.1 21.42 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.082 0.468 . . . . 0.0 110.142 174.77 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 22.4 tpt180 -151.37 123.81 8.38 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 175.212 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 4.5 tmt_? -134.03 139.04 45.76 Favored 'General case' 0 CA--C 1.501 -0.928 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -141.53 179.2 2.26 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 N-CA-C 105.939 -1.874 . . . . 0.0 105.939 -176.55 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 8.1 ttm180 -131.32 111.99 12.36 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 175.726 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -77.67 169.51 54.73 Favored Glycine 0 C--O 1.229 -0.216 0 N-CA-C 108.699 -1.76 . . . . 0.0 108.699 176.972 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -65.44 -42.29 95.95 Favored Glycine 0 C--O 1.219 -0.826 0 C-N-CA 120.613 -0.804 . . . . 0.0 112.36 -177.939 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -90.57 14.45 13.18 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 122.617 1.199 . . . . 0.0 111.764 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 90.86 -12.37 69.09 Favored Glycine 0 C--N 1.314 -0.664 0 CA-C-N 113.958 -1.474 . . . . 0.0 115.979 175.697 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 4.4 mppt? -57.79 132.63 53.89 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.586 0.708 . . . . 0.0 109.409 179.358 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 26.1 ptm -132.43 -171.49 2.66 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 114.747 -1.115 . . . . 0.0 112.358 -176.147 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 60.9 mmtt -112.71 -119.72 0.3 Allowed 'General case' 0 C--O 1.219 -0.519 0 C-N-CA 123.477 0.711 . . . . 0.0 109.282 -178.958 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 57.8 m-20 -66.97 141.46 57.59 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 111.729 0.27 . . . . 0.0 111.729 -174.918 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 55.8 mt -87.94 -61.65 1.67 Allowed 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 177.318 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 71.0 p -112.35 166.12 11.61 Favored Pre-proline 0 C--O 1.243 0.724 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 178.231 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -73.31 163.81 36.88 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 116.3 -2.0 . . . . 0.0 112.416 177.168 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.595 ' HB2' ' HB1' ' A' ' 15' ' ' ALA . 0.0 OUTLIER -140.44 160.83 39.13 Favored 'General case' 0 C--N 1.326 -0.423 0 O-C-N 122.148 -0.345 . . . . 0.0 110.847 179.037 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 67.0 m95 -117.74 133.98 55.38 Favored 'General case' 0 C--O 1.214 -0.777 0 C-N-CA 122.871 0.468 . . . . 0.0 111.067 -178.138 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.558 ' CZ ' ' HB2' ' A' ' 15' ' ' ALA . 52.1 m-85 -110.39 163.29 13.82 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 106.438 -1.69 . . . . 0.0 106.438 179.041 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 81.0 t80 -110.81 138.25 47.44 Favored 'General case' 0 CA--C 1.51 -0.589 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 -179.066 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -137.6 136.47 37.56 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.114 -0.948 . . . . 0.0 108.548 -176.274 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 34.2 m-85 -70.66 159.52 34.28 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.012 178.469 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -53.56 127.72 26.36 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 113.106 0.78 . . . . 0.0 113.106 -177.181 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 64.47 33.45 87.27 Favored Glycine 0 C--O 1.224 -0.506 0 N-CA-C 115.434 0.934 . . . . 0.0 115.434 174.02 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 4.1 p -89.2 146.12 24.97 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 177.79 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 106.77 144.35 11.74 Favored Glycine 0 CA--C 1.521 0.455 0 N-CA-C 108.12 -1.992 . . . . 0.0 108.12 -175.463 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -70.0 -40.21 5.2 Favored 'Trans proline' 0 C--N 1.346 0.4 0 CA-C-N 119.652 1.726 . . . . 0.0 116.12 -173.733 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -113.81 24.33 12.2 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.69 -0.687 . . . . 0.0 110.662 -176.637 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -57.86 -44.28 86.49 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 113.052 0.76 . . . . 0.0 113.052 -176.055 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 57.26 22.99 46.04 Favored Glycine 0 CA--C 1.522 0.484 0 N-CA-C 115.59 0.996 . . . . 0.0 115.59 178.706 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 19.1 mt -105.9 103.96 46.84 Favored Pre-proline 0 C--O 1.238 0.472 0 N-CA-C 114.117 1.155 . . . . 0.0 114.117 -176.986 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -76.77 165.64 28.33 Favored 'Trans proline' 0 N--CA 1.462 -0.345 0 C-N-CA 121.12 1.213 . . . . 0.0 109.171 172.656 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.425 ' CE1' ' HB3' ' A' ' 92' ' ' TRP . 74.4 t80 -62.37 131.88 50.75 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 120.398 -0.521 . . . . 0.0 110.359 -179.485 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 90.07 -1.33 80.11 Favored Glycine 0 CA--C 1.518 0.235 0 CA-C-O 119.834 -0.426 . . . . 0.0 113.903 178.36 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -61.73 130.26 44.94 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 117.667 0.733 . . . . 0.0 111.348 178.985 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 54.3 t30 -79.42 120.63 24.1 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.452 -178.639 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 50.4 tttm -153.71 149.95 28.03 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 179.396 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -66.03 134.95 53.96 Favored 'General case' 0 C--O 1.238 0.49 0 CA-C-O 120.809 0.338 . . . . 0.0 110.405 179.179 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 70.65 23.57 77.63 Favored Glycine 0 N--CA 1.45 -0.397 0 CA-C-O 119.419 -0.656 . . . . 0.0 113.637 178.616 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 42.2 mm -129.59 130.83 67.2 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 CA-C-N 117.385 0.592 . . . . 0.0 110.401 -179.51 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.1 pt -135.59 120.18 27.03 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 CA-C-O 121.387 0.613 . . . . 0.0 110.251 176.196 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' TRP . . . . . 0.425 ' HB3' ' CE1' ' A' ' 83' ' ' TYR . 93.6 m95 -87.8 137.61 32.19 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 113.087 0.773 . . . . 0.0 113.087 -176.087 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 18.9 m -137.04 154.41 31.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 179.108 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -160.33 166.58 29.17 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 106.465 -1.68 . . . . 0.0 106.465 -178.368 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 11.3 t -138.8 174.73 10.22 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 105.618 -1.993 . . . . 0.0 105.618 177.278 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 59.8 tt0 -67.45 137.43 55.86 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.324 0.583 . . . . 0.0 110.861 -179.011 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 95.26 -11.85 68.63 Favored Glycine 0 N--CA 1.46 0.268 0 CA-C-N 115.756 -0.657 . . . . 0.0 113.3 178.053 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.421 ' HA ' ' HA ' ' A' ' 41' ' ' ASP . . . -76.57 143.05 40.54 Favored 'General case' 0 C--N 1.322 -0.592 0 O-C-N 122.598 -0.354 . . . . 0.0 110.541 179.441 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 46.2 mt -105.4 134.37 48.63 Favored 'General case' 0 CA--C 1.513 -0.459 0 N-CA-C 113.855 1.057 . . . . 0.0 113.855 -178.14 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -79.24 65.58 4.45 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.223 -0.899 . . . . 0.0 111.142 -178.548 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 1.2 t -134.77 156.18 78.79 Favored Pre-proline 0 C--N 1.322 -0.629 0 N-CA-C 105.359 -2.089 . . . . 0.0 105.359 -179.408 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -65.93 153.11 79.48 Favored 'Trans proline' 0 C--N 1.344 0.322 0 N-CA-C 115.05 1.135 . . . . 0.0 115.05 179.34 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.475 ' HB3' HD12 ' A' ' 106' ' ' ILE . 72.0 mmtt -122.94 32.46 5.7 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.201 -0.909 . . . . 0.0 109.149 -178.619 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 15.4 p-10 -50.92 -44.24 60.08 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.989 -177.907 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 16.0 p80 -69.78 -8.92 52.28 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 114.015 1.117 . . . . 0.0 114.015 -178.9 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.475 HD12 ' HB3' ' A' ' 103' ' ' LYS . 33.8 mt -96.15 -41.7 11.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 O-C-N 122.186 -0.321 . . . . 0.0 110.214 179.186 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -68.44 14.75 0.66 Allowed Glycine 0 N--CA 1.466 0.67 0 N-CA-C 117.995 1.958 . . . . 0.0 117.995 -176.224 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 8.9 t -90.27 28.77 1.36 Allowed 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 123.695 0.798 . . . . 0.0 111.976 -178.902 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 73.9 ttp85 -57.75 121.4 10.36 Favored 'General case' 0 N--CA 1.474 0.737 0 O-C-N 121.451 -0.781 . . . . 0.0 109.956 -179.684 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 63.3 m-20 -90.57 118.09 68.46 Favored Pre-proline 0 C--N 1.322 -0.591 0 N-CA-C 106.174 -1.788 . . . . 0.0 106.174 179.618 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.403 ' HD2' HD21 ' A' ' 8' ' ' ASN . 83.6 Cg_endo -71.09 -14.79 32.11 Favored 'Trans proline' 0 C--O 1.218 -0.523 0 C-N-CA 117.902 -0.932 . . . . 0.0 113.384 -177.052 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -75.53 -26.8 58.37 Favored 'General case' 0 C--O 1.22 -0.484 0 CA-C-O 120.858 0.361 . . . . 0.0 110.41 177.565 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 -104.33 -26.51 12.43 Favored 'General case' 0 C--O 1.222 -0.358 0 N-CA-C 113.284 0.846 . . . . 0.0 113.284 -174.314 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 18.9 t-20 -146.0 143.99 29.81 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 -178.062 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -87.29 149.71 24.36 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.731 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -68.71 146.76 52.68 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 177.943 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 9.0 mt -78.61 134.58 27.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 -178.642 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 98.8 t -63.14 118.96 5.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 106.423 -1.695 . . . . 0.0 106.423 176.404 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.484 HD13 HD13 ' A' ' 16' ' ' LEU . 5.0 tt -67.02 125.31 25.61 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.398 0.618 . . . . 0.0 110.796 -176.303 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -132.7 161.02 35.06 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 105.6 -2.0 . . . . 0.0 105.6 179.452 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 20.1 mt -117.2 146.33 37.91 Favored Pre-proline 0 C--N 1.322 -0.594 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 179.435 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -73.14 171.58 17.29 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 121.183 1.256 . . . . 0.0 114.522 -175.463 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 39.6 tt0 -53.41 129.99 33.93 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.874 -179.311 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 90.99 -16.03 59.52 Favored Glycine 0 C--O 1.226 -0.357 0 CA-C-N 115.963 -0.562 . . . . 0.0 113.229 -179.884 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 19.2 m -108.61 127.15 53.71 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 179.501 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 4.8 p -125.28 148.28 48.75 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.754 0.312 . . . . 0.0 110.668 -176.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 84.8 mt -66.41 152.23 94.88 Favored Pre-proline 0 C--N 1.327 -0.406 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 177.197 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -76.83 168.1 24.11 Favored 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 117.747 -1.035 . . . . 0.0 110.859 -179.571 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -59.44 126.73 28.79 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 91.58 27.96 15.84 Favored Glycine 0 C--O 1.224 -0.5 0 N-CA-C 114.938 0.735 . . . . 0.0 114.938 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -139.07 147.42 41.99 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 117.701 0.75 . . . . 0.0 111.369 177.883 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 54.0 p90 -153.93 165.22 36.8 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 176.401 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -100.25 142.03 32.28 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 114.146 1.165 . . . . 0.0 114.146 -175.375 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -67.96 140.63 56.42 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 107.181 -1.415 . . . . 0.0 107.181 175.926 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 90.7 -34.79 4.07 Favored Glycine 0 C--O 1.23 -0.151 0 C-N-CA 121.457 -0.401 . . . . 0.0 112.327 -179.055 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 22.9 t -71.89 102.64 2.95 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 179.671 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 52.01 46.94 25.74 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 122.39 1.09 . . . . 0.0 110.037 -177.2 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -89.64 -39.79 6.16 Favored Glycine 0 C--O 1.225 -0.415 0 CA-C-N 114.7 -1.136 . . . . 0.0 112.9 -179.391 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -132.97 -167.86 11.81 Favored Glycine 0 C--O 1.235 0.2 0 N-CA-C 109.998 -1.241 . . . . 0.0 109.998 -178.818 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 46.8 t . . . . . 0 C--O 1.251 1.161 0 N-CA-C 104.888 -2.264 . . . . 0.0 104.888 179.474 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.827 0 CA-C-O 118.476 -1.18 . . . . 0.0 111.018 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -74.16 150.3 40.49 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 105.273 -2.121 . . . . 0.0 105.273 175.605 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 22.0 ptt? -127.27 8.36 6.58 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.886 0.851 . . . . 0.0 110.962 -178.846 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -175.84 124.78 1.01 Allowed Glycine 0 N--CA 1.437 -1.256 0 N-CA-C 104.54 -3.424 . . . . 0.0 104.54 -175.154 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 80.4 mt -131.07 141.82 43.34 Favored Pre-proline 0 C--N 1.314 -0.95 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 177.986 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -77.4 163.89 29.37 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 118.133 -0.778 . . . . 0.0 111.488 177.161 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 58.9 t30 -63.73 -34.86 78.83 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.026 0.441 . . . . 0.0 109.834 176.541 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 -168.23 -73.69 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.036 175.838 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 66.0 p 41.71 77.5 0.06 Allowed 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 116.573 2.064 . . . . 0.0 116.573 179.355 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -101.2 145.0 29.38 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.105 178.8 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 58.3 p -61.62 145.18 52.98 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.752 178.633 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 15.8 m95 -67.93 -24.13 65.16 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 112.609 0.596 . . . . 0.0 112.609 179.392 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 25.8 m-85 -121.48 163.35 18.94 Favored 'General case' 0 CA--C 1.505 -0.754 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -172.156 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 70.1 p -70.64 164.17 25.51 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 176.528 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -80.5 152.04 28.91 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.449 0.642 . . . . 0.0 112.656 -176.871 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 21.8 mt -85.02 146.37 27.22 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 102.753 -3.055 . . . . 0.0 102.753 168.605 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 52.4 m -119.64 129.51 54.63 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 179.528 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -85.34 133.25 34.15 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.648 -179.412 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 21.9 t-160 -139.16 94.94 2.86 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 103.533 -2.766 . . . . 0.0 103.533 168.591 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 166.46 -131.26 2.32 Favored Glycine 0 C--O 1.226 -0.379 0 C-N-CA 120.184 -1.008 . . . . 0.0 113.119 -174.902 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 64.1 mttm -130.96 -38.5 1.25 Allowed 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 116.973 2.212 . . . . 0.0 116.973 -176.327 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -75.62 163.32 27.45 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 179.513 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -72.22 -62.66 1.35 Allowed 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 178.284 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 48.4 tp 174.47 134.2 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 104.843 -2.28 . . . . 0.0 104.843 173.256 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 11.1 tmtt? -148.24 127.51 13.0 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 118.403 0.547 . . . . 0.0 111.386 178.266 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 16.0 m-85 -113.22 153.16 45.54 Favored Pre-proline 0 C--O 1.243 0.716 0 CA-C-O 120.562 0.22 . . . . 0.0 111.306 176.811 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.42 162.57 41.38 Favored 'Trans proline' 0 C--N 1.353 0.765 0 C-N-CA 120.02 0.48 . . . . 0.0 112.541 177.594 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 16.9 tpt180 -69.93 134.63 48.6 Favored 'General case' 0 C--O 1.216 -0.704 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 -176.837 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 78.92 15.1 81.21 Favored Glycine 0 C--O 1.224 -0.506 0 C-N-CA 121.136 -0.554 . . . . 0.0 111.908 178.859 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 4.7 mt-30 -151.63 170.49 19.57 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 -175.291 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 108.09 -16.73 35.6 Favored Glycine 0 CA--C 1.501 -0.805 0 CA-C-N 116.236 -0.438 . . . . 0.0 112.676 175.373 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 95.0 t -65.7 129.29 94.3 Favored Pre-proline 0 C--N 1.319 -0.718 0 N-CA-C 106.968 -1.494 . . . . 0.0 106.968 177.41 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -73.29 170.33 20.14 Favored 'Trans proline' 0 N--CA 1.461 -0.422 0 O-C-N 122.17 0.563 . . . . 0.0 111.297 177.869 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 91.6 mt -69.39 107.63 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 179.829 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -97.67 84.75 3.44 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 114.409 -1.269 . . . . 0.0 109.857 -176.817 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 69.8 p -66.59 -15.65 63.59 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.647 -0.706 . . . . 0.0 112.699 -178.869 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -107.32 22.62 15.7 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.152 -0.931 . . . . 0.0 112.162 -177.917 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 14.3 m -141.92 148.06 38.06 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 114.518 1.303 . . . . 0.0 114.518 -176.233 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -74.65 168.35 27.9 Favored Pre-proline 0 N--CA 1.468 0.46 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 176.424 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -64.65 -28.98 60.6 Favored 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 114.807 -2.996 . . . . 0.0 112.3 178.756 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -62.92 -24.07 67.67 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 123.74 0.816 . . . . 0.0 111.667 176.289 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 70.3 m-20 -98.93 -1.49 39.86 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 114.865 1.431 . . . . 0.0 114.865 -172.354 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 93.7 mm-40 -60.36 -29.26 68.8 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 114.459 1.281 . . . . 0.0 114.459 -178.888 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 20.8 tt -58.61 139.65 18.0 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.882 0 CA-C-O 122.32 1.057 . . . . 0.0 113.774 -177.296 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -179.18 -156.65 17.91 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.434 -178.738 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 46.6 p90 -155.12 171.52 19.65 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 178.653 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 19.9 m-85 -113.15 139.45 48.74 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 106.365 -1.717 . . . . 0.0 106.365 173.131 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 55.8 ttt180 -110.33 119.71 40.09 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.033 -176.951 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 11.8 ttp180 -65.92 137.92 57.49 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 177.431 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -143.8 142.67 31.0 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.772 0.796 . . . . 0.0 111.266 -179.976 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 41.4 p -142.99 172.49 12.63 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 102.284 -3.228 . . . . 0.0 102.284 174.995 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 17.9 tpt180 -140.62 125.98 18.79 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 120.345 -0.542 . . . . 0.0 111.025 176.557 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.26 148.11 33.12 Favored 'General case' 0 CA--C 1.488 -1.436 0 CA-C-O 121.611 0.719 . . . . 0.0 109.537 179.604 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -144.61 179.61 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.055 0 N-CA-C 102.123 -3.288 . . . . 0.0 102.123 178.804 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 79.2 ttt180 -132.7 121.16 22.68 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 175.295 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -97.33 147.07 18.53 Favored Glycine 0 N--CA 1.448 -0.547 0 N-CA-C 106.582 -2.607 . . . . 0.0 106.582 175.543 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -68.73 -30.94 72.72 Favored Glycine 0 C--O 1.216 -1.016 0 N-CA-C 109.798 -1.321 . . . . 0.0 109.798 179.507 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 30.7 t0 -87.26 17.02 4.62 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-O 122.016 0.912 . . . . 0.0 111.394 179.99 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 84.93 -6.49 78.63 Favored Glycine 0 C--O 1.223 -0.55 0 N-CA-C 116.462 1.345 . . . . 0.0 116.462 174.196 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.13 132.11 47.16 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.959 0.885 . . . . 0.0 112.509 -179.277 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 91.6 mmm -121.79 179.38 4.51 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 113.81 -1.541 . . . . 0.0 108.485 -177.917 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 13.6 mmtt -111.41 -54.35 2.62 Favored 'General case' 0 C--O 1.215 -0.761 0 CA-C-O 120.857 0.36 . . . . 0.0 110.155 178.268 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 49.58 50.0 18.99 Favored 'General case' 0 C--N 1.323 -0.579 0 O-C-N 124.993 1.433 . . . . 0.0 113.867 174.972 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 63.9 mt -70.97 142.08 51.02 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 107.143 -1.429 . . . . 0.0 107.143 176.453 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 72.6 p -58.92 153.59 42.93 Favored Pre-proline 0 C--O 1.239 0.515 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -176.423 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -65.84 128.99 21.0 Favored 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 117.898 -0.935 . . . . 0.0 112.406 -178.918 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 18.1 mtt-85 -134.7 160.83 36.91 Favored 'General case' 0 CA--C 1.51 -0.592 0 CA-C-N 115.249 -0.887 . . . . 0.0 111.214 -176.499 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 57.6 m95 -129.49 129.19 44.25 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 178.152 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 40.4 m-85 -111.43 139.35 46.92 Favored 'General case' 0 C--O 1.217 -0.627 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 -178.491 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 92.0 t80 -86.9 136.64 32.88 Favored 'General case' 0 CA--C 1.509 -0.604 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 -177.973 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -141.77 144.91 34.22 Favored 'General case' 0 N--CA 1.441 -0.905 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 -175.434 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 -80.76 159.38 25.2 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 112.276 0.472 . . . . 0.0 112.276 -174.726 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 15.8 tp -58.1 126.95 29.7 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 121.363 0.602 . . . . 0.0 110.177 -179.423 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 85.21 16.73 64.11 Favored Glycine 0 C--O 1.221 -0.704 0 N-CA-C 116.086 1.195 . . . . 0.0 116.086 178.468 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 19.4 p -90.65 146.11 24.29 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 118.971 1.385 . . . . 0.0 111.187 179.941 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 113.98 143.86 8.55 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 -178.673 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -71.75 -39.13 3.63 Favored 'Trans proline' 0 C--N 1.347 0.496 0 CA-C-N 119.776 1.788 . . . . 0.0 114.978 -174.402 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -115.2 32.42 6.06 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 -178.766 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -60.81 -55.45 32.89 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.811 -0.631 . . . . 0.0 112.014 -176.177 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 56.54 23.88 44.68 Favored Glycine 0 CA--C 1.523 0.555 0 CA-C-N 116.277 -0.42 . . . . 0.0 114.09 -178.989 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 43.9 mt -105.59 111.18 64.81 Favored Pre-proline 0 N--CA 1.449 -0.483 0 N-CA-C 115.525 1.676 . . . . 0.0 115.525 -174.989 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -77.52 166.02 26.41 Favored 'Trans proline' 0 N--CA 1.461 -0.407 0 N-CA-C 108.388 -1.428 . . . . 0.0 108.388 169.274 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 64.1 t80 -63.14 132.51 52.05 Favored 'General case' 0 C--N 1.322 -0.602 0 O-C-N 121.947 -0.471 . . . . 0.0 109.958 -179.677 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 91.39 -4.91 80.6 Favored Glycine 0 CA--C 1.52 0.353 0 N-CA-C 114.637 0.615 . . . . 0.0 114.637 178.868 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -65.14 132.3 48.8 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 118.038 0.919 . . . . 0.0 112.357 179.781 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 50.1 t30 -74.96 125.9 29.87 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.863 -178.807 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 26.9 ttmt -156.26 151.6 26.7 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 107.178 -1.416 . . . . 0.0 107.178 177.321 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 15.6 t0 -61.97 129.63 41.82 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.013 0.435 . . . . 0.0 110.853 179.423 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 69.19 27.85 73.35 Favored Glycine 0 N--CA 1.447 -0.609 0 CA-C-N 115.82 -0.627 . . . . 0.0 114.319 176.032 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 45.1 mm -125.11 120.77 59.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 117.365 0.583 . . . . 0.0 110.062 178.764 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.1 pt -123.68 113.79 38.75 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 CA-C-O 121.896 0.855 . . . . 0.0 110.592 176.972 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 96.5 m95 -80.51 132.67 35.72 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.763 -0.653 . . . . 0.0 112.601 -176.978 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 17.0 m -135.59 149.7 28.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.795 0.807 . . . . 0.0 109.492 179.599 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -156.28 166.57 33.06 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 103.531 -2.766 . . . . 0.0 103.531 -179.282 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 14.5 t -131.53 168.94 16.8 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 104.221 -2.511 . . . . 0.0 104.221 177.522 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -65.41 134.17 52.91 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 -178.681 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 95.75 -7.06 67.75 Favored Glycine 0 C--O 1.226 -0.369 0 CA-C-N 116.004 -0.544 . . . . 0.0 113.529 179.4 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -80.51 135.42 36.11 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 122.096 -0.649 . . . . 0.0 109.823 179.029 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 37.0 mt -81.86 136.25 35.38 Favored 'General case' 0 CA--C 1.511 -0.529 0 CA-C-O 121.161 0.505 . . . . 0.0 111.479 -178.878 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 63.4 t30 -84.08 65.22 8.62 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.633 -179.664 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -140.1 153.75 69.55 Favored Pre-proline 0 C--N 1.324 -0.519 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 -178.553 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -66.85 149.89 83.23 Favored 'Trans proline' 0 C--N 1.344 0.319 0 N-CA-C 113.977 0.722 . . . . 0.0 113.977 177.252 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 1.5 ptpm? -149.15 55.51 0.99 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 123.036 1.398 . . . . 0.0 109.571 179.759 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 13.6 p-10 -54.92 -35.1 63.83 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 113.451 -1.704 . . . . 0.0 112.344 179.52 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 37.5 p-80 -60.3 -14.6 19.09 Favored 'General case' 0 C--O 1.219 -0.549 0 N-CA-C 114.728 1.381 . . . . 0.0 114.728 -177.839 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 62.8 mt -84.42 -39.16 14.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 178.515 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -74.16 14.6 3.8 Favored Glycine 0 C--O 1.221 -0.678 0 N-CA-C 116.126 1.211 . . . . 0.0 116.126 -176.558 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 11.5 t -94.29 23.11 5.35 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 117.968 0.884 . . . . 0.0 112.667 -178.038 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 65.3 ttp85 -55.91 133.65 51.56 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.387 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 15.1 m-20 -104.28 125.18 34.97 Favored Pre-proline 0 C--N 1.324 -0.523 0 N-CA-C 106.854 -1.536 . . . . 0.0 106.854 -179.389 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_endo -69.59 -18.51 37.75 Favored 'Trans proline' 0 C--O 1.217 -0.527 0 N-CA-C 114.037 0.745 . . . . 0.0 114.037 -177.903 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -73.63 -26.28 60.7 Favored 'General case' 0 C--O 1.22 -0.498 0 CA-C-O 120.877 0.37 . . . . 0.0 110.675 178.1 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -102.11 -23.93 14.0 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 113.142 0.793 . . . . 0.0 113.142 -174.978 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 -154.55 148.37 25.52 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 112.578 0.584 . . . . 0.0 112.578 -178.361 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -88.94 149.1 23.46 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-O 121.432 0.634 . . . . 0.0 111.702 179.575 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -70.08 145.18 51.83 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.221 0.534 . . . . 0.0 110.446 178.369 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 14.4 mt -86.3 138.8 18.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 115.393 -0.821 . . . . 0.0 108.815 -178.601 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 75.6 t -61.16 123.9 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 N-CA-C 106.077 -1.823 . . . . 0.0 106.077 174.848 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 7.1 tt -66.84 130.11 42.07 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.134 0.492 . . . . 0.0 110.379 -177.021 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 30.2 mt-30 -132.72 157.94 43.62 Favored 'General case' 0 CA--C 1.511 -0.551 0 N-CA-C 106.615 -1.624 . . . . 0.0 106.615 -179.445 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 13.3 mt -112.31 148.18 38.59 Favored Pre-proline 0 C--N 1.322 -0.588 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 177.12 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -73.2 166.17 30.68 Favored 'Trans proline' 0 N--CA 1.462 -0.371 0 O-C-N 122.325 0.645 . . . . 0.0 112.933 -179.501 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 60.2 tp60 -54.27 130.37 38.56 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.887 -179.879 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 97.15 -17.12 59.73 Favored Glycine 0 C--O 1.227 -0.3 0 CA-C-N 115.907 -0.588 . . . . 0.0 113.611 -179.926 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 9.5 m -106.71 127.01 53.02 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 118.149 0.975 . . . . 0.0 109.984 178.288 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 17.3 p -120.02 148.32 43.71 Favored 'General case' 0 CA--C 1.511 -0.534 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.845 -179.132 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 88.8 mt -70.4 156.1 92.41 Favored Pre-proline 0 C--N 1.323 -0.561 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 177.559 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -74.55 169.11 23.26 Favored 'Trans proline' 0 C--O 1.236 0.406 0 C-N-CA 117.749 -1.034 . . . . 0.0 110.343 178.302 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 12.4 tmtt? -63.72 120.67 12.29 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 -176.823 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 95.18 37.94 4.98 Favored Glycine 0 N--CA 1.452 -0.257 0 N-CA-C 114.943 0.737 . . . . 0.0 114.943 178.942 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -142.31 146.15 34.73 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 176.85 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 48.6 p90 -147.11 162.38 38.94 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 176.627 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -97.68 143.26 28.53 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.042 0.449 . . . . 0.0 110.547 -178.345 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -71.34 135.84 47.54 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 178.812 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 87.87 -13.53 60.84 Favored Glycine 0 C--O 1.227 -0.299 0 CA-C-N 116.109 -0.496 . . . . 0.0 113.147 -178.24 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 35.2 t -89.51 124.7 34.75 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 178.733 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 6.0 tpt180 -141.88 34.4 1.58 Allowed 'General case' 0 C--O 1.219 -0.504 0 CA-C-O 121.347 0.594 . . . . 0.0 112.143 179.143 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -72.22 -18.39 78.02 Favored Glycine 0 C--O 1.224 -0.49 0 CA-C-O 122.315 0.953 . . . . 0.0 111.41 178.363 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -168.86 177.18 42.81 Favored Glycine 0 C--O 1.241 0.541 0 N-CA-C 104.378 -3.489 . . . . 0.0 104.378 178.345 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 43.6 t . . . . . 0 C--O 1.247 0.972 0 CA-C-O 116.209 -1.853 . . . . 0.0 106.139 179.962 . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.108 0 CA-C-O 118.766 -1.019 . . . . 0.0 111.328 . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -65.68 148.65 51.41 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 177.598 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 75.5 mtp -124.88 15.31 8.6 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -177.836 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -109.53 28.47 10.75 Favored Glycine 0 C--O 1.219 -0.792 0 CA-C-N 116.286 -0.416 . . . . 0.0 112.875 -178.326 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -71.12 142.33 87.29 Favored Pre-proline 0 C--N 1.32 -0.689 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 -178.654 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -68.08 151.01 77.74 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 117.238 -1.375 . . . . 0.0 111.504 178.079 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 66.9 t30 -140.82 72.06 1.38 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.578 0.704 . . . . 0.0 110.188 -176.988 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -77.24 23.38 0.2 Allowed 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 115.13 -0.941 . . . . 0.0 112.005 -177.615 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 16.9 p -140.89 129.69 23.0 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 104.67 -2.345 . . . . 0.0 104.67 -177.862 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -106.44 139.74 40.45 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 -179.78 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 62.5 p -63.06 141.07 58.9 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 178.865 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 12' ' ' TRP . . . . . 0.415 ' CD2' ' HD3' ' A' ' 109' ' ' ARG . 10.9 m95 -67.95 -27.21 66.4 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.038 0.447 . . . . 0.0 111.772 178.716 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 20.1 m-85 -121.53 163.97 17.99 Favored 'General case' 0 C--O 1.242 0.68 0 CA-C-N 115.517 -0.765 . . . . 0.0 112.537 -171.349 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 63.7 p -70.19 166.5 19.87 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 177.096 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.433 ' HB1' ' HB3' ' A' ' 67' ' ' ARG . . . -83.58 148.17 27.32 Favored 'General case' 0 N--CA 1.443 -0.785 0 N-CA-C 113.529 0.937 . . . . 0.0 113.529 -175.371 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 15.6 mt -81.88 144.92 30.65 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 103.768 -2.679 . . . . 0.0 103.768 170.902 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 26.4 m -123.28 131.03 53.52 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.108 0.48 . . . . 0.0 110.052 -178.008 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -83.39 141.93 31.38 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.34 -0.845 . . . . 0.0 111.94 -178.627 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 23.0 t-160 -139.11 99.71 3.83 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 105.83 -1.915 . . . . 0.0 105.83 168.477 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 151.02 -134.59 4.76 Favored Glycine 0 C--N 1.322 -0.242 0 N-CA-C 111.134 -0.786 . . . . 0.0 111.134 -176.841 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 51.6 mttp -132.7 -16.1 2.65 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 114.993 1.479 . . . . 0.0 114.993 -179.351 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 59.7 mt-10 -73.98 155.49 38.55 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 107.1 -1.444 . . . . 0.0 107.1 178.027 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -82.17 -62.6 1.58 Allowed 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 120.458 -0.497 . . . . 0.0 109.791 -178.685 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 56.5 tp 168.58 136.7 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 103.661 -2.718 . . . . 0.0 103.661 175.411 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -157.01 138.87 14.3 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 176.511 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 25.6 m-85 -127.55 151.38 75.01 Favored Pre-proline 0 C--N 1.324 -0.531 0 O-C-N 123.307 0.379 . . . . 0.0 110.212 176.804 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -79.72 165.89 22.08 Favored 'Trans proline' 0 CA--C 1.541 0.83 0 C-N-CA 120.568 0.845 . . . . 0.0 113.03 176.755 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 2.2 tmt_? -67.3 138.33 56.75 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 116.548 -0.296 . . . . 0.0 110.257 -179.384 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 86.66 2.73 84.39 Favored Glycine 0 C--O 1.224 -0.503 0 N-CA-C 110.894 -0.883 . . . . 0.0 110.894 178.008 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -143.86 -179.62 6.58 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 -175.14 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.448 ' H ' HG21 ' A' ' 125' ' ' THR . . . 95.54 -28.97 10.4 Favored Glycine 0 CA--C 1.5 -0.896 0 CA-C-N 115.794 -0.639 . . . . 0.0 113.555 174.716 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 91.6 t -64.14 127.3 91.78 Favored Pre-proline 0 C--N 1.319 -0.721 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 177.486 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -72.91 171.72 16.88 Favored 'Trans proline' 0 N--CA 1.461 -0.433 0 C-N-CA 120.128 0.552 . . . . 0.0 111.717 178.409 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 85.6 mt -69.21 107.89 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-O 122.299 1.047 . . . . 0.0 108.539 179.415 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -98.45 86.33 3.58 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 114.122 -1.399 . . . . 0.0 109.874 -176.614 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 67.0 p -67.56 -15.79 63.84 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.525 -0.761 . . . . 0.0 112.627 -178.848 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -107.11 21.09 18.08 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 114.9 -1.046 . . . . 0.0 113.014 -177.31 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 9.9 m -140.16 150.38 44.15 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 115.741 1.756 . . . . 0.0 115.741 -174.817 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 4.6 m -72.49 166.28 43.49 Favored Pre-proline 0 N--CA 1.468 0.464 0 CA-C-N 115.415 -0.812 . . . . 0.0 109.553 176.22 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -66.03 -27.98 49.75 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 114.533 -3.178 . . . . 0.0 113.944 -179.805 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.402 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 5.6 p-10 -75.06 -21.55 58.92 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 121.66 -0.65 . . . . 0.0 111.213 177.113 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 75.0 m-20 -81.36 -10.53 59.52 Favored 'General case' 0 C--O 1.221 -0.415 0 N-CA-C 113.453 0.908 . . . . 0.0 113.453 -176.034 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 96.6 mm-40 -56.69 -27.29 58.65 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 115.155 1.539 . . . . 0.0 115.155 -176.59 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 19.7 tt -55.31 138.46 15.57 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.941 0 N-CA-C 114.418 1.266 . . . . 0.0 114.418 -178.077 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -176.88 -159.95 23.09 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.416 -0.897 . . . . 0.0 114.353 -179.406 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 44.8 p90 -154.92 170.47 21.63 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 179.242 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 17.6 m-85 -114.39 141.46 47.62 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 172.905 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 58.3 ttt180 -113.56 117.24 31.1 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 124.415 1.086 . . . . 0.0 110.992 -175.428 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 46.6 ttp180 -65.6 137.52 57.41 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 178.356 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -150.41 150.06 30.87 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.854 0.359 . . . . 0.0 111.149 -178.029 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 21.6 p -141.94 140.13 32.69 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.826 176.282 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 14.0 tpt180 -142.74 123.87 14.53 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 174.742 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.52 133.84 52.22 Favored 'General case' 0 CA--C 1.494 -1.187 0 CA-C-O 121.584 0.706 . . . . 0.0 110.963 -176.508 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -129.17 179.1 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.883 0 N-CA-C 105.472 -2.047 . . . . 0.0 105.472 178.238 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 27.8 tpt180 -139.57 107.93 5.83 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 106.803 -1.554 . . . . 0.0 106.803 172.502 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -74.17 156.61 50.36 Favored Glycine 0 N--CA 1.447 -0.568 0 N-CA-C 107.681 -2.168 . . . . 0.0 107.681 176.608 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -69.34 -33.23 72.66 Favored Glycine 0 C--O 1.216 -0.983 0 N-CA-C 108.62 -1.792 . . . . 0.0 108.62 179.373 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.1 t0 -84.75 16.61 3.19 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-O 122.55 1.167 . . . . 0.0 109.689 177.715 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 85.03 -14.6 48.35 Favored Glycine 0 N--CA 1.455 -0.086 0 N-CA-C 116.961 1.544 . . . . 0.0 116.961 173.457 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -55.91 142.01 37.15 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 114.968 1.469 . . . . 0.0 114.968 -176.74 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 95.3 mmm -116.48 177.98 4.5 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 112.543 -2.117 . . . . 0.0 109.475 -177.095 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 13.7 tppt? -126.28 -53.76 1.49 Allowed 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 178.208 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 -120.43 149.42 42.4 Favored 'General case' 0 CA--C 1.506 -0.716 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 178.499 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -133.49 -44.18 0.83 Allowed 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 104.306 -2.479 . . . . 0.0 104.306 176.256 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 33.3 t -112.02 153.27 44.63 Favored Pre-proline 0 C--O 1.243 0.748 0 N-CA-C 105.42 -2.066 . . . . 0.0 105.42 175.954 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -68.75 156.74 64.48 Favored 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 117.06 -1.494 . . . . 0.0 114.983 -179.381 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.433 ' HB3' ' HB1' ' A' ' 15' ' ' ALA . 94.0 mtt-85 -113.98 165.46 12.58 Favored 'General case' 0 CA--C 1.509 -0.6 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.523 178.015 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 49.8 m95 -132.03 129.47 40.11 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 176.247 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 17.0 m-85 -110.77 141.34 44.23 Favored 'General case' 0 C--O 1.216 -0.658 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 -176.863 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -88.7 136.87 32.78 Favored 'General case' 0 CA--C 1.506 -0.732 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 -176.527 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -141.36 143.44 33.99 Favored 'General case' 0 N--CA 1.438 -1.032 0 N-CA-C 106.976 -1.491 . . . . 0.0 106.976 -175.888 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 66.8 m-85 -82.94 159.35 22.29 Favored 'General case' 0 C--N 1.317 -0.842 0 O-C-N 122.21 -0.306 . . . . 0.0 110.94 -175.342 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 15.4 tp -54.59 131.49 43.16 Favored 'General case' 0 C--O 1.218 -0.583 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 179.452 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 74.54 25.43 70.22 Favored Glycine 0 C--O 1.225 -0.466 0 N-CA-C 115.8 1.08 . . . . 0.0 115.8 177.633 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 49.8 p -108.78 146.17 34.02 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 118.421 1.11 . . . . 0.0 110.279 176.167 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 110.04 132.62 6.37 Favored Glycine 0 CA--C 1.522 0.495 0 N-CA-C 108.722 -1.751 . . . . 0.0 108.722 -176.677 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -66.61 -43.2 7.96 Favored 'Trans proline' 0 C--N 1.347 0.485 0 CA-C-N 119.776 1.788 . . . . 0.0 115.184 -174.457 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 90.9 mt-10 -110.07 31.13 6.11 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 -179.442 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -66.04 -48.32 71.49 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.553 -178.396 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 54.56 41.6 73.9 Favored Glycine 0 N--CA 1.46 0.279 0 C-N-CA 121.288 -0.482 . . . . 0.0 112.19 179.744 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 15.4 mt -124.61 104.32 31.02 Favored Pre-proline 0 N--CA 1.442 -0.858 0 N-CA-C 115.291 1.589 . . . . 0.0 115.291 -175.218 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -78.59 161.83 27.77 Favored 'Trans proline' 0 N--CA 1.461 -0.393 0 C-N-CA 122.516 2.144 . . . . 0.0 107.229 167.596 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 49.7 t80 -61.46 133.54 55.87 Favored 'General case' 0 C--N 1.319 -0.718 0 C-N-CA 120.425 -0.51 . . . . 0.0 110.283 -177.331 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 90.68 -8.62 79.53 Favored Glycine 0 CA--C 1.518 0.278 0 CA-C-O 119.518 -0.601 . . . . 0.0 114.394 179.599 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -66.3 130.3 42.76 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 118.569 1.184 . . . . 0.0 111.624 179.669 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 48.8 t-20 -80.25 130.33 35.13 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.479 -179.441 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 28.0 ttmt -156.1 154.56 31.12 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 106.865 -1.531 . . . . 0.0 106.865 -179.844 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -58.78 124.04 18.43 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.914 0.388 . . . . 0.0 110.868 -179.164 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 69.31 31.48 71.59 Favored Glycine 0 N--CA 1.449 -0.446 0 CA-C-O 119.044 -0.864 . . . . 0.0 115.029 177.556 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 43.2 mm -124.71 127.67 72.89 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 CA-C-N 118.045 0.922 . . . . 0.0 110.992 179.534 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -129.49 123.51 57.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.4 176.357 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 98.7 m95 -88.34 138.14 31.7 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 114.05 1.13 . . . . 0.0 114.05 -176.241 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 16.2 m -139.0 149.8 23.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 121.693 0.759 . . . . 0.0 110.053 178.936 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -159.22 161.12 36.04 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 103.915 -2.624 . . . . 0.0 103.915 178.405 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 13.9 t -118.23 172.78 7.2 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 105.227 -2.138 . . . . 0.0 105.227 178.559 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -66.43 131.95 47.19 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.811 0.339 . . . . 0.0 110.238 -178.624 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 90.98 -4.1 81.28 Favored Glycine 0 CA--C 1.519 0.283 0 C-N-CA 121.359 -0.448 . . . . 0.0 113.746 178.806 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.402 ' HA ' ' HA ' ' A' ' 41' ' ' ASP . . . -73.83 136.06 43.48 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 178.44 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 30.3 mt -89.22 140.55 29.36 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.51 0.671 . . . . 0.0 112.195 -177.071 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 61.9 t30 -83.98 64.95 8.42 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.193 -179.304 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -137.46 155.84 75.29 Favored Pre-proline 0 C--N 1.322 -0.593 0 N-CA-C 106.438 -1.69 . . . . 0.0 106.438 -178.956 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -66.48 151.43 83.05 Favored 'Trans proline' 0 C--N 1.342 0.223 0 N-CA-C 115.359 1.253 . . . . 0.0 115.359 179.993 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.557 ' HB3' HD12 ' A' ' 106' ' ' ILE . 73.3 mmtt -123.02 41.19 3.53 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 114.44 -1.254 . . . . 0.0 108.909 -178.757 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 18.3 p-10 -51.22 -43.4 61.43 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 114.235 -1.348 . . . . 0.0 111.329 178.848 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 46.5 p-80 -66.45 -10.94 49.19 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 124.567 1.147 . . . . 0.0 113.953 -178.839 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.557 HD12 ' HB3' ' A' ' 103' ' ' LYS . 50.4 mt -96.11 -38.22 8.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 179.806 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -74.58 1.74 50.63 Favored Glycine 0 C--O 1.225 -0.453 0 N-CA-C 115.59 0.996 . . . . 0.0 115.59 -177.759 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 14.7 t -83.39 18.8 1.69 Allowed 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 117.869 0.835 . . . . 0.0 112.753 -176.635 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.442 ' HD2' ' OD1' ' A' ' 114' ' ' ASN . 64.2 ttp85 -57.03 130.57 46.69 Favored 'General case' 0 N--CA 1.467 0.391 0 O-C-N 121.998 -0.439 . . . . 0.0 110.129 178.862 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 35.8 m120 -88.49 117.63 68.56 Favored Pre-proline 0 C--N 1.323 -0.546 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 179.843 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -72.76 -13.2 26.87 Favored 'Trans proline' 0 C--O 1.217 -0.531 0 C-N-CA 117.128 -1.448 . . . . 0.0 112.835 -179.528 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -78.4 -27.18 46.66 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.568 177.413 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 -102.06 -25.69 13.65 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 113.237 0.829 . . . . 0.0 113.237 -174.795 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 114' ' ' ASN . . . . . 0.442 ' OD1' ' HD2' ' A' ' 109' ' ' ARG . 5.0 t-20 -128.7 147.61 50.77 Favored 'General case' 0 N--CA 1.442 -0.829 0 N-CA-C 113.149 0.796 . . . . 0.0 113.149 -177.905 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -95.28 129.23 42.49 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 173.808 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -62.16 148.15 45.4 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.448 -0.796 . . . . 0.0 112.371 -178.236 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 9.8 mt -80.72 138.99 18.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 114.89 -1.05 . . . . 0.0 109.432 -177.832 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 79.5 t -63.11 123.38 15.76 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 N-CA-C 106.12 -1.807 . . . . 0.0 106.12 174.516 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 6.6 tt -65.63 130.48 43.46 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.258 0.552 . . . . 0.0 111.045 -176.876 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 31.0 mt-30 -132.99 159.02 41.21 Favored 'General case' 0 CA--C 1.513 -0.461 0 N-CA-C 106.729 -1.582 . . . . 0.0 106.729 -179.553 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 13.5 mt -112.97 146.73 35.72 Favored Pre-proline 0 C--N 1.323 -0.559 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 177.836 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -73.11 166.78 29.09 Favored 'Trans proline' 0 C--N 1.345 0.348 0 O-C-N 122.272 0.617 . . . . 0.0 113.038 -179.367 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 39.9 tt0 -54.89 131.53 44.53 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.902 179.998 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 95.8 -17.06 60.0 Favored Glycine 0 C--O 1.226 -0.371 0 CA-C-N 115.903 -0.589 . . . . 0.0 113.311 179.944 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.448 HG21 ' H ' ' A' ' 31' ' ' GLY . 16.0 m -103.72 128.85 51.04 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 118.073 0.937 . . . . 0.0 111.032 178.811 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 5.8 p -117.23 148.26 41.79 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.795 -179.416 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 83.4 mt -71.23 157.8 89.41 Favored Pre-proline 0 C--N 1.324 -0.504 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 176.989 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -75.55 174.15 13.3 Favored 'Trans proline' 0 C--O 1.237 0.451 0 C-N-CA 117.514 -1.191 . . . . 0.0 109.866 178.367 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 64.1 tttm -62.06 125.94 25.61 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.437 0.636 . . . . 0.0 110.454 -177.141 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 82.31 45.44 6.99 Favored Glycine 0 C--O 1.226 -0.378 0 N-CA-C 115.275 0.87 . . . . 0.0 115.275 178.3 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -141.54 150.87 42.7 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 117.856 0.828 . . . . 0.0 111.476 177.852 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 42.6 p90 -149.95 165.61 32.12 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 176.65 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -101.92 145.32 29.4 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.155 0.502 . . . . 0.0 111.468 -177.993 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -72.69 127.83 33.73 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 179.964 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 92.21 -15.04 63.04 Favored Glycine 0 C--O 1.228 -0.224 0 CA-C-N 115.948 -0.569 . . . . 0.0 113.574 179.506 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 33.5 t -78.79 126.97 31.43 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 179.978 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 72.3 mtm-85 -144.82 157.99 43.96 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 179.584 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -93.65 -177.3 39.85 Favored Glycine 0 C--N 1.321 -0.299 0 N-CA-C 107.587 -2.205 . . . . 0.0 107.587 173.306 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -173.82 169.67 42.74 Favored Glycine 0 N--CA 1.45 -0.395 0 N-CA-C 107.076 -2.41 . . . . 0.0 107.076 178.737 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 14.4 m . . . . . 0 C--O 1.246 0.893 0 O-C-N 124.924 1.014 . . . . 0.0 110.579 -176.7 . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.215 0 CA-C-O 118.109 -1.384 . . . . 0.0 111.043 . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -103.14 14.77 31.0 Favored 'General case' 0 C--O 1.211 -0.926 0 N-CA-C 114.975 1.472 . . . . 0.0 114.975 -175.695 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 41.1 mtm 61.68 -9.44 0.08 Allowed 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 119.119 3.007 . . . . 0.0 119.119 178.47 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -79.02 65.64 3.53 Favored Glycine 0 C--N 1.309 -0.96 0 CA-C-N 114.932 -1.031 . . . . 0.0 114.066 -176.933 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 89.6 mt -83.74 134.13 45.12 Favored Pre-proline 0 C--N 1.32 -0.7 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 178.783 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -76.3 110.34 3.05 Favored 'Trans proline' 0 CA--C 1.534 0.5 0 C-N-CA 118.653 -0.432 . . . . 0.0 111.885 177.868 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 88.8 m-20 -87.41 -33.18 19.19 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 114.299 1.222 . . . . 0.0 114.299 -176.903 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 52.5 t30 -145.57 39.12 1.15 Allowed 'General case' 0 C--O 1.218 -0.602 0 CA-C-O 121.672 0.748 . . . . 0.0 111.661 -179.428 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 25.3 p -138.9 137.83 36.85 Favored 'General case' 0 CA--C 1.504 -0.803 0 N-CA-C 100.825 -3.768 . . . . 0.0 100.825 179.121 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -141.1 145.96 36.46 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-O 121.3 0.571 . . . . 0.0 111.137 -179.284 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 17.1 t -65.73 139.96 58.41 Favored 'General case' 0 CA--C 1.512 -0.513 0 N-CA-C 106.954 -1.499 . . . . 0.0 106.954 176.825 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 6.9 m95 -69.62 -21.91 63.53 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.136 0.493 . . . . 0.0 110.276 177.939 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 17.5 m-85 -121.42 161.91 21.35 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.393 -0.821 . . . . 0.0 112.452 -172.223 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.418 ' HB ' ' HB3' ' A' ' 134' ' ' GLU . 67.8 p -69.13 164.77 21.8 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 179.079 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -81.1 140.26 35.16 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 113.06 0.763 . . . . 0.0 113.06 -176.592 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 20.1 mt -78.82 148.22 32.95 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 103.576 -2.75 . . . . 0.0 103.576 170.614 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 16.2 m -130.12 134.76 47.56 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 118.189 0.45 . . . . 0.0 110.605 -178.005 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.42 ' HB2' ' CZ ' ' A' ' 131' ' ' PHE . 4.1 tp60 -100.87 141.56 33.58 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 -177.804 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 52.1 t60 -128.56 99.66 5.46 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 104.636 -2.357 . . . . 0.0 104.636 169.126 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 164.43 -158.76 31.54 Favored Glycine 0 N--CA 1.452 -0.251 0 N-CA-C 108.239 -1.945 . . . . 0.0 108.239 -175.892 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -115.59 -20.9 9.98 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 117.688 0.744 . . . . 0.0 111.127 179.18 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -72.11 153.69 41.53 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.201 -0.909 . . . . 0.0 109.121 178.701 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -82.23 -62.89 1.5 Allowed 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 113.905 1.076 . . . . 0.0 113.905 -176.832 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 50.1 tp 165.33 142.18 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.268 0 N-CA-C 105.815 -1.92 . . . . 0.0 105.815 179.025 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 51.8 tptt -157.25 139.6 14.67 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 173.46 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 16.3 m-85 -122.47 151.92 60.48 Favored Pre-proline 0 C--O 1.241 0.636 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 175.865 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -70.4 161.32 46.43 Favored 'Trans proline' 0 C--N 1.351 0.659 0 O-C-N 122.261 0.611 . . . . 0.0 112.496 178.625 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 22.7 tpt180 -67.83 135.55 52.75 Favored 'General case' 0 C--O 1.216 -0.673 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 -178.249 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 82.55 10.78 82.91 Favored Glycine 0 C--O 1.223 -0.565 0 C-N-CA 121.218 -0.515 . . . . 0.0 111.87 178.87 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 10.2 mt-30 -150.37 170.5 18.89 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 -175.116 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 105.68 -16.56 43.83 Favored Glycine 0 CA--C 1.503 -0.711 0 CA-C-N 116.289 -0.414 . . . . 0.0 113.393 174.887 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 94.1 t -65.75 130.03 94.43 Favored Pre-proline 0 C--N 1.319 -0.726 0 N-CA-C 106.273 -1.751 . . . . 0.0 106.273 177.027 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -72.64 171.17 17.76 Favored 'Trans proline' 0 N--CA 1.46 -0.468 0 O-C-N 122.194 0.576 . . . . 0.0 111.23 178.084 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 87.9 mt -71.01 107.06 2.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 179.801 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 -99.55 84.82 3.02 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.523 -1.217 . . . . 0.0 110.55 -176.329 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 75.7 p -67.97 -14.96 63.38 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.644 -0.707 . . . . 0.0 112.568 -179.204 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -108.48 21.71 16.93 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.15 -0.932 . . . . 0.0 112.871 -177.646 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 11.8 m -140.71 148.09 40.21 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 113.454 0.909 . . . . 0.0 113.454 -177.14 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -72.0 166.08 44.09 Favored Pre-proline 0 C--N 1.326 -0.418 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 177.068 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -64.8 -27.22 59.7 Favored 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 115.376 -2.616 . . . . 0.0 111.793 178.69 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -62.26 -28.77 69.94 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.786 0.803 . . . . 0.0 111.132 176.451 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -96.6 1.02 50.82 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 115.348 1.611 . . . . 0.0 115.348 -171.042 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 94.9 mm-40 -61.4 -30.1 70.34 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 113.841 1.052 . . . . 0.0 113.841 179.641 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 14.6 tt -61.22 138.0 22.65 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.789 0 CA-C-O 122.322 1.058 . . . . 0.0 113.346 -177.937 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 179.17 -155.55 16.29 Favored Glycine 0 N--CA 1.449 -0.447 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.468 -177.976 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 46.8 p90 -155.07 171.14 20.25 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 179.786 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 22.4 m-85 -111.56 138.92 47.46 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 173.813 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 40.4 ttt-85 -110.96 120.16 41.45 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 124.034 0.934 . . . . 0.0 110.298 -177.229 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 52.0 ttp180 -68.26 140.92 56.02 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 178.183 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -142.77 148.73 37.66 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.223 0.535 . . . . 0.0 110.344 179.231 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -158.14 154.22 27.08 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 104.387 -2.449 . . . . 0.0 104.387 176.252 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 20.9 tpt85 -150.81 133.02 15.39 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 177.462 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 72.4 ttt180 -143.38 153.2 42.46 Favored 'General case' 0 CA--C 1.496 -1.131 0 CA-C-O 121.835 0.826 . . . . 0.0 110.528 178.281 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -148.13 -179.68 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 N-CA-C 103.463 -2.791 . . . . 0.0 103.463 179.971 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.64 99.23 6.2 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 174.305 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -71.54 159.63 53.87 Favored Glycine 0 C--O 1.227 -0.308 0 N-CA-C 106.894 -2.482 . . . . 0.0 106.894 176.84 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -60.72 -42.49 99.41 Favored Glycine 0 C--O 1.222 -0.65 0 CA-C-N 118.867 1.333 . . . . 0.0 111.832 -179.486 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -92.82 17.02 11.14 Favored 'General case' 0 CA--C 1.546 0.825 0 CA-C-O 122.895 1.331 . . . . 0.0 110.782 178.822 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 90.06 -1.24 80.01 Favored Glycine 0 N--CA 1.462 0.402 0 N-CA-C 118.163 2.025 . . . . 0.0 118.163 169.145 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.408 ' H ' ' HD2' ' A' ' 60' ' ' LYS . 2.1 mptp? -59.27 139.66 56.76 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.999 0.904 . . . . 0.0 111.992 -178.023 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 63.4 mtp -97.23 -178.26 4.11 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 113.419 -1.719 . . . . 0.0 109.475 178.041 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 5.4 tmtt? -109.94 -55.71 2.41 Favored 'General case' 0 CA--C 1.508 -0.64 0 CA-C-O 121.538 0.685 . . . . 0.0 110.836 -178.782 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -125.07 165.05 18.88 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 103.307 -2.849 . . . . 0.0 103.307 177.105 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 94.3 mt -119.57 -99.68 0.44 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 117.888 0.313 . . . . 0.0 111.228 -176.715 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.21 156.38 88.25 Favored Pre-proline 0 C--N 1.325 -0.476 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 179.018 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -68.43 142.59 54.77 Favored 'Trans proline' 0 C--O 1.241 0.674 0 C-N-CA 114.777 -3.015 . . . . 0.0 112.628 -179.775 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 13.4 mtp180 -119.79 160.47 22.56 Favored 'General case' 0 CA--C 1.511 -0.539 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.662 -178.944 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 55.7 m95 -131.29 128.63 40.19 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.445 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 50.0 m-85 -110.45 144.87 38.59 Favored 'General case' 0 C--O 1.217 -0.622 0 N-CA-C 107.505 -1.295 . . . . 0.0 107.505 -177.773 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -89.84 129.97 36.15 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 118.801 0.728 . . . . 0.0 109.254 -178.297 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -132.35 133.07 43.54 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 -175.799 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -71.65 159.49 34.31 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.705 -0.68 . . . . 0.0 112.552 -176.13 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -53.99 129.26 33.57 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-O 121.069 0.461 . . . . 0.0 111.916 -179.448 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 73.26 26.66 69.9 Favored Glycine 0 C--O 1.22 -0.75 0 N-CA-C 115.887 1.115 . . . . 0.0 115.887 176.971 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 2.9 p -90.63 146.07 24.34 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 118.601 1.201 . . . . 0.0 109.336 178.904 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 100.32 136.1 9.2 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 110.126 -1.19 . . . . 0.0 110.126 -178.737 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -69.33 -41.63 4.63 Favored 'Trans proline' 0 C--N 1.349 0.556 0 CA-C-N 119.628 1.714 . . . . 0.0 116.068 -174.122 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -107.03 23.09 14.97 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 121.725 0.774 . . . . 0.0 108.921 -177.574 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -58.51 -45.23 89.22 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.736 -0.666 . . . . 0.0 111.27 -176.337 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 56.16 35.01 63.36 Favored Glycine 0 C--O 1.228 -0.256 0 CA-C-N 116.021 -0.536 . . . . 0.0 112.571 179.447 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 15.1 mt -119.04 103.85 47.27 Favored Pre-proline 0 N--CA 1.446 -0.653 0 N-CA-C 115.112 1.523 . . . . 0.0 115.112 -175.477 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -78.79 163.72 26.02 Favored 'Trans proline' 0 N--CA 1.461 -0.427 0 C-N-CA 121.939 1.759 . . . . 0.0 107.994 168.531 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.407 ' CE1' ' HB3' ' A' ' 92' ' ' TRP . 74.9 t80 -61.5 130.58 46.68 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 120.305 -0.558 . . . . 0.0 111.085 -177.729 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 92.19 -7.74 78.16 Favored Glycine 0 CA--C 1.519 0.305 0 CA-C-O 119.326 -0.708 . . . . 0.0 114.704 178.699 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -64.0 131.81 48.72 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 118.391 1.096 . . . . 0.0 111.656 179.948 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 47.1 t-20 -77.83 128.12 33.48 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.647 -179.465 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 26.4 ttmt -155.46 150.37 26.54 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 106.567 -1.642 . . . . 0.0 106.567 179.269 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -64.24 129.05 38.44 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.902 0.382 . . . . 0.0 110.968 -177.219 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 71.04 26.45 73.85 Favored Glycine 0 CA--C 1.52 0.346 0 CA-C-O 119.348 -0.696 . . . . 0.0 114.767 179.764 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 41.8 mm -126.83 129.25 71.41 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 CA-C-N 117.572 0.686 . . . . 0.0 111.007 -179.965 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.1 pt -132.02 119.34 40.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 CA-C-O 121.542 0.687 . . . . 0.0 111.186 176.133 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 92' ' ' TRP . . . . . 0.407 ' HB3' ' CE1' ' A' ' 83' ' ' TYR . 95.3 m95 -84.68 138.92 32.39 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 113.651 0.982 . . . . 0.0 113.651 -176.9 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 16.5 m -138.03 151.28 25.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 179.03 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -159.89 166.62 29.85 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 105.497 -2.038 . . . . 0.0 105.497 -178.502 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 12.0 t -136.51 175.61 9.45 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 105.657 -1.979 . . . . 0.0 105.657 177.15 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -66.26 136.81 56.38 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.155 0.502 . . . . 0.0 110.783 -179.466 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 92.76 -10.53 73.83 Favored Glycine 0 C--O 1.224 -0.513 0 CA-C-N 115.839 -0.619 . . . . 0.0 113.566 177.311 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -74.24 134.34 42.68 Favored 'General case' 0 C--N 1.323 -0.586 0 O-C-N 122.409 -0.465 . . . . 0.0 111.227 -179.849 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 38.3 mt -91.73 133.36 35.67 Favored 'General case' 0 CA--C 1.513 -0.48 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 -177.804 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 55.6 t30 -81.27 70.43 8.11 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.188 -0.914 . . . . 0.0 110.838 -178.977 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 1.3 t -139.19 155.29 72.55 Favored Pre-proline 0 C--N 1.322 -0.629 0 N-CA-C 106.1 -1.815 . . . . 0.0 106.1 -179.392 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -67.32 148.46 79.96 Favored 'Trans proline' 0 CA--C 1.53 0.32 0 C-N-CA 118.114 -0.791 . . . . 0.0 113.176 176.418 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -148.64 52.55 0.99 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 122.788 1.28 . . . . 0.0 110.435 179.243 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 13.0 p-10 -60.28 -30.48 69.49 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 114.047 -1.433 . . . . 0.0 110.829 179.268 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 16.0 p80 -59.15 -12.59 5.33 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 114.578 1.325 . . . . 0.0 114.578 -179.149 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 54.0 mt -86.5 -32.08 6.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 178.721 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -75.33 12.96 6.55 Favored Glycine 0 CA--C 1.522 0.479 0 N-CA-C 114.764 0.666 . . . . 0.0 114.764 -177.462 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 11.8 t -83.13 13.4 4.15 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 113.103 0.779 . . . . 0.0 113.103 -178.471 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 66.7 ttp85 -58.66 122.55 13.74 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 178.369 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -97.79 129.59 30.95 Favored Pre-proline 0 C--N 1.321 -0.669 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 -178.872 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -69.68 -15.4 37.38 Favored 'Trans proline' 0 C--O 1.219 -0.462 0 O-C-N 122.072 0.511 . . . . 0.0 113.087 -179.193 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -75.94 -26.58 57.02 Favored 'General case' 0 C--O 1.221 -0.425 0 CA-C-O 120.847 0.356 . . . . 0.0 110.404 177.738 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 76.1 m-20 -104.13 -27.23 12.2 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 113.724 1.009 . . . . 0.0 113.724 -174.727 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 -152.15 149.04 28.34 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 113.078 0.77 . . . . 0.0 113.078 -177.283 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -90.44 150.45 21.82 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-O 121.457 0.646 . . . . 0.0 111.476 179.325 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -70.18 145.23 51.62 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.248 0.547 . . . . 0.0 111.284 178.867 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 17.9 mt -82.86 139.33 17.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 -179.029 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 99.2 t -59.58 122.9 10.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 N-CA-C 106.642 -1.614 . . . . 0.0 106.642 175.299 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 7.2 tt -68.18 129.04 38.74 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.139 0.495 . . . . 0.0 110.112 -176.703 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 31.5 mt-30 -131.12 158.74 39.63 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 -179.162 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 13.7 mt -113.27 147.57 37.67 Favored Pre-proline 0 C--N 1.322 -0.623 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 177.822 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -74.37 168.9 23.72 Favored 'Trans proline' 0 C--O 1.235 0.366 0 O-C-N 122.224 0.592 . . . . 0.0 113.276 -179.313 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 38.6 tt0 -54.14 131.95 42.1 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.518 -0.765 . . . . 0.0 109.415 179.411 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 99.01 -22.58 40.28 Favored Glycine 0 C--O 1.227 -0.282 0 CA-C-O 119.542 -0.588 . . . . 0.0 113.193 -179.779 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 4.1 m -106.63 127.58 53.46 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 118.361 1.081 . . . . 0.0 111.203 178.887 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 7.1 p -121.14 148.38 44.28 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.951 -179.562 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 92.7 mt -70.5 151.28 95.6 Favored Pre-proline 0 C--N 1.324 -0.513 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 178.874 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -78.6 172.92 14.43 Favored 'Trans proline' 0 N--CA 1.463 -0.303 0 O-C-N 122.0 0.473 . . . . 0.0 111.385 178.796 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 1.7 tmmt? -54.44 130.05 38.06 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.78 -177.847 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 91.53 -7.43 79.92 Favored Glycine 0 C--O 1.229 -0.19 0 N-CA-C 115.794 1.078 . . . . 0.0 115.794 175.655 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.42 ' CZ ' ' HB2' ' A' ' 18' ' ' GLN . 2.3 m-85 -97.84 142.54 29.48 Favored 'General case' 0 N--CA 1.441 -0.888 0 CA-C-O 122.311 1.053 . . . . 0.0 112.859 -177.818 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 47.0 p90 -141.73 165.1 28.41 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 113.473 -1.694 . . . . 0.0 106.961 173.974 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -102.51 143.75 31.82 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.731 0.3 . . . . 0.0 110.274 -178.583 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.418 ' HB3' ' HB ' ' A' ' 14' ' ' THR . 6.5 tp10 -71.55 135.7 47.16 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 106.762 -1.57 . . . . 0.0 106.762 177.84 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 93.33 -7.82 75.33 Favored Glycine 0 C--O 1.225 -0.412 0 C-N-CA 121.369 -0.443 . . . . 0.0 113.497 -177.626 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 34.6 t -136.12 131.79 35.21 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 117.842 0.821 . . . . 0.0 111.221 177.194 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 16.9 mmt85 -143.32 -44.92 0.29 Allowed 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 113.521 0.934 . . . . 0.0 113.521 -179.962 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 84.38 -176.87 51.56 Favored Glycine 0 N--CA 1.453 -0.199 0 N-CA-C 108.668 -1.773 . . . . 0.0 108.668 -176.031 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 166.84 -163.58 37.16 Favored Glycine 0 N--CA 1.451 -0.35 0 N-CA-C 106.875 -2.49 . . . . 0.0 106.875 -178.42 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 54.8 p . . . . . 0 C--O 1.241 0.62 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 177.794 . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.763 0 CA-C-O 118.553 -1.137 . . . . 0.0 111.088 . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -86.55 49.07 1.73 Allowed 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 118.344 1.072 . . . . 0.0 108.899 177.959 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -162.95 176.06 10.54 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 102.742 -3.059 . . . . 0.0 102.742 -175.235 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 152.24 -29.38 0.88 Allowed Glycine 0 C--N 1.319 -0.389 0 CA-C-O 121.543 0.524 . . . . 0.0 112.019 -178.689 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 94.7 mt -110.42 136.4 20.58 Favored Pre-proline 0 C--N 1.322 -0.592 0 N-CA-C 107.478 -1.305 . . . . 0.0 107.478 177.752 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -73.99 155.42 47.93 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 117.276 -1.349 . . . . 0.0 112.976 -178.452 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 10.0 m120 -68.25 -32.99 73.55 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.315 179.659 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 31.7 t30 -164.67 -80.58 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 178.1 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 44.4 p 36.3 75.86 0.06 Allowed 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 115.148 1.536 . . . . 0.0 115.148 -179.911 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -102.28 131.65 48.73 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.382 -0.826 . . . . 0.0 109.813 -178.726 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 39.3 p -65.47 142.77 58.04 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.806 -0.812 . . . . 0.0 108.806 177.93 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 12' ' ' TRP . . . . . 0.44 ' CD2' ' HD3' ' A' ' 109' ' ' ARG . 14.8 m95 -67.69 -21.85 65.31 Favored 'General case' 0 CA--C 1.511 -0.557 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 178.066 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 44.4 m-85 -121.42 160.87 23.23 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 113.8 1.037 . . . . 0.0 113.8 -170.518 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 59.0 p -71.85 166.99 20.95 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 113.891 -1.504 . . . . 0.0 109.637 179.243 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.431 ' HB2' ' CZ ' ' A' ' 69' ' ' TYR . . . -80.29 131.11 35.6 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 -177.136 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 13.8 mt -74.51 146.43 42.71 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 103.278 -2.86 . . . . 0.0 103.278 170.1 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 24.8 m -126.8 136.65 52.67 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 -177.207 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.452 ' HB2' ' CZ ' ' A' ' 131' ' ' PHE . 4.7 tp60 -111.9 139.97 46.95 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 114.036 1.125 . . . . 0.0 114.036 -175.328 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 57.7 t60 -130.32 99.48 5.04 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 106.541 -1.652 . . . . 0.0 106.541 170.496 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 173.95 -170.57 43.71 Favored Glycine 0 C--O 1.227 -0.293 0 N-CA-C 109.014 -1.634 . . . . 0.0 109.014 -177.973 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -97.97 -24.25 15.45 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 117.523 0.662 . . . . 0.0 111.694 178.963 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -83.5 157.45 22.39 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 106.111 -1.811 . . . . 0.0 106.111 174.816 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -93.18 -62.76 1.31 Allowed 'General case' 0 C--O 1.215 -0.73 0 C-N-CA 120.123 -0.631 . . . . 0.0 112.637 -176.838 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 42.5 tp -169.83 138.62 1.82 Allowed 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 175.291 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 10.8 tmtt? -153.89 128.59 9.38 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 176.303 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -117.91 159.35 43.06 Favored Pre-proline 0 CA--C 1.547 0.835 0 N-CA-C 110.378 -0.23 . . . . 0.0 110.378 178.096 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -69.12 173.92 9.7 Favored 'Trans proline' 0 C--N 1.354 0.821 0 C-N-CA 121.687 1.591 . . . . 0.0 115.015 -179.574 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -78.37 132.74 37.51 Favored 'General case' 0 C--O 1.216 -0.699 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 178.116 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 69.42 14.21 68.96 Favored Glycine 0 C--O 1.225 -0.415 0 N-CA-C 115.089 0.796 . . . . 0.0 115.089 175.732 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 4.8 tt0 -157.77 148.11 20.65 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 105.758 -1.942 . . . . 0.0 105.758 -178.079 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 136.04 -17.12 3.89 Favored Glycine 0 CA--C 1.502 -0.72 0 C-N-CA 120.187 -1.006 . . . . 0.0 112.723 175.648 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 30.3 m -70.46 145.21 92.65 Favored Pre-proline 0 C--N 1.321 -0.666 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 177.042 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -76.76 167.53 25.19 Favored 'Trans proline' 0 N--CA 1.461 -0.395 0 C-N-CA 122.187 1.925 . . . . 0.0 113.74 179.695 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 97.9 mt -69.68 128.11 32.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 178.696 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 51.4 t-20 -125.49 122.17 35.85 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.889 -0.411 . . . . 0.0 109.889 175.998 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 74.2 p -92.74 -15.49 26.58 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 113.668 0.988 . . . . 0.0 113.668 -177.189 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 20.0 p30 -109.27 21.49 17.04 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 115.259 1.577 . . . . 0.0 115.259 -174.009 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 37.8 m -147.42 164.88 31.94 Favored 'General case' 0 N--CA 1.468 0.437 0 O-C-N 121.918 -0.489 . . . . 0.0 111.538 -179.875 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 32.6 m -75.27 164.44 61.11 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.703 -178.632 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -65.16 -24.81 58.52 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 115.529 -2.514 . . . . 0.0 111.769 177.362 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -59.75 -33.78 72.11 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 122.051 0.929 . . . . 0.0 110.613 176.559 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -83.35 -7.65 59.54 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 114.954 1.465 . . . . 0.0 114.954 -173.903 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 93.0 mm-40 -65.85 -31.64 72.71 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 114.521 1.304 . . . . 0.0 114.521 -174.806 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 14.7 tt -58.9 138.75 19.56 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 CA-C-O 122.076 0.941 . . . . 0.0 112.078 179.314 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 179.0 -148.36 8.21 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.124 -175.556 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.412 ' CE1' HD12 ' A' ' 90' ' ' ILE . 46.1 p90 -154.96 166.87 32.19 Favored 'General case' 0 C--N 1.32 -0.711 0 O-C-N 122.438 -0.448 . . . . 0.0 110.263 179.786 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 40.3 m-85 -107.51 141.97 38.11 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 174.116 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 58.6 ttt-85 -114.22 120.53 40.76 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 123.454 0.702 . . . . 0.0 112.028 -175.926 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 62.8 ttt-85 -64.43 141.4 58.79 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 122.789 0.436 . . . . 0.0 110.165 177.697 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -150.67 132.94 15.45 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.173 0.511 . . . . 0.0 112.249 178.624 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 7.0 p -149.48 139.74 22.26 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 107.259 -1.386 . . . . 0.0 107.259 175.818 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 25.0 tpt180 -147.1 123.98 11.29 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 175.385 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.53 145.34 47.41 Favored 'General case' 0 CA--C 1.484 -1.592 0 CA-C-O 122.313 1.054 . . . . 0.0 112.434 -178.951 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -142.32 176.32 3.89 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 N-CA-C 104.686 -2.338 . . . . 0.0 104.686 176.23 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 4.1 tmt_? -129.2 101.62 6.09 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 105.192 -2.151 . . . . 0.0 105.192 176.472 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -69.01 154.7 53.46 Favored Glycine 0 C--O 1.221 -0.697 0 N-CA-C 109.903 -1.279 . . . . 0.0 109.903 -178.434 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -64.93 -37.95 94.9 Favored Glycine 0 C--O 1.222 -0.637 0 N-CA-C 110.095 -1.202 . . . . 0.0 110.095 -178.219 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 27.5 t0 -89.79 16.95 7.16 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-O 122.339 1.066 . . . . 0.0 110.269 179.208 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 86.93 -15.66 51.71 Favored Glycine 0 C--O 1.227 -0.33 0 N-CA-C 115.818 1.087 . . . . 0.0 115.818 174.087 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -62.1 135.78 57.66 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 122.189 0.995 . . . . 0.0 112.705 -177.911 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 87.5 mtp -108.32 -174.21 2.46 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 113.704 -1.589 . . . . 0.0 109.821 -178.431 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 11.4 mmtt -105.56 -61.83 1.44 Allowed 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 120.979 0.418 . . . . 0.0 110.963 -179.077 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 19.8 p30 -132.74 168.28 18.61 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 176.734 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -128.99 -60.99 1.06 Allowed 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 -179.267 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -81.35 151.31 69.01 Favored Pre-proline 0 C--N 1.32 -0.714 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 176.395 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -70.58 152.02 64.77 Favored 'Trans proline' 0 C--O 1.239 0.569 0 C-N-CA 116.551 -1.833 . . . . 0.0 111.397 177.672 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 7.4 mtp180 -125.07 158.57 33.48 Favored 'General case' 0 CA--C 1.515 -0.4 0 C-N-CA 121.09 -0.244 . . . . 0.0 110.7 -179.786 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 48.2 m95 -131.75 136.4 47.56 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 178.312 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.431 ' CZ ' ' HB2' ' A' ' 15' ' ' ALA . 48.1 m-85 -110.37 172.95 6.56 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 104.804 -2.295 . . . . 0.0 104.804 -179.91 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 92.4 t80 -124.03 136.72 54.46 Favored 'General case' 0 CA--C 1.51 -0.595 0 CA-C-N 119.526 1.057 . . . . 0.0 108.597 -178.721 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 34.6 m-85 -137.51 148.89 46.35 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 -176.246 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 44.0 m-85 -84.05 159.52 21.15 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.359 -176.152 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -54.93 132.04 45.83 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.203 178.054 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 67.29 38.37 91.51 Favored Glycine 0 C--O 1.225 -0.436 0 N-CA-C 115.206 0.842 . . . . 0.0 115.206 177.124 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.2 p -94.05 146.16 24.15 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 175.757 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 90.5 136.0 6.37 Favored Glycine 0 CA--C 1.525 0.686 0 CA-C-O 119.699 -0.5 . . . . 0.0 112.289 -178.033 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -68.86 -41.73 5.23 Favored 'Trans proline' 0 C--N 1.348 0.539 0 N-CA-C 116.257 1.599 . . . . 0.0 116.257 -175.513 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -113.02 23.41 13.4 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.445 0.64 . . . . 0.0 109.717 -177.855 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -61.48 -32.86 72.89 Favored 'General case' 0 C--O 1.239 0.509 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.432 -177.563 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 59.02 33.03 72.29 Favored Glycine 0 C--O 1.227 -0.295 0 CA-C-N 115.406 -0.815 . . . . 0.0 114.184 176.681 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 14.7 mt -118.28 103.65 49.13 Favored Pre-proline 0 N--CA 1.444 -0.76 0 N-CA-C 114.874 1.435 . . . . 0.0 114.874 -177.704 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -79.73 164.69 23.01 Favored 'Trans proline' 0 C--O 1.235 0.36 0 C-N-CA 122.783 2.322 . . . . 0.0 107.78 167.455 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 60.6 t80 -62.32 131.67 50.09 Favored 'General case' 0 C--N 1.321 -0.666 0 C-N-CA 120.367 -0.533 . . . . 0.0 110.338 -178.066 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 91.14 -5.65 81.44 Favored Glycine 0 C--O 1.228 -0.273 0 N-CA-C 114.901 0.72 . . . . 0.0 114.901 179.031 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -66.77 130.49 43.33 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 118.649 1.225 . . . . 0.0 111.608 179.499 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 57.0 t30 -74.92 128.37 35.41 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.892 -179.186 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 26.4 ttmt -156.01 152.01 27.59 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 106.354 -1.721 . . . . 0.0 106.354 178.476 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -65.61 132.7 49.48 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.069 0.461 . . . . 0.0 110.615 -178.059 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 69.31 25.92 75.04 Favored Glycine 0 N--CA 1.449 -0.495 0 CA-C-N 115.714 -0.675 . . . . 0.0 114.239 177.97 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.412 HD12 ' CE1' ' A' ' 46' ' ' TYR . 47.7 mm -124.82 126.63 71.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 117.345 0.572 . . . . 0.0 110.842 179.945 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -127.08 116.98 46.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.356 176.243 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 96.9 m95 -82.22 135.66 35.21 Favored 'General case' 0 C--N 1.319 -0.72 0 O-C-N 121.864 -0.522 . . . . 0.0 112.227 -177.676 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -142.22 154.97 18.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 -178.113 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -154.92 166.52 33.28 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 106.193 -1.78 . . . . 0.0 106.193 -176.635 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 14.7 t -121.79 164.63 17.13 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 103.211 -2.885 . . . . 0.0 103.211 171.53 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -67.56 136.08 53.95 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 -179.099 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 92.84 -9.67 75.14 Favored Glycine 0 C--O 1.224 -0.501 0 CA-C-N 115.986 -0.552 . . . . 0.0 113.833 178.504 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -74.16 143.08 45.41 Favored 'General case' 0 CA--C 1.545 0.756 0 O-C-N 122.339 -0.506 . . . . 0.0 110.429 179.143 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 40.2 mt -93.17 133.48 36.32 Favored 'General case' 0 CA--C 1.516 -0.347 0 N-CA-C 115.004 1.483 . . . . 0.0 115.004 -175.496 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 61.6 t30 -79.67 64.68 4.61 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 114.683 -1.144 . . . . 0.0 110.966 -178.256 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -135.85 157.41 76.07 Favored Pre-proline 0 C--N 1.322 -0.588 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 -178.152 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -73.27 148.24 43.45 Favored 'Trans proline' 0 CA--C 1.534 0.493 0 N-CA-C 114.496 0.921 . . . . 0.0 114.496 175.338 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.54 58.85 1.07 Allowed 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 177.595 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -64.01 -14.37 53.68 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.275 176.449 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 18.0 p-80 -61.53 -14.46 29.78 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 179.396 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 23.4 mt -92.81 -26.7 4.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 121.329 0.585 . . . . 0.0 109.616 179.456 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -81.3 10.34 49.83 Favored Glycine 0 N--CA 1.459 0.232 0 O-C-N 122.007 -0.433 . . . . 0.0 113.63 -178.128 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 12.4 t -83.22 6.48 19.33 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 122.295 -0.532 . . . . 0.0 111.262 -178.4 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.44 ' HD3' ' CD2' ' A' ' 12' ' ' TRP . 63.5 ttp85 -54.51 133.61 46.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.509 179.908 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 35.0 m120 -96.97 115.82 65.85 Favored Pre-proline 0 C--N 1.326 -0.455 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 178.8 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -73.23 -11.53 25.03 Favored 'Trans proline' 0 C--O 1.219 -0.473 0 C-N-CA 117.45 -1.233 . . . . 0.0 113.351 -178.155 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -80.54 -25.45 38.63 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.215 177.436 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 -101.99 -25.44 13.76 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 113.543 0.942 . . . . 0.0 113.543 -174.334 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -140.42 154.27 46.6 Favored 'General case' 0 N--CA 1.434 -1.226 0 CA-C-O 121.497 0.665 . . . . 0.0 109.45 -177.59 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -93.36 144.45 25.31 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 114.938 -1.028 . . . . 0.0 110.837 -179.531 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -68.83 145.44 53.73 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.37 0.605 . . . . 0.0 110.561 178.853 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 27.8 mt -81.59 137.44 21.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 -178.723 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 1.2 p -62.08 125.99 19.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 176.324 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 6.4 tt -67.11 127.52 32.91 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.01 0.434 . . . . 0.0 110.116 -177.013 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 29.7 mt-30 -130.86 155.84 46.04 Favored 'General case' 0 CA--C 1.512 -0.488 0 N-CA-C 107.251 -1.388 . . . . 0.0 107.251 -179.132 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 13.5 mt -111.97 148.6 39.35 Favored Pre-proline 0 C--N 1.322 -0.616 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 179.029 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -71.5 164.52 35.45 Favored 'Trans proline' 0 C--N 1.346 0.403 0 O-C-N 122.278 0.62 . . . . 0.0 112.814 -179.037 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 65.1 tt0 -55.12 132.51 47.59 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.422 -179.649 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 96.57 -16.48 60.95 Favored Glycine 0 C--O 1.227 -0.32 0 CA-C-N 116.039 -0.528 . . . . 0.0 112.945 -179.002 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 6.1 m -107.59 126.77 52.96 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 117.907 0.853 . . . . 0.0 110.559 178.329 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 14.8 p -117.0 148.14 41.72 Favored 'General case' 0 CA--C 1.509 -0.605 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.534 -179.454 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 82.7 mt -68.37 152.37 96.62 Favored Pre-proline 0 C--N 1.321 -0.636 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 178.036 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -76.83 173.01 15.16 Favored 'Trans proline' 0 N--CA 1.462 -0.342 0 C-N-CA 117.87 -0.953 . . . . 0.0 110.43 177.989 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 84.4 tttt -57.27 128.42 36.9 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 113.485 0.92 . . . . 0.0 113.485 -174.12 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 95.12 -6.02 68.74 Favored Glycine 0 CA--C 1.518 0.227 0 N-CA-C 115.854 1.101 . . . . 0.0 115.854 176.15 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.452 ' CZ ' ' HB2' ' A' ' 18' ' ' GLN . 4.6 m-85 -92.38 147.09 23.18 Favored 'General case' 0 N--CA 1.437 -1.092 0 CA-C-O 122.962 1.363 . . . . 0.0 114.004 -178.194 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 48.5 p90 -146.76 163.51 35.76 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 112.29 -2.232 . . . . 0.0 107.274 172.94 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -105.31 143.69 33.12 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 112.762 0.653 . . . . 0.0 112.762 -177.398 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -76.78 147.95 36.96 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 175.368 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 95.02 -33.66 5.26 Favored Glycine 0 C--O 1.227 -0.333 0 C-N-CA 121.428 -0.415 . . . . 0.0 113.964 178.184 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -61.27 123.02 16.56 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.201 0.524 . . . . 0.0 111.658 177.113 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 28.9 mmm180 -124.72 16.19 8.73 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.541 179.08 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -67.51 143.99 43.31 Favored Glycine 0 C--N 1.319 -0.392 0 N-CA-C 108.44 -1.864 . . . . 0.0 108.44 177.362 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 165.94 -157.06 29.37 Favored Glycine 0 N--CA 1.451 -0.356 0 N-CA-C 108.224 -1.95 . . . . 0.0 108.224 -177.675 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 56.4 p . . . . . 0 C--O 1.253 1.244 0 CA-C-O 115.477 -2.201 . . . . 0.0 105.485 179.316 . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.484 0 CA-C-O 118.769 -1.017 . . . . 0.0 111.318 . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -101.37 131.89 47.23 Favored 'General case' 0 C--O 1.22 -0.45 0 CA-C-N 118.457 1.128 . . . . 0.0 111.932 -177.302 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 5.5 ttt 53.02 14.48 0.47 Allowed 'General case' 0 N--CA 1.483 1.211 0 N-CA-C 117.637 2.458 . . . . 0.0 117.637 174.969 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -82.85 -33.75 23.46 Favored Glycine 0 C--O 1.225 -0.454 0 N-CA-C 115.794 1.078 . . . . 0.0 115.794 -177.797 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 96.3 mt -101.74 141.02 21.72 Favored Pre-proline 0 C--N 1.324 -0.535 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 -178.489 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -73.4 -17.94 23.49 Favored 'Trans proline' 0 C--N 1.351 0.661 0 N-CA-C 114.133 0.782 . . . . 0.0 114.133 -179.122 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 64.9 t30 50.48 43.33 27.15 Favored 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 114.525 1.306 . . . . 0.0 114.525 175.808 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -93.62 23.33 4.74 Favored 'General case' 0 N--CA 1.471 0.616 0 O-C-N 121.593 -0.692 . . . . 0.0 110.902 -179.67 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 20.1 p -73.98 88.68 1.88 Allowed 'General case' 0 C--O 1.239 0.522 0 C-N-CA 124.285 1.034 . . . . 0.0 111.115 -174.75 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -101.48 152.17 21.08 Favored 'General case' 0 N--CA 1.441 -0.898 0 CA-C-N 114.979 -1.009 . . . . 0.0 112.296 -175.634 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -61.8 143.65 55.98 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 114.767 -1.106 . . . . 0.0 110.287 177.785 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 21.1 m95 -69.38 -23.64 63.77 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 114.864 1.431 . . . . 0.0 114.864 -178.514 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 86.2 m-85 -121.52 161.07 22.95 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.186 0.517 . . . . 0.0 112.384 -172.747 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 74.6 p -70.31 161.58 30.12 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 177.013 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -74.83 153.79 38.57 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.902 0.858 . . . . 0.0 113.191 -175.995 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 22.6 mt -90.94 148.79 22.2 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 102.497 -3.149 . . . . 0.0 102.497 168.171 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 51.9 m -123.85 139.59 53.82 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 179.893 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.449 ' HB2' ' CZ ' ' A' ' 131' ' ' PHE . 4.3 tp60 -110.41 138.98 46.08 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-O 121.527 0.679 . . . . 0.0 112.298 -178.531 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 73.0 t60 -134.14 99.44 4.41 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 103.391 -2.818 . . . . 0.0 103.391 169.773 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 173.13 -165.97 38.34 Favored Glycine 0 C--O 1.225 -0.452 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 -176.055 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 37.9 mtmm -102.18 -25.09 13.83 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 113.956 1.095 . . . . 0.0 113.956 -178.221 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -89.21 162.1 16.08 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.056 -179.154 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -77.62 -62.95 1.5 Allowed 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.203 -176.916 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 34.6 tp 172.99 142.66 0.04 OUTLIER 'General case' 0 N--CA 1.482 1.133 0 N-CA-C 105.545 -2.02 . . . . 0.0 105.545 176.409 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 12.0 tmtt? -154.95 125.45 6.89 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 175.459 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -106.81 152.46 40.87 Favored Pre-proline 0 C--O 1.242 0.676 0 CA-C-O 120.457 0.17 . . . . 0.0 110.711 177.842 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -68.71 161.48 45.17 Favored 'Trans proline' 0 C--N 1.352 0.724 0 CA-C-O 121.226 0.427 . . . . 0.0 112.799 178.455 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 71.6 ttt180 -69.86 132.37 45.91 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 122.182 -0.324 . . . . 0.0 111.361 -175.846 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 79.35 13.6 82.53 Favored Glycine 0 C--O 1.222 -0.612 0 N-CA-C 111.697 -0.561 . . . . 0.0 111.697 179.254 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 31.0 mt-30 -148.23 171.74 15.45 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.18 -1.045 . . . . 0.0 108.18 -175.327 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 107.71 -10.22 38.11 Favored Glycine 0 CA--C 1.501 -0.786 0 CA-C-N 116.159 -0.473 . . . . 0.0 112.803 175.851 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.408 HG11 ' HB3' ' A' ' 43' ' ' GLN . 57.4 t -74.37 130.89 81.29 Favored Pre-proline 0 C--N 1.32 -0.685 0 N-CA-C 106.437 -1.69 . . . . 0.0 106.437 176.739 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -71.62 172.84 13.56 Favored 'Trans proline' 0 C--O 1.221 -0.34 0 O-C-N 122.179 0.568 . . . . 0.0 112.505 177.658 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 64.8 mt -75.85 106.3 5.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 122.228 1.013 . . . . 0.0 110.341 -179.111 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 38.8 m-20 -97.67 77.89 2.59 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 114.184 -1.371 . . . . 0.0 108.407 -179.425 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 80.7 p -63.88 -25.56 68.21 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 115.289 1.588 . . . . 0.0 115.289 -174.677 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -116.19 32.23 6.24 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 -176.369 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 5.9 m -133.06 166.87 21.42 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.678 0.275 . . . . 0.0 111.356 -178.903 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 25.0 m -77.57 155.92 81.0 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-N 116.583 -0.281 . . . . 0.0 111.657 -177.527 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -68.95 -20.91 38.08 Favored 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 116.804 -1.664 . . . . 0.0 114.378 -179.809 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.408 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 1.9 p-10 -76.95 -23.19 52.39 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 121.434 -0.791 . . . . 0.0 110.978 177.203 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -76.69 -13.08 60.07 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 114.715 1.376 . . . . 0.0 114.715 -170.924 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.408 ' HB3' HG11 ' A' ' 32' ' ' VAL . 29.2 mm100 -55.01 -28.15 49.78 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 113.934 1.086 . . . . 0.0 113.934 -175.025 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 13.6 tt -64.63 135.82 27.51 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.784 0 CA-C-O 122.316 1.055 . . . . 0.0 111.981 178.643 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 179.36 -155.91 17.06 Favored Glycine 0 N--CA 1.45 -0.432 0 N-CA-C 110.755 -0.938 . . . . 0.0 110.755 -177.54 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 33.2 p90 -155.1 168.34 27.35 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.882 0.341 . . . . 0.0 110.554 179.826 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 29.1 m-85 -112.79 141.2 46.87 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 175.345 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 73.7 ttt-85 -116.77 125.04 51.05 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.661 -0.7 . . . . 0.0 112.675 -177.969 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 50.4 ttp85 -69.15 141.05 54.71 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 121.084 0.468 . . . . 0.0 111.092 177.518 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -152.05 157.54 41.8 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 179.104 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 68.1 p -129.43 166.29 19.87 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 104.058 -2.571 . . . . 0.0 104.058 172.571 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 21.5 tpt180 -96.09 118.96 33.72 Favored 'General case' 0 C--O 1.218 -0.584 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 178.667 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 6.7 tmm_? -139.59 139.1 36.7 Favored 'General case' 0 CA--C 1.502 -0.88 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 -178.951 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -137.29 -179.6 2.93 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 114.802 -1.09 . . . . 0.0 108.245 -175.982 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 13.1 tpp85 -129.14 125.14 36.42 Favored 'General case' 0 C--O 1.221 -0.431 0 N-CA-C 105.02 -2.215 . . . . 0.0 105.02 174.339 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -156.02 144.03 10.43 Favored Glycine 0 C--O 1.224 -0.489 0 N-CA-C 107.524 -2.23 . . . . 0.0 107.524 177.325 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -65.87 -60.65 6.28 Favored Glycine 0 C--O 1.227 -0.319 0 CA-C-N 117.883 0.842 . . . . 0.0 112.391 -177.958 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -107.34 8.39 29.69 Favored 'General case' 0 C--O 1.215 -0.744 0 CA-C-O 121.967 0.889 . . . . 0.0 110.838 178.715 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -95.95 -11.59 54.49 Favored Glycine 0 CA--C 1.504 -0.653 0 N-CA-C 105.542 -3.023 . . . . 0.0 105.542 179.318 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 53.7 mmtt 52.93 -161.59 0.11 Allowed 'General case' 0 N--CA 1.442 -0.846 0 CA-C-N 112.95 -1.625 . . . . 0.0 111.723 176.79 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 70.1 mtp -90.43 -179.02 5.49 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 114.516 -1.22 . . . . 0.0 109.865 176.875 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 18.5 mmtm -134.8 -69.53 0.51 Allowed 'General case' 0 C--O 1.211 -0.941 0 CA-C-O 120.897 0.38 . . . . 0.0 110.503 179.497 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.7 t0 52.1 51.41 16.44 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 114.318 -1.31 . . . . 0.0 111.923 178.918 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -61.97 162.59 8.92 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 114.116 -1.402 . . . . 0.0 111.969 -179.687 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -45.76 146.18 2.01 Favored Pre-proline 0 C--O 1.25 1.08 0 CA-C-N 115.047 -0.979 . . . . 0.0 113.495 -177.335 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -61.86 142.54 93.73 Favored 'Trans proline' 0 C--N 1.349 0.601 0 CA-C-O 122.768 1.07 . . . . 0.0 114.209 -174.895 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 22.6 mtt85 -128.95 155.77 44.8 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-N 113.2 -1.818 . . . . 0.0 108.054 -178.629 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 66.5 m95 -127.8 131.63 49.57 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 179.711 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 70.9 m-85 -111.41 148.23 33.52 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 107.289 -1.375 . . . . 0.0 107.289 179.064 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 68.1 t80 -95.79 131.35 42.18 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 -177.778 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -134.36 146.52 50.0 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 -178.263 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -83.34 159.51 21.85 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 113.016 0.747 . . . . 0.0 113.016 -174.956 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -55.53 132.91 49.74 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.391 179.489 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 72.56 33.96 60.5 Favored Glycine 0 C--O 1.221 -0.696 0 N-CA-C 115.469 0.947 . . . . 0.0 115.469 176.629 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 9.2 p -99.97 146.09 27.1 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.226 -1.028 . . . . 0.0 108.226 177.818 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 103.21 138.62 9.98 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 108.572 -1.811 . . . . 0.0 108.572 -176.619 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -70.51 -40.43 4.16 Favored 'Trans proline' 0 C--N 1.347 0.458 0 CA-C-N 119.748 1.774 . . . . 0.0 115.577 -173.494 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -123.18 39.14 4.03 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 -177.538 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -64.95 -41.78 95.19 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.529 -0.76 . . . . 0.0 111.621 -177.818 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 61.23 24.56 63.51 Favored Glycine 0 C--O 1.226 -0.385 0 CA-C-N 116.127 -0.488 . . . . 0.0 113.654 179.854 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 21.3 mt -109.47 103.89 53.91 Favored Pre-proline 0 C--O 1.238 0.468 0 N-CA-C 114.273 1.212 . . . . 0.0 114.273 -176.719 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -78.5 167.19 23.12 Favored 'Trans proline' 0 N--CA 1.461 -0.436 0 N-CA-C 108.439 -1.408 . . . . 0.0 108.439 170.895 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.43 ' CE1' ' HB3' ' A' ' 92' ' ' TRP . 77.9 t80 -61.24 132.47 53.74 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 120.357 -0.537 . . . . 0.0 110.254 179.979 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 90.43 -4.9 82.71 Favored Glycine 0 CA--C 1.518 0.276 0 N-CA-C 115.065 0.786 . . . . 0.0 115.065 178.03 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -65.38 128.09 34.47 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 118.463 1.132 . . . . 0.0 111.472 179.407 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 45.9 t-20 -78.05 128.01 33.2 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.322 -176.576 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 16.7 ttmm -156.08 152.09 27.57 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 179.54 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -62.73 132.76 53.34 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.744 0.307 . . . . 0.0 110.441 179.447 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 68.86 24.41 75.64 Favored Glycine 0 N--CA 1.449 -0.44 0 CA-C-O 119.477 -0.624 . . . . 0.0 113.734 178.033 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 38.6 mm -129.32 128.51 66.57 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.304 0 CA-C-N 117.362 0.581 . . . . 0.0 110.077 179.866 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.1 pt -134.56 123.71 42.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.573 176.036 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 92' ' ' TRP . . . . . 0.43 ' HB3' ' CE1' ' A' ' 83' ' ' TYR . 90.0 m95 -89.37 139.42 30.53 Favored 'General case' 0 C--N 1.321 -0.671 0 O-C-N 121.908 -0.495 . . . . 0.0 111.617 -176.933 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 17.8 m -135.09 153.77 34.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 179.903 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -162.03 166.56 25.77 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 105.812 -1.921 . . . . 0.0 105.812 -178.63 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 13.5 t -130.41 169.29 15.69 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 104.628 -2.36 . . . . 0.0 104.628 176.137 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -66.22 135.07 53.97 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.225 0.536 . . . . 0.0 110.218 -178.601 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 93.81 -12.73 68.86 Favored Glycine 0 CA--C 1.517 0.195 0 CA-C-N 115.982 -0.554 . . . . 0.0 113.998 178.395 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.408 ' HA ' ' HA ' ' A' ' 41' ' ' ASP . . . -68.16 135.97 52.92 Favored 'General case' 0 CA--C 1.542 0.667 0 O-C-N 122.33 -0.512 . . . . 0.0 110.133 179.088 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 32.4 mt -89.34 130.31 35.73 Favored 'General case' 0 CA--C 1.507 -0.681 0 N-CA-C 113.416 0.895 . . . . 0.0 113.416 -177.145 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 53.5 t30 -81.17 73.8 8.2 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 114.526 -1.215 . . . . 0.0 110.564 -178.718 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 1.5 t -142.97 153.83 61.12 Favored Pre-proline 0 C--N 1.321 -0.631 0 N-CA-C 106.427 -1.694 . . . . 0.0 106.427 179.723 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -67.65 147.74 76.63 Favored 'Trans proline' 0 CA--C 1.528 0.213 0 C-N-CA 117.824 -0.984 . . . . 0.0 113.089 176.018 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 6.6 ptpt -145.73 56.95 1.22 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 122.722 1.248 . . . . 0.0 110.593 179.066 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -58.54 -31.05 67.58 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.149 -1.387 . . . . 0.0 111.9 179.304 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 18.3 p80 -62.62 -7.41 4.72 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 113.944 1.09 . . . . 0.0 113.944 -179.34 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 29.1 mt -96.24 -45.29 13.02 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.53 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 177.148 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -69.92 14.66 1.1 Allowed Glycine 0 CA--C 1.524 0.609 0 N-CA-C 116.436 1.334 . . . . 0.0 116.436 -177.798 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 15.2 t -95.77 26.51 3.99 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.328 0.651 . . . . 0.0 112.111 -178.841 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 67.7 ttp85 -59.29 125.94 25.65 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 178.429 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -101.26 128.02 30.34 Favored Pre-proline 0 C--N 1.322 -0.615 0 N-CA-C 106.671 -1.603 . . . . 0.0 106.671 -178.28 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -68.53 -20.3 41.48 Favored 'Trans proline' 0 C--O 1.219 -0.468 0 N-CA-C 114.605 0.964 . . . . 0.0 114.605 -176.81 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -74.17 -24.62 59.41 Favored 'General case' 0 C--O 1.221 -0.428 0 CA-C-O 120.861 0.362 . . . . 0.0 110.619 178.269 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 84.7 m-20 -100.94 -24.32 14.37 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 -175.714 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -158.23 149.74 21.27 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 113.364 0.876 . . . . 0.0 113.364 -177.634 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -91.61 150.52 21.13 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-O 121.428 0.632 . . . . 0.0 111.787 179.512 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -69.96 146.62 50.99 Favored 'General case' 0 C--N 1.323 -0.543 0 CA-C-O 121.261 0.553 . . . . 0.0 111.451 178.996 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 15.6 mt -86.68 136.45 22.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.828 -178.714 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 70.0 t -62.94 120.89 10.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 N-CA-C 106.179 -1.785 . . . . 0.0 106.179 175.109 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 6.0 tt -68.47 134.43 50.11 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -175.58 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 50.8 mt-30 -135.19 161.91 34.03 Favored 'General case' 0 CA--C 1.513 -0.452 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 178.328 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.44 HD13 HG22 ' A' ' 125' ' ' THR . 13.3 mt -114.63 146.3 35.68 Favored Pre-proline 0 C--N 1.323 -0.58 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 175.646 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -71.71 165.91 31.07 Favored 'Trans proline' 0 C--N 1.345 0.384 0 O-C-N 122.243 0.601 . . . . 0.0 113.619 -177.64 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 41.3 tt0 -53.26 128.83 29.53 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.238 -179.421 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 97.68 -17.32 59.08 Favored Glycine 0 C--O 1.227 -0.299 0 CA-C-N 115.886 -0.597 . . . . 0.0 113.058 -179.279 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.44 HG22 HD13 ' A' ' 121' ' ' LEU . 5.8 m -108.73 125.96 52.48 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 117.721 0.76 . . . . 0.0 109.263 178.083 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 5.8 p -124.8 148.23 48.27 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 -179.176 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 81.6 mt -69.56 155.04 94.24 Favored Pre-proline 0 C--N 1.325 -0.493 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 179.876 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_endo -74.44 169.06 23.35 Favored 'Trans proline' 0 N--CA 1.463 -0.299 0 C-N-CA 118.235 -0.71 . . . . 0.0 110.846 178.026 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -61.73 130.42 45.72 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.269 -176.191 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 95.2 -5.7 68.32 Favored Glycine 0 CA--C 1.518 0.224 0 CA-C-N 115.762 -0.653 . . . . 0.0 114.584 179.103 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.449 ' CZ ' ' HB2' ' A' ' 18' ' ' GLN . 1.2 m-85 -101.2 142.49 32.55 Favored 'General case' 0 N--CA 1.445 -0.725 0 CA-C-O 121.712 0.767 . . . . 0.0 110.678 179.441 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 45.6 p90 -145.22 164.19 32.1 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 114.478 -1.237 . . . . 0.0 108.019 175.194 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -100.77 145.78 28.08 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.094 0.474 . . . . 0.0 110.708 -177.949 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -70.58 129.01 38.07 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 -179.86 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 91.55 -32.02 5.5 Favored Glycine 0 CA--C 1.52 0.357 0 CA-C-N 116.159 -0.473 . . . . 0.0 113.967 -179.965 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 34.3 t -80.77 138.96 36.3 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 117.577 0.688 . . . . 0.0 110.177 -178.949 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? -100.9 -5.68 25.71 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.058 -0.974 . . . . 0.0 110.103 176.594 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 85.13 174.8 50.41 Favored Glycine 0 N--CA 1.452 -0.245 0 N-CA-C 107.478 -2.249 . . . . 0.0 107.478 -173.448 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 139.36 -154.76 23.68 Favored Glycine 0 CA--C 1.511 -0.21 0 N-CA-C 109.272 -1.531 . . . . 0.0 109.272 -178.553 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 61.8 p . . . . . 0 C--O 1.241 0.631 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 178.532 . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.704 0 CA-C-O 119.015 -0.881 . . . . 0.0 111.369 . . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -152.61 166.44 32.06 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 105.219 -2.141 . . . . 0.0 105.219 179.466 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -128.48 112.65 14.58 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-O 121.578 0.704 . . . . 0.0 110.299 -179.828 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 135.68 127.21 2.65 Favored Glycine 0 C--O 1.228 -0.261 0 N-CA-C 107.122 -2.391 . . . . 0.0 107.122 -177.031 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 10.5 mp -72.73 142.25 83.26 Favored Pre-proline 0 C--N 1.324 -0.543 0 CA-C-N 117.38 0.59 . . . . 0.0 110.46 -177.745 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -78.92 159.5 27.46 Favored 'Trans proline' 0 C--N 1.344 0.341 0 CA-C-O 121.343 0.476 . . . . 0.0 112.972 178.075 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 -143.86 -29.39 0.5 Allowed 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 175.557 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 43.1 t30 67.26 30.54 7.08 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.87 1.268 . . . . 0.0 112.268 174.217 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 35.3 p -108.83 89.01 2.86 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 106.937 -1.505 . . . . 0.0 106.937 178.745 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -92.56 138.25 31.67 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.499 -175.096 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -57.48 138.4 55.15 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.018 -0.992 . . . . 0.0 109.65 177.245 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 38.1 m95 -67.39 -21.83 65.58 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 114.127 1.158 . . . . 0.0 114.127 -178.437 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -121.46 159.31 26.52 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.435 0.636 . . . . 0.0 112.433 -174.09 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 56.7 p -67.93 165.07 18.49 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.457 -1.247 . . . . 0.0 108.318 178.185 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.431 ' HB2' ' CE2' ' A' ' 69' ' ' TYR . . . -83.37 148.6 27.22 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 113.716 1.006 . . . . 0.0 113.716 -175.006 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 85.0 mt -84.95 148.88 25.99 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 102.627 -3.101 . . . . 0.0 102.627 166.975 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 81.7 m -106.85 125.04 50.49 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 178.366 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -88.95 105.64 17.9 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 179.09 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 73.5 t60 -113.48 97.52 6.51 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 104.18 -2.526 . . . . 0.0 104.18 173.107 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 148.99 -168.01 29.43 Favored Glycine 0 N--CA 1.45 -0.41 0 N-CA-C 108.828 -1.709 . . . . 0.0 108.828 -176.128 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -104.4 -22.3 13.35 Favored 'General case' 0 C--O 1.215 -0.738 0 N-CA-C 115.369 1.618 . . . . 0.0 115.369 -176.487 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -71.12 146.36 49.25 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.6 0.714 . . . . 0.0 112.638 -176.357 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -95.58 33.29 1.65 Allowed 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 122.691 1.234 . . . . 0.0 111.918 -176.605 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 31.4 tp 62.52 146.29 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.99 0 CA-C-N 112.791 -2.004 . . . . 0.0 115.305 176.219 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 51.9 tptt -158.16 140.39 14.23 Favored 'General case' 0 CA--C 1.514 -0.433 0 O-C-N 121.118 -0.989 . . . . 0.0 109.869 174.58 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 -125.51 151.36 70.16 Favored Pre-proline 0 C--O 1.241 0.655 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 175.411 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -74.66 165.68 31.02 Favored 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 120.674 0.916 . . . . 0.0 113.863 -179.906 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 16.7 tpt180 -65.07 133.97 52.78 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.885 -178.211 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 83.96 2.32 89.59 Favored Glycine 0 C--O 1.227 -0.293 0 CA-C-O 121.305 0.392 . . . . 0.0 112.351 177.959 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 30.2 mt-30 -141.29 171.14 14.47 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 123.674 0.79 . . . . 0.0 109.803 -173.74 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 105.1 -19.58 40.2 Favored Glycine 0 CA--C 1.497 -1.062 0 N-CA-C 111.254 -0.738 . . . . 0.0 111.254 175.987 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 84.8 t -65.74 127.81 93.34 Favored Pre-proline 0 C--N 1.317 -0.818 0 N-CA-C 105.813 -1.921 . . . . 0.0 105.813 176.311 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -71.62 172.96 13.31 Favored 'Trans proline' 0 N--CA 1.46 -0.485 0 O-C-N 122.292 0.627 . . . . 0.0 111.295 178.141 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 78.4 mt -74.29 108.97 6.31 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 -179.324 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 30.4 m-20 -110.11 74.43 0.88 Allowed 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.648 -1.16 . . . . 0.0 110.454 -175.455 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 65.8 p -66.08 -23.0 66.44 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 115.588 1.699 . . . . 0.0 115.588 -174.298 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -110.76 31.3 6.1 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 112.259 0.466 . . . . 0.0 112.259 -176.474 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 73.8 p -132.9 167.56 20.0 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 178.988 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 44.6 m -84.26 162.45 51.41 Favored Pre-proline 0 C--N 1.321 -0.672 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.417 -178.59 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -67.64 -21.79 45.01 Favored 'Trans proline' 0 C--N 1.351 0.69 0 C-N-CA 116.526 -1.849 . . . . 0.0 114.668 -178.836 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.42 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 6.3 p-10 -75.19 -18.15 60.22 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 121.73 -0.606 . . . . 0.0 109.858 177.785 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -90.42 2.11 55.96 Favored 'General case' 0 C--O 1.219 -0.525 0 N-CA-C 114.32 1.23 . . . . 0.0 114.32 -175.016 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 93.0 mm-40 -65.26 -23.76 67.14 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-O 121.624 0.726 . . . . 0.0 109.99 176.789 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.499 ' HB ' ' HB1' ' A' ' 98' ' ' ALA . 9.0 tt -66.59 141.09 18.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 122.044 0.926 . . . . 0.0 111.083 177.964 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 175.18 -160.98 30.04 Favored Glycine 0 CA--C 1.504 -0.626 0 C-N-CA 120.2 -1.0 . . . . 0.0 110.636 179.364 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 44.3 p90 -155.1 170.73 21.11 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 178.832 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -112.8 140.24 47.76 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 106.522 -1.658 . . . . 0.0 106.522 175.213 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 63.9 ttt180 -115.49 121.97 44.3 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 123.831 0.852 . . . . 0.0 112.152 -175.59 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 32.3 ttp85 -68.65 138.66 55.18 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 176.977 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -143.64 138.73 29.19 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 123.217 0.607 . . . . 0.0 109.597 179.954 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.8 t -161.38 155.08 21.88 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 105.076 -2.194 . . . . 0.0 105.076 176.721 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 11.6 tpt180 -141.42 123.81 15.77 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 107.243 -1.392 . . . . 0.0 107.243 176.495 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 7.7 tmm_? -132.77 129.7 38.95 Favored 'General case' 0 CA--C 1.49 -1.341 0 CA-C-O 121.983 0.897 . . . . 0.0 110.221 179.931 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -139.68 176.82 5.17 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 N-CA-C 104.853 -2.277 . . . . 0.0 104.853 -178.75 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 30.2 ttt85 -127.42 115.91 19.65 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 105.847 -1.909 . . . . 0.0 105.847 175.172 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -82.35 156.83 35.92 Favored Glycine 0 N--CA 1.448 -0.502 0 N-CA-C 108.092 -2.003 . . . . 0.0 108.092 177.802 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -75.45 -31.66 56.39 Favored Glycine 0 C--O 1.215 -1.055 0 N-CA-C 108.808 -1.717 . . . . 0.0 108.808 178.964 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -71.76 -20.69 61.85 Favored 'General case' 0 C--O 1.217 -0.627 0 CA-C-N 114.17 -1.015 . . . . 0.0 109.718 178.211 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 115.65 -9.89 19.17 Favored Glycine 0 CA--C 1.506 -0.48 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.869 173.841 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 5.0 pttt -79.13 154.06 29.62 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 122.085 0.945 . . . . 0.0 113.354 -176.822 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 94.4 mtp -122.48 -160.24 0.87 Allowed 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 113.89 -1.504 . . . . 0.0 110.053 -176.865 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 18.7 mmtt -118.75 -70.0 0.82 Allowed 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 122.199 0.2 . . . . 0.0 111.103 -179.397 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -141.13 160.43 40.12 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 177.269 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -121.17 -28.23 4.76 Favored 'General case' 0 N--CA 1.469 0.5 0 O-C-N 123.892 0.745 . . . . 0.0 110.792 -177.664 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -110.03 130.83 22.4 Favored Pre-proline 0 C--O 1.238 0.469 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 -179.22 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -65.23 162.61 32.46 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 117.386 -1.276 . . . . 0.0 113.439 179.492 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 29.2 mtt-85 -123.31 156.74 34.72 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 178.654 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 54.6 m95 -129.78 125.14 35.08 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 177.215 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.431 ' CE2' ' HB2' ' A' ' 15' ' ' ALA . 88.4 m-85 -112.22 147.5 36.08 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 -178.582 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 79.2 t80 -91.0 136.9 32.76 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 -179.335 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -140.53 140.68 35.28 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.338 -0.847 . . . . 0.0 109.364 -173.93 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 34.7 m-85 -74.44 159.53 32.17 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.173 0.511 . . . . 0.0 111.373 -179.605 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -54.74 124.95 18.06 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.76 -0.654 . . . . 0.0 112.105 -177.994 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 81.18 16.73 73.63 Favored Glycine 0 C--O 1.221 -0.7 0 N-CA-C 117.012 1.565 . . . . 0.0 117.012 176.868 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 19.4 p -88.98 146.05 25.12 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 119.173 1.486 . . . . 0.0 111.704 -179.88 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 122.65 154.82 9.18 Favored Glycine 0 CA--C 1.523 0.536 0 N-CA-C 109.841 -1.304 . . . . 0.0 109.841 -179.137 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -70.92 -39.86 3.96 Favored 'Trans proline' 0 C--O 1.22 -0.423 0 CA-C-N 119.315 1.557 . . . . 0.0 115.204 -175.714 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -127.53 35.81 4.47 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 108.002 -1.111 . . . . 0.0 108.002 -177.859 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -55.13 -55.55 29.82 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.17 -0.923 . . . . 0.0 112.405 -175.628 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 55.73 32.21 58.53 Favored Glycine 0 C--O 1.227 -0.336 0 C-N-CA 121.264 -0.493 . . . . 0.0 112.474 -179.236 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 16.9 mt -114.83 103.9 54.5 Favored Pre-proline 0 N--CA 1.449 -0.514 0 N-CA-C 115.486 1.662 . . . . 0.0 115.486 -174.783 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -78.51 163.16 27.19 Favored 'Trans proline' 0 N--CA 1.461 -0.406 0 N-CA-C 107.698 -1.693 . . . . 0.0 107.698 168.269 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 55.0 t80 -61.62 133.61 55.84 Favored 'General case' 0 C--N 1.321 -0.668 0 C-N-CA 120.466 -0.493 . . . . 0.0 110.372 -178.305 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 90.7 -7.84 80.69 Favored Glycine 0 CA--C 1.517 0.206 0 CA-C-O 119.548 -0.584 . . . . 0.0 114.346 178.841 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -65.48 130.81 44.62 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 118.386 1.093 . . . . 0.0 111.03 179.098 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 59.1 t30 -79.71 129.21 34.28 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.381 -179.421 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 30.7 ttmt -156.07 152.96 28.66 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 106.571 -1.641 . . . . 0.0 106.571 179.451 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -60.95 127.47 31.71 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 -179.645 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 70.22 28.65 71.19 Favored Glycine 0 N--CA 1.449 -0.485 0 CA-C-O 119.382 -0.677 . . . . 0.0 114.677 176.593 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 43.5 mm -126.69 122.43 60.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 117.601 0.7 . . . . 0.0 110.842 179.406 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.1 pt -127.49 116.41 43.55 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 CA-C-O 121.762 0.792 . . . . 0.0 111.828 176.612 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 95.2 m95 -81.68 137.84 35.36 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 113.223 0.823 . . . . 0.0 113.223 -177.597 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 18.2 m -137.2 152.43 27.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 178.305 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -163.01 165.99 24.25 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 104.754 -2.313 . . . . 0.0 104.754 -179.999 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 6.5 t -140.2 -178.94 5.7 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 105.938 -1.875 . . . . 0.0 105.938 177.583 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -67.63 136.32 54.22 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.338 0.589 . . . . 0.0 110.614 -178.675 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 96.65 -13.69 65.04 Favored Glycine 0 N--CA 1.459 0.215 0 CA-C-N 115.668 -0.696 . . . . 0.0 112.967 178.48 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.499 ' HB1' ' HB ' ' A' ' 44' ' ' ILE . . . -75.59 140.02 42.42 Favored 'General case' 0 C--N 1.322 -0.608 0 O-C-N 122.716 -0.285 . . . . 0.0 110.573 179.997 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 36.4 mt -96.53 139.89 31.96 Favored 'General case' 0 C--O 1.218 -0.555 0 CA-C-O 121.259 0.552 . . . . 0.0 111.69 -179.373 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 58.9 t30 -86.16 68.77 10.38 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.711 179.473 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 1.1 t -140.67 150.77 61.33 Favored Pre-proline 0 C--N 1.325 -0.489 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 179.12 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -67.74 149.57 78.76 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 118.345 -0.636 . . . . 0.0 113.544 176.908 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.64 47.12 1.19 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 122.732 1.253 . . . . 0.0 110.839 179.061 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 16.0 p-10 -47.73 -39.34 17.47 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 113.44 -1.709 . . . . 0.0 113.34 178.752 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 50.1 p-80 -60.74 -17.1 46.53 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 115.336 1.606 . . . . 0.0 115.336 -177.814 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 68.9 mt -81.55 -29.16 10.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 178.896 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -72.06 14.65 2.12 Favored Glycine 0 CA--C 1.522 0.525 0 N-CA-C 115.771 1.068 . . . . 0.0 115.771 -177.622 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 15.2 t -83.29 28.16 0.55 Allowed 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 123.54 0.736 . . . . 0.0 112.981 -177.711 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 72.9 ttp85 -61.61 116.38 4.7 Favored 'General case' 0 N--CA 1.469 0.514 0 O-C-N 121.221 -0.924 . . . . 0.0 108.647 178.443 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 14.5 m-20 -82.88 118.39 71.61 Favored Pre-proline 0 C--N 1.323 -0.554 0 N-CA-C 105.351 -2.092 . . . . 0.0 105.351 179.279 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -71.66 -13.61 29.88 Favored 'Trans proline' 0 C--O 1.219 -0.46 0 C-N-CA 117.312 -1.326 . . . . 0.0 113.891 -176.418 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -81.25 -24.91 37.01 Favored 'General case' 0 C--O 1.22 -0.465 0 CA-C-O 120.892 0.377 . . . . 0.0 110.241 178.252 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 81.2 m-20 -102.86 -24.78 13.67 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 113.521 0.934 . . . . 0.0 113.521 -175.315 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -145.97 145.42 30.64 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 -178.349 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -89.23 149.68 22.99 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.368 -179.927 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -70.24 148.31 48.72 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.305 0.574 . . . . 0.0 110.61 178.129 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 8.0 mt -83.43 139.33 17.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 -179.178 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 89.7 t -62.55 121.43 11.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 176.069 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 5.5 tt -68.07 126.92 31.01 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.244 0.545 . . . . 0.0 109.996 -177.798 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 30.8 mt-30 -132.96 154.23 50.67 Favored 'General case' 0 CA--C 1.509 -0.628 0 N-CA-C 106.656 -1.609 . . . . 0.0 106.656 -179.85 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 12.8 mt -110.73 147.45 36.48 Favored Pre-proline 0 C--N 1.321 -0.657 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 176.779 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -72.96 162.18 41.67 Favored 'Trans proline' 0 C--O 1.236 0.376 0 O-C-N 122.265 0.613 . . . . 0.0 112.491 -179.718 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 56.8 tt0 -55.15 131.27 44.82 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 -179.797 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 104.27 -22.8 33.65 Favored Glycine 0 C--O 1.226 -0.359 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.842 -178.267 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 3.8 m -108.72 126.98 53.59 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 117.641 0.72 . . . . 0.0 109.791 177.778 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 15.5 p -121.64 148.41 44.6 Favored 'General case' 0 CA--C 1.508 -0.635 0 CA-C-O 121.029 0.442 . . . . 0.0 110.25 179.912 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 83.0 mt -71.79 152.92 93.31 Favored Pre-proline 0 C--N 1.321 -0.634 0 N-CA-C 107.305 -1.369 . . . . 0.0 107.305 178.011 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -77.63 172.58 15.54 Favored 'Trans proline' 0 C--O 1.237 0.439 0 CA-C-O 121.384 0.493 . . . . 0.0 111.252 179.022 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 65.2 tttm -57.61 127.51 32.4 Favored 'General case' 0 C--O 1.219 -0.519 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.778 -178.047 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 91.82 7.84 64.15 Favored Glycine 0 C--O 1.226 -0.406 0 N-CA-C 115.625 1.01 . . . . 0.0 115.625 177.678 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 34.5 m-85 -118.86 136.87 53.81 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 118.064 0.932 . . . . 0.0 109.927 177.774 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 55.2 p90 -144.93 161.8 38.46 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 176.683 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -99.45 146.27 26.52 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.617 0.722 . . . . 0.0 112.893 -175.665 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -75.39 132.02 40.61 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 178.658 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 88.6 -6.85 83.18 Favored Glycine 0 C--O 1.225 -0.412 0 C-N-CA 121.323 -0.465 . . . . 0.0 112.959 -179.032 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 31.6 t -107.5 122.41 46.6 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 178.848 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 2.8 tmt_? 47.66 56.31 7.27 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-O 121.979 0.895 . . . . 0.0 111.724 -179.413 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -73.14 145.04 35.64 Favored Glycine 0 N--CA 1.451 -0.326 0 N-CA-C 107.175 -2.37 . . . . 0.0 107.175 175.633 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 81.03 -147.59 27.69 Favored Glycine 0 C--O 1.236 0.254 0 N-CA-C 110.223 -1.151 . . . . 0.0 110.223 -178.098 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 75.3 m . . . . . 0 C--O 1.245 0.858 0 CA-C-O 116.541 -1.695 . . . . 0.0 108.085 178.827 . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.125 0 CA-C-O 118.123 -1.376 . . . . 0.0 111.501 . . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 62.01 -23.19 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.279 0 N-CA-C 120.149 3.388 . . . . 0.0 120.149 177.504 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 77.2 mtm -76.09 90.24 3.06 Favored 'General case' 0 C--N 1.308 -1.226 0 C-N-CA 123.17 0.588 . . . . 0.0 110.714 -179.594 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -90.15 43.07 2.93 Favored Glycine 0 C--O 1.228 -0.242 0 CA-C-N 116.121 -0.49 . . . . 0.0 113.95 -179.584 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 10.2 mp -66.04 144.69 98.88 Favored Pre-proline 0 C--N 1.326 -0.454 0 CA-C-N 117.126 0.463 . . . . 0.0 109.949 -178.641 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -74.55 148.02 36.88 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 117.696 -1.069 . . . . 0.0 112.735 179.405 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 49.3 t30 -90.69 -27.94 18.67 Favored 'General case' 0 C--O 1.215 -0.761 0 CA-C-O 121.36 0.6 . . . . 0.0 109.494 177.879 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 30.1 t30 65.18 32.13 10.33 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 125.495 1.518 . . . . 0.0 112.536 178.442 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 44.7 p -146.15 167.39 23.56 Favored 'General case' 0 N--CA 1.435 -1.204 0 N-CA-C 101.376 -3.565 . . . . 0.0 101.376 -179.329 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -148.33 151.32 35.15 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 116.004 -0.544 . . . . 0.0 109.574 178.58 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 34.0 p -64.21 145.65 55.63 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 178.351 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 13.1 m95 -64.73 -24.35 67.54 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.955 0.407 . . . . 0.0 112.086 179.5 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -121.38 163.93 17.91 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.578 -0.737 . . . . 0.0 112.416 -172.269 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 47.0 p -70.43 165.96 21.4 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 177.093 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -79.34 146.56 32.83 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.715 0.769 . . . . 0.0 112.472 -176.507 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.407 HD23 ' HA ' ' A' ' 16' ' ' LEU . 12.1 mt -83.32 146.73 28.35 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 102.931 -2.989 . . . . 0.0 102.931 169.151 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 29.9 m -129.78 138.75 51.23 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 -178.686 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.438 ' HB2' ' CZ ' ' A' ' 131' ' ' PHE . 4.0 tp60 -106.67 136.91 45.66 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.837 0.68 . . . . 0.0 112.837 -176.93 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 5.7 t60 -130.75 94.77 3.69 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 103.014 -2.958 . . . . 0.0 103.014 168.612 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 173.33 -157.33 26.01 Favored Glycine 0 C--O 1.223 -0.541 0 N-CA-C 110.957 -0.857 . . . . 0.0 110.957 -174.302 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 29.8 mtpp -112.32 -24.86 9.55 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 115.321 1.601 . . . . 0.0 115.321 -177.436 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 88.3 mt-10 -80.5 158.29 25.89 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 177.759 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -79.91 -62.8 1.57 Allowed 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 177.667 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 44.3 tp -179.25 141.09 0.16 Allowed 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 172.56 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 23.8 tptm -156.07 140.45 16.7 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 174.188 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 15.3 m-85 -125.02 152.1 69.92 Favored Pre-proline 0 C--O 1.242 0.68 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 175.817 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -72.69 160.41 46.43 Favored 'Trans proline' 0 CA--C 1.54 0.778 0 C-N-CA 120.658 0.905 . . . . 0.0 112.859 178.292 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.02 131.91 47.32 Favored 'General case' 0 C--O 1.216 -0.665 0 O-C-N 122.172 -0.33 . . . . 0.0 110.813 -178.033 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 85.45 7.27 82.64 Favored Glycine 0 N--CA 1.46 0.292 0 C-N-CA 121.445 -0.407 . . . . 0.0 112.181 179.195 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 13.1 mt-30 -145.95 170.53 16.42 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 123.19 0.596 . . . . 0.0 109.983 -174.991 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 105.41 -16.88 44.36 Favored Glycine 0 CA--C 1.501 -0.819 0 CA-C-N 116.1 -0.5 . . . . 0.0 113.139 174.881 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 93.9 t -65.78 129.08 94.24 Favored Pre-proline 0 C--N 1.32 -0.704 0 N-CA-C 106.52 -1.659 . . . . 0.0 106.52 176.988 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -73.27 170.77 19.08 Favored 'Trans proline' 0 C--O 1.219 -0.433 0 O-C-N 122.148 0.552 . . . . 0.0 111.052 177.764 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 86.1 mt -70.55 106.56 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-O 122.009 0.909 . . . . 0.0 108.693 -179.601 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -98.14 84.1 3.21 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 114.514 -1.221 . . . . 0.0 110.017 -176.915 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 77.3 p -68.3 -14.08 62.73 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.775 0.798 . . . . 0.0 112.48 -179.313 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 11.5 p30 -106.69 22.98 15.02 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 114.82 -1.082 . . . . 0.0 111.718 -177.776 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 19.0 m -141.15 150.97 43.48 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 113.745 1.016 . . . . 0.0 113.745 -176.424 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.1 m -72.28 166.88 37.38 Favored Pre-proline 0 C--N 1.326 -0.441 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 176.415 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -66.4 -25.62 48.65 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 114.792 -3.005 . . . . 0.0 114.112 -179.714 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.472 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 4.5 p-10 -78.66 -20.63 49.82 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.586 0.708 . . . . 0.0 110.891 177.546 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 -81.64 -6.68 59.24 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 -176.086 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 96.0 mm-40 -57.7 -26.81 62.26 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 114.124 1.157 . . . . 0.0 114.124 -178.481 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.423 ' HB ' ' HB1' ' A' ' 98' ' ' ALA . 8.5 tt -59.31 138.35 20.49 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.939 0 N-CA-C 113.872 1.064 . . . . 0.0 113.872 -178.367 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -178.34 -158.2 20.57 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.389 -179.376 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 36.4 p90 -154.95 168.14 27.97 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 179.427 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 29.1 m-85 -112.77 141.74 46.22 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 174.634 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 69.2 ttt-85 -115.14 124.15 50.75 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 123.423 0.689 . . . . 0.0 112.514 -178.353 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 50.0 ttt180 -64.64 136.33 56.87 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 122.784 0.434 . . . . 0.0 110.12 177.3 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -152.13 150.92 30.42 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.713 0.634 . . . . 0.0 112.713 -179.791 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 6.4 p -144.15 147.88 34.29 Favored 'General case' 0 C--O 1.238 0.494 0 N-CA-C 105.488 -2.041 . . . . 0.0 105.488 172.704 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 16.1 tpt180 -166.22 123.86 1.42 Allowed 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 177.698 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 7.8 tmm_? -94.35 124.03 38.12 Favored 'General case' 0 CA--C 1.485 -1.553 0 CA-C-O 122.375 1.083 . . . . 0.0 111.0 177.973 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -126.74 174.64 10.2 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.076 0 CA-C-N 112.841 -1.981 . . . . 0.0 106.596 176.273 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 78.6 ttt180 -122.94 121.44 36.16 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 105.46 -2.052 . . . . 0.0 105.46 175.289 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -90.42 157.64 25.86 Favored Glycine 0 N--CA 1.448 -0.511 0 N-CA-C 106.969 -2.452 . . . . 0.0 106.969 177.955 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -72.21 -34.27 61.33 Favored Glycine 0 C--O 1.217 -0.966 0 N-CA-C 107.588 -2.205 . . . . 0.0 107.588 178.141 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 30.8 t0 -93.62 14.82 17.79 Favored 'General case' 0 C--O 1.217 -0.642 0 CA-C-O 122.529 1.157 . . . . 0.0 109.497 178.409 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 83.66 -17.21 26.8 Favored Glycine 0 C--O 1.227 -0.295 0 N-CA-C 117.101 1.601 . . . . 0.0 117.101 172.794 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.74 125.96 22.14 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 114.026 1.121 . . . . 0.0 114.026 -176.853 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 78.5 mtp -104.24 -179.32 3.91 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 114.37 -1.286 . . . . 0.0 112.239 -177.971 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 10.5 mptt -131.85 -47.25 0.95 Allowed 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.893 0.877 . . . . 0.0 111.331 -179.913 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -66.3 -172.07 0.14 Allowed 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 113.158 -1.837 . . . . 0.0 114.405 -179.512 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 79.52 -54.43 0.41 Allowed 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 126.855 2.062 . . . . 0.0 109.14 -177.967 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 22.3 p -92.14 131.84 33.9 Favored Pre-proline 0 C--N 1.32 -0.712 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 174.965 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -70.48 149.64 62.58 Favored 'Trans proline' 0 C--O 1.24 0.615 0 C-N-CA 115.513 -2.524 . . . . 0.0 111.112 178.734 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.409 HH12 ' CD ' ' A' ' 134' ' ' GLU . 0.1 OUTLIER -123.78 158.96 30.54 Favored 'General case' 0 CA--C 1.504 -0.803 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.096 -176.75 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 65.9 m95 -133.47 128.08 34.65 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 177.163 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 43.4 m-85 -110.92 143.26 41.83 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 106.669 -1.604 . . . . 0.0 106.669 -178.796 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 92.1 t80 -94.72 135.09 36.61 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 -175.844 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -137.92 155.55 48.81 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 108.072 -1.085 . . . . 0.0 108.072 -177.747 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 80.9 m-85 -89.39 159.47 17.3 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 112.06 0.393 . . . . 0.0 112.06 -174.362 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -55.05 128.95 36.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.01 -177.958 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 68.13 39.18 88.62 Favored Glycine 0 C--O 1.217 -0.91 0 CA-C-O 119.201 -0.777 . . . . 0.0 114.822 175.672 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -89.03 142.24 27.8 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 106.408 -1.701 . . . . 0.0 106.408 177.719 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 96.93 139.15 10.46 Favored Glycine 0 CA--C 1.527 0.822 0 N-CA-C 107.239 -2.344 . . . . 0.0 107.239 -173.25 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -68.26 -43.2 4.75 Favored 'Trans proline' 0 C--N 1.346 0.447 0 CA-C-N 120.033 1.917 . . . . 0.0 116.338 -172.733 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -117.13 42.07 2.62 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 -177.617 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -63.23 -30.51 71.64 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.0 -1.0 . . . . 0.0 111.923 -178.147 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 59.52 27.75 64.0 Favored Glycine 0 C--O 1.229 -0.195 0 CA-C-N 115.902 -0.59 . . . . 0.0 114.248 178.243 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 17.5 mt -118.66 103.84 48.09 Favored Pre-proline 0 N--CA 1.445 -0.72 0 N-CA-C 113.501 0.926 . . . . 0.0 113.501 -177.709 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -78.29 166.61 24.21 Favored 'Trans proline' 0 N--CA 1.46 -0.471 0 C-N-CA 121.54 1.494 . . . . 0.0 108.323 170.655 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.402 ' CE1' ' HB3' ' A' ' 92' ' ' TRP . 70.6 t80 -61.74 131.16 48.98 Favored 'General case' 0 C--N 1.321 -0.63 0 C-N-CA 120.371 -0.532 . . . . 0.0 109.978 -179.978 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 92.34 -7.07 78.31 Favored Glycine 0 CA--C 1.52 0.354 0 N-CA-C 114.943 0.737 . . . . 0.0 114.943 178.093 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -64.19 129.51 40.27 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 118.433 1.117 . . . . 0.0 111.866 -179.991 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -75.53 130.15 38.39 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.492 -177.778 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 28.1 ttmt -156.17 151.75 27.04 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 105.58 -2.007 . . . . 0.0 105.58 177.43 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 31.1 t0 -66.2 133.62 51.01 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.017 0.436 . . . . 0.0 110.423 -177.89 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 69.03 25.6 75.3 Favored Glycine 0 N--CA 1.449 -0.442 0 CA-C-O 119.46 -0.633 . . . . 0.0 114.089 179.234 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 41.3 mm -127.15 128.75 70.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 117.504 0.652 . . . . 0.0 110.484 179.898 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.1 pt -131.52 122.48 50.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 CA-C-N 115.782 -0.644 . . . . 0.0 109.719 175.312 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 92' ' ' TRP . . . . . 0.402 ' HB3' ' CE1' ' A' ' 83' ' ' TYR . 94.0 m95 -88.35 138.75 31.16 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 -176.975 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 16.2 m -137.56 149.73 25.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 121.687 0.756 . . . . 0.0 109.635 178.806 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -158.5 166.6 31.77 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 102.684 -3.08 . . . . 0.0 102.684 -179.494 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 8.4 t -134.34 177.19 7.95 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 105.52 -2.03 . . . . 0.0 105.52 178.267 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 64.4 tt0 -67.46 134.46 51.41 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.142 0.496 . . . . 0.0 109.9 -178.547 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 96.01 -13.75 65.59 Favored Glycine 0 C--O 1.229 -0.19 0 CA-C-N 115.92 -0.582 . . . . 0.0 112.942 -179.804 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.472 ' HA ' ' HA ' ' A' ' 41' ' ' ASP . . . -73.42 138.17 45.06 Favored 'General case' 0 CA--C 1.54 0.575 0 O-C-N 122.498 -0.413 . . . . 0.0 110.288 178.964 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 31.7 mt -97.02 139.33 33.2 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 121.269 0.557 . . . . 0.0 112.398 -179.441 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -83.0 62.87 6.79 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.804 -178.872 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 1.2 t -131.98 152.89 81.04 Favored Pre-proline 0 C--N 1.324 -0.54 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 178.99 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -67.51 152.34 78.63 Favored 'Trans proline' 0 C--N 1.344 0.292 0 N-CA-C 114.489 0.919 . . . . 0.0 114.489 178.304 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 1.3 ptpt -151.87 59.07 0.86 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 122.879 1.324 . . . . 0.0 111.124 178.466 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 15.0 p-10 -56.33 -36.04 68.27 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 113.628 -1.624 . . . . 0.0 111.556 177.803 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 38.0 p-80 -60.58 -10.82 5.66 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 114.891 1.441 . . . . 0.0 114.891 -177.868 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 55.0 mt -92.36 -43.72 13.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 178.117 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -72.97 14.65 2.67 Favored Glycine 0 CA--C 1.523 0.541 0 N-CA-C 116.256 1.262 . . . . 0.0 116.256 -176.339 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 14.4 t -95.73 25.52 4.56 Favored 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 -177.382 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 62.4 ttp85 -55.62 129.98 41.21 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 179.629 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 6.5 m-20 -99.72 126.1 38.28 Favored Pre-proline 0 C--N 1.323 -0.57 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 -178.528 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -69.9 -17.88 36.69 Favored 'Trans proline' 0 C--O 1.219 -0.444 0 C-N-CA 118.041 -0.839 . . . . 0.0 113.465 -178.127 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -73.3 -28.67 62.23 Favored 'General case' 0 C--O 1.22 -0.463 0 CA-C-O 120.96 0.409 . . . . 0.0 110.681 178.239 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 76.1 m-20 -102.3 -24.72 13.85 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 -174.107 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 -153.2 149.51 28.06 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 113.176 0.806 . . . . 0.0 113.176 -178.209 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -89.15 148.21 23.78 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-O 121.382 0.61 . . . . 0.0 111.497 179.392 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -68.49 143.47 54.97 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.374 0.606 . . . . 0.0 110.968 178.808 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 19.4 mt -85.28 139.87 16.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 -179.164 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 91.5 t -63.3 123.31 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 N-CA-C 106.105 -1.813 . . . . 0.0 106.105 175.271 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 6.8 tt -66.0 130.32 42.84 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.151 0.5 . . . . 0.0 110.598 -176.705 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 32.7 mt-30 -132.61 159.81 38.46 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 106.892 -1.521 . . . . 0.0 106.892 -179.376 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 13.7 mt -113.59 147.85 38.46 Favored Pre-proline 0 C--N 1.322 -0.589 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 177.256 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -72.82 169.51 21.87 Favored 'Trans proline' 0 C--N 1.344 0.34 0 O-C-N 122.254 0.607 . . . . 0.0 113.356 -178.6 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 60.3 tt0 -54.7 131.76 44.2 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.715 -179.638 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 93.13 -16.76 59.76 Favored Glycine 0 C--O 1.227 -0.339 0 CA-C-O 119.654 -0.525 . . . . 0.0 114.168 179.767 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 15.1 m -106.36 127.78 53.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 118.396 1.098 . . . . 0.0 110.547 178.864 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 10.4 p -121.23 148.7 43.92 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.593 -178.82 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 79.0 mt -71.05 153.52 94.54 Favored Pre-proline 0 C--N 1.324 -0.534 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 178.937 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -75.09 170.34 20.61 Favored 'Trans proline' 0 C--O 1.236 0.398 0 N-CA-C 110.363 -0.668 . . . . 0.0 110.363 178.089 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 13.9 tmtt? -54.74 121.4 8.45 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 113.314 0.857 . . . . 0.0 113.314 -174.093 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 95.24 -6.01 68.43 Favored Glycine 0 C--N 1.328 0.106 0 N-CA-C 116.719 1.448 . . . . 0.0 116.719 174.684 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.438 ' CZ ' ' HB2' ' A' ' 18' ' ' GLN . 1.5 m-85 -87.51 145.69 26.13 Favored 'General case' 0 N--CA 1.436 -1.16 0 CA-C-O 122.192 0.996 . . . . 0.0 110.342 178.813 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 37.4 p90 -145.4 163.11 35.6 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 113.458 -1.701 . . . . 0.0 107.625 175.326 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -102.98 145.39 29.94 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.081 0.467 . . . . 0.0 110.659 -177.787 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.409 ' CD ' HH12 ' A' ' 67' ' ' ARG . 33.7 tt0 -73.56 132.28 42.65 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 107.081 -1.452 . . . . 0.0 107.081 178.303 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 92.92 -2.4 72.28 Favored Glycine 0 C--O 1.223 -0.539 0 N-CA-C 111.125 -0.79 . . . . 0.0 111.125 -177.636 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 8.9 t -130.01 -177.22 4.21 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 177.496 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 4.3 tmt_? 65.06 -48.53 0.35 Allowed 'General case' 0 N--CA 1.484 1.252 0 N-CA-C 115.996 1.85 . . . . 0.0 115.996 179.33 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 72.99 -156.56 51.77 Favored Glycine 0 CA--C 1.518 0.263 0 CA-C-N 118.636 0.653 . . . . 0.0 111.97 179.789 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 145.25 -162.28 28.17 Favored Glycine 0 CA--C 1.508 -0.382 0 N-CA-C 110.17 -1.172 . . . . 0.0 110.17 179.465 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 22.1 m . . . . . 0 C--O 1.241 0.616 0 N-CA-C 106.279 -1.748 . . . . 0.0 106.279 176.97 . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.916 0 CA-C-O 118.099 -1.389 . . . . 0.0 111.315 . . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 54.87 45.28 26.89 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 117.849 0.825 . . . . 0.0 111.594 -177.614 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 11.6 mtp -132.11 103.18 6.13 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 105.476 -2.046 . . . . 0.0 105.476 179.839 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -176.88 122.52 0.85 Allowed Glycine 0 N--CA 1.443 -0.894 0 N-CA-C 107.843 -2.103 . . . . 0.0 107.843 -176.433 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 96.2 mt -128.32 153.2 78.95 Favored Pre-proline 0 C--N 1.315 -0.897 0 N-CA-C 105.552 -2.018 . . . . 0.0 105.552 177.185 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -72.63 -22.69 20.51 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 117.829 -0.981 . . . . 0.0 114.585 -177.979 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 15.0 t-20 -164.99 -157.22 0.34 Allowed 'General case' 0 N--CA 1.437 -1.085 1 N-CA-C 96.655 -5.313 . . . . 0.0 96.655 178.494 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 -71.23 -39.9 71.4 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 118.58 0.627 . . . . 0.0 110.013 179.121 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 16.8 p 24.55 78.76 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.076 0 N-CA-C 116.769 2.137 . . . . 0.0 116.769 177.395 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -109.88 153.09 24.94 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.912 -177.655 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 54.0 p -63.27 144.99 56.47 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.02 178.478 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 42.8 m95 -68.78 -23.44 64.3 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 113.69 0.996 . . . . 0.0 113.69 179.987 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -116.84 160.09 21.37 Favored 'General case' 0 C--O 1.242 0.668 0 CA-C-O 121.239 0.542 . . . . 0.0 111.69 -174.898 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.474 ' HB ' ' HB3' ' A' ' 134' ' ' GLU . 75.9 p -70.13 163.1 27.02 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.694 -1.139 . . . . 0.0 109.482 178.999 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -82.65 135.87 34.92 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 113.478 0.918 . . . . 0.0 113.478 -175.809 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.452 HD11 HD22 ' A' ' 119' ' ' LEU . 3.0 mp -80.19 146.83 31.55 Favored 'General case' 0 CA--C 1.503 -0.854 0 N-CA-C 106.466 -1.679 . . . . 0.0 106.466 173.419 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 25.2 m -106.08 136.2 46.19 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 178.01 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 -110.78 128.2 55.66 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.265 0.555 . . . . 0.0 111.198 -178.359 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 40.7 t60 -129.12 99.47 5.27 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 106.229 -1.767 . . . . 0.0 106.229 175.18 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 165.79 -173.13 41.4 Favored Glycine 0 N--CA 1.451 -0.347 0 N-CA-C 110.418 -1.073 . . . . 0.0 110.418 -178.502 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -98.01 -16.94 19.44 Favored 'General case' 0 C--O 1.218 -0.566 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 -179.387 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 84.0 mt-10 -71.04 169.16 15.55 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 113.49 0.922 . . . . 0.0 113.49 -176.29 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 70.0 m-20 -116.17 24.33 11.49 Favored 'General case' 0 C--O 1.221 -0.428 0 CA-C-O 122.013 0.911 . . . . 0.0 111.797 178.895 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 62.2 tp 66.54 144.19 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 126.598 1.959 . . . . 0.0 113.597 179.987 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 49.3 tptt -157.74 138.15 12.79 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 176.234 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -123.56 136.27 27.04 Favored Pre-proline 0 C--O 1.242 0.699 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 173.535 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -64.04 162.34 29.79 Favored 'Trans proline' 0 CA--C 1.539 0.74 0 C-N-CA 121.205 1.27 . . . . 0.0 113.344 175.349 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -67.13 143.2 56.77 Favored 'General case' 0 C--O 1.22 -0.495 0 O-C-N 122.017 -0.427 . . . . 0.0 112.007 -179.278 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 78.29 13.65 83.06 Favored Glycine 0 C--O 1.222 -0.62 0 N-CA-C 111.115 -0.794 . . . . 0.0 111.115 178.951 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -152.52 168.6 25.0 Favored 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 -173.938 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 104.2 -19.87 41.96 Favored Glycine 0 CA--C 1.499 -0.951 0 CA-C-O 121.015 0.231 . . . . 0.0 112.881 173.809 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 58.3 t -72.01 127.25 90.8 Favored Pre-proline 0 C--N 1.319 -0.749 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 177.911 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -68.64 175.23 7.39 Favored 'Trans proline' 0 CA--C 1.531 0.36 0 N-CA-C 113.7 0.616 . . . . 0.0 113.7 177.404 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 88.0 mt -75.56 110.41 10.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 121.882 0.848 . . . . 0.0 109.174 178.616 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -108.35 83.26 1.75 Allowed 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 114.674 -1.148 . . . . 0.0 109.637 -178.406 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 80.9 p -69.71 -18.37 63.53 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 113.704 1.001 . . . . 0.0 113.704 -176.783 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -119.64 32.11 6.23 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 -175.916 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.4 m -136.35 157.38 46.93 Favored 'General case' 0 C--N 1.327 -0.394 0 O-C-N 122.045 -0.409 . . . . 0.0 111.456 179.214 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 15.0 m -72.68 159.35 85.57 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.017 -179.979 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -65.42 -24.92 56.47 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 116.127 -2.115 . . . . 0.0 111.331 176.833 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -62.14 -29.79 70.59 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.444 176.578 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 35.4 t0 -88.25 -6.38 57.83 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 113.737 1.014 . . . . 0.0 113.737 -172.536 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 95.1 mm-40 -62.03 -31.84 72.27 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 112.95 0.722 . . . . 0.0 112.95 -177.177 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 13.6 tt -62.42 137.86 23.54 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 CA-C-O 122.135 0.969 . . . . 0.0 110.753 177.902 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -179.25 -159.55 23.54 Favored Glycine 0 CA--C 1.504 -0.638 0 C-N-CA 120.1 -1.048 . . . . 0.0 111.51 -178.247 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 38.2 p90 -155.09 168.52 26.73 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 109.838 -0.431 . . . . 0.0 109.838 179.408 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 14.2 m-85 -110.34 137.32 48.21 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 175.615 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 47.6 ttt-85 -112.03 125.3 53.93 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 124.12 0.968 . . . . 0.0 109.936 -176.941 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 9.1 ttt180 -72.77 145.96 46.7 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 122.051 0.929 . . . . 0.0 109.339 179.343 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -75.91 170.8 15.55 Favored 'General case' 0 N--CA 1.432 -1.337 0 CA-C-N 114.165 -1.379 . . . . 0.0 109.895 178.472 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 8.5 t -61.7 147.82 44.78 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 122.222 1.011 . . . . 0.0 110.615 -178.747 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 10.2 tpt180 -72.46 147.42 46.11 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.687 -1.142 . . . . 0.0 111.661 -175.938 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 3.2 tmt_? -88.44 129.06 35.52 Favored 'General case' 0 CA--C 1.504 -0.799 0 N-CA-C 106.113 -1.81 . . . . 0.0 106.113 175.919 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -132.43 176.87 8.04 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-N 114.381 -1.282 . . . . 0.0 111.397 -172.639 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 18.8 ttm180 -112.68 117.03 31.12 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 103.92 -2.622 . . . . 0.0 103.92 174.783 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -92.79 142.41 15.97 Favored Glycine 0 C--O 1.222 -0.596 0 N-CA-C 109.301 -1.52 . . . . 0.0 109.301 179.45 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -70.9 -27.19 72.66 Favored Glycine 0 C--O 1.214 -1.125 0 C-N-CA 121.02 -0.61 . . . . 0.0 114.0 -177.337 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -83.55 -2.34 55.78 Favored 'General case' 0 C--O 1.218 -0.581 0 CA-C-O 121.516 0.674 . . . . 0.0 112.551 -178.319 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 102.94 12.14 32.72 Favored Glycine 0 CA--C 1.504 -0.624 0 CA-C-O 121.557 0.532 . . . . 0.0 112.267 172.037 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 2.6 pttt -130.22 149.23 52.01 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 111.875 0.324 . . . . 0.0 111.875 -177.895 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 23.1 ptm -147.8 176.92 9.74 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 114.594 1.331 . . . . 0.0 114.594 -170.282 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 13.4 mptt -82.35 -45.42 14.91 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.399 178.696 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 8.2 t0 62.45 -169.66 0.18 Allowed 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 112.129 -2.305 . . . . 0.0 113.657 -177.344 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER 66.53 165.16 0.2 Allowed 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 115.23 1.567 . . . . 0.0 115.23 -179.681 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -79.76 157.35 74.39 Favored Pre-proline 0 C--O 1.238 0.494 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 177.909 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -67.43 143.74 64.65 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 114.969 -2.887 . . . . 0.0 112.088 178.805 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 25.6 mtp180 -118.82 166.02 13.31 Favored 'General case' 0 CA--C 1.511 -0.531 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 179.396 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 71.3 m95 -131.09 132.05 44.6 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 178.031 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 61.1 m-85 -112.68 152.1 29.42 Favored 'General case' 0 C--O 1.214 -0.79 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 -178.792 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 77.8 t80 -102.03 136.67 41.46 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 119.35 0.977 . . . . 0.0 109.804 -177.816 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -141.03 146.6 37.44 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.981 -175.288 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 30.5 m-85 -77.82 159.48 28.95 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.128 0.49 . . . . 0.0 111.884 -178.62 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -55.31 131.76 46.37 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.015 179.436 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 72.09 27.82 69.54 Favored Glycine 0 C--O 1.219 -0.816 0 N-CA-C 116.095 1.198 . . . . 0.0 116.095 176.542 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 3.7 p -88.97 146.06 25.12 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 118.575 1.187 . . . . 0.0 108.527 177.734 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 104.67 143.76 12.45 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 109.656 -1.378 . . . . 0.0 109.656 -177.995 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -71.7 -40.22 2.96 Favored 'Trans proline' 0 C--N 1.347 0.448 0 CA-C-N 119.612 1.706 . . . . 0.0 115.553 -173.473 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -119.57 30.17 7.22 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.865 0.841 . . . . 0.0 109.743 -177.768 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -56.0 -43.51 77.75 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.94 -177.009 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 57.99 30.07 63.02 Favored Glycine 0 C--O 1.228 -0.274 0 CA-C-N 115.95 -0.568 . . . . 0.0 112.608 179.375 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 16.7 mt -114.72 103.75 54.67 Favored Pre-proline 0 N--CA 1.449 -0.508 0 N-CA-C 114.637 1.347 . . . . 0.0 114.637 -175.597 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -78.34 165.61 25.31 Favored 'Trans proline' 0 N--CA 1.462 -0.362 0 C-N-CA 121.525 1.484 . . . . 0.0 108.653 169.865 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 88.2 t80 -61.39 128.47 36.47 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.983 0.42 . . . . 0.0 110.505 -179.222 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 93.25 -6.83 75.74 Favored Glycine 0 CA--C 1.521 0.409 0 N-CA-C 115.364 0.905 . . . . 0.0 115.364 178.676 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -63.32 133.6 54.39 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 118.433 1.117 . . . . 0.0 112.417 -179.961 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -78.02 125.87 29.99 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.415 -179.246 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 29.6 ttmt -156.22 151.32 26.41 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 107.046 -1.464 . . . . 0.0 107.046 178.145 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -66.44 133.04 49.61 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 -178.204 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 70.44 24.04 77.06 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.889 -0.672 . . . . 0.0 114.019 178.022 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 43.5 mm -127.3 125.67 66.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 117.241 0.52 . . . . 0.0 109.918 179.229 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.1 pt -131.21 122.07 50.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 121.6 0.714 . . . . 0.0 110.5 177.055 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 94.0 m95 -88.25 138.28 31.58 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 -176.261 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 23.4 m -135.95 155.46 35.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 178.916 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -162.93 166.09 24.31 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 105.412 -2.07 . . . . 0.0 105.412 -179.843 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 11.9 t -135.98 173.66 11.47 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 105.37 -2.085 . . . . 0.0 105.37 178.38 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -67.6 136.72 54.89 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.161 0.505 . . . . 0.0 110.443 -178.646 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 92.51 -6.71 77.83 Favored Glycine 0 C--O 1.227 -0.289 0 CA-C-N 115.943 -0.572 . . . . 0.0 114.266 177.571 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -78.05 148.26 34.39 Favored 'General case' 0 C--N 1.322 -0.596 0 O-C-N 122.439 -0.448 . . . . 0.0 110.696 179.228 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 70.5 mt -81.21 170.78 15.68 Favored 'General case' 0 C--O 1.208 -1.095 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 178.015 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -112.96 28.84 8.46 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 121.239 0.542 . . . . 0.0 109.898 177.709 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -109.94 151.74 42.6 Favored Pre-proline 0 CA--C 1.546 0.825 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 -174.36 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -71.01 151.07 61.62 Favored 'Trans proline' 0 C--N 1.352 0.744 0 C-N-CA 120.481 0.787 . . . . 0.0 113.569 177.391 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 6.6 pttp -154.33 57.44 0.7 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 122.548 1.166 . . . . 0.0 111.423 -177.631 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -57.24 -31.99 66.11 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 114.518 -1.219 . . . . 0.0 112.511 179.813 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 11.9 p80 -60.67 -11.32 7.01 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 114.929 1.455 . . . . 0.0 114.929 -177.991 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 45.8 mt -92.31 -43.4 13.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 177.495 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -70.85 14.68 1.42 Allowed Glycine 0 CA--C 1.523 0.558 0 N-CA-C 117.296 1.678 . . . . 0.0 117.296 -175.556 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 12.3 t -90.31 30.24 1.15 Allowed 'General case' 0 CA--C 1.548 0.876 0 N-CA-C 112.527 0.566 . . . . 0.0 112.527 -178.108 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 68.8 ttp85 -56.19 131.25 47.3 Favored 'General case' 0 N--CA 1.475 0.808 0 O-C-N 121.426 -0.796 . . . . 0.0 109.846 179.398 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 37.1 m-20 -100.52 119.57 58.42 Favored Pre-proline 0 C--N 1.325 -0.465 0 N-CA-C 105.125 -2.176 . . . . 0.0 105.125 178.698 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -71.05 -17.34 31.84 Favored 'Trans proline' 0 C--N 1.347 0.469 0 N-CA-C 114.793 1.036 . . . . 0.0 114.793 -174.824 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -75.0 -25.37 58.76 Favored 'General case' 0 C--O 1.22 -0.48 0 CA-C-O 120.946 0.403 . . . . 0.0 110.064 177.631 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 -100.55 -24.67 14.4 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 113.296 0.85 . . . . 0.0 113.296 -175.519 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -149.56 145.44 26.82 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.933 0.716 . . . . 0.0 112.933 -179.446 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -83.66 147.54 27.63 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-O 121.617 0.722 . . . . 0.0 112.305 -179.914 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -72.33 147.46 46.29 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.669 178.315 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 9.9 mt -83.71 133.76 28.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 -179.255 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 74.0 t -62.73 120.93 10.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 N-CA-C 105.853 -1.906 . . . . 0.0 105.853 175.534 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.452 HD22 HD11 ' A' ' 16' ' ' LEU . 6.7 tt -68.44 128.95 38.44 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.21 0.529 . . . . 0.0 110.483 -176.919 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 29.8 mt-30 -132.14 156.51 46.26 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 105.835 -1.913 . . . . 0.0 105.835 179.065 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 14.1 mt -112.25 149.8 41.54 Favored Pre-proline 0 C--N 1.321 -0.631 0 N-CA-C 105.93 -1.878 . . . . 0.0 105.93 177.744 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -69.9 171.01 15.41 Favored 'Trans proline' 0 C--N 1.344 0.302 0 N-CA-C 115.136 1.168 . . . . 0.0 115.136 -175.061 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -54.9 130.94 43.19 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.835 -178.116 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 88.12 -10.68 69.92 Favored Glycine 0 C--O 1.227 -0.315 0 CA-C-N 115.89 -0.595 . . . . 0.0 112.648 -179.99 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 27.9 m -108.66 127.68 54.18 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.146 0.498 . . . . 0.0 110.662 -179.854 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 19.2 p -124.22 152.99 42.28 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.301 0.572 . . . . 0.0 112.309 -177.532 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 71.4 mt -70.36 155.45 93.41 Favored Pre-proline 0 C--N 1.326 -0.433 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 176.833 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -76.86 172.77 15.59 Favored 'Trans proline' 0 N--CA 1.463 -0.265 0 O-C-N 121.933 0.438 . . . . 0.0 111.038 179.085 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 48.5 tptt -60.78 132.57 54.3 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 -178.341 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 86.81 22.53 45.76 Favored Glycine 0 CA--C 1.518 0.247 0 N-CA-C 114.844 0.698 . . . . 0.0 114.844 177.816 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -131.91 143.43 50.13 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 117.35 0.575 . . . . 0.0 112.258 178.553 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 49.2 p90 -148.94 158.71 44.38 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 106.267 -1.753 . . . . 0.0 106.267 172.507 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -100.43 148.47 24.71 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.816 0.341 . . . . 0.0 110.279 -178.412 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.474 ' HB3' ' HB ' ' A' ' 14' ' ' THR . 8.7 tp10 -67.39 134.33 51.26 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.204 -1.035 . . . . 0.0 108.204 177.593 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 85.78 -7.89 75.08 Favored Glycine 0 C--O 1.227 -0.33 0 CA-C-N 116.058 -0.519 . . . . 0.0 112.941 -177.9 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 20.8 t -100.91 152.74 20.18 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.459 0.647 . . . . 0.0 109.86 179.95 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 41.3 mmt180 -140.38 -171.52 3.23 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 105.578 -2.008 . . . . 0.0 105.578 -178.924 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 101.51 34.5 4.42 Favored Glycine 0 C--O 1.223 -0.537 0 C-N-CA 120.916 -0.659 . . . . 0.0 113.042 179.812 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -158.41 175.78 35.47 Favored Glycine 0 N--CA 1.45 -0.424 0 N-CA-C 107.039 -2.425 . . . . 0.0 107.039 178.823 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 59.0 p . . . . . 0 C--O 1.253 1.288 0 CA-C-O 115.786 -2.054 . . . . 0.0 106.169 -179.215 . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.735 0 CA-C-O 119.269 -0.739 . . . . 0.0 111.452 . . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -73.63 153.77 40.02 Favored 'General case' 0 C--O 1.222 -0.392 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 178.323 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 87.9 mtp -120.89 34.31 5.26 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 121.296 0.57 . . . . 0.0 109.529 -179.953 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -91.25 42.44 2.84 Favored Glycine 0 C--O 1.22 -0.72 0 CA-C-N 116.018 -0.537 . . . . 0.0 114.073 -177.522 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -66.08 138.21 96.09 Favored Pre-proline 0 C--O 1.239 0.526 0 CA-C-N 117.297 0.548 . . . . 0.0 110.111 -177.923 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -74.84 152.81 42.07 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 118.327 -0.649 . . . . 0.0 111.783 177.412 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 59.4 t30 -155.94 98.06 1.86 Allowed 'General case' 0 C--N 1.327 -0.382 0 O-C-N 122.343 -0.223 . . . . 0.0 111.444 179.96 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -104.79 30.43 5.48 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-O 121.657 0.741 . . . . 0.0 110.438 179.966 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 22.6 p -140.93 162.54 35.22 Favored 'General case' 0 N--CA 1.433 -1.276 1 N-CA-C 98.539 -4.615 . . . . 0.0 98.539 -179.135 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -152.73 152.05 31.24 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-O 121.387 0.613 . . . . 0.0 112.273 -178.261 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.7 t -58.53 139.81 55.13 Favored 'General case' 0 CA--C 1.508 -0.647 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 174.902 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 22.1 m95 -64.27 -21.82 66.73 Favored 'General case' 0 C--N 1.323 -0.564 0 O-C-N 123.188 0.305 . . . . 0.0 111.323 177.855 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 51.6 m-85 -121.5 163.17 19.26 Favored 'General case' 0 C--O 1.241 0.628 0 N-CA-C 114.259 1.207 . . . . 0.0 114.259 -172.727 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 57.4 p -68.51 164.7 20.62 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 114.562 -1.199 . . . . 0.0 110.476 179.513 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.499 ' HB2' ' CZ ' ' A' ' 69' ' ' TYR . . . -80.73 137.92 36.3 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 -176.34 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -90.21 147.3 23.64 Favored 'General case' 0 CA--C 1.502 -0.883 0 N-CA-C 105.767 -1.938 . . . . 0.0 105.767 171.883 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 91.8 m -123.7 141.71 51.76 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 -178.538 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.411 ' HB2' ' CZ ' ' A' ' 131' ' ' PHE . 4.3 tp60 -111.23 136.14 50.74 Favored 'General case' 0 C--N 1.329 -0.295 0 O-C-N 123.629 0.581 . . . . 0.0 112.543 -177.783 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 46.0 t60 -133.32 99.44 4.53 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 103.813 -2.662 . . . . 0.0 103.813 169.551 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 179.12 -158.78 23.13 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.537 -0.839 . . . . 0.0 111.028 -175.204 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 35.3 mmtp -108.52 -28.09 9.52 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 113.958 1.096 . . . . 0.0 113.958 -178.225 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -90.94 167.45 12.41 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 176.231 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -81.81 -62.62 1.59 Allowed 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 -178.855 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 36.5 tp -174.39 142.79 0.8 Allowed 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 105.51 -2.033 . . . . 0.0 105.51 174.043 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 79.5 tttt -151.48 146.18 25.73 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 174.946 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -135.7 157.62 75.84 Favored Pre-proline 0 C--N 1.323 -0.562 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 176.939 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -71.78 172.82 13.73 Favored 'Trans proline' 0 CA--C 1.536 0.614 0 C-N-CA 120.718 0.945 . . . . 0.0 114.002 -179.429 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 25.3 tpt180 -78.41 130.97 36.72 Favored 'General case' 0 C--O 1.216 -0.675 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 177.798 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 81.07 7.15 88.86 Favored Glycine 0 C--O 1.225 -0.461 0 N-CA-C 115.279 0.871 . . . . 0.0 115.279 175.886 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 4.8 tt0 -158.52 146.48 18.24 Favored 'General case' 0 C--O 1.217 -0.654 0 N-CA-C 106.457 -1.682 . . . . 0.0 106.457 -177.854 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 136.65 -17.21 3.73 Favored Glycine 0 CA--C 1.503 -0.676 0 C-N-CA 120.344 -0.932 . . . . 0.0 112.556 177.7 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 33.1 m -71.27 146.52 92.25 Favored Pre-proline 0 C--N 1.321 -0.637 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 176.922 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_endo -76.1 173.49 14.39 Favored 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 121.121 1.214 . . . . 0.0 112.606 178.65 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 93.3 mt -76.09 113.06 14.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 N-CA-C 108.042 -1.095 . . . . 0.0 108.042 178.517 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 45.0 m-20 -104.67 83.91 2.09 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 -178.801 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 69.0 p -64.26 -22.2 66.86 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 115.352 1.612 . . . . 0.0 115.352 -174.422 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 11.1 p30 -106.02 18.28 22.31 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.293 -177.384 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 9.4 m -125.55 157.88 35.96 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -175.152 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -74.29 162.26 74.62 Favored Pre-proline 0 C--N 1.323 -0.56 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 178.23 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -66.11 -23.03 53.67 Favored 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 115.159 -2.76 . . . . 0.0 112.015 177.542 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.496 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 0.0 OUTLIER -72.37 -13.56 61.5 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.278 0.561 . . . . 0.0 111.128 178.824 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -104.83 1.06 28.7 Favored 'General case' 0 C--O 1.219 -0.528 0 N-CA-C 114.541 1.311 . . . . 0.0 114.541 -175.063 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 86.6 mm-40 -62.54 -21.64 65.71 Favored 'General case' 0 CA--C 1.548 0.881 0 O-C-N 120.633 -1.292 . . . . 0.0 110.749 178.193 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.506 ' HB ' ' HB1' ' A' ' 98' ' ' ALA . 14.3 tt -62.69 143.26 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 CA-C-O 121.96 0.886 . . . . 0.0 112.827 178.413 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 177.14 -153.77 14.4 Favored Glycine 0 N--CA 1.446 -0.668 0 N-CA-C 110.774 -0.93 . . . . 0.0 110.774 178.565 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 43.2 p90 -154.95 168.48 26.82 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 178.242 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 40.1 m-85 -111.31 140.96 45.45 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 106.66 -1.607 . . . . 0.0 106.66 175.186 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 34.4 ttt180 -114.59 125.73 54.1 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 123.273 0.629 . . . . 0.0 111.913 -178.203 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 27.8 ttt180 -67.5 139.0 56.99 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 176.28 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -136.72 129.75 31.01 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.058 0.456 . . . . 0.0 110.855 179.339 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 27.3 p -145.54 154.41 42.15 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 106.533 -1.654 . . . . 0.0 106.533 176.322 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 15.8 tpt180 -163.33 121.69 1.99 Allowed 'General case' 0 CA--C 1.513 -0.443 0 N-CA-C 106.561 -1.644 . . . . 0.0 106.561 173.323 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 3.3 tmt_? -132.07 144.78 50.99 Favored 'General case' 0 CA--C 1.495 -1.136 0 CA-C-O 121.448 0.642 . . . . 0.0 109.81 -176.684 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -140.92 178.25 3.14 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 N-CA-C 105.378 -2.082 . . . . 0.0 105.378 -178.378 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 6.8 tmm_? -137.25 105.74 5.8 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 175.134 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -72.38 163.22 54.67 Favored Glycine 0 N--CA 1.448 -0.503 0 N-CA-C 108.853 -1.699 . . . . 0.0 108.853 178.305 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -71.24 -32.29 65.52 Favored Glycine 0 C--O 1.214 -1.11 0 N-CA-C 108.689 -1.764 . . . . 0.0 108.689 179.331 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 30.6 t0 -89.43 17.07 6.58 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 122.4 1.095 . . . . 0.0 109.478 178.47 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 84.16 -16.2 34.8 Favored Glycine 0 N--CA 1.46 0.259 0 N-CA-C 116.228 1.251 . . . . 0.0 116.228 173.302 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -56.52 134.37 54.11 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 113.886 1.069 . . . . 0.0 113.886 -176.976 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 47.1 mtp -112.83 -168.84 1.38 Allowed 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 113.536 -1.665 . . . . 0.0 110.29 -179.978 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 15.7 mmtt -122.75 -57.94 1.7 Allowed 'General case' 0 C--O 1.217 -0.61 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -178.689 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 58.0 p30 -135.55 174.72 10.3 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.433 -0.803 . . . . 0.0 112.062 -179.076 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 80.4 mt -136.17 -66.2 0.55 Allowed 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 177.681 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 20.0 m -79.98 150.87 72.6 Favored Pre-proline 0 C--O 1.244 0.771 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.036 178.857 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -75.04 157.56 42.53 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 117.111 -1.46 . . . . 0.0 111.417 176.233 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 7.6 ptt-85 -131.64 162.5 30.24 Favored 'General case' 0 CA--C 1.51 -0.569 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 177.128 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 64.3 m95 -129.57 147.67 51.39 Favored 'General case' 0 C--N 1.318 -0.769 0 O-C-N 123.458 0.474 . . . . 0.0 110.114 -178.316 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.499 ' CZ ' ' HB2' ' A' ' 15' ' ' ALA . 72.9 m-85 -127.47 150.46 49.65 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 178.728 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 87.6 t80 -96.55 135.8 37.96 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 -179.621 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -136.07 140.75 44.02 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 121.822 0.82 . . . . 0.0 109.314 -176.949 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 78.2 m-85 -74.62 159.43 32.13 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 114.602 -1.181 . . . . 0.0 110.651 -176.624 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -57.16 135.81 56.4 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 114.088 1.144 . . . . 0.0 114.088 -176.619 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 65.54 29.17 74.56 Favored Glycine 0 C--O 1.224 -0.511 0 N-CA-C 115.869 1.108 . . . . 0.0 115.869 175.036 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 16.8 p -94.54 146.1 24.35 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 118.001 0.9 . . . . 0.0 110.19 179.739 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 108.21 141.56 9.74 Favored Glycine 0 CA--C 1.523 0.569 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 -177.57 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -69.59 -41.8 4.17 Favored 'Trans proline' 0 C--N 1.347 0.486 0 CA-C-N 119.824 1.812 . . . . 0.0 116.257 -173.337 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -109.34 19.58 19.22 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.522 0.677 . . . . 0.0 109.428 -177.351 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -60.54 -51.61 68.71 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.252 -175.794 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 56.45 26.98 53.02 Favored Glycine 0 C--O 1.224 -0.472 0 CA-C-N 115.857 -0.61 . . . . 0.0 114.386 179.45 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 52.1 mt -103.54 110.85 64.59 Favored Pre-proline 0 N--CA 1.447 -0.606 0 N-CA-C 115.278 1.584 . . . . 0.0 115.278 -175.465 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -78.58 167.65 22.35 Favored 'Trans proline' 0 C--O 1.238 0.501 0 N-CA-C 108.832 -1.257 . . . . 0.0 108.832 170.51 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 68.2 t80 -61.59 130.35 45.49 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 120.558 -0.457 . . . . 0.0 110.321 179.458 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 93.47 -5.48 74.19 Favored Glycine 0 CA--C 1.519 0.283 0 N-CA-C 115.013 0.765 . . . . 0.0 115.013 178.212 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -66.2 129.42 39.75 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 118.459 1.129 . . . . 0.0 112.381 179.977 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 54.7 t30 -75.8 128.1 34.42 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.772 -0.649 . . . . 0.0 112.104 -177.758 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 22.2 ttmt -156.23 152.98 28.45 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 106.978 -1.489 . . . . 0.0 106.978 178.116 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 22.4 t0 -64.86 133.09 51.14 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 -179.19 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 68.75 28.23 73.26 Favored Glycine 0 N--CA 1.448 -0.547 0 CA-C-O 119.557 -0.579 . . . . 0.0 114.308 178.14 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 40.2 mm -129.39 129.22 67.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 117.376 0.588 . . . . 0.0 110.17 179.418 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -131.64 117.75 36.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 CA-C-O 121.446 0.641 . . . . 0.0 110.517 176.172 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 95.9 m95 -86.26 133.07 33.85 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 112.23 0.456 . . . . 0.0 112.23 -177.269 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 1.2 m -140.87 151.12 20.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 -177.571 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -155.64 166.43 33.54 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 105.776 -1.935 . . . . 0.0 105.776 -177.908 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 11.4 t -127.18 171.29 11.56 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 105.621 -1.992 . . . . 0.0 105.621 175.21 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -64.76 136.28 56.75 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.327 0.584 . . . . 0.0 110.578 -179.544 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 94.2 -9.72 72.11 Favored Glycine 0 C--O 1.23 -0.117 0 CA-C-N 115.75 -0.659 . . . . 0.0 113.047 177.92 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.506 ' HB1' ' HB ' ' A' ' 44' ' ' ILE . . . -79.83 139.56 37.15 Favored 'General case' 0 CA--C 1.543 0.692 0 O-C-N 122.543 -0.386 . . . . 0.0 110.846 179.971 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 42.2 mt -102.03 137.67 40.01 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 114.65 1.352 . . . . 0.0 114.65 -176.437 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 50.3 t30 -81.18 75.39 8.15 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.101 -0.954 . . . . 0.0 110.252 179.29 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 2.0 t -139.24 157.55 70.74 Favored Pre-proline 0 CA--C 1.541 0.619 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 -179.373 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -64.35 145.01 87.56 Favored 'Trans proline' 0 C--N 1.348 0.512 0 N-CA-C 114.328 0.857 . . . . 0.0 114.328 -179.108 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 67.4 mmtt -126.41 33.55 4.98 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.664 0.745 . . . . 0.0 109.738 -178.11 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -51.45 -45.52 62.72 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.379 -0.828 . . . . 0.0 112.815 -177.189 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 17.8 p80 -72.93 -4.26 30.96 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 114.353 1.242 . . . . 0.0 114.353 -178.273 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 31.7 mt -96.35 -44.08 12.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 122.191 -0.318 . . . . 0.0 110.496 -179.154 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -74.06 12.11 5.62 Favored Glycine 0 CA--C 1.522 0.514 0 N-CA-C 115.205 0.842 . . . . 0.0 115.205 -178.306 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 13.4 t -83.29 19.72 1.44 Allowed 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 113.812 1.042 . . . . 0.0 113.812 -177.147 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 69.3 ttp85 -56.83 126.13 25.59 Favored 'General case' 0 N--CA 1.471 0.593 0 O-C-N 121.488 -0.757 . . . . 0.0 109.905 -179.3 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 34.4 m120 -93.56 124.21 57.82 Favored Pre-proline 0 C--N 1.322 -0.597 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 179.134 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -70.4 -17.73 34.48 Favored 'Trans proline' 0 C--O 1.219 -0.463 0 C-N-CA 117.021 -1.519 . . . . 0.0 113.15 -179.38 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -76.37 -26.86 56.08 Favored 'General case' 0 C--O 1.22 -0.454 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.247 178.021 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 84.1 m-20 -101.65 -23.69 14.22 Favored 'General case' 0 C--O 1.223 -0.33 0 N-CA-C 113.49 0.922 . . . . 0.0 113.49 -174.991 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -149.74 150.64 32.37 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 -178.373 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -88.21 149.02 24.09 Favored 'General case' 0 CA--C 1.545 0.779 0 CA-C-O 121.711 0.767 . . . . 0.0 112.559 179.639 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -72.74 149.86 43.35 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.905 178.364 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 16.7 mt -91.44 139.5 17.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 -179.26 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 93.2 t -62.73 123.79 16.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 N-CA-C 106.021 -1.844 . . . . 0.0 106.021 174.992 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 7.1 tt -66.11 131.25 45.74 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.129 0.49 . . . . 0.0 110.096 -177.215 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 28.3 mt-30 -129.31 152.17 49.16 Favored 'General case' 0 CA--C 1.508 -0.666 0 N-CA-C 106.227 -1.768 . . . . 0.0 106.227 179.838 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 14.3 mt -111.5 148.52 39.01 Favored Pre-proline 0 C--N 1.32 -0.682 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 178.891 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -71.07 165.61 31.82 Favored 'Trans proline' 0 C--N 1.345 0.38 0 O-C-N 122.231 0.595 . . . . 0.0 112.886 -178.546 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 59.5 tt0 -54.65 130.71 41.28 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.504 -177.8 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 94.12 -16.74 60.3 Favored Glycine 0 C--O 1.228 -0.276 0 CA-C-N 115.901 -0.591 . . . . 0.0 113.093 -179.4 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 10.5 m -102.64 129.51 49.25 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 117.652 0.726 . . . . 0.0 109.765 179.366 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 2.7 p -127.39 148.33 50.27 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.671 -177.788 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 72.9 mt -68.76 154.14 95.1 Favored Pre-proline 0 C--N 1.327 -0.378 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 177.719 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -74.92 170.7 19.81 Favored 'Trans proline' 0 C--O 1.233 0.256 0 C-N-CA 117.724 -1.051 . . . . 0.0 110.681 178.674 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 1.3 tptm -60.78 130.59 47.26 Favored 'General case' 0 C--N 1.324 -0.543 0 O-C-N 122.085 -0.384 . . . . 0.0 111.32 -176.13 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 95.19 -2.63 65.9 Favored Glycine 0 CA--C 1.518 0.225 0 N-CA-C 115.111 0.804 . . . . 0.0 115.111 178.256 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.411 ' CZ ' ' HB2' ' A' ' 18' ' ' GLN . 1.2 m-85 -102.37 144.31 31.02 Favored 'General case' 0 N--CA 1.441 -0.903 0 CA-C-O 122.106 0.955 . . . . 0.0 111.23 -179.964 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 47.6 p90 -146.32 163.33 35.88 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 114.022 -1.444 . . . . 0.0 108.305 174.492 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -111.35 146.44 37.08 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.775 0.322 . . . . 0.0 111.158 -177.429 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -73.29 138.12 45.27 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 178.837 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 84.75 -4.23 85.28 Favored Glycine 0 C--O 1.228 -0.28 0 CA-C-N 116.217 -0.447 . . . . 0.0 112.121 -176.787 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 7.5 t -119.04 -151.92 0.49 Allowed 'General case' 0 C--O 1.238 0.452 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 179.816 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 87.9 mmt-85 -137.95 162.01 35.19 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 105.624 -1.991 . . . . 0.0 105.624 178.048 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -127.09 179.84 16.16 Favored Glycine 0 C--N 1.319 -0.395 0 N-CA-C 108.514 -1.834 . . . . 0.0 108.514 178.756 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -124.08 167.73 16.34 Favored Glycine 0 N--CA 1.454 -0.14 0 N-CA-C 109.948 -1.261 . . . . 0.0 109.948 179.219 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 18.0 m . . . . . 0 C--O 1.247 0.966 0 CA-C-O 118.021 -0.99 . . . . 0.0 110.728 179.443 . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 2.807 0 CA-C-O 118.911 -0.938 . . . . 0.0 111.571 . . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -155.34 151.51 28.03 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 179.47 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -160.83 176.42 11.48 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 100.668 -3.827 . . . . 0.0 100.668 178.878 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 58.7 46.34 93.51 Favored Glycine 0 CA--C 1.507 -0.43 0 N-CA-C 115.662 1.025 . . . . 0.0 115.662 177.496 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 92.6 mt -62.86 130.83 94.22 Favored Pre-proline 0 C--N 1.325 -0.468 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 -179.592 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -74.46 146.32 34.88 Favored 'Trans proline' 0 N--CA 1.462 -0.362 0 C-N-CA 118.17 -0.753 . . . . 0.0 113.241 -177.413 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 51.5 t30 -104.81 -44.85 4.73 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.261 0.553 . . . . 0.0 111.792 178.879 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 15.9 p-10 -111.21 -1.39 16.15 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 113.677 0.991 . . . . 0.0 113.677 -176.787 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 40.6 p -115.75 99.52 7.37 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.588 0.709 . . . . 0.0 112.006 -177.45 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -105.84 145.87 30.65 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.26 -178.672 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 43.1 t -55.63 137.12 49.84 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 177.173 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 7.9 m95 -66.14 -21.93 66.36 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 178.798 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 44.2 m-85 -121.48 163.04 19.46 Favored 'General case' 0 CA--C 1.509 -0.598 0 N-CA-C 113.261 0.837 . . . . 0.0 113.261 -171.023 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 73.6 p -72.28 164.28 26.54 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.079 -0.964 . . . . 0.0 109.175 178.765 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -82.81 131.33 35.2 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 112.715 0.635 . . . . 0.0 112.715 -176.039 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 17.1 mt -72.06 148.04 46.19 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 174.134 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 6.2 m -117.58 140.3 49.82 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 -179.406 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 3.8 tp60 -109.72 128.18 55.1 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 123.557 0.536 . . . . 0.0 111.088 179.112 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 41.5 t60 -116.61 99.51 7.19 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 103.615 -2.735 . . . . 0.0 103.615 171.043 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 160.37 -159.2 30.62 Favored Glycine 0 N--CA 1.45 -0.391 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 -175.643 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 69.1 mttm -118.77 -23.43 7.01 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 114.106 1.15 . . . . 0.0 114.106 -178.304 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -74.35 159.75 31.97 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.763 -177.991 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -71.66 -62.95 1.23 Allowed 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 112.976 0.732 . . . . 0.0 112.976 -177.815 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 40.8 tp 153.73 143.43 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.306 0 N-CA-C 103.759 -2.682 . . . . 0.0 103.759 -176.183 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 50.0 tptt -156.44 141.02 16.87 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 175.477 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -125.38 149.91 65.9 Favored Pre-proline 0 C--O 1.241 0.634 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 175.908 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -71.75 161.3 45.56 Favored 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 120.651 0.901 . . . . 0.0 112.793 178.664 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 40.0 tpt85 -66.73 133.29 49.87 Favored 'General case' 0 C--O 1.216 -0.695 0 O-C-N 122.059 -0.401 . . . . 0.0 109.964 -178.437 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 86.02 7.0 81.35 Favored Glycine 0 C--O 1.223 -0.566 0 N-CA-C 111.66 -0.576 . . . . 0.0 111.66 178.839 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 15.5 mt-30 -146.42 170.57 16.56 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 -175.031 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 103.63 -15.08 53.36 Favored Glycine 0 CA--C 1.501 -0.84 0 CA-C-N 116.122 -0.49 . . . . 0.0 113.434 174.78 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.417 HG11 ' HB3' ' A' ' 43' ' ' GLN . 92.4 t -67.61 128.92 93.6 Favored Pre-proline 0 C--N 1.317 -0.81 0 N-CA-C 106.241 -1.763 . . . . 0.0 106.241 176.726 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -72.87 170.69 19.07 Favored 'Trans proline' 0 N--CA 1.459 -0.502 0 O-C-N 122.26 0.611 . . . . 0.0 111.214 178.22 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 90.6 mt -70.73 107.31 2.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-O 122.075 0.94 . . . . 0.0 108.715 -179.345 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 71.3 m-20 -101.46 84.98 2.69 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 114.357 -1.292 . . . . 0.0 109.417 -177.299 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 72.6 p -68.5 -15.03 63.4 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.722 0.772 . . . . 0.0 112.527 -178.704 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 21.0 p30 -106.0 21.96 16.44 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 114.845 -1.071 . . . . 0.0 112.062 -177.22 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 50.5 m -139.51 150.05 44.67 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 113.577 0.954 . . . . 0.0 113.577 -176.044 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 2.5 m -71.65 166.61 38.08 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.448 176.675 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -66.22 -25.9 49.81 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 114.811 -2.993 . . . . 0.0 114.159 -179.775 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.471 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 3.4 p-10 -78.06 -21.01 51.25 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.551 0.691 . . . . 0.0 110.922 177.194 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 62.0 m-20 -81.35 -8.29 59.71 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 113.214 0.82 . . . . 0.0 113.214 -175.34 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.417 ' HB3' HG11 ' A' ' 32' ' ' VAL . 97.1 mm-40 -57.83 -25.95 61.35 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 114.495 1.295 . . . . 0.0 114.495 -178.876 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.438 ' HB ' ' HB1' ' A' ' 98' ' ' ALA . 9.6 tt -58.38 138.92 18.75 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.971 0 CA-C-O 122.179 0.99 . . . . 0.0 113.638 -178.676 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 179.04 -159.67 24.69 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.411 -179.36 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 43.5 p90 -155.05 170.79 20.96 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 178.958 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 14.5 m-85 -113.1 140.07 48.19 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 173.764 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -110.26 121.66 45.82 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 123.938 0.895 . . . . 0.0 110.436 -178.579 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 40.2 ttp180 -70.84 130.84 42.72 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 174.535 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -142.5 146.6 34.88 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.177 0.513 . . . . 0.0 111.605 -178.737 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 10.2 t -155.4 162.47 40.78 Favored 'General case' 0 C--O 1.245 0.84 0 N-CA-C 104.021 -2.585 . . . . 0.0 104.021 174.186 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 10.1 tpp85 -169.68 139.7 2.04 Favored 'General case' 0 C--O 1.215 -0.733 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 -179.423 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 7.0 ttm180 -121.21 131.15 54.06 Favored 'General case' 0 CA--C 1.497 -1.068 0 N-CA-C 106.39 -1.707 . . . . 0.0 106.39 172.635 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -140.62 178.05 3.46 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 CA-C-N 114.684 -1.144 . . . . 0.0 107.961 -175.396 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.66 99.4 5.97 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 104.813 -2.291 . . . . 0.0 104.813 171.801 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -69.91 161.48 52.95 Favored Glycine 0 C--O 1.227 -0.319 0 N-CA-C 108.755 -1.738 . . . . 0.0 108.755 179.416 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -58.26 -41.41 94.91 Favored Glycine 0 C--O 1.223 -0.592 0 CA-C-N 118.036 0.918 . . . . 0.0 113.566 -178.039 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 32.2 t0 -89.12 15.67 8.41 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-O 122.343 1.068 . . . . 0.0 111.759 -179.584 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 87.45 9.11 73.05 Favored Glycine 0 C--O 1.221 -0.66 0 CA-C-N 115.326 -0.852 . . . . 0.0 113.191 172.865 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 21.8 mmtt -79.6 139.7 37.38 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.184 0.516 . . . . 0.0 109.697 -175.56 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 84.2 mtp -114.75 -167.36 1.21 Allowed 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.794 -177.91 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 57.3 mmtt -144.27 -73.76 0.26 Allowed 'General case' 0 C--O 1.213 -0.819 0 C-N-CA 123.14 0.576 . . . . 0.0 109.476 -177.806 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 30.74 -121.65 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.64 0 O-C-N 125.18 1.55 . . . . 0.0 114.606 179.102 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 59.47 -168.45 0.15 Allowed 'General case' 0 C--N 1.318 -0.766 0 O-C-N 124.772 1.295 . . . . 0.0 112.371 -179.487 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 18.9 m -62.09 153.73 72.77 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.744 179.411 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -65.74 148.57 86.89 Favored 'Trans proline' 0 C--O 1.237 0.447 0 C-N-CA 115.845 -2.303 . . . . 0.0 111.733 178.709 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 31.8 mtp180 -118.61 158.13 26.05 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 -177.653 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 64.2 m95 -120.13 129.58 54.22 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 120.852 0.358 . . . . 0.0 110.436 -179.054 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 24.1 m-85 -110.35 142.21 42.32 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 -178.778 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 85.4 t80 -94.22 136.76 34.16 Favored 'General case' 0 CA--C 1.511 -0.536 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 -178.182 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -139.63 146.56 39.9 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 -177.056 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -81.58 159.51 24.06 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.135 -175.703 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -54.59 131.53 43.22 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.921 0.391 . . . . 0.0 111.786 -179.277 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 71.38 33.71 64.21 Favored Glycine 0 C--O 1.222 -0.618 0 N-CA-C 115.583 0.993 . . . . 0.0 115.583 176.375 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 4.2 p -97.75 146.12 25.69 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 118.135 0.967 . . . . 0.0 110.384 178.64 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 98.61 147.86 22.68 Favored Glycine 0 CA--C 1.525 0.66 0 CA-C-O 119.769 -0.462 . . . . 0.0 112.743 178.968 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -69.14 -48.26 0.89 Allowed 'Trans proline' 0 C--N 1.35 0.614 0 N-CA-C 117.063 1.909 . . . . 0.0 117.063 -173.593 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -119.04 32.72 5.98 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.963 0.887 . . . . 0.0 108.718 -178.075 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -56.91 -40.67 76.75 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.4 -178.865 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 56.21 42.01 87.43 Favored Glycine 0 C--N 1.33 0.226 0 CA-C-N 115.839 -0.619 . . . . 0.0 112.391 178.006 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 13.7 mt -128.26 103.75 20.31 Favored Pre-proline 0 N--CA 1.441 -0.886 0 N-CA-C 114.136 1.162 . . . . 0.0 114.136 -177.175 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -78.63 161.52 27.82 Favored 'Trans proline' 0 N--CA 1.461 -0.398 0 N-CA-C 107.444 -1.791 . . . . 0.0 107.444 167.956 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 58.2 t80 -60.21 132.55 54.28 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 120.187 -0.605 . . . . 0.0 110.226 -178.313 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 91.84 -8.52 78.19 Favored Glycine 0 N--CA 1.452 -0.27 0 CA-C-O 119.193 -0.782 . . . . 0.0 114.712 178.873 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -66.03 129.63 40.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 118.788 1.294 . . . . 0.0 111.171 179.889 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 46.7 t-20 -79.32 128.72 33.69 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.421 -178.542 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 30.5 ttmt -156.18 153.19 28.85 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 107.483 -1.302 . . . . 0.0 107.483 -178.699 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -59.58 125.12 22.38 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.853 0.359 . . . . 0.0 111.807 -178.561 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 68.2 31.39 74.58 Favored Glycine 0 N--CA 1.448 -0.551 0 CA-C-O 119.286 -0.73 . . . . 0.0 113.9 178.262 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 43.4 mm -126.53 128.09 70.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 117.535 0.668 . . . . 0.0 109.954 178.442 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.1 pt -132.75 116.26 26.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 121.53 0.681 . . . . 0.0 110.599 176.555 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 94.8 m95 -82.94 138.45 33.82 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 112.216 0.45 . . . . 0.0 112.216 -177.86 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 16.0 m -137.69 150.91 25.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 178.816 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -160.3 165.33 31.54 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 103.523 -2.769 . . . . 0.0 103.523 179.837 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 14.8 t -125.07 175.82 7.1 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 104.941 -2.244 . . . . 0.0 104.941 178.114 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 -67.52 134.85 52.06 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 -179.826 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 91.49 -8.46 78.88 Favored Glycine 0 C--O 1.228 -0.244 0 CA-C-N 116.123 -0.49 . . . . 0.0 113.536 179.156 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.471 ' HA ' ' HA ' ' A' ' 41' ' ' ASP . . . -71.99 131.9 43.56 Favored 'General case' 0 CA--C 1.542 0.666 0 O-C-N 122.393 -0.475 . . . . 0.0 110.345 179.403 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 23.4 mt -88.91 138.89 31.0 Favored 'General case' 0 CA--C 1.51 -0.569 0 N-CA-C 112.995 0.739 . . . . 0.0 112.995 -177.433 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 56.9 t30 -83.94 72.11 10.45 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.353 -0.839 . . . . 0.0 111.046 179.475 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 2.3 t -143.4 155.38 60.94 Favored Pre-proline 0 C--N 1.324 -0.503 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 178.754 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_exo -67.61 153.25 76.74 Favored 'Trans proline' 0 CA--C 1.514 -0.495 0 CA-C-N 118.454 0.483 . . . . 0.0 113.183 179.175 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -152.02 52.73 0.8 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.928 0.871 . . . . 0.0 111.144 176.59 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -57.55 -26.54 61.57 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 114.918 -1.037 . . . . 0.0 109.972 175.194 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 9.6 p80 -57.18 -12.59 2.35 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 114.643 1.349 . . . . 0.0 114.643 179.198 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 64.2 mt -92.72 -45.19 14.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 178.372 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -70.59 14.72 1.32 Allowed Glycine 0 C--O 1.211 -1.298 0 N-CA-C 117.205 1.642 . . . . 0.0 117.205 -175.414 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 30.8 p -83.04 3.79 28.84 Favored 'General case' 0 CA--C 1.506 -0.718 0 C-N-CA 124.015 0.926 . . . . 0.0 113.249 -174.08 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 67.0 ttp85 -44.36 121.0 2.38 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 114.056 -1.429 . . . . 0.0 110.666 179.655 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 36.5 m120 -90.02 126.09 58.39 Favored Pre-proline 0 C--N 1.322 -0.624 0 N-CA-C 107.675 -1.232 . . . . 0.0 107.675 -179.579 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -69.89 -18.27 36.5 Favored 'Trans proline' 0 C--O 1.219 -0.473 0 C-N-CA 117.015 -1.524 . . . . 0.0 113.045 179.273 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -75.74 -27.95 58.32 Favored 'General case' 0 C--O 1.219 -0.536 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.308 178.125 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 -101.88 -23.96 14.09 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 113.283 0.846 . . . . 0.0 113.283 -175.244 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 18.6 t-20 -150.63 148.63 28.86 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.941 0.719 . . . . 0.0 112.941 -178.201 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -87.86 147.33 25.16 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-O 121.521 0.677 . . . . 0.0 111.32 179.419 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -70.02 145.05 52.04 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.554 178.576 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 13.7 mt -83.18 139.06 18.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 -178.744 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 1.4 p -62.05 126.08 19.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 175.721 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 5.7 tt -65.91 128.57 36.56 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.156 0.503 . . . . 0.0 110.3 -176.748 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -132.33 157.55 44.17 Favored 'General case' 0 CA--C 1.509 -0.633 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 -178.73 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.429 HD13 HG22 ' A' ' 125' ' ' THR . 13.7 mt -113.58 148.76 40.42 Favored Pre-proline 0 C--N 1.322 -0.622 0 N-CA-C 108.091 -1.078 . . . . 0.0 108.091 177.059 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -73.43 165.52 32.28 Favored 'Trans proline' 0 N--CA 1.463 -0.314 0 O-C-N 122.227 0.593 . . . . 0.0 112.867 -178.846 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 40.6 tt0 -54.69 130.35 40.15 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.655 -179.682 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 101.38 -22.45 38.91 Favored Glycine 0 C--O 1.224 -0.509 0 CA-C-N 116.043 -0.526 . . . . 0.0 112.838 -179.056 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.429 HG22 HD13 ' A' ' 121' ' ' LEU . 9.8 m -108.63 127.26 53.81 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 117.795 0.798 . . . . 0.0 109.456 178.167 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 16.5 p -119.69 148.33 43.51 Favored 'General case' 0 CA--C 1.51 -0.575 0 CA-C-O 121.035 0.445 . . . . 0.0 110.837 -179.398 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 91.8 mt -69.07 152.29 96.82 Favored Pre-proline 0 C--N 1.324 -0.529 0 N-CA-C 107.108 -1.441 . . . . 0.0 107.108 177.678 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -77.67 174.08 13.17 Favored 'Trans proline' 0 N--CA 1.462 -0.37 0 CA-C-O 121.425 0.51 . . . . 0.0 111.782 179.834 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -56.19 129.25 39.37 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.23 -178.487 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 91.65 -4.92 79.78 Favored Glycine 0 C--O 1.226 -0.353 0 N-CA-C 115.601 1.001 . . . . 0.0 115.601 177.063 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -102.39 136.75 41.66 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 117.937 0.868 . . . . 0.0 112.465 -178.068 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 41.5 p90 -143.46 163.14 33.94 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 114.213 -1.358 . . . . 0.0 108.269 174.895 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -103.82 138.0 41.04 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 -176.351 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -66.28 141.83 57.88 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.237 -0.892 . . . . 0.0 108.976 176.288 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 94.81 -32.79 5.79 Favored Glycine 0 N--CA 1.458 0.142 0 C-N-CA 121.604 -0.331 . . . . 0.0 113.366 179.756 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 32.7 t -68.7 123.59 21.33 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 177.249 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 64.1 ttp85 53.2 79.12 0.13 Allowed 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 114.057 1.132 . . . . 0.0 114.057 -178.982 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -70.62 168.63 48.93 Favored Glycine 0 CA--C 1.52 0.356 0 N-CA-C 110.539 -1.024 . . . . 0.0 110.539 176.916 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -175.88 -166.75 33.79 Favored Glycine 0 N--CA 1.451 -0.346 0 N-CA-C 107.708 -2.157 . . . . 0.0 107.708 -179.08 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 22.1 m . . . . . 0 C--O 1.25 1.101 0 CA-C-O 117.423 -1.275 . . . . 0.0 109.834 178.206 . . . . . . . . 0 0 . 1 . 031 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.589 0 CA-C-O 118.447 -1.196 . . . . 0.0 111.054 . . . . . . . . . 0 0 . 1 . 031 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -61.34 145.2 52.3 Favored 'General case' 0 C--O 1.239 0.509 0 N-CA-C 113.662 0.986 . . . . 0.0 113.662 -176.79 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 5.0 ppp? -165.0 169.39 16.42 Favored 'General case' 0 C--N 1.322 -0.619 1 N-CA-C 99.995 -4.076 . . . . 0.0 99.995 176.932 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 79.9 33.15 34.26 Favored Glycine 0 C--O 1.225 -0.441 0 C-N-CA 119.943 -1.122 . . . . 0.0 112.495 179.448 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -64.51 148.09 96.84 Favored Pre-proline 0 CA--C 1.539 0.548 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 179.536 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -73.02 -12.29 25.83 Favored 'Trans proline' 0 C--N 1.35 0.634 0 N-CA-C 113.361 0.485 . . . . 0.0 113.361 -179.534 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -149.58 -143.06 0.13 Allowed 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 101.364 -3.569 . . . . 0.0 101.364 176.79 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 12.6 m-80 -101.05 -34.35 9.77 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 112.813 0.671 . . . . 0.0 112.813 -179.467 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 40.5 p 35.69 78.9 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 115.7 1.741 . . . . 0.0 115.7 179.506 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -124.4 147.24 48.38 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 -174.737 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.431 ' HB3' ' CE1' ' A' ' 71' ' ' TYR . 11.6 p -60.22 139.22 57.7 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.389 178.568 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 12' ' ' TRP . . . . . 0.412 ' CD2' ' HD3' ' A' ' 109' ' ' ARG . 47.5 m95 -71.3 -21.93 62.01 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 114.95 1.463 . . . . 0.0 114.95 -178.762 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -121.49 162.07 21.16 Favored 'General case' 0 C--O 1.24 0.562 0 N-CA-C 113.734 1.013 . . . . 0.0 113.734 -173.329 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 77.8 p -68.68 163.39 23.97 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 114.548 -1.206 . . . . 0.0 109.849 179.418 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.401 ' HB2' ' CZ ' ' A' ' 69' ' ' TYR . . . -86.08 145.57 26.99 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 113.486 0.921 . . . . 0.0 113.486 -175.722 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -94.67 137.77 33.35 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 108.245 -1.021 . . . . 0.0 108.245 173.731 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 62.4 m -87.56 129.28 35.15 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 -179.924 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 16.6 tm0? -91.07 128.32 36.85 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 177.98 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 58.7 t60 -139.25 99.53 3.77 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 172.11 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 173.0 -170.91 44.06 Favored Glycine 0 C--O 1.229 -0.213 0 C-N-CA 120.496 -0.859 . . . . 0.0 111.445 179.511 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -97.66 -25.64 15.04 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 120.686 0.279 . . . . 0.0 110.529 178.631 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -96.5 163.23 13.13 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 105.594 -2.002 . . . . 0.0 105.594 174.631 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -88.62 -62.89 1.39 Allowed 'General case' 0 C--O 1.216 -0.691 0 N-CA-C 115.187 1.551 . . . . 0.0 115.187 -173.926 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 53.4 tp -176.87 142.93 0.41 Allowed 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 178.11 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 23.5 tptm -157.49 141.02 15.65 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 174.226 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 13.7 m-85 -123.92 152.49 66.5 Favored Pre-proline 0 C--O 1.24 0.595 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 175.53 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -70.41 159.09 54.1 Favored 'Trans proline' 0 CA--C 1.538 0.71 0 C-N-CA 120.449 0.766 . . . . 0.0 112.331 177.427 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 15.8 tpt180 -69.27 137.29 52.95 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 -178.377 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 83.85 8.64 84.02 Favored Glycine 0 C--O 1.222 -0.614 0 N-CA-C 111.345 -0.702 . . . . 0.0 111.345 179.082 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 6.6 mt-30 -150.92 170.95 18.06 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 -173.886 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 102.94 -16.67 54.08 Favored Glycine 0 CA--C 1.499 -0.928 0 CA-C-N 116.219 -0.446 . . . . 0.0 112.031 175.756 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 77.9 t -66.07 128.68 93.98 Favored Pre-proline 0 C--N 1.319 -0.759 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 177.144 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -73.46 170.11 20.7 Favored 'Trans proline' 0 N--CA 1.461 -0.435 0 O-C-N 122.201 0.579 . . . . 0.0 112.373 178.404 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 78.5 mt -73.01 112.38 9.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 -179.851 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 48.9 m-20 -109.89 77.29 1.04 Allowed 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 114.622 -1.172 . . . . 0.0 109.406 -177.189 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 71.5 p -65.11 -20.96 66.72 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 115.586 1.698 . . . . 0.0 115.586 -173.658 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -113.64 31.05 6.78 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.976 -176.175 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 78.0 p -134.42 166.57 22.55 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.011 0.434 . . . . 0.0 110.839 179.63 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 28.1 m -81.58 160.32 64.72 Favored Pre-proline 0 C--N 1.322 -0.612 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.75 -179.219 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -67.81 -24.23 40.69 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 116.453 -1.898 . . . . 0.0 114.033 -179.461 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.402 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 8.4 p-10 -75.52 -12.62 60.26 Favored 'General case' 0 C--N 1.322 -0.592 0 O-C-N 121.562 -0.711 . . . . 0.0 111.264 177.241 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 27.3 t0 -94.84 1.05 55.32 Favored 'General case' 0 C--O 1.214 -0.798 0 N-CA-C 113.328 0.862 . . . . 0.0 113.328 -177.371 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 93.1 mm-40 -62.34 -20.2 64.12 Favored 'General case' 0 CA--C 1.548 0.89 0 O-C-N 121.074 -1.016 . . . . 0.0 111.711 178.965 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.456 ' HB ' ' HB1' ' A' ' 98' ' ' ALA . 17.5 tt -63.98 140.46 19.65 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-O 122.118 0.961 . . . . 0.0 112.293 177.701 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 178.49 -161.17 27.62 Favored Glycine 0 CA--C 1.502 -0.737 0 C-N-CA 119.794 -1.193 . . . . 0.0 112.781 178.328 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.4 ' HB3' ' CE3' ' A' ' 92' ' ' TRP . 46.1 p90 -155.24 165.68 35.92 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 178.642 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 19.0 m-85 -106.87 139.68 40.9 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 106.771 -1.566 . . . . 0.0 106.771 175.986 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 42.5 ttt180 -113.47 118.23 33.93 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.08 -174.869 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 26.3 ttt180 -66.47 137.72 57.03 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 176.655 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -137.3 125.65 23.32 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.733 0.777 . . . . 0.0 111.465 179.923 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 37.7 p -136.74 154.28 50.63 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 106.079 -1.823 . . . . 0.0 106.079 177.128 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 65.1 ttt180 -159.73 124.04 3.85 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 121.06 -0.256 . . . . 0.0 110.486 177.399 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.35 144.33 51.32 Favored 'General case' 0 CA--C 1.484 -1.581 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 175.647 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -142.47 175.23 4.77 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.132 0 N-CA-C 105.854 -1.906 . . . . 0.0 105.854 179.023 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 78.0 ttt180 -119.67 128.89 54.25 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 102.466 -3.161 . . . . 0.0 102.466 171.14 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -80.89 -176.8 51.03 Favored Glycine 0 C--O 1.221 -0.667 0 N-CA-C 110.796 -0.922 . . . . 0.0 110.796 -179.784 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -78.75 -34.29 35.21 Favored Glycine 0 C--O 1.216 -1.005 0 N-CA-C 107.886 -2.086 . . . . 0.0 107.886 179.385 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -71.38 -20.69 62.11 Favored 'General case' 0 C--O 1.217 -0.655 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 175.184 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 108.43 -15.52 35.42 Favored Glycine 0 CA--C 1.503 -0.696 0 N-CA-C 110.351 -1.1 . . . . 0.0 110.351 172.593 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.8 144.57 57.16 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-O 122.394 1.092 . . . . 0.0 112.294 -177.96 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 5.4 mtp -87.8 175.08 8.0 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 114.01 -1.45 . . . . 0.0 112.57 -177.184 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 1.6 tmtm? -78.4 -46.04 20.87 Favored 'General case' 0 C--O 1.217 -0.642 0 CA-C-O 121.949 0.881 . . . . 0.0 109.797 176.915 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.2 t0 47.39 24.85 0.51 Allowed 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 119.054 2.983 . . . . 0.0 119.054 178.573 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.6 mp -83.45 149.01 26.93 Favored 'General case' 0 C--O 1.239 0.528 0 O-C-N 121.397 -0.814 . . . . 0.0 111.752 178.543 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -66.71 158.42 79.65 Favored Pre-proline 0 C--O 1.243 0.738 0 CA-C-N 115.395 -0.82 . . . . 0.0 111.909 178.834 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -71.44 147.21 51.87 Favored 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 118.126 -0.782 . . . . 0.0 112.582 177.585 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 1.2 mtt180 -134.14 165.81 24.22 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.998 176.228 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 62.5 m95 -121.89 135.03 54.86 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 176.328 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.401 ' CZ ' ' HB2' ' A' ' 15' ' ' ALA . 68.6 m-85 -112.83 171.77 7.33 Favored 'General case' 0 C--O 1.215 -0.738 0 N-CA-C 105.891 -1.892 . . . . 0.0 105.891 178.142 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -118.4 139.47 51.34 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 178.673 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.431 ' CE1' ' HB3' ' A' ' 11' ' ' SER . 14.2 m-85 -139.06 139.33 37.74 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 -176.545 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 45.3 m-85 -68.67 159.51 32.0 Favored 'General case' 0 C--O 1.24 0.585 0 N-CA-C 110.013 -0.366 . . . . 0.0 110.013 177.14 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 19.7 tp -53.4 130.56 35.74 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 121.18 0.514 . . . . 0.0 112.229 -178.515 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 67.49 28.41 73.6 Favored Glycine 0 C--O 1.223 -0.573 0 N-CA-C 116.269 1.268 . . . . 0.0 116.269 174.636 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 16.2 p -92.17 146.02 24.05 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 118.262 1.031 . . . . 0.0 110.409 177.927 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 104.15 137.69 9.36 Favored Glycine 0 CA--C 1.527 0.829 0 N-CA-C 110.701 -0.96 . . . . 0.0 110.701 -178.913 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -69.96 -36.65 9.91 Favored 'Trans proline' 0 C--N 1.348 0.516 0 N-CA-C 116.272 1.605 . . . . 0.0 116.272 -174.506 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -103.44 15.15 29.76 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 -176.838 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -63.68 -50.95 67.22 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 120.217 -0.593 . . . . 0.0 111.547 -174.438 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 55.97 34.55 61.93 Favored Glycine 0 CA--C 1.519 0.325 0 CA-C-N 116.186 -0.461 . . . . 0.0 113.059 -179.979 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 18.1 mt -116.83 103.79 51.86 Favored Pre-proline 0 N--CA 1.448 -0.543 0 N-CA-C 115.939 1.829 . . . . 0.0 115.939 -175.394 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -78.76 164.01 25.87 Favored 'Trans proline' 0 N--CA 1.462 -0.344 0 C-N-CA 122.42 2.08 . . . . 0.0 108.176 168.274 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 56.2 t80 -62.08 132.29 52.38 Favored 'General case' 0 C--N 1.321 -0.642 0 O-C-N 121.947 -0.471 . . . . 0.0 110.627 -177.698 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 90.4 -6.17 82.43 Favored Glycine 0 C--O 1.227 -0.29 0 N-CA-C 114.528 0.571 . . . . 0.0 114.528 179.131 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -65.15 132.04 48.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 118.242 1.021 . . . . 0.0 111.821 179.677 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 50.5 t30 -78.68 127.31 31.92 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.523 179.403 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 28.2 ttmt -156.19 152.14 27.48 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 106.266 -1.753 . . . . 0.0 106.266 178.578 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 19.1 t0 -64.55 131.83 48.14 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 -179.249 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 69.66 28.84 71.71 Favored Glycine 0 N--CA 1.446 -0.655 0 N-CA-C 114.958 0.743 . . . . 0.0 114.958 177.116 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 42.7 mm -127.89 128.15 68.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 117.401 0.6 . . . . 0.0 109.985 179.044 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.1 pt -131.58 123.62 52.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.351 176.98 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 92' ' ' TRP . . . . . 0.4 ' CE3' ' HB3' ' A' ' 46' ' ' TYR . 97.8 m95 -88.39 135.57 33.4 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 114.149 1.166 . . . . 0.0 114.149 -175.304 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 17.8 m -136.16 152.03 29.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 178.778 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -163.97 166.6 21.44 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 103.514 -2.773 . . . . 0.0 103.514 -179.969 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 13.3 t -134.53 174.72 10.24 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 104.78 -2.304 . . . . 0.0 104.78 177.675 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 78.2 tt0 -66.71 135.21 53.67 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.185 0.516 . . . . 0.0 109.999 -178.955 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 95.75 -9.72 68.56 Favored Glycine 0 C--O 1.228 -0.234 0 CA-C-N 115.93 -0.577 . . . . 0.0 113.623 178.635 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.456 ' HB1' ' HB ' ' A' ' 44' ' ' ILE . . . -76.78 137.95 39.6 Favored 'General case' 0 CA--C 1.54 0.571 0 O-C-N 122.323 -0.516 . . . . 0.0 109.859 179.457 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 32.3 mt -92.56 140.29 29.7 Favored 'General case' 0 C--O 1.22 -0.471 0 CA-C-O 121.555 0.693 . . . . 0.0 112.324 -178.236 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 61.3 t30 -85.04 66.59 9.83 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.498 -0.773 . . . . 0.0 110.518 -179.037 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -136.37 152.84 75.73 Favored Pre-proline 0 C--N 1.324 -0.502 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 -179.527 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -68.45 150.87 75.94 Favored 'Trans proline' 0 C--N 1.344 0.326 0 N-CA-C 115.249 1.211 . . . . 0.0 115.249 178.779 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.492 ' HB3' HD12 ' A' ' 106' ' ' ILE . 67.5 mmtt -127.12 31.61 5.22 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.189 -0.914 . . . . 0.0 113.32 -176.339 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 18.1 t0 -60.98 -27.56 68.37 Favored 'General case' 0 N--CA 1.475 0.789 0 O-C-N 121.287 -0.883 . . . . 0.0 111.616 -178.135 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 47.2 p-80 -67.95 -16.78 64.22 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.806 177.853 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.492 HD12 ' HB3' ' A' ' 103' ' ' LYS . 66.3 mt -94.25 -38.56 9.45 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 176.078 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -72.96 6.73 11.72 Favored Glycine 0 C--O 1.225 -0.429 0 N-CA-C 115.668 1.027 . . . . 0.0 115.668 -178.214 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 14.5 t -83.05 25.44 0.69 Allowed 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 117.785 0.792 . . . . 0.0 111.684 -178.862 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.413 ' HD2' ' OD1' ' A' ' 114' ' ' ASN . 65.3 ttp85 -57.45 131.82 51.29 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.949 -179.42 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 55.1 m-20 -99.65 115.1 65.89 Favored Pre-proline 0 C--N 1.326 -0.423 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 178.804 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -72.8 -12.54 26.47 Favored 'Trans proline' 0 C--O 1.218 -0.518 0 N-CA-C 114.089 0.765 . . . . 0.0 114.089 -177.352 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -74.87 -24.56 58.58 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 176.042 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 -102.19 -30.78 10.92 Favored 'General case' 0 C--O 1.222 -0.344 0 N-CA-C 113.012 0.745 . . . . 0.0 113.012 -176.036 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 114' ' ' ASN . . . . . 0.413 ' OD1' ' HD2' ' A' ' 109' ' ' ARG . 0.9 OUTLIER -132.07 150.26 52.2 Favored 'General case' 0 N--CA 1.44 -0.937 0 CA-C-O 121.279 0.561 . . . . 0.0 112.265 -177.186 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -100.65 138.4 37.75 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 175.701 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -66.33 150.01 49.51 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.303 0.573 . . . . 0.0 111.722 -179.191 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 3.1 mt -87.96 141.48 14.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.669 -177.323 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 1.3 p -62.22 125.92 19.47 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 176.211 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 7.0 tt -70.07 129.62 39.92 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.25 -178.055 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 25.6 mt-30 -131.71 159.49 38.25 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 106.47 -1.678 . . . . 0.0 106.47 179.378 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 14.2 mt -114.37 146.09 35.12 Favored Pre-proline 0 C--N 1.323 -0.561 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 177.98 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -74.63 172.07 16.94 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 120.228 0.619 . . . . 0.0 113.678 -178.547 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 6.0 tp-100 -53.65 137.07 38.13 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.753 179.42 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 89.82 -20.71 34.04 Favored Glycine 0 N--CA 1.453 -0.229 0 CA-C-N 115.927 -0.579 . . . . 0.0 113.733 -179.11 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 3.9 m -108.56 129.81 55.3 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 118.274 1.037 . . . . 0.0 111.143 -179.995 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 2.3 p -125.87 148.27 49.23 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 -178.951 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 91.0 mt -68.93 154.57 94.82 Favored Pre-proline 0 C--N 1.327 -0.38 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 178.357 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -75.57 170.55 20.0 Favored 'Trans proline' 0 N--CA 1.463 -0.296 0 C-N-CA 118.342 -0.639 . . . . 0.0 111.48 -179.615 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -60.2 129.16 40.34 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 179.253 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 89.73 21.34 40.34 Favored Glycine 0 C--O 1.225 -0.444 0 C-N-CA 120.904 -0.665 . . . . 0.0 114.734 178.835 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -131.15 141.76 50.14 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 117.472 0.636 . . . . 0.0 111.651 178.115 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 51.8 p90 -150.47 163.79 37.53 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 175.508 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -107.35 147.25 30.56 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 113.396 0.887 . . . . 0.0 113.396 -175.826 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -73.52 142.7 46.72 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.091 -0.959 . . . . 0.0 109.666 177.206 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 93.38 -39.56 2.93 Favored Glycine 0 CA--C 1.519 0.298 0 N-CA-C 114.169 0.428 . . . . 0.0 114.169 178.665 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -66.31 137.47 56.94 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-O 121.854 0.835 . . . . 0.0 111.425 178.514 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 16.2 mtm105 -127.86 137.37 52.32 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 105.734 -1.95 . . . . 0.0 105.734 176.368 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -79.11 -25.29 59.92 Favored Glycine 0 C--O 1.224 -0.487 0 CA-C-O 121.697 0.609 . . . . 0.0 114.076 -177.944 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 167.88 -164.74 38.2 Favored Glycine 0 C--N 1.319 -0.391 0 N-CA-C 107.433 -2.267 . . . . 0.0 107.433 -178.658 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 15.7 m . . . . . 0 C--O 1.245 0.842 0 O-C-N 124.805 0.944 . . . . 0.0 111.042 -179.195 . . . . . . . . 0 0 . 1 . 032 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.577 0 CA-C-O 117.909 -1.495 . . . . 0.0 111.044 . . . . . . . . . 0 0 . 1 . 032 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 54.9 -158.22 0.2 Allowed 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 117.695 0.747 . . . . 0.0 110.061 -176.168 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 67.0 mtm 54.69 35.36 23.69 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.257 0.623 . . . . 0.0 112.037 179.474 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -173.42 116.48 0.6 Allowed Glycine 0 N--CA 1.445 -0.736 0 N-CA-C 107.09 -2.404 . . . . 0.0 107.09 -178.035 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 91.5 mt -110.61 153.11 43.73 Favored Pre-proline 0 C--N 1.319 -0.74 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 179.414 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -69.18 142.82 51.58 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 116.495 -1.87 . . . . 0.0 113.439 -178.114 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 32.4 t-20 -89.06 81.21 6.85 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 122.05 0.929 . . . . 0.0 110.098 -179.227 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -109.8 24.4 13.09 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 106.611 -1.626 . . . . 0.0 106.611 174.136 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 8.4 p -95.74 90.21 5.59 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 -176.769 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -95.52 142.61 27.66 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-O 121.422 0.629 . . . . 0.0 109.668 -177.924 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 61.6 p -58.14 141.53 50.05 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.213 -0.903 . . . . 0.0 109.882 179.108 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 12' ' ' TRP . . . . . 0.444 ' CD2' ' HD3' ' A' ' 109' ' ' ARG . 23.9 m95 -65.65 -26.44 67.8 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.769 178.213 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 78.0 m-85 -121.74 162.87 20.04 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.302 0.572 . . . . 0.0 112.379 -174.235 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 73.1 p -71.44 164.86 24.99 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 176.529 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -77.74 157.04 30.23 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.855 0.836 . . . . 0.0 113.219 -177.672 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 25.0 mt -92.39 148.91 21.74 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 102.919 -2.993 . . . . 0.0 102.919 168.005 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 33.2 m -121.36 128.5 52.31 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 120.897 0.379 . . . . 0.0 110.396 -178.03 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 1.9 tm0? -90.42 130.03 36.54 Favored 'General case' 0 CA--C 1.512 -0.501 0 CA-C-N 115.567 -0.742 . . . . 0.0 112.82 -177.554 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 52.9 t60 -138.76 99.9 3.92 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 106.354 -1.721 . . . . 0.0 106.354 167.217 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 159.58 -140.86 7.09 Favored Glycine 0 C--N 1.323 -0.181 0 C-N-CA 119.589 -1.291 . . . . 0.0 113.813 -176.969 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -115.71 -27.18 7.15 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 114.875 1.435 . . . . 0.0 114.875 -177.692 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -78.46 151.96 32.37 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 177.403 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -79.13 -57.55 3.67 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 179.197 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 41.9 tp 175.96 135.16 0.05 OUTLIER 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 101.254 -3.61 . . . . 0.0 101.254 171.103 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 11.2 tmtt? -154.22 133.23 12.43 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 179.448 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 21.8 m-85 -122.33 153.3 61.89 Favored Pre-proline 0 C--O 1.241 0.636 0 O-C-N 123.023 0.202 . . . . 0.0 111.44 176.726 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -74.51 159.91 42.3 Favored 'Trans proline' 0 CA--C 1.538 0.702 0 CA-C-O 120.935 0.306 . . . . 0.0 111.768 175.727 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 17.0 tpt180 -70.71 139.75 51.25 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 -178.411 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 87.05 2.11 84.0 Favored Glycine 0 C--O 1.221 -0.687 0 N-CA-C 110.707 -0.957 . . . . 0.0 110.707 179.524 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 31.2 mt-30 -146.69 -179.66 6.94 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 -174.797 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 99.36 -20.26 50.54 Favored Glycine 0 CA--C 1.498 -0.987 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.714 176.232 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 86.8 t -67.92 126.87 93.16 Favored Pre-proline 0 C--N 1.317 -0.818 0 N-CA-C 106.703 -1.592 . . . . 0.0 106.703 177.295 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -73.28 167.53 27.08 Favored 'Trans proline' 0 N--CA 1.46 -0.485 0 C-N-CA 120.111 0.541 . . . . 0.0 112.494 178.649 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 85.6 mt -67.25 111.74 2.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 122.023 0.916 . . . . 0.0 109.352 -178.869 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 26.6 m-20 -94.82 100.79 12.62 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 114.394 -1.276 . . . . 0.0 110.157 -177.973 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 80.7 p -80.52 -20.32 43.8 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 113.912 1.078 . . . . 0.0 113.912 -176.901 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -117.45 3.66 12.49 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 115.411 1.634 . . . . 0.0 115.411 -174.486 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -110.77 157.27 19.97 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 115.756 1.761 . . . . 0.0 115.756 -171.926 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 47.6 m -79.23 162.77 62.76 Favored Pre-proline 0 C--N 1.318 -0.783 0 CA-C-N 113.896 -1.502 . . . . 0.0 108.845 177.937 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -67.48 -20.66 47.56 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 116.986 -1.543 . . . . 0.0 114.878 -177.46 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.417 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 6.2 p-10 -75.21 -20.39 59.3 Favored 'General case' 0 C--N 1.321 -0.637 0 O-C-N 121.74 -0.6 . . . . 0.0 111.075 178.359 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -88.79 0.87 56.1 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 114.394 1.257 . . . . 0.0 114.394 -174.746 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 94.4 mm-40 -62.45 -29.03 70.23 Favored 'General case' 0 C--N 1.316 -0.876 0 O-C-N 121.062 -1.024 . . . . 0.0 111.526 -179.382 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 13.3 tt -64.93 139.04 22.07 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.771 0 CA-C-O 122.009 0.909 . . . . 0.0 112.112 178.419 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 176.46 -158.97 25.65 Favored Glycine 0 CA--C 1.509 -0.305 0 C-N-CA 120.401 -0.904 . . . . 0.0 111.969 -177.722 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 42.8 p90 -155.04 169.97 22.86 Favored 'General case' 0 C--N 1.32 -0.715 0 O-C-N 122.458 -0.436 . . . . 0.0 109.996 -179.788 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 10.6 m-85 -112.73 138.04 50.13 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 173.43 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.06 119.12 38.38 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 123.896 0.878 . . . . 0.0 109.733 -179.26 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 49.5 ttp180 -65.7 134.28 52.88 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 174.765 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -143.74 147.82 34.75 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.844 0.354 . . . . 0.0 110.814 -178.072 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 5.8 p -148.36 139.83 23.52 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 175.623 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 12.4 tpt180 -130.34 133.69 46.62 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 173.55 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 2.7 tpp180 -147.32 148.31 31.26 Favored 'General case' 0 CA--C 1.487 -1.463 0 CA-C-O 121.51 0.671 . . . . 0.0 110.77 -176.169 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -138.4 177.14 5.56 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.922 0 N-CA-C 103.715 -2.698 . . . . 0.0 103.715 178.9 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 48.1 ttp180 -138.77 117.09 11.92 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 177.578 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -100.48 155.8 19.43 Favored Glycine 0 C--O 1.222 -0.656 0 N-CA-C 108.146 -1.982 . . . . 0.0 108.146 177.787 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -75.27 -24.55 70.78 Favored Glycine 0 C--O 1.22 -0.731 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 178.458 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.4 p30 -83.28 -20.36 34.6 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 114.469 -0.865 . . . . 0.0 110.235 177.334 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 110.12 8.46 25.53 Favored Glycine 0 C--O 1.227 -0.307 0 N-CA-C 114.78 0.672 . . . . 0.0 114.78 173.136 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 10.6 pttt -66.01 137.23 56.97 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 122.319 1.057 . . . . 0.0 111.83 179.399 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 99.1 mmm -118.9 172.29 7.64 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 113.234 -1.803 . . . . 0.0 108.844 -178.929 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 14.2 tppt? -116.35 -66.56 1.07 Allowed 'General case' 0 C--O 1.219 -0.552 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 177.636 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -107.09 147.64 29.76 Favored 'General case' 0 CA--C 1.506 -0.722 0 N-CA-C 105.552 -2.018 . . . . 0.0 105.552 176.201 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -113.45 -47.07 3.02 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 105.657 -1.979 . . . . 0.0 105.657 175.616 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -102.38 151.82 38.23 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-N 114.867 -1.061 . . . . 0.0 110.378 179.205 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -64.07 150.73 87.74 Favored 'Trans proline' 0 C--N 1.35 0.658 0 O-C-N 122.033 0.491 . . . . 0.0 113.079 176.441 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 90.6 mtt-85 -116.7 159.21 22.59 Favored 'General case' 0 C--O 1.222 -0.394 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 178.748 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 53.7 m95 -137.33 125.38 22.86 Favored 'General case' 0 C--O 1.214 -0.765 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 174.77 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 59.9 m-85 -110.43 142.67 41.83 Favored 'General case' 0 C--O 1.216 -0.671 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 -177.08 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 81.1 t80 -93.01 135.95 33.72 Favored 'General case' 0 CA--C 1.507 -0.708 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 -176.142 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -139.01 137.72 36.58 Favored 'General case' 0 N--CA 1.441 -0.911 0 CA-C-N 114.739 -1.119 . . . . 0.0 109.195 -175.246 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 27.3 m-85 -67.74 159.39 30.27 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.71 179.065 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -50.46 122.53 7.19 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 113.743 1.016 . . . . 0.0 113.743 -177.258 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 68.53 22.13 74.88 Favored Glycine 0 C--O 1.226 -0.351 0 N-CA-C 116.193 1.237 . . . . 0.0 116.193 176.028 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 33.8 p -90.16 146.76 24.03 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 118.351 1.075 . . . . 0.0 111.017 179.306 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 110.33 137.03 7.48 Favored Glycine 0 CA--C 1.522 0.471 0 N-CA-C 109.236 -1.546 . . . . 0.0 109.236 -177.431 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -72.67 -30.79 11.44 Favored 'Trans proline' 0 CA--C 1.513 -0.557 0 CA-C-N 119.433 1.617 . . . . 0.0 115.225 -175.704 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -102.09 11.16 38.81 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 114.257 -1.338 . . . . 0.0 108.256 -176.967 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -64.23 -54.91 25.97 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -172.727 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 54.21 44.86 74.87 Favored Glycine 0 CA--C 1.52 0.383 0 C-N-CA 121.258 -0.496 . . . . 0.0 112.884 -179.128 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 16.4 mt -128.51 103.9 19.67 Favored Pre-proline 0 N--CA 1.442 -0.839 0 N-CA-C 116.289 1.959 . . . . 0.0 116.289 -175.272 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -78.46 160.81 28.67 Favored 'Trans proline' 0 C--O 1.233 0.227 0 C-N-CA 122.337 2.025 . . . . 0.0 107.417 167.949 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 60.3 t80 -60.85 132.76 54.89 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 120.291 -0.564 . . . . 0.0 110.957 -176.855 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 90.04 -6.53 82.65 Favored Glycine 0 N--CA 1.453 -0.215 0 CA-C-O 119.484 -0.62 . . . . 0.0 114.177 179.452 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -66.17 130.52 43.51 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 118.533 1.167 . . . . 0.0 111.332 179.459 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 52.5 t30 -80.86 128.54 33.79 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.332 -0.849 . . . . 0.0 109.091 179.431 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.429 ' HB3' HG13 ' A' ' 90' ' ' ILE . 27.7 ttmt -156.21 158.9 38.39 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 107.375 -1.343 . . . . 0.0 107.375 -178.921 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -54.67 122.34 10.43 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.053 0.39 . . . . 0.0 112.053 179.33 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 64.49 35.66 92.22 Favored Glycine 0 N--CA 1.448 -0.527 0 CA-C-O 119.189 -0.784 . . . . 0.0 114.376 174.436 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.429 HG13 ' HB3' ' A' ' 87' ' ' LYS . 49.4 mm -121.06 126.0 74.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 117.631 0.715 . . . . 0.0 110.939 179.225 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -126.92 117.73 48.56 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.706 176.254 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 97.5 m95 -85.38 136.3 33.52 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 -177.72 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 16.5 m -134.77 155.17 38.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 178.8 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -165.68 165.32 18.75 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 -178.373 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 12.3 t -130.42 168.32 17.18 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 104.969 -2.234 . . . . 0.0 104.969 174.107 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 76.6 tt0 -67.39 137.82 56.24 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.342 0.592 . . . . 0.0 110.88 -178.777 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 94.91 -10.58 70.21 Favored Glycine 0 C--O 1.229 -0.162 0 CA-C-N 115.662 -0.699 . . . . 0.0 113.093 177.578 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.417 ' HA ' ' HA ' ' A' ' 41' ' ' ASP . . . -78.75 118.4 20.78 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-O 120.974 0.416 . . . . 0.0 111.149 -179.938 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -68.6 133.42 48.47 Favored 'General case' 0 CA--C 1.51 -0.593 0 N-CA-C 114.101 1.148 . . . . 0.0 114.101 -177.628 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 46.9 t30 -83.26 76.23 9.9 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 113.825 -1.534 . . . . 0.0 109.062 178.776 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 1.4 t -146.44 155.36 49.61 Favored Pre-proline 0 C--N 1.322 -0.615 0 N-CA-C 106.053 -1.832 . . . . 0.0 106.053 -177.88 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -61.56 150.16 86.6 Favored 'Trans proline' 0 C--N 1.345 0.346 0 N-CA-C 115.446 1.287 . . . . 0.0 115.446 178.475 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.511 ' HB3' HD12 ' A' ' 106' ' ' ILE . 71.9 mmtt -123.29 30.47 6.3 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.748 -179.983 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 15.4 p-10 -51.34 -42.91 61.58 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.897 -0.592 . . . . 0.0 112.174 -176.914 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 15.6 p80 -68.5 -11.38 59.76 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 113.962 1.097 . . . . 0.0 113.962 -179.652 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.511 HD12 ' HB3' ' A' ' 103' ' ' LYS . 28.1 mt -95.54 -43.28 12.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 121.7 0.762 . . . . 0.0 110.488 178.826 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -72.8 4.03 24.38 Favored Glycine 0 C--O 1.221 -0.717 0 N-CA-C 116.119 1.208 . . . . 0.0 116.119 -176.543 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 13.1 t -83.38 25.78 0.71 Allowed 'General case' 0 CA--C 1.543 0.711 0 CA-C-O 121.492 0.663 . . . . 0.0 111.497 179.57 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.444 ' HD3' ' CD2' ' A' ' 12' ' ' TRP . 63.6 ttp85 -58.51 129.19 40.88 Favored 'General case' 0 CA--C 1.517 -0.319 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 -179.786 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 34.2 m120 -89.71 121.77 68.74 Favored Pre-proline 0 C--N 1.322 -0.617 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 -177.397 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -72.89 -15.22 26.5 Favored 'Trans proline' 0 C--O 1.218 -0.492 0 C-N-CA 116.789 -1.674 . . . . 0.0 112.188 178.95 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -77.03 -28.98 55.09 Favored 'General case' 0 C--O 1.221 -0.447 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.182 178.199 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 84.7 m-20 -102.69 -22.63 13.92 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 113.673 0.99 . . . . 0.0 113.673 -175.12 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -140.23 153.48 46.57 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 -177.852 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -95.55 143.73 26.61 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-O 121.264 0.554 . . . . 0.0 110.358 178.298 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -72.88 149.25 43.65 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.315 0.578 . . . . 0.0 110.9 178.893 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 8.9 mt -84.69 136.93 21.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.213 -178.817 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 78.7 t -62.27 121.97 11.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 N-CA-C 106.037 -1.838 . . . . 0.0 106.037 174.927 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 5.9 tt -67.04 130.27 42.58 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.095 0.474 . . . . 0.0 111.338 -176.145 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 31.5 mt-30 -134.48 158.56 43.62 Favored 'General case' 0 CA--C 1.513 -0.475 0 N-CA-C 106.751 -1.574 . . . . 0.0 106.751 -179.607 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 13.2 mt -112.24 147.15 36.36 Favored Pre-proline 0 C--N 1.322 -0.592 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 177.637 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -73.96 165.64 31.59 Favored 'Trans proline' 0 C--N 1.346 0.408 0 O-C-N 122.168 0.562 . . . . 0.0 113.059 -179.92 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 58.3 tp60 -53.85 130.18 36.23 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.296 -0.865 . . . . 0.0 109.453 179.381 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 103.4 -24.2 30.78 Favored Glycine 0 C--O 1.226 -0.355 0 CA-C-N 115.618 -0.719 . . . . 0.0 112.767 -179.376 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 4.7 m -103.54 129.7 50.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 118.307 1.053 . . . . 0.0 111.958 178.844 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 3.7 p -117.37 148.12 42.03 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.309 -0.859 . . . . 0.0 109.569 179.126 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 82.5 mt -70.52 157.38 90.2 Favored Pre-proline 0 C--N 1.323 -0.545 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 177.566 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -73.06 173.09 14.2 Favored 'Trans proline' 0 C--O 1.236 0.42 0 N-CA-C 110.111 -0.765 . . . . 0.0 110.111 178.395 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -68.71 122.83 19.35 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 119.704 -0.798 . . . . 0.0 111.192 -173.605 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 90.08 45.85 4.34 Favored Glycine 0 N--CA 1.452 -0.279 0 CA-C-N 115.1 -0.954 . . . . 0.0 113.877 -179.886 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -141.93 150.0 40.89 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 117.265 0.532 . . . . 0.0 111.765 179.016 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 42.3 p90 -150.69 166.11 31.36 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 175.718 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -100.63 147.03 26.43 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.031 0.443 . . . . 0.0 111.137 -178.481 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -70.51 136.8 49.67 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 179.296 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 86.52 -30.93 4.34 Favored Glycine 0 C--O 1.227 -0.295 0 CA-C-N 116.21 -0.45 . . . . 0.0 112.777 -177.699 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 19.6 t -76.97 95.45 4.15 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 122.117 -0.637 . . . . 0.0 110.404 -179.132 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 1.4 tmt_? 57.51 30.16 18.25 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 115.252 -0.886 . . . . 0.0 110.946 -179.694 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -74.24 -21.02 79.52 Favored Glycine 0 C--O 1.225 -0.426 0 CA-C-O 122.468 1.038 . . . . 0.0 111.744 179.351 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -166.33 -165.06 23.07 Favored Glycine 0 C--N 1.317 -0.479 0 N-CA-C 107.147 -2.381 . . . . 0.0 107.147 179.947 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 59.3 p . . . . . 0 C--O 1.242 0.693 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 178.785 . . . . . . . . 0 0 . 1 . 033 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.948 0 CA-C-O 118.457 -1.19 . . . . 0.0 111.106 . . . . . . . . . 0 0 . 1 . 033 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -78.17 129.57 35.29 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 106.222 -1.77 . . . . 0.0 106.222 177.172 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 16.3 mmt -127.53 70.53 1.32 Allowed 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 -178.167 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 109.64 135.48 7.22 Favored Glycine 0 N--CA 1.44 -1.043 0 N-CA-C 107.248 -2.341 . . . . 0.0 107.248 -175.298 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 96.3 mt -115.27 148.9 41.76 Favored Pre-proline 0 C--N 1.315 -0.922 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 177.182 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -72.2 156.61 55.14 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 116.742 -1.705 . . . . 0.0 112.172 179.473 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 54.8 t30 -65.85 -26.89 67.86 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 112.732 0.642 . . . . 0.0 112.732 -179.585 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 52.3 t30 -156.08 -102.48 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 179.897 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 39.1 p 40.51 74.34 0.1 Allowed 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 115.788 1.773 . . . . 0.0 115.788 -179.175 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -105.11 137.77 42.35 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.239 -0.891 . . . . 0.0 109.5 179.429 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 54.2 p -59.54 144.3 47.75 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 178.876 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 24.8 m95 -65.56 -21.9 66.65 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.574 0.583 . . . . 0.0 112.574 178.809 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 12.7 m-85 -121.43 163.33 18.92 Favored 'General case' 0 CA--C 1.507 -0.673 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 -170.562 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 72.0 p -70.47 165.36 22.74 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 114.517 -1.219 . . . . 0.0 107.794 177.35 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -80.04 149.57 30.66 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.561 0.696 . . . . 0.0 112.004 -177.853 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 13.9 mt -85.83 145.07 27.37 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 102.416 -3.179 . . . . 0.0 102.416 169.362 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 65.0 m -120.46 141.28 50.33 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 -179.256 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.455 ' HB2' ' CZ ' ' A' ' 131' ' ' PHE . 4.4 tp60 -111.04 136.03 50.65 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -177.091 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 60.1 t60 -132.06 99.47 4.74 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 103.42 -2.807 . . . . 0.0 103.42 168.612 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 171.79 -167.03 40.04 Favored Glycine 0 N--CA 1.451 -0.328 0 N-CA-C 110.254 -1.138 . . . . 0.0 110.254 -175.479 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 49.8 mtpt -102.61 -27.25 12.85 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 115.126 1.528 . . . . 0.0 115.126 -177.454 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -85.71 166.28 16.26 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 -179.982 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -77.19 -62.91 1.5 Allowed 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.698 -178.708 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 29.3 tp 178.64 140.01 0.1 Allowed 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 104.864 -2.273 . . . . 0.0 104.864 175.474 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 44.0 tptt -148.18 135.31 20.3 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.064 0.459 . . . . 0.0 110.825 175.282 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -125.3 155.08 71.99 Favored Pre-proline 0 C--O 1.243 0.739 0 N-CA-C 105.594 -2.002 . . . . 0.0 105.594 174.852 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -71.58 173.13 13.0 Favored 'Trans proline' 0 C--N 1.347 0.485 0 CA-C-O 121.88 0.7 . . . . 0.0 113.652 -179.067 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 52.9 tpt85 -77.48 123.87 27.15 Favored 'General case' 0 C--O 1.217 -0.651 0 O-C-N 121.377 -0.827 . . . . 0.0 109.703 179.886 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 85.51 10.64 76.49 Favored Glycine 0 C--O 1.223 -0.569 0 CA-C-N 115.122 -0.945 . . . . 0.0 115.264 176.346 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -157.54 143.35 17.43 Favored 'General case' 0 C--O 1.219 -0.545 0 N-CA-C 106.747 -1.575 . . . . 0.0 106.747 -179.418 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 139.37 -13.32 3.25 Favored Glycine 0 CA--C 1.507 -0.428 0 C-N-CA 120.274 -0.965 . . . . 0.0 113.652 178.205 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 34.6 m -71.8 144.96 88.86 Favored Pre-proline 0 C--N 1.322 -0.616 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 177.898 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -76.92 171.62 17.66 Favored 'Trans proline' 0 N--CA 1.46 -0.441 0 C-N-CA 121.621 1.548 . . . . 0.0 113.203 179.685 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 94.8 mt -75.05 115.75 16.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 121.578 0.704 . . . . 0.0 109.369 178.893 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.413 ' HB2' HE22 ' A' ' 43' ' ' GLN . 76.8 m-20 -94.63 85.01 4.38 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 107.243 -1.391 . . . . 0.0 107.243 178.113 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 73.4 p -61.64 -21.82 64.73 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 115.971 1.841 . . . . 0.0 115.971 -173.79 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -114.25 16.31 17.98 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 113.376 0.88 . . . . 0.0 113.376 -176.556 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.4 m -132.55 172.55 12.36 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 115.94 1.83 . . . . 0.0 115.94 -174.857 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 42.0 m -82.0 159.18 66.2 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 115.218 -0.901 . . . . 0.0 112.525 -176.273 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -67.28 -19.69 49.86 Favored 'Trans proline' 0 C--N 1.351 0.675 0 C-N-CA 117.219 -1.388 . . . . 0.0 114.279 -179.548 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.411 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 0.4 OUTLIER -71.3 -24.15 62.09 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 121.746 -0.596 . . . . 0.0 110.776 177.898 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -85.11 -10.73 56.47 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 116.021 1.86 . . . . 0.0 116.021 -170.939 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.413 HE22 ' HB2' ' A' ' 35' ' ' ASN . 85.0 mm-40 -56.93 -26.59 59.75 Favored 'General case' 0 C--O 1.217 -0.631 0 N-CA-C 113.807 1.039 . . . . 0.0 113.807 -173.151 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 14.0 tt -62.12 139.42 20.88 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 CA-C-O 122.313 1.054 . . . . 0.0 112.875 178.539 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 177.68 -152.66 12.1 Favored Glycine 0 CA--C 1.505 -0.563 0 C-N-CA 120.402 -0.904 . . . . 0.0 110.994 -178.975 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 51.3 p90 -155.06 169.38 24.25 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 178.685 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 35.9 m-85 -111.34 143.4 42.19 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 106.764 -1.569 . . . . 0.0 106.764 173.983 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 71.7 ttt-85 -117.48 124.4 48.68 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 123.744 0.817 . . . . 0.0 111.595 -177.694 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 2.1 ptm180 -71.03 146.2 49.5 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.203 0.525 . . . . 0.0 110.525 179.412 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -146.24 144.86 30.15 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.419 0.628 . . . . 0.0 110.736 179.108 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 41.1 p -142.99 171.61 13.82 Favored 'General case' 0 C--O 1.249 1.034 0 N-CA-C 104.364 -2.458 . . . . 0.0 104.364 175.451 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -140.65 123.9 16.7 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 122.004 -0.435 . . . . 0.0 111.55 176.25 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 4.6 tmt_? -140.78 137.01 33.05 Favored 'General case' 0 CA--C 1.496 -1.109 0 CA-C-O 121.611 0.72 . . . . 0.0 110.562 -178.568 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -140.24 -179.38 2.0 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 N-CA-C 105.949 -1.871 . . . . 0.0 105.949 -179.453 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 6.3 ttm180 -128.94 119.25 24.02 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 175.216 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -80.72 -179.87 53.14 Favored Glycine 0 C--O 1.224 -0.476 0 N-CA-C 108.481 -1.847 . . . . 0.0 108.481 176.243 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -63.63 -46.96 90.93 Favored Glycine 0 C--O 1.219 -0.827 0 CA-C-N 118.343 1.072 . . . . 0.0 112.625 -178.463 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -75.8 -8.41 56.8 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 121.724 0.774 . . . . 0.0 110.11 178.995 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 104.43 -13.77 51.05 Favored Glycine 0 CA--C 1.51 -0.269 0 CA-C-N 115.32 -0.855 . . . . 0.0 111.501 178.875 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 12.0 pttt -56.37 136.59 53.54 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-O 122.112 0.958 . . . . 0.0 110.795 -178.877 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 15.0 ptm -132.05 165.76 23.26 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 114.375 -1.284 . . . . 0.0 114.127 -173.698 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 40.2 mttt -77.08 -60.13 2.49 Favored 'General case' 0 C--O 1.212 -0.903 0 N-CA-C 114.623 1.342 . . . . 0.0 114.623 -176.182 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 52.97 48.04 23.3 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 113.785 1.031 . . . . 0.0 113.785 178.509 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.4 mp -60.97 141.97 56.88 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.389 179.951 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 59.3 p -55.39 148.97 30.11 Favored Pre-proline 0 C--O 1.25 1.086 0 CA-C-N 115.071 -0.968 . . . . 0.0 111.753 -176.903 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -65.22 138.71 57.2 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 117.529 -1.18 . . . . 0.0 112.813 -176.979 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 5.4 ptp180 -141.38 155.78 45.88 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.425 -1.261 . . . . 0.0 108.517 -178.834 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 48.0 m95 -123.64 137.9 54.64 Favored 'General case' 0 C--N 1.318 -0.777 0 C-N-CA 122.671 0.389 . . . . 0.0 110.494 -176.16 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 29.5 m-85 -114.84 139.4 49.79 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 -179.464 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 88.5 t80 -88.49 135.94 33.24 Favored 'General case' 0 CA--C 1.505 -0.77 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 -178.825 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -139.73 139.13 36.45 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 -176.054 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 64.6 m-85 -71.21 159.47 34.59 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.351 -0.84 . . . . 0.0 112.326 -175.117 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -54.84 126.76 25.59 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.843 -179.624 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 68.61 38.21 85.88 Favored Glycine 0 C--O 1.218 -0.85 0 N-CA-C 115.482 0.953 . . . . 0.0 115.482 176.59 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -89.17 145.98 25.08 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 118.927 1.364 . . . . 0.0 107.985 178.058 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 97.98 141.8 12.64 Favored Glycine 0 CA--C 1.526 0.773 0 N-CA-C 108.72 -1.752 . . . . 0.0 108.72 -175.353 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -70.03 -42.42 3.14 Favored 'Trans proline' 0 C--N 1.347 0.479 0 CA-C-N 119.799 1.799 . . . . 0.0 116.222 -173.753 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -114.61 39.62 2.78 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 -177.346 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -64.1 -40.63 96.63 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.053 -0.976 . . . . 0.0 111.511 -177.962 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 60.21 26.07 63.26 Favored Glycine 0 C--O 1.228 -0.257 0 CA-C-N 115.916 -0.584 . . . . 0.0 113.832 179.305 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 17.8 mt -114.46 103.81 54.8 Favored Pre-proline 0 N--CA 1.447 -0.623 0 N-CA-C 114.249 1.203 . . . . 0.0 114.249 -176.964 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -78.86 165.16 24.7 Favored 'Trans proline' 0 C--O 1.237 0.431 0 C-N-CA 121.817 1.678 . . . . 0.0 108.414 170.239 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 61.4 t80 -61.6 131.17 49.16 Favored 'General case' 0 C--N 1.321 -0.654 0 C-N-CA 120.445 -0.502 . . . . 0.0 109.855 -179.958 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 92.45 -5.31 77.45 Favored Glycine 0 C--O 1.227 -0.315 0 N-CA-C 114.775 0.67 . . . . 0.0 114.775 178.806 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -65.57 126.76 29.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 118.412 1.106 . . . . 0.0 111.966 179.127 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 70.3 m-20 -71.97 126.79 30.64 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 114.624 -1.171 . . . . 0.0 110.335 -178.579 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 13.7 ttmm -156.12 151.35 26.62 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 178.564 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -62.55 131.05 47.8 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.274 178.931 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 68.46 27.86 73.55 Favored Glycine 0 N--CA 1.452 -0.275 0 N-CA-C 115.395 0.918 . . . . 0.0 115.395 177.809 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 39.3 mm -129.33 131.35 67.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 117.35 0.575 . . . . 0.0 110.494 -179.999 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.1 pt -131.48 114.85 26.67 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 CA-C-O 121.495 0.665 . . . . 0.0 110.774 175.643 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 95.7 m95 -82.24 135.13 35.29 Favored 'General case' 0 C--N 1.321 -0.662 0 O-C-N 121.831 -0.543 . . . . 0.0 112.227 -177.604 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -142.1 152.02 18.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.824 -0.626 . . . . 0.0 109.312 -178.525 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -155.98 166.59 33.02 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 105.646 -1.983 . . . . 0.0 105.646 -177.826 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 11.6 t -134.38 173.83 11.19 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 105.973 -1.862 . . . . 0.0 105.973 176.263 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -66.57 138.02 57.18 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.343 0.592 . . . . 0.0 110.925 -179.603 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 95.05 -14.66 64.91 Favored Glycine 0 N--CA 1.458 0.146 0 CA-C-N 115.568 -0.742 . . . . 0.0 112.836 177.652 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.411 ' HA ' ' HA ' ' A' ' 41' ' ' ASP . . . -75.06 136.08 41.2 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-O 120.738 0.304 . . . . 0.0 111.311 -179.633 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 30.2 mt -93.75 134.16 36.37 Favored 'General case' 0 CA--C 1.51 -0.58 0 N-CA-C 113.072 0.767 . . . . 0.0 113.072 -178.923 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 55.5 t30 -81.45 71.73 8.47 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 114.878 -1.055 . . . . 0.0 110.838 -178.391 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 1.3 t -142.17 154.79 64.94 Favored Pre-proline 0 C--N 1.322 -0.601 0 N-CA-C 106.129 -1.804 . . . . 0.0 106.129 179.784 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -68.78 148.71 71.88 Favored 'Trans proline' 0 CA--C 1.531 0.362 0 C-N-CA 118.347 -0.635 . . . . 0.0 113.537 176.34 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 5.8 ptpt -149.19 56.12 0.99 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 122.522 1.153 . . . . 0.0 111.169 178.384 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -57.46 -33.23 67.75 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.434 -1.257 . . . . 0.0 112.39 179.703 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 16.9 p80 -62.72 -7.66 5.3 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 115.015 1.487 . . . . 0.0 115.015 -177.862 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 44.7 mt -93.58 -39.25 10.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 177.857 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -72.81 14.65 2.57 Favored Glycine 0 C--O 1.218 -0.88 0 N-CA-C 115.612 1.005 . . . . 0.0 115.612 -178.409 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 14.3 t -99.67 27.98 5.0 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 113.322 0.86 . . . . 0.0 113.322 -176.928 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 62.4 ttp85 -51.52 133.08 30.4 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 177.477 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -90.45 117.88 68.33 Favored Pre-proline 0 C--N 1.326 -0.434 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 -179.538 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -71.45 -15.17 31.06 Favored 'Trans proline' 0 C--O 1.219 -0.462 0 C-N-CA 117.569 -1.154 . . . . 0.0 114.651 -177.086 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -81.1 -24.86 37.42 Favored 'General case' 0 C--O 1.22 -0.485 0 CA-C-O 121.052 0.453 . . . . 0.0 110.277 178.779 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 -100.89 -25.54 14.06 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 -175.02 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 19.9 t-20 -147.96 144.37 27.96 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 113.284 0.846 . . . . 0.0 113.284 -178.404 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -84.27 146.46 27.75 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.13 179.823 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -67.77 143.67 55.74 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.405 0.622 . . . . 0.0 110.434 178.587 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 20.6 mt -83.84 139.43 17.64 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 -178.807 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.48 HG11 ' HB2' ' A' ' 136' ' ' SER . 71.3 t -58.89 126.81 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 N-CA-C 106.393 -1.706 . . . . 0.0 106.393 175.252 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 7.7 tt -67.29 129.31 39.49 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 -178.933 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -130.34 156.61 44.41 Favored 'General case' 0 CA--C 1.511 -0.534 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 -178.474 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.415 HD13 HG22 ' A' ' 125' ' ' THR . 14.8 mt -113.56 147.72 38.16 Favored Pre-proline 0 C--N 1.323 -0.582 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 178.879 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -71.94 166.77 28.56 Favored 'Trans proline' 0 C--N 1.345 0.382 0 O-C-N 122.338 0.652 . . . . 0.0 113.262 -178.721 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 34.0 tt0 -54.86 129.78 38.66 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.284 -179.409 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 93.71 -13.24 67.92 Favored Glycine 0 C--O 1.226 -0.363 0 CA-C-N 115.985 -0.552 . . . . 0.0 113.552 179.976 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.415 HG22 HD13 ' A' ' 121' ' ' LEU . 23.0 m -103.92 126.69 51.23 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 117.904 0.852 . . . . 0.0 110.265 179.035 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 11.6 p -121.67 148.4 44.63 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.934 -177.227 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 77.4 mt -74.13 154.08 88.49 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.301 178.286 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -76.86 173.87 13.77 Favored 'Trans proline' 0 C--N 1.345 0.393 0 N-CA-C 110.471 -0.627 . . . . 0.0 110.471 177.103 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 4.8 tmtt? -61.04 123.28 17.19 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.785 0.661 . . . . 0.0 112.785 -174.687 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 95.23 0.8 63.06 Favored Glycine 0 C--N 1.328 0.122 0 N-CA-C 115.141 0.817 . . . . 0.0 115.141 175.201 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.455 ' CZ ' ' HB2' ' A' ' 18' ' ' GLN . 1.2 m-85 -100.87 135.33 42.48 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-O 121.777 0.799 . . . . 0.0 110.538 -179.64 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 37.8 p90 -140.46 160.5 39.86 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 114.531 -1.213 . . . . 0.0 108.762 177.469 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -96.59 139.37 32.78 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.14 0.495 . . . . 0.0 111.454 -177.292 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -70.15 135.91 49.59 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 177.966 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 93.9 -9.01 73.44 Favored Glycine 0 CA--C 1.519 0.328 0 N-CA-C 114.716 0.646 . . . . 0.0 114.716 179.601 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 136' ' ' SER . . . . . 0.48 ' HB2' HG11 ' A' ' 118' ' ' VAL . 8.4 t -145.02 -176.15 4.98 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 117.803 0.801 . . . . 0.0 110.781 178.44 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 11.9 mpt_? -99.31 118.97 37.16 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 106.752 -1.573 . . . . 0.0 106.752 179.738 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -86.28 -173.89 49.33 Favored Glycine 0 C--N 1.318 -0.456 0 N-CA-C 108.671 -1.772 . . . . 0.0 108.671 176.439 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -117.72 -161.29 11.98 Favored Glycine 0 N--CA 1.452 -0.243 0 N-CA-C 108.867 -1.693 . . . . 0.0 108.867 178.598 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 28.6 t . . . . . 0 C--O 1.263 1.772 0 C-N-CA 123.644 0.778 . . . . 0.0 112.874 178.312 . . . . . . . . 0 0 . 1 . 034 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.612 0 CA-C-O 118.881 -0.955 . . . . 0.0 110.996 . . . . . . . . . 0 0 . 1 . 034 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -80.25 137.64 36.67 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 104.325 -2.472 . . . . 0.0 104.325 174.759 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -154.25 168.37 26.79 Favored 'General case' 0 N--CA 1.445 -0.72 0 N-CA-C 101.617 -3.475 . . . . 0.0 101.617 -177.781 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 99.76 77.07 1.28 Allowed Glycine 0 C--N 1.318 -0.451 0 N-CA-C 110.843 -0.903 . . . . 0.0 110.843 -178.884 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 96.2 mt -59.13 136.9 88.18 Favored Pre-proline 0 C--O 1.242 0.66 0 CA-C-O 120.997 0.427 . . . . 0.0 111.142 -179.169 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -73.79 158.19 46.97 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 118.19 -0.74 . . . . 0.0 113.629 -177.531 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 29.8 t30 58.07 23.91 10.6 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 114.059 1.133 . . . . 0.0 114.059 177.846 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 17.0 m-20 -91.3 -21.8 20.87 Favored 'General case' 0 C--O 1.221 -0.409 0 N-CA-C 104.765 -2.309 . . . . 0.0 104.765 174.57 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 75.6 p -151.13 160.56 43.8 Favored 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 100.3 -3.963 . . . . 0.0 100.3 -177.932 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -151.47 151.98 32.39 Favored 'General case' 0 C--N 1.313 -1.002 0 O-C-N 123.685 0.615 . . . . 0.0 109.776 177.122 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 31.3 t -61.36 136.92 58.21 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.448 178.368 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 12' ' ' TRP . . . . . 0.408 ' CD2' ' HD3' ' A' ' 109' ' ' ARG . 4.3 m95 -68.91 -26.26 65.01 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-O 121.24 0.543 . . . . 0.0 111.005 177.126 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -121.58 162.68 20.19 Favored 'General case' 0 CA--C 1.51 -0.592 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.385 -171.191 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 64.1 p -68.05 163.31 22.67 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 178.454 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -75.08 152.36 38.59 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.839 0.828 . . . . 0.0 113.166 -176.26 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 12.7 mt -91.35 148.68 22.15 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 102.882 -3.007 . . . . 0.0 102.882 169.458 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 25.9 m -127.76 140.36 52.1 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 -178.38 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.455 ' HB2' ' CZ ' ' A' ' 131' ' ' PHE . 4.6 tp60 -119.34 139.59 51.73 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 114.313 1.227 . . . . 0.0 114.313 -175.668 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 34.7 t60 -136.17 99.57 4.16 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 104.045 -2.576 . . . . 0.0 104.045 168.047 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 177.04 -158.56 24.35 Favored Glycine 0 C--O 1.228 -0.277 0 N-CA-C 110.801 -0.92 . . . . 0.0 110.801 -175.165 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 60.8 mttp -114.16 -22.32 10.05 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 114.16 1.17 . . . . 0.0 114.16 -178.579 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -84.76 157.38 21.04 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 107.883 -1.155 . . . . 0.0 107.883 177.785 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -76.67 -62.68 1.55 Allowed 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 -177.758 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 41.1 tp 177.23 145.14 0.1 Allowed 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 104.084 -2.561 . . . . 0.0 104.084 173.279 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 79.7 tttt -157.77 145.29 18.47 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 175.115 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 17.3 m-85 -134.53 151.21 75.65 Favored Pre-proline 0 C--N 1.323 -0.546 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 175.572 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -77.68 162.29 30.15 Favored 'Trans proline' 0 CA--C 1.538 0.716 0 O-C-N 122.02 0.484 . . . . 0.0 113.106 178.558 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 17.7 tpt180 -64.7 136.5 57.01 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.466 -178.862 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 90.26 -5.7 82.76 Favored Glycine 0 C--N 1.329 0.181 0 N-CA-C 111.397 -0.681 . . . . 0.0 111.397 178.132 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 55.0 mt-30 -138.48 -179.68 5.95 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 123.714 0.805 . . . . 0.0 109.354 -174.665 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 100.22 -27.29 21.03 Favored Glycine 0 CA--C 1.497 -1.058 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.516 176.046 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 92.3 t -65.45 126.17 90.97 Favored Pre-proline 0 N--CA 1.444 -0.772 0 N-CA-C 106.207 -1.775 . . . . 0.0 106.207 176.288 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -72.44 164.26 36.16 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 O-C-N 122.175 0.566 . . . . 0.0 111.248 178.624 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 87.3 mt -63.85 115.58 2.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-O 121.658 0.742 . . . . 0.0 109.695 -176.692 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 6.7 m-80 -95.91 108.05 20.38 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.18 -0.918 . . . . 0.0 111.914 -177.026 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 70.3 p -91.3 -12.73 34.2 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.909 0.861 . . . . 0.0 110.827 177.662 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 12.5 p30 -110.27 9.01 23.74 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 116.993 2.219 . . . . 0.0 116.993 -173.247 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 87.6 p -154.08 165.57 35.78 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 115.19 1.552 . . . . 0.0 115.19 -175.23 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 25.4 m -78.65 167.56 34.22 Favored Pre-proline 0 N--CA 1.472 0.637 0 C-N-CA 124.311 1.044 . . . . 0.0 112.624 -176.42 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -64.54 -24.69 63.13 Favored 'Trans proline' 0 C--N 1.354 0.845 0 C-N-CA 115.62 -2.453 . . . . 0.0 112.843 177.575 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -63.0 -25.93 68.62 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.506 0.67 . . . . 0.0 111.211 176.168 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -97.3 -1.45 44.64 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 115.06 1.504 . . . . 0.0 115.06 -170.877 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 94.5 mm-40 -60.74 -26.12 66.96 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 113.243 0.831 . . . . 0.0 113.243 -177.614 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.411 ' HB ' ' HB1' ' A' ' 98' ' ' ALA . 19.0 tt -58.61 137.7 20.63 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 CA-C-O 122.384 1.087 . . . . 0.0 113.683 -177.994 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 178.9 -161.01 27.05 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.473 -0.87 . . . . 0.0 113.43 -178.787 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 44.7 p90 -154.76 169.09 24.76 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 179.357 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 13.6 m-85 -112.17 139.93 47.29 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 172.369 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.14 129.78 54.15 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 179.407 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 17.6 ttm105 -73.25 132.94 43.74 Favored 'General case' 0 CA--C 1.5 -0.971 0 N-CA-C 104.873 -2.269 . . . . 0.0 104.873 175.496 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -69.86 165.93 20.52 Favored 'General case' 0 N--CA 1.426 -1.648 0 CA-C-O 122.654 1.216 . . . . 0.0 111.89 -177.14 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 77.2 p -71.11 160.63 32.54 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 113.672 -1.603 . . . . 0.0 112.826 -176.27 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 6.0 tpt180 -65.71 154.07 39.97 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 114.555 -1.202 . . . . 0.0 111.657 -177.913 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.476 ' HG3' ' H ' ' A' ' 63' ' ' ASP . 10.0 ttm180 -88.68 136.97 32.73 Favored 'General case' 0 CA--C 1.504 -0.82 0 N-CA-C 108.266 -1.012 . . . . 0.0 108.266 177.367 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -143.04 175.11 4.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 N-CA-C 105.988 -1.856 . . . . 0.0 105.988 -176.355 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 14.9 tpt180 -92.88 116.4 29.0 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 106.27 -1.752 . . . . 0.0 106.27 176.137 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -79.65 137.64 19.12 Favored Glycine 0 N--CA 1.446 -0.645 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 177.917 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -72.01 -18.93 78.08 Favored Glycine 0 C--O 1.219 -0.841 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 178.733 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -64.37 -12.01 38.41 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 124.286 1.034 . . . . 0.0 110.11 176.234 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 109.26 15.92 11.93 Favored Glycine 0 CA--C 1.5 -0.862 0 CA-C-N 115.933 -0.576 . . . . 0.0 112.663 169.521 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.4 167.89 24.91 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 116.19 1.922 . . . . 0.0 116.19 -173.353 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -84.92 156.02 21.41 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.873 179.66 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -80.51 -55.15 5.07 Favored 'General case' 0 C--O 1.216 -0.693 0 CA-C-O 121.959 0.885 . . . . 0.0 112.717 -179.953 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.476 ' H ' ' HG3' ' A' ' 53' ' ' ARG . 1.0 OUTLIER -150.06 179.28 8.2 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 114.44 -1.254 . . . . 0.0 111.403 -174.259 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 95.6 mt -112.28 -83.73 0.58 Allowed 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 175.643 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -88.85 162.8 37.3 Favored Pre-proline 0 C--N 1.323 -0.564 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 177.849 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -69.52 142.98 50.5 Favored 'Trans proline' 0 C--N 1.348 0.503 0 C-N-CA 115.708 -2.395 . . . . 0.0 112.235 176.841 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 93.5 mtt-85 -121.59 166.25 14.49 Favored 'General case' 0 CA--C 1.513 -0.455 0 N-CA-C 112.99 0.737 . . . . 0.0 112.99 179.701 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 57.9 m95 -131.94 145.83 51.73 Favored 'General case' 0 C--O 1.216 -0.672 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 175.349 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 29.8 m-85 -125.88 154.1 43.21 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 105.661 -1.977 . . . . 0.0 105.661 -178.891 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 90.8 t80 -105.9 135.96 46.39 Favored 'General case' 0 CA--C 1.508 -0.672 0 CA-C-N 119.006 0.821 . . . . 0.0 109.54 -174.586 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 21.2 m-85 -140.91 144.81 35.42 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 107.259 -1.386 . . . . 0.0 107.259 -175.989 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 53.7 m-85 -84.83 159.52 20.39 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.453 -174.465 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 16.8 tp -53.29 129.98 33.44 Favored 'General case' 0 C--O 1.216 -0.677 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 179.884 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 70.81 22.26 78.18 Favored Glycine 0 C--O 1.223 -0.577 0 N-CA-C 116.375 1.31 . . . . 0.0 116.375 176.831 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 18.9 p -90.9 146.15 24.14 Favored 'General case' 0 CA--C 1.511 -0.522 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 175.658 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 97.76 129.12 6.23 Favored Glycine 0 CA--C 1.523 0.576 0 N-CA-C 108.845 -1.702 . . . . 0.0 108.845 -176.971 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -67.89 -35.92 19.55 Favored 'Trans proline' 0 CA--C 1.516 -0.406 0 CA-C-N 119.575 1.687 . . . . 0.0 115.421 -174.22 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -108.37 21.02 17.9 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 114.637 -1.165 . . . . 0.0 109.395 -176.031 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -61.02 -42.07 97.75 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.695 -175.32 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 55.94 43.91 87.73 Favored Glycine 0 CA--C 1.516 0.117 0 CA-C-N 115.894 -0.594 . . . . 0.0 113.198 178.862 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 12.9 mt -130.82 104.23 15.65 Favored Pre-proline 0 N--CA 1.438 -1.061 0 N-CA-C 114.075 1.139 . . . . 0.0 114.075 -177.999 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -78.84 161.5 27.19 Favored 'Trans proline' 0 N--CA 1.462 -0.368 0 C-N-CA 122.268 1.978 . . . . 0.0 107.192 167.819 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 56.0 t80 -61.09 132.85 55.1 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 120.226 -0.589 . . . . 0.0 110.063 -177.704 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 91.1 -7.15 81.27 Favored Glycine 0 CA--C 1.519 0.337 0 CA-C-O 119.333 -0.704 . . . . 0.0 114.541 179.407 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -67.68 129.73 40.81 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 118.804 1.302 . . . . 0.0 111.808 179.909 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 51.1 t30 -79.04 128.76 33.68 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.042 -179.893 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.4 ' HB3' HG13 ' A' ' 90' ' ' ILE . 28.7 ttmt -155.94 157.9 37.04 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 106.964 -1.495 . . . . 0.0 106.964 -178.774 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -54.87 120.2 6.49 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.473 0.546 . . . . 0.0 112.473 -179.696 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 66.12 35.6 90.73 Favored Glycine 0 CA--C 1.507 -0.467 0 CA-C-O 118.989 -0.895 . . . . 0.0 114.022 175.176 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.4 HG13 ' HB3' ' A' ' 87' ' ' LYS . 49.6 mm -122.47 126.29 73.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 117.452 0.626 . . . . 0.0 110.856 178.904 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -126.84 121.17 57.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.892 175.666 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 98.7 m95 -87.57 135.67 33.26 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 113.602 0.964 . . . . 0.0 113.602 -176.71 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 15.8 m -137.2 149.78 26.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 121.638 0.733 . . . . 0.0 109.069 178.618 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -162.46 161.97 27.37 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 103.363 -2.829 . . . . 0.0 103.363 179.416 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 6.0 t -126.43 173.85 9.06 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 105.098 -2.186 . . . . 0.0 105.098 178.151 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -67.26 134.42 51.59 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.054 0.454 . . . . 0.0 109.957 -178.303 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 96.0 -9.65 67.98 Favored Glycine 0 C--O 1.226 -0.396 0 CA-C-N 115.97 -0.559 . . . . 0.0 113.05 179.318 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.411 ' HB1' ' HB ' ' A' ' 44' ' ' ILE . . . -76.37 134.02 39.78 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 178.891 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 65.9 mt -87.75 140.96 28.98 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.174 0.511 . . . . 0.0 112.147 -176.743 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 63.4 t30 -84.29 61.98 6.89 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.968 -179.599 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -135.91 156.47 77.17 Favored Pre-proline 0 C--N 1.322 -0.617 0 N-CA-C 106.159 -1.793 . . . . 0.0 106.159 -178.592 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -67.73 152.8 77.3 Favored 'Trans proline' 0 C--N 1.343 0.272 0 N-CA-C 114.793 1.036 . . . . 0.0 114.793 -179.889 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.507 ' HB3' HD12 ' A' ' 106' ' ' ILE . 73.8 mmtt -126.07 37.9 4.25 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 114.648 -1.16 . . . . 0.0 110.079 -177.111 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 15.9 p-10 -53.32 -41.22 65.49 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.168 -179.051 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 16.3 p80 -66.21 -8.88 27.14 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 114.359 1.244 . . . . 0.0 114.359 179.99 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.507 HD12 ' HB3' ' A' ' 103' ' ' LYS . 31.3 mt -95.27 -44.64 13.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 178.727 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -70.66 3.04 13.24 Favored Glycine 0 C--O 1.221 -0.673 0 N-CA-C 115.661 1.024 . . . . 0.0 115.661 -177.537 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 14.6 t -83.15 15.13 3.0 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 117.637 0.719 . . . . 0.0 112.28 -177.868 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.408 ' HD3' ' CD2' ' A' ' 12' ' ' TRP . 57.6 ttp85 -58.72 130.83 48.75 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 176.629 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -98.6 137.62 20.66 Favored Pre-proline 0 C--N 1.323 -0.585 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 178.399 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -74.96 -19.84 17.53 Favored 'Trans proline' 0 C--O 1.219 -0.434 0 N-CA-C 113.863 0.678 . . . . 0.0 113.863 179.424 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -81.36 -25.14 36.57 Favored 'General case' 0 C--O 1.221 -0.437 0 CA-C-O 121.163 0.506 . . . . 0.0 110.226 179.293 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 -97.76 -21.54 16.91 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 113.437 0.903 . . . . 0.0 113.437 -175.128 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 -150.31 153.24 35.76 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 111.884 0.328 . . . . 0.0 111.884 -178.77 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -89.45 140.92 29.05 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-O 121.246 0.546 . . . . 0.0 110.586 178.4 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -70.99 147.64 48.44 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.136 0.494 . . . . 0.0 110.355 178.667 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 11.7 mt -81.89 136.47 22.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.473 -178.494 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 77.0 t -58.78 121.9 7.47 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 N-CA-C 106.43 -1.693 . . . . 0.0 106.43 174.601 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 6.1 tt -67.35 127.54 33.05 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.297 0.57 . . . . 0.0 110.328 -176.662 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 -133.98 155.08 50.59 Favored 'General case' 0 CA--C 1.508 -0.661 0 N-CA-C 106.489 -1.671 . . . . 0.0 106.489 -179.233 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 12.9 mt -111.08 147.96 37.66 Favored Pre-proline 0 C--N 1.319 -0.724 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 177.738 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -73.3 163.5 37.71 Favored 'Trans proline' 0 C--O 1.237 0.439 0 C-N-CA 118.016 -0.856 . . . . 0.0 112.626 -179.934 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 40.1 tt0 -54.47 130.65 40.34 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.06 179.963 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 105.94 -26.25 21.4 Favored Glycine 0 C--O 1.227 -0.309 0 CA-C-N 115.871 -0.604 . . . . 0.0 112.251 -178.656 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 4.6 m -102.36 129.91 48.95 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 118.276 1.038 . . . . 0.0 112.131 178.586 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 3.1 p -116.61 147.86 41.49 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.274 178.625 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 82.8 mt -72.11 153.79 92.48 Favored Pre-proline 0 C--N 1.323 -0.559 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 177.911 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -75.54 175.53 11.16 Favored 'Trans proline' 0 C--O 1.235 0.334 0 N-CA-C 110.576 -0.586 . . . . 0.0 110.576 177.901 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 76.1 tttt -64.55 124.51 22.04 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 114.023 1.12 . . . . 0.0 114.023 -170.811 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 95.19 -1.86 65.18 Favored Glycine 0 CA--C 1.518 0.243 0 CA-C-N 114.891 -1.05 . . . . 0.0 115.342 177.101 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.455 ' CZ ' ' HB2' ' A' ' 18' ' ' GLN . 3.5 m-85 -94.81 143.12 26.71 Favored 'General case' 0 N--CA 1.436 -1.14 0 CA-C-O 122.465 1.126 . . . . 0.0 111.619 -179.328 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 43.7 p90 -144.19 164.46 30.64 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 113.053 -1.885 . . . . 0.0 107.375 173.992 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -105.18 148.55 26.79 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.253 0.549 . . . . 0.0 111.465 -176.759 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -79.05 139.8 38.05 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 179.397 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 81.98 -0.21 88.79 Favored Glycine 0 C--O 1.226 -0.369 0 C-N-CA 121.161 -0.543 . . . . 0.0 112.241 -178.283 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 8.3 t -98.24 -151.4 0.38 Allowed 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 178.288 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 1.5 tmm_? -66.1 97.67 0.39 Allowed 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 177.421 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -88.74 174.55 42.9 Favored Glycine 0 N--CA 1.452 -0.245 0 CA-C-N 116.115 -0.493 . . . . 0.0 112.077 179.984 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 93.74 -178.7 38.08 Favored Glycine 0 C--O 1.229 -0.188 0 N-CA-C 108.987 -1.645 . . . . 0.0 108.987 -178.19 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 30.2 t . . . . . 0 C--O 1.241 0.657 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 179.049 . . . . . . . . 0 0 . 1 . 035 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.876 0 CA-C-O 117.316 -1.825 . . . . 0.0 110.966 . . . . . . . . . 0 0 . 1 . 035 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 53.36 51.65 14.99 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 118.345 1.073 . . . . 0.0 112.536 179.004 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -153.55 176.68 11.77 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 103.759 -2.682 . . . . 0.0 103.759 -178.12 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 153.3 -71.87 0.28 Allowed Glycine 0 CA--C 1.521 0.414 0 N-CA-C 117.176 1.63 . . . . 0.0 117.176 177.593 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 96.0 mt -101.6 144.96 29.6 Favored Pre-proline 0 N--CA 1.468 0.438 0 CA-C-N 117.486 0.643 . . . . 0.0 111.662 -176.416 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -76.5 159.82 35.63 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 118.285 -0.676 . . . . 0.0 112.015 177.359 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 90.1 m-20 -65.04 -31.6 72.9 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 112.438 0.533 . . . . 0.0 112.438 -179.861 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 30.5 t30 -158.43 -91.8 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 177.734 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 27.8 p 41.59 75.98 0.08 Allowed 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.981 0.912 . . . . 0.0 112.685 -176.456 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -91.27 135.17 33.99 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.446 -0.797 . . . . 0.0 108.885 -177.939 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 69.6 p -63.18 144.02 57.28 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 178.259 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 14.8 m95 -70.9 -22.82 62.22 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 111.923 0.342 . . . . 0.0 111.923 179.225 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 33.9 m-85 -121.48 162.53 20.33 Favored 'General case' 0 C--O 1.243 0.736 0 N-CA-C 113.239 0.829 . . . . 0.0 113.239 -172.353 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.43 ' HB ' ' HB3' ' A' ' 134' ' ' GLU . 70.5 p -71.13 165.0 24.5 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 114.806 -1.088 . . . . 0.0 108.245 178.149 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -83.4 145.13 29.17 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 113.803 1.038 . . . . 0.0 113.803 -176.401 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 22.9 mt -78.0 148.91 34.17 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 103.942 -2.614 . . . . 0.0 103.942 168.832 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 26.8 m -126.96 140.42 52.33 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 107.432 -1.321 . . . . 0.0 107.432 179.392 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 56.7 tt0 -116.44 148.69 40.47 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 114.936 1.458 . . . . 0.0 114.936 -174.172 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 63.3 t60 -134.52 99.62 4.41 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 105.375 -2.083 . . . . 0.0 105.375 169.967 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -178.95 -163.01 29.34 Favored Glycine 0 CA--C 1.522 0.494 0 C-N-CA 121.006 -0.616 . . . . 0.0 113.233 -176.621 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 68.9 mmtt -116.27 -31.7 5.55 Favored 'General case' 0 N--CA 1.48 1.062 0 N-CA-C 113.919 1.081 . . . . 0.0 113.919 -178.899 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -84.23 -166.67 1.5 Allowed 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 178.61 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 13.7 p-10 -105.74 -66.08 1.01 Allowed 'General case' 0 CA--C 1.556 1.187 0 N-CA-C 117.699 2.481 . . . . 0.0 117.699 -177.614 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 49.3 tp 172.7 141.62 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 179.777 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -154.26 145.36 22.77 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 107.062 -1.459 . . . . 0.0 107.062 -178.732 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -134.51 148.44 67.48 Favored Pre-proline 0 C--N 1.322 -0.589 0 N-CA-C 105.779 -1.934 . . . . 0.0 105.779 176.23 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -69.98 150.22 66.6 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 117.875 -0.95 . . . . 0.0 111.71 179.433 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 16.8 tpt180 -65.98 134.98 54.07 Favored 'General case' 0 C--O 1.217 -0.651 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 -178.369 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 98.84 -3.6 58.9 Favored Glycine 0 C--O 1.222 -0.608 0 N-CA-C 110.335 -1.106 . . . . 0.0 110.335 -179.377 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -146.57 170.51 16.76 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 -179.372 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 128.88 -31.41 3.52 Favored Glycine 0 CA--C 1.48 -2.096 0 N-CA-C 108.774 -1.731 . . . . 0.0 108.774 165.142 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 35.7 m -66.47 139.63 96.23 Favored Pre-proline 0 N--CA 1.43 -1.458 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 177.378 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -72.77 174.01 12.5 Favored 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 121.785 1.657 . . . . 0.0 111.6 177.049 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 90.9 mt -72.1 113.46 9.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 N-CA-C 107.656 -1.239 . . . . 0.0 107.656 178.083 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.557 HD22 ' HA ' ' A' ' 43' ' ' GLN . 37.8 m-20 -109.75 82.16 1.55 Allowed 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.431 -0.804 . . . . 0.0 108.947 -178.31 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 67.7 p -64.87 -24.41 67.53 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.46 -0.791 . . . . 0.0 112.972 -177.044 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 72.7 m-80 -100.72 35.75 2.09 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.647 -178.191 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 21.1 m -147.88 151.7 36.33 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.6 -0.273 . . . . 0.0 110.596 -179.269 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 18.4 m -72.17 165.45 50.4 Favored Pre-proline 0 C--N 1.324 -0.507 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 176.877 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -64.68 -27.79 60.53 Favored 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 114.94 -2.907 . . . . 0.0 111.62 177.813 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -60.84 -30.8 70.32 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 122.121 0.963 . . . . 0.0 110.629 175.784 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 92.6 m-20 -95.58 -0.16 52.26 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 114.931 1.456 . . . . 0.0 114.931 -170.552 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.557 ' HA ' HD22 ' A' ' 35' ' ' ASN . 91.4 mm-40 -60.89 -25.56 66.8 Favored 'General case' 0 C--O 1.219 -0.509 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 178.653 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.494 ' HB ' ' HB1' ' A' ' 98' ' ' ALA . 21.5 tt -55.79 142.56 10.41 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 N-CA-C 115.209 1.559 . . . . 0.0 115.209 -178.621 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 179.22 -155.23 15.43 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.089 178.079 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 43.0 p90 -155.11 168.03 28.38 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 178.254 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 33.6 m-85 -109.28 137.68 46.79 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 174.722 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 60.9 ttt180 -111.9 119.32 38.14 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.474 -0.784 . . . . 0.0 110.827 -177.776 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 1.1 ttp-105 -65.5 134.33 53.17 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 106.78 -1.563 . . . . 0.0 106.78 175.871 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -135.59 153.4 51.68 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.052 0.453 . . . . 0.0 110.541 -177.487 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.477 ' HB ' HD22 ' A' ' 64' ' ' LEU . 32.7 p -133.4 159.01 41.58 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.272 -177.639 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 63.4 ttt180 -158.34 129.71 6.55 Favored 'General case' 0 N--CA 1.477 0.92 0 O-C-N 122.235 -0.291 . . . . 0.0 111.27 177.471 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.81 142.16 24.24 Favored 'General case' 0 CA--C 1.498 -1.039 0 N-CA-C 104.224 -2.51 . . . . 0.0 104.224 -179.933 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -132.1 173.94 13.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 -177.076 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.08 107.39 17.69 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 -179.39 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -74.38 151.82 44.0 Favored Glycine 0 N--CA 1.452 -0.24 0 N-CA-C 107.059 -2.417 . . . . 0.0 107.059 177.201 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -63.38 -42.79 99.02 Favored Glycine 0 C--O 1.223 -0.578 0 CA-C-N 118.559 1.18 . . . . 0.0 111.907 -178.643 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -76.2 -3.22 35.15 Favored 'General case' 0 C--O 1.218 -0.572 0 CA-C-O 121.518 0.675 . . . . 0.0 111.967 179.594 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 96.72 -1.1 61.41 Favored Glycine 0 C--O 1.227 -0.313 0 CA-C-N 115.855 -0.612 . . . . 0.0 112.617 177.395 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 12.8 pttt -63.82 133.66 53.82 Favored 'General case' 0 C--O 1.24 0.581 0 CA-C-O 122.147 0.975 . . . . 0.0 112.587 -178.089 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 13.8 mmt -90.78 145.44 24.78 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 114.171 -1.377 . . . . 0.0 113.022 -179.619 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 2.1 tmtm? -102.11 -23.43 14.06 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.048 -0.978 . . . . 0.0 109.814 176.259 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 13.3 t0 63.7 164.37 0.12 Allowed 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 115.998 1.851 . . . . 0.0 115.998 178.338 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.477 HD22 ' HB ' ' A' ' 51' ' ' THR . 57.4 mt -88.61 131.12 35.1 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.331 0.586 . . . . 0.0 111.304 -176.538 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 4.8 p -112.31 131.29 22.65 Favored Pre-proline 0 C--N 1.319 -0.722 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 176.215 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -74.95 98.14 1.13 Allowed 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 117.35 -1.3 . . . . 0.0 112.065 178.044 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.4 HH22 ' CD ' ' A' ' 134' ' ' GLU . 11.7 mtp180 -110.34 152.81 25.76 Favored 'General case' 0 CA--C 1.507 -0.69 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 178.018 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 64.0 m95 -127.69 126.37 41.78 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 179.666 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 58.7 m-85 -110.35 141.17 43.74 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 -178.592 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 86.1 t80 -87.73 135.87 33.19 Favored 'General case' 0 CA--C 1.506 -0.732 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 -178.581 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -139.42 143.49 37.66 Favored 'General case' 0 N--CA 1.439 -0.995 0 CA-C-N 115.076 -0.965 . . . . 0.0 108.434 -175.376 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -77.01 159.45 29.9 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.089 0.471 . . . . 0.0 110.743 -176.847 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 15.8 tp -59.62 128.17 35.67 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.855 -0.612 . . . . 0.0 110.819 -178.455 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 80.73 24.73 57.81 Favored Glycine 0 C--O 1.218 -0.856 0 N-CA-C 116.342 1.297 . . . . 0.0 116.342 177.603 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 3.7 p -89.12 146.13 25.0 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 118.873 1.336 . . . . 0.0 110.67 -179.609 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 108.19 143.6 10.68 Favored Glycine 0 CA--C 1.523 0.538 0 N-CA-C 109.274 -1.53 . . . . 0.0 109.274 -177.778 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -69.23 -41.71 4.68 Favored 'Trans proline' 0 C--N 1.348 0.512 0 CA-C-N 119.94 1.87 . . . . 0.0 115.958 -173.463 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -116.5 27.57 9.12 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.748 0.785 . . . . 0.0 109.841 -178.21 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -60.43 -46.43 90.06 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.782 -177.032 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 56.7 27.54 55.44 Favored Glycine 0 C--O 1.223 -0.547 0 O-C-N 123.5 0.5 . . . . 0.0 113.942 179.468 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 27.6 mt -105.88 105.32 52.87 Favored Pre-proline 0 C--O 1.238 0.492 0 N-CA-C 115.103 1.519 . . . . 0.0 115.103 -175.422 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -78.25 169.19 20.58 Favored 'Trans proline' 0 C--O 1.235 0.352 0 C-N-CA 121.815 1.676 . . . . 0.0 109.483 171.566 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 51.3 t80 -63.49 130.5 44.63 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 179.564 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 92.13 -3.98 77.21 Favored Glycine 0 C--O 1.225 -0.409 0 N-CA-C 114.754 0.662 . . . . 0.0 114.754 178.691 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -68.44 123.69 21.5 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 118.63 1.215 . . . . 0.0 111.471 178.747 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 74.6 m-20 -71.66 126.05 28.69 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 114.799 -1.091 . . . . 0.0 111.839 -176.805 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 29.2 ttmt -156.13 151.5 26.77 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 106.927 -1.509 . . . . 0.0 106.927 177.153 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 18.5 t0 -66.82 133.4 50.02 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.904 0.383 . . . . 0.0 110.032 -178.892 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 72.46 21.42 79.46 Favored Glycine 0 CA--C 1.507 -0.467 0 C-N-CA 120.938 -0.649 . . . . 0.0 113.962 177.731 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 44.0 mm -125.31 124.21 66.7 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.421 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 178.864 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.1 pt -127.68 114.47 35.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.725 176.63 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 95.8 m95 -81.09 128.77 34.1 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.371 -177.704 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 2.8 m -136.7 149.74 26.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 121.483 0.659 . . . . 0.0 109.572 -177.347 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -157.51 164.63 37.18 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 105.134 -2.173 . . . . 0.0 105.134 -178.696 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 14.5 t -122.96 174.83 6.93 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 105.705 -1.961 . . . . 0.0 105.705 177.985 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -64.97 133.81 52.55 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.197 0.523 . . . . 0.0 109.812 -179.679 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 92.07 -9.22 76.92 Favored Glycine 0 C--O 1.225 -0.445 0 CA-C-N 115.886 -0.597 . . . . 0.0 113.232 178.482 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.494 ' HB1' ' HB ' ' A' ' 44' ' ' ILE . . . -77.74 137.73 38.63 Favored 'General case' 0 C--N 1.324 -0.534 0 O-C-N 122.249 -0.56 . . . . 0.0 109.523 179.434 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 51.7 mt -92.82 134.18 35.33 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 113.523 0.935 . . . . 0.0 113.523 -176.64 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 71.6 m-20 -79.47 56.16 2.1 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.411 -179.196 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -130.85 152.34 80.42 Favored Pre-proline 0 C--N 1.323 -0.549 0 N-CA-C 107.953 -1.128 . . . . 0.0 107.953 -179.595 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -66.76 149.9 83.5 Favored 'Trans proline' 0 C--N 1.343 0.256 0 N-CA-C 114.281 0.839 . . . . 0.0 114.281 178.364 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 4.5 ptpt -151.18 56.13 0.88 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 122.71 1.243 . . . . 0.0 110.467 178.955 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -57.81 -30.71 65.92 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 113.852 -1.522 . . . . 0.0 111.411 178.338 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 29.5 p-80 -59.67 -16.62 27.83 Favored 'General case' 0 C--O 1.218 -0.602 0 N-CA-C 114.205 1.187 . . . . 0.0 114.205 -178.901 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 64.0 mt -81.41 -32.63 12.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 178.305 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -73.86 14.8 3.39 Favored Glycine 0 CA--C 1.522 0.479 0 N-CA-C 115.023 0.769 . . . . 0.0 115.023 -178.337 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 11.6 t -83.1 17.65 1.93 Allowed 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 112.846 0.684 . . . . 0.0 112.846 -177.718 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 73.3 ttp85 -58.83 130.27 46.14 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 178.838 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -101.77 125.44 37.13 Favored Pre-proline 0 C--N 1.322 -0.625 0 N-CA-C 105.778 -1.934 . . . . 0.0 105.778 179.352 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -68.69 -17.35 42.66 Favored 'Trans proline' 0 C--O 1.218 -0.525 0 C-N-CA 117.766 -1.023 . . . . 0.0 114.397 -176.705 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -78.77 -24.3 44.77 Favored 'General case' 0 C--O 1.22 -0.468 0 CA-C-O 120.932 0.396 . . . . 0.0 110.516 178.339 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 -100.11 -23.04 14.97 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 -174.923 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 -158.2 149.13 20.77 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.473 0.545 . . . . 0.0 112.473 -178.706 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -92.64 154.16 18.54 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-O 121.518 0.675 . . . . 0.0 111.825 179.606 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -69.39 144.26 53.45 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.216 0.531 . . . . 0.0 111.031 178.87 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 15.3 mt -85.77 139.94 16.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.303 -178.287 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 92.5 t -60.77 124.77 15.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 175.918 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 6.9 tt -67.29 129.0 38.5 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.966 -177.093 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 29.5 mt-30 -132.14 156.64 46.03 Favored 'General case' 0 C--O 1.219 -0.513 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 -179.467 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 13.4 mt -112.29 148.04 38.28 Favored Pre-proline 0 C--N 1.323 -0.578 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 178.449 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -72.65 168.54 24.2 Favored 'Trans proline' 0 C--N 1.346 0.409 0 O-C-N 122.219 0.589 . . . . 0.0 113.615 -179.128 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 39.1 tt0 -53.82 131.87 40.49 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.309 -0.86 . . . . 0.0 109.553 179.554 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 96.38 -18.94 56.57 Favored Glycine 0 C--O 1.226 -0.403 0 CA-C-N 115.919 -0.582 . . . . 0.0 113.452 179.991 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 4.1 m -108.43 128.48 54.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 118.227 1.014 . . . . 0.0 111.375 179.239 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 10.0 p -122.46 150.77 42.05 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.278 179.172 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 87.8 mt -70.79 151.88 95.19 Favored Pre-proline 0 C--N 1.324 -0.533 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 179.076 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -76.03 166.17 28.42 Favored 'Trans proline' 0 C--O 1.236 0.383 0 C-N-CA 117.775 -1.016 . . . . 0.0 110.973 178.864 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 14.7 tmtt? -59.04 127.02 30.11 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.121 -177.293 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 95.1 15.59 44.31 Favored Glycine 0 C--O 1.227 -0.344 0 N-CA-C 114.865 0.706 . . . . 0.0 114.865 178.785 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -125.52 149.17 48.53 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 117.688 0.744 . . . . 0.0 110.637 177.873 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 43.6 p90 -150.37 161.97 41.46 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 174.43 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -99.92 147.01 26.01 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.825 0.345 . . . . 0.0 110.412 -179.017 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.43 ' HB3' ' HB ' ' A' ' 14' ' ' THR . 3.6 tp10 -72.18 133.76 45.31 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 106.65 -1.611 . . . . 0.0 106.65 177.81 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 89.48 -3.17 83.6 Favored Glycine 0 C--O 1.224 -0.5 0 N-CA-C 111.254 -0.738 . . . . 0.0 111.254 -177.144 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 9.7 t -129.11 -175.89 3.7 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 177.42 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -131.6 135.69 47.18 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 -178.775 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -114.68 165.1 12.03 Favored Glycine 0 C--O 1.235 0.194 0 N-CA-C 108.587 -1.805 . . . . 0.0 108.587 176.763 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 118.66 -149.31 18.29 Favored Glycine 0 CA--C 1.509 -0.333 0 N-CA-C 106.493 -2.643 . . . . 0.0 106.493 -176.939 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 11.8 t . . . . . 0 C--O 1.248 0.998 0 O-C-N 125.023 1.072 . . . . 0.0 109.304 -178.177 . . . . . . . . 0 0 . 1 . 036 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.783 0 CA-C-O 118.261 -1.299 . . . . 0.0 110.991 . . . . . . . . . 0 0 . 1 . 036 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -67.93 144.18 55.34 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 118.628 1.214 . . . . 0.0 108.558 178.582 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 87.3 mtp -135.32 -135.62 0.16 Allowed 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 -179.498 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 81.62 26.91 49.16 Favored Glycine 0 CA--C 1.501 -0.827 0 N-CA-C 115.288 0.875 . . . . 0.0 115.288 177.669 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -72.01 134.34 83.31 Favored Pre-proline 0 C--N 1.316 -0.856 0 N-CA-C 105.891 -1.892 . . . . 0.0 105.891 178.32 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -78.3 157.26 29.53 Favored 'Trans proline' 0 N--CA 1.463 -0.312 0 C-N-CA 117.79 -1.007 . . . . 0.0 111.985 179.144 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 -68.33 -31.38 70.75 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 176.113 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 -163.13 -86.77 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.843 177.215 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 82.8 p 39.43 79.03 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 116.34 1.978 . . . . 0.0 116.34 178.476 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -96.69 147.83 23.5 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.262 -179.383 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 54.3 p -59.72 143.72 50.05 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.254 -0.884 . . . . 0.0 109.231 177.907 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 13.4 m95 -65.87 -26.75 67.78 Favored 'General case' 0 CA--C 1.512 -0.485 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 179.26 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 27.4 m-85 -121.46 164.79 16.59 Favored 'General case' 0 CA--C 1.503 -0.831 0 CA-C-N 115.784 -0.644 . . . . 0.0 112.109 -172.201 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.466 ' HB ' ' HB3' ' A' ' 134' ' ' GLU . 67.1 p -70.35 166.41 20.31 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 114.614 -1.175 . . . . 0.0 108.629 177.642 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -87.23 149.92 24.27 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 113.306 0.854 . . . . 0.0 113.306 -176.507 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.466 HD21 HD22 ' A' ' 119' ' ' LEU . 53.0 mt -85.54 148.81 25.77 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 173.18 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 24.2 m -125.19 131.98 53.1 Favored 'General case' 0 C--N 1.32 -0.716 0 C-N-CA 122.515 0.326 . . . . 0.0 110.698 -179.822 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 3.9 tp-100 -95.6 141.67 28.83 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 179.129 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 41.5 t60 -135.35 100.04 4.41 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 102.54 -3.133 . . . . 0.0 102.54 166.598 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 167.77 -143.9 8.53 Favored Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 120.286 -0.959 . . . . 0.0 111.545 -175.027 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -124.74 -32.3 3.1 Favored 'General case' 0 C--O 1.221 -0.405 0 N-CA-C 115.449 1.648 . . . . 0.0 115.449 -177.811 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -77.69 165.77 23.82 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 178.57 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -79.66 -62.89 1.55 Allowed 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 -179.249 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 48.0 tp 173.88 141.04 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.221 0 N-CA-C 106.114 -1.81 . . . . 0.0 106.114 176.057 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 56.2 tptt -153.71 139.46 17.99 Favored 'General case' 0 C--O 1.222 -0.371 0 CA-C-N 118.077 0.399 . . . . 0.0 110.539 173.983 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 20.5 m-85 -126.27 151.49 72.32 Favored Pre-proline 0 C--O 1.24 0.59 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 175.189 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -78.98 166.95 22.64 Favored 'Trans proline' 0 C--N 1.353 0.813 0 C-N-CA 120.934 1.089 . . . . 0.0 113.535 178.347 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 2.0 tmt_? -66.86 137.07 56.32 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.821 -178.732 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 86.67 -0.21 86.52 Favored Glycine 0 C--O 1.223 -0.536 0 N-CA-C 111.302 -0.719 . . . . 0.0 111.302 177.169 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 58.5 mt-30 -140.65 -179.69 6.18 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 -175.176 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.52 -28.28 13.98 Favored Glycine 0 CA--C 1.498 -1.025 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.87 176.104 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 76.2 t -64.44 126.45 90.61 Favored Pre-proline 0 C--N 1.32 -0.705 0 N-CA-C 106.177 -1.786 . . . . 0.0 106.177 176.559 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -73.66 168.87 23.69 Favored 'Trans proline' 0 N--CA 1.459 -0.513 0 O-C-N 122.225 0.592 . . . . 0.0 111.446 179.134 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 87.6 mt -66.71 110.1 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-O 122.06 0.934 . . . . 0.0 109.177 -179.761 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 71.6 m-80 -97.94 91.45 5.33 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 114.636 -1.165 . . . . 0.0 110.734 -177.493 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 75.7 p -71.38 -14.89 62.32 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.744 0.783 . . . . 0.0 111.469 178.667 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 10.7 p30 -111.14 20.52 17.32 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 114.915 1.45 . . . . 0.0 114.915 -175.893 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 6.1 m -138.91 152.32 47.66 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 115.938 1.829 . . . . 0.0 115.938 -175.728 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 2.0 m -70.22 164.7 50.81 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 115.085 -0.962 . . . . 0.0 109.936 176.219 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -66.36 -28.38 46.84 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 114.758 -3.028 . . . . 0.0 113.915 -179.823 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.41 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 4.2 p-10 -75.3 -21.59 58.35 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.657 0.741 . . . . 0.0 110.688 177.319 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -83.28 -5.76 59.24 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 114.063 1.134 . . . . 0.0 114.063 -174.776 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 93.6 mm-40 -58.89 -26.52 64.36 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 113.248 0.833 . . . . 0.0 113.248 -179.427 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.453 ' HB ' ' HB1' ' A' ' 98' ' ' ALA . 20.1 tt -57.66 138.86 18.03 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.726 0 N-CA-C 114.402 1.26 . . . . 0.0 114.402 -178.744 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -177.07 -159.35 22.18 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.57 -0.824 . . . . 0.0 111.977 178.806 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 51.5 p90 -155.05 172.7 17.68 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 177.907 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 16.9 m-85 -113.49 138.89 49.47 Favored 'General case' 0 C--N 1.319 -0.761 0 N-CA-C 106.125 -1.806 . . . . 0.0 106.125 173.869 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 36.2 ttt180 -108.23 120.01 41.14 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 114.991 -1.004 . . . . 0.0 110.387 -176.728 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 13.1 ttt180 -64.33 131.7 48.04 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 176.316 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -142.18 129.77 21.44 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.544 0.688 . . . . 0.0 110.882 -179.693 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 15.3 t -156.8 155.46 31.59 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 175.183 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 15.0 tpt85 -154.88 135.12 13.18 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 104.865 -2.272 . . . . 0.0 104.865 178.11 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -127.82 136.37 51.35 Favored 'General case' 0 CA--C 1.495 -1.138 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 -179.423 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.447 HD13 ' HB2' ' A' ' 62' ' ' LYS . 0.1 OUTLIER -132.67 172.4 16.49 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 -177.38 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 5.5 tmm_? -116.08 112.3 21.54 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 105.439 -2.06 . . . . 0.0 105.439 176.71 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -75.76 150.07 39.1 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 121.008 -0.615 . . . . 0.0 112.368 -177.512 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -70.89 -22.16 78.26 Favored Glycine 0 C--O 1.218 -0.896 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.44 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 41.1 t0 -65.16 -12.9 56.0 Favored 'General case' 0 CA--C 1.548 0.903 0 CA-C-N 114.236 -0.982 . . . . 0.0 110.363 176.951 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 108.07 18.46 9.86 Favored Glycine 0 CA--C 1.501 -0.827 0 CA-C-N 116.105 -0.498 . . . . 0.0 112.818 169.338 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.66 160.28 42.86 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 116.583 2.068 . . . . 0.0 116.583 -174.155 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 93.9 mmm -85.03 160.25 20.05 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.589 -0.732 . . . . 0.0 112.873 -176.398 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.447 ' HB2' HD13 ' A' ' 54' ' ' ILE . 13.3 tmtt? -63.86 -42.91 97.43 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 122.316 1.055 . . . . 0.0 112.412 176.64 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 13.1 t70 56.15 -139.85 0.92 Allowed 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 112.444 -2.162 . . . . 0.0 109.988 -174.916 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER 66.9 156.23 0.11 Allowed 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 116.001 1.852 . . . . 0.0 116.001 178.777 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 14.1 p -81.26 162.59 58.44 Favored Pre-proline 0 C--O 1.242 0.675 0 CA-C-N 114.462 -1.245 . . . . 0.0 110.678 -179.949 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -71.6 156.5 57.61 Favored 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 116.434 -1.911 . . . . 0.0 111.293 175.563 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 11.7 mtt180 -116.7 161.46 19.19 Favored 'General case' 0 CA--C 1.506 -0.737 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 178.251 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 62.3 m95 -123.18 125.98 46.13 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 179.919 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 11.3 m-85 -110.37 138.06 47.26 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 107.278 -1.378 . . . . 0.0 107.278 -176.742 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 79.7 t80 -85.25 133.8 34.16 Favored 'General case' 0 CA--C 1.509 -0.629 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 -177.248 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -141.47 135.49 30.31 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 -175.254 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 86.3 m-85 -73.73 159.54 32.82 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 -175.652 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 11.3 tp -57.02 126.55 27.68 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.312 0.577 . . . . 0.0 109.615 179.849 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 82.03 18.68 66.8 Favored Glycine 0 C--O 1.22 -0.751 0 N-CA-C 116.49 1.356 . . . . 0.0 116.49 178.041 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 16.7 p -89.72 146.07 24.76 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 119.331 1.566 . . . . 0.0 110.228 178.622 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 97.13 142.85 13.83 Favored Glycine 0 CA--C 1.528 0.891 0 N-CA-C 110.716 -0.953 . . . . 0.0 110.716 -177.461 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -71.34 -46.62 0.63 Allowed 'Trans proline' 0 C--N 1.35 0.614 0 CA-C-N 119.844 1.822 . . . . 0.0 116.481 -174.908 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 68.1 mt-10 -107.56 39.33 1.93 Allowed 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 106.269 -1.752 . . . . 0.0 106.269 -178.265 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -65.25 -43.52 91.07 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.499 -1.228 . . . . 0.0 109.603 -178.702 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 57.24 33.27 64.84 Favored Glycine 0 C--O 1.226 -0.375 0 CA-C-N 115.724 -0.671 . . . . 0.0 114.136 177.666 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.406 ' HA ' ' HD2' ' A' ' 82' ' ' PRO . 15.0 mt -124.21 103.84 32.56 Favored Pre-proline 0 N--CA 1.44 -0.968 0 N-CA-C 116.027 1.862 . . . . 0.0 116.027 -175.311 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.406 ' HD2' ' HA ' ' A' ' 81' ' ' LEU . 90.8 Cg_endo -78.47 162.21 27.9 Favored 'Trans proline' 0 N--CA 1.462 -0.357 0 C-N-CA 122.684 2.256 . . . . 0.0 107.165 166.962 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 59.1 t80 -61.44 132.56 53.86 Favored 'General case' 0 C--N 1.32 -0.712 0 C-N-CA 120.239 -0.584 . . . . 0.0 110.35 -177.499 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 91.4 -8.98 78.45 Favored Glycine 0 CA--C 1.519 0.324 0 N-CA-C 114.953 0.741 . . . . 0.0 114.953 179.296 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -66.35 131.54 46.33 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 118.676 1.238 . . . . 0.0 111.711 179.84 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 56.9 t30 -78.81 131.31 36.45 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.287 -179.724 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 32.7 tttt -156.22 156.77 34.7 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 106.807 -1.553 . . . . 0.0 106.807 -179.568 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -64.56 127.76 32.87 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.719 -0.475 . . . . 0.0 109.719 -178.129 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 67.41 33.02 80.74 Favored Glycine 0 N--CA 1.444 -0.778 0 N-CA-C 115.171 0.829 . . . . 0.0 115.171 176.8 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 41.0 mm -126.34 125.44 67.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 117.404 0.602 . . . . 0.0 110.132 179.067 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -127.41 112.45 28.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.202 177.278 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 98.6 m95 -78.02 137.29 38.19 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 113.371 0.878 . . . . 0.0 113.371 -177.681 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 14.0 m -139.45 149.75 22.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 177.843 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -160.7 164.17 31.87 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 104.299 -2.482 . . . . 0.0 104.299 179.385 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 14.1 t -124.08 174.58 7.53 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 105.668 -1.975 . . . . 0.0 105.668 178.48 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -65.99 132.28 48.21 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.992 0.425 . . . . 0.0 110.438 -178.752 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 92.59 -6.72 77.6 Favored Glycine 0 C--O 1.23 -0.154 0 CA-C-N 116.103 -0.498 . . . . 0.0 113.543 178.997 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.453 ' HB1' ' HB ' ' A' ' 44' ' ' ILE . . . -74.8 138.88 42.9 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 178.681 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 40.2 mt -94.6 139.01 31.76 Favored 'General case' 0 C--O 1.222 -0.39 0 N-CA-C 113.442 0.905 . . . . 0.0 113.442 -177.053 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 74.0 m-20 -83.18 62.08 6.44 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.869 -178.782 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -135.39 154.33 78.49 Favored Pre-proline 0 C--N 1.32 -0.692 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 -179.495 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -68.39 150.68 76.06 Favored 'Trans proline' 0 C--N 1.342 0.191 0 N-CA-C 114.476 0.914 . . . . 0.0 114.476 178.699 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -149.27 59.39 1.03 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 122.94 1.352 . . . . 0.0 110.988 178.006 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 14.0 p-10 -58.61 -30.43 67.24 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 113.694 -1.594 . . . . 0.0 110.206 176.894 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 23.0 p-80 -59.77 -14.66 15.54 Favored 'General case' 0 C--O 1.222 -0.366 0 N-CA-C 114.214 1.19 . . . . 0.0 114.214 -179.272 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 51.9 mt -90.33 -48.51 14.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 177.846 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -71.69 14.37 1.99 Allowed Glycine 0 C--O 1.219 -0.823 0 N-CA-C 116.094 1.197 . . . . 0.0 116.094 -176.271 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 13.8 t -90.95 19.88 5.28 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 117.596 0.698 . . . . 0.0 111.947 179.987 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 65.6 ttp85 -57.47 135.11 56.57 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 178.988 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -105.11 136.21 19.21 Favored Pre-proline 0 C--N 1.323 -0.559 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 178.515 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -73.96 -17.96 21.93 Favored 'Trans proline' 0 C--O 1.219 -0.464 0 O-C-N 121.967 0.456 . . . . 0.0 113.148 -179.885 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -80.07 -24.61 40.52 Favored 'General case' 0 C--O 1.221 -0.409 0 CA-C-O 121.148 0.499 . . . . 0.0 110.271 178.938 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 88.4 m-20 -99.4 -22.37 15.57 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 113.464 0.913 . . . . 0.0 113.464 -175.32 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 -158.7 149.72 20.4 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.135 0.42 . . . . 0.0 112.135 -178.659 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -85.34 145.29 27.57 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-O 121.427 0.632 . . . . 0.0 111.872 179.68 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -69.6 148.1 49.82 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.17 0.51 . . . . 0.0 110.544 178.361 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 17.4 mt -89.42 138.99 18.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 -179.045 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 79.7 t -62.81 124.92 18.3 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 N-CA-C 106.088 -1.819 . . . . 0.0 106.088 174.259 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.466 HD22 HD21 ' A' ' 16' ' ' LEU . 7.2 tt -67.55 130.61 43.59 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 -177.782 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -135.0 154.11 51.85 Favored 'General case' 0 CA--C 1.51 -0.591 0 N-CA-C 106.135 -1.802 . . . . 0.0 106.135 -179.152 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 13.1 mt -108.56 147.34 35.54 Favored Pre-proline 0 C--N 1.321 -0.673 0 CA-C-O 120.574 0.226 . . . . 0.0 110.732 177.15 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -73.34 163.91 36.58 Favored 'Trans proline' 0 C--O 1.236 0.401 0 C-N-CA 118.371 -0.62 . . . . 0.0 113.378 -179.873 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 39.4 tt0 -53.87 129.22 33.04 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.274 -0.876 . . . . 0.0 109.09 178.999 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 108.65 -26.89 14.65 Favored Glycine 0 C--O 1.225 -0.408 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.911 -178.681 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 5.0 m -108.56 132.28 54.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 118.012 0.906 . . . . 0.0 111.545 178.499 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 2.8 p -121.14 148.18 44.56 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 177.3 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 75.9 mt -70.02 153.59 95.27 Favored Pre-proline 0 C--N 1.323 -0.566 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 177.739 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -74.1 168.82 23.88 Favored 'Trans proline' 0 C--O 1.235 0.354 0 N-CA-C 110.714 -0.533 . . . . 0.0 110.714 179.176 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -60.17 125.81 25.09 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.988 0.423 . . . . 0.0 111.49 -175.268 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 94.95 -2.9 66.73 Favored Glycine 0 C--O 1.227 -0.307 0 N-CA-C 115.131 0.813 . . . . 0.0 115.131 178.444 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -102.89 138.91 39.15 Favored 'General case' 0 N--CA 1.441 -0.911 0 CA-C-O 122.175 0.988 . . . . 0.0 110.39 -179.899 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 45.9 p90 -141.81 159.88 41.32 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 113.989 -1.46 . . . . 0.0 107.656 175.846 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -98.89 150.65 21.69 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 -179.505 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.466 ' HB3' ' HB ' ' A' ' 14' ' ' THR . 2.9 tp10 -73.17 129.03 37.16 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 106.77 -1.567 . . . . 0.0 106.77 179.74 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 89.03 -2.92 84.41 Favored Glycine 0 C--O 1.227 -0.318 0 C-N-CA 121.341 -0.457 . . . . 0.0 112.183 -177.615 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 46.4 t -118.0 165.65 13.48 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 178.218 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 49.4 mtm180 -84.97 -16.86 39.48 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.498 0.666 . . . . 0.0 109.478 177.584 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 104.04 175.18 25.52 Favored Glycine 0 C--N 1.319 -0.413 0 N-CA-C 107.153 -2.379 . . . . 0.0 107.153 -176.179 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 81.03 50.07 5.32 Favored Glycine 0 C--O 1.228 -0.271 0 N-CA-C 109.326 -1.51 . . . . 0.0 109.326 -176.025 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 62.5 m . . . . . 0 N--CA 1.48 1.06 0 C-N-CA 125.977 1.711 . . . . 0.0 110.845 -177.45 . . . . . . . . 0 0 . 1 . 037 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.46 0 CA-C-O 119.016 -0.88 . . . . 0.0 111.193 . . . . . . . . . 0 0 . 1 . 037 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -143.67 162.82 34.96 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 117.979 0.889 . . . . 0.0 109.816 -177.301 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 21.7 ttt -141.23 172.34 12.81 Favored 'General case' 0 C--N 1.321 -0.645 1 N-CA-C 98.627 -4.583 . . . . 0.0 98.627 177.989 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 90.41 67.02 1.2 Allowed Glycine 0 C--N 1.316 -0.57 0 C-N-CA 120.734 -0.746 . . . . 0.0 111.855 -175.08 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 10.2 mp -97.68 142.05 23.95 Favored Pre-proline 0 C--N 1.325 -0.46 0 N-CA-C 106.784 -1.561 . . . . 0.0 106.784 179.178 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -74.5 152.24 43.21 Favored 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 117.664 -1.091 . . . . 0.0 113.418 -179.233 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 36.4 t30 -151.6 -59.33 0.16 Allowed 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.653 177.691 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -88.26 -3.61 58.83 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 120.983 0.421 . . . . 0.0 111.375 -177.914 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 16.8 p -133.48 118.51 18.42 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 106.102 -1.814 . . . . 0.0 106.102 -178.311 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -108.55 146.69 32.88 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.252 0.549 . . . . 0.0 109.664 -178.398 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 53.2 p -64.97 144.27 57.4 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 178.303 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 6.3 m95 -66.31 -26.3 67.25 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 111.959 0.355 . . . . 0.0 111.959 177.86 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 32.1 m-85 -121.72 159.15 27.19 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.361 -171.851 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 45.4 p -68.22 166.75 15.68 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.266 -0.879 . . . . 0.0 111.271 -178.246 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -85.38 127.2 34.28 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 113.695 0.998 . . . . 0.0 113.695 -175.513 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 22.6 mt -67.76 147.93 51.93 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 105.332 -2.099 . . . . 0.0 105.332 172.763 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 34.6 m -123.69 133.0 53.96 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 -178.733 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -94.48 140.94 29.18 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 114.266 1.21 . . . . 0.0 114.266 -176.43 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 57.3 t60 -138.82 100.1 3.97 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 105.673 -1.973 . . . . 0.0 105.673 166.04 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 166.3 -153.83 23.95 Favored Glycine 0 C--O 1.224 -0.503 0 C-N-CA 120.844 -0.693 . . . . 0.0 111.537 -177.756 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 40.2 mtpt -117.43 -21.73 8.52 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 113.556 0.947 . . . . 0.0 113.556 -179.42 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -76.1 156.74 33.57 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 178.369 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -73.75 -62.41 1.5 Allowed 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 179.776 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 35.4 tp 171.3 142.24 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 103.418 -2.808 . . . . 0.0 103.418 174.169 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 52.7 tptt -151.78 134.72 15.71 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 118.424 0.556 . . . . 0.0 111.281 174.823 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -123.02 149.13 56.14 Favored Pre-proline 0 C--O 1.243 0.74 0 N-CA-C 108.42 -0.955 . . . . 0.0 108.42 174.152 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -77.39 167.68 24.12 Favored 'Trans proline' 0 CA--C 1.537 0.653 0 C-N-CA 120.906 1.071 . . . . 0.0 113.671 179.268 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 71.3 ttt180 -67.96 137.65 55.32 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.759 -178.871 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 85.93 -0.11 87.61 Favored Glycine 0 C--O 1.224 -0.487 0 N-CA-C 111.562 -0.615 . . . . 0.0 111.562 178.336 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 -140.52 -179.48 6.04 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 -176.288 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 101.15 -29.14 13.15 Favored Glycine 0 CA--C 1.501 -0.842 0 CA-C-N 115.732 -0.667 . . . . 0.0 112.866 175.613 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 98.5 t -66.1 127.39 93.17 Favored Pre-proline 0 C--N 1.322 -0.621 0 N-CA-C 105.456 -2.053 . . . . 0.0 105.456 176.867 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -71.46 167.4 26.45 Favored 'Trans proline' 0 N--CA 1.461 -0.44 0 C-N-CA 120.329 0.686 . . . . 0.0 111.955 179.543 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 95.7 mt -63.36 121.32 12.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 106.227 -1.768 . . . . 0.0 106.227 179.481 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 43.3 t-20 -116.93 122.65 44.89 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.287 -0.87 . . . . 0.0 110.881 -173.913 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 73.4 p -103.03 -11.88 17.83 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.393 -0.821 . . . . 0.0 112.716 -177.475 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 17.5 p30 -114.24 15.99 18.04 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 116.324 1.972 . . . . 0.0 116.324 -173.063 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 29.0 m -141.83 154.31 45.09 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 113.742 1.015 . . . . 0.0 113.742 -177.694 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 18.6 m -72.44 164.45 59.6 Favored Pre-proline 0 C--O 1.238 0.464 0 CA-C-N 115.331 -0.85 . . . . 0.0 109.014 176.696 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -64.3 -28.44 63.68 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 115.4 -2.6 . . . . 0.0 112.46 178.918 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -62.65 -24.21 67.5 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 123.735 0.814 . . . . 0.0 111.613 177.643 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.445 ' HA ' ' HE3' ' A' ' 103' ' ' LYS . 33.4 m-20 -99.81 -2.49 34.92 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 114.75 1.389 . . . . 0.0 114.75 -171.622 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 96.9 mm-40 -60.46 -37.79 82.11 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 115.937 1.828 . . . . 0.0 115.937 -179.992 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 15.7 tt -59.33 138.3 20.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-O 122.313 1.054 . . . . 0.0 112.59 -176.965 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -178.77 -152.34 10.36 Favored Glycine 0 C--O 1.226 -0.383 0 CA-C-N 115.338 -0.847 . . . . 0.0 111.964 -174.862 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 47.8 p90 -154.7 173.59 16.18 Favored 'General case' 0 C--N 1.321 -0.636 0 O-C-N 122.379 -0.483 . . . . 0.0 110.448 -179.33 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -113.98 140.12 48.68 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 171.29 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -105.73 119.33 38.86 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 124.192 0.997 . . . . 0.0 109.69 -178.348 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -70.89 133.18 46.24 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 175.556 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -143.93 154.79 43.68 Favored 'General case' 0 C--N 1.321 -0.654 0 C-N-CA 122.814 0.445 . . . . 0.0 110.175 -177.441 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 15.2 t -156.68 166.98 31.84 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 174.975 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.7 tpt85 -160.29 153.81 22.33 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 103.421 -2.807 . . . . 0.0 103.421 179.475 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 21.8 ttm180 -131.37 146.07 52.12 Favored 'General case' 0 CA--C 1.495 -1.168 0 CA-C-N 118.804 0.729 . . . . 0.0 111.908 179.387 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -142.67 177.71 2.65 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 N-CA-C 104.823 -2.288 . . . . 0.0 104.823 179.205 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 7.1 tmm_? -128.09 103.05 7.0 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 104.999 -2.223 . . . . 0.0 104.999 174.852 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -70.49 154.89 52.76 Favored Glycine 0 C--O 1.22 -0.776 0 N-CA-C 110.731 -0.947 . . . . 0.0 110.731 -176.55 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -67.45 -34.8 85.69 Favored Glycine 0 C--O 1.215 -1.051 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 -179.817 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.1 t0 -94.24 16.91 13.71 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-O 122.483 1.135 . . . . 0.0 109.532 178.416 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 86.42 -17.53 38.35 Favored Glycine 0 C--O 1.225 -0.41 0 N-CA-C 116.225 1.25 . . . . 0.0 116.225 173.801 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -58.9 135.51 57.58 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 122.286 1.041 . . . . 0.0 113.319 -177.314 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 79.3 mtp -113.63 -175.76 2.75 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 113.472 -1.695 . . . . 0.0 111.728 -177.416 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 12.2 mptt -130.29 -41.98 1.22 Allowed 'General case' 0 N--CA 1.476 0.831 0 CA-C-O 122.641 1.21 . . . . 0.0 111.674 -178.984 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 15.7 t0 -61.02 -177.6 0.08 Allowed 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 111.657 -2.52 . . . . 0.0 113.456 179.014 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER 81.02 -52.41 0.3 Allowed 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 126.952 2.101 . . . . 0.0 110.162 -179.206 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 37.9 t -83.81 113.71 49.24 Favored Pre-proline 0 C--N 1.321 -0.662 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 175.459 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -73.45 150.01 45.53 Favored 'Trans proline' 0 C--O 1.239 0.565 0 C-N-CA 114.803 -2.998 . . . . 0.0 111.062 177.94 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 36.6 mtp180 -120.08 157.79 28.21 Favored 'General case' 0 CA--C 1.503 -0.855 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 -179.45 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 77.3 m95 -128.78 126.8 40.69 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 120.77 0.319 . . . . 0.0 110.874 -179.088 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 13.2 m-85 -110.52 134.25 52.54 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 106.769 -1.567 . . . . 0.0 106.769 -177.501 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 88.4 t80 -83.66 134.21 34.79 Favored 'General case' 0 CA--C 1.508 -0.661 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 -178.139 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -139.67 145.49 38.48 Favored 'General case' 0 N--CA 1.44 -0.935 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 -175.899 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 76.9 m-85 -83.12 159.55 22.06 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.937 -172.971 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -56.48 126.63 27.33 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 179.462 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 78.96 26.8 57.63 Favored Glycine 0 C--O 1.223 -0.559 0 N-CA-C 115.908 1.123 . . . . 0.0 115.908 178.224 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 22.2 p -102.82 146.21 28.62 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 118.829 1.314 . . . . 0.0 109.746 177.201 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 103.78 137.62 9.42 Favored Glycine 0 CA--C 1.527 0.821 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.824 -179.912 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -73.1 -38.4 2.82 Favored 'Trans proline' 0 C--N 1.349 0.586 0 CA-C-N 119.446 1.623 . . . . 0.0 116.229 -175.117 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -103.82 17.57 23.82 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 -176.968 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -65.28 -55.47 18.14 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.204 -176.241 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 55.94 34.06 61.19 Favored Glycine 0 C--O 1.225 -0.449 0 C-N-CA 121.302 -0.475 . . . . 0.0 112.32 -179.402 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 18.5 mt -112.61 103.83 55.68 Favored Pre-proline 0 N--CA 1.447 -0.588 0 N-CA-C 116.628 2.084 . . . . 0.0 116.628 -174.002 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -78.63 163.1 26.94 Favored 'Trans proline' 0 N--CA 1.461 -0.386 0 C-N-CA 122.305 2.004 . . . . 0.0 107.732 167.898 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.407 ' CE1' ' HB3' ' A' ' 92' ' ' TRP . 65.9 t80 -61.9 132.06 51.78 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 120.307 -0.557 . . . . 0.0 110.651 -177.005 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 92.1 -9.21 76.91 Favored Glycine 0 C--O 1.228 -0.277 0 CA-C-O 119.595 -0.559 . . . . 0.0 114.359 179.092 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -65.01 130.71 44.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 118.256 1.028 . . . . 0.0 111.39 179.403 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 57.0 t30 -79.36 130.75 35.74 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.413 -179.246 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 26.9 ttmt -154.84 150.71 27.77 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 178.454 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 32.1 t0 -64.4 120.78 12.89 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.284 0.564 . . . . 0.0 110.402 -178.047 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 78.41 29.76 51.92 Favored Glycine 0 N--CA 1.451 -0.309 0 CA-C-N 115.437 -0.802 . . . . 0.0 114.506 179.471 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 41.6 mm -127.06 126.38 68.09 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 CA-C-N 117.612 0.706 . . . . 0.0 110.712 179.099 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -127.16 116.04 42.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 CA-C-O 121.478 0.656 . . . . 0.0 111.381 176.337 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 92' ' ' TRP . . . . . 0.407 ' HB3' ' CE1' ' A' ' 83' ' ' TYR . 96.7 m95 -79.91 138.48 37.14 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -178.326 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 16.1 m -138.29 153.23 26.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 179.15 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -160.1 165.92 30.84 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 107.073 -1.454 . . . . 0.0 107.073 -178.407 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 14.0 t -133.05 165.97 23.49 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 105.007 -2.22 . . . . 0.0 105.007 176.205 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 61.0 tt0 -67.41 138.18 56.5 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.096 0.474 . . . . 0.0 110.163 -179.06 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 94.97 -8.53 70.33 Favored Glycine 0 C--O 1.225 -0.432 0 CA-C-N 115.853 -0.612 . . . . 0.0 112.999 178.756 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -81.3 143.0 32.55 Favored 'General case' 0 C--N 1.323 -0.543 0 O-C-N 122.543 -0.386 . . . . 0.0 110.364 178.878 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 38.7 mt -100.53 134.76 43.0 Favored 'General case' 0 CA--C 1.514 -0.404 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -178.409 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -78.55 48.07 0.76 Allowed 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 115.184 -0.916 . . . . 0.0 112.049 -177.248 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 1.4 t -114.91 154.85 46.98 Favored Pre-proline 0 C--N 1.32 -0.717 0 N-CA-C 105.366 -2.087 . . . . 0.0 105.366 -179.98 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -64.97 149.01 90.03 Favored 'Trans proline' 0 C--N 1.342 0.197 0 N-CA-C 113.636 0.591 . . . . 0.0 113.636 176.802 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.445 ' HE3' ' HA ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -143.99 54.96 1.3 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 123.551 1.644 . . . . 0.0 109.603 178.616 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -58.32 -30.66 66.86 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 113.128 -1.851 . . . . 0.0 111.456 178.501 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 29.4 p-80 -57.08 -16.65 7.89 Favored 'General case' 0 C--O 1.222 -0.389 0 N-CA-C 115.026 1.491 . . . . 0.0 115.026 -178.422 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 4.4 mt -92.02 -21.01 6.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 121.256 0.55 . . . . 0.0 110.515 -179.946 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -77.11 3.0 59.32 Favored Glycine 0 C--O 1.225 -0.413 0 C-N-CA 120.806 -0.711 . . . . 0.0 113.81 -177.692 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 9.9 t -83.34 11.33 6.9 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 114.235 1.198 . . . . 0.0 114.235 -176.588 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 66.9 ttp85 -59.69 126.09 26.22 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 107.794 -1.188 . . . . 0.0 107.794 178.417 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -97.45 137.38 21.1 Favored Pre-proline 0 C--N 1.322 -0.623 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 178.574 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -74.68 -20.27 17.84 Favored 'Trans proline' 0 C--O 1.219 -0.458 0 N-CA-C 113.815 0.66 . . . . 0.0 113.815 179.999 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -81.6 -24.87 36.18 Favored 'General case' 0 C--O 1.221 -0.408 0 CA-C-O 121.116 0.484 . . . . 0.0 110.145 179.919 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 87.4 m-20 -97.32 -22.27 16.74 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 113.503 0.927 . . . . 0.0 113.503 -175.266 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 -157.22 151.35 24.82 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 112.315 0.487 . . . . 0.0 112.315 -178.005 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -89.08 146.19 24.98 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-O 121.433 0.635 . . . . 0.0 111.435 179.196 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -70.75 149.06 47.29 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.348 0.594 . . . . 0.0 110.923 178.713 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 22.7 mt -81.21 137.88 20.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 179.864 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 87.7 t -61.35 121.09 8.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 106.679 -1.6 . . . . 0.0 106.679 175.109 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 6.1 tt -67.39 125.53 26.41 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.074 0.464 . . . . 0.0 110.075 -176.985 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -134.46 159.12 42.09 Favored 'General case' 0 CA--C 1.508 -0.643 0 N-CA-C 106.491 -1.67 . . . . 0.0 106.491 -179.169 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 13.6 mt -112.97 148.31 39.12 Favored Pre-proline 0 C--N 1.32 -0.713 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 178.501 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -73.17 163.75 37.23 Favored 'Trans proline' 0 C--O 1.236 0.425 0 C-N-CA 118.254 -0.698 . . . . 0.0 112.836 -179.933 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 39.0 tt0 -54.6 129.55 36.82 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 179.403 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 108.83 -27.82 12.45 Favored Glycine 0 C--O 1.225 -0.416 0 CA-C-N 115.853 -0.612 . . . . 0.0 112.08 -178.461 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 4.3 m -105.6 129.29 53.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 118.128 0.964 . . . . 0.0 111.507 178.54 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 3.3 p -116.97 148.28 41.56 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.809 179.35 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 89.5 mt -73.2 151.43 90.16 Favored Pre-proline 0 C--N 1.323 -0.552 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 177.987 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -78.49 -172.04 1.4 Allowed 'Trans proline' 0 C--O 1.238 0.52 0 C-N-CA 121.061 1.174 . . . . 0.0 112.346 179.396 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 7.8 tmtt? -55.15 120.71 7.41 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 114.235 1.198 . . . . 0.0 114.235 -171.893 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 66.36 22.79 71.41 Favored Glycine 0 C--O 1.224 -0.494 0 CA-C-N 114.888 -1.051 . . . . 0.0 115.522 173.703 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -99.84 134.41 42.78 Favored 'General case' 0 N--CA 1.439 -0.977 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 177.774 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 42.5 p90 -139.8 161.27 37.97 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.051 -0.977 . . . . 0.0 108.711 178.392 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -98.08 144.93 27.05 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.727 0.775 . . . . 0.0 112.508 -176.716 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -78.29 139.24 38.87 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 106.566 -1.642 . . . . 0.0 106.566 176.212 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 91.75 -5.04 79.55 Favored Glycine 0 C--O 1.224 -0.471 0 C-N-CA 120.956 -0.64 . . . . 0.0 111.887 -178.355 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 21.9 t -82.51 174.81 10.73 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 105.635 -1.987 . . . . 0.0 105.635 175.948 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.02 100.42 1.99 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.135 0.493 . . . . 0.0 110.676 -178.264 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -167.24 -179.52 40.23 Favored Glycine 0 N--CA 1.45 -0.373 0 N-CA-C 107.649 -2.181 . . . . 0.0 107.649 179.679 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 71.18 16.99 75.49 Favored Glycine 0 C--O 1.227 -0.313 0 N-CA-C 110.875 -0.89 . . . . 0.0 110.875 -179.234 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 4.7 p . . . . . 0 C--O 1.257 1.477 0 N-CA-C 102.411 -3.181 . . . . 0.0 102.411 -177.39 . . . . . . . . 0 0 . 1 . 038 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 2.017 0 CA-C-O 119.028 -0.873 . . . . 0.0 111.469 . . . . . . . . . 0 0 . 1 . 038 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -62.38 135.54 57.5 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 177.596 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 86.9 mtp 57.39 10.72 0.99 Allowed 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 114.057 1.132 . . . . 0.0 114.057 -177.46 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -130.45 59.46 0.69 Allowed Glycine 0 CA--C 1.509 -0.313 0 N-CA-C 107.766 -2.133 . . . . 0.0 107.766 -179.032 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 10.7 mp -85.06 158.56 58.41 Favored Pre-proline 0 C--N 1.32 -0.679 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 -177.817 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -67.23 -15.58 46.41 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 117.184 -1.411 . . . . 0.0 111.79 176.214 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 9.2 m120 -72.91 1.9 7.86 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 123.53 0.732 . . . . 0.0 112.121 178.622 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 9.6 m-20 -81.43 11.01 4.85 Favored 'General case' 0 C--O 1.217 -0.609 0 C-N-CA 122.448 0.299 . . . . 0.0 110.321 177.774 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 58.8 p -120.75 114.87 22.26 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-O 122.272 1.034 . . . . 0.0 108.467 -177.973 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -143.26 155.06 44.4 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 114.227 -1.351 . . . . 0.0 110.017 -179.828 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -61.24 137.41 58.24 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 178.246 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 9.8 m95 -68.81 -27.01 65.47 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 113.151 0.797 . . . . 0.0 113.151 -179.851 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 54.5 m-85 -121.65 163.4 19.05 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 113.342 0.868 . . . . 0.0 113.342 -170.321 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 59.7 p -68.25 167.29 14.64 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 114.51 -1.223 . . . . 0.0 108.327 177.49 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -78.53 152.53 31.91 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 122.346 1.069 . . . . 0.0 112.803 -177.207 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.42 HD23 ' HA ' ' A' ' 16' ' ' LEU . 14.9 mt -91.98 142.26 27.73 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 102.383 -3.191 . . . . 0.0 102.383 167.527 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 33.1 m -124.71 140.01 53.33 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 -176.806 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.461 ' HB2' ' CZ ' ' A' ' 131' ' ' PHE . 4.9 tp60 -120.76 146.0 46.95 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 116.095 1.887 . . . . 0.0 116.095 -172.725 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 78.2 t60 -133.14 99.47 4.56 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 106.811 -1.551 . . . . 0.0 106.811 169.706 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 178.03 -164.58 33.51 Favored Glycine 0 C--O 1.227 -0.294 0 N-CA-C 109.008 -1.637 . . . . 0.0 109.008 -177.722 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -99.79 -25.0 14.51 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 177.905 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -77.52 152.39 34.12 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 114.279 -1.328 . . . . 0.0 109.617 -179.897 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -88.97 -62.44 1.48 Allowed 'General case' 0 C--O 1.212 -0.891 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 178.095 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 45.0 tp -174.93 141.29 0.59 Allowed 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 174.699 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 9.8 tmtt? -156.94 131.58 8.74 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 176.193 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -120.73 153.63 56.94 Favored Pre-proline 0 CA--C 1.543 0.69 0 N-CA-C 111.517 0.191 . . . . 0.0 111.517 177.171 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_endo -78.39 164.18 26.65 Favored 'Trans proline' 0 CA--C 1.542 0.91 0 C-N-CA 120.695 0.93 . . . . 0.0 112.965 176.571 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 1.6 tmt_? -70.75 139.15 51.01 Favored 'General case' 0 N--CA 1.475 0.786 0 O-C-N 122.261 -0.275 . . . . 0.0 110.424 -178.753 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 85.31 4.27 86.33 Favored Glycine 0 C--O 1.223 -0.551 0 N-CA-C 110.851 -0.9 . . . . 0.0 110.851 177.66 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 -147.16 -179.86 7.12 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 -174.257 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 97.48 -28.35 14.57 Favored Glycine 0 CA--C 1.499 -0.943 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.816 175.543 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 94.6 t -64.4 127.9 92.71 Favored Pre-proline 0 C--N 1.321 -0.642 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 177.1 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -73.76 170.72 19.37 Favored 'Trans proline' 0 N--CA 1.461 -0.431 0 O-C-N 122.236 0.598 . . . . 0.0 111.793 178.902 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 94.6 mt -68.07 112.7 3.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 178.784 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 80.5 m-20 -104.12 93.42 4.83 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 114.68 -1.145 . . . . 0.0 110.303 -176.855 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 67.4 p -69.39 -16.79 63.59 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.584 -0.734 . . . . 0.0 112.281 -179.032 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 10.9 p30 -106.92 22.76 15.46 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.057 -0.974 . . . . 0.0 113.227 -177.006 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 16.3 m -139.5 147.02 40.7 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 116.742 2.127 . . . . 0.0 116.742 -175.242 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 2.0 m -71.34 166.55 37.87 Favored Pre-proline 0 N--CA 1.468 0.431 0 CA-C-N 114.706 -1.133 . . . . 0.0 109.658 175.228 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -66.65 -27.97 44.89 Favored 'Trans proline' 0 CA--C 1.536 0.613 0 C-N-CA 114.238 -3.375 . . . . 0.0 113.922 -179.796 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.458 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 3.1 p-10 -75.28 -20.64 59.03 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.871 0.843 . . . . 0.0 110.944 178.057 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -83.49 -11.43 57.48 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 114.09 1.144 . . . . 0.0 114.09 -173.747 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 97.5 mm-40 -56.69 -29.79 62.75 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 115.512 1.671 . . . . 0.0 115.512 -177.03 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 12.0 tt -56.79 139.57 16.13 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.007 0 N-CA-C 114.385 1.254 . . . . 0.0 114.385 -176.948 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -177.31 -157.4 18.18 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.619 -0.8 . . . . 0.0 113.428 -178.413 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 41.4 p90 -154.66 170.53 21.33 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 179.766 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 23.5 m-85 -113.68 142.03 46.51 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 173.546 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 59.8 ttt180 -113.57 120.02 39.51 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 114.96 -1.018 . . . . 0.0 110.888 -175.455 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 3.6 ttt180 -63.06 140.95 58.93 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 123.184 0.594 . . . . 0.0 109.488 176.985 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -144.48 128.96 18.01 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.804 0.335 . . . . 0.0 110.173 177.442 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -158.79 134.17 8.58 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.129 178.574 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 18.5 tpt180 -145.94 123.74 11.94 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.479 0.657 . . . . 0.0 110.929 174.438 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 9.2 ttp180 -113.08 141.44 46.88 Favored 'General case' 0 CA--C 1.489 -1.394 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.423 178.495 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -131.56 177.77 6.53 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 N-CA-C 106.442 -1.688 . . . . 0.0 106.442 178.111 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 17.0 ttt85 -138.39 112.28 8.42 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 106.193 -1.781 . . . . 0.0 106.193 178.505 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -150.78 175.5 29.74 Favored Glycine 0 N--CA 1.444 -0.772 0 N-CA-C 107.145 -2.382 . . . . 0.0 107.145 178.395 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -75.25 -59.31 3.64 Favored Glycine 0 C--O 1.222 -0.624 0 N-CA-C 108.238 -1.945 . . . . 0.0 108.238 178.251 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.501 ' C ' ' H ' ' A' ' 60' ' ' LYS . 0.7 OUTLIER -94.26 -3.19 51.09 Favored 'General case' 0 C--O 1.217 -0.634 0 N-CA-C 105.207 -2.146 . . . . 0.0 105.207 174.266 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -89.53 33.89 4.21 Favored Glycine 0 N--CA 1.451 -0.314 0 N-CA-C 106.088 -2.805 . . . . 0.0 106.088 173.243 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.501 ' H ' ' C ' ' A' ' 58' ' ' ASP . 1.3 pttt -50.67 167.55 0.06 Allowed 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 113.415 -1.393 . . . . 0.0 111.028 172.268 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -46.69 129.59 11.31 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 113.926 -1.488 . . . . 0.0 113.698 -175.745 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -98.52 -73.99 0.6 Allowed 'General case' 0 C--O 1.219 -0.543 0 CA-C-N 113.666 -1.606 . . . . 0.0 114.044 -174.866 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 73.6 m-20 -95.06 96.66 9.4 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 179.349 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -74.58 -40.85 61.37 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 179.147 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 4.5 p -112.23 152.82 44.73 Favored Pre-proline 0 C--O 1.24 0.6 0 CA-C-N 114.962 -1.017 . . . . 0.0 108.985 179.723 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -74.34 156.68 45.96 Favored 'Trans proline' 0 C--O 1.238 0.497 0 C-N-CA 117.108 -1.461 . . . . 0.0 112.6 178.174 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 58.1 mtt-85 -124.58 149.87 46.55 Favored 'General case' 0 CA--C 1.513 -0.449 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.677 -179.657 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 35.0 m95 -134.75 129.82 35.24 Favored 'General case' 0 C--O 1.216 -0.662 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 175.565 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 60.0 m-85 -110.48 156.38 20.94 Favored 'General case' 0 C--O 1.212 -0.91 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 -178.96 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -97.97 136.91 37.57 Favored 'General case' 0 CA--C 1.509 -0.608 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 -179.84 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -139.12 130.31 26.73 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 107.097 -1.446 . . . . 0.0 107.097 -175.846 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 86.1 m-85 -70.69 159.47 34.4 Favored 'General case' 0 C--N 1.319 -0.756 0 O-C-N 122.191 -0.318 . . . . 0.0 111.063 -178.009 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -49.01 121.59 4.93 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 113.496 0.925 . . . . 0.0 113.496 -175.973 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 70.32 21.53 77.36 Favored Glycine 0 C--O 1.224 -0.529 0 N-CA-C 116.44 1.336 . . . . 0.0 116.44 176.009 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 34.2 p -89.37 146.38 24.72 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 118.604 1.202 . . . . 0.0 111.648 -179.742 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 108.68 144.53 10.93 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 108.296 -1.922 . . . . 0.0 108.296 -176.163 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -73.15 -34.51 6.14 Favored 'Trans proline' 0 CA--C 1.518 -0.307 0 CA-C-N 119.792 1.796 . . . . 0.0 115.164 -175.731 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -97.78 14.0 28.51 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 114.771 -1.104 . . . . 0.0 109.435 -177.216 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -54.17 -55.48 27.45 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 -171.03 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 54.66 33.86 55.44 Favored Glycine 0 C--O 1.226 -0.357 0 C-N-CA 121.194 -0.527 . . . . 0.0 113.044 178.898 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 14.7 mt -126.68 103.86 24.37 Favored Pre-proline 0 N--CA 1.444 -0.775 0 N-CA-C 115.412 1.634 . . . . 0.0 115.412 -174.225 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -77.62 161.77 30.72 Favored 'Trans proline' 0 N--CA 1.461 -0.401 0 C-N-CA 122.061 1.84 . . . . 0.0 107.404 168.501 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 57.6 t80 -61.12 131.86 51.87 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 120.379 -0.529 . . . . 0.0 110.395 -177.177 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 92.98 -11.97 70.94 Favored Glycine 0 C--O 1.225 -0.432 0 CA-C-O 119.399 -0.667 . . . . 0.0 114.41 179.409 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -65.1 130.37 43.09 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 118.497 1.149 . . . . 0.0 112.071 -179.51 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 30.9 m120 -77.72 132.64 38.24 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 114.563 -1.199 . . . . 0.0 110.146 179.724 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 30.6 ttmt -156.21 155.35 32.26 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 104.148 -2.538 . . . . 0.0 104.148 177.795 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -65.75 133.22 50.57 Favored 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 120.273 -0.571 . . . . 0.0 109.672 -179.03 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 69.06 28.53 72.85 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.772 -0.728 . . . . 0.0 114.794 177.572 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 46.4 mm -126.01 126.6 70.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 117.476 0.638 . . . . 0.0 110.548 179.725 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -129.24 123.11 57.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.565 177.023 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 96.9 m95 -87.78 138.7 31.23 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 -176.758 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 13.7 m -138.02 151.49 25.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 179.102 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -160.29 165.86 30.57 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 104.833 -2.284 . . . . 0.0 104.833 -179.973 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 14.1 t -127.09 170.78 11.99 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 105.237 -2.135 . . . . 0.0 105.237 178.479 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -66.07 133.55 50.99 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.088 0.471 . . . . 0.0 110.651 -178.635 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 92.69 -7.5 77.21 Favored Glycine 0 N--CA 1.459 0.172 0 CA-C-N 116.017 -0.538 . . . . 0.0 113.422 178.749 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.458 ' HA ' ' HA ' ' A' ' 41' ' ' ASP . . . -74.63 140.49 44.33 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 178.504 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 39.6 mt -99.27 138.03 36.95 Favored 'General case' 0 CA--C 1.515 -0.385 0 N-CA-C 113.398 0.888 . . . . 0.0 113.398 -177.763 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -81.4 66.55 6.99 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.438 -178.751 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 1.2 t -133.11 155.36 81.1 Favored Pre-proline 0 C--N 1.32 -0.697 0 N-CA-C 105.327 -2.101 . . . . 0.0 105.327 -179.5 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -61.17 147.82 94.57 Favored 'Trans proline' 0 C--N 1.343 0.253 0 N-CA-C 114.614 0.967 . . . . 0.0 114.614 -179.603 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.522 ' HB3' HD12 ' A' ' 106' ' ' ILE . 74.1 mmtt -121.39 38.17 4.16 Favored 'General case' 0 CA--C 1.508 -0.643 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.332 -179.402 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 16.7 p-10 -59.9 -33.62 72.1 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 176.514 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 7.9 p80 -62.79 -16.19 56.94 Favored 'General case' 0 C--O 1.221 -0.411 0 N-CA-C 113.158 0.799 . . . . 0.0 113.158 177.973 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.522 HD12 ' HB3' ' A' ' 103' ' ' LYS . 60.2 mt -95.93 -49.96 11.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 120.977 0.418 . . . . 0.0 110.896 178.281 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -71.02 14.19 1.63 Allowed Glycine 0 C--O 1.22 -0.741 0 N-CA-C 117.53 1.772 . . . . 0.0 117.53 -174.124 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 9.0 t -83.59 26.43 0.68 Allowed 'General case' 0 CA--C 1.551 0.988 0 CA-C-O 121.671 0.748 . . . . 0.0 111.744 -179.31 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 64.8 ttp85 -68.32 119.43 12.84 Favored 'General case' 0 N--CA 1.465 0.325 0 O-C-N 121.271 -0.893 . . . . 0.0 109.978 178.66 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -86.54 122.17 71.95 Favored Pre-proline 0 C--N 1.323 -0.569 0 N-CA-C 105.103 -2.184 . . . . 0.0 105.103 176.571 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -72.78 -15.43 26.79 Favored 'Trans proline' 0 C--O 1.218 -0.494 0 C-N-CA 116.907 -1.595 . . . . 0.0 114.374 -177.174 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -81.57 -24.56 36.43 Favored 'General case' 0 C--O 1.221 -0.422 0 CA-C-O 120.963 0.411 . . . . 0.0 110.479 178.745 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 -100.15 -22.98 14.97 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 -174.504 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 18.2 t-20 -145.72 148.69 33.28 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -178.314 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -86.37 148.44 25.58 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-O 121.654 0.74 . . . . 0.0 112.536 -179.776 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -73.74 151.02 40.79 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.635 178.132 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 14.2 mt -90.73 139.62 17.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.565 -178.738 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 73.1 t -62.83 121.82 12.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 174.588 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 5.2 tt -67.18 129.45 39.95 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.189 0.519 . . . . 0.0 111.088 -176.923 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 34.5 mt-30 -135.88 158.41 44.47 Favored 'General case' 0 C--O 1.218 -0.562 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 -179.226 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 13.4 mt -112.18 148.0 38.16 Favored Pre-proline 0 C--N 1.322 -0.598 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 177.577 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -73.59 163.02 38.52 Favored 'Trans proline' 0 C--O 1.237 0.457 0 O-C-N 122.195 0.576 . . . . 0.0 112.546 179.179 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 53.9 tt0 -55.24 132.0 46.74 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 179.508 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 106.57 -27.06 17.9 Favored Glycine 0 C--O 1.226 -0.37 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.983 -178.515 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 8.9 m -105.44 129.33 53.77 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 118.04 0.92 . . . . 0.0 111.198 178.395 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 3.0 p -115.65 148.21 39.94 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.15 178.44 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 86.2 mt -71.4 152.94 94.09 Favored Pre-proline 0 C--N 1.323 -0.587 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 177.647 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -76.53 175.02 11.89 Favored 'Trans proline' 0 CA--C 1.531 0.325 0 N-CA-C 110.615 -0.571 . . . . 0.0 110.615 178.529 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 12.0 tmtt? -53.49 128.65 29.66 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 -175.571 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 88.43 -3.54 85.29 Favored Glycine 0 C--O 1.23 -0.151 0 N-CA-C 116.74 1.456 . . . . 0.0 116.74 173.497 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.461 ' CZ ' ' HB2' ' A' ' 18' ' ' GLN . 1.8 m-85 -93.18 144.09 25.62 Favored 'General case' 0 N--CA 1.433 -1.316 0 CA-C-O 122.718 1.247 . . . . 0.0 112.072 -178.464 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 34.6 p90 -144.52 164.47 30.79 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-N 112.636 -2.074 . . . . 0.0 106.773 174.193 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -106.35 147.06 29.65 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.243 0.545 . . . . 0.0 110.736 -177.381 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -75.8 129.91 37.77 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 -179.59 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 87.63 -0.32 84.78 Favored Glycine 0 C--O 1.225 -0.464 0 C-N-CA 121.161 -0.542 . . . . 0.0 112.55 -178.093 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 24.9 t -117.77 145.61 44.38 Favored 'General case' 0 C--N 1.327 -0.386 0 O-C-N 122.433 -0.451 . . . . 0.0 110.106 178.491 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 9.9 tpt180 52.15 36.17 18.46 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 113.478 0.918 . . . . 0.0 113.478 178.639 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -155.66 166.81 32.96 Favored Glycine 0 N--CA 1.449 -0.483 0 N-CA-C 104.56 -3.416 . . . . 0.0 104.56 177.699 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 82.54 -156.46 35.12 Favored Glycine 0 CA--C 1.517 0.189 0 N-CA-C 109.022 -1.631 . . . . 0.0 109.022 -176.918 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 41.2 t . . . . . 0 C--O 1.251 1.139 0 N-CA-C 105.394 -2.076 . . . . 0.0 105.394 179.509 . . . . . . . . 0 0 . 1 . 039 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.664 0 CA-C-O 118.658 -1.079 . . . . 0.0 111.231 . . . . . . . . . 0 0 . 1 . 039 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -70.28 141.0 52.45 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 117.992 0.896 . . . . 0.0 109.58 179.888 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 21.5 ptp -165.91 33.55 0.05 Allowed 'General case' 0 N--CA 1.474 0.768 0 CA-C-O 121.866 0.841 . . . . 0.0 109.024 -179.258 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -106.29 80.2 0.28 Allowed Glycine 0 N--CA 1.449 -0.459 0 N-CA-C 111.007 -0.837 . . . . 0.0 111.007 -174.651 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 94.0 mt -59.09 140.35 87.31 Favored Pre-proline 0 C--N 1.322 -0.621 0 N-CA-C 106.88 -1.526 . . . . 0.0 106.88 176.13 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -74.28 -21.79 17.22 Favored 'Trans proline' 0 C--N 1.345 0.379 0 N-CA-C 116.079 1.53 . . . . 0.0 116.079 -172.488 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -168.74 -55.34 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.305 0.574 . . . . 0.0 110.707 -178.397 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 11.0 t30 -144.74 -69.04 0.3 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.421 -177.392 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.2 p 41.65 77.15 0.06 Allowed 'General case' 0 N--CA 1.477 0.917 0 CA-C-O 122.006 0.908 . . . . 0.0 112.996 -178.133 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -103.67 143.7 32.42 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.17 -0.923 . . . . 0.0 113.379 -173.138 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 28.4 t -58.88 134.97 57.39 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 114.548 -1.205 . . . . 0.0 108.63 174.591 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 3.1 m95 -67.55 -26.87 66.52 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 178.058 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -121.73 161.34 22.75 Favored 'General case' 0 CA--C 1.507 -0.676 0 CA-C-O 121.192 0.52 . . . . 0.0 110.312 -171.375 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 64.8 p -67.33 161.26 25.46 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 122.195 0.997 . . . . 0.0 109.561 179.622 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -92.14 120.71 33.0 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 114.686 -1.143 . . . . 0.0 112.474 -174.156 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -68.59 148.81 49.96 Favored 'General case' 0 CA--C 1.505 -0.768 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 179.96 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.487 HG23 HH22 ' A' ' 53' ' ' ARG . 17.4 m -93.26 136.62 33.35 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 176.947 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 20.0 tm0? -107.28 117.5 34.24 Favored 'General case' 0 CA--C 1.509 -0.621 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 177.144 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 22.7 t-160 -139.32 99.88 3.85 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 172.728 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 173.53 -166.12 38.33 Favored Glycine 0 C--N 1.319 -0.407 0 N-CA-C 110.521 -1.032 . . . . 0.0 110.521 -178.977 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 89.0 mttt -92.53 -24.8 18.64 Favored 'General case' 0 CA--C 1.512 -0.516 0 CA-C-O 121.993 0.901 . . . . 0.0 109.635 179.449 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -90.6 152.11 21.02 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 114.175 -1.375 . . . . 0.0 108.384 179.311 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -87.57 -62.4 1.51 Allowed 'General case' 0 C--O 1.21 -0.977 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.062 -177.421 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 49.6 tp 172.34 141.71 0.03 OUTLIER 'General case' 0 CA--C 1.506 -0.75 0 N-CA-C 104.572 -2.381 . . . . 0.0 104.572 176.824 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 23.3 tptt -161.94 143.38 10.99 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 106.606 -1.627 . . . . 0.0 106.606 178.185 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 16.6 m-85 -132.62 150.0 74.6 Favored Pre-proline 0 C--N 1.323 -0.558 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 177.398 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -76.56 166.87 26.56 Favored 'Trans proline' 0 C--N 1.351 0.702 0 C-N-CA 120.159 0.573 . . . . 0.0 113.402 179.593 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 21.3 tpt180 -64.14 136.11 56.95 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.587 -178.647 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 86.32 -1.91 87.48 Favored Glycine 0 N--CA 1.46 0.24 0 CA-C-O 121.395 0.442 . . . . 0.0 112.145 177.751 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 54.9 mt-30 -138.67 170.52 15.86 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 123.408 0.683 . . . . 0.0 110.433 -174.144 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 107.06 -26.82 17.88 Favored Glycine 0 CA--C 1.496 -1.103 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.67 175.249 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 85.1 t -65.27 125.49 89.51 Favored Pre-proline 0 C--N 1.32 -0.699 0 N-CA-C 105.498 -2.038 . . . . 0.0 105.498 176.372 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -71.6 164.52 35.44 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 N-CA-C 110.579 -0.585 . . . . 0.0 110.579 178.422 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 84.8 mt -61.99 115.0 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 -177.237 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -116.98 74.84 0.93 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 122.667 1.223 . . . . 0.0 112.307 -170.377 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 72.7 p -69.73 -19.51 63.54 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 114.371 -1.286 . . . . 0.0 113.506 -175.53 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 23.6 m120 -106.38 29.04 7.19 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.644 -0.707 . . . . 0.0 112.165 -174.195 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 97.8 p -146.46 160.73 41.72 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.919 0.39 . . . . 0.0 111.032 179.786 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.3 m -71.67 163.83 63.14 Favored Pre-proline 0 C--N 1.323 -0.546 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.67 -178.313 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -67.34 -28.39 39.56 Favored 'Trans proline' 0 C--N 1.351 0.658 0 C-N-CA 115.167 -2.755 . . . . 0.0 113.669 179.041 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.448 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 1.6 p-10 -75.13 -19.84 59.71 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 121.525 -0.734 . . . . 0.0 110.518 176.714 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.416 ' CG ' HD11 ' A' ' 106' ' ' ILE . 34.6 m-20 -84.45 -6.9 59.42 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 113.955 1.094 . . . . 0.0 113.955 -173.335 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 97.6 mm-40 -57.54 -32.53 67.17 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 114.144 1.165 . . . . 0.0 114.144 -179.113 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.488 ' HB ' ' HB1' ' A' ' 98' ' ' ALA . 10.4 tt -58.43 139.24 18.38 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 CA-C-O 122.382 1.087 . . . . 0.0 113.49 -176.904 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -176.26 -159.65 22.26 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.277 -0.964 . . . . 0.0 112.899 -178.166 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 38.3 p90 -154.82 166.6 32.97 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 179.511 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 13.3 m-85 -109.27 142.9 39.46 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 174.472 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 62.9 ttt180 -116.15 125.45 52.34 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 123.182 0.593 . . . . 0.0 111.044 -176.89 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 47.8 ttp180 -74.06 134.19 42.95 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 109.592 -0.522 . . . . 0.0 109.592 177.329 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -152.0 170.0 20.95 Favored 'General case' 0 C--O 1.213 -0.846 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 -179.072 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 8.9 t -136.82 142.41 42.89 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 119.161 0.891 . . . . 0.0 110.574 172.106 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 14.7 tpt180 -166.79 128.66 1.73 Allowed 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 179.226 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.487 HH22 HG23 ' A' ' 17' ' ' THR . 21.9 mmt180 -147.63 -179.42 6.86 Favored 'General case' 0 CA--C 1.48 -1.72 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 -179.01 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -117.25 170.92 6.19 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.97 0 CA-C-N 113.686 -1.597 . . . . 0.0 107.043 -177.105 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 8.7 ttm-85 -143.44 129.69 19.83 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 175.886 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -82.01 178.99 53.45 Favored Glycine 0 C--O 1.221 -0.703 0 N-CA-C 109.882 -1.287 . . . . 0.0 109.882 178.583 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -67.59 -36.34 87.89 Favored Glycine 0 C--O 1.217 -0.951 0 C-N-CA 121.008 -0.615 . . . . 0.0 114.116 -176.425 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -80.3 -16.59 54.28 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 122.143 0.973 . . . . 0.0 109.054 178.787 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 114.37 -6.37 23.03 Favored Glycine 0 N--CA 1.452 -0.293 0 CA-C-N 114.496 -1.229 . . . . 0.0 114.584 179.587 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.429 ' H ' ' HD2' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -61.33 150.47 34.91 Favored 'General case' 0 CA--C 1.506 -0.725 0 CA-C-N 118.334 1.067 . . . . 0.0 111.242 -178.404 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 89.7 mtp -126.88 164.2 21.94 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 113.978 -1.464 . . . . 0.0 112.249 -176.647 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 2.0 tppt? -77.87 -37.43 48.2 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.298 -179.031 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 60.2 t0 -175.53 167.1 3.27 Favored 'General case' 0 C--N 1.318 -0.778 1 N-CA-C 99.283 -4.34 . . . . 0.0 99.283 -177.242 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -109.95 -31.83 7.25 Favored 'General case' 0 N--CA 1.435 -1.205 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 176.72 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.5 m -55.91 156.55 9.64 Favored Pre-proline 0 C--O 1.245 0.853 0 N-CA-C 116.342 1.979 . . . . 0.0 116.342 -174.949 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -75.62 -176.68 3.1 Favored 'Trans proline' 0 C--N 1.354 0.822 0 C-N-CA 121.039 1.16 . . . . 0.0 114.276 -179.275 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 81.0 mtt-85 -133.75 166.36 22.83 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.488 -177.836 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 50.9 m95 -125.39 131.72 52.9 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 173.751 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 24.1 m-85 -110.55 166.86 10.66 Favored 'General case' 0 C--O 1.216 -0.683 0 N-CA-C 105.45 -2.055 . . . . 0.0 105.45 -177.595 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 93.4 t80 -117.92 134.91 54.49 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-N 119.287 0.948 . . . . 0.0 109.721 -178.949 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 16.7 m-85 -136.36 158.88 43.38 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 -177.316 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 63.3 m-85 -98.63 159.34 15.02 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 -174.794 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -53.83 127.71 27.06 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.986 0.422 . . . . 0.0 111.039 -178.167 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 68.17 31.78 75.29 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.439 -0.886 . . . . 0.0 114.84 176.76 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.478 HG22 ' HA ' ' A' ' 104' ' ' ASP . 2.3 p -89.39 146.28 24.77 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 105.181 -2.155 . . . . 0.0 105.181 174.16 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 83.96 130.87 1.93 Allowed Glycine 0 CA--C 1.532 1.145 0 C-N-CA 121.462 -0.399 . . . . 0.0 112.294 -178.316 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -75.42 -27.88 8.98 Favored 'Trans proline' 0 CA--C 1.512 -0.613 0 CA-C-N 119.182 1.491 . . . . 0.0 115.317 -177.33 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -97.02 5.83 49.71 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 113.592 -1.64 . . . . 0.0 108.08 -174.88 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -60.6 -42.6 97.08 Favored 'General case' 0 N--CA 1.436 -1.125 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.976 -172.866 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 56.68 37.47 76.79 Favored Glycine 0 C--N 1.331 0.275 0 CA-C-N 115.67 -0.695 . . . . 0.0 112.241 179.165 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 13.2 mt -129.06 103.87 18.42 Favored Pre-proline 0 N--CA 1.44 -0.972 0 N-CA-C 115.039 1.496 . . . . 0.0 115.039 -176.073 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -78.4 161.61 28.45 Favored 'Trans proline' 0 N--CA 1.461 -0.424 0 C-N-CA 122.226 1.951 . . . . 0.0 107.304 167.772 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 57.7 t80 -61.11 130.66 47.44 Favored 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 120.315 -0.554 . . . . 0.0 110.44 -177.576 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 93.27 -8.51 75.32 Favored Glycine 0 CA--C 1.52 0.351 0 CA-C-O 119.35 -0.694 . . . . 0.0 114.352 178.956 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -67.12 131.73 46.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 118.607 1.203 . . . . 0.0 111.247 179.754 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 57.0 t30 -78.93 132.13 36.62 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.734 -0.667 . . . . 0.0 110.167 179.895 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 29.0 ttmt -155.97 154.38 31.02 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 106.146 -1.798 . . . . 0.0 106.146 179.28 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -61.4 129.32 40.64 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.081 0.467 . . . . 0.0 111.136 -178.648 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 67.86 30.08 74.11 Favored Glycine 0 N--CA 1.449 -0.474 0 CA-C-O 119.175 -0.792 . . . . 0.0 114.185 177.624 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 43.3 mm -126.04 131.86 71.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 117.845 0.822 . . . . 0.0 111.286 179.632 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -134.93 122.64 38.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.776 175.636 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 95.8 m95 -87.18 137.97 31.89 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 113.167 0.803 . . . . 0.0 113.167 -176.913 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 17.7 m -137.48 150.67 25.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.607 179.326 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -160.39 166.03 30.06 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 105.03 -2.211 . . . . 0.0 105.03 179.907 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 7.1 t -134.41 176.63 8.43 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 105.305 -2.109 . . . . 0.0 105.305 177.849 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -67.56 135.24 52.64 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.302 0.572 . . . . 0.0 110.702 -178.473 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 96.57 -12.7 66.1 Favored Glycine 0 C--O 1.228 -0.269 0 CA-C-N 115.703 -0.68 . . . . 0.0 112.911 178.341 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.488 ' HB1' ' HB ' ' A' ' 44' ' ' ILE . . . -77.16 137.09 38.67 Favored 'General case' 0 CA--C 1.543 0.676 0 O-C-N 122.694 -0.297 . . . . 0.0 110.622 179.982 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 40.6 mt -98.78 138.55 35.76 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 -177.884 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -80.11 63.8 4.73 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.165 -179.023 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 1.4 t -132.27 154.96 81.8 Favored Pre-proline 0 C--N 1.323 -0.581 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 -179.399 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -66.52 148.23 83.38 Favored 'Trans proline' 0 CA--C 1.53 0.319 0 N-CA-C 114.48 0.915 . . . . 0.0 114.48 175.974 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -148.83 57.9 1.04 Allowed 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 113.571 0.952 . . . . 0.0 113.571 179.212 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 104' ' ' ASP . . . . . 0.478 ' HA ' HG22 ' A' ' 75' ' ' THR . 12.5 t0 -64.56 -11.34 33.51 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 121.28 0.562 . . . . 0.0 110.658 175.782 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 12.5 p-80 -62.45 -13.42 29.88 Favored 'General case' 0 N--CA 1.468 0.473 0 O-C-N 122.038 -0.414 . . . . 0.0 111.679 177.412 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.416 HD11 ' CG ' ' A' ' 42' ' ' ASP . 20.6 mt -96.09 -28.75 3.91 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 CA-C-O 120.819 0.342 . . . . 0.0 111.023 179.079 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -73.46 3.74 31.05 Favored Glycine 0 N--CA 1.462 0.387 0 N-CA-C 115.09 0.796 . . . . 0.0 115.09 -176.117 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 14.4 t -83.22 19.03 1.56 Allowed 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 113.515 0.931 . . . . 0.0 113.515 -177.694 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 67.1 ttp85 -64.39 114.95 4.63 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 177.664 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 58.8 m-20 -91.12 121.36 67.93 Favored Pre-proline 0 C--N 1.318 -0.78 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 -178.596 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -68.93 -18.74 40.85 Favored 'Trans proline' 0 C--N 1.347 0.493 0 N-CA-C 114.343 0.863 . . . . 0.0 114.343 -176.176 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -73.77 -26.01 60.43 Favored 'General case' 0 C--O 1.22 -0.469 0 CA-C-O 120.734 0.302 . . . . 0.0 110.548 177.365 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 76.5 m-20 -103.49 -27.1 12.58 Favored 'General case' 0 C--O 1.222 -0.361 0 N-CA-C 113.421 0.897 . . . . 0.0 113.421 -174.95 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 18.6 t-20 -147.35 145.04 29.17 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.818 0.673 . . . . 0.0 112.818 -178.751 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -83.19 146.16 28.76 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-O 121.517 0.675 . . . . 0.0 111.911 -179.79 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -70.38 144.13 51.69 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 177.325 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 12.0 mt -76.9 135.63 26.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 -178.406 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 72.9 t -63.75 118.33 5.8 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 N-CA-C 103.633 -2.729 . . . . 0.0 103.633 172.859 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 6.8 tt -63.18 130.99 46.96 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.38 0.609 . . . . 0.0 112.072 -174.061 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 30.8 mt-30 -130.58 150.46 51.77 Favored 'General case' 0 CA--C 1.508 -0.671 0 N-CA-C 106.084 -1.821 . . . . 0.0 106.084 179.089 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 12.5 mt -110.37 148.3 38.13 Favored Pre-proline 0 C--N 1.319 -0.76 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 177.773 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -73.71 166.07 30.69 Favored 'Trans proline' 0 C--O 1.236 0.416 0 C-N-CA 118.239 -0.707 . . . . 0.0 112.659 -179.605 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 40.5 tt0 -54.04 131.88 41.52 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.073 179.425 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 104.1 -27.35 19.77 Favored Glycine 0 C--O 1.226 -0.356 0 CA-C-N 115.91 -0.587 . . . . 0.0 112.288 -178.598 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 2.7 m -105.98 129.34 54.12 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 118.207 1.004 . . . . 0.0 112.205 178.759 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 9.4 p -119.8 148.24 43.68 Favored 'General case' 0 CA--C 1.509 -0.607 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.899 178.423 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 93.1 mt -68.07 154.31 94.06 Favored Pre-proline 0 C--N 1.323 -0.571 0 N-CA-C 106.935 -1.506 . . . . 0.0 106.935 177.2 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -76.77 177.6 8.65 Favored 'Trans proline' 0 N--CA 1.464 -0.214 0 CA-C-O 121.446 0.519 . . . . 0.0 112.442 -178.795 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 3.0 ttpm? -59.77 130.65 47.85 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.118 -0.492 . . . . 0.0 109.701 179.072 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 84.26 23.21 52.36 Favored Glycine 0 N--CA 1.454 -0.138 0 N-CA-C 115.44 0.936 . . . . 0.0 115.44 176.876 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -124.73 141.72 51.91 Favored 'General case' 0 CA--C 1.51 -0.568 0 CA-C-O 121.426 0.631 . . . . 0.0 112.152 179.382 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 45.4 p90 -145.6 153.21 40.81 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 107.259 -1.386 . . . . 0.0 107.259 172.584 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -89.18 139.21 30.71 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.186 0.517 . . . . 0.0 111.025 -177.577 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -71.38 137.87 48.72 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 176.325 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 89.34 -2.34 83.15 Favored Glycine 0 C--O 1.224 -0.53 0 N-CA-C 111.653 -0.579 . . . . 0.0 111.653 -178.215 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 9.6 t -114.25 171.89 7.34 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 177.46 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 7.8 tpt180 51.69 58.0 5.95 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 121.993 0.901 . . . . 0.0 112.871 -178.395 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -89.98 -147.06 16.34 Favored Glycine 0 N--CA 1.452 -0.245 0 N-CA-C 108.51 -1.836 . . . . 0.0 108.51 175.731 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -101.57 155.16 18.93 Favored Glycine 0 N--CA 1.453 -0.214 0 N-CA-C 107.34 -2.304 . . . . 0.0 107.34 176.71 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 11.3 t . . . . . 0 C--O 1.252 1.208 0 CA-C-O 117.146 -1.407 . . . . 0.0 110.419 -177.477 . . . . . . . . 0 0 . 1 . 040 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.224 0 CA-C-O 119.128 -0.818 . . . . 0.0 111.379 . . . . . . . . . 0 0 . 1 . 040 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 51.93 42.43 30.2 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 117.51 0.655 . . . . 0.0 112.762 178.866 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 33.2 tpp -78.29 55.95 1.63 Allowed 'General case' 0 CA--C 1.544 0.715 0 CA-C-O 122.034 0.921 . . . . 0.0 112.423 -178.274 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -95.49 -22.32 22.04 Favored Glycine 0 C--O 1.229 -0.167 0 N-CA-C 109.322 -1.511 . . . . 0.0 109.322 176.363 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -72.9 153.4 91.07 Favored Pre-proline 0 C--N 1.322 -0.608 0 CA-C-N 114.224 -0.988 . . . . 0.0 108.823 179.935 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -69.08 145.07 59.9 Favored 'Trans proline' 0 C--N 1.345 0.395 0 C-N-CA 115.966 -2.223 . . . . 0.0 110.884 176.786 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 26.0 p30 -86.44 -13.27 46.7 Favored 'General case' 0 C--O 1.218 -0.553 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -178.323 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 36.4 t30 60.28 42.99 14.24 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.193 0.997 . . . . 0.0 112.538 178.957 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 58.6 p -137.68 152.89 49.76 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 102.718 -3.068 . . . . 0.0 102.718 179.991 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -148.78 142.82 25.89 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.476 177.227 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 46.6 t -64.01 141.83 58.63 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 177.973 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 17.8 m95 -68.44 -21.72 64.63 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 111.944 0.35 . . . . 0.0 111.944 178.284 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 64.8 m-85 -121.53 164.38 17.32 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 -172.366 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 73.8 p -70.01 161.53 29.9 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 178.97 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.452 ' HB2' ' CZ ' ' A' ' 69' ' ' TYR . . . -76.22 149.74 37.18 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 113.743 1.016 . . . . 0.0 113.743 -175.425 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 13.9 mt -91.99 148.87 21.87 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 103.818 -2.66 . . . . 0.0 103.818 170.425 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 19.6 m -122.33 137.63 54.79 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 -179.186 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.435 ' HB2' ' CZ ' ' A' ' 131' ' ' PHE . 4.4 tp60 -112.05 133.11 54.41 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 -177.669 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 8.7 t60 -126.9 99.43 5.73 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 105.178 -2.156 . . . . 0.0 105.178 171.18 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 175.25 -172.77 45.78 Favored Glycine 0 C--O 1.227 -0.286 0 N-CA-C 110.212 -1.155 . . . . 0.0 110.212 -177.626 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -99.21 -27.29 13.87 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 121.048 0.451 . . . . 0.0 111.27 179.496 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -80.93 166.7 20.62 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 107.038 -1.467 . . . . 0.0 107.038 177.06 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -94.48 -62.78 1.27 Allowed 'General case' 0 CA--C 1.548 0.888 0 CA-C-O 118.443 -0.789 . . . . 0.0 112.156 -176.662 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.426 HD13 ' CZ ' ' A' ' 131' ' ' PHE . 33.7 tp -175.08 140.95 0.54 Allowed 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 124.044 0.938 . . . . 0.0 109.413 172.821 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 50.2 tptt -151.77 138.85 19.14 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 172.67 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -122.25 153.71 61.78 Favored Pre-proline 0 C--O 1.242 0.671 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 176.533 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -70.33 158.15 57.1 Favored 'Trans proline' 0 C--N 1.353 0.795 0 O-C-N 122.079 0.515 . . . . 0.0 112.727 179.458 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 70.9 ttt180 -70.16 134.36 48.05 Favored 'General case' 0 C--O 1.216 -0.688 0 O-C-N 121.848 -0.533 . . . . 0.0 111.072 -177.725 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 90.13 1.16 76.25 Favored Glycine 0 N--CA 1.462 0.409 0 CA-C-O 121.649 0.583 . . . . 0.0 112.035 179.262 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -146.77 170.45 16.97 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 107.497 -1.298 . . . . 0.0 107.497 -176.941 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 127.09 -28.39 4.6 Favored Glycine 0 CA--C 1.483 -1.948 0 N-CA-C 108.46 -1.856 . . . . 0.0 108.46 165.79 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 32.8 m -67.72 140.69 94.45 Favored Pre-proline 0 N--CA 1.429 -1.477 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 177.462 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -74.37 173.93 13.39 Favored 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 121.226 1.284 . . . . 0.0 111.91 178.918 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 92.7 mt -73.72 115.03 14.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 N-CA-C 107.494 -1.298 . . . . 0.0 107.494 177.823 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 31.6 m-20 -111.79 80.33 1.31 Allowed 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.423 -177.791 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 81.2 p -67.76 -16.2 64.01 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 113.835 1.05 . . . . 0.0 113.835 -176.877 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -106.83 21.31 17.72 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.375 -177.15 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 5.3 m -134.97 157.79 45.99 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.78 0.324 . . . . 0.0 111.483 -176.47 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 20.0 m -72.85 161.36 79.74 Favored Pre-proline 0 C--N 1.323 -0.549 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 178.615 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -65.19 -26.62 56.96 Favored 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 114.93 -2.913 . . . . 0.0 110.49 176.021 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -61.75 -19.32 62.32 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 124.578 1.151 . . . . 0.0 111.652 175.713 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -107.92 1.0 22.34 Favored 'General case' 0 C--O 1.217 -0.618 0 N-CA-C 115.027 1.491 . . . . 0.0 115.027 -172.617 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 85.7 mm-40 -61.45 -27.57 68.66 Favored 'General case' 0 C--O 1.216 -0.694 0 O-C-N 121.045 -1.034 . . . . 0.0 111.068 178.995 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 13.0 tt -60.35 144.05 13.65 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 N-CA-C 113.797 1.036 . . . . 0.0 113.797 179.209 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 178.85 -152.57 11.41 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.527 -0.844 . . . . 0.0 111.21 178.543 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 47.1 p90 -155.08 168.88 25.54 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 177.22 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 25.4 m-85 -113.34 141.07 47.48 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 106.648 -1.612 . . . . 0.0 106.648 174.071 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 38.6 ttt180 -111.05 127.6 55.6 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.37 -178.695 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 28.4 ttm180 -68.04 134.54 50.81 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 106.353 -1.721 . . . . 0.0 106.353 176.602 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -139.57 127.89 22.7 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 -176.734 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 6.8 p -139.62 131.95 28.37 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 174.773 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 11.2 tpt180 -160.73 123.83 3.34 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 178.621 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 2.5 tpp180 -97.17 137.42 36.23 Favored 'General case' 0 CA--C 1.501 -0.935 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 179.801 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -124.87 171.44 13.73 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 -179.201 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 8.1 tmm_? -134.66 114.03 12.32 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 106.324 -1.732 . . . . 0.0 106.324 177.745 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -74.5 165.07 54.75 Favored Glycine 0 N--CA 1.449 -0.497 0 N-CA-C 110.733 -0.947 . . . . 0.0 110.733 179.489 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -75.3 -27.42 63.84 Favored Glycine 0 C--O 1.217 -0.954 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 -179.562 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -89.77 14.61 11.45 Favored 'General case' 0 C--O 1.219 -0.523 0 CA-C-O 122.256 1.027 . . . . 0.0 109.706 179.077 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 86.21 -12.81 59.39 Favored Glycine 0 C--O 1.227 -0.288 0 N-CA-C 115.897 1.119 . . . . 0.0 115.897 173.706 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -64.5 130.49 43.9 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.699 0.762 . . . . 0.0 111.614 -178.609 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 94.8 mmm -91.86 -170.65 2.62 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 114.527 -1.215 . . . . 0.0 110.399 -178.489 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 18.4 tptp -92.79 -53.95 3.96 Favored 'General case' 0 CA--C 1.515 -0.395 0 N-CA-C 114.085 1.142 . . . . 0.0 114.085 179.436 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 38.45 -140.78 0.04 OUTLIER 'General case' 0 C--O 1.245 0.861 0 O-C-N 125.135 1.522 . . . . 0.0 113.025 -175.571 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 61.29 170.8 0.11 Allowed 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.694 1.198 . . . . 0.0 113.999 -176.232 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -74.69 165.35 54.46 Favored Pre-proline 0 C--O 1.24 0.589 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.71 -179.655 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -66.18 152.16 81.84 Favored 'Trans proline' 0 C--N 1.355 0.87 0 C-N-CA 117.818 -0.988 . . . . 0.0 112.053 178.67 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 30.7 mtt180 -124.02 166.3 15.97 Favored 'General case' 0 CA--C 1.51 -0.57 0 N-CA-C 114.779 1.4 . . . . 0.0 114.779 -175.958 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 67.4 m95 -130.43 146.84 52.06 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 177.922 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.452 ' CZ ' ' HB2' ' A' ' 15' ' ' ALA . 25.5 m-85 -130.64 144.11 51.2 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 -178.799 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 77.4 t80 -89.91 136.42 33.05 Favored 'General case' 0 CA--C 1.512 -0.485 0 N-CA-C 109.001 -0.741 . . . . 0.0 109.001 -177.218 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -139.64 143.23 37.09 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 108.812 -0.811 . . . . 0.0 108.812 -176.333 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -74.23 159.43 32.51 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.67 -175.993 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.1 tt -55.89 129.54 40.0 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 -176.137 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 69.0 34.54 76.79 Favored Glycine 0 C--O 1.222 -0.649 0 N-CA-C 115.487 0.955 . . . . 0.0 115.487 175.498 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -89.11 145.99 25.1 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 118.28 1.04 . . . . 0.0 111.334 -179.989 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 105.2 142.25 11.19 Favored Glycine 0 CA--C 1.529 0.909 0 N-CA-C 111.046 -0.822 . . . . 0.0 111.046 -177.905 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -66.01 -44.07 8.08 Favored 'Trans proline' 0 C--N 1.35 0.64 0 N-CA-C 116.928 1.857 . . . . 0.0 116.928 -173.31 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 -109.2 27.29 9.68 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.674 0.749 . . . . 0.0 109.232 -178.846 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -58.88 -48.35 81.7 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.381 -176.685 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 57.48 32.23 64.26 Favored Glycine 0 C--O 1.225 -0.438 0 O-C-N 123.71 0.631 . . . . 0.0 112.012 -179.447 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 20.2 mt -111.57 103.88 55.53 Favored Pre-proline 0 N--CA 1.448 -0.551 0 N-CA-C 115.683 1.734 . . . . 0.0 115.683 -174.728 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -78.89 166.27 23.5 Favored 'Trans proline' 0 N--CA 1.46 -0.458 0 C-N-CA 121.826 1.684 . . . . 0.0 108.034 168.707 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 54.2 t80 -62.2 132.34 52.44 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 120.622 -0.431 . . . . 0.0 109.935 -179.96 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 92.06 -8.25 78.01 Favored Glycine 0 CA--C 1.52 0.358 0 N-CA-C 115.085 0.794 . . . . 0.0 115.085 178.794 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -64.35 131.48 47.38 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 118.321 1.06 . . . . 0.0 112.007 -179.963 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 33.4 t-20 -73.98 127.16 32.15 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.595 -178.517 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 26.4 ttmt -156.18 150.1 25.15 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 104.992 -2.225 . . . . 0.0 104.992 175.74 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -71.13 136.05 47.97 Favored 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 120.198 -0.601 . . . . 0.0 109.723 -177.376 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 73.58 21.09 79.81 Favored Glycine 0 N--CA 1.447 -0.59 0 CA-C-O 119.19 -0.783 . . . . 0.0 113.353 178.665 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 44.3 mm -124.87 121.83 62.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 117.542 0.671 . . . . 0.0 110.376 179.402 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -122.75 112.52 34.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 CA-C-O 121.862 0.839 . . . . 0.0 110.793 175.749 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 96.4 m95 -78.44 133.21 37.51 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.126 -178.814 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 1.7 m -140.81 149.73 20.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 -178.689 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -157.98 166.05 33.57 Favored 'General case' 0 CA--C 1.507 -0.696 0 N-CA-C 106.491 -1.67 . . . . 0.0 106.491 -178.404 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 5.9 t -132.44 171.5 13.68 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 105.94 -1.874 . . . . 0.0 105.94 174.897 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -67.65 138.86 56.67 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.258 0.551 . . . . 0.0 110.81 -178.142 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 96.46 -7.67 66.2 Favored Glycine 0 C--O 1.226 -0.386 0 CA-C-N 115.705 -0.68 . . . . 0.0 113.143 178.943 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -85.6 147.23 26.5 Favored 'General case' 0 CA--C 1.544 0.74 0 O-C-N 122.632 -0.334 . . . . 0.0 111.489 179.982 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 45.2 mt -92.02 139.7 30.38 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -178.274 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 60.8 t30 -90.45 66.61 6.43 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.057 0.456 . . . . 0.0 110.83 -179.463 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -141.31 155.88 67.62 Favored Pre-proline 0 C--N 1.323 -0.57 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 179.889 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -73.77 152.4 47.32 Favored 'Trans proline' 0 CA--C 1.535 0.565 0 N-CA-C 114.955 1.098 . . . . 0.0 114.955 178.313 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.54 57.96 1.12 Allowed 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 121.827 0.823 . . . . 0.0 111.125 179.171 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -57.9 -31.6 66.93 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.609 179.071 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 42.7 p-80 -63.12 -13.95 42.77 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 114.273 1.212 . . . . 0.0 114.273 -178.162 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 94.8 mt -87.92 -29.06 5.46 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 177.617 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -75.58 4.2 44.6 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 115.239 0.856 . . . . 0.0 115.239 -177.304 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 12.7 t -83.09 21.06 1.12 Allowed 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 -178.134 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 69.2 ttp85 -56.25 126.61 26.94 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 179.25 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -95.93 127.36 41.28 Favored Pre-proline 0 C--N 1.322 -0.619 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 -179.623 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -74.19 -15.14 23.04 Favored 'Trans proline' 0 C--O 1.219 -0.425 0 O-C-N 121.898 0.42 . . . . 0.0 112.717 -178.452 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -77.87 -25.34 48.57 Favored 'General case' 0 C--O 1.222 -0.394 0 CA-C-O 120.863 0.363 . . . . 0.0 110.239 178.188 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 -104.3 -25.63 12.79 Favored 'General case' 0 C--O 1.223 -0.341 0 N-CA-C 113.977 1.103 . . . . 0.0 113.977 -174.867 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 -147.2 150.18 34.4 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 -177.26 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -92.49 147.1 23.16 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 121.238 0.542 . . . . 0.0 111.206 179.405 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -74.11 153.39 39.6 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.239 177.931 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 2.5 mt -96.76 142.13 14.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 -178.132 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 87.0 t -58.05 125.04 13.42 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 176.87 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 6.4 tt -68.75 128.01 35.11 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.085 -177.848 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 29.8 mt-30 -132.36 154.42 49.79 Favored 'General case' 0 CA--C 1.508 -0.635 0 N-CA-C 107.119 -1.437 . . . . 0.0 107.119 -178.942 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 12.6 mt -109.44 148.93 39.07 Favored Pre-proline 0 C--N 1.321 -0.651 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 176.955 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -70.9 160.89 47.93 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 118.057 -0.829 . . . . 0.0 112.21 179.767 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -55.37 136.12 49.61 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 -179.249 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 95.11 -16.78 60.62 Favored Glycine 0 C--O 1.226 -0.374 0 CA-C-N 116.005 -0.543 . . . . 0.0 112.81 -177.566 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 6.2 m -108.63 128.3 54.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 117.827 0.814 . . . . 0.0 109.834 178.003 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 8.2 p -120.48 148.37 43.92 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.848 -178.522 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 85.7 mt -72.37 153.41 92.08 Favored Pre-proline 0 C--N 1.324 -0.515 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 177.776 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -76.32 170.89 19.1 Favored 'Trans proline' 0 N--CA 1.462 -0.352 0 C-N-CA 118.334 -0.644 . . . . 0.0 110.711 178.513 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -60.82 130.88 48.66 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.569 -177.44 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 95.1 -2.48 65.96 Favored Glycine 0 CA--C 1.517 0.189 0 N-CA-C 114.774 0.67 . . . . 0.0 114.774 178.209 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.435 ' CZ ' ' HB2' ' A' ' 18' ' ' GLN . 2.6 m-85 -106.43 140.07 39.92 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-O 121.732 0.777 . . . . 0.0 111.973 -179.376 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 52.6 p90 -145.52 164.34 31.93 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 114.423 -1.262 . . . . 0.0 108.069 174.515 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -105.38 147.18 28.48 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 112.481 0.549 . . . . 0.0 112.481 -176.465 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -74.97 134.88 41.41 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 178.645 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 86.03 -0.74 87.71 Favored Glycine 0 C--O 1.227 -0.321 0 C-N-CA 121.094 -0.574 . . . . 0.0 112.717 -179.959 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 8.7 t -106.41 -179.52 3.96 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 178.03 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 1.5 mmm180 -146.14 150.12 35.3 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 106.236 -1.764 . . . . 0.0 106.236 -179.84 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 142.23 131.39 2.6 Favored Glycine 0 C--O 1.224 -0.504 0 N-CA-C 108.149 -1.98 . . . . 0.0 108.149 -177.979 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 86.06 -35.03 3.31 Favored Glycine 0 N--CA 1.462 0.396 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 -175.623 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 68.6 m . . . . . 0 C--O 1.243 0.738 0 N-CA-C 103.139 -2.912 . . . . 0.0 103.139 176.056 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.502 0 CA-C-O 121.568 0.699 . . . . 0.0 111.186 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 12.3 p -59.92 142.69 53.21 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.225 -0.898 . . . . 0.0 109.98 177.053 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . 0.437 ' CD2' ' HD3' ' A' ' 109' ' ' ARG . 12.4 m95 -67.3 -21.86 65.66 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 114.648 1.351 . . . . 0.0 114.648 -178.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -121.48 163.36 18.92 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 113.992 1.108 . . . . 0.0 113.992 -170.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 65.6 p -70.96 168.39 17.07 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.304 -1.317 . . . . 0.0 108.258 178.087 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.581 ' HB2' ' CZ ' ' A' ' 69' ' ' TYR . . . -78.34 149.4 33.44 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 114.182 1.178 . . . . 0.0 114.182 -175.515 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 13.9 mt -92.3 143.75 26.08 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 102.439 -3.171 . . . . 0.0 102.439 166.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 44.2 m -124.58 131.83 53.46 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 -178.494 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.403 ' HB2' ' CZ ' ' A' ' 131' ' ' PHE . 4.0 tp-100 -95.59 139.19 32.21 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.616 0.599 . . . . 0.0 112.616 -178.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 64.2 t60 -136.08 99.5 4.15 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 105.352 -2.092 . . . . 0.0 105.352 170.171 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 166.39 -160.02 33.47 Favored Glycine 0 C--O 1.227 -0.309 0 N-CA-C 110.294 -1.123 . . . . 0.0 110.294 -176.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -104.32 -23.69 13.18 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 112.809 0.67 . . . . 0.0 112.809 179.302 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 52.7 mm-40 -75.07 168.04 20.75 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 177.292 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -95.81 -62.84 1.22 Allowed 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 177.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 51.9 tp 173.76 136.04 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 125.761 1.624 . . . . 0.0 106.887 173.459 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 54.7 tptt -155.48 139.75 16.64 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 107.934 -1.135 . . . . 0.0 107.934 172.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 14.4 m-85 -117.84 142.82 31.4 Favored Pre-proline 0 C--O 1.241 0.655 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 176.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -64.6 165.89 19.27 Favored 'Trans proline' 0 CA--C 1.54 0.825 0 C-N-CA 122.209 1.939 . . . . 0.0 114.696 176.037 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 17.1 tpt180 -62.47 133.59 55.21 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.888 -178.347 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 77.53 15.81 80.98 Favored Glycine 0 C--O 1.223 -0.542 0 CA-C-N 115.894 -0.593 . . . . 0.0 112.651 175.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -148.37 167.66 24.67 Favored 'General case' 0 N--CA 1.442 -0.862 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 -174.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 111.58 -23.49 17.58 Favored Glycine 0 CA--C 1.497 -1.08 0 C-N-CA 121.809 -0.234 . . . . 0.0 113.36 173.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 93.1 t -65.67 127.12 92.8 Favored Pre-proline 0 C--N 1.318 -0.762 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 178.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -75.21 170.03 21.25 Favored 'Trans proline' 0 N--CA 1.461 -0.425 0 O-C-N 122.102 0.527 . . . . 0.0 111.429 178.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 97.6 mt -67.95 109.57 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-O 121.931 0.872 . . . . 0.0 109.109 179.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 73.2 m-80 -99.97 87.43 3.49 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 114.756 -1.111 . . . . 0.0 109.223 -179.052 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 72.5 p -67.82 -16.35 64.06 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 -178.592 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 11.4 p30 -108.19 22.9 15.3 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.318 -0.856 . . . . 0.0 112.843 -177.03 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 15.3 m -138.94 152.05 47.4 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 114.729 1.381 . . . . 0.0 114.729 -175.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 67.5 m -74.86 164.97 57.74 Favored Pre-proline 0 CA--C 1.537 0.469 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.479 177.492 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -65.48 -24.85 56.14 Favored 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 115.341 -2.64 . . . . 0.0 114.538 -178.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.436 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 6.1 p-10 -76.45 -26.09 55.06 Favored 'General case' 0 C--N 1.324 -0.539 0 O-C-N 121.625 -0.672 . . . . 0.0 110.906 177.026 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.555 ' HA ' ' HE3' ' A' ' 103' ' ' LYS . 15.2 m-20 -75.76 -10.75 59.69 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.198 0.999 . . . . 0.0 112.952 -175.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 96.8 mm-40 -58.55 -29.07 66.08 Favored 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 114.782 1.401 . . . . 0.0 114.782 -176.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.493 ' HB ' ' HB1' ' A' ' 98' ' ' ALA . 11.9 tt -59.5 140.22 18.0 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.874 0 CA-C-O 122.287 1.042 . . . . 0.0 112.843 -178.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -179.34 -155.63 15.47 Favored Glycine 0 CA--C 1.506 -0.482 0 C-N-CA 120.406 -0.902 . . . . 0.0 112.49 -178.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 50.3 p90 -154.99 171.7 19.31 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 179.021 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 19.3 m-85 -112.89 140.06 48.01 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 173.304 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 69.4 ttt-85 -111.33 124.66 52.68 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.979 -177.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 37.7 ttt-85 -65.05 141.1 58.86 Favored 'General case' 0 C--N 1.322 -0.625 0 O-C-N 123.557 0.536 . . . . 0.0 109.764 177.164 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -151.03 150.42 30.72 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.997 0.427 . . . . 0.0 110.605 179.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 34.0 p -145.89 168.41 20.89 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 103.621 -2.733 . . . . 0.0 103.621 174.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 14.5 tpt180 -149.08 131.08 15.28 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.604 0.716 . . . . 0.0 111.664 175.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 37.6 mtt180 -140.98 165.82 26.5 Favored 'General case' 0 CA--C 1.493 -1.241 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 178.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -132.33 175.93 10.19 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 N-CA-C 104.24 -2.504 . . . . 0.0 104.24 -179.186 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 3.5 tmt_? -120.69 99.38 6.5 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 178.232 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -76.09 150.36 38.95 Favored Glycine 0 N--CA 1.45 -0.43 0 N-CA-C 105.627 -2.989 . . . . 0.0 105.627 173.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -63.64 -36.1 92.9 Favored Glycine 0 C--O 1.217 -0.964 0 CA-C-N 118.669 1.235 . . . . 0.0 111.718 -179.422 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 27.2 t0 -89.08 17.15 6.12 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-O 122.328 1.061 . . . . 0.0 111.433 179.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 85.47 14.79 67.58 Favored Glycine 0 C--O 1.223 -0.578 0 CA-C-N 115.505 -0.77 . . . . 0.0 113.575 173.239 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 49.9 mmtt -69.61 133.67 47.86 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.58 0.705 . . . . 0.0 110.59 -176.451 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 4.0 mmt -113.11 155.3 25.18 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 114.225 -1.352 . . . . 0.0 111.101 -176.322 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 1.2 mmtp -96.28 -41.95 8.41 Favored 'General case' 0 CA--C 1.5 -0.979 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 173.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 11.3 t0 45.61 57.3 5.09 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 111.206 -2.724 . . . . 0.0 115.796 176.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 64.4 mt -68.58 138.68 55.28 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 177.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -58.67 161.81 7.68 Favored Pre-proline 0 C--O 1.242 0.698 0 CA-C-N 115.316 -0.856 . . . . 0.0 112.931 -177.587 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -62.22 134.85 51.07 Favored 'Trans proline' 0 C--N 1.354 0.864 0 C-N-CA 116.814 -1.657 . . . . 0.0 112.119 179.381 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 20.9 mtt-85 -132.15 161.12 34.12 Favored 'General case' 0 CA--C 1.503 -0.83 0 CA-C-N 114.338 -1.301 . . . . 0.0 109.805 -175.485 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 70.2 m95 -134.52 143.42 47.43 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 177.24 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.581 ' CZ ' ' HB2' ' A' ' 15' ' ' ALA . 70.7 m-85 -126.38 148.61 49.57 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 106.334 -1.728 . . . . 0.0 106.334 178.592 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 86.8 t80 -94.71 138.12 32.95 Favored 'General case' 0 CA--C 1.506 -0.727 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 -176.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 11.2 m-85 -138.86 142.19 38.61 Favored 'General case' 0 N--CA 1.438 -1.072 0 N-CA-C 106.53 -1.656 . . . . 0.0 106.53 -174.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 88.5 m-85 -80.89 159.52 24.98 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.437 0.161 . . . . 0.0 110.845 -175.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -56.12 126.69 27.13 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.9 0.381 . . . . 0.0 110.79 -177.722 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 69.29 38.63 81.74 Favored Glycine 0 C--O 1.218 -0.88 0 CA-C-O 119.106 -0.83 . . . . 0.0 114.75 176.179 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.326 -0.444 0 N-CA-C 105.623 -1.992 . . . . 0.0 105.623 177.591 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 17.3 mt . . . . . 0 N--CA 1.446 -0.657 0 N-CA-C 114.39 1.256 . . . . 0.0 114.39 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -78.58 164.49 25.92 Favored 'Trans proline' 0 C--O 1.235 0.374 0 C-N-CA 121.963 1.775 . . . . 0.0 108.318 169.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 57.9 t80 -61.79 132.03 51.8 Favored 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 120.396 -0.522 . . . . 0.0 110.085 -179.462 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 91.64 -5.98 79.99 Favored Glycine 0 CA--C 1.518 0.258 0 CA-C-O 119.417 -0.657 . . . . 0.0 114.493 178.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -63.5 131.24 47.49 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 118.369 1.085 . . . . 0.0 111.453 179.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 36.1 t-20 -77.87 127.3 32.16 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.496 -178.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 28.7 ttmt -156.2 151.26 26.38 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 105.508 -2.034 . . . . 0.0 105.508 178.03 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -64.66 132.14 48.89 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.085 0.469 . . . . 0.0 110.666 -178.044 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 68.29 27.31 73.8 Favored Glycine 0 N--CA 1.449 -0.439 0 CA-C-N 115.719 -0.673 . . . . 0.0 114.256 178.156 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 45.8 mm -124.84 123.42 65.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 117.419 0.609 . . . . 0.0 110.669 179.375 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.1 pt -127.16 111.94 27.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 CA-C-O 121.953 0.882 . . . . 0.0 111.762 177.051 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 95.1 m95 -77.36 136.83 38.47 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 112.983 0.734 . . . . 0.0 112.983 -177.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 17.3 m -138.86 151.61 23.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 C-N-CA 123.481 0.712 . . . . 0.0 109.824 179.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -157.01 166.59 32.93 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 105.877 -1.898 . . . . 0.0 105.877 179.494 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 14.5 t -130.34 176.34 8.21 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 105.521 -2.029 . . . . 0.0 105.521 178.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -67.58 135.07 52.35 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.162 0.506 . . . . 0.0 110.169 -179.253 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 93.19 -10.79 73.02 Favored Glycine 0 C--O 1.229 -0.182 0 CA-C-N 115.938 -0.574 . . . . 0.0 113.302 178.253 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.493 ' HB1' ' HB ' ' A' ' 44' ' ' ILE . . . -73.9 136.76 43.38 Favored 'General case' 0 CA--C 1.543 0.687 0 O-C-N 122.543 -0.387 . . . . 0.0 110.617 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 36.7 mt -95.72 139.57 31.76 Favored 'General case' 0 C--O 1.218 -0.601 0 N-CA-C 113.725 1.009 . . . . 0.0 113.725 -176.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 57.3 t30 -84.4 73.91 10.43 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.497 0.665 . . . . 0.0 110.52 179.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -146.41 159.25 45.56 Favored Pre-proline 0 C--N 1.321 -0.659 0 N-CA-C 103.024 -2.954 . . . . 0.0 103.024 179.445 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -73.27 149.95 46.38 Favored 'Trans proline' 0 CA--C 1.537 0.644 0 N-CA-C 114.061 0.754 . . . . 0.0 114.061 177.489 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.555 ' HE3' ' HA ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -142.29 58.69 1.46 Allowed 'General case' 0 N--CA 1.475 0.823 0 CA-C-O 122.799 1.285 . . . . 0.0 109.402 176.835 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -63.12 -23.77 67.59 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.263 -1.335 . . . . 0.0 110.963 178.235 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 17.9 p80 -55.87 -17.94 7.62 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 114.516 1.302 . . . . 0.0 114.516 -178.439 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 22.5 mt -88.81 -38.33 11.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 121.393 0.616 . . . . 0.0 109.842 -179.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -76.15 14.66 6.12 Favored Glycine 0 C--O 1.22 -0.767 0 N-CA-C 116.748 1.459 . . . . 0.0 116.748 -174.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 13.4 t -83.14 15.97 2.61 Favored 'General case' 0 CA--C 1.545 0.777 0 CA-C-N 117.985 0.893 . . . . 0.0 111.427 179.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.437 ' HD3' ' CD2' ' A' ' 12' ' ' TRP . 59.8 ttp85 -62.73 138.7 58.58 Favored 'General case' 0 C--N 1.327 -0.397 0 O-C-N 122.02 -0.425 . . . . 0.0 111.002 -178.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -110.28 123.64 35.41 Favored Pre-proline 0 C--O 1.236 0.342 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 177.122 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -75.06 -10.85 21.29 Favored 'Trans proline' 0 C--O 1.219 -0.453 0 N-CA-C 113.324 0.471 . . . . 0.0 113.324 -176.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -77.76 -24.96 48.83 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.045 178.012 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 75.2 m-20 -104.12 -25.56 12.9 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 113.989 1.107 . . . . 0.0 113.989 -173.334 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -142.67 154.55 44.44 Favored 'General case' 0 N--CA 1.433 -1.307 0 CA-C-O 121.261 0.553 . . . . 0.0 109.71 -176.301 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -92.93 142.7 27.01 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.197 -0.911 . . . . 0.0 110.206 179.321 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -68.74 147.11 52.28 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.239 0.543 . . . . 0.0 110.761 179.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 25.3 mt -81.77 138.38 19.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 -178.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 82.7 t -60.91 123.69 14.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 175.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 6.0 tt -67.66 128.82 37.87 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 -178.161 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -134.96 157.86 45.82 Favored 'General case' 0 CA--C 1.508 -0.653 0 N-CA-C 107.273 -1.38 . . . . 0.0 107.273 -177.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 13.8 mt -113.2 150.38 42.91 Favored Pre-proline 0 C--N 1.32 -0.699 0 N-CA-C 105.747 -1.946 . . . . 0.0 105.747 175.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -70.42 168.2 23.1 Favored 'Trans proline' 0 C--N 1.342 0.22 0 N-CA-C 114.143 0.786 . . . . 0.0 114.143 -176.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 49.7 tt0 -55.23 133.43 49.25 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.273 -178.032 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 89.61 -13.77 63.21 Favored Glycine 0 C--O 1.228 -0.28 0 CA-C-N 115.964 -0.562 . . . . 0.0 112.659 -179.343 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 18.6 m -106.92 128.38 54.26 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 117.356 0.578 . . . . 0.0 110.511 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 13.7 p -121.71 148.32 44.76 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.316 0.579 . . . . 0.0 112.483 -177.227 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 86.0 mt -68.52 156.26 90.99 Favored Pre-proline 0 C--N 1.326 -0.435 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 177.267 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -74.25 164.86 33.23 Favored 'Trans proline' 0 N--CA 1.461 -0.394 0 C-N-CA 117.655 -1.096 . . . . 0.0 110.941 178.431 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -60.13 130.46 46.77 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.174 -177.185 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 95.08 -3.93 67.28 Favored Glycine 0 C--O 1.225 -0.447 0 N-CA-C 114.823 0.689 . . . . 0.0 114.823 179.357 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.403 ' CZ ' ' HB2' ' A' ' 18' ' ' GLN . 0.8 OUTLIER -106.78 141.97 37.16 Favored 'General case' 0 CA--C 1.507 -0.703 0 CA-C-N 117.874 0.837 . . . . 0.0 110.743 179.306 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 43.7 p90 -142.53 161.29 38.44 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 114.382 -1.281 . . . . 0.0 107.983 175.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -104.86 146.98 28.25 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.652 0.739 . . . . 0.0 111.496 -177.501 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -74.23 127.52 33.18 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 179.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 87.94 -5.66 84.57 Favored Glycine 0 C--O 1.224 -0.523 0 CA-C-N 116.091 -0.504 . . . . 0.0 113.076 -178.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 33.7 t . . . . . 0 C--N 1.326 -0.447 0 CA-C-O 121.411 0.624 . . . . 0.0 109.379 179.572 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.239 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 41.3 t -61.13 140.9 57.79 Favored 'General case' 0 CA--C 1.513 -0.476 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 178.244 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 7.5 m95 -68.41 -21.93 64.65 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.486 178.373 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 29.8 m-85 -121.4 163.02 19.39 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 115.872 -0.604 . . . . 0.0 112.559 -171.36 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.418 ' HB ' ' HB3' ' A' ' 134' ' ' GLU . 71.7 p -71.55 163.07 28.42 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.495 -0.775 . . . . 0.0 108.926 178.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.445 ' HB2' ' CZ ' ' A' ' 69' ' ' TYR . . . -76.81 138.05 39.62 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -176.44 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 13.8 mt -82.74 145.03 29.79 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 104.45 -2.426 . . . . 0.0 104.45 171.486 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 20.0 m -127.47 133.27 49.91 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 118.331 0.514 . . . . 0.0 110.597 -178.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 4.0 tp-100 -89.52 150.74 22.31 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.869 179.27 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 73.5 t60 -136.38 99.25 4.04 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 103.189 -2.893 . . . . 0.0 103.189 166.383 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 162.79 -173.07 38.97 Favored Glycine 0 N--CA 1.451 -0.328 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 -175.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 55.3 mtmt -93.34 -29.44 15.63 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 114.962 1.467 . . . . 0.0 114.962 -176.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -87.39 157.31 19.27 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 106.906 -1.516 . . . . 0.0 106.906 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -83.52 -62.75 1.5 Allowed 'General case' 0 C--O 1.218 -0.566 0 N-CA-C 115.405 1.631 . . . . 0.0 115.405 -174.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 56.8 tp 179.1 143.3 0.13 Allowed 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 124.356 1.062 . . . . 0.0 108.154 178.06 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 13.6 tptm -158.86 141.23 14.05 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 173.333 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 7.9 m-85 -123.56 140.57 34.42 Favored Pre-proline 0 C--N 1.324 -0.524 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 176.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -61.54 155.52 52.57 Favored 'Trans proline' 0 CA--C 1.538 0.71 0 C-N-CA 120.283 0.656 . . . . 0.0 113.206 175.343 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 16.9 tpt180 -63.68 135.66 56.89 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.604 -177.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 83.9 10.31 81.2 Favored Glycine 0 C--O 1.225 -0.452 0 C-N-CA 121.368 -0.444 . . . . 0.0 112.348 178.435 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -148.14 168.64 21.9 Favored 'General case' 0 N--CA 1.443 -0.792 0 N-CA-C 106.975 -1.491 . . . . 0.0 106.975 -176.504 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 110.69 -19.89 25.45 Favored Glycine 0 CA--C 1.499 -0.946 0 CA-C-O 121.14 0.3 . . . . 0.0 113.643 172.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 99.2 t -65.41 128.16 93.56 Favored Pre-proline 0 C--N 1.319 -0.756 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 178.617 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -74.19 170.99 18.9 Favored 'Trans proline' 0 N--CA 1.46 -0.448 0 O-C-N 122.116 0.535 . . . . 0.0 111.327 178.02 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 89.9 mt -69.34 107.32 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-O 122.155 0.978 . . . . 0.0 108.656 179.379 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 -98.94 84.56 3.1 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 114.278 -1.328 . . . . 0.0 109.444 -177.326 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 70.4 p -66.56 -15.03 63.11 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.687 0.756 . . . . 0.0 112.895 -178.6 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 20.7 p30 -109.11 20.69 18.08 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 114.93 -1.032 . . . . 0.0 112.986 -177.128 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 27.9 m -139.02 147.95 42.77 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 113.693 0.997 . . . . 0.0 113.693 -176.46 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -72.21 167.14 34.84 Favored Pre-proline 0 C--N 1.327 -0.399 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 176.292 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -64.49 -28.18 62.03 Favored 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 115.185 -2.744 . . . . 0.0 111.958 178.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -62.31 -29.21 70.28 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 123.626 0.77 . . . . 0.0 111.422 176.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.598 ' HA ' ' HE3' ' A' ' 103' ' ' LYS . 62.1 m-20 -95.28 -0.3 53.06 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 114.584 1.328 . . . . 0.0 114.584 -171.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 94.7 mm-40 -60.7 -30.89 70.23 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 114.097 1.147 . . . . 0.0 114.097 178.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.43 ' HB ' ' HB1' ' A' ' 98' ' ' ALA . 20.6 tt -59.28 140.4 17.58 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.745 0 CA-C-O 122.385 1.088 . . . . 0.0 113.64 -177.674 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 179.88 -154.98 14.39 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.629 -178.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 50.4 p90 -155.02 171.13 20.25 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 178.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 17.8 m-85 -113.99 142.8 45.71 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 172.449 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 57.9 ttt180 -112.11 129.2 56.31 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.435 -179.005 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 27.5 ttt180 -67.22 136.27 54.72 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 123.452 0.701 . . . . 0.0 110.042 177.252 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -151.31 142.67 23.39 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.733 0.301 . . . . 0.0 110.606 178.44 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 9.3 t -148.42 151.24 34.9 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 176.585 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 8.3 tpt180 -164.84 124.97 1.94 Allowed 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 -178.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 15.1 ptt85 -106.93 158.92 16.66 Favored 'General case' 0 CA--C 1.508 -0.652 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 175.446 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -144.4 -179.57 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.913 0 N-CA-C 104.626 -2.361 . . . . 0.0 104.626 -175.321 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 5.6 mtt-85 -138.65 124.84 20.25 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 175.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -86.14 170.88 43.7 Favored Glycine 0 C--O 1.225 -0.412 0 N-CA-C 107.82 -2.112 . . . . 0.0 107.82 175.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -79.06 -28.59 53.68 Favored Glycine 0 C--O 1.216 -1.014 0 N-CA-C 108.194 -1.963 . . . . 0.0 108.194 179.459 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 43.2 t0 -76.22 -5.03 45.0 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-N 113.069 -1.566 . . . . 0.0 108.627 176.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 90.48 -11.72 70.54 Favored Glycine 0 CA--C 1.51 -0.277 0 CA-C-N 114.721 -1.127 . . . . 0.0 113.787 176.406 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -71.8 138.26 48.22 Favored 'General case' 0 CA--C 1.507 -0.692 0 CA-C-O 121.939 0.876 . . . . 0.0 109.868 -177.322 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 28.2 ptm -133.18 167.57 20.11 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 114.152 -1.385 . . . . 0.0 110.049 -178.398 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 29.0 mttp -75.67 -56.54 4.59 Favored 'General case' 0 C--O 1.219 -0.551 0 N-CA-C 113.814 1.042 . . . . 0.0 113.814 -177.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.6 t70 54.45 -140.13 0.96 Allowed 'General case' 0 CA--C 1.541 0.613 0 O-C-N 124.79 1.306 . . . . 0.0 110.065 -178.046 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 8.8 mt 61.11 173.84 0.11 Allowed 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 116.911 2.189 . . . . 0.0 116.911 177.463 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 36.6 m -67.52 160.79 70.35 Favored Pre-proline 0 C--O 1.238 0.497 0 CA-C-N 114.654 -1.157 . . . . 0.0 110.064 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -63.15 162.07 27.8 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 117.821 -0.986 . . . . 0.0 114.548 -179.507 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 18.5 mtp180 -108.01 160.29 15.9 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 106.801 -1.555 . . . . 0.0 106.801 -179.414 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 50.1 m95 -127.05 133.98 50.37 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.445 ' CZ ' ' HB2' ' A' ' 15' ' ' ALA . 54.4 m-85 -114.71 141.23 48.11 Favored 'General case' 0 C--O 1.216 -0.699 0 N-CA-C 107.961 -1.125 . . . . 0.0 107.961 -177.812 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 88.2 t80 -89.97 134.7 34.08 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 118.474 0.579 . . . . 0.0 109.847 -177.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -137.71 147.27 44.65 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 -177.404 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -82.4 159.46 22.99 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 -173.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 16.9 tp -59.43 128.8 38.86 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.383 0.611 . . . . 0.0 109.595 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 78.23 26.66 59.32 Favored Glycine 0 C--O 1.217 -0.964 0 N-CA-C 115.704 1.042 . . . . 0.0 115.704 177.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 2.4 p . . . . . 0 C--N 1.326 -0.451 0 CA-C-N 119.093 1.447 . . . . 0.0 109.286 178.854 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 24.2 mt . . . . . 0 N--CA 1.448 -0.573 0 N-CA-C 115.212 1.56 . . . . 0.0 115.212 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -77.22 164.76 28.81 Favored 'Trans proline' 0 N--CA 1.459 -0.506 0 N-CA-C 108.002 -1.576 . . . . 0.0 108.002 170.05 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 70.0 t80 -62.62 128.57 36.6 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 120.478 -0.489 . . . . 0.0 110.584 -178.22 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 94.07 -5.5 72.03 Favored Glycine 0 CA--C 1.52 0.404 0 N-CA-C 114.851 0.7 . . . . 0.0 114.851 179.427 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -65.39 128.78 37.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 118.43 1.115 . . . . 0.0 112.314 179.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 72.2 m-20 -71.15 128.09 34.77 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 114.766 -1.107 . . . . 0.0 111.142 -178.345 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 25.2 ttmt -156.03 153.03 28.82 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 105.884 -1.895 . . . . 0.0 105.884 177.236 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 20.0 t0 -68.46 135.38 51.58 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.081 0.467 . . . . 0.0 110.12 -178.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 68.8 25.7 75.03 Favored Glycine 0 N--CA 1.447 -0.63 0 CA-C-N 115.735 -0.666 . . . . 0.0 114.133 177.488 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 42.8 mm -125.52 127.68 71.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 117.427 0.614 . . . . 0.0 109.989 179.669 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -129.39 115.91 37.17 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 CA-C-O 121.61 0.719 . . . . 0.0 110.202 176.64 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 97.7 m95 -82.38 134.79 35.26 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 113.773 1.027 . . . . 0.0 113.773 -175.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 20.8 m -136.6 149.81 27.01 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 CA-C-O 121.529 0.68 . . . . 0.0 110.537 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -157.03 166.56 32.98 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 103.93 -2.618 . . . . 0.0 103.93 -179.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 13.4 t -136.59 174.05 11.04 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 105.14 -2.17 . . . . 0.0 105.14 178.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -64.92 134.44 53.98 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.01 0.434 . . . . 0.0 109.971 -179.456 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 95.42 -5.86 67.87 Favored Glycine 0 C--O 1.225 -0.436 0 CA-C-N 115.992 -0.549 . . . . 0.0 113.769 178.459 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.43 ' HB1' ' HB ' ' A' ' 44' ' ' ILE . . . -83.15 138.25 33.73 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 122.262 -0.552 . . . . 0.0 110.46 -179.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 56.0 mt -88.79 141.11 28.77 Favored 'General case' 0 C--O 1.22 -0.485 0 CA-C-O 121.149 0.499 . . . . 0.0 111.559 -178.581 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -83.57 58.8 4.77 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.358 0.599 . . . . 0.0 110.98 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -139.02 158.31 69.87 Favored Pre-proline 0 C--N 1.325 -0.484 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 -177.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -73.09 158.89 48.68 Favored 'Trans proline' 0 CA--C 1.537 0.633 0 N-CA-C 115.272 1.22 . . . . 0.0 115.272 179.308 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.598 ' HE3' ' HA ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -154.42 57.93 0.7 Allowed 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 122.813 1.292 . . . . 0.0 109.572 177.137 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -59.04 -30.39 68.0 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.103 -1.408 . . . . 0.0 112.177 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 17.5 p80 -58.72 -11.2 2.89 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 115.091 1.515 . . . . 0.0 115.091 -177.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 33.3 mt -91.82 -32.28 5.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 178.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -71.75 -3.39 54.89 Favored Glycine 0 C--O 1.224 -0.479 0 N-CA-C 116.082 1.193 . . . . 0.0 116.082 -175.468 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 15.0 t -83.16 26.56 0.62 Allowed 'General case' 0 CA--C 1.549 0.92 0 N-CA-C 113.67 0.989 . . . . 0.0 113.67 -177.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 70.8 ttp85 -57.27 122.99 13.83 Favored 'General case' 0 N--CA 1.472 0.667 0 O-C-N 121.398 -0.814 . . . . 0.0 109.039 178.35 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 60.2 m-20 -90.0 119.08 69.35 Favored Pre-proline 0 C--N 1.324 -0.504 0 N-CA-C 107.208 -1.405 . . . . 0.0 107.208 -179.4 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -70.84 -15.93 33.02 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 117.898 -0.934 . . . . 0.0 114.117 -177.089 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -77.41 -25.76 51.05 Favored 'General case' 0 C--O 1.219 -0.503 0 CA-C-O 120.87 0.367 . . . . 0.0 110.391 178.191 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -102.8 -24.55 13.7 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 113.183 0.808 . . . . 0.0 113.183 -174.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 18.8 t30 -149.12 146.54 27.74 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -177.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -88.35 151.14 22.8 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-O 121.575 0.702 . . . . 0.0 112.356 -179.444 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -75.01 149.72 39.18 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.412 177.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 7.9 mt -90.26 139.91 16.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 -178.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 85.4 t -60.58 124.24 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 N-CA-C 106.245 -1.761 . . . . 0.0 106.245 175.339 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 6.6 tt -67.23 130.84 44.38 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.148 0.499 . . . . 0.0 110.223 -176.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -134.09 158.22 44.17 Favored 'General case' 0 CA--C 1.509 -0.605 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 -178.342 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 13.7 mt -112.49 149.77 41.6 Favored Pre-proline 0 C--N 1.322 -0.626 0 N-CA-C 105.915 -1.883 . . . . 0.0 105.915 175.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_endo -70.35 168.83 21.2 Favored 'Trans proline' 0 C--N 1.342 0.213 0 N-CA-C 114.531 0.935 . . . . 0.0 114.531 -176.466 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 39.4 tt0 -54.52 130.85 41.33 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.758 -178.333 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 89.97 -11.79 69.58 Favored Glycine 0 C--O 1.226 -0.357 0 CA-C-N 115.786 -0.643 . . . . 0.0 112.87 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 18.1 m -106.99 126.64 52.59 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 117.37 0.585 . . . . 0.0 110.535 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 22.8 p -118.05 148.35 42.35 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 113.261 0.837 . . . . 0.0 113.261 -177.34 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 86.2 mt -68.74 155.91 92.15 Favored Pre-proline 0 C--N 1.324 -0.504 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 176.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -75.23 166.3 29.2 Favored 'Trans proline' 0 N--CA 1.462 -0.372 0 C-N-CA 117.44 -1.24 . . . . 0.0 110.315 177.258 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -58.94 130.96 49.52 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.061 -176.383 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 95.13 -9.88 69.93 Favored Glycine 0 C--O 1.224 -0.474 0 N-CA-C 115.137 0.815 . . . . 0.0 115.137 178.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -94.4 143.4 26.43 Favored 'General case' 0 N--CA 1.439 -1.002 0 CA-C-O 122.498 1.142 . . . . 0.0 111.717 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 39.9 p90 -142.32 163.78 31.91 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 113.231 -1.804 . . . . 0.0 107.654 175.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -106.46 144.17 33.51 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.1 0.476 . . . . 0.0 111.454 -177.344 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.418 ' HB3' ' HB ' ' A' ' 14' ' ' THR . 1.6 tp10 -69.62 129.95 41.06 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 106.544 -1.65 . . . . 0.0 106.544 177.446 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 93.1 -6.3 75.95 Favored Glycine 0 C--O 1.225 -0.446 0 C-N-CA 121.325 -0.464 . . . . 0.0 113.235 -179.281 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 35.3 t . . . . . 0 C--N 1.326 -0.436 0 N-CA-C 109.125 -0.695 . . . . 0.0 109.125 177.779 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.861 0 CA-C-O 121.98 0.895 . . . . 0.0 112.388 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.8 t -54.83 137.57 44.73 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 114.325 -1.307 . . . . 0.0 108.962 174.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 15.6 m95 -64.54 -21.89 66.82 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 178.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 46.5 m-85 -121.5 159.56 26.05 Favored 'General case' 0 C--O 1.241 0.612 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 -172.087 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.432 ' HB ' ' HB3' ' A' ' 134' ' ' GLU . 76.0 p -69.12 163.6 24.44 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 114.949 -1.023 . . . . 0.0 108.861 178.831 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -81.47 141.23 34.06 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 -176.417 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 27.5 mt -78.78 148.85 32.79 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 104.64 -2.356 . . . . 0.0 104.64 170.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 30.6 m -112.95 128.59 56.53 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 179.243 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 2.6 tm0? -93.24 134.82 35.04 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.025 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 78.0 t60 -139.41 99.45 3.74 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 106.172 -1.788 . . . . 0.0 106.172 168.313 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 169.49 -166.14 39.43 Favored Glycine 0 C--O 1.226 -0.373 0 C-N-CA 120.156 -1.021 . . . . 0.0 112.574 -177.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -101.79 -24.58 14.04 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -179.447 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -91.78 153.32 19.68 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 179.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -72.4 -62.85 1.29 Allowed 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -174.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 43.0 tp 174.6 145.77 0.06 Allowed 'General case' 0 N--CA 1.483 1.212 0 N-CA-C 105.949 -1.871 . . . . 0.0 105.949 175.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 54.0 tptt -156.03 138.7 15.1 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 175.138 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 16.8 m-85 -124.88 152.68 70.27 Favored Pre-proline 0 C--O 1.243 0.752 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 174.428 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -70.31 161.47 45.9 Favored 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 120.201 0.6 . . . . 0.0 112.672 178.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 20.9 tpt180 -69.07 135.25 50.5 Favored 'General case' 0 C--O 1.216 -0.66 0 O-C-N 122.147 -0.346 . . . . 0.0 110.105 -177.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 82.34 11.49 82.05 Favored Glycine 0 C--O 1.223 -0.576 0 N-CA-C 111.785 -0.526 . . . . 0.0 111.785 179.017 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 10.6 mt-30 -150.7 170.5 19.05 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 -175.218 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 107.37 -16.28 38.2 Favored Glycine 0 CA--C 1.503 -0.69 0 C-N-CA 121.429 -0.415 . . . . 0.0 113.204 175.217 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 57.4 t -67.91 129.19 93.31 Favored Pre-proline 0 C--N 1.319 -0.739 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 177.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -74.22 163.13 37.22 Favored 'Trans proline' 0 N--CA 1.459 -0.517 0 O-C-N 122.193 0.575 . . . . 0.0 111.967 178.375 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 93.7 mt -66.49 122.95 18.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.612 -177.55 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 44.8 t-20 -124.74 93.43 3.89 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.693 0.758 . . . . 0.0 110.373 179.342 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 82.6 p -75.98 -16.63 59.95 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 112.953 0.723 . . . . 0.0 112.953 -175.272 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 65.5 m-80 -104.33 32.77 3.83 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.631 -174.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 82.4 p -144.88 -179.08 6.37 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 114.735 1.383 . . . . 0.0 114.735 -176.354 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 56.8 m -105.05 165.93 12.33 Favored Pre-proline 0 CA--C 1.544 0.718 0 CA-C-N 114.947 -1.024 . . . . 0.0 108.942 178.449 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_endo -68.84 -18.96 41.3 Favored 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 116.405 -1.93 . . . . 0.0 114.983 -178.292 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.449 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 5.5 p-10 -75.03 -21.38 59.1 Favored 'General case' 0 C--N 1.324 -0.526 0 O-C-N 121.728 -0.608 . . . . 0.0 111.907 179.516 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -74.18 -23.09 59.18 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 114.183 1.179 . . . . 0.0 114.183 -174.362 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 93.7 mm-40 -53.61 -26.2 20.93 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 115.57 1.692 . . . . 0.0 115.57 -171.218 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.444 ' HB ' ' HB1' ' A' ' 98' ' ' ALA . 9.1 tt -64.43 136.5 26.41 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 CA-C-O 122.553 1.168 . . . . 0.0 112.203 -179.469 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 175.49 -156.89 22.95 Favored Glycine 0 CA--C 1.502 -0.72 0 C-N-CA 120.156 -1.021 . . . . 0.0 111.863 -178.447 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 47.1 p90 -155.1 170.45 21.76 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 -179.492 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 21.9 m-85 -109.53 139.49 44.47 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 106.538 -1.652 . . . . 0.0 106.538 174.084 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 58.4 ttt-85 -113.43 120.84 42.45 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 123.698 0.799 . . . . 0.0 111.253 -176.199 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 37.9 ttp85 -69.41 140.21 54.12 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.959 0.409 . . . . 0.0 109.933 177.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -144.28 149.41 36.23 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 122.979 0.511 . . . . 0.0 110.111 179.434 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 15.3 t -154.29 167.01 31.37 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 176.285 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 15.7 tpt180 -147.98 129.63 15.05 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 178.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 6.1 tpp180 -133.58 138.85 46.21 Favored 'General case' 0 CA--C 1.499 -1.01 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 -178.627 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -138.76 174.23 10.39 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 -178.284 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 1.7 ttt-85 -122.37 118.57 28.74 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 104.894 -2.262 . . . . 0.0 104.894 175.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -71.74 172.36 46.1 Favored Glycine 0 C--O 1.221 -0.71 0 N-CA-C 109.132 -1.587 . . . . 0.0 109.132 177.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -68.89 -37.69 84.05 Favored Glycine 0 C--O 1.222 -0.647 0 N-CA-C 110.303 -1.119 . . . . 0.0 110.303 -179.521 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -74.53 -12.27 60.43 Favored 'General case' 0 C--O 1.214 -0.799 0 CA-C-O 122.131 0.967 . . . . 0.0 109.582 177.143 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 104.54 -7.9 46.9 Favored Glycine 0 CA--C 1.505 -0.562 0 CA-C-N 115.685 -0.689 . . . . 0.0 113.14 173.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.95 139.5 58.25 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 122.143 0.973 . . . . 0.0 112.211 -177.048 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 91.1 mmm -93.84 166.16 12.32 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 113.845 -1.525 . . . . 0.0 110.615 -177.652 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 10.5 tttt -79.69 -49.01 12.73 Favored 'General case' 0 C--O 1.213 -0.862 0 N-CA-C 112.978 0.732 . . . . 0.0 112.978 177.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 44.88 24.02 0.1 Allowed 'General case' 0 N--CA 1.481 1.124 0 N-CA-C 117.815 2.524 . . . . 0.0 117.815 -178.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.4 mp -76.88 152.65 35.33 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 121.451 -0.781 . . . . 0.0 110.329 177.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -59.15 150.79 60.77 Favored Pre-proline 0 C--O 1.245 0.851 0 CA-C-N 115.188 -0.914 . . . . 0.0 113.391 -178.219 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -72.53 158.66 50.63 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 117.364 -1.291 . . . . 0.0 111.166 177.733 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 17.1 mtp180 -125.5 162.55 24.64 Favored 'General case' 0 CA--C 1.508 -0.648 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 -178.417 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 69.6 m95 -126.31 131.98 51.73 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 178.411 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 63.0 m-85 -111.4 150.23 30.08 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 106.113 -1.81 . . . . 0.0 106.113 178.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 79.1 t80 -94.1 134.91 36.02 Favored 'General case' 0 CA--C 1.507 -0.707 0 N-CA-C 106.44 -1.689 . . . . 0.0 106.44 179.226 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 8.8 m-85 -137.59 130.08 29.63 Favored 'General case' 0 N--CA 1.439 -0.984 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 -176.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.415 ' HB3' ' HB2' ' A' ' 103' ' ' LYS . 66.5 m-85 -66.08 159.56 25.79 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 114.581 -1.19 . . . . 0.0 111.745 -176.833 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -52.54 129.12 28.13 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.009 0.433 . . . . 0.0 111.229 -179.422 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 72.94 25.87 72.62 Favored Glycine 0 C--O 1.224 -0.511 0 N-CA-C 116.189 1.236 . . . . 0.0 116.189 177.038 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 63.2 p . . . . . 0 N--CA 1.469 0.479 0 CA-C-N 118.647 1.223 . . . . 0.0 111.361 178.264 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 18.7 mt . . . . . 0 C--O 1.238 0.489 0 N-CA-C 116.314 1.968 . . . . 0.0 116.314 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -79.35 163.65 24.61 Favored 'Trans proline' 0 CA--C 1.53 0.305 0 C-N-CA 122.42 2.08 . . . . 0.0 108.296 168.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 75.0 t80 -61.51 130.86 48.01 Favored 'General case' 0 C--N 1.323 -0.555 0 O-C-N 121.88 -0.512 . . . . 0.0 111.283 -176.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 90.89 -5.95 81.95 Favored Glycine 0 C--O 1.227 -0.307 0 CA-C-O 119.286 -0.73 . . . . 0.0 114.519 178.765 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -64.22 130.44 43.91 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 118.438 1.119 . . . . 0.0 111.256 179.416 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 56.9 t30 -79.96 127.0 31.74 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.522 -178.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 29.8 ttmt -156.25 152.68 28.06 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 179.417 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 15.0 t0 -66.34 135.91 55.04 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 110.248 -0.279 . . . . 0.0 110.248 -179.492 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 67.14 27.18 73.4 Favored Glycine 0 N--CA 1.45 -0.403 0 CA-C-O 119.671 -0.516 . . . . 0.0 113.617 178.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 44.5 mm -129.31 128.44 66.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 121.168 0.509 . . . . 0.0 109.977 179.556 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -133.58 116.95 25.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 CA-C-O 121.359 0.6 . . . . 0.0 111.404 177.429 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 96.1 m95 -81.84 136.69 35.36 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 113.57 0.952 . . . . 0.0 113.57 -177.414 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 17.7 m -136.84 156.04 34.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 178.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -164.0 166.56 21.42 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 103.297 -2.853 . . . . 0.0 103.297 -179.335 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 10.8 t -137.59 -179.62 5.85 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 106.148 -1.797 . . . . 0.0 106.148 177.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -65.15 134.72 54.36 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.217 0.532 . . . . 0.0 110.56 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 92.7 -9.32 75.87 Favored Glycine 0 N--CA 1.458 0.136 0 CA-C-N 115.918 -0.583 . . . . 0.0 114.128 177.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.449 ' HA ' ' HA ' ' A' ' 41' ' ' ASP . . . -72.22 133.61 45.18 Favored 'General case' 0 CA--C 1.544 0.735 0 O-C-N 122.441 -0.446 . . . . 0.0 111.395 -179.44 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 25.6 mt -93.23 136.86 33.1 Favored 'General case' 0 CA--C 1.507 -0.711 0 CA-C-O 120.931 0.396 . . . . 0.0 111.601 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 62.8 t30 -80.58 69.47 7.09 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.215 -179.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 2.0 t -144.57 156.25 56.62 Favored Pre-proline 0 CA--C 1.541 0.599 0 N-CA-C 106.932 -1.507 . . . . 0.0 106.932 179.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -63.68 153.21 76.59 Favored 'Trans proline' 0 C--N 1.348 0.518 0 N-CA-C 114.629 0.973 . . . . 0.0 114.629 -179.121 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.503 ' HB3' HD12 ' A' ' 106' ' ' ILE . 73.5 mmtt -125.22 41.19 3.57 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 123.289 0.636 . . . . 0.0 110.02 -179.426 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 15.5 p-10 -53.11 -43.59 67.0 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.717 -0.674 . . . . 0.0 112.314 -177.363 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 17.7 p80 -70.33 -6.56 36.06 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 114.45 1.278 . . . . 0.0 114.45 -178.509 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.503 HD12 ' HB3' ' A' ' 103' ' ' LYS . 32.0 mt -96.35 -44.88 12.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 118.075 0.398 . . . . 0.0 109.938 178.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -71.35 14.68 1.68 Allowed Glycine 0 C--O 1.223 -0.592 0 N-CA-C 116.357 1.303 . . . . 0.0 116.357 -177.22 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 15.3 t -94.3 25.71 3.71 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 -177.487 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 65.2 ttp85 -58.13 121.07 9.79 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 178.454 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -88.8 126.68 58.75 Favored Pre-proline 0 C--N 1.322 -0.598 0 N-CA-C 106.588 -1.634 . . . . 0.0 106.588 -177.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -73.23 -14.36 25.68 Favored 'Trans proline' 0 C--O 1.218 -0.488 0 C-N-CA 117.629 -1.114 . . . . 0.0 114.019 -177.295 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -81.56 -24.46 36.54 Favored 'General case' 0 C--O 1.22 -0.462 0 CA-C-O 121.124 0.487 . . . . 0.0 110.098 178.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 74.9 m-20 -101.82 -24.84 13.99 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 113.343 0.868 . . . . 0.0 113.343 -174.13 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 30.7 t30 -151.35 149.95 29.92 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 113.001 0.741 . . . . 0.0 113.001 -177.432 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -89.44 148.15 23.62 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-O 121.538 0.685 . . . . 0.0 111.867 179.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -71.25 147.23 48.4 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.186 178.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 18.8 mt -86.47 139.56 17.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 -179.357 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 75.0 t -62.0 123.64 15.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 N-CA-C 106.564 -1.643 . . . . 0.0 106.564 175.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 6.8 tt -67.01 127.41 32.47 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.017 0.436 . . . . 0.0 109.994 -177.37 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 33.3 mt-30 -132.76 157.16 45.64 Favored 'General case' 0 CA--C 1.511 -0.557 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 -179.254 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 13.3 mt -112.04 147.74 37.55 Favored Pre-proline 0 C--N 1.322 -0.612 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 177.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -73.04 164.63 34.98 Favored 'Trans proline' 0 C--O 1.236 0.387 0 O-C-N 122.272 0.617 . . . . 0.0 112.529 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 51.8 tt0 -55.35 133.74 49.82 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 100.34 -22.86 38.15 Favored Glycine 0 C--O 1.227 -0.337 0 CA-C-N 116.128 -0.487 . . . . 0.0 112.631 -178.607 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 5.0 m -107.02 128.4 54.33 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 117.961 0.88 . . . . 0.0 110.293 178.458 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 8.1 p -120.69 148.34 44.07 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.776 -178.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 88.4 mt -73.48 153.37 89.88 Favored Pre-proline 0 C--N 1.324 -0.517 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 177.284 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -76.51 171.2 18.49 Favored 'Trans proline' 0 C--O 1.234 0.281 0 C-N-CA 118.566 -0.489 . . . . 0.0 111.225 178.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 24.2 tptm -60.58 129.23 40.51 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 -179.301 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 91.03 18.4 47.05 Favored Glycine 0 C--O 1.223 -0.548 0 C-N-CA 120.931 -0.652 . . . . 0.0 114.655 178.262 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -127.21 141.71 51.67 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 117.596 0.698 . . . . 0.0 111.509 177.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 45.3 p90 -150.04 162.98 39.33 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 176.263 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -100.99 147.73 25.84 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.246 0.546 . . . . 0.0 111.844 -177.404 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.432 ' HB3' ' HB ' ' A' ' 14' ' ' THR . 0.9 OUTLIER -69.74 128.93 38.13 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 177.372 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 89.82 -7.31 82.0 Favored Glycine 0 C--O 1.225 -0.465 0 CA-C-N 116.315 -0.402 . . . . 0.0 113.54 179.422 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 34.5 t . . . . . 0 C--N 1.324 -0.516 0 CA-C-O 121.402 0.62 . . . . 0.0 110.869 179.476 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.456 -0.131 0 CA-C-O 121.379 0.609 . . . . 0.0 111.286 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 40.9 t -64.71 145.14 56.64 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 177.572 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 11.7 m95 -67.27 -21.91 65.69 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 122.799 0.44 . . . . 0.0 111.999 177.582 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 40.1 m-85 -121.4 165.56 15.38 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 114.136 1.161 . . . . 0.0 114.136 -170.458 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 73.6 p -71.85 163.13 28.37 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 114.63 -1.168 . . . . 0.0 108.662 177.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.46 ' HB2' ' CZ ' ' A' ' 69' ' ' TYR . . . -74.43 141.66 45.01 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -176.434 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.401 HD23 ' HA ' ' A' ' 16' ' ' LEU . 11.8 mt -85.94 143.84 27.96 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 102.962 -2.977 . . . . 0.0 102.962 169.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 21.5 m -124.54 137.39 54.41 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 -177.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.434 ' HB2' ' CZ ' ' A' ' 131' ' ' PHE . 4.7 tp60 -114.36 140.19 48.86 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 113.505 0.928 . . . . 0.0 113.505 -176.405 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 72.0 t60 -134.59 99.67 4.41 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 105.112 -2.181 . . . . 0.0 105.112 169.62 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 177.33 -169.2 41.31 Favored Glycine 0 N--CA 1.451 -0.334 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 -176.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 65.4 mttp -99.58 -26.95 13.92 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 117.398 0.599 . . . . 0.0 112.544 -179.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -85.74 158.01 20.13 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 178.614 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -82.46 -62.72 1.54 Allowed 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 120.786 -0.366 . . . . 0.0 111.782 -177.485 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 39.0 tp 179.62 142.55 0.14 Allowed 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 106.843 -1.54 . . . . 0.0 106.843 174.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -157.52 139.25 14.03 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 174.244 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 13.3 m-85 -123.22 151.57 62.42 Favored Pre-proline 0 C--O 1.239 0.537 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 176.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -74.28 165.55 31.58 Favored 'Trans proline' 0 CA--C 1.539 0.746 0 C-N-CA 120.058 0.505 . . . . 0.0 113.028 178.601 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 21.7 tpt180 -66.95 135.23 53.47 Favored 'General case' 0 C--O 1.216 -0.687 0 O-C-N 122.145 -0.347 . . . . 0.0 110.977 -177.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 82.95 4.24 90.1 Favored Glycine 0 C--O 1.223 -0.582 0 N-CA-C 111.935 -0.466 . . . . 0.0 111.935 178.156 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 40.0 mt-30 -141.79 170.6 15.4 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 123.206 0.602 . . . . 0.0 109.844 -174.465 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 105.61 -23.1 30.71 Favored Glycine 0 CA--C 1.498 -0.989 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.906 175.503 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 95.7 t -65.1 126.44 91.28 Favored Pre-proline 0 C--N 1.32 -0.694 0 N-CA-C 105.963 -1.866 . . . . 0.0 105.963 176.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -74.41 169.06 23.36 Favored 'Trans proline' 0 N--CA 1.459 -0.522 0 O-C-N 122.221 0.59 . . . . 0.0 110.912 179.168 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 92.8 mt -68.28 108.94 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 -179.435 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 75.0 m-80 -99.25 87.1 3.56 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 114.759 -1.109 . . . . 0.0 110.307 -177.243 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 73.7 p -68.73 -14.76 63.23 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.772 0.796 . . . . 0.0 112.243 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 10.8 p30 -107.34 18.8 21.15 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.861 -1.063 . . . . 0.0 113.357 -176.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 12.9 m -137.8 152.62 49.32 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 114.999 1.481 . . . . 0.0 114.999 -175.199 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.7 m -72.04 164.96 54.65 Favored Pre-proline 0 C--N 1.325 -0.482 0 CA-C-N 115.138 -0.937 . . . . 0.0 109.39 177.303 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -66.28 -27.3 48.24 Favored 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 114.858 -2.961 . . . . 0.0 113.861 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.448 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 2.1 p-10 -75.39 -22.32 57.56 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 121.57 -0.706 . . . . 0.0 110.916 177.01 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 56.4 m-20 -81.73 -7.18 59.57 Favored 'General case' 0 C--O 1.221 -0.406 0 N-CA-C 113.654 0.983 . . . . 0.0 113.654 -175.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 96.4 mm-40 -58.61 -28.18 65.38 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 113.797 1.036 . . . . 0.0 113.797 -178.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.528 ' HB ' ' HB1' ' A' ' 98' ' ' ALA . 9.8 tt -58.71 139.53 18.27 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.877 0 CA-C-O 122.302 1.049 . . . . 0.0 113.251 -179.214 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -179.88 -157.7 20.58 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.457 -0.878 . . . . 0.0 112.742 -179.509 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 41.6 p90 -155.06 171.75 19.25 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 179.441 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 20.2 m-85 -113.3 138.65 49.71 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 173.585 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 50.7 ttt180 -109.3 127.14 54.06 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.006 -178.3 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 40.8 ttt-85 -66.78 140.66 57.85 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 177.714 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -147.05 146.61 30.07 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.51 0.672 . . . . 0.0 111.361 179.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 21.2 p -144.31 157.65 44.16 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 104.235 -2.506 . . . . 0.0 104.235 175.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 19.0 tpp85 -147.3 125.68 12.34 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 118.296 0.498 . . . . 0.0 110.282 178.18 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 6.0 tmm_? -147.36 139.23 24.21 Favored 'General case' 0 CA--C 1.492 -1.282 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 179.431 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -132.56 179.1 4.71 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 N-CA-C 105.461 -2.052 . . . . 0.0 105.461 -178.529 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 56.1 ttp180 -120.96 113.61 20.35 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 106.855 -1.535 . . . . 0.0 106.855 172.479 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -95.98 147.36 18.62 Favored Glycine 0 C--N 1.317 -0.488 0 N-CA-C 106.114 -2.794 . . . . 0.0 106.114 177.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -63.92 -33.33 86.94 Favored Glycine 0 C--O 1.216 -0.969 0 CA-C-N 118.459 1.13 . . . . 0.0 111.584 -179.752 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 38.5 t0 -89.95 17.04 7.22 Favored 'General case' 0 CA--C 1.549 0.918 0 CA-C-O 122.263 1.03 . . . . 0.0 111.308 179.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 81.04 22.91 60.23 Favored Glycine 0 C--O 1.226 -0.404 0 CA-C-O 121.798 0.666 . . . . 0.0 113.823 172.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 21.9 mmtt -85.74 149.4 25.31 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.745 0.783 . . . . 0.0 112.26 -174.508 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 15.6 mtp -115.38 -179.89 3.77 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 113.824 -1.535 . . . . 0.0 110.886 -177.141 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -119.86 -65.4 1.16 Allowed 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 113.626 0.973 . . . . 0.0 113.626 -177.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -130.18 159.21 37.52 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 103.525 -2.768 . . . . 0.0 103.525 177.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 93.5 mt -121.22 -70.7 0.77 Allowed 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 120.769 0.318 . . . . 0.0 111.306 -179.49 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 16.0 m -67.73 152.72 96.07 Favored Pre-proline 0 C--O 1.239 0.55 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.13 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -68.2 148.15 74.12 Favored 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 116.99 -1.54 . . . . 0.0 111.858 178.146 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 34.6 mtt180 -128.7 164.13 23.61 Favored 'General case' 0 CA--C 1.508 -0.641 0 CA-C-N 115.923 -0.581 . . . . 0.0 112.477 -178.2 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 73.0 m95 -134.58 145.94 49.16 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 178.134 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.46 ' CZ ' ' HB2' ' A' ' 15' ' ' ALA . 22.1 m-85 -128.24 141.95 51.3 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 106.327 -1.731 . . . . 0.0 106.327 179.38 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 76.4 t80 -88.8 136.68 32.88 Favored 'General case' 0 CA--C 1.507 -0.702 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 -177.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -140.52 135.73 32.18 Favored 'General case' 0 N--CA 1.439 -1.0 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 -175.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 84.8 m-85 -73.26 159.5 33.33 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.425 -174.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -54.38 126.1 22.01 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.121 0.486 . . . . 0.0 111.545 -177.253 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 68.38 36.01 83.36 Favored Glycine 0 N--CA 1.448 -0.544 0 CA-C-O 119.048 -0.862 . . . . 0.0 114.326 176.45 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.3 p . . . . . 0 C--N 1.325 -0.46 0 N-CA-C 106.619 -1.622 . . . . 0.0 106.619 176.145 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 14.4 mt . . . . . 0 N--CA 1.443 -0.814 0 N-CA-C 115.076 1.509 . . . . 0.0 115.076 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -79.01 163.27 25.77 Favored 'Trans proline' 0 N--CA 1.462 -0.359 0 C-N-CA 122.352 2.035 . . . . 0.0 107.706 167.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 58.4 t80 -61.8 132.03 51.77 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 120.329 -0.549 . . . . 0.0 110.352 -178.027 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 90.94 -5.71 81.91 Favored Glycine 0 C--O 1.226 -0.362 0 CA-C-O 119.37 -0.683 . . . . 0.0 114.408 178.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -66.35 130.33 42.84 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 118.582 1.191 . . . . 0.0 111.117 179.126 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 57.5 t30 -77.11 128.07 33.78 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.24 -179.252 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 30.1 ttmt -156.17 151.78 27.07 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 179.499 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 29.4 t0 -64.81 132.38 49.34 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.933 0.397 . . . . 0.0 110.36 -178.398 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 68.1 28.83 73.24 Favored Glycine 0 N--CA 1.451 -0.351 0 CA-C-O 119.447 -0.64 . . . . 0.0 114.281 178.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 44.7 mm -128.3 127.56 67.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 117.465 0.632 . . . . 0.0 110.61 179.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -131.29 118.83 41.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.997 176.193 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 95.9 m95 -84.99 137.25 33.2 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 113.499 0.925 . . . . 0.0 113.499 -176.584 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 15.9 m -137.79 149.71 25.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.43 0.633 . . . . 0.0 109.856 179.488 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -157.81 166.43 32.74 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 105.43 -2.063 . . . . 0.0 105.43 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 14.7 t -131.34 179.84 5.78 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 105.94 -1.874 . . . . 0.0 105.94 178.492 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -67.54 135.38 52.89 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.231 0.539 . . . . 0.0 110.436 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 90.72 -9.33 78.01 Favored Glycine 0 C--O 1.23 -0.133 0 CA-C-N 115.932 -0.576 . . . . 0.0 113.513 177.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.528 ' HB1' ' HB ' ' A' ' 44' ' ' ILE . . . -73.15 131.43 42.03 Favored 'General case' 0 CA--C 1.544 0.733 0 O-C-N 122.525 -0.397 . . . . 0.0 110.646 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 26.7 mt -91.58 139.24 30.89 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 113.117 0.784 . . . . 0.0 113.117 -177.485 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 53.4 t30 -84.01 73.09 10.4 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.361 -179.613 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 1.3 t -142.23 152.33 60.81 Favored Pre-proline 0 C--N 1.323 -0.566 0 N-CA-C 107.551 -1.278 . . . . 0.0 107.551 179.131 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -66.45 149.18 84.68 Favored 'Trans proline' 0 CA--C 1.528 0.221 0 N-CA-C 114.278 0.838 . . . . 0.0 114.278 177.05 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -148.97 57.55 1.03 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.852 0.834 . . . . 0.0 112.733 179.124 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 32.0 t0 -60.51 -20.3 59.7 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.577 176.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 15.6 p80 -59.94 -10.98 4.67 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 113.543 0.942 . . . . 0.0 113.543 179.135 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 41.3 mt -96.21 -30.14 3.92 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 CA-C-O 120.698 0.285 . . . . 0.0 110.78 179.153 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -75.13 4.8 37.5 Favored Glycine 0 N--CA 1.462 0.413 0 N-CA-C 115.375 0.91 . . . . 0.0 115.375 -176.122 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 14.6 t -83.1 15.83 2.65 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 113.991 1.108 . . . . 0.0 113.991 -177.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 62.6 ttp85 -63.84 126.84 28.91 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 177.713 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -108.56 134.59 20.21 Favored Pre-proline 0 C--N 1.323 -0.551 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_endo -69.05 -18.22 40.47 Favored 'Trans proline' 0 C--O 1.218 -0.49 0 N-CA-C 114.934 1.09 . . . . 0.0 114.934 -175.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -77.03 -24.15 52.09 Favored 'General case' 0 C--O 1.221 -0.41 0 CA-C-O 121.106 0.479 . . . . 0.0 110.085 178.31 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -99.32 -28.48 13.28 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.64 -0.709 . . . . 0.0 112.848 -175.188 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 21.9 t30 -155.68 147.26 22.93 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 -178.343 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -84.1 145.55 28.38 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-O 121.44 0.638 . . . . 0.0 111.638 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -69.54 145.54 52.54 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.208 0.527 . . . . 0.0 110.525 178.389 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 18.3 mt -86.54 138.22 19.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 -178.445 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 92.5 t -61.24 124.03 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 N-CA-C 105.912 -1.885 . . . . 0.0 105.912 175.235 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 6.3 tt -66.4 128.78 37.5 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.155 0.502 . . . . 0.0 110.038 -176.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 -132.84 156.02 47.93 Favored 'General case' 0 CA--C 1.508 -0.659 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 -178.606 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 13.2 mt -111.75 148.87 39.83 Favored Pre-proline 0 C--N 1.322 -0.629 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 177.399 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -72.96 164.26 36.06 Favored 'Trans proline' 0 N--CA 1.462 -0.361 0 C-N-CA 118.079 -0.814 . . . . 0.0 112.575 -179.502 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -55.17 130.98 44.16 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 104.31 -23.77 30.84 Favored Glycine 0 C--O 1.226 -0.402 0 CA-C-N 116.01 -0.541 . . . . 0.0 112.538 -178.524 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 7.7 m -108.4 129.71 55.25 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 118.137 0.968 . . . . 0.0 111.23 178.308 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 4.7 p -119.73 148.33 43.53 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.572 179.067 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 80.4 mt -69.75 154.81 94.42 Favored Pre-proline 0 C--N 1.324 -0.539 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 178.115 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -76.78 168.77 22.98 Favored 'Trans proline' 0 C--O 1.233 0.232 0 C-N-CA 117.775 -1.017 . . . . 0.0 110.5 176.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 7.5 tmtm? -57.74 130.56 46.96 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.967 0.413 . . . . 0.0 111.863 -175.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 95.14 -6.99 69.32 Favored Glycine 0 C--O 1.235 0.204 0 CA-C-N 115.461 -0.791 . . . . 0.0 114.907 177.382 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.434 ' CZ ' ' HB2' ' A' ' 18' ' ' GLN . 2.5 m-85 -95.99 138.6 33.39 Favored 'General case' 0 CA--C 1.502 -0.877 0 CA-C-O 122.086 0.946 . . . . 0.0 111.126 179.818 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 38.6 p90 -142.64 160.28 40.6 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 113.583 -1.644 . . . . 0.0 107.867 175.106 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -102.5 144.89 30.36 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.121 0.486 . . . . 0.0 111.189 -177.445 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -71.87 136.14 46.85 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 106.63 -1.619 . . . . 0.0 106.63 177.567 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 86.13 -2.63 87.6 Favored Glycine 0 C--O 1.227 -0.333 0 C-N-CA 121.211 -0.519 . . . . 0.0 112.545 -177.201 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 8.2 t . . . . . 0 C--N 1.326 -0.425 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 177.722 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.456 -0.151 0 CA-C-O 120.885 0.374 . . . . 0.0 110.974 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 26.6 t -60.32 137.03 58.2 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 176.393 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . 0.4 ' HA ' ' HD3' ' A' ' 109' ' ' ARG . 9.8 m95 -70.83 -23.19 62.3 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.963 0.411 . . . . 0.0 111.18 178.451 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 24.8 m-85 -121.4 158.39 28.41 Favored 'General case' 0 C--O 1.241 0.634 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -171.128 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.424 ' HB ' ' HB3' ' A' ' 134' ' ' GLU . 72.0 p -69.06 163.34 24.93 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.012 -0.994 . . . . 0.0 109.189 179.153 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.426 ' HB2' ' CZ ' ' A' ' 69' ' ' TYR . . . -74.78 145.27 43.07 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 113.333 0.864 . . . . 0.0 113.333 -175.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 16.5 mt -85.74 148.9 25.64 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 103.754 -2.684 . . . . 0.0 103.754 169.349 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 31.0 m -124.86 128.97 49.49 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 178.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -82.42 137.26 34.75 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.018 179.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 72.0 t60 -139.32 94.93 2.85 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 104.085 -2.561 . . . . 0.0 104.085 168.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 163.74 -143.04 8.26 Favored Glycine 0 C--O 1.225 -0.437 0 C-N-CA 120.628 -0.796 . . . . 0.0 111.975 -175.561 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 54.7 mtpt -120.39 -25.56 5.59 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 116.98 2.215 . . . . 0.0 116.98 -175.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -94.41 159.37 15.14 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 117.861 0.3 . . . . 0.0 110.736 -176.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -63.07 -62.85 1.43 Allowed 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 111.999 0.37 . . . . 0.0 111.999 -178.217 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 51.3 tp 165.28 141.94 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.111 0 N-CA-C 103.849 -2.648 . . . . 0.0 103.849 178.51 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 23.3 tptm -156.76 140.66 16.2 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 118.242 0.474 . . . . 0.0 109.813 176.034 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 26.1 m-85 -126.89 150.43 71.66 Favored Pre-proline 0 C--N 1.324 -0.538 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 175.435 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -77.2 165.79 27.38 Favored 'Trans proline' 0 CA--C 1.538 0.697 0 C-N-CA 120.395 0.73 . . . . 0.0 112.571 177.382 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 75.7 ttt180 -66.81 136.37 55.34 Favored 'General case' 0 N--CA 1.472 0.649 0 O-C-N 122.107 -0.37 . . . . 0.0 110.318 -179.201 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 85.56 6.38 83.45 Favored Glycine 0 C--O 1.222 -0.596 0 N-CA-C 111.498 -0.641 . . . . 0.0 111.498 178.746 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.587 HE21 HG23 ' A' ' 125' ' ' THR . 23.3 mt-30 -146.25 170.55 16.53 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 -175.354 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.416 ' H ' HG21 ' A' ' 125' ' ' THR . . . 103.28 -21.64 38.89 Favored Glycine 0 CA--C 1.499 -0.952 0 CA-C-N 115.772 -0.649 . . . . 0.0 114.017 173.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 92.7 t -65.71 128.52 93.87 Favored Pre-proline 0 C--N 1.319 -0.739 0 N-CA-C 106.468 -1.679 . . . . 0.0 106.468 177.531 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -71.91 171.7 16.06 Favored 'Trans proline' 0 C--O 1.22 -0.384 0 O-C-N 122.183 0.57 . . . . 0.0 111.221 177.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 92.1 mt -71.09 106.36 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 179.584 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -96.44 84.2 3.67 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 114.399 -1.273 . . . . 0.0 109.318 -176.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 67.8 p -66.97 -14.72 63.14 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.69 0.757 . . . . 0.0 112.749 -178.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 10.6 p30 -106.18 20.32 19.14 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 114.906 -1.043 . . . . 0.0 112.441 -177.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 15.1 m -139.91 151.23 45.43 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 114.886 1.439 . . . . 0.0 114.886 -175.259 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 2.2 m -72.24 166.33 42.37 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.314 176.612 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -66.27 -25.97 49.34 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 114.964 -2.891 . . . . 0.0 114.19 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.451 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 3.3 p-10 -77.53 -21.43 52.64 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 121.51 -0.744 . . . . 0.0 110.83 177.491 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 70.7 m-20 -81.39 -7.14 59.53 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 113.69 0.996 . . . . 0.0 113.69 -175.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 96.1 mm-40 -58.6 -26.5 63.74 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 114.262 1.208 . . . . 0.0 114.262 -178.44 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.425 ' HB ' ' HB1' ' A' ' 98' ' ' ALA . 9.9 tt -58.66 138.31 19.86 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.958 0 N-CA-C 113.87 1.063 . . . . 0.0 113.87 -178.246 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -179.72 -156.98 19.12 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.746 -0.74 . . . . 0.0 111.903 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 42.8 p90 -155.16 171.06 20.41 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 178.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 23.5 m-85 -113.96 142.22 46.42 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 106.924 -1.51 . . . . 0.0 106.924 173.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 52.7 ttt180 -115.06 126.9 55.24 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.668 -178.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 10.1 ttp85 -70.05 133.06 46.8 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 176.22 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -115.51 123.55 48.82 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 176.267 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -153.2 144.31 23.01 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 114.974 -1.012 . . . . 0.0 108.546 -179.339 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 22.7 tpp180 -153.98 123.82 6.77 Favored 'General case' 0 C--O 1.217 -0.646 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 175.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.56 145.63 48.16 Favored 'General case' 0 CA--C 1.49 -1.334 0 CA-C-O 121.684 0.754 . . . . 0.0 110.895 179.356 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -142.79 176.41 3.48 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.959 0 N-CA-C 104.389 -2.448 . . . . 0.0 104.389 178.537 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 5.5 tmm_? -128.07 99.21 5.39 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 106.238 -1.764 . . . . 0.0 106.238 175.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -70.04 146.93 43.79 Favored Glycine 0 N--CA 1.451 -0.364 0 N-CA-C 108.878 -1.689 . . . . 0.0 108.878 178.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -63.06 -33.43 87.22 Favored Glycine 0 C--O 1.215 -1.048 0 C-N-CA 120.453 -0.88 . . . . 0.0 110.981 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 27.2 t0 -90.06 17.63 6.71 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-O 121.936 0.874 . . . . 0.0 111.598 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 86.6 -7.0 81.21 Favored Glycine 0 N--CA 1.462 0.391 0 N-CA-C 116.326 1.291 . . . . 0.0 116.326 174.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.71 128.44 36.29 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 114.211 1.189 . . . . 0.0 114.211 -178.159 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 98.3 mmm -96.56 177.95 5.5 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 106.503 -1.666 . . . . 0.0 106.503 176.304 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 6.6 tmtt? -103.63 -57.23 2.07 Favored 'General case' 0 CA--C 1.507 -0.675 0 CA-C-O 121.474 0.654 . . . . 0.0 110.49 177.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 25.4 p30 -133.8 170.34 15.72 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 178.395 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -125.02 -53.58 1.63 Allowed 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 179.736 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 25.9 t -108.09 147.43 35.51 Favored Pre-proline 0 C--O 1.24 0.558 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 178.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -72.93 155.13 53.35 Favored 'Trans proline' 0 C--O 1.24 0.612 0 N-CA-C 115.376 1.26 . . . . 0.0 115.376 -178.585 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 25.5 mtp180 -115.45 161.57 18.39 Favored 'General case' 0 CA--C 1.509 -0.604 0 N-CA-C 106.651 -1.611 . . . . 0.0 106.651 173.304 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 61.0 m95 -129.81 142.76 50.63 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 178.196 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.426 ' CZ ' ' HB2' ' A' ' 15' ' ' ALA . 53.8 m-85 -123.89 144.37 49.8 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 179.467 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 86.1 t80 -93.55 138.02 32.24 Favored 'General case' 0 CA--C 1.511 -0.54 0 N-CA-C 108.415 -0.958 . . . . 0.0 108.415 -177.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -141.49 143.14 33.67 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 -177.522 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -76.66 159.48 30.2 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.794 -0.639 . . . . 0.0 112.23 -176.05 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -55.08 131.22 44.53 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.571 -179.391 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 77.53 25.03 63.95 Favored Glycine 0 C--O 1.22 -0.719 0 N-CA-C 115.921 1.128 . . . . 0.0 115.921 176.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 7.4 p . . . . . 0 C--N 1.325 -0.467 0 CA-C-N 118.46 1.13 . . . . 0.0 109.364 179.01 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 21.2 mt . . . . . 0 C--O 1.237 0.425 0 N-CA-C 115.319 1.6 . . . . 0.0 115.319 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -77.06 164.22 29.82 Favored 'Trans proline' 0 N--CA 1.461 -0.43 0 N-CA-C 108.213 -1.495 . . . . 0.0 108.213 169.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 57.1 t80 -61.19 132.43 53.67 Favored 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 120.594 -0.442 . . . . 0.0 110.074 -179.073 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 91.63 -7.65 79.46 Favored Glycine 0 CA--C 1.52 0.349 0 N-CA-C 114.683 0.633 . . . . 0.0 114.683 178.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -64.89 131.74 47.52 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 118.267 1.034 . . . . 0.0 111.682 179.558 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 34.3 t-20 -77.27 128.56 34.55 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.764 -177.638 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 20.5 ttmt -156.14 150.93 26.09 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 106.41 -1.7 . . . . 0.0 106.41 177.398 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -65.09 133.64 52.06 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.823 0.344 . . . . 0.0 110.168 -179.363 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 69.87 24.98 76.1 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 121.018 -0.611 . . . . 0.0 114.181 177.463 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 39.1 mm -126.31 127.4 70.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 117.335 0.568 . . . . 0.0 109.682 178.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.1 pt -131.32 116.73 33.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 CA-C-O 121.752 0.787 . . . . 0.0 110.268 176.549 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 94.8 m95 -82.52 137.12 34.7 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.081 -0.509 . . . . 0.0 112.355 -177.01 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 16.4 m -137.83 149.7 25.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.646 0.736 . . . . 0.0 110.186 179.39 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -157.91 165.59 34.81 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 104.093 -2.558 . . . . 0.0 104.093 179.58 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 14.3 t -130.18 178.85 6.25 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 105.467 -2.049 . . . . 0.0 105.467 179.018 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -67.39 134.98 52.47 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.178 0.513 . . . . 0.0 109.849 -179.555 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 92.89 -12.38 70.04 Favored Glycine 0 C--O 1.227 -0.284 0 CA-C-N 115.92 -0.582 . . . . 0.0 113.255 178.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.451 ' HA ' ' HA ' ' A' ' 41' ' ' ASP . . . -70.16 130.7 42.79 Favored 'General case' 0 CA--C 1.542 0.668 0 O-C-N 122.56 -0.376 . . . . 0.0 110.644 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 24.4 mt -90.33 140.4 29.74 Favored 'General case' 0 C--O 1.219 -0.518 0 CA-C-O 121.392 0.615 . . . . 0.0 112.137 -178.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 58.6 t30 -84.14 70.12 10.48 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.681 -179.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 1.1 t -140.78 153.39 67.67 Favored Pre-proline 0 C--N 1.323 -0.559 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 179.434 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -68.0 152.35 76.87 Favored 'Trans proline' 0 C--N 1.343 0.26 0 N-CA-C 114.249 0.827 . . . . 0.0 114.249 177.525 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -152.08 55.15 0.82 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 122.904 1.335 . . . . 0.0 110.896 178.232 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 15.0 p-10 -58.67 -32.51 69.18 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 113.635 -1.62 . . . . 0.0 110.695 177.703 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 30.9 p-80 -58.94 -16.67 18.91 Favored 'General case' 0 C--O 1.218 -0.591 0 N-CA-C 114.429 1.27 . . . . 0.0 114.429 -179.043 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 75.0 mt -79.93 -33.39 14.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 178.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -76.97 11.21 15.87 Favored Glycine 0 C--O 1.225 -0.422 0 N-CA-C 116.006 1.163 . . . . 0.0 116.006 -176.216 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 15.2 t -83.06 25.19 0.71 Allowed 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 118.224 1.012 . . . . 0.0 112.021 -177.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.434 ' HD2' ' OD1' ' A' ' 114' ' ' ASN . 66.1 ttp85 -62.35 125.28 23.36 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 121.736 -0.602 . . . . 0.0 111.301 -178.549 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 7.8 m120 -88.38 115.63 63.84 Favored Pre-proline 0 C--N 1.326 -0.427 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 179.01 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -73.1 -11.22 25.14 Favored 'Trans proline' 0 C--O 1.218 -0.496 0 C-N-CA 117.963 -0.891 . . . . 0.0 114.233 -177.569 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -81.49 -24.47 36.69 Favored 'General case' 0 C--O 1.22 -0.46 0 CA-C-O 121.002 0.43 . . . . 0.0 110.086 177.341 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -99.84 -30.37 12.08 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.779 -0.646 . . . . 0.0 112.383 -175.239 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . 0.434 ' OD1' ' HD2' ' A' ' 109' ' ' ARG . 0.5 OUTLIER -131.97 151.08 51.95 Favored 'General case' 0 N--CA 1.437 -1.075 0 CA-C-O 121.338 0.59 . . . . 0.0 111.623 -178.31 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -94.82 137.55 33.75 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.084 -0.962 . . . . 0.0 108.852 176.421 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -63.66 146.14 54.37 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.405 0.621 . . . . 0.0 111.208 -179.392 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 24.1 mt -82.04 134.2 27.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.155 -178.009 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 67.7 t -60.1 123.28 12.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 N-CA-C 105.879 -1.897 . . . . 0.0 105.879 174.435 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 6.3 tt -66.26 127.58 32.78 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.488 0.661 . . . . 0.0 110.28 -176.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 34.5 mt-30 -132.71 162.12 32.25 Favored 'General case' 0 CA--C 1.511 -0.527 0 N-CA-C 106.277 -1.749 . . . . 0.0 106.277 -178.703 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 17.2 mt -117.51 147.67 41.24 Favored Pre-proline 0 C--N 1.321 -0.633 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 178.174 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -73.75 173.37 14.07 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 120.662 0.908 . . . . 0.0 114.156 -177.5 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 56.5 tt0 -54.22 133.15 44.51 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.152 -179.698 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 88.25 -15.23 56.97 Favored Glycine 0 C--O 1.227 -0.295 0 CA-C-N 116.045 -0.525 . . . . 0.0 113.651 179.489 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.587 HG23 HE21 ' A' ' 30' ' ' GLN . 12.6 m -108.6 126.1 52.58 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 117.886 0.843 . . . . 0.0 110.445 -179.437 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 9.3 p -123.46 148.33 46.3 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.995 -178.178 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 91.9 mt -66.49 153.41 93.13 Favored Pre-proline 0 C--N 1.326 -0.452 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 177.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -76.03 169.53 21.91 Favored 'Trans proline' 0 N--CA 1.461 -0.396 0 C-N-CA 118.154 -0.764 . . . . 0.0 111.074 -179.205 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 58.7 tttp -59.7 126.75 28.82 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 179.705 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 89.36 30.76 12.96 Favored Glycine 0 C--O 1.225 -0.42 0 N-CA-C 115.947 1.139 . . . . 0.0 115.947 178.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -140.57 149.15 42.03 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 117.811 0.806 . . . . 0.0 111.35 177.113 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 46.2 p90 -149.42 164.51 34.78 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 107.216 -1.402 . . . . 0.0 107.216 175.485 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -106.72 149.97 26.75 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.228 0.537 . . . . 0.0 110.926 -178.562 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.424 ' HB3' ' HB ' ' A' ' 14' ' ' THR . 0.9 OUTLIER -71.67 131.32 42.99 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 108.293 -1.002 . . . . 0.0 108.293 179.462 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 81.88 2.29 90.51 Favored Glycine 0 C--O 1.225 -0.455 0 C-N-CA 121.23 -0.51 . . . . 0.0 112.708 -179.379 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 6.9 t . . . . . 0 C--N 1.325 -0.483 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 179.383 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 0.227 0 CA-C-O 121.252 0.548 . . . . 0.0 109.549 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 42.1 t -59.22 142.29 52.16 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.57 177.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 14.9 m95 -64.85 -23.33 67.2 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 113.132 0.79 . . . . 0.0 113.132 178.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 43.3 m-85 -121.48 164.16 17.63 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 113.284 0.846 . . . . 0.0 113.284 -170.132 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 66.9 p -70.16 163.63 25.91 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 108.199 -1.038 . . . . 0.0 108.199 178.457 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -73.8 149.96 41.35 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.425 0.631 . . . . 0.0 111.569 -176.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.408 HD23 ' HA ' ' A' ' 16' ' ' LEU . 12.2 mt -89.86 137.82 32.01 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 102.859 -3.015 . . . . 0.0 102.859 168.66 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 49.4 m -113.82 126.72 55.52 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -77.57 136.4 38.28 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 178.624 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 32.3 t60 -139.23 94.87 2.85 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 104.786 -2.302 . . . . 0.0 104.786 170.604 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 152.26 -134.69 4.65 Favored Glycine 0 C--O 1.227 -0.293 0 C-N-CA 120.245 -0.979 . . . . 0.0 112.671 -175.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -126.73 -24.77 3.49 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 116.963 2.208 . . . . 0.0 116.963 -176.275 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -73.44 156.45 38.25 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 178.687 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -77.24 -58.31 3.35 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 178.396 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 62.4 tp 167.52 137.37 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.177 0 N-CA-C 104.772 -2.307 . . . . 0.0 104.772 173.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 22.9 tptm -157.64 142.53 16.68 Favored 'General case' 0 C--O 1.221 -0.44 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 176.11 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 27.9 m-85 -127.67 151.26 75.03 Favored Pre-proline 0 C--O 1.24 0.577 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 176.128 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -72.2 156.8 54.94 Favored 'Trans proline' 0 C--N 1.351 0.686 0 O-C-N 122.107 0.53 . . . . 0.0 111.996 176.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.67 134.34 52.06 Favored 'General case' 0 N--CA 1.472 0.637 0 O-C-N 121.986 -0.446 . . . . 0.0 110.487 -178.161 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 90.67 1.85 73.43 Favored Glycine 0 N--CA 1.46 0.295 0 N-CA-C 111.174 -0.77 . . . . 0.0 111.174 179.624 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 30.7 mt-30 -144.33 170.49 15.91 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 123.846 0.858 . . . . 0.0 108.902 -175.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 107.3 -17.42 37.26 Favored Glycine 0 CA--C 1.498 -0.981 0 CA-C-N 116.059 -0.518 . . . . 0.0 113.369 173.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.413 HG11 ' HB3' ' A' ' 43' ' ' GLN . 57.2 t -67.39 129.17 93.73 Favored Pre-proline 0 C--N 1.319 -0.722 0 N-CA-C 105.767 -1.938 . . . . 0.0 105.767 176.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -71.73 171.01 17.31 Favored 'Trans proline' 0 N--CA 1.459 -0.505 0 O-C-N 122.196 0.577 . . . . 0.0 111.2 178.146 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 95.0 mt -71.09 107.44 2.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 179.529 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.418 ' HB2' HE22 ' A' ' 43' ' ' GLN . 90.7 m-20 -93.11 84.33 4.83 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 114.175 -1.375 . . . . 0.0 109.354 -177.386 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 81.0 p -66.9 -15.06 63.41 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 114.003 1.112 . . . . 0.0 114.003 -177.101 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -111.39 17.28 20.29 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.282 -0.872 . . . . 0.0 112.846 -176.42 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -140.73 169.78 16.99 Favored 'General case' 0 CA--C 1.543 0.673 0 N-CA-C 115.891 1.812 . . . . 0.0 115.891 -171.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 35.4 m -94.41 161.35 29.48 Favored Pre-proline 0 C--O 1.218 -0.597 0 C-N-CA 124.343 1.057 . . . . 0.0 112.592 -174.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -65.24 -24.71 58.1 Favored 'Trans proline' 0 CA--C 1.535 0.557 0 C-N-CA 115.474 -2.551 . . . . 0.0 115.572 -178.249 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -75.16 -24.42 57.91 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 121.551 -0.718 . . . . 0.0 111.921 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 15.5 p30 -95.07 1.0 54.94 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 115.021 1.489 . . . . 0.0 115.021 -171.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.418 HE22 ' HB2' ' A' ' 35' ' ' ASN . 82.7 mm-40 -56.96 -24.09 50.44 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.591 -0.731 . . . . 0.0 112.8 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 11.3 tt -61.14 136.98 24.14 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.805 0 CA-C-O 122.533 1.158 . . . . 0.0 112.652 179.448 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 178.23 -156.35 19.11 Favored Glycine 0 N--CA 1.448 -0.527 0 N-CA-C 111.187 -0.765 . . . . 0.0 111.187 -178.165 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 45.3 p90 -155.15 172.11 18.69 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 179.278 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 14.3 m-85 -113.14 138.75 49.48 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 173.12 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 54.4 ttt-85 -108.12 124.69 50.62 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.549 -178.055 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 43.8 ttt180 -63.75 135.98 57.09 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 176.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -135.67 127.03 28.45 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.5 0.667 . . . . 0.0 111.928 -179.472 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 11.3 p -137.21 131.16 32.05 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 176.505 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 10.5 tpp180 -167.38 135.71 2.54 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 178.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 45.2 mtt180 -121.13 165.81 14.82 Favored 'General case' 0 CA--C 1.497 -1.071 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 177.277 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -134.79 173.97 13.68 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 N-CA-C 104.707 -2.331 . . . . 0.0 104.707 -179.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.31 109.03 7.5 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 175.421 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -77.73 159.64 48.09 Favored Glycine 0 C--O 1.228 -0.228 0 N-CA-C 107.263 -2.335 . . . . 0.0 107.263 176.353 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -58.12 -42.05 94.97 Favored Glycine 0 C--O 1.224 -0.527 0 CA-C-N 118.464 1.132 . . . . 0.0 112.082 -178.366 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.7 t0 -80.07 17.16 1.04 Allowed 'General case' 0 CA--C 1.548 0.881 0 CA-C-O 122.278 1.037 . . . . 0.0 112.658 -179.618 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 85.03 14.94 68.27 Favored Glycine 0 CA--C 1.504 -0.605 0 CA-C-N 115.417 -0.811 . . . . 0.0 113.179 171.314 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 33.3 mmtt -76.34 128.26 34.5 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.128 0.49 . . . . 0.0 110.374 -175.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 93.6 mmm -116.52 157.99 24.35 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 108.002 -1.111 . . . . 0.0 108.002 -178.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 14.0 tppt? -84.51 -43.46 14.54 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 106.638 -1.615 . . . . 0.0 106.638 176.274 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.5 t70 53.26 -145.53 0.59 Allowed 'General case' 0 C--O 1.241 0.623 0 CA-C-N 114.616 -1.174 . . . . 0.0 111.076 177.395 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.2 mm? 67.17 173.93 0.26 Allowed 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 116.062 1.875 . . . . 0.0 116.062 175.353 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -67.97 169.28 10.13 Favored Pre-proline 0 C--O 1.24 0.574 0 CA-C-N 113.962 -1.472 . . . . 0.0 113.91 -176.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -67.49 155.86 68.53 Favored 'Trans proline' 0 C--N 1.354 0.846 0 C-N-CA 116.107 -2.128 . . . . 0.0 112.659 177.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.31 160.1 21.65 Favored 'General case' 0 CA--C 1.505 -0.764 0 N-CA-C 105.377 -2.083 . . . . 0.0 105.377 178.051 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 53.1 m95 -131.47 146.53 52.29 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 178.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -126.75 142.32 51.58 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 179.343 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 81.3 t80 -88.79 136.88 32.77 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 108.59 -0.892 . . . . 0.0 108.59 -178.22 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -140.4 139.52 35.3 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 -176.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 75.2 m-85 -74.35 159.48 32.33 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.762 -0.653 . . . . 0.0 111.527 -175.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -55.91 131.12 46.27 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.194 0.521 . . . . 0.0 112.373 -178.131 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 75.5 26.8 64.71 Favored Glycine 0 C--O 1.218 -0.882 0 N-CA-C 115.842 1.097 . . . . 0.0 115.842 175.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 2.8 p . . . . . 0 C--N 1.323 -0.548 0 CA-C-N 118.606 1.203 . . . . 0.0 108.472 178.674 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 16.3 mt . . . . . 0 N--CA 1.445 -0.692 0 N-CA-C 114.768 1.395 . . . . 0.0 114.768 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -78.33 164.89 26.15 Favored 'Trans proline' 0 N--CA 1.461 -0.409 0 N-CA-C 107.97 -1.588 . . . . 0.0 107.97 169.32 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.429 ' CE1' ' HB3' ' A' ' 92' ' ' TRP . 66.7 t80 -61.25 133.08 55.53 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 120.353 -0.539 . . . . 0.0 110.148 -179.535 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 90.73 -7.03 81.87 Favored Glycine 0 CA--C 1.519 0.325 0 N-CA-C 114.797 0.679 . . . . 0.0 114.797 178.442 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -65.02 129.18 38.74 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 118.469 1.135 . . . . 0.0 111.546 179.597 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 60.0 t30 -76.62 127.54 32.99 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.694 -178.052 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 27.7 ttmt -156.14 152.14 27.56 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 106.686 -1.598 . . . . 0.0 106.686 179.687 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 17.6 t0 -63.79 129.48 40.27 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.14 0.495 . . . . 0.0 110.167 -178.18 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 70.18 26.69 73.9 Favored Glycine 0 N--CA 1.443 -0.835 0 CA-C-N 115.723 -0.671 . . . . 0.0 114.672 176.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 47.2 mm -125.41 123.52 65.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 178.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -126.88 115.43 41.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.514 -0.767 . . . . 0.0 110.163 176.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . 0.429 ' HB3' ' CE1' ' A' ' 83' ' ' TYR . 96.2 m95 -82.02 137.29 35.12 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 112.697 0.629 . . . . 0.0 112.697 -176.577 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 17.3 m -136.93 149.73 26.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 178.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -158.97 166.59 31.43 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 103.465 -2.791 . . . . 0.0 103.465 -178.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 6.6 t -134.76 -179.03 5.35 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 106.311 -1.737 . . . . 0.0 106.311 177.685 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -67.53 134.13 50.72 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.235 0.54 . . . . 0.0 110.688 -178.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 92.06 -10.05 75.21 Favored Glycine 0 C--O 1.229 -0.174 0 CA-C-N 115.915 -0.584 . . . . 0.0 113.662 177.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -70.83 134.9 47.73 Favored 'General case' 0 CA--C 1.544 0.728 0 O-C-N 122.523 -0.399 . . . . 0.0 111.247 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 29.3 mt -93.39 135.77 34.3 Favored 'General case' 0 CA--C 1.511 -0.552 0 N-CA-C 112.997 0.74 . . . . 0.0 112.997 -178.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 52.1 t30 -85.09 76.62 10.21 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.57 -178.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 1.2 t -146.42 155.66 49.67 Favored Pre-proline 0 C--N 1.322 -0.616 0 N-CA-C 105.607 -1.997 . . . . 0.0 105.607 179.47 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -69.01 149.96 72.24 Favored 'Trans proline' 0 CA--C 1.531 0.338 0 N-CA-C 113.729 0.627 . . . . 0.0 113.729 177.068 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 4.7 ptpt -152.8 56.67 0.79 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 122.78 1.276 . . . . 0.0 110.184 178.526 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -58.85 -31.31 68.4 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.08 -1.418 . . . . 0.0 112.586 -179.202 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 16.2 p80 -61.0 -9.09 3.78 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 114.589 1.329 . . . . 0.0 114.589 -177.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 50.4 mt -91.08 -37.92 9.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 178.194 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -75.48 14.64 5.21 Favored Glycine 0 CA--C 1.52 0.396 0 N-CA-C 115.428 0.931 . . . . 0.0 115.428 -177.073 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 11.6 t -95.61 24.24 5.43 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -177.658 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.42 ' HD2' HD22 ' A' ' 114' ' ' ASN . 62.5 ttp85 -59.37 130.91 49.24 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 177.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -101.98 135.42 19.69 Favored Pre-proline 0 C--N 1.323 -0.586 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 179.563 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -73.47 -18.33 22.95 Favored 'Trans proline' 0 C--O 1.219 -0.427 0 C-N-CA 118.387 -0.609 . . . . 0.0 113.017 -178.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -77.42 -25.05 50.36 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.894 0.378 . . . . 0.0 110.369 178.37 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 95.2 m-20 -101.1 -21.4 14.99 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 114.062 1.134 . . . . 0.0 114.062 -175.389 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . 0.42 HD22 ' HD2' ' A' ' 109' ' ' ARG . 29.8 t30 -158.26 151.99 23.63 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 -178.277 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -88.78 145.64 25.48 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-O 121.436 0.636 . . . . 0.0 111.711 178.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -70.18 147.51 49.76 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.18 0.514 . . . . 0.0 111.144 178.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 12.1 mt -88.61 138.29 19.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.095 -178.696 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 71.7 t -59.65 122.39 9.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 N-CA-C 106.908 -1.515 . . . . 0.0 106.908 175.148 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 6.4 tt -67.71 128.22 35.66 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.251 0.548 . . . . 0.0 109.695 -177.387 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -134.27 160.26 38.45 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 106.359 -1.719 . . . . 0.0 106.359 -179.273 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 13.6 mt -113.91 147.65 38.19 Favored Pre-proline 0 C--N 1.322 -0.629 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 177.197 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -72.7 164.93 34.18 Favored 'Trans proline' 0 C--O 1.236 0.396 0 O-C-N 122.26 0.611 . . . . 0.0 112.574 -179.338 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -55.42 131.48 46.0 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.289 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 101.98 -22.3 38.68 Favored Glycine 0 C--O 1.226 -0.35 0 CA-C-N 115.945 -0.571 . . . . 0.0 112.505 -178.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 9.5 m -108.58 130.79 55.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 117.992 0.896 . . . . 0.0 110.98 178.498 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 6.1 p -122.05 148.35 44.95 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.651 -179.492 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 84.5 mt -66.53 156.14 86.81 Favored Pre-proline 0 C--N 1.324 -0.515 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 178.246 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -74.22 173.99 13.23 Favored 'Trans proline' 0 C--O 1.238 0.486 0 N-CA-C 110.453 -0.634 . . . . 0.0 110.453 -179.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -62.73 123.46 18.48 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.643 0.735 . . . . 0.0 110.269 -176.413 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 85.95 45.9 5.54 Favored Glycine 0 N--CA 1.449 -0.491 0 N-CA-C 115.854 1.102 . . . . 0.0 115.854 179.021 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -145.6 149.18 34.06 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 117.534 0.667 . . . . 0.0 111.726 177.565 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 47.1 p90 -148.14 165.32 31.22 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 174.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -105.63 145.43 31.03 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.754 0.311 . . . . 0.0 110.186 -178.326 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -68.87 131.44 45.12 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 -179.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 86.73 -15.15 53.71 Favored Glycine 0 CA--C 1.521 0.455 0 CA-C-N 115.971 -0.558 . . . . 0.0 114.11 -177.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 32.9 t . . . . . 0 C--N 1.326 -0.44 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 179.749 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 -0.183 0 CA-C-O 121.7 0.762 . . . . 0.0 111.894 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.67 143.77 55.82 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 114.773 -1.103 . . . . 0.0 108.249 177.536 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . 0.467 ' CD2' ' HD3' ' A' ' 109' ' ' ARG . 16.2 m95 -68.45 -21.86 64.61 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 113.627 0.973 . . . . 0.0 113.627 179.417 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 25.4 m-85 -121.37 161.1 22.7 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 114.226 1.195 . . . . 0.0 114.226 -171.144 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.403 ' HB ' ' HB3' ' A' ' 134' ' ' GLU . 72.9 p -68.34 163.29 23.38 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 114.43 -1.259 . . . . 0.0 111.247 -178.566 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.545 ' HB2' ' CZ ' ' A' ' 69' ' ' TYR . . . -75.99 134.11 40.24 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 113.563 0.949 . . . . 0.0 113.563 -175.801 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.433 HD13 HD13 ' A' ' 119' ' ' LEU . 1.9 mp -84.8 146.67 27.23 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 105.388 -2.078 . . . . 0.0 105.388 170.286 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 69.8 m -126.24 131.03 52.02 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 -177.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.441 ' HB2' ' CZ ' ' A' ' 131' ' ' PHE . 4.1 tp60 -97.79 138.58 34.95 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.912 -0.586 . . . . 0.0 112.11 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 52.6 t60 -128.55 99.22 5.29 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 104.722 -2.325 . . . . 0.0 104.722 168.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 168.46 -166.18 39.38 Favored Glycine 0 N--CA 1.451 -0.334 0 N-CA-C 109.14 -1.584 . . . . 0.0 109.14 -176.293 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -103.45 -26.9 12.7 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 113.404 0.89 . . . . 0.0 113.404 -178.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -80.87 160.17 24.83 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 106.981 -1.488 . . . . 0.0 106.981 177.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -85.86 -62.9 1.42 Allowed 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 113.051 0.759 . . . . 0.0 113.051 -177.734 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 51.2 tp -177.79 142.79 0.31 Allowed 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 106.892 -1.522 . . . . 0.0 106.892 175.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.1 tmtp? -158.11 138.41 12.59 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 175.593 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 14.9 m-85 -121.87 153.36 60.38 Favored Pre-proline 0 C--O 1.239 0.534 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 176.205 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -70.48 158.76 55.06 Favored 'Trans proline' 0 C--N 1.351 0.67 0 O-C-N 121.957 0.451 . . . . 0.0 112.468 177.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 9.7 tpp85 -64.29 135.59 56.36 Favored 'General case' 0 C--O 1.217 -0.651 0 CA-C-N 116.572 -0.286 . . . . 0.0 111.251 -178.541 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 78.94 13.63 82.88 Favored Glycine 0 C--O 1.224 -0.487 0 C-N-CA 121.268 -0.491 . . . . 0.0 112.259 178.188 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 8.4 mt-30 -150.24 170.49 18.86 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 -175.541 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 106.96 -18.69 36.49 Favored Glycine 0 CA--C 1.503 -0.681 0 CA-C-N 116.278 -0.419 . . . . 0.0 113.16 175.115 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 99.1 t -65.6 128.4 93.78 Favored Pre-proline 0 C--N 1.321 -0.669 0 N-CA-C 106.962 -1.495 . . . . 0.0 106.962 177.655 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.415 ' HB3' HD21 ' A' ' 119' ' ' LEU . 84.2 Cg_endo -75.17 170.02 21.27 Favored 'Trans proline' 0 N--CA 1.461 -0.438 0 O-C-N 122.217 0.588 . . . . 0.0 111.84 179.296 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 91.2 mt -69.36 109.03 2.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 178.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 78.1 m-20 -99.25 85.69 3.25 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 114.506 -1.224 . . . . 0.0 109.924 -177.294 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 72.9 p -67.79 -15.1 63.47 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.524 0.678 . . . . 0.0 112.542 -178.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 11.6 p30 -108.17 19.61 19.71 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 114.977 -1.011 . . . . 0.0 113.287 -177.224 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 7.6 m -137.94 152.85 49.36 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 114.689 1.366 . . . . 0.0 114.689 -175.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 58.9 m -73.78 164.14 63.31 Favored Pre-proline 0 CA--C 1.537 0.476 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.65 177.341 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -66.21 -25.18 50.47 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 115.362 -2.625 . . . . 0.0 114.499 -178.475 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.443 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 6.4 p-10 -75.23 -26.45 58.92 Favored 'General case' 0 C--N 1.323 -0.569 0 O-C-N 121.616 -0.677 . . . . 0.0 110.579 177.152 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.547 ' HA ' ' HE3' ' A' ' 103' ' ' LYS . 32.6 m-20 -76.69 -8.11 56.62 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.485 1.114 . . . . 0.0 113.674 -175.801 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 95.0 mm-40 -59.64 -31.24 69.33 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 114.667 1.358 . . . . 0.0 114.667 -177.456 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.419 ' HB ' ' HB1' ' A' ' 98' ' ' ALA . 14.8 tt -60.17 140.04 18.78 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.81 0 CA-C-O 122.223 1.011 . . . . 0.0 112.567 -179.729 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 179.35 -155.36 15.69 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.494 -0.86 . . . . 0.0 111.678 -178.18 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 49.9 p90 -155.13 173.38 16.69 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 179.449 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 20.0 m-85 -113.33 140.39 48.05 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 106.927 -1.509 . . . . 0.0 106.927 173.381 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 66.7 ttt-85 -112.4 130.68 55.89 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.981 -177.535 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 29.2 ttt-85 -68.96 142.49 54.67 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 176.001 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -142.23 133.17 25.82 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.799 0.333 . . . . 0.0 110.109 177.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -156.74 131.8 9.06 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 177.072 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -129.1 123.98 33.62 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 108.253 -1.018 . . . . 0.0 108.253 174.079 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.55 137.24 54.82 Favored 'General case' 0 CA--C 1.488 -1.421 0 CA-C-O 121.493 0.663 . . . . 0.0 110.206 -177.44 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -127.49 176.91 6.48 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 N-CA-C 106.636 -1.616 . . . . 0.0 106.636 179.212 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 56.1 ttp180 -127.85 116.87 20.82 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 174.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -85.06 161.56 36.16 Favored Glycine 0 C--O 1.224 -0.474 0 N-CA-C 106.233 -2.747 . . . . 0.0 106.233 176.129 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -64.91 -35.93 92.49 Favored Glycine 0 C--O 1.216 -0.998 0 CA-C-N 118.671 1.235 . . . . 0.0 110.345 179.441 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 32.1 t0 -91.26 17.17 8.65 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-O 122.374 1.083 . . . . 0.0 110.62 178.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 84.16 -7.06 73.05 Favored Glycine 0 N--CA 1.46 0.27 0 N-CA-C 117.25 1.66 . . . . 0.0 117.25 172.579 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.56 150.53 31.33 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 122.586 1.184 . . . . 0.0 112.914 -177.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 73.1 mtp -119.95 -174.49 2.77 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 112.775 -2.011 . . . . 0.0 112.871 -174.535 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 25.4 mmtt -123.23 -72.99 0.66 Allowed 'General case' 0 C--O 1.219 -0.535 0 C-N-CA 122.917 0.487 . . . . 0.0 109.701 179.511 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -93.7 147.63 22.85 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 106.935 -1.506 . . . . 0.0 106.935 177.06 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -124.74 -63.57 1.17 Allowed 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 106.194 -1.78 . . . . 0.0 106.194 178.347 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -82.02 152.49 68.58 Favored Pre-proline 0 C--O 1.241 0.657 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 176.392 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -75.39 149.28 34.93 Favored 'Trans proline' 0 C--O 1.238 0.491 0 C-N-CA 115.632 -2.445 . . . . 0.0 112.701 179.068 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 94.8 mtt-85 -103.89 152.18 22.25 Favored 'General case' 0 CA--C 1.506 -0.745 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 177.206 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 71.7 m95 -132.44 137.67 47.35 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 175.313 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.545 ' CZ ' ' HB2' ' A' ' 15' ' ' ALA . 78.1 m-85 -127.63 147.39 50.36 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 -179.35 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 74.1 t80 -90.76 137.0 32.7 Favored 'General case' 0 CA--C 1.507 -0.68 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -139.25 140.3 37.65 Favored 'General case' 0 N--CA 1.439 -1.007 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 -175.501 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -79.87 159.51 26.4 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.428 -174.485 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -53.39 124.12 13.87 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.97 0.414 . . . . 0.0 111.608 -178.082 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 82.86 13.51 77.58 Favored Glycine 0 C--O 1.222 -0.595 0 N-CA-C 116.514 1.366 . . . . 0.0 116.514 178.012 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 23.7 p . . . . . 0 N--CA 1.47 0.561 0 CA-C-N 119.032 1.416 . . . . 0.0 111.224 179.733 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 15.9 mt . . . . . 0 N--CA 1.448 -0.535 0 N-CA-C 115.94 1.83 . . . . 0.0 115.94 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -77.8 161.66 30.25 Favored 'Trans proline' 0 N--CA 1.461 -0.384 0 N-CA-C 107.416 -1.802 . . . . 0.0 107.416 168.238 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 58.1 t80 -61.41 133.22 55.55 Favored 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 120.277 -0.569 . . . . 0.0 110.848 -177.289 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 90.99 -9.02 78.99 Favored Glycine 0 CA--C 1.519 0.31 0 CA-C-O 119.445 -0.642 . . . . 0.0 114.366 179.279 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -65.37 130.8 44.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 118.343 1.072 . . . . 0.0 111.154 179.461 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 58.4 t30 -79.01 130.17 35.24 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.389 -179.244 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 28.4 ttmt -156.14 152.0 27.39 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 107.675 -1.232 . . . . 0.0 107.675 179.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 38.2 t0 -62.58 129.79 42.16 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.883 0.373 . . . . 0.0 110.421 -179.117 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 69.57 27.52 73.32 Favored Glycine 0 N--CA 1.45 -0.404 0 CA-C-O 119.324 -0.709 . . . . 0.0 114.696 178.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 40.8 mm -127.5 128.82 70.2 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 CA-C-N 117.643 0.722 . . . . 0.0 110.918 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -132.81 117.15 29.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 CA-C-O 121.465 0.65 . . . . 0.0 111.352 177.049 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 97.4 m95 -81.52 138.26 35.48 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 114.063 1.134 . . . . 0.0 114.063 -176.444 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 16.3 m -139.32 151.15 22.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.626 -0.716 . . . . 0.0 109.153 178.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -158.8 166.54 31.7 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 105.87 -1.9 . . . . 0.0 105.87 -179.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 14.5 t -133.95 169.45 17.09 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 105.361 -2.088 . . . . 0.0 105.361 178.126 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -65.89 136.26 55.89 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.263 0.554 . . . . 0.0 109.954 -179.105 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 96.21 -12.17 66.89 Favored Glycine 0 C--O 1.229 -0.182 0 CA-C-N 115.768 -0.651 . . . . 0.0 113.044 178.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.443 ' HA ' ' HA ' ' A' ' 41' ' ' ASP . . . -76.66 139.95 40.75 Favored 'General case' 0 CA--C 1.542 0.635 0 O-C-N 122.458 -0.436 . . . . 0.0 110.22 179.109 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 39.7 mt -98.32 137.79 36.52 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 113.771 1.026 . . . . 0.0 113.771 -177.126 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 56.9 t30 -82.95 76.43 9.78 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.544 0.687 . . . . 0.0 110.299 179.388 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 1.2 t -146.26 160.69 41.75 Favored Pre-proline 0 C--N 1.321 -0.67 0 N-CA-C 102.218 -3.253 . . . . 0.0 102.218 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -72.59 148.91 48.39 Favored 'Trans proline' 0 CA--C 1.538 0.678 0 N-CA-C 114.172 0.797 . . . . 0.0 114.172 176.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.547 ' HE3' ' HA ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -143.91 54.88 1.31 Allowed 'General case' 0 N--CA 1.474 0.727 0 CA-C-O 123.406 1.574 . . . . 0.0 108.485 176.835 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 14.6 p-10 -64.56 -25.39 67.96 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 113.244 -1.798 . . . . 0.0 110.721 178.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 20.6 p-80 -56.33 -19.64 15.4 Favored 'General case' 0 C--O 1.221 -0.415 0 N-CA-C 114.205 1.187 . . . . 0.0 114.205 -179.026 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.421 HD11 ' CG ' ' A' ' 42' ' ' ASP . 20.5 mt -82.69 -28.15 8.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-O 121.371 0.605 . . . . 0.0 109.735 -179.243 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -77.28 5.13 52.32 Favored Glycine 0 CA--C 1.519 0.317 0 N-CA-C 115.84 1.096 . . . . 0.0 115.84 -175.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 12.0 t -83.17 11.18 6.81 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 117.323 0.562 . . . . 0.0 112.321 -178.356 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.467 ' HD3' ' CD2' ' A' ' 12' ' ' TRP . 63.5 ttp85 -58.38 130.16 45.42 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 178.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -97.63 128.91 32.85 Favored Pre-proline 0 C--N 1.326 -0.454 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 178.102 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -75.69 -13.08 20.13 Favored 'Trans proline' 0 C--O 1.219 -0.451 0 N-CA-C 113.197 0.422 . . . . 0.0 113.197 -178.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -81.12 -24.09 37.92 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.092 0.472 . . . . 0.0 109.888 178.392 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -101.01 -27.41 13.29 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 113.293 0.849 . . . . 0.0 113.293 -174.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . 0.446 ' OD1' ' HD2' ' A' ' 109' ' ' ARG . 0.4 OUTLIER -139.39 152.43 47.11 Favored 'General case' 0 N--CA 1.437 -1.108 0 CA-C-O 121.263 0.554 . . . . 0.0 111.263 -177.595 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -95.73 137.31 34.98 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 115.199 -0.909 . . . . 0.0 108.94 176.19 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -65.32 148.6 51.42 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.435 0.636 . . . . 0.0 111.966 -178.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 16.8 mt -83.24 136.69 22.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.127 -178.459 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 88.7 t -61.64 122.77 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 N-CA-C 106.376 -1.713 . . . . 0.0 106.376 175.287 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.433 HD13 HD13 ' A' ' 16' ' ' LEU . 7.3 tt -66.76 131.32 45.69 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.237 0.542 . . . . 0.0 110.718 -176.414 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -130.96 154.48 48.1 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 106.452 -1.684 . . . . 0.0 106.452 179.416 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 13.3 mt -110.85 149.02 39.79 Favored Pre-proline 0 C--N 1.322 -0.603 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 178.059 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -73.83 167.06 28.16 Favored 'Trans proline' 0 C--N 1.345 0.343 0 O-C-N 122.2 0.579 . . . . 0.0 112.856 -179.497 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 55.7 tt0 -55.07 132.0 46.27 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.672 -0.694 . . . . 0.0 109.402 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 98.75 -20.98 48.19 Favored Glycine 0 C--O 1.226 -0.374 0 CA-C-N 115.981 -0.554 . . . . 0.0 113.065 -179.487 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 7.0 m -108.0 129.29 55.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 118.127 0.964 . . . . 0.0 110.688 178.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 4.8 p -122.34 148.44 45.05 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.245 -179.432 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 87.6 mt -70.64 153.42 94.95 Favored Pre-proline 0 C--N 1.325 -0.488 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 176.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -75.63 169.07 23.08 Favored 'Trans proline' 0 N--CA 1.463 -0.307 0 C-N-CA 117.949 -0.901 . . . . 0.0 110.913 178.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 39.8 tptt -60.13 131.83 52.05 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.125 -176.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 95.12 -6.06 68.78 Favored Glycine 0 C--O 1.228 -0.265 0 N-CA-C 115.006 0.762 . . . . 0.0 115.006 178.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.441 ' CZ ' ' HB2' ' A' ' 18' ' ' GLN . 1.3 m-85 -102.61 143.92 31.67 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-O 122.177 0.989 . . . . 0.0 111.752 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 45.2 p90 -146.45 165.61 28.87 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 113.6 -1.636 . . . . 0.0 107.342 173.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -108.56 148.07 30.85 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.949 0.405 . . . . 0.0 110.556 -178.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.403 ' HB3' ' HB ' ' A' ' 14' ' ' THR . 6.4 tp10 -70.43 136.51 49.6 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 178.769 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 81.22 -0.24 87.88 Favored Glycine 0 CA--C 1.52 0.385 0 C-N-CA 121.356 -0.449 . . . . 0.0 112.322 -176.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 4.3 t . . . . . 0 C--N 1.327 -0.407 0 CA-C-O 121.253 0.549 . . . . 0.0 110.22 179.998 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.177 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 29.1 p -66.36 144.69 56.39 Favored 'General case' 0 CA--C 1.508 -0.661 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 177.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 12.1 m95 -69.65 -21.9 63.5 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 120.859 0.361 . . . . 0.0 111.695 178.439 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -121.4 164.1 17.64 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -173.315 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 67.2 p -70.35 168.99 14.81 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.45 -1.25 . . . . 0.0 108.476 178.392 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.588 ' HB2' ' CZ ' ' A' ' 69' ' ' TYR . . . -73.87 156.7 37.44 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 122.309 1.052 . . . . 0.0 113.523 -176.306 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 11.5 mt -101.42 137.78 39.3 Favored 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 101.81 -3.404 . . . . 0.0 101.81 166.359 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 34.3 m -115.88 136.45 53.04 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 -177.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.454 ' HB2' ' CZ ' ' A' ' 131' ' ' PHE . 4.2 tp60 -114.0 137.58 51.51 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 113.959 1.096 . . . . 0.0 113.959 -176.091 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 6.5 t-160 -131.78 99.37 4.75 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 104.644 -2.354 . . . . 0.0 104.644 169.48 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 174.78 -168.35 40.95 Favored Glycine 0 C--O 1.225 -0.467 0 N-CA-C 110.562 -1.015 . . . . 0.0 110.562 -177.014 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -102.11 -25.18 13.82 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 112.832 0.678 . . . . 0.0 112.832 -179.177 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -82.86 158.23 22.8 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.316 -0.402 . . . . 0.0 109.999 -179.356 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -74.59 -62.93 1.36 Allowed 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.307 -178.462 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 28.6 tp 173.71 144.55 0.05 OUTLIER 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 103.333 -2.84 . . . . 0.0 103.333 177.338 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 11.0 tmtt? -155.45 134.26 12.02 Favored 'General case' 0 C--O 1.221 -0.442 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 176.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 9.6 m-85 -122.13 155.74 60.92 Favored Pre-proline 0 C--O 1.243 0.739 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 177.061 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -72.72 168.24 25.06 Favored 'Trans proline' 0 C--N 1.352 0.745 0 N-CA-C 113.409 0.503 . . . . 0.0 113.409 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 20.8 tpt180 -72.8 135.78 45.3 Favored 'General case' 0 C--O 1.215 -0.725 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 -178.244 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 83.86 7.32 85.86 Favored Glycine 0 C--O 1.223 -0.576 0 C-N-CA 121.236 -0.507 . . . . 0.0 112.893 177.527 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -150.19 168.42 24.04 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 -177.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 131.15 -30.29 3.35 Favored Glycine 0 CA--C 1.483 -1.927 0 N-CA-C 109.188 -1.565 . . . . 0.0 109.188 166.317 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 33.9 m -65.67 141.2 97.72 Favored Pre-proline 0 N--CA 1.433 -1.279 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 177.288 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_endo -74.01 176.48 9.45 Favored 'Trans proline' 0 N--CA 1.456 -0.691 0 C-N-CA 121.745 1.63 . . . . 0.0 110.821 178.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 91.3 mt -73.09 114.99 13.33 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 178.038 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 29.5 m-80 -109.14 82.86 1.66 Allowed 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 -179.412 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 60.9 p -67.28 -21.99 65.67 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 113.018 0.747 . . . . 0.0 113.018 -176.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 69.1 m-80 -106.1 35.74 2.82 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.054 -176.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 17.4 m -145.51 152.48 39.82 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 -179.217 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 4.6 m -73.08 164.79 58.33 Favored Pre-proline 0 C--N 1.324 -0.513 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 178.017 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -64.59 -26.24 61.75 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 114.748 -3.035 . . . . 0.0 111.14 177.624 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -62.18 -27.47 68.99 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 123.862 0.865 . . . . 0.0 111.573 175.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 77.3 m-20 -96.44 -4.9 40.86 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 115.225 1.565 . . . . 0.0 115.225 -171.418 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 90.6 mm-40 -59.6 -28.41 67.15 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 113.599 0.962 . . . . 0.0 113.599 -177.574 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 13.8 tt -57.45 141.52 14.34 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 N-CA-C 114.46 1.281 . . . . 0.0 114.46 -178.195 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -179.53 -153.47 11.87 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.071 179.318 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 49.5 p90 -155.03 169.51 23.94 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 177.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 19.3 m-85 -111.63 143.01 43.22 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 173.244 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 17.4 ttt180 -116.18 125.88 52.9 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.698 -178.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 18.2 ttp85 -68.67 135.93 52.15 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 107.956 -1.128 . . . . 0.0 107.956 176.56 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -127.52 125.32 40.19 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.401 0.619 . . . . 0.0 109.719 179.552 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -146.19 117.55 7.94 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.142 -0.935 . . . . 0.0 108.954 179.406 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 6.7 tpp85 -147.78 127.57 13.46 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 178.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 29.1 mtt85 -130.89 165.92 22.03 Favored 'General case' 0 CA--C 1.495 -1.153 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 177.39 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -141.06 179.4 2.34 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 -177.553 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 19.1 ttm180 -115.05 104.96 12.4 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 106.182 -1.785 . . . . 0.0 106.182 174.194 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -84.18 143.25 21.04 Favored Glycine 0 C--O 1.226 -0.392 0 N-CA-C 107.275 -2.33 . . . . 0.0 107.275 178.041 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -64.7 -38.5 95.71 Favored Glycine 0 C--O 1.219 -0.83 0 CA-C-N 118.404 1.102 . . . . 0.0 112.339 -177.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -85.76 11.58 10.77 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.7 0.762 . . . . 0.0 112.083 -179.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 84.7 20.33 58.34 Favored Glycine 0 C--O 1.226 -0.399 0 CA-C-N 115.235 -0.893 . . . . 0.0 112.467 176.657 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 21.6 mmtt -88.21 130.85 34.96 Favored 'General case' 0 C--N 1.324 -0.542 0 O-C-N 122.21 -0.582 . . . . 0.0 110.872 -175.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 86.8 mmm -100.98 159.9 14.82 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.156 -0.929 . . . . 0.0 109.128 -178.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 16.5 tppt? -83.22 -48.68 10.22 Favored 'General case' 0 C--O 1.219 -0.526 0 N-CA-C 108.401 -0.962 . . . . 0.0 108.401 177.526 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 21.3 t0 -162.82 163.53 26.53 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 105.327 -2.101 . . . . 0.0 105.327 177.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -117.28 -34.24 4.39 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 177.38 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 20.9 m -85.33 148.53 50.01 Favored Pre-proline 0 C--N 1.326 -0.425 0 N-CA-C 113.753 1.02 . . . . 0.0 113.753 -176.058 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -77.59 145.57 23.42 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 117.97 -0.887 . . . . 0.0 112.187 174.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 47.8 mtt180 -119.1 165.09 14.59 Favored 'General case' 0 CA--C 1.508 -0.656 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.864 179.049 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 64.9 m95 -134.25 144.32 48.32 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 106.588 -1.634 . . . . 0.0 106.588 172.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.588 ' CZ ' ' HB2' ' A' ' 15' ' ' ALA . 71.5 m-85 -130.16 148.51 52.01 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 178.144 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 76.1 t80 -92.59 134.73 34.71 Favored 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 -177.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -137.11 140.19 41.75 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 -176.493 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -77.87 159.51 28.88 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.167 -177.194 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -53.33 138.94 31.45 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 -179.233 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 70.51 38.27 69.03 Favored Glycine 0 C--O 1.225 -0.454 0 N-CA-C 115.726 1.05 . . . . 0.0 115.726 175.22 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 12.7 p . . . . . 0 C--N 1.325 -0.483 0 CA-C-N 117.804 0.802 . . . . 0.0 111.238 178.832 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 47.2 mt . . . . . 0 C--O 1.239 0.528 0 N-CA-C 114.892 1.442 . . . . 0.0 114.892 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -77.87 167.68 23.38 Favored 'Trans proline' 0 C--O 1.237 0.451 0 N-CA-C 108.725 -1.298 . . . . 0.0 108.725 170.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 62.8 t80 -62.42 131.46 49.3 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 179.161 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 92.97 -5.94 76.21 Favored Glycine 0 CA--C 1.52 0.344 0 N-CA-C 114.967 0.747 . . . . 0.0 114.967 178.577 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -64.49 129.18 38.88 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 118.296 1.048 . . . . 0.0 112.085 179.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 43.3 t-20 -75.24 126.6 31.35 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.912 -177.406 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 9.9 ttmm -156.18 150.85 25.93 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 177.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -63.58 134.05 54.82 Favored 'General case' 0 C--N 1.324 -0.529 0 O-C-N 123.176 0.298 . . . . 0.0 110.526 179.416 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 68.51 26.9 74.11 Favored Glycine 0 N--CA 1.45 -0.387 0 CA-C-O 119.496 -0.613 . . . . 0.0 114.081 177.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 34.0 mm -130.18 130.81 65.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 117.417 0.608 . . . . 0.0 109.831 179.277 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.1 pt -132.5 113.49 21.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 CA-C-O 121.5 0.667 . . . . 0.0 110.815 175.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 95.1 m95 -80.98 131.85 35.35 Favored 'General case' 0 C--N 1.321 -0.662 0 O-C-N 121.893 -0.505 . . . . 0.0 111.492 -177.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 2.8 m -139.96 150.86 21.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.819 -177.269 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -156.71 166.57 33.02 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 106.071 -1.826 . . . . 0.0 106.071 -178.553 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 14.8 t -125.9 167.48 15.2 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 105.072 -2.195 . . . . 0.0 105.072 176.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -66.45 136.6 55.94 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 -179.491 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 96.09 -10.87 67.81 Favored Glycine 0 C--O 1.225 -0.432 0 CA-C-N 115.966 -0.561 . . . . 0.0 113.114 178.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -78.44 141.43 38.28 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 122.308 -0.525 . . . . 0.0 110.744 179.378 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 33.9 mt -91.79 135.64 33.76 Favored 'General case' 0 CA--C 1.51 -0.57 0 CA-C-O 121.429 0.633 . . . . 0.0 112.561 -178.577 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 58.5 t30 -82.32 70.05 9.19 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.601 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 2.0 t -142.48 157.55 62.3 Favored Pre-proline 0 CA--C 1.54 0.578 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 -178.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_exo -61.86 149.21 91.04 Favored 'Trans proline' 0 C--N 1.348 0.539 0 N-CA-C 114.407 0.887 . . . . 0.0 114.407 -179.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.478 ' HB3' HD12 ' A' ' 106' ' ' ILE . 74.7 mmtt -124.79 41.13 3.58 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 122.017 0.913 . . . . 0.0 108.73 -178.579 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 16.7 p-10 -50.36 -46.55 55.91 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 114.583 -1.189 . . . . 0.0 112.855 -178.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 48.2 p-80 -69.78 -9.15 53.51 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 113.577 0.955 . . . . 0.0 113.577 -177.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.478 HD12 ' HB3' ' A' ' 103' ' ' LYS . 40.8 mt -95.31 -40.13 10.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 178.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -72.14 1.31 34.11 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 115.804 1.081 . . . . 0.0 115.804 -178.149 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 6.2 t -83.03 19.22 1.45 Allowed 'General case' 0 CA--C 1.549 0.934 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 -178.261 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.476 ' HD2' HD22 ' A' ' 114' ' ' ASN . 66.5 ttp85 -59.24 130.67 48.06 Favored 'General case' 0 N--CA 1.47 0.55 0 O-C-N 121.101 -1.0 . . . . 0.0 109.142 179.478 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -103.88 127.03 30.23 Favored Pre-proline 0 C--N 1.323 -0.567 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 178.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -72.7 -14.76 27.18 Favored 'Trans proline' 0 C--O 1.22 -0.411 0 C-N-CA 118.098 -0.801 . . . . 0.0 113.234 -178.171 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -74.32 -27.09 60.54 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.919 0.39 . . . . 0.0 110.497 178.201 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 79.7 m-20 -104.27 -23.05 13.27 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 113.908 1.077 . . . . 0.0 113.908 -174.109 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . 0.476 HD22 ' HD2' ' A' ' 109' ' ' ARG . 26.1 t30 -148.37 151.91 36.12 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -177.325 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -91.52 148.83 22.01 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-O 121.384 0.611 . . . . 0.0 111.943 179.438 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -74.65 150.12 39.71 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.441 178.114 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 6.9 mt -92.22 140.34 16.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 -178.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 95.2 t -61.49 124.78 16.58 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 N-CA-C 107.162 -1.422 . . . . 0.0 107.162 175.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 5.3 tt -67.4 129.15 39.0 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.137 0.494 . . . . 0.0 111.108 -176.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 29.2 mt-30 -133.01 154.51 50.45 Favored 'General case' 0 C--O 1.219 -0.531 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 -179.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 12.8 mt -110.9 147.92 37.53 Favored Pre-proline 0 C--N 1.322 -0.622 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 177.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -73.33 166.84 28.84 Favored 'Trans proline' 0 C--N 1.346 0.444 0 O-C-N 122.197 0.577 . . . . 0.0 113.196 179.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 39.3 tt0 -54.08 133.03 43.83 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.779 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 97.02 -20.55 50.41 Favored Glycine 0 C--O 1.227 -0.337 0 CA-C-N 115.941 -0.572 . . . . 0.0 112.93 -179.477 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 1.5 m -104.95 127.38 52.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 117.916 0.858 . . . . 0.0 110.569 178.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 6.9 p -122.79 148.29 45.54 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.739 -179.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 85.2 mt -71.86 150.52 92.95 Favored Pre-proline 0 C--N 1.324 -0.538 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 179.181 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -78.74 179.79 6.16 Favored 'Trans proline' 0 C--O 1.236 0.387 0 O-C-N 121.99 0.468 . . . . 0.0 111.341 178.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 8.1 tmtt? -57.11 126.93 29.42 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 -175.306 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 89.56 -0.03 79.83 Favored Glycine 0 CA--C 1.51 -0.26 0 N-CA-C 116.233 1.253 . . . . 0.0 116.233 173.533 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.454 ' CZ ' ' HB2' ' A' ' 18' ' ' GLN . 4.0 m-85 -99.53 137.9 37.38 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-O 121.881 0.848 . . . . 0.0 111.762 -179.113 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 40.0 p90 -145.43 161.75 38.95 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 114.166 -1.379 . . . . 0.0 107.741 174.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -99.68 142.86 30.6 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.573 0.701 . . . . 0.0 112.468 -175.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -70.4 129.77 40.17 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 107.367 -1.345 . . . . 0.0 107.367 178.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 95.21 -21.51 43.75 Favored Glycine 0 C--O 1.227 -0.331 0 CA-C-N 116.15 -0.477 . . . . 0.0 112.761 -178.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 20.0 t . . . . . 0 C--N 1.326 -0.422 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 179.181 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.642 0 CA-C-O 121.592 0.71 . . . . 0.0 110.403 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 37.2 p -62.94 142.29 58.39 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 114.994 -1.003 . . . . 0.0 108.883 177.108 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . 0.43 ' CD2' ' HD3' ' A' ' 109' ' ' ARG . 7.4 m95 -66.23 -21.87 66.31 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 177.754 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -121.41 161.51 22.04 Favored 'General case' 0 CA--C 1.509 -0.619 0 N-CA-C 113.944 1.09 . . . . 0.0 113.944 -172.102 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 77.4 p -72.55 172.69 10.08 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 113.692 -1.594 . . . . 0.0 109.136 177.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.591 ' HB2' ' CZ ' ' A' ' 69' ' ' TYR . . . -77.67 142.6 38.73 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 -176.598 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.405 HD23 ' HA ' ' A' ' 16' ' ' LEU . 11.8 mt -90.48 133.59 34.94 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 102.299 -3.223 . . . . 0.0 102.299 167.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 64.5 m -118.37 138.59 52.32 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 118.143 0.429 . . . . 0.0 110.264 -176.103 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.429 ' HB2' ' CZ ' ' A' ' 131' ' ' PHE . 4.0 tp60 -105.84 139.89 39.72 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 113.596 0.962 . . . . 0.0 113.596 -177.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 59.7 t60 -128.74 99.71 5.44 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 104.476 -2.416 . . . . 0.0 104.476 168.241 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 160.78 -162.38 33.47 Favored Glycine 0 C--O 1.226 -0.375 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 -176.333 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 54.0 mttp -110.04 -15.79 13.96 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 113.508 0.929 . . . . 0.0 113.508 -179.632 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -74.05 153.52 39.62 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 179.395 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 63.0 m-20 -79.82 -62.85 1.56 Allowed 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 120.566 0.222 . . . . 0.0 110.975 -178.133 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 48.3 tp 165.69 137.38 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 102.763 -3.051 . . . . 0.0 102.763 177.418 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -155.43 135.78 13.19 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 177.007 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -124.47 157.84 63.7 Favored Pre-proline 0 C--N 1.322 -0.599 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 177.467 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -69.33 174.39 9.21 Favored 'Trans proline' 0 CA--C 1.539 0.762 0 C-N-CA 121.704 1.602 . . . . 0.0 114.933 -178.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 17.3 tpt180 -78.25 129.54 35.19 Favored 'General case' 0 C--O 1.216 -0.681 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 178.367 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 75.42 12.29 83.73 Favored Glycine 0 C--O 1.225 -0.411 0 N-CA-C 114.99 0.756 . . . . 0.0 114.99 175.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 33.6 tt0 -157.29 145.16 19.04 Favored 'General case' 0 C--O 1.219 -0.523 0 N-CA-C 106.378 -1.712 . . . . 0.0 106.378 -178.489 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 138.66 -14.39 3.4 Favored Glycine 0 CA--C 1.506 -0.504 0 C-N-CA 120.038 -1.077 . . . . 0.0 113.707 177.42 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 30.8 m -72.56 145.31 87.31 Favored Pre-proline 0 C--N 1.319 -0.729 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 177.044 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -75.69 166.28 28.66 Favored 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 122.104 1.869 . . . . 0.0 113.775 179.386 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 97.6 mt -73.3 124.84 31.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.34 -0.846 . . . . 0.0 110.568 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 16.3 t-20 -125.41 122.76 37.65 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.861 0.362 . . . . 0.0 110.921 174.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 72.7 p -91.04 -15.91 28.77 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 113.837 1.051 . . . . 0.0 113.837 -177.195 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 11.8 p30 -112.96 25.37 11.47 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.637 -0.711 . . . . 0.0 112.385 -176.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 68.3 m -136.36 153.34 51.15 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 178.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 2.9 m -68.62 162.9 59.24 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.527 -178.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -66.47 -28.61 45.77 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 114.493 -3.204 . . . . 0.0 113.638 179.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.53 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 5.1 p-10 -75.23 -23.08 57.5 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 121.621 -0.674 . . . . 0.0 111.608 177.151 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.482 ' HA ' ' HE3' ' A' ' 103' ' ' LYS . 18.8 m-20 -73.25 -13.15 61.08 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.712 0.805 . . . . 0.0 112.901 -176.406 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 93.1 mm-40 -62.44 -24.53 67.47 Favored 'General case' 0 C--O 1.219 -0.547 0 N-CA-C 114.492 1.293 . . . . 0.0 114.492 -177.092 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.567 ' HB ' ' HB1' ' A' ' 98' ' ' ALA . 12.9 tt -57.16 140.15 15.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 CA-C-O 122.303 1.049 . . . . 0.0 112.952 179.473 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 178.35 -151.78 10.89 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.122 -1.037 . . . . 0.0 113.14 -179.116 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 48.7 p90 -154.71 168.71 25.91 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 179.074 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -108.67 138.4 45.04 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 173.151 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.96 126.01 51.68 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 123.821 0.849 . . . . 0.0 108.758 -179.379 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 34.1 ttt180 -70.78 144.16 50.94 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 122.339 0.256 . . . . 0.0 111.404 177.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -149.16 160.22 43.55 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.709 0.766 . . . . 0.0 111.679 178.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 8.4 t -169.13 176.28 5.35 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 102.09 -3.3 . . . . 0.0 102.09 174.485 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 12.9 tpt180 -128.41 123.86 34.85 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 177.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 3.3 tmt_? -134.95 142.22 46.45 Favored 'General case' 0 CA--C 1.5 -0.974 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 -177.505 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -141.88 179.75 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 -177.605 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 24.9 tpt85 -134.96 104.52 5.99 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 105.669 -1.975 . . . . 0.0 105.669 171.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -77.54 152.54 39.5 Favored Glycine 0 N--CA 1.45 -0.385 0 N-CA-C 105.078 -3.209 . . . . 0.0 105.078 176.258 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -59.76 -38.21 93.57 Favored Glycine 0 C--O 1.222 -0.617 0 CA-C-N 118.9 1.35 . . . . 0.0 112.147 -178.357 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 37.5 t0 -81.83 15.73 2.11 Favored 'General case' 0 CA--C 1.551 0.993 0 CA-C-O 122.345 1.069 . . . . 0.0 112.057 -179.557 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 85.13 15.46 66.95 Favored Glycine 0 C--O 1.222 -0.64 0 CA-C-N 115.664 -0.698 . . . . 0.0 113.294 171.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 21.1 mmtt -82.34 140.55 33.47 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.399 0.619 . . . . 0.0 109.855 -175.384 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 61.7 mtp -125.51 -178.37 4.22 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 114.418 -1.265 . . . . 0.0 110.451 -176.297 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 34.6 mmtt -136.88 -57.95 0.72 Allowed 'General case' 0 CA--C 1.504 -0.817 0 CA-C-O 121.33 0.586 . . . . 0.0 109.441 -177.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 34.47 64.04 0.41 Allowed 'General case' 0 C--N 1.322 -0.63 0 O-C-N 126.172 2.17 . . . . 0.0 112.897 173.528 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 75.9 mt -61.74 159.33 13.77 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 113.669 -1.605 . . . . 0.0 112.258 -176.376 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 54.1 p -55.61 142.77 60.96 Favored Pre-proline 0 C--O 1.252 1.187 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.368 179.327 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -66.46 142.06 63.9 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 116.7 -1.733 . . . . 0.0 112.554 -176.464 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.445 ' HB2' ' HB1' ' A' ' 15' ' ' ALA . 6.9 ptp180 -139.26 162.81 34.09 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 114.477 -1.238 . . . . 0.0 108.198 -179.739 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 53.1 m95 -132.65 148.92 52.36 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 -177.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.591 ' CZ ' ' HB2' ' A' ' 15' ' ' ALA . 45.1 m-85 -125.09 150.46 46.81 Favored 'General case' 0 C--O 1.215 -0.763 0 N-CA-C 106.17 -1.789 . . . . 0.0 106.17 179.433 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 86.3 t80 -97.06 139.01 33.71 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 118.818 0.735 . . . . 0.0 109.756 -175.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -140.99 152.28 44.8 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 -175.171 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 65.9 m-85 -85.53 159.47 19.9 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -175.045 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -54.2 126.61 23.62 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.127 178.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 72.92 30.79 62.92 Favored Glycine 0 C--O 1.22 -0.737 0 N-CA-C 116.105 1.202 . . . . 0.0 116.105 177.226 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.2 p . . . . . 0 C--N 1.327 -0.374 0 CA-C-N 119.133 1.467 . . . . 0.0 108.154 178.922 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 15.0 mt . . . . . 0 N--CA 1.446 -0.662 0 N-CA-C 115.401 1.63 . . . . 0.0 115.401 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -79.48 163.99 24.06 Favored 'Trans proline' 0 N--CA 1.46 -0.47 0 C-N-CA 122.421 2.08 . . . . 0.0 107.846 167.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 48.6 t80 -61.51 131.01 48.75 Favored 'General case' 0 C--N 1.319 -0.733 0 C-N-CA 120.467 -0.493 . . . . 0.0 110.214 -178.614 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 92.89 -7.65 76.7 Favored Glycine 0 CA--C 1.52 0.368 0 CA-C-O 119.349 -0.695 . . . . 0.0 114.778 178.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -66.88 130.59 43.65 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 118.58 1.19 . . . . 0.0 111.655 179.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 56.4 t30 -76.44 129.7 36.92 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.606 -179.328 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 22.0 ttmt -156.07 153.13 28.91 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 179.304 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 35.0 t0 -60.2 125.23 22.88 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.312 0.577 . . . . 0.0 111.48 -178.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 69.66 30.92 70.49 Favored Glycine 0 N--CA 1.449 -0.472 0 CA-C-O 118.908 -0.94 . . . . 0.0 114.484 177.57 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 42.8 mm -126.0 129.86 72.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 117.844 0.822 . . . . 0.0 111.445 179.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -130.82 117.88 39.9 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.662 175.25 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 96.4 m95 -82.99 136.68 34.43 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 113.81 1.041 . . . . 0.0 113.81 -176.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -144.77 155.37 14.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.611 -179.121 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -155.81 166.6 33.01 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 104.729 -2.323 . . . . 0.0 104.729 -178.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 15.1 t -116.28 170.04 8.83 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 104.892 -2.262 . . . . 0.0 104.892 173.711 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -66.13 135.1 54.1 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 178.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 91.3 -7.52 80.34 Favored Glycine 0 CA--C 1.517 0.188 0 CA-C-N 116.143 -0.481 . . . . 0.0 113.169 179.48 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.567 ' HB1' ' HB ' ' A' ' 44' ' ' ILE . . . -72.16 134.34 45.66 Favored 'General case' 0 CA--C 1.539 0.542 0 O-C-N 122.322 -0.516 . . . . 0.0 110.337 178.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 31.8 mt -85.96 138.19 32.18 Favored 'General case' 0 CA--C 1.511 -0.532 0 CA-C-O 121.48 0.657 . . . . 0.0 112.591 -177.163 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 60.0 t30 -85.43 69.73 10.72 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.277 -179.542 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -145.1 158.52 51.83 Favored Pre-proline 0 C--N 1.321 -0.657 0 N-CA-C 104.237 -2.505 . . . . 0.0 104.237 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -73.08 149.9 47.25 Favored 'Trans proline' 0 CA--C 1.534 0.515 0 N-CA-C 113.938 0.707 . . . . 0.0 113.938 177.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.482 ' HE3' ' HA ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -146.83 56.84 1.15 Allowed 'General case' 0 N--CA 1.477 0.883 0 CA-C-O 122.702 1.239 . . . . 0.0 109.205 176.444 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -65.14 -21.38 66.78 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.291 -1.322 . . . . 0.0 111.519 179.382 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 19.0 p80 -56.83 -19.67 18.61 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 114.307 1.225 . . . . 0.0 114.307 -179.13 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 11.7 mt -83.58 -27.91 7.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 121.698 0.761 . . . . 0.0 109.017 -179.413 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -78.2 14.66 10.72 Favored Glycine 0 C--O 1.219 -0.798 0 CA-C-N 115.715 -0.675 . . . . 0.0 114.416 -176.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 7.8 t -83.05 15.42 2.81 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-O 122.079 0.942 . . . . 0.0 110.467 -179.652 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.43 ' HD3' ' CD2' ' A' ' 12' ' ' TRP . 57.8 ttp85 -63.46 131.3 47.72 Favored 'General case' 0 C--N 1.327 -0.41 0 O-C-N 121.851 -0.531 . . . . 0.0 110.212 -179.512 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 66.4 m-20 -106.65 120.18 49.19 Favored Pre-proline 0 C--N 1.327 -0.404 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 179.289 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -70.71 -13.92 32.67 Favored 'Trans proline' 0 C--N 1.347 0.489 0 N-CA-C 113.808 0.657 . . . . 0.0 113.808 -176.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -72.61 -26.04 61.54 Favored 'General case' 0 C--O 1.22 -0.46 0 CA-C-O 120.717 0.294 . . . . 0.0 110.825 177.09 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 -104.05 -24.82 13.17 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 114.273 1.212 . . . . 0.0 114.273 -174.196 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . 0.404 ' OD1' ' HD2' ' A' ' 109' ' ' ARG . 0.1 OUTLIER -143.26 154.98 44.37 Favored 'General case' 0 N--CA 1.434 -1.238 0 CA-C-O 121.284 0.564 . . . . 0.0 110.308 -176.211 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -94.99 144.1 25.95 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.462 178.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -70.3 148.23 48.74 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.197 0.522 . . . . 0.0 110.958 179.501 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 15.0 mt -84.45 136.98 21.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 -178.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -62.67 125.92 20.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 106.776 -1.564 . . . . 0.0 106.776 175.628 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 4.2 tt -66.08 128.39 35.89 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.163 0.506 . . . . 0.0 111.005 -177.398 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -132.03 156.86 45.52 Favored 'General case' 0 CA--C 1.509 -0.612 0 N-CA-C 106.946 -1.502 . . . . 0.0 106.946 -179.58 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.4 HD13 HG22 ' A' ' 125' ' ' THR . 14.3 mt -115.3 147.49 38.71 Favored Pre-proline 0 C--N 1.32 -0.679 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 179.688 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -73.29 169.38 22.42 Favored 'Trans proline' 0 C--N 1.346 0.421 0 O-C-N 122.361 0.664 . . . . 0.0 113.754 -178.579 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 39.7 tt0 -53.6 131.85 39.49 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.426 -0.806 . . . . 0.0 109.899 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 94.26 -18.05 57.67 Favored Glycine 0 C--O 1.228 -0.248 0 CA-C-N 115.904 -0.589 . . . . 0.0 113.395 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.4 HG22 HD13 ' A' ' 121' ' ' LEU . 3.3 m -104.66 126.77 52.06 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 118.108 0.954 . . . . 0.0 111.261 178.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 5.5 p -119.87 148.27 43.68 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.964 -179.348 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 88.7 mt -69.86 152.8 95.9 Favored Pre-proline 0 C--N 1.324 -0.535 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 178.204 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -76.58 175.37 11.45 Favored 'Trans proline' 0 N--CA 1.462 -0.375 0 C-N-CA 118.524 -0.517 . . . . 0.0 111.077 178.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 62.6 tttm -56.9 126.62 27.89 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 113.431 0.9 . . . . 0.0 113.431 -174.552 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 89.56 -6.42 83.17 Favored Glycine 0 CA--C 1.517 0.197 0 N-CA-C 116.106 1.202 . . . . 0.0 116.106 175.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.429 ' CZ ' ' HB2' ' A' ' 18' ' ' GLN . 2.7 m-85 -91.68 145.68 24.39 Favored 'General case' 0 N--CA 1.434 -1.26 0 CA-C-O 122.653 1.216 . . . . 0.0 111.681 -178.685 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 50.2 p90 -145.34 162.5 37.08 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 112.902 -1.953 . . . . 0.0 107.896 175.162 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -105.48 136.53 44.87 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.162 0.506 . . . . 0.0 111.913 -176.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -67.56 133.73 49.97 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.356 -0.838 . . . . 0.0 108.92 177.584 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 91.88 -27.51 9.92 Favored Glycine 0 CA--C 1.522 0.513 0 N-CA-C 113.663 0.225 . . . . 0.0 113.663 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 4.9 t . . . . . 0 C--N 1.323 -0.552 0 CA-C-O 121.306 0.574 . . . . 0.0 111.248 178.139 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.464 0 N-CA-C 113.318 0.858 . . . . 0.0 113.318 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 16.2 t -66.2 141.86 57.91 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.78 178.431 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 27.3 m95 -68.35 -23.21 64.66 Favored 'General case' 0 CA--C 1.509 -0.634 0 O-C-N 123.372 0.42 . . . . 0.0 111.457 177.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 36.7 m-85 -121.38 158.26 28.69 Favored 'General case' 0 CA--C 1.506 -0.714 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.83 -173.396 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.419 ' HB ' ' HB3' ' A' ' 134' ' ' GLU . 69.8 p -65.67 160.43 22.74 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.235 -0.893 . . . . 0.0 109.838 -179.65 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.434 ' HB2' ' CE1' ' A' ' 69' ' ' TYR . . . -80.25 139.34 36.73 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.147 -0.933 . . . . 0.0 112.166 -174.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.464 HD11 HD22 ' A' ' 119' ' ' LEU . 3.8 mp -83.15 148.9 27.19 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 172.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 64.7 m -124.49 138.76 54.32 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 179.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.415 ' HB2' ' CZ ' ' A' ' 131' ' ' PHE . 4.3 tp60 -111.85 136.44 51.14 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 -178.023 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 56.0 t60 -131.22 94.97 3.68 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 104.318 -2.475 . . . . 0.0 104.318 169.152 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 178.61 -166.32 36.06 Favored Glycine 0 C--O 1.224 -0.475 0 N-CA-C 110.802 -0.919 . . . . 0.0 110.802 -176.3 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 91.9 mttt -101.11 -21.79 14.88 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 114.442 1.275 . . . . 0.0 114.442 -177.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -94.03 161.53 14.25 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 179.6 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -77.76 -62.92 1.51 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.517 -179.012 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 45.0 tp 179.44 140.7 0.12 Allowed 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 105.387 -2.079 . . . . 0.0 105.387 175.619 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 23.7 tptm -155.67 134.84 12.21 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 118.051 0.387 . . . . 0.0 110.49 174.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 20.1 m-85 -121.24 151.69 56.19 Favored Pre-proline 0 C--O 1.242 0.66 0 N-CA-C 107.178 -1.416 . . . . 0.0 107.178 174.062 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -73.97 160.63 42.74 Favored 'Trans proline' 0 CA--C 1.535 0.541 0 O-C-N 122.058 0.504 . . . . 0.0 111.946 177.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 3.8 tmt_? -64.3 132.02 48.99 Favored 'General case' 0 N--CA 1.47 0.539 0 O-C-N 122.169 -0.332 . . . . 0.0 110.35 -178.102 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 83.23 15.38 72.04 Favored Glycine 0 C--O 1.223 -0.557 0 C-N-CA 121.249 -0.501 . . . . 0.0 112.375 177.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.577 HE21 HG23 ' A' ' 125' ' ' THR . 0.8 OUTLIER -150.92 170.54 19.07 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 -176.668 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 100.32 -10.83 59.89 Favored Glycine 0 CA--C 1.508 -0.384 0 N-CA-C 115.183 0.833 . . . . 0.0 115.183 174.643 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 90.3 t -68.91 130.07 91.85 Favored Pre-proline 0 C--N 1.321 -0.669 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 177.342 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -73.18 171.75 16.98 Favored 'Trans proline' 0 C--O 1.221 -0.357 0 O-C-N 122.183 0.57 . . . . 0.0 112.351 178.343 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 92.6 mt -71.57 106.44 2.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 179.304 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 -96.17 86.55 4.28 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 114.33 -1.305 . . . . 0.0 109.755 -176.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 77.5 p -67.65 -14.89 63.33 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.543 -0.753 . . . . 0.0 112.816 -178.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -108.35 21.04 17.88 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.158 -0.928 . . . . 0.0 112.022 -177.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.475 ' HB3' ' HB2' ' A' ' 42' ' ' ASP . 2.0 m -143.17 149.84 38.58 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 114.333 1.234 . . . . 0.0 114.333 -175.824 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.2 m -76.8 168.41 28.32 Favored Pre-proline 0 N--CA 1.471 0.595 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 177.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -64.39 -27.44 62.94 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 114.731 -3.046 . . . . 0.0 112.095 178.634 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -62.84 -23.97 67.55 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 124.104 0.962 . . . . 0.0 112.322 176.242 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.475 ' HB2' ' HB3' ' A' ' 38' ' ' SER . 68.7 m-20 -99.28 -1.98 37.66 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 114.106 1.151 . . . . 0.0 114.106 -171.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 91.8 mm-40 -61.89 -26.01 67.9 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 114.002 1.112 . . . . 0.0 114.002 -177.433 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 8.5 tt -59.04 137.26 21.72 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.83 0 CA-C-O 122.242 1.02 . . . . 0.0 112.977 -179.281 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -179.33 -159.18 22.97 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.437 -0.887 . . . . 0.0 112.505 -178.637 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.414 ' CE2' HD12 ' A' ' 90' ' ' ILE . 42.7 p90 -155.02 168.12 28.08 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 179.468 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 31.9 m-85 -109.37 140.77 42.66 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 175.314 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 66.0 ttt-85 -116.85 120.77 39.54 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.892 -175.054 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 50.1 ttp180 -70.73 143.7 51.19 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 110.244 -0.28 . . . . 0.0 110.244 177.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -144.32 141.26 29.65 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 122.734 0.414 . . . . 0.0 110.327 178.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 25.4 p -144.49 151.5 39.25 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 178.192 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 13.3 tpt180 -149.14 130.52 14.72 Favored 'General case' 0 N--CA 1.469 0.517 0 O-C-N 122.176 -0.328 . . . . 0.0 111.3 176.674 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 4.2 tmm_? -144.07 138.83 28.57 Favored 'General case' 0 CA--C 1.5 -0.96 0 CA-C-O 121.157 0.503 . . . . 0.0 109.793 179.654 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -131.81 179.2 4.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 -179.658 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 5.0 ttt85 -115.36 99.16 7.18 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 174.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -77.91 157.69 45.58 Favored Glycine 0 C--O 1.223 -0.551 0 N-CA-C 107.359 -2.296 . . . . 0.0 107.359 176.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -66.04 -41.9 94.91 Favored Glycine 0 C--O 1.217 -0.953 0 CA-C-N 118.427 1.114 . . . . 0.0 111.899 179.641 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -85.35 -11.05 55.5 Favored 'General case' 0 C--O 1.215 -0.719 0 CA-C-O 122.137 0.97 . . . . 0.0 110.328 178.551 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 103.57 9.7 37.48 Favored Glycine 0 C--O 1.226 -0.398 0 CA-C-N 115.288 -0.869 . . . . 0.0 112.781 177.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 59.5 mmtt -61.12 132.36 53.48 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.274 0.559 . . . . 0.0 110.59 -179.391 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 95.8 mmm -86.19 167.62 14.72 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 114.781 -1.099 . . . . 0.0 111.185 179.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 16.2 tppt? -108.61 -39.42 5.39 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 176.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 15.2 t0 -141.77 164.98 28.72 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 105.253 -2.129 . . . . 0.0 105.253 178.531 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -121.2 -94.27 0.5 Allowed 'General case' 0 C--N 1.325 -0.469 0 O-C-N 123.502 0.501 . . . . 0.0 110.597 -176.334 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -72.45 159.4 85.48 Favored Pre-proline 0 C--N 1.326 -0.43 0 C-N-CA 122.717 0.407 . . . . 0.0 109.976 179.667 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -68.79 140.86 47.62 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 115.116 -2.789 . . . . 0.0 111.377 177.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 53.5 mtt180 -104.2 155.65 18.54 Favored 'General case' 0 CA--C 1.504 -0.798 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.067 179.479 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 66.0 m95 -127.53 125.85 41.13 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 174.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.434 ' CE1' ' HB2' ' A' ' 15' ' ' ALA . 69.6 m-85 -110.32 160.22 16.75 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 106.605 -1.628 . . . . 0.0 106.605 -178.615 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -103.55 132.8 49.49 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 179.378 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -131.65 145.69 51.8 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 -176.081 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 58.8 m-85 -87.26 161.59 17.9 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 120.755 0.312 . . . . 0.0 110.289 -176.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -53.42 132.46 39.69 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 120.747 0.308 . . . . 0.0 111.379 -178.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 70.37 27.98 71.95 Favored Glycine 0 C--O 1.224 -0.508 0 N-CA-C 116.264 1.266 . . . . 0.0 116.264 176.529 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 69.9 p . . . . . 0 N--CA 1.467 0.422 0 CA-C-N 118.278 1.039 . . . . 0.0 111.286 178.891 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 27.4 mt . . . . . 0 C--O 1.238 0.482 0 N-CA-C 117.348 2.351 . . . . 0.0 117.348 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -77.88 164.36 27.69 Favored 'Trans proline' 0 C--O 1.234 0.303 0 C-N-CA 121.787 1.658 . . . . 0.0 108.011 167.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 53.5 t80 -62.43 133.1 54.55 Favored 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 120.493 -0.483 . . . . 0.0 111.191 -176.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 89.52 -7.6 81.59 Favored Glycine 0 CA--C 1.517 0.202 0 CA-C-O 119.6 -0.556 . . . . 0.0 114.373 178.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -63.5 131.61 48.68 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 118.134 0.967 . . . . 0.0 111.084 179.62 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -78.25 130.13 35.9 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.242 -179.277 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 24.8 ttmt -156.2 150.97 26.04 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 105.37 -2.085 . . . . 0.0 105.37 176.501 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 42.4 t0 -70.88 135.85 48.28 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.827 -0.435 . . . . 0.0 109.827 -177.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 71.95 24.5 76.48 Favored Glycine 0 N--CA 1.453 -0.222 0 C-N-CA 121.158 -0.544 . . . . 0.0 113.937 -179.373 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.414 HD12 ' CE2' ' A' ' 46' ' ' TYR . 41.6 mm -129.36 129.61 67.27 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 CA-C-N 117.198 0.499 . . . . 0.0 110.593 -179.712 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.1 pt -132.91 125.22 51.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 CA-C-O 121.17 0.51 . . . . 0.0 110.591 176.472 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 95.9 m95 -88.63 138.96 30.95 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 113.62 0.97 . . . . 0.0 113.62 -176.023 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 16.6 m -137.78 152.21 26.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 108.982 -0.748 . . . . 0.0 108.982 178.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -160.62 166.6 28.63 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 103.368 -2.827 . . . . 0.0 103.368 -179.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 12.4 t -138.63 177.24 8.03 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 106.059 -1.83 . . . . 0.0 106.059 178.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -67.5 135.71 53.47 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.983 0.421 . . . . 0.0 109.972 -179.415 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 96.16 -8.52 67.36 Favored Glycine 0 C--O 1.224 -0.514 0 CA-C-N 115.952 -0.567 . . . . 0.0 113.506 178.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -80.92 138.76 36.13 Favored 'General case' 0 CA--C 1.538 0.491 0 O-C-N 122.37 -0.488 . . . . 0.0 111.678 -179.534 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 91.9 mt -88.05 154.93 20.09 Favored 'General case' 0 C--O 1.214 -0.808 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 178.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 57.8 t30 -96.99 64.88 2.02 Favored 'General case' 0 C--N 1.323 -0.572 0 O-C-N 122.14 -0.35 . . . . 0.0 110.516 178.237 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -138.24 154.51 73.95 Favored Pre-proline 0 CA--C 1.538 0.518 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 -179.119 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -68.02 154.17 73.32 Favored 'Trans proline' 0 C--N 1.349 0.602 0 N-CA-C 114.332 0.859 . . . . 0.0 114.332 -179.222 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.441 ' HE3' ' HA ' ' A' ' 42' ' ' ASP . 70.9 mmtt -128.67 54.35 1.78 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.552 0.691 . . . . 0.0 109.627 -178.364 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 12.7 p-10 -60.48 -37.23 80.36 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.573 -177.017 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 10.6 p80 -65.56 -15.18 62.46 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 113.205 0.817 . . . . 0.0 113.205 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.411 HD12 ' HB3' ' A' ' 103' ' ' LYS . 25.1 mt -91.21 -38.19 10.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 178.276 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -75.74 2.75 53.18 Favored Glycine 0 CA--C 1.521 0.438 0 N-CA-C 116.013 1.165 . . . . 0.0 116.013 -177.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 6.2 t -91.17 22.45 3.78 Favored 'General case' 0 CA--C 1.548 0.876 0 CA-C-O 121.98 0.895 . . . . 0.0 111.728 -178.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.437 ' HD2' ' OD1' ' A' ' 114' ' ' ASN . 61.1 ttp85 -59.11 131.41 50.96 Favored 'General case' 0 N--CA 1.468 0.464 0 O-C-N 121.507 -0.745 . . . . 0.0 110.918 -179.625 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 71.1 m-20 -104.38 121.41 47.42 Favored Pre-proline 0 C--N 1.327 -0.394 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_endo -70.09 -14.72 35.37 Favored 'Trans proline' 0 C--N 1.348 0.516 0 N-CA-C 113.994 0.729 . . . . 0.0 113.994 -178.101 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -73.79 -25.61 60.21 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 120.665 0.269 . . . . 0.0 110.899 177.06 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 -101.89 -25.41 13.8 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 113.325 0.861 . . . . 0.0 113.325 -175.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . 0.437 ' OD1' ' HD2' ' A' ' 109' ' ' ARG . 0.4 OUTLIER -141.8 151.92 43.26 Favored 'General case' 0 N--CA 1.439 -1.013 0 CA-C-O 121.196 0.522 . . . . 0.0 111.451 -176.782 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -97.24 140.47 31.67 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 115.382 -0.826 . . . . 0.0 109.594 177.395 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -68.88 151.99 45.87 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.275 0.56 . . . . 0.0 111.459 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 5.3 mt -95.4 139.43 18.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.066 -178.018 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 71.8 t -62.07 125.9 19.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 N-CA-C 106.391 -1.707 . . . . 0.0 106.391 175.389 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.464 HD22 HD11 ' A' ' 16' ' ' LEU . 7.6 tt -66.85 128.14 35.17 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.225 0.536 . . . . 0.0 109.58 -177.392 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 29.5 mt-30 -129.45 158.26 39.68 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 105.417 -2.068 . . . . 0.0 105.417 179.391 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 21.3 mt -115.02 148.28 40.2 Favored Pre-proline 0 C--N 1.321 -0.662 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 179.588 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -72.65 170.33 19.76 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 120.49 0.793 . . . . 0.0 113.636 -177.673 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 4.1 tp-100 -53.84 129.08 32.43 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.391 -179.371 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 89.66 -10.97 71.7 Favored Glycine 0 CA--C 1.519 0.34 0 CA-C-N 115.999 -0.546 . . . . 0.0 114.385 179.399 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.577 HG23 HE21 ' A' ' 30' ' ' GLN . 25.7 m -108.67 127.05 53.64 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 117.955 0.877 . . . . 0.0 110.002 179.052 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 12.7 p -125.07 152.52 44.23 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 123.054 0.541 . . . . 0.0 110.83 -178.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 83.7 mt -69.62 153.27 95.82 Favored Pre-proline 0 C--N 1.328 -0.362 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 179.398 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -77.96 176.48 9.94 Favored 'Trans proline' 0 C--N 1.345 0.377 0 O-C-N 121.946 0.445 . . . . 0.0 111.283 178.401 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -59.48 125.59 24.24 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 113.85 1.056 . . . . 0.0 113.85 -174.572 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 91.51 -4.0 79.39 Favored Glycine 0 C--N 1.33 0.2 0 N-CA-C 115.748 1.059 . . . . 0.0 115.748 175.683 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.415 ' CZ ' ' HB2' ' A' ' 18' ' ' GLN . 2.4 m-85 -96.58 142.51 28.55 Favored 'General case' 0 N--CA 1.44 -0.964 0 CA-C-O 122.09 0.947 . . . . 0.0 113.055 -177.696 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 52.8 p90 -146.04 161.62 39.72 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 113.66 -1.609 . . . . 0.0 107.568 173.201 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -104.83 151.31 23.96 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 -178.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.419 ' HB3' ' HB ' ' A' ' 14' ' ' THR . 4.9 tp10 -70.92 134.94 47.65 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 178.488 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 84.56 -4.45 84.34 Favored Glycine 0 CA--C 1.521 0.438 0 C-N-CA 121.537 -0.364 . . . . 0.0 113.72 -177.675 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 18.2 t . . . . . 0 C--N 1.326 -0.431 0 CA-C-O 121.636 0.731 . . . . 0.0 109.292 178.87 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.173 0 CA-C-O 121.545 0.688 . . . . 0.0 112.101 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -59.17 142.48 51.54 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.184 -0.916 . . . . 0.0 110.305 177.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 21.4 m95 -67.19 -21.92 65.76 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 114.066 1.135 . . . . 0.0 114.066 -179.191 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 39.2 m-85 -121.48 162.21 20.91 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 114.336 1.236 . . . . 0.0 114.336 -170.714 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 53.8 p -68.87 164.58 21.72 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.377 -1.283 . . . . 0.0 110.811 -179.64 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.462 ' HB2' ' CZ ' ' A' ' 69' ' ' TYR . . . -85.59 131.56 34.33 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.261 -0.881 . . . . 0.0 112.388 -176.731 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -81.61 148.85 28.87 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 105.466 -2.05 . . . . 0.0 105.466 173.793 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 57.1 m -118.21 139.66 50.95 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 179.441 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 4.1 tp60 -110.03 136.91 48.55 Favored 'General case' 0 C--N 1.328 -0.345 0 O-C-N 123.426 0.454 . . . . 0.0 111.338 -179.079 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 42.8 t60 -128.09 99.38 5.45 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 105.402 -2.073 . . . . 0.0 105.402 171.674 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 169.7 -167.57 40.62 Favored Glycine 0 C--O 1.225 -0.432 0 N-CA-C 109.289 -1.524 . . . . 0.0 109.289 -176.781 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 64.8 mttp -103.77 -23.32 13.42 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 179.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -82.51 158.85 23.01 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 -179.504 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -76.75 -62.86 1.5 Allowed 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 -179.369 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 32.7 tp 172.62 144.8 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 104.228 -2.508 . . . . 0.0 104.228 179.347 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 22.2 tptm -155.59 141.08 17.8 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 174.284 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -126.08 157.91 67.99 Favored Pre-proline 0 C--O 1.241 0.634 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 177.043 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -70.77 176.15 7.93 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 121.307 1.338 . . . . 0.0 114.678 -178.449 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 77.5 ttt180 -74.86 126.41 30.88 Favored 'General case' 0 C--O 1.217 -0.633 0 O-C-N 121.803 -0.56 . . . . 0.0 110.443 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 76.79 13.08 83.94 Favored Glycine 0 C--O 1.223 -0.54 0 N-CA-C 115.483 0.953 . . . . 0.0 115.483 175.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.542 HE21 HG23 ' A' ' 125' ' ' THR . 34.1 tt0 -157.01 142.5 17.47 Favored 'General case' 0 C--O 1.22 -0.458 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 -177.722 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 141.29 -18.06 2.69 Favored Glycine 0 CA--C 1.506 -0.503 0 C-N-CA 120.308 -0.949 . . . . 0.0 113.391 179.108 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 31.6 m -69.49 145.45 95.38 Favored Pre-proline 0 C--N 1.323 -0.566 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 176.381 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -75.9 172.45 16.25 Favored 'Trans proline' 0 CA--C 1.511 -0.64 0 C-N-CA 121.211 1.274 . . . . 0.0 112.582 -179.739 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 97.9 mt -71.8 109.97 4.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 176.842 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 69.6 m-80 -101.1 85.59 2.86 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 114.681 -1.145 . . . . 0.0 108.986 -177.812 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 73.7 p -66.16 -15.85 63.48 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 113.021 0.749 . . . . 0.0 113.021 -177.589 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 10.4 p30 -105.65 21.89 16.46 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.253 -0.885 . . . . 0.0 111.315 -178.276 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 14.2 m -141.44 150.95 42.98 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 113.306 0.854 . . . . 0.0 113.306 -176.624 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -73.72 166.57 43.01 Favored Pre-proline 0 C--N 1.326 -0.441 0 N-CA-C 108.396 -0.965 . . . . 0.0 108.396 176.761 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -64.22 -27.92 64.38 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 115.12 -2.787 . . . . 0.0 111.715 178.737 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -61.25 -28.68 69.34 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 123.778 0.831 . . . . 0.0 111.31 176.051 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 75.3 m-20 -98.51 -0.37 43.47 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 115.242 1.571 . . . . 0.0 115.242 -171.35 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 92.7 mm-40 -61.39 -25.63 67.31 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 113.554 0.946 . . . . 0.0 113.554 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 12.3 tt -58.78 141.08 16.22 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 N-CA-C 113.917 1.081 . . . . 0.0 113.917 -178.81 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 179.54 -152.59 11.15 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.422 -0.894 . . . . 0.0 112.294 179.388 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 48.7 p90 -155.07 165.67 35.99 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 108.312 -0.995 . . . . 0.0 108.312 178.475 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 24.9 m-85 -105.98 142.07 36.31 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 107.413 -1.328 . . . . 0.0 107.413 174.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 69.3 ttt-85 -116.77 123.56 47.44 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 123.597 0.759 . . . . 0.0 112.048 -176.155 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 50.4 ttp180 -71.53 144.46 49.58 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.024 177.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -144.82 143.3 30.56 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 175.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 35.3 p -138.67 171.35 14.48 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 103.379 -2.823 . . . . 0.0 103.379 175.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 23.5 tpt180 -135.7 122.61 21.25 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.253 -0.579 . . . . 0.0 109.941 174.628 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.76 144.44 25.12 Favored 'General case' 0 CA--C 1.498 -1.024 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 179.684 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -144.22 178.5 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 N-CA-C 104.123 -2.547 . . . . 0.0 104.123 -178.101 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.77 112.0 15.54 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 105.878 -1.897 . . . . 0.0 105.878 174.175 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -74.17 167.36 54.62 Favored Glycine 0 C--O 1.224 -0.483 0 N-CA-C 108.097 -2.001 . . . . 0.0 108.097 177.661 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -62.56 -48.23 83.36 Favored Glycine 0 C--O 1.224 -0.501 0 N-CA-C 109.677 -1.369 . . . . 0.0 109.677 -177.572 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -85.32 17.2 3.2 Favored 'General case' 0 C--O 1.217 -0.61 0 CA-C-O 122.432 1.11 . . . . 0.0 110.758 178.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 87.81 -19.43 33.59 Favored Glycine 0 C--O 1.228 -0.225 0 N-CA-C 115.699 1.039 . . . . 0.0 115.699 174.031 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -56.74 131.1 48.21 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.799 0.809 . . . . 0.0 110.548 -178.333 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 22.4 ptm -127.34 -163.21 1.23 Allowed 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 114.391 -1.277 . . . . 0.0 113.865 -171.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 10.8 mptt -126.14 -57.82 1.39 Allowed 'General case' 0 C--O 1.211 -0.942 0 C-N-CA 123.502 0.721 . . . . 0.0 111.624 -175.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 50.47 51.12 17.48 Favored 'General case' 0 N--CA 1.477 0.918 0 O-C-N 124.695 1.247 . . . . 0.0 113.587 178.325 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -66.37 138.69 57.77 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.632 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -57.42 157.71 12.5 Favored Pre-proline 0 C--O 1.242 0.677 0 CA-C-N 114.803 -1.089 . . . . 0.0 112.71 -179.355 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -68.11 135.85 35.92 Favored 'Trans proline' 0 C--O 1.24 0.592 0 C-N-CA 116.6 -1.8 . . . . 0.0 114.974 -177.665 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 30.0 mtp180 -119.76 158.13 27.16 Favored 'General case' 0 CA--C 1.507 -0.695 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 174.585 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 59.7 m95 -128.3 129.72 46.74 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.186 0.517 . . . . 0.0 109.974 178.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.462 ' CZ ' ' HB2' ' A' ' 15' ' ' ALA . 70.4 m-85 -110.58 163.13 14.03 Favored 'General case' 0 C--O 1.213 -0.858 0 N-CA-C 105.505 -2.035 . . . . 0.0 105.505 179.251 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 89.6 t80 -109.88 136.71 48.74 Favored 'General case' 0 CA--C 1.511 -0.55 0 N-CA-C 107.305 -1.368 . . . . 0.0 107.305 177.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 9.8 m-85 -136.57 148.92 47.79 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 -176.477 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -82.46 159.42 22.92 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.484 -175.761 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -54.61 129.62 37.14 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.812 -178.262 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 66.85 39.73 93.5 Favored Glycine 0 C--O 1.222 -0.599 0 CA-C-O 119.187 -0.785 . . . . 0.0 114.863 176.196 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.326 -0.441 0 CA-C-N 118.187 0.993 . . . . 0.0 108.351 177.507 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 26.6 mt . . . . . 0 C--O 1.238 0.469 0 N-CA-C 114.7 1.37 . . . . 0.0 114.7 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -78.2 167.86 22.63 Favored 'Trans proline' 0 N--CA 1.461 -0.389 0 C-N-CA 121.671 1.58 . . . . 0.0 108.972 170.812 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 61.0 t80 -63.06 133.54 54.67 Favored 'General case' 0 C--N 1.32 -0.701 0 O-C-N 121.986 -0.446 . . . . 0.0 110.135 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 89.23 -3.19 84.1 Favored Glycine 0 CA--C 1.519 0.296 0 N-CA-C 114.437 0.535 . . . . 0.0 114.437 178.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -63.56 128.79 37.4 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 117.843 0.821 . . . . 0.0 112.873 -179.397 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 44.8 t30 -68.26 118.74 11.76 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.882 -179.436 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 16.1 ttmm -152.92 145.96 24.59 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 176.364 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 33.0 t0 -67.37 132.97 48.72 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.277 -0.874 . . . . 0.0 109.919 -179.272 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 71.81 24.67 76.33 Favored Glycine 0 C--O 1.24 0.498 0 CA-C-O 119.505 -0.608 . . . . 0.0 114.612 179.789 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 36.9 mm -131.66 132.6 62.11 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 CA-C-N 117.286 0.543 . . . . 0.0 110.495 -179.506 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.1 pt -131.44 117.14 34.62 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 CA-C-O 121.551 0.691 . . . . 0.0 110.572 175.5 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 96.1 m95 -82.53 134.74 35.2 Favored 'General case' 0 C--N 1.321 -0.645 0 O-C-N 121.966 -0.458 . . . . 0.0 111.996 -177.552 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -142.9 150.53 17.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 121.522 0.677 . . . . 0.0 109.788 -178.275 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -155.0 166.57 33.16 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 105.333 -2.099 . . . . 0.0 105.333 -178.756 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 14.7 t -128.1 167.9 16.11 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 105.186 -2.153 . . . . 0.0 105.186 176.703 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -65.04 137.0 57.43 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 95.68 -8.0 68.33 Favored Glycine 0 C--O 1.225 -0.417 0 CA-C-N 115.919 -0.582 . . . . 0.0 113.204 179.247 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -82.35 142.8 31.72 Favored 'General case' 0 CA--C 1.541 0.597 0 O-C-N 122.26 -0.553 . . . . 0.0 111.473 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 34.9 mt -90.98 135.55 33.66 Favored 'General case' 0 CA--C 1.513 -0.471 0 CA-C-O 121.386 0.612 . . . . 0.0 112.456 -179.242 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 55.3 t30 -84.69 72.27 10.72 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.526 -178.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -146.39 153.25 47.73 Favored Pre-proline 0 C--N 1.324 -0.531 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 -179.583 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -68.65 150.37 74.52 Favored 'Trans proline' 0 C--N 1.344 0.291 0 N-CA-C 114.103 0.77 . . . . 0.0 114.103 178.227 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 3.3 ptpt -151.78 56.82 0.86 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.791 0.805 . . . . 0.0 112.906 -179.432 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -56.76 -28.16 60.75 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 115.557 -0.747 . . . . 0.0 112.146 177.521 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 12.2 p80 -59.76 -10.82 4.16 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 114.363 1.246 . . . . 0.0 114.363 -178.775 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 55.7 mt -93.19 -42.16 13.01 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.496 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 178.118 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -72.06 14.65 2.12 Favored Glycine 0 N--CA 1.464 0.534 0 N-CA-C 116.559 1.384 . . . . 0.0 116.559 -176.007 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 15.2 t -90.45 23.73 2.87 Favored 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 112.768 0.655 . . . . 0.0 112.768 -178.132 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 62.0 ttp85 -55.39 130.19 41.6 Favored 'General case' 0 N--CA 1.475 0.788 0 O-C-N 121.58 -0.7 . . . . 0.0 109.62 -179.514 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 36.3 m120 -95.47 122.92 58.1 Favored Pre-proline 0 C--N 1.322 -0.608 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 -179.404 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -68.44 -20.17 42.22 Favored 'Trans proline' 0 C--O 1.219 -0.443 0 C-N-CA 117.159 -1.427 . . . . 0.0 113.133 179.624 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -73.26 -29.26 62.63 Favored 'General case' 0 C--O 1.22 -0.498 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.427 178.228 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 -100.63 -25.81 14.03 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -175.414 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 26.7 t30 -151.61 144.44 24.42 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 113.448 0.907 . . . . 0.0 113.448 -178.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -83.84 146.92 27.84 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.113 179.549 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -66.34 139.99 58.07 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.209 0.528 . . . . 0.0 110.274 178.676 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 14.3 mt -82.38 138.74 18.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 -177.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -61.15 125.71 17.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 175.328 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 7.8 tt -67.08 128.78 37.66 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 -178.018 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 29.6 mt-30 -128.65 153.35 47.37 Favored 'General case' 0 CA--C 1.507 -0.7 0 N-CA-C 106.088 -1.819 . . . . 0.0 106.088 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 17.0 mt -113.31 149.51 41.6 Favored Pre-proline 0 C--N 1.321 -0.661 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 178.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -72.15 170.65 18.55 Favored 'Trans proline' 0 C--N 1.343 0.278 0 N-CA-C 113.888 0.688 . . . . 0.0 113.888 -177.562 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -54.45 130.86 41.03 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.219 -179.349 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 90.13 -12.21 68.49 Favored Glycine 0 C--O 1.227 -0.325 0 CA-C-N 115.931 -0.577 . . . . 0.0 113.363 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.542 HG23 HE21 ' A' ' 30' ' ' GLN . 8.8 m -108.56 125.63 52.04 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 117.659 0.73 . . . . 0.0 110.271 179.145 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 10.3 p -126.21 150.43 48.36 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.929 -177.738 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 83.0 mt -69.53 153.79 95.42 Favored Pre-proline 0 C--N 1.325 -0.488 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 176.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -76.03 169.55 21.89 Favored 'Trans proline' 0 N--CA 1.464 -0.251 0 C-N-CA 118.349 -0.634 . . . . 0.0 111.23 178.491 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 60.0 tttm -61.3 130.72 47.55 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 122.144 -0.348 . . . . 0.0 110.507 -177.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 95.29 -3.57 66.47 Favored Glycine 0 C--O 1.226 -0.354 0 CA-C-N 115.923 -0.58 . . . . 0.0 114.106 178.681 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -106.47 137.83 43.75 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 179.506 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 51.1 p90 -141.53 160.04 40.97 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 175.157 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -107.14 139.74 41.1 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.594 0.59 . . . . 0.0 112.594 -175.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -73.68 143.8 46.08 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 177.183 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 96.51 -37.58 3.39 Favored Glycine 0 C--O 1.224 -0.506 0 N-CA-C 111.208 -0.757 . . . . 0.0 111.208 -178.449 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 36.9 t . . . . . 0 C--N 1.323 -0.559 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 176.419 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 0.227 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -60.16 142.28 54.57 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.053 178.688 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 19.0 m95 -69.75 -23.98 63.46 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 113.816 1.043 . . . . 0.0 113.816 -179.089 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 52.7 m-85 -121.54 162.68 20.15 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 113.343 0.868 . . . . 0.0 113.343 -171.752 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 66.3 p -68.42 164.48 20.93 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.787 -1.097 . . . . 0.0 108.959 178.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.447 ' HB2' ' CZ ' ' A' ' 69' ' ' TYR . . . -75.87 145.57 40.44 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 113.242 0.83 . . . . 0.0 113.242 -176.84 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 15.7 mt -87.4 140.3 29.67 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 102.175 -3.269 . . . . 0.0 102.175 167.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 63.7 m -116.7 128.5 55.4 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 -179.501 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -82.72 138.79 33.96 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.909 179.512 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 9.5 t-160 -139.46 94.74 2.82 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 103.589 -2.745 . . . . 0.0 103.589 167.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 163.13 -143.04 8.31 Favored Glycine 0 C--O 1.226 -0.386 0 C-N-CA 120.432 -0.889 . . . . 0.0 112.267 -175.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -121.19 -27.35 4.91 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 116.179 1.918 . . . . 0.0 116.179 -176.596 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -78.75 158.05 28.35 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 179.467 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -72.35 -62.87 1.28 Allowed 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.416 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 53.3 tp 175.54 143.93 0.06 Allowed 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 104.216 -2.512 . . . . 0.0 104.216 173.407 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.9 tppp? -158.13 141.23 14.99 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 108.855 -0.795 . . . . 0.0 108.855 176.669 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -126.01 153.12 73.86 Favored Pre-proline 0 C--N 1.325 -0.49 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 175.745 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -68.77 162.23 42.17 Favored 'Trans proline' 0 C--N 1.352 0.717 0 O-C-N 122.151 0.553 . . . . 0.0 113.09 179.481 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 18.0 tpt180 -64.02 131.88 48.92 Favored 'General case' 0 C--O 1.216 -0.678 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.895 -177.279 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 76.18 17.37 80.04 Favored Glycine 0 C--O 1.224 -0.486 0 C-N-CA 121.319 -0.467 . . . . 0.0 112.911 178.234 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 8.8 mt-30 -150.35 170.49 18.91 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 -175.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 109.2 -14.87 33.4 Favored Glycine 0 CA--C 1.502 -0.735 0 C-N-CA 121.455 -0.402 . . . . 0.0 113.345 175.275 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 89.2 t -66.13 129.6 94.24 Favored Pre-proline 0 C--N 1.319 -0.741 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 177.338 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_endo -74.21 169.55 22.21 Favored 'Trans proline' 0 N--CA 1.46 -0.481 0 O-C-N 122.143 0.549 . . . . 0.0 111.492 178.11 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 89.1 mt -70.33 107.73 2.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-O 122.084 0.945 . . . . 0.0 108.69 -179.643 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 76.1 m-20 -98.85 85.22 3.24 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 114.34 -1.3 . . . . 0.0 108.837 -178.213 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 70.1 p -66.29 -15.85 63.56 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 113.761 1.023 . . . . 0.0 113.761 -176.674 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 20.0 p30 -110.01 23.72 13.98 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.297 -0.865 . . . . 0.0 112.204 -177.398 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.41 ' HB3' ' HB2' ' A' ' 42' ' ' ASP . 15.9 m -138.55 149.25 45.12 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 113.227 0.825 . . . . 0.0 113.227 -175.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -73.77 166.71 41.83 Favored Pre-proline 0 C--O 1.236 0.379 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 177.751 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -64.66 -27.35 60.79 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 114.936 -2.909 . . . . 0.0 111.661 178.443 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -61.87 -27.67 68.96 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 123.69 0.796 . . . . 0.0 111.7 176.776 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.41 ' HB2' ' HB3' ' A' ' 38' ' ' SER . 77.3 m-20 -94.87 -4.17 47.47 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 114.696 1.369 . . . . 0.0 114.696 -171.123 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 96.2 mm-40 -59.78 -28.94 67.85 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 114.465 1.283 . . . . 0.0 114.465 -177.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 11.4 tt -58.54 138.19 19.89 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.884 0 CA-C-O 122.308 1.051 . . . . 0.0 113.804 -177.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -178.82 -156.9 18.27 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.616 -0.802 . . . . 0.0 113.004 -178.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 46.6 p90 -155.14 170.54 21.59 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 179.389 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 20.0 m-85 -111.35 140.26 46.07 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 173.363 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -109.55 120.3 42.06 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 124.122 0.969 . . . . 0.0 109.933 -177.694 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 40.2 ttp180 -68.08 136.19 53.39 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 175.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -144.83 147.24 32.62 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 123.054 0.542 . . . . 0.0 110.817 -177.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.415 HG23 ' HA ' ' A' ' 66' ' ' PRO . 0.1 OUTLIER -153.39 129.03 10.04 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.082 176.254 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 15.0 tpp180 -90.04 123.73 34.17 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 105.048 -2.205 . . . . 0.0 105.048 174.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 4.3 tmt_? -145.51 130.85 18.6 Favored 'General case' 0 CA--C 1.489 -1.371 0 CA-C-O 122.351 1.072 . . . . 0.0 111.029 -178.067 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -140.04 -179.94 2.36 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 CA-C-N 112.685 -2.052 . . . . 0.0 106.661 -177.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 3.3 tmt_? -129.32 103.77 7.12 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 105.677 -1.971 . . . . 0.0 105.677 172.027 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -72.83 158.35 53.05 Favored Glycine 0 N--CA 1.452 -0.241 0 N-CA-C 107.708 -2.157 . . . . 0.0 107.708 177.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -60.7 -37.07 92.93 Favored Glycine 0 C--O 1.222 -0.649 0 CA-C-N 118.173 0.986 . . . . 0.0 111.998 -179.371 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 39.5 t0 -86.96 13.98 8.16 Favored 'General case' 0 CA--C 1.55 0.951 0 CA-C-O 122.731 1.253 . . . . 0.0 111.248 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 86.85 6.37 79.79 Favored Glycine 0 C--O 1.224 -0.47 0 CA-C-N 115.393 -0.821 . . . . 0.0 113.543 171.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 20.9 mmtt -74.62 151.15 39.38 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-O 121.812 0.815 . . . . 0.0 111.463 -174.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 83.2 mtp -118.17 -173.94 2.56 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 114.059 -1.428 . . . . 0.0 109.576 -179.145 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 16.0 mmtt -119.94 -75.96 0.58 Allowed 'General case' 0 C--O 1.22 -0.478 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 179.774 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 52.3 m-20 -95.18 149.72 20.99 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 104.628 -2.36 . . . . 0.0 104.628 176.71 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 84.5 mt -118.96 -57.24 2.04 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 106.327 -1.731 . . . . 0.0 106.327 177.072 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -78.96 141.28 58.65 Favored Pre-proline 0 C--O 1.245 0.824 0 CA-C-N 115.058 -0.973 . . . . 0.0 108.929 175.468 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.415 ' HA ' HG23 ' A' ' 51' ' ' THR . 97.5 Cg_endo -73.06 155.88 52.2 Favored 'Trans proline' 0 C--O 1.239 0.531 0 C-N-CA 116.808 -1.661 . . . . 0.0 112.273 178.691 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 29.6 mtt85 -123.94 159.93 28.67 Favored 'General case' 0 CA--C 1.507 -0.685 0 CA-C-N 115.958 -0.564 . . . . 0.0 109.779 -178.742 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 54.4 m95 -134.01 140.9 47.01 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 177.779 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.447 ' CZ ' ' HB2' ' A' ' 15' ' ' ALA . 61.6 m-85 -120.56 154.62 35.12 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 106.567 -1.642 . . . . 0.0 106.567 178.791 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 86.1 t80 -98.27 137.88 36.35 Favored 'General case' 0 CA--C 1.507 -0.696 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 -179.165 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -137.67 144.05 41.63 Favored 'General case' 0 N--CA 1.44 -0.925 0 N-CA-C 106.838 -1.542 . . . . 0.0 106.838 -176.599 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 55.5 m-85 -81.84 159.47 23.73 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.137 -176.37 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -53.86 132.16 41.19 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 112.473 0.546 . . . . 0.0 112.473 -177.499 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 65.56 29.88 76.18 Favored Glycine 0 C--O 1.224 -0.492 0 N-CA-C 115.83 1.092 . . . . 0.0 115.83 173.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 13.6 p . . . . . 0 C--N 1.322 -0.592 0 CA-C-N 117.958 0.879 . . . . 0.0 108.881 177.978 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 17.5 mt . . . . . 0 N--CA 1.446 -0.633 0 N-CA-C 114.31 1.226 . . . . 0.0 114.31 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -78.57 165.2 25.3 Favored 'Trans proline' 0 C--O 1.237 0.445 0 C-N-CA 121.625 1.55 . . . . 0.0 108.147 169.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 68.0 t80 -61.85 131.43 49.76 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 120.343 -0.543 . . . . 0.0 110.216 -179.363 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 92.21 -6.64 78.58 Favored Glycine 0 CA--C 1.52 0.372 0 N-CA-C 115.101 0.8 . . . . 0.0 115.101 178.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -64.42 129.02 38.28 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 118.431 1.115 . . . . 0.0 112.36 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 58.0 t30 -75.09 127.95 34.39 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.287 -178.318 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 1.2 ttmp? -156.18 153.2 28.87 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 179.33 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -62.11 129.06 39.09 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.812 0.339 . . . . 0.0 111.766 -179.434 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 66.39 31.38 78.73 Favored Glycine 0 N--CA 1.451 -0.301 0 CA-C-O 119.457 -0.635 . . . . 0.0 114.238 178.041 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 43.8 mm -128.61 129.95 68.79 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 CA-C-N 117.419 0.61 . . . . 0.0 109.942 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.1 pt -132.86 120.33 40.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.204 176.025 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 96.0 m95 -85.98 136.81 33.11 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 -176.678 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 16.3 m -138.15 149.74 24.66 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 CA-C-O 121.525 0.679 . . . . 0.0 109.623 179.523 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -155.97 166.62 32.93 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 104.43 -2.433 . . . . 0.0 104.43 -179.359 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 12.6 t -137.93 175.14 9.85 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 105.936 -1.876 . . . . 0.0 105.936 179.311 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -64.96 135.48 55.71 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.162 0.506 . . . . 0.0 110.549 -179.409 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 94.39 -7.9 71.93 Favored Glycine 0 C--O 1.224 -0.526 0 CA-C-N 115.881 -0.599 . . . . 0.0 113.755 177.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -79.35 138.84 37.84 Favored 'General case' 0 CA--C 1.538 0.505 0 O-C-N 122.443 -0.445 . . . . 0.0 111.92 -179.449 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 34.7 mt -95.08 137.08 34.62 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-O 121.007 0.432 . . . . 0.0 111.993 -179.455 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 58.9 t30 -82.0 69.54 8.73 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.11 0.481 . . . . 0.0 110.764 -179.437 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -141.26 155.65 67.85 Favored Pre-proline 0 C--N 1.323 -0.562 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 -178.626 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -64.62 150.53 88.04 Favored 'Trans proline' 0 C--N 1.344 0.338 0 N-CA-C 115.262 1.216 . . . . 0.0 115.262 179.649 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.478 ' HB3' HD12 ' A' ' 106' ' ' ILE . 74.1 mmtt -124.8 37.75 4.34 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 114.609 -1.178 . . . . 0.0 109.054 -177.644 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 16.6 p-10 -48.89 -45.96 41.95 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 114.742 -1.117 . . . . 0.0 112.869 -179.647 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 48.8 p-80 -70.05 -9.5 55.56 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 124.38 1.072 . . . . 0.0 113.747 -177.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.478 HD12 ' HB3' ' A' ' 103' ' ' LYS . 48.8 mt -94.9 -48.04 13.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 179.055 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -74.99 14.66 4.53 Favored Glycine 0 C--O 1.224 -0.502 0 N-CA-C 116.397 1.319 . . . . 0.0 116.397 -177.122 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 13.6 t -92.95 24.56 3.62 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 117.41 0.605 . . . . 0.0 111.099 179.478 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.492 ' HD2' HD22 ' A' ' 114' ' ' ASN . 65.9 ttp85 -57.8 136.28 56.93 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 178.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -109.09 132.22 21.34 Favored Pre-proline 0 C--N 1.324 -0.51 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -72.6 -15.35 27.37 Favored 'Trans proline' 0 C--O 1.219 -0.447 0 C-N-CA 117.877 -0.949 . . . . 0.0 113.52 -178.177 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -75.62 -25.62 57.07 Favored 'General case' 0 C--O 1.22 -0.481 0 CA-C-O 120.942 0.401 . . . . 0.0 110.303 178.401 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 82.7 m-20 -102.6 -23.31 13.88 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 113.745 1.017 . . . . 0.0 113.745 -174.339 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . 0.492 HD22 ' HD2' ' A' ' 109' ' ' ARG . 35.7 t30 -153.98 152.36 30.45 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.62 0.6 . . . . 0.0 112.62 -176.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -94.27 146.9 23.69 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-O 121.184 0.516 . . . . 0.0 110.749 178.402 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -71.38 148.47 46.95 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.005 0.431 . . . . 0.0 110.833 178.759 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 3.4 mt -92.41 142.33 13.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 -178.322 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -59.47 126.19 16.76 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 175.825 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 6.0 tt -68.55 128.88 38.2 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.956 -177.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 30.2 mt-30 -132.36 157.93 43.23 Favored 'General case' 0 CA--C 1.511 -0.544 0 N-CA-C 106.677 -1.601 . . . . 0.0 106.677 -179.122 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 13.7 mt -113.69 147.56 37.89 Favored Pre-proline 0 C--N 1.322 -0.62 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 177.6 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -73.32 167.0 28.44 Favored 'Trans proline' 0 C--N 1.346 0.397 0 O-C-N 122.223 0.591 . . . . 0.0 112.928 -179.342 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 43.6 tt0 -54.88 131.39 44.2 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.604 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 97.89 -19.45 54.54 Favored Glycine 0 C--O 1.227 -0.303 0 CA-C-N 116.004 -0.543 . . . . 0.0 113.256 -179.511 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 6.9 m -106.71 127.57 53.48 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 118.148 0.974 . . . . 0.0 110.576 178.713 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 17.2 p -120.24 148.36 43.79 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.541 -179.535 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 91.7 mt -67.24 154.87 91.96 Favored Pre-proline 0 C--N 1.324 -0.526 0 N-CA-C 107.953 -1.128 . . . . 0.0 107.953 178.082 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -75.16 170.47 20.3 Favored 'Trans proline' 0 N--CA 1.461 -0.385 0 C-N-CA 118.208 -0.728 . . . . 0.0 110.854 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 23.8 tptm -60.9 120.66 10.61 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 -178.094 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 91.13 41.53 5.21 Favored Glycine 0 C--O 1.227 -0.331 0 N-CA-C 115.297 0.879 . . . . 0.0 115.297 178.736 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -145.19 148.53 33.65 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 117.384 0.592 . . . . 0.0 110.403 177.557 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 54.8 p90 -147.73 165.05 31.68 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.212 -1.032 . . . . 0.0 108.212 176.106 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -105.99 139.81 39.95 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.01 0.433 . . . . 0.0 111.851 -176.703 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -74.09 143.56 45.34 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 178.236 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 95.59 -38.14 3.21 Favored Glycine 0 CA--C 1.518 0.25 0 C-N-CA 121.687 -0.292 . . . . 0.0 113.486 179.373 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 32.2 t . . . . . 0 C--N 1.324 -0.518 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 177.101 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.598 0 CA-C-O 122.464 1.126 . . . . 0.0 113.72 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 30.9 t -58.98 142.21 51.72 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 113.986 -1.461 . . . . 0.0 109.974 175.21 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 17.1 m95 -64.33 -21.94 66.78 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 114.104 1.15 . . . . 0.0 114.104 178.545 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -121.41 162.96 19.49 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 114.312 1.227 . . . . 0.0 114.312 -169.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 68.3 p -70.76 162.66 28.72 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 114.575 -1.193 . . . . 0.0 107.855 176.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.471 ' HB2' ' CZ ' ' A' ' 69' ' ' TYR . . . -75.72 141.98 42.54 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 113.243 0.831 . . . . 0.0 113.243 -175.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.419 HD23 ' HA ' ' A' ' 16' ' ' LEU . 12.4 mt -85.66 142.46 29.04 Favored 'General case' 0 C--O 1.213 -0.868 0 N-CA-C 102.678 -3.082 . . . . 0.0 102.678 169.257 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 40.9 m -123.84 135.77 53.96 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 118.638 0.654 . . . . 0.0 110.267 -177.603 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.438 ' HB2' ' CZ ' ' A' ' 131' ' ' PHE . 4.1 tp60 -100.7 139.25 36.65 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.493 -0.776 . . . . 0.0 112.005 -178.133 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 16.1 t-160 -126.58 99.6 5.87 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 103.775 -2.676 . . . . 0.0 103.775 168.674 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 157.17 -173.54 34.72 Favored Glycine 0 C--O 1.225 -0.417 0 N-CA-C 109.098 -1.601 . . . . 0.0 109.098 -176.629 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -97.68 -21.86 16.78 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 114.629 1.344 . . . . 0.0 114.629 -177.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -71.4 157.18 38.52 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.723 0.297 . . . . 0.0 110.351 -178.471 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -74.98 -63.0 1.36 Allowed 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.837 -0.345 . . . . 0.0 111.292 -178.092 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 36.0 tp 161.03 141.78 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.203 0 N-CA-C 102.299 -3.223 . . . . 0.0 102.299 179.094 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 13.8 tmtt? -156.71 131.07 8.63 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 176.625 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 -114.77 142.43 28.32 Favored Pre-proline 0 CA--C 1.54 0.592 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 176.491 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -62.88 154.12 68.52 Favored 'Trans proline' 0 CA--C 1.541 0.869 0 CA-C-O 121.325 0.469 . . . . 0.0 112.958 173.347 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 4.1 tmt_? -63.66 134.14 54.89 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.943 -177.701 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 87.96 6.85 75.09 Favored Glycine 0 C--O 1.226 -0.347 0 O-C-N 123.4 0.438 . . . . 0.0 112.381 178.381 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -145.72 167.78 22.31 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 -176.108 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 112.59 -19.38 21.73 Favored Glycine 0 CA--C 1.5 -0.846 0 C-N-CA 121.716 -0.278 . . . . 0.0 113.638 173.449 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.417 HG11 ' HB3' ' A' ' 43' ' ' GLN . 95.8 t -67.33 127.82 93.55 Favored Pre-proline 0 C--N 1.32 -0.712 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 178.473 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -74.93 164.03 34.25 Favored 'Trans proline' 0 N--CA 1.459 -0.504 0 O-C-N 122.124 0.539 . . . . 0.0 111.801 178.12 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 97.9 mt -66.84 123.44 19.9 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 -178.573 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 46.1 t-20 -125.61 113.83 17.91 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 177.239 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 67.0 p -90.68 -14.83 31.47 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 -175.509 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -111.51 28.99 8.23 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 113.408 0.892 . . . . 0.0 113.408 -175.65 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 99.3 p -141.58 164.88 29.02 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.713 0.292 . . . . 0.0 110.998 -179.412 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 4.2 m -77.13 164.95 55.73 Favored Pre-proline 0 C--N 1.321 -0.642 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.85 -178.294 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -68.31 -25.03 36.7 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 115.068 -2.821 . . . . 0.0 113.425 178.03 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.52 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 3.4 p-10 -76.64 -19.06 58.21 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 121.375 -0.828 . . . . 0.0 111.563 176.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 78.1 m-20 -78.57 -6.92 56.86 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 113.469 0.914 . . . . 0.0 113.469 -176.695 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.417 ' HB3' HG11 ' A' ' 32' ' ' VAL . 95.7 mm-40 -62.16 -24.91 67.46 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 113.595 0.961 . . . . 0.0 113.595 -177.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.449 ' HB ' ' HB1' ' A' ' 98' ' ' ALA . 7.9 tt -60.93 137.9 22.61 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.811 0 CA-C-O 122.205 1.003 . . . . 0.0 112.761 179.47 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 179.15 -156.9 19.7 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.465 -0.874 . . . . 0.0 112.382 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 45.3 p90 -155.02 170.45 21.74 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 179.1 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 19.5 m-85 -112.59 141.75 45.99 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 107.219 -1.401 . . . . 0.0 107.219 173.559 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 67.8 ttt-85 -112.24 130.24 55.99 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.971 -0.558 . . . . 0.0 111.237 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 44.8 ttt85 -71.67 145.35 48.95 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.472 0.653 . . . . 0.0 112.249 179.222 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -152.2 170.07 20.9 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 105.501 -2.037 . . . . 0.0 105.501 177.479 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 12.1 t -156.6 166.65 32.8 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 176.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 34.8 tpt85 -130.25 127.5 39.7 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 173.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 2.9 tmt_? -151.04 152.05 32.9 Favored 'General case' 0 CA--C 1.495 -1.147 0 N-CA-C 105.229 -2.137 . . . . 0.0 105.229 -178.68 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -125.99 174.17 10.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 26.8 tpt180 -141.99 122.31 13.96 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 106.106 -1.813 . . . . 0.0 106.106 177.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -82.65 174.56 53.14 Favored Glycine 0 C--O 1.224 -0.505 0 N-CA-C 109.24 -1.544 . . . . 0.0 109.24 178.003 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -72.26 -40.24 55.98 Favored Glycine 0 C--O 1.216 -1.023 0 N-CA-C 111.241 -0.744 . . . . 0.0 111.241 -177.485 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 27.3 t0 -71.93 -20.67 61.72 Favored 'General case' 0 C--O 1.217 -0.65 0 CA-C-O 122.635 1.207 . . . . 0.0 108.4 177.577 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 116.55 -12.39 15.82 Favored Glycine 0 CA--C 1.501 -0.803 0 CA-C-N 114.74 -1.118 . . . . 0.0 111.051 172.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 4.0 pttt -67.69 140.68 56.79 Favored 'General case' 0 CA--C 1.505 -0.755 0 CA-C-O 121.974 0.892 . . . . 0.0 110.495 -177.613 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 16.9 ptm -136.34 -177.47 4.73 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 114.027 -1.442 . . . . 0.0 112.155 -174.327 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 58.4 mmtt -90.58 -125.21 0.07 Allowed 'General case' 0 C--O 1.216 -0.663 0 N-CA-C 104.16 -2.533 . . . . 0.0 104.16 175.305 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 38.2 t0 -143.92 177.2 8.71 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 103.882 -2.636 . . . . 0.0 103.882 177.182 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -80.92 136.98 36.13 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 178.292 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.1 p -112.23 89.92 13.03 Favored Pre-proline 0 C--N 1.322 -0.593 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 173.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -69.13 131.82 22.99 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 115.632 -2.445 . . . . 0.0 112.107 -178.356 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 33.5 ptt180 -141.46 157.99 44.44 Favored 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 179.182 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 57.3 m95 -129.57 148.07 51.44 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 120.668 0.271 . . . . 0.0 111.306 -175.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.471 ' CZ ' ' HB2' ' A' ' 15' ' ' ALA . 48.1 m-85 -124.68 146.09 49.32 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 106.499 -1.667 . . . . 0.0 106.499 -179.433 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 75.1 t80 -95.74 131.5 41.94 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 -175.411 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -133.87 159.81 39.56 Favored 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 107.096 -1.446 . . . . 0.0 107.096 -175.201 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 71.5 m-85 -99.95 159.56 14.98 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 111.713 0.264 . . . . 0.0 111.713 -171.637 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -54.51 129.69 37.01 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.688 -178.759 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 68.72 34.48 78.13 Favored Glycine 0 C--O 1.221 -0.665 0 CA-C-O 118.804 -0.998 . . . . 0.0 115.57 176.666 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.327 -0.391 0 CA-C-N 118.633 1.216 . . . . 0.0 109.225 177.623 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 53.0 mt . . . . . 0 N--CA 1.447 -0.624 0 N-CA-C 115.015 1.487 . . . . 0.0 115.015 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -77.32 167.87 23.91 Favored 'Trans proline' 0 C--O 1.237 0.432 0 N-CA-C 108.749 -1.289 . . . . 0.0 108.749 170.454 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 66.7 t80 -62.77 134.0 55.62 Favored 'General case' 0 C--N 1.321 -0.658 0 O-C-N 121.957 -0.465 . . . . 0.0 110.019 179.431 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 89.64 -3.25 83.31 Favored Glycine 0 CA--C 1.519 0.327 0 N-CA-C 114.505 0.562 . . . . 0.0 114.505 178.236 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -63.14 130.13 43.3 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 117.812 0.806 . . . . 0.0 112.061 179.71 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 50.1 t-20 -76.6 124.67 27.98 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.692 -178.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 23.3 tttt -155.33 152.15 28.82 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 178.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -64.12 130.49 44.15 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.962 -178.117 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 65.62 30.27 77.01 Favored Glycine 0 N--CA 1.45 -0.395 0 CA-C-O 119.597 -0.557 . . . . 0.0 114.238 179.057 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 37.1 mm -129.83 128.71 65.56 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 CA-C-N 117.362 0.581 . . . . 0.0 110.154 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -133.16 118.27 31.78 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 CA-C-O 121.425 0.631 . . . . 0.0 110.747 177.175 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 92.8 m95 -84.98 137.27 33.19 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 113.395 0.887 . . . . 0.0 113.395 -175.675 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 18.6 m -137.85 149.7 25.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.66 0.743 . . . . 0.0 110.016 179.653 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -159.63 166.64 30.24 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 104.049 -2.575 . . . . 0.0 104.049 -179.404 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 10.6 t -131.73 173.92 10.66 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 104.956 -2.239 . . . . 0.0 104.956 177.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -67.69 135.14 52.3 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 -178.293 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 95.84 -11.14 68.22 Favored Glycine 0 CA--C 1.518 0.231 0 CA-C-N 115.883 -0.598 . . . . 0.0 112.945 -179.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.52 ' HA ' ' HA ' ' A' ' 41' ' ' ASP . . . -74.24 133.01 42.65 Favored 'General case' 0 CA--C 1.541 0.609 0 O-C-N 122.413 -0.463 . . . . 0.0 109.864 178.847 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 27.8 mt -88.53 140.39 29.51 Favored 'General case' 0 CA--C 1.513 -0.473 0 CA-C-O 121.367 0.603 . . . . 0.0 111.917 -178.148 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 58.0 t30 -84.43 68.08 10.13 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.371 -179.263 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -138.41 151.95 70.28 Favored Pre-proline 0 C--O 1.24 0.594 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -68.14 150.89 77.39 Favored 'Trans proline' 0 C--N 1.343 0.256 0 N-CA-C 114.62 0.969 . . . . 0.0 114.62 177.304 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 1.6 ptpt -150.99 58.45 0.91 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.987 0.898 . . . . 0.0 111.863 178.496 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -56.47 -28.47 59.8 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 115.037 -0.983 . . . . 0.0 111.225 177.061 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 14.2 p80 -59.24 -10.38 2.89 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 114.544 1.312 . . . . 0.0 114.544 -178.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 37.9 mt -96.31 -36.3 6.33 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.577 0 CA-C-N 117.92 0.327 . . . . 0.0 110.165 178.128 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -74.11 14.44 3.86 Favored Glycine 0 N--CA 1.464 0.538 0 N-CA-C 116.023 1.169 . . . . 0.0 116.023 -176.314 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 15.2 t -96.5 23.29 6.96 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 -177.179 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 57.8 ttp85 -63.05 126.63 27.97 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 106.943 -1.503 . . . . 0.0 106.943 177.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 18.3 m-20 -110.84 131.96 21.87 Favored Pre-proline 0 C--N 1.32 -0.684 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 -178.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -67.64 -21.45 45.56 Favored 'Trans proline' 0 C--N 1.349 0.589 0 N-CA-C 114.728 1.011 . . . . 0.0 114.728 -175.072 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -71.99 -25.0 61.67 Favored 'General case' 0 C--O 1.219 -0.526 0 CA-C-O 120.784 0.326 . . . . 0.0 110.266 177.559 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 -101.81 -28.54 12.38 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 113.486 0.921 . . . . 0.0 113.486 -175.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 18.9 t30 -159.36 148.91 18.53 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -178.117 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -85.28 149.62 25.35 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-O 121.675 0.75 . . . . 0.0 112.862 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -70.73 147.39 49.08 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.762 178.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 23.5 mt -86.8 139.31 17.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.387 -179.141 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 73.1 t -61.87 122.02 11.56 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 174.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 5.8 tt -67.79 129.38 39.73 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.957 0.408 . . . . 0.0 110.123 -177.433 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -134.79 158.1 45.04 Favored 'General case' 0 CA--C 1.513 -0.472 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 -178.581 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 14.9 mt -114.45 149.2 41.78 Favored Pre-proline 0 C--N 1.322 -0.618 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 176.346 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_endo -70.56 168.81 21.52 Favored 'Trans proline' 0 C--N 1.343 0.27 0 N-CA-C 114.377 0.876 . . . . 0.0 114.377 -177.042 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -55.5 133.82 50.34 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.415 -178.242 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 88.27 -12.16 65.45 Favored Glycine 0 C--O 1.227 -0.333 0 CA-C-N 115.854 -0.612 . . . . 0.0 112.619 -179.688 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 16.2 m -107.38 125.9 51.79 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.113 0.483 . . . . 0.0 110.28 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 17.7 p -121.48 148.26 44.67 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 113.027 0.751 . . . . 0.0 113.027 -176.572 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 89.3 mt -69.79 156.28 92.0 Favored Pre-proline 0 C--N 1.326 -0.439 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 177.147 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -75.49 168.16 25.07 Favored 'Trans proline' 0 C--O 1.235 0.334 0 C-N-CA 118.42 -0.587 . . . . 0.0 111.252 178.506 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 1.8 tmtp? -58.72 128.79 38.97 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.702 -177.609 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 95.0 -5.57 68.76 Favored Glycine 0 C--O 1.225 -0.421 0 N-CA-C 114.664 0.625 . . . . 0.0 114.664 177.627 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.438 ' CZ ' ' HB2' ' A' ' 18' ' ' GLN . 1.4 m-85 -104.27 140.24 38.15 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-O 121.873 0.844 . . . . 0.0 111.199 -179.521 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 46.1 p90 -142.19 165.67 26.8 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 114.174 -1.376 . . . . 0.0 107.461 176.092 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -106.98 144.61 33.35 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.927 0.394 . . . . 0.0 111.358 -177.37 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -72.67 136.94 45.73 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 178.747 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 89.64 -30.0 5.97 Favored Glycine 0 CA--C 1.518 0.241 0 CA-C-N 116.139 -0.482 . . . . 0.0 112.786 -177.242 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 22.7 t . . . . . 0 C--N 1.325 -0.476 0 CA-C-N 117.386 0.593 . . . . 0.0 110.635 -179.942 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.836 0 CA-C-O 121.703 0.763 . . . . 0.0 112.724 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 51.2 p -60.66 144.84 51.12 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 114.908 -1.042 . . . . 0.0 110.293 178.652 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 22.3 m95 -70.8 -24.36 62.55 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 114.727 1.38 . . . . 0.0 114.727 -178.369 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 26.3 m-85 -121.49 162.47 20.46 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 -171.645 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 73.0 p -70.25 162.68 27.99 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 179.195 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -79.42 149.17 31.68 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.953 0.882 . . . . 0.0 112.991 -177.782 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 37.1 mt -89.52 148.95 23.12 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 102.77 -3.048 . . . . 0.0 102.77 168.637 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 33.6 m -122.83 138.51 54.63 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.444 ' HB2' ' CZ ' ' A' ' 131' ' ' PHE . 4.1 tp60 -110.66 135.08 51.81 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.246 0.546 . . . . 0.0 112.3 -176.785 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 7.7 t-160 -130.9 94.68 3.66 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 104.055 -2.572 . . . . 0.0 104.055 170.751 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -178.76 -171.21 41.76 Favored Glycine 0 C--O 1.224 -0.494 0 N-CA-C 110.19 -1.164 . . . . 0.0 110.19 -176.622 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -97.69 -26.45 14.74 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 113.844 1.053 . . . . 0.0 113.844 -177.646 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 25.6 pt-20 -92.23 166.41 12.63 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 179.024 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -79.22 -62.93 1.54 Allowed 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 120.704 -0.398 . . . . 0.0 111.753 -177.255 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 36.8 tp 171.61 144.18 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 105.822 -1.918 . . . . 0.0 105.822 178.059 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 55.0 tttm -156.03 142.69 18.7 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 171.434 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 15.5 m-85 -119.66 157.9 50.86 Favored Pre-proline 0 C--O 1.247 0.955 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 176.175 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.415 ' HG2' ' HB3' ' A' ' 30' ' ' GLN . 50.0 Cg_endo -64.99 163.78 27.26 Favored 'Trans proline' 0 C--N 1.352 0.745 0 C-N-CA 121.355 1.37 . . . . 0.0 112.755 175.64 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 25.9 tpt180 -78.14 132.63 37.73 Favored 'General case' 0 C--O 1.216 -0.696 0 O-C-N 121.845 -0.534 . . . . 0.0 110.743 -177.435 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 77.95 17.81 77.88 Favored Glycine 0 C--O 1.223 -0.571 0 O-C-N 123.386 0.429 . . . . 0.0 112.315 177.21 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.415 ' HB3' ' HG2' ' A' ' 27' ' ' PRO . 49.3 tt0 -157.33 170.47 22.39 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 104.451 -2.425 . . . . 0.0 104.451 -175.497 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 105.73 -8.74 43.55 Favored Glycine 0 N--CA 1.462 0.41 0 CA-C-N 118.525 0.602 . . . . 0.0 113.811 177.399 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 76.2 t -70.9 133.8 86.03 Favored Pre-proline 0 C--N 1.321 -0.665 0 N-CA-C 106.791 -1.559 . . . . 0.0 106.791 176.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -69.98 171.87 13.9 Favored 'Trans proline' 0 N--CA 1.464 -0.246 0 C-N-CA 120.588 0.858 . . . . 0.0 112.967 178.113 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 83.7 mt -74.85 112.05 11.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 179.113 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 64.7 m-20 -109.6 80.74 1.35 Allowed 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 114.842 -1.072 . . . . 0.0 109.865 -175.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 76.2 p -69.87 -17.71 63.37 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 114.124 1.157 . . . . 0.0 114.124 -176.255 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 70.3 m-80 -112.54 35.46 3.82 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.701 -178.116 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.7 m -146.54 165.69 28.7 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 111.716 0.265 . . . . 0.0 111.716 -177.579 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 47.0 m -93.15 158.78 36.72 Favored Pre-proline 0 CA--C 1.536 0.439 0 C-N-CA 123.219 0.608 . . . . 0.0 111.718 -176.041 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -65.91 -23.92 54.1 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 115.71 -2.393 . . . . 0.0 115.253 -177.768 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -76.84 -20.23 56.59 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 121.68 -0.638 . . . . 0.0 112.675 179.051 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 12.4 p30 -96.41 0.99 51.28 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 114.643 1.349 . . . . 0.0 114.643 -174.565 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 86.4 mm-40 -57.36 -22.32 41.67 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.667 0.746 . . . . 0.0 112.675 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 8.2 tt -62.73 135.66 26.85 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.741 0 CA-C-O 122.366 1.079 . . . . 0.0 111.752 177.769 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 179.3 -156.81 19.36 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.212 -0.994 . . . . 0.0 112.232 -178.164 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 39.9 p90 -155.12 166.98 31.88 Favored 'General case' 0 C--N 1.318 -0.803 0 O-C-N 122.564 -0.374 . . . . 0.0 110.263 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 32.4 m-85 -108.22 140.68 41.1 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 175.556 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 48.5 ttt180 -115.85 120.21 38.5 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 124.1 0.96 . . . . 0.0 112.56 -175.215 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 36.7 ttt180 -66.32 141.21 58.07 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 123.785 0.834 . . . . 0.0 111.427 178.675 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -149.88 143.2 25.15 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 122.609 0.364 . . . . 0.0 111.116 176.752 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 14.6 t -161.0 165.86 29.18 Favored 'General case' 0 C--O 1.239 0.544 0 N-CA-C 106.078 -1.823 . . . . 0.0 106.078 174.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 3.9 tpt180 -144.9 127.97 16.58 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.78 0.324 . . . . 0.0 110.392 178.078 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 7.5 tmm_? -139.39 131.62 28.21 Favored 'General case' 0 CA--C 1.498 -1.023 0 CA-C-O 121.54 0.686 . . . . 0.0 109.698 178.369 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -139.85 179.28 2.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 N-CA-C 105.775 -1.935 . . . . 0.0 105.775 -178.564 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 17.4 tpp180 -124.9 103.51 8.09 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 106.244 -1.762 . . . . 0.0 106.244 173.808 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -75.57 159.04 50.89 Favored Glycine 0 C--O 1.227 -0.304 0 N-CA-C 106.945 -2.462 . . . . 0.0 106.945 176.067 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -60.51 -38.23 94.55 Favored Glycine 0 C--O 1.22 -0.765 0 CA-C-N 118.277 1.038 . . . . 0.0 113.698 -178.011 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -86.03 7.09 25.92 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.691 0.758 . . . . 0.0 111.593 179.731 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 96.62 -2.21 62.34 Favored Glycine 0 C--N 1.321 -0.29 0 CA-C-N 115.241 -0.89 . . . . 0.0 113.711 177.617 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 18.3 mttt -59.55 140.25 56.46 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.852 0.834 . . . . 0.0 112.703 -178.51 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 84.1 mtp -111.81 -169.97 1.56 Allowed 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 113.974 -1.466 . . . . 0.0 109.562 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 8.4 mmtt -121.28 -69.0 0.86 Allowed 'General case' 0 C--O 1.217 -0.636 0 N-CA-C 111.801 0.297 . . . . 0.0 111.801 -179.126 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 70.4 m-20 -126.46 158.71 35.33 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 -179.446 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 95.2 mt -122.4 -68.74 0.87 Allowed 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 177.231 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -71.17 135.25 84.82 Favored Pre-proline 0 C--N 1.323 -0.561 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.682 177.566 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -75.06 155.5 42.64 Favored 'Trans proline' 0 C--O 1.236 0.4 0 C-N-CA 117.048 -1.501 . . . . 0.0 113.165 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 75.6 mtt85 -111.59 160.02 17.6 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.234 178.33 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 71.2 m95 -132.64 127.4 34.82 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 175.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 65.7 m-85 -110.29 167.1 10.45 Favored 'General case' 0 C--O 1.21 -0.993 0 N-CA-C 104.758 -2.312 . . . . 0.0 104.758 -179.59 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 85.2 t80 -114.88 139.73 49.54 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 119.339 0.972 . . . . 0.0 109.118 -179.05 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 -138.61 148.69 44.42 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.515 -176.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 71.5 m-85 -82.2 159.49 23.25 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.423 -177.48 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -54.12 129.46 34.76 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-O 121.234 0.54 . . . . 0.0 112.407 -177.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 73.9 28.34 64.97 Favored Glycine 0 C--O 1.219 -0.837 0 N-CA-C 115.804 1.081 . . . . 0.0 115.804 175.714 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 2.3 p . . . . . 0 C--N 1.323 -0.545 0 CA-C-N 118.675 1.238 . . . . 0.0 108.56 179.39 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 74.7 mt . . . . . 0 N--CA 1.449 -0.488 0 N-CA-C 114.935 1.457 . . . . 0.0 114.935 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -76.57 166.96 26.41 Favored 'Trans proline' 0 C--O 1.238 0.482 0 N-CA-C 109.078 -1.162 . . . . 0.0 109.078 170.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.415 ' CE1' ' HB3' ' A' ' 92' ' ' TRP . 83.3 t80 -61.04 128.89 38.67 Favored 'General case' 0 C--N 1.323 -0.557 0 O-C-N 121.989 -0.444 . . . . 0.0 110.898 -179.747 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 93.89 -4.92 72.29 Favored Glycine 0 CA--C 1.518 0.277 0 N-CA-C 114.977 0.751 . . . . 0.0 114.977 178.228 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -63.81 133.2 52.99 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 118.027 0.913 . . . . 0.0 111.935 179.376 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 -77.95 130.31 36.38 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.096 -179.108 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 39.2 tttm -156.07 150.29 25.52 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 176.123 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -63.36 131.65 48.94 Favored 'General case' 0 C--O 1.24 0.573 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 178.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 72.33 23.33 78.11 Favored Glycine 0 N--CA 1.445 -0.757 0 N-CA-C 114.894 0.718 . . . . 0.0 114.894 177.439 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 42.7 mm -130.45 127.46 62.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 117.146 0.473 . . . . 0.0 109.946 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -133.17 123.56 47.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.929 176.678 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . 0.415 ' HB3' ' CE1' ' A' ' 83' ' ' TYR . 92.9 m95 -89.55 137.41 32.36 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 113.225 0.824 . . . . 0.0 113.225 -175.453 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 15.8 m -136.74 153.06 29.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 178.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -157.5 166.53 32.71 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 102.863 -3.014 . . . . 0.0 102.863 -179.51 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 11.4 t -136.05 175.26 9.76 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 106.215 -1.772 . . . . 0.0 106.215 179.33 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -64.02 133.55 53.33 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.011 0.434 . . . . 0.0 110.226 -179.666 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 93.85 -9.4 73.21 Favored Glycine 0 N--CA 1.46 0.237 0 CA-C-N 116.061 -0.518 . . . . 0.0 114.116 178.108 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -74.58 139.38 43.66 Favored 'General case' 0 CA--C 1.54 0.576 0 O-C-N 122.484 -0.421 . . . . 0.0 111.425 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 18.5 mt -82.13 162.48 22.47 Favored 'General case' 0 C--O 1.213 -0.86 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 177.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 59.4 t30 -114.87 69.53 0.72 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.075 0.464 . . . . 0.0 110.405 178.409 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -143.1 152.54 58.45 Favored Pre-proline 0 C--O 1.241 0.616 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -67.44 150.94 80.72 Favored 'Trans proline' 0 C--N 1.345 0.355 0 N-CA-C 113.511 0.543 . . . . 0.0 113.511 177.77 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 4.9 ptpt -151.6 59.11 0.88 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 122.777 1.275 . . . . 0.0 109.128 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -60.39 -30.6 69.69 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 113.846 -1.524 . . . . 0.0 113.028 -178.307 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 48.5 p-80 -60.84 -22.92 64.7 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 113.095 0.776 . . . . 0.0 113.095 -178.02 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 67.4 mt -71.45 -31.83 44.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 178.586 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -74.93 14.64 4.49 Favored Glycine 0 CA--C 1.524 0.596 0 N-CA-C 115.638 1.015 . . . . 0.0 115.638 -178.082 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 9.5 t -83.27 16.19 2.58 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 113.773 1.027 . . . . 0.0 113.773 -178.395 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 65.3 ttp85 -59.17 130.02 44.96 Favored 'General case' 0 N--CA 1.47 0.552 0 O-C-N 121.225 -0.922 . . . . 0.0 108.861 -178.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -107.93 130.18 23.14 Favored Pre-proline 0 C--N 1.322 -0.606 0 N-CA-C 106.408 -1.701 . . . . 0.0 106.408 179.475 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -69.61 -17.78 38.08 Favored 'Trans proline' 0 C--O 1.219 -0.461 0 C-N-CA 117.826 -0.982 . . . . 0.0 113.667 -177.652 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -74.14 -26.14 60.15 Favored 'General case' 0 C--O 1.22 -0.47 0 CA-C-O 120.838 0.352 . . . . 0.0 110.657 178.191 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 77.9 m-20 -102.23 -25.07 13.82 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 113.195 0.813 . . . . 0.0 113.195 -174.481 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 30.9 t30 -156.04 147.15 22.33 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.623 0.601 . . . . 0.0 112.623 -178.603 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -89.5 146.99 24.24 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.706 179.368 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -70.71 147.43 49.07 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.928 0.394 . . . . 0.0 109.969 178.129 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 2.0 mt -91.36 142.65 12.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 -178.129 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 87.8 t -59.14 123.08 10.72 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 N-CA-C 107.883 -1.155 . . . . 0.0 107.883 177.077 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 7.3 tt -70.46 127.89 34.28 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 -178.499 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 36.5 mt-30 -132.77 162.74 30.67 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 -178.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 15.4 mt -114.81 145.55 34.19 Favored Pre-proline 0 C--N 1.323 -0.584 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 179.268 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -72.93 170.34 19.97 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 120.329 0.686 . . . . 0.0 113.84 -177.567 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -54.61 133.36 46.53 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.738 -179.645 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 92.6 -17.43 57.67 Favored Glycine 0 C--O 1.227 -0.331 0 CA-C-N 116.001 -0.545 . . . . 0.0 113.191 -179.383 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 3.8 m -108.62 126.22 52.72 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 117.773 0.786 . . . . 0.0 110.303 178.689 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 14.5 p -123.4 152.19 41.83 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.057 -0.52 . . . . 0.0 109.922 -178.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 90.4 mt -72.34 151.47 92.05 Favored Pre-proline 0 C--N 1.324 -0.527 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 178.299 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -77.81 173.08 14.62 Favored 'Trans proline' 0 N--CA 1.462 -0.34 0 O-C-N 121.966 0.456 . . . . 0.0 111.06 178.418 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 66.3 tttp -59.78 127.89 34.2 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 122.074 -0.392 . . . . 0.0 111.519 -177.631 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 95.17 -1.48 64.87 Favored Glycine 0 C--O 1.227 -0.292 0 N-CA-C 115.142 0.817 . . . . 0.0 115.142 176.696 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.444 ' CZ ' ' HB2' ' A' ' 18' ' ' GLN . 1.2 m-85 -103.75 141.69 35.65 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-O 121.601 0.715 . . . . 0.0 111.632 -179.25 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 47.2 p90 -146.13 166.07 27.25 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 114.572 -1.194 . . . . 0.0 107.833 175.415 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -106.47 145.57 31.64 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 112.446 0.536 . . . . 0.0 112.446 -176.31 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -72.81 139.35 46.97 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 177.489 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 90.69 -36.85 3.48 Favored Glycine 0 CA--C 1.515 0.079 0 CA-C-N 116.177 -0.465 . . . . 0.0 112.821 -178.613 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 31.3 t . . . . . 0 C--N 1.325 -0.488 0 N-CA-C 109.541 -0.541 . . . . 0.0 109.541 -179.445 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.311 0 CA-C-O 121.134 0.492 . . . . 0.0 110.714 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 5.3 m -61.14 145.86 49.54 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.877 176.523 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 18.7 m95 -67.04 -22.83 65.86 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 113.452 0.908 . . . . 0.0 113.452 179.804 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -121.43 162.32 20.65 Favored 'General case' 0 CA--C 1.507 -0.688 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.974 -172.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 76.5 p -70.5 161.97 29.64 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 177.473 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -83.58 144.76 29.26 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.9 -0.591 . . . . 0.0 112.392 -175.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.41 HD21 HD22 ' A' ' 119' ' ' LEU . 66.2 mt -76.32 148.85 37.21 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 104.798 -2.297 . . . . 0.0 104.798 171.525 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 31.3 m -128.14 148.58 50.6 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 105.24 -2.133 . . . . 0.0 105.24 179.12 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -138.47 163.12 32.77 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 114.925 1.454 . . . . 0.0 114.925 -178.336 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 52.9 t60 -89.71 99.5 12.5 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 100.705 -3.813 . . . . 0.0 100.705 168.811 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -42.07 103.05 0.03 OUTLIER Glycine 0 N--CA 1.461 0.313 0 N-CA-C 118.538 2.175 . . . . 0.0 118.538 -173.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 82.4 mttt -142.97 -44.93 0.3 Allowed 'General case' 0 C--O 1.221 -0.401 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 177.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -120.67 169.61 10.22 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 -179.393 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -106.01 32.74 4.19 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 122.967 1.365 . . . . 0.0 110.045 178.873 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 32.6 tp 64.23 141.49 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 111.283 -2.689 . . . . 0.0 114.619 176.798 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 43.1 tptt -153.68 138.22 16.84 Favored 'General case' 0 C--N 1.324 -0.532 0 O-C-N 121.31 -0.869 . . . . 0.0 110.529 171.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -122.66 149.14 55.14 Favored Pre-proline 0 C--N 1.321 -0.633 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 176.073 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -70.25 159.44 53.04 Favored 'Trans proline' 0 C--N 1.349 0.576 0 O-C-N 122.188 0.573 . . . . 0.0 112.7 179.149 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 16.0 tpt180 -67.04 136.15 54.79 Favored 'General case' 0 C--O 1.218 -0.598 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 -178.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 85.94 6.96 81.63 Favored Glycine 0 C--O 1.222 -0.621 0 N-CA-C 111.241 -0.744 . . . . 0.0 111.241 179.606 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 20.3 mt-30 -147.77 172.68 13.74 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 123.27 0.628 . . . . 0.0 109.433 -175.356 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 104.23 -20.47 40.22 Favored Glycine 0 CA--C 1.501 -0.816 0 CA-C-N 115.883 -0.599 . . . . 0.0 113.558 174.424 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 57.6 t -67.28 128.22 93.66 Favored Pre-proline 0 C--N 1.32 -0.706 0 N-CA-C 106.76 -1.57 . . . . 0.0 106.76 177.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -71.59 171.61 15.98 Favored 'Trans proline' 0 C--O 1.223 -0.265 0 O-C-N 122.161 0.558 . . . . 0.0 111.329 177.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 87.6 mt -70.01 106.57 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-O 121.96 0.886 . . . . 0.0 108.791 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 -98.1 83.67 3.15 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 114.663 -1.153 . . . . 0.0 110.616 -176.55 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 73.1 p -68.02 -14.21 62.79 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.707 0.765 . . . . 0.0 112.725 -179.51 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 11.1 p30 -108.84 21.61 17.01 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.008 -0.997 . . . . 0.0 112.724 -177.216 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 5.8 m -142.83 151.47 41.16 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 113.366 0.876 . . . . 0.0 113.366 -176.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 52.8 m -78.32 166.53 42.37 Favored Pre-proline 0 C--N 1.327 -0.407 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 177.224 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.418 ' HA ' ' HG2' ' A' ' 43' ' ' GLN . 60.6 Cg_endo -63.94 -26.67 66.63 Favored 'Trans proline' 0 C--N 1.353 0.77 0 C-N-CA 115.24 -2.707 . . . . 0.0 112.86 179.65 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -60.81 -32.82 72.17 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.663 0.744 . . . . 0.0 110.78 177.192 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 68.8 m-20 -88.7 -6.15 57.64 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 115.416 1.636 . . . . 0.0 115.416 -172.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.418 ' HG2' ' HA ' ' A' ' 40' ' ' PRO . 96.5 mm-40 -58.33 -29.25 65.77 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 114.295 1.22 . . . . 0.0 114.295 -176.248 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.43 ' HB ' ' HB1' ' A' ' 98' ' ' ALA . 11.2 tt -59.5 136.69 22.85 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-O 122.408 1.099 . . . . 0.0 112.244 -179.299 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -179.04 -157.9 20.4 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.495 -0.86 . . . . 0.0 111.996 -177.57 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 47.7 p90 -155.01 171.41 19.79 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 179.438 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 19.1 m-85 -112.71 141.05 46.95 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 106.551 -1.648 . . . . 0.0 106.551 173.548 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 69.4 ttt-85 -114.18 124.79 52.92 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.758 -177.144 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 15.2 ttt-85 -63.22 137.82 58.34 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 175.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -149.27 140.87 23.45 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.776 0.798 . . . . 0.0 112.708 179.477 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 12.2 p -133.26 142.64 48.63 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 104.602 -2.37 . . . . 0.0 104.602 174.34 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 11.8 tpt180 -160.68 128.23 4.38 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 112.959 0.726 . . . . 0.0 112.959 -179.81 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.5 tpp180 -116.68 142.7 46.56 Favored 'General case' 0 CA--C 1.507 -0.69 0 N-CA-C 105.734 -1.951 . . . . 0.0 105.734 173.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -138.37 177.1 5.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 -177.043 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.93 117.41 19.2 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 104.434 -2.432 . . . . 0.0 104.434 172.65 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -82.79 163.41 42.04 Favored Glycine 0 C--O 1.224 -0.511 0 N-CA-C 107.57 -2.212 . . . . 0.0 107.57 176.681 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -64.35 -32.58 84.68 Favored Glycine 0 C--O 1.214 -1.112 0 CA-C-N 118.121 0.96 . . . . 0.0 111.609 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -90.86 17.91 7.22 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-O 122.147 0.975 . . . . 0.0 110.551 178.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 85.36 -6.25 80.51 Favored Glycine 0 N--CA 1.46 0.247 0 N-CA-C 116.338 1.295 . . . . 0.0 116.338 173.54 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.42 128.69 37.54 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.807 0.813 . . . . 0.0 112.634 -178.069 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 97.8 mmm -99.32 -174.73 2.81 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 114.323 -1.308 . . . . 0.0 108.051 178.466 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 6.3 tttp -117.02 -62.0 1.64 Allowed 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 175.34 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.1 t0 54.74 -152.82 0.33 Allowed 'General case' 0 C--O 1.24 0.59 0 O-C-N 124.771 1.294 . . . . 0.0 110.955 178.346 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.9 mm? 67.16 -179.47 0.22 Allowed 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 115.372 1.619 . . . . 0.0 115.372 174.069 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -58.26 156.34 21.89 Favored Pre-proline 0 C--O 1.24 0.585 0 N-CA-C 116.804 2.15 . . . . 0.0 116.804 -174.874 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -66.41 156.57 64.62 Favored 'Trans proline' 0 C--N 1.354 0.838 0 CA-C-O 121.3 0.458 . . . . 0.0 111.817 177.431 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 42.2 mtt-85 -128.69 163.31 25.38 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.622 -175.326 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 61.8 m95 -127.42 129.97 48.48 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 179.122 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 24.2 m-85 -111.27 149.08 31.56 Favored 'General case' 0 C--O 1.213 -0.838 0 N-CA-C 106.949 -1.5 . . . . 0.0 106.949 -178.38 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 86.8 t80 -98.1 139.97 33.12 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.909 -0.775 . . . . 0.0 108.909 -178.224 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -142.36 153.13 43.56 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 -179.052 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 69.1 m-85 -88.12 159.51 18.18 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.87 -174.502 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -54.43 131.01 41.5 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.77 0.319 . . . . 0.0 110.686 -179.487 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 69.67 32.98 71.0 Favored Glycine 0 C--O 1.223 -0.578 0 N-CA-C 115.345 0.898 . . . . 0.0 115.345 176.37 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.433 HG22 ' HA ' ' A' ' 104' ' ' ASP . 1.4 p . . . . . 0 C--N 1.325 -0.463 0 CA-C-N 118.108 0.954 . . . . 0.0 109.312 177.268 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 52.2 mt . . . . . 0 C--O 1.238 0.491 0 N-CA-C 115.65 1.722 . . . . 0.0 115.65 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -78.15 168.0 22.49 Favored 'Trans proline' 0 CA--C 1.53 0.32 0 C-N-CA 120.954 1.103 . . . . 0.0 109.442 170.783 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.432 ' CE2' ' HB3' ' A' ' 92' ' ' TRP . 73.2 t80 -62.26 131.96 51.09 Favored 'General case' 0 C--N 1.323 -0.575 0 O-C-N 121.883 -0.511 . . . . 0.0 110.309 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 90.55 -3.6 81.72 Favored Glycine 0 C--O 1.228 -0.265 0 N-CA-C 114.585 0.594 . . . . 0.0 114.585 177.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -63.09 131.0 47.08 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 118.016 0.908 . . . . 0.0 111.403 179.392 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 53.7 t30 -77.84 124.92 28.58 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.181 -178.641 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 12.1 tttp -156.15 151.74 27.05 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 178.322 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 20.3 t0 -66.41 133.79 51.18 Favored 'General case' 0 C--N 1.322 -0.623 0 O-C-N 123.395 0.435 . . . . 0.0 110.068 -179.197 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 67.31 27.56 73.53 Favored Glycine 0 N--CA 1.45 -0.431 0 N-CA-C 114.749 0.66 . . . . 0.0 114.749 178.529 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 41.7 mm -129.27 125.84 62.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 117.266 0.533 . . . . 0.0 110.655 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.1 pt -129.78 116.16 36.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 CA-C-O 121.909 0.861 . . . . 0.0 112.536 176.782 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . 0.432 ' HB3' ' CE2' ' A' ' 83' ' ' TYR . 94.8 m95 -80.52 135.28 36.07 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 113.533 0.938 . . . . 0.0 113.533 -176.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 17.1 m -135.13 151.99 31.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 179.427 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -160.6 166.5 28.84 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 104.683 -2.34 . . . . 0.0 104.683 -178.801 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 13.5 t -136.39 178.78 6.8 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 105.151 -2.166 . . . . 0.0 105.151 177.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -66.99 136.48 55.38 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.318 0.58 . . . . 0.0 110.693 -179.257 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 92.24 -14.32 64.88 Favored Glycine 0 C--O 1.226 -0.374 0 CA-C-N 115.715 -0.675 . . . . 0.0 113.563 177.256 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.43 ' HB1' ' HB ' ' A' ' 44' ' ' ILE . . . -69.96 126.71 30.48 Favored 'General case' 0 C--N 1.322 -0.624 0 O-C-N 122.43 -0.453 . . . . 0.0 110.975 -179.492 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 43.6 mt -83.49 138.37 33.47 Favored 'General case' 0 CA--C 1.515 -0.392 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 -177.224 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 61.5 t30 -82.08 65.11 7.06 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.527 0.68 . . . . 0.0 110.729 179.816 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -140.11 155.18 70.71 Favored Pre-proline 0 C--N 1.322 -0.619 0 N-CA-C 105.639 -1.985 . . . . 0.0 105.639 179.591 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_endo -73.33 155.83 50.94 Favored 'Trans proline' 0 CA--C 1.532 0.377 0 N-CA-C 115.016 1.122 . . . . 0.0 115.016 179.438 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.79 58.02 1.05 Allowed 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 121.852 0.834 . . . . 0.0 112.055 176.338 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . 0.433 ' HA ' HG22 ' A' ' 75' ' ' THR . 33.7 t70 -56.98 -26.94 60.94 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.117 178.115 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 17.1 p80 -58.84 -11.52 3.36 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 114.521 1.304 . . . . 0.0 114.521 -178.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 23.2 mt -96.35 -36.14 6.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 122.175 -0.328 . . . . 0.0 110.836 178.22 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -73.83 14.51 3.55 Favored Glycine 0 CA--C 1.522 0.495 0 N-CA-C 116.189 1.235 . . . . 0.0 116.189 -175.334 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 9.7 t -107.33 29.26 7.3 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-O 121.057 0.456 . . . . 0.0 111.971 -177.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.479 ' HD2' HD22 ' A' ' 114' ' ' ASN . 64.2 ttp85 -54.73 134.36 47.44 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 177.513 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 41.6 m-20 -102.06 122.73 46.01 Favored Pre-proline 0 C--N 1.325 -0.497 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 -178.129 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -68.74 -18.6 42.02 Favored 'Trans proline' 0 C--O 1.217 -0.531 0 N-CA-C 114.425 0.894 . . . . 0.0 114.425 -176.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -75.69 -25.92 57.15 Favored 'General case' 0 C--O 1.22 -0.477 0 CA-C-O 120.842 0.353 . . . . 0.0 110.657 178.121 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 83.0 m-20 -100.75 -23.84 14.53 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 -175.39 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . 0.479 HD22 ' HD2' ' A' ' 109' ' ' ARG . 31.4 t30 -154.98 147.91 24.6 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.764 0.654 . . . . 0.0 112.764 -178.879 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -88.37 148.57 24.18 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-O 121.454 0.645 . . . . 0.0 111.404 179.493 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -68.97 142.45 54.67 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.226 0.536 . . . . 0.0 110.183 178.378 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 18.9 mt -84.8 136.56 22.5 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 -179.038 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 74.4 t -60.49 124.69 15.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 N-CA-C 105.295 -2.113 . . . . 0.0 105.295 174.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.41 HD22 HD21 ' A' ' 16' ' ' LEU . 7.6 tt -66.18 127.93 34.1 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.199 0.523 . . . . 0.0 109.968 -176.65 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 30.1 mt-30 -129.68 156.35 44.4 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 106.169 -1.789 . . . . 0.0 106.169 -179.483 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 13.6 mt -112.37 148.02 38.27 Favored Pre-proline 0 C--N 1.321 -0.661 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 177.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -72.43 165.37 32.88 Favored 'Trans proline' 0 C--O 1.236 0.38 0 O-C-N 122.293 0.628 . . . . 0.0 112.454 -179.354 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 65.1 tt0 -54.86 130.41 41.06 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.491 -179.471 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 99.47 -19.8 52.27 Favored Glycine 0 C--O 1.226 -0.39 0 CA-C-N 115.873 -0.603 . . . . 0.0 113.601 -179.278 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 11.2 m -105.76 130.91 53.66 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 118.251 1.025 . . . . 0.0 110.684 178.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 16.9 p -124.54 152.11 43.88 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.614 -178.035 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 90.3 mt -78.67 155.3 78.45 Favored Pre-proline 0 C--N 1.326 -0.432 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 177.287 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -75.19 170.25 20.77 Favored 'Trans proline' 0 C--O 1.237 0.44 0 CA-C-O 121.55 0.562 . . . . 0.0 111.367 177.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 48.1 tptt -63.5 122.49 16.4 Favored 'General case' 0 C--O 1.218 -0.579 0 CA-C-O 121.006 0.432 . . . . 0.0 111.234 -175.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 95.21 7.36 59.54 Favored Glycine 0 C--O 1.228 -0.263 0 N-CA-C 115.236 0.854 . . . . 0.0 115.236 178.331 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -110.48 143.48 40.74 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 107.332 -1.358 . . . . 0.0 107.332 176.788 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 35.2 p90 -147.56 163.95 34.99 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 177.263 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -99.55 145.6 27.34 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.894 0.378 . . . . 0.0 110.625 -178.393 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -72.07 135.84 46.42 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 178.28 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 86.41 -10.47 66.68 Favored Glycine 0 C--O 1.226 -0.396 0 CA-C-N 116.28 -0.418 . . . . 0.0 113.464 -178.641 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 32.2 t . . . . . 0 C--N 1.326 -0.429 0 CA-C-N 117.535 0.668 . . . . 0.0 110.089 179.482 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.623 0 CA-C-O 121.486 0.66 . . . . 0.0 109.667 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -58.37 140.28 53.88 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.608 177.674 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 35.7 m95 -65.82 -22.0 66.52 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 114.283 1.216 . . . . 0.0 114.283 -178.769 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 82.6 m-85 -121.37 161.84 21.4 Favored 'General case' 0 CA--C 1.506 -0.714 0 N-CA-C 114.453 1.279 . . . . 0.0 114.453 -171.086 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.423 ' HB ' ' HB3' ' A' ' 134' ' ' GLU . 73.1 p -69.89 163.59 25.62 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 114.045 -1.434 . . . . 0.0 108.468 177.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.468 ' HB2' ' CZ ' ' A' ' 69' ' ' TYR . . . -77.43 139.3 39.64 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 -175.224 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 12.8 mt -84.49 145.62 28.02 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 103.927 -2.619 . . . . 0.0 103.927 170.8 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 21.9 m -129.31 133.2 47.33 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 118.13 0.423 . . . . 0.0 109.96 -179.4 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.414 ' HB2' ' CZ ' ' A' ' 131' ' ' PHE . 3.8 tp60 -95.34 143.33 26.79 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 123.615 0.572 . . . . 0.0 111.577 -179.568 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 23.1 t-160 -138.97 96.5 3.13 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 102.609 -3.108 . . . . 0.0 102.609 165.57 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 172.57 -161.22 32.67 Favored Glycine 0 C--O 1.226 -0.399 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 -173.531 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 49.6 mtmt -104.54 -27.89 11.61 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 116.332 1.975 . . . . 0.0 116.332 -176.634 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -85.58 162.44 18.86 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 179.231 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -76.03 -62.9 1.44 Allowed 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 -178.519 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 36.4 tp -178.32 138.14 0.18 Allowed 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 104.799 -2.297 . . . . 0.0 104.799 172.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 11.0 tmtt? -149.28 133.33 17.18 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 176.606 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -121.05 159.8 47.78 Favored Pre-proline 0 C--O 1.243 0.748 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 177.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -65.39 171.52 9.16 Favored 'Trans proline' 0 CA--C 1.539 0.746 0 C-N-CA 121.004 1.136 . . . . 0.0 114.706 -179.82 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 25.5 tpt180 -78.4 128.0 33.0 Favored 'General case' 0 C--O 1.215 -0.758 0 O-C-N 121.561 -0.712 . . . . 0.0 109.289 179.448 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 72.12 18.68 78.06 Favored Glycine 0 C--O 1.225 -0.459 0 N-CA-C 114.552 0.581 . . . . 0.0 114.552 176.583 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 43.1 tt0 -159.32 149.59 19.17 Favored 'General case' 0 C--O 1.22 -0.46 0 N-CA-C 105.652 -1.981 . . . . 0.0 105.652 -178.437 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 136.05 -14.74 4.05 Favored Glycine 0 CA--C 1.505 -0.548 0 C-N-CA 120.323 -0.941 . . . . 0.0 113.225 176.524 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 27.6 m -71.6 145.93 90.6 Favored Pre-proline 0 C--N 1.32 -0.698 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 177.382 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -77.17 173.03 15.03 Favored 'Trans proline' 0 N--CA 1.46 -0.491 0 C-N-CA 121.507 1.471 . . . . 0.0 112.578 178.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 91.5 mt -79.3 116.74 23.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.129 -179.379 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.456 ' HB2' HE22 ' A' ' 43' ' ' GLN . 22.4 m-20 -100.95 86.13 3.0 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 176.664 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 69.8 p -60.39 -27.06 67.14 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 115.661 1.726 . . . . 0.0 115.661 -173.69 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 19.7 p30 -108.18 21.38 17.43 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 -177.37 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 15.1 m -130.19 169.32 15.52 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 112.165 0.432 . . . . 0.0 112.165 -175.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 68.8 m -83.7 158.39 62.64 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.295 -176.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -67.42 -21.53 46.77 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 116.882 -1.612 . . . . 0.0 114.751 -177.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.464 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 4.1 p-10 -74.65 -17.04 60.75 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 121.927 -0.483 . . . . 0.0 110.856 178.814 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.446 ' HA ' ' HE3' ' A' ' 103' ' ' LYS . 0.0 OUTLIER -87.04 -16.32 35.99 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 114.925 1.454 . . . . 0.0 114.925 -174.269 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.456 HE22 ' HB2' ' A' ' 35' ' ' ASN . 84.0 mm-40 -57.81 -20.63 37.21 Favored 'General case' 0 C--O 1.218 -0.582 0 N-CA-C 114.093 1.145 . . . . 0.0 114.093 -172.154 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.412 ' HB ' ' HB1' ' A' ' 98' ' ' ALA . 20.6 tt -58.8 139.93 17.83 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 CA-C-O 122.401 1.095 . . . . 0.0 113.076 178.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 177.86 -153.61 13.54 Favored Glycine 0 N--CA 1.444 -0.792 0 C-N-CA 119.924 -1.131 . . . . 0.0 112.653 178.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 51.6 p90 -155.1 167.75 29.31 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 178.361 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 38.2 m-85 -108.74 140.28 42.38 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 106.435 -1.691 . . . . 0.0 106.435 174.419 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 65.3 ttt-85 -113.33 122.73 48.28 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.923 -177.82 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 49.0 ttp85 -68.62 136.89 53.71 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 177.008 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -134.85 136.41 42.43 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 179.041 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 14.8 t -152.9 159.19 42.98 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 106.697 -1.594 . . . . 0.0 106.697 176.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 21.6 tpt180 -157.74 142.27 16.33 Favored 'General case' 0 C--O 1.216 -0.663 0 N-CA-C 105.955 -1.869 . . . . 0.0 105.955 179.618 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -129.05 130.64 46.82 Favored 'General case' 0 CA--C 1.493 -1.223 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 176.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -128.89 173.05 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.003 0 N-CA-C 105.664 -1.976 . . . . 0.0 105.664 -179.14 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 6.6 tmm_? -140.33 112.76 7.9 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 106.024 -1.843 . . . . 0.0 106.024 175.811 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -74.04 164.24 54.7 Favored Glycine 0 C--O 1.226 -0.376 0 N-CA-C 110.448 -1.061 . . . . 0.0 110.448 -179.808 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -65.93 -33.8 86.7 Favored Glycine 0 C--O 1.217 -0.935 0 N-CA-C 110.522 -1.031 . . . . 0.0 110.522 -179.269 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.0 t0 -85.2 16.96 3.23 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-O 122.157 0.98 . . . . 0.0 110.968 179.352 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 84.77 -4.81 84.17 Favored Glycine 0 CA--C 1.509 -0.298 0 N-CA-C 116.071 1.188 . . . . 0.0 116.071 172.277 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.59 123.16 20.1 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.488 0.661 . . . . 0.0 111.785 -177.394 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 93.4 mmm -88.84 169.49 11.55 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.01 -0.996 . . . . 0.0 108.663 178.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 5.4 tmtt? -74.99 -52.74 10.37 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 177.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 58.37 -174.27 0.09 Allowed 'General case' 0 C--O 1.243 0.713 0 N-CA-C 115.547 1.684 . . . . 0.0 115.547 178.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.5 mm? 64.79 169.77 0.19 Allowed 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 115.018 1.488 . . . . 0.0 115.018 -179.461 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -70.62 163.25 65.35 Favored Pre-proline 0 C--O 1.243 0.723 0 CA-C-N 114.603 -1.181 . . . . 0.0 114.181 -176.331 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -72.12 166.8 28.58 Favored 'Trans proline' 0 C--N 1.351 0.666 0 CA-C-O 121.562 0.568 . . . . 0.0 112.736 177.748 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 22.9 mtp180 -117.91 166.3 12.65 Favored 'General case' 0 CA--C 1.512 -0.497 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 178.795 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 62.8 m95 -127.45 143.4 51.2 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 177.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.468 ' CZ ' ' HB2' ' A' ' 15' ' ' ALA . 60.7 m-85 -124.02 147.49 47.78 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 178.889 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 86.5 t80 -95.79 139.24 32.31 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 -177.356 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -142.44 140.6 32.01 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 -176.471 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.407 ' HB3' ' HB2' ' A' ' 103' ' ' LYS . 74.9 m-85 -68.1 159.44 30.91 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -179.313 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 19.1 tp -59.44 134.72 57.27 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 175.147 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 75.66 35.28 46.76 Favored Glycine 0 C--O 1.222 -0.638 0 N-CA-C 115.881 1.112 . . . . 0.0 115.881 177.22 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 21.7 p . . . . . 0 C--N 1.325 -0.459 0 CA-C-N 118.288 1.044 . . . . 0.0 109.832 177.867 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 75.2 mt . . . . . 0 C--O 1.238 0.48 0 N-CA-C 114.874 1.435 . . . . 0.0 114.874 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -76.85 166.75 26.44 Favored 'Trans proline' 0 N--CA 1.461 -0.41 0 N-CA-C 109.231 -1.103 . . . . 0.0 109.231 171.253 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 62.1 t80 -62.95 131.26 48.08 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 120.708 -0.397 . . . . 0.0 110.29 -179.219 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 92.39 -3.48 75.72 Favored Glycine 0 CA--C 1.52 0.396 0 N-CA-C 114.524 0.569 . . . . 0.0 114.524 179.156 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -63.03 130.94 46.89 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 117.863 0.832 . . . . 0.0 112.104 179.406 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 32.7 t-20 -78.3 125.85 29.95 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.568 -178.466 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 14.7 ttmm -155.55 150.47 26.53 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 176.743 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -63.36 131.36 48.01 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.245 179.585 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 70.66 25.88 74.98 Favored Glycine 0 N--CA 1.45 -0.418 0 CA-C-O 119.375 -0.681 . . . . 0.0 114.184 177.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 39.7 mm -128.83 128.14 67.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 117.515 0.658 . . . . 0.0 109.963 179.339 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.1 pt -130.13 115.26 32.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 CA-C-O 121.422 0.63 . . . . 0.0 110.891 176.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 97.4 m95 -82.07 132.22 35.25 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 112.941 0.719 . . . . 0.0 112.941 -176.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 1.1 m -142.05 152.95 18.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.187 -178.127 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -155.12 166.53 33.28 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 103.371 -2.826 . . . . 0.0 103.371 -178.824 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 14.5 t -122.76 169.13 11.39 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 104.206 -2.516 . . . . 0.0 104.206 174.481 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -65.37 137.16 57.32 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.193 0.52 . . . . 0.0 109.922 -179.495 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 91.19 -5.79 81.29 Favored Glycine 0 CA--C 1.516 0.119 0 CA-C-N 115.749 -0.659 . . . . 0.0 113.4 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.464 ' HA ' ' HA ' ' A' ' 41' ' ' ASP . . . -77.81 135.48 37.96 Favored 'General case' 0 CA--C 1.537 0.478 0 O-C-N 122.307 -0.525 . . . . 0.0 109.647 179.2 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 28.8 mt -88.25 136.37 33.01 Favored 'General case' 0 CA--C 1.509 -0.615 0 CA-C-O 121.601 0.715 . . . . 0.0 111.979 -178.249 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 54.4 t30 -82.59 67.95 8.84 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.978 -1.01 . . . . 0.0 110.588 -178.683 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -142.77 155.63 63.0 Favored Pre-proline 0 C--N 1.323 -0.57 0 N-CA-C 106.382 -1.711 . . . . 0.0 106.382 -179.102 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -66.83 150.6 83.23 Favored 'Trans proline' 0 CA--C 1.53 0.292 0 N-CA-C 114.78 1.031 . . . . 0.0 114.78 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.581 ' HB3' HD12 ' A' ' 106' ' ' ILE . 71.1 mmtt -126.89 36.88 4.38 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.152 179.758 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 14.0 p-10 -49.55 -42.77 45.04 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.268 0.556 . . . . 0.0 112.003 -177.796 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 15.4 p80 -67.5 -10.3 50.36 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 115.121 1.526 . . . . 0.0 115.121 -178.589 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.581 HD12 ' HB3' ' A' ' 103' ' ' LYS . 38.8 mt -91.93 -31.95 5.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 179.535 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -74.12 14.6 3.76 Favored Glycine 0 C--O 1.222 -0.597 0 N-CA-C 115.488 0.955 . . . . 0.0 115.488 -177.79 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 15.1 t -83.17 24.44 0.79 Allowed 'General case' 0 CA--C 1.547 0.862 0 N-CA-C 113.814 1.042 . . . . 0.0 113.814 -177.145 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 69.9 ttp85 -62.17 124.92 22.16 Favored 'General case' 0 N--CA 1.471 0.584 0 O-C-N 121.033 -1.042 . . . . 0.0 108.691 179.604 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 11.4 m-20 -99.56 125.34 41.17 Favored Pre-proline 0 C--N 1.323 -0.563 0 N-CA-C 106.307 -1.738 . . . . 0.0 106.307 179.381 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -68.85 -18.5 41.4 Favored 'Trans proline' 0 C--O 1.22 -0.421 0 C-N-CA 117.98 -0.88 . . . . 0.0 114.315 -176.126 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -75.41 -26.19 58.19 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.854 0.359 . . . . 0.0 110.621 178.04 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 -100.58 -25.86 14.03 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 -174.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 27.7 t30 -152.11 145.6 24.87 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 -179.423 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -86.7 149.39 24.92 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.402 179.69 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -66.8 142.34 57.39 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.295 0.569 . . . . 0.0 110.381 178.668 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 22.8 mt -84.15 139.26 17.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.312 -0.858 . . . . 0.0 108.689 -178.152 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 91.6 t -61.67 124.52 16.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 105.789 -1.93 . . . . 0.0 105.789 175.134 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 6.1 tt -66.51 128.74 37.37 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.098 0.475 . . . . 0.0 109.906 -177.257 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -129.88 151.8 50.05 Favored 'General case' 0 CA--C 1.507 -0.696 0 N-CA-C 106.285 -1.746 . . . . 0.0 106.285 -179.31 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 13.0 mt -110.16 148.32 38.1 Favored Pre-proline 0 C--N 1.321 -0.655 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 178.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -71.59 164.26 36.28 Favored 'Trans proline' 0 C--N 1.345 0.349 0 O-C-N 122.228 0.594 . . . . 0.0 112.999 -178.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 54.8 tt0 -54.25 131.12 40.93 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.628 -0.714 . . . . 0.0 109.685 -179.412 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 98.93 -17.7 57.84 Favored Glycine 0 C--O 1.228 -0.262 0 CA-C-N 115.829 -0.623 . . . . 0.0 112.494 -178.822 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 1.8 m -108.62 128.94 55.28 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 117.716 0.758 . . . . 0.0 110.587 178.052 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 6.0 p -124.91 151.05 45.88 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 179.37 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 72.6 mt -67.33 153.28 95.07 Favored Pre-proline 0 C--N 1.324 -0.525 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 -179.705 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -75.06 168.08 25.58 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 117.938 -0.908 . . . . 0.0 110.406 178.461 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -57.0 124.52 18.96 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 112.92 0.711 . . . . 0.0 112.92 -174.074 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 95.2 -6.06 68.55 Favored Glycine 0 C--O 1.229 -0.201 0 N-CA-C 115.818 1.087 . . . . 0.0 115.818 177.402 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.414 ' CZ ' ' HB2' ' A' ' 18' ' ' GLN . 1.7 m-85 -93.13 146.32 23.75 Favored 'General case' 0 N--CA 1.439 -1.013 0 CA-C-O 122.096 0.95 . . . . 0.0 110.416 179.362 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 46.8 p90 -144.75 160.58 41.0 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 113.793 -1.549 . . . . 0.0 108.12 174.438 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -102.56 142.84 33.07 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.092 0.472 . . . . 0.0 111.02 -177.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.423 ' HB3' ' HB ' ' A' ' 14' ' ' THR . 3.5 tp10 -70.12 131.61 44.56 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 177.779 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 92.29 -10.98 73.22 Favored Glycine 0 C--O 1.227 -0.298 0 C-N-CA 121.359 -0.448 . . . . 0.0 112.944 -178.526 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 41.9 t . . . . . 0 C--N 1.327 -0.395 0 N-CA-C 106.957 -1.497 . . . . 0.0 106.957 176.84 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.095 0 CA-C-O 121.462 0.649 . . . . 0.0 111.73 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 35.7 t -63.16 144.0 57.3 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.144 177.775 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 18.1 m95 -67.34 -21.83 65.63 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 112.824 0.675 . . . . 0.0 112.824 178.025 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 39.8 m-85 -121.55 165.6 15.43 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 114.663 1.357 . . . . 0.0 114.663 -170.437 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 76.1 p -71.44 166.45 21.69 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 114.459 -1.246 . . . . 0.0 107.758 176.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.495 ' HB2' ' CZ ' ' A' ' 69' ' ' TYR . . . -78.01 157.51 29.62 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 113.54 0.941 . . . . 0.0 113.54 -175.554 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 12.9 mt -102.05 137.1 40.77 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 105.288 -2.116 . . . . 0.0 105.288 171.114 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 37.0 m -122.19 145.4 48.23 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 -177.278 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.419 ' HB2' ' CZ ' ' A' ' 131' ' ' PHE . 4.2 tp60 -112.51 142.89 44.54 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 114.664 1.357 . . . . 0.0 114.664 -175.172 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 72.4 t60 -131.98 99.46 4.75 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 104.663 -2.347 . . . . 0.0 104.663 166.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 171.04 -152.97 19.74 Favored Glycine 0 C--O 1.227 -0.309 0 N-CA-C 109.954 -1.258 . . . . 0.0 109.954 -175.374 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -117.39 -21.97 8.43 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-O 121.44 0.638 . . . . 0.0 110.865 179.455 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -72.65 151.0 42.5 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.311 -179.646 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 16.8 t0 -76.61 -62.59 1.58 Allowed 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 178.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 43.1 tp 179.64 143.35 0.15 Allowed 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 103.478 -2.786 . . . . 0.0 103.478 171.299 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 56.8 tptt -154.56 134.57 13.06 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 118.047 0.385 . . . . 0.0 110.188 176.001 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 12.0 m-85 -125.0 157.27 67.42 Favored Pre-proline 0 C--O 1.244 0.811 0 N-CA-C 106.291 -1.744 . . . . 0.0 106.291 175.363 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -72.2 175.02 10.51 Favored 'Trans proline' 0 CA--C 1.536 0.611 0 C-N-CA 121.174 1.249 . . . . 0.0 114.527 -178.526 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 46.7 tpt85 -78.33 127.45 32.24 Favored 'General case' 0 C--O 1.214 -0.815 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 178.351 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 80.17 10.5 85.41 Favored Glycine 0 C--O 1.223 -0.567 0 N-CA-C 115.417 0.927 . . . . 0.0 115.417 175.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.555 HE21 HG23 ' A' ' 125' ' ' THR . 22.3 tt0 -157.71 145.5 18.71 Favored 'General case' 0 C--O 1.219 -0.521 0 N-CA-C 106.264 -1.754 . . . . 0.0 106.264 -179.537 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 138.5 -14.61 3.43 Favored Glycine 0 CA--C 1.504 -0.607 0 C-N-CA 120.042 -1.075 . . . . 0.0 113.523 177.298 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 27.8 m -70.06 144.72 93.14 Favored Pre-proline 0 C--N 1.322 -0.595 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 176.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -76.16 174.28 13.09 Favored 'Trans proline' 0 N--CA 1.46 -0.496 0 C-N-CA 121.483 1.455 . . . . 0.0 111.773 178.523 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 92.4 mt -71.86 118.47 16.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 178.404 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 45.1 m-80 -111.29 87.08 2.46 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 179.515 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 82.1 p -66.84 -21.94 66.01 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 112.769 0.655 . . . . 0.0 112.769 -177.091 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 71.6 m-80 -105.62 34.71 3.15 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.875 -177.249 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 20.6 m -145.84 150.41 36.11 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.745 0.307 . . . . 0.0 111.603 -179.4 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 25.3 m -71.31 164.19 59.39 Favored Pre-proline 0 C--N 1.325 -0.484 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 176.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -64.57 -26.8 61.66 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 114.926 -2.916 . . . . 0.0 111.598 177.721 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 51.2 m-20 -63.03 -27.39 69.38 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.827 177.001 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.491 ' HA ' ' HE3' ' A' ' 103' ' ' LYS . 67.9 m-20 -93.41 -6.62 46.68 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 115.569 1.692 . . . . 0.0 115.569 -171.878 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 92.0 mm-40 -60.43 -33.12 72.06 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 115.097 1.517 . . . . 0.0 115.097 -176.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 14.5 tt -60.1 140.62 17.86 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 CA-C-O 122.137 0.97 . . . . 0.0 113.117 -178.686 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 179.85 -149.34 8.53 Favored Glycine 0 C--O 1.227 -0.325 0 CA-C-N 115.623 -0.717 . . . . 0.0 112.455 -176.675 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 50.7 p90 -155.08 171.98 18.89 Favored 'General case' 0 C--N 1.319 -0.72 0 O-C-N 122.187 -0.596 . . . . 0.0 109.959 179.164 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 28.7 m-85 -114.25 142.99 45.57 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 173.222 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 68.5 ttt180 -115.22 125.88 53.89 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 123.739 0.815 . . . . 0.0 110.628 -178.329 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 6.3 ttp85 -71.26 135.52 47.49 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 107.675 -1.231 . . . . 0.0 107.675 176.317 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -135.35 129.64 33.73 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 123.218 0.607 . . . . 0.0 111.212 -178.732 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 15.0 t -159.96 155.43 25.45 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 174.271 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 20.3 tpt180 -161.26 139.18 9.33 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 105.319 -2.104 . . . . 0.0 105.319 178.021 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -88.44 135.38 33.5 Favored 'General case' 0 CA--C 1.505 -0.761 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 179.532 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -127.87 173.56 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.766 0 N-CA-C 106.826 -1.546 . . . . 0.0 106.826 -178.854 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.15 117.15 15.29 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 178.611 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -73.87 157.25 51.32 Favored Glycine 0 C--O 1.23 -0.125 0 N-CA-C 107.273 -2.331 . . . . 0.0 107.273 176.09 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -58.49 -35.7 81.19 Favored Glycine 0 N--CA 1.461 0.347 0 CA-C-N 119.017 1.408 . . . . 0.0 112.184 -177.038 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -73.43 0.8 11.25 Favored 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 124.64 1.176 . . . . 0.0 113.553 -179.376 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 93.44 14.54 53.32 Favored Glycine 0 C--N 1.317 -0.505 0 CA-C-N 114.38 -1.282 . . . . 0.0 113.027 174.239 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 16.4 mmtt -79.02 130.6 35.7 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.393 0.616 . . . . 0.0 110.635 -175.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 1.4 mmt -86.08 161.06 19.09 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.008 -0.997 . . . . 0.0 110.47 179.613 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 22.6 tptp -64.45 -52.52 57.6 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.383 176.771 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.4 t70 45.33 -149.89 0.07 Allowed 'General case' 0 CA--C 1.549 0.905 0 O-C-N 124.842 1.339 . . . . 0.0 112.315 -176.424 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 62.0 mt 52.94 178.73 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.814 0 N-CA-C 118.407 2.743 . . . . 0.0 118.407 174.335 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 2.1 p -74.2 159.51 83.66 Favored Pre-proline 0 C--O 1.245 0.853 0 CA-C-N 115.124 -0.943 . . . . 0.0 112.904 -177.721 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -77.05 175.89 10.82 Favored 'Trans proline' 0 C--N 1.352 0.722 0 N-CA-C 110.796 -0.502 . . . . 0.0 110.796 174.088 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 33.3 ptt-85 -132.13 163.32 28.77 Favored 'General case' 0 C--O 1.218 -0.56 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 177.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 56.3 m95 -122.93 150.2 43.25 Favored 'General case' 0 C--O 1.212 -0.882 0 C-N-CA 122.468 0.307 . . . . 0.0 111.224 -177.186 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.495 ' CZ ' ' HB2' ' A' ' 15' ' ' ALA . 56.1 m-85 -128.12 147.29 50.54 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 177.72 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 88.7 t80 -94.43 135.46 35.83 Favored 'General case' 0 CA--C 1.506 -0.747 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 -177.274 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -136.99 131.98 33.68 Favored 'General case' 0 N--CA 1.437 -1.096 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 -175.657 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 74.2 m-85 -70.89 159.57 34.41 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.037 -176.134 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -53.07 125.46 17.41 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.829 -178.218 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 71.57 23.32 78.18 Favored Glycine 0 C--O 1.224 -0.474 0 N-CA-C 116.309 1.284 . . . . 0.0 116.309 177.056 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 18.3 p . . . . . 0 C--N 1.326 -0.453 0 CA-C-N 119.056 1.428 . . . . 0.0 108.842 177.402 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 14.7 mt . . . . . 0 N--CA 1.444 -0.767 0 N-CA-C 115.503 1.668 . . . . 0.0 115.503 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -79.08 161.89 26.29 Favored 'Trans proline' 0 N--CA 1.463 -0.313 0 C-N-CA 122.517 2.145 . . . . 0.0 107.683 167.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 57.1 t80 -60.86 131.21 49.96 Favored 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 120.373 -0.531 . . . . 0.0 110.579 -177.411 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 92.33 -7.51 78.02 Favored Glycine 0 C--O 1.228 -0.269 0 CA-C-O 119.349 -0.695 . . . . 0.0 114.65 179.11 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -66.62 131.12 45.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 118.649 1.224 . . . . 0.0 111.336 179.503 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 56.7 t30 -78.73 129.18 34.38 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.627 -179.388 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 30.0 ttmt -156.17 153.27 28.99 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 106.492 -1.67 . . . . 0.0 106.492 179.29 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -63.48 130.82 46.01 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.051 0.453 . . . . 0.0 111.165 -178.105 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 68.5 27.64 73.68 Favored Glycine 0 N--CA 1.449 -0.483 0 CA-C-O 119.263 -0.743 . . . . 0.0 113.994 177.652 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 45.9 mm -123.28 125.57 72.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 117.487 0.644 . . . . 0.0 110.303 179.331 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -127.85 115.25 38.56 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 CA-C-O 121.575 0.702 . . . . 0.0 111.296 177.061 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 97.7 m95 -80.45 137.45 36.49 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -177.794 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -142.61 154.34 17.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 -178.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -157.27 166.64 32.6 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 105.695 -1.965 . . . . 0.0 105.695 -177.096 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 14.7 t -125.84 166.49 16.75 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 104.03 -2.582 . . . . 0.0 104.03 173.205 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 77.7 tt0 -67.68 137.67 55.72 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 121.108 0.48 . . . . 0.0 109.879 -178.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 95.45 -19.23 55.25 Favored Glycine 0 C--O 1.224 -0.521 0 CA-C-N 115.705 -0.68 . . . . 0.0 112.973 178.042 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -67.81 137.93 55.75 Favored 'General case' 0 CA--C 1.542 0.661 0 O-C-N 122.542 -0.387 . . . . 0.0 110.753 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 47.0 mt -92.21 136.55 33.1 Favored 'General case' 0 CA--C 1.514 -0.425 0 N-CA-C 113.771 1.026 . . . . 0.0 113.771 -176.349 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 63.6 t30 -80.39 61.34 4.12 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.21 -0.905 . . . . 0.0 110.939 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 2.6 t -133.12 160.93 66.73 Favored Pre-proline 0 C--N 1.322 -0.588 0 N-CA-C 104.452 -2.425 . . . . 0.0 104.452 -179.133 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_exo -64.58 152.06 83.24 Favored 'Trans proline' 0 CA--C 1.534 0.475 0 N-CA-C 116.669 1.757 . . . . 0.0 116.669 -177.298 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.491 ' HE3' ' HA ' ' A' ' 42' ' ' ASP . 0.4 OUTLIER -127.19 31.93 5.15 Favored 'General case' 0 CA--C 1.515 -0.388 0 C-N-CA 124.545 1.138 . . . . 0.0 109.416 176.784 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 15.2 p-10 -55.22 -36.89 66.46 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.285 -0.871 . . . . 0.0 109.84 179.284 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 16.7 p80 -60.8 -13.65 16.63 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 114.832 1.419 . . . . 0.0 114.832 179.377 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 10.8 mt -96.27 -23.71 4.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 121.14 0.495 . . . . 0.0 110.787 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -76.19 1.25 60.74 Favored Glycine 0 C--O 1.227 -0.303 0 N-CA-C 115.559 0.984 . . . . 0.0 115.559 -175.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 14.6 t -83.08 16.06 2.53 Favored 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 113.848 1.055 . . . . 0.0 113.848 -177.514 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.446 ' HD2' HD22 ' A' ' 114' ' ' ASN . 63.1 ttp85 -66.26 129.75 40.89 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 177.781 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -111.73 134.19 21.36 Favored Pre-proline 0 C--N 1.325 -0.491 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 179.429 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_endo -69.76 -21.55 33.31 Favored 'Trans proline' 0 C--O 1.217 -0.535 0 N-CA-C 115.314 1.236 . . . . 0.0 115.314 -174.447 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -74.81 -24.09 58.58 Favored 'General case' 0 C--O 1.22 -0.49 0 CA-C-O 121.094 0.473 . . . . 0.0 110.478 178.391 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 83.5 m-20 -97.72 -22.49 16.41 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 113.302 0.853 . . . . 0.0 113.302 -175.068 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . 0.446 HD22 ' HD2' ' A' ' 109' ' ' ARG . 19.6 t30 -157.99 150.03 21.99 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 112.0 0.371 . . . . 0.0 112.0 -178.356 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -87.27 147.47 25.52 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-O 121.575 0.702 . . . . 0.0 112.182 179.751 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -72.73 147.92 45.15 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.27 178.13 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 15.0 mt -91.42 139.43 17.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.226 -178.156 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 73.9 t -60.13 125.41 16.2 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 N-CA-C 106.572 -1.64 . . . . 0.0 106.572 175.084 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 6.4 tt -66.6 129.19 39.04 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.101 0.477 . . . . 0.0 110.168 -177.324 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 31.0 mt-30 -131.26 156.66 45.03 Favored 'General case' 0 CA--C 1.511 -0.534 0 N-CA-C 107.062 -1.459 . . . . 0.0 107.062 -178.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.426 HD13 HG22 ' A' ' 125' ' ' THR . 14.4 mt -113.25 148.07 38.75 Favored Pre-proline 0 C--N 1.321 -0.631 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 178.438 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -72.06 167.5 26.58 Favored 'Trans proline' 0 C--N 1.345 0.392 0 O-C-N 122.229 0.594 . . . . 0.0 112.969 -179.335 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -55.56 133.48 50.35 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.814 -179.498 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 91.91 -14.75 63.48 Favored Glycine 0 C--O 1.227 -0.332 0 CA-C-N 116.05 -0.523 . . . . 0.0 113.368 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.555 HG23 HE21 ' A' ' 30' ' ' GLN . 16.7 m -105.95 126.94 52.79 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 117.841 0.82 . . . . 0.0 110.309 179.012 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 6.9 p -118.51 148.24 42.83 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.78 -178.268 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 84.9 mt -69.94 153.61 95.31 Favored Pre-proline 0 C--N 1.325 -0.472 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 177.661 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -76.15 173.48 14.42 Favored 'Trans proline' 0 C--O 1.235 0.345 0 N-CA-C 110.531 -0.604 . . . . 0.0 110.531 178.624 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 8.2 tmtt? -53.83 126.61 22.84 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.21 0.528 . . . . 0.0 112.224 -175.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 85.29 -1.55 88.52 Favored Glycine 0 N--CA 1.454 -0.144 0 N-CA-C 116.861 1.504 . . . . 0.0 116.861 173.743 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.419 ' CZ ' ' HB2' ' A' ' 18' ' ' GLN . 1.5 m-85 -94.71 141.26 28.82 Favored 'General case' 0 N--CA 1.436 -1.167 0 CA-C-O 122.069 0.938 . . . . 0.0 110.436 -179.209 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 42.8 p90 -142.08 161.47 37.92 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 113.639 -1.618 . . . . 0.0 108.351 176.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -103.0 143.74 32.18 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.345 0.593 . . . . 0.0 111.705 -176.842 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -70.68 135.3 48.22 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 179.693 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 81.89 -9.69 55.43 Favored Glycine 0 CA--C 1.52 0.365 0 CA-C-N 116.118 -0.492 . . . . 0.0 114.095 -178.75 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 28.8 t . . . . . 0 C--N 1.326 -0.439 0 CA-C-N 117.926 0.863 . . . . 0.0 110.51 -179.534 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.44 -0.943 0 CA-C-O 121.876 0.846 . . . . 0.0 113.157 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 32.9 p -62.21 140.91 58.44 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 114.853 -1.067 . . . . 0.0 109.982 178.803 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . 0.405 ' CD2' ' HD3' ' A' ' 109' ' ' ARG . 17.4 m95 -67.62 -21.81 65.37 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 113.795 1.035 . . . . 0.0 113.795 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 36.8 m-85 -121.55 160.87 23.39 Favored 'General case' 0 CA--C 1.509 -0.621 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 -172.598 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 67.7 p -69.47 162.03 28.26 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 178.836 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.445 ' HB2' ' CZ ' ' A' ' 69' ' ' TYR . . . -78.31 147.12 34.38 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 114.084 1.142 . . . . 0.0 114.084 -175.726 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 27.1 mt -89.02 148.88 23.52 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 105.149 -2.167 . . . . 0.0 105.149 170.634 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.6 m -122.97 144.85 48.97 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 179.473 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 3.8 tp60 -109.99 154.79 22.67 Favored 'General case' 0 C--N 1.328 -0.339 0 O-C-N 123.762 0.664 . . . . 0.0 110.742 -176.283 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 67.9 t60 -139.34 99.51 3.76 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 105.588 -2.004 . . . . 0.0 105.588 170.086 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 163.09 -171.63 38.9 Favored Glycine 0 N--CA 1.452 -0.239 0 N-CA-C 110.653 -0.979 . . . . 0.0 110.653 -177.778 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -99.56 -22.52 15.43 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 112.477 0.547 . . . . 0.0 112.477 179.672 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -83.44 161.99 21.12 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.963 -178.168 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -75.55 -62.94 1.4 Allowed 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 114.539 1.311 . . . . 0.0 114.539 -175.894 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 32.2 tp 157.23 144.84 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.283 0 N-CA-C 104.935 -2.246 . . . . 0.0 104.935 -175.56 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 56.1 tptt -156.02 141.39 17.61 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 108.779 -0.822 . . . . 0.0 108.779 173.009 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 15.1 m-85 -122.97 150.7 59.77 Favored Pre-proline 0 C--O 1.242 0.699 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 175.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -74.22 163.21 37.04 Favored 'Trans proline' 0 C--N 1.352 0.752 0 C-N-CA 120.88 1.053 . . . . 0.0 113.383 179.467 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 4.1 tmt_? -65.36 133.71 51.95 Favored 'General case' 0 N--CA 1.473 0.707 0 O-C-N 122.045 -0.409 . . . . 0.0 110.493 -178.484 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 88.12 1.34 82.0 Favored Glycine 0 C--O 1.228 -0.235 0 N-CA-C 111.912 -0.475 . . . . 0.0 111.912 178.614 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 33.0 mt-30 -141.83 171.65 13.77 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 123.455 0.702 . . . . 0.0 110.4 -174.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 107.06 -25.26 22.78 Favored Glycine 0 CA--C 1.497 -1.049 0 CA-C-N 115.54 -0.754 . . . . 0.0 111.937 175.176 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 95.7 t -63.72 127.4 91.47 Favored Pre-proline 0 C--N 1.318 -0.779 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 177.736 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -73.46 171.58 17.42 Favored 'Trans proline' 0 N--CA 1.462 -0.351 0 O-C-N 122.142 0.548 . . . . 0.0 111.385 178.189 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 86.1 mt -69.81 107.02 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-O 121.963 0.887 . . . . 0.0 108.892 -179.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 75.3 m-20 -99.96 84.82 2.94 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 114.626 -1.17 . . . . 0.0 109.9 -177.36 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 69.6 p -67.06 -15.74 63.91 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 112.94 0.719 . . . . 0.0 112.94 -178.631 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 12.3 p30 -107.13 22.77 15.47 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.375 -0.83 . . . . 0.0 112.382 -177.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 15.0 m -140.5 148.89 41.77 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 113.787 1.032 . . . . 0.0 113.787 -176.525 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -74.37 167.35 36.73 Favored Pre-proline 0 N--CA 1.468 0.447 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 177.194 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -64.93 -28.48 58.27 Favored 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 114.663 -3.091 . . . . 0.0 111.827 178.309 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -62.11 -24.31 67.06 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 123.883 0.873 . . . . 0.0 111.658 176.743 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 71.6 m-20 -98.41 -2.57 38.81 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 114.957 1.466 . . . . 0.0 114.957 -172.183 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 94.5 mm-40 -60.77 -28.94 69.11 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 114.543 1.312 . . . . 0.0 114.543 -178.21 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 12.9 tt -60.07 139.31 19.78 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.846 0 CA-C-O 122.358 1.075 . . . . 0.0 113.339 -177.677 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -177.94 -155.96 15.38 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.84 -0.695 . . . . 0.0 111.903 -178.478 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 49.8 p90 -155.05 168.59 26.51 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 178.665 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 22.5 m-85 -108.99 141.35 41.22 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 172.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 51.7 ttt180 -115.0 120.54 40.23 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 114.917 -1.038 . . . . 0.0 111.919 -174.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 38.9 ttp180 -68.47 134.7 50.52 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 176.159 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -150.79 151.11 31.85 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.159 0.504 . . . . 0.0 111.494 -178.393 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 14.3 t -158.9 164.98 35.18 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 174.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 14.3 tpt180 -149.83 123.83 9.38 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 105.367 -2.086 . . . . 0.0 105.367 177.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 4.6 tmm_? -88.9 128.01 35.66 Favored 'General case' 0 CA--C 1.498 -1.054 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 -179.21 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -128.6 169.83 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.107 0 N-CA-C 105.725 -1.954 . . . . 0.0 105.725 179.032 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 1.1 ttt-85 -144.04 110.72 5.62 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 176.131 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -71.17 160.88 54.13 Favored Glycine 0 N--CA 1.449 -0.443 0 N-CA-C 107.891 -2.084 . . . . 0.0 107.891 176.492 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -69.94 -33.8 70.61 Favored Glycine 0 C--O 1.222 -0.596 0 N-CA-C 109.899 -1.28 . . . . 0.0 109.899 -178.106 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.2 t0 -73.12 3.54 5.45 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 114.133 -1.033 . . . . 0.0 111.831 179.422 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 96.6 -9.12 66.53 Favored Glycine 0 C--O 1.226 -0.353 0 CA-C-N 115.725 -0.67 . . . . 0.0 114.5 175.48 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.49 106.7 4.68 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.759 0.79 . . . . 0.0 111.751 -178.185 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 18.6 mtp -88.8 -179.98 6.1 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 114.783 -1.099 . . . . 0.0 109.124 179.313 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 23.9 tptp -73.88 -59.5 2.69 Favored 'General case' 0 CA--C 1.51 -0.58 0 C-N-CA 120.603 -0.439 . . . . 0.0 111.409 -179.609 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 47.02 -161.53 0.03 OUTLIER 'General case' 0 C--O 1.25 1.082 0 O-C-N 125.358 1.661 . . . . 0.0 115.256 -179.339 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 82.2 mt 53.48 -176.66 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 116.489 2.033 . . . . 0.0 116.489 178.711 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 24.3 m -65.04 154.01 87.65 Favored Pre-proline 0 C--O 1.24 0.596 0 CA-C-N 115.182 -0.917 . . . . 0.0 112.336 -177.303 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -73.8 175.5 10.69 Favored 'Trans proline' 0 C--N 1.348 0.506 0 CA-C-O 122.015 0.756 . . . . 0.0 113.72 -179.353 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 1.2 mmt180 -106.55 159.99 15.76 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 114.897 -1.047 . . . . 0.0 108.294 -178.817 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 73.2 m95 -128.3 125.02 37.96 Favored 'General case' 0 C--O 1.215 -0.748 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 176.252 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.445 ' CZ ' ' HB2' ' A' ' 15' ' ' ALA . 33.9 m-85 -110.99 156.54 21.09 Favored 'General case' 0 C--O 1.213 -0.849 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 -178.727 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 81.2 t80 -101.76 135.31 43.5 Favored 'General case' 0 CA--C 1.51 -0.596 0 CA-C-N 119.204 0.911 . . . . 0.0 108.94 -179.297 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -136.92 147.46 46.41 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 -176.583 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 84.3 m-85 -82.5 159.43 22.86 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.069 -176.709 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -54.67 130.26 39.71 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.991 0.424 . . . . 0.0 111.066 -179.28 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 73.54 26.23 70.41 Favored Glycine 0 C--O 1.219 -0.837 0 N-CA-C 116.107 1.203 . . . . 0.0 116.107 176.63 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 5.3 p . . . . . 0 C--N 1.326 -0.433 0 CA-C-N 118.775 1.287 . . . . 0.0 109.724 178.13 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 42.9 mt . . . . . 0 C--O 1.238 0.452 0 N-CA-C 115.318 1.599 . . . . 0.0 115.318 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -76.97 166.14 27.25 Favored 'Trans proline' 0 C--O 1.237 0.427 0 N-CA-C 108.669 -1.32 . . . . 0.0 108.669 170.144 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.417 ' CE1' ' HB3' ' A' ' 92' ' ' TRP . 62.5 t80 -62.8 133.68 55.12 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 120.491 -0.484 . . . . 0.0 110.069 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 90.37 -5.45 82.7 Favored Glycine 0 CA--C 1.519 0.317 0 N-CA-C 114.489 0.556 . . . . 0.0 114.489 178.815 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -63.08 132.33 51.54 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 117.901 0.85 . . . . 0.0 112.22 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 51.5 t30 -74.52 126.26 30.39 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.903 -0.59 . . . . 0.0 112.094 -178.809 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 15.2 ttmm -156.14 149.86 24.96 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 176.799 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -63.63 132.79 52.26 Favored 'General case' 0 C--N 1.321 -0.64 0 O-C-N 123.251 0.345 . . . . 0.0 110.802 -179.646 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 66.87 28.41 73.77 Favored Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 121.037 -0.602 . . . . 0.0 114.481 177.328 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 40.9 mm -127.5 126.43 67.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 117.302 0.551 . . . . 0.0 109.993 179.41 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.1 pt -128.13 115.15 37.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 121.812 0.815 . . . . 0.0 110.889 176.307 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . 0.417 ' HB3' ' CE1' ' A' ' 83' ' ' TYR . 95.8 m95 -79.03 135.73 36.97 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.983 -0.553 . . . . 0.0 112.34 -177.886 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 17.0 m -137.3 149.72 25.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.566 0.698 . . . . 0.0 109.534 179.72 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -157.59 166.6 32.44 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 104.333 -2.469 . . . . 0.0 104.333 -178.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 6.6 t -138.21 177.04 8.17 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 106.037 -1.838 . . . . 0.0 106.037 177.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -67.61 135.08 52.32 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.056 0.455 . . . . 0.0 110.51 -178.255 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 96.02 -8.29 67.59 Favored Glycine 0 C--O 1.224 -0.52 0 CA-C-N 115.938 -0.574 . . . . 0.0 113.514 178.688 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -81.22 139.23 35.62 Favored 'General case' 0 C--N 1.324 -0.541 0 O-C-N 122.443 -0.446 . . . . 0.0 111.456 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 47.3 mt -90.04 138.7 31.29 Favored 'General case' 0 CA--C 1.512 -0.495 0 CA-C-O 120.805 0.336 . . . . 0.0 111.284 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 62.4 t30 -83.42 68.13 9.6 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.992 0.425 . . . . 0.0 110.743 179.806 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 1.1 t -141.67 151.71 60.96 Favored Pre-proline 0 C--O 1.24 0.566 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 -178.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -66.24 153.15 79.18 Favored 'Trans proline' 0 C--N 1.345 0.39 0 N-CA-C 113.645 0.594 . . . . 0.0 113.645 176.597 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 1.4 ptpm? -152.25 56.49 0.83 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 122.502 1.144 . . . . 0.0 110.809 -179.235 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -59.66 -27.13 66.12 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 114.535 -1.211 . . . . 0.0 111.443 179.35 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 12.7 p80 -59.71 -12.4 6.97 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 114.029 1.122 . . . . 0.0 114.029 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 55.3 mt -91.94 -43.07 13.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 177.367 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -77.12 11.45 15.92 Favored Glycine 0 C--O 1.224 -0.495 0 N-CA-C 114.825 0.69 . . . . 0.0 114.825 -177.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 6.6 t -83.2 17.84 1.91 Allowed 'General case' 0 CA--C 1.545 0.778 0 CA-C-O 122.214 1.007 . . . . 0.0 110.416 178.782 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.442 ' HD2' ' OD1' ' A' ' 114' ' ' ASN . 62.7 ttp85 -59.32 131.46 51.06 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.786 -179.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 10.2 m-20 -100.22 122.04 51.58 Favored Pre-proline 0 C--N 1.326 -0.444 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -71.06 -15.06 32.3 Favored 'Trans proline' 0 C--O 1.218 -0.485 0 N-CA-C 113.672 0.604 . . . . 0.0 113.672 -177.74 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -76.16 -24.38 54.82 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.853 0.359 . . . . 0.0 110.912 177.628 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -101.47 -26.09 13.69 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 113.499 0.926 . . . . 0.0 113.499 -175.5 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . 0.442 ' OD1' ' HD2' ' A' ' 109' ' ' ARG . 0.4 OUTLIER -142.77 153.64 43.46 Favored 'General case' 0 N--CA 1.437 -1.119 0 CA-C-O 121.031 0.443 . . . . 0.0 111.428 -176.694 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -99.23 142.22 30.99 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.626 177.082 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -69.23 150.07 47.85 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.403 0.62 . . . . 0.0 112.17 -179.08 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 6.8 mt -86.14 138.42 19.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.382 -0.826 . . . . 0.0 109.23 -178.591 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 97.1 t -60.73 124.08 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 N-CA-C 106.754 -1.573 . . . . 0.0 106.754 176.064 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 6.7 tt -66.5 130.6 43.74 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.226 0.536 . . . . 0.0 111.372 -175.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 28.7 mt-30 -131.82 156.77 45.46 Favored 'General case' 0 CA--C 1.514 -0.43 0 N-CA-C 106.827 -1.545 . . . . 0.0 106.827 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 13.9 mt -113.12 147.4 37.21 Favored Pre-proline 0 C--N 1.323 -0.559 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 178.151 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -74.76 169.67 22.06 Favored 'Trans proline' 0 C--N 1.345 0.374 0 O-C-N 122.224 0.592 . . . . 0.0 113.465 -179.384 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 36.8 tt0 -54.25 131.34 41.39 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.317 178.857 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 99.78 -22.47 40.23 Favored Glycine 0 C--O 1.227 -0.321 0 CA-C-O 119.439 -0.645 . . . . 0.0 113.474 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 5.7 m -108.75 129.29 55.37 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 118.461 1.13 . . . . 0.0 111.179 179.071 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 7.1 p -123.34 149.16 45.24 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.793 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 96.7 mt -71.48 151.09 93.93 Favored Pre-proline 0 C--N 1.324 -0.522 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 178.448 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -79.11 178.25 7.72 Favored 'Trans proline' 0 CA--C 1.531 0.361 0 C-N-CA 120.33 0.686 . . . . 0.0 112.296 179.31 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 64.4 tttp -57.17 129.95 44.02 Favored 'General case' 0 C--O 1.219 -0.504 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.224 -178.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 87.18 -1.98 86.61 Favored Glycine 0 C--O 1.226 -0.379 0 N-CA-C 115.425 0.93 . . . . 0.0 115.425 175.76 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -101.1 137.11 39.9 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-O 121.883 0.849 . . . . 0.0 112.433 -178.136 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 48.4 p90 -145.4 164.44 31.51 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 114.343 -1.299 . . . . 0.0 108.735 176.564 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -104.84 144.89 31.15 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 -176.246 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -71.62 136.23 47.27 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 177.804 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 94.06 -8.96 73.0 Favored Glycine 0 C--O 1.225 -0.445 0 C-N-CA 121.425 -0.417 . . . . 0.0 112.297 178.859 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 32.8 t . . . . . 0 C--N 1.325 -0.496 0 N-CA-C 110.305 -0.257 . . . . 0.0 110.305 178.018 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.119 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 34.7 p -66.84 141.74 57.57 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 -178.291 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . 0.407 ' CD2' ' HD3' ' A' ' 109' ' ' ARG . 20.6 m95 -67.07 -26.95 66.99 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 178.597 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 24.9 m-85 -121.38 164.89 16.35 Favored 'General case' 0 C--O 1.241 0.633 0 N-CA-C 113.74 1.015 . . . . 0.0 113.74 -171.837 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 56.1 p -68.23 167.97 13.23 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 114.609 -1.178 . . . . 0.0 110.204 179.045 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.489 ' HB2' ' CZ ' ' A' ' 69' ' ' TYR . . . -81.61 142.35 32.86 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 114.531 1.308 . . . . 0.0 114.531 -174.845 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 25.3 mt -84.42 146.8 27.46 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 102.55 -3.13 . . . . 0.0 102.55 167.554 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 29.8 m -130.12 141.28 50.7 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 -178.182 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.402 ' HB2' ' CZ ' ' A' ' 131' ' ' PHE . 4.3 tp60 -109.64 140.42 43.5 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 -176.181 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 53.6 t60 -131.07 99.93 5.05 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 104.054 -2.573 . . . . 0.0 104.054 168.846 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 163.97 -162.93 35.57 Favored Glycine 0 C--O 1.227 -0.301 0 N-CA-C 108.252 -1.939 . . . . 0.0 108.252 -175.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 90.2 mttt -111.36 -22.17 11.47 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 115.207 1.558 . . . . 0.0 115.207 -178.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -75.2 158.95 32.17 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 106.602 -1.629 . . . . 0.0 106.602 174.757 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -83.59 -62.12 1.66 Allowed 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 120.545 -0.462 . . . . 0.0 110.851 -178.726 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 41.5 tp -175.08 150.83 1.23 Allowed 'General case' 0 N--CA 1.481 1.094 0 N-CA-C 105.637 -1.986 . . . . 0.0 105.637 173.53 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -158.11 134.61 9.59 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 178.113 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -129.35 148.65 70.09 Favored Pre-proline 0 C--N 1.323 -0.551 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 173.693 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -72.63 155.74 54.21 Favored 'Trans proline' 0 C--N 1.35 0.654 0 O-C-N 122.194 0.576 . . . . 0.0 112.703 178.082 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 17.3 tpt180 -67.56 137.76 55.96 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 -179.23 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 89.26 0.67 79.88 Favored Glycine 0 C--O 1.222 -0.612 0 N-CA-C 110.684 -0.967 . . . . 0.0 110.684 179.501 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 -146.71 -179.62 6.91 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 -174.793 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 99.96 -27.06 22.06 Favored Glycine 0 CA--C 1.5 -0.906 0 CA-C-N 116.241 -0.436 . . . . 0.0 112.219 175.325 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 71.9 t -63.32 128.52 92.58 Favored Pre-proline 0 C--N 1.319 -0.736 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 177.062 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -74.74 168.39 24.94 Favored 'Trans proline' 0 N--CA 1.458 -0.575 0 O-C-N 122.165 0.56 . . . . 0.0 110.86 178.557 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 97.4 mt -68.01 116.92 8.83 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 69.2 m-80 -105.06 98.38 8.1 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.448 -179.455 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 67.6 p -73.4 -22.18 60.31 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.19 0.519 . . . . 0.0 111.683 -179.192 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 71.2 m-80 -111.12 36.85 3.02 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.496 -0.774 . . . . 0.0 112.682 -177.64 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 17.5 m -144.59 146.96 32.59 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 179.313 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -72.26 166.39 41.89 Favored Pre-proline 0 C--N 1.327 -0.405 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 176.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -64.79 -27.03 59.76 Favored 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 115.198 -2.735 . . . . 0.0 111.86 178.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -62.22 -29.07 70.13 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.662 0.744 . . . . 0.0 111.17 176.377 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 76.6 m-20 -96.29 0.8 51.34 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 115.288 1.588 . . . . 0.0 115.288 -170.628 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 94.7 mm-40 -61.58 -27.12 68.41 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 121.345 0.593 . . . . 0.0 112.478 178.845 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.402 ' HB ' ' HB1' ' A' ' 98' ' ' ALA . 19.5 tt -57.52 138.67 18.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-O 122.236 1.017 . . . . 0.0 113.712 -179.325 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -177.82 -158.74 21.39 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.274 -0.965 . . . . 0.0 113.158 -179.47 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 38.2 p90 -155.04 169.12 24.84 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 107.721 -1.214 . . . . 0.0 107.721 179.291 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 29.1 m-85 -113.63 141.42 47.23 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 106.784 -1.562 . . . . 0.0 106.784 173.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 44.4 ttt-85 -112.21 131.71 55.33 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.826 -0.624 . . . . 0.0 112.231 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 39.2 ttt-85 -65.39 142.44 58.2 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.437 176.134 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -147.98 166.13 28.66 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 177.52 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 6.3 t -152.37 162.46 41.14 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 -177.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 10.1 ttm180 -90.72 123.88 34.66 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 104.619 -2.363 . . . . 0.0 104.619 176.032 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 8.3 tmm_? -148.25 144.65 27.8 Favored 'General case' 0 CA--C 1.508 -0.665 0 CA-C-O 121.105 0.479 . . . . 0.0 111.633 -172.321 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.463 HD12 ' HB2' ' A' ' 62' ' ' LYS . 0.0 OUTLIER -126.68 -179.68 2.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 -178.61 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -117.37 104.32 11.0 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 171.598 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -71.84 165.02 54.07 Favored Glycine 0 C--O 1.222 -0.625 0 N-CA-C 108.189 -1.964 . . . . 0.0 108.189 178.68 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -61.15 -42.45 99.79 Favored Glycine 0 C--O 1.217 -0.935 0 CA-C-N 118.483 1.142 . . . . 0.0 112.131 -179.256 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 41.2 t0 -95.67 16.94 15.99 Favored 'General case' 0 CA--C 1.549 0.923 0 CA-C-O 122.912 1.339 . . . . 0.0 110.39 179.434 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 86.01 6.86 81.55 Favored Glycine 0 C--O 1.226 -0.384 0 CA-C-N 114.769 -1.105 . . . . 0.0 113.833 172.759 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 23.9 mmtt -69.49 142.48 53.72 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 122.235 1.017 . . . . 0.0 112.472 -173.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 5.1 mmt -93.82 172.42 8.26 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 113.135 -1.848 . . . . 0.0 113.961 -175.748 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.463 ' HB2' HD12 ' A' ' 54' ' ' ILE . 12.2 tptt -124.34 -41.74 2.16 Favored 'General case' 0 CA--C 1.491 -1.311 0 CA-C-N 114.811 -1.086 . . . . 0.0 108.896 173.351 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 26.56 86.27 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.872 0 O-C-N 126.814 2.571 . . . . 0.0 116.315 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -75.89 173.01 11.74 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 114.141 -1.39 . . . . 0.0 108.904 -179.695 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 5.7 m -46.13 140.07 5.29 Favored Pre-proline 0 C--O 1.244 0.814 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 -179.141 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -68.14 148.36 74.89 Favored 'Trans proline' 0 C--O 1.24 0.598 0 C-N-CA 116.73 -1.713 . . . . 0.0 114.191 -175.687 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 26.0 mtp180 -124.96 162.15 25.1 Favored 'General case' 0 CA--C 1.501 -0.941 0 N-CA-C 106.692 -1.595 . . . . 0.0 106.692 177.401 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 62.4 m95 -132.72 133.51 43.59 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 179.256 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.489 ' CZ ' ' HB2' ' A' ' 15' ' ' ALA . 80.5 m-85 -116.59 146.42 42.68 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 -178.872 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 82.9 t80 -94.85 134.04 37.93 Favored 'General case' 0 CA--C 1.509 -0.628 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 -175.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 11.5 m-85 -137.33 152.96 50.29 Favored 'General case' 0 N--CA 1.439 -0.988 0 N-CA-C 106.674 -1.602 . . . . 0.0 106.674 -175.69 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -91.96 159.38 15.77 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 112.338 0.495 . . . . 0.0 112.338 -173.709 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 15.2 tp -57.13 127.13 30.41 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.38 0.61 . . . . 0.0 110.088 179.749 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 71.04 28.66 70.04 Favored Glycine 0 N--CA 1.45 -0.422 0 N-CA-C 116.848 1.499 . . . . 0.0 116.848 175.435 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.421 ' HA ' ' HA ' ' A' ' 104' ' ' ASP . 24.0 p . . . . . 0 CA--C 1.508 -0.635 0 CA-C-N 119.487 1.644 . . . . 0.0 109.079 175.379 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 12.4 mt . . . . . 0 N--CA 1.436 -1.139 0 N-CA-C 114.404 1.261 . . . . 0.0 114.404 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -78.29 161.7 28.74 Favored 'Trans proline' 0 N--CA 1.461 -0.404 0 C-N-CA 122.168 1.912 . . . . 0.0 107.3 167.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 55.0 t80 -61.19 131.93 52.04 Favored 'General case' 0 C--N 1.32 -0.678 0 C-N-CA 120.274 -0.57 . . . . 0.0 110.257 -177.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 91.6 -6.73 80.18 Favored Glycine 0 C--O 1.227 -0.298 0 CA-C-O 119.407 -0.663 . . . . 0.0 114.622 179.277 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -68.6 130.76 43.8 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 118.647 1.224 . . . . 0.0 111.714 179.731 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 56.0 t30 -78.17 130.99 37.0 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.337 179.675 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 26.1 ttmt -156.18 155.81 33.11 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 106.983 -1.488 . . . . 0.0 106.983 -179.28 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 15.2 t0 -56.41 121.37 9.43 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.261 0.553 . . . . 0.0 111.719 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 68.58 33.4 76.44 Favored Glycine 0 N--CA 1.448 -0.536 0 CA-C-O 118.975 -0.903 . . . . 0.0 114.971 177.157 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 41.3 mm -125.66 129.46 72.68 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 CA-C-N 118.079 0.939 . . . . 0.0 112.091 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -130.34 125.24 59.19 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.841 174.277 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 96.9 m95 -90.94 138.28 31.72 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 113.631 0.975 . . . . 0.0 113.631 -176.353 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 13.9 m -138.87 149.66 23.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.547 0.689 . . . . 0.0 109.445 178.844 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -160.82 164.75 31.17 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 105.058 -2.201 . . . . 0.0 105.058 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 14.8 t -130.35 168.9 16.19 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 105.091 -2.188 . . . . 0.0 105.091 178.197 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -67.4 137.49 55.98 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 -179.284 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 97.76 -12.73 64.3 Favored Glycine 0 C--O 1.225 -0.416 0 CA-C-N 115.832 -0.622 . . . . 0.0 112.145 179.352 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.402 ' HB1' ' HB ' ' A' ' 44' ' ' ILE . . . -79.65 136.77 36.9 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 178.839 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 44.1 mt -87.15 138.05 31.82 Favored 'General case' 0 CA--C 1.512 -0.512 0 CA-C-O 121.43 0.633 . . . . 0.0 112.288 -177.279 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 60.3 t30 -84.46 66.95 9.72 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.849 -179.462 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -142.46 156.45 63.69 Favored Pre-proline 0 C--N 1.322 -0.629 0 N-CA-C 107.078 -1.453 . . . . 0.0 107.078 -178.316 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -70.93 153.69 63.42 Favored 'Trans proline' 0 CA--C 1.531 0.329 0 N-CA-C 114.227 0.818 . . . . 0.0 114.227 178.401 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -145.92 60.66 1.25 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 123.103 1.43 . . . . 0.0 111.356 178.877 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . 0.421 ' HA ' ' HA ' ' A' ' 75' ' ' THR . 16.7 p-10 -53.38 -39.48 64.25 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 113.229 -1.805 . . . . 0.0 112.789 178.024 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 48.2 p-80 -62.22 -8.21 5.34 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 115.071 1.508 . . . . 0.0 115.071 -178.116 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 57.9 mt -95.77 -45.32 13.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 177.683 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -74.19 -1.17 59.5 Favored Glycine 0 C--O 1.223 -0.543 0 N-CA-C 115.53 0.972 . . . . 0.0 115.53 -177.193 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 13.3 t -83.29 21.13 1.17 Allowed 'General case' 0 CA--C 1.542 0.672 0 CA-C-O 121.757 0.789 . . . . 0.0 111.542 -178.597 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.441 ' HD2' ' OD1' ' A' ' 114' ' ' ASN . 65.4 ttp85 -52.77 131.92 35.76 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.145 178.658 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 36.4 m120 -88.37 117.44 68.39 Favored Pre-proline 0 C--N 1.323 -0.549 0 N-CA-C 107.718 -1.215 . . . . 0.0 107.718 179.631 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -72.4 -13.39 27.84 Favored 'Trans proline' 0 C--O 1.216 -0.583 0 C-N-CA 117.243 -1.372 . . . . 0.0 112.817 -179.051 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -78.49 -26.93 46.12 Favored 'General case' 0 C--O 1.219 -0.506 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.638 177.3 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 -102.21 -24.86 13.87 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 113.203 0.816 . . . . 0.0 113.203 -174.795 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . 0.441 ' OD1' ' HD2' ' A' ' 109' ' ' ARG . 5.6 t-20 -128.7 147.2 50.74 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 113.508 0.929 . . . . 0.0 113.508 -178.229 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -95.93 129.92 43.05 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 107.686 -1.228 . . . . 0.0 107.686 173.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -64.65 151.51 44.7 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.441 -0.8 . . . . 0.0 112.28 -178.9 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 4.0 mt -89.83 144.11 9.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.288 -0.869 . . . . 0.0 109.692 -177.508 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 72.5 t -60.8 124.54 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 175.111 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 6.7 tt -69.07 128.07 35.36 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.181 0.515 . . . . 0.0 109.736 -178.577 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 33.0 mt-30 -133.4 157.87 44.46 Favored 'General case' 0 CA--C 1.511 -0.526 0 N-CA-C 106.785 -1.561 . . . . 0.0 106.785 -178.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 13.4 mt -112.88 148.05 38.52 Favored Pre-proline 0 C--N 1.32 -0.688 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 178.022 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -73.97 167.54 26.97 Favored 'Trans proline' 0 C--O 1.237 0.459 0 O-C-N 122.291 0.627 . . . . 0.0 112.837 179.376 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 60.8 tt0 -54.46 134.04 45.94 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.265 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 100.42 -28.19 16.94 Favored Glycine 0 C--O 1.227 -0.315 0 CA-C-N 115.944 -0.571 . . . . 0.0 112.867 -179.297 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 4.1 m -100.04 128.87 46.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 118.4 1.1 . . . . 0.0 112.116 179.451 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 3.2 p -120.35 148.11 44.17 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.188 178.695 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 90.3 mt -71.5 153.18 93.83 Favored Pre-proline 0 C--N 1.323 -0.559 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 178.408 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -75.19 168.72 24.09 Favored 'Trans proline' 0 N--CA 1.463 -0.299 0 C-N-CA 118.508 -0.528 . . . . 0.0 111.005 178.599 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 53.0 tptt -59.59 130.23 45.83 Favored 'General case' 0 C--N 1.324 -0.539 0 O-C-N 122.199 -0.313 . . . . 0.0 111.018 -176.564 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 95.15 -10.64 69.74 Favored Glycine 0 C--O 1.23 -0.124 0 CA-C-N 115.547 -0.752 . . . . 0.0 114.846 178.33 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.402 ' CZ ' ' HB2' ' A' ' 18' ' ' GLN . 1.3 m-85 -95.41 144.41 25.95 Favored 'General case' 0 N--CA 1.436 -1.168 0 CA-C-O 122.39 1.091 . . . . 0.0 110.53 179.888 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 38.1 p90 -143.13 164.76 29.27 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 113.168 -1.833 . . . . 0.0 107.892 175.484 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -108.22 153.53 23.06 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.08 0.466 . . . . 0.0 110.446 -176.648 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -90.12 132.22 35.55 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.322 -178.813 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 97.2 -33.76 5.57 Favored Glycine 0 C--O 1.225 -0.414 0 CA-C-N 116.044 -0.525 . . . . 0.0 113.102 179.082 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.442 -0.848 0 CA-C-O 121.798 0.808 . . . . 0.0 111.121 179.402 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.822 0 CA-C-O 121.822 0.82 . . . . 0.0 111.473 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -58.59 140.6 54.12 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 114.635 -1.166 . . . . 0.0 110.808 178.67 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 26.5 m95 -73.05 -21.95 60.7 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 114.906 1.447 . . . . 0.0 114.906 -178.217 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -121.47 156.15 33.39 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-O 121.015 0.436 . . . . 0.0 111.867 -174.454 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 75.9 p -68.6 162.99 24.68 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.745 -1.116 . . . . 0.0 110.078 -179.647 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.595 ' HB1' ' HB2' ' A' ' 67' ' ' ARG . . . -79.61 126.62 31.14 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 116.299 1.963 . . . . 0.0 116.299 -174.481 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.484 HD13 HD13 ' A' ' 119' ' ' LEU . 0.0 OUTLIER -74.32 121.28 21.1 Favored 'General case' 0 N--CA 1.438 -1.029 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 170.272 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 56.7 m -87.19 126.92 35.11 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 -176.309 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 3.2 tm0? -88.27 135.02 33.65 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 -179.685 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 37.8 t60 -139.36 99.49 3.75 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 169.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 162.34 -161.37 33.5 Favored Glycine 0 C--O 1.226 -0.355 0 C-N-CA 120.008 -1.091 . . . . 0.0 113.371 -179.481 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -105.59 -24.09 12.65 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -85.68 153.55 22.27 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 178.612 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -78.22 -62.81 1.56 Allowed 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 120.598 -0.441 . . . . 0.0 110.964 -176.315 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 58.2 tp 173.66 145.62 0.05 OUTLIER 'General case' 0 N--CA 1.485 1.316 0 N-CA-C 106.104 -1.813 . . . . 0.0 106.104 174.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 2.5 tppp? -158.92 140.87 13.67 Favored 'General case' 0 C--O 1.223 -0.336 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 175.325 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 20.9 m-85 -127.24 151.49 74.64 Favored Pre-proline 0 C--N 1.325 -0.499 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 174.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -73.7 162.68 39.08 Favored 'Trans proline' 0 C--N 1.349 0.574 0 O-C-N 122.183 0.57 . . . . 0.0 113.269 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 16.6 tpt180 -64.59 133.3 52.0 Favored 'General case' 0 C--O 1.218 -0.605 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.647 -178.344 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 79.83 15.66 78.79 Favored Glycine 0 C--O 1.221 -0.671 0 CA-C-N 116.252 -0.431 . . . . 0.0 112.248 178.543 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.589 HE21 HG23 ' A' ' 125' ' ' THR . 0.9 OUTLIER -151.86 170.59 19.44 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 -175.094 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 99.53 -8.61 60.28 Favored Glycine 0 C--O 1.222 -0.656 0 N-CA-C 114.501 0.561 . . . . 0.0 114.501 174.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 96.4 t -69.21 130.92 90.75 Favored Pre-proline 0 C--N 1.319 -0.729 0 N-CA-C 106.471 -1.677 . . . . 0.0 106.471 176.747 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -70.11 174.5 9.71 Favored 'Trans proline' 0 C--O 1.223 -0.228 0 O-C-N 122.314 0.639 . . . . 0.0 113.22 178.659 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 74.2 mt -75.65 105.64 4.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 122.3 1.048 . . . . 0.0 108.485 179.765 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 50.8 m-20 -100.6 79.64 2.11 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 113.96 -1.473 . . . . 0.0 109.027 -176.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 69.7 p -66.65 -22.43 66.1 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 114.797 1.406 . . . . 0.0 114.797 -175.039 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 10.5 p30 -120.87 30.28 6.96 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 -176.022 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -128.59 157.24 41.81 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 179.134 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.6 p -74.18 162.22 74.84 Favored Pre-proline 0 C--N 1.321 -0.64 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 -179.426 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -65.89 -20.54 58.1 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 115.78 -2.346 . . . . 0.0 112.561 177.222 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.421 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 3.3 p-10 -75.19 -21.89 58.38 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 119.636 -0.825 . . . . 0.0 110.747 179.785 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 31.3 t0 -89.92 0.82 56.85 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 114.147 1.166 . . . . 0.0 114.147 -175.401 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 91.4 mm-40 -63.21 -28.11 69.82 Favored 'General case' 0 C--N 1.318 -0.786 0 O-C-N 121.047 -1.033 . . . . 0.0 111.634 -179.787 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 12.8 tt -66.58 137.84 24.09 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-O 122.259 1.028 . . . . 0.0 111.531 178.08 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 178.4 -158.08 22.44 Favored Glycine 0 CA--C 1.505 -0.581 0 C-N-CA 120.443 -0.884 . . . . 0.0 111.456 -178.255 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 43.9 p90 -155.09 167.61 29.78 Favored 'General case' 0 C--N 1.319 -0.738 0 O-C-N 122.627 -0.337 . . . . 0.0 110.574 179.598 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 16.2 m-85 -109.16 141.9 40.72 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 176.356 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 62.4 ttt-85 -120.39 117.99 29.19 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 124.112 0.965 . . . . 0.0 112.346 -174.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 28.5 ttp85 -69.78 136.48 50.92 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 177.386 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -146.26 138.53 25.18 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.341 0.656 . . . . 0.0 110.281 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 14.1 t -160.21 153.1 21.42 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.082 0.468 . . . . 0.0 110.142 174.77 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 22.4 tpt180 -151.37 123.81 8.38 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 175.212 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 4.5 tmt_? -134.03 139.04 45.76 Favored 'General case' 0 CA--C 1.501 -0.928 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -141.53 179.2 2.26 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 N-CA-C 105.939 -1.874 . . . . 0.0 105.939 -176.55 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 8.1 ttm180 -131.32 111.99 12.36 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 175.726 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -77.67 169.51 54.73 Favored Glycine 0 C--O 1.229 -0.216 0 N-CA-C 108.699 -1.76 . . . . 0.0 108.699 176.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -65.44 -42.29 95.95 Favored Glycine 0 C--O 1.219 -0.826 0 C-N-CA 120.613 -0.804 . . . . 0.0 112.36 -177.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -90.57 14.45 13.18 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 122.617 1.199 . . . . 0.0 111.764 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 90.86 -12.37 69.09 Favored Glycine 0 C--N 1.314 -0.664 0 CA-C-N 113.958 -1.474 . . . . 0.0 115.979 175.697 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 4.4 mppt? -57.79 132.63 53.89 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.586 0.708 . . . . 0.0 109.409 179.358 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 26.1 ptm -132.43 -171.49 2.66 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 114.747 -1.115 . . . . 0.0 112.358 -176.147 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 60.9 mmtt -112.71 -119.72 0.3 Allowed 'General case' 0 C--O 1.219 -0.519 0 C-N-CA 123.477 0.711 . . . . 0.0 109.282 -178.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 57.8 m-20 -66.97 141.46 57.59 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 111.729 0.27 . . . . 0.0 111.729 -174.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 55.8 mt -87.94 -61.65 1.67 Allowed 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 177.318 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 71.0 p -112.35 166.12 11.61 Favored Pre-proline 0 C--O 1.243 0.724 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 178.231 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -73.31 163.81 36.88 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 116.3 -2.0 . . . . 0.0 112.416 177.168 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.595 ' HB2' ' HB1' ' A' ' 15' ' ' ALA . 0.0 OUTLIER -140.44 160.83 39.13 Favored 'General case' 0 C--N 1.326 -0.423 0 O-C-N 122.148 -0.345 . . . . 0.0 110.847 179.037 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 67.0 m95 -117.74 133.98 55.38 Favored 'General case' 0 C--O 1.214 -0.777 0 C-N-CA 122.871 0.468 . . . . 0.0 111.067 -178.138 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.558 ' CZ ' ' HB2' ' A' ' 15' ' ' ALA . 52.1 m-85 -110.39 163.29 13.82 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 106.438 -1.69 . . . . 0.0 106.438 179.041 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 81.0 t80 -110.81 138.25 47.44 Favored 'General case' 0 CA--C 1.51 -0.589 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 -179.066 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -137.6 136.47 37.56 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.114 -0.948 . . . . 0.0 108.548 -176.274 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 34.2 m-85 -70.66 159.52 34.28 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.012 178.469 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -53.56 127.72 26.36 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 113.106 0.78 . . . . 0.0 113.106 -177.181 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 64.47 33.45 87.27 Favored Glycine 0 C--O 1.224 -0.506 0 N-CA-C 115.434 0.934 . . . . 0.0 115.434 174.02 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 4.1 p . . . . . 0 C--N 1.323 -0.555 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 177.79 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 19.1 mt . . . . . 0 C--O 1.238 0.472 0 N-CA-C 114.117 1.155 . . . . 0.0 114.117 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -76.77 165.64 28.33 Favored 'Trans proline' 0 N--CA 1.462 -0.345 0 C-N-CA 121.12 1.213 . . . . 0.0 109.171 172.656 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.425 ' CE1' ' HB3' ' A' ' 92' ' ' TRP . 74.4 t80 -62.37 131.88 50.75 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 120.398 -0.521 . . . . 0.0 110.359 -179.485 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 90.07 -1.33 80.11 Favored Glycine 0 CA--C 1.518 0.235 0 CA-C-O 119.834 -0.426 . . . . 0.0 113.903 178.36 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -61.73 130.26 44.94 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 117.667 0.733 . . . . 0.0 111.348 178.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 54.3 t30 -79.42 120.63 24.1 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.452 -178.639 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 50.4 tttm -153.71 149.95 28.03 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 179.396 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -66.03 134.95 53.96 Favored 'General case' 0 C--O 1.238 0.49 0 CA-C-O 120.809 0.338 . . . . 0.0 110.405 179.179 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 70.65 23.57 77.63 Favored Glycine 0 N--CA 1.45 -0.397 0 CA-C-O 119.419 -0.656 . . . . 0.0 113.637 178.616 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 42.2 mm -129.59 130.83 67.2 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 CA-C-N 117.385 0.592 . . . . 0.0 110.401 -179.51 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.1 pt -135.59 120.18 27.03 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 CA-C-O 121.387 0.613 . . . . 0.0 110.251 176.196 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . 0.425 ' HB3' ' CE1' ' A' ' 83' ' ' TYR . 93.6 m95 -87.8 137.61 32.19 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 113.087 0.773 . . . . 0.0 113.087 -176.087 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 18.9 m -137.04 154.41 31.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 179.108 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -160.33 166.58 29.17 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 106.465 -1.68 . . . . 0.0 106.465 -178.368 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 11.3 t -138.8 174.73 10.22 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 105.618 -1.993 . . . . 0.0 105.618 177.278 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 59.8 tt0 -67.45 137.43 55.86 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.324 0.583 . . . . 0.0 110.861 -179.011 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 95.26 -11.85 68.63 Favored Glycine 0 N--CA 1.46 0.268 0 CA-C-N 115.756 -0.657 . . . . 0.0 113.3 178.053 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.421 ' HA ' ' HA ' ' A' ' 41' ' ' ASP . . . -76.57 143.05 40.54 Favored 'General case' 0 C--N 1.322 -0.592 0 O-C-N 122.598 -0.354 . . . . 0.0 110.541 179.441 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 46.2 mt -105.4 134.37 48.63 Favored 'General case' 0 CA--C 1.513 -0.459 0 N-CA-C 113.855 1.057 . . . . 0.0 113.855 -178.14 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -79.24 65.58 4.45 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.223 -0.899 . . . . 0.0 111.142 -178.548 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 1.2 t -134.77 156.18 78.79 Favored Pre-proline 0 C--N 1.322 -0.629 0 N-CA-C 105.359 -2.089 . . . . 0.0 105.359 -179.408 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -65.93 153.11 79.48 Favored 'Trans proline' 0 C--N 1.344 0.322 0 N-CA-C 115.05 1.135 . . . . 0.0 115.05 179.34 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.475 ' HB3' HD12 ' A' ' 106' ' ' ILE . 72.0 mmtt -122.94 32.46 5.7 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.201 -0.909 . . . . 0.0 109.149 -178.619 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 15.4 p-10 -50.92 -44.24 60.08 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.989 -177.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 16.0 p80 -69.78 -8.92 52.28 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 114.015 1.117 . . . . 0.0 114.015 -178.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.475 HD12 ' HB3' ' A' ' 103' ' ' LYS . 33.8 mt -96.15 -41.7 11.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 O-C-N 122.186 -0.321 . . . . 0.0 110.214 179.186 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -68.44 14.75 0.66 Allowed Glycine 0 N--CA 1.466 0.67 0 N-CA-C 117.995 1.958 . . . . 0.0 117.995 -176.224 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 8.9 t -90.27 28.77 1.36 Allowed 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 123.695 0.798 . . . . 0.0 111.976 -178.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 73.9 ttp85 -57.75 121.4 10.36 Favored 'General case' 0 N--CA 1.474 0.737 0 O-C-N 121.451 -0.781 . . . . 0.0 109.956 -179.684 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 63.3 m-20 -90.57 118.09 68.46 Favored Pre-proline 0 C--N 1.322 -0.591 0 N-CA-C 106.174 -1.788 . . . . 0.0 106.174 179.618 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -71.09 -14.79 32.11 Favored 'Trans proline' 0 C--O 1.218 -0.523 0 C-N-CA 117.902 -0.932 . . . . 0.0 113.384 -177.052 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -75.53 -26.8 58.37 Favored 'General case' 0 C--O 1.22 -0.484 0 CA-C-O 120.858 0.361 . . . . 0.0 110.41 177.565 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 -104.33 -26.51 12.43 Favored 'General case' 0 C--O 1.222 -0.358 0 N-CA-C 113.284 0.846 . . . . 0.0 113.284 -174.314 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 25.5 t30 -146.0 143.99 29.81 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 -178.062 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -87.29 149.71 24.36 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.731 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -68.71 146.76 52.68 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 177.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 9.0 mt -78.61 134.58 27.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 -178.642 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 98.8 t -63.14 118.96 5.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 106.423 -1.695 . . . . 0.0 106.423 176.404 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.484 HD13 HD13 ' A' ' 16' ' ' LEU . 5.0 tt -67.02 125.31 25.61 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.398 0.618 . . . . 0.0 110.796 -176.303 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -132.7 161.02 35.06 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 105.6 -2.0 . . . . 0.0 105.6 179.452 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 20.1 mt -117.2 146.33 37.91 Favored Pre-proline 0 C--N 1.322 -0.594 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 179.435 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -73.14 171.58 17.29 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 121.183 1.256 . . . . 0.0 114.522 -175.463 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 39.6 tt0 -53.41 129.99 33.93 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.874 -179.311 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 90.99 -16.03 59.52 Favored Glycine 0 C--O 1.226 -0.357 0 CA-C-N 115.963 -0.562 . . . . 0.0 113.229 -179.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.589 HG23 HE21 ' A' ' 30' ' ' GLN . 19.2 m -108.61 127.15 53.71 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 179.501 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 4.8 p -125.28 148.28 48.75 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.754 0.312 . . . . 0.0 110.668 -176.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 84.8 mt -66.41 152.23 94.88 Favored Pre-proline 0 C--N 1.327 -0.406 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 177.197 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -76.83 168.1 24.11 Favored 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 117.747 -1.035 . . . . 0.0 110.859 -179.571 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -59.44 126.73 28.79 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 91.58 27.96 15.84 Favored Glycine 0 C--O 1.224 -0.5 0 N-CA-C 114.938 0.735 . . . . 0.0 114.938 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -139.07 147.42 41.99 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 117.701 0.75 . . . . 0.0 111.369 177.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 54.0 p90 -153.93 165.22 36.8 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 176.401 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -100.25 142.03 32.28 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 114.146 1.165 . . . . 0.0 114.146 -175.375 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -67.96 140.63 56.42 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 107.181 -1.415 . . . . 0.0 107.181 175.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 90.7 -34.79 4.07 Favored Glycine 0 C--O 1.23 -0.151 0 C-N-CA 121.457 -0.401 . . . . 0.0 112.327 -179.055 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 22.9 t . . . . . 0 C--N 1.327 -0.407 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 179.671 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.431 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 58.3 p -61.62 145.18 52.98 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.752 178.633 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 15.8 m95 -67.93 -24.13 65.16 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 112.609 0.596 . . . . 0.0 112.609 179.392 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 25.8 m-85 -121.48 163.35 18.94 Favored 'General case' 0 CA--C 1.505 -0.754 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -172.156 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 70.1 p -70.64 164.17 25.51 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 176.528 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -80.5 152.04 28.91 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.449 0.642 . . . . 0.0 112.656 -176.871 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 21.8 mt -85.02 146.37 27.22 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 102.753 -3.055 . . . . 0.0 102.753 168.605 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 52.4 m -119.64 129.51 54.63 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 179.528 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -85.34 133.25 34.15 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.648 -179.412 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 21.9 t-160 -139.16 94.94 2.86 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 103.533 -2.766 . . . . 0.0 103.533 168.591 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 166.46 -131.26 2.32 Favored Glycine 0 C--O 1.226 -0.379 0 C-N-CA 120.184 -1.008 . . . . 0.0 113.119 -174.902 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 64.1 mttm -130.96 -38.5 1.25 Allowed 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 116.973 2.212 . . . . 0.0 116.973 -176.327 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -75.62 163.32 27.45 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 179.513 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -72.22 -62.66 1.35 Allowed 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 178.284 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 48.4 tp 174.47 134.2 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 104.843 -2.28 . . . . 0.0 104.843 173.256 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 11.1 tmtt? -148.24 127.51 13.0 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 118.403 0.547 . . . . 0.0 111.386 178.266 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 16.0 m-85 -113.22 153.16 45.54 Favored Pre-proline 0 C--O 1.243 0.716 0 CA-C-O 120.562 0.22 . . . . 0.0 111.306 176.811 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.42 162.57 41.38 Favored 'Trans proline' 0 C--N 1.353 0.765 0 C-N-CA 120.02 0.48 . . . . 0.0 112.541 177.594 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 16.9 tpt180 -69.93 134.63 48.6 Favored 'General case' 0 C--O 1.216 -0.704 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 -176.837 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 78.92 15.1 81.21 Favored Glycine 0 C--O 1.224 -0.506 0 C-N-CA 121.136 -0.554 . . . . 0.0 111.908 178.859 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 8.9 mt-30 -151.63 170.49 19.57 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 -175.291 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 108.09 -16.73 35.6 Favored Glycine 0 CA--C 1.501 -0.805 0 CA-C-N 116.236 -0.438 . . . . 0.0 112.676 175.373 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 95.0 t -65.7 129.29 94.3 Favored Pre-proline 0 C--N 1.319 -0.718 0 N-CA-C 106.968 -1.494 . . . . 0.0 106.968 177.41 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -73.29 170.33 20.14 Favored 'Trans proline' 0 N--CA 1.461 -0.422 0 O-C-N 122.17 0.563 . . . . 0.0 111.297 177.869 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 91.6 mt -69.39 107.63 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 179.829 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 -97.67 84.75 3.44 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 114.409 -1.269 . . . . 0.0 109.857 -176.817 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 69.8 p -66.59 -15.65 63.59 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.647 -0.706 . . . . 0.0 112.699 -178.869 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -107.32 22.62 15.7 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.152 -0.931 . . . . 0.0 112.162 -177.917 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 14.3 m -141.92 148.06 38.06 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 114.518 1.303 . . . . 0.0 114.518 -176.233 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -74.65 168.35 27.9 Favored Pre-proline 0 N--CA 1.468 0.46 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 176.424 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -64.65 -28.98 60.6 Favored 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 114.807 -2.996 . . . . 0.0 112.3 178.756 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -62.92 -24.07 67.67 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 123.74 0.816 . . . . 0.0 111.667 176.289 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 70.3 m-20 -98.93 -1.49 39.86 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 114.865 1.431 . . . . 0.0 114.865 -172.354 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 93.7 mm-40 -60.36 -29.26 68.8 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 114.459 1.281 . . . . 0.0 114.459 -178.888 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 20.8 tt -58.61 139.65 18.0 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.882 0 CA-C-O 122.32 1.057 . . . . 0.0 113.774 -177.296 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -179.18 -156.65 17.91 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.434 -178.738 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 46.6 p90 -155.12 171.52 19.65 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 178.653 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 19.9 m-85 -113.15 139.45 48.74 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 106.365 -1.717 . . . . 0.0 106.365 173.131 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 55.8 ttt180 -110.33 119.71 40.09 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.033 -176.951 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 11.8 ttp180 -65.92 137.92 57.49 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 177.431 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -143.8 142.67 31.0 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.772 0.796 . . . . 0.0 111.266 -179.976 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 41.4 p -142.99 172.49 12.63 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 102.284 -3.228 . . . . 0.0 102.284 174.995 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 17.9 tpt180 -140.62 125.98 18.79 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 120.345 -0.542 . . . . 0.0 111.025 176.557 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.26 148.11 33.12 Favored 'General case' 0 CA--C 1.488 -1.436 0 CA-C-O 121.611 0.719 . . . . 0.0 109.537 179.604 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -144.61 179.61 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.055 0 N-CA-C 102.123 -3.288 . . . . 0.0 102.123 178.804 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 79.2 ttt180 -132.7 121.16 22.68 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 175.295 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -97.33 147.07 18.53 Favored Glycine 0 N--CA 1.448 -0.547 0 N-CA-C 106.582 -2.607 . . . . 0.0 106.582 175.543 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -68.73 -30.94 72.72 Favored Glycine 0 C--O 1.216 -1.016 0 N-CA-C 109.798 -1.321 . . . . 0.0 109.798 179.507 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 30.7 t0 -87.26 17.02 4.62 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-O 122.016 0.912 . . . . 0.0 111.394 179.99 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 84.93 -6.49 78.63 Favored Glycine 0 C--O 1.223 -0.55 0 N-CA-C 116.462 1.345 . . . . 0.0 116.462 174.196 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.13 132.11 47.16 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.959 0.885 . . . . 0.0 112.509 -179.277 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 91.6 mmm -121.79 179.38 4.51 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 113.81 -1.541 . . . . 0.0 108.485 -177.917 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 13.6 mmtt -111.41 -54.35 2.62 Favored 'General case' 0 C--O 1.215 -0.761 0 CA-C-O 120.857 0.36 . . . . 0.0 110.155 178.268 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 49.58 50.0 18.99 Favored 'General case' 0 C--N 1.323 -0.579 0 O-C-N 124.993 1.433 . . . . 0.0 113.867 174.972 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 63.9 mt -70.97 142.08 51.02 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 107.143 -1.429 . . . . 0.0 107.143 176.453 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 72.6 p -58.92 153.59 42.93 Favored Pre-proline 0 C--O 1.239 0.515 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -176.423 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -65.84 128.99 21.0 Favored 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 117.898 -0.935 . . . . 0.0 112.406 -178.918 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 18.1 mtt-85 -134.7 160.83 36.91 Favored 'General case' 0 CA--C 1.51 -0.592 0 CA-C-N 115.249 -0.887 . . . . 0.0 111.214 -176.499 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 57.6 m95 -129.49 129.19 44.25 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 178.152 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 40.4 m-85 -111.43 139.35 46.92 Favored 'General case' 0 C--O 1.217 -0.627 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 -178.491 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 92.0 t80 -86.9 136.64 32.88 Favored 'General case' 0 CA--C 1.509 -0.604 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 -177.973 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -141.77 144.91 34.22 Favored 'General case' 0 N--CA 1.441 -0.905 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 -175.434 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 -80.76 159.38 25.2 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 112.276 0.472 . . . . 0.0 112.276 -174.726 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 15.8 tp -58.1 126.95 29.7 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 121.363 0.602 . . . . 0.0 110.177 -179.423 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 85.21 16.73 64.11 Favored Glycine 0 C--O 1.221 -0.704 0 N-CA-C 116.086 1.195 . . . . 0.0 116.086 178.468 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 19.4 p . . . . . 0 N--CA 1.469 0.477 0 CA-C-N 118.971 1.385 . . . . 0.0 111.187 179.941 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 43.9 mt . . . . . 0 N--CA 1.449 -0.483 0 N-CA-C 115.525 1.676 . . . . 0.0 115.525 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -77.52 166.02 26.41 Favored 'Trans proline' 0 N--CA 1.461 -0.407 0 N-CA-C 108.388 -1.428 . . . . 0.0 108.388 169.274 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 64.1 t80 -63.14 132.51 52.05 Favored 'General case' 0 C--N 1.322 -0.602 0 O-C-N 121.947 -0.471 . . . . 0.0 109.958 -179.677 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 91.39 -4.91 80.6 Favored Glycine 0 CA--C 1.52 0.353 0 N-CA-C 114.637 0.615 . . . . 0.0 114.637 178.868 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -65.14 132.3 48.8 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 118.038 0.919 . . . . 0.0 112.357 179.781 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 50.1 t30 -74.96 125.9 29.87 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.863 -178.807 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 26.9 ttmt -156.26 151.6 26.7 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 107.178 -1.416 . . . . 0.0 107.178 177.321 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 15.6 t0 -61.97 129.63 41.82 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.013 0.435 . . . . 0.0 110.853 179.423 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 69.19 27.85 73.35 Favored Glycine 0 N--CA 1.447 -0.609 0 CA-C-N 115.82 -0.627 . . . . 0.0 114.319 176.032 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 45.1 mm -125.11 120.77 59.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 117.365 0.583 . . . . 0.0 110.062 178.764 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.1 pt -123.68 113.79 38.75 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 CA-C-O 121.896 0.855 . . . . 0.0 110.592 176.972 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 96.5 m95 -80.51 132.67 35.72 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.763 -0.653 . . . . 0.0 112.601 -176.978 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 17.0 m -135.59 149.7 28.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.795 0.807 . . . . 0.0 109.492 179.599 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -156.28 166.57 33.06 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 103.531 -2.766 . . . . 0.0 103.531 -179.282 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 14.5 t -131.53 168.94 16.8 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 104.221 -2.511 . . . . 0.0 104.221 177.522 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -65.41 134.17 52.91 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 -178.681 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 95.75 -7.06 67.75 Favored Glycine 0 C--O 1.226 -0.369 0 CA-C-N 116.004 -0.544 . . . . 0.0 113.529 179.4 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -80.51 135.42 36.11 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 122.096 -0.649 . . . . 0.0 109.823 179.029 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 37.0 mt -81.86 136.25 35.38 Favored 'General case' 0 CA--C 1.511 -0.529 0 CA-C-O 121.161 0.505 . . . . 0.0 111.479 -178.878 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 63.4 t30 -84.08 65.22 8.62 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.633 -179.664 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -140.1 153.75 69.55 Favored Pre-proline 0 C--N 1.324 -0.519 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 -178.553 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -66.85 149.89 83.23 Favored 'Trans proline' 0 C--N 1.344 0.319 0 N-CA-C 113.977 0.722 . . . . 0.0 113.977 177.252 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 1.5 ptpm? -149.15 55.51 0.99 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 123.036 1.398 . . . . 0.0 109.571 179.759 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 13.6 p-10 -54.92 -35.1 63.83 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 113.451 -1.704 . . . . 0.0 112.344 179.52 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 37.5 p-80 -60.3 -14.6 19.09 Favored 'General case' 0 C--O 1.219 -0.549 0 N-CA-C 114.728 1.381 . . . . 0.0 114.728 -177.839 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 62.8 mt -84.42 -39.16 14.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 178.515 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -74.16 14.6 3.8 Favored Glycine 0 C--O 1.221 -0.678 0 N-CA-C 116.126 1.211 . . . . 0.0 116.126 -176.558 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 11.5 t -94.29 23.11 5.35 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 117.968 0.884 . . . . 0.0 112.667 -178.038 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.428 ' HD2' HD22 ' A' ' 114' ' ' ASN . 65.3 ttp85 -55.91 133.65 51.56 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.387 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 15.1 m-20 -104.28 125.18 34.97 Favored Pre-proline 0 C--N 1.324 -0.523 0 N-CA-C 106.854 -1.536 . . . . 0.0 106.854 -179.389 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_endo -69.59 -18.51 37.75 Favored 'Trans proline' 0 C--O 1.217 -0.527 0 N-CA-C 114.037 0.745 . . . . 0.0 114.037 -177.903 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -73.63 -26.28 60.7 Favored 'General case' 0 C--O 1.22 -0.498 0 CA-C-O 120.877 0.37 . . . . 0.0 110.675 178.1 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -102.11 -23.93 14.0 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 113.142 0.793 . . . . 0.0 113.142 -174.978 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . 0.428 HD22 ' HD2' ' A' ' 109' ' ' ARG . 26.8 t30 -154.55 148.37 25.52 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 112.578 0.584 . . . . 0.0 112.578 -178.361 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -88.94 149.1 23.46 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-O 121.432 0.634 . . . . 0.0 111.702 179.575 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -70.08 145.18 51.83 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.221 0.534 . . . . 0.0 110.446 178.369 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 14.4 mt -86.3 138.8 18.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 115.393 -0.821 . . . . 0.0 108.815 -178.601 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 75.6 t -61.16 123.9 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 N-CA-C 106.077 -1.823 . . . . 0.0 106.077 174.848 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 7.1 tt -66.84 130.11 42.07 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.134 0.492 . . . . 0.0 110.379 -177.021 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 30.2 mt-30 -132.72 157.94 43.62 Favored 'General case' 0 CA--C 1.511 -0.551 0 N-CA-C 106.615 -1.624 . . . . 0.0 106.615 -179.445 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 13.3 mt -112.31 148.18 38.59 Favored Pre-proline 0 C--N 1.322 -0.588 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 177.12 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -73.2 166.17 30.68 Favored 'Trans proline' 0 N--CA 1.462 -0.371 0 O-C-N 122.325 0.645 . . . . 0.0 112.933 -179.501 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 60.2 tp60 -54.27 130.37 38.56 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.887 -179.879 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 97.15 -17.12 59.73 Favored Glycine 0 C--O 1.227 -0.3 0 CA-C-N 115.907 -0.588 . . . . 0.0 113.611 -179.926 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 9.5 m -106.71 127.01 53.02 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 118.149 0.975 . . . . 0.0 109.984 178.288 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 17.3 p -120.02 148.32 43.71 Favored 'General case' 0 CA--C 1.511 -0.534 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.845 -179.132 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 88.8 mt -70.4 156.1 92.41 Favored Pre-proline 0 C--N 1.323 -0.561 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 177.559 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -74.55 169.11 23.26 Favored 'Trans proline' 0 C--O 1.236 0.406 0 C-N-CA 117.749 -1.034 . . . . 0.0 110.343 178.302 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 12.4 tmtt? -63.72 120.67 12.29 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 -176.823 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 95.18 37.94 4.98 Favored Glycine 0 N--CA 1.452 -0.257 0 N-CA-C 114.943 0.737 . . . . 0.0 114.943 178.942 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -142.31 146.15 34.73 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 176.85 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 48.6 p90 -147.11 162.38 38.94 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 176.627 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -97.68 143.26 28.53 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.042 0.449 . . . . 0.0 110.547 -178.345 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -71.34 135.84 47.54 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 178.812 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 87.87 -13.53 60.84 Favored Glycine 0 C--O 1.227 -0.299 0 CA-C-N 116.109 -0.496 . . . . 0.0 113.147 -178.24 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 35.2 t . . . . . 0 C--N 1.326 -0.43 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 178.733 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.456 -0.128 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 62.5 p -63.06 141.07 58.9 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 178.865 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . 0.415 ' CD2' ' HD3' ' A' ' 109' ' ' ARG . 10.9 m95 -67.95 -27.21 66.4 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.038 0.447 . . . . 0.0 111.772 178.716 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 20.1 m-85 -121.53 163.97 17.99 Favored 'General case' 0 C--O 1.242 0.68 0 CA-C-N 115.517 -0.765 . . . . 0.0 112.537 -171.349 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 63.7 p -70.19 166.5 19.87 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 177.096 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.433 ' HB1' ' HB3' ' A' ' 67' ' ' ARG . . . -83.58 148.17 27.32 Favored 'General case' 0 N--CA 1.443 -0.785 0 N-CA-C 113.529 0.937 . . . . 0.0 113.529 -175.371 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 15.6 mt -81.88 144.92 30.65 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 103.768 -2.679 . . . . 0.0 103.768 170.902 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 26.4 m -123.28 131.03 53.52 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.108 0.48 . . . . 0.0 110.052 -178.008 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -83.39 141.93 31.38 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.34 -0.845 . . . . 0.0 111.94 -178.627 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 23.0 t-160 -139.11 99.71 3.83 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 105.83 -1.915 . . . . 0.0 105.83 168.477 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 151.02 -134.59 4.76 Favored Glycine 0 C--N 1.322 -0.242 0 N-CA-C 111.134 -0.786 . . . . 0.0 111.134 -176.841 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 51.6 mttp -132.7 -16.1 2.65 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 114.993 1.479 . . . . 0.0 114.993 -179.351 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 59.7 mt-10 -73.98 155.49 38.55 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 107.1 -1.444 . . . . 0.0 107.1 178.027 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -82.17 -62.6 1.58 Allowed 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 120.458 -0.497 . . . . 0.0 109.791 -178.685 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 56.5 tp 168.58 136.7 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 103.661 -2.718 . . . . 0.0 103.661 175.411 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -157.01 138.87 14.3 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 176.511 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 25.6 m-85 -127.55 151.38 75.01 Favored Pre-proline 0 C--N 1.324 -0.531 0 O-C-N 123.307 0.379 . . . . 0.0 110.212 176.804 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -79.72 165.89 22.08 Favored 'Trans proline' 0 CA--C 1.541 0.83 0 C-N-CA 120.568 0.845 . . . . 0.0 113.03 176.755 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 2.2 tmt_? -67.3 138.33 56.75 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 116.548 -0.296 . . . . 0.0 110.257 -179.384 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 86.66 2.73 84.39 Favored Glycine 0 C--O 1.224 -0.503 0 N-CA-C 110.894 -0.883 . . . . 0.0 110.894 178.008 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.578 HE21 HG23 ' A' ' 125' ' ' THR . 27.6 mt-30 -143.86 -179.62 6.58 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 -175.14 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.448 ' H ' HG21 ' A' ' 125' ' ' THR . . . 95.54 -28.97 10.4 Favored Glycine 0 CA--C 1.5 -0.896 0 CA-C-N 115.794 -0.639 . . . . 0.0 113.555 174.716 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 91.6 t -64.14 127.3 91.78 Favored Pre-proline 0 C--N 1.319 -0.721 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 177.486 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -72.91 171.72 16.88 Favored 'Trans proline' 0 N--CA 1.461 -0.433 0 C-N-CA 120.128 0.552 . . . . 0.0 111.717 178.409 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 85.6 mt -69.21 107.89 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-O 122.299 1.047 . . . . 0.0 108.539 179.415 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 84.7 m-20 -98.45 86.33 3.58 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 114.122 -1.399 . . . . 0.0 109.874 -176.614 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 67.0 p -67.56 -15.79 63.84 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.525 -0.761 . . . . 0.0 112.627 -178.848 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 11.2 p30 -107.11 21.09 18.08 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 114.9 -1.046 . . . . 0.0 113.014 -177.31 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 9.9 m -140.16 150.38 44.15 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 115.741 1.756 . . . . 0.0 115.741 -174.817 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 4.6 m -72.49 166.28 43.49 Favored Pre-proline 0 N--CA 1.468 0.464 0 CA-C-N 115.415 -0.812 . . . . 0.0 109.553 176.22 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -66.03 -27.98 49.75 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 114.533 -3.178 . . . . 0.0 113.944 -179.805 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.402 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 5.6 p-10 -75.06 -21.55 58.92 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 121.66 -0.65 . . . . 0.0 111.213 177.113 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 75.0 m-20 -81.36 -10.53 59.52 Favored 'General case' 0 C--O 1.221 -0.415 0 N-CA-C 113.453 0.908 . . . . 0.0 113.453 -176.034 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 96.6 mm-40 -56.69 -27.29 58.65 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 115.155 1.539 . . . . 0.0 115.155 -176.59 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 19.7 tt -55.31 138.46 15.57 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.941 0 N-CA-C 114.418 1.266 . . . . 0.0 114.418 -178.077 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -176.88 -159.95 23.09 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.416 -0.897 . . . . 0.0 114.353 -179.406 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 44.8 p90 -154.92 170.47 21.63 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 179.242 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 17.6 m-85 -114.39 141.46 47.62 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 172.905 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 58.3 ttt180 -113.56 117.24 31.1 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 124.415 1.086 . . . . 0.0 110.992 -175.428 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 46.6 ttp180 -65.6 137.52 57.41 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 178.356 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -150.41 150.06 30.87 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.854 0.359 . . . . 0.0 111.149 -178.029 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 21.6 p -141.94 140.13 32.69 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.826 176.282 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 14.0 tpt180 -142.74 123.87 14.53 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 174.742 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.52 133.84 52.22 Favored 'General case' 0 CA--C 1.494 -1.187 0 CA-C-O 121.584 0.706 . . . . 0.0 110.963 -176.508 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -129.17 179.1 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.883 0 N-CA-C 105.472 -2.047 . . . . 0.0 105.472 178.238 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 27.8 tpt180 -139.57 107.93 5.83 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 106.803 -1.554 . . . . 0.0 106.803 172.502 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -74.17 156.61 50.36 Favored Glycine 0 N--CA 1.447 -0.568 0 N-CA-C 107.681 -2.168 . . . . 0.0 107.681 176.608 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -69.34 -33.23 72.66 Favored Glycine 0 C--O 1.216 -0.983 0 N-CA-C 108.62 -1.792 . . . . 0.0 108.62 179.373 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.1 t0 -84.75 16.61 3.19 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-O 122.55 1.167 . . . . 0.0 109.689 177.715 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 85.03 -14.6 48.35 Favored Glycine 0 N--CA 1.455 -0.086 0 N-CA-C 116.961 1.544 . . . . 0.0 116.961 173.457 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -55.91 142.01 37.15 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 114.968 1.469 . . . . 0.0 114.968 -176.74 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 95.3 mmm -116.48 177.98 4.5 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 112.543 -2.117 . . . . 0.0 109.475 -177.095 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 13.7 tppt? -126.28 -53.76 1.49 Allowed 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 178.208 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 -120.43 149.42 42.4 Favored 'General case' 0 CA--C 1.506 -0.716 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 178.499 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -133.49 -44.18 0.83 Allowed 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 104.306 -2.479 . . . . 0.0 104.306 176.256 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 33.3 t -112.02 153.27 44.63 Favored Pre-proline 0 C--O 1.243 0.748 0 N-CA-C 105.42 -2.066 . . . . 0.0 105.42 175.954 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -68.75 156.74 64.48 Favored 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 117.06 -1.494 . . . . 0.0 114.983 -179.381 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.433 ' HB3' ' HB1' ' A' ' 15' ' ' ALA . 94.0 mtt-85 -113.98 165.46 12.58 Favored 'General case' 0 CA--C 1.509 -0.6 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.523 178.015 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 49.8 m95 -132.03 129.47 40.11 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 176.247 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 17.0 m-85 -110.77 141.34 44.23 Favored 'General case' 0 C--O 1.216 -0.658 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 -176.863 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -88.7 136.87 32.78 Favored 'General case' 0 CA--C 1.506 -0.732 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 -176.527 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -141.36 143.44 33.99 Favored 'General case' 0 N--CA 1.438 -1.032 0 N-CA-C 106.976 -1.491 . . . . 0.0 106.976 -175.888 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 66.8 m-85 -82.94 159.35 22.29 Favored 'General case' 0 C--N 1.317 -0.842 0 O-C-N 122.21 -0.306 . . . . 0.0 110.94 -175.342 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 15.4 tp -54.59 131.49 43.16 Favored 'General case' 0 C--O 1.218 -0.583 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 179.452 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 74.54 25.43 70.22 Favored Glycine 0 C--O 1.225 -0.466 0 N-CA-C 115.8 1.08 . . . . 0.0 115.8 177.633 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 49.8 p . . . . . 0 N--CA 1.466 0.353 0 CA-C-N 118.421 1.11 . . . . 0.0 110.279 176.167 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 15.4 mt . . . . . 0 N--CA 1.442 -0.858 0 N-CA-C 115.291 1.589 . . . . 0.0 115.291 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -78.59 161.83 27.77 Favored 'Trans proline' 0 N--CA 1.461 -0.393 0 C-N-CA 122.516 2.144 . . . . 0.0 107.229 167.596 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 49.7 t80 -61.46 133.54 55.87 Favored 'General case' 0 C--N 1.319 -0.718 0 C-N-CA 120.425 -0.51 . . . . 0.0 110.283 -177.331 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 90.68 -8.62 79.53 Favored Glycine 0 CA--C 1.518 0.278 0 CA-C-O 119.518 -0.601 . . . . 0.0 114.394 179.599 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -66.3 130.3 42.76 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 118.569 1.184 . . . . 0.0 111.624 179.669 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 48.8 t-20 -80.25 130.33 35.13 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.479 -179.441 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 28.0 ttmt -156.1 154.56 31.12 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 106.865 -1.531 . . . . 0.0 106.865 -179.844 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -58.78 124.04 18.43 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.914 0.388 . . . . 0.0 110.868 -179.164 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 69.31 31.48 71.59 Favored Glycine 0 N--CA 1.449 -0.446 0 CA-C-O 119.044 -0.864 . . . . 0.0 115.029 177.556 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 43.2 mm -124.71 127.67 72.89 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 CA-C-N 118.045 0.922 . . . . 0.0 110.992 179.534 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -129.49 123.51 57.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.4 176.357 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 98.7 m95 -88.34 138.14 31.7 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 114.05 1.13 . . . . 0.0 114.05 -176.241 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 16.2 m -139.0 149.8 23.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 121.693 0.759 . . . . 0.0 110.053 178.936 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -159.22 161.12 36.04 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 103.915 -2.624 . . . . 0.0 103.915 178.405 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 13.9 t -118.23 172.78 7.2 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 105.227 -2.138 . . . . 0.0 105.227 178.559 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -66.43 131.95 47.19 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.811 0.339 . . . . 0.0 110.238 -178.624 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 90.98 -4.1 81.28 Favored Glycine 0 CA--C 1.519 0.283 0 C-N-CA 121.359 -0.448 . . . . 0.0 113.746 178.806 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.402 ' HA ' ' HA ' ' A' ' 41' ' ' ASP . . . -73.83 136.06 43.48 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 178.44 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 30.3 mt -89.22 140.55 29.36 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.51 0.671 . . . . 0.0 112.195 -177.071 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 61.9 t30 -83.98 64.95 8.42 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.193 -179.304 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -137.46 155.84 75.29 Favored Pre-proline 0 C--N 1.322 -0.593 0 N-CA-C 106.438 -1.69 . . . . 0.0 106.438 -178.956 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -66.48 151.43 83.05 Favored 'Trans proline' 0 C--N 1.342 0.223 0 N-CA-C 115.359 1.253 . . . . 0.0 115.359 179.993 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.557 ' HB3' HD12 ' A' ' 106' ' ' ILE . 73.3 mmtt -123.02 41.19 3.53 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 114.44 -1.254 . . . . 0.0 108.909 -178.757 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 18.3 p-10 -51.22 -43.4 61.43 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 114.235 -1.348 . . . . 0.0 111.329 178.848 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 46.5 p-80 -66.45 -10.94 49.19 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 124.567 1.147 . . . . 0.0 113.953 -178.839 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.557 HD12 ' HB3' ' A' ' 103' ' ' LYS . 50.4 mt -96.11 -38.22 8.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 179.806 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -74.58 1.74 50.63 Favored Glycine 0 C--O 1.225 -0.453 0 N-CA-C 115.59 0.996 . . . . 0.0 115.59 -177.759 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 14.7 t -83.39 18.8 1.69 Allowed 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 117.869 0.835 . . . . 0.0 112.753 -176.635 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.442 ' HD2' ' OD1' ' A' ' 114' ' ' ASN . 64.2 ttp85 -57.03 130.57 46.69 Favored 'General case' 0 N--CA 1.467 0.391 0 O-C-N 121.998 -0.439 . . . . 0.0 110.129 178.862 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 35.8 m120 -88.49 117.63 68.56 Favored Pre-proline 0 C--N 1.323 -0.546 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 179.843 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -72.76 -13.2 26.87 Favored 'Trans proline' 0 C--O 1.217 -0.531 0 C-N-CA 117.128 -1.448 . . . . 0.0 112.835 -179.528 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -78.4 -27.18 46.66 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.568 177.413 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 -102.06 -25.69 13.65 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 113.237 0.829 . . . . 0.0 113.237 -174.795 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . 0.442 ' OD1' ' HD2' ' A' ' 109' ' ' ARG . 5.0 t-20 -128.7 147.61 50.77 Favored 'General case' 0 N--CA 1.442 -0.829 0 N-CA-C 113.149 0.796 . . . . 0.0 113.149 -177.905 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -95.28 129.23 42.49 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 173.808 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -62.16 148.15 45.4 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.448 -0.796 . . . . 0.0 112.371 -178.236 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 9.8 mt -80.72 138.99 18.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 114.89 -1.05 . . . . 0.0 109.432 -177.832 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 79.5 t -63.11 123.38 15.76 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 N-CA-C 106.12 -1.807 . . . . 0.0 106.12 174.516 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 6.6 tt -65.63 130.48 43.46 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.258 0.552 . . . . 0.0 111.045 -176.876 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 31.0 mt-30 -132.99 159.02 41.21 Favored 'General case' 0 CA--C 1.513 -0.461 0 N-CA-C 106.729 -1.582 . . . . 0.0 106.729 -179.553 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 13.5 mt -112.97 146.73 35.72 Favored Pre-proline 0 C--N 1.323 -0.559 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 177.836 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -73.11 166.78 29.09 Favored 'Trans proline' 0 C--N 1.345 0.348 0 O-C-N 122.272 0.617 . . . . 0.0 113.038 -179.367 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 39.9 tt0 -54.89 131.53 44.53 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.902 179.998 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 95.8 -17.06 60.0 Favored Glycine 0 C--O 1.226 -0.371 0 CA-C-N 115.903 -0.589 . . . . 0.0 113.311 179.944 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.578 HG23 HE21 ' A' ' 30' ' ' GLN . 16.0 m -103.72 128.85 51.04 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 118.073 0.937 . . . . 0.0 111.032 178.811 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 5.8 p -117.23 148.26 41.79 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.795 -179.416 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 83.4 mt -71.23 157.8 89.41 Favored Pre-proline 0 C--N 1.324 -0.504 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 176.989 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -75.55 174.15 13.3 Favored 'Trans proline' 0 C--O 1.237 0.451 0 C-N-CA 117.514 -1.191 . . . . 0.0 109.866 178.367 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 64.1 tttm -62.06 125.94 25.61 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.437 0.636 . . . . 0.0 110.454 -177.141 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 82.31 45.44 6.99 Favored Glycine 0 C--O 1.226 -0.378 0 N-CA-C 115.275 0.87 . . . . 0.0 115.275 178.3 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -141.54 150.87 42.7 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 117.856 0.828 . . . . 0.0 111.476 177.852 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 42.6 p90 -149.95 165.61 32.12 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 176.65 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -101.92 145.32 29.4 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.155 0.502 . . . . 0.0 111.468 -177.993 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -72.69 127.83 33.73 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 179.964 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 92.21 -15.04 63.04 Favored Glycine 0 C--O 1.228 -0.224 0 CA-C-N 115.948 -0.569 . . . . 0.0 113.574 179.506 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 33.5 t . . . . . 0 C--N 1.325 -0.489 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 179.978 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.265 0 CA-C-O 121.3 0.571 . . . . 0.0 111.137 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 17.1 t -65.73 139.96 58.41 Favored 'General case' 0 CA--C 1.512 -0.513 0 N-CA-C 106.954 -1.499 . . . . 0.0 106.954 176.825 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 6.9 m95 -69.62 -21.91 63.53 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.136 0.493 . . . . 0.0 110.276 177.939 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 17.5 m-85 -121.42 161.91 21.35 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.393 -0.821 . . . . 0.0 112.452 -172.223 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.418 ' HB ' ' HB3' ' A' ' 134' ' ' GLU . 67.8 p -69.13 164.77 21.8 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 179.079 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -81.1 140.26 35.16 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 113.06 0.763 . . . . 0.0 113.06 -176.592 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 20.1 mt -78.82 148.22 32.95 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 103.576 -2.75 . . . . 0.0 103.576 170.614 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 16.2 m -130.12 134.76 47.56 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 118.189 0.45 . . . . 0.0 110.605 -178.005 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.42 ' HB2' ' CZ ' ' A' ' 131' ' ' PHE . 4.1 tp60 -100.87 141.56 33.58 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 -177.804 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 52.1 t60 -128.56 99.66 5.46 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 104.636 -2.357 . . . . 0.0 104.636 169.126 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 164.43 -158.76 31.54 Favored Glycine 0 N--CA 1.452 -0.251 0 N-CA-C 108.239 -1.945 . . . . 0.0 108.239 -175.892 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -115.59 -20.9 9.98 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 117.688 0.744 . . . . 0.0 111.127 179.18 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -72.11 153.69 41.53 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.201 -0.909 . . . . 0.0 109.121 178.701 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -82.23 -62.89 1.5 Allowed 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 113.905 1.076 . . . . 0.0 113.905 -176.832 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 50.1 tp 165.33 142.18 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.268 0 N-CA-C 105.815 -1.92 . . . . 0.0 105.815 179.025 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 51.8 tptt -157.25 139.6 14.67 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 173.46 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 16.3 m-85 -122.47 151.92 60.48 Favored Pre-proline 0 C--O 1.241 0.636 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 175.865 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -70.4 161.32 46.43 Favored 'Trans proline' 0 C--N 1.351 0.659 0 O-C-N 122.261 0.611 . . . . 0.0 112.496 178.625 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 22.7 tpt180 -67.83 135.55 52.75 Favored 'General case' 0 C--O 1.216 -0.673 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 -178.249 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 82.55 10.78 82.91 Favored Glycine 0 C--O 1.223 -0.565 0 C-N-CA 121.218 -0.515 . . . . 0.0 111.87 178.87 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 10.2 mt-30 -150.37 170.5 18.89 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 -175.116 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 105.68 -16.56 43.83 Favored Glycine 0 CA--C 1.503 -0.711 0 CA-C-N 116.289 -0.414 . . . . 0.0 113.393 174.887 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 94.1 t -65.75 130.03 94.43 Favored Pre-proline 0 C--N 1.319 -0.726 0 N-CA-C 106.273 -1.751 . . . . 0.0 106.273 177.027 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -72.64 171.17 17.76 Favored 'Trans proline' 0 N--CA 1.46 -0.468 0 O-C-N 122.194 0.576 . . . . 0.0 111.23 178.084 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 87.9 mt -71.01 107.06 2.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 179.801 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 -99.55 84.82 3.02 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.523 -1.217 . . . . 0.0 110.55 -176.329 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 75.7 p -67.97 -14.96 63.38 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.644 -0.707 . . . . 0.0 112.568 -179.204 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 12.5 p30 -108.48 21.71 16.93 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.15 -0.932 . . . . 0.0 112.871 -177.646 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 11.8 m -140.71 148.09 40.21 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 113.454 0.909 . . . . 0.0 113.454 -177.14 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -72.0 166.08 44.09 Favored Pre-proline 0 C--N 1.326 -0.418 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 177.068 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -64.8 -27.22 59.7 Favored 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 115.376 -2.616 . . . . 0.0 111.793 178.69 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -62.26 -28.77 69.94 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.786 0.803 . . . . 0.0 111.132 176.451 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -96.6 1.02 50.82 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 115.348 1.611 . . . . 0.0 115.348 -171.042 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 94.9 mm-40 -61.4 -30.1 70.34 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 113.841 1.052 . . . . 0.0 113.841 179.641 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 14.6 tt -61.22 138.0 22.65 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.789 0 CA-C-O 122.322 1.058 . . . . 0.0 113.346 -177.937 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 179.17 -155.55 16.29 Favored Glycine 0 N--CA 1.449 -0.447 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.468 -177.976 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 46.8 p90 -155.07 171.14 20.25 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 179.786 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 22.4 m-85 -111.56 138.92 47.46 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 173.813 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 40.4 ttt-85 -110.96 120.16 41.45 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 124.034 0.934 . . . . 0.0 110.298 -177.229 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 52.0 ttp180 -68.26 140.92 56.02 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 178.183 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -142.77 148.73 37.66 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.223 0.535 . . . . 0.0 110.344 179.231 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -158.14 154.22 27.08 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 104.387 -2.449 . . . . 0.0 104.387 176.252 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 20.9 tpt85 -150.81 133.02 15.39 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 177.462 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 72.4 ttt180 -143.38 153.2 42.46 Favored 'General case' 0 CA--C 1.496 -1.131 0 CA-C-O 121.835 0.826 . . . . 0.0 110.528 178.281 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -148.13 -179.68 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 N-CA-C 103.463 -2.791 . . . . 0.0 103.463 179.971 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.64 99.23 6.2 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 174.305 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -71.54 159.63 53.87 Favored Glycine 0 C--O 1.227 -0.308 0 N-CA-C 106.894 -2.482 . . . . 0.0 106.894 176.84 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -60.72 -42.49 99.41 Favored Glycine 0 C--O 1.222 -0.65 0 CA-C-N 118.867 1.333 . . . . 0.0 111.832 -179.486 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -92.82 17.02 11.14 Favored 'General case' 0 CA--C 1.546 0.825 0 CA-C-O 122.895 1.331 . . . . 0.0 110.782 178.822 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 90.06 -1.24 80.01 Favored Glycine 0 N--CA 1.462 0.402 0 N-CA-C 118.163 2.025 . . . . 0.0 118.163 169.145 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.408 ' H ' ' HD2' ' A' ' 60' ' ' LYS . 2.1 mptp? -59.27 139.66 56.76 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.999 0.904 . . . . 0.0 111.992 -178.023 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 63.4 mtp -97.23 -178.26 4.11 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 113.419 -1.719 . . . . 0.0 109.475 178.041 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 5.4 tmtt? -109.94 -55.71 2.41 Favored 'General case' 0 CA--C 1.508 -0.64 0 CA-C-O 121.538 0.685 . . . . 0.0 110.836 -178.782 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -125.07 165.05 18.88 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 103.307 -2.849 . . . . 0.0 103.307 177.105 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 94.3 mt -119.57 -99.68 0.44 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 117.888 0.313 . . . . 0.0 111.228 -176.715 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.21 156.38 88.25 Favored Pre-proline 0 C--N 1.325 -0.476 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 179.018 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -68.43 142.59 54.77 Favored 'Trans proline' 0 C--O 1.241 0.674 0 C-N-CA 114.777 -3.015 . . . . 0.0 112.628 -179.775 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 13.4 mtp180 -119.79 160.47 22.56 Favored 'General case' 0 CA--C 1.511 -0.539 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.662 -178.944 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 55.7 m95 -131.29 128.63 40.19 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.445 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 50.0 m-85 -110.45 144.87 38.59 Favored 'General case' 0 C--O 1.217 -0.622 0 N-CA-C 107.505 -1.295 . . . . 0.0 107.505 -177.773 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -89.84 129.97 36.15 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 118.801 0.728 . . . . 0.0 109.254 -178.297 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -132.35 133.07 43.54 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 -175.799 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -71.65 159.49 34.31 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.705 -0.68 . . . . 0.0 112.552 -176.13 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -53.99 129.26 33.57 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-O 121.069 0.461 . . . . 0.0 111.916 -179.448 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 73.26 26.66 69.9 Favored Glycine 0 C--O 1.22 -0.75 0 N-CA-C 115.887 1.115 . . . . 0.0 115.887 176.971 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 2.9 p . . . . . 0 C--N 1.325 -0.466 0 CA-C-N 118.601 1.201 . . . . 0.0 109.336 178.904 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 15.1 mt . . . . . 0 N--CA 1.446 -0.653 0 N-CA-C 115.112 1.523 . . . . 0.0 115.112 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -78.79 163.72 26.02 Favored 'Trans proline' 0 N--CA 1.461 -0.427 0 C-N-CA 121.939 1.759 . . . . 0.0 107.994 168.531 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.407 ' CE1' ' HB3' ' A' ' 92' ' ' TRP . 74.9 t80 -61.5 130.58 46.68 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 120.305 -0.558 . . . . 0.0 111.085 -177.729 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 92.19 -7.74 78.16 Favored Glycine 0 CA--C 1.519 0.305 0 CA-C-O 119.326 -0.708 . . . . 0.0 114.704 178.699 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -64.0 131.81 48.72 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 118.391 1.096 . . . . 0.0 111.656 179.948 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 47.1 t-20 -77.83 128.12 33.48 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.647 -179.465 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 26.4 ttmt -155.46 150.37 26.54 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 106.567 -1.642 . . . . 0.0 106.567 179.269 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -64.24 129.05 38.44 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.902 0.382 . . . . 0.0 110.968 -177.219 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 71.04 26.45 73.85 Favored Glycine 0 CA--C 1.52 0.346 0 CA-C-O 119.348 -0.696 . . . . 0.0 114.767 179.764 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 41.8 mm -126.83 129.25 71.41 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 CA-C-N 117.572 0.686 . . . . 0.0 111.007 -179.965 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.1 pt -132.02 119.34 40.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 CA-C-O 121.542 0.687 . . . . 0.0 111.186 176.133 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . 0.407 ' HB3' ' CE1' ' A' ' 83' ' ' TYR . 95.3 m95 -84.68 138.92 32.39 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 113.651 0.982 . . . . 0.0 113.651 -176.9 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 16.5 m -138.03 151.28 25.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 179.03 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -159.89 166.62 29.85 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 105.497 -2.038 . . . . 0.0 105.497 -178.502 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 12.0 t -136.51 175.61 9.45 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 105.657 -1.979 . . . . 0.0 105.657 177.15 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -66.26 136.81 56.38 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.155 0.502 . . . . 0.0 110.783 -179.466 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 92.76 -10.53 73.83 Favored Glycine 0 C--O 1.224 -0.513 0 CA-C-N 115.839 -0.619 . . . . 0.0 113.566 177.311 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -74.24 134.34 42.68 Favored 'General case' 0 C--N 1.323 -0.586 0 O-C-N 122.409 -0.465 . . . . 0.0 111.227 -179.849 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 38.3 mt -91.73 133.36 35.67 Favored 'General case' 0 CA--C 1.513 -0.48 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 -177.804 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 55.6 t30 -81.27 70.43 8.11 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.188 -0.914 . . . . 0.0 110.838 -178.977 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 1.3 t -139.19 155.29 72.55 Favored Pre-proline 0 C--N 1.322 -0.629 0 N-CA-C 106.1 -1.815 . . . . 0.0 106.1 -179.392 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -67.32 148.46 79.96 Favored 'Trans proline' 0 CA--C 1.53 0.32 0 C-N-CA 118.114 -0.791 . . . . 0.0 113.176 176.418 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -148.64 52.55 0.99 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 122.788 1.28 . . . . 0.0 110.435 179.243 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 13.0 p-10 -60.28 -30.48 69.49 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 114.047 -1.433 . . . . 0.0 110.829 179.268 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 16.0 p80 -59.15 -12.59 5.33 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 114.578 1.325 . . . . 0.0 114.578 -179.149 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 54.0 mt -86.5 -32.08 6.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 178.721 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -75.33 12.96 6.55 Favored Glycine 0 CA--C 1.522 0.479 0 N-CA-C 114.764 0.666 . . . . 0.0 114.764 -177.462 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 11.8 t -83.13 13.4 4.15 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 113.103 0.779 . . . . 0.0 113.103 -178.471 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 66.7 ttp85 -58.66 122.55 13.74 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 178.369 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -97.79 129.59 30.95 Favored Pre-proline 0 C--N 1.321 -0.669 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 -178.872 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -69.68 -15.4 37.38 Favored 'Trans proline' 0 C--O 1.219 -0.462 0 O-C-N 122.072 0.511 . . . . 0.0 113.087 -179.193 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -75.94 -26.58 57.02 Favored 'General case' 0 C--O 1.221 -0.425 0 CA-C-O 120.847 0.356 . . . . 0.0 110.404 177.738 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 76.1 m-20 -104.13 -27.23 12.2 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 113.724 1.009 . . . . 0.0 113.724 -174.727 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 29.7 t30 -152.15 149.04 28.34 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 113.078 0.77 . . . . 0.0 113.078 -177.283 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -90.44 150.45 21.82 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-O 121.457 0.646 . . . . 0.0 111.476 179.325 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -70.18 145.23 51.62 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.248 0.547 . . . . 0.0 111.284 178.867 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 17.9 mt -82.86 139.33 17.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 -179.029 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 99.2 t -59.58 122.9 10.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 N-CA-C 106.642 -1.614 . . . . 0.0 106.642 175.299 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 7.2 tt -68.18 129.04 38.74 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.139 0.495 . . . . 0.0 110.112 -176.703 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 31.5 mt-30 -131.12 158.74 39.63 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 -179.162 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 13.7 mt -113.27 147.57 37.67 Favored Pre-proline 0 C--N 1.322 -0.623 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 177.822 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -74.37 168.9 23.72 Favored 'Trans proline' 0 C--O 1.235 0.366 0 O-C-N 122.224 0.592 . . . . 0.0 113.276 -179.313 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 38.6 tt0 -54.14 131.95 42.1 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.518 -0.765 . . . . 0.0 109.415 179.411 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 99.01 -22.58 40.28 Favored Glycine 0 C--O 1.227 -0.282 0 CA-C-O 119.542 -0.588 . . . . 0.0 113.193 -179.779 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 4.1 m -106.63 127.58 53.46 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 118.361 1.081 . . . . 0.0 111.203 178.887 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 7.1 p -121.14 148.38 44.28 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.951 -179.562 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 92.7 mt -70.5 151.28 95.6 Favored Pre-proline 0 C--N 1.324 -0.513 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 178.874 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -78.6 172.92 14.43 Favored 'Trans proline' 0 N--CA 1.463 -0.303 0 O-C-N 122.0 0.473 . . . . 0.0 111.385 178.796 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 1.7 tmmt? -54.44 130.05 38.06 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.78 -177.847 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 91.53 -7.43 79.92 Favored Glycine 0 C--O 1.229 -0.19 0 N-CA-C 115.794 1.078 . . . . 0.0 115.794 175.655 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.42 ' CZ ' ' HB2' ' A' ' 18' ' ' GLN . 2.3 m-85 -97.84 142.54 29.48 Favored 'General case' 0 N--CA 1.441 -0.888 0 CA-C-O 122.311 1.053 . . . . 0.0 112.859 -177.818 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 47.0 p90 -141.73 165.1 28.41 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 113.473 -1.694 . . . . 0.0 106.961 173.974 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -102.51 143.75 31.82 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.731 0.3 . . . . 0.0 110.274 -178.583 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.418 ' HB3' ' HB ' ' A' ' 14' ' ' THR . 6.5 tp10 -71.55 135.7 47.16 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 106.762 -1.57 . . . . 0.0 106.762 177.84 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 93.33 -7.82 75.33 Favored Glycine 0 C--O 1.225 -0.412 0 C-N-CA 121.369 -0.443 . . . . 0.0 113.497 -177.626 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 34.6 t . . . . . 0 N--CA 1.468 0.433 0 CA-C-N 117.842 0.821 . . . . 0.0 111.221 177.194 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.456 -0.126 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 39.3 p -65.47 142.77 58.04 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.806 -0.812 . . . . 0.0 108.806 177.93 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . 0.44 ' CD2' ' HD3' ' A' ' 109' ' ' ARG . 14.8 m95 -67.69 -21.85 65.31 Favored 'General case' 0 CA--C 1.511 -0.557 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 178.066 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 44.4 m-85 -121.42 160.87 23.23 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 113.8 1.037 . . . . 0.0 113.8 -170.518 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 59.0 p -71.85 166.99 20.95 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 113.891 -1.504 . . . . 0.0 109.637 179.243 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.431 ' HB2' ' CZ ' ' A' ' 69' ' ' TYR . . . -80.29 131.11 35.6 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 -177.136 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 13.8 mt -74.51 146.43 42.71 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 103.278 -2.86 . . . . 0.0 103.278 170.1 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 24.8 m -126.8 136.65 52.67 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 -177.207 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.452 ' HB2' ' CZ ' ' A' ' 131' ' ' PHE . 4.7 tp60 -111.9 139.97 46.95 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 114.036 1.125 . . . . 0.0 114.036 -175.328 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 57.7 t60 -130.32 99.48 5.04 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 106.541 -1.652 . . . . 0.0 106.541 170.496 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 173.95 -170.57 43.71 Favored Glycine 0 C--O 1.227 -0.293 0 N-CA-C 109.014 -1.634 . . . . 0.0 109.014 -177.973 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -97.97 -24.25 15.45 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 117.523 0.662 . . . . 0.0 111.694 178.963 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -83.5 157.45 22.39 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 106.111 -1.811 . . . . 0.0 106.111 174.816 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -93.18 -62.76 1.31 Allowed 'General case' 0 C--O 1.215 -0.73 0 C-N-CA 120.123 -0.631 . . . . 0.0 112.637 -176.838 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 42.5 tp -169.83 138.62 1.82 Allowed 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 175.291 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 10.8 tmtt? -153.89 128.59 9.38 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 176.303 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -117.91 159.35 43.06 Favored Pre-proline 0 CA--C 1.547 0.835 0 N-CA-C 110.378 -0.23 . . . . 0.0 110.378 178.096 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -69.12 173.92 9.7 Favored 'Trans proline' 0 C--N 1.354 0.821 0 C-N-CA 121.687 1.591 . . . . 0.0 115.015 -179.574 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -78.37 132.74 37.51 Favored 'General case' 0 C--O 1.216 -0.699 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 178.116 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 69.42 14.21 68.96 Favored Glycine 0 C--O 1.225 -0.415 0 N-CA-C 115.089 0.796 . . . . 0.0 115.089 175.732 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 39.1 tt0 -157.77 148.11 20.65 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 105.758 -1.942 . . . . 0.0 105.758 -178.079 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 136.04 -17.12 3.89 Favored Glycine 0 CA--C 1.502 -0.72 0 C-N-CA 120.187 -1.006 . . . . 0.0 112.723 175.648 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 30.3 m -70.46 145.21 92.65 Favored Pre-proline 0 C--N 1.321 -0.666 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 177.042 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -76.76 167.53 25.19 Favored 'Trans proline' 0 N--CA 1.461 -0.395 0 C-N-CA 122.187 1.925 . . . . 0.0 113.74 179.695 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 97.9 mt -69.68 128.11 32.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 178.696 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 51.4 t-20 -125.49 122.17 35.85 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.889 -0.411 . . . . 0.0 109.889 175.998 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 74.2 p -92.74 -15.49 26.58 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 113.668 0.988 . . . . 0.0 113.668 -177.189 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 20.0 p30 -109.27 21.49 17.04 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 115.259 1.577 . . . . 0.0 115.259 -174.009 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 37.8 m -147.42 164.88 31.94 Favored 'General case' 0 N--CA 1.468 0.437 0 O-C-N 121.918 -0.489 . . . . 0.0 111.538 -179.875 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 32.6 m -75.27 164.44 61.11 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.703 -178.632 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -65.16 -24.81 58.52 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 115.529 -2.514 . . . . 0.0 111.769 177.362 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -59.75 -33.78 72.11 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 122.051 0.929 . . . . 0.0 110.613 176.559 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -83.35 -7.65 59.54 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 114.954 1.465 . . . . 0.0 114.954 -173.903 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 93.0 mm-40 -65.85 -31.64 72.71 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 114.521 1.304 . . . . 0.0 114.521 -174.806 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 14.7 tt -58.9 138.75 19.56 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 CA-C-O 122.076 0.941 . . . . 0.0 112.078 179.314 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 179.0 -148.36 8.21 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.124 -175.556 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.412 ' CE1' HD12 ' A' ' 90' ' ' ILE . 46.1 p90 -154.96 166.87 32.19 Favored 'General case' 0 C--N 1.32 -0.711 0 O-C-N 122.438 -0.448 . . . . 0.0 110.263 179.786 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 40.3 m-85 -107.51 141.97 38.11 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 174.116 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 58.6 ttt-85 -114.22 120.53 40.76 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 123.454 0.702 . . . . 0.0 112.028 -175.926 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 62.8 ttt-85 -64.43 141.4 58.79 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 122.789 0.436 . . . . 0.0 110.165 177.697 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -150.67 132.94 15.45 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.173 0.511 . . . . 0.0 112.249 178.624 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 7.0 p -149.48 139.74 22.26 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 107.259 -1.386 . . . . 0.0 107.259 175.818 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 25.0 tpt180 -147.1 123.98 11.29 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 175.385 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.53 145.34 47.41 Favored 'General case' 0 CA--C 1.484 -1.592 0 CA-C-O 122.313 1.054 . . . . 0.0 112.434 -178.951 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -142.32 176.32 3.89 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 N-CA-C 104.686 -2.338 . . . . 0.0 104.686 176.23 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 4.1 tmt_? -129.2 101.62 6.09 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 105.192 -2.151 . . . . 0.0 105.192 176.472 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -69.01 154.7 53.46 Favored Glycine 0 C--O 1.221 -0.697 0 N-CA-C 109.903 -1.279 . . . . 0.0 109.903 -178.434 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -64.93 -37.95 94.9 Favored Glycine 0 C--O 1.222 -0.637 0 N-CA-C 110.095 -1.202 . . . . 0.0 110.095 -178.219 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 27.5 t0 -89.79 16.95 7.16 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-O 122.339 1.066 . . . . 0.0 110.269 179.208 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 86.93 -15.66 51.71 Favored Glycine 0 C--O 1.227 -0.33 0 N-CA-C 115.818 1.087 . . . . 0.0 115.818 174.087 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -62.1 135.78 57.66 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 122.189 0.995 . . . . 0.0 112.705 -177.911 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 87.5 mtp -108.32 -174.21 2.46 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 113.704 -1.589 . . . . 0.0 109.821 -178.431 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 11.4 mmtt -105.56 -61.83 1.44 Allowed 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 120.979 0.418 . . . . 0.0 110.963 -179.077 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 19.8 p30 -132.74 168.28 18.61 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 176.734 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -128.99 -60.99 1.06 Allowed 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 -179.267 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -81.35 151.31 69.01 Favored Pre-proline 0 C--N 1.32 -0.714 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 176.395 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -70.58 152.02 64.77 Favored 'Trans proline' 0 C--O 1.239 0.569 0 C-N-CA 116.551 -1.833 . . . . 0.0 111.397 177.672 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 7.4 mtp180 -125.07 158.57 33.48 Favored 'General case' 0 CA--C 1.515 -0.4 0 C-N-CA 121.09 -0.244 . . . . 0.0 110.7 -179.786 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 48.2 m95 -131.75 136.4 47.56 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 178.312 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.431 ' CZ ' ' HB2' ' A' ' 15' ' ' ALA . 48.1 m-85 -110.37 172.95 6.56 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 104.804 -2.295 . . . . 0.0 104.804 -179.91 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 92.4 t80 -124.03 136.72 54.46 Favored 'General case' 0 CA--C 1.51 -0.595 0 CA-C-N 119.526 1.057 . . . . 0.0 108.597 -178.721 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 34.6 m-85 -137.51 148.89 46.35 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 -176.246 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 44.0 m-85 -84.05 159.52 21.15 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.359 -176.152 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -54.93 132.04 45.83 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.203 178.054 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 67.29 38.37 91.51 Favored Glycine 0 C--O 1.225 -0.436 0 N-CA-C 115.206 0.842 . . . . 0.0 115.206 177.124 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.2 p . . . . . 0 C--N 1.327 -0.392 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 175.757 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 14.7 mt . . . . . 0 N--CA 1.444 -0.76 0 N-CA-C 114.874 1.435 . . . . 0.0 114.874 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -79.73 164.69 23.01 Favored 'Trans proline' 0 C--O 1.235 0.36 0 C-N-CA 122.783 2.322 . . . . 0.0 107.78 167.455 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 60.6 t80 -62.32 131.67 50.09 Favored 'General case' 0 C--N 1.321 -0.666 0 C-N-CA 120.367 -0.533 . . . . 0.0 110.338 -178.066 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 91.14 -5.65 81.44 Favored Glycine 0 C--O 1.228 -0.273 0 N-CA-C 114.901 0.72 . . . . 0.0 114.901 179.031 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -66.77 130.49 43.33 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 118.649 1.225 . . . . 0.0 111.608 179.499 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 57.0 t30 -74.92 128.37 35.41 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.892 -179.186 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 26.4 ttmt -156.01 152.01 27.59 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 106.354 -1.721 . . . . 0.0 106.354 178.476 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -65.61 132.7 49.48 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.069 0.461 . . . . 0.0 110.615 -178.059 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 69.31 25.92 75.04 Favored Glycine 0 N--CA 1.449 -0.495 0 CA-C-N 115.714 -0.675 . . . . 0.0 114.239 177.97 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.412 HD12 ' CE1' ' A' ' 46' ' ' TYR . 47.7 mm -124.82 126.63 71.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 117.345 0.572 . . . . 0.0 110.842 179.945 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -127.08 116.98 46.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.356 176.243 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 96.9 m95 -82.22 135.66 35.21 Favored 'General case' 0 C--N 1.319 -0.72 0 O-C-N 121.864 -0.522 . . . . 0.0 112.227 -177.676 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -142.22 154.97 18.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 -178.113 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -154.92 166.52 33.28 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 106.193 -1.78 . . . . 0.0 106.193 -176.635 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 14.7 t -121.79 164.63 17.13 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 103.211 -2.885 . . . . 0.0 103.211 171.53 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -67.56 136.08 53.95 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 -179.099 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 92.84 -9.67 75.14 Favored Glycine 0 C--O 1.224 -0.501 0 CA-C-N 115.986 -0.552 . . . . 0.0 113.833 178.504 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -74.16 143.08 45.41 Favored 'General case' 0 CA--C 1.545 0.756 0 O-C-N 122.339 -0.506 . . . . 0.0 110.429 179.143 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 40.2 mt -93.17 133.48 36.32 Favored 'General case' 0 CA--C 1.516 -0.347 0 N-CA-C 115.004 1.483 . . . . 0.0 115.004 -175.496 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 61.6 t30 -79.67 64.68 4.61 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 114.683 -1.144 . . . . 0.0 110.966 -178.256 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -135.85 157.41 76.07 Favored Pre-proline 0 C--N 1.322 -0.588 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 -178.152 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -73.27 148.24 43.45 Favored 'Trans proline' 0 CA--C 1.534 0.493 0 N-CA-C 114.496 0.921 . . . . 0.0 114.496 175.338 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.54 58.85 1.07 Allowed 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 177.595 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -64.01 -14.37 53.68 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.275 176.449 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 18.0 p-80 -61.53 -14.46 29.78 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 179.396 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 23.4 mt -92.81 -26.7 4.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 121.329 0.585 . . . . 0.0 109.616 179.456 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -81.3 10.34 49.83 Favored Glycine 0 N--CA 1.459 0.232 0 O-C-N 122.007 -0.433 . . . . 0.0 113.63 -178.128 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 12.4 t -83.22 6.48 19.33 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 122.295 -0.532 . . . . 0.0 111.262 -178.4 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.44 ' HD3' ' CD2' ' A' ' 12' ' ' TRP . 63.5 ttp85 -54.51 133.61 46.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.509 179.908 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 35.0 m120 -96.97 115.82 65.85 Favored Pre-proline 0 C--N 1.326 -0.455 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 178.8 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -73.23 -11.53 25.03 Favored 'Trans proline' 0 C--O 1.219 -0.473 0 C-N-CA 117.45 -1.233 . . . . 0.0 113.351 -178.155 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -80.54 -25.45 38.63 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.215 177.436 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 -101.99 -25.44 13.76 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 113.543 0.942 . . . . 0.0 113.543 -174.334 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -140.42 154.27 46.6 Favored 'General case' 0 N--CA 1.434 -1.226 0 CA-C-O 121.497 0.665 . . . . 0.0 109.45 -177.59 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -93.36 144.45 25.31 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 114.938 -1.028 . . . . 0.0 110.837 -179.531 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -68.83 145.44 53.73 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.37 0.605 . . . . 0.0 110.561 178.853 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 27.8 mt -81.59 137.44 21.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 -178.723 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 1.2 p -62.08 125.99 19.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 176.324 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 6.4 tt -67.11 127.52 32.91 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.01 0.434 . . . . 0.0 110.116 -177.013 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 29.7 mt-30 -130.86 155.84 46.04 Favored 'General case' 0 CA--C 1.512 -0.488 0 N-CA-C 107.251 -1.388 . . . . 0.0 107.251 -179.132 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 13.5 mt -111.97 148.6 39.35 Favored Pre-proline 0 C--N 1.322 -0.616 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 179.029 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -71.5 164.52 35.45 Favored 'Trans proline' 0 C--N 1.346 0.403 0 O-C-N 122.278 0.62 . . . . 0.0 112.814 -179.037 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 65.1 tt0 -55.12 132.51 47.59 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.422 -179.649 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 96.57 -16.48 60.95 Favored Glycine 0 C--O 1.227 -0.32 0 CA-C-N 116.039 -0.528 . . . . 0.0 112.945 -179.002 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 6.1 m -107.59 126.77 52.96 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 117.907 0.853 . . . . 0.0 110.559 178.329 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 14.8 p -117.0 148.14 41.72 Favored 'General case' 0 CA--C 1.509 -0.605 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.534 -179.454 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 82.7 mt -68.37 152.37 96.62 Favored Pre-proline 0 C--N 1.321 -0.636 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 178.036 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -76.83 173.01 15.16 Favored 'Trans proline' 0 N--CA 1.462 -0.342 0 C-N-CA 117.87 -0.953 . . . . 0.0 110.43 177.989 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 84.4 tttt -57.27 128.42 36.9 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 113.485 0.92 . . . . 0.0 113.485 -174.12 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 95.12 -6.02 68.74 Favored Glycine 0 CA--C 1.518 0.227 0 N-CA-C 115.854 1.101 . . . . 0.0 115.854 176.15 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.452 ' CZ ' ' HB2' ' A' ' 18' ' ' GLN . 4.6 m-85 -92.38 147.09 23.18 Favored 'General case' 0 N--CA 1.437 -1.092 0 CA-C-O 122.962 1.363 . . . . 0.0 114.004 -178.194 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 48.5 p90 -146.76 163.51 35.76 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 112.29 -2.232 . . . . 0.0 107.274 172.94 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -105.31 143.69 33.12 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 112.762 0.653 . . . . 0.0 112.762 -177.398 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -76.78 147.95 36.96 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 175.368 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 95.02 -33.66 5.26 Favored Glycine 0 C--O 1.227 -0.333 0 C-N-CA 121.428 -0.415 . . . . 0.0 113.964 178.184 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.323 -0.548 0 CA-C-O 121.201 0.524 . . . . 0.0 111.658 177.113 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -0.898 0 CA-C-O 121.871 0.843 . . . . 0.0 112.296 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -61.8 143.65 55.98 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 114.767 -1.106 . . . . 0.0 110.287 177.785 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 21.1 m95 -69.38 -23.64 63.77 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 114.864 1.431 . . . . 0.0 114.864 -178.514 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 86.2 m-85 -121.52 161.07 22.95 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.186 0.517 . . . . 0.0 112.384 -172.747 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 74.6 p -70.31 161.58 30.12 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 177.013 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -74.83 153.79 38.57 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.902 0.858 . . . . 0.0 113.191 -175.995 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 22.6 mt -90.94 148.79 22.2 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 102.497 -3.149 . . . . 0.0 102.497 168.171 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 51.9 m -123.85 139.59 53.82 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 179.893 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.449 ' HB2' ' CZ ' ' A' ' 131' ' ' PHE . 4.3 tp60 -110.41 138.98 46.08 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-O 121.527 0.679 . . . . 0.0 112.298 -178.531 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 73.0 t60 -134.14 99.44 4.41 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 103.391 -2.818 . . . . 0.0 103.391 169.773 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 173.13 -165.97 38.34 Favored Glycine 0 C--O 1.225 -0.452 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 -176.055 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 37.9 mtmm -102.18 -25.09 13.83 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 113.956 1.095 . . . . 0.0 113.956 -178.221 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -89.21 162.1 16.08 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.056 -179.154 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -77.62 -62.95 1.5 Allowed 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.203 -176.916 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 34.6 tp 172.99 142.66 0.04 OUTLIER 'General case' 0 N--CA 1.482 1.133 0 N-CA-C 105.545 -2.02 . . . . 0.0 105.545 176.409 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 12.0 tmtt? -154.95 125.45 6.89 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 175.459 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -106.81 152.46 40.87 Favored Pre-proline 0 C--O 1.242 0.676 0 CA-C-O 120.457 0.17 . . . . 0.0 110.711 177.842 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -68.71 161.48 45.17 Favored 'Trans proline' 0 C--N 1.352 0.724 0 CA-C-O 121.226 0.427 . . . . 0.0 112.799 178.455 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 71.6 ttt180 -69.86 132.37 45.91 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 122.182 -0.324 . . . . 0.0 111.361 -175.846 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 79.35 13.6 82.53 Favored Glycine 0 C--O 1.222 -0.612 0 N-CA-C 111.697 -0.561 . . . . 0.0 111.697 179.254 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 31.0 mt-30 -148.23 171.74 15.45 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.18 -1.045 . . . . 0.0 108.18 -175.327 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 107.71 -10.22 38.11 Favored Glycine 0 CA--C 1.501 -0.786 0 CA-C-N 116.159 -0.473 . . . . 0.0 112.803 175.851 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.408 HG11 ' HB3' ' A' ' 43' ' ' GLN . 57.4 t -74.37 130.89 81.29 Favored Pre-proline 0 C--N 1.32 -0.685 0 N-CA-C 106.437 -1.69 . . . . 0.0 106.437 176.739 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -71.62 172.84 13.56 Favored 'Trans proline' 0 C--O 1.221 -0.34 0 O-C-N 122.179 0.568 . . . . 0.0 112.505 177.658 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 64.8 mt -75.85 106.3 5.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 122.228 1.013 . . . . 0.0 110.341 -179.111 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.54 ' HB2' HE22 ' A' ' 43' ' ' GLN . 38.8 m-20 -97.67 77.89 2.59 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 114.184 -1.371 . . . . 0.0 108.407 -179.425 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 80.7 p -63.88 -25.56 68.21 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 115.289 1.588 . . . . 0.0 115.289 -174.677 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -116.19 32.23 6.24 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 -176.369 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 5.9 m -133.06 166.87 21.42 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.678 0.275 . . . . 0.0 111.356 -178.903 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 25.0 m -77.57 155.92 81.0 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-N 116.583 -0.281 . . . . 0.0 111.657 -177.527 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -68.95 -20.91 38.08 Favored 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 116.804 -1.664 . . . . 0.0 114.378 -179.809 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.408 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 1.9 p-10 -76.95 -23.19 52.39 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 121.434 -0.791 . . . . 0.0 110.978 177.203 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -76.69 -13.08 60.07 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 114.715 1.376 . . . . 0.0 114.715 -170.924 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.54 HE22 ' HB2' ' A' ' 35' ' ' ASN . 94.8 mm-40 -55.01 -28.15 49.78 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 113.934 1.086 . . . . 0.0 113.934 -175.025 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 13.6 tt -64.63 135.82 27.51 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.784 0 CA-C-O 122.316 1.055 . . . . 0.0 111.981 178.643 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 179.36 -155.91 17.06 Favored Glycine 0 N--CA 1.45 -0.432 0 N-CA-C 110.755 -0.938 . . . . 0.0 110.755 -177.54 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 33.2 p90 -155.1 168.34 27.35 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.882 0.341 . . . . 0.0 110.554 179.826 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 29.1 m-85 -112.79 141.2 46.87 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 175.345 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 73.7 ttt-85 -116.77 125.04 51.05 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.661 -0.7 . . . . 0.0 112.675 -177.969 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 50.4 ttp85 -69.15 141.05 54.71 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 121.084 0.468 . . . . 0.0 111.092 177.518 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -152.05 157.54 41.8 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 179.104 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 68.1 p -129.43 166.29 19.87 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 104.058 -2.571 . . . . 0.0 104.058 172.571 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 21.5 tpt180 -96.09 118.96 33.72 Favored 'General case' 0 C--O 1.218 -0.584 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 178.667 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 6.7 tmm_? -139.59 139.1 36.7 Favored 'General case' 0 CA--C 1.502 -0.88 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 -178.951 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -137.29 -179.6 2.93 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 114.802 -1.09 . . . . 0.0 108.245 -175.982 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 13.1 tpp85 -129.14 125.14 36.42 Favored 'General case' 0 C--O 1.221 -0.431 0 N-CA-C 105.02 -2.215 . . . . 0.0 105.02 174.339 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -156.02 144.03 10.43 Favored Glycine 0 C--O 1.224 -0.489 0 N-CA-C 107.524 -2.23 . . . . 0.0 107.524 177.325 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -65.87 -60.65 6.28 Favored Glycine 0 C--O 1.227 -0.319 0 CA-C-N 117.883 0.842 . . . . 0.0 112.391 -177.958 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -107.34 8.39 29.69 Favored 'General case' 0 C--O 1.215 -0.744 0 CA-C-O 121.967 0.889 . . . . 0.0 110.838 178.715 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -95.95 -11.59 54.49 Favored Glycine 0 CA--C 1.504 -0.653 0 N-CA-C 105.542 -3.023 . . . . 0.0 105.542 179.318 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 53.7 mmtt 52.93 -161.59 0.11 Allowed 'General case' 0 N--CA 1.442 -0.846 0 CA-C-N 112.95 -1.625 . . . . 0.0 111.723 176.79 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 70.1 mtp -90.43 -179.02 5.49 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 114.516 -1.22 . . . . 0.0 109.865 176.875 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 18.5 mmtm -134.8 -69.53 0.51 Allowed 'General case' 0 C--O 1.211 -0.941 0 CA-C-O 120.897 0.38 . . . . 0.0 110.503 179.497 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.7 t0 52.1 51.41 16.44 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 114.318 -1.31 . . . . 0.0 111.923 178.918 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -61.97 162.59 8.92 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 114.116 -1.402 . . . . 0.0 111.969 -179.687 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -45.76 146.18 2.01 Favored Pre-proline 0 C--O 1.25 1.08 0 CA-C-N 115.047 -0.979 . . . . 0.0 113.495 -177.335 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -61.86 142.54 93.73 Favored 'Trans proline' 0 C--N 1.349 0.601 0 CA-C-O 122.768 1.07 . . . . 0.0 114.209 -174.895 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 22.6 mtt85 -128.95 155.77 44.8 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-N 113.2 -1.818 . . . . 0.0 108.054 -178.629 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 66.5 m95 -127.8 131.63 49.57 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 179.711 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 70.9 m-85 -111.41 148.23 33.52 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 107.289 -1.375 . . . . 0.0 107.289 179.064 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 68.1 t80 -95.79 131.35 42.18 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 -177.778 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -134.36 146.52 50.0 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 -178.263 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -83.34 159.51 21.85 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 113.016 0.747 . . . . 0.0 113.016 -174.956 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -55.53 132.91 49.74 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.391 179.489 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 72.56 33.96 60.5 Favored Glycine 0 C--O 1.221 -0.696 0 N-CA-C 115.469 0.947 . . . . 0.0 115.469 176.629 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 9.2 p . . . . . 0 C--N 1.325 -0.468 0 N-CA-C 108.226 -1.028 . . . . 0.0 108.226 177.818 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 21.3 mt . . . . . 0 C--O 1.238 0.468 0 N-CA-C 114.273 1.212 . . . . 0.0 114.273 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -78.5 167.19 23.12 Favored 'Trans proline' 0 N--CA 1.461 -0.436 0 N-CA-C 108.439 -1.408 . . . . 0.0 108.439 170.895 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.43 ' CE1' ' HB3' ' A' ' 92' ' ' TRP . 77.9 t80 -61.24 132.47 53.74 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 120.357 -0.537 . . . . 0.0 110.254 179.979 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 90.43 -4.9 82.71 Favored Glycine 0 CA--C 1.518 0.276 0 N-CA-C 115.065 0.786 . . . . 0.0 115.065 178.03 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -65.38 128.09 34.47 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 118.463 1.132 . . . . 0.0 111.472 179.407 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 45.9 t-20 -78.05 128.01 33.2 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.322 -176.576 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 16.7 ttmm -156.08 152.09 27.57 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 179.54 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -62.73 132.76 53.34 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.744 0.307 . . . . 0.0 110.441 179.447 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 68.86 24.41 75.64 Favored Glycine 0 N--CA 1.449 -0.44 0 CA-C-O 119.477 -0.624 . . . . 0.0 113.734 178.033 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 38.6 mm -129.32 128.51 66.57 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.304 0 CA-C-N 117.362 0.581 . . . . 0.0 110.077 179.866 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.1 pt -134.56 123.71 42.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.573 176.036 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . 0.43 ' HB3' ' CE1' ' A' ' 83' ' ' TYR . 90.0 m95 -89.37 139.42 30.53 Favored 'General case' 0 C--N 1.321 -0.671 0 O-C-N 121.908 -0.495 . . . . 0.0 111.617 -176.933 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 17.8 m -135.09 153.77 34.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 179.903 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -162.03 166.56 25.77 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 105.812 -1.921 . . . . 0.0 105.812 -178.63 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 13.5 t -130.41 169.29 15.69 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 104.628 -2.36 . . . . 0.0 104.628 176.137 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -66.22 135.07 53.97 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.225 0.536 . . . . 0.0 110.218 -178.601 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 93.81 -12.73 68.86 Favored Glycine 0 CA--C 1.517 0.195 0 CA-C-N 115.982 -0.554 . . . . 0.0 113.998 178.395 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.408 ' HA ' ' HA ' ' A' ' 41' ' ' ASP . . . -68.16 135.97 52.92 Favored 'General case' 0 CA--C 1.542 0.667 0 O-C-N 122.33 -0.512 . . . . 0.0 110.133 179.088 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 32.4 mt -89.34 130.31 35.73 Favored 'General case' 0 CA--C 1.507 -0.681 0 N-CA-C 113.416 0.895 . . . . 0.0 113.416 -177.145 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 53.5 t30 -81.17 73.8 8.2 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 114.526 -1.215 . . . . 0.0 110.564 -178.718 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 1.5 t -142.97 153.83 61.12 Favored Pre-proline 0 C--N 1.321 -0.631 0 N-CA-C 106.427 -1.694 . . . . 0.0 106.427 179.723 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -67.65 147.74 76.63 Favored 'Trans proline' 0 CA--C 1.528 0.213 0 C-N-CA 117.824 -0.984 . . . . 0.0 113.089 176.018 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 6.6 ptpt -145.73 56.95 1.22 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 122.722 1.248 . . . . 0.0 110.593 179.066 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -58.54 -31.05 67.58 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.149 -1.387 . . . . 0.0 111.9 179.304 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 18.3 p80 -62.62 -7.41 4.72 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 113.944 1.09 . . . . 0.0 113.944 -179.34 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 29.1 mt -96.24 -45.29 13.02 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.53 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 177.148 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -69.92 14.66 1.1 Allowed Glycine 0 CA--C 1.524 0.609 0 N-CA-C 116.436 1.334 . . . . 0.0 116.436 -177.798 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 15.2 t -95.77 26.51 3.99 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.328 0.651 . . . . 0.0 112.111 -178.841 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 67.7 ttp85 -59.29 125.94 25.65 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 178.429 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -101.26 128.02 30.34 Favored Pre-proline 0 C--N 1.322 -0.615 0 N-CA-C 106.671 -1.603 . . . . 0.0 106.671 -178.28 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -68.53 -20.3 41.48 Favored 'Trans proline' 0 C--O 1.219 -0.468 0 N-CA-C 114.605 0.964 . . . . 0.0 114.605 -176.81 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -74.17 -24.62 59.41 Favored 'General case' 0 C--O 1.221 -0.428 0 CA-C-O 120.861 0.362 . . . . 0.0 110.619 178.269 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 84.7 m-20 -100.94 -24.32 14.37 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 -175.714 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 33.0 t30 -158.23 149.74 21.27 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 113.364 0.876 . . . . 0.0 113.364 -177.634 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -91.61 150.52 21.13 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-O 121.428 0.632 . . . . 0.0 111.787 179.512 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -69.96 146.62 50.99 Favored 'General case' 0 C--N 1.323 -0.543 0 CA-C-O 121.261 0.553 . . . . 0.0 111.451 178.996 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 15.6 mt -86.68 136.45 22.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.828 -178.714 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 70.0 t -62.94 120.89 10.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 N-CA-C 106.179 -1.785 . . . . 0.0 106.179 175.109 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 6.0 tt -68.47 134.43 50.11 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -175.58 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 50.8 mt-30 -135.19 161.91 34.03 Favored 'General case' 0 CA--C 1.513 -0.452 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 178.328 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.44 HD13 HG22 ' A' ' 125' ' ' THR . 13.3 mt -114.63 146.3 35.68 Favored Pre-proline 0 C--N 1.323 -0.58 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 175.646 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -71.71 165.91 31.07 Favored 'Trans proline' 0 C--N 1.345 0.384 0 O-C-N 122.243 0.601 . . . . 0.0 113.619 -177.64 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 41.3 tt0 -53.26 128.83 29.53 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.238 -179.421 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 97.68 -17.32 59.08 Favored Glycine 0 C--O 1.227 -0.299 0 CA-C-N 115.886 -0.597 . . . . 0.0 113.058 -179.279 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.44 HG22 HD13 ' A' ' 121' ' ' LEU . 5.8 m -108.73 125.96 52.48 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 117.721 0.76 . . . . 0.0 109.263 178.083 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 5.8 p -124.8 148.23 48.27 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 -179.176 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 81.6 mt -69.56 155.04 94.24 Favored Pre-proline 0 C--N 1.325 -0.493 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 179.876 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_endo -74.44 169.06 23.35 Favored 'Trans proline' 0 N--CA 1.463 -0.299 0 C-N-CA 118.235 -0.71 . . . . 0.0 110.846 178.026 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -61.73 130.42 45.72 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.269 -176.191 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 95.2 -5.7 68.32 Favored Glycine 0 CA--C 1.518 0.224 0 CA-C-N 115.762 -0.653 . . . . 0.0 114.584 179.103 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.449 ' CZ ' ' HB2' ' A' ' 18' ' ' GLN . 1.2 m-85 -101.2 142.49 32.55 Favored 'General case' 0 N--CA 1.445 -0.725 0 CA-C-O 121.712 0.767 . . . . 0.0 110.678 179.441 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 45.6 p90 -145.22 164.19 32.1 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 114.478 -1.237 . . . . 0.0 108.019 175.194 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -100.77 145.78 28.08 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.094 0.474 . . . . 0.0 110.708 -177.949 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -70.58 129.01 38.07 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 -179.86 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 91.55 -32.02 5.5 Favored Glycine 0 CA--C 1.52 0.357 0 CA-C-N 116.159 -0.473 . . . . 0.0 113.967 -179.965 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 34.3 t . . . . . 0 C--N 1.323 -0.547 0 CA-C-N 117.577 0.688 . . . . 0.0 110.177 -178.949 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.679 0 CA-C-O 121.57 0.7 . . . . 0.0 110.499 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -57.48 138.4 55.15 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.018 -0.992 . . . . 0.0 109.65 177.245 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 38.1 m95 -67.39 -21.83 65.58 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 114.127 1.158 . . . . 0.0 114.127 -178.437 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -121.46 159.31 26.52 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.435 0.636 . . . . 0.0 112.433 -174.09 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 56.7 p -67.93 165.07 18.49 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.457 -1.247 . . . . 0.0 108.318 178.185 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.431 ' HB2' ' CE2' ' A' ' 69' ' ' TYR . . . -83.37 148.6 27.22 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 113.716 1.006 . . . . 0.0 113.716 -175.006 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 85.0 mt -84.95 148.88 25.99 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 102.627 -3.101 . . . . 0.0 102.627 166.975 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 81.7 m -106.85 125.04 50.49 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 178.366 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -88.95 105.64 17.9 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 179.09 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 73.5 t60 -113.48 97.52 6.51 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 104.18 -2.526 . . . . 0.0 104.18 173.107 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 148.99 -168.01 29.43 Favored Glycine 0 N--CA 1.45 -0.41 0 N-CA-C 108.828 -1.709 . . . . 0.0 108.828 -176.128 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -104.4 -22.3 13.35 Favored 'General case' 0 C--O 1.215 -0.738 0 N-CA-C 115.369 1.618 . . . . 0.0 115.369 -176.487 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -71.12 146.36 49.25 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.6 0.714 . . . . 0.0 112.638 -176.357 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -95.58 33.29 1.65 Allowed 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 122.691 1.234 . . . . 0.0 111.918 -176.605 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 31.4 tp 62.52 146.29 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.99 0 CA-C-N 112.791 -2.004 . . . . 0.0 115.305 176.219 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 51.9 tptt -158.16 140.39 14.23 Favored 'General case' 0 CA--C 1.514 -0.433 0 O-C-N 121.118 -0.989 . . . . 0.0 109.869 174.58 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 -125.51 151.36 70.16 Favored Pre-proline 0 C--O 1.241 0.655 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 175.411 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -74.66 165.68 31.02 Favored 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 120.674 0.916 . . . . 0.0 113.863 -179.906 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 16.7 tpt180 -65.07 133.97 52.78 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.885 -178.211 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 83.96 2.32 89.59 Favored Glycine 0 C--O 1.227 -0.293 0 CA-C-O 121.305 0.392 . . . . 0.0 112.351 177.959 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 30.2 mt-30 -141.29 171.14 14.47 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 123.674 0.79 . . . . 0.0 109.803 -173.74 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 105.1 -19.58 40.2 Favored Glycine 0 CA--C 1.497 -1.062 0 N-CA-C 111.254 -0.738 . . . . 0.0 111.254 175.987 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 84.8 t -65.74 127.81 93.34 Favored Pre-proline 0 C--N 1.317 -0.818 0 N-CA-C 105.813 -1.921 . . . . 0.0 105.813 176.311 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -71.62 172.96 13.31 Favored 'Trans proline' 0 N--CA 1.46 -0.485 0 O-C-N 122.292 0.627 . . . . 0.0 111.295 178.141 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 78.4 mt -74.29 108.97 6.31 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 -179.324 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 30.4 m-20 -110.11 74.43 0.88 Allowed 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.648 -1.16 . . . . 0.0 110.454 -175.455 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 65.8 p -66.08 -23.0 66.44 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 115.588 1.699 . . . . 0.0 115.588 -174.298 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -110.76 31.3 6.1 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 112.259 0.466 . . . . 0.0 112.259 -176.474 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 73.8 p -132.9 167.56 20.0 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 178.988 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 44.6 m -84.26 162.45 51.41 Favored Pre-proline 0 C--N 1.321 -0.672 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.417 -178.59 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -67.64 -21.79 45.01 Favored 'Trans proline' 0 C--N 1.351 0.69 0 C-N-CA 116.526 -1.849 . . . . 0.0 114.668 -178.836 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.42 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 6.3 p-10 -75.19 -18.15 60.22 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 121.73 -0.606 . . . . 0.0 109.858 177.785 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -90.42 2.11 55.96 Favored 'General case' 0 C--O 1.219 -0.525 0 N-CA-C 114.32 1.23 . . . . 0.0 114.32 -175.016 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 93.0 mm-40 -65.26 -23.76 67.14 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-O 121.624 0.726 . . . . 0.0 109.99 176.789 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.499 ' HB ' ' HB1' ' A' ' 98' ' ' ALA . 9.0 tt -66.59 141.09 18.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 122.044 0.926 . . . . 0.0 111.083 177.964 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 175.18 -160.98 30.04 Favored Glycine 0 CA--C 1.504 -0.626 0 C-N-CA 120.2 -1.0 . . . . 0.0 110.636 179.364 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 44.3 p90 -155.1 170.73 21.11 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 178.832 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -112.8 140.24 47.76 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 106.522 -1.658 . . . . 0.0 106.522 175.213 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 63.9 ttt180 -115.49 121.97 44.3 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 123.831 0.852 . . . . 0.0 112.152 -175.59 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 32.3 ttp85 -68.65 138.66 55.18 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 176.977 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -143.64 138.73 29.19 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 123.217 0.607 . . . . 0.0 109.597 179.954 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.8 t -161.38 155.08 21.88 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 105.076 -2.194 . . . . 0.0 105.076 176.721 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 11.6 tpt180 -141.42 123.81 15.77 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 107.243 -1.392 . . . . 0.0 107.243 176.495 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 7.7 tmm_? -132.77 129.7 38.95 Favored 'General case' 0 CA--C 1.49 -1.341 0 CA-C-O 121.983 0.897 . . . . 0.0 110.221 179.931 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -139.68 176.82 5.17 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 N-CA-C 104.853 -2.277 . . . . 0.0 104.853 -178.75 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 30.2 ttt85 -127.42 115.91 19.65 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 105.847 -1.909 . . . . 0.0 105.847 175.172 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -82.35 156.83 35.92 Favored Glycine 0 N--CA 1.448 -0.502 0 N-CA-C 108.092 -2.003 . . . . 0.0 108.092 177.802 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -75.45 -31.66 56.39 Favored Glycine 0 C--O 1.215 -1.055 0 N-CA-C 108.808 -1.717 . . . . 0.0 108.808 178.964 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -71.76 -20.69 61.85 Favored 'General case' 0 C--O 1.217 -0.627 0 CA-C-N 114.17 -1.015 . . . . 0.0 109.718 178.211 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 115.65 -9.89 19.17 Favored Glycine 0 CA--C 1.506 -0.48 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.869 173.841 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 5.0 pttt -79.13 154.06 29.62 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 122.085 0.945 . . . . 0.0 113.354 -176.822 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 94.4 mtp -122.48 -160.24 0.87 Allowed 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 113.89 -1.504 . . . . 0.0 110.053 -176.865 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 18.7 mmtt -118.75 -70.0 0.82 Allowed 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 122.199 0.2 . . . . 0.0 111.103 -179.397 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -141.13 160.43 40.12 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 177.269 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -121.17 -28.23 4.76 Favored 'General case' 0 N--CA 1.469 0.5 0 O-C-N 123.892 0.745 . . . . 0.0 110.792 -177.664 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -110.03 130.83 22.4 Favored Pre-proline 0 C--O 1.238 0.469 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 -179.22 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -65.23 162.61 32.46 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 117.386 -1.276 . . . . 0.0 113.439 179.492 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 29.2 mtt-85 -123.31 156.74 34.72 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 178.654 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 54.6 m95 -129.78 125.14 35.08 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 177.215 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.431 ' CE2' ' HB2' ' A' ' 15' ' ' ALA . 88.4 m-85 -112.22 147.5 36.08 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 -178.582 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 79.2 t80 -91.0 136.9 32.76 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 -179.335 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -140.53 140.68 35.28 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.338 -0.847 . . . . 0.0 109.364 -173.93 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 34.7 m-85 -74.44 159.53 32.17 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.173 0.511 . . . . 0.0 111.373 -179.605 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -54.74 124.95 18.06 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.76 -0.654 . . . . 0.0 112.105 -177.994 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 81.18 16.73 73.63 Favored Glycine 0 C--O 1.221 -0.7 0 N-CA-C 117.012 1.565 . . . . 0.0 117.012 176.868 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 19.4 p . . . . . 0 N--CA 1.47 0.536 0 CA-C-N 119.173 1.486 . . . . 0.0 111.704 -179.88 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 16.9 mt . . . . . 0 N--CA 1.449 -0.514 0 N-CA-C 115.486 1.662 . . . . 0.0 115.486 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -78.51 163.16 27.19 Favored 'Trans proline' 0 N--CA 1.461 -0.406 0 N-CA-C 107.698 -1.693 . . . . 0.0 107.698 168.269 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 55.0 t80 -61.62 133.61 55.84 Favored 'General case' 0 C--N 1.321 -0.668 0 C-N-CA 120.466 -0.493 . . . . 0.0 110.372 -178.305 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 90.7 -7.84 80.69 Favored Glycine 0 CA--C 1.517 0.206 0 CA-C-O 119.548 -0.584 . . . . 0.0 114.346 178.841 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -65.48 130.81 44.62 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 118.386 1.093 . . . . 0.0 111.03 179.098 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 59.1 t30 -79.71 129.21 34.28 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.381 -179.421 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 30.7 ttmt -156.07 152.96 28.66 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 106.571 -1.641 . . . . 0.0 106.571 179.451 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -60.95 127.47 31.71 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 -179.645 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 70.22 28.65 71.19 Favored Glycine 0 N--CA 1.449 -0.485 0 CA-C-O 119.382 -0.677 . . . . 0.0 114.677 176.593 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 43.5 mm -126.69 122.43 60.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 117.601 0.7 . . . . 0.0 110.842 179.406 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.1 pt -127.49 116.41 43.55 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 CA-C-O 121.762 0.792 . . . . 0.0 111.828 176.612 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 95.2 m95 -81.68 137.84 35.36 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 113.223 0.823 . . . . 0.0 113.223 -177.597 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 18.2 m -137.2 152.43 27.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 178.305 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -163.01 165.99 24.25 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 104.754 -2.313 . . . . 0.0 104.754 -179.999 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 6.5 t -140.2 -178.94 5.7 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 105.938 -1.875 . . . . 0.0 105.938 177.583 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -67.63 136.32 54.22 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.338 0.589 . . . . 0.0 110.614 -178.675 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 96.65 -13.69 65.04 Favored Glycine 0 N--CA 1.459 0.215 0 CA-C-N 115.668 -0.696 . . . . 0.0 112.967 178.48 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.499 ' HB1' ' HB ' ' A' ' 44' ' ' ILE . . . -75.59 140.02 42.42 Favored 'General case' 0 C--N 1.322 -0.608 0 O-C-N 122.716 -0.285 . . . . 0.0 110.573 179.997 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 36.4 mt -96.53 139.89 31.96 Favored 'General case' 0 C--O 1.218 -0.555 0 CA-C-O 121.259 0.552 . . . . 0.0 111.69 -179.373 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 58.9 t30 -86.16 68.77 10.38 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.711 179.473 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 1.1 t -140.67 150.77 61.33 Favored Pre-proline 0 C--N 1.325 -0.489 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 179.12 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -67.74 149.57 78.76 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 118.345 -0.636 . . . . 0.0 113.544 176.908 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.64 47.12 1.19 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 122.732 1.253 . . . . 0.0 110.839 179.061 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 16.0 p-10 -47.73 -39.34 17.47 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 113.44 -1.709 . . . . 0.0 113.34 178.752 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 50.1 p-80 -60.74 -17.1 46.53 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 115.336 1.606 . . . . 0.0 115.336 -177.814 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 68.9 mt -81.55 -29.16 10.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 178.896 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -72.06 14.65 2.12 Favored Glycine 0 CA--C 1.522 0.525 0 N-CA-C 115.771 1.068 . . . . 0.0 115.771 -177.622 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 15.2 t -83.29 28.16 0.55 Allowed 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 123.54 0.736 . . . . 0.0 112.981 -177.711 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 72.9 ttp85 -61.61 116.38 4.7 Favored 'General case' 0 N--CA 1.469 0.514 0 O-C-N 121.221 -0.924 . . . . 0.0 108.647 178.443 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 14.5 m-20 -82.88 118.39 71.61 Favored Pre-proline 0 C--N 1.323 -0.554 0 N-CA-C 105.351 -2.092 . . . . 0.0 105.351 179.279 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -71.66 -13.61 29.88 Favored 'Trans proline' 0 C--O 1.219 -0.46 0 C-N-CA 117.312 -1.326 . . . . 0.0 113.891 -176.418 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -81.25 -24.91 37.01 Favored 'General case' 0 C--O 1.22 -0.465 0 CA-C-O 120.892 0.377 . . . . 0.0 110.241 178.252 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 81.2 m-20 -102.86 -24.78 13.67 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 113.521 0.934 . . . . 0.0 113.521 -175.315 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 30.7 t30 -145.97 145.42 30.64 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 -178.349 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -89.23 149.68 22.99 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.368 -179.927 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -70.24 148.31 48.72 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.305 0.574 . . . . 0.0 110.61 178.129 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 8.0 mt -83.43 139.33 17.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 -179.178 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 89.7 t -62.55 121.43 11.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 176.069 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 5.5 tt -68.07 126.92 31.01 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.244 0.545 . . . . 0.0 109.996 -177.798 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 30.8 mt-30 -132.96 154.23 50.67 Favored 'General case' 0 CA--C 1.509 -0.628 0 N-CA-C 106.656 -1.609 . . . . 0.0 106.656 -179.85 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 12.8 mt -110.73 147.45 36.48 Favored Pre-proline 0 C--N 1.321 -0.657 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 176.779 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -72.96 162.18 41.67 Favored 'Trans proline' 0 C--O 1.236 0.376 0 O-C-N 122.265 0.613 . . . . 0.0 112.491 -179.718 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 56.8 tt0 -55.15 131.27 44.82 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 -179.797 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 104.27 -22.8 33.65 Favored Glycine 0 C--O 1.226 -0.359 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.842 -178.267 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 3.8 m -108.72 126.98 53.59 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 117.641 0.72 . . . . 0.0 109.791 177.778 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 15.5 p -121.64 148.41 44.6 Favored 'General case' 0 CA--C 1.508 -0.635 0 CA-C-O 121.029 0.442 . . . . 0.0 110.25 179.912 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 83.0 mt -71.79 152.92 93.31 Favored Pre-proline 0 C--N 1.321 -0.634 0 N-CA-C 107.305 -1.369 . . . . 0.0 107.305 178.011 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -77.63 172.58 15.54 Favored 'Trans proline' 0 C--O 1.237 0.439 0 CA-C-O 121.384 0.493 . . . . 0.0 111.252 179.022 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 65.2 tttm -57.61 127.51 32.4 Favored 'General case' 0 C--O 1.219 -0.519 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.778 -178.047 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 91.82 7.84 64.15 Favored Glycine 0 C--O 1.226 -0.406 0 N-CA-C 115.625 1.01 . . . . 0.0 115.625 177.678 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 34.5 m-85 -118.86 136.87 53.81 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 118.064 0.932 . . . . 0.0 109.927 177.774 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 55.2 p90 -144.93 161.8 38.46 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 176.683 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -99.45 146.27 26.52 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.617 0.722 . . . . 0.0 112.893 -175.665 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -75.39 132.02 40.61 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 178.658 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 88.6 -6.85 83.18 Favored Glycine 0 C--O 1.225 -0.412 0 C-N-CA 121.323 -0.465 . . . . 0.0 112.959 -179.032 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 31.6 t . . . . . 0 C--N 1.328 -0.363 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 178.848 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.245 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 34.0 p -64.21 145.65 55.63 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 178.351 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 13.1 m95 -64.73 -24.35 67.54 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.955 0.407 . . . . 0.0 112.086 179.5 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -121.38 163.93 17.91 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.578 -0.737 . . . . 0.0 112.416 -172.269 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 47.0 p -70.43 165.96 21.4 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 177.093 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -79.34 146.56 32.83 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.715 0.769 . . . . 0.0 112.472 -176.507 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.407 HD23 ' HA ' ' A' ' 16' ' ' LEU . 12.1 mt -83.32 146.73 28.35 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 102.931 -2.989 . . . . 0.0 102.931 169.151 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 29.9 m -129.78 138.75 51.23 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 -178.686 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.438 ' HB2' ' CZ ' ' A' ' 131' ' ' PHE . 4.0 tp60 -106.67 136.91 45.66 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.837 0.68 . . . . 0.0 112.837 -176.93 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 5.7 t60 -130.75 94.77 3.69 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 103.014 -2.958 . . . . 0.0 103.014 168.612 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 173.33 -157.33 26.01 Favored Glycine 0 C--O 1.223 -0.541 0 N-CA-C 110.957 -0.857 . . . . 0.0 110.957 -174.302 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 29.8 mtpp -112.32 -24.86 9.55 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 115.321 1.601 . . . . 0.0 115.321 -177.436 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 88.3 mt-10 -80.5 158.29 25.89 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 177.759 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -79.91 -62.8 1.57 Allowed 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 177.667 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 44.3 tp -179.25 141.09 0.16 Allowed 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 172.56 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 23.8 tptm -156.07 140.45 16.7 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 174.188 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 15.3 m-85 -125.02 152.1 69.92 Favored Pre-proline 0 C--O 1.242 0.68 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 175.817 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -72.69 160.41 46.43 Favored 'Trans proline' 0 CA--C 1.54 0.778 0 C-N-CA 120.658 0.905 . . . . 0.0 112.859 178.292 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.02 131.91 47.32 Favored 'General case' 0 C--O 1.216 -0.665 0 O-C-N 122.172 -0.33 . . . . 0.0 110.813 -178.033 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 85.45 7.27 82.64 Favored Glycine 0 N--CA 1.46 0.292 0 C-N-CA 121.445 -0.407 . . . . 0.0 112.181 179.195 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.407 HE21 HG23 ' A' ' 125' ' ' THR . 16.9 mt-30 -145.95 170.53 16.42 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 123.19 0.596 . . . . 0.0 109.983 -174.991 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 105.41 -16.88 44.36 Favored Glycine 0 CA--C 1.501 -0.819 0 CA-C-N 116.1 -0.5 . . . . 0.0 113.139 174.881 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 93.9 t -65.78 129.08 94.24 Favored Pre-proline 0 C--N 1.32 -0.704 0 N-CA-C 106.52 -1.659 . . . . 0.0 106.52 176.988 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -73.27 170.77 19.08 Favored 'Trans proline' 0 C--O 1.219 -0.433 0 O-C-N 122.148 0.552 . . . . 0.0 111.052 177.764 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 86.1 mt -70.55 106.56 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-O 122.009 0.909 . . . . 0.0 108.693 -179.601 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -98.14 84.1 3.21 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 114.514 -1.221 . . . . 0.0 110.017 -176.915 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 77.3 p -68.3 -14.08 62.73 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.775 0.798 . . . . 0.0 112.48 -179.313 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 11.5 p30 -106.69 22.98 15.02 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 114.82 -1.082 . . . . 0.0 111.718 -177.776 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 19.0 m -141.15 150.97 43.48 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 113.745 1.016 . . . . 0.0 113.745 -176.424 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.1 m -72.28 166.88 37.38 Favored Pre-proline 0 C--N 1.326 -0.441 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 176.415 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -66.4 -25.62 48.65 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 114.792 -3.005 . . . . 0.0 114.112 -179.714 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.472 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 4.5 p-10 -78.66 -20.63 49.82 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.586 0.708 . . . . 0.0 110.891 177.546 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 -81.64 -6.68 59.24 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 -176.086 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 96.0 mm-40 -57.7 -26.81 62.26 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 114.124 1.157 . . . . 0.0 114.124 -178.481 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.423 ' HB ' ' HB1' ' A' ' 98' ' ' ALA . 8.5 tt -59.31 138.35 20.49 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.939 0 N-CA-C 113.872 1.064 . . . . 0.0 113.872 -178.367 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -178.34 -158.2 20.57 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.389 -179.376 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 36.4 p90 -154.95 168.14 27.97 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 179.427 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 29.1 m-85 -112.77 141.74 46.22 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 174.634 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 69.2 ttt-85 -115.14 124.15 50.75 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 123.423 0.689 . . . . 0.0 112.514 -178.353 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 50.0 ttt180 -64.64 136.33 56.87 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 122.784 0.434 . . . . 0.0 110.12 177.3 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -152.13 150.92 30.42 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.713 0.634 . . . . 0.0 112.713 -179.791 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 6.4 p -144.15 147.88 34.29 Favored 'General case' 0 C--O 1.238 0.494 0 N-CA-C 105.488 -2.041 . . . . 0.0 105.488 172.704 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 16.1 tpt180 -166.22 123.86 1.42 Allowed 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 177.698 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 7.8 tmm_? -94.35 124.03 38.12 Favored 'General case' 0 CA--C 1.485 -1.553 0 CA-C-O 122.375 1.083 . . . . 0.0 111.0 177.973 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -126.74 174.64 10.2 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.076 0 CA-C-N 112.841 -1.981 . . . . 0.0 106.596 176.273 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 78.6 ttt180 -122.94 121.44 36.16 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 105.46 -2.052 . . . . 0.0 105.46 175.289 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -90.42 157.64 25.86 Favored Glycine 0 N--CA 1.448 -0.511 0 N-CA-C 106.969 -2.452 . . . . 0.0 106.969 177.955 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -72.21 -34.27 61.33 Favored Glycine 0 C--O 1.217 -0.966 0 N-CA-C 107.588 -2.205 . . . . 0.0 107.588 178.141 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 30.8 t0 -93.62 14.82 17.79 Favored 'General case' 0 C--O 1.217 -0.642 0 CA-C-O 122.529 1.157 . . . . 0.0 109.497 178.409 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 83.66 -17.21 26.8 Favored Glycine 0 C--O 1.227 -0.295 0 N-CA-C 117.101 1.601 . . . . 0.0 117.101 172.794 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.74 125.96 22.14 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 114.026 1.121 . . . . 0.0 114.026 -176.853 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 78.5 mtp -104.24 -179.32 3.91 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 114.37 -1.286 . . . . 0.0 112.239 -177.971 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 10.5 mptt -131.85 -47.25 0.95 Allowed 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.893 0.877 . . . . 0.0 111.331 -179.913 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -66.3 -172.07 0.14 Allowed 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 113.158 -1.837 . . . . 0.0 114.405 -179.512 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 79.52 -54.43 0.41 Allowed 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 126.855 2.062 . . . . 0.0 109.14 -177.967 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 22.3 p -92.14 131.84 33.9 Favored Pre-proline 0 C--N 1.32 -0.712 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 174.965 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -70.48 149.64 62.58 Favored 'Trans proline' 0 C--O 1.24 0.615 0 C-N-CA 115.513 -2.524 . . . . 0.0 111.112 178.734 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.409 HH12 ' CD ' ' A' ' 134' ' ' GLU . 0.1 OUTLIER -123.78 158.96 30.54 Favored 'General case' 0 CA--C 1.504 -0.803 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.096 -176.75 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 65.9 m95 -133.47 128.08 34.65 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 177.163 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 43.4 m-85 -110.92 143.26 41.83 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 106.669 -1.604 . . . . 0.0 106.669 -178.796 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 92.1 t80 -94.72 135.09 36.61 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 -175.844 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -137.92 155.55 48.81 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 108.072 -1.085 . . . . 0.0 108.072 -177.747 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 80.9 m-85 -89.39 159.47 17.3 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 112.06 0.393 . . . . 0.0 112.06 -174.362 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -55.05 128.95 36.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.01 -177.958 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 68.13 39.18 88.62 Favored Glycine 0 C--O 1.217 -0.91 0 CA-C-O 119.201 -0.777 . . . . 0.0 114.822 175.672 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.325 -0.486 0 N-CA-C 106.408 -1.701 . . . . 0.0 106.408 177.719 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 17.5 mt . . . . . 0 N--CA 1.445 -0.72 0 N-CA-C 113.501 0.926 . . . . 0.0 113.501 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -78.29 166.61 24.21 Favored 'Trans proline' 0 N--CA 1.46 -0.471 0 C-N-CA 121.54 1.494 . . . . 0.0 108.323 170.655 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.402 ' CE1' ' HB3' ' A' ' 92' ' ' TRP . 70.6 t80 -61.74 131.16 48.98 Favored 'General case' 0 C--N 1.321 -0.63 0 C-N-CA 120.371 -0.532 . . . . 0.0 109.978 -179.978 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 92.34 -7.07 78.31 Favored Glycine 0 CA--C 1.52 0.354 0 N-CA-C 114.943 0.737 . . . . 0.0 114.943 178.093 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -64.19 129.51 40.27 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 118.433 1.117 . . . . 0.0 111.866 -179.991 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -75.53 130.15 38.39 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.492 -177.778 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 28.1 ttmt -156.17 151.75 27.04 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 105.58 -2.007 . . . . 0.0 105.58 177.43 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 31.1 t0 -66.2 133.62 51.01 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.017 0.436 . . . . 0.0 110.423 -177.89 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 69.03 25.6 75.3 Favored Glycine 0 N--CA 1.449 -0.442 0 CA-C-O 119.46 -0.633 . . . . 0.0 114.089 179.234 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 41.3 mm -127.15 128.75 70.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 117.504 0.652 . . . . 0.0 110.484 179.898 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.1 pt -131.52 122.48 50.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 CA-C-N 115.782 -0.644 . . . . 0.0 109.719 175.312 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . 0.402 ' HB3' ' CE1' ' A' ' 83' ' ' TYR . 94.0 m95 -88.35 138.75 31.16 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 -176.975 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 16.2 m -137.56 149.73 25.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 121.687 0.756 . . . . 0.0 109.635 178.806 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -158.5 166.6 31.77 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 102.684 -3.08 . . . . 0.0 102.684 -179.494 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 8.4 t -134.34 177.19 7.95 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 105.52 -2.03 . . . . 0.0 105.52 178.267 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 64.4 tt0 -67.46 134.46 51.41 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.142 0.496 . . . . 0.0 109.9 -178.547 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 96.01 -13.75 65.59 Favored Glycine 0 C--O 1.229 -0.19 0 CA-C-N 115.92 -0.582 . . . . 0.0 112.942 -179.804 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.472 ' HA ' ' HA ' ' A' ' 41' ' ' ASP . . . -73.42 138.17 45.06 Favored 'General case' 0 CA--C 1.54 0.575 0 O-C-N 122.498 -0.413 . . . . 0.0 110.288 178.964 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 31.7 mt -97.02 139.33 33.2 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 121.269 0.557 . . . . 0.0 112.398 -179.441 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -83.0 62.87 6.79 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.804 -178.872 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 1.2 t -131.98 152.89 81.04 Favored Pre-proline 0 C--N 1.324 -0.54 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 178.99 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -67.51 152.34 78.63 Favored 'Trans proline' 0 C--N 1.344 0.292 0 N-CA-C 114.489 0.919 . . . . 0.0 114.489 178.304 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 1.3 ptpt -151.87 59.07 0.86 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 122.879 1.324 . . . . 0.0 111.124 178.466 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 15.0 p-10 -56.33 -36.04 68.27 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 113.628 -1.624 . . . . 0.0 111.556 177.803 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 38.0 p-80 -60.58 -10.82 5.66 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 114.891 1.441 . . . . 0.0 114.891 -177.868 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 55.0 mt -92.36 -43.72 13.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 178.117 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -72.97 14.65 2.67 Favored Glycine 0 CA--C 1.523 0.541 0 N-CA-C 116.256 1.262 . . . . 0.0 116.256 -176.339 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 14.4 t -95.73 25.52 4.56 Favored 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 -177.382 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.401 ' HD2' HD22 ' A' ' 114' ' ' ASN . 62.4 ttp85 -55.62 129.98 41.21 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 179.629 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 6.5 m-20 -99.72 126.1 38.28 Favored Pre-proline 0 C--N 1.323 -0.57 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 -178.528 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -69.9 -17.88 36.69 Favored 'Trans proline' 0 C--O 1.219 -0.444 0 C-N-CA 118.041 -0.839 . . . . 0.0 113.465 -178.127 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -73.3 -28.67 62.23 Favored 'General case' 0 C--O 1.22 -0.463 0 CA-C-O 120.96 0.409 . . . . 0.0 110.681 178.239 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 76.1 m-20 -102.3 -24.72 13.85 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 -174.107 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . 0.401 HD22 ' HD2' ' A' ' 109' ' ' ARG . 31.9 t30 -153.2 149.51 28.06 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 113.176 0.806 . . . . 0.0 113.176 -178.209 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -89.15 148.21 23.78 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-O 121.382 0.61 . . . . 0.0 111.497 179.392 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -68.49 143.47 54.97 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.374 0.606 . . . . 0.0 110.968 178.808 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 19.4 mt -85.28 139.87 16.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 -179.164 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 91.5 t -63.3 123.31 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 N-CA-C 106.105 -1.813 . . . . 0.0 106.105 175.271 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 6.8 tt -66.0 130.32 42.84 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.151 0.5 . . . . 0.0 110.598 -176.705 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 32.7 mt-30 -132.61 159.81 38.46 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 106.892 -1.521 . . . . 0.0 106.892 -179.376 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 13.7 mt -113.59 147.85 38.46 Favored Pre-proline 0 C--N 1.322 -0.589 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 177.256 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -72.82 169.51 21.87 Favored 'Trans proline' 0 C--N 1.344 0.34 0 O-C-N 122.254 0.607 . . . . 0.0 113.356 -178.6 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 60.3 tt0 -54.7 131.76 44.2 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.715 -179.638 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 93.13 -16.76 59.76 Favored Glycine 0 C--O 1.227 -0.339 0 CA-C-O 119.654 -0.525 . . . . 0.0 114.168 179.767 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.407 HG23 HE21 ' A' ' 30' ' ' GLN . 15.1 m -106.36 127.78 53.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 118.396 1.098 . . . . 0.0 110.547 178.864 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 10.4 p -121.23 148.7 43.92 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.593 -178.82 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 79.0 mt -71.05 153.52 94.54 Favored Pre-proline 0 C--N 1.324 -0.534 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 178.937 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -75.09 170.34 20.61 Favored 'Trans proline' 0 C--O 1.236 0.398 0 N-CA-C 110.363 -0.668 . . . . 0.0 110.363 178.089 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 13.9 tmtt? -54.74 121.4 8.45 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 113.314 0.857 . . . . 0.0 113.314 -174.093 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 95.24 -6.01 68.43 Favored Glycine 0 C--N 1.328 0.106 0 N-CA-C 116.719 1.448 . . . . 0.0 116.719 174.684 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.438 ' CZ ' ' HB2' ' A' ' 18' ' ' GLN . 1.5 m-85 -87.51 145.69 26.13 Favored 'General case' 0 N--CA 1.436 -1.16 0 CA-C-O 122.192 0.996 . . . . 0.0 110.342 178.813 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 37.4 p90 -145.4 163.11 35.6 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 113.458 -1.701 . . . . 0.0 107.625 175.326 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -102.98 145.39 29.94 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.081 0.467 . . . . 0.0 110.659 -177.787 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.409 ' CD ' HH12 ' A' ' 67' ' ' ARG . 33.7 tt0 -73.56 132.28 42.65 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 107.081 -1.452 . . . . 0.0 107.081 178.303 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 92.92 -2.4 72.28 Favored Glycine 0 C--O 1.223 -0.539 0 N-CA-C 111.125 -0.79 . . . . 0.0 111.125 -177.636 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 8.9 t . . . . . 0 C--N 1.325 -0.469 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 177.496 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.415 0 CA-C-O 121.352 0.596 . . . . 0.0 110.912 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 54.0 p -63.27 144.99 56.47 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.02 178.478 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 42.8 m95 -68.78 -23.44 64.3 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 113.69 0.996 . . . . 0.0 113.69 179.987 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -116.84 160.09 21.37 Favored 'General case' 0 C--O 1.242 0.668 0 CA-C-O 121.239 0.542 . . . . 0.0 111.69 -174.898 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.474 ' HB ' ' HB3' ' A' ' 134' ' ' GLU . 75.9 p -70.13 163.1 27.02 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.694 -1.139 . . . . 0.0 109.482 178.999 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -82.65 135.87 34.92 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 113.478 0.918 . . . . 0.0 113.478 -175.809 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.452 HD11 HD22 ' A' ' 119' ' ' LEU . 3.0 mp -80.19 146.83 31.55 Favored 'General case' 0 CA--C 1.503 -0.854 0 N-CA-C 106.466 -1.679 . . . . 0.0 106.466 173.419 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 25.2 m -106.08 136.2 46.19 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 178.01 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 -110.78 128.2 55.66 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.265 0.555 . . . . 0.0 111.198 -178.359 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 40.7 t60 -129.12 99.47 5.27 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 106.229 -1.767 . . . . 0.0 106.229 175.18 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 165.79 -173.13 41.4 Favored Glycine 0 N--CA 1.451 -0.347 0 N-CA-C 110.418 -1.073 . . . . 0.0 110.418 -178.502 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -98.01 -16.94 19.44 Favored 'General case' 0 C--O 1.218 -0.566 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 -179.387 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 84.0 mt-10 -71.04 169.16 15.55 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 113.49 0.922 . . . . 0.0 113.49 -176.29 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 70.0 m-20 -116.17 24.33 11.49 Favored 'General case' 0 C--O 1.221 -0.428 0 CA-C-O 122.013 0.911 . . . . 0.0 111.797 178.895 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 62.2 tp 66.54 144.19 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 126.598 1.959 . . . . 0.0 113.597 179.987 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 49.3 tptt -157.74 138.15 12.79 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 176.234 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -123.56 136.27 27.04 Favored Pre-proline 0 C--O 1.242 0.699 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 173.535 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -64.04 162.34 29.79 Favored 'Trans proline' 0 CA--C 1.539 0.74 0 C-N-CA 121.205 1.27 . . . . 0.0 113.344 175.349 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -67.13 143.2 56.77 Favored 'General case' 0 C--O 1.22 -0.495 0 O-C-N 122.017 -0.427 . . . . 0.0 112.007 -179.278 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 78.29 13.65 83.06 Favored Glycine 0 C--O 1.222 -0.62 0 N-CA-C 111.115 -0.794 . . . . 0.0 111.115 178.951 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -152.52 168.6 25.0 Favored 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 -173.938 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 104.2 -19.87 41.96 Favored Glycine 0 CA--C 1.499 -0.951 0 CA-C-O 121.015 0.231 . . . . 0.0 112.881 173.809 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 58.3 t -72.01 127.25 90.8 Favored Pre-proline 0 C--N 1.319 -0.749 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 177.911 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -68.64 175.23 7.39 Favored 'Trans proline' 0 CA--C 1.531 0.36 0 N-CA-C 113.7 0.616 . . . . 0.0 113.7 177.404 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 88.0 mt -75.56 110.41 10.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 121.882 0.848 . . . . 0.0 109.174 178.616 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -108.35 83.26 1.75 Allowed 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 114.674 -1.148 . . . . 0.0 109.637 -178.406 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 80.9 p -69.71 -18.37 63.53 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 113.704 1.001 . . . . 0.0 113.704 -176.783 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -119.64 32.11 6.23 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 -175.916 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.4 m -136.35 157.38 46.93 Favored 'General case' 0 C--N 1.327 -0.394 0 O-C-N 122.045 -0.409 . . . . 0.0 111.456 179.214 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 15.0 m -72.68 159.35 85.57 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.017 -179.979 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -65.42 -24.92 56.47 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 116.127 -2.115 . . . . 0.0 111.331 176.833 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -62.14 -29.79 70.59 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.444 176.578 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 35.4 t0 -88.25 -6.38 57.83 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 113.737 1.014 . . . . 0.0 113.737 -172.536 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 95.1 mm-40 -62.03 -31.84 72.27 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 112.95 0.722 . . . . 0.0 112.95 -177.177 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 13.6 tt -62.42 137.86 23.54 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 CA-C-O 122.135 0.969 . . . . 0.0 110.753 177.902 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -179.25 -159.55 23.54 Favored Glycine 0 CA--C 1.504 -0.638 0 C-N-CA 120.1 -1.048 . . . . 0.0 111.51 -178.247 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 38.2 p90 -155.09 168.52 26.73 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 109.838 -0.431 . . . . 0.0 109.838 179.408 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 14.2 m-85 -110.34 137.32 48.21 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 175.615 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 47.6 ttt-85 -112.03 125.3 53.93 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 124.12 0.968 . . . . 0.0 109.936 -176.941 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 9.1 ttt180 -72.77 145.96 46.7 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 122.051 0.929 . . . . 0.0 109.339 179.343 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -75.91 170.8 15.55 Favored 'General case' 0 N--CA 1.432 -1.337 0 CA-C-N 114.165 -1.379 . . . . 0.0 109.895 178.472 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 8.5 t -61.7 147.82 44.78 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 122.222 1.011 . . . . 0.0 110.615 -178.747 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 10.2 tpt180 -72.46 147.42 46.11 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.687 -1.142 . . . . 0.0 111.661 -175.938 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 3.2 tmt_? -88.44 129.06 35.52 Favored 'General case' 0 CA--C 1.504 -0.799 0 N-CA-C 106.113 -1.81 . . . . 0.0 106.113 175.919 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -132.43 176.87 8.04 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-N 114.381 -1.282 . . . . 0.0 111.397 -172.639 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 18.8 ttm180 -112.68 117.03 31.12 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 103.92 -2.622 . . . . 0.0 103.92 174.783 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -92.79 142.41 15.97 Favored Glycine 0 C--O 1.222 -0.596 0 N-CA-C 109.301 -1.52 . . . . 0.0 109.301 179.45 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -70.9 -27.19 72.66 Favored Glycine 0 C--O 1.214 -1.125 0 C-N-CA 121.02 -0.61 . . . . 0.0 114.0 -177.337 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -83.55 -2.34 55.78 Favored 'General case' 0 C--O 1.218 -0.581 0 CA-C-O 121.516 0.674 . . . . 0.0 112.551 -178.319 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 102.94 12.14 32.72 Favored Glycine 0 CA--C 1.504 -0.624 0 CA-C-O 121.557 0.532 . . . . 0.0 112.267 172.037 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 2.6 pttt -130.22 149.23 52.01 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 111.875 0.324 . . . . 0.0 111.875 -177.895 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 23.1 ptm -147.8 176.92 9.74 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 114.594 1.331 . . . . 0.0 114.594 -170.282 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 13.4 mptt -82.35 -45.42 14.91 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.399 178.696 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 8.2 t0 62.45 -169.66 0.18 Allowed 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 112.129 -2.305 . . . . 0.0 113.657 -177.344 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER 66.53 165.16 0.2 Allowed 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 115.23 1.567 . . . . 0.0 115.23 -179.681 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -79.76 157.35 74.39 Favored Pre-proline 0 C--O 1.238 0.494 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 177.909 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -67.43 143.74 64.65 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 114.969 -2.887 . . . . 0.0 112.088 178.805 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 25.6 mtp180 -118.82 166.02 13.31 Favored 'General case' 0 CA--C 1.511 -0.531 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 179.396 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 71.3 m95 -131.09 132.05 44.6 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 178.031 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 61.1 m-85 -112.68 152.1 29.42 Favored 'General case' 0 C--O 1.214 -0.79 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 -178.792 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 77.8 t80 -102.03 136.67 41.46 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 119.35 0.977 . . . . 0.0 109.804 -177.816 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -141.03 146.6 37.44 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.981 -175.288 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 30.5 m-85 -77.82 159.48 28.95 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.128 0.49 . . . . 0.0 111.884 -178.62 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -55.31 131.76 46.37 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.015 179.436 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 72.09 27.82 69.54 Favored Glycine 0 C--O 1.219 -0.816 0 N-CA-C 116.095 1.198 . . . . 0.0 116.095 176.542 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 3.7 p . . . . . 0 C--N 1.325 -0.462 0 CA-C-N 118.575 1.187 . . . . 0.0 108.527 177.734 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 16.7 mt . . . . . 0 N--CA 1.449 -0.508 0 N-CA-C 114.637 1.347 . . . . 0.0 114.637 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -78.34 165.61 25.31 Favored 'Trans proline' 0 N--CA 1.462 -0.362 0 C-N-CA 121.525 1.484 . . . . 0.0 108.653 169.865 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 88.2 t80 -61.39 128.47 36.47 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.983 0.42 . . . . 0.0 110.505 -179.222 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 93.25 -6.83 75.74 Favored Glycine 0 CA--C 1.521 0.409 0 N-CA-C 115.364 0.905 . . . . 0.0 115.364 178.676 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -63.32 133.6 54.39 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 118.433 1.117 . . . . 0.0 112.417 -179.961 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -78.02 125.87 29.99 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.415 -179.246 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 29.6 ttmt -156.22 151.32 26.41 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 107.046 -1.464 . . . . 0.0 107.046 178.145 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -66.44 133.04 49.61 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 -178.204 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 70.44 24.04 77.06 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.889 -0.672 . . . . 0.0 114.019 178.022 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 43.5 mm -127.3 125.67 66.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 117.241 0.52 . . . . 0.0 109.918 179.229 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.1 pt -131.21 122.07 50.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 121.6 0.714 . . . . 0.0 110.5 177.055 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 94.0 m95 -88.25 138.28 31.58 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 -176.261 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 23.4 m -135.95 155.46 35.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 178.916 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -162.93 166.09 24.31 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 105.412 -2.07 . . . . 0.0 105.412 -179.843 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 11.9 t -135.98 173.66 11.47 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 105.37 -2.085 . . . . 0.0 105.37 178.38 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -67.6 136.72 54.89 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.161 0.505 . . . . 0.0 110.443 -178.646 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 92.51 -6.71 77.83 Favored Glycine 0 C--O 1.227 -0.289 0 CA-C-N 115.943 -0.572 . . . . 0.0 114.266 177.571 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -78.05 148.26 34.39 Favored 'General case' 0 C--N 1.322 -0.596 0 O-C-N 122.439 -0.448 . . . . 0.0 110.696 179.228 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 70.5 mt -81.21 170.78 15.68 Favored 'General case' 0 C--O 1.208 -1.095 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 178.015 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -112.96 28.84 8.46 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 121.239 0.542 . . . . 0.0 109.898 177.709 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -109.94 151.74 42.6 Favored Pre-proline 0 CA--C 1.546 0.825 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 -174.36 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -71.01 151.07 61.62 Favored 'Trans proline' 0 C--N 1.352 0.744 0 C-N-CA 120.481 0.787 . . . . 0.0 113.569 177.391 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 6.6 pttp -154.33 57.44 0.7 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 122.548 1.166 . . . . 0.0 111.423 -177.631 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -57.24 -31.99 66.11 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 114.518 -1.219 . . . . 0.0 112.511 179.813 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 11.9 p80 -60.67 -11.32 7.01 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 114.929 1.455 . . . . 0.0 114.929 -177.991 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 45.8 mt -92.31 -43.4 13.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 177.495 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -70.85 14.68 1.42 Allowed Glycine 0 CA--C 1.523 0.558 0 N-CA-C 117.296 1.678 . . . . 0.0 117.296 -175.556 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 12.3 t -90.31 30.24 1.15 Allowed 'General case' 0 CA--C 1.548 0.876 0 N-CA-C 112.527 0.566 . . . . 0.0 112.527 -178.108 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 68.8 ttp85 -56.19 131.25 47.3 Favored 'General case' 0 N--CA 1.475 0.808 0 O-C-N 121.426 -0.796 . . . . 0.0 109.846 179.398 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 37.1 m-20 -100.52 119.57 58.42 Favored Pre-proline 0 C--N 1.325 -0.465 0 N-CA-C 105.125 -2.176 . . . . 0.0 105.125 178.698 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -71.05 -17.34 31.84 Favored 'Trans proline' 0 C--N 1.347 0.469 0 N-CA-C 114.793 1.036 . . . . 0.0 114.793 -174.824 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -75.0 -25.37 58.76 Favored 'General case' 0 C--O 1.22 -0.48 0 CA-C-O 120.946 0.403 . . . . 0.0 110.064 177.631 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 -100.55 -24.67 14.4 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 113.296 0.85 . . . . 0.0 113.296 -175.519 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 23.5 t30 -149.56 145.44 26.82 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.933 0.716 . . . . 0.0 112.933 -179.446 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -83.66 147.54 27.63 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-O 121.617 0.722 . . . . 0.0 112.305 -179.914 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -72.33 147.46 46.29 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.669 178.315 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 9.9 mt -83.71 133.76 28.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 -179.255 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 74.0 t -62.73 120.93 10.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 N-CA-C 105.853 -1.906 . . . . 0.0 105.853 175.534 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.452 HD22 HD11 ' A' ' 16' ' ' LEU . 6.7 tt -68.44 128.95 38.44 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.21 0.529 . . . . 0.0 110.483 -176.919 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 29.8 mt-30 -132.14 156.51 46.26 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 105.835 -1.913 . . . . 0.0 105.835 179.065 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 14.1 mt -112.25 149.8 41.54 Favored Pre-proline 0 C--N 1.321 -0.631 0 N-CA-C 105.93 -1.878 . . . . 0.0 105.93 177.744 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -69.9 171.01 15.41 Favored 'Trans proline' 0 C--N 1.344 0.302 0 N-CA-C 115.136 1.168 . . . . 0.0 115.136 -175.061 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -54.9 130.94 43.19 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.835 -178.116 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 88.12 -10.68 69.92 Favored Glycine 0 C--O 1.227 -0.315 0 CA-C-N 115.89 -0.595 . . . . 0.0 112.648 -179.99 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 27.9 m -108.66 127.68 54.18 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.146 0.498 . . . . 0.0 110.662 -179.854 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 19.2 p -124.22 152.99 42.28 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.301 0.572 . . . . 0.0 112.309 -177.532 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 71.4 mt -70.36 155.45 93.41 Favored Pre-proline 0 C--N 1.326 -0.433 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 176.833 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -76.86 172.77 15.59 Favored 'Trans proline' 0 N--CA 1.463 -0.265 0 O-C-N 121.933 0.438 . . . . 0.0 111.038 179.085 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 48.5 tptt -60.78 132.57 54.3 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 -178.341 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 86.81 22.53 45.76 Favored Glycine 0 CA--C 1.518 0.247 0 N-CA-C 114.844 0.698 . . . . 0.0 114.844 177.816 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -131.91 143.43 50.13 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 117.35 0.575 . . . . 0.0 112.258 178.553 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 49.2 p90 -148.94 158.71 44.38 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 106.267 -1.753 . . . . 0.0 106.267 172.507 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -100.43 148.47 24.71 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.816 0.341 . . . . 0.0 110.279 -178.412 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.474 ' HB3' ' HB ' ' A' ' 14' ' ' THR . 8.7 tp10 -67.39 134.33 51.26 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.204 -1.035 . . . . 0.0 108.204 177.593 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 85.78 -7.89 75.08 Favored Glycine 0 C--O 1.227 -0.33 0 CA-C-N 116.058 -0.519 . . . . 0.0 112.941 -177.9 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 20.8 t . . . . . 0 C--N 1.325 -0.488 0 CA-C-O 121.459 0.647 . . . . 0.0 109.86 179.95 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.241 0 CA-C-O 121.387 0.613 . . . . 0.0 112.273 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.7 t -58.53 139.81 55.13 Favored 'General case' 0 CA--C 1.508 -0.647 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 174.902 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 22.1 m95 -64.27 -21.82 66.73 Favored 'General case' 0 C--N 1.323 -0.564 0 O-C-N 123.188 0.305 . . . . 0.0 111.323 177.855 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 51.6 m-85 -121.5 163.17 19.26 Favored 'General case' 0 C--O 1.241 0.628 0 N-CA-C 114.259 1.207 . . . . 0.0 114.259 -172.727 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 57.4 p -68.51 164.7 20.62 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 114.562 -1.199 . . . . 0.0 110.476 179.513 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.499 ' HB2' ' CZ ' ' A' ' 69' ' ' TYR . . . -80.73 137.92 36.3 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 -176.34 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -90.21 147.3 23.64 Favored 'General case' 0 CA--C 1.502 -0.883 0 N-CA-C 105.767 -1.938 . . . . 0.0 105.767 171.883 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 91.8 m -123.7 141.71 51.76 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 -178.538 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.411 ' HB2' ' CZ ' ' A' ' 131' ' ' PHE . 4.3 tp60 -111.23 136.14 50.74 Favored 'General case' 0 C--N 1.329 -0.295 0 O-C-N 123.629 0.581 . . . . 0.0 112.543 -177.783 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 46.0 t60 -133.32 99.44 4.53 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 103.813 -2.662 . . . . 0.0 103.813 169.551 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 179.12 -158.78 23.13 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.537 -0.839 . . . . 0.0 111.028 -175.204 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 35.3 mmtp -108.52 -28.09 9.52 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 113.958 1.096 . . . . 0.0 113.958 -178.225 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -90.94 167.45 12.41 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 176.231 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -81.81 -62.62 1.59 Allowed 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 -178.855 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 36.5 tp -174.39 142.79 0.8 Allowed 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 105.51 -2.033 . . . . 0.0 105.51 174.043 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 79.5 tttt -151.48 146.18 25.73 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 174.946 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -135.7 157.62 75.84 Favored Pre-proline 0 C--N 1.323 -0.562 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 176.939 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -71.78 172.82 13.73 Favored 'Trans proline' 0 CA--C 1.536 0.614 0 C-N-CA 120.718 0.945 . . . . 0.0 114.002 -179.429 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 25.3 tpt180 -78.41 130.97 36.72 Favored 'General case' 0 C--O 1.216 -0.675 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 177.798 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 81.07 7.15 88.86 Favored Glycine 0 C--O 1.225 -0.461 0 N-CA-C 115.279 0.871 . . . . 0.0 115.279 175.886 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.522 HE21 HG23 ' A' ' 125' ' ' THR . 25.2 tt0 -158.52 146.48 18.24 Favored 'General case' 0 C--O 1.217 -0.654 0 N-CA-C 106.457 -1.682 . . . . 0.0 106.457 -177.854 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 136.65 -17.21 3.73 Favored Glycine 0 CA--C 1.503 -0.676 0 C-N-CA 120.344 -0.932 . . . . 0.0 112.556 177.7 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 33.1 m -71.27 146.52 92.25 Favored Pre-proline 0 C--N 1.321 -0.637 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 176.922 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_endo -76.1 173.49 14.39 Favored 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 121.121 1.214 . . . . 0.0 112.606 178.65 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 93.3 mt -76.09 113.06 14.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 N-CA-C 108.042 -1.095 . . . . 0.0 108.042 178.517 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 45.0 m-20 -104.67 83.91 2.09 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 -178.801 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 69.0 p -64.26 -22.2 66.86 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 115.352 1.612 . . . . 0.0 115.352 -174.422 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 11.1 p30 -106.02 18.28 22.31 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.293 -177.384 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 9.4 m -125.55 157.88 35.96 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -175.152 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -74.29 162.26 74.62 Favored Pre-proline 0 C--N 1.323 -0.56 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 178.23 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -66.11 -23.03 53.67 Favored 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 115.159 -2.76 . . . . 0.0 112.015 177.542 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.496 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 0.0 OUTLIER -72.37 -13.56 61.5 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.278 0.561 . . . . 0.0 111.128 178.824 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -104.83 1.06 28.7 Favored 'General case' 0 C--O 1.219 -0.528 0 N-CA-C 114.541 1.311 . . . . 0.0 114.541 -175.063 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 86.6 mm-40 -62.54 -21.64 65.71 Favored 'General case' 0 CA--C 1.548 0.881 0 O-C-N 120.633 -1.292 . . . . 0.0 110.749 178.193 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.506 ' HB ' ' HB1' ' A' ' 98' ' ' ALA . 14.3 tt -62.69 143.26 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 CA-C-O 121.96 0.886 . . . . 0.0 112.827 178.413 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 177.14 -153.77 14.4 Favored Glycine 0 N--CA 1.446 -0.668 0 N-CA-C 110.774 -0.93 . . . . 0.0 110.774 178.565 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 43.2 p90 -154.95 168.48 26.82 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 178.242 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 40.1 m-85 -111.31 140.96 45.45 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 106.66 -1.607 . . . . 0.0 106.66 175.186 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 34.4 ttt180 -114.59 125.73 54.1 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 123.273 0.629 . . . . 0.0 111.913 -178.203 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 27.8 ttt180 -67.5 139.0 56.99 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 176.28 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -136.72 129.75 31.01 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.058 0.456 . . . . 0.0 110.855 179.339 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 27.3 p -145.54 154.41 42.15 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 106.533 -1.654 . . . . 0.0 106.533 176.322 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 15.8 tpt180 -163.33 121.69 1.99 Allowed 'General case' 0 CA--C 1.513 -0.443 0 N-CA-C 106.561 -1.644 . . . . 0.0 106.561 173.323 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 3.3 tmt_? -132.07 144.78 50.99 Favored 'General case' 0 CA--C 1.495 -1.136 0 CA-C-O 121.448 0.642 . . . . 0.0 109.81 -176.684 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -140.92 178.25 3.14 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 N-CA-C 105.378 -2.082 . . . . 0.0 105.378 -178.378 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 6.8 tmm_? -137.25 105.74 5.8 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 175.134 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -72.38 163.22 54.67 Favored Glycine 0 N--CA 1.448 -0.503 0 N-CA-C 108.853 -1.699 . . . . 0.0 108.853 178.305 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -71.24 -32.29 65.52 Favored Glycine 0 C--O 1.214 -1.11 0 N-CA-C 108.689 -1.764 . . . . 0.0 108.689 179.331 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 30.6 t0 -89.43 17.07 6.58 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 122.4 1.095 . . . . 0.0 109.478 178.47 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 84.16 -16.2 34.8 Favored Glycine 0 N--CA 1.46 0.259 0 N-CA-C 116.228 1.251 . . . . 0.0 116.228 173.302 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -56.52 134.37 54.11 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 113.886 1.069 . . . . 0.0 113.886 -176.976 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 47.1 mtp -112.83 -168.84 1.38 Allowed 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 113.536 -1.665 . . . . 0.0 110.29 -179.978 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 15.7 mmtt -122.75 -57.94 1.7 Allowed 'General case' 0 C--O 1.217 -0.61 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -178.689 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 58.0 p30 -135.55 174.72 10.3 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.433 -0.803 . . . . 0.0 112.062 -179.076 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 80.4 mt -136.17 -66.2 0.55 Allowed 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 177.681 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 20.0 m -79.98 150.87 72.6 Favored Pre-proline 0 C--O 1.244 0.771 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.036 178.857 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -75.04 157.56 42.53 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 117.111 -1.46 . . . . 0.0 111.417 176.233 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 7.6 ptt-85 -131.64 162.5 30.24 Favored 'General case' 0 CA--C 1.51 -0.569 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 177.128 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 64.3 m95 -129.57 147.67 51.39 Favored 'General case' 0 C--N 1.318 -0.769 0 O-C-N 123.458 0.474 . . . . 0.0 110.114 -178.316 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.499 ' CZ ' ' HB2' ' A' ' 15' ' ' ALA . 72.9 m-85 -127.47 150.46 49.65 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 178.728 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 87.6 t80 -96.55 135.8 37.96 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 -179.621 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -136.07 140.75 44.02 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 121.822 0.82 . . . . 0.0 109.314 -176.949 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 78.2 m-85 -74.62 159.43 32.13 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 114.602 -1.181 . . . . 0.0 110.651 -176.624 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -57.16 135.81 56.4 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 114.088 1.144 . . . . 0.0 114.088 -176.619 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 65.54 29.17 74.56 Favored Glycine 0 C--O 1.224 -0.511 0 N-CA-C 115.869 1.108 . . . . 0.0 115.869 175.036 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 16.8 p . . . . . 0 C--N 1.324 -0.502 0 CA-C-N 118.001 0.9 . . . . 0.0 110.19 179.739 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 52.1 mt . . . . . 0 N--CA 1.447 -0.606 0 N-CA-C 115.278 1.584 . . . . 0.0 115.278 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -78.58 167.65 22.35 Favored 'Trans proline' 0 C--O 1.238 0.501 0 N-CA-C 108.832 -1.257 . . . . 0.0 108.832 170.51 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 68.2 t80 -61.59 130.35 45.49 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 120.558 -0.457 . . . . 0.0 110.321 179.458 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 93.47 -5.48 74.19 Favored Glycine 0 CA--C 1.519 0.283 0 N-CA-C 115.013 0.765 . . . . 0.0 115.013 178.212 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -66.2 129.42 39.75 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 118.459 1.129 . . . . 0.0 112.381 179.977 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 54.7 t30 -75.8 128.1 34.42 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.772 -0.649 . . . . 0.0 112.104 -177.758 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 22.2 ttmt -156.23 152.98 28.45 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 106.978 -1.489 . . . . 0.0 106.978 178.116 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 22.4 t0 -64.86 133.09 51.14 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 -179.19 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 68.75 28.23 73.26 Favored Glycine 0 N--CA 1.448 -0.547 0 CA-C-O 119.557 -0.579 . . . . 0.0 114.308 178.14 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 40.2 mm -129.39 129.22 67.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 117.376 0.588 . . . . 0.0 110.17 179.418 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -131.64 117.75 36.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 CA-C-O 121.446 0.641 . . . . 0.0 110.517 176.172 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 95.9 m95 -86.26 133.07 33.85 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 112.23 0.456 . . . . 0.0 112.23 -177.269 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 1.2 m -140.87 151.12 20.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 -177.571 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -155.64 166.43 33.54 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 105.776 -1.935 . . . . 0.0 105.776 -177.908 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 11.4 t -127.18 171.29 11.56 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 105.621 -1.992 . . . . 0.0 105.621 175.21 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -64.76 136.28 56.75 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.327 0.584 . . . . 0.0 110.578 -179.544 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 94.2 -9.72 72.11 Favored Glycine 0 C--O 1.23 -0.117 0 CA-C-N 115.75 -0.659 . . . . 0.0 113.047 177.92 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.506 ' HB1' ' HB ' ' A' ' 44' ' ' ILE . . . -79.83 139.56 37.15 Favored 'General case' 0 CA--C 1.543 0.692 0 O-C-N 122.543 -0.386 . . . . 0.0 110.846 179.971 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 42.2 mt -102.03 137.67 40.01 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 114.65 1.352 . . . . 0.0 114.65 -176.437 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 50.3 t30 -81.18 75.39 8.15 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.101 -0.954 . . . . 0.0 110.252 179.29 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 2.0 t -139.24 157.55 70.74 Favored Pre-proline 0 CA--C 1.541 0.619 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 -179.373 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -64.35 145.01 87.56 Favored 'Trans proline' 0 C--N 1.348 0.512 0 N-CA-C 114.328 0.857 . . . . 0.0 114.328 -179.108 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 67.4 mmtt -126.41 33.55 4.98 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.664 0.745 . . . . 0.0 109.738 -178.11 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -51.45 -45.52 62.72 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.379 -0.828 . . . . 0.0 112.815 -177.189 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 17.8 p80 -72.93 -4.26 30.96 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 114.353 1.242 . . . . 0.0 114.353 -178.273 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 31.7 mt -96.35 -44.08 12.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 122.191 -0.318 . . . . 0.0 110.496 -179.154 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -74.06 12.11 5.62 Favored Glycine 0 CA--C 1.522 0.514 0 N-CA-C 115.205 0.842 . . . . 0.0 115.205 -178.306 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 13.4 t -83.29 19.72 1.44 Allowed 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 113.812 1.042 . . . . 0.0 113.812 -177.147 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.422 ' HD2' HD22 ' A' ' 114' ' ' ASN . 69.3 ttp85 -56.83 126.13 25.59 Favored 'General case' 0 N--CA 1.471 0.593 0 O-C-N 121.488 -0.757 . . . . 0.0 109.905 -179.3 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 34.4 m120 -93.56 124.21 57.82 Favored Pre-proline 0 C--N 1.322 -0.597 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 179.134 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -70.4 -17.73 34.48 Favored 'Trans proline' 0 C--O 1.219 -0.463 0 C-N-CA 117.021 -1.519 . . . . 0.0 113.15 -179.38 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -76.37 -26.86 56.08 Favored 'General case' 0 C--O 1.22 -0.454 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.247 178.021 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 84.1 m-20 -101.65 -23.69 14.22 Favored 'General case' 0 C--O 1.223 -0.33 0 N-CA-C 113.49 0.922 . . . . 0.0 113.49 -174.991 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . 0.422 HD22 ' HD2' ' A' ' 109' ' ' ARG . 24.2 t30 -149.74 150.64 32.37 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 -178.373 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -88.21 149.02 24.09 Favored 'General case' 0 CA--C 1.545 0.779 0 CA-C-O 121.711 0.767 . . . . 0.0 112.559 179.639 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -72.74 149.86 43.35 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.905 178.364 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 16.7 mt -91.44 139.5 17.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 -179.26 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 93.2 t -62.73 123.79 16.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 N-CA-C 106.021 -1.844 . . . . 0.0 106.021 174.992 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 7.1 tt -66.11 131.25 45.74 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.129 0.49 . . . . 0.0 110.096 -177.215 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 28.3 mt-30 -129.31 152.17 49.16 Favored 'General case' 0 CA--C 1.508 -0.666 0 N-CA-C 106.227 -1.768 . . . . 0.0 106.227 179.838 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 14.3 mt -111.5 148.52 39.01 Favored Pre-proline 0 C--N 1.32 -0.682 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 178.891 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -71.07 165.61 31.82 Favored 'Trans proline' 0 C--N 1.345 0.38 0 O-C-N 122.231 0.595 . . . . 0.0 112.886 -178.546 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 59.5 tt0 -54.65 130.71 41.28 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.504 -177.8 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 94.12 -16.74 60.3 Favored Glycine 0 C--O 1.228 -0.276 0 CA-C-N 115.901 -0.591 . . . . 0.0 113.093 -179.4 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.522 HG23 HE21 ' A' ' 30' ' ' GLN . 10.5 m -102.64 129.51 49.25 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 117.652 0.726 . . . . 0.0 109.765 179.366 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 2.7 p -127.39 148.33 50.27 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.671 -177.788 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 72.9 mt -68.76 154.14 95.1 Favored Pre-proline 0 C--N 1.327 -0.378 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 177.719 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -74.92 170.7 19.81 Favored 'Trans proline' 0 C--O 1.233 0.256 0 C-N-CA 117.724 -1.051 . . . . 0.0 110.681 178.674 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 1.3 tptm -60.78 130.59 47.26 Favored 'General case' 0 C--N 1.324 -0.543 0 O-C-N 122.085 -0.384 . . . . 0.0 111.32 -176.13 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 95.19 -2.63 65.9 Favored Glycine 0 CA--C 1.518 0.225 0 N-CA-C 115.111 0.804 . . . . 0.0 115.111 178.256 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.411 ' CZ ' ' HB2' ' A' ' 18' ' ' GLN . 1.2 m-85 -102.37 144.31 31.02 Favored 'General case' 0 N--CA 1.441 -0.903 0 CA-C-O 122.106 0.955 . . . . 0.0 111.23 -179.964 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 47.6 p90 -146.32 163.33 35.88 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 114.022 -1.444 . . . . 0.0 108.305 174.492 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -111.35 146.44 37.08 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.775 0.322 . . . . 0.0 111.158 -177.429 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -73.29 138.12 45.27 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 178.837 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 84.75 -4.23 85.28 Favored Glycine 0 C--O 1.228 -0.28 0 CA-C-N 116.217 -0.447 . . . . 0.0 112.121 -176.787 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 7.5 t . . . . . 0 C--O 1.238 0.452 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 179.816 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.288 0 CA-C-O 121.171 0.51 . . . . 0.0 110.26 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 43.1 t -55.63 137.12 49.84 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 177.173 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 7.9 m95 -66.14 -21.93 66.36 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 178.798 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 44.2 m-85 -121.48 163.04 19.46 Favored 'General case' 0 CA--C 1.509 -0.598 0 N-CA-C 113.261 0.837 . . . . 0.0 113.261 -171.023 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 73.6 p -72.28 164.28 26.54 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.079 -0.964 . . . . 0.0 109.175 178.765 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -82.81 131.33 35.2 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 112.715 0.635 . . . . 0.0 112.715 -176.039 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 17.1 mt -72.06 148.04 46.19 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 174.134 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 6.2 m -117.58 140.3 49.82 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 -179.406 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 3.8 tp60 -109.72 128.18 55.1 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 123.557 0.536 . . . . 0.0 111.088 179.112 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 41.5 t60 -116.61 99.51 7.19 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 103.615 -2.735 . . . . 0.0 103.615 171.043 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 160.37 -159.2 30.62 Favored Glycine 0 N--CA 1.45 -0.391 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 -175.643 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 69.1 mttm -118.77 -23.43 7.01 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 114.106 1.15 . . . . 0.0 114.106 -178.304 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -74.35 159.75 31.97 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.763 -177.991 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -71.66 -62.95 1.23 Allowed 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 112.976 0.732 . . . . 0.0 112.976 -177.815 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 40.8 tp 153.73 143.43 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.306 0 N-CA-C 103.759 -2.682 . . . . 0.0 103.759 -176.183 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 50.0 tptt -156.44 141.02 16.87 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 175.477 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -125.38 149.91 65.9 Favored Pre-proline 0 C--O 1.241 0.634 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 175.908 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -71.75 161.3 45.56 Favored 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 120.651 0.901 . . . . 0.0 112.793 178.664 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 40.0 tpt85 -66.73 133.29 49.87 Favored 'General case' 0 C--O 1.216 -0.695 0 O-C-N 122.059 -0.401 . . . . 0.0 109.964 -178.437 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 86.02 7.0 81.35 Favored Glycine 0 C--O 1.223 -0.566 0 N-CA-C 111.66 -0.576 . . . . 0.0 111.66 178.839 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 18.4 mt-30 -146.42 170.57 16.56 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 -175.031 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 103.63 -15.08 53.36 Favored Glycine 0 CA--C 1.501 -0.84 0 CA-C-N 116.122 -0.49 . . . . 0.0 113.434 174.78 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.417 HG11 ' HB3' ' A' ' 43' ' ' GLN . 92.4 t -67.61 128.92 93.6 Favored Pre-proline 0 C--N 1.317 -0.81 0 N-CA-C 106.241 -1.763 . . . . 0.0 106.241 176.726 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -72.87 170.69 19.07 Favored 'Trans proline' 0 N--CA 1.459 -0.502 0 O-C-N 122.26 0.611 . . . . 0.0 111.214 178.22 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 90.6 mt -70.73 107.31 2.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-O 122.075 0.94 . . . . 0.0 108.715 -179.345 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 71.3 m-20 -101.46 84.98 2.69 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 114.357 -1.292 . . . . 0.0 109.417 -177.299 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 72.6 p -68.5 -15.03 63.4 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.722 0.772 . . . . 0.0 112.527 -178.704 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 21.0 p30 -106.0 21.96 16.44 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 114.845 -1.071 . . . . 0.0 112.062 -177.22 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 50.5 m -139.51 150.05 44.67 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 113.577 0.954 . . . . 0.0 113.577 -176.044 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 2.5 m -71.65 166.61 38.08 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.448 176.675 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -66.22 -25.9 49.81 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 114.811 -2.993 . . . . 0.0 114.159 -179.775 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.471 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 3.4 p-10 -78.06 -21.01 51.25 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.551 0.691 . . . . 0.0 110.922 177.194 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 62.0 m-20 -81.35 -8.29 59.71 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 113.214 0.82 . . . . 0.0 113.214 -175.34 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.417 ' HB3' HG11 ' A' ' 32' ' ' VAL . 97.1 mm-40 -57.83 -25.95 61.35 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 114.495 1.295 . . . . 0.0 114.495 -178.876 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.438 ' HB ' ' HB1' ' A' ' 98' ' ' ALA . 9.6 tt -58.38 138.92 18.75 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.971 0 CA-C-O 122.179 0.99 . . . . 0.0 113.638 -178.676 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 179.04 -159.67 24.69 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.411 -179.36 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 43.5 p90 -155.05 170.79 20.96 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 178.958 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 14.5 m-85 -113.1 140.07 48.19 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 173.764 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -110.26 121.66 45.82 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 123.938 0.895 . . . . 0.0 110.436 -178.579 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 40.2 ttp180 -70.84 130.84 42.72 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 174.535 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -142.5 146.6 34.88 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.177 0.513 . . . . 0.0 111.605 -178.737 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 10.2 t -155.4 162.47 40.78 Favored 'General case' 0 C--O 1.245 0.84 0 N-CA-C 104.021 -2.585 . . . . 0.0 104.021 174.186 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 10.1 tpp85 -169.68 139.7 2.04 Favored 'General case' 0 C--O 1.215 -0.733 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 -179.423 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 7.0 ttm180 -121.21 131.15 54.06 Favored 'General case' 0 CA--C 1.497 -1.068 0 N-CA-C 106.39 -1.707 . . . . 0.0 106.39 172.635 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -140.62 178.05 3.46 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 CA-C-N 114.684 -1.144 . . . . 0.0 107.961 -175.396 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.66 99.4 5.97 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 104.813 -2.291 . . . . 0.0 104.813 171.801 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -69.91 161.48 52.95 Favored Glycine 0 C--O 1.227 -0.319 0 N-CA-C 108.755 -1.738 . . . . 0.0 108.755 179.416 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -58.26 -41.41 94.91 Favored Glycine 0 C--O 1.223 -0.592 0 CA-C-N 118.036 0.918 . . . . 0.0 113.566 -178.039 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 32.2 t0 -89.12 15.67 8.41 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-O 122.343 1.068 . . . . 0.0 111.759 -179.584 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 87.45 9.11 73.05 Favored Glycine 0 C--O 1.221 -0.66 0 CA-C-N 115.326 -0.852 . . . . 0.0 113.191 172.865 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 21.8 mmtt -79.6 139.7 37.38 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.184 0.516 . . . . 0.0 109.697 -175.56 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 84.2 mtp -114.75 -167.36 1.21 Allowed 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.794 -177.91 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 57.3 mmtt -144.27 -73.76 0.26 Allowed 'General case' 0 C--O 1.213 -0.819 0 C-N-CA 123.14 0.576 . . . . 0.0 109.476 -177.806 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 30.74 -121.65 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.64 0 O-C-N 125.18 1.55 . . . . 0.0 114.606 179.102 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 59.47 -168.45 0.15 Allowed 'General case' 0 C--N 1.318 -0.766 0 O-C-N 124.772 1.295 . . . . 0.0 112.371 -179.487 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 18.9 m -62.09 153.73 72.77 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.744 179.411 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -65.74 148.57 86.89 Favored 'Trans proline' 0 C--O 1.237 0.447 0 C-N-CA 115.845 -2.303 . . . . 0.0 111.733 178.709 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 31.8 mtp180 -118.61 158.13 26.05 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 -177.653 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 64.2 m95 -120.13 129.58 54.22 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 120.852 0.358 . . . . 0.0 110.436 -179.054 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 24.1 m-85 -110.35 142.21 42.32 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 -178.778 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 85.4 t80 -94.22 136.76 34.16 Favored 'General case' 0 CA--C 1.511 -0.536 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 -178.182 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -139.63 146.56 39.9 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 -177.056 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -81.58 159.51 24.06 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.135 -175.703 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -54.59 131.53 43.22 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.921 0.391 . . . . 0.0 111.786 -179.277 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 71.38 33.71 64.21 Favored Glycine 0 C--O 1.222 -0.618 0 N-CA-C 115.583 0.993 . . . . 0.0 115.583 176.375 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 4.2 p . . . . . 0 C--N 1.326 -0.426 0 CA-C-N 118.135 0.967 . . . . 0.0 110.384 178.64 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 13.7 mt . . . . . 0 N--CA 1.441 -0.886 0 N-CA-C 114.136 1.162 . . . . 0.0 114.136 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -78.63 161.52 27.82 Favored 'Trans proline' 0 N--CA 1.461 -0.398 0 N-CA-C 107.444 -1.791 . . . . 0.0 107.444 167.956 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 58.2 t80 -60.21 132.55 54.28 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 120.187 -0.605 . . . . 0.0 110.226 -178.313 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 91.84 -8.52 78.19 Favored Glycine 0 N--CA 1.452 -0.27 0 CA-C-O 119.193 -0.782 . . . . 0.0 114.712 178.873 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -66.03 129.63 40.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 118.788 1.294 . . . . 0.0 111.171 179.889 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 46.7 t-20 -79.32 128.72 33.69 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.421 -178.542 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 30.5 ttmt -156.18 153.19 28.85 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 107.483 -1.302 . . . . 0.0 107.483 -178.699 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -59.58 125.12 22.38 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.853 0.359 . . . . 0.0 111.807 -178.561 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 68.2 31.39 74.58 Favored Glycine 0 N--CA 1.448 -0.551 0 CA-C-O 119.286 -0.73 . . . . 0.0 113.9 178.262 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 43.4 mm -126.53 128.09 70.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 117.535 0.668 . . . . 0.0 109.954 178.442 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.1 pt -132.75 116.26 26.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 121.53 0.681 . . . . 0.0 110.599 176.555 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 94.8 m95 -82.94 138.45 33.82 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 112.216 0.45 . . . . 0.0 112.216 -177.86 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 16.0 m -137.69 150.91 25.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 178.816 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -160.3 165.33 31.54 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 103.523 -2.769 . . . . 0.0 103.523 179.837 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 14.8 t -125.07 175.82 7.1 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 104.941 -2.244 . . . . 0.0 104.941 178.114 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 -67.52 134.85 52.06 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 -179.826 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 91.49 -8.46 78.88 Favored Glycine 0 C--O 1.228 -0.244 0 CA-C-N 116.123 -0.49 . . . . 0.0 113.536 179.156 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.471 ' HA ' ' HA ' ' A' ' 41' ' ' ASP . . . -71.99 131.9 43.56 Favored 'General case' 0 CA--C 1.542 0.666 0 O-C-N 122.393 -0.475 . . . . 0.0 110.345 179.403 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 23.4 mt -88.91 138.89 31.0 Favored 'General case' 0 CA--C 1.51 -0.569 0 N-CA-C 112.995 0.739 . . . . 0.0 112.995 -177.433 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 56.9 t30 -83.94 72.11 10.45 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.353 -0.839 . . . . 0.0 111.046 179.475 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 2.3 t -143.4 155.38 60.94 Favored Pre-proline 0 C--N 1.324 -0.503 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 178.754 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_exo -67.61 153.25 76.74 Favored 'Trans proline' 0 CA--C 1.514 -0.495 0 CA-C-N 118.454 0.483 . . . . 0.0 113.183 179.175 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -152.02 52.73 0.8 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.928 0.871 . . . . 0.0 111.144 176.59 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -57.55 -26.54 61.57 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 114.918 -1.037 . . . . 0.0 109.972 175.194 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 9.6 p80 -57.18 -12.59 2.35 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 114.643 1.349 . . . . 0.0 114.643 179.198 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 64.2 mt -92.72 -45.19 14.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 178.372 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -70.59 14.72 1.32 Allowed Glycine 0 C--O 1.211 -1.298 0 N-CA-C 117.205 1.642 . . . . 0.0 117.205 -175.414 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 30.8 p -83.04 3.79 28.84 Favored 'General case' 0 CA--C 1.506 -0.718 0 C-N-CA 124.015 0.926 . . . . 0.0 113.249 -174.08 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 67.0 ttp85 -44.36 121.0 2.38 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 114.056 -1.429 . . . . 0.0 110.666 179.655 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 36.5 m120 -90.02 126.09 58.39 Favored Pre-proline 0 C--N 1.322 -0.624 0 N-CA-C 107.675 -1.232 . . . . 0.0 107.675 -179.579 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -69.89 -18.27 36.5 Favored 'Trans proline' 0 C--O 1.219 -0.473 0 C-N-CA 117.015 -1.524 . . . . 0.0 113.045 179.273 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -75.74 -27.95 58.32 Favored 'General case' 0 C--O 1.219 -0.536 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.308 178.125 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 -101.88 -23.96 14.09 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 113.283 0.846 . . . . 0.0 113.283 -175.244 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 26.8 t30 -150.63 148.63 28.86 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.941 0.719 . . . . 0.0 112.941 -178.201 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -87.86 147.33 25.16 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-O 121.521 0.677 . . . . 0.0 111.32 179.419 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -70.02 145.05 52.04 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.554 178.576 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 13.7 mt -83.18 139.06 18.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 -178.744 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 1.4 p -62.05 126.08 19.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 175.721 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 5.7 tt -65.91 128.57 36.56 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.156 0.503 . . . . 0.0 110.3 -176.748 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -132.33 157.55 44.17 Favored 'General case' 0 CA--C 1.509 -0.633 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 -178.73 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.429 HD13 HG22 ' A' ' 125' ' ' THR . 13.7 mt -113.58 148.76 40.42 Favored Pre-proline 0 C--N 1.322 -0.622 0 N-CA-C 108.091 -1.078 . . . . 0.0 108.091 177.059 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -73.43 165.52 32.28 Favored 'Trans proline' 0 N--CA 1.463 -0.314 0 O-C-N 122.227 0.593 . . . . 0.0 112.867 -178.846 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 40.6 tt0 -54.69 130.35 40.15 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.655 -179.682 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 101.38 -22.45 38.91 Favored Glycine 0 C--O 1.224 -0.509 0 CA-C-N 116.043 -0.526 . . . . 0.0 112.838 -179.056 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.429 HG22 HD13 ' A' ' 121' ' ' LEU . 9.8 m -108.63 127.26 53.81 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 117.795 0.798 . . . . 0.0 109.456 178.167 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 16.5 p -119.69 148.33 43.51 Favored 'General case' 0 CA--C 1.51 -0.575 0 CA-C-O 121.035 0.445 . . . . 0.0 110.837 -179.398 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 91.8 mt -69.07 152.29 96.82 Favored Pre-proline 0 C--N 1.324 -0.529 0 N-CA-C 107.108 -1.441 . . . . 0.0 107.108 177.678 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -77.67 174.08 13.17 Favored 'Trans proline' 0 N--CA 1.462 -0.37 0 CA-C-O 121.425 0.51 . . . . 0.0 111.782 179.834 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -56.19 129.25 39.37 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.23 -178.487 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 91.65 -4.92 79.78 Favored Glycine 0 C--O 1.226 -0.353 0 N-CA-C 115.601 1.001 . . . . 0.0 115.601 177.063 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -102.39 136.75 41.66 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 117.937 0.868 . . . . 0.0 112.465 -178.068 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 41.5 p90 -143.46 163.14 33.94 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 114.213 -1.358 . . . . 0.0 108.269 174.895 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -103.82 138.0 41.04 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 -176.351 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -66.28 141.83 57.88 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.237 -0.892 . . . . 0.0 108.976 176.288 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 94.81 -32.79 5.79 Favored Glycine 0 N--CA 1.458 0.142 0 C-N-CA 121.604 -0.331 . . . . 0.0 113.366 179.756 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 32.7 t . . . . . 0 C--N 1.325 -0.494 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 177.249 . . . . . . . . 0 0 . 1 . 031 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 0.344 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 . . . . . . . . . 0 0 . 1 . 031 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.431 ' HB3' ' CE1' ' A' ' 71' ' ' TYR . 11.6 p -60.22 139.22 57.7 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.389 178.568 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . 0.412 ' CD2' ' HD3' ' A' ' 109' ' ' ARG . 47.5 m95 -71.3 -21.93 62.01 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 114.95 1.463 . . . . 0.0 114.95 -178.762 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -121.49 162.07 21.16 Favored 'General case' 0 C--O 1.24 0.562 0 N-CA-C 113.734 1.013 . . . . 0.0 113.734 -173.329 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 77.8 p -68.68 163.39 23.97 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 114.548 -1.206 . . . . 0.0 109.849 179.418 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.401 ' HB2' ' CZ ' ' A' ' 69' ' ' TYR . . . -86.08 145.57 26.99 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 113.486 0.921 . . . . 0.0 113.486 -175.722 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -94.67 137.77 33.35 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 108.245 -1.021 . . . . 0.0 108.245 173.731 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 62.4 m -87.56 129.28 35.15 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 -179.924 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 16.6 tm0? -91.07 128.32 36.85 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 177.98 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 58.7 t60 -139.25 99.53 3.77 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 172.11 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 173.0 -170.91 44.06 Favored Glycine 0 C--O 1.229 -0.213 0 C-N-CA 120.496 -0.859 . . . . 0.0 111.445 179.511 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -97.66 -25.64 15.04 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 120.686 0.279 . . . . 0.0 110.529 178.631 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -96.5 163.23 13.13 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 105.594 -2.002 . . . . 0.0 105.594 174.631 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -88.62 -62.89 1.39 Allowed 'General case' 0 C--O 1.216 -0.691 0 N-CA-C 115.187 1.551 . . . . 0.0 115.187 -173.926 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 53.4 tp -176.87 142.93 0.41 Allowed 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 178.11 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 23.5 tptm -157.49 141.02 15.65 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 174.226 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 13.7 m-85 -123.92 152.49 66.5 Favored Pre-proline 0 C--O 1.24 0.595 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 175.53 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -70.41 159.09 54.1 Favored 'Trans proline' 0 CA--C 1.538 0.71 0 C-N-CA 120.449 0.766 . . . . 0.0 112.331 177.427 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 15.8 tpt180 -69.27 137.29 52.95 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 -178.377 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 83.85 8.64 84.02 Favored Glycine 0 C--O 1.222 -0.614 0 N-CA-C 111.345 -0.702 . . . . 0.0 111.345 179.082 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 9.1 mt-30 -150.92 170.95 18.06 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 -173.886 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 102.94 -16.67 54.08 Favored Glycine 0 CA--C 1.499 -0.928 0 CA-C-N 116.219 -0.446 . . . . 0.0 112.031 175.756 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 77.9 t -66.07 128.68 93.98 Favored Pre-proline 0 C--N 1.319 -0.759 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 177.144 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -73.46 170.11 20.7 Favored 'Trans proline' 0 N--CA 1.461 -0.435 0 O-C-N 122.201 0.579 . . . . 0.0 112.373 178.404 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 78.5 mt -73.01 112.38 9.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 -179.851 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 48.9 m-20 -109.89 77.29 1.04 Allowed 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 114.622 -1.172 . . . . 0.0 109.406 -177.189 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 71.5 p -65.11 -20.96 66.72 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 115.586 1.698 . . . . 0.0 115.586 -173.658 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.404 HD21 HD13 ' A' ' 117' ' ' ILE . 5.5 p30 -113.64 31.05 6.78 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.976 -176.175 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 78.0 p -134.42 166.57 22.55 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.011 0.434 . . . . 0.0 110.839 179.63 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 28.1 m -81.58 160.32 64.72 Favored Pre-proline 0 C--N 1.322 -0.612 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.75 -179.219 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -67.81 -24.23 40.69 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 116.453 -1.898 . . . . 0.0 114.033 -179.461 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.402 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 8.4 p-10 -75.52 -12.62 60.26 Favored 'General case' 0 C--N 1.322 -0.592 0 O-C-N 121.562 -0.711 . . . . 0.0 111.264 177.241 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 27.3 t0 -94.84 1.05 55.32 Favored 'General case' 0 C--O 1.214 -0.798 0 N-CA-C 113.328 0.862 . . . . 0.0 113.328 -177.371 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 93.1 mm-40 -62.34 -20.2 64.12 Favored 'General case' 0 CA--C 1.548 0.89 0 O-C-N 121.074 -1.016 . . . . 0.0 111.711 178.965 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.456 ' HB ' ' HB1' ' A' ' 98' ' ' ALA . 17.5 tt -63.98 140.46 19.65 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-O 122.118 0.961 . . . . 0.0 112.293 177.701 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 178.49 -161.17 27.62 Favored Glycine 0 CA--C 1.502 -0.737 0 C-N-CA 119.794 -1.193 . . . . 0.0 112.781 178.328 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.4 ' HB3' ' CE3' ' A' ' 92' ' ' TRP . 46.1 p90 -155.24 165.68 35.92 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 178.642 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 19.0 m-85 -106.87 139.68 40.9 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 106.771 -1.566 . . . . 0.0 106.771 175.986 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 42.5 ttt180 -113.47 118.23 33.93 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.08 -174.869 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 26.3 ttt180 -66.47 137.72 57.03 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 176.655 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -137.3 125.65 23.32 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.733 0.777 . . . . 0.0 111.465 179.923 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 37.7 p -136.74 154.28 50.63 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 106.079 -1.823 . . . . 0.0 106.079 177.128 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 65.1 ttt180 -159.73 124.04 3.85 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 121.06 -0.256 . . . . 0.0 110.486 177.399 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.35 144.33 51.32 Favored 'General case' 0 CA--C 1.484 -1.581 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 175.647 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -142.47 175.23 4.77 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.132 0 N-CA-C 105.854 -1.906 . . . . 0.0 105.854 179.023 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 78.0 ttt180 -119.67 128.89 54.25 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 102.466 -3.161 . . . . 0.0 102.466 171.14 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -80.89 -176.8 51.03 Favored Glycine 0 C--O 1.221 -0.667 0 N-CA-C 110.796 -0.922 . . . . 0.0 110.796 -179.784 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -78.75 -34.29 35.21 Favored Glycine 0 C--O 1.216 -1.005 0 N-CA-C 107.886 -2.086 . . . . 0.0 107.886 179.385 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -71.38 -20.69 62.11 Favored 'General case' 0 C--O 1.217 -0.655 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 175.184 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 108.43 -15.52 35.42 Favored Glycine 0 CA--C 1.503 -0.696 0 N-CA-C 110.351 -1.1 . . . . 0.0 110.351 172.593 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.8 144.57 57.16 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-O 122.394 1.092 . . . . 0.0 112.294 -177.96 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 5.4 mtp -87.8 175.08 8.0 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 114.01 -1.45 . . . . 0.0 112.57 -177.184 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 1.6 tmtm? -78.4 -46.04 20.87 Favored 'General case' 0 C--O 1.217 -0.642 0 CA-C-O 121.949 0.881 . . . . 0.0 109.797 176.915 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.2 t0 47.39 24.85 0.51 Allowed 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 119.054 2.983 . . . . 0.0 119.054 178.573 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.6 mp -83.45 149.01 26.93 Favored 'General case' 0 C--O 1.239 0.528 0 O-C-N 121.397 -0.814 . . . . 0.0 111.752 178.543 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -66.71 158.42 79.65 Favored Pre-proline 0 C--O 1.243 0.738 0 CA-C-N 115.395 -0.82 . . . . 0.0 111.909 178.834 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -71.44 147.21 51.87 Favored 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 118.126 -0.782 . . . . 0.0 112.582 177.585 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 1.2 mtt180 -134.14 165.81 24.22 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.998 176.228 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 62.5 m95 -121.89 135.03 54.86 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 176.328 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.401 ' CZ ' ' HB2' ' A' ' 15' ' ' ALA . 68.6 m-85 -112.83 171.77 7.33 Favored 'General case' 0 C--O 1.215 -0.738 0 N-CA-C 105.891 -1.892 . . . . 0.0 105.891 178.142 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -118.4 139.47 51.34 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 178.673 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.431 ' CE1' ' HB3' ' A' ' 11' ' ' SER . 14.2 m-85 -139.06 139.33 37.74 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 -176.545 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 45.3 m-85 -68.67 159.51 32.0 Favored 'General case' 0 C--O 1.24 0.585 0 N-CA-C 110.013 -0.366 . . . . 0.0 110.013 177.14 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 19.7 tp -53.4 130.56 35.74 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 121.18 0.514 . . . . 0.0 112.229 -178.515 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 67.49 28.41 73.6 Favored Glycine 0 C--O 1.223 -0.573 0 N-CA-C 116.269 1.268 . . . . 0.0 116.269 174.636 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 16.2 p . . . . . 0 C--N 1.324 -0.528 0 CA-C-N 118.262 1.031 . . . . 0.0 110.409 177.927 . . . . . . . . 0 0 . 1 . 031 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 18.1 mt . . . . . 0 N--CA 1.448 -0.543 0 N-CA-C 115.939 1.829 . . . . 0.0 115.939 . . . . . . . . . 0 0 . 1 . 031 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -78.76 164.01 25.87 Favored 'Trans proline' 0 N--CA 1.462 -0.344 0 C-N-CA 122.42 2.08 . . . . 0.0 108.176 168.274 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 56.2 t80 -62.08 132.29 52.38 Favored 'General case' 0 C--N 1.321 -0.642 0 O-C-N 121.947 -0.471 . . . . 0.0 110.627 -177.698 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 90.4 -6.17 82.43 Favored Glycine 0 C--O 1.227 -0.29 0 N-CA-C 114.528 0.571 . . . . 0.0 114.528 179.131 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -65.15 132.04 48.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 118.242 1.021 . . . . 0.0 111.821 179.677 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 50.5 t30 -78.68 127.31 31.92 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.523 179.403 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 28.2 ttmt -156.19 152.14 27.48 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 106.266 -1.753 . . . . 0.0 106.266 178.578 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 19.1 t0 -64.55 131.83 48.14 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 -179.249 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 69.66 28.84 71.71 Favored Glycine 0 N--CA 1.446 -0.655 0 N-CA-C 114.958 0.743 . . . . 0.0 114.958 177.116 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 42.7 mm -127.89 128.15 68.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 117.401 0.6 . . . . 0.0 109.985 179.044 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.1 pt -131.58 123.62 52.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.351 176.98 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . 0.4 ' CE3' ' HB3' ' A' ' 46' ' ' TYR . 97.8 m95 -88.39 135.57 33.4 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 114.149 1.166 . . . . 0.0 114.149 -175.304 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 17.8 m -136.16 152.03 29.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 178.778 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -163.97 166.6 21.44 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 103.514 -2.773 . . . . 0.0 103.514 -179.969 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 13.3 t -134.53 174.72 10.24 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 104.78 -2.304 . . . . 0.0 104.78 177.675 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 78.2 tt0 -66.71 135.21 53.67 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.185 0.516 . . . . 0.0 109.999 -178.955 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 95.75 -9.72 68.56 Favored Glycine 0 C--O 1.228 -0.234 0 CA-C-N 115.93 -0.577 . . . . 0.0 113.623 178.635 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.456 ' HB1' ' HB ' ' A' ' 44' ' ' ILE . . . -76.78 137.95 39.6 Favored 'General case' 0 CA--C 1.54 0.571 0 O-C-N 122.323 -0.516 . . . . 0.0 109.859 179.457 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 32.3 mt -92.56 140.29 29.7 Favored 'General case' 0 C--O 1.22 -0.471 0 CA-C-O 121.555 0.693 . . . . 0.0 112.324 -178.236 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 61.3 t30 -85.04 66.59 9.83 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.498 -0.773 . . . . 0.0 110.518 -179.037 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -136.37 152.84 75.73 Favored Pre-proline 0 C--N 1.324 -0.502 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 -179.527 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -68.45 150.87 75.94 Favored 'Trans proline' 0 C--N 1.344 0.326 0 N-CA-C 115.249 1.211 . . . . 0.0 115.249 178.779 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.492 ' HB3' HD12 ' A' ' 106' ' ' ILE . 67.5 mmtt -127.12 31.61 5.22 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.189 -0.914 . . . . 0.0 113.32 -176.339 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 18.1 t0 -60.98 -27.56 68.37 Favored 'General case' 0 N--CA 1.475 0.789 0 O-C-N 121.287 -0.883 . . . . 0.0 111.616 -178.135 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 47.2 p-80 -67.95 -16.78 64.22 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.806 177.853 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.492 HD12 ' HB3' ' A' ' 103' ' ' LYS . 66.3 mt -94.25 -38.56 9.45 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 176.078 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -72.96 6.73 11.72 Favored Glycine 0 C--O 1.225 -0.429 0 N-CA-C 115.668 1.027 . . . . 0.0 115.668 -178.214 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 14.5 t -83.05 25.44 0.69 Allowed 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 117.785 0.792 . . . . 0.0 111.684 -178.862 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.413 ' HD2' ' OD1' ' A' ' 114' ' ' ASN . 65.3 ttp85 -57.45 131.82 51.29 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.949 -179.42 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 55.1 m-20 -99.65 115.1 65.89 Favored Pre-proline 0 C--N 1.326 -0.423 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 178.804 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -72.8 -12.54 26.47 Favored 'Trans proline' 0 C--O 1.218 -0.518 0 N-CA-C 114.089 0.765 . . . . 0.0 114.089 -177.352 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -74.87 -24.56 58.58 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 176.042 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 -102.19 -30.78 10.92 Favored 'General case' 0 C--O 1.222 -0.344 0 N-CA-C 113.012 0.745 . . . . 0.0 113.012 -176.036 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . 0.413 ' OD1' ' HD2' ' A' ' 109' ' ' ARG . 0.9 OUTLIER -132.07 150.26 52.2 Favored 'General case' 0 N--CA 1.44 -0.937 0 CA-C-O 121.279 0.561 . . . . 0.0 112.265 -177.186 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -100.65 138.4 37.75 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 175.701 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -66.33 150.01 49.51 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.303 0.573 . . . . 0.0 111.722 -179.191 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.404 HD13 HD21 ' A' ' 37' ' ' ASN . 3.1 mt -87.96 141.48 14.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.669 -177.323 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 1.3 p -62.22 125.92 19.47 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 176.211 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 7.0 tt -70.07 129.62 39.92 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.25 -178.055 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 25.6 mt-30 -131.71 159.49 38.25 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 106.47 -1.678 . . . . 0.0 106.47 179.378 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 14.2 mt -114.37 146.09 35.12 Favored Pre-proline 0 C--N 1.323 -0.561 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 177.98 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -74.63 172.07 16.94 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 120.228 0.619 . . . . 0.0 113.678 -178.547 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 6.0 tp-100 -53.65 137.07 38.13 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.753 179.42 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 89.82 -20.71 34.04 Favored Glycine 0 N--CA 1.453 -0.229 0 CA-C-N 115.927 -0.579 . . . . 0.0 113.733 -179.11 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 3.9 m -108.56 129.81 55.3 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 118.274 1.037 . . . . 0.0 111.143 -179.995 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 2.3 p -125.87 148.27 49.23 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 -178.951 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 91.0 mt -68.93 154.57 94.82 Favored Pre-proline 0 C--N 1.327 -0.38 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 178.357 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -75.57 170.55 20.0 Favored 'Trans proline' 0 N--CA 1.463 -0.296 0 C-N-CA 118.342 -0.639 . . . . 0.0 111.48 -179.615 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -60.2 129.16 40.34 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 179.253 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 89.73 21.34 40.34 Favored Glycine 0 C--O 1.225 -0.444 0 C-N-CA 120.904 -0.665 . . . . 0.0 114.734 178.835 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -131.15 141.76 50.14 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 117.472 0.636 . . . . 0.0 111.651 178.115 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 51.8 p90 -150.47 163.79 37.53 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 175.508 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -107.35 147.25 30.56 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 113.396 0.887 . . . . 0.0 113.396 -175.826 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -73.52 142.7 46.72 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.091 -0.959 . . . . 0.0 109.666 177.206 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 93.38 -39.56 2.93 Favored Glycine 0 CA--C 1.519 0.298 0 N-CA-C 114.169 0.428 . . . . 0.0 114.169 178.665 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.445 -0.698 0 CA-C-O 121.854 0.835 . . . . 0.0 111.425 178.514 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.849 0 CA-C-O 121.422 0.629 . . . . 0.0 109.668 . . . . . . . . . 0 0 . 1 . 032 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 61.6 p -58.14 141.53 50.05 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.213 -0.903 . . . . 0.0 109.882 179.108 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . 0.444 ' CD2' ' HD3' ' A' ' 109' ' ' ARG . 23.9 m95 -65.65 -26.44 67.8 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.769 178.213 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 78.0 m-85 -121.74 162.87 20.04 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.302 0.572 . . . . 0.0 112.379 -174.235 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 73.1 p -71.44 164.86 24.99 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 176.529 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -77.74 157.04 30.23 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.855 0.836 . . . . 0.0 113.219 -177.672 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 25.0 mt -92.39 148.91 21.74 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 102.919 -2.993 . . . . 0.0 102.919 168.005 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 33.2 m -121.36 128.5 52.31 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 120.897 0.379 . . . . 0.0 110.396 -178.03 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 1.9 tm0? -90.42 130.03 36.54 Favored 'General case' 0 CA--C 1.512 -0.501 0 CA-C-N 115.567 -0.742 . . . . 0.0 112.82 -177.554 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 52.9 t60 -138.76 99.9 3.92 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 106.354 -1.721 . . . . 0.0 106.354 167.217 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 159.58 -140.86 7.09 Favored Glycine 0 C--N 1.323 -0.181 0 C-N-CA 119.589 -1.291 . . . . 0.0 113.813 -176.969 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -115.71 -27.18 7.15 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 114.875 1.435 . . . . 0.0 114.875 -177.692 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -78.46 151.96 32.37 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 177.403 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -79.13 -57.55 3.67 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 179.197 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 41.9 tp 175.96 135.16 0.05 OUTLIER 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 101.254 -3.61 . . . . 0.0 101.254 171.103 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 11.2 tmtt? -154.22 133.23 12.43 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 179.448 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 21.8 m-85 -122.33 153.3 61.89 Favored Pre-proline 0 C--O 1.241 0.636 0 O-C-N 123.023 0.202 . . . . 0.0 111.44 176.726 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -74.51 159.91 42.3 Favored 'Trans proline' 0 CA--C 1.538 0.702 0 CA-C-O 120.935 0.306 . . . . 0.0 111.768 175.727 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 17.0 tpt180 -70.71 139.75 51.25 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 -178.411 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 87.05 2.11 84.0 Favored Glycine 0 C--O 1.221 -0.687 0 N-CA-C 110.707 -0.957 . . . . 0.0 110.707 179.524 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 30.6 mt-30 -146.69 -179.66 6.94 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 -174.797 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 99.36 -20.26 50.54 Favored Glycine 0 CA--C 1.498 -0.987 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.714 176.232 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 86.8 t -67.92 126.87 93.16 Favored Pre-proline 0 C--N 1.317 -0.818 0 N-CA-C 106.703 -1.592 . . . . 0.0 106.703 177.295 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -73.28 167.53 27.08 Favored 'Trans proline' 0 N--CA 1.46 -0.485 0 C-N-CA 120.111 0.541 . . . . 0.0 112.494 178.649 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 85.6 mt -67.25 111.74 2.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 122.023 0.916 . . . . 0.0 109.352 -178.869 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 26.6 m-20 -94.82 100.79 12.62 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 114.394 -1.276 . . . . 0.0 110.157 -177.973 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 80.7 p -80.52 -20.32 43.8 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 113.912 1.078 . . . . 0.0 113.912 -176.901 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -117.45 3.66 12.49 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 115.411 1.634 . . . . 0.0 115.411 -174.486 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -110.77 157.27 19.97 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 115.756 1.761 . . . . 0.0 115.756 -171.926 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 47.6 m -79.23 162.77 62.76 Favored Pre-proline 0 C--N 1.318 -0.783 0 CA-C-N 113.896 -1.502 . . . . 0.0 108.845 177.937 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -67.48 -20.66 47.56 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 116.986 -1.543 . . . . 0.0 114.878 -177.46 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.417 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 6.2 p-10 -75.21 -20.39 59.3 Favored 'General case' 0 C--N 1.321 -0.637 0 O-C-N 121.74 -0.6 . . . . 0.0 111.075 178.359 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -88.79 0.87 56.1 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 114.394 1.257 . . . . 0.0 114.394 -174.746 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 94.4 mm-40 -62.45 -29.03 70.23 Favored 'General case' 0 C--N 1.316 -0.876 0 O-C-N 121.062 -1.024 . . . . 0.0 111.526 -179.382 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 13.3 tt -64.93 139.04 22.07 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.771 0 CA-C-O 122.009 0.909 . . . . 0.0 112.112 178.419 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 176.46 -158.97 25.65 Favored Glycine 0 CA--C 1.509 -0.305 0 C-N-CA 120.401 -0.904 . . . . 0.0 111.969 -177.722 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 42.8 p90 -155.04 169.97 22.86 Favored 'General case' 0 C--N 1.32 -0.715 0 O-C-N 122.458 -0.436 . . . . 0.0 109.996 -179.788 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 10.6 m-85 -112.73 138.04 50.13 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 173.43 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.06 119.12 38.38 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 123.896 0.878 . . . . 0.0 109.733 -179.26 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 49.5 ttp180 -65.7 134.28 52.88 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 174.765 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -143.74 147.82 34.75 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.844 0.354 . . . . 0.0 110.814 -178.072 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 5.8 p -148.36 139.83 23.52 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 175.623 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 12.4 tpt180 -130.34 133.69 46.62 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 173.55 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 2.7 tpp180 -147.32 148.31 31.26 Favored 'General case' 0 CA--C 1.487 -1.463 0 CA-C-O 121.51 0.671 . . . . 0.0 110.77 -176.169 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -138.4 177.14 5.56 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.922 0 N-CA-C 103.715 -2.698 . . . . 0.0 103.715 178.9 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 48.1 ttp180 -138.77 117.09 11.92 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 177.578 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -100.48 155.8 19.43 Favored Glycine 0 C--O 1.222 -0.656 0 N-CA-C 108.146 -1.982 . . . . 0.0 108.146 177.787 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -75.27 -24.55 70.78 Favored Glycine 0 C--O 1.22 -0.731 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 178.458 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.4 p30 -83.28 -20.36 34.6 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 114.469 -0.865 . . . . 0.0 110.235 177.334 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 110.12 8.46 25.53 Favored Glycine 0 C--O 1.227 -0.307 0 N-CA-C 114.78 0.672 . . . . 0.0 114.78 173.136 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 10.6 pttt -66.01 137.23 56.97 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 122.319 1.057 . . . . 0.0 111.83 179.399 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 99.1 mmm -118.9 172.29 7.64 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 113.234 -1.803 . . . . 0.0 108.844 -178.929 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 14.2 tppt? -116.35 -66.56 1.07 Allowed 'General case' 0 C--O 1.219 -0.552 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 177.636 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -107.09 147.64 29.76 Favored 'General case' 0 CA--C 1.506 -0.722 0 N-CA-C 105.552 -2.018 . . . . 0.0 105.552 176.201 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -113.45 -47.07 3.02 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 105.657 -1.979 . . . . 0.0 105.657 175.616 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -102.38 151.82 38.23 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-N 114.867 -1.061 . . . . 0.0 110.378 179.205 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -64.07 150.73 87.74 Favored 'Trans proline' 0 C--N 1.35 0.658 0 O-C-N 122.033 0.491 . . . . 0.0 113.079 176.441 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 90.6 mtt-85 -116.7 159.21 22.59 Favored 'General case' 0 C--O 1.222 -0.394 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 178.748 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 53.7 m95 -137.33 125.38 22.86 Favored 'General case' 0 C--O 1.214 -0.765 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 174.77 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 59.9 m-85 -110.43 142.67 41.83 Favored 'General case' 0 C--O 1.216 -0.671 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 -177.08 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 81.1 t80 -93.01 135.95 33.72 Favored 'General case' 0 CA--C 1.507 -0.708 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 -176.142 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -139.01 137.72 36.58 Favored 'General case' 0 N--CA 1.441 -0.911 0 CA-C-N 114.739 -1.119 . . . . 0.0 109.195 -175.246 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 27.3 m-85 -67.74 159.39 30.27 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.71 179.065 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -50.46 122.53 7.19 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 113.743 1.016 . . . . 0.0 113.743 -177.258 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 68.53 22.13 74.88 Favored Glycine 0 C--O 1.226 -0.351 0 N-CA-C 116.193 1.237 . . . . 0.0 116.193 176.028 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 33.8 p . . . . . 0 C--N 1.325 -0.495 0 CA-C-N 118.351 1.075 . . . . 0.0 111.017 179.306 . . . . . . . . 0 0 . 1 . 032 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 16.4 mt . . . . . 0 N--CA 1.442 -0.839 0 N-CA-C 116.289 1.959 . . . . 0.0 116.289 . . . . . . . . . 0 0 . 1 . 032 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -78.46 160.81 28.67 Favored 'Trans proline' 0 C--O 1.233 0.227 0 C-N-CA 122.337 2.025 . . . . 0.0 107.417 167.949 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 60.3 t80 -60.85 132.76 54.89 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 120.291 -0.564 . . . . 0.0 110.957 -176.855 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 90.04 -6.53 82.65 Favored Glycine 0 N--CA 1.453 -0.215 0 CA-C-O 119.484 -0.62 . . . . 0.0 114.177 179.452 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -66.17 130.52 43.51 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 118.533 1.167 . . . . 0.0 111.332 179.459 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 52.5 t30 -80.86 128.54 33.79 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.332 -0.849 . . . . 0.0 109.091 179.431 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.429 ' HB3' HG13 ' A' ' 90' ' ' ILE . 27.7 ttmt -156.21 158.9 38.39 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 107.375 -1.343 . . . . 0.0 107.375 -178.921 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -54.67 122.34 10.43 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.053 0.39 . . . . 0.0 112.053 179.33 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 64.49 35.66 92.22 Favored Glycine 0 N--CA 1.448 -0.527 0 CA-C-O 119.189 -0.784 . . . . 0.0 114.376 174.436 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.429 HG13 ' HB3' ' A' ' 87' ' ' LYS . 49.4 mm -121.06 126.0 74.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 117.631 0.715 . . . . 0.0 110.939 179.225 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -126.92 117.73 48.56 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.706 176.254 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 97.5 m95 -85.38 136.3 33.52 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 -177.72 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 16.5 m -134.77 155.17 38.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 178.8 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -165.68 165.32 18.75 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 -178.373 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 12.3 t -130.42 168.32 17.18 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 104.969 -2.234 . . . . 0.0 104.969 174.107 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 76.6 tt0 -67.39 137.82 56.24 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.342 0.592 . . . . 0.0 110.88 -178.777 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 94.91 -10.58 70.21 Favored Glycine 0 C--O 1.229 -0.162 0 CA-C-N 115.662 -0.699 . . . . 0.0 113.093 177.578 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.417 ' HA ' ' HA ' ' A' ' 41' ' ' ASP . . . -78.75 118.4 20.78 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-O 120.974 0.416 . . . . 0.0 111.149 -179.938 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -68.6 133.42 48.47 Favored 'General case' 0 CA--C 1.51 -0.593 0 N-CA-C 114.101 1.148 . . . . 0.0 114.101 -177.628 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 46.9 t30 -83.26 76.23 9.9 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 113.825 -1.534 . . . . 0.0 109.062 178.776 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 1.4 t -146.44 155.36 49.61 Favored Pre-proline 0 C--N 1.322 -0.615 0 N-CA-C 106.053 -1.832 . . . . 0.0 106.053 -177.88 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -61.56 150.16 86.6 Favored 'Trans proline' 0 C--N 1.345 0.346 0 N-CA-C 115.446 1.287 . . . . 0.0 115.446 178.475 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.511 ' HB3' HD12 ' A' ' 106' ' ' ILE . 71.9 mmtt -123.29 30.47 6.3 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.748 -179.983 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 15.4 p-10 -51.34 -42.91 61.58 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.897 -0.592 . . . . 0.0 112.174 -176.914 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 15.6 p80 -68.5 -11.38 59.76 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 113.962 1.097 . . . . 0.0 113.962 -179.652 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.511 HD12 ' HB3' ' A' ' 103' ' ' LYS . 28.1 mt -95.54 -43.28 12.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 121.7 0.762 . . . . 0.0 110.488 178.826 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -72.8 4.03 24.38 Favored Glycine 0 C--O 1.221 -0.717 0 N-CA-C 116.119 1.208 . . . . 0.0 116.119 -176.543 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 13.1 t -83.38 25.78 0.71 Allowed 'General case' 0 CA--C 1.543 0.711 0 CA-C-O 121.492 0.663 . . . . 0.0 111.497 179.57 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.484 ' HD2' HD22 ' A' ' 114' ' ' ASN . 63.6 ttp85 -58.51 129.19 40.88 Favored 'General case' 0 CA--C 1.517 -0.319 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 -179.786 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 34.2 m120 -89.71 121.77 68.74 Favored Pre-proline 0 C--N 1.322 -0.617 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 -177.397 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -72.89 -15.22 26.5 Favored 'Trans proline' 0 C--O 1.218 -0.492 0 C-N-CA 116.789 -1.674 . . . . 0.0 112.188 178.95 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -77.03 -28.98 55.09 Favored 'General case' 0 C--O 1.221 -0.447 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.182 178.199 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 84.7 m-20 -102.69 -22.63 13.92 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 113.673 0.99 . . . . 0.0 113.673 -175.12 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . 0.484 HD22 ' HD2' ' A' ' 109' ' ' ARG . 37.6 t30 -140.23 153.48 46.57 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 -177.852 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -95.55 143.73 26.61 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-O 121.264 0.554 . . . . 0.0 110.358 178.298 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -72.88 149.25 43.65 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.315 0.578 . . . . 0.0 110.9 178.893 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 8.9 mt -84.69 136.93 21.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.213 -178.817 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 78.7 t -62.27 121.97 11.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 N-CA-C 106.037 -1.838 . . . . 0.0 106.037 174.927 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 5.9 tt -67.04 130.27 42.58 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.095 0.474 . . . . 0.0 111.338 -176.145 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 31.5 mt-30 -134.48 158.56 43.62 Favored 'General case' 0 CA--C 1.513 -0.475 0 N-CA-C 106.751 -1.574 . . . . 0.0 106.751 -179.607 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 13.2 mt -112.24 147.15 36.36 Favored Pre-proline 0 C--N 1.322 -0.592 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 177.637 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -73.96 165.64 31.59 Favored 'Trans proline' 0 C--N 1.346 0.408 0 O-C-N 122.168 0.562 . . . . 0.0 113.059 -179.92 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 58.3 tp60 -53.85 130.18 36.23 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.296 -0.865 . . . . 0.0 109.453 179.381 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 103.4 -24.2 30.78 Favored Glycine 0 C--O 1.226 -0.355 0 CA-C-N 115.618 -0.719 . . . . 0.0 112.767 -179.376 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 4.7 m -103.54 129.7 50.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 118.307 1.053 . . . . 0.0 111.958 178.844 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 3.7 p -117.37 148.12 42.03 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.309 -0.859 . . . . 0.0 109.569 179.126 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 82.5 mt -70.52 157.38 90.2 Favored Pre-proline 0 C--N 1.323 -0.545 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 177.566 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -73.06 173.09 14.2 Favored 'Trans proline' 0 C--O 1.236 0.42 0 N-CA-C 110.111 -0.765 . . . . 0.0 110.111 178.395 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -68.71 122.83 19.35 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 119.704 -0.798 . . . . 0.0 111.192 -173.605 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 90.08 45.85 4.34 Favored Glycine 0 N--CA 1.452 -0.279 0 CA-C-N 115.1 -0.954 . . . . 0.0 113.877 -179.886 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -141.93 150.0 40.89 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 117.265 0.532 . . . . 0.0 111.765 179.016 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 42.3 p90 -150.69 166.11 31.36 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 175.718 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -100.63 147.03 26.43 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.031 0.443 . . . . 0.0 111.137 -178.481 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -70.51 136.8 49.67 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 179.296 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 86.52 -30.93 4.34 Favored Glycine 0 C--O 1.227 -0.295 0 CA-C-N 116.21 -0.45 . . . . 0.0 112.777 -177.699 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 19.6 t . . . . . 0 C--N 1.325 -0.486 0 O-C-N 122.117 -0.637 . . . . 0.0 110.404 -179.132 . . . . . . . . 0 0 . 1 . 033 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 0.243 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 . . . . . . . . . 0 0 . 1 . 033 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 54.2 p -59.54 144.3 47.75 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 178.876 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 24.8 m95 -65.56 -21.9 66.65 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.574 0.583 . . . . 0.0 112.574 178.809 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 12.7 m-85 -121.43 163.33 18.92 Favored 'General case' 0 CA--C 1.507 -0.673 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 -170.562 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 72.0 p -70.47 165.36 22.74 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 114.517 -1.219 . . . . 0.0 107.794 177.35 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -80.04 149.57 30.66 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.561 0.696 . . . . 0.0 112.004 -177.853 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 13.9 mt -85.83 145.07 27.37 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 102.416 -3.179 . . . . 0.0 102.416 169.362 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 65.0 m -120.46 141.28 50.33 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 -179.256 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.455 ' HB2' ' CZ ' ' A' ' 131' ' ' PHE . 4.4 tp60 -111.04 136.03 50.65 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -177.091 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 60.1 t60 -132.06 99.47 4.74 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 103.42 -2.807 . . . . 0.0 103.42 168.612 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 171.79 -167.03 40.04 Favored Glycine 0 N--CA 1.451 -0.328 0 N-CA-C 110.254 -1.138 . . . . 0.0 110.254 -175.479 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 49.8 mtpt -102.61 -27.25 12.85 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 115.126 1.528 . . . . 0.0 115.126 -177.454 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -85.71 166.28 16.26 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 -179.982 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -77.19 -62.91 1.5 Allowed 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.698 -178.708 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 29.3 tp 178.64 140.01 0.1 Allowed 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 104.864 -2.273 . . . . 0.0 104.864 175.474 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 44.0 tptt -148.18 135.31 20.3 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.064 0.459 . . . . 0.0 110.825 175.282 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -125.3 155.08 71.99 Favored Pre-proline 0 C--O 1.243 0.739 0 N-CA-C 105.594 -2.002 . . . . 0.0 105.594 174.852 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -71.58 173.13 13.0 Favored 'Trans proline' 0 C--N 1.347 0.485 0 CA-C-O 121.88 0.7 . . . . 0.0 113.652 -179.067 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 52.9 tpt85 -77.48 123.87 27.15 Favored 'General case' 0 C--O 1.217 -0.651 0 O-C-N 121.377 -0.827 . . . . 0.0 109.703 179.886 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 85.51 10.64 76.49 Favored Glycine 0 C--O 1.223 -0.569 0 CA-C-N 115.122 -0.945 . . . . 0.0 115.264 176.346 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.545 HE21 HG23 ' A' ' 125' ' ' THR . 18.9 tt0 -157.54 143.35 17.43 Favored 'General case' 0 C--O 1.219 -0.545 0 N-CA-C 106.747 -1.575 . . . . 0.0 106.747 -179.418 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 139.37 -13.32 3.25 Favored Glycine 0 CA--C 1.507 -0.428 0 C-N-CA 120.274 -0.965 . . . . 0.0 113.652 178.205 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 34.6 m -71.8 144.96 88.86 Favored Pre-proline 0 C--N 1.322 -0.616 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 177.898 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -76.92 171.62 17.66 Favored 'Trans proline' 0 N--CA 1.46 -0.441 0 C-N-CA 121.621 1.548 . . . . 0.0 113.203 179.685 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 94.8 mt -75.05 115.75 16.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 121.578 0.704 . . . . 0.0 109.369 178.893 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.413 ' HB2' HE22 ' A' ' 43' ' ' GLN . 76.8 m-20 -94.63 85.01 4.38 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 107.243 -1.391 . . . . 0.0 107.243 178.113 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 73.4 p -61.64 -21.82 64.73 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 115.971 1.841 . . . . 0.0 115.971 -173.79 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -114.25 16.31 17.98 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 113.376 0.88 . . . . 0.0 113.376 -176.556 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.4 m -132.55 172.55 12.36 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 115.94 1.83 . . . . 0.0 115.94 -174.857 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 42.0 m -82.0 159.18 66.2 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 115.218 -0.901 . . . . 0.0 112.525 -176.273 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -67.28 -19.69 49.86 Favored 'Trans proline' 0 C--N 1.351 0.675 0 C-N-CA 117.219 -1.388 . . . . 0.0 114.279 -179.548 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.411 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 0.4 OUTLIER -71.3 -24.15 62.09 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 121.746 -0.596 . . . . 0.0 110.776 177.898 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -85.11 -10.73 56.47 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 116.021 1.86 . . . . 0.0 116.021 -170.939 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.413 HE22 ' HB2' ' A' ' 35' ' ' ASN . 85.0 mm-40 -56.93 -26.59 59.75 Favored 'General case' 0 C--O 1.217 -0.631 0 N-CA-C 113.807 1.039 . . . . 0.0 113.807 -173.151 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 14.0 tt -62.12 139.42 20.88 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 CA-C-O 122.313 1.054 . . . . 0.0 112.875 178.539 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 177.68 -152.66 12.1 Favored Glycine 0 CA--C 1.505 -0.563 0 C-N-CA 120.402 -0.904 . . . . 0.0 110.994 -178.975 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 51.3 p90 -155.06 169.38 24.25 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 178.685 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 35.9 m-85 -111.34 143.4 42.19 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 106.764 -1.569 . . . . 0.0 106.764 173.983 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 71.7 ttt-85 -117.48 124.4 48.68 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 123.744 0.817 . . . . 0.0 111.595 -177.694 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 2.1 ptm180 -71.03 146.2 49.5 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.203 0.525 . . . . 0.0 110.525 179.412 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -146.24 144.86 30.15 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.419 0.628 . . . . 0.0 110.736 179.108 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 41.1 p -142.99 171.61 13.82 Favored 'General case' 0 C--O 1.249 1.034 0 N-CA-C 104.364 -2.458 . . . . 0.0 104.364 175.451 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -140.65 123.9 16.7 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 122.004 -0.435 . . . . 0.0 111.55 176.25 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 4.6 tmt_? -140.78 137.01 33.05 Favored 'General case' 0 CA--C 1.496 -1.109 0 CA-C-O 121.611 0.72 . . . . 0.0 110.562 -178.568 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -140.24 -179.38 2.0 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 N-CA-C 105.949 -1.871 . . . . 0.0 105.949 -179.453 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 6.3 ttm180 -128.94 119.25 24.02 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 175.216 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -80.72 -179.87 53.14 Favored Glycine 0 C--O 1.224 -0.476 0 N-CA-C 108.481 -1.847 . . . . 0.0 108.481 176.243 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -63.63 -46.96 90.93 Favored Glycine 0 C--O 1.219 -0.827 0 CA-C-N 118.343 1.072 . . . . 0.0 112.625 -178.463 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -75.8 -8.41 56.8 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 121.724 0.774 . . . . 0.0 110.11 178.995 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 104.43 -13.77 51.05 Favored Glycine 0 CA--C 1.51 -0.269 0 CA-C-N 115.32 -0.855 . . . . 0.0 111.501 178.875 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 12.0 pttt -56.37 136.59 53.54 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-O 122.112 0.958 . . . . 0.0 110.795 -178.877 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 15.0 ptm -132.05 165.76 23.26 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 114.375 -1.284 . . . . 0.0 114.127 -173.698 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 40.2 mttt -77.08 -60.13 2.49 Favored 'General case' 0 C--O 1.212 -0.903 0 N-CA-C 114.623 1.342 . . . . 0.0 114.623 -176.182 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 52.97 48.04 23.3 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 113.785 1.031 . . . . 0.0 113.785 178.509 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.4 mp -60.97 141.97 56.88 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.389 179.951 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 59.3 p -55.39 148.97 30.11 Favored Pre-proline 0 C--O 1.25 1.086 0 CA-C-N 115.071 -0.968 . . . . 0.0 111.753 -176.903 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -65.22 138.71 57.2 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 117.529 -1.18 . . . . 0.0 112.813 -176.979 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 5.4 ptp180 -141.38 155.78 45.88 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.425 -1.261 . . . . 0.0 108.517 -178.834 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 48.0 m95 -123.64 137.9 54.64 Favored 'General case' 0 C--N 1.318 -0.777 0 C-N-CA 122.671 0.389 . . . . 0.0 110.494 -176.16 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 29.5 m-85 -114.84 139.4 49.79 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 -179.464 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 88.5 t80 -88.49 135.94 33.24 Favored 'General case' 0 CA--C 1.505 -0.77 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 -178.825 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -139.73 139.13 36.45 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 -176.054 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 64.6 m-85 -71.21 159.47 34.59 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.351 -0.84 . . . . 0.0 112.326 -175.117 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -54.84 126.76 25.59 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.843 -179.624 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 68.61 38.21 85.88 Favored Glycine 0 C--O 1.218 -0.85 0 N-CA-C 115.482 0.953 . . . . 0.0 115.482 176.59 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.327 -0.411 0 CA-C-N 118.927 1.364 . . . . 0.0 107.985 178.058 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 17.8 mt . . . . . 0 N--CA 1.447 -0.623 0 N-CA-C 114.249 1.203 . . . . 0.0 114.249 . . . . . . . . . 0 0 . 1 . 033 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -78.86 165.16 24.7 Favored 'Trans proline' 0 C--O 1.237 0.431 0 C-N-CA 121.817 1.678 . . . . 0.0 108.414 170.239 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 61.4 t80 -61.6 131.17 49.16 Favored 'General case' 0 C--N 1.321 -0.654 0 C-N-CA 120.445 -0.502 . . . . 0.0 109.855 -179.958 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 92.45 -5.31 77.45 Favored Glycine 0 C--O 1.227 -0.315 0 N-CA-C 114.775 0.67 . . . . 0.0 114.775 178.806 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -65.57 126.76 29.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 118.412 1.106 . . . . 0.0 111.966 179.127 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 70.3 m-20 -71.97 126.79 30.64 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 114.624 -1.171 . . . . 0.0 110.335 -178.579 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 13.7 ttmm -156.12 151.35 26.62 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 178.564 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -62.55 131.05 47.8 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.274 178.931 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 68.46 27.86 73.55 Favored Glycine 0 N--CA 1.452 -0.275 0 N-CA-C 115.395 0.918 . . . . 0.0 115.395 177.809 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 39.3 mm -129.33 131.35 67.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 117.35 0.575 . . . . 0.0 110.494 -179.999 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.1 pt -131.48 114.85 26.67 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 CA-C-O 121.495 0.665 . . . . 0.0 110.774 175.643 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 95.7 m95 -82.24 135.13 35.29 Favored 'General case' 0 C--N 1.321 -0.662 0 O-C-N 121.831 -0.543 . . . . 0.0 112.227 -177.604 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -142.1 152.02 18.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.824 -0.626 . . . . 0.0 109.312 -178.525 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -155.98 166.59 33.02 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 105.646 -1.983 . . . . 0.0 105.646 -177.826 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 11.6 t -134.38 173.83 11.19 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 105.973 -1.862 . . . . 0.0 105.973 176.263 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -66.57 138.02 57.18 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.343 0.592 . . . . 0.0 110.925 -179.603 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 95.05 -14.66 64.91 Favored Glycine 0 N--CA 1.458 0.146 0 CA-C-N 115.568 -0.742 . . . . 0.0 112.836 177.652 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.411 ' HA ' ' HA ' ' A' ' 41' ' ' ASP . . . -75.06 136.08 41.2 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-O 120.738 0.304 . . . . 0.0 111.311 -179.633 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 30.2 mt -93.75 134.16 36.37 Favored 'General case' 0 CA--C 1.51 -0.58 0 N-CA-C 113.072 0.767 . . . . 0.0 113.072 -178.923 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 55.5 t30 -81.45 71.73 8.47 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 114.878 -1.055 . . . . 0.0 110.838 -178.391 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 1.3 t -142.17 154.79 64.94 Favored Pre-proline 0 C--N 1.322 -0.601 0 N-CA-C 106.129 -1.804 . . . . 0.0 106.129 179.784 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -68.78 148.71 71.88 Favored 'Trans proline' 0 CA--C 1.531 0.362 0 C-N-CA 118.347 -0.635 . . . . 0.0 113.537 176.34 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 5.8 ptpt -149.19 56.12 0.99 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 122.522 1.153 . . . . 0.0 111.169 178.384 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -57.46 -33.23 67.75 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.434 -1.257 . . . . 0.0 112.39 179.703 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 16.9 p80 -62.72 -7.66 5.3 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 115.015 1.487 . . . . 0.0 115.015 -177.862 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 44.7 mt -93.58 -39.25 10.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 177.857 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -72.81 14.65 2.57 Favored Glycine 0 C--O 1.218 -0.88 0 N-CA-C 115.612 1.005 . . . . 0.0 115.612 -178.409 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 14.3 t -99.67 27.98 5.0 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 113.322 0.86 . . . . 0.0 113.322 -176.928 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 62.4 ttp85 -51.52 133.08 30.4 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 177.477 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -90.45 117.88 68.33 Favored Pre-proline 0 C--N 1.326 -0.434 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 -179.538 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -71.45 -15.17 31.06 Favored 'Trans proline' 0 C--O 1.219 -0.462 0 C-N-CA 117.569 -1.154 . . . . 0.0 114.651 -177.086 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -81.1 -24.86 37.42 Favored 'General case' 0 C--O 1.22 -0.485 0 CA-C-O 121.052 0.453 . . . . 0.0 110.277 178.779 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 -100.89 -25.54 14.06 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 -175.02 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 27.3 t30 -147.96 144.37 27.96 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 113.284 0.846 . . . . 0.0 113.284 -178.404 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -84.27 146.46 27.75 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.13 179.823 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -67.77 143.67 55.74 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.405 0.622 . . . . 0.0 110.434 178.587 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 20.6 mt -83.84 139.43 17.64 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 -178.807 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.48 HG11 ' HB2' ' A' ' 136' ' ' SER . 71.3 t -58.89 126.81 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 N-CA-C 106.393 -1.706 . . . . 0.0 106.393 175.252 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 7.7 tt -67.29 129.31 39.49 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 -178.933 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -130.34 156.61 44.41 Favored 'General case' 0 CA--C 1.511 -0.534 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 -178.474 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.415 HD13 HG22 ' A' ' 125' ' ' THR . 14.8 mt -113.56 147.72 38.16 Favored Pre-proline 0 C--N 1.323 -0.582 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 178.879 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -71.94 166.77 28.56 Favored 'Trans proline' 0 C--N 1.345 0.382 0 O-C-N 122.338 0.652 . . . . 0.0 113.262 -178.721 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 34.0 tt0 -54.86 129.78 38.66 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.284 -179.409 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 93.71 -13.24 67.92 Favored Glycine 0 C--O 1.226 -0.363 0 CA-C-N 115.985 -0.552 . . . . 0.0 113.552 179.976 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.545 HG23 HE21 ' A' ' 30' ' ' GLN . 23.0 m -103.92 126.69 51.23 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 117.904 0.852 . . . . 0.0 110.265 179.035 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 11.6 p -121.67 148.4 44.63 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.934 -177.227 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 77.4 mt -74.13 154.08 88.49 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.301 178.286 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -76.86 173.87 13.77 Favored 'Trans proline' 0 C--N 1.345 0.393 0 N-CA-C 110.471 -0.627 . . . . 0.0 110.471 177.103 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 4.8 tmtt? -61.04 123.28 17.19 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.785 0.661 . . . . 0.0 112.785 -174.687 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 95.23 0.8 63.06 Favored Glycine 0 C--N 1.328 0.122 0 N-CA-C 115.141 0.817 . . . . 0.0 115.141 175.201 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.455 ' CZ ' ' HB2' ' A' ' 18' ' ' GLN . 1.2 m-85 -100.87 135.33 42.48 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-O 121.777 0.799 . . . . 0.0 110.538 -179.64 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 37.8 p90 -140.46 160.5 39.86 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 114.531 -1.213 . . . . 0.0 108.762 177.469 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -96.59 139.37 32.78 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.14 0.495 . . . . 0.0 111.454 -177.292 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -70.15 135.91 49.59 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 177.966 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 93.9 -9.01 73.44 Favored Glycine 0 CA--C 1.519 0.328 0 N-CA-C 114.716 0.646 . . . . 0.0 114.716 179.601 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . 0.48 ' HB2' HG11 ' A' ' 118' ' ' VAL . 8.4 t . . . . . 0 C--N 1.326 -0.426 0 CA-C-N 117.803 0.801 . . . . 0.0 110.781 178.44 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.163 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 . . . . . . . . . 0 0 . 1 . 034 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 31.3 t -61.36 136.92 58.21 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.448 178.368 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . 0.408 ' CD2' ' HD3' ' A' ' 109' ' ' ARG . 4.3 m95 -68.91 -26.26 65.01 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-O 121.24 0.543 . . . . 0.0 111.005 177.126 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -121.58 162.68 20.19 Favored 'General case' 0 CA--C 1.51 -0.592 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.385 -171.191 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 64.1 p -68.05 163.31 22.67 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 178.454 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -75.08 152.36 38.59 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.839 0.828 . . . . 0.0 113.166 -176.26 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 12.7 mt -91.35 148.68 22.15 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 102.882 -3.007 . . . . 0.0 102.882 169.458 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 25.9 m -127.76 140.36 52.1 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 -178.38 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.455 ' HB2' ' CZ ' ' A' ' 131' ' ' PHE . 4.6 tp60 -119.34 139.59 51.73 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 114.313 1.227 . . . . 0.0 114.313 -175.668 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 34.7 t60 -136.17 99.57 4.16 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 104.045 -2.576 . . . . 0.0 104.045 168.047 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 177.04 -158.56 24.35 Favored Glycine 0 C--O 1.228 -0.277 0 N-CA-C 110.801 -0.92 . . . . 0.0 110.801 -175.165 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 60.8 mttp -114.16 -22.32 10.05 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 114.16 1.17 . . . . 0.0 114.16 -178.579 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -84.76 157.38 21.04 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 107.883 -1.155 . . . . 0.0 107.883 177.785 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -76.67 -62.68 1.55 Allowed 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 -177.758 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 41.1 tp 177.23 145.14 0.1 Allowed 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 104.084 -2.561 . . . . 0.0 104.084 173.279 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 79.7 tttt -157.77 145.29 18.47 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 175.115 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 17.3 m-85 -134.53 151.21 75.65 Favored Pre-proline 0 C--N 1.323 -0.546 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 175.572 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -77.68 162.29 30.15 Favored 'Trans proline' 0 CA--C 1.538 0.716 0 O-C-N 122.02 0.484 . . . . 0.0 113.106 178.558 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 17.7 tpt180 -64.7 136.5 57.01 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.466 -178.862 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 90.26 -5.7 82.76 Favored Glycine 0 C--N 1.329 0.181 0 N-CA-C 111.397 -0.681 . . . . 0.0 111.397 178.132 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 -138.48 -179.68 5.95 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 123.714 0.805 . . . . 0.0 109.354 -174.665 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 100.22 -27.29 21.03 Favored Glycine 0 CA--C 1.497 -1.058 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.516 176.046 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 92.3 t -65.45 126.17 90.97 Favored Pre-proline 0 N--CA 1.444 -0.772 0 N-CA-C 106.207 -1.775 . . . . 0.0 106.207 176.288 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -72.44 164.26 36.16 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 O-C-N 122.175 0.566 . . . . 0.0 111.248 178.624 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 87.3 mt -63.85 115.58 2.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-O 121.658 0.742 . . . . 0.0 109.695 -176.692 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 6.7 m-80 -95.91 108.05 20.38 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.18 -0.918 . . . . 0.0 111.914 -177.026 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 70.3 p -91.3 -12.73 34.2 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.909 0.861 . . . . 0.0 110.827 177.662 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 12.5 p30 -110.27 9.01 23.74 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 116.993 2.219 . . . . 0.0 116.993 -173.247 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 87.6 p -154.08 165.57 35.78 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 115.19 1.552 . . . . 0.0 115.19 -175.23 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 25.4 m -78.65 167.56 34.22 Favored Pre-proline 0 N--CA 1.472 0.637 0 C-N-CA 124.311 1.044 . . . . 0.0 112.624 -176.42 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -64.54 -24.69 63.13 Favored 'Trans proline' 0 C--N 1.354 0.845 0 C-N-CA 115.62 -2.453 . . . . 0.0 112.843 177.575 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -63.0 -25.93 68.62 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.506 0.67 . . . . 0.0 111.211 176.168 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -97.3 -1.45 44.64 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 115.06 1.504 . . . . 0.0 115.06 -170.877 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 94.5 mm-40 -60.74 -26.12 66.96 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 113.243 0.831 . . . . 0.0 113.243 -177.614 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.411 ' HB ' ' HB1' ' A' ' 98' ' ' ALA . 19.0 tt -58.61 137.7 20.63 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 CA-C-O 122.384 1.087 . . . . 0.0 113.683 -177.994 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 178.9 -161.01 27.05 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.473 -0.87 . . . . 0.0 113.43 -178.787 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 44.7 p90 -154.76 169.09 24.76 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 179.357 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 13.6 m-85 -112.17 139.93 47.29 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 172.369 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.14 129.78 54.15 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 179.407 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 17.6 ttm105 -73.25 132.94 43.74 Favored 'General case' 0 CA--C 1.5 -0.971 0 N-CA-C 104.873 -2.269 . . . . 0.0 104.873 175.496 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -69.86 165.93 20.52 Favored 'General case' 0 N--CA 1.426 -1.648 0 CA-C-O 122.654 1.216 . . . . 0.0 111.89 -177.14 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 77.2 p -71.11 160.63 32.54 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 113.672 -1.603 . . . . 0.0 112.826 -176.27 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 6.0 tpt180 -65.71 154.07 39.97 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 114.555 -1.202 . . . . 0.0 111.657 -177.913 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.476 ' HG3' ' H ' ' A' ' 63' ' ' ASP . 10.0 ttm180 -88.68 136.97 32.73 Favored 'General case' 0 CA--C 1.504 -0.82 0 N-CA-C 108.266 -1.012 . . . . 0.0 108.266 177.367 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -143.04 175.11 4.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 N-CA-C 105.988 -1.856 . . . . 0.0 105.988 -176.355 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 14.9 tpt180 -92.88 116.4 29.0 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 106.27 -1.752 . . . . 0.0 106.27 176.137 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -79.65 137.64 19.12 Favored Glycine 0 N--CA 1.446 -0.645 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 177.917 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -72.01 -18.93 78.08 Favored Glycine 0 C--O 1.219 -0.841 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 178.733 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -64.37 -12.01 38.41 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 124.286 1.034 . . . . 0.0 110.11 176.234 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 109.26 15.92 11.93 Favored Glycine 0 CA--C 1.5 -0.862 0 CA-C-N 115.933 -0.576 . . . . 0.0 112.663 169.521 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.4 167.89 24.91 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 116.19 1.922 . . . . 0.0 116.19 -173.353 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -84.92 156.02 21.41 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.873 179.66 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -80.51 -55.15 5.07 Favored 'General case' 0 C--O 1.216 -0.693 0 CA-C-O 121.959 0.885 . . . . 0.0 112.717 -179.953 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.476 ' H ' ' HG3' ' A' ' 53' ' ' ARG . 1.0 OUTLIER -150.06 179.28 8.2 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 114.44 -1.254 . . . . 0.0 111.403 -174.259 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 95.6 mt -112.28 -83.73 0.58 Allowed 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 175.643 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -88.85 162.8 37.3 Favored Pre-proline 0 C--N 1.323 -0.564 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 177.849 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -69.52 142.98 50.5 Favored 'Trans proline' 0 C--N 1.348 0.503 0 C-N-CA 115.708 -2.395 . . . . 0.0 112.235 176.841 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 93.5 mtt-85 -121.59 166.25 14.49 Favored 'General case' 0 CA--C 1.513 -0.455 0 N-CA-C 112.99 0.737 . . . . 0.0 112.99 179.701 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 57.9 m95 -131.94 145.83 51.73 Favored 'General case' 0 C--O 1.216 -0.672 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 175.349 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 29.8 m-85 -125.88 154.1 43.21 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 105.661 -1.977 . . . . 0.0 105.661 -178.891 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 90.8 t80 -105.9 135.96 46.39 Favored 'General case' 0 CA--C 1.508 -0.672 0 CA-C-N 119.006 0.821 . . . . 0.0 109.54 -174.586 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 21.2 m-85 -140.91 144.81 35.42 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 107.259 -1.386 . . . . 0.0 107.259 -175.989 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 53.7 m-85 -84.83 159.52 20.39 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.453 -174.465 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 16.8 tp -53.29 129.98 33.44 Favored 'General case' 0 C--O 1.216 -0.677 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 179.884 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 70.81 22.26 78.18 Favored Glycine 0 C--O 1.223 -0.577 0 N-CA-C 116.375 1.31 . . . . 0.0 116.375 176.831 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 18.9 p . . . . . 0 CA--C 1.511 -0.522 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 175.658 . . . . . . . . 0 0 . 1 . 034 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 12.9 mt . . . . . 0 N--CA 1.438 -1.061 0 N-CA-C 114.075 1.139 . . . . 0.0 114.075 . . . . . . . . . 0 0 . 1 . 034 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -78.84 161.5 27.19 Favored 'Trans proline' 0 N--CA 1.462 -0.368 0 C-N-CA 122.268 1.978 . . . . 0.0 107.192 167.819 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 56.0 t80 -61.09 132.85 55.1 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 120.226 -0.589 . . . . 0.0 110.063 -177.704 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 91.1 -7.15 81.27 Favored Glycine 0 CA--C 1.519 0.337 0 CA-C-O 119.333 -0.704 . . . . 0.0 114.541 179.407 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -67.68 129.73 40.81 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 118.804 1.302 . . . . 0.0 111.808 179.909 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 51.1 t30 -79.04 128.76 33.68 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.042 -179.893 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.4 ' HB3' HG13 ' A' ' 90' ' ' ILE . 28.7 ttmt -155.94 157.9 37.04 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 106.964 -1.495 . . . . 0.0 106.964 -178.774 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -54.87 120.2 6.49 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.473 0.546 . . . . 0.0 112.473 -179.696 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 66.12 35.6 90.73 Favored Glycine 0 CA--C 1.507 -0.467 0 CA-C-O 118.989 -0.895 . . . . 0.0 114.022 175.176 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.4 HG13 ' HB3' ' A' ' 87' ' ' LYS . 49.6 mm -122.47 126.29 73.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 117.452 0.626 . . . . 0.0 110.856 178.904 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -126.84 121.17 57.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.892 175.666 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 98.7 m95 -87.57 135.67 33.26 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 113.602 0.964 . . . . 0.0 113.602 -176.71 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 15.8 m -137.2 149.78 26.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 121.638 0.733 . . . . 0.0 109.069 178.618 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -162.46 161.97 27.37 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 103.363 -2.829 . . . . 0.0 103.363 179.416 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 6.0 t -126.43 173.85 9.06 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 105.098 -2.186 . . . . 0.0 105.098 178.151 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -67.26 134.42 51.59 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.054 0.454 . . . . 0.0 109.957 -178.303 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 96.0 -9.65 67.98 Favored Glycine 0 C--O 1.226 -0.396 0 CA-C-N 115.97 -0.559 . . . . 0.0 113.05 179.318 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.411 ' HB1' ' HB ' ' A' ' 44' ' ' ILE . . . -76.37 134.02 39.78 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 178.891 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 65.9 mt -87.75 140.96 28.98 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.174 0.511 . . . . 0.0 112.147 -176.743 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 63.4 t30 -84.29 61.98 6.89 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.968 -179.599 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -135.91 156.47 77.17 Favored Pre-proline 0 C--N 1.322 -0.617 0 N-CA-C 106.159 -1.793 . . . . 0.0 106.159 -178.592 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -67.73 152.8 77.3 Favored 'Trans proline' 0 C--N 1.343 0.272 0 N-CA-C 114.793 1.036 . . . . 0.0 114.793 -179.889 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.507 ' HB3' HD12 ' A' ' 106' ' ' ILE . 73.8 mmtt -126.07 37.9 4.25 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 114.648 -1.16 . . . . 0.0 110.079 -177.111 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 15.9 p-10 -53.32 -41.22 65.49 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.168 -179.051 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 16.3 p80 -66.21 -8.88 27.14 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 114.359 1.244 . . . . 0.0 114.359 179.99 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.507 HD12 ' HB3' ' A' ' 103' ' ' LYS . 31.3 mt -95.27 -44.64 13.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 178.727 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -70.66 3.04 13.24 Favored Glycine 0 C--O 1.221 -0.673 0 N-CA-C 115.661 1.024 . . . . 0.0 115.661 -177.537 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 14.6 t -83.15 15.13 3.0 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 117.637 0.719 . . . . 0.0 112.28 -177.868 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.418 ' HD2' HD22 ' A' ' 114' ' ' ASN . 57.6 ttp85 -58.72 130.83 48.75 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 176.629 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -98.6 137.62 20.66 Favored Pre-proline 0 C--N 1.323 -0.585 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 178.399 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -74.96 -19.84 17.53 Favored 'Trans proline' 0 C--O 1.219 -0.434 0 N-CA-C 113.863 0.678 . . . . 0.0 113.863 179.424 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -81.36 -25.14 36.57 Favored 'General case' 0 C--O 1.221 -0.437 0 CA-C-O 121.163 0.506 . . . . 0.0 110.226 179.293 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 -97.76 -21.54 16.91 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 113.437 0.903 . . . . 0.0 113.437 -175.128 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . 0.418 HD22 ' HD2' ' A' ' 109' ' ' ARG . 29.5 t30 -150.31 153.24 35.76 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 111.884 0.328 . . . . 0.0 111.884 -178.77 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -89.45 140.92 29.05 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-O 121.246 0.546 . . . . 0.0 110.586 178.4 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -70.99 147.64 48.44 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.136 0.494 . . . . 0.0 110.355 178.667 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 11.7 mt -81.89 136.47 22.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.473 -178.494 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 77.0 t -58.78 121.9 7.47 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 N-CA-C 106.43 -1.693 . . . . 0.0 106.43 174.601 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 6.1 tt -67.35 127.54 33.05 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.297 0.57 . . . . 0.0 110.328 -176.662 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 -133.98 155.08 50.59 Favored 'General case' 0 CA--C 1.508 -0.661 0 N-CA-C 106.489 -1.671 . . . . 0.0 106.489 -179.233 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 12.9 mt -111.08 147.96 37.66 Favored Pre-proline 0 C--N 1.319 -0.724 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 177.738 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -73.3 163.5 37.71 Favored 'Trans proline' 0 C--O 1.237 0.439 0 C-N-CA 118.016 -0.856 . . . . 0.0 112.626 -179.934 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 40.1 tt0 -54.47 130.65 40.34 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.06 179.963 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 105.94 -26.25 21.4 Favored Glycine 0 C--O 1.227 -0.309 0 CA-C-N 115.871 -0.604 . . . . 0.0 112.251 -178.656 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 4.6 m -102.36 129.91 48.95 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 118.276 1.038 . . . . 0.0 112.131 178.586 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 3.1 p -116.61 147.86 41.49 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.274 178.625 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 82.8 mt -72.11 153.79 92.48 Favored Pre-proline 0 C--N 1.323 -0.559 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 177.911 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -75.54 175.53 11.16 Favored 'Trans proline' 0 C--O 1.235 0.334 0 N-CA-C 110.576 -0.586 . . . . 0.0 110.576 177.901 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 76.1 tttt -64.55 124.51 22.04 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 114.023 1.12 . . . . 0.0 114.023 -170.811 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 95.19 -1.86 65.18 Favored Glycine 0 CA--C 1.518 0.243 0 CA-C-N 114.891 -1.05 . . . . 0.0 115.342 177.101 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.455 ' CZ ' ' HB2' ' A' ' 18' ' ' GLN . 3.5 m-85 -94.81 143.12 26.71 Favored 'General case' 0 N--CA 1.436 -1.14 0 CA-C-O 122.465 1.126 . . . . 0.0 111.619 -179.328 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 43.7 p90 -144.19 164.46 30.64 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 113.053 -1.885 . . . . 0.0 107.375 173.992 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -105.18 148.55 26.79 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.253 0.549 . . . . 0.0 111.465 -176.759 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -79.05 139.8 38.05 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 179.397 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 81.98 -0.21 88.79 Favored Glycine 0 C--O 1.226 -0.369 0 C-N-CA 121.161 -0.543 . . . . 0.0 112.241 -178.283 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 8.3 t . . . . . 0 C--N 1.324 -0.515 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 178.288 . . . . . . . . 0 0 . 1 . 035 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.537 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 . . . . . . . . . 0 0 . 1 . 035 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 69.6 p -63.18 144.02 57.28 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 178.259 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 14.8 m95 -70.9 -22.82 62.22 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 111.923 0.342 . . . . 0.0 111.923 179.225 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 33.9 m-85 -121.48 162.53 20.33 Favored 'General case' 0 C--O 1.243 0.736 0 N-CA-C 113.239 0.829 . . . . 0.0 113.239 -172.353 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.43 ' HB ' ' HB3' ' A' ' 134' ' ' GLU . 70.5 p -71.13 165.0 24.5 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 114.806 -1.088 . . . . 0.0 108.245 178.149 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -83.4 145.13 29.17 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 113.803 1.038 . . . . 0.0 113.803 -176.401 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 22.9 mt -78.0 148.91 34.17 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 103.942 -2.614 . . . . 0.0 103.942 168.832 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 26.8 m -126.96 140.42 52.33 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 107.432 -1.321 . . . . 0.0 107.432 179.392 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 56.7 tt0 -116.44 148.69 40.47 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 114.936 1.458 . . . . 0.0 114.936 -174.172 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 63.3 t60 -134.52 99.62 4.41 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 105.375 -2.083 . . . . 0.0 105.375 169.967 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -178.95 -163.01 29.34 Favored Glycine 0 CA--C 1.522 0.494 0 C-N-CA 121.006 -0.616 . . . . 0.0 113.233 -176.621 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 68.9 mmtt -116.27 -31.7 5.55 Favored 'General case' 0 N--CA 1.48 1.062 0 N-CA-C 113.919 1.081 . . . . 0.0 113.919 -178.899 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -84.23 -166.67 1.5 Allowed 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 178.61 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 13.7 p-10 -105.74 -66.08 1.01 Allowed 'General case' 0 CA--C 1.556 1.187 0 N-CA-C 117.699 2.481 . . . . 0.0 117.699 -177.614 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 49.3 tp 172.7 141.62 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 179.777 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -154.26 145.36 22.77 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 107.062 -1.459 . . . . 0.0 107.062 -178.732 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -134.51 148.44 67.48 Favored Pre-proline 0 C--N 1.322 -0.589 0 N-CA-C 105.779 -1.934 . . . . 0.0 105.779 176.23 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -69.98 150.22 66.6 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 117.875 -0.95 . . . . 0.0 111.71 179.433 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 16.8 tpt180 -65.98 134.98 54.07 Favored 'General case' 0 C--O 1.217 -0.651 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 -178.369 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 98.84 -3.6 58.9 Favored Glycine 0 C--O 1.222 -0.608 0 N-CA-C 110.335 -1.106 . . . . 0.0 110.335 -179.377 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -146.57 170.51 16.76 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 -179.372 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 128.88 -31.41 3.52 Favored Glycine 0 CA--C 1.48 -2.096 0 N-CA-C 108.774 -1.731 . . . . 0.0 108.774 165.142 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 35.7 m -66.47 139.63 96.23 Favored Pre-proline 0 N--CA 1.43 -1.458 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 177.378 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -72.77 174.01 12.5 Favored 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 121.785 1.657 . . . . 0.0 111.6 177.049 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 90.9 mt -72.1 113.46 9.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 N-CA-C 107.656 -1.239 . . . . 0.0 107.656 178.083 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.557 HD22 ' HA ' ' A' ' 43' ' ' GLN . 37.8 m-20 -109.75 82.16 1.55 Allowed 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.431 -0.804 . . . . 0.0 108.947 -178.31 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 67.7 p -64.87 -24.41 67.53 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.46 -0.791 . . . . 0.0 112.972 -177.044 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 72.7 m-80 -100.72 35.75 2.09 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.647 -178.191 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 21.1 m -147.88 151.7 36.33 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.6 -0.273 . . . . 0.0 110.596 -179.269 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 18.4 m -72.17 165.45 50.4 Favored Pre-proline 0 C--N 1.324 -0.507 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 176.877 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -64.68 -27.79 60.53 Favored 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 114.94 -2.907 . . . . 0.0 111.62 177.813 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -60.84 -30.8 70.32 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 122.121 0.963 . . . . 0.0 110.629 175.784 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 92.6 m-20 -95.58 -0.16 52.26 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 114.931 1.456 . . . . 0.0 114.931 -170.552 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.557 ' HA ' HD22 ' A' ' 35' ' ' ASN . 91.4 mm-40 -60.89 -25.56 66.8 Favored 'General case' 0 C--O 1.219 -0.509 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 178.653 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.494 ' HB ' ' HB1' ' A' ' 98' ' ' ALA . 21.5 tt -55.79 142.56 10.41 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 N-CA-C 115.209 1.559 . . . . 0.0 115.209 -178.621 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 179.22 -155.23 15.43 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.089 178.079 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 43.0 p90 -155.11 168.03 28.38 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 178.254 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 33.6 m-85 -109.28 137.68 46.79 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 174.722 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 60.9 ttt180 -111.9 119.32 38.14 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.474 -0.784 . . . . 0.0 110.827 -177.776 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 1.1 ttp-105 -65.5 134.33 53.17 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 106.78 -1.563 . . . . 0.0 106.78 175.871 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -135.59 153.4 51.68 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.052 0.453 . . . . 0.0 110.541 -177.487 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.477 ' HB ' HD22 ' A' ' 64' ' ' LEU . 32.7 p -133.4 159.01 41.58 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.272 -177.639 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 63.4 ttt180 -158.34 129.71 6.55 Favored 'General case' 0 N--CA 1.477 0.92 0 O-C-N 122.235 -0.291 . . . . 0.0 111.27 177.471 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.81 142.16 24.24 Favored 'General case' 0 CA--C 1.498 -1.039 0 N-CA-C 104.224 -2.51 . . . . 0.0 104.224 -179.933 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -132.1 173.94 13.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 -177.076 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.08 107.39 17.69 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 -179.39 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -74.38 151.82 44.0 Favored Glycine 0 N--CA 1.452 -0.24 0 N-CA-C 107.059 -2.417 . . . . 0.0 107.059 177.201 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -63.38 -42.79 99.02 Favored Glycine 0 C--O 1.223 -0.578 0 CA-C-N 118.559 1.18 . . . . 0.0 111.907 -178.643 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -76.2 -3.22 35.15 Favored 'General case' 0 C--O 1.218 -0.572 0 CA-C-O 121.518 0.675 . . . . 0.0 111.967 179.594 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 96.72 -1.1 61.41 Favored Glycine 0 C--O 1.227 -0.313 0 CA-C-N 115.855 -0.612 . . . . 0.0 112.617 177.395 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 12.8 pttt -63.82 133.66 53.82 Favored 'General case' 0 C--O 1.24 0.581 0 CA-C-O 122.147 0.975 . . . . 0.0 112.587 -178.089 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 13.8 mmt -90.78 145.44 24.78 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 114.171 -1.377 . . . . 0.0 113.022 -179.619 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 2.1 tmtm? -102.11 -23.43 14.06 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.048 -0.978 . . . . 0.0 109.814 176.259 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 13.3 t0 63.7 164.37 0.12 Allowed 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 115.998 1.851 . . . . 0.0 115.998 178.338 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.477 HD22 ' HB ' ' A' ' 51' ' ' THR . 57.4 mt -88.61 131.12 35.1 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.331 0.586 . . . . 0.0 111.304 -176.538 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 4.8 p -112.31 131.29 22.65 Favored Pre-proline 0 C--N 1.319 -0.722 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 176.215 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -74.95 98.14 1.13 Allowed 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 117.35 -1.3 . . . . 0.0 112.065 178.044 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.4 HH22 ' CD ' ' A' ' 134' ' ' GLU . 11.7 mtp180 -110.34 152.81 25.76 Favored 'General case' 0 CA--C 1.507 -0.69 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 178.018 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 64.0 m95 -127.69 126.37 41.78 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 179.666 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 58.7 m-85 -110.35 141.17 43.74 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 -178.592 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 86.1 t80 -87.73 135.87 33.19 Favored 'General case' 0 CA--C 1.506 -0.732 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 -178.581 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -139.42 143.49 37.66 Favored 'General case' 0 N--CA 1.439 -0.995 0 CA-C-N 115.076 -0.965 . . . . 0.0 108.434 -175.376 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -77.01 159.45 29.9 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.089 0.471 . . . . 0.0 110.743 -176.847 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 15.8 tp -59.62 128.17 35.67 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.855 -0.612 . . . . 0.0 110.819 -178.455 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 80.73 24.73 57.81 Favored Glycine 0 C--O 1.218 -0.856 0 N-CA-C 116.342 1.297 . . . . 0.0 116.342 177.603 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 3.7 p . . . . . 0 N--CA 1.467 0.408 0 CA-C-N 118.873 1.336 . . . . 0.0 110.67 -179.609 . . . . . . . . 0 0 . 1 . 035 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 27.6 mt . . . . . 0 C--O 1.238 0.492 0 N-CA-C 115.103 1.519 . . . . 0.0 115.103 . . . . . . . . . 0 0 . 1 . 035 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -78.25 169.19 20.58 Favored 'Trans proline' 0 C--O 1.235 0.352 0 C-N-CA 121.815 1.676 . . . . 0.0 109.483 171.566 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 51.3 t80 -63.49 130.5 44.63 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 179.564 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 92.13 -3.98 77.21 Favored Glycine 0 C--O 1.225 -0.409 0 N-CA-C 114.754 0.662 . . . . 0.0 114.754 178.691 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -68.44 123.69 21.5 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 118.63 1.215 . . . . 0.0 111.471 178.747 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 74.6 m-20 -71.66 126.05 28.69 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 114.799 -1.091 . . . . 0.0 111.839 -176.805 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 29.2 ttmt -156.13 151.5 26.77 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 106.927 -1.509 . . . . 0.0 106.927 177.153 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 18.5 t0 -66.82 133.4 50.02 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.904 0.383 . . . . 0.0 110.032 -178.892 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 72.46 21.42 79.46 Favored Glycine 0 CA--C 1.507 -0.467 0 C-N-CA 120.938 -0.649 . . . . 0.0 113.962 177.731 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 44.0 mm -125.31 124.21 66.7 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.421 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 178.864 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.1 pt -127.68 114.47 35.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.725 176.63 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 95.8 m95 -81.09 128.77 34.1 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.371 -177.704 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 2.8 m -136.7 149.74 26.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 121.483 0.659 . . . . 0.0 109.572 -177.347 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -157.51 164.63 37.18 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 105.134 -2.173 . . . . 0.0 105.134 -178.696 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 14.5 t -122.96 174.83 6.93 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 105.705 -1.961 . . . . 0.0 105.705 177.985 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -64.97 133.81 52.55 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.197 0.523 . . . . 0.0 109.812 -179.679 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 92.07 -9.22 76.92 Favored Glycine 0 C--O 1.225 -0.445 0 CA-C-N 115.886 -0.597 . . . . 0.0 113.232 178.482 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.494 ' HB1' ' HB ' ' A' ' 44' ' ' ILE . . . -77.74 137.73 38.63 Favored 'General case' 0 C--N 1.324 -0.534 0 O-C-N 122.249 -0.56 . . . . 0.0 109.523 179.434 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 51.7 mt -92.82 134.18 35.33 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 113.523 0.935 . . . . 0.0 113.523 -176.64 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 71.6 m-20 -79.47 56.16 2.1 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.411 -179.196 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -130.85 152.34 80.42 Favored Pre-proline 0 C--N 1.323 -0.549 0 N-CA-C 107.953 -1.128 . . . . 0.0 107.953 -179.595 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -66.76 149.9 83.5 Favored 'Trans proline' 0 C--N 1.343 0.256 0 N-CA-C 114.281 0.839 . . . . 0.0 114.281 178.364 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 4.5 ptpt -151.18 56.13 0.88 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 122.71 1.243 . . . . 0.0 110.467 178.955 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -57.81 -30.71 65.92 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 113.852 -1.522 . . . . 0.0 111.411 178.338 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 29.5 p-80 -59.67 -16.62 27.83 Favored 'General case' 0 C--O 1.218 -0.602 0 N-CA-C 114.205 1.187 . . . . 0.0 114.205 -178.901 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 64.0 mt -81.41 -32.63 12.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 178.305 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -73.86 14.8 3.39 Favored Glycine 0 CA--C 1.522 0.479 0 N-CA-C 115.023 0.769 . . . . 0.0 115.023 -178.337 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 11.6 t -83.1 17.65 1.93 Allowed 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 112.846 0.684 . . . . 0.0 112.846 -177.718 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 73.3 ttp85 -58.83 130.27 46.14 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 178.838 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -101.77 125.44 37.13 Favored Pre-proline 0 C--N 1.322 -0.625 0 N-CA-C 105.778 -1.934 . . . . 0.0 105.778 179.352 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -68.69 -17.35 42.66 Favored 'Trans proline' 0 C--O 1.218 -0.525 0 C-N-CA 117.766 -1.023 . . . . 0.0 114.397 -176.705 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -78.77 -24.3 44.77 Favored 'General case' 0 C--O 1.22 -0.468 0 CA-C-O 120.932 0.396 . . . . 0.0 110.516 178.339 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 -100.11 -23.04 14.97 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 -174.923 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 28.2 t30 -158.2 149.13 20.77 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.473 0.545 . . . . 0.0 112.473 -178.706 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -92.64 154.16 18.54 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-O 121.518 0.675 . . . . 0.0 111.825 179.606 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -69.39 144.26 53.45 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.216 0.531 . . . . 0.0 111.031 178.87 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 15.3 mt -85.77 139.94 16.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.303 -178.287 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 92.5 t -60.77 124.77 15.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 175.918 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 6.9 tt -67.29 129.0 38.5 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.966 -177.093 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 29.5 mt-30 -132.14 156.64 46.03 Favored 'General case' 0 C--O 1.219 -0.513 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 -179.467 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 13.4 mt -112.29 148.04 38.28 Favored Pre-proline 0 C--N 1.323 -0.578 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 178.449 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -72.65 168.54 24.2 Favored 'Trans proline' 0 C--N 1.346 0.409 0 O-C-N 122.219 0.589 . . . . 0.0 113.615 -179.128 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 39.1 tt0 -53.82 131.87 40.49 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.309 -0.86 . . . . 0.0 109.553 179.554 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 96.38 -18.94 56.57 Favored Glycine 0 C--O 1.226 -0.403 0 CA-C-N 115.919 -0.582 . . . . 0.0 113.452 179.991 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 4.1 m -108.43 128.48 54.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 118.227 1.014 . . . . 0.0 111.375 179.239 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 10.0 p -122.46 150.77 42.05 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.278 179.172 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 87.8 mt -70.79 151.88 95.19 Favored Pre-proline 0 C--N 1.324 -0.533 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 179.076 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -76.03 166.17 28.42 Favored 'Trans proline' 0 C--O 1.236 0.383 0 C-N-CA 117.775 -1.016 . . . . 0.0 110.973 178.864 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 14.7 tmtt? -59.04 127.02 30.11 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.121 -177.293 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 95.1 15.59 44.31 Favored Glycine 0 C--O 1.227 -0.344 0 N-CA-C 114.865 0.706 . . . . 0.0 114.865 178.785 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -125.52 149.17 48.53 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 117.688 0.744 . . . . 0.0 110.637 177.873 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 43.6 p90 -150.37 161.97 41.46 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 174.43 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -99.92 147.01 26.01 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.825 0.345 . . . . 0.0 110.412 -179.017 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.43 ' HB3' ' HB ' ' A' ' 14' ' ' THR . 3.6 tp10 -72.18 133.76 45.31 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 106.65 -1.611 . . . . 0.0 106.65 177.81 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 89.48 -3.17 83.6 Favored Glycine 0 C--O 1.224 -0.5 0 N-CA-C 111.254 -0.738 . . . . 0.0 111.254 -177.144 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 9.7 t . . . . . 0 C--N 1.325 -0.471 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 177.42 . . . . . . . . 0 0 . 1 . 036 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.667 0 CA-C-O 121.475 0.655 . . . . 0.0 109.262 . . . . . . . . . 0 0 . 1 . 036 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 54.3 p -59.72 143.72 50.05 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.254 -0.884 . . . . 0.0 109.231 177.907 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 13.4 m95 -65.87 -26.75 67.78 Favored 'General case' 0 CA--C 1.512 -0.485 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 179.26 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 27.4 m-85 -121.46 164.79 16.59 Favored 'General case' 0 CA--C 1.503 -0.831 0 CA-C-N 115.784 -0.644 . . . . 0.0 112.109 -172.201 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.466 ' HB ' ' HB3' ' A' ' 134' ' ' GLU . 67.1 p -70.35 166.41 20.31 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 114.614 -1.175 . . . . 0.0 108.629 177.642 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -87.23 149.92 24.27 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 113.306 0.854 . . . . 0.0 113.306 -176.507 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.466 HD21 HD22 ' A' ' 119' ' ' LEU . 53.0 mt -85.54 148.81 25.77 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 173.18 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 24.2 m -125.19 131.98 53.1 Favored 'General case' 0 C--N 1.32 -0.716 0 C-N-CA 122.515 0.326 . . . . 0.0 110.698 -179.822 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 3.9 tp-100 -95.6 141.67 28.83 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 179.129 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 41.5 t60 -135.35 100.04 4.41 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 102.54 -3.133 . . . . 0.0 102.54 166.598 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 167.77 -143.9 8.53 Favored Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 120.286 -0.959 . . . . 0.0 111.545 -175.027 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -124.74 -32.3 3.1 Favored 'General case' 0 C--O 1.221 -0.405 0 N-CA-C 115.449 1.648 . . . . 0.0 115.449 -177.811 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -77.69 165.77 23.82 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 178.57 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -79.66 -62.89 1.55 Allowed 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 -179.249 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 48.0 tp 173.88 141.04 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.221 0 N-CA-C 106.114 -1.81 . . . . 0.0 106.114 176.057 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 56.2 tptt -153.71 139.46 17.99 Favored 'General case' 0 C--O 1.222 -0.371 0 CA-C-N 118.077 0.399 . . . . 0.0 110.539 173.983 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 20.5 m-85 -126.27 151.49 72.32 Favored Pre-proline 0 C--O 1.24 0.59 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 175.189 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -78.98 166.95 22.64 Favored 'Trans proline' 0 C--N 1.353 0.813 0 C-N-CA 120.934 1.089 . . . . 0.0 113.535 178.347 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 2.0 tmt_? -66.86 137.07 56.32 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.821 -178.732 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 86.67 -0.21 86.52 Favored Glycine 0 C--O 1.223 -0.536 0 N-CA-C 111.302 -0.719 . . . . 0.0 111.302 177.169 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -140.65 -179.69 6.18 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 -175.176 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.52 -28.28 13.98 Favored Glycine 0 CA--C 1.498 -1.025 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.87 176.104 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 76.2 t -64.44 126.45 90.61 Favored Pre-proline 0 C--N 1.32 -0.705 0 N-CA-C 106.177 -1.786 . . . . 0.0 106.177 176.559 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -73.66 168.87 23.69 Favored 'Trans proline' 0 N--CA 1.459 -0.513 0 O-C-N 122.225 0.592 . . . . 0.0 111.446 179.134 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 87.6 mt -66.71 110.1 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-O 122.06 0.934 . . . . 0.0 109.177 -179.761 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 71.6 m-80 -97.94 91.45 5.33 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 114.636 -1.165 . . . . 0.0 110.734 -177.493 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 75.7 p -71.38 -14.89 62.32 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.744 0.783 . . . . 0.0 111.469 178.667 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 10.7 p30 -111.14 20.52 17.32 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 114.915 1.45 . . . . 0.0 114.915 -175.893 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 6.1 m -138.91 152.32 47.66 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 115.938 1.829 . . . . 0.0 115.938 -175.728 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 2.0 m -70.22 164.7 50.81 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 115.085 -0.962 . . . . 0.0 109.936 176.219 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -66.36 -28.38 46.84 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 114.758 -3.028 . . . . 0.0 113.915 -179.823 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.41 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 4.2 p-10 -75.3 -21.59 58.35 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.657 0.741 . . . . 0.0 110.688 177.319 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -83.28 -5.76 59.24 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 114.063 1.134 . . . . 0.0 114.063 -174.776 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 93.6 mm-40 -58.89 -26.52 64.36 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 113.248 0.833 . . . . 0.0 113.248 -179.427 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.453 ' HB ' ' HB1' ' A' ' 98' ' ' ALA . 20.1 tt -57.66 138.86 18.03 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.726 0 N-CA-C 114.402 1.26 . . . . 0.0 114.402 -178.744 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -177.07 -159.35 22.18 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.57 -0.824 . . . . 0.0 111.977 178.806 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 51.5 p90 -155.05 172.7 17.68 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 177.907 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 16.9 m-85 -113.49 138.89 49.47 Favored 'General case' 0 C--N 1.319 -0.761 0 N-CA-C 106.125 -1.806 . . . . 0.0 106.125 173.869 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 36.2 ttt180 -108.23 120.01 41.14 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 114.991 -1.004 . . . . 0.0 110.387 -176.728 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 13.1 ttt180 -64.33 131.7 48.04 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 176.316 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -142.18 129.77 21.44 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.544 0.688 . . . . 0.0 110.882 -179.693 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 15.3 t -156.8 155.46 31.59 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 175.183 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 15.0 tpt85 -154.88 135.12 13.18 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 104.865 -2.272 . . . . 0.0 104.865 178.11 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -127.82 136.37 51.35 Favored 'General case' 0 CA--C 1.495 -1.138 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 -179.423 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.447 HD13 ' HB2' ' A' ' 62' ' ' LYS . 0.1 OUTLIER -132.67 172.4 16.49 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 -177.38 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 5.5 tmm_? -116.08 112.3 21.54 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 105.439 -2.06 . . . . 0.0 105.439 176.71 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -75.76 150.07 39.1 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 121.008 -0.615 . . . . 0.0 112.368 -177.512 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -70.89 -22.16 78.26 Favored Glycine 0 C--O 1.218 -0.896 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.44 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 41.1 t0 -65.16 -12.9 56.0 Favored 'General case' 0 CA--C 1.548 0.903 0 CA-C-N 114.236 -0.982 . . . . 0.0 110.363 176.951 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 108.07 18.46 9.86 Favored Glycine 0 CA--C 1.501 -0.827 0 CA-C-N 116.105 -0.498 . . . . 0.0 112.818 169.338 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.66 160.28 42.86 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 116.583 2.068 . . . . 0.0 116.583 -174.155 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 93.9 mmm -85.03 160.25 20.05 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.589 -0.732 . . . . 0.0 112.873 -176.398 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.447 ' HB2' HD13 ' A' ' 54' ' ' ILE . 13.3 tmtt? -63.86 -42.91 97.43 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 122.316 1.055 . . . . 0.0 112.412 176.64 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 13.1 t70 56.15 -139.85 0.92 Allowed 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 112.444 -2.162 . . . . 0.0 109.988 -174.916 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER 66.9 156.23 0.11 Allowed 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 116.001 1.852 . . . . 0.0 116.001 178.777 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 14.1 p -81.26 162.59 58.44 Favored Pre-proline 0 C--O 1.242 0.675 0 CA-C-N 114.462 -1.245 . . . . 0.0 110.678 -179.949 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -71.6 156.5 57.61 Favored 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 116.434 -1.911 . . . . 0.0 111.293 175.563 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 11.7 mtt180 -116.7 161.46 19.19 Favored 'General case' 0 CA--C 1.506 -0.737 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 178.251 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 62.3 m95 -123.18 125.98 46.13 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 179.919 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 11.3 m-85 -110.37 138.06 47.26 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 107.278 -1.378 . . . . 0.0 107.278 -176.742 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 79.7 t80 -85.25 133.8 34.16 Favored 'General case' 0 CA--C 1.509 -0.629 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 -177.248 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -141.47 135.49 30.31 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 -175.254 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 86.3 m-85 -73.73 159.54 32.82 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 -175.652 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 11.3 tp -57.02 126.55 27.68 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.312 0.577 . . . . 0.0 109.615 179.849 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 82.03 18.68 66.8 Favored Glycine 0 C--O 1.22 -0.751 0 N-CA-C 116.49 1.356 . . . . 0.0 116.49 178.041 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 16.7 p . . . . . 0 N--CA 1.469 0.478 0 CA-C-N 119.331 1.566 . . . . 0.0 110.228 178.622 . . . . . . . . 0 0 . 1 . 036 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.406 ' HA ' ' HD2' ' A' ' 82' ' ' PRO . 15.0 mt . . . . . 0 N--CA 1.44 -0.968 0 N-CA-C 116.027 1.862 . . . . 0.0 116.027 . . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.406 ' HD2' ' HA ' ' A' ' 81' ' ' LEU . 90.8 Cg_endo -78.47 162.21 27.9 Favored 'Trans proline' 0 N--CA 1.462 -0.357 0 C-N-CA 122.684 2.256 . . . . 0.0 107.165 166.962 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 59.1 t80 -61.44 132.56 53.86 Favored 'General case' 0 C--N 1.32 -0.712 0 C-N-CA 120.239 -0.584 . . . . 0.0 110.35 -177.499 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 91.4 -8.98 78.45 Favored Glycine 0 CA--C 1.519 0.324 0 N-CA-C 114.953 0.741 . . . . 0.0 114.953 179.296 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -66.35 131.54 46.33 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 118.676 1.238 . . . . 0.0 111.711 179.84 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 56.9 t30 -78.81 131.31 36.45 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.287 -179.724 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 32.7 tttt -156.22 156.77 34.7 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 106.807 -1.553 . . . . 0.0 106.807 -179.568 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -64.56 127.76 32.87 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.719 -0.475 . . . . 0.0 109.719 -178.129 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 67.41 33.02 80.74 Favored Glycine 0 N--CA 1.444 -0.778 0 N-CA-C 115.171 0.829 . . . . 0.0 115.171 176.8 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 41.0 mm -126.34 125.44 67.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 117.404 0.602 . . . . 0.0 110.132 179.067 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -127.41 112.45 28.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.202 177.278 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 98.6 m95 -78.02 137.29 38.19 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 113.371 0.878 . . . . 0.0 113.371 -177.681 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 14.0 m -139.45 149.75 22.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 177.843 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -160.7 164.17 31.87 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 104.299 -2.482 . . . . 0.0 104.299 179.385 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 14.1 t -124.08 174.58 7.53 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 105.668 -1.975 . . . . 0.0 105.668 178.48 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -65.99 132.28 48.21 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.992 0.425 . . . . 0.0 110.438 -178.752 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 92.59 -6.72 77.6 Favored Glycine 0 C--O 1.23 -0.154 0 CA-C-N 116.103 -0.498 . . . . 0.0 113.543 178.997 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.453 ' HB1' ' HB ' ' A' ' 44' ' ' ILE . . . -74.8 138.88 42.9 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 178.681 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 40.2 mt -94.6 139.01 31.76 Favored 'General case' 0 C--O 1.222 -0.39 0 N-CA-C 113.442 0.905 . . . . 0.0 113.442 -177.053 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 74.0 m-20 -83.18 62.08 6.44 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.869 -178.782 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -135.39 154.33 78.49 Favored Pre-proline 0 C--N 1.32 -0.692 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 -179.495 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -68.39 150.68 76.06 Favored 'Trans proline' 0 C--N 1.342 0.191 0 N-CA-C 114.476 0.914 . . . . 0.0 114.476 178.699 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -149.27 59.39 1.03 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 122.94 1.352 . . . . 0.0 110.988 178.006 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 14.0 p-10 -58.61 -30.43 67.24 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 113.694 -1.594 . . . . 0.0 110.206 176.894 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 23.0 p-80 -59.77 -14.66 15.54 Favored 'General case' 0 C--O 1.222 -0.366 0 N-CA-C 114.214 1.19 . . . . 0.0 114.214 -179.272 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 51.9 mt -90.33 -48.51 14.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 177.846 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -71.69 14.37 1.99 Allowed Glycine 0 C--O 1.219 -0.823 0 N-CA-C 116.094 1.197 . . . . 0.0 116.094 -176.271 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 13.8 t -90.95 19.88 5.28 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 117.596 0.698 . . . . 0.0 111.947 179.987 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.435 ' HD2' HD22 ' A' ' 114' ' ' ASN . 65.6 ttp85 -57.47 135.11 56.57 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 178.988 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -105.11 136.21 19.21 Favored Pre-proline 0 C--N 1.323 -0.559 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 178.515 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -73.96 -17.96 21.93 Favored 'Trans proline' 0 C--O 1.219 -0.464 0 O-C-N 121.967 0.456 . . . . 0.0 113.148 -179.885 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -80.07 -24.61 40.52 Favored 'General case' 0 C--O 1.221 -0.409 0 CA-C-O 121.148 0.499 . . . . 0.0 110.271 178.938 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 88.4 m-20 -99.4 -22.37 15.57 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 113.464 0.913 . . . . 0.0 113.464 -175.32 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . 0.435 HD22 ' HD2' ' A' ' 109' ' ' ARG . 20.4 t30 -158.7 149.72 20.4 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.135 0.42 . . . . 0.0 112.135 -178.659 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -85.34 145.29 27.57 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-O 121.427 0.632 . . . . 0.0 111.872 179.68 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -69.6 148.1 49.82 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.17 0.51 . . . . 0.0 110.544 178.361 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 17.4 mt -89.42 138.99 18.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 -179.045 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 79.7 t -62.81 124.92 18.3 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 N-CA-C 106.088 -1.819 . . . . 0.0 106.088 174.259 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.466 HD22 HD21 ' A' ' 16' ' ' LEU . 7.2 tt -67.55 130.61 43.59 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 -177.782 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -135.0 154.11 51.85 Favored 'General case' 0 CA--C 1.51 -0.591 0 N-CA-C 106.135 -1.802 . . . . 0.0 106.135 -179.152 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 13.1 mt -108.56 147.34 35.54 Favored Pre-proline 0 C--N 1.321 -0.673 0 CA-C-O 120.574 0.226 . . . . 0.0 110.732 177.15 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -73.34 163.91 36.58 Favored 'Trans proline' 0 C--O 1.236 0.401 0 C-N-CA 118.371 -0.62 . . . . 0.0 113.378 -179.873 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 39.4 tt0 -53.87 129.22 33.04 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.274 -0.876 . . . . 0.0 109.09 178.999 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 108.65 -26.89 14.65 Favored Glycine 0 C--O 1.225 -0.408 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.911 -178.681 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 5.0 m -108.56 132.28 54.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 118.012 0.906 . . . . 0.0 111.545 178.499 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 2.8 p -121.14 148.18 44.56 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 177.3 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 75.9 mt -70.02 153.59 95.27 Favored Pre-proline 0 C--N 1.323 -0.566 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 177.739 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -74.1 168.82 23.88 Favored 'Trans proline' 0 C--O 1.235 0.354 0 N-CA-C 110.714 -0.533 . . . . 0.0 110.714 179.176 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -60.17 125.81 25.09 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.988 0.423 . . . . 0.0 111.49 -175.268 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 94.95 -2.9 66.73 Favored Glycine 0 C--O 1.227 -0.307 0 N-CA-C 115.131 0.813 . . . . 0.0 115.131 178.444 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -102.89 138.91 39.15 Favored 'General case' 0 N--CA 1.441 -0.911 0 CA-C-O 122.175 0.988 . . . . 0.0 110.39 -179.899 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 45.9 p90 -141.81 159.88 41.32 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 113.989 -1.46 . . . . 0.0 107.656 175.846 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -98.89 150.65 21.69 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 -179.505 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.466 ' HB3' ' HB ' ' A' ' 14' ' ' THR . 2.9 tp10 -73.17 129.03 37.16 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 106.77 -1.567 . . . . 0.0 106.77 179.74 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 89.03 -2.92 84.41 Favored Glycine 0 C--O 1.227 -0.318 0 C-N-CA 121.341 -0.457 . . . . 0.0 112.183 -177.615 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 46.4 t . . . . . 0 C--N 1.326 -0.422 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 178.218 . . . . . . . . 0 0 . 1 . 037 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.255 0 CA-C-O 121.252 0.549 . . . . 0.0 109.664 . . . . . . . . . 0 0 . 1 . 037 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 53.2 p -64.97 144.27 57.4 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 178.303 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 6.3 m95 -66.31 -26.3 67.25 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 111.959 0.355 . . . . 0.0 111.959 177.86 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 32.1 m-85 -121.72 159.15 27.19 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.361 -171.851 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 45.4 p -68.22 166.75 15.68 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.266 -0.879 . . . . 0.0 111.271 -178.246 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -85.38 127.2 34.28 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 113.695 0.998 . . . . 0.0 113.695 -175.513 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 22.6 mt -67.76 147.93 51.93 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 105.332 -2.099 . . . . 0.0 105.332 172.763 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 34.6 m -123.69 133.0 53.96 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 -178.733 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -94.48 140.94 29.18 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 114.266 1.21 . . . . 0.0 114.266 -176.43 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 57.3 t60 -138.82 100.1 3.97 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 105.673 -1.973 . . . . 0.0 105.673 166.04 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 166.3 -153.83 23.95 Favored Glycine 0 C--O 1.224 -0.503 0 C-N-CA 120.844 -0.693 . . . . 0.0 111.537 -177.756 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 40.2 mtpt -117.43 -21.73 8.52 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 113.556 0.947 . . . . 0.0 113.556 -179.42 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -76.1 156.74 33.57 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 178.369 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -73.75 -62.41 1.5 Allowed 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 179.776 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 35.4 tp 171.3 142.24 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 103.418 -2.808 . . . . 0.0 103.418 174.169 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 52.7 tptt -151.78 134.72 15.71 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 118.424 0.556 . . . . 0.0 111.281 174.823 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -123.02 149.13 56.14 Favored Pre-proline 0 C--O 1.243 0.74 0 N-CA-C 108.42 -0.955 . . . . 0.0 108.42 174.152 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -77.39 167.68 24.12 Favored 'Trans proline' 0 CA--C 1.537 0.653 0 C-N-CA 120.906 1.071 . . . . 0.0 113.671 179.268 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 71.3 ttt180 -67.96 137.65 55.32 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.759 -178.871 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 85.93 -0.11 87.61 Favored Glycine 0 C--O 1.224 -0.487 0 N-CA-C 111.562 -0.615 . . . . 0.0 111.562 178.336 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 -140.52 -179.48 6.04 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 -176.288 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 101.15 -29.14 13.15 Favored Glycine 0 CA--C 1.501 -0.842 0 CA-C-N 115.732 -0.667 . . . . 0.0 112.866 175.613 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 98.5 t -66.1 127.39 93.17 Favored Pre-proline 0 C--N 1.322 -0.621 0 N-CA-C 105.456 -2.053 . . . . 0.0 105.456 176.867 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -71.46 167.4 26.45 Favored 'Trans proline' 0 N--CA 1.461 -0.44 0 C-N-CA 120.329 0.686 . . . . 0.0 111.955 179.543 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 95.7 mt -63.36 121.32 12.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 106.227 -1.768 . . . . 0.0 106.227 179.481 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 43.3 t-20 -116.93 122.65 44.89 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.287 -0.87 . . . . 0.0 110.881 -173.913 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 73.4 p -103.03 -11.88 17.83 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.393 -0.821 . . . . 0.0 112.716 -177.475 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 17.5 p30 -114.24 15.99 18.04 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 116.324 1.972 . . . . 0.0 116.324 -173.063 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 29.0 m -141.83 154.31 45.09 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 113.742 1.015 . . . . 0.0 113.742 -177.694 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 18.6 m -72.44 164.45 59.6 Favored Pre-proline 0 C--O 1.238 0.464 0 CA-C-N 115.331 -0.85 . . . . 0.0 109.014 176.696 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -64.3 -28.44 63.68 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 115.4 -2.6 . . . . 0.0 112.46 178.918 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -62.65 -24.21 67.5 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 123.735 0.814 . . . . 0.0 111.613 177.643 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.445 ' HA ' ' HE3' ' A' ' 103' ' ' LYS . 33.4 m-20 -99.81 -2.49 34.92 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 114.75 1.389 . . . . 0.0 114.75 -171.622 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 96.9 mm-40 -60.46 -37.79 82.11 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 115.937 1.828 . . . . 0.0 115.937 -179.992 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 15.7 tt -59.33 138.3 20.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-O 122.313 1.054 . . . . 0.0 112.59 -176.965 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -178.77 -152.34 10.36 Favored Glycine 0 C--O 1.226 -0.383 0 CA-C-N 115.338 -0.847 . . . . 0.0 111.964 -174.862 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 47.8 p90 -154.7 173.59 16.18 Favored 'General case' 0 C--N 1.321 -0.636 0 O-C-N 122.379 -0.483 . . . . 0.0 110.448 -179.33 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -113.98 140.12 48.68 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 171.29 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -105.73 119.33 38.86 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 124.192 0.997 . . . . 0.0 109.69 -178.348 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -70.89 133.18 46.24 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 175.556 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -143.93 154.79 43.68 Favored 'General case' 0 C--N 1.321 -0.654 0 C-N-CA 122.814 0.445 . . . . 0.0 110.175 -177.441 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 15.2 t -156.68 166.98 31.84 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 174.975 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.7 tpt85 -160.29 153.81 22.33 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 103.421 -2.807 . . . . 0.0 103.421 179.475 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 21.8 ttm180 -131.37 146.07 52.12 Favored 'General case' 0 CA--C 1.495 -1.168 0 CA-C-N 118.804 0.729 . . . . 0.0 111.908 179.387 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -142.67 177.71 2.65 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 N-CA-C 104.823 -2.288 . . . . 0.0 104.823 179.205 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 7.1 tmm_? -128.09 103.05 7.0 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 104.999 -2.223 . . . . 0.0 104.999 174.852 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -70.49 154.89 52.76 Favored Glycine 0 C--O 1.22 -0.776 0 N-CA-C 110.731 -0.947 . . . . 0.0 110.731 -176.55 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -67.45 -34.8 85.69 Favored Glycine 0 C--O 1.215 -1.051 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 -179.817 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.1 t0 -94.24 16.91 13.71 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-O 122.483 1.135 . . . . 0.0 109.532 178.416 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 86.42 -17.53 38.35 Favored Glycine 0 C--O 1.225 -0.41 0 N-CA-C 116.225 1.25 . . . . 0.0 116.225 173.801 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -58.9 135.51 57.58 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 122.286 1.041 . . . . 0.0 113.319 -177.314 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 79.3 mtp -113.63 -175.76 2.75 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 113.472 -1.695 . . . . 0.0 111.728 -177.416 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 12.2 mptt -130.29 -41.98 1.22 Allowed 'General case' 0 N--CA 1.476 0.831 0 CA-C-O 122.641 1.21 . . . . 0.0 111.674 -178.984 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 15.7 t0 -61.02 -177.6 0.08 Allowed 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 111.657 -2.52 . . . . 0.0 113.456 179.014 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER 81.02 -52.41 0.3 Allowed 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 126.952 2.101 . . . . 0.0 110.162 -179.206 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 37.9 t -83.81 113.71 49.24 Favored Pre-proline 0 C--N 1.321 -0.662 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 175.459 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -73.45 150.01 45.53 Favored 'Trans proline' 0 C--O 1.239 0.565 0 C-N-CA 114.803 -2.998 . . . . 0.0 111.062 177.94 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 36.6 mtp180 -120.08 157.79 28.21 Favored 'General case' 0 CA--C 1.503 -0.855 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 -179.45 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 77.3 m95 -128.78 126.8 40.69 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 120.77 0.319 . . . . 0.0 110.874 -179.088 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 13.2 m-85 -110.52 134.25 52.54 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 106.769 -1.567 . . . . 0.0 106.769 -177.501 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 88.4 t80 -83.66 134.21 34.79 Favored 'General case' 0 CA--C 1.508 -0.661 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 -178.139 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -139.67 145.49 38.48 Favored 'General case' 0 N--CA 1.44 -0.935 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 -175.899 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 76.9 m-85 -83.12 159.55 22.06 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.937 -172.971 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -56.48 126.63 27.33 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 179.462 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 78.96 26.8 57.63 Favored Glycine 0 C--O 1.223 -0.559 0 N-CA-C 115.908 1.123 . . . . 0.0 115.908 178.224 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 22.2 p . . . . . 0 N--CA 1.469 0.515 0 CA-C-N 118.829 1.314 . . . . 0.0 109.746 177.201 . . . . . . . . 0 0 . 1 . 037 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 18.5 mt . . . . . 0 N--CA 1.447 -0.588 0 N-CA-C 116.628 2.084 . . . . 0.0 116.628 . . . . . . . . . 0 0 . 1 . 037 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -78.63 163.1 26.94 Favored 'Trans proline' 0 N--CA 1.461 -0.386 0 C-N-CA 122.305 2.004 . . . . 0.0 107.732 167.898 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.407 ' CE1' ' HB3' ' A' ' 92' ' ' TRP . 65.9 t80 -61.9 132.06 51.78 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 120.307 -0.557 . . . . 0.0 110.651 -177.005 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 92.1 -9.21 76.91 Favored Glycine 0 C--O 1.228 -0.277 0 CA-C-O 119.595 -0.559 . . . . 0.0 114.359 179.092 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -65.01 130.71 44.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 118.256 1.028 . . . . 0.0 111.39 179.403 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 57.0 t30 -79.36 130.75 35.74 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.413 -179.246 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 26.9 ttmt -154.84 150.71 27.77 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 178.454 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 32.1 t0 -64.4 120.78 12.89 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.284 0.564 . . . . 0.0 110.402 -178.047 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 78.41 29.76 51.92 Favored Glycine 0 N--CA 1.451 -0.309 0 CA-C-N 115.437 -0.802 . . . . 0.0 114.506 179.471 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 41.6 mm -127.06 126.38 68.09 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 CA-C-N 117.612 0.706 . . . . 0.0 110.712 179.099 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -127.16 116.04 42.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 CA-C-O 121.478 0.656 . . . . 0.0 111.381 176.337 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . 0.407 ' HB3' ' CE1' ' A' ' 83' ' ' TYR . 96.7 m95 -79.91 138.48 37.14 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -178.326 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 16.1 m -138.29 153.23 26.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 179.15 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -160.1 165.92 30.84 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 107.073 -1.454 . . . . 0.0 107.073 -178.407 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 14.0 t -133.05 165.97 23.49 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 105.007 -2.22 . . . . 0.0 105.007 176.205 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 61.0 tt0 -67.41 138.18 56.5 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.096 0.474 . . . . 0.0 110.163 -179.06 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 94.97 -8.53 70.33 Favored Glycine 0 C--O 1.225 -0.432 0 CA-C-N 115.853 -0.612 . . . . 0.0 112.999 178.756 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -81.3 143.0 32.55 Favored 'General case' 0 C--N 1.323 -0.543 0 O-C-N 122.543 -0.386 . . . . 0.0 110.364 178.878 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 38.7 mt -100.53 134.76 43.0 Favored 'General case' 0 CA--C 1.514 -0.404 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -178.409 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -78.55 48.07 0.76 Allowed 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 115.184 -0.916 . . . . 0.0 112.049 -177.248 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 1.4 t -114.91 154.85 46.98 Favored Pre-proline 0 C--N 1.32 -0.717 0 N-CA-C 105.366 -2.087 . . . . 0.0 105.366 -179.98 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -64.97 149.01 90.03 Favored 'Trans proline' 0 C--N 1.342 0.197 0 N-CA-C 113.636 0.591 . . . . 0.0 113.636 176.802 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.445 ' HE3' ' HA ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -143.99 54.96 1.3 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 123.551 1.644 . . . . 0.0 109.603 178.616 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -58.32 -30.66 66.86 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 113.128 -1.851 . . . . 0.0 111.456 178.501 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 29.4 p-80 -57.08 -16.65 7.89 Favored 'General case' 0 C--O 1.222 -0.389 0 N-CA-C 115.026 1.491 . . . . 0.0 115.026 -178.422 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 4.4 mt -92.02 -21.01 6.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 121.256 0.55 . . . . 0.0 110.515 -179.946 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -77.11 3.0 59.32 Favored Glycine 0 C--O 1.225 -0.413 0 C-N-CA 120.806 -0.711 . . . . 0.0 113.81 -177.692 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 9.9 t -83.34 11.33 6.9 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 114.235 1.198 . . . . 0.0 114.235 -176.588 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 66.9 ttp85 -59.69 126.09 26.22 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 107.794 -1.188 . . . . 0.0 107.794 178.417 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -97.45 137.38 21.1 Favored Pre-proline 0 C--N 1.322 -0.623 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 178.574 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -74.68 -20.27 17.84 Favored 'Trans proline' 0 C--O 1.219 -0.458 0 N-CA-C 113.815 0.66 . . . . 0.0 113.815 179.999 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -81.6 -24.87 36.18 Favored 'General case' 0 C--O 1.221 -0.408 0 CA-C-O 121.116 0.484 . . . . 0.0 110.145 179.919 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 87.4 m-20 -97.32 -22.27 16.74 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 113.503 0.927 . . . . 0.0 113.503 -175.266 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 24.4 t30 -157.22 151.35 24.82 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 112.315 0.487 . . . . 0.0 112.315 -178.005 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -89.08 146.19 24.98 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-O 121.433 0.635 . . . . 0.0 111.435 179.196 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -70.75 149.06 47.29 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.348 0.594 . . . . 0.0 110.923 178.713 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 22.7 mt -81.21 137.88 20.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 179.864 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 87.7 t -61.35 121.09 8.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 106.679 -1.6 . . . . 0.0 106.679 175.109 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 6.1 tt -67.39 125.53 26.41 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.074 0.464 . . . . 0.0 110.075 -176.985 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -134.46 159.12 42.09 Favored 'General case' 0 CA--C 1.508 -0.643 0 N-CA-C 106.491 -1.67 . . . . 0.0 106.491 -179.169 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 13.6 mt -112.97 148.31 39.12 Favored Pre-proline 0 C--N 1.32 -0.713 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 178.501 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -73.17 163.75 37.23 Favored 'Trans proline' 0 C--O 1.236 0.425 0 C-N-CA 118.254 -0.698 . . . . 0.0 112.836 -179.933 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 39.0 tt0 -54.6 129.55 36.82 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 179.403 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 108.83 -27.82 12.45 Favored Glycine 0 C--O 1.225 -0.416 0 CA-C-N 115.853 -0.612 . . . . 0.0 112.08 -178.461 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 4.3 m -105.6 129.29 53.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 118.128 0.964 . . . . 0.0 111.507 178.54 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 3.3 p -116.97 148.28 41.56 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.809 179.35 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 89.5 mt -73.2 151.43 90.16 Favored Pre-proline 0 C--N 1.323 -0.552 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 177.987 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -78.49 -172.04 1.4 Allowed 'Trans proline' 0 C--O 1.238 0.52 0 C-N-CA 121.061 1.174 . . . . 0.0 112.346 179.396 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 7.8 tmtt? -55.15 120.71 7.41 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 114.235 1.198 . . . . 0.0 114.235 -171.893 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 66.36 22.79 71.41 Favored Glycine 0 C--O 1.224 -0.494 0 CA-C-N 114.888 -1.051 . . . . 0.0 115.522 173.703 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -99.84 134.41 42.78 Favored 'General case' 0 N--CA 1.439 -0.977 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 177.774 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 42.5 p90 -139.8 161.27 37.97 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.051 -0.977 . . . . 0.0 108.711 178.392 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -98.08 144.93 27.05 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.727 0.775 . . . . 0.0 112.508 -176.716 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -78.29 139.24 38.87 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 106.566 -1.642 . . . . 0.0 106.566 176.212 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 91.75 -5.04 79.55 Favored Glycine 0 C--O 1.224 -0.471 0 C-N-CA 120.956 -0.64 . . . . 0.0 111.887 -178.355 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 21.9 t . . . . . 0 N--CA 1.449 -0.487 0 N-CA-C 105.635 -1.987 . . . . 0.0 105.635 175.948 . . . . . . . . 0 0 . 1 . 038 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 0.237 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 . . . . . . . . . 0 0 . 1 . 038 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -61.24 137.41 58.24 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 178.246 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 9.8 m95 -68.81 -27.01 65.47 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 113.151 0.797 . . . . 0.0 113.151 -179.851 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 54.5 m-85 -121.65 163.4 19.05 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 113.342 0.868 . . . . 0.0 113.342 -170.321 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 59.7 p -68.25 167.29 14.64 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 114.51 -1.223 . . . . 0.0 108.327 177.49 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -78.53 152.53 31.91 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 122.346 1.069 . . . . 0.0 112.803 -177.207 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.42 HD23 ' HA ' ' A' ' 16' ' ' LEU . 14.9 mt -91.98 142.26 27.73 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 102.383 -3.191 . . . . 0.0 102.383 167.527 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 33.1 m -124.71 140.01 53.33 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 -176.806 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.461 ' HB2' ' CZ ' ' A' ' 131' ' ' PHE . 4.9 tp60 -120.76 146.0 46.95 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 116.095 1.887 . . . . 0.0 116.095 -172.725 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 78.2 t60 -133.14 99.47 4.56 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 106.811 -1.551 . . . . 0.0 106.811 169.706 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 178.03 -164.58 33.51 Favored Glycine 0 C--O 1.227 -0.294 0 N-CA-C 109.008 -1.637 . . . . 0.0 109.008 -177.722 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -99.79 -25.0 14.51 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 177.905 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -77.52 152.39 34.12 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 114.279 -1.328 . . . . 0.0 109.617 -179.897 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -88.97 -62.44 1.48 Allowed 'General case' 0 C--O 1.212 -0.891 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 178.095 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 45.0 tp -174.93 141.29 0.59 Allowed 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 174.699 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 9.8 tmtt? -156.94 131.58 8.74 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 176.193 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -120.73 153.63 56.94 Favored Pre-proline 0 CA--C 1.543 0.69 0 N-CA-C 111.517 0.191 . . . . 0.0 111.517 177.171 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_endo -78.39 164.18 26.65 Favored 'Trans proline' 0 CA--C 1.542 0.91 0 C-N-CA 120.695 0.93 . . . . 0.0 112.965 176.571 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 1.6 tmt_? -70.75 139.15 51.01 Favored 'General case' 0 N--CA 1.475 0.786 0 O-C-N 122.261 -0.275 . . . . 0.0 110.424 -178.753 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 85.31 4.27 86.33 Favored Glycine 0 C--O 1.223 -0.551 0 N-CA-C 110.851 -0.9 . . . . 0.0 110.851 177.66 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 38.5 mt-30 -147.16 -179.86 7.12 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 -174.257 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 97.48 -28.35 14.57 Favored Glycine 0 CA--C 1.499 -0.943 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.816 175.543 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 94.6 t -64.4 127.9 92.71 Favored Pre-proline 0 C--N 1.321 -0.642 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 177.1 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -73.76 170.72 19.37 Favored 'Trans proline' 0 N--CA 1.461 -0.431 0 O-C-N 122.236 0.598 . . . . 0.0 111.793 178.902 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 94.6 mt -68.07 112.7 3.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 178.784 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 80.5 m-20 -104.12 93.42 4.83 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 114.68 -1.145 . . . . 0.0 110.303 -176.855 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 67.4 p -69.39 -16.79 63.59 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.584 -0.734 . . . . 0.0 112.281 -179.032 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 10.9 p30 -106.92 22.76 15.46 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.057 -0.974 . . . . 0.0 113.227 -177.006 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 16.3 m -139.5 147.02 40.7 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 116.742 2.127 . . . . 0.0 116.742 -175.242 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 2.0 m -71.34 166.55 37.87 Favored Pre-proline 0 N--CA 1.468 0.431 0 CA-C-N 114.706 -1.133 . . . . 0.0 109.658 175.228 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -66.65 -27.97 44.89 Favored 'Trans proline' 0 CA--C 1.536 0.613 0 C-N-CA 114.238 -3.375 . . . . 0.0 113.922 -179.796 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.458 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 3.1 p-10 -75.28 -20.64 59.03 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.871 0.843 . . . . 0.0 110.944 178.057 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -83.49 -11.43 57.48 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 114.09 1.144 . . . . 0.0 114.09 -173.747 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 97.5 mm-40 -56.69 -29.79 62.75 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 115.512 1.671 . . . . 0.0 115.512 -177.03 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 12.0 tt -56.79 139.57 16.13 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.007 0 N-CA-C 114.385 1.254 . . . . 0.0 114.385 -176.948 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -177.31 -157.4 18.18 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.619 -0.8 . . . . 0.0 113.428 -178.413 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 41.4 p90 -154.66 170.53 21.33 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 179.766 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 23.5 m-85 -113.68 142.03 46.51 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 173.546 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 59.8 ttt180 -113.57 120.02 39.51 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 114.96 -1.018 . . . . 0.0 110.888 -175.455 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 3.6 ttt180 -63.06 140.95 58.93 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 123.184 0.594 . . . . 0.0 109.488 176.985 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -144.48 128.96 18.01 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.804 0.335 . . . . 0.0 110.173 177.442 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -158.79 134.17 8.58 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.129 178.574 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 18.5 tpt180 -145.94 123.74 11.94 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.479 0.657 . . . . 0.0 110.929 174.438 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 9.2 ttp180 -113.08 141.44 46.88 Favored 'General case' 0 CA--C 1.489 -1.394 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.423 178.495 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -131.56 177.77 6.53 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 N-CA-C 106.442 -1.688 . . . . 0.0 106.442 178.111 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 17.0 ttt85 -138.39 112.28 8.42 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 106.193 -1.781 . . . . 0.0 106.193 178.505 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -150.78 175.5 29.74 Favored Glycine 0 N--CA 1.444 -0.772 0 N-CA-C 107.145 -2.382 . . . . 0.0 107.145 178.395 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -75.25 -59.31 3.64 Favored Glycine 0 C--O 1.222 -0.624 0 N-CA-C 108.238 -1.945 . . . . 0.0 108.238 178.251 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.501 ' C ' ' H ' ' A' ' 60' ' ' LYS . 0.7 OUTLIER -94.26 -3.19 51.09 Favored 'General case' 0 C--O 1.217 -0.634 0 N-CA-C 105.207 -2.146 . . . . 0.0 105.207 174.266 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -89.53 33.89 4.21 Favored Glycine 0 N--CA 1.451 -0.314 0 N-CA-C 106.088 -2.805 . . . . 0.0 106.088 173.243 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.501 ' H ' ' C ' ' A' ' 58' ' ' ASP . 1.3 pttt -50.67 167.55 0.06 Allowed 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 113.415 -1.393 . . . . 0.0 111.028 172.268 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -46.69 129.59 11.31 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 113.926 -1.488 . . . . 0.0 113.698 -175.745 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -98.52 -73.99 0.6 Allowed 'General case' 0 C--O 1.219 -0.543 0 CA-C-N 113.666 -1.606 . . . . 0.0 114.044 -174.866 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 73.6 m-20 -95.06 96.66 9.4 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 179.349 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -74.58 -40.85 61.37 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 179.147 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 4.5 p -112.23 152.82 44.73 Favored Pre-proline 0 C--O 1.24 0.6 0 CA-C-N 114.962 -1.017 . . . . 0.0 108.985 179.723 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -74.34 156.68 45.96 Favored 'Trans proline' 0 C--O 1.238 0.497 0 C-N-CA 117.108 -1.461 . . . . 0.0 112.6 178.174 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 58.1 mtt-85 -124.58 149.87 46.55 Favored 'General case' 0 CA--C 1.513 -0.449 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.677 -179.657 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 35.0 m95 -134.75 129.82 35.24 Favored 'General case' 0 C--O 1.216 -0.662 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 175.565 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 60.0 m-85 -110.48 156.38 20.94 Favored 'General case' 0 C--O 1.212 -0.91 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 -178.96 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -97.97 136.91 37.57 Favored 'General case' 0 CA--C 1.509 -0.608 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 -179.84 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -139.12 130.31 26.73 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 107.097 -1.446 . . . . 0.0 107.097 -175.846 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 86.1 m-85 -70.69 159.47 34.4 Favored 'General case' 0 C--N 1.319 -0.756 0 O-C-N 122.191 -0.318 . . . . 0.0 111.063 -178.009 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -49.01 121.59 4.93 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 113.496 0.925 . . . . 0.0 113.496 -175.973 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 70.32 21.53 77.36 Favored Glycine 0 C--O 1.224 -0.529 0 N-CA-C 116.44 1.336 . . . . 0.0 116.44 176.009 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 34.2 p . . . . . 0 C--O 1.236 0.387 0 CA-C-N 118.604 1.202 . . . . 0.0 111.648 -179.742 . . . . . . . . 0 0 . 1 . 038 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 14.7 mt . . . . . 0 N--CA 1.444 -0.775 0 N-CA-C 115.412 1.634 . . . . 0.0 115.412 . . . . . . . . . 0 0 . 1 . 038 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -77.62 161.77 30.72 Favored 'Trans proline' 0 N--CA 1.461 -0.401 0 C-N-CA 122.061 1.84 . . . . 0.0 107.404 168.501 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 57.6 t80 -61.12 131.86 51.87 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 120.379 -0.529 . . . . 0.0 110.395 -177.177 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 92.98 -11.97 70.94 Favored Glycine 0 C--O 1.225 -0.432 0 CA-C-O 119.399 -0.667 . . . . 0.0 114.41 179.409 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -65.1 130.37 43.09 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 118.497 1.149 . . . . 0.0 112.071 -179.51 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 30.9 m120 -77.72 132.64 38.24 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 114.563 -1.199 . . . . 0.0 110.146 179.724 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 30.6 ttmt -156.21 155.35 32.26 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 104.148 -2.538 . . . . 0.0 104.148 177.795 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -65.75 133.22 50.57 Favored 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 120.273 -0.571 . . . . 0.0 109.672 -179.03 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 69.06 28.53 72.85 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.772 -0.728 . . . . 0.0 114.794 177.572 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 46.4 mm -126.01 126.6 70.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 117.476 0.638 . . . . 0.0 110.548 179.725 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -129.24 123.11 57.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.565 177.023 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 96.9 m95 -87.78 138.7 31.23 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 -176.758 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 13.7 m -138.02 151.49 25.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 179.102 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -160.29 165.86 30.57 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 104.833 -2.284 . . . . 0.0 104.833 -179.973 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 14.1 t -127.09 170.78 11.99 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 105.237 -2.135 . . . . 0.0 105.237 178.479 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -66.07 133.55 50.99 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.088 0.471 . . . . 0.0 110.651 -178.635 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 92.69 -7.5 77.21 Favored Glycine 0 N--CA 1.459 0.172 0 CA-C-N 116.017 -0.538 . . . . 0.0 113.422 178.749 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.458 ' HA ' ' HA ' ' A' ' 41' ' ' ASP . . . -74.63 140.49 44.33 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 178.504 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 39.6 mt -99.27 138.03 36.95 Favored 'General case' 0 CA--C 1.515 -0.385 0 N-CA-C 113.398 0.888 . . . . 0.0 113.398 -177.763 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -81.4 66.55 6.99 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.438 -178.751 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 1.2 t -133.11 155.36 81.1 Favored Pre-proline 0 C--N 1.32 -0.697 0 N-CA-C 105.327 -2.101 . . . . 0.0 105.327 -179.5 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -61.17 147.82 94.57 Favored 'Trans proline' 0 C--N 1.343 0.253 0 N-CA-C 114.614 0.967 . . . . 0.0 114.614 -179.603 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.522 ' HB3' HD12 ' A' ' 106' ' ' ILE . 74.1 mmtt -121.39 38.17 4.16 Favored 'General case' 0 CA--C 1.508 -0.643 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.332 -179.402 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 16.7 p-10 -59.9 -33.62 72.1 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 176.514 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 7.9 p80 -62.79 -16.19 56.94 Favored 'General case' 0 C--O 1.221 -0.411 0 N-CA-C 113.158 0.799 . . . . 0.0 113.158 177.973 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.522 HD12 ' HB3' ' A' ' 103' ' ' LYS . 60.2 mt -95.93 -49.96 11.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 120.977 0.418 . . . . 0.0 110.896 178.281 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -71.02 14.19 1.63 Allowed Glycine 0 C--O 1.22 -0.741 0 N-CA-C 117.53 1.772 . . . . 0.0 117.53 -174.124 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 9.0 t -83.59 26.43 0.68 Allowed 'General case' 0 CA--C 1.551 0.988 0 CA-C-O 121.671 0.748 . . . . 0.0 111.744 -179.31 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 64.8 ttp85 -68.32 119.43 12.84 Favored 'General case' 0 N--CA 1.465 0.325 0 O-C-N 121.271 -0.893 . . . . 0.0 109.978 178.66 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -86.54 122.17 71.95 Favored Pre-proline 0 C--N 1.323 -0.569 0 N-CA-C 105.103 -2.184 . . . . 0.0 105.103 176.571 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -72.78 -15.43 26.79 Favored 'Trans proline' 0 C--O 1.218 -0.494 0 C-N-CA 116.907 -1.595 . . . . 0.0 114.374 -177.174 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -81.57 -24.56 36.43 Favored 'General case' 0 C--O 1.221 -0.422 0 CA-C-O 120.963 0.411 . . . . 0.0 110.479 178.745 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 -100.15 -22.98 14.97 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 -174.504 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 15.5 t30 -145.72 148.69 33.28 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -178.314 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -86.37 148.44 25.58 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-O 121.654 0.74 . . . . 0.0 112.536 -179.776 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -73.74 151.02 40.79 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.635 178.132 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 14.2 mt -90.73 139.62 17.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.565 -178.738 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 73.1 t -62.83 121.82 12.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 174.588 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 5.2 tt -67.18 129.45 39.95 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.189 0.519 . . . . 0.0 111.088 -176.923 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 34.5 mt-30 -135.88 158.41 44.47 Favored 'General case' 0 C--O 1.218 -0.562 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 -179.226 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 13.4 mt -112.18 148.0 38.16 Favored Pre-proline 0 C--N 1.322 -0.598 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 177.577 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -73.59 163.02 38.52 Favored 'Trans proline' 0 C--O 1.237 0.457 0 O-C-N 122.195 0.576 . . . . 0.0 112.546 179.179 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 53.9 tt0 -55.24 132.0 46.74 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 179.508 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 106.57 -27.06 17.9 Favored Glycine 0 C--O 1.226 -0.37 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.983 -178.515 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 8.9 m -105.44 129.33 53.77 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 118.04 0.92 . . . . 0.0 111.198 178.395 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 3.0 p -115.65 148.21 39.94 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.15 178.44 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 86.2 mt -71.4 152.94 94.09 Favored Pre-proline 0 C--N 1.323 -0.587 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 177.647 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -76.53 175.02 11.89 Favored 'Trans proline' 0 CA--C 1.531 0.325 0 N-CA-C 110.615 -0.571 . . . . 0.0 110.615 178.529 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 12.0 tmtt? -53.49 128.65 29.66 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 -175.571 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 88.43 -3.54 85.29 Favored Glycine 0 C--O 1.23 -0.151 0 N-CA-C 116.74 1.456 . . . . 0.0 116.74 173.497 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.461 ' CZ ' ' HB2' ' A' ' 18' ' ' GLN . 1.8 m-85 -93.18 144.09 25.62 Favored 'General case' 0 N--CA 1.433 -1.316 0 CA-C-O 122.718 1.247 . . . . 0.0 112.072 -178.464 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 34.6 p90 -144.52 164.47 30.79 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-N 112.636 -2.074 . . . . 0.0 106.773 174.193 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -106.35 147.06 29.65 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.243 0.545 . . . . 0.0 110.736 -177.381 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -75.8 129.91 37.77 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 -179.59 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 87.63 -0.32 84.78 Favored Glycine 0 C--O 1.225 -0.464 0 C-N-CA 121.161 -0.542 . . . . 0.0 112.55 -178.093 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 24.9 t . . . . . 0 C--N 1.327 -0.386 0 O-C-N 122.433 -0.451 . . . . 0.0 110.106 178.491 . . . . . . . . 0 0 . 1 . 039 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.217 0 N-CA-C 113.379 0.881 . . . . 0.0 113.379 . . . . . . . . . 0 0 . 1 . 039 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 28.4 t -58.88 134.97 57.39 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 114.548 -1.205 . . . . 0.0 108.63 174.591 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 3.1 m95 -67.55 -26.87 66.52 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 178.058 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -121.73 161.34 22.75 Favored 'General case' 0 CA--C 1.507 -0.676 0 CA-C-O 121.192 0.52 . . . . 0.0 110.312 -171.375 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 64.8 p -67.33 161.26 25.46 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 122.195 0.997 . . . . 0.0 109.561 179.622 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -92.14 120.71 33.0 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 114.686 -1.143 . . . . 0.0 112.474 -174.156 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -68.59 148.81 49.96 Favored 'General case' 0 CA--C 1.505 -0.768 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 179.96 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.487 HG23 HH22 ' A' ' 53' ' ' ARG . 17.4 m -93.26 136.62 33.35 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 176.947 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 20.0 tm0? -107.28 117.5 34.24 Favored 'General case' 0 CA--C 1.509 -0.621 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 177.144 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 22.7 t-160 -139.32 99.88 3.85 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 172.728 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 173.53 -166.12 38.33 Favored Glycine 0 C--N 1.319 -0.407 0 N-CA-C 110.521 -1.032 . . . . 0.0 110.521 -178.977 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 89.0 mttt -92.53 -24.8 18.64 Favored 'General case' 0 CA--C 1.512 -0.516 0 CA-C-O 121.993 0.901 . . . . 0.0 109.635 179.449 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -90.6 152.11 21.02 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 114.175 -1.375 . . . . 0.0 108.384 179.311 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -87.57 -62.4 1.51 Allowed 'General case' 0 C--O 1.21 -0.977 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.062 -177.421 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 49.6 tp 172.34 141.71 0.03 OUTLIER 'General case' 0 CA--C 1.506 -0.75 0 N-CA-C 104.572 -2.381 . . . . 0.0 104.572 176.824 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 23.3 tptt -161.94 143.38 10.99 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 106.606 -1.627 . . . . 0.0 106.606 178.185 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 16.6 m-85 -132.62 150.0 74.6 Favored Pre-proline 0 C--N 1.323 -0.558 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 177.398 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -76.56 166.87 26.56 Favored 'Trans proline' 0 C--N 1.351 0.702 0 C-N-CA 120.159 0.573 . . . . 0.0 113.402 179.593 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 21.3 tpt180 -64.14 136.11 56.95 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.587 -178.647 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 86.32 -1.91 87.48 Favored Glycine 0 N--CA 1.46 0.24 0 CA-C-O 121.395 0.442 . . . . 0.0 112.145 177.751 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -138.67 170.52 15.86 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 123.408 0.683 . . . . 0.0 110.433 -174.144 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 107.06 -26.82 17.88 Favored Glycine 0 CA--C 1.496 -1.103 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.67 175.249 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 85.1 t -65.27 125.49 89.51 Favored Pre-proline 0 C--N 1.32 -0.699 0 N-CA-C 105.498 -2.038 . . . . 0.0 105.498 176.372 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -71.6 164.52 35.44 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 N-CA-C 110.579 -0.585 . . . . 0.0 110.579 178.422 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 84.8 mt -61.99 115.0 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 -177.237 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -116.98 74.84 0.93 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 122.667 1.223 . . . . 0.0 112.307 -170.377 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 72.7 p -69.73 -19.51 63.54 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 114.371 -1.286 . . . . 0.0 113.506 -175.53 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 52.9 m-80 -106.38 29.04 7.19 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.644 -0.707 . . . . 0.0 112.165 -174.195 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 97.8 p -146.46 160.73 41.72 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.919 0.39 . . . . 0.0 111.032 179.786 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.3 m -71.67 163.83 63.14 Favored Pre-proline 0 C--N 1.323 -0.546 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.67 -178.313 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -67.34 -28.39 39.56 Favored 'Trans proline' 0 C--N 1.351 0.658 0 C-N-CA 115.167 -2.755 . . . . 0.0 113.669 179.041 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.448 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 1.6 p-10 -75.13 -19.84 59.71 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 121.525 -0.734 . . . . 0.0 110.518 176.714 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.416 ' CG ' HD11 ' A' ' 106' ' ' ILE . 34.6 m-20 -84.45 -6.9 59.42 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 113.955 1.094 . . . . 0.0 113.955 -173.335 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 97.6 mm-40 -57.54 -32.53 67.17 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 114.144 1.165 . . . . 0.0 114.144 -179.113 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.488 ' HB ' ' HB1' ' A' ' 98' ' ' ALA . 10.4 tt -58.43 139.24 18.38 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 CA-C-O 122.382 1.087 . . . . 0.0 113.49 -176.904 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -176.26 -159.65 22.26 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.277 -0.964 . . . . 0.0 112.899 -178.166 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 38.3 p90 -154.82 166.6 32.97 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 179.511 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 13.3 m-85 -109.27 142.9 39.46 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 174.472 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 62.9 ttt180 -116.15 125.45 52.34 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 123.182 0.593 . . . . 0.0 111.044 -176.89 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 47.8 ttp180 -74.06 134.19 42.95 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 109.592 -0.522 . . . . 0.0 109.592 177.329 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -152.0 170.0 20.95 Favored 'General case' 0 C--O 1.213 -0.846 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 -179.072 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 8.9 t -136.82 142.41 42.89 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 119.161 0.891 . . . . 0.0 110.574 172.106 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 14.7 tpt180 -166.79 128.66 1.73 Allowed 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 179.226 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.487 HH22 HG23 ' A' ' 17' ' ' THR . 21.9 mmt180 -147.63 -179.42 6.86 Favored 'General case' 0 CA--C 1.48 -1.72 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 -179.01 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -117.25 170.92 6.19 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.97 0 CA-C-N 113.686 -1.597 . . . . 0.0 107.043 -177.105 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 8.7 ttm-85 -143.44 129.69 19.83 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 175.886 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -82.01 178.99 53.45 Favored Glycine 0 C--O 1.221 -0.703 0 N-CA-C 109.882 -1.287 . . . . 0.0 109.882 178.583 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -67.59 -36.34 87.89 Favored Glycine 0 C--O 1.217 -0.951 0 C-N-CA 121.008 -0.615 . . . . 0.0 114.116 -176.425 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -80.3 -16.59 54.28 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 122.143 0.973 . . . . 0.0 109.054 178.787 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 114.37 -6.37 23.03 Favored Glycine 0 N--CA 1.452 -0.293 0 CA-C-N 114.496 -1.229 . . . . 0.0 114.584 179.587 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.429 ' H ' ' HD2' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -61.33 150.47 34.91 Favored 'General case' 0 CA--C 1.506 -0.725 0 CA-C-N 118.334 1.067 . . . . 0.0 111.242 -178.404 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 89.7 mtp -126.88 164.2 21.94 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 113.978 -1.464 . . . . 0.0 112.249 -176.647 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 2.0 tppt? -77.87 -37.43 48.2 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.298 -179.031 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 60.2 t0 -175.53 167.1 3.27 Favored 'General case' 0 C--N 1.318 -0.778 1 N-CA-C 99.283 -4.34 . . . . 0.0 99.283 -177.242 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -109.95 -31.83 7.25 Favored 'General case' 0 N--CA 1.435 -1.205 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 176.72 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.5 m -55.91 156.55 9.64 Favored Pre-proline 0 C--O 1.245 0.853 0 N-CA-C 116.342 1.979 . . . . 0.0 116.342 -174.949 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -75.62 -176.68 3.1 Favored 'Trans proline' 0 C--N 1.354 0.822 0 C-N-CA 121.039 1.16 . . . . 0.0 114.276 -179.275 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 81.0 mtt-85 -133.75 166.36 22.83 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.488 -177.836 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 50.9 m95 -125.39 131.72 52.9 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 173.751 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 24.1 m-85 -110.55 166.86 10.66 Favored 'General case' 0 C--O 1.216 -0.683 0 N-CA-C 105.45 -2.055 . . . . 0.0 105.45 -177.595 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 93.4 t80 -117.92 134.91 54.49 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-N 119.287 0.948 . . . . 0.0 109.721 -178.949 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 16.7 m-85 -136.36 158.88 43.38 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 -177.316 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 63.3 m-85 -98.63 159.34 15.02 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 -174.794 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -53.83 127.71 27.06 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.986 0.422 . . . . 0.0 111.039 -178.167 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 68.17 31.78 75.29 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.439 -0.886 . . . . 0.0 114.84 176.76 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.478 HG22 ' HA ' ' A' ' 104' ' ' ASP . 2.3 p . . . . . 0 C--N 1.327 -0.37 0 N-CA-C 105.181 -2.155 . . . . 0.0 105.181 174.16 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 13.2 mt . . . . . 0 N--CA 1.44 -0.972 0 N-CA-C 115.039 1.496 . . . . 0.0 115.039 . . . . . . . . . 0 0 . 1 . 039 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -78.4 161.61 28.45 Favored 'Trans proline' 0 N--CA 1.461 -0.424 0 C-N-CA 122.226 1.951 . . . . 0.0 107.304 167.772 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 57.7 t80 -61.11 130.66 47.44 Favored 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 120.315 -0.554 . . . . 0.0 110.44 -177.576 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 93.27 -8.51 75.32 Favored Glycine 0 CA--C 1.52 0.351 0 CA-C-O 119.35 -0.694 . . . . 0.0 114.352 178.956 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -67.12 131.73 46.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 118.607 1.203 . . . . 0.0 111.247 179.754 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 57.0 t30 -78.93 132.13 36.62 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.734 -0.667 . . . . 0.0 110.167 179.895 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 29.0 ttmt -155.97 154.38 31.02 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 106.146 -1.798 . . . . 0.0 106.146 179.28 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -61.4 129.32 40.64 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.081 0.467 . . . . 0.0 111.136 -178.648 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 67.86 30.08 74.11 Favored Glycine 0 N--CA 1.449 -0.474 0 CA-C-O 119.175 -0.792 . . . . 0.0 114.185 177.624 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 43.3 mm -126.04 131.86 71.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 117.845 0.822 . . . . 0.0 111.286 179.632 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -134.93 122.64 38.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.776 175.636 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 95.8 m95 -87.18 137.97 31.89 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 113.167 0.803 . . . . 0.0 113.167 -176.913 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 17.7 m -137.48 150.67 25.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.607 179.326 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -160.39 166.03 30.06 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 105.03 -2.211 . . . . 0.0 105.03 179.907 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 7.1 t -134.41 176.63 8.43 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 105.305 -2.109 . . . . 0.0 105.305 177.849 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -67.56 135.24 52.64 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.302 0.572 . . . . 0.0 110.702 -178.473 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 96.57 -12.7 66.1 Favored Glycine 0 C--O 1.228 -0.269 0 CA-C-N 115.703 -0.68 . . . . 0.0 112.911 178.341 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.488 ' HB1' ' HB ' ' A' ' 44' ' ' ILE . . . -77.16 137.09 38.67 Favored 'General case' 0 CA--C 1.543 0.676 0 O-C-N 122.694 -0.297 . . . . 0.0 110.622 179.982 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 40.6 mt -98.78 138.55 35.76 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 -177.884 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -80.11 63.8 4.73 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.165 -179.023 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 1.4 t -132.27 154.96 81.8 Favored Pre-proline 0 C--N 1.323 -0.581 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 -179.399 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -66.52 148.23 83.38 Favored 'Trans proline' 0 CA--C 1.53 0.319 0 N-CA-C 114.48 0.915 . . . . 0.0 114.48 175.974 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -148.83 57.9 1.04 Allowed 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 113.571 0.952 . . . . 0.0 113.571 179.212 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . 0.478 ' HA ' HG22 ' A' ' 75' ' ' THR . 12.5 t0 -64.56 -11.34 33.51 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 121.28 0.562 . . . . 0.0 110.658 175.782 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 12.5 p-80 -62.45 -13.42 29.88 Favored 'General case' 0 N--CA 1.468 0.473 0 O-C-N 122.038 -0.414 . . . . 0.0 111.679 177.412 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.416 HD11 ' CG ' ' A' ' 42' ' ' ASP . 20.6 mt -96.09 -28.75 3.91 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 CA-C-O 120.819 0.342 . . . . 0.0 111.023 179.079 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -73.46 3.74 31.05 Favored Glycine 0 N--CA 1.462 0.387 0 N-CA-C 115.09 0.796 . . . . 0.0 115.09 -176.117 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 14.4 t -83.22 19.03 1.56 Allowed 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 113.515 0.931 . . . . 0.0 113.515 -177.694 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 67.1 ttp85 -64.39 114.95 4.63 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 177.664 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 58.8 m-20 -91.12 121.36 67.93 Favored Pre-proline 0 C--N 1.318 -0.78 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 -178.596 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -68.93 -18.74 40.85 Favored 'Trans proline' 0 C--N 1.347 0.493 0 N-CA-C 114.343 0.863 . . . . 0.0 114.343 -176.176 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -73.77 -26.01 60.43 Favored 'General case' 0 C--O 1.22 -0.469 0 CA-C-O 120.734 0.302 . . . . 0.0 110.548 177.365 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 76.5 m-20 -103.49 -27.1 12.58 Favored 'General case' 0 C--O 1.222 -0.361 0 N-CA-C 113.421 0.897 . . . . 0.0 113.421 -174.95 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 19.0 t30 -147.35 145.04 29.17 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.818 0.673 . . . . 0.0 112.818 -178.751 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -83.19 146.16 28.76 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-O 121.517 0.675 . . . . 0.0 111.911 -179.79 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -70.38 144.13 51.69 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 177.325 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 12.0 mt -76.9 135.63 26.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 -178.406 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 72.9 t -63.75 118.33 5.8 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 N-CA-C 103.633 -2.729 . . . . 0.0 103.633 172.859 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 6.8 tt -63.18 130.99 46.96 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.38 0.609 . . . . 0.0 112.072 -174.061 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 30.8 mt-30 -130.58 150.46 51.77 Favored 'General case' 0 CA--C 1.508 -0.671 0 N-CA-C 106.084 -1.821 . . . . 0.0 106.084 179.089 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 12.5 mt -110.37 148.3 38.13 Favored Pre-proline 0 C--N 1.319 -0.76 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 177.773 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -73.71 166.07 30.69 Favored 'Trans proline' 0 C--O 1.236 0.416 0 C-N-CA 118.239 -0.707 . . . . 0.0 112.659 -179.605 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 40.5 tt0 -54.04 131.88 41.52 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.073 179.425 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 104.1 -27.35 19.77 Favored Glycine 0 C--O 1.226 -0.356 0 CA-C-N 115.91 -0.587 . . . . 0.0 112.288 -178.598 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 2.7 m -105.98 129.34 54.12 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 118.207 1.004 . . . . 0.0 112.205 178.759 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 9.4 p -119.8 148.24 43.68 Favored 'General case' 0 CA--C 1.509 -0.607 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.899 178.423 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 93.1 mt -68.07 154.31 94.06 Favored Pre-proline 0 C--N 1.323 -0.571 0 N-CA-C 106.935 -1.506 . . . . 0.0 106.935 177.2 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -76.77 177.6 8.65 Favored 'Trans proline' 0 N--CA 1.464 -0.214 0 CA-C-O 121.446 0.519 . . . . 0.0 112.442 -178.795 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 3.0 ttpm? -59.77 130.65 47.85 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.118 -0.492 . . . . 0.0 109.701 179.072 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 84.26 23.21 52.36 Favored Glycine 0 N--CA 1.454 -0.138 0 N-CA-C 115.44 0.936 . . . . 0.0 115.44 176.876 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -124.73 141.72 51.91 Favored 'General case' 0 CA--C 1.51 -0.568 0 CA-C-O 121.426 0.631 . . . . 0.0 112.152 179.382 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 45.4 p90 -145.6 153.21 40.81 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 107.259 -1.386 . . . . 0.0 107.259 172.584 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -89.18 139.21 30.71 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.186 0.517 . . . . 0.0 111.025 -177.577 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -71.38 137.87 48.72 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 176.325 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 89.34 -2.34 83.15 Favored Glycine 0 C--O 1.224 -0.53 0 N-CA-C 111.653 -0.579 . . . . 0.0 111.653 -178.215 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 9.6 t . . . . . 0 C--N 1.327 -0.409 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 177.46 . . . . . . . . 0 0 . 1 . 040 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.228 -0.078 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 . . . . . . . . . 0 0 . 1 . 040 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 46.6 t -64.01 141.83 58.63 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 177.973 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 17.8 m95 -68.44 -21.72 64.63 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 111.944 0.35 . . . . 0.0 111.944 178.284 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 64.8 m-85 -121.53 164.38 17.32 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 -172.366 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 73.8 p -70.01 161.53 29.9 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 178.97 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.452 ' HB2' ' CZ ' ' A' ' 69' ' ' TYR . . . -76.22 149.74 37.18 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 113.743 1.016 . . . . 0.0 113.743 -175.425 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 13.9 mt -91.99 148.87 21.87 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 103.818 -2.66 . . . . 0.0 103.818 170.425 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 19.6 m -122.33 137.63 54.79 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 -179.186 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.435 ' HB2' ' CZ ' ' A' ' 131' ' ' PHE . 4.4 tp60 -112.05 133.11 54.41 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 -177.669 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 8.7 t60 -126.9 99.43 5.73 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 105.178 -2.156 . . . . 0.0 105.178 171.18 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 175.25 -172.77 45.78 Favored Glycine 0 C--O 1.227 -0.286 0 N-CA-C 110.212 -1.155 . . . . 0.0 110.212 -177.626 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -99.21 -27.29 13.87 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 121.048 0.451 . . . . 0.0 111.27 179.496 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -80.93 166.7 20.62 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 107.038 -1.467 . . . . 0.0 107.038 177.06 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -94.48 -62.78 1.27 Allowed 'General case' 0 CA--C 1.548 0.888 0 CA-C-O 118.443 -0.789 . . . . 0.0 112.156 -176.662 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.426 HD13 ' CZ ' ' A' ' 131' ' ' PHE . 33.7 tp -175.08 140.95 0.54 Allowed 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 124.044 0.938 . . . . 0.0 109.413 172.821 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 50.2 tptt -151.77 138.85 19.14 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 172.67 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -122.25 153.71 61.78 Favored Pre-proline 0 C--O 1.242 0.671 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 176.533 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -70.33 158.15 57.1 Favored 'Trans proline' 0 C--N 1.353 0.795 0 O-C-N 122.079 0.515 . . . . 0.0 112.727 179.458 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 70.9 ttt180 -70.16 134.36 48.05 Favored 'General case' 0 C--O 1.216 -0.688 0 O-C-N 121.848 -0.533 . . . . 0.0 111.072 -177.725 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 90.13 1.16 76.25 Favored Glycine 0 N--CA 1.462 0.409 0 CA-C-O 121.649 0.583 . . . . 0.0 112.035 179.262 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -146.77 170.45 16.97 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 107.497 -1.298 . . . . 0.0 107.497 -176.941 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 127.09 -28.39 4.6 Favored Glycine 0 CA--C 1.483 -1.948 0 N-CA-C 108.46 -1.856 . . . . 0.0 108.46 165.79 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 32.8 m -67.72 140.69 94.45 Favored Pre-proline 0 N--CA 1.429 -1.477 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 177.462 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -74.37 173.93 13.39 Favored 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 121.226 1.284 . . . . 0.0 111.91 178.918 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 92.7 mt -73.72 115.03 14.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 N-CA-C 107.494 -1.298 . . . . 0.0 107.494 177.823 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 31.6 m-20 -111.79 80.33 1.31 Allowed 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.423 -177.791 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 81.2 p -67.76 -16.2 64.01 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 113.835 1.05 . . . . 0.0 113.835 -176.877 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -106.83 21.31 17.72 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.375 -177.15 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 5.3 m -134.97 157.79 45.99 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.78 0.324 . . . . 0.0 111.483 -176.47 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 20.0 m -72.85 161.36 79.74 Favored Pre-proline 0 C--N 1.323 -0.549 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 178.615 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -65.19 -26.62 56.96 Favored 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 114.93 -2.913 . . . . 0.0 110.49 176.021 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -61.75 -19.32 62.32 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 124.578 1.151 . . . . 0.0 111.652 175.713 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -107.92 1.0 22.34 Favored 'General case' 0 C--O 1.217 -0.618 0 N-CA-C 115.027 1.491 . . . . 0.0 115.027 -172.617 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 85.7 mm-40 -61.45 -27.57 68.66 Favored 'General case' 0 C--O 1.216 -0.694 0 O-C-N 121.045 -1.034 . . . . 0.0 111.068 178.995 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 13.0 tt -60.35 144.05 13.65 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 N-CA-C 113.797 1.036 . . . . 0.0 113.797 179.209 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 178.85 -152.57 11.41 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.527 -0.844 . . . . 0.0 111.21 178.543 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 47.1 p90 -155.08 168.88 25.54 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 177.22 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 25.4 m-85 -113.34 141.07 47.48 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 106.648 -1.612 . . . . 0.0 106.648 174.071 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 38.6 ttt180 -111.05 127.6 55.6 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.37 -178.695 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 28.4 ttm180 -68.04 134.54 50.81 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 106.353 -1.721 . . . . 0.0 106.353 176.602 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -139.57 127.89 22.7 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 -176.734 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 6.8 p -139.62 131.95 28.37 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 174.773 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 11.2 tpt180 -160.73 123.83 3.34 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 178.621 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 2.5 tpp180 -97.17 137.42 36.23 Favored 'General case' 0 CA--C 1.501 -0.935 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 179.801 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -124.87 171.44 13.73 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 -179.201 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 8.1 tmm_? -134.66 114.03 12.32 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 106.324 -1.732 . . . . 0.0 106.324 177.745 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -74.5 165.07 54.75 Favored Glycine 0 N--CA 1.449 -0.497 0 N-CA-C 110.733 -0.947 . . . . 0.0 110.733 179.489 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -75.3 -27.42 63.84 Favored Glycine 0 C--O 1.217 -0.954 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 -179.562 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -89.77 14.61 11.45 Favored 'General case' 0 C--O 1.219 -0.523 0 CA-C-O 122.256 1.027 . . . . 0.0 109.706 179.077 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 86.21 -12.81 59.39 Favored Glycine 0 C--O 1.227 -0.288 0 N-CA-C 115.897 1.119 . . . . 0.0 115.897 173.706 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -64.5 130.49 43.9 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.699 0.762 . . . . 0.0 111.614 -178.609 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 94.8 mmm -91.86 -170.65 2.62 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 114.527 -1.215 . . . . 0.0 110.399 -178.489 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 18.4 tptp -92.79 -53.95 3.96 Favored 'General case' 0 CA--C 1.515 -0.395 0 N-CA-C 114.085 1.142 . . . . 0.0 114.085 179.436 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 38.45 -140.78 0.04 OUTLIER 'General case' 0 C--O 1.245 0.861 0 O-C-N 125.135 1.522 . . . . 0.0 113.025 -175.571 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 61.29 170.8 0.11 Allowed 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.694 1.198 . . . . 0.0 113.999 -176.232 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -74.69 165.35 54.46 Favored Pre-proline 0 C--O 1.24 0.589 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.71 -179.655 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -66.18 152.16 81.84 Favored 'Trans proline' 0 C--N 1.355 0.87 0 C-N-CA 117.818 -0.988 . . . . 0.0 112.053 178.67 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 30.7 mtt180 -124.02 166.3 15.97 Favored 'General case' 0 CA--C 1.51 -0.57 0 N-CA-C 114.779 1.4 . . . . 0.0 114.779 -175.958 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 67.4 m95 -130.43 146.84 52.06 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 177.922 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.452 ' CZ ' ' HB2' ' A' ' 15' ' ' ALA . 25.5 m-85 -130.64 144.11 51.2 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 -178.799 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 77.4 t80 -89.91 136.42 33.05 Favored 'General case' 0 CA--C 1.512 -0.485 0 N-CA-C 109.001 -0.741 . . . . 0.0 109.001 -177.218 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -139.64 143.23 37.09 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 108.812 -0.811 . . . . 0.0 108.812 -176.333 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -74.23 159.43 32.51 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.67 -175.993 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.1 tt -55.89 129.54 40.0 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 -176.137 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 69.0 34.54 76.79 Favored Glycine 0 C--O 1.222 -0.649 0 N-CA-C 115.487 0.955 . . . . 0.0 115.487 175.498 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.326 -0.432 0 CA-C-N 118.28 1.04 . . . . 0.0 111.334 -179.989 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 20.2 mt . . . . . 0 N--CA 1.448 -0.551 0 N-CA-C 115.683 1.734 . . . . 0.0 115.683 . . . . . . . . . 0 0 . 1 . 040 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -78.89 166.27 23.5 Favored 'Trans proline' 0 N--CA 1.46 -0.458 0 C-N-CA 121.826 1.684 . . . . 0.0 108.034 168.707 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 54.2 t80 -62.2 132.34 52.44 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 120.622 -0.431 . . . . 0.0 109.935 -179.96 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 92.06 -8.25 78.01 Favored Glycine 0 CA--C 1.52 0.358 0 N-CA-C 115.085 0.794 . . . . 0.0 115.085 178.794 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -64.35 131.48 47.38 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 118.321 1.06 . . . . 0.0 112.007 -179.963 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 33.4 t-20 -73.98 127.16 32.15 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.595 -178.517 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 26.4 ttmt -156.18 150.1 25.15 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 104.992 -2.225 . . . . 0.0 104.992 175.74 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -71.13 136.05 47.97 Favored 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 120.198 -0.601 . . . . 0.0 109.723 -177.376 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 73.58 21.09 79.81 Favored Glycine 0 N--CA 1.447 -0.59 0 CA-C-O 119.19 -0.783 . . . . 0.0 113.353 178.665 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 44.3 mm -124.87 121.83 62.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 117.542 0.671 . . . . 0.0 110.376 179.402 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -122.75 112.52 34.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 CA-C-O 121.862 0.839 . . . . 0.0 110.793 175.749 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 96.4 m95 -78.44 133.21 37.51 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.126 -178.814 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 1.7 m -140.81 149.73 20.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 -178.689 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -157.98 166.05 33.57 Favored 'General case' 0 CA--C 1.507 -0.696 0 N-CA-C 106.491 -1.67 . . . . 0.0 106.491 -178.404 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 5.9 t -132.44 171.5 13.68 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 105.94 -1.874 . . . . 0.0 105.94 174.897 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -67.65 138.86 56.67 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.258 0.551 . . . . 0.0 110.81 -178.142 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 96.46 -7.67 66.2 Favored Glycine 0 C--O 1.226 -0.386 0 CA-C-N 115.705 -0.68 . . . . 0.0 113.143 178.943 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -85.6 147.23 26.5 Favored 'General case' 0 CA--C 1.544 0.74 0 O-C-N 122.632 -0.334 . . . . 0.0 111.489 179.982 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 45.2 mt -92.02 139.7 30.38 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -178.274 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 60.8 t30 -90.45 66.61 6.43 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.057 0.456 . . . . 0.0 110.83 -179.463 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -141.31 155.88 67.62 Favored Pre-proline 0 C--N 1.323 -0.57 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 179.889 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -73.77 152.4 47.32 Favored 'Trans proline' 0 CA--C 1.535 0.565 0 N-CA-C 114.955 1.098 . . . . 0.0 114.955 178.313 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.54 57.96 1.12 Allowed 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 121.827 0.823 . . . . 0.0 111.125 179.171 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -57.9 -31.6 66.93 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.609 179.071 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 42.7 p-80 -63.12 -13.95 42.77 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 114.273 1.212 . . . . 0.0 114.273 -178.162 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 94.8 mt -87.92 -29.06 5.46 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 177.617 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -75.58 4.2 44.6 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 115.239 0.856 . . . . 0.0 115.239 -177.304 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 12.7 t -83.09 21.06 1.12 Allowed 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 -178.134 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.404 ' HD2' HD22 ' A' ' 114' ' ' ASN . 69.2 ttp85 -56.25 126.61 26.94 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 179.25 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -95.93 127.36 41.28 Favored Pre-proline 0 C--N 1.322 -0.619 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 -179.623 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -74.19 -15.14 23.04 Favored 'Trans proline' 0 C--O 1.219 -0.425 0 O-C-N 121.898 0.42 . . . . 0.0 112.717 -178.452 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -77.87 -25.34 48.57 Favored 'General case' 0 C--O 1.222 -0.394 0 CA-C-O 120.863 0.363 . . . . 0.0 110.239 178.188 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 -104.3 -25.63 12.79 Favored 'General case' 0 C--O 1.223 -0.341 0 N-CA-C 113.977 1.103 . . . . 0.0 113.977 -174.867 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . 0.404 HD22 ' HD2' ' A' ' 109' ' ' ARG . 30.4 t30 -147.2 150.18 34.4 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 -177.26 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -92.49 147.1 23.16 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 121.238 0.542 . . . . 0.0 111.206 179.405 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -74.11 153.39 39.6 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.239 177.931 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 2.5 mt -96.76 142.13 14.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 -178.132 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 87.0 t -58.05 125.04 13.42 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 176.87 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 6.4 tt -68.75 128.01 35.11 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.085 -177.848 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 29.8 mt-30 -132.36 154.42 49.79 Favored 'General case' 0 CA--C 1.508 -0.635 0 N-CA-C 107.119 -1.437 . . . . 0.0 107.119 -178.942 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 12.6 mt -109.44 148.93 39.07 Favored Pre-proline 0 C--N 1.321 -0.651 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 176.955 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -70.9 160.89 47.93 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 118.057 -0.829 . . . . 0.0 112.21 179.767 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -55.37 136.12 49.61 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 -179.249 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 95.11 -16.78 60.62 Favored Glycine 0 C--O 1.226 -0.374 0 CA-C-N 116.005 -0.543 . . . . 0.0 112.81 -177.566 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 6.2 m -108.63 128.3 54.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 117.827 0.814 . . . . 0.0 109.834 178.003 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 8.2 p -120.48 148.37 43.92 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.848 -178.522 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 85.7 mt -72.37 153.41 92.08 Favored Pre-proline 0 C--N 1.324 -0.515 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 177.776 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -76.32 170.89 19.1 Favored 'Trans proline' 0 N--CA 1.462 -0.352 0 C-N-CA 118.334 -0.644 . . . . 0.0 110.711 178.513 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -60.82 130.88 48.66 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.569 -177.44 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 95.1 -2.48 65.96 Favored Glycine 0 CA--C 1.517 0.189 0 N-CA-C 114.774 0.67 . . . . 0.0 114.774 178.209 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.435 ' CZ ' ' HB2' ' A' ' 18' ' ' GLN . 2.6 m-85 -106.43 140.07 39.92 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-O 121.732 0.777 . . . . 0.0 111.973 -179.376 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 52.6 p90 -145.52 164.34 31.93 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 114.423 -1.262 . . . . 0.0 108.069 174.515 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -105.38 147.18 28.48 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 112.481 0.549 . . . . 0.0 112.481 -176.465 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -74.97 134.88 41.41 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 178.645 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 86.03 -0.74 87.71 Favored Glycine 0 C--O 1.227 -0.321 0 C-N-CA 121.094 -0.574 . . . . 0.0 112.717 -179.959 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 8.7 t . . . . . 0 C--N 1.325 -0.465 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 178.03 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.683 0 CA-C-O 118.978 -0.901 . . . . 0.0 111.269 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -76.59 161.06 28.89 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 177.422 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 77.3 mtm -133.55 130.03 37.88 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 104.921 -2.251 . . . . 0.0 104.921 178.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -149.25 49.47 0.57 Allowed Glycine 0 C--O 1.225 -0.466 0 O-C-N 123.485 0.49 . . . . 0.0 112.414 -177.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 10.9 mp -64.56 145.15 98.66 Favored Pre-proline 0 CA--C 1.539 0.521 0 N-CA-C 108.031 -1.099 . . . . 0.0 108.031 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -77.15 50.59 3.18 Favored 'Trans proline' 0 CA--C 1.543 0.956 0 C-N-CA 121.71 1.607 . . . . 0.0 114.952 -177.13 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 -123.8 92.24 3.64 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 -179.554 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 17.9 t-20 -71.48 -55.59 7.58 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 116.107 -0.497 . . . . 0.0 112.221 -177.579 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 18.6 p 35.11 77.09 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 116.322 1.971 . . . . 0.0 116.322 178.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -95.76 140.8 30.03 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.186 -178.226 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 12.3 p -59.92 142.69 53.21 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.225 -0.898 . . . . 0.0 109.98 177.053 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . 0.437 ' CD2' ' HD3' ' A' ' 109' ' ' ARG . 12.4 m95 -67.3 -21.86 65.66 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 114.648 1.351 . . . . 0.0 114.648 -178.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -121.48 163.36 18.92 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 113.992 1.108 . . . . 0.0 113.992 -170.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 65.6 p -70.96 168.39 17.07 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.304 -1.317 . . . . 0.0 108.258 178.087 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.581 ' HB2' ' CZ ' ' A' ' 69' ' ' TYR . . . -78.34 149.4 33.44 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 114.182 1.178 . . . . 0.0 114.182 -175.515 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 13.9 mt -92.3 143.75 26.08 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 102.439 -3.171 . . . . 0.0 102.439 166.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 44.2 m -124.58 131.83 53.46 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 -178.494 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.403 ' HB2' ' CZ ' ' A' ' 131' ' ' PHE . 4.0 tp-100 -95.59 139.19 32.21 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.616 0.599 . . . . 0.0 112.616 -178.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 64.2 t60 -136.08 99.5 4.15 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 105.352 -2.092 . . . . 0.0 105.352 170.171 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 166.39 -160.02 33.47 Favored Glycine 0 C--O 1.227 -0.309 0 N-CA-C 110.294 -1.123 . . . . 0.0 110.294 -176.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -104.32 -23.69 13.18 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 112.809 0.67 . . . . 0.0 112.809 179.302 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 52.7 mm-40 -75.07 168.04 20.75 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 177.292 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -95.81 -62.84 1.22 Allowed 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 177.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 51.9 tp 173.76 136.04 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 125.761 1.624 . . . . 0.0 106.887 173.459 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 54.7 tptt -155.48 139.75 16.64 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 107.934 -1.135 . . . . 0.0 107.934 172.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 14.4 m-85 -117.84 142.82 31.4 Favored Pre-proline 0 C--O 1.241 0.655 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 176.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -64.6 165.89 19.27 Favored 'Trans proline' 0 CA--C 1.54 0.825 0 C-N-CA 122.209 1.939 . . . . 0.0 114.696 176.037 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 17.1 tpt180 -62.47 133.59 55.21 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.888 -178.347 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 77.53 15.81 80.98 Favored Glycine 0 C--O 1.223 -0.542 0 CA-C-N 115.894 -0.593 . . . . 0.0 112.651 175.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -148.37 167.66 24.67 Favored 'General case' 0 N--CA 1.442 -0.862 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 -174.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 111.58 -23.49 17.58 Favored Glycine 0 CA--C 1.497 -1.08 0 C-N-CA 121.809 -0.234 . . . . 0.0 113.36 173.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 93.1 t -65.67 127.12 92.8 Favored Pre-proline 0 C--N 1.318 -0.762 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 178.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -75.21 170.03 21.25 Favored 'Trans proline' 0 N--CA 1.461 -0.425 0 O-C-N 122.102 0.527 . . . . 0.0 111.429 178.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 97.6 mt -67.95 109.57 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-O 121.931 0.872 . . . . 0.0 109.109 179.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 73.2 m-80 -99.97 87.43 3.49 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 114.756 -1.111 . . . . 0.0 109.223 -179.052 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 72.5 p -67.82 -16.35 64.06 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 -178.592 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 11.4 p30 -108.19 22.9 15.3 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.318 -0.856 . . . . 0.0 112.843 -177.03 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 15.3 m -138.94 152.05 47.4 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 114.729 1.381 . . . . 0.0 114.729 -175.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 67.5 m -74.86 164.97 57.74 Favored Pre-proline 0 CA--C 1.537 0.469 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.479 177.492 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -65.48 -24.85 56.14 Favored 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 115.341 -2.64 . . . . 0.0 114.538 -178.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.436 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 6.1 p-10 -76.45 -26.09 55.06 Favored 'General case' 0 C--N 1.324 -0.539 0 O-C-N 121.625 -0.672 . . . . 0.0 110.906 177.026 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.555 ' HA ' ' HE3' ' A' ' 103' ' ' LYS . 15.2 m-20 -75.76 -10.75 59.69 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.198 0.999 . . . . 0.0 112.952 -175.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 96.8 mm-40 -58.55 -29.07 66.08 Favored 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 114.782 1.401 . . . . 0.0 114.782 -176.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.493 ' HB ' ' HB1' ' A' ' 98' ' ' ALA . 11.9 tt -59.5 140.22 18.0 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.874 0 CA-C-O 122.287 1.042 . . . . 0.0 112.843 -178.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -179.34 -155.63 15.47 Favored Glycine 0 CA--C 1.506 -0.482 0 C-N-CA 120.406 -0.902 . . . . 0.0 112.49 -178.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 50.3 p90 -154.99 171.7 19.31 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 179.021 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 19.3 m-85 -112.89 140.06 48.01 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 173.304 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 69.4 ttt-85 -111.33 124.66 52.68 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.979 -177.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 37.7 ttt-85 -65.05 141.1 58.86 Favored 'General case' 0 C--N 1.322 -0.625 0 O-C-N 123.557 0.536 . . . . 0.0 109.764 177.164 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -151.03 150.42 30.72 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.997 0.427 . . . . 0.0 110.605 179.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 34.0 p -145.89 168.41 20.89 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 103.621 -2.733 . . . . 0.0 103.621 174.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 14.5 tpt180 -149.08 131.08 15.28 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.604 0.716 . . . . 0.0 111.664 175.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 37.6 mtt180 -140.98 165.82 26.5 Favored 'General case' 0 CA--C 1.493 -1.241 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 178.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -132.33 175.93 10.19 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 N-CA-C 104.24 -2.504 . . . . 0.0 104.24 -179.186 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 3.5 tmt_? -120.69 99.38 6.5 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 178.232 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -76.09 150.36 38.95 Favored Glycine 0 N--CA 1.45 -0.43 0 N-CA-C 105.627 -2.989 . . . . 0.0 105.627 173.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -63.64 -36.1 92.9 Favored Glycine 0 C--O 1.217 -0.964 0 CA-C-N 118.669 1.235 . . . . 0.0 111.718 -179.422 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 27.2 t0 -89.08 17.15 6.12 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-O 122.328 1.061 . . . . 0.0 111.433 179.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 85.47 14.79 67.58 Favored Glycine 0 C--O 1.223 -0.578 0 CA-C-N 115.505 -0.77 . . . . 0.0 113.575 173.239 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 49.9 mmtt -69.61 133.67 47.86 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.58 0.705 . . . . 0.0 110.59 -176.451 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 4.0 mmt -113.11 155.3 25.18 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 114.225 -1.352 . . . . 0.0 111.101 -176.322 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 1.2 mmtp -96.28 -41.95 8.41 Favored 'General case' 0 CA--C 1.5 -0.979 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 173.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 11.3 t0 45.61 57.3 5.09 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 111.206 -2.724 . . . . 0.0 115.796 176.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 64.4 mt -68.58 138.68 55.28 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 177.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -58.67 161.81 7.68 Favored Pre-proline 0 C--O 1.242 0.698 0 CA-C-N 115.316 -0.856 . . . . 0.0 112.931 -177.587 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -62.22 134.85 51.07 Favored 'Trans proline' 0 C--N 1.354 0.864 0 C-N-CA 116.814 -1.657 . . . . 0.0 112.119 179.381 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 20.9 mtt-85 -132.15 161.12 34.12 Favored 'General case' 0 CA--C 1.503 -0.83 0 CA-C-N 114.338 -1.301 . . . . 0.0 109.805 -175.485 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 70.2 m95 -134.52 143.42 47.43 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 177.24 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.581 ' CZ ' ' HB2' ' A' ' 15' ' ' ALA . 70.7 m-85 -126.38 148.61 49.57 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 106.334 -1.728 . . . . 0.0 106.334 178.592 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 86.8 t80 -94.71 138.12 32.95 Favored 'General case' 0 CA--C 1.506 -0.727 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 -176.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 11.2 m-85 -138.86 142.19 38.61 Favored 'General case' 0 N--CA 1.438 -1.072 0 N-CA-C 106.53 -1.656 . . . . 0.0 106.53 -174.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 88.5 m-85 -80.89 159.52 24.98 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.437 0.161 . . . . 0.0 110.845 -175.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -56.12 126.69 27.13 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.9 0.381 . . . . 0.0 110.79 -177.722 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 69.29 38.63 81.74 Favored Glycine 0 C--O 1.218 -0.88 0 CA-C-O 119.106 -0.83 . . . . 0.0 114.75 176.179 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -89.17 146.1 25.0 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 105.623 -1.992 . . . . 0.0 105.623 177.591 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 92.2 131.47 5.48 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 106.4 -2.68 . . . . 0.0 106.4 -171.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -68.13 -39.32 10.73 Favored 'Trans proline' 0 C--N 1.346 0.42 0 CA-C-N 120.102 1.951 . . . . 0.0 116.127 -172.216 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -114.93 35.57 4.25 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.894 0.854 . . . . 0.0 108.897 -176.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -65.31 -29.1 69.82 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.769 -178.197 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 61.18 28.69 69.5 Favored Glycine 0 C--O 1.227 -0.283 0 N-CA-C 114.733 0.653 . . . . 0.0 114.733 178.041 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 17.3 mt -117.48 103.83 50.57 Favored Pre-proline 0 N--CA 1.446 -0.657 0 N-CA-C 114.39 1.256 . . . . 0.0 114.39 -177.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -78.58 164.49 25.92 Favored 'Trans proline' 0 C--O 1.235 0.374 0 C-N-CA 121.963 1.775 . . . . 0.0 108.318 169.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 57.9 t80 -61.79 132.03 51.8 Favored 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 120.396 -0.522 . . . . 0.0 110.085 -179.462 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 91.64 -5.98 79.99 Favored Glycine 0 CA--C 1.518 0.258 0 CA-C-O 119.417 -0.657 . . . . 0.0 114.493 178.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -63.5 131.24 47.49 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 118.369 1.085 . . . . 0.0 111.453 179.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 36.1 t-20 -77.87 127.3 32.16 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.496 -178.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 28.7 ttmt -156.2 151.26 26.38 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 105.508 -2.034 . . . . 0.0 105.508 178.03 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -64.66 132.14 48.89 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.085 0.469 . . . . 0.0 110.666 -178.044 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 68.29 27.31 73.8 Favored Glycine 0 N--CA 1.449 -0.439 0 CA-C-N 115.719 -0.673 . . . . 0.0 114.256 178.156 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 45.8 mm -124.84 123.42 65.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 117.419 0.609 . . . . 0.0 110.669 179.375 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.1 pt -127.16 111.94 27.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 CA-C-O 121.953 0.882 . . . . 0.0 111.762 177.051 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 95.1 m95 -77.36 136.83 38.47 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 112.983 0.734 . . . . 0.0 112.983 -177.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 17.3 m -138.86 151.61 23.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 C-N-CA 123.481 0.712 . . . . 0.0 109.824 179.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -157.01 166.59 32.93 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 105.877 -1.898 . . . . 0.0 105.877 179.494 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 14.5 t -130.34 176.34 8.21 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 105.521 -2.029 . . . . 0.0 105.521 178.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -67.58 135.07 52.35 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.162 0.506 . . . . 0.0 110.169 -179.253 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 93.19 -10.79 73.02 Favored Glycine 0 C--O 1.229 -0.182 0 CA-C-N 115.938 -0.574 . . . . 0.0 113.302 178.253 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.493 ' HB1' ' HB ' ' A' ' 44' ' ' ILE . . . -73.9 136.76 43.38 Favored 'General case' 0 CA--C 1.543 0.687 0 O-C-N 122.543 -0.387 . . . . 0.0 110.617 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 36.7 mt -95.72 139.57 31.76 Favored 'General case' 0 C--O 1.218 -0.601 0 N-CA-C 113.725 1.009 . . . . 0.0 113.725 -176.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 57.3 t30 -84.4 73.91 10.43 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.497 0.665 . . . . 0.0 110.52 179.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -146.41 159.25 45.56 Favored Pre-proline 0 C--N 1.321 -0.659 0 N-CA-C 103.024 -2.954 . . . . 0.0 103.024 179.445 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -73.27 149.95 46.38 Favored 'Trans proline' 0 CA--C 1.537 0.644 0 N-CA-C 114.061 0.754 . . . . 0.0 114.061 177.489 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.555 ' HE3' ' HA ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -142.29 58.69 1.46 Allowed 'General case' 0 N--CA 1.475 0.823 0 CA-C-O 122.799 1.285 . . . . 0.0 109.402 176.835 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -63.12 -23.77 67.59 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.263 -1.335 . . . . 0.0 110.963 178.235 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 17.9 p80 -55.87 -17.94 7.62 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 114.516 1.302 . . . . 0.0 114.516 -178.439 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 22.5 mt -88.81 -38.33 11.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 121.393 0.616 . . . . 0.0 109.842 -179.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -76.15 14.66 6.12 Favored Glycine 0 C--O 1.22 -0.767 0 N-CA-C 116.748 1.459 . . . . 0.0 116.748 -174.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 13.4 t -83.14 15.97 2.61 Favored 'General case' 0 CA--C 1.545 0.777 0 CA-C-N 117.985 0.893 . . . . 0.0 111.427 179.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.437 ' HD3' ' CD2' ' A' ' 12' ' ' TRP . 59.8 ttp85 -62.73 138.7 58.58 Favored 'General case' 0 C--N 1.327 -0.397 0 O-C-N 122.02 -0.425 . . . . 0.0 111.002 -178.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -110.28 123.64 35.41 Favored Pre-proline 0 C--O 1.236 0.342 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 177.122 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -75.06 -10.85 21.29 Favored 'Trans proline' 0 C--O 1.219 -0.453 0 N-CA-C 113.324 0.471 . . . . 0.0 113.324 -176.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -77.76 -24.96 48.83 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.045 178.012 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 75.2 m-20 -104.12 -25.56 12.9 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 113.989 1.107 . . . . 0.0 113.989 -173.334 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -142.67 154.55 44.44 Favored 'General case' 0 N--CA 1.433 -1.307 0 CA-C-O 121.261 0.553 . . . . 0.0 109.71 -176.301 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -92.93 142.7 27.01 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.197 -0.911 . . . . 0.0 110.206 179.321 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -68.74 147.11 52.28 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.239 0.543 . . . . 0.0 110.761 179.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 25.3 mt -81.77 138.38 19.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 -178.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 82.7 t -60.91 123.69 14.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 175.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 6.0 tt -67.66 128.82 37.87 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 -178.161 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -134.96 157.86 45.82 Favored 'General case' 0 CA--C 1.508 -0.653 0 N-CA-C 107.273 -1.38 . . . . 0.0 107.273 -177.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 13.8 mt -113.2 150.38 42.91 Favored Pre-proline 0 C--N 1.32 -0.699 0 N-CA-C 105.747 -1.946 . . . . 0.0 105.747 175.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -70.42 168.2 23.1 Favored 'Trans proline' 0 C--N 1.342 0.22 0 N-CA-C 114.143 0.786 . . . . 0.0 114.143 -176.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 49.7 tt0 -55.23 133.43 49.25 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.273 -178.032 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 89.61 -13.77 63.21 Favored Glycine 0 C--O 1.228 -0.28 0 CA-C-N 115.964 -0.562 . . . . 0.0 112.659 -179.343 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 18.6 m -106.92 128.38 54.26 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 117.356 0.578 . . . . 0.0 110.511 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 13.7 p -121.71 148.32 44.76 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.316 0.579 . . . . 0.0 112.483 -177.227 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 86.0 mt -68.52 156.26 90.99 Favored Pre-proline 0 C--N 1.326 -0.435 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 177.267 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -74.25 164.86 33.23 Favored 'Trans proline' 0 N--CA 1.461 -0.394 0 C-N-CA 117.655 -1.096 . . . . 0.0 110.941 178.431 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -60.13 130.46 46.77 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.174 -177.185 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 95.08 -3.93 67.28 Favored Glycine 0 C--O 1.225 -0.447 0 N-CA-C 114.823 0.689 . . . . 0.0 114.823 179.357 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.403 ' CZ ' ' HB2' ' A' ' 18' ' ' GLN . 0.8 OUTLIER -106.78 141.97 37.16 Favored 'General case' 0 CA--C 1.507 -0.703 0 CA-C-N 117.874 0.837 . . . . 0.0 110.743 179.306 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 43.7 p90 -142.53 161.29 38.44 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 114.382 -1.281 . . . . 0.0 107.983 175.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -104.86 146.98 28.25 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.652 0.739 . . . . 0.0 111.496 -177.501 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -74.23 127.52 33.18 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 179.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 87.94 -5.66 84.57 Favored Glycine 0 C--O 1.224 -0.523 0 CA-C-N 116.091 -0.504 . . . . 0.0 113.076 -178.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 33.7 t -96.17 148.57 22.57 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.411 0.624 . . . . 0.0 109.379 179.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 25.5 mmt85 -144.43 164.49 30.7 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 105.285 -2.117 . . . . 0.0 105.285 177.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -118.57 161.58 13.58 Favored Glycine 0 C--N 1.322 -0.231 0 N-CA-C 107.225 -2.35 . . . . 0.0 107.225 176.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 84.28 -160.09 36.1 Favored Glycine 0 N--CA 1.453 -0.196 0 N-CA-C 108.783 -1.727 . . . . 0.0 108.783 -177.328 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 7.2 m . . . . . 0 C--O 1.247 0.953 0 C-N-CA 123.751 0.82 . . . . 0.0 111.127 -177.71 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.79 0 CA-C-O 118.377 -1.235 . . . . 0.0 111.025 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -153.36 172.1 17.59 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 105.956 -1.868 . . . . 0.0 105.956 -178.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 59.6 mtt 54.07 46.0 26.36 Favored 'General case' 0 N--CA 1.474 0.74 0 O-C-N 124.231 0.957 . . . . 0.0 113.158 177.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -81.78 49.17 4.02 Favored Glycine 0 N--CA 1.461 0.337 0 N-CA-C 111.752 -0.539 . . . . 0.0 111.752 178.168 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 91.1 mt -75.13 155.32 86.33 Favored Pre-proline 0 C--N 1.322 -0.59 0 C-N-CA 123.019 0.528 . . . . 0.0 110.617 -177.364 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -68.75 158.03 59.46 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 117.471 -1.219 . . . . 0.0 111.665 177.61 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 -144.69 -61.93 0.37 Allowed 'General case' 0 C--O 1.217 -0.646 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.533 -177.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 9.0 t30 57.36 50.44 11.44 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 113.794 1.035 . . . . 0.0 113.794 177.171 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 33.5 p -134.32 136.3 43.38 Favored 'General case' 0 N--CA 1.437 -1.099 0 N-CA-C 103.51 -2.774 . . . . 0.0 103.51 177.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -141.12 141.25 34.2 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 115.024 -0.989 . . . . 0.0 108.657 179.076 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 41.3 t -61.13 140.9 57.79 Favored 'General case' 0 CA--C 1.513 -0.476 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 178.244 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 7.5 m95 -68.41 -21.93 64.65 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.486 178.373 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 29.8 m-85 -121.4 163.02 19.39 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 115.872 -0.604 . . . . 0.0 112.559 -171.36 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.418 ' HB ' ' HB3' ' A' ' 134' ' ' GLU . 71.7 p -71.55 163.07 28.42 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.495 -0.775 . . . . 0.0 108.926 178.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.445 ' HB2' ' CZ ' ' A' ' 69' ' ' TYR . . . -76.81 138.05 39.62 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -176.44 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 13.8 mt -82.74 145.03 29.79 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 104.45 -2.426 . . . . 0.0 104.45 171.486 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 20.0 m -127.47 133.27 49.91 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 118.331 0.514 . . . . 0.0 110.597 -178.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 4.0 tp-100 -89.52 150.74 22.31 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.869 179.27 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 73.5 t60 -136.38 99.25 4.04 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 103.189 -2.893 . . . . 0.0 103.189 166.383 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 162.79 -173.07 38.97 Favored Glycine 0 N--CA 1.451 -0.328 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 -175.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 55.3 mtmt -93.34 -29.44 15.63 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 114.962 1.467 . . . . 0.0 114.962 -176.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -87.39 157.31 19.27 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 106.906 -1.516 . . . . 0.0 106.906 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -83.52 -62.75 1.5 Allowed 'General case' 0 C--O 1.218 -0.566 0 N-CA-C 115.405 1.631 . . . . 0.0 115.405 -174.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 56.8 tp 179.1 143.3 0.13 Allowed 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 124.356 1.062 . . . . 0.0 108.154 178.06 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 13.6 tptm -158.86 141.23 14.05 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 173.333 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 7.9 m-85 -123.56 140.57 34.42 Favored Pre-proline 0 C--N 1.324 -0.524 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 176.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -61.54 155.52 52.57 Favored 'Trans proline' 0 CA--C 1.538 0.71 0 C-N-CA 120.283 0.656 . . . . 0.0 113.206 175.343 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 16.9 tpt180 -63.68 135.66 56.89 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.604 -177.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 83.9 10.31 81.2 Favored Glycine 0 C--O 1.225 -0.452 0 C-N-CA 121.368 -0.444 . . . . 0.0 112.348 178.435 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -148.14 168.64 21.9 Favored 'General case' 0 N--CA 1.443 -0.792 0 N-CA-C 106.975 -1.491 . . . . 0.0 106.975 -176.504 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 110.69 -19.89 25.45 Favored Glycine 0 CA--C 1.499 -0.946 0 CA-C-O 121.14 0.3 . . . . 0.0 113.643 172.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 99.2 t -65.41 128.16 93.56 Favored Pre-proline 0 C--N 1.319 -0.756 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 178.617 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -74.19 170.99 18.9 Favored 'Trans proline' 0 N--CA 1.46 -0.448 0 O-C-N 122.116 0.535 . . . . 0.0 111.327 178.02 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 89.9 mt -69.34 107.32 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-O 122.155 0.978 . . . . 0.0 108.656 179.379 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 -98.94 84.56 3.1 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 114.278 -1.328 . . . . 0.0 109.444 -177.326 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 70.4 p -66.56 -15.03 63.11 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.687 0.756 . . . . 0.0 112.895 -178.6 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 20.7 p30 -109.11 20.69 18.08 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 114.93 -1.032 . . . . 0.0 112.986 -177.128 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 27.9 m -139.02 147.95 42.77 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 113.693 0.997 . . . . 0.0 113.693 -176.46 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -72.21 167.14 34.84 Favored Pre-proline 0 C--N 1.327 -0.399 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 176.292 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -64.49 -28.18 62.03 Favored 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 115.185 -2.744 . . . . 0.0 111.958 178.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -62.31 -29.21 70.28 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 123.626 0.77 . . . . 0.0 111.422 176.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.598 ' HA ' ' HE3' ' A' ' 103' ' ' LYS . 62.1 m-20 -95.28 -0.3 53.06 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 114.584 1.328 . . . . 0.0 114.584 -171.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 94.7 mm-40 -60.7 -30.89 70.23 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 114.097 1.147 . . . . 0.0 114.097 178.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.43 ' HB ' ' HB1' ' A' ' 98' ' ' ALA . 20.6 tt -59.28 140.4 17.58 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.745 0 CA-C-O 122.385 1.088 . . . . 0.0 113.64 -177.674 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 179.88 -154.98 14.39 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.629 -178.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 50.4 p90 -155.02 171.13 20.25 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 178.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 17.8 m-85 -113.99 142.8 45.71 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 172.449 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 57.9 ttt180 -112.11 129.2 56.31 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.435 -179.005 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 27.5 ttt180 -67.22 136.27 54.72 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 123.452 0.701 . . . . 0.0 110.042 177.252 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -151.31 142.67 23.39 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.733 0.301 . . . . 0.0 110.606 178.44 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 9.3 t -148.42 151.24 34.9 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 176.585 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 8.3 tpt180 -164.84 124.97 1.94 Allowed 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 -178.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 15.1 ptt85 -106.93 158.92 16.66 Favored 'General case' 0 CA--C 1.508 -0.652 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 175.446 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -144.4 -179.57 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.913 0 N-CA-C 104.626 -2.361 . . . . 0.0 104.626 -175.321 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 5.6 mtt-85 -138.65 124.84 20.25 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 175.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -86.14 170.88 43.7 Favored Glycine 0 C--O 1.225 -0.412 0 N-CA-C 107.82 -2.112 . . . . 0.0 107.82 175.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -79.06 -28.59 53.68 Favored Glycine 0 C--O 1.216 -1.014 0 N-CA-C 108.194 -1.963 . . . . 0.0 108.194 179.459 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 43.2 t0 -76.22 -5.03 45.0 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-N 113.069 -1.566 . . . . 0.0 108.627 176.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 90.48 -11.72 70.54 Favored Glycine 0 CA--C 1.51 -0.277 0 CA-C-N 114.721 -1.127 . . . . 0.0 113.787 176.406 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -71.8 138.26 48.22 Favored 'General case' 0 CA--C 1.507 -0.692 0 CA-C-O 121.939 0.876 . . . . 0.0 109.868 -177.322 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 28.2 ptm -133.18 167.57 20.11 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 114.152 -1.385 . . . . 0.0 110.049 -178.398 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 29.0 mttp -75.67 -56.54 4.59 Favored 'General case' 0 C--O 1.219 -0.551 0 N-CA-C 113.814 1.042 . . . . 0.0 113.814 -177.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.6 t70 54.45 -140.13 0.96 Allowed 'General case' 0 CA--C 1.541 0.613 0 O-C-N 124.79 1.306 . . . . 0.0 110.065 -178.046 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 8.8 mt 61.11 173.84 0.11 Allowed 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 116.911 2.189 . . . . 0.0 116.911 177.463 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 36.6 m -67.52 160.79 70.35 Favored Pre-proline 0 C--O 1.238 0.497 0 CA-C-N 114.654 -1.157 . . . . 0.0 110.064 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -63.15 162.07 27.8 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 117.821 -0.986 . . . . 0.0 114.548 -179.507 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 18.5 mtp180 -108.01 160.29 15.9 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 106.801 -1.555 . . . . 0.0 106.801 -179.414 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 50.1 m95 -127.05 133.98 50.37 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.445 ' CZ ' ' HB2' ' A' ' 15' ' ' ALA . 54.4 m-85 -114.71 141.23 48.11 Favored 'General case' 0 C--O 1.216 -0.699 0 N-CA-C 107.961 -1.125 . . . . 0.0 107.961 -177.812 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 88.2 t80 -89.97 134.7 34.08 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 118.474 0.579 . . . . 0.0 109.847 -177.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -137.71 147.27 44.65 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 -177.404 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -82.4 159.46 22.99 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 -173.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 16.9 tp -59.43 128.8 38.86 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.383 0.611 . . . . 0.0 109.595 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 78.23 26.66 59.32 Favored Glycine 0 C--O 1.217 -0.964 0 N-CA-C 115.704 1.042 . . . . 0.0 115.704 177.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 2.4 p -89.4 146.06 24.92 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 119.093 1.447 . . . . 0.0 109.286 178.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 101.04 139.01 10.51 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 108.901 -1.68 . . . . 0.0 108.901 -176.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -68.36 -43.45 4.33 Favored 'Trans proline' 0 C--N 1.348 0.523 0 CA-C-N 119.787 1.794 . . . . 0.0 115.987 -173.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -112.79 36.64 3.38 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 -177.507 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -64.58 -43.33 94.2 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.678 -177.447 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 57.62 30.01 61.81 Favored Glycine 0 C--O 1.226 -0.396 0 CA-C-N 115.82 -0.627 . . . . 0.0 113.512 179.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 24.2 mt -111.47 103.83 55.46 Favored Pre-proline 0 N--CA 1.448 -0.573 0 N-CA-C 115.212 1.56 . . . . 0.0 115.212 -175.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -77.22 164.76 28.81 Favored 'Trans proline' 0 N--CA 1.459 -0.506 0 N-CA-C 108.002 -1.576 . . . . 0.0 108.002 170.05 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 70.0 t80 -62.62 128.57 36.6 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 120.478 -0.489 . . . . 0.0 110.584 -178.22 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 94.07 -5.5 72.03 Favored Glycine 0 CA--C 1.52 0.404 0 N-CA-C 114.851 0.7 . . . . 0.0 114.851 179.427 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -65.39 128.78 37.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 118.43 1.115 . . . . 0.0 112.314 179.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 72.2 m-20 -71.15 128.09 34.77 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 114.766 -1.107 . . . . 0.0 111.142 -178.345 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 25.2 ttmt -156.03 153.03 28.82 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 105.884 -1.895 . . . . 0.0 105.884 177.236 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 20.0 t0 -68.46 135.38 51.58 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.081 0.467 . . . . 0.0 110.12 -178.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 68.8 25.7 75.03 Favored Glycine 0 N--CA 1.447 -0.63 0 CA-C-N 115.735 -0.666 . . . . 0.0 114.133 177.488 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 42.8 mm -125.52 127.68 71.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 117.427 0.614 . . . . 0.0 109.989 179.669 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -129.39 115.91 37.17 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 CA-C-O 121.61 0.719 . . . . 0.0 110.202 176.64 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 97.7 m95 -82.38 134.79 35.26 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 113.773 1.027 . . . . 0.0 113.773 -175.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 20.8 m -136.6 149.81 27.01 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 CA-C-O 121.529 0.68 . . . . 0.0 110.537 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -157.03 166.56 32.98 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 103.93 -2.618 . . . . 0.0 103.93 -179.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 13.4 t -136.59 174.05 11.04 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 105.14 -2.17 . . . . 0.0 105.14 178.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -64.92 134.44 53.98 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.01 0.434 . . . . 0.0 109.971 -179.456 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 95.42 -5.86 67.87 Favored Glycine 0 C--O 1.225 -0.436 0 CA-C-N 115.992 -0.549 . . . . 0.0 113.769 178.459 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.43 ' HB1' ' HB ' ' A' ' 44' ' ' ILE . . . -83.15 138.25 33.73 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 122.262 -0.552 . . . . 0.0 110.46 -179.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 56.0 mt -88.79 141.11 28.77 Favored 'General case' 0 C--O 1.22 -0.485 0 CA-C-O 121.149 0.499 . . . . 0.0 111.559 -178.581 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -83.57 58.8 4.77 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.358 0.599 . . . . 0.0 110.98 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -139.02 158.31 69.87 Favored Pre-proline 0 C--N 1.325 -0.484 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 -177.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -73.09 158.89 48.68 Favored 'Trans proline' 0 CA--C 1.537 0.633 0 N-CA-C 115.272 1.22 . . . . 0.0 115.272 179.308 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.598 ' HE3' ' HA ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -154.42 57.93 0.7 Allowed 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 122.813 1.292 . . . . 0.0 109.572 177.137 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -59.04 -30.39 68.0 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.103 -1.408 . . . . 0.0 112.177 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 17.5 p80 -58.72 -11.2 2.89 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 115.091 1.515 . . . . 0.0 115.091 -177.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 33.3 mt -91.82 -32.28 5.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 178.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -71.75 -3.39 54.89 Favored Glycine 0 C--O 1.224 -0.479 0 N-CA-C 116.082 1.193 . . . . 0.0 116.082 -175.468 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 15.0 t -83.16 26.56 0.62 Allowed 'General case' 0 CA--C 1.549 0.92 0 N-CA-C 113.67 0.989 . . . . 0.0 113.67 -177.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 70.8 ttp85 -57.27 122.99 13.83 Favored 'General case' 0 N--CA 1.472 0.667 0 O-C-N 121.398 -0.814 . . . . 0.0 109.039 178.35 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 60.2 m-20 -90.0 119.08 69.35 Favored Pre-proline 0 C--N 1.324 -0.504 0 N-CA-C 107.208 -1.405 . . . . 0.0 107.208 -179.4 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -70.84 -15.93 33.02 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 117.898 -0.934 . . . . 0.0 114.117 -177.089 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -77.41 -25.76 51.05 Favored 'General case' 0 C--O 1.219 -0.503 0 CA-C-O 120.87 0.367 . . . . 0.0 110.391 178.191 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -102.8 -24.55 13.7 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 113.183 0.808 . . . . 0.0 113.183 -174.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 18.8 t30 -149.12 146.54 27.74 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -177.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -88.35 151.14 22.8 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-O 121.575 0.702 . . . . 0.0 112.356 -179.444 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -75.01 149.72 39.18 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.412 177.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 7.9 mt -90.26 139.91 16.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 -178.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 85.4 t -60.58 124.24 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 N-CA-C 106.245 -1.761 . . . . 0.0 106.245 175.339 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 6.6 tt -67.23 130.84 44.38 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.148 0.499 . . . . 0.0 110.223 -176.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -134.09 158.22 44.17 Favored 'General case' 0 CA--C 1.509 -0.605 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 -178.342 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 13.7 mt -112.49 149.77 41.6 Favored Pre-proline 0 C--N 1.322 -0.626 0 N-CA-C 105.915 -1.883 . . . . 0.0 105.915 175.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_endo -70.35 168.83 21.2 Favored 'Trans proline' 0 C--N 1.342 0.213 0 N-CA-C 114.531 0.935 . . . . 0.0 114.531 -176.466 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 39.4 tt0 -54.52 130.85 41.33 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.758 -178.333 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 89.97 -11.79 69.58 Favored Glycine 0 C--O 1.226 -0.357 0 CA-C-N 115.786 -0.643 . . . . 0.0 112.87 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 18.1 m -106.99 126.64 52.59 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 117.37 0.585 . . . . 0.0 110.535 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 22.8 p -118.05 148.35 42.35 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 113.261 0.837 . . . . 0.0 113.261 -177.34 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 86.2 mt -68.74 155.91 92.15 Favored Pre-proline 0 C--N 1.324 -0.504 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 176.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -75.23 166.3 29.2 Favored 'Trans proline' 0 N--CA 1.462 -0.372 0 C-N-CA 117.44 -1.24 . . . . 0.0 110.315 177.258 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -58.94 130.96 49.52 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.061 -176.383 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 95.13 -9.88 69.93 Favored Glycine 0 C--O 1.224 -0.474 0 N-CA-C 115.137 0.815 . . . . 0.0 115.137 178.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -94.4 143.4 26.43 Favored 'General case' 0 N--CA 1.439 -1.002 0 CA-C-O 122.498 1.142 . . . . 0.0 111.717 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 39.9 p90 -142.32 163.78 31.91 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 113.231 -1.804 . . . . 0.0 107.654 175.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -106.46 144.17 33.51 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.1 0.476 . . . . 0.0 111.454 -177.344 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.418 ' HB3' ' HB ' ' A' ' 14' ' ' THR . 1.6 tp10 -69.62 129.95 41.06 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 106.544 -1.65 . . . . 0.0 106.544 177.446 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 93.1 -6.3 75.95 Favored Glycine 0 C--O 1.225 -0.446 0 C-N-CA 121.325 -0.464 . . . . 0.0 113.235 -179.281 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 35.3 t -111.17 137.0 49.4 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.125 -0.695 . . . . 0.0 109.125 177.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -145.63 116.3 7.67 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 110.501 -0.185 . . . . 0.0 110.501 -179.076 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -76.95 149.12 35.71 Favored Glycine 0 CA--C 1.516 0.132 0 N-CA-C 108.575 -1.81 . . . . 0.0 108.575 176.084 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -142.6 42.69 1.1 Allowed Glycine 0 C--O 1.225 -0.432 0 CA-C-N 117.949 0.875 . . . . 0.0 112.525 -177.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 18.9 m . . . . . 0 C--O 1.24 0.581 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 -179.287 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.57 0 CA-C-O 119.068 -0.851 . . . . 0.0 111.361 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -69.08 157.18 37.34 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 117.723 0.762 . . . . 0.0 109.266 179.253 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 20.6 ptp -155.95 158.51 38.04 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 103.722 -2.696 . . . . 0.0 103.722 178.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 78.78 30.19 49.02 Favored Glycine 0 C--O 1.223 -0.573 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.97 178.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 10.5 mp -60.98 140.54 93.88 Favored Pre-proline 0 C--O 1.24 0.567 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 -179.127 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -73.43 154.19 50.48 Favored 'Trans proline' 0 C--N 1.345 0.364 0 O-C-N 122.053 0.502 . . . . 0.0 112.923 -178.412 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 30.5 t-20 -158.64 114.55 2.66 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 178.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 11.7 p-10 -104.32 -6.93 20.37 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 111.881 0.326 . . . . 0.0 111.881 179.329 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 24.7 p -87.57 83.7 7.21 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 -178.601 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -93.18 147.55 22.79 Favored 'General case' 0 N--CA 1.442 -0.861 0 CA-C-N 115.169 -0.923 . . . . 0.0 112.388 -174.543 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.8 t -54.83 137.57 44.73 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 114.325 -1.307 . . . . 0.0 108.962 174.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 15.6 m95 -64.54 -21.89 66.82 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 178.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 46.5 m-85 -121.5 159.56 26.05 Favored 'General case' 0 C--O 1.241 0.612 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 -172.087 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.432 ' HB ' ' HB3' ' A' ' 134' ' ' GLU . 76.0 p -69.12 163.6 24.44 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 114.949 -1.023 . . . . 0.0 108.861 178.831 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -81.47 141.23 34.06 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 -176.417 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 27.5 mt -78.78 148.85 32.79 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 104.64 -2.356 . . . . 0.0 104.64 170.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 30.6 m -112.95 128.59 56.53 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 179.243 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 2.6 tm0? -93.24 134.82 35.04 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.025 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 78.0 t60 -139.41 99.45 3.74 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 106.172 -1.788 . . . . 0.0 106.172 168.313 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 169.49 -166.14 39.43 Favored Glycine 0 C--O 1.226 -0.373 0 C-N-CA 120.156 -1.021 . . . . 0.0 112.574 -177.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -101.79 -24.58 14.04 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -179.447 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -91.78 153.32 19.68 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 179.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -72.4 -62.85 1.29 Allowed 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -174.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 43.0 tp 174.6 145.77 0.06 Allowed 'General case' 0 N--CA 1.483 1.212 0 N-CA-C 105.949 -1.871 . . . . 0.0 105.949 175.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 54.0 tptt -156.03 138.7 15.1 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 175.138 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 16.8 m-85 -124.88 152.68 70.27 Favored Pre-proline 0 C--O 1.243 0.752 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 174.428 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -70.31 161.47 45.9 Favored 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 120.201 0.6 . . . . 0.0 112.672 178.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 20.9 tpt180 -69.07 135.25 50.5 Favored 'General case' 0 C--O 1.216 -0.66 0 O-C-N 122.147 -0.346 . . . . 0.0 110.105 -177.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 82.34 11.49 82.05 Favored Glycine 0 C--O 1.223 -0.576 0 N-CA-C 111.785 -0.526 . . . . 0.0 111.785 179.017 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 10.6 mt-30 -150.7 170.5 19.05 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 -175.218 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 107.37 -16.28 38.2 Favored Glycine 0 CA--C 1.503 -0.69 0 C-N-CA 121.429 -0.415 . . . . 0.0 113.204 175.217 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 57.4 t -67.91 129.19 93.31 Favored Pre-proline 0 C--N 1.319 -0.739 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 177.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -74.22 163.13 37.22 Favored 'Trans proline' 0 N--CA 1.459 -0.517 0 O-C-N 122.193 0.575 . . . . 0.0 111.967 178.375 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 93.7 mt -66.49 122.95 18.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.612 -177.55 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 44.8 t-20 -124.74 93.43 3.89 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.693 0.758 . . . . 0.0 110.373 179.342 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 82.6 p -75.98 -16.63 59.95 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 112.953 0.723 . . . . 0.0 112.953 -175.272 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 65.5 m-80 -104.33 32.77 3.83 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.631 -174.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 82.4 p -144.88 -179.08 6.37 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 114.735 1.383 . . . . 0.0 114.735 -176.354 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 56.8 m -105.05 165.93 12.33 Favored Pre-proline 0 CA--C 1.544 0.718 0 CA-C-N 114.947 -1.024 . . . . 0.0 108.942 178.449 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_endo -68.84 -18.96 41.3 Favored 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 116.405 -1.93 . . . . 0.0 114.983 -178.292 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.449 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 5.5 p-10 -75.03 -21.38 59.1 Favored 'General case' 0 C--N 1.324 -0.526 0 O-C-N 121.728 -0.608 . . . . 0.0 111.907 179.516 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -74.18 -23.09 59.18 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 114.183 1.179 . . . . 0.0 114.183 -174.362 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 93.7 mm-40 -53.61 -26.2 20.93 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 115.57 1.692 . . . . 0.0 115.57 -171.218 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.444 ' HB ' ' HB1' ' A' ' 98' ' ' ALA . 9.1 tt -64.43 136.5 26.41 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 CA-C-O 122.553 1.168 . . . . 0.0 112.203 -179.469 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 175.49 -156.89 22.95 Favored Glycine 0 CA--C 1.502 -0.72 0 C-N-CA 120.156 -1.021 . . . . 0.0 111.863 -178.447 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 47.1 p90 -155.1 170.45 21.76 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 -179.492 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 21.9 m-85 -109.53 139.49 44.47 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 106.538 -1.652 . . . . 0.0 106.538 174.084 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 58.4 ttt-85 -113.43 120.84 42.45 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 123.698 0.799 . . . . 0.0 111.253 -176.199 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 37.9 ttp85 -69.41 140.21 54.12 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.959 0.409 . . . . 0.0 109.933 177.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -144.28 149.41 36.23 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 122.979 0.511 . . . . 0.0 110.111 179.434 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 15.3 t -154.29 167.01 31.37 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 176.285 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 15.7 tpt180 -147.98 129.63 15.05 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 178.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 6.1 tpp180 -133.58 138.85 46.21 Favored 'General case' 0 CA--C 1.499 -1.01 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 -178.627 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -138.76 174.23 10.39 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 -178.284 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 1.7 ttt-85 -122.37 118.57 28.74 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 104.894 -2.262 . . . . 0.0 104.894 175.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -71.74 172.36 46.1 Favored Glycine 0 C--O 1.221 -0.71 0 N-CA-C 109.132 -1.587 . . . . 0.0 109.132 177.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -68.89 -37.69 84.05 Favored Glycine 0 C--O 1.222 -0.647 0 N-CA-C 110.303 -1.119 . . . . 0.0 110.303 -179.521 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -74.53 -12.27 60.43 Favored 'General case' 0 C--O 1.214 -0.799 0 CA-C-O 122.131 0.967 . . . . 0.0 109.582 177.143 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 104.54 -7.9 46.9 Favored Glycine 0 CA--C 1.505 -0.562 0 CA-C-N 115.685 -0.689 . . . . 0.0 113.14 173.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.95 139.5 58.25 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 122.143 0.973 . . . . 0.0 112.211 -177.048 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 91.1 mmm -93.84 166.16 12.32 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 113.845 -1.525 . . . . 0.0 110.615 -177.652 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 10.5 tttt -79.69 -49.01 12.73 Favored 'General case' 0 C--O 1.213 -0.862 0 N-CA-C 112.978 0.732 . . . . 0.0 112.978 177.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 44.88 24.02 0.1 Allowed 'General case' 0 N--CA 1.481 1.124 0 N-CA-C 117.815 2.524 . . . . 0.0 117.815 -178.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.4 mp -76.88 152.65 35.33 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 121.451 -0.781 . . . . 0.0 110.329 177.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -59.15 150.79 60.77 Favored Pre-proline 0 C--O 1.245 0.851 0 CA-C-N 115.188 -0.914 . . . . 0.0 113.391 -178.219 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -72.53 158.66 50.63 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 117.364 -1.291 . . . . 0.0 111.166 177.733 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 17.1 mtp180 -125.5 162.55 24.64 Favored 'General case' 0 CA--C 1.508 -0.648 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 -178.417 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 69.6 m95 -126.31 131.98 51.73 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 178.411 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 63.0 m-85 -111.4 150.23 30.08 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 106.113 -1.81 . . . . 0.0 106.113 178.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 79.1 t80 -94.1 134.91 36.02 Favored 'General case' 0 CA--C 1.507 -0.707 0 N-CA-C 106.44 -1.689 . . . . 0.0 106.44 179.226 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 8.8 m-85 -137.59 130.08 29.63 Favored 'General case' 0 N--CA 1.439 -0.984 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 -176.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.415 ' HB3' ' HB2' ' A' ' 103' ' ' LYS . 66.5 m-85 -66.08 159.56 25.79 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 114.581 -1.19 . . . . 0.0 111.745 -176.833 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -52.54 129.12 28.13 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.009 0.433 . . . . 0.0 111.229 -179.422 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 72.94 25.87 72.62 Favored Glycine 0 C--O 1.224 -0.511 0 N-CA-C 116.189 1.236 . . . . 0.0 116.189 177.038 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 63.2 p -108.19 148.87 29.3 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 118.647 1.223 . . . . 0.0 111.361 178.264 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 117.18 140.51 6.68 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 108.416 -1.873 . . . . 0.0 108.416 -177.205 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -68.16 -41.97 6.5 Favored 'Trans proline' 0 C--N 1.347 0.499 0 CA-C-N 120.044 1.922 . . . . 0.0 115.744 -173.298 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -111.6 23.65 13.67 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.757 0.789 . . . . 0.0 109.371 -178.351 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -62.4 -55.6 26.33 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.998 -176.009 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 56.18 35.95 66.73 Favored Glycine 0 C--O 1.226 -0.386 0 N-CA-C 111.561 -0.615 . . . . 0.0 111.561 -178.162 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 18.7 mt -113.73 103.86 55.27 Favored Pre-proline 0 C--O 1.238 0.489 0 N-CA-C 116.314 1.968 . . . . 0.0 116.314 -173.629 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -79.35 163.65 24.61 Favored 'Trans proline' 0 CA--C 1.53 0.305 0 C-N-CA 122.42 2.08 . . . . 0.0 108.296 168.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 75.0 t80 -61.51 130.86 48.01 Favored 'General case' 0 C--N 1.323 -0.555 0 O-C-N 121.88 -0.512 . . . . 0.0 111.283 -176.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 90.89 -5.95 81.95 Favored Glycine 0 C--O 1.227 -0.307 0 CA-C-O 119.286 -0.73 . . . . 0.0 114.519 178.765 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -64.22 130.44 43.91 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 118.438 1.119 . . . . 0.0 111.256 179.416 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 56.9 t30 -79.96 127.0 31.74 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.522 -178.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 29.8 ttmt -156.25 152.68 28.06 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 179.417 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 15.0 t0 -66.34 135.91 55.04 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 110.248 -0.279 . . . . 0.0 110.248 -179.492 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 67.14 27.18 73.4 Favored Glycine 0 N--CA 1.45 -0.403 0 CA-C-O 119.671 -0.516 . . . . 0.0 113.617 178.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 44.5 mm -129.31 128.44 66.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 121.168 0.509 . . . . 0.0 109.977 179.556 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -133.58 116.95 25.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 CA-C-O 121.359 0.6 . . . . 0.0 111.404 177.429 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 96.1 m95 -81.84 136.69 35.36 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 113.57 0.952 . . . . 0.0 113.57 -177.414 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 17.7 m -136.84 156.04 34.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 178.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -164.0 166.56 21.42 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 103.297 -2.853 . . . . 0.0 103.297 -179.335 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 10.8 t -137.59 -179.62 5.85 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 106.148 -1.797 . . . . 0.0 106.148 177.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -65.15 134.72 54.36 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.217 0.532 . . . . 0.0 110.56 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 92.7 -9.32 75.87 Favored Glycine 0 N--CA 1.458 0.136 0 CA-C-N 115.918 -0.583 . . . . 0.0 114.128 177.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.449 ' HA ' ' HA ' ' A' ' 41' ' ' ASP . . . -72.22 133.61 45.18 Favored 'General case' 0 CA--C 1.544 0.735 0 O-C-N 122.441 -0.446 . . . . 0.0 111.395 -179.44 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 25.6 mt -93.23 136.86 33.1 Favored 'General case' 0 CA--C 1.507 -0.711 0 CA-C-O 120.931 0.396 . . . . 0.0 111.601 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 62.8 t30 -80.58 69.47 7.09 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.215 -179.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 2.0 t -144.57 156.25 56.62 Favored Pre-proline 0 CA--C 1.541 0.599 0 N-CA-C 106.932 -1.507 . . . . 0.0 106.932 179.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -63.68 153.21 76.59 Favored 'Trans proline' 0 C--N 1.348 0.518 0 N-CA-C 114.629 0.973 . . . . 0.0 114.629 -179.121 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.503 ' HB3' HD12 ' A' ' 106' ' ' ILE . 73.5 mmtt -125.22 41.19 3.57 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 123.289 0.636 . . . . 0.0 110.02 -179.426 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 15.5 p-10 -53.11 -43.59 67.0 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.717 -0.674 . . . . 0.0 112.314 -177.363 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 17.7 p80 -70.33 -6.56 36.06 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 114.45 1.278 . . . . 0.0 114.45 -178.509 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.503 HD12 ' HB3' ' A' ' 103' ' ' LYS . 32.0 mt -96.35 -44.88 12.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 118.075 0.398 . . . . 0.0 109.938 178.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -71.35 14.68 1.68 Allowed Glycine 0 C--O 1.223 -0.592 0 N-CA-C 116.357 1.303 . . . . 0.0 116.357 -177.22 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 15.3 t -94.3 25.71 3.71 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 -177.487 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 65.2 ttp85 -58.13 121.07 9.79 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 178.454 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -88.8 126.68 58.75 Favored Pre-proline 0 C--N 1.322 -0.598 0 N-CA-C 106.588 -1.634 . . . . 0.0 106.588 -177.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -73.23 -14.36 25.68 Favored 'Trans proline' 0 C--O 1.218 -0.488 0 C-N-CA 117.629 -1.114 . . . . 0.0 114.019 -177.295 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -81.56 -24.46 36.54 Favored 'General case' 0 C--O 1.22 -0.462 0 CA-C-O 121.124 0.487 . . . . 0.0 110.098 178.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 74.9 m-20 -101.82 -24.84 13.99 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 113.343 0.868 . . . . 0.0 113.343 -174.13 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 30.7 t30 -151.35 149.95 29.92 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 113.001 0.741 . . . . 0.0 113.001 -177.432 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -89.44 148.15 23.62 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-O 121.538 0.685 . . . . 0.0 111.867 179.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -71.25 147.23 48.4 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.186 178.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 18.8 mt -86.47 139.56 17.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 -179.357 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 75.0 t -62.0 123.64 15.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 N-CA-C 106.564 -1.643 . . . . 0.0 106.564 175.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 6.8 tt -67.01 127.41 32.47 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.017 0.436 . . . . 0.0 109.994 -177.37 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 33.3 mt-30 -132.76 157.16 45.64 Favored 'General case' 0 CA--C 1.511 -0.557 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 -179.254 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 13.3 mt -112.04 147.74 37.55 Favored Pre-proline 0 C--N 1.322 -0.612 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 177.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -73.04 164.63 34.98 Favored 'Trans proline' 0 C--O 1.236 0.387 0 O-C-N 122.272 0.617 . . . . 0.0 112.529 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 51.8 tt0 -55.35 133.74 49.82 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 100.34 -22.86 38.15 Favored Glycine 0 C--O 1.227 -0.337 0 CA-C-N 116.128 -0.487 . . . . 0.0 112.631 -178.607 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 5.0 m -107.02 128.4 54.33 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 117.961 0.88 . . . . 0.0 110.293 178.458 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 8.1 p -120.69 148.34 44.07 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.776 -178.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 88.4 mt -73.48 153.37 89.88 Favored Pre-proline 0 C--N 1.324 -0.517 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 177.284 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -76.51 171.2 18.49 Favored 'Trans proline' 0 C--O 1.234 0.281 0 C-N-CA 118.566 -0.489 . . . . 0.0 111.225 178.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 24.2 tptm -60.58 129.23 40.51 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 -179.301 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 91.03 18.4 47.05 Favored Glycine 0 C--O 1.223 -0.548 0 C-N-CA 120.931 -0.652 . . . . 0.0 114.655 178.262 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -127.21 141.71 51.67 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 117.596 0.698 . . . . 0.0 111.509 177.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 45.3 p90 -150.04 162.98 39.33 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 176.263 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -100.99 147.73 25.84 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.246 0.546 . . . . 0.0 111.844 -177.404 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.432 ' HB3' ' HB ' ' A' ' 14' ' ' THR . 0.9 OUTLIER -69.74 128.93 38.13 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 177.372 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 89.82 -7.31 82.0 Favored Glycine 0 C--O 1.225 -0.465 0 CA-C-N 116.315 -0.402 . . . . 0.0 113.54 179.422 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 34.5 t -79.34 127.21 31.79 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.402 0.62 . . . . 0.0 110.869 179.476 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 30.3 mmt180 -143.91 148.64 35.69 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 106.136 -1.802 . . . . 0.0 106.136 176.007 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 144.51 -172.78 25.38 Favored Glycine 0 CA--C 1.509 -0.292 0 N-CA-C 105.082 -3.207 . . . . 0.0 105.082 -178.161 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 74.58 49.84 10.52 Favored Glycine 0 C--O 1.229 -0.199 0 CA-C-N 118.553 1.177 . . . . 0.0 112.074 178.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 37.8 m . . . . . 0 C--O 1.253 1.278 0 CA-C-O 115.324 -2.274 . . . . 0.0 105.09 179.945 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.082 0 CA-C-O 118.703 -1.054 . . . . 0.0 111.273 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -70.97 125.08 25.88 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 118.611 1.206 . . . . 0.0 109.989 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 65.7 mtt -129.96 42.02 3.34 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 179.714 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -79.72 65.36 3.72 Favored Glycine 0 N--CA 1.459 0.205 0 CA-C-N 115.522 -0.763 . . . . 0.0 113.973 -177.64 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 10.8 mp -71.22 145.62 91.2 Favored Pre-proline 0 C--N 1.322 -0.628 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 178.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_endo -77.1 164.94 28.85 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 118.759 -0.36 . . . . 0.0 112.056 178.03 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 38.3 m-80 -141.7 -153.63 0.47 Allowed 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 101.377 -3.564 . . . . 0.0 101.377 177.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -97.59 44.18 1.05 Allowed 'General case' 0 C--N 1.313 -1.01 0 CA-C-O 121.969 0.89 . . . . 0.0 109.368 -176.727 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 24.0 p -142.44 129.45 20.75 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 103.822 -2.658 . . . . 0.0 103.822 -179.2 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -145.51 149.7 35.11 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.379 0.609 . . . . 0.0 111.286 -178.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 40.9 t -64.71 145.14 56.64 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 177.572 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 11.7 m95 -67.27 -21.91 65.69 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 122.799 0.44 . . . . 0.0 111.999 177.582 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 40.1 m-85 -121.4 165.56 15.38 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 114.136 1.161 . . . . 0.0 114.136 -170.458 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 73.6 p -71.85 163.13 28.37 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 114.63 -1.168 . . . . 0.0 108.662 177.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.46 ' HB2' ' CZ ' ' A' ' 69' ' ' TYR . . . -74.43 141.66 45.01 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -176.434 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.401 HD23 ' HA ' ' A' ' 16' ' ' LEU . 11.8 mt -85.94 143.84 27.96 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 102.962 -2.977 . . . . 0.0 102.962 169.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 21.5 m -124.54 137.39 54.41 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 -177.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.434 ' HB2' ' CZ ' ' A' ' 131' ' ' PHE . 4.7 tp60 -114.36 140.19 48.86 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 113.505 0.928 . . . . 0.0 113.505 -176.405 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 72.0 t60 -134.59 99.67 4.41 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 105.112 -2.181 . . . . 0.0 105.112 169.62 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 177.33 -169.2 41.31 Favored Glycine 0 N--CA 1.451 -0.334 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 -176.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 65.4 mttp -99.58 -26.95 13.92 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 117.398 0.599 . . . . 0.0 112.544 -179.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -85.74 158.01 20.13 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 178.614 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -82.46 -62.72 1.54 Allowed 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 120.786 -0.366 . . . . 0.0 111.782 -177.485 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 39.0 tp 179.62 142.55 0.14 Allowed 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 106.843 -1.54 . . . . 0.0 106.843 174.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -157.52 139.25 14.03 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 174.244 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 13.3 m-85 -123.22 151.57 62.42 Favored Pre-proline 0 C--O 1.239 0.537 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 176.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -74.28 165.55 31.58 Favored 'Trans proline' 0 CA--C 1.539 0.746 0 C-N-CA 120.058 0.505 . . . . 0.0 113.028 178.601 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 21.7 tpt180 -66.95 135.23 53.47 Favored 'General case' 0 C--O 1.216 -0.687 0 O-C-N 122.145 -0.347 . . . . 0.0 110.977 -177.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 82.95 4.24 90.1 Favored Glycine 0 C--O 1.223 -0.582 0 N-CA-C 111.935 -0.466 . . . . 0.0 111.935 178.156 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 40.0 mt-30 -141.79 170.6 15.4 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 123.206 0.602 . . . . 0.0 109.844 -174.465 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 105.61 -23.1 30.71 Favored Glycine 0 CA--C 1.498 -0.989 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.906 175.503 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 95.7 t -65.1 126.44 91.28 Favored Pre-proline 0 C--N 1.32 -0.694 0 N-CA-C 105.963 -1.866 . . . . 0.0 105.963 176.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -74.41 169.06 23.36 Favored 'Trans proline' 0 N--CA 1.459 -0.522 0 O-C-N 122.221 0.59 . . . . 0.0 110.912 179.168 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 92.8 mt -68.28 108.94 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 -179.435 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 75.0 m-80 -99.25 87.1 3.56 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 114.759 -1.109 . . . . 0.0 110.307 -177.243 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 73.7 p -68.73 -14.76 63.23 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.772 0.796 . . . . 0.0 112.243 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 10.8 p30 -107.34 18.8 21.15 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.861 -1.063 . . . . 0.0 113.357 -176.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 12.9 m -137.8 152.62 49.32 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 114.999 1.481 . . . . 0.0 114.999 -175.199 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.7 m -72.04 164.96 54.65 Favored Pre-proline 0 C--N 1.325 -0.482 0 CA-C-N 115.138 -0.937 . . . . 0.0 109.39 177.303 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -66.28 -27.3 48.24 Favored 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 114.858 -2.961 . . . . 0.0 113.861 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.448 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 2.1 p-10 -75.39 -22.32 57.56 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 121.57 -0.706 . . . . 0.0 110.916 177.01 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 56.4 m-20 -81.73 -7.18 59.57 Favored 'General case' 0 C--O 1.221 -0.406 0 N-CA-C 113.654 0.983 . . . . 0.0 113.654 -175.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 96.4 mm-40 -58.61 -28.18 65.38 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 113.797 1.036 . . . . 0.0 113.797 -178.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.528 ' HB ' ' HB1' ' A' ' 98' ' ' ALA . 9.8 tt -58.71 139.53 18.27 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.877 0 CA-C-O 122.302 1.049 . . . . 0.0 113.251 -179.214 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -179.88 -157.7 20.58 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.457 -0.878 . . . . 0.0 112.742 -179.509 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 41.6 p90 -155.06 171.75 19.25 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 179.441 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 20.2 m-85 -113.3 138.65 49.71 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 173.585 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 50.7 ttt180 -109.3 127.14 54.06 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.006 -178.3 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 40.8 ttt-85 -66.78 140.66 57.85 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 177.714 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -147.05 146.61 30.07 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.51 0.672 . . . . 0.0 111.361 179.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 21.2 p -144.31 157.65 44.16 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 104.235 -2.506 . . . . 0.0 104.235 175.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 19.0 tpp85 -147.3 125.68 12.34 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 118.296 0.498 . . . . 0.0 110.282 178.18 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 6.0 tmm_? -147.36 139.23 24.21 Favored 'General case' 0 CA--C 1.492 -1.282 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 179.431 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -132.56 179.1 4.71 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 N-CA-C 105.461 -2.052 . . . . 0.0 105.461 -178.529 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 56.1 ttp180 -120.96 113.61 20.35 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 106.855 -1.535 . . . . 0.0 106.855 172.479 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -95.98 147.36 18.62 Favored Glycine 0 C--N 1.317 -0.488 0 N-CA-C 106.114 -2.794 . . . . 0.0 106.114 177.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -63.92 -33.33 86.94 Favored Glycine 0 C--O 1.216 -0.969 0 CA-C-N 118.459 1.13 . . . . 0.0 111.584 -179.752 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 38.5 t0 -89.95 17.04 7.22 Favored 'General case' 0 CA--C 1.549 0.918 0 CA-C-O 122.263 1.03 . . . . 0.0 111.308 179.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 81.04 22.91 60.23 Favored Glycine 0 C--O 1.226 -0.404 0 CA-C-O 121.798 0.666 . . . . 0.0 113.823 172.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 21.9 mmtt -85.74 149.4 25.31 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.745 0.783 . . . . 0.0 112.26 -174.508 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 15.6 mtp -115.38 -179.89 3.77 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 113.824 -1.535 . . . . 0.0 110.886 -177.141 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -119.86 -65.4 1.16 Allowed 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 113.626 0.973 . . . . 0.0 113.626 -177.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -130.18 159.21 37.52 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 103.525 -2.768 . . . . 0.0 103.525 177.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 93.5 mt -121.22 -70.7 0.77 Allowed 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 120.769 0.318 . . . . 0.0 111.306 -179.49 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 16.0 m -67.73 152.72 96.07 Favored Pre-proline 0 C--O 1.239 0.55 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.13 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -68.2 148.15 74.12 Favored 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 116.99 -1.54 . . . . 0.0 111.858 178.146 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 34.6 mtt180 -128.7 164.13 23.61 Favored 'General case' 0 CA--C 1.508 -0.641 0 CA-C-N 115.923 -0.581 . . . . 0.0 112.477 -178.2 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 73.0 m95 -134.58 145.94 49.16 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 178.134 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.46 ' CZ ' ' HB2' ' A' ' 15' ' ' ALA . 22.1 m-85 -128.24 141.95 51.3 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 106.327 -1.731 . . . . 0.0 106.327 179.38 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 76.4 t80 -88.8 136.68 32.88 Favored 'General case' 0 CA--C 1.507 -0.702 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 -177.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -140.52 135.73 32.18 Favored 'General case' 0 N--CA 1.439 -1.0 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 -175.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 84.8 m-85 -73.26 159.5 33.33 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.425 -174.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -54.38 126.1 22.01 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.121 0.486 . . . . 0.0 111.545 -177.253 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 68.38 36.01 83.36 Favored Glycine 0 N--CA 1.448 -0.544 0 CA-C-O 119.048 -0.862 . . . . 0.0 114.326 176.45 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.3 p -89.2 146.04 25.02 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 106.619 -1.622 . . . . 0.0 106.619 176.145 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 89.69 129.67 3.85 Favored Glycine 0 CA--C 1.528 0.86 0 N-CA-C 108.977 -1.649 . . . . 0.0 108.977 -174.206 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -68.6 -36.99 13.45 Favored 'Trans proline' 0 C--N 1.346 0.417 0 CA-C-N 119.6 1.7 . . . . 0.0 116.437 -174.31 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 57.5 mt-10 -104.79 24.09 12.4 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 -175.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -63.04 -36.85 84.96 Favored 'General case' 0 C--O 1.24 0.553 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.568 -175.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 60.17 33.0 78.03 Favored Glycine 0 C--O 1.229 -0.193 0 CA-C-N 115.544 -0.753 . . . . 0.0 113.486 178.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 14.4 mt -124.66 103.91 31.17 Favored Pre-proline 0 N--CA 1.443 -0.814 0 N-CA-C 115.076 1.509 . . . . 0.0 115.076 -177.346 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -79.01 163.27 25.77 Favored 'Trans proline' 0 N--CA 1.462 -0.359 0 C-N-CA 122.352 2.035 . . . . 0.0 107.706 167.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 58.4 t80 -61.8 132.03 51.77 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 120.329 -0.549 . . . . 0.0 110.352 -178.027 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 90.94 -5.71 81.91 Favored Glycine 0 C--O 1.226 -0.362 0 CA-C-O 119.37 -0.683 . . . . 0.0 114.408 178.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -66.35 130.33 42.84 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 118.582 1.191 . . . . 0.0 111.117 179.126 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 57.5 t30 -77.11 128.07 33.78 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.24 -179.252 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 30.1 ttmt -156.17 151.78 27.07 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 179.499 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 29.4 t0 -64.81 132.38 49.34 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.933 0.397 . . . . 0.0 110.36 -178.398 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 68.1 28.83 73.24 Favored Glycine 0 N--CA 1.451 -0.351 0 CA-C-O 119.447 -0.64 . . . . 0.0 114.281 178.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 44.7 mm -128.3 127.56 67.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 117.465 0.632 . . . . 0.0 110.61 179.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -131.29 118.83 41.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.997 176.193 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 95.9 m95 -84.99 137.25 33.2 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 113.499 0.925 . . . . 0.0 113.499 -176.584 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 15.9 m -137.79 149.71 25.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.43 0.633 . . . . 0.0 109.856 179.488 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -157.81 166.43 32.74 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 105.43 -2.063 . . . . 0.0 105.43 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 14.7 t -131.34 179.84 5.78 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 105.94 -1.874 . . . . 0.0 105.94 178.492 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -67.54 135.38 52.89 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.231 0.539 . . . . 0.0 110.436 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 90.72 -9.33 78.01 Favored Glycine 0 C--O 1.23 -0.133 0 CA-C-N 115.932 -0.576 . . . . 0.0 113.513 177.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.528 ' HB1' ' HB ' ' A' ' 44' ' ' ILE . . . -73.15 131.43 42.03 Favored 'General case' 0 CA--C 1.544 0.733 0 O-C-N 122.525 -0.397 . . . . 0.0 110.646 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 26.7 mt -91.58 139.24 30.89 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 113.117 0.784 . . . . 0.0 113.117 -177.485 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 53.4 t30 -84.01 73.09 10.4 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.361 -179.613 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 1.3 t -142.23 152.33 60.81 Favored Pre-proline 0 C--N 1.323 -0.566 0 N-CA-C 107.551 -1.278 . . . . 0.0 107.551 179.131 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -66.45 149.18 84.68 Favored 'Trans proline' 0 CA--C 1.528 0.221 0 N-CA-C 114.278 0.838 . . . . 0.0 114.278 177.05 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -148.97 57.55 1.03 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.852 0.834 . . . . 0.0 112.733 179.124 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 32.0 t0 -60.51 -20.3 59.7 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.577 176.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 15.6 p80 -59.94 -10.98 4.67 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 113.543 0.942 . . . . 0.0 113.543 179.135 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 41.3 mt -96.21 -30.14 3.92 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 CA-C-O 120.698 0.285 . . . . 0.0 110.78 179.153 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -75.13 4.8 37.5 Favored Glycine 0 N--CA 1.462 0.413 0 N-CA-C 115.375 0.91 . . . . 0.0 115.375 -176.122 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 14.6 t -83.1 15.83 2.65 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 113.991 1.108 . . . . 0.0 113.991 -177.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 62.6 ttp85 -63.84 126.84 28.91 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 177.713 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -108.56 134.59 20.21 Favored Pre-proline 0 C--N 1.323 -0.551 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_endo -69.05 -18.22 40.47 Favored 'Trans proline' 0 C--O 1.218 -0.49 0 N-CA-C 114.934 1.09 . . . . 0.0 114.934 -175.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -77.03 -24.15 52.09 Favored 'General case' 0 C--O 1.221 -0.41 0 CA-C-O 121.106 0.479 . . . . 0.0 110.085 178.31 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -99.32 -28.48 13.28 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.64 -0.709 . . . . 0.0 112.848 -175.188 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 21.9 t30 -155.68 147.26 22.93 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 -178.343 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -84.1 145.55 28.38 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-O 121.44 0.638 . . . . 0.0 111.638 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -69.54 145.54 52.54 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.208 0.527 . . . . 0.0 110.525 178.389 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 18.3 mt -86.54 138.22 19.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 -178.445 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 92.5 t -61.24 124.03 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 N-CA-C 105.912 -1.885 . . . . 0.0 105.912 175.235 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 6.3 tt -66.4 128.78 37.5 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.155 0.502 . . . . 0.0 110.038 -176.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 -132.84 156.02 47.93 Favored 'General case' 0 CA--C 1.508 -0.659 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 -178.606 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 13.2 mt -111.75 148.87 39.83 Favored Pre-proline 0 C--N 1.322 -0.629 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 177.399 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -72.96 164.26 36.06 Favored 'Trans proline' 0 N--CA 1.462 -0.361 0 C-N-CA 118.079 -0.814 . . . . 0.0 112.575 -179.502 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -55.17 130.98 44.16 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 104.31 -23.77 30.84 Favored Glycine 0 C--O 1.226 -0.402 0 CA-C-N 116.01 -0.541 . . . . 0.0 112.538 -178.524 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 7.7 m -108.4 129.71 55.25 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 118.137 0.968 . . . . 0.0 111.23 178.308 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 4.7 p -119.73 148.33 43.53 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.572 179.067 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 80.4 mt -69.75 154.81 94.42 Favored Pre-proline 0 C--N 1.324 -0.539 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 178.115 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -76.78 168.77 22.98 Favored 'Trans proline' 0 C--O 1.233 0.232 0 C-N-CA 117.775 -1.017 . . . . 0.0 110.5 176.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 7.5 tmtm? -57.74 130.56 46.96 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.967 0.413 . . . . 0.0 111.863 -175.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 95.14 -6.99 69.32 Favored Glycine 0 C--O 1.235 0.204 0 CA-C-N 115.461 -0.791 . . . . 0.0 114.907 177.382 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.434 ' CZ ' ' HB2' ' A' ' 18' ' ' GLN . 2.5 m-85 -95.99 138.6 33.39 Favored 'General case' 0 CA--C 1.502 -0.877 0 CA-C-O 122.086 0.946 . . . . 0.0 111.126 179.818 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 38.6 p90 -142.64 160.28 40.6 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 113.583 -1.644 . . . . 0.0 107.867 175.106 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -102.5 144.89 30.36 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.121 0.486 . . . . 0.0 111.189 -177.445 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -71.87 136.14 46.85 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 106.63 -1.619 . . . . 0.0 106.63 177.567 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 86.13 -2.63 87.6 Favored Glycine 0 C--O 1.227 -0.333 0 C-N-CA 121.211 -0.519 . . . . 0.0 112.545 -177.201 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 8.2 t -118.28 -176.9 3.16 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 177.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 24.7 tpt180 -141.05 138.83 33.9 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 92.95 168.79 39.46 Favored Glycine 0 C--O 1.226 -0.349 0 N-CA-C 110.01 -1.236 . . . . 0.0 110.01 -178.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -174.25 173.31 45.93 Favored Glycine 0 N--CA 1.45 -0.372 0 N-CA-C 107.095 -2.402 . . . . 0.0 107.095 -178.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 19.3 m . . . . . 0 C--O 1.244 0.796 0 CA-C-O 117.694 -1.146 . . . . 0.0 112.986 -177.361 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.734 0 CA-C-O 118.846 -0.974 . . . . 0.0 111.329 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -97.76 158.4 15.53 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 177.469 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 2.8 mpt? -126.34 114.79 18.7 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 178.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -175.22 78.15 0.08 OUTLIER Glycine 0 C--O 1.225 -0.416 0 C-N-CA 120.975 -0.631 . . . . 0.0 112.496 -178.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 96.1 mt -72.54 149.28 90.89 Favored Pre-proline 0 C--N 1.323 -0.563 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 178.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -69.45 138.79 39.66 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 115.991 -2.206 . . . . 0.0 111.216 178.55 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 32.9 t30 -143.92 -8.69 0.71 Allowed 'General case' 0 C--O 1.216 -0.677 0 N-CA-C 113.221 0.823 . . . . 0.0 113.221 -179.354 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 53.5 t30 56.59 43.37 25.74 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.064 0.946 . . . . 0.0 112.045 -179.458 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 41.6 p -116.68 111.89 20.45 Favored 'General case' 0 CA--C 1.509 -0.633 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 -179.355 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -131.46 142.84 50.07 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 114.969 -1.014 . . . . 0.0 110.974 -178.207 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 26.6 t -60.32 137.03 58.2 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 176.393 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . 0.4 ' HA ' ' HD3' ' A' ' 109' ' ' ARG . 9.8 m95 -70.83 -23.19 62.3 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.963 0.411 . . . . 0.0 111.18 178.451 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 24.8 m-85 -121.4 158.39 28.41 Favored 'General case' 0 C--O 1.241 0.634 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -171.128 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.424 ' HB ' ' HB3' ' A' ' 134' ' ' GLU . 72.0 p -69.06 163.34 24.93 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.012 -0.994 . . . . 0.0 109.189 179.153 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.426 ' HB2' ' CZ ' ' A' ' 69' ' ' TYR . . . -74.78 145.27 43.07 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 113.333 0.864 . . . . 0.0 113.333 -175.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 16.5 mt -85.74 148.9 25.64 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 103.754 -2.684 . . . . 0.0 103.754 169.349 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 31.0 m -124.86 128.97 49.49 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 178.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -82.42 137.26 34.75 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.018 179.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 72.0 t60 -139.32 94.93 2.85 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 104.085 -2.561 . . . . 0.0 104.085 168.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 163.74 -143.04 8.26 Favored Glycine 0 C--O 1.225 -0.437 0 C-N-CA 120.628 -0.796 . . . . 0.0 111.975 -175.561 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 54.7 mtpt -120.39 -25.56 5.59 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 116.98 2.215 . . . . 0.0 116.98 -175.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -94.41 159.37 15.14 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 117.861 0.3 . . . . 0.0 110.736 -176.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -63.07 -62.85 1.43 Allowed 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 111.999 0.37 . . . . 0.0 111.999 -178.217 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 51.3 tp 165.28 141.94 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.111 0 N-CA-C 103.849 -2.648 . . . . 0.0 103.849 178.51 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 23.3 tptm -156.76 140.66 16.2 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 118.242 0.474 . . . . 0.0 109.813 176.034 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 26.1 m-85 -126.89 150.43 71.66 Favored Pre-proline 0 C--N 1.324 -0.538 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 175.435 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -77.2 165.79 27.38 Favored 'Trans proline' 0 CA--C 1.538 0.697 0 C-N-CA 120.395 0.73 . . . . 0.0 112.571 177.382 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 75.7 ttt180 -66.81 136.37 55.34 Favored 'General case' 0 N--CA 1.472 0.649 0 O-C-N 122.107 -0.37 . . . . 0.0 110.318 -179.201 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 85.56 6.38 83.45 Favored Glycine 0 C--O 1.222 -0.596 0 N-CA-C 111.498 -0.641 . . . . 0.0 111.498 178.746 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.587 HE21 HG23 ' A' ' 125' ' ' THR . 23.3 mt-30 -146.25 170.55 16.53 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 -175.354 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.416 ' H ' HG21 ' A' ' 125' ' ' THR . . . 103.28 -21.64 38.89 Favored Glycine 0 CA--C 1.499 -0.952 0 CA-C-N 115.772 -0.649 . . . . 0.0 114.017 173.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 92.7 t -65.71 128.52 93.87 Favored Pre-proline 0 C--N 1.319 -0.739 0 N-CA-C 106.468 -1.679 . . . . 0.0 106.468 177.531 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -71.91 171.7 16.06 Favored 'Trans proline' 0 C--O 1.22 -0.384 0 O-C-N 122.183 0.57 . . . . 0.0 111.221 177.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 92.1 mt -71.09 106.36 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 179.584 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -96.44 84.2 3.67 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 114.399 -1.273 . . . . 0.0 109.318 -176.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 67.8 p -66.97 -14.72 63.14 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.69 0.757 . . . . 0.0 112.749 -178.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 10.6 p30 -106.18 20.32 19.14 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 114.906 -1.043 . . . . 0.0 112.441 -177.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 15.1 m -139.91 151.23 45.43 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 114.886 1.439 . . . . 0.0 114.886 -175.259 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 2.2 m -72.24 166.33 42.37 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.314 176.612 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -66.27 -25.97 49.34 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 114.964 -2.891 . . . . 0.0 114.19 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.451 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 3.3 p-10 -77.53 -21.43 52.64 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 121.51 -0.744 . . . . 0.0 110.83 177.491 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 70.7 m-20 -81.39 -7.14 59.53 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 113.69 0.996 . . . . 0.0 113.69 -175.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 96.1 mm-40 -58.6 -26.5 63.74 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 114.262 1.208 . . . . 0.0 114.262 -178.44 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.425 ' HB ' ' HB1' ' A' ' 98' ' ' ALA . 9.9 tt -58.66 138.31 19.86 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.958 0 N-CA-C 113.87 1.063 . . . . 0.0 113.87 -178.246 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -179.72 -156.98 19.12 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.746 -0.74 . . . . 0.0 111.903 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 42.8 p90 -155.16 171.06 20.41 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 178.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 23.5 m-85 -113.96 142.22 46.42 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 106.924 -1.51 . . . . 0.0 106.924 173.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 52.7 ttt180 -115.06 126.9 55.24 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.668 -178.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 10.1 ttp85 -70.05 133.06 46.8 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 176.22 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -115.51 123.55 48.82 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 176.267 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -153.2 144.31 23.01 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 114.974 -1.012 . . . . 0.0 108.546 -179.339 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 22.7 tpp180 -153.98 123.82 6.77 Favored 'General case' 0 C--O 1.217 -0.646 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 175.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.56 145.63 48.16 Favored 'General case' 0 CA--C 1.49 -1.334 0 CA-C-O 121.684 0.754 . . . . 0.0 110.895 179.356 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -142.79 176.41 3.48 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.959 0 N-CA-C 104.389 -2.448 . . . . 0.0 104.389 178.537 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 5.5 tmm_? -128.07 99.21 5.39 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 106.238 -1.764 . . . . 0.0 106.238 175.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -70.04 146.93 43.79 Favored Glycine 0 N--CA 1.451 -0.364 0 N-CA-C 108.878 -1.689 . . . . 0.0 108.878 178.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -63.06 -33.43 87.22 Favored Glycine 0 C--O 1.215 -1.048 0 C-N-CA 120.453 -0.88 . . . . 0.0 110.981 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 27.2 t0 -90.06 17.63 6.71 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-O 121.936 0.874 . . . . 0.0 111.598 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 86.6 -7.0 81.21 Favored Glycine 0 N--CA 1.462 0.391 0 N-CA-C 116.326 1.291 . . . . 0.0 116.326 174.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.71 128.44 36.29 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 114.211 1.189 . . . . 0.0 114.211 -178.159 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 98.3 mmm -96.56 177.95 5.5 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 106.503 -1.666 . . . . 0.0 106.503 176.304 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 6.6 tmtt? -103.63 -57.23 2.07 Favored 'General case' 0 CA--C 1.507 -0.675 0 CA-C-O 121.474 0.654 . . . . 0.0 110.49 177.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 25.4 p30 -133.8 170.34 15.72 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 178.395 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -125.02 -53.58 1.63 Allowed 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 179.736 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 25.9 t -108.09 147.43 35.51 Favored Pre-proline 0 C--O 1.24 0.558 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 178.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -72.93 155.13 53.35 Favored 'Trans proline' 0 C--O 1.24 0.612 0 N-CA-C 115.376 1.26 . . . . 0.0 115.376 -178.585 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 25.5 mtp180 -115.45 161.57 18.39 Favored 'General case' 0 CA--C 1.509 -0.604 0 N-CA-C 106.651 -1.611 . . . . 0.0 106.651 173.304 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 61.0 m95 -129.81 142.76 50.63 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 178.196 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.426 ' CZ ' ' HB2' ' A' ' 15' ' ' ALA . 53.8 m-85 -123.89 144.37 49.8 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 179.467 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 86.1 t80 -93.55 138.02 32.24 Favored 'General case' 0 CA--C 1.511 -0.54 0 N-CA-C 108.415 -0.958 . . . . 0.0 108.415 -177.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -141.49 143.14 33.67 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 -177.522 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -76.66 159.48 30.2 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.794 -0.639 . . . . 0.0 112.23 -176.05 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -55.08 131.22 44.53 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.571 -179.391 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 77.53 25.03 63.95 Favored Glycine 0 C--O 1.22 -0.719 0 N-CA-C 115.921 1.128 . . . . 0.0 115.921 176.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 7.4 p -92.53 146.1 23.94 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 118.46 1.13 . . . . 0.0 109.364 179.01 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 101.26 132.73 7.86 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 -177.346 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -69.59 -38.34 8.31 Favored 'Trans proline' 0 C--N 1.347 0.464 0 CA-C-N 119.706 1.753 . . . . 0.0 115.575 -174.338 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -107.84 30.0 6.73 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 -177.127 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -64.66 -51.02 64.75 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.831 -176.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 57.9 26.75 58.48 Favored Glycine 0 C--O 1.226 -0.393 0 CA-C-N 115.858 -0.61 . . . . 0.0 113.001 -179.329 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 21.2 mt -111.33 105.36 56.88 Favored Pre-proline 0 C--O 1.237 0.425 0 N-CA-C 115.319 1.6 . . . . 0.0 115.319 -174.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -77.06 164.22 29.82 Favored 'Trans proline' 0 N--CA 1.461 -0.43 0 N-CA-C 108.213 -1.495 . . . . 0.0 108.213 169.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 57.1 t80 -61.19 132.43 53.67 Favored 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 120.594 -0.442 . . . . 0.0 110.074 -179.073 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 91.63 -7.65 79.46 Favored Glycine 0 CA--C 1.52 0.349 0 N-CA-C 114.683 0.633 . . . . 0.0 114.683 178.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -64.89 131.74 47.52 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 118.267 1.034 . . . . 0.0 111.682 179.558 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 34.3 t-20 -77.27 128.56 34.55 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.764 -177.638 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 20.5 ttmt -156.14 150.93 26.09 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 106.41 -1.7 . . . . 0.0 106.41 177.398 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -65.09 133.64 52.06 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.823 0.344 . . . . 0.0 110.168 -179.363 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 69.87 24.98 76.1 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 121.018 -0.611 . . . . 0.0 114.181 177.463 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 39.1 mm -126.31 127.4 70.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 117.335 0.568 . . . . 0.0 109.682 178.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.1 pt -131.32 116.73 33.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 CA-C-O 121.752 0.787 . . . . 0.0 110.268 176.549 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 94.8 m95 -82.52 137.12 34.7 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.081 -0.509 . . . . 0.0 112.355 -177.01 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 16.4 m -137.83 149.7 25.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.646 0.736 . . . . 0.0 110.186 179.39 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -157.91 165.59 34.81 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 104.093 -2.558 . . . . 0.0 104.093 179.58 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 14.3 t -130.18 178.85 6.25 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 105.467 -2.049 . . . . 0.0 105.467 179.018 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -67.39 134.98 52.47 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.178 0.513 . . . . 0.0 109.849 -179.555 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 92.89 -12.38 70.04 Favored Glycine 0 C--O 1.227 -0.284 0 CA-C-N 115.92 -0.582 . . . . 0.0 113.255 178.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.451 ' HA ' ' HA ' ' A' ' 41' ' ' ASP . . . -70.16 130.7 42.79 Favored 'General case' 0 CA--C 1.542 0.668 0 O-C-N 122.56 -0.376 . . . . 0.0 110.644 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 24.4 mt -90.33 140.4 29.74 Favored 'General case' 0 C--O 1.219 -0.518 0 CA-C-O 121.392 0.615 . . . . 0.0 112.137 -178.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 58.6 t30 -84.14 70.12 10.48 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.681 -179.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 1.1 t -140.78 153.39 67.67 Favored Pre-proline 0 C--N 1.323 -0.559 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 179.434 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -68.0 152.35 76.87 Favored 'Trans proline' 0 C--N 1.343 0.26 0 N-CA-C 114.249 0.827 . . . . 0.0 114.249 177.525 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -152.08 55.15 0.82 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 122.904 1.335 . . . . 0.0 110.896 178.232 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 15.0 p-10 -58.67 -32.51 69.18 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 113.635 -1.62 . . . . 0.0 110.695 177.703 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 30.9 p-80 -58.94 -16.67 18.91 Favored 'General case' 0 C--O 1.218 -0.591 0 N-CA-C 114.429 1.27 . . . . 0.0 114.429 -179.043 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 75.0 mt -79.93 -33.39 14.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 178.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -76.97 11.21 15.87 Favored Glycine 0 C--O 1.225 -0.422 0 N-CA-C 116.006 1.163 . . . . 0.0 116.006 -176.216 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 15.2 t -83.06 25.19 0.71 Allowed 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 118.224 1.012 . . . . 0.0 112.021 -177.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.434 ' HD2' ' OD1' ' A' ' 114' ' ' ASN . 66.1 ttp85 -62.35 125.28 23.36 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 121.736 -0.602 . . . . 0.0 111.301 -178.549 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 7.8 m120 -88.38 115.63 63.84 Favored Pre-proline 0 C--N 1.326 -0.427 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 179.01 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -73.1 -11.22 25.14 Favored 'Trans proline' 0 C--O 1.218 -0.496 0 C-N-CA 117.963 -0.891 . . . . 0.0 114.233 -177.569 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -81.49 -24.47 36.69 Favored 'General case' 0 C--O 1.22 -0.46 0 CA-C-O 121.002 0.43 . . . . 0.0 110.086 177.341 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -99.84 -30.37 12.08 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.779 -0.646 . . . . 0.0 112.383 -175.239 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.434 ' OD1' ' HD2' ' A' ' 109' ' ' ARG . 0.5 OUTLIER -131.97 151.08 51.95 Favored 'General case' 0 N--CA 1.437 -1.075 0 CA-C-O 121.338 0.59 . . . . 0.0 111.623 -178.31 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -94.82 137.55 33.75 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.084 -0.962 . . . . 0.0 108.852 176.421 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -63.66 146.14 54.37 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.405 0.621 . . . . 0.0 111.208 -179.392 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 24.1 mt -82.04 134.2 27.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.155 -178.009 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 67.7 t -60.1 123.28 12.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 N-CA-C 105.879 -1.897 . . . . 0.0 105.879 174.435 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 6.3 tt -66.26 127.58 32.78 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.488 0.661 . . . . 0.0 110.28 -176.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 34.5 mt-30 -132.71 162.12 32.25 Favored 'General case' 0 CA--C 1.511 -0.527 0 N-CA-C 106.277 -1.749 . . . . 0.0 106.277 -178.703 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 17.2 mt -117.51 147.67 41.24 Favored Pre-proline 0 C--N 1.321 -0.633 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 178.174 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -73.75 173.37 14.07 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 120.662 0.908 . . . . 0.0 114.156 -177.5 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 56.5 tt0 -54.22 133.15 44.51 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.152 -179.698 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 88.25 -15.23 56.97 Favored Glycine 0 C--O 1.227 -0.295 0 CA-C-N 116.045 -0.525 . . . . 0.0 113.651 179.489 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.587 HG23 HE21 ' A' ' 30' ' ' GLN . 12.6 m -108.6 126.1 52.58 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 117.886 0.843 . . . . 0.0 110.445 -179.437 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 9.3 p -123.46 148.33 46.3 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.995 -178.178 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 91.9 mt -66.49 153.41 93.13 Favored Pre-proline 0 C--N 1.326 -0.452 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 177.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -76.03 169.53 21.91 Favored 'Trans proline' 0 N--CA 1.461 -0.396 0 C-N-CA 118.154 -0.764 . . . . 0.0 111.074 -179.205 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 58.7 tttp -59.7 126.75 28.82 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 179.705 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 89.36 30.76 12.96 Favored Glycine 0 C--O 1.225 -0.42 0 N-CA-C 115.947 1.139 . . . . 0.0 115.947 178.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -140.57 149.15 42.03 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 117.811 0.806 . . . . 0.0 111.35 177.113 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 46.2 p90 -149.42 164.51 34.78 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 107.216 -1.402 . . . . 0.0 107.216 175.485 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -106.72 149.97 26.75 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.228 0.537 . . . . 0.0 110.926 -178.562 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.424 ' HB3' ' HB ' ' A' ' 14' ' ' THR . 0.9 OUTLIER -71.67 131.32 42.99 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 108.293 -1.002 . . . . 0.0 108.293 179.462 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 81.88 2.29 90.51 Favored Glycine 0 C--O 1.225 -0.455 0 C-N-CA 121.23 -0.51 . . . . 0.0 112.708 -179.379 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 6.9 t -109.6 -173.74 2.33 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 179.383 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 61.35 25.66 15.59 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.724 0.81 . . . . 0.0 112.757 178.787 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -71.04 -24.39 77.15 Favored Glycine 0 C--O 1.22 -0.746 0 C-N-CA 121.173 -0.537 . . . . 0.0 113.339 179.221 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 107.21 -42.78 1.84 Allowed Glycine 0 C--O 1.228 -0.252 0 N-CA-C 111.732 -0.547 . . . . 0.0 111.732 179.474 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 42.8 m . . . . . 0 C--O 1.248 0.982 0 CA-C-O 117.557 -1.211 . . . . 0.0 112.27 179.021 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.873 0 CA-C-O 118.77 -1.016 . . . . 0.0 111.655 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 61.92 154.21 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 116.989 2.218 . . . . 0.0 116.989 178.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 2.1 mpt? -84.66 87.73 7.31 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.679 -1.146 . . . . 0.0 109.554 -178.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -83.15 61.79 4.72 Favored Glycine 0 C--O 1.228 -0.239 0 CA-C-N 116.145 -0.479 . . . . 0.0 113.189 -179.222 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 95.8 mt -86.33 150.59 52.12 Favored Pre-proline 0 C--N 1.324 -0.509 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -74.04 155.62 47.61 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 117.821 -0.986 . . . . 0.0 112.548 178.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 26.4 p30 -144.02 -144.82 0.16 Allowed 'General case' 0 N--CA 1.434 -1.269 0 N-CA-C 105.796 -1.927 . . . . 0.0 105.796 179.022 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 -94.49 -1.27 53.79 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 114.158 1.17 . . . . 0.0 114.158 -175.387 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 41.0 p -117.89 90.78 3.41 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.662 0.615 . . . . 0.0 112.662 -175.16 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -106.46 149.47 27.03 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.252 0.548 . . . . 0.0 109.549 179.083 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 42.1 t -59.22 142.29 52.16 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.57 177.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 14.9 m95 -64.85 -23.33 67.2 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 113.132 0.79 . . . . 0.0 113.132 178.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 43.3 m-85 -121.48 164.16 17.63 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 113.284 0.846 . . . . 0.0 113.284 -170.132 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 66.9 p -70.16 163.63 25.91 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 108.199 -1.038 . . . . 0.0 108.199 178.457 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -73.8 149.96 41.35 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.425 0.631 . . . . 0.0 111.569 -176.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.408 HD23 ' HA ' ' A' ' 16' ' ' LEU . 12.2 mt -89.86 137.82 32.01 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 102.859 -3.015 . . . . 0.0 102.859 168.66 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 49.4 m -113.82 126.72 55.52 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -77.57 136.4 38.28 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 178.624 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 32.3 t60 -139.23 94.87 2.85 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 104.786 -2.302 . . . . 0.0 104.786 170.604 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 152.26 -134.69 4.65 Favored Glycine 0 C--O 1.227 -0.293 0 C-N-CA 120.245 -0.979 . . . . 0.0 112.671 -175.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -126.73 -24.77 3.49 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 116.963 2.208 . . . . 0.0 116.963 -176.275 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -73.44 156.45 38.25 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 178.687 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -77.24 -58.31 3.35 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 178.396 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 62.4 tp 167.52 137.37 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.177 0 N-CA-C 104.772 -2.307 . . . . 0.0 104.772 173.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 22.9 tptm -157.64 142.53 16.68 Favored 'General case' 0 C--O 1.221 -0.44 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 176.11 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 27.9 m-85 -127.67 151.26 75.03 Favored Pre-proline 0 C--O 1.24 0.577 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 176.128 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -72.2 156.8 54.94 Favored 'Trans proline' 0 C--N 1.351 0.686 0 O-C-N 122.107 0.53 . . . . 0.0 111.996 176.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.67 134.34 52.06 Favored 'General case' 0 N--CA 1.472 0.637 0 O-C-N 121.986 -0.446 . . . . 0.0 110.487 -178.161 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 90.67 1.85 73.43 Favored Glycine 0 N--CA 1.46 0.295 0 N-CA-C 111.174 -0.77 . . . . 0.0 111.174 179.624 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 30.7 mt-30 -144.33 170.49 15.91 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 123.846 0.858 . . . . 0.0 108.902 -175.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 107.3 -17.42 37.26 Favored Glycine 0 CA--C 1.498 -0.981 0 CA-C-N 116.059 -0.518 . . . . 0.0 113.369 173.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.413 HG11 ' HB3' ' A' ' 43' ' ' GLN . 57.2 t -67.39 129.17 93.73 Favored Pre-proline 0 C--N 1.319 -0.722 0 N-CA-C 105.767 -1.938 . . . . 0.0 105.767 176.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -71.73 171.01 17.31 Favored 'Trans proline' 0 N--CA 1.459 -0.505 0 O-C-N 122.196 0.577 . . . . 0.0 111.2 178.146 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 95.0 mt -71.09 107.44 2.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 179.529 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.418 ' HB2' HE22 ' A' ' 43' ' ' GLN . 90.7 m-20 -93.11 84.33 4.83 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 114.175 -1.375 . . . . 0.0 109.354 -177.386 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 81.0 p -66.9 -15.06 63.41 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 114.003 1.112 . . . . 0.0 114.003 -177.101 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -111.39 17.28 20.29 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.282 -0.872 . . . . 0.0 112.846 -176.42 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -140.73 169.78 16.99 Favored 'General case' 0 CA--C 1.543 0.673 0 N-CA-C 115.891 1.812 . . . . 0.0 115.891 -171.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 35.4 m -94.41 161.35 29.48 Favored Pre-proline 0 C--O 1.218 -0.597 0 C-N-CA 124.343 1.057 . . . . 0.0 112.592 -174.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -65.24 -24.71 58.1 Favored 'Trans proline' 0 CA--C 1.535 0.557 0 C-N-CA 115.474 -2.551 . . . . 0.0 115.572 -178.249 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -75.16 -24.42 57.91 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 121.551 -0.718 . . . . 0.0 111.921 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 15.5 p30 -95.07 1.0 54.94 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 115.021 1.489 . . . . 0.0 115.021 -171.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.418 HE22 ' HB2' ' A' ' 35' ' ' ASN . 82.7 mm-40 -56.96 -24.09 50.44 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.591 -0.731 . . . . 0.0 112.8 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 11.3 tt -61.14 136.98 24.14 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.805 0 CA-C-O 122.533 1.158 . . . . 0.0 112.652 179.448 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 178.23 -156.35 19.11 Favored Glycine 0 N--CA 1.448 -0.527 0 N-CA-C 111.187 -0.765 . . . . 0.0 111.187 -178.165 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 45.3 p90 -155.15 172.11 18.69 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 179.278 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 14.3 m-85 -113.14 138.75 49.48 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 173.12 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 54.4 ttt-85 -108.12 124.69 50.62 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.549 -178.055 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 43.8 ttt180 -63.75 135.98 57.09 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 176.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -135.67 127.03 28.45 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.5 0.667 . . . . 0.0 111.928 -179.472 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 11.3 p -137.21 131.16 32.05 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 176.505 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 10.5 tpp180 -167.38 135.71 2.54 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 178.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 45.2 mtt180 -121.13 165.81 14.82 Favored 'General case' 0 CA--C 1.497 -1.071 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 177.277 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -134.79 173.97 13.68 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 N-CA-C 104.707 -2.331 . . . . 0.0 104.707 -179.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.31 109.03 7.5 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 175.421 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -77.73 159.64 48.09 Favored Glycine 0 C--O 1.228 -0.228 0 N-CA-C 107.263 -2.335 . . . . 0.0 107.263 176.353 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -58.12 -42.05 94.97 Favored Glycine 0 C--O 1.224 -0.527 0 CA-C-N 118.464 1.132 . . . . 0.0 112.082 -178.366 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.7 t0 -80.07 17.16 1.04 Allowed 'General case' 0 CA--C 1.548 0.881 0 CA-C-O 122.278 1.037 . . . . 0.0 112.658 -179.618 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 85.03 14.94 68.27 Favored Glycine 0 CA--C 1.504 -0.605 0 CA-C-N 115.417 -0.811 . . . . 0.0 113.179 171.314 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 33.3 mmtt -76.34 128.26 34.5 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.128 0.49 . . . . 0.0 110.374 -175.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 93.6 mmm -116.52 157.99 24.35 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 108.002 -1.111 . . . . 0.0 108.002 -178.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 14.0 tppt? -84.51 -43.46 14.54 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 106.638 -1.615 . . . . 0.0 106.638 176.274 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.5 t70 53.26 -145.53 0.59 Allowed 'General case' 0 C--O 1.241 0.623 0 CA-C-N 114.616 -1.174 . . . . 0.0 111.076 177.395 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.2 mm? 67.17 173.93 0.26 Allowed 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 116.062 1.875 . . . . 0.0 116.062 175.353 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -67.97 169.28 10.13 Favored Pre-proline 0 C--O 1.24 0.574 0 CA-C-N 113.962 -1.472 . . . . 0.0 113.91 -176.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -67.49 155.86 68.53 Favored 'Trans proline' 0 C--N 1.354 0.846 0 C-N-CA 116.107 -2.128 . . . . 0.0 112.659 177.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.31 160.1 21.65 Favored 'General case' 0 CA--C 1.505 -0.764 0 N-CA-C 105.377 -2.083 . . . . 0.0 105.377 178.051 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 53.1 m95 -131.47 146.53 52.29 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 178.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -126.75 142.32 51.58 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 179.343 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 81.3 t80 -88.79 136.88 32.77 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 108.59 -0.892 . . . . 0.0 108.59 -178.22 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -140.4 139.52 35.3 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 -176.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 75.2 m-85 -74.35 159.48 32.33 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.762 -0.653 . . . . 0.0 111.527 -175.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -55.91 131.12 46.27 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.194 0.521 . . . . 0.0 112.373 -178.131 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 75.5 26.8 64.71 Favored Glycine 0 C--O 1.218 -0.882 0 N-CA-C 115.842 1.097 . . . . 0.0 115.842 175.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 2.8 p -88.9 145.98 25.21 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 118.606 1.203 . . . . 0.0 108.472 178.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 100.32 138.45 10.28 Favored Glycine 0 CA--C 1.527 0.799 0 N-CA-C 109.953 -1.259 . . . . 0.0 109.953 -176.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -70.33 -40.25 4.61 Favored 'Trans proline' 0 C--N 1.348 0.519 0 CA-C-N 119.778 1.789 . . . . 0.0 115.74 -174.332 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -112.31 37.0 3.15 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 -177.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -62.99 -46.31 88.29 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.597 -177.132 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 57.29 30.54 61.42 Favored Glycine 0 C--N 1.33 0.228 0 CA-C-N 115.897 -0.592 . . . . 0.0 112.679 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 16.3 mt -118.78 103.72 47.99 Favored Pre-proline 0 N--CA 1.445 -0.692 0 N-CA-C 114.768 1.395 . . . . 0.0 114.768 -175.53 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -78.33 164.89 26.15 Favored 'Trans proline' 0 N--CA 1.461 -0.409 0 N-CA-C 107.97 -1.588 . . . . 0.0 107.97 169.32 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.429 ' CE1' ' HB3' ' A' ' 92' ' ' TRP . 66.7 t80 -61.25 133.08 55.53 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 120.353 -0.539 . . . . 0.0 110.148 -179.535 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 90.73 -7.03 81.87 Favored Glycine 0 CA--C 1.519 0.325 0 N-CA-C 114.797 0.679 . . . . 0.0 114.797 178.442 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -65.02 129.18 38.74 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 118.469 1.135 . . . . 0.0 111.546 179.597 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 60.0 t30 -76.62 127.54 32.99 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.694 -178.052 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 27.7 ttmt -156.14 152.14 27.56 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 106.686 -1.598 . . . . 0.0 106.686 179.687 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 17.6 t0 -63.79 129.48 40.27 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.14 0.495 . . . . 0.0 110.167 -178.18 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 70.18 26.69 73.9 Favored Glycine 0 N--CA 1.443 -0.835 0 CA-C-N 115.723 -0.671 . . . . 0.0 114.672 176.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 47.2 mm -125.41 123.52 65.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 178.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -126.88 115.43 41.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.514 -0.767 . . . . 0.0 110.163 176.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . 0.429 ' HB3' ' CE1' ' A' ' 83' ' ' TYR . 96.2 m95 -82.02 137.29 35.12 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 112.697 0.629 . . . . 0.0 112.697 -176.577 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 17.3 m -136.93 149.73 26.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 178.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -158.97 166.59 31.43 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 103.465 -2.791 . . . . 0.0 103.465 -178.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 6.6 t -134.76 -179.03 5.35 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 106.311 -1.737 . . . . 0.0 106.311 177.685 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -67.53 134.13 50.72 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.235 0.54 . . . . 0.0 110.688 -178.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 92.06 -10.05 75.21 Favored Glycine 0 C--O 1.229 -0.174 0 CA-C-N 115.915 -0.584 . . . . 0.0 113.662 177.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -70.83 134.9 47.73 Favored 'General case' 0 CA--C 1.544 0.728 0 O-C-N 122.523 -0.399 . . . . 0.0 111.247 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 29.3 mt -93.39 135.77 34.3 Favored 'General case' 0 CA--C 1.511 -0.552 0 N-CA-C 112.997 0.74 . . . . 0.0 112.997 -178.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 52.1 t30 -85.09 76.62 10.21 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.57 -178.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 1.2 t -146.42 155.66 49.67 Favored Pre-proline 0 C--N 1.322 -0.616 0 N-CA-C 105.607 -1.997 . . . . 0.0 105.607 179.47 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -69.01 149.96 72.24 Favored 'Trans proline' 0 CA--C 1.531 0.338 0 N-CA-C 113.729 0.627 . . . . 0.0 113.729 177.068 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 4.7 ptpt -152.8 56.67 0.79 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 122.78 1.276 . . . . 0.0 110.184 178.526 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -58.85 -31.31 68.4 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.08 -1.418 . . . . 0.0 112.586 -179.202 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 16.2 p80 -61.0 -9.09 3.78 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 114.589 1.329 . . . . 0.0 114.589 -177.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 50.4 mt -91.08 -37.92 9.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 178.194 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -75.48 14.64 5.21 Favored Glycine 0 CA--C 1.52 0.396 0 N-CA-C 115.428 0.931 . . . . 0.0 115.428 -177.073 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 11.6 t -95.61 24.24 5.43 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -177.658 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.42 ' HD2' HD22 ' A' ' 114' ' ' ASN . 62.5 ttp85 -59.37 130.91 49.24 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 177.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -101.98 135.42 19.69 Favored Pre-proline 0 C--N 1.323 -0.586 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 179.563 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -73.47 -18.33 22.95 Favored 'Trans proline' 0 C--O 1.219 -0.427 0 C-N-CA 118.387 -0.609 . . . . 0.0 113.017 -178.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -77.42 -25.05 50.36 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.894 0.378 . . . . 0.0 110.369 178.37 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 95.2 m-20 -101.1 -21.4 14.99 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 114.062 1.134 . . . . 0.0 114.062 -175.389 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.42 HD22 ' HD2' ' A' ' 109' ' ' ARG . 29.8 t30 -158.26 151.99 23.63 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 -178.277 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -88.78 145.64 25.48 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-O 121.436 0.636 . . . . 0.0 111.711 178.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -70.18 147.51 49.76 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.18 0.514 . . . . 0.0 111.144 178.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 12.1 mt -88.61 138.29 19.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.095 -178.696 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 71.7 t -59.65 122.39 9.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 N-CA-C 106.908 -1.515 . . . . 0.0 106.908 175.148 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 6.4 tt -67.71 128.22 35.66 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.251 0.548 . . . . 0.0 109.695 -177.387 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -134.27 160.26 38.45 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 106.359 -1.719 . . . . 0.0 106.359 -179.273 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 13.6 mt -113.91 147.65 38.19 Favored Pre-proline 0 C--N 1.322 -0.629 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 177.197 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -72.7 164.93 34.18 Favored 'Trans proline' 0 C--O 1.236 0.396 0 O-C-N 122.26 0.611 . . . . 0.0 112.574 -179.338 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -55.42 131.48 46.0 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.289 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 101.98 -22.3 38.68 Favored Glycine 0 C--O 1.226 -0.35 0 CA-C-N 115.945 -0.571 . . . . 0.0 112.505 -178.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 9.5 m -108.58 130.79 55.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 117.992 0.896 . . . . 0.0 110.98 178.498 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 6.1 p -122.05 148.35 44.95 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.651 -179.492 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 84.5 mt -66.53 156.14 86.81 Favored Pre-proline 0 C--N 1.324 -0.515 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 178.246 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -74.22 173.99 13.23 Favored 'Trans proline' 0 C--O 1.238 0.486 0 N-CA-C 110.453 -0.634 . . . . 0.0 110.453 -179.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -62.73 123.46 18.48 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.643 0.735 . . . . 0.0 110.269 -176.413 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 85.95 45.9 5.54 Favored Glycine 0 N--CA 1.449 -0.491 0 N-CA-C 115.854 1.102 . . . . 0.0 115.854 179.021 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -145.6 149.18 34.06 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 117.534 0.667 . . . . 0.0 111.726 177.565 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 47.1 p90 -148.14 165.32 31.22 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 174.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -105.63 145.43 31.03 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.754 0.311 . . . . 0.0 110.186 -178.326 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -68.87 131.44 45.12 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 -179.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 86.73 -15.15 53.71 Favored Glycine 0 CA--C 1.521 0.455 0 CA-C-N 115.971 -0.558 . . . . 0.0 114.11 -177.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 32.9 t -82.62 123.59 29.38 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 179.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 6.0 tpt180 51.83 44.77 29.11 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 121.488 0.661 . . . . 0.0 110.535 -177.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -62.93 145.58 50.09 Favored Glycine 0 CA--C 1.517 0.216 0 N-CA-C 110.405 -1.078 . . . . 0.0 110.405 178.438 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 179.61 -161.57 27.59 Favored Glycine 0 N--CA 1.45 -0.388 0 N-CA-C 107.168 -2.373 . . . . 0.0 107.168 -178.175 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 21.1 m . . . . . 0 C--O 1.246 0.889 0 CA-C-O 118.27 -0.871 . . . . 0.0 109.77 178.122 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.881 0 CA-C-O 118.925 -0.931 . . . . 0.0 111.354 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -78.3 126.33 30.63 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 177.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 15.2 mmt -81.99 51.7 1.81 Allowed 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 112.511 0.56 . . . . 0.0 112.511 -177.311 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -87.47 43.0 3.16 Favored Glycine 0 C--O 1.226 -0.377 0 N-CA-C 111.353 -0.699 . . . . 0.0 111.353 -179.412 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 61.7 mt -61.75 147.66 88.7 Favored Pre-proline 0 C--O 1.243 0.727 0 C-N-CA 123.358 0.663 . . . . 0.0 112.607 -174.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -71.39 153.55 61.07 Favored 'Trans proline' 0 C--N 1.349 0.566 0 N-CA-C 113.851 0.673 . . . . 0.0 113.851 -179.431 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 48.0 t30 -147.97 95.18 2.45 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.516 -0.765 . . . . 0.0 109.417 178.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 44.9 t30 -108.18 41.09 1.62 Allowed 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 121.873 0.844 . . . . 0.0 108.989 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -146.24 159.32 43.49 Favored 'General case' 0 N--CA 1.438 -1.07 1 N-CA-C 98.025 -4.805 . . . . 0.0 98.025 -178.226 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -139.66 139.16 36.59 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-O 121.7 0.762 . . . . 0.0 111.894 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.67 143.77 55.82 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 114.773 -1.103 . . . . 0.0 108.249 177.536 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . 0.467 ' CD2' ' HD3' ' A' ' 109' ' ' ARG . 16.2 m95 -68.45 -21.86 64.61 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 113.627 0.973 . . . . 0.0 113.627 179.417 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 25.4 m-85 -121.37 161.1 22.7 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 114.226 1.195 . . . . 0.0 114.226 -171.144 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.403 ' HB ' ' HB3' ' A' ' 134' ' ' GLU . 72.9 p -68.34 163.29 23.38 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 114.43 -1.259 . . . . 0.0 111.247 -178.566 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.545 ' HB2' ' CZ ' ' A' ' 69' ' ' TYR . . . -75.99 134.11 40.24 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 113.563 0.949 . . . . 0.0 113.563 -175.801 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.433 HD13 HD13 ' A' ' 119' ' ' LEU . 1.9 mp -84.8 146.67 27.23 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 105.388 -2.078 . . . . 0.0 105.388 170.286 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 69.8 m -126.24 131.03 52.02 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 -177.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.441 ' HB2' ' CZ ' ' A' ' 131' ' ' PHE . 4.1 tp60 -97.79 138.58 34.95 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.912 -0.586 . . . . 0.0 112.11 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 52.6 t60 -128.55 99.22 5.29 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 104.722 -2.325 . . . . 0.0 104.722 168.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 168.46 -166.18 39.38 Favored Glycine 0 N--CA 1.451 -0.334 0 N-CA-C 109.14 -1.584 . . . . 0.0 109.14 -176.293 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -103.45 -26.9 12.7 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 113.404 0.89 . . . . 0.0 113.404 -178.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -80.87 160.17 24.83 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 106.981 -1.488 . . . . 0.0 106.981 177.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -85.86 -62.9 1.42 Allowed 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 113.051 0.759 . . . . 0.0 113.051 -177.734 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 51.2 tp -177.79 142.79 0.31 Allowed 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 106.892 -1.522 . . . . 0.0 106.892 175.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.1 tmtp? -158.11 138.41 12.59 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 175.593 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 14.9 m-85 -121.87 153.36 60.38 Favored Pre-proline 0 C--O 1.239 0.534 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 176.205 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -70.48 158.76 55.06 Favored 'Trans proline' 0 C--N 1.351 0.67 0 O-C-N 121.957 0.451 . . . . 0.0 112.468 177.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 9.7 tpp85 -64.29 135.59 56.36 Favored 'General case' 0 C--O 1.217 -0.651 0 CA-C-N 116.572 -0.286 . . . . 0.0 111.251 -178.541 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 78.94 13.63 82.88 Favored Glycine 0 C--O 1.224 -0.487 0 C-N-CA 121.268 -0.491 . . . . 0.0 112.259 178.188 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 8.4 mt-30 -150.24 170.49 18.86 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 -175.541 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 106.96 -18.69 36.49 Favored Glycine 0 CA--C 1.503 -0.681 0 CA-C-N 116.278 -0.419 . . . . 0.0 113.16 175.115 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 99.1 t -65.6 128.4 93.78 Favored Pre-proline 0 C--N 1.321 -0.669 0 N-CA-C 106.962 -1.495 . . . . 0.0 106.962 177.655 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.415 ' HB3' HD21 ' A' ' 119' ' ' LEU . 84.2 Cg_endo -75.17 170.02 21.27 Favored 'Trans proline' 0 N--CA 1.461 -0.438 0 O-C-N 122.217 0.588 . . . . 0.0 111.84 179.296 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 91.2 mt -69.36 109.03 2.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 178.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 78.1 m-20 -99.25 85.69 3.25 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 114.506 -1.224 . . . . 0.0 109.924 -177.294 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 72.9 p -67.79 -15.1 63.47 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.524 0.678 . . . . 0.0 112.542 -178.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 11.6 p30 -108.17 19.61 19.71 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 114.977 -1.011 . . . . 0.0 113.287 -177.224 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 7.6 m -137.94 152.85 49.36 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 114.689 1.366 . . . . 0.0 114.689 -175.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 58.9 m -73.78 164.14 63.31 Favored Pre-proline 0 CA--C 1.537 0.476 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.65 177.341 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -66.21 -25.18 50.47 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 115.362 -2.625 . . . . 0.0 114.499 -178.475 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.443 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 6.4 p-10 -75.23 -26.45 58.92 Favored 'General case' 0 C--N 1.323 -0.569 0 O-C-N 121.616 -0.677 . . . . 0.0 110.579 177.152 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.547 ' HA ' ' HE3' ' A' ' 103' ' ' LYS . 32.6 m-20 -76.69 -8.11 56.62 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.485 1.114 . . . . 0.0 113.674 -175.801 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 95.0 mm-40 -59.64 -31.24 69.33 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 114.667 1.358 . . . . 0.0 114.667 -177.456 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.419 ' HB ' ' HB1' ' A' ' 98' ' ' ALA . 14.8 tt -60.17 140.04 18.78 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.81 0 CA-C-O 122.223 1.011 . . . . 0.0 112.567 -179.729 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 179.35 -155.36 15.69 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.494 -0.86 . . . . 0.0 111.678 -178.18 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 49.9 p90 -155.13 173.38 16.69 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 179.449 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 20.0 m-85 -113.33 140.39 48.05 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 106.927 -1.509 . . . . 0.0 106.927 173.381 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 66.7 ttt-85 -112.4 130.68 55.89 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.981 -177.535 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 29.2 ttt-85 -68.96 142.49 54.67 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 176.001 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -142.23 133.17 25.82 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.799 0.333 . . . . 0.0 110.109 177.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -156.74 131.8 9.06 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 177.072 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -129.1 123.98 33.62 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 108.253 -1.018 . . . . 0.0 108.253 174.079 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.55 137.24 54.82 Favored 'General case' 0 CA--C 1.488 -1.421 0 CA-C-O 121.493 0.663 . . . . 0.0 110.206 -177.44 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -127.49 176.91 6.48 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 N-CA-C 106.636 -1.616 . . . . 0.0 106.636 179.212 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 56.1 ttp180 -127.85 116.87 20.82 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 174.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -85.06 161.56 36.16 Favored Glycine 0 C--O 1.224 -0.474 0 N-CA-C 106.233 -2.747 . . . . 0.0 106.233 176.129 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -64.91 -35.93 92.49 Favored Glycine 0 C--O 1.216 -0.998 0 CA-C-N 118.671 1.235 . . . . 0.0 110.345 179.441 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 32.1 t0 -91.26 17.17 8.65 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-O 122.374 1.083 . . . . 0.0 110.62 178.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 84.16 -7.06 73.05 Favored Glycine 0 N--CA 1.46 0.27 0 N-CA-C 117.25 1.66 . . . . 0.0 117.25 172.579 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.56 150.53 31.33 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 122.586 1.184 . . . . 0.0 112.914 -177.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 73.1 mtp -119.95 -174.49 2.77 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 112.775 -2.011 . . . . 0.0 112.871 -174.535 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 25.4 mmtt -123.23 -72.99 0.66 Allowed 'General case' 0 C--O 1.219 -0.535 0 C-N-CA 122.917 0.487 . . . . 0.0 109.701 179.511 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -93.7 147.63 22.85 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 106.935 -1.506 . . . . 0.0 106.935 177.06 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -124.74 -63.57 1.17 Allowed 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 106.194 -1.78 . . . . 0.0 106.194 178.347 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -82.02 152.49 68.58 Favored Pre-proline 0 C--O 1.241 0.657 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 176.392 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -75.39 149.28 34.93 Favored 'Trans proline' 0 C--O 1.238 0.491 0 C-N-CA 115.632 -2.445 . . . . 0.0 112.701 179.068 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 94.8 mtt-85 -103.89 152.18 22.25 Favored 'General case' 0 CA--C 1.506 -0.745 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 177.206 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 71.7 m95 -132.44 137.67 47.35 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 175.313 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.545 ' CZ ' ' HB2' ' A' ' 15' ' ' ALA . 78.1 m-85 -127.63 147.39 50.36 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 -179.35 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 74.1 t80 -90.76 137.0 32.7 Favored 'General case' 0 CA--C 1.507 -0.68 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -139.25 140.3 37.65 Favored 'General case' 0 N--CA 1.439 -1.007 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 -175.501 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -79.87 159.51 26.4 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.428 -174.485 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -53.39 124.12 13.87 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.97 0.414 . . . . 0.0 111.608 -178.082 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 82.86 13.51 77.58 Favored Glycine 0 C--O 1.222 -0.595 0 N-CA-C 116.514 1.366 . . . . 0.0 116.514 178.012 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 23.7 p -89.2 146.26 24.88 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 119.032 1.416 . . . . 0.0 111.224 179.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 111.35 141.86 8.73 Favored Glycine 0 CA--C 1.523 0.551 0 N-CA-C 110.094 -1.203 . . . . 0.0 110.094 -179.201 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -68.86 -39.55 8.19 Favored 'Trans proline' 0 C--N 1.348 0.528 0 CA-C-N 119.602 1.701 . . . . 0.0 115.755 -174.213 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -109.44 25.14 12.14 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.853 -178.208 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -57.88 -55.67 31.92 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.071 -0.513 . . . . 0.0 112.305 -174.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 54.47 33.83 54.23 Favored Glycine 0 CA--C 1.522 0.472 0 C-N-CA 121.071 -0.585 . . . . 0.0 112.31 179.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 15.9 mt -117.24 103.93 50.94 Favored Pre-proline 0 N--CA 1.448 -0.535 0 N-CA-C 115.94 1.83 . . . . 0.0 115.94 -172.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -77.8 161.66 30.25 Favored 'Trans proline' 0 N--CA 1.461 -0.384 0 N-CA-C 107.416 -1.802 . . . . 0.0 107.416 168.238 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 58.1 t80 -61.41 133.22 55.55 Favored 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 120.277 -0.569 . . . . 0.0 110.848 -177.289 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 90.99 -9.02 78.99 Favored Glycine 0 CA--C 1.519 0.31 0 CA-C-O 119.445 -0.642 . . . . 0.0 114.366 179.279 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -65.37 130.8 44.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 118.343 1.072 . . . . 0.0 111.154 179.461 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 58.4 t30 -79.01 130.17 35.24 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.389 -179.244 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 28.4 ttmt -156.14 152.0 27.39 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 107.675 -1.232 . . . . 0.0 107.675 179.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 38.2 t0 -62.58 129.79 42.16 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.883 0.373 . . . . 0.0 110.421 -179.117 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 69.57 27.52 73.32 Favored Glycine 0 N--CA 1.45 -0.404 0 CA-C-O 119.324 -0.709 . . . . 0.0 114.696 178.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 40.8 mm -127.5 128.82 70.2 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 CA-C-N 117.643 0.722 . . . . 0.0 110.918 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -132.81 117.15 29.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 CA-C-O 121.465 0.65 . . . . 0.0 111.352 177.049 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 97.4 m95 -81.52 138.26 35.48 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 114.063 1.134 . . . . 0.0 114.063 -176.444 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 16.3 m -139.32 151.15 22.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.626 -0.716 . . . . 0.0 109.153 178.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -158.8 166.54 31.7 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 105.87 -1.9 . . . . 0.0 105.87 -179.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 14.5 t -133.95 169.45 17.09 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 105.361 -2.088 . . . . 0.0 105.361 178.126 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -65.89 136.26 55.89 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.263 0.554 . . . . 0.0 109.954 -179.105 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 96.21 -12.17 66.89 Favored Glycine 0 C--O 1.229 -0.182 0 CA-C-N 115.768 -0.651 . . . . 0.0 113.044 178.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.443 ' HA ' ' HA ' ' A' ' 41' ' ' ASP . . . -76.66 139.95 40.75 Favored 'General case' 0 CA--C 1.542 0.635 0 O-C-N 122.458 -0.436 . . . . 0.0 110.22 179.109 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 39.7 mt -98.32 137.79 36.52 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 113.771 1.026 . . . . 0.0 113.771 -177.126 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 56.9 t30 -82.95 76.43 9.78 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.544 0.687 . . . . 0.0 110.299 179.388 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 1.2 t -146.26 160.69 41.75 Favored Pre-proline 0 C--N 1.321 -0.67 0 N-CA-C 102.218 -3.253 . . . . 0.0 102.218 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -72.59 148.91 48.39 Favored 'Trans proline' 0 CA--C 1.538 0.678 0 N-CA-C 114.172 0.797 . . . . 0.0 114.172 176.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.547 ' HE3' ' HA ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -143.91 54.88 1.31 Allowed 'General case' 0 N--CA 1.474 0.727 0 CA-C-O 123.406 1.574 . . . . 0.0 108.485 176.835 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 14.6 p-10 -64.56 -25.39 67.96 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 113.244 -1.798 . . . . 0.0 110.721 178.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 20.6 p-80 -56.33 -19.64 15.4 Favored 'General case' 0 C--O 1.221 -0.415 0 N-CA-C 114.205 1.187 . . . . 0.0 114.205 -179.026 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.421 HD11 ' CG ' ' A' ' 42' ' ' ASP . 20.5 mt -82.69 -28.15 8.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-O 121.371 0.605 . . . . 0.0 109.735 -179.243 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -77.28 5.13 52.32 Favored Glycine 0 CA--C 1.519 0.317 0 N-CA-C 115.84 1.096 . . . . 0.0 115.84 -175.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 12.0 t -83.17 11.18 6.81 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 117.323 0.562 . . . . 0.0 112.321 -178.356 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.467 ' HD3' ' CD2' ' A' ' 12' ' ' TRP . 63.5 ttp85 -58.38 130.16 45.42 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 178.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -97.63 128.91 32.85 Favored Pre-proline 0 C--N 1.326 -0.454 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 178.102 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -75.69 -13.08 20.13 Favored 'Trans proline' 0 C--O 1.219 -0.451 0 N-CA-C 113.197 0.422 . . . . 0.0 113.197 -178.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -81.12 -24.09 37.92 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.092 0.472 . . . . 0.0 109.888 178.392 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -101.01 -27.41 13.29 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 113.293 0.849 . . . . 0.0 113.293 -174.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.446 ' OD1' ' HD2' ' A' ' 109' ' ' ARG . 0.4 OUTLIER -139.39 152.43 47.11 Favored 'General case' 0 N--CA 1.437 -1.108 0 CA-C-O 121.263 0.554 . . . . 0.0 111.263 -177.595 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -95.73 137.31 34.98 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 115.199 -0.909 . . . . 0.0 108.94 176.19 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -65.32 148.6 51.42 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.435 0.636 . . . . 0.0 111.966 -178.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 16.8 mt -83.24 136.69 22.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.127 -178.459 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 88.7 t -61.64 122.77 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 N-CA-C 106.376 -1.713 . . . . 0.0 106.376 175.287 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.433 HD13 HD13 ' A' ' 16' ' ' LEU . 7.3 tt -66.76 131.32 45.69 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.237 0.542 . . . . 0.0 110.718 -176.414 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -130.96 154.48 48.1 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 106.452 -1.684 . . . . 0.0 106.452 179.416 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 13.3 mt -110.85 149.02 39.79 Favored Pre-proline 0 C--N 1.322 -0.603 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 178.059 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -73.83 167.06 28.16 Favored 'Trans proline' 0 C--N 1.345 0.343 0 O-C-N 122.2 0.579 . . . . 0.0 112.856 -179.497 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 55.7 tt0 -55.07 132.0 46.27 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.672 -0.694 . . . . 0.0 109.402 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 98.75 -20.98 48.19 Favored Glycine 0 C--O 1.226 -0.374 0 CA-C-N 115.981 -0.554 . . . . 0.0 113.065 -179.487 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 7.0 m -108.0 129.29 55.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 118.127 0.964 . . . . 0.0 110.688 178.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 4.8 p -122.34 148.44 45.05 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.245 -179.432 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 87.6 mt -70.64 153.42 94.95 Favored Pre-proline 0 C--N 1.325 -0.488 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 176.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -75.63 169.07 23.08 Favored 'Trans proline' 0 N--CA 1.463 -0.307 0 C-N-CA 117.949 -0.901 . . . . 0.0 110.913 178.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 39.8 tptt -60.13 131.83 52.05 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.125 -176.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 95.12 -6.06 68.78 Favored Glycine 0 C--O 1.228 -0.265 0 N-CA-C 115.006 0.762 . . . . 0.0 115.006 178.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.441 ' CZ ' ' HB2' ' A' ' 18' ' ' GLN . 1.3 m-85 -102.61 143.92 31.67 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-O 122.177 0.989 . . . . 0.0 111.752 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 45.2 p90 -146.45 165.61 28.87 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 113.6 -1.636 . . . . 0.0 107.342 173.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -108.56 148.07 30.85 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.949 0.405 . . . . 0.0 110.556 -178.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.403 ' HB3' ' HB ' ' A' ' 14' ' ' THR . 6.4 tp10 -70.43 136.51 49.6 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 178.769 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 81.22 -0.24 87.88 Favored Glycine 0 CA--C 1.52 0.385 0 C-N-CA 121.356 -0.449 . . . . 0.0 112.322 -176.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 4.3 t -122.07 -166.83 1.45 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.253 0.549 . . . . 0.0 110.22 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 37.1 mmt180 -138.25 170.79 15.42 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 105.564 -2.013 . . . . 0.0 105.564 178.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -152.03 174.67 30.99 Favored Glycine 0 C--N 1.317 -0.524 0 N-CA-C 105.633 -2.987 . . . . 0.0 105.633 178.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -162.75 -173.3 31.28 Favored Glycine 0 C--O 1.237 0.293 0 N-CA-C 109.23 -1.548 . . . . 0.0 109.23 -178.652 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 16.0 m . . . . . 0 C--O 1.247 0.93 0 CA-C-O 116.144 -1.884 . . . . 0.0 106.193 -179.447 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.288 0 CA-C-O 119.034 -0.87 . . . . 0.0 111.548 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -78.31 69.98 4.59 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 118.206 1.003 . . . . 0.0 112.687 -177.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 18.5 ptt? -136.27 48.33 2.16 Favored 'General case' 0 C--O 1.218 -0.554 0 CA-C-O 121.821 0.82 . . . . 0.0 109.542 179.412 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -166.27 -34.67 0.02 OUTLIER Glycine 0 C--O 1.222 -0.634 0 CA-C-N 115.342 -0.845 . . . . 0.0 112.444 -178.519 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 95.2 mt -62.47 135.79 95.58 Favored Pre-proline 0 C--O 1.241 0.634 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 177.082 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -79.37 173.79 12.76 Favored 'Trans proline' 0 C--N 1.347 0.492 0 O-C-N 122.21 0.584 . . . . 0.0 112.953 -179.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 33.9 t30 -147.58 108.31 4.17 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 177.117 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 25.4 t30 -109.38 39.61 2.04 Favored 'General case' 0 C--N 1.323 -0.578 0 O-C-N 123.396 0.435 . . . . 0.0 111.192 -178.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 81.0 p -146.08 155.72 42.96 Favored 'General case' 0 N--CA 1.441 -0.88 0 N-CA-C 101.901 -3.37 . . . . 0.0 101.901 179.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -145.56 146.58 31.45 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 177.158 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 29.1 p -66.36 144.69 56.39 Favored 'General case' 0 CA--C 1.508 -0.661 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 177.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 12.1 m95 -69.65 -21.9 63.5 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 120.859 0.361 . . . . 0.0 111.695 178.439 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -121.4 164.1 17.64 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -173.315 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 67.2 p -70.35 168.99 14.81 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.45 -1.25 . . . . 0.0 108.476 178.392 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.588 ' HB2' ' CZ ' ' A' ' 69' ' ' TYR . . . -73.87 156.7 37.44 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 122.309 1.052 . . . . 0.0 113.523 -176.306 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 11.5 mt -101.42 137.78 39.3 Favored 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 101.81 -3.404 . . . . 0.0 101.81 166.359 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 34.3 m -115.88 136.45 53.04 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 -177.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.454 ' HB2' ' CZ ' ' A' ' 131' ' ' PHE . 4.2 tp60 -114.0 137.58 51.51 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 113.959 1.096 . . . . 0.0 113.959 -176.091 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 6.5 t-160 -131.78 99.37 4.75 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 104.644 -2.354 . . . . 0.0 104.644 169.48 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 174.78 -168.35 40.95 Favored Glycine 0 C--O 1.225 -0.467 0 N-CA-C 110.562 -1.015 . . . . 0.0 110.562 -177.014 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -102.11 -25.18 13.82 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 112.832 0.678 . . . . 0.0 112.832 -179.177 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -82.86 158.23 22.8 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.316 -0.402 . . . . 0.0 109.999 -179.356 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -74.59 -62.93 1.36 Allowed 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.307 -178.462 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 28.6 tp 173.71 144.55 0.05 OUTLIER 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 103.333 -2.84 . . . . 0.0 103.333 177.338 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 11.0 tmtt? -155.45 134.26 12.02 Favored 'General case' 0 C--O 1.221 -0.442 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 176.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 9.6 m-85 -122.13 155.74 60.92 Favored Pre-proline 0 C--O 1.243 0.739 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 177.061 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -72.72 168.24 25.06 Favored 'Trans proline' 0 C--N 1.352 0.745 0 N-CA-C 113.409 0.503 . . . . 0.0 113.409 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 20.8 tpt180 -72.8 135.78 45.3 Favored 'General case' 0 C--O 1.215 -0.725 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 -178.244 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 83.86 7.32 85.86 Favored Glycine 0 C--O 1.223 -0.576 0 C-N-CA 121.236 -0.507 . . . . 0.0 112.893 177.527 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -150.19 168.42 24.04 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 -177.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 131.15 -30.29 3.35 Favored Glycine 0 CA--C 1.483 -1.927 0 N-CA-C 109.188 -1.565 . . . . 0.0 109.188 166.317 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 33.9 m -65.67 141.2 97.72 Favored Pre-proline 0 N--CA 1.433 -1.279 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 177.288 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_endo -74.01 176.48 9.45 Favored 'Trans proline' 0 N--CA 1.456 -0.691 0 C-N-CA 121.745 1.63 . . . . 0.0 110.821 178.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 91.3 mt -73.09 114.99 13.33 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 178.038 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 29.5 m-80 -109.14 82.86 1.66 Allowed 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 -179.412 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 60.9 p -67.28 -21.99 65.67 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 113.018 0.747 . . . . 0.0 113.018 -176.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 69.1 m-80 -106.1 35.74 2.82 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.054 -176.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 17.4 m -145.51 152.48 39.82 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 -179.217 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 4.6 m -73.08 164.79 58.33 Favored Pre-proline 0 C--N 1.324 -0.513 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 178.017 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -64.59 -26.24 61.75 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 114.748 -3.035 . . . . 0.0 111.14 177.624 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -62.18 -27.47 68.99 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 123.862 0.865 . . . . 0.0 111.573 175.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 77.3 m-20 -96.44 -4.9 40.86 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 115.225 1.565 . . . . 0.0 115.225 -171.418 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 90.6 mm-40 -59.6 -28.41 67.15 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 113.599 0.962 . . . . 0.0 113.599 -177.574 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 13.8 tt -57.45 141.52 14.34 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 N-CA-C 114.46 1.281 . . . . 0.0 114.46 -178.195 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -179.53 -153.47 11.87 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.071 179.318 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 49.5 p90 -155.03 169.51 23.94 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 177.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 19.3 m-85 -111.63 143.01 43.22 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 173.244 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 17.4 ttt180 -116.18 125.88 52.9 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.698 -178.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 18.2 ttp85 -68.67 135.93 52.15 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 107.956 -1.128 . . . . 0.0 107.956 176.56 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -127.52 125.32 40.19 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.401 0.619 . . . . 0.0 109.719 179.552 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -146.19 117.55 7.94 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.142 -0.935 . . . . 0.0 108.954 179.406 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 6.7 tpp85 -147.78 127.57 13.46 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 178.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 29.1 mtt85 -130.89 165.92 22.03 Favored 'General case' 0 CA--C 1.495 -1.153 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 177.39 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -141.06 179.4 2.34 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 -177.553 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 19.1 ttm180 -115.05 104.96 12.4 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 106.182 -1.785 . . . . 0.0 106.182 174.194 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -84.18 143.25 21.04 Favored Glycine 0 C--O 1.226 -0.392 0 N-CA-C 107.275 -2.33 . . . . 0.0 107.275 178.041 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -64.7 -38.5 95.71 Favored Glycine 0 C--O 1.219 -0.83 0 CA-C-N 118.404 1.102 . . . . 0.0 112.339 -177.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -85.76 11.58 10.77 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.7 0.762 . . . . 0.0 112.083 -179.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 84.7 20.33 58.34 Favored Glycine 0 C--O 1.226 -0.399 0 CA-C-N 115.235 -0.893 . . . . 0.0 112.467 176.657 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 21.6 mmtt -88.21 130.85 34.96 Favored 'General case' 0 C--N 1.324 -0.542 0 O-C-N 122.21 -0.582 . . . . 0.0 110.872 -175.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 86.8 mmm -100.98 159.9 14.82 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.156 -0.929 . . . . 0.0 109.128 -178.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 16.5 tppt? -83.22 -48.68 10.22 Favored 'General case' 0 C--O 1.219 -0.526 0 N-CA-C 108.401 -0.962 . . . . 0.0 108.401 177.526 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 21.3 t0 -162.82 163.53 26.53 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 105.327 -2.101 . . . . 0.0 105.327 177.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -117.28 -34.24 4.39 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 177.38 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 20.9 m -85.33 148.53 50.01 Favored Pre-proline 0 C--N 1.326 -0.425 0 N-CA-C 113.753 1.02 . . . . 0.0 113.753 -176.058 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -77.59 145.57 23.42 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 117.97 -0.887 . . . . 0.0 112.187 174.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 47.8 mtt180 -119.1 165.09 14.59 Favored 'General case' 0 CA--C 1.508 -0.656 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.864 179.049 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 64.9 m95 -134.25 144.32 48.32 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 106.588 -1.634 . . . . 0.0 106.588 172.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.588 ' CZ ' ' HB2' ' A' ' 15' ' ' ALA . 71.5 m-85 -130.16 148.51 52.01 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 178.144 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 76.1 t80 -92.59 134.73 34.71 Favored 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 -177.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -137.11 140.19 41.75 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 -176.493 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -77.87 159.51 28.88 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.167 -177.194 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -53.33 138.94 31.45 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 -179.233 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 70.51 38.27 69.03 Favored Glycine 0 C--O 1.225 -0.454 0 N-CA-C 115.726 1.05 . . . . 0.0 115.726 175.22 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 12.7 p -109.49 146.09 35.16 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 117.804 0.802 . . . . 0.0 111.238 178.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 112.01 145.39 9.81 Favored Glycine 0 C--O 1.223 -0.548 0 N-CA-C 108.141 -1.984 . . . . 0.0 108.141 -176.501 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -67.59 -48.42 1.58 Allowed 'Trans proline' 0 C--N 1.348 0.514 0 CA-C-N 119.907 1.853 . . . . 0.0 115.702 -173.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -121.63 40.49 3.6 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 -179.397 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -65.53 -43.96 88.37 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.652 -178.066 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 57.62 24.84 54.19 Favored Glycine 0 C--O 1.224 -0.482 0 CA-C-N 115.992 -0.549 . . . . 0.0 113.972 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 47.2 mt -101.12 109.65 59.07 Favored Pre-proline 0 C--O 1.239 0.528 0 N-CA-C 114.892 1.442 . . . . 0.0 114.892 -175.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -77.87 167.68 23.38 Favored 'Trans proline' 0 C--O 1.237 0.451 0 N-CA-C 108.725 -1.298 . . . . 0.0 108.725 170.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 62.8 t80 -62.42 131.46 49.3 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 179.161 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 92.97 -5.94 76.21 Favored Glycine 0 CA--C 1.52 0.344 0 N-CA-C 114.967 0.747 . . . . 0.0 114.967 178.577 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -64.49 129.18 38.88 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 118.296 1.048 . . . . 0.0 112.085 179.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 43.3 t-20 -75.24 126.6 31.35 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.912 -177.406 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 9.9 ttmm -156.18 150.85 25.93 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 177.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -63.58 134.05 54.82 Favored 'General case' 0 C--N 1.324 -0.529 0 O-C-N 123.176 0.298 . . . . 0.0 110.526 179.416 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 68.51 26.9 74.11 Favored Glycine 0 N--CA 1.45 -0.387 0 CA-C-O 119.496 -0.613 . . . . 0.0 114.081 177.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 34.0 mm -130.18 130.81 65.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 117.417 0.608 . . . . 0.0 109.831 179.277 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.1 pt -132.5 113.49 21.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 CA-C-O 121.5 0.667 . . . . 0.0 110.815 175.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 95.1 m95 -80.98 131.85 35.35 Favored 'General case' 0 C--N 1.321 -0.662 0 O-C-N 121.893 -0.505 . . . . 0.0 111.492 -177.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 2.8 m -139.96 150.86 21.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.819 -177.269 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -156.71 166.57 33.02 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 106.071 -1.826 . . . . 0.0 106.071 -178.553 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 14.8 t -125.9 167.48 15.2 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 105.072 -2.195 . . . . 0.0 105.072 176.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -66.45 136.6 55.94 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 -179.491 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 96.09 -10.87 67.81 Favored Glycine 0 C--O 1.225 -0.432 0 CA-C-N 115.966 -0.561 . . . . 0.0 113.114 178.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -78.44 141.43 38.28 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 122.308 -0.525 . . . . 0.0 110.744 179.378 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 33.9 mt -91.79 135.64 33.76 Favored 'General case' 0 CA--C 1.51 -0.57 0 CA-C-O 121.429 0.633 . . . . 0.0 112.561 -178.577 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 58.5 t30 -82.32 70.05 9.19 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.601 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 2.0 t -142.48 157.55 62.3 Favored Pre-proline 0 CA--C 1.54 0.578 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 -178.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_exo -61.86 149.21 91.04 Favored 'Trans proline' 0 C--N 1.348 0.539 0 N-CA-C 114.407 0.887 . . . . 0.0 114.407 -179.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.478 ' HB3' HD12 ' A' ' 106' ' ' ILE . 74.7 mmtt -124.79 41.13 3.58 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 122.017 0.913 . . . . 0.0 108.73 -178.579 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 16.7 p-10 -50.36 -46.55 55.91 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 114.583 -1.189 . . . . 0.0 112.855 -178.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 48.2 p-80 -69.78 -9.15 53.51 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 113.577 0.955 . . . . 0.0 113.577 -177.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.478 HD12 ' HB3' ' A' ' 103' ' ' LYS . 40.8 mt -95.31 -40.13 10.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 178.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -72.14 1.31 34.11 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 115.804 1.081 . . . . 0.0 115.804 -178.149 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 6.2 t -83.03 19.22 1.45 Allowed 'General case' 0 CA--C 1.549 0.934 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 -178.261 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.476 ' HD2' HD22 ' A' ' 114' ' ' ASN . 66.5 ttp85 -59.24 130.67 48.06 Favored 'General case' 0 N--CA 1.47 0.55 0 O-C-N 121.101 -1.0 . . . . 0.0 109.142 179.478 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -103.88 127.03 30.23 Favored Pre-proline 0 C--N 1.323 -0.567 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 178.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -72.7 -14.76 27.18 Favored 'Trans proline' 0 C--O 1.22 -0.411 0 C-N-CA 118.098 -0.801 . . . . 0.0 113.234 -178.171 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -74.32 -27.09 60.54 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.919 0.39 . . . . 0.0 110.497 178.201 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 79.7 m-20 -104.27 -23.05 13.27 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 113.908 1.077 . . . . 0.0 113.908 -174.109 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.476 HD22 ' HD2' ' A' ' 109' ' ' ARG . 26.1 t30 -148.37 151.91 36.12 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -177.325 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -91.52 148.83 22.01 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-O 121.384 0.611 . . . . 0.0 111.943 179.438 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -74.65 150.12 39.71 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.441 178.114 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 6.9 mt -92.22 140.34 16.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 -178.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 95.2 t -61.49 124.78 16.58 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 N-CA-C 107.162 -1.422 . . . . 0.0 107.162 175.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 5.3 tt -67.4 129.15 39.0 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.137 0.494 . . . . 0.0 111.108 -176.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 29.2 mt-30 -133.01 154.51 50.45 Favored 'General case' 0 C--O 1.219 -0.531 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 -179.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 12.8 mt -110.9 147.92 37.53 Favored Pre-proline 0 C--N 1.322 -0.622 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 177.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -73.33 166.84 28.84 Favored 'Trans proline' 0 C--N 1.346 0.444 0 O-C-N 122.197 0.577 . . . . 0.0 113.196 179.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 39.3 tt0 -54.08 133.03 43.83 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.779 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 97.02 -20.55 50.41 Favored Glycine 0 C--O 1.227 -0.337 0 CA-C-N 115.941 -0.572 . . . . 0.0 112.93 -179.477 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 1.5 m -104.95 127.38 52.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 117.916 0.858 . . . . 0.0 110.569 178.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 6.9 p -122.79 148.29 45.54 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.739 -179.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 85.2 mt -71.86 150.52 92.95 Favored Pre-proline 0 C--N 1.324 -0.538 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 179.181 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -78.74 179.79 6.16 Favored 'Trans proline' 0 C--O 1.236 0.387 0 O-C-N 121.99 0.468 . . . . 0.0 111.341 178.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 8.1 tmtt? -57.11 126.93 29.42 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 -175.306 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 89.56 -0.03 79.83 Favored Glycine 0 CA--C 1.51 -0.26 0 N-CA-C 116.233 1.253 . . . . 0.0 116.233 173.533 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.454 ' CZ ' ' HB2' ' A' ' 18' ' ' GLN . 4.0 m-85 -99.53 137.9 37.38 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-O 121.881 0.848 . . . . 0.0 111.762 -179.113 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 40.0 p90 -145.43 161.75 38.95 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 114.166 -1.379 . . . . 0.0 107.741 174.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -99.68 142.86 30.6 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.573 0.701 . . . . 0.0 112.468 -175.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -70.4 129.77 40.17 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 107.367 -1.345 . . . . 0.0 107.367 178.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 95.21 -21.51 43.75 Favored Glycine 0 C--O 1.227 -0.331 0 CA-C-N 116.15 -0.477 . . . . 0.0 112.761 -178.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 20.0 t -89.96 89.45 7.72 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 179.181 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 47.3 ttp180 60.3 93.05 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 124.38 1.072 . . . . 0.0 112.193 -177.027 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -87.33 -144.97 9.27 Favored Glycine 0 C--O 1.225 -0.438 0 CA-C-N 115.384 -0.825 . . . . 0.0 111.195 -178.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -85.08 18.54 26.95 Favored Glycine 0 CA--C 1.519 0.284 0 N-CA-C 111.444 -0.662 . . . . 0.0 111.444 178.153 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 40.1 t . . . . . 0 C--O 1.26 1.653 0 N-CA-C 103.491 -2.781 . . . . 0.0 103.491 -179.895 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.766 0 CA-C-O 118.251 -1.305 . . . . 0.0 111.184 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -154.95 173.52 16.42 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 -179.024 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 67.6 ttp -138.74 132.86 31.4 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 103.908 -2.627 . . . . 0.0 103.908 178.251 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 151.9 128.65 1.43 Allowed Glycine 0 N--CA 1.446 -0.645 0 N-CA-C 106.721 -2.552 . . . . 0.0 106.721 -176.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 96.7 mt -126.9 146.28 56.88 Favored Pre-proline 0 C--N 1.319 -0.726 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 -179.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -75.82 161.69 36.01 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 117.749 -1.034 . . . . 0.0 111.885 177.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 58.3 t30 -65.74 -32.0 73.3 Favored 'General case' 0 C--O 1.22 -0.458 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 179.479 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 -158.59 -98.28 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 177.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 34.6 p 39.87 73.19 0.12 Allowed 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 114.651 1.352 . . . . 0.0 114.651 -179.055 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -96.89 145.87 25.47 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 114.926 -1.034 . . . . 0.0 110.403 -176.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 37.2 p -62.94 142.29 58.39 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 114.994 -1.003 . . . . 0.0 108.883 177.108 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . 0.43 ' CD2' ' HD3' ' A' ' 109' ' ' ARG . 7.4 m95 -66.23 -21.87 66.31 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 177.754 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -121.41 161.51 22.04 Favored 'General case' 0 CA--C 1.509 -0.619 0 N-CA-C 113.944 1.09 . . . . 0.0 113.944 -172.102 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 77.4 p -72.55 172.69 10.08 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 113.692 -1.594 . . . . 0.0 109.136 177.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.591 ' HB2' ' CZ ' ' A' ' 69' ' ' TYR . . . -77.67 142.6 38.73 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 -176.598 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.405 HD23 ' HA ' ' A' ' 16' ' ' LEU . 11.8 mt -90.48 133.59 34.94 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 102.299 -3.223 . . . . 0.0 102.299 167.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 64.5 m -118.37 138.59 52.32 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 118.143 0.429 . . . . 0.0 110.264 -176.103 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.429 ' HB2' ' CZ ' ' A' ' 131' ' ' PHE . 4.0 tp60 -105.84 139.89 39.72 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 113.596 0.962 . . . . 0.0 113.596 -177.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 59.7 t60 -128.74 99.71 5.44 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 104.476 -2.416 . . . . 0.0 104.476 168.241 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 160.78 -162.38 33.47 Favored Glycine 0 C--O 1.226 -0.375 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 -176.333 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 54.0 mttp -110.04 -15.79 13.96 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 113.508 0.929 . . . . 0.0 113.508 -179.632 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -74.05 153.52 39.62 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 179.395 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 63.0 m-20 -79.82 -62.85 1.56 Allowed 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 120.566 0.222 . . . . 0.0 110.975 -178.133 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 48.3 tp 165.69 137.38 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 102.763 -3.051 . . . . 0.0 102.763 177.418 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -155.43 135.78 13.19 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 177.007 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -124.47 157.84 63.7 Favored Pre-proline 0 C--N 1.322 -0.599 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 177.467 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -69.33 174.39 9.21 Favored 'Trans proline' 0 CA--C 1.539 0.762 0 C-N-CA 121.704 1.602 . . . . 0.0 114.933 -178.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 17.3 tpt180 -78.25 129.54 35.19 Favored 'General case' 0 C--O 1.216 -0.681 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 178.367 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 75.42 12.29 83.73 Favored Glycine 0 C--O 1.225 -0.411 0 N-CA-C 114.99 0.756 . . . . 0.0 114.99 175.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 33.6 tt0 -157.29 145.16 19.04 Favored 'General case' 0 C--O 1.219 -0.523 0 N-CA-C 106.378 -1.712 . . . . 0.0 106.378 -178.489 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 138.66 -14.39 3.4 Favored Glycine 0 CA--C 1.506 -0.504 0 C-N-CA 120.038 -1.077 . . . . 0.0 113.707 177.42 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 30.8 m -72.56 145.31 87.31 Favored Pre-proline 0 C--N 1.319 -0.729 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 177.044 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -75.69 166.28 28.66 Favored 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 122.104 1.869 . . . . 0.0 113.775 179.386 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 97.6 mt -73.3 124.84 31.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.34 -0.846 . . . . 0.0 110.568 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 16.3 t-20 -125.41 122.76 37.65 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.861 0.362 . . . . 0.0 110.921 174.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 72.7 p -91.04 -15.91 28.77 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 113.837 1.051 . . . . 0.0 113.837 -177.195 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 11.8 p30 -112.96 25.37 11.47 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.637 -0.711 . . . . 0.0 112.385 -176.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 68.3 m -136.36 153.34 51.15 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 178.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 2.9 m -68.62 162.9 59.24 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.527 -178.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -66.47 -28.61 45.77 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 114.493 -3.204 . . . . 0.0 113.638 179.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.53 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 5.1 p-10 -75.23 -23.08 57.5 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 121.621 -0.674 . . . . 0.0 111.608 177.151 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.482 ' HA ' ' HE3' ' A' ' 103' ' ' LYS . 18.8 m-20 -73.25 -13.15 61.08 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.712 0.805 . . . . 0.0 112.901 -176.406 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 93.1 mm-40 -62.44 -24.53 67.47 Favored 'General case' 0 C--O 1.219 -0.547 0 N-CA-C 114.492 1.293 . . . . 0.0 114.492 -177.092 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.567 ' HB ' ' HB1' ' A' ' 98' ' ' ALA . 12.9 tt -57.16 140.15 15.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 CA-C-O 122.303 1.049 . . . . 0.0 112.952 179.473 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 178.35 -151.78 10.89 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.122 -1.037 . . . . 0.0 113.14 -179.116 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 48.7 p90 -154.71 168.71 25.91 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 179.074 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -108.67 138.4 45.04 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 173.151 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.96 126.01 51.68 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 123.821 0.849 . . . . 0.0 108.758 -179.379 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 34.1 ttt180 -70.78 144.16 50.94 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 122.339 0.256 . . . . 0.0 111.404 177.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -149.16 160.22 43.55 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.709 0.766 . . . . 0.0 111.679 178.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 8.4 t -169.13 176.28 5.35 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 102.09 -3.3 . . . . 0.0 102.09 174.485 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 12.9 tpt180 -128.41 123.86 34.85 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 177.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 3.3 tmt_? -134.95 142.22 46.45 Favored 'General case' 0 CA--C 1.5 -0.974 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 -177.505 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -141.88 179.75 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 -177.605 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 24.9 tpt85 -134.96 104.52 5.99 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 105.669 -1.975 . . . . 0.0 105.669 171.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -77.54 152.54 39.5 Favored Glycine 0 N--CA 1.45 -0.385 0 N-CA-C 105.078 -3.209 . . . . 0.0 105.078 176.258 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -59.76 -38.21 93.57 Favored Glycine 0 C--O 1.222 -0.617 0 CA-C-N 118.9 1.35 . . . . 0.0 112.147 -178.357 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 37.5 t0 -81.83 15.73 2.11 Favored 'General case' 0 CA--C 1.551 0.993 0 CA-C-O 122.345 1.069 . . . . 0.0 112.057 -179.557 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 85.13 15.46 66.95 Favored Glycine 0 C--O 1.222 -0.64 0 CA-C-N 115.664 -0.698 . . . . 0.0 113.294 171.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 21.1 mmtt -82.34 140.55 33.47 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.399 0.619 . . . . 0.0 109.855 -175.384 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 61.7 mtp -125.51 -178.37 4.22 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 114.418 -1.265 . . . . 0.0 110.451 -176.297 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 34.6 mmtt -136.88 -57.95 0.72 Allowed 'General case' 0 CA--C 1.504 -0.817 0 CA-C-O 121.33 0.586 . . . . 0.0 109.441 -177.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 34.47 64.04 0.41 Allowed 'General case' 0 C--N 1.322 -0.63 0 O-C-N 126.172 2.17 . . . . 0.0 112.897 173.528 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 75.9 mt -61.74 159.33 13.77 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 113.669 -1.605 . . . . 0.0 112.258 -176.376 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 54.1 p -55.61 142.77 60.96 Favored Pre-proline 0 C--O 1.252 1.187 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.368 179.327 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -66.46 142.06 63.9 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 116.7 -1.733 . . . . 0.0 112.554 -176.464 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.445 ' HB2' ' HB1' ' A' ' 15' ' ' ALA . 6.9 ptp180 -139.26 162.81 34.09 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 114.477 -1.238 . . . . 0.0 108.198 -179.739 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 53.1 m95 -132.65 148.92 52.36 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 -177.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.591 ' CZ ' ' HB2' ' A' ' 15' ' ' ALA . 45.1 m-85 -125.09 150.46 46.81 Favored 'General case' 0 C--O 1.215 -0.763 0 N-CA-C 106.17 -1.789 . . . . 0.0 106.17 179.433 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 86.3 t80 -97.06 139.01 33.71 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 118.818 0.735 . . . . 0.0 109.756 -175.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -140.99 152.28 44.8 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 -175.171 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 65.9 m-85 -85.53 159.47 19.9 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -175.045 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -54.2 126.61 23.62 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.127 178.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 72.92 30.79 62.92 Favored Glycine 0 C--O 1.22 -0.737 0 N-CA-C 116.105 1.202 . . . . 0.0 116.105 177.226 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.2 p -89.31 146.21 24.86 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 119.133 1.467 . . . . 0.0 108.154 178.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 98.01 133.09 7.8 Favored Glycine 0 CA--C 1.527 0.786 0 N-CA-C 109.186 -1.565 . . . . 0.0 109.186 -176.51 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -70.41 -36.45 9.06 Favored 'Trans proline' 0 C--N 1.346 0.433 0 CA-C-N 119.716 1.758 . . . . 0.0 116.036 -173.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -105.24 15.16 27.86 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 114.983 -1.008 . . . . 0.0 108.884 -176.62 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -60.3 -43.07 96.63 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.349 -175.291 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 56.48 35.13 65.16 Favored Glycine 0 C--O 1.228 -0.242 0 CA-C-N 115.871 -0.604 . . . . 0.0 112.687 179.434 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 15.0 mt -113.28 103.91 55.57 Favored Pre-proline 0 N--CA 1.446 -0.662 0 N-CA-C 115.401 1.63 . . . . 0.0 115.401 -175.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -79.48 163.99 24.06 Favored 'Trans proline' 0 N--CA 1.46 -0.47 0 C-N-CA 122.421 2.08 . . . . 0.0 107.846 167.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 48.6 t80 -61.51 131.01 48.75 Favored 'General case' 0 C--N 1.319 -0.733 0 C-N-CA 120.467 -0.493 . . . . 0.0 110.214 -178.614 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 92.89 -7.65 76.7 Favored Glycine 0 CA--C 1.52 0.368 0 CA-C-O 119.349 -0.695 . . . . 0.0 114.778 178.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -66.88 130.59 43.65 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 118.58 1.19 . . . . 0.0 111.655 179.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 56.4 t30 -76.44 129.7 36.92 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.606 -179.328 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 22.0 ttmt -156.07 153.13 28.91 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 179.304 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 35.0 t0 -60.2 125.23 22.88 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.312 0.577 . . . . 0.0 111.48 -178.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 69.66 30.92 70.49 Favored Glycine 0 N--CA 1.449 -0.472 0 CA-C-O 118.908 -0.94 . . . . 0.0 114.484 177.57 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 42.8 mm -126.0 129.86 72.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 117.844 0.822 . . . . 0.0 111.445 179.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -130.82 117.88 39.9 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.662 175.25 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 96.4 m95 -82.99 136.68 34.43 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 113.81 1.041 . . . . 0.0 113.81 -176.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -144.77 155.37 14.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.611 -179.121 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -155.81 166.6 33.01 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 104.729 -2.323 . . . . 0.0 104.729 -178.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 15.1 t -116.28 170.04 8.83 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 104.892 -2.262 . . . . 0.0 104.892 173.711 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -66.13 135.1 54.1 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 178.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 91.3 -7.52 80.34 Favored Glycine 0 CA--C 1.517 0.188 0 CA-C-N 116.143 -0.481 . . . . 0.0 113.169 179.48 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.567 ' HB1' ' HB ' ' A' ' 44' ' ' ILE . . . -72.16 134.34 45.66 Favored 'General case' 0 CA--C 1.539 0.542 0 O-C-N 122.322 -0.516 . . . . 0.0 110.337 178.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 31.8 mt -85.96 138.19 32.18 Favored 'General case' 0 CA--C 1.511 -0.532 0 CA-C-O 121.48 0.657 . . . . 0.0 112.591 -177.163 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 60.0 t30 -85.43 69.73 10.72 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.277 -179.542 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -145.1 158.52 51.83 Favored Pre-proline 0 C--N 1.321 -0.657 0 N-CA-C 104.237 -2.505 . . . . 0.0 104.237 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -73.08 149.9 47.25 Favored 'Trans proline' 0 CA--C 1.534 0.515 0 N-CA-C 113.938 0.707 . . . . 0.0 113.938 177.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.482 ' HE3' ' HA ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -146.83 56.84 1.15 Allowed 'General case' 0 N--CA 1.477 0.883 0 CA-C-O 122.702 1.239 . . . . 0.0 109.205 176.444 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -65.14 -21.38 66.78 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.291 -1.322 . . . . 0.0 111.519 179.382 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 19.0 p80 -56.83 -19.67 18.61 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 114.307 1.225 . . . . 0.0 114.307 -179.13 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 11.7 mt -83.58 -27.91 7.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 121.698 0.761 . . . . 0.0 109.017 -179.413 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -78.2 14.66 10.72 Favored Glycine 0 C--O 1.219 -0.798 0 CA-C-N 115.715 -0.675 . . . . 0.0 114.416 -176.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 7.8 t -83.05 15.42 2.81 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-O 122.079 0.942 . . . . 0.0 110.467 -179.652 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.43 ' HD3' ' CD2' ' A' ' 12' ' ' TRP . 57.8 ttp85 -63.46 131.3 47.72 Favored 'General case' 0 C--N 1.327 -0.41 0 O-C-N 121.851 -0.531 . . . . 0.0 110.212 -179.512 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 66.4 m-20 -106.65 120.18 49.19 Favored Pre-proline 0 C--N 1.327 -0.404 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 179.289 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -70.71 -13.92 32.67 Favored 'Trans proline' 0 C--N 1.347 0.489 0 N-CA-C 113.808 0.657 . . . . 0.0 113.808 -176.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -72.61 -26.04 61.54 Favored 'General case' 0 C--O 1.22 -0.46 0 CA-C-O 120.717 0.294 . . . . 0.0 110.825 177.09 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 -104.05 -24.82 13.17 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 114.273 1.212 . . . . 0.0 114.273 -174.196 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.404 ' OD1' ' HD2' ' A' ' 109' ' ' ARG . 0.1 OUTLIER -143.26 154.98 44.37 Favored 'General case' 0 N--CA 1.434 -1.238 0 CA-C-O 121.284 0.564 . . . . 0.0 110.308 -176.211 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -94.99 144.1 25.95 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.462 178.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -70.3 148.23 48.74 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.197 0.522 . . . . 0.0 110.958 179.501 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 15.0 mt -84.45 136.98 21.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 -178.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -62.67 125.92 20.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 106.776 -1.564 . . . . 0.0 106.776 175.628 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 4.2 tt -66.08 128.39 35.89 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.163 0.506 . . . . 0.0 111.005 -177.398 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -132.03 156.86 45.52 Favored 'General case' 0 CA--C 1.509 -0.612 0 N-CA-C 106.946 -1.502 . . . . 0.0 106.946 -179.58 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.4 HD13 HG22 ' A' ' 125' ' ' THR . 14.3 mt -115.3 147.49 38.71 Favored Pre-proline 0 C--N 1.32 -0.679 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 179.688 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -73.29 169.38 22.42 Favored 'Trans proline' 0 C--N 1.346 0.421 0 O-C-N 122.361 0.664 . . . . 0.0 113.754 -178.579 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 39.7 tt0 -53.6 131.85 39.49 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.426 -0.806 . . . . 0.0 109.899 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 94.26 -18.05 57.67 Favored Glycine 0 C--O 1.228 -0.248 0 CA-C-N 115.904 -0.589 . . . . 0.0 113.395 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.4 HG22 HD13 ' A' ' 121' ' ' LEU . 3.3 m -104.66 126.77 52.06 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 118.108 0.954 . . . . 0.0 111.261 178.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 5.5 p -119.87 148.27 43.68 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.964 -179.348 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 88.7 mt -69.86 152.8 95.9 Favored Pre-proline 0 C--N 1.324 -0.535 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 178.204 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -76.58 175.37 11.45 Favored 'Trans proline' 0 N--CA 1.462 -0.375 0 C-N-CA 118.524 -0.517 . . . . 0.0 111.077 178.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 62.6 tttm -56.9 126.62 27.89 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 113.431 0.9 . . . . 0.0 113.431 -174.552 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 89.56 -6.42 83.17 Favored Glycine 0 CA--C 1.517 0.197 0 N-CA-C 116.106 1.202 . . . . 0.0 116.106 175.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.429 ' CZ ' ' HB2' ' A' ' 18' ' ' GLN . 2.7 m-85 -91.68 145.68 24.39 Favored 'General case' 0 N--CA 1.434 -1.26 0 CA-C-O 122.653 1.216 . . . . 0.0 111.681 -178.685 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 50.2 p90 -145.34 162.5 37.08 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 112.902 -1.953 . . . . 0.0 107.896 175.162 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -105.48 136.53 44.87 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.162 0.506 . . . . 0.0 111.913 -176.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -67.56 133.73 49.97 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.356 -0.838 . . . . 0.0 108.92 177.584 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 91.88 -27.51 9.92 Favored Glycine 0 CA--C 1.522 0.513 0 N-CA-C 113.663 0.225 . . . . 0.0 113.663 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 4.9 t -71.41 177.84 3.75 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.306 0.574 . . . . 0.0 111.248 178.139 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 42.7 ttt180 65.0 0.46 1.23 Allowed 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 124.985 1.314 . . . . 0.0 114.42 -179.268 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -68.27 161.03 50.62 Favored Glycine 0 CA--C 1.52 0.351 0 N-CA-C 109.776 -1.329 . . . . 0.0 109.776 174.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -127.55 35.04 2.88 Favored Glycine 0 N--CA 1.457 0.093 0 N-CA-C 112.077 -0.409 . . . . 0.0 112.077 -178.384 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 50.1 m . . . . . 0 C--O 1.252 1.199 0 CA-C-O 115.619 -2.134 . . . . 0.0 105.869 -179.396 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.91 0 CA-C-O 118.311 -1.272 . . . . 0.0 111.167 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -69.73 151.65 45.57 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 118.678 1.239 . . . . 0.0 107.867 177.586 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 26.6 mmt -80.62 52.38 1.66 Allowed 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -178.383 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 61.14 28.76 69.55 Favored Glycine 0 C--O 1.224 -0.522 0 CA-C-O 121.492 0.496 . . . . 0.0 113.78 179.448 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 80.2 mt -65.96 141.52 97.6 Favored Pre-proline 0 C--N 1.323 -0.556 0 CA-C-N 115.683 -0.258 . . . . 0.0 110.922 -176.758 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -74.03 89.79 1.01 Allowed 'Trans proline' 0 C--N 1.352 0.723 0 CA-C-O 122.224 0.843 . . . . 0.0 112.903 179.193 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 14.0 p-10 -81.91 28.61 0.42 Allowed 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 115.222 1.564 . . . . 0.0 115.222 -175.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -70.38 -31.86 69.28 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 178.462 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 26.8 p -17.75 97.41 0.01 OUTLIER 'General case' 0 C--O 1.24 0.571 0 C-N-CA 127.092 2.157 . . . . 0.0 115.569 178.351 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -128.6 140.26 51.86 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 114.527 -1.215 . . . . 0.0 113.318 -175.608 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 16.2 t -66.2 141.86 57.91 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.78 178.431 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 27.3 m95 -68.35 -23.21 64.66 Favored 'General case' 0 CA--C 1.509 -0.634 0 O-C-N 123.372 0.42 . . . . 0.0 111.457 177.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 36.7 m-85 -121.38 158.26 28.69 Favored 'General case' 0 CA--C 1.506 -0.714 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.83 -173.396 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.419 ' HB ' ' HB3' ' A' ' 134' ' ' GLU . 69.8 p -65.67 160.43 22.74 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.235 -0.893 . . . . 0.0 109.838 -179.65 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.434 ' HB2' ' CE1' ' A' ' 69' ' ' TYR . . . -80.25 139.34 36.73 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.147 -0.933 . . . . 0.0 112.166 -174.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.464 HD11 HD22 ' A' ' 119' ' ' LEU . 3.8 mp -83.15 148.9 27.19 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 172.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 64.7 m -124.49 138.76 54.32 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 179.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.415 ' HB2' ' CZ ' ' A' ' 131' ' ' PHE . 4.3 tp60 -111.85 136.44 51.14 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 -178.023 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 56.0 t60 -131.22 94.97 3.68 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 104.318 -2.475 . . . . 0.0 104.318 169.152 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 178.61 -166.32 36.06 Favored Glycine 0 C--O 1.224 -0.475 0 N-CA-C 110.802 -0.919 . . . . 0.0 110.802 -176.3 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 91.9 mttt -101.11 -21.79 14.88 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 114.442 1.275 . . . . 0.0 114.442 -177.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -94.03 161.53 14.25 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 179.6 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -77.76 -62.92 1.51 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.517 -179.012 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 45.0 tp 179.44 140.7 0.12 Allowed 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 105.387 -2.079 . . . . 0.0 105.387 175.619 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 23.7 tptm -155.67 134.84 12.21 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 118.051 0.387 . . . . 0.0 110.49 174.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 20.1 m-85 -121.24 151.69 56.19 Favored Pre-proline 0 C--O 1.242 0.66 0 N-CA-C 107.178 -1.416 . . . . 0.0 107.178 174.062 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -73.97 160.63 42.74 Favored 'Trans proline' 0 CA--C 1.535 0.541 0 O-C-N 122.058 0.504 . . . . 0.0 111.946 177.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 3.8 tmt_? -64.3 132.02 48.99 Favored 'General case' 0 N--CA 1.47 0.539 0 O-C-N 122.169 -0.332 . . . . 0.0 110.35 -178.102 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 83.23 15.38 72.04 Favored Glycine 0 C--O 1.223 -0.557 0 C-N-CA 121.249 -0.501 . . . . 0.0 112.375 177.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.577 HE21 HG23 ' A' ' 125' ' ' THR . 0.8 OUTLIER -150.92 170.54 19.07 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 -176.668 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 100.32 -10.83 59.89 Favored Glycine 0 CA--C 1.508 -0.384 0 N-CA-C 115.183 0.833 . . . . 0.0 115.183 174.643 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 90.3 t -68.91 130.07 91.85 Favored Pre-proline 0 C--N 1.321 -0.669 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 177.342 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -73.18 171.75 16.98 Favored 'Trans proline' 0 C--O 1.221 -0.357 0 O-C-N 122.183 0.57 . . . . 0.0 112.351 178.343 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 92.6 mt -71.57 106.44 2.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 179.304 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 -96.17 86.55 4.28 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 114.33 -1.305 . . . . 0.0 109.755 -176.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 77.5 p -67.65 -14.89 63.33 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.543 -0.753 . . . . 0.0 112.816 -178.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -108.35 21.04 17.88 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.158 -0.928 . . . . 0.0 112.022 -177.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.475 ' HB3' ' HB2' ' A' ' 42' ' ' ASP . 2.0 m -143.17 149.84 38.58 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 114.333 1.234 . . . . 0.0 114.333 -175.824 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.2 m -76.8 168.41 28.32 Favored Pre-proline 0 N--CA 1.471 0.595 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 177.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -64.39 -27.44 62.94 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 114.731 -3.046 . . . . 0.0 112.095 178.634 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -62.84 -23.97 67.55 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 124.104 0.962 . . . . 0.0 112.322 176.242 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.475 ' HB2' ' HB3' ' A' ' 38' ' ' SER . 68.7 m-20 -99.28 -1.98 37.66 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 114.106 1.151 . . . . 0.0 114.106 -171.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 91.8 mm-40 -61.89 -26.01 67.9 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 114.002 1.112 . . . . 0.0 114.002 -177.433 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 8.5 tt -59.04 137.26 21.72 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.83 0 CA-C-O 122.242 1.02 . . . . 0.0 112.977 -179.281 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -179.33 -159.18 22.97 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.437 -0.887 . . . . 0.0 112.505 -178.637 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.414 ' CE2' HD12 ' A' ' 90' ' ' ILE . 42.7 p90 -155.02 168.12 28.08 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 179.468 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 31.9 m-85 -109.37 140.77 42.66 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 175.314 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 66.0 ttt-85 -116.85 120.77 39.54 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.892 -175.054 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 50.1 ttp180 -70.73 143.7 51.19 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 110.244 -0.28 . . . . 0.0 110.244 177.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -144.32 141.26 29.65 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 122.734 0.414 . . . . 0.0 110.327 178.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 25.4 p -144.49 151.5 39.25 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 178.192 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 13.3 tpt180 -149.14 130.52 14.72 Favored 'General case' 0 N--CA 1.469 0.517 0 O-C-N 122.176 -0.328 . . . . 0.0 111.3 176.674 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 4.2 tmm_? -144.07 138.83 28.57 Favored 'General case' 0 CA--C 1.5 -0.96 0 CA-C-O 121.157 0.503 . . . . 0.0 109.793 179.654 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -131.81 179.2 4.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 -179.658 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 5.0 ttt85 -115.36 99.16 7.18 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 174.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -77.91 157.69 45.58 Favored Glycine 0 C--O 1.223 -0.551 0 N-CA-C 107.359 -2.296 . . . . 0.0 107.359 176.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -66.04 -41.9 94.91 Favored Glycine 0 C--O 1.217 -0.953 0 CA-C-N 118.427 1.114 . . . . 0.0 111.899 179.641 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -85.35 -11.05 55.5 Favored 'General case' 0 C--O 1.215 -0.719 0 CA-C-O 122.137 0.97 . . . . 0.0 110.328 178.551 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 103.57 9.7 37.48 Favored Glycine 0 C--O 1.226 -0.398 0 CA-C-N 115.288 -0.869 . . . . 0.0 112.781 177.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 59.5 mmtt -61.12 132.36 53.48 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.274 0.559 . . . . 0.0 110.59 -179.391 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 95.8 mmm -86.19 167.62 14.72 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 114.781 -1.099 . . . . 0.0 111.185 179.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 16.2 tppt? -108.61 -39.42 5.39 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 176.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 15.2 t0 -141.77 164.98 28.72 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 105.253 -2.129 . . . . 0.0 105.253 178.531 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -121.2 -94.27 0.5 Allowed 'General case' 0 C--N 1.325 -0.469 0 O-C-N 123.502 0.501 . . . . 0.0 110.597 -176.334 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -72.45 159.4 85.48 Favored Pre-proline 0 C--N 1.326 -0.43 0 C-N-CA 122.717 0.407 . . . . 0.0 109.976 179.667 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -68.79 140.86 47.62 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 115.116 -2.789 . . . . 0.0 111.377 177.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 53.5 mtt180 -104.2 155.65 18.54 Favored 'General case' 0 CA--C 1.504 -0.798 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.067 179.479 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 66.0 m95 -127.53 125.85 41.13 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 174.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.434 ' CE1' ' HB2' ' A' ' 15' ' ' ALA . 69.6 m-85 -110.32 160.22 16.75 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 106.605 -1.628 . . . . 0.0 106.605 -178.615 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -103.55 132.8 49.49 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 179.378 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -131.65 145.69 51.8 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 -176.081 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 58.8 m-85 -87.26 161.59 17.9 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 120.755 0.312 . . . . 0.0 110.289 -176.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -53.42 132.46 39.69 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 120.747 0.308 . . . . 0.0 111.379 -178.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 70.37 27.98 71.95 Favored Glycine 0 C--O 1.224 -0.508 0 N-CA-C 116.264 1.266 . . . . 0.0 116.264 176.529 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 69.9 p -110.27 154.96 22.7 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 118.278 1.039 . . . . 0.0 111.286 178.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 111.48 146.21 10.34 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.387 -1.085 . . . . 0.0 110.387 -178.201 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -70.41 -40.4 4.34 Favored 'Trans proline' 0 C--N 1.348 0.545 0 CA-C-N 119.588 1.694 . . . . 0.0 116.4 -173.448 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -117.92 23.74 11.47 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.972 0.892 . . . . 0.0 109.649 -178.003 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -66.75 -55.64 14.09 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.855 -0.612 . . . . 0.0 111.554 -176.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 55.77 35.28 62.49 Favored Glycine 0 C--O 1.223 -0.552 0 N-CA-C 111.398 -0.681 . . . . 0.0 111.398 -177.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 27.4 mt -106.39 104.73 51.69 Favored Pre-proline 0 C--O 1.238 0.482 0 N-CA-C 117.348 2.351 . . . . 0.0 117.348 -172.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -77.88 164.36 27.69 Favored 'Trans proline' 0 C--O 1.234 0.303 0 C-N-CA 121.787 1.658 . . . . 0.0 108.011 167.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 53.5 t80 -62.43 133.1 54.55 Favored 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 120.493 -0.483 . . . . 0.0 111.191 -176.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 89.52 -7.6 81.59 Favored Glycine 0 CA--C 1.517 0.202 0 CA-C-O 119.6 -0.556 . . . . 0.0 114.373 178.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -63.5 131.61 48.68 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 118.134 0.967 . . . . 0.0 111.084 179.62 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -78.25 130.13 35.9 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.242 -179.277 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 24.8 ttmt -156.2 150.97 26.04 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 105.37 -2.085 . . . . 0.0 105.37 176.501 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 42.4 t0 -70.88 135.85 48.28 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.827 -0.435 . . . . 0.0 109.827 -177.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 71.95 24.5 76.48 Favored Glycine 0 N--CA 1.453 -0.222 0 C-N-CA 121.158 -0.544 . . . . 0.0 113.937 -179.373 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.414 HD12 ' CE2' ' A' ' 46' ' ' TYR . 41.6 mm -129.36 129.61 67.27 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 CA-C-N 117.198 0.499 . . . . 0.0 110.593 -179.712 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.1 pt -132.91 125.22 51.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 CA-C-O 121.17 0.51 . . . . 0.0 110.591 176.472 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 95.9 m95 -88.63 138.96 30.95 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 113.62 0.97 . . . . 0.0 113.62 -176.023 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 16.6 m -137.78 152.21 26.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 108.982 -0.748 . . . . 0.0 108.982 178.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -160.62 166.6 28.63 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 103.368 -2.827 . . . . 0.0 103.368 -179.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 12.4 t -138.63 177.24 8.03 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 106.059 -1.83 . . . . 0.0 106.059 178.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -67.5 135.71 53.47 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.983 0.421 . . . . 0.0 109.972 -179.415 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 96.16 -8.52 67.36 Favored Glycine 0 C--O 1.224 -0.514 0 CA-C-N 115.952 -0.567 . . . . 0.0 113.506 178.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -80.92 138.76 36.13 Favored 'General case' 0 CA--C 1.538 0.491 0 O-C-N 122.37 -0.488 . . . . 0.0 111.678 -179.534 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 91.9 mt -88.05 154.93 20.09 Favored 'General case' 0 C--O 1.214 -0.808 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 178.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 57.8 t30 -96.99 64.88 2.02 Favored 'General case' 0 C--N 1.323 -0.572 0 O-C-N 122.14 -0.35 . . . . 0.0 110.516 178.237 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -138.24 154.51 73.95 Favored Pre-proline 0 CA--C 1.538 0.518 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 -179.119 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -68.02 154.17 73.32 Favored 'Trans proline' 0 C--N 1.349 0.602 0 N-CA-C 114.332 0.859 . . . . 0.0 114.332 -179.222 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.441 ' HE3' ' HA ' ' A' ' 42' ' ' ASP . 70.9 mmtt -128.67 54.35 1.78 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.552 0.691 . . . . 0.0 109.627 -178.364 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 12.7 p-10 -60.48 -37.23 80.36 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.573 -177.017 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 10.6 p80 -65.56 -15.18 62.46 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 113.205 0.817 . . . . 0.0 113.205 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.411 HD12 ' HB3' ' A' ' 103' ' ' LYS . 25.1 mt -91.21 -38.19 10.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 178.276 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -75.74 2.75 53.18 Favored Glycine 0 CA--C 1.521 0.438 0 N-CA-C 116.013 1.165 . . . . 0.0 116.013 -177.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 6.2 t -91.17 22.45 3.78 Favored 'General case' 0 CA--C 1.548 0.876 0 CA-C-O 121.98 0.895 . . . . 0.0 111.728 -178.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.437 ' HD2' ' OD1' ' A' ' 114' ' ' ASN . 61.1 ttp85 -59.11 131.41 50.96 Favored 'General case' 0 N--CA 1.468 0.464 0 O-C-N 121.507 -0.745 . . . . 0.0 110.918 -179.625 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 71.1 m-20 -104.38 121.41 47.42 Favored Pre-proline 0 C--N 1.327 -0.394 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_endo -70.09 -14.72 35.37 Favored 'Trans proline' 0 C--N 1.348 0.516 0 N-CA-C 113.994 0.729 . . . . 0.0 113.994 -178.101 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -73.79 -25.61 60.21 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 120.665 0.269 . . . . 0.0 110.899 177.06 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 -101.89 -25.41 13.8 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 113.325 0.861 . . . . 0.0 113.325 -175.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.437 ' OD1' ' HD2' ' A' ' 109' ' ' ARG . 0.4 OUTLIER -141.8 151.92 43.26 Favored 'General case' 0 N--CA 1.439 -1.013 0 CA-C-O 121.196 0.522 . . . . 0.0 111.451 -176.782 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -97.24 140.47 31.67 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 115.382 -0.826 . . . . 0.0 109.594 177.395 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -68.88 151.99 45.87 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.275 0.56 . . . . 0.0 111.459 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 5.3 mt -95.4 139.43 18.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.066 -178.018 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 71.8 t -62.07 125.9 19.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 N-CA-C 106.391 -1.707 . . . . 0.0 106.391 175.389 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.464 HD22 HD11 ' A' ' 16' ' ' LEU . 7.6 tt -66.85 128.14 35.17 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.225 0.536 . . . . 0.0 109.58 -177.392 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 29.5 mt-30 -129.45 158.26 39.68 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 105.417 -2.068 . . . . 0.0 105.417 179.391 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 21.3 mt -115.02 148.28 40.2 Favored Pre-proline 0 C--N 1.321 -0.662 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 179.588 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -72.65 170.33 19.76 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 120.49 0.793 . . . . 0.0 113.636 -177.673 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 4.1 tp-100 -53.84 129.08 32.43 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.391 -179.371 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 89.66 -10.97 71.7 Favored Glycine 0 CA--C 1.519 0.34 0 CA-C-N 115.999 -0.546 . . . . 0.0 114.385 179.399 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.577 HG23 HE21 ' A' ' 30' ' ' GLN . 25.7 m -108.67 127.05 53.64 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 117.955 0.877 . . . . 0.0 110.002 179.052 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 12.7 p -125.07 152.52 44.23 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 123.054 0.541 . . . . 0.0 110.83 -178.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 83.7 mt -69.62 153.27 95.82 Favored Pre-proline 0 C--N 1.328 -0.362 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 179.398 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -77.96 176.48 9.94 Favored 'Trans proline' 0 C--N 1.345 0.377 0 O-C-N 121.946 0.445 . . . . 0.0 111.283 178.401 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -59.48 125.59 24.24 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 113.85 1.056 . . . . 0.0 113.85 -174.572 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 91.51 -4.0 79.39 Favored Glycine 0 C--N 1.33 0.2 0 N-CA-C 115.748 1.059 . . . . 0.0 115.748 175.683 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.415 ' CZ ' ' HB2' ' A' ' 18' ' ' GLN . 2.4 m-85 -96.58 142.51 28.55 Favored 'General case' 0 N--CA 1.44 -0.964 0 CA-C-O 122.09 0.947 . . . . 0.0 113.055 -177.696 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 52.8 p90 -146.04 161.62 39.72 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 113.66 -1.609 . . . . 0.0 107.568 173.201 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -104.83 151.31 23.96 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 -178.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.419 ' HB3' ' HB ' ' A' ' 14' ' ' THR . 4.9 tp10 -70.92 134.94 47.65 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 178.488 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 84.56 -4.45 84.34 Favored Glycine 0 CA--C 1.521 0.438 0 C-N-CA 121.537 -0.364 . . . . 0.0 113.72 -177.675 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 18.2 t -85.89 173.06 10.25 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.636 0.731 . . . . 0.0 109.292 178.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 56.2 mmm-85 -130.63 173.08 11.24 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 105.534 -2.025 . . . . 0.0 105.534 177.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -164.43 -172.92 32.49 Favored Glycine 0 C--N 1.316 -0.557 0 N-CA-C 105.839 -2.904 . . . . 0.0 105.839 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -145.59 -173.54 16.95 Favored Glycine 0 N--CA 1.452 -0.244 0 N-CA-C 107.972 -2.051 . . . . 0.0 107.972 179.508 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 25.7 m . . . . . 0 C--O 1.249 1.032 0 CA-C-O 117.317 -1.325 . . . . 0.0 109.868 178.938 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.758 0 CA-C-O 118.499 -1.167 . . . . 0.0 111.44 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 54.22 28.74 9.52 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 115.353 1.612 . . . . 0.0 115.353 177.692 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 3.3 tmm? -156.8 130.29 8.1 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 178.485 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -174.18 -79.02 0.05 OUTLIER Glycine 0 C--O 1.229 -0.18 0 C-N-CA 120.797 -0.715 . . . . 0.0 113.344 179.153 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 91.1 mt -118.58 153.95 52.29 Favored Pre-proline 0 C--N 1.327 -0.41 0 N-CA-C 110.094 -0.336 . . . . 0.0 110.094 -177.32 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -78.84 173.11 14.02 Favored 'Trans proline' 0 C--N 1.349 0.562 0 O-C-N 122.061 0.506 . . . . 0.0 111.345 176.251 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 79.3 m-20 -115.72 -142.38 0.38 Allowed 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 105.659 -1.978 . . . . 0.0 105.659 178.101 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 66.6 t30 -103.91 50.49 0.8 Allowed 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.295 0.569 . . . . 0.0 111.33 -176.494 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 22.3 p -139.4 149.49 44.16 Favored 'General case' 0 N--CA 1.439 -1.023 0 N-CA-C 100.285 -3.969 . . . . 0.0 100.285 -179.698 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -146.8 147.53 30.98 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-O 121.545 0.688 . . . . 0.0 112.101 -177.11 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -59.17 142.48 51.54 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.184 -0.916 . . . . 0.0 110.305 177.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 21.4 m95 -67.19 -21.92 65.76 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 114.066 1.135 . . . . 0.0 114.066 -179.191 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 39.2 m-85 -121.48 162.21 20.91 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 114.336 1.236 . . . . 0.0 114.336 -170.714 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 53.8 p -68.87 164.58 21.72 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.377 -1.283 . . . . 0.0 110.811 -179.64 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.462 ' HB2' ' CZ ' ' A' ' 69' ' ' TYR . . . -85.59 131.56 34.33 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.261 -0.881 . . . . 0.0 112.388 -176.731 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -81.61 148.85 28.87 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 105.466 -2.05 . . . . 0.0 105.466 173.793 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 57.1 m -118.21 139.66 50.95 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 179.441 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 4.1 tp60 -110.03 136.91 48.55 Favored 'General case' 0 C--N 1.328 -0.345 0 O-C-N 123.426 0.454 . . . . 0.0 111.338 -179.079 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 42.8 t60 -128.09 99.38 5.45 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 105.402 -2.073 . . . . 0.0 105.402 171.674 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 169.7 -167.57 40.62 Favored Glycine 0 C--O 1.225 -0.432 0 N-CA-C 109.289 -1.524 . . . . 0.0 109.289 -176.781 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 64.8 mttp -103.77 -23.32 13.42 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 179.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -82.51 158.85 23.01 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 -179.504 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -76.75 -62.86 1.5 Allowed 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 -179.369 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 32.7 tp 172.62 144.8 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 104.228 -2.508 . . . . 0.0 104.228 179.347 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 22.2 tptm -155.59 141.08 17.8 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 174.284 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -126.08 157.91 67.99 Favored Pre-proline 0 C--O 1.241 0.634 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 177.043 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -70.77 176.15 7.93 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 121.307 1.338 . . . . 0.0 114.678 -178.449 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 77.5 ttt180 -74.86 126.41 30.88 Favored 'General case' 0 C--O 1.217 -0.633 0 O-C-N 121.803 -0.56 . . . . 0.0 110.443 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 76.79 13.08 83.94 Favored Glycine 0 C--O 1.223 -0.54 0 N-CA-C 115.483 0.953 . . . . 0.0 115.483 175.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.542 HE21 HG23 ' A' ' 125' ' ' THR . 34.1 tt0 -157.01 142.5 17.47 Favored 'General case' 0 C--O 1.22 -0.458 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 -177.722 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 141.29 -18.06 2.69 Favored Glycine 0 CA--C 1.506 -0.503 0 C-N-CA 120.308 -0.949 . . . . 0.0 113.391 179.108 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 31.6 m -69.49 145.45 95.38 Favored Pre-proline 0 C--N 1.323 -0.566 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 176.381 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -75.9 172.45 16.25 Favored 'Trans proline' 0 CA--C 1.511 -0.64 0 C-N-CA 121.211 1.274 . . . . 0.0 112.582 -179.739 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 97.9 mt -71.8 109.97 4.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 176.842 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 69.6 m-80 -101.1 85.59 2.86 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 114.681 -1.145 . . . . 0.0 108.986 -177.812 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 73.7 p -66.16 -15.85 63.48 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 113.021 0.749 . . . . 0.0 113.021 -177.589 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 10.4 p30 -105.65 21.89 16.46 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.253 -0.885 . . . . 0.0 111.315 -178.276 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 14.2 m -141.44 150.95 42.98 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 113.306 0.854 . . . . 0.0 113.306 -176.624 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -73.72 166.57 43.01 Favored Pre-proline 0 C--N 1.326 -0.441 0 N-CA-C 108.396 -0.965 . . . . 0.0 108.396 176.761 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -64.22 -27.92 64.38 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 115.12 -2.787 . . . . 0.0 111.715 178.737 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -61.25 -28.68 69.34 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 123.778 0.831 . . . . 0.0 111.31 176.051 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 75.3 m-20 -98.51 -0.37 43.47 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 115.242 1.571 . . . . 0.0 115.242 -171.35 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 92.7 mm-40 -61.39 -25.63 67.31 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 113.554 0.946 . . . . 0.0 113.554 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 12.3 tt -58.78 141.08 16.22 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 N-CA-C 113.917 1.081 . . . . 0.0 113.917 -178.81 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 179.54 -152.59 11.15 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.422 -0.894 . . . . 0.0 112.294 179.388 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 48.7 p90 -155.07 165.67 35.99 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 108.312 -0.995 . . . . 0.0 108.312 178.475 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 24.9 m-85 -105.98 142.07 36.31 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 107.413 -1.328 . . . . 0.0 107.413 174.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 69.3 ttt-85 -116.77 123.56 47.44 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 123.597 0.759 . . . . 0.0 112.048 -176.155 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 50.4 ttp180 -71.53 144.46 49.58 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.024 177.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -144.82 143.3 30.56 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 175.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 35.3 p -138.67 171.35 14.48 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 103.379 -2.823 . . . . 0.0 103.379 175.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 23.5 tpt180 -135.7 122.61 21.25 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.253 -0.579 . . . . 0.0 109.941 174.628 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.76 144.44 25.12 Favored 'General case' 0 CA--C 1.498 -1.024 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 179.684 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -144.22 178.5 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 N-CA-C 104.123 -2.547 . . . . 0.0 104.123 -178.101 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.77 112.0 15.54 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 105.878 -1.897 . . . . 0.0 105.878 174.175 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -74.17 167.36 54.62 Favored Glycine 0 C--O 1.224 -0.483 0 N-CA-C 108.097 -2.001 . . . . 0.0 108.097 177.661 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -62.56 -48.23 83.36 Favored Glycine 0 C--O 1.224 -0.501 0 N-CA-C 109.677 -1.369 . . . . 0.0 109.677 -177.572 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -85.32 17.2 3.2 Favored 'General case' 0 C--O 1.217 -0.61 0 CA-C-O 122.432 1.11 . . . . 0.0 110.758 178.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 87.81 -19.43 33.59 Favored Glycine 0 C--O 1.228 -0.225 0 N-CA-C 115.699 1.039 . . . . 0.0 115.699 174.031 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -56.74 131.1 48.21 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.799 0.809 . . . . 0.0 110.548 -178.333 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 22.4 ptm -127.34 -163.21 1.23 Allowed 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 114.391 -1.277 . . . . 0.0 113.865 -171.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 10.8 mptt -126.14 -57.82 1.39 Allowed 'General case' 0 C--O 1.211 -0.942 0 C-N-CA 123.502 0.721 . . . . 0.0 111.624 -175.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 50.47 51.12 17.48 Favored 'General case' 0 N--CA 1.477 0.918 0 O-C-N 124.695 1.247 . . . . 0.0 113.587 178.325 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -66.37 138.69 57.77 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.632 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -57.42 157.71 12.5 Favored Pre-proline 0 C--O 1.242 0.677 0 CA-C-N 114.803 -1.089 . . . . 0.0 112.71 -179.355 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -68.11 135.85 35.92 Favored 'Trans proline' 0 C--O 1.24 0.592 0 C-N-CA 116.6 -1.8 . . . . 0.0 114.974 -177.665 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 30.0 mtp180 -119.76 158.13 27.16 Favored 'General case' 0 CA--C 1.507 -0.695 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 174.585 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 59.7 m95 -128.3 129.72 46.74 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.186 0.517 . . . . 0.0 109.974 178.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.462 ' CZ ' ' HB2' ' A' ' 15' ' ' ALA . 70.4 m-85 -110.58 163.13 14.03 Favored 'General case' 0 C--O 1.213 -0.858 0 N-CA-C 105.505 -2.035 . . . . 0.0 105.505 179.251 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 89.6 t80 -109.88 136.71 48.74 Favored 'General case' 0 CA--C 1.511 -0.55 0 N-CA-C 107.305 -1.368 . . . . 0.0 107.305 177.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 9.8 m-85 -136.57 148.92 47.79 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 -176.477 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -82.46 159.42 22.92 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.484 -175.761 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -54.61 129.62 37.14 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.812 -178.262 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 66.85 39.73 93.5 Favored Glycine 0 C--O 1.222 -0.599 0 CA-C-O 119.187 -0.785 . . . . 0.0 114.863 176.196 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -89.01 146.11 25.07 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 118.187 0.993 . . . . 0.0 108.351 177.507 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 98.18 145.18 18.38 Favored Glycine 0 CA--C 1.527 0.834 0 N-CA-C 110.36 -1.096 . . . . 0.0 110.36 -176.528 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -69.27 -44.9 2.11 Favored 'Trans proline' 0 C--N 1.35 0.62 0 N-CA-C 116.804 1.809 . . . . 0.0 116.804 -173.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -114.74 33.21 5.5 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.527 0.679 . . . . 0.0 109.25 -177.434 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -62.78 -40.76 98.31 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.767 -178.017 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 58.83 28.86 63.81 Favored Glycine 0 C--O 1.226 -0.355 0 CA-C-N 115.886 -0.597 . . . . 0.0 113.47 179.286 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 26.6 mt -109.09 103.89 53.51 Favored Pre-proline 0 C--O 1.238 0.469 0 N-CA-C 114.7 1.37 . . . . 0.0 114.7 -176.606 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -78.2 167.86 22.63 Favored 'Trans proline' 0 N--CA 1.461 -0.389 0 C-N-CA 121.671 1.58 . . . . 0.0 108.972 170.812 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 61.0 t80 -63.06 133.54 54.67 Favored 'General case' 0 C--N 1.32 -0.701 0 O-C-N 121.986 -0.446 . . . . 0.0 110.135 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 89.23 -3.19 84.1 Favored Glycine 0 CA--C 1.519 0.296 0 N-CA-C 114.437 0.535 . . . . 0.0 114.437 178.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -63.56 128.79 37.4 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 117.843 0.821 . . . . 0.0 112.873 -179.397 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 44.8 t30 -68.26 118.74 11.76 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.882 -179.436 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 16.1 ttmm -152.92 145.96 24.59 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 176.364 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 33.0 t0 -67.37 132.97 48.72 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.277 -0.874 . . . . 0.0 109.919 -179.272 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 71.81 24.67 76.33 Favored Glycine 0 C--O 1.24 0.498 0 CA-C-O 119.505 -0.608 . . . . 0.0 114.612 179.789 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 36.9 mm -131.66 132.6 62.11 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 CA-C-N 117.286 0.543 . . . . 0.0 110.495 -179.506 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.1 pt -131.44 117.14 34.62 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 CA-C-O 121.551 0.691 . . . . 0.0 110.572 175.5 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 96.1 m95 -82.53 134.74 35.2 Favored 'General case' 0 C--N 1.321 -0.645 0 O-C-N 121.966 -0.458 . . . . 0.0 111.996 -177.552 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -142.9 150.53 17.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 121.522 0.677 . . . . 0.0 109.788 -178.275 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -155.0 166.57 33.16 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 105.333 -2.099 . . . . 0.0 105.333 -178.756 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 14.7 t -128.1 167.9 16.11 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 105.186 -2.153 . . . . 0.0 105.186 176.703 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -65.04 137.0 57.43 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 95.68 -8.0 68.33 Favored Glycine 0 C--O 1.225 -0.417 0 CA-C-N 115.919 -0.582 . . . . 0.0 113.204 179.247 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -82.35 142.8 31.72 Favored 'General case' 0 CA--C 1.541 0.597 0 O-C-N 122.26 -0.553 . . . . 0.0 111.473 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 34.9 mt -90.98 135.55 33.66 Favored 'General case' 0 CA--C 1.513 -0.471 0 CA-C-O 121.386 0.612 . . . . 0.0 112.456 -179.242 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 55.3 t30 -84.69 72.27 10.72 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.526 -178.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -146.39 153.25 47.73 Favored Pre-proline 0 C--N 1.324 -0.531 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 -179.583 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -68.65 150.37 74.52 Favored 'Trans proline' 0 C--N 1.344 0.291 0 N-CA-C 114.103 0.77 . . . . 0.0 114.103 178.227 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 3.3 ptpt -151.78 56.82 0.86 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.791 0.805 . . . . 0.0 112.906 -179.432 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -56.76 -28.16 60.75 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 115.557 -0.747 . . . . 0.0 112.146 177.521 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 12.2 p80 -59.76 -10.82 4.16 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 114.363 1.246 . . . . 0.0 114.363 -178.775 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 55.7 mt -93.19 -42.16 13.01 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.496 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 178.118 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -72.06 14.65 2.12 Favored Glycine 0 N--CA 1.464 0.534 0 N-CA-C 116.559 1.384 . . . . 0.0 116.559 -176.007 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 15.2 t -90.45 23.73 2.87 Favored 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 112.768 0.655 . . . . 0.0 112.768 -178.132 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 62.0 ttp85 -55.39 130.19 41.6 Favored 'General case' 0 N--CA 1.475 0.788 0 O-C-N 121.58 -0.7 . . . . 0.0 109.62 -179.514 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 36.3 m120 -95.47 122.92 58.1 Favored Pre-proline 0 C--N 1.322 -0.608 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 -179.404 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -68.44 -20.17 42.22 Favored 'Trans proline' 0 C--O 1.219 -0.443 0 C-N-CA 117.159 -1.427 . . . . 0.0 113.133 179.624 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -73.26 -29.26 62.63 Favored 'General case' 0 C--O 1.22 -0.498 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.427 178.228 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 -100.63 -25.81 14.03 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -175.414 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 26.7 t30 -151.61 144.44 24.42 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 113.448 0.907 . . . . 0.0 113.448 -178.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -83.84 146.92 27.84 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.113 179.549 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -66.34 139.99 58.07 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.209 0.528 . . . . 0.0 110.274 178.676 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 14.3 mt -82.38 138.74 18.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 -177.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -61.15 125.71 17.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 175.328 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 7.8 tt -67.08 128.78 37.66 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 -178.018 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 29.6 mt-30 -128.65 153.35 47.37 Favored 'General case' 0 CA--C 1.507 -0.7 0 N-CA-C 106.088 -1.819 . . . . 0.0 106.088 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 17.0 mt -113.31 149.51 41.6 Favored Pre-proline 0 C--N 1.321 -0.661 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 178.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -72.15 170.65 18.55 Favored 'Trans proline' 0 C--N 1.343 0.278 0 N-CA-C 113.888 0.688 . . . . 0.0 113.888 -177.562 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -54.45 130.86 41.03 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.219 -179.349 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 90.13 -12.21 68.49 Favored Glycine 0 C--O 1.227 -0.325 0 CA-C-N 115.931 -0.577 . . . . 0.0 113.363 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.542 HG23 HE21 ' A' ' 30' ' ' GLN . 8.8 m -108.56 125.63 52.04 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 117.659 0.73 . . . . 0.0 110.271 179.145 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 10.3 p -126.21 150.43 48.36 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.929 -177.738 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 83.0 mt -69.53 153.79 95.42 Favored Pre-proline 0 C--N 1.325 -0.488 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 176.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -76.03 169.55 21.89 Favored 'Trans proline' 0 N--CA 1.464 -0.251 0 C-N-CA 118.349 -0.634 . . . . 0.0 111.23 178.491 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 60.0 tttm -61.3 130.72 47.55 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 122.144 -0.348 . . . . 0.0 110.507 -177.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 95.29 -3.57 66.47 Favored Glycine 0 C--O 1.226 -0.354 0 CA-C-N 115.923 -0.58 . . . . 0.0 114.106 178.681 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -106.47 137.83 43.75 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 179.506 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 51.1 p90 -141.53 160.04 40.97 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 175.157 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -107.14 139.74 41.1 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.594 0.59 . . . . 0.0 112.594 -175.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -73.68 143.8 46.08 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 177.183 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 96.51 -37.58 3.39 Favored Glycine 0 C--O 1.224 -0.506 0 N-CA-C 111.208 -0.757 . . . . 0.0 111.208 -178.449 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 36.9 t -75.87 140.75 42.37 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 176.419 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? -146.64 163.29 36.34 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 103.218 -2.882 . . . . 0.0 103.218 178.476 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 87.2 27.96 26.64 Favored Glycine 0 C--O 1.224 -0.49 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.845 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -117.08 -177.43 17.75 Favored Glycine 0 C--N 1.323 -0.139 0 N-CA-C 107.736 -2.146 . . . . 0.0 107.736 177.71 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 24.0 m . . . . . 0 C--O 1.25 1.106 0 CA-C-O 116.367 -1.778 . . . . 0.0 108.053 -178.837 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.902 0 CA-C-O 118.641 -1.088 . . . . 0.0 111.145 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -70.7 148.64 47.79 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 105.69 -1.967 . . . . 0.0 105.69 175.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 70.6 mtm -126.91 34.32 4.79 Favored 'General case' 0 C--O 1.218 -0.583 0 N-CA-C 108.482 -0.932 . . . . 0.0 108.482 -178.281 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 147.53 131.26 2.11 Favored Glycine 0 N--CA 1.444 -0.831 0 N-CA-C 106.081 -2.807 . . . . 0.0 106.081 -176.393 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 9.1 mp -113.45 141.68 26.29 Favored Pre-proline 0 C--N 1.318 -0.763 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 178.774 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -73.56 154.62 50.06 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 117.529 -1.181 . . . . 0.0 110.709 177.257 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 57.3 t30 -123.08 -60.6 1.49 Allowed 'General case' 0 C--O 1.22 -0.456 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -179.027 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 15.9 p-10 -105.27 12.79 31.4 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 113.29 0.848 . . . . 0.0 113.29 -176.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 37.6 p -119.67 90.01 3.24 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 113.313 0.857 . . . . 0.0 113.313 -174.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -105.52 142.75 34.72 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 177.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -60.16 142.28 54.57 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.053 178.688 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 19.0 m95 -69.75 -23.98 63.46 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 113.816 1.043 . . . . 0.0 113.816 -179.089 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 52.7 m-85 -121.54 162.68 20.15 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 113.343 0.868 . . . . 0.0 113.343 -171.752 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 66.3 p -68.42 164.48 20.93 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.787 -1.097 . . . . 0.0 108.959 178.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.447 ' HB2' ' CZ ' ' A' ' 69' ' ' TYR . . . -75.87 145.57 40.44 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 113.242 0.83 . . . . 0.0 113.242 -176.84 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 15.7 mt -87.4 140.3 29.67 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 102.175 -3.269 . . . . 0.0 102.175 167.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 63.7 m -116.7 128.5 55.4 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 -179.501 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -82.72 138.79 33.96 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.909 179.512 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 9.5 t-160 -139.46 94.74 2.82 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 103.589 -2.745 . . . . 0.0 103.589 167.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 163.13 -143.04 8.31 Favored Glycine 0 C--O 1.226 -0.386 0 C-N-CA 120.432 -0.889 . . . . 0.0 112.267 -175.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -121.19 -27.35 4.91 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 116.179 1.918 . . . . 0.0 116.179 -176.596 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -78.75 158.05 28.35 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 179.467 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -72.35 -62.87 1.28 Allowed 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.416 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 53.3 tp 175.54 143.93 0.06 Allowed 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 104.216 -2.512 . . . . 0.0 104.216 173.407 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.9 tppp? -158.13 141.23 14.99 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 108.855 -0.795 . . . . 0.0 108.855 176.669 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -126.01 153.12 73.86 Favored Pre-proline 0 C--N 1.325 -0.49 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 175.745 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -68.77 162.23 42.17 Favored 'Trans proline' 0 C--N 1.352 0.717 0 O-C-N 122.151 0.553 . . . . 0.0 113.09 179.481 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 18.0 tpt180 -64.02 131.88 48.92 Favored 'General case' 0 C--O 1.216 -0.678 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.895 -177.279 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 76.18 17.37 80.04 Favored Glycine 0 C--O 1.224 -0.486 0 C-N-CA 121.319 -0.467 . . . . 0.0 112.911 178.234 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 8.8 mt-30 -150.35 170.49 18.91 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 -175.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 109.2 -14.87 33.4 Favored Glycine 0 CA--C 1.502 -0.735 0 C-N-CA 121.455 -0.402 . . . . 0.0 113.345 175.275 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 89.2 t -66.13 129.6 94.24 Favored Pre-proline 0 C--N 1.319 -0.741 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 177.338 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_endo -74.21 169.55 22.21 Favored 'Trans proline' 0 N--CA 1.46 -0.481 0 O-C-N 122.143 0.549 . . . . 0.0 111.492 178.11 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 89.1 mt -70.33 107.73 2.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-O 122.084 0.945 . . . . 0.0 108.69 -179.643 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 76.1 m-20 -98.85 85.22 3.24 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 114.34 -1.3 . . . . 0.0 108.837 -178.213 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 70.1 p -66.29 -15.85 63.56 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 113.761 1.023 . . . . 0.0 113.761 -176.674 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 20.0 p30 -110.01 23.72 13.98 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.297 -0.865 . . . . 0.0 112.204 -177.398 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.41 ' HB3' ' HB2' ' A' ' 42' ' ' ASP . 15.9 m -138.55 149.25 45.12 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 113.227 0.825 . . . . 0.0 113.227 -175.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -73.77 166.71 41.83 Favored Pre-proline 0 C--O 1.236 0.379 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 177.751 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -64.66 -27.35 60.79 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 114.936 -2.909 . . . . 0.0 111.661 178.443 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -61.87 -27.67 68.96 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 123.69 0.796 . . . . 0.0 111.7 176.776 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.41 ' HB2' ' HB3' ' A' ' 38' ' ' SER . 77.3 m-20 -94.87 -4.17 47.47 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 114.696 1.369 . . . . 0.0 114.696 -171.123 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 96.2 mm-40 -59.78 -28.94 67.85 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 114.465 1.283 . . . . 0.0 114.465 -177.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 11.4 tt -58.54 138.19 19.89 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.884 0 CA-C-O 122.308 1.051 . . . . 0.0 113.804 -177.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -178.82 -156.9 18.27 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.616 -0.802 . . . . 0.0 113.004 -178.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 46.6 p90 -155.14 170.54 21.59 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 179.389 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 20.0 m-85 -111.35 140.26 46.07 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 173.363 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -109.55 120.3 42.06 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 124.122 0.969 . . . . 0.0 109.933 -177.694 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 40.2 ttp180 -68.08 136.19 53.39 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 175.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -144.83 147.24 32.62 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 123.054 0.542 . . . . 0.0 110.817 -177.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.415 HG23 ' HA ' ' A' ' 66' ' ' PRO . 0.1 OUTLIER -153.39 129.03 10.04 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.082 176.254 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 15.0 tpp180 -90.04 123.73 34.17 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 105.048 -2.205 . . . . 0.0 105.048 174.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 4.3 tmt_? -145.51 130.85 18.6 Favored 'General case' 0 CA--C 1.489 -1.371 0 CA-C-O 122.351 1.072 . . . . 0.0 111.029 -178.067 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -140.04 -179.94 2.36 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 CA-C-N 112.685 -2.052 . . . . 0.0 106.661 -177.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 3.3 tmt_? -129.32 103.77 7.12 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 105.677 -1.971 . . . . 0.0 105.677 172.027 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -72.83 158.35 53.05 Favored Glycine 0 N--CA 1.452 -0.241 0 N-CA-C 107.708 -2.157 . . . . 0.0 107.708 177.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -60.7 -37.07 92.93 Favored Glycine 0 C--O 1.222 -0.649 0 CA-C-N 118.173 0.986 . . . . 0.0 111.998 -179.371 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 39.5 t0 -86.96 13.98 8.16 Favored 'General case' 0 CA--C 1.55 0.951 0 CA-C-O 122.731 1.253 . . . . 0.0 111.248 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 86.85 6.37 79.79 Favored Glycine 0 C--O 1.224 -0.47 0 CA-C-N 115.393 -0.821 . . . . 0.0 113.543 171.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 20.9 mmtt -74.62 151.15 39.38 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-O 121.812 0.815 . . . . 0.0 111.463 -174.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 83.2 mtp -118.17 -173.94 2.56 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 114.059 -1.428 . . . . 0.0 109.576 -179.145 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 16.0 mmtt -119.94 -75.96 0.58 Allowed 'General case' 0 C--O 1.22 -0.478 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 179.774 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 52.3 m-20 -95.18 149.72 20.99 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 104.628 -2.36 . . . . 0.0 104.628 176.71 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 84.5 mt -118.96 -57.24 2.04 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 106.327 -1.731 . . . . 0.0 106.327 177.072 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -78.96 141.28 58.65 Favored Pre-proline 0 C--O 1.245 0.824 0 CA-C-N 115.058 -0.973 . . . . 0.0 108.929 175.468 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.415 ' HA ' HG23 ' A' ' 51' ' ' THR . 97.5 Cg_endo -73.06 155.88 52.2 Favored 'Trans proline' 0 C--O 1.239 0.531 0 C-N-CA 116.808 -1.661 . . . . 0.0 112.273 178.691 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 29.6 mtt85 -123.94 159.93 28.67 Favored 'General case' 0 CA--C 1.507 -0.685 0 CA-C-N 115.958 -0.564 . . . . 0.0 109.779 -178.742 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 54.4 m95 -134.01 140.9 47.01 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 177.779 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.447 ' CZ ' ' HB2' ' A' ' 15' ' ' ALA . 61.6 m-85 -120.56 154.62 35.12 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 106.567 -1.642 . . . . 0.0 106.567 178.791 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 86.1 t80 -98.27 137.88 36.35 Favored 'General case' 0 CA--C 1.507 -0.696 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 -179.165 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -137.67 144.05 41.63 Favored 'General case' 0 N--CA 1.44 -0.925 0 N-CA-C 106.838 -1.542 . . . . 0.0 106.838 -176.599 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 55.5 m-85 -81.84 159.47 23.73 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.137 -176.37 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -53.86 132.16 41.19 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 112.473 0.546 . . . . 0.0 112.473 -177.499 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 65.56 29.88 76.18 Favored Glycine 0 C--O 1.224 -0.492 0 N-CA-C 115.83 1.092 . . . . 0.0 115.83 173.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 13.6 p -89.0 146.1 25.08 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 117.958 0.879 . . . . 0.0 108.881 177.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 105.92 145.99 13.65 Favored Glycine 0 CA--C 1.522 0.486 0 N-CA-C 108.038 -2.025 . . . . 0.0 108.038 -175.546 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -68.83 -44.25 2.95 Favored 'Trans proline' 0 C--N 1.346 0.426 0 CA-C-N 119.687 1.743 . . . . 0.0 116.132 -173.776 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -119.94 40.73 3.35 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 -177.234 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -62.84 -40.62 98.02 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.513 -177.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 57.99 29.22 61.92 Favored Glycine 0 C--O 1.228 -0.245 0 CA-C-N 116.168 -0.469 . . . . 0.0 113.645 179.424 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 17.5 mt -114.41 103.8 54.83 Favored Pre-proline 0 N--CA 1.446 -0.633 0 N-CA-C 114.31 1.226 . . . . 0.0 114.31 -176.604 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -78.57 165.2 25.3 Favored 'Trans proline' 0 C--O 1.237 0.445 0 C-N-CA 121.625 1.55 . . . . 0.0 108.147 169.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 68.0 t80 -61.85 131.43 49.76 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 120.343 -0.543 . . . . 0.0 110.216 -179.363 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 92.21 -6.64 78.58 Favored Glycine 0 CA--C 1.52 0.372 0 N-CA-C 115.101 0.8 . . . . 0.0 115.101 178.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -64.42 129.02 38.28 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 118.431 1.115 . . . . 0.0 112.36 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 58.0 t30 -75.09 127.95 34.39 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.287 -178.318 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 1.2 ttmp? -156.18 153.2 28.87 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 179.33 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -62.11 129.06 39.09 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.812 0.339 . . . . 0.0 111.766 -179.434 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 66.39 31.38 78.73 Favored Glycine 0 N--CA 1.451 -0.301 0 CA-C-O 119.457 -0.635 . . . . 0.0 114.238 178.041 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 43.8 mm -128.61 129.95 68.79 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 CA-C-N 117.419 0.61 . . . . 0.0 109.942 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.1 pt -132.86 120.33 40.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.204 176.025 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 96.0 m95 -85.98 136.81 33.11 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 -176.678 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 16.3 m -138.15 149.74 24.66 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 CA-C-O 121.525 0.679 . . . . 0.0 109.623 179.523 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -155.97 166.62 32.93 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 104.43 -2.433 . . . . 0.0 104.43 -179.359 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 12.6 t -137.93 175.14 9.85 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 105.936 -1.876 . . . . 0.0 105.936 179.311 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -64.96 135.48 55.71 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.162 0.506 . . . . 0.0 110.549 -179.409 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 94.39 -7.9 71.93 Favored Glycine 0 C--O 1.224 -0.526 0 CA-C-N 115.881 -0.599 . . . . 0.0 113.755 177.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -79.35 138.84 37.84 Favored 'General case' 0 CA--C 1.538 0.505 0 O-C-N 122.443 -0.445 . . . . 0.0 111.92 -179.449 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 34.7 mt -95.08 137.08 34.62 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-O 121.007 0.432 . . . . 0.0 111.993 -179.455 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 58.9 t30 -82.0 69.54 8.73 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.11 0.481 . . . . 0.0 110.764 -179.437 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -141.26 155.65 67.85 Favored Pre-proline 0 C--N 1.323 -0.562 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 -178.626 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -64.62 150.53 88.04 Favored 'Trans proline' 0 C--N 1.344 0.338 0 N-CA-C 115.262 1.216 . . . . 0.0 115.262 179.649 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.478 ' HB3' HD12 ' A' ' 106' ' ' ILE . 74.1 mmtt -124.8 37.75 4.34 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 114.609 -1.178 . . . . 0.0 109.054 -177.644 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 16.6 p-10 -48.89 -45.96 41.95 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 114.742 -1.117 . . . . 0.0 112.869 -179.647 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 48.8 p-80 -70.05 -9.5 55.56 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 124.38 1.072 . . . . 0.0 113.747 -177.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.478 HD12 ' HB3' ' A' ' 103' ' ' LYS . 48.8 mt -94.9 -48.04 13.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 179.055 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -74.99 14.66 4.53 Favored Glycine 0 C--O 1.224 -0.502 0 N-CA-C 116.397 1.319 . . . . 0.0 116.397 -177.122 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 13.6 t -92.95 24.56 3.62 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 117.41 0.605 . . . . 0.0 111.099 179.478 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.492 ' HD2' HD22 ' A' ' 114' ' ' ASN . 65.9 ttp85 -57.8 136.28 56.93 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 178.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -109.09 132.22 21.34 Favored Pre-proline 0 C--N 1.324 -0.51 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -72.6 -15.35 27.37 Favored 'Trans proline' 0 C--O 1.219 -0.447 0 C-N-CA 117.877 -0.949 . . . . 0.0 113.52 -178.177 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -75.62 -25.62 57.07 Favored 'General case' 0 C--O 1.22 -0.481 0 CA-C-O 120.942 0.401 . . . . 0.0 110.303 178.401 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 82.7 m-20 -102.6 -23.31 13.88 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 113.745 1.017 . . . . 0.0 113.745 -174.339 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.492 HD22 ' HD2' ' A' ' 109' ' ' ARG . 35.7 t30 -153.98 152.36 30.45 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.62 0.6 . . . . 0.0 112.62 -176.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -94.27 146.9 23.69 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-O 121.184 0.516 . . . . 0.0 110.749 178.402 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -71.38 148.47 46.95 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.005 0.431 . . . . 0.0 110.833 178.759 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 3.4 mt -92.41 142.33 13.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 -178.322 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -59.47 126.19 16.76 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 175.825 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 6.0 tt -68.55 128.88 38.2 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.956 -177.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 30.2 mt-30 -132.36 157.93 43.23 Favored 'General case' 0 CA--C 1.511 -0.544 0 N-CA-C 106.677 -1.601 . . . . 0.0 106.677 -179.122 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 13.7 mt -113.69 147.56 37.89 Favored Pre-proline 0 C--N 1.322 -0.62 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 177.6 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -73.32 167.0 28.44 Favored 'Trans proline' 0 C--N 1.346 0.397 0 O-C-N 122.223 0.591 . . . . 0.0 112.928 -179.342 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 43.6 tt0 -54.88 131.39 44.2 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.604 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 97.89 -19.45 54.54 Favored Glycine 0 C--O 1.227 -0.303 0 CA-C-N 116.004 -0.543 . . . . 0.0 113.256 -179.511 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 6.9 m -106.71 127.57 53.48 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 118.148 0.974 . . . . 0.0 110.576 178.713 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 17.2 p -120.24 148.36 43.79 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.541 -179.535 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 91.7 mt -67.24 154.87 91.96 Favored Pre-proline 0 C--N 1.324 -0.526 0 N-CA-C 107.953 -1.128 . . . . 0.0 107.953 178.082 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -75.16 170.47 20.3 Favored 'Trans proline' 0 N--CA 1.461 -0.385 0 C-N-CA 118.208 -0.728 . . . . 0.0 110.854 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 23.8 tptm -60.9 120.66 10.61 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 -178.094 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 91.13 41.53 5.21 Favored Glycine 0 C--O 1.227 -0.331 0 N-CA-C 115.297 0.879 . . . . 0.0 115.297 178.736 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -145.19 148.53 33.65 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 117.384 0.592 . . . . 0.0 110.403 177.557 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 54.8 p90 -147.73 165.05 31.68 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.212 -1.032 . . . . 0.0 108.212 176.106 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -105.99 139.81 39.95 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.01 0.433 . . . . 0.0 111.851 -176.703 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -74.09 143.56 45.34 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 178.236 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 95.59 -38.14 3.21 Favored Glycine 0 CA--C 1.518 0.25 0 C-N-CA 121.687 -0.292 . . . . 0.0 113.486 179.373 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 32.2 t -72.13 117.91 14.35 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 177.101 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 12.6 mmm-85 -93.68 -44.21 8.28 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 -179.349 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 76.64 -63.2 3.09 Favored Glycine 0 CA--C 1.521 0.462 0 N-CA-C 114.526 0.57 . . . . 0.0 114.526 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -130.57 -159.46 9.66 Favored Glycine 0 C--O 1.24 0.517 0 CA-C-N 116.944 0.372 . . . . 0.0 113.231 -177.751 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 34.8 t . . . . . 0 C--O 1.243 0.712 0 CA-C-O 118.202 -0.904 . . . . 0.0 109.71 179.486 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.498 -0.974 0 N-CA-C 110.993 -0.843 . . . . 0.0 110.993 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -61.19 140.76 57.86 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 114.186 1.18 . . . . 0.0 114.186 -176.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 27.3 ttt -143.19 138.41 29.7 Favored 'General case' 0 C--O 1.214 -0.791 1 N-CA-C 99.866 -4.124 . . . . 0.0 99.866 173.223 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 81.34 42.86 8.97 Favored Glycine 0 CA--C 1.519 0.304 0 N-CA-C 109.097 -1.601 . . . . 0.0 109.097 -174.051 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 9.1 mp -61.98 142.73 95.12 Favored Pre-proline 0 C--O 1.236 0.345 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 -179.796 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -69.2 133.77 27.44 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 116.047 -2.168 . . . . 0.0 113.579 -176.206 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.411 ' H ' HG23 ' A' ' 9' ' ' THR . 54.7 t-20 -137.88 65.98 1.46 Allowed 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 104.367 -2.457 . . . . 0.0 104.367 178.192 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 75.23 -51.62 0.66 Allowed 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 126.156 1.782 . . . . 0.0 109.755 -172.636 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.411 HG23 ' H ' ' A' ' 7' ' ' ASN . 15.4 p 28.31 81.13 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 115.568 1.692 . . . . 0.0 115.568 172.271 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -105.7 158.25 16.85 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 122.464 1.126 . . . . 0.0 113.72 -173.619 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 30.9 t -58.98 142.21 51.72 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 113.986 -1.461 . . . . 0.0 109.974 175.21 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 17.1 m95 -64.33 -21.94 66.78 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 114.104 1.15 . . . . 0.0 114.104 178.545 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -121.41 162.96 19.49 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 114.312 1.227 . . . . 0.0 114.312 -169.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 68.3 p -70.76 162.66 28.72 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 114.575 -1.193 . . . . 0.0 107.855 176.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.471 ' HB2' ' CZ ' ' A' ' 69' ' ' TYR . . . -75.72 141.98 42.54 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 113.243 0.831 . . . . 0.0 113.243 -175.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.419 HD23 ' HA ' ' A' ' 16' ' ' LEU . 12.4 mt -85.66 142.46 29.04 Favored 'General case' 0 C--O 1.213 -0.868 0 N-CA-C 102.678 -3.082 . . . . 0.0 102.678 169.257 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 40.9 m -123.84 135.77 53.96 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 118.638 0.654 . . . . 0.0 110.267 -177.603 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.438 ' HB2' ' CZ ' ' A' ' 131' ' ' PHE . 4.1 tp60 -100.7 139.25 36.65 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.493 -0.776 . . . . 0.0 112.005 -178.133 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 16.1 t-160 -126.58 99.6 5.87 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 103.775 -2.676 . . . . 0.0 103.775 168.674 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 157.17 -173.54 34.72 Favored Glycine 0 C--O 1.225 -0.417 0 N-CA-C 109.098 -1.601 . . . . 0.0 109.098 -176.629 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -97.68 -21.86 16.78 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 114.629 1.344 . . . . 0.0 114.629 -177.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -71.4 157.18 38.52 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.723 0.297 . . . . 0.0 110.351 -178.471 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -74.98 -63.0 1.36 Allowed 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.837 -0.345 . . . . 0.0 111.292 -178.092 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 36.0 tp 161.03 141.78 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.203 0 N-CA-C 102.299 -3.223 . . . . 0.0 102.299 179.094 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 13.8 tmtt? -156.71 131.07 8.63 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 176.625 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 -114.77 142.43 28.32 Favored Pre-proline 0 CA--C 1.54 0.592 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 176.491 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -62.88 154.12 68.52 Favored 'Trans proline' 0 CA--C 1.541 0.869 0 CA-C-O 121.325 0.469 . . . . 0.0 112.958 173.347 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 4.1 tmt_? -63.66 134.14 54.89 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.943 -177.701 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 87.96 6.85 75.09 Favored Glycine 0 C--O 1.226 -0.347 0 O-C-N 123.4 0.438 . . . . 0.0 112.381 178.381 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -145.72 167.78 22.31 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 -176.108 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 112.59 -19.38 21.73 Favored Glycine 0 CA--C 1.5 -0.846 0 C-N-CA 121.716 -0.278 . . . . 0.0 113.638 173.449 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.417 HG11 ' HB3' ' A' ' 43' ' ' GLN . 95.8 t -67.33 127.82 93.55 Favored Pre-proline 0 C--N 1.32 -0.712 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 178.473 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -74.93 164.03 34.25 Favored 'Trans proline' 0 N--CA 1.459 -0.504 0 O-C-N 122.124 0.539 . . . . 0.0 111.801 178.12 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 97.9 mt -66.84 123.44 19.9 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 -178.573 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 46.1 t-20 -125.61 113.83 17.91 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 177.239 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 67.0 p -90.68 -14.83 31.47 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 -175.509 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -111.51 28.99 8.23 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 113.408 0.892 . . . . 0.0 113.408 -175.65 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 99.3 p -141.58 164.88 29.02 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.713 0.292 . . . . 0.0 110.998 -179.412 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 4.2 m -77.13 164.95 55.73 Favored Pre-proline 0 C--N 1.321 -0.642 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.85 -178.294 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -68.31 -25.03 36.7 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 115.068 -2.821 . . . . 0.0 113.425 178.03 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.52 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 3.4 p-10 -76.64 -19.06 58.21 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 121.375 -0.828 . . . . 0.0 111.563 176.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 78.1 m-20 -78.57 -6.92 56.86 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 113.469 0.914 . . . . 0.0 113.469 -176.695 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.417 ' HB3' HG11 ' A' ' 32' ' ' VAL . 95.7 mm-40 -62.16 -24.91 67.46 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 113.595 0.961 . . . . 0.0 113.595 -177.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.449 ' HB ' ' HB1' ' A' ' 98' ' ' ALA . 7.9 tt -60.93 137.9 22.61 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.811 0 CA-C-O 122.205 1.003 . . . . 0.0 112.761 179.47 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 179.15 -156.9 19.7 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.465 -0.874 . . . . 0.0 112.382 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 45.3 p90 -155.02 170.45 21.74 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 179.1 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 19.5 m-85 -112.59 141.75 45.99 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 107.219 -1.401 . . . . 0.0 107.219 173.559 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 67.8 ttt-85 -112.24 130.24 55.99 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.971 -0.558 . . . . 0.0 111.237 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 44.8 ttt85 -71.67 145.35 48.95 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.472 0.653 . . . . 0.0 112.249 179.222 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -152.2 170.07 20.9 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 105.501 -2.037 . . . . 0.0 105.501 177.479 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 12.1 t -156.6 166.65 32.8 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 176.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 34.8 tpt85 -130.25 127.5 39.7 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 173.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 2.9 tmt_? -151.04 152.05 32.9 Favored 'General case' 0 CA--C 1.495 -1.147 0 N-CA-C 105.229 -2.137 . . . . 0.0 105.229 -178.68 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -125.99 174.17 10.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 26.8 tpt180 -141.99 122.31 13.96 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 106.106 -1.813 . . . . 0.0 106.106 177.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -82.65 174.56 53.14 Favored Glycine 0 C--O 1.224 -0.505 0 N-CA-C 109.24 -1.544 . . . . 0.0 109.24 178.003 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -72.26 -40.24 55.98 Favored Glycine 0 C--O 1.216 -1.023 0 N-CA-C 111.241 -0.744 . . . . 0.0 111.241 -177.485 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 27.3 t0 -71.93 -20.67 61.72 Favored 'General case' 0 C--O 1.217 -0.65 0 CA-C-O 122.635 1.207 . . . . 0.0 108.4 177.577 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 116.55 -12.39 15.82 Favored Glycine 0 CA--C 1.501 -0.803 0 CA-C-N 114.74 -1.118 . . . . 0.0 111.051 172.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 4.0 pttt -67.69 140.68 56.79 Favored 'General case' 0 CA--C 1.505 -0.755 0 CA-C-O 121.974 0.892 . . . . 0.0 110.495 -177.613 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 16.9 ptm -136.34 -177.47 4.73 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 114.027 -1.442 . . . . 0.0 112.155 -174.327 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 58.4 mmtt -90.58 -125.21 0.07 Allowed 'General case' 0 C--O 1.216 -0.663 0 N-CA-C 104.16 -2.533 . . . . 0.0 104.16 175.305 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 38.2 t0 -143.92 177.2 8.71 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 103.882 -2.636 . . . . 0.0 103.882 177.182 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -80.92 136.98 36.13 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 178.292 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.1 p -112.23 89.92 13.03 Favored Pre-proline 0 C--N 1.322 -0.593 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 173.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -69.13 131.82 22.99 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 115.632 -2.445 . . . . 0.0 112.107 -178.356 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 33.5 ptt180 -141.46 157.99 44.44 Favored 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 179.182 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 57.3 m95 -129.57 148.07 51.44 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 120.668 0.271 . . . . 0.0 111.306 -175.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.471 ' CZ ' ' HB2' ' A' ' 15' ' ' ALA . 48.1 m-85 -124.68 146.09 49.32 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 106.499 -1.667 . . . . 0.0 106.499 -179.433 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 75.1 t80 -95.74 131.5 41.94 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 -175.411 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -133.87 159.81 39.56 Favored 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 107.096 -1.446 . . . . 0.0 107.096 -175.201 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 71.5 m-85 -99.95 159.56 14.98 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 111.713 0.264 . . . . 0.0 111.713 -171.637 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -54.51 129.69 37.01 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.688 -178.759 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 68.72 34.48 78.13 Favored Glycine 0 C--O 1.221 -0.665 0 CA-C-O 118.804 -0.998 . . . . 0.0 115.57 176.666 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -89.35 146.08 24.93 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 118.633 1.216 . . . . 0.0 109.225 177.623 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 105.52 158.85 22.86 Favored Glycine 0 CA--C 1.522 0.524 0 CA-C-N 116.27 -0.423 . . . . 0.0 112.475 179.531 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -63.97 -50.3 3.15 Favored 'Trans proline' 0 C--N 1.346 0.427 0 N-CA-C 117.349 2.019 . . . . 0.0 117.349 -172.821 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 64.4 mt-10 -138.12 44.67 2.14 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 106.827 -1.545 . . . . 0.0 106.827 -179.369 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -60.28 -39.37 86.66 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.006 -178.249 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 62.3 22.44 63.22 Favored Glycine 0 C--O 1.223 -0.545 0 N-CA-C 115.53 0.972 . . . . 0.0 115.53 177.097 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 53.0 mt -102.31 110.95 63.93 Favored Pre-proline 0 N--CA 1.447 -0.624 0 N-CA-C 115.015 1.487 . . . . 0.0 115.015 -177.258 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -77.32 167.87 23.91 Favored 'Trans proline' 0 C--O 1.237 0.432 0 N-CA-C 108.749 -1.289 . . . . 0.0 108.749 170.454 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 66.7 t80 -62.77 134.0 55.62 Favored 'General case' 0 C--N 1.321 -0.658 0 O-C-N 121.957 -0.465 . . . . 0.0 110.019 179.431 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 89.64 -3.25 83.31 Favored Glycine 0 CA--C 1.519 0.327 0 N-CA-C 114.505 0.562 . . . . 0.0 114.505 178.236 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -63.14 130.13 43.3 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 117.812 0.806 . . . . 0.0 112.061 179.71 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 50.1 t-20 -76.6 124.67 27.98 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.692 -178.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 23.3 tttt -155.33 152.15 28.82 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 178.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -64.12 130.49 44.15 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.962 -178.117 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 65.62 30.27 77.01 Favored Glycine 0 N--CA 1.45 -0.395 0 CA-C-O 119.597 -0.557 . . . . 0.0 114.238 179.057 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 37.1 mm -129.83 128.71 65.56 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 CA-C-N 117.362 0.581 . . . . 0.0 110.154 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -133.16 118.27 31.78 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 CA-C-O 121.425 0.631 . . . . 0.0 110.747 177.175 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 92.8 m95 -84.98 137.27 33.19 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 113.395 0.887 . . . . 0.0 113.395 -175.675 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 18.6 m -137.85 149.7 25.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.66 0.743 . . . . 0.0 110.016 179.653 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -159.63 166.64 30.24 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 104.049 -2.575 . . . . 0.0 104.049 -179.404 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 10.6 t -131.73 173.92 10.66 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 104.956 -2.239 . . . . 0.0 104.956 177.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -67.69 135.14 52.3 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 -178.293 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 95.84 -11.14 68.22 Favored Glycine 0 CA--C 1.518 0.231 0 CA-C-N 115.883 -0.598 . . . . 0.0 112.945 -179.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.52 ' HA ' ' HA ' ' A' ' 41' ' ' ASP . . . -74.24 133.01 42.65 Favored 'General case' 0 CA--C 1.541 0.609 0 O-C-N 122.413 -0.463 . . . . 0.0 109.864 178.847 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 27.8 mt -88.53 140.39 29.51 Favored 'General case' 0 CA--C 1.513 -0.473 0 CA-C-O 121.367 0.603 . . . . 0.0 111.917 -178.148 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 58.0 t30 -84.43 68.08 10.13 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.371 -179.263 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -138.41 151.95 70.28 Favored Pre-proline 0 C--O 1.24 0.594 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -68.14 150.89 77.39 Favored 'Trans proline' 0 C--N 1.343 0.256 0 N-CA-C 114.62 0.969 . . . . 0.0 114.62 177.304 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 1.6 ptpt -150.99 58.45 0.91 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.987 0.898 . . . . 0.0 111.863 178.496 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -56.47 -28.47 59.8 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 115.037 -0.983 . . . . 0.0 111.225 177.061 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 14.2 p80 -59.24 -10.38 2.89 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 114.544 1.312 . . . . 0.0 114.544 -178.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 37.9 mt -96.31 -36.3 6.33 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.577 0 CA-C-N 117.92 0.327 . . . . 0.0 110.165 178.128 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -74.11 14.44 3.86 Favored Glycine 0 N--CA 1.464 0.538 0 N-CA-C 116.023 1.169 . . . . 0.0 116.023 -176.314 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 15.2 t -96.5 23.29 6.96 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 -177.179 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 57.8 ttp85 -63.05 126.63 27.97 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 106.943 -1.503 . . . . 0.0 106.943 177.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 18.3 m-20 -110.84 131.96 21.87 Favored Pre-proline 0 C--N 1.32 -0.684 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 -178.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -67.64 -21.45 45.56 Favored 'Trans proline' 0 C--N 1.349 0.589 0 N-CA-C 114.728 1.011 . . . . 0.0 114.728 -175.072 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -71.99 -25.0 61.67 Favored 'General case' 0 C--O 1.219 -0.526 0 CA-C-O 120.784 0.326 . . . . 0.0 110.266 177.559 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 -101.81 -28.54 12.38 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 113.486 0.921 . . . . 0.0 113.486 -175.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 18.9 t30 -159.36 148.91 18.53 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -178.117 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -85.28 149.62 25.35 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-O 121.675 0.75 . . . . 0.0 112.862 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -70.73 147.39 49.08 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.762 178.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 23.5 mt -86.8 139.31 17.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.387 -179.141 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 73.1 t -61.87 122.02 11.56 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 174.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 5.8 tt -67.79 129.38 39.73 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.957 0.408 . . . . 0.0 110.123 -177.433 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -134.79 158.1 45.04 Favored 'General case' 0 CA--C 1.513 -0.472 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 -178.581 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 14.9 mt -114.45 149.2 41.78 Favored Pre-proline 0 C--N 1.322 -0.618 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 176.346 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_endo -70.56 168.81 21.52 Favored 'Trans proline' 0 C--N 1.343 0.27 0 N-CA-C 114.377 0.876 . . . . 0.0 114.377 -177.042 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -55.5 133.82 50.34 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.415 -178.242 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 88.27 -12.16 65.45 Favored Glycine 0 C--O 1.227 -0.333 0 CA-C-N 115.854 -0.612 . . . . 0.0 112.619 -179.688 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 16.2 m -107.38 125.9 51.79 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.113 0.483 . . . . 0.0 110.28 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 17.7 p -121.48 148.26 44.67 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 113.027 0.751 . . . . 0.0 113.027 -176.572 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 89.3 mt -69.79 156.28 92.0 Favored Pre-proline 0 C--N 1.326 -0.439 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 177.147 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -75.49 168.16 25.07 Favored 'Trans proline' 0 C--O 1.235 0.334 0 C-N-CA 118.42 -0.587 . . . . 0.0 111.252 178.506 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 1.8 tmtp? -58.72 128.79 38.97 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.702 -177.609 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 95.0 -5.57 68.76 Favored Glycine 0 C--O 1.225 -0.421 0 N-CA-C 114.664 0.625 . . . . 0.0 114.664 177.627 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.438 ' CZ ' ' HB2' ' A' ' 18' ' ' GLN . 1.4 m-85 -104.27 140.24 38.15 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-O 121.873 0.844 . . . . 0.0 111.199 -179.521 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 46.1 p90 -142.19 165.67 26.8 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 114.174 -1.376 . . . . 0.0 107.461 176.092 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -106.98 144.61 33.35 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.927 0.394 . . . . 0.0 111.358 -177.37 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -72.67 136.94 45.73 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 178.747 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 89.64 -30.0 5.97 Favored Glycine 0 CA--C 1.518 0.241 0 CA-C-N 116.139 -0.482 . . . . 0.0 112.786 -177.242 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 22.7 t -86.07 100.2 12.01 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 117.386 0.593 . . . . 0.0 110.635 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 3.0 mpt_? -96.47 71.37 2.7 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 179.579 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -85.95 136.44 14.25 Favored Glycine 0 C--O 1.228 -0.258 0 N-CA-C 109.879 -1.288 . . . . 0.0 109.879 178.556 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 167.82 -177.32 42.18 Favored Glycine 0 N--CA 1.451 -0.358 0 N-CA-C 107.926 -2.07 . . . . 0.0 107.926 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 57.1 p . . . . . 0 C--O 1.253 1.26 0 CA-C-O 115.19 -2.338 . . . . 0.0 104.991 178.847 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.811 0 CA-C-O 118.553 -1.137 . . . . 0.0 111.281 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -138.66 103.41 4.84 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 118.319 1.059 . . . . 0.0 109.433 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 98.1 mtp -132.94 70.97 1.46 Allowed 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 -179.341 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -126.19 84.62 0.34 Allowed Glycine 0 C--O 1.227 -0.321 0 CA-C-N 115.969 -0.56 . . . . 0.0 113.055 -176.782 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -76.33 150.89 83.08 Favored Pre-proline 0 C--N 1.323 -0.578 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 178.084 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -68.37 -27.58 33.89 Favored 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 117.055 -1.497 . . . . 0.0 115.265 -177.491 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 64.1 t30 45.95 53.02 9.45 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 114.376 1.25 . . . . 0.0 114.376 175.618 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 84.7 m-20 -61.49 -43.7 98.4 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 115.501 1.667 . . . . 0.0 115.501 -174.589 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 23.1 p 10.21 83.83 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 125.945 1.698 . . . . 0.0 115.243 178.343 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -93.39 140.81 29.15 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-O 121.703 0.763 . . . . 0.0 112.724 -171.668 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 51.2 p -60.66 144.84 51.12 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 114.908 -1.042 . . . . 0.0 110.293 178.652 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 22.3 m95 -70.8 -24.36 62.55 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 114.727 1.38 . . . . 0.0 114.727 -178.369 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 26.3 m-85 -121.49 162.47 20.46 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 -171.645 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 73.0 p -70.25 162.68 27.99 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 179.195 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -79.42 149.17 31.68 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.953 0.882 . . . . 0.0 112.991 -177.782 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 37.1 mt -89.52 148.95 23.12 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 102.77 -3.048 . . . . 0.0 102.77 168.637 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 33.6 m -122.83 138.51 54.63 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.444 ' HB2' ' CZ ' ' A' ' 131' ' ' PHE . 4.1 tp60 -110.66 135.08 51.81 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.246 0.546 . . . . 0.0 112.3 -176.785 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 7.7 t-160 -130.9 94.68 3.66 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 104.055 -2.572 . . . . 0.0 104.055 170.751 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -178.76 -171.21 41.76 Favored Glycine 0 C--O 1.224 -0.494 0 N-CA-C 110.19 -1.164 . . . . 0.0 110.19 -176.622 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -97.69 -26.45 14.74 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 113.844 1.053 . . . . 0.0 113.844 -177.646 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 25.6 pt-20 -92.23 166.41 12.63 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 179.024 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -79.22 -62.93 1.54 Allowed 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 120.704 -0.398 . . . . 0.0 111.753 -177.255 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 36.8 tp 171.61 144.18 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 105.822 -1.918 . . . . 0.0 105.822 178.059 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 55.0 tttm -156.03 142.69 18.7 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 171.434 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 15.5 m-85 -119.66 157.9 50.86 Favored Pre-proline 0 C--O 1.247 0.955 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 176.175 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.415 ' HG2' ' HB3' ' A' ' 30' ' ' GLN . 50.0 Cg_endo -64.99 163.78 27.26 Favored 'Trans proline' 0 C--N 1.352 0.745 0 C-N-CA 121.355 1.37 . . . . 0.0 112.755 175.64 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 25.9 tpt180 -78.14 132.63 37.73 Favored 'General case' 0 C--O 1.216 -0.696 0 O-C-N 121.845 -0.534 . . . . 0.0 110.743 -177.435 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 77.95 17.81 77.88 Favored Glycine 0 C--O 1.223 -0.571 0 O-C-N 123.386 0.429 . . . . 0.0 112.315 177.21 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.415 ' HB3' ' HG2' ' A' ' 27' ' ' PRO . 49.3 tt0 -157.33 170.47 22.39 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 104.451 -2.425 . . . . 0.0 104.451 -175.497 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 105.73 -8.74 43.55 Favored Glycine 0 N--CA 1.462 0.41 0 CA-C-N 118.525 0.602 . . . . 0.0 113.811 177.399 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 76.2 t -70.9 133.8 86.03 Favored Pre-proline 0 C--N 1.321 -0.665 0 N-CA-C 106.791 -1.559 . . . . 0.0 106.791 176.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -69.98 171.87 13.9 Favored 'Trans proline' 0 N--CA 1.464 -0.246 0 C-N-CA 120.588 0.858 . . . . 0.0 112.967 178.113 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 83.7 mt -74.85 112.05 11.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 179.113 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 64.7 m-20 -109.6 80.74 1.35 Allowed 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 114.842 -1.072 . . . . 0.0 109.865 -175.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 76.2 p -69.87 -17.71 63.37 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 114.124 1.157 . . . . 0.0 114.124 -176.255 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 70.3 m-80 -112.54 35.46 3.82 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.701 -178.116 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.7 m -146.54 165.69 28.7 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 111.716 0.265 . . . . 0.0 111.716 -177.579 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 47.0 m -93.15 158.78 36.72 Favored Pre-proline 0 CA--C 1.536 0.439 0 C-N-CA 123.219 0.608 . . . . 0.0 111.718 -176.041 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -65.91 -23.92 54.1 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 115.71 -2.393 . . . . 0.0 115.253 -177.768 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -76.84 -20.23 56.59 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 121.68 -0.638 . . . . 0.0 112.675 179.051 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 12.4 p30 -96.41 0.99 51.28 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 114.643 1.349 . . . . 0.0 114.643 -174.565 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 86.4 mm-40 -57.36 -22.32 41.67 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.667 0.746 . . . . 0.0 112.675 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 8.2 tt -62.73 135.66 26.85 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.741 0 CA-C-O 122.366 1.079 . . . . 0.0 111.752 177.769 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 179.3 -156.81 19.36 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.212 -0.994 . . . . 0.0 112.232 -178.164 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 39.9 p90 -155.12 166.98 31.88 Favored 'General case' 0 C--N 1.318 -0.803 0 O-C-N 122.564 -0.374 . . . . 0.0 110.263 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 32.4 m-85 -108.22 140.68 41.1 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 175.556 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 48.5 ttt180 -115.85 120.21 38.5 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 124.1 0.96 . . . . 0.0 112.56 -175.215 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 36.7 ttt180 -66.32 141.21 58.07 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 123.785 0.834 . . . . 0.0 111.427 178.675 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -149.88 143.2 25.15 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 122.609 0.364 . . . . 0.0 111.116 176.752 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 14.6 t -161.0 165.86 29.18 Favored 'General case' 0 C--O 1.239 0.544 0 N-CA-C 106.078 -1.823 . . . . 0.0 106.078 174.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 3.9 tpt180 -144.9 127.97 16.58 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.78 0.324 . . . . 0.0 110.392 178.078 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 7.5 tmm_? -139.39 131.62 28.21 Favored 'General case' 0 CA--C 1.498 -1.023 0 CA-C-O 121.54 0.686 . . . . 0.0 109.698 178.369 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -139.85 179.28 2.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 N-CA-C 105.775 -1.935 . . . . 0.0 105.775 -178.564 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 17.4 tpp180 -124.9 103.51 8.09 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 106.244 -1.762 . . . . 0.0 106.244 173.808 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -75.57 159.04 50.89 Favored Glycine 0 C--O 1.227 -0.304 0 N-CA-C 106.945 -2.462 . . . . 0.0 106.945 176.067 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -60.51 -38.23 94.55 Favored Glycine 0 C--O 1.22 -0.765 0 CA-C-N 118.277 1.038 . . . . 0.0 113.698 -178.011 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -86.03 7.09 25.92 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.691 0.758 . . . . 0.0 111.593 179.731 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 96.62 -2.21 62.34 Favored Glycine 0 C--N 1.321 -0.29 0 CA-C-N 115.241 -0.89 . . . . 0.0 113.711 177.617 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 18.3 mttt -59.55 140.25 56.46 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.852 0.834 . . . . 0.0 112.703 -178.51 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 84.1 mtp -111.81 -169.97 1.56 Allowed 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 113.974 -1.466 . . . . 0.0 109.562 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 8.4 mmtt -121.28 -69.0 0.86 Allowed 'General case' 0 C--O 1.217 -0.636 0 N-CA-C 111.801 0.297 . . . . 0.0 111.801 -179.126 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 70.4 m-20 -126.46 158.71 35.33 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 -179.446 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 95.2 mt -122.4 -68.74 0.87 Allowed 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 177.231 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -71.17 135.25 84.82 Favored Pre-proline 0 C--N 1.323 -0.561 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.682 177.566 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -75.06 155.5 42.64 Favored 'Trans proline' 0 C--O 1.236 0.4 0 C-N-CA 117.048 -1.501 . . . . 0.0 113.165 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 75.6 mtt85 -111.59 160.02 17.6 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.234 178.33 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 71.2 m95 -132.64 127.4 34.82 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 175.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 65.7 m-85 -110.29 167.1 10.45 Favored 'General case' 0 C--O 1.21 -0.993 0 N-CA-C 104.758 -2.312 . . . . 0.0 104.758 -179.59 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 85.2 t80 -114.88 139.73 49.54 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 119.339 0.972 . . . . 0.0 109.118 -179.05 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 -138.61 148.69 44.42 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.515 -176.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 71.5 m-85 -82.2 159.49 23.25 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.423 -177.48 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -54.12 129.46 34.76 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-O 121.234 0.54 . . . . 0.0 112.407 -177.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 73.9 28.34 64.97 Favored Glycine 0 C--O 1.219 -0.837 0 N-CA-C 115.804 1.081 . . . . 0.0 115.804 175.714 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 2.3 p -89.0 145.88 25.21 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 118.675 1.238 . . . . 0.0 108.56 179.39 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 102.86 131.67 7.4 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 108.191 -1.963 . . . . 0.0 108.191 -175.494 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -68.23 -36.0 17.63 Favored 'Trans proline' 0 CA--C 1.516 -0.393 0 CA-C-N 119.676 1.738 . . . . 0.0 115.671 -172.806 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -114.19 32.07 6.15 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 -177.551 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -68.52 -49.75 57.26 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.823 -179.414 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 60.64 18.38 51.86 Favored Glycine 0 C--O 1.226 -0.403 0 N-CA-C 114.942 0.737 . . . . 0.0 114.942 179.172 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 74.7 mt -99.81 113.4 65.08 Favored Pre-proline 0 N--CA 1.449 -0.488 0 N-CA-C 114.935 1.457 . . . . 0.0 114.935 -176.048 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -76.57 166.96 26.41 Favored 'Trans proline' 0 C--O 1.238 0.482 0 N-CA-C 109.078 -1.162 . . . . 0.0 109.078 170.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.415 ' CE1' ' HB3' ' A' ' 92' ' ' TRP . 83.3 t80 -61.04 128.89 38.67 Favored 'General case' 0 C--N 1.323 -0.557 0 O-C-N 121.989 -0.444 . . . . 0.0 110.898 -179.747 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 93.89 -4.92 72.29 Favored Glycine 0 CA--C 1.518 0.277 0 N-CA-C 114.977 0.751 . . . . 0.0 114.977 178.228 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -63.81 133.2 52.99 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 118.027 0.913 . . . . 0.0 111.935 179.376 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 -77.95 130.31 36.38 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.096 -179.108 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 39.2 tttm -156.07 150.29 25.52 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 176.123 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -63.36 131.65 48.94 Favored 'General case' 0 C--O 1.24 0.573 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 178.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 72.33 23.33 78.11 Favored Glycine 0 N--CA 1.445 -0.757 0 N-CA-C 114.894 0.718 . . . . 0.0 114.894 177.439 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 42.7 mm -130.45 127.46 62.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 117.146 0.473 . . . . 0.0 109.946 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -133.17 123.56 47.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.929 176.678 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . 0.415 ' HB3' ' CE1' ' A' ' 83' ' ' TYR . 92.9 m95 -89.55 137.41 32.36 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 113.225 0.824 . . . . 0.0 113.225 -175.453 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 15.8 m -136.74 153.06 29.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 178.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -157.5 166.53 32.71 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 102.863 -3.014 . . . . 0.0 102.863 -179.51 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 11.4 t -136.05 175.26 9.76 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 106.215 -1.772 . . . . 0.0 106.215 179.33 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -64.02 133.55 53.33 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.011 0.434 . . . . 0.0 110.226 -179.666 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 93.85 -9.4 73.21 Favored Glycine 0 N--CA 1.46 0.237 0 CA-C-N 116.061 -0.518 . . . . 0.0 114.116 178.108 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -74.58 139.38 43.66 Favored 'General case' 0 CA--C 1.54 0.576 0 O-C-N 122.484 -0.421 . . . . 0.0 111.425 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 18.5 mt -82.13 162.48 22.47 Favored 'General case' 0 C--O 1.213 -0.86 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 177.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 59.4 t30 -114.87 69.53 0.72 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.075 0.464 . . . . 0.0 110.405 178.409 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -143.1 152.54 58.45 Favored Pre-proline 0 C--O 1.241 0.616 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -67.44 150.94 80.72 Favored 'Trans proline' 0 C--N 1.345 0.355 0 N-CA-C 113.511 0.543 . . . . 0.0 113.511 177.77 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 4.9 ptpt -151.6 59.11 0.88 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 122.777 1.275 . . . . 0.0 109.128 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -60.39 -30.6 69.69 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 113.846 -1.524 . . . . 0.0 113.028 -178.307 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 48.5 p-80 -60.84 -22.92 64.7 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 113.095 0.776 . . . . 0.0 113.095 -178.02 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 67.4 mt -71.45 -31.83 44.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 178.586 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -74.93 14.64 4.49 Favored Glycine 0 CA--C 1.524 0.596 0 N-CA-C 115.638 1.015 . . . . 0.0 115.638 -178.082 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 9.5 t -83.27 16.19 2.58 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 113.773 1.027 . . . . 0.0 113.773 -178.395 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 65.3 ttp85 -59.17 130.02 44.96 Favored 'General case' 0 N--CA 1.47 0.552 0 O-C-N 121.225 -0.922 . . . . 0.0 108.861 -178.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -107.93 130.18 23.14 Favored Pre-proline 0 C--N 1.322 -0.606 0 N-CA-C 106.408 -1.701 . . . . 0.0 106.408 179.475 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -69.61 -17.78 38.08 Favored 'Trans proline' 0 C--O 1.219 -0.461 0 C-N-CA 117.826 -0.982 . . . . 0.0 113.667 -177.652 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -74.14 -26.14 60.15 Favored 'General case' 0 C--O 1.22 -0.47 0 CA-C-O 120.838 0.352 . . . . 0.0 110.657 178.191 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 77.9 m-20 -102.23 -25.07 13.82 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 113.195 0.813 . . . . 0.0 113.195 -174.481 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 30.9 t30 -156.04 147.15 22.33 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.623 0.601 . . . . 0.0 112.623 -178.603 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -89.5 146.99 24.24 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.706 179.368 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -70.71 147.43 49.07 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.928 0.394 . . . . 0.0 109.969 178.129 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 2.0 mt -91.36 142.65 12.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 -178.129 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 87.8 t -59.14 123.08 10.72 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 N-CA-C 107.883 -1.155 . . . . 0.0 107.883 177.077 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 7.3 tt -70.46 127.89 34.28 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 -178.499 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 36.5 mt-30 -132.77 162.74 30.67 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 -178.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 15.4 mt -114.81 145.55 34.19 Favored Pre-proline 0 C--N 1.323 -0.584 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 179.268 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -72.93 170.34 19.97 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 120.329 0.686 . . . . 0.0 113.84 -177.567 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -54.61 133.36 46.53 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.738 -179.645 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 92.6 -17.43 57.67 Favored Glycine 0 C--O 1.227 -0.331 0 CA-C-N 116.001 -0.545 . . . . 0.0 113.191 -179.383 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 3.8 m -108.62 126.22 52.72 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 117.773 0.786 . . . . 0.0 110.303 178.689 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 14.5 p -123.4 152.19 41.83 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.057 -0.52 . . . . 0.0 109.922 -178.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 90.4 mt -72.34 151.47 92.05 Favored Pre-proline 0 C--N 1.324 -0.527 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 178.299 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -77.81 173.08 14.62 Favored 'Trans proline' 0 N--CA 1.462 -0.34 0 O-C-N 121.966 0.456 . . . . 0.0 111.06 178.418 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 66.3 tttp -59.78 127.89 34.2 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 122.074 -0.392 . . . . 0.0 111.519 -177.631 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 95.17 -1.48 64.87 Favored Glycine 0 C--O 1.227 -0.292 0 N-CA-C 115.142 0.817 . . . . 0.0 115.142 176.696 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.444 ' CZ ' ' HB2' ' A' ' 18' ' ' GLN . 1.2 m-85 -103.75 141.69 35.65 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-O 121.601 0.715 . . . . 0.0 111.632 -179.25 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 47.2 p90 -146.13 166.07 27.25 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 114.572 -1.194 . . . . 0.0 107.833 175.415 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -106.47 145.57 31.64 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 112.446 0.536 . . . . 0.0 112.446 -176.31 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -72.81 139.35 46.97 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 177.489 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 90.69 -36.85 3.48 Favored Glycine 0 CA--C 1.515 0.079 0 CA-C-N 116.177 -0.465 . . . . 0.0 112.821 -178.613 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 31.3 t -77.26 131.64 38.28 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.541 -0.541 . . . . 0.0 109.541 -179.445 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 1.2 mpp_? -140.69 144.65 35.75 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 107.297 -1.371 . . . . 0.0 107.297 178.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 149.46 177.52 23.63 Favored Glycine 0 C--O 1.227 -0.342 0 N-CA-C 106.639 -2.584 . . . . 0.0 106.639 179.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 93.32 -146.64 18.21 Favored Glycine 0 N--CA 1.454 -0.115 0 CA-C-N 118.102 0.951 . . . . 0.0 110.738 -178.503 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 67.0 p . . . . . 0 C--O 1.243 0.724 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 -179.51 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.671 0 CA-C-O 118.588 -1.118 . . . . 0.0 111.148 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -70.92 152.05 44.05 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 178.022 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 53.6 ttp -148.31 142.23 25.82 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 104.798 -2.297 . . . . 0.0 104.798 179.406 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -172.99 -117.06 0.44 Allowed Glycine 0 C--O 1.222 -0.615 0 N-CA-C 110.933 -0.867 . . . . 0.0 110.933 -179.238 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 86.4 mt -77.9 145.78 70.77 Favored Pre-proline 0 C--N 1.322 -0.589 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 -179.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -73.89 167.0 28.28 Favored 'Trans proline' 0 C--N 1.345 0.365 0 O-C-N 122.138 0.546 . . . . 0.0 111.392 176.658 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 24.3 t30 -63.4 -33.3 75.23 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 114.058 1.132 . . . . 0.0 114.058 -177.229 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 33.5 m120 -144.42 -104.1 0.11 Allowed 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 119.722 -0.18 . . . . 0.0 111.403 -177.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 41.4 p 40.55 79.64 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 115.101 1.519 . . . . 0.0 115.101 -179.562 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -110.9 148.78 31.71 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.714 -178.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 5.3 m -61.14 145.86 49.54 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.877 176.523 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 18.7 m95 -67.04 -22.83 65.86 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 113.452 0.908 . . . . 0.0 113.452 179.804 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -121.43 162.32 20.65 Favored 'General case' 0 CA--C 1.507 -0.688 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.974 -172.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 76.5 p -70.5 161.97 29.64 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 177.473 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -83.58 144.76 29.26 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.9 -0.591 . . . . 0.0 112.392 -175.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.41 HD21 HD22 ' A' ' 119' ' ' LEU . 66.2 mt -76.32 148.85 37.21 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 104.798 -2.297 . . . . 0.0 104.798 171.525 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 31.3 m -128.14 148.58 50.6 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 105.24 -2.133 . . . . 0.0 105.24 179.12 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -138.47 163.12 32.77 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 114.925 1.454 . . . . 0.0 114.925 -178.336 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 52.9 t60 -89.71 99.5 12.5 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 100.705 -3.813 . . . . 0.0 100.705 168.811 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -42.07 103.05 0.03 OUTLIER Glycine 0 N--CA 1.461 0.313 0 N-CA-C 118.538 2.175 . . . . 0.0 118.538 -173.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 82.4 mttt -142.97 -44.93 0.3 Allowed 'General case' 0 C--O 1.221 -0.401 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 177.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -120.67 169.61 10.22 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 -179.393 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -106.01 32.74 4.19 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 122.967 1.365 . . . . 0.0 110.045 178.873 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 32.6 tp 64.23 141.49 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 111.283 -2.689 . . . . 0.0 114.619 176.798 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 43.1 tptt -153.68 138.22 16.84 Favored 'General case' 0 C--N 1.324 -0.532 0 O-C-N 121.31 -0.869 . . . . 0.0 110.529 171.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -122.66 149.14 55.14 Favored Pre-proline 0 C--N 1.321 -0.633 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 176.073 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -70.25 159.44 53.04 Favored 'Trans proline' 0 C--N 1.349 0.576 0 O-C-N 122.188 0.573 . . . . 0.0 112.7 179.149 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 16.0 tpt180 -67.04 136.15 54.79 Favored 'General case' 0 C--O 1.218 -0.598 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 -178.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 85.94 6.96 81.63 Favored Glycine 0 C--O 1.222 -0.621 0 N-CA-C 111.241 -0.744 . . . . 0.0 111.241 179.606 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 20.3 mt-30 -147.77 172.68 13.74 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 123.27 0.628 . . . . 0.0 109.433 -175.356 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 104.23 -20.47 40.22 Favored Glycine 0 CA--C 1.501 -0.816 0 CA-C-N 115.883 -0.599 . . . . 0.0 113.558 174.424 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 57.6 t -67.28 128.22 93.66 Favored Pre-proline 0 C--N 1.32 -0.706 0 N-CA-C 106.76 -1.57 . . . . 0.0 106.76 177.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -71.59 171.61 15.98 Favored 'Trans proline' 0 C--O 1.223 -0.265 0 O-C-N 122.161 0.558 . . . . 0.0 111.329 177.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 87.6 mt -70.01 106.57 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-O 121.96 0.886 . . . . 0.0 108.791 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 -98.1 83.67 3.15 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 114.663 -1.153 . . . . 0.0 110.616 -176.55 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 73.1 p -68.02 -14.21 62.79 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.707 0.765 . . . . 0.0 112.725 -179.51 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 11.1 p30 -108.84 21.61 17.01 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.008 -0.997 . . . . 0.0 112.724 -177.216 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 5.8 m -142.83 151.47 41.16 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 113.366 0.876 . . . . 0.0 113.366 -176.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 52.8 m -78.32 166.53 42.37 Favored Pre-proline 0 C--N 1.327 -0.407 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 177.224 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.418 ' HA ' ' HG2' ' A' ' 43' ' ' GLN . 60.6 Cg_endo -63.94 -26.67 66.63 Favored 'Trans proline' 0 C--N 1.353 0.77 0 C-N-CA 115.24 -2.707 . . . . 0.0 112.86 179.65 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -60.81 -32.82 72.17 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.663 0.744 . . . . 0.0 110.78 177.192 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 68.8 m-20 -88.7 -6.15 57.64 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 115.416 1.636 . . . . 0.0 115.416 -172.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.418 ' HG2' ' HA ' ' A' ' 40' ' ' PRO . 96.5 mm-40 -58.33 -29.25 65.77 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 114.295 1.22 . . . . 0.0 114.295 -176.248 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.43 ' HB ' ' HB1' ' A' ' 98' ' ' ALA . 11.2 tt -59.5 136.69 22.85 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-O 122.408 1.099 . . . . 0.0 112.244 -179.299 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -179.04 -157.9 20.4 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.495 -0.86 . . . . 0.0 111.996 -177.57 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 47.7 p90 -155.01 171.41 19.79 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 179.438 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 19.1 m-85 -112.71 141.05 46.95 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 106.551 -1.648 . . . . 0.0 106.551 173.548 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 69.4 ttt-85 -114.18 124.79 52.92 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.758 -177.144 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 15.2 ttt-85 -63.22 137.82 58.34 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 175.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -149.27 140.87 23.45 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.776 0.798 . . . . 0.0 112.708 179.477 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 12.2 p -133.26 142.64 48.63 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 104.602 -2.37 . . . . 0.0 104.602 174.34 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 11.8 tpt180 -160.68 128.23 4.38 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 112.959 0.726 . . . . 0.0 112.959 -179.81 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.5 tpp180 -116.68 142.7 46.56 Favored 'General case' 0 CA--C 1.507 -0.69 0 N-CA-C 105.734 -1.951 . . . . 0.0 105.734 173.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -138.37 177.1 5.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 -177.043 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.93 117.41 19.2 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 104.434 -2.432 . . . . 0.0 104.434 172.65 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -82.79 163.41 42.04 Favored Glycine 0 C--O 1.224 -0.511 0 N-CA-C 107.57 -2.212 . . . . 0.0 107.57 176.681 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -64.35 -32.58 84.68 Favored Glycine 0 C--O 1.214 -1.112 0 CA-C-N 118.121 0.96 . . . . 0.0 111.609 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -90.86 17.91 7.22 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-O 122.147 0.975 . . . . 0.0 110.551 178.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 85.36 -6.25 80.51 Favored Glycine 0 N--CA 1.46 0.247 0 N-CA-C 116.338 1.295 . . . . 0.0 116.338 173.54 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.42 128.69 37.54 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.807 0.813 . . . . 0.0 112.634 -178.069 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 97.8 mmm -99.32 -174.73 2.81 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 114.323 -1.308 . . . . 0.0 108.051 178.466 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 6.3 tttp -117.02 -62.0 1.64 Allowed 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 175.34 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.1 t0 54.74 -152.82 0.33 Allowed 'General case' 0 C--O 1.24 0.59 0 O-C-N 124.771 1.294 . . . . 0.0 110.955 178.346 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.9 mm? 67.16 -179.47 0.22 Allowed 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 115.372 1.619 . . . . 0.0 115.372 174.069 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -58.26 156.34 21.89 Favored Pre-proline 0 C--O 1.24 0.585 0 N-CA-C 116.804 2.15 . . . . 0.0 116.804 -174.874 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -66.41 156.57 64.62 Favored 'Trans proline' 0 C--N 1.354 0.838 0 CA-C-O 121.3 0.458 . . . . 0.0 111.817 177.431 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 42.2 mtt-85 -128.69 163.31 25.38 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.622 -175.326 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 61.8 m95 -127.42 129.97 48.48 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 179.122 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 24.2 m-85 -111.27 149.08 31.56 Favored 'General case' 0 C--O 1.213 -0.838 0 N-CA-C 106.949 -1.5 . . . . 0.0 106.949 -178.38 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 86.8 t80 -98.1 139.97 33.12 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.909 -0.775 . . . . 0.0 108.909 -178.224 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -142.36 153.13 43.56 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 -179.052 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 69.1 m-85 -88.12 159.51 18.18 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.87 -174.502 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -54.43 131.01 41.5 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.77 0.319 . . . . 0.0 110.686 -179.487 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 69.67 32.98 71.0 Favored Glycine 0 C--O 1.223 -0.578 0 N-CA-C 115.345 0.898 . . . . 0.0 115.345 176.37 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.433 HG22 ' HA ' ' A' ' 104' ' ' ASP . 1.4 p -89.92 146.16 24.6 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 118.108 0.954 . . . . 0.0 109.312 177.268 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 99.09 147.08 21.41 Favored Glycine 0 CA--C 1.523 0.576 0 N-CA-C 111.637 -0.585 . . . . 0.0 111.637 -179.725 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -71.21 -40.13 3.44 Favored 'Trans proline' 0 C--N 1.347 0.492 0 N-CA-C 116.775 1.798 . . . . 0.0 116.775 -173.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 19.0 pt-20 -116.68 19.37 14.57 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.397 0.617 . . . . 0.0 110.825 -176.058 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -61.9 -44.87 95.9 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.52 -0.472 . . . . 0.0 110.752 -177.195 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 56.43 24.05 44.51 Favored Glycine 0 C--O 1.226 -0.371 0 N-CA-C 115.628 1.011 . . . . 0.0 115.628 178.348 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 52.2 mt -99.87 110.99 61.02 Favored Pre-proline 0 C--O 1.238 0.491 0 N-CA-C 115.65 1.722 . . . . 0.0 115.65 -176.121 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -78.15 168.0 22.49 Favored 'Trans proline' 0 CA--C 1.53 0.32 0 C-N-CA 120.954 1.103 . . . . 0.0 109.442 170.783 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.432 ' CE2' ' HB3' ' A' ' 92' ' ' TRP . 73.2 t80 -62.26 131.96 51.09 Favored 'General case' 0 C--N 1.323 -0.575 0 O-C-N 121.883 -0.511 . . . . 0.0 110.309 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 90.55 -3.6 81.72 Favored Glycine 0 C--O 1.228 -0.265 0 N-CA-C 114.585 0.594 . . . . 0.0 114.585 177.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -63.09 131.0 47.08 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 118.016 0.908 . . . . 0.0 111.403 179.392 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 53.7 t30 -77.84 124.92 28.58 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.181 -178.641 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 12.1 tttp -156.15 151.74 27.05 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 178.322 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 20.3 t0 -66.41 133.79 51.18 Favored 'General case' 0 C--N 1.322 -0.623 0 O-C-N 123.395 0.435 . . . . 0.0 110.068 -179.197 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 67.31 27.56 73.53 Favored Glycine 0 N--CA 1.45 -0.431 0 N-CA-C 114.749 0.66 . . . . 0.0 114.749 178.529 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 41.7 mm -129.27 125.84 62.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 117.266 0.533 . . . . 0.0 110.655 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.1 pt -129.78 116.16 36.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 CA-C-O 121.909 0.861 . . . . 0.0 112.536 176.782 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . 0.432 ' HB3' ' CE2' ' A' ' 83' ' ' TYR . 94.8 m95 -80.52 135.28 36.07 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 113.533 0.938 . . . . 0.0 113.533 -176.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 17.1 m -135.13 151.99 31.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 179.427 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -160.6 166.5 28.84 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 104.683 -2.34 . . . . 0.0 104.683 -178.801 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 13.5 t -136.39 178.78 6.8 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 105.151 -2.166 . . . . 0.0 105.151 177.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -66.99 136.48 55.38 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.318 0.58 . . . . 0.0 110.693 -179.257 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 92.24 -14.32 64.88 Favored Glycine 0 C--O 1.226 -0.374 0 CA-C-N 115.715 -0.675 . . . . 0.0 113.563 177.256 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.43 ' HB1' ' HB ' ' A' ' 44' ' ' ILE . . . -69.96 126.71 30.48 Favored 'General case' 0 C--N 1.322 -0.624 0 O-C-N 122.43 -0.453 . . . . 0.0 110.975 -179.492 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 43.6 mt -83.49 138.37 33.47 Favored 'General case' 0 CA--C 1.515 -0.392 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 -177.224 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 61.5 t30 -82.08 65.11 7.06 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.527 0.68 . . . . 0.0 110.729 179.816 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -140.11 155.18 70.71 Favored Pre-proline 0 C--N 1.322 -0.619 0 N-CA-C 105.639 -1.985 . . . . 0.0 105.639 179.591 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_endo -73.33 155.83 50.94 Favored 'Trans proline' 0 CA--C 1.532 0.377 0 N-CA-C 115.016 1.122 . . . . 0.0 115.016 179.438 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.79 58.02 1.05 Allowed 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 121.852 0.834 . . . . 0.0 112.055 176.338 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . 0.433 ' HA ' HG22 ' A' ' 75' ' ' THR . 33.7 t70 -56.98 -26.94 60.94 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.117 178.115 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 17.1 p80 -58.84 -11.52 3.36 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 114.521 1.304 . . . . 0.0 114.521 -178.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 23.2 mt -96.35 -36.14 6.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 122.175 -0.328 . . . . 0.0 110.836 178.22 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -73.83 14.51 3.55 Favored Glycine 0 CA--C 1.522 0.495 0 N-CA-C 116.189 1.235 . . . . 0.0 116.189 -175.334 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 9.7 t -107.33 29.26 7.3 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-O 121.057 0.456 . . . . 0.0 111.971 -177.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.479 ' HD2' HD22 ' A' ' 114' ' ' ASN . 64.2 ttp85 -54.73 134.36 47.44 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 177.513 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 41.6 m-20 -102.06 122.73 46.01 Favored Pre-proline 0 C--N 1.325 -0.497 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 -178.129 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -68.74 -18.6 42.02 Favored 'Trans proline' 0 C--O 1.217 -0.531 0 N-CA-C 114.425 0.894 . . . . 0.0 114.425 -176.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -75.69 -25.92 57.15 Favored 'General case' 0 C--O 1.22 -0.477 0 CA-C-O 120.842 0.353 . . . . 0.0 110.657 178.121 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 83.0 m-20 -100.75 -23.84 14.53 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 -175.39 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.479 HD22 ' HD2' ' A' ' 109' ' ' ARG . 31.4 t30 -154.98 147.91 24.6 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.764 0.654 . . . . 0.0 112.764 -178.879 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -88.37 148.57 24.18 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-O 121.454 0.645 . . . . 0.0 111.404 179.493 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -68.97 142.45 54.67 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.226 0.536 . . . . 0.0 110.183 178.378 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 18.9 mt -84.8 136.56 22.5 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 -179.038 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 74.4 t -60.49 124.69 15.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 N-CA-C 105.295 -2.113 . . . . 0.0 105.295 174.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.41 HD22 HD21 ' A' ' 16' ' ' LEU . 7.6 tt -66.18 127.93 34.1 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.199 0.523 . . . . 0.0 109.968 -176.65 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 30.1 mt-30 -129.68 156.35 44.4 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 106.169 -1.789 . . . . 0.0 106.169 -179.483 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 13.6 mt -112.37 148.02 38.27 Favored Pre-proline 0 C--N 1.321 -0.661 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 177.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -72.43 165.37 32.88 Favored 'Trans proline' 0 C--O 1.236 0.38 0 O-C-N 122.293 0.628 . . . . 0.0 112.454 -179.354 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 65.1 tt0 -54.86 130.41 41.06 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.491 -179.471 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 99.47 -19.8 52.27 Favored Glycine 0 C--O 1.226 -0.39 0 CA-C-N 115.873 -0.603 . . . . 0.0 113.601 -179.278 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 11.2 m -105.76 130.91 53.66 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 118.251 1.025 . . . . 0.0 110.684 178.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 16.9 p -124.54 152.11 43.88 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.614 -178.035 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 90.3 mt -78.67 155.3 78.45 Favored Pre-proline 0 C--N 1.326 -0.432 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 177.287 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -75.19 170.25 20.77 Favored 'Trans proline' 0 C--O 1.237 0.44 0 CA-C-O 121.55 0.562 . . . . 0.0 111.367 177.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 48.1 tptt -63.5 122.49 16.4 Favored 'General case' 0 C--O 1.218 -0.579 0 CA-C-O 121.006 0.432 . . . . 0.0 111.234 -175.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 95.21 7.36 59.54 Favored Glycine 0 C--O 1.228 -0.263 0 N-CA-C 115.236 0.854 . . . . 0.0 115.236 178.331 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -110.48 143.48 40.74 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 107.332 -1.358 . . . . 0.0 107.332 176.788 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 35.2 p90 -147.56 163.95 34.99 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 177.263 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -99.55 145.6 27.34 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.894 0.378 . . . . 0.0 110.625 -178.393 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -72.07 135.84 46.42 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 178.28 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 86.41 -10.47 66.68 Favored Glycine 0 C--O 1.226 -0.396 0 CA-C-N 116.28 -0.418 . . . . 0.0 113.464 -178.641 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 32.2 t -85.08 118.44 24.64 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 117.535 0.668 . . . . 0.0 110.089 179.482 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 1.8 mmm180 -152.91 162.38 41.38 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 105.24 -2.133 . . . . 0.0 105.24 179.382 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 103.69 -168.71 17.49 Favored Glycine 0 C--O 1.229 -0.196 0 N-CA-C 111.654 -0.578 . . . . 0.0 111.654 178.573 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 136.74 -24.88 3.13 Favored Glycine 0 C--O 1.228 -0.24 0 N-CA-C 107.348 -2.301 . . . . 0.0 107.348 -177.783 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 61.4 m . . . . . 0 C--O 1.26 1.649 0 N-CA-C 101.73 -3.433 . . . . 0.0 101.73 175.924 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.612 0 CA-C-O 118.746 -1.03 . . . . 0.0 111.141 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -70.42 152.71 43.77 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 118.069 0.935 . . . . 0.0 110.839 -179.608 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 28.1 ttt -149.01 143.97 26.44 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 102.033 -3.321 . . . . 0.0 102.033 178.247 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 80.29 35.24 27.17 Favored Glycine 0 C--O 1.224 -0.514 0 C-N-CA 120.266 -0.969 . . . . 0.0 111.243 -177.663 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 8.9 mp -59.69 145.67 82.68 Favored Pre-proline 0 C--O 1.239 0.534 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 -179.173 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -69.01 152.08 73.25 Favored 'Trans proline' 0 C--N 1.347 0.499 0 N-CA-C 114.286 0.841 . . . . 0.0 114.286 -176.5 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 35.2 t30 -144.38 89.73 2.03 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.429 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 17.5 t30 -125.21 14.09 8.35 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 121.421 0.629 . . . . 0.0 110.276 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 22.6 p -133.48 89.48 2.6 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 -178.118 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -90.58 141.28 28.93 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-O 121.486 0.66 . . . . 0.0 109.667 -177.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -58.37 140.28 53.88 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.608 177.674 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 35.7 m95 -65.82 -22.0 66.52 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 114.283 1.216 . . . . 0.0 114.283 -178.769 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 82.6 m-85 -121.37 161.84 21.4 Favored 'General case' 0 CA--C 1.506 -0.714 0 N-CA-C 114.453 1.279 . . . . 0.0 114.453 -171.086 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.423 ' HB ' ' HB3' ' A' ' 134' ' ' GLU . 73.1 p -69.89 163.59 25.62 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 114.045 -1.434 . . . . 0.0 108.468 177.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.468 ' HB2' ' CZ ' ' A' ' 69' ' ' TYR . . . -77.43 139.3 39.64 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 -175.224 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 12.8 mt -84.49 145.62 28.02 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 103.927 -2.619 . . . . 0.0 103.927 170.8 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 21.9 m -129.31 133.2 47.33 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 118.13 0.423 . . . . 0.0 109.96 -179.4 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.414 ' HB2' ' CZ ' ' A' ' 131' ' ' PHE . 3.8 tp60 -95.34 143.33 26.79 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 123.615 0.572 . . . . 0.0 111.577 -179.568 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 23.1 t-160 -138.97 96.5 3.13 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 102.609 -3.108 . . . . 0.0 102.609 165.57 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 172.57 -161.22 32.67 Favored Glycine 0 C--O 1.226 -0.399 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 -173.531 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 49.6 mtmt -104.54 -27.89 11.61 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 116.332 1.975 . . . . 0.0 116.332 -176.634 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -85.58 162.44 18.86 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 179.231 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -76.03 -62.9 1.44 Allowed 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 -178.519 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 36.4 tp -178.32 138.14 0.18 Allowed 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 104.799 -2.297 . . . . 0.0 104.799 172.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 11.0 tmtt? -149.28 133.33 17.18 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 176.606 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -121.05 159.8 47.78 Favored Pre-proline 0 C--O 1.243 0.748 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 177.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -65.39 171.52 9.16 Favored 'Trans proline' 0 CA--C 1.539 0.746 0 C-N-CA 121.004 1.136 . . . . 0.0 114.706 -179.82 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 25.5 tpt180 -78.4 128.0 33.0 Favored 'General case' 0 C--O 1.215 -0.758 0 O-C-N 121.561 -0.712 . . . . 0.0 109.289 179.448 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 72.12 18.68 78.06 Favored Glycine 0 C--O 1.225 -0.459 0 N-CA-C 114.552 0.581 . . . . 0.0 114.552 176.583 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 43.1 tt0 -159.32 149.59 19.17 Favored 'General case' 0 C--O 1.22 -0.46 0 N-CA-C 105.652 -1.981 . . . . 0.0 105.652 -178.437 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 136.05 -14.74 4.05 Favored Glycine 0 CA--C 1.505 -0.548 0 C-N-CA 120.323 -0.941 . . . . 0.0 113.225 176.524 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 27.6 m -71.6 145.93 90.6 Favored Pre-proline 0 C--N 1.32 -0.698 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 177.382 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -77.17 173.03 15.03 Favored 'Trans proline' 0 N--CA 1.46 -0.491 0 C-N-CA 121.507 1.471 . . . . 0.0 112.578 178.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 91.5 mt -79.3 116.74 23.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.129 -179.379 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.456 ' HB2' HE22 ' A' ' 43' ' ' GLN . 22.4 m-20 -100.95 86.13 3.0 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 176.664 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 69.8 p -60.39 -27.06 67.14 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 115.661 1.726 . . . . 0.0 115.661 -173.69 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 19.7 p30 -108.18 21.38 17.43 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 -177.37 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 15.1 m -130.19 169.32 15.52 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 112.165 0.432 . . . . 0.0 112.165 -175.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 68.8 m -83.7 158.39 62.64 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.295 -176.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -67.42 -21.53 46.77 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 116.882 -1.612 . . . . 0.0 114.751 -177.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.464 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 4.1 p-10 -74.65 -17.04 60.75 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 121.927 -0.483 . . . . 0.0 110.856 178.814 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.446 ' HA ' ' HE3' ' A' ' 103' ' ' LYS . 0.0 OUTLIER -87.04 -16.32 35.99 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 114.925 1.454 . . . . 0.0 114.925 -174.269 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.456 HE22 ' HB2' ' A' ' 35' ' ' ASN . 84.0 mm-40 -57.81 -20.63 37.21 Favored 'General case' 0 C--O 1.218 -0.582 0 N-CA-C 114.093 1.145 . . . . 0.0 114.093 -172.154 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.412 ' HB ' ' HB1' ' A' ' 98' ' ' ALA . 20.6 tt -58.8 139.93 17.83 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 CA-C-O 122.401 1.095 . . . . 0.0 113.076 178.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 177.86 -153.61 13.54 Favored Glycine 0 N--CA 1.444 -0.792 0 C-N-CA 119.924 -1.131 . . . . 0.0 112.653 178.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 51.6 p90 -155.1 167.75 29.31 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 178.361 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 38.2 m-85 -108.74 140.28 42.38 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 106.435 -1.691 . . . . 0.0 106.435 174.419 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 65.3 ttt-85 -113.33 122.73 48.28 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.923 -177.82 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 49.0 ttp85 -68.62 136.89 53.71 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 177.008 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -134.85 136.41 42.43 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 179.041 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 14.8 t -152.9 159.19 42.98 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 106.697 -1.594 . . . . 0.0 106.697 176.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 21.6 tpt180 -157.74 142.27 16.33 Favored 'General case' 0 C--O 1.216 -0.663 0 N-CA-C 105.955 -1.869 . . . . 0.0 105.955 179.618 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -129.05 130.64 46.82 Favored 'General case' 0 CA--C 1.493 -1.223 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 176.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -128.89 173.05 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.003 0 N-CA-C 105.664 -1.976 . . . . 0.0 105.664 -179.14 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 6.6 tmm_? -140.33 112.76 7.9 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 106.024 -1.843 . . . . 0.0 106.024 175.811 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -74.04 164.24 54.7 Favored Glycine 0 C--O 1.226 -0.376 0 N-CA-C 110.448 -1.061 . . . . 0.0 110.448 -179.808 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -65.93 -33.8 86.7 Favored Glycine 0 C--O 1.217 -0.935 0 N-CA-C 110.522 -1.031 . . . . 0.0 110.522 -179.269 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.0 t0 -85.2 16.96 3.23 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-O 122.157 0.98 . . . . 0.0 110.968 179.352 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 84.77 -4.81 84.17 Favored Glycine 0 CA--C 1.509 -0.298 0 N-CA-C 116.071 1.188 . . . . 0.0 116.071 172.277 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.59 123.16 20.1 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.488 0.661 . . . . 0.0 111.785 -177.394 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 93.4 mmm -88.84 169.49 11.55 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.01 -0.996 . . . . 0.0 108.663 178.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 5.4 tmtt? -74.99 -52.74 10.37 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 177.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 58.37 -174.27 0.09 Allowed 'General case' 0 C--O 1.243 0.713 0 N-CA-C 115.547 1.684 . . . . 0.0 115.547 178.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.5 mm? 64.79 169.77 0.19 Allowed 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 115.018 1.488 . . . . 0.0 115.018 -179.461 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -70.62 163.25 65.35 Favored Pre-proline 0 C--O 1.243 0.723 0 CA-C-N 114.603 -1.181 . . . . 0.0 114.181 -176.331 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -72.12 166.8 28.58 Favored 'Trans proline' 0 C--N 1.351 0.666 0 CA-C-O 121.562 0.568 . . . . 0.0 112.736 177.748 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 22.9 mtp180 -117.91 166.3 12.65 Favored 'General case' 0 CA--C 1.512 -0.497 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 178.795 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 62.8 m95 -127.45 143.4 51.2 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 177.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.468 ' CZ ' ' HB2' ' A' ' 15' ' ' ALA . 60.7 m-85 -124.02 147.49 47.78 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 178.889 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 86.5 t80 -95.79 139.24 32.31 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 -177.356 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -142.44 140.6 32.01 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 -176.471 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.407 ' HB3' ' HB2' ' A' ' 103' ' ' LYS . 74.9 m-85 -68.1 159.44 30.91 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -179.313 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 19.1 tp -59.44 134.72 57.27 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 175.147 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 75.66 35.28 46.76 Favored Glycine 0 C--O 1.222 -0.638 0 N-CA-C 115.881 1.112 . . . . 0.0 115.881 177.22 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 21.7 p -110.13 153.08 25.2 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 118.288 1.044 . . . . 0.0 109.832 177.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 106.04 143.06 11.3 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 -177.528 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -71.11 -39.26 4.16 Favored 'Trans proline' 0 C--N 1.348 0.529 0 CA-C-N 119.651 1.725 . . . . 0.0 116.215 -173.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -117.09 17.56 14.82 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.436 -176.721 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -64.75 -52.04 59.12 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.882 -176.155 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 55.72 27.38 49.34 Favored Glycine 0 C--O 1.225 -0.458 0 N-CA-C 114.691 0.636 . . . . 0.0 114.691 179.179 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 75.2 mt -95.05 114.53 63.89 Favored Pre-proline 0 C--O 1.238 0.48 0 N-CA-C 114.874 1.435 . . . . 0.0 114.874 -175.449 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -76.85 166.75 26.44 Favored 'Trans proline' 0 N--CA 1.461 -0.41 0 N-CA-C 109.231 -1.103 . . . . 0.0 109.231 171.253 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 62.1 t80 -62.95 131.26 48.08 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 120.708 -0.397 . . . . 0.0 110.29 -179.219 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 92.39 -3.48 75.72 Favored Glycine 0 CA--C 1.52 0.396 0 N-CA-C 114.524 0.569 . . . . 0.0 114.524 179.156 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -63.03 130.94 46.89 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 117.863 0.832 . . . . 0.0 112.104 179.406 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 32.7 t-20 -78.3 125.85 29.95 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.568 -178.466 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 14.7 ttmm -155.55 150.47 26.53 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 176.743 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -63.36 131.36 48.01 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.245 179.585 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 70.66 25.88 74.98 Favored Glycine 0 N--CA 1.45 -0.418 0 CA-C-O 119.375 -0.681 . . . . 0.0 114.184 177.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 39.7 mm -128.83 128.14 67.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 117.515 0.658 . . . . 0.0 109.963 179.339 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.1 pt -130.13 115.26 32.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 CA-C-O 121.422 0.63 . . . . 0.0 110.891 176.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 97.4 m95 -82.07 132.22 35.25 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 112.941 0.719 . . . . 0.0 112.941 -176.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 1.1 m -142.05 152.95 18.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.187 -178.127 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -155.12 166.53 33.28 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 103.371 -2.826 . . . . 0.0 103.371 -178.824 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 14.5 t -122.76 169.13 11.39 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 104.206 -2.516 . . . . 0.0 104.206 174.481 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -65.37 137.16 57.32 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.193 0.52 . . . . 0.0 109.922 -179.495 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 91.19 -5.79 81.29 Favored Glycine 0 CA--C 1.516 0.119 0 CA-C-N 115.749 -0.659 . . . . 0.0 113.4 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.464 ' HA ' ' HA ' ' A' ' 41' ' ' ASP . . . -77.81 135.48 37.96 Favored 'General case' 0 CA--C 1.537 0.478 0 O-C-N 122.307 -0.525 . . . . 0.0 109.647 179.2 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 28.8 mt -88.25 136.37 33.01 Favored 'General case' 0 CA--C 1.509 -0.615 0 CA-C-O 121.601 0.715 . . . . 0.0 111.979 -178.249 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 54.4 t30 -82.59 67.95 8.84 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.978 -1.01 . . . . 0.0 110.588 -178.683 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -142.77 155.63 63.0 Favored Pre-proline 0 C--N 1.323 -0.57 0 N-CA-C 106.382 -1.711 . . . . 0.0 106.382 -179.102 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -66.83 150.6 83.23 Favored 'Trans proline' 0 CA--C 1.53 0.292 0 N-CA-C 114.78 1.031 . . . . 0.0 114.78 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.581 ' HB3' HD12 ' A' ' 106' ' ' ILE . 71.1 mmtt -126.89 36.88 4.38 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.152 179.758 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 14.0 p-10 -49.55 -42.77 45.04 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.268 0.556 . . . . 0.0 112.003 -177.796 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 15.4 p80 -67.5 -10.3 50.36 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 115.121 1.526 . . . . 0.0 115.121 -178.589 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.581 HD12 ' HB3' ' A' ' 103' ' ' LYS . 38.8 mt -91.93 -31.95 5.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 179.535 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -74.12 14.6 3.76 Favored Glycine 0 C--O 1.222 -0.597 0 N-CA-C 115.488 0.955 . . . . 0.0 115.488 -177.79 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 15.1 t -83.17 24.44 0.79 Allowed 'General case' 0 CA--C 1.547 0.862 0 N-CA-C 113.814 1.042 . . . . 0.0 113.814 -177.145 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 69.9 ttp85 -62.17 124.92 22.16 Favored 'General case' 0 N--CA 1.471 0.584 0 O-C-N 121.033 -1.042 . . . . 0.0 108.691 179.604 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 11.4 m-20 -99.56 125.34 41.17 Favored Pre-proline 0 C--N 1.323 -0.563 0 N-CA-C 106.307 -1.738 . . . . 0.0 106.307 179.381 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -68.85 -18.5 41.4 Favored 'Trans proline' 0 C--O 1.22 -0.421 0 C-N-CA 117.98 -0.88 . . . . 0.0 114.315 -176.126 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -75.41 -26.19 58.19 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.854 0.359 . . . . 0.0 110.621 178.04 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 -100.58 -25.86 14.03 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 -174.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 27.7 t30 -152.11 145.6 24.87 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 -179.423 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -86.7 149.39 24.92 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.402 179.69 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -66.8 142.34 57.39 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.295 0.569 . . . . 0.0 110.381 178.668 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 22.8 mt -84.15 139.26 17.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.312 -0.858 . . . . 0.0 108.689 -178.152 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 91.6 t -61.67 124.52 16.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 105.789 -1.93 . . . . 0.0 105.789 175.134 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 6.1 tt -66.51 128.74 37.37 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.098 0.475 . . . . 0.0 109.906 -177.257 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -129.88 151.8 50.05 Favored 'General case' 0 CA--C 1.507 -0.696 0 N-CA-C 106.285 -1.746 . . . . 0.0 106.285 -179.31 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 13.0 mt -110.16 148.32 38.1 Favored Pre-proline 0 C--N 1.321 -0.655 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 178.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -71.59 164.26 36.28 Favored 'Trans proline' 0 C--N 1.345 0.349 0 O-C-N 122.228 0.594 . . . . 0.0 112.999 -178.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 54.8 tt0 -54.25 131.12 40.93 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.628 -0.714 . . . . 0.0 109.685 -179.412 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 98.93 -17.7 57.84 Favored Glycine 0 C--O 1.228 -0.262 0 CA-C-N 115.829 -0.623 . . . . 0.0 112.494 -178.822 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 1.8 m -108.62 128.94 55.28 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 117.716 0.758 . . . . 0.0 110.587 178.052 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 6.0 p -124.91 151.05 45.88 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 179.37 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 72.6 mt -67.33 153.28 95.07 Favored Pre-proline 0 C--N 1.324 -0.525 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 -179.705 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -75.06 168.08 25.58 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 117.938 -0.908 . . . . 0.0 110.406 178.461 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -57.0 124.52 18.96 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 112.92 0.711 . . . . 0.0 112.92 -174.074 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 95.2 -6.06 68.55 Favored Glycine 0 C--O 1.229 -0.201 0 N-CA-C 115.818 1.087 . . . . 0.0 115.818 177.402 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.414 ' CZ ' ' HB2' ' A' ' 18' ' ' GLN . 1.7 m-85 -93.13 146.32 23.75 Favored 'General case' 0 N--CA 1.439 -1.013 0 CA-C-O 122.096 0.95 . . . . 0.0 110.416 179.362 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 46.8 p90 -144.75 160.58 41.0 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 113.793 -1.549 . . . . 0.0 108.12 174.438 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -102.56 142.84 33.07 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.092 0.472 . . . . 0.0 111.02 -177.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.423 ' HB3' ' HB ' ' A' ' 14' ' ' THR . 3.5 tp10 -70.12 131.61 44.56 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 177.779 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 92.29 -10.98 73.22 Favored Glycine 0 C--O 1.227 -0.298 0 C-N-CA 121.359 -0.448 . . . . 0.0 112.944 -178.526 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 41.9 t -91.69 144.02 25.95 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 106.957 -1.497 . . . . 0.0 106.957 176.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 2.9 tmt_? -78.0 -20.55 52.34 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.558 178.368 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 126.29 176.53 14.53 Favored Glycine 0 C--O 1.227 -0.306 0 N-CA-C 107.272 -2.331 . . . . 0.0 107.272 -177.335 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 80.28 42.79 10.13 Favored Glycine 0 C--O 1.226 -0.377 0 N-CA-C 110.246 -1.142 . . . . 0.0 110.246 -178.016 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 6.7 m . . . . . 0 C--O 1.25 1.083 0 N-CA-C 106.944 -1.502 . . . . 0.0 106.944 -178.149 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.762 0 CA-C-O 118.883 -0.954 . . . . 0.0 111.331 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -61.93 147.48 46.72 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 118.034 0.917 . . . . 0.0 108.691 178.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 65.2 mtm 59.7 16.79 5.75 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 113.596 0.961 . . . . 0.0 113.596 -179.207 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -84.26 60.18 4.86 Favored Glycine 0 C--O 1.227 -0.339 0 N-CA-C 112.124 -0.39 . . . . 0.0 112.124 178.639 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 10.3 mp -65.96 140.89 97.31 Favored Pre-proline 0 C--N 1.325 -0.488 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 -178.426 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -74.21 -22.28 16.87 Favored 'Trans proline' 0 C--N 1.349 0.567 0 N-CA-C 113.862 0.678 . . . . 0.0 113.862 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 26.7 t30 48.91 43.35 21.59 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 114.073 1.138 . . . . 0.0 114.073 178.134 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 15.4 t30 -83.13 46.63 1.14 Allowed 'General case' 0 N--CA 1.474 0.753 0 CA-C-O 121.421 0.629 . . . . 0.0 111.213 -179.154 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 17.4 p -148.1 129.27 14.61 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 104.078 -2.564 . . . . 0.0 104.078 179.124 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -139.19 146.39 40.49 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.462 0.649 . . . . 0.0 111.73 -179.057 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 35.7 t -63.16 144.0 57.3 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.144 177.775 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 18.1 m95 -67.34 -21.83 65.63 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 112.824 0.675 . . . . 0.0 112.824 178.025 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 39.8 m-85 -121.55 165.6 15.43 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 114.663 1.357 . . . . 0.0 114.663 -170.437 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 76.1 p -71.44 166.45 21.69 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 114.459 -1.246 . . . . 0.0 107.758 176.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.495 ' HB2' ' CZ ' ' A' ' 69' ' ' TYR . . . -78.01 157.51 29.62 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 113.54 0.941 . . . . 0.0 113.54 -175.554 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 12.9 mt -102.05 137.1 40.77 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 105.288 -2.116 . . . . 0.0 105.288 171.114 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 37.0 m -122.19 145.4 48.23 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 -177.278 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.419 ' HB2' ' CZ ' ' A' ' 131' ' ' PHE . 4.2 tp60 -112.51 142.89 44.54 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 114.664 1.357 . . . . 0.0 114.664 -175.172 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 72.4 t60 -131.98 99.46 4.75 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 104.663 -2.347 . . . . 0.0 104.663 166.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 171.04 -152.97 19.74 Favored Glycine 0 C--O 1.227 -0.309 0 N-CA-C 109.954 -1.258 . . . . 0.0 109.954 -175.374 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -117.39 -21.97 8.43 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-O 121.44 0.638 . . . . 0.0 110.865 179.455 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -72.65 151.0 42.5 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.311 -179.646 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 16.8 t0 -76.61 -62.59 1.58 Allowed 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 178.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 43.1 tp 179.64 143.35 0.15 Allowed 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 103.478 -2.786 . . . . 0.0 103.478 171.299 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 56.8 tptt -154.56 134.57 13.06 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 118.047 0.385 . . . . 0.0 110.188 176.001 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 12.0 m-85 -125.0 157.27 67.42 Favored Pre-proline 0 C--O 1.244 0.811 0 N-CA-C 106.291 -1.744 . . . . 0.0 106.291 175.363 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -72.2 175.02 10.51 Favored 'Trans proline' 0 CA--C 1.536 0.611 0 C-N-CA 121.174 1.249 . . . . 0.0 114.527 -178.526 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 46.7 tpt85 -78.33 127.45 32.24 Favored 'General case' 0 C--O 1.214 -0.815 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 178.351 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 80.17 10.5 85.41 Favored Glycine 0 C--O 1.223 -0.567 0 N-CA-C 115.417 0.927 . . . . 0.0 115.417 175.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.555 HE21 HG23 ' A' ' 125' ' ' THR . 22.3 tt0 -157.71 145.5 18.71 Favored 'General case' 0 C--O 1.219 -0.521 0 N-CA-C 106.264 -1.754 . . . . 0.0 106.264 -179.537 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 138.5 -14.61 3.43 Favored Glycine 0 CA--C 1.504 -0.607 0 C-N-CA 120.042 -1.075 . . . . 0.0 113.523 177.298 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 27.8 m -70.06 144.72 93.14 Favored Pre-proline 0 C--N 1.322 -0.595 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 176.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -76.16 174.28 13.09 Favored 'Trans proline' 0 N--CA 1.46 -0.496 0 C-N-CA 121.483 1.455 . . . . 0.0 111.773 178.523 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 92.4 mt -71.86 118.47 16.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 178.404 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 45.1 m-80 -111.29 87.08 2.46 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 179.515 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 82.1 p -66.84 -21.94 66.01 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 112.769 0.655 . . . . 0.0 112.769 -177.091 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 71.6 m-80 -105.62 34.71 3.15 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.875 -177.249 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 20.6 m -145.84 150.41 36.11 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.745 0.307 . . . . 0.0 111.603 -179.4 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 25.3 m -71.31 164.19 59.39 Favored Pre-proline 0 C--N 1.325 -0.484 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 176.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -64.57 -26.8 61.66 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 114.926 -2.916 . . . . 0.0 111.598 177.721 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 51.2 m-20 -63.03 -27.39 69.38 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.827 177.001 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.491 ' HA ' ' HE3' ' A' ' 103' ' ' LYS . 67.9 m-20 -93.41 -6.62 46.68 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 115.569 1.692 . . . . 0.0 115.569 -171.878 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 92.0 mm-40 -60.43 -33.12 72.06 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 115.097 1.517 . . . . 0.0 115.097 -176.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 14.5 tt -60.1 140.62 17.86 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 CA-C-O 122.137 0.97 . . . . 0.0 113.117 -178.686 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 179.85 -149.34 8.53 Favored Glycine 0 C--O 1.227 -0.325 0 CA-C-N 115.623 -0.717 . . . . 0.0 112.455 -176.675 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 50.7 p90 -155.08 171.98 18.89 Favored 'General case' 0 C--N 1.319 -0.72 0 O-C-N 122.187 -0.596 . . . . 0.0 109.959 179.164 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 28.7 m-85 -114.25 142.99 45.57 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 173.222 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 68.5 ttt180 -115.22 125.88 53.89 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 123.739 0.815 . . . . 0.0 110.628 -178.329 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 6.3 ttp85 -71.26 135.52 47.49 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 107.675 -1.231 . . . . 0.0 107.675 176.317 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -135.35 129.64 33.73 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 123.218 0.607 . . . . 0.0 111.212 -178.732 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 15.0 t -159.96 155.43 25.45 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 174.271 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 20.3 tpt180 -161.26 139.18 9.33 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 105.319 -2.104 . . . . 0.0 105.319 178.021 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -88.44 135.38 33.5 Favored 'General case' 0 CA--C 1.505 -0.761 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 179.532 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -127.87 173.56 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.766 0 N-CA-C 106.826 -1.546 . . . . 0.0 106.826 -178.854 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.15 117.15 15.29 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 178.611 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -73.87 157.25 51.32 Favored Glycine 0 C--O 1.23 -0.125 0 N-CA-C 107.273 -2.331 . . . . 0.0 107.273 176.09 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -58.49 -35.7 81.19 Favored Glycine 0 N--CA 1.461 0.347 0 CA-C-N 119.017 1.408 . . . . 0.0 112.184 -177.038 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -73.43 0.8 11.25 Favored 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 124.64 1.176 . . . . 0.0 113.553 -179.376 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 93.44 14.54 53.32 Favored Glycine 0 C--N 1.317 -0.505 0 CA-C-N 114.38 -1.282 . . . . 0.0 113.027 174.239 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 16.4 mmtt -79.02 130.6 35.7 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.393 0.616 . . . . 0.0 110.635 -175.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 1.4 mmt -86.08 161.06 19.09 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.008 -0.997 . . . . 0.0 110.47 179.613 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 22.6 tptp -64.45 -52.52 57.6 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.383 176.771 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.4 t70 45.33 -149.89 0.07 Allowed 'General case' 0 CA--C 1.549 0.905 0 O-C-N 124.842 1.339 . . . . 0.0 112.315 -176.424 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 62.0 mt 52.94 178.73 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.814 0 N-CA-C 118.407 2.743 . . . . 0.0 118.407 174.335 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 2.1 p -74.2 159.51 83.66 Favored Pre-proline 0 C--O 1.245 0.853 0 CA-C-N 115.124 -0.943 . . . . 0.0 112.904 -177.721 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -77.05 175.89 10.82 Favored 'Trans proline' 0 C--N 1.352 0.722 0 N-CA-C 110.796 -0.502 . . . . 0.0 110.796 174.088 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 33.3 ptt-85 -132.13 163.32 28.77 Favored 'General case' 0 C--O 1.218 -0.56 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 177.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 56.3 m95 -122.93 150.2 43.25 Favored 'General case' 0 C--O 1.212 -0.882 0 C-N-CA 122.468 0.307 . . . . 0.0 111.224 -177.186 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.495 ' CZ ' ' HB2' ' A' ' 15' ' ' ALA . 56.1 m-85 -128.12 147.29 50.54 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 177.72 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 88.7 t80 -94.43 135.46 35.83 Favored 'General case' 0 CA--C 1.506 -0.747 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 -177.274 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -136.99 131.98 33.68 Favored 'General case' 0 N--CA 1.437 -1.096 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 -175.657 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 74.2 m-85 -70.89 159.57 34.41 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.037 -176.134 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -53.07 125.46 17.41 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.829 -178.218 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 71.57 23.32 78.18 Favored Glycine 0 C--O 1.224 -0.474 0 N-CA-C 116.309 1.284 . . . . 0.0 116.309 177.056 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 18.3 p -89.27 146.09 24.96 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 119.056 1.428 . . . . 0.0 108.842 177.402 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 99.32 133.05 7.94 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 110.167 -1.173 . . . . 0.0 110.167 -177.821 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -72.3 -31.48 11.59 Favored 'Trans proline' 0 CA--C 1.516 -0.419 0 CA-C-N 119.524 1.662 . . . . 0.0 115.389 -175.133 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -102.77 12.13 36.66 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 114.133 -1.394 . . . . 0.0 108.93 -175.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -60.79 -48.15 83.09 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.577 -173.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 55.66 36.77 65.92 Favored Glycine 0 C--N 1.33 0.21 0 CA-C-N 116.043 -0.526 . . . . 0.0 112.718 179.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 14.7 mt -124.78 103.92 30.79 Favored Pre-proline 0 N--CA 1.444 -0.767 0 N-CA-C 115.503 1.668 . . . . 0.0 115.503 -175.471 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -79.08 161.89 26.29 Favored 'Trans proline' 0 N--CA 1.463 -0.313 0 C-N-CA 122.517 2.145 . . . . 0.0 107.683 167.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 57.1 t80 -60.86 131.21 49.96 Favored 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 120.373 -0.531 . . . . 0.0 110.579 -177.411 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 92.33 -7.51 78.02 Favored Glycine 0 C--O 1.228 -0.269 0 CA-C-O 119.349 -0.695 . . . . 0.0 114.65 179.11 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -66.62 131.12 45.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 118.649 1.224 . . . . 0.0 111.336 179.503 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 56.7 t30 -78.73 129.18 34.38 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.627 -179.388 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 30.0 ttmt -156.17 153.27 28.99 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 106.492 -1.67 . . . . 0.0 106.492 179.29 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -63.48 130.82 46.01 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.051 0.453 . . . . 0.0 111.165 -178.105 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 68.5 27.64 73.68 Favored Glycine 0 N--CA 1.449 -0.483 0 CA-C-O 119.263 -0.743 . . . . 0.0 113.994 177.652 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 45.9 mm -123.28 125.57 72.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 117.487 0.644 . . . . 0.0 110.303 179.331 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -127.85 115.25 38.56 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 CA-C-O 121.575 0.702 . . . . 0.0 111.296 177.061 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 97.7 m95 -80.45 137.45 36.49 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -177.794 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -142.61 154.34 17.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 -178.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -157.27 166.64 32.6 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 105.695 -1.965 . . . . 0.0 105.695 -177.096 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 14.7 t -125.84 166.49 16.75 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 104.03 -2.582 . . . . 0.0 104.03 173.205 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 77.7 tt0 -67.68 137.67 55.72 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 121.108 0.48 . . . . 0.0 109.879 -178.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 95.45 -19.23 55.25 Favored Glycine 0 C--O 1.224 -0.521 0 CA-C-N 115.705 -0.68 . . . . 0.0 112.973 178.042 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -67.81 137.93 55.75 Favored 'General case' 0 CA--C 1.542 0.661 0 O-C-N 122.542 -0.387 . . . . 0.0 110.753 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 47.0 mt -92.21 136.55 33.1 Favored 'General case' 0 CA--C 1.514 -0.425 0 N-CA-C 113.771 1.026 . . . . 0.0 113.771 -176.349 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 63.6 t30 -80.39 61.34 4.12 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.21 -0.905 . . . . 0.0 110.939 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 2.6 t -133.12 160.93 66.73 Favored Pre-proline 0 C--N 1.322 -0.588 0 N-CA-C 104.452 -2.425 . . . . 0.0 104.452 -179.133 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_exo -64.58 152.06 83.24 Favored 'Trans proline' 0 CA--C 1.534 0.475 0 N-CA-C 116.669 1.757 . . . . 0.0 116.669 -177.298 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.491 ' HE3' ' HA ' ' A' ' 42' ' ' ASP . 0.4 OUTLIER -127.19 31.93 5.15 Favored 'General case' 0 CA--C 1.515 -0.388 0 C-N-CA 124.545 1.138 . . . . 0.0 109.416 176.784 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 15.2 p-10 -55.22 -36.89 66.46 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.285 -0.871 . . . . 0.0 109.84 179.284 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 16.7 p80 -60.8 -13.65 16.63 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 114.832 1.419 . . . . 0.0 114.832 179.377 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 10.8 mt -96.27 -23.71 4.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 121.14 0.495 . . . . 0.0 110.787 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -76.19 1.25 60.74 Favored Glycine 0 C--O 1.227 -0.303 0 N-CA-C 115.559 0.984 . . . . 0.0 115.559 -175.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 14.6 t -83.08 16.06 2.53 Favored 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 113.848 1.055 . . . . 0.0 113.848 -177.514 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.446 ' HD2' HD22 ' A' ' 114' ' ' ASN . 63.1 ttp85 -66.26 129.75 40.89 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 177.781 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -111.73 134.19 21.36 Favored Pre-proline 0 C--N 1.325 -0.491 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 179.429 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_endo -69.76 -21.55 33.31 Favored 'Trans proline' 0 C--O 1.217 -0.535 0 N-CA-C 115.314 1.236 . . . . 0.0 115.314 -174.447 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -74.81 -24.09 58.58 Favored 'General case' 0 C--O 1.22 -0.49 0 CA-C-O 121.094 0.473 . . . . 0.0 110.478 178.391 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 83.5 m-20 -97.72 -22.49 16.41 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 113.302 0.853 . . . . 0.0 113.302 -175.068 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.446 HD22 ' HD2' ' A' ' 109' ' ' ARG . 19.6 t30 -157.99 150.03 21.99 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 112.0 0.371 . . . . 0.0 112.0 -178.356 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -87.27 147.47 25.52 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-O 121.575 0.702 . . . . 0.0 112.182 179.751 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -72.73 147.92 45.15 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.27 178.13 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 15.0 mt -91.42 139.43 17.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.226 -178.156 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 73.9 t -60.13 125.41 16.2 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 N-CA-C 106.572 -1.64 . . . . 0.0 106.572 175.084 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 6.4 tt -66.6 129.19 39.04 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.101 0.477 . . . . 0.0 110.168 -177.324 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 31.0 mt-30 -131.26 156.66 45.03 Favored 'General case' 0 CA--C 1.511 -0.534 0 N-CA-C 107.062 -1.459 . . . . 0.0 107.062 -178.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.426 HD13 HG22 ' A' ' 125' ' ' THR . 14.4 mt -113.25 148.07 38.75 Favored Pre-proline 0 C--N 1.321 -0.631 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 178.438 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -72.06 167.5 26.58 Favored 'Trans proline' 0 C--N 1.345 0.392 0 O-C-N 122.229 0.594 . . . . 0.0 112.969 -179.335 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -55.56 133.48 50.35 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.814 -179.498 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 91.91 -14.75 63.48 Favored Glycine 0 C--O 1.227 -0.332 0 CA-C-N 116.05 -0.523 . . . . 0.0 113.368 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.555 HG23 HE21 ' A' ' 30' ' ' GLN . 16.7 m -105.95 126.94 52.79 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 117.841 0.82 . . . . 0.0 110.309 179.012 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 6.9 p -118.51 148.24 42.83 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.78 -178.268 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 84.9 mt -69.94 153.61 95.31 Favored Pre-proline 0 C--N 1.325 -0.472 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 177.661 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -76.15 173.48 14.42 Favored 'Trans proline' 0 C--O 1.235 0.345 0 N-CA-C 110.531 -0.604 . . . . 0.0 110.531 178.624 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 8.2 tmtt? -53.83 126.61 22.84 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.21 0.528 . . . . 0.0 112.224 -175.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 85.29 -1.55 88.52 Favored Glycine 0 N--CA 1.454 -0.144 0 N-CA-C 116.861 1.504 . . . . 0.0 116.861 173.743 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.419 ' CZ ' ' HB2' ' A' ' 18' ' ' GLN . 1.5 m-85 -94.71 141.26 28.82 Favored 'General case' 0 N--CA 1.436 -1.167 0 CA-C-O 122.069 0.938 . . . . 0.0 110.436 -179.209 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 42.8 p90 -142.08 161.47 37.92 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 113.639 -1.618 . . . . 0.0 108.351 176.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -103.0 143.74 32.18 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.345 0.593 . . . . 0.0 111.705 -176.842 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -70.68 135.3 48.22 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 179.693 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 81.89 -9.69 55.43 Favored Glycine 0 CA--C 1.52 0.365 0 CA-C-N 116.118 -0.492 . . . . 0.0 114.095 -178.75 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 28.8 t -86.66 122.46 30.6 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 117.926 0.863 . . . . 0.0 110.51 -179.534 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 26.2 mmt180 -96.85 -21.46 17.49 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.767 177.355 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 81.18 -44.68 3.08 Favored Glycine 0 C--O 1.225 -0.449 0 C-N-CA 121.71 -0.281 . . . . 0.0 112.974 -178.125 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -168.0 -167.86 29.27 Favored Glycine 0 N--CA 1.451 -0.34 0 N-CA-C 107.487 -2.245 . . . . 0.0 107.487 179.299 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 47.2 t . . . . . 0 C--O 1.245 0.827 0 N-CA-C 105.097 -2.186 . . . . 0.0 105.097 179.01 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.177 0 CA-C-O 118.265 -1.297 . . . . 0.0 111.299 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 50.76 36.5 14.51 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 115.771 1.767 . . . . 0.0 115.771 176.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 26.9 ptt? -81.79 15.43 2.2 Favored 'General case' 0 N--CA 1.473 0.69 0 O-C-N 121.74 -0.6 . . . . 0.0 112.507 -179.409 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -115.71 43.14 1.73 Allowed Glycine 0 C--O 1.223 -0.538 0 N-CA-C 111.708 -0.557 . . . . 0.0 111.708 -178.362 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 89.6 mt -64.17 147.41 96.81 Favored Pre-proline 0 CA--C 1.539 0.539 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 -179.755 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -76.24 51.22 3.12 Favored 'Trans proline' 0 CA--C 1.546 1.104 0 C-N-CA 122.454 2.102 . . . . 0.0 114.712 -177.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 44.2 t30 -102.54 87.02 2.9 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.478 0.656 . . . . 0.0 109.857 -178.463 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 16.9 m-80 -67.15 -23.43 65.79 Favored 'General case' 0 C--O 1.216 -0.666 0 N-CA-C 116.581 2.067 . . . . 0.0 116.581 -178.788 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 40.6 p -37.24 94.88 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 125.809 1.644 . . . . 0.0 114.827 -174.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -109.27 146.18 34.7 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 113.114 -1.857 . . . . 0.0 113.157 -173.523 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 32.9 p -62.21 140.91 58.44 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 114.853 -1.067 . . . . 0.0 109.982 178.803 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . 0.405 ' CD2' ' HD3' ' A' ' 109' ' ' ARG . 17.4 m95 -67.62 -21.81 65.37 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 113.795 1.035 . . . . 0.0 113.795 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 36.8 m-85 -121.55 160.87 23.39 Favored 'General case' 0 CA--C 1.509 -0.621 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 -172.598 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 67.7 p -69.47 162.03 28.26 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 178.836 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.445 ' HB2' ' CZ ' ' A' ' 69' ' ' TYR . . . -78.31 147.12 34.38 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 114.084 1.142 . . . . 0.0 114.084 -175.726 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 27.1 mt -89.02 148.88 23.52 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 105.149 -2.167 . . . . 0.0 105.149 170.634 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.6 m -122.97 144.85 48.97 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 179.473 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 3.8 tp60 -109.99 154.79 22.67 Favored 'General case' 0 C--N 1.328 -0.339 0 O-C-N 123.762 0.664 . . . . 0.0 110.742 -176.283 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 67.9 t60 -139.34 99.51 3.76 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 105.588 -2.004 . . . . 0.0 105.588 170.086 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 163.09 -171.63 38.9 Favored Glycine 0 N--CA 1.452 -0.239 0 N-CA-C 110.653 -0.979 . . . . 0.0 110.653 -177.778 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -99.56 -22.52 15.43 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 112.477 0.547 . . . . 0.0 112.477 179.672 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -83.44 161.99 21.12 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.963 -178.168 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -75.55 -62.94 1.4 Allowed 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 114.539 1.311 . . . . 0.0 114.539 -175.894 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 32.2 tp 157.23 144.84 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.283 0 N-CA-C 104.935 -2.246 . . . . 0.0 104.935 -175.56 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 56.1 tptt -156.02 141.39 17.61 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 108.779 -0.822 . . . . 0.0 108.779 173.009 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 15.1 m-85 -122.97 150.7 59.77 Favored Pre-proline 0 C--O 1.242 0.699 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 175.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -74.22 163.21 37.04 Favored 'Trans proline' 0 C--N 1.352 0.752 0 C-N-CA 120.88 1.053 . . . . 0.0 113.383 179.467 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 4.1 tmt_? -65.36 133.71 51.95 Favored 'General case' 0 N--CA 1.473 0.707 0 O-C-N 122.045 -0.409 . . . . 0.0 110.493 -178.484 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 88.12 1.34 82.0 Favored Glycine 0 C--O 1.228 -0.235 0 N-CA-C 111.912 -0.475 . . . . 0.0 111.912 178.614 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 33.0 mt-30 -141.83 171.65 13.77 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 123.455 0.702 . . . . 0.0 110.4 -174.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 107.06 -25.26 22.78 Favored Glycine 0 CA--C 1.497 -1.049 0 CA-C-N 115.54 -0.754 . . . . 0.0 111.937 175.176 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 95.7 t -63.72 127.4 91.47 Favored Pre-proline 0 C--N 1.318 -0.779 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 177.736 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -73.46 171.58 17.42 Favored 'Trans proline' 0 N--CA 1.462 -0.351 0 O-C-N 122.142 0.548 . . . . 0.0 111.385 178.189 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 86.1 mt -69.81 107.02 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-O 121.963 0.887 . . . . 0.0 108.892 -179.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 75.3 m-20 -99.96 84.82 2.94 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 114.626 -1.17 . . . . 0.0 109.9 -177.36 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 69.6 p -67.06 -15.74 63.91 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 112.94 0.719 . . . . 0.0 112.94 -178.631 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 12.3 p30 -107.13 22.77 15.47 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.375 -0.83 . . . . 0.0 112.382 -177.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 15.0 m -140.5 148.89 41.77 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 113.787 1.032 . . . . 0.0 113.787 -176.525 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -74.37 167.35 36.73 Favored Pre-proline 0 N--CA 1.468 0.447 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 177.194 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -64.93 -28.48 58.27 Favored 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 114.663 -3.091 . . . . 0.0 111.827 178.309 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -62.11 -24.31 67.06 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 123.883 0.873 . . . . 0.0 111.658 176.743 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 71.6 m-20 -98.41 -2.57 38.81 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 114.957 1.466 . . . . 0.0 114.957 -172.183 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 94.5 mm-40 -60.77 -28.94 69.11 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 114.543 1.312 . . . . 0.0 114.543 -178.21 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 12.9 tt -60.07 139.31 19.78 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.846 0 CA-C-O 122.358 1.075 . . . . 0.0 113.339 -177.677 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -177.94 -155.96 15.38 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.84 -0.695 . . . . 0.0 111.903 -178.478 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 49.8 p90 -155.05 168.59 26.51 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 178.665 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 22.5 m-85 -108.99 141.35 41.22 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 172.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 51.7 ttt180 -115.0 120.54 40.23 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 114.917 -1.038 . . . . 0.0 111.919 -174.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 38.9 ttp180 -68.47 134.7 50.52 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 176.159 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -150.79 151.11 31.85 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.159 0.504 . . . . 0.0 111.494 -178.393 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 14.3 t -158.9 164.98 35.18 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 174.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 14.3 tpt180 -149.83 123.83 9.38 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 105.367 -2.086 . . . . 0.0 105.367 177.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 4.6 tmm_? -88.9 128.01 35.66 Favored 'General case' 0 CA--C 1.498 -1.054 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 -179.21 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -128.6 169.83 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.107 0 N-CA-C 105.725 -1.954 . . . . 0.0 105.725 179.032 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 1.1 ttt-85 -144.04 110.72 5.62 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 176.131 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -71.17 160.88 54.13 Favored Glycine 0 N--CA 1.449 -0.443 0 N-CA-C 107.891 -2.084 . . . . 0.0 107.891 176.492 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -69.94 -33.8 70.61 Favored Glycine 0 C--O 1.222 -0.596 0 N-CA-C 109.899 -1.28 . . . . 0.0 109.899 -178.106 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.2 t0 -73.12 3.54 5.45 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 114.133 -1.033 . . . . 0.0 111.831 179.422 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 96.6 -9.12 66.53 Favored Glycine 0 C--O 1.226 -0.353 0 CA-C-N 115.725 -0.67 . . . . 0.0 114.5 175.48 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.49 106.7 4.68 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.759 0.79 . . . . 0.0 111.751 -178.185 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 18.6 mtp -88.8 -179.98 6.1 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 114.783 -1.099 . . . . 0.0 109.124 179.313 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 23.9 tptp -73.88 -59.5 2.69 Favored 'General case' 0 CA--C 1.51 -0.58 0 C-N-CA 120.603 -0.439 . . . . 0.0 111.409 -179.609 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 47.02 -161.53 0.03 OUTLIER 'General case' 0 C--O 1.25 1.082 0 O-C-N 125.358 1.661 . . . . 0.0 115.256 -179.339 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 82.2 mt 53.48 -176.66 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 116.489 2.033 . . . . 0.0 116.489 178.711 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 24.3 m -65.04 154.01 87.65 Favored Pre-proline 0 C--O 1.24 0.596 0 CA-C-N 115.182 -0.917 . . . . 0.0 112.336 -177.303 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -73.8 175.5 10.69 Favored 'Trans proline' 0 C--N 1.348 0.506 0 CA-C-O 122.015 0.756 . . . . 0.0 113.72 -179.353 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 1.2 mmt180 -106.55 159.99 15.76 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 114.897 -1.047 . . . . 0.0 108.294 -178.817 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 73.2 m95 -128.3 125.02 37.96 Favored 'General case' 0 C--O 1.215 -0.748 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 176.252 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.445 ' CZ ' ' HB2' ' A' ' 15' ' ' ALA . 33.9 m-85 -110.99 156.54 21.09 Favored 'General case' 0 C--O 1.213 -0.849 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 -178.727 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 81.2 t80 -101.76 135.31 43.5 Favored 'General case' 0 CA--C 1.51 -0.596 0 CA-C-N 119.204 0.911 . . . . 0.0 108.94 -179.297 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -136.92 147.46 46.41 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 -176.583 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 84.3 m-85 -82.5 159.43 22.86 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.069 -176.709 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -54.67 130.26 39.71 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.991 0.424 . . . . 0.0 111.066 -179.28 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 73.54 26.23 70.41 Favored Glycine 0 C--O 1.219 -0.837 0 N-CA-C 116.107 1.203 . . . . 0.0 116.107 176.63 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 5.3 p -89.14 146.16 24.97 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 118.775 1.287 . . . . 0.0 109.724 178.13 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 105.89 139.73 9.75 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 107.395 -2.282 . . . . 0.0 107.395 -175.489 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -67.24 -42.91 6.93 Favored 'Trans proline' 0 C--N 1.346 0.424 0 CA-C-N 119.915 1.858 . . . . 0.0 116.126 -172.724 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -114.78 39.1 2.94 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 -177.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -66.83 -47.38 72.17 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.967 -178.055 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 57.52 23.93 50.76 Favored Glycine 0 CA--C 1.521 0.464 0 N-CA-C 114.439 0.536 . . . . 0.0 114.439 179.377 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 42.9 mt -102.57 109.72 61.43 Favored Pre-proline 0 C--O 1.238 0.452 0 N-CA-C 115.318 1.599 . . . . 0.0 115.318 -175.6 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -76.97 166.14 27.25 Favored 'Trans proline' 0 C--O 1.237 0.427 0 N-CA-C 108.669 -1.32 . . . . 0.0 108.669 170.144 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.417 ' CE1' ' HB3' ' A' ' 92' ' ' TRP . 62.5 t80 -62.8 133.68 55.12 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 120.491 -0.484 . . . . 0.0 110.069 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 90.37 -5.45 82.7 Favored Glycine 0 CA--C 1.519 0.317 0 N-CA-C 114.489 0.556 . . . . 0.0 114.489 178.815 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -63.08 132.33 51.54 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 117.901 0.85 . . . . 0.0 112.22 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 51.5 t30 -74.52 126.26 30.39 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.903 -0.59 . . . . 0.0 112.094 -178.809 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 15.2 ttmm -156.14 149.86 24.96 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 176.799 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -63.63 132.79 52.26 Favored 'General case' 0 C--N 1.321 -0.64 0 O-C-N 123.251 0.345 . . . . 0.0 110.802 -179.646 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 66.87 28.41 73.77 Favored Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 121.037 -0.602 . . . . 0.0 114.481 177.328 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 40.9 mm -127.5 126.43 67.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 117.302 0.551 . . . . 0.0 109.993 179.41 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.1 pt -128.13 115.15 37.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 121.812 0.815 . . . . 0.0 110.889 176.307 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . 0.417 ' HB3' ' CE1' ' A' ' 83' ' ' TYR . 95.8 m95 -79.03 135.73 36.97 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.983 -0.553 . . . . 0.0 112.34 -177.886 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 17.0 m -137.3 149.72 25.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.566 0.698 . . . . 0.0 109.534 179.72 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -157.59 166.6 32.44 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 104.333 -2.469 . . . . 0.0 104.333 -178.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 6.6 t -138.21 177.04 8.17 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 106.037 -1.838 . . . . 0.0 106.037 177.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -67.61 135.08 52.32 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.056 0.455 . . . . 0.0 110.51 -178.255 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 96.02 -8.29 67.59 Favored Glycine 0 C--O 1.224 -0.52 0 CA-C-N 115.938 -0.574 . . . . 0.0 113.514 178.688 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -81.22 139.23 35.62 Favored 'General case' 0 C--N 1.324 -0.541 0 O-C-N 122.443 -0.446 . . . . 0.0 111.456 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 47.3 mt -90.04 138.7 31.29 Favored 'General case' 0 CA--C 1.512 -0.495 0 CA-C-O 120.805 0.336 . . . . 0.0 111.284 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 62.4 t30 -83.42 68.13 9.6 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.992 0.425 . . . . 0.0 110.743 179.806 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 1.1 t -141.67 151.71 60.96 Favored Pre-proline 0 C--O 1.24 0.566 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 -178.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -66.24 153.15 79.18 Favored 'Trans proline' 0 C--N 1.345 0.39 0 N-CA-C 113.645 0.594 . . . . 0.0 113.645 176.597 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 1.4 ptpm? -152.25 56.49 0.83 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 122.502 1.144 . . . . 0.0 110.809 -179.235 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -59.66 -27.13 66.12 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 114.535 -1.211 . . . . 0.0 111.443 179.35 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 12.7 p80 -59.71 -12.4 6.97 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 114.029 1.122 . . . . 0.0 114.029 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 55.3 mt -91.94 -43.07 13.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 177.367 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -77.12 11.45 15.92 Favored Glycine 0 C--O 1.224 -0.495 0 N-CA-C 114.825 0.69 . . . . 0.0 114.825 -177.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 6.6 t -83.2 17.84 1.91 Allowed 'General case' 0 CA--C 1.545 0.778 0 CA-C-O 122.214 1.007 . . . . 0.0 110.416 178.782 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.442 ' HD2' ' OD1' ' A' ' 114' ' ' ASN . 62.7 ttp85 -59.32 131.46 51.06 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.786 -179.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 10.2 m-20 -100.22 122.04 51.58 Favored Pre-proline 0 C--N 1.326 -0.444 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -71.06 -15.06 32.3 Favored 'Trans proline' 0 C--O 1.218 -0.485 0 N-CA-C 113.672 0.604 . . . . 0.0 113.672 -177.74 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -76.16 -24.38 54.82 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.853 0.359 . . . . 0.0 110.912 177.628 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -101.47 -26.09 13.69 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 113.499 0.926 . . . . 0.0 113.499 -175.5 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.442 ' OD1' ' HD2' ' A' ' 109' ' ' ARG . 0.4 OUTLIER -142.77 153.64 43.46 Favored 'General case' 0 N--CA 1.437 -1.119 0 CA-C-O 121.031 0.443 . . . . 0.0 111.428 -176.694 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -99.23 142.22 30.99 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.626 177.082 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -69.23 150.07 47.85 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.403 0.62 . . . . 0.0 112.17 -179.08 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 6.8 mt -86.14 138.42 19.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.382 -0.826 . . . . 0.0 109.23 -178.591 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 97.1 t -60.73 124.08 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 N-CA-C 106.754 -1.573 . . . . 0.0 106.754 176.064 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 6.7 tt -66.5 130.6 43.74 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.226 0.536 . . . . 0.0 111.372 -175.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 28.7 mt-30 -131.82 156.77 45.46 Favored 'General case' 0 CA--C 1.514 -0.43 0 N-CA-C 106.827 -1.545 . . . . 0.0 106.827 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 13.9 mt -113.12 147.4 37.21 Favored Pre-proline 0 C--N 1.323 -0.559 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 178.151 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -74.76 169.67 22.06 Favored 'Trans proline' 0 C--N 1.345 0.374 0 O-C-N 122.224 0.592 . . . . 0.0 113.465 -179.384 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 36.8 tt0 -54.25 131.34 41.39 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.317 178.857 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 99.78 -22.47 40.23 Favored Glycine 0 C--O 1.227 -0.321 0 CA-C-O 119.439 -0.645 . . . . 0.0 113.474 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 5.7 m -108.75 129.29 55.37 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 118.461 1.13 . . . . 0.0 111.179 179.071 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 7.1 p -123.34 149.16 45.24 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.793 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 96.7 mt -71.48 151.09 93.93 Favored Pre-proline 0 C--N 1.324 -0.522 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 178.448 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -79.11 178.25 7.72 Favored 'Trans proline' 0 CA--C 1.531 0.361 0 C-N-CA 120.33 0.686 . . . . 0.0 112.296 179.31 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 64.4 tttp -57.17 129.95 44.02 Favored 'General case' 0 C--O 1.219 -0.504 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.224 -178.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 87.18 -1.98 86.61 Favored Glycine 0 C--O 1.226 -0.379 0 N-CA-C 115.425 0.93 . . . . 0.0 115.425 175.76 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -101.1 137.11 39.9 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-O 121.883 0.849 . . . . 0.0 112.433 -178.136 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 48.4 p90 -145.4 164.44 31.51 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 114.343 -1.299 . . . . 0.0 108.735 176.564 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -104.84 144.89 31.15 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 -176.246 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -71.62 136.23 47.27 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 177.804 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 94.06 -8.96 73.0 Favored Glycine 0 C--O 1.225 -0.445 0 C-N-CA 121.425 -0.417 . . . . 0.0 112.297 178.859 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 32.8 t -112.29 142.93 44.19 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 110.305 -0.257 . . . . 0.0 110.305 178.018 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER 52.29 63.84 2.08 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 113.722 1.008 . . . . 0.0 113.722 176.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -162.56 171.46 38.41 Favored Glycine 0 C--O 1.225 -0.442 0 N-CA-C 107.012 -2.435 . . . . 0.0 107.012 177.276 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 80.02 34.11 31.16 Favored Glycine 0 C--O 1.227 -0.298 0 CA-C-N 118.266 1.033 . . . . 0.0 112.636 179.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 78.7 p . . . . . 0 C--O 1.256 1.412 0 CA-C-O 115.273 -2.299 . . . . 0.0 106.433 -178.997 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.706 0 CA-C-O 118.693 -1.059 . . . . 0.0 111.122 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -68.75 147.7 51.41 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 117.989 0.894 . . . . 0.0 110.945 -179.406 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 26.6 ttt -157.17 138.74 13.98 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 105.217 -2.142 . . . . 0.0 105.217 177.041 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 136.27 -66.57 0.55 Allowed Glycine 0 C--O 1.227 -0.325 0 C-N-CA 121.199 -0.524 . . . . 0.0 112.958 178.227 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 9.5 mp -67.74 139.21 93.54 Favored Pre-proline 0 C--N 1.326 -0.447 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 -178.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -79.79 138.3 13.21 Favored 'Trans proline' 0 CA--C 1.533 0.441 0 C-N-CA 118.446 -0.569 . . . . 0.0 112.317 176.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 49.1 t30 -79.8 -20.53 45.93 Favored 'General case' 0 C--O 1.219 -0.514 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 175.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 59.7 t30 60.4 49.38 6.93 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.94 1.296 . . . . 0.0 112.058 178.131 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 69.0 p -140.12 131.09 26.15 Favored 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 -177.539 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -134.07 135.75 43.5 Favored 'General case' 0 C--N 1.312 -1.038 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 174.735 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 34.7 p -66.84 141.74 57.57 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 -178.291 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . 0.407 ' CD2' ' HD3' ' A' ' 109' ' ' ARG . 20.6 m95 -67.07 -26.95 66.99 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 178.597 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 24.9 m-85 -121.38 164.89 16.35 Favored 'General case' 0 C--O 1.241 0.633 0 N-CA-C 113.74 1.015 . . . . 0.0 113.74 -171.837 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 56.1 p -68.23 167.97 13.23 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 114.609 -1.178 . . . . 0.0 110.204 179.045 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.489 ' HB2' ' CZ ' ' A' ' 69' ' ' TYR . . . -81.61 142.35 32.86 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 114.531 1.308 . . . . 0.0 114.531 -174.845 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 25.3 mt -84.42 146.8 27.46 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 102.55 -3.13 . . . . 0.0 102.55 167.554 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 29.8 m -130.12 141.28 50.7 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 -178.182 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.402 ' HB2' ' CZ ' ' A' ' 131' ' ' PHE . 4.3 tp60 -109.64 140.42 43.5 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 -176.181 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 53.6 t60 -131.07 99.93 5.05 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 104.054 -2.573 . . . . 0.0 104.054 168.846 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 163.97 -162.93 35.57 Favored Glycine 0 C--O 1.227 -0.301 0 N-CA-C 108.252 -1.939 . . . . 0.0 108.252 -175.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 90.2 mttt -111.36 -22.17 11.47 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 115.207 1.558 . . . . 0.0 115.207 -178.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -75.2 158.95 32.17 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 106.602 -1.629 . . . . 0.0 106.602 174.757 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -83.59 -62.12 1.66 Allowed 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 120.545 -0.462 . . . . 0.0 110.851 -178.726 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 41.5 tp -175.08 150.83 1.23 Allowed 'General case' 0 N--CA 1.481 1.094 0 N-CA-C 105.637 -1.986 . . . . 0.0 105.637 173.53 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -158.11 134.61 9.59 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 178.113 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -129.35 148.65 70.09 Favored Pre-proline 0 C--N 1.323 -0.551 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 173.693 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -72.63 155.74 54.21 Favored 'Trans proline' 0 C--N 1.35 0.654 0 O-C-N 122.194 0.576 . . . . 0.0 112.703 178.082 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 17.3 tpt180 -67.56 137.76 55.96 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 -179.23 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 89.26 0.67 79.88 Favored Glycine 0 C--O 1.222 -0.612 0 N-CA-C 110.684 -0.967 . . . . 0.0 110.684 179.501 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 -146.71 -179.62 6.91 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 -174.793 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 99.96 -27.06 22.06 Favored Glycine 0 CA--C 1.5 -0.906 0 CA-C-N 116.241 -0.436 . . . . 0.0 112.219 175.325 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 71.9 t -63.32 128.52 92.58 Favored Pre-proline 0 C--N 1.319 -0.736 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 177.062 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -74.74 168.39 24.94 Favored 'Trans proline' 0 N--CA 1.458 -0.575 0 O-C-N 122.165 0.56 . . . . 0.0 110.86 178.557 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 97.4 mt -68.01 116.92 8.83 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 69.2 m-80 -105.06 98.38 8.1 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.448 -179.455 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 67.6 p -73.4 -22.18 60.31 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.19 0.519 . . . . 0.0 111.683 -179.192 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 71.2 m-80 -111.12 36.85 3.02 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.496 -0.774 . . . . 0.0 112.682 -177.64 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 17.5 m -144.59 146.96 32.59 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 179.313 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -72.26 166.39 41.89 Favored Pre-proline 0 C--N 1.327 -0.405 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 176.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -64.79 -27.03 59.76 Favored 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 115.198 -2.735 . . . . 0.0 111.86 178.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -62.22 -29.07 70.13 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.662 0.744 . . . . 0.0 111.17 176.377 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 76.6 m-20 -96.29 0.8 51.34 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 115.288 1.588 . . . . 0.0 115.288 -170.628 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 94.7 mm-40 -61.58 -27.12 68.41 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 121.345 0.593 . . . . 0.0 112.478 178.845 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.402 ' HB ' ' HB1' ' A' ' 98' ' ' ALA . 19.5 tt -57.52 138.67 18.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-O 122.236 1.017 . . . . 0.0 113.712 -179.325 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -177.82 -158.74 21.39 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.274 -0.965 . . . . 0.0 113.158 -179.47 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 38.2 p90 -155.04 169.12 24.84 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 107.721 -1.214 . . . . 0.0 107.721 179.291 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 29.1 m-85 -113.63 141.42 47.23 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 106.784 -1.562 . . . . 0.0 106.784 173.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 44.4 ttt-85 -112.21 131.71 55.33 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.826 -0.624 . . . . 0.0 112.231 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 39.2 ttt-85 -65.39 142.44 58.2 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.437 176.134 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -147.98 166.13 28.66 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 177.52 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 6.3 t -152.37 162.46 41.14 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 -177.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 10.1 ttm180 -90.72 123.88 34.66 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 104.619 -2.363 . . . . 0.0 104.619 176.032 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 8.3 tmm_? -148.25 144.65 27.8 Favored 'General case' 0 CA--C 1.508 -0.665 0 CA-C-O 121.105 0.479 . . . . 0.0 111.633 -172.321 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.463 HD12 ' HB2' ' A' ' 62' ' ' LYS . 0.0 OUTLIER -126.68 -179.68 2.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 -178.61 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -117.37 104.32 11.0 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 171.598 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -71.84 165.02 54.07 Favored Glycine 0 C--O 1.222 -0.625 0 N-CA-C 108.189 -1.964 . . . . 0.0 108.189 178.68 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -61.15 -42.45 99.79 Favored Glycine 0 C--O 1.217 -0.935 0 CA-C-N 118.483 1.142 . . . . 0.0 112.131 -179.256 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 41.2 t0 -95.67 16.94 15.99 Favored 'General case' 0 CA--C 1.549 0.923 0 CA-C-O 122.912 1.339 . . . . 0.0 110.39 179.434 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 86.01 6.86 81.55 Favored Glycine 0 C--O 1.226 -0.384 0 CA-C-N 114.769 -1.105 . . . . 0.0 113.833 172.759 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 23.9 mmtt -69.49 142.48 53.72 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 122.235 1.017 . . . . 0.0 112.472 -173.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 5.1 mmt -93.82 172.42 8.26 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 113.135 -1.848 . . . . 0.0 113.961 -175.748 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.463 ' HB2' HD12 ' A' ' 54' ' ' ILE . 12.2 tptt -124.34 -41.74 2.16 Favored 'General case' 0 CA--C 1.491 -1.311 0 CA-C-N 114.811 -1.086 . . . . 0.0 108.896 173.351 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 26.56 86.27 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.872 0 O-C-N 126.814 2.571 . . . . 0.0 116.315 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -75.89 173.01 11.74 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 114.141 -1.39 . . . . 0.0 108.904 -179.695 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 5.7 m -46.13 140.07 5.29 Favored Pre-proline 0 C--O 1.244 0.814 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 -179.141 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -68.14 148.36 74.89 Favored 'Trans proline' 0 C--O 1.24 0.598 0 C-N-CA 116.73 -1.713 . . . . 0.0 114.191 -175.687 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 26.0 mtp180 -124.96 162.15 25.1 Favored 'General case' 0 CA--C 1.501 -0.941 0 N-CA-C 106.692 -1.595 . . . . 0.0 106.692 177.401 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 62.4 m95 -132.72 133.51 43.59 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 179.256 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.489 ' CZ ' ' HB2' ' A' ' 15' ' ' ALA . 80.5 m-85 -116.59 146.42 42.68 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 -178.872 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 82.9 t80 -94.85 134.04 37.93 Favored 'General case' 0 CA--C 1.509 -0.628 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 -175.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 11.5 m-85 -137.33 152.96 50.29 Favored 'General case' 0 N--CA 1.439 -0.988 0 N-CA-C 106.674 -1.602 . . . . 0.0 106.674 -175.69 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -91.96 159.38 15.77 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 112.338 0.495 . . . . 0.0 112.338 -173.709 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 15.2 tp -57.13 127.13 30.41 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.38 0.61 . . . . 0.0 110.088 179.749 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 71.04 28.66 70.04 Favored Glycine 0 N--CA 1.45 -0.422 0 N-CA-C 116.848 1.499 . . . . 0.0 116.848 175.435 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.421 ' HA ' ' HA ' ' A' ' 104' ' ' ASP . 24.0 p -89.42 146.12 24.87 Favored 'General case' 0 CA--C 1.508 -0.635 0 CA-C-N 119.487 1.644 . . . . 0.0 109.079 175.379 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 89.32 138.56 6.82 Favored Glycine 0 CA--C 1.527 0.812 0 O-C-N 123.822 0.701 . . . . 0.0 112.295 -178.306 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -70.87 -38.65 5.12 Favored 'Trans proline' 0 C--N 1.346 0.415 0 N-CA-C 116.977 1.876 . . . . 0.0 116.977 -176.007 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -102.3 17.77 22.63 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 -174.293 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -61.19 -41.53 96.99 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 115.375 -0.829 . . . . 0.0 111.776 -175.289 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 55.1 43.57 83.43 Favored Glycine 0 CA--C 1.518 0.219 0 CA-C-N 115.552 -0.749 . . . . 0.0 114.492 178.291 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 12.4 mt -132.66 103.88 13.27 Favored Pre-proline 0 N--CA 1.436 -1.139 0 N-CA-C 114.404 1.261 . . . . 0.0 114.404 -178.537 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -78.29 161.7 28.74 Favored 'Trans proline' 0 N--CA 1.461 -0.404 0 C-N-CA 122.168 1.912 . . . . 0.0 107.3 167.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 55.0 t80 -61.19 131.93 52.04 Favored 'General case' 0 C--N 1.32 -0.678 0 C-N-CA 120.274 -0.57 . . . . 0.0 110.257 -177.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 91.6 -6.73 80.18 Favored Glycine 0 C--O 1.227 -0.298 0 CA-C-O 119.407 -0.663 . . . . 0.0 114.622 179.277 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -68.6 130.76 43.8 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 118.647 1.224 . . . . 0.0 111.714 179.731 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 56.0 t30 -78.17 130.99 37.0 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.337 179.675 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 26.1 ttmt -156.18 155.81 33.11 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 106.983 -1.488 . . . . 0.0 106.983 -179.28 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 15.2 t0 -56.41 121.37 9.43 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.261 0.553 . . . . 0.0 111.719 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 68.58 33.4 76.44 Favored Glycine 0 N--CA 1.448 -0.536 0 CA-C-O 118.975 -0.903 . . . . 0.0 114.971 177.157 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 41.3 mm -125.66 129.46 72.68 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 CA-C-N 118.079 0.939 . . . . 0.0 112.091 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -130.34 125.24 59.19 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.841 174.277 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 96.9 m95 -90.94 138.28 31.72 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 113.631 0.975 . . . . 0.0 113.631 -176.353 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 13.9 m -138.87 149.66 23.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.547 0.689 . . . . 0.0 109.445 178.844 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -160.82 164.75 31.17 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 105.058 -2.201 . . . . 0.0 105.058 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 14.8 t -130.35 168.9 16.19 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 105.091 -2.188 . . . . 0.0 105.091 178.197 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -67.4 137.49 55.98 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 -179.284 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 97.76 -12.73 64.3 Favored Glycine 0 C--O 1.225 -0.416 0 CA-C-N 115.832 -0.622 . . . . 0.0 112.145 179.352 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.402 ' HB1' ' HB ' ' A' ' 44' ' ' ILE . . . -79.65 136.77 36.9 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 178.839 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 44.1 mt -87.15 138.05 31.82 Favored 'General case' 0 CA--C 1.512 -0.512 0 CA-C-O 121.43 0.633 . . . . 0.0 112.288 -177.279 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 60.3 t30 -84.46 66.95 9.72 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.849 -179.462 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -142.46 156.45 63.69 Favored Pre-proline 0 C--N 1.322 -0.629 0 N-CA-C 107.078 -1.453 . . . . 0.0 107.078 -178.316 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -70.93 153.69 63.42 Favored 'Trans proline' 0 CA--C 1.531 0.329 0 N-CA-C 114.227 0.818 . . . . 0.0 114.227 178.401 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -145.92 60.66 1.25 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 123.103 1.43 . . . . 0.0 111.356 178.877 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . 0.421 ' HA ' ' HA ' ' A' ' 75' ' ' THR . 16.7 p-10 -53.38 -39.48 64.25 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 113.229 -1.805 . . . . 0.0 112.789 178.024 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 48.2 p-80 -62.22 -8.21 5.34 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 115.071 1.508 . . . . 0.0 115.071 -178.116 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 57.9 mt -95.77 -45.32 13.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 177.683 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -74.19 -1.17 59.5 Favored Glycine 0 C--O 1.223 -0.543 0 N-CA-C 115.53 0.972 . . . . 0.0 115.53 -177.193 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 13.3 t -83.29 21.13 1.17 Allowed 'General case' 0 CA--C 1.542 0.672 0 CA-C-O 121.757 0.789 . . . . 0.0 111.542 -178.597 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.441 ' HD2' ' OD1' ' A' ' 114' ' ' ASN . 65.4 ttp85 -52.77 131.92 35.76 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.145 178.658 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 36.4 m120 -88.37 117.44 68.39 Favored Pre-proline 0 C--N 1.323 -0.549 0 N-CA-C 107.718 -1.215 . . . . 0.0 107.718 179.631 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -72.4 -13.39 27.84 Favored 'Trans proline' 0 C--O 1.216 -0.583 0 C-N-CA 117.243 -1.372 . . . . 0.0 112.817 -179.051 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -78.49 -26.93 46.12 Favored 'General case' 0 C--O 1.219 -0.506 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.638 177.3 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 -102.21 -24.86 13.87 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 113.203 0.816 . . . . 0.0 113.203 -174.795 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.441 ' OD1' ' HD2' ' A' ' 109' ' ' ARG . 5.6 t-20 -128.7 147.2 50.74 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 113.508 0.929 . . . . 0.0 113.508 -178.229 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -95.93 129.92 43.05 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 107.686 -1.228 . . . . 0.0 107.686 173.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -64.65 151.51 44.7 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.441 -0.8 . . . . 0.0 112.28 -178.9 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 4.0 mt -89.83 144.11 9.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.288 -0.869 . . . . 0.0 109.692 -177.508 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 72.5 t -60.8 124.54 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 175.111 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 6.7 tt -69.07 128.07 35.36 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.181 0.515 . . . . 0.0 109.736 -178.577 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 33.0 mt-30 -133.4 157.87 44.46 Favored 'General case' 0 CA--C 1.511 -0.526 0 N-CA-C 106.785 -1.561 . . . . 0.0 106.785 -178.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 13.4 mt -112.88 148.05 38.52 Favored Pre-proline 0 C--N 1.32 -0.688 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 178.022 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -73.97 167.54 26.97 Favored 'Trans proline' 0 C--O 1.237 0.459 0 O-C-N 122.291 0.627 . . . . 0.0 112.837 179.376 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 60.8 tt0 -54.46 134.04 45.94 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.265 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 100.42 -28.19 16.94 Favored Glycine 0 C--O 1.227 -0.315 0 CA-C-N 115.944 -0.571 . . . . 0.0 112.867 -179.297 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 4.1 m -100.04 128.87 46.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 118.4 1.1 . . . . 0.0 112.116 179.451 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 3.2 p -120.35 148.11 44.17 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.188 178.695 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 90.3 mt -71.5 153.18 93.83 Favored Pre-proline 0 C--N 1.323 -0.559 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 178.408 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -75.19 168.72 24.09 Favored 'Trans proline' 0 N--CA 1.463 -0.299 0 C-N-CA 118.508 -0.528 . . . . 0.0 111.005 178.599 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 53.0 tptt -59.59 130.23 45.83 Favored 'General case' 0 C--N 1.324 -0.539 0 O-C-N 122.199 -0.313 . . . . 0.0 111.018 -176.564 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 95.15 -10.64 69.74 Favored Glycine 0 C--O 1.23 -0.124 0 CA-C-N 115.547 -0.752 . . . . 0.0 114.846 178.33 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.402 ' CZ ' ' HB2' ' A' ' 18' ' ' GLN . 1.3 m-85 -95.41 144.41 25.95 Favored 'General case' 0 N--CA 1.436 -1.168 0 CA-C-O 122.39 1.091 . . . . 0.0 110.53 179.888 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 38.1 p90 -143.13 164.76 29.27 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 113.168 -1.833 . . . . 0.0 107.892 175.484 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -108.22 153.53 23.06 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.08 0.466 . . . . 0.0 110.446 -176.648 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -90.12 132.22 35.55 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.322 -178.813 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 97.2 -33.76 5.57 Favored Glycine 0 C--O 1.225 -0.414 0 CA-C-N 116.044 -0.525 . . . . 0.0 113.102 179.082 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -74.02 130.19 39.34 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-O 121.798 0.808 . . . . 0.0 111.121 179.402 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 25.8 tpt180 -143.54 153.12 42.25 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 105.233 -2.136 . . . . 0.0 105.233 178.526 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -129.34 -71.76 0.13 Allowed Glycine 0 C--O 1.224 -0.516 0 N-CA-C 109.067 -1.613 . . . . 0.0 109.067 179.548 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -79.9 163.62 47.75 Favored Glycine 0 N--CA 1.452 -0.253 0 N-CA-C 105.835 -2.906 . . . . 0.0 105.835 173.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 32.4 t . . . . . 0 C--O 1.246 0.888 0 CA-C-N 118.088 0.944 . . . . 0.0 110.292 -178.736 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.701 0 CA-C-O 118.495 -1.169 . . . . 0.0 111.109 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -71.22 135.79 47.7 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 177.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 96.4 mtp -136.31 54.76 1.88 Allowed 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 -179.245 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -93.46 -91.1 1.58 Allowed Glycine 0 C--O 1.224 -0.528 0 CA-C-N 115.839 -0.619 . . . . 0.0 113.108 -178.677 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 99.1 mt -128.52 146.15 58.82 Favored Pre-proline 0 C--N 1.327 -0.372 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 179.353 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -75.54 -20.37 15.9 Favored 'Trans proline' 0 C--N 1.347 0.467 0 N-CA-C 114.18 0.8 . . . . 0.0 114.18 -179.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -104.97 -46.73 4.2 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 109.762 -0.458 . . . . 0.0 109.762 179.091 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.403 HD21 ' HD2' ' A' ' 111' ' ' PRO . 21.5 t30 56.35 32.14 19.95 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.112 0.965 . . . . 0.0 113.599 174.54 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 36.0 p -85.62 87.59 7.42 Favored 'General case' 0 C--O 1.24 0.584 0 CA-C-O 122.008 0.909 . . . . 0.0 108.613 -178.011 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -92.62 141.54 28.37 Favored 'General case' 0 N--CA 1.443 -0.822 0 CA-C-N 115.094 -0.957 . . . . 0.0 111.473 -175.562 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -58.59 140.6 54.12 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 114.635 -1.166 . . . . 0.0 110.808 178.67 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 26.5 m95 -73.05 -21.95 60.7 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 114.906 1.447 . . . . 0.0 114.906 -178.217 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -121.47 156.15 33.39 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-O 121.015 0.436 . . . . 0.0 111.867 -174.454 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 75.9 p -68.6 162.99 24.68 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.745 -1.116 . . . . 0.0 110.078 -179.647 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.595 ' HB1' ' HB2' ' A' ' 67' ' ' ARG . . . -79.61 126.62 31.14 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 116.299 1.963 . . . . 0.0 116.299 -174.481 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.484 HD13 HD13 ' A' ' 119' ' ' LEU . 0.0 OUTLIER -74.32 121.28 21.1 Favored 'General case' 0 N--CA 1.438 -1.029 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 170.272 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 56.7 m -87.19 126.92 35.11 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 -176.309 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 3.2 tm0? -88.27 135.02 33.65 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 -179.685 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 37.8 t60 -139.36 99.49 3.75 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 169.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 162.34 -161.37 33.5 Favored Glycine 0 C--O 1.226 -0.355 0 C-N-CA 120.008 -1.091 . . . . 0.0 113.371 -179.481 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -105.59 -24.09 12.65 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -85.68 153.55 22.27 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 178.612 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -78.22 -62.81 1.56 Allowed 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 120.598 -0.441 . . . . 0.0 110.964 -176.315 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 58.2 tp 173.66 145.62 0.05 OUTLIER 'General case' 0 N--CA 1.485 1.316 0 N-CA-C 106.104 -1.813 . . . . 0.0 106.104 174.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 2.5 tppp? -158.92 140.87 13.67 Favored 'General case' 0 C--O 1.223 -0.336 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 175.325 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 20.9 m-85 -127.24 151.49 74.64 Favored Pre-proline 0 C--N 1.325 -0.499 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 174.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -73.7 162.68 39.08 Favored 'Trans proline' 0 C--N 1.349 0.574 0 O-C-N 122.183 0.57 . . . . 0.0 113.269 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 16.6 tpt180 -64.59 133.3 52.0 Favored 'General case' 0 C--O 1.218 -0.605 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.647 -178.344 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 79.83 15.66 78.79 Favored Glycine 0 C--O 1.221 -0.671 0 CA-C-N 116.252 -0.431 . . . . 0.0 112.248 178.543 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.589 HE21 HG23 ' A' ' 125' ' ' THR . 0.9 OUTLIER -151.86 170.59 19.44 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 -175.094 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 99.53 -8.61 60.28 Favored Glycine 0 C--O 1.222 -0.656 0 N-CA-C 114.501 0.561 . . . . 0.0 114.501 174.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 96.4 t -69.21 130.92 90.75 Favored Pre-proline 0 C--N 1.319 -0.729 0 N-CA-C 106.471 -1.677 . . . . 0.0 106.471 176.747 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -70.11 174.5 9.71 Favored 'Trans proline' 0 C--O 1.223 -0.228 0 O-C-N 122.314 0.639 . . . . 0.0 113.22 178.659 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 74.2 mt -75.65 105.64 4.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 122.3 1.048 . . . . 0.0 108.485 179.765 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 50.8 m-20 -100.6 79.64 2.11 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 113.96 -1.473 . . . . 0.0 109.027 -176.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 69.7 p -66.65 -22.43 66.1 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 114.797 1.406 . . . . 0.0 114.797 -175.039 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 10.5 p30 -120.87 30.28 6.96 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 -176.022 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -128.59 157.24 41.81 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 179.134 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.6 p -74.18 162.22 74.84 Favored Pre-proline 0 C--N 1.321 -0.64 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 -179.426 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -65.89 -20.54 58.1 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 115.78 -2.346 . . . . 0.0 112.561 177.222 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.421 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 3.3 p-10 -75.19 -21.89 58.38 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 119.636 -0.825 . . . . 0.0 110.747 179.785 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 31.3 t0 -89.92 0.82 56.85 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 114.147 1.166 . . . . 0.0 114.147 -175.401 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 91.4 mm-40 -63.21 -28.11 69.82 Favored 'General case' 0 C--N 1.318 -0.786 0 O-C-N 121.047 -1.033 . . . . 0.0 111.634 -179.787 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 12.8 tt -66.58 137.84 24.09 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-O 122.259 1.028 . . . . 0.0 111.531 178.08 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 178.4 -158.08 22.44 Favored Glycine 0 CA--C 1.505 -0.581 0 C-N-CA 120.443 -0.884 . . . . 0.0 111.456 -178.255 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 43.9 p90 -155.09 167.61 29.78 Favored 'General case' 0 C--N 1.319 -0.738 0 O-C-N 122.627 -0.337 . . . . 0.0 110.574 179.598 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 16.2 m-85 -109.16 141.9 40.72 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 176.356 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 62.4 ttt-85 -120.39 117.99 29.19 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 124.112 0.965 . . . . 0.0 112.346 -174.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 28.5 ttp85 -69.78 136.48 50.92 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 177.386 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -146.26 138.53 25.18 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.341 0.656 . . . . 0.0 110.281 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 14.1 t -160.21 153.1 21.42 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.082 0.468 . . . . 0.0 110.142 174.77 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 22.4 tpt180 -151.37 123.81 8.38 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 175.212 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 4.5 tmt_? -134.03 139.04 45.76 Favored 'General case' 0 CA--C 1.501 -0.928 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -141.53 179.2 2.26 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 N-CA-C 105.939 -1.874 . . . . 0.0 105.939 -176.55 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 8.1 ttm180 -131.32 111.99 12.36 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 175.726 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -77.67 169.51 54.73 Favored Glycine 0 C--O 1.229 -0.216 0 N-CA-C 108.699 -1.76 . . . . 0.0 108.699 176.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -65.44 -42.29 95.95 Favored Glycine 0 C--O 1.219 -0.826 0 C-N-CA 120.613 -0.804 . . . . 0.0 112.36 -177.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -90.57 14.45 13.18 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 122.617 1.199 . . . . 0.0 111.764 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 90.86 -12.37 69.09 Favored Glycine 0 C--N 1.314 -0.664 0 CA-C-N 113.958 -1.474 . . . . 0.0 115.979 175.697 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 4.4 mppt? -57.79 132.63 53.89 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.586 0.708 . . . . 0.0 109.409 179.358 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 26.1 ptm -132.43 -171.49 2.66 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 114.747 -1.115 . . . . 0.0 112.358 -176.147 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 60.9 mmtt -112.71 -119.72 0.3 Allowed 'General case' 0 C--O 1.219 -0.519 0 C-N-CA 123.477 0.711 . . . . 0.0 109.282 -178.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 57.8 m-20 -66.97 141.46 57.59 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 111.729 0.27 . . . . 0.0 111.729 -174.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 55.8 mt -87.94 -61.65 1.67 Allowed 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 177.318 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 71.0 p -112.35 166.12 11.61 Favored Pre-proline 0 C--O 1.243 0.724 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 178.231 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -73.31 163.81 36.88 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 116.3 -2.0 . . . . 0.0 112.416 177.168 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.595 ' HB2' ' HB1' ' A' ' 15' ' ' ALA . 0.0 OUTLIER -140.44 160.83 39.13 Favored 'General case' 0 C--N 1.326 -0.423 0 O-C-N 122.148 -0.345 . . . . 0.0 110.847 179.037 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 67.0 m95 -117.74 133.98 55.38 Favored 'General case' 0 C--O 1.214 -0.777 0 C-N-CA 122.871 0.468 . . . . 0.0 111.067 -178.138 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.558 ' CZ ' ' HB2' ' A' ' 15' ' ' ALA . 52.1 m-85 -110.39 163.29 13.82 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 106.438 -1.69 . . . . 0.0 106.438 179.041 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 81.0 t80 -110.81 138.25 47.44 Favored 'General case' 0 CA--C 1.51 -0.589 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 -179.066 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -137.6 136.47 37.56 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.114 -0.948 . . . . 0.0 108.548 -176.274 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 34.2 m-85 -70.66 159.52 34.28 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.012 178.469 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -53.56 127.72 26.36 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 113.106 0.78 . . . . 0.0 113.106 -177.181 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 64.47 33.45 87.27 Favored Glycine 0 C--O 1.224 -0.506 0 N-CA-C 115.434 0.934 . . . . 0.0 115.434 174.02 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 4.1 p -89.2 146.12 24.97 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 177.79 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 106.77 144.35 11.74 Favored Glycine 0 CA--C 1.521 0.455 0 N-CA-C 108.12 -1.992 . . . . 0.0 108.12 -175.463 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -70.0 -40.21 5.2 Favored 'Trans proline' 0 C--N 1.346 0.4 0 CA-C-N 119.652 1.726 . . . . 0.0 116.12 -173.733 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -113.81 24.33 12.2 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.69 -0.687 . . . . 0.0 110.662 -176.637 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -57.86 -44.28 86.49 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 113.052 0.76 . . . . 0.0 113.052 -176.055 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 57.26 22.99 46.04 Favored Glycine 0 CA--C 1.522 0.484 0 N-CA-C 115.59 0.996 . . . . 0.0 115.59 178.706 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 19.1 mt -105.9 103.96 46.84 Favored Pre-proline 0 C--O 1.238 0.472 0 N-CA-C 114.117 1.155 . . . . 0.0 114.117 -176.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -76.77 165.64 28.33 Favored 'Trans proline' 0 N--CA 1.462 -0.345 0 C-N-CA 121.12 1.213 . . . . 0.0 109.171 172.656 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.425 ' CE1' ' HB3' ' A' ' 92' ' ' TRP . 74.4 t80 -62.37 131.88 50.75 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 120.398 -0.521 . . . . 0.0 110.359 -179.485 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 90.07 -1.33 80.11 Favored Glycine 0 CA--C 1.518 0.235 0 CA-C-O 119.834 -0.426 . . . . 0.0 113.903 178.36 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -61.73 130.26 44.94 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 117.667 0.733 . . . . 0.0 111.348 178.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 54.3 t30 -79.42 120.63 24.1 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.452 -178.639 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 50.4 tttm -153.71 149.95 28.03 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 179.396 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -66.03 134.95 53.96 Favored 'General case' 0 C--O 1.238 0.49 0 CA-C-O 120.809 0.338 . . . . 0.0 110.405 179.179 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 70.65 23.57 77.63 Favored Glycine 0 N--CA 1.45 -0.397 0 CA-C-O 119.419 -0.656 . . . . 0.0 113.637 178.616 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 42.2 mm -129.59 130.83 67.2 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 CA-C-N 117.385 0.592 . . . . 0.0 110.401 -179.51 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.1 pt -135.59 120.18 27.03 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 CA-C-O 121.387 0.613 . . . . 0.0 110.251 176.196 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . 0.425 ' HB3' ' CE1' ' A' ' 83' ' ' TYR . 93.6 m95 -87.8 137.61 32.19 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 113.087 0.773 . . . . 0.0 113.087 -176.087 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 18.9 m -137.04 154.41 31.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 179.108 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -160.33 166.58 29.17 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 106.465 -1.68 . . . . 0.0 106.465 -178.368 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 11.3 t -138.8 174.73 10.22 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 105.618 -1.993 . . . . 0.0 105.618 177.278 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 59.8 tt0 -67.45 137.43 55.86 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.324 0.583 . . . . 0.0 110.861 -179.011 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 95.26 -11.85 68.63 Favored Glycine 0 N--CA 1.46 0.268 0 CA-C-N 115.756 -0.657 . . . . 0.0 113.3 178.053 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.421 ' HA ' ' HA ' ' A' ' 41' ' ' ASP . . . -76.57 143.05 40.54 Favored 'General case' 0 C--N 1.322 -0.592 0 O-C-N 122.598 -0.354 . . . . 0.0 110.541 179.441 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 46.2 mt -105.4 134.37 48.63 Favored 'General case' 0 CA--C 1.513 -0.459 0 N-CA-C 113.855 1.057 . . . . 0.0 113.855 -178.14 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -79.24 65.58 4.45 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.223 -0.899 . . . . 0.0 111.142 -178.548 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 1.2 t -134.77 156.18 78.79 Favored Pre-proline 0 C--N 1.322 -0.629 0 N-CA-C 105.359 -2.089 . . . . 0.0 105.359 -179.408 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -65.93 153.11 79.48 Favored 'Trans proline' 0 C--N 1.344 0.322 0 N-CA-C 115.05 1.135 . . . . 0.0 115.05 179.34 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.475 ' HB3' HD12 ' A' ' 106' ' ' ILE . 72.0 mmtt -122.94 32.46 5.7 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.201 -0.909 . . . . 0.0 109.149 -178.619 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 15.4 p-10 -50.92 -44.24 60.08 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.989 -177.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 16.0 p80 -69.78 -8.92 52.28 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 114.015 1.117 . . . . 0.0 114.015 -178.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.475 HD12 ' HB3' ' A' ' 103' ' ' LYS . 33.8 mt -96.15 -41.7 11.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 O-C-N 122.186 -0.321 . . . . 0.0 110.214 179.186 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -68.44 14.75 0.66 Allowed Glycine 0 N--CA 1.466 0.67 0 N-CA-C 117.995 1.958 . . . . 0.0 117.995 -176.224 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 8.9 t -90.27 28.77 1.36 Allowed 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 123.695 0.798 . . . . 0.0 111.976 -178.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 73.9 ttp85 -57.75 121.4 10.36 Favored 'General case' 0 N--CA 1.474 0.737 0 O-C-N 121.451 -0.781 . . . . 0.0 109.956 -179.684 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 63.3 m-20 -90.57 118.09 68.46 Favored Pre-proline 0 C--N 1.322 -0.591 0 N-CA-C 106.174 -1.788 . . . . 0.0 106.174 179.618 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.403 ' HD2' HD21 ' A' ' 8' ' ' ASN . 83.6 Cg_endo -71.09 -14.79 32.11 Favored 'Trans proline' 0 C--O 1.218 -0.523 0 C-N-CA 117.902 -0.932 . . . . 0.0 113.384 -177.052 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -75.53 -26.8 58.37 Favored 'General case' 0 C--O 1.22 -0.484 0 CA-C-O 120.858 0.361 . . . . 0.0 110.41 177.565 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 -104.33 -26.51 12.43 Favored 'General case' 0 C--O 1.222 -0.358 0 N-CA-C 113.284 0.846 . . . . 0.0 113.284 -174.314 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 25.5 t30 -146.0 143.99 29.81 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 -178.062 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -87.29 149.71 24.36 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.731 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -68.71 146.76 52.68 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 177.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 9.0 mt -78.61 134.58 27.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 -178.642 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 98.8 t -63.14 118.96 5.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 106.423 -1.695 . . . . 0.0 106.423 176.404 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.484 HD13 HD13 ' A' ' 16' ' ' LEU . 5.0 tt -67.02 125.31 25.61 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.398 0.618 . . . . 0.0 110.796 -176.303 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -132.7 161.02 35.06 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 105.6 -2.0 . . . . 0.0 105.6 179.452 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 20.1 mt -117.2 146.33 37.91 Favored Pre-proline 0 C--N 1.322 -0.594 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 179.435 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -73.14 171.58 17.29 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 121.183 1.256 . . . . 0.0 114.522 -175.463 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 39.6 tt0 -53.41 129.99 33.93 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.874 -179.311 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 90.99 -16.03 59.52 Favored Glycine 0 C--O 1.226 -0.357 0 CA-C-N 115.963 -0.562 . . . . 0.0 113.229 -179.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.589 HG23 HE21 ' A' ' 30' ' ' GLN . 19.2 m -108.61 127.15 53.71 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 179.501 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 4.8 p -125.28 148.28 48.75 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.754 0.312 . . . . 0.0 110.668 -176.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 84.8 mt -66.41 152.23 94.88 Favored Pre-proline 0 C--N 1.327 -0.406 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 177.197 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -76.83 168.1 24.11 Favored 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 117.747 -1.035 . . . . 0.0 110.859 -179.571 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -59.44 126.73 28.79 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 91.58 27.96 15.84 Favored Glycine 0 C--O 1.224 -0.5 0 N-CA-C 114.938 0.735 . . . . 0.0 114.938 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -139.07 147.42 41.99 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 117.701 0.75 . . . . 0.0 111.369 177.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 54.0 p90 -153.93 165.22 36.8 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 176.401 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -100.25 142.03 32.28 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 114.146 1.165 . . . . 0.0 114.146 -175.375 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -67.96 140.63 56.42 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 107.181 -1.415 . . . . 0.0 107.181 175.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 90.7 -34.79 4.07 Favored Glycine 0 C--O 1.23 -0.151 0 C-N-CA 121.457 -0.401 . . . . 0.0 112.327 -179.055 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 22.9 t -71.89 102.64 2.95 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 179.671 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 52.01 46.94 25.74 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 122.39 1.09 . . . . 0.0 110.037 -177.2 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -89.64 -39.79 6.16 Favored Glycine 0 C--O 1.225 -0.415 0 CA-C-N 114.7 -1.136 . . . . 0.0 112.9 -179.391 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -132.97 -167.86 11.81 Favored Glycine 0 C--O 1.235 0.2 0 N-CA-C 109.998 -1.241 . . . . 0.0 109.998 -178.818 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 46.8 t . . . . . 0 C--O 1.251 1.161 0 N-CA-C 104.888 -2.264 . . . . 0.0 104.888 179.474 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.827 0 CA-C-O 118.476 -1.18 . . . . 0.0 111.018 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -74.16 150.3 40.49 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 105.273 -2.121 . . . . 0.0 105.273 175.605 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 22.0 ptt? -127.27 8.36 6.58 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.886 0.851 . . . . 0.0 110.962 -178.846 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -175.84 124.78 1.01 Allowed Glycine 0 N--CA 1.437 -1.256 0 N-CA-C 104.54 -3.424 . . . . 0.0 104.54 -175.154 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 80.4 mt -131.07 141.82 43.34 Favored Pre-proline 0 C--N 1.314 -0.95 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 177.986 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -77.4 163.89 29.37 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 118.133 -0.778 . . . . 0.0 111.488 177.161 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 58.9 t30 -63.73 -34.86 78.83 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.026 0.441 . . . . 0.0 109.834 176.541 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 -168.23 -73.69 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.036 175.838 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 66.0 p 41.71 77.5 0.06 Allowed 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 116.573 2.064 . . . . 0.0 116.573 179.355 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -101.2 145.0 29.38 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.105 178.8 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 58.3 p -61.62 145.18 52.98 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.752 178.633 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 15.8 m95 -67.93 -24.13 65.16 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 112.609 0.596 . . . . 0.0 112.609 179.392 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 25.8 m-85 -121.48 163.35 18.94 Favored 'General case' 0 CA--C 1.505 -0.754 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -172.156 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 70.1 p -70.64 164.17 25.51 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 176.528 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -80.5 152.04 28.91 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.449 0.642 . . . . 0.0 112.656 -176.871 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 21.8 mt -85.02 146.37 27.22 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 102.753 -3.055 . . . . 0.0 102.753 168.605 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 52.4 m -119.64 129.51 54.63 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 179.528 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -85.34 133.25 34.15 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.648 -179.412 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 21.9 t-160 -139.16 94.94 2.86 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 103.533 -2.766 . . . . 0.0 103.533 168.591 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 166.46 -131.26 2.32 Favored Glycine 0 C--O 1.226 -0.379 0 C-N-CA 120.184 -1.008 . . . . 0.0 113.119 -174.902 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 64.1 mttm -130.96 -38.5 1.25 Allowed 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 116.973 2.212 . . . . 0.0 116.973 -176.327 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -75.62 163.32 27.45 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 179.513 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -72.22 -62.66 1.35 Allowed 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 178.284 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 48.4 tp 174.47 134.2 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 104.843 -2.28 . . . . 0.0 104.843 173.256 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 11.1 tmtt? -148.24 127.51 13.0 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 118.403 0.547 . . . . 0.0 111.386 178.266 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 16.0 m-85 -113.22 153.16 45.54 Favored Pre-proline 0 C--O 1.243 0.716 0 CA-C-O 120.562 0.22 . . . . 0.0 111.306 176.811 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.42 162.57 41.38 Favored 'Trans proline' 0 C--N 1.353 0.765 0 C-N-CA 120.02 0.48 . . . . 0.0 112.541 177.594 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 16.9 tpt180 -69.93 134.63 48.6 Favored 'General case' 0 C--O 1.216 -0.704 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 -176.837 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 78.92 15.1 81.21 Favored Glycine 0 C--O 1.224 -0.506 0 C-N-CA 121.136 -0.554 . . . . 0.0 111.908 178.859 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 8.9 mt-30 -151.63 170.49 19.57 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 -175.291 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 108.09 -16.73 35.6 Favored Glycine 0 CA--C 1.501 -0.805 0 CA-C-N 116.236 -0.438 . . . . 0.0 112.676 175.373 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 95.0 t -65.7 129.29 94.3 Favored Pre-proline 0 C--N 1.319 -0.718 0 N-CA-C 106.968 -1.494 . . . . 0.0 106.968 177.41 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -73.29 170.33 20.14 Favored 'Trans proline' 0 N--CA 1.461 -0.422 0 O-C-N 122.17 0.563 . . . . 0.0 111.297 177.869 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 91.6 mt -69.39 107.63 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 179.829 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 -97.67 84.75 3.44 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 114.409 -1.269 . . . . 0.0 109.857 -176.817 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 69.8 p -66.59 -15.65 63.59 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.647 -0.706 . . . . 0.0 112.699 -178.869 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -107.32 22.62 15.7 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.152 -0.931 . . . . 0.0 112.162 -177.917 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 14.3 m -141.92 148.06 38.06 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 114.518 1.303 . . . . 0.0 114.518 -176.233 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -74.65 168.35 27.9 Favored Pre-proline 0 N--CA 1.468 0.46 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 176.424 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -64.65 -28.98 60.6 Favored 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 114.807 -2.996 . . . . 0.0 112.3 178.756 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -62.92 -24.07 67.67 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 123.74 0.816 . . . . 0.0 111.667 176.289 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 70.3 m-20 -98.93 -1.49 39.86 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 114.865 1.431 . . . . 0.0 114.865 -172.354 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 93.7 mm-40 -60.36 -29.26 68.8 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 114.459 1.281 . . . . 0.0 114.459 -178.888 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 20.8 tt -58.61 139.65 18.0 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.882 0 CA-C-O 122.32 1.057 . . . . 0.0 113.774 -177.296 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -179.18 -156.65 17.91 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.434 -178.738 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 46.6 p90 -155.12 171.52 19.65 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 178.653 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 19.9 m-85 -113.15 139.45 48.74 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 106.365 -1.717 . . . . 0.0 106.365 173.131 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 55.8 ttt180 -110.33 119.71 40.09 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.033 -176.951 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 11.8 ttp180 -65.92 137.92 57.49 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 177.431 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -143.8 142.67 31.0 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.772 0.796 . . . . 0.0 111.266 -179.976 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 41.4 p -142.99 172.49 12.63 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 102.284 -3.228 . . . . 0.0 102.284 174.995 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 17.9 tpt180 -140.62 125.98 18.79 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 120.345 -0.542 . . . . 0.0 111.025 176.557 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.26 148.11 33.12 Favored 'General case' 0 CA--C 1.488 -1.436 0 CA-C-O 121.611 0.719 . . . . 0.0 109.537 179.604 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -144.61 179.61 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.055 0 N-CA-C 102.123 -3.288 . . . . 0.0 102.123 178.804 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 79.2 ttt180 -132.7 121.16 22.68 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 175.295 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -97.33 147.07 18.53 Favored Glycine 0 N--CA 1.448 -0.547 0 N-CA-C 106.582 -2.607 . . . . 0.0 106.582 175.543 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -68.73 -30.94 72.72 Favored Glycine 0 C--O 1.216 -1.016 0 N-CA-C 109.798 -1.321 . . . . 0.0 109.798 179.507 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 30.7 t0 -87.26 17.02 4.62 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-O 122.016 0.912 . . . . 0.0 111.394 179.99 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 84.93 -6.49 78.63 Favored Glycine 0 C--O 1.223 -0.55 0 N-CA-C 116.462 1.345 . . . . 0.0 116.462 174.196 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.13 132.11 47.16 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.959 0.885 . . . . 0.0 112.509 -179.277 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 91.6 mmm -121.79 179.38 4.51 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 113.81 -1.541 . . . . 0.0 108.485 -177.917 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 13.6 mmtt -111.41 -54.35 2.62 Favored 'General case' 0 C--O 1.215 -0.761 0 CA-C-O 120.857 0.36 . . . . 0.0 110.155 178.268 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 49.58 50.0 18.99 Favored 'General case' 0 C--N 1.323 -0.579 0 O-C-N 124.993 1.433 . . . . 0.0 113.867 174.972 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 63.9 mt -70.97 142.08 51.02 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 107.143 -1.429 . . . . 0.0 107.143 176.453 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 72.6 p -58.92 153.59 42.93 Favored Pre-proline 0 C--O 1.239 0.515 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -176.423 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -65.84 128.99 21.0 Favored 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 117.898 -0.935 . . . . 0.0 112.406 -178.918 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 18.1 mtt-85 -134.7 160.83 36.91 Favored 'General case' 0 CA--C 1.51 -0.592 0 CA-C-N 115.249 -0.887 . . . . 0.0 111.214 -176.499 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 57.6 m95 -129.49 129.19 44.25 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 178.152 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 40.4 m-85 -111.43 139.35 46.92 Favored 'General case' 0 C--O 1.217 -0.627 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 -178.491 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 92.0 t80 -86.9 136.64 32.88 Favored 'General case' 0 CA--C 1.509 -0.604 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 -177.973 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -141.77 144.91 34.22 Favored 'General case' 0 N--CA 1.441 -0.905 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 -175.434 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 -80.76 159.38 25.2 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 112.276 0.472 . . . . 0.0 112.276 -174.726 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 15.8 tp -58.1 126.95 29.7 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 121.363 0.602 . . . . 0.0 110.177 -179.423 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 85.21 16.73 64.11 Favored Glycine 0 C--O 1.221 -0.704 0 N-CA-C 116.086 1.195 . . . . 0.0 116.086 178.468 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 19.4 p -90.65 146.11 24.29 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 118.971 1.385 . . . . 0.0 111.187 179.941 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 113.98 143.86 8.55 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 -178.673 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -71.75 -39.13 3.63 Favored 'Trans proline' 0 C--N 1.347 0.496 0 CA-C-N 119.776 1.788 . . . . 0.0 114.978 -174.402 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -115.2 32.42 6.06 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 -178.766 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -60.81 -55.45 32.89 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.811 -0.631 . . . . 0.0 112.014 -176.177 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 56.54 23.88 44.68 Favored Glycine 0 CA--C 1.523 0.555 0 CA-C-N 116.277 -0.42 . . . . 0.0 114.09 -178.989 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 43.9 mt -105.59 111.18 64.81 Favored Pre-proline 0 N--CA 1.449 -0.483 0 N-CA-C 115.525 1.676 . . . . 0.0 115.525 -174.989 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -77.52 166.02 26.41 Favored 'Trans proline' 0 N--CA 1.461 -0.407 0 N-CA-C 108.388 -1.428 . . . . 0.0 108.388 169.274 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 64.1 t80 -63.14 132.51 52.05 Favored 'General case' 0 C--N 1.322 -0.602 0 O-C-N 121.947 -0.471 . . . . 0.0 109.958 -179.677 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 91.39 -4.91 80.6 Favored Glycine 0 CA--C 1.52 0.353 0 N-CA-C 114.637 0.615 . . . . 0.0 114.637 178.868 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -65.14 132.3 48.8 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 118.038 0.919 . . . . 0.0 112.357 179.781 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 50.1 t30 -74.96 125.9 29.87 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.863 -178.807 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 26.9 ttmt -156.26 151.6 26.7 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 107.178 -1.416 . . . . 0.0 107.178 177.321 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 15.6 t0 -61.97 129.63 41.82 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.013 0.435 . . . . 0.0 110.853 179.423 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 69.19 27.85 73.35 Favored Glycine 0 N--CA 1.447 -0.609 0 CA-C-N 115.82 -0.627 . . . . 0.0 114.319 176.032 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 45.1 mm -125.11 120.77 59.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 117.365 0.583 . . . . 0.0 110.062 178.764 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.1 pt -123.68 113.79 38.75 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 CA-C-O 121.896 0.855 . . . . 0.0 110.592 176.972 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 96.5 m95 -80.51 132.67 35.72 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.763 -0.653 . . . . 0.0 112.601 -176.978 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 17.0 m -135.59 149.7 28.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.795 0.807 . . . . 0.0 109.492 179.599 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -156.28 166.57 33.06 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 103.531 -2.766 . . . . 0.0 103.531 -179.282 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 14.5 t -131.53 168.94 16.8 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 104.221 -2.511 . . . . 0.0 104.221 177.522 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -65.41 134.17 52.91 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 -178.681 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 95.75 -7.06 67.75 Favored Glycine 0 C--O 1.226 -0.369 0 CA-C-N 116.004 -0.544 . . . . 0.0 113.529 179.4 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -80.51 135.42 36.11 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 122.096 -0.649 . . . . 0.0 109.823 179.029 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 37.0 mt -81.86 136.25 35.38 Favored 'General case' 0 CA--C 1.511 -0.529 0 CA-C-O 121.161 0.505 . . . . 0.0 111.479 -178.878 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 63.4 t30 -84.08 65.22 8.62 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.633 -179.664 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -140.1 153.75 69.55 Favored Pre-proline 0 C--N 1.324 -0.519 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 -178.553 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -66.85 149.89 83.23 Favored 'Trans proline' 0 C--N 1.344 0.319 0 N-CA-C 113.977 0.722 . . . . 0.0 113.977 177.252 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 1.5 ptpm? -149.15 55.51 0.99 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 123.036 1.398 . . . . 0.0 109.571 179.759 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 13.6 p-10 -54.92 -35.1 63.83 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 113.451 -1.704 . . . . 0.0 112.344 179.52 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 37.5 p-80 -60.3 -14.6 19.09 Favored 'General case' 0 C--O 1.219 -0.549 0 N-CA-C 114.728 1.381 . . . . 0.0 114.728 -177.839 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 62.8 mt -84.42 -39.16 14.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 178.515 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -74.16 14.6 3.8 Favored Glycine 0 C--O 1.221 -0.678 0 N-CA-C 116.126 1.211 . . . . 0.0 116.126 -176.558 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 11.5 t -94.29 23.11 5.35 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 117.968 0.884 . . . . 0.0 112.667 -178.038 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.428 ' HD2' HD22 ' A' ' 114' ' ' ASN . 65.3 ttp85 -55.91 133.65 51.56 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.387 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 15.1 m-20 -104.28 125.18 34.97 Favored Pre-proline 0 C--N 1.324 -0.523 0 N-CA-C 106.854 -1.536 . . . . 0.0 106.854 -179.389 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_endo -69.59 -18.51 37.75 Favored 'Trans proline' 0 C--O 1.217 -0.527 0 N-CA-C 114.037 0.745 . . . . 0.0 114.037 -177.903 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -73.63 -26.28 60.7 Favored 'General case' 0 C--O 1.22 -0.498 0 CA-C-O 120.877 0.37 . . . . 0.0 110.675 178.1 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -102.11 -23.93 14.0 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 113.142 0.793 . . . . 0.0 113.142 -174.978 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.428 HD22 ' HD2' ' A' ' 109' ' ' ARG . 26.8 t30 -154.55 148.37 25.52 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 112.578 0.584 . . . . 0.0 112.578 -178.361 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -88.94 149.1 23.46 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-O 121.432 0.634 . . . . 0.0 111.702 179.575 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -70.08 145.18 51.83 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.221 0.534 . . . . 0.0 110.446 178.369 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 14.4 mt -86.3 138.8 18.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 115.393 -0.821 . . . . 0.0 108.815 -178.601 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 75.6 t -61.16 123.9 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 N-CA-C 106.077 -1.823 . . . . 0.0 106.077 174.848 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 7.1 tt -66.84 130.11 42.07 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.134 0.492 . . . . 0.0 110.379 -177.021 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 30.2 mt-30 -132.72 157.94 43.62 Favored 'General case' 0 CA--C 1.511 -0.551 0 N-CA-C 106.615 -1.624 . . . . 0.0 106.615 -179.445 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 13.3 mt -112.31 148.18 38.59 Favored Pre-proline 0 C--N 1.322 -0.588 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 177.12 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -73.2 166.17 30.68 Favored 'Trans proline' 0 N--CA 1.462 -0.371 0 O-C-N 122.325 0.645 . . . . 0.0 112.933 -179.501 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 60.2 tp60 -54.27 130.37 38.56 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.887 -179.879 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 97.15 -17.12 59.73 Favored Glycine 0 C--O 1.227 -0.3 0 CA-C-N 115.907 -0.588 . . . . 0.0 113.611 -179.926 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 9.5 m -106.71 127.01 53.02 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 118.149 0.975 . . . . 0.0 109.984 178.288 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 17.3 p -120.02 148.32 43.71 Favored 'General case' 0 CA--C 1.511 -0.534 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.845 -179.132 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 88.8 mt -70.4 156.1 92.41 Favored Pre-proline 0 C--N 1.323 -0.561 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 177.559 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -74.55 169.11 23.26 Favored 'Trans proline' 0 C--O 1.236 0.406 0 C-N-CA 117.749 -1.034 . . . . 0.0 110.343 178.302 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 12.4 tmtt? -63.72 120.67 12.29 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 -176.823 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 95.18 37.94 4.98 Favored Glycine 0 N--CA 1.452 -0.257 0 N-CA-C 114.943 0.737 . . . . 0.0 114.943 178.942 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -142.31 146.15 34.73 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 176.85 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 48.6 p90 -147.11 162.38 38.94 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 176.627 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -97.68 143.26 28.53 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.042 0.449 . . . . 0.0 110.547 -178.345 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -71.34 135.84 47.54 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 178.812 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 87.87 -13.53 60.84 Favored Glycine 0 C--O 1.227 -0.299 0 CA-C-N 116.109 -0.496 . . . . 0.0 113.147 -178.24 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 35.2 t -89.51 124.7 34.75 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 178.733 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 6.0 tpt180 -141.88 34.4 1.58 Allowed 'General case' 0 C--O 1.219 -0.504 0 CA-C-O 121.347 0.594 . . . . 0.0 112.143 179.143 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -72.22 -18.39 78.02 Favored Glycine 0 C--O 1.224 -0.49 0 CA-C-O 122.315 0.953 . . . . 0.0 111.41 178.363 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -168.86 177.18 42.81 Favored Glycine 0 C--O 1.241 0.541 0 N-CA-C 104.378 -3.489 . . . . 0.0 104.378 178.345 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 43.6 t . . . . . 0 C--O 1.247 0.972 0 CA-C-O 116.209 -1.853 . . . . 0.0 106.139 179.962 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.108 0 CA-C-O 118.766 -1.019 . . . . 0.0 111.328 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -65.68 148.65 51.41 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 177.598 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 75.5 mtp -124.88 15.31 8.6 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -177.836 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -109.53 28.47 10.75 Favored Glycine 0 C--O 1.219 -0.792 0 CA-C-N 116.286 -0.416 . . . . 0.0 112.875 -178.326 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -71.12 142.33 87.29 Favored Pre-proline 0 C--N 1.32 -0.689 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 -178.654 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -68.08 151.01 77.74 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 117.238 -1.375 . . . . 0.0 111.504 178.079 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 66.9 t30 -140.82 72.06 1.38 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.578 0.704 . . . . 0.0 110.188 -176.988 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -77.24 23.38 0.2 Allowed 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 115.13 -0.941 . . . . 0.0 112.005 -177.615 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 16.9 p -140.89 129.69 23.0 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 104.67 -2.345 . . . . 0.0 104.67 -177.862 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -106.44 139.74 40.45 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 -179.78 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 62.5 p -63.06 141.07 58.9 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 178.865 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . 0.415 ' CD2' ' HD3' ' A' ' 109' ' ' ARG . 10.9 m95 -67.95 -27.21 66.4 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.038 0.447 . . . . 0.0 111.772 178.716 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 20.1 m-85 -121.53 163.97 17.99 Favored 'General case' 0 C--O 1.242 0.68 0 CA-C-N 115.517 -0.765 . . . . 0.0 112.537 -171.349 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 63.7 p -70.19 166.5 19.87 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 177.096 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.433 ' HB1' ' HB3' ' A' ' 67' ' ' ARG . . . -83.58 148.17 27.32 Favored 'General case' 0 N--CA 1.443 -0.785 0 N-CA-C 113.529 0.937 . . . . 0.0 113.529 -175.371 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 15.6 mt -81.88 144.92 30.65 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 103.768 -2.679 . . . . 0.0 103.768 170.902 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 26.4 m -123.28 131.03 53.52 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.108 0.48 . . . . 0.0 110.052 -178.008 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -83.39 141.93 31.38 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.34 -0.845 . . . . 0.0 111.94 -178.627 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 23.0 t-160 -139.11 99.71 3.83 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 105.83 -1.915 . . . . 0.0 105.83 168.477 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 151.02 -134.59 4.76 Favored Glycine 0 C--N 1.322 -0.242 0 N-CA-C 111.134 -0.786 . . . . 0.0 111.134 -176.841 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 51.6 mttp -132.7 -16.1 2.65 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 114.993 1.479 . . . . 0.0 114.993 -179.351 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 59.7 mt-10 -73.98 155.49 38.55 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 107.1 -1.444 . . . . 0.0 107.1 178.027 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -82.17 -62.6 1.58 Allowed 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 120.458 -0.497 . . . . 0.0 109.791 -178.685 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 56.5 tp 168.58 136.7 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 103.661 -2.718 . . . . 0.0 103.661 175.411 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -157.01 138.87 14.3 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 176.511 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 25.6 m-85 -127.55 151.38 75.01 Favored Pre-proline 0 C--N 1.324 -0.531 0 O-C-N 123.307 0.379 . . . . 0.0 110.212 176.804 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -79.72 165.89 22.08 Favored 'Trans proline' 0 CA--C 1.541 0.83 0 C-N-CA 120.568 0.845 . . . . 0.0 113.03 176.755 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 2.2 tmt_? -67.3 138.33 56.75 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 116.548 -0.296 . . . . 0.0 110.257 -179.384 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 86.66 2.73 84.39 Favored Glycine 0 C--O 1.224 -0.503 0 N-CA-C 110.894 -0.883 . . . . 0.0 110.894 178.008 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.578 HE21 HG23 ' A' ' 125' ' ' THR . 27.6 mt-30 -143.86 -179.62 6.58 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 -175.14 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.448 ' H ' HG21 ' A' ' 125' ' ' THR . . . 95.54 -28.97 10.4 Favored Glycine 0 CA--C 1.5 -0.896 0 CA-C-N 115.794 -0.639 . . . . 0.0 113.555 174.716 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 91.6 t -64.14 127.3 91.78 Favored Pre-proline 0 C--N 1.319 -0.721 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 177.486 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -72.91 171.72 16.88 Favored 'Trans proline' 0 N--CA 1.461 -0.433 0 C-N-CA 120.128 0.552 . . . . 0.0 111.717 178.409 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 85.6 mt -69.21 107.89 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-O 122.299 1.047 . . . . 0.0 108.539 179.415 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 84.7 m-20 -98.45 86.33 3.58 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 114.122 -1.399 . . . . 0.0 109.874 -176.614 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 67.0 p -67.56 -15.79 63.84 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.525 -0.761 . . . . 0.0 112.627 -178.848 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 11.2 p30 -107.11 21.09 18.08 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 114.9 -1.046 . . . . 0.0 113.014 -177.31 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 9.9 m -140.16 150.38 44.15 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 115.741 1.756 . . . . 0.0 115.741 -174.817 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 4.6 m -72.49 166.28 43.49 Favored Pre-proline 0 N--CA 1.468 0.464 0 CA-C-N 115.415 -0.812 . . . . 0.0 109.553 176.22 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -66.03 -27.98 49.75 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 114.533 -3.178 . . . . 0.0 113.944 -179.805 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.402 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 5.6 p-10 -75.06 -21.55 58.92 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 121.66 -0.65 . . . . 0.0 111.213 177.113 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 75.0 m-20 -81.36 -10.53 59.52 Favored 'General case' 0 C--O 1.221 -0.415 0 N-CA-C 113.453 0.908 . . . . 0.0 113.453 -176.034 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 96.6 mm-40 -56.69 -27.29 58.65 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 115.155 1.539 . . . . 0.0 115.155 -176.59 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 19.7 tt -55.31 138.46 15.57 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.941 0 N-CA-C 114.418 1.266 . . . . 0.0 114.418 -178.077 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -176.88 -159.95 23.09 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.416 -0.897 . . . . 0.0 114.353 -179.406 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 44.8 p90 -154.92 170.47 21.63 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 179.242 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 17.6 m-85 -114.39 141.46 47.62 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 172.905 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 58.3 ttt180 -113.56 117.24 31.1 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 124.415 1.086 . . . . 0.0 110.992 -175.428 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 46.6 ttp180 -65.6 137.52 57.41 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 178.356 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -150.41 150.06 30.87 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.854 0.359 . . . . 0.0 111.149 -178.029 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 21.6 p -141.94 140.13 32.69 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.826 176.282 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 14.0 tpt180 -142.74 123.87 14.53 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 174.742 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.52 133.84 52.22 Favored 'General case' 0 CA--C 1.494 -1.187 0 CA-C-O 121.584 0.706 . . . . 0.0 110.963 -176.508 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -129.17 179.1 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.883 0 N-CA-C 105.472 -2.047 . . . . 0.0 105.472 178.238 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 27.8 tpt180 -139.57 107.93 5.83 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 106.803 -1.554 . . . . 0.0 106.803 172.502 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -74.17 156.61 50.36 Favored Glycine 0 N--CA 1.447 -0.568 0 N-CA-C 107.681 -2.168 . . . . 0.0 107.681 176.608 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -69.34 -33.23 72.66 Favored Glycine 0 C--O 1.216 -0.983 0 N-CA-C 108.62 -1.792 . . . . 0.0 108.62 179.373 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.1 t0 -84.75 16.61 3.19 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-O 122.55 1.167 . . . . 0.0 109.689 177.715 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 85.03 -14.6 48.35 Favored Glycine 0 N--CA 1.455 -0.086 0 N-CA-C 116.961 1.544 . . . . 0.0 116.961 173.457 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -55.91 142.01 37.15 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 114.968 1.469 . . . . 0.0 114.968 -176.74 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 95.3 mmm -116.48 177.98 4.5 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 112.543 -2.117 . . . . 0.0 109.475 -177.095 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 13.7 tppt? -126.28 -53.76 1.49 Allowed 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 178.208 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 -120.43 149.42 42.4 Favored 'General case' 0 CA--C 1.506 -0.716 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 178.499 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -133.49 -44.18 0.83 Allowed 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 104.306 -2.479 . . . . 0.0 104.306 176.256 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 33.3 t -112.02 153.27 44.63 Favored Pre-proline 0 C--O 1.243 0.748 0 N-CA-C 105.42 -2.066 . . . . 0.0 105.42 175.954 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -68.75 156.74 64.48 Favored 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 117.06 -1.494 . . . . 0.0 114.983 -179.381 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.433 ' HB3' ' HB1' ' A' ' 15' ' ' ALA . 94.0 mtt-85 -113.98 165.46 12.58 Favored 'General case' 0 CA--C 1.509 -0.6 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.523 178.015 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 49.8 m95 -132.03 129.47 40.11 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 176.247 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 17.0 m-85 -110.77 141.34 44.23 Favored 'General case' 0 C--O 1.216 -0.658 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 -176.863 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -88.7 136.87 32.78 Favored 'General case' 0 CA--C 1.506 -0.732 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 -176.527 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -141.36 143.44 33.99 Favored 'General case' 0 N--CA 1.438 -1.032 0 N-CA-C 106.976 -1.491 . . . . 0.0 106.976 -175.888 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 66.8 m-85 -82.94 159.35 22.29 Favored 'General case' 0 C--N 1.317 -0.842 0 O-C-N 122.21 -0.306 . . . . 0.0 110.94 -175.342 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 15.4 tp -54.59 131.49 43.16 Favored 'General case' 0 C--O 1.218 -0.583 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 179.452 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 74.54 25.43 70.22 Favored Glycine 0 C--O 1.225 -0.466 0 N-CA-C 115.8 1.08 . . . . 0.0 115.8 177.633 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 49.8 p -108.78 146.17 34.02 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 118.421 1.11 . . . . 0.0 110.279 176.167 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 110.04 132.62 6.37 Favored Glycine 0 CA--C 1.522 0.495 0 N-CA-C 108.722 -1.751 . . . . 0.0 108.722 -176.677 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -66.61 -43.2 7.96 Favored 'Trans proline' 0 C--N 1.347 0.485 0 CA-C-N 119.776 1.788 . . . . 0.0 115.184 -174.457 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 90.9 mt-10 -110.07 31.13 6.11 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 -179.442 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -66.04 -48.32 71.49 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.553 -178.396 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 54.56 41.6 73.9 Favored Glycine 0 N--CA 1.46 0.279 0 C-N-CA 121.288 -0.482 . . . . 0.0 112.19 179.744 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 15.4 mt -124.61 104.32 31.02 Favored Pre-proline 0 N--CA 1.442 -0.858 0 N-CA-C 115.291 1.589 . . . . 0.0 115.291 -175.218 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -78.59 161.83 27.77 Favored 'Trans proline' 0 N--CA 1.461 -0.393 0 C-N-CA 122.516 2.144 . . . . 0.0 107.229 167.596 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 49.7 t80 -61.46 133.54 55.87 Favored 'General case' 0 C--N 1.319 -0.718 0 C-N-CA 120.425 -0.51 . . . . 0.0 110.283 -177.331 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 90.68 -8.62 79.53 Favored Glycine 0 CA--C 1.518 0.278 0 CA-C-O 119.518 -0.601 . . . . 0.0 114.394 179.599 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -66.3 130.3 42.76 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 118.569 1.184 . . . . 0.0 111.624 179.669 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 48.8 t-20 -80.25 130.33 35.13 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.479 -179.441 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 28.0 ttmt -156.1 154.56 31.12 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 106.865 -1.531 . . . . 0.0 106.865 -179.844 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -58.78 124.04 18.43 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.914 0.388 . . . . 0.0 110.868 -179.164 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 69.31 31.48 71.59 Favored Glycine 0 N--CA 1.449 -0.446 0 CA-C-O 119.044 -0.864 . . . . 0.0 115.029 177.556 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 43.2 mm -124.71 127.67 72.89 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 CA-C-N 118.045 0.922 . . . . 0.0 110.992 179.534 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -129.49 123.51 57.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.4 176.357 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 98.7 m95 -88.34 138.14 31.7 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 114.05 1.13 . . . . 0.0 114.05 -176.241 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 16.2 m -139.0 149.8 23.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 121.693 0.759 . . . . 0.0 110.053 178.936 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -159.22 161.12 36.04 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 103.915 -2.624 . . . . 0.0 103.915 178.405 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 13.9 t -118.23 172.78 7.2 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 105.227 -2.138 . . . . 0.0 105.227 178.559 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -66.43 131.95 47.19 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.811 0.339 . . . . 0.0 110.238 -178.624 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 90.98 -4.1 81.28 Favored Glycine 0 CA--C 1.519 0.283 0 C-N-CA 121.359 -0.448 . . . . 0.0 113.746 178.806 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.402 ' HA ' ' HA ' ' A' ' 41' ' ' ASP . . . -73.83 136.06 43.48 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 178.44 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 30.3 mt -89.22 140.55 29.36 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.51 0.671 . . . . 0.0 112.195 -177.071 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 61.9 t30 -83.98 64.95 8.42 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.193 -179.304 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -137.46 155.84 75.29 Favored Pre-proline 0 C--N 1.322 -0.593 0 N-CA-C 106.438 -1.69 . . . . 0.0 106.438 -178.956 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -66.48 151.43 83.05 Favored 'Trans proline' 0 C--N 1.342 0.223 0 N-CA-C 115.359 1.253 . . . . 0.0 115.359 179.993 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.557 ' HB3' HD12 ' A' ' 106' ' ' ILE . 73.3 mmtt -123.02 41.19 3.53 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 114.44 -1.254 . . . . 0.0 108.909 -178.757 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 18.3 p-10 -51.22 -43.4 61.43 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 114.235 -1.348 . . . . 0.0 111.329 178.848 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 46.5 p-80 -66.45 -10.94 49.19 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 124.567 1.147 . . . . 0.0 113.953 -178.839 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.557 HD12 ' HB3' ' A' ' 103' ' ' LYS . 50.4 mt -96.11 -38.22 8.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 179.806 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -74.58 1.74 50.63 Favored Glycine 0 C--O 1.225 -0.453 0 N-CA-C 115.59 0.996 . . . . 0.0 115.59 -177.759 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 14.7 t -83.39 18.8 1.69 Allowed 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 117.869 0.835 . . . . 0.0 112.753 -176.635 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.442 ' HD2' ' OD1' ' A' ' 114' ' ' ASN . 64.2 ttp85 -57.03 130.57 46.69 Favored 'General case' 0 N--CA 1.467 0.391 0 O-C-N 121.998 -0.439 . . . . 0.0 110.129 178.862 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 35.8 m120 -88.49 117.63 68.56 Favored Pre-proline 0 C--N 1.323 -0.546 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 179.843 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -72.76 -13.2 26.87 Favored 'Trans proline' 0 C--O 1.217 -0.531 0 C-N-CA 117.128 -1.448 . . . . 0.0 112.835 -179.528 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -78.4 -27.18 46.66 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.568 177.413 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 -102.06 -25.69 13.65 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 113.237 0.829 . . . . 0.0 113.237 -174.795 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.442 ' OD1' ' HD2' ' A' ' 109' ' ' ARG . 5.0 t-20 -128.7 147.61 50.77 Favored 'General case' 0 N--CA 1.442 -0.829 0 N-CA-C 113.149 0.796 . . . . 0.0 113.149 -177.905 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -95.28 129.23 42.49 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 173.808 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -62.16 148.15 45.4 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.448 -0.796 . . . . 0.0 112.371 -178.236 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 9.8 mt -80.72 138.99 18.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 114.89 -1.05 . . . . 0.0 109.432 -177.832 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 79.5 t -63.11 123.38 15.76 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 N-CA-C 106.12 -1.807 . . . . 0.0 106.12 174.516 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 6.6 tt -65.63 130.48 43.46 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.258 0.552 . . . . 0.0 111.045 -176.876 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 31.0 mt-30 -132.99 159.02 41.21 Favored 'General case' 0 CA--C 1.513 -0.461 0 N-CA-C 106.729 -1.582 . . . . 0.0 106.729 -179.553 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 13.5 mt -112.97 146.73 35.72 Favored Pre-proline 0 C--N 1.323 -0.559 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 177.836 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -73.11 166.78 29.09 Favored 'Trans proline' 0 C--N 1.345 0.348 0 O-C-N 122.272 0.617 . . . . 0.0 113.038 -179.367 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 39.9 tt0 -54.89 131.53 44.53 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.902 179.998 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 95.8 -17.06 60.0 Favored Glycine 0 C--O 1.226 -0.371 0 CA-C-N 115.903 -0.589 . . . . 0.0 113.311 179.944 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.578 HG23 HE21 ' A' ' 30' ' ' GLN . 16.0 m -103.72 128.85 51.04 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 118.073 0.937 . . . . 0.0 111.032 178.811 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 5.8 p -117.23 148.26 41.79 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.795 -179.416 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 83.4 mt -71.23 157.8 89.41 Favored Pre-proline 0 C--N 1.324 -0.504 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 176.989 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -75.55 174.15 13.3 Favored 'Trans proline' 0 C--O 1.237 0.451 0 C-N-CA 117.514 -1.191 . . . . 0.0 109.866 178.367 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 64.1 tttm -62.06 125.94 25.61 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.437 0.636 . . . . 0.0 110.454 -177.141 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 82.31 45.44 6.99 Favored Glycine 0 C--O 1.226 -0.378 0 N-CA-C 115.275 0.87 . . . . 0.0 115.275 178.3 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -141.54 150.87 42.7 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 117.856 0.828 . . . . 0.0 111.476 177.852 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 42.6 p90 -149.95 165.61 32.12 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 176.65 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -101.92 145.32 29.4 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.155 0.502 . . . . 0.0 111.468 -177.993 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -72.69 127.83 33.73 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 179.964 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 92.21 -15.04 63.04 Favored Glycine 0 C--O 1.228 -0.224 0 CA-C-N 115.948 -0.569 . . . . 0.0 113.574 179.506 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 33.5 t -78.79 126.97 31.43 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 179.978 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 72.3 mtm-85 -144.82 157.99 43.96 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 179.584 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -93.65 -177.3 39.85 Favored Glycine 0 C--N 1.321 -0.299 0 N-CA-C 107.587 -2.205 . . . . 0.0 107.587 173.306 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -173.82 169.67 42.74 Favored Glycine 0 N--CA 1.45 -0.395 0 N-CA-C 107.076 -2.41 . . . . 0.0 107.076 178.737 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 14.4 m . . . . . 0 C--O 1.246 0.893 0 O-C-N 124.924 1.014 . . . . 0.0 110.579 -176.7 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.215 0 CA-C-O 118.109 -1.384 . . . . 0.0 111.043 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -103.14 14.77 31.0 Favored 'General case' 0 C--O 1.211 -0.926 0 N-CA-C 114.975 1.472 . . . . 0.0 114.975 -175.695 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 41.1 mtm 61.68 -9.44 0.08 Allowed 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 119.119 3.007 . . . . 0.0 119.119 178.47 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -79.02 65.64 3.53 Favored Glycine 0 C--N 1.309 -0.96 0 CA-C-N 114.932 -1.031 . . . . 0.0 114.066 -176.933 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 89.6 mt -83.74 134.13 45.12 Favored Pre-proline 0 C--N 1.32 -0.7 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 178.783 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -76.3 110.34 3.05 Favored 'Trans proline' 0 CA--C 1.534 0.5 0 C-N-CA 118.653 -0.432 . . . . 0.0 111.885 177.868 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 88.8 m-20 -87.41 -33.18 19.19 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 114.299 1.222 . . . . 0.0 114.299 -176.903 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -145.57 39.12 1.15 Allowed 'General case' 0 C--O 1.218 -0.602 0 CA-C-O 121.672 0.748 . . . . 0.0 111.661 -179.428 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 25.3 p -138.9 137.83 36.85 Favored 'General case' 0 CA--C 1.504 -0.803 0 N-CA-C 100.825 -3.768 . . . . 0.0 100.825 179.121 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -141.1 145.96 36.46 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-O 121.3 0.571 . . . . 0.0 111.137 -179.284 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 17.1 t -65.73 139.96 58.41 Favored 'General case' 0 CA--C 1.512 -0.513 0 N-CA-C 106.954 -1.499 . . . . 0.0 106.954 176.825 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 6.9 m95 -69.62 -21.91 63.53 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.136 0.493 . . . . 0.0 110.276 177.939 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 17.5 m-85 -121.42 161.91 21.35 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.393 -0.821 . . . . 0.0 112.452 -172.223 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.418 ' HB ' ' HB3' ' A' ' 134' ' ' GLU . 67.8 p -69.13 164.77 21.8 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 179.079 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -81.1 140.26 35.16 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 113.06 0.763 . . . . 0.0 113.06 -176.592 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 20.1 mt -78.82 148.22 32.95 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 103.576 -2.75 . . . . 0.0 103.576 170.614 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 16.2 m -130.12 134.76 47.56 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 118.189 0.45 . . . . 0.0 110.605 -178.005 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.42 ' HB2' ' CZ ' ' A' ' 131' ' ' PHE . 4.1 tp60 -100.87 141.56 33.58 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 -177.804 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 52.1 t60 -128.56 99.66 5.46 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 104.636 -2.357 . . . . 0.0 104.636 169.126 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 164.43 -158.76 31.54 Favored Glycine 0 N--CA 1.452 -0.251 0 N-CA-C 108.239 -1.945 . . . . 0.0 108.239 -175.892 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -115.59 -20.9 9.98 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 117.688 0.744 . . . . 0.0 111.127 179.18 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -72.11 153.69 41.53 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.201 -0.909 . . . . 0.0 109.121 178.701 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -82.23 -62.89 1.5 Allowed 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 113.905 1.076 . . . . 0.0 113.905 -176.832 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 50.1 tp 165.33 142.18 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.268 0 N-CA-C 105.815 -1.92 . . . . 0.0 105.815 179.025 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 51.8 tptt -157.25 139.6 14.67 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 173.46 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 16.3 m-85 -122.47 151.92 60.48 Favored Pre-proline 0 C--O 1.241 0.636 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 175.865 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -70.4 161.32 46.43 Favored 'Trans proline' 0 C--N 1.351 0.659 0 O-C-N 122.261 0.611 . . . . 0.0 112.496 178.625 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 22.7 tpt180 -67.83 135.55 52.75 Favored 'General case' 0 C--O 1.216 -0.673 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 -178.249 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 82.55 10.78 82.91 Favored Glycine 0 C--O 1.223 -0.565 0 C-N-CA 121.218 -0.515 . . . . 0.0 111.87 178.87 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 10.2 mt-30 -150.37 170.5 18.89 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 -175.116 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 105.68 -16.56 43.83 Favored Glycine 0 CA--C 1.503 -0.711 0 CA-C-N 116.289 -0.414 . . . . 0.0 113.393 174.887 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 94.1 t -65.75 130.03 94.43 Favored Pre-proline 0 C--N 1.319 -0.726 0 N-CA-C 106.273 -1.751 . . . . 0.0 106.273 177.027 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -72.64 171.17 17.76 Favored 'Trans proline' 0 N--CA 1.46 -0.468 0 O-C-N 122.194 0.576 . . . . 0.0 111.23 178.084 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 87.9 mt -71.01 107.06 2.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 179.801 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 -99.55 84.82 3.02 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.523 -1.217 . . . . 0.0 110.55 -176.329 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 75.7 p -67.97 -14.96 63.38 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.644 -0.707 . . . . 0.0 112.568 -179.204 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 12.5 p30 -108.48 21.71 16.93 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.15 -0.932 . . . . 0.0 112.871 -177.646 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 11.8 m -140.71 148.09 40.21 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 113.454 0.909 . . . . 0.0 113.454 -177.14 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -72.0 166.08 44.09 Favored Pre-proline 0 C--N 1.326 -0.418 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 177.068 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -64.8 -27.22 59.7 Favored 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 115.376 -2.616 . . . . 0.0 111.793 178.69 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -62.26 -28.77 69.94 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.786 0.803 . . . . 0.0 111.132 176.451 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -96.6 1.02 50.82 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 115.348 1.611 . . . . 0.0 115.348 -171.042 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 94.9 mm-40 -61.4 -30.1 70.34 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 113.841 1.052 . . . . 0.0 113.841 179.641 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 14.6 tt -61.22 138.0 22.65 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.789 0 CA-C-O 122.322 1.058 . . . . 0.0 113.346 -177.937 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 179.17 -155.55 16.29 Favored Glycine 0 N--CA 1.449 -0.447 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.468 -177.976 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 46.8 p90 -155.07 171.14 20.25 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 179.786 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 22.4 m-85 -111.56 138.92 47.46 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 173.813 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 40.4 ttt-85 -110.96 120.16 41.45 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 124.034 0.934 . . . . 0.0 110.298 -177.229 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 52.0 ttp180 -68.26 140.92 56.02 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 178.183 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -142.77 148.73 37.66 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.223 0.535 . . . . 0.0 110.344 179.231 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -158.14 154.22 27.08 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 104.387 -2.449 . . . . 0.0 104.387 176.252 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 20.9 tpt85 -150.81 133.02 15.39 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 177.462 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 72.4 ttt180 -143.38 153.2 42.46 Favored 'General case' 0 CA--C 1.496 -1.131 0 CA-C-O 121.835 0.826 . . . . 0.0 110.528 178.281 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -148.13 -179.68 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 N-CA-C 103.463 -2.791 . . . . 0.0 103.463 179.971 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.64 99.23 6.2 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 174.305 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -71.54 159.63 53.87 Favored Glycine 0 C--O 1.227 -0.308 0 N-CA-C 106.894 -2.482 . . . . 0.0 106.894 176.84 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -60.72 -42.49 99.41 Favored Glycine 0 C--O 1.222 -0.65 0 CA-C-N 118.867 1.333 . . . . 0.0 111.832 -179.486 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -92.82 17.02 11.14 Favored 'General case' 0 CA--C 1.546 0.825 0 CA-C-O 122.895 1.331 . . . . 0.0 110.782 178.822 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 90.06 -1.24 80.01 Favored Glycine 0 N--CA 1.462 0.402 0 N-CA-C 118.163 2.025 . . . . 0.0 118.163 169.145 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.408 ' H ' ' HD2' ' A' ' 60' ' ' LYS . 2.1 mptp? -59.27 139.66 56.76 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.999 0.904 . . . . 0.0 111.992 -178.023 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 63.4 mtp -97.23 -178.26 4.11 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 113.419 -1.719 . . . . 0.0 109.475 178.041 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 5.4 tmtt? -109.94 -55.71 2.41 Favored 'General case' 0 CA--C 1.508 -0.64 0 CA-C-O 121.538 0.685 . . . . 0.0 110.836 -178.782 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -125.07 165.05 18.88 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 103.307 -2.849 . . . . 0.0 103.307 177.105 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 94.3 mt -119.57 -99.68 0.44 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 117.888 0.313 . . . . 0.0 111.228 -176.715 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.21 156.38 88.25 Favored Pre-proline 0 C--N 1.325 -0.476 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 179.018 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -68.43 142.59 54.77 Favored 'Trans proline' 0 C--O 1.241 0.674 0 C-N-CA 114.777 -3.015 . . . . 0.0 112.628 -179.775 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 13.4 mtp180 -119.79 160.47 22.56 Favored 'General case' 0 CA--C 1.511 -0.539 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.662 -178.944 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 55.7 m95 -131.29 128.63 40.19 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.445 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 50.0 m-85 -110.45 144.87 38.59 Favored 'General case' 0 C--O 1.217 -0.622 0 N-CA-C 107.505 -1.295 . . . . 0.0 107.505 -177.773 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -89.84 129.97 36.15 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 118.801 0.728 . . . . 0.0 109.254 -178.297 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -132.35 133.07 43.54 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 -175.799 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -71.65 159.49 34.31 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.705 -0.68 . . . . 0.0 112.552 -176.13 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -53.99 129.26 33.57 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-O 121.069 0.461 . . . . 0.0 111.916 -179.448 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 73.26 26.66 69.9 Favored Glycine 0 C--O 1.22 -0.75 0 N-CA-C 115.887 1.115 . . . . 0.0 115.887 176.971 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 2.9 p -90.63 146.07 24.34 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 118.601 1.201 . . . . 0.0 109.336 178.904 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 100.32 136.1 9.2 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 110.126 -1.19 . . . . 0.0 110.126 -178.737 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -69.33 -41.63 4.63 Favored 'Trans proline' 0 C--N 1.349 0.556 0 CA-C-N 119.628 1.714 . . . . 0.0 116.068 -174.122 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -107.03 23.09 14.97 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 121.725 0.774 . . . . 0.0 108.921 -177.574 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -58.51 -45.23 89.22 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.736 -0.666 . . . . 0.0 111.27 -176.337 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 56.16 35.01 63.36 Favored Glycine 0 C--O 1.228 -0.256 0 CA-C-N 116.021 -0.536 . . . . 0.0 112.571 179.447 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 15.1 mt -119.04 103.85 47.27 Favored Pre-proline 0 N--CA 1.446 -0.653 0 N-CA-C 115.112 1.523 . . . . 0.0 115.112 -175.477 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -78.79 163.72 26.02 Favored 'Trans proline' 0 N--CA 1.461 -0.427 0 C-N-CA 121.939 1.759 . . . . 0.0 107.994 168.531 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.407 ' CE1' ' HB3' ' A' ' 92' ' ' TRP . 74.9 t80 -61.5 130.58 46.68 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 120.305 -0.558 . . . . 0.0 111.085 -177.729 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 92.19 -7.74 78.16 Favored Glycine 0 CA--C 1.519 0.305 0 CA-C-O 119.326 -0.708 . . . . 0.0 114.704 178.699 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -64.0 131.81 48.72 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 118.391 1.096 . . . . 0.0 111.656 179.948 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 47.1 t-20 -77.83 128.12 33.48 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.647 -179.465 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 26.4 ttmt -155.46 150.37 26.54 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 106.567 -1.642 . . . . 0.0 106.567 179.269 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -64.24 129.05 38.44 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.902 0.382 . . . . 0.0 110.968 -177.219 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 71.04 26.45 73.85 Favored Glycine 0 CA--C 1.52 0.346 0 CA-C-O 119.348 -0.696 . . . . 0.0 114.767 179.764 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 41.8 mm -126.83 129.25 71.41 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 CA-C-N 117.572 0.686 . . . . 0.0 111.007 -179.965 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.1 pt -132.02 119.34 40.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 CA-C-O 121.542 0.687 . . . . 0.0 111.186 176.133 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . 0.407 ' HB3' ' CE1' ' A' ' 83' ' ' TYR . 95.3 m95 -84.68 138.92 32.39 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 113.651 0.982 . . . . 0.0 113.651 -176.9 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 16.5 m -138.03 151.28 25.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 179.03 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -159.89 166.62 29.85 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 105.497 -2.038 . . . . 0.0 105.497 -178.502 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 12.0 t -136.51 175.61 9.45 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 105.657 -1.979 . . . . 0.0 105.657 177.15 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -66.26 136.81 56.38 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.155 0.502 . . . . 0.0 110.783 -179.466 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 92.76 -10.53 73.83 Favored Glycine 0 C--O 1.224 -0.513 0 CA-C-N 115.839 -0.619 . . . . 0.0 113.566 177.311 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -74.24 134.34 42.68 Favored 'General case' 0 C--N 1.323 -0.586 0 O-C-N 122.409 -0.465 . . . . 0.0 111.227 -179.849 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 38.3 mt -91.73 133.36 35.67 Favored 'General case' 0 CA--C 1.513 -0.48 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 -177.804 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 55.6 t30 -81.27 70.43 8.11 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.188 -0.914 . . . . 0.0 110.838 -178.977 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 1.3 t -139.19 155.29 72.55 Favored Pre-proline 0 C--N 1.322 -0.629 0 N-CA-C 106.1 -1.815 . . . . 0.0 106.1 -179.392 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -67.32 148.46 79.96 Favored 'Trans proline' 0 CA--C 1.53 0.32 0 C-N-CA 118.114 -0.791 . . . . 0.0 113.176 176.418 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -148.64 52.55 0.99 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 122.788 1.28 . . . . 0.0 110.435 179.243 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 13.0 p-10 -60.28 -30.48 69.49 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 114.047 -1.433 . . . . 0.0 110.829 179.268 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 16.0 p80 -59.15 -12.59 5.33 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 114.578 1.325 . . . . 0.0 114.578 -179.149 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 54.0 mt -86.5 -32.08 6.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 178.721 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -75.33 12.96 6.55 Favored Glycine 0 CA--C 1.522 0.479 0 N-CA-C 114.764 0.666 . . . . 0.0 114.764 -177.462 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 11.8 t -83.13 13.4 4.15 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 113.103 0.779 . . . . 0.0 113.103 -178.471 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 66.7 ttp85 -58.66 122.55 13.74 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 178.369 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -97.79 129.59 30.95 Favored Pre-proline 0 C--N 1.321 -0.669 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 -178.872 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -69.68 -15.4 37.38 Favored 'Trans proline' 0 C--O 1.219 -0.462 0 O-C-N 122.072 0.511 . . . . 0.0 113.087 -179.193 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -75.94 -26.58 57.02 Favored 'General case' 0 C--O 1.221 -0.425 0 CA-C-O 120.847 0.356 . . . . 0.0 110.404 177.738 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 76.1 m-20 -104.13 -27.23 12.2 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 113.724 1.009 . . . . 0.0 113.724 -174.727 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 29.7 t30 -152.15 149.04 28.34 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 113.078 0.77 . . . . 0.0 113.078 -177.283 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -90.44 150.45 21.82 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-O 121.457 0.646 . . . . 0.0 111.476 179.325 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -70.18 145.23 51.62 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.248 0.547 . . . . 0.0 111.284 178.867 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 17.9 mt -82.86 139.33 17.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 -179.029 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 99.2 t -59.58 122.9 10.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 N-CA-C 106.642 -1.614 . . . . 0.0 106.642 175.299 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 7.2 tt -68.18 129.04 38.74 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.139 0.495 . . . . 0.0 110.112 -176.703 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 31.5 mt-30 -131.12 158.74 39.63 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 -179.162 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 13.7 mt -113.27 147.57 37.67 Favored Pre-proline 0 C--N 1.322 -0.623 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 177.822 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -74.37 168.9 23.72 Favored 'Trans proline' 0 C--O 1.235 0.366 0 O-C-N 122.224 0.592 . . . . 0.0 113.276 -179.313 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 38.6 tt0 -54.14 131.95 42.1 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.518 -0.765 . . . . 0.0 109.415 179.411 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 99.01 -22.58 40.28 Favored Glycine 0 C--O 1.227 -0.282 0 CA-C-O 119.542 -0.588 . . . . 0.0 113.193 -179.779 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 4.1 m -106.63 127.58 53.46 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 118.361 1.081 . . . . 0.0 111.203 178.887 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 7.1 p -121.14 148.38 44.28 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.951 -179.562 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 92.7 mt -70.5 151.28 95.6 Favored Pre-proline 0 C--N 1.324 -0.513 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 178.874 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -78.6 172.92 14.43 Favored 'Trans proline' 0 N--CA 1.463 -0.303 0 O-C-N 122.0 0.473 . . . . 0.0 111.385 178.796 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 1.7 tmmt? -54.44 130.05 38.06 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.78 -177.847 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 91.53 -7.43 79.92 Favored Glycine 0 C--O 1.229 -0.19 0 N-CA-C 115.794 1.078 . . . . 0.0 115.794 175.655 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.42 ' CZ ' ' HB2' ' A' ' 18' ' ' GLN . 2.3 m-85 -97.84 142.54 29.48 Favored 'General case' 0 N--CA 1.441 -0.888 0 CA-C-O 122.311 1.053 . . . . 0.0 112.859 -177.818 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 47.0 p90 -141.73 165.1 28.41 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 113.473 -1.694 . . . . 0.0 106.961 173.974 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -102.51 143.75 31.82 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.731 0.3 . . . . 0.0 110.274 -178.583 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.418 ' HB3' ' HB ' ' A' ' 14' ' ' THR . 6.5 tp10 -71.55 135.7 47.16 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 106.762 -1.57 . . . . 0.0 106.762 177.84 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 93.33 -7.82 75.33 Favored Glycine 0 C--O 1.225 -0.412 0 C-N-CA 121.369 -0.443 . . . . 0.0 113.497 -177.626 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 34.6 t -136.12 131.79 35.21 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 117.842 0.821 . . . . 0.0 111.221 177.194 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 16.9 mmt85 -143.32 -44.92 0.29 Allowed 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 113.521 0.934 . . . . 0.0 113.521 -179.962 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 84.38 -176.87 51.56 Favored Glycine 0 N--CA 1.453 -0.199 0 N-CA-C 108.668 -1.773 . . . . 0.0 108.668 -176.031 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 166.84 -163.58 37.16 Favored Glycine 0 N--CA 1.451 -0.35 0 N-CA-C 106.875 -2.49 . . . . 0.0 106.875 -178.42 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 54.8 p . . . . . 0 C--O 1.241 0.62 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 177.794 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.763 0 CA-C-O 118.553 -1.137 . . . . 0.0 111.088 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -86.55 49.07 1.73 Allowed 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 118.344 1.072 . . . . 0.0 108.899 177.959 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -162.95 176.06 10.54 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 102.742 -3.059 . . . . 0.0 102.742 -175.235 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 152.24 -29.38 0.88 Allowed Glycine 0 C--N 1.319 -0.389 0 CA-C-O 121.543 0.524 . . . . 0.0 112.019 -178.689 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 94.7 mt -110.42 136.4 20.58 Favored Pre-proline 0 C--N 1.322 -0.592 0 N-CA-C 107.478 -1.305 . . . . 0.0 107.478 177.752 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -73.99 155.42 47.93 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 117.276 -1.349 . . . . 0.0 112.976 -178.452 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 10.0 m120 -68.25 -32.99 73.55 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.315 179.659 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 31.7 t30 -164.67 -80.58 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 178.1 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 44.4 p 36.3 75.86 0.06 Allowed 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 115.148 1.536 . . . . 0.0 115.148 -179.911 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -102.28 131.65 48.73 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.382 -0.826 . . . . 0.0 109.813 -178.726 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 39.3 p -65.47 142.77 58.04 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.806 -0.812 . . . . 0.0 108.806 177.93 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . 0.44 ' CD2' ' HD3' ' A' ' 109' ' ' ARG . 14.8 m95 -67.69 -21.85 65.31 Favored 'General case' 0 CA--C 1.511 -0.557 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 178.066 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 44.4 m-85 -121.42 160.87 23.23 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 113.8 1.037 . . . . 0.0 113.8 -170.518 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 59.0 p -71.85 166.99 20.95 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 113.891 -1.504 . . . . 0.0 109.637 179.243 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.431 ' HB2' ' CZ ' ' A' ' 69' ' ' TYR . . . -80.29 131.11 35.6 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 -177.136 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 13.8 mt -74.51 146.43 42.71 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 103.278 -2.86 . . . . 0.0 103.278 170.1 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 24.8 m -126.8 136.65 52.67 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 -177.207 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.452 ' HB2' ' CZ ' ' A' ' 131' ' ' PHE . 4.7 tp60 -111.9 139.97 46.95 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 114.036 1.125 . . . . 0.0 114.036 -175.328 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 57.7 t60 -130.32 99.48 5.04 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 106.541 -1.652 . . . . 0.0 106.541 170.496 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 173.95 -170.57 43.71 Favored Glycine 0 C--O 1.227 -0.293 0 N-CA-C 109.014 -1.634 . . . . 0.0 109.014 -177.973 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -97.97 -24.25 15.45 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 117.523 0.662 . . . . 0.0 111.694 178.963 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -83.5 157.45 22.39 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 106.111 -1.811 . . . . 0.0 106.111 174.816 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -93.18 -62.76 1.31 Allowed 'General case' 0 C--O 1.215 -0.73 0 C-N-CA 120.123 -0.631 . . . . 0.0 112.637 -176.838 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 42.5 tp -169.83 138.62 1.82 Allowed 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 175.291 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 10.8 tmtt? -153.89 128.59 9.38 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 176.303 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -117.91 159.35 43.06 Favored Pre-proline 0 CA--C 1.547 0.835 0 N-CA-C 110.378 -0.23 . . . . 0.0 110.378 178.096 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -69.12 173.92 9.7 Favored 'Trans proline' 0 C--N 1.354 0.821 0 C-N-CA 121.687 1.591 . . . . 0.0 115.015 -179.574 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -78.37 132.74 37.51 Favored 'General case' 0 C--O 1.216 -0.699 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 178.116 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 69.42 14.21 68.96 Favored Glycine 0 C--O 1.225 -0.415 0 N-CA-C 115.089 0.796 . . . . 0.0 115.089 175.732 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 39.1 tt0 -157.77 148.11 20.65 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 105.758 -1.942 . . . . 0.0 105.758 -178.079 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 136.04 -17.12 3.89 Favored Glycine 0 CA--C 1.502 -0.72 0 C-N-CA 120.187 -1.006 . . . . 0.0 112.723 175.648 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 30.3 m -70.46 145.21 92.65 Favored Pre-proline 0 C--N 1.321 -0.666 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 177.042 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -76.76 167.53 25.19 Favored 'Trans proline' 0 N--CA 1.461 -0.395 0 C-N-CA 122.187 1.925 . . . . 0.0 113.74 179.695 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 97.9 mt -69.68 128.11 32.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 178.696 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 51.4 t-20 -125.49 122.17 35.85 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.889 -0.411 . . . . 0.0 109.889 175.998 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 74.2 p -92.74 -15.49 26.58 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 113.668 0.988 . . . . 0.0 113.668 -177.189 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 20.0 p30 -109.27 21.49 17.04 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 115.259 1.577 . . . . 0.0 115.259 -174.009 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 37.8 m -147.42 164.88 31.94 Favored 'General case' 0 N--CA 1.468 0.437 0 O-C-N 121.918 -0.489 . . . . 0.0 111.538 -179.875 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 32.6 m -75.27 164.44 61.11 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.703 -178.632 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -65.16 -24.81 58.52 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 115.529 -2.514 . . . . 0.0 111.769 177.362 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -59.75 -33.78 72.11 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 122.051 0.929 . . . . 0.0 110.613 176.559 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -83.35 -7.65 59.54 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 114.954 1.465 . . . . 0.0 114.954 -173.903 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 93.0 mm-40 -65.85 -31.64 72.71 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 114.521 1.304 . . . . 0.0 114.521 -174.806 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 14.7 tt -58.9 138.75 19.56 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 CA-C-O 122.076 0.941 . . . . 0.0 112.078 179.314 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 179.0 -148.36 8.21 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.124 -175.556 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.412 ' CE1' HD12 ' A' ' 90' ' ' ILE . 46.1 p90 -154.96 166.87 32.19 Favored 'General case' 0 C--N 1.32 -0.711 0 O-C-N 122.438 -0.448 . . . . 0.0 110.263 179.786 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 40.3 m-85 -107.51 141.97 38.11 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 174.116 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 58.6 ttt-85 -114.22 120.53 40.76 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 123.454 0.702 . . . . 0.0 112.028 -175.926 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 62.8 ttt-85 -64.43 141.4 58.79 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 122.789 0.436 . . . . 0.0 110.165 177.697 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -150.67 132.94 15.45 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.173 0.511 . . . . 0.0 112.249 178.624 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 7.0 p -149.48 139.74 22.26 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 107.259 -1.386 . . . . 0.0 107.259 175.818 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 25.0 tpt180 -147.1 123.98 11.29 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 175.385 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.53 145.34 47.41 Favored 'General case' 0 CA--C 1.484 -1.592 0 CA-C-O 122.313 1.054 . . . . 0.0 112.434 -178.951 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -142.32 176.32 3.89 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 N-CA-C 104.686 -2.338 . . . . 0.0 104.686 176.23 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 4.1 tmt_? -129.2 101.62 6.09 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 105.192 -2.151 . . . . 0.0 105.192 176.472 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -69.01 154.7 53.46 Favored Glycine 0 C--O 1.221 -0.697 0 N-CA-C 109.903 -1.279 . . . . 0.0 109.903 -178.434 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -64.93 -37.95 94.9 Favored Glycine 0 C--O 1.222 -0.637 0 N-CA-C 110.095 -1.202 . . . . 0.0 110.095 -178.219 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 27.5 t0 -89.79 16.95 7.16 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-O 122.339 1.066 . . . . 0.0 110.269 179.208 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 86.93 -15.66 51.71 Favored Glycine 0 C--O 1.227 -0.33 0 N-CA-C 115.818 1.087 . . . . 0.0 115.818 174.087 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -62.1 135.78 57.66 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 122.189 0.995 . . . . 0.0 112.705 -177.911 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 87.5 mtp -108.32 -174.21 2.46 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 113.704 -1.589 . . . . 0.0 109.821 -178.431 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 11.4 mmtt -105.56 -61.83 1.44 Allowed 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 120.979 0.418 . . . . 0.0 110.963 -179.077 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 19.8 p30 -132.74 168.28 18.61 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 176.734 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -128.99 -60.99 1.06 Allowed 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 -179.267 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -81.35 151.31 69.01 Favored Pre-proline 0 C--N 1.32 -0.714 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 176.395 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -70.58 152.02 64.77 Favored 'Trans proline' 0 C--O 1.239 0.569 0 C-N-CA 116.551 -1.833 . . . . 0.0 111.397 177.672 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 7.4 mtp180 -125.07 158.57 33.48 Favored 'General case' 0 CA--C 1.515 -0.4 0 C-N-CA 121.09 -0.244 . . . . 0.0 110.7 -179.786 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 48.2 m95 -131.75 136.4 47.56 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 178.312 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.431 ' CZ ' ' HB2' ' A' ' 15' ' ' ALA . 48.1 m-85 -110.37 172.95 6.56 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 104.804 -2.295 . . . . 0.0 104.804 -179.91 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 92.4 t80 -124.03 136.72 54.46 Favored 'General case' 0 CA--C 1.51 -0.595 0 CA-C-N 119.526 1.057 . . . . 0.0 108.597 -178.721 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 34.6 m-85 -137.51 148.89 46.35 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 -176.246 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 44.0 m-85 -84.05 159.52 21.15 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.359 -176.152 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -54.93 132.04 45.83 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.203 178.054 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 67.29 38.37 91.51 Favored Glycine 0 C--O 1.225 -0.436 0 N-CA-C 115.206 0.842 . . . . 0.0 115.206 177.124 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.2 p -94.05 146.16 24.15 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 175.757 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 90.5 136.0 6.37 Favored Glycine 0 CA--C 1.525 0.686 0 CA-C-O 119.699 -0.5 . . . . 0.0 112.289 -178.033 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -68.86 -41.73 5.23 Favored 'Trans proline' 0 C--N 1.348 0.539 0 N-CA-C 116.257 1.599 . . . . 0.0 116.257 -175.513 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -113.02 23.41 13.4 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.445 0.64 . . . . 0.0 109.717 -177.855 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -61.48 -32.86 72.89 Favored 'General case' 0 C--O 1.239 0.509 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.432 -177.563 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 59.02 33.03 72.29 Favored Glycine 0 C--O 1.227 -0.295 0 CA-C-N 115.406 -0.815 . . . . 0.0 114.184 176.681 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 14.7 mt -118.28 103.65 49.13 Favored Pre-proline 0 N--CA 1.444 -0.76 0 N-CA-C 114.874 1.435 . . . . 0.0 114.874 -177.704 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -79.73 164.69 23.01 Favored 'Trans proline' 0 C--O 1.235 0.36 0 C-N-CA 122.783 2.322 . . . . 0.0 107.78 167.455 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 60.6 t80 -62.32 131.67 50.09 Favored 'General case' 0 C--N 1.321 -0.666 0 C-N-CA 120.367 -0.533 . . . . 0.0 110.338 -178.066 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 91.14 -5.65 81.44 Favored Glycine 0 C--O 1.228 -0.273 0 N-CA-C 114.901 0.72 . . . . 0.0 114.901 179.031 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -66.77 130.49 43.33 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 118.649 1.225 . . . . 0.0 111.608 179.499 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 57.0 t30 -74.92 128.37 35.41 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.892 -179.186 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 26.4 ttmt -156.01 152.01 27.59 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 106.354 -1.721 . . . . 0.0 106.354 178.476 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -65.61 132.7 49.48 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.069 0.461 . . . . 0.0 110.615 -178.059 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 69.31 25.92 75.04 Favored Glycine 0 N--CA 1.449 -0.495 0 CA-C-N 115.714 -0.675 . . . . 0.0 114.239 177.97 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.412 HD12 ' CE1' ' A' ' 46' ' ' TYR . 47.7 mm -124.82 126.63 71.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 117.345 0.572 . . . . 0.0 110.842 179.945 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -127.08 116.98 46.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.356 176.243 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 96.9 m95 -82.22 135.66 35.21 Favored 'General case' 0 C--N 1.319 -0.72 0 O-C-N 121.864 -0.522 . . . . 0.0 112.227 -177.676 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -142.22 154.97 18.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 -178.113 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -154.92 166.52 33.28 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 106.193 -1.78 . . . . 0.0 106.193 -176.635 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 14.7 t -121.79 164.63 17.13 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 103.211 -2.885 . . . . 0.0 103.211 171.53 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -67.56 136.08 53.95 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 -179.099 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 92.84 -9.67 75.14 Favored Glycine 0 C--O 1.224 -0.501 0 CA-C-N 115.986 -0.552 . . . . 0.0 113.833 178.504 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -74.16 143.08 45.41 Favored 'General case' 0 CA--C 1.545 0.756 0 O-C-N 122.339 -0.506 . . . . 0.0 110.429 179.143 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 40.2 mt -93.17 133.48 36.32 Favored 'General case' 0 CA--C 1.516 -0.347 0 N-CA-C 115.004 1.483 . . . . 0.0 115.004 -175.496 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 61.6 t30 -79.67 64.68 4.61 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 114.683 -1.144 . . . . 0.0 110.966 -178.256 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -135.85 157.41 76.07 Favored Pre-proline 0 C--N 1.322 -0.588 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 -178.152 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -73.27 148.24 43.45 Favored 'Trans proline' 0 CA--C 1.534 0.493 0 N-CA-C 114.496 0.921 . . . . 0.0 114.496 175.338 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.54 58.85 1.07 Allowed 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 177.595 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -64.01 -14.37 53.68 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.275 176.449 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 18.0 p-80 -61.53 -14.46 29.78 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 179.396 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 23.4 mt -92.81 -26.7 4.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 121.329 0.585 . . . . 0.0 109.616 179.456 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -81.3 10.34 49.83 Favored Glycine 0 N--CA 1.459 0.232 0 O-C-N 122.007 -0.433 . . . . 0.0 113.63 -178.128 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 12.4 t -83.22 6.48 19.33 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 122.295 -0.532 . . . . 0.0 111.262 -178.4 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.44 ' HD3' ' CD2' ' A' ' 12' ' ' TRP . 63.5 ttp85 -54.51 133.61 46.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.509 179.908 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 35.0 m120 -96.97 115.82 65.85 Favored Pre-proline 0 C--N 1.326 -0.455 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 178.8 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -73.23 -11.53 25.03 Favored 'Trans proline' 0 C--O 1.219 -0.473 0 C-N-CA 117.45 -1.233 . . . . 0.0 113.351 -178.155 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -80.54 -25.45 38.63 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.215 177.436 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 -101.99 -25.44 13.76 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 113.543 0.942 . . . . 0.0 113.543 -174.334 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -140.42 154.27 46.6 Favored 'General case' 0 N--CA 1.434 -1.226 0 CA-C-O 121.497 0.665 . . . . 0.0 109.45 -177.59 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -93.36 144.45 25.31 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 114.938 -1.028 . . . . 0.0 110.837 -179.531 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -68.83 145.44 53.73 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.37 0.605 . . . . 0.0 110.561 178.853 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 27.8 mt -81.59 137.44 21.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 -178.723 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 1.2 p -62.08 125.99 19.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 176.324 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 6.4 tt -67.11 127.52 32.91 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.01 0.434 . . . . 0.0 110.116 -177.013 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 29.7 mt-30 -130.86 155.84 46.04 Favored 'General case' 0 CA--C 1.512 -0.488 0 N-CA-C 107.251 -1.388 . . . . 0.0 107.251 -179.132 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 13.5 mt -111.97 148.6 39.35 Favored Pre-proline 0 C--N 1.322 -0.616 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 179.029 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -71.5 164.52 35.45 Favored 'Trans proline' 0 C--N 1.346 0.403 0 O-C-N 122.278 0.62 . . . . 0.0 112.814 -179.037 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 65.1 tt0 -55.12 132.51 47.59 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.422 -179.649 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 96.57 -16.48 60.95 Favored Glycine 0 C--O 1.227 -0.32 0 CA-C-N 116.039 -0.528 . . . . 0.0 112.945 -179.002 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 6.1 m -107.59 126.77 52.96 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 117.907 0.853 . . . . 0.0 110.559 178.329 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 14.8 p -117.0 148.14 41.72 Favored 'General case' 0 CA--C 1.509 -0.605 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.534 -179.454 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 82.7 mt -68.37 152.37 96.62 Favored Pre-proline 0 C--N 1.321 -0.636 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 178.036 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -76.83 173.01 15.16 Favored 'Trans proline' 0 N--CA 1.462 -0.342 0 C-N-CA 117.87 -0.953 . . . . 0.0 110.43 177.989 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 84.4 tttt -57.27 128.42 36.9 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 113.485 0.92 . . . . 0.0 113.485 -174.12 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 95.12 -6.02 68.74 Favored Glycine 0 CA--C 1.518 0.227 0 N-CA-C 115.854 1.101 . . . . 0.0 115.854 176.15 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.452 ' CZ ' ' HB2' ' A' ' 18' ' ' GLN . 4.6 m-85 -92.38 147.09 23.18 Favored 'General case' 0 N--CA 1.437 -1.092 0 CA-C-O 122.962 1.363 . . . . 0.0 114.004 -178.194 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 48.5 p90 -146.76 163.51 35.76 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 112.29 -2.232 . . . . 0.0 107.274 172.94 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -105.31 143.69 33.12 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 112.762 0.653 . . . . 0.0 112.762 -177.398 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -76.78 147.95 36.96 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 175.368 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 95.02 -33.66 5.26 Favored Glycine 0 C--O 1.227 -0.333 0 C-N-CA 121.428 -0.415 . . . . 0.0 113.964 178.184 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -61.27 123.02 16.56 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.201 0.524 . . . . 0.0 111.658 177.113 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 28.9 mmm180 -124.72 16.19 8.73 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.541 179.08 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -67.51 143.99 43.31 Favored Glycine 0 C--N 1.319 -0.392 0 N-CA-C 108.44 -1.864 . . . . 0.0 108.44 177.362 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 165.94 -157.06 29.37 Favored Glycine 0 N--CA 1.451 -0.356 0 N-CA-C 108.224 -1.95 . . . . 0.0 108.224 -177.675 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 56.4 p . . . . . 0 C--O 1.253 1.244 0 CA-C-O 115.477 -2.201 . . . . 0.0 105.485 179.316 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.484 0 CA-C-O 118.769 -1.017 . . . . 0.0 111.318 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -101.37 131.89 47.23 Favored 'General case' 0 C--O 1.22 -0.45 0 CA-C-N 118.457 1.128 . . . . 0.0 111.932 -177.302 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 5.5 ttt 53.02 14.48 0.47 Allowed 'General case' 0 N--CA 1.483 1.211 0 N-CA-C 117.637 2.458 . . . . 0.0 117.637 174.969 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -82.85 -33.75 23.46 Favored Glycine 0 C--O 1.225 -0.454 0 N-CA-C 115.794 1.078 . . . . 0.0 115.794 -177.797 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 96.3 mt -101.74 141.02 21.72 Favored Pre-proline 0 C--N 1.324 -0.535 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 -178.489 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -73.4 -17.94 23.49 Favored 'Trans proline' 0 C--N 1.351 0.661 0 N-CA-C 114.133 0.782 . . . . 0.0 114.133 -179.122 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 50.48 43.33 27.15 Favored 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 114.525 1.306 . . . . 0.0 114.525 175.808 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -93.62 23.33 4.74 Favored 'General case' 0 N--CA 1.471 0.616 0 O-C-N 121.593 -0.692 . . . . 0.0 110.902 -179.67 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 20.1 p -73.98 88.68 1.88 Allowed 'General case' 0 C--O 1.239 0.522 0 C-N-CA 124.285 1.034 . . . . 0.0 111.115 -174.75 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -101.48 152.17 21.08 Favored 'General case' 0 N--CA 1.441 -0.898 0 CA-C-N 114.979 -1.009 . . . . 0.0 112.296 -175.634 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -61.8 143.65 55.98 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 114.767 -1.106 . . . . 0.0 110.287 177.785 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 21.1 m95 -69.38 -23.64 63.77 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 114.864 1.431 . . . . 0.0 114.864 -178.514 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 86.2 m-85 -121.52 161.07 22.95 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.186 0.517 . . . . 0.0 112.384 -172.747 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 74.6 p -70.31 161.58 30.12 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 177.013 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -74.83 153.79 38.57 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.902 0.858 . . . . 0.0 113.191 -175.995 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 22.6 mt -90.94 148.79 22.2 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 102.497 -3.149 . . . . 0.0 102.497 168.171 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 51.9 m -123.85 139.59 53.82 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 179.893 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.449 ' HB2' ' CZ ' ' A' ' 131' ' ' PHE . 4.3 tp60 -110.41 138.98 46.08 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-O 121.527 0.679 . . . . 0.0 112.298 -178.531 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 73.0 t60 -134.14 99.44 4.41 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 103.391 -2.818 . . . . 0.0 103.391 169.773 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 173.13 -165.97 38.34 Favored Glycine 0 C--O 1.225 -0.452 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 -176.055 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 37.9 mtmm -102.18 -25.09 13.83 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 113.956 1.095 . . . . 0.0 113.956 -178.221 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -89.21 162.1 16.08 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.056 -179.154 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -77.62 -62.95 1.5 Allowed 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.203 -176.916 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 34.6 tp 172.99 142.66 0.04 OUTLIER 'General case' 0 N--CA 1.482 1.133 0 N-CA-C 105.545 -2.02 . . . . 0.0 105.545 176.409 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 12.0 tmtt? -154.95 125.45 6.89 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 175.459 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -106.81 152.46 40.87 Favored Pre-proline 0 C--O 1.242 0.676 0 CA-C-O 120.457 0.17 . . . . 0.0 110.711 177.842 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -68.71 161.48 45.17 Favored 'Trans proline' 0 C--N 1.352 0.724 0 CA-C-O 121.226 0.427 . . . . 0.0 112.799 178.455 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 71.6 ttt180 -69.86 132.37 45.91 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 122.182 -0.324 . . . . 0.0 111.361 -175.846 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 79.35 13.6 82.53 Favored Glycine 0 C--O 1.222 -0.612 0 N-CA-C 111.697 -0.561 . . . . 0.0 111.697 179.254 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 31.0 mt-30 -148.23 171.74 15.45 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.18 -1.045 . . . . 0.0 108.18 -175.327 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 107.71 -10.22 38.11 Favored Glycine 0 CA--C 1.501 -0.786 0 CA-C-N 116.159 -0.473 . . . . 0.0 112.803 175.851 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.408 HG11 ' HB3' ' A' ' 43' ' ' GLN . 57.4 t -74.37 130.89 81.29 Favored Pre-proline 0 C--N 1.32 -0.685 0 N-CA-C 106.437 -1.69 . . . . 0.0 106.437 176.739 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -71.62 172.84 13.56 Favored 'Trans proline' 0 C--O 1.221 -0.34 0 O-C-N 122.179 0.568 . . . . 0.0 112.505 177.658 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 64.8 mt -75.85 106.3 5.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 122.228 1.013 . . . . 0.0 110.341 -179.111 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.54 ' HB2' HE22 ' A' ' 43' ' ' GLN . 38.8 m-20 -97.67 77.89 2.59 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 114.184 -1.371 . . . . 0.0 108.407 -179.425 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 80.7 p -63.88 -25.56 68.21 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 115.289 1.588 . . . . 0.0 115.289 -174.677 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -116.19 32.23 6.24 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 -176.369 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 5.9 m -133.06 166.87 21.42 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.678 0.275 . . . . 0.0 111.356 -178.903 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 25.0 m -77.57 155.92 81.0 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-N 116.583 -0.281 . . . . 0.0 111.657 -177.527 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -68.95 -20.91 38.08 Favored 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 116.804 -1.664 . . . . 0.0 114.378 -179.809 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.408 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 1.9 p-10 -76.95 -23.19 52.39 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 121.434 -0.791 . . . . 0.0 110.978 177.203 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -76.69 -13.08 60.07 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 114.715 1.376 . . . . 0.0 114.715 -170.924 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.54 HE22 ' HB2' ' A' ' 35' ' ' ASN . 94.8 mm-40 -55.01 -28.15 49.78 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 113.934 1.086 . . . . 0.0 113.934 -175.025 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 13.6 tt -64.63 135.82 27.51 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.784 0 CA-C-O 122.316 1.055 . . . . 0.0 111.981 178.643 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 179.36 -155.91 17.06 Favored Glycine 0 N--CA 1.45 -0.432 0 N-CA-C 110.755 -0.938 . . . . 0.0 110.755 -177.54 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 33.2 p90 -155.1 168.34 27.35 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.882 0.341 . . . . 0.0 110.554 179.826 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 29.1 m-85 -112.79 141.2 46.87 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 175.345 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 73.7 ttt-85 -116.77 125.04 51.05 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.661 -0.7 . . . . 0.0 112.675 -177.969 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 50.4 ttp85 -69.15 141.05 54.71 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 121.084 0.468 . . . . 0.0 111.092 177.518 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -152.05 157.54 41.8 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 179.104 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 68.1 p -129.43 166.29 19.87 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 104.058 -2.571 . . . . 0.0 104.058 172.571 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 21.5 tpt180 -96.09 118.96 33.72 Favored 'General case' 0 C--O 1.218 -0.584 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 178.667 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 6.7 tmm_? -139.59 139.1 36.7 Favored 'General case' 0 CA--C 1.502 -0.88 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 -178.951 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -137.29 -179.6 2.93 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 114.802 -1.09 . . . . 0.0 108.245 -175.982 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 13.1 tpp85 -129.14 125.14 36.42 Favored 'General case' 0 C--O 1.221 -0.431 0 N-CA-C 105.02 -2.215 . . . . 0.0 105.02 174.339 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -156.02 144.03 10.43 Favored Glycine 0 C--O 1.224 -0.489 0 N-CA-C 107.524 -2.23 . . . . 0.0 107.524 177.325 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -65.87 -60.65 6.28 Favored Glycine 0 C--O 1.227 -0.319 0 CA-C-N 117.883 0.842 . . . . 0.0 112.391 -177.958 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -107.34 8.39 29.69 Favored 'General case' 0 C--O 1.215 -0.744 0 CA-C-O 121.967 0.889 . . . . 0.0 110.838 178.715 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -95.95 -11.59 54.49 Favored Glycine 0 CA--C 1.504 -0.653 0 N-CA-C 105.542 -3.023 . . . . 0.0 105.542 179.318 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 53.7 mmtt 52.93 -161.59 0.11 Allowed 'General case' 0 N--CA 1.442 -0.846 0 CA-C-N 112.95 -1.625 . . . . 0.0 111.723 176.79 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 70.1 mtp -90.43 -179.02 5.49 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 114.516 -1.22 . . . . 0.0 109.865 176.875 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 18.5 mmtm -134.8 -69.53 0.51 Allowed 'General case' 0 C--O 1.211 -0.941 0 CA-C-O 120.897 0.38 . . . . 0.0 110.503 179.497 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.7 t0 52.1 51.41 16.44 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 114.318 -1.31 . . . . 0.0 111.923 178.918 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -61.97 162.59 8.92 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 114.116 -1.402 . . . . 0.0 111.969 -179.687 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -45.76 146.18 2.01 Favored Pre-proline 0 C--O 1.25 1.08 0 CA-C-N 115.047 -0.979 . . . . 0.0 113.495 -177.335 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -61.86 142.54 93.73 Favored 'Trans proline' 0 C--N 1.349 0.601 0 CA-C-O 122.768 1.07 . . . . 0.0 114.209 -174.895 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 22.6 mtt85 -128.95 155.77 44.8 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-N 113.2 -1.818 . . . . 0.0 108.054 -178.629 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 66.5 m95 -127.8 131.63 49.57 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 179.711 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 70.9 m-85 -111.41 148.23 33.52 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 107.289 -1.375 . . . . 0.0 107.289 179.064 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 68.1 t80 -95.79 131.35 42.18 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 -177.778 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -134.36 146.52 50.0 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 -178.263 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -83.34 159.51 21.85 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 113.016 0.747 . . . . 0.0 113.016 -174.956 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -55.53 132.91 49.74 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.391 179.489 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 72.56 33.96 60.5 Favored Glycine 0 C--O 1.221 -0.696 0 N-CA-C 115.469 0.947 . . . . 0.0 115.469 176.629 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 9.2 p -99.97 146.09 27.1 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.226 -1.028 . . . . 0.0 108.226 177.818 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 103.21 138.62 9.98 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 108.572 -1.811 . . . . 0.0 108.572 -176.619 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -70.51 -40.43 4.16 Favored 'Trans proline' 0 C--N 1.347 0.458 0 CA-C-N 119.748 1.774 . . . . 0.0 115.577 -173.494 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -123.18 39.14 4.03 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 -177.538 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -64.95 -41.78 95.19 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.529 -0.76 . . . . 0.0 111.621 -177.818 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 61.23 24.56 63.51 Favored Glycine 0 C--O 1.226 -0.385 0 CA-C-N 116.127 -0.488 . . . . 0.0 113.654 179.854 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 21.3 mt -109.47 103.89 53.91 Favored Pre-proline 0 C--O 1.238 0.468 0 N-CA-C 114.273 1.212 . . . . 0.0 114.273 -176.719 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -78.5 167.19 23.12 Favored 'Trans proline' 0 N--CA 1.461 -0.436 0 N-CA-C 108.439 -1.408 . . . . 0.0 108.439 170.895 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.43 ' CE1' ' HB3' ' A' ' 92' ' ' TRP . 77.9 t80 -61.24 132.47 53.74 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 120.357 -0.537 . . . . 0.0 110.254 179.979 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 90.43 -4.9 82.71 Favored Glycine 0 CA--C 1.518 0.276 0 N-CA-C 115.065 0.786 . . . . 0.0 115.065 178.03 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -65.38 128.09 34.47 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 118.463 1.132 . . . . 0.0 111.472 179.407 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 45.9 t-20 -78.05 128.01 33.2 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.322 -176.576 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 16.7 ttmm -156.08 152.09 27.57 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 179.54 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -62.73 132.76 53.34 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.744 0.307 . . . . 0.0 110.441 179.447 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 68.86 24.41 75.64 Favored Glycine 0 N--CA 1.449 -0.44 0 CA-C-O 119.477 -0.624 . . . . 0.0 113.734 178.033 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 38.6 mm -129.32 128.51 66.57 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.304 0 CA-C-N 117.362 0.581 . . . . 0.0 110.077 179.866 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.1 pt -134.56 123.71 42.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.573 176.036 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . 0.43 ' HB3' ' CE1' ' A' ' 83' ' ' TYR . 90.0 m95 -89.37 139.42 30.53 Favored 'General case' 0 C--N 1.321 -0.671 0 O-C-N 121.908 -0.495 . . . . 0.0 111.617 -176.933 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 17.8 m -135.09 153.77 34.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 179.903 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -162.03 166.56 25.77 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 105.812 -1.921 . . . . 0.0 105.812 -178.63 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 13.5 t -130.41 169.29 15.69 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 104.628 -2.36 . . . . 0.0 104.628 176.137 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -66.22 135.07 53.97 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.225 0.536 . . . . 0.0 110.218 -178.601 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 93.81 -12.73 68.86 Favored Glycine 0 CA--C 1.517 0.195 0 CA-C-N 115.982 -0.554 . . . . 0.0 113.998 178.395 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.408 ' HA ' ' HA ' ' A' ' 41' ' ' ASP . . . -68.16 135.97 52.92 Favored 'General case' 0 CA--C 1.542 0.667 0 O-C-N 122.33 -0.512 . . . . 0.0 110.133 179.088 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 32.4 mt -89.34 130.31 35.73 Favored 'General case' 0 CA--C 1.507 -0.681 0 N-CA-C 113.416 0.895 . . . . 0.0 113.416 -177.145 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 53.5 t30 -81.17 73.8 8.2 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 114.526 -1.215 . . . . 0.0 110.564 -178.718 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 1.5 t -142.97 153.83 61.12 Favored Pre-proline 0 C--N 1.321 -0.631 0 N-CA-C 106.427 -1.694 . . . . 0.0 106.427 179.723 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -67.65 147.74 76.63 Favored 'Trans proline' 0 CA--C 1.528 0.213 0 C-N-CA 117.824 -0.984 . . . . 0.0 113.089 176.018 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 6.6 ptpt -145.73 56.95 1.22 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 122.722 1.248 . . . . 0.0 110.593 179.066 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -58.54 -31.05 67.58 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.149 -1.387 . . . . 0.0 111.9 179.304 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 18.3 p80 -62.62 -7.41 4.72 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 113.944 1.09 . . . . 0.0 113.944 -179.34 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 29.1 mt -96.24 -45.29 13.02 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.53 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 177.148 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -69.92 14.66 1.1 Allowed Glycine 0 CA--C 1.524 0.609 0 N-CA-C 116.436 1.334 . . . . 0.0 116.436 -177.798 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 15.2 t -95.77 26.51 3.99 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.328 0.651 . . . . 0.0 112.111 -178.841 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 67.7 ttp85 -59.29 125.94 25.65 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 178.429 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -101.26 128.02 30.34 Favored Pre-proline 0 C--N 1.322 -0.615 0 N-CA-C 106.671 -1.603 . . . . 0.0 106.671 -178.28 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -68.53 -20.3 41.48 Favored 'Trans proline' 0 C--O 1.219 -0.468 0 N-CA-C 114.605 0.964 . . . . 0.0 114.605 -176.81 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -74.17 -24.62 59.41 Favored 'General case' 0 C--O 1.221 -0.428 0 CA-C-O 120.861 0.362 . . . . 0.0 110.619 178.269 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 84.7 m-20 -100.94 -24.32 14.37 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 -175.714 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 33.0 t30 -158.23 149.74 21.27 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 113.364 0.876 . . . . 0.0 113.364 -177.634 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -91.61 150.52 21.13 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-O 121.428 0.632 . . . . 0.0 111.787 179.512 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -69.96 146.62 50.99 Favored 'General case' 0 C--N 1.323 -0.543 0 CA-C-O 121.261 0.553 . . . . 0.0 111.451 178.996 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 15.6 mt -86.68 136.45 22.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.828 -178.714 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 70.0 t -62.94 120.89 10.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 N-CA-C 106.179 -1.785 . . . . 0.0 106.179 175.109 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 6.0 tt -68.47 134.43 50.11 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -175.58 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 50.8 mt-30 -135.19 161.91 34.03 Favored 'General case' 0 CA--C 1.513 -0.452 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 178.328 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.44 HD13 HG22 ' A' ' 125' ' ' THR . 13.3 mt -114.63 146.3 35.68 Favored Pre-proline 0 C--N 1.323 -0.58 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 175.646 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -71.71 165.91 31.07 Favored 'Trans proline' 0 C--N 1.345 0.384 0 O-C-N 122.243 0.601 . . . . 0.0 113.619 -177.64 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 41.3 tt0 -53.26 128.83 29.53 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.238 -179.421 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 97.68 -17.32 59.08 Favored Glycine 0 C--O 1.227 -0.299 0 CA-C-N 115.886 -0.597 . . . . 0.0 113.058 -179.279 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.44 HG22 HD13 ' A' ' 121' ' ' LEU . 5.8 m -108.73 125.96 52.48 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 117.721 0.76 . . . . 0.0 109.263 178.083 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 5.8 p -124.8 148.23 48.27 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 -179.176 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 81.6 mt -69.56 155.04 94.24 Favored Pre-proline 0 C--N 1.325 -0.493 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 179.876 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_endo -74.44 169.06 23.35 Favored 'Trans proline' 0 N--CA 1.463 -0.299 0 C-N-CA 118.235 -0.71 . . . . 0.0 110.846 178.026 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -61.73 130.42 45.72 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.269 -176.191 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 95.2 -5.7 68.32 Favored Glycine 0 CA--C 1.518 0.224 0 CA-C-N 115.762 -0.653 . . . . 0.0 114.584 179.103 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.449 ' CZ ' ' HB2' ' A' ' 18' ' ' GLN . 1.2 m-85 -101.2 142.49 32.55 Favored 'General case' 0 N--CA 1.445 -0.725 0 CA-C-O 121.712 0.767 . . . . 0.0 110.678 179.441 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 45.6 p90 -145.22 164.19 32.1 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 114.478 -1.237 . . . . 0.0 108.019 175.194 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -100.77 145.78 28.08 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.094 0.474 . . . . 0.0 110.708 -177.949 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -70.58 129.01 38.07 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 -179.86 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 91.55 -32.02 5.5 Favored Glycine 0 CA--C 1.52 0.357 0 CA-C-N 116.159 -0.473 . . . . 0.0 113.967 -179.965 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 34.3 t -80.77 138.96 36.3 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 117.577 0.688 . . . . 0.0 110.177 -178.949 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? -100.9 -5.68 25.71 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.058 -0.974 . . . . 0.0 110.103 176.594 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 85.13 174.8 50.41 Favored Glycine 0 N--CA 1.452 -0.245 0 N-CA-C 107.478 -2.249 . . . . 0.0 107.478 -173.448 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 139.36 -154.76 23.68 Favored Glycine 0 CA--C 1.511 -0.21 0 N-CA-C 109.272 -1.531 . . . . 0.0 109.272 -178.553 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 61.8 p . . . . . 0 C--O 1.241 0.631 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 178.532 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.704 0 CA-C-O 119.015 -0.881 . . . . 0.0 111.369 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -152.61 166.44 32.06 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 105.219 -2.141 . . . . 0.0 105.219 179.466 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -128.48 112.65 14.58 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-O 121.578 0.704 . . . . 0.0 110.299 -179.828 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 135.68 127.21 2.65 Favored Glycine 0 C--O 1.228 -0.261 0 N-CA-C 107.122 -2.391 . . . . 0.0 107.122 -177.031 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 10.5 mp -72.73 142.25 83.26 Favored Pre-proline 0 C--N 1.324 -0.543 0 CA-C-N 117.38 0.59 . . . . 0.0 110.46 -177.745 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -78.92 159.5 27.46 Favored 'Trans proline' 0 C--N 1.344 0.341 0 CA-C-O 121.343 0.476 . . . . 0.0 112.972 178.075 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 -143.86 -29.39 0.5 Allowed 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 175.557 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 43.1 t30 67.26 30.54 7.08 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.87 1.268 . . . . 0.0 112.268 174.217 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 35.3 p -108.83 89.01 2.86 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 106.937 -1.505 . . . . 0.0 106.937 178.745 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -92.56 138.25 31.67 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.499 -175.096 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -57.48 138.4 55.15 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.018 -0.992 . . . . 0.0 109.65 177.245 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 38.1 m95 -67.39 -21.83 65.58 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 114.127 1.158 . . . . 0.0 114.127 -178.437 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -121.46 159.31 26.52 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.435 0.636 . . . . 0.0 112.433 -174.09 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 56.7 p -67.93 165.07 18.49 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.457 -1.247 . . . . 0.0 108.318 178.185 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.431 ' HB2' ' CE2' ' A' ' 69' ' ' TYR . . . -83.37 148.6 27.22 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 113.716 1.006 . . . . 0.0 113.716 -175.006 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 85.0 mt -84.95 148.88 25.99 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 102.627 -3.101 . . . . 0.0 102.627 166.975 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 81.7 m -106.85 125.04 50.49 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 178.366 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -88.95 105.64 17.9 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 179.09 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 73.5 t60 -113.48 97.52 6.51 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 104.18 -2.526 . . . . 0.0 104.18 173.107 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 148.99 -168.01 29.43 Favored Glycine 0 N--CA 1.45 -0.41 0 N-CA-C 108.828 -1.709 . . . . 0.0 108.828 -176.128 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -104.4 -22.3 13.35 Favored 'General case' 0 C--O 1.215 -0.738 0 N-CA-C 115.369 1.618 . . . . 0.0 115.369 -176.487 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -71.12 146.36 49.25 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.6 0.714 . . . . 0.0 112.638 -176.357 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -95.58 33.29 1.65 Allowed 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 122.691 1.234 . . . . 0.0 111.918 -176.605 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 31.4 tp 62.52 146.29 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.99 0 CA-C-N 112.791 -2.004 . . . . 0.0 115.305 176.219 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 51.9 tptt -158.16 140.39 14.23 Favored 'General case' 0 CA--C 1.514 -0.433 0 O-C-N 121.118 -0.989 . . . . 0.0 109.869 174.58 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 -125.51 151.36 70.16 Favored Pre-proline 0 C--O 1.241 0.655 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 175.411 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -74.66 165.68 31.02 Favored 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 120.674 0.916 . . . . 0.0 113.863 -179.906 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 16.7 tpt180 -65.07 133.97 52.78 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.885 -178.211 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 83.96 2.32 89.59 Favored Glycine 0 C--O 1.227 -0.293 0 CA-C-O 121.305 0.392 . . . . 0.0 112.351 177.959 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 30.2 mt-30 -141.29 171.14 14.47 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 123.674 0.79 . . . . 0.0 109.803 -173.74 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 105.1 -19.58 40.2 Favored Glycine 0 CA--C 1.497 -1.062 0 N-CA-C 111.254 -0.738 . . . . 0.0 111.254 175.987 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 84.8 t -65.74 127.81 93.34 Favored Pre-proline 0 C--N 1.317 -0.818 0 N-CA-C 105.813 -1.921 . . . . 0.0 105.813 176.311 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -71.62 172.96 13.31 Favored 'Trans proline' 0 N--CA 1.46 -0.485 0 O-C-N 122.292 0.627 . . . . 0.0 111.295 178.141 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 78.4 mt -74.29 108.97 6.31 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 -179.324 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 30.4 m-20 -110.11 74.43 0.88 Allowed 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.648 -1.16 . . . . 0.0 110.454 -175.455 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 65.8 p -66.08 -23.0 66.44 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 115.588 1.699 . . . . 0.0 115.588 -174.298 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -110.76 31.3 6.1 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 112.259 0.466 . . . . 0.0 112.259 -176.474 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 73.8 p -132.9 167.56 20.0 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 178.988 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 44.6 m -84.26 162.45 51.41 Favored Pre-proline 0 C--N 1.321 -0.672 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.417 -178.59 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -67.64 -21.79 45.01 Favored 'Trans proline' 0 C--N 1.351 0.69 0 C-N-CA 116.526 -1.849 . . . . 0.0 114.668 -178.836 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.42 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 6.3 p-10 -75.19 -18.15 60.22 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 121.73 -0.606 . . . . 0.0 109.858 177.785 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -90.42 2.11 55.96 Favored 'General case' 0 C--O 1.219 -0.525 0 N-CA-C 114.32 1.23 . . . . 0.0 114.32 -175.016 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 93.0 mm-40 -65.26 -23.76 67.14 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-O 121.624 0.726 . . . . 0.0 109.99 176.789 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.499 ' HB ' ' HB1' ' A' ' 98' ' ' ALA . 9.0 tt -66.59 141.09 18.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 122.044 0.926 . . . . 0.0 111.083 177.964 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 175.18 -160.98 30.04 Favored Glycine 0 CA--C 1.504 -0.626 0 C-N-CA 120.2 -1.0 . . . . 0.0 110.636 179.364 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 44.3 p90 -155.1 170.73 21.11 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 178.832 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -112.8 140.24 47.76 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 106.522 -1.658 . . . . 0.0 106.522 175.213 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 63.9 ttt180 -115.49 121.97 44.3 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 123.831 0.852 . . . . 0.0 112.152 -175.59 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 32.3 ttp85 -68.65 138.66 55.18 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 176.977 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -143.64 138.73 29.19 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 123.217 0.607 . . . . 0.0 109.597 179.954 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.8 t -161.38 155.08 21.88 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 105.076 -2.194 . . . . 0.0 105.076 176.721 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 11.6 tpt180 -141.42 123.81 15.77 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 107.243 -1.392 . . . . 0.0 107.243 176.495 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 7.7 tmm_? -132.77 129.7 38.95 Favored 'General case' 0 CA--C 1.49 -1.341 0 CA-C-O 121.983 0.897 . . . . 0.0 110.221 179.931 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -139.68 176.82 5.17 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 N-CA-C 104.853 -2.277 . . . . 0.0 104.853 -178.75 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 30.2 ttt85 -127.42 115.91 19.65 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 105.847 -1.909 . . . . 0.0 105.847 175.172 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -82.35 156.83 35.92 Favored Glycine 0 N--CA 1.448 -0.502 0 N-CA-C 108.092 -2.003 . . . . 0.0 108.092 177.802 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -75.45 -31.66 56.39 Favored Glycine 0 C--O 1.215 -1.055 0 N-CA-C 108.808 -1.717 . . . . 0.0 108.808 178.964 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -71.76 -20.69 61.85 Favored 'General case' 0 C--O 1.217 -0.627 0 CA-C-N 114.17 -1.015 . . . . 0.0 109.718 178.211 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 115.65 -9.89 19.17 Favored Glycine 0 CA--C 1.506 -0.48 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.869 173.841 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 5.0 pttt -79.13 154.06 29.62 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 122.085 0.945 . . . . 0.0 113.354 -176.822 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 94.4 mtp -122.48 -160.24 0.87 Allowed 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 113.89 -1.504 . . . . 0.0 110.053 -176.865 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 18.7 mmtt -118.75 -70.0 0.82 Allowed 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 122.199 0.2 . . . . 0.0 111.103 -179.397 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -141.13 160.43 40.12 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 177.269 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -121.17 -28.23 4.76 Favored 'General case' 0 N--CA 1.469 0.5 0 O-C-N 123.892 0.745 . . . . 0.0 110.792 -177.664 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -110.03 130.83 22.4 Favored Pre-proline 0 C--O 1.238 0.469 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 -179.22 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -65.23 162.61 32.46 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 117.386 -1.276 . . . . 0.0 113.439 179.492 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 29.2 mtt-85 -123.31 156.74 34.72 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 178.654 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 54.6 m95 -129.78 125.14 35.08 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 177.215 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.431 ' CE2' ' HB2' ' A' ' 15' ' ' ALA . 88.4 m-85 -112.22 147.5 36.08 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 -178.582 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 79.2 t80 -91.0 136.9 32.76 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 -179.335 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -140.53 140.68 35.28 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.338 -0.847 . . . . 0.0 109.364 -173.93 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 34.7 m-85 -74.44 159.53 32.17 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.173 0.511 . . . . 0.0 111.373 -179.605 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -54.74 124.95 18.06 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.76 -0.654 . . . . 0.0 112.105 -177.994 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 81.18 16.73 73.63 Favored Glycine 0 C--O 1.221 -0.7 0 N-CA-C 117.012 1.565 . . . . 0.0 117.012 176.868 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 19.4 p -88.98 146.05 25.12 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 119.173 1.486 . . . . 0.0 111.704 -179.88 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 122.65 154.82 9.18 Favored Glycine 0 CA--C 1.523 0.536 0 N-CA-C 109.841 -1.304 . . . . 0.0 109.841 -179.137 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -70.92 -39.86 3.96 Favored 'Trans proline' 0 C--O 1.22 -0.423 0 CA-C-N 119.315 1.557 . . . . 0.0 115.204 -175.714 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -127.53 35.81 4.47 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 108.002 -1.111 . . . . 0.0 108.002 -177.859 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -55.13 -55.55 29.82 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.17 -0.923 . . . . 0.0 112.405 -175.628 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 55.73 32.21 58.53 Favored Glycine 0 C--O 1.227 -0.336 0 C-N-CA 121.264 -0.493 . . . . 0.0 112.474 -179.236 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 16.9 mt -114.83 103.9 54.5 Favored Pre-proline 0 N--CA 1.449 -0.514 0 N-CA-C 115.486 1.662 . . . . 0.0 115.486 -174.783 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -78.51 163.16 27.19 Favored 'Trans proline' 0 N--CA 1.461 -0.406 0 N-CA-C 107.698 -1.693 . . . . 0.0 107.698 168.269 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 55.0 t80 -61.62 133.61 55.84 Favored 'General case' 0 C--N 1.321 -0.668 0 C-N-CA 120.466 -0.493 . . . . 0.0 110.372 -178.305 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 90.7 -7.84 80.69 Favored Glycine 0 CA--C 1.517 0.206 0 CA-C-O 119.548 -0.584 . . . . 0.0 114.346 178.841 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -65.48 130.81 44.62 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 118.386 1.093 . . . . 0.0 111.03 179.098 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 59.1 t30 -79.71 129.21 34.28 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.381 -179.421 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 30.7 ttmt -156.07 152.96 28.66 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 106.571 -1.641 . . . . 0.0 106.571 179.451 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -60.95 127.47 31.71 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 -179.645 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 70.22 28.65 71.19 Favored Glycine 0 N--CA 1.449 -0.485 0 CA-C-O 119.382 -0.677 . . . . 0.0 114.677 176.593 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 43.5 mm -126.69 122.43 60.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 117.601 0.7 . . . . 0.0 110.842 179.406 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.1 pt -127.49 116.41 43.55 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 CA-C-O 121.762 0.792 . . . . 0.0 111.828 176.612 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 95.2 m95 -81.68 137.84 35.36 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 113.223 0.823 . . . . 0.0 113.223 -177.597 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 18.2 m -137.2 152.43 27.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 178.305 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -163.01 165.99 24.25 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 104.754 -2.313 . . . . 0.0 104.754 -179.999 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 6.5 t -140.2 -178.94 5.7 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 105.938 -1.875 . . . . 0.0 105.938 177.583 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -67.63 136.32 54.22 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.338 0.589 . . . . 0.0 110.614 -178.675 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 96.65 -13.69 65.04 Favored Glycine 0 N--CA 1.459 0.215 0 CA-C-N 115.668 -0.696 . . . . 0.0 112.967 178.48 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.499 ' HB1' ' HB ' ' A' ' 44' ' ' ILE . . . -75.59 140.02 42.42 Favored 'General case' 0 C--N 1.322 -0.608 0 O-C-N 122.716 -0.285 . . . . 0.0 110.573 179.997 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 36.4 mt -96.53 139.89 31.96 Favored 'General case' 0 C--O 1.218 -0.555 0 CA-C-O 121.259 0.552 . . . . 0.0 111.69 -179.373 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 58.9 t30 -86.16 68.77 10.38 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.711 179.473 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 1.1 t -140.67 150.77 61.33 Favored Pre-proline 0 C--N 1.325 -0.489 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 179.12 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -67.74 149.57 78.76 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 118.345 -0.636 . . . . 0.0 113.544 176.908 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.64 47.12 1.19 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 122.732 1.253 . . . . 0.0 110.839 179.061 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 16.0 p-10 -47.73 -39.34 17.47 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 113.44 -1.709 . . . . 0.0 113.34 178.752 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 50.1 p-80 -60.74 -17.1 46.53 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 115.336 1.606 . . . . 0.0 115.336 -177.814 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 68.9 mt -81.55 -29.16 10.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 178.896 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -72.06 14.65 2.12 Favored Glycine 0 CA--C 1.522 0.525 0 N-CA-C 115.771 1.068 . . . . 0.0 115.771 -177.622 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 15.2 t -83.29 28.16 0.55 Allowed 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 123.54 0.736 . . . . 0.0 112.981 -177.711 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 72.9 ttp85 -61.61 116.38 4.7 Favored 'General case' 0 N--CA 1.469 0.514 0 O-C-N 121.221 -0.924 . . . . 0.0 108.647 178.443 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 14.5 m-20 -82.88 118.39 71.61 Favored Pre-proline 0 C--N 1.323 -0.554 0 N-CA-C 105.351 -2.092 . . . . 0.0 105.351 179.279 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -71.66 -13.61 29.88 Favored 'Trans proline' 0 C--O 1.219 -0.46 0 C-N-CA 117.312 -1.326 . . . . 0.0 113.891 -176.418 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -81.25 -24.91 37.01 Favored 'General case' 0 C--O 1.22 -0.465 0 CA-C-O 120.892 0.377 . . . . 0.0 110.241 178.252 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 81.2 m-20 -102.86 -24.78 13.67 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 113.521 0.934 . . . . 0.0 113.521 -175.315 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 30.7 t30 -145.97 145.42 30.64 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 -178.349 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -89.23 149.68 22.99 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.368 -179.927 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -70.24 148.31 48.72 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.305 0.574 . . . . 0.0 110.61 178.129 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 8.0 mt -83.43 139.33 17.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 -179.178 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 89.7 t -62.55 121.43 11.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 176.069 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 5.5 tt -68.07 126.92 31.01 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.244 0.545 . . . . 0.0 109.996 -177.798 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 30.8 mt-30 -132.96 154.23 50.67 Favored 'General case' 0 CA--C 1.509 -0.628 0 N-CA-C 106.656 -1.609 . . . . 0.0 106.656 -179.85 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 12.8 mt -110.73 147.45 36.48 Favored Pre-proline 0 C--N 1.321 -0.657 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 176.779 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -72.96 162.18 41.67 Favored 'Trans proline' 0 C--O 1.236 0.376 0 O-C-N 122.265 0.613 . . . . 0.0 112.491 -179.718 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 56.8 tt0 -55.15 131.27 44.82 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 -179.797 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 104.27 -22.8 33.65 Favored Glycine 0 C--O 1.226 -0.359 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.842 -178.267 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 3.8 m -108.72 126.98 53.59 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 117.641 0.72 . . . . 0.0 109.791 177.778 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 15.5 p -121.64 148.41 44.6 Favored 'General case' 0 CA--C 1.508 -0.635 0 CA-C-O 121.029 0.442 . . . . 0.0 110.25 179.912 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 83.0 mt -71.79 152.92 93.31 Favored Pre-proline 0 C--N 1.321 -0.634 0 N-CA-C 107.305 -1.369 . . . . 0.0 107.305 178.011 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -77.63 172.58 15.54 Favored 'Trans proline' 0 C--O 1.237 0.439 0 CA-C-O 121.384 0.493 . . . . 0.0 111.252 179.022 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 65.2 tttm -57.61 127.51 32.4 Favored 'General case' 0 C--O 1.219 -0.519 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.778 -178.047 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 91.82 7.84 64.15 Favored Glycine 0 C--O 1.226 -0.406 0 N-CA-C 115.625 1.01 . . . . 0.0 115.625 177.678 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 34.5 m-85 -118.86 136.87 53.81 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 118.064 0.932 . . . . 0.0 109.927 177.774 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 55.2 p90 -144.93 161.8 38.46 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 176.683 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -99.45 146.27 26.52 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.617 0.722 . . . . 0.0 112.893 -175.665 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -75.39 132.02 40.61 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 178.658 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 88.6 -6.85 83.18 Favored Glycine 0 C--O 1.225 -0.412 0 C-N-CA 121.323 -0.465 . . . . 0.0 112.959 -179.032 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 31.6 t -107.5 122.41 46.6 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 178.848 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 2.8 tmt_? 47.66 56.31 7.27 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-O 121.979 0.895 . . . . 0.0 111.724 -179.413 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -73.14 145.04 35.64 Favored Glycine 0 N--CA 1.451 -0.326 0 N-CA-C 107.175 -2.37 . . . . 0.0 107.175 175.633 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 81.03 -147.59 27.69 Favored Glycine 0 C--O 1.236 0.254 0 N-CA-C 110.223 -1.151 . . . . 0.0 110.223 -178.098 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 75.3 m . . . . . 0 C--O 1.245 0.858 0 CA-C-O 116.541 -1.695 . . . . 0.0 108.085 178.827 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.125 0 CA-C-O 118.123 -1.376 . . . . 0.0 111.501 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 62.01 -23.19 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.279 0 N-CA-C 120.149 3.388 . . . . 0.0 120.149 177.504 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 77.2 mtm -76.09 90.24 3.06 Favored 'General case' 0 C--N 1.308 -1.226 0 C-N-CA 123.17 0.588 . . . . 0.0 110.714 -179.594 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -90.15 43.07 2.93 Favored Glycine 0 C--O 1.228 -0.242 0 CA-C-N 116.121 -0.49 . . . . 0.0 113.95 -179.584 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 10.2 mp -66.04 144.69 98.88 Favored Pre-proline 0 C--N 1.326 -0.454 0 CA-C-N 117.126 0.463 . . . . 0.0 109.949 -178.641 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -74.55 148.02 36.88 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 117.696 -1.069 . . . . 0.0 112.735 179.405 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 49.3 t30 -90.69 -27.94 18.67 Favored 'General case' 0 C--O 1.215 -0.761 0 CA-C-O 121.36 0.6 . . . . 0.0 109.494 177.879 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 30.1 t30 65.18 32.13 10.33 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 125.495 1.518 . . . . 0.0 112.536 178.442 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 44.7 p -146.15 167.39 23.56 Favored 'General case' 0 N--CA 1.435 -1.204 0 N-CA-C 101.376 -3.565 . . . . 0.0 101.376 -179.329 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -148.33 151.32 35.15 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 116.004 -0.544 . . . . 0.0 109.574 178.58 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 34.0 p -64.21 145.65 55.63 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 178.351 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 13.1 m95 -64.73 -24.35 67.54 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.955 0.407 . . . . 0.0 112.086 179.5 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -121.38 163.93 17.91 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.578 -0.737 . . . . 0.0 112.416 -172.269 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 47.0 p -70.43 165.96 21.4 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 177.093 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -79.34 146.56 32.83 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.715 0.769 . . . . 0.0 112.472 -176.507 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.407 HD23 ' HA ' ' A' ' 16' ' ' LEU . 12.1 mt -83.32 146.73 28.35 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 102.931 -2.989 . . . . 0.0 102.931 169.151 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 29.9 m -129.78 138.75 51.23 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 -178.686 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.438 ' HB2' ' CZ ' ' A' ' 131' ' ' PHE . 4.0 tp60 -106.67 136.91 45.66 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.837 0.68 . . . . 0.0 112.837 -176.93 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 5.7 t60 -130.75 94.77 3.69 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 103.014 -2.958 . . . . 0.0 103.014 168.612 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 173.33 -157.33 26.01 Favored Glycine 0 C--O 1.223 -0.541 0 N-CA-C 110.957 -0.857 . . . . 0.0 110.957 -174.302 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 29.8 mtpp -112.32 -24.86 9.55 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 115.321 1.601 . . . . 0.0 115.321 -177.436 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 88.3 mt-10 -80.5 158.29 25.89 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 177.759 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -79.91 -62.8 1.57 Allowed 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 177.667 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 44.3 tp -179.25 141.09 0.16 Allowed 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 172.56 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 23.8 tptm -156.07 140.45 16.7 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 174.188 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 15.3 m-85 -125.02 152.1 69.92 Favored Pre-proline 0 C--O 1.242 0.68 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 175.817 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -72.69 160.41 46.43 Favored 'Trans proline' 0 CA--C 1.54 0.778 0 C-N-CA 120.658 0.905 . . . . 0.0 112.859 178.292 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.02 131.91 47.32 Favored 'General case' 0 C--O 1.216 -0.665 0 O-C-N 122.172 -0.33 . . . . 0.0 110.813 -178.033 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 85.45 7.27 82.64 Favored Glycine 0 N--CA 1.46 0.292 0 C-N-CA 121.445 -0.407 . . . . 0.0 112.181 179.195 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.407 HE21 HG23 ' A' ' 125' ' ' THR . 16.9 mt-30 -145.95 170.53 16.42 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 123.19 0.596 . . . . 0.0 109.983 -174.991 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 105.41 -16.88 44.36 Favored Glycine 0 CA--C 1.501 -0.819 0 CA-C-N 116.1 -0.5 . . . . 0.0 113.139 174.881 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 93.9 t -65.78 129.08 94.24 Favored Pre-proline 0 C--N 1.32 -0.704 0 N-CA-C 106.52 -1.659 . . . . 0.0 106.52 176.988 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -73.27 170.77 19.08 Favored 'Trans proline' 0 C--O 1.219 -0.433 0 O-C-N 122.148 0.552 . . . . 0.0 111.052 177.764 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 86.1 mt -70.55 106.56 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-O 122.009 0.909 . . . . 0.0 108.693 -179.601 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -98.14 84.1 3.21 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 114.514 -1.221 . . . . 0.0 110.017 -176.915 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 77.3 p -68.3 -14.08 62.73 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.775 0.798 . . . . 0.0 112.48 -179.313 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 11.5 p30 -106.69 22.98 15.02 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 114.82 -1.082 . . . . 0.0 111.718 -177.776 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 19.0 m -141.15 150.97 43.48 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 113.745 1.016 . . . . 0.0 113.745 -176.424 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.1 m -72.28 166.88 37.38 Favored Pre-proline 0 C--N 1.326 -0.441 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 176.415 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -66.4 -25.62 48.65 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 114.792 -3.005 . . . . 0.0 114.112 -179.714 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.472 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 4.5 p-10 -78.66 -20.63 49.82 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.586 0.708 . . . . 0.0 110.891 177.546 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 -81.64 -6.68 59.24 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 -176.086 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 96.0 mm-40 -57.7 -26.81 62.26 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 114.124 1.157 . . . . 0.0 114.124 -178.481 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.423 ' HB ' ' HB1' ' A' ' 98' ' ' ALA . 8.5 tt -59.31 138.35 20.49 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.939 0 N-CA-C 113.872 1.064 . . . . 0.0 113.872 -178.367 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -178.34 -158.2 20.57 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.389 -179.376 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 36.4 p90 -154.95 168.14 27.97 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 179.427 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 29.1 m-85 -112.77 141.74 46.22 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 174.634 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 69.2 ttt-85 -115.14 124.15 50.75 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 123.423 0.689 . . . . 0.0 112.514 -178.353 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 50.0 ttt180 -64.64 136.33 56.87 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 122.784 0.434 . . . . 0.0 110.12 177.3 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -152.13 150.92 30.42 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.713 0.634 . . . . 0.0 112.713 -179.791 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 6.4 p -144.15 147.88 34.29 Favored 'General case' 0 C--O 1.238 0.494 0 N-CA-C 105.488 -2.041 . . . . 0.0 105.488 172.704 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 16.1 tpt180 -166.22 123.86 1.42 Allowed 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 177.698 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 7.8 tmm_? -94.35 124.03 38.12 Favored 'General case' 0 CA--C 1.485 -1.553 0 CA-C-O 122.375 1.083 . . . . 0.0 111.0 177.973 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -126.74 174.64 10.2 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.076 0 CA-C-N 112.841 -1.981 . . . . 0.0 106.596 176.273 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 78.6 ttt180 -122.94 121.44 36.16 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 105.46 -2.052 . . . . 0.0 105.46 175.289 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -90.42 157.64 25.86 Favored Glycine 0 N--CA 1.448 -0.511 0 N-CA-C 106.969 -2.452 . . . . 0.0 106.969 177.955 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -72.21 -34.27 61.33 Favored Glycine 0 C--O 1.217 -0.966 0 N-CA-C 107.588 -2.205 . . . . 0.0 107.588 178.141 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 30.8 t0 -93.62 14.82 17.79 Favored 'General case' 0 C--O 1.217 -0.642 0 CA-C-O 122.529 1.157 . . . . 0.0 109.497 178.409 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 83.66 -17.21 26.8 Favored Glycine 0 C--O 1.227 -0.295 0 N-CA-C 117.101 1.601 . . . . 0.0 117.101 172.794 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.74 125.96 22.14 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 114.026 1.121 . . . . 0.0 114.026 -176.853 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 78.5 mtp -104.24 -179.32 3.91 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 114.37 -1.286 . . . . 0.0 112.239 -177.971 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 10.5 mptt -131.85 -47.25 0.95 Allowed 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.893 0.877 . . . . 0.0 111.331 -179.913 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -66.3 -172.07 0.14 Allowed 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 113.158 -1.837 . . . . 0.0 114.405 -179.512 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 79.52 -54.43 0.41 Allowed 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 126.855 2.062 . . . . 0.0 109.14 -177.967 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 22.3 p -92.14 131.84 33.9 Favored Pre-proline 0 C--N 1.32 -0.712 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 174.965 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -70.48 149.64 62.58 Favored 'Trans proline' 0 C--O 1.24 0.615 0 C-N-CA 115.513 -2.524 . . . . 0.0 111.112 178.734 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.409 HH12 ' CD ' ' A' ' 134' ' ' GLU . 0.1 OUTLIER -123.78 158.96 30.54 Favored 'General case' 0 CA--C 1.504 -0.803 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.096 -176.75 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 65.9 m95 -133.47 128.08 34.65 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 177.163 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 43.4 m-85 -110.92 143.26 41.83 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 106.669 -1.604 . . . . 0.0 106.669 -178.796 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 92.1 t80 -94.72 135.09 36.61 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 -175.844 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -137.92 155.55 48.81 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 108.072 -1.085 . . . . 0.0 108.072 -177.747 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 80.9 m-85 -89.39 159.47 17.3 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 112.06 0.393 . . . . 0.0 112.06 -174.362 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -55.05 128.95 36.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.01 -177.958 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 68.13 39.18 88.62 Favored Glycine 0 C--O 1.217 -0.91 0 CA-C-O 119.201 -0.777 . . . . 0.0 114.822 175.672 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -89.03 142.24 27.8 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 106.408 -1.701 . . . . 0.0 106.408 177.719 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 96.93 139.15 10.46 Favored Glycine 0 CA--C 1.527 0.822 0 N-CA-C 107.239 -2.344 . . . . 0.0 107.239 -173.25 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -68.26 -43.2 4.75 Favored 'Trans proline' 0 C--N 1.346 0.447 0 CA-C-N 120.033 1.917 . . . . 0.0 116.338 -172.733 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -117.13 42.07 2.62 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 -177.617 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -63.23 -30.51 71.64 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.0 -1.0 . . . . 0.0 111.923 -178.147 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 59.52 27.75 64.0 Favored Glycine 0 C--O 1.229 -0.195 0 CA-C-N 115.902 -0.59 . . . . 0.0 114.248 178.243 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 17.5 mt -118.66 103.84 48.09 Favored Pre-proline 0 N--CA 1.445 -0.72 0 N-CA-C 113.501 0.926 . . . . 0.0 113.501 -177.709 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -78.29 166.61 24.21 Favored 'Trans proline' 0 N--CA 1.46 -0.471 0 C-N-CA 121.54 1.494 . . . . 0.0 108.323 170.655 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.402 ' CE1' ' HB3' ' A' ' 92' ' ' TRP . 70.6 t80 -61.74 131.16 48.98 Favored 'General case' 0 C--N 1.321 -0.63 0 C-N-CA 120.371 -0.532 . . . . 0.0 109.978 -179.978 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 92.34 -7.07 78.31 Favored Glycine 0 CA--C 1.52 0.354 0 N-CA-C 114.943 0.737 . . . . 0.0 114.943 178.093 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -64.19 129.51 40.27 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 118.433 1.117 . . . . 0.0 111.866 -179.991 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -75.53 130.15 38.39 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.492 -177.778 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 28.1 ttmt -156.17 151.75 27.04 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 105.58 -2.007 . . . . 0.0 105.58 177.43 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 31.1 t0 -66.2 133.62 51.01 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.017 0.436 . . . . 0.0 110.423 -177.89 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 69.03 25.6 75.3 Favored Glycine 0 N--CA 1.449 -0.442 0 CA-C-O 119.46 -0.633 . . . . 0.0 114.089 179.234 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 41.3 mm -127.15 128.75 70.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 117.504 0.652 . . . . 0.0 110.484 179.898 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.1 pt -131.52 122.48 50.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 CA-C-N 115.782 -0.644 . . . . 0.0 109.719 175.312 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . 0.402 ' HB3' ' CE1' ' A' ' 83' ' ' TYR . 94.0 m95 -88.35 138.75 31.16 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 -176.975 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 16.2 m -137.56 149.73 25.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 121.687 0.756 . . . . 0.0 109.635 178.806 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -158.5 166.6 31.77 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 102.684 -3.08 . . . . 0.0 102.684 -179.494 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 8.4 t -134.34 177.19 7.95 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 105.52 -2.03 . . . . 0.0 105.52 178.267 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 64.4 tt0 -67.46 134.46 51.41 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.142 0.496 . . . . 0.0 109.9 -178.547 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 96.01 -13.75 65.59 Favored Glycine 0 C--O 1.229 -0.19 0 CA-C-N 115.92 -0.582 . . . . 0.0 112.942 -179.804 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.472 ' HA ' ' HA ' ' A' ' 41' ' ' ASP . . . -73.42 138.17 45.06 Favored 'General case' 0 CA--C 1.54 0.575 0 O-C-N 122.498 -0.413 . . . . 0.0 110.288 178.964 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 31.7 mt -97.02 139.33 33.2 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 121.269 0.557 . . . . 0.0 112.398 -179.441 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -83.0 62.87 6.79 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.804 -178.872 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 1.2 t -131.98 152.89 81.04 Favored Pre-proline 0 C--N 1.324 -0.54 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 178.99 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -67.51 152.34 78.63 Favored 'Trans proline' 0 C--N 1.344 0.292 0 N-CA-C 114.489 0.919 . . . . 0.0 114.489 178.304 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 1.3 ptpt -151.87 59.07 0.86 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 122.879 1.324 . . . . 0.0 111.124 178.466 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 15.0 p-10 -56.33 -36.04 68.27 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 113.628 -1.624 . . . . 0.0 111.556 177.803 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 38.0 p-80 -60.58 -10.82 5.66 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 114.891 1.441 . . . . 0.0 114.891 -177.868 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 55.0 mt -92.36 -43.72 13.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 178.117 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -72.97 14.65 2.67 Favored Glycine 0 CA--C 1.523 0.541 0 N-CA-C 116.256 1.262 . . . . 0.0 116.256 -176.339 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 14.4 t -95.73 25.52 4.56 Favored 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 -177.382 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.401 ' HD2' HD22 ' A' ' 114' ' ' ASN . 62.4 ttp85 -55.62 129.98 41.21 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 179.629 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 6.5 m-20 -99.72 126.1 38.28 Favored Pre-proline 0 C--N 1.323 -0.57 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 -178.528 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -69.9 -17.88 36.69 Favored 'Trans proline' 0 C--O 1.219 -0.444 0 C-N-CA 118.041 -0.839 . . . . 0.0 113.465 -178.127 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -73.3 -28.67 62.23 Favored 'General case' 0 C--O 1.22 -0.463 0 CA-C-O 120.96 0.409 . . . . 0.0 110.681 178.239 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 76.1 m-20 -102.3 -24.72 13.85 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 -174.107 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.401 HD22 ' HD2' ' A' ' 109' ' ' ARG . 31.9 t30 -153.2 149.51 28.06 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 113.176 0.806 . . . . 0.0 113.176 -178.209 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -89.15 148.21 23.78 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-O 121.382 0.61 . . . . 0.0 111.497 179.392 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -68.49 143.47 54.97 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.374 0.606 . . . . 0.0 110.968 178.808 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 19.4 mt -85.28 139.87 16.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 -179.164 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 91.5 t -63.3 123.31 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 N-CA-C 106.105 -1.813 . . . . 0.0 106.105 175.271 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 6.8 tt -66.0 130.32 42.84 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.151 0.5 . . . . 0.0 110.598 -176.705 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 32.7 mt-30 -132.61 159.81 38.46 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 106.892 -1.521 . . . . 0.0 106.892 -179.376 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 13.7 mt -113.59 147.85 38.46 Favored Pre-proline 0 C--N 1.322 -0.589 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 177.256 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -72.82 169.51 21.87 Favored 'Trans proline' 0 C--N 1.344 0.34 0 O-C-N 122.254 0.607 . . . . 0.0 113.356 -178.6 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 60.3 tt0 -54.7 131.76 44.2 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.715 -179.638 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 93.13 -16.76 59.76 Favored Glycine 0 C--O 1.227 -0.339 0 CA-C-O 119.654 -0.525 . . . . 0.0 114.168 179.767 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.407 HG23 HE21 ' A' ' 30' ' ' GLN . 15.1 m -106.36 127.78 53.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 118.396 1.098 . . . . 0.0 110.547 178.864 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 10.4 p -121.23 148.7 43.92 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.593 -178.82 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 79.0 mt -71.05 153.52 94.54 Favored Pre-proline 0 C--N 1.324 -0.534 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 178.937 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -75.09 170.34 20.61 Favored 'Trans proline' 0 C--O 1.236 0.398 0 N-CA-C 110.363 -0.668 . . . . 0.0 110.363 178.089 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 13.9 tmtt? -54.74 121.4 8.45 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 113.314 0.857 . . . . 0.0 113.314 -174.093 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 95.24 -6.01 68.43 Favored Glycine 0 C--N 1.328 0.106 0 N-CA-C 116.719 1.448 . . . . 0.0 116.719 174.684 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.438 ' CZ ' ' HB2' ' A' ' 18' ' ' GLN . 1.5 m-85 -87.51 145.69 26.13 Favored 'General case' 0 N--CA 1.436 -1.16 0 CA-C-O 122.192 0.996 . . . . 0.0 110.342 178.813 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 37.4 p90 -145.4 163.11 35.6 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 113.458 -1.701 . . . . 0.0 107.625 175.326 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -102.98 145.39 29.94 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.081 0.467 . . . . 0.0 110.659 -177.787 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.409 ' CD ' HH12 ' A' ' 67' ' ' ARG . 33.7 tt0 -73.56 132.28 42.65 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 107.081 -1.452 . . . . 0.0 107.081 178.303 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 92.92 -2.4 72.28 Favored Glycine 0 C--O 1.223 -0.539 0 N-CA-C 111.125 -0.79 . . . . 0.0 111.125 -177.636 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 8.9 t -130.01 -177.22 4.21 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 177.496 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 4.3 tmt_? 65.06 -48.53 0.35 Allowed 'General case' 0 N--CA 1.484 1.252 0 N-CA-C 115.996 1.85 . . . . 0.0 115.996 179.33 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 72.99 -156.56 51.77 Favored Glycine 0 CA--C 1.518 0.263 0 CA-C-N 118.636 0.653 . . . . 0.0 111.97 179.789 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 145.25 -162.28 28.17 Favored Glycine 0 CA--C 1.508 -0.382 0 N-CA-C 110.17 -1.172 . . . . 0.0 110.17 179.465 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 22.1 m . . . . . 0 C--O 1.241 0.616 0 N-CA-C 106.279 -1.748 . . . . 0.0 106.279 176.97 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.916 0 CA-C-O 118.099 -1.389 . . . . 0.0 111.315 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 54.87 45.28 26.89 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 117.849 0.825 . . . . 0.0 111.594 -177.614 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 11.6 mtp -132.11 103.18 6.13 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 105.476 -2.046 . . . . 0.0 105.476 179.839 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -176.88 122.52 0.85 Allowed Glycine 0 N--CA 1.443 -0.894 0 N-CA-C 107.843 -2.103 . . . . 0.0 107.843 -176.433 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 96.2 mt -128.32 153.2 78.95 Favored Pre-proline 0 C--N 1.315 -0.897 0 N-CA-C 105.552 -2.018 . . . . 0.0 105.552 177.185 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -72.63 -22.69 20.51 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 117.829 -0.981 . . . . 0.0 114.585 -177.979 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 15.0 t-20 -164.99 -157.22 0.34 Allowed 'General case' 0 N--CA 1.437 -1.085 1 N-CA-C 96.655 -5.313 . . . . 0.0 96.655 178.494 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -71.23 -39.9 71.4 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 118.58 0.627 . . . . 0.0 110.013 179.121 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 16.8 p 24.55 78.76 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.076 0 N-CA-C 116.769 2.137 . . . . 0.0 116.769 177.395 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -109.88 153.09 24.94 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.912 -177.655 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 54.0 p -63.27 144.99 56.47 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.02 178.478 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 42.8 m95 -68.78 -23.44 64.3 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 113.69 0.996 . . . . 0.0 113.69 179.987 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -116.84 160.09 21.37 Favored 'General case' 0 C--O 1.242 0.668 0 CA-C-O 121.239 0.542 . . . . 0.0 111.69 -174.898 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.474 ' HB ' ' HB3' ' A' ' 134' ' ' GLU . 75.9 p -70.13 163.1 27.02 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.694 -1.139 . . . . 0.0 109.482 178.999 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -82.65 135.87 34.92 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 113.478 0.918 . . . . 0.0 113.478 -175.809 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.452 HD11 HD22 ' A' ' 119' ' ' LEU . 3.0 mp -80.19 146.83 31.55 Favored 'General case' 0 CA--C 1.503 -0.854 0 N-CA-C 106.466 -1.679 . . . . 0.0 106.466 173.419 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 25.2 m -106.08 136.2 46.19 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 178.01 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 -110.78 128.2 55.66 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.265 0.555 . . . . 0.0 111.198 -178.359 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 40.7 t60 -129.12 99.47 5.27 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 106.229 -1.767 . . . . 0.0 106.229 175.18 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 165.79 -173.13 41.4 Favored Glycine 0 N--CA 1.451 -0.347 0 N-CA-C 110.418 -1.073 . . . . 0.0 110.418 -178.502 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -98.01 -16.94 19.44 Favored 'General case' 0 C--O 1.218 -0.566 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 -179.387 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 84.0 mt-10 -71.04 169.16 15.55 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 113.49 0.922 . . . . 0.0 113.49 -176.29 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 70.0 m-20 -116.17 24.33 11.49 Favored 'General case' 0 C--O 1.221 -0.428 0 CA-C-O 122.013 0.911 . . . . 0.0 111.797 178.895 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 62.2 tp 66.54 144.19 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 126.598 1.959 . . . . 0.0 113.597 179.987 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 49.3 tptt -157.74 138.15 12.79 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 176.234 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -123.56 136.27 27.04 Favored Pre-proline 0 C--O 1.242 0.699 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 173.535 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -64.04 162.34 29.79 Favored 'Trans proline' 0 CA--C 1.539 0.74 0 C-N-CA 121.205 1.27 . . . . 0.0 113.344 175.349 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -67.13 143.2 56.77 Favored 'General case' 0 C--O 1.22 -0.495 0 O-C-N 122.017 -0.427 . . . . 0.0 112.007 -179.278 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 78.29 13.65 83.06 Favored Glycine 0 C--O 1.222 -0.62 0 N-CA-C 111.115 -0.794 . . . . 0.0 111.115 178.951 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -152.52 168.6 25.0 Favored 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 -173.938 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 104.2 -19.87 41.96 Favored Glycine 0 CA--C 1.499 -0.951 0 CA-C-O 121.015 0.231 . . . . 0.0 112.881 173.809 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 58.3 t -72.01 127.25 90.8 Favored Pre-proline 0 C--N 1.319 -0.749 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 177.911 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -68.64 175.23 7.39 Favored 'Trans proline' 0 CA--C 1.531 0.36 0 N-CA-C 113.7 0.616 . . . . 0.0 113.7 177.404 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 88.0 mt -75.56 110.41 10.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 121.882 0.848 . . . . 0.0 109.174 178.616 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -108.35 83.26 1.75 Allowed 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 114.674 -1.148 . . . . 0.0 109.637 -178.406 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 80.9 p -69.71 -18.37 63.53 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 113.704 1.001 . . . . 0.0 113.704 -176.783 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -119.64 32.11 6.23 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 -175.916 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.4 m -136.35 157.38 46.93 Favored 'General case' 0 C--N 1.327 -0.394 0 O-C-N 122.045 -0.409 . . . . 0.0 111.456 179.214 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 15.0 m -72.68 159.35 85.57 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.017 -179.979 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -65.42 -24.92 56.47 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 116.127 -2.115 . . . . 0.0 111.331 176.833 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -62.14 -29.79 70.59 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.444 176.578 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 35.4 t0 -88.25 -6.38 57.83 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 113.737 1.014 . . . . 0.0 113.737 -172.536 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 95.1 mm-40 -62.03 -31.84 72.27 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 112.95 0.722 . . . . 0.0 112.95 -177.177 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 13.6 tt -62.42 137.86 23.54 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 CA-C-O 122.135 0.969 . . . . 0.0 110.753 177.902 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -179.25 -159.55 23.54 Favored Glycine 0 CA--C 1.504 -0.638 0 C-N-CA 120.1 -1.048 . . . . 0.0 111.51 -178.247 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 38.2 p90 -155.09 168.52 26.73 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 109.838 -0.431 . . . . 0.0 109.838 179.408 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 14.2 m-85 -110.34 137.32 48.21 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 175.615 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 47.6 ttt-85 -112.03 125.3 53.93 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 124.12 0.968 . . . . 0.0 109.936 -176.941 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 9.1 ttt180 -72.77 145.96 46.7 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 122.051 0.929 . . . . 0.0 109.339 179.343 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -75.91 170.8 15.55 Favored 'General case' 0 N--CA 1.432 -1.337 0 CA-C-N 114.165 -1.379 . . . . 0.0 109.895 178.472 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 8.5 t -61.7 147.82 44.78 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 122.222 1.011 . . . . 0.0 110.615 -178.747 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 10.2 tpt180 -72.46 147.42 46.11 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.687 -1.142 . . . . 0.0 111.661 -175.938 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 3.2 tmt_? -88.44 129.06 35.52 Favored 'General case' 0 CA--C 1.504 -0.799 0 N-CA-C 106.113 -1.81 . . . . 0.0 106.113 175.919 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -132.43 176.87 8.04 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-N 114.381 -1.282 . . . . 0.0 111.397 -172.639 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 18.8 ttm180 -112.68 117.03 31.12 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 103.92 -2.622 . . . . 0.0 103.92 174.783 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -92.79 142.41 15.97 Favored Glycine 0 C--O 1.222 -0.596 0 N-CA-C 109.301 -1.52 . . . . 0.0 109.301 179.45 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -70.9 -27.19 72.66 Favored Glycine 0 C--O 1.214 -1.125 0 C-N-CA 121.02 -0.61 . . . . 0.0 114.0 -177.337 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -83.55 -2.34 55.78 Favored 'General case' 0 C--O 1.218 -0.581 0 CA-C-O 121.516 0.674 . . . . 0.0 112.551 -178.319 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 102.94 12.14 32.72 Favored Glycine 0 CA--C 1.504 -0.624 0 CA-C-O 121.557 0.532 . . . . 0.0 112.267 172.037 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 2.6 pttt -130.22 149.23 52.01 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 111.875 0.324 . . . . 0.0 111.875 -177.895 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 23.1 ptm -147.8 176.92 9.74 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 114.594 1.331 . . . . 0.0 114.594 -170.282 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 13.4 mptt -82.35 -45.42 14.91 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.399 178.696 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 8.2 t0 62.45 -169.66 0.18 Allowed 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 112.129 -2.305 . . . . 0.0 113.657 -177.344 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER 66.53 165.16 0.2 Allowed 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 115.23 1.567 . . . . 0.0 115.23 -179.681 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -79.76 157.35 74.39 Favored Pre-proline 0 C--O 1.238 0.494 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 177.909 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -67.43 143.74 64.65 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 114.969 -2.887 . . . . 0.0 112.088 178.805 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 25.6 mtp180 -118.82 166.02 13.31 Favored 'General case' 0 CA--C 1.511 -0.531 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 179.396 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 71.3 m95 -131.09 132.05 44.6 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 178.031 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 61.1 m-85 -112.68 152.1 29.42 Favored 'General case' 0 C--O 1.214 -0.79 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 -178.792 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 77.8 t80 -102.03 136.67 41.46 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 119.35 0.977 . . . . 0.0 109.804 -177.816 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -141.03 146.6 37.44 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.981 -175.288 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 30.5 m-85 -77.82 159.48 28.95 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.128 0.49 . . . . 0.0 111.884 -178.62 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -55.31 131.76 46.37 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.015 179.436 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 72.09 27.82 69.54 Favored Glycine 0 C--O 1.219 -0.816 0 N-CA-C 116.095 1.198 . . . . 0.0 116.095 176.542 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 3.7 p -88.97 146.06 25.12 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 118.575 1.187 . . . . 0.0 108.527 177.734 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 104.67 143.76 12.45 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 109.656 -1.378 . . . . 0.0 109.656 -177.995 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -71.7 -40.22 2.96 Favored 'Trans proline' 0 C--N 1.347 0.448 0 CA-C-N 119.612 1.706 . . . . 0.0 115.553 -173.473 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -119.57 30.17 7.22 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.865 0.841 . . . . 0.0 109.743 -177.768 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -56.0 -43.51 77.75 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.94 -177.009 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 57.99 30.07 63.02 Favored Glycine 0 C--O 1.228 -0.274 0 CA-C-N 115.95 -0.568 . . . . 0.0 112.608 179.375 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 16.7 mt -114.72 103.75 54.67 Favored Pre-proline 0 N--CA 1.449 -0.508 0 N-CA-C 114.637 1.347 . . . . 0.0 114.637 -175.597 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -78.34 165.61 25.31 Favored 'Trans proline' 0 N--CA 1.462 -0.362 0 C-N-CA 121.525 1.484 . . . . 0.0 108.653 169.865 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 88.2 t80 -61.39 128.47 36.47 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.983 0.42 . . . . 0.0 110.505 -179.222 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 93.25 -6.83 75.74 Favored Glycine 0 CA--C 1.521 0.409 0 N-CA-C 115.364 0.905 . . . . 0.0 115.364 178.676 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -63.32 133.6 54.39 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 118.433 1.117 . . . . 0.0 112.417 -179.961 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -78.02 125.87 29.99 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.415 -179.246 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 29.6 ttmt -156.22 151.32 26.41 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 107.046 -1.464 . . . . 0.0 107.046 178.145 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -66.44 133.04 49.61 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 -178.204 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 70.44 24.04 77.06 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.889 -0.672 . . . . 0.0 114.019 178.022 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 43.5 mm -127.3 125.67 66.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 117.241 0.52 . . . . 0.0 109.918 179.229 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.1 pt -131.21 122.07 50.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 121.6 0.714 . . . . 0.0 110.5 177.055 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 94.0 m95 -88.25 138.28 31.58 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 -176.261 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 23.4 m -135.95 155.46 35.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 178.916 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -162.93 166.09 24.31 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 105.412 -2.07 . . . . 0.0 105.412 -179.843 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 11.9 t -135.98 173.66 11.47 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 105.37 -2.085 . . . . 0.0 105.37 178.38 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -67.6 136.72 54.89 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.161 0.505 . . . . 0.0 110.443 -178.646 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 92.51 -6.71 77.83 Favored Glycine 0 C--O 1.227 -0.289 0 CA-C-N 115.943 -0.572 . . . . 0.0 114.266 177.571 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -78.05 148.26 34.39 Favored 'General case' 0 C--N 1.322 -0.596 0 O-C-N 122.439 -0.448 . . . . 0.0 110.696 179.228 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 70.5 mt -81.21 170.78 15.68 Favored 'General case' 0 C--O 1.208 -1.095 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 178.015 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -112.96 28.84 8.46 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 121.239 0.542 . . . . 0.0 109.898 177.709 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -109.94 151.74 42.6 Favored Pre-proline 0 CA--C 1.546 0.825 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 -174.36 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -71.01 151.07 61.62 Favored 'Trans proline' 0 C--N 1.352 0.744 0 C-N-CA 120.481 0.787 . . . . 0.0 113.569 177.391 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 6.6 pttp -154.33 57.44 0.7 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 122.548 1.166 . . . . 0.0 111.423 -177.631 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -57.24 -31.99 66.11 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 114.518 -1.219 . . . . 0.0 112.511 179.813 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 11.9 p80 -60.67 -11.32 7.01 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 114.929 1.455 . . . . 0.0 114.929 -177.991 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 45.8 mt -92.31 -43.4 13.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 177.495 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -70.85 14.68 1.42 Allowed Glycine 0 CA--C 1.523 0.558 0 N-CA-C 117.296 1.678 . . . . 0.0 117.296 -175.556 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 12.3 t -90.31 30.24 1.15 Allowed 'General case' 0 CA--C 1.548 0.876 0 N-CA-C 112.527 0.566 . . . . 0.0 112.527 -178.108 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 68.8 ttp85 -56.19 131.25 47.3 Favored 'General case' 0 N--CA 1.475 0.808 0 O-C-N 121.426 -0.796 . . . . 0.0 109.846 179.398 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 37.1 m-20 -100.52 119.57 58.42 Favored Pre-proline 0 C--N 1.325 -0.465 0 N-CA-C 105.125 -2.176 . . . . 0.0 105.125 178.698 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -71.05 -17.34 31.84 Favored 'Trans proline' 0 C--N 1.347 0.469 0 N-CA-C 114.793 1.036 . . . . 0.0 114.793 -174.824 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -75.0 -25.37 58.76 Favored 'General case' 0 C--O 1.22 -0.48 0 CA-C-O 120.946 0.403 . . . . 0.0 110.064 177.631 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 -100.55 -24.67 14.4 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 113.296 0.85 . . . . 0.0 113.296 -175.519 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 23.5 t30 -149.56 145.44 26.82 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.933 0.716 . . . . 0.0 112.933 -179.446 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -83.66 147.54 27.63 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-O 121.617 0.722 . . . . 0.0 112.305 -179.914 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -72.33 147.46 46.29 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.669 178.315 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 9.9 mt -83.71 133.76 28.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 -179.255 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 74.0 t -62.73 120.93 10.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 N-CA-C 105.853 -1.906 . . . . 0.0 105.853 175.534 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.452 HD22 HD11 ' A' ' 16' ' ' LEU . 6.7 tt -68.44 128.95 38.44 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.21 0.529 . . . . 0.0 110.483 -176.919 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 29.8 mt-30 -132.14 156.51 46.26 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 105.835 -1.913 . . . . 0.0 105.835 179.065 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 14.1 mt -112.25 149.8 41.54 Favored Pre-proline 0 C--N 1.321 -0.631 0 N-CA-C 105.93 -1.878 . . . . 0.0 105.93 177.744 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -69.9 171.01 15.41 Favored 'Trans proline' 0 C--N 1.344 0.302 0 N-CA-C 115.136 1.168 . . . . 0.0 115.136 -175.061 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -54.9 130.94 43.19 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.835 -178.116 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 88.12 -10.68 69.92 Favored Glycine 0 C--O 1.227 -0.315 0 CA-C-N 115.89 -0.595 . . . . 0.0 112.648 -179.99 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 27.9 m -108.66 127.68 54.18 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.146 0.498 . . . . 0.0 110.662 -179.854 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 19.2 p -124.22 152.99 42.28 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.301 0.572 . . . . 0.0 112.309 -177.532 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 71.4 mt -70.36 155.45 93.41 Favored Pre-proline 0 C--N 1.326 -0.433 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 176.833 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -76.86 172.77 15.59 Favored 'Trans proline' 0 N--CA 1.463 -0.265 0 O-C-N 121.933 0.438 . . . . 0.0 111.038 179.085 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 48.5 tptt -60.78 132.57 54.3 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 -178.341 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 86.81 22.53 45.76 Favored Glycine 0 CA--C 1.518 0.247 0 N-CA-C 114.844 0.698 . . . . 0.0 114.844 177.816 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -131.91 143.43 50.13 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 117.35 0.575 . . . . 0.0 112.258 178.553 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 49.2 p90 -148.94 158.71 44.38 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 106.267 -1.753 . . . . 0.0 106.267 172.507 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -100.43 148.47 24.71 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.816 0.341 . . . . 0.0 110.279 -178.412 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.474 ' HB3' ' HB ' ' A' ' 14' ' ' THR . 8.7 tp10 -67.39 134.33 51.26 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.204 -1.035 . . . . 0.0 108.204 177.593 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 85.78 -7.89 75.08 Favored Glycine 0 C--O 1.227 -0.33 0 CA-C-N 116.058 -0.519 . . . . 0.0 112.941 -177.9 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 20.8 t -100.91 152.74 20.18 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.459 0.647 . . . . 0.0 109.86 179.95 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 41.3 mmt180 -140.38 -171.52 3.23 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 105.578 -2.008 . . . . 0.0 105.578 -178.924 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 101.51 34.5 4.42 Favored Glycine 0 C--O 1.223 -0.537 0 C-N-CA 120.916 -0.659 . . . . 0.0 113.042 179.812 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -158.41 175.78 35.47 Favored Glycine 0 N--CA 1.45 -0.424 0 N-CA-C 107.039 -2.425 . . . . 0.0 107.039 178.823 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 59.0 p . . . . . 0 C--O 1.253 1.288 0 CA-C-O 115.786 -2.054 . . . . 0.0 106.169 -179.215 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.735 0 CA-C-O 119.269 -0.739 . . . . 0.0 111.452 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -73.63 153.77 40.02 Favored 'General case' 0 C--O 1.222 -0.392 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 178.323 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 87.9 mtp -120.89 34.31 5.26 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 121.296 0.57 . . . . 0.0 109.529 -179.953 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -91.25 42.44 2.84 Favored Glycine 0 C--O 1.22 -0.72 0 CA-C-N 116.018 -0.537 . . . . 0.0 114.073 -177.522 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -66.08 138.21 96.09 Favored Pre-proline 0 C--O 1.239 0.526 0 CA-C-N 117.297 0.548 . . . . 0.0 110.111 -177.923 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -74.84 152.81 42.07 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 118.327 -0.649 . . . . 0.0 111.783 177.412 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 59.4 t30 -155.94 98.06 1.86 Allowed 'General case' 0 C--N 1.327 -0.382 0 O-C-N 122.343 -0.223 . . . . 0.0 111.444 179.96 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -104.79 30.43 5.48 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-O 121.657 0.741 . . . . 0.0 110.438 179.966 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 22.6 p -140.93 162.54 35.22 Favored 'General case' 0 N--CA 1.433 -1.276 1 N-CA-C 98.539 -4.615 . . . . 0.0 98.539 -179.135 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -152.73 152.05 31.24 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-O 121.387 0.613 . . . . 0.0 112.273 -178.261 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.7 t -58.53 139.81 55.13 Favored 'General case' 0 CA--C 1.508 -0.647 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 174.902 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 22.1 m95 -64.27 -21.82 66.73 Favored 'General case' 0 C--N 1.323 -0.564 0 O-C-N 123.188 0.305 . . . . 0.0 111.323 177.855 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 51.6 m-85 -121.5 163.17 19.26 Favored 'General case' 0 C--O 1.241 0.628 0 N-CA-C 114.259 1.207 . . . . 0.0 114.259 -172.727 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 57.4 p -68.51 164.7 20.62 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 114.562 -1.199 . . . . 0.0 110.476 179.513 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.499 ' HB2' ' CZ ' ' A' ' 69' ' ' TYR . . . -80.73 137.92 36.3 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 -176.34 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -90.21 147.3 23.64 Favored 'General case' 0 CA--C 1.502 -0.883 0 N-CA-C 105.767 -1.938 . . . . 0.0 105.767 171.883 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 91.8 m -123.7 141.71 51.76 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 -178.538 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.411 ' HB2' ' CZ ' ' A' ' 131' ' ' PHE . 4.3 tp60 -111.23 136.14 50.74 Favored 'General case' 0 C--N 1.329 -0.295 0 O-C-N 123.629 0.581 . . . . 0.0 112.543 -177.783 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 46.0 t60 -133.32 99.44 4.53 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 103.813 -2.662 . . . . 0.0 103.813 169.551 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 179.12 -158.78 23.13 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.537 -0.839 . . . . 0.0 111.028 -175.204 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 35.3 mmtp -108.52 -28.09 9.52 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 113.958 1.096 . . . . 0.0 113.958 -178.225 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -90.94 167.45 12.41 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 176.231 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -81.81 -62.62 1.59 Allowed 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 -178.855 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 36.5 tp -174.39 142.79 0.8 Allowed 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 105.51 -2.033 . . . . 0.0 105.51 174.043 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 79.5 tttt -151.48 146.18 25.73 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 174.946 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -135.7 157.62 75.84 Favored Pre-proline 0 C--N 1.323 -0.562 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 176.939 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -71.78 172.82 13.73 Favored 'Trans proline' 0 CA--C 1.536 0.614 0 C-N-CA 120.718 0.945 . . . . 0.0 114.002 -179.429 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 25.3 tpt180 -78.41 130.97 36.72 Favored 'General case' 0 C--O 1.216 -0.675 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 177.798 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 81.07 7.15 88.86 Favored Glycine 0 C--O 1.225 -0.461 0 N-CA-C 115.279 0.871 . . . . 0.0 115.279 175.886 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.522 HE21 HG23 ' A' ' 125' ' ' THR . 25.2 tt0 -158.52 146.48 18.24 Favored 'General case' 0 C--O 1.217 -0.654 0 N-CA-C 106.457 -1.682 . . . . 0.0 106.457 -177.854 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 136.65 -17.21 3.73 Favored Glycine 0 CA--C 1.503 -0.676 0 C-N-CA 120.344 -0.932 . . . . 0.0 112.556 177.7 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 33.1 m -71.27 146.52 92.25 Favored Pre-proline 0 C--N 1.321 -0.637 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 176.922 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_endo -76.1 173.49 14.39 Favored 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 121.121 1.214 . . . . 0.0 112.606 178.65 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 93.3 mt -76.09 113.06 14.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 N-CA-C 108.042 -1.095 . . . . 0.0 108.042 178.517 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 45.0 m-20 -104.67 83.91 2.09 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 -178.801 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 69.0 p -64.26 -22.2 66.86 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 115.352 1.612 . . . . 0.0 115.352 -174.422 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 11.1 p30 -106.02 18.28 22.31 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.293 -177.384 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 9.4 m -125.55 157.88 35.96 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -175.152 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -74.29 162.26 74.62 Favored Pre-proline 0 C--N 1.323 -0.56 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 178.23 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -66.11 -23.03 53.67 Favored 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 115.159 -2.76 . . . . 0.0 112.015 177.542 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.496 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 0.0 OUTLIER -72.37 -13.56 61.5 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.278 0.561 . . . . 0.0 111.128 178.824 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -104.83 1.06 28.7 Favored 'General case' 0 C--O 1.219 -0.528 0 N-CA-C 114.541 1.311 . . . . 0.0 114.541 -175.063 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 86.6 mm-40 -62.54 -21.64 65.71 Favored 'General case' 0 CA--C 1.548 0.881 0 O-C-N 120.633 -1.292 . . . . 0.0 110.749 178.193 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.506 ' HB ' ' HB1' ' A' ' 98' ' ' ALA . 14.3 tt -62.69 143.26 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 CA-C-O 121.96 0.886 . . . . 0.0 112.827 178.413 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 177.14 -153.77 14.4 Favored Glycine 0 N--CA 1.446 -0.668 0 N-CA-C 110.774 -0.93 . . . . 0.0 110.774 178.565 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 43.2 p90 -154.95 168.48 26.82 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 178.242 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 40.1 m-85 -111.31 140.96 45.45 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 106.66 -1.607 . . . . 0.0 106.66 175.186 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 34.4 ttt180 -114.59 125.73 54.1 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 123.273 0.629 . . . . 0.0 111.913 -178.203 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 27.8 ttt180 -67.5 139.0 56.99 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 176.28 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -136.72 129.75 31.01 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.058 0.456 . . . . 0.0 110.855 179.339 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 27.3 p -145.54 154.41 42.15 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 106.533 -1.654 . . . . 0.0 106.533 176.322 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 15.8 tpt180 -163.33 121.69 1.99 Allowed 'General case' 0 CA--C 1.513 -0.443 0 N-CA-C 106.561 -1.644 . . . . 0.0 106.561 173.323 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 3.3 tmt_? -132.07 144.78 50.99 Favored 'General case' 0 CA--C 1.495 -1.136 0 CA-C-O 121.448 0.642 . . . . 0.0 109.81 -176.684 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -140.92 178.25 3.14 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 N-CA-C 105.378 -2.082 . . . . 0.0 105.378 -178.378 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 6.8 tmm_? -137.25 105.74 5.8 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 175.134 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -72.38 163.22 54.67 Favored Glycine 0 N--CA 1.448 -0.503 0 N-CA-C 108.853 -1.699 . . . . 0.0 108.853 178.305 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -71.24 -32.29 65.52 Favored Glycine 0 C--O 1.214 -1.11 0 N-CA-C 108.689 -1.764 . . . . 0.0 108.689 179.331 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 30.6 t0 -89.43 17.07 6.58 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 122.4 1.095 . . . . 0.0 109.478 178.47 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 84.16 -16.2 34.8 Favored Glycine 0 N--CA 1.46 0.259 0 N-CA-C 116.228 1.251 . . . . 0.0 116.228 173.302 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -56.52 134.37 54.11 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 113.886 1.069 . . . . 0.0 113.886 -176.976 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 47.1 mtp -112.83 -168.84 1.38 Allowed 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 113.536 -1.665 . . . . 0.0 110.29 -179.978 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 15.7 mmtt -122.75 -57.94 1.7 Allowed 'General case' 0 C--O 1.217 -0.61 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -178.689 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 58.0 p30 -135.55 174.72 10.3 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.433 -0.803 . . . . 0.0 112.062 -179.076 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 80.4 mt -136.17 -66.2 0.55 Allowed 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 177.681 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 20.0 m -79.98 150.87 72.6 Favored Pre-proline 0 C--O 1.244 0.771 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.036 178.857 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -75.04 157.56 42.53 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 117.111 -1.46 . . . . 0.0 111.417 176.233 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 7.6 ptt-85 -131.64 162.5 30.24 Favored 'General case' 0 CA--C 1.51 -0.569 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 177.128 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 64.3 m95 -129.57 147.67 51.39 Favored 'General case' 0 C--N 1.318 -0.769 0 O-C-N 123.458 0.474 . . . . 0.0 110.114 -178.316 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.499 ' CZ ' ' HB2' ' A' ' 15' ' ' ALA . 72.9 m-85 -127.47 150.46 49.65 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 178.728 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 87.6 t80 -96.55 135.8 37.96 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 -179.621 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -136.07 140.75 44.02 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 121.822 0.82 . . . . 0.0 109.314 -176.949 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 78.2 m-85 -74.62 159.43 32.13 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 114.602 -1.181 . . . . 0.0 110.651 -176.624 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -57.16 135.81 56.4 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 114.088 1.144 . . . . 0.0 114.088 -176.619 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 65.54 29.17 74.56 Favored Glycine 0 C--O 1.224 -0.511 0 N-CA-C 115.869 1.108 . . . . 0.0 115.869 175.036 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 16.8 p -94.54 146.1 24.35 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 118.001 0.9 . . . . 0.0 110.19 179.739 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 108.21 141.56 9.74 Favored Glycine 0 CA--C 1.523 0.569 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 -177.57 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -69.59 -41.8 4.17 Favored 'Trans proline' 0 C--N 1.347 0.486 0 CA-C-N 119.824 1.812 . . . . 0.0 116.257 -173.337 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -109.34 19.58 19.22 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.522 0.677 . . . . 0.0 109.428 -177.351 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -60.54 -51.61 68.71 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.252 -175.794 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 56.45 26.98 53.02 Favored Glycine 0 C--O 1.224 -0.472 0 CA-C-N 115.857 -0.61 . . . . 0.0 114.386 179.45 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 52.1 mt -103.54 110.85 64.59 Favored Pre-proline 0 N--CA 1.447 -0.606 0 N-CA-C 115.278 1.584 . . . . 0.0 115.278 -175.465 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -78.58 167.65 22.35 Favored 'Trans proline' 0 C--O 1.238 0.501 0 N-CA-C 108.832 -1.257 . . . . 0.0 108.832 170.51 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 68.2 t80 -61.59 130.35 45.49 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 120.558 -0.457 . . . . 0.0 110.321 179.458 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 93.47 -5.48 74.19 Favored Glycine 0 CA--C 1.519 0.283 0 N-CA-C 115.013 0.765 . . . . 0.0 115.013 178.212 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -66.2 129.42 39.75 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 118.459 1.129 . . . . 0.0 112.381 179.977 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 54.7 t30 -75.8 128.1 34.42 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.772 -0.649 . . . . 0.0 112.104 -177.758 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 22.2 ttmt -156.23 152.98 28.45 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 106.978 -1.489 . . . . 0.0 106.978 178.116 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 22.4 t0 -64.86 133.09 51.14 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 -179.19 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 68.75 28.23 73.26 Favored Glycine 0 N--CA 1.448 -0.547 0 CA-C-O 119.557 -0.579 . . . . 0.0 114.308 178.14 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 40.2 mm -129.39 129.22 67.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 117.376 0.588 . . . . 0.0 110.17 179.418 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -131.64 117.75 36.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 CA-C-O 121.446 0.641 . . . . 0.0 110.517 176.172 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 95.9 m95 -86.26 133.07 33.85 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 112.23 0.456 . . . . 0.0 112.23 -177.269 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 1.2 m -140.87 151.12 20.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 -177.571 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -155.64 166.43 33.54 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 105.776 -1.935 . . . . 0.0 105.776 -177.908 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 11.4 t -127.18 171.29 11.56 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 105.621 -1.992 . . . . 0.0 105.621 175.21 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -64.76 136.28 56.75 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.327 0.584 . . . . 0.0 110.578 -179.544 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 94.2 -9.72 72.11 Favored Glycine 0 C--O 1.23 -0.117 0 CA-C-N 115.75 -0.659 . . . . 0.0 113.047 177.92 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.506 ' HB1' ' HB ' ' A' ' 44' ' ' ILE . . . -79.83 139.56 37.15 Favored 'General case' 0 CA--C 1.543 0.692 0 O-C-N 122.543 -0.386 . . . . 0.0 110.846 179.971 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 42.2 mt -102.03 137.67 40.01 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 114.65 1.352 . . . . 0.0 114.65 -176.437 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 50.3 t30 -81.18 75.39 8.15 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.101 -0.954 . . . . 0.0 110.252 179.29 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 2.0 t -139.24 157.55 70.74 Favored Pre-proline 0 CA--C 1.541 0.619 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 -179.373 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -64.35 145.01 87.56 Favored 'Trans proline' 0 C--N 1.348 0.512 0 N-CA-C 114.328 0.857 . . . . 0.0 114.328 -179.108 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 67.4 mmtt -126.41 33.55 4.98 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.664 0.745 . . . . 0.0 109.738 -178.11 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -51.45 -45.52 62.72 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.379 -0.828 . . . . 0.0 112.815 -177.189 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 17.8 p80 -72.93 -4.26 30.96 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 114.353 1.242 . . . . 0.0 114.353 -178.273 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 31.7 mt -96.35 -44.08 12.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 122.191 -0.318 . . . . 0.0 110.496 -179.154 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -74.06 12.11 5.62 Favored Glycine 0 CA--C 1.522 0.514 0 N-CA-C 115.205 0.842 . . . . 0.0 115.205 -178.306 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 13.4 t -83.29 19.72 1.44 Allowed 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 113.812 1.042 . . . . 0.0 113.812 -177.147 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.422 ' HD2' HD22 ' A' ' 114' ' ' ASN . 69.3 ttp85 -56.83 126.13 25.59 Favored 'General case' 0 N--CA 1.471 0.593 0 O-C-N 121.488 -0.757 . . . . 0.0 109.905 -179.3 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 34.4 m120 -93.56 124.21 57.82 Favored Pre-proline 0 C--N 1.322 -0.597 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 179.134 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -70.4 -17.73 34.48 Favored 'Trans proline' 0 C--O 1.219 -0.463 0 C-N-CA 117.021 -1.519 . . . . 0.0 113.15 -179.38 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -76.37 -26.86 56.08 Favored 'General case' 0 C--O 1.22 -0.454 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.247 178.021 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 84.1 m-20 -101.65 -23.69 14.22 Favored 'General case' 0 C--O 1.223 -0.33 0 N-CA-C 113.49 0.922 . . . . 0.0 113.49 -174.991 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.422 HD22 ' HD2' ' A' ' 109' ' ' ARG . 24.2 t30 -149.74 150.64 32.37 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 -178.373 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -88.21 149.02 24.09 Favored 'General case' 0 CA--C 1.545 0.779 0 CA-C-O 121.711 0.767 . . . . 0.0 112.559 179.639 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -72.74 149.86 43.35 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.905 178.364 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 16.7 mt -91.44 139.5 17.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 -179.26 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 93.2 t -62.73 123.79 16.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 N-CA-C 106.021 -1.844 . . . . 0.0 106.021 174.992 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 7.1 tt -66.11 131.25 45.74 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.129 0.49 . . . . 0.0 110.096 -177.215 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 28.3 mt-30 -129.31 152.17 49.16 Favored 'General case' 0 CA--C 1.508 -0.666 0 N-CA-C 106.227 -1.768 . . . . 0.0 106.227 179.838 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 14.3 mt -111.5 148.52 39.01 Favored Pre-proline 0 C--N 1.32 -0.682 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 178.891 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -71.07 165.61 31.82 Favored 'Trans proline' 0 C--N 1.345 0.38 0 O-C-N 122.231 0.595 . . . . 0.0 112.886 -178.546 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 59.5 tt0 -54.65 130.71 41.28 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.504 -177.8 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 94.12 -16.74 60.3 Favored Glycine 0 C--O 1.228 -0.276 0 CA-C-N 115.901 -0.591 . . . . 0.0 113.093 -179.4 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.522 HG23 HE21 ' A' ' 30' ' ' GLN . 10.5 m -102.64 129.51 49.25 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 117.652 0.726 . . . . 0.0 109.765 179.366 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 2.7 p -127.39 148.33 50.27 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.671 -177.788 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 72.9 mt -68.76 154.14 95.1 Favored Pre-proline 0 C--N 1.327 -0.378 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 177.719 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -74.92 170.7 19.81 Favored 'Trans proline' 0 C--O 1.233 0.256 0 C-N-CA 117.724 -1.051 . . . . 0.0 110.681 178.674 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 1.3 tptm -60.78 130.59 47.26 Favored 'General case' 0 C--N 1.324 -0.543 0 O-C-N 122.085 -0.384 . . . . 0.0 111.32 -176.13 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 95.19 -2.63 65.9 Favored Glycine 0 CA--C 1.518 0.225 0 N-CA-C 115.111 0.804 . . . . 0.0 115.111 178.256 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.411 ' CZ ' ' HB2' ' A' ' 18' ' ' GLN . 1.2 m-85 -102.37 144.31 31.02 Favored 'General case' 0 N--CA 1.441 -0.903 0 CA-C-O 122.106 0.955 . . . . 0.0 111.23 -179.964 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 47.6 p90 -146.32 163.33 35.88 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 114.022 -1.444 . . . . 0.0 108.305 174.492 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -111.35 146.44 37.08 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.775 0.322 . . . . 0.0 111.158 -177.429 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -73.29 138.12 45.27 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 178.837 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 84.75 -4.23 85.28 Favored Glycine 0 C--O 1.228 -0.28 0 CA-C-N 116.217 -0.447 . . . . 0.0 112.121 -176.787 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 7.5 t -119.04 -151.92 0.49 Allowed 'General case' 0 C--O 1.238 0.452 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 179.816 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 87.9 mmt-85 -137.95 162.01 35.19 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 105.624 -1.991 . . . . 0.0 105.624 178.048 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -127.09 179.84 16.16 Favored Glycine 0 C--N 1.319 -0.395 0 N-CA-C 108.514 -1.834 . . . . 0.0 108.514 178.756 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -124.08 167.73 16.34 Favored Glycine 0 N--CA 1.454 -0.14 0 N-CA-C 109.948 -1.261 . . . . 0.0 109.948 179.219 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 18.0 m . . . . . 0 C--O 1.247 0.966 0 CA-C-O 118.021 -0.99 . . . . 0.0 110.728 179.443 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 2.807 0 CA-C-O 118.911 -0.938 . . . . 0.0 111.571 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -155.34 151.51 28.03 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 179.47 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -160.83 176.42 11.48 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 100.668 -3.827 . . . . 0.0 100.668 178.878 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 58.7 46.34 93.51 Favored Glycine 0 CA--C 1.507 -0.43 0 N-CA-C 115.662 1.025 . . . . 0.0 115.662 177.496 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 92.6 mt -62.86 130.83 94.22 Favored Pre-proline 0 C--N 1.325 -0.468 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 -179.592 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -74.46 146.32 34.88 Favored 'Trans proline' 0 N--CA 1.462 -0.362 0 C-N-CA 118.17 -0.753 . . . . 0.0 113.241 -177.413 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 51.5 t30 -104.81 -44.85 4.73 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.261 0.553 . . . . 0.0 111.792 178.879 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 15.9 p-10 -111.21 -1.39 16.15 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 113.677 0.991 . . . . 0.0 113.677 -176.787 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 40.6 p -115.75 99.52 7.37 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.588 0.709 . . . . 0.0 112.006 -177.45 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -105.84 145.87 30.65 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.26 -178.672 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 43.1 t -55.63 137.12 49.84 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 177.173 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 7.9 m95 -66.14 -21.93 66.36 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 178.798 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 44.2 m-85 -121.48 163.04 19.46 Favored 'General case' 0 CA--C 1.509 -0.598 0 N-CA-C 113.261 0.837 . . . . 0.0 113.261 -171.023 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 73.6 p -72.28 164.28 26.54 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.079 -0.964 . . . . 0.0 109.175 178.765 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -82.81 131.33 35.2 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 112.715 0.635 . . . . 0.0 112.715 -176.039 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 17.1 mt -72.06 148.04 46.19 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 174.134 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 6.2 m -117.58 140.3 49.82 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 -179.406 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 3.8 tp60 -109.72 128.18 55.1 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 123.557 0.536 . . . . 0.0 111.088 179.112 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 41.5 t60 -116.61 99.51 7.19 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 103.615 -2.735 . . . . 0.0 103.615 171.043 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 160.37 -159.2 30.62 Favored Glycine 0 N--CA 1.45 -0.391 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 -175.643 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 69.1 mttm -118.77 -23.43 7.01 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 114.106 1.15 . . . . 0.0 114.106 -178.304 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -74.35 159.75 31.97 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.763 -177.991 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -71.66 -62.95 1.23 Allowed 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 112.976 0.732 . . . . 0.0 112.976 -177.815 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 40.8 tp 153.73 143.43 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.306 0 N-CA-C 103.759 -2.682 . . . . 0.0 103.759 -176.183 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 50.0 tptt -156.44 141.02 16.87 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 175.477 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -125.38 149.91 65.9 Favored Pre-proline 0 C--O 1.241 0.634 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 175.908 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -71.75 161.3 45.56 Favored 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 120.651 0.901 . . . . 0.0 112.793 178.664 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 40.0 tpt85 -66.73 133.29 49.87 Favored 'General case' 0 C--O 1.216 -0.695 0 O-C-N 122.059 -0.401 . . . . 0.0 109.964 -178.437 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 86.02 7.0 81.35 Favored Glycine 0 C--O 1.223 -0.566 0 N-CA-C 111.66 -0.576 . . . . 0.0 111.66 178.839 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 18.4 mt-30 -146.42 170.57 16.56 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 -175.031 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 103.63 -15.08 53.36 Favored Glycine 0 CA--C 1.501 -0.84 0 CA-C-N 116.122 -0.49 . . . . 0.0 113.434 174.78 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.417 HG11 ' HB3' ' A' ' 43' ' ' GLN . 92.4 t -67.61 128.92 93.6 Favored Pre-proline 0 C--N 1.317 -0.81 0 N-CA-C 106.241 -1.763 . . . . 0.0 106.241 176.726 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -72.87 170.69 19.07 Favored 'Trans proline' 0 N--CA 1.459 -0.502 0 O-C-N 122.26 0.611 . . . . 0.0 111.214 178.22 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 90.6 mt -70.73 107.31 2.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-O 122.075 0.94 . . . . 0.0 108.715 -179.345 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 71.3 m-20 -101.46 84.98 2.69 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 114.357 -1.292 . . . . 0.0 109.417 -177.299 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 72.6 p -68.5 -15.03 63.4 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.722 0.772 . . . . 0.0 112.527 -178.704 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 21.0 p30 -106.0 21.96 16.44 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 114.845 -1.071 . . . . 0.0 112.062 -177.22 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 50.5 m -139.51 150.05 44.67 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 113.577 0.954 . . . . 0.0 113.577 -176.044 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 2.5 m -71.65 166.61 38.08 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.448 176.675 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -66.22 -25.9 49.81 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 114.811 -2.993 . . . . 0.0 114.159 -179.775 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.471 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 3.4 p-10 -78.06 -21.01 51.25 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.551 0.691 . . . . 0.0 110.922 177.194 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 62.0 m-20 -81.35 -8.29 59.71 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 113.214 0.82 . . . . 0.0 113.214 -175.34 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.417 ' HB3' HG11 ' A' ' 32' ' ' VAL . 97.1 mm-40 -57.83 -25.95 61.35 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 114.495 1.295 . . . . 0.0 114.495 -178.876 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.438 ' HB ' ' HB1' ' A' ' 98' ' ' ALA . 9.6 tt -58.38 138.92 18.75 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.971 0 CA-C-O 122.179 0.99 . . . . 0.0 113.638 -178.676 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 179.04 -159.67 24.69 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.411 -179.36 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 43.5 p90 -155.05 170.79 20.96 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 178.958 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 14.5 m-85 -113.1 140.07 48.19 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 173.764 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -110.26 121.66 45.82 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 123.938 0.895 . . . . 0.0 110.436 -178.579 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 40.2 ttp180 -70.84 130.84 42.72 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 174.535 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -142.5 146.6 34.88 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.177 0.513 . . . . 0.0 111.605 -178.737 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 10.2 t -155.4 162.47 40.78 Favored 'General case' 0 C--O 1.245 0.84 0 N-CA-C 104.021 -2.585 . . . . 0.0 104.021 174.186 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 10.1 tpp85 -169.68 139.7 2.04 Favored 'General case' 0 C--O 1.215 -0.733 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 -179.423 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 7.0 ttm180 -121.21 131.15 54.06 Favored 'General case' 0 CA--C 1.497 -1.068 0 N-CA-C 106.39 -1.707 . . . . 0.0 106.39 172.635 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -140.62 178.05 3.46 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 CA-C-N 114.684 -1.144 . . . . 0.0 107.961 -175.396 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.66 99.4 5.97 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 104.813 -2.291 . . . . 0.0 104.813 171.801 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -69.91 161.48 52.95 Favored Glycine 0 C--O 1.227 -0.319 0 N-CA-C 108.755 -1.738 . . . . 0.0 108.755 179.416 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -58.26 -41.41 94.91 Favored Glycine 0 C--O 1.223 -0.592 0 CA-C-N 118.036 0.918 . . . . 0.0 113.566 -178.039 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 32.2 t0 -89.12 15.67 8.41 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-O 122.343 1.068 . . . . 0.0 111.759 -179.584 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 87.45 9.11 73.05 Favored Glycine 0 C--O 1.221 -0.66 0 CA-C-N 115.326 -0.852 . . . . 0.0 113.191 172.865 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 21.8 mmtt -79.6 139.7 37.38 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.184 0.516 . . . . 0.0 109.697 -175.56 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 84.2 mtp -114.75 -167.36 1.21 Allowed 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.794 -177.91 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 57.3 mmtt -144.27 -73.76 0.26 Allowed 'General case' 0 C--O 1.213 -0.819 0 C-N-CA 123.14 0.576 . . . . 0.0 109.476 -177.806 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 30.74 -121.65 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.64 0 O-C-N 125.18 1.55 . . . . 0.0 114.606 179.102 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 59.47 -168.45 0.15 Allowed 'General case' 0 C--N 1.318 -0.766 0 O-C-N 124.772 1.295 . . . . 0.0 112.371 -179.487 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 18.9 m -62.09 153.73 72.77 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.744 179.411 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -65.74 148.57 86.89 Favored 'Trans proline' 0 C--O 1.237 0.447 0 C-N-CA 115.845 -2.303 . . . . 0.0 111.733 178.709 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 31.8 mtp180 -118.61 158.13 26.05 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 -177.653 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 64.2 m95 -120.13 129.58 54.22 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 120.852 0.358 . . . . 0.0 110.436 -179.054 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 24.1 m-85 -110.35 142.21 42.32 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 -178.778 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 85.4 t80 -94.22 136.76 34.16 Favored 'General case' 0 CA--C 1.511 -0.536 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 -178.182 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -139.63 146.56 39.9 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 -177.056 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -81.58 159.51 24.06 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.135 -175.703 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -54.59 131.53 43.22 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.921 0.391 . . . . 0.0 111.786 -179.277 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 71.38 33.71 64.21 Favored Glycine 0 C--O 1.222 -0.618 0 N-CA-C 115.583 0.993 . . . . 0.0 115.583 176.375 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 4.2 p -97.75 146.12 25.69 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 118.135 0.967 . . . . 0.0 110.384 178.64 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 98.61 147.86 22.68 Favored Glycine 0 CA--C 1.525 0.66 0 CA-C-O 119.769 -0.462 . . . . 0.0 112.743 178.968 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -69.14 -48.26 0.89 Allowed 'Trans proline' 0 C--N 1.35 0.614 0 N-CA-C 117.063 1.909 . . . . 0.0 117.063 -173.593 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -119.04 32.72 5.98 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.963 0.887 . . . . 0.0 108.718 -178.075 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -56.91 -40.67 76.75 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.4 -178.865 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 56.21 42.01 87.43 Favored Glycine 0 C--N 1.33 0.226 0 CA-C-N 115.839 -0.619 . . . . 0.0 112.391 178.006 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 13.7 mt -128.26 103.75 20.31 Favored Pre-proline 0 N--CA 1.441 -0.886 0 N-CA-C 114.136 1.162 . . . . 0.0 114.136 -177.175 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -78.63 161.52 27.82 Favored 'Trans proline' 0 N--CA 1.461 -0.398 0 N-CA-C 107.444 -1.791 . . . . 0.0 107.444 167.956 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 58.2 t80 -60.21 132.55 54.28 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 120.187 -0.605 . . . . 0.0 110.226 -178.313 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 91.84 -8.52 78.19 Favored Glycine 0 N--CA 1.452 -0.27 0 CA-C-O 119.193 -0.782 . . . . 0.0 114.712 178.873 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -66.03 129.63 40.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 118.788 1.294 . . . . 0.0 111.171 179.889 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 46.7 t-20 -79.32 128.72 33.69 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.421 -178.542 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 30.5 ttmt -156.18 153.19 28.85 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 107.483 -1.302 . . . . 0.0 107.483 -178.699 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -59.58 125.12 22.38 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.853 0.359 . . . . 0.0 111.807 -178.561 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 68.2 31.39 74.58 Favored Glycine 0 N--CA 1.448 -0.551 0 CA-C-O 119.286 -0.73 . . . . 0.0 113.9 178.262 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 43.4 mm -126.53 128.09 70.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 117.535 0.668 . . . . 0.0 109.954 178.442 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.1 pt -132.75 116.26 26.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 121.53 0.681 . . . . 0.0 110.599 176.555 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 94.8 m95 -82.94 138.45 33.82 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 112.216 0.45 . . . . 0.0 112.216 -177.86 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 16.0 m -137.69 150.91 25.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 178.816 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -160.3 165.33 31.54 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 103.523 -2.769 . . . . 0.0 103.523 179.837 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 14.8 t -125.07 175.82 7.1 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 104.941 -2.244 . . . . 0.0 104.941 178.114 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 -67.52 134.85 52.06 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 -179.826 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 91.49 -8.46 78.88 Favored Glycine 0 C--O 1.228 -0.244 0 CA-C-N 116.123 -0.49 . . . . 0.0 113.536 179.156 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.471 ' HA ' ' HA ' ' A' ' 41' ' ' ASP . . . -71.99 131.9 43.56 Favored 'General case' 0 CA--C 1.542 0.666 0 O-C-N 122.393 -0.475 . . . . 0.0 110.345 179.403 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 23.4 mt -88.91 138.89 31.0 Favored 'General case' 0 CA--C 1.51 -0.569 0 N-CA-C 112.995 0.739 . . . . 0.0 112.995 -177.433 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 56.9 t30 -83.94 72.11 10.45 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.353 -0.839 . . . . 0.0 111.046 179.475 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 2.3 t -143.4 155.38 60.94 Favored Pre-proline 0 C--N 1.324 -0.503 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 178.754 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_exo -67.61 153.25 76.74 Favored 'Trans proline' 0 CA--C 1.514 -0.495 0 CA-C-N 118.454 0.483 . . . . 0.0 113.183 179.175 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -152.02 52.73 0.8 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.928 0.871 . . . . 0.0 111.144 176.59 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -57.55 -26.54 61.57 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 114.918 -1.037 . . . . 0.0 109.972 175.194 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 9.6 p80 -57.18 -12.59 2.35 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 114.643 1.349 . . . . 0.0 114.643 179.198 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 64.2 mt -92.72 -45.19 14.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 178.372 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -70.59 14.72 1.32 Allowed Glycine 0 C--O 1.211 -1.298 0 N-CA-C 117.205 1.642 . . . . 0.0 117.205 -175.414 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 30.8 p -83.04 3.79 28.84 Favored 'General case' 0 CA--C 1.506 -0.718 0 C-N-CA 124.015 0.926 . . . . 0.0 113.249 -174.08 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 67.0 ttp85 -44.36 121.0 2.38 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 114.056 -1.429 . . . . 0.0 110.666 179.655 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 36.5 m120 -90.02 126.09 58.39 Favored Pre-proline 0 C--N 1.322 -0.624 0 N-CA-C 107.675 -1.232 . . . . 0.0 107.675 -179.579 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -69.89 -18.27 36.5 Favored 'Trans proline' 0 C--O 1.219 -0.473 0 C-N-CA 117.015 -1.524 . . . . 0.0 113.045 179.273 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -75.74 -27.95 58.32 Favored 'General case' 0 C--O 1.219 -0.536 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.308 178.125 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 -101.88 -23.96 14.09 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 113.283 0.846 . . . . 0.0 113.283 -175.244 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 26.8 t30 -150.63 148.63 28.86 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.941 0.719 . . . . 0.0 112.941 -178.201 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -87.86 147.33 25.16 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-O 121.521 0.677 . . . . 0.0 111.32 179.419 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -70.02 145.05 52.04 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.554 178.576 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 13.7 mt -83.18 139.06 18.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 -178.744 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 1.4 p -62.05 126.08 19.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 175.721 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 5.7 tt -65.91 128.57 36.56 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.156 0.503 . . . . 0.0 110.3 -176.748 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -132.33 157.55 44.17 Favored 'General case' 0 CA--C 1.509 -0.633 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 -178.73 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.429 HD13 HG22 ' A' ' 125' ' ' THR . 13.7 mt -113.58 148.76 40.42 Favored Pre-proline 0 C--N 1.322 -0.622 0 N-CA-C 108.091 -1.078 . . . . 0.0 108.091 177.059 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -73.43 165.52 32.28 Favored 'Trans proline' 0 N--CA 1.463 -0.314 0 O-C-N 122.227 0.593 . . . . 0.0 112.867 -178.846 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 40.6 tt0 -54.69 130.35 40.15 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.655 -179.682 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 101.38 -22.45 38.91 Favored Glycine 0 C--O 1.224 -0.509 0 CA-C-N 116.043 -0.526 . . . . 0.0 112.838 -179.056 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.429 HG22 HD13 ' A' ' 121' ' ' LEU . 9.8 m -108.63 127.26 53.81 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 117.795 0.798 . . . . 0.0 109.456 178.167 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 16.5 p -119.69 148.33 43.51 Favored 'General case' 0 CA--C 1.51 -0.575 0 CA-C-O 121.035 0.445 . . . . 0.0 110.837 -179.398 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 91.8 mt -69.07 152.29 96.82 Favored Pre-proline 0 C--N 1.324 -0.529 0 N-CA-C 107.108 -1.441 . . . . 0.0 107.108 177.678 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -77.67 174.08 13.17 Favored 'Trans proline' 0 N--CA 1.462 -0.37 0 CA-C-O 121.425 0.51 . . . . 0.0 111.782 179.834 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -56.19 129.25 39.37 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.23 -178.487 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 91.65 -4.92 79.78 Favored Glycine 0 C--O 1.226 -0.353 0 N-CA-C 115.601 1.001 . . . . 0.0 115.601 177.063 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -102.39 136.75 41.66 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 117.937 0.868 . . . . 0.0 112.465 -178.068 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 41.5 p90 -143.46 163.14 33.94 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 114.213 -1.358 . . . . 0.0 108.269 174.895 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -103.82 138.0 41.04 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 -176.351 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -66.28 141.83 57.88 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.237 -0.892 . . . . 0.0 108.976 176.288 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 94.81 -32.79 5.79 Favored Glycine 0 N--CA 1.458 0.142 0 C-N-CA 121.604 -0.331 . . . . 0.0 113.366 179.756 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 32.7 t -68.7 123.59 21.33 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 177.249 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 64.1 ttp85 53.2 79.12 0.13 Allowed 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 114.057 1.132 . . . . 0.0 114.057 -178.982 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -70.62 168.63 48.93 Favored Glycine 0 CA--C 1.52 0.356 0 N-CA-C 110.539 -1.024 . . . . 0.0 110.539 176.916 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -175.88 -166.75 33.79 Favored Glycine 0 N--CA 1.451 -0.346 0 N-CA-C 107.708 -2.157 . . . . 0.0 107.708 -179.08 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 22.1 m . . . . . 0 C--O 1.25 1.101 0 CA-C-O 117.423 -1.275 . . . . 0.0 109.834 178.206 . . . . . . . . 0 0 . 1 . 031 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.589 0 CA-C-O 118.447 -1.196 . . . . 0.0 111.054 . . . . . . . . . 0 0 . 1 . 031 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -61.34 145.2 52.3 Favored 'General case' 0 C--O 1.239 0.509 0 N-CA-C 113.662 0.986 . . . . 0.0 113.662 -176.79 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 5.0 ppp? -165.0 169.39 16.42 Favored 'General case' 0 C--N 1.322 -0.619 1 N-CA-C 99.995 -4.076 . . . . 0.0 99.995 176.932 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 79.9 33.15 34.26 Favored Glycine 0 C--O 1.225 -0.441 0 C-N-CA 119.943 -1.122 . . . . 0.0 112.495 179.448 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -64.51 148.09 96.84 Favored Pre-proline 0 CA--C 1.539 0.548 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 179.536 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -73.02 -12.29 25.83 Favored 'Trans proline' 0 C--N 1.35 0.634 0 N-CA-C 113.361 0.485 . . . . 0.0 113.361 -179.534 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -149.58 -143.06 0.13 Allowed 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 101.364 -3.569 . . . . 0.0 101.364 176.79 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 12.6 m-80 -101.05 -34.35 9.77 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 112.813 0.671 . . . . 0.0 112.813 -179.467 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 40.5 p 35.69 78.9 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 115.7 1.741 . . . . 0.0 115.7 179.506 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -124.4 147.24 48.38 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 -174.737 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.431 ' HB3' ' CE1' ' A' ' 71' ' ' TYR . 11.6 p -60.22 139.22 57.7 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.389 178.568 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . 0.412 ' CD2' ' HD3' ' A' ' 109' ' ' ARG . 47.5 m95 -71.3 -21.93 62.01 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 114.95 1.463 . . . . 0.0 114.95 -178.762 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -121.49 162.07 21.16 Favored 'General case' 0 C--O 1.24 0.562 0 N-CA-C 113.734 1.013 . . . . 0.0 113.734 -173.329 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 77.8 p -68.68 163.39 23.97 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 114.548 -1.206 . . . . 0.0 109.849 179.418 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.401 ' HB2' ' CZ ' ' A' ' 69' ' ' TYR . . . -86.08 145.57 26.99 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 113.486 0.921 . . . . 0.0 113.486 -175.722 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -94.67 137.77 33.35 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 108.245 -1.021 . . . . 0.0 108.245 173.731 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 62.4 m -87.56 129.28 35.15 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 -179.924 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 16.6 tm0? -91.07 128.32 36.85 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 177.98 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 58.7 t60 -139.25 99.53 3.77 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 172.11 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 173.0 -170.91 44.06 Favored Glycine 0 C--O 1.229 -0.213 0 C-N-CA 120.496 -0.859 . . . . 0.0 111.445 179.511 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -97.66 -25.64 15.04 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 120.686 0.279 . . . . 0.0 110.529 178.631 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -96.5 163.23 13.13 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 105.594 -2.002 . . . . 0.0 105.594 174.631 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -88.62 -62.89 1.39 Allowed 'General case' 0 C--O 1.216 -0.691 0 N-CA-C 115.187 1.551 . . . . 0.0 115.187 -173.926 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 53.4 tp -176.87 142.93 0.41 Allowed 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 178.11 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 23.5 tptm -157.49 141.02 15.65 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 174.226 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 13.7 m-85 -123.92 152.49 66.5 Favored Pre-proline 0 C--O 1.24 0.595 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 175.53 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -70.41 159.09 54.1 Favored 'Trans proline' 0 CA--C 1.538 0.71 0 C-N-CA 120.449 0.766 . . . . 0.0 112.331 177.427 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 15.8 tpt180 -69.27 137.29 52.95 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 -178.377 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 83.85 8.64 84.02 Favored Glycine 0 C--O 1.222 -0.614 0 N-CA-C 111.345 -0.702 . . . . 0.0 111.345 179.082 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 9.1 mt-30 -150.92 170.95 18.06 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 -173.886 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 102.94 -16.67 54.08 Favored Glycine 0 CA--C 1.499 -0.928 0 CA-C-N 116.219 -0.446 . . . . 0.0 112.031 175.756 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 77.9 t -66.07 128.68 93.98 Favored Pre-proline 0 C--N 1.319 -0.759 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 177.144 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -73.46 170.11 20.7 Favored 'Trans proline' 0 N--CA 1.461 -0.435 0 O-C-N 122.201 0.579 . . . . 0.0 112.373 178.404 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 78.5 mt -73.01 112.38 9.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 -179.851 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 48.9 m-20 -109.89 77.29 1.04 Allowed 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 114.622 -1.172 . . . . 0.0 109.406 -177.189 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 71.5 p -65.11 -20.96 66.72 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 115.586 1.698 . . . . 0.0 115.586 -173.658 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.404 HD21 HD13 ' A' ' 117' ' ' ILE . 5.5 p30 -113.64 31.05 6.78 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.976 -176.175 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 78.0 p -134.42 166.57 22.55 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.011 0.434 . . . . 0.0 110.839 179.63 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 28.1 m -81.58 160.32 64.72 Favored Pre-proline 0 C--N 1.322 -0.612 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.75 -179.219 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -67.81 -24.23 40.69 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 116.453 -1.898 . . . . 0.0 114.033 -179.461 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.402 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 8.4 p-10 -75.52 -12.62 60.26 Favored 'General case' 0 C--N 1.322 -0.592 0 O-C-N 121.562 -0.711 . . . . 0.0 111.264 177.241 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 27.3 t0 -94.84 1.05 55.32 Favored 'General case' 0 C--O 1.214 -0.798 0 N-CA-C 113.328 0.862 . . . . 0.0 113.328 -177.371 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 93.1 mm-40 -62.34 -20.2 64.12 Favored 'General case' 0 CA--C 1.548 0.89 0 O-C-N 121.074 -1.016 . . . . 0.0 111.711 178.965 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.456 ' HB ' ' HB1' ' A' ' 98' ' ' ALA . 17.5 tt -63.98 140.46 19.65 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-O 122.118 0.961 . . . . 0.0 112.293 177.701 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 178.49 -161.17 27.62 Favored Glycine 0 CA--C 1.502 -0.737 0 C-N-CA 119.794 -1.193 . . . . 0.0 112.781 178.328 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.4 ' HB3' ' CE3' ' A' ' 92' ' ' TRP . 46.1 p90 -155.24 165.68 35.92 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 178.642 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 19.0 m-85 -106.87 139.68 40.9 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 106.771 -1.566 . . . . 0.0 106.771 175.986 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 42.5 ttt180 -113.47 118.23 33.93 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.08 -174.869 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 26.3 ttt180 -66.47 137.72 57.03 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 176.655 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -137.3 125.65 23.32 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.733 0.777 . . . . 0.0 111.465 179.923 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 37.7 p -136.74 154.28 50.63 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 106.079 -1.823 . . . . 0.0 106.079 177.128 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 65.1 ttt180 -159.73 124.04 3.85 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 121.06 -0.256 . . . . 0.0 110.486 177.399 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.35 144.33 51.32 Favored 'General case' 0 CA--C 1.484 -1.581 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 175.647 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -142.47 175.23 4.77 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.132 0 N-CA-C 105.854 -1.906 . . . . 0.0 105.854 179.023 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 78.0 ttt180 -119.67 128.89 54.25 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 102.466 -3.161 . . . . 0.0 102.466 171.14 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -80.89 -176.8 51.03 Favored Glycine 0 C--O 1.221 -0.667 0 N-CA-C 110.796 -0.922 . . . . 0.0 110.796 -179.784 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -78.75 -34.29 35.21 Favored Glycine 0 C--O 1.216 -1.005 0 N-CA-C 107.886 -2.086 . . . . 0.0 107.886 179.385 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -71.38 -20.69 62.11 Favored 'General case' 0 C--O 1.217 -0.655 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 175.184 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 108.43 -15.52 35.42 Favored Glycine 0 CA--C 1.503 -0.696 0 N-CA-C 110.351 -1.1 . . . . 0.0 110.351 172.593 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.8 144.57 57.16 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-O 122.394 1.092 . . . . 0.0 112.294 -177.96 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 5.4 mtp -87.8 175.08 8.0 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 114.01 -1.45 . . . . 0.0 112.57 -177.184 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 1.6 tmtm? -78.4 -46.04 20.87 Favored 'General case' 0 C--O 1.217 -0.642 0 CA-C-O 121.949 0.881 . . . . 0.0 109.797 176.915 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.2 t0 47.39 24.85 0.51 Allowed 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 119.054 2.983 . . . . 0.0 119.054 178.573 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.6 mp -83.45 149.01 26.93 Favored 'General case' 0 C--O 1.239 0.528 0 O-C-N 121.397 -0.814 . . . . 0.0 111.752 178.543 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -66.71 158.42 79.65 Favored Pre-proline 0 C--O 1.243 0.738 0 CA-C-N 115.395 -0.82 . . . . 0.0 111.909 178.834 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -71.44 147.21 51.87 Favored 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 118.126 -0.782 . . . . 0.0 112.582 177.585 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 1.2 mtt180 -134.14 165.81 24.22 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.998 176.228 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 62.5 m95 -121.89 135.03 54.86 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 176.328 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.401 ' CZ ' ' HB2' ' A' ' 15' ' ' ALA . 68.6 m-85 -112.83 171.77 7.33 Favored 'General case' 0 C--O 1.215 -0.738 0 N-CA-C 105.891 -1.892 . . . . 0.0 105.891 178.142 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -118.4 139.47 51.34 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 178.673 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.431 ' CE1' ' HB3' ' A' ' 11' ' ' SER . 14.2 m-85 -139.06 139.33 37.74 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 -176.545 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 45.3 m-85 -68.67 159.51 32.0 Favored 'General case' 0 C--O 1.24 0.585 0 N-CA-C 110.013 -0.366 . . . . 0.0 110.013 177.14 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 19.7 tp -53.4 130.56 35.74 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 121.18 0.514 . . . . 0.0 112.229 -178.515 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 67.49 28.41 73.6 Favored Glycine 0 C--O 1.223 -0.573 0 N-CA-C 116.269 1.268 . . . . 0.0 116.269 174.636 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 16.2 p -92.17 146.02 24.05 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 118.262 1.031 . . . . 0.0 110.409 177.927 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 104.15 137.69 9.36 Favored Glycine 0 CA--C 1.527 0.829 0 N-CA-C 110.701 -0.96 . . . . 0.0 110.701 -178.913 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -69.96 -36.65 9.91 Favored 'Trans proline' 0 C--N 1.348 0.516 0 N-CA-C 116.272 1.605 . . . . 0.0 116.272 -174.506 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -103.44 15.15 29.76 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 -176.838 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -63.68 -50.95 67.22 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 120.217 -0.593 . . . . 0.0 111.547 -174.438 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 55.97 34.55 61.93 Favored Glycine 0 CA--C 1.519 0.325 0 CA-C-N 116.186 -0.461 . . . . 0.0 113.059 -179.979 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 18.1 mt -116.83 103.79 51.86 Favored Pre-proline 0 N--CA 1.448 -0.543 0 N-CA-C 115.939 1.829 . . . . 0.0 115.939 -175.394 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -78.76 164.01 25.87 Favored 'Trans proline' 0 N--CA 1.462 -0.344 0 C-N-CA 122.42 2.08 . . . . 0.0 108.176 168.274 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 56.2 t80 -62.08 132.29 52.38 Favored 'General case' 0 C--N 1.321 -0.642 0 O-C-N 121.947 -0.471 . . . . 0.0 110.627 -177.698 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 90.4 -6.17 82.43 Favored Glycine 0 C--O 1.227 -0.29 0 N-CA-C 114.528 0.571 . . . . 0.0 114.528 179.131 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -65.15 132.04 48.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 118.242 1.021 . . . . 0.0 111.821 179.677 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 50.5 t30 -78.68 127.31 31.92 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.523 179.403 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 28.2 ttmt -156.19 152.14 27.48 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 106.266 -1.753 . . . . 0.0 106.266 178.578 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 19.1 t0 -64.55 131.83 48.14 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 -179.249 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 69.66 28.84 71.71 Favored Glycine 0 N--CA 1.446 -0.655 0 N-CA-C 114.958 0.743 . . . . 0.0 114.958 177.116 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 42.7 mm -127.89 128.15 68.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 117.401 0.6 . . . . 0.0 109.985 179.044 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.1 pt -131.58 123.62 52.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.351 176.98 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . 0.4 ' CE3' ' HB3' ' A' ' 46' ' ' TYR . 97.8 m95 -88.39 135.57 33.4 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 114.149 1.166 . . . . 0.0 114.149 -175.304 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 17.8 m -136.16 152.03 29.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 178.778 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -163.97 166.6 21.44 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 103.514 -2.773 . . . . 0.0 103.514 -179.969 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 13.3 t -134.53 174.72 10.24 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 104.78 -2.304 . . . . 0.0 104.78 177.675 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 78.2 tt0 -66.71 135.21 53.67 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.185 0.516 . . . . 0.0 109.999 -178.955 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 95.75 -9.72 68.56 Favored Glycine 0 C--O 1.228 -0.234 0 CA-C-N 115.93 -0.577 . . . . 0.0 113.623 178.635 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.456 ' HB1' ' HB ' ' A' ' 44' ' ' ILE . . . -76.78 137.95 39.6 Favored 'General case' 0 CA--C 1.54 0.571 0 O-C-N 122.323 -0.516 . . . . 0.0 109.859 179.457 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 32.3 mt -92.56 140.29 29.7 Favored 'General case' 0 C--O 1.22 -0.471 0 CA-C-O 121.555 0.693 . . . . 0.0 112.324 -178.236 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 61.3 t30 -85.04 66.59 9.83 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.498 -0.773 . . . . 0.0 110.518 -179.037 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -136.37 152.84 75.73 Favored Pre-proline 0 C--N 1.324 -0.502 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 -179.527 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -68.45 150.87 75.94 Favored 'Trans proline' 0 C--N 1.344 0.326 0 N-CA-C 115.249 1.211 . . . . 0.0 115.249 178.779 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.492 ' HB3' HD12 ' A' ' 106' ' ' ILE . 67.5 mmtt -127.12 31.61 5.22 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.189 -0.914 . . . . 0.0 113.32 -176.339 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 18.1 t0 -60.98 -27.56 68.37 Favored 'General case' 0 N--CA 1.475 0.789 0 O-C-N 121.287 -0.883 . . . . 0.0 111.616 -178.135 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 47.2 p-80 -67.95 -16.78 64.22 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.806 177.853 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.492 HD12 ' HB3' ' A' ' 103' ' ' LYS . 66.3 mt -94.25 -38.56 9.45 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 176.078 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -72.96 6.73 11.72 Favored Glycine 0 C--O 1.225 -0.429 0 N-CA-C 115.668 1.027 . . . . 0.0 115.668 -178.214 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 14.5 t -83.05 25.44 0.69 Allowed 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 117.785 0.792 . . . . 0.0 111.684 -178.862 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.413 ' HD2' ' OD1' ' A' ' 114' ' ' ASN . 65.3 ttp85 -57.45 131.82 51.29 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.949 -179.42 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 55.1 m-20 -99.65 115.1 65.89 Favored Pre-proline 0 C--N 1.326 -0.423 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 178.804 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -72.8 -12.54 26.47 Favored 'Trans proline' 0 C--O 1.218 -0.518 0 N-CA-C 114.089 0.765 . . . . 0.0 114.089 -177.352 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -74.87 -24.56 58.58 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 176.042 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 -102.19 -30.78 10.92 Favored 'General case' 0 C--O 1.222 -0.344 0 N-CA-C 113.012 0.745 . . . . 0.0 113.012 -176.036 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.413 ' OD1' ' HD2' ' A' ' 109' ' ' ARG . 0.9 OUTLIER -132.07 150.26 52.2 Favored 'General case' 0 N--CA 1.44 -0.937 0 CA-C-O 121.279 0.561 . . . . 0.0 112.265 -177.186 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -100.65 138.4 37.75 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 175.701 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -66.33 150.01 49.51 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.303 0.573 . . . . 0.0 111.722 -179.191 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.404 HD13 HD21 ' A' ' 37' ' ' ASN . 3.1 mt -87.96 141.48 14.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.669 -177.323 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 1.3 p -62.22 125.92 19.47 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 176.211 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 7.0 tt -70.07 129.62 39.92 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.25 -178.055 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 25.6 mt-30 -131.71 159.49 38.25 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 106.47 -1.678 . . . . 0.0 106.47 179.378 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 14.2 mt -114.37 146.09 35.12 Favored Pre-proline 0 C--N 1.323 -0.561 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 177.98 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -74.63 172.07 16.94 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 120.228 0.619 . . . . 0.0 113.678 -178.547 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 6.0 tp-100 -53.65 137.07 38.13 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.753 179.42 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 89.82 -20.71 34.04 Favored Glycine 0 N--CA 1.453 -0.229 0 CA-C-N 115.927 -0.579 . . . . 0.0 113.733 -179.11 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 3.9 m -108.56 129.81 55.3 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 118.274 1.037 . . . . 0.0 111.143 -179.995 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 2.3 p -125.87 148.27 49.23 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 -178.951 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 91.0 mt -68.93 154.57 94.82 Favored Pre-proline 0 C--N 1.327 -0.38 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 178.357 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -75.57 170.55 20.0 Favored 'Trans proline' 0 N--CA 1.463 -0.296 0 C-N-CA 118.342 -0.639 . . . . 0.0 111.48 -179.615 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -60.2 129.16 40.34 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 179.253 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 89.73 21.34 40.34 Favored Glycine 0 C--O 1.225 -0.444 0 C-N-CA 120.904 -0.665 . . . . 0.0 114.734 178.835 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -131.15 141.76 50.14 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 117.472 0.636 . . . . 0.0 111.651 178.115 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 51.8 p90 -150.47 163.79 37.53 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 175.508 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -107.35 147.25 30.56 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 113.396 0.887 . . . . 0.0 113.396 -175.826 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -73.52 142.7 46.72 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.091 -0.959 . . . . 0.0 109.666 177.206 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 93.38 -39.56 2.93 Favored Glycine 0 CA--C 1.519 0.298 0 N-CA-C 114.169 0.428 . . . . 0.0 114.169 178.665 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -66.31 137.47 56.94 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-O 121.854 0.835 . . . . 0.0 111.425 178.514 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 16.2 mtm105 -127.86 137.37 52.32 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 105.734 -1.95 . . . . 0.0 105.734 176.368 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -79.11 -25.29 59.92 Favored Glycine 0 C--O 1.224 -0.487 0 CA-C-O 121.697 0.609 . . . . 0.0 114.076 -177.944 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 167.88 -164.74 38.2 Favored Glycine 0 C--N 1.319 -0.391 0 N-CA-C 107.433 -2.267 . . . . 0.0 107.433 -178.658 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 15.7 m . . . . . 0 C--O 1.245 0.842 0 O-C-N 124.805 0.944 . . . . 0.0 111.042 -179.195 . . . . . . . . 0 0 . 1 . 032 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.577 0 CA-C-O 117.909 -1.495 . . . . 0.0 111.044 . . . . . . . . . 0 0 . 1 . 032 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 54.9 -158.22 0.2 Allowed 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 117.695 0.747 . . . . 0.0 110.061 -176.168 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 67.0 mtm 54.69 35.36 23.69 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.257 0.623 . . . . 0.0 112.037 179.474 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -173.42 116.48 0.6 Allowed Glycine 0 N--CA 1.445 -0.736 0 N-CA-C 107.09 -2.404 . . . . 0.0 107.09 -178.035 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 91.5 mt -110.61 153.11 43.73 Favored Pre-proline 0 C--N 1.319 -0.74 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 179.414 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -69.18 142.82 51.58 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 116.495 -1.87 . . . . 0.0 113.439 -178.114 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 32.4 t-20 -89.06 81.21 6.85 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 122.05 0.929 . . . . 0.0 110.098 -179.227 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -109.8 24.4 13.09 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 106.611 -1.626 . . . . 0.0 106.611 174.136 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 8.4 p -95.74 90.21 5.59 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 -176.769 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -95.52 142.61 27.66 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-O 121.422 0.629 . . . . 0.0 109.668 -177.924 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 61.6 p -58.14 141.53 50.05 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.213 -0.903 . . . . 0.0 109.882 179.108 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . 0.444 ' CD2' ' HD3' ' A' ' 109' ' ' ARG . 23.9 m95 -65.65 -26.44 67.8 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.769 178.213 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 78.0 m-85 -121.74 162.87 20.04 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.302 0.572 . . . . 0.0 112.379 -174.235 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 73.1 p -71.44 164.86 24.99 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 176.529 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -77.74 157.04 30.23 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.855 0.836 . . . . 0.0 113.219 -177.672 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 25.0 mt -92.39 148.91 21.74 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 102.919 -2.993 . . . . 0.0 102.919 168.005 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 33.2 m -121.36 128.5 52.31 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 120.897 0.379 . . . . 0.0 110.396 -178.03 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 1.9 tm0? -90.42 130.03 36.54 Favored 'General case' 0 CA--C 1.512 -0.501 0 CA-C-N 115.567 -0.742 . . . . 0.0 112.82 -177.554 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 52.9 t60 -138.76 99.9 3.92 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 106.354 -1.721 . . . . 0.0 106.354 167.217 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 159.58 -140.86 7.09 Favored Glycine 0 C--N 1.323 -0.181 0 C-N-CA 119.589 -1.291 . . . . 0.0 113.813 -176.969 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -115.71 -27.18 7.15 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 114.875 1.435 . . . . 0.0 114.875 -177.692 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -78.46 151.96 32.37 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 177.403 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -79.13 -57.55 3.67 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 179.197 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 41.9 tp 175.96 135.16 0.05 OUTLIER 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 101.254 -3.61 . . . . 0.0 101.254 171.103 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 11.2 tmtt? -154.22 133.23 12.43 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 179.448 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 21.8 m-85 -122.33 153.3 61.89 Favored Pre-proline 0 C--O 1.241 0.636 0 O-C-N 123.023 0.202 . . . . 0.0 111.44 176.726 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -74.51 159.91 42.3 Favored 'Trans proline' 0 CA--C 1.538 0.702 0 CA-C-O 120.935 0.306 . . . . 0.0 111.768 175.727 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 17.0 tpt180 -70.71 139.75 51.25 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 -178.411 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 87.05 2.11 84.0 Favored Glycine 0 C--O 1.221 -0.687 0 N-CA-C 110.707 -0.957 . . . . 0.0 110.707 179.524 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 30.6 mt-30 -146.69 -179.66 6.94 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 -174.797 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 99.36 -20.26 50.54 Favored Glycine 0 CA--C 1.498 -0.987 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.714 176.232 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 86.8 t -67.92 126.87 93.16 Favored Pre-proline 0 C--N 1.317 -0.818 0 N-CA-C 106.703 -1.592 . . . . 0.0 106.703 177.295 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -73.28 167.53 27.08 Favored 'Trans proline' 0 N--CA 1.46 -0.485 0 C-N-CA 120.111 0.541 . . . . 0.0 112.494 178.649 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 85.6 mt -67.25 111.74 2.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 122.023 0.916 . . . . 0.0 109.352 -178.869 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 26.6 m-20 -94.82 100.79 12.62 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 114.394 -1.276 . . . . 0.0 110.157 -177.973 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 80.7 p -80.52 -20.32 43.8 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 113.912 1.078 . . . . 0.0 113.912 -176.901 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -117.45 3.66 12.49 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 115.411 1.634 . . . . 0.0 115.411 -174.486 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -110.77 157.27 19.97 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 115.756 1.761 . . . . 0.0 115.756 -171.926 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 47.6 m -79.23 162.77 62.76 Favored Pre-proline 0 C--N 1.318 -0.783 0 CA-C-N 113.896 -1.502 . . . . 0.0 108.845 177.937 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -67.48 -20.66 47.56 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 116.986 -1.543 . . . . 0.0 114.878 -177.46 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.417 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 6.2 p-10 -75.21 -20.39 59.3 Favored 'General case' 0 C--N 1.321 -0.637 0 O-C-N 121.74 -0.6 . . . . 0.0 111.075 178.359 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -88.79 0.87 56.1 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 114.394 1.257 . . . . 0.0 114.394 -174.746 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 94.4 mm-40 -62.45 -29.03 70.23 Favored 'General case' 0 C--N 1.316 -0.876 0 O-C-N 121.062 -1.024 . . . . 0.0 111.526 -179.382 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 13.3 tt -64.93 139.04 22.07 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.771 0 CA-C-O 122.009 0.909 . . . . 0.0 112.112 178.419 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 176.46 -158.97 25.65 Favored Glycine 0 CA--C 1.509 -0.305 0 C-N-CA 120.401 -0.904 . . . . 0.0 111.969 -177.722 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 42.8 p90 -155.04 169.97 22.86 Favored 'General case' 0 C--N 1.32 -0.715 0 O-C-N 122.458 -0.436 . . . . 0.0 109.996 -179.788 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 10.6 m-85 -112.73 138.04 50.13 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 173.43 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.06 119.12 38.38 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 123.896 0.878 . . . . 0.0 109.733 -179.26 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 49.5 ttp180 -65.7 134.28 52.88 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 174.765 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -143.74 147.82 34.75 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.844 0.354 . . . . 0.0 110.814 -178.072 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 5.8 p -148.36 139.83 23.52 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 175.623 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 12.4 tpt180 -130.34 133.69 46.62 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 173.55 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 2.7 tpp180 -147.32 148.31 31.26 Favored 'General case' 0 CA--C 1.487 -1.463 0 CA-C-O 121.51 0.671 . . . . 0.0 110.77 -176.169 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -138.4 177.14 5.56 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.922 0 N-CA-C 103.715 -2.698 . . . . 0.0 103.715 178.9 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 48.1 ttp180 -138.77 117.09 11.92 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 177.578 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -100.48 155.8 19.43 Favored Glycine 0 C--O 1.222 -0.656 0 N-CA-C 108.146 -1.982 . . . . 0.0 108.146 177.787 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -75.27 -24.55 70.78 Favored Glycine 0 C--O 1.22 -0.731 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 178.458 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.4 p30 -83.28 -20.36 34.6 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 114.469 -0.865 . . . . 0.0 110.235 177.334 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 110.12 8.46 25.53 Favored Glycine 0 C--O 1.227 -0.307 0 N-CA-C 114.78 0.672 . . . . 0.0 114.78 173.136 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 10.6 pttt -66.01 137.23 56.97 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 122.319 1.057 . . . . 0.0 111.83 179.399 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 99.1 mmm -118.9 172.29 7.64 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 113.234 -1.803 . . . . 0.0 108.844 -178.929 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 14.2 tppt? -116.35 -66.56 1.07 Allowed 'General case' 0 C--O 1.219 -0.552 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 177.636 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -107.09 147.64 29.76 Favored 'General case' 0 CA--C 1.506 -0.722 0 N-CA-C 105.552 -2.018 . . . . 0.0 105.552 176.201 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -113.45 -47.07 3.02 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 105.657 -1.979 . . . . 0.0 105.657 175.616 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -102.38 151.82 38.23 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-N 114.867 -1.061 . . . . 0.0 110.378 179.205 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -64.07 150.73 87.74 Favored 'Trans proline' 0 C--N 1.35 0.658 0 O-C-N 122.033 0.491 . . . . 0.0 113.079 176.441 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 90.6 mtt-85 -116.7 159.21 22.59 Favored 'General case' 0 C--O 1.222 -0.394 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 178.748 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 53.7 m95 -137.33 125.38 22.86 Favored 'General case' 0 C--O 1.214 -0.765 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 174.77 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 59.9 m-85 -110.43 142.67 41.83 Favored 'General case' 0 C--O 1.216 -0.671 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 -177.08 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 81.1 t80 -93.01 135.95 33.72 Favored 'General case' 0 CA--C 1.507 -0.708 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 -176.142 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -139.01 137.72 36.58 Favored 'General case' 0 N--CA 1.441 -0.911 0 CA-C-N 114.739 -1.119 . . . . 0.0 109.195 -175.246 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 27.3 m-85 -67.74 159.39 30.27 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.71 179.065 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -50.46 122.53 7.19 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 113.743 1.016 . . . . 0.0 113.743 -177.258 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 68.53 22.13 74.88 Favored Glycine 0 C--O 1.226 -0.351 0 N-CA-C 116.193 1.237 . . . . 0.0 116.193 176.028 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 33.8 p -90.16 146.76 24.03 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 118.351 1.075 . . . . 0.0 111.017 179.306 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 110.33 137.03 7.48 Favored Glycine 0 CA--C 1.522 0.471 0 N-CA-C 109.236 -1.546 . . . . 0.0 109.236 -177.431 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -72.67 -30.79 11.44 Favored 'Trans proline' 0 CA--C 1.513 -0.557 0 CA-C-N 119.433 1.617 . . . . 0.0 115.225 -175.704 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -102.09 11.16 38.81 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 114.257 -1.338 . . . . 0.0 108.256 -176.967 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -64.23 -54.91 25.97 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -172.727 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 54.21 44.86 74.87 Favored Glycine 0 CA--C 1.52 0.383 0 C-N-CA 121.258 -0.496 . . . . 0.0 112.884 -179.128 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 16.4 mt -128.51 103.9 19.67 Favored Pre-proline 0 N--CA 1.442 -0.839 0 N-CA-C 116.289 1.959 . . . . 0.0 116.289 -175.272 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -78.46 160.81 28.67 Favored 'Trans proline' 0 C--O 1.233 0.227 0 C-N-CA 122.337 2.025 . . . . 0.0 107.417 167.949 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 60.3 t80 -60.85 132.76 54.89 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 120.291 -0.564 . . . . 0.0 110.957 -176.855 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 90.04 -6.53 82.65 Favored Glycine 0 N--CA 1.453 -0.215 0 CA-C-O 119.484 -0.62 . . . . 0.0 114.177 179.452 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -66.17 130.52 43.51 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 118.533 1.167 . . . . 0.0 111.332 179.459 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 52.5 t30 -80.86 128.54 33.79 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.332 -0.849 . . . . 0.0 109.091 179.431 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.429 ' HB3' HG13 ' A' ' 90' ' ' ILE . 27.7 ttmt -156.21 158.9 38.39 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 107.375 -1.343 . . . . 0.0 107.375 -178.921 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -54.67 122.34 10.43 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.053 0.39 . . . . 0.0 112.053 179.33 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 64.49 35.66 92.22 Favored Glycine 0 N--CA 1.448 -0.527 0 CA-C-O 119.189 -0.784 . . . . 0.0 114.376 174.436 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.429 HG13 ' HB3' ' A' ' 87' ' ' LYS . 49.4 mm -121.06 126.0 74.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 117.631 0.715 . . . . 0.0 110.939 179.225 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -126.92 117.73 48.56 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.706 176.254 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 97.5 m95 -85.38 136.3 33.52 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 -177.72 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 16.5 m -134.77 155.17 38.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 178.8 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -165.68 165.32 18.75 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 -178.373 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 12.3 t -130.42 168.32 17.18 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 104.969 -2.234 . . . . 0.0 104.969 174.107 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 76.6 tt0 -67.39 137.82 56.24 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.342 0.592 . . . . 0.0 110.88 -178.777 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 94.91 -10.58 70.21 Favored Glycine 0 C--O 1.229 -0.162 0 CA-C-N 115.662 -0.699 . . . . 0.0 113.093 177.578 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.417 ' HA ' ' HA ' ' A' ' 41' ' ' ASP . . . -78.75 118.4 20.78 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-O 120.974 0.416 . . . . 0.0 111.149 -179.938 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -68.6 133.42 48.47 Favored 'General case' 0 CA--C 1.51 -0.593 0 N-CA-C 114.101 1.148 . . . . 0.0 114.101 -177.628 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 46.9 t30 -83.26 76.23 9.9 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 113.825 -1.534 . . . . 0.0 109.062 178.776 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 1.4 t -146.44 155.36 49.61 Favored Pre-proline 0 C--N 1.322 -0.615 0 N-CA-C 106.053 -1.832 . . . . 0.0 106.053 -177.88 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -61.56 150.16 86.6 Favored 'Trans proline' 0 C--N 1.345 0.346 0 N-CA-C 115.446 1.287 . . . . 0.0 115.446 178.475 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.511 ' HB3' HD12 ' A' ' 106' ' ' ILE . 71.9 mmtt -123.29 30.47 6.3 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.748 -179.983 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 15.4 p-10 -51.34 -42.91 61.58 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.897 -0.592 . . . . 0.0 112.174 -176.914 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 15.6 p80 -68.5 -11.38 59.76 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 113.962 1.097 . . . . 0.0 113.962 -179.652 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.511 HD12 ' HB3' ' A' ' 103' ' ' LYS . 28.1 mt -95.54 -43.28 12.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 121.7 0.762 . . . . 0.0 110.488 178.826 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -72.8 4.03 24.38 Favored Glycine 0 C--O 1.221 -0.717 0 N-CA-C 116.119 1.208 . . . . 0.0 116.119 -176.543 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 13.1 t -83.38 25.78 0.71 Allowed 'General case' 0 CA--C 1.543 0.711 0 CA-C-O 121.492 0.663 . . . . 0.0 111.497 179.57 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.484 ' HD2' HD22 ' A' ' 114' ' ' ASN . 63.6 ttp85 -58.51 129.19 40.88 Favored 'General case' 0 CA--C 1.517 -0.319 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 -179.786 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 34.2 m120 -89.71 121.77 68.74 Favored Pre-proline 0 C--N 1.322 -0.617 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 -177.397 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -72.89 -15.22 26.5 Favored 'Trans proline' 0 C--O 1.218 -0.492 0 C-N-CA 116.789 -1.674 . . . . 0.0 112.188 178.95 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -77.03 -28.98 55.09 Favored 'General case' 0 C--O 1.221 -0.447 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.182 178.199 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 84.7 m-20 -102.69 -22.63 13.92 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 113.673 0.99 . . . . 0.0 113.673 -175.12 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.484 HD22 ' HD2' ' A' ' 109' ' ' ARG . 37.6 t30 -140.23 153.48 46.57 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 -177.852 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -95.55 143.73 26.61 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-O 121.264 0.554 . . . . 0.0 110.358 178.298 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -72.88 149.25 43.65 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.315 0.578 . . . . 0.0 110.9 178.893 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 8.9 mt -84.69 136.93 21.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.213 -178.817 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 78.7 t -62.27 121.97 11.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 N-CA-C 106.037 -1.838 . . . . 0.0 106.037 174.927 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 5.9 tt -67.04 130.27 42.58 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.095 0.474 . . . . 0.0 111.338 -176.145 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 31.5 mt-30 -134.48 158.56 43.62 Favored 'General case' 0 CA--C 1.513 -0.475 0 N-CA-C 106.751 -1.574 . . . . 0.0 106.751 -179.607 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 13.2 mt -112.24 147.15 36.36 Favored Pre-proline 0 C--N 1.322 -0.592 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 177.637 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -73.96 165.64 31.59 Favored 'Trans proline' 0 C--N 1.346 0.408 0 O-C-N 122.168 0.562 . . . . 0.0 113.059 -179.92 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 58.3 tp60 -53.85 130.18 36.23 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.296 -0.865 . . . . 0.0 109.453 179.381 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 103.4 -24.2 30.78 Favored Glycine 0 C--O 1.226 -0.355 0 CA-C-N 115.618 -0.719 . . . . 0.0 112.767 -179.376 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 4.7 m -103.54 129.7 50.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 118.307 1.053 . . . . 0.0 111.958 178.844 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 3.7 p -117.37 148.12 42.03 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.309 -0.859 . . . . 0.0 109.569 179.126 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 82.5 mt -70.52 157.38 90.2 Favored Pre-proline 0 C--N 1.323 -0.545 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 177.566 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -73.06 173.09 14.2 Favored 'Trans proline' 0 C--O 1.236 0.42 0 N-CA-C 110.111 -0.765 . . . . 0.0 110.111 178.395 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -68.71 122.83 19.35 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 119.704 -0.798 . . . . 0.0 111.192 -173.605 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 90.08 45.85 4.34 Favored Glycine 0 N--CA 1.452 -0.279 0 CA-C-N 115.1 -0.954 . . . . 0.0 113.877 -179.886 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -141.93 150.0 40.89 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 117.265 0.532 . . . . 0.0 111.765 179.016 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 42.3 p90 -150.69 166.11 31.36 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 175.718 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -100.63 147.03 26.43 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.031 0.443 . . . . 0.0 111.137 -178.481 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -70.51 136.8 49.67 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 179.296 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 86.52 -30.93 4.34 Favored Glycine 0 C--O 1.227 -0.295 0 CA-C-N 116.21 -0.45 . . . . 0.0 112.777 -177.699 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 19.6 t -76.97 95.45 4.15 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 122.117 -0.637 . . . . 0.0 110.404 -179.132 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 1.4 tmt_? 57.51 30.16 18.25 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 115.252 -0.886 . . . . 0.0 110.946 -179.694 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -74.24 -21.02 79.52 Favored Glycine 0 C--O 1.225 -0.426 0 CA-C-O 122.468 1.038 . . . . 0.0 111.744 179.351 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -166.33 -165.06 23.07 Favored Glycine 0 C--N 1.317 -0.479 0 N-CA-C 107.147 -2.381 . . . . 0.0 107.147 179.947 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 59.3 p . . . . . 0 C--O 1.242 0.693 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 178.785 . . . . . . . . 0 0 . 1 . 033 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.948 0 CA-C-O 118.457 -1.19 . . . . 0.0 111.106 . . . . . . . . . 0 0 . 1 . 033 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -78.17 129.57 35.29 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 106.222 -1.77 . . . . 0.0 106.222 177.172 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 16.3 mmt -127.53 70.53 1.32 Allowed 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 -178.167 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 109.64 135.48 7.22 Favored Glycine 0 N--CA 1.44 -1.043 0 N-CA-C 107.248 -2.341 . . . . 0.0 107.248 -175.298 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 96.3 mt -115.27 148.9 41.76 Favored Pre-proline 0 C--N 1.315 -0.922 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 177.182 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -72.2 156.61 55.14 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 116.742 -1.705 . . . . 0.0 112.172 179.473 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 54.8 t30 -65.85 -26.89 67.86 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 112.732 0.642 . . . . 0.0 112.732 -179.585 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 52.3 t30 -156.08 -102.48 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 179.897 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 39.1 p 40.51 74.34 0.1 Allowed 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 115.788 1.773 . . . . 0.0 115.788 -179.175 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -105.11 137.77 42.35 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.239 -0.891 . . . . 0.0 109.5 179.429 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 54.2 p -59.54 144.3 47.75 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 178.876 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 24.8 m95 -65.56 -21.9 66.65 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.574 0.583 . . . . 0.0 112.574 178.809 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 12.7 m-85 -121.43 163.33 18.92 Favored 'General case' 0 CA--C 1.507 -0.673 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 -170.562 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 72.0 p -70.47 165.36 22.74 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 114.517 -1.219 . . . . 0.0 107.794 177.35 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -80.04 149.57 30.66 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.561 0.696 . . . . 0.0 112.004 -177.853 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 13.9 mt -85.83 145.07 27.37 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 102.416 -3.179 . . . . 0.0 102.416 169.362 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 65.0 m -120.46 141.28 50.33 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 -179.256 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.455 ' HB2' ' CZ ' ' A' ' 131' ' ' PHE . 4.4 tp60 -111.04 136.03 50.65 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -177.091 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 60.1 t60 -132.06 99.47 4.74 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 103.42 -2.807 . . . . 0.0 103.42 168.612 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 171.79 -167.03 40.04 Favored Glycine 0 N--CA 1.451 -0.328 0 N-CA-C 110.254 -1.138 . . . . 0.0 110.254 -175.479 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 49.8 mtpt -102.61 -27.25 12.85 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 115.126 1.528 . . . . 0.0 115.126 -177.454 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -85.71 166.28 16.26 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 -179.982 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -77.19 -62.91 1.5 Allowed 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.698 -178.708 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 29.3 tp 178.64 140.01 0.1 Allowed 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 104.864 -2.273 . . . . 0.0 104.864 175.474 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 44.0 tptt -148.18 135.31 20.3 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.064 0.459 . . . . 0.0 110.825 175.282 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -125.3 155.08 71.99 Favored Pre-proline 0 C--O 1.243 0.739 0 N-CA-C 105.594 -2.002 . . . . 0.0 105.594 174.852 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -71.58 173.13 13.0 Favored 'Trans proline' 0 C--N 1.347 0.485 0 CA-C-O 121.88 0.7 . . . . 0.0 113.652 -179.067 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 52.9 tpt85 -77.48 123.87 27.15 Favored 'General case' 0 C--O 1.217 -0.651 0 O-C-N 121.377 -0.827 . . . . 0.0 109.703 179.886 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 85.51 10.64 76.49 Favored Glycine 0 C--O 1.223 -0.569 0 CA-C-N 115.122 -0.945 . . . . 0.0 115.264 176.346 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.545 HE21 HG23 ' A' ' 125' ' ' THR . 18.9 tt0 -157.54 143.35 17.43 Favored 'General case' 0 C--O 1.219 -0.545 0 N-CA-C 106.747 -1.575 . . . . 0.0 106.747 -179.418 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 139.37 -13.32 3.25 Favored Glycine 0 CA--C 1.507 -0.428 0 C-N-CA 120.274 -0.965 . . . . 0.0 113.652 178.205 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 34.6 m -71.8 144.96 88.86 Favored Pre-proline 0 C--N 1.322 -0.616 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 177.898 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -76.92 171.62 17.66 Favored 'Trans proline' 0 N--CA 1.46 -0.441 0 C-N-CA 121.621 1.548 . . . . 0.0 113.203 179.685 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 94.8 mt -75.05 115.75 16.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 121.578 0.704 . . . . 0.0 109.369 178.893 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.413 ' HB2' HE22 ' A' ' 43' ' ' GLN . 76.8 m-20 -94.63 85.01 4.38 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 107.243 -1.391 . . . . 0.0 107.243 178.113 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 73.4 p -61.64 -21.82 64.73 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 115.971 1.841 . . . . 0.0 115.971 -173.79 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -114.25 16.31 17.98 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 113.376 0.88 . . . . 0.0 113.376 -176.556 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.4 m -132.55 172.55 12.36 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 115.94 1.83 . . . . 0.0 115.94 -174.857 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 42.0 m -82.0 159.18 66.2 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 115.218 -0.901 . . . . 0.0 112.525 -176.273 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -67.28 -19.69 49.86 Favored 'Trans proline' 0 C--N 1.351 0.675 0 C-N-CA 117.219 -1.388 . . . . 0.0 114.279 -179.548 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.411 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 0.4 OUTLIER -71.3 -24.15 62.09 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 121.746 -0.596 . . . . 0.0 110.776 177.898 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -85.11 -10.73 56.47 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 116.021 1.86 . . . . 0.0 116.021 -170.939 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.413 HE22 ' HB2' ' A' ' 35' ' ' ASN . 85.0 mm-40 -56.93 -26.59 59.75 Favored 'General case' 0 C--O 1.217 -0.631 0 N-CA-C 113.807 1.039 . . . . 0.0 113.807 -173.151 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 14.0 tt -62.12 139.42 20.88 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 CA-C-O 122.313 1.054 . . . . 0.0 112.875 178.539 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 177.68 -152.66 12.1 Favored Glycine 0 CA--C 1.505 -0.563 0 C-N-CA 120.402 -0.904 . . . . 0.0 110.994 -178.975 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 51.3 p90 -155.06 169.38 24.25 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 178.685 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 35.9 m-85 -111.34 143.4 42.19 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 106.764 -1.569 . . . . 0.0 106.764 173.983 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 71.7 ttt-85 -117.48 124.4 48.68 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 123.744 0.817 . . . . 0.0 111.595 -177.694 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 2.1 ptm180 -71.03 146.2 49.5 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.203 0.525 . . . . 0.0 110.525 179.412 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -146.24 144.86 30.15 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.419 0.628 . . . . 0.0 110.736 179.108 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 41.1 p -142.99 171.61 13.82 Favored 'General case' 0 C--O 1.249 1.034 0 N-CA-C 104.364 -2.458 . . . . 0.0 104.364 175.451 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -140.65 123.9 16.7 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 122.004 -0.435 . . . . 0.0 111.55 176.25 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 4.6 tmt_? -140.78 137.01 33.05 Favored 'General case' 0 CA--C 1.496 -1.109 0 CA-C-O 121.611 0.72 . . . . 0.0 110.562 -178.568 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -140.24 -179.38 2.0 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 N-CA-C 105.949 -1.871 . . . . 0.0 105.949 -179.453 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 6.3 ttm180 -128.94 119.25 24.02 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 175.216 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -80.72 -179.87 53.14 Favored Glycine 0 C--O 1.224 -0.476 0 N-CA-C 108.481 -1.847 . . . . 0.0 108.481 176.243 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -63.63 -46.96 90.93 Favored Glycine 0 C--O 1.219 -0.827 0 CA-C-N 118.343 1.072 . . . . 0.0 112.625 -178.463 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -75.8 -8.41 56.8 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 121.724 0.774 . . . . 0.0 110.11 178.995 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 104.43 -13.77 51.05 Favored Glycine 0 CA--C 1.51 -0.269 0 CA-C-N 115.32 -0.855 . . . . 0.0 111.501 178.875 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 12.0 pttt -56.37 136.59 53.54 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-O 122.112 0.958 . . . . 0.0 110.795 -178.877 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 15.0 ptm -132.05 165.76 23.26 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 114.375 -1.284 . . . . 0.0 114.127 -173.698 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 40.2 mttt -77.08 -60.13 2.49 Favored 'General case' 0 C--O 1.212 -0.903 0 N-CA-C 114.623 1.342 . . . . 0.0 114.623 -176.182 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 52.97 48.04 23.3 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 113.785 1.031 . . . . 0.0 113.785 178.509 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.4 mp -60.97 141.97 56.88 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.389 179.951 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 59.3 p -55.39 148.97 30.11 Favored Pre-proline 0 C--O 1.25 1.086 0 CA-C-N 115.071 -0.968 . . . . 0.0 111.753 -176.903 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -65.22 138.71 57.2 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 117.529 -1.18 . . . . 0.0 112.813 -176.979 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 5.4 ptp180 -141.38 155.78 45.88 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.425 -1.261 . . . . 0.0 108.517 -178.834 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 48.0 m95 -123.64 137.9 54.64 Favored 'General case' 0 C--N 1.318 -0.777 0 C-N-CA 122.671 0.389 . . . . 0.0 110.494 -176.16 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 29.5 m-85 -114.84 139.4 49.79 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 -179.464 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 88.5 t80 -88.49 135.94 33.24 Favored 'General case' 0 CA--C 1.505 -0.77 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 -178.825 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -139.73 139.13 36.45 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 -176.054 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 64.6 m-85 -71.21 159.47 34.59 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.351 -0.84 . . . . 0.0 112.326 -175.117 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -54.84 126.76 25.59 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.843 -179.624 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 68.61 38.21 85.88 Favored Glycine 0 C--O 1.218 -0.85 0 N-CA-C 115.482 0.953 . . . . 0.0 115.482 176.59 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -89.17 145.98 25.08 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 118.927 1.364 . . . . 0.0 107.985 178.058 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 97.98 141.8 12.64 Favored Glycine 0 CA--C 1.526 0.773 0 N-CA-C 108.72 -1.752 . . . . 0.0 108.72 -175.353 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -70.03 -42.42 3.14 Favored 'Trans proline' 0 C--N 1.347 0.479 0 CA-C-N 119.799 1.799 . . . . 0.0 116.222 -173.753 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -114.61 39.62 2.78 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 -177.346 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -64.1 -40.63 96.63 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.053 -0.976 . . . . 0.0 111.511 -177.962 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 60.21 26.07 63.26 Favored Glycine 0 C--O 1.228 -0.257 0 CA-C-N 115.916 -0.584 . . . . 0.0 113.832 179.305 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 17.8 mt -114.46 103.81 54.8 Favored Pre-proline 0 N--CA 1.447 -0.623 0 N-CA-C 114.249 1.203 . . . . 0.0 114.249 -176.964 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -78.86 165.16 24.7 Favored 'Trans proline' 0 C--O 1.237 0.431 0 C-N-CA 121.817 1.678 . . . . 0.0 108.414 170.239 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 61.4 t80 -61.6 131.17 49.16 Favored 'General case' 0 C--N 1.321 -0.654 0 C-N-CA 120.445 -0.502 . . . . 0.0 109.855 -179.958 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 92.45 -5.31 77.45 Favored Glycine 0 C--O 1.227 -0.315 0 N-CA-C 114.775 0.67 . . . . 0.0 114.775 178.806 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -65.57 126.76 29.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 118.412 1.106 . . . . 0.0 111.966 179.127 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 70.3 m-20 -71.97 126.79 30.64 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 114.624 -1.171 . . . . 0.0 110.335 -178.579 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 13.7 ttmm -156.12 151.35 26.62 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 178.564 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -62.55 131.05 47.8 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.274 178.931 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 68.46 27.86 73.55 Favored Glycine 0 N--CA 1.452 -0.275 0 N-CA-C 115.395 0.918 . . . . 0.0 115.395 177.809 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 39.3 mm -129.33 131.35 67.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 117.35 0.575 . . . . 0.0 110.494 -179.999 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.1 pt -131.48 114.85 26.67 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 CA-C-O 121.495 0.665 . . . . 0.0 110.774 175.643 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 95.7 m95 -82.24 135.13 35.29 Favored 'General case' 0 C--N 1.321 -0.662 0 O-C-N 121.831 -0.543 . . . . 0.0 112.227 -177.604 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -142.1 152.02 18.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.824 -0.626 . . . . 0.0 109.312 -178.525 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -155.98 166.59 33.02 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 105.646 -1.983 . . . . 0.0 105.646 -177.826 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 11.6 t -134.38 173.83 11.19 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 105.973 -1.862 . . . . 0.0 105.973 176.263 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -66.57 138.02 57.18 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.343 0.592 . . . . 0.0 110.925 -179.603 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 95.05 -14.66 64.91 Favored Glycine 0 N--CA 1.458 0.146 0 CA-C-N 115.568 -0.742 . . . . 0.0 112.836 177.652 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.411 ' HA ' ' HA ' ' A' ' 41' ' ' ASP . . . -75.06 136.08 41.2 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-O 120.738 0.304 . . . . 0.0 111.311 -179.633 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 30.2 mt -93.75 134.16 36.37 Favored 'General case' 0 CA--C 1.51 -0.58 0 N-CA-C 113.072 0.767 . . . . 0.0 113.072 -178.923 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 55.5 t30 -81.45 71.73 8.47 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 114.878 -1.055 . . . . 0.0 110.838 -178.391 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 1.3 t -142.17 154.79 64.94 Favored Pre-proline 0 C--N 1.322 -0.601 0 N-CA-C 106.129 -1.804 . . . . 0.0 106.129 179.784 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -68.78 148.71 71.88 Favored 'Trans proline' 0 CA--C 1.531 0.362 0 C-N-CA 118.347 -0.635 . . . . 0.0 113.537 176.34 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 5.8 ptpt -149.19 56.12 0.99 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 122.522 1.153 . . . . 0.0 111.169 178.384 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -57.46 -33.23 67.75 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.434 -1.257 . . . . 0.0 112.39 179.703 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 16.9 p80 -62.72 -7.66 5.3 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 115.015 1.487 . . . . 0.0 115.015 -177.862 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 44.7 mt -93.58 -39.25 10.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 177.857 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -72.81 14.65 2.57 Favored Glycine 0 C--O 1.218 -0.88 0 N-CA-C 115.612 1.005 . . . . 0.0 115.612 -178.409 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 14.3 t -99.67 27.98 5.0 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 113.322 0.86 . . . . 0.0 113.322 -176.928 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 62.4 ttp85 -51.52 133.08 30.4 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 177.477 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -90.45 117.88 68.33 Favored Pre-proline 0 C--N 1.326 -0.434 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 -179.538 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -71.45 -15.17 31.06 Favored 'Trans proline' 0 C--O 1.219 -0.462 0 C-N-CA 117.569 -1.154 . . . . 0.0 114.651 -177.086 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -81.1 -24.86 37.42 Favored 'General case' 0 C--O 1.22 -0.485 0 CA-C-O 121.052 0.453 . . . . 0.0 110.277 178.779 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 -100.89 -25.54 14.06 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 -175.02 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 27.3 t30 -147.96 144.37 27.96 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 113.284 0.846 . . . . 0.0 113.284 -178.404 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -84.27 146.46 27.75 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.13 179.823 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -67.77 143.67 55.74 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.405 0.622 . . . . 0.0 110.434 178.587 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 20.6 mt -83.84 139.43 17.64 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 -178.807 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.48 HG11 ' HB2' ' A' ' 136' ' ' SER . 71.3 t -58.89 126.81 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 N-CA-C 106.393 -1.706 . . . . 0.0 106.393 175.252 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 7.7 tt -67.29 129.31 39.49 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 -178.933 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -130.34 156.61 44.41 Favored 'General case' 0 CA--C 1.511 -0.534 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 -178.474 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.415 HD13 HG22 ' A' ' 125' ' ' THR . 14.8 mt -113.56 147.72 38.16 Favored Pre-proline 0 C--N 1.323 -0.582 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 178.879 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -71.94 166.77 28.56 Favored 'Trans proline' 0 C--N 1.345 0.382 0 O-C-N 122.338 0.652 . . . . 0.0 113.262 -178.721 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 34.0 tt0 -54.86 129.78 38.66 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.284 -179.409 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 93.71 -13.24 67.92 Favored Glycine 0 C--O 1.226 -0.363 0 CA-C-N 115.985 -0.552 . . . . 0.0 113.552 179.976 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.545 HG23 HE21 ' A' ' 30' ' ' GLN . 23.0 m -103.92 126.69 51.23 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 117.904 0.852 . . . . 0.0 110.265 179.035 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 11.6 p -121.67 148.4 44.63 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.934 -177.227 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 77.4 mt -74.13 154.08 88.49 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.301 178.286 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -76.86 173.87 13.77 Favored 'Trans proline' 0 C--N 1.345 0.393 0 N-CA-C 110.471 -0.627 . . . . 0.0 110.471 177.103 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 4.8 tmtt? -61.04 123.28 17.19 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.785 0.661 . . . . 0.0 112.785 -174.687 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 95.23 0.8 63.06 Favored Glycine 0 C--N 1.328 0.122 0 N-CA-C 115.141 0.817 . . . . 0.0 115.141 175.201 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.455 ' CZ ' ' HB2' ' A' ' 18' ' ' GLN . 1.2 m-85 -100.87 135.33 42.48 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-O 121.777 0.799 . . . . 0.0 110.538 -179.64 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 37.8 p90 -140.46 160.5 39.86 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 114.531 -1.213 . . . . 0.0 108.762 177.469 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -96.59 139.37 32.78 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.14 0.495 . . . . 0.0 111.454 -177.292 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -70.15 135.91 49.59 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 177.966 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 93.9 -9.01 73.44 Favored Glycine 0 CA--C 1.519 0.328 0 N-CA-C 114.716 0.646 . . . . 0.0 114.716 179.601 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . 0.48 ' HB2' HG11 ' A' ' 118' ' ' VAL . 8.4 t -145.02 -176.15 4.98 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 117.803 0.801 . . . . 0.0 110.781 178.44 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 11.9 mpt_? -99.31 118.97 37.16 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 106.752 -1.573 . . . . 0.0 106.752 179.738 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -86.28 -173.89 49.33 Favored Glycine 0 C--N 1.318 -0.456 0 N-CA-C 108.671 -1.772 . . . . 0.0 108.671 176.439 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -117.72 -161.29 11.98 Favored Glycine 0 N--CA 1.452 -0.243 0 N-CA-C 108.867 -1.693 . . . . 0.0 108.867 178.598 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 28.6 t . . . . . 0 C--O 1.263 1.772 0 C-N-CA 123.644 0.778 . . . . 0.0 112.874 178.312 . . . . . . . . 0 0 . 1 . 034 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.612 0 CA-C-O 118.881 -0.955 . . . . 0.0 110.996 . . . . . . . . . 0 0 . 1 . 034 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -80.25 137.64 36.67 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 104.325 -2.472 . . . . 0.0 104.325 174.759 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -154.25 168.37 26.79 Favored 'General case' 0 N--CA 1.445 -0.72 0 N-CA-C 101.617 -3.475 . . . . 0.0 101.617 -177.781 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 99.76 77.07 1.28 Allowed Glycine 0 C--N 1.318 -0.451 0 N-CA-C 110.843 -0.903 . . . . 0.0 110.843 -178.884 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 96.2 mt -59.13 136.9 88.18 Favored Pre-proline 0 C--O 1.242 0.66 0 CA-C-O 120.997 0.427 . . . . 0.0 111.142 -179.169 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -73.79 158.19 46.97 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 118.19 -0.74 . . . . 0.0 113.629 -177.531 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 29.8 t30 58.07 23.91 10.6 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 114.059 1.133 . . . . 0.0 114.059 177.846 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -91.3 -21.8 20.87 Favored 'General case' 0 C--O 1.221 -0.409 0 N-CA-C 104.765 -2.309 . . . . 0.0 104.765 174.57 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 75.6 p -151.13 160.56 43.8 Favored 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 100.3 -3.963 . . . . 0.0 100.3 -177.932 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -151.47 151.98 32.39 Favored 'General case' 0 C--N 1.313 -1.002 0 O-C-N 123.685 0.615 . . . . 0.0 109.776 177.122 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 31.3 t -61.36 136.92 58.21 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.448 178.368 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . 0.408 ' CD2' ' HD3' ' A' ' 109' ' ' ARG . 4.3 m95 -68.91 -26.26 65.01 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-O 121.24 0.543 . . . . 0.0 111.005 177.126 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -121.58 162.68 20.19 Favored 'General case' 0 CA--C 1.51 -0.592 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.385 -171.191 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 64.1 p -68.05 163.31 22.67 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 178.454 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -75.08 152.36 38.59 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.839 0.828 . . . . 0.0 113.166 -176.26 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 12.7 mt -91.35 148.68 22.15 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 102.882 -3.007 . . . . 0.0 102.882 169.458 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 25.9 m -127.76 140.36 52.1 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 -178.38 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.455 ' HB2' ' CZ ' ' A' ' 131' ' ' PHE . 4.6 tp60 -119.34 139.59 51.73 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 114.313 1.227 . . . . 0.0 114.313 -175.668 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 34.7 t60 -136.17 99.57 4.16 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 104.045 -2.576 . . . . 0.0 104.045 168.047 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 177.04 -158.56 24.35 Favored Glycine 0 C--O 1.228 -0.277 0 N-CA-C 110.801 -0.92 . . . . 0.0 110.801 -175.165 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 60.8 mttp -114.16 -22.32 10.05 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 114.16 1.17 . . . . 0.0 114.16 -178.579 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -84.76 157.38 21.04 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 107.883 -1.155 . . . . 0.0 107.883 177.785 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -76.67 -62.68 1.55 Allowed 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 -177.758 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 41.1 tp 177.23 145.14 0.1 Allowed 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 104.084 -2.561 . . . . 0.0 104.084 173.279 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 79.7 tttt -157.77 145.29 18.47 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 175.115 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 17.3 m-85 -134.53 151.21 75.65 Favored Pre-proline 0 C--N 1.323 -0.546 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 175.572 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -77.68 162.29 30.15 Favored 'Trans proline' 0 CA--C 1.538 0.716 0 O-C-N 122.02 0.484 . . . . 0.0 113.106 178.558 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 17.7 tpt180 -64.7 136.5 57.01 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.466 -178.862 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 90.26 -5.7 82.76 Favored Glycine 0 C--N 1.329 0.181 0 N-CA-C 111.397 -0.681 . . . . 0.0 111.397 178.132 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 -138.48 -179.68 5.95 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 123.714 0.805 . . . . 0.0 109.354 -174.665 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 100.22 -27.29 21.03 Favored Glycine 0 CA--C 1.497 -1.058 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.516 176.046 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 92.3 t -65.45 126.17 90.97 Favored Pre-proline 0 N--CA 1.444 -0.772 0 N-CA-C 106.207 -1.775 . . . . 0.0 106.207 176.288 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -72.44 164.26 36.16 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 O-C-N 122.175 0.566 . . . . 0.0 111.248 178.624 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 87.3 mt -63.85 115.58 2.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-O 121.658 0.742 . . . . 0.0 109.695 -176.692 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 6.7 m-80 -95.91 108.05 20.38 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.18 -0.918 . . . . 0.0 111.914 -177.026 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 70.3 p -91.3 -12.73 34.2 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.909 0.861 . . . . 0.0 110.827 177.662 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 12.5 p30 -110.27 9.01 23.74 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 116.993 2.219 . . . . 0.0 116.993 -173.247 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 87.6 p -154.08 165.57 35.78 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 115.19 1.552 . . . . 0.0 115.19 -175.23 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 25.4 m -78.65 167.56 34.22 Favored Pre-proline 0 N--CA 1.472 0.637 0 C-N-CA 124.311 1.044 . . . . 0.0 112.624 -176.42 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -64.54 -24.69 63.13 Favored 'Trans proline' 0 C--N 1.354 0.845 0 C-N-CA 115.62 -2.453 . . . . 0.0 112.843 177.575 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -63.0 -25.93 68.62 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.506 0.67 . . . . 0.0 111.211 176.168 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -97.3 -1.45 44.64 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 115.06 1.504 . . . . 0.0 115.06 -170.877 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 94.5 mm-40 -60.74 -26.12 66.96 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 113.243 0.831 . . . . 0.0 113.243 -177.614 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.411 ' HB ' ' HB1' ' A' ' 98' ' ' ALA . 19.0 tt -58.61 137.7 20.63 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 CA-C-O 122.384 1.087 . . . . 0.0 113.683 -177.994 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 178.9 -161.01 27.05 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.473 -0.87 . . . . 0.0 113.43 -178.787 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 44.7 p90 -154.76 169.09 24.76 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 179.357 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 13.6 m-85 -112.17 139.93 47.29 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 172.369 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.14 129.78 54.15 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 179.407 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 17.6 ttm105 -73.25 132.94 43.74 Favored 'General case' 0 CA--C 1.5 -0.971 0 N-CA-C 104.873 -2.269 . . . . 0.0 104.873 175.496 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -69.86 165.93 20.52 Favored 'General case' 0 N--CA 1.426 -1.648 0 CA-C-O 122.654 1.216 . . . . 0.0 111.89 -177.14 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 77.2 p -71.11 160.63 32.54 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 113.672 -1.603 . . . . 0.0 112.826 -176.27 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 6.0 tpt180 -65.71 154.07 39.97 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 114.555 -1.202 . . . . 0.0 111.657 -177.913 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.476 ' HG3' ' H ' ' A' ' 63' ' ' ASP . 10.0 ttm180 -88.68 136.97 32.73 Favored 'General case' 0 CA--C 1.504 -0.82 0 N-CA-C 108.266 -1.012 . . . . 0.0 108.266 177.367 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -143.04 175.11 4.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 N-CA-C 105.988 -1.856 . . . . 0.0 105.988 -176.355 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 14.9 tpt180 -92.88 116.4 29.0 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 106.27 -1.752 . . . . 0.0 106.27 176.137 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -79.65 137.64 19.12 Favored Glycine 0 N--CA 1.446 -0.645 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 177.917 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -72.01 -18.93 78.08 Favored Glycine 0 C--O 1.219 -0.841 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 178.733 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -64.37 -12.01 38.41 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 124.286 1.034 . . . . 0.0 110.11 176.234 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 109.26 15.92 11.93 Favored Glycine 0 CA--C 1.5 -0.862 0 CA-C-N 115.933 -0.576 . . . . 0.0 112.663 169.521 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.4 167.89 24.91 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 116.19 1.922 . . . . 0.0 116.19 -173.353 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -84.92 156.02 21.41 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.873 179.66 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -80.51 -55.15 5.07 Favored 'General case' 0 C--O 1.216 -0.693 0 CA-C-O 121.959 0.885 . . . . 0.0 112.717 -179.953 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.476 ' H ' ' HG3' ' A' ' 53' ' ' ARG . 1.0 OUTLIER -150.06 179.28 8.2 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 114.44 -1.254 . . . . 0.0 111.403 -174.259 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 95.6 mt -112.28 -83.73 0.58 Allowed 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 175.643 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -88.85 162.8 37.3 Favored Pre-proline 0 C--N 1.323 -0.564 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 177.849 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -69.52 142.98 50.5 Favored 'Trans proline' 0 C--N 1.348 0.503 0 C-N-CA 115.708 -2.395 . . . . 0.0 112.235 176.841 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 93.5 mtt-85 -121.59 166.25 14.49 Favored 'General case' 0 CA--C 1.513 -0.455 0 N-CA-C 112.99 0.737 . . . . 0.0 112.99 179.701 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 57.9 m95 -131.94 145.83 51.73 Favored 'General case' 0 C--O 1.216 -0.672 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 175.349 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 29.8 m-85 -125.88 154.1 43.21 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 105.661 -1.977 . . . . 0.0 105.661 -178.891 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 90.8 t80 -105.9 135.96 46.39 Favored 'General case' 0 CA--C 1.508 -0.672 0 CA-C-N 119.006 0.821 . . . . 0.0 109.54 -174.586 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 21.2 m-85 -140.91 144.81 35.42 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 107.259 -1.386 . . . . 0.0 107.259 -175.989 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 53.7 m-85 -84.83 159.52 20.39 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.453 -174.465 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 16.8 tp -53.29 129.98 33.44 Favored 'General case' 0 C--O 1.216 -0.677 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 179.884 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 70.81 22.26 78.18 Favored Glycine 0 C--O 1.223 -0.577 0 N-CA-C 116.375 1.31 . . . . 0.0 116.375 176.831 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 18.9 p -90.9 146.15 24.14 Favored 'General case' 0 CA--C 1.511 -0.522 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 175.658 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 97.76 129.12 6.23 Favored Glycine 0 CA--C 1.523 0.576 0 N-CA-C 108.845 -1.702 . . . . 0.0 108.845 -176.971 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -67.89 -35.92 19.55 Favored 'Trans proline' 0 CA--C 1.516 -0.406 0 CA-C-N 119.575 1.687 . . . . 0.0 115.421 -174.22 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -108.37 21.02 17.9 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 114.637 -1.165 . . . . 0.0 109.395 -176.031 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -61.02 -42.07 97.75 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.695 -175.32 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 55.94 43.91 87.73 Favored Glycine 0 CA--C 1.516 0.117 0 CA-C-N 115.894 -0.594 . . . . 0.0 113.198 178.862 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 12.9 mt -130.82 104.23 15.65 Favored Pre-proline 0 N--CA 1.438 -1.061 0 N-CA-C 114.075 1.139 . . . . 0.0 114.075 -177.999 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -78.84 161.5 27.19 Favored 'Trans proline' 0 N--CA 1.462 -0.368 0 C-N-CA 122.268 1.978 . . . . 0.0 107.192 167.819 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 56.0 t80 -61.09 132.85 55.1 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 120.226 -0.589 . . . . 0.0 110.063 -177.704 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 91.1 -7.15 81.27 Favored Glycine 0 CA--C 1.519 0.337 0 CA-C-O 119.333 -0.704 . . . . 0.0 114.541 179.407 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -67.68 129.73 40.81 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 118.804 1.302 . . . . 0.0 111.808 179.909 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 51.1 t30 -79.04 128.76 33.68 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.042 -179.893 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.4 ' HB3' HG13 ' A' ' 90' ' ' ILE . 28.7 ttmt -155.94 157.9 37.04 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 106.964 -1.495 . . . . 0.0 106.964 -178.774 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -54.87 120.2 6.49 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.473 0.546 . . . . 0.0 112.473 -179.696 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 66.12 35.6 90.73 Favored Glycine 0 CA--C 1.507 -0.467 0 CA-C-O 118.989 -0.895 . . . . 0.0 114.022 175.176 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.4 HG13 ' HB3' ' A' ' 87' ' ' LYS . 49.6 mm -122.47 126.29 73.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 117.452 0.626 . . . . 0.0 110.856 178.904 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -126.84 121.17 57.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.892 175.666 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 98.7 m95 -87.57 135.67 33.26 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 113.602 0.964 . . . . 0.0 113.602 -176.71 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 15.8 m -137.2 149.78 26.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 121.638 0.733 . . . . 0.0 109.069 178.618 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -162.46 161.97 27.37 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 103.363 -2.829 . . . . 0.0 103.363 179.416 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 6.0 t -126.43 173.85 9.06 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 105.098 -2.186 . . . . 0.0 105.098 178.151 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -67.26 134.42 51.59 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.054 0.454 . . . . 0.0 109.957 -178.303 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 96.0 -9.65 67.98 Favored Glycine 0 C--O 1.226 -0.396 0 CA-C-N 115.97 -0.559 . . . . 0.0 113.05 179.318 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.411 ' HB1' ' HB ' ' A' ' 44' ' ' ILE . . . -76.37 134.02 39.78 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 178.891 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 65.9 mt -87.75 140.96 28.98 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.174 0.511 . . . . 0.0 112.147 -176.743 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 63.4 t30 -84.29 61.98 6.89 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.968 -179.599 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -135.91 156.47 77.17 Favored Pre-proline 0 C--N 1.322 -0.617 0 N-CA-C 106.159 -1.793 . . . . 0.0 106.159 -178.592 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -67.73 152.8 77.3 Favored 'Trans proline' 0 C--N 1.343 0.272 0 N-CA-C 114.793 1.036 . . . . 0.0 114.793 -179.889 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.507 ' HB3' HD12 ' A' ' 106' ' ' ILE . 73.8 mmtt -126.07 37.9 4.25 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 114.648 -1.16 . . . . 0.0 110.079 -177.111 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 15.9 p-10 -53.32 -41.22 65.49 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.168 -179.051 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 16.3 p80 -66.21 -8.88 27.14 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 114.359 1.244 . . . . 0.0 114.359 179.99 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.507 HD12 ' HB3' ' A' ' 103' ' ' LYS . 31.3 mt -95.27 -44.64 13.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 178.727 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -70.66 3.04 13.24 Favored Glycine 0 C--O 1.221 -0.673 0 N-CA-C 115.661 1.024 . . . . 0.0 115.661 -177.537 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 14.6 t -83.15 15.13 3.0 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 117.637 0.719 . . . . 0.0 112.28 -177.868 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.418 ' HD2' HD22 ' A' ' 114' ' ' ASN . 57.6 ttp85 -58.72 130.83 48.75 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 176.629 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -98.6 137.62 20.66 Favored Pre-proline 0 C--N 1.323 -0.585 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 178.399 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -74.96 -19.84 17.53 Favored 'Trans proline' 0 C--O 1.219 -0.434 0 N-CA-C 113.863 0.678 . . . . 0.0 113.863 179.424 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -81.36 -25.14 36.57 Favored 'General case' 0 C--O 1.221 -0.437 0 CA-C-O 121.163 0.506 . . . . 0.0 110.226 179.293 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 -97.76 -21.54 16.91 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 113.437 0.903 . . . . 0.0 113.437 -175.128 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.418 HD22 ' HD2' ' A' ' 109' ' ' ARG . 29.5 t30 -150.31 153.24 35.76 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 111.884 0.328 . . . . 0.0 111.884 -178.77 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -89.45 140.92 29.05 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-O 121.246 0.546 . . . . 0.0 110.586 178.4 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -70.99 147.64 48.44 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.136 0.494 . . . . 0.0 110.355 178.667 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 11.7 mt -81.89 136.47 22.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.473 -178.494 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 77.0 t -58.78 121.9 7.47 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 N-CA-C 106.43 -1.693 . . . . 0.0 106.43 174.601 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 6.1 tt -67.35 127.54 33.05 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.297 0.57 . . . . 0.0 110.328 -176.662 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 -133.98 155.08 50.59 Favored 'General case' 0 CA--C 1.508 -0.661 0 N-CA-C 106.489 -1.671 . . . . 0.0 106.489 -179.233 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 12.9 mt -111.08 147.96 37.66 Favored Pre-proline 0 C--N 1.319 -0.724 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 177.738 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -73.3 163.5 37.71 Favored 'Trans proline' 0 C--O 1.237 0.439 0 C-N-CA 118.016 -0.856 . . . . 0.0 112.626 -179.934 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 40.1 tt0 -54.47 130.65 40.34 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.06 179.963 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 105.94 -26.25 21.4 Favored Glycine 0 C--O 1.227 -0.309 0 CA-C-N 115.871 -0.604 . . . . 0.0 112.251 -178.656 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 4.6 m -102.36 129.91 48.95 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 118.276 1.038 . . . . 0.0 112.131 178.586 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 3.1 p -116.61 147.86 41.49 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.274 178.625 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 82.8 mt -72.11 153.79 92.48 Favored Pre-proline 0 C--N 1.323 -0.559 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 177.911 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -75.54 175.53 11.16 Favored 'Trans proline' 0 C--O 1.235 0.334 0 N-CA-C 110.576 -0.586 . . . . 0.0 110.576 177.901 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 76.1 tttt -64.55 124.51 22.04 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 114.023 1.12 . . . . 0.0 114.023 -170.811 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 95.19 -1.86 65.18 Favored Glycine 0 CA--C 1.518 0.243 0 CA-C-N 114.891 -1.05 . . . . 0.0 115.342 177.101 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.455 ' CZ ' ' HB2' ' A' ' 18' ' ' GLN . 3.5 m-85 -94.81 143.12 26.71 Favored 'General case' 0 N--CA 1.436 -1.14 0 CA-C-O 122.465 1.126 . . . . 0.0 111.619 -179.328 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 43.7 p90 -144.19 164.46 30.64 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 113.053 -1.885 . . . . 0.0 107.375 173.992 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -105.18 148.55 26.79 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.253 0.549 . . . . 0.0 111.465 -176.759 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -79.05 139.8 38.05 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 179.397 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 81.98 -0.21 88.79 Favored Glycine 0 C--O 1.226 -0.369 0 C-N-CA 121.161 -0.543 . . . . 0.0 112.241 -178.283 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 8.3 t -98.24 -151.4 0.38 Allowed 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 178.288 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 1.5 tmm_? -66.1 97.67 0.39 Allowed 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 177.421 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -88.74 174.55 42.9 Favored Glycine 0 N--CA 1.452 -0.245 0 CA-C-N 116.115 -0.493 . . . . 0.0 112.077 179.984 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 93.74 -178.7 38.08 Favored Glycine 0 C--O 1.229 -0.188 0 N-CA-C 108.987 -1.645 . . . . 0.0 108.987 -178.19 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 30.2 t . . . . . 0 C--O 1.241 0.657 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 179.049 . . . . . . . . 0 0 . 1 . 035 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.876 0 CA-C-O 117.316 -1.825 . . . . 0.0 110.966 . . . . . . . . . 0 0 . 1 . 035 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 53.36 51.65 14.99 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 118.345 1.073 . . . . 0.0 112.536 179.004 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -153.55 176.68 11.77 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 103.759 -2.682 . . . . 0.0 103.759 -178.12 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 153.3 -71.87 0.28 Allowed Glycine 0 CA--C 1.521 0.414 0 N-CA-C 117.176 1.63 . . . . 0.0 117.176 177.593 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 96.0 mt -101.6 144.96 29.6 Favored Pre-proline 0 N--CA 1.468 0.438 0 CA-C-N 117.486 0.643 . . . . 0.0 111.662 -176.416 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -76.5 159.82 35.63 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 118.285 -0.676 . . . . 0.0 112.015 177.359 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 90.1 m-20 -65.04 -31.6 72.9 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 112.438 0.533 . . . . 0.0 112.438 -179.861 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 30.5 t30 -158.43 -91.8 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 177.734 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 27.8 p 41.59 75.98 0.08 Allowed 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.981 0.912 . . . . 0.0 112.685 -176.456 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -91.27 135.17 33.99 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.446 -0.797 . . . . 0.0 108.885 -177.939 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 69.6 p -63.18 144.02 57.28 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 178.259 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 14.8 m95 -70.9 -22.82 62.22 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 111.923 0.342 . . . . 0.0 111.923 179.225 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 33.9 m-85 -121.48 162.53 20.33 Favored 'General case' 0 C--O 1.243 0.736 0 N-CA-C 113.239 0.829 . . . . 0.0 113.239 -172.353 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.43 ' HB ' ' HB3' ' A' ' 134' ' ' GLU . 70.5 p -71.13 165.0 24.5 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 114.806 -1.088 . . . . 0.0 108.245 178.149 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -83.4 145.13 29.17 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 113.803 1.038 . . . . 0.0 113.803 -176.401 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 22.9 mt -78.0 148.91 34.17 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 103.942 -2.614 . . . . 0.0 103.942 168.832 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 26.8 m -126.96 140.42 52.33 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 107.432 -1.321 . . . . 0.0 107.432 179.392 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 56.7 tt0 -116.44 148.69 40.47 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 114.936 1.458 . . . . 0.0 114.936 -174.172 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 63.3 t60 -134.52 99.62 4.41 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 105.375 -2.083 . . . . 0.0 105.375 169.967 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -178.95 -163.01 29.34 Favored Glycine 0 CA--C 1.522 0.494 0 C-N-CA 121.006 -0.616 . . . . 0.0 113.233 -176.621 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 68.9 mmtt -116.27 -31.7 5.55 Favored 'General case' 0 N--CA 1.48 1.062 0 N-CA-C 113.919 1.081 . . . . 0.0 113.919 -178.899 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -84.23 -166.67 1.5 Allowed 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 178.61 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 13.7 p-10 -105.74 -66.08 1.01 Allowed 'General case' 0 CA--C 1.556 1.187 0 N-CA-C 117.699 2.481 . . . . 0.0 117.699 -177.614 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 49.3 tp 172.7 141.62 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 179.777 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -154.26 145.36 22.77 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 107.062 -1.459 . . . . 0.0 107.062 -178.732 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -134.51 148.44 67.48 Favored Pre-proline 0 C--N 1.322 -0.589 0 N-CA-C 105.779 -1.934 . . . . 0.0 105.779 176.23 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -69.98 150.22 66.6 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 117.875 -0.95 . . . . 0.0 111.71 179.433 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 16.8 tpt180 -65.98 134.98 54.07 Favored 'General case' 0 C--O 1.217 -0.651 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 -178.369 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 98.84 -3.6 58.9 Favored Glycine 0 C--O 1.222 -0.608 0 N-CA-C 110.335 -1.106 . . . . 0.0 110.335 -179.377 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -146.57 170.51 16.76 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 -179.372 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 128.88 -31.41 3.52 Favored Glycine 0 CA--C 1.48 -2.096 0 N-CA-C 108.774 -1.731 . . . . 0.0 108.774 165.142 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 35.7 m -66.47 139.63 96.23 Favored Pre-proline 0 N--CA 1.43 -1.458 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 177.378 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -72.77 174.01 12.5 Favored 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 121.785 1.657 . . . . 0.0 111.6 177.049 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 90.9 mt -72.1 113.46 9.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 N-CA-C 107.656 -1.239 . . . . 0.0 107.656 178.083 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.557 HD22 ' HA ' ' A' ' 43' ' ' GLN . 37.8 m-20 -109.75 82.16 1.55 Allowed 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.431 -0.804 . . . . 0.0 108.947 -178.31 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 67.7 p -64.87 -24.41 67.53 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.46 -0.791 . . . . 0.0 112.972 -177.044 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 72.7 m-80 -100.72 35.75 2.09 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.647 -178.191 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 21.1 m -147.88 151.7 36.33 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.6 -0.273 . . . . 0.0 110.596 -179.269 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 18.4 m -72.17 165.45 50.4 Favored Pre-proline 0 C--N 1.324 -0.507 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 176.877 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -64.68 -27.79 60.53 Favored 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 114.94 -2.907 . . . . 0.0 111.62 177.813 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -60.84 -30.8 70.32 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 122.121 0.963 . . . . 0.0 110.629 175.784 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 92.6 m-20 -95.58 -0.16 52.26 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 114.931 1.456 . . . . 0.0 114.931 -170.552 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.557 ' HA ' HD22 ' A' ' 35' ' ' ASN . 91.4 mm-40 -60.89 -25.56 66.8 Favored 'General case' 0 C--O 1.219 -0.509 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 178.653 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.494 ' HB ' ' HB1' ' A' ' 98' ' ' ALA . 21.5 tt -55.79 142.56 10.41 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 N-CA-C 115.209 1.559 . . . . 0.0 115.209 -178.621 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 179.22 -155.23 15.43 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.089 178.079 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 43.0 p90 -155.11 168.03 28.38 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 178.254 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 33.6 m-85 -109.28 137.68 46.79 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 174.722 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 60.9 ttt180 -111.9 119.32 38.14 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.474 -0.784 . . . . 0.0 110.827 -177.776 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 1.1 ttp-105 -65.5 134.33 53.17 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 106.78 -1.563 . . . . 0.0 106.78 175.871 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -135.59 153.4 51.68 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.052 0.453 . . . . 0.0 110.541 -177.487 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.477 ' HB ' HD22 ' A' ' 64' ' ' LEU . 32.7 p -133.4 159.01 41.58 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.272 -177.639 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 63.4 ttt180 -158.34 129.71 6.55 Favored 'General case' 0 N--CA 1.477 0.92 0 O-C-N 122.235 -0.291 . . . . 0.0 111.27 177.471 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.81 142.16 24.24 Favored 'General case' 0 CA--C 1.498 -1.039 0 N-CA-C 104.224 -2.51 . . . . 0.0 104.224 -179.933 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -132.1 173.94 13.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 -177.076 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.08 107.39 17.69 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 -179.39 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -74.38 151.82 44.0 Favored Glycine 0 N--CA 1.452 -0.24 0 N-CA-C 107.059 -2.417 . . . . 0.0 107.059 177.201 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -63.38 -42.79 99.02 Favored Glycine 0 C--O 1.223 -0.578 0 CA-C-N 118.559 1.18 . . . . 0.0 111.907 -178.643 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -76.2 -3.22 35.15 Favored 'General case' 0 C--O 1.218 -0.572 0 CA-C-O 121.518 0.675 . . . . 0.0 111.967 179.594 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 96.72 -1.1 61.41 Favored Glycine 0 C--O 1.227 -0.313 0 CA-C-N 115.855 -0.612 . . . . 0.0 112.617 177.395 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 12.8 pttt -63.82 133.66 53.82 Favored 'General case' 0 C--O 1.24 0.581 0 CA-C-O 122.147 0.975 . . . . 0.0 112.587 -178.089 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 13.8 mmt -90.78 145.44 24.78 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 114.171 -1.377 . . . . 0.0 113.022 -179.619 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 2.1 tmtm? -102.11 -23.43 14.06 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.048 -0.978 . . . . 0.0 109.814 176.259 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 13.3 t0 63.7 164.37 0.12 Allowed 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 115.998 1.851 . . . . 0.0 115.998 178.338 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.477 HD22 ' HB ' ' A' ' 51' ' ' THR . 57.4 mt -88.61 131.12 35.1 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.331 0.586 . . . . 0.0 111.304 -176.538 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 4.8 p -112.31 131.29 22.65 Favored Pre-proline 0 C--N 1.319 -0.722 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 176.215 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -74.95 98.14 1.13 Allowed 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 117.35 -1.3 . . . . 0.0 112.065 178.044 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.4 HH22 ' CD ' ' A' ' 134' ' ' GLU . 11.7 mtp180 -110.34 152.81 25.76 Favored 'General case' 0 CA--C 1.507 -0.69 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 178.018 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 64.0 m95 -127.69 126.37 41.78 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 179.666 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 58.7 m-85 -110.35 141.17 43.74 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 -178.592 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 86.1 t80 -87.73 135.87 33.19 Favored 'General case' 0 CA--C 1.506 -0.732 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 -178.581 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -139.42 143.49 37.66 Favored 'General case' 0 N--CA 1.439 -0.995 0 CA-C-N 115.076 -0.965 . . . . 0.0 108.434 -175.376 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -77.01 159.45 29.9 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.089 0.471 . . . . 0.0 110.743 -176.847 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 15.8 tp -59.62 128.17 35.67 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.855 -0.612 . . . . 0.0 110.819 -178.455 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 80.73 24.73 57.81 Favored Glycine 0 C--O 1.218 -0.856 0 N-CA-C 116.342 1.297 . . . . 0.0 116.342 177.603 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 3.7 p -89.12 146.13 25.0 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 118.873 1.336 . . . . 0.0 110.67 -179.609 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 108.19 143.6 10.68 Favored Glycine 0 CA--C 1.523 0.538 0 N-CA-C 109.274 -1.53 . . . . 0.0 109.274 -177.778 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -69.23 -41.71 4.68 Favored 'Trans proline' 0 C--N 1.348 0.512 0 CA-C-N 119.94 1.87 . . . . 0.0 115.958 -173.463 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -116.5 27.57 9.12 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.748 0.785 . . . . 0.0 109.841 -178.21 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -60.43 -46.43 90.06 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.782 -177.032 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 56.7 27.54 55.44 Favored Glycine 0 C--O 1.223 -0.547 0 O-C-N 123.5 0.5 . . . . 0.0 113.942 179.468 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 27.6 mt -105.88 105.32 52.87 Favored Pre-proline 0 C--O 1.238 0.492 0 N-CA-C 115.103 1.519 . . . . 0.0 115.103 -175.422 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -78.25 169.19 20.58 Favored 'Trans proline' 0 C--O 1.235 0.352 0 C-N-CA 121.815 1.676 . . . . 0.0 109.483 171.566 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 51.3 t80 -63.49 130.5 44.63 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 179.564 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 92.13 -3.98 77.21 Favored Glycine 0 C--O 1.225 -0.409 0 N-CA-C 114.754 0.662 . . . . 0.0 114.754 178.691 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -68.44 123.69 21.5 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 118.63 1.215 . . . . 0.0 111.471 178.747 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 74.6 m-20 -71.66 126.05 28.69 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 114.799 -1.091 . . . . 0.0 111.839 -176.805 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 29.2 ttmt -156.13 151.5 26.77 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 106.927 -1.509 . . . . 0.0 106.927 177.153 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 18.5 t0 -66.82 133.4 50.02 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.904 0.383 . . . . 0.0 110.032 -178.892 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 72.46 21.42 79.46 Favored Glycine 0 CA--C 1.507 -0.467 0 C-N-CA 120.938 -0.649 . . . . 0.0 113.962 177.731 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 44.0 mm -125.31 124.21 66.7 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.421 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 178.864 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.1 pt -127.68 114.47 35.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.725 176.63 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 95.8 m95 -81.09 128.77 34.1 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.371 -177.704 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 2.8 m -136.7 149.74 26.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 121.483 0.659 . . . . 0.0 109.572 -177.347 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -157.51 164.63 37.18 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 105.134 -2.173 . . . . 0.0 105.134 -178.696 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 14.5 t -122.96 174.83 6.93 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 105.705 -1.961 . . . . 0.0 105.705 177.985 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -64.97 133.81 52.55 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.197 0.523 . . . . 0.0 109.812 -179.679 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 92.07 -9.22 76.92 Favored Glycine 0 C--O 1.225 -0.445 0 CA-C-N 115.886 -0.597 . . . . 0.0 113.232 178.482 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.494 ' HB1' ' HB ' ' A' ' 44' ' ' ILE . . . -77.74 137.73 38.63 Favored 'General case' 0 C--N 1.324 -0.534 0 O-C-N 122.249 -0.56 . . . . 0.0 109.523 179.434 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 51.7 mt -92.82 134.18 35.33 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 113.523 0.935 . . . . 0.0 113.523 -176.64 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 71.6 m-20 -79.47 56.16 2.1 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.411 -179.196 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -130.85 152.34 80.42 Favored Pre-proline 0 C--N 1.323 -0.549 0 N-CA-C 107.953 -1.128 . . . . 0.0 107.953 -179.595 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -66.76 149.9 83.5 Favored 'Trans proline' 0 C--N 1.343 0.256 0 N-CA-C 114.281 0.839 . . . . 0.0 114.281 178.364 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 4.5 ptpt -151.18 56.13 0.88 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 122.71 1.243 . . . . 0.0 110.467 178.955 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -57.81 -30.71 65.92 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 113.852 -1.522 . . . . 0.0 111.411 178.338 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 29.5 p-80 -59.67 -16.62 27.83 Favored 'General case' 0 C--O 1.218 -0.602 0 N-CA-C 114.205 1.187 . . . . 0.0 114.205 -178.901 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 64.0 mt -81.41 -32.63 12.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 178.305 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -73.86 14.8 3.39 Favored Glycine 0 CA--C 1.522 0.479 0 N-CA-C 115.023 0.769 . . . . 0.0 115.023 -178.337 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 11.6 t -83.1 17.65 1.93 Allowed 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 112.846 0.684 . . . . 0.0 112.846 -177.718 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 73.3 ttp85 -58.83 130.27 46.14 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 178.838 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -101.77 125.44 37.13 Favored Pre-proline 0 C--N 1.322 -0.625 0 N-CA-C 105.778 -1.934 . . . . 0.0 105.778 179.352 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -68.69 -17.35 42.66 Favored 'Trans proline' 0 C--O 1.218 -0.525 0 C-N-CA 117.766 -1.023 . . . . 0.0 114.397 -176.705 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -78.77 -24.3 44.77 Favored 'General case' 0 C--O 1.22 -0.468 0 CA-C-O 120.932 0.396 . . . . 0.0 110.516 178.339 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 -100.11 -23.04 14.97 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 -174.923 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 28.2 t30 -158.2 149.13 20.77 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.473 0.545 . . . . 0.0 112.473 -178.706 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -92.64 154.16 18.54 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-O 121.518 0.675 . . . . 0.0 111.825 179.606 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -69.39 144.26 53.45 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.216 0.531 . . . . 0.0 111.031 178.87 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 15.3 mt -85.77 139.94 16.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.303 -178.287 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 92.5 t -60.77 124.77 15.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 175.918 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 6.9 tt -67.29 129.0 38.5 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.966 -177.093 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 29.5 mt-30 -132.14 156.64 46.03 Favored 'General case' 0 C--O 1.219 -0.513 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 -179.467 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 13.4 mt -112.29 148.04 38.28 Favored Pre-proline 0 C--N 1.323 -0.578 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 178.449 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -72.65 168.54 24.2 Favored 'Trans proline' 0 C--N 1.346 0.409 0 O-C-N 122.219 0.589 . . . . 0.0 113.615 -179.128 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 39.1 tt0 -53.82 131.87 40.49 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.309 -0.86 . . . . 0.0 109.553 179.554 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 96.38 -18.94 56.57 Favored Glycine 0 C--O 1.226 -0.403 0 CA-C-N 115.919 -0.582 . . . . 0.0 113.452 179.991 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 4.1 m -108.43 128.48 54.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 118.227 1.014 . . . . 0.0 111.375 179.239 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 10.0 p -122.46 150.77 42.05 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.278 179.172 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 87.8 mt -70.79 151.88 95.19 Favored Pre-proline 0 C--N 1.324 -0.533 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 179.076 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -76.03 166.17 28.42 Favored 'Trans proline' 0 C--O 1.236 0.383 0 C-N-CA 117.775 -1.016 . . . . 0.0 110.973 178.864 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 14.7 tmtt? -59.04 127.02 30.11 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.121 -177.293 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 95.1 15.59 44.31 Favored Glycine 0 C--O 1.227 -0.344 0 N-CA-C 114.865 0.706 . . . . 0.0 114.865 178.785 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -125.52 149.17 48.53 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 117.688 0.744 . . . . 0.0 110.637 177.873 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 43.6 p90 -150.37 161.97 41.46 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 174.43 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -99.92 147.01 26.01 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.825 0.345 . . . . 0.0 110.412 -179.017 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.43 ' HB3' ' HB ' ' A' ' 14' ' ' THR . 3.6 tp10 -72.18 133.76 45.31 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 106.65 -1.611 . . . . 0.0 106.65 177.81 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 89.48 -3.17 83.6 Favored Glycine 0 C--O 1.224 -0.5 0 N-CA-C 111.254 -0.738 . . . . 0.0 111.254 -177.144 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 9.7 t -129.11 -175.89 3.7 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 177.42 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -131.6 135.69 47.18 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 -178.775 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -114.68 165.1 12.03 Favored Glycine 0 C--O 1.235 0.194 0 N-CA-C 108.587 -1.805 . . . . 0.0 108.587 176.763 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 118.66 -149.31 18.29 Favored Glycine 0 CA--C 1.509 -0.333 0 N-CA-C 106.493 -2.643 . . . . 0.0 106.493 -176.939 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 11.8 t . . . . . 0 C--O 1.248 0.998 0 O-C-N 125.023 1.072 . . . . 0.0 109.304 -178.177 . . . . . . . . 0 0 . 1 . 036 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.783 0 CA-C-O 118.261 -1.299 . . . . 0.0 110.991 . . . . . . . . . 0 0 . 1 . 036 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -67.93 144.18 55.34 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 118.628 1.214 . . . . 0.0 108.558 178.582 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 87.3 mtp -135.32 -135.62 0.16 Allowed 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 -179.498 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 81.62 26.91 49.16 Favored Glycine 0 CA--C 1.501 -0.827 0 N-CA-C 115.288 0.875 . . . . 0.0 115.288 177.669 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -72.01 134.34 83.31 Favored Pre-proline 0 C--N 1.316 -0.856 0 N-CA-C 105.891 -1.892 . . . . 0.0 105.891 178.32 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -78.3 157.26 29.53 Favored 'Trans proline' 0 N--CA 1.463 -0.312 0 C-N-CA 117.79 -1.007 . . . . 0.0 111.985 179.144 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 -68.33 -31.38 70.75 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 176.113 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 -163.13 -86.77 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.843 177.215 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 82.8 p 39.43 79.03 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 116.34 1.978 . . . . 0.0 116.34 178.476 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -96.69 147.83 23.5 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.262 -179.383 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 54.3 p -59.72 143.72 50.05 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.254 -0.884 . . . . 0.0 109.231 177.907 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 13.4 m95 -65.87 -26.75 67.78 Favored 'General case' 0 CA--C 1.512 -0.485 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 179.26 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 27.4 m-85 -121.46 164.79 16.59 Favored 'General case' 0 CA--C 1.503 -0.831 0 CA-C-N 115.784 -0.644 . . . . 0.0 112.109 -172.201 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.466 ' HB ' ' HB3' ' A' ' 134' ' ' GLU . 67.1 p -70.35 166.41 20.31 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 114.614 -1.175 . . . . 0.0 108.629 177.642 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -87.23 149.92 24.27 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 113.306 0.854 . . . . 0.0 113.306 -176.507 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.466 HD21 HD22 ' A' ' 119' ' ' LEU . 53.0 mt -85.54 148.81 25.77 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 173.18 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 24.2 m -125.19 131.98 53.1 Favored 'General case' 0 C--N 1.32 -0.716 0 C-N-CA 122.515 0.326 . . . . 0.0 110.698 -179.822 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 3.9 tp-100 -95.6 141.67 28.83 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 179.129 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 41.5 t60 -135.35 100.04 4.41 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 102.54 -3.133 . . . . 0.0 102.54 166.598 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 167.77 -143.9 8.53 Favored Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 120.286 -0.959 . . . . 0.0 111.545 -175.027 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -124.74 -32.3 3.1 Favored 'General case' 0 C--O 1.221 -0.405 0 N-CA-C 115.449 1.648 . . . . 0.0 115.449 -177.811 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -77.69 165.77 23.82 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 178.57 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -79.66 -62.89 1.55 Allowed 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 -179.249 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 48.0 tp 173.88 141.04 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.221 0 N-CA-C 106.114 -1.81 . . . . 0.0 106.114 176.057 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 56.2 tptt -153.71 139.46 17.99 Favored 'General case' 0 C--O 1.222 -0.371 0 CA-C-N 118.077 0.399 . . . . 0.0 110.539 173.983 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 20.5 m-85 -126.27 151.49 72.32 Favored Pre-proline 0 C--O 1.24 0.59 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 175.189 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -78.98 166.95 22.64 Favored 'Trans proline' 0 C--N 1.353 0.813 0 C-N-CA 120.934 1.089 . . . . 0.0 113.535 178.347 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 2.0 tmt_? -66.86 137.07 56.32 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.821 -178.732 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 86.67 -0.21 86.52 Favored Glycine 0 C--O 1.223 -0.536 0 N-CA-C 111.302 -0.719 . . . . 0.0 111.302 177.169 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -140.65 -179.69 6.18 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 -175.176 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.52 -28.28 13.98 Favored Glycine 0 CA--C 1.498 -1.025 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.87 176.104 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 76.2 t -64.44 126.45 90.61 Favored Pre-proline 0 C--N 1.32 -0.705 0 N-CA-C 106.177 -1.786 . . . . 0.0 106.177 176.559 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -73.66 168.87 23.69 Favored 'Trans proline' 0 N--CA 1.459 -0.513 0 O-C-N 122.225 0.592 . . . . 0.0 111.446 179.134 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 87.6 mt -66.71 110.1 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-O 122.06 0.934 . . . . 0.0 109.177 -179.761 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 71.6 m-80 -97.94 91.45 5.33 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 114.636 -1.165 . . . . 0.0 110.734 -177.493 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 75.7 p -71.38 -14.89 62.32 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.744 0.783 . . . . 0.0 111.469 178.667 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 10.7 p30 -111.14 20.52 17.32 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 114.915 1.45 . . . . 0.0 114.915 -175.893 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 6.1 m -138.91 152.32 47.66 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 115.938 1.829 . . . . 0.0 115.938 -175.728 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 2.0 m -70.22 164.7 50.81 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 115.085 -0.962 . . . . 0.0 109.936 176.219 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -66.36 -28.38 46.84 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 114.758 -3.028 . . . . 0.0 113.915 -179.823 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.41 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 4.2 p-10 -75.3 -21.59 58.35 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.657 0.741 . . . . 0.0 110.688 177.319 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -83.28 -5.76 59.24 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 114.063 1.134 . . . . 0.0 114.063 -174.776 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 93.6 mm-40 -58.89 -26.52 64.36 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 113.248 0.833 . . . . 0.0 113.248 -179.427 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.453 ' HB ' ' HB1' ' A' ' 98' ' ' ALA . 20.1 tt -57.66 138.86 18.03 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.726 0 N-CA-C 114.402 1.26 . . . . 0.0 114.402 -178.744 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -177.07 -159.35 22.18 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.57 -0.824 . . . . 0.0 111.977 178.806 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 51.5 p90 -155.05 172.7 17.68 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 177.907 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 16.9 m-85 -113.49 138.89 49.47 Favored 'General case' 0 C--N 1.319 -0.761 0 N-CA-C 106.125 -1.806 . . . . 0.0 106.125 173.869 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 36.2 ttt180 -108.23 120.01 41.14 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 114.991 -1.004 . . . . 0.0 110.387 -176.728 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 13.1 ttt180 -64.33 131.7 48.04 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 176.316 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -142.18 129.77 21.44 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.544 0.688 . . . . 0.0 110.882 -179.693 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 15.3 t -156.8 155.46 31.59 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 175.183 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 15.0 tpt85 -154.88 135.12 13.18 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 104.865 -2.272 . . . . 0.0 104.865 178.11 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -127.82 136.37 51.35 Favored 'General case' 0 CA--C 1.495 -1.138 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 -179.423 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.447 HD13 ' HB2' ' A' ' 62' ' ' LYS . 0.1 OUTLIER -132.67 172.4 16.49 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 -177.38 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 5.5 tmm_? -116.08 112.3 21.54 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 105.439 -2.06 . . . . 0.0 105.439 176.71 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -75.76 150.07 39.1 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 121.008 -0.615 . . . . 0.0 112.368 -177.512 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -70.89 -22.16 78.26 Favored Glycine 0 C--O 1.218 -0.896 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.44 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 41.1 t0 -65.16 -12.9 56.0 Favored 'General case' 0 CA--C 1.548 0.903 0 CA-C-N 114.236 -0.982 . . . . 0.0 110.363 176.951 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 108.07 18.46 9.86 Favored Glycine 0 CA--C 1.501 -0.827 0 CA-C-N 116.105 -0.498 . . . . 0.0 112.818 169.338 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.66 160.28 42.86 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 116.583 2.068 . . . . 0.0 116.583 -174.155 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 93.9 mmm -85.03 160.25 20.05 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.589 -0.732 . . . . 0.0 112.873 -176.398 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.447 ' HB2' HD13 ' A' ' 54' ' ' ILE . 13.3 tmtt? -63.86 -42.91 97.43 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 122.316 1.055 . . . . 0.0 112.412 176.64 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 13.1 t70 56.15 -139.85 0.92 Allowed 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 112.444 -2.162 . . . . 0.0 109.988 -174.916 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER 66.9 156.23 0.11 Allowed 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 116.001 1.852 . . . . 0.0 116.001 178.777 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 14.1 p -81.26 162.59 58.44 Favored Pre-proline 0 C--O 1.242 0.675 0 CA-C-N 114.462 -1.245 . . . . 0.0 110.678 -179.949 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -71.6 156.5 57.61 Favored 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 116.434 -1.911 . . . . 0.0 111.293 175.563 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 11.7 mtt180 -116.7 161.46 19.19 Favored 'General case' 0 CA--C 1.506 -0.737 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 178.251 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 62.3 m95 -123.18 125.98 46.13 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 179.919 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 11.3 m-85 -110.37 138.06 47.26 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 107.278 -1.378 . . . . 0.0 107.278 -176.742 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 79.7 t80 -85.25 133.8 34.16 Favored 'General case' 0 CA--C 1.509 -0.629 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 -177.248 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -141.47 135.49 30.31 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 -175.254 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 86.3 m-85 -73.73 159.54 32.82 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 -175.652 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 11.3 tp -57.02 126.55 27.68 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.312 0.577 . . . . 0.0 109.615 179.849 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 82.03 18.68 66.8 Favored Glycine 0 C--O 1.22 -0.751 0 N-CA-C 116.49 1.356 . . . . 0.0 116.49 178.041 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 16.7 p -89.72 146.07 24.76 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 119.331 1.566 . . . . 0.0 110.228 178.622 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 97.13 142.85 13.83 Favored Glycine 0 CA--C 1.528 0.891 0 N-CA-C 110.716 -0.953 . . . . 0.0 110.716 -177.461 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -71.34 -46.62 0.63 Allowed 'Trans proline' 0 C--N 1.35 0.614 0 CA-C-N 119.844 1.822 . . . . 0.0 116.481 -174.908 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 68.1 mt-10 -107.56 39.33 1.93 Allowed 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 106.269 -1.752 . . . . 0.0 106.269 -178.265 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -65.25 -43.52 91.07 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.499 -1.228 . . . . 0.0 109.603 -178.702 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 57.24 33.27 64.84 Favored Glycine 0 C--O 1.226 -0.375 0 CA-C-N 115.724 -0.671 . . . . 0.0 114.136 177.666 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.406 ' HA ' ' HD2' ' A' ' 82' ' ' PRO . 15.0 mt -124.21 103.84 32.56 Favored Pre-proline 0 N--CA 1.44 -0.968 0 N-CA-C 116.027 1.862 . . . . 0.0 116.027 -175.311 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.406 ' HD2' ' HA ' ' A' ' 81' ' ' LEU . 90.8 Cg_endo -78.47 162.21 27.9 Favored 'Trans proline' 0 N--CA 1.462 -0.357 0 C-N-CA 122.684 2.256 . . . . 0.0 107.165 166.962 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 59.1 t80 -61.44 132.56 53.86 Favored 'General case' 0 C--N 1.32 -0.712 0 C-N-CA 120.239 -0.584 . . . . 0.0 110.35 -177.499 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 91.4 -8.98 78.45 Favored Glycine 0 CA--C 1.519 0.324 0 N-CA-C 114.953 0.741 . . . . 0.0 114.953 179.296 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -66.35 131.54 46.33 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 118.676 1.238 . . . . 0.0 111.711 179.84 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 56.9 t30 -78.81 131.31 36.45 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.287 -179.724 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 32.7 tttt -156.22 156.77 34.7 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 106.807 -1.553 . . . . 0.0 106.807 -179.568 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -64.56 127.76 32.87 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.719 -0.475 . . . . 0.0 109.719 -178.129 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 67.41 33.02 80.74 Favored Glycine 0 N--CA 1.444 -0.778 0 N-CA-C 115.171 0.829 . . . . 0.0 115.171 176.8 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 41.0 mm -126.34 125.44 67.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 117.404 0.602 . . . . 0.0 110.132 179.067 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -127.41 112.45 28.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.202 177.278 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 98.6 m95 -78.02 137.29 38.19 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 113.371 0.878 . . . . 0.0 113.371 -177.681 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 14.0 m -139.45 149.75 22.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 177.843 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -160.7 164.17 31.87 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 104.299 -2.482 . . . . 0.0 104.299 179.385 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 14.1 t -124.08 174.58 7.53 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 105.668 -1.975 . . . . 0.0 105.668 178.48 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -65.99 132.28 48.21 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.992 0.425 . . . . 0.0 110.438 -178.752 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 92.59 -6.72 77.6 Favored Glycine 0 C--O 1.23 -0.154 0 CA-C-N 116.103 -0.498 . . . . 0.0 113.543 178.997 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.453 ' HB1' ' HB ' ' A' ' 44' ' ' ILE . . . -74.8 138.88 42.9 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 178.681 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 40.2 mt -94.6 139.01 31.76 Favored 'General case' 0 C--O 1.222 -0.39 0 N-CA-C 113.442 0.905 . . . . 0.0 113.442 -177.053 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 74.0 m-20 -83.18 62.08 6.44 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.869 -178.782 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -135.39 154.33 78.49 Favored Pre-proline 0 C--N 1.32 -0.692 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 -179.495 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -68.39 150.68 76.06 Favored 'Trans proline' 0 C--N 1.342 0.191 0 N-CA-C 114.476 0.914 . . . . 0.0 114.476 178.699 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -149.27 59.39 1.03 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 122.94 1.352 . . . . 0.0 110.988 178.006 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 14.0 p-10 -58.61 -30.43 67.24 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 113.694 -1.594 . . . . 0.0 110.206 176.894 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 23.0 p-80 -59.77 -14.66 15.54 Favored 'General case' 0 C--O 1.222 -0.366 0 N-CA-C 114.214 1.19 . . . . 0.0 114.214 -179.272 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 51.9 mt -90.33 -48.51 14.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 177.846 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -71.69 14.37 1.99 Allowed Glycine 0 C--O 1.219 -0.823 0 N-CA-C 116.094 1.197 . . . . 0.0 116.094 -176.271 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 13.8 t -90.95 19.88 5.28 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 117.596 0.698 . . . . 0.0 111.947 179.987 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.435 ' HD2' HD22 ' A' ' 114' ' ' ASN . 65.6 ttp85 -57.47 135.11 56.57 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 178.988 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -105.11 136.21 19.21 Favored Pre-proline 0 C--N 1.323 -0.559 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 178.515 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -73.96 -17.96 21.93 Favored 'Trans proline' 0 C--O 1.219 -0.464 0 O-C-N 121.967 0.456 . . . . 0.0 113.148 -179.885 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -80.07 -24.61 40.52 Favored 'General case' 0 C--O 1.221 -0.409 0 CA-C-O 121.148 0.499 . . . . 0.0 110.271 178.938 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 88.4 m-20 -99.4 -22.37 15.57 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 113.464 0.913 . . . . 0.0 113.464 -175.32 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.435 HD22 ' HD2' ' A' ' 109' ' ' ARG . 20.4 t30 -158.7 149.72 20.4 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.135 0.42 . . . . 0.0 112.135 -178.659 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -85.34 145.29 27.57 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-O 121.427 0.632 . . . . 0.0 111.872 179.68 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -69.6 148.1 49.82 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.17 0.51 . . . . 0.0 110.544 178.361 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 17.4 mt -89.42 138.99 18.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 -179.045 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 79.7 t -62.81 124.92 18.3 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 N-CA-C 106.088 -1.819 . . . . 0.0 106.088 174.259 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.466 HD22 HD21 ' A' ' 16' ' ' LEU . 7.2 tt -67.55 130.61 43.59 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 -177.782 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -135.0 154.11 51.85 Favored 'General case' 0 CA--C 1.51 -0.591 0 N-CA-C 106.135 -1.802 . . . . 0.0 106.135 -179.152 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 13.1 mt -108.56 147.34 35.54 Favored Pre-proline 0 C--N 1.321 -0.673 0 CA-C-O 120.574 0.226 . . . . 0.0 110.732 177.15 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -73.34 163.91 36.58 Favored 'Trans proline' 0 C--O 1.236 0.401 0 C-N-CA 118.371 -0.62 . . . . 0.0 113.378 -179.873 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 39.4 tt0 -53.87 129.22 33.04 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.274 -0.876 . . . . 0.0 109.09 178.999 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 108.65 -26.89 14.65 Favored Glycine 0 C--O 1.225 -0.408 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.911 -178.681 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 5.0 m -108.56 132.28 54.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 118.012 0.906 . . . . 0.0 111.545 178.499 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 2.8 p -121.14 148.18 44.56 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 177.3 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 75.9 mt -70.02 153.59 95.27 Favored Pre-proline 0 C--N 1.323 -0.566 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 177.739 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -74.1 168.82 23.88 Favored 'Trans proline' 0 C--O 1.235 0.354 0 N-CA-C 110.714 -0.533 . . . . 0.0 110.714 179.176 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -60.17 125.81 25.09 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.988 0.423 . . . . 0.0 111.49 -175.268 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 94.95 -2.9 66.73 Favored Glycine 0 C--O 1.227 -0.307 0 N-CA-C 115.131 0.813 . . . . 0.0 115.131 178.444 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -102.89 138.91 39.15 Favored 'General case' 0 N--CA 1.441 -0.911 0 CA-C-O 122.175 0.988 . . . . 0.0 110.39 -179.899 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 45.9 p90 -141.81 159.88 41.32 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 113.989 -1.46 . . . . 0.0 107.656 175.846 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -98.89 150.65 21.69 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 -179.505 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.466 ' HB3' ' HB ' ' A' ' 14' ' ' THR . 2.9 tp10 -73.17 129.03 37.16 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 106.77 -1.567 . . . . 0.0 106.77 179.74 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 89.03 -2.92 84.41 Favored Glycine 0 C--O 1.227 -0.318 0 C-N-CA 121.341 -0.457 . . . . 0.0 112.183 -177.615 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 46.4 t -118.0 165.65 13.48 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 178.218 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 49.4 mtm180 -84.97 -16.86 39.48 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.498 0.666 . . . . 0.0 109.478 177.584 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 104.04 175.18 25.52 Favored Glycine 0 C--N 1.319 -0.413 0 N-CA-C 107.153 -2.379 . . . . 0.0 107.153 -176.179 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 81.03 50.07 5.32 Favored Glycine 0 C--O 1.228 -0.271 0 N-CA-C 109.326 -1.51 . . . . 0.0 109.326 -176.025 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 62.5 m . . . . . 0 N--CA 1.48 1.06 0 C-N-CA 125.977 1.711 . . . . 0.0 110.845 -177.45 . . . . . . . . 0 0 . 1 . 037 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.46 0 CA-C-O 119.016 -0.88 . . . . 0.0 111.193 . . . . . . . . . 0 0 . 1 . 037 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -143.67 162.82 34.96 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 117.979 0.889 . . . . 0.0 109.816 -177.301 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 21.7 ttt -141.23 172.34 12.81 Favored 'General case' 0 C--N 1.321 -0.645 1 N-CA-C 98.627 -4.583 . . . . 0.0 98.627 177.989 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 90.41 67.02 1.2 Allowed Glycine 0 C--N 1.316 -0.57 0 C-N-CA 120.734 -0.746 . . . . 0.0 111.855 -175.08 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 10.2 mp -97.68 142.05 23.95 Favored Pre-proline 0 C--N 1.325 -0.46 0 N-CA-C 106.784 -1.561 . . . . 0.0 106.784 179.178 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -74.5 152.24 43.21 Favored 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 117.664 -1.091 . . . . 0.0 113.418 -179.233 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 36.4 t30 -151.6 -59.33 0.16 Allowed 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.653 177.691 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -88.26 -3.61 58.83 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 120.983 0.421 . . . . 0.0 111.375 -177.914 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 16.8 p -133.48 118.51 18.42 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 106.102 -1.814 . . . . 0.0 106.102 -178.311 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -108.55 146.69 32.88 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.252 0.549 . . . . 0.0 109.664 -178.398 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 53.2 p -64.97 144.27 57.4 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 178.303 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 6.3 m95 -66.31 -26.3 67.25 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 111.959 0.355 . . . . 0.0 111.959 177.86 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 32.1 m-85 -121.72 159.15 27.19 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.361 -171.851 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 45.4 p -68.22 166.75 15.68 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.266 -0.879 . . . . 0.0 111.271 -178.246 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -85.38 127.2 34.28 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 113.695 0.998 . . . . 0.0 113.695 -175.513 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 22.6 mt -67.76 147.93 51.93 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 105.332 -2.099 . . . . 0.0 105.332 172.763 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 34.6 m -123.69 133.0 53.96 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 -178.733 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -94.48 140.94 29.18 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 114.266 1.21 . . . . 0.0 114.266 -176.43 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 57.3 t60 -138.82 100.1 3.97 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 105.673 -1.973 . . . . 0.0 105.673 166.04 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 166.3 -153.83 23.95 Favored Glycine 0 C--O 1.224 -0.503 0 C-N-CA 120.844 -0.693 . . . . 0.0 111.537 -177.756 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 40.2 mtpt -117.43 -21.73 8.52 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 113.556 0.947 . . . . 0.0 113.556 -179.42 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -76.1 156.74 33.57 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 178.369 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -73.75 -62.41 1.5 Allowed 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 179.776 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 35.4 tp 171.3 142.24 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 103.418 -2.808 . . . . 0.0 103.418 174.169 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 52.7 tptt -151.78 134.72 15.71 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 118.424 0.556 . . . . 0.0 111.281 174.823 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -123.02 149.13 56.14 Favored Pre-proline 0 C--O 1.243 0.74 0 N-CA-C 108.42 -0.955 . . . . 0.0 108.42 174.152 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -77.39 167.68 24.12 Favored 'Trans proline' 0 CA--C 1.537 0.653 0 C-N-CA 120.906 1.071 . . . . 0.0 113.671 179.268 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 71.3 ttt180 -67.96 137.65 55.32 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.759 -178.871 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 85.93 -0.11 87.61 Favored Glycine 0 C--O 1.224 -0.487 0 N-CA-C 111.562 -0.615 . . . . 0.0 111.562 178.336 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 -140.52 -179.48 6.04 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 -176.288 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 101.15 -29.14 13.15 Favored Glycine 0 CA--C 1.501 -0.842 0 CA-C-N 115.732 -0.667 . . . . 0.0 112.866 175.613 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 98.5 t -66.1 127.39 93.17 Favored Pre-proline 0 C--N 1.322 -0.621 0 N-CA-C 105.456 -2.053 . . . . 0.0 105.456 176.867 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -71.46 167.4 26.45 Favored 'Trans proline' 0 N--CA 1.461 -0.44 0 C-N-CA 120.329 0.686 . . . . 0.0 111.955 179.543 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 95.7 mt -63.36 121.32 12.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 106.227 -1.768 . . . . 0.0 106.227 179.481 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 43.3 t-20 -116.93 122.65 44.89 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.287 -0.87 . . . . 0.0 110.881 -173.913 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 73.4 p -103.03 -11.88 17.83 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.393 -0.821 . . . . 0.0 112.716 -177.475 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 17.5 p30 -114.24 15.99 18.04 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 116.324 1.972 . . . . 0.0 116.324 -173.063 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 29.0 m -141.83 154.31 45.09 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 113.742 1.015 . . . . 0.0 113.742 -177.694 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 18.6 m -72.44 164.45 59.6 Favored Pre-proline 0 C--O 1.238 0.464 0 CA-C-N 115.331 -0.85 . . . . 0.0 109.014 176.696 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -64.3 -28.44 63.68 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 115.4 -2.6 . . . . 0.0 112.46 178.918 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -62.65 -24.21 67.5 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 123.735 0.814 . . . . 0.0 111.613 177.643 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.445 ' HA ' ' HE3' ' A' ' 103' ' ' LYS . 33.4 m-20 -99.81 -2.49 34.92 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 114.75 1.389 . . . . 0.0 114.75 -171.622 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 96.9 mm-40 -60.46 -37.79 82.11 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 115.937 1.828 . . . . 0.0 115.937 -179.992 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 15.7 tt -59.33 138.3 20.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-O 122.313 1.054 . . . . 0.0 112.59 -176.965 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -178.77 -152.34 10.36 Favored Glycine 0 C--O 1.226 -0.383 0 CA-C-N 115.338 -0.847 . . . . 0.0 111.964 -174.862 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 47.8 p90 -154.7 173.59 16.18 Favored 'General case' 0 C--N 1.321 -0.636 0 O-C-N 122.379 -0.483 . . . . 0.0 110.448 -179.33 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -113.98 140.12 48.68 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 171.29 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -105.73 119.33 38.86 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 124.192 0.997 . . . . 0.0 109.69 -178.348 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -70.89 133.18 46.24 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 175.556 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -143.93 154.79 43.68 Favored 'General case' 0 C--N 1.321 -0.654 0 C-N-CA 122.814 0.445 . . . . 0.0 110.175 -177.441 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 15.2 t -156.68 166.98 31.84 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 174.975 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.7 tpt85 -160.29 153.81 22.33 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 103.421 -2.807 . . . . 0.0 103.421 179.475 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 21.8 ttm180 -131.37 146.07 52.12 Favored 'General case' 0 CA--C 1.495 -1.168 0 CA-C-N 118.804 0.729 . . . . 0.0 111.908 179.387 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -142.67 177.71 2.65 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 N-CA-C 104.823 -2.288 . . . . 0.0 104.823 179.205 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 7.1 tmm_? -128.09 103.05 7.0 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 104.999 -2.223 . . . . 0.0 104.999 174.852 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -70.49 154.89 52.76 Favored Glycine 0 C--O 1.22 -0.776 0 N-CA-C 110.731 -0.947 . . . . 0.0 110.731 -176.55 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -67.45 -34.8 85.69 Favored Glycine 0 C--O 1.215 -1.051 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 -179.817 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.1 t0 -94.24 16.91 13.71 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-O 122.483 1.135 . . . . 0.0 109.532 178.416 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 86.42 -17.53 38.35 Favored Glycine 0 C--O 1.225 -0.41 0 N-CA-C 116.225 1.25 . . . . 0.0 116.225 173.801 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -58.9 135.51 57.58 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 122.286 1.041 . . . . 0.0 113.319 -177.314 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 79.3 mtp -113.63 -175.76 2.75 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 113.472 -1.695 . . . . 0.0 111.728 -177.416 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 12.2 mptt -130.29 -41.98 1.22 Allowed 'General case' 0 N--CA 1.476 0.831 0 CA-C-O 122.641 1.21 . . . . 0.0 111.674 -178.984 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 15.7 t0 -61.02 -177.6 0.08 Allowed 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 111.657 -2.52 . . . . 0.0 113.456 179.014 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER 81.02 -52.41 0.3 Allowed 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 126.952 2.101 . . . . 0.0 110.162 -179.206 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 37.9 t -83.81 113.71 49.24 Favored Pre-proline 0 C--N 1.321 -0.662 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 175.459 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -73.45 150.01 45.53 Favored 'Trans proline' 0 C--O 1.239 0.565 0 C-N-CA 114.803 -2.998 . . . . 0.0 111.062 177.94 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 36.6 mtp180 -120.08 157.79 28.21 Favored 'General case' 0 CA--C 1.503 -0.855 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 -179.45 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 77.3 m95 -128.78 126.8 40.69 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 120.77 0.319 . . . . 0.0 110.874 -179.088 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 13.2 m-85 -110.52 134.25 52.54 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 106.769 -1.567 . . . . 0.0 106.769 -177.501 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 88.4 t80 -83.66 134.21 34.79 Favored 'General case' 0 CA--C 1.508 -0.661 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 -178.139 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -139.67 145.49 38.48 Favored 'General case' 0 N--CA 1.44 -0.935 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 -175.899 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 76.9 m-85 -83.12 159.55 22.06 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.937 -172.971 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -56.48 126.63 27.33 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 179.462 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 78.96 26.8 57.63 Favored Glycine 0 C--O 1.223 -0.559 0 N-CA-C 115.908 1.123 . . . . 0.0 115.908 178.224 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 22.2 p -102.82 146.21 28.62 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 118.829 1.314 . . . . 0.0 109.746 177.201 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 103.78 137.62 9.42 Favored Glycine 0 CA--C 1.527 0.821 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.824 -179.912 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -73.1 -38.4 2.82 Favored 'Trans proline' 0 C--N 1.349 0.586 0 CA-C-N 119.446 1.623 . . . . 0.0 116.229 -175.117 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -103.82 17.57 23.82 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 -176.968 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -65.28 -55.47 18.14 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.204 -176.241 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 55.94 34.06 61.19 Favored Glycine 0 C--O 1.225 -0.449 0 C-N-CA 121.302 -0.475 . . . . 0.0 112.32 -179.402 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 18.5 mt -112.61 103.83 55.68 Favored Pre-proline 0 N--CA 1.447 -0.588 0 N-CA-C 116.628 2.084 . . . . 0.0 116.628 -174.002 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -78.63 163.1 26.94 Favored 'Trans proline' 0 N--CA 1.461 -0.386 0 C-N-CA 122.305 2.004 . . . . 0.0 107.732 167.898 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.407 ' CE1' ' HB3' ' A' ' 92' ' ' TRP . 65.9 t80 -61.9 132.06 51.78 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 120.307 -0.557 . . . . 0.0 110.651 -177.005 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 92.1 -9.21 76.91 Favored Glycine 0 C--O 1.228 -0.277 0 CA-C-O 119.595 -0.559 . . . . 0.0 114.359 179.092 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -65.01 130.71 44.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 118.256 1.028 . . . . 0.0 111.39 179.403 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 57.0 t30 -79.36 130.75 35.74 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.413 -179.246 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 26.9 ttmt -154.84 150.71 27.77 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 178.454 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 32.1 t0 -64.4 120.78 12.89 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.284 0.564 . . . . 0.0 110.402 -178.047 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 78.41 29.76 51.92 Favored Glycine 0 N--CA 1.451 -0.309 0 CA-C-N 115.437 -0.802 . . . . 0.0 114.506 179.471 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 41.6 mm -127.06 126.38 68.09 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 CA-C-N 117.612 0.706 . . . . 0.0 110.712 179.099 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -127.16 116.04 42.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 CA-C-O 121.478 0.656 . . . . 0.0 111.381 176.337 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . 0.407 ' HB3' ' CE1' ' A' ' 83' ' ' TYR . 96.7 m95 -79.91 138.48 37.14 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -178.326 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 16.1 m -138.29 153.23 26.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 179.15 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -160.1 165.92 30.84 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 107.073 -1.454 . . . . 0.0 107.073 -178.407 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 14.0 t -133.05 165.97 23.49 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 105.007 -2.22 . . . . 0.0 105.007 176.205 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 61.0 tt0 -67.41 138.18 56.5 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.096 0.474 . . . . 0.0 110.163 -179.06 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 94.97 -8.53 70.33 Favored Glycine 0 C--O 1.225 -0.432 0 CA-C-N 115.853 -0.612 . . . . 0.0 112.999 178.756 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -81.3 143.0 32.55 Favored 'General case' 0 C--N 1.323 -0.543 0 O-C-N 122.543 -0.386 . . . . 0.0 110.364 178.878 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 38.7 mt -100.53 134.76 43.0 Favored 'General case' 0 CA--C 1.514 -0.404 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -178.409 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -78.55 48.07 0.76 Allowed 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 115.184 -0.916 . . . . 0.0 112.049 -177.248 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 1.4 t -114.91 154.85 46.98 Favored Pre-proline 0 C--N 1.32 -0.717 0 N-CA-C 105.366 -2.087 . . . . 0.0 105.366 -179.98 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -64.97 149.01 90.03 Favored 'Trans proline' 0 C--N 1.342 0.197 0 N-CA-C 113.636 0.591 . . . . 0.0 113.636 176.802 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.445 ' HE3' ' HA ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -143.99 54.96 1.3 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 123.551 1.644 . . . . 0.0 109.603 178.616 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -58.32 -30.66 66.86 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 113.128 -1.851 . . . . 0.0 111.456 178.501 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 29.4 p-80 -57.08 -16.65 7.89 Favored 'General case' 0 C--O 1.222 -0.389 0 N-CA-C 115.026 1.491 . . . . 0.0 115.026 -178.422 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 4.4 mt -92.02 -21.01 6.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 121.256 0.55 . . . . 0.0 110.515 -179.946 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -77.11 3.0 59.32 Favored Glycine 0 C--O 1.225 -0.413 0 C-N-CA 120.806 -0.711 . . . . 0.0 113.81 -177.692 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 9.9 t -83.34 11.33 6.9 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 114.235 1.198 . . . . 0.0 114.235 -176.588 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 66.9 ttp85 -59.69 126.09 26.22 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 107.794 -1.188 . . . . 0.0 107.794 178.417 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -97.45 137.38 21.1 Favored Pre-proline 0 C--N 1.322 -0.623 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 178.574 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -74.68 -20.27 17.84 Favored 'Trans proline' 0 C--O 1.219 -0.458 0 N-CA-C 113.815 0.66 . . . . 0.0 113.815 179.999 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -81.6 -24.87 36.18 Favored 'General case' 0 C--O 1.221 -0.408 0 CA-C-O 121.116 0.484 . . . . 0.0 110.145 179.919 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 87.4 m-20 -97.32 -22.27 16.74 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 113.503 0.927 . . . . 0.0 113.503 -175.266 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 24.4 t30 -157.22 151.35 24.82 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 112.315 0.487 . . . . 0.0 112.315 -178.005 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -89.08 146.19 24.98 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-O 121.433 0.635 . . . . 0.0 111.435 179.196 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -70.75 149.06 47.29 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.348 0.594 . . . . 0.0 110.923 178.713 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 22.7 mt -81.21 137.88 20.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 179.864 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 87.7 t -61.35 121.09 8.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 106.679 -1.6 . . . . 0.0 106.679 175.109 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 6.1 tt -67.39 125.53 26.41 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.074 0.464 . . . . 0.0 110.075 -176.985 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -134.46 159.12 42.09 Favored 'General case' 0 CA--C 1.508 -0.643 0 N-CA-C 106.491 -1.67 . . . . 0.0 106.491 -179.169 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 13.6 mt -112.97 148.31 39.12 Favored Pre-proline 0 C--N 1.32 -0.713 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 178.501 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -73.17 163.75 37.23 Favored 'Trans proline' 0 C--O 1.236 0.425 0 C-N-CA 118.254 -0.698 . . . . 0.0 112.836 -179.933 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 39.0 tt0 -54.6 129.55 36.82 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 179.403 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 108.83 -27.82 12.45 Favored Glycine 0 C--O 1.225 -0.416 0 CA-C-N 115.853 -0.612 . . . . 0.0 112.08 -178.461 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 4.3 m -105.6 129.29 53.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 118.128 0.964 . . . . 0.0 111.507 178.54 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 3.3 p -116.97 148.28 41.56 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.809 179.35 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 89.5 mt -73.2 151.43 90.16 Favored Pre-proline 0 C--N 1.323 -0.552 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 177.987 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -78.49 -172.04 1.4 Allowed 'Trans proline' 0 C--O 1.238 0.52 0 C-N-CA 121.061 1.174 . . . . 0.0 112.346 179.396 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 7.8 tmtt? -55.15 120.71 7.41 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 114.235 1.198 . . . . 0.0 114.235 -171.893 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 66.36 22.79 71.41 Favored Glycine 0 C--O 1.224 -0.494 0 CA-C-N 114.888 -1.051 . . . . 0.0 115.522 173.703 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -99.84 134.41 42.78 Favored 'General case' 0 N--CA 1.439 -0.977 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 177.774 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 42.5 p90 -139.8 161.27 37.97 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.051 -0.977 . . . . 0.0 108.711 178.392 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -98.08 144.93 27.05 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.727 0.775 . . . . 0.0 112.508 -176.716 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -78.29 139.24 38.87 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 106.566 -1.642 . . . . 0.0 106.566 176.212 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 91.75 -5.04 79.55 Favored Glycine 0 C--O 1.224 -0.471 0 C-N-CA 120.956 -0.64 . . . . 0.0 111.887 -178.355 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 21.9 t -82.51 174.81 10.73 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 105.635 -1.987 . . . . 0.0 105.635 175.948 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.02 100.42 1.99 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.135 0.493 . . . . 0.0 110.676 -178.264 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -167.24 -179.52 40.23 Favored Glycine 0 N--CA 1.45 -0.373 0 N-CA-C 107.649 -2.181 . . . . 0.0 107.649 179.679 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 71.18 16.99 75.49 Favored Glycine 0 C--O 1.227 -0.313 0 N-CA-C 110.875 -0.89 . . . . 0.0 110.875 -179.234 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 4.7 p . . . . . 0 C--O 1.257 1.477 0 N-CA-C 102.411 -3.181 . . . . 0.0 102.411 -177.39 . . . . . . . . 0 0 . 1 . 038 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 2.017 0 CA-C-O 119.028 -0.873 . . . . 0.0 111.469 . . . . . . . . . 0 0 . 1 . 038 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -62.38 135.54 57.5 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 177.596 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 86.9 mtp 57.39 10.72 0.99 Allowed 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 114.057 1.132 . . . . 0.0 114.057 -177.46 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -130.45 59.46 0.69 Allowed Glycine 0 CA--C 1.509 -0.313 0 N-CA-C 107.766 -2.133 . . . . 0.0 107.766 -179.032 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 10.7 mp -85.06 158.56 58.41 Favored Pre-proline 0 C--N 1.32 -0.679 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 -177.817 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -67.23 -15.58 46.41 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 117.184 -1.411 . . . . 0.0 111.79 176.214 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 9.2 m120 -72.91 1.9 7.86 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 123.53 0.732 . . . . 0.0 112.121 178.622 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 9.6 m-20 -81.43 11.01 4.85 Favored 'General case' 0 C--O 1.217 -0.609 0 C-N-CA 122.448 0.299 . . . . 0.0 110.321 177.774 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 58.8 p -120.75 114.87 22.26 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-O 122.272 1.034 . . . . 0.0 108.467 -177.973 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -143.26 155.06 44.4 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 114.227 -1.351 . . . . 0.0 110.017 -179.828 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -61.24 137.41 58.24 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 178.246 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 9.8 m95 -68.81 -27.01 65.47 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 113.151 0.797 . . . . 0.0 113.151 -179.851 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 54.5 m-85 -121.65 163.4 19.05 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 113.342 0.868 . . . . 0.0 113.342 -170.321 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 59.7 p -68.25 167.29 14.64 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 114.51 -1.223 . . . . 0.0 108.327 177.49 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -78.53 152.53 31.91 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 122.346 1.069 . . . . 0.0 112.803 -177.207 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.42 HD23 ' HA ' ' A' ' 16' ' ' LEU . 14.9 mt -91.98 142.26 27.73 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 102.383 -3.191 . . . . 0.0 102.383 167.527 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 33.1 m -124.71 140.01 53.33 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 -176.806 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.461 ' HB2' ' CZ ' ' A' ' 131' ' ' PHE . 4.9 tp60 -120.76 146.0 46.95 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 116.095 1.887 . . . . 0.0 116.095 -172.725 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 78.2 t60 -133.14 99.47 4.56 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 106.811 -1.551 . . . . 0.0 106.811 169.706 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 178.03 -164.58 33.51 Favored Glycine 0 C--O 1.227 -0.294 0 N-CA-C 109.008 -1.637 . . . . 0.0 109.008 -177.722 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -99.79 -25.0 14.51 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 177.905 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -77.52 152.39 34.12 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 114.279 -1.328 . . . . 0.0 109.617 -179.897 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -88.97 -62.44 1.48 Allowed 'General case' 0 C--O 1.212 -0.891 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 178.095 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 45.0 tp -174.93 141.29 0.59 Allowed 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 174.699 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 9.8 tmtt? -156.94 131.58 8.74 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 176.193 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -120.73 153.63 56.94 Favored Pre-proline 0 CA--C 1.543 0.69 0 N-CA-C 111.517 0.191 . . . . 0.0 111.517 177.171 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_endo -78.39 164.18 26.65 Favored 'Trans proline' 0 CA--C 1.542 0.91 0 C-N-CA 120.695 0.93 . . . . 0.0 112.965 176.571 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 1.6 tmt_? -70.75 139.15 51.01 Favored 'General case' 0 N--CA 1.475 0.786 0 O-C-N 122.261 -0.275 . . . . 0.0 110.424 -178.753 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 85.31 4.27 86.33 Favored Glycine 0 C--O 1.223 -0.551 0 N-CA-C 110.851 -0.9 . . . . 0.0 110.851 177.66 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 38.5 mt-30 -147.16 -179.86 7.12 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 -174.257 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 97.48 -28.35 14.57 Favored Glycine 0 CA--C 1.499 -0.943 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.816 175.543 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 94.6 t -64.4 127.9 92.71 Favored Pre-proline 0 C--N 1.321 -0.642 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 177.1 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -73.76 170.72 19.37 Favored 'Trans proline' 0 N--CA 1.461 -0.431 0 O-C-N 122.236 0.598 . . . . 0.0 111.793 178.902 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 94.6 mt -68.07 112.7 3.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 178.784 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 80.5 m-20 -104.12 93.42 4.83 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 114.68 -1.145 . . . . 0.0 110.303 -176.855 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 67.4 p -69.39 -16.79 63.59 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.584 -0.734 . . . . 0.0 112.281 -179.032 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 10.9 p30 -106.92 22.76 15.46 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.057 -0.974 . . . . 0.0 113.227 -177.006 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 16.3 m -139.5 147.02 40.7 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 116.742 2.127 . . . . 0.0 116.742 -175.242 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 2.0 m -71.34 166.55 37.87 Favored Pre-proline 0 N--CA 1.468 0.431 0 CA-C-N 114.706 -1.133 . . . . 0.0 109.658 175.228 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -66.65 -27.97 44.89 Favored 'Trans proline' 0 CA--C 1.536 0.613 0 C-N-CA 114.238 -3.375 . . . . 0.0 113.922 -179.796 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.458 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 3.1 p-10 -75.28 -20.64 59.03 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.871 0.843 . . . . 0.0 110.944 178.057 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -83.49 -11.43 57.48 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 114.09 1.144 . . . . 0.0 114.09 -173.747 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 97.5 mm-40 -56.69 -29.79 62.75 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 115.512 1.671 . . . . 0.0 115.512 -177.03 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 12.0 tt -56.79 139.57 16.13 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.007 0 N-CA-C 114.385 1.254 . . . . 0.0 114.385 -176.948 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -177.31 -157.4 18.18 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.619 -0.8 . . . . 0.0 113.428 -178.413 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 41.4 p90 -154.66 170.53 21.33 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 179.766 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 23.5 m-85 -113.68 142.03 46.51 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 173.546 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 59.8 ttt180 -113.57 120.02 39.51 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 114.96 -1.018 . . . . 0.0 110.888 -175.455 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 3.6 ttt180 -63.06 140.95 58.93 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 123.184 0.594 . . . . 0.0 109.488 176.985 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -144.48 128.96 18.01 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.804 0.335 . . . . 0.0 110.173 177.442 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -158.79 134.17 8.58 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.129 178.574 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 18.5 tpt180 -145.94 123.74 11.94 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.479 0.657 . . . . 0.0 110.929 174.438 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 9.2 ttp180 -113.08 141.44 46.88 Favored 'General case' 0 CA--C 1.489 -1.394 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.423 178.495 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -131.56 177.77 6.53 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 N-CA-C 106.442 -1.688 . . . . 0.0 106.442 178.111 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 17.0 ttt85 -138.39 112.28 8.42 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 106.193 -1.781 . . . . 0.0 106.193 178.505 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -150.78 175.5 29.74 Favored Glycine 0 N--CA 1.444 -0.772 0 N-CA-C 107.145 -2.382 . . . . 0.0 107.145 178.395 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -75.25 -59.31 3.64 Favored Glycine 0 C--O 1.222 -0.624 0 N-CA-C 108.238 -1.945 . . . . 0.0 108.238 178.251 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.501 ' C ' ' H ' ' A' ' 60' ' ' LYS . 0.7 OUTLIER -94.26 -3.19 51.09 Favored 'General case' 0 C--O 1.217 -0.634 0 N-CA-C 105.207 -2.146 . . . . 0.0 105.207 174.266 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -89.53 33.89 4.21 Favored Glycine 0 N--CA 1.451 -0.314 0 N-CA-C 106.088 -2.805 . . . . 0.0 106.088 173.243 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.501 ' H ' ' C ' ' A' ' 58' ' ' ASP . 1.3 pttt -50.67 167.55 0.06 Allowed 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 113.415 -1.393 . . . . 0.0 111.028 172.268 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -46.69 129.59 11.31 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 113.926 -1.488 . . . . 0.0 113.698 -175.745 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -98.52 -73.99 0.6 Allowed 'General case' 0 C--O 1.219 -0.543 0 CA-C-N 113.666 -1.606 . . . . 0.0 114.044 -174.866 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 73.6 m-20 -95.06 96.66 9.4 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 179.349 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -74.58 -40.85 61.37 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 179.147 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 4.5 p -112.23 152.82 44.73 Favored Pre-proline 0 C--O 1.24 0.6 0 CA-C-N 114.962 -1.017 . . . . 0.0 108.985 179.723 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -74.34 156.68 45.96 Favored 'Trans proline' 0 C--O 1.238 0.497 0 C-N-CA 117.108 -1.461 . . . . 0.0 112.6 178.174 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 58.1 mtt-85 -124.58 149.87 46.55 Favored 'General case' 0 CA--C 1.513 -0.449 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.677 -179.657 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 35.0 m95 -134.75 129.82 35.24 Favored 'General case' 0 C--O 1.216 -0.662 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 175.565 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 60.0 m-85 -110.48 156.38 20.94 Favored 'General case' 0 C--O 1.212 -0.91 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 -178.96 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -97.97 136.91 37.57 Favored 'General case' 0 CA--C 1.509 -0.608 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 -179.84 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -139.12 130.31 26.73 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 107.097 -1.446 . . . . 0.0 107.097 -175.846 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 86.1 m-85 -70.69 159.47 34.4 Favored 'General case' 0 C--N 1.319 -0.756 0 O-C-N 122.191 -0.318 . . . . 0.0 111.063 -178.009 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -49.01 121.59 4.93 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 113.496 0.925 . . . . 0.0 113.496 -175.973 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 70.32 21.53 77.36 Favored Glycine 0 C--O 1.224 -0.529 0 N-CA-C 116.44 1.336 . . . . 0.0 116.44 176.009 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 34.2 p -89.37 146.38 24.72 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 118.604 1.202 . . . . 0.0 111.648 -179.742 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 108.68 144.53 10.93 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 108.296 -1.922 . . . . 0.0 108.296 -176.163 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -73.15 -34.51 6.14 Favored 'Trans proline' 0 CA--C 1.518 -0.307 0 CA-C-N 119.792 1.796 . . . . 0.0 115.164 -175.731 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -97.78 14.0 28.51 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 114.771 -1.104 . . . . 0.0 109.435 -177.216 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -54.17 -55.48 27.45 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 -171.03 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 54.66 33.86 55.44 Favored Glycine 0 C--O 1.226 -0.357 0 C-N-CA 121.194 -0.527 . . . . 0.0 113.044 178.898 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 14.7 mt -126.68 103.86 24.37 Favored Pre-proline 0 N--CA 1.444 -0.775 0 N-CA-C 115.412 1.634 . . . . 0.0 115.412 -174.225 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -77.62 161.77 30.72 Favored 'Trans proline' 0 N--CA 1.461 -0.401 0 C-N-CA 122.061 1.84 . . . . 0.0 107.404 168.501 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 57.6 t80 -61.12 131.86 51.87 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 120.379 -0.529 . . . . 0.0 110.395 -177.177 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 92.98 -11.97 70.94 Favored Glycine 0 C--O 1.225 -0.432 0 CA-C-O 119.399 -0.667 . . . . 0.0 114.41 179.409 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -65.1 130.37 43.09 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 118.497 1.149 . . . . 0.0 112.071 -179.51 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 30.9 m120 -77.72 132.64 38.24 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 114.563 -1.199 . . . . 0.0 110.146 179.724 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 30.6 ttmt -156.21 155.35 32.26 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 104.148 -2.538 . . . . 0.0 104.148 177.795 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -65.75 133.22 50.57 Favored 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 120.273 -0.571 . . . . 0.0 109.672 -179.03 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 69.06 28.53 72.85 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.772 -0.728 . . . . 0.0 114.794 177.572 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 46.4 mm -126.01 126.6 70.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 117.476 0.638 . . . . 0.0 110.548 179.725 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -129.24 123.11 57.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.565 177.023 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 96.9 m95 -87.78 138.7 31.23 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 -176.758 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 13.7 m -138.02 151.49 25.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 179.102 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -160.29 165.86 30.57 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 104.833 -2.284 . . . . 0.0 104.833 -179.973 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 14.1 t -127.09 170.78 11.99 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 105.237 -2.135 . . . . 0.0 105.237 178.479 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -66.07 133.55 50.99 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.088 0.471 . . . . 0.0 110.651 -178.635 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 92.69 -7.5 77.21 Favored Glycine 0 N--CA 1.459 0.172 0 CA-C-N 116.017 -0.538 . . . . 0.0 113.422 178.749 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.458 ' HA ' ' HA ' ' A' ' 41' ' ' ASP . . . -74.63 140.49 44.33 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 178.504 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 39.6 mt -99.27 138.03 36.95 Favored 'General case' 0 CA--C 1.515 -0.385 0 N-CA-C 113.398 0.888 . . . . 0.0 113.398 -177.763 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -81.4 66.55 6.99 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.438 -178.751 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 1.2 t -133.11 155.36 81.1 Favored Pre-proline 0 C--N 1.32 -0.697 0 N-CA-C 105.327 -2.101 . . . . 0.0 105.327 -179.5 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -61.17 147.82 94.57 Favored 'Trans proline' 0 C--N 1.343 0.253 0 N-CA-C 114.614 0.967 . . . . 0.0 114.614 -179.603 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.522 ' HB3' HD12 ' A' ' 106' ' ' ILE . 74.1 mmtt -121.39 38.17 4.16 Favored 'General case' 0 CA--C 1.508 -0.643 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.332 -179.402 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 16.7 p-10 -59.9 -33.62 72.1 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 176.514 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 7.9 p80 -62.79 -16.19 56.94 Favored 'General case' 0 C--O 1.221 -0.411 0 N-CA-C 113.158 0.799 . . . . 0.0 113.158 177.973 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.522 HD12 ' HB3' ' A' ' 103' ' ' LYS . 60.2 mt -95.93 -49.96 11.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 120.977 0.418 . . . . 0.0 110.896 178.281 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -71.02 14.19 1.63 Allowed Glycine 0 C--O 1.22 -0.741 0 N-CA-C 117.53 1.772 . . . . 0.0 117.53 -174.124 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 9.0 t -83.59 26.43 0.68 Allowed 'General case' 0 CA--C 1.551 0.988 0 CA-C-O 121.671 0.748 . . . . 0.0 111.744 -179.31 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 64.8 ttp85 -68.32 119.43 12.84 Favored 'General case' 0 N--CA 1.465 0.325 0 O-C-N 121.271 -0.893 . . . . 0.0 109.978 178.66 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -86.54 122.17 71.95 Favored Pre-proline 0 C--N 1.323 -0.569 0 N-CA-C 105.103 -2.184 . . . . 0.0 105.103 176.571 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -72.78 -15.43 26.79 Favored 'Trans proline' 0 C--O 1.218 -0.494 0 C-N-CA 116.907 -1.595 . . . . 0.0 114.374 -177.174 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -81.57 -24.56 36.43 Favored 'General case' 0 C--O 1.221 -0.422 0 CA-C-O 120.963 0.411 . . . . 0.0 110.479 178.745 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 -100.15 -22.98 14.97 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 -174.504 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 15.5 t30 -145.72 148.69 33.28 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -178.314 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -86.37 148.44 25.58 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-O 121.654 0.74 . . . . 0.0 112.536 -179.776 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -73.74 151.02 40.79 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.635 178.132 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 14.2 mt -90.73 139.62 17.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.565 -178.738 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 73.1 t -62.83 121.82 12.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 174.588 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 5.2 tt -67.18 129.45 39.95 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.189 0.519 . . . . 0.0 111.088 -176.923 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 34.5 mt-30 -135.88 158.41 44.47 Favored 'General case' 0 C--O 1.218 -0.562 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 -179.226 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 13.4 mt -112.18 148.0 38.16 Favored Pre-proline 0 C--N 1.322 -0.598 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 177.577 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -73.59 163.02 38.52 Favored 'Trans proline' 0 C--O 1.237 0.457 0 O-C-N 122.195 0.576 . . . . 0.0 112.546 179.179 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 53.9 tt0 -55.24 132.0 46.74 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 179.508 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 106.57 -27.06 17.9 Favored Glycine 0 C--O 1.226 -0.37 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.983 -178.515 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 8.9 m -105.44 129.33 53.77 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 118.04 0.92 . . . . 0.0 111.198 178.395 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 3.0 p -115.65 148.21 39.94 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.15 178.44 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 86.2 mt -71.4 152.94 94.09 Favored Pre-proline 0 C--N 1.323 -0.587 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 177.647 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -76.53 175.02 11.89 Favored 'Trans proline' 0 CA--C 1.531 0.325 0 N-CA-C 110.615 -0.571 . . . . 0.0 110.615 178.529 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 12.0 tmtt? -53.49 128.65 29.66 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 -175.571 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 88.43 -3.54 85.29 Favored Glycine 0 C--O 1.23 -0.151 0 N-CA-C 116.74 1.456 . . . . 0.0 116.74 173.497 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.461 ' CZ ' ' HB2' ' A' ' 18' ' ' GLN . 1.8 m-85 -93.18 144.09 25.62 Favored 'General case' 0 N--CA 1.433 -1.316 0 CA-C-O 122.718 1.247 . . . . 0.0 112.072 -178.464 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 34.6 p90 -144.52 164.47 30.79 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-N 112.636 -2.074 . . . . 0.0 106.773 174.193 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -106.35 147.06 29.65 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.243 0.545 . . . . 0.0 110.736 -177.381 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -75.8 129.91 37.77 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 -179.59 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 87.63 -0.32 84.78 Favored Glycine 0 C--O 1.225 -0.464 0 C-N-CA 121.161 -0.542 . . . . 0.0 112.55 -178.093 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 24.9 t -117.77 145.61 44.38 Favored 'General case' 0 C--N 1.327 -0.386 0 O-C-N 122.433 -0.451 . . . . 0.0 110.106 178.491 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 9.9 tpt180 52.15 36.17 18.46 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 113.478 0.918 . . . . 0.0 113.478 178.639 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -155.66 166.81 32.96 Favored Glycine 0 N--CA 1.449 -0.483 0 N-CA-C 104.56 -3.416 . . . . 0.0 104.56 177.699 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 82.54 -156.46 35.12 Favored Glycine 0 CA--C 1.517 0.189 0 N-CA-C 109.022 -1.631 . . . . 0.0 109.022 -176.918 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 41.2 t . . . . . 0 C--O 1.251 1.139 0 N-CA-C 105.394 -2.076 . . . . 0.0 105.394 179.509 . . . . . . . . 0 0 . 1 . 039 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.664 0 CA-C-O 118.658 -1.079 . . . . 0.0 111.231 . . . . . . . . . 0 0 . 1 . 039 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -70.28 141.0 52.45 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 117.992 0.896 . . . . 0.0 109.58 179.888 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 21.5 ptp -165.91 33.55 0.05 Allowed 'General case' 0 N--CA 1.474 0.768 0 CA-C-O 121.866 0.841 . . . . 0.0 109.024 -179.258 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -106.29 80.2 0.28 Allowed Glycine 0 N--CA 1.449 -0.459 0 N-CA-C 111.007 -0.837 . . . . 0.0 111.007 -174.651 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 94.0 mt -59.09 140.35 87.31 Favored Pre-proline 0 C--N 1.322 -0.621 0 N-CA-C 106.88 -1.526 . . . . 0.0 106.88 176.13 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -74.28 -21.79 17.22 Favored 'Trans proline' 0 C--N 1.345 0.379 0 N-CA-C 116.079 1.53 . . . . 0.0 116.079 -172.488 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -168.74 -55.34 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.305 0.574 . . . . 0.0 110.707 -178.397 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 11.0 t30 -144.74 -69.04 0.3 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.421 -177.392 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.2 p 41.65 77.15 0.06 Allowed 'General case' 0 N--CA 1.477 0.917 0 CA-C-O 122.006 0.908 . . . . 0.0 112.996 -178.133 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -103.67 143.7 32.42 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.17 -0.923 . . . . 0.0 113.379 -173.138 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 28.4 t -58.88 134.97 57.39 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 114.548 -1.205 . . . . 0.0 108.63 174.591 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 3.1 m95 -67.55 -26.87 66.52 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 178.058 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -121.73 161.34 22.75 Favored 'General case' 0 CA--C 1.507 -0.676 0 CA-C-O 121.192 0.52 . . . . 0.0 110.312 -171.375 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 64.8 p -67.33 161.26 25.46 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 122.195 0.997 . . . . 0.0 109.561 179.622 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -92.14 120.71 33.0 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 114.686 -1.143 . . . . 0.0 112.474 -174.156 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -68.59 148.81 49.96 Favored 'General case' 0 CA--C 1.505 -0.768 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 179.96 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.487 HG23 HH22 ' A' ' 53' ' ' ARG . 17.4 m -93.26 136.62 33.35 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 176.947 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 20.0 tm0? -107.28 117.5 34.24 Favored 'General case' 0 CA--C 1.509 -0.621 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 177.144 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 22.7 t-160 -139.32 99.88 3.85 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 172.728 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 173.53 -166.12 38.33 Favored Glycine 0 C--N 1.319 -0.407 0 N-CA-C 110.521 -1.032 . . . . 0.0 110.521 -178.977 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 89.0 mttt -92.53 -24.8 18.64 Favored 'General case' 0 CA--C 1.512 -0.516 0 CA-C-O 121.993 0.901 . . . . 0.0 109.635 179.449 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -90.6 152.11 21.02 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 114.175 -1.375 . . . . 0.0 108.384 179.311 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -87.57 -62.4 1.51 Allowed 'General case' 0 C--O 1.21 -0.977 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.062 -177.421 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 49.6 tp 172.34 141.71 0.03 OUTLIER 'General case' 0 CA--C 1.506 -0.75 0 N-CA-C 104.572 -2.381 . . . . 0.0 104.572 176.824 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 23.3 tptt -161.94 143.38 10.99 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 106.606 -1.627 . . . . 0.0 106.606 178.185 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 16.6 m-85 -132.62 150.0 74.6 Favored Pre-proline 0 C--N 1.323 -0.558 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 177.398 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -76.56 166.87 26.56 Favored 'Trans proline' 0 C--N 1.351 0.702 0 C-N-CA 120.159 0.573 . . . . 0.0 113.402 179.593 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 21.3 tpt180 -64.14 136.11 56.95 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.587 -178.647 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 86.32 -1.91 87.48 Favored Glycine 0 N--CA 1.46 0.24 0 CA-C-O 121.395 0.442 . . . . 0.0 112.145 177.751 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -138.67 170.52 15.86 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 123.408 0.683 . . . . 0.0 110.433 -174.144 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 107.06 -26.82 17.88 Favored Glycine 0 CA--C 1.496 -1.103 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.67 175.249 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 85.1 t -65.27 125.49 89.51 Favored Pre-proline 0 C--N 1.32 -0.699 0 N-CA-C 105.498 -2.038 . . . . 0.0 105.498 176.372 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -71.6 164.52 35.44 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 N-CA-C 110.579 -0.585 . . . . 0.0 110.579 178.422 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 84.8 mt -61.99 115.0 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 -177.237 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -116.98 74.84 0.93 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 122.667 1.223 . . . . 0.0 112.307 -170.377 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 72.7 p -69.73 -19.51 63.54 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 114.371 -1.286 . . . . 0.0 113.506 -175.53 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 52.9 m-80 -106.38 29.04 7.19 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.644 -0.707 . . . . 0.0 112.165 -174.195 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 97.8 p -146.46 160.73 41.72 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.919 0.39 . . . . 0.0 111.032 179.786 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.3 m -71.67 163.83 63.14 Favored Pre-proline 0 C--N 1.323 -0.546 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.67 -178.313 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -67.34 -28.39 39.56 Favored 'Trans proline' 0 C--N 1.351 0.658 0 C-N-CA 115.167 -2.755 . . . . 0.0 113.669 179.041 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.448 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 1.6 p-10 -75.13 -19.84 59.71 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 121.525 -0.734 . . . . 0.0 110.518 176.714 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.416 ' CG ' HD11 ' A' ' 106' ' ' ILE . 34.6 m-20 -84.45 -6.9 59.42 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 113.955 1.094 . . . . 0.0 113.955 -173.335 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 97.6 mm-40 -57.54 -32.53 67.17 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 114.144 1.165 . . . . 0.0 114.144 -179.113 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.488 ' HB ' ' HB1' ' A' ' 98' ' ' ALA . 10.4 tt -58.43 139.24 18.38 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 CA-C-O 122.382 1.087 . . . . 0.0 113.49 -176.904 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -176.26 -159.65 22.26 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.277 -0.964 . . . . 0.0 112.899 -178.166 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 38.3 p90 -154.82 166.6 32.97 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 179.511 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 13.3 m-85 -109.27 142.9 39.46 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 174.472 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 62.9 ttt180 -116.15 125.45 52.34 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 123.182 0.593 . . . . 0.0 111.044 -176.89 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 47.8 ttp180 -74.06 134.19 42.95 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 109.592 -0.522 . . . . 0.0 109.592 177.329 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -152.0 170.0 20.95 Favored 'General case' 0 C--O 1.213 -0.846 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 -179.072 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 8.9 t -136.82 142.41 42.89 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 119.161 0.891 . . . . 0.0 110.574 172.106 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 14.7 tpt180 -166.79 128.66 1.73 Allowed 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 179.226 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.487 HH22 HG23 ' A' ' 17' ' ' THR . 21.9 mmt180 -147.63 -179.42 6.86 Favored 'General case' 0 CA--C 1.48 -1.72 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 -179.01 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -117.25 170.92 6.19 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.97 0 CA-C-N 113.686 -1.597 . . . . 0.0 107.043 -177.105 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 8.7 ttm-85 -143.44 129.69 19.83 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 175.886 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -82.01 178.99 53.45 Favored Glycine 0 C--O 1.221 -0.703 0 N-CA-C 109.882 -1.287 . . . . 0.0 109.882 178.583 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -67.59 -36.34 87.89 Favored Glycine 0 C--O 1.217 -0.951 0 C-N-CA 121.008 -0.615 . . . . 0.0 114.116 -176.425 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -80.3 -16.59 54.28 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 122.143 0.973 . . . . 0.0 109.054 178.787 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 114.37 -6.37 23.03 Favored Glycine 0 N--CA 1.452 -0.293 0 CA-C-N 114.496 -1.229 . . . . 0.0 114.584 179.587 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.429 ' H ' ' HD2' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -61.33 150.47 34.91 Favored 'General case' 0 CA--C 1.506 -0.725 0 CA-C-N 118.334 1.067 . . . . 0.0 111.242 -178.404 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 89.7 mtp -126.88 164.2 21.94 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 113.978 -1.464 . . . . 0.0 112.249 -176.647 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 2.0 tppt? -77.87 -37.43 48.2 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.298 -179.031 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 60.2 t0 -175.53 167.1 3.27 Favored 'General case' 0 C--N 1.318 -0.778 1 N-CA-C 99.283 -4.34 . . . . 0.0 99.283 -177.242 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -109.95 -31.83 7.25 Favored 'General case' 0 N--CA 1.435 -1.205 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 176.72 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.5 m -55.91 156.55 9.64 Favored Pre-proline 0 C--O 1.245 0.853 0 N-CA-C 116.342 1.979 . . . . 0.0 116.342 -174.949 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -75.62 -176.68 3.1 Favored 'Trans proline' 0 C--N 1.354 0.822 0 C-N-CA 121.039 1.16 . . . . 0.0 114.276 -179.275 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 81.0 mtt-85 -133.75 166.36 22.83 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.488 -177.836 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 50.9 m95 -125.39 131.72 52.9 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 173.751 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 24.1 m-85 -110.55 166.86 10.66 Favored 'General case' 0 C--O 1.216 -0.683 0 N-CA-C 105.45 -2.055 . . . . 0.0 105.45 -177.595 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 93.4 t80 -117.92 134.91 54.49 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-N 119.287 0.948 . . . . 0.0 109.721 -178.949 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 16.7 m-85 -136.36 158.88 43.38 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 -177.316 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 63.3 m-85 -98.63 159.34 15.02 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 -174.794 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -53.83 127.71 27.06 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.986 0.422 . . . . 0.0 111.039 -178.167 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 68.17 31.78 75.29 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.439 -0.886 . . . . 0.0 114.84 176.76 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.478 HG22 ' HA ' ' A' ' 104' ' ' ASP . 2.3 p -89.39 146.28 24.77 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 105.181 -2.155 . . . . 0.0 105.181 174.16 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 83.96 130.87 1.93 Allowed Glycine 0 CA--C 1.532 1.145 0 C-N-CA 121.462 -0.399 . . . . 0.0 112.294 -178.316 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -75.42 -27.88 8.98 Favored 'Trans proline' 0 CA--C 1.512 -0.613 0 CA-C-N 119.182 1.491 . . . . 0.0 115.317 -177.33 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -97.02 5.83 49.71 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 113.592 -1.64 . . . . 0.0 108.08 -174.88 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -60.6 -42.6 97.08 Favored 'General case' 0 N--CA 1.436 -1.125 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.976 -172.866 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 56.68 37.47 76.79 Favored Glycine 0 C--N 1.331 0.275 0 CA-C-N 115.67 -0.695 . . . . 0.0 112.241 179.165 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 13.2 mt -129.06 103.87 18.42 Favored Pre-proline 0 N--CA 1.44 -0.972 0 N-CA-C 115.039 1.496 . . . . 0.0 115.039 -176.073 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -78.4 161.61 28.45 Favored 'Trans proline' 0 N--CA 1.461 -0.424 0 C-N-CA 122.226 1.951 . . . . 0.0 107.304 167.772 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 57.7 t80 -61.11 130.66 47.44 Favored 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 120.315 -0.554 . . . . 0.0 110.44 -177.576 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 93.27 -8.51 75.32 Favored Glycine 0 CA--C 1.52 0.351 0 CA-C-O 119.35 -0.694 . . . . 0.0 114.352 178.956 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -67.12 131.73 46.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 118.607 1.203 . . . . 0.0 111.247 179.754 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 57.0 t30 -78.93 132.13 36.62 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.734 -0.667 . . . . 0.0 110.167 179.895 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 29.0 ttmt -155.97 154.38 31.02 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 106.146 -1.798 . . . . 0.0 106.146 179.28 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -61.4 129.32 40.64 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.081 0.467 . . . . 0.0 111.136 -178.648 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 67.86 30.08 74.11 Favored Glycine 0 N--CA 1.449 -0.474 0 CA-C-O 119.175 -0.792 . . . . 0.0 114.185 177.624 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 43.3 mm -126.04 131.86 71.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 117.845 0.822 . . . . 0.0 111.286 179.632 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -134.93 122.64 38.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.776 175.636 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 95.8 m95 -87.18 137.97 31.89 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 113.167 0.803 . . . . 0.0 113.167 -176.913 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 17.7 m -137.48 150.67 25.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.607 179.326 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -160.39 166.03 30.06 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 105.03 -2.211 . . . . 0.0 105.03 179.907 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 7.1 t -134.41 176.63 8.43 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 105.305 -2.109 . . . . 0.0 105.305 177.849 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -67.56 135.24 52.64 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.302 0.572 . . . . 0.0 110.702 -178.473 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 96.57 -12.7 66.1 Favored Glycine 0 C--O 1.228 -0.269 0 CA-C-N 115.703 -0.68 . . . . 0.0 112.911 178.341 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.488 ' HB1' ' HB ' ' A' ' 44' ' ' ILE . . . -77.16 137.09 38.67 Favored 'General case' 0 CA--C 1.543 0.676 0 O-C-N 122.694 -0.297 . . . . 0.0 110.622 179.982 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 40.6 mt -98.78 138.55 35.76 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 -177.884 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -80.11 63.8 4.73 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.165 -179.023 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 1.4 t -132.27 154.96 81.8 Favored Pre-proline 0 C--N 1.323 -0.581 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 -179.399 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -66.52 148.23 83.38 Favored 'Trans proline' 0 CA--C 1.53 0.319 0 N-CA-C 114.48 0.915 . . . . 0.0 114.48 175.974 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -148.83 57.9 1.04 Allowed 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 113.571 0.952 . . . . 0.0 113.571 179.212 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . 0.478 ' HA ' HG22 ' A' ' 75' ' ' THR . 12.5 t0 -64.56 -11.34 33.51 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 121.28 0.562 . . . . 0.0 110.658 175.782 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 12.5 p-80 -62.45 -13.42 29.88 Favored 'General case' 0 N--CA 1.468 0.473 0 O-C-N 122.038 -0.414 . . . . 0.0 111.679 177.412 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.416 HD11 ' CG ' ' A' ' 42' ' ' ASP . 20.6 mt -96.09 -28.75 3.91 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 CA-C-O 120.819 0.342 . . . . 0.0 111.023 179.079 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -73.46 3.74 31.05 Favored Glycine 0 N--CA 1.462 0.387 0 N-CA-C 115.09 0.796 . . . . 0.0 115.09 -176.117 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 14.4 t -83.22 19.03 1.56 Allowed 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 113.515 0.931 . . . . 0.0 113.515 -177.694 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 67.1 ttp85 -64.39 114.95 4.63 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 177.664 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 58.8 m-20 -91.12 121.36 67.93 Favored Pre-proline 0 C--N 1.318 -0.78 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 -178.596 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -68.93 -18.74 40.85 Favored 'Trans proline' 0 C--N 1.347 0.493 0 N-CA-C 114.343 0.863 . . . . 0.0 114.343 -176.176 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -73.77 -26.01 60.43 Favored 'General case' 0 C--O 1.22 -0.469 0 CA-C-O 120.734 0.302 . . . . 0.0 110.548 177.365 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 76.5 m-20 -103.49 -27.1 12.58 Favored 'General case' 0 C--O 1.222 -0.361 0 N-CA-C 113.421 0.897 . . . . 0.0 113.421 -174.95 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 19.0 t30 -147.35 145.04 29.17 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.818 0.673 . . . . 0.0 112.818 -178.751 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -83.19 146.16 28.76 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-O 121.517 0.675 . . . . 0.0 111.911 -179.79 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -70.38 144.13 51.69 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 177.325 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 12.0 mt -76.9 135.63 26.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 -178.406 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 72.9 t -63.75 118.33 5.8 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 N-CA-C 103.633 -2.729 . . . . 0.0 103.633 172.859 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 6.8 tt -63.18 130.99 46.96 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.38 0.609 . . . . 0.0 112.072 -174.061 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 30.8 mt-30 -130.58 150.46 51.77 Favored 'General case' 0 CA--C 1.508 -0.671 0 N-CA-C 106.084 -1.821 . . . . 0.0 106.084 179.089 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 12.5 mt -110.37 148.3 38.13 Favored Pre-proline 0 C--N 1.319 -0.76 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 177.773 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -73.71 166.07 30.69 Favored 'Trans proline' 0 C--O 1.236 0.416 0 C-N-CA 118.239 -0.707 . . . . 0.0 112.659 -179.605 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 40.5 tt0 -54.04 131.88 41.52 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.073 179.425 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 104.1 -27.35 19.77 Favored Glycine 0 C--O 1.226 -0.356 0 CA-C-N 115.91 -0.587 . . . . 0.0 112.288 -178.598 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 2.7 m -105.98 129.34 54.12 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 118.207 1.004 . . . . 0.0 112.205 178.759 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 9.4 p -119.8 148.24 43.68 Favored 'General case' 0 CA--C 1.509 -0.607 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.899 178.423 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 93.1 mt -68.07 154.31 94.06 Favored Pre-proline 0 C--N 1.323 -0.571 0 N-CA-C 106.935 -1.506 . . . . 0.0 106.935 177.2 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -76.77 177.6 8.65 Favored 'Trans proline' 0 N--CA 1.464 -0.214 0 CA-C-O 121.446 0.519 . . . . 0.0 112.442 -178.795 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 3.0 ttpm? -59.77 130.65 47.85 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.118 -0.492 . . . . 0.0 109.701 179.072 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 84.26 23.21 52.36 Favored Glycine 0 N--CA 1.454 -0.138 0 N-CA-C 115.44 0.936 . . . . 0.0 115.44 176.876 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -124.73 141.72 51.91 Favored 'General case' 0 CA--C 1.51 -0.568 0 CA-C-O 121.426 0.631 . . . . 0.0 112.152 179.382 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 45.4 p90 -145.6 153.21 40.81 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 107.259 -1.386 . . . . 0.0 107.259 172.584 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -89.18 139.21 30.71 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.186 0.517 . . . . 0.0 111.025 -177.577 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -71.38 137.87 48.72 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 176.325 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 89.34 -2.34 83.15 Favored Glycine 0 C--O 1.224 -0.53 0 N-CA-C 111.653 -0.579 . . . . 0.0 111.653 -178.215 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 9.6 t -114.25 171.89 7.34 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 177.46 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 7.8 tpt180 51.69 58.0 5.95 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 121.993 0.901 . . . . 0.0 112.871 -178.395 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -89.98 -147.06 16.34 Favored Glycine 0 N--CA 1.452 -0.245 0 N-CA-C 108.51 -1.836 . . . . 0.0 108.51 175.731 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -101.57 155.16 18.93 Favored Glycine 0 N--CA 1.453 -0.214 0 N-CA-C 107.34 -2.304 . . . . 0.0 107.34 176.71 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 11.3 t . . . . . 0 C--O 1.252 1.208 0 CA-C-O 117.146 -1.407 . . . . 0.0 110.419 -177.477 . . . . . . . . 0 0 . 1 . 040 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.224 0 CA-C-O 119.128 -0.818 . . . . 0.0 111.379 . . . . . . . . . 0 0 . 1 . 040 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 51.93 42.43 30.2 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 117.51 0.655 . . . . 0.0 112.762 178.866 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 33.2 tpp -78.29 55.95 1.63 Allowed 'General case' 0 CA--C 1.544 0.715 0 CA-C-O 122.034 0.921 . . . . 0.0 112.423 -178.274 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -95.49 -22.32 22.04 Favored Glycine 0 C--O 1.229 -0.167 0 N-CA-C 109.322 -1.511 . . . . 0.0 109.322 176.363 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -72.9 153.4 91.07 Favored Pre-proline 0 C--N 1.322 -0.608 0 CA-C-N 114.224 -0.988 . . . . 0.0 108.823 179.935 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -69.08 145.07 59.9 Favored 'Trans proline' 0 C--N 1.345 0.395 0 C-N-CA 115.966 -2.223 . . . . 0.0 110.884 176.786 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 26.0 p30 -86.44 -13.27 46.7 Favored 'General case' 0 C--O 1.218 -0.553 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -178.323 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 36.4 t30 60.28 42.99 14.24 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.193 0.997 . . . . 0.0 112.538 178.957 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 58.6 p -137.68 152.89 49.76 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 102.718 -3.068 . . . . 0.0 102.718 179.991 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -148.78 142.82 25.89 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.476 177.227 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 46.6 t -64.01 141.83 58.63 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 177.973 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 17.8 m95 -68.44 -21.72 64.63 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 111.944 0.35 . . . . 0.0 111.944 178.284 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 64.8 m-85 -121.53 164.38 17.32 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 -172.366 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 73.8 p -70.01 161.53 29.9 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 178.97 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.452 ' HB2' ' CZ ' ' A' ' 69' ' ' TYR . . . -76.22 149.74 37.18 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 113.743 1.016 . . . . 0.0 113.743 -175.425 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 13.9 mt -91.99 148.87 21.87 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 103.818 -2.66 . . . . 0.0 103.818 170.425 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 19.6 m -122.33 137.63 54.79 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 -179.186 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.435 ' HB2' ' CZ ' ' A' ' 131' ' ' PHE . 4.4 tp60 -112.05 133.11 54.41 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 -177.669 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 8.7 t60 -126.9 99.43 5.73 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 105.178 -2.156 . . . . 0.0 105.178 171.18 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 175.25 -172.77 45.78 Favored Glycine 0 C--O 1.227 -0.286 0 N-CA-C 110.212 -1.155 . . . . 0.0 110.212 -177.626 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -99.21 -27.29 13.87 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 121.048 0.451 . . . . 0.0 111.27 179.496 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -80.93 166.7 20.62 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 107.038 -1.467 . . . . 0.0 107.038 177.06 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -94.48 -62.78 1.27 Allowed 'General case' 0 CA--C 1.548 0.888 0 CA-C-O 118.443 -0.789 . . . . 0.0 112.156 -176.662 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.426 HD13 ' CZ ' ' A' ' 131' ' ' PHE . 33.7 tp -175.08 140.95 0.54 Allowed 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 124.044 0.938 . . . . 0.0 109.413 172.821 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 50.2 tptt -151.77 138.85 19.14 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 172.67 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -122.25 153.71 61.78 Favored Pre-proline 0 C--O 1.242 0.671 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 176.533 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -70.33 158.15 57.1 Favored 'Trans proline' 0 C--N 1.353 0.795 0 O-C-N 122.079 0.515 . . . . 0.0 112.727 179.458 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 70.9 ttt180 -70.16 134.36 48.05 Favored 'General case' 0 C--O 1.216 -0.688 0 O-C-N 121.848 -0.533 . . . . 0.0 111.072 -177.725 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 90.13 1.16 76.25 Favored Glycine 0 N--CA 1.462 0.409 0 CA-C-O 121.649 0.583 . . . . 0.0 112.035 179.262 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -146.77 170.45 16.97 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 107.497 -1.298 . . . . 0.0 107.497 -176.941 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 127.09 -28.39 4.6 Favored Glycine 0 CA--C 1.483 -1.948 0 N-CA-C 108.46 -1.856 . . . . 0.0 108.46 165.79 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 32.8 m -67.72 140.69 94.45 Favored Pre-proline 0 N--CA 1.429 -1.477 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 177.462 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -74.37 173.93 13.39 Favored 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 121.226 1.284 . . . . 0.0 111.91 178.918 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 92.7 mt -73.72 115.03 14.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 N-CA-C 107.494 -1.298 . . . . 0.0 107.494 177.823 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 31.6 m-20 -111.79 80.33 1.31 Allowed 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.423 -177.791 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 81.2 p -67.76 -16.2 64.01 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 113.835 1.05 . . . . 0.0 113.835 -176.877 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -106.83 21.31 17.72 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.375 -177.15 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 5.3 m -134.97 157.79 45.99 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.78 0.324 . . . . 0.0 111.483 -176.47 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 20.0 m -72.85 161.36 79.74 Favored Pre-proline 0 C--N 1.323 -0.549 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 178.615 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -65.19 -26.62 56.96 Favored 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 114.93 -2.913 . . . . 0.0 110.49 176.021 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -61.75 -19.32 62.32 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 124.578 1.151 . . . . 0.0 111.652 175.713 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -107.92 1.0 22.34 Favored 'General case' 0 C--O 1.217 -0.618 0 N-CA-C 115.027 1.491 . . . . 0.0 115.027 -172.617 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 85.7 mm-40 -61.45 -27.57 68.66 Favored 'General case' 0 C--O 1.216 -0.694 0 O-C-N 121.045 -1.034 . . . . 0.0 111.068 178.995 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 13.0 tt -60.35 144.05 13.65 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 N-CA-C 113.797 1.036 . . . . 0.0 113.797 179.209 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 178.85 -152.57 11.41 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.527 -0.844 . . . . 0.0 111.21 178.543 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 47.1 p90 -155.08 168.88 25.54 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 177.22 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 25.4 m-85 -113.34 141.07 47.48 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 106.648 -1.612 . . . . 0.0 106.648 174.071 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 38.6 ttt180 -111.05 127.6 55.6 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.37 -178.695 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 28.4 ttm180 -68.04 134.54 50.81 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 106.353 -1.721 . . . . 0.0 106.353 176.602 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -139.57 127.89 22.7 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 -176.734 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 6.8 p -139.62 131.95 28.37 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 174.773 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 11.2 tpt180 -160.73 123.83 3.34 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 178.621 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 2.5 tpp180 -97.17 137.42 36.23 Favored 'General case' 0 CA--C 1.501 -0.935 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 179.801 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -124.87 171.44 13.73 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 -179.201 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 8.1 tmm_? -134.66 114.03 12.32 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 106.324 -1.732 . . . . 0.0 106.324 177.745 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -74.5 165.07 54.75 Favored Glycine 0 N--CA 1.449 -0.497 0 N-CA-C 110.733 -0.947 . . . . 0.0 110.733 179.489 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -75.3 -27.42 63.84 Favored Glycine 0 C--O 1.217 -0.954 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 -179.562 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -89.77 14.61 11.45 Favored 'General case' 0 C--O 1.219 -0.523 0 CA-C-O 122.256 1.027 . . . . 0.0 109.706 179.077 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 86.21 -12.81 59.39 Favored Glycine 0 C--O 1.227 -0.288 0 N-CA-C 115.897 1.119 . . . . 0.0 115.897 173.706 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -64.5 130.49 43.9 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.699 0.762 . . . . 0.0 111.614 -178.609 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 94.8 mmm -91.86 -170.65 2.62 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 114.527 -1.215 . . . . 0.0 110.399 -178.489 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 18.4 tptp -92.79 -53.95 3.96 Favored 'General case' 0 CA--C 1.515 -0.395 0 N-CA-C 114.085 1.142 . . . . 0.0 114.085 179.436 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 38.45 -140.78 0.04 OUTLIER 'General case' 0 C--O 1.245 0.861 0 O-C-N 125.135 1.522 . . . . 0.0 113.025 -175.571 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 61.29 170.8 0.11 Allowed 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.694 1.198 . . . . 0.0 113.999 -176.232 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -74.69 165.35 54.46 Favored Pre-proline 0 C--O 1.24 0.589 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.71 -179.655 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -66.18 152.16 81.84 Favored 'Trans proline' 0 C--N 1.355 0.87 0 C-N-CA 117.818 -0.988 . . . . 0.0 112.053 178.67 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 30.7 mtt180 -124.02 166.3 15.97 Favored 'General case' 0 CA--C 1.51 -0.57 0 N-CA-C 114.779 1.4 . . . . 0.0 114.779 -175.958 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 67.4 m95 -130.43 146.84 52.06 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 177.922 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.452 ' CZ ' ' HB2' ' A' ' 15' ' ' ALA . 25.5 m-85 -130.64 144.11 51.2 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 -178.799 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 77.4 t80 -89.91 136.42 33.05 Favored 'General case' 0 CA--C 1.512 -0.485 0 N-CA-C 109.001 -0.741 . . . . 0.0 109.001 -177.218 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -139.64 143.23 37.09 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 108.812 -0.811 . . . . 0.0 108.812 -176.333 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -74.23 159.43 32.51 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.67 -175.993 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.1 tt -55.89 129.54 40.0 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 -176.137 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 69.0 34.54 76.79 Favored Glycine 0 C--O 1.222 -0.649 0 N-CA-C 115.487 0.955 . . . . 0.0 115.487 175.498 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -89.11 145.99 25.1 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 118.28 1.04 . . . . 0.0 111.334 -179.989 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 105.2 142.25 11.19 Favored Glycine 0 CA--C 1.529 0.909 0 N-CA-C 111.046 -0.822 . . . . 0.0 111.046 -177.905 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -66.01 -44.07 8.08 Favored 'Trans proline' 0 C--N 1.35 0.64 0 N-CA-C 116.928 1.857 . . . . 0.0 116.928 -173.31 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 -109.2 27.29 9.68 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.674 0.749 . . . . 0.0 109.232 -178.846 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -58.88 -48.35 81.7 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.381 -176.685 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 57.48 32.23 64.26 Favored Glycine 0 C--O 1.225 -0.438 0 O-C-N 123.71 0.631 . . . . 0.0 112.012 -179.447 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 20.2 mt -111.57 103.88 55.53 Favored Pre-proline 0 N--CA 1.448 -0.551 0 N-CA-C 115.683 1.734 . . . . 0.0 115.683 -174.728 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -78.89 166.27 23.5 Favored 'Trans proline' 0 N--CA 1.46 -0.458 0 C-N-CA 121.826 1.684 . . . . 0.0 108.034 168.707 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 54.2 t80 -62.2 132.34 52.44 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 120.622 -0.431 . . . . 0.0 109.935 -179.96 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 92.06 -8.25 78.01 Favored Glycine 0 CA--C 1.52 0.358 0 N-CA-C 115.085 0.794 . . . . 0.0 115.085 178.794 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -64.35 131.48 47.38 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 118.321 1.06 . . . . 0.0 112.007 -179.963 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 33.4 t-20 -73.98 127.16 32.15 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.595 -178.517 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 26.4 ttmt -156.18 150.1 25.15 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 104.992 -2.225 . . . . 0.0 104.992 175.74 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -71.13 136.05 47.97 Favored 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 120.198 -0.601 . . . . 0.0 109.723 -177.376 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 73.58 21.09 79.81 Favored Glycine 0 N--CA 1.447 -0.59 0 CA-C-O 119.19 -0.783 . . . . 0.0 113.353 178.665 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 44.3 mm -124.87 121.83 62.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 117.542 0.671 . . . . 0.0 110.376 179.402 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -122.75 112.52 34.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 CA-C-O 121.862 0.839 . . . . 0.0 110.793 175.749 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 96.4 m95 -78.44 133.21 37.51 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.126 -178.814 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 1.7 m -140.81 149.73 20.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 -178.689 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -157.98 166.05 33.57 Favored 'General case' 0 CA--C 1.507 -0.696 0 N-CA-C 106.491 -1.67 . . . . 0.0 106.491 -178.404 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 5.9 t -132.44 171.5 13.68 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 105.94 -1.874 . . . . 0.0 105.94 174.897 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -67.65 138.86 56.67 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.258 0.551 . . . . 0.0 110.81 -178.142 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 96.46 -7.67 66.2 Favored Glycine 0 C--O 1.226 -0.386 0 CA-C-N 115.705 -0.68 . . . . 0.0 113.143 178.943 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -85.6 147.23 26.5 Favored 'General case' 0 CA--C 1.544 0.74 0 O-C-N 122.632 -0.334 . . . . 0.0 111.489 179.982 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 45.2 mt -92.02 139.7 30.38 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -178.274 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 60.8 t30 -90.45 66.61 6.43 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.057 0.456 . . . . 0.0 110.83 -179.463 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -141.31 155.88 67.62 Favored Pre-proline 0 C--N 1.323 -0.57 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 179.889 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -73.77 152.4 47.32 Favored 'Trans proline' 0 CA--C 1.535 0.565 0 N-CA-C 114.955 1.098 . . . . 0.0 114.955 178.313 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.54 57.96 1.12 Allowed 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 121.827 0.823 . . . . 0.0 111.125 179.171 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -57.9 -31.6 66.93 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.609 179.071 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 42.7 p-80 -63.12 -13.95 42.77 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 114.273 1.212 . . . . 0.0 114.273 -178.162 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 94.8 mt -87.92 -29.06 5.46 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 177.617 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -75.58 4.2 44.6 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 115.239 0.856 . . . . 0.0 115.239 -177.304 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 12.7 t -83.09 21.06 1.12 Allowed 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 -178.134 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.404 ' HD2' HD22 ' A' ' 114' ' ' ASN . 69.2 ttp85 -56.25 126.61 26.94 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 179.25 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -95.93 127.36 41.28 Favored Pre-proline 0 C--N 1.322 -0.619 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 -179.623 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -74.19 -15.14 23.04 Favored 'Trans proline' 0 C--O 1.219 -0.425 0 O-C-N 121.898 0.42 . . . . 0.0 112.717 -178.452 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -77.87 -25.34 48.57 Favored 'General case' 0 C--O 1.222 -0.394 0 CA-C-O 120.863 0.363 . . . . 0.0 110.239 178.188 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 -104.3 -25.63 12.79 Favored 'General case' 0 C--O 1.223 -0.341 0 N-CA-C 113.977 1.103 . . . . 0.0 113.977 -174.867 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.404 HD22 ' HD2' ' A' ' 109' ' ' ARG . 30.4 t30 -147.2 150.18 34.4 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 -177.26 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -92.49 147.1 23.16 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 121.238 0.542 . . . . 0.0 111.206 179.405 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -74.11 153.39 39.6 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.239 177.931 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 2.5 mt -96.76 142.13 14.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 -178.132 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 87.0 t -58.05 125.04 13.42 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 176.87 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 6.4 tt -68.75 128.01 35.11 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.085 -177.848 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 29.8 mt-30 -132.36 154.42 49.79 Favored 'General case' 0 CA--C 1.508 -0.635 0 N-CA-C 107.119 -1.437 . . . . 0.0 107.119 -178.942 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 12.6 mt -109.44 148.93 39.07 Favored Pre-proline 0 C--N 1.321 -0.651 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 176.955 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -70.9 160.89 47.93 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 118.057 -0.829 . . . . 0.0 112.21 179.767 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -55.37 136.12 49.61 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 -179.249 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 95.11 -16.78 60.62 Favored Glycine 0 C--O 1.226 -0.374 0 CA-C-N 116.005 -0.543 . . . . 0.0 112.81 -177.566 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 6.2 m -108.63 128.3 54.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 117.827 0.814 . . . . 0.0 109.834 178.003 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 8.2 p -120.48 148.37 43.92 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.848 -178.522 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 85.7 mt -72.37 153.41 92.08 Favored Pre-proline 0 C--N 1.324 -0.515 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 177.776 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -76.32 170.89 19.1 Favored 'Trans proline' 0 N--CA 1.462 -0.352 0 C-N-CA 118.334 -0.644 . . . . 0.0 110.711 178.513 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -60.82 130.88 48.66 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.569 -177.44 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 95.1 -2.48 65.96 Favored Glycine 0 CA--C 1.517 0.189 0 N-CA-C 114.774 0.67 . . . . 0.0 114.774 178.209 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.435 ' CZ ' ' HB2' ' A' ' 18' ' ' GLN . 2.6 m-85 -106.43 140.07 39.92 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-O 121.732 0.777 . . . . 0.0 111.973 -179.376 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 52.6 p90 -145.52 164.34 31.93 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 114.423 -1.262 . . . . 0.0 108.069 174.515 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -105.38 147.18 28.48 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 112.481 0.549 . . . . 0.0 112.481 -176.465 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -74.97 134.88 41.41 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 178.645 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 86.03 -0.74 87.71 Favored Glycine 0 C--O 1.227 -0.321 0 C-N-CA 121.094 -0.574 . . . . 0.0 112.717 -179.959 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 8.7 t -106.41 -179.52 3.96 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 178.03 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 1.5 mmm180 -146.14 150.12 35.3 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 106.236 -1.764 . . . . 0.0 106.236 -179.84 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 142.23 131.39 2.6 Favored Glycine 0 C--O 1.224 -0.504 0 N-CA-C 108.149 -1.98 . . . . 0.0 108.149 -177.979 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 86.06 -35.03 3.31 Favored Glycine 0 N--CA 1.462 0.396 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 -175.623 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 68.6 m . . . . . 0 C--O 1.243 0.738 0 N-CA-C 103.139 -2.912 . . . . 0.0 103.139 176.056 . . . . . . . . 0 0 . 1 stop_ save_